<SEC-DOCUMENT>0001213900-18-012108.txt : 20180905
<SEC-HEADER>0001213900-18-012108.hdr.sgml : 20180905
<ACCEPTANCE-DATETIME>20180905134826
ACCESSION NUMBER:		0001213900-18-012108
CONFORMED SUBMISSION TYPE:	F-1
PUBLIC DOCUMENT COUNT:		89
FILED AS OF DATE:		20180905
DATE AS OF CHANGE:		20180905

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Aptorum Group Ltd
		CENTRAL INDEX KEY:			0001734005
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			E9
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		F-1
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-227198
		FILM NUMBER:		181054755

	BUSINESS ADDRESS:	
		STREET 1:		17/F, GUANGDONG INVESTMENT TOWER
		STREET 2:		148 CONNAUGHT ROAD CENTRAL
		CITY:			HONG KONG
		STATE:			F4
		ZIP:			999077
		BUSINESS PHONE:		852 2117 6611

	MAIL ADDRESS:	
		STREET 1:		17/F, GUANGDONG INVESTMENT TOWER
		STREET 2:		148 CONNAUGHT ROAD CENTRAL
		CITY:			HONG KONG
		STATE:			F4
		ZIP:			999077
</SEC-HEADER>
<DOCUMENT>
<TYPE>F-1
<SEQUENCE>1
<FILENAME>ff12018_aptorumgroup.htm
<DESCRIPTION>REGISTRATION STATEMENT
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin-top: 0; text-align: center; margin-bottom: 0; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>As
filed with the Securities and Exchange Commission on September 5, 2018</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Registration
No. 333-[&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;]</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 0; margin-bottom: 0"><DIV STYLE="font-size: 1pt; border-top: Black 2pt solid; border-bottom: Black 1pt solid; width: 100%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>UNITED
STATES</B><BR>
<B>SECURITIES AND EXCHANGE COMMISSION</B><BR>
<B>Washington, D.C. 20549</B></FONT></P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 1pt; margin-bottom: 1pt; font-family: Times New Roman, Times, Serif"><DIV STYLE="font: 1pt Times New Roman, Times, Serif; border-top: black 1.5pt solid; width: 100%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>FORM
F-1</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>REGISTRATION
STATEMENT UNDER THE SECURITIES ACT OF 1933</B></FONT></P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 1pt; margin-bottom: 1pt; font-family: Times New Roman, Times, Serif"><DIV STYLE="font: 1pt Times New Roman, Times, Serif; border-top: black 1.5pt solid; width: 100%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>APTORUM
GROUP LIMITED</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><I>(Exact
Name of Registrant as Specified in its Charter)</I></FONT></P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 1pt; margin-bottom: 1pt; font-family: Times New Roman, Times, Serif"><DIV STYLE="font: 1pt Times New Roman, Times, Serif; border-top: black 1.5pt solid; width: 100%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="font-family: Times New Roman, Times, Serif">
    <TD STYLE="vertical-align: top; width: 32%; border-bottom: black 1.5pt solid; text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Cayman
    Islands</B></FONT></TD>
    <TD STYLE="width: 2%; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; width: 32%; border-bottom: black 1.5pt solid; text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>2834</B></FONT></TD>
    <TD STYLE="width: 2%; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; width: 32%; border-bottom: black 1.5pt solid; text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Not
    Applicable</B></FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif">
    <TD STYLE="vertical-align: top; text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>(State
    or Other Jurisdiction of</I></FONT><FONT STYLE="font-family: Times New Roman, Times, Serif"><BR>
    <FONT STYLE="font-size: 10pt"><I>Incorporation or Organization)</I></FONT></FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>(Primary
Standard Industrial</I></FONT><BR>
<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Classification Code Number)</I></FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><I>(I.R.S.
                                         Employer</I></FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><I>Identification
        No.)</I></FONT></P></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">17<SUP>th
</SUP>Floor, Guangdong Investment Tower</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">148
Connaught Road Central</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">Hong
Kong</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">Telephone:
+852 2117 6611</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><I>(Address,
including zip code, and telephone number, including area code, of Registrant&rsquo;s principal executive offices)</I></FONT></P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 1pt; margin-bottom: 1pt; font-family: Times New Roman, Times, Serif"><DIV STYLE="font: 1pt Times New Roman, Times, Serif; border-top: black 1.5pt solid; width: 100%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><I>Copies
to:</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 50%; padding-right: 5.4pt; padding-left: 5.4pt; font-family: Times New Roman, Times, Serif"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">Louis
                                         Taubman, Esq.</FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">Arila
        Er Zhou, Esq.<BR>
        Hunter Taubman Fischer &amp; Li LLC<BR>
        1450 Broadway, 26<SUP>th</SUP>&nbsp;Floor</FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">New
        York, NY 10018<BR>
        Tel: 917.512.0827<BR>
        Fax: 212.202.6380</FONT></P></TD>
    <TD STYLE="width: 50%; padding-right: 5.4pt; padding-left: 5.4pt; font-family: Times New Roman, Times, Serif"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">Elizabeth
                                         F. Chen, Esq.</FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">Stephen
        M. Goodman, Esq.</FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">Pryor
        Cashman LLP</FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">7
        Times Square</FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">New
        York, NY 10036</FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">Tel:
        212.421.4100</FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">Fax:
        212.326.0806</FONT></P></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Approximate
date of commencement of proposed sale to the public:</B> As soon as practicable after effectiveness of this registration statement.</FONT></P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 1pt; margin-bottom: 1pt; font-family: Times New Roman, Times, Serif"><DIV STYLE="font: 1pt Times New Roman, Times, Serif; border-top: black 1.5pt solid; width: 100%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">If
any of the securities being registered on this Form are to be offered on a delayed or continuous basis pursuant to Rule 415 under
the Securities Act of 1933, check the following box. &#9744;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">If
this Form is filed to register additional securities for an offering pursuant to Rule 462(b) under the Securities Act, check the
following box and list the Securities Act registration statement number of the earlier effective registration statement for the
same offering. &#9744;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">If
this Form is a post-effective amendment filed pursuant to Rule 462(c) under the Securities Act, check the following box and list
the Securities Act registration statement number of the earlier effective registration statement for the same offering. &#9744;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">If
this Form is a post-effective amendment filed pursuant to Rule 462(d) under the Securities Act, check the following box and list
the Securities Act registration statement number of the earlier effective registration statement for the same offering. &#9744;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Indicate
by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act or Rule 12b-2
of the Securities Exchange Act of 1934.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">Emerging
growth company &#9746;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">If
an emerging growth company that prepares its financial statements in accordance with U.S. GAAP, indicate by check mark if the
registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards
provided pursuant to Section 7(a)(2)(B) of the Securities Act.&nbsp;&#9;&#9744;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt"></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>CALCULATION
OF REGISTRATION FEE</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: bottom; font-family: Times New Roman, Times, Serif">
    <TD STYLE="border-bottom: black 1.5pt solid; padding-left: 10pt; text-indent: -10pt; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Title&nbsp;of&nbsp;Each
    Class&nbsp;of&nbsp;Securities&nbsp;to&nbsp;be&nbsp;Registered</B></FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: black 1.5pt solid; text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Amount&nbsp;to
    </B></FONT><FONT STYLE="font-family: Times New Roman, Times, Serif"><BR>
    <FONT STYLE="font-size: 10pt"><B>be </B></FONT><BR>
    <FONT STYLE="font-size: 10pt"><B>Registered</B></FONT></FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: black 1.5pt solid; text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Proposed
    </B></FONT><FONT STYLE="font-family: Times New Roman, Times, Serif"><BR>
    <FONT STYLE="font-size: 10pt"><B>Maximum </B></FONT><BR>
    <FONT STYLE="font-size: 10pt"><B>Aggregate Price&nbsp;Per Share</B></FONT></FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: black 1.5pt solid; font-family: Times New Roman, Times, Serif"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Proposed
                                         Maximum Aggregate Offering</B></FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Price<SUP>(1)</SUP></B></FONT></P></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: black 1.5pt solid; text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Amount&nbsp;of
    Registration Fee</B></FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: #CCEEFF; font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 52%; padding-left: 10pt; text-indent: -10pt; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Class
    A Ordinary Shares, par value $1.00 per share<SUP>(2)</SUP></FONT></TD>
    <TD STYLE="width: 1%; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 9%; text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[&nbsp;&nbsp;&nbsp;]</FONT></TD>
    <TD STYLE="width: 1%; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD>
    <TD STYLE="width: 9%; text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[&nbsp;&nbsp;&nbsp;]</FONT></TD>
    <TD STYLE="width: 1%; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD>
    <TD STYLE="width: 9%; text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[&nbsp;&nbsp;&nbsp;]</FONT></TD>
    <TD STYLE="width: 1%; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD>
    <TD STYLE="width: 9%; text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[&nbsp;&nbsp;&nbsp;]</FONT></TD>
    <TD STYLE="width: 1%; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: white; font-family: Times New Roman, Times, Serif">
    <TD STYLE="padding-left: 10pt; text-indent: -10pt; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Underwriters&rsquo;
    Warrants<SUP>(3)</SUP></FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[&nbsp;&nbsp;&nbsp;]</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD>
    <TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[&nbsp;&nbsp;&nbsp;]</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD>
    <TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[&nbsp;&nbsp;&nbsp;]</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD>
    <TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[&nbsp;&nbsp;&nbsp;]</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: #CCEEFF; font-family: Times New Roman, Times, Serif">
    <TD STYLE="padding-left: 10pt; text-indent: -10pt; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Class
    A Ordinary Shares underlying Underwriter&rsquo;s Warrants<SUP>(3)</SUP></FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[&nbsp;&nbsp;&nbsp;]</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD>
    <TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[&nbsp;&nbsp;&nbsp;]</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD>
    <TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[&nbsp;&nbsp;&nbsp;]</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD>
    <TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[&nbsp;&nbsp;&nbsp;]</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: white; font-family: Times New Roman, Times, Serif">
    <TD STYLE="padding-left: 10pt; text-indent: -10pt; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Class
    A Ordinary Shares underlying the Bond<SUP>(4)</SUP></FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[&nbsp;&nbsp;&nbsp;]</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD>
    <TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[&nbsp;&nbsp;&nbsp;]</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD>
    <TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[&nbsp;&nbsp;&nbsp;]</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD>
    <TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[&nbsp;&nbsp;&nbsp;]</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: #CCEEFF; font-family: Times New Roman, Times, Serif">
    <TD STYLE="padding-left: 10pt; text-indent: -10pt; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Class
    A Ordinary Shares underlying Placement Agent Warrants<SUP>(5)</SUP></FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[&nbsp;&nbsp;&nbsp;]</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD>
    <TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[&nbsp;&nbsp;&nbsp;]</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD>
    <TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[&nbsp;&nbsp;&nbsp;]</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD>
    <TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[&nbsp;&nbsp;&nbsp;]</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="background-color: white; font-family: Times New Roman, Times, Serif">
    <TD STYLE="vertical-align: bottom; padding-left: 10pt; text-indent: -10pt; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Class
    A Ordinary Shares underlying Series A Notes<SUP>(6)</SUP></FONT></TD>
    <TD STYLE="vertical-align: bottom; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[&nbsp;&nbsp;&nbsp;]</FONT></TD>
    <TD STYLE="vertical-align: bottom; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[&nbsp;&nbsp;&nbsp;]</FONT></TD>
    <TD STYLE="vertical-align: bottom; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[&nbsp;&nbsp;&nbsp;]</FONT></TD>
    <TD STYLE="vertical-align: bottom; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[&nbsp;&nbsp;&nbsp;]</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: #CCEEFF; font-family: Times New Roman, Times, Serif">
    <TD STYLE="padding-left: 10pt; text-indent: -10pt; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Class
    A Ordinary Shares underlying Placement Agent Warrants<SUP>(7)</SUP></FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[&nbsp;&nbsp;&nbsp;]</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD>
    <TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[&nbsp;&nbsp;&nbsp;]</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD>
    <TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[&nbsp;&nbsp;&nbsp;]</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD>
    <TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[&nbsp;&nbsp;&nbsp;]</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: white; font-family: Times New Roman, Times, Serif">
    <TD STYLE="padding-left: 10pt; text-indent: -10pt; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[&nbsp;&nbsp;&nbsp;]</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD>
    <TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[&nbsp;&nbsp;&nbsp;]</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD>
    <TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">35,000,000</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD>
    <TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4,357.50</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 24px; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    registration fee is based on an estimate of the Proposed Maximum Aggregate Offering Price of the securities, assuming the
    sale of the maximum number of shares at the highest expected offering price, and such estimate is solely for the purpose of
    calculating the registration fee pursuant to Rule 457(o).</FONT></TD></TR>
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
    accordance with Rule 416(a), the Registrant is also registering an indeterminate number of additional Class A Ordinary Shares
    that shall be issuable pursuant to Rule 416 to prevent dilution resulting from share splits, share dividends or similar transactions.
    </FONT></TD></TR>
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3)</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    Registrant will issue to <FONT STYLE="background-color: white">Boustead Securities, LLC (&ldquo;Boustead&rdquo;</FONT>), one
    of the lead underwriters in this Offering, warrants to purchase a number of Class A Ordinary Shares equal to a specified percentage
    of the Class A Ordinary Shares (the &ldquo;Underwriter Warrants&rdquo;) sold in this Offering sourced by the Company, depending
    on the final amount raised in this Offering. The closing date will be a date mutually acceptable to the Registrant and the
    Underwriters after the minimum offering has been sold. The exercise price of the Underwriter Warrants is equal to 100% of
    the offering price of the Class A Ordinary Shares offered hereby. Assuming a maximum placement and an exercise price of $[&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;]
    per share, we would receive, in the aggregate, $[&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;] upon exercise of the Underwriter Warrants,
    of which there can be no guarantee. The Class A Ordinary Shares underlying the Underwriter Warrants are exercisable upon closing
    of the offering and within a 2.5-year-period, at any time and from time to time, in whole or in part.</FONT></TD></TR>
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(4)</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Reflects
    the resale by a Selling Shareholder included herein of its Class A Ordinary Shares underlying a Bond at a conversion price
    of $[&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;] per share that the Registrant issued to such Selling Shareholder in connection with a
    Bond Offering it consummated on April 25, 2018.</FONT></TD></TR>
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(5)</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Representing
    the Class A Ordinary Shares underlying placement agent warrants at an exercise price of $[&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;]
    per share that the Registrant issued to Boustead, one of the placement agents in connection with the Bond Offering.</FONT></TD></TR>
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(6)</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Reflects
    the resale by Selling Shareholders included herein of their Class A Ordinary Shares underlying the Series A Notes issued to
    such Selling Shareholders in a private placement that closed in May 2018.</FONT></TD></TR>
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(7)</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Representing
    the Class A Ordinary Shares underlying placement agent warrants at an exercise price of $[&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;]
    per share issued to Boustead, the placement agent in connection with the private placement of the Series A Notes.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>The
Registrant hereby amends this registration statement on such date or dates as may be necessary to delay its effective date until
the registrant shall file a further amendment which specifically states that this registration statement shall thereafter become
effective in accordance with Section 8(a) of the Securities Act of 1933 or until the registration statement shall become effective
on such date as the Securities and Exchange Commission acting pursuant to said Section 8(a) may determine.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt"></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">The
information in this prospectus is not complete and may be changed. Neither we nor the Selling Shareholders may sell these securities
until the registration statement filed with the Securities and Exchange Commission is effective. This prospectus is not an offer
to sell these securities and is not soliciting an offer to buy these securities in any state where the offer or sale is not permitted.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>SUBJECT
TO COMPLETION </B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>DATED
SEPTEMBER 5, 2018</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>PRELIMINARY
PROSPECTUS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>APTORUM
GROUP LIMITED</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Minimum
Offering: $[&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ] Class A Ordinary Shares</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Maximum
Offering: $[ &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;] Class A Ordinary Shares</B></FONT></P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 1pt; margin-bottom: 1pt; font-family: Times New Roman, Times, Serif"><DIV STYLE="font: 1pt Times New Roman, Times, Serif; border-top: black 1.5pt solid; width: 100%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">This
is an initial public offering (the &ldquo;Offering&rdquo;) of securities of Aptorum Group Limited (&ldquo;Aptorum Group&rdquo;),
a Cayman Islands exempted company with limited liability whose principal place of business is in Hong Kong. We are offering on
a best efforts basis, a minimum of $[ ] and a maximum of $[ ] of our Class A Ordinary Shares, par value $1.00 per share (the &ldquo;Class
A Ordinary Shares&rdquo;). Prior to this Offering, there has been no public market for our Class A Ordinary Shares. We expect
the offering price of our Class A Ordinary Shares to be between $[ &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;] and $[&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
] per share. This <FONT STYLE="background-color: white">prospectus also includes the resale of up to [&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;]
Class A Ordinary Shares (the &ldquo;Resale Shares&rdquo;), including: (1) [&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;] Class A Ordinary
Shares underlying a bond we issued to one investor (See &ldquo;Prospectus Summary </FONT>&ndash; <FONT STYLE="background-color: white">Recent
Financings </FONT>&ndash; <FONT STYLE="background-color: white">The Bond Offering&rdquo;); (2) [&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;]
Class A Ordinary Shares underlying the placement agent warrants we issued to a placement agent in connection with the Bond Offering;
(3) [&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;] Class A Ordinary Shares underlying the Series A convertible note we issued in a private placement,
(See &ldquo;Prospectus Summary </FONT>&ndash; <FONT STYLE="background-color: white">Recent Financings </FONT>&ndash; <FONT STYLE="background-color: white">The
Series A Note Offering&rdquo;); and (4) [&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;] Class A Ordinary Shares underlying the placement agent
warrants we issued to a placement agent in connection with the Series A Note Offering. The selling shareholders named herein (the
&ldquo;Selling Shareholders&rdquo;) may sell Resale Shares </FONT><FONT STYLE="font-weight: normal">at a fixed price until the
Class A Ordinary Shares are listed on NASDAQ and thereafter, the Selling Shareholders will be able sell their Class A Ordinary
Shares at prevailing market prices or privately negotiated prices.</FONT> <FONT STYLE="background-color: white">We will not receive
any proceeds from the sales by the Selling Shareholders.</FONT></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">Our
authorized share capital is divided into Class A Ordinary Shares and Class B Ordinary Shares. As of the date of the prospectus,
we have 60,000,000 Class A Ordinary Shares, par value $1.00 each and 40,000,000 Class B Ordinary Shares, par value $1.00 each,
authorized, among which 5,426,381 Class A Ordinary Shares and 22,437,754 Class B Ordinary Shares are issued and outstanding, respectively.
Holders of Class A Ordinary Shares and Class B Ordinary Shares have the same rights except for voting and conversion rights. In
respect of matters requiring a shareholder vote, each Class A Ordinary Share will be entitled to one vote and each Class B Ordinary
Share will be entitled to ten votes. The Class A Ordinary Shares are not convertible into shares of any other class. The Class
B Ordinary Shares are convertible into Class A Ordinary Shares at any time after issuance at the option of the holder on a one
to one basis.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">We
plan to apply to list our Class A Ordinary Shares on the NASDAQ Global Market under the symbol &ldquo;[APM]&rdquo;.</FONT></P>





<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">We
are an &ldquo;emerging growth company,&rdquo; as defined in the U.S. Jumpstart Our Business Startups Act of 2012 (the &ldquo;JOBS
Act&rdquo;) and will be subject to reduced public company reporting requirements.</FONT></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Investing
in our Class A Ordinary Shares involves a high degree of risk. See &ldquo;Risk Factors&rdquo; beginning on page [13] of this prospectus
for a discussion of information that should be considered in connection with an investment in our Class A Ordinary Shares.</B></FONT></P>





<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Neither
the Securities and Exchange Commission nor any state securities commission has approved or disapproved of these securities or
determined if this prospectus is truthful or complete. Any representation to the contrary is a criminal offense.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: bottom; font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: black 1.5pt solid; text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Per
    Share</B></FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: black 1.5pt solid; text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Total</B></FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: #CCEEFF; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Initial
    public offering price</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD>
    <TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD>
    <TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: white; font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 78%; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Underwriting
    discounts and commissions<SUP>(1)</SUP></FONT></TD>
    <TD STYLE="width: 1%; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD>
    <TD STYLE="width: 8%; text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD>
    <TD STYLE="width: 8%; text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: #CCEEFF; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Proceeds
    to us (before expenses)</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD>
    <TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD>
    <TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: white; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Proceeds
    to the Selling Shareholders, before expenses<SUP>(2)</SUP></FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD>
    <TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD>
    <TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 24px; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">See
    &ldquo;Underwriting&rdquo; for a description of commission payable to the underwriters.</FONT></TD></TR>
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
    will not receive any proceeds from the Selling Shareholders&rsquo; sale of Class A Ordinary Shares. </FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">The
underwriters are selling our Class A Ordinary Shares in this Offering on a best efforts basis. The underwriters are not required
to sell any specific number or dollar amount of Class A Ordinary Shares but will use their best efforts to sell the Class A Ordinary
Shares offered. One of the conditions to our obligation to sell any securities through the underwriters is that, upon the closing
of the Offering, the Class A Ordinary Shares would qualify or reasonably expect to be qualified for listing on the NASDAQ Global
Market.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">The
underwriters expect to deliver the Class A Ordinary Shares to purchasers in the Offering on or about [ &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;],
2018.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 34pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">The
offering will terminate upon the earlier of: (i) a date mutually acceptable to us and our Underwriters after the minimum offering
is sold or (ii) [&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;], 2018. If the Underwriters do not sell at least [&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;]
Class A Ordinary Shares by [&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;], 2018, all funds will be returned within five business
days to subscribers without interest or deduction. If this Offering completes, then on the closing date, net proceeds will be
delivered to us and we will issue the Class A Ordinary Shares to purchasers. Until we sell at least [ ] Class A Ordinary Shares,
all investor funds will be held in an escrow account at [ ]. If we do not sell at least [ ] Class A Ordinary Shares by [ ], unless
mutually extended by the Company and the Underwriter, all funds will be promptly returned to investors (within five (5) business
days) without interest or deduction. One of the conditions to our obligation to sell any securities through the Underwriter is
that, upon the final closing of the offering, the Class A Ordinary Shares would qualify for listing on the NASDAQ Global Market.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">The
Selling Shareholders will offer their Class A Ordinary Shares through their brokerage firms and there is no termination date of
the Selling Shareholders&rsquo; offering. The Selling Shareholders may sell their Class A Ordinary Shares described in this prospectus
in a number of different ways and at varying prices.&nbsp;However, the Selling Shareholders will not be able to sell any of their
Class A Ordinary Shares on any trading market until the Company raises the minimum offering amount from the Company&rsquo;s offering
and the Company&rsquo;s Class A Ordinary Shares are approved for listing on NASDAQ Global Market, as further discussed herein.
Furthermore, <FONT STYLE="font-weight: normal">the Selling Shareholders will only be able to sell their Class A Ordinary Shares
at a fixed price until the Class A Ordinary Shares are listed on NASDAQ and thereafter, the Selling Shareholders will be able
sell their Class A Ordinary Shares at prevailing market prices or privately negotiated prices. </FONT></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 2in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 33%; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif"><IMG SRC="img_001.jpg" ALT="" STYLE="height: 29px; width: 235px"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></FONT></TD>
    <TD STYLE="width: 34%; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 33%; text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif"><IMG SRC="img_002.jpg" ALT=""><FONT STYLE="font-size: 10pt">&nbsp;</FONT></FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">The
date of this prospectus is </FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Page; Sequence: 4 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt"></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><A NAME="toc"></A>TABLE
OF CONTENTS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: bottom; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: black 1.5pt solid; text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Page</B></FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: #CCEEFF; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><A HREF="#w1"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Commonly Used Defined Terms</FONT></A></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif">iii</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: white; font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 91%; font-family: Times New Roman, Times, Serif"><A HREF="#w2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Prospectus Summary</FONT></A></TD>
    <TD STYLE="width: 1%; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 8%; text-align: center; font-family: Times New Roman, Times, Serif">1</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: #CCEEFF; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><A HREF="#w3"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Risk Factors</FONT></A></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif">13</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: white; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><A HREF="#w4"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Special Note Regarding Forward-Looking Statements</FONT></A></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif">50</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: #CCEEFF; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><A HREF="#w5"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Trademarks, Service Marks and Tradenames</FONT></A></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif">52</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: white; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><A HREF="#w6"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Use of Proceeds</FONT></A></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif">52</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: #CCEEFF; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><A HREF="#w7"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dividend Policy</FONT></A></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif">53</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: white; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><A HREF="#w8"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Capitalization</FONT></A></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif">54</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: #CCEEFF; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><A HREF="#w9"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dilution</FONT></A></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif">55</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: white; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><A HREF="#w10"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Selected Financial Data</FONT></A></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif">56</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: #CCEEFF; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><A HREF="#w11"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Management&rsquo;s Discussion and Analysis of Financial Condition and Results of Operations</FONT></A></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif">58</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: white; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><A HREF="#w12"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our Business</FONT></A></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif">66</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: #CCEEFF; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><A HREF="#w13"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Management</FONT></A></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif">102</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: white; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><A HREF="#w14"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Transactions with Related Persons</FONT></A></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif">111</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: #CCEEFF; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><A HREF="#w15"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Principal and Selling Shareholders</FONT></A></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif">115</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: white; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><A HREF="#w16"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Plan of Distribution</FONT></A></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif">120</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: #CCEEFF; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><A HREF="#w17"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Shares Eligible for Future Sale</FONT></A></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif">122</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: white; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><A HREF="#w18"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Description of Share Capital</FONT></A></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif">124</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: #CCEEFF; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><A HREF="#w19"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Taxation</FONT></A></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif">137</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: white; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><A HREF="#w20"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Underwriting</FONT></A></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif">142</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: #CCEEFF; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><A HREF="#w21"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Expenses of This Offering</FONT></A></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif">149</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: white; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><A HREF="#w22"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Legal Matters</FONT></A></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif">150</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: #CCEEFF; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><A HREF="#w23"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Experts</FONT></A></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif">150</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: white; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><A HREF="#w24"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Enforcement of Civil Liabilities</FONT></A></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif">150</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: #CCEEFF; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><A HREF="#w25"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Where You Can Find More Information</FONT></A></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif">151</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: white; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><A HREF="#w26"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Index to Financial Statements and Consolidated Financial Statements</FONT></A></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif">F-1</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<!-- Field: Page; Sequence: 5; Options: NewSection; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: LowerRoman; Name: PageNo -->i<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"><A HREF="#toc">Table of Contents</A></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>We
have not, and the underwriters have not, authorized any person to provide you with information different from that contained in
this prospectus or any related free-writing prospectus that we authorize to be distributed to you. This prospectus is not an offer
to sell, nor is it seeking an offer to buy, these securities in any jurisdiction where the offer or sale is not permitted. The
information in this prospectus speaks only as of the date of this prospectus unless the information specifically indicates that
another date applies, regardless of the time of delivery of this prospectus or of any sale of the securities offered hereby.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">For
investors outside of the United States: We have not, and the underwriters have not, done anything that would permit this Offering
or possession or distribution of this prospectus in any jurisdiction where action for that purpose is required, other than the
United States. Persons outside of the United States who come into possession of this prospectus must inform themselves about,
and observe any restrictions relating to, the offering of the Class A Ordinary Shares and the distribution of this prospectus
outside of the United States.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">This
prospectus includes statistical and other industry and market data that we obtained from industry publications and research, surveys
and studies conducted by third parties. Industry publications and third-party research, surveys and studies generally indicate
that their information has been obtained from sources believed to be reliable, although they do not guarantee the accuracy or
completeness of such information. While we believe these industry publications and third-party research, surveys and studies are
reliable, you are cautioned not to give undue weight to this information.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">All
references in this prospectus to &ldquo;$,&rdquo; &ldquo;U.S.$,&rdquo; &ldquo;U.S. dollars,&rdquo; &ldquo;dollars,&rdquo; &ldquo;US$,&rdquo;
and &ldquo;USD&rdquo; mean United States dollars unless otherwise noted. All references to the &ldquo;PRC&rdquo; or &ldquo;China&rdquo;
in this prospectus refer to the People&rsquo;s Republic of China. All references to &ldquo;Hong Kong&rdquo; or &ldquo;H.K.&rdquo;
in this prospectus refer to Hong Kong Special Administrative Region of the People&rsquo;s Republic of China. All references to
the &ldquo;United States,&rdquo; &ldquo;U.S.&rdquo; or &ldquo;US&rdquo; refer to the United States of America.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Page; Sequence: 6; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: LowerRoman; Name: PageNo -->ii<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"><A HREF="#toc">Table of Contents</A></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><A NAME="w1"></A>COMMONLY
USED DEFINED TERMS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 0.5in; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 0.25in; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;Acticule&rdquo;
    refers to Acticule Life Sciences Limited, an 80% owned subsidiary of Aptorum Group.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 0.5in; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 0.25in; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;Aeneas&rdquo;
    refers to AENEAS CAPITAL LIMITED, a wholly-owned subsidiary of Aeneas Group Limited, which is an indirect wholly-owned subsidiary
    of Jurchen Investment Corporation through Aeneas Limited. Because Mr. Huen, our CEO, holds 100% equity interest in Jurchen
    Investment Corporation, we refer Aeneas as a fellow subsidiary of Aptorum Group.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 0.5in; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 0.25in; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;AGL&rdquo;
    refers to Aeneas Group Limited, a wholly-owned subsidiary of Aeneas Limited and we refer AGL as a fellow subsidiary of Aptorum
    Group.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 0.5in; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 0.25in; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;AL&rdquo;
    refers to Aeneas Limited, an entity wholly-owned by Jurchen Investment Corporation and we refer AL as a fellow subsidiary
    of Aptorum Group.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 0.5in; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 0.25in; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;AML&rdquo;
    refers to Aptorum Medical Limited, a 95% owned-subsidiary of Aptorum Group.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 0.5in; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 0.25in; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;AML
    Clinic&rdquo; refers to an outpatient medical clinic operated by AML under the name of Talem Medical.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 0.5in; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 0.25in; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;APD&rdquo;
    refers to Aptorum Pharmaceutical Development Limited, a wholly-owned subsidiary of Aptorum Group.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 0.5in; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 0.25in; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;Aptorum
    Group,&rdquo; &ldquo;Company,&rdquo; &ldquo;we,&rdquo; &ldquo;Group&rdquo; and &ldquo;us&rdquo; refer to Aptorum Group Limited,
    a Cayman Islands exempted company with limited liability whose principal place of business is in Hong Kong.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 0.5in; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 0.25in; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;Aptorum
    Non-Therapeutics Group&rdquo; refers to the Company&rsquo;s non-therapeutics segment that encompasses: (i) the development
    of surgical robotics and medical devices, which is operated through Signate Life Sciences Limited and (ii) AML Clinic.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 0.5in; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 0.25in; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;Aptorum
    Therapeutics Group&rdquo; refers to the Company&rsquo;s therapeutics segment that is operated through its wholly-owned subsidiary,
    Aptorum Therapeutics Limited, a Cayman Islands exempted company with limited liability, whose principal place of business
    is in Hong Kong and its indirect subsidiary companies, whose principal places of business are in Hong Kong.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 0.5in; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 0.25in; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;Bond&rdquo;
    refers to a $15,000,000 convertible bond the Company issued to Peace Range (as hereinafter defined) in the Bond Offering.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 0.5in; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 0.25in; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;Bond
    Offering&rdquo; refers to the Company&rsquo;s private offering of the Bond that closed on April 25, 2018.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 0.5in; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 0.25in; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;Boustead&rdquo;
    refers to Boustead Securities, LLC.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 0.5in; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 0.25in; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;CFDA&rdquo;
    refers to China Food and Drug Administration.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 0.5in; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 0.25in; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;cGCP&rdquo;
    refers to Current Good Clinical Practice as adopted by the applicable regulatory authority.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 0.5in; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 0.25in; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;cGLP&rdquo;
    refers to Current Good Laboratory Practice as adopted by the applicable regulatory authority.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 0.5in; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 0.25in; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;cGMP&rdquo;
    refers to Current Good Manufacturing Practice as adopted by the applicable regulatory authority.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 0.5in; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 0.25in; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;China
    Renaissance&rdquo; refers to China Renaissance Securities (HK) Limited.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 0.5in; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 0.25in; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;Class
    A Ordinary Shares&rdquo; refers to the Company&rsquo;s Class A Ordinary Shares, par value $1.00 per share.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 0.5in; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 0.25in; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;CMC&rdquo;
    refers to chemical, manufacturing and control.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 0.5in; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 0.25in; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;Covar&rdquo;
    refers to Covar Pharmaceuticals Incorporated, a contract research organization engaged by the Company.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 0.5in; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 0.25in; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;CROs&rdquo;
    refers to contract research organizations.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 0.5in; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 0.25in; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;EMA&rdquo;
    refers to the European Medicines Agency.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 0.5in; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 0.25in; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;EMEA&rdquo;
    refers to Europe, the Middle East and Africa.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 0.5in; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 0.25in; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;EPO&rdquo;
    refers to the European Patent Organization or the European Patent Office operated by it.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<!-- Field: Page; Sequence: 7; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: LowerRoman; Name: PageNo -->iii<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"><A HREF="#toc">Table of Contents</A></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 0.5in; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 0.25in; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;European
    Patent&rdquo; refers to patents issuable by the EPO.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 0.5in; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 0.25in; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;Exchange
    Act&rdquo; refers to the U.S. Securities Exchange Act of 1934, as amended.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 0.5in; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 0.25in; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;FDA&rdquo;
    refers to U.S. Food and Drug Administration.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 0.5in; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 0.25in; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;FDCA&rdquo;
    refers to the U.S. Federal Food, Drug and Cosmetic Act.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 0.5in; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 0.25in; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;HKD&rdquo;
    refers to Hong Kong Dollars.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 0.5in; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 0.25in; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;Hong
    Kong&rdquo; or &ldquo;H.K.&rdquo; refers to Hong Kong Special Administrative Region of the People&rsquo;s Republic of China.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 0.5in; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 0.25in; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;Hong
    Kong Doctors&rdquo; refers to the doctors in Hong Kong under the employment of AML Clinic.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 0.5in; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 0.25in; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;IND&rdquo;
    refers to Investigational New Drugs.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 0.5in; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 0.25in; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;IP&rdquo;
    refers to intellectual property.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 0.5in; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 0.25in; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;Jurchen&rdquo;
    refers to Jurchen Investment Corporation, a company wholly-owned by our CEO, Ian Huen, and a holding company of Aptorum Group.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 0.5in; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 0.25in; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;Major
    Patent Jurisdictions&rdquo; refers to the United States, member states of the European Patent Organization and the People&rsquo;s
    Republic of China.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 0.5in; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 0.25in; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;Nativus&rdquo;
    refers to Nativus Life Sciences Limited, a wholly-owned subsidiary of Aptorum Group.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 0.5in; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 0.25in; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;NDA&rdquo;
    refers to a New Drug Application issued by the FDA.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 0.5in; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 0.25in; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;Offering&rdquo;
    refers to the initial public offering of Aptorum Group.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 0.5in; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 0.25in; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;PRC&rdquo;
    and &ldquo;China&rdquo; refer to the People&rsquo;s Republic of China.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 0.5in; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 0.25in; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;Restructure&rdquo;
    refers to the Company&rsquo;s change from an investment fund with management shares and non-voting participating redeemable preference
    shares to a holding company with operating subsidiaries, effective as of March 1, 2017.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 0.5in; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 0.25in; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;R&amp;D&rdquo;
    refers to research and development.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 0.5in; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 0.25in; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;R&amp;D
    Center&rdquo; refers to an in-house pharmaceutical development center operated by APD.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 0.5in; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 0.25in; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;SEC&rdquo;
    refers to the U.S. Securities and Exchange Commission.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 0.5in; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 0.25in; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;Securities
    Act&rdquo; refers to the U.S. Securities Act of 1933, as amended.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 0.5in; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 0.25in; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;Selling
    Shareholders&rdquo; refers to our pre-existing shareholders who are selling their Class A Ordinary Shares pursuant to the
    F-1.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 0.5in; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 0.25in; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;Series
    A Notes&rdquo; refers to Series A convertible notes, at a purchase price of $10,000 per note, sold in the Series A Note Offering.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 0.5in; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 0.25in; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;Series
    A Note Investors&rdquo; refers to the investors who purchased Series A Notes.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 0.5in; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 0.25in; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;Series
    A Note Offering&rdquo; refers to the private offering of Series A Notes, pursuant to Regulation S or Regulation D, as promulgated
    under the Securities Act that closed on May 15, 2018.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 0.5in; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 0.25in; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;Signate&rdquo;
    refers to Signate Life Sciences Limited, a wholly-owned subsidiary of Aptorum Group.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 0.5in; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 0.25in; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;UK&rdquo;
    refers to the United Kingdom.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 0.5in; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 0.25in; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;Underwriter
    Warrants&rdquo; refers to warrants issued to the underwriters of the IPO.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 0.5in; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 0.25in; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;United
    States,&rdquo; &ldquo;U.S.&rdquo; and &ldquo;US&rdquo; refer to the United States of America.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 0.5in; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 0.25in; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;Videns&rdquo;
    refers to Videns Incorporation Limited, a wholly-owned subsidiary of Aptorum Group.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 0.5in; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 0.25in; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;$,&rdquo;
    &ldquo;U.S. $,&rdquo; &ldquo;U.S. dollars,&rdquo; &ldquo;dollars,&rdquo; &ldquo;US$&rdquo; and &ldquo;USD&rdquo; refer to
    the United States dollars.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<!-- Field: Page; Sequence: 8; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: LowerRoman; Name: PageNo -->iv<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"><A HREF="#toc">Table of Contents</A></P></DIV>
    <!-- Field: /Page -->

<DIV STYLE="padding: 5; border: Black 1.5pt solid; width: 98%">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>&nbsp;&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><A NAME="w2"></A>PROSPECTUS
SUMMARY</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><I>This
summary highlights information contained elsewhere in this prospectus and does not contain all of the information that you should
consider in making your investment decision. Before investing in our Class A Ordinary Shares, you should carefully read the entire
prospectus, including our financial statements and the related notes included elsewhere in this prospectus. You should also consider,
among other things, the matters described under &ldquo;Risk Factors&rdquo; and &ldquo;Management&rsquo;s Discussion and Analysis
of Financial Condition and Results of Operations,&rdquo; in each case appearing elsewhere in this prospectus. Unless otherwise
stated, all references to &ldquo;us,&rdquo; &ldquo;our,&rdquo; &ldquo;Aptorum,&rdquo; &ldquo;we,&rdquo; the &ldquo;Company,&rdquo;
the &ldquo;group&rdquo; and similar designations refer to Aptorum Group Limited, a Cayman Islands exempted company with limited
liability, and its consolidated subsidiaries on or after March 1, 2017; prior to March 1, 2017, these designations refer to Aptorum
Group Limited as a single entity. See Note 1 to our consolidated financial statements&nbsp;as of the ten months ended December
31, 2017 included elsewhere in this prospectus.</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><I>Overview
</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">We
are a Hong Kong based pharmaceutical company currently in the preclinical stage, dedicated to developing and commercializing a
broad range of therapeutic and diagnostic technologies to tackle unmet medical needs. We have obtained exclusive licenses for
our technologies. In addition, we are also developing certain proprietary technologies as product candidates. We are pursuing
therapeutic and diagnostic projects (including projects seeking to use extracts or derivatives from natural substances to treat
diseases) in neurology, infectious diseases, gastroenterology, oncology and other disease areas. We also have projects focused
on surgical robotics. (See &ldquo;Our Business &ndash; Lead Projects and Other Projects under Development &ndash; Lead Projects&rdquo;
and &ldquo;Our Business &ndash; Lead Projects and Other Projects under Development &ndash; Other Projects under Development&rdquo;)
Also, we opened a medical clinic, AML Clinic, in June 2018. Its initial focus is on treatment of chronic diseases resulting from
modern sedentary lifestyles and aging population.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">Although
none of our drug or device candidates has yet been approved for testing in humans, our goal is to develop a broad range of early
stage novel therapeutics and diagnostics across a wide range of disease/therapeutic areas. Key components of our strategy for
achieving this goal include: (for details of our strategy, see &ldquo;Our Business &ndash; Our Strategy&rdquo;)</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 0.5in; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 0.25in; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Developing
    therapeutic and diagnostic innovations across a wide range of disease/therapeutic areas;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 0.5in; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 0.25in; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Selectively
    expanding our portfolio with potential products that may be able to attain orphan drug designation and/or satisfy current
    unmet medical needs;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 0.5in; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 0.25in; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Collaborating
    with leading academic institutions and CROs;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 0.5in; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 0.25in; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Expanding
    our in-house pharmaceutical development center;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 0.5in; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 0.25in; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Leveraging
    our management&rsquo;s expertise, experience and commercial networks;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 0.5in; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 0.25in; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Strategically
    developing opportunities in Hong Kong to promote access to the PRC market; and</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 0.5in; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 0.25in; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Obtaining
    and leveraging government grants to fund project development.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">We
intend to devote a significant percentage of our resources, including a substantial portion of the proceeds of this offering,
to three therapeutic projects (&ldquo;Lead Projects&rdquo;). The drug candidates being advanced as the Lead Projects are NLS-1,
ALS-1 and ALS-4, described in further detail below. If the results of the remaining preclinical studies of these drug candidates
are positive, we expect to be able to submit by 2020 or 2021 an Investigational New Drug Application (&ldquo;IND&rdquo;) for at
least one of these candidates to the U.S. Food and Drug Administration (&ldquo;FDA&rdquo;) or an equivalent application to the
regulatory authorities in one or more other jurisdictions such as the China Food and Drug Administration (&ldquo;CFDA&rdquo;)
and/or the European Medicines Agency (&ldquo;EMA&rdquo;). Acceptance of these applications by the relevant regulatory authority
would enable the Company to begin testing that drug candidate in humans in that jurisdiction. Our ability to obtain any approval
of such applications is entirely dependent upon the results of our preclinical studies, none of which have yet been completed.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

</DIV>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 9; Options: NewSection; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"><A HREF="#toc">Table of Contents</A></P></DIV>
    <!-- Field: /Page -->

<DIV STYLE="padding: 5; border: Black 1.5pt solid; width: 98%">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">Our
current business consists of &ldquo;therapeutics&rdquo; and &ldquo;non-therapeutics&rdquo; segments. However, our focus is on
the therapeutics segments. Because of the risks, costs and extended development time required for successful drug development,
we have determined to pursue projects within our non-therapeutics segments, such as AML Clinic, to provide some interim revenue
and medical robots that may be brought to market and generate revenue more quickly.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif"><I><U>Therapeutics
Segment</U></I>. In our therapeutics segment (&ldquo;Aptorum Therapeutics Group&rdquo;), we are currently seeking to develop various
drug molecules (including projects seeking to use extracts or derivatives from natural substances to treat diseases) and certain
technologies for the treatment (&ldquo;therapeutics&rdquo;) and diagnosis (&ldquo;diagnostics&rdquo;) of human disease conditions
in neurology, infectious diseases, gastroenterology, oncology and other disease areas. In addition, we are seeking to identify
additional prospects which may qualify for potential orphan drug designation (e.g., rare types of cancer) or which address other
current unmet medical needs. Aptorum Therapeutics Group is operated through Aptorum&rsquo;s wholly-owned subsidiary, Aptorum Therapeutics
Limited, a Cayman Islands exempted company with limited liability, whose principal place of business is in Hong Kong and its indirect
subsidiary companies (who we sometimes refer to herein as project companies), whose principal places of business are also in Hong
Kong.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif"><I><U>Non-Therapeutics
Segment</U></I>. The non-therapeutics segment (&ldquo;Aptorum Non-Therapeutics Group&rdquo;) encompasses two businesses: (i) the
development of surgical robotics and medical devices and (ii) AML Clinic. The development of surgical robotics and medical devices
business is operated through Signate Life Sciences Limited, a subsidiary of Aptorum Therapeutics Limited. The outpatient clinic
is operated through our subsidiary, Aptorum Medical Limited. Effective as of March 2018, we leased office space in Central Hong
Kong as the home to our medical clinic (&ldquo;AML Clinic&rdquo;). AML Clinic commenced operations under the name of Talem Medical
in June 2018. The estimated operating expenses under full capacity operation is to be no more than USD 90,000 per month. The clinic
is expected to reach operating profit in 18 months from the clinic reaching its full operating capacity upon (i) the successful
recruitment of a minimum of six full time physicians (AML Clinic currently has two full time physicians) and (ii) establishing
steady patients flow via brand development. (See &ldquo;Our Business &ndash; Lead Projects and Other Projects under Development
&ndash; Other Projects under Development &ndash; Aptorum Medical Limited - AML Clinic&rdquo;)</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">The
Company has already obtained opportunities resulting in our existing licensing agreements from various contractual relationships
that we have entered into, including service/consulting agreements with some of the world&rsquo;s leading specialists and clinicians
in our areas of interest, with academic institutions and organizations, and with contract research organizations (&ldquo;CROs&rdquo;).
We anticipate that these relationships will generate additional licensing opportunities in the future. In addition, we have established
and are continuing to expand our in-house research facilities (collectively, the &ldquo;R&amp;D Center&rdquo;) to develop some
of our drug and device candidates internally and to collaborate with third-party researchers.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">Prior
to March 2017, the Company had pursued passive healthcare related investments in early stage companies primarily in the United
States. However, we have since ceased pursuing further passive investment operations and intend to exit all such portfolio investments
over an appropriate timeframe to focus resources on our current business.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

</DIV>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 10; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"><A HREF="#toc">Table of Contents</A></P></DIV>
    <!-- Field: /Page -->

<DIV STYLE="padding: 5; border: Black 1.5pt solid; width: 98%">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Aptorum&rsquo;s
Lead Projects</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">Based
on evaluation of preliminary data by our Scientific Assessment Committee and our consideration of a number of
factors including substantial unmet needs, benefits over existing therapies, potential market size, competition in market,
the Company have decided to prioritize our resources in developing our three Lead Projects, namely, ALS-1, ALS-4 </FONT><FONT STYLE="font-family: Times New Roman, Times, Serif">and
NLS-1, among all our Projects under Development. Overall, our rationale for selecting Lead Projects was not based on
any mechanical formula or rigid selection criteria, but instead focused on a combination of the factors and individual
attributes of the Lead Projects themselves.</FONT></P>





<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><IMG SRC="img_003.jpg" ALT="" STYLE="width: 750px; height: 163px"><FONT STYLE="font-family: Times New Roman, Times, Serif"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>For
the definition of different stages of development, such as Target Identification &amp; Selection, Lead Discovery, Lead Optimization,
etc., please refer to Page 68.</B></FONT></P>





<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>ALS-1:
Small molecule intended for the treatment of viral infections caused by Influenza virus A</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">Professor
Richard Kao (Inventor of ALS-1, Founder and Principal Investigator of Acticule) was the first to identify nucleoprotein (&ldquo;NP&rdquo;)
as an effective drug target (Nature Biotechnology. 28:600-605) for the treatment of viral infections caused by Influenza virus
A. It is hypothesized that influenza A NP is an essential protein for the proliferation of the influenza virus. ALS-1 is a novel
small drug molecule which targets viral NP and triggers the aggregation of NP, which prevents the aggregated NP from entering the
nucleus. ALS-1 is designed to target a broad range of NP variants and we believe it is unlikely that ALS-1 will experience the
resistance developed by the viruses against the existing anti-viral therapy. </FONT><FONT STYLE="font-family: Times New Roman, Times, Serif">We
are exploring ALS-1 as a potential treatment for viral infections caused by Influenza virus A. It is currently at the Lead Optimization
Stage to optimize its drug-like properties.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Market
size of target indication</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">Influenza
can cause severe illness or death especially in people with high risk. Globally, the annual epidemics are estimated to result
in about 3 to 5 million cases of severe illness and about 290,000 to 650,000 deaths each year<SUP>1</SUP>. The market for influenza
drugs is huge, the total Influenza therapeutics market is expected to swell to US$1.2 billion by 2025, from US$600 million in
2016<SUP>2</SUP>. Specifically, ALS-1 is a drug that targets Influenza virus A, a highly contagious respiratory illness caused
by infection with virus. Around 50%-80% if Influenza cases are type A<SUP>3</SUP>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Significant
unmet medical needs and benefits over existing treatments</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">The
emergence of antiviral drug resistance in influenza virus is a major concern for treatment of same. ALS-1 targets </FONT><FONT STYLE="font-family: Times New Roman, Times, Serif">a
broad range of NP variants. As NP is essential to the replication of influenza virus, by disrupting NP, ALS-1 aims to suppress
viral replication. As ALS-1 acts on a novel therapeutic target, we believe </FONT><FONT STYLE="font-family: Times New Roman, Times, Serif">it
is unlikely that ALS-1 will experience the resistance developed by the viruses against the existing anti-viral therapy. </FONT></P>





<P STYLE="margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 0; margin-bottom: 0"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid; width: 25%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="width: 100%; margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.3in"><FONT STYLE="font-family: Times New Roman, Times, Serif"><SUP>1</SUP></FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">World Health Organization, &ldquo;Influenza
    (Seasonal)&rdquo;, World Health Organization, 31 January 2018, http://www.who.int/en/news-room/fact-sheets/detail/influenza-(seasonal)</FONT></TD></TR>
</TABLE>


<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="width: 100%; margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.3in"><FONT STYLE="font-family: Times New Roman, Times, Serif"><SUP>2</SUP></FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&ldquo;What You Should Know About Influenza (Flu) Antiviral Drugs&rdquo;,
U.S. Department of Health and Human Services, November 22, 2016, https://www.cdc.gov/flu/pdf/freeresources/updated/antiviral-factsheet-updated.pdf</FONT></TD></TR>
</TABLE>


<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="width: 100%; margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.3in"><FONT STYLE="font-family: Times New Roman, Times, Serif"><SUP>3</SUP></FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">World Health Organization, &ldquo;Global circulation of influenza viruses&rdquo;,
Influenza Laboratory Surveillance Information generated on 28/08/2018 21:28:47 UTC by the Global Influenza Surveillance and Response
System (GISRS), http://apps.who.int/flumart/Default?ReportNo=6</FONT></TD></TR>
</TABLE>




<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

</DIV>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 11; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"><A HREF="#toc">Table of Contents</A></P></DIV>
    <!-- Field: /Page -->

<DIV STYLE="padding: 5; border: Black 1.5pt solid; width: 98%">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>ALS-4:
Small molecule for the treatment of bacterial infections caused by Staphylococcus aureus including Methicillin-resistant Staphylococcus
aureus (&ldquo;MRSA&rdquo;)</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">ALS-4
is a small drug molecule which appears to target the products produced by bacterial genes that facilitate the successful colonization
and survival of the bacterium in the body or that cause damage to the body&rsquo;s systems. These products of bacterial genes are
referred to as &ldquo;virulence expression&rdquo;. Targeting bacterial virulence is an alternative approach to antimicrobial therapy
that offers promising opportunities to overcome the emergence and increasing prevalence of antibiotic-resistant bacteria. </FONT>&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">ALS-4 is directed to
a novel drug target, an enzyme essential for Staphylococcus aureus (including MRSA) survival in vivo. We believe that the product
of this enzyme promotes Staphylococcus aureus (including MRSA) survival by shielding the bacteria from the attack by the immune
system. ALS-4 may have particular value if it can be shown to be an effective therapy in situations where a Staphylococcus aureus
infection is resistant to available antibiotics (i.e., where the pathogen is MRSA).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">ALS-4
is at present under active development for the treatment of bacterial infections caused by Staphylococcus aureus including
MRSA. It is currently at the Lead Optimization stage to optimize its drug-like properties. A U.S. provisional patent
application was filed for the underlying technology, but it was expired; we filed a U.S. non-provisional application and a
PCT application which claimed priority to the U.S. provisional application. We do have an exclusive license for the above
U.S. non-provisional application and PCT application with respect to ALS-4.</FONT>&nbsp;</P>





<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Market
size of target indication</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">Staphylococcus
aureus&nbsp;is a&nbsp;<U>commensal bacterium</U>, meaning that it infects about 30% of the human population without causing symptoms
or harm. A study shows that as many as 53 million people worldwide carry MRSA, which is one of the most commonly identified antibiotic-resistant
pathogens.<SUP>4</SUP> In its symptomatic form, it is one of the five most common causes of hospital-acquired infections and is
often the cause of wound infections following surgery. In the U.S. alone, approximately 126,000 hospitalizations are due to MRSA
yearly, where severe MRSA infections occur in approximately 94,000 people each year and are associated with approximately 19,000
deaths<SUP>5</SUP>. Global MRSA drugs market generated US$2.97 billion of revenue in 2016, and the market for MRSA drugs is estimated
to reach US$ 3.9 billion by the end of 2025<SUP>6</SUP>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Significant
unmet medical needs and benefits over existing treatments</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; background-color: white">Staphylococcus
aureus commonly causes skin infections including abscesses, respiratory infections such as sinusitis, and food poisoning. </FONT><FONT STYLE="font-family: Times New Roman, Times, Serif">Existing
treatments for <FONT STYLE="background-color: white">Staphylococcus aureus&nbsp;consist of</FONT> antibiotics administered to
kill the bacteria. However, MRSA is a type of Staphylococcus aureus that causes particularly difficult-to-treat infections in
humans. Nicknamed to be a &ldquo;Super Bug,&rdquo; MRSA is a major hospital acquired pathogen that causes severe morbidity and
mortality worldwide. MRSA has developed resistance to many common antibiotics that once destroyed it. It is now resistant to methicillin,
amoxicillin, penicillin, oxacillin, and many other common antibiotics and may overtime develops resistance to other new antibiotics.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">ALS-4
does not work as a typical antibiotic but instead targets virulence expression without direct bactericidal properties to kill
the bacteria. It presents an alternative treatment to antimicrobial therapy and offers promising opportunities to overcome the
emergence and increasing prevalence of antibiotic-resistant bacteria. Specifically, ALS-4 appears to inhibit the production of
staphyloxanthin (i.e., a virulence factor that would escape from the host immune system) without killing the bacteria, and thereby
enabling the immune system to clear MRSA. The Company believes that, ALS-4, less likely to be susceptible to antibiotic resistance,
could possibly offer a novel treatment for <FONT STYLE="background-color: white">Staphylococcus aureus&nbsp;</FONT>infections
and MRSA.</FONT></P>





<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 0; margin-bottom: 0"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid; width: 25%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="width: 100%; margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.3in"><FONT STYLE="font-family: Times New Roman, Times, Serif"><SUP>4</SUP></FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">Roche, &ldquo;Roche&rsquo;s Annual Report 2017&rdquo;, https://www.roche.com/dam/jcr:78519d71-10af-4e02-b490-7b4648a5edb8/en/ar17e.pdf</FONT></TD></TR>
</TABLE>


<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="width: 100%; margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.3in"><FONT STYLE="font-family: Times New Roman, Times, Serif"><SUP>5</SUP></FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">Charles Patrick Davis, Melissa Conrad St&ouml;ppler, &ldquo;MRSA&rdquo;,
November 9, 2017, eMedicineHealth, https://www.emedicinehealth.com/mrsa_infection/article_em.htm#how_common_is_mrsa</FONT></TD></TR>
</TABLE>


<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="width: 100%; margin-bottom: 0pt">
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left; width: 0.3in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><SUP>6</SUP></FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Market Research Reports
    Search Engine (MRRSE), &ldquo;Global Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Market Analysis and Forecast
    Predictions&rdquo;, HEALTHCAREDIVE, https://www.healthcaredive.com/press-release/20180405-global-methicillin-resistant-staphylococcus-aureus-mrsa-drugs-market-anal/</FONT></TD></TR>
</TABLE>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

</DIV>

<!-- Field: Page; Sequence: 12; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"><A HREF="#toc">Table of Contents</A></P></DIV>
    <!-- Field: /Page -->

<DIV STYLE="padding: 5; border: Black 1.5pt solid; width: 98%">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>NLS-1:
A Derivative of Epigallocatechin-3-Gallate (&ldquo;Pro-EGCG&rdquo;) for the treatment of Endometriosis</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">NLS-1,
a drug molecule derived from natural products (green tea), is currently under development </FONT><FONT STYLE="font-family: Times New Roman, Times, Serif">for
the treatment of endometriosis, a disease in which the tissue that normally lines the uterus (endometrium) grows outside the
uterus. It can grow on the ovaries, fallopian tubes, bowels, or bladder. Rarely, it grows in other parts of the body. Many
studies have assessed the applications of EGCG, a naturally occurring</FONT> <FONT STYLE="font-family: Times New Roman, Times, Serif">molecule
extracted from green tea, for the treatment of endometriosis in vitro and in animal models with encouraging results. (Hum
Reprod. 2014 29(8):1677; Hum Reprod. 2013 28(1):178; Fertil Steril. 2011 96(4):1021). For example, in a mouse model, Ricci et
al (Hum Reprod. 2013 28(1):178) demonstrated that EGCG significantly reduced the mean number (P &lt; 0.05 versus control) and
the volume of established lesions (P &lt; 0.05 versus control). The treatment consistently statistically significantly
diminished cell proliferation (P &lt; 0.05, versus control), reduced vascular density p &lt; 0.001, versus control) and
increased apoptosis within the lesions (p &lt; 0.05, versus control). EGCG induced reduction in human EEC proliferation (p
&lt; 0.05 versus basal) and increased apoptosis (p &lt; 0.05 versus basal) in primary cultures. Matsuzaki and Darcha (Hum
Reprod. 2014 29(8):1677) also showed that EGCG prevented the progression of fibrosis in endometriosis in an animal
model.</FONT></P>





<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">However,
the attractiveness of EGCG as a drug candidate has been diminished by its chemical and metabolic instability (Hum Reprod. 2014
29(8):1677; Angiogenesis. 2013 16(1):59). The Company&rsquo;s drug candidate, NLS-1 is supposed to overcome these challenges.
NLS-1 is an EGCG derivative synthesized by acetylation of the reactive hydroxyl groups, which appears to prevent generation of
reactive phenoxide anions and radicals for dimerization and metabolism, thereby overcoming the chemical and metabolic instability
of EGCG.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">NLS-1
is under active development for the treatment of endometriosis. It is currently under lead optimization to optimize its drug-like
properties.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Market
size of target indication</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 35.45pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Endometriosis
affects an estimated approximately 176 million women in the world (approximately 1 in 10 women during their reproductive years)<SUP>7</SUP>.
It is estimated that 30-40% of women with endometriosis are subject to risk of infertility and may develop complications during
pregnancy<SUP>8,9</SUP>. The market for the treatment of endometriosis across the seven major countries of the U.S., France, Germany,
Italy, Spain, the U.K., and Japan, is approximately $1.72 billion in 2015. It is expected to grow to over $2 billion by 2025<SUP>10</SUP>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Significant
unmet medical needs and benefits over existing treatments</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="background-color: white">Endometriosis
is a condition where tissue that normally lines inside of uterus grows outside of it, and would often cause pelvic pain and infertility
to the patient. At present, endometriosis is usually treated with hormonal therapy (including Gonadotropin-releasing hormone),
which is a non-invasive therapy to</FONT> slow growth of endometrial tissue growth and prevent new implants of endometrial tissue.
<FONT STYLE="background-color: white">However, hormone-based therapy often causes adverse side effect, such as menopausal symptoms,
infertility, b</FONT>one density loss, higher risk of osteoporosis, mood swings, hair loss, etc., and is not a permanent cure as
the symptoms may return after stopping of treatment. <FONT STYLE="background-color: white">Surgery can be effective to remove endometriosis
lesions and scar tissue, but success rates are dependent on the extent of disease and are invasive.</FONT></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; background-color: white">In
view of the above, a non-invasive drug without the current side effects of hormone-based therapy are highly desirable to the market,
and NLS-1 could address this unmet need. NLS-1 is a drug molecule derived from natural extracts and offers a potential non-hormonal
treatment of endometriosis. Preclinical studies have shown that NLS-1 prevents the progression of fibrosis in endometriosis in
mice. Specifically, as demonstrated in animal models, NLS-1 exhibits the following attributes in these studies: (i) significant
inhibition against development, growth and angiogenesis of uterine tissue, and (ii) greater reduction of lesions than with conventional
hormone-based therapy. In animal studies, <FONT STYLE="color: #111111">NLS-1 reduced the lesion size significantly better than
EGCG and other hormone-based therapy. </FONT></FONT>&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 0; margin-bottom: 0"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid; width: 25%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 29px; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><SUP>7</SUP></FONT></TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ENDOMETRIOSIS.org, &ldquo;Facts about endometriosis&rdquo;, http://endometriosis.org/resources/articles/facts-about-endometriosis/</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 29px; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><SUP>8</SUP></FONT></TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Washington University Physicians, &ldquo;Endometriosis&rdquo;, https://fertility.wustl.edu/getting-started-infertility/infertility-factors/endometriosis/</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 29px; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><SUP>9</SUP></FONT></TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">J. Fisher M. Kirkman, &ldquo;Endometriosis and fertility: women&rsquo;s accounts of healthcare&rdquo;, Human Reproduction, Volume 31, Issue 3, March 1, 2016, Pages 554&ndash;562, January 11, 2016, https://doi.org/10.1093/humrep/dev337</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 29px; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><SUP>10</SUP></FONT></TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">GlobalData, &ldquo;Endometriosis Market Expected to Surpass $2 Billion by 2025&rdquo;, November 11, 2016, R&amp;D, https://www.rdmag.com/news/2016/11/endometriosis-market-expected-surpass-2-billion-2025</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

</DIV>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 13; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"><A HREF="#toc">Table of Contents</A></P></DIV>
    <!-- Field: /Page -->

<DIV STYLE="padding: 5; border: Black 1.5pt solid; width: 98%">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><I>Our
Structure</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">The
following diagram illustrates our corporate structure as of the date of this prospectus. For more details regarding our corporate
history and current structure, please refer to &ldquo;Corporate History and Background&rdquo; appearing on page 82 of this prospectus.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; background-color: white">Prior
to the completion of this Offering, and as long as our officers and directors, either individually or in the </FONT><FONT STYLE="font-family: Times New Roman, Times, Serif">aggregate,
own at least 50% of the voting power of our Company, we will be a &ldquo;controlled company&rdquo; as defined under NASDAQ Marketplace
Rules. However, even if we qualify as a &ldquo;controlled company&rdquo; after the Offering, we do not intend to rely on the controlled
company exemption provided under NASDAQ Marketplace Rules. To that extent, we have set up the Audit Committee, the Compensation
Committee, and the Nominating and Corporate Governance Committee, all of which consist solely of independent directors and adopted
a charter for each committee.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><IMG SRC="img_004.jpg" ALT="" STYLE="height: 316px; width: 625px"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; background-color: white"><B><I>Controlled
Company</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">Prior
to the completion of this Offering, and as long as our officers and directors, either individually or in the aggregate, own at
least 50% of the voting power of our Company, we will be a &ldquo;controlled company&rdquo; as defined under NASDAQ Marketplace
Rules. If we raise the minimum offering amount, we will continue to be a &ldquo;controlled company&rdquo;; if we raise the maximum
offering amount, we will continue to be a &ldquo;controlled company.&rdquo;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">For
so as we are a&nbsp;controlled company&nbsp;under that definition, we are permitted to elect to rely, and may rely, on certain
exemptions from corporate governance rules, including:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 0.5in; text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 0.25in; text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">an
    exemption from the rule that a majority of our board of directors must be independent directors;</FONT></TD></TR>

<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">an
    exemption from the rule that the compensation of our chief executive officer must be determined or recommended solely by independent
    directors; and</FONT></TD></TR>

<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">an
    exemption from the rule that our director nominees must be selected or recommended solely by independent directors.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">As
a result, you will not have the same protection afforded to shareholders of companies that are subject to these corporate governance
requirements.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">Although
we do not intend to rely on the &ldquo;controlled company&rdquo; exemption under the Nasdaq listing rules, we could elect to rely
on this exemption in the future. If we elect to rely on the &ldquo;controlled company&rdquo; exemption, a majority of the members
of our board of directors might not be independent directors and our nominating and corporate governance and compensation committees
might not consist entirely of independent directors. (See &ndash; Risk Factor &ldquo;<B><I>As a &ldquo;controlled company&rdquo;
under the rules of the NASDAQ Global Market, we may exempt our company from certain corporate governance requirements that could
adversely affect our public shareholders.</I></B>)</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

</DIV>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 14; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"><A HREF="#toc">Table of Contents</A></P></DIV>
    <!-- Field: /Page -->

<DIV STYLE="padding: 5; border: Black 1.5pt solid; width: 98%">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><I>Risks
Associated with Our Business</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">Investing
in our Class A Ordinary Shares involves risks. You should carefully consider the risks described in &ldquo;Risk Factors&rdquo;
beginning on page 13 of this prospectus before making a decision to purchase Class A Ordinary Shares. If any of these risks actually
occurs, our business, financial condition or results of operations would likely be materially adversely affected. In such case,
the trading price of our Class A Ordinary Shares would likely decline, and you may lose all or part of your investment.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><I>Recent
Financings</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>The
Series A Note Offering</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">On
May 15, 2018, we closed a private financing with certain investors (the &ldquo;Series A Note Investors&rdquo;) who purchased an
aggregate of approximately $1,600,400 Series A convertible notes, at a purchase price of $10,000 per note (the &ldquo;Series A
Notes&rdquo;), pursuant to a note purchase agreement. Some of the Series A Note Investors are either affiliates of the Company
or &ldquo;related persons,&rdquo; as such term is defined in Item 404 of Regulation S-K (See &ldquo;Transactions with Related
Persons&rdquo; and &ldquo;Selling Shareholders&rdquo;). We refer to this private placement transaction as the &ldquo;Series A
Note Offering.&rdquo; The Series A Note Investors entered into a lock-up agreement, pursuant to which they agreed not to sell
or otherwise transfer or dispose the Series A Notes or the Class A Ordinary Shares underlying the Series A Notes during the six-month
period commencing on the date our Class A Ordinary Shares commence trading on NASDAQ Global Market. The Series A Notes will automatically
convert into Class A Ordinary Shares at the closing of the Offering and at the commencement of trading our Class A Ordinary Shares
on NASDAQ Global Market at a conversion price equal to a 56% discount to the actual price per Class A Ordinary Share (&ldquo;Conversion
Price&rdquo;) in this Offering. As a result, the investors in this Offering will experience immediate dilution when the Series
A Notes are automatically converted. (See &ldquo;Risk Factors &ndash; You will experience immediate and substantial dilution as
a result of this Offering and may experience additional dilution in the future&rdquo;)</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">One
of the underwriters in this Offering, Boustead, also served as a placement agent for the Series A Note Offering and received:
(i) a cash success fee of $68,516 and (ii) warrants to purchase a number of Class A Ordinary Shares equal to 5.5% of the number
of Class A Ordinary Shares issuable upon conversion of the Series A Notes, at an exercise price per share equal to the Conversion
Price, subject to adjustment (the &ldquo;Series A Note PA Warrants&rdquo;). The Series A Note PA Warrants are also exercisable
on a cashless basis, at the holder&rsquo;s discretion. Boustead also participated in the Series A Note Offering as an investor
with a purchase of Series A Notes in the amount of $150,000.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The
issuance and sale of Series A Notes, Series A Note PA Warrants, and the underlying Class A Ordinary Shares to the Series A Note
Investors and the placement agent in the Series A Note Offering were made in reliance on an exemption from registration contained
in either Regulation D or Regulation S of the Securities Act of 1933, as amended (the &ldquo;Securities Act&rdquo;). The securities
sold in the Series A Note Offering are not registered by the registration statement of which this prospectus is a part and have
not been registered under the Securities Act, and may be offered or sold only pursuant to an effective registration statement
or pursuant to an available exemption from the registration requirements of the Securities Act. However, the Series A Note Investors
have piggyback registration rights with respect to the Class A Ordinary Shares underlying the Series A Notes that entitle the
Series A Note Investors to request their securities be included in a future Securities Act registration statement, after this
Offering, subject to certain exceptions and conditions. However, we decided to include the Class A Ordinary Shares underlying
the Series A Notes and the Series A Note PA Warrants in this registration statement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

</DIV>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 15; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"><A HREF="#toc">Table of Contents</A></P></DIV>
    <!-- Field: /Page -->

<DIV STYLE="padding: 5; border: Black 1.5pt solid; width: 98%">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>&nbsp;</B>&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>The
Bond Offering</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">On
April 6, 2018, we entered into a subscription agreement (the &ldquo;Bond Subscription Agreement&rdquo;) with Peace Range Limited
(&ldquo;Peace Range&rdquo;), a company incorporated under the laws of the British Virgin Islands and wholly-owned special purpose
vehicle of Adamas Ping An Opportunities Fund L.P. Adamas Ping An Opportunities Fund L.P. is the third fund from Adamas Asset Management
(HK) Limited (&ldquo;Adamas&rdquo;) and the first fund from the joint venture between Adamas and Yun Sheng Capital Company Limited,
a subsidiary of Ping An Insurance (Group) Company of China, Limited and is advised by Ping An Capital Company Limited. Pursuant
to the Bond Subscription Agreement, we issued Peace Range a $15,000,000 convertible bond (the &ldquo;Bond&rdquo; and the &ldquo;Bond
Offering&rdquo;), minus a structuring fee equal to 2% of the principal amount of the Bond, on April 25, 2018. We also agreed to
pay certain expenses, up to an aggregate limit of $250,000, incurred by Peace Range in connection with the Bond Offering. The
closing of the transaction contemplated by the Bond Subscription Agreement and the issuance of the Bond are subject to standard
closing conditions, which may be satisfied or waived by the impacted party. The Bond earns interest at the rate of 8% per annum,
payable semi-annually. The payment of the Bond is guaranteed by our holding company, Jurchen Investment Corporation (&ldquo;Jurchen&rdquo;),
a company wholly-owned by our CEO, Ian Huen (See &ldquo;Transactions with Related Persons &ndash; Share Transfer: Change in direct
substantial shareholders of the Company&rdquo;), pursuant to a deed of guarantee (the &ldquo;Guarantee&rdquo;). In addition, the
repayment of the principal of the Bond and interest payables is secured by a fund we set aside in a debt service reserve account,
with the funds in the debt service reserve account to be released in an amount pro rata to the principal amount of the Bond being
converted. The Bond shall mature on the twelfth calendar month following the issuance date, or with prior written consent of the
holders of the Bond, the business day falling six calendar months thereafter. 10% of the principal amount of the Bond shall be
automatically converted into our Class A Ordinary Shares upon the closing of this Offering and the rest of the Bond is convertible
at the option of the holder commencing on the closing of this Offering until the earlier of the date falling 12 calendar months
after the maturity of the Bond and the date falling 12 calendar months after the closing of this Offering. We closed the Bond
Offering on April 25, 2018 and issued a Bond to Peace Range pursuant to the Bond Subscription Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">The
Bond Subscription Agreement, including the terms and conditions of the Bond, is attached as Exhibit 10.19 to this prospectus.
The parties to the Bond Subscription Agreement also entered into a Share Charge and Account Charge to perfect the security interest
created under the Bond Subscription Agreement; such agreements are attached as Exhibit 10.20 and 10.22, respectively to this prospectus.
(See &ldquo;Description of Share Capital &ndash; Convertible Bond&rdquo;)</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">One
of the underwriters in this Offering, Boustead, also served as a placement agent for the Bond Offering and received (i) a cash
success fee of $600,000 and (ii) warrants to purchase a number of Class A Ordinary Shares equal to 5.5% of the number of Class
A Ordinary Shares issuable upon conversion of the Bond, at an exercise price equal to a 23% discount to this Offering price, subject
to adjustment (the &ldquo;Bond PA Warrants&rdquo;). The Bond PA Warrants are exercisable on a cashless basis. China Renaissance
Securities (HK) Limited (&ldquo;China Renaissance&rdquo;) also served as a placement agent for the Bond Offering; for such services,
China Renaissance received</FONT> <FONT STYLE="font-family: Times New Roman, Times, Serif">a cash success fee of $150,000.</FONT></P>





<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">As
a result, the investors in this Offering will experience immediate dilution when the Bond is automatically converted. (See &ldquo;Risk
Factors &ndash; You will experience immediate and substantial dilution as a result of this Offering and may experience additional
dilution in the future&rdquo;)</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><I>Our
Securities</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">Our
authorized share capital is divided into Class A Ordinary Shares and Class B Ordinary Shares prior to the completion of this Offering.
Holders of Class A Ordinary Shares and Class B Ordinary Shares have the same rights except for voting and conversion rights. In
respect of matters requiring a shareholder vote, each Class A Ordinary Share will be entitled to one vote and each Class B Ordinary
Share will be entitled to ten votes. Due to the Class B Ordinary Share&rsquo;s voting power, the holders of Class B Ordinary shares
currently and may continue to have a concentration of voting power, which limits the holders of Class A Ordinary Shares&rsquo;
ability to influence corporate matters. <FONT STYLE="background-color: white">(See &ldquo;Risk Factors - </FONT><B><I>Our Class
B Ordinary Shares have stronger voting power than our Class A Ordinary Shares and certain existing shareholders have substantial
influence over our Company and their interests may not be aligned with the interests of our other shareholders and holders of
our Series A Notes and the Bond.&rdquo;) </I></B>Each Class B Ordinary Share is convertible into one Class A Ordinary Share at
any time by the holder thereof. Class A Ordinary Shares are not convertible into Class B Ordinary Shares under any circumstances.
(See &ldquo;Description of Share Capital&rdquo;)</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">Unless
the context requires otherwise, all references to the number of shares of Class A and Class B Ordinary Shares to
be outstanding after our initial public offering is based on 5,426,381 Class A Ordinary Shares and 22,437,754 Class B
Ordinary Shares outstanding as of September 5, 2018, and excludes (a) the issuance of
[&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ] Class A Ordinary Shares upon the automatic conversion of Series A Notes issued in the
Series A Note Offering, (b) up to [&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;] Class A Ordinary Shares reserved for issuance upon
exercise of the Series A Note PA Warrants, (c) the issuance of [&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;] Class A Ordinary Shares
upon the automatic conversion of the Bond issued in the Bond Offering, (d) up to [&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;] Class
A Ordinary Shares reserved for issuance upon optional conversion of Bond issued in the Bond Offering if the holder chooses to
convert, (e) up to [&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;] Class A Ordinary Shares reserved for issuance upon exercise of the
Bond PA Warrants, and (f) [&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;] Class A Ordinary Shares reserved for issuance under our 2017
Share Option Plan (the &ldquo;Option Plan&rdquo;), which was adopted on October 13, 2017.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 34pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 34pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Unless
otherwise indicated, all information in this prospectus assumes a price to the public in this Offering of $[&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
] per share, the midpoint of the price range set forth on the cover page of this prospectus.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><I>&nbsp;</I></B></FONT></P>

</DIV>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 16; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"><A HREF="#toc">Table of Contents</A></P></DIV>
    <!-- Field: /Page -->

<DIV STYLE="padding: 5; border: Black 1.5pt solid; width: 98%">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><I>Corporate
Information</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 34pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 34pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Our
principal executive office is located on the 17<SUP>th</SUP> Floor, Guangdong Investment Tower, 148 Connaught Road Central, Hong
Kong. Our telephone number is +852 2117 6611.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 34pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 34pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Our
website is www.aptorumgroup.com. <B>The information on our website is not part of this prospectus.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 34pt"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><I>Implications
of Being an Emerging Growth Company </I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">We
qualify as an &ldquo;emerging growth company&rdquo; as defined in the JOBS Act. As an emerging growth company, we may take advantage
of specified reduced disclosure and other requirements that are otherwise applicable generally to public companies. These provisions
include:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 0.5in; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 0.25in; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">not
    being required to comply with the auditor attestation requirements of Section 404 of the Sarbanes-Oxley Act of 2002 (&ldquo;Sarbanes-Oxley
    Act&rdquo;);</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 0.5in; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 0.25in; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    ability to include only two years of audited financial statements in addition to any required interim financial statements
    and correspondingly reduced disclosure in management&rsquo;s discussion and analysis of financial condition and results of
    operations in the registration statement for this Offering of which this prospectus forms a part; and</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 0.5in; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 0.25in; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">to
    the extent that we no longer qualify as a foreign private issuer, (1) reduced disclosure obligations regarding executive compensation
    in our periodic reports and proxy statements; and (2) exemptions from the requirements of holding a non-binding advisory vote
    on executive compensation, including golden parachute compensation.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">We
may take advantage of these exemptions for up to five years or such earlier time that we are no longer an emerging growth company.
We would cease to be an emerging growth company upon the earliest to occur of (1) the last day of the fiscal year in which we
have more than $1.0 billion in annual revenue; (2) the date we qualify as a &ldquo;large accelerated filer&rdquo; with at least
$700 million of equity securities held by non-affiliates; (3) the issuance, in any three-year period, by our Company of more than
$1.0 billion in non-convertible debt securities; and (4) the last day of the fiscal year ending after the fifth anniversary of
this Offering. We may choose to take advantage of some but not all of these exemptions. For example, Section 107 of the JOBS Act
provides that an emerging growth company can use the extended transition period provided in Section 7(a)(2)(B) of the Securities
Act for complying with new or revised accounting standards. We are choosing to elect to use the extended transition period for
complying with new or revised accounting standards under Section 102(b)(2) of the JOBS Act, which allows us to delay the adoption
of new or revised accounting standards that have different effective dates for public and private companies until those standards
apply to private companies. Accordingly, the information contained herein may be different than the information you receive from
other public companies in which you hold equity securities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><I>Implications
of Being a Foreign Private Issuer</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">We
are also considered a &ldquo;foreign private issuer&rdquo;. In our capacity as a foreign private issuer, we are exempted from
certain rules under the U.S. Securities Exchange Act of 1934, as amended (&ldquo;Exchange Act&rdquo;), that impose certain disclosure
obligations and procedural requirements for proxy solicitations under Section 14 of the Exchange Act. In addition, our officers,
directors and principal shareholders are exempt from the reporting and &ldquo;short-swing&rdquo; profit recovery provisions of
Section 16 of the Exchange Act and the rules under the Exchange Act with respect to their purchases and sales of our Class A Ordinary
Shares. Moreover, we are not required to file periodic reports and financial statements with the U.S. Securities and Exchange
Commission (&ldquo;SEC&rdquo;), as frequently or as promptly as U.S. companies whose securities are registered under the Exchange
Act. In addition, we are not required to comply with Regulation FD, which restricts the selective disclosure of material information.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">We
may take advantage of these exemptions until such time as we are no longer a foreign private issuer. We would cease to be a foreign
private issuer at such time when more than 50% of our outstanding voting securities are held by U.S. residents and any of the
following three circumstances applies: (1) the majority of our executive officers or directors are U.S. citizens or residents;
(2) more than 50% of our assets are located in the United States; or (3) our business is administered principally in the United
States.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">We
have taken advantage of certain reduced reporting and other requirements in this prospectus. Accordingly, the information contained
herein may be different than the information you receive from other public companies in which you hold equity securities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><I>Notes
on Prospectus Presentation</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">Numerical
figures included in this prospectus have been subject to rounding adjustments. Accordingly, numerical figures shown as totals
in various tables may not be arithmetic aggregations of the figures that precede them. Certain market data and other statistical
information contained in this prospectus is based on information from independent industry organizations, publications, surveys
and forecasts. Some market data and statistical information contained in this prospectus are also based on management&rsquo;s
estimates and calculations, which are derived from our review and interpretation of the independent sources listed above, our
internal research and our knowledge of pharmaceutical industry. While we believe such information is reliable, we have not independently
verified any third-party information and our internal data has not been verified by any independent source.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">Accordingly,
actual events or circumstances may differ materially from events and circumstances that are assumed in this information and you
are cautioned not to give undue weight to such data.</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

</DIV>

<!-- Field: Page; Sequence: 17; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"><A HREF="#toc">Table of Contents</A></P></DIV>
    <!-- Field: /Page -->

<DIV STYLE="padding: 5; border: Black 1.5pt solid; width: 98%">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;<B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Offering
Summary</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 35%; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Issuer:
    </FONT></TD>
    <TD STYLE="width: 2%; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 63%; text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Aptorum
    Group Limited</B></FONT></TD></TR>
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Securities
    being Offered by us</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[
    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;] Class A Ordinary Shares</FONT></TD></TR>
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Securities
    being Offered by Selling Shareholders</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">Up
                                         to ___________ Class A Ordinary Shares. <FONT STYLE="background-color: white">The Selling
                                         Shareholders named herein may sell Resale Shares from time to </FONT><FONT STYLE="font-weight: normal">at
                                         a fixed price until the Class A Ordinary Shares are listed on NASDAQ and thereafter,
                                         the Selling Shareholders will be able sell their Class A Ordinary Shares at prevailing
                                         market prices or privately negotiated prices</FONT><FONT STYLE="background-color: white">.
                                         We will not receive any proceeds from the sales by the Selling Shareholders. </FONT></FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Resale
        Shares include: (1) <FONT STYLE="background-color: white">[&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;] Class A Ordinary Shares
        underlying the Bond; (2) [ &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;] Class A Ordinary Shares underlying the Bond PA Warrants; (3)
        [ &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;] Class A Ordinary Shares underlying the Series A Notes; and (4) [ &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;]
        Class A Ordinary Shares underlying the Series A Note PA Warrants. </FONT></FONT></P></TD></TR>
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Price
    per Share</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
    ]</FONT></TD></TR>
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Class
    A Ordinary Shares Outstanding before the Offering </FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5,426,381</FONT></TD></TR>
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Class
    A Ordinary Shares Outstanding following the consummation of the Offering</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;]</FONT></TD></TR>
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Amount
    of the Offering</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">up
    to $[ &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;]</FONT></TD></TR>
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Symbol</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
    plan to apply to list our Class A Ordinary Shares on the NASDAQ Global Market under the symbol &ldquo;[&nbsp;&nbsp;&nbsp;&nbsp;
    ]&rdquo;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Transfer
    Agent</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Continental
    Stock Transfer &amp; Trust Company</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif"></FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 35%; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Use
    of Proceeds</FONT></TD>
    <TD STYLE="width: 2%; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 63%; text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
    estimate that we will receive net proceeds from this Offering of up to $[&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;] million, based
    on an assumed price to the public in this Offering of $[&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;], the midpoint of the price range
    set forth on the cover page of this prospectus, after deducting underwriting discounts and commissions and estimated offering
    expenses. We currently intend to use the net proceeds we receive from this Offering for general corporate purposes. See &ldquo;Use
    of Proceeds&rdquo; for additional information.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT>&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif; width: 35%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Risk
    Factors</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif; width: 63%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Investing
    in our Class A Ordinary Shares involves a high degree of risk and purchasers of our Class A Ordinary Shares may lose part
    or all of their investment. See &ldquo;Risk Factors&rdquo; for a discussion of factors you should carefully consider before
    deciding to invest in our Class A Ordinary Shares beginning on Page 13. </FONT></TD></TR>
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Lock-Up</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    Series A Note Investors and the Bond holder agreed to a lock-up period of six (6) months and ninety (90) calendar days, respectively
    from the date our Class A Ordinary Shares commence trading on NASDAQ Global Market. In addition, our directors, executive
    officers, and substantially all of our existing shareholders are expected to enter into a lock-up agreement with the Underwriters
    not to sell, transfer or dispose of any Class A Ordinary Shares for a period of 180 days after the date of this prospectus.
    See &ldquo;Shares Eligible for Future Sale,&rdquo; &ldquo;Underwriting&rdquo; and &ldquo;Lock-Up Agreements&rdquo;.</FONT></TD></TR>
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dividend
    Policy</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
    have no present plan to declare dividends and plan to retain our earnings to continue to grow our business.</FONT></TD></TR>
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Voting
    Rights</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 7.45pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Shares
                                         of Class A Ordinary Share are entitled to one vote per share.</FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 7.45pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 7.45pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Shares
        of Class&nbsp;B Ordinary Share are entitled to ten votes per share.</FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 7.45pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 7.45pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Holders
        of our Class&nbsp;A Ordinary Share and Class&nbsp;B Ordinary Share will generally vote together as a single class, unless
        otherwise required by law. Mr.&nbsp;Ian Huen, who after our initial public offering will control more than [&nbsp;&nbsp;&nbsp;&nbsp;]%
        of the voting power of our outstanding ordinary share, will have the ability to control the outcome of matters submitted
        to our shareholders for approval, including the election of our directors. See &ldquo;Description of Share Capital.&rdquo;</FONT></P></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

</DIV>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Page; Sequence: 18; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"><A HREF="#toc">Table of Contents</A></P></DIV>
    <!-- Field: /Page -->

<DIV STYLE="padding: 5; border: Black 1.5pt solid; width: 98%">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Summary
Financial Data</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">The
following summary statements of operations (predecessor basis) for the year ended December 31, 2016 and for the period January
1, 2017 through February 28, 2017, as well as the related consolidated statements of operations and comprehensive loss (successor
basis) for the period March 1, 2017 through December 31, 2017, have been derived from our audited financial statements included
elsewhere in this prospectus.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">Our
management believes that the assumptions underlying our financial statements and the above allocations are reasonable. Our financial
statements, however, may not necessarily reflect our results of operations, financial position and cash flows as if we had operated
as a separate, stand-alone company during the periods presented. You should not view our historical results as an indicator of
our future performance.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">The
following table presents our summary statements of operations (predecessor basis) for the year ended December 31, 2016 and the
period January 1, 2017 through February 28, 2017.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">Selected
Statements of Operations (Predecessor Basis)</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">(In
U.S. Dollars)</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">Year
    Ended December 31, <BR> 2016</FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>January
                                         1,</B></FONT></P>
                                                                                 <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>2017</B></FONT></P>
                                                                                 <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>through</B></FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>February&nbsp;28,</B></FONT></P>
                                                                                                                                                                                                                                                           <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>2017</B></FONT></P></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">Investment income:</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 76%; text-align: left; padding-left: 9pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Dividend
    income from unaffiliated issuers</FONT></TD><TD STYLE="width: 1%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="width: 9%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">57,642</FONT></TD><TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="width: 1%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="width: 9%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt; padding-left: 9pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Interest
    income</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">28,800</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">3,011</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Total investment
    income</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">86,442</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">3,011</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">Expenses</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-left: 9pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">General and administrative
    fees</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">79,750</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">17,516</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-left: 9pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Management fees</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">641,807</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">108,958</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-left: 9pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Legal and professional
    fees</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">106,031</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">98,646</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt; padding-left: 9pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Other
    operating expenses</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">50,646</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">1,907</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Total expenses</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">878,234</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">227,027</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: bold; text-align: left; padding-bottom: 4pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Net
    investment loss</FONT></TD><TD STYLE="padding-bottom: 4pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="border-bottom: Black 4pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(791,792</FONT></TD><TD STYLE="padding-bottom: 4pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD><TD STYLE="padding-bottom: 4pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="border-bottom: Black 4pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(224,016</FONT></TD><TD STYLE="padding-bottom: 4pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Realized and unrealized losses</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-left: 9pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Net realized losses
    on investments in unaffiliated issuers</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(840,485</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(15,327</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt; padding-left: 9pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Net
    change in unrealized depreciation on investments</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(502,238</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(386,741</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Net realized
    and unrealized losses</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(1,342,723</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(402,068</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold; text-align: left; padding-bottom: 4pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Net
    decrease in net assets resulting from operations</FONT></TD><TD STYLE="padding-bottom: 4pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="border-bottom: Black 4pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(2,134,515</FONT></TD><TD STYLE="padding-bottom: 4pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD><TD STYLE="padding-bottom: 4pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="border-bottom: Black 4pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(626,084</FONT></TD><TD STYLE="padding-bottom: 4pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

</DIV>

<!-- Field: Page; Sequence: 19; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"><A HREF="#toc">Table of Contents</A></P></DIV>
    <!-- Field: /Page -->

<DIV STYLE="padding: 5; border: Black 1.5pt solid; width: 98%">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">The
following table presents our summary consolidated statement of operations and comprehensive loss (successor basis) for the period
March 1, 2017 through December 31, 2017.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">Selected
Consolidated Statement of Operations and Comprehensive Loss (Successor Basis)</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">(In
U.S. Dollars, except number of shares)</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">Expenses:</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 88%; text-align: left; padding-left: 9pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Research
    and development expenses</FONT></TD><TD STYLE="width: 1%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="width: 9%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">2,560,323</FONT></TD><TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-left: 9pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">General and administrative
    fees</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">1,480,093</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-left: 9pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Legal and professional
    fees</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">1,395,490</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt; padding-left: 9pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Other
    operating expenses</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">257,177</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Total expenses</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">5,693,083</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Other income:</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-left: 9pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Gain on investments
    in marketable securities, net</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">3,912,500</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-left: 9pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Loss on investments
    in derivatives, net</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(827,501</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-left: 9pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Interest income</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">44,269</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt; padding-left: 9pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Dividend
    income</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">2,308</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Total other income,
    net</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">3,131,576</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold; text-align: left; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Net
    loss</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(2,561,507</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Less: net loss attributable to non-controlling
    interests</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(14,045</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: bold; text-align: left; padding-bottom: 4pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Net
    loss attributable to Aptorum Group Limited</FONT></TD><TD STYLE="padding-bottom: 4pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="border-bottom: Black 4pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(2,547,462</FONT></TD><TD STYLE="padding-bottom: 4pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Net loss per share &ndash; basic and
    diluted*</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(0.09</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-bottom: 4pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Weighted-average
    shares outstanding &ndash; basic and diluted</FONT></TD><TD STYLE="padding-bottom: 4pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 4pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">26,963,435</FONT></TD><TD STYLE="padding-bottom: 4pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Net loss</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(2,561,507</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Other comprehensive
    loss</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt; padding-left: 9pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Unrealized
    loss on investments in available-for-sale securities</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(367,782</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Other comprehensive
    loss</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(367,782</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold; text-align: left; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Comprehensive
    loss</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(2,929,289</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Less: comprehensive
    loss attributable to non-controlling interests</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(14,045</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: bold; text-align: left; padding-bottom: 4pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Comprehensive
    loss attributable to the shareholders of Aptorum Group Limited</FONT></TD><TD STYLE="padding-bottom: 4pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="border-bottom: Black 4pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(2,915,244</FONT></TD><TD STYLE="padding-bottom: 4pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 24px; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    shares and per share data are presented at a weighted average basis to reflect the nominal share issuance.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">The
following table presents our summary consolidated balance sheet (successor basis) as of December 31, 2017.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">As
    of <BR> December&nbsp;31, 2017</FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 88%; text-align: left; text-indent: -10pt; padding-left: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Cash
    and restricted cash</FONT></TD><TD STYLE="width: 1%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="width: 9%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">16,725,807</FONT></TD><TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; text-indent: -10pt; padding-left: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Total
    current assets</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">20,283,399</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; text-indent: -10pt; padding-left: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Total
    assets</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">31,559,982</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; text-indent: -10pt; padding-left: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Total
    liabilities</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">1,330,734</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; text-indent: -10pt; padding-left: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Total
    equity attributable to the shareholders of Aptorum Group Limited</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">30,243,293</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; text-indent: -10pt; padding-left: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Non-controlling
    interests</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(14,045</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; text-indent: -10pt; padding-left: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Total
    equity</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">30,229,248</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; text-indent: -10pt; padding-left: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Total
    liabilities and equity</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">31,559,982</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

</DIV>

<!-- Field: Page; Sequence: 20; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"><A HREF="#toc">Table of Contents</A></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><A NAME="w3"></A>RISK
FACTORS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><I>Investing
in our Class A Ordinary Shares involves a high degree of risk. You should carefully consider the following risks and all other
information contained in this prospectus, including our financial statements, consolidated financial statements and the related
notes, before making an investment decision regarding our securities. The risks and uncertainties described below are those significant
risk factors, currently known and specific to us that we believe are relevant to an investment in our securities. If any of these
risks materialize, our business, financial condition or results of operations could suffer, the price of our Class A Ordinary
Shares could decline and you could lose part or all of your investment.</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Risks
Related to Our Financial Position and Need for Additional Capital </B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><I>We
are a Hong Kong based pharmaceutical company, currently in the preclinical stage with a limited operating history, which may make
it difficult to evaluate our current business and predict our future performance. </I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">As
of March 1, 2017, Aptorum Group Limited was restructured into its current form as an operating company (the &ldquo;Restructure&rdquo;).
Prior to that, Aptorum Group Limited was formerly known as APTUS Holdings Limited and STRIKER ASIA OPPORTUNITIES FUND CORPORATION,
which was set up on September 13, 2010, and invested primarily in U.S.-based life sciences companies on a portfolio investment
basis.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">We
have not yet demonstrated the ability to initiate or successfully complete large-scale and pivotal clinical trials, obtain regulatory
approvals, manufacture drugs at commercial scales, or arrange for others to do so on our behalf, or conduct sales and marketing
activities necessary for successful commercialization. We have not yet obtained regulatory approval for, or demonstrated an ability
to commercialize any of our drug candidates. We have no products approved for commercial sale and have not generated any revenue
from product sales. Consequently, any forecasts or assumptions regarding our future success or viability may not be as accurate
as they could be if we had a longer operating history.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">For
example, one of our major focuses is the discovery and development of innovative imaging agents for diagnosing early stage Alzheimer&rsquo;s
disease and related neurodegenerative diseases. Our limited operating history, particularly in light of the rapidly evolving Alzheimer&rsquo;s
research and treatment field, may make it difficult to evaluate our current business and prospects for future performance. Our
short history subjects any assessment of our future performance to significant uncertainty. We will encounter risks and difficulties
that are frequently experienced by early stage companies in rapidly evolving fields, as we seek to transition into a company which
is capable of supporting commercial activities. In addition, as a new business, we may be more likely to encounter unforeseen
expenses, difficulties, complications and delays due to our limited experience. If we do not address these risks and difficulties
successfully, our business will be adversely affected.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><I>We
currently do not generate revenue from product sales and may never become profitable; unless we can raise more capital through
additional financings, of which there can be no guarantee, our principal source of revenue will be from AML Clinic, which may
not be substantial.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">Our
ability to generate revenue and become profitable depends upon our ability to successfully complete the development of, and obtain
the necessary regulatory approvals for, the drug candidates in our Lead Projects and any future drug candidates we may develop,
as we do not currently have any drugs that are available for commercial sale. We expect to continue to incur losses before commercialization
of our drug candidates and any future drug candidates. None of our drug candidates has been approved for marketing in the U.S.,
Europe, the PRC or any other jurisdictions and may never receive such approval. Our ability to generate revenue and achieve profitability
is dependent on our ability to complete the development of our drug candidates and any future drug candidates we develop in our
portfolio, obtain necessary regulatory approvals, and have our drugs products under development manufactured and successfully
marketed, of which there can be no guarantee. Although AML Clinic commenced operations in June 2018 and we expect to receive some
revenue from such operations, even at full capacity, AML Clinic may not bring enough revenue to support our operation and R&amp;D.
Thus, we may not be able to generate a profit until our drug candidates become profitable.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">Even
if we receive regulatory approval and marketing authorization for one or more of our drug candidates or one or more of any future
drug candidates for commercial sale, a potential product may not generate revenue at all unless we are successful in:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 0.5in; text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 0.25in; text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">developing
    a sustainable and scalable manufacturing process for our drug candidates and any approved products, including establishing
    and maintaining commercially viable supply relationships with third parties;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">launching
    and commercializing drug candidates following regulatory approvals and marketing authorizations, either directly or with a
    collaborator or distributor;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">obtaining
    market acceptance of our drug candidates as viable treatment options;&nbsp;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 0.5in; text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 0.25in; text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">addressing
    any competing technological and market developments;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">negotiating
    and maintaining favorable terms in any collaboration, licensing or other arrangement into which we may enter to commercialize
    drug candidates for which we have obtained required approvals and marketing authorizations; and</FONT></TD></TR>
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">maintaining,
    protecting and expanding our portfolio of IP rights, including patents, trade secrets and know-how. </FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<!-- Field: Page; Sequence: 21; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"><A HREF="#toc">Table of Contents</A></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">In
addition, our ability to achieve and maintain profitability depends on timing and the amount of expenses we will incur. Our expenses
could increase materially if we are required by the FDA, CFDA, EMA or other comparable regulatory authorities to perform studies
in addition to those that we currently have anticipated. Even if our drug candidates are approved for commercial sale, we anticipate
incurring significant costs associated with the commercial launch of these products.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">Our
ability to become and remain profitable depends on our ability to generate revenue. Even if we are able to generate revenues from
AML Clinic or the sale or sublicense of any products we may develop or license, we may not become profitable on a sustainable
basis or at all. Our failure to become and remain profitable would decrease the value of our Company and adversely affect the
market price of our Class A Ordinary Shares, which could impair our ability to raise capital, expand our business or continue
our operations, and may cause you to lose all or part of your investment.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><I>AML
Clinic&rsquo;s operations may be our principal source of revenue for the foreseeable future and most likely, without additional
financing, such revenue will not be sufficient for us to carry out all of our plans. </I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">As
stated above, we have not generated any revenue and do not foresee generating any revenue from our drug candidates in the near
future. As stated elsewhere in this prospectus, effective as of March 2018, we leased the property in Central Hong Kong that is
the home to AML Clinic, which commenced operations in June 2018.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">Until
our therapeutic candidates produce revenue, our principal source of revenue shall be from AML Clinic, but we cannot guarantee
that it will provide the expected revenue, and even if expected revenue is realized, it will not be sufficient by itself to fund
our other operations. Based on the above, we will need to seek additional financing to carry out our business and meet our goals.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;<BR>
<B><I>We expect to incur net losses in each period for the foreseeable future primarily due to ongoing research and development
costs. </I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">Product
development is highly speculative because it entails substantial upfront capital expenditures and significant risk that a drug
or device candidate will fail to gain regulatory approval and/or achieve commercial viability and acceptance by patients, doctors
and payors.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">We
have devoted most of our financial resources to research and development, including licensing fees, sponsored research expenses
and our preclinical studies and CMC costs. We have not obtained marketing approvals or generated any revenue from product sales
to date, and we continue to incur significant development and other expenses related to our ongoing operations. As a result, we
are not profitable and have incurred losses in each period since our inception. For the ten months ended December 31, 2017, we
reported a consolidated net loss of $2.56 million. For the two-months ended February 28, 2017, we reported a net loss of $0.63
million based on entity level. For the twelve months ended December 31, 2016, we reported a net loss of $2.13 million. Substantially
all of our operating expenses in 2017 and 2016 were related to ongoing administrative costs and research and development costs.
In relation to fiscal 2018 and onwards, we expect Aptorum Group to continue to incur net operating losses from costs incurred
in connection with our research and development programs and from general and administrative costs associated with our operations.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">We
expect to continue to incur losses in the foreseeable future, and we expect these losses to increase as we continue the development
of and request for regulatory approvals for our drug and device candidates (in particular, for our drug candidates), and begin
to commercialize the approved drugs, if any. Typically, it takes almost ten years to develop a new drug from &ldquo;discovery
to commercialization.&rdquo; We may encounter unforeseen expenses, difficulties, complications, delays and other unknown factors
that may increase our expenses and adversely affect our ability to generate revenue. The size of our future net losses will depend,
in part, on the rate of future growth of our expenses, our ability to generate revenues and the timing and amount of milestones
and other required payments in connection with our potential future arrangements with others. If any of our drug or device candidates
fail in clinical trials or do not gain regulatory approval, or if approved, fail to achieve market acceptance, we may never become
profitable. Even if we achieve profitability in the future, we may not be able to sustain profitability in subsequent periods.
Our prior losses and expected future losses have had, and will continue to have, an adverse effect on our shareholders&rsquo;
equity and working capital.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<!-- Field: Page; Sequence: 22; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"><A HREF="#toc">Table of Contents</A></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">We
expect our R&amp;D expenses to continue to be significant in connection with our continued investment in our ongoing and preclinical
development and studies for our current drug and device candidates and any future drug candidates we may develop. Furthermore,
if we obtain regulatory approval for our drug and device candidates, we expect to incur increased sales and marketing expenses.
In addition, once we are a public company, we will incur additional costs associated with operating as a public company. As a
result, we expect to continue to incur significant and increasing operating losses and negative cash flows for the foreseeable
future. Such losses have had and will continue to have a material adverse effect on our shareholders&rsquo; equity, financial
position, cash flows and working capital.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><I>We
need to obtain additional financing to fund our future operations. If we are unable to obtain such financing, we may be unable
to complete the development and commercialization of our current or future drug candidates. </I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">According
to a 2014 Pew Trust article (http://www.pewtrusts.org/en/research-and-analysis/articles/2014/03/12/from-lab-bench-to-bedside-a-backgrounder-on-drug-development),
&ldquo;Moving a potential therapy from concept to market can take between 10 and 15 years and cost developers as much as $1 billion.&rdquo;
Furthermore, a 2018 news release from the FDA (https://www.fdanews.com/articles/185475-new-big-data-study-from-mit-puts-clinical-trial-success-rate-at-14-percent)
reported an MIT study concluding that, in the United States, one-in-seven (approximately 14%) of all drugs that enter clinical
trials after approval of an IND filing eventually win marketing approval from the FDA.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">We
have financed our operations with a combination of existing equity from shareholders, equity and debt offerings, as well as public
grants. Until December 31, 2017, we raised approximately $8.6 million in equity financing, bringing the total equity invested
in the Group to $30.2 million as of December 31, 2017. As of the date hereof, we have not received any upfront payment or milestone
payment from third parties who may sublicense our drug candidates. Our drug candidates will require the completion of regulatory
review, significant marketing efforts and substantial investment before they can provide us with any revenue from product sales
or licensing.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">Our
operations have consumed substantial amounts of cash since inception. The net cash used for our operating activities was $5.78
million, $0.27 million and $2.81 million for the ten months ended December 31, 2017, the two months ended February 28, 2017 and
the year ended December 31, 2016, respectively. We expect to continue to spend substantial amounts on discovering new drug candidates,
licensing assets, advancing the development of our drug candidates, completion of clinical supply manufacturing and manufacturing
activities at commercial scales, and launching and commercializing any drug candidates for which we receive regulatory approval,
including building our own commercial organizations to address certain markets. We need to obtain additional financing to fund
our future operations, including completing the development and commercialization of the drug candidates in our Lead Projects:
NLS-1, ALS-1 and ALS-4. We need to obtain additional financing to conduct additional preclinical studies and clinical trials for
the approval of our drug candidates, and completing the development of any additional drug candidates we discover and/or license.
Moreover, our fixed expenses such as rents, interest expenses and other contractual commitments are substantial and are expected
to increase in the future.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">Our
future funding requirements will depend on many factors, including but not limited to:&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 0.5in; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 0.25in; text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    progress, timing, scope and costs of our future preclinical development and clinical trials, including the ability to timely
    enroll patients in clinical trials; </FONT></TD></TR>
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    outcome, timing and cost of regulatory approvals by the FDA, CFDA, EMA and comparable regulatory authorities, including any
    additional studies we may be required to perform; </FONT></TD></TR>
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    cost of commercialization of our drug candidates; </FONT></TD></TR>
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    cost and timing of completion of clinical supply and our outsourced manufacturing activities at commercial scales;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: white; font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
    ability to successfully incubate and commercialize our drug candidates;</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: white; font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    amount of profit we earn from drug candidates that we succeed in commercializing, if any, including the sales prices for such
    potential products and the availability of adequate third-party reimbursement; </FONT></TD></TR>
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    amount and timing of the milestone and royalty payments we may receive from collaborators under licensing or sublicensing
    arrangements we may enter into in the future, if any; </FONT></TD></TR>
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    cost of filing, prosecuting, defending and enforcing any patent claims and other IP rights, including those which we have
    licensed from other parties; </FONT></TD></TR>
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    expenses associated with any potential future collaborations, licensing or other arrangements that we may establish; </FONT></TD></TR>
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">cash
    requirements of any future acquisitions and the development of other drug candidates; </FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 0.5in; text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 0.25in; text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    costs of operating as a public company; </FONT></TD></TR>
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    time and cost necessary to respond to technological and market developments; and</FONT></TD></TR>
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    number and characteristics of drug candidates that we may develop and expenses associated with such developments.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<!-- Field: Page; Sequence: 23; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"><A HREF="#toc">Table of Contents</A></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">We
may finance our future cash needs through public or private equity offerings and debt financings, as well as asset licenses or
sales or business combination or other restructuring transactions that generate cash for operations.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">Although
we believe that the net proceeds from this Offering, together with cash on hand and the proceeds of our recent Note and Bond offerings,
will be sufficient for us to continue to operate for the next 12 months, we may utilize our capital resources sooner than we expect.
However, such capital will not be sufficient to enable us to complete the preclinical development or commercial launch of our
current drug candidates. In addition, development of other drug candidates will require substantial additional funds. Accordingly,
we will require further funding which may not be available to us on reasonable terms, or at all. If we are unable to raise capital
when needed or on attractive terms, we would be forced to delay, reduce or completely abandon our research and development programs
or future commercialization efforts. Our inability to obtain additional funding when we needed could seriously harm our business.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><I>We
may allocate our limited resources to pursue a particular drug candidate or indication and fail to capitalize on drug candidates
or indications that may later prove to be more profitable or for which there is a greater likelihood of success.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">Because
we have limited financial and managerial resources, we must focus our licensing, research and development programs on specific
drug candidates that we identify as more likely in the current environment to achieve success. As a result, we may be forced to
forego or delay pursuit of opportunities with other drug candidates or for other indications or services that may later prove
to have greater commercial potential. Our resource allocation decisions may cause us to fail to capitalize on viable commercial
products or profitable market opportunities. In addition, if we do not accurately evaluate the commercial potential or target
market for a particular drug candidate, we may relinquish valuable rights to that drug candidate through collaboration, licensing
or other royalty arrangements when it would have been more advantageous for us to retain sole development and commercialization
rights to such drug candidate.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Risks
Related to the Preclinical and Clinical Development of Our Drug Candidates </B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><I>We
depend substantially on the success of the drug candidates being researched as our current Lead Projects, which are in the preclinical
stage of development. The preclinical development, IND-enabling, and clinical trials of our drug candidates may not be successful.
If we are unable to license or sublicense, sell or otherwise commercialize our drug candidates, or experience significant delays
in doing so, our business will be materially harmed. </I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">Our
business and the ability to generate revenue related to product sales, if ever achieved, will depend on the successful development,
regulatory approval and licensing or sublicensing or other commercialization of our drug candidates or any other drug candidates
we may develop. We have invested a significant amount of financial resources in the development of our drug candidates and we
expect to invest in other drug candidates. The success of our drug candidates and any other potential drug candidates will depend
on many factors, including but not limited to:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 0.5in; text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 0.25in; text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">successful
    enrollment in, and completion of, studies in animals and clinical trials; </FONT></TD></TR>
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">other
    parties&rsquo; ability in conducting our clinical trials safely, efficiently and according to the agreed protocol; </FONT></TD></TR>
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">receipt
    of regulatory approvals from the FDA, CFDA, EMA and other comparable regulatory authorities for our drug candidates; </FONT></TD></TR>
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
    ability to establish commercial manufacturing capabilities by making arrangements with third-party manufacturers; </FONT></TD></TR>
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">reliance
    on other parties to conduct our clinical trials swiftly and effectively; </FONT></TD></TR>
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">launch
    of commercial sales of our drug candidates, if and when approved;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">obtaining
    and maintaining patents, trade secrets and other IP protection and regulatory exclusivity, as well as protecting our rights
    in our own IP; </FONT></TD></TR>
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ensuring
    that we do not infringe, misappropriate or otherwise violate patents, trade secrets or other IP rights of other parties; </FONT></TD></TR>
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">obtaining
    acceptance of our drug candidates by doctors and patients;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 0.5in; text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 0.25in; text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">obtaining
    reimbursement from third-party payors for our drug candidates, if and when approved; </FONT></TD></TR>
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
    ability to compete with other drug candidates and drugs; and</FONT></TD></TR>
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">maintenance
    of an acceptable safety profile for our drug candidates following regulatory approval, if and when received.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<!-- Field: Page; Sequence: 24; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"><A HREF="#toc">Table of Contents</A></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">We
may not achieve regulatory approval and commercialization in a timely manner or at all. Significant delays in obtaining approval
for and/or to successfully commercialize our drug candidates would materially harm our business and we may not be able to generate
sufficient revenues and cash flows to continue our operations.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><I>We
may not be successful in our efforts to identify or discover additional drug candidates. Due to our limited resources and access
to capital, we must continue to prioritize development of certain drug candidates; such decisions may prove to be wrong and may
adversely affect our business.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">Although
we intend to explore other therapeutic opportunities in addition to the drug candidates that we are currently developing, we may
fail to identify other drug candidates for a number of reasons. For example, our research methodology may be unsuccessful in identifying
potential drug candidates or those we identify may be shown to have harmful side effects or other undesirable characteristics
that make them unmarketable or unlikely to receive regulatory approval.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">Research
programs to pursue the development of our drug candidates for additional indications and to identify new drug candidates and disease
targets require substantial technical, financial and human resources whether or not we ultimately are successful. Our research
programs may initially show promise in identifying potential indications and/or drug candidates, yet fail to yield results for
clinical development for a number of reasons, including but not limited to:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 0.5in; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 0.25in; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    research methodology used may not be successful in identifying potential indications and/or drug candidates;&nbsp;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 0.5in; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 0.25in; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">potential
    drug candidates may, after further study, be shown to have harmful adverse effects or other characteristics that indicate
    they are unlikely to be effective drugs; or&nbsp;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 0.5in; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 0.25in; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">it
    may take greater human and financial resources to identify additional therapeutic opportunities for our drug candidates or
    to develop suitable potential drug candidates through internal research programs than we will possess, thereby limiting our
    ability to diversify and expand our drug portfolio.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">Because
we have limited financial and managerial resources, we have chosen to focus at present on our three Lead Projects, which may ultimately
prove to be unsuccessful. As a result of this focus, we may forego or delay pursuit of opportunities with other drug candidates,
or for other indications that later prove to have greater commercial potential or a greater likelihood of success. Even if we
determine to pursue alternative therapeutic or diagnostic drug candidates, these other drug candidates or other potential programs
may ultimately prove to be unsuccessful. In short, our resource allocation decisions may cause us to fail to capitalize on viable
commercial products or profitable market opportunities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">Accordingly,
there can be no assurance that we will ever be able to develop suitable potential drug candidates through internal research programs.
This could materially adversely affect our future growth and prospects.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><I>If
we encounter difficulties enrolling patients in our clinical trials, our clinical development activities could be delayed or otherwise
adversely affected. </I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">While
we have not commenced any clinical trials and do not expect to start our first clinical trials until at least 2020 or 2021, assuming
we obtain approval to do so from at least one regulatory authority, of which there can be no assurance, timely completion of clinical
trials in accordance with their protocols depends, among other things, on our ability to enroll a sufficient number of patients
who meet the trial criteria and remain in the trial until its conclusion. We may experience difficulties enrolling and retaining
appropriate patients in our clinical trials for a variety of reasons, including but not limited to:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 0.5in; text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 0.25in; text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    size and nature of the patient population; </FONT></TD></TR>
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">patient
    eligibility criteria defined in the clinical protocol; </FONT></TD></TR>
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    size of study population required for statistical analysis of the trial&rsquo;s primary endpoints; </FONT></TD></TR>
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    proximity of patients to trial sites; </FONT></TD></TR>
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    design of the trial and changes to the design of the trial; </FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<!-- Field: Page; Sequence: 25; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"><A HREF="#toc">Table of Contents</A></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 0.5in; text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 0.25in; text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
    ability to recruit clinical trial investigators with the appropriate competencies and experience; </FONT></TD></TR>
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">competing
    clinical trials for similar therapies or other new therapeutics exist and will reduce the number and types of patients available
    to us; </FONT></TD></TR>
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">clinicians&rsquo;
    and patients&rsquo; perceptions as to the potential advantages and side effects of the drug candidate being studied in relation
    to other available therapies, including any new drugs or treatments that may be approved for the indications we are investigating;
    </FONT></TD></TR>
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
    ability to obtain and maintain patient consents; </FONT></TD></TR>
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">patients
    enrolled in clinical trials may not complete a clinical trial; and </FONT></TD></TR>
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">the
availability of approved therapies that are similar to our drug candidates.&nbsp;</FONT></P></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">Even
if we are able to enroll a sufficient number of patients in our clinical trials, delays in patient enrollment may result in increased
costs or may affect the timing or outcome of the planned clinical trials, which could prevent completion of these trials and adversely
affect our ability to advance the development of our drug candidates.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><I>Clinical
drug development involves a lengthy and expensive process and could fail at any stage of the process. We have limited experience
in conducting clinical trials and results of earlier studies and trials may not be reproduced in future clinical trials. </I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">For
our drug candidates, clinical testing is expensive and can take many years to complete, while failure can occur at any time during
the clinical trial process. The results of studies in animals and early clinical trials of our drug candidates may not predict
the results of later-stage clinical trials. Drug candidates in later stages of clinical trials may fail to show the desired safety
and efficacy traits despite having progressed through studies in animals and initial clinical trials. In some instances, there
can be significant variability in safety and/or efficacy results between different trials of the same drug candidate due to numerous
factors, including changes in trial procedures set forth in protocols, differences in the size and type of the patient populations
(including genetic differences), patient adherence to the dosing regimen and the patient dropout rate. Results in later trials
may also differ from earlier trials due to a larger number of clinical trial sites and additional countries and languages involved
in such trials. In addition, the design of a clinical trial can determine whether its results will support approval of a drug
candidate, and flaws in the design of a clinical trial may not become apparent until the clinical trial is well advanced and significant
expense has been incurred.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">A
number of companies in the pharmaceutical and biotechnology industries have suffered significant setbacks in advanced clinical
trials due to lack of demonstrated efficacy or adverse safety profiles, notwithstanding promising results in earlier trials. Clinical
trials of potential products often reveal that it is not practical or feasible to continue development efforts. Furthermore, if
the trials we conduct fail to meet their primary statistical and clinical endpoints, they will not support the approval from the
FDA, CFDA, EMA or other comparable regulatory authorities for our drug candidates. If this occurs, we would need to replace the
failed study with new trials, which would require significant additional expense, cause substantial delays in commercialization
and materially adversely affect our business, financial condition, cash flows and results of operations. (See &ldquo;We are subject
to risks related to the carrying out and outcome of clinical trials of medical devices&rdquo;)</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><I>If
clinical trials of our drug candidates fail to demonstrate safety and efficacy to the satisfaction of the FDA, CFDA, EMA or other
comparable regulatory authorities, or do not otherwise produce positive results, we may incur additional costs or experience delays
in completing, or ultimately be unable to complete, the development and commercialization of our drug candidates. </I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">Before
applying for and obtaining regulatory approval for the sale of any of our drug candidates, we must conduct extensive clinical
trials to demonstrate the safety and efficacy of our drug candidates in humans. Clinical testing is expensive, difficult to design
and implement, can take many years to complete and may fail. A failure of one or more of our clinical trials can occur at any
stage of testing and successful interim results of a clinical trial do not necessarily predict successful final results.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">We
and our CROs are required to comply with current Good Clinical Practices (&ldquo;cGCP&rdquo;) requirements, which are regulations
and guidelines enforced by the FDA, CFDA, EMA and other comparable regulatory authorities for all drugs in clinical development.
Regulatory authorities enforce these cGCP through periodic inspections of trial sponsors, principal investigators and trial sites.
Compliance with cGCP can be costly and if we or any of our CROs fail to comply with applicable cGCP, the clinical data generated
in our clinical trials may be deemed unreliable and the FDA, CFDA, EMA or comparable regulatory authorities may require us to
perform additional clinical trials before approving our marketing applications.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<!-- Field: Page; Sequence: 26; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"><A HREF="#toc">Table of Contents</A></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">We
may experience numerous unexpected events during, or as a result of, clinical trials that could delay or prevent our ability to
receive regulatory approval or commercialize our drug candidates, including but not limited to:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 0.5in; text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 0.25in; text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">regulators,
    institutional review boards (&ldquo;IRBs&rdquo;) or ethics committees may not authorize us or our investigators to commence
    a clinical trial or conduct a clinical trial at a prospective trial site; </FONT></TD></TR>
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">clinical
    trials of our drug candidates may produce negative or inconclusive results, and we may decide, or regulators may require us,
    to conduct additional clinical trials or abandon drug development programs; </FONT></TD></TR>
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    number of patients required for clinical trials of our drug candidates may be larger than we anticipate, enrollment may be
    insufficient or slower than we anticipate or patients may drop out at a higher rate than we anticipate; </FONT></TD></TR>
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
    contractors and investigators may fail to comply with regulatory requirements or meet their contractual obligations to us
    in a timely manner, or at all; </FONT></TD></TR>
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">we
    might have to suspend or terminate clinical trials of our drug candidates for various reasons, including a lack of clinical
    response or a determination that participants are being exposed to unacceptable health risks; </FONT></TD></TR>
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">regulators,
    IRBs or ethics committees may require that we or our investigators suspend or terminate clinical research for various reasons,
    including non-compliance with regulatory requirements; </FONT></TD></TR>
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    cost of clinical trials of our drug candidates may be greater than we anticipate; </FONT></TD></TR>
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    supply or quality of our drug candidates or other materials necessary to conduct clinical trials of our drug candidates may
    be insufficient or inadequate; and </FONT></TD></TR>
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
    drug candidates may cause adverse events, have undesirable side effects or other unexpected characteristics, causing us, our
    investigators, or regulators to suspend or terminate the trials.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">If
we are required to conduct additional clinical trials or other testing of our drug candidates beyond those that we currently contemplate,
if we are unable to successfully complete clinical trials of our drug candidates or other testing, if the results of these trials
or tests are not positive or are only modestly positive or if they raise safety concerns, we may:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 0.5in; text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 0.25in; text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">be
    delayed in obtaining regulatory approval for our drug candidates; </FONT></TD></TR>
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">not
    obtain regulatory approval at all; </FONT></TD></TR>
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">obtain
    approval for indications that are not as broad as intended; </FONT></TD></TR>
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">have
    a drug removed from the market after obtaining regulatory approval; </FONT></TD></TR>
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">be
    subject to additional post-marketing testing requirements; </FONT></TD></TR>
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">be
    subject to restrictions on how a drug is distributed or used; or </FONT></TD></TR>
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">be
    unable to obtain reimbursement for use of a drug.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">Delays
in testing or approvals may result in increases in our drug development costs. We do not know whether any clinical trials will
begin as planned, will need to be restructured, or will be completed on schedule, or at all. Clinical trials may produce negative
or inconclusive results. Moreover, these trials may be delayed or proceed less quickly than intended. Delays in completing our
clinical trials will increase our costs, slow down our drug candidate development and approval process, and jeopardize our ability
to commence product sales and generate revenues and we may not have sufficient funding to complete the testing and approval process.
Any of these events may significantly harm our business, financial condition and prospects, lead to the denial of regulatory approval
of our drug candidates or allow our competitors to bring drugs to market before we do, impairing our ability to commercialize
our drugs if and when approved.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">Significant
clinical trial delays also could shorten any periods during which we have the exclusive right to commercialize our drug candidates
or allow our competitors to bring products to market before we do, impair our ability to commercialize our drug candidates and
may harm our business and results of operations.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></P>

<!-- Field: Page; Sequence: 27; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"><A HREF="#toc">Table of Contents</A></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><I>We
may in the future conduct clinical trials for our drug candidates in sites outside the U.S. and the FDA may not accept data from
trials conducted in such locations.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">We
may in the future conduct certain of our clinical trials outside the U.S. Although the FDA may accept data from clinical trials
conducted outside the U.S. for our New Drug Application (&ldquo;NDA&rdquo;), acceptance of this data is subject to certain conditions
imposed by the FDA. There can be no assurance the FDA will accept data from any of the clinical trials we conduct outside the
U.S. If the FDA does not accept the data from any of our clinical trials conducted outside the U.S., it would likely result in
the need for additional clinical trials in the U.S., which would be costly and time-consuming and could delay or prevent the commercialization
of any of our drug candidates.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Risks
Related to Obtaining Regulatory Approval for Our Drug Candidates </B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><I>The
regulatory approval processes of the FDA, CFDA, EMA and other comparable regulatory authorities are lengthy, time-consuming and
inherently unpredictable, and if we are ultimately unable to obtain regulatory approval for our current drug candidates or any
future drug candidates we may develop, our business will be substantially harmed. </I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">We
cannot commercialize drug candidates without first obtaining regulatory approval to market each drug from the FDA, CFDA, EMA or
comparable regulatory authorities. Before obtaining regulatory approvals for the commercial sale of any drug candidate for a target
indication, we must demonstrate in studies in animals and well-controlled clinical trials, and, with respect to approval in the
United States and other regulatory agencies, to the satisfaction of the FDA, CFDA, EMA or comparable regulatory authorities, that
the drug candidate is safe and effective for use for that target indication and that the manufacturing facilities, processes and
controls are adequate.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">The
time required to obtain approval from the FDA, CFDA, EMA and other comparable regulatory authorities is unpredictable but typically
takes many years following the commencement of studies in animals and clinical trials and depends upon numerous factors, including
the substantial discretion of the regulatory authorities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">In
addition, approval policies, regulations or the type and amount of clinical data necessary to gain approval can differ among regulatory
authorities and may change during the course of the development of a drug candidate. We have not obtained regulatory approval
for any drug candidate. It is possible that neither our existing drug candidates nor any drug candidates we may discover or acquire
for development in the future will ever obtain regulatory approval. Even if we obtain regulatory approval in one jurisdiction,
we may not obtain it in other jurisdictions.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">Our
drug candidates could fail to receive regulatory approval from any of the FDA, CFDA, EMA or other comparable regulatory authorities
for many reasons, including but not limited to:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 0.5in; text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 0.25in; text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">disagreement
    with regulators regarding the design or implementation of our clinical trials; </FONT></TD></TR>
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">failure
    to demonstrate that a drug candidate is safe and effective or safe, pure and potent for its proposed indication; </FONT></TD></TR>
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">failure
    of clinical trial results to meet the level of statistical significance required for approval; </FONT></TD></TR>
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">failure
    to demonstrate that a drug candidate&rsquo;s clinical and other benefits outweigh its safety risks; </FONT></TD></TR>
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">disagreement
    with regulators regarding our interpretation of data from studies in animals or clinical trials; </FONT></TD></TR>
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">insufficiency
    of data collected from clinical trials of our drug candidates to support the submission and filing of a New Drug Application
    (&ldquo;NDA&rdquo;), or other submission or to obtain marketing approval; </FONT></TD></TR>
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    FDA, CFDA, EMA or a comparable regulatory authority&rsquo;s finding of deficiencies related to the manufacturing processes
    or facilities of third-party manufacturers with whom we contract for clinical and commercial supplies; and </FONT></TD></TR>
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">changes
    in approval policies or regulations that render our preclinical studies and clinical data insufficient for approval.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">Any
of the FDA, CFDA, EMA or other comparable regulatory authorities may require more information, including additional preclinical
studies or clinical data, to support approval, which may delay or prevent approval and our commercialization plans, or we may
decide to abandon the development program. If we were to obtain approval, regulatory authorities may approve any of our drug candidates
for fewer or more limited indications than we request. Regulatory authorities also may grant approval contingent on the performance
of costly post-marketing clinical trials, or may approve a drug candidate with a label that is not desirable for the successful
commercialization of that drug candidate. In addition, if our drug candidate produces undesirable side effects or involves other
safety issues, the FDA may require the establishment of a Risk Evaluation Mitigation Strategy (&ldquo;REMS&rdquo;), or CFDA, EMA
or other comparable regulatory authorities may require the establishment of a similar strategy. Such a strategy may, for instance,
restrict distribution of our drug candidates, require patient or physician education, or impose other burdensome implementation
requirements on us.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<!-- Field: Page; Sequence: 28; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"><A HREF="#toc">Table of Contents</A></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><I>Regulatory
approval may be substantially delayed or may not be obtained for one or all of our drug candidates if regulatory authorities require
additional time or studies to assess the safety or efficacy of our drug candidates. </I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">We
currently do not have any drug candidates that have gained approval for sale by the FDA, CFDA or EMA or other regulatory authorities
in any other country, and we cannot guarantee that we will ever have marketable drugs. Our business is substantially dependent
on our ability to complete the development of, obtain marketing approval for and successfully commercialize drug candidates in
a timely manner. We cannot commercialize drug candidates without first obtaining marketing approval from the FDA, CFDA, EMA and
comparable regulatory authorities. In the U.S., we hope to file INDs for the drug candidates from our Lead Projects and, subject
to the approval of IND, Phase 1 clinical trials in humans. Even if we are permitted to commence such clinical trials, they may
not be successful and regulators may not agree with our conclusions regarding the data generated by our clinical trials.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">We
may be unable to complete development of our drug candidates or initiate or complete development of any future drug candidates
we may develop on our projected schedule. While we believe that the net proceeds of this Offering, together with existing cash,
will likely enable us to complete the preclinical development of at least one of our current Lead Projects, even assuming we can
complete such preclinical studies for any drug candidate by 2021, the full clinical development, manufacturing and launch of that
drug candidate, will take significant additional time and likely require funding beyond the proceeds of this Offering. In addition,
if regulatory authorities require additional time or studies to assess the safety or efficacy of our drug candidates, we may not
have or be able to obtain adequate funding to complete the necessary steps for approval for our drug candidates or any future
drug candidates.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">Preclinical
studies in animals and clinical trials in humans to demonstrate the safety and efficacy of our drug candidates are time-consuming,
expensive and take several years or more to complete. Delays in preclinical or clinical trials, regulatory approvals or rejections
of applications for regulatory approval in the U.S., Europe, the PRC or other markets may result from many factors, including
but not limited to:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 0.5in; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 0.25in; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
    inability to obtain sufficient funds required to conduct or continue a trial, including lack of funding due to unforeseen
    costs or other business decisions; </FONT></TD></TR>
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">regulatory
    reports for additional analysts, reports, data, preclinical studies and clinical trials; </FONT></TD></TR>
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">failure
    to reach agreement with, or inability to comply with conditions imposed by the FDA, CFDA, EMA or other regulators regarding
    the scope or design of our clinical trials;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">regulatory
    questions regarding interpretations of data and results and the emergence of new information regarding our drug candidates
    or other products;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">delay
    or failure in obtaining authorization to commence a clinical trial or inability to comply with conditions imposed by a regulatory
    authority regarding the scope or design of a clinical trial;&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">withdrawal
    of clinical trial sites from our clinical trials as a result of changing standards of care or the ineligibility of a site
    to participate in our clinical trials;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">unfavorable
    or inconclusive results of clinical trials and supportive non-clinical studies, including unfavorable results regarding effectiveness
    of drug candidates during clinical trials;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">difficulty
    in maintaining contact with patients during or after treatment, resulting in incomplete data;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
    inability to obtain approval from IRBs or ethics committees to conduct clinical trials at their respective sites;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
    inability to enroll and retain a sufficient number of patients who meet the inclusion and exclusion criteria in a clinical
    trial;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
    inability to conduct a clinical trial in accordance with regulatory requirements or our clinical protocols; </FONT></TD></TR>
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">clinical
    sites and investigators deviating from trial protocol, failing to conduct the trial in accordance with regulatory requirements,
    withdrawing from or dropping out of a trial, or becoming ineligible to participate in a trial; </FONT></TD></TR>
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">failure
    of our clinical trial managers to satisfy their contractual duties or meet expected deadlines; </FONT></TD></TR>
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#9679;</FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">manufacturing
    issues, including problems with manufacturing or timely obtaining from third parties sufficient quantities of a drug candidate
    for use in a clinical trial;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ambiguous
    or negative interim results, or results that are inconsistent with earlier results; </FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<!-- Field: Page; Sequence: 29; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->21<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"><A HREF="#toc">Table of Contents</A></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 0.5in; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 0.25in; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">feedback
    from the FDA, CFDA, EMA, an IRB, data safety monitoring boards, or comparable entities, or results from earlier stage or concurrent
    studies in animals and clinical trials, regarding our drug candidates, including which might require modification of a trial
    protocol;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">unacceptable
    risk-benefit profile or unforeseen safety issues or adverse side effects; and</FONT></TD></TR>
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a
    decision by the FDA, CFDA, EMA, an IRB, comparable entities, or the Company, or recommendation by a data safety monitoring
    board or comparable regulatory entity, to suspend or terminate clinical trials at any time for safety issues or for any other
    reason.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">Changes
in regulatory requirements and guidance may also occur, and we may need to amend clinical trial protocols submitted to applicable
regulatory authorities to reflect these changes. Amendments may require us to resubmit clinical trial protocols to IRBs or ethics
committees for re-examination, which may increase the costs or time required to complete a clinical trial.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">If
we experience delays in the completion of, or the termination of, a clinical trial, of any of our drug candidates, the commercial
prospects of our drug candidates will be harmed, and our ability to generate product sales revenues from any of those drug candidates
will be delayed. In addition, any delay in completing our clinical trials will increase our costs, slow down our drug candidate
development and approval process, and jeopardize our ability to commence product sales and generate revenues. Any of these occurrences
may harm our business, financial condition and prospects significantly. In addition, many of the factors that cause, or lead to,
a delay in the commencement or completion of clinical trials may also ultimately lead to the denial of regulatory approval of
our drug candidates.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">If
we are required to conduct additional clinical trials or other studies with respect to any of our drug candidates beyond those
that we initially contemplated, if we are unable to successfully complete our clinical trials or other studies or if the results
of these studies are not positive or are only modestly positive, we may be delayed in obtaining regulatory approval for that drug
candidate, we may not be able to obtain regulatory approval at all or we may obtain approval for indications that are not as broad
as intended. Our product development costs will also increase if we experience delays in testing or approvals, and we may not
have sufficient funding to complete the testing and approval process. Significant clinical trial delays could allow our competitors
to bring their products to market before we do and impair our ability to commercialize our drugs, if and when approved. If any
of this occurs, our business will be materially harmed.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><I>Our
drug candidates may cause undesirable adverse events or have other properties that could delay or prevent their regulatory approval,
limit the commercial profile of an approved label, or result in significant negative consequences following any regulatory approval.
</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">Undesirable
adverse events caused by our drug candidates or any future drug candidates we may develop could cause us or regulatory authorities
to interrupt, delay or halt clinical trials and could result in a more restrictive label or the delay or denial of regulatory
approval by the FDA, CFDA, EMA or other comparable regulatory authorities. Results of our potential clinical trials could reveal
a high and unacceptable severity or prevalence of adverse effects. In such event, our trials could be suspended or terminated
and the FDA, CFDA, EMA or other comparable regulatory authorities could order us to cease further development of, or deny approval
of, our drug candidates for any or all target indications. Drug-related adverse events could also affect patient recruitment or
the ability of enrolled subjects to complete the trial, could result in potential product liability claims and may harm our reputation,
business, financial condition and business prospects significantly.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">Additionally,
if any of our current or future drug candidates receives regulatory approval, and we or others later identify undesirable side
effects caused by such drugs, a number of potentially significant negative consequences could result, including but not limited
to:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 0.5in; text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 0.25in; text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">suspending
    the marketing of the drug; </FONT></TD></TR>
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">having
    regulatory authorities withdraw approvals of the drug; </FONT></TD></TR>
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">adding
    warnings on the label; </FONT></TD></TR>
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">developing
    a REMS for the drug or, if a REMS is already in place, incorporating additional requirements under the REMS, or to develop
    a similar strategy as required by a comparable regulatory authority; </FONT></TD></TR>
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">conducting
    post-market studies; </FONT></TD></TR>
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">being
    sued and held liable for harm caused to subjects or patients; and</FONT></TD></TR>
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">damage
    to our reputation.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">Any
of these events could prevent us from achieving or maintaining market acceptance of the particular drug candidate, if approved,
and could significantly harm our business, results of operations and prospects.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<!-- Field: Page; Sequence: 30; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->22<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"><A HREF="#toc">Table of Contents</A></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><I>Even
if we receive regulatory approval for our drug candidates, we will be subject to ongoing regulatory obligations and continued
regulatory review, which may result in significant additional expense and we may be subject to penalties if we fail to comply
with regulatory requirements or experience unanticipated problems with our drug candidates. </I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">If
our drug candidates or any future drug candidates we develop are approved, they will be subject to ongoing regulatory requirements
for manufacturing, labeling, packaging, storage, advertising, promotion, sampling, record-keeping, conduct of post-marketing studies,
and submission of safety, efficacy, and other post-market information, including both federal and state requirements in the United
States and requirements of comparable regulatory authorities outside of the United States.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">Manufacturers
and manufacturers&rsquo; facilities are required to comply with extensive requirements from the FDA, CFDA, EMA and comparable
regulatory authorities, including, in the United States, ensuring that quality control and manufacturing procedures conform to
cGMP regulations. As such, our contract manufacturers will be subject to continual review and inspections to assess compliance
with cGMP and adherence to commitments made in any NDA, other marketing application, and previous responses to inspection observations.
Accordingly, we and others with whom we work must continue to expend time, money and effort in all areas of regulatory compliance,
including manufacturing, production and quality control.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">Any
regulatory approvals that we receive for our drug candidates may be subject to limitations on the approved indicated uses for
which the drug may be marketed or to the conditions of approval, or contain requirements for potentially costly post-marketing
testing, including Phase 4 clinical trials and surveillance to monitor the safety and efficacy of the drug candidate. The regulatory
authorities may also require risk management plans or programs as a condition of approval of our drug candidates (such as REMS
of the FDA and risk-management plan of the EMA), which could entail requirements for long-term patient follow-up, a medication
guide, physician communication plans or additional elements to ensure safe use, such as restricted distribution methods, patient
registries and other risk minimization tools. In addition, if the FDA, CFDA, EMA or a comparable regulatory authority approves
our drug candidates, we will have to comply with requirements including, for example, submissions of safety and other post-marketing
information and reports, registration, as well as continued compliance with cGCP and cGMP, for any clinical trials that we conduct
post-approval.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">The
FDA may impose consent decrees or withdraw approval if compliance with regulatory requirements and standards is not maintained
or if problems occur after the drug reaches the market. Later discovery of previously unknown problems with our drug candidates,
including adverse events of unanticipated severity or frequency, or with our third-party manufacturers or manufacturing processes,
or failure to comply with regulatory requirements, may result in revisions to the approved labeling to add new safety information;
imposition of post-market studies or clinical studies to assess new safety risks; or imposition of distribution restrictions or
other restrictions under a REMS program. Other potential consequences include, among other things:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 0.5in; text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 0.25in; text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">restrictions
    on the marketing or manufacturing of our drug candidates, withdrawal of the product from the market, or voluntary or mandatory
    product recalls; </FONT></TD></TR>
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">fines,
    untitled or warning letters, or holds on clinical trials; </FONT></TD></TR>
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">refusal
    by the FDA to approve pending applications or supplements to approved applications filed by us or suspension or revocation
    of license approvals; </FONT></TD></TR>
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">product
    seizure or detention, or refusal to permit the import or export of our drug candidates; and</FONT></TD></TR>
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">injunctions
    or the imposition of civil or criminal penalties.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">The
FDA strictly regulates marketing, labeling, advertising and promotion of products that are placed on the market. Companies may
promote drugs only for the approved indications and in accordance with the provisions of the approved label and may not promote
drugs for any off-label use, such as uses that are not described in the product&rsquo;s labeling and that differ from those approved
by the regulatory authorities. However, physicians may prescribe drug products for off-label uses and such off-label uses are
common across some medical specialties. Thus, they may, unbeknownst to us, use our product for an &ldquo;off label&rdquo; indication
for a specific treatment recipient. The FDA, CFDA, EMA and other regulatory authorities actively enforce the laws and regulations
prohibiting the promotion of off-label uses, and if we are found to be out of compliance with the requirements and restrictions
imposed on us under those laws and restrictions, we may be subject to significant liability, including civil and administrative
remedies as well as criminal sanctions, and the off-label use of our products may increase the risk of product liability claims.
In addition, management&rsquo;s attention could be diverted from our business operations and our reputation could be damaged.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<!-- Field: Page; Sequence: 31; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->23<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"><A HREF="#toc">Table of Contents</A></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">The
policies of the FDA, CFDA, EMA and other regulatory authorities may change and we cannot predict the likelihood, nature or extent
of government regulation that may arise from future legislation or administrative action, either in the United States or abroad.
If we are slow or unable to adapt to changes in existing requirements or the adoption of new requirements or policies, or if we
are not able to maintain regulatory compliance, we may lose any regulatory approval that we may have obtained and we may not achieve
or sustain profitability.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><I>We
may be subject to government regulations for dietary supplements </I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">The
Company may develop some of the molecules under development in formulations intended as dietary supplements. The FDA regulates
dietary supplements and drugs under different regulatory schemes, and the Company&rsquo;s dietary supplement formulations will
also be subject to other government regulation, including regulation by the Centers for Medicare &amp; Medicaid Services, or CMS,
other divisions of the U.S. Department of Health and Human Services, state and local governments and the foreign equivalents of
the FDA and these other agencies.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">For
example, the FDA regulates the research, development, preclinical and clinical testing, safety, effectiveness, record keeping,
reporting, labeling, storage processing, formulation, safety, manufacturing, packaging, labeling, advertising and distribution
import and export of pharmaceutical products under various regulatory provisions. If any dietary supplements we develop are tested
or marketed abroad, they will also be subject to extensive regulation by foreign governments, whether or not we have obtained
FDA approval for a given product and its uses. Such foreign regulation may be equally or more demanding than corresponding U.S.
regulation.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">In
addition, the regulatory policies of the agencies in the U.S. or other countries may change and additional government regulations
may be issued that could prevent, limit, or delay regulatory approval of our dietary supplement candidates, or impose more stringent
product labeling and post-marketing testing and other requirements.<BR>
<BR>
<B><I>Risks Related to Commercialization of Our Drug Candidates </I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><I>Even
if any of our drug candidates receive regulatory approval, it may fail to achieve the degree of market acceptance by physicians,
patients, third-party payors and others in the medical community necessary for commercial success. </I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">After
we complete clinical trials and receive regulatory approval for any of our drug candidates, which may not happen for some time,
we recognize that such candidate(s) may ultimately fail to gain sufficient market acceptance by physicians, patients, third-party
payors and others in the medical community. We may not be able to achieve or maintain market acceptance of our products over time
if new products or technology are introduced that are more favorably received than our products, are more cost effective or render
our drug obsolete. We will face competition with respect to our drug candidates from other pharmaceutical companies developing
products in the same disease/therapeutic area and specialty pharmaceutical and biotechnology companies worldwide. Many of the
companies against which we may be competing have significantly greater financial resources and expertise in research and development,
manufacturing, animal testing, conducting clinical trials, obtaining regulatory approvals and marketing approval for drugs than
we do. Physicians, patients and third-party payors may prefer other novel products to ours, which means that we may not generate
significant sales revenues for that product and that product may not become profitable. The degree of market acceptance of our
drug candidates, if approved for commercial sale, will depend on a number of factors, including but not limited to:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 0.5in; text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 0.25in; text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">clinical
    indications for which our drug candidates are approved; </FONT></TD></TR>
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">physicians,
    hospitals, and patients considering our drug candidates as a safe and effective treatment; </FONT></TD></TR>
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    potential and perceived advantages of our drug candidates over alternative treatments; </FONT></TD></TR>
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    prevalence and severity of any side effects; </FONT></TD></TR>
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">product
    labeling or product insert requirements of the FDA, CFDA, EMA or other comparable regulatory authorities; </FONT></TD></TR>
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">limitations
    or warnings contained in the labeling approved by the FDA, CFDA, EMA or other comparable regulatory authorities; </FONT></TD></TR>
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    timing of market introduction of our drug candidates as well as competitive drugs; </FONT></TD></TR>
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    cost of treatment in relation to alternative treatments and their relative benefits; </FONT></TD></TR>
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    availability of adequate coverage, reimbursement and pricing by third-party payors and government authorities; </FONT></TD></TR>
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">lack
    of experience and financial and other limitations on our ability to create and sustain effective sales and marketing efforts
    or ineffectiveness of our sales and marketing partners; and</FONT></TD></TR>
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">changes
    in legislative and regulatory requirements that could prevent or delay regulatory approval of our drug candidates, restrict
    or regulate post-approval activities and affect our ability to profitably sell any drug candidates for which we obtain regulatory
    approval.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<!-- Field: Page; Sequence: 32; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->24<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"><A HREF="#toc">Table of Contents</A></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Risks
Related to Our IP </B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><I>A
significant portion of our IP portfolio currently includes pending patent applications that have not yet been issued as granted
patents and if the pending patent applications covering our product candidates fail to be issued, our business will be adversely
affected. If we or our licensors are unable to obtain and maintain patent protection for our technology and drugs, our competitors
could develop and commercialize technology and drugs similar or identical to ours, and our ability to successfully commercialize
our technology and drugs may be adversely affected. </I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">Our
success depends largely on our ability to obtain and maintain patent protection <FONT STYLE="background-color: white">and other
forms of IP rights for the composition of matter, method of use and/or method of manufacture for each of our drug candidates.
Failure to obtain, maintain protection, enforce or extend adequate patent and other IP rights could materially adversely affect
our ability to develop and market one or more of our drug candidates. We also rely on trade secrets and know-how to develop and
maintain our proprietary and IP position for each of our drug candidates. Any failure to protect our trade secrets and know-how
with respect to any specific drug and device candidate could adversely affect the market potential of that potential product.</FONT></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">As
of the date of the prospectus, the Company has, through its licenses, obtained rights to patents and patent applications covering
some or all its drug and device candidates that have been filed in major jurisdictions such as the United States, member states
of the European Patent Organization (the &ldquo;EPO&rdquo;) and the PRC (collectively, &ldquo;Major Patent Jurisdictions&rdquo;),
as well as in other countries. As of the date hereof, we are the exclusive licensee of 12 U.S. patents and 5 pending U.S. non-provisional
applications, as well as corresponding patents and patent applications internationally. In addition, we are the exclusive licensee
of 4 international patent applications under the Patent Cooperation Treaty (the &ldquo;PCT&rdquo;) which we have filed and/or </FONT><FONT STYLE="font-family: Times New Roman, Times, Serif">plan
to file nationally in member states of the EPO, PRC and other jurisdictions before the expiration of the time limits for entry
of national stage application. Moreover, we are the owner of 1 U.S. provisional patent application. To the extent we do not seek
or obtain patent protection in a particular jurisdiction, we may not have commercial incentive to seek marketing authorization
in such jurisdiction. Nonetheless, other parties might enter those markets with generic versions or copies of our products and
received regulatory approval without having significantly invested in their own research and development costs compared to the
Company&rsquo;s investment. For more information about our IP portfolio, please refer to the Intellectual Property section below.</FONT></P>





<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">With
respect to issued patents in certain jurisdictions, for example in the U.S. and under the EPO, we may be entitled to obtain a
patent term extension to extend the patent expiration date provided we meet the applicable requirements for obtaining such patent
term extensions. We have sought to support our proprietary position by working with our licensors in filing patent applications
in the names of the licensors in the United States and through the PCT, related to the Lead Projects and certain other drug candidates.
In the future, we intend to file patent applications on supplemental or improvement IP derived from the licensed technologies,
where those IP would be solely or jointly owned by the Company pursuant to the terms of respective license agreements. Filing
patents covering multiple technologies in multiple countries is time-consuming and expensive, and we may not have the resources
file and prosecute all necessary or desirable patent applications in a timely manner. It is also possible that we will fail to
identify patentable aspects of our research and development output before it is too late to obtain patent protection.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">We
cannot be certain that patents will be issued or granted with respect to patent applications that are currently pending, or that
issued or granted patents will not later be found to be invalid or unenforceable.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">The
patent position of biotechnology and pharmaceutical companies is generally uncertain because it involves complex legal and factual
considerations. The standards applied by the EPO, the U.S. Patent and Trademark Office, or USPTO, and foreign patent offices in
granting patents are not always applied uniformly or predictably. For example, there is no uniform worldwide policy regarding
patentable subject matter or the scope of claims allowable in biotechnology and pharmaceutical patents. Consequently, patents
may not issue from our pending patent applications and even if they do issue, such patents may not issue in a form that effectively
prevents others from commercializing competing products. As such, we do not know the degree of future protection that we will
have on our proprietary products and technology.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<!-- Field: Page; Sequence: 33; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->25<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"><A HREF="#toc">Table of Contents</A></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">Additionally,
the issuance of a patent is not conclusive as to its inventorship, scope, validity or enforceability, and our patents may be challenged
in the courts or patent offices in the United States and abroad. Even if patents do successfully issue and even if such patents
cover our drug candidates, other parties may initiate, for patents filed before March 16, 2013 (i.e., the enactment of the America
Invents Act), interference or re-examination proceedings, for patents filed on or after March 16, 2013, post-grant review,&nbsp;<I>inter
partes</I>&nbsp;review, nullification or derivation proceedings, in court or before patent offices, or similar proceedings challenging
the validity, enforceability or scope of such patents, which may result in the patent claims being narrowed or invalidated. Successful
defense of its patents can constitute a material factor in a company&rsquo;s expenses. According to an August 2017 article published
by Bloomberg News (https://www.bna.com/cost-patent-infringement-n73014463011/), depending on the value at stake, the American
Intellectual Property Law Association&rsquo;s &ldquo;2017 Report of the Economic Survey&rdquo; reported the average cost of a
patent litigation in 2017 to be $1.7 million.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; background-color: white">In
addition, the fact that the Company has exclusive rights to prevent others from using a patented invention does not </FONT><FONT STYLE="font-family: Times New Roman, Times, Serif">necessarily
<FONT STYLE="background-color: white">mean that the Company itself will have the unrestricted right to use that invention. </FONT>Other
parties may obtain ownership or licenses to patents or other IP rights that cover the manufacture, use or sale of our current
or future products (or elements thereof). <FONT STYLE="background-color: white">This may enable such other parties to enforce
their patents or IP rights against us, and may, as a result, affect the commercialization of our products or exploitation of our
own technology</FONT>. <FONT STYLE="background-color: white">We endeavor to identify early patents and patent applications which
may block development of a product or technology and minimize this risk by conducting prior art searches before and during the
projects. However, relevant documents may be overlooked, yet-to-be published or missed, which may in turn impact on the freedom
to commercialize the relevant asset.</FONT> In such cases, we may not be in a position to develop or commercialize products or
drug candidates unless we successfully pursue litigation to nullify or invalidate the other IP rights concerned, or enter into
a license agreement with the IP right holder, if available on commercially reasonable terms.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><I>If
we are unable to obtain and maintain the appropriate scope for our patents, our competitors could develop and commercialize technology
and drugs similar or identical to ours, and our ability to successfully commercialize our technology and drugs may be adversely
affected.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">We
may not obtain sufficient claim scope in those patents to prevent another party from competing successfully with our drug and
device candidates. Even if our patent applications issue as patents, they may not issue in a form that will provide us with any
meaningful protection, prevent competitors from competing with us or otherwise provide us with any competitive advantage. Our
competitors may be able to circumvent our patents by developing similar or alternative technology or drug and device candidates
in a non-infringing manner. The issuance of a patent is not conclusive as to its scope, validity or enforceability, and our patents
may be challenged in the courts or patent offices in the United States and abroad. Such challenges may result in patent claims
being narrowed, invalidated or held unenforceable, which could limit our ability to stop or prevent us from stopping others from
using or commercializing similar or identical technology and drug and device candidates, or limit the duration of the patent protection
of our technology and drug and device candidates. Given the amount of time required for the development, testing and regulatory
review of new drug and device candidates, patents protecting such candidates might expire before or shortly after such candidates
are commercialized. As a result, our patent portfolio may not provide us with sufficient rights to exclude others from commercializing
drug and device candidates similar or identical to ours.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">Further,
the issuance, scope, validity, enforceability and commercial value of our and our current or future licensors&rsquo; or collaboration
partners&rsquo; patent rights are highly uncertain. Our and our licensors&rsquo; pending and future patent applications may not
result in patents being issued which protect our technology or products, in whole or in part, or which effectively prevent others
from commercializing competitive technologies and products.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><I>We
may not be able to protect and enforce our IP rights throughout the world. </I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">Our
commercial success will depend, in part, on our ability to maintain IP protection for our drug candidates in which we seek to
develop and commercialize. While we rely primarily upon a combination of patents, trademarks, trade secrets and other contractual
obligations to protect the IP related to our brands, products and other proprietary technologies, these legal means may afford
only limited protection.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">Filing
and prosecuting patents on drug candidates and defending the validity of the same (if challenged) in all countries throughout
the world could be prohibitively expensive for us, and our IP rights in countries outside the Major Patent Jurisdictions can be
less extensive than those in the Major Patent Jurisdictions. In addition, the laws of some countries in the rest of the world
such as India do not protect IP rights to the same extent as laws in the Major Patent Jurisdictions. Consequently, we may not
be able to prevent other parties from practicing our inventions in the rest of the world. Competitors may use our technology in
jurisdictions where we have not or not yet obtained patent protection to develop their own drugs and further, may export otherwise
infringing drugs to non-U.S. jurisdictions where we have patent protection.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">Our,
our licensors&rsquo; or collaboration partners&rsquo; patent applications cannot be enforced against other parties practicing
the technology claimed in such applications unless and until a patent issues from such applications, and then only to the extent
the issued claims cover the technology. In addition, patents and other IP rights also will not protect our technology, drug candidates
if another party, including our competitors, design around our protected technology, drug candidates without infringing, misappropriating
or otherwise violating our patents or other IP rights.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<!-- Field: Page; Sequence: 34; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->26<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"><A HREF="#toc">Table of Contents</A></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">Moreover,
currently and as our R&amp;D continues to progress, some of our patents and patent applications are or may be co-owned with another
party. Some of our licenses already provide that future-developed technologies (and any resulting patents) will be co-owned with
the licensors and other patents for technologies we may acquire or develop with other parties may also be jointly owned. If we
are unable to obtain an exclusive license to any such co-owners&rsquo; interest in such patents or patent applications, such co-owners
may be able to license their rights to other persons, including our competitors, and our competitors could market competing products
and technology, and we will be unable to transfer or grant exclusive rights to potential purchasers or development partners of
such co-owned technologies. In addition, we may need the cooperation of any such co-owners of our patents in order to enforce
such patents against other parties, and such cooperation may not be provided to us. Any of the foregoing could limit the revenue
we might generate from our patents or patent applications and thus have a material adverse effect on our competitive position,
business, financial conditions, results of operations, and prospects.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">Because
patent applications are confidential for a period of time after filing, and some remain so until issued, we cannot be certain
that we or our licensors or collaborators were or will be the first to file any patent application related to a drug or device
candidate. Furthermore, in the United States, if patent applications of other parties have an effective filing date before March&nbsp;16,
2013, an interference proceeding can be initiated by such other party to determine who was the first to invent any of the subject
matter covered by the patent claims of our applications. If patent applications of other parties have an effective filing date
on or after March&nbsp;16, 2013, in the United States a derivation proceeding can be initiated by such other parties to determine
whether our invention was derived from theirs.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">Even
where we have a valid and enforceable patent, we may not be able to exclude others from practicing our invention where the other
party can show that they used the invention in commerce before our filing date or the other party benefits from a compulsory license.
In addition, we may be subject to other challenges regarding our exclusive ownership of our IP. If another party were successful
in challenging our exclusive ownership of any of our IP, we may lose our right to use such IP, such other party may be able to
license such IP to other parties, including our competitors, and our competitors could market competing products and technology.
Any of the foregoing could have a material adverse effect on our competitive position, business, financial conditions, results
of operations, and prospects.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">Many
companies have encountered significant problems in protecting and defending IP rights in jurisdictions outside Major Patent Jurisdictions.
The legal systems of some countries do not favor the enforcement of patents, trade secrets and other IP, which could make it difficult
in those jurisdictions for us to stop the infringement or misappropriation of our patents or other IP rights, or the marketing
of competing drugs in violation of our proprietary rights generally.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">To
date, we have not sought to enforce any issued patents in any jurisdictions. Proceedings to enforce our patent and other IP rights
in any jurisdictions could result in substantial costs and divert our efforts and attention from other aspects of our business.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">Furthermore,
such proceedings could put our patents at risk of being invalidated, held unenforceable, or interpreted narrowly, could put our
patent applications at risk of not issuing, and could provoke other parties to assert claims of infringement or misappropriation
against us. We may not prevail in any lawsuits that we initiate in jurisdictions where opposition proceedings are available and
the damages or other remedies awarded, if any, may not be commercially meaningful. The requirements for patentability may differ
in certain countries, particularly developing countries. Certain countries in Europe, the PRC, and developing countries including
India, have compulsory licensing laws under which a patent owner may be compelled to grant licenses to other parties. In those
countries, we and our licensors may have limited remedies if patents are infringed or if we or our licensors are compelled to
grant a license to another party, which could materially diminish the value of those patents. This could limit our potential revenue
opportunities. Accordingly, our efforts to enforce our IP rights around the world may be inadequate to obtain a significant commercial
advantage from the IP that we develop.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><I>We
may become involved in lawsuits to protect or enforce our IP, which could be expensive, time-consuming and unsuccessful. Our patent
rights relating to our drug and device candidates could be found invalid or unenforceable if challenged in court or before the
USPTO or comparable non-U.S. authority.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">Competitors
may infringe our patent rights or misappropriate or otherwise violate our IP rights. To counter infringement or unauthorized use,
litigation may be necessary in the future to enforce or defend our IP rights, to protect our trade secrets or determine the validity
and scope of our own IP rights or the proprietary rights of others. This can be expensive and time-consuming. Any claim that we
assert against perceived infringers could also provoke these parties to assert counterclaims against us alleging that we infringe
their IP rights. Many of our current and potential competitors have the ability to dedicate substantially greater resources to
enforce and/or defend their IP rights than we can. Accordingly, despite our efforts, we may not be able to prevent other parties
from infringing upon or misappropriating our IP. Litigation could result in substantial costs and diversion of management resources,
which could harm our business and financial results. In addition, in an infringement proceeding, a court may decide that patent
rights or other IP rights owned by us are invalid or unenforceable, or may refuse to stop the other party from using the technology
at issue on the grounds that our patent rights or other IP rights do not cover the technology in question. An adverse result in
any litigation proceeding could put our patent, as well as any patents that may issue in the future from our pending patent applications,
at risk of being invalidated, held unenforceable or interpreted narrowly. Furthermore, because of the substantial amount of discovery
required in connection with IP litigation, there is risk that some of our confidential information could be compromised by disclosure
during this type of litigation.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<!-- Field: Page; Sequence: 35; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->27<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"><A HREF="#toc">Table of Contents</A></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">If
we initiate legal proceedings against another party to enforce our patent, or any patents that may be issued in the future from
our patent applications, that relates to one of our drug and device candidates, the defendant could counterclaim that such patent
rights are invalid or unenforceable. In patent litigation in the United States, defendant counterclaims alleging invalidity or
unenforceability are commonplace, and there are numerous grounds upon which another party can assert invalidity or unenforceability
of a patent. Parties may also raise similar claims before administrative bodies in the United States or abroad, even outside the
context of litigation. Such mechanisms include ex parte re-examination, <I>inter partes</I> review, post-grant review, derivation
and equivalent proceedings in non-U.S. jurisdictions, such as opposition proceedings. Such proceedings could result in revocation
or amendment to our patents in such a way that they no longer cover and protect our drug and device candidates. With respect to
the validity of our patents, for example, there may be invalidating prior art of which we, our patent counsel, and the patent
examiner were unaware during prosecution. If a defendant were to prevail on a legal assertion of invalidity and/or unenforceability,
we would lose at least part, and perhaps all, of the patent protection on our drug and device candidates. Such a loss of patent
protection could have a material adverse impact on our business.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">We
may not be able to prevent misappropriation of our trade secrets or confidential information, particularly in countries where
the laws may not protect those rights as fully as in the United States. Furthermore, because of the substantial amount of discovery
required in connection with IP litigation, there is a risk that some of our confidential information could be compromised by disclosure
during this type of litigation.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><I>We
may be subject to claims challenging the inventorship of our patents and other IP. </I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">Although
we are not currently experiencing any claims challenging the inventorship of our patents or ownership of our IP, we may in the
future be subject to claims that former employees, collaborators or other parties have an interest in our patents or other IP
as inventors or co-inventors. For example, we may have inventorship disputes arise from conflicting obligations of consultants
or others who are involved in developing our drug and device candidates and who have not clearly contracted to transfer or assign
any rights they may have to the Company. In addition, for our licensed patents, although a majority of our licensors have procured
assignment forms and records from inventors to affirm their ownership in the licensed IP, a<FONT STYLE="background-color: white">nother
party or former employee or collaborator of our licensors not named in the patents may challenge the inventorship of claim an
ownership interest in one or more of our or our licensors&rsquo; patents. </FONT>Litigation may be necessary to defend against
these and other claims challenging inventorship. If we fail in defending any such claims, in addition to paying monetary damages,
we may lose rights such as exclusive ownership of, or right to use, our patent rights or other IP. Such an outcome could have
a material adverse effect on our business. Even if we are successful in defending against such claims, litigation could result
in substantial costs and be a distraction to management and other employees.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><I>If
we are sued for infringing IP rights of other parties, such litigation could be costly and time-consuming and could prevent or
delay us from developing or commercializing our drug candidates, the outcome of which would be uncertain and could have a material
adverse effect on the success of our business. </I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">Our
commercial success depends in part on our avoiding infringement of the patents and other IP rights of other parties. There is
a substantial amount of litigation involving patent and other IP rights in the biotechnology and pharmaceutical industries. Numerous
issued patents, provisional patents and pending patent applications, which are owned by other parties, exist in the fields in
which we are developing drug candidates. As the biotechnology and pharmaceutical industries expand and more patents are issued,
the risk increases that our drug candidates may give rise to claims of infringement of the patent rights of others.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">Other
parties may assert that we are employing their proprietary technology without authorization. There may be other patents of which
we are currently unaware with claims to materials, formulations, methods of manufacture or methods for treatment related to the
use or manufacture of our drug candidates. Because patent applications can take many years to issue, there may be currently pending
patent applications or provisional patents which may later result in issued patents that our drug candidates may infringe. In
addition, other parties may obtain patents in the future and claim that use of our technology infringes upon these patents. If
any other patents were held by a court of competent jurisdiction to cover the manufacturing process of any of our drug candidates,
any molecules formed during the manufacturing process or any final drug itself, the holders of any such patents may be able to
prevent us from commercializing such drug candidate unless we obtain a license under the applicable patents, or until such patents
expire or they are finally determined to be held invalid or unenforceable. Similarly, if any other patent were held by a court
of competent jurisdiction to cover aspects of our formulations, processes for manufacture or methods of use, including combination
therapy or patient selection methods, the holders of any such patent may be able to block our ability to develop and commercialize
the applicable drug candidate unless we obtain a license, limit our uses, or until such patent expires, or is finally determined
to be held invalid or unenforceable. In either case, such a license may not be available on commercially reasonable terms or at
all.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<!-- Field: Page; Sequence: 36; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->28<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"><A HREF="#toc">Table of Contents</A></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">Other
parties who bring successful claims against us for infringement of their IP rights may obtain injunctive or other equitable relief,
which could prevent us from developing and commercializing one or more of our drug candidates. Defense of these claims, regardless
of their merits, would involve substantial litigation expense and be a substantial diversion of employee resources from our business.
In the event of a successful claim of infringement or misappropriation against us, we may have to pay substantial damages, including
treble damages and attorneys&rsquo; fees in the case of willful infringement, obtain one or more licenses from other parties,
pay royalties or redesign our infringing drug candidates, which may be impossible or require substantial time and monetary expenditure.
In the event of an adverse result in any such litigation, or even in the absence of litigation, we may need to obtain licenses
from other parties to advance our research or allow commercialization of our drug candidates. Any required license may not be
available at all, or may not be available on commercially reasonable terms. In the event that we are unable to obtain such a license,
we would be unable to further develop and commercialize one or more of our drug candidates, which could harm our business significantly.
We may also elect to enter into license agreements in order to settle patent infringement claims or resolve disputes prior to
litigation, and any such license agreements may require us to pay royalties and other fees that could significantly reduce our
profitability for any product related to that patent and thus harm our business.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">Even
if resolved in our favor, litigation or other legal proceedings relating to IP claims may cause us to incur significant expenses,
and could distract our technical personnel, management personnel, or both from their normal responsibilities. In addition, there
could be public announcements of the results of hearings, motions or other interim proceedings or developments, and if securities
analysts or investors perceive these results to be negative, it could have a substantial adverse effect on the market price of
our Class A Ordinary Shares. Such litigation or proceedings could substantially increase our operating losses and reduce the resources
available for development activities or any future sales, marketing or distribution activities. We may not have sufficient financial
or other resources to adequately conduct such litigation or proceedings. Some of our competitors may be able to sustain the costs
of such litigation or proceedings more effectively than we can because of their greater financial resources. Uncertainties resulting
from the initiation and continuation of patent litigation or other proceedings could have a material adverse effect on our ability
to compete in the marketplace.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><I>There
may be patent applications pending of which we are not aware, but which cover similar products to the ones we are attempting to
license or develop, which may result in lost time and money, as well as litigation. </I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">It
is possible that we have failed to identify relevant outstanding patents or applications. For example, U.S. applications filed
before November&nbsp;29, 2000 and certain U.S. applications filed after that date that will not be filed outside the United States
remain confidential until patents are issued. Patent applications filed in the United States after November 29, 2000 and generally
filed elsewhere are published approximately 18 months after the earliest filing for which priority is claimed, with such earliest
filing date being commonly referred to as the priority date. Therefore, patent applications covering our products could have been
filed by others without our knowledge. Additionally, pending patent applications which have been published can, subject to certain
limitations, be later amended in a manner that could cover our products or the use of our products. Holders of any such unanticipated
patents or patent applications may actively bring infringement claims against us, with the same potential litigation consequences
as alluded to elsewhere in this Prospectus. Any of these events could require us to divert substantial financial and management
resources that we would otherwise be able to devote to our business.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><I>Obtaining
and maintaining our patent protection depends on compliance with various procedural, document submission, fee payment, and other
requirements imposed by governmental patent agencies, and our patent protection could be reduced or eliminated for non-compliance
with these requirements. </I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">Periodic
maintenance fees on any issued patent are due to be paid to the USPTO and other patent agencies in several stages over the lifetime
of the patent. The USPTO and various non-U.S. governmental patent agencies require compliance with a number of procedural, documentary,
fee payment, and other similar provisions during the patent application process. Although an inadvertent lapse can in many cases
be cured by payment of a late fee or by other means in accordance with the applicable rules, there are situations in which non-compliance
can result in abandonment or lapse of the patent or patent application, resulting in partial or complete loss of patent rights
in the relevant jurisdiction. Non-compliance events that could result in abandonment or lapse of a patent or patent application
include failure to respond to official actions within prescribed time limits, non-payment of fees, and failure to properly submit
documents requesting an extension of time. In any such event, our competitors might be able to enter the market, which would have
a material adverse effect on our business.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<!-- Field: Page; Sequence: 37; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->29<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"><A HREF="#toc">Table of Contents</A></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><I>The
terms of our patents may not be sufficient to effectively protect our drug and device candidates and business. </I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">In
most countries in which we file, including the United States, the term of an issued patent is generally 20 years from the earliest
claimed filing date of a non-provisional patent application in the applicable country. Although various extensions may be available,
the life of a patent and the protection it affords is limited. For example, depending upon the timing, duration and specifics
of the FDA regulatory approval for our drug candidates, one or more of our U.S. patents, if issued, might be eligible for limited
patent term restoration under the Drug Price Competition and Patent Term Restoration Act of 1984, referred to as the Hatch-Waxman
Amendments. The Hatch-Waxman Amendments permit a patent term extension of up to five years as compensation for patent term lost
during drug development and the FDA regulatory review process. Patent term extensions, however, cannot extend the remaining term
of a patent beyond a total of 14 years from the date of drug approval by the FDA, and only one patent can be extended for a particular
drug. The application for patent term extension is subject to approval by the USPTO, in conjunction with the FDA. We may not be
granted an extension because of, for example, failing to apply within applicable deadlines, failing to apply prior to expiration
of relevant patents or otherwise failing to satisfy applicable requirements. Moreover, the applicable time period or the scope
of patent protection afforded could be less than we request. If we are unable to obtain a patent term extension for a given patent
or the term of any such extension is less than we request, the period during which we will have the right to exclusively market
our drug will be that of the originally issued patents themselves.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">Even
if patents covering one of our drug candidates are obtained, thereby giving us a period of exclusivity for manufacturing and marketing
that drug, we will not be able to assert such patent rights upon the expiration of the issued patents against potential competitors
who may begin marketing generic copies of our medications, and our business and results of operations may be adversely affected.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><I>Changes
in patent law in the United States could diminish the value of patents in general, thereby impairing our ability to protect our
drug and device candidates. </I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">The
United States has recently enacted and is currently implementing wide-ranging patent reform legislation. Recent U.S. Supreme Court
rulings have narrowed the scope of patent protection available in certain circumstances and weakened the rights of patent owners
in certain situations. In addition to increasing uncertainty with regard to our ability to obtain patents in the future, this
combination of events has created uncertainty with respect to the value of patents once obtained, if any. Depending on decisions
by the U.S. Congress, the federal courts and the USPTO, the laws and regulations governing patents in the United States could
change in unpredictable ways that would weaken our ability to obtain new patents, or to enforce our existing patents and patents
that we might obtain in the future. For example, in a recent case, <I>Assoc. for Molecular Pathology v. Myriad Genetics, Inc.</I>,
the U.S. Supreme Court held that certain claims to naturally-occurring substances are not patentable. Although we do not believe
that any of the patents owned or licensed by us will be found invalid based on this decision, future decisions by the courts,
the U.S. Congress or the USPTO may impact the value of our patent rights. There could be similar changes in the laws of foreign
jurisdictions that may impact the value of our patent rights or our other IP rights.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">In
addition, recent patent reform legislation in the U.S., including the Leahy-Smith America Invents Act, or the America Invents
Act, could increase those uncertainties and costs. The America Invents Act was signed into law on September&nbsp;16, 2011, and
many of the substantive changes became effective on March&nbsp;16, 2013. The America Invents Act reforms U.S. patent law in part
by changing the U.S. patent system from a &ldquo;first to invent&rdquo; system to a &ldquo;first inventor to file&rdquo; system,
expanding the definition of prior art, and developing a post-grant review system, thus changing the U.S. patent law in a way that
may weaken our ability to obtain patent protection in the U.S. for those applications filed after March&nbsp;16, 2013. Further,
the America Invents Act created new procedures to challenge the validity of issued patents in the U.S., including post-grant review
and<I>&nbsp;inter </I>partes&nbsp;review proceedings, which some other parties have been using to cause the cancellation of selected
or all claims of issued patents of competitors. For a patent with an effective filing date of March&nbsp;16, 2013 or later, a
petition for post-grant review can be filed by another party in a nine-month window from issuance of the patent. A petition for<I>&nbsp;inter
partes</I>&nbsp;review can be filed immediately following the issuance of a patent if the patent has an effective filing date
prior to March&nbsp;16, 2013. A petition for<I>&nbsp;inter partes</I>&nbsp;review can be filed after the nine-month-period for
filing a post-grant review petition has expired for a patent with an effective filing date of March&nbsp;16, 2013 or later. Post-grant
review proceedings can be brought on any ground of invalidity, whereas<I>&nbsp;inter partes</I>&nbsp;review proceedings can only
raise an invalidity challenge based on published prior art and patents. These adversarial actions at the USPTO review patent claims
without the presumption of validity afforded to U.S. patents in lawsuits in U.S. federal courts, and use a lower burden of proof
than used in litigation in U.S. federal courts. Therefore, it is generally considered easier for a competitor or other party to
have a U.S. patent invalidated in a USPTO post-grant review or <I>inter partes</I>&nbsp;review proceeding than invalidated in
a litigation in a U.S. federal court. If any of our patents are challenged by another party in such a USPTO proceeding, there
is no guarantee that we or our licensors or collaborators will be successful in defending the patent, which would result in our
loss of the challenged patent right.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<!-- Field: Page; Sequence: 38; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->30<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"><A HREF="#toc">Table of Contents</A></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><I>If
we are unable to protect the confidentiality of our trade secrets, our business and competitive position would be harmed. </I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">In
addition to our issued patents, provisional patent, and pending patent applications, we expect to rely on trade secrets, including
unpatented know-how, technology and other proprietary information, to maintain our competitive position and protect our drug and
device candidates. We seek to protect these trade secrets, in part, by entering into non-disclosure and confidentiality agreements
with parties that have access to them, such as our employees, corporate collaborators, outside scientific collaborators, sponsored
researchers, contract manufacturers, consultants, advisors and other parties. We also enter into confidentiality and invention
or patent assignment agreements with our employees and consultants. However, any of these parties may breach such agreements and
disclose our proprietary information, and we may not be able to obtain adequate remedies for such breaches. Enforcing a claim
that a party illegally disclosed or misappropriated a trade secret can be difficult, expensive and time-consuming, and the outcome
is unpredictable. If trade secrets which are material to our business were to be obtained by a competitor, our competitive position
would be harmed.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><I>We
may be subject to claims that our employees have wrongfully used or disclosed alleged trade secrets of their former employers.
</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">Although
we try to ensure that our employees do not use the proprietary information or know-how of others in their work for us, we may
be subject to claims that we or these employees have used or disclosed IP, including trade secrets or other proprietary information,
of any such employee&rsquo;s former employer. In addition, while we typically require our employees, consultants and contractors
who may be involved in the development of IP to execute agreements assigning such IP to us, we may be unsuccessful in executing
such an agreement with each party who in fact develops IP that we regard as our own, which may result in claims by or against
us related to the ownership of such IP. We are not aware of any threatened or pending claims that any of our projects involve
misappropriated IP or other proprietary information, but in the future litigation may be necessary to defend against such claims.
If we fail in defending any such claims, in addition to paying monetary damages, we may lose valuable IP rights. Even if we are
successful in defending against such claims, litigation could result in substantial costs and be a distraction to management.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><I>We
may be unable to execute on the optimal development plan for one or more of our existing product candidates if we are unable to
obtain or maintain necessary rights for some aspect of the developing technology through acquisitions or licenses. </I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">Our
existing programs currently use or may in the future use additional technologies subject to proprietary rights held by others,
such as particular compositions or methods of manufacture, treatment or use. The licensing and acquisition of IP rights is a competitive
area, and more established companies may pursue strategies to license or acquire such IP rights that we may consider necessary
or useful. These established companies may have a competitive advantage over us due to their size, cash resources and greater
capabilities in clinical development and commercialization.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">In
addition, companies that perceive us to be a competitor may be unwilling to assign or license rights to us. We also may be unable
to license or acquire IP rights on terms that would allow us to make an appropriate return on our investment. If we are unable
to successfully obtain or maintain licenses or other rights from other parties to use IP of those parties, our business, financial
condition and prospects for growth could suffer.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><I>If
we fail to comply with our obligations in the agreements under which we license IP rights from other parties or otherwise experience
disruptions to our business relationships with our licensors, we could be required to pay monetary damages or could lose license
rights that are important to our business.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">Many
of our projects (including our Lead Projects) are based on IP which we have licensed from other parties. (See &ldquo;Our Business
&ndash; Intellectual Property&rdquo;) Certain of these license agreements impose diligence, development or commercialization obligations
on us, such as obligations to pay royalties on net product sales of our drug and device candidates once commercialized by us,
to pay a percentage of sublicensing revenues if the licensed product is sublicensed, to make other specified milestone and/or
annual payments relating to our drug candidates or to pay license maintenance and other fees, as well as obligations to pursue
commercialization with due diligence. Specifically, a number of our license agreements also require us to meet development timelines
in order to maintain the related license(s). In spite of our efforts, our licensors might conclude that we have materially breached
our obligations under such license agreements and might therefore seek to terminate the license agreements. If one of our licensors,
despite our efforts, were to be successful in terminating its agreement with us, we would not be able to continue to develop,
manufacture or market any drug candidate under that license agreements, and we could face claims for monetary damages or other
penalties under that agreement. Such an occurrence would diminish or eliminate the value of that project to our Company, even
if we are able to negotiate new or reinstated agreements, which may have less favorable terms. Depending on the importance of
the IP and the related project, any such development could have a material adverse effect on our competitive position, business,
financial conditions, results of operations, and prospects.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<!-- Field: Page; Sequence: 39; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->31<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"><A HREF="#toc">Table of Contents</A></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">Moreover,
disputes may arise regarding intellectual property subject to a licensing agreement, including:&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 0.5in; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: top; width: 0.25in; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="vertical-align: top; text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    scope of rights granted under the license agreement and other interpretation-related issues;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: top; text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="vertical-align: top; text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    extent to which our technology and processes infringe on intellectual property of the licensor that is not subject to the
    licensing agreement;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: top; text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="vertical-align: top; text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    sublicensing of patent and other rights under our collaborative development relationships;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: top; text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="vertical-align: top; text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
    diligence obligations under the license agreement and what activities satisfy those diligence obligations;&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: top; text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="vertical-align: top; text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    inventorship and ownership of inventions and know-how resulting from the joint creation or use of intellectual property by
    our licensors and us and our partners; and</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: top; text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="vertical-align: top; text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    priority of invention of patented technology.&nbsp;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">In
addition, the agreements under which we currently license intellectual property or technology from other parties are complex,
and certain provisions in such agreements may be susceptible to multiple interpretations. The resolution of any contract interpretation
disagreement that may arise could narrow what we believe to be the scope of our rights to the relevant intellectual property or
technology, or increase what we believe to be our financial or other obligations under the relevant agreement, either of which
(depending on the importance of the IP and the related project) could have a material adverse effect on our business, financial
condition, results of operations, and prospects. Moreover, if disputes over intellectual property that we have licensed prevent
or impair our ability to maintain our current licensing arrangement for a project on commercially acceptable terms, we may be
unable to successfully develop and commercialize the affected drug or device candidates, which could have a material adverse effect
on our business, financial conditions, results of operations, and prospects.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><I>We
may not have complete control of the preparation, filing and prosecution of patent applications, or to maintain patents, licensed
by us from other parties.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">The
Company has in-licensed, and expects in the future to in-license patents owned or controlled by others for our use as part of
our development plans. We also may out-license or sublicense patents which we own or control in collaborations with others for
development and commercialization of our products. In either case, the continuing right to control the preparation, filing and
prosecution of patent applications, or to maintain the patents, covering technology under development is a matter for negotiation
and we may not always be the party that obtains such control, in which case we will be reliant on our licensors, collaboration
partners or sublicensees for determining strategies with respect to those patents. For our existing licenses, while we have an
understanding with most of the licensors who maintain control over patent prosecution and we have jointly appointed and engaged
patent agents nominated by us under one or more of our licenses, we cannot guarantee that such licensors or collaborators will
always accept prosecution strategies proposed by us and/or our patent agents. Therefore, these patents and applications may not
be prosecuted and enforced in a manner consistent with the best interests of our business. If our current or future licensors
or collaboration partners fail to establish, maintain or protect such patents and other IP rights, such rights may be reduced
or eliminated. If our licensors or joint development partners are not fully cooperative or disagree with us as to the prosecution,
maintenance or enforcement of any patent rights, such patent rights could be compromised.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Risks
Related to Our Reliance on Unrelated Parties </B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><I>We
rely on unrelated parties to conduct discovery and further improvement of our innovations and licensed technologies, as well as
our preclinical studies and clinical trials. If these unrelated parties do not successfully carry out their contractual duties
or meet expected deadlines, we may not be able to obtain regulatory approval for or commercialize our drug candidates, and our
business could be substantially harmed. </I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">We
have relied upon and plan to continue to rely upon CROs and collaborating institutions to monitor and manage data for our ongoing
preclinical studies and programs. We rely on these parties for execution of preclinical studies and clinical trials, and control
only certain aspects of their activities. Nevertheless, we are responsible for ensuring that each of our studies is conducted
in accordance with the applicable protocol, legal, and regulatory requirements and scientific standards, and our reliance on the
CROs and collaborating institutions does not relieve us of our regulatory responsibilities. If CROs, collaborating institutions
or clinical investigators do not successfully carry out their contractual duties or obligations or meet expected deadlines, development
of our product candidates could be delayed and our business could be adversely affected.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">In
addition, our CROs and collaborating institutions, are subject to numerous environmental, health and safety laws and regulations,
including those governing laboratory procedures and the handling, use, storage, treatment and disposal of hazardous materials
and waste. In the event of contamination or injury resulting from our use of hazardous materials, we might be held liable for
any resulting damages, and any liability could exceed our resources. We could also be subject to civil or criminal fines and penalties,
and significant associated costs.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<!-- Field: Page; Sequence: 40; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->32<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"><A HREF="#toc">Table of Contents</A></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><I>If
the Company obtains approval of an IND for one of our drug candidates and moves into human clinical trials requiring significantly
larger quantities of the candidate to be tested, we expect to rely on unrelated parties to manufacture supplies of that candidate.
If those unrelated parties fail to provide us with sufficient quantities of clinical supply on that candidate or fail to do so
at acceptable quality levels or prices, or fail to maintain required cGMP licenses, we may not be able to manufacture that candidate
in sufficient quantities to conduct the necessary human trials. Should the failure by the CRO occur in anticipation of or after
marketing approval of that candidate, we may be unable to generate as much revenue as rapidly (and such revenue may not be as
profitable) as we had anticipated.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">The
manufacture of many drug products, particularly in commercial quantities, can be complex and may require significant expertise
and capital investment, particularly if the development of advanced manufacturing techniques and process controls are required.
If we obtain approval of an IND for any of our drug candidates, of which there can be no assurance, we intend to contract with
outside contractors to manufacture clinical supplies and process our drug candidates. We have not yet had our drug candidates
to be manufactured or processed on a commercial scale and may not be able to do so for any of our drug candidates.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">As
we expect to engage contract manufacturers, the Company will be exposed to the following risks:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 0.5in; text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 0.25in; text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">we
    might be unable to identify manufacturers on acceptable terms or at all because the FDA, CFDA, EMA or other comparable regulatory
    authorities must approve any manufacturers we determine to use and any potential manufacturer may be unable to satisfy federal,
    state or international regulatory standards;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">although
    we would be choosing manufacturers with the type of experience most suitable for our drug candidates, it is possible that
    our contract manufacturers may not be able to execute unique manufacturing procedures and other logistical support requirements
    we have developed and they might require a significant amount of support from us to implement and maintain the infrastructure
    and processes required to manufacture our particular drug candidates;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
    contract manufacturers might be unable to reproduce the quantity and quality of the drugs we need to meet our clinical and
    commercial needs within the time frames when we require those drugs;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
    contract manufacturers may breach their contracts with us, including by not performing as agreed or not devoting sufficient
    resources to our drug candidates, or they may not remain in the contract manufacturing business for the time required to supply
    our clinical trials or to successfully produce, store and distribute our products;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">even
                                         if initially accepted by regulatory authorities, a manufacturer remains subject to ongoing
                                         periodic unannounced inspection by regulatory authorities to ensure strict compliance
                                         with cGMP and other government regulations, and our contract manufacturers may fail to
                                         comply with these regulations and requirements, resulting in rescission of cGMP licenses
                                         and our inability to continue using their services, requiring us to find a replacement
                                         manufacturer;</FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P></TD></TR>
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">depending
    on the terms of our agreement with a manufacturer, we may not own, or may have to share, the IP rights to any improvements
    made by the manufacturer in the manufacturing process for our drug candidates; and </FONT></TD></TR>
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
    contract manufacturers may have unacceptable or inconsistent product quality success rates and yields.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">Each
of these risks could delay or prevent the completion of our clinical trials or the approval of any of our drug candidates by the
FDA, CFDA, EMA or other comparable regulatory authorities, result in higher costs or adversely impact commercialization of our
drug candidates.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">We
are also responsible for quality control by our manufacturers. We intend to rely on those unrelated-party manufactures to perform
certain quality assurance tests on our drug candidates prior to delivery to patients. If these tests are not appropriately done
and test data are not reliable, patients could be put at risk of serious harm and the FDA, CFDA, EMA or other comparable regulatory
authorities could place significant restrictions on our Company until deficiencies are remedied.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<!-- Field: Page; Sequence: 41; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->33<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"><A HREF="#toc">Table of Contents</A></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">Manufacturers
of drug products often encounter difficulties in production, particularly in scaling up or out, validating the production process,
and assuring high reliability of the manufacturing process (including the absence of contamination). These problems include logistics
and shipping, difficulties with production costs and yields, quality control, including stability of the product, product testing,
operator error, availability of qualified personnel, as well as compliance with strictly enforced federal, state and non-U.S.
regulations. Furthermore, if contaminants are discovered in our supply of our drug candidates or in the manufacturing facilities,
such manufacturing facilities may need to be closed for an extended period of time to investigate and remedy the contamination.
It is possible that stability failures or other issues relating to the manufacture of our drug candidates may occur in the future.
Additionally, our manufacturers may experience manufacturing difficulties due to resource constraints, or as a result of labor
disputes or unstable political environments. If our manufacturers were to encounter any of these difficulties, or otherwise fail
to comply with their contractual obligations, our ability to provide our drug candidate to patients in clinical trials would be
jeopardized. Any delay or interruption in the manufacturing of clinical trial supplies could delay the completion of clinical
trials, increase the costs associated with maintaining clinical trial programs and, depending upon the period of delay, require
us to begin new clinical trials with additional costs or terminate clinical trials completely.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><I>Review
of changes in the manufacturing process of our drug candidates could cause delays resulting from the need for additional regulatory
approvals.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">Changes
in a process or procedure for manufacturing one of our drug candidates, including a change in the location where the drug candidate
is manufactured or a change of a contract manufacturer, could require prior review by the FDA, CFDA, EMA or other comparable regulatory
authorities and approval of the manufacturing process and procedures in accordance with the FDA, CFDA or EMA&rsquo;s regulations,
or comparable requirements. This review may be costly and time-consuming and could delay or prevent the launch of a product. The
new facility will also be subject to pre-approval inspection. In addition, we would have to demonstrate that the product made
at the new facility is equivalent to the product made at the former facility by physical and chemical methods, which are costly
and time-consuming. It is also possible that the FDA, CFDA, EMA or other comparable regulatory authorities may require clinical
testing as a way to prove equivalency, which would result in additional costs and delay.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Risks
Related to AML Clinic</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><I>Failure
to comply with all laws and regulations applicable to the business of AML Clinic could have a material, adverse impact on the
Company&rsquo;s business.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">Operation
of AML Clinic subjects the Company to a variety of Hong Kong laws and regulations specific to companies and professionals in the
business of delivering medical care. We and our employees will be subject to licensing and professional qualifications that do
not apply to our other businesses. Breach of any of these laws, regulations or licensing requirements could subject the Company
to significant fines and other penalties and possibly damage the Company&rsquo;s reputation, which could have a material adverse
effect on the Company&rsquo;s business.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Risks
Related to Our Device Candidates</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><I>We
are subject to risks related to obtaining regulatory approval for device candidates. </I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">The
Company&rsquo;s device candidates (including those being developed under VLS-3 and SLS-1), are likely to be regulated as medical
devices. Medical devices are subject to extensive regulations, supervised by regulatory authorities around the world, including
the FDA, CFDA and applicable national authorities in relevant European countries. The regulatory framework related to medical
devices covers research, development, design, manufacturing, safety, reporting, testing, labeling, packaging, storage, installation,
servicing, marketing, sales and distribution. The Company is and may also be, in addition to these industry-specific regulations,
subject to numerous other ongoing regulatory obligations, such as data protection, environmental, health and safety laws and restrictions.
The costs of compliance with applicable regulations, requirements or guidelines could be substantial. Furthermore, the regulatory
environment has generally become more stringent and extensive over time. Failure to comply with these regulations could result
in sanctions including fines, injunctions, civil penalties, denial of applications for marketing approval of the Company&rsquo;s
products, delays, suspension or withdrawal of approvals, license revocation, seizures or recalls of products, operating restrictions,
partial suspension or total shutdown of production and criminal prosecutions, any of which could significantly increase the Company&rsquo;s
costs, delay the development and commercialization of its device candidates.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><I>We
are subject to risks related to the carrying out and outcome of clinical trials of medical devices.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">The
Company may sponsor studies on human participants in clinical studies of its device candidates. Such clinical studies are performed
to support regulatory approvals for market access or to generate evidence relating to clinical benefits and cost benefits of using
such device candidates. Clinical studies are costly and time consuming and associated with risks such as finding trial sites,
recruitment of suitable patients, the actual cost per patient exceeding budget and inadequacies in the execution of the trials.
There is also a risk of delays in the performance of clinical studies, which can occur for a variety of reasons. For example,
delays in obtaining regulatory approval to commence a trial, reaching agreements on acceptable terms with prospective contract
research organizations and clinical investigational sites, obtaining institutional review board approval at each site, difficulties
in patient enrolment, patients failing to complete a trial or return for follow-up, adding new sites or obtaining sufficient supplies
of products or clinical sites dropping out of a trial. If delays persist, there is a risk that studies eventually are suspended
or terminated if the delays occur due to circumstances that a sponsor of a clinical trial has difficulties controlling, or is
unable to control, or if the measures required for conducting the studies further are deemed too costly or extensive in relation
to the scopes and goals of the studies.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<!-- Field: Page; Sequence: 42; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->34<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"><A HREF="#toc">Table of Contents</A></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">There
are many factors which may affect patient enrollment. Amongst these are the size and nature of the patient population, the proximity
of patients to clinical sites, the eligibility criteria for the trial, the design of the clinical study and competing clinical
studies. Furthermore, clinicians&rsquo; and patients&rsquo; perceptions as to the potential advantages of the product being studied
in relation to other available therapies, including any new products that may be approved for the indications the company is investigating.
Clinical studies may also be suspended or terminated if participating subjects are exposed to unacceptable health risks or undesired
side-effects.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">Furthermore,
there is a risk that clinical studies may not demonstrate the required clinical benefit for the prospective indication the trial
is aimed at. Failure in premarketing clinical studies could lead to market clearance or approvals not being obtained which could
delay or jeopardize the Company&rsquo;s ability to develop, market and sell the device candidates being studied. At any stage
of the development, the Company may discontinue device candidate based on review of available preclinical and clinical data, the
estimated costs of continued development, market considerations and other factors. Furthermore, with respect to the clinical studies
of device candidates conducted by CROs and others, the Company may have less control over their timing or outcome.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Risks
Related to Our Industry, Business and Operation&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><I>If
we do not comply with laws regulating the protection of the environment and health and human safety, our business could be adversely
affected.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">Our
research, development and clinic operations involve the use of hazardous materials, chemicals and various radioactive compounds/radiation
and AML Clinic may create medical waste and radiation. Our R&amp;D Center may maintain quantities of various flammable and toxic
chemicals in our facilities that are required for our research, development and manufacturing activities. We are subject to local
laws and regulations governing the use, manufacture, storage, handling and disposal of these hazardous materials and of medical
waste at the jurisdictions where we operate our clinic and research facilities, which are currently limited to Hong Kong. We believe
our procedures for storing, handling and disposing of these materials comply with the relevant guidelines and laws of the jurisdictions
in which our facilities are located. Although we believe that our safety procedures for handling and disposing of these materials
comply with the standards mandated by applicable regulations, the risk of accidental contamination or injury from these materials
cannot be eliminated. If an accident occurs, we could be held liable for resulting damages, which could be substantial. We are
also subject to numerous environmental, health and workplace safety laws and regulations, including those governing laboratory
procedures, exposure to blood-borne pathogens and the handling of biohazardous materials and medical waste.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">Although
we maintain workers&rsquo; compensation insurance to cover us for costs and expenses we may incur due to injuries to our employees
resulting from the use of these materials, this insurance may not provide adequate coverage against potential liabilities. We
do not maintain insurance for environmental liability or toxic tort claims that may be asserted against us in connection with
our storage or disposal of biological, hazardous or radioactive materials. Additional federal, state and local laws and regulations
affecting our operations may be adopted in the future. We may incur substantial costs to comply with, and substantial fines or
penalties, if we violate any of these laws or regulations.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><I>Our
future success depends on our ability to retain our Chief Executive Officer, our scientific and clinical advisors, and other key
executives and to attract, retain and motivate qualified personnel. </I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">We
are highly dependent on Ian Huen, our Chief Executive Officer, as well as, other principal members of our management teams, scientific
teams as well as scientific and clinical advisors. Although we have formal employment agreements, which we refer to as appointment
letters, with all of our executive officers, these agreements do not prevent our executives from terminating their employment
with us at any time, subject to applicable notice periods. We intend to obtain &ldquo;key person&rdquo; insurance for our executives
or other employees in the near future. Nevertheless, the loss of the services of any of these persons could impede the achievement
of our research, development and commercialization objectives.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">To
induce valuable employees to remain at our Company, in addition to salary and cash incentives, we plan to provide share incentive
grants that vest over time. The value to employees of these equity grants that vest over time may be significantly affected by
movements in the price of our Class A Ordinary Shares that are beyond our control, and may at any time be insufficient to counteract
more lucrative offers from other companies. Although we have appointment letters with our key employees, any of our employees
could resign at any time, with 1-month to 3-months prior written notice or with payment in lieu of notice.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<!-- Field: Page; Sequence: 43; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->35<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"><A HREF="#toc">Table of Contents</A></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">Recruiting
and retaining qualified officers, scientific, clinical, sales and marketing personnel or consultants will also be critical to
our success. In addition, we rely on consultants and advisors, including scientific and clinical advisors, to assist us in formulating
our discovery and preclinical studies development and commercialization strategy. The loss of the services of our executive officers
or other key employees and consultants could impede the achievement of our research, development and commercialization objectives
and seriously harm our ability to successfully implement our business strategy.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">Furthermore,
replacing executive officers and key employees or consultants may be difficult and may take an extended period of time, because
of the limited number of individuals in our industry with the breadth of skills and experience required to successfully develop,
gain regulatory approval of and commercialize drug and device candidates. Competition to hire from this limited pool is intense,
and we may be unable to hire, train, retain or motivate these key personnel or consultants on acceptable terms given the competition
among numerous pharmaceutical and biotechnology companies for similar personnel.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">We
also experience competition for the hiring of scientific and clinical personnel from universities and research institutions. Our
consultants and advisors may be employed by employers other than us and may have commitments under consulting or advisory contracts
with other entities that may limit their availability to us. If we are unable to continue to attract and retain high quality personnel,
our ability to pursue our growth strategy will be limited.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><I>We
will need to increase the size and capabilities of our organization, and we may experience difficulties in managing our growth.
</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">As
of the date of this prospectus, we have 42 employees, including 41 full-time employees and 1 part-time employees. Of these,
15 are engaged in full-time research and development and laboratory operations, 22 are engaged in general and administrative
functions, 4 are full-time employees engaged in the clinic operation and 1 part-time employees are engaged in sponsored
research and development, laboratory operations and legal clerical support. As of the date of this prospectus, 41 of our
employees are located in Hong Kong and 1 of our employees is located in the UK. In addition, we have engaged and may continue
to engage 26 independent contracted consultants and advisors to assist us with our operations. As our development and
commercialization plans and strategies develop, and as we transition into operating as a public company, we will need to
establish and maintain effective disclosure and financial controls and make changes in our corporate governance practices. We
will need to add a significant number of additional managerial, operational, sales, marketing, financial and other personnel
with the appropriate public company experience and technical knowledge and we may not successfully recruit and maintain such
personnel. Future growth will impose significant added responsibilities on members of management, including:</FONT></P>





<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 0.5in; text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 0.25in; text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">identifying,
    recruiting, integrating, maintaining and motivating additional employees;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">managing
    our internal development efforts effectively, including clinical, the FDA or other comparable regulatory authority review
    process for our drug and device candidates, while complying with our contractual obligations to contractors and others; and</FONT></TD></TR>
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">improving
    our operational, financial and management controls, reporting systems and procedures.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">Our
future financial performance and our ability to commercialize our drug candidates will depend, in part, on our ability to effectively
manage our future growth, and our management may also have to divert a disproportionate amount of its attention away from day-to-day
activities in order to devote a substantial amount of time to managing these growth activities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">We
currently rely, and for the foreseeable future will continue to rely, in substantial part on certain independent organizations,
advisors and consultants for significant input in selecting and evaluating new products to pursue. These independent organizations,
advisors and consultants may not continue to be available to us on a timely basis when needed, and in such case, we may not have
the ability to find qualified replacements. In addition, if we are unable to effectively manage our outsourced activities, or
if the quality or accuracy of the services provided by consultants is compromised for any reason, our clinical trials may be extended,
delayed or terminated, and we may not be able to obtain regulatory approval of our drug candidates or otherwise advance our business.
Furthermore, we may not be able to manage our existing consultants or find other competent outside contractors and consultants
on economically reasonable terms, if at all.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">If
we are not able to effectively expand our organization by hiring new employees and expanding our groups of consultants and contractors,
we may not be able to successfully implement the tasks necessary to further develop and commercialize our drug and device candidates
and, accordingly, may not achieve our research, development and commercialization goals.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<!-- Field: Page; Sequence: 44; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->36<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"><A HREF="#toc">Table of Contents</A></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><I>We
intend to seek additional collaborations, strategic alliances or acquisitions or enter into royalty-seeking or sublicensing arrangements
in the future, but we may not realize the benefits of these arrangements. </I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">We
intend to form or seek strategic alliances, create joint ventures or collaborations, acquire complimentary products, IP rights,
technology or businesses or enter into additional licensing arrangements with unrelated parties that we determine may complement
or augment our development and commercialization efforts with respect to our drug and device candidates. Any of these relationships
may require us to incur non-recurring and other charges, increase our near and long-term expenditures, issue securities that dilute
our existing shareholders, or disrupt our management and business.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">We
will face significant competition in seeking appropriate strategic partners and the negotiation process is likely to be time-consuming,
costly and complex. Moreover, we may not be successful in our efforts to establish a strategic partnership or another alternative
arrangement for any of our drug and device candidates because their state of development may be deemed to be too early for collaborative
effort and others may not view our drug and device candidates as having the requisite potential to demonstrate safety and efficacy.
If and when we enter into an agreement with a collaboration partner or sublicensee for development and commercialization of a
drug or device candidate, we can expect to relinquish some or all of the control over the future success of that drug and device
candidate to the unrelated-party.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">Further,
even if we enter into a collaboration involving any of our drug and device candidates, the arrangement will be subject to numerous
risks, which may include the following:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 0.5in; text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 0.25in; text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">the
collaborators will likely have significant discretion in determining the efforts and resources that they will apply to a collaboration;&nbsp;</FONT></P></TD></TR>
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">the
collaborator may ultimately choose not pursue development and commercialization of our drug candidates or may elect not to continue
or renew development or commercialization programs, based on clinical trial results, changes in their strategic focus due to the
acquisition of competitive drugs, availability of funding, or other external factors, such as a business combination that diverts
resources or creates competing priorities;&nbsp;</FONT></P></TD></TR>
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">the
collaborator may delay clinical trials, provide insufficient funding for a clinical trial, stop a clinical trial, abandon a drug
or device candidate, repeat or conduct new clinical trials, or require a new formulation of a drug or device candidate for clinical
testing;&nbsp;</FONT></P></TD></TR>
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">the
collaborator could independently develop, or develop with unrelated parties, drugs that compete directly or indirectly with our
drugs or drug and device candidates;&nbsp;</FONT></P></TD></TR>
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">the
collaborator with marketing and distribution rights to one or more drugs may not commit sufficient resources to their marketing
and distribution;&nbsp;</FONT></P></TD></TR>
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">the
collaborator may not properly maintain or defend our IP rights or may use our IP or proprietary information in a way that gives
rise to actual or threatened litigation that could jeopardize or invalidate our IP or proprietary information or expose us to
potential liability;&nbsp;</FONT></P></TD></TR>
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">disputes
may arise between us and the collaborator that cause the delay or termination of the research, development or commercialization
of our drug and device candidates, or that result in costly litigation or arbitration that diverts management attention and resources;&nbsp;</FONT></P></TD></TR>
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">the
collaboration may be terminated and, if terminated, may result the Company needing additional capital to pursue further development
or commercialization of the applicable drug and device candidates;&nbsp;</FONT></P></TD></TR>
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">the
collaborator may own or co-own IP covering our drugs that results from our collaborating with them, and in such cases, we would
not have the exclusive right to commercialize such IP;&nbsp;</FONT></P></TD></TR>
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">the
collaboration may result in increased operating expenses or the assumption of indebtedness or contingent liabilities; and&nbsp;</FONT></P></TD></TR>
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    collaboration arrangement may result in the loss of key personnel and uncertainties in our ability to maintain key business
    relationships.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<!-- Field: Page; Sequence: 45; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->37<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"><A HREF="#toc">Table of Contents</A></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">As
a result, if we enter into collaboration agreements and strategic partnerships or license our drugs, we may not be able to realize
the benefit of such transactions, which could delay our timelines or otherwise adversely affect our business. Following a strategic
transaction or license, we may not achieve the revenue or specific net income that justifies such transaction. If we are unable
to reach agreements with a suitable collaborator on a timely basis, on acceptable terms, or at all, we may have to curtail the
development of a drug or device candidate, reduce or delay its development program or one or more of our other development programs,
delay its potential commercialization or reduce the scope of any sales or marketing activities, or increase our expenditures and
undertake development or commercialization activities at our own expense.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">If
we fail to enter into collaborations, we may seek to fund and undertake development or commercialization activities on our own,
but we may not have sufficient funds or expertise to undertake the necessary development and commercialization activities. In
such a case, we may not be able to further develop our drug and device candidates or bring them to market and generate product
sales revenue, which would harm our business prospects, financial condition and results of operations.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><I>Our
employees, independent contractors, consultants, commercial partners and vendors may engage in misconduct or other improper activities,
including non-compliance with regulatory standards and requirements. </I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">We
are exposed to the risk of fraud, misconduct or other illegal activity by our employees, independent contractors, consultants,
commercial partners and vendors. Misconduct by these parties could include intentional, reckless and negligent conduct that fails
to: comply with the laws of the FDA and other similar non-U.S. regulatory authorities; provide true, complete and accurate information
to the FDA and other similar non-U.S. regulatory authorities; comply with manufacturing standards we have established; comply
with healthcare fraud and abuse laws in the United States and similar non-U.S. fraudulent misconduct laws; or report financial
information or data accurately or to disclose unauthorized activities to us. If we obtain the FDA approval for any of our drug
and device candidates and begin commercializing those drugs in the United States, our potential exposure under U.S. laws will
increase significantly and our costs associated with compliance with such laws are also likely to increase. These laws may impact,
among other things, our current activities with principal investigators of our sponsored researches and research patients and
our use of information obtained in the course of patient recruitment for clinical trials, as well as proposed and future sales,
marketing and education programs. In particular, the promotion, sales and marketing of healthcare items and services, as well
as certain business arrangements in the healthcare industry, are subject to extensive laws designed to prevent fraud, kickbacks,
self-dealing and other abusive practices. These laws and regulations may restrict or prohibit a wide range of pricing, discounting,
marketing and promotion, structuring and commission(s), certain customer incentive programs and other business arrangements generally.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">It
is not always possible to identify and deter misconduct by employees and other parties, and the precautions we take to detect
and prevent this activity may not be effective in controlling unknown or unmanaged risks or losses, or in protecting us from governmental
investigations or other actions or lawsuits stemming from a failure to comply with these laws or regulations. If any such actions
are instituted against us, and we are not successful in defending ourselves or asserting our rights, those actions could have
a significant impact on our business, including the imposition of significant fines or other sanctions.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><I>Our
disclosure controls and procedures may not prevent or detect all errors or acts of fraud.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">Upon
completion of this Offering, we will become subject to the periodic reporting requirements of the Exchange Act. Our disclosure
controls and procedures are designed to reasonably assure that information required to be disclosed by us in reports we file or
submit under the Exchange Act is accumulated and communicated to management, and recorded, processed, summarized and reported
within the time periods specified in the rules and forms of the SEC.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">We
believe that any disclosure controls and procedures, or internal controls and procedures, no matter how well conceived and operated,
can provide only reasonable, not absolute, assurance that the objectives of the control system are met.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">These
inherent limitations include the realities that judgments in decision-making can be faulty, and that breakdowns can occur because
of simple error or mistake. Additionally, controls can be circumvented by the individual acts of some persons, by collusion of
two or more people or by an unauthorized override of the controls. Accordingly, because of the inherent limitations in our control
system, misstatements due to error or fraud may occur and not be detected, which <FONT STYLE="background-color: white">would likely
cause investors to lose confidence in our reported financial information. This could in turn limit our access to capital markets,
harm our results of operations, and lead to a decline in the trading price of our Class A Ordinary Shares. Additionally, ineffective
internal control over financial reporting could expose us to increased risk of fraud or misuse of corporate assets and subject
us to potential delisting from the stock exchange on which we list, regulatory investigations and civil or criminal sanctions.
We may also be required to restate our financial statements from prior periods</FONT>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<!-- Field: Page; Sequence: 46; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->38<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"><A HREF="#toc">Table of Contents</A></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><I>If
we fail to establish and maintain proper internal financial reporting controls, our ability to produce accurate financial statements
or comply with applicable regulations could be impaired.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">Pursuant
to Section 404 of the Sarbanes-Oxley Act, we will be required to file a report by our management on our internal control over
financial reporting, including an attestation report on internal control over financial reporting issued by our independent registered
public accounting firm. However, while we remain an emerging growth company, we will not be required to include an attestation
report on internal control over financial reporting issued by our independent registered public accounting firm. The presence
of material weaknesses in internal control over financial reporting could result in financial statement errors which, in turn,
could lead to errors in our financial reports and/or delays in our financial reporting, which could require us to restate our
operating results. In connection with the audit of our statements of net assets (predecessor basis) including the schedule of
portfolio investments as of December 31, 2016 and February 28, 2017, and the related statements (predecessor basis) of operations,
changes in net assets, and cash flows for the year ended December 31, 2016, the statements (predecessor basis) of operations,
changes in net assets, and cash flows for the period January 1, 2017 through February 28, 2017, the consolidated balance sheet
(successor basis) as of December 31, 2017, the related consolidated statements (successor basis) of operations and comprehensive
loss, stockholders&rsquo; equity and cash flows for the period March 1, 2017 through December 31, 2017, we and our independent
registered public accounting firm identified one material weakness in our internal control over financial reporting, as defined
in the standards established by the Public Company Accounting Oversight Board of the United States, as of December 31, 2017. The
material weakness identified was the lack of dedicated resources to take responsibility for the finance and accounting functions
and the preparation of financial statements in compliance with generally accepted accounting principles in the United States,
or U.S. GAAP.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">We
have already taken some steps and will continue to implement measures to remediate the material weakness identified. However,
we cannot assure you that we will be able to continue implementing these measures in the future, or that we will not identify
additional material weaknesses or significant deficiencies in the future.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">If
we are unable to conclude that we have effective internal controls over financial reporting, investors may lose confidence in
our operating results, the price of the Class A Ordinary Shares could decline and we may be subject to litigation or regulatory
enforcement actions. In addition, if we are unable to meet the requirements of Section 404 of the Sarbanes-Oxley Act, the Class
A Ordinary Shares may not be able to remain listed on the NASDAQ Global Market.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><I>We
may market our products, if approved, globally; if we do, we will be subject to the risk of doing business internationally.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">We
operate and expect to operate in various countries, and we may not be able to market our products in, or develop new products
successfully for, these markets. We may also encounter other risks of doing business internationally including but not limited
to:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 0.5in; text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 0.25in; text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">unexpected
    changes in, or impositions of, legislative or regulatory requirements;&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">efforts
    to develop an international sales, marketing and distribution organization may increase our expenses, divert our management&rsquo;s
    attention from the acquisition or development of drug candidates or cause us to forgo profitable licensing opportunities in
    these geographies;&nbsp;&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    occurrence of economic weakness, including inflation or political instability;&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    effects of applicable non-U.S. tax structures and potentially adverse tax consequences;&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">differences
    in protection of our IP rights including patent rights of other parties;&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    burden of complying with a variety of foreign laws including difficulties in effective enforcement of contractual provisions;&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">delays
    resulting from difficulty in obtaining export licenses, tariffs and other barriers and restrictions, potentially longer payment
    cycles, greater difficulty in accounts receivable collection and potentially adverse tax treatment; and&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">production
    shortages resulting from any events affecting raw material supply or manufacturing capabilities abroad.&nbsp;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">In
addition, we are subject to general geopolitical risks in foreign countries where we operate, such as political and economic instability
and changes in diplomatic and trade relationships, which could affect, among other things, customers&rsquo; inventory levels and
consumer purchasing, which could cause our results to fluctuate and our net sales to decline. The occurrence of any one or more
of these risks of doing business internationally, individually or in the aggregate, could materially and adversely affect our
business and results of operations.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<!-- Field: Page; Sequence: 47; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->39<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"><A HREF="#toc">Table of Contents</A></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><I>If
we engage in future acquisitions or strategic partnerships, this may increase our capital requirements, dilute our shareholders,
cause us to incur debt or assume contingent liabilities, and subject us to other risks.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">We
may evaluate various acquisitions and strategic partnerships, including licensing or acquiring complementary products, IP rights,
technology or businesses. Any potential acquisition or strategic partnership may entail numerous risks, including, but not limited
to:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 0.5in; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 0.25in; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">increase
    in operating expenses and cash requirements;&nbsp;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 0.5in; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 0.25in; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    assumption of additional indebtedness or contingent liabilities;&nbsp;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 0.5in; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 0.25in; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    issuance of our equity securities;&nbsp;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 0.5in; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 0.25in; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">assimilation
    of operations, IP and products of an acquired company, including difficulties associated with integrating new personnel;&nbsp;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 0.5in; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 0.25in; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    diversion of our management&rsquo;s attention from our existing product programs and initiatives in pursuing such a strategic
    merger or acquisition;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 0.5in; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 0.25in; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">retention
    of key employees, the loss of key personnel, and uncertainties in our ability to maintain key business relationships;&nbsp;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 0.5in; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 0.25in; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">risks
    and uncertainties associated with the other party to such a transaction, including the prospects of that party and their existing
    drugs or drug and device candidates and regulatory approvals; and</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 0.5in; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 0.25in; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
    inability to generate revenue from acquired technology and/or products sufficient to meet our objectives in undertaking the
    acquisition or even to offset the associated acquisition and maintenance costs.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">In
addition, if we undertake acquisitions, we may issue dilutive securities, assume or incur debt obligations, incur large one-time
expenses and acquire intangible assets that could result in significant future amortization expense. Moreover, we may not be able
to locate suitable acquisition opportunities and this inability could impair our ability to grow or obtain access to technology
or products that may be important to the development of our business.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><I>If
we fail to comply with the U.S. Foreign Corrupt Practices Act (&ldquo;FCPA&rdquo;),&nbsp;or other anti-bribery laws, our reputation
may be harmed and we could be subject to penalties and significant expenses that have a material adverse effect on our business,
financial condition and results of operations.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">We
are subject to the FCPA. The FCPA generally prohibits us from making improper payments to non-U.S. officials for the purpose of
obtaining or retaining business. We are also subject to the anti-bribery laws of other jurisdictions, particularly the PRC. As
our business expands, the applicability of the FCPA and other anti-bribery laws to our operations will increase. Our procedures
and controls to monitor anti-bribery compliance may fail to protect us from reckless or criminal acts committed by our employees
or agents. If we, due to either our own deliberate or inadvertent acts or those of others, fail to comply with applicable anti-bribery
laws, our reputation could be harmed and we could incur criminal or civil penalties, other sanctions and/or significant expenses,
which could have a material adverse effect on our business, including our financial condition, results of operations, cash flows
and prospects.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><I>If
we commence clinical trials of one of our drug or device candidates, and product liability lawsuits are brought against us, we
may incur substantial liabilities and the commercialization of such drug or device candidates may be affected.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">If
any of our drug or device candidates enter clinical trials, we will face an inherent risk of product liability suits and will
face an even greater risk if we obtain approval to commercialize any drugs. For example, we may be sued if our drug candidates
cause or are perceived to cause injury or are found to be otherwise unsuitable during clinical testing, manufacturing, marketing
or sale. Any such product liability claims may include allegations of defects in manufacturing, defects in design, a failure to
warn of dangers inherent in the drug, negligence, strict liability or a breach of warranties. Claims could also be asserted under
state consumer protection acts. If we cannot successfully defend ourselves against product liability claims, we may incur substantial
liabilities or be required to limit commercialization of our drug candidates. Even successful defense would require significant
financial and management resources. Regardless of the merits or eventual outcome, liability claims may result in:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 0.5in; text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 0.25in; text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">decreased
    demand for our drugs; </FONT></TD></TR>
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">injury
    to our reputation; </FONT></TD></TR>
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">withdrawal
    of clinical trial participants and inability to continue clinical trials; </FONT></TD></TR>
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">initiation
    of investigations by regulators; </FONT></TD></TR>
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">costs
    to defend the related litigation; </FONT></TD></TR>
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a
    diversion of management&rsquo;s time and our resources; </FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<!-- Field: Page; Sequence: 48; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->40<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"><A HREF="#toc">Table of Contents</A></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 0.5in; text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 24px; text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">substantial
    monetary awards to trial participants or patients; </FONT></TD></TR>
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">product
    recalls, withdrawals or labeling, marketing or promotional restrictions; </FONT></TD></TR>
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">loss
    of revenue; </FONT></TD></TR>
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">exhaustion
    of any available insurance and our capital resources; </FONT></TD></TR>
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    inability to commercialize any drug candidate; and </FONT></TD></TR>
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a
    decline in the price of our Class A Ordinary Shares.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">We
shall seek to obtain the appropriate insurance once our candidates are ready for clinical trial. However, our inability to obtain
sufficient product liability insurance at an acceptable cost to protect against potential product liability claims could prevent
or inhibit the commercialization of drugs we develop, alone or with collaborators. We currently do not have in place product liability
insurance and although we plan to have in place such insurance as and when the products are ready for commercialization, as well
as insurance covering clinical trials, the amount of such insurance coverage may not be adequate, we may be unable to maintain
such insurance, or we may not be able to obtain additional or replacement insurance at a reasonable cost, if at all. Our insurance
policies may also have various exclusions, and we may be subject to a product liability claim for which we have no coverage. We
may have to pay any amounts awarded by a court or negotiated in a settlement that exceed our coverage limitations or that are
not covered by our insurance, and we may not have, or be able to obtain, sufficient capital to pay such amounts. Even if our agreements
with any future corporate collaborators entitle us to indemnification against losses, such indemnification may not be available
or adequate should any claim arise.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">Additionally,
we may be sued if the products that we commercialize, market or sell cause or are perceived to cause injury or are found to be
otherwise unsuitable, and may result in:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 0.5in; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 24px; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">decreased
    demand for those products;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">damage
    to our reputation;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">costs
    incurred related to product recalls;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">limiting
    our opportunities to enter into future commercial partnership; and</FONT></TD></TR>
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a
    decline in the price of our Class A Ordinary Shares.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><I>Our
insurance coverage may be inadequate to protect us against losses.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">We
currently maintain property insurance for our office premises (including one unit of server and accessories). We hold employer&rsquo;s
liability insurance generally covering death or work-related injury of employees; we maintain &ldquo;Office Care Plan Insurance&rdquo;
for those persons working in our offices and &ldquo;Medical Plan&rdquo; for our employee. We hold public liability insurance covering
certain incidents involving unrelated parties that occur on or in the premises of the Company. We do not yet have directors and
officers liability insurance but intend to enter into such policies immediately prior to or after the consummation of this Offering.
We do not yet have key-man life insurance on any of our senior management or key personnel, or business interruption insurance
but intend to enter into such policies immediately prior to or after the consummation of this Offering. Our insurance coverage
may be insufficient to cover any claim for product liability, damage to our fixed assets or employee injuries. If any claims for
damage are brought against us, or if we experience any business disruption, litigation or natural disaster, we might incur substantial
costs and diversion of resources.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><I>Fluctuations
in exchange rates could result in foreign currency exchange losses and could materially reduce the value of your investment. </I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">Our
operations and equity are funded in U.S. dollars and we currently incur the majority of our expenses in U.S. dollars or in H.K.
dollars. H.K. dollar is currently pegged to the U.S. dollar; however, we cannot guarantee that such peg will continue to be in
place in the future. Our exposure to foreign exchange risk primarily relates to the limited cash denominated in currencies other
than the functional currencies of each entity and limited revenue contracts dominated in H.K. dollars in certain PRC operating
entities. We do not believe that we currently have any significant direct foreign exchange risk and have not hedged exposures
denominated in foreign currencies or any other derivative financial instruments. However, the value of your investment in our
Series A Ordinary Shares may be affected by the foreign exchange rate between U.S. dollars and the H.K. dollar because the primary
value of our business is effectively denominated in H.K. dollars, in addition to U.S. dollars.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">If
we are exposed to foreign currency exchange risk as our results of operations, cash flows maybe subject to fluctuations in foreign
currency exchange rates. For example, if a significant portion of our clinical trial activities may be conducted outside of the
United States, and associated costs may be incurred in the local currency of the country in which the trial is being conducted,
which costs could be subject to fluctuations in currency exchange rates. We currently do not engage in hedging transactions to
protect against uncertainty in future exchange rates between particular foreign currencies and the U.S. dollar. A decline in the
value of the U.S. dollar against currencies in countries in which we conduct clinical trials could have a negative impact on our
research and development costs. Foreign currency fluctuations are unpredictable and may adversely affect our financial condition,
results of operations and cash flows.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<!-- Field: Page; Sequence: 49; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->41<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"><A HREF="#toc">Table of Contents</A></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><I>Our
investments are subject to risks that could result in losses. </I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">We
had cash of $16.25 million and $0.30 million as of December 31, 2017 and December 31, 2016, respectively. We may invest our cash
in a variety of financial instruments. All of these investments are subject to credit, liquidity, market and interest rate risk.
Such risks, including the failure or severe financial distress of the financial institutions that hold our cash, cash equivalents
and investments, may result in a loss of liquidity, impairment to our investments, realization of substantial future losses, or
a complete loss of the investments in the long-term, which may have a material adverse effect on our business, results of operations,
liquidity and financial condition. While we believe our cash position does not expose us to excessive risk, future investments
may be subject to adverse changes in market value.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><I>We
are exposed to risks associated with our computer hardware, network security and data storage.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">Similar
to all other computer network users, our computer network system is vulnerable to attack of computer virus, worms, trojan horses,
hackers or other similar computer network disruptive problems. Any failure in safeguarding our computer network system from these
disruptive problems may cause breakdown of our computer network system and leakage of confidential information of the Company.
Any failure in the protection of our computer network system from external threat may disrupt our operation and may damage our
reputation for any breach of confidentiality to our customers, which in turn may adversely affect our business operation and performance.
In the event that our confidential information is stolen and misused, we may become exposed to potential risks of losses from
litigation and possible liability.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">In
addition, we are highly dependent on our IT infrastructure to store research data and information and manage our business operations.
We do not backup all data on a real-time basis and the effectiveness of our business operations may be materially affected by
any failure in our IT infrastructure. If our communications and IT systems do not function properly, or if there is any partial
or complete failure of our systems, we could suffer financial losses, business disruption or damage to our reputation.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><I>Business
disruptions could seriously harm our future revenue and financial condition and increase our costs and expenses.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">Our
operations, and those of our research institution collaborators, CROs, suppliers and other contractors and consultants, could
be subject to earthquakes, power shortages, telecommunications failures, damage from computer viruses, material computer system
failures, water shortages, floods, hurricanes, typhoons, fires, extreme weather conditions, medical epidemics and other natural
or man-made disasters or business interruptions. In addition, we partially rely on our research institution collaborators for
conducting research and development of our drug candidates, and they may be affected by government shutdowns or withdrawn funding.
The occurrence of any of these business disruptions could seriously harm our operations and financial condition and increase our
costs and expenses. We rely on contract manufacturers to produce and process our drug candidates. Our ability to obtain clinical
supplies of our drug candidates could be disrupted if the operations of these suppliers are affected by a man-made or natural
disaster or other business interruption. A large portion of our contract manufacturer&rsquo;s operations is located in a single
facility. Damage or extended periods of interruption to our corporate or our contract manufacturer&rsquo;s development or research
facilities due to fire, natural disaster, power loss, communications failure, unauthorized entry or other events could cause us
to cease or delay development of some or all of our drug candidates.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><I>Although
we do not currently conduct any business in the PRC, we may in the future; in doing so we would be exposed to various risks related
to doing business in the PRC. </I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">Although
we currently do not conduct any business in the PRC, we are the exclusive licensee to certain PRC patents directed to our drug
candidates such as ALS-1, NLS-2 and SPLS-1, and we intend to file application for certain products in the PRC. The pharmaceutical
industry in the PRC is subject to comprehensive government regulation and supervision, encompassing the approval, registration,
manufacturing, packaging, licensing and marketing of new drugs. (See &ldquo;Our Business &ndash; Government Regulation &ndash;
PRC Regulation&rdquo;). In recent years, the regulatory framework in the PRC regarding the pharmaceutical industry has undergone
significant changes, and we expect that it will continue to undergo significant changes. Any such changes or amendments may result
in increased compliance costs on our business or cause delays in or prevent the successful development or commercialization of
our drug candidates in the PRC and reduce the current benefits that we believe are available to us from developing and manufacturing
drugs in the PRC. Chinese authorities have become increasingly vigilant in enforcing laws in the pharmaceutical industry and any
failure by us or our partners to maintain compliance with applicable laws and regulations or obtain and maintain required licenses
and permits may result in the suspension or termination of our business activities in the PRC. We believe our strategy and approach
is aligned with the PRC government&rsquo;s policies, but we cannot ensure that our strategy and approach will continue to be aligned.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 50; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->42<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"><A HREF="#toc">Table of Contents</A></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">If
in the future, we commence business or operation in the PRC, changes in the political and economic policies of the PRC government
may materially and adversely affect our business, financial condition and results of operations and may result in our inability
to sustain our growth and expansion strategies. Once we start doing business in the PRC, our financial condition and results of
operation in the PRC could be materially and adversely affected by government control over capital investments or changes in tax
regulations that are applicable to us, and consequently have a material adverse effect on our businesses, financial condition
and results of operations.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><I>The
SEC could take the position that we are an &ldquo;investment company&rdquo; subject to the extensive requirements of the Investment
Company Act of 1940. Such a characterization and the associated compliance requirements could have a material adverse effect on
our business, financial condition, and results of operations.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">Our
business had historically included passive healthcare related investments in early stage companies primarily in the United States.
Although we are in the process of liquidating those securities that remain in our portfolio, we still hold some such investments
and these are included as assets of our Company on a consolidated basis. As part of the Restructure, we resolved to exit such
portfolio investments over an appropriate timeframe and focus our resources on our current business. Since the date of the Restructure,
we have not held ourselves out as an investment company and we do not believe we are an &ldquo;investment company&rdquo; under
the&nbsp;Investment Company Act of 1940. If the SEC or a court, however, were to disagree with us, we could be required to register
as an investment company. This would subject us to disclosure and accounting rules geared toward investment companies, rather
than operating companies, which may limit our ability to borrow money, issue options, issue multiple classes of stock and debt,
and engage in transactions with affiliates, and may require us to undertake significant costs and expenses to meet the disclosure
and regulatory requirements to which we would be subject as a registered investment company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><I>If
we are classified as a passive foreign investment company for U.S. federal income tax purposes, United States holders of our Class
A Ordinary Shares may be subject to adverse United States federal income tax consequences.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">A
non-U.S. corporation will be a passive foreign investment company (&ldquo;PFIC&rdquo;) for U.S. federal income tax purposes, for
such year, either</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 0.5in; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 0.25in; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">At
    least 75% of its gross income for such year is passive income; or</FONT></TD></TR>
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    average percentage of our assets (determined at the end of each quarter) during such year which produce passive income or
    which are held for the production of passive income is at least 50%.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">Passive
income generally includes dividends, interests, rents and royalties (other than rents or royalties derived from the active conduct
of a trade or business) and gains from the disposition of passive assets.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 15pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">A
separate determination must be made after the close of each taxable year as to whether a non-U.S. corporation is a PFIC for that
year. For purposes of the PFIC analysis, in general, a non-U.S. corporation is deemed to own its pro rata share of the gross income
and assets of any entity in which it is considered to own at least 25% of the equity by value. Based on the current and anticipated
value of our assets, we believe we were a PFIC for U.S. federal income tax purposes for our taxable year ending December 31, 2017,
and we may be a PFIC for U.S. federal income tax purposes for our current taxable year ending December 31, 2018.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">In
determining whether we are a PFIC, cash is considered by the U.S. Internal Revenue Service (&ldquo;IRS&rdquo;) to be a passive
asset. During our taxable year ending December 31, 2017, we believe that the amount of cash we had on hand was greater than 50%
of our total assets. The composition of our assets during the current taxable year, which will include the proceeds from this
Offering, may cause us to continue to be classified as a PFIC. The determination of whether we will be a PFIC for our current
taxable year or a future year may depend in part upon how quickly we spend our liquid assets, and on the value of our goodwill
and other unbooked intangibles not reflected on our balance sheet, which may depend upon the market value of our Class A Ordinary
Shares from time to time. Further, while we will endeavor to use a classification methodology and valuation approach that is reasonable,
the IRS may challenge our classification or valuation of our goodwill and other unbooked intangibles for purposes of determining
whether we are a PFIC in the current or one or more future taxable years.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">If
we are a PFIC for any taxable year during which a U.S. Holder owns our Class A Ordinary Shares, certain adverse U.S. federal income
tax consequences could apply to such U.S. Holder. As discussed under &ldquo;Taxation &ndash; Material U.S. Federal Income Tax
Considerations for U.S. Holders &ndash; Passive Foreign Investment Company Rules&rdquo;, a U.S. Holder may be able to make certain
tax elections that would lessen the adverse impact of PFIC status; however, in order to make such elections the U.S. holder will
usually have to have been provided information about the company by us, and there is no assurance that the company will provide
such information.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 15pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">For
a more detailed discussion of the application of the PFIC rules to us and the consequences to U.S. holders if we were determined
to be a PFIC. (See &ldquo;Taxation&nbsp;&ndash;&nbsp;Material U.S. Federal Income Tax Considerations for U.S. Holders&nbsp;&ndash;&nbsp;Passive
Foreign Investment Company Rules&rdquo;)</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 51; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->43<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"><A HREF="#toc">Table of Contents</A></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Risks
Related to Our Corporate Structure</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><I>Our
CEO has control over key decision making as a result of his control of a majority of our voting shares.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">Our
Founder, CEO, and our Executive Director, Mr. Ian Huen, and his affiliates which he deemed to have control and/or have substantial
influence will be able to exercise full voting rights with respect to an aggregate of 181,788,298 ordinary shares, representing
a majority of the voting power of our outstanding ordinary shares following our initial public offering. As a result, Mr.&nbsp;Huen
has the ability to control the outcome of matters submitted to our stockholders for approval, including the election of directors
and any merger, consolidation, or sale of all or substantially all of our assets. In addition, Mr.&nbsp;Huen has the ability to
control the management and affairs of our company as a result of his position as our CEO and his ability to control the election
of our directors. Additionally, in the event that Mr. Huen controls our company at the time of his death, control may be transferred
to a person or entity that he designates as his successor. As a board member and officer, Mr.&nbsp;Huen owes a fiduciary duty
to our shareholders and must act in good faith in a manner he reasonably believes to be in the best interests of our shareholders.
As a shareholder, even a controlling shareholder, Mr.&nbsp;Huen is entitled to vote his shares, and shares over which he has voting
control as a result of voting agreements, in his own interests, which may not always be in the interests of our stockholders generally.
For a description of the voting rights, see &ldquo;Description of Share Capital&mdash;Voting Rights.&rdquo;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><I>The
dual class structure of our ordinary shares has the effect of concentrating voting control with our CEO, directors and their affiliates.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 23pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Our
Class B Ordinary Share has ten votes per share, and our Class&nbsp;A Ordinary Share, which is the share we are offering in our
initial public offering, has one vote per share. Shareholders who hold shares of Class&nbsp;B Ordinary Shares, including our executive
officers and their affiliates, will together hold approximately [&nbsp;&nbsp;&nbsp;&nbsp;]% of the voting power of our outstanding
ordinary shares following our initial public offering. Because of the ten-to-one voting ratio between our Class&nbsp;B and Class&nbsp;A
Ordinary Shares, the holders of our Class&nbsp;B Ordinary Shares collectively will continue to control a majority of the combined
voting power of our ordinary share and therefore be able to control all matters submitted to our shareholders for approval so
long as the shares of Class&nbsp;B Ordinary Shares represent at least 9.1% of all outstanding shares of our Class&nbsp;A and Class&nbsp;B
Ordinary Shares. This concentrated control will limit your ability to influence corporate matters for the foreseeable future.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 23pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Future
transfers by holders of Class&nbsp;B Ordinary Shares will generally result in those shares converting to Class&nbsp;A Ordinary
Shares, subject to limited exceptions, such as certain transfers effected for estate planning purposes. The conversion of Class&nbsp;B
Ordinary Shares to Class&nbsp;A Ordinary Shares will have the effect, over time, of increasing the relative voting power of those
holders of Class&nbsp;B Ordinary Shares who retain their shares in the long term. If, for example, Mr.&nbsp;Huen retains a significant
portion of his holdings of Class&nbsp;B Ordinary Share for an extended period of time, he could, in the future, continue to control
a majority of the combined voting power of our Class&nbsp;A Ordinary Shares and Class&nbsp;B Ordinary Shares. For a description
of the dual class structure, see &ldquo;Description of Capital Stock&mdash;Anti-Takeover Provisions.&rdquo;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 23pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><I>As
a &ldquo;controlled company&rdquo; under the rules of the NASDAQ Stock Market, we may choose to exempt our company from certain
corporate governance requirements that could have an adverse effect on our public shareholders.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Prior
to the completion of this Offering, our directors and officers beneficially own a majority of the voting power of our outstanding
Class A Ordinary Shares. Even if we raise the maximum offering amount, we may continue to be a &ldquo;controlled company.&rdquo;
Under the Rule 4350(c) of the NASDAQ Stock Market, a company of which more than 50% of the voting power is held by an individual,
group or another company is a &ldquo;controlled company&rdquo; and may elect <B><I>not</I></B> to comply with certain corporate
governance requirements, including the requirement that a majority of our directors be independent, as defined in the NASDAQ Stock
Market Rules, and the requirement that our compensation and nominating and corporate governance committees consist entirely of
independent directors. Although we do not intend to rely on the &ldquo;controlled company&rdquo; exemption under the Nasdaq listing
rules, we could elect to rely on this exemption in the future. If we elect to rely on the &ldquo;controlled company&rdquo; exemption,
a majority of the members of our board of directors might not be independent directors and our nominating and corporate governance
and compensation committees might not consist entirely of independent directors. Accordingly,</FONT> <FONT STYLE="font-family: Times New Roman, Times, Serif">during
any time while <FONT STYLE="font-size: 10pt">we remain a&nbsp;controlled company&nbsp;relying on the exemption and during any
transition period following a time when we are no longer a&nbsp;controlled company, you would not have the same protections afforded
to shareholders of companies that are subject to all of the NASDAQ Stock Market corporate governance requirements. Our status
as a controlled company could cause our Class&nbsp;A Ordinary Share to look less attractive to certain investors or otherwise
harm our trading price. </FONT></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 23pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Risks
Related to this Offering and our Series A Notes and Bond</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><I>If
we are unable to comply with the restrictions and covenants in our note purchase agreements or the indenture governing the Series
A Notes or the Bond, there could be a default under the terms of these agreements, which could cause repayment of our debt to
be accelerated. </I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">If
we are unable to comply with the restrictions and covenants in the indenture governing the Series A Notes or Bond, or our current
or future debt and other agreements, there could be a default under the terms of these agreements. In the event of a default under
these agreements, the holders of the debt could terminate their commitments to lend to us, accelerate the debt and declare all
amounts borrowed due and payable or terminate the agreements, as the case may be.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">Furthermore,
some of our debt agreements may contain cross-acceleration or cross-default provisions. As a result, our default under one debt
agreement may cause the acceleration of debt or result in a default under our other debt agreements. If any of these events occur,
we cannot assure you that our assets and cash flow would be sufficient to repay in full all of our indebtedness, or that we would
be able to find alternative financing. Even if we could obtain alternative financing, we cannot assure you that it would be on
terms that are favorable or acceptable to us.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 52; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->44<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"><A HREF="#toc">Table of Contents</A></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><I>The
initial public offering price of our Class A Ordinary Shares may not be indicative of the market price of our Class A Ordinary
Shares after this Offering. In addition, an active, liquid and orderly trading market for our Class A Ordinary Shares may not
develop or be maintained, and our stock price may be volatile.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">Prior
to this Offering, our Class A Ordinary Shares were not traded on any market. An active, liquid and orderly trading market for
our Class A Ordinary Shares may not develop or be maintained after this Offering. Active, liquid and orderly trading markets usually
result in less price volatility and more efficiency in carrying out investors&rsquo; purchase and sale orders. The market price
of our Class A Ordinary Shares could vary significantly as a result of a number of factors, some of which are beyond our control.
In the event of a drop in the market price of our Class A Ordinary Shares, you could lose a substantial part or all of your investment
in our shares. The initial public offering price will be determined by us, based on numerous factors and may not be indicative
of the market price of our Class A Ordinary Shares after this Offering. Consequently, you may not be able to sell our Class A
Ordinary Shares at prices equal to or greater than the price paid by you in this Offering.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">The
following factors could affect our share price:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 0.5in; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 0.25in; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
    operating and financial performance;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 0.5in; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 0.25in; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">quarterly
    variations in the rate of growth of our financial indicators, such as net income per share, net income and revenues;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 0.5in; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 0.25in; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    public reaction to our press releases, our other public announcements and our filings with the SEC;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 0.5in; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 0.25in; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">strategic
    actions by our competitors;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 0.5in; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 0.25in; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">changes
    in revenue or earnings estimates, or changes in recommendations or withdrawal of research coverage, by equity research analysts;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 0.5in; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 0.25in; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">speculation
    in the press or investment community;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 0.5in; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 0.25in; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    failure of research analysts to cover our securities;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 0.5in; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 0.25in; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">sales
    of our Class A Ordinary Shares by us or other shareholders, or the perception that such sales may occur;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 0.5in; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 0.25in; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">changes
    in accounting principles, policies, guidance, interpretations or standards;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 0.5in; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 0.25in; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">additions
    or departures of key management personnel;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 0.5in; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 0.25in; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">actions
    by our shareholders;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 0.5in; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 0.25in; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">domestic
    and international economic, legal and regulatory factors unrelated to our performance; and</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 0.5in; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 0.25in; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    realization of any risks describes under this &ldquo;Risk Factors&rdquo; section.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<!-- Field: Page; Sequence: 53; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->45<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"><A HREF="#toc">Table of Contents</A></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">The
stock markets in general have experienced extreme volatility that has often been unrelated to the operating performance of particular
companies. These broad market fluctuations may adversely affect the trading price of our Class A Ordinary Shares. Securities class
action litigation has often been instituted against companies following periods of volatility in the overall market and in the
market price of a company&rsquo;s securities. Such litigation, if instituted against us, could result in very substantial costs,
divert our management&rsquo;s attention and resources and harm our business, operating results and financial condition.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><I>The
price of the Class A Ordinary Shares and other terms of this Offering have been determined by us along with our underwriters.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">If
you purchase our Class A Ordinary Shares in this Offering, you will pay a price that was not established in a competitive market.
Rather, you will pay a price that was determined by us along with our underwriters. The offering price for our Class A Ordinary
Shares may bear no relationship to our assets, book value, historical results of operations or any other established criterion
of value. The trading price, if any, of the Class A Ordinary Shares that may prevail in any market that may develop in the future,
for which there can be no assurance, may be higher or lower than the price you paid for our Class A Ordinary Shares.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><I>Shares
eligible for future sale may adversely affect the market price of our Class A Ordinary Shares if the shares are successfully listed
on NASDAQ or other stock markets, as the future sale of a substantial amount of outstanding Class A Ordinary Shares in the public
marketplace could reduce the price of our Class A Ordinary Shares.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">The
market price of our Class A Ordinary Shares could decline as a result of sales of substantial amounts of our Class A Ordinary
Shares in the public market, or the perception that these sales could occur. In addition, these factors could make it more difficult
for us to raise funds through future offerings of our Class A Ordinary Shares. An aggregate of [&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;]
Class A Ordinary Shares will be outstanding before the consummation of this Offering, all of which, except those held by management,
are or will be freely tradable immediately upon effectiveness of this registration statement. All of the Class A Ordinary Shares
sold in the offering will be freely transferable without restriction or further registration under the Securities Act. The remaining
Class A Ordinary Shares will be &ldquo;restricted securities&rdquo; as defined in Rule 144. These Class A Ordinary Shares may
be sold without registration under the Securities Act to the extent permitted by Rule 144 or other exemptions under the Securities
Act. (See &ldquo;Shares Eligible for Future Sale&rdquo;)</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><I>A
sale or perceived sale of a substantial number of our Ordinary Shares may cause the price of our Class A Ordinary Shares to decline.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 15pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">All
of our executive officers and directors, the Series A Note Investors, the holders of the Bond and warrants, and almost all of
our shareholders have agreed not to sell our Class A Ordinary Shares for a period of six months following this Offering, subject
to extension under specified circumstances. (See &ldquo;Shares Eligible for Future Sale &ndash; Lock-Up Agreements&rdquo;) Class
A Ordinary shares subject to these lock-up agreements will become eligible for sale in the public market upon expiration of these
lock-up agreements, subject to limitations imposed by Rule 144 under the Securities Act of 1933, as amended. If our shareholders
sell substantial amounts of our Class A Ordinary Shares in the public market, the market price of our Class A Ordinary Shares
could fall. Moreover, the perceived risk of this potential dilution could cause shareholders to attempt to sell their shares and
investors to short our Class A Ordinary Shares. These sales also may make it more difficult for us to sell equity or equity-related
securities in the future at a time and price that we deem reasonable or appropriate.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><I>We
have not paid dividends in the past and do not expect to pay dividends in the future, and any return on investment may be limited
to the value of our shares.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">We
have never paid any cash dividends on our Class A Ordinary Shares and do not anticipate paying any cash dividends on our Class
A Ordinary Shares in the foreseeable future, and any return on investment may be limited to the value of our Class A Ordinary
Shares. We plan to retain any future earnings to finance growth.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">Our
dividend policy is subject to the discretion of our Board of Directors and will depend on, among other things, our earnings, financial
condition, capital requirements and other factors. There is no assurance that our Board of Directors will declare dividends even
if we are profitable. Under Cayman Islands law, dividends may be declared and paid only out of funds legally available therefor,
namely out of either profit or our share premium account, and provided further that a dividend may not be paid if this would result
in our Company being unable to pay its debts as they fall due in the ordinary course of business and the realizable value of assets
of our Company will not be less than the sum of our total liabilities, other than deferred taxes as shown on our books of account,
and our capital.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<!-- Field: Page; Sequence: 54; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->46<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"><A HREF="#toc">Table of Contents</A></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><I>Our
Class B Ordinary Shares have stronger voting power than our Class A Ordinary Shares and certain existing shareholders have substantial
influence over our Company and their interests may not be aligned with the interests of our other shareholders and holders of
our Series A Notes and the Bond.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">We
have a dual-class voting structure consisting of Class A Ordinary Shares and Class B Ordinary Shares. Under this structure, holders
of Class A Ordinary Shares are entitled to one vote per share, and holders of Class B Ordinary Shares are entitled to ten votes
per share, which can cause the holders of Class B Ordinary Shares to have an unbalanced, higher concentration of voting power.
Immediately prior to the Offering, our management team as a group beneficially own over 20 million Class B Ordinary Shares representing
over 90% voting power. As a result, until such time as their collective voting power is below 50%, our management team as a group
of controlling shareholders have substantial influence over our business, including decisions regarding mergers, consolidations
and the sale of all or substantially all of our assets, election of directors and other significant corporate actions. They may
take actions that are not in the best interests of us or our other shareholders. These corporate actions may be taken even if
they are opposed by our other shareholders, including those who hold Class A Ordinary Shares converted from the Series A Notes
and the Bond. <FONT STYLE="background-color: white">Further,&nbsp;concentration&nbsp;of ownership of our Class B Ordinary Shares
may discourage, prevent or delay the consummation of change of control transactions that stockholders may consider favorable,
including transactions in which stockholders might otherwise receive a premium for their shares. Future issuances of Class B Ordinary
Shares may also be dilutive to the holders of Class A Ordinary Shares. As a result, the market price of our Class A Ordinary Shares
could be adversely affected. </FONT></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">Shareholders
who hold shares of Class&nbsp;B Ordinary Shares, including our executive officers and their affiliates, will together hold approximately
[&nbsp;&nbsp;&nbsp;&nbsp;]% or [ ]% of the voting power of our outstanding ordinary shares following this Offering if the maximum
offering amount or minimum offering amount, respectively is sold. Because of the ten-to-one voting ratio between our Class&nbsp;B
and Class&nbsp;A Ordinary Shares, the holders of our Class&nbsp;B Ordinary Shares will collectively continue to control a majority
of the combined voting power of our Ordinary Shares and therefore be able to control all matters submitted to our shareholders
for approval, so long as the Class&nbsp;B Ordinary Shares represent at least 9.1% of all outstanding shares of our Ordinary Shares.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><I>You
will experience immediate and substantial dilution as a result of this Offering and may experience additional dilution in the
future.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 20.9pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">You
will incur immediate and substantial dilution as a result of this Offering and the automatic conversion of the Series A Notes
and the Bond. After giving effect to the sale by us of up to [&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ] Class A Ordinary Shares offered
in this Offering at an assumed public offering price of $[&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;] per share (the mid-point of the
range indicated on the front cover of this prospectus), issuance of [&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;] Class A Ordinary Shares
upon the automatic conversion of the Series A Notes and automatic conversion of the Bond at the closing of this Offering and the
commencement of the trading of the Class A Ordinary Shares on NASDAQ Global Market, investors in this Offering can expect an immediate
dilution of $[&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;] per share, or [&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;]% at the assumed public
offering price. You may also experience further dilution to the extent that Class A Ordinary Shares are to be issued upon exercise
of the Series A Note PA Warrants and the Bond PA Warrants and upon the Bond holder&rsquo;s voluntary conversion of the balance
of the Bond. Additionally, in the event that those warrants or options we may grant to our officers, directors and employees are
ultimately exercised, you will sustain future dilution. We may also acquire or license other technology or finance strategic alliances
by issuing equity, which may result in additional dilution to our shareholders.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><I>Raising
additional capital may cause dilution to our shareholders, restrict our operations or require us to relinquish rights to our technology
or drug and device candidates. </I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">We
may seek additional funding through a combination of equity offerings, debt financings, collaborations, licensing arrangements,
strategic alliances and marketing or distribution arrangements. To the extent that we raise additional capital through the sale
of equity or convertible debt securities, your ownership interest will be diluted, and the terms may include liquidation or other
preferences that adversely affect your rights as a holder of our Class A Ordinary Shares. The incurrence of additional indebtedness
or the issuance of certain equity securities could result in increased fixed payment obligations, and could also result in certain
additional restrictive covenants, such as limitations on our ability to incur additional debt or issue additional equity, limitations
on our ability to acquire or license IP rights and other operating restrictions that could adversely impact our ability to conduct
our business. In addition, issuance of additional equity securities, or the possibility of such issuance, may cause the market
price of our Class A Ordinary Shares to decline. In the event that we enter into collaborations or licensing arrangements to raise
capital, we may be required to accept unfavorable terms, including relinquishing or licensing to another party on unfavorable
terms our rights to technology or drug and device candidates that we otherwise would seek to develop or commercialize ourselves
or potentially reserve for future potential arrangements when we might be able to achieve more favorable terms.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><I>Resales
of our Class A Ordinary Shares in the public market during this Offering by the Selling Shareholders or investors in this Offering
may cause the market price of our Class A Ordinary Shares to decline.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">Sales
of Resale Shares, as well as the issuance of Class A Ordinary Shares in this Offering could result in resales of our Class A Ordinary
Shares by our current shareholders concerned about the potential dilution of their holdings. In turn, these resales could have
the effect of depressing the market price for our Class A Ordinary Shares.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><I>&nbsp;</I></B></FONT></P>

<!-- Field: Page; Sequence: 55; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->47<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"><A HREF="#toc">Table of Contents</A></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><I>Since
we are a Cayman Islands exempted company, the rights of our shareholders may be more limited than those of shareholders of a company
organized in the United States.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">Our
corporate affairs are governed by our Second Amended and Restated Memorandum and Articles of Association (as may be amended from
time to time) (&ldquo;Memorandum and Articles&rdquo;), the Companies Law (2018 Revision) of the Cayman Islands (the &ldquo;Companies
Law&rdquo;) and the common law of the Cayman Islands. <FONT STYLE="background-color: white">The rights of shareholders to take
action against the directors, actions by minority shareholders and the fiduciary responsibilities of our directors are to a large
extent governed by the common law of the Cayman Islands. This common law is derived in part from comparatively limited judicial
precedent in the Cayman Islands as well as from English common law, which has persuasive, but not binding, authority on a court
in the Cayman Islands. </FONT>Under the laws of some jurisdictions in the United States, majority and controlling shareholders
generally have certain fiduciary responsibilities to the minority shareholders. Shareholder action must be taken in good faith,
and actions by controlling shareholders which are obviously unreasonable may be declared null and void. Cayman Islands law protecting
the interests of minority shareholders may not be as protective in all circumstances as the law protecting minority shareholders
in some U.S. jurisdictions. In addition, the circumstances in which a shareholder of a Cayman Islands company may sue the company
derivatively, and the procedures and defenses that may be available to the company, may result in the rights of shareholders of
a Cayman Islands company being more limited than those of shareholders of a company organized in the United States. Accordingly,
shareholders may have fewer alternatives available to them if they believe that corporate wrongdoing has occurred. The Cayman
Islands courts are also unlikely to recognize or enforce judgments from U.S. courts based on certain liability provisions of U.S.
securities laws that are penal in nature. There is no statutory recognition in the Cayman Islands of judgments obtained in the
United States, although the courts of the Cayman Islands will generally recognize and enforce non-penal judgment of a foreign
court of competent jurisdiction without retrial on its merits. This means, even if shareholders were to sue us successfully, they
may not be able to recover anything to make up for the losses suffered.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">Furthermore,
our directors have the power to take certain actions without shareholder approval which would require shareholder approval under
the laws of most U.S. jurisdictions. For example, the directors of a Cayman Islands company, without shareholder approval, may
implement a sale of any assets, property, part of the business, or securities of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">While
Cayman Islands law allows a dissenting shareholder to express the shareholder&rsquo;s view that a court sanctioned reorganization
of a Cayman Islands company would not provide fair value for the shareholder&rsquo;s shares, Cayman Islands statutory law does
not specifically provide for shareholder appraisal rights on a merger or consolidation of a company. This may make it more difficult
for you to assess the value of any consideration you may receive in a merger or consolidation or to require that the acquirer
gives you additional consideration if you believe the consideration offered is insufficient. However, Cayman Islands&rsquo; statutory
law does provide a mechanism for a dissenting shareholder in a merger or consolidation to apply to the Grand Court for a determination
of the fair value of the dissenter&rsquo;s shares, if it is not possible for the Company and the dissenter to agree a fair price
within the time limits prescribed.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">Shareholders
of Cayman Islands exempted companies, such as our Company, have no general rights under Cayman Islands&rsquo; law to inspect corporate
records and accounts or to obtain copies of lists of shareholders. Our directors have discretion under our Memorandum and Articles
to determine whether or not, and under what conditions, our corporate records may be inspected by our shareholders, but are not
obliged to make them available to our shareholders. This may make it more difficult for you to obtain the information needed to
establish any facts necessary for a shareholder motion or to solicit proxies from other shareholders in connection with a proxy
contest.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">Lastly,
under the law of the Cayman Islands, there is little statutory law for the protection of minority shareholders. The principal
protection under statutory law is that shareholders may bring an action to enforce the constituent documents of the corporation,
our Memorandum and Articles. Shareholders are entitled to have the affairs of the company conducted in accordance with the general
law and the memorandum and articles of association.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">There
are common law rights for the protection of shareholders that may be invoked, largely dependent on English company law, since
the common law of the Cayman Islands for business companies is limited. Under the general rule pursuant to English company law
known as the rule in Foss v. Harbottle, a court will generally refuse to interfere with the management of a company at the insistence
of a minority of its shareholders who express dissatisfaction with the conduct of the company&rsquo;s affairs by the majority
or the board of directors. However, every shareholder is entitled to have the affairs of the company conducted properly according
to law and the constituent documents of the company. As such, if those who control the company have persistently disregarded the
requirements of company law or the provisions of the company&rsquo;s memorandum and articles of association, then the courts will
grant relief. Generally, the areas in which the courts will intervene are the following: (1) an act complained of which is outside
the scope of the authorized business or is illegal or not capable of ratification by the majority; (2) acts that constitute fraud
on the minority where the wrongdoers control the company; (3) acts that infringe on the personal rights of the shareholders, such
as the right to vote; and (4) where the company has not complied with provisions requiring approval of a special or extraordinary
majority of shareholders, which are more limited than the rights afforded minority shareholders under the laws of many states
in the United States. Our Cayman Islands&rsquo; counsel has advised us that they are aware of one recent as yet unreported derivative
action having been brought in a Cayman Islands&rsquo; court. Class actions are not recognized in the Cayman Islands, but groups
of shareholders with identical interests may bring representative proceedings, which are similar.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">As
a result, you may be limited in your ability to protect your interests if you are harmed in a manner that would otherwise enable
you to sue in a United States federal court. In addition, shareholders of Cayman Islands companies may not have standing to initiate
a shareholder derivative action in U.S. federal courts.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<!-- Field: Page; Sequence: 56; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->48<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"><A HREF="#toc">Table of Contents</A></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">As
a result of all of the above, shareholders of our Company may have more difficulty in protecting their interests in the face of
actions taken by management, members of the board of directors or controlling shareholders than they would have as shareholders
of a public U.S. company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><I>You
may face difficulties in protecting your interests, and your ability to protect your rights through the U.S. federal courts may
be limited because we are incorporated under Cayman Islands law, we currently conduct substantially all of our operations outside
the United States and some of our directors and executive officers reside outside the United States.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">We
are incorporated in the Cayman Islands and currently conduct substantially all of our operations outside the United States through
our subsidiaries. Some of our directors and executive officers reside outside the United States and a substantial portion of their
assets are located outside of the United States. As a result, it may be difficult or impossible for you to bring an action against
us or against these individuals in the Cayman Islands or in Hong Kong, in the event that you believe that your rights have been
infringed under the securities laws of the United States or otherwise. Even if you are successful in bringing an action of this
kind, the laws of the Cayman Islands and Hong Kong may render you unable to enforce a judgment against our assets or the assets
of our directors and officers. There is no statutory recognition in the Cayman Islands of judgments obtained in the United States
or Hong Kong, although the courts of the Cayman Islands will generally recognize and enforce a non-penal judgment of a foreign
court of competent jurisdiction without retrial on the merits if such judgment is final, for a liquidated sum, not in the nature
of taxes, a fine or penalty, is not inconsistent with a Cayman Islands&rsquo; judgment in respect of the same matters, and was
not obtained in a manner which is contrary to public policy. In addition, a Cayman Islands court may stay proceedings if concurrent
proceedings are being brought elsewhere.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><I>You
must rely on the judgment of our management as to the use of the net proceeds from this Offering, and such use may not produce
income.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">A
significant portion of the net proceeds of this Offering is allocated for general corporate purposes, including funding research
and development, clinical trials, potential investments in and acquisitions of complementary businesses, assets and technology.
Although we describe a number of projects currently under development, including three that we have described as being our Lead
Projects, because other opportunities may arise and because of the uncertainties inherent in drug development, our management
will have considerable discretion in the application of the net proceeds received by us. You will not have the opportunity, as
part of your investment decision, to assess whether proceeds are being used appropriately. The net proceeds may be used for corporate
purposes that do not improve our efforts to achieve or maintain profitability. The net proceeds from this Offering may be expended
on projects that do not produce income or that lose value.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><I>We
are an emerging growth company within the meaning of the Securities Act and will take advantage of certain reduced reporting requirements.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">Upon
the consummation of this Offering, we will be an &ldquo;emerging growth company,&rdquo; as defined in the JOBS Act and we may take
advantage of certain exemptions from various requirements applicable to other public companies that are not emerging growth companies
including, most significantly, not being required to comply with the auditor attestation requirements of Section 404 of the Sarbanes-Oxley
Act for so long as we are an emerging growth company. As a result, if we elect not to comply with such auditor attestation requirements,
our investors, including the holders of Class A Ordinary Shares converted from the Series A Notes and Bonds, may not have access
to certain information they may deem important.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">The
JOBS Act also provides that an emerging growth company does not need to comply with any new or revised financial accounting standards
until such date that a private company is otherwise required to comply with such new or revised accounting standards. The Company
has elected to use the extended transition period for complying with new or revised accounting standard under Section 102(b)(2)
of the Jobs Act, that allows the Company to delay the adoption of new or revised accounting standards that have different effective
dates for public and private companies until those standards apply to private companies.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><I>We
will incur increased costs as a result of operating as a public company, and our management will be required to devote substantial
time to new compliance initiatives and corporate governance practices.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">As
a public company, we will incur significant legal, accounting and other expenses that we did not incur as a private company. The
Sarbanes-Oxley Act, the Dodd-Frank Wall Street Reform and Consumer Protection Act, the listing requirements of the NASDAQ Stock
Market and other applicable securities rules and regulations impose various requirements on public companies, including establishment
and maintenance of effective disclosure and financial controls and corporate governance practices. Our management and other personnel
will need to devote a substantial amount of time to these compliance initiatives. Moreover, these rules and regulations will increase
our legal and financial compliance costs and will make some activities more time-consuming and costly. For example, we expect
that these rules and regulations may make it more difficult and more expensive for us to obtain director and officer liability
insurance, which in turn could make it more difficult for us to attract and retain qualified members of our Board of Directors.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<!-- Field: Page; Sequence: 57; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->49<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"><A HREF="#toc">Table of Contents</A></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">We
are evaluating these rules and regulations, and cannot predict or estimate the amount of additional costs we may incur or the
timing of such costs. These rules and regulations are often subject to varying interpretations, in many cases due to their lack
of specificity, and, as a result, their application in practice may evolve over time as new guidance is provided by regulatory
and governing bodies. This could result in continuing uncertainty regarding compliance matters and higher costs necessitated by
ongoing revisions to disclosure and governance practices.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">Pursuant
to Section&nbsp;404 of the Sarbanes-Oxley Act, we will first be required to furnish a report by our management on our internal
control over financial reporting for the year ending December&nbsp;31, 2018. However, while we remain an emerging growth company,
we will not be required to include an attestation report on internal control over financial reporting issued by our independent
registered public accounting firm. To achieve compliance with Section&nbsp;404 of the Sarbanes-Oxley Act within the prescribed
period, we will be engaged in a process to document and evaluate our internal control over financial reporting, which is both
costly and challenging. In this regard, we will need to continue to dedicate internal resources, potentially engage outside consultants
and adopt a detailed work plan to assess and document the adequacy of internal control over financial reporting, continue steps
to improve control processes as appropriate, validate through testing that controls are functioning as documented and implement
a continuous reporting and improvement process for internal control over financial reporting. Despite our efforts, there is a
risk that we will not be able to conclude, within the prescribed timeframe or at all, that our internal control over financial
reporting is effective as required by Section&nbsp;404 of the Sarbanes-Oxley Act. If we identify one or more material weaknesses,
it could result in an adverse reaction in the financial markets due to a loss of confidence in the reliability of our financial
statements.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><A NAME="w4"></A>SPECIAL
NOTE REGARDING FORWARD-LOOKING STATEMENTS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">This
prospectus, including the sections titled &ldquo;Prospectus Summary,&rdquo; &ldquo;Risk Factors,&rdquo; &ldquo;Management&rsquo;s
Discussion and Analysis of Financial Condition and Results of Operations&rdquo; and &ldquo;Our Business&rdquo; contains forward-looking
statements that are based on our management&rsquo;s belief and assumptions and on information currently available to our management.
Although we believe that the expectations reflected in these forward-looking statements are reasonable, these statements relate
to future events or our future financial performance, and involve known and unknown risks, uncertainties and other factors that
may cause our actual results, levels of activity, performance or achievements to be materially different from any future results,
levels of activity, performance or achievements expressed or implied by these forward-looking statements. Forward-looking statements
in this prospectus include, but are not limited to, statements about:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 0.5in; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 0.25in; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    initiation, timing, progress and results of our preclinical and clinical trials, and our research and development programs;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 0.5in; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 0.25in; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
    ability to advance our drug candidates into, and successfully complete, clinical trials;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 0.5in; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 0.25in; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
    ability to identify and develop new drug and device candidates;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 0.5in; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 0.25in; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
    reliance on the success of our drug candidates currently undergoing preclinical development; in particular, our Lead Project
    candidates;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<!-- Field: Page; Sequence: 58; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->50<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"><A HREF="#toc">Table of Contents</A></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 0.5in; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 0.25in; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    timing or likelihood of regulatory filings and approvals;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 0.5in; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 0.25in; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    commercialization of our drug and device candidates, if approved;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 0.5in; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 0.25in; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
    ability to develop sales and marketing capabilities;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 0.5in; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 0.25in; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    pricing and reimbursement of our drug candidates, if approved;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 0.5in; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 0.25in; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    implementation of our business model, strategic plans for our business and technology;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 0.5in; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 0.25in; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    scope of protection we are able to establish and maintain for IP rights covering our drug and device candidates and technology;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 0.5in; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 0.25in; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
    ability to operate our business without infringing the IP rights and proprietary technology of other parties;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 0.5in; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 0.25in; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">costs
    associated with defending IP infringement, product liability and other claims;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 0.5in; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 0.25in; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">regulatory
    development in the U.S., Europe and PRC and other jurisdictions;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 0.5in; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 0.25in; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">estimates
    of our expenses, future revenues, capital requirements and our needs for additional financing;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 0.5in; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 0.25in; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    potential benefits of strategic collaboration agreements and our ability to enter into strategic arrangements;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 0.5in; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 0.25in; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
    ability to maintain and establish collaborations or obtain additional grant funding; the rate and degree of market acceptance
    of our drug and device candidates;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 0.5in; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 0.25in; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">developments
    relating to our competitors and industry, including competing therapies;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 0.5in; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 0.25in; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
    ability to effectively manage our anticipated growth;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 0.5in; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 0.25in; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
    ability to attract and retain qualified employees and key personnel;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 0.5in; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 0.25in; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
    expectations regarding the period during which we qualify as an emerging growth company under the JOBS Act;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 0.5in; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 0.25in; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">statements
    regarding future revenue, hiring plans, expenses, capital expenditures, capital requirements and share performance;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 0.5in; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 0.25in; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
    expected use of proceeds of this Offering, the Series A Note Offering and the Bond Offering;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 0.5in; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 0.25in; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    future trading price of our Class A Ordinary Shares and impact of securities analysts&rsquo; reports on these prices; and</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 0.5in; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 0.25in; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">other
    risks and uncertainties, including those listed under the caption &ldquo;Risk Factors&rdquo;.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">In
some cases, you can identify forward-looking statements by terminology such as &ldquo;may,&rdquo; &ldquo;will,&rdquo; &ldquo;should,&rdquo;
&ldquo;expects,&rdquo; &ldquo;intends,&rdquo; &ldquo;plans,&rdquo; &ldquo;anticipates,&rdquo; &ldquo;believes,&rdquo; &ldquo;estimates,&rdquo;
&ldquo;predicts,&rdquo; &ldquo;potential,&rdquo; &ldquo;continue&rdquo; or the negative of these terms or other comparable terminologies.
These statements are only predictions. You should not place undue reliance on forward-looking statements because they involve
known and unknown risks, uncertainties and other factors, which are, in some cases, beyond our control and which could materially
affect results. Factors that may cause actual results to differ materially from current expectations include, among other things,
those listed under &ldquo;Risk Factors&rdquo; and elsewhere in this prospectus. If one or more of these risks or uncertainties
occur, or if our underlying assumptions prove to be incorrect, actual events or results may vary significantly from those implied
or projected by the forward-looking statements. No forward-looking statement is a guarantee of future performance. You should
read this prospectus and the documents that we reference in this prospectus and have filed with the SEC as exhibits to the registration
statement, of which this prospectus is a part, completely and with the understanding that our actual future results may be materially
different from any future results expressed or implied by these forward-looking statements.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<!-- Field: Page; Sequence: 59; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->51<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"><A HREF="#toc">Table of Contents</A></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">The
forward-looking statements in this prospectus represent our views as of the date of this prospectus. We anticipate that subsequent
events and developments will cause our views to change. However, while we may elect to update these forward-looking statements
at some point in the future, we have no current intention of doing so except to the extent required by applicable law. You should
therefore not rely on these forward-looking statements as representing our views as of any date subsequent to the date of this
prospectus.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">This
prospectus contains market data and industry forecasts that were obtained from industry publications. These data involve a number
of assumptions and limitations, and you are cautioned not to give undue weight to such estimates. While we believe the market
position, market opportunity and market size information included in this prospectus is generally reliable, such information is
inherently imprecise.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><A NAME="w5"></A>TRADEMARKS,
SERVICE MARKS AND TRADENAMES</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">This
prospectus contains trademarks, service marks and trade names of others, which are the property of their respective owners. Solely
for convenience, the trademarks, service marks, logos and trade names referred to in this prospectus are included without the
&reg; and &trade; symbols. All trademarks, service marks and trade names appearing in this prospectus are, to our knowledge, the
property of their respective owners. We do not intend our use or display of other companies&rsquo; trademarks, service marks,
copyrights or trade names to imply a relationship with, or endorsement or sponsorship of us by, any other companies or unrelated
parties.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><A NAME="w6"></A>USE
OF PROCEEDS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">We
estimate that we will receive net proceeds from this Offering of up to $[&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;] million,
based on an assumed price to the public in this Offering of $[&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;], the midpoint
of the price range set forth on the cover page of this prospectus, after deducting underwriting discounts and commissions and
estimated offering expenses.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif"></FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: bottom; background-color: white">
    <TD STYLE="padding-left: 10pt; text-indent: -10pt">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: black 1.5pt solid">
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B><I>Use of net proceeds</I></B></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B><I>(in millions)<BR>
        (Minimum offering amount)</I></B></P></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: black 1.5pt solid">
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B><I>Use of net proceeds</I></B></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B><I>(in millions)<BR>
        (Maximum offering amount)</I></B></P></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: white">
    <TD STYLE="padding-left: 10pt; text-indent: -10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Fund preclinical and clinical development:</I></B></FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: #CCEEFF">
    <TD STYLE="width: 68%; padding-left: 20pt; text-indent: -10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Development through Phase I of our Lead Projects</I></B></FONT></TD>
    <TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="white-space: nowrap; width: 15%; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>approximately US$7.0</I></B></FONT></TD>
    <TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="white-space: nowrap; width: 15%; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>approximately US$18.0</I></B></FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: white">
    <TD STYLE="padding-left: 20pt; text-indent: -10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Development of our non-therapeutic projects</I></B></FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>approximately US$0.5</I></B></FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>approximately US$3.0</I></B></FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: #CCEEFF">
    <TD STYLE="padding-left: 10pt; text-indent: -10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Set up self-owned laboratory in Fo Tan, Hong Kong</I></B></FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>approximately US$1.0</I></B></FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="white-space: nowrap; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>approximately US$2.5</I></B></FONT></TD></TR>
<TR STYLE="background-color: white">
    <TD STYLE="vertical-align: bottom; padding-left: 10pt; text-indent: -10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Fund Other non-Lead Projects under Development (other than non-therapeutic projects), general research and development activities, working capital and other general corporate activities</I></B></FONT></TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>approximately US$0.5</I></B></FONT></TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>approximately US$3.5</I></B></FONT></TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">As
of the date of this prospectus, we cannot specify with certainty all of the particular uses for the net proceeds from this Offering.
The amounts and timing of our actual expenditures may vary significantly from our expectations depending upon numerous factors,
including the progress of our research, development and commercialization efforts, the progress of our preclinical trials, and
our operating costs and capital expenditures. Drug discovery and development in the pharmaceutical industry is characterized by
significant risks and uncertainties inherent in the research, clinical development and regulatory approval process. These uncertainties
make it difficult for us to estimate the costs to conduct our research and development and complete our preclinical trials. Accordingly,
we will retain broad discretion in the allocation of the net proceeds of this Offering, and we reserve the right to change the
allocation of use of these proceeds as a result of contingencies such as the progress and results of our preclinical trials and
our research and development activities, the results of our commercialization efforts, competitive developments and our manufacturing
requirements. In addition, when and if the opportunity arises, we may use a portion of the proceeds to license, acquire or invest
in complementary businesses, products, or technologies. In order to license, acquire or invest in complementary businesses, products
or technologies, we may need to curtail our development of our Other Projects under Development described above, or enter into
agreements allowing others to obtain rights for further development of one or more of our drug and device candidates earlier than
anticipated. We currently have no commitments or agreements to acquire any such businesses, products or technologies, and we cannot
determine with certainty which, if any, of the programs above might be affected should we enter into any such commitments.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; background-color: white">We
will not receive any of the proceeds from the sale of the Class A Ordinary Shares being offered by the Selling Shareholders, although
we may receive additional proceeds of up to approximately $[&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;] if all of the Series A Note
PA Warrants and the Bond PA Warrants are exercised for cash. We will not receive any additional proceeds to the extent that the&nbsp;Series
A Note PA Warrants </FONT><FONT STYLE="font-family: Times New Roman, Times, Serif">and <FONT STYLE="background-color: white">the
Bond PA Warrants are exercised by cashless exercise. We expect to use the proceeds received from the exercise of those warrants,
if any, for general working capital purposes. We cannot assure you, however, that any of those warrants will ever be exercised.</FONT></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">The net proceeds from
this offering, together with our cash and marketable securities, will not be sufficient for us to fund any of our product
candidates through regulatory approval, and we will need to raise additional capital to complete the development of our
product candidates. We may satisfy our future cash needs through the sale of equity securities, debt financings, working
capital lines of credit, corporate collaborations or license agreements, grant funding, through interest income earned on
cash balances or a combination of one or more of these sources. This expected use of net proceeds from this offering
represents our intentions based upon our current plans and business conditions, which could change in the future as our plans
and business conditions evolve. The amounts and timing of our actual expenditures may vary significantly depending on
numerous factors, including the progress of our development, the status of and results from different preclinical and
clinical trials, as well as any collaborations that we may enter into with third parties for our programs, and any unforeseen
cash needs. As a result, our management will retain broad discretion over the allocation of the net proceeds. We cannot
specify with certainty all of the particular uses for the net proceeds to be received upon the closing of this offering.</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<!-- Field: Page; Sequence: 60; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->52<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"><A HREF="#toc">Table of Contents</A></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><A NAME="w7"></A>DIVIDEND
POLICY</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">We
have never declared or paid cash dividends to our shareholders, and we do not intend to pay cash dividends in the foreseeable
future. We intend to reinvest any earnings in developing and expanding our business. Any future determination relating to our
dividend policy will be at the discretion of our Board of Directors and will depend on a number of factors, including future earnings,
our financial condition, operating results, contractual restrictions, capital requirements, business prospects, our strategic
goals and plans to expand our business, applicable law and other factors that our Board of Directors may deem relevant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">Under
Cayman Islands law, dividends may be declared and paid only out of funds legally available therefor, namely out of either profit
or our share premium account, and provided further that a dividend may not be paid if this would result in our Company being unable
to pay its debts as they fall due in the ordinary course of business.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(See
&ldquo;Risk Factors &ndash; We have not paid dividends in the past and do not expect to pay dividends in the future, and any return
on investment may be limited to the value of our shares&rdquo; and &ldquo;Description of Share Capital &ndash; Dividends&rdquo;)</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 61; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->53<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"><A HREF="#toc">Table of Contents</A></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><A NAME="w8"></A>CAPITALIZATION</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">The
following table presents our capitalization as of December 31, 2017:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 0.5in; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 0.25in; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">on
    an actual basis;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 0.5in; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 0.25in; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">on
    a pro forma basis, to give effect to the issuance to [&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;] [&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;]
    Class A Ordinary Shares issuable upon conversion of the Class B Ordinary Shares; (See &ldquo;Transactions with Related Persons&rdquo;);
    and</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 0.5in; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 0.25in; text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">on
    a pro forma as-adjusted basis, to give effect and the issuance of [&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;] Class
    A Ordinary Shares in this Offering and the issuance of [&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;] Class A Ordinary
    Shares as a result of the automatic conversion of the Notes issued in the Series A Note Offering, each at an assumed price
    to the public of $[&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;] per share, the midpoint of the price range set forth
    on the cover page of this prospectus after deducting underwriting discounts and commissions and estimated offering expenses,
    and the issuance of [&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;] Class A Ordinary Shares as a result of the automatic
    partial conversion of the Bond.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">This
table should be read in conjunction with &ldquo;Management&rsquo;s Discussion and Analysis of Financial Condition and Results
of Operations&rdquo; and our financial statements, consolidated financial statements and related notes included elsewhere in this
prospectus.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="6" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">December
    31, 2017</FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">Actual</FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">As
    adjusted<BR> (Minimum<BR> offering amount)</FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">As
    adjusted<BR> (Maximum<BR> offering amount)</FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">US$</FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">US$</FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">US$</FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">Equity</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="width: 64%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Class A Ordinary Shares</FONT></TD><TD STYLE="width: 1%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="width: 9%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">5,426,381</FONT></TD><TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="width: 1%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="width: 9%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD><TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="width: 1%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="width: 9%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD><TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Class B Ordinary Shares</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">22,437,754</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Additional paid-in
    capital<SUP>(1)</SUP></FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">5,294,402</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Accumulated other comprehensive loss</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(367,782</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Accumulated deficit</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(2,547,462</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Non-controlling
    interests</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(14,045</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Total equity</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">30,229,248</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold; text-align: left; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Total
    capitalization</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">30,229,248</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 48px; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pro
    forma additional paid-in capital reflects the net proceeds we expect to receive, after deducting underwriting fee, underwriters
    expense allowance and other expenses. We expect to receive net proceeds of (a) approximately $[&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;]
    if minimum offering is raised or (b) approximately $[&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;] if maximum
    offering is raised).</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">The
information above is illustrative only and our capitalization following the completion of this Offering and the Series A Note
Offering will be adjusted based on the actual initial public offering price and other terms of this Offering determined at pricing.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">A
$1.00 increase (decrease) in the assumed initial public offering price of $[&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;] per Class
A Ordinary Share, the midpoint of the estimated price range shown on the cover page of this prospectus, would increase (decrease)
the amount of cash and cash equivalents, additional paid-in capital, total (deficit) equity and total capitalization on a pro
forma as adjusted basis by approximately $[&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;] million, assuming the number of Class
A Ordinary Shares offered by us, as set forth on the cover page of this prospectus, remains the same and after deducting underwriting
discounts and commissions and estimated offering expenses payable by us. Similarly, each increase (decrease) of [&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;]
Class A Ordinary Shares offered by us would increase (decrease) cash and cash equivalents, total (deficit) equity and total capitalization
on a pro forma as adjusted basis by approximately $[&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;] million, assuming
the assumed initial public offering price remains the same, and after deducting underwriting discounts and commissions and estimated
offering expenses payable by us.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 62; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->54<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"><A HREF="#toc">Table of Contents</A></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><A NAME="w9"></A>DILUTION</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">If
you invest in the Class A Ordinary Shares in this Offering, your interest will be diluted to the extent of the difference between
the initial public offering price per Class A Ordinary Share and the pro forma as adjusted net tangible book value per Class A
Ordinary Share immediately after this Offering. Dilution results from the fact that the initial public offering price per Class
A Ordinary Share is substantially in excess of the book value per Class A Ordinary Share attributable to the existing shareholders
for our presently outstanding Class A Ordinary Share.&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">As
of December 31, 2017, our pro forma net tangible book value was approximately $28.76 million, or $1.03 per Class A Ordinary Share.
Our pro forma net tangible book value per Class A Ordinary Share is our net tangible book value divided by the number of Class
A Ordinary Shares including the Class A Ordinary Shares to be issued upon conversion of outstanding Class B Ordinary Shares)outstanding
as of December 31, 2017 after giving effect to the issuance of 22,437,754 Class A Ordinary Shares upon conversion of the Class
B Ordinary Shares, which represents [&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;]% of our fully-diluted equity
capitalization immediately prior to the consummation of this Offering. (See &ldquo;Transactions with Related Persons&rdquo;)</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">After
giving effect to (a) the pro forma adjustment described above and (b) our issuance and sale of [&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;]
Class A Ordinary Shares in this Offering and our issuance of [&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;] Class
A Ordinary Shares underlying the Bond and Series A Notes automatically converted at the discounted rate based on an assumed initial
public offering price of $[&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;] per Class A Ordinary Share, the midpoint
of the estimated initial public offering price range set forth on the cover page of this prospectus, after deducting underwriting
discounts and commissions and estimated offering expenses payable by us, our pro forma as adjusted net tangible book value as
of December 31, 2017 would have been approximately $[&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;] million, or
$[&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;] per Class A Ordinary Share. This amount represents an immediate
increase in pro forma net tangible book value of $[&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;] per Class A Ordinary
Share to the existing shareholders and an immediate dilution in net tangible book value of [________]% per share or $[&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;]
per Class A Ordinary Share to investors purchasing Class A Ordinary Shares in this Offering. We determined dilution by subtracting
the pro forma as adjusted net tangible book value per Class A Ordinary Share after this Offering and the Series A Note Offering
from the assumed initial public offering price per Class A Ordinary Share.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">The
following table illustrates such dilution:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">A
$[&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;] increase (decrease) in the assumed initial public offering price
of $[&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;] per Class A Ordinary Share would increase (decrease) the dilution
to new investors by $[&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;] per Class A Ordinary Share, assuming the number
of Class A Ordinary Shares offered by us, as set forth on the cover page of this prospectus, remains the same but adjusting the
number of Class A Ordinary Shares issuable upon the automatic conversion of the Bond and Series A Notes sold by us in the Series
A Note Offering in accordance with the terms thereof, and after deducting underwriting discounts and commissions and estimated
expenses payable by us. Similarly, each increase (decrease) of [&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;]
Class A Ordinary Shares offered by us would decrease (increase) the dilution to new investors by $[&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;]
per Class A Ordinary Share, assuming the assumed initial public offering price remains the same and after deducting underwriting
discounts and commissions and estimated expenses payable by us.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">The
following table summarizes, on a pro forma as adjusted basis as of December 31, 2017, the differences between existing shareholders,
the investors in the Series A Note Offering and new investors in this Offering with respect to the number of Class A Ordinary
Shares purchased from us, the total consideration paid and the average price per Class A Ordinary Share paid before deducting
underwriting discounts and commissions and estimated offering expenses payable by us, at an assumed initial public offering price
of $[&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;] per Class A Ordinary Share, the midpoint of the price range
set forth on the cover of this prospectus. The total number of Class A Ordinary Shares does not include Class A Ordinary Shares
issuable upon the exercise of the PA Warrants.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">The
pro forma as adjusted information discussed above is illustrative only. Our net tangible book value following the closing of this
Offering and the Series A Note Offering is subject to adjustment based on the actual initial public offering price of the Class
A Ordinary Shares and other terms of this Offering determined at pricing.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">To
the extent that any equity awards are granted under the Option Plan in the future, you will experience further dilution. In addition,
we may choose to raise additional capital due to market conditions or strategic considerations even if we believe we have sufficient
funds for our current or future operating plans. To the extent that additional capital is raised through the sale of equity or
convertible debt securities, the issuance of these securities may result in further dilution to our shareholders.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></P>

<!-- Field: Page; Sequence: 63; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->55<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"><A HREF="#toc">Table of Contents</A></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><A NAME="w10"></A>SELECTED
FINANCIAL DATA </B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">The
following selected data is derived from our audited consolidated financial statements included elsewhere in this prospectus. You
should read this data together with our audited consolidated financial statements and related notes appearing elsewhere in this
prospectus and the information under the captions &ldquo;Capitalization&rdquo; and &ldquo;Management&rsquo;s Discussion and Analysis
of Financial Condition and Results of Operations.&rdquo; Our historical results are not necessarily indicative of our future results.
Our consolidated financial statements have been prepared in accordance with generally accepted accounting principles in the United
States, or U.S. GAAP.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font-weight: bold; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">Selected
    statements of operations data (Predecessor basis):</FONT></TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">Year
    ended <BR> December&nbsp;31,<BR> 2016</FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">January&nbsp;1,<BR>
    2017 through<BR> February&nbsp;28,<BR> 2017</FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 76%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Total investment income</FONT></TD><TD STYLE="width: 1%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="width: 9%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">86,442</FONT></TD><TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="width: 1%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="width: 9%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">3,011</FONT></TD><TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Total expense</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">878,234</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">227,027</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Net investment
    loss</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(791,792</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(224,016</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 4pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Net realized and
    unrealized losses</FONT></TD><TD STYLE="padding-bottom: 4pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 4pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(1,342,723</FONT></TD><TD STYLE="padding-bottom: 4pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD><TD STYLE="padding-bottom: 4pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 4pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(402,068</FONT></TD><TD STYLE="padding-bottom: 4pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 4pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Net decrease in
    net assets resulting from operations</FONT></TD><TD STYLE="padding-bottom: 4pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="border-bottom: Black 4pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(2,134,515</FONT></TD><TD STYLE="padding-bottom: 4pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD><TD STYLE="padding-bottom: 4pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="border-bottom: Black 4pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(626,084</FONT></TD><TD STYLE="padding-bottom: 4pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font-weight: bold; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">Selected
    consolidated statements of operations and comprehensive loss data (Successor basis):</FONT></TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">March&nbsp;1,<BR>
    2017 through<BR> December&nbsp;31,<BR> 2017</FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 88%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Total expense</FONT></TD><TD STYLE="width: 1%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="width: 9%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">5,693,083</FONT></TD><TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Total other income,
    net</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">3,131,576</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Net loss</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(2,561,507</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Less: net loss
    attributable to non-controlling interests</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(14,045</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-bottom: 4pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Net loss attributable
    to Aptorum Group Limited</FONT></TD><TD STYLE="padding-bottom: 4pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="border-bottom: Black 4pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(2,547,462</FONT></TD><TD STYLE="padding-bottom: 4pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-bottom: 4pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Net loss per share
    - basic and diluted</FONT></TD><TD STYLE="padding-bottom: 4pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="border-bottom: Black 4pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(0.09</FONT></TD><TD STYLE="padding-bottom: 4pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-bottom: 4pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Weighted-average
    shares outstanding - basic and diluted</FONT></TD><TD STYLE="padding-bottom: 4pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="border-bottom: Black 4pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">26,963,435</FONT></TD><TD STYLE="padding-bottom: 4pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-bottom: 4pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Comprehensive loss</FONT></TD><TD STYLE="padding-bottom: 4pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="border-bottom: Black 4pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(2,929,289</FONT></TD><TD STYLE="padding-bottom: 4pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font-weight: bold; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">Selected
    statements of net assets data (Predecessor basis):</FONT></TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">December&nbsp;31,<BR>
    2016</FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">February&nbsp;28,<BR>
    2017</FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 76%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Total assets</FONT></TD><TD STYLE="width: 1%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="width: 9%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">25,384,582</FONT></TD><TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="width: 1%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="width: 9%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">24,713,446</FONT></TD><TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Total liabilities</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">269,836</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">224,784</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Net assets</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">25,114,746</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">24,488,662</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">Net assets value per share</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">97.85</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">95.45</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Page; Sequence: 64; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->56<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"><A HREF="#toc">Table of Contents</A></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font-weight: bold; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">Selected
    consolidated balance sheet data (Successor basis):</FONT></TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">December&nbsp;31,<BR>
    2017</FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 88%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Total assets</FONT></TD><TD STYLE="width: 1%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="width: 9%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">31,559,982</FONT></TD><TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Total liabilities</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">1,330,734</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Non-controlling interests</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(14,045</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Total equity attributable to the shareholders
    of Aptorum Group Limited</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">30,243,293</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font-weight: bold; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">Selected
    statements of cash flows data (Predecessor basis):</FONT></TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">Year
    ended <BR> December&nbsp;31,<BR> 2016</FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">January&nbsp;1,<BR>
    2017 through<BR> February&nbsp;28,<BR> 2017</FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 76%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Net cash used in operating
    activities</FONT></TD><TD STYLE="width: 1%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="width: 9%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(2,807,549</FONT></TD><TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD><TD STYLE="width: 1%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="width: 9%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(271,660</FONT></TD><TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Net cash provided
    by financing activities</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">438,298</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Net decrease
    in cash</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(2,369,251</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(271,660</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Cash at beginning of period</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">2,670,894</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">301,643</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-bottom: 4pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Cash at end of period</FONT></TD><TD STYLE="padding-bottom: 4pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="border-bottom: Black 4pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">301,643</FONT></TD><TD STYLE="padding-bottom: 4pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 4pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="border-bottom: Black 4pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">29,983</FONT></TD><TD STYLE="padding-bottom: 4pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font-weight: bold; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">Selected
    consolidated statement of cash flows data (Successor basis):</FONT></TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">March&nbsp;1,<BR>
    2017 through<BR> December&nbsp;31,<BR> 2017</FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 88%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Net cash used in operating
    activities</FONT></TD><TD STYLE="width: 1%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="width: 9%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(5,782,695</FONT></TD><TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Net cash provided by investing activities</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">12,802,718</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Net cash provided
    by financing activities</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">9,082,001</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Net increase
    in cash and restricted cash</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">16,102,024</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Cash and restricted
    cash at beginning of period</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">623,783</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-bottom: 4pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Cash and restricted
    cash at end of period</FONT></TD><TD STYLE="padding-bottom: 4pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="border-bottom: Black 4pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">16,725,807</FONT></TD><TD STYLE="padding-bottom: 4pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<!-- Field: Page; Sequence: 65; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->57<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"><A HREF="#toc">Table of Contents</A></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><A NAME="w11"></A>MANAGEMENT&rsquo;S
DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>AND
RESULTS OF OPERATIONS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><I>You
should read the following discussion and analysis of our financial condition and results of operations together with the section
titled &ldquo;Selected Financial Data&rdquo; and the financial statements, consolidated financial statements and related notes
included elsewhere in this prospectus. This discussion contains forward-looking statements based upon current expectations that
involve risks and uncertainties. Our actual results may differ materially from those anticipated in these forward-looking statements
as a result of various factors, including those discussed in the section titled &ldquo;Risk Factors&rdquo; and in other parts
of this prospectus. Our financial statements and consolidated financial statements have been prepared in accordance with U.S.
GAAP. </I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Overview</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">We
are a Hong Kong based pharmaceutical company currently in the preclinical stage, dedicated to developing and commercializing a
broad range of therapeutic and diagnostic technologies to tackle unmet medical needs. We have obtained exclusive licenses for
our technologies. In addition, we are also developing certain proprietary technologies as product candidates. We are pursuing
therapeutic and diagnostic projects (including projects seeking to use extracts or derivatives from natural substances to treat
diseases) in neurology, infectious diseases, gastroenterology, oncology, and other disease areas. We also have projects focused
on surgical robotics. (See &ldquo;Our Business &ndash; Lead Projects and Other Projects under Development &ndash; Lead Projects&rdquo;
and &ldquo;Our Business &ndash; Other Projects under Development&rdquo;) Also, we opened a medical clinic, AML Clinic, in June
2018. Its initial focus is on treatment of chronic diseases resulting from modern sedentary lifestyles and aging population.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">Although
none of our drug or device candidates has yet been approved for testing in humans, our goal is to develop a broad range of early
stage novel therapeutics and diagnostics across a wide range of disease/therapeutic areas. Key components of our strategy for
achieving this goal include: (for details of our strategy, see &ldquo;Our Business &ndash; Our Strategy&rdquo;)</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 0.5in; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 0.25in; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Developing
    therapeutic and diagnostic innovations across a wide range of disease/therapeutic areas;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 60pt; text-align: justify; text-indent: 231.95pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 0.5in; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 0.25in; text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Selectively
    expanding our portfolio with potential products that may be able to attain orphan drug designation and/or satisfy current
    unmet medical needs;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 0.5in; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 0.25in; text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Collaborating
    with leading academic institutions and CROs;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 60pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 0.5in; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 0.25in; text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Expanding
    our in-house pharmaceutical development center;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 60pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 0.5in; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 0.25in; text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Leveraging
    our management&rsquo;s expertise, experience and commercial networks;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 60pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 0.5in; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 0.25in; text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Strategically
    developing opportunities in Hong Kong to promote access to the PRC market; and</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 60pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 0.5in; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 0.25in; text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Obtaining
    and leveraging government grants, to fund project development.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<!-- Field: Page; Sequence: 66; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->58<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"><A HREF="#toc">Table of Contents</A></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">Based
on our evaluation of the preclinical test results of each of our drug and device candidates, we have determined to devote a significant
percentage of our resources, including a substantial portion of the proceeds of this offering, to three therapeutic projects (&ldquo;Lead
Projects&rdquo;). The drug candidates being advanced by the Lead Projects are NLS-1, ALS-1 and ALS-4, described in further detail
below. If the results of the remaining preclinical studies of these drug candidates are positive, we expect to be able to submit
by 2020 or 2021 an Investigational New Drug Application (&ldquo;IND&rdquo;) for at least one of these candidates to the U.S. Food
and Drug Administration (&ldquo;FDA&rdquo;) or an equivalent application to the regulatory authorities in one or more other jurisdictions
such as the China Food and Drug Administration (&ldquo;CFDA&rdquo;) and/or the European Medicines Agency (&ldquo;EMA&rdquo;).
Acceptance of these applications by the relevant regulatory authority would enable the Company to begin testing that drug candidate
in humans in that jurisdiction. Our ability to obtain any approval of such applications is entirely dependent upon the results
of our preclinical studies, none of which have yet been completed.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">Our
current business consists of &ldquo;therapeutics&rdquo; and &ldquo;non-therapeutics&rdquo; segments. However, our focus is on
the therapeutics segments. Because of the risks, costs and extended development times required for successful drug development,
we have determined to pursue projects within our non-therapeutics segments, such as AML Clinic, to provide some interim revenue
and medical robots that may be brought to market and generate revenue more quickly.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif"><I><U>Therapeutics
Segment</U></I>. In our therapeutics segment (&ldquo;Aptorum Therapeutics Group&rdquo;), we are currently seeking to develop various
drug molecules (including projects seeking to use extracts or derivatives from natural substances to treat diseases) and certain
technologies for the treatment (&ldquo;therapeutics&rdquo;) and diagnosis (&ldquo;diagnostics&rdquo;) of human disease conditions
in neurology, infectious diseases, gastroenterology, oncology and other disease areas. In addition, we are seeking to identify
additional prospects which may qualify for potential orphan drug designation (e.g., rare types of cancer) or which address other
current unmet medical needs. Aptorum Therapeutics Group is operated through Aptorum&rsquo;s wholly-owned subsidiary, Aptorum Therapeutics
Limited, a Cayman Islands exempted company with limited liability, whose principal place of business is in Hong Kong and its indirect
subsidiary companies (who we sometimes refer to herein as project companies), whose principal places of business are also in Hong
Kong.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif"><I><U>Non-Therapeutics
Segment</U></I>. The non-therapeutics segment (&ldquo;Aptorum Non-Therapeutics Group&rdquo;) encompasses two businesses: (i) the
development of surgical robotics and medical devices and (ii) AML Clinic. The development of surgical robotics and medical devices
business is operated through Signate Life Sciences Limited, a subsidiary of Aptorum Therapeutics Limited. The outpatient clinic
is operated through our subsidiary, Aptorum Medical Limited. Effective as of March 2018, we leased office space in Central Hong
Kong as the home to AML Clinic. AML Clinic has commenced operations under the name of Talem Medical in June 2018. (See &ldquo;Our
Business &ndash; Lead Projects and Other Projects under Development &ndash; Other Projects under Development &ndash; Aptorum Medical
Limited - AML Clinic&rdquo;)</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">The
Company has already obtained opportunities resulting in our existing licensing agreements from various contractual relationships
that we have entered into including service/consulting agreements with some of the world&rsquo;s leading specialists and clinicians
in our areas of interest, with academic institutions and organizations, and with contract research organizations (&ldquo;CROs&rdquo;).
We anticipate that these relationships will generate additional licensing opportunities in the future. In addition, we have established
and are continuing to expand our in-house research facilities (collectively, the &ldquo;R&amp;D Center&rdquo;) to develop some
of our drug and device candidates internally and to collaborate with third-party researchers.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">Prior
to March 2017, the Company had pursued passive healthcare related investments in early stage companies primarily in the United
States. However, we have since ceased pursuing further passive investment operations and intend to exit all such portfolio investments
over an appropriate timeframe to focus resources on our current business.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>CRITICAL
ACCOUNTING POLICIES, ESTIMATES AND ASSUMPTIONS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">Our
discussion and analysis of our financial condition and results of operations are based on our consolidated financial statements
and financial statements contained elsewhere in this prospectus, which have been prepared in accordance with U.S. GAAP. Our notes
to the consolidated financial statements contained elsewhere in this prospectus describe the significant accounting policies essential
to our consolidated financial statements. Preparation of our financial statements requires estimates, judgments and assumptions.
We believe that the estimates, judgments and assumptions that we have used are appropriate and correct based on information available
at the time they were made. These estimates, judgments and assumptions can affect our reported assets and liabilities as of the
date of the financial statements, as well as the reported revenues and expenses during the periods presented. If there are material
differences between these estimates, judgments and assumptions and actual facts, our financial statements may be affected.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">In
many cases, the accounting treatment of a particular transaction is specifically dictated by U.S. GAAP and does not require our
judgment in its application. There are areas in which our judgment in selecting among available alternatives would not produce
a materially different result, but there are some areas in which our judgment in selecting among available alternatives would
produce a materially different result. See the notes to the consolidated financial statements and financial statements that contain
additional information regarding our accounting policies and other disclosures.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<!-- Field: Page; Sequence: 67; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->59<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"><A HREF="#toc">Table of Contents</A></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>CRITICAL
ACCOUNTING POLICIES, ESTIMATES AND ASSUMPTIONS (PREDECESSOR BASIS)</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif"><U>Basis
of presentation</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">The
accompanying financial statements are prepared in accordance with U.S. GAAP. As discussed in Note 2 of our audited financial statements
included elsewhere in this prospectus, before March 1, 2017, the Company was an investment company under U.S. GAAP for the purposes
of financial reporting. U.S. GAAP for an investment company requires investments to be recorded at estimated fair value and the
unrealized gains and/or losses in an investment&rsquo;s fair value are recognized on a current basis in the statements of operations.
In addition, the Company did not consolidate its subsidiaries, since they were operating companies and not investment companies.
Such entities were fair valued in accordance with ASC Topic 946 (&ldquo;ASC 946&rdquo;) and ASC Topic 820 (&ldquo;ASC 820&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">As
of March 1, 2017, after the change of business purpose, legal form and substantive activities, the Company&rsquo;s status changed
to an operating company from an investment company since it no longer met the criteria to qualify as an investment company under
the ASC 946. The Company discontinued applying the guidance in ASC 946 and began to account for the change in status prospectively
by accounting for its investments in accordance with other U.S. GAAP topics.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">This
change in status and the accounting policies affect the comparability of the financial statements. As such, for the year ended
December 31, 2016 and for the period January 1, 2017 through February 28, 2017, the statements of net assets, statements of operations,
statements of cash flows and statements of changes in net assets have been presented on the predecessor basis of accounting as
an investment company, and on the basis of accounting as an operating company from March 1, 2017 through December 31, 2017. The
consolidated balance sheet as of December 31, 2017 has been presented on the successor basis.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif"><U>Use
of estimates</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">The
preparation of the financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that
affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial
statements and the reported amounts of increases and decreases in net assets from operations as well as income and expenses during
the reporting period. Significant accounting estimates reflected in the Company&rsquo;s financial statements include investments
at fair value. Actual results could differ from those estimates.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif"><U>Foreign
currency</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">The
Company&rsquo;s functional currency is US dollars (&ldquo;USD&rdquo; or &ldquo;$&rdquo;), which is the currency of the primary
environment in which it operates in Hong Kong. The Company&rsquo;s performance is evaluated in USD. The fees, charges and allocations
are calculated in USD. All subscriptions and redemptions are transacted in USD.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">All
assets and liabilities denominated in foreign currencies are translated into USD amounts at the date of valuation. Purchases and
sales of securities and income items denominated in foreign currencies are translated into USD amounts on the respective dates
of such transactions. The Company does not separately account for that portion of the results of operations resulting from changes
in foreign exchange rates on investments and the fluctuations arising from changes in market prices of securities held. Such fluctuations
are included with the net realized and unrealized gains or losses on investments in the statements of operations. Adjustments
arising from foreign currency transactions are reflected in the statements of operations.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif"><U>Fair
value measurement</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">The
Company follows a fair value hierarchy that distinguishes between market data obtained from independent sources (observable inputs)
and the Company&rsquo;s own market assumptions (unobservable inputs). These inputs are used in determining the value of the Company&rsquo;s
investments and are summarized in the following fair value hierarchy:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">Level
1 - Unadjusted quoted market prices in active markets for identical assets or liabilities that the Company has the ability to
access at the measurement date.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">Level
2 - Observable inputs other than quoted prices included in Level 1 that are observable for the asset or liability either directly
or indirectly. These inputs may include quoted prices for the identical instrument on an inactive market, prices for similar instruments,
interest rates, prepayment speeds, credit risk, yield-curves, default rates, and similar data.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">Level
3 - Unobservable inputs for the asset or liability to the extent that relevant observable inputs are not available, representing
the Company&rsquo;s own assumptions about the assumptions that a market participant would use in valuing the asset or liability,
and that would be based on the best information available.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></P>

<!-- Field: Page; Sequence: 68; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->60<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"><A HREF="#toc">Table of Contents</A></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>CRITICAL
ACCOUNTING POLICIES, ESTIMATES AND ASSUMPTIONS (SUCCESSOR BASIS)</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif"><U>Basis
of presentation</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">The
consolidated financial statements are prepared in accordance with U.S. GAAP.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">As
of March 1, 2017, after the change of business purpose, legal form and substantive activities, the Company&rsquo;s status changed
to an operating company from an investment company since it no longer met the criteria to qualify as an investment company under
the ASC 946. The Company discontinued applying the guidance in ASC 946 and began to account for the change in status prospectively
by accounting for its investments in accordance with other U.S. GAAP topics.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif"><U>Principles
of consolidation</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">The
consolidated financial statements of the Group are presented on the accrual basis of accounting in accordance with U.S. GAAP and
include the accounts of the Company, its direct and indirect wholly and majority owned subsidiaries and a variable interest entity.
All material intercompany balances and transactions have been eliminated in preparation of the consolidated financial statements.
Non-controlling interests represent the equity interest that is not owned by the Group.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif"><U>Use
of estimates</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">The
preparation of the consolidated financial statements on successor basis in conformity with U.S. GAAP requires management to make
estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities
at the date of the financial statements and the reported amounts of increases and decreases in net assets from operations as well
as income and expenses during the reporting period. Significant accounting estimates reflected in the Group&rsquo;s consolidated
financial statements include fair value of investments in securities, the useful lives of intangible assets and equipment, impairment
of long-lived assets, collectability of receivables. Actual results could differ from those estimates.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif"><U>Foreign
currency translation and transaction</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">USD
is the reporting currency. The functional currency of subsidiaries in the Cayman Islands is USD, the functional currency of subsidiaries
in Hong Kong is Hong Kong Dollars (&ldquo;HKD&rdquo;) and the functional currency of subsidiaries in Macao is Macanese Pataca
(&ldquo;MOP&rdquo;). An entity&rsquo;s functional currency is the currency of the primary economic environment in which it operates,
normally that is the currency of the environment in which it primarily generates and expends cash. The management considered various
indicators, such as cash flows, market expenses, financing and inter-company transactions and arrangements in determining the
Group&rsquo;s functional currency.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">In
the consolidated financial statements, the financial information of the Company and its subsidiaries, which use HKD and MOP as
their functional currency, has been translated into USD. Assets and liabilities are translated from each subsidiary&rsquo;s functional
currency at the exchange rates on the balance sheet date, equity amounts are translated at historical exchange rates, and revenues,
expenses, gains, and losses are translated using the average rate for the year. Translation adjustments are reported as cumulative
translation adjustments and are shown as a separate component of other comprehensive income or loss in the statement of shareholders&rsquo;
equity and comprehensive income.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif"><U>Fair
value measurement</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">Fair
value is defined as the price that would be received from selling an asset or paid to transfer a liability in an orderly transaction
between market participants at the measurement date. When determining the fair value measurements for assets and liabilities required
or permitted to be recorded at fair value, the Group considers the principal or most advantageous market in which it would transact
its business, and it considers assumptions that market participants would use when pricing the asset or liability.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">As
a basis for considering such assumptions, a three-tier fair value hierarchy prioritizes the inputs utilized in measuring fair
value as follows:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 66.15pt; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 0.5in; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 0.25in; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level
    1 applies to assets or liabilities for which there are quoted prices in active markets for identical assets or liabilities.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 66.15pt; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 0.5in; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 24px; text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level
    2 applies to assets or liabilities for which there are inputs other than quoted prices included within Level 1 that are observable
    for the asset or liability such as quoted prices for similar assets or liabilities in active markets; quoted prices for identical
    assets or liabilities in markets with insufficient volume or infrequent transactions (less active markets); or model-derived
    valuations in which significant inputs are observable or can be derived principally from, or corroborated by, observable market
    data.</FONT></TD></TR>
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level
    3 applies to assets or liabilities for which there are unobservable inputs to the valuation methodology that are significant
    to the measurement of the fair value of the assets or liabilities.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif"><U>Impairment
of long-lived assets</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">The
Group reviews its long-lived assets for impairment whenever events or changes in circumstances indicate that the carrying amount
of an asset may no longer be recoverable. When these events occur, the Group measures impairment by comparing the carrying value
of the long-lived assets to the estimated undiscounted future cash flows expected to result from the use of the assets and their
eventual disposition. If the sum of the expected undiscounted cash flow is less than the carrying amount of the assets, the Group
would recognize an impairment loss, which is the excess of carrying amount over the fair value of the assets, using the expected
future discounted cash flows.</FONT></P>

<!-- Field: Page; Sequence: 69; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->61<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"><A HREF="#toc">Table of Contents</A></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif"><U>Revenue
recognition</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">Dividend
income is recorded on the ex-dividend date, and interest income is recorded on an accrual basis.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">After
the Restructure, the Group has yet to generate operating income stream from its pharmaceutical products for the period from March
1, 2017 to December 31, 2017.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif"><U>Income
taxes</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">The
Group accounts for income taxes under the asset and liability method. Under this method, deferred income taxes are determined
based on differences between the financial carrying amounts of existing assets and liabilities and their tax bases. Income taxes
are provided for in accordance with the laws of the relevant taxing authorities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">A
valuation allowance is provided for deferred tax assets if it is more likely than not that these items will either expire before
the Group is able to realize their benefits, or that future deductibility is uncertain. Valuation allowances are established,
when necessary, to reduce deferred tax assets to the amount expected to be realized.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>RESULTS
OF OPERATION (PREDECESSOR BASIS)</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><I>Explanatory
Note </I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">Before
March 1, 2017, Aptorum Group Limited was incorporated as an exempted open-ended investment company with limited liability in the
Cayman Islands, which would own and oversee the management, operations and investments of its subsidiaries. On February 21, 2017,
a special resolution was passed at a directors&rsquo; meeting, and on March 1, 2017, a resolution also was passed at a shareholders&rsquo;
meeting. According to which, the Company changed from an investment fund with management shares and non-voting participating redeemable
preference shares to a holding company with operating subsidiaries (the &ldquo;Restructure&rdquo;). After the Restructure, the
Company has become a Hong Kong based pharmaceutical company currently in the preclinical stage. The results of operations and
cash flows of the Company for the periods ended on or prior to February 28, 2017, and its financial position as of balance sheet
date on or prior to February 28, 2017 are referred to as &ldquo;Predecessor&rdquo; financial information.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">Financial
statements and information are presented for the year ended December 31, 2016 (Predecessor), two months ended February 28, 2017
(Predecessor), which may not be comparable with amounts shown in each year/period.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><I>General
and administrative fees</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">For
year ended December 31, 2016 and the period January 1, 2017 to February 28, 2017, the general and administrative fees were $79,750
and $17,516, respectively, which are miscellaneous expenses.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><I>Management
fees</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">AENEAS
CAPTIAL LIMITED, formerly known as APTUS CAPITAL LIMITED, a related company of the Group/Company, provided management and administrative
services to the Group and incurred pre-determined management fees. For year ended December 31, 2016 and the period January 1,
2017 to February 28, 2017, AENEAS CAPITAL LIMITED was entitled to receive a management fee which was equal to 2.5% per annum of
the net asset value of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><I>Legal
and professional fees</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">For
year ended December 31, 2016 and the period January 1, 2017 to February 28, 2017, the legal and professional fees were $106,031
and $98,646, respectively.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><I>Other
operating expenses</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">For
the year ended December 31, 2016, other operating expenses were $50,646. For the period January 1, 2017 to February 28, 2017,
other operating expenses were $1,907.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><I>Other
income</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">The
Company met the assessment of an investment company under the Financial Accounting Standards Board (the &ldquo;FASB&rdquo;) Accounting
Standards Codification Topic 946 (&ldquo;ASC 946&rdquo;) and was an investment company under U.S. GAAP for the purposes of financial
reporting for year ended December 31, 2016 and the period January 1, 2017 to February 28, 2017, which the total income comprising
interest income and dividend income were $86,442 and $3,011, respectively.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<!-- Field: Page; Sequence: 70; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->62<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"><A HREF="#toc">Table of Contents</A></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><I>Realized
and unrealized losses on investments and foreign exchange </I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">Realized
and unrealized losses on investments and foreign exchange mainly consist of net realized loss on investments in unaffiliated issuers
and net unrealized appreciation/depreciation on investments in unaffiliated issuers. For year ended December 31, 2016 and the
period January 1, 2017 to February 28, 2017, the realized and unrealized losses were $1,342,723 and $402,068, respectively.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><I>Net
decrease in net assets resulting from operations</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">For
year ended December 31, 2016 and the period January 1, 2017 to February 28, 2017, the net decrease in net assets resulting from
operations was $2,134,515 and $626,084, respectively.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>RESULTS
OF OPERATION (SUCCESSOR BASIS)</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><I>Explanatory
Note </I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 35.45pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 35.45pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">After
the Restructure, the results of operations and cash flows of the Group for period beginning March 1, 2017 and its financial position
as of March 1, 2017 and subsequent balance sheet dates are referred to herein as &ldquo;Successor&rdquo; consolidated financial
information.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 35.45pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 35.45pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Financial
statements and information are presented for the ten months ended December 31, 2017 (Successor), which may not be comparable with
amounts shown in each year/period.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><I>Research
and development expenses</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Research
and development expenses are comprised of costs incurred in performing research and development activities, including our sponsored
research programs with various universities and research institutions and costs in acquiring IP rights which did not meet the
criteria of capitalization under U.S. GAAP. </FONT><FONT STYLE="font-family: Times New Roman, Times, Serif">We currently do not
maintain a system to keep track of costs spent by each project, however, we are currently developing a system based on actual
consumption and Company&rsquo;s estimation in allocating various general costs. <FONT STYLE="font-size: 10pt">For the period March
1, 2017 to December 31, 2017, the research and development expenses mainly represented sponsored research of $1,327,247,
research grant of $800,056, salary of $95,078, consultation of $92,129, amortization and depreciation of $58,903, and general
R&amp;D expenses of $186,910.</FONT></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><I>General
and administrative fees</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">For
the period March 1, 2017 to December 31, 2017, the general and administrative fees were $1,480,093, which mainly consisted of
administrative fees of $640,932, payroll expenses of $306,967, traveling expenses of $175,671 and recruitment expenses of $125,535.
The increase in general and administration fees was mainly due to the increased headcount in the Group to support the business
development and the reclassification of management fees which was separately presented as &ldquo;Management Fees&rdquo; before
the Restructure. The administrative fees were HKD500,000 (approximately $64,103) per calendar month for the period March 1, 2017
to December 31, 2017.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><I>Management
fees</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">AENEAS
CAPITAL LIMITED, formerly known as APTUS CAPITAL LIMITED, a related company of the Group/Company, provided management and administrative
services to the Group and incurred pre-determined management fees. For the period March 1, 2017 to December 31, 2017, the administrative
fees of $640,932 has been reclassified to general and administrative fees due to the Restructure and since the Company has become
a Hong Kong-based pharmaceutical company, so the management fees are no longer determined by net asset value since then.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><I>Legal
and professional fees</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">For
the period March 1, 2017 to December 31, 2017, the legal and professional fees were $1,395,490. The increase in legal and professional
fees was mainly due to the preparation of IPO and business expansion.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><I>Other
operating expenses</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">For
the period March 1, 2017 to December 31, 2017, other operating expenses were $257,177, which mainly consisted of event and meeting
expenses of $82,027 and commission expenses of $55,726.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><I>Other
income</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">For
the period March 1, 2017 to December 31, 2017, other income was $3,131,576, which consisted of interest income of $44,269, dividend
income of $2,308, net gain on investments in marketable securities of $3,912,500 and net loss on investments in derivatives of
$827,501.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<!-- Field: Page; Sequence: 71; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->63<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"><A HREF="#toc">Table of Contents</A></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><I>Net
loss attributable to Aptorum Group Limited</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">For
the period March 1, 2017 to December 31, 2017, net loss attributable to Aptorum Group Limited (excluding net loss attributable
to non-controlling interests) was $2,547,462.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>LIQUIDITY
AND CAPITAL RESOURCES</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">We
had cash of approximately $16.2 million as of December 31, 2017, as compared to $0.3 million as of December 31, 2016. Our cash
consists of cash on hand and bank deposits, which are unrestricted as to withdrawal or use.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">The
Group believes that available cash should enable the Group to meet present anticipated cash needs for at least the next 12 months
after the date that the financial statements are issued, and the Group has prepared the consolidated financial statements on a
going concern basis.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>CAPITAL
COMMITMENTS</B><BR>
<BR></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">We
have entered into agreements with unrelated parties for purchasing office and laboratory equipment. As of December 31, 2017, we
had non-cancellable purchase commitments of $1,756,560.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">The
Company has additional contingency payment obligations under each of the license agreements, such as milestone payments, royalties,
research and development funding, if certain condition or milestone is met. For the period March 1, 2017 through December 31,
2017, the Company did not owe any milestone payments, royalties or research and development funding. As of December 31, 2017, no
milestone payments had been triggered under any of the existing license agreements.</FONT>&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>CONDENSED
SUMMARY OF OUR CASH FLOWS (PREDECESSOR BASIS)</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><I>Operating
activities</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">Net
cash used in operating activities amounted to $2.8 million for the year ended December 31, 2016. During the year, the Company
had net decrease in net assets resulting from operations of $2.1 million. In addition, the Group had unrealized depreciation on
investments of $0.5 million, net realized loss on sales of investments in unaffiliated issuers of $0.8 million, capital invested
in a subsidiary of $1.0 million, proceeds from sales of investment securities of $4.1 million, and purchases of investment securities
of $5.0 million.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">Net
cash used in operating activities amounted to $0.3 million for the period January 1, 2017 to February 28, 2017. During the period,
the Company had net decrease in net assets resulting from operations of $0.6 million and unrealized depreciation on investments
of $0.4 million.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><I>Investing
activities</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&#9;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">No
cash flow from investing activities for year ended December 31, 2016 and the period January 1, 2017 to February 28, 2017.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><I>Financing
activities</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">Net
cash provided by financing activities amounted to $0.4 million for the year ended December 31, 2016. During the year, the Company
had repayment of short term loans of $2.1 million and proceeds from issuance of shares of $2.5 million.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">Net
cash flow from financing activities was nil for the period January 1, 2017 to February 28, 2017.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B></B></FONT></P>

<!-- Field: Page; Sequence: 72; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->64<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"><A HREF="#toc">Table of Contents</A></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>CONDENSED
SUMMARY OF OUR CASH FLOWS (SUCCESSOR BASIS)</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><I>Operating
activities</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">Net
cash used in operating activities amounted to $5.8 million for the period March 1, 2017 to December 31, 2017. During the period,
the Group had net loss of $2.6 million. Meanwhile, the Group had gain on investment in marketable securities of $3.9 million,
loss on investments in derivatives of $0.8 million and an increase of other receivables and prepayments of $0.3 million.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><I>Investing
activities</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">Net
cash provided by investing activities amounted to $12.8 million for the period March 1, 2017 to December 31, 2017. During the
period, the Group had proceeds from sales of investment securities of $16.0 million, purchase of intangible assets of $1.0 million
and purchase of equipment of $2.1 million.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><I>Financing
activities</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">Net
cash provided by financing activities amounted to $9.1 million for the period March 1, 2017 to December 31, 2017. During the period,
the Group had proceeds from issuance of shares of $8.6 million and proceeds from issuance of convertible promissory notes of $0.5
million.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>RECENT
ACCOUNTING PRONOUNCEMENTS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 30pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">See
Note 14 to our consolidated financial statements included elsewhere in this prospectus.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>RESEARCH
AND DEVELOPMENT (SUCCESSOR BASIS)</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">As
of December 31, 2017, the Company has obtained 11 exclusively licensed technologies in neurology, infectious diseases, gastroenterology,
oncology, surgical robotics and natural health and is in the process of developing two &ldquo;in-house&rdquo; projects in the
neurology area. For the period March 1, 2017 to December 31, 2017, the Company incurred $2,560,323 on research and development
expenses.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>OFF-BALANCE
SHEET ARRANGEMENTS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 30pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&#9;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 30pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">As
at December 31, 2017, the Company did not have any off-balance sheet debt, nor do we have any transactions, arrangements or relationships
with any special purpose entities.</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></P>

<!-- Field: Page; Sequence: 73; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->65<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"><A HREF="#toc">Table of Contents</A></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>&nbsp;&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><A NAME="w12"></A>OUR
BUSINESS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><I>Overview
</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">We
are a Hong Kong based pharmaceutical company currently in the preclinical stage, dedicated to developing and commercializing a
broad range of therapeutic and diagnostic technologies to tackle unmet medical needs. We have obtained exclusive licenses for
our technologies. In addition, we are also developing certain proprietary technologies as product candidates. We are pursuing
therapeutic and diagnostic projects (including projects seeking to use extracts or derivatives from natural substances to treat
diseases) in neurology, infectious diseases, gastroenterology, oncology and other disease areas. We also have projects focused
on surgical robotics. (See &ldquo;Our Business &ndash; Lead Projects and Other Projects under Development &ndash; Lead Projects&rdquo;
and &ldquo;Our Business &ndash; Lead Projects and Other Projects under Development &ndash; Other Projects under Development&rdquo;)
Also, we opened a medical clinic, AML Clinic, in June 2018. Its initial focus is on treatment of chronic diseases resulting from
modern sedentary lifestyles and aging population.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">Although
none of our drug or device candidates has yet been approved for testing in humans, our goal is to develop a broad range of early
stage novel therapeutics and diagnostics across a wide range of disease/therapeutic areas. Key components of our strategy for
achieving this goal include: (for details of our strategy, see &ldquo;Our Business &ndash; Our Strategy&rdquo;)</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 0.5in; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 0.25in; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Developing
    therapeutic and diagnostic innovations across a wide range of disease/therapeutic areas;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 0.5in; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 0.25in; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Selectively
    expanding our portfolio with potential products that may be able to attain orphan drug designation and/or satisfy current
    unmet medical needs;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 0.5in; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 0.25in; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Collaborating
    with leading academic institutions and CROs;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 0.5in; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 0.25in; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Expanding
    our in-house pharmaceutical development center;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 0.5in; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 0.25in; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Leveraging
    our management&rsquo;s expertise, experience and commercial networks;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 0.5in; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 0.25in; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Strategically
    developing opportunities in Hong Kong to promote access to the PRC market; and</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 0.5in; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 0.25in; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Obtaining
    and leveraging government grants to fund project development.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">Based
on our evaluation of the preclinical test results of each of our drug and device candidates, we have determined to devote a significant
percentage of our resources, including a substantial portion of the proceeds of this offering, to three therapeutic projects (&ldquo;Lead
Projects&rdquo;). The drug candidates being advanced as the Lead Projects are NLS-1, ALS-1 and ALS-4, described in further detail
below. If the results of the remaining preclinical studies of these drug candidates are positive, we expect to be able to submit
by 2020 or 2021 an Investigational New Drug Application (&ldquo;IND&rdquo;) for at least one of these candidates to the U.S. Food
and Drug Administration (&ldquo;FDA&rdquo;) or an equivalent application to the regulatory authorities in one or more other jurisdictions
such as the China Food and Drug Administration (&ldquo;CFDA&rdquo;) and/or the European Medicines Agency (&ldquo;EMA&rdquo;).
Acceptance of these applications by the relevant regulatory authority would enable the Company to begin testing that drug candidate
in humans in that jurisdiction. Our ability to obtain any approval of such applications is entirely dependent upon the results
of our preclinical studies, none of which have yet been completed.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">Our
current business consists of &ldquo;therapeutics&rdquo; and &ldquo;non-therapeutics&rdquo; segments. However, our focus is on
the therapeutics segments. Because of the risks, costs and extended development times required for successful drug development,
we have determined to pursue projects within our non-therapeutics segments, such as AML Clinic, to provide some interim revenue
and medical robots that may be brought to market and generate revenue more quickly.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif"><I><U>Therapeutics
Segment</U></I>. In our therapeutics segment (&ldquo;Aptorum Therapeutics Group&rdquo;), we are currently seeking to develop various
drug molecules (including projects seeking to use extracts or derivatives from natural substances to treat diseases) and certain
technologies for the treatment (&ldquo;therapeutics&rdquo;) and diagnosis (&ldquo;diagnostics&rdquo;) of human disease conditions
in neurology, infectious diseases, gastroenterology, oncology and other disease areas. In addition, we are seeking to identify
additional prospects which may qualify for potential orphan drug designation (e.g., rare types of cancer) or which address other
current unmet medical needs. Aptorum Therapeutics Group is operated through Aptorum&rsquo;s wholly-owned subsidiary, Aptorum Therapeutics
Limited, a Cayman Islands exempted company with limited liability, whose principal place of business is in Hong Kong and its indirect
subsidiary companies (who we sometimes refer to herein as project companies), whose principal places of business are also in Hong
Kong.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif"><I><U>Non-Therapeutics
Segment</U></I>. The non-therapeutics segment (&ldquo;Aptorum Non-Therapeutics Group&rdquo;) encompasses two businesses: (i) the
development of surgical robotics and medical devices and (ii) AML Clinic. The development of surgical robotics and medical devices
business is operated through Signate Life Sciences Limited, a subsidiary of Aptorum Therapeutics Limited. The outpatient clinic
is operated through our subsidiary, Aptorum Medical Limited. Effective as of March 2018, we leased office space in Central Hong
Kong as the home to AML Clinic. AML Clinic has commenced operations under the name of Talem Medical in June 2018. (See &ldquo;Our
Business &ndash; Lead Projects and Other Projects under Development &ndash; Other Projects under Development &ndash; Aptorum Medical
Limited - AML Clinic&rdquo;)</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<!-- Field: Page; Sequence: 74; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->66<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"><A HREF="#toc">Table of Contents</A></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">The
Company has already obtained opportunities resulting in our existing licensing agreements from various contractual relationships
that we have entered into, including service/consulting agreements with some of the world&rsquo;s leading specialists and clinicians
in our areas of interest, with academic institutions and organizations, and with CROs. We anticipate that these relationships
will generate additional licensing opportunities in the future. In addition, we have established and are continuing to expand
our in-house research facilities (collectively, the &ldquo;R&amp;D Center&rdquo;) to develop some of our drug and device candidates
internally and to collaborate with third-party researchers.&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">Prior
to March 2017, the Company had pursued passive healthcare related investments in early stage companies primarily in the United
States. However, we have since ceased pursuing further passive investment operations and intend to exit all such portfolio investments
over an appropriate timeframe to focus resources on our current business.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><I>Our
Strategy</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">Although
we plan to continue the development and improvement of a broad range of novel therapeutics and diagnostics across a wide range
of disease/therapeutic areas, over the next 24-36 months we plan to concentrate on development of our Lead Projects, while also
allocating some resources to develop SLS-1 and maintaining our AML Clinic.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">We
believe that execution of this strategy will position the Company to catalyze the development and improvement of a broad range
of early-staged novel therapeutics and diagnostics across a wide range of disease/therapeutic areas. Failure to achieve positive
results in at least one of the programs for a Lead Project could have a material adverse effect on the Company&rsquo;s prospects
and business.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">To
achieve this goal, we are implementing the following strategies:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 0.5in; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 0.25in; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Developing
    therapeutic and diagnostic innovations across a wide range of disease/therapeutic areas. </B>We are currently developing drug
    and device candidates in several disease/therapeutic areas. We believe that by diversifying our research efforts, it would
    increase the likelihood that at least one of our projects will achieve clinical success and therefore add value to the Company.
    As of December 31, 2017, we have obtained 11 exclusively licenses of technologies across the areas of neurology, infectious
    diseases, gastroenterology, oncology, surgical robotics and natural health. Our initial focus will be on developing our Lead
    Projects, but intend to continue developing our other current projects and seeking new licensing opportunities where we determine
    that the market potential justifies the additional commitment of our limited resources.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 24pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 0.5in; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 0.25in; text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Selectively
    expanding our line of Projects under Development with potential products that may be able to attain orphan drug designation
    and/or satisfy current unmet medical needs. </B>We have selected innovations for development which we believe are of superior
    scientific quality, whilst taking into account the potential market size and demand for same, for example, taking into consideration
    whether the relevant product can satisfy significant unmet medical needs. In particular, Aptorum Therapeutics Limited has
    established a Scientific Assessment Committee, which helped us to select our current projects and which we expect will provide
    input from a scientific perspective towards any future opportunities for acquiring or licensing life science innovations.
    We intend to continue expanding our line of Projects under Development, and subject to our financial and other resource limitations,
    exploring acquisitions or licenses of additional products which may be able to attain orphan drug designations (e.g., rare
    types of cancer) or satisfy significant unmet medical needs and that show strong preclinical and/or early clinical data to
    provide promising opportunities for clinical and commercial success.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 0.5in; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 0.25in; text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Collaborating
    with leading academic institutions and CROs. </B>In building and developing our product portfolio, we believe that accessing
    external innovation, expertise and technology through collaboration with leading academic institutions and CROs is a vital
    and cost-efficient strategy. We have established strong relationships with leading academic institutions around the world
    and expect to continue to strengthen our collaborations by, for example, seeking to provide their affiliated Principal Investigators
    resources through sponsorship to conduct further research in specialty fields of interest and association with personnel connected
    to our current project companies, in exchange for obtaining for the Company the first right to negotiate for an exclusive
    license to any resulting innovations. In addition, we have entered and will continue to actively source arrangements with
    pharmaceutical companies, in most cases in roles as contract research organizations, to streamline the development of our
    projects. This may include outsourcing part of the preclinical, clinical studies and clinical supplies manufacturing to externally
    accredited cGLP, cGMP and cGCP standard contract research organizations or laboratories in order to attain the required studies
    for submission to the regulatory authorities as part of the clinical development plan. (See &ldquo;Arrangements with Other
    Parties&rdquo;)</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 0.5in; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 0.25in; text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Expanding
    the R&amp;D Center to accelerate project development. </B>We believe collaborations between the R&amp;D Center operated by
    APD and the scientists engaged in work for our project companies will enhance clinical and commercial potential of the projects.
    In addition, APD will assist the project companies by engaging external pharmaceutical companies and/or contract research
    organizations to outsource any part of the preclinical or clinical development work that cannot be performed by the R&amp;D
    Center in order to obtain the resources necessary for our development process.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 0.5in; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 0.25in; text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Leveraging
    our management&rsquo;s expertise, experience and commercial networks. </B>We believe the combination of our management&rsquo;s
    expertise and experience, with their academic and commercial networks make us an effective platform for advancing healthcare
    innovations towards clinical studies and commercialization in key global markets. We have assembled a management team with
    global experience and an extensive record of accomplishments in medical research, consulting and financing, and identification
    and acquisition of pharmaceutical and biopharmaceutical drug and device candidates.&nbsp;&nbsp;Our Chief Scientific Officer
    also has extensive experiences in drug development. We also employ key management personnel with banking and financial experience,
    which enhances our capability to establish the most efficient financial structure for the development of our programs.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<!-- Field: Page; Sequence: 75; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->67<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"><A HREF="#toc">Table of Contents</A></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 0.5in; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 0.25in; text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Strategically
    developing opportunities in Hong Kong to provide access to the PRC market. </B>The PRC is the world&rsquo;s second largest
    healthcare market (<U>https://seekingalpha.com/article/4038677-opportunities-chinas-healthcare-market</U>) and we plan to
    market our products there in the future as part of our overall growth strategy. In October 2017, the PRC government
    announced     that the country is planning to accept trial data gathered overseas to speed up drug approvals
    (<U>https://www.reuters.com/article/us-china-pharmaceuticals/china-to-accept-overseas-trial-data-in-bid-to-speed-up-drug-approvals-idUSKBN1CE080</U>
    and <U>http://www.lawinfochina.com/display.aspx?id=26778&amp;lib=law</U>), which is a potential boon for foreign
    pharmaceutical     companies. We believe strategically locating our principal businesses in Hong Kong, as a Special
    Administrative Region of     the PRC, may provide us distinctive advantages in accessing the PRC healthcare market. Two of
    our key collaborators, The University     of Hong Kong (the &ldquo;HKU&rdquo;) and the Chinese University of Hong Kong (the
    &ldquo;CUHK&rdquo;) have received clinical     drug trial accreditation by the CFDA for their clinical trial units/centers
    (<U>http://www.crmo.med.cuhk.edu.hk/en-us/cfdaaccreditation.aspx</U> and <U>https://www.ctc.hku.hk/assurance_cfda.php</U>).</FONT></TD></TR>
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Obtaining
    and leveraging government grants to fund project development. </B>The Hong Kong government pays close attention to the development
    of the biotechnology sector in Hong Kong and provides support and funding. We intend to aggressively seek government support
    from Hong Kong for our product development and to facilitate the development of some of our projects.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><I>Arrangements
with Other Parties</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">As
mentioned above, part of our business model includes collaborating with research entities such as academic institutions and CROs,
as well as highly regarded experts in their respective fields. We engage these entities and researchers either for purposes of
exploring new innovations or advancing preclinical studies of our existing licensed drug candidates. Although the financial cost
of these arrangements does not represent a material expense to the Company, the relationships we can access through, specifically,
sponsored research arrangements (&ldquo;SRAs&rdquo;) with academic institutions and organizations can provide significant value
for our business; for example, we may decide whether to continue development of certain early-staged projects and/or out-license
a project based on the data and results from research governed by SRAs. However, as of the date of this prospectus, we do not
consider the particulars of any of our SRAs to be material to the success of our current business plans.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">Our
drug discovery programs are based upon licenses from universities and are mainly conducted in universities via SRAs. As for the
development of our drug candidates, our R&amp;D Center conducts part of the CMC work. However, since our current facilities are
not cGMP, cGLP or cGCP qualified, we will have to rely on CROs to conduct that type of work, if and when our drug candidates reach
the level of development that requires such qualification.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><I>Lead
Projects and Other Projects under Development</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">We
are actively operating and managing the development of our drug and device candidates through various subsidiaries. Each candidate
is being researched in a subsidiary with a medical/scientific area of focus related to the drug and device candidate in development.
We refer to these as our &ldquo;Project Companies&rdquo; and their products or areas of focus as either our Lead Projects (i.e.,
ALS-1, ALS-4 and NLS-1) or Other Projects under Development (as defined below). The selection of a drug and device candidate is
based on our estimate of the market potential for that candidate, the scientific expertise required to develop it, and our overall
corporate strategy, including our ability to commit personnel and future investment to that candidate.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">To
pursue a number of our current projects, our Project Companies have entered into standard license agreements with various university
and licensing entities customized to the nature of each project. These license agreements largely contain the same terms, as is
typically seen in license agreements for an early-stage life science invention; such terms include a worldwide license with licensed
field comprising indications in the intended treatment areas, having upfront payments, certain royalty
rates, sublicensing royalties, as well as provisions for payments
upon occurrence of development and/or regulatory milestones. Under the license agreements, the Project Company must also adhere
to certain diligence obligations and may or may not be required to obtain prior consent from the licensor to sublicense the invention.
The license terms of our Lead Projects are discussed in detail below.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Generally speaking, pharmaceutical development consists of preclinical and clinical phases. Our immediate
efforts would be on the preclinical phase which can further sub-divided into the following stages:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><U>Target
Identification &amp; Selection</U>: The target is the naturally existing cellular or modular structure that appears to have an
important role in a particular disease pathway and will be targeted by the drug that will subsequently be developed. Target validation
techniques for different disease areas can be very different but typically include from in vitro and in silico methods through
to the use of whole animal models.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><U>Lead
Discovery</U>: Following &ldquo;Target Identification &amp; Selection,&rdquo; compound screening assays are developed as part
of the Lead Discovery. &lsquo;Lead&rsquo; molecules can mean slightly different things to different researches or companies, but
in this Registration Statement, we refer to Lead Discovery as the process of identifying one or more small molecules with the
desired activity against the identified targets. Leads can be identified through one or more approaches, which can depend on the
target and what, if any, previous knowledge exists.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><U>Lead
Optimization</U>: In this stage of the drug discovery process, the aim is to produce a preclinical drug candidate by maintaining
the desired and favorable properties in the lead compounds, while repairing or reducing deficiencies in their structures. For
example, to optimize the chemical structures to improve, among others, efficacy, reduce toxicity, improve metabolism, absorption
and pharmacokinetic properties.</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<!-- Field: Page; Sequence: 76; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->68<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"><A HREF="#toc">Table of Contents</A></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><U>IND-Enabling
Studies</U>: Includes all the essential studies such as GLP toxicology studies, pharmacology and efficacy, pharmacokinetics, in
vitro metabolism, CMC studies, and the data of which are used for IND submission.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><IMG SRC="img_005.jpg" ALT="" STYLE="width: 780px; height: 685px"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">Another
subsidiary, Aptorum Medical Limited (&ldquo;AML&rdquo;),<SUP>1</SUP> is our vehicle for developing our business of delivering
medical services in the form of AML Clinic.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">We
anticipate allocating approximately 20% of our resources to develop projects other than our Lead Projects (such other projects
being referred to herein as &ldquo;Other Projects under Development&rdquo;), with a strong focus on SLS-1 and AML Clinic. As a
device candidate, SLS-1 may not need to undergo the same regulatory approval process as a drug candidate and therefore we may
be able to bring it to market sooner. AML Clinic is expected to provide us with a modest amount of revenue. Even if SLS-1 achieves
commercial sales, of which there can be no assurance, revenue from these products alone will not be sufficient for us to carry
out all of our plans, but it will assist with name recognition and supplement our income while we develop our Lead Projects.&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 0; margin-bottom: 0"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid; width: 25%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif"></FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 29px; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><SUP>1</SUP></FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Clark
    Cheng, our Chief Medical Officer and an Executive Director, owns 5% of Aptorum Medical Limited.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<!-- Field: Page; Sequence: 77; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->69<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"><A HREF="#toc">Table of Contents</A></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><I>Lead
Projects </I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><IMG SRC="img_006.jpg" ALT="" STYLE="width: 750px; height: 163px"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>ALS-1: Small molecule intended for the treatment of viral
infections caused by Influenza virus A</B></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">Professor
Richard Kao (Inventor of ALS-1, Founder and Principal Investigator of Acticule) was the first to identify NP as an effective drug
target (Nature Biotechnology. 28:600-605). We are exploring ALS-1 as a potential treatment for viral infections caused by Influenza
virus A (&ldquo;IVA&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 180.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">Two
widely prescribed antiviral drug classes for the treatment of influenza are neuraminidase inhibitors (&ldquo;NI&rdquo;) and M2
protein inhibitors. Zanamivir is a second-generation neuraminidase inhibitor for the treatment of both influenza A and B in adults
and children (5 years old and above). Oseltamivir is a third-generation neuraminidase inhibitor for the treatment of influenza
A and B in individuals older than 1 year of age. Amantadine and rimantadine are M2 membrane protein inhibitors that block the
M2 ion channel activity of influenza A but have no effect on influenza B. Given the widespread resistance to M2 inhibitors, amantadine
and rimantadine are no longer recommended for the treatment of influenza A.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">It is our
hypothesis that influenza A NP is an essential protein for the proliferation of the influenza virus. ALS-1 targets NP and
triggers the aggregation of NP and this prevents the aggregated NP from entering the nucleus. In a paper published by the
inventor, Prof. Richard Kao, in Nature Biotechnology (28 (6): 600, 2010), ALS-1 inhibited infection of MDCK cells by the
influenza A/WSN/33, H3N2 (clinical isolate) and Vietnam/1194/04 (H5N1) viruses with an EC50 of 0.069 &plusmn; 0.003 &mu;M,
0.16 &plusmn; 0.01 &mu;M and 0.33 &plusmn; 0.04 &mu;M in plaque reduction assay (PRA), respectively (Figure 1A). In this
study, oseltamivir (sold under the brand name Tamiflu&reg;) was also included as a control. In this cell culture, ALS-1
outperformed oseltamivir with a lower EC50 (Figure 1a). ALS-1 inhibited viral growth even when added within 6 h after
infection of the MDCK cells with the virus (Figure 1B), indicating that the antiviral activities of ALS-1 arise from
post-entry and post-nuclear events, suggesting that multiple processes involving NP may be affected, although only the
nuclear import process of NP can be readily observed.</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">In
the treatment-free control group, all mice died 7 days after inoculation. After treating with ALS-1, 50% of the mice receiving
two doses of ALS-1 (100 &mu;l of 2.3 mg/ml ALS-1) per day for 7 days survived for more than 21 days. Three mice were sacrificed
from each treated and untreated group on the 6th day after infection and their lungs tested for live virus by a plaque reduction
assay. About a 10x reduction of viral load in the lungs of the ALS-1-treated mice was observed compared to the untreated control
group. The animal study results strongly suggest that ALS-1 protected mice against hypervirulent influenza A H5N1 virus <I>in
vivo</I> and thus has the potential to be developed into useful anti-influenza therapeutics.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 78; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->70<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"><A HREF="#toc">Table of Contents</A></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">ALS-1
is designed to target a broad range of NP variants, a novel therapeutic target, and we believe it is unlikely that ALS-1 will
experience the resistance developed by the viruses against the existing anti-viral therapy. ALS-1 is currently undergoing
Lead Optimization to optimize its drug-like properties.</FONT>&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: bottom; font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif">Figure
1A</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif">Figure 1B</TD></TR>
<TR STYLE="vertical-align: bottom; font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 49%; text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif"><IMG SRC="img_007.jpg" ALT="" STYLE="height: 292px; width: 371px"></FONT></TD>
    <TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 49%; text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif"><IMG SRC="img_008.jpg" ALT="" STYLE="height: 250px; width: 284px"></FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;<FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;</FONT></P>

<P STYLE="margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">Figure 1A: ALS-1 is shown to
cause a greater reduction in the number of infectious virus particles of human <FONT STYLE="font-family: Times New Roman, Times, Serif">H1N1,
H3N2 and H5N1 influenza viruses. MDCK cells were infected with different strains of virus and antiviral activities of
different treatments were determined by plaque reduction assay (PRA). Oseltamivir (curve in red) was included for
comparisons of in vitro efficacies. The PRA assay was conducted in triplicate and repeated twice for confirmation. PFU =
plaque-forming units, a measure of number of infectious virus particles Nucleozin = ALS-1 (Adapted from Nature
Biotechnology (28 (6): 600, 2010).</FONT></FONT></P>





<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">Figure
1B: Efficacies of ALS-1 added at various time points. The experiments were carried out in triplicate and repeated twice for confirmation.
The mean value is shown with s.d.; PFU = plaque-forming units, a measure of number of infectious virus particulates (Adapted from
Nature Biotechnology (28 (6): 600,2010)).&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Patent
License</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">On
October 18, 2017, the Company&rsquo;s subsidiary, Acticule, entered into an exclusive license agreement with Versitech Limited,
the licensing entity of HKU, for the rights to ALS-1. Subsequently on June 7, 2018, the parties entered into a first amendment
to the license agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">Under
the exclusive license agreement, we were granted an exclusive, royalty-bearing, sublicensable license to develop, make, have made,
use, sell, offer for sale and import products that are covered by the licensed patents (as described below). The territory of
the license is worldwide and the field of the license is for treatment or prevention of viral infections including influenza.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">We
paid an upfront fee upon entering into the license agreement and are obligated to pay additional fees during the term. We are
required to pay a low single-digit percentage of the net sales of the licensed products sold by us or our affiliates as royalties,
as well as a low teens percentage of sublicense royalties that we receive from our sublicensees, if any. In addition, we agreed
to pay certain milestone payments as the product achieves specified regulatory, clinical and commercial/sale milestones, as set
forth in the license agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">Pursuant
to the license agreement, Acticule became the exclusive licensee of 1 U.S. patent, 1 European Patent, 1 PRC patent and 1 German
patent. The claimed invention is described as: &ldquo;Antiviral Compounds and Methods of Making and Using Thereof&rdquo;. The
U.S. patent will expire in 2031; the European Patent in 2030; the PRC patent in 2030 and the German patent in 2030.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">Acticule
has the right to grant sublicenses under the license agreement without prior approval from Versitech Limited and to assign the
agreement to any successor to the business related to the license. In the event that Acticule makes an improvement to the licensed
technologies, so long as the improvement does not incorporate any licensed patents, Acticule will be the owner of such improvement,
subject to a non-exclusive royalty-free license being granted back to Versitech Limited for academic and research purposes only.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">The exclusive license agreement shall be in effect until the expiration
of all licensed patents (please refer to the patent expiration dates <FONT STYLE="font-family: Times New Roman, Times, Serif">under
&ldquo;Our Business &ndash; Intellectual Property&rdquo;). Acticule may terminate the license at any time with 6-month written
notice in advance. Either party may terminate the agreement upon a material breach by other party.</FONT></FONT></P>





<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<!-- Field: Page; Sequence: 79; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->71<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"><A HREF="#toc">Table of Contents</A></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>ALS-4:
Small molecule for the treatment of bacterial infections caused by Staphylococcus aureus including Methicillin-resistant Staphylococcus
aureus (&ldquo;MRSA&rdquo;)</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">Just
as certain strains of viruses, such as human immunodeficiency virus (&ldquo;HIV&rdquo;) and influenza have developed resistance
to drugs developed to treat them, certain bacteria such as <I>Staphylococcus aureus</I>, <I>Mycobacterium tuberculosis</I> and
<I>Pseudomonas aeruginosa </I>have become &ldquo;superbugs&rdquo;, having developed resistance to many, if not all, of the existing
drugs available to treat them, rendering those treatments ineffective in many instances. MRSA is one such bacterium, a gram-positive
bacterium that is genetically different from other strains of Staphylococcus aureus. Staphylococcus aureus and MRSA can cause
a variety of problems ranging from skin infections and sepsis to pneumonia and bloodstream infections. It is estimated that about
one out of every three people (33%) carry Staphylococcus aureus in their nose, usually without any illness; about two in a hundred
(2%) carry MRSA (<I>source: https://www.cdc.gov/mrsa/tracking/index.html</I>). Both adults and children may carry MRSA.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">Most
MRSA infections occur in people who have been in hospital or other health care settings, such as nursing homes and dialysis centers
(<I>source: https://www.mayoclinic.org/diseases-conditions/mrsa/symptoms-causes/syc-20375336</I>), which is known as Healthcare-Associated
MRSA (&ldquo;HA-MRSA&rdquo;). HA-MRSA infections are typically associated with invasive procedures or devices, such as surgeries,
intravenous tubing or artificial joints. Another type of MRSA infection, known as Community-Associated MRSA (&ldquo;CA-MRSA&rdquo;),
has occurred in wider community among healthy people. It often begins as a painful skin boil and spreads by skin-to-skin contact.
About 85% of serious, invasive MRSA infections are healthcare associated infections (https://www.cdc.gov/media/pressrel/2007/r071016.htm).
The incidence of CA-MRSA varies according to population and geographic location. In the U.S., more than 94,000 people develop
serious MRSA infection and about 19,000 patients die as a result each year (https://www.cdc.gov/media/pressrel/2007/r071016.htm).
According to the US Centers for Disease Control and Prevention (&ldquo;CDC&rdquo;), Staphylococcus aureus, including MRSA, caused
about 11% of healthcare-associated infections in 2011 (source: http://www.healthcommunities.com/mrsa-infection/incidence.shtml).
Each year in the U.S., around one out of every twenty-five hospitalized patients contracts at least one infection in the hospital
(N Engl J Med. 2014, 27;370(13):1198-208). In the U.S., there were over 80,000 invasive MRSA infections and 11,285 related deaths
in 2011 (source: https://edition.cnn.com/2013/06/28/us/mrsa-fast-facts/index.html). Indeed, severe MRSA infections most commonly
occur during or soon after inpatient medical care. More than 290,000 hospitalized patients are infected with Staphylococcus aureus
and of these staphylococcal infections, approximately 126,000 are related to MRSA (source: http://www.healthcommunities.com/mrsa-infection/incidence.shtml).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">ALS-4
is a small drug molecule which appears to target the products produced by bacterial genes that facilitate the successful colonization
and survival of the bacterium in the body or that cause damage to the body&rsquo;s systems. These products of bacterial genes
are referred to as &ldquo;virulence expression&rdquo;. Targeting bacterial virulence is an alternative approach to antimicrobial
therapy that offers promising opportunities to overcome the emergence and increasing prevalence of antibiotic-resistant bacteria.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">Professor
Richard Kao from The University of Hong Kong (who is also the Founder and Principal Investigator of Acticule and Inventor of ALS-2,
ALS-3 and ALS-4) initiated a high throughput approach for screening compounds which are active against virulence expression, which
resulted in the discovery of ALS-2, ALS-3 and ALS-4. </FONT>&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">ALS-4
targets an enzyme essential for Staphylococcus aureus (including MRSA) survival in vivo. This enzyme is involved in the production
of Staphyloxanthin, a carotenoid pigment produced by Staphylococcus aureus including MRSA, and is responsible for the characteristic
golden color. This pigment has proven to be an important factor in promoting bacterial invasion as well as rendering the bacteria
resistant to attack from reactive oxygen species (ROS) and neutrophils. In other words, pigmented bacteria have increased resistance
to the host&rsquo;s immune defenses. ALS-4 may have particular value if it can be shown to be an effective therapy in situations
where a Staphylococcus aureus infection is resistant to available antibiotics (i.e., where the pathogen is MRSA).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In a recent publication
by the inventor, Prof. Richard Kao, in mBio (8(5): e01224, 2017), ALS-4 demonstrates potent activity against Staphylococcus aureus
pigment formation in vitro, as indicated in Figure 2A, with an IC50 equal to 300 nM (Figure 2B). In addition, ALS-4 exhibits
low cytotoxicity in MDCK, Vero, A549, Huh-7, or 293T cells, with 50% toxic concentrations higher than 500 &micro;M.</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<!-- Field: Page; Sequence: 80; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->72<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"><A HREF="#toc">Table of Contents</A></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">Figure
2</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><IMG SRC="img_009.jpg" ALT="" STYLE="height: 381px; width: 400px"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 6pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Figure
2: In vitro pigment inhibition by compound ALS-4.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">(A)
Inhibition of wild-type (WT) Staphylococcus aureus pigmentation in the presence of increasing concentrations of ALS-4.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">(B)
Pigment inhibition by ALS-4; the IC50 for pigment formation is roughly 300 nM.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">All
data represent mean values &plusmn; SD.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">NP16
= ALS-4</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">This
assay was conducted in triplicate and repeated twice for confirmation</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 6pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">(Adapted
from mBio (8(5): e01224, 2017))</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 224.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 6pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">By employing a systemic
Staphylococcus aureus mouse infection model, the treatment (0.35 mg of ALS-4 twice daily) and control groups (vehicle) were compared.
In case of Staphylococcus aureus COL bacterial infection, the bacterial counts in the livers (P = 0.0085) and spleens (P = 0.0032)
of mice treated with compound ALS-4 were significantly lower than those of the no treatment group (Figure 3C and D) at 72 hours
after the infection. Regarding AE052 infections, bacterial counts in the kidneys of ALS-4-treated mice were significantly lower
than those of the no treatment group (P = 0.0465), with levels in 6 of 10 animals below the detection threshold, compared to undetectable
levels in only 2 of 10 animals in the control group (Figure 3F), indicating a 98% reduction in surviving bacteria in the treatment
groups infected with COL or AE052.</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 224.5pt"><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Figure
3</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><IMG SRC="img_014.jpg" ALT=""></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 3pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">Figure
3</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">(C
and D) Bacteria recovered from the spleens and livers of mice infected with the COL strain, with or without compound NP16 treatment.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">(F)
Bacteria recovered from the kidneys of mice infected with strain AE052, with or without compound ALS-4 treatment.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">All data represent
mean values &plusmn; the standard errors of the means. *, P &lt; 0.05; **, P &lt; 0.01; ***, P &lt; 0.001. P values were determined
using GraphPad Prism with an unpaired parametric t test and Welch&rsquo;s correction.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">CFU
= Colony Forming Unit, a unit used to estimate the number of viable bacteria in a sample</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">PBS
= Phosphate buffered saline</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">NP16
= ALS-4<FONT STYLE="font-size: 3pt">&nbsp;</FONT></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">(Adapted
from mBio (8(5): e01224, 2017))</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">ALS-4
is currently undergoing Lead Optimization to optimize its drug-like properties.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></P>

<!-- Field: Page; Sequence: 81; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->73<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"><A HREF="#toc">Table of Contents</A></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Patent
License </B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">On
October 18, 2017, the Company&rsquo;s subsidiary, Acticule, entered into an exclusive license agreement with Versitech Limited,
the licensing entity of HKU, for ALS-4. Subsequently on June 7, 2018, the parties entered into a first amendment to the exclusive
license agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">Under
the exclusive license agreement, we were granted an exclusive, royalty-bearing, sublicensable license to develop, make, have made,
use, sell, offer for sale and import products that are covered by the licensed patents (as described below). The territory of
the license is worldwide and the field of the license is for treatment or prevention of bacterial infections caused by Staphylococcus
aureus including MRSA and bacterial virulence.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">We
paid an upfront fee upon entering into the license agreement and are obligated to pay additional fees during the term. We are
required to pay a low single-digit percentage of the net sales of the licensed products sold by us or our affiliates as royalties,
as well as a low teens percentage of sublicense royalties that we receive from our sublicensees, if any. In addition, we agreed
to pay certain milestone payments as the product achieves specified regulatory, clinical and commercial/sale milestones, as set
forth in the license agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">Pursuant
to the license agreement, Acticule became the exclusive licensee of 1 pending U.S. non-provisional patent application and 1 PCT
application. With respect to the PCT application, we plan to enter national phase in member states of the EPO, in PRC and other
jurisdictions before the deadline on January 23, 2021. The claimed inventions are described as: &ldquo;Compounds and Methods for
the Treatment of Staphylococcal Infections.&rdquo;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">Acticule
has the right to grant sublicenses to third parties under the license agreement without prior approval from Versitech Limited
and to assign the agreement to any successor to the business related to the license. In the event that Acticule makes an improvement
to the licensed technologies, so long as the improvement does not incorporate any licensed patent, Acticule will be the owner
to such improvement, subject to a non-exclusive royalty-free license being granted back to Versitech Limited for academic and
research purposes only.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">The
exclusive license agreement shall be in effect until the expiration of all licensed patents (please refer to the patent expiration
dates under &ldquo;Our Business &ndash; Intellectual Property&rdquo;). Acticule may terminate the license at any time with 6-month written
notice in advance. Either party may terminate the agreement upon a material breach by other party.</FONT></P>





<P STYLE="margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>NLS-1:
A Derivative of Epigallocatechin-3-Gallate (&ldquo;Pro-EGCG&rdquo;) for the treatment of Endometriosis</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">NLS-1,
a drug molecule derived from natural products (green tea), is currently under development for the treatment of endometriosis, a
disease in which the tissue that normally lines the uterus (endometrium) grows outside the uterus. It can grow on the ovaries,
fallopian tubes, bowels, or bladder. Rarely, it grows in other parts of the body. Many studies have assessed the applications of
EGCG, a naturally occurring molecule extracted from green tea, for the treatment of endometriosis <I>in vitro</I> and in animal
models with encouraging results (Hum Reprod. 2014 29(8):1677; Hum Reprod. 2013 28(1):178; Fertil Steril. 2011 96(4):1021). For
example, in a mouse model, Ricci et al (Hum Reprod. 2013 28(1):178) demonstrated that </FONT><FONT STYLE="font-family: Times New Roman, Times, Serif">EGCG
significantly reduced the mean number (P &lt; 0.05 versus control) and the volume of established lesions (P &lt; 0.05 versus control).
The treatment consistently statistically significantly diminished cell proliferation (P &lt; 0.05, versus control), reduced vascular
density p &lt; 0.001, versus control) and increased apoptosis within the lesions (p &lt; 0.05, versus control). EGCG induced reduction
in human EEC proliferation (p &lt; 0.05 versus basal) and increased apoptosis (p &lt; 0.05 versus basal) in primary cultures. Matsuzaki
and Darcha (Hum Reprod. 2014 29(8):1677) also showed that EGCG prevented the progression of fibrosis in endometriosis in an animal
model.</FONT></P>





<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">However,
the attractiveness of epigallocatechin-3-gallate as a drug candidate has been diminished by its chemical and metabolic instability
(Hum Reprod. 2014 29(8):1677; Angiogenesis. 2013 16(1):59). The Company&rsquo;s drug candidate, NLS-1 or EGCG octaacetate, is
supposed to overcome these challenges. NLS-1 is an EGCG derivative synthesized by acetylation of the reactive hydroxyl groups,
which appears to prevent generation of reactive phenoxide anions and radicals for dimerization and metabolism, thereby overcoming
the chemical and metabolic instability of EGCG.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">Despite
different hypotheses proposed for the pathogenesis of endometriosis, it is widely accepted that endometriosis is an angiogenesis-dependent
disorder, and that angiogenesis plays an essential role in the growth and survival of endometriotic lesions. Endometriotic lesions
require new vessel formation to deliver oxygen and nutrients that are essential to the development and progression of endometriosis.
Dense vascularization is a typical pathological feature of endometriosis. Numerous peritoneal blood vessels can be observed around
the endometriotic lesions during laparoscopy, and ectopic endometrium is highly vascularized under histological examination. Researchers
have confirmed in animal models that angiogenesis occurs in endometriosis, by demonstrating the development of adjacent blood
vessels from the surrounding vasculature into the endometriotic implants. Anti-angiogenesis therapy offers a potential novel treatment
of endometriosis.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<!-- Field: Page; Sequence: 82; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->74<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"><A HREF="#toc">Table of Contents</A></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">In
a paper published by the inventors in Angiogenesis (16:59, 2013), NLS-1 significantly decreased the growth of endometrial implants
from the 2nd week to the 4th week of intervention in mice. In addition, it significantly reduced the lesion size and weight, inhibited
functional and structural microvessels in the lesions, and enhanced lesion apoptosis at the end of interventions (Figure 4A &amp;
B). The inhibition by NLS-1 in all the angiogenesis parameters was significantly greater than that by EGCG (Figure 5A &amp; B),
and NLS-1 also had better bioavailability and greater antioxidation and anti-angiogenesis capacities compared with EGCG.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">In
addition, regarding a safety study in mice, no signs of stress to NLS-1 administration were observed during the treatment period.
No significant weight change was observed over the course of the experiment. Histological examination revealed no obvious reproductive
effects on ovarian follicles and endometrial glands under NLS-1 treatments (Figure 6). Also, vascularization of the ovaries and
the uterus was not affected in the NLS-1 treatment group.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Figure
4</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><IMG SRC="img_010.jpg" ALT="" STYLE="height: 300px; width: 665px"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">Figure
4A &amp; B</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">NLS-1
(Pro-EGCG) limits the development of experimental endometriosis in mice. Upper panels show the endometrial implants developed
in the right ventral abdominal wall under laparotomy. Arrows indicate the greatest length and perpendicular width of the lesions
for lesion size calculation. Lower panels show the sandwich structures of outer skin and subcutaneous layers (s), middle endometriotic
lesions with endometrial glands (g) and endometrial cyst-like structures (c), and inner abdominal muscle and peritoneum (m). Scale
bars: 0.5 mm. b Bar charts of the lesion size and weight in different groups and representative lesion pictures are shown. Mean
&plusmn; SEM, student&rsquo;s t test, *P &lt; 0.05 compared with saline group; P &lt; 0.05 compared with EGCG group.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">The
sample size was 4 (N=4) for each group.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">(Adapted
from Angiogenesis (16:59, 2013))</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 83; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->75<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"><A HREF="#toc">Table of Contents</A></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Figure
5:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT><IMG SRC="img_011.jpg" ALT="" STYLE="width: 800px; height: 278px"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">Figure
5A &amp; B</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">NLS-1
inhibits the angiogenesis of experimental endometriosis in mice. Upper panels: Microvessels in the endometriotic implants were
perfused with FITC-Dextran and captured by Cellvizio (white colour) (N=8). Middle panels: Microvessel architectures surrounding
the lesions and within the lesions were perfused with microfil contrast medium and captured by lCT (yellow dots) (N=4). Lower
panels: Microvessels in the endometriotic lesions were determined by specific antimouse antibodies CD31 for endothelial cells
in red, aSMA for smooth muscles in green, and DAPI for nuclei in blue (N=4). New microvessels are CD31-positively and aSMA-negatively
stained (closed arrows), old microvessels are CD31-positively and aSMA-positively stained (opened arrows). g: endometrial glands;
c: endometrial cyst-like structures; m: abdominal muscle. Representative images in different groups are shown. Scale bars: 10
lm. b Bar charts of the lesion microvessel parameters in different groups are presented. Mean &plusmn; - SEM, student&rsquo;s
t test, *P &lt; 0.05 compared with saline group; P &lt; 0.05 compared with EGCG group. (Adapted from Angiogenesis (16:59, 2013)).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<!-- Field: Page; Sequence: 84; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->76<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"><A HREF="#toc">Table of Contents</A></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Figure
6</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><IMG SRC="img_012.jpg" ALT="" STYLE="height: 447px; width: 602px"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">Figure
6</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">NLS-1
preserves normal ovarian follicles and endometrial glands. Ovarian follicles and endometrial glands were determined by H&amp;E
staining and microvessels in ovarian and endometrial stroma were determined by anti-mouse CD34 immunostaining in ovaries (upper
panels) and uterus (lower panels). Representative images in different groups are shown. Scale bars: 0.5 mm.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">N=8
was conducted for each group.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">(Adapted
from Angiogenesis (16:59, 2013)).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<!-- Field: Page; Sequence: 85; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->77<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"><A HREF="#toc">Table of Contents</A></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">As
a follow-up study in an animal model of endometriosis, orally administered NLS-1 reduced the lesion size significantly better than
oral EGCG (p&lt;0.05-0.001 at week 3- 8, ANOVA) and other hormone-based therapy such as intramuscular GnRH analog (p&lt;0.05 at
week 4-8, ANOVA) and other synthetic anti-angiogenesis agents such as intraperitoneal PTK787 (p&lt;0.05-0.01 at week 4-8, ANOVA),
as reflected in Figure 7.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Figure
7</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><IMG SRC="img_013.jpg" ALT="" STYLE="width: 750px; height: 374px"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">Figure
7</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">Comparison
of the efficacy of different treatment in an experimental endometriosis model</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">The
current approved treatment for endometriosis is hormonal therapy, which can cause severe undesirable side effects. At present,
there are only a few non-hormonal therapeutics with different mechanisms than NLS-1 that are under preclinical or clinical development,
such as:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 24px; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 24px; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1)</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">BAY
    1128688, which is a non-hormonal approach developed by Bayer HealthCare for endometriosis and which entered Phase 2 study
    in Spain in 2017 (<U>https://adisinsight.springer.com/drugs/800041929</U>); and, </FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 24px; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 24px; text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2)</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Small
    molecules co-developed by Bayer and Evotec that have entered Phase 1 studies (Source: https://www.businesswire.com/news/home/20180417006820/en/Evotec-Bayer-Advance-Endometriosis-Programme-Phase-Clinical).</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">NLS-1
is under active development for the treatment of endometriosis. It is currently at the Lead Optimization stage to optimize its
drug-like properties.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<!-- Field: Page; Sequence: 86; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->78<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"><A HREF="#toc">Table of Contents</A></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Patent
License</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">On
July 3, 2017, the Company&rsquo;s subsidiary, Aptorum Therapeutics Limited, entered into an exclusive license agreement with PolyU
Technology and Consultancy Limited, The Royal Institution for the Advancement of Learning/McGill University, Wayne State University,
H. Lee Moffitt Cancer Center and Research Institute Inc. and CUHK (all representing the licensors) for NLS-1.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;</FONT></P>

<P STYLE="margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">We paid an upfront fee upon entering
into the license agreement and are obligated to pay certain milestone payments as the product achieves specified regulatory, clinical
and commercial/sale milestone, as applicable, as set forth in the license agreement.<FONT STYLE="font-family: Times New Roman, Times, Serif; background-color: white">&nbsp;</FONT></FONT></P>





<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">Pursuant
to the license agreement, Aptorum Therapeutics Limited became the exclusive licensee of 5 U.S. patents, 1 European Patent, 1
PRC patent, 1 Indian patent and 1 Japanese patent, as well as 1 pending US patent application, 1 pending PRC patent
application and 1 pending Hong Kong patent application. Two technologies are claimed in the patents: &ldquo;Epigallocatechin
Gallate Derivatives for Inhibiting Proteasome,&rdquo; which is jointly owned by PolyU Technology and Consultancy Limited, The
Royal Institution for the Advancement of Learning/McGill University, Wayne State University and H. Lee Moffitt Cancer Center
and Research Institute Inc. and &ldquo;Pro-EGCG for Use in the Treatment of Endometriosis,&rdquo; which is jointly owned by
PolyU Technology and Consultancy Limited and CUHK. The licensors have nominated PolyU Technology and Consultancy Limited to
represent them and take the lead in negotiating and managing the license.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">Aptorum
Therapeutics Limited has the right to grant sublicenses under the license agreement with prior consent from the licensors, and
such approval shall not be unreasonably withheld. In the event that Aptorum Therapeutics Limited develops any improvements or
new development, such licensee inventions are to be jointly owned by the licensors and Aptorum Therapeutics Limited, so that both
owners will have the right to use any such inventions for any purpose. In such a case, the Company expects to negotiate a separate
agreement with the licensors governing the terms on which the licensors may use such inventions.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;</FONT></P>

<P STYLE="margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">In addition, Aptorum Therapeutics Limited also committed to providing HK$3
million (US$384,615) of research funding before July 3, 2020 to sponsor research carried out by the three principle individual
inventors upon their request with respect to further R&amp;D on the licensed technologies. The research funding shall be in the
form of matching funds provided by the Innovation Technology Fund (&ldquo;ITF&rdquo;). The ITF is administered by the Innovation
and Technology Commission of the Government of Hong Kong and encompasses a scheme where the Hong Kong government offers matching
grant for joint researches to foster collaboration between private companies and public research institutions. If an ITF application
is approved, the Hong Kong government will provide a grant that matches the contribution by the private company in the research
projects. Since the ITF funding is merit-based and there is no guarantee that an ITF application will be granted, Aptorum Therapeutics&rsquo;
obligation to contribute to the research fund under the agreement will be contingent on the successful application of ITF scheme
granting HK$3 million fund that matches our proposed contribution. In the event that an ITF application related to NLS-1 is not
successful, the parties have agreed to negotiate for and agree to enter into new funding terms to support the ongoing research.
<FONT STYLE="font-family: Times New Roman, Times, Serif">As of today, the inventors have not filed such ITF application.&nbsp;</FONT></FONT></P>





<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">During
the term of the license agreement and for two years thereafter, Aptorum Therapeutics Limited undertakes not to develop or commercialize
any product that directly competes with any marketed product that is covered by the licensed technology.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">The
exclusive license agreement shall be in effect until the later of (1) the expiry of the term of the last to expire licensed
patent set forth in the agreement, (2) final disposition of the last of the pending patent application set forth in the
agreement, and (3) ten years following the first commercial sale of the product. Please refer to the patent expiration dates
under &ldquo;Our Business &ndash; Intellectual Property&rdquo; for information regarding (1) and (2). Either party may
terminate the agreement upon a material breach by or insolvency of the other party. Further, the Licensors may terminate the
agreement if the licensee commits any act or omission that could tarnish the reputation of any licensors.</FONT>&nbsp;</P>





<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><I>FDA
Application Status</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">As
of the date of this prospectus, we have not submitted any applications for investigational new drugs (&ldquo;IND&rdquo;) to the
US Food and Drug Administration (&ldquo;FDA&rdquo;). By 2020 or 2021, we expect to be in a position to submit at least one application
for one of our drug candidates to commence trials in humans (INDs to the FDA or an equivalent application to the regulatory authorities
in another jurisdiction such as the China Food and Drug Administrative (the &ldquo;CFDA&rdquo;) or the European Medicines Agency
(&ldquo;EMA&rdquo;)). However, there can be no assurance we will be able to make any such application by such time. Should we
be delayed in making such filing or should such filing not be approved, our business will be adversely affected.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><I>Other
Projects under Development</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">The
following provides additional detail regarding Other Projects under Development:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>VLS-1:
Curcumin-conjugated superparamagnetic iron oxide nanoparticles (&ldquo;Curcumin-MNP&rdquo;) for MRI (&ldquo;magnetic resonance
imaging&rdquo;) imaging of amyloid beta plaques in Alzheimer&rsquo;s disease (&ldquo;AD&rdquo;)</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">VLS-1
is an MRI contrast agent, which the Company believes may enable superior imaging for identifying amyloid beta plaques in Alzheimer&rsquo;s
disease. VLS-1 differs from other existing contrast agents for amyloid imaging, such as Amyvid (Eli Lilly), Vizamyl (GE Healthcare)
and Neuraceq (Piramal Healthcare), in the following respects: 1) utilization of a natural compound, curcumin, with a known high
amyloid beta binding affinity and proven safety; 2) a nanoparticle-based system to enhance delivery efficiency to the brain; and
3) the combination of curcumin with iron oxide, known to be an effective MRI contrast agent.</FONT></P>

<!-- Field: Page; Sequence: 87; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->79<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"><A HREF="#toc">Table of Contents</A></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>VLS-2:
mTOR-independent transcription factor EB activator (&ldquo;MITA&rdquo;) as autophagy activator for treatment of neurodegenerative
diseases</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">Autophagy
is an endogenous cellular mechanism for clearing multiple pathological protein aggregates including tau, the presence of which
is believed to account for neurodegeneration in AD and other neurodegenerative diseases. mTOR is part of a biological pathway
that is a central regulator of mammalian metabolism and physiology. Inhibition of mTOR activity is associated with various side
effects, such as immunosuppression. Many other molecules that activate autophagy also inhibit mTOR activity. VLS-2 is a small
drug molecule that appears to activate autophagy without inhibiting mTOR function. VLS-2 is currently at the Lead Discovery stage.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>VLS-3:
Novel retinal imaging agent for retinal imaging of amyloid plaques</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">VLS-3
consists of two components, a curcumin oral formulation and an integrated retinal imaging system. VLS-3 is currently at Lead Discovery
stage. Curcumin is a naturally occurring molecule that binds to amyloid plaques and its fluorescent nature enables it to be easily
detected. However, curcumin is a very challenging molecule due its low aqueous solubility and poor oral bioavailability. We intend
to develop a new formulation to overcome some of these hurdles. Our prototype oral curcumin formulation exhibits an ability to
disperse in aqueous media and yields a higher dissolution rate compared with the neat drug and a commercially available product.
The current formulation has passed a short-term stability assessment and a long-term stability study is underway. Animal pharmacokinetic
and efficacy studies are currently being planned. If tested successfully, the Company intends to market VLS-3 as a convenient
and non-invasive means for preliminary screening of the retina prior to use of VLS-1 for a full brain MRI.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>VLS-4:
Other contrast agents for MRI diagnostics</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">In
addition to VLS-1, the Company is actively developing a new class of MRI contrast agents for diagnosis of neurodegenerative diseases.
The design of these agents takes into consideration the physicochemical properties that need to be optimized for best imaging
performance, and the novel agents are currently undergoing rigorous evaluation.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>ALS-2:
Small molecule for the treatment of bacterial infections caused by Staphylococcus aureus including MRSA</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">ALS-2
is a next generation small molecule targeting bacterial virulence for the treatment of bacterial infections caused by Staphylococcus
aureus including MRSA. In a recent paper published by the inventor, Professor Richard Kao from The University of Hong Kong (also
the Founder and Principal Investigator of Acticule), in PNAS (115(310: 8003, 2018), ALS-2 suppresses the expression of multiple
virulence factors in Staphylococcus aureus simultaneously. In a lethal infection mouse model, compared with the vehicle group,
ALS-2 protected against Staphylococcus aureus for all the mice in the group, with significant differences between the treatment
and control groups [P = 0.0057, by log-rank (Mantel-Cox) test].</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">ALS-2
is currently at the Lead Optimization stage to optimize its drug-like properties.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>ALS-3:
Small molecule acting synergistically with certain existing antibiotics</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">ALS-3
is a novel small molecule that is at present under investigation to combine with certain classes of existing antibiotics to overcome
drug resistance. We are exploring ALS-3 for the treatment of bacterial infections including MRSA. ALS-3 is currently at the Lead
Optimization stage to optimize its drug-like properties.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>NLS-2:
An extract from Chinese Yam for relief of menopausal symptoms</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">NLS-2
is </FONT><FONT STYLE="font-family: Times New Roman, Times, Serif">an extract isolated from Chinese Yam, Dioscorea opposita
Thunb. In development for the treatment of menopausal syndrome, we expect NLS-2 is to be formulated into an oral dosage form or
nasal spray for administration. Each therapy cycle is expected to last for 3 months. Menopausal syndrome refers to the symptoms
experienced by women during menopause, such as hot flashes, mood disorders, night sweats, depression, nervous tension and insomnia
that are related to estrogen deficiency. Our research suggests that NLS-2 stimulates estradiol biosynthesis in rat ovarian granulosa
cells; induces estradiol and progesterone secretion in aged rats by upregulating expressions of follicle-stimulating hormone receptor
and ovarian aromatase; counteracts the progression of osteoporosis and augments bone mineral density; and improves cognitive functioning
by upregulating protein expressions of brain-derived neurotrophic factor and TrkB receptors in the prefrontal cortex. Furthermore,
NLS-2</FONT> <FONT STYLE="font-family: Times New Roman, Times, Serif">does not appear to stimulate the proliferation of
breast cancer and ovarian cancer cells, which suggests that it could be a more efficacious and safer alternative to hormone replacement
therapy (Sci Rep. 2015 5:10179).</FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>NLS-3:
Extract from garlic for the treatment of and protection against retinal ischemia/reperfusion injury</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">NLS-3
is based on S-Allyl L-Cysteine (&ldquo;SAC&rdquo;), an active organosulfur compound in aged garlic extract which has been reported
to possess antioxidative activity. In macrophages and endothelium, it has been shown that SAC possesses potent antioxidative effects
involving the scavenging of superoxide radicals, hydroxyl radicals and hydrogen peroxide. Central/branch retinal artery/vein occlusion,
glaucoma and, possibly, age related macular degeneration (&ldquo;AMD&rdquo;) are conditions associated with retinal ischemia.
All these diseases may lead to severe complications or after-effects. Furthermore, after retinal ischemia/reperfusion (&ldquo;I/R&rdquo;),
large amounts of reactive oxygen species (&ldquo;ROS&rdquo;) are produced, which attack nearby cells and cause tissue damage.
Therefore, management of retinal ischemia is vital and NLS-3 is being developed for the treatment of and protection against ischemia/reperfusion
injury.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></P>

<!-- Field: Page; Sequence: 88; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->80<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"><A HREF="#toc">Table of Contents</A></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>SPLS-1:
A quinoline derivate for liver cancer treatment</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">SPLS-1,
a novel quinoline derivative from Ephedra pachyclada, is at present under active investigation for the treatment of liver cancer.
It is currently at the Lead Discovery stage.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>SLS-1:
Robotic Catheter Platform for Intra-operative MRI-guided Cardiac Catheterization</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">SLS-1
is our robotic catheter platform for MRI-guided cardiovascular intervention for the treatment of arrhythmia. The platform consists
of a magnetic resonance imaging (&ldquo;MRI-guided&rdquo;) robotic electrophysiology (&ldquo;EP&rdquo;) catheter system, an MR-based
positional tracking unit, and a navigation interface. This platform has the potential to offer a major step toward achievement
of several clinical goals: (i) enhancing catheter manipulation and lesion ablation, which we believe will decrease the chance
of arrhythmia recurrence; (ii) improving the safety of catheter navigation, thereby decreasing the rates of undesired or inadvertent
tissue damage; and (iii) enhancing catheter control, thus facilitating shorter learning curves for surgeons and better treatment
in more complex patient cases. Should such goals be demonstrated, patient outcomes should be improved, compensating for the cost
of using MRI and reducing the overall expenditure.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">To
date, a product prototype has been developed. Lab-based experiments have been conducted to verify the performance of the robot
towards an image-guided pulmonary vein isolation (&ldquo;PVI&rdquo;) task. The MR-based tracking unit has also been developed
and validated in MRI scanners. The next step is to test the robotic catheterization using a dynamic heart phantom simulated with
the pulsatile liquid flow. Preclinical trials can then be conducted with all the components ready. RF ablation will be conducted
in a live porcine model, prepared with arrhythmia. If all the results are positive, we will approach the US FDA or other regulatory
agencies to apply for conducting clinical trials on the equipment.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">SLS-1 is currently in Lab-based Phantom Trial and
it will follow the regulatory pathway for approval as indicated in the table in Page 69<FONT STYLE="font-family: Times New Roman, Times, Serif">.</FONT></FONT></P>





<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;<FONT STYLE="font-family: Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B></B></FONT></P>

<!-- Field: Page; Sequence: 89; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->81<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"><A HREF="#toc">Table of Contents</A></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Aptorum
Medical Limited - AML Clinic </B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">Incorporated
in August 2017, Aptorum Medical Limited is a Hong Kong-based company incorporated in Cayman Islands focused on delivering premium
healthcare and clinic services. AML can draw on the expertise of many of the region&rsquo;s most experienced medical practitioners,
and is committed to providing a comprehensive cross-functional facility for healthcare professionals to practice evidence-based
medicine and offer high-quality medical services to their patients. We also intend that AML will offer to conduct clinical trials
of both the Company&rsquo;s and third parties&rsquo; new drug and device products.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">Effective
as of March 2018, we leased office space in Central, the commercial and financial heart of Hong Kong, as the home to AML Clinic
(See &ldquo;Facilities&rdquo;). We operate the AML Clinic under the name of Talem Medical. AML Clinic has commenced operation
in June 2018.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">The
recently renovated medical center is staffed by our group of medical professionals and offers state-of-the-art facilities. Initially
we expect to focus our expertise on treatment of chronic diseases resulting from modern sedentary lifestyles and an aging population.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><I>Corporate
History and Background</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">Aptorum
was incorporated under the laws of the Cayman Islands on September 13, 2010. Our share capital is $100,000,000.00 divided into
60,000,000 Class A Ordinary Shares with a nominal or par value of $1.00 each and 40,000,000 Class B Ordinary Shares with a nominal
or par value of $1.00 each.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">Please
see the chart illustrating our current corporate structure, under the heading of &ldquo;Our Structure&rdquo; in the Prospectus
Summary, included earlier in this prospectus.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; background-color: white">Prior
to the completion of this Offering and as long as our officers and directors, either individually or in the </FONT><FONT STYLE="font-family: Times New Roman, Times, Serif">aggregate,
own at least 50% of the voting power of our Company, we will be a &ldquo;controlled company&rdquo; as defined under NASDAQ Marketplace
Rules (specifically, as defined in Rule 5615(c)). We have no current intention to rely on the&nbsp;controlled company&nbsp;exemptions
afforded to a controlled company under the NASDAQ Marketplace Rules.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">APTUS
CAPITAL LIMITED, which has since been renamed to AENEAS CAPITAL LIMITED and which we refer to herein as Aeneas, was always under
the direct ownership of Jurchen and not under the ownership chain of Aptorum Group. However, Aptus Asia Financial Holdings Limited
(&ldquo;AAFH&rdquo;) was transferred out of the Aptorum Group on November 10, 2017 to be held directly by Jurchen Investment Corporation
and that subsequently, APTUS CAPITAL LIMITED was then transferred to be under AAFH.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">On
March 1, 2017, the Company&rsquo;s board of directors and shareholders resolved to restructure the Company from an investment
fund with management shares and non-voting participating redeemable preference shares to a holding company with operating subsidiaries
(the &ldquo;Restructuring Plan&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">According
to the Restructuring Plan, the 256,571.12 issued participating shares with par value of $0.01 (&ldquo;Participating Shares&rdquo;)
were redeemed and 4,743,418.88 unissued Participating Shares were cancelled; following such redemption and cancellation, we no
longer have any Participating Shares authorized or issued. Additionally, the Company authorized a class of securities consisting
of 100,000,000 ordinary shares, par value $1.00 per share (&ldquo;Ordinary Shares&rdquo;) and issued 25,657,110 Ordinary Shares
to our original investors.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 30pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">During
the period March 1, 2017 through October 13, 2017, an aggregate of 2,207,025 Ordinary Shares were issued at a price of approximately
$3.90 per share in a private placement we described as a &ldquo;Series A&rdquo; offering. Each investor of the Series A offering,
in addition to a subscription agreement, signed a shareholder agreement, which set forth the basic governance terms of the Company,
as well as our capital structure. The shareholders agreement was terminated in October 2017.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 30pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">On
October 13, 2017, ordinary resolutions were passed at an extraordinary general meeting of the Company approving: (i) converting
72,135,865 of authorized but unissued Ordinary Shares into 54,573,619 authorized but unissued Class A ordinary shares, par value
of $1.00 per share (&ldquo;Class A Ordinary Shares&rdquo;) and 17,562,246 authorized but unissued Class B ordinary shares, par
value of $1.00 per share (&ldquo;Class B Ordinary Shares&rdquo;), respectively; (ii) converting 24,930,839 Ordinary Shares held
by three shareholders into an aggregate of 2,493,085 Class A Ordinary Shares and 22,437,754 Class B Ordinary Shares; and (iii)
converting 2,933,296 Ordinary Shares held by 24 shareholders into an aggregate 2,933,296 Class A Ordinary Shares. Following these
issuances, we had 27 shareholders of record.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">On
October 19, 2017, we changed our name from APTUS Holdings Limited to our current name, Aptorum Group Limited.</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<!-- Field: Page; Sequence: 90; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->82<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"><A HREF="#toc">Table of Contents</A></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;<B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><I>Intellectual
Property</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">The
technologies underlying our various research and development projects are the subject of various patents and patent applications
claiming, in certain instances, composition of matter and, in other instances, methods of use. Prosecution, maintenance and enforcement
of these patents, as well as those on any future protectable technologies we may acquire, are and will continue to be an important
part of our strategy to develop and commercialize novel medicines and medical devices, as described in more detail below. Through
entering into license agreements with their owners, we have obtained exclusive rights to these patents, applications and related
know-how in the U.S. and certain other countries to develop, manufacture and commercialize the products using or incorporating
the protected inventions that are described in this Prospectus and that are expected to contribute significant value to our business.
The technologies protected by these patents may also for the basis for the development of other products.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">In
addition to licensed intellectual property, our in-house science team has been actively developing our own proprietary intellectual
property. No patent applications have yet been filed in the Company&rsquo;s own name for the Lead Projects. We have, however,
filed one U.S. provisional patent application (U.S. Provisional Application No. 62/590,369) directed to a retinal imaging system
for detection of neurodegenerative disease that is under development (VLS-3). The U.S. Provisional Application No. 62/590,369
was filed on November 24, 2017 to secure an earlier filing date.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">The
U.S. patent system permits the filing of provisional and non-provisional patent applications (i.e., a regular patent application).
A non-provisional patent application is examined by the USPTO, and can mature into a patent once the USPTO determines that the
claimed invention meets the standards for patentability. On the other hand, a provisional patent application is not examined for
patentability, and automatically expires 12 months after its filing date. As a result, a provisional patent application cannot
mature into a patent.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">Provisional
applications are often used, among other things, to establish an earlier filing date for a subsequent non-provisional patent application.
The term of individual patents depends upon the legal term of the patents in the countries in which they are obtained.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">The
effective filing date of a non-provisional patent application is used by the USPTO to determine what information is prior art
when it considers the patentability of a claimed invention. If certain requirements are satisfied, a non-provisional patent application
can claim the benefit of the filing date of an earlier filed provisional patent application. As a result, the filing date accorded
by the provisional patent application may supersede information that otherwise could preclude the patentability of an invention.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">A
provisional patent application is not eligible to become an issued patent unless, among other things, we file a non-provisional
patent application within 12 months of the filing date of the provisional patent application. <FONT STYLE="background-color: white">Depending
on the progress of our development for VLS-3, the Company may elect to file a non-provisional application claiming priority to
US Provisional Application No. </FONT>62/590,369 before its expiration on November 24, 2018. <FONT STYLE="background-color: white">If
we do not timely file&nbsp;a non-provisional patent application claiming priority to said provisional application, we may lose
our priority date with respect to our provisional patent applications. Further, if any (self or by others) publication of the
invention is made after such priority date, and if we do not file a non-provisional application claiming priority to said provisional
application, our invention may become unpatentable.&nbsp;</FONT></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">Moreover,
we cannot predict whether such future patent applications will result in the issuance of patents that effectively protect any
of our product candidates or will effectively prevent others from commercializing competitive products.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 2pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">Other
than US Provisional <FONT STYLE="background-color: white">Application No. </FONT>62/590,369, we do not currently own, nor have
we acquired any rights in any provisional patent application.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">We
do not expect to incur material expenses in the prosecution of the VLS-3 provisional application or other licensed patent applications.
We expect to fund the patent costs from our cash and restricted cash.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 2pt; text-align: justify; text-indent: 34pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">The
value of our drug and device products will depend significantly on our ability to obtain and maintain patent and other proprietary
protection for those products, preserve the confidentiality of our trade secrets and operate without infringing the valid and
enforceable patents and proprietary rights of other parties.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 2pt; text-align: justify; text-indent: 34pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<!-- Field: Page; Sequence: 91; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->83<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"><A HREF="#toc">Table of Contents</A></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 2pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">The
following table sets forth a list related to our Lead Projects of our patent rights under the exclusive licenses as of the date
of this prospectus:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: bottom; font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 11%; border-bottom: black 1.5pt solid; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Project
    Company / Project name </B></FONT></TD>
    <TD STYLE="width: 1%; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 16%; border-bottom: black 1.5pt solid; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>License
    Agreement</B></FONT></TD>
    <TD STYLE="width: 1%; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 11%; border-bottom: black 1.5pt solid; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Licensor(s)</B></FONT></TD>
    <TD STYLE="width: 1%; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 11%; border-bottom: black 1.5pt solid; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Licensee</B></FONT></TD>
    <TD STYLE="width: 1%; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 25%; border-bottom: black 1.5pt solid; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Licensed
    / IP Rights</B></FONT></TD>
    <TD STYLE="width: 1%; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 21%; border-bottom: black 1.5pt solid; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Patent
    Expiration Dates</B></FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: #CCEEFF; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Acticule
    / ALS-1</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">Exclusive
                                         Patent License Agreement, dated October 18, 2017</FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">First
        Amendment to Exclusive License Agreement, dated July 7, 2018</FONT></P></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Versitech
    Limited</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Acticule
    Life Sciences Limited</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exclusive
    licensee: 1 U.S. patent (US9212177), 1 European Patent (EP2462138B1), 1 PRC patent (CN102596946B), 1 German patent (DE60 2010
    019 171.0)</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">The
                                         licensed IP rights include granted patents in the U.S., Switzerland, Germany, Great Britain
                                         and PRC.</FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">The
        U.S. patent will expire in 2031; the European Patent in 2030; the PRC patent in 2030 and the German patent in 2030.</FONT></P></TD></TR>
<TR STYLE="vertical-align: top; background-color: white; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: #CCEEFF; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Acticule
    / ALS-4</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">Exclusive
                                         Patent License Agreement, dated October 18, 2017</FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">First
        Amendment to Exclusive License Agreement dated July 7, 2018</FONT></P></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Versitech
    Limited</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Acticule
    Life Sciences Limited</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exclusive
    licensee: 1 pending U.S. application 16/041,836), and 1 pending PCT application (PCT/IB2018/055458), in which we intend to
    file national stage applications PRC and before the EPO prior to the 30-month entry deadline falling on January 2021.</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">The
                                         licensed IP rights include pending patent applications in the U.S. and under the PCT.</FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">Any
        patent based on the application, if granted, will have a 20-year patent term from 2018.</FONT></P></TD></TR>
<TR STYLE="vertical-align: top; background-color: white; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: #CCEEFF; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Nativus
    / NLS-1</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">1)
                                         Exclusive License Agreement, dated July 3, 2017</FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">2)
        Addendum to License Agreement, dated February 9, 2018</FONT></P></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">1)
                                         PolyU Technology and Consultancy Company Limited</FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">2)
        McGill University</FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">3)
        Wayne State University</FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">4)
        H. Lee Moffitt Cancer Center and Research Institute Inc.</FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">5)
        The Chinese University of Hong Kong</FONT></P></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">APTUS
    Therapeutics Limited</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exclusive
    licensee: 5 U.S. patents (US9713603, US7544816, US8193377, US8710248, US9169230), 1 European Patent (EP1778663), 1 PRC patent
    (CN101072764B), 1 Indian patent (IN263365) and 1 Japanese patent (JP5265915), as well as 1 pending U.S. application (US20170281591A1),
    1 pending PRC application (CN104703596A), and 1 pending Hong Kong application (HK15111955.3) </FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">The
                                         licensed IP rights include granted patents in the U.S., Switzerland, Germany, Great Britain,
                                         Ireland, Luxemburg, Monaco, PRC, India and Japan, as well as pending patent applications
                                         in the U,S., PRC and Hong Kong. We cannot predict whether such future patent applications
                                         will result in the issuance of patents that effectively protect the candidate.</FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">The
        U.S., European and PRC patents covering the compound will expire in 2025; the indication U.S. patent will not expire until
        2032.</FONT></P></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">Because
of the extensive time required for clinical development and regulatory review of a drug we may develop, it is possible that, before
any of our drug and device candidates can be commercialized, any related patent may expire or remain in force for only a short
period following commercialization, thereby reducing any advantage of any such patent. If appropriate, the Company may seek to
extend the period during which it has exclusive rights to a product by pursuing patent term extensions and marketing exclusivity
periods that are available from the regulatory authorities of certain countries (including the United States) and the EPO.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 2pt; text-align: justify; text-indent: 34pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">Even
though the Company has certain patent rights, the ability to obtain and maintain protection of biotechnology and pharmaceutical
products and processes such as those we intend to develop and commercialize involves complex legal and factual questions. No consistent
policy regarding the breadth of claims allowed in such patents has emerged to date in the U.S. The scope of patent protection
outside the United States is even more uncertain. Changes in the patent laws or in interpretations of patent laws in the United
States and other countries have diminished (and may further diminish) our ability to protect our inventions and enforce our IP
rights and, more generally, could affect the value of IP.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 2pt; text-align: justify; text-indent: 34pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">While
we have already secured rights to a number of issued patents directed to our drug candidates, we cannot predict the breadth of
claims that may issue from the pending patent applications and provisional patents that we have licensed or that we have filed.
Substantial scientific and commercial research has been conducted for many years in the areas in which we have focused our development
efforts, which has resulted in other parties having a number of issued patents, provisional patents and pending patent applications
relating to such areas. The patent examiner in any particular jurisdiction may take the view that prior issued patents and prior
publications render our patent claims &ldquo;obvious&rdquo; and therefore unpatentable or require us to reduce the scope of the
claims for which we are seeking patent protection.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<!-- Field: Page; Sequence: 92; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->84<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"><A HREF="#toc">Table of Contents</A></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">In
addition, patent applications in the United States and elsewhere generally are not available to the public until at least 18 months
from the priority date, and the publication of discoveries in the scientific or patent literature frequently occurs substantially
later than the date on which the underlying discoveries were made. Therefore, patent applications relating to drugs and devices
similar to our drug and device candidates may have already been filed, which (if they result in issued patents) could restrict
or prohibit our ability to commercialize our drug and device candidates.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">The
biotechnology and pharmaceutical industries are characterized by extensive litigation regarding patents and other IP rights. Our
ability to prevent competition for our drug and device candidates and technologies will depend on our success in obtaining patents
containing substantial and enforceable claims for those candidates and enforcing those claims once granted. With respect to any
applications which have not yet resulted in issued patents, there can be no assurance that meaningful claims will be obtained.
Even issued patents may be challenged or invalidated. If others have prepared and filed patent applications in the United States
that also claim technology to which we have filed patent applications or otherwise wish to challenge our patents, we may have
to participate in interferences, post-grant reviews, inter parties reviews, derivation or other proceedings in the USPTO and other
patent offices to determine issues such as priority of claimed invention or validity of such patent applications as well as our
own patent applications and issued patents. Patents may also be circumvented, and our competitors may be able to independently
develop and commercialize similar drugs or mimic our technology, business model or strategy without infringing our patents. The
rights granted under any issued patents may not provide us with proprietary protection or competitive advantages against competitors
with similar technology.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 2pt; text-align: justify; text-indent: 34pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">We
may rely, in some limited circumstances, on unpatented trade secrets and know-how to protect aspects of our technology. However,
it is challenging to monitor and prevent the disclosure of trade secrets. We seek to protect our proprietary trade secrets and
know-how, in part, by entering into confidentiality agreements with consultants, scientific advisors and contractors and invention
assignment agreements with our employees. We also seek to preserve the integrity and confidentiality of our data and trade secrets
by maintaining physical security of our premises and physical and electronic security of our information technology systems. While
we have confidence in these individuals, organizations and systems, agreements or security measures may be breached, giving our
competitors knowledge of our trade secrets and know-how, and we may not have adequate remedies for any such breach, in which case
our business could be adversely affected. Our trade secrets will not prevent our competitors from independently discovering or
developing the same know-how. Although our agreements with our consultants, contractors or collaborators require them to provide
us only original work product and prohibit them from incorporating or using IP owned by others in their work for us, if they breach
these obligations, disputes may arise as to the rights in any know-how or inventions that arise from their work.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 2pt; text-align: justify; text-indent: 34pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">Our
commercial success will also depend in part on not infringing the proprietary rights of other parties. Although we seek to review
the patent landscape relevant to our technologies on an ongoing basis, we may become aware of a new patent which has been issued
to others with claims covering or related to aspects of one of our drug or device candidate. The issuance of such a patent could
require us to alter our development plans for that candidate, redesign the candidate, obtain a license from the patent holder
or cease development. Our inability to obtain a license to proprietary rights that we may require to develop or commercialize
any of our drug and device candidates would have a material adverse impact on us.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(See
&ldquo;Risk Factors &ndash; Risks Related to Our Intellectual Property&rdquo;)</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Trademarks
</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">As
at the date of this prospectus, we have four registered EU Trade Marks (&ldquo;EUTM&rdquo;) on &ldquo;Aptorum Therapeutics,&rdquo;
&ldquo;Videns Life Sciences&rdquo; and the company logos, and we are in the process of applying for registration of registered
trademarks in other jurisdictions including the U.S., United Kingdom, the PRC and Hong Kong.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">Specifically,
we own certain unregistered trademark rights or have submitted applications for trademarks in, for example, &ldquo;Aptorum Therapeutics,&rdquo;
&ldquo;Videns Life Sciences,&rdquo; &ldquo;Claves Life Sciences,&rdquo; &ldquo;Acticule,&rdquo; &ldquo;Nativus Life Sciences,&rdquo;
&ldquo;Scipio Life Sciences,&rdquo; &ldquo;Signate,&rdquo; &ldquo;Talem&rdquo; and our company logos.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">All
other trade names, trademarks and service marks of other companies appearing in this prospectus are the property of their respective
holders. Solely for convenience, the trademarks and trade names in this prospectus are referred to without the &reg; and &trade;
symbols, but such references should not be construed as any indicator that their respective owners will not assert, to the fullest
extent under applicable law, their rights thereto. We do not intend our use or display of other companies&rsquo; trademarks and
trade names to imply a relationship with, or endorsement or sponsorship of us by, any other companies.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<!-- Field: Page; Sequence: 93; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->85<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"><A HREF="#toc">Table of Contents</A></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Important
Advisors and Consultants to the Company</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">In
addition to Company management, the following individuals provide the Company with significant advice and insight in their respective
fields:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><I>Senior
Clinical Advisor of Aptorum Therapeutics Limited </I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>DR.
NISHANT AGRAWAL</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">Dr.
Agrawal, MD, has been serving as the Director of Head and Neck Surgical Oncology, and Professor of Surgery at The University of
Chicago School of Medicine since October 2015. He is specialized in management of patients with benign and malignant tumors of
the head and neck, and has been practicing Otolaryngology - Head and Neck Surgery, at The University of Chicago Medicine, and
Center for Advanced Medicine, both in Chicago since 2009.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">Dr.
Agrawal&rsquo;s work has achieved international recognition in the field of head and neck surgical oncology, as well as head and neck
cancer genetics. Under his leadership, a team of researchers completed a landmark study that examined the genome of head and neck
squamous cell carcinoma. His team has published extensively in the genomic landscapes of major head and neck cancers, including
esophageal squamous cell carcinoma, esophageal adenocarcinoma, medullary thyroid cancer, adenoid cystic carcinoma, and mucoepidermoid
carcinoma. Dr. Agrawal then applied these findings to identify tumor DNA as a biomarker that improves cancer diagnostics in the
saliva and plasma of patients with head and neck squamous cell carcinoma. His researches focus on the application of cancer genetics
to design diagnostic approaches to reduce morbidity and mortality from head and neck cancer.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">In
addition to his clinical and research contributions, Dr. Agrawal is an accomplished educator-teaching medical students, residents,
and fellows about the management of patients with head and neck cancer. Prior to joining the University of Chicago, Dr. Agrawal
was an associate professor at Johns Hopkins University, where he completed his medical training in 2001, followed by internship
and residency.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">In
addition, Dr. Agrawal was granted fellowships from the Memorial Sloan Kettering Cancer Center, New York (Head and Neck Surgical
Oncology), and from Johns Hopkins University School of Medicine, Baltimore (Molecular Genetics). He holds numerous Memberships
from accredited American medical associations and institutions.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">Specifically,
as a Senior Clinical Advisor, Dr. Agrawal supports our efforts to identify, develop and commercialize novel therapies for patients
and the healthcare industry. He provides a diverse collection of academic, industrial and regulatory expertise.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><I>Senior
Advisors of Aptorum Therapeutics Limited </I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>DR.
HENRY CHAN LIK YUEN</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">Dr.
Chan has been serving as an Assistant Dean (External Affairs) at the Faculty of Medicine at CUHK, and the Head of Division of
Gastroenterology and Hepatology, Department of Medicine and Therapeutics, since January 2013.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">Dr.
Chan specializes in Gastroenterology and Hepatology. Key areas of his research interest include viral hepatitis, liver fibrosis,
liver cancer, anti-viral therapy, and fatty liver disease. Currently, Dr. Chan is also the Director at the Institute of Digestive
Disease, the Director at the Centre for Liver Health, and the Director at the Office of Global Engagement. His other honorary
appointments include the Chairman for the Strategic and Technical Advisory Committee for Viral Hepatitis at the Western Pacific
Regional Office of World Health Organization (&ldquo;WHO&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">Dr.
Chan is a key investigator in over 30 Phase 1 to Phase 4 international trials on antiviral treatment of chronic hepatitis B and
C, and is the global lead author in publications on peginterferon-alfa, peginterferon-lambda, telbivudine, tenofovir disoproxil
fumarate, and tenofovir alafenamide for the treatment of viral hepatitis B. He has received numerous local, national, and international
research awards including the Excellent Research Award by the Food and Health Bureau, Hong Kong in 2010 and 2014, and the National
Award for Science and Technology Progress in 2012. He has published over 400 papers in peer-reviewed journals.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">Dr.
Chan graduated in medicine and completed his doctoral degree at CUHK in August 2001, where he was also appointed to a full professorship
in the Department of Medicine and Therapeutics in August 2008. He is currently a Fellow of the Hong Kong College of Physicians,
a Fellow of the Royal College of Physicians of Edinburgh and London, a fellow of the American Association for the Study of Liver
Diseases, and an Honorary Consultant at the Prince of Wales Hospital. Prior to this, he joined the staff of the Prince of Wales
Hospital in July 1993.<B></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">As
an expert in Gastroenterology and Hepatology, Dr. Chan is responsible for providing advice for Claves, our project company specializing
in modulating microbiota in the gastrointestinal tract for curing various diseases; and Scipio, our project company specializing
in the development of oncology products. At preclinical stage, Dr. Chan is providing advice as to different indications that our
product candidates are targeting for. With extensive experience in conducting clinical trials for pharmaceutical companies, Dr.
Chan will provide advice on the design of clinical trials for our products candidates at clinical stages.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B></B></FONT></P>

<!-- Field: Page; Sequence: 94; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->86<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"><A HREF="#toc">Table of Contents</A></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>DR.
PHILIP WY CHIU</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">Dr.
Philip Chiu has been a Professor of Department of Surgery, Institute of Digestive Disease since August 2010; the Director of CUHK
Jockey Club Minimal Invasive Surgical Skills Center since November 2011; the Director of CUHK Chow Yuk Ho Technology Center for
Innovative Medicine and the Assistant Dean (External Affairs), Faculty of Medicine, CUHK, since 2013.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">Dr.
Chiu graduated from the Faculty of Medicine, CUHK in 1994 with two scholarships. He became a fellow of the Royal College of Surgeons
of Edinburgh, Hong Kong Academy of Medicine in 2001 and received his Doctor of Medicine at CUHK in 2009. Dr. Chiu was the first
to perform endoscopic submucosal dissection (&ldquo;ESD&rdquo;) for the treatment of early GI cancers in Hong Kong. In 2010, he
performed the first Per-oral Endoscopic Myotomy (&ldquo;P.O.E.M.&rdquo;) in Hong Kong. His research interests include upper gastrointestinal
bleeding, esophageal cancer and minimally invasive and robotic esophagectomy, novel endoscopic technology for diagnosis of early
GI cancers, ESD and novel endoscopic procedures as well as Natural Orifices Transluminal Endoscopic Surgery (&ldquo;NOTES&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">Currently
Dr. Chiu is an honorary treasurer of the College of Surgeons of Hong Kong. He published over 100 peer-reviewed journals and four
book chapters. He has received numerous prestigious awards including State Scientific Technology and Progress Award from the PRC
in 2007 and 2nd class award in Technological Advancement, Ministry of Education of the PRC in 2011. Recently his research on P.O.E.M.
was awarded the best of DDW 2011 and the first prize of ASGE world cup of endoscopy 2012. He is currently an associate editor
of Digestive Endoscopy and co-editor of Endoscopy.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">As
a surgeon by training, especially in minimally invasive and robotic surgery, Dr. Chiu is providing advice for Signate, our project
company specializing in the development of surgical robots. Specifically, he is involved in the design of SLS-1 and will be involved
in the design of clinical trials at a later stage.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>DR.
VINCENT MOK CHUNG TONG</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">Dr.
Vincent Mok has been serving as the Assistant Dean (Admissions) at the Faculty of Medicine, CUHK since January 2014, the Head
of Division of Neurology of the Department of Medicine and Therapeutics, since December 2016 and has been appointed as the Mok
Hing Yiu Professor of Medicine since November 2017. He has also been serving in Master Programme in Stroke and Clinical Neurosciences
since July 2007.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">Dr.
Mok specializes in Neurology, Dementia, and Movement disorders. Key areas of research interest include Vascular Cognitive Impairment,
Cerebral Small Vessel Disease, Neuroimaging in Cognitive Impairment, and Parkinson&rsquo;s Disease. Dr. Mok has also been serving
as a Convener of Lui Che Woo Institute of Innovative Medicine - Brain Theme since January 2017, the Director of Therese Pei Fong
Chow Research Centre for Prevention of Dementia since May 2016, and Executive Committee Member of Chow Yuk Ho Technology Center
for Innovative Medicine since January 2015.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">Dr.
Mok&rsquo;s qualifications include: Doctor of Medicine at CUHK (December 2005), Fellow of the Royal College of Physicians (Edinburgh)
(July 2007), Fellow of the Hong Kong Academy of Medicine (December 2000), Fellow of the Hong Kong College of Physicians (July
2000), Member of the Royal College of Physicians (November 1996), and Bachelor of Medicine and Bachelor of Surgery (University
of Sydney) (April 1993).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">As
an expert in neurology, Dr. Mok is responsible for providing advice for Videns, our project company specializing in the development
of neurology products. At preclinical stage, Dr. Mok is providing directions in product development targeting different indications
related to neurodegenerative diseases. At a later stage, he will be involved in the clinical design once our candidates enter
clinical trials.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 95; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->87<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"><A HREF="#toc">Table of Contents</A></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><I>External
Experts serve as the members of Aptorum Therapeutics Limited&rsquo;s Scientific Assessment Committee</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">The
members of our Scientific Assessment Committee work together to provide valuable input from a scientific perspective towards target
acquisition or in-licensing opportunities of life science innovations. This committee, together with the Senior Clinical Advisors
and internal experts, performs an 8-Dimensions assessment process (Pharmacology/Animal efficacy, Medicinal Chemistry, Chemistry,
Manufacturing &amp; Control (CMC), Drug Metabolism and Pharmacokinetics (DMPK), Clinical Trials, Technology, Legal/IPs and Business/Financing)
that helps to evaluate the market potential and scientific quality of our product portfolio. After collecting all the advice from
different advisors and internal experts, the chairs of the Committee will jointly make decisions on licensing.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>DR.
WILLIAM WU KA KEI</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">Dr.
William Wu has been an Assistant Professor in the Department of Anaesthesia and Intensive Care at CUHK since December 2014. Prior
to this, Dr. Wu was appointed as a Research Assistant Professor in the Institute of Digestive Diseases at CUHK from December 2011
to November 2014. He is an expert in molecular pharmacology and toxicology. He has published extensively in cancer biomarkers
and novel therapeutics, with over 220 peer-reviewed journals published on international journals, including <I>Nature Communications</I>,
<I>Molecular Biology and Evolution</I>, <I>Autophagy</I>, <I>Cell Research</I>, and <I>Cancer Research</I>, and six book chapters
with citations over 6,000 and an h-index of 40 (Scopus). His research has been recognized both nationally and internationally.
He has earned his Fellowship of the Royal College of Pathologists (FRCPath) from his original works in toxicology, and has been
conferred the Young Research Award by CUHK, the First-Class Higher Education Outstanding Scientific Research Output Award (Natural
Science) by the Ministry of Education of the PRC, and the Second-Class State Natural Science Award.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">Dr.
Wu obtained his Ph.D. in Medical Sciences in December 2009 and received post-doctoral training from 2009 to 2011 in the Institute
of Digestive Diseases both from CUHK.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">As
a basic scientist in cancer biology, Dr. Wu is responsible for assessing pharmacology/animal efficacy of our potential drug candidates,
especially candidates for Scipio, our project company specializing in the development of oncology products.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>DR.
JASON Y. K. CHAN</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">Dr.
Jason Chan has been an Assistant Professor in the Department of Otorhinolaryngology, Head &amp; Neck Surgery at CUHK since September
2014. Between June 2013 and September 2014, Dr. Jason Chan satisfied the Hong Kong Medical Council&rsquo;s requirements to practice
medicine in Hong Kong and obtained his American Board certification while continuing his research interests. Dr. Chan graduated
from Guy&rsquo;s, King&rsquo;s and St Thomas&rsquo; School of Medicine in London in July 2005, followed by completion of specialist
training in Otolaryngology, Head and Neck surgery at the Johns Hopkins School of Medicine with advanced training in head and neck
surgery on microvascular reconstruction and robotics in June 2013.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">His
research interests include genomics, microbiome, diagnosis, treatment and surveillance of head and neck cancers and the development
of novel robotic applications for head and neck surgery.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">Dr.
Chan&rsquo;s qualifications include: Licentiate of Medical Council of Hong Kong, Bachelor of Medicine and Bachelor of Surgery
(London), Diplomate American Board of Otolaryngology, Head and Neck Surgery, Fellow of the Hong Kong College of Otorhinolaryngology,
Fellow of the Hong Kong Academy of Medicine (Otorhinolaryngology), and Fellow of the Royal College of Surgeons Edinburgh (Otolaryngology).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">As
an experienced user of surgical robots in conducting head and neck surgery, Dr. Chan is responsible for assessing technology related
to surgical robotics, especially candidates for Signate, our project company specializing in the development of surgical robots.</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<!-- Field: Page; Sequence: 96; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->88<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"><A HREF="#toc">Table of Contents</A></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>DR.
KA-WAI KWOK</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">Dr.
Ka-Wai Kwok has been serving as Assistant Professor in Department of Mechanical Engineering, HKU since August 2014. He has also
been serving as an Adjunct Assistant Professor in the School of Science and Engineering at The Chinese University of Hong Kong,
Shenzhen (&ldquo;CUHK SZ&rdquo;), since October 2016.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">His
research interests focus on surgical robotics, intra-operative medical image processing, and their uses of high-performance computing
techniques. To date, he has been involving in various designs of surgical robotic devices and interfaces for endoscopy, laparoscopy,
stereotactic and intra-cardiac catheter interventions. His works have been highly recognized and winning several awards from IEEE
international conferences in robotics and computing, including ICRA&rsquo;18, RCAR&rsquo;17, ICRA&rsquo;17, ICRA&rsquo;14, IROS&rsquo;13
and FCCM&rsquo;11, Hamlyn Symposium&rsquo;12 and &rsquo;08, and Surgical Robot Challenge&rsquo;16. He also became the recipient
of Early Career Awards 2015/16 offered by Research Grants Council of Hong Kong. He currently serves as associate editor for an
academic journal, &ldquo;Frontier in Robotics and AI&rdquo;.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">He
obtained his Ph.D. in The Hamlyn Centre for Robotic Surgery, Department of Computing, Imperial College London in March 2012, where
he continued research on surgical robotics as a postdoctoral fellow between March 2012 and May 2013 and obtained the Croucher
Foundation Fellowship between August 2013 and August 2014. This subsequently supported his research jointly hosted by The University
of Georgia and Brigham and Women&rsquo;s Hospital - Harvard Medical School.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">As
a mechanical engineer specializing in the design of surgical robotics, Dr. Kwok is responsible for assessing technology related
surgical robotics, especially candidates for Signate, our project company specializing in the development of surgical robots.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>DR.
KENNY YU KWOK HEI</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">Dr.
Kenny Yu was appointed as the NIHR Academic Clinical Lecturer at the University of Manchester in the United Kingdom in 2017.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">Dr.
Kenny Yu commenced specialist training in Neurosurgery at Salford Royal Hospital, United Kingdom in 2008 and attained his FRCS
(Surgical Neurology) specialist qualification in 2018. His research interests are in myeloid cell infiltration in malignant gliomas,
intra-tumoral delivery of therapeutics and in the application of advanced data analytical technology for biological and clinical
datasets. He completed his Ph.D. in 2016 at the Stem Cell and Neurotherapies Laboratory at the University of Manchester under
Prof Brian Bigger and subsequently completed a post-doctoral research fellowship at Dr. Peter Dirks laboratory in Toronto, Canada.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">Dr.
Yu&rsquo;s key areas of research interests include Neurosurgery, Neuro-oncology, Cancer Inflammation and Cancer Immunology.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">As
both a basic and clinical scientist, Dr. Yu is responsible for assessing pharmacology/animal efficacy and clinical trials of our
potential drug candidates, especially candidates for Scipio, our project company specializing in the development of oncology products;
and Videns, our project company specializing in the development of neurology products.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>DR.
OWEN KO HO</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">Dr.
Ko has been serving as a principal investigator and executive committee member at the Gerald Choa Neuroscience Center since 2017,
a principal investigator at the Li Ka Shing Institute of Health Sciences and a clinical lecturer (from 2016 to 2018) and Assistant
Professor (since 2018) in the Department of Medicine and Therapeutics, with all appointments at CUHK. Leading a team with diverse
expertise in biology, chemistry and engineering, his research work focuses on the principles by which neural circuits mediate
sensory perception and learning, as well as development of novel neuroimaging techniques.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">Dr.
Ko was admitted to the Bachelor of Medicine and Bachelor of Surgery Programme (MBChB) at CUHK in 2005. After completing his second
year of studies, he pursued a one-year Intercalated Bachelor of Medical Sciences (BMedSci), followed by a three-year Ph.D. program
in neuroscience at University College London (&ldquo;UCL&rdquo;) in the UK under the guidance of Professor Thomas Mrsic-Flogel.
In 2012, Dr. Ko returned to Hong Kong and completed clinical training in 2015. He has published two first-authored Nature papers
and one first-authored Nature Neuroscience paper from his Ph.D. studies. His breakthrough research has led to his runner-up award
of the 2014 Eppendorf &amp; Science Prize for Neurobiology, as the first awardee in Hong Kong.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">As
a neuroscientist and medical doctor, Dr. Ko is responsible for assessing pharmacology/animal efficacy and clinical trials of our
potential drug candidates, especially candidates for Videns, our project company specializing in the development of neurology
products.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>DR.
WAI-LUNG NG</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">Dr.
Wai-Lung Ng obtained his B.Sc. degree with a First-Class Honors in Chemistry from CUHK in 2010. With the support of the Hong Kong
Ph.D. Fellowship and T.C. Cheng Postgraduate Scholarship, he completed his Ph.D. studies at CUHK in 2014. He was a Fulbright Scholar
(2013-2014) at Massachusetts Institute of Technology (&ldquo;MIT&rdquo;), under the support from Lee Hysan Foundation and the
Fulbright Program. He was then recruited to University of Oxford as a Croucher Foundation Postdoctoral Fellow from 2014-2016.
He is currently a research fellow at Dana-Farber Cancer Institute/Harvard Medical School, researching in the field of chemical
biology and cancer epigenetics.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<!-- Field: Page; Sequence: 97; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->89<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"><A HREF="#toc">Table of Contents</A></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">Dr.
Ng has strong interest in understanding diseases at the molecular level with a goal of developing tools to diagnose and treat
them. His Ph.D. research focused on the synthesis of a new class of anti-diabetic agents, namely sodium-dependent glucose co-transporter
2 (&ldquo;SGLT2&rdquo;) inhibitors. His research work has led to the identification of several stable, potent and selective SGLT2
inhibitors that potentially provide an alternative solution for treating diabetes. The central aim of his current research is
to uncover the underlying mechanism of epigenetic regulations and to develop novel treatments for cancers and other human diseases.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">As
an organic/medicinal chemist by training, Dr. Ng is responsible for assessing medicinal chemistry and CMC of our potential drug
candidates.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>DR.
SUNNY WONG HEI</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">Dr.
Sunny Wong has been an Assistant Professor in the Department of Medicine and Therapeutics, and an investigator at the laboratory
of the Li Ka Shing Institute of Health Science at CUHK since December 2013. He is also the leader of the Clinical Metagenomics
Research Group, with a focus to study the mechanistic role and translational potential of host-microbial interactions in diseases.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">Dr.
Wong has been a specialist in Gastroenterology and Hepatology since September 2016, and is a Physician-Scientist with expertise
in genomics and molecular microbiology. He has published over 60 peer-reviewed journals in international journals, including the
New England Journal of Medicine, Nature Genetics, Nature Communications, Gastroenterology and Gut as of December 2017. He has
been an investigator in epidemiological studies and clinical trials, and a member of the local clinical research ethics committee
since 2016.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">Dr.
Wong&rsquo;s qualifications include: MBChB(Hons)(CUHK) (June 2006); DPhil (Oxon) (June 2010); MRCP (UK) (February 2012); FHKCP
(September 2016); FHKAM (Medicine) (December 2016); FRCP (Edin) (September 2017); FRCPath (February 2018).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">As
both a basic scientist and Gastroenterologist, Dr. Wong is responsible for assessing pharmacology/animal efficacy and clinical
trials of our potential drug candidates, especially candidates for Claves, our project company specializing in modulating microbiota
in the gastrointestinal tract for curing various diseases.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Competition</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">Our
industry is highly competitive and subject to rapid and significant change. While we believe that our development and commercialization
experience, scientific knowledge and industry relationships provide us with competitive advantages, we face competition from pharmaceutical
and biotechnology companies, including specialty pharmaceutical companies, and generic drug companies, academic institutions,
government agencies and research institutions.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">There
are a number of large pharmaceutical and biotechnology companies that currently market and sell drugs or are pursuing the development
of drugs and devices for the diagnosis and treatment of diseases for which we are developing products or technology. Moreover,
a number of additional drugs are currently in clinical trials and may become competitors if and when they receive regulatory approval.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">Many
of our competitors have longer operating histories, better name recognition, stronger management capabilities, better supplier
relationships, a larger technical staff and sales force and greater financial, technical or marketing resources than we do. Mergers
and acquisitions in the pharmaceutical and biotechnology industries may result in even more resources being concentrated among
a smaller number of our competitors. Our commercial opportunity could be reduced or eliminated if our competitors develop or market
products or other novel therapies that are more effective, safer or less costly than our current drug candidates, or any future
drug candidates we may develop, or obtain regulatory approval for their products more rapidly than we may obtain approval for
our current drug candidates or any such future drug candidates. Our success will be based in part on our ability to identify,
develop and manage a portfolio of drug and device candidates that are safer and more effective than competing products.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Government
Regulation</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 2pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">Government
authorities in the United States at the federal, state and local level and in other countries extensively regulate, among other
things, the research and clinical development, testing, manufacture, quality control, approval, labeling, packaging, storage,
record-keeping, promotion, advertising, distribution, post-approval monitoring and reporting, marketing, pricing, export and import
of drug and device products (&ldquo;Regulated Products&rdquo;), such as those we are developing. Generally, before a new Regulated
Product can be marketed, considerable data demonstrating its quality, safety and efficacy must be obtained, organized to address
the requirements of and in the format specific to each regulatory authority, submitted for review and approved by the regulatory
authority. This process is very lengthy and expensive, and success is uncertain.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">Regulated
Products are also subject to other federal, state and local statutes and regulations in the United States and other countries,
as applicable. The process of obtaining regulatory approvals and the subsequent compliance with appropriate federal, state, local
and foreign statutes and regulations require the expenditure of substantial time and financial resources. Failure to comply with
the applicable regulatory requirements at any time during the product development process, approval process or after approval,
may subject an applicant to administrative or judicial sanctions. These sanctions could include, among other actions, the regulatory
authority&rsquo;s refusal to approve pending applications, withdrawal of an approval, clinical holds, untitled or warning letters,
voluntary product recalls or withdrawals from the market, product seizures, total or partial suspension of production or distribution,
injunctions, disbarment, fines, refusals of government contracts, restitution, disgorgement, or civil or criminal penalties. Any
such administrative or judicial enforcement action could have a material adverse effect on us.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 2pt; text-align: justify; text-indent: 34pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<!-- Field: Page; Sequence: 98; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->90<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"><A HREF="#toc">Table of Contents</A></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 2pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">As
the Company&rsquo;s principal place of business is in Hong Kong, and because AML Clinic is located there, the Company is subject
to various Hong Kong laws and regulation covering its business activities there, described in further detail below. Also, the
Company anticipates that, if it obtains marketing approval for any of its drug and device candidates, it intends to focus its
marketing and sales efforts primarily in three regions: the United States, Europe and PRC. The regulatory framework for each of
these regions is described below.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 2pt; text-align: justify; text-indent: 34pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><I>U.S.
Drug Development Process</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 2pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">The
process of obtaining regulatory approvals and maintaining compliance with appropriate federal, state and local statutes and regulations
requires the expenditure of substantial time and financial resources. Failure to comply with the applicable U.S. requirements
at any time during the product development process, approval process, or after approval, may subject an applicant to administrative
or judicial sanctions or lead to voluntary product recalls. Administrative or judicial sanctions could include the FDA&rsquo;s
refusal to approve pending applications, withdrawal of an approval, a clinical hold, untitled or warning letters, product seizures,
total or partial suspension of production or distribution, injunctions, fines, refusals of government contracts, restitution,
disgorgement or civil or criminal penalties. The process required by the FDA before a drug may be marketed in the United States
generally involves the following:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 2pt; text-align: justify; text-indent: 20.25pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 0.5in; text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 0.25in; text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">completion
    of non-clinical laboratory tests, preclinical studies according to cGLP and manufacturing of clinical supplies according to
    cGMP;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">submission
    to the FDA of an IND, which must become effective before human clinical trials may begin;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">approval
    by an independent IRB, at each clinical site before each trial may be initiated;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">performance
    of adequate and well-controlled human clinical trials according to cGCP, to establish the safety and efficacy of the proposed
    product for its intended use;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">preparation
    and submission to the FDA of an NDA, for a drug;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">satisfactory
    completion of an FDA advisory committee review, if applicable;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">satisfactory
    completion of an FDA inspection of the manufacturing facility or facilities at which the product, or components thereof, are
    produced to assess compliance with cGMP; and</FONT></TD></TR>
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">payment
    of user fees and the FDA review and approval of the NDA.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 2pt; text-align: justify; text-indent: 34pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">Devices
are subject to different forms of testing and approval, but (except for certain laboratory-developed diagnostic tests) still require
satisfaction of various FDA requirements in order to be brought to market. As of the date of this prospectus, the device candidate
currently under development is SLS-1. We do not currently have a commercialization timeline for SLS-1 and cannot assure you that
SLS-1 will ever be ready for commercialization.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 2pt; text-align: justify; text-indent: -2pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">The
testing and approval process requires substantial time, effort and financial resources and we cannot be certain that any approvals
for our drug candidates, or any future drug candidates we may develop, will be granted on a timely basis, if at all.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 2pt; text-align: justify; text-indent: 34pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">Once
a drug candidate is identified for development, it enters the non-clinical testing stage. Non-clinical tests include laboratory
evaluations of product chemistry, toxicity, formulation and stability, as well as preclinical studies. An IND sponsor must submit
the results of the non-clinical tests, together with manufacturing information, analytical data and any available clinical data
or literature, to the FDA as part of the IND prior to commencing any testing in humans. An IND sponsor must also include a protocol
detailing, among other things, the objectives of the clinical trial, dosing procedures, subject selection and exclusion criteria,
the parameters to be used in monitoring safety, and the effectiveness criteria to be evaluated if the initial clinical trial lends
itself to an efficacy evaluation. Some non-clinical testing may continue even after the IND is submitted. The IND automatically
becomes effective 30 days after receipt by the FDA, unless the FDA raises concerns or questions related to a proposed clinical
trial and places the trial on a clinical hold within that 30-day time period. In such a case, the IND sponsor and the FDA must
resolve any outstanding concerns before the clinical trial can begin. Clinical holds also may be imposed by the FDA at any time
before or during clinical trials due to safety concerns or non-compliance, and may be imposed on all products within a certain
class of products. The FDA also can impose partial clinical holds, for example, prohibiting the initiation of clinical trials
for certain duration or for certain doses.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 2pt; text-align: justify; text-indent: 34pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<!-- Field: Page; Sequence: 99; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->91<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"><A HREF="#toc">Table of Contents</A></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 2pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">All
clinical trials must be conducted under the supervision of one or more qualified investigators in accordance with cGCP regulations.
These regulations include the requirement that all research subjects provide informed consent in writing before their participation
in any clinical trial. Further, an IRB representing each institution participating in a clinical trial must review and approve
the plan for any clinical trial before it commences at that institution, and the IRB must conduct continuing review and reapprove
the study at least annually. An IRB is responsible for protecting the rights of clinical trial subjects and considers, among other
things, whether the risks to individuals participating in the clinical trial are minimized and are reasonable in relation to anticipated
benefits. The IRB also approves the information regarding the clinical trial and the consent form that must be provided to each
clinical trial subject or his or her legal representative and must monitor the clinical trial until completed. Each new clinical
protocol and any amendments to the protocol must be submitted to the FDA for review, and to the IRBs for approval. Protocol detail,
among other things, includes the objectives of the clinical trial, testing procedures, sublease selection and exclusion criteria,
and the parameters to be used to monitor subject safety.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 2pt; text-align: justify; text-indent: 34pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">Human
clinical trials are typically conducted in three sequential phases that may overlap or be combined:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 2pt; text-indent: 34pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 0.5in; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 0.25in; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Phase
    1.</B> Phase 1 includes the initial introduction of an investigational new drug into humans. These studies are closely monitored
    and may be conducted in patients, but are usually conducted in healthy volunteer subjects. These studies are designed to determine
    the metabolic and pharmacologic actions of the drug in humans, the side effects associated with increasing doses, and, if
    possible, to gain early evidence on effectiveness. During Phase 1, sufficient information about the drug&rsquo;s pharmacokinetics
    and pharmacological effects should be obtained to permit the design of well-controlled, scientifically valid, Phase 2 studies.
    Phase 1 studies also evaluate drug metabolism, structure-activity relationships, and the mechanism of action in humans. These
    studies also determine which investigational drugs are used as research tools to explore biological phenomena or disease processes.
    The total number of subjects included in Phase 1 studies varies with the drug, but is generally in the range of twenty to
    eighty. </FONT></TD></TR>
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Phase
    2.</B> Phase 2 includes the early controlled clinical studies conducted to obtain some preliminary data on the effectiveness
    of the drug for a particular indication or indications in patients with the disease or condition. This phase of testing also
    helps determine the common short-term side effects and risks associated with the drug. Phase 2 studies are typically well-controlled,
    closely monitored, and conducted in a relatively small number of patients, usually involving several hundred people. </FONT></TD></TR>
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Phase
    3. </B>Phase 3 studies are expanded controlled and uncontrolled trials. They are performed after preliminary evidence suggesting
    effectiveness of the drug has been obtained in Phase 2, and are intended to gather the additional information about effectiveness
    and safety that is needed to evaluate the overall benefit-risk relationship of the drug. Phase 3 studies are designed to provide
    an adequate basis for extrapolating the results to the general population and transmitting that information in the physician
    labeling. Phase 3 studies usually include several hundred to several thousand people.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 2pt; text-align: justify; text-indent: 34pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">Progress
reports detailing the results of the clinical trials must be submitted at least annually to the FDA and safety reports must be
submitted to the FDA and clinical investigators within 15 calendar days for serious and unexpected suspected adverse events, any
clinically important increase in the rate of a serious suspected adverse reaction over that listed in the protocol or investigator&rsquo;s
brochure, or any findings from other studies or animal or in vitro testing that suggest a significant risk in humans exposed to
the drug candidate. Additionally, a sponsor must notify the FDA of any unexpected fatal or life-threatening suspected adverse
reaction no later than 7 calendar days after the sponsor&rsquo;s receipt of the information. There is no assurance that Phase
1, Phase 2 and Phase 3 testing can be completed successfully within any specified period, or at all. The FDA or the sponsor may
suspend or terminate a clinical trial at any time on various grounds, including a finding that the research subjects or patients
are being exposed to an unacceptable health risk. Similarly, an IRB can suspend or terminate approval of a clinical trial at its
institution if the clinical trial is not being conducted in accordance with the IRB&rsquo;s requirements or if the product has
been associated with unexpected serious harm to subjects.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 2pt; text-align: justify; text-indent: 34pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">Concurrent
with clinical trials, companies usually complete additional preclinical studies and must also develop additional information about
the chemistry and physical characteristics of the product and finalize a process for manufacturing the product in commercial quantities
in accordance with cGMP requirements. The manufacturing process must be capable of consistently producing quality batches of the
product drug and, among other things, the manufacturer must develop methods for testing the identity, strength, quality and purity
of the final product. Additionally, appropriate packaging must be selected and tested and stability studies must be conducted
to demonstrate that the product drug does not undergo unacceptable deterioration over its shelf life.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 2.15pt; text-align: justify; text-indent: 33.85pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">The
results of product development, non-clinical studies and clinical trials, together with other detailed information regarding the
manufacturing process, analytical tests conducted on the product, proposed labeling and other relevant information, are submitted
to the FDA as part of an NDA requesting approval to market the new drug. The FDA reviews all NDAs submitted within 60 days of
submission to ensure that they are sufficiently complete for substantive review before it accepts them for filing. If the submission
is accepted for filing, the FDA begins an in-depth substantive review.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 2.15pt; text-align: justify; text-indent: 33.85pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<!-- Field: Page; Sequence: 100; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->92<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"><A HREF="#toc">Table of Contents</A></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 2.15pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">The
approval process is lengthy and difficult and the FDA may refuse to approve an NDA if the applicable regulatory criteria are not
satisfied or may require additional clinical data or other data and information. Even if such data and information are submitted,
the FDA may ultimately decide that the NDA does not satisfy the criteria for approval. Data obtained from clinical trials are
not always conclusive, and the FDA may interpret data differently than we interpret the same data. The FDA will issue a complete
response letter if the agency decides not to approve the NDA in its present form. The complete response letter usually describes
all of the specific deficiencies that the FDA identified in the NDA that must be satisfactorily addressed before it can be approved.
The deficiencies identified may be minor, for example, requiring labeling changes, or major, for example, requiring additional
clinical trials. Additionally, the complete response letter may include recommended actions that the applicant might take to place
the application in a condition for approval. If a complete response letter is issued, the applicant may either resubmit the NDA,
addressing all of the deficiencies identified in the letter, or withdraw the application or request an opportunity for a hearing.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 2.15pt; text-align: justify; text-indent: 33.85pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">If
after such review a product receives regulatory approval, the approval may be significantly limited to specific diseases and dosages
or the indications for use may otherwise be limited, which could restrict the commercial value of the product. Further, the FDA
may require that certain contraindications, warnings or precautions be included in the product labeling. Any products for which
we receive the FDA approval would be subject to continuing regulation by the FDA, including, among other things, record-keeping
requirements, reporting of adverse experiences with the product, providing the FDA with updated safety and efficacy information,
product sampling and distribution requirements, complying with certain electronic records and signature requirements and complying
with the FDA promotion and advertising requirements. In addition, the FDA may require post-approval studies, including Phase 4
clinical trials, to further assess a product&rsquo;s safety and effectiveness after NDA approval and may require testing and surveillance
programs to monitor the safety of approved products that have been commercialized. The FDA also may conclude that an NDA may only
be approved with a Risk Evaluation and Mitigation Strategy designed to mitigate risks through, for example, a medication guide,
physician communication plan, or other elements to assure safe use, such as restricted distribution methods, patient registries
and other risk minimization tools.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 2pt"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><I>Post-Approval
Requirements</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 2pt; text-align: justify; text-indent: 34pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">Any
products for which we receive the FDA approval are subject to continuing regulation by the FDA, including, among other things,
record-keeping requirements, reporting of adverse experiences with the product, providing the FDA with updated safety and efficacy
information, product sampling and distribution requirements, complying with certain electronic records and signature requirements
and complying with the FDA promotion and advertising requirements. The FDA strictly regulates labeling, advertising, promotion
and other types of information on products that are placed on the market. Products may be promoted only for the approved indications
and in accordance with the provisions of the approved label. Further, manufacturers must continue to comply with cGMP requirements,
which are extensive and require considerable time, resources and ongoing investment to ensure compliance. In addition, changes
to the manufacturing process generally require prior the FDA approval before being implemented and other types of changes to the
approved product, such as adding new indications and additional labeling claims, are also subject to further the FDA review and
approval.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 2pt; text-align: justify; text-indent: 34pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">The
FDA may withdraw a product approval if compliance with regulatory requirements is not maintained or if problems occur after the
product reaches the market. Later discovery of previously unknown problems with a product may result in restrictions on the product&rsquo;s
marketing or even complete withdrawal of the product from the market. Further, the failure to maintain compliance with regulatory
requirements may result in administrative or judicial actions, such as fines, untitled or warning letters, holds on clinical trials,
product seizures, product detention or refusal to permit the import or export of products, refusal to approve pending applications
or supplements, restrictions on marketing or manufacturing, injunctions or consent decrees, or civil or criminal penalties, or
may lead to voluntary product recalls.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 2pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><I>Patent
Term Restoration and Marketing Exclusivity</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 2pt; text-align: justify; text-indent: 34pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">Because
drug approval can take an extended period of time, there may be limited remaining life for the patents covering the approved drug,
meaning that the company has limited time to use the patents to protect the sponsor&rsquo;s exclusive rights to make, use and
sell that drug. In such a case, U.S. patents may be eligible for limited patent term extension under the Drug Price Competition
and Patent Term Restoration Act of 1984, commonly referred to as the Hatch-Waxman Act. The Hatch-Waxman Act permits a patent restoration
term of up to five years as compensation for patent term lost during product development and the FDA regulatory review process.
However, patent term restoration cannot extend the remaining term of a patent beyond a total of 14 years from the product&rsquo;s
approval date.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 2pt; text-align: justify; text-indent: 34pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">In
addition, the FDCA provides a five-year period of non-patent marketing exclusivity within the United States to the first applicant
to gain approval of an NDA for a new chemical entity. A drug is a new chemical entity if the FDA has not previously approved any
other new drug containing the same active moiety, which is the molecule or ion responsible for the action of the drug substance.
During the exclusivity period, the FDA may not accept for review an abbreviated new drug application (&ldquo;ANDA&rdquo;) or a
505(b)(2) NDA submitted by another company for another version of such drug where the applicant does not own or have a legal right
of reference to all the data required for approval.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">In
the future, if appropriate, we intend to apply for restorations of patent term and/or marketing exclusivity for some of our products;
however, there can be no assurance that any such extension or exclusivity will be granted to us.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 2pt; text-align: justify; text-indent: 34pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<!-- Field: Page; Sequence: 101; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->93<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"><A HREF="#toc">Table of Contents</A></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 2pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><I>Disclosure
of Clinical Trial Information</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 2pt; text-align: justify; text-indent: 34pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">Sponsors
of clinical trials of the FDA-regulated products, including drugs are required to register and disclose certain clinical trial
information, which is publicly available at www.clinicaltrials.gov. Information related to the product, patient population, phase
of investigation, study sites and investigators, and other aspects of the clinical trial is then made public as part of the registration.
Sponsors are also obligated to disclose the results of their clinical trials after completion. Disclosure of the results of these
trials can be delayed until the new product or new indication being studied has been approved. Competitors may use this publicly
available information to gain knowledge regarding the progress of development programs.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 2pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><I>Pharmaceutical
Coverage, Pricing and Reimbursement</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 2pt; text-align: justify; text-indent: 34pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">Much
of the revenue generated by new Regulated Products depends on the willingness of third-party payors to reimburse the price of
the product. Significant uncertainty exists as to the coverage and reimbursement status of any products for which we may obtain
regulatory approval. In the United States, sales of any products for which we may receive regulatory approval for commercial sale
will depend in part on the availability of coverage and reimbursement from third-party payors. Third-party payors include government
authorities, managed care providers, private health insurers and other organizations. The process for determining whether a payor
will provide coverage for a product may be separate from the process for setting the reimbursement rate that the payor will pay
for the product. Third-party payors may limit coverage to specific products on an approved list, or formulary, which is not required
to include all of the FDA-approved products for a particular indication. Moreover, a payor&rsquo;s decision to provide coverage
for a product does not imply that an adequate reimbursement rate will be approved. Adequate third-party reimbursement may not
be available to enable us to maintain price levels sufficient to realize an appropriate return on our investment in product development.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 2pt; text-align: justify; text-indent: 34pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">Third-party
payors are increasingly challenging the price and examining the medical necessity and cost- effectiveness of medical products
and services, in addition to their safety and efficacy. To obtain coverage and reimbursement for any product that might be approved
for sale, we may need to conduct expensive pharmacoeconomic studies in order to demonstrate the medical necessity and cost-effectiveness
of any products, in addition to the costs required to obtain regulatory approvals. Our product candidates may not be considered
medically necessary or cost-effective. If third-party payors do not consider a product to be cost-effective compared to other
available therapies, they may not cover the product after approval as a benefit under their plans or, if they do, the level of
payment may not be sufficient to allow a company to sell its products at a profit.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 2pt; text-align: justify; text-indent: 34pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">The
U.S. government and state legislatures have shown significant interest in implementing cost containment programs to limit the
growth of government-paid health care costs, including price controls, restrictions on reimbursement and requirements for substitution
of generic products for branded prescription drugs. Adoption of government controls and measures, and tightening of restrictive
policies in jurisdictions with existing controls and measures, could limit payments for pharmaceuticals.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 2pt; text-align: justify; text-indent: 34pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">Even
if favorable coverage and reimbursement status is attained for one or more products for which we receive regulatory approval,
less favorable coverage policies and reimbursement rates may be implemented in the future. Unfavorable coverage or reimbursement
policies regarding any of the Company&rsquo;s products would have a material adverse impact on the value of that product.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 2pt"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><I>Other
Healthcare Laws and Compliance Requirements</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 2pt; text-align: justify; text-indent: 34pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">If
we obtain regulatory approval of our products, we may be subject to various federal and state laws targeting fraud and abuse in
the healthcare industry. These laws may impact, among other things, our proposed sales, marketing and education programs. In addition,
we may be subject to patient privacy regulation by both the federal government and the states in which we conduct our business.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 2pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<!-- Field: Page; Sequence: 102; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->94<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"><A HREF="#toc">Table of Contents</A></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 2pt"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><I>Patient
Protection and the Affordable Care Act</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 2pt; text-align: justify; text-indent: 34pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">The
Affordable Care Act, enacted in March 2010, includes measures that have or will significantly change the way health care is financed
in the United States by both governmental and private insurers. Among the provisions of the Affordable Care Act of greatest importance
to the pharmaceutical industry are the following:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 2.15pt; text-align: justify; text-indent: 20.15pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 0.5in; text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 0.25in; text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    Medicaid Drug Rebate Program requires pharmaceutical manufacturers to enter into and have in effect a national rebate agreement
    with the Secretary of the Department of Health and Human Services as a condition for states to receive federal matching funds
    for the manufacturer&rsquo;s outpatient drugs furnished to Medicaid patients. The Affordable Care Act increased pharmaceutical
    manufacturers&rsquo; rebate liability on most branded prescription drugs from 15.1% of the average manufacturer price to 23.1%
    of the average manufacturer price, added a new rebate calculation for line extensions of solid oral dosage forms of branded
    products, and modified the statutory definition of average manufacturer price. The Affordable Care Act also expanded the universe
    of Medicaid utilization subject to drug rebates by requiring pharmaceutical manufacturers to pay rebates on Medicaid managed
    care utilization and expanding the population potentially eligible for Medicaid drug benefits.</FONT></TD></TR>
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
    order for a pharmaceutical product to receive federal reimbursement under the Medicare Part B and Medicaid programs or to
    be sold directly to U.S. government agencies, the manufacturer must extend discounts to entities eligible to participate in
    the 340B drug pricing program. The Affordable Care Act expanded the types of entities eligible to receive discounted 340B
    pricing.</FONT></TD></TR>
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    Affordable Care Act imposed a requirement on manufacturers of branded drugs to provide a 50% discount off the negotiated price
    of branded drugs dispensed to Medicare Part D patients in the coverage gap (i.e., the &ldquo;donut hole&rdquo;).</FONT></TD></TR>
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    Affordable Care Act imposed an annual, non-deductible fee on any entity that manufactures or imports certain branded prescription
    drugs, apportioned among these entities according to their market share in certain government healthcare programs, although
    this fee does not apply to sales of certain products approved exclusively for orphan indications.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 2pt; text-align: justify; text-indent: 34pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 2pt; text-align: justify; text-indent: 34pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">In
addition to these provisions, the Affordable Care Act established a number of bodies whose work may have a future impact on the
market for certain pharmaceutical products. These include the Patient-Centered Outcomes Research Institute, established to oversee,
identify priorities in, and conduct comparative clinical effectiveness research, the Independent Payment Advisory Board, which
has authority to recommend certain changes to the Medicare program to reduce expenditures by the program, and the Center for Medicare
and Medicaid Innovation within the Centers for Medicare and Medicaid Services, to test innovative payment and service delivery
models to lower Medicare and Medicaid spending.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 2pt; text-align: justify; text-indent: 34pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 2pt; text-align: justify; text-indent: 34pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">These
and other laws may result in additional reductions in healthcare funding, which could have a material adverse effect on customers
for our product candidates, if we gain approval for any of them. Although we cannot predict the full effect on our business of
the implementation of existing legislation or the enactment of additional legislation pursuant to healthcare and other legislative
reform, we believe that legislation or regulations that would reduce reimbursement for, or restrict coverage of, our products
could adversely affect how much or under what circumstances healthcare providers will use our product candidates if we gain approval
for any of them.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>U.S.
Medical Device Regulatory Approval Process </B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">Medical
Devices are subject to different forms of testing and approval, and require satisfaction of various FDA requirements including
the Food, Drug and Cosmetic Act (FDCA) in order to be brought to market.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 2pt; text-align: justify; text-indent: 34pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">The
two primary types of FDA marketing authorization applicable to a medical device are premarket notification, also called 510(k)
clearance, and premarket approval. The type of marketing authorization is generally linked to the classification of the device.
The FDA classifies medical devices into one of three classes &mdash; Class I, Class II or Class III &mdash; based on the degree
of risk the FDA determines to be associated with a device and the level of regulatory control deemed necessary to ensure the device&rsquo;s
safety and effectiveness. Devices requiring fewer controls because they are deemed to pose lower risk are placed in Class I or
II. Class I devices are deemed to pose the least risk and are subject only to general controls applicable to all devices, such
as requirements for device labeling, premarket notification, and adherence to the FDA&rsquo;s Good Manufacturing Practices. Class II
devices are intermediate risk devices that are subject to general controls and may also be subject to special controls such as
performance standards, product-specific guidance documents, special labeling requirements, patient registries, or post-market
surveillance. Class III devices are those for which insufficient information exists to assure safety and effectiveness solely
through general controls or if the device is a life-sustaining, life-supporting or a device of substantial importance in preventing
impairment of human health, or which presents a potential, unreasonable risk of illness or injury and special controls are not
adequate to assure safety and effectiveness.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 103; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->95<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"><A HREF="#toc">Table of Contents</A></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">Most
Class I devices and some Class II devices are exempted by regulation from the 510(k) clearance requirement and can be marketed
without prior authorization from the FDA. Most Class II devices (and certain Class I devices that are not exempt) are eligible
for marketing through the 510(k) clearance pathway. By contrast, devices placed in Class III generally require premarket approval
or 510(k) de novo clearance prior to commercial marketing. The premarket approval process is more stringent, time-consuming, and
expensive than the 510(k) clearance process. However, the 510(k) clearance process has also become increasingly stringent and
expensive.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">510(k)
Clearance Pathway. When a 510(k) clearance is required, a premarket notification must be submitted to the FDA demonstrating that
a proposed device is &ldquo;substantially equivalent&rdquo; to a previously cleared and legally marketed 510(k) device or a device
that was in commercial distribution before May 28, 1976 for which the FDA has not yet called for the submission of a premarket
approval application, which is commonly known as the &ldquo;predicate device.&rdquo; A device is substantially equivalent if, with
respect to the predicate device, it has the same intended use and has either (i) the same technological characteristics or (ii)
different technological characteristics and the information submitted demonstrates that the device is as safe and effective as
a legally marked device and does not raise different questions of safety or effectiveness. By law, the FDA is required to clear
or deny a 510(k) premarket notification within 90 days of submission of the application. As a practical matter, clearance often
takes significantly longer. The FDA may require further information, including clinical data, to make a determination regarding
substantial equivalence. If the FDA determines that the device, or its intended use, is not substantially equivalent to a previously-cleared
device or use, the FDA will issue a not substantially equivalent decision. This means the device cannot be cleared through the
510k process and will require marketing authorization through the premarket approval pathway.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">Premarket
Approval Pathway. A premarket approval application must be submitted to the FDA if the device cannot be cleared through the 510(k)
process. The premarket approval application process is much more demanding than the 510(k) premarket notification process and
requires the payment of significant user fees. A premarket approval application must be supported by valid scientific evidence,
which typically requires extensive data, including but not limited to technical, preclinical, clinical trials, manufacturing and
labeling to demonstrate to the FDA&rsquo;s satisfaction reasonable evidence of safety and effectiveness of the device. The FDA has 45
days from its receipt of a premarket approval application to determine whether the application will be accepted for filing based
on the FDA&rsquo;s threshold determination that it is sufficiently complete to permit substantive review. After the FDA determines that
the application is sufficiently complete to permit a substantive review, the FDA will accept the application and begin its in-depth
review. The FDA has 180 days to review an &ldquo;accepted&rdquo; premarket approval application, although this process typically
takes significantly longer and may require several years to complete. During this review period, the FDA may request additional
information or clarification of the information already provided. Also, an advisory panel of experts from outside the FDA may
be convened to review and evaluate the application and provide recommendations to the FDA as to the approvability of the device.
In addition, the FDA will conduct a preapproval inspection of the manufacturing facility to ensure compliance with quality system
regulations. The FDA may delay, limit or deny approval of a premarket approval application for many reasons, including:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%"><TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font-family: Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.25in; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#9679;</FONT></TD><TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">failure
                                         of the applicant to demonstrate that there is reasonable assurance that the medical device
                                         is safe or effective under the conditions of use prescribed, recommended or suggested
                                         in the proposed labeling;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
<TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
<TD STYLE="font-family: Times New Roman, Times, Serif"></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#9679;</FONT></TD><TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">insufficient
                                         data from the preclinical studies and clinical trials;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
<TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
<TD STYLE="font-family: Times New Roman, Times, Serif"></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#9679;</FONT></TD><TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">the
                                         manufacturing processes, methods, controls or facilities used for the manufacture, processing,
                                         packing or installation of the device do not meet applicable requirements. If the FDA
                                         evaluations of both the premarket approval application and the manufacturing facilities
                                         are favorable, the FDA will either issue an approval order or an approvable letter, which
                                         usually contains a number of conditions that must be met in order to secure final approval
                                         of the premarket approval application. If the FDA&rsquo;s evaluation of the premarket approval
                                         application or manufacturing facilities is not favorable, the FDA will deny approval
                                         of the premarket approval application or issue a not approvable letter. A not approvable
                                         letter will outline the deficiencies in the application and, where practical, will identify
                                         what is necessary to make the premarket approval application. The FDA may also determine
                                         that additional clinical trials are necessary, in which case the premarket approval application
                                         may be delayed for several months or years while the trials are conducted and then the
                                         data submitted in an amendment to the premarket approval application. Once granted, a
                                         premarket approval application may be withdrawn by the FDA if compliance with post approval
                                         requirements, conditions of approval or other regulatory standards is not maintained
                                         or problems are identified following initial marketing.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 104; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->96<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"><A HREF="#toc">Table of Contents</A></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">Clinical
Trials. Clinical trials are almost always required to support premarket approval and are sometimes required for 510(k) clearance.
In the United States, these trials generally require submission of an application for an Investigational Device Exemption, or
IDE, to the FDA. The IDE application must be supported by appropriate data, such as animal and laboratory testing results, showing
it is safe to test the device in humans and that the testing protocol is scientifically sound. The FDA must approve the IDE in
advance of trials for a specific number of patients unless the product is deemed a non-significant risk device eligible for more
abbreviated IDE requirements or the clinical investigation is exempt from the IDE regulations. Clinical trials for significant
risk devices may not begin until the IDE application is approved by the FDA and the appropriate institutional review boards, or
IRBs, at the clinical trial sites. The applicant, the FDA or the IRB at each site at which a clinical trial is being performed
may suspend a clinical trial at any time for various reasons, including a belief that the risks to study subjects outweigh the
benefits. Even if a trial is completed, the results of clinical testing may not demonstrate the safety and efficacy of the device,
may be equivocal or may otherwise not be sufficient to obtain approval or clearance of the product.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">Both
the 510(k) and premarket approval processes can be expensive and lengthy and require the payment of significant fees, unless an
exemption applies. The FDA&rsquo;s 510(k) clearance process usually takes from approximately three to 12 months, but may take longer.
The process of obtaining a premarket approval is much more costly and uncertain than the 510(k) clearance process and generally
takes from approximately one to five years, or longer, from the time the application is submitted to the FDA until an approval
is obtained. The process of obtaining regulatory clearances or approvals to market a medical device can be costly and time consuming,
and the applicant may not be able to obtain these clearances or approvals on a timely basis, if at all.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">As
of the date of this prospectus, our sole device candidate currently under development is SLS-1, which is a cardiovascular robotic
surgical catheter conventionally classified as a <FONT STYLE="background-color: #F9F9F3">cardiovascular steerable catheter.</FONT>
We do not currently have a commercialization timeline for SLS-1 and cannot assure you that SLS-1 will ever be ready for commercialization.
If we are ready to seek regulatory approval for the SLS-1 device in the U.S., we expect that the FDA will classify it as a Class
II non-exempted device requiring premarket clearance under Section 510(k) of the FDCA. If our device cannot clear through the
510(k) process, we will need to obtain marketing authorization through the premarket approval pathway, which will be more costly,
lengthy and uncertain.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>European
Union Regulation</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><I>Regulation
in the European Union </I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 2pt; text-align: justify; text-indent: 34pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">The
process governing approval of medicinal products in the EU generally follows the same lines as in the United States. It entails
satisfactory completion of pharmaceutical development, non-clinical studies and adequate and well-controlled clinical trials to
establish the safety and efficacy of the medicinal product for each proposed indication. It also requires the submission to relevant
competent authorities for clinical trials authorization and to the European Medicines Authority, or EMA, for a marketing authorization
application, or MAA, and granting of a marketing authorization by these authorities before the product can be marketed and sold
in the EU.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><I>Clinical
Trial Approval</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 2pt; text-align: justify; text-indent: 34pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 2pt; text-align: justify; text-indent: 34pt"><FONT STYLE="font-family: Times New Roman, Times, Serif"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Pursuant to the currently
applicable Clinical Trials Directive 2001/20/EC and the Directive 2005/28/EC on cGCP, a system for the approval of clinical trials
in the EU (the equivalent of the IND process in the United States) has been implemented through national legislation of the EU
member states. Under this system, an applicant must obtain approval from the competent national authority of an EU member state
in which the clinical trial is to be conducted or in multiple EU member states if the clinical trial is to be conducted in a number
of EU member states. Furthermore, the applicant may only start a clinical trial at a specific study site after the independent
ethics committee has issued a favorable opinion. The clinical trial application, or CTA, must be accompanied by an investigational
medicinal product dossier with supporting information prescribed by Directive 2001/20/EC and Directive 2005/28/EC and corresponding
national laws of the EU member states and further detailed in applicable guidance documents.</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 2pt; text-align: justify; text-indent: 34pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<!-- Field: Page; Sequence: 105; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->97<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"><A HREF="#toc">Table of Contents</A></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 2pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">In
April 2014, the EU adopted a new Clinical Trials Regulation (EU) No 536/2014, which is set to replace the current Clinical Trials
Directive 2001/20/EC. It is expected that the new Clinical Trials Regulation will apply in 2019. It will overhaul the current
system of approvals for clinical trials in the EU. Specifically, the new regulation, which will be directly applicable in all
EU member states, aims at simplifying and streamlining the approval of clinical trials in the EU. For instance, the new Clinical
Trials Regulation provides for a streamlined application procedure using a single entry point and strictly defined deadlines for
the assessment of clinical trial applications.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><I>Marketing
Authorization</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 2pt; text-align: justify; text-indent: 34pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">To
obtain a marketing authorization for a product under the EU regulatory system (the equivalent of the NDA process in the United
States), an applicant must submit an MAA, either under a centralized procedure administered by the EMA or one of the procedures
administered by competent authorities in EU member states (decentralized procedure, national procedure, or mutual recognition
procedure). A marketing authorization may be granted only to an applicant established in the EU. Regulation (EC) No. 1901/2006
provides that prior to obtaining a marketing authorization in the EU, an applicant must demonstrate compliance with all measures
included in an EMA-approved Pediatric Investigation Plan, or PIP, covering all subsets of the pediatric population, unless the
EMA has granted a product-specific waiver, class waiver, or a deferral for one or more of the measures included in the PIP.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">The
centralized procedure provides for the grant of a single marketing authorization by the European Commission that is valid for
all EU member states. Pursuant to Regulation (EC) No. 726/2004, the centralized procedure is compulsory for specific products,
including for medicines produced by certain biotechnological processes, products designated as orphan medicinal products, advanced
therapy products and products with a new active substance indicated for the treatment of certain diseases, including products
for the treatment of cancer. For products with a new active substance indicated for the treatment of other diseases and products
that are highly innovative or for which a centralized process is in the interest of patients, the centralized procedure may be
optional.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">Under
the centralized procedure, the Committee for Medicinal Products for Human Use, or the CHMP, established by the EMA is responsible
for conducting the assessment of a product to define its risk/benefit profile. Under the centralized procedure, the maximum timeframe
for the evaluation of an MAA is 210 days, excluding clock stops when additional information or written or oral explanation is
to be provided by the applicant in response to questions of the CHMP. Accelerated evaluation may be granted by the CHMP in exceptional
cases, when a medicinal product is of major interest from the point of view of public health and, in particular, from the viewpoint
of therapeutic innovation.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">If
the CHMP accepts such a request, the time limit of 210 days will be reduced to 150 days, but it is possible that the CHMP may
revert to the standard time limit for the centralized procedure if it determines that it is no longer appropriate to conduct an
accelerated assessment.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><I>Periods
of Authorization and Renewals</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">A
marketing authorization is valid for five years, in principle, and it may be renewed after five years on the basis of a reevaluation
of the risk benefit balance by the EMA or by the competent authority of the authorizing Member State. To that end, the marketing
authorization holder must provide the EMA or the competent authority with a consolidated version of the file in respect of quality,
safety and efficacy, including all variations introduced since the marketing authorization was granted, at least six months before
the marketing authorization ceases to be valid. Once renewed, the marketing authorization is valid for an unlimited period, unless
the European Commission or the competent authority decides, on justified grounds relating to pharmacovigilance, to proceed with
one additional five-year renewal period. Any authorization that is not followed by the placement of the drug on the EU market
(in the case of the centralized procedure) or on the market of the authorizing Member State within three years after authorization
ceases to be valid.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><I>Regulatory
Requirements after Marketing Authorization</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">Following
approval, the holder of the marketing authorization is required to comply with a range of requirements applicable to the manufacturing,
marketing, promotion and sale of the medicinal product. These include compliance with the EU&rsquo;s stringent pharmacovigilance
or safety reporting rules, pursuant to which post-authorization studies and additional monitoring obligations can be imposed.
In addition, the manufacturing of authorized products, for which a separate manufacturer&rsquo;s license is mandatory, must also
be conducted in strict compliance with the EMA&rsquo;s cGMP requirements and comparable requirements of other regulatory bodies
in the EU, which mandate the methods, facilities and controls used in manufacturing, processing and packing of drugs to assure
their safety and identity. Finally, the marketing and promotion of authorized products, including industry-sponsored continuing
medical education and advertising directed toward the prescribers of drugs and/or the general public, are strictly regulated in
the EU under Directive 2001/83EC, as amended.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<!-- Field: Page; Sequence: 106; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->98<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"><A HREF="#toc">Table of Contents</A></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><I>Orphan
Drug Designation and Exclusivity&#9;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">Regulation
(EC) No. 141/2000 and Regulation (EC) No. 847/2000 provide that a product can be designated as an orphan drug by the European
Commission if its sponsor can establish: that the product is intended for the diagnosis, prevention or treatment of (1) a life-threatening
or chronically debilitating condition affecting not more than five in ten thousand persons in the EU when the application is made,
or (2) a life-threatening, seriously debilitating or serious and chronic condition in the EU and that without incentives it is
unlikely that the marketing of the drug in the EU would generate sufficient return to justify the necessary investment. For either
of these conditions, the applicant must demonstrate that there exists no satisfactory method of diagnosis, prevention, or treatment
of the condition in question that has been authorized in the EU or, if such method exists, the drug has to be of significant benefit
compared to products available for the condition.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">An
orphan drug designation provides a number of benefits, including fee reductions, regulatory assistance and the possibility to
apply for a centralized EU marketing authorization. Marketing authorization for an orphan drug leads to a ten-year period of market
exclusivity. During this market exclusivity period, neither the EMA nor the European Commission or the EU member states can accept
an application or grant a marketing authorization for a &ldquo;similar medicinal product&rdquo;. A &ldquo;similar medicinal product&rdquo;
is defined as a medicinal product containing a similar active substance or substances as contained in an authorized orphan medicinal
product, and which is intended for the same therapeutic indication. The market exclusivity period for the authorized therapeutic
indication may, however, be reduced to six years if, at the end of the fifth year, it is established that the product no longer
meets the criteria for orphan drug designation because, for example, the product is sufficiently profitable not to justify market
exclusivity.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">As
in the United States, there is a separate regulatory framework for approval of medical devices. If the Company determines to commercialize
SLS-1 or another medical device, it will become subject to all of the requirements for approval required by those regulations.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>PRC
Regulation</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">In
order to protect our potential market in the PRC, we have obtained an exclusive license of certain PRC patents directed to certain
of the drug candidates that we are developing and are currently seeking approval of additional patent and other IP filings in
the PRC. We do not otherwise conduct business in the PRC. Seeking IP approval in the PRC subjects us to some of the rules and
practices of the PRC government. Since the Company intends eventually to market its products in the PRC, at least some of our
drug candidates may become subject to regulatory approval and marketing authorization in the PRC.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Hong
Kong Regulation </B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">The
operations of AML Clinic in Hong Kong are subject to certain general laws and regulations in relation to Chief Medical Professionals,
trade description and safety of consumer goods, medical advertisement and importation, exportation, dealing in and sale of pharmaceutical
products and drugs.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><I>Medical
Clinics Ordinance</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">The
Medical Clinics Ordinance provides for the registration, control and inspection of medical clinics. It requires a medical clinic
to be registered, with name and address and other prescribed particulars. &ldquo;Medical clinic&rdquo; means any premises used
or intended to be used for the medical diagnosis or treatment of persons suffering from, or believed to be suffering from, any
disease, injury or disability of mind or body, with specific exceptions, including private consulting rooms used exclusively by
registered medical practitioners in the course of their practice on their own account and not bearing any title or description
which includes the word &ldquo;clinic&rdquo; or &ldquo;polyclinic&rdquo; in the English language.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">The
application of registration may be refused if:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 48px; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 30px; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    income derived or to be derived from the establishment or operation of the clinic is not, or will not be, applied solely towards
    the promotion of the objects of the clinic; or</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 48px; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 30px; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">any
    portion of such income, except payment of remuneration to employed registered medical practitioners, nurses and menial servants,
    will be paid by way of dividend, bonus or otherwise howsoever by way of profit to the applicant himself, or to any persons
    properly so employed, or to any other persons howsoever.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">We
do not believe that the Medical Clinic Ordinance is applicable to the business of our Group, having considered, among others,
the following:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 48px; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 30px; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii)</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    legislative intent behind the Medical Clinics Ordinance was to provide for registration of non-profit making clinics;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<!-- Field: Page; Sequence: 107; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->99<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"><A HREF="#toc">Table of Contents</A></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 48px; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 30px; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iv)</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    Food and Health Bureau of Hong Kong published a consultation document, &ldquo;Regulation of Private Healthcare Facilities&rdquo;
    in 2014 which specifically states that the Medical Clinics Ordinance and the Code of Practice For Clinics Registered Under
    The Medical Clinics Ordinance (Chapter 343 of the Laws of Hong Kong) set out the regulatory framework for non-profit-making
    medical clinics and that other private healthcare facilities, such as ambulatory medical centers and clinics operated by medical
    groups or individual medical practitioners, are not subject to direct statutory control beyond the regulation of an individual&rsquo;s
    professional practice; and</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 48px; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 30px; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(v)</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
    business is one which makes and intends to continue making profit as a listed entity. The payment of bonuses to some of our
    Hong Kong Doctors is clearly a reflection of the profit-making nature of our business.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">Hence,
we do not believe that AML Clinic is required to be registered under the Medical Clinics Ordinance.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><I>Waste
Disposal Ordinance</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">The
Waste Disposal Ordinance (Chapter 354 of the Laws of Hong Kong) (&ldquo;WDO&rdquo;) and the Waste Disposal (Clinical Waste) (General)
Regulation (Chapter 354O of the Laws of Hong Kong) (the &ldquo;WDR&rdquo;) provide for, among others, the control and regulation
of the production, storage, collection and disposal of clinical waste.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">Under
the WDO, clinical waste means waste consisting of any substance, matter or thing generated in connection with:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 0.5in; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 0.25in; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a
    dental, medical, nursing or veterinary practice;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 0.5in; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 0.25in; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">any
    other practice, or establishment (howsoever described), that provides medical care and services for the sick, injured, infirm
    or those who require medical treatment;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 0.5in; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 0.25in; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">dental,
    medical, nursing, veterinary, pathological or pharmaceutical research; or</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 0.5in; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 0.25in; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a
    dental, medical, veterinary or pathological laboratory practice,</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">and
which consists wholly or partly of any of the materials specified in one or more of the groups listed below:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 0.5in; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 0.25in; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">used
    or contaminated sharps;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 0.5in; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 0.25in; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">laboratory
    waste;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 0.5in; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 0.25in; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">human
    and animal tissues;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 0.5in; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 0.25in; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">infectious
    materials;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 0.5in; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 0.25in; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">dressings;
    and</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 0.5in; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 0.25in; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">such
    other wastes as specified by the Director of the Environmental Protection Department (&ldquo;EPD&rdquo;) of Hong Kong.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">Given
the medical services provided by AML Clinic and the research works in our R&amp;D Center may produce used or contaminated sharps
such as syringes and needles as well as dressings, we are subject to WDO, WDR and the Code of Practice.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Rest
of the World Regulation</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">For
other countries in the world, the requirements governing the conduct of clinical trials, medical product licensing, pricing and
reimbursement vary from country to country. In all cases if clinical trials are required, they must be conducted in accordance
with cGCP requirements and the applicable regulatory requirements and the ethical principles having their origin in the Declaration
of Helsinki.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">If
we fail to comply with applicable foreign regulatory requirements, we may be subject to, among other things, fines, suspension
or withdrawal of regulatory approvals, product recalls, seizure of products, operating restrictions and criminal prosecution.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Employees</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">As
of the date of this prospectus, we have 42 employees, including 41 full-time employees and 1 part-time employees. Of these, 15
are engaged in full-time research and development and laboratory operations, 22 are engaged in general and administrative functions,
4 are full-time employees engaged in the clinic operation and 1 part-time employees are engaged in sponsored </FONT><FONT STYLE="font-family: Times New Roman, Times, Serif">research
and development, laboratory operations and legal clerical support. As of the date of this prospectus, 41 of our employees are located
in Hong Kong and 1 of our employees is located in the UK. In addition, we have engaged and may continue to engage 26 independent
contracted consultants and advisors to assist us with our operations. None of our employees are represented by a labor union or
covered by a collective bargaining agreement. We have never experienced any employment related work stoppages, and we consider
our relations with our employees to be good.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36pt">&nbsp;</P>

<!-- Field: Page; Sequence: 108; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->100<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"><A HREF="#toc">Table of Contents</A></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Facilities</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">We
have several operating leases, primarily for offices. Our principal executive offices are located in Hong Kong; we also have offices
in London and Jersey City.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">Our
facilities in Hong Kong consists of: (i) 638 square foot lab space under a lease that commenced in December 2017 and expires in
December 2020, that carries a monthly rent of $2,127 and which is used for the center run by APD (the &ldquo;R&amp;D Center&rdquo;);
(ii) 851 square foot office space under a lease that commenced in December 2017 and expires in December 2020 that carries a monthly
rent of $2,509, which is also used for the center run by APD (the &ldquo;HKSTP Office Space&rdquo;); and (iii) 3,250 square foot
office space under a lease that commenced in February 2018 and expires in January 2021 and that carries a monthly rent of $16,667
(the &ldquo;Guangdong Investment Tower Lease&rdquo;). (See &ldquo;Transactions with Related Persons &ndash; Leased Facilities&rdquo;)</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">Pursuant
to the lease agreement for the R&amp;D Center, we are also obligated to pay $1,090 per month as service charges (this is an increase,
as of April 2018, from $1,058 per month with one month notice from landlord in accordance with the lease).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">Pursuant
to the lease agreement for the HKSTP Office Space, we are also obligated to pay $666 per month as service charges (this is an
increase, as of April 2018, from $633 per month with one month notice from landlord in accordance to the lease).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">Our
office space in London consists of approximately 111 square feet under a lease that commenced in April 2018 and expires in September
2018 and has a rent of $2,814 per month. Our office space in Jersey City, New Jersey consists of approximately 81 square feet
under a lease that commenced in April 2018 and expires in October 2019 and has a rent of $1,466 per month.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">Payments
under operating leases are expensed on a straight-line basis over the periods of the respective leases, and the terms of the leases
do not contain rent escalation, contingent rent, and renewal or purchase options.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">Effective
March 2018, we entered into a 4-year rental agreement to lease a facility in Central Hong Kong (the &ldquo;AML Lease&rdquo;),
which is home to AML Clinic. The AML Lease is guaranteed by Clark Cheng, our Chief Medical Officer and one of our Executive Directors,
who is also an executive director of AML. The facility covered by the AML Lease is a 3,173 square foot space that carries a monthly
rent of approximately $29,500 for the first year; the monthly rent increases each year thereafter by about $810 per month. We
must also pay a monthly management fee and air conditioning fee of about $3,370 per month under the AML Lease. Pursuant to the
terms of the AML Lease, if we fail to pay any sums that are due thereunder, we shall incur interest at the rate of 2% per calendar
month until full payment is made of all owed sums. The landlord maintains the right to terminate the AML Lease with no less than
six months&rsquo; notice if the landlord enters into a contract to sell the building of which the property we rented forms a part
or determines to redevelop or renovate the building.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">In
March 2018, Aptorum Therapeutics Limited began negotiations to purchase a premise in Fo Tan, Hong Kong, for developing into a
self-owned laboratory, and per the terms of the related agreement, we have paid a deposit of approximately $137,000. In May 2018,
we completed this transaction with a total purchase price of approximately $1,370,000.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">We
believe our current facilities are sufficient to meet our needs.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Legal
Proceedings</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">From
time to time we may become involved in legal proceedings or be subject to claims arising in the ordinary course of our business.
We are not presently a party to any legal proceedings that, if determined adversely to us, would individually or taken together
have a material adverse effect on our business, results of operations, financial condition or cash flows. Regardless of the outcome,
litigation can have an adverse impact on us because of defense and settlement costs, diversion of management resources and other
factors.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<!-- Field: Page; Sequence: 109; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->101<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"><A HREF="#toc">Table of Contents</A></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><A NAME="w13"></A>MANAGEMENT</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Directors
and Executive Officers </B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">Below
is a list of our directors and executive officers, as of the date of this prospectus, and a brief account of the business experience
of each of them. The business address for the directors and officers of Aptorum Group Limited is 17<SUP>th</SUP> floor, Guangdong
Investment Tower, 148 Connaught Road Central, Hong Kong.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: bottom; font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 20%; border-bottom: black 1.5pt solid; text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Name</B></FONT></TD>
    <TD STYLE="width: 1%; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 7%; border-bottom: black 1.5pt solid; text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Age</B></FONT></TD>
    <TD STYLE="width: 1%; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 71%; border-bottom: black 1.5pt solid; text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Position</B></FONT></TD></TR>
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Executive
    Officers</I></FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: #CCEEFF; font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ian
    Huen</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">38</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Founder,
    Chief Executive Officer and Executive Director</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: white; font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Darren
    Lui </FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">37</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">President,
    Chief Business Officer and Executive Director</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: #CCEEFF; font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Clark
    Cheng </FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">38</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief
    Medical Officer and Executive Director</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: white; font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Keith
    Chan</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">72</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief
    Scientific Officer</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: #CCEEFF; font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Sabrina
    Khan</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">37</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief
    Financial Officer </FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: white; font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Non-Management
    Directors</I></FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: #CCEEFF; font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Charles
    Bathurst</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">63</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Independent
    Non-Executive Director and Chair of Audit Committee</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: white; font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mirko
    Scherer</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">50</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Independent
    Non-Executive Director</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: #CCEEFF; font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Justin
    Wu</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">48</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Independent
    Non-Executive Director and Chair of Compensation Committee</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: white; font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Douglas
    Arner</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">49</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Independent
    Non-Executive Director and Chair of Nominating and Corporate Governance Committee</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><I>Executive
Officers</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>MR.
IAN HUEN, Founder, Chief Executive Officer and Executive Director</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">Mr.
Ian Huen is the Founder, Chief Executive Officer and Executive Director of Aptorum Group Limited. Mr. Huen is also the Executive
Director and Co-Founder of a Hong Kong company, AENEAS CAPITAL LIMITED, a licensed corporation regulated by the Hong Kong Securities
&amp; Futures Commission as a Type 9 Asset Manager, since 2005. He has over 15 years of global asset management experience and
previously covered the U.S. healthcare sector as an equity research analyst at Janus Henderson Group plc (formerly known as Janus
Capital). Mr. Huen was the financial advisor in the sale of Seng Heng Bank Limited (Macau) to Industrial and Commercial Bank of
China in 2007 and was appointed as the vice president of the Board of General Meeting in Industrial and Commercial Bank of China
(Macau) Limited in March 2007 for a term of 12 years until March 2019.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">As
a trustee board member of the Dr. Stanley Ho Medical Development Foundation, Mr. Huen facilitates advisory, development funding,
access to research resources across Asia and continues to establish relationships with leading academic institutions to propel
innovations in healthcare.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">Mr.
Huen graduated from Princeton University with an A.B. degree in Economics in June 2001, earned a MA in Comparative and Public
History from CUHK in June 2016. Mr. Huen is also a Chartered Financial Analyst (&ldquo;CFA&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>MR.
DARREN LUI</B>, <B>President, Chief Business Officer and Executive Director</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">Mr.
Darren Lui is the President, Chief Business Officer and Executive Director of Aptorum Group Limited. Mr. Lui is also an Executive
Director and Co-Founder of AENEAS CAPITAL LIMITED, a licensed corporation regulated by the Hong Kong Securities &amp; Futures
Commission as a Type 9 Asset Manager.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">Mr.
Lui was previously the founder, director and responsible officer of Varengold Capital Securities Limited and Varengold Capital
Asset Management Limited in Hong Kong, with subsidiaries operating brokerage, asset management, and investment businesses in Asia
established since January 2015.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">Prior
to this, he was a Director within the Fixed Income Group of Barclays Capital, where he spent over nine years from September 2005
to February 2014 developing and establishing their London, Singapore and New York structuring teams. From September 2002 to August
2005 he was qualified as a Chartered Accountant with Ernst &amp; Young LLP (London), specializing in capital markets advisory.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">Mr.
Lui graduated with First-Class Honors from Imperial College, London with a BSc degree in Biochemistry in June 2002. He is a Chartered
Accountant (ICAS), a CFA, and an Associate of Chartered Institute of Securities &amp; Investments (UK).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>DR.
CLARK CHENG, Chief Medical Officer and Executive Director, Aptorum Group Limited </B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Executive
Director, Aptorum Medical Limited</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">Dr.
Clark Cheng is the Chief Medical Officer and Executive Director of Aptorum Group Limited; he is also an executive director of
AML (See &ldquo;Our Business &mdash; Facilities&rdquo; regarding the AML Lease). Prior to this appointment, Dr. Cheng served as
the Operations Director since 2009 of Raffles Medical Group, and the company&rsquo;s Deputy General Manager since 2011, representing
an expanded role in the region. During his employment with Raffles Medical Group, he practiced as a full-time medical administrator
to overlook Raffles Medical Hong Kong operations and supported its development in the PRC.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<!-- Field: Page; Sequence: 110; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->102<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"><A HREF="#toc">Table of Contents</A></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">Dr.
Cheng received his medical training at the University College London, UK, in 2005 and completed his foundation year training at
The Royal Free Hospital in 2007. Pursuing his career in surgery, he obtained his membership of the Royal College of Surgeons of
Edinburgh in 2009 and commenced his training in Orthopaedics where he practiced as Specialist Registrar at the National University
Hospital, Singapore, with special interest in Traumatology of the lower limbs. In 2011, he also obtained his Master in Business
&amp; Administration with distinction from Tippie College of Business, University of Iowa, US.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">Dr.
Cheng is an active member of the Singapore Chamber of Commerce, and appears regularly as a guest speaker for The Open University
of Hong Kong, The Airport Authority Hong Kong and other corporate events.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>DR.
KEITH CHAN, Chief Scientific Officer</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">Dr.
Keith Chan is the Chief Scientific Officer of Aptorum Group Limited. Dr. Chan assists the Group with strategizing its clinical
programs and approaches with the FDA and CFDA. The appointment of Dr. Chan is through a Consultancy Agreement by and between the
Company and GloboAsia LLC, a firm based in Rockville, Maryland (&ldquo;GloboAsia&rdquo;), where Dr. Chan serves as Director of
International Affairs, on the basis of at least one working day per week for the Group.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">Dr.
Chan is currently a Senior Advisor of Cornerstone Intellectual Property Foundation in Taiwan. He is also serving as an adjunct
professor at the Graduate Institute of Intellectual Property, College of Commerce, National Chengchi University and adjunct professor
and advisor at the Research Center for Drug Discovery, National Yang Ming University in Taipei, Taiwan.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">Dr.
Chan co-founded GloboMax LLC, a drug development organization, in Hanover, Maryland, in July 1997, and served as a consultant
for numerous multi-national pharmaceutical and biotech firms in the U.S, Europe and Asia. GloboMax LLC was acquired by ICON, plc.
in August 2003, and Dr. Chan exited the operation. Prior to that, he joined the FDA in 1995 as a Director of Division of Bioequivalence,
Office of Generic Drugs, responsible for managing and approval of generic drugs in the States. Dr. Chan had worked for Ciba-Geigy
Corporation in Ardsley, New York, for 15 years, and held various senior and management positions. Dr. Chan also has extensive
experience in new and generic drug development in executing preclinical animal studies, bioassay development, Phases I to VI Pharmacokinetics,
pharmacodynamics, bioavailability, bioequivalence studies, outside contract, regulatory submission, advanced drug delivery systems,
and all phases of new drug development. In addition, he has served as Professor/adjunct Professor at the School of Pharmacy, University
of Maryland at Baltimore during 1996-2009 and also as Adjunct Professor and National Board of Advisor, College of Pharmacy, University
of Minnesota during 1984 - 2006. He has published more than 150 abstracts and research articles in peer-reviewed journals and
delivered over 200 professional presentations. He was elected as Fellow of the American Association of Pharmaceutical Scientists
(&ldquo;AAPS&rdquo;) in 1995 for his scientific accomplishments on drug absorption in humans.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">Although
much of his career was based in the United States, Dr. Chan has been assisting Asian pharmaceutical and biotech companies for
over 14 years. He has organized numerous workshops and conferences in the PRC, Taiwan, Hong Kong, Singapore and Korea. He lectures
frequently in Asia and serves as a scientific advisor for many regulatory agencies in Asia. Over the last several years, he has
successfully assisted many Asian companies in their technology transfers and licensing deals to and from the U.S., as well as
with numerous regulatory submissions to the FDA.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">Dr.
Chan obtained his Ph.D. degree in Pharmaceutics from the University of Minnesota in January 1980.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>MISS
SABRINA KHAN, Chief Financial Officer</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">Miss
Sabrina Khan is the Chief Financial Officer of Aptorum Group Limited. She leads the Company&rsquo;s financial strategy and operations,
as well as Investor Relations. She has extensive experience working at KPMG (Hong Kong) and Ernst &amp; Young LLP (Hong Kong).
She was recently the regional financial controller in Asia for St. James&rsquo;s Place Wealth Management (Hong Kong), which St.
James&rsquo;s Place Wealth Management Group (LON: STJ) is a FTSE100 company with &pound;89.9 billion of client funds under management.
Prior to that, she served as the senior finance manager of Neo Derm Group, a leading medical aesthetic group in Asia, in charge
of its finance-related matters and expansion in the PRC. From August 2009 to May 2013, she served as the senior finance manager
of Global Cord Blood Corporation (formerly known as China Cord Blood Corporation (NYSE: CO)), which was a subsidiary of Golden
Meditech Holdings Limited (HK: 801), where she played an important role with the NYSE listing filings, investor relations and
post IPO reporting. During her employment with Global Cord Blood Corporation, she was actively involved in the issuance of convertible
bonds to Kohlberg Kravis Roberts and various merger and acquisition projects, facilitated and liaised with investment banks on
due diligence, deal structuring, and also involved in commercial negotiation with respect to major contract terms.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">Miss
Khan qualified as certified public accountant and graduated with a BBA (Hons) in Accounting &amp; Finance at The University of
Hong Kong in 2003. She was qualified as an Advanced China Certified Taxation Consultant in 2015.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<!-- Field: Page; Sequence: 111; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->103<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"><A HREF="#toc">Table of Contents</A></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><I>Independent
Non-Executive Directors</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>MR.
CHARLES BATHURST</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">Mr.
Bathurst is an Independent Non-Executive Director of Aptorum Group Limited. He has over 40 years&rsquo; experience of management
and senior executive roles primarily in financial services. In 2011, he set up his own independent consultancy service, Summerhill
Advisors Limited, advising on management structure, business development, financial reporting, internal audit controls and compliance
to both emerging and multinational companies. Today he holds Non-Executive and Advisory board positions on fast-growing companies
in healthcare, technology and financial services.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">Prior
to establishing Summerhill, he served as a Director for J.O. Hambro Investment Management from September 2008 to August 2011,
where he oversaw the restructuring and commercialization a range of in-house investment funds. He was appointed to the management
board and supervised reporting teams including Business development, accounting teams, regulatory reporting teams and internal
controls.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">From
April 2004 to March 2008, Mr. Bathurst served in multiple roles at Old Mutual Asset Managers (UK), including being a member of
the senior management team and head of international sales. Duties included business development, launching new investment funds,
recruitment, establishing and supervision of regulatory and financial reporting teams, as well as ensuring compliance with funds&rsquo;
regulatory requirements and corporate governance standards.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">Prior
to this, Mr. Bathurst was an advisor to Lion Capital Advisors Limited from April 2003 to March 2004, and from June 2002 to March
2003 business development reporting to the board of management of LCF Rothschild Asset Management Limited.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">From
April 1995 to March 2002, Mr. Bathurst joined a newly formed alternative investment management team at Credit Agricole Asset Management,
establishing the London Branch as the Managing Director in 1998. He was responsible for the recruitment and development strategy
for marketing, sales, investment, financial reporting, compliance and regulatory controls and investor relations.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">Between
the period of September 1989 and December 1994, Mr. Bathurst worked for GNI, the largest futures and options execution and clearing
broker on the London International Financial futures Exchange, where he focused on marketing to European and Middle East financial
institutions. In 1991, he joined a new management team to launch a series of specialist investment funds while serving as the
Head of Sales and Product Development.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">Mr.
Bathurst graduated from the Royal Military Academy Sandhurst in November 1974 and commissioned into the British Army serving in
the UK and Germany.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>DR.
MIRKO SCHERER</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">Dr.
Mirko Scherer is an Independent Non-Executive Director of Aptorum Group Limited. Dr. Scherer has been serving as the CEO at TVM
Capital China in Hong Kong since March 2015. TVM China focuses on cross-border activities&nbsp;in the life science industry&nbsp;between
China and the West. TVM China acts as a bridge between China and the West, assisting Chinese investors and pharmaceutical companies
accessing western innovations, while collaborating with innovative life science companies from the West to enter the fast-growing
China market.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">Dr.
Mirko Scherer has served on the Board of the Frankfurt Stock Exchange and has been a board member of the Stichting Preferente
Aandelen QIAGEN since 2004. From August 2016 through July 2018, Dr. Scherer served as a Non-Executive board member of Quantapore
Inc. and from April 2015 through September 2017, he was a director of China BioPharma Capital I, (GP).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">Dr.
Scherer is an experienced biotechnology executive and has led numerous financing M&amp;A and licensing transactions, in both public
and private markets, in Europe and the U.S. for over 20 years. He consulted MPM Capital for the period between July 2012 and December
2014, focusing on deal sourcing for MPM in Europe. Dr. Scherer was also a co-founder and partner of KI Kapital from November 2008
to February 2014, a company specializing in providing consultation in life science industry.&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">Prior
to working in the venture capital industry, Dr. Scherer co-founded GPC Biotech (Munich and Princeton, NJ) and served as the Chief
Financial Officer from October 1997 to December 2007. GPC Biotech engaged in numerous pharmaceutical alliances with companies
such as Sanofi Aventis, Boehringer Ingelheim, Altana (now part of Takeda), Yakult, and Pharmion (now part of Celgene). Over the
past 20 years, Dr. Scherer has established an extensive network in the U.S., European, and China&rsquo;s biotechnology and venture
capital industry. Prior to his time at GPC Biotech, Dr. Scherer worked as a consultant from May 1993 to June 1994 at the Boston
Consulting Group.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<!-- Field: Page; Sequence: 112; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->104<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"><A HREF="#toc">Table of Contents</A></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">Dr.
Scherer earned a Doctorate in Finance from the European Business School in Oestrich-Winkel/Germany in 1998, a MBA from Harvard
Business School in June 1996, and a degree in Business Administration from the University of Mannheim/Germany in February 1993.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>DR.
JUSTIN WU</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">Dr.
Justin Wu is an Independent Non-Executive Director of Aptorum Group Limited. He has been serving as the Associate Dean of the
Faculty of Medicine at CUHK since July 2014, a Professor in the Department of Medicine and Therapeutics since 2009, also the Director
of the S. H. Ho Center for Digestive Health, a research center specializing in functional gastrointestinal diseases, reflux and
motility disorders, and digestive endoscopy. Active in research publications and assessments, Dr. Wu is currently the International
Associate Editor of American Journal of Gastroenterology (&ldquo;AJG&rdquo;), and Managing Editor of Journal of Gastroenterology
and Hepatology (&ldquo;JGH&rdquo;). He is also the Secretary General of the Asian Neurogastroenterology and Motility Association
(&ldquo;ANMA&rdquo;), and Honorary Treasurer of the Asia Pacific Association of Gastroenterology (&ldquo;APAGE&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">Dr.
Wu has won a number of awards including the Emerging Leader in Gastroenterology Award by the JGH Foundation, and the Vice Chancellor&rsquo;s
Exemplary Teaching Award at CUHK. Aside from his expertise in gastroenterology, Dr. Wu has an extensive interest in the development
of Integrative Medicine in Hong Kong. He is the Founding Director of the Hong Kong Institute of Integrative Medicine, working
closely with the School of Chinese Medicine to develop an integrative model at an international level. The institute aims at maximizing
the strength of Western and Chinese medicine to provide a safe and effective integrative treatment to patients.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">Dr.
Wu served as a consultant and an advisory board member for Takeda Pharmaceutical, AstraZeneca, Menarini, Reckitt Benckiser and
Abbott Laboratory. He earned his Bachelor of Medicine and Bachelor of Surgery Degree (1993), and his Doctor of Medicine Degree
(2000) from CUHK. Additionally, he attained Fellowships of the Royal College of Physicians of Edinburgh and London in 2007 and
2012 respectively, Fellowship of the Hong Kong College of Physicians in 2002, Fellowship of the Hong Kong Academy of Medicine
in 2002, and has been an American Gastroenterological Association Fellow since 2012.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>PROFESSOR
DOUGLAS ARNER </B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">Professor
Douglas W. Arner is an Independent Non-Executive Director of Aptorum Group Limited. He is also the Kerry Holdings Professor in
Law at the University of Hong Kong (&ldquo;HKU&rdquo;), Project Coordinator of a significant project funded by the Hong Kong Research
Grants Council Theme-based Research Scheme on &ldquo;Enhancing Hong Kong&rsquo;s Future as a Leading International Financial Centre&rdquo;
and the Director of HKU&rsquo;s East Asian International Economic Law and Policy Program. In addition, he is the Faculty Director
of HKU&rsquo;s LLM in Compliance and Regulation and a Senior Visiting Fellow of Melbourne Law School, University of Melbourne.
Douglas served as the Head of the HKU Department of Law from 2011 to 2014 and as Co-Director of the Duke University-HKU Asia-America
Institute in Transnational Law from 2005 to 2016. From 2006 to 2011 he was the Director of HKU&rsquo;s Asian Institute of International
Financial Law, which he co-founded in 1999 along with the LLM in Corporate and Financial Law (of which he serves as the Faculty
Director). Since March 1, 2018, Professor Arner is the Senior Regulatory &amp; Strategic Advisor of AENEAS CAPITAL LIMITED, a
licensed corporation regulated by the Hong Kong Securities &amp; Futures Commission as a Type 9 Asset Manager.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">Professor
Arner is a member of the Hong Kong Financial Services Development Council and an Executive Committee Member of the Asia Pacific
Structured Finance Association. He has served as a consultant with, among others, the Asian Development Bank, World Bank, APEC,&nbsp;and
European Bank for Reconstruction and Development, and has lectured, co-organized conferences and seminars and&nbsp;been involved
with&nbsp;financial sector reform projects in over 20 economies&nbsp;in Africa, Asia and Europe. He has been a visiting professor
or fellow at Duke, Harvard, the Hong Kong Institute for Monetary Research, IDC Herzliya, McGill, Melbourne, National University
of Singapore, University of New South Wales, Shanghai University of Finance and Economics, and Zurich, among others.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">He
holds a BA from Drury College (where he studied literature, economics and political science) in 1992, a JD (cum laude) from Southern
Methodist University in 1995, an LLM (with distinction) in banking and finance law from the University of London (Queen Mary College)
in 1996, and a PhD from the University of London in 2005.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><I>Significant
Employee</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">The
following person is not an executive officer of Aptorum Group Limited, but is expected to make significant contributions to our
business.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>DR.
THOMAS LEE WAI YIP, Chief Executive Officer and Chief Scientific Officer, Aptorum Therapeutics Limited</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">Dr.
Thomas Lee is the Chief Executive Officer and Chief Scientific Officer of Aptorum Therapeutics Limited, a wholly-owned therapeutics
subsidiary of Aptorum Group Limited. Dr. Lee served as an Assistant Professor in the School of Pharmacy, Faculty of Medicine,
CUHK from August 2013 to January 2018 and joined Aptorum Therapeutics Limited in January 2018. Dr. Lee&rsquo;s key area research
involves drug delivery with specialties on formulation development of poorly soluble compounds, oral delivery, Nanotechnology,
and similar fields.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<!-- Field: Page; Sequence: 113; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->105<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"><A HREF="#toc">Table of Contents</A></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">Prior
to academia, Dr. Lee accumulated big-pharma experience by spending a decade in two multinational pharmaceutical companies in the
U.S. He was working at Novartis Pharmaceuticals Corporation from June 2003 to November 2008, and subsequently recruited to Celgene
Corporation as a senior scientist (manager) of the Formulations Research &amp; Development from November 2008 to July 2013.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">Dr.
Lee graduated with B.Pharm. (Hons) Degree from the formerly Department of Pharmacy at the CUHK in August 1995, and received his
Ph.D. in Pharmaceutical Sciences (Drug Delivery) from the University of Wisconsin-Madison in the U.S in May 2003.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Corporate
Governance </B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 34pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; background-color: white">Prior
to the completion of this Offering and as long as our officers and directors, either individually or in the </FONT><FONT STYLE="font-family: Times New Roman, Times, Serif">aggregate,
own at least 50% of the voting power of our Company, we will be a &ldquo;controlled company&rdquo; as defined under NASDAQ Marketplace
Rules (specifically, as defined in Rule 5615(c)). We have no current intention to rely on the&nbsp;controlled company&nbsp;exemptions
afforded to a controlled company under the NASDAQ Marketplace Rules.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 34pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><I>Composition
of Our Board of Directors</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 34pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Our
Board of Directors currently consists of seven members, all of whom were elected pursuant to our current Memorandum and Articles.
Our nominating and governance committee and board of directors will consider a broad range of factors relating to the qualifications
and background of nominees, which may include diversity and is not limited to race, gender or national origin. We have no formal
policy regarding board diversity. Our nominating and governance committee&rsquo;s and board of directors&rsquo; priority in selecting
board members is identification of persons who will further the interests of our shareholders through his or her established record
of professional accomplishment, the ability to contribute positively to the collaborative culture among board members, knowledge
of our business, understanding of the competitive landscape and professional and personal experiences and expertise relevant to
our growth strategy.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 34pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 34pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">There
is no Cayman Islands law requirement that a director must hold office for a certain term and stand for re-election unless the
resolutions appointing the director impose a term on the appointment. The Memorandum and Articles provide that our directors will
be elected annually to serve a term of one year, or until his or her earlier resignation or removal. We do not have any age limit
requirements relating to our director&rsquo;s term of office.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 34pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 34pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Our
Memorandum and Articles also provide that our directors may be removed by the directors or ordinary resolution of the shareholders,
and that any vacancy on our Board of Directors, including a vacancy resulting from an enlargement of our Board of Directors (which
shall not exceed any maximum number stated therein), may be filled by ordinary resolution or by vote of a majority of our directors
then in office.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 34pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><I>Director
Independence</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 34pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Our
Board of Directors has determined that Justin Wu, Mirko Scherer, Douglas Arner and Charles Bathurst are independent, as determined
in accordance with the rules of the NASDAQ Global Market. In making such independence determination, our Board of Directors considered
the relationships that each such non-employee director has with us and all other facts and circumstances that the board of directors
deemed relevant in determining their independence, including the beneficial ownership of our share capital by each non-employee
director and the transactions involving them described in the section titled &ldquo;Transactions with Related Persons&rdquo;.
Upon the closing of this Offering, we expect that the composition and functioning of our Board of Directors and each of our committees
will comply with all applicable requirements of the NASDAQ Global Market and the rules and regulations of the SEC. There are no
family relationships among any of our directors or executive officers.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 34pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><I>Board&rsquo;s
Role in Risk Oversight </I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 34pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Our
Board of Directors oversees the management of risks inherent in the operation of our business and the implementation of our business
strategies. Our Board of Directors performs this oversight role by using several different levels of review. In connection with
its reviews of our operations and corporate functions, our Board of Directors addresses the primary risks associated with those
operations and corporate functions. In addition, our Board of Directors reviews the risks associated with our business strategies
periodically throughout the year as part of its consideration of undertaking any such business strategies.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 34pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 34pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Each
of our board committees also oversees the management of our risk that falls within the committee&rsquo;s areas of responsibility.
In performing this function, each committee has full access to management, as well as the ability to engage advisors. Our Chief
Financial Officer reports to the audit committee and is responsible for identifying, evaluating and implementing risk management
controls and methodologies to address any identified risks. In connection with its risk management role, our audit committee meets
privately with representatives from our independent registered public accounting firm and our Chief Financial Officer. The audit
committee oversees the operation of our risk management program, including the identification of the primary risks associated
with our business and periodic updates to such risks, and reports to our Board of Directors regarding these activities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 34pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<!-- Field: Page; Sequence: 114; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->106<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"><A HREF="#toc">Table of Contents</A></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><I>Board
Committees </I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 34pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Our
Board of Directors has established an audit committee, a compensation committee and a nominating and corporate governance committee,
each of which operates pursuant to a separate charter adopted by our Board of Directors. The composition and functioning of all
of our committees will comply with all applicable requirements of the Sarbanes-Oxley Act, the Dodd-Frank Wall Street Reform and
Consumer Protection Act, the NASDAQ Global Market and SEC rules and regulations. Our Board of Directors may establish other committees
from time to time.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 34pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><I>Audit
Committee</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 34pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Charles
Bathurst, Douglas Arner and Justin Wu currently serve on the audit committee, which is chaired by Charles Bathurst. Our Board
of Directors has determined that each member of the audit committee is &ldquo;independent&rdquo; for audit committee purposes
as that term is defined in the rules of the SEC and the applicable rules of the NASDAQ Global Market. The audit committee&rsquo;s
responsibilities include:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 34pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 0.5in; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 0.25in; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">selecting
    and appointing our independent registered public accounting firm, and approving the audit and permitted non-audit services
    to be provided by our independent registered public accounting firm;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 0.5in; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 0.25in; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">evaluating
    the performance and independence of our independent registered public accounting firm;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 0.5in; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 0.25in; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">monitoring
    the integrity of our financial statements and our compliance with legal and regulatory requirements as they relate to our
    financial statements or accounting matters;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 0.5in; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 0.25in; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">reviewing
    the adequacy and effectiveness of our accounting and internal control policies and procedures;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 0.5in; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 0.25in; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">establishing
    procedures for the receipt, retention and treatment of accounting-related complaints and concerns;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 0.5in; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 0.25in; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">reviewing
    and discussing with the independent registered public accounting firm the results of our year-end audit, and recommending
    to our Board of Directors, based upon such review and discussions, whether our financial statements shall be included in our
    Annual Report on Form 20-F;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 0.5in; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 0.25in; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">reviewing
    all related party transactions for potential conflict of interest situations and approving all such transactions; and</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 0.5in; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 0.25in; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">reviewing
    the type and presentation of information to be included in our earnings press releases, as well as financial information and
    earnings guidance provided by us to analysts and rating agencies.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><I>Audit
Committee Financial Expert</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 34pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">We
have one financial expert as of the date of this report. Our Board of Directors has determined that Mr. Charles Bathurst, Chair
of our audit committee, qualifies as an &ldquo;audit committee financial expert&rdquo; as defined in the SEC rules and satisfies
the financial sophistication requirements of The NASDAQ Global Market.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 34pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><I>Compensation
Committee</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 34pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Charles
Bathurst, Douglas Arner and Justin Wu currently serve on the compensation committee, which is chaired by Justin Wu. Our Board
of Directors has determined that each member of the compensation committee is &ldquo;independent&rdquo; as that term is defined
in the applicable rules of the NASDAQ Global Market. The compensation committee&rsquo;s responsibilities include:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 34pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 0.5in; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 0.25in; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">reviewing
    the goals and objectives of our executive compensation plans, as well as our executive compensation plans in light of such
    goals and objectives;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 0.5in; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 0.25in; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">evaluating
    the performance of our executive officers in light of the goals and objectives of our executive compensation plans and recommending
    to our Board of Directors with respect to the compensation of our executive officers;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 0.5in; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 0.25in; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">reviewing
    the goals and objectives of our general compensation plans and other employee benefit plans as well as our general compensation
    plans and other employee benefit plans in light of such goals and objectives;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 0.5in; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 0.25in; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">retaining
    and approving the compensation of any compensation advisors;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 0.5in; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 0.25in; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">reviewing
    all equity-compensation plans to be submitted for shareholder approval under the NASDAQ listing rules, and reviewing and approving
    all equity-compensation plans that are exempt from such shareholder approval requirement;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 0.5in; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 0.25in; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">evaluating
    the appropriate level of compensation for board and board committee service by non-employee directors; and</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 0.5in; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 0.25in; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">reviewing
    and approving description of executive compensation included in our Annual Report on Form 20-F.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<!-- Field: Page; Sequence: 115; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->107<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"><A HREF="#toc">Table of Contents</A></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><I>Nominating
and Corporate Governance Committee</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">Charles
Bathurst, Douglas Arner and Justin Wu currently serve on the nominating and corporate governance committee, which is chaired by
Mr. Arner. Our Board of Directors has determined that each member of the nominating and corporate governance committee is &ldquo;independent&rdquo;
as that term is defined in the applicable rules of the NASDAQ Global Market. The nominating and corporate governance committee&rsquo;s
responsibilities include:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 34pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 0.5in; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 0.25in; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">assisting
    our Board of Directors in identifying prospective director nominees and recommending nominees for election by the shareholders
    or appointment by our Board of Directors;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 0.5in; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 0.25in; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">advising
    the board of directors periodically with respect to significant developments in the law and practice of corporate governance
    as well as our compliance with applicable laws and regulations, and making recommendations to our Board of Directors on all
    matters of corporate governance and on any corrective action to be taken;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 0.5in; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 0.25in; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">overseeing
    the evaluation of our Board of Directors; and</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 0.5in; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 0.25in; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">recommending
    members for each board committee of our Board of Directors.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif"><I>Code
of Business Conduct and Ethics</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our board has adopted
a code of business conduct and ethics that applies to our directors, officers and employees. A copy of this code will be available
on our website: <U>www.aptorumgroup.com</U> upon effectiveness of the F-1. We intend to disclose on our website or in a current
report on Form 6-K, any amendments to the Code of Business Conduct and Ethics and any waivers of the Code of Business Conduct and
Ethics that apply to our principal executive officer, principal financial officer, principal accounting officer, controller, or
persons performing similar functions.</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><I>Duties
of Directors </I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">Under
Cayman Islands law, our directors have a duty to act honestly, in good faith and with a view to our best interests. Our directors
also have a duty to exercise the care, diligence and skills that a reasonably prudent person would exercise in comparable circumstances.
(See &ldquo;Description of Share Capital &ndash; Differences in Corporate Law&rdquo;) In fulfilling their duty of care to us,
our directors must ensure compliance with our Memorandum and Articles. We have the right to seek damages if a duty owed by our
directors is breached.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">The
functions and powers of our Board of Directors include, among others:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 0.5in; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 0.25in; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">appointing
    officers and determining the term of office of the officers;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 0.5in; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 0.25in; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">authorizing
    the payment of donations to religious, charitable, public or other bodies, clubs, funds or associations as deemed advisable;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 0.5in; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 0.25in; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">exercising
    the borrowing powers of the company and mortgaging the property of the company;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 0.5in; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 0.25in; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">executing
    checks, promissory notes and other negotiable instruments on behalf of the company; and</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 0.5in; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 0.25in; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">maintaining
    or registering a register of mortgages, charges or other encumbrances of the company.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><I>Interested
Transactions </I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">So
long as it does not adversely affect such person&rsquo;s performance of duties or responsibilities to the Company and so long
as it is not in direct competition with the Company and the Company&rsquo;s business, no director or officer shall be disqualified
by his office from contracting and/or dealing with the Company as vendor, purchaser or otherwise; nor shall any such contract
or any contract or arrangement entered into by or on behalf of the Company in which any director or officer shall be in any way
interested be or be liable to be avoided; nor shall any director or officer so contracting or being so interested be liable to
account to the Company for any profit realized by any such contract or arrangement by reason of such director or officer holding
that office or the fiduciary relationship thereby established. However, any such transaction that would reasonably be likely to
affect a director status as an &ldquo;Independent Director,&rdquo; or that would constitute a &ldquo;related party transaction&rdquo;
pursuant to the laws or rules promulgated by the SEC or the stock exchange on which our shares are then listed, shall require
the review and approval of the Audit Committee. The nature of the director&rsquo;s interest must be disclosed by him at the meeting
of the directors at which the contract or arrangement is considered if his interest then exists, or in any other case, at the
first meeting of the directors after the acquisition of his interest. A director, having disclosed his interest as aforesaid,
shall not be counted in the quorum and shall refrain from voting as a director in respect of any contract or arrangement in which
he is as interested as aforesaid.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<!-- Field: Page; Sequence: 116; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->108<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"><A HREF="#toc">Table of Contents</A></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">A
director must promptly disclose the interest to all other directors after becoming aware of the fact that he or she is interested
in a transaction we have entered into or are to enter into. A general notice or disclosure to the board or otherwise contained
in the minutes of a meeting or a written resolution of the board or any committee of the board that a director is a shareholder,
director, officer or trustee of any specified firm or company and is to be regarded as interested in any transaction with such
firm or company will be sufficient disclosure, and, after such general notice, it will not be necessary to give special notice
relating to any particular transaction.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><I>Qualification
</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">The
shareholding qualification for directors may be fixed by the Company in general meeting, and unless and until so fixed no qualification
shall be required.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Compensation
of Executive Officers and Directors</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">The
following table sets forth all cash compensation paid by us, as well as certain other compensation paid or accrued, in 2017 and
2016 to each of the following named executive officers. The total amount was $0.21 million in 2017 and $nil in 2016, respectively.
This amount does not include business travel, relocation, professional and business association dues and expenses reimbursed to
such persons, and other benefits commonly reimbursed or paid by companies in our industry.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: bottom; font-family: Times New Roman, Times, Serif">
    <TD STYLE="border-bottom: black 1.5pt solid; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Name
    and Principal Position</B></FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: black 1.5pt solid; text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Fiscal
    Year</B></FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: black 1.5pt solid; text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Salary</B></FONT><FONT STYLE="font-family: Times New Roman, Times, Serif"><BR>
    <FONT STYLE="font-size: 10pt"><B>($)<SUP>(1)</SUP></B></FONT></FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: black 1.5pt solid; text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Bonus</B></FONT><FONT STYLE="font-family: Times New Roman, Times, Serif"><BR>
    <FONT STYLE="font-size: 10pt"><B>($)</B></FONT></FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: black 1.5pt solid; text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Option</B></FONT><FONT STYLE="font-family: Times New Roman, Times, Serif"><BR>
    <FONT STYLE="font-size: 10pt"><B>Awards</B></FONT><BR>
    <FONT STYLE="font-size: 10pt"><B>($)</B></FONT></FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: black 1.5pt solid; font-family: Times New Roman, Times, Serif"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Non-</B></FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Equity</B></FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Incentive</B><BR>
        <B>Plan</B><BR>
        <B>Compensation</B><BR>
        <B>($)</B></FONT></P></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: black 1.5pt solid; text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Change
    in Pension Value and Nonqualified Deferred Compensation Earnings</B></FONT><FONT STYLE="font-family: Times New Roman, Times, Serif"><BR>
    <FONT STYLE="font-size: 10pt"><B>($)</B></FONT></FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: black 1.5pt solid; font-family: Times New Roman, Times, Serif"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>All
                                         Other</B></FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Compensation</B><BR>
        <B>($)</B></FONT></P></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: black 1.5pt solid; text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Total</B></FONT><FONT STYLE="font-family: Times New Roman, Times, Serif"><BR>
    <FONT STYLE="font-size: 10pt"><B>($)</B></FONT></FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: #CCEEFF; font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 21%; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Ian
    Huen<SUP>(2)</SUP></B></FONT></TD>
    <TD STYLE="width: 1%; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 7%; text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>2017</B></FONT></TD>
    <TD STYLE="width: 1%; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 7%; text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">69,230</FONT></TD>
    <TD STYLE="width: 1%; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 7%; text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">23,077</FONT></TD>
    <TD STYLE="width: 1%; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 7%; text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD>
    <TD STYLE="width: 1%; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 7%; text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;-</FONT></TD>
    <TD STYLE="width: 1%; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 7%; text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;577</FONT></TD>
    <TD STYLE="width: 1%; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 7%; text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;-</FONT></TD>
    <TD STYLE="width: 1%; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 7%; text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">92,884</FONT></TD>
    <TD STYLE="width: 1%; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: #CCEEFF; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(CEO)</B></FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>2016</B></FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: white; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: #CCEEFF; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Darren
    Lui<SUP>(3)</SUP></B></FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>2017</B></FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">57,692</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4,847</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">577</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">63,116</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: #CCEEFF; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(CBO,
    President)</B></FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>2016</B></FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: white; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: #CCEEFF; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Clark
    Cheng<SUP>(4)</SUP></B></FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>2017</B></FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><SUP>(7)</SUP></FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: #CCEEFF; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(CMO)</B></FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>2016</B></FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: white; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: #CCEEFF; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Keith
    Chan<SUP>(5)</SUP></B></FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>2017</B></FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">44,516</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><SUP>(8)</SUP></FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">44,516</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: #CCEEFF; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(CSO)</B></FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>2016</B></FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: white; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: #CCEEFF; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Sabrina
    Khan<SUP>(6)</SUP></B></FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>2017</B></FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">33,064</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">577</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">33,641</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: #CCEEFF; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(CFO)</B></FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>2016</B></FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 30px; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    Appointment Letters provide salaries in HKD; for purposes of this table, we used a conversion ratio of HKD7.80 to USD1.00
    to determine the salary in USD.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 30px; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mr.
    Huen is the founder and was appointed as the Chief Executive Officer of Aptorum Group on October 1, 2017. Before that, he
    was a director of the Company.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 30px; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3)</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mr.
    Lui was appointed as the Chief Business Officer and President of Aptorum Group on October 1, 2017.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 30px; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(4)</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dr.
    Cheng was appointed as the Chief Medical Officer of Aptorum Group on January 2, 2018.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 30px; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(5)</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dr.
    Chan was appointed as the Chief Scientific Officer of Aptorum Group on August 18, 2017.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 30px; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(6)</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Miss
    Khan was appointed as the Chief Financial Officer of Aptorum Group on October 16, 2017; as per an addendum to her appointment
    letter that we entered into with Miss Khan on April 24, 2018, her monthly salary increased to HKD122,500 as of April 1, 2018.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 30px; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(7)</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
    to his appointment letter, Dr. Cheng also received a share bonus of 526 ordinary shares of AML, representing 5% of AML&rsquo;s
    issued and outstanding ordinary shares (the &ldquo;Share Bonus&rdquo;). Based on the Company&rsquo;s financial position and
    Dr. Cheng&rsquo;s performance, on each anniversary of Dr. Cheng&rsquo;s employment commencement date, the Share Bonus is eligible
    to increase by 1% of AML&rsquo;s then issued and outstanding ordinary share count per year up to a maximum additional amount
    of 5% of AML&rsquo;s then issued and outstanding ordinary share count by the 5th anniversary from his employment commencement
    date.</FONT></TD></TR>
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(8)</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
    described elsewhere in this prospectus, we maintain a consulting agreement with GloboAsia, LLC, for which Dr. Chan serves
    as the Director of International Affairs. All fees payable to Dr. Chan for services provided to us as Chief Scientific Officer
    are paid to GloboAsia, LLC, pursuant to the consulting agreement and appointment letter with Dr. Chan. (See &ldquo;Transactions
    with Related Persons &ndash; Consulting Arrangements&rdquo;)</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 49.5pt; text-align: justify; text-indent: -22.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<!-- Field: Page; Sequence: 117; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->109<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"><A HREF="#toc">Table of Contents</A></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 49.5pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><I>Compensation
of Directors </I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">The
following table sets forth information for the fiscal year ended December 31, 2017 regarding the compensation of our directors
who at December 31, 2017, were not also named executive officers.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font-weight: bold; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">Name</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Fees</B></FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Earned&nbsp;or</B></FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Paid
                                         in</B></FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Cash</B></FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>($)</B></FONT></P></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Stock</B></FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Awards</B></FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>($)</B></FONT></P></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Option</B></FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Awards</B></FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>($)</B></FONT></P></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Non-</B></FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Equity</B></FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Incentive</B></FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Plan</B></FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Compensation</B></FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>($)</B></FONT></P></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Non-</B></FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>qualified</B></FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Deferred</B></FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Compensation</B></FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Earnings</B></FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>($)</B></FONT></P></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>All
                                         Other</B></FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Compen-</B></FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>sation</B></FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>($)</B></FONT></P></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">Total<BR>
    ($)</FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 16%; font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Charles
    Bathurst <SUP>(1)</SUP></B></FONT></TD><TD STYLE="width: 1%; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="width: 9%; font-weight: bold; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">10,684</FONT></TD><TD STYLE="width: 1%; font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif"><SUP>(2)</SUP></FONT></TD><TD STYLE="width: 1%; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="width: 9%; font-weight: bold; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="width: 1%; font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="width: 1%; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="width: 9%; font-weight: bold; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="width: 1%; font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="width: 1%; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="width: 9%; font-weight: bold; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="width: 1%; font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="width: 1%; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="width: 9%; font-weight: bold; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="width: 1%; font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="width: 1%; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="width: 9%; font-weight: bold; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="width: 1%; font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="width: 1%; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="width: 9%; font-weight: bold; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">10,684</FONT></TD><TD STYLE="width: 1%; font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Mirko Scherer<SUP>(3)</SUP></B></FONT></TD><TD STYLE="font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-weight: bold; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">6,371</FONT></TD><TD STYLE="font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-weight: bold; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-weight: bold; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-weight: bold; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-weight: bold; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-weight: bold; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-weight: bold; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">6,371</FONT></TD><TD STYLE="font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Justin
    Wu <SUP>(4)</SUP></B></FONT></TD><TD STYLE="font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-weight: bold; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">6,371</FONT></TD><TD STYLE="font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-weight: bold; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-weight: bold; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-weight: bold; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-weight: bold; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-weight: bold; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-weight: bold; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">6,371</FONT></TD><TD STYLE="font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>William Lo<SUP>(5)</SUP></B></FONT></TD><TD STYLE="font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-weight: bold; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">4,722</FONT></TD><TD STYLE="font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-weight: bold; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-weight: bold; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-weight: bold; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-weight: bold; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-weight: bold; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-weight: bold; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">4,722</FONT></TD><TD STYLE="font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 24px; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mr.
    Bathurst was appointed as one of our directors as of October 2017 and pursuant to his appointment letter, is entitled to receive
    $50,400 annually for his combined services as a director and a committee member.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 24px; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mr.
    Bathurst&rsquo;s appointment Letter provides his salary in GBP. For purposes of this table, we used a conversion ratio of
    GBP0.71 to USD1.00 to determine his salary in USD; however, the ultimate amount paid is based on the actual rate as of the
    relevant pay day at the end of each month.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 24px; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3)</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dr.
    Scherer was appointed as one of our directors as of October 2017 and pursuant to his appointment letter, is entitled to receive
    $30,000 annually for his services as a director.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 24px; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(4)</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dr.
    Wu was appointed as one of our directors as of October 2017 and pursuant to his appointment letter, is entitled to receive
    $30,000 annually for his combined services as a director and a committee member.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 24px; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(5)</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dr.
    Lo was appointed as one of our directors in November 2017, but resigned in December 2017; he has since been appointed as strategic
    advisor for Videns.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">Professor
Arner&rsquo;s appointment as one of our directors became effective as of April 1, 2018. Pursuant to his appointment letter, Professor
Arner is entitled to receive $30,000 annually for his combined services as a director and a committee member; he also received
a signing bonus of $2,500.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 22.25pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">According
to our Memorandum and Articles, the remuneration to be paid to the directors shall be such remuneration as the directors shall
determine and as is in accordance with the Charter of the Compensation Committee, as applicable and the Company&rsquo;s other
corporate governance documents. Such remuneration shall be deemed to accrue from day to day. The directors also may be paid travelling,
hotel and other expenses properly incurred by them in attending and returning from meetings of the directors or any committee
of the directors or general meetings of the Company or in connection with the business of the Company or the discharge of their
duties as a director, or receive a fixed allowance in respect thereof as may be determined by the directors from time to time
or a combination of partly of one such method and partly the other. The directors may provide benefits, whether by the payment
of gratuities or pensions or by insurance or otherwise, for any existing director or any director who has held but no longer holds
any executive office or employment with the Company or with any entity which is or has been a subsidiary of the Company or a predecessor
in business of the Company or of any such subsidiary, and for any member of his family (including a spouse and a former spouse)
or any person who is or was dependent on him, and may (as well before as after he ceases to hold such office or employment) contribute
to any fund and pay premiums for the purchase or provision of any such benefit.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<!-- Field: Page; Sequence: 118; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->110<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"><A HREF="#toc">Table of Contents</A></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><I>Omnibus
Incentive Plan</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">On
October 13, 2017, we adopted the Option Plan. Under the Option Plan, up to an aggregate of 5,500,000 Class A Ordinary Shares (subject
to subsequent adjustments described more fully below) may be issued pursuant to awards under the Option Plan. Subsequent adjustments
include that on each January 1, starting with January 1, 2020, an additional number of shares equal to the lesser of (A) 2% of
the outstanding number of Class A Ordinary Shares (on a fully diluted basis) on the immediate preceding December 31, and (B) such
lower number of Class A Ordinary Shares as may be determined by the board of directors, subject in all cases to adjustments as
provided in Section 10 of the Aptorum Group Limited 2017 Share Option Plan. Awards will be made pursuant to agreements and may
be subject to vesting and other restrictions as determined by the board of directors.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">We
adopted the Option Plan to provide additional incentives to selected directors, officers, employees and consultants, and enable
our Company to obtain and retain the services of these individuals. The Option Plan will enable us to grant options, restricted
shares or other awards to our directors, employees and consultants. Awards will be made pursuant to agreements and may be subject
to vesting and other restrictions as determined by the board of directors.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif"><I>Limitation
on Liability and Other Indemnification Matters</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">The
Companies Law does not limit the extent to which a company&rsquo;s memorandum and articles of association may provide for indemnification
of officers and directors, except to the extent any such provision may be held by the Cayman Islands courts to be contrary to
public policy, such as to provide indemnification against civil fraud or the consequences of committing a crime. Our Memorandum
and Articles permit indemnification of officers and directors for actions, proceedings, claims, losses, damages, costs, liabilities
and expenses (&ldquo;Indemnified Losses&rdquo;) incurred in their capacities as such unless such Indemnified Losses arise from
dishonesty of such directors or officers. This standard of conduct is generally the same as permitted under the Delaware General
Corporation Law for a Delaware corporation.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">Insofar
as indemnification for liabilities arising under the Securities Act may be permitted to our directors, officers or persons controlling
us under the foregoing provisions, we have been informed that in the opinion of the SEC, such indemnification is against public
policy as expressed in the Securities Act and is therefore unenforceable.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><A NAME="w14"></A>TRANSACTIONS
WITH RELATED PERSONS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">Since
January 1, 2016 there has not been, nor is there currently proposed, any material transaction or series of similar material transactions
in which the amount involved exceeds the lesser of $120,000 or one percent of the average of the Company&rsquo;s total assets
at year-end for the last two completed fiscal years in which we were or are to be a participant and in which a related person
had or will have a direct or indirect material interest, other than the compensation and shareholding arrangements we describe
in &ldquo;Management&rdquo; and &ldquo;Principal Shareholders&rdquo; and the transactions we describe below. A related person
is: (i) an executive officer, director or director nominee of the Company, (ii) a beneficial owner of more than 5% of our Class
A or Class B Ordinary Shares, (iii) an immediate family member of an executive officer, director or director nominee or beneficial
owner of more than 5% of any class of our Ordinary Shares, or (iv) any entity that is owned or controlled by any of the foregoing
persons or in which any of the foregoing persons has a substantial ownership interest or control.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Sales
and Purchases of Securities</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 20.25pt"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><I>Share
Issuances</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 20.25pt"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">During
the period of March 2017 through December 2017, we issued an aggregate of 2,207,025 Ordinary Share at a purchase price of approximately
$3.90 per share, in a private placement we described as a &ldquo;Series A&rdquo; offering. Each investor of the Series A offering,
in addition to a subscription agreement, signed a shareholder agreement, which set forth the basic governance terms of the Company,
as well as our capital structure. The shareholders agreement was terminated in October 2017.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 30pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">On
October 13, 2017, ordinary resolutions were passed at an extraordinary general meeting of the Company approving: (i) converting
72,135,865 of authorized but unissued Ordinary Shares into 54,573,619 authorized but unissued Class A ordinary shares, par value
of $1.00 per share (&ldquo;Class A Ordinary Shares&rdquo;) and 17,562,246 authorized but unissued Class B ordinary shares, par
value of $1.00 per share (&ldquo;Class B Ordinary Shares&rdquo;), respectively; (ii) converting 24,930,839 Ordinary Shares held
by three shareholders into an aggregate of 2,493,085 Class A Ordinary Shares and 22,437,754 Class B Ordinary Shares; and (iii)
converting 2,933,296 Ordinary Shares held by 24 shareholders into an aggregate 2,933,296 Class A Ordinary Shares. Following these
issuances, we had 27 shareholders of record.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">KHE
Holdings Limited, which is owned by Dr. Kenny Yu&rsquo;s family, purchased $200,000 Series A Notes. Dr. Yu is a member of our
Scientific Assessment Committee.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<!-- Field: Page; Sequence: 119; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->111<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"><A HREF="#toc">Table of Contents</A></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Share
Transfer: Change in direct substantial shareholders of the Company</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">On
May 4, 2017, Mr. Huen transferred all of the ordinary shares in the Company he owned (in the amount of 22,307,596) to Jurchen,
a company incorporated in the British Virgin Islands and wholly-owned by Mr. Huen. On October 13, 2017, the ordinary shares held
by Jurchen were redesignated as 2,230,760 Class A Ordinary Shares and 20,076,836 Class B Ordinary Shares.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 22.25pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">On
March 23, 2018, Jurchen transferred 446,152 Class A Ordinary Shares and 4,015,367 Class B Ordinary Shares to CGY Investments Limited,
a company incorporated in Hong Kong and which we deem Mr. Darren Lui controls and/or of which he has substantial influence on
the disposition rights and voting rights of such shares.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Underwriters</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">Boustead
also acted as the placement agent in the Series A Note Offering and one of the placement agents for the Bond Offering. For such
services, Boustead received: (x) for the Series A Note Offering: (i) a cash success fee of $68,516 and (ii) the Series A Note
PA Warrants; and (y) for the Bond Offering: (i) a cash success fee of $600,000 and (ii) the Bond PA Warrants. Boustead also purchased
$150,000 Series A Notes in the Series A Note Offering. Boustead also participated in the Series A Note Offering as an investor
with a purchase of Series A Notes in the amount of $150,000.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 34pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">China
Renaissance also acted as a placement agent for the Bond Offering. For such services, China Renaissance received a cash success
fee of $150,000.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 34pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 34pt"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">The
underwriters and their affiliates may also provide from time to time in the future certain commercial banking, financial advisory,
investment banking and other services for us and such affiliates in the ordinary course of their business, for which they may
receive customary fees and commissions. In addition, from time to time, the underwriters and their affiliates may effect transactions
for their own account or the account of customers, and hold on behalf of themselves or their customers, long or short positions
in our debt or equity securities or loans, and may do so in the future.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Consulting
Arrangements </B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 22.25pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">1.&nbsp;<U>GloboAsia,
LLC</U> - We entered into a consulting agreement with GloboAsia effective as of August 18, 2017. Pursuant to this agreement, GloboAsia
provides advisory and management services to us. Dr. Keith Chan, our Chief Scientific Officer serves as the Director of International
Affairs of GloboAsia. Although Dr. Chan is our Chief Scientific Officer, he is not an Executive Director and does not have the
legal nor professional authority to dictate the commercial decisions of the Executive Board. The service fees payable to GloboAsia
equate to a monthly rate of $10,000 and are paid with the expectation that Dr. Chan devotes at least one working day per week
to the Company. The term of this agreement is two years from the date of commencement and GloboAsia must give the Company not
less than two months&rsquo; notice in writing if it wants to terminate the agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 40.25pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 22.25pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">2.&nbsp;<U>Aeneas</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 58.25pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">a.&nbsp;We
entered into a Management Agreement with Aeneas in October 2010, as amended (the &ldquo;Management Agreement&rdquo;). Our CEO,
Mr. Huen is the sole beneficial owner and one of the executive directors of Aeneas, which is a Hong Kong incorporated licensed
corporation regulated by the Securities &amp; Futures Commission for asset management activities. Prior to the Restructure, pursuant
to which we no longer invest in companies on a portfolio investment basis, Aeneas was the Company&rsquo;s asset manager. Pursuant
to the Management Agreement, we were to pay Aeneas certain management fees and performance fees. In February 2017, as part of
the Restructure, the Management Agreement was terminated and no further fees were payable pursuant thereto. Prior to termination,
we paid Aeneas an aggregate of $4.8 million pursuant to the terms of the Management Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 58.25pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 58.25pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">b.&nbsp;In
March 2017, we entered into a new Management Agreement with Aeneas (the &ldquo;2017 Agreement&rdquo;), pursuant to which Aeneas
will provide certain management and administrative functions, as well as investment functions related to the Company, IP acquisitions
and other investor relations services (the &ldquo;Services&rdquo;). In consideration for the Services, we shall pay Aeneas HK$500,000
per month (approximately US$64,103 per month), payable on the last day of each month. The 2017 Agreement was terminated in July
2018.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 76.25pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<!-- Field: Page; Sequence: 120; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->112<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"><A HREF="#toc">Table of Contents</A></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 76.25pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">Aeneas
is wholly-owned by Aeneas Group Limited (&ldquo;AGL&rdquo;), which in turn is wholly-owned by Aeneas Limited (&ldquo;AL&rdquo;).
AL is wholly-owned by Jurchen, which is wholly-owned by Mr. Huen, our CEO. Mr. Huen and Mr. Lui both serve as the executive directors
of Aeneas and Professor Arner, one of our directors, is a Senior Regulatory and Strategic Advisor for Aeneas. Under his agreement
with AGL dated March 12, 2018, Professor Arner shall, among other services, advise the board of AGL with its management, execution
of business, and regulatory initiatives of AGL and AL, assist AGL with access to expert networks as appropriate and required.
Professor Arner&rsquo;s compensation thereunder is HK$240,000 per year (approximately US$30,800 per year) and Professor Arner
is entitled to participate in AGL&rsquo;s share option plans.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 22.25pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">3.&nbsp;<U>Covar
Pharmaceuticals Incorporated</U> - In May 2017, we entered into a service agreement (the &ldquo;Covar Agreement&rdquo;) with Covar
Pharmaceuticals Incorporated (&ldquo;Covar&rdquo;), an advisor, through a wholly-owned subsidiary, Videns, which is one of our
project companies and is developing four of our projects.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">Pursuant
to the Covar Agreement, Covar would act as a product and clinical development advisor to Videns with respect to the development
of contrast agents for MRI imaging applicable to the human brain (VLS-1) (the &ldquo;Original Service Scope&rdquo;). Covar shall
receive fees for their services in amounts to be determined by the parties at the time of each service. Pursuant to the Covar
Agreement, two employees of Covar, Mr. Austin Freedman (&ldquo;Mr. Freedman&rdquo;) and Dr. Kwok Chow (&ldquo;Dr. Chow&rdquo;)
would provide the technical services at the rate of $150 per hour and $200 per hour, respectively; other technical and support
staff shall provide services at the rate of $65-$100 per hour depending on background and experience. Covar has since adjusted
its fees pursuant to a new fee schedule, where effective January 2018, the effective rates of Dr. Chow and Mr. Freedman are now
$220 per hour and $165 per hour respectively, and the rates of other technical and support staff are now between $90-$250 per
hour depending on background and experience. Mr. Freedman will provide the lead program management services for the project contemplated
by the Covar Agreement and Dr. Chow will provide management support when needed; otherwise, Dr. Chow will provide technical and
consulting services including pharmaceutical and analytical development services. Videns shall also reimburse Covar for certain
out of pocket expenses that are pre-approved in writing.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 40.25pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">The
Covar Agreement has an initial term of 12 months that may be automatically renewed for an additional 12-month period and then
by mutual agreement among the parties. Either party may terminate the Covar Agreement at any time with or without cause upon written
notice to the other party at least 15 days prior to such termination. Upon termination or expiration of the Covar Agreement, Videns
shall pay for all unbilled compensation and expenses to the date of termination, unless however Videns terminates the Covar Agreement
because of Covar&rsquo;s permanent incapacity to perform the services and/or breach of its obligation under the Covar Agreement,
in which case, Covar shall complete the work in progress and receive payment for such finished work.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 40.25pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">Starting
on August 1, 2017, the services provided by Covar, Mr. Freedman and Dr. Chow expanded beyond the Original Service Scope as they
began to advise Videns on other research and development projects Aptorum was undertaking. As a result, we appointed Mr. Freedman
and Dr. Chow as two of our Senior Clinical Development Managers, effective as of August 1, 2017 pursuant to an Appointment Letter
and Addendum to Service Agreement with each of Dr. Chow and Mr. Freedman (each, an &ldquo;Addendum&rdquo;). Mr. Freedman and Dr.
Chow&rsquo;s services are limited to those services set forth in their appointment letters and shall each be paid at the rate
of $200 per hour or as otherwise agreed to by us and Covar.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">Each
Addendum shall be in effect for two years and shall terminate if the Covar Agreement is terminated or such person is no longer
a member or affiliate of Covar, by Covar after giving us no less than two months&rsquo; written notice, by us after giving written
notice to Covar or by us, without notice or compensation for Covar&rsquo;s dishonesty, refusal to carry out any order or instruction
or repeated breach of any rules or regulations applicable to us or those as governed by the laws of Canada. Renewal of each appointment
shall be negotiated three months prior to the expiration of the term and subject to mutual consent among all of the parties.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">According
to the Cover Agreement, all intellectual property generated or derived by Mr. Freedman and Dr. Chow in the course of performing
the services, to the extent it is specific to the development, manufacture, use and sale of the product of Videns that is the
subject of the services, will be the exclusive property of the Videns. All intellectual property generated or derived by Mr. Freedman
and Dr. Chow while performing the services which is not specific to, or dependent upon, Viden&rsquo;s product will be the exclusive
property of Mr. Freedman and Dr. Chow. Mr. Freedman and Dr. Chow grants to Videns a non-exclusive, paid-up, royalty-free, transferable
license of the intellectual property which Videns may use for the manufacture of its product.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 121; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->113<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"><A HREF="#toc">Table of Contents</A></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Appointment
Letters </B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">We
have entered into Appointment Letters with each of our executive officers. The terms of the Appointment Letters for each of our
executive officers are consistent with each other, except with regard to the individual&rsquo;s compensation, term of employment
and duties and responsibilities, the latter of which coincides with the standard functions normally associated with the given
position. Below, we set forth the specific compensation and term of employment terms of each of our executive officer&rsquo;s
appointment letter:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 48px">&nbsp;</TD>
    <TD STYLE="width: 24px"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ian Huen - Chief Executive Officer and Executive Director- US$23,077 (HKD180,000) per month payable in an equivalent amount of thirteen (13) months per calendar year with no set term of employment. </FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Darren Lui - President, Chief Business Officer and Executive Director- US$19,231 (HKD150,000) per month payable in an equivalent amount of thirteen (13) months per calendar year with no set term of employment</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dr. Clark Cheng - Chief Medical Officer and Executive Director- US$19,231 (HKD150,000) per month payable in twelve (12) instalments per calendar year with no set term of employment. Dr. Cheng is also entitled to receive a share bonus of 5% of Aptorum Medical Limited&rsquo;s ordinary shares upon commencement of employment, which shall be increased by 1% annually up to a maximum additional amount of 5% of issued ordinary share capital of Aptorum Medial Limited. </FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dr. Keith Chan -
    Chief Scientific Officer- Dr. Chan&rsquo;s Appointment Letter is in connection with the Consultancy Agreement we entered into
    with Globo Asia LLC, for which Dr. Chan serves as Director of International Affairs. Pursuant to this agreement, Dr. Chan
    must work for the Company at least one day per week and we are obligated to pay Globo Asia LLC a monthly fee of US$10,000.
    The term of the agreement is for a period of two years. </FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Sabrina Khan - Chief Financial Officer- US$15,705 (HKD122,500) per month payable in an equivalent amount of twelve (12) months per calendar year with no set term of employment. </FONT></TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">Remaining
material terms of the appointment agreements are described below.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">We
may terminate employment for cause, at any time, without advance notice or remuneration, for certain acts of the executive officer,
such as conviction or plea of guilty to a felony or any crime involving moral turpitude, negligent or dishonest acts to our detriment,
or misconduct or a failure to perform agreed duties. We may also terminate an executive officer&rsquo;s employment without cause upon
three-month advance written notice. In such case of termination by us, we will provide severance payments to the executive officer
as expressly required by applicable law of the jurisdiction where the executive officer is based. The executive officer may resign
at any time with three-month advance written notice.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<!-- Field: Page; Sequence: 122; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->114<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"><A HREF="#toc">Table of Contents</A></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">Each
executive officer has agreed to hold, both during and after the termination or expiration of his or her Appointment Letter, in
strict confidence and not to use, except as required in the performance of his or her duties in connection with the employment
or pursuant to applicable law, any of our confidential information or trade secrets, any confidential information or trade secrets
of our clients or prospective clients, or the confidential or proprietary information of any third-party received by us and for
which we have confidential obligations.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">In
addition, each executive officer has agreed to be bound by non-solicitation and non-compete restrictions during the term of his
or her employment and typically for one year following the last date of employment. Specifically, each executive officer has agreed
not to (i)&nbsp;solicit or entice away from the Company, any person, firm, company or organization that is or shall have been
at any time within 12 months prior to termination of employee a customer, client, identified prospective customer or client of
the Company or in the habit of dealing with the Company; (ii) employ, solicit or entice away from the Company any person who is
or shall have been on the date of or within 12 months prior to termination of employment an employee of the Company; or (iii)
assume employment with or provide services to, or otherwise engage in income generating activities with any of our competitors,
or engage, whether as principal, partner, licensor or otherwise, any of our competitors, without our express consent.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">Some
of our Appointment Letters also provide for the executive officer to participate in our mandatory provident fund, which is similar
to a pension fund.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Convertible
Bond</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">As
disclosed elsewhere in this prospectus, on April 6, 2018, we entered into a Bond Subscription Agreement for the Bond. Jurchen,
a company wholly-owned by our CEO, is the guarantor of the Bond. (See &ldquo;Description of Share Capital &ndash; Convertible
Bond&rdquo;)</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Leased
Facilities</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">Our
lease for our office at Guangdong Investment Tower is a Sub-Tenancy Agreement between Jurchen Investment Corporation and Aptus
Management Limited.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Other
Relationships</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">As
stated elsewhere in this prospectus, Dr. Cheng serves as our Chief Medical Officer and one of our Executive Directors, who is
also an Executive Director of Aptorum Medical. Dr. Cheng is also the guarantor on the AML Lease.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><A NAME="w15"></A>PRINCIPAL
AND SELLING SHAREHOLDERS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">The
following table sets forth information with respect to the beneficial ownership of our Class A Ordinary Shares (including Class
A Ordinary Shares issuable upon the conversion of outstanding Class B Ordinary Shares), subject to certain assumptions set forth
in the footnotes and as adjusted to reflect the sale of our Class A Ordinary Shares offered in this Offering for:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 0.5in; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 0.25in; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">each
    person or group of affiliated persons known by us to own beneficially 5% or more of our outstanding Class A Ordinary
    Shares or Class B Ordinary Shares;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -13.75pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 0.5in; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 0.25in; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">each
    of our directors and named executive officers individually; and</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 20.25pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 0.5in; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 0.25in; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">all
    of our executive officers and directors as a group.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 20.25pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">The
beneficial ownership of our Class A Ordinary Shares is determined in accordance with the rules of the SEC and generally includes
any shares over which a person exercises sole or shared voting or investment power, and includes the Class A Ordinary Shares issuable
upon the conversion of the outstanding Class B Ordinary Shares and the Class A Ordinary Shares issuable pursuant to share options
that are exercisable within 60 days of the date of this prospectus. Class A Ordinary Shares issuable pursuant to share options
are deemed outstanding for computing the percentage of the person holding such options but are not outstanding for computing the
percentage of any other person. As of the date of this prospectus, there were no Class A Ordinary Shares issuable pursuant to
share options exercisable within 60 days thereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">The
percentage of Class A Ordinary Shares beneficially owned prior to the Offering is based on 5,426,381 Class A Ordinary Shares outstanding
as of the date of this prospectus. The percentage of Class B Ordinary Shares beneficially owned prior to the Offering is based
on 22,437,754 Class B Ordinary Shares outstanding as of the date of this prospectus. Except where otherwise indicated, we believe,
based on information furnished to us by such owners, that the beneficial owners of the Class A Ordinary Shares and Class B Ordinary
Shares listed below have sole investment and voting power with respect to such shares.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<!-- Field: Page; Sequence: 123; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->115<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"><A HREF="#toc">Table of Contents</A></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: bottom; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="14" STYLE="border-bottom: black 1.5pt solid; text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Beneficial
    Ownership Prior to the Offering</B></FONT></TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="8" STYLE="border-bottom: black 1.5pt solid; text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Beneficial
    Ownership After the Offering</B></FONT></TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>%
    of Total Voting</B></FONT></TD></TR>
<TR STYLE="vertical-align: bottom; font-family: Times New Roman, Times, Serif">
    <TD STYLE="border-bottom: black 1.5pt solid; font-family: Times New Roman, Times, Serif"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Name
                                         and Address of</B></FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Beneficial</B></FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Owner<SUP>(1)</SUP></B></FONT></P></TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="6" STYLE="border-bottom: black 1.5pt solid; font-family: Times New Roman, Times, Serif"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><I>Class
                                         A</I></B></FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><I>Ordinary
        Shares</I></B></FONT></P></TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="6" STYLE="border-bottom: black 1.5pt solid; font-family: Times New Roman, Times, Serif"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><I>Class
                                         B</I></B></FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><I>Ordinary
        Shares</I></B></FONT></P></TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="4" STYLE="border-bottom: black 1.5pt solid; font-family: Times New Roman, Times, Serif"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><I>Class
                                         A</I></B></FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><I>Ordinary
        Shares</I></B></FONT></P></TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: black 1.5pt solid; text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Power
    (as-</B></FONT><FONT STYLE="font-family: Times New Roman, Times, Serif"><BR>
    <FONT STYLE="font-size: 10pt"><B>converted)*</B></FONT></FONT></TD></TR>
<TR STYLE="vertical-align: bottom; font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: black 1.5pt solid; text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Shares</B></FONT></TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: black 1.5pt solid; text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>%</B></FONT></TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: black 1.5pt solid; text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Shares</B></FONT></TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: black 1.5pt solid; text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>%</B></FONT></TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: black 1.5pt solid; text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Shares</B></FONT></TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: black 1.5pt solid; text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>%</B></FONT></TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: black 1.5pt solid; text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Shares</B></FONT></TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: white; font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 24%; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Directors
    and Named Executive Officers</I></FONT></TD>
    <TD STYLE="width: 1%; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 7%; text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 7%; text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 7%; text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 7%; text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 7%; text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 7%; text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 7%; text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 7%; text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: #CCEEFF; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ian
    Huen<SUP>(2)</SUP></FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,094,908</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">38.61</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">17,969,339</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">80.09</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: white; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Darren
    Lui<SUP>(3)</SUP></FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">522,148</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">9.62</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4,468,415</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">19.91</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: #CCEEFF; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Clark
    Cheng<SUP>(4)</SUP></FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: white; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Keith
    Chan</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: #CCEEFF; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Sabrina
    Khan</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: white; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Charles
    Bathurst</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: #CCEEFF; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mirko
    Scherer</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: white; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Justin
    Wu<SUP>(5)</SUP></FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">205,256</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.78</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: #CCEEFF; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Douglas
    Arner</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: white; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">All
    directors and executive officers as a group (9 persons)</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,822,312</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">52.01</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">22,437,754</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">100</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: #CCEEFF; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: white; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>5%
    Beneficial Owner</I></FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: #CCEEFF; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Jurchen
    Investment Corporation<SUP>(2)</SUP></FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,784,608</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">32.89</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">16,061,469</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">71.58</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: white; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Sui
    Fong Isabel Huen Ng<SUP>(2)</SUP></FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">211,986</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.91</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,907,870</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8.50</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: #CCEEFF; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">CGY
    Investments Limited<SUP>(3)</SUP></FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">471,809</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8.69</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4,015,367</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">17.90</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: white; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Adamas
    Ping An Opportunities Fund L.P., through its wholly-owned special purpose vehicle, Peace Range Limited</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 29px; text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Represents
    the voting power with respect to all of our Class A Ordinary Shares and Class B Ordinary Shares, voting as a single class
    and on an as-converted basis. Following this Offering, each Class B Ordinary Share can be converted at any time on a one-for-one
    basis into Class A Ordinary Share at the discretion of the holder. (See &ldquo;Description of Share Capital&rdquo;)</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 30px; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Unless
    otherwise indicated, the business address of each of the individuals is 17th Floor, Guangdong Investment Tower, 148 Connaught
    Road Central, Hong Kong.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 30px; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Includes
    (i) 1,784,608 Class A Ordinary Shares and 16,061,469 Class B Ordinary Shares held by Jurchen Investment Corporation, a company
    wholly-owned by Mr. Huen. Mr. Huen maintains sole voting control over the shares held by Jurchen, the principal office address
    of which is at 17th Floor, Guangdong Investment Tower, 148 Connaught Road Central, Hong Kong; (ii) 211,986 Class A Ordinary
    Shares and 1,907,870 Class B Ordinary Shares held by Sui Fong Isabel Huen Ng, the mother of Mr. Ian Huen; and (iii) 98,314
    Class A Ordinary Shares held by Huen Wing Sze Patricia, the sister of Mr. Huen. Due to close family relationship, we deem
    Mr. Huen controls and/or has substantial influence on the disposition rights and voting rights of the shares held by his mother
    and sister.</FONT></TD></TR>
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3)</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Includes
    (i) 50,339 Class A Ordinary Shares and 453,048 Class B Ordinary Shares held by DSF Investment Holdings Limited, which is wholly-owned
    by Mr. Lui and located at Flat A2, 11th Floor, Wing Hang Insurance Building, 11 Wing Kut Street, Hong Kong and (ii) 471,809
    Class A Ordinary Shares and 4,015,367 Class B Ordinary Shares held by CGY Investments Limited, which is 50% held by Seng Fun
    Yee, the spouse of Mr. Darren Lui, 25% held by Mandy Lui, a sister of Mr. Lui and 25% held by Adrian Lui, a brother of Mr.
    Lui. Due to close family relationship, we deem Mr. Lui controls and/or has substantial influence on the disposition rights
    and voting rights of the shares included herein.</FONT></TD></TR>
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(4)</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dr.
    Cheng does not directly own any Company shares; however, pursuant to his appointment letter, Dr. Cheng received a stock bonus
    in the amount of 5% of Aptorum Medical Limited&rsquo;s ordinary shares.</FONT></TD></TR>
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(5)</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Includes
    (i) 128,285 Class A Ordinary Shares held by Chi Ling Lily Heung, the wife of Dr. Wu and (ii) 76,971 Class A Ordinary Shares
    held by Dr. Wu.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<!-- Field: Page; Sequence: 124; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->116<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"><A HREF="#toc">Table of Contents</A></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Selling
Shareholders</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">We
are registering for resale our Class A Ordinary Shares underlying our Series A Note, Bond, Series A Note PA Warrants and Bond
PA Warrants identified below (the &ldquo;Resale Shares&rdquo;). The securities listed herein were issued in accordance with the
exemption from the registration provisions of the Securities Act of 1933, as amended, provided by Section 4(a)(2) of such Act
for issuances not involving any public offering and Rule 506 of Regulation D promulgated thereunder. We are registering the shares
to permit the Selling Shareholders and their pledgees, donees, transferees and other successors-in-interest that receive their
shares from a Selling Shareholder as a gift, partnership distribution or other non-sale related transfer after the date of this
prospectus to resell the shares when and as they deem appropriate in the manner described in the &ldquo;Plan of Distribution&rdquo;.&nbsp;As
of the date of this prospectus, there are 5,426,381&nbsp;Class A Ordinary Shares issued and outstanding.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">The
following table sets forth:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 0.5in; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 0.25in; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    name of the Selling Shareholders;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 0.5in; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 0.25in; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    number of our Class A Ordinary Shares that the Selling Shareholders beneficially owned prior to the offering for resale of
    the shares under this prospectus;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 0.5in; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 0.25in; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    maximum number of our Class A Ordinary Shares that may be offered for resale for the account of the Selling Shareholders under
    this prospectus; and</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 0.5in; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 0.25in; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    number and percentage of our Class A Ordinary Shares beneficially owned by the Selling Shareholders after the offering of
    the shares (assuming all of the offered shares are sold by the Selling Shareholders and the closing of this Offering).</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">Except
for Boustead, who served as our placement agent and an investor in the Series A Note Offering and Bond Offering and one of our
underwriters in this Offering, we have not had a material relationship with any of the Selling Shareholders within the last three
years.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">Boustead
was issued the warrants registered herein in exchange for services provided to us pursuant to an engagement agreement dated August
24, 2017, as amended on May 11, 2018. Other than Boustead, all of the Selling Shareholders named below received their securities
in connection with the Series A Note Offering or the Bond Offering.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">Pursuant
to the engagement agreement with Boustead, as amended, Boustead received the following compensation for acting as a placement
agent in the Series A Note Offering and the Bond Offering: (x) for the Series A Note Offering: (i) a cash success fee of $68,516
and (ii) the Series A Note PA Warrants; and (y) for the Bond Offering: (i) a cash success fee of $600,000 and (ii) the Bond PA
Warrants. Boustead also purchased $150,000 Series A Notes in the Series A Note Offering.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">China
Renaissance also acted as a placement agent for the Bond Offering. For such services, China Renaissance received a cash success
fee of $150,000.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">Except
for Boustead, none of the Selling Shareholders is a broker dealer.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<!-- Field: Page; Sequence: 125; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->117<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"><A HREF="#toc">Table of Contents</A></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">None
of the Selling Shareholders is an affiliate of a broker dealer. None of the Selling Shareholders has any agreement or understanding
to distribute any of the shares being registered.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">Each
Selling Shareholder may offer for sale all or part of the shares from time to time. The table below assumes that the Selling Shareholders
will sell all of the shares offered for sale. A Selling Shareholder is under no obligation, however, to sell any shares pursuant
to this prospectus.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">The
address for all Selling Shareholders is 17<SUP>th</SUP> Floor, Guangdong Investment Tower, 148 Connaught Road Central, Hong Kong.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: bottom; background-color: white; font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 20%; border-bottom: black 1.5pt solid; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Name&nbsp;of&nbsp;Selling&nbsp;Shareholder</B></FONT></TD>
    <TD STYLE="width: 1%; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 19%; border-bottom: black 1.5pt solid; font-family: Times New Roman, Times, Serif"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Class
                                         A Ordinary Shares</B></FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Beneficially</B></FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Owned&nbsp;Prior</B></FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>to&nbsp;Offering<SUP>(1)</SUP></B></FONT></P></TD>
    <TD STYLE="width: 1%; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 19%; border-bottom: black 1.5pt solid; font-family: Times New Roman, Times, Serif"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Maximum</B></FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Number&nbsp;of
        Class A Ordinary Shares to&nbsp;be</B></FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Sold<SUP>(2)</SUP></B></FONT></P></TD>
    <TD STYLE="width: 1%; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 19%; border-bottom: black 1.5pt solid; font-family: Times New Roman, Times, Serif"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Number&nbsp;of
                                         Class A Ordinary Shares Owned After</B></FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Offering<SUP>(3)</SUP></B></FONT></P></TD>
    <TD STYLE="width: 1%; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 17%; border-bottom: black 1.5pt solid; font-family: Times New Roman, Times, Serif"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Percentage</B></FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Ownership</B></FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>After</B></FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Offering<SUP>(4)</SUP></B></FONT></P></TD>
    <TD STYLE="width: 1%; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: #CCEEFF; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Bik-Chun
    Pauline Chan<SUP>(5)</SUP></FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[&nbsp;&nbsp;]</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;[&nbsp;&nbsp;]</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[&nbsp;&nbsp;]</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: white; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Lam
    Chan</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[&nbsp;&nbsp;]</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;[&nbsp;&nbsp;]</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[&nbsp;&nbsp;]</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: #CCEEFF; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">She
    Sam Chan<SUP>(6)</SUP></FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[&nbsp;&nbsp;]</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;[&nbsp;&nbsp;]</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[&nbsp;&nbsp;]</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: white; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Tat
    Ming Chan</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[&nbsp;&nbsp;]</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;[&nbsp;&nbsp;]</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[&nbsp;&nbsp;]</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: #CCEEFF; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Kin
    Wai Chan</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[&nbsp;&nbsp;]</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;[&nbsp;&nbsp;]</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[&nbsp;&nbsp;]</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: white; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Wai
    Yan Philip Chiu<SUP>(7)</SUP></FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[&nbsp;&nbsp;]</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;[&nbsp;&nbsp;]</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[&nbsp;&nbsp;]</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: #CCEEFF; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Kai
    Lai Chow</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[&nbsp;&nbsp;]</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;[&nbsp;&nbsp;]</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[&nbsp;&nbsp;]</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: white; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ellie
    Ngai<SUP>(8)</SUP></FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[&nbsp;&nbsp;]</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;[&nbsp;&nbsp;]</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[&nbsp;&nbsp;]</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: #CCEEFF; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Evangeline
    Lung</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[&nbsp;&nbsp;]</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;[&nbsp;&nbsp;]</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[&nbsp;&nbsp;]</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: white; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Tak
    Jim Fong</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[&nbsp;&nbsp;]</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;[&nbsp;&nbsp;]</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[&nbsp;&nbsp;]</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: #CCEEFF; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ka
    Yen Hung</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[&nbsp;&nbsp;]</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;[&nbsp;&nbsp;]</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[&nbsp;&nbsp;]</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: white; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">KHE
    Holdings Limited<SUP>(9)</SUP></FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[&nbsp;&nbsp;]</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;[&nbsp;&nbsp;]</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[&nbsp;&nbsp;]</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: #CCEEFF; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pik
    Shan Kong</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[&nbsp;&nbsp;]</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;[&nbsp;&nbsp;]</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[&nbsp;&nbsp;]</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: white; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Yuk
    Tong Lee</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[&nbsp;&nbsp;]</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;[&nbsp;&nbsp;]</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[&nbsp;&nbsp;]</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: #CCEEFF; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Leorich&nbsp;Management&nbsp;Limited<SUP>(10)</SUP></FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[&nbsp;&nbsp;]</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;[&nbsp;&nbsp;]</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[&nbsp;&nbsp;]</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: white; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Sai
    Yan Patrick Ma</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[&nbsp;&nbsp;]</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;[&nbsp;&nbsp;]</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[&nbsp;&nbsp;]</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: #CCEEFF; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chung
    Tong Vincent Mok<SUP>(11)</SUP></FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[&nbsp;&nbsp;]</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;[&nbsp;&nbsp;]</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[&nbsp;&nbsp;]</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: white; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Kum
    Yuen Gilbert Ng</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[&nbsp;&nbsp;]</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;[&nbsp;&nbsp;]</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[&nbsp;&nbsp;]</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: #CCEEFF; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chun
    Mo Ngan</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[&nbsp;&nbsp;]</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;[&nbsp;&nbsp;]</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[&nbsp;&nbsp;]</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: white; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Sharnie
    Wing San Wong</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[&nbsp;&nbsp;]</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;[&nbsp;&nbsp;]</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[&nbsp;&nbsp;]</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: #CCEEFF; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chin
    Yau Siah</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[&nbsp;&nbsp;]</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;[&nbsp;&nbsp;]</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[&nbsp;&nbsp;]</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: white; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Wing
    Yee So</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[&nbsp;&nbsp;]</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;[&nbsp;&nbsp;]</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[&nbsp;&nbsp;]</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: #CCEEFF; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Martin
    Pak Wai</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[&nbsp;&nbsp;]</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;[&nbsp;&nbsp;]</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[&nbsp;&nbsp;]</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: white; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ka
    Wai Wong<SUP>(12)</SUP></FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[&nbsp;&nbsp;]</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;[&nbsp;&nbsp;]</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[&nbsp;&nbsp;]</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: #CCEEFF; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Yuk
    Hwa Teresa Wong</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[&nbsp;&nbsp;]</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;[&nbsp;&nbsp;]</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[&nbsp;&nbsp;]</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: white; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Boustead
    Securities, LLC<SUP>(13)</SUP></FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[&nbsp;&nbsp;]</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;[&nbsp;&nbsp;]</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[&nbsp;&nbsp;]</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: #CCEEFF; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Man
    Wai Vivian Ng</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[&nbsp;&nbsp;]</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;[&nbsp;&nbsp;]</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[&nbsp;&nbsp;]</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: white; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Hung
    Cheung Tsui</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[&nbsp;&nbsp;]</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;[&nbsp;&nbsp;]</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[&nbsp;&nbsp;]</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: #CCEEFF; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Kinger
    Lau</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[&nbsp;&nbsp;]</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;[&nbsp;&nbsp;]</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[&nbsp;&nbsp;]</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: white; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Wei
    Shin Liu</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[&nbsp;&nbsp;]</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;[&nbsp;&nbsp;]</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[&nbsp;&nbsp;]</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: #CCEEFF; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Wai
    Keung Li</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[&nbsp;&nbsp;]</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;[&nbsp;&nbsp;]</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[&nbsp;&nbsp;]</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: white; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Kwok
    Wai Ng</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[&nbsp;&nbsp;]</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;[&nbsp;&nbsp;]</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[&nbsp;&nbsp;]</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: #CCEEFF; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Siu
    Man Simon Ng</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[&nbsp;&nbsp;]</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;[&nbsp;&nbsp;]</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[&nbsp;&nbsp;]</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: white; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Peace
    Range Limited<SUP>(14)</SUP></FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[&nbsp;&nbsp;]</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;[&nbsp;&nbsp;]</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[&nbsp;&nbsp;]</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 29px; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Represents
    beneficial ownership of less than one percent of our outstanding shares (assuming all of the offered shares are sold by the
    Selling Shareholders and the closing of this Offering).</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<!-- Field: Page; Sequence: 126; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->118<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"><A HREF="#toc">Table of Contents</A></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 5%; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)&nbsp;</FONT></TD>
    <TD STYLE="width: 95%; text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Unless
    otherwise noted, the Selling Shareholders became one of our shareholders pursuant to the Series A Note Offering and the Bond
    Offering.&nbsp;Accordingly, prior to this Offering, the Selling Shareholders only owned the Series A Notes, Class A Ordinary
    Shares underlying the Series A Notes, the Bond and Class A Ordinary Shares underlying the Bond, as to Boustead, the warrants
    and Class A Ordinary Shares underlying the warrants, as applicable, (collectively, the &ldquo;Resale Shares&rdquo;). The conversion
    price of the Series A Notes and Bond, as well as the exercise price of the various warrants are subject to certain anti-dilution
    provisions, which would be triggered if we were to sell securities at a price below the price at which we sold the Notes.&nbsp;(See
    &ldquo;Prospectus Summary &ndash; Recent Financings&rdquo;&nbsp;and &ldquo;Description of Share Capital&rdquo;)</FONT></TD></TR>
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
    number represents all of the Resale Shares that the Selling Shareholder received pursuant to the Series A Note Offering and
    the Bond Offering, which we agreed to register.</FONT></TD></TR>
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3)&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Since
    we do not have the ability to control how many, if any, of their shares each of the Selling Shareholders will sell, we have
    assumed that the Selling Shareholders will sell all of the shares offered herein for purposes of determining how many shares
    they will own after the Offering and their percentage of ownership following the offering.</FONT></TD></TR>
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(4)</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">All
    percentages have been rounded up to the nearest one hundredth of one percent.</FONT></TD></TR>
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(5)</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    shareholder is the mother-in-law of Dr. Jason Chan, a scientific assessment committee member of the Company. </FONT></TD></TR>
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(6)</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    shareholder is the father of Dr. Jason Chan, a scientific assessment committee member of the Company. </FONT></TD></TR>
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(7)</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    shareholder is a senior advisor of the Company. </FONT></TD></TR>
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(8)</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    shareholder is the mother of Dr. Clark Cheng, the Chief Medical Officer and a Director of the Company. </FONT></TD></TR>
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(9)</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">The
    person having voting, dispositive or investment powers over </FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">KHE
    Holdings Limited is [&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;], a family member to Dr. Yu. Dr. Yu is a member of our Scientific
    Assessment Committee. The address for KHE Holdings Limited is [&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;].</FONT></TD></TR>
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(10)</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">The
    person having voting, dispositive or investment powers over </FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Leorich
    Management Limited is [&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;]. The address for Leorich Management Limited is [&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;].</FONT></TD></TR>
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(11)</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">The
    shareholder is a senior advisor of the Company. </FONT></TD></TR>
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(12)</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">The
    shareholder is a principal investigator of certain SRAs of the Company.</FONT></TD></TR>
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(13)</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; background-color: white">Daniel
                                         McClory and Keith Moore jointly have voting, dispositive or investment powers over Boustead
                                         Securities, LLC. The address for Boustead Securities, LLC is 6 Venture, Suite 265, Irvine,
                                         CA 92618</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif">.</FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P></TD></TR>
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(14)</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">The
    person having voting, dispositive or investment powers over Peace Range Limited is Paul Lincoln Heffner. The address for Peace
    Range Limited is [&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;].</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0.5in; background-color: white"></P>

<!-- Field: Page; Sequence: 127; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->119<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"><A HREF="#toc">Table of Contents</A></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; background-color: white"><B><A NAME="w16"></A>PLAN
OF DISTRIBUTION</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">The
Selling Shareholders and any of their pledgees, donees, transferees, assignees and successors-in-interest may, from time to time,
sell any or all of their Resale Shares <FONT STYLE="font-weight: normal">at a fixed price until the Class A Ordinary Shares are
listed on NASDAQ and thereafter, the Selling Shareholders will be able sell their Class A Ordinary Shares at prevailing market
prices or privately negotiated prices.</FONT> The Selling Shareholders may use any one or more of the following methods when selling
Resale Shares once Class A Ordinary Shares are listed on NASDAQ:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 0.5in; font-family: Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 0.25in; font-family: Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ordinary
    brokerage transactions and transactions in which the broker-dealer solicits investors;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 0.5in; font-family: Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 0.25in; font-family: Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">block
    trades in which the broker-dealer will attempt to sell the Class A Ordinary Shares as agent but may position and resell a
    portion of the block as principal to facilitate the transaction;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 0.5in; font-family: Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 0.25in; font-family: Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">purchases
    by a broker-dealer as principal and resale by the broker-dealer for its account;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 0.5in; font-family: Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 0.25in; font-family: Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">an
    exchange distribution in accordance with the rules of the applicable exchange;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 0.5in; font-family: Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 0.25in; font-family: Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">privately
    negotiated transactions;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 0.5in; font-family: Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 0.25in; font-family: Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">to
    cover short sales made after the date that this registration statement is declared effective by the SEC;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 0.5in; font-family: Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 0.25in; font-family: Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">broker-dealers
    may agree with the Selling Shareholders to sell a specified number of such Resale Shares at a stipulated price per share;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 0.5in; font-family: Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 0.25in; font-family: Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">through
    the writing or settlement of options or other hedging transactions, whether through an options exchange or otherwise;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 0.5in; font-family: Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 0.25in; font-family: Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a
    combination of any such methods of sale; and</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 0.5in; font-family: Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 0.25in; font-family: Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">any
    other method permitted pursuant to applicable law.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">The
Selling Shareholders may also sell Resale Shares under Rule 144 under the Securities Act, if&nbsp;all of the conditions in Rule
144(i)(2) are satisfied at the time of the proposed sale, rather than under this prospectus.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">In
connection with the sale of the Resale Shares or interests therein, the Selling Shareholders may enter into hedging transactions
with broker-dealers or other financial institutions, which may in turn engage in short sales of the Resale Shares in the course
of hedging the positions they assume. The Selling Shareholders may also sell the Resale Shares short and deliver these securities
to close out their short positions, or loan or pledge the Resale Shares to broker-dealers that in turn may sell these securities.
The Selling Shareholders may also enter into option or other transactions with broker-dealers or other financial institutions
or the creation of one or more derivative securities which require the delivery to such broker-dealer or other financial institution
of Resale Shares offered by this prospectus, which shares such broker-dealer or other financial institution may resell pursuant
to this prospectus (as supplemented or amended to reflect such transaction).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">Broker-dealers
engaged by the Selling Shareholders may arrange for other brokers-dealers to participate in sales. Broker-dealers may receive
commissions or discounts from the Selling Shareholders (or, if any broker-dealer acts as agent for the purchaser of shares, from
the purchaser) in amounts to be negotiated. The Selling Shareholders do not expect these commissions and discounts to exceed what
is customary in the types of transactions involved.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<!-- Field: Page; Sequence: 128; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->120<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"><A HREF="#toc">Table of Contents</A></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">The
Selling Shareholders may from time to time pledge or grant a security interest in some or all of the Resale Shares owned by them
and, if they default in the performance of their secured obligations, the amendment or supplement to this prospectus under Rule
424(b)(3) or other applicable provision of the Securities Act of 1933&nbsp;will be filed amending the list of Selling Shareholders
to include the pledgee, transferee or other successors in interest as Selling Shareholders under this prospectus and the pledgees
or secured parties may offer and sell Resale Shares from time to time under the supplement or&nbsp;amendment to this prospectus.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">The
Selling Shareholders also may transfer the Resale Shares in other circumstances, in which case the transferees, pledgees or other
successors in interest will be the selling beneficial owners for purposes of this prospectus.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">The
Selling Shareholders are subject to certain lock up agreements which, subject to certain exceptions, prevent them from selling
or otherwise disposing of any of our shares, or any securities convertible into or exercisable or exchangeable for shares for
certain periods of time (respectively, a &ldquo;Lock Up Period&rdquo;). The Lock Up Period for the Series A Note Investors is
180 days following the date of this Offering. The Lock Up Period for the Bond holder is 90 days. None of the Selling Shareholders
may sell their shares prior to the end of their respective Lock Up Period without the prior written consent of the Underwriters.
The Underwriters may in their sole discretion and at any time without notice (except in the case of officers and directors) release
some or all of the shares subject to lock-up agreements prior to the expiration of the Lock Up Period. When determining whether
or not to release shares from the lock-up agreements, the underwriters may consider, among other factors, the shareholder&rsquo;s
reasons for requesting the release, the number of shares for which the release is being requested and market conditions at the
time.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">The
Selling Shareholders and any broker-dealers or agents that are involved in selling the Resale Shares may be deemed to be &ldquo;underwriters&rdquo;
within the meaning of the Securities Act in connection with such sales. In such event, any commissions received by such broker-dealers
or agents and any profit on the resale of the Resale Shares purchased by them may be deemed to be underwriting commissions or
discounts under the Securities Act. Discounts, concessions, commissions and similar selling expenses, if any, that can be attributed
to the sale of Resale Shares will be paid by the Selling Shareholder and/or the purchasers. Each Selling Shareholder has represented
and warranted to the Company that it acquired the securities subject to this registration statement in the ordinary course of
such Selling Shareholder&rsquo;s business and, at the time of its purchase of such securities such Selling Shareholder had no
agreements or understandings, directly or indirectly, with any person to distribute any such securities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">Boustead
is a registered broker dealer and Financial Industry Regulatory Authority (&ldquo;FINRA&rdquo;) member firm and listed as a Selling
Shareholder in this prospectus. Boustead served as placement agent for our Series A Note Offering, which was completed on May
15, 2018 and as one of the placement agents for our Bond Offering, which was completed on April 6, 2018.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">Pursuant
to the engagement agreement with Boustead, as amended, we paid Boustead a cash fee of $68,516 and shall issue them the Series
A Note PA Warrants for their placement agent services for the Series A Note Offering. In addition, we paid Boustead a cash fee
of $600,000 and the Bond PA Warrants for their placement agent services for the Bond Offering. The Resale Shares issuable upon
exercise of Boustead&rsquo;s placement agent warrants are transferable within Boustead or to its assigns or designees, at the
discretion of Boustead, and in accordance with the Securities Act of 1933, as amended. Boustead also participated in the Series
A Note Offering as an investor with a purchase of Series A Notes in the amount of $150,000.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">Boustead
is one of the underwriters in this Offering. Boustead does not have an underwriting agreement with the Selling Shareholders and
no Selling Shareholder is required to execute transactions through Boustead. Further, other than any existing brokerage relationship
as customers with Boustead, no Selling Shareholder has any pre-arranged agreement, written or otherwise, with Boustead to sell
their securities through Boustead.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">FINRA
Rule 5110 requires FINRA member firms (unless an exemption applies) to satisfy the filing requirements of Rule 5110 in connection
with the resale, on behalf of Selling Shareholders, of the securities on a principal or agency basis. NASD Notice to Members 88-101
states that in the event a Selling Shareholder intends to sell any of the shares registered for resale in this prospectus through
a member of FINRA participating in a distribution of our securities, such member is responsible for insuring that a timely filing,
if required, is first made with the Corporate Finance Department of FINRA and disclosing to FINRA the following:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 0.5in; text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 0.25in; text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">it
    intends to take possession of the registered securities or to facilitate the transfer of such certificates;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<!-- Field: Page; Sequence: 129; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->121<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"><A HREF="#toc">Table of Contents</A></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 0.5in; text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 0.25in; text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    complete details of how the Selling Shareholders&rsquo; shares are and will be held, including location of the particular
    accounts;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 0.5in; text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 0.25in; text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">whether
    the member firm or any direct or indirect affiliates thereof have entered into, will facilitate or otherwise participate in
    any type of payment transaction with the Selling Shareholders, including details regarding any such transactions; and</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 0.5in; text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 0.25in; text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">in
    the event any of the securities offered by the Selling Shareholders are sold, transferred, assigned or hypothecated by any
    Selling Shareholder in a transaction that directly or indirectly involves a member firm of FINRA or any affiliates thereof,
    that prior to or at the time of said transaction the member firm will timely file all relevant documents with respect to such
    transaction(s) with the Corporate Finance Department of FINRA for review.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">No
FINRA member firm may receive compensation in excess of that allowable under FINRA rules, including Rule 2710, in connection with
the resale of the securities by the Selling Shareholders, which total compensation may not exceed 8%.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">We
have advised each Selling Shareholder that it may not use shares registered on this registration statement to cover short sales
of Resale Shares made prior to the date on which this registration statement shall have been declared effective by the SEC. If
a Selling Shareholder uses this prospectus for any sale of the Resale Shares, it will be subject to the prospectus delivery requirements
of the Securities Act. The Selling Shareholders will be responsible to comply with the applicable provisions of the Securities
Act and Exchange Act, and the rules and regulations thereunder promulgated, including, without limitation, Regulation M, as applicable
to such Selling Shareholders in connection with resales of their respective Resale Shares under this registration statement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">We
are required to pay all fees and expenses incident to the registration of the Resale Shares, but the Company will not receive
any proceeds from the sale of the Resale Shares. The Company has agreed to indemnify the Selling Shareholders against certain
losses, claims, damages and liabilities, including liabilities under the Securities Act.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><A NAME="w17"></A>SHARES
ELIGIBLE FOR FUTURE SALE</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 34pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Prior
to this Offering, no public market existed for our Class A Ordinary Shares. We cannot assure you that a liquid trading market
for our ordinary shares will develop on NASDAQ or be sustained after this offering. Once approved for listing on NASDAQ, sales
of substantial amounts of our Class A Ordinary Shares following this Offering, or the perception that these sales could occur,
could adversely affect prevailing market prices of our Class A Ordinary Shares and could impair our future ability to obtain capital,
especially through an offering of equity securities. We will have an aggregate of [&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;]
Class A Ordinary Shares outstanding upon the closing of this Offering. Of these shares, the [&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;]
Class A Ordinary Shares sold in this Offering will be freely tradable without restriction or further registration under the Securities
Act, unless purchased by &ldquo;affiliates&rdquo; (as that term is defined under Rule 144 of the Securities Act, or Rule 144),
who may sell only the volume of shares described below and whose sales would be subject to additional restrictions described below.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">Upon
completion of this Offering and assuming the issuance of&nbsp;[&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;] Class A Ordinary
Shares offered hereby, we will have an aggregate of [&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;] Class A Ordinary Shares
outstanding, or [&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;] if the maximum number of shares are sold in this offering.&nbsp;The&nbsp;shares
sold in this offering or sold by the Selling Shareholders will be freely tradable without restriction or further registration
under the Securities Act.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">As
of the date of this prospectus, [&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;] Class A Ordinary Shares held by existing shareholders
are deemed &ldquo;restricted securities&rdquo; as that term is defined in Rule 144 and may not be resold except pursuant to an
effective registration statement or an applicable exemption from registration, including Rule 144. [&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;]
of our currently outstanding Class A Ordinary Shares will be subject to &ldquo;lock-up&rdquo; agreements described below on the
effective date of this Offering.&nbsp;Upon expiration of the respective lock-up periods after the date of this prospectus, outstanding
shares will become eligible for sale, subject in most cases to the limitations of Rule 144.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: bottom; background-color: white; font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 30%; border-bottom: black 1.5pt solid; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Days
After Date of this Prospectus</B></FONT></TD>
    <TD STYLE="width: 1%; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 18%; border-bottom: black 1.5pt solid; text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Shares
    Eligible</B></FONT><FONT STYLE="font-family: Times New Roman, Times, Serif"><BR>
    <FONT STYLE="font-size: 10pt"><B>for Sale</B></FONT></FONT></TD>
    <TD STYLE="width: 1%; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 50%; border-bottom: black 1.5pt solid; text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Comment</B></FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: #CCEEFF; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Upon
    Effectiveness</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[&nbsp;&nbsp;]</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Freely
    tradable shares sold in the offering.</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: white; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: #CCEEFF; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">90
    days</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[&nbsp;&nbsp;]</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Shares
    saleable under Rule 144 and after expiration of the lock-up.</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: white; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: #CCEEFF; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Six
    months</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[&nbsp;&nbsp;]</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Shares
    saleable under Rule 144 and after expiration of the lock-up.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<!-- Field: Page; Sequence: 130; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->122<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"><A HREF="#toc">Table of Contents</A></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Regulation
S</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">Regulation
S under the Securities Act provides an exemption from registration requirements in the United States for offers and sales of securities
that occur outside the United States. Rule 903 of Regulation S provides the conditions to the exemption for a sale by an issuer,
a distributor, their respective affiliates or anyone acting on their behalf, while Rule 904 of Regulation S provides the conditions
to the exemption for a resale by persons other than those covered by Rule 903. In each case, any sale must be completed in an
offshore transaction, as that term is defined in Regulation S, and no directed selling efforts, as that term is defined in Regulation
S, may be made in the United States.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">We
are a foreign issuer as defined in Regulation S. As a foreign issuer, securities that we sell outside the United States pursuant
to Regulation S are not considered to be restricted securities under the Securities Act, and are freely tradable without registration
or restrictions under the Securities Act, unless the securities are held by our affiliates. Generally, subject to certain limitations,
holders of our restricted shares who are not our affiliates or who are our affiliates solely by virtue of their status as an officer
or director of us may, under Regulation S, resell their restricted shares in an &ldquo;offshore transaction&rdquo; if none of
the seller, its affiliate nor any person acting on their behalf engages in directed selling efforts in the United States and,
in the case of a sale of our restricted shares by an officer or director who is an affiliate of us solely by virtue of holding
such position, no selling commission, fee or other remuneration is paid in connection with the offer or sale other than the usual
and customary broker&rsquo;s commission that would be received by a person executing such transaction as agent. Additional restrictions
are applicable to a holder of our restricted shares who will be an affiliate of us other than by virtue of his or her status as
an officer or director of us.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">We
are not claiming the potential exemption offered by Regulation S in connection with the offering of newly issued shares outside
the United States and will register all of the newly issued shares under the Securities Act.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Rule
144</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">In
general, under Rule 144, beginning ninety days after the date of this prospectus, a person who is not our affiliate and has not
been our affiliate at any time during the preceding three months will be entitled to sell any ordinary shares that such person
has held for at least six months, including the holding period of any prior owner other than one of our affiliates, without regard
to volume limitations.&nbsp;Sales of our ordinary shares by any such person would be subject to the availability of current public
information about us if the shares to be sold were held by such person for less than one year.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">In
addition, under Rule 144, a person may sell our ordinary shares acquired from us immediately upon the completion of this offering,
without regard to volume limitations or the availability of public information about us, if:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 0.5in; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 0.25in; text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    person is not our affiliate and has not been our affiliate at any time during the preceding three months; and</FONT></TD></TR>
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    person has beneficially owned the shares to be sold for at least six months, including the holding period of any prior owner
    other than one of our affiliates.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">Beginning
ninety days after the date of this prospectus, our affiliates who have beneficially owned our ordinary shares for at least six
months, including the holding period of any prior owner other than another of our affiliates, would be entitled to sell within
any three-month period those shares and any other shares they have acquired that are not restricted securities, provided that
the aggregate number of shares sold does not exceed the greater of:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 0.5in; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 0.25in; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1%
    of the number of our ordinary shares then outstanding, which will equal approximately ordinary shares immediately after this
    offering; or</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 0.5in; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 0.25in; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    average weekly trading volume in our ordinary shares on the listing exchange during the four calendar weeks preceding the
    filing of a notice on Form 144 with respect to such sale.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">Sales
under Rule 144 by our affiliates are generally subject to the availability of current public information about us, as well as
certain &ldquo;manner of sale&rdquo; and notice requirements.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<!-- Field: Page; Sequence: 131; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->123<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"><A HREF="#toc">Table of Contents</A></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Lock-up
Agreements</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">See
&ldquo;Description of Share Capital &ndash; Lock-up Agreements&rdquo; for a description of the lock up agreement imposed upon
certain of our shareholders.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Rule
701</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">In
general, under Rule 701 of the Securities Act as currently in effect, each of our employees, consultants or advisors who purchases
our ordinary shares from us in connection with a compensatory stock or option plan or other written agreement relating to compensation
is eligible to resell such ordinary shares 90 days after we became a reporting company under the Exchange Act in reliance on Rule
144, but without compliance with some of the restrictions, including the holding period, contained in Rule 144. However, these
shares would remain subject to lock-up arrangements and would only become eligible for sale when the lock-up period expires.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><A NAME="w18"></A>DESCRIPTION
OF SHARE CAPITAL</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">We
are a Cayman Islands exempted company with limited liability and our affairs are governed by our Memorandum and Articles, the
Companies Law, the common law of the Cayman Islands, our corporate governance documents and rules and regulations of the stock
exchange on which are shares are traded.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">As
of the date of the prospectus, the authorized share capital of the Company is $100,000,000, consisting of 60,000,000 Class A Ordinary
Shares, par value $1.00 each and 40,000,000 Class B Ordinary Shares, par value $1.00 each. As of the date of this prospectus,
5,426,381 Class A Ordinary Shares and 22,437,754 Class B Ordinary Shares are issued and outstanding. All of our issued and outstanding
Class A Ordinary Shares and Class B Ordinary Shares are fully paid. Immediately upon the completion of this Offering, there will
be [&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;] Class A Ordinary Shares and [&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;]
Class B Ordinary Shares outstanding.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 22.25pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><I>Ordinary
Shares</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">The
following are summaries of material provisions of our Memorandum and Articles, corporate governance policies and the Companies
Law insofar as they relate to the material terms of our Class A Ordinary Shares and Class B Ordinary Shares.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><I>Objects
of Our Company </I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">Under
our Memorandum and Articles, the objects of our Company are unrestricted and we have the full power and authority to carry out
any object not prohibited by the law of the Cayman Islands.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><I>Share
Capital</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">Our
authorized share capital is divided into Class A Ordinary Shares and Class B Ordinary Shares. Holders of our Class A Ordinary
Shares and Class B Ordinary Shares will have the same rights except for voting rights and conversion rights.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">The
holders of Class A Ordinary Shares are entitled to one vote for each such share held and shall be entitled to notice of any shareholders&rsquo;
meeting, and, subject to the terms of Memorandum and Articles, to vote thereat. The Class A Ordinary Shares are not redeemable
at the option of the holder and are not convertible into shares of any other class.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<!-- Field: Page; Sequence: 132; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->124<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"><A HREF="#toc">Table of Contents</A></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">The
holders of Class B Ordinary Shares shall have the right to ten votes for each such share held, and shall be entitled to notice
of any shareholders&rsquo; meeting and, subject to the terms of the Memorandum and Articles, to vote thereat. The Class B Ordinary Shares
are not redeemable at the option of the holder but are convertible into Class A Ordinary Shares at any time after issue at the
option of the holder on a one to one basis.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><I>Dividends
</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">The
holders of our Class A Ordinary Shares and Class B Ordinary Shares are entitled to such dividends as may be declared by our Board
of Directors subject to the Companies Law and to our Memorandum and Articles.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><I>Voting
Rights </I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">In
respect of all matters subject to a shareholders&rsquo; vote, each Class B Ordinary Share is entitled to ten votes, and each Class
A Ordinary Share is entitled to one vote, voting together as one class. Voting at any shareholders&rsquo; meeting is by show of
hands unless a poll is demanded by the chairman or persons holding certain amounts of shares as set forth in the Memorandum and
Articles. Actions that may be taken at a general meeting also may be taken by a unanimous resolution of the shareholders in writing.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">No
business shall be transacted at any general meeting unless a quorum of members is present at the time when the meeting proceeds
to business; two members present in person or by proxy, one of whom shall be the holder of the majority of the shares in the Company,
shall be a quorum provided always that if the Company has one member of record the quorum shall be that one member present in
person or by proxy. An ordinary resolution to be passed at a general meeting requires the affirmative vote of a simple majority
of the votes cast, while a special resolution requires the affirmative vote of at least two-thirds of votes cast at a general
meeting. A special resolution will be required for important matters.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">A
special resolution of members is required to change the name of the Company, approve a merger, wind up the Company, amend the
Memorandum and Articles and reduce the share capital.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><I>Conversion</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">Class
A Ordinary Shares are not convertible. Each Class B Ordinary Share shall be convertible, at the option of the holder thereof,
into such number of fully paid and non-assessable Class A Ordinary Shares on the basis that one Class B Ordinary Share shall be
converted into one Class A Ordinary Share (being a 1:1 ratio and hereafter referred to as the &ldquo;<B>Conversion Rate</B>&rdquo;),
subject to adjustment.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><I>Transfer
of Ordinary Shares </I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">Subject
to the restrictions set out below, any of our shareholders may transfer all or any of his, its or her Class A Ordinary Shares
or Class B Ordinary Shares by an instrument of transfer in the usual or common form or any other form approved by our Board of
Directors or in a form prescribed by the stock exchange on which our shares are then listed.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">Our
Board of Directors may, in its sole discretion, decline to register any transfer of any Class A Ordinary Shares or Class B Ordinary
Shares whether or not it is fully paid up to the total consideration paid for such shares. Our directors may also decline to register
any transfer of any Class A Ordinary Shares or Class B Ordinary Shares if (a) the instrument of transfer is not accompanied by
the certificate covering the shares to which it relates or any other evidence as our Board of Directors may reasonably require
to prove the title of the transferor to, or his/her right to transfer the shares; or (b) the instrument of transfer is in respect
of more than one class of shares.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">If
our directors refuse to register a transfer, they shall, within two months after the date on which the instrument of transfer
was lodged, send to the transferee notice of such refusal.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">The
registration of transfers may be suspended and the register closed at such times and for such periods as our Board of Directors
may from time to time determine, provided, however, that the registration of transfers shall not be suspended nor the register
closed for more than 30 days in any year.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"></P>

<!-- Field: Page; Sequence: 133; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->125<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"><A HREF="#toc">Table of Contents</A></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><I>Winding-Up/Liquidation
</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">On
a return of capital on winding up or otherwise (other than on conversion, redemption or purchase of shares), a liquidator may
be appointed to determine how to distribute the assets among the holders of the Class A Ordinary Shares and Class B Ordinary Shares.
If our assets available for distribution are insufficient to repay all of the paid-up capital, the assets will be distributed
so that the losses are borne by our shareholders proportionately; a similar basis will be employed if the assets are more than
sufficient to repay the whole of the capital at the commencement of the winding up.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><I>Calls
on Ordinary Shares and Forfeiture of Ordinary Shares </I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">Our
Board of Directors may from time to time make calls upon shareholders for any amounts unpaid on their Class A Ordinary Shares
or Class B Ordinary Shares in a notice served to such shareholders at least 14 days prior to the specified time and place of payment.
The shares that have been called upon and remain unpaid on the specified time are subject to forfeiture.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><I>Redemption
of Shares </I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">We
may issue shares on terms that are subject to redemption, at our option or at the option of the holders, on such terms and in
such manner as may be determined by our Board of Directors.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><I>Variations
of Rights of Shares </I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">All
or any of the special rights attached to any class of shares may, be varied with the resolution of at least two thirds of the
issued shares of that class or a resolution passed at a general meeting of the holders of the shares of that class present in
person or by proxy or with the consent in writing of the holders of at least two-thirds of the issued shares of that class.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><I>Inspection
of Books and Records </I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">Directors
shall from time to time determine whether and to what extent and at what times and places and under what conditions or regulations
the accounts and books of the Company or any of them shall be open to the inspection of members not being Directors and no member
(not being a Director) shall have any right of inspecting any account or book or document of the Company except as conferred by
Companies Law or authorized by the Directors or by the Company in a general meeting. However, the Directors shall from time to
time cause to be prepared and to be laid before the Company in a general meeting, profit and loss accounts, balance sheets, group
accounts (if any) and such other reports and accounts as may be required by Companies Law. (See &ldquo;Where You Can Find More
Information&rdquo;)</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><I>Issuance
of Additional Shares </I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">Our
Memorandum and Articles authorize our Board of Directors to issue additional Class A Ordinary Shares or Class B Ordinary Shares
from time to time as our Board of Directors shall determine, to the extent there are available authorized but unissued shares.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">Our
Memorandum and Articles also authorizes our Board of Directors to establish from time to time one or more series of preferred
shares and to determine, subject to compliance with the variation of rights of shares provision in the Memorandum and Articles,
with respect to any series of preferred shares, the terms and rights of that series, including:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 0.5in; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 0.25in; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    designation of the series;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 40.25pt; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 0.5in; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 0.25in; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    number of shares of the series;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 40.25pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 0.5in; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 0.25in; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    dividend rights, dividend rates, conversion rights, voting rights; and</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 40.25pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 0.5in; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 0.25in; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    rights and terms of redemption and liquidation preferences.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<!-- Field: Page; Sequence: 134; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->126<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"><A HREF="#toc">Table of Contents</A></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">Our
Board of Directors may, issue preferred shares without action by our shareholders to the extent there are authorized but unissued
shares available. Issuance of additional shares may dilute the voting power of holders of Class A Ordinary Shares and Class B
Ordinary Shares. However, our Memorandum of Association provides for authorized share capital comprising Class A Ordinary Shares
and Class B Ordinary Shares and to the extent the rights attached to any class may be varied, the Company must comply with the
provisions in the Memorandum and Articles relating to variations to rights of shares.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><I>Anti-Takeover
Provisions</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">Some
provisions of our Memorandum and Articles may discourage, delay or prevent a change of control of our Company or management that
shareholders may consider favorable, including provisions that:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 0.5in; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 0.25in; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">authorize
    our Board of Directors to issue preferred shares in one or more series and to designate the price, rights, preferences, privileges
    and restrictions of such preferred shares without any further vote or action by our shareholders (subject to variation of
    rights of shares provisions in our Memorandum and Articles); and</FONT></TD></TR>
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">limit
    the ability of shareholders to requisition and convene general meetings of shareholders. Our Memorandum and Articles allow
    our shareholders holding shares representing in aggregate not less than ten percent of our paid up share capital (as to the
    total consideration paid for such shares) in issue to requisition an extraordinary general meeting of our shareholders, in
    which case our directors are obliged to call such meeting and to put the resolutions so requisitioned to a vote at such meeting.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">However,
under Cayman Islands law, our directors may only exercise the rights and powers granted to them under our Memorandum and Articles
for a proper purpose and for what they believe in good faith to be in the best interests of our Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><I>General
Meetings of Shareholders and Shareholder Proposals </I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">Our
shareholders&rsquo; general meetings may be held in such place within or outside the Cayman Islands as our Board of Directors
considers appropriate.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">As
a Cayman Islands exempted company, we are not obliged by the Companies Law to call shareholders&rsquo; annual general meetings.
However, our Memorandum and Articles provide that we shall hold a general meeting in each year as our annual general meeting other
than the year in which the Memorandum and Articles were adopted at such time and place as determined by the directors. The directors
may, whenever they think fit, convene an extraordinary general meeting.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">Shareholders&rsquo;
annual general meetings and any other general meetings of our shareholders may be convened by a majority of our Board of Directors.
Our Board of Directors shall give not less than seven days&rsquo; written notice of a shareholders&rsquo; meeting to those persons
whose names appear as members in our register of members on the date the notice is given (or on any other date determined by our
directors to be the record date for such meeting) and who are entitled to vote at the meeting.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">Cayman
Islands law provides shareholders with only limited rights to requisition a general meeting, and does not provide shareholders
with any right to put any proposal before a general meeting. However, these rights may be provided in a company&rsquo;s articles
of association. Our Memorandum and Articles allow our shareholders holding shares representing in aggregate not less than ten
percent of our paid up share capital (as to the total consideration paid for such shares) in issue to requisition an extraordinary
general meeting of our shareholders, in which case our directors are obliged to call such meeting and to put the resolutions so
requisitioned to a vote at such meeting; otherwise, our Memorandum and Articles do not provide our shareholders with any right
to put any proposals before annual general meetings or extraordinary general meetings not called by such shareholders.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><I>Exempted
Company </I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">We
are an exempted company with limited liability under the Companies Law. The Companies Law distinguishes between ordinary resident
companies and exempted companies. A Cayman Islands exempted company:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 0.5in; text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 0.25in; text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">is
    a company that conducts its business mainly outside of the Cayman Islands;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">is
    exempted from certain requirements of the Companies Law, including the filing an annual return of its shareholders with the
    Registrar of Companies or the Immigration Board;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">does
    not have to make its register of members open for inspection;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<!-- Field: Page; Sequence: 135; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->127<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"><A HREF="#toc">Table of Contents</A></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 0.5in; text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 0.25in; text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">does
    not have to hold an annual general meeting;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">may
    issue negotiable or bearer shares or shares with no par value (subject to the provisions of the Companies Law);</FONT></TD></TR>
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">may
    obtain an undertaking against the imposition of any future taxation (such undertakings are usually given for 20 years in the
    first instance); and</FONT></TD></TR>
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">may
    register by way of continuation in another jurisdiction and be deregistered in the Cayman Islands.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">&ldquo;Limited
liability&rdquo; means that the liability of each shareholder is limited to the amount unpaid by the shareholder on the shares
of the company (except in exceptional circumstances, such as involving fraud, the establishment of an agency relationship or an
illegal or improper purpose or other circumstances in which a court may be prepared to pierce or lift the corporate veil).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><I>Register
of Members</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">Under
Cayman Islands law, we must keep a register of members and there should be entered therein:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 0.5in; text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 0.25in; text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    names and addresses of the members, a statement of the shares held by each member, and of the amount paid or agreed to be
    considered as paid, on the shares of each member;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    date on which the name of any person was entered on the register as a member; and</FONT></TD></TR>
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    date on which any person ceased to be a member.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">Under
Cayman Islands law, the register of members of our Company is prima facie evidence of the matters set out therein (i.e. the register
of members will raise a presumption of fact on the matters referred to above unless rebutted) and a member registered in the register
of members is deemed as a matter of Cayman Islands law to have legal title to the shares as set against its name in the register
of members. Once our register of members has been updated, the shareholders recorded in the register of members are deemed to
have legal title to the shares set against their name.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">If
the name of any person is incorrectly entered in, or omitted from, our register of members, or if there is any default or unnecessary
delay in entering on the register the fact of any person having ceased to be a member of our Company, the person or member aggrieved
(or any member of our Company or our Company itself) may apply to the Cayman Islands Grand Court for an order that the register
be rectified, and the Court may either refuse such application or it may, if satisfied of the justice of the case, make an order
for the rectification of the register.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><I>Indemnification
of Directors and Executive Officers and Limitation of Liability </I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">Cayman
Islands law does not limit the extent to which a company&rsquo;s memorandum and articles of association may provide for indemnification
of officers and directors, except to the extent any such provision may be held by the Cayman Islands courts to be contrary to
public policy, such as to provide indemnification against civil fraud or the consequences of committing a crime. Our Memorandum
and Articles require us to indemnify our officers and directors for actions, proceedings, claims, losses, damages, costs, liabilities
and expenses (&ldquo;Indemnified Losses&rdquo;) incurred in their capacities as such unless such Indemnified Losses arise from
dishonesty of such directors or officers. This standard of conduct is generally the same as permitted under the Delaware General
Corporation Law for a Delaware corporation.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">Insofar
as indemnification for liabilities arising under the Securities Act may be permitted to our directors, officers or persons controlling
us under the foregoing provisions, we have been informed that in the opinion of the SEC, such indemnification is against public
policy as expressed in the Securities Act and is therefore unenforceable.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></P>

<!-- Field: Page; Sequence: 136; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->128<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"><A HREF="#toc">Table of Contents</A></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><I>Convertible
Bond</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">As
of the date of this prospectus, we have a $15,000,000 Bond outstanding; we were required to pay a structuring fee equal to 2%
of the principal amount of the Bond to the subscriber at issuance. The following are summaries of material terms of the Subscription
Agreement for the Bond and the Bond itself; such summaries do not purport to be a complete description of the terms, the Subscription
Agreement or any transactions contemplated by the Subscription Agreement and you are urged to read the agreements in their entirety.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><I>Conversion
</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">Upon
the closing of this Offering, 10% of the then-outstanding Principal Amount shall automatically convert into Class A Ordinary Shares.
The holders of the Bond also maintain the right to convert the Bond following the closing of this Offering, until the earlier
of: (i) the date falling 12 calendar months after the Maturity Date or the Extended Maturity Date (as such terms are defined in
the Bond), as the case may be (both days inclusive); and (ii) the date falling 12 calendar months after the closing of this Offering.
Subject to adjustment, the Bond shall convert at the following conversion price (the &ldquo;Conversion Price&rdquo;):</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 24px; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 24px; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(A)</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">if
    this Offering closes on or before the date falling 12 calendar months after April 25, 2018 (the date we issued the Bond),
    at a discount of 23.0% to the initial public offering price; or</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 63pt; text-align: justify; text-indent: -27pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 24px; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 24px; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(B)</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">if
    this Offering closes after the date falling 12 calendar months after April 25, 2018, at a discount of 28.0% to the initial
    public offering price.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 63pt; text-align: justify; text-indent: -27pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">If
any interest has been accrued and/or paid by us to the holders of the Bond prior to the closing of this Offering, 50% of such
accrued or paid interest shall be deducted from the discount set forth above when determining the Bond Conversion Price. The number
of Class A Ordinary Shares to be issued upon conversion of the Bond shall be determined by dividing the principal amount of the
Bond to be converted by the Conversion Price in effect on the relevant conversion date.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><I>Interest</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 35.45pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">The
Bond accrue interest at the rate of 8% per annum, payable semi-annually in arrears in equal instalments of $10,000 per Calculation
Amount (as defined below) on the date falling on the 6th calendar month following the Issue Date and the date falling on the 12th
calendar month following the Issue Date, and if the Maturity Date is extended to the Extended Maturity Date, on the date falling
on the 18th calendar month following the Issue Date.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 35.45pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Interest
in respect of any Bond shall be calculated per $250,000 in principal amount of the Bond (the &ldquo;Calculation Amount&rdquo;).
The amount of interest payable per Calculation Amount for any period shall, save as provided above in relation to equal instalments,
be equal to the product of 8% per annum, the Calculation Amount and the day-count fraction (as determined in accordance with the
formula set forth in Schedule 1 to the Subscription Agreement) for the relevant period, rounding the resulting figure to the nearest
cent ($0.005 being rounded upward).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 35.45pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">The
interest rate shall increase upon the occurrence of an event of default, as set forth in Schedule 1 to the Subscription Agreement
(the &ldquo;Default Interest Rate&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><I>Event
of Default</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 35.45pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Upon
the occurrence of an event of default, the holder of the Bond may give us and Jurchen notice that the Bond are, and they shall
immediately become, due and repayable at their principal amount together with interest, at the Default Interest Rate.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 35.45pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Events
of default include non-payment of any sums due under the Bond, failure to deliver any shares due under the Bond, breach of our
covenants, representations and warranties, breach of our obligations under other liabilities or indebtedness, enforcement proceedings,
our insolvency, if the holders of the Bond cease to have adequate control over the Debt Service Reserve Account and if the guarantee
or security rights are not enforceable. The Subscription Agreements allows for some cure periods and/or notice prior to declaring
the Bond due.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><I>Redemption
Rights</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 35.45pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">So
long as any Bond remains outstanding, we may redeem such outstanding Bond in whole, but not in part, in accordance with the terms
set forth in Schedule 1 to the Subscription Agreement, by giving not less than 15 days&rsquo; notice to the holders of the Bond.
We are entitled to exercise this option so long as an Event of Default has not occurred and is not continuing.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<!-- Field: Page; Sequence: 137; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->129<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"><A HREF="#toc">Table of Contents</A></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 35.45pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Following
the occurrence of certain specified events, including if our Class A Ordinary Shares cease to be listed on the relevant stock
exchange or a change in control, the holders of the Bond have the right to require us to redeem all but not some of the Bond at
the rate of 100% of the outstanding Bond, including interest and agreed upon premiums.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><I>Security
and Guarantee</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 35.45pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Pursuant
to the Subscription Agreement we are required to deposit that amount of money equal to (i) 2% of the Principal Amount plus (ii)
the amount of Peace Range&rsquo;s expenses, which shall be agreed in writing between us and Peace Range five business days prior
to the Issue Date, plus (iii) an amount in US dollars equal to the aggregate amount of interest due and payable for two consecutive
interest periods commencing from, and including, the Interest Date, into a separate escrow account (the &ldquo;Debt Service Reserve
Account&rdquo;), over which the holders of the Bond maintain control while the Bond remains outstanding. Peace Range&rsquo;s expenses
are subject to a limit of $250,000, $225,000 of which we paid prior to signing the Subscription Agreement; Peace Range is also
entitled to reimbursement, subject to a $25,000 annual limit, for costs and expenses in relation to the on-going monitoring of
our business and operations in accordance with the terms of the Bond.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 35.45pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Our
obligations, along with those of Jurchen under the Bond and in connection with the transaction contemplated thereby are secured
by: (i) 1,393,207 Class B Ordinary Shares, representing 5% of the Class A Ordinary Shares issuable upon conversion of our issued
and outstanding Class B Ordinary Shares as of the Issue Date, held by Jurchen and (ii) a security interest in the Debt Service
Reserve Account.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><I>Negative
Covenants</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">The
Subscription Agreement contains certain negative covenants, including our inability to incur certain liabilities before and after
the closing of this Offering without the Bond holders&rsquo; prior written consent, limits on our ability to issue equity securities
and limits on certain corporate actions.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><I>Voting
Rights</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 35.45pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Pursuant
to the Subscription Agreement, Jurchen agreed to exercise its voting rights in our Company to have one board observer or one Non-Executive
Director nominated by Peace Range to be appointed to our Board of Directors in the future.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><I>Lock-Up</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 35.45pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">So
long as an event of default under the Bond is not occurring, Peace Range agreed not to directly or indirectly, sell or otherwise
transfer any of the shares underlying the Bond for a period of 90 calendar days following the first trading day after the closing
of this Offering.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><I>Termination
Rights</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">Peace
Range maintains the right to terminate the Subscription Agreement prior to the Issue Date under certain circumstances, including
our breach of any of our representations, warranties or undertakings or a change in national or international economic conditions
that Peace Range believes would materially prejudice the success of the transaction contemplated by the Subscription Agreement.
Following such termination, we shall remain liable to pay certain fees to Peace Range, as set forth in the Subscription Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">We
maintain the right to terminate the Subscription Agreement prior to the Issue Date if Peace Range breaches any of its representations
and warranties or upon the occurrence of an event that renders such untrue or incorrect. Following such termination, we shall
remain liable for Peace Range&rsquo;s out of pocket expenses (including legal and due diligence fees).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><I>Bond
PA Warrants</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 22.25pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">As
of the date of this prospectus, we have Bond PA Warrants outstanding. The following are summaries of material terms of the Bond
PA Warrants; such summaries do not purport to be a complete description of the terms of the Bond PA Warrants and you are urged
to read the warrant agreement in its entirety.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 22.25pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<!-- Field: Page; Sequence: 138; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->130<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"><A HREF="#toc">Table of Contents</A></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">Upon
closing of the Bond Offering, we issued Bond PA Warrants to purchase a number of Class A Ordinary Shares equal to 5.5% of the
number of Class A Ordinary Shares issuable upon conversion of the Bond, at an exercise price equal to a 23% discount to this Offering
price, subject to adjustment. The Bond PA Warrants are exercisable at an exercise price equal to a 23% discount to this Offering
price, subject to adjustment. The Bond PA Warrants can be exercised on a cashless basis, at the holder&rsquo;s discretion.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 22.25pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><I>Series
A Notes</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">As
of the date of this prospectus, we have $1,600,400 Series A Notes outstanding. The following are summaries of material terms of
the Series A Notes; such summaries do not purport to be a complete description of the terms of the Series A Notes and you are
urged to read the related agreements in their entirety.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><I>Conversion</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">All
outstanding Series A Notes shall be converted automatically upon the closing of this Offering at a 56% discount to the actual
price per Class A Ordinary Share paid in this Offering (the &ldquo;Conversion Price&rdquo;), subject to adjustment as set forth
in the Series A Notes.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><I>Maturity</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">The
Series A Notes shall mature on the earlier of the 12<SUP>th</SUP> month anniversary of the issuance date of the Series A Notes
and the date when the Company redeems the Series A Notes at the then-outstanding principal amount, provided that we have not consummated
this Offering within 12 months of the issuance date of the Series A Notes; otherwise, the Series A Notes mature on the closing
of this Offering.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><I>Interest</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">Commencing
from the date of issuance until the maturity of the Series A Notes, interest shall accrue on the outstanding unconverted and unpaid
principal amount of the Series A Notes at 1% per annum and shall be compounded annually.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><I>Event
of Default</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 35.45pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Pursuant
to the terms of the Series A Notes, certain events of default require the holders of the Series A Notes to provide us with notice
prior to declaring the Series A Notes immediately due and payable and other events do not require any notice. If we fail to pay
any amounts due under the Series A Notes and do not cure such failure within three days after the due date, until such time as
we make the required payment, interest shall accrue at 10% per annum.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 35.45pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Other
events of default include breach of our covenants, our insolvency and our default on other liability in excess of $500,000.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><I>Voting
Rights</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">Prior
to conversion, holders of Series A Notes will not have the right to vote as a shareholder and upon conversion, holders of then
Class A Ordinary Shares will have the same voting rights and vote together with the holders of Class A Ordinary Shares, and not
as a separate class, except where otherwise required by law.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><I>Ranking</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">The
Series A Notes, before conversion, are senior to all Class A Ordinary Shares and Class B Ordinary Shares with respect to distribution
rights upon liquidation and dividend rights.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><I>Dividends</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">Holders
of Series A Notes are entitled to dividends only if, as and when declared by the Company&rsquo;s Board of Directors out of funds legally
available therefor.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<!-- Field: Page; Sequence: 139; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->131<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"><A HREF="#toc">Table of Contents</A></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><I>Registration
Rights</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">We
agreed to register the Class A Ordinary Shares underlying the Series A Notes in this registration statement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><I>Lock-up
</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">The
holders of Series A Notes are required to enter into a lock-up agreement with the Company and the Placement Agent that prohibits
the Series A Note Investors from, directly or indirectly, offering, selling, pledging or otherwise transferring or disposing of
any of the Class A Ordinary Shares underlying the Series A Notes for a period of six months following the closing date of this
Offering.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><I>Negative
Covenants</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">The
Series A Notes contain certain negative covenants, including our inability to incur certain liabilities without the Series A Note
Investors&rsquo; prior written consent and limits on certain corporate actions.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><I>Series
A Note PA Warrants </I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">As
of the date of this prospectus, we have a Series A Note PA Warrants outstanding. The following are summaries of material terms
of the Series A Note PA Warrants; such summaries do not purport to be a complete description of the terms of the Series A Note
PA Warrants and you are urged to read the warrant agreement in its entirety.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">Upon
closing of the Series A Note Offering, we issued Series A Note PA Warrants to purchase that number of Class A Ordinary Shares
equal to an aggregate of five and one half percent (5.5%) of the principal amount of the Series A Notes sold in the Series A Note
Offering. The exercise price of the Series A Note PA Warrants is equal to a 56% discount to the actual price per Class A Ordinary
Share paid in this Offering, subject to adjustment as set forth in the warrant agreement, and are also exercisable on a cashless
basis. The Series A Note PA Warrants are exercisable, at any time, and from time to time, in whole or in part, within two and
one half (2.5) years commencing on or after the earlier of (i) six months from the issuance date of the warrant or (ii) the date
on which this Offering closes.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><I>Underwriter&rsquo;s
Warrants</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">Please
see &ldquo;Underwriting &ndash; Underwriter&rsquo;s Warrants&rdquo; below for a full description of the warrants (and shares underlying
such warrants) that we are issuing to the Underwriter in connection with this Offering.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Differences
in Corporate Law</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">The
Companies Law is modeled after that of English law but does not follow many recent English law statutory enactments. In addition,
the Companies Law differs from laws applicable to United States corporations and their shareholders. Set forth below is a summary
of some of the significant differences between the provisions of the Companies Law applicable to us and the laws applicable to
companies incorporated in the State of Delaware.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 35.55pt"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><I>Mergers
and Similar Arrangements.</I></B> The Companies Law permits mergers and consolidations between Cayman Islands companies and between
Cayman Islands companies and non-Cayman Islands companies. For these purposes, a &ldquo;merger&rdquo; means the merging of two
or more constituent companies and the vesting of their undertaking, property and liabilities in one of such companies as the surviving
company, and a &ldquo;consolidation&rdquo; means the combination of two or more constituent companies into a consolidated company
and the vesting of the undertaking, property and liabilities of such companies to the consolidated company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 35.4pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">In
order to effect a merger or consolidation, the directors of each constituent company must approve a written plan of merger or
consolidation, which must then be authorized by a special resolution of the shareholders of each constituent company, and such
other authorization, if any, as may be specified in such constituent company&rsquo;s articles of association.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<!-- Field: Page; Sequence: 140; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->132<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"><A HREF="#toc">Table of Contents</A></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">The
plan of merger or consolidation must be filed with the Registrar of Companies of the Cayman Islands together with a declaration
as to: the solvency of the consolidated or surviving company, the merger or consolidation being bona fide and not intended to
defraud creditors, no petition or other proceeding, order or resolution to wind up the Company, no receiver, administrator or
similar having been appointed over assets or property and no scheme or other arrangement having been entered into with creditors;
a list of the assets and liabilities of each constituent company and an undertaking that a copy of the certificate of merger or
consolidation will be given to the members and creditors of each constituent company; and that notification of the merger and
consolidation will be published in the Cayman Islands Gazette. The non-surviving constituent company must have resigned from any
fiduciary office held or will do so and each constituent company having complied with any applicable regulatory laws. Dissenting
shareholders have the right to be paid the fair value of their shares if they follow the required procedures under the Companies
Law subject to certain exceptions. The fair value of the shares will be determined by the Cayman Islands court if it cannot be
agreed among the parties. Court approval is not required for a merger or consolidation effected in compliance with these statutory
procedures.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">In
addition, there are statutory provisions that facilitate the reconstruction and amalgamation of companies, provided that the arrangement
is approved by a majority in number of each class of shareholders and creditors with whom the arrangement is to be made, and who
must in addition represent three-fourths in value of each such class of shareholders or creditors, as the case may be, that are
present and voting either in person or by proxy at a meeting, or meetings, convened for that purpose. The convening of the meetings
and subsequently the arrangement must be sanctioned by the Grand Court of the Cayman Islands.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">While
a dissenting shareholder has the right to express to the court the view that the transaction ought not to be approved, the court
can be expected to approve the arrangement if it determines that:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 0.5in; text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 0.25in; text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    statutory provisions as to the required majority vote have been met;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    shareholders have been fairly represented at the meeting in question;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    arrangement is such that an intelligent and honest man of that class acting in respect of his interest would reasonably approve;
    and</FONT></TD></TR>
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    arrangement is not one that would more properly be sanctioned under some other provision of the Companies Law or that would
    amount to a &ldquo;fraud on the minority&rdquo;.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">When
a take-over offer is made and accepted by holders of not less than 90% of the shares within four months, the offer, or may, within
a two-month period commencing on the expiration of such four months period, require the holders of the remaining shares to transfer
such shares on the terms of the offer. An objection can be made to the Grand Court of the Cayman Islands but this is unlikely
to succeed unless there is evidence of fraud, bad faith or collusion.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">If
the arrangement and reconstruction is thus approved, the dissenting shareholder would have no rights comparable to appraisal rights,
which would otherwise ordinarily be available to dissenting shareholders of United States corporations, providing rights to receive
payment in cash for the judicially determined value of the shares.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><I>Shareholders&rsquo;
Suits.</I></B> In principle, we will normally be the proper plaintiff to sue for a wrong done to us as a company and as a general
rule a derivative action may not be brought by a minority shareholder. However, based on English authorities, which would in all
likelihood be of persuasive authority in the Cayman Islands, there are exceptions to the foregoing principle, including when:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 0.5in; text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 0.25in; text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a
    company acts or proposes to act illegally or ultra vires and is therefore incapable of ratification by the shareholders;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    act complained of, although not ultra vires, could only be duly effected if authorized by more than a simple majority vote
    that has not been obtained; and</FONT></TD></TR>
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">those
    who control the company are perpetrating a &ldquo;fraud on the minority&rdquo;.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><I>Indemnification
of Directors and Executive Officers and Limitation of Liability.</I></B> The Companies Law does not limit the extent to which
a company&rsquo;s memorandum and articles of association may provide for indemnification of officers and directors, except to
the extent any such provision may be held by the Cayman Islands courts to be contrary to public policy, such as to provide indemnification
against civil fraud or the consequences of committing a crime. As stated above, our Memorandum and Articles permit indemnification
of officers and directors for actions, proceedings, claims, losses, damages, costs, liabilities and expenses (&ldquo;Indemnified
Losses&rdquo;) incurred in their capacities as such unless such losses or damages arise from dishonesty of such directors or officers.
This standard of conduct is generally the same as permitted under the Delaware General Corporation Law for a Delaware corporation.
Insofar as indemnification for liabilities arising under the Securities Act may be permitted to our directors, officers or persons
controlling us under the foregoing provisions, we have been informed that in the opinion of the SEC, such indemnification is against
public policy as expressed in the Securities Act and is therefore unenforceable.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<!-- Field: Page; Sequence: 141; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->133<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"><A HREF="#toc">Table of Contents</A></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><I>Directors&rsquo;
Fiduciary Duties.</I></B> Under Delaware corporate law, a director of a Delaware corporation has a fiduciary duty to the corporation
and its shareholders. This duty has two components: the duty of care and the duty of loyalty. The duty of care requires that a
director act in good faith, with the care that an ordinarily prudent person would exercise under similar circumstances. Under
this duty, a director must inform himself of, and disclose to shareholders, all material information reasonably available regarding
a significant transaction. The duty of loyalty requires that a director acts in a manner he reasonably believes to be in the best
interests of the corporation. He must not use his corporate position for personal gain or advantage. This duty prohibits self-dealing
by a director and mandates that the best interest of the corporation and its shareholders take precedence over any interest possessed
by a director, officer or controlling shareholder and not shared by the shareholders generally. In general, actions of a director
are presumed to have been made on an informed basis, in good faith and in the honest belief that the action taken was in the best
interests of the corporation. However, this presumption may be rebutted by evidence of a breach of one of the fiduciary duties.
Should such evidence be presented concerning a transaction by a director, the director must prove the procedural fairness of the
transaction, and that the transaction was of fair value to the corporation. As a matter of Cayman Islands law, a director of a
Cayman Islands company is in the position of a fiduciary with respect to the company and therefore it is considered that he or
she owes the following duties to the company: a duty to act bona fide in the best interests of the company, a duty not to make
a profit based on his or her position as director (unless the company permits him or her to do so) and a duty not to put himself
or herself in a position where the interests of the company conflict with his or her personal interest or his or her duty to a
third-party. Our Memorandum and Articles do not disqualify a director from acting or from contacting with the Company as a vendor,
purchaser or otherwise provided that it does not adversely affect his or her performance of duties or responsibilities and the
nature of the interest is disclosed at the meeting at which the contract or arrangement is considered (if not previously disclosed),
and having disclosed such interest the director is not counted in the quorum and must refrain from voting on the contract or arrangement.
A director of a Cayman Islands company also owes to the company a duty to exercise the powers for the purpose for which they were
given and the duty to act with skill and care. It was previously considered that a director need not exhibit in the performance
of his or her duties a greater degree of skill than may reasonably be expected from a person of his or her knowledge and experience.
However, courts are moving towards an objective standard with regard to the required skill and care and these authorities are
likely to be followed in the Cayman Islands.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><I>Shareholder
Action by Written Consent.</I></B> Under the Delaware General Corporation Law, a corporation may eliminate the right of shareholders
to act by written consent by amendment to its certificate of incorporation. Cayman Islands law and our Memorandum and Articles
provide that shareholders may approve corporate matters by way of a unanimous written resolution signed by or on behalf of each
shareholder who would have been entitled to vote on such matter at a general meeting without a meeting being held.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><I>Shareholder
Proposals.</I></B> Under the Delaware General Corporation Law, a shareholder has the right to put any proposal before the annual
meeting of shareholders, provided it complies with the notice provisions in the governing documents. A special meeting may be
called by the board of directors or any other person authorized to do so in the governing documents, but shareholders may be precluded
from calling special meetings. The Companies Law provides shareholders with only limited rights to requisition a general meeting
and does not provide shareholders with any right to put any proposal before a general meeting. However, these rights may be provided
in articles of association. Our Memorandum and Articles allow our shareholders holding not less than 1/10 of all voting power
of our (paid up) share capital in issue to requisition a shareholder&rsquo;s meeting. Other than this right to requisition a shareholders&rsquo;
meeting, our Memorandum and Articles do not provide our shareholders other rights to put proposal before a meeting. As an exempted
Cayman Islands company, we are not obliged by law to call shareholders&rsquo; annual general meetings although our Memorandum
and Articles provide for same.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><I>Cumulative
Voting.</I></B> Under the Delaware General Corporation Law, cumulative voting for elections of directors is not permitted unless
the corporation&rsquo;s certificate of incorporation specifically provides for it. Cumulative voting potentially facilitates the
representation of minority shareholders on a board of directors since it permits the minority shareholder to cast all the votes
to which the shareholder is entitled on a single director, which increases the shareholder&rsquo;s voting power with respect to
electing such director. There are no prohibitions in relation to cumulative voting under the Companies Law but our Memorandum
and Articles do not provide for cumulative voting.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<!-- Field: Page; Sequence: 142; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->134<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"><A HREF="#toc">Table of Contents</A></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><I>Removal
of Directors.</I></B> Under the Delaware General Corporation Law, a director of a corporation with a may be removed with the approval
of a majority of the outstanding shares entitled to vote, unless the certificate of incorporation provides otherwise. Under our
Memorandum and Articles, directors may be removed with or without cause, by the directors or by an ordinary resolution of our
shareholders.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><I>Transactions
with Interested Shareholders.</I></B> The Delaware General Corporation Law contains a business combination statute applicable
to Delaware corporations whereby, unless the corporation has specifically elected not to be governed by such statute by amendment
to its certificate of incorporation, it is prohibited from engaging in certain business combinations with an &ldquo;interested
shareholder&rdquo; for three years following the date that such person becomes an interested shareholder. An interested shareholder
generally is a person or a group who or which owns or owned 15% or more of the target&rsquo;s outstanding voting share within
the past three years. This has the effect of limiting the ability of a potential acquirer to make a two-tiered bid for the target
in which all shareholders would not be treated equally. The statute does not apply if, among other things, prior to the date on
which such shareholder becomes an interested shareholder, the board of directors approves either the business combination or the
transaction which resulted in the person becoming an interested shareholder. This encourages any potential acquirer of a Delaware
corporation to negotiate the terms of any acquisition transaction with the target&rsquo;s board of directors. The Cayman Islands
has no comparable statute. As a result, we cannot avail ourselves of the types of protections afforded by the Delaware business
combination statute. However, although Cayman Islands law does not regulate transactions between a company and its significant
shareholders, it does provide that such transactions must be entered into bona fide in the best interests of the company and for
a proper corporate purpose and not with the effect of constituting a fraud on the minority shareholders. Our Memorandum and Articles,
as well as our Code of Business Conduct and Ethics that applies to our officers, directors and employees outlines how to handle
these types of transactions and other potential conflicts of interest.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><I>Dissolution;
Winding up.</I></B> Under the Delaware General Corporation Law, unless the board of directors approves the proposal to dissolve,
dissolution must be approved by shareholders holding 100% of the total voting power of the corporation. Only if the dissolution
is initiated by the board of directors may it be approved by a simple majority of the corporation&rsquo;s outstanding shares.
Delaware law allows a Delaware corporation to include in its certificate of incorporation a supermajority voting requirement in
connection with dissolutions initiated by the board. Under the Companies Law, a company may be wound up by either an order of
the courts of the Cayman Islands or by a special resolution of its members or, if the company is unable to pay its debts as they
fall due, by an ordinary resolution of its members. The court has authority to order winding up in a number of specified circumstances
including where it is, in the opinion of the court, just and equitable to do so. Under the Companies Law a company may be dissolved,
liquidated or wound up by a special resolution of our shareholders; however, under our Memorandum and Articles, only our Directors
have power to present a winding up petition in the name of the Company and/or to apply for the appointment of provisional liquidators
in respect of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><I>Variation
of Rights of Shares.</I></B> Under the Delaware General Corporation Law, a corporation may vary the rights of a class of shares
with the approval of a majority of the outstanding shares of such class, unless the certificate of incorporation provides otherwise.
Under the Companies Law and our Memorandum and Articles, if our share capital is divided into more than one class of shares, we
may vary the rights attached to any class with the written consent of the holders of two-thirds of the issued shares of that class
or with the sanction of a special resolution passed at a separate general meeting of the holders of the shares of that class.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><I>Amendment
of Governing Documents.</I></B> Under the Delaware General Corporation Law, a corporation&rsquo;s governing documents may be amended
with the approval of a majority of the outstanding shares entitled to vote, unless the certificate of incorporation provides otherwise.
As permitted by the Companies Law, each of our Memorandum of Association and Articles of Association may only be amended with
a special resolution of our shareholders.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><I>Rights
of Non-resident or Foreign Shareholders.</I></B> There are no limitations imposed by our Memorandum and Articles on the rights
of non-resident or foreign shareholders to hold or exercise voting rights on our shares. In addition, there are no provisions
in our Memorandum and Articles governing the ownership threshold above which shareholder ownership must be disclosed.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<!-- Field: Page; Sequence: 143; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->135<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"><A HREF="#toc">Table of Contents</A></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><I>Lock-up
Agreements</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">In
connection with this Offering, all of our directors and executive officers, the Series A Note Investors, the holder of the Bond
and substantially all of our existing shareholders, have signed lock-up agreements which, subject to certain exceptions, prevent
them from selling or otherwise disposing of any of our shares, or any securities convertible into or exercisable or exchangeable
for shares for a period of not less than 180 days for the investors in this Offering and the Series A Note Investors and 90 days
for the Bond holder, from the date of this prospectus (each, a &ldquo;Lock Up Period&rdquo;), without the prior written consent
of the underwriters. The underwriters may in their sole discretion and at any time without notice (except in the case of officers
and directors) release some or all of the shares subject to lock-up agreements prior to the expiration of the Lock Up Period.
When determining whether or not to release shares from the lock-up agreements, the underwriters may consider, among other factors,
the shareholder&rsquo;s reasons for requesting the release, the number of shares for which the release is being requested and
market conditions at the time.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 34pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;<BR>
<B><I>Rule 144 </I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 22.25pt"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><I>Shares
Held for Six Months </I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 22.25pt"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">In
general, under Rule 144 as currently in effect, and subject to the terms of any lock-up agreement, commencing 90 days after the
closing of this Offering, a person (or persons whose shares are aggregated), including an affiliate, who has beneficially owned
our Class A Ordinary Shares for six months or more, including the holding period of any prior owner other than one of our affiliates
(i.e., commencing when the shares were acquired from our Company or from an affiliate of our Company as restricted securities),
is entitled to sell our shares, subject to the availability of current public information about us. In the case of an affiliate
shareholder, the right to sell is also subject to the fulfillment of certain additional conditions, including manner of sale provisions
and notice requirements, and to a volume limitation that limits the number of shares to be sold thereby, within any three-month
period, to the greater of:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 34pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 0.5in; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 0.25in; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1%
    of the number of Class A Ordinary Shares then outstanding; or</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 40.5pt; text-align: justify; text-indent: -9pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 0.5in; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 0.25in; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    average weekly trading volume of our Class A Ordinary Shares on the NASDAQ Global Market during the four calendar weeks preceding
    the filing of a notice on Form 144 with respect to the sale.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 40.5pt; text-align: justify; text-indent: -9pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">The
six-month holding period of Rule 144 does not apply to sales of unrestricted securities. Accordingly, persons who hold unrestricted
securities may sell them under the requirements of Rule 144 described above without regard to the six-month holding period, even
if they were considered our affiliates at the time of the sale or at any time during the 90 days preceding such date.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 34pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 20.25pt"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><I>Shares
Held by Non-Affiliates for One Year</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 20.25pt"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">Under
Rule 144 as currently in effect, a person (or persons whose shares are aggregated) who is not considered to have been one of our
affiliates at any time during the 90 days preceding a sale and who has beneficially owned the shares proposed to be sold for at
least one year, including the holding period of any prior owner other than one of our affiliates, is entitled to sell his, her
or its shares under Rule 144 without complying with the provisions relating to the availability of current public information
or with any other conditions under Rule 144. Therefore, unless subject to a lock-up agreement or otherwise restricted, such shares
may be sold immediately upon the closing of this Offering.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 34pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 20.25pt"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><I>Registration
Rights</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 20.25pt"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">Pursuant
to the terms of the Bond, we agreed to register the Class A Ordinary Shares underlying the Bond in this registration statement.
We also agreed to register the Class A Ordinary Shares underlying the PA Warrants in this registration statement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 34pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 20.25pt"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><I>Piggyback
Registration Rights</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 20.25pt"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">Pursuant
to the terms of the Series A Note Offering, the Series A Note Investors received piggyback registration rights with respect to
the Class A Ordinary Shares underlying the Series A Notes (the &ldquo;Conversion Shares&rdquo;) that entitle the Series A Note
Investors to request their securities be included in a future Securities Act registration statement that is filed after this Offering.
If so requested, the Company will include in such future registration statement, all Conversion Shares on a pro rata basis based
upon the total number of Conversion Shares with respect to which the Company has received written requests for inclusion within
fifteen (15) business days after the applicable holder&rsquo;s receipt of the Company&rsquo;s notice that it is filing such a
registration statement. The piggyback registration rights described herein, also apply to the Class A Ordinary Shares underlying
the warrants issued to the placement agent in the Series A Note Offering.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 34pt"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></P>

<!-- Field: Page; Sequence: 144; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->136<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"><A HREF="#toc">Table of Contents</A></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><A NAME="w19"></A>TAXATION</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; background-color: white"><I>The
following summary contains a description of certain Cayman Islands and U.S. federal income tax consequences of the acquisition,
ownership and disposition of Class A Ordinary Shares. Please note that this summary should not be considered a comprehensive description
of all the tax considerations that may be relevant to the decision to purchase Class A Ordinary Shares. The summary is based upon
the tax laws of the Cayman Islands and regulations thereunder and on the tax laws of the United States and regulations thereunder
as of the date hereof, which are subject to change</I>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Cayman
Islands Tax Considerations</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">The
Cayman Islands currently levies no taxes on individuals or corporations based upon profits, income, gains or appreciation and
there is no taxation in the nature of inheritance tax or estate duty. There are no other taxes likely to be material to us levied
by the government of the Cayman Islands except for stamp duties which may be applicable on instruments executed in, or brought
within, the jurisdiction of the Cayman Islands. The Cayman Islands is not party to any double tax treaties which are applicable
to any payments made by or to our Company. There are no exchange control regulations or currency restrictions in the Cayman Islands.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">Payments
of dividends and capital in respect of our Class A Ordinary Shares will not be subject to taxation in the Cayman Islands and no
withholding will be required on the payment of a dividend or capital to any holder of our Class A Ordinary Shares, nor will gains
derived from the disposal of our Class A Ordinary Shares be subject to Cayman Islands income or corporation tax.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">No
stamp duty is payable in respect of the issue of our Class A Ordinary Shares or on an instrument of transfer in respect of our
Class A Ordinary Shares except on instruments executed in, or brought within, the jurisdiction of the Cayman Islands.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">The
Cayman Islands has signed an inter-governmental agreement with the United States to improve international tax compliance and the
exchange of information and which gives effect to the automatic tax information exchange requirements of the U.S. Foreign Account
Tax Compliance Act (&ldquo;FATCA&rdquo;). FATCA and the regulations promulgated thereunder impose a thirty percent (30%) withholding
tax on certain payments of U.S. source income, such as interest and dividends, received by certain foreign entities, unless the
payee entity agrees to comply with certain due diligence, reporting and related requirements. FATCA regulations provide for the
identification of and reporting on certain direct and indirect U.S. Holders who are U.S. citizens and impact us and our shareholders.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">The
Cayman Islands has also committed, along with over 90 other countries, to the implementation of the OECD Standard for Automatic
Exchange of Financial Account Information &ndash; Common Reporting Standard (the &ldquo;CRS&rdquo;). Cayman Islands regulations
require &ldquo;reporting financial institutions&rdquo; to identify and report information in respect of specified persons in the
jurisdictions which sign and implement the CRS. As the OECD initiative continues to develop, further inter-governmental agreements
may be entered into by the Cayman Islands government which will form part of CRS.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">&ldquo;AEOI&rdquo;
means (i) Sections 1471 through 1474 of the Code, and any associated legislation, regulations (including the U.S. Treasury Regulations),
forms, instructions, notices or official pronouncements or other guidance issued now or in the future and any other legislation,
regulations, forms, instructions or other guidance enacted, issued or published in any jurisdiction which seeks to implement similar
financial account information reporting and/or withholding tax regimes; (ii) the Organization for Economic Cooperation and Development
Standard for Automatic Exchange of Financial Account Information in Tax Matters &ndash; the Common Reporting Standard and any
associated guidance; (iii) any intergovernmental agreement or other similar agreement between the United States and one or more
other governments or tax authorities that is entered into in order to facilitate compliance with, or otherwise relates to, any
of the preceding, together with any regulations, forms, instructions or other guidance issued (now or in the future) by any government
or tax authority in a jurisdiction other than the United States in relation to any intergovernmental agreement or similar agreement;
(iv) any intergovernmental agreement, treaty, regulation, guidance, standard or other agreement between the Cayman Islands (or
any Cayman Islands government body) and any other jurisdiction (including any government bodies or taxing authorities in such
jurisdiction), entered into in order to comply with, facilitate, supplement or implement (or otherwise related to) the legislation,
regulations, guidance or standards described in sub-paragraphs (i), (ii), (iii) and (iv); (v) any legislation, regulations, forms,
instructions or other guidance relevant to the Cayman Islands that give effect to the matters outlined in the preceding sub-paragraphs;
and (vi) any legislation in any jurisdiction that we reasonably believe to be similar to any of the foregoing.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">Holders
will be required to timely furnish to us any information, certification, representation, form or other documentation reasonably
requested by us to fulfill our obligations under AEOI and to avoid being subject to withholding thereunder. Any such information
provided to us may be shared with the Cayman Islands Tax Information Authority, the IRS and other governmental and taxing authorities
and must be timely updated to the extent that such information has expired or become obsolete or inaccurate in any respect.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">Holders
should consult their tax advisors regarding the impact of AEOI.<B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 145; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->137<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"><A HREF="#toc">Table of Contents</A></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Material
U.S. Federal Income Tax Considerations for U.S. Holders</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">The
following is a description of the material U.S. federal income tax consequences to U.S. Holders (as defined below) of purchasing,
owning and disposing of Class A Ordinary Shares. It is not a comprehensive description of all U.S. federal income tax considerations
that may be relevant to a particular person&rsquo;s decision to acquire Class A Ordinary Shares. This discussion applies only
to a U.S. Holder that holds a Class A Ordinary Share as a capital asset for U.S. federal income tax purposes (generally, property
held for investment). In addition, it does not describe all of the tax consequences that may be relevant in light of a U.S. Holder&rsquo;s
particular circumstances, including state and local tax consequences, non-U.S. tax consequences, federal estate or gift tax consequences,
alternative minimum tax consequences, the potential application of the provisions of the Code known as the Medicare Contribution
Tax, and tax consequences applicable to U.S. Holders subject to special rules, such as:&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 0.5in; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 0.25in; text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">banks
    and other financial institutions;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 0.5in; text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 0.25in; text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">insurance
    companies;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">dealers
    or traders in securities who use a mark-to-market method of tax accounting;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 0.5in; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 0.25in; text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">persons
    holding Class A Ordinary Shares as part of a hedging transaction, &ldquo;straddle,&rdquo; wash sale, conversion transaction
    or integrated transaction or persons entering into a constructive sale with respect to the Class A Ordinary Shares;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 0.5in; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 0.25in; text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">persons
    whose &ldquo;functional currency&rdquo; for U.S. federal income tax purposes is not the U.S. dollar;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 0.5in; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 0.25in; text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">tax
    exempt entities, including &ldquo;individual retirement accounts&rdquo; and &ldquo;Roth IRAs&rdquo;;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 0.5in; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 0.25in; text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">former
    citizens or long-term residents of the United States;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 0.5in; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 0.25in; text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">entities
    or arrangements classified as partnerships for U.S. federal income tax purposes;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 0.5in; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 0.25in; text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">regulated
    investment companies or real estate investment trusts;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 0.5in; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 0.25in; text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">persons
    who acquired our Class A Ordinary Shares pursuant to the exercise of an employee share option or otherwise as compensation;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 0.5in; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 0.25in; text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">persons
    that own or are deemed to own ten percent or more of our shares; and</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 0.5in; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 0.25in; text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">persons
    holding Class A Ordinary Shares in connection with a trade or business conducted outside the United States.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<!-- Field: Page; Sequence: 146; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->138<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"><A HREF="#toc">Table of Contents</A></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">If
an entity or arrangement that is classified as a partnership for U.S. federal income tax purposes holds Class A Ordinary Shares,
the U.S. federal income tax treatment of such partnership and each partner thereof will generally depend on the status of the
partner and the activities of the partnership. Partnerships holding Class A Ordinary Shares and partners in such partnerships
are encouraged to consult their tax advisors as to the particular U.S. federal income tax consequences of purchasing, holding
and disposing of Class A Ordinary Shares.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">The
discussion is based on the Code, the Treasury Regulations issued thereunder, and administrative and judicial interpretations thereof,
all as in effect on the date hereof and all of which are subject to change, possibly with retroactive effect, or to different
interpretation. Such change could materially and adversely affect the tax consequences described below.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">For
purposes of this discussion, a &ldquo;U.S. Holder&rdquo; is a holder who, for U.S. federal income tax purposes, is a beneficial
owner of Class A Ordinary Shares and that is:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; background-color: white; border-collapse: collapse">
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 0.25in">&nbsp;</TD>
    <TD STYLE="width: 0.25in; text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">an
    individual citizen or resident of the United States;</FONT></TD></TR>

<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a
    corporation, or other entity taxable as a corporation, created or organized in or under the laws of the United States, any
    state therein or the District of Columbia;</FONT></TD></TR>

<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3)</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">an
    estate, the income of which is subject to U.S. federal income taxation regardless of its source; or</FONT></TD></TR>
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(4)</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a
    trust, (i) if a court within the United States is able to exercise primary supervision over its administration and one or
    more &ldquo;U.S. persons&rdquo; (within the meaning of the Code) have the authority to control all of its substantial decisions,
    or (ii) if a valid election is in effect for the trust to be treated as a U.S. person.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">U.S.
Holders are encouraged to consult their tax advisors concerning the U.S. federal, state, local and foreign tax consequences of
purchasing, owning and disposing of Class A Ordinary Shares in their particular circumstances.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 23.5pt; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><I>Taxation
of Distributions</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 23.5pt; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">Subject
to the discussion below under &ldquo;Passive Foreign Investment Company Rules,&rdquo; a U.S. Holder will be required to include
in gross income as dividend income the gross amount of any distributions paid on Class A Ordinary Shares (including any amount
of taxes withheld), other than certain&nbsp;<I>pro rata&nbsp;</I>distributions of Class A Ordinary Shares, to the extent paid
out of our current or accumulated earnings and profits (as determined under U.S. federal income tax principles). Distributions
in excess of our current and accumulated earnings and profits would be treated as a non-taxable return of capital to the extent
of the U.S. Holder&rsquo;s adjusted tax basis in the Class A Ordinary Shares and thereafter as a gain from the sale of the Class
A Ordinary Shares. However, because we do not calculate our earnings and profits under U.S. federal income tax principles, we
expect that distributions generally will be reported to U.S. Holders as dividends.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">In
case of a U.S. Holder that is a corporation, dividends paid on the Class A Ordinary Shares will be subject to regular corporate
rates and will not be eligible for the &ldquo;dividends received&rdquo; deduction generally allowed to corporate shareholders
with respect to dividends received from U.S. corporations.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">Dividends
received by an individual, trust or estate will be subject to taxation at standard tax rates. A reduced income tax rate applies
to dividends paid by a &ldquo;qualified foreign corporations&rdquo; (if certain holding period requirements and other conditions
are met). A non-U.S. corporation generally will be considered to be a qualified foreign corporation (i) if it is eligible for
the benefits of a comprehensive tax treaty with the United States which includes an exchange of information program or (ii) with
respect to any dividend it pays on stock which is readily tradable on an established securities market in the United States. US.
Treasury Department guidance indicates that our Class A Ordinary Shares, which will be listed on the NASDAQ Global Market will
be readily tradable on an established securities market in the United States. There can be no assurance, however, that our Class
A Ordinary Shares will be considered readily tradable on an established securities market in later years.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">Non-corporate
U.S. Holders will not be eligible for reduced rates of taxation on any dividends received from us if we are a PFIC in the taxable
year in which such dividends are paid or in the preceding taxable year (see &ldquo;&mdash;Passive Foreign Investment Company Rules&rdquo;
below).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">A
U.S. Holder may be eligible, subject to a number of complex limitations, to claim a foreign tax credit in respect of any foreign
withholding taxes imposed on dividends received on the Class A Ordinary Shares. A U.S. Holder who does not elect to claim a foreign
tax credit for foreign income tax withheld may instead claim a deduction for U.S. federal income tax purposes in respect of such
withholding, but only for a year in which such investor elects to do so for all creditable foreign income taxes. For purposes
of calculating the foreign tax credit limitation, dividends paid by us will, depending on the circumstances of the U.S. Holder,
be either general or passive income.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">While
we do not expect to pay dividends in the near future, in the event any dividends are paid and if a dividend is paid in non-U.S.
currency, it must be included in a U.S. Holder&rsquo;s income as a U.S. dollar amount based on the exchange rate in effect on
the date such dividend is actually or constructively received, regardless of whether the dividend is in fact converted into U.S.
dollars. If the dividend is converted to U.S. dollars on the date of receipt, a U.S. Holder generally will not recognize a foreign
currency gain or loss. If the non-U.S. currency is converted into U.S. dollars on a later date, however, the U.S. Holder must
include in income any gain or loss resulting from any exchange rate fluctuations. Such gain or loss will generally be ordinary
income or loss and will be from sources within the United States for foreign tax credit limitation purposes. U.S. Holders should
consult their own tax advisors regarding the tax consequences to them if we pay dividends in non-U.S. currency.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 147; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->139<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"><A HREF="#toc">Table of Contents</A></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 23.5pt; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><I>Sale
or Other Taxable Disposition of Shares</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 23.5pt; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">Subject
to the discussion below under &ldquo;Passive Foreign Investment Company Rules,&rdquo; gain or loss realized on the sale or other
taxable disposition of Class A Ordinary Shares will be capital gain or loss, and will be long-term capital gain or loss if the
U.S. Holder held the Class A Ordinary Shares for more than one year. The amount of the gain or loss will equal the difference
between the U.S. Holder&rsquo;s tax basis in the Class A Ordinary Shares disposed of and the amount realized on the disposition.
Long-term capital gain of a non-corporate U.S. Holder is generally taxed at preferential rates. This gain or loss will generally
be U.S.-source gain or loss for foreign tax credit purposes. The deductibility of capital losses is subject to limitations. U.S.
Holders are urged to consult their tax advisors regarding the tax consequences if a foreign tax is imposed on the disposition
of Class A Ordinary Shares, including the availability of the foreign tax credit under an investor&rsquo;s own particular circumstances.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">A
U.S. Holder that receives non-U.S. currency on the disposition of the Class A Ordinary Shares will realize an amount equal to
the U.S. dollar value of the foreign currency received on the date of disposition (or in the case of cash basis and electing accrual
basis taxpayers, the settlement date) whether or not converted into U.S. dollars at that time. Very generally, the U.S. Holder
will recognize currency gain or loss if the U.S. dollar value of the currency received on the settlement date differs from the
amount realized with respect to the Class A Ordinary Shares. Any currency gain or loss on the settlement date or on any subsequent
disposition of the foreign currency generally will be U.S.-source ordinary income or loss.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 23.5pt; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><I>Passive
Foreign Investment Company Rules</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 23.5pt; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">Special
U.S. federal income tax rules apply to a U.S. Holder that holds stock in a foreign corporation classified as a PFIC for U.S. federal
income tax purposes. In general, a non-U.S. corporation will be classified as a PFIC for any taxable year in which, after applying
certain look-through rules, either:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 0.5in; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 0.25in; text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">at
    least 75% of its gross income for such taxable year is passive income (e.g., dividends, interest, capital gains and rents
    derived other than in the active conduct of a rental business); or</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 0.5in; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 0.25in; text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">at
    least 50% of its gross assets (determined on the basis of a quarterly average) is attributable to assets that produce passive
    income or are held for the production of passive income.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">We
will be treated as owning our proportionate share of the assets and earning our proportionate share of the income of any other
corporation in which we own, directly or indirectly, 25% or more (by value) of the equity.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">A
separate determination must be made after the close of each taxable year as to whether we are a PFIC for that year. As a result,
our PFIC status may change. In particular, the total value of our assets generally will be calculated using the market price of
our Class A Ordinary Shares, which may fluctuate considerably. Fluctuations in the market price of our Class A Ordinary Shares
may result in our being a PFIC for any taxable year.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">Due
to the amount of cash that we had on hand during our year ending December 31, 2017, we believe that we were classified as a PFIC
for that tax year. Depending on the future composition and value of our assets and how quickly we spend the cash raised in this
Offering, we may be classified as a PFIC for 2018, as well, and for future years.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">If
we were to be classified as a PFIC, a U.S. Holder would be subject to different taxation rules depending on whether the U.S. Holder
(i) takes no action, (ii) makes an election to treat us as a &ldquo;Qualified Electing Fund&rdquo; (a &ldquo;QEF election&rdquo;)
or (iii) if permitted, makes a &ldquo;mark-to-market&rdquo; election with respect to our Class A Ordinary Shares. A U.S. Holder
of our Class A Ordinary Shares will also be required under applicable Treasury Regulations to file an annual information return
(Form 8621) containing information regarding our company. Additional explanations of the PFIC rules are set forth below: this
material is complex and may affect different U.S. Holders differently. Accordingly, U.S. Holders should consult their own tax
advisors about the consequences of our company being classified as a PFIC and about what steps, if any, they might take to lessen
the tax impact of our PFIC status on them.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">A
U.S. Holder who does not make a timely QEF or mark-to-market election (a &ldquo;Non-Electing Holder,&rdquo;), as discussed below,
will be subject to special tax rules with respect to any &ldquo;excess distribution&rdquo; that you receive and any gain you realize
from a sale or other disposition (including a pledge) of Class A Ordinary Shares. Distributions you receive in a taxable year
that are greater than 125% of the average annual distributions you received during the shorter of the three preceding taxable
years or your holding period for the Class A Ordinary Shares will be treated as an excess distribution. Under these special tax
rules:&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 0.5in; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 0.25in; text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    excess distribution or gain will be allocated ratably over your holding period for the Class A Ordinary Shares;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 0.5in; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 0.25in; text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    amount allocated to the current taxable year, and any taxable year prior to the first taxable year in which we became a PFIC,
    will be treated as ordinary income; and</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 0.5in; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 0.25in; text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    amount allocated to each other year will be subject to the highest tax rate in effect for that year and the interest charge
    generally applicable to underpayments of tax will be imposed on the resulting tax attributable to each such year.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">It
should be noted that, until such time as we make a distribution, there are no tax consequences to Non-Electing Holders. However,
if we ever did make a distribution it would in all likelihood be an excess distribution (because we would not have previously
made any distributions to holders of Class A Ordinary Shares). At that point, and for all subsequent distributions, the rules
described above would apply to Non-Electing Holders. The tax liability for amounts allocated to years prior to the year of disposition
or &ldquo;excess distribution&rdquo; cannot be offset by any net operating losses for such years, and gains (but not losses) realized
on the sale of the Class A Ordinary Shares cannot be treated as capital, even if you hold the Ordinary Shares as capital assets.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 148; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->140<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"><A HREF="#toc">Table of Contents</A></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">Certain
elections may be available that would result in alternative treatments. The adverse consequences of owning stock in a PFIC could
be mitigated if a U.S. Holder makes a valid QEF election (a U.S. Holder which we refer to as an &ldquo;Electing Holder&rdquo;)
which, among other things, would require the Electing Holder to include currently in income its pro rata share of the PFIC&rsquo;s
net capital gain and ordinary earnings, if any, for our taxable year that ends with or within the taxable year of the Electing
Holder, regardless of whether or not the Electing Holder actually received distributions from us. When an Electing Holder makes
a QEF election, its adjusted tax basis in our Class A Ordinary Shares is increased to reflect taxed but undistributed earnings
and profits. Distributions of earnings and profits that had been previously taxed will result in a corresponding reduction in
the adjusted tax basis in our Class A Ordinary Shares and will not be taxed again once distributed. An Electing Holder would generally
recognize capital gain or loss on the sale, exchange or other disposition of our Class A Ordinary Shares.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">A
U.S. Holder can make a QEF election with respect to any year that we are a PFIC by filing IRS Form 8621 with its U.S. federal
income tax return. This election must be made by the deadline (including extensions) for filing the U.S. Holder&rsquo;s federal
tax return for the year in question. U.S. Holders should discuss their election alternatives with their own tax advisors. Once
an election is made, the Electing Holder is subject to the QEF rules for as long as we are a PFIC.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">It
should be noted that in order to make a QEF election a U.S. Holder needs information from us concerning our PFIC status and our
financial results for the year. We cannot assure our U.S. Holders that we will provide such information.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">As
an alternative to making a QEF election, a U.S. Holder may make a &ldquo;mark-to-market&rdquo; election with respect to our Class
A Ordinary Shares provided our Class A Ordinary Shares are treated as &ldquo;marketable stock.&rdquo; The Class A Ordinary Shares
generally will be treated as marketable stock if they are regularly traded on a &ldquo;qualified exchange or other market&rdquo;
(within the meaning of applicable Treasury Regulations) on at least 15 days during each calendar quarter (other than in de minimis
amounts).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">If
a U.S. Holder makes an effective mark-to-market election, for each taxable year that we are a PFIC, the U.S. Holder will include
as ordinary income the excess of the fair market value of its Class A Ordinary Shares at the end of the year over its adjusted
tax basis in the Class A Ordinary Shares. You will be entitled to deduct as an ordinary loss in each such year the excess of your
adjusted tax basis in the Class A Ordinary Shares over their fair market value at the end of the year, but only to the extent
of the net amount previously included in income as a result of the mark-to-market election. A U.S. Holder&rsquo;s adjusted tax
basis in the Class A Ordinary Shares will be increased by the amount of any income inclusion and decreased by the amount of any
deductions under the mark-to-market rules. In addition, upon the sale or other disposition of your Class A Ordinary Shares in
a year that we are PFIC, any gain will be treated as ordinary income and any loss will be treated as ordinary loss, but only to
the extent of the net amount of previously included income as a result of the mark-to-market election.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">If
a U.S. Holder makes a mark-to-market election, it will be effective for the taxable year for which the election is made and all
subsequent taxable years unless the Class A Ordinary Shares are no longer regularly traded on a qualified exchange or other market,
or the IRS consents to the revocation of the election. You are urged to consult your tax advisor about the availability of the
mark-to-market election, and whether making the election would be advisable in your particular circumstances.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<!-- Field: Page; Sequence: 149; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->141<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"><A HREF="#toc">Table of Contents</A></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 23.5pt; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><I>Information
Reporting and Backup Withholding</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 23.5pt; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">Payments
of dividends and sales proceeds that are made within the United States or through certain U.S.-related financial intermediaries
generally are subject to information reporting, and may be subject to backup withholding, unless (i)&nbsp;the U.S. Holder is a
corporation or other exempt recipient or (ii)&nbsp;in the case of backup withholding, the U.S. Holder provides a correct taxpayer
identification number and certifies that it is not subject to backup withholding.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">Backup
withholding is not an additional tax. The amount of any backup withholding from a payment to a U.S. Holder will be allowed as
a credit against the holder&rsquo;s U.S. federal income tax liability and may entitle it to a refund, provided that the required
information is timely furnished to the IRS.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 23.5pt; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><I>Information
with Respect to Foreign Financial Assets</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 23.5pt; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">Certain
U.S. Holders may be required to report information relating to the Class A Ordinary Shares, subject to certain exceptions (including
an exception for Class A Ordinary Shares held in accounts maintained by certain U.S. financial institutions). U.S. Holders should
consult their tax advisors regarding their reporting obligations with respect to their purchase, ownership and disposition of
the Class A Ordinary Shares.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><A NAME="w20"></A>UNDERWRITING</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">We
intend to offer our securities described in this prospectus, excluding the Class A Ordinary Shares offered by the Selling Shareholders,
through Boustead and China Renaissance - the underwriters. Subject to the terms and conditions of the respective underwriting
agreements, the underwriters we have agreed to issue and sell to the public through the underwriters, and the underwriters have
agreed to offer and sell, on a best efforts basis, at the public offering price less the underwriting fees and commissions set
forth on the cover page of this prospectus, a minimum of [&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;] Class A Ordinary Shares
and a maximum of [&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;] Class A Ordinary Shares on a best efforts basis. The offering
is being made without a firm commitment by the underwriters, neither of which has any obligation or commitment to purchase any
securities. The underwriters are not required to sell any specific number or dollar amount of Class A Ordinary Shares, but rather
they have agreed to use their best efforts to arrange for the sale of all of the securities offered hereby. The Underwriters may
retain other brokers or dealers to act as a sub-agents or selected dealers on their behalf in connection with this Offering.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 34pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">We
do not intend to close this offering unless we sell at least the minimum number of Class A Ordinary Shares, at a public offering
price less the underwriting discounts and commissions set forth on the cover page of this prospectus, A copy of each of the underwriting
agreements is filed as an exhibit to the registration statement of which this prospectus forms a part.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 34pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 34pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">The
Underwriters must sell the minimum number of securities offered ([&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;] Class A Ordinary
Shares) if any shares are sold. The Underwriters are required to use only their best efforts to sell the securities offered and
therefore the underwriters do not have an obligation to purchase any securities, and, as a result, we may not be able to sell
the minimum number of Class A Ordinary Shares. The offering will terminate upon the earlier of: (i) a date mutually acceptable
to us and our Underwriters after which the minimum offering is sold or (ii) [&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;],
2018. On the closing date, the following will occur:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 34pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 0.5in; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 0.25in; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">we
    will receive funds in the amount of the aggregate purchase price of the shares being sold by us on such closing date;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 0.5in; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 0.25in; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">we
    will cause to be delivered the Class A Ordinary Shares being sold on such closing date in book-entry form; and</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 0.5in; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 0.25in; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">we
    will pay the Underwriters their commissions.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<!-- Field: Page; Sequence: 150; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->142<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"><A HREF="#toc">Table of Contents</A></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">Pursuant
to an escrow agreement among us, the Underwriters and [&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;] (the &ldquo;Escrow Agent&rdquo;),
as escrow agent, until at least [&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;] Class A Ordinary Shares are sold, all funds received
in payment for securities sold in this Offering will be required to be submitted by subscribers to a non-interest bearing escrow
account with the Escrow Agent and will be held by the Escrow Agent for such account. The Underwriters and we shall require all
investor checks for payment for the securities to be made payable to [&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;]. All subscription
agreements and checks should be delivered to [&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;]. Failure to do so will result in checks
being returned to the investor who submitted the check. The investors will have sole claim to the proceeds held in trust prior
to the receipt of the minimum offering proceeds. The funds are held for the benefit of the investors until the minimum is reached.
Prior to reaching the minimum, claims may not be reached by creditors of the Company. If the Underwriters do not sell at least
[&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;] Class A Ordinary Shares by [&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;], 2018, all
funds will be returned within five business days to subscribers without interest or deduction. If this Offering completes, then
on the closing date, net proceeds will be delivered to us and we will issue the Class A Ordinary Shares to purchasers. Unless
purchasers instruct us otherwise, we will deliver the shares electronically upon receipt of purchaser funds to the accounts of
those purchasers who hold accounts at the Underwriters, or elsewhere, as specified by the purchaser, within seven business days
upon the closing of the Offering. Alternately, purchasers who do not carry an account at the Underwriters may request that the
shares be held in book-entry at the Company&rsquo;s transfer agent, or may be issued in book-entry at the Company&rsquo;s transfer
agent and subsequently delivered electronically to the purchasers&rsquo; respective brokerage account upon request of the purchasers.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Fees,
Commissions and Expense Reimbursement</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">The
following table shows the cash commission payable to the Underwriters.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: bottom; background-color: white; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: black 1.5pt solid; text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Boustead</B>&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: black 1.5pt solid; text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>China
    Renaissance</B></FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: #CCEEFF; font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 28%; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Offering
    proceeds</FONT></TD>
    <TD STYLE="width: 1%; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 15%; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cash
    commission</FONT></TD>
    <TD STYLE="width: 1%; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 27%; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)&nbsp;&le;$6,125,000:
    7% of the proceeds sourced by the Company </FONT><FONT STYLE="font-family: Times New Roman, Times, Serif"><BR>
    <FONT STYLE="font-size: 10pt">(ii)&nbsp;&gt;$6,125,000: 3% of the Offering proceeds</FONT></FONT></TD>
    <TD STYLE="width: 1%; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 27%; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">7%
    of the proceeds sourced by China Renaissance</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: white; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Commission
    that Exceeds the Threshold</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$1,200,000</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$800,000</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: #CCEEFF; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">China
    Renaissance exceeds the threshold</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cash
    commission</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">40%
    of the 7% commission which exceeds $800,000 is payable to Boustead</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">60%
    of the 7% commission which exceeds $800,000 is kept by China Renaissance</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: white; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Boustead
    exceeds the threshold</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cash
    commission</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">60%
    of the 7% commission which exceeds $1,200,000 is kept by Boustead</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">40%
    of the 7% commission which exceeds $1,200,000 is payable to China Renaissance</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">The
following table shows, for each of the minimum and maximum offering amounts, the per share and maximum total public offering price,
underwriting fees and commissions to be paid to the Underwriters by us, and proceeds to us, before expenses and assuming a $[&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
] per share offering price.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: bottom; background-color: white; font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: black 1.5pt solid; text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Per
    Share</B></FONT></TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: black 1.5pt solid; text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Minimum
    Offering</B></FONT></TD>
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: black 1.5pt solid; text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Maximum
    Offering</B></FONT></TD></TR>
<TR STYLE="background-color: #CCEEFF; font-family: Times New Roman, Times, Serif">
    <TD STYLE="vertical-align: top; width: 62%; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Public
    Offering Price</FONT></TD>
    <TD STYLE="vertical-align: bottom; width: 1%; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; width: 1%; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: top; width: 11%; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD>
    <TD STYLE="vertical-align: bottom; width: 1%; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; width: 1%; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; width: 11%; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD>
    <TD STYLE="vertical-align: bottom; width: 1%; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; width: 11%; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD></TR>
<TR STYLE="background-color: white; font-family: Times New Roman, Times, Serif">
    <TD STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Underwriting
    fees and commissions</FONT></TD>
    <TD STYLE="vertical-align: bottom; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="background-color: #CCEEFF; font-family: Times New Roman, Times, Serif">
    <TD STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Boustead</FONT></TD>
    <TD STYLE="vertical-align: bottom; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD>
    <TD STYLE="vertical-align: bottom; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD>
    <TD STYLE="vertical-align: bottom; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD></TR>
<TR STYLE="background-color: white; font-family: Times New Roman, Times, Serif">
    <TD STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">China
    Renaissance</FONT></TD>
    <TD STYLE="vertical-align: bottom; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD>
    <TD STYLE="vertical-align: bottom; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD>
    <TD STYLE="vertical-align: bottom; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD></TR>
<TR STYLE="background-color: #CCEEFF; font-family: Times New Roman, Times, Serif">
    <TD STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Proceeds
    to Us, Before Expenses</FONT></TD>
    <TD STYLE="vertical-align: bottom; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD>
    <TD STYLE="vertical-align: bottom; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD>
    <TD STYLE="vertical-align: bottom; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">Because
the actual amount to be raised in this Offering is uncertain, the actual total offering commissions are not presently determinable
and may be substantially less than the maximum amount set forth above. The Selling Shareholders do not engage the Underwriters
to facilitate the sales of their Class A Ordinary Shares in any manner.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<!-- Field: Page; Sequence: 151; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->143<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"><A HREF="#toc">Table of Contents</A></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">Our
obligation to issue and sell securities to the purchasers is subject to the conditions set forth in the subscription agreement,
which may be waived by us at our discretion. A purchaser&rsquo;s obligation to purchase securities is subject to the conditions
set forth in the subscription agreement as well, which also may be waived.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">In
addition to the cash commission, we will also reimburse the Underwriters for the full amount of their reasonable out-of-pocket
expenses, including their legal expenses, in an amount not to exceed $[&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;] and $[&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;]
for a third-party due diligence report incurred by the Underwriters in connection with the offering; we shall also pay them a
financial advisory fee of $[&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;] (with an additional $[&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;]
upon filing our listing application with NASDAQ).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">We
estimate that the total expenses of the offering, including registration, filing and listing fees, printing fees and legal and
accounting expenses, but excluding Underwriters&rsquo; fees and commissions, will be approximately $[&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;],
all of which are payable by us.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">The
Underwriters intend to offer our Class A Ordinary Shares to their retail customers only in states in which we are permitted to
offer our Class A Ordinary Shares. We have relied on an exemption to the blue sky registration requirements afforded to &ldquo;covered
securities&rdquo;. Securities listed on the NASDAQ Global Market are &ldquo;covered securities&rdquo;. If we were unable to meet
the NASDAQ Global Market&rsquo;s listing standards, then we would be unable to rely on the covered securities exemption to blue
sky registration requirements and we would need to register the offering in each state in which we planned to sell shares. Consequently,
we will not complete this Offering unless we meet the NASDAQ Global Market&rsquo;s listing requirements.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">The
foregoing does not purport to be a complete statement of the terms and conditions of the underwriting agreement and subscription
agreement. The underwriting agreement and a form of subscription agreement are included as exhibits to the registration statement
of which this prospectus forms a part.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 34pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Lock-Up
Agreements</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">We
and each of our officers, directors, and all existing shareholders agree not to offer, issue, sell, contract to sell, encumber,
grant any option for the sale of or otherwise dispose of any Class A Ordinary Shares or other securities convertible into or exercisable
or exchangeable for Class A Ordinary Shares for a period of six months after the effective date of the registration statement
of which this prospectus is a part without the prior written consent of the underwriters. As for the Selling Shareholders, the
Series A Note Investors agreed to the same lock up period for the Class A Ordinary Shares underlying the Series A Notes; the Bond
holder agreed to the same lock up period for the Class A Ordinary Shares underlying the Bond, but for a period of 90 days after
the effective date of the registration statement of which this prospectus is a part.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">The
underwriters may in their sole discretion and at any time without notice release some or all of the shares subject to lock-up
agreements prior to the expiration of the lock-up period. When determining whether or not to release shares from the lock-up agreements,
the underwriters will consider, among other factors, the security holder&rsquo;s reasons for requesting the release, the number
of shares for which the release is being requested and market conditions at the time.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 34pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 34pt"></P>

<!-- Field: Page; Sequence: 152; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->144<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"><A HREF="#toc">Table of Contents</A></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 34pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Underwriter&rsquo;s
Warrants</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">We
have agreed to issue to Boustead, warrants to purchase the number of Class A Ordinary Shares equal to specified percentages of
the Class A Ordinary Shares sold in this Offering by either Boustead, the Company and/or China Renaissance, depending on the final
amount raised in this Offering. The following table shows the percentage of warrants issuable to Boustead based on the terms of
our agreement with them and with China Renaissance.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 34pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top; background-color: white; font-family: Times New Roman, Times, Serif">
    <TD COLSPAN="3" STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: black 1.5pt solid; text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Boustead</B></FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: black 1.5pt solid; text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>China
    Renaissance</B></FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: #CCEEFF; font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 26%; font-family: Times New Roman, Times, Serif"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">IPO</FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P></TD>
    <TD STYLE="width: 1%; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 18%; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Warrants</FONT></TD>
    <TD STYLE="width: 1%; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 35%; font-family: Times New Roman, Times, Serif"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">5.5%
                                         of the number of Class A Ordinary Shares sourced by the Company</FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Exercisable
        at final Offering Price for a period of 2.5 years from the date of issuance</FONT></P></TD>
    <TD STYLE="width: 1%; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 18%; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">N/A</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: white; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: white; font-family: Times New Roman, Times, Serif">
    <TD COLSPAN="3" STYLE="border-bottom: black 1.5pt solid; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Commission
    that Exceeds the Threshold</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: black 1.5pt solid; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$1,200,000</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: black 1.5pt solid; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$800,000</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: #CCEEFF; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">China
                                         Renaissance exceeds the threshold</FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Warrants</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Grant
                                         Boustead warrants to purchase Class A Ordinary Shares equal to 5.5% of the number of
                                         Class A Ordinary Shares sold by China Renaissance which exceeds $800,000 x 40%</FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Exercise
        at final Offering Price for a period of 2.5 years from the date of issuance</FONT></P></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">N/A</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: white; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: #CCEEFF; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Boustead
    exceeds the threshold</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Warrants</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Grant
                                         Boustead warrants to purchase Class A Ordinary Shares equal to 5.5% of the number of
                                         Class A Ordinary Shares sold by Boustead which exceeds $1,200,000 x 60%</FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Exercise
        at final Offering Price for a period of 2.5 years from the date of issuance</FONT></P></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">N/A</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 34pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">The
warrants will be exercisable at any time, and from time to time, in whole or in part, from the effective date of the offering
until the period specified in the table above in compliance with FINRA Rule 5110(f)(2)(G)(i). The warrants are exercisable at
a per share price equal to 100% of the public offering price per share in the offering. The warrants are also exercisable on a
cashless basis. The warrants have been deemed compensation by FINRA and are therefore subject to a 180-day lock-up pursuant to
Rule 5110(g)(1) of FINRA. Neither our underwriters, nor permitted assignees under Rule 5110(g)(1), will sell, transfer, assign,
pledge, or hypothecate these warrants or the securities underlying these warrants, nor will they engage in any hedging, short
sale, derivative, put, or call transaction that would result in the effective economic disposition of the warrants or the underlying
securities for a period of 180 days from the effective date of the offering. In addition, the warrants provide for registration
rights upon request, in certain cases. The piggyback registration right provided will not be greater than seven years from the
effective date of the offering in compliance with FINRA Rule 5110(f)(2)(G)(v). We will bear all fees and expenses attendant to
registering the securities issuable on exercise of the warrants other than underwriting commissions incurred and payable by the
holders. The exercise price and number of shares issuable upon exercise of the warrants may be adjusted in certain circumstances
including in the event of a share dividend, extraordinary cash dividend or our recapitalization, reorganization, merger or consolidation.
The warrant exercise price and/or underlying shares also may be adjusted for issuances of ordinary shares at a price below the
warrant exercise price.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 34pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Price
Stabilization</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">The
Underwriters will be required to comply with the Securities Act and the Exchange Act, including without limitation, Rule 10b-5
and Regulation M under the Exchange Act. These rules and regulations may limit the timing of purchases and sales of shares of
capital stock by the Underwriters acting as principal. Under these rules and regulations, the Underwriters:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 34pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 0.5in; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 0.25in; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">may
    not engage in any stabilization activity in connection with our securities; and</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 0.5in; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 0.25in; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">may
    not bid for or purchase any of our securities or attempt to induce any person to purchase any of our securities, other than
    as permitted under the Exchange Act, until it has completed its participation in the distribution.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<!-- Field: Page; Sequence: 153; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->145<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"><A HREF="#toc">Table of Contents</A></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Determination
of Offering Price</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">The
public offering price of the shares we are offering was determined by us in consultation with the Underwriters based on discussions
with potential investors in light of the history and prospects of our Company, the stage of development of our business, our business
plans for the future and the extent to which they have been implemented, an assessment of our management, the public stock price
for similar companies, general conditions of the securities markets at the time of the Offering and such other factors as were
deemed relevant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 34pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Electronic
Offer, Sale and Distribution of Securities.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">A
prospectus in electronic format may be delivered to potential investors by the Underwriters. The prospectus in electronic format
will be identical to the paper version of such prospectus. Other than the prospectus in electronic format, the information on
the Underwriters&rsquo; website and any information contained in any other website maintained by the Underwriters is not part
of the prospectus or the registration statement of which this prospectus forms a part.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 34pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Foreign
Regulatory Restrictions on Purchase of our Shares</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">We
have not taken any action to permit a public offering of our shares outside the United States or to permit the possession or distribution
of this prospectus outside the United States. People outside the United States who come into possession of this prospectus must
inform themselves about and observe any restrictions relating to this Offering of our shares and the distribution of this prospectus
outside the United States.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 34pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Indemnification</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">We
have agreed to indemnify the underwriters against liabilities relating to the Offering arising under the Securities Act and the
Exchange Act and to contribute to payments that the underwriters may be required to make for these liabilities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 34pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Application
for NASDAQ Market Listing</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">We
intend to apply to have our Class A Ordinary Shares approved for listing/quotation on the NASDAQ Global Market under the symbol
&ldquo;[&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;]&rdquo;. We will not consummate and close this Offering without a listing
approval letter from the NASDAQ Global Market. Our receipt of a listing approval letter is not the same as an actual listing on
the NASDAQ Global Market. The listing approval letter will serve only to confirm that, if we sell a number of shares on a best
efforts basis offering sufficient to satisfy applicable listing criteria, our Class A Ordinary Shares will in fact be listed.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 34pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">If
our Class A Ordinary Shares are listed on the NASDAQ Global Market, we will be subject to continued listing requirements and corporate
governance standards. We expect these new rules and regulations to significantly increase our legal, accounting and financial
compliance costs.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 34pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Relationships</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">Boustead
acted as the placement agent in the Series A Note Offering and one of the placement agents Bond Offering. For such services, Boustead
received: (a) for the Series A Note Offering: a cash commission of $68,516 and the Series A Note PA Warrants; and (b) for the
Bond Offering: (i) a cash commission of $600,000 and (ii) the Bond PA Warrants. In addition, Boustead purchased $150,000 Series
A Notes in the Series A Note Offering.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 34pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">China
Renaissance also acted as a placement agent for the Bond Offering. For such services, China Renaissance received a cash success
fee of $150,000.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 34pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">The
underwriters and their affiliates may provide from time to time in the future certain commercial banking, financial advisory,
investment banking and other services for us and such affiliates in the ordinary course of their business, for which they may
receive customary fees and commissions. In addition, from time to time, the underwriters and their affiliates may effect transactions
for their own account or the account of customers, and hold on behalf of themselves or their customers, long or short positions
in our debt or equity securities or loans, and may do so in the future.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 154; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->146<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"><A HREF="#toc">Table of Contents</A></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Selling
Restrictions Outside the United States</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Notice
to Prospective Investors in Canada</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">Securities
legislation in certain provinces or territories of Canada may provide a purchaser with remedies for rescission or damages if this
prospectus (including any amendment thereto) contains a misrepresentation, provided that the remedies for rescission or damages
are exercised by the purchaser within the time limit prescribed by the securities legislation of the purchaser&rsquo;s province
or territory. The purchaser should refer to any applicable provisions of the securities legislation of the purchaser&rsquo;s province
or territory for particulars of these rights or consult with a legal advisor.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">Pursuant
to section 3A.3 (or, in the case of securities issued or guaranteed by the government of a non-Canadian jurisdiction, section
3A.4) of National Instrument 33-105 Underwriting Conflicts (NI 33-105), the underwriters are not required to comply with the disclosure
requirements of NI 33-105 regarding underwriter conflicts of interest in connection with this offering.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">The
Class A Ordinary Shares may be sold only to purchasers purchasing, or deemed to be purchasing, as principal that are accredited
investors, as defined in National Instrument 45-106&nbsp;<I>Prospectus Exemptions&nbsp;</I>or subsection 73.3(1) of the&nbsp;<I>Securities
Act&nbsp;</I>(Ontario), and are permitted clients, as defined in National Instrument 31-103&nbsp;<I>Registration Requirements,
Exemptions and Ongoing Registrant Obligations</I>. Any resale of the Class A Ordinary Shares must be made in accordance with an
exemption from, or in a transaction not subject to, the prospectus requirements of applicable securities laws.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Notice
to Prospective Investors in Hong Kong </B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">The
Class A Ordinary Shares may not be offered or sold in Hong Kong by means of any document other than (i) in circumstances which
do not constitute an offer to the public within the meaning of the Companies Ordinance (Cap. 32, Laws of Hong Kong), (ii) to &ldquo;professional
investors&rdquo; within the meaning of the Securities and Futures Ordinance (Cap. 571, Laws of Hong Kong) and any rules made thereunder,
or (iii) in other circumstances which do not result in the document being a &ldquo;prospectus&rdquo; within the meaning of the
Companies Ordinance (Cap. 32, Laws of Hong Kong) and no advertisement, invitation or document relating to our Class A Ordinary
Shares be issued or may be in the possession of any person for the purpose of issue (in each case whether in Hong Kong or elsewhere),
which is directed at, or the contents of which are likely to be accessed or read by, the public in Hong Kong (except if permitted
to do so under the laws of Hong Kong) other than with respect to our Class A Ordinary Shares which are or are intended to be disposed
of only to persons outside Hong Kong or only to &ldquo;professional investors&rdquo; within the meaning of the Securities and
Futures Ordinance (Cap. 571, Laws of Hong Kong) and any rules made thereunder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 34pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Notice
to Prospective Investors in the People&rsquo;s Republic of China</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">This
prospectus may not be circulated or distributed in the PRC and the Class A Ordinary Shares may not be offered or sold, and will
not offer or sell to any person for re-offering or resale directly or indirectly to any resident of the PRC except pursuant to
applicable laws, rules and regulations of the PRC. For the purpose of this paragraph only, the PRC does not include Taiwan, Hong
Kong Special Administrative Region and Macau Special Administrative Region.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 34pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Notice
to Prospective Investors in the EEA </B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">In
relation to each Member State of the European Economic Area which has implemented the Prospectus Directive (as defined below)
and each, a Relevant Member State, from and including the date on which the EU Prospectus Directive (the &ldquo;EU Prospectus
Directive&rdquo;) was implemented in that Relevant Member State, or the Relevant Implementation Date, an offer of securities described
in this prospectus may not be made to the public in that Relevant Member State prior to the publication of a prospectus in relation
to the shares which has been approved by the competent authority in that Relevant Member State or, where appropriate, approved
in another Relevant Member State and notified to the competent authority in that Relevant Member State, all in accordance with
the EU Prospectus Directive, except that, with effect from and including the Relevant Implementation Date, an offer of securities
described in this prospectus may be made to the public in that Relevant Member State at any time:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 34pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 0.5in; text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 0.25in; text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">to
    any legal entity which is a qualified investor as defined under the EU Prospectus Directive;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">to
    fewer than 100 or, if the Relevant Member State has implemented the relevant provision of the 2010 PD Amending Directive,
    150 natural or legal persons (other than qualified investors as defined in the EU Prospectus Directive); or</FONT></TD></TR>
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">in
    any other circumstances falling within Article 3(2) of the EU Prospectus Directive, provided that no such offer of securities
    described in this prospectus shall result in a requirement for the publication by us of a prospectus pursuant to Article 3
    of the EU Prospectus Directive. </FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<!-- Field: Page; Sequence: 155; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->147<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"><A HREF="#toc">Table of Contents</A></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">For
the purposes of this provision, the expression an &ldquo;offer of securities to the public&rdquo; in relation to any securities
in any Relevant Member State means the communication in any form and by any means of sufficient information on the terms of the
offer and the securities to be offered so as to enable an investor to decide to purchase or subscribe for the securities, as the
same may be varied in that Member State by any measure implementing the EU Prospectus Directive in that Member State. The expression
&ldquo;EU Prospectus Directive&rdquo; means Directive 2003/71/EC (and any amendments thereto, including the 2010 PD Amending Directive,
to the extent implemented in the Relevant Member State) and includes any relevant implementing measure in each Relevant Member
State, and the expression &ldquo;2010 PD Amending Directive&rdquo; means Directive 2010/73/EU.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 34pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Notice
to Prospective Investors in the United Kingdom </B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">This
prospectus is only being distributed to and is only directed at persons in the United Kingdom that are qualified investors within
the meaning of Article 2(1)(e) of the Prospectus Directive that are also (i) to investment professionals falling within Article
19(5) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 within, and/or (ii) high net worth entities,
and other persons to whom it may lawfully be communicated, falling with Article 49(2)(a) to (d) (all such persons together being
referred to as &ldquo;relevant persons&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 34pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">This
prospectus and its contents are confidential and should not be distributed, published or reproduced (in whole or in part) or disclosed
by recipients to any other persons in the United Kingdom. Any person in the United Kingdom who is not a relevant person should
not act or rely on this document or any of its contents.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 34pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">The
underwriters have represented, warranted and agreed that:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 34pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(A)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;it
has only communicated or caused to be communicated and will only communicate or cause to be communicated an invitation or inducement
to engage in investment activity (within the meaning of Section 21 of the UK Financial Services and Markets Act 2000, as amended
(the &ldquo;FSMA&rdquo;)) received by it in connection with the issue or sale of the Shares in circumstances in which Section
21(1) of the FSMA does not apply to us; and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(B)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;it
has complied and will comply with all applicable provisions of the FSMA with respect to anything done by it in relation to our
Ordinary Shares in, from or otherwise involving the United Kingdom.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 20.25pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Notice
to Prospective Investors in Japan </B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">The
Class A Ordinary Shares offered in this prospectus have not been and will not be registered under the Financial Instruments and
Exchange Law of Japan. Our Class A Ordinary Shares have not been offered or sold and will not be offered or sold, directly or
indirectly, in Japan or to or for the account of any resident of Japan (including any corporation or other entity organized under
the laws of Japan), except (i) pursuant to an exemption from the registration requirements of the Financial Instruments and Exchange
Law and (ii) in compliance with any other applicable requirements of Japanese law.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 34pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Notice
to Prospective Investors in Singapore </B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">This
prospectus has not been registered as a prospectus with the Monetary Authority of Singapore. Accordingly, this prospectus and
any other document or material in connection with the offer or sale, or invitation for subscription or purchase, of the Class
A Ordinary Shares may not be circulated or distributed, nor may the Class A Ordinary Shares be offered or sold, or be made the
subject of an invitation for subscription or purchase, whether directly or indirectly, to persons in Singapore other than (i)
to an institutional investor under Section 274 of the Securities and Futures Act, Chapter 289 of Singapore (the &ldquo;SFA&rdquo;),
(ii) to a relevant person pursuant to Section 275(1), or any person pursuant to Section 275(1A), and in accordance with the conditions
specified in Section 275 of the SFA or (iii) otherwise pursuant to, and in accordance with the conditions of, any other applicable
provision of the SFA, in each case subject to compliance with conditions set forth in the SFA.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 34pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<!-- Field: Page; Sequence: 156; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->148<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"><A HREF="#toc">Table of Contents</A></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Notice
to Prospective Investors in Germany </B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">Any
offer or solicitation of securities within Germany must be in full compliance with the German Securities Prospectus Act (Wertpapierprospektgesetz-WpPG).
The offer and solicitation of securities to the public in Germany requires the publication of a prospectus that has to be filed
with and approved by the German Federal Financial Services Supervisory Authority (Bundesanstalt f&uuml;r Finanzdienstleistungsaufsicht-BaFin).
This prospectus has not been and will not be submitted for filing and approval to the BaFin and, consequently, will not be published.
Therefore, this prospectus does not constitute a public offer under the German Securities Prospectus Act (Wertpapierprospektgesetz).
This prospectus and any other document relating to our Class A Ordinary Shares, as well as any information contained therein,
must therefore not be supplied to the public in Germany or used in connection with any offer for subscription of our Class A Ordinary
Shares to the public in Germany, any public marketing of our Class A Ordinary Shares or any public solicitation for offers to
subscribe for or otherwise acquire our Class A Ordinary Shares. This prospectus and other offering materials relating to the offer
of our Class A Ordinary Shares are strictly confidential and may not be distributed to any person or entity other than the designated
recipients hereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 34pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Notice
to Prospective Investors in Switzerland </B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">This
document, as well as any other material relating to the shares which are the subject of the offering contemplated by this prospectus,
do not constitute an issue prospectus pursuant to Article 652a and/or 1156 of the Swiss Code of Obligations. The shares will not
be listed on the SIX Swiss Exchange and, therefore, the documents relating to the shares, including, but not limited to, this
document, do not claim to comply with the disclosure standards of the listing rules of SIX Swiss Exchange and corresponding prospectus
schemes annexed to the listing rules of the SIX Swiss Exchange. The shares are being offered in Switzerland by way of a private
placement, i.e., to a small number of selected investors only, without any public offer and only to investors who do not purchase
the shares with the intention to distribute them to the public. The investors will be individually approached by the issuer from
time to time. This document, as well as any other material relating to the shares, is personal and confidential and do not constitute
an offer to any other person. This document may only be used by those investors to whom it has been handed out in connection with
the offering described herein and may neither directly nor indirectly be distributed or made available to other persons without
express consent of the issuer. It may not be used in connection with any other offer and shall in particular not be copied and/or
distributed to the public in (or from) Switzerland.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><A NAME="w21"></A>EXPENSES
OF THIS OFFERING</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">Set
forth below is an itemization of our total expenses, excluding underwriting discounts and commissions, which are expected to be
incurred in connection with the offer and sale of the Class A Ordinary Shares by us. With the exception of the SEC registration
fee, the FINRA filing fee and the NASDAQ Global Market listing fee, all amounts are estimates.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 34pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: bottom; background-color: #CCEEFF; font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 89%; text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Securities
    and Exchange Commission registration fee</FONT></TD>
    <TD STYLE="width: 1%; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 8%; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: white; font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Financial
    Industry Regulatory Authority filing fee</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: #CCEEFF; font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">NASDAQ
    Global Market listing fee</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: white; font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Printing
    and engraving expenses</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: #CCEEFF; font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Legal
    fees and expenses</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: white; font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">IPO
    Advisor fees and expenses</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: #CCEEFF; font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accounting
    fees and expenses</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: white; font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Miscellaneous</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: #CCEEFF; font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Total</B></FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 20.25pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<!-- Field: Page; Sequence: 157; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->149<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"><A HREF="#toc">Table of Contents</A></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><A NAME="w22"></A>LEGAL
MATTERS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">The
validity of the Class A Ordinary Shares being offered by this prospectus and other legal matters concerning this Offering relating
to Cayman Islands law will be passed upon for us by Campbells. Certain legal matters in connection with this Offering with respect
to the United States federal securities law and New York law will be passed upon for us by Hunter Taubman Fischer &amp; Li LLC,
New York, New York. Certain legal matters with respect to the United States federal securities and New York law in connection
with this Offering will be passed upon for the underwriters by Pryor Cashman LLP, New York, New York.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><A NAME="w23"></A>EXPERTS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">The
accompanying statements of net assets (predecessor basis) including the schedule of portfolio investments of Aptorum Group Limited
as of December 31, 2016 and February 28, 2017, and the related statements (predecessor basis) of operations, changes in net assets,
and cash flows for the year ended December 31, 2016, the statements (predecessor basis) of operations, changes in net assets,
and cash flows for the period January 1, 2017 through February 28, 2017, the consolidated balance sheet (successor basis) as of
December 31, 2017, the related consolidated statements (successor basis) of operations and comprehensive loss, stockholders&rsquo;
equity and cash flows for the period March 1, 2017 through December 31, 2017, and the related notes (collectively referred to
as the &ldquo;financial statements&rdquo;), appearing in this prospectus and Registration Statement have been audited by Marcum
Bernstein &amp; Pinchuk LLP, an independent registered public accounting firm, as set forth in their report thereon appearing
elsewhere herein, and are included in reliance upon such report given on the authority of such firm as experts in accounting and
auditing.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><A NAME="w24"></A>ENFORCEMENT
OF CIVIL LIABILITIES</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">We
are incorporated under the laws of the Cayman Islands as an exempted company with limited liability. We incorporated in the Cayman
Islands because of certain benefits associated with being a Cayman Islands corporation, such as political and economic stability,
an effective judicial system, a favorable tax system, the absence of foreign exchange control or currency restrictions and the
availability of professional and support services. However, the Cayman Islands have a less developed body of securities laws that
provide significantly less protection to investors as compared to the securities laws of the United States. In addition, Cayman
Islands companies may not have standing to sue before the federal courts of the United States.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 34pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">All
of our assets are located in Hong Kong. In addition, some of our directors and officers are residents of jurisdictions other than
the United States and all or a substantial portion of their assets are located outside the United States. As a result, it may
be difficult for investors to effect service of process within the United States upon us or our directors and officers, or to
enforce against us or them judgments obtained in United States courts, including judgments predicated upon the civil liability
provisions of the securities laws of the United States or any state in the United States.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 34pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">According
to our local Cayman Islands&rsquo; counsel, there is uncertainty with regard to Cayman Islands law relating to whether a judgment
obtained from the United States or Hong Kong courts under civil liability provisions of the securities laws will be determined
by the courts of the Cayman Islands as penal or punitive in nature. If such a determination is made, the courts of the Cayman
Islands will not recognize or enforce the judgment against a Cayman Islands&rsquo; company. The courts of the Cayman Islands in
the past determined that disgorgement proceedings brought at the instance of the Securities and Exchange Commission are penal
or punitive in nature and such judgments would not be enforceable in the Cayman Islands. Other civil liability provisions of the
securities laws may be characterized as remedial, and therefore enforceable but the Cayman Islands&rsquo; Courts have not yet
ruled in this regard. Our Cayman Islands&rsquo; counsel has further advised us that a final and conclusive judgment in the federal
or state courts of the United States under which a sum of money is payable other than a sum payable in respect of taxes, fines,
penalties or similar charges, may be subject to enforcement proceedings as a debt in the courts of the Cayman Islands.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 34pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">As
of the date of this prospectus, no treaty or other form of reciprocity exists between the Cayman Islands and Hong Kong governing
the recognition and enforcement of judgments.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 34pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">Cayman
Islands&rsquo; counsel further advised that although there is no statutory enforcement in the Cayman Islands of judgments obtained
in the United States or Hong Kong, a judgment obtained in such jurisdictions will be recognized and enforced in the courts of
the Cayman Islands at common law, without any re-examination of the merits of the underlying dispute, by an action commenced on
the foreign judgment debt in the Grand Court of the Cayman Islands, provided such judgment (1) is given by a foreign court of
competent jurisdiction, (2) imposes on the judgment debtor a liability to pay a liquidated sum for which the judgment has been
given, (3) is final, (4) is not in respect of taxes, a fine or a penalty, and (5) was not obtained in a manner and is of a kind
the enforcement of which is contrary to natural justice or the public policy of the Cayman Islands.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 34pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<!-- Field: Page; Sequence: 158; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->150<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"><A HREF="#toc">Table of Contents</A></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><A NAME="w25"></A>WHERE
YOU CAN FIND MORE INFORMATION</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">We
have filed with the SEC a registration statement on Form F-1 under the Securities Act relating to this Offering of our Class A
Ordinary Shares. This prospectus does not contain all of the information contained in the registration statement. The rules and
regulations of the SEC allow us to omit certain information from this prospectus that is included in the registration statement.
Statements made in this prospectus concerning the contents of any contract, agreement or other document are summaries of all material
information about the documents summarized, but are not complete descriptions of all terms of these documents. If we filed any
of these documents as an exhibit to the registration statement, you may read the document itself for a complete description of
its terms.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 34pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">You
may read and copy the registration statement, including the related exhibits and schedules, and any document we file with the
SEC without charge at the SEC&rsquo;s public reference room at 100 F Street, N.E., Room 1580, Washington, D.C. 20549. You may
also obtain copies of the documents at prescribed rates by writing to the Public Reference Section of the SEC at 100 F Street,
N.E., Room 1580, Washington, D.C. 20549. Please call the SEC at 1-800-SEC-0330 for further information on the public reference
room. The SEC also maintains an Internet website that contains reports and other information regarding issuers that file electronically
with the SEC. Our filings with the SEC are also available to the public through the SEC&rsquo;s website at http://www.sec.gov.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 34pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">Upon
completion of this Offering, we will be subject to the information reporting requirements of the Exchange Act that are applicable
to foreign private issuers, and under those requirements will file reports with the SEC. Those other reports or other information
may be inspected without charge at the locations described above. As a foreign private issuer, we will be exempt from the rules
under the Exchange Act related to the furnishing and content of proxy statements, and our officers, directors and principal shareholders
will be exempt from the reporting and short-swing profit recovery provisions contained in Section 16 of the Exchange Act. In addition,
we will not be required under the Exchange Act to file annual, quarterly and current reports and financial statements with the
SEC as frequently or as promptly as U.S. companies whose securities are registered under the Exchange Act. However, we will file
with the SEC, within 120 days after the end of each fiscal year, or such applicable time as required by the SEC, an annual report
on Form 20-F containing financial statements audited by an independent registered public accounting firm, and will submit to the
SEC, on Form 6-K, unaudited quarterly financial information for the first three quarters of each fiscal year.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 34pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">We
maintain a corporate website at www.aptorumgroup.com. Information contained on, or that can be accessed through, our website does
not constitute a part of this prospectus.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 34pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<!-- Field: Page; Sequence: 159; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->151<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"><A HREF="#toc">Table of Contents</A></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif"><A NAME="a_026"></A><FONT STYLE="font-size: 10pt"><B>APTORUM
GROUP LIMITED </B></FONT></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><A NAME="w26"></A>Financial
Statements</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif"><A NAME="toc1"></A><FONT STYLE="font-size: 10pt"><B>Table
of Contents</B></FONT></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="width: 90%; font: 10pt Times New Roman, Times, Serif; padding: 0 0 0 10pt; text-indent: -10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif"><A HREF="#f_001"><FONT STYLE="font-size: 10pt">Report
    of Independent Registered Public Accounting Firm</FONT></A></FONT></TD>
    <TD STYLE="width: 10%; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: center; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">F-2</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0 0 0 10pt; text-indent: -10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif"><A HREF="#f_002"><FONT STYLE="font-size: 10pt">Statements
    of Net Assets (Predecessor Basis) as of December 31, 2016 and February 28, 2017</FONT></A></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: center; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">F-3</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0 0 0 10pt; text-indent: -10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif"><A HREF="#f_003"><FONT STYLE="font-size: 10pt">Consolidated
    Balance Sheet (Successor Basis) as of December 31, 2017</FONT></A></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: center; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">F-4</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD STYLE="padding: 0 0 0 10pt; text-indent: -10pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif"><A HREF="#f_004"><FONT STYLE="font-size: 10pt">Statements
    of Operations (Predecessor Basis) for the year ended December 31, 2016 and period January 1, 2017 through February 28, 2017</FONT></A></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: center; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">F-5</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="padding: 0 0 0 10pt; text-indent: -10pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif"><A HREF="#f_005"><FONT STYLE="font-size: 10pt">Consolidated
    Statement of Operations and Comprehensive Loss (Successor Basis) for the period March 1, 2017 through December 31, 2017</FONT></A></FONT></TD>
    <TD STYLE="padding: 0; text-align: center; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">F-6</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD STYLE="padding: 0 0 0 10pt; text-indent: -10pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif"><A HREF="#f_006"><FONT STYLE="font-size: 10pt">Statements
    of Changes in Net Assets (Predecessor Basis) for the year ended December 31, 2016 and period January 1, 2017 through February
    28, 2017</FONT></A></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: center; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">F-7</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="padding: 0 0 0 10pt; text-indent: -10pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif"><A HREF="#f_007"><FONT STYLE="font-size: 10pt">Consolidated
    Statement of Shareholders&rsquo; Equity (Successor Basis) for the period March 1, 2017 through December 31, 2017</FONT></A></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: center; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">F-8</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD STYLE="padding: 0 0 0 10pt; text-indent: -10pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif"><A HREF="#f_008"><FONT STYLE="font-size: 10pt">Statements
    of Cash Flows (Predecessor Basis) for the year ended December 31, 2016 and period January 1, 2017 through February 28, 2017</FONT></A></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: center; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">F-9</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="padding: 0 0 0 10pt; text-indent: -10pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif"><A HREF="#f_009"><FONT STYLE="font-size: 10pt">Consolidated
    Statement of Cash Flows (Successor Basis) for the period March 1, 2017 through December 31, 2017</FONT></A></FONT></TD>
    <TD STYLE="padding: 0; text-align: center; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">F-10</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0 0 0 10pt; text-indent: -10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif"><A HREF="#f_010"><FONT STYLE="font-size: 10pt">Schedule
    of Portfolio Investments as of December 31, 2016</FONT></A></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: center; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">F-11</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0 0 0 10pt; text-indent: -10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif"><A HREF="#f_011"><FONT STYLE="font-size: 10pt">Schedule
    of Portfolio Investments as of February 28, 2017</FONT></A></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: center; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">F-12</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0 0 0 10pt; text-indent: -10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif"><A HREF="#f_012"><FONT STYLE="font-size: 10pt">Notes
    to Financial Statements (Predecessor Basis)</FONT></A></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: center; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">F-13</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0 0 0 10pt; text-indent: -10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif"><A HREF="#f_013"><FONT STYLE="font-size: 10pt">Notes
    to Consolidated Financial Statements (Successor Basis)</FONT></A></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: center; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">F-33</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 160; Options: NewSection; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt; font: 10pt Times New Roman, Times, Serif"><A HREF="#toc">Table of Contents</A>&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><IMG SRC="img_015.jpg" ALT=""></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><A NAME="f_001"></A><FONT STYLE="font-size: 10pt"><B>REPORT
OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM</B></FONT></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">To
the Shareholders and Board of Directors of</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Aptorum
Group Limited</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Opinion
on the Financial Statements</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have audited the accompanying statements of net assets (predecessor basis) including the schedule of portfolio investments of
Aptorum Group Limited (formally known as APTUS Holdings Limited and STRIKER ASIA OPPORTUNITIES FUND CORPORATION, the &ldquo;Company&rdquo;)
as of December 31, 2016 and February 28, 2017, and the related statements (predecessor basis) of operations, changes in net assets,
and cash flows for the year ended December 31, 2016, the statements (predecessor basis) of operations, changes in net assets,
and cash flows for the period January 1, 2017 through February 28, 2017, the consolidated balance sheet (successor basis) as of
December 31, 2017, the related consolidated statements (successor basis) of operations and comprehensive loss, stockholders&rsquo;
equity and cash flows for the period March 1, 2017 through December 31, 2017, and the related notes (collectively referred to
as the &ldquo;financial statements&rdquo;). In our opinion, the financial statements present fairly, in all material respects,
the financial position of the Company as of December 31, 2016 and 2017, and the results of its operations and its cash flows for
the year ended December 31, 2016, the period January 1, 2017 through February 28, 2017 and the period March 1, 2017 through December
31, 2017, in conformity with accounting principles generally accepted in the United States of America (&ldquo;U.S. GAAP&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Change
in Investment Company Status</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
discussed in Note 4 and Note 15 to the financial statements, effective March 1, 2017, the Company changed its financial reporting
to that of an operating company from an investment company since it no longer met the assessment of an investment company under
the Financial Accounting Standards Board (&ldquo;FASB&rdquo;) Accounting Standards Codification Topic 946 (&ldquo;ASC 946&rdquo;).
The Company discontinued applying the guidance in ASC 946 and began to account for the change in status prospectively by accounting
for its investments in accordance with other U.S. GAAP topics as of the date of the change in status. The change in status affects
the comparability of the financial statements. Our opinion is not modified with respect to this matter.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Basis
for Opinion</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 486.35pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">These
financial statements are the responsibility of the Company&rsquo;s management. Our responsibility is to express an opinion on the Company&rsquo;s
financial statements based on our audits. We are a public accounting firm registered with the Public Company Accounting Oversight
Board (United States) (&ldquo;PCAOB&rdquo;) and are required to be independent with respect to the Company in accordance with the
U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">We
conducted our audits in accordance with the standards of the PCAOB.</FONT> &nbsp;<FONT STYLE="font-family: Times New Roman, Times, Serif">Those
standards require that we plan and perform the audits to obtain reasonable assurance about whether the financial statements are
free of material misstatement, whether due to error or fraud. Our audits included performing procedures to assess the risks of
material misstatement of the financial statements, whether due to error or fraud, and performing procedures that respond to those
risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the financial statements.
Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating
the overall presentation of the financial statements. We believe that our audits provide a reasonable basis for our opinion.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/
Marcum Bernstein &amp; Pinchuk <FONT STYLE="font-variant: small-caps">llp</FONT></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-variant: small-caps">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Marcum
Bernstein &amp; Pinchuk <FONT STYLE="font-variant: small-caps">llp</FONT></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-variant: small-caps">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have served as the Company&rsquo;s auditor since 2017.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">New
York, New York</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif"><BR>
<FONT STYLE="font-size: 10pt">July 13, 2018</FONT></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><IMG SRC="img_016.jpg" ALT=""><FONT STYLE="font-family: Times New Roman, Times, Serif"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">NEW
YORK OFFICE &#9679;  7 Penn Plaza &#9679;  Suite 830 &#9679;  New York, New York &#9679;  10001</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Phone
646.442.4845 &#9679;  Fax 646.349.5200 &#9679;  www.marcumbp.com</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 161; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt; font: 10pt Times New Roman, Times, Serif"><A HREF="#toc">Table of Contents</A>&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>




<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>APTORUM
GROUP LIMITED</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><A NAME="f_002"></A><FONT STYLE="font-size: 10pt"><B>STATEMENTS
OF NET ASSETS (PREDECESSOR BASIS)</B></FONT></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>December
31, 2016 and February 28, 2017</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(Stated
in U.S. Dollars)</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0 0 0 10pt; text-indent: -10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.8pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>December
                                         31, </B></FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.8pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>2016</B></FONT></P></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-align: center; border-bottom: Black 1.5pt solid; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">February
    28, </FONT><FONT STYLE="font-family: Times New Roman, Times, Serif"><BR> <FONT STYLE="font-size: 10pt">2017</FONT></FONT></TD><TD STYLE="padding: 0; font: bold 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding: 0 0 0 10pt; text-indent: -10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ASSETS</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="padding: 0 0 0 10pt; font: 10pt Times New Roman, Times, Serif; text-indent: -10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Investments,
    at fair value</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 76%; text-indent: -10pt; padding: 0 0 0 10pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Unaffiliated
    issuers (cost $22,783,506 as of December 31, 2016 and $22,739,748 as of February 28, 2017)</FONT></TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD><TD STYLE="width: 9%; text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">24,126,392</FONT></TD><TD STYLE="width: 1%; text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD><TD STYLE="width: 9%; text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">23,794,333</FONT></TD><TD STYLE="width: 1%; text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="padding: 0 0 0 10pt; text-indent: -10pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Aptorum
    Therapeutics - related party (cost $1,000,000 as of December 31, 2016 and February 28, 2017)</FONT></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: right; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">856,081</FONT></TD><TD STYLE="padding: 0; text-align: left; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: right; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">757,647</FONT></TD><TD STYLE="padding: 0; text-align: left; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-indent: -10pt; padding: 0 0 0 10pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">24,982,473</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">24,551,980</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-indent: -10pt; padding: 0 0 0 10pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cash</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">301,643</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">29,983</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: -10pt; padding: 0 0 0 10pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Due
    from brokers</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">96,896</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">125,334</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: -10pt; padding: 0 0 0 10pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Interest
    receivable</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,050</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6,149</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; padding: 0 0 0 10pt; text-indent: -10pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other
    receivables and prepayments</FONT></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: right; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,520</FONT></TD><TD STYLE="padding: 0; text-align: left; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: right; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD><TD STYLE="padding: 0; text-align: left; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding: 0 0 0 10pt; text-align: left; text-indent: -10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total
    Assets</FONT></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD><TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: right; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">25,384,582</FONT></TD><TD STYLE="padding: 0; text-align: left; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD><TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: right; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">24,713,446</FONT></TD><TD STYLE="padding: 0; text-align: left; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-indent: -10pt; padding: 0 0 0 10pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding: 0 0 0 10pt; text-indent: -10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">LIABILITIES</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: -10pt; padding: 0 0 0 10pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accounts
    payable and accrued expenses</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">92,385</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">106,163</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: -10pt; padding: 0 0 0 10pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Equalization
    payable - related party</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">9,663</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">9,663</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; padding: 0 0 0 10pt; text-indent: -10pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Management
    fees payable - related party</FONT></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: right; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">167,788</FONT></TD><TD STYLE="padding: 0; text-align: left; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: right; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">108,958</FONT></TD><TD STYLE="padding: 0; text-align: left; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding: 0 0 0 10pt; text-align: left; text-indent: -10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total
    Liabilities</FONT></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: right; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">269,836</FONT></TD><TD STYLE="padding: 0; text-align: left; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: right; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">224,784</FONT></TD><TD STYLE="padding: 0; text-align: left; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-indent: -10pt; padding: 0 0 0 10pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding: 0 0 0 10pt; text-align: left; text-indent: -10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Net
    Assets</FONT></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD><TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: right; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">25,114,746</FONT></TD><TD STYLE="padding: 0; text-align: left; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD><TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: right; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">24,488,662</FONT></TD><TD STYLE="padding: 0; text-align: left; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-indent: -10pt; padding: 0 0 0 10pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding: 0 0 0 10pt; text-indent: -10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Net
    Asset Value Per Share</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="padding: 0 0 0 10pt; text-indent: -10pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(5,000,000
    shares of $0.01 par value authorized, 256,664 and 256,571 shares outstanding as of December 31, 2016 and February 28, 2017,
    respectively)</FONT></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD><TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: right; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">97.85</FONT></TD><TD STYLE="padding: 0; text-align: left; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD><TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: right; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">95.45</FONT></TD><TD STYLE="padding: 0; text-align: left; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-indent: -10pt; padding: 0 0 0 10pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding: 0 0 0 10pt; text-align: left; text-indent: -10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Net
    Assets Consist of</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: -10pt; padding: 0 0 0 10pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Paid-in
    capital</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">25,787,834</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">25,778,171</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: -10pt; padding: 0 0 0 10pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Equalization
    payable</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(9,663</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: -10pt; padding: 0 0 0 10pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Undistributed
    ordinary income</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3,212,713</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,988,697</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: -10pt; padding: 0 0 0 10pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accumulated
    undistributed net realized loss on investments</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(5,075,105</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(5,090,432</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; padding: 0 0 0 10pt; text-indent: -10pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Net
    unrealized appreciation on investments</FONT></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: right; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,198,967</FONT></TD><TD STYLE="padding: 0; text-align: left; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: right; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">812,226</FONT></TD><TD STYLE="padding: 0; text-align: left; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="padding: 0 0 0 10pt; text-indent: -10pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD><TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: right; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">25,114,746</FONT></TD><TD STYLE="padding: 0; text-align: left; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD><TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: right; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">24,488,662</FONT></TD><TD STYLE="padding: 0; text-align: left; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">See
accompanying notes to the financial statements.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<!-- Field: Page; Sequence: 162; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt; font: 10pt Times New Roman, Times, Serif"><A HREF="#toc">Table of Contents</A>&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>




<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>APTORUM
GROUP LIMITED</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><A NAME="f_003"></A><FONT STYLE="font-size: 10pt"><B>CONSOLIDATED
BALANCE SHEET (SUCCESSOR BASIS)</B></FONT></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>December
31, 2017</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(Stated
in U.S. Dollars)</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ASSETS</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Current
    assets:</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 88%; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cash</FONT></TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD><TD STYLE="width: 9%; text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">16,245,807</FONT></TD><TD STYLE="width: 1%; text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Restricted
    cash</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">480,000</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Marketable
    securities, at fair value</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,972,648</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Investments
    in derivatives</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,095,122</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Due
    from brokers</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">179,492</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other
    receivables and prepayments</FONT></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: right; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">310,330</FONT></TD><TD STYLE="padding: 0; text-align: left; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total
    current assets</FONT></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: right; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">20,283,399</FONT></TD><TD STYLE="padding: 0; text-align: left; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Equipment,
    net</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">346,587</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Non-marketable
    investments, at cost</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">7,394,713</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Intangible
    assets, net</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,472,707</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Amounts
    due from related parties</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">304,820</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Long-term
    deposits</FONT></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: right; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,757,756</FONT></TD><TD STYLE="padding: 0; text-align: left; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total
    Assets</FONT></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD><TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: right; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">31,559,982</FONT></TD><TD STYLE="padding: 0; text-align: left; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">LIABILITIES
    AND EQUITY</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">LIABILITIES</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Current
    liabilities:</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Amount
    due to a related party</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">197,386</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accounts
    payable and accrued expenses</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">653,348</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Convertible
    promissory notes</FONT></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: right; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">480,000</FONT></TD><TD STYLE="padding: 0; text-align: left; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total
    current liabilities</FONT></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: right; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,330,734</FONT></TD><TD STYLE="padding: 0; text-align: left; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total
    Liabilities</FONT></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD><TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: right; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,330,734</FONT></TD><TD STYLE="padding: 0; text-align: left; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Commitments
    and contingencies</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-align: right; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">EQUITY</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; padding: 0 0 0 10pt; text-indent: -10pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Class
    A Ordinary Shares ($1.00 par value; 60,000,000 shares authorized, 5,426,381 shares issued and outstanding)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0 0 0 10pt; text-indent: -10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5,426,381</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0 0 0 10pt; text-indent: -10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; padding: 0 0 0 10pt; text-indent: -10pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Class
    B Ordinary Shares ($1.00 par value; 40,000,000 shares authorized, 22,437,754 shares issued and outstanding)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">22,437,754</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Additional
    paid-in capital</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5,294,402</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accumulated
    other comprehensive loss</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(367,782</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accumulated
    deficit</FONT></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: right; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2,547,462</FONT></TD><TD STYLE="padding: 0; text-align: left; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total
    equity attributable to the shareholders of Aptorum Group Limited</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">30,243,293</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Non-controlling
    interests</FONT></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: right; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(14,045</FONT></TD><TD STYLE="padding: 0; text-align: left; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total
    equity</FONT></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: right; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">30,229,248</FONT></TD><TD STYLE="padding: 0; text-align: left; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total
    Liabilities and Equity</FONT></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD><TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: right; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">31,559,982</FONT></TD><TD STYLE="padding: 0; text-align: left; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">See
accompanying notes to the consolidated financial statements.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Page; Sequence: 163; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt; font: 10pt Times New Roman, Times, Serif"><A HREF="#toc">Table of Contents</A>&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>




<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>APTORUM
GROUP LIMITED</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><A NAME="f_004"></A><FONT STYLE="font-size: 10pt"><B>STATEMENTS
OF OPERATIONS (PREDECESSOR BASIS)</B></FONT></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>For
the Year Ended December 31, 2016 and Period January 1, 2017 through February 28, 2017</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(Stated
in U.S. Dollars)</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Year Ended December&nbsp;31, <BR> 2016</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.8pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>January 1, 2017 through</B></FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.8pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>February&nbsp;28, </B></FONT><FONT STYLE="font-family: Times New Roman, Times, Serif"><BR> <FONT STYLE="font-size: 10pt"><B>2017</B></FONT></FONT></P></TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font-weight: bold">Investment income</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 76%; text-align: left">Dividend income from unaffiliated issuers</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 9%; text-align: right">57,642</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 9%; text-align: right">-&nbsp;&nbsp;</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt">Interest income</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">28,800</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">3,011</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt">Total investment income</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">86,442</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">3,011</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold">Expenses</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">General and administrative fees</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">79,750</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">17,516</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Management fees</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">641,807</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">108,958</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Legal and professional fees</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">106,031</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">98,646</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt">Other operating expenses</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">50,646</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">1,907</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt">Total expenses</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">878,234</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">227,027</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: bold; text-align: left; padding-bottom: 4pt">Net investment loss</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">(791,792</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">)</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">(224,016</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: bold; text-align: left">Realized and unrealized losses</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Net realized losses on investments in unaffiliated issuers</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">(840,485</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">(15,327</TD><TD STYLE="text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Net change in unrealized depreciation on investments</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Aptorum Therapeutics - related party</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(143,919</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(98,434</TD><TD STYLE="text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt">Unaffiliated issuers</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(358,319</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(288,307</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt">Net realized and unrealized losses</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(1,342,723</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(402,068</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold; text-align: left; padding-bottom: 4pt">Net decrease in net assets resulting from operations</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">(2,134,515</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">)</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">(626,084</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">)</TD></TR>
</TABLE>




<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">See
accompanying notes to the financial statements.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Page; Sequence: 164; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt; font: 10pt Times New Roman, Times, Serif"><A HREF="#toc">Table of Contents</A>&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>




<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>APTORUM
GROUP LIMITED</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><A NAME="f_005"></A><FONT STYLE="font-size: 10pt"><B>CONSOLIDATED
STATEMENT OF OPERATIONS AND COMPREHENSIVE LOSS (SUCCESSOR BASIS)</B></FONT></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>For
the Period March 1, 2017 through December 31, 2017</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(Stated
in U.S. Dollars)</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: left"><B>Expenses</B></TD><TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: right">&nbsp;</TD><TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 88%; text-align: left">Research and development expenses</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 9%; text-align: right">2,560,323</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">General and administrative fees</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,480,093</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Legal and professional fees</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,395,490</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt">Other operating expenses</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">257,177</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt">Total expenses</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">5,693,083</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold; text-align: left">Other income</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Gain on investments in marketable securities, net</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">3,912,500</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Loss on investments in derivatives, net</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(827,501</TD><TD STYLE="text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Interest income</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">44,269</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt">Dividend income</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">2,308</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt">Total other income, net</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">3,131,576</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: bold; text-align: left; padding-bottom: 1.5pt">Net loss</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(2,561,507</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Less: net loss attributable to non-controlling interests</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(14,045</TD><TD STYLE="text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold; text-align: left; padding-bottom: 4pt">Net loss attributable to Aptorum Group Limited</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">(2,547,462</TD><TD STYLE="padding-bottom: 4pt; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Net loss per share &ndash; basic and diluted</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">(0.09</TD><TD STYLE="text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 4pt">Weighted-average shares outstanding &ndash; basic and diluted</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">26,963,435</TD><TD STYLE="padding-bottom: 4pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: bold; text-align: left">Net loss</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">(2,561,507</TD><TD STYLE="text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: bold; text-align: left">Other Comprehensive loss</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt">Unrealized loss on investments in available-for-sale securities</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(367,782</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt">Other Comprehensive loss</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(367,782</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: bold; text-align: left; padding-bottom: 1.5pt">Comprehensive loss</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(2,929,289</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Less: comprehensive loss attributable to non-controlling interests</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(14,045</TD><TD STYLE="text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold; text-align: left; padding-bottom: 4pt">Comprehensive loss attributable to the shareholders of Aptorum Group Limited</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">(2,915,244</TD><TD STYLE="padding-bottom: 4pt; text-align: left">)</TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">See
accompanying notes to the consolidated financial statements.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Page; Sequence: 165; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt; font: 10pt Times New Roman, Times, Serif"><A HREF="#toc">Table of Contents</A>&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>




<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>APTORUM
GROUP LIMITED</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><A NAME="f_006"></A><FONT STYLE="font-size: 10pt"><B>STATEMENTS
OF CHANGES IN NET ASSETS (PREDECESSOR BASIS)</B></FONT></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>For
the Year Ended December 31, 2016 and Period January 1, 2017 through February 28, 2017</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(Stated
in U.S. Dollars)</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 1.8pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Year
                                         Ended</B></FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 1.8pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>December&nbsp;31,
                                         2016</B></FONT></P></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-align: center; border-bottom: Black 1.5pt solid; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">January
    1, 2017 through February&nbsp;28, 2017</FONT></TD><TD STYLE="padding: 0; font: bold 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Operations</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 76%; text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Net
    investment losses</FONT></TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD><TD STYLE="width: 9%; text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(791,792</FONT></TD><TD STYLE="width: 1%; text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</FONT></TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD><TD STYLE="width: 9%; text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(224,016</FONT></TD><TD STYLE="width: 1%; text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Net
    realized losses</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(840,485</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(15,327</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Net
    change in unrealized depreciation</FONT></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: right; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(502,238</FONT></TD><TD STYLE="padding: 0; text-align: left; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</FONT></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: right; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(386,741</FONT></TD><TD STYLE="padding: 0; text-align: left; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Net
    decrease in net assets resulting from operations</FONT></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: right; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2,134,515</FONT></TD><TD STYLE="padding: 0; text-align: left; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</FONT></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: right; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(626,084</FONT></TD><TD STYLE="padding: 0; text-align: left; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Distributions
    to shareholders</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Equalization
    payable</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(9,663</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">9,663</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Return
    of capital</FONT></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: right; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD><TD STYLE="padding: 0; text-align: left; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: right; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(9,663</FONT></TD><TD STYLE="padding: 0; text-align: left; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total
    distributions</FONT></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: right; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(9,663</FONT></TD><TD STYLE="padding: 0; text-align: left; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</FONT></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: right; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD><TD STYLE="padding: 0; text-align: left; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Issuance
    of shares</FONT></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: right; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,900,000</FONT></TD><TD STYLE="padding: 0; text-align: left; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: right; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD><TD STYLE="padding: 0; text-align: left; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total
    increase (decrease) in net assets</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">755,822</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(626,084</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Net
    assets</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Beginning
    of period</FONT></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: right; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">24,358,924</FONT></TD><TD STYLE="padding: 0; text-align: left; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: right; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">25,114,746</FONT></TD><TD STYLE="padding: 0; text-align: left; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">End
    of period</FONT></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD><TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: right; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">25,114,746</FONT></TD><TD STYLE="padding: 0; text-align: left; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD><TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: right; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">24,488,662</FONT></TD><TD STYLE="padding: 0; text-align: left; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">See
accompanying notes to the financial statements.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Page; Sequence: 166; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt; font: 10pt Times New Roman, Times, Serif"><A HREF="#toc">Table of Contents</A>&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>




<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>APTORUM
GROUP LIMITED</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><A NAME="f_007"></A><FONT STYLE="font-size: 10pt"><B>CONSOLIDATED
STATEMENT OF SHAREHOLDERS&rsquo; EQUITY (SUCCESSOR BASIS)</B></FONT></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>For
the Period March 1, 2017 through December 31, 2017</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(Stated
in U.S. Dollars)</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 88%; font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Net
    assets to allocate to shareholders&rsquo; equity at February 28, 2017</FONT></TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD><TD STYLE="width: 9%; text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">24,488,662</FONT></TD><TD STYLE="width: 1%; text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: center; padding: 0 0 0 3pt; text-indent: -3pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">&nbsp;</FONT></TD>
    <TD COLSPAN="6" STYLE="font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-align: center; border-bottom: Black 1.5pt solid; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">Ordinary
    shares</FONT></TD><TD STYLE="padding: 0; font: bold 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">&nbsp;</FONT></TD>
    <TD COLSPAN="6" STYLE="font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-align: center; border-bottom: Black 1.5pt solid; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">Class
    A Ordinary Shares</FONT></TD><TD STYLE="padding: 0; font: bold 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">&nbsp;</FONT></TD>
    <TD COLSPAN="6" STYLE="font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-align: center; border-bottom: Black 1.5pt solid; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">Class
    B Ordinary Shares</FONT></TD><TD STYLE="padding: 0; font: bold 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-align: center; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">Additional
    Paid-in Capital</FONT></TD><TD STYLE="padding: 0; font: bold 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-align: center; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">Accumulated
    deficit</FONT></TD><TD STYLE="padding: 0; font: bold 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-align: center; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">Accumulated
    other comprehensive loss</FONT></TD><TD STYLE="padding: 0; font: bold 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-align: center; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">Non-controlling
    interests</FONT></TD><TD STYLE="padding: 0; font: bold 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-align: center; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">Total</FONT></TD><TD STYLE="padding: 0; font: bold 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="padding: 0 0 0 3pt; text-indent: -3pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-align: center; border-bottom: Black 1.5pt solid; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">Shares</FONT></TD><TD STYLE="padding: 0; font: bold 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-align: center; border-bottom: Black 1.5pt solid; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">Amount</FONT></TD><TD STYLE="padding: 0; font: bold 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-align: center; border-bottom: Black 1.5pt solid; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">Shares</FONT></TD><TD STYLE="padding: 0; font: bold 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-align: center; border-bottom: Black 1.5pt solid; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">Amount</FONT></TD><TD STYLE="padding: 0; font: bold 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-align: center; border-bottom: Black 1.5pt solid; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">Shares</FONT></TD><TD STYLE="padding: 0; font: bold 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-align: center; border-bottom: Black 1.5pt solid; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">Amount</FONT></TD><TD STYLE="padding: 0; font: bold 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-align: center; border-bottom: Black 1.5pt solid; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">Amount</FONT></TD><TD STYLE="padding: 0; font: bold 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-align: center; border-bottom: Black 1.5pt solid; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">Amount</FONT></TD><TD STYLE="padding: 0; font: bold 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-align: center; border-bottom: Black 1.5pt solid; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">Amount</FONT></TD><TD STYLE="padding: 0; font: bold 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-align: center; border-bottom: Black 1.5pt solid; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">Amount</FONT></TD><TD STYLE="padding: 0; font: bold 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-align: center; border-bottom: Black 1.5pt solid; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">Amount</FONT></TD><TD STYLE="padding: 0; font: bold 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="padding: 0 0 0 3pt; text-indent: -3pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding: 0 0 0 3pt; text-indent: -3pt; width: 11.5%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">Balance,
    March 1, 2017</FONT></TD><TD STYLE="width: 0%; font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 0.5%; font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="width: 7%; font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-align: right; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">25,657,110</FONT></TD><TD STYLE="width: 0.5%; font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="width: 0%; font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 0.5%; font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">$</FONT></TD><TD STYLE="width: 7%; font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-align: right; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">25,657,110</FONT></TD><TD STYLE="width: 0.5%; font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="width: 0%; font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 0.5%; font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="width: 7%; font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-align: right; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">-</FONT></TD><TD STYLE="width: 0.5%; font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="width: 0.5%; font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 0.5%; font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">$</FONT></TD><TD STYLE="width: 7%; font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-align: right; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">-</FONT></TD><TD STYLE="width: 0.5%; font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="width: 0%; font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 0.5%; font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="width: 7%; font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-align: right; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">-</FONT></TD><TD STYLE="width: 0.5%; font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="width: 0%; font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 0.5%; font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">$</FONT></TD><TD STYLE="width: 7%; font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-align: right; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">-</FONT></TD><TD STYLE="width: 0.5%; font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="width: 0%; font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 0.5%; font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">$</FONT></TD><TD STYLE="width: 7%; font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-align: right; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">(1,168,448</FONT></TD><TD STYLE="width: 0.5%; font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">)</FONT></TD><TD STYLE="width: 0%; font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 0.5%; font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">$</FONT></TD><TD STYLE="width: 7%; font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-align: right; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">-</FONT></TD><TD STYLE="width: 0.5%; font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="width: 0%; font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 0.5%; font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">$</FONT></TD><TD STYLE="width: 7%; font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-align: right; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">-</FONT></TD><TD STYLE="width: 0.5%; font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="width: 0%; font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 0.5%; font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">$</FONT></TD><TD STYLE="width: 7%; font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-align: right; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">-</FONT></TD><TD STYLE="width: 0.5%; font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="width: 0%; font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 0.5%; font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">$</FONT></TD><TD STYLE="width: 7%; font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-align: right; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">24,488,662</FONT></TD><TD STYLE="width: 0.5%; font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="padding: 0 0 0 3pt; text-indent: -3pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">Proceeds
    from issuance of shares</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">2,207,025</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">2,207,025</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">-</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">-</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">-</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">-</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">6,394,976</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">-</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">-</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">-</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-align: right; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">8,602,001</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; padding: 0 0 0 3pt; text-indent: -3pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">Converted
    from ordinary shares</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">(27,864,135</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">(27,864,135</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">5,426,381</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">5,426,381</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">22,437,754</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">22,437,754</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">-</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">-</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">-</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">-</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-align: right; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">-</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; padding: 0 0 0 3pt; text-indent: -3pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">Unrealized
    loss on investments in available-for-sale securities</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">-</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">-</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">-</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">-</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">-</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">-</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">-</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">-</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">(367,782</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">-</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-align: right; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">(367,782</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">)</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; padding: 0 0 0 3pt; text-indent: -3pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">Gain
    on disposal of entity under common control</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">-</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">-</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">-</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">-</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">-</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">-</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">67,874</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">-</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">-</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">-</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-align: right; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">67,874</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; padding: 0 0 0 3pt; text-indent: -3pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">Net
    loss</FONT></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: right; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">-</FONT></TD><TD STYLE="padding: 0; text-align: left; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: right; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">-</FONT></TD><TD STYLE="padding: 0; text-align: left; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: right; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">-</FONT></TD><TD STYLE="padding: 0; text-align: left; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: right; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">-</FONT></TD><TD STYLE="padding: 0; text-align: left; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: right; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">-</FONT></TD><TD STYLE="padding: 0; text-align: left; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: right; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">-</FONT></TD><TD STYLE="padding: 0; text-align: left; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: right; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">-</FONT></TD><TD STYLE="padding: 0; text-align: left; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: right; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">(2,547,462</FONT></TD><TD STYLE="padding: 0; text-align: left; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">)</FONT></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: right; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">-</FONT></TD><TD STYLE="padding: 0; text-align: left; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: right; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">(14,045</FONT></TD><TD STYLE="padding: 0; text-align: left; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">)</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-align: right; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">(2,561,507</FONT></TD><TD STYLE="padding: 0; font: bold 10pt Times New Roman, Times, Serif; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">)</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="padding: 0 0 0 3pt; text-indent: -3pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding: 0 0 0 3pt; text-indent: -3pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">Balance,
    December 31, 2017</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 4pt double; font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 4pt double; font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-align: right; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">-</FONT></TD><TD STYLE="padding: 0; font: bold 10pt Times New Roman, Times, Serif; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 4pt double; font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">$</FONT></TD><TD STYLE="border-bottom: Black 4pt double; font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-align: right; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">-</FONT></TD><TD STYLE="padding: 0; font: bold 10pt Times New Roman, Times, Serif; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 4pt double; font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 4pt double; font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-align: right; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">5,426,381</FONT></TD><TD STYLE="padding: 0; font: bold 10pt Times New Roman, Times, Serif; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 4pt double; font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">$</FONT></TD><TD STYLE="border-bottom: Black 4pt double; font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-align: right; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">5,426,381</FONT></TD><TD STYLE="padding: 0; font: bold 10pt Times New Roman, Times, Serif; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 4pt double; font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 4pt double; font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-align: right; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">22,437,754</FONT></TD><TD STYLE="padding: 0; font: bold 10pt Times New Roman, Times, Serif; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 4pt double; font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">$</FONT></TD><TD STYLE="border-bottom: Black 4pt double; font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-align: right; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">22,437,754</FONT></TD><TD STYLE="padding: 0; font: bold 10pt Times New Roman, Times, Serif; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 4pt double; font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">$</FONT></TD><TD STYLE="border-bottom: Black 4pt double; font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-align: right; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">5,294,402</FONT></TD><TD STYLE="padding: 0; font: bold 10pt Times New Roman, Times, Serif; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 4pt double; font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">$</FONT></TD><TD STYLE="border-bottom: Black 4pt double; font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-align: right; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">(2,547,462</FONT></TD><TD STYLE="padding: 0; font: bold 10pt Times New Roman, Times, Serif; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">)</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 4pt double; font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">$</FONT></TD><TD STYLE="border-bottom: Black 4pt double; font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-align: right; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">(367,782</FONT></TD><TD STYLE="padding: 0; font: bold 10pt Times New Roman, Times, Serif; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">)</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 4pt double; font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">$</FONT></TD><TD STYLE="border-bottom: Black 4pt double; font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-align: right; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">(14,045</FONT></TD><TD STYLE="padding: 0; font: bold 10pt Times New Roman, Times, Serif; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">)</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 4pt double; font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">$</FONT></TD><TD STYLE="border-bottom: Black 4pt double; font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-align: right; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">30,229,248</FONT></TD><TD STYLE="padding: 0; font: bold 10pt Times New Roman, Times, Serif; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">&nbsp;</FONT></TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">See
accompanying notes to the consolidated financial statements.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Page; Sequence: 167; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt; font: 10pt Times New Roman, Times, Serif"><A HREF="#toc">Table of Contents</A>&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>




<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>APTORUM
GROUP LIMITED</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><A NAME="f_008"></A><FONT STYLE="font-size: 10pt"><B>STATEMENTS
OF CASH FLOWS (PREDECESSOR BASIS)</B></FONT></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>For
the Year Ended December 31, 2016 and Period January 1, 2017 through February 28, 2017</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(Stated
in U.S. Dollars)</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.8pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Year
                                         Ended</B></FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.8pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>December&nbsp;31,
                                         2016</B></FONT></P></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.8pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>January
                                         1, 2017 through</B></FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.8pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>February&nbsp;28,
                                         2017</B></FONT></P></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cash
    flows from operating activities</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 76%; font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Net
    decrease in net assets resulting from operations</FONT></TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD><TD STYLE="width: 9%; text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2,134,515</FONT></TD><TD STYLE="width: 1%; text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</FONT></TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD><TD STYLE="width: 9%; text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(626,084</FONT></TD><TD STYLE="width: 1%; text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0 0 0 10pt; text-indent: -10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Adjustments
    to reconcile net decrease in net assets resulting from operations to net cash used in operating activities:</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Net
    change in unrealized depreciation on investments</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">502,238</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">386,741</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Net
    realized loss on sales of investments in unaffiliated issuers</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">840,485</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">15,327</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dividends
    paid-in-kind</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(51,881</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Purchase
    of investment in Aptorum Therapeutics - related party</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1,000,000</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Proceeds
    from sales of investment securities</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4,068,543</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">28,425</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Purchases
    of investment securities</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(5,009,996</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Decrease
    (increase) in interest receivable</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">98</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(5,099</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Increase
    in due from brokers</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(96,896</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(28,438</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Increase)
    decrease in other receivable and prepayments</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2,520</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,520</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Increase
    in accounts payable and accrued expenses</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">65,573</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">13,778</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Increase
    (decrease) in management fees payable - related party</FONT></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: right; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">11,322</FONT></TD><TD STYLE="padding: 0; text-align: left; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: right; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(58,830</FONT></TD><TD STYLE="padding: 0; text-align: left; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Net
    cash used in operating activities</FONT></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: right; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2,807,549</FONT></TD><TD STYLE="padding: 0; text-align: left; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</FONT></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: right; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(271,660</FONT></TD><TD STYLE="padding: 0; text-align: left; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cash
    flows from financing activities</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Repayments
    under line of credit, net</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2,086,702</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Proceeds
    from the issuance of shares</FONT></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: right; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,525,000</FONT></TD><TD STYLE="padding: 0; text-align: left; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: right; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD><TD STYLE="padding: 0; text-align: left; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Net
    cash provided by financing activities</FONT></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: right; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">438,298</FONT></TD><TD STYLE="padding: 0; text-align: left; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: right; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD><TD STYLE="padding: 0; text-align: left; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Net
    decrease in cash</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2,369,251</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(271,660</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cash
    - Beginning of period</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,670,894</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">301,643</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cash
    - End of period</FONT></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD><TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: right; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">301,643</FONT></TD><TD STYLE="padding: 0; text-align: left; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD><TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: right; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">29,983</FONT></TD><TD STYLE="padding: 0; text-align: left; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Supplemental
    disclosures of cash flow information</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Interest
    paid</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,665</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Income
    taxes paid</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-align: right; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">See
accompanying notes to the financial statements.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Page; Sequence: 168; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt; font: 10pt Times New Roman, Times, Serif"><A HREF="#toc">Table of Contents</A>&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>




<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>APTORUM
GROUP LIMITED</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><A NAME="f_009"></A><FONT STYLE="font-size: 10pt"><B>CONSOLIDATED
STATEMENT OF CASH FLOWS (SUCCESSOR BASIS)</B></FONT></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>For
the Period March 1, 2017 through December 31, 2017</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(Stated
in U.S. Dollars)</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cash
    flows from operating activities</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 88%; font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Net
    loss</FONT></TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD><TD STYLE="width: 9%; text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2,561,507</FONT></TD><TD STYLE="width: 1%; text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Adjustments
    to reconcile net loss to net cash used in operating activities</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Amortization
    and depreciation</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">58,903</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Gain
    on investments in marketable securities, net</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3,912,500</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Loss
    on investments in derivatives, net</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">827,501</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Changes
    in operating assets and liabilities:</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other
    receivables and prepayments</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(310,074</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Interest
    receivable</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6,149</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Long-term
    deposits</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(20,092</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Due
    from brokers</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(54,158</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accounts
    payable and accrued expenses</FONT></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: right; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">183,083</FONT></TD><TD STYLE="padding: 0; text-align: left; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Net
    cash used in operating activities</FONT></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: right; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(5,782,695</FONT></TD><TD STYLE="padding: 0; text-align: left; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cash
    flows from investing activities</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Advances
    to/payments received from related parties</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(186,898</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Purchases
    of intangible assets</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(968,730</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Purchases
    of equipment</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2,090,721</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Proceeds
    from sales of investment securities</FONT></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: right; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">16,049,067</FONT></TD><TD STYLE="padding: 0; text-align: left; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Net
    cash provided by investing activities</FONT></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: right; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">12,802,718</FONT></TD><TD STYLE="padding: 0; text-align: left; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cash
    flows from financing activities</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Proceeds
    from issuance of convertible promissory notes</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">480,000</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Proceeds
    from issuance of shares</FONT></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: right; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8,602,001</FONT></TD><TD STYLE="padding: 0; text-align: left; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Net
    cash provided by financing activities</FONT></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: right; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">9,082,001</FONT></TD><TD STYLE="padding: 0; text-align: left; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Net
    increase in cash and restricted cash</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">16,102,024</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cash
    and restricted cash, March 1, 2017</FONT></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">623,783</FONT></TD><TD STYLE="text-align: left; padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cash
    and restricted cash, December 31, 2017</FONT></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD><TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: right; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">16,725,807</FONT></TD><TD STYLE="padding: 0; text-align: left; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Supplemental
    disclosures of cash flow information</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Interest
    paid</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Income
    taxes paid</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
</TABLE>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">See
accompanying notes to the consolidated financial statements.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Page; Sequence: 169; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt; font: 10pt Times New Roman, Times, Serif"><A HREF="#toc">Table of Contents</A>&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>APTORUM
GROUP LIMITED</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><A NAME="f_010"></A><FONT STYLE="font-size: 10pt"><B>SCHEDULE
OF PORTFOLIO INVESTMENTS</B></FONT></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>December
31, 2016</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(Stated
in U.S. Dollars)</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-align: center; border-bottom: Black 1.5pt solid; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Shares/Par/#
    of Contract</FONT></TD><TD STYLE="padding: 0; font: bold 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-align: center; border-bottom: Black 1.5pt solid; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Issuers</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-align: center; border-bottom: Black 1.5pt solid; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cost</FONT></TD><TD STYLE="padding: 0; font: bold 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-align: center; border-bottom: Black 1.5pt solid; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Fair
    Value</FONT></TD><TD STYLE="padding: 0; font: bold 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD COLSPAN="2" STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">PREFERRED
    STOCKS (17.17%)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD COLSPAN="2" STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">United
    States (17.17%)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD COLSPAN="2" STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pharmaceutical
    and Biotechnology (17.17%)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 1%; text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="width: 9%; text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">500,000</FONT></TD><TD STYLE="width: 1%; text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 64%; text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Atea
    Pharmaceuticals Incorporated, (6.03%), Series A</FONT></TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD><TD STYLE="width: 9%; text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">500,000</FONT></TD><TD STYLE="width: 1%; text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD><TD STYLE="width: 9%; text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,515,000</FONT></TD><TD STYLE="width: 1%; text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">165,016</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Atea
    Pharmaceuticals Incorporated, (1.99%), Series B</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">499,998</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">499,998</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">354,609</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Kezar
    Life Sciences Incorporated, (1.19%), Series A</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">299,999</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">299,999</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">265,958</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">X4
    Pharmaceuticals Incorporated, (1.99%), Series A</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">500,001</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">500,001</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">270,270</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Atreca
    Incorporated, (1.99%), Series A</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">500,000</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">500,000</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="padding: 0; text-align: left; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding: 0; text-align: right; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3,333,333</FONT></TD><TD STYLE="padding: 0; text-align: left; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Anabios
    Corporation, (3.98%), Series B</FONT></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: right; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,000,000</FONT></TD><TD STYLE="padding: 0; text-align: left; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: right; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,000,000</FONT></TD><TD STYLE="padding: 0; text-align: left; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="padding: 0; text-align: left; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding: 0; text-align: right; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding: 0; text-align: left; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: right; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3,299,998</FONT></TD><TD STYLE="padding: 0; text-align: left; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: right; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4,314,998</FONT></TD><TD STYLE="padding: 0; text-align: left; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="padding: 0; text-align: left; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding: 0; text-align: right; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding: 0; text-align: left; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total
    United States</FONT></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: right; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3,299,998</FONT></TD><TD STYLE="padding: 0; text-align: left; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: right; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4,314,998</FONT></TD><TD STYLE="padding: 0; text-align: left; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Israel
    (0.00%)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pharmaceutical
    and Biotechnology (0.00%)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="padding: 0; text-align: left; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding: 0; text-align: right; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">15,145</FONT></TD><TD STYLE="padding: 0; text-align: left; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">APOS
    - Medical and Sports Technologies Ltd.</FONT></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: right; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">749,980</FONT></TD><TD STYLE="padding: 0; text-align: left; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: right; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD><TD STYLE="padding: 0; text-align: left; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="padding: 0; text-align: left; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding: 0; text-align: right; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding: 0; text-align: left; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: right; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">749,980</FONT></TD><TD STYLE="padding: 0; text-align: left; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: right; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD><TD STYLE="padding: 0; text-align: left; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="padding: 0; text-align: left; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding: 0; text-align: right; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding: 0; text-align: left; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total
    Israel</FONT></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: right; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">749,980</FONT></TD><TD STYLE="padding: 0; text-align: left; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: right; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD><TD STYLE="padding: 0; text-align: left; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="padding: 0; text-align: left; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding: 0; text-align: right; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding: 0; text-align: left; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">TOTAL
    PREFERRED STOCKS</FONT></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: right; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4,049,978</FONT></TD><TD STYLE="padding: 0; text-align: left; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: right; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4,314,998</FONT></TD><TD STYLE="padding: 0; text-align: left; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">COMMON
    STOCKS (58.18%)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">United
    States (57.35%)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pharmaceutical
    and Biotechnology (47.11%)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">80,608</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cerecor
    Inc., (0.28%)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">415,385</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">70,967</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">139,983</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Argos
    Therapeutics Incorporated, (2.73%)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,093,830</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">685,917</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">86,863</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Axsome
    Therapeutics Inc., (2.33%)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">498,279</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">586,325</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,228,981</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Rezolute,
    Inc., (8.88%)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,368,709</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,228,981</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">193,349</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Contrafect
    Corp., (1.35%)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">980,079</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">338,361</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="padding: 0; text-align: left; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding: 0; text-align: right; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">720,000</FONT></TD><TD STYLE="padding: 0; text-align: left; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Athenex
    Incorporated, (31.54%)</FONT></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: right; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3,960,000</FONT></TD><TD STYLE="padding: 0; text-align: left; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: right; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">7,920,000</FONT></TD><TD STYLE="padding: 0; text-align: left; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="padding: 0; text-align: left; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding: 0; text-align: right; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding: 0; text-align: left; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: right; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">9,316,282</FONT></TD><TD STYLE="padding: 0; text-align: left; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: right; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">11,830,551</FONT></TD><TD STYLE="padding: 0; text-align: left; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Healthcare
    (10.24%)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">265,425</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Obalon
    Therapeutics Inc., (9.35%)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,000,000</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,349,011</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="padding: 0; text-align: left; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding: 0; text-align: right; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">65,976</FONT></TD><TD STYLE="padding: 0; text-align: left; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">MRI
    Interventions Inc., (0.89%)</FONT></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: right; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,599,999</FONT></TD><TD STYLE="padding: 0; text-align: left; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: right; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">224,318</FONT></TD><TD STYLE="padding: 0; text-align: left; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="padding: 0; text-align: left; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding: 0; text-align: right; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding: 0; text-align: left; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: right; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3,599,999</FONT></TD><TD STYLE="padding: 0; text-align: left; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: right; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,573,329</FONT></TD><TD STYLE="padding: 0; text-align: left; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="padding: 0; text-align: left; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding: 0; text-align: right; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding: 0; text-align: left; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total
    United States</FONT></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: right; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">12,916,281</FONT></TD><TD STYLE="padding: 0; text-align: left; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: right; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">14,403,880</FONT></TD><TD STYLE="padding: 0; text-align: left; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Taiwan
    (0.00%)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Commercial
    Services (0.00%)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="padding: 0; text-align: left; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding: 0; text-align: right; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,000,000</FONT></TD><TD STYLE="padding: 0; text-align: left; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Sim2Travel
    Incorporated, (0.00%)</FONT></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: right; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,000,000</FONT></TD><TD STYLE="padding: 0; text-align: left; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: right; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD><TD STYLE="padding: 0; text-align: left; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="padding: 0; text-align: left; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding: 0; text-align: right; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding: 0; text-align: left; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: right; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,000,000</FONT></TD><TD STYLE="padding: 0; text-align: left; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: right; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD><TD STYLE="padding: 0; text-align: left; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="padding: 0; text-align: left; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding: 0; text-align: right; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding: 0; text-align: left; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total
    Taiwan</FONT></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: right; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,000,000</FONT></TD><TD STYLE="padding: 0; text-align: left; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: right; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD><TD STYLE="padding: 0; text-align: left; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Hong
    Kong (0.83%)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Financial
    Services (0.83%)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="padding: 0; text-align: left; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding: 0; text-align: right; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8,800</FONT></TD><TD STYLE="padding: 0; text-align: left; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Hong
    Kong Exchange and Clearing Ltd., (0.83%)</FONT></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: right; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">325,397</FONT></TD><TD STYLE="padding: 0; text-align: left; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: right; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">207,903</FONT></TD><TD STYLE="padding: 0; text-align: left; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="padding: 0; text-align: left; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding: 0; text-align: right; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding: 0; text-align: left; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: right; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">325,397</FONT></TD><TD STYLE="padding: 0; text-align: left; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: right; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">207,903</FONT></TD><TD STYLE="padding: 0; text-align: left; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="padding: 0; text-align: left; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding: 0; text-align: right; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding: 0; text-align: left; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total
    Hong Kong</FONT></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: right; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">325,397</FONT></TD><TD STYLE="padding: 0; text-align: left; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: right; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">207,903</FONT></TD><TD STYLE="padding: 0; text-align: left; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="padding: 0; text-align: left; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding: 0; text-align: right; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding: 0; text-align: left; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">TOTAL
    COMMON STOCKS</FONT></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: right; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">15,241,678</FONT></TD><TD STYLE="padding: 0; text-align: left; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: right; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">14,611,783</FONT></TD><TD STYLE="padding: 0; text-align: left; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">BONDS
    (1.25%)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mainland
    China (1.25%)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Bank
    (1.25%)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="padding: 0; text-align: left; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD><TD STYLE="padding: 0; text-align: right; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">300,000</FONT></TD><TD STYLE="padding: 0; text-align: left; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Industrial
    &amp; Commercial Bank of China, with 6% coupon rate and no maturity date, (1.25%)</FONT></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: right; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">311,750</FONT></TD><TD STYLE="padding: 0; text-align: left; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: right; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">314,160</FONT></TD><TD STYLE="padding: 0; text-align: left; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="padding: 0; text-align: left; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding: 0; text-align: right; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding: 0; text-align: left; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: right; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">311,750</FONT></TD><TD STYLE="padding: 0; text-align: left; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: right; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">314,160</FONT></TD><TD STYLE="padding: 0; text-align: left; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="padding: 0; text-align: left; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding: 0; text-align: right; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding: 0; text-align: left; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total
    Mainland China</FONT></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: right; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">311,750</FONT></TD><TD STYLE="padding: 0; text-align: left; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: right; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">314,160</FONT></TD><TD STYLE="padding: 0; text-align: left; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="padding: 0; text-align: left; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding: 0; text-align: right; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding: 0; text-align: left; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">TOTAL
    BONDS</FONT></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: right; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">311,750</FONT></TD><TD STYLE="padding: 0; text-align: left; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: right; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">314,160</FONT></TD><TD STYLE="padding: 0; text-align: left; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>

<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; background-color: White; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; background-color: White; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: left; background-color: White; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding: 0; background-color: White; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; background-color: White; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="background-color: White; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; background-color: White; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; background-color: White; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: left; background-color: White; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="background-color: White; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; background-color: White; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; background-color: White; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: left; background-color: White; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">CONVERTIBLE
    NOTES (12.18%)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD COLSPAN="2" STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">United
    States (12.18%)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD COLSPAN="2" STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pharmaceutical
    and Biotechnology (12.18%)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 1%; text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD><TD STYLE="width: 9%; text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">500,000</FONT></TD><TD STYLE="width: 1%; text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 64%; text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Centrexion
    Therapeutics Corporation, (2.07%), Series C, (Due Date: 6/1/2019, Interest Rate: 5.00%)</FONT></TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD><TD STYLE="width: 9%; text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">500,000</FONT></TD><TD STYLE="width: 1%; text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD><TD STYLE="width: 9%; text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">520,960</FONT></TD><TD STYLE="width: 1%; text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,500,000</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Alzheon
    Incorporated, (6.32%), Series A, (Due Date: 7/13/2017, Interest Rate: 4.00%)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,500,000</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,588,438</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="padding: 0; text-align: left; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD><TD STYLE="padding: 0; text-align: right; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">900,000</FONT></TD><TD STYLE="padding: 0; text-align: left; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Alzheon
    Incorporated, (3.79%), Series B, (Due Date: 7/13/2017, Interest Rate: 4.00%)</FONT></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: right; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">900,000</FONT></TD><TD STYLE="padding: 0; text-align: left; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: right; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">953,063</FONT></TD><TD STYLE="padding: 0; text-align: left; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="padding: 0; text-align: left; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding: 0; text-align: right; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding: 0; text-align: left; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: right; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,900,000</FONT></TD><TD STYLE="padding: 0; text-align: left; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: right; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3,062,461</FONT></TD><TD STYLE="padding: 0; text-align: left; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="padding: 0; text-align: left; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding: 0; text-align: right; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding: 0; text-align: left; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total
    United States</FONT></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: right; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,900,000</FONT></TD><TD STYLE="padding: 0; text-align: left; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: right; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3,062,461</FONT></TD><TD STYLE="padding: 0; text-align: left; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Israel
    (0.00%)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pharmaceutical
    and Biotechnology (0.00%)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="padding: 0; text-align: left; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD><TD STYLE="padding: 0; text-align: right; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">100,000</FONT></TD><TD STYLE="padding: 0; text-align: left; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">APOS
    - Medical and Sports Technologies Ltd., (0.00%), (Due Date: 12/17/2017, Interest Rate: 10.00%)</FONT></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: right; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">100,000</FONT></TD><TD STYLE="padding: 0; text-align: left; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: right; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD><TD STYLE="padding: 0; text-align: left; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="padding: 0; text-align: left; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding: 0; text-align: right; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding: 0; text-align: left; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: right; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">100,000</FONT></TD><TD STYLE="padding: 0; text-align: left; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: right; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD><TD STYLE="padding: 0; text-align: left; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="padding: 0; text-align: left; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding: 0; text-align: right; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding: 0; text-align: left; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total
    Israel</FONT></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: right; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">100,000</FONT></TD><TD STYLE="padding: 0; text-align: left; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: right; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD><TD STYLE="padding: 0; text-align: left; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="padding: 0; text-align: left; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding: 0; text-align: right; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding: 0; text-align: left; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">TOTAL
    CONVERTIBLE NOTES</FONT></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: right; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3,000,000</FONT></TD><TD STYLE="padding: 0; text-align: left; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: right; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3,062,461</FONT></TD><TD STYLE="padding: 0; text-align: left; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">WARRANTS
    (7.25%)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">United
    States (7.25%)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pharmaceutical
    and Biotechnology (7.13%)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,228,981</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Rezolute,
    Inc., (7.07%), (Expiration Date: 6/24/2021)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">83,168</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,776,275</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">80,608</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cerecor
    Inc., (0.01%), (Expiration Date: 4/20/2017)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">36,932</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,822</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="padding: 0; text-align: left; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding: 0; text-align: right; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">80,608</FONT></TD><TD STYLE="padding: 0; text-align: left; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cerecor
    Inc., (0.05%), (Expiration Date: 10/20/2018)</FONT></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: right; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">60,000</FONT></TD><TD STYLE="padding: 0; text-align: left; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: right; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">12,897</FONT></TD><TD STYLE="padding: 0; text-align: left; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="padding: 0; text-align: left; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding: 0; text-align: right; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding: 0; text-align: left; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: right; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">180,100</FONT></TD><TD STYLE="padding: 0; text-align: left; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: right; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,791,994</FONT></TD><TD STYLE="padding: 0; text-align: left; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Healthcare
    (0.12%)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,311</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">MRI
    Interventions Inc., (0.02%), (Expiration Date: 12/18/2020)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4,252</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">23,310</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">MRI
    Interventions Inc., (0.08%), (Expiration Date: 12/24/2019)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">20,660</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="padding: 0; text-align: left; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding: 0; text-align: right; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3,081</FONT></TD><TD STYLE="padding: 0; text-align: left; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">MRI
    Interventions Inc., (0.02%), (Expiration Date: 12/18/2020)</FONT></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: right; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD><TD STYLE="padding: 0; text-align: left; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: right; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6,084</FONT></TD><TD STYLE="padding: 0; text-align: left; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="padding: 0; text-align: left; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding: 0; text-align: right; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding: 0; text-align: left; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: right; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD><TD STYLE="padding: 0; text-align: left; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: right; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">30,996</FONT></TD><TD STYLE="padding: 0; text-align: left; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="padding: 0; text-align: left; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding: 0; text-align: right; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding: 0; text-align: left; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total
    United States</FONT></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: right; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">180,100</FONT></TD><TD STYLE="padding: 0; text-align: left; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: right; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,822,990</FONT></TD><TD STYLE="padding: 0; text-align: left; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="padding: 0; text-align: left; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding: 0; text-align: right; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding: 0; text-align: left; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">TOTAL
    WARRANTS</FONT></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: right; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">180,100</FONT></TD><TD STYLE="padding: 0; text-align: left; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: right; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,822,990</FONT></TD><TD STYLE="padding: 0; text-align: left; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="padding: 0; text-align: left; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding: 0; text-align: right; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding: 0; text-align: left; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: right; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding: 0; text-align: left; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: right; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding: 0; text-align: left; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="padding: 0; text-align: left; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding: 0; text-align: right; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding: 0; text-align: left; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">TOTAL
    UNAFFILIATED ISSUERS</FONT></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: right; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">22,783,506</FONT></TD><TD STYLE="padding: 0; text-align: left; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: right; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">24,126,392</FONT></TD><TD STYLE="padding: 0; text-align: left; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
    RELATED PARTY (3.41%)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Hong
    Kong (3.41%)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pharmaceutical
    and Biotechnology (3.41%)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="padding: 0; text-align: left; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding: 0; text-align: right; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,000,000</FONT></TD><TD STYLE="padding: 0; text-align: left; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Aptorum
    Therapeutics Limited, (3.41%), (100% Owned)</FONT></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: right; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,000,000</FONT></TD><TD STYLE="padding: 0; text-align: left; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: right; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">856,081</FONT></TD><TD STYLE="padding: 0; text-align: left; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="padding: 0; text-align: left; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding: 0; text-align: right; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding: 0; text-align: left; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: right; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,000,000</FONT></TD><TD STYLE="padding: 0; text-align: left; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: right; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">856,081</FONT></TD><TD STYLE="padding: 0; text-align: left; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="padding: 0; text-align: left; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding: 0; text-align: right; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding: 0; text-align: left; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total
    Hong Kong</FONT></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: right; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,000,000</FONT></TD><TD STYLE="padding: 0; text-align: left; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: right; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">856,081</FONT></TD><TD STYLE="padding: 0; text-align: left; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="padding: 0; text-align: left; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding: 0; text-align: right; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding: 0; text-align: left; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">TOTAL
    RELATED PARTY</FONT></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: right; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,000,000</FONT></TD><TD STYLE="padding: 0; text-align: left; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: right; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">856,081</FONT></TD><TD STYLE="padding: 0; text-align: left; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="padding: 0; text-align: left; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding: 0; text-align: right; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding: 0; text-align: left; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total
    investments at fair value (99.44%*)</FONT></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD><TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: right; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">23,783,506</FONT></TD><TD STYLE="padding: 0; text-align: left; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD><TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: right; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">24,982,473</FONT></TD><TD STYLE="padding: 0; text-align: left; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
</TABLE>




<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.8pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="width: 100%; margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.3in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Represents the ratio of total investments at fair value
to net assets as of December 31, 2016.</FONT></TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.8pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.8pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">See
accompanying notes to the financial statements.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Page; Sequence: 170; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt; font: 10pt Times New Roman, Times, Serif"><A HREF="#toc">Table of Contents</A>&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>APTORUM
GROUP LIMITED</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><A NAME="f_011"></A><FONT STYLE="font-size: 10pt"><B>SCHEDULE
OF PORTFOLIO INVESTMENTS</B></FONT></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>February
28, 2017</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(Stated
in U.S. Dollars)</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.8pt 0pt 0; text-align: center"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-align: center; border-bottom: Black 1.5pt solid; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Shares/Par/#
    of Contract</FONT></TD><TD STYLE="padding: 0; font: bold 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-align: center; border-bottom: Black 1.5pt solid; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Issuers</FONT></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: center; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Cost</B></FONT></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-align: center; border-bottom: Black 1.5pt solid; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Fair
    Value</FONT></TD><TD STYLE="padding: 0; font: bold 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD COLSPAN="2" STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">PREFERRED
    STOCKS (17.62%)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD COLSPAN="2" STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">United
    States (17.62%)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD COLSPAN="2" STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pharmaceutical
    and Biotechnology (17.62%)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 1%; text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="width: 9%; text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">500,000</FONT></TD><TD STYLE="width: 1%; text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 64%; text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Atea
    Pharmaceuticals Incorporated, (6.19%), Series A</FONT></TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD><TD STYLE="width: 9%; text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">500,000</FONT></TD><TD STYLE="width: 1%; text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD><TD STYLE="width: 9%; text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,515,000</FONT></TD><TD STYLE="width: 1%; text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">165,016</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Atea
    Pharmaceuticals Incorporated, (2.04%), Series B</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">499,998</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">499,998</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">354,609</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Kezar
    Life Sciences Incorporated, (1.23%), Series A</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">299,999</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">299,999</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">265,958</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">X4
    Pharmaceuticals Incorporated, (2.04%), Series A</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">500,001</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">500,001</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">270,270</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Atreca
    Incorporated, (2.04%), Series A</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">500,000</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">500,000</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="padding: 0; text-align: left; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding: 0; text-align: right; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3,333,333</FONT></TD><TD STYLE="padding: 0; text-align: left; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Anabios
    Corporation, (4.08%), Series B</FONT></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: right; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,000,000</FONT></TD><TD STYLE="padding: 0; text-align: left; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: right; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,000,000</FONT></TD><TD STYLE="padding: 0; text-align: left; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="padding: 0; text-align: left; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding: 0; text-align: right; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding: 0; text-align: left; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: right; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3,299,998</FONT></TD><TD STYLE="padding: 0; text-align: left; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: right; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4,314,998</FONT></TD><TD STYLE="padding: 0; text-align: left; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="padding: 0; text-align: left; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding: 0; text-align: right; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding: 0; text-align: left; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total
    United States</FONT></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: right; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3,299,998</FONT></TD><TD STYLE="padding: 0; text-align: left; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: right; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4,314,998</FONT></TD><TD STYLE="padding: 0; text-align: left; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Israel
    (0.00%)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pharmaceutical
    and Biotechnology (0.00%)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="padding: 0; text-align: left; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding: 0; text-align: right; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">15,145</FONT></TD><TD STYLE="padding: 0; text-align: left; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">APOS
    - Medical and Sports Technologies Ltd.</FONT></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: right; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">749,980</FONT></TD><TD STYLE="padding: 0; text-align: left; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: right; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD><TD STYLE="padding: 0; text-align: left; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="padding: 0; text-align: left; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding: 0; text-align: right; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding: 0; text-align: left; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: right; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">749,980</FONT></TD><TD STYLE="padding: 0; text-align: left; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: right; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD><TD STYLE="padding: 0; text-align: left; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="padding: 0; text-align: left; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding: 0; text-align: right; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding: 0; text-align: left; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total
    Israel</FONT></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: right; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">749,980</FONT></TD><TD STYLE="padding: 0; text-align: left; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: right; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD><TD STYLE="padding: 0; text-align: left; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="padding: 0; text-align: left; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding: 0; text-align: right; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding: 0; text-align: left; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">TOTAL
    PREFERRED STOCKS</FONT></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: right; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4,049,978</FONT></TD><TD STYLE="padding: 0; text-align: left; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: right; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4,314,998</FONT></TD><TD STYLE="padding: 0; text-align: left; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">COMMON
    STOCKS (57.81%)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">United
    States (56.92%)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pharmaceutical
    and Biotechnology (46.08%)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">80,608</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cerecor
    Inc., (0.24%)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">415,385</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">58,844</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">134,383</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Argos
    Therapeutics Incorporated, (0.63%)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,050,072</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">154,540</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">86,863</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Axsome
    Therapeutics Inc., (1.61%)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">498,279</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">395,227</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,228,981</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Rezolute,
    Inc., (9.56%)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,368,709</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,340,430</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">193,349</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Contrafect
    Corp., (1.70%)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">980,079</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">415,700</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="padding: 0; text-align: left; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding: 0; text-align: right; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">720,000</FONT></TD><TD STYLE="padding: 0; text-align: left; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Athenex
    Incorporated, (32.34%)</FONT></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: right; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3,960,000</FONT></TD><TD STYLE="padding: 0; text-align: left; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: right; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">7,920,000</FONT></TD><TD STYLE="padding: 0; text-align: left; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="padding: 0; text-align: left; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding: 0; text-align: right; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding: 0; text-align: left; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: right; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">9,272,524</FONT></TD><TD STYLE="padding: 0; text-align: left; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: right; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">11,284,741</FONT></TD><TD STYLE="padding: 0; text-align: left; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Healthcare
    (10.84%)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">265,425</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Obalon
    Therapeutics Inc., (10.10%)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,000,000</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,473,761</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="padding: 0; text-align: left; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding: 0; text-align: right; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">65,976</FONT></TD><TD STYLE="padding: 0; text-align: left; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">MRI
    Interventions Inc., (0.74%)</FONT></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: right; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,599,999</FONT></TD><TD STYLE="padding: 0; text-align: left; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: right; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">181,434</FONT></TD><TD STYLE="padding: 0; text-align: left; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="padding: 0; text-align: left; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding: 0; text-align: right; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding: 0; text-align: left; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: right; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3,599,999</FONT></TD><TD STYLE="padding: 0; text-align: left; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: right; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,655,195</FONT></TD><TD STYLE="padding: 0; text-align: left; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="padding: 0; text-align: left; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding: 0; text-align: right; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding: 0; text-align: left; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total
    United States</FONT></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: right; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">12,872,523</FONT></TD><TD STYLE="padding: 0; text-align: left; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: right; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">13,939,936</FONT></TD><TD STYLE="padding: 0; text-align: left; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Taiwan
    (0.00%)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Commercial
    Services (0.00%)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="padding: 0; text-align: left; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding: 0; text-align: right; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,000,000</FONT></TD><TD STYLE="padding: 0; text-align: left; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Sim2Travel
    Incorporated, (0.00%)</FONT></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: right; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,000,000</FONT></TD><TD STYLE="padding: 0; text-align: left; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: right; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD><TD STYLE="padding: 0; text-align: left; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="padding: 0; text-align: left; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding: 0; text-align: right; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding: 0; text-align: left; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: right; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,000,000</FONT></TD><TD STYLE="padding: 0; text-align: left; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: right; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD><TD STYLE="padding: 0; text-align: left; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="padding: 0; text-align: left; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding: 0; text-align: right; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding: 0; text-align: left; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total
    Taiwan</FONT></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: right; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,000,000</FONT></TD><TD STYLE="padding: 0; text-align: left; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: right; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD><TD STYLE="padding: 0; text-align: left; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Hong
    Kong (0.89%)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Financial
    Services (0.89%)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="padding: 0; text-align: left; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding: 0; text-align: right; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8,800</FONT></TD><TD STYLE="padding: 0; text-align: left; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Hong
    Kong Exchange and Clearing Ltd., (0.89%)</FONT></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: right; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">325,397</FONT></TD><TD STYLE="padding: 0; text-align: left; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: right; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">218,458</FONT></TD><TD STYLE="padding: 0; text-align: left; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="padding: 0; text-align: left; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding: 0; text-align: right; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding: 0; text-align: left; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: right; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">325,397</FONT></TD><TD STYLE="padding: 0; text-align: left; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: right; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">218,458</FONT></TD><TD STYLE="padding: 0; text-align: left; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="padding: 0; text-align: left; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding: 0; text-align: right; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding: 0; text-align: left; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total
    Hong Kong</FONT></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: right; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">325,397</FONT></TD><TD STYLE="padding: 0; text-align: left; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: right; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">218,458</FONT></TD><TD STYLE="padding: 0; text-align: left; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="padding: 0; text-align: left; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding: 0; text-align: right; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding: 0; text-align: left; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">TOTAL
    COMMON STOCKS</FONT></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: right; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">15,197,920</FONT></TD><TD STYLE="padding: 0; text-align: left; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: right; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">14,158,394</FONT></TD><TD STYLE="padding: 0; text-align: left; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">BONDS
    (1.29%)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mainland
    China (1.29%)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Bank
    (1.29%)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="padding: 0; text-align: left; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD><TD STYLE="padding: 0; text-align: right; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">300,000</FONT></TD><TD STYLE="padding: 0; text-align: left; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Industrial
    &amp; Commercial Bank of China, with 6% coupon rate and no maturity date, (1.29%)</FONT></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: right; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">311,750</FONT></TD><TD STYLE="padding: 0; text-align: left; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: right; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">316,296</FONT></TD><TD STYLE="padding: 0; text-align: left; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="padding: 0; text-align: left; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding: 0; text-align: right; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding: 0; text-align: left; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: right; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">311,750</FONT></TD><TD STYLE="padding: 0; text-align: left; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: right; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">316,296</FONT></TD><TD STYLE="padding: 0; text-align: left; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="padding: 0; text-align: left; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding: 0; text-align: right; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding: 0; text-align: left; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total
    Mainland China</FONT></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: right; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">311,750</FONT></TD><TD STYLE="padding: 0; text-align: left; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: right; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">316,296</FONT></TD><TD STYLE="padding: 0; text-align: left; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="padding: 0; text-align: left; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding: 0; text-align: right; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding: 0; text-align: left; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">TOTAL
    BONDS</FONT></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: right; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">311,750</FONT></TD><TD STYLE="padding: 0; text-align: left; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: right; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">316,296</FONT></TD><TD STYLE="padding: 0; text-align: left; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">CONVERTIBLE
    NOTES (12.59%)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">United
    States (12.59%)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pharmaceutical
    and Biotechnology (12.59%)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">500,000</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Centrexion
    Therapeutics Corporation, (2.14%), Series C, (Due Date: 6/1/2019, Interest Rate: 5.00%)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">500,000</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">525,001</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,500,000</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Alzheon
    Incorporated, (6.53%), Series A, (Due Date: 7/13/2017, Interest Rate: 4.00%)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,500,000</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,598,137</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="padding: 0; text-align: left; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD><TD STYLE="padding: 0; text-align: right; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">900,000</FONT></TD><TD STYLE="padding: 0; text-align: left; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Alzheon
    Incorporated, (3.92%), Series B, (Due Date: 7/13/2017, Interest Rate: 4.00%)</FONT></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: right; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">900,000</FONT></TD><TD STYLE="padding: 0; text-align: left; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: right; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">958,882</FONT></TD><TD STYLE="padding: 0; text-align: left; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="padding: 0; text-align: left; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding: 0; text-align: right; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding: 0; text-align: left; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: right; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,900,000</FONT></TD><TD STYLE="padding: 0; text-align: left; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: right; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3,082,020</FONT></TD><TD STYLE="padding: 0; text-align: left; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="padding: 0; text-align: left; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding: 0; text-align: right; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding: 0; text-align: left; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total
    United States</FONT></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: right; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,900,000</FONT></TD><TD STYLE="padding: 0; text-align: left; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: right; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3,082,020</FONT></TD><TD STYLE="padding: 0; text-align: left; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Israel
    (0.00%)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pharmaceutical
    and Biotechnology (0.00%)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="padding: 0; text-align: left; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD><TD STYLE="padding: 0; text-align: right; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">100,000</FONT></TD><TD STYLE="padding: 0; text-align: left; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">APOS
    - Medical and Sports Technologies Ltd., (0.00%), (Due Date: 12/17/2017, Interest Rate: 10.00%)</FONT></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: right; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">100,000</FONT></TD><TD STYLE="padding: 0; text-align: left; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: right; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD><TD STYLE="padding: 0; text-align: left; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="padding: 0; text-align: left; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding: 0; text-align: right; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding: 0; text-align: left; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: right; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">100,000</FONT></TD><TD STYLE="padding: 0; text-align: left; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: right; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD><TD STYLE="padding: 0; text-align: left; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="padding: 0; text-align: left; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding: 0; text-align: right; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding: 0; text-align: left; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total
    Israel</FONT></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: right; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">100,000</FONT></TD><TD STYLE="padding: 0; text-align: left; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: right; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD><TD STYLE="padding: 0; text-align: left; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="padding: 0; text-align: left; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding: 0; text-align: right; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding: 0; text-align: left; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">TOTAL
    CONVERTIBLE NOTES</FONT></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: right; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3,000,000</FONT></TD><TD STYLE="padding: 0; text-align: left; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: right; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3,082,020</FONT></TD><TD STYLE="padding: 0; text-align: left; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">WARRANTS
    (7.85%)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">United
    States (7.85%)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pharmaceutical
    and Biotechnology (7.76%)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,228,981</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Rezolute,
    Inc., (7.70%), (Expiration Date: 6/24/2021)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">83,168</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,884,826</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">80,608</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cerecor
    Inc., (0.03%), (Expiration Date: 4/20/2017)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">36,932</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">7,094</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="padding: 0; text-align: left; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding: 0; text-align: right; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">80,608</FONT></TD><TD STYLE="padding: 0; text-align: left; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cerecor
    Inc., (0.03%), (Expiration Date: 10/20/2018)</FONT></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: right; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">60,000</FONT></TD><TD STYLE="padding: 0; text-align: left; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: right; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8,061</FONT></TD><TD STYLE="padding: 0; text-align: left; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="padding: 0; text-align: left; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding: 0; text-align: right; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding: 0; text-align: left; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: right; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">180,100</FONT></TD><TD STYLE="padding: 0; text-align: left; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: right; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,899,981</FONT></TD><TD STYLE="padding: 0; text-align: left; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Healthcare
    (0.09%)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,311</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">MRI
    Interventions Inc., (0.01%), (Expiration Date: 12/18/2020)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3,203</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">23,310</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">MRI
    Interventions Inc., (0.06%), (Expiration Date: 12/24/2019)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">14,830</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="padding: 0; text-align: left; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding: 0; text-align: right; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3,081</FONT></TD><TD STYLE="padding: 0; text-align: left; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">MRI
    Interventions Inc., (0.02%), (Expiration Date: 12/18/2020)</FONT></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: right; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD><TD STYLE="padding: 0; text-align: left; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: right; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4,611</FONT></TD><TD STYLE="padding: 0; text-align: left; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="padding: 0; text-align: left; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding: 0; text-align: right; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding: 0; text-align: left; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: right; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD><TD STYLE="padding: 0; text-align: left; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: right; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">22,644</FONT></TD><TD STYLE="padding: 0; text-align: left; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="padding: 0; text-align: left; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding: 0; text-align: right; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding: 0; text-align: left; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total
    United States</FONT></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: right; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">180,100</FONT></TD><TD STYLE="padding: 0; text-align: left; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: right; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,922,625</FONT></TD><TD STYLE="padding: 0; text-align: left; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="padding: 0; text-align: left; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding: 0; text-align: right; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding: 0; text-align: left; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">TOTAL
    WARRANTS</FONT></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: right; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">180,100</FONT></TD><TD STYLE="padding: 0; text-align: left; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: right; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,922,625</FONT></TD><TD STYLE="padding: 0; text-align: left; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="padding: 0; text-align: left; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding: 0; text-align: right; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding: 0; text-align: left; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: right; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding: 0; text-align: left; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: right; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding: 0; text-align: left; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="padding: 0; text-align: left; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding: 0; text-align: right; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding: 0; text-align: left; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">TOTAL
    UNAFFILIATED ISSUERS</FONT></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: right; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">22,739,748</FONT></TD><TD STYLE="padding: 0; text-align: left; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: right; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">23,794,333</FONT></TD><TD STYLE="padding: 0; text-align: left; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
    RELATED PARTY (3.09%)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Hong
    Kong (3.09%)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pharmaceutical
    and Biotechnology (3.09%)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="padding: 0; text-align: left; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding: 0; text-align: right; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,000,000</FONT></TD><TD STYLE="padding: 0; text-align: left; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Aptorum
    Therapeutics Limited, (3.09%), (100% Owned)</FONT></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: right; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,000,000</FONT></TD><TD STYLE="padding: 0; text-align: left; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: right; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">757,647</FONT></TD><TD STYLE="padding: 0; text-align: left; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="padding: 0; text-align: left; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding: 0; text-align: right; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding: 0; text-align: left; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: right; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,000,000</FONT></TD><TD STYLE="padding: 0; text-align: left; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: right; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">757,647</FONT></TD><TD STYLE="padding: 0; text-align: left; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="padding: 0; text-align: left; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding: 0; text-align: right; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding: 0; text-align: left; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total
    Hong Kong</FONT></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: right; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,000,000</FONT></TD><TD STYLE="padding: 0; text-align: left; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: right; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">757,647</FONT></TD><TD STYLE="padding: 0; text-align: left; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="padding: 0; text-align: left; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding: 0; text-align: right; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding: 0; text-align: left; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">TOTAL
    RELATED PARTY</FONT></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: right; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,000,000</FONT></TD><TD STYLE="padding: 0; text-align: left; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: right; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">757,647</FONT></TD><TD STYLE="padding: 0; text-align: left; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="padding: 0; text-align: left; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding: 0; text-align: right; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding: 0; text-align: left; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total
    investments at fair value (100.25%*)</FONT></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD><TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: right; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">23,739,748</FONT></TD><TD STYLE="padding: 0; text-align: left; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD><TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: right; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">24,551,980</FONT></TD><TD STYLE="padding: 0; text-align: left; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
</TABLE>




<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.8pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="width: 100%; margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 0.3in; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Represents
    the ratio of total investments at fair value to net assets as of February 28, 2017.</FONT></TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.8pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">See
accompanying notes to the financial statements.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.8pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.8pt 0pt 0; text-align: center"></P>

<!-- Field: Page; Sequence: 171; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt; font: 10pt Times New Roman, Times, Serif"><A HREF="#toc">Table of Contents</A>&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.8pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.8pt 0pt 0; text-align: center"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><A NAME="f_012"></A><FONT STYLE="font-size: 10pt"><B>APTORUM
GROUP LIMITED</B></FONT></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>NOTES
TO FINANCIAL STATEMENTS (PREDECESSOR BASIS)</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(Stated
in U.S. Dollars)</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>1.
THE COMPANY</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Aptorum
Group Limited (the &ldquo;Company&rdquo;), formally known as APTUS Holdings Limited and STRIKER ASIA OPPORTUNITIES FUND CORPORATION,
is a company incorporated on September 13, 2010 under the laws of the Cayman Islands with limited liability.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Before
March 1, 2017, the Company was incorporated as an exempted company with limited liability in the Cayman Islands, and operated
as an open ended investment company which would own and oversee the management, operations and investments of its subsidiaries.
The Company was managed by AENEAS CAPITAL LIMITED, formerly known as APTUS CAPITAL LIMITED or Guardian Capital Management Limited
(the &ldquo;Manager&rdquo;), with its objective to generate long-term capital appreciation by acquiring, holding and/or investing
in, by itself or through one or more of its subsidiaries or other investment vehicles, a wide range of investments, assets and/or
rights, with a focus on the healthcare industry. Since March 1, 2017, the Company has operated as a holding company and the Manager
entered into a new management agreement with the Company to manage certain investment and reinvestment.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">SS&amp;C
Technologies, Inc. (formerly known as Wells Fargo Global Fund Services LLC before January 1, 2017) and DBS Bank Limited, Hong
Kong Branch were appointed as the administrator (the &ldquo;Administrator&rdquo;) and cash custodian (the &ldquo;Cash Custodian&rdquo;)
of the Company, respectively.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
April 21, 2015, the directors of the Company approved the Company&rsquo;s deregistration as a mutual fund from the Cayman Islands
Monetary Authority (&ldquo;CIMA&rdquo;) for the Company has less than 15 investors and so it intended to rely on the exemption
from registration. The Company ceased operating as CIMA registered fund on October 8, 2015.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
February 21, 2017, written resolutions were passed by the sole director of the Company and on March 1, 2017, resolutions were
passed by the sole holder of management shares in the Company according to which, the Company changed from an investment fund
with management shares and non-voting participating redeemable preference shares to a holding company with operating subsidiaries
(the &ldquo;Restructure&rdquo;). (See Note 4 and Note 15 for further discussion)</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
March 1, 2017, a special resolution was passed by written resolution and the issue of the Certificate of Incorporation on Change
of Name by the Cayman Islands Registrar of Companies changed the name of the Company from STRIKER ASIA OPPORTUNITIES FUND CORPORATION
to APTUS Holdings Limited on March 3, 2017.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
October 13, 2017, a special resolution was passed at the extraordinary general meeting of the Company, and on October 19, 2017,
the Cayman Islands Registrar of Companies issued the Certificate of Incorporation on Change of Name changing the name of the Company
from APTUS Holdings Limited to Aptorum Group Limited.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>2.
INVESTMENT COMPANY STATUS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company did not register as an investment company under the Investment Company Act of 1940, as amended (the &ldquo;1940 Act&rdquo;
or the &ldquo;Investment Company Act&rdquo;), in reliance on Section 3(c)(1). Section 3(c)(1) of the 1940 Act exempts from the
1940 Act&rsquo;s registration requirements privately placed investment funds whose securities are beneficially owned by not more
than 100 persons and purchase their interests in a private placement. In addition, under certain current interpretations of the
Securities and Exchange Commission (&ldquo;SEC&rdquo;), Section 7(d) of the 1940 Act exempts from registration any non-U.S. investment
fund all of whose outstanding securities are beneficially owned either by non-U.S. residents or by U.S. residents that are qualified
purchasers and purchase their interests in a private placement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Management
has determined that the Company met the assessment of an investment company under the Financial Accounting Standards Board (&ldquo;FASB&rdquo;)
Accounting Standards Codification (&ldquo;ASC&rdquo;) Topic 946 and was an investment company under U.S. generally accepted accounting
principles (&ldquo;U.S. GAAP&rdquo;) for the purposes of financial reporting.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<!-- Field: Page; Sequence: 172; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt; font: 10pt Times New Roman, Times, Serif"><A HREF="#toc">Table of Contents</A>&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>APTORUM
GROUP LIMITED</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>NOTES
TO FINANCIAL STATEMENTS (PREDECESSOR BASIS)</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(Stated
in U.S. Dollars)</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>3.
PRIVATE PLACING MEMORANDUM</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
January 2013, the Company issued a private placing memorandum (the &ldquo;PPM&rdquo;) relating to the placing of up to 4,999,990
participating shares of US$0.01 each (the &ldquo;Participating Shares&rdquo;). Participating Shares may be issued on any dealing
day at the subscription price (the &ldquo;Subscription Price&rdquo;) and may be redeemed on any dealing day at the redemption
price (&ldquo;Redemption Price&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Subscription Price or Redemption Price of each Participating Share of the relevant class for any relevant dealing day would, subject
as provided below, be determined by:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)
allocating the net asset value (the &ldquo;NAV&rdquo;) of the Company to each class (if any) in proportion to the NAV for such
classes immediately following the preceding valuation point;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)
deducting from the NAV of the class in question the fees, costs, expenses or other liabilities attributable to the relevant class
not already deducted in ascertaining the NAV of the Company and adding to the NAV assets specifically attributable to the relevant
class, in order to arrive at the actual NAV of the relevant class; and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii)
dividing the NAV of the relevant class calculated in (ii) above as at the valuation point relating to that dealing day by the
number of Participating Shares of the relevant class in issue.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
minimum subscription for each applicant was US$500,000 inclusive of any initial charge. The minimum addition to any holding was
US$100,000 inclusive of any initial charge.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Income
of the Company would not be distributed unless the directors of the Company otherwise determined. Retained income would be reflected
in the value of Participating Shares. Dividends, if any, unclaimed for six years after the date of declaration would be forfeited
and paid back to the Predecessor Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other
key terms of the private placing memorandum included:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Manager might cause the Company to purchase, to the extent consistent with Rules 5130 and 5131 of Financial Industry Regulatory
Authority (&ldquo;FINRA&rdquo;) new issue rules, equity securities that were part of an initial public offering. In the event
that the Manager decided, in its sole discretion, that the Company would invest in public offerings of securities that would be
deemed &ldquo;new issues&rdquo; under Rules 5130 and 5131 of FINRA, the Manager reserved the right to restructure any existing
class of Participating Shares into two classes.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
first class of Participating Shares of the Company would be a restricted class (&ldquo;Restricted Participating Shares&rdquo;)
which would be issued to restricted persons and would have no economic participation in new issues assets so that no profits or
losses associated with new issues were allocated to such class of Participating Shares. The second class of Participating Shares
of the Company would be an unrestricted class (the &ldquo;Unrestricted Participating Shares&rdquo;) which would be issued to non-Restricted
Persons (the &ldquo;Unrestricted Persons&rdquo;) and would have full economic participation in new issues profits. The Company
might, however, avail itself of a &ldquo;de minimis&rdquo; exemption pursuant to which a portion of any new issue profits and
losses might be allocated to the Restricted Participating Shares and thus to restricted persons.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company might permit holders of Restricted Participating Shares who were eligible to own Unrestricted Participating Shares to
convert their Restricted Participating Shares to Unrestricted Participating Shares based upon their relative net asset values
at the time of conversion, and any such holder would be required to execute a statement regarding his eligibility to participate
in &ldquo;new issue&rdquo; securities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
private placement was terminated on March 1, 2017 by a special resolution passed at the directors&rsquo; meeting.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<!-- Field: Page; Sequence: 173; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt; font: 10pt Times New Roman, Times, Serif"><A HREF="#toc">Table of Contents</A>&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>APTORUM
GROUP LIMITED</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>NOTES
TO FINANCIAL STATEMENTS (PREDECESSOR BASIS)</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(Stated
in U.S. Dollars)</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>4.
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Basis
of presentation</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
accompanying financial statements are prepared in accordance with U.S. GAAP. As discussed in Note 2, before March 1, 2017, the
Company was an investment company under U.S. GAAP for the purposes of financial reporting. U.S. GAAP for an investment company
requires investments to be recorded at estimated fair value and the unrealized gains and/or losses in an investment&rsquo;s fair
value are recognized on a current basis in the statements of operations. In addition, the Company did not consolidate its subsidiaries,
since they were operating companies and not investment companies. Such entities were fair valued in accordance with ASC Topic
946 (&ldquo;ASC 946&rdquo;) and ASC Topic 820 (&ldquo;ASC 820&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of March 1, 2017, after the change of business purpose, legal form and substantive activities, the Company&rsquo;s status changed
to an operating company from an investment company since it no longer met the criteria to qualify as an investment company under
the ASC 946. The Company discontinued applying the guidance in ASC 946 and began to account for the change in status prospectively
by accounting for its investments in accordance with other U.S. GAAP topics.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
change in status and the accounting policies affect the comparability of the financial statements. As such, for the year ended
December 31, 2016 and for the period January 1, 2017 through February 28, 2017, the statements of net assets, statements of operations,
statements of cash flows and statements of changes in net assets have been presented on the predecessor basis of accounting as
an investment company, and on the basis of accounting as an operating company from March 1, 2017 through December 31, 2017. The
consolidated balance sheet as of December 31, 2017 has been presented on the successor basis.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Use
of estimates</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
preparation of the financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that
affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial
statements and the reported amounts of increases and decreases in net assets from operations as well as income and expenses during
the reporting period. Significant accounting estimates reflected in the Company&rsquo;s financial statements include investments
at fair value. Actual results could differ from those estimates.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Valuation</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">All
investments are recorded at their estimated fair value, as described in Note 5.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Cash</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cash
consists of cash on hand and bank deposits and cash denominated in foreign currencies, which is unrestricted as to withdrawal
and use. As of December 31, 2016 and February 28, 2017, the cash denominated in foreign currencies were $5,765 and $5,760 respectively.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Due
from brokers</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Due
from brokers consist primarily of cash and cash equivalents, cash collateral and the amounts receivable or payable for securities
that have not yet settled, with the Company&rsquo;s clearing broker. Cash at broker and deposits on transactions are restricted
until these securities are purchased or until the transactions are settled or terminated. Cash balances held at the brokers, as
well as securities owned by the Company serve as collateral for margin account debit balances existing at the brokers.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 174; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt; font: 10pt Times New Roman, Times, Serif"><A HREF="#toc">Table of Contents</A>&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>APTORUM
GROUP LIMITED</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>NOTES
TO FINANCIAL STATEMENTS (PREDECESSOR BASIS)</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(Stated
in U.S. Dollars)</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Investments,
at fair value</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company&rsquo;s investments include common stock, preferred stock of listed, unlisted and private companies, corporate bonds and
other equity securities, which are collectively presented as &ldquo;Investments, at fair value&rdquo; prior to the Restructure
and recorded on a trade date basis. Investments in securities are initially measure at their transaction price, which include
commissions and other charges that are part of the purchase transaction. The Company subsequently measures the investments at
fair value through earnings. Realized gain and loss from security transactions are calculated on the specific identification basis,
unless otherwise identifiable, and recorded in earnings on the date of sale. Unrealized gain and loss on these securities are
included in the statements of operations.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Investment
transaction, income and expense</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Interest
income and expense are recorded on the accrual basis. The Company amortizes premiums and accretes discounts as adjustments to
interest income. Discounts and premiums on investments purchased are accreted and amortized to interest income over the lives
of the respective investments. Discounts for high-yield debt securities and other debt securities are not amortized to the extent
that interest income is not expected to be realized. Dividend income and expense are recorded on the ex-dividend dates, except
certain dividends from foreign securities where the ex-dividend date may have passed. These dividends are recorded as soon as
the Company is informed of the ex-dividend date. Dividend income on foreign securities is recorded net of any applicable withholding
tax. Distributions that represent returns of capital in excess of cumulative profits and losses are credited to investment cost
rather than investment income.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Foreign
currency</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company&rsquo;s functional currency is US dollars (&ldquo;USD&rdquo; or &ldquo;$&rdquo;), which is the currency of the primary
environment in which it operates in Hong Kong. The Company&rsquo;s performance is evaluated in USD. The fees, charges and allocations
are calculated in USD. All subscriptions and redemptions are transacted in USD.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">All
assets and liabilities denominated in foreign currencies are translated into USD amounts at the date of valuation. Purchases and
sales of securities and income items denominated in foreign currencies are translated into USD amounts on the respective dates
of such transactions. The Company does not separately account for that portion of the results of operations resulting from changes
in foreign exchange rates on investments and the fluctuations arising from changes in market prices of securities held. Such fluctuations
are included with the net realized and unrealized gains or losses on investments in the statements of operations. Adjustments
arising from foreign currency transactions are reflected in the statements of operations.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Redemption
payable</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company recognizes redemptions as liabilities, net of the performance fees, when the amount requested in the redemption represents
a fixed and determinable obligation. This may generally occur either at the time of the receipt of the notice, or on the last
day of a fiscal period, depending on the nature of the request. Redemptions paid after the end of the year, but based upon year-end
net asset balances are reflected as redemptions payable at December 31. Redemption notices received for which the dollar amount
is not fixed results in net assets not being recognized as a liability until the dollar amount is determined.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Equalization
payable</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
net asset value of each share of share capital sold or repurchased comprises the par value of the shares, undistributed income,
and paid-in and other surplus. When shares are sold or repurchased, the Company calculates the amount of undistributed income
available for distribution to its shareholders and, based on the number of shares outstanding, determines the amount associated
with each share. The per share amount determined to be associated with undistributed income is credited to the equalization account
when shares are sold and charged to the equalization account when shares are repurchased which reduces the required distribution
requirement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<!-- Field: Page; Sequence: 175; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt; font: 10pt Times New Roman, Times, Serif"><A HREF="#toc">Table of Contents</A>&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>APTORUM
GROUP LIMITED</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>NOTES
TO FINANCIAL STATEMENTS (PREDECESSOR BASIS)</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(Stated
in U.S. Dollars)</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Income
taxes</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under
current legislation, the Company is not subject to direct taxation in the Cayman Islands and any income subject to tax has been
satisfied through withholdings by such tax jurisdictions at prevailing treaty or standard withholding rates, accordingly, no provision
for income taxes is reflected in the accompanying financial statements. Certain foreign securities held by the Company may be
subject to foreign taxation on gains, dividends and interest income received. Foreign taxes due, if any, are recorded based on
the tax laws in the applicable foreign jurisdictions and are shown net of foreign income taxes withheld. For all open tax years
and for all major taxing jurisdictions, the Manager had concluded that the entity is exempt from income taxes (other than withholding
taxes noted above) and there are no uncertain tax positions that would require recognition in the financial statements. If the
Company were to incur an income tax liability in the future, interest on any income tax liability would be reported as interest
expense and penalties on any income tax liability would be reported as income taxes. No interest expense or penalties have been
recognized as of or for the year ended December 31, 2016 and the period January 1, 2017 through February 28, 2017. However, the
Manager&rsquo;s conclusions regarding uncertain tax positions may be subject to review and adjustment at a later date based upon
ongoing analyses of tax laws, regulations and interpretations thereof as well as other factors including but not limited to, questioning
the timing and amount of deductions, the nexus of income among various tax jurisdictions, compliance with foreign income tax laws,
and changes in administrative practices and precedents of the relevant taxing authorities. The Company is subject to income tax
examinations by major taxing authorities for all tax years since its inception.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>5.
FAIR VALUE MEASUREMENTS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company follows a fair value hierarchy that distinguishes between market data obtained from independent sources (observable inputs)
and the Company&rsquo;s own market assumptions (unobservable inputs). These inputs are used in determining the value of the Company&rsquo;s
investments and are summarized in the following fair value hierarchy:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%"><TR STYLE="vertical-align: top; text-align: justify; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"></TD><TD STYLE="width: 0.25in; text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level
                                         1 - Unadjusted quoted market prices in active markets for identical assets or liabilities
                                         that the Company has the ability to access at the measurement date.</FONT></TD>
</TR>
<TR STYLE="vertical-align: top; text-align: justify; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; text-align: justify; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level
                                         2 - Observable inputs other than quoted prices included in Level 1 that are observable
                                         for the asset or liability either directly or indirectly. These inputs may include quoted
                                         prices for the identical instrument on an inactive market, prices for similar instruments,
                                         interest rates, prepayment speeds, credit risk, yield-curves, default rates, and similar
                                         data.</FONT></TD>
</TR>
<TR STYLE="vertical-align: top; text-align: justify; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; text-align: justify; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level
                                         3 - Unobservable inputs for the asset or liability to the extent that relevant observable
                                         inputs are not available, representing the Company&rsquo;s own assumptions about the
                                         assumptions that a market participant would use in valuing the asset or liability, and
                                         that would be based on the best information available.</FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Investments
for which market quotations are not readily available are fair valued as determined by the Manager. Fair value is a market-based
measure considered from the perspective of a market participant rather than an entity-specific measure. Therefore, even when market
assumptions are not readily available, the Company&rsquo;s own assumptions are set to reflect those that market participants would
use in pricing the asset or liability at the measurement date. The Company uses prices and inputs that are current as of the measurement
date, including periods of market dislocation. In periods of market dislocation, the observability of prices and inputs may be
reduced for many securities. This condition could cause a security to be reclassified to a lower level within the fair value hierarchy.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Fair
value pricing may be used where: (i) an investment is illiquid (restricted securities); (ii) the market or exchange for an investment
is closed on an ordinary trading day and no other market prices are available; (iii) the investment is so thinly traded that there
have been no transactions in the security over an extended period; or (iv) the validity of a market quotation received is questionable.
In addition, fair value pricing will be used if emergency or unusual situations have occurred, such as when trading of a security
on an exchange is suspended; or when an event occurs after the close of the exchange on which the security is principally traded
that is likely to have changed the value of the investment.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<!-- Field: Page; Sequence: 176; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt; font: 10pt Times New Roman, Times, Serif"><A HREF="#toc">Table of Contents</A>&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>APTORUM
GROUP LIMITED</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>NOTES
TO FINANCIAL STATEMENTS (PREDECESSOR BASIS)</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(Stated
in U.S. Dollars)</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
use of valuation techniques and the availability of observable inputs can vary from investment to investment and is affected by
a wide variety of factors and other characteristics particular to the transaction. As a general principle, the current fair value
of an issue of investments being valued by the Manager would be the amount which the owner might reasonably expect to receive
for them upon their current sale. The Manager may employ a market-based valuation approach which may use related or comparable
investments, recent transactions, market multiples, book values, and other relevant information to determine fair value. The Manager
may also use an income-based valuation approach in which anticipated future cash flows of the financial instrument are discounted
to calculate fair value. Fair value methods used, which are in accordance with this principle may, for example, be based on (i)
a multiple of earnings; (ii) a discount from market of a similar freely traded security (including a derivative security or a
basket of securities traded on other markets, exchanges or among dealers); or (iii) yield to maturity with respect to debt issues,
or a combination of these and other methods. Good faith pricing is permitted if, in the Manager&rsquo;s opinion, the validity
of market quotations appears to be questionable based on factors such as evidence of a thin market in the security based on a
small number of quotations, a significant event occurs after the close of a market but before a Company&rsquo;s net asset value
(&ldquo;NAV&rdquo;) calculation that may affect a security&rsquo;s value, or the Manager is aware of any other data that calls
into question the reliability of market quotations. Good faith pricing may also be used in instances when the investments the
Company invests in may default or otherwise cease to have market quotations readily available. Factors that may be considered
when fair valuing an investment are: fundamental analytical data relating to the investment; evaluation of the forces that influence
the market in which the investment is purchased and sold; type of investment or asset; financial statements of issuer; special
reports prepared by analysts or the Manager; information as to any transactions or offers with respect to the security; and the
historical tendency of the investment&rsquo;s price to track or respond to general and specific market movements (in terms of
indices, sectors, or other market measurements), liquidity of markets, and other characteristics particular to the transaction.
To the extent that valuation is based on models or inputs that are less observable or unobservable in the market, the determination
of fair value requires more judgment. Those estimated values do not necessarily represent the amounts that may be ultimately realized
due to the occurrence of future circumstances that cannot be reasonably determined. Because of the inherent uncertainty of valuation,
those estimated values may be materially higher or lower than the values that would have been used had a ready market for the
securities existed, and the differences could be material. Accordingly, the degree of judgment exercised by the Company in determining
fair value is greatest for securities categorized in Level 3.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table provides the assets and liabilities carried at fair value measured on a recurring basis as of December 31, 2016
and February 28, 2017:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding: 0; border-bottom: Black 1.5pt solid; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">December
    31, 2016</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-align: center; border-bottom: Black 1.5pt solid; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level
    1</FONT></TD><TD STYLE="padding: 0; font: bold 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-align: center; border-bottom: Black 1.5pt solid; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level
    2</FONT></TD><TD STYLE="padding: 0; font: bold 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-align: center; border-bottom: Black 1.5pt solid; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level
    3</FONT></TD><TD STYLE="padding: 0; font: bold 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-align: center; border-bottom: Black 1.5pt solid; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total</FONT></TD><TD STYLE="padding: 0; font: bold 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Assets</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Investments
    in securities</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 52%; text-align: left; text-indent: 0; font: 10pt Times New Roman, Times, Serif; padding: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Aptorum
    Therapeutics - related party</FONT></TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD><TD STYLE="width: 9%; text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD><TD STYLE="width: 1%; text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD><TD STYLE="width: 9%; text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD><TD STYLE="width: 1%; text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD><TD STYLE="width: 9%; text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">856,081</FONT></TD><TD STYLE="width: 1%; text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD><TD STYLE="width: 9%; text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">856,081</FONT></TD><TD STYLE="width: 1%; text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: 0; font: 10pt Times New Roman, Times, Serif; padding: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Common
    stocks</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,113,791</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4,577,992</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">7,920,000</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">14,611,783</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: 0; font: 10pt Times New Roman, Times, Serif; padding: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Preferred
    stocks</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4,314,998</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4,314,998</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-indent: 0; font: 10pt Times New Roman, Times, Serif; padding: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Warrants</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">15,719</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,807,271</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,822,990</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: 0; font: 10pt Times New Roman, Times, Serif; padding: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Convertible
    notes</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3,062,461</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3,062,461</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Corporate
    bonds</FONT></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: right; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD><TD STYLE="padding: 0; text-align: left; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: right; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">314,160</FONT></TD><TD STYLE="padding: 0; text-align: left; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: right; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD><TD STYLE="padding: 0; text-align: left; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: right; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">314,160</FONT></TD><TD STYLE="padding: 0; text-align: left; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total
    assets at fair value</FONT></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD><TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: right; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,129,510</FONT></TD><TD STYLE="padding: 0; text-align: left; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD><TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: right; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4,892,152</FONT></TD><TD STYLE="padding: 0; text-align: left; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD><TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: right; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">17,960,811</FONT></TD><TD STYLE="padding: 0; text-align: left; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD><TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: right; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">24,982,473</FONT></TD><TD STYLE="padding: 0; text-align: left; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding: 0; border-bottom: Black 1.5pt solid; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">February
    28, 2017</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-align: center; border-bottom: Black 1.5pt solid; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level
    1</FONT></TD><TD STYLE="padding: 0; font: bold 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-align: center; border-bottom: Black 1.5pt solid; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level
    2</FONT></TD><TD STYLE="padding: 0; font: bold 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-align: center; border-bottom: Black 1.5pt solid; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level
    3</FONT></TD><TD STYLE="padding: 0; font: bold 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-align: center; border-bottom: Black 1.5pt solid; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total</FONT></TD><TD STYLE="padding: 0; font: bold 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Assets</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Investments
    in securities</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 52%; text-align: left; text-indent: 0; font: 10pt Times New Roman, Times, Serif; padding: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Aptorum
    Therapeutics - related party</FONT></TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD><TD STYLE="width: 9%; text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD><TD STYLE="width: 1%; text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD><TD STYLE="width: 9%; text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD><TD STYLE="width: 1%; text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD><TD STYLE="width: 9%; text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">757,647</FONT></TD><TD STYLE="width: 1%; text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD><TD STYLE="width: 9%; text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">757,647</FONT></TD><TD STYLE="width: 1%; text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: 0; font: 10pt Times New Roman, Times, Serif; padding: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Common
    stocks</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,424203</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4,814,191</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">7,920,000</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">14,158,394</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: 0; font: 10pt Times New Roman, Times, Serif; padding: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Preferred
    stocks</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4,314,998</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4,314,998</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-indent: 0; font: 10pt Times New Roman, Times, Serif; padding: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Warrants</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">15,155</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,907,470</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,922,625</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: 0; font: 10pt Times New Roman, Times, Serif; padding: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Convertible
    notes</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3,082,020</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3,082,020</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Corporate
    bonds</FONT></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: right; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD><TD STYLE="padding: 0; text-align: left; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: right; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">316,296</FONT></TD><TD STYLE="padding: 0; text-align: left; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: right; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD><TD STYLE="padding: 0; text-align: left; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: right; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">316,296</FONT></TD><TD STYLE="padding: 0; text-align: left; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total
    assets at fair value</FONT></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD><TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: right; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,439,358</FONT></TD><TD STYLE="padding: 0; text-align: left; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD><TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: right; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5,130,487</FONT></TD><TD STYLE="padding: 0; text-align: left; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD><TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: right; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">17,982,135</FONT></TD><TD STYLE="padding: 0; text-align: left; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD><TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: right; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">24,551,980</FONT></TD><TD STYLE="padding: 0; text-align: left; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Page; Sequence: 177; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt; font: 10pt Times New Roman, Times, Serif"><A HREF="#toc">Table of Contents</A>&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>APTORUM
GROUP LIMITED</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>NOTES
TO FINANCIAL STATEMENTS (PREDECESSOR BASIS)</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(Stated
in U.S. Dollars)</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following is a reconciliation of level 3 assets for the year ended December 31, 2016:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="padding: 0 0 0 10pt; text-indent: -10pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-align: center; border-bottom: Black 1.5pt solid; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Aptorum
    Therapeutics - related party</FONT></TD><TD STYLE="padding: 0; font: bold 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-align: center; border-bottom: Black 1.5pt solid; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Common
    Stocks</FONT></TD><TD STYLE="padding: 0; font: bold 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-align: center; border-bottom: Black 1.5pt solid; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Preferred
    Stocks</FONT></TD><TD STYLE="padding: 0; font: bold 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-align: center; border-bottom: Black 1.5pt solid; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Warrants</FONT></TD><TD STYLE="padding: 0; font: bold 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-align: center; border-bottom: Black 1.5pt solid; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Convertible
    Notes</FONT></TD><TD STYLE="padding: 0; font: bold 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-align: center; border-bottom: Black 1.5pt solid; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total</FONT></TD><TD STYLE="padding: 0; font: bold 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 28%; font: bold 10pt Times New Roman, Times, Serif; padding: 0 0 0 10pt; text-indent: -10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Balance
    at December 31, 2015</FONT></TD><TD STYLE="width: 1%; font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD><TD STYLE="width: 9%; font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-align: right; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD><TD STYLE="width: 1%; font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="width: 1%; font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD><TD STYLE="width: 9%; font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-align: right; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8,480,000</FONT></TD><TD STYLE="width: 1%; font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="width: 1%; font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD><TD STYLE="width: 9%; font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-align: right; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5,049,979</FONT></TD><TD STYLE="width: 1%; font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="width: 1%; font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD><TD STYLE="width: 9%; font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-align: right; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">144,165</FONT></TD><TD STYLE="width: 1%; font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="width: 1%; font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD><TD STYLE="width: 9%; font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-align: right; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,628,274</FONT></TD><TD STYLE="width: 1%; font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="width: 1%; font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD><TD STYLE="width: 9%; font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-align: right; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">15,302,418</FONT></TD><TD STYLE="width: 1%; font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="padding: 0 0 0 10pt; text-indent: -10pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Purchases</FONT></TD><TD STYLE="padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,000,000</FONT></TD><TD STYLE="text-align: left; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD><TD STYLE="text-align: left; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3,399,996</FONT></TD><TD STYLE="text-align: left; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD><TD STYLE="text-align: left; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,400,000</FONT></TD><TD STYLE="text-align: left; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5,799,996</FONT></TD><TD STYLE="text-align: left; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; padding: 0 0 0 10pt; text-indent: -10pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Reclassification
    between different investment type (a)</FONT></TD><TD STYLE="padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD><TD STYLE="text-align: left; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD><TD STYLE="text-align: left; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(81,406</FONT></TD><TD STYLE="text-align: left; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</FONT></TD><TD STYLE="padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">83,168</FONT></TD><TD STYLE="text-align: left; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD><TD STYLE="text-align: left; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,762</FONT></TD><TD STYLE="text-align: left; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; padding: 0 0 0 10pt; text-indent: -10pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Transfer
    out of Level 3 (a) (b)</FONT></TD><TD STYLE="padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD><TD STYLE="text-align: left; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD><TD STYLE="text-align: left; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(4,318,594</FONT></TD><TD STYLE="text-align: left; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</FONT></TD><TD STYLE="padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD><TD STYLE="text-align: left; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD><TD STYLE="text-align: left; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(4,318,594</FONT></TD><TD STYLE="text-align: left; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; padding: 0 0 0 10pt; text-indent: -10pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Change
    in unrealized (depreciation) appreciation</FONT></TD><TD STYLE="padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(143,919</FONT></TD><TD STYLE="text-align: left; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</FONT></TD><TD STYLE="padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(560,000</FONT></TD><TD STYLE="text-align: left; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</FONT></TD><TD STYLE="padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">265,023</FONT></TD><TD STYLE="text-align: left; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,579,938</FONT></TD><TD STYLE="text-align: left; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">34,187</FONT></TD><TD STYLE="text-align: left; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,175,229</FONT></TD><TD STYLE="text-align: left; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding: 0 0 0 10pt; text-indent: -10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Balance
    at December 31, 2016</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-align: right; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">856,081</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-align: right; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">7,920,000</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-align: right; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4,314,998</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-align: right; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,807,271</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-align: right; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3,062,461</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-align: right; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">17,960,811</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; padding: 0 0 0 10pt; text-indent: -10pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Net
    change in unrealized (depreciation) appreciation relating to investments still held at 31 December, 2016</FONT></TD><TD STYLE="padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(143,919</FONT></TD><TD STYLE="text-align: left; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</FONT></TD><TD STYLE="padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(560,000</FONT></TD><TD STYLE="text-align: left; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</FONT></TD><TD STYLE="padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">265,023</FONT></TD><TD STYLE="text-align: left; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,579,938</FONT></TD><TD STYLE="text-align: left; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">34,187</FONT></TD><TD STYLE="text-align: left; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,175,229</FONT></TD><TD STYLE="text-align: left; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
</TABLE>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following is a reconciliation of level 3 assets for the period January 1, 2017 through February 28, 2017:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="padding: 0 0 0 10pt; text-indent: -10pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.8pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Aptorum
                                         Therapeutics</B></FONT></P>
                                                                                 <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.8pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&ndash;</B></FONT><FONT STYLE="font-family: Times New Roman, Times, Serif"><BR>
                                         <FONT STYLE="font-size: 10pt"><B>related party</B></FONT></FONT></P></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.8pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Common</B></FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.8pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Stocks</B></FONT></P></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.8pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Preferred</B></FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.8pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Stocks</B></FONT></P></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-align: center; border-bottom: Black 1.5pt solid; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Warrants</FONT></TD><TD STYLE="padding: 0; font: bold 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.8pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Convertible</B></FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.8pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Notes</B></FONT></P></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-align: center; border-bottom: Black 1.5pt solid; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total</FONT></TD><TD STYLE="padding: 0; font: bold 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 28%; padding: 0 0 0 10pt; text-indent: -10pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Balance
    at December 31, 2016 </B></FONT></TD><TD STYLE="width: 1%; font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD><TD STYLE="width: 9%; border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-align: right; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">856,081</FONT></TD><TD STYLE="width: 1%; padding: 0; font: bold 10pt Times New Roman, Times, Serif; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="width: 1%; font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD><TD STYLE="width: 9%; border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-align: right; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">7,920,000</FONT></TD><TD STYLE="width: 1%; padding: 0; font: bold 10pt Times New Roman, Times, Serif; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="width: 1%; font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD><TD STYLE="width: 9%; border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-align: right; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4,314,998</FONT></TD><TD STYLE="width: 1%; padding: 0; font: bold 10pt Times New Roman, Times, Serif; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="width: 1%; font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD><TD STYLE="width: 9%; border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-align: right; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,807,271</FONT></TD><TD STYLE="width: 1%; padding: 0; font: bold 10pt Times New Roman, Times, Serif; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="width: 1%; font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD><TD STYLE="width: 9%; border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-align: right; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3,062,461</FONT></TD><TD STYLE="width: 1%; padding: 0; font: bold 10pt Times New Roman, Times, Serif; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="width: 1%; font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD><TD STYLE="width: 9%; border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-align: right; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">17,960,811</FONT></TD><TD STYLE="width: 1%; padding: 0; font: bold 10pt Times New Roman, Times, Serif; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; padding: 0 0 0 10pt; text-indent: -10pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Change
    in unrealized (depreciation) appreciation</FONT></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: right; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(98,434</FONT></TD><TD STYLE="padding: 0; text-align: left; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</FONT></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: right; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD><TD STYLE="padding: 0; text-align: left; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: right; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD><TD STYLE="padding: 0; text-align: left; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: right; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">100,199</FONT></TD><TD STYLE="padding: 0; text-align: left; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: right; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">19,559</FONT></TD><TD STYLE="padding: 0; text-align: left; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: right; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">21,324</FONT></TD><TD STYLE="padding: 0; text-align: left; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding: 0 0 0 10pt; text-indent: -10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Balance
    at February 28, 2017</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 4pt double; font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD><TD STYLE="border-bottom: Black 4pt double; font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-align: right; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">757,647</FONT></TD><TD STYLE="padding: 0; font: bold 10pt Times New Roman, Times, Serif; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 4pt double; font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD><TD STYLE="border-bottom: Black 4pt double; font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-align: right; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">7,920,000</FONT></TD><TD STYLE="padding: 0; font: bold 10pt Times New Roman, Times, Serif; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 4pt double; font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD><TD STYLE="border-bottom: Black 4pt double; font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-align: right; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4,314,998</FONT></TD><TD STYLE="padding: 0; font: bold 10pt Times New Roman, Times, Serif; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 4pt double; font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD><TD STYLE="border-bottom: Black 4pt double; font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-align: right; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,907,470</FONT></TD><TD STYLE="padding: 0; font: bold 10pt Times New Roman, Times, Serif; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 4pt double; font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD><TD STYLE="border-bottom: Black 4pt double; font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-align: right; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3,082,020</FONT></TD><TD STYLE="padding: 0; font: bold 10pt Times New Roman, Times, Serif; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 4pt double; font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD><TD STYLE="border-bottom: Black 4pt double; font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-align: right; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">17,982,135</FONT></TD><TD STYLE="padding: 0; font: bold 10pt Times New Roman, Times, Serif; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; padding: 0 0 0 10pt; text-indent: -10pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Net
    change in unrealized (depreciation) appreciation relating to investments still held at February 28, 2017</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(98,434</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">100,199</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">19,559</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">21,324</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="width: 100%; margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; width: 0.3in; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Rezolute,
    Inc. was listed on the over-the-counter (&ldquo;OTC&rdquo;) market beginning in June 2016 and preferred stock with amount
    of $2,318,594 was transferred to common stock in Level 2 from Level 3 due to observable market data becoming available. Additionally,
    the Company received some warrants from the investee and the cost was allocated between common stock and warrants, in the
    amount of the warrants of $83,168 with dividend income being recognized of $1,762.</FONT></TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="width: 100%; margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; width: 0.3in; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Obalon
    Therapeutics was listed on the OTC market beginning in October 2016 and the Company transferred $2,000,000 of preferred stock
    in the healthcare industry into common stock in Level 2 from Level 3 due to the increased liquidity of the investments due
    to observable market data becoming available.</FONT></TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="width: 100%; margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 0.3in; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    Company policy is to recognize transfers in and transfers out of each level as of the actual date of the event or change in
    circumstances that caused the transfer.</FONT></TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 178; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt; font: 10pt Times New Roman, Times, Serif"><A HREF="#toc">Table of Contents</A>&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>APTORUM
GROUP LIMITED</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>NOTES
TO FINANCIAL STATEMENTS (PREDECESSOR BASIS)</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(Stated
in U.S. Dollars)</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>Valuation
techniques and inputs</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
description of the valuation techniques applied to the Company&rsquo;s major classes of assets measured at fair value on a recurring
basis follows.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Equity
Securities</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Equity
securities including common stock, warrants and preferred securities, are generally valued by using market quotations, but may
be valued on the basis of prices furnished by a pricing service when the Manager believes such prices more accurately reflect
the fair value of such securities. Securities that are traded on any stock exchange are generally valued by the pricing service
at the last quoted sale price. Lacking a last sale price, an exchange traded security is generally valued by the pricing service
at its last bid price if held long and the last asked price if sold short Securities traded in the NASDAQ Over-the-Counter and
Hong Kong Exchanges and Clearing (the &ldquo;HKEx&rdquo;) market are generally valued by the pricing service at the NASDAQ and
HKEx official closing price. When using the market quotations or close prices provided by the pricing service and when the market
is considered active, the security will be classified as a Level 1 security. Sometimes, an equity security owned by the Company
will be valued by the pricing service with factors other than market quotations or when the market is considered inactive or valued
by reference to similar instruments. When this happens, the security will be classified as a Level 2 security. When market quotations
are not readily available, when the Manager determines that the market quotation or the price provided by the pricing service
does not accurately reflect the current fair value, or when certain restricted or illiquid securities are being valued, such securities
are valued as determined in good faith by the Manager. These securities will be categorized as Level 3 securities. The Manager
has used inputs such as the financial condition of underlying issuers, anticipated restructuring settlements, and expected liquidation
proceeds in determining the fair value of such Level 3 securities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Unlisted
or listed securities for which closing sales prices or closing quotations are not available are valued at the mean between the
latest available bid and asked prices or, in the case of preferred equity securities that are not listed or traded in the OTC
market, by a third-party pricing service that will use various techniques that consider factors including, but not limited to,
prices or yields of securities with similar characteristics, benchmark yields, broker/dealer quotes, quotes of underlying common
stock, issuer spreads, as well as industry and economic events.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">At
each period end, the Company observed the active market price without adjustment to determine the fair value for the equity securities
classified as Level 1 securities. The listed securities without sufficient trading volume (less active markets) were classified
as Level 2 securities using quoted prices without adjustment to determine the fair value. For the equity securities without market
quotations not readily available on if the market was not considered active, the Company measured them using either the recent
transaction price or the quoted market price if determined to be representative of fair value.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Fixed
Income Securities</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Fixed
income securities such as convertible notes, when valued using market quotations in an active market, will be categorized as Level
1 securities. However, they may be valued on the basis of prices furnished by a pricing service when the Manager believes such
prices more accurately reflect the fair value of such securities. A pricing service utilizes electronic data processing techniques
based on yield spreads relating to securities with similar characteristics to determine prices for normal institutional-size trading
units of debt securities without regard to sale or bid prices. These securities will generally be categorized as Level 2 securities.
If the Manager decides that a price provided by the pricing service does not accurately reflect the fair value of the securities,
when prices are not readily available from a pricing service, or when certain restricted or illiquid securities are being valued,
securities are valued at fair value as determined in good faith by the Manager, in conformity with guidelines adopted by and subject
to review of the board of directors. These securities will be categorized as Level 3 securities. The Manager has used inputs such
as evaluated broker quotes in inactive markets, actual trade prices in relatively inactive markets, multiples of earnings, yields
on similar securities, and expected liquidation proceeds in determining the fair value of such Level 3 securities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
convertible notes were valued based on the unadjusted principal amount with interest as fair value.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 179; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt; font: 10pt Times New Roman, Times, Serif"><A HREF="#toc">Table of Contents</A>&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>APTORUM
GROUP LIMITED</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>NOTES
TO FINANCIAL STATEMENTS (PREDECESSOR BASIS)</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(Stated
in U.S. Dollars)</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Foreign
Securities and Currencies</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Foreign
securities and currencies are valued in U.S. dollars, based on foreign currency exchange rate quotations supplied by a third-party
pricing service. The pricing service uses a proprietary model to determine the exchange rate. Inputs to the model include reported
trades and implied bid/ask spreads. The daily valuation of exchange-traded foreign securities generally is determined as of the
close of trading on the principal exchange on which such securities trade. Events occurring after the close of trading on foreign
exchanges may result in adjustments to the valuation of foreign securities to more accurately reflect their fair value as of the
close of regular trading on the New York Stock Exchange. When valuing foreign equity securities that meet certain criteria, the
Manager has approved the use of a fair value service that values such securities to reflect market trading that occurs after the
close of the applicable foreign markets of comparable securities or other instruments that have a strong correlation to the fair-valued
securities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Corporate
Bonds</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
fair value of corporate bonds is estimated using recently executed transactions in securities if the issuer or comparable issuers,
market price quotations (where observable), bond spreads, fundamental data relating to the issuer or credit default swap spreads.
The spread data used is for the same maturity as the bond. If the spread data does not reference the issuer, then data that references
a comparable issuer is used. When observable price quotations are not available, fair value is determined based on cash flow models
with yield curves, bond or single name credit default swap spreads and recovery rates based on collateral values as key inputs.
Corporate bonds are generally categorized in Levels 1 or 2 of the fair value hierarchy. In instances where significant inputs
are unobservable, they are categorized in Level 3 of the hierarchy.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Derivative
Instruments</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company records its derivative activities at fair value. Unrealized gains and losses from derivative contracts are included in
net change in unrealized appreciation and depreciation on investments in the statements of operations. The Company considers the
effects of credit risk and counterparty risk when determining the fair value of its derivatives.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Warrants</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Warrants
which are listed on securities exchanges are valued at their last reported sales price as of the valuation date. The fair value
of warrants are valued using the Black-Scholes option pricing model. This model takes into account the contract terms (including
as well as inputs, including time value, volatility ranging from 123% to 131% and from 125% to 134% as of December 31, 2016 and
February 28, 2017, respectively, equity prices, interest rates and currency rates). Warrants are generally categorized in Levels
2 or 3 of the fair value hierarchy.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Investments
in Private Operating Companies</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company&rsquo;s investments in private operating companies consist of direct private common and preferred stock (together or individually
&ldquo;equity&rdquo;) investments. The transaction price, excluding transaction costs, is typically the Company&rsquo;s best estimate
of fair value at inception. When evidence supports a change to the carrying value from the transaction price, adjustments are
made to reflect expected exit values in the investment&rsquo;s principal market under current market conditions. Ongoing reviews
by the Company&rsquo;s management are based on an assessment of each underlying investment from the inception date through the
most recent valuation date. These assessments typically incorporate valuation techniques that consider the evaluation of financing
and sale transactions with third parties, an income approach reflecting a discounted cash flow analysis using an appropriate risk-adjusted
discount rate, and a market approach that includes comparative analysis of acquisition multiples and pricing multiples generated
by market participants. In certain instances, the Company may use multiple valuation techniques for a particular investment and
estimate its fair value based on a weighted average or a selected outcome within a range of multiple valuation results.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 180; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->21<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt; font: 10pt Times New Roman, Times, Serif"><A HREF="#toc">Table of Contents</A>&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>APTORUM
GROUP LIMITED</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>NOTES
TO FINANCIAL STATEMENTS (PREDECESSOR BASIS)</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(Stated
in U.S. Dollars)</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company also may use the guideline company method of the market approach which involves selecting companies that are similar in
size, operating strategy, market position and/or geographic location to the target company. Inputs relied upon by the income approach
include annual projected cash flows for each investment through their respective investment horizons. The cash flow assumption
may be probability-weighted to reflect the risks associated with achieving expected performance levels across various business
scenarios. Investments valued using a market approach utilized valuation multiples times the annual earnings before interest,
taxes, depreciation and amortization (&ldquo;EBITDA&rdquo;), or another performance metric such as net earnings or revenues. The
selected valuation multiples were estimated through comparative analysis of the performance and characteristics of each investment
within a range of comparable companies or transactions in the observable marketplace.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Investments
in private operating companies also consist of direct private debt investments. The transaction price, excluding transaction costs,
is typically the Company&rsquo;s best estimate of fair value at inception. When evidence supports a change to the carrying value
from the transaction price, adjustments are made to reflect expected exit values in the investment&rsquo;s principal market under
current market conditions. Ongoing reviews by management are based on an assessment of each underlying investment from the inception
date through the most recent valuation date. These assessments typically incorporate valuation techniques that consider trends
in the performance and credit profile of each underlying investment, evaluation of arm&rsquo;s length financing, an income approach
based upon a discounted cash flow analysis and sales transactions with third parties. Inputs relied upon by debt investments using
the income approach include an understanding of the underlying company&rsquo;s compliance with debt covenants, the operating performance
of the underlying company, trends in liquidity and financial leverage ratios of the underlying company from the point of the original
investment to the stated valuation date, an assessment of the credit profile of the underlying company from the original investment
to the stated valuation date, as well as an assessment of the underlying company&rsquo;s business enterprise value, liquidation
value and debt repayment capacity of each subject debt investment. In addition, inputs include an assessment of potential yield
adjustments for each debt investment based upon trends in the credit profile of the underlying company and trends in the interest
rate environment from the date of the original investment to the stated valuation date.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">These
investments in private operating companies are generally included in Level 3 of the fair value hierarchy.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Restricted
Securities (Public Companies)</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Investments
in restricted securities of public companies cannot be offered for sale to the public until the Company complies with certain
statutory requirements. The valuation of the securities by management takes into consideration the type and duration of the restriction,
but in no event does the valuation exceed the listed price on a national securities exchange or the NASDAQ national market. The
Company may apply liquidity discounts to similar publicly traded securities which consider the respective financial performance
of the public companies and expected holding period for the restrictions. Investments in restricted securities of public companies
are generally included in Level 2 of the fair value hierarchy. However, to the extent that significant inputs used to determine
liquidity discounts are not observable, investments in restricted securities in public companies may be included in Level 3 of
the fair value hierarchy.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Restricted
Securities (Equity and Debt - nonpublic companies)</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Restricted
securities for which quotations are not readily available are valued at fair value as determined by the Manager. Restricted securities
issued by nonpublic entities may be valued by reference to comparable public entities and/or fundamental data relating to the
issuer which considers the respective financial performance and expected holding period for the restrictions. Depending on the
relative significance of valuation inputs, these instruments may be classified in either Level 2 or Level 3 of the fair value
hierarchy.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 181; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->22<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt; font: 10pt Times New Roman, Times, Serif"><A HREF="#toc">Table of Contents</A>&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>APTORUM
GROUP LIMITED</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>NOTES
TO FINANCIAL STATEMENTS (PREDECESSOR BASIS)</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(Stated
in U.S. Dollars)</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Fair
Value &ndash; Valuation Processes</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">An
Executive Director of the Manager (&ldquo;ED of the Manager&rdquo;), reports to the Manager&rsquo;s other directors on a quarterly
basis. In the event that a financial instrument cannot be valued based upon a price from a national securities exchange, pricing
service provider or broker quotation, or such prices are deemed to not reflect current market value, ED of the Manager may value
the financial instrument in good faith under the policies and procedures approved by other board of directors based on current
facts and circumstances. Determination of this value may include significant unobservable inputs and therefore would be reflected
as Level 3 of the fair value hierarchy.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ED
of the Manager reviews and discusses with other professionals the appropriateness of such fair values using more current information
such as, recent security news, recent market transactions, updated corporate action information and/or other macro or security
specific events. ED of the Manager is responsible for developing the Manager&rsquo;s written valuation processes and procedures,
conducting periodic reviews of the valuation policies, and evaluating the overall fairness and consistent application of the valuation
policies as well as ensuring that the valuation methodologies for investments that are categorized within Level 3 of the fair
value hierarchy are fair, consistent, and verifiable. Valuations determined by the Manager are required to be supported by market
data, third-party pricing sources, industry accepted third-party pricing models, counterparty prices, or other methods ED of the
Manager deems to be appropriate, including the use of internal proprietary pricing models. When determining the reliability of
third-party pricing information for investments owned by the Manager, ED of the Manager, among other things, conducts due diligence
reviews of pricing vendors, monitors the daily change in prices and reviews transactions among market participants.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table presents the quantitative information about the Company&rsquo;s Level 3 fair value measurements of investment
as of December 31, 2016, which utilized significant unobservable internally-developed inputs:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 30pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 30pt"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; vertical-align: top; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-align: center; border-bottom: Black 1.5pt solid; text-indent: 0"><P STYLE="margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Fair value</FONT></P>
                                                                                <P STYLE="margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>$</B></FONT></P></TD><TD STYLE="padding: 0; font: bold 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-align: center; border-bottom: Black 1.5pt solid; vertical-align: bottom; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Valuation
    technique</FONT></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: center; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Unobservable
    input</B></FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-align: center; border-bottom: Black 1.5pt solid; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Range
    (weighted average)</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-align: center; border-bottom: Black 1.5pt solid; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Sensitivity
    of fair value to input</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; vertical-align: top; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 16%; text-align: left; vertical-align: top; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Common
    stocks</FONT></TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD><TD STYLE="width: 14%; text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">7,920,000</FONT></TD><TD STYLE="width: 1%; text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 16%; text-align: center; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Unadjusted
    transaction price</FONT></TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 16%; text-align: center; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Not
    applicable</FONT></TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 16%; text-align: center; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Not
    applicable</FONT></TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 15%; text-align: center; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Not
    applicable</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; vertical-align: top; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Preferred
    stocks</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4,314,998</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Unadjusted
    transaction price</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Not
    applicable</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Not
    applicable</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Not
    applicable</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; vertical-align: top; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Convertible
    notes</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3,062,461</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Discounted
    cash flow model</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Remaining
    maturities discount rates</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">7-29
    months (11 months) 4% - 10% (4%)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Not
    applicable</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; vertical-align: top; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Aptorum
    Therapeutics &ndash; related party</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">856,081</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Manager
    recommendation</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Unadjusted
    purchase price of prepaid patented and prepaid unpatented license agreements plus net working capital</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Not
    applicable</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Not
    applicable</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="padding: 0; text-align: left; vertical-align: top; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Warrants</FONT></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: right; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,807,271</FONT></TD><TD STYLE="padding: 0; text-align: left; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; padding: 0; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Black-Scholes
    Model</FONT></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Estimated
    time to exit Historical Volatility</FONT></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4-66
    months 123% - 131%</FONT></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10%
    increase (decrease) in volatility would result in increase (decrease) in fair value by US$109,351</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; vertical-align: top; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total</FONT></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD><TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: right; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">17,960,811</FONT></TD><TD STYLE="padding: 0; text-align: left; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; padding: 0; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
</TABLE>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 30pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 30pt"></P>

<!-- Field: Page; Sequence: 182; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->23<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt; font: 10pt Times New Roman, Times, Serif"><A HREF="#toc">Table of Contents</A>&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 30pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>APTORUM
GROUP LIMITED</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>NOTES
TO FINANCIAL STATEMENTS (PREDECESSOR BASIS)</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(Stated
in U.S. Dollars)</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table presents the quantitative information about the Company&rsquo;s Level 3 fair value measurements of investment
as of February 28, 2017, which utilized significant unobservable internally-developed inputs:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; vertical-align: top; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-align: center; border-bottom: Black 1.5pt solid; text-indent: 0"><P STYLE="margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Fair value</FONT></P>
                                                                                <P STYLE="margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>$</B></FONT></P></TD><TD STYLE="padding: 0; font: bold 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-align: center; border-bottom: Black 1.5pt solid; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Valuation
    technique</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-align: center; border-bottom: Black 1.5pt solid; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Unobservable
    input</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-align: center; border-bottom: Black 1.5pt solid; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Range
    (weighted average)</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-align: center; border-bottom: Black 1.5pt solid; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Sensitivity
    of fair value to input</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; vertical-align: top; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 16%; text-align: left; vertical-align: top; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Common
    stocks</FONT></TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD><TD STYLE="width: 14%; text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">7,920,000</FONT></TD><TD STYLE="width: 1%; text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 16%; text-align: center; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Unadjusted
    transaction price</FONT></TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 16%; text-align: center; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Not
    applicable</FONT></TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 16%; text-align: center; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Not
    applicable</FONT></TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 15%; text-align: center; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Not
    applicable</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; vertical-align: top; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Preferred
    stocks</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4,314,998</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Unadjusted
    transaction price</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Not
    applicable</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Not
    applicable</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Not
    applicable</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; vertical-align: top; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Convertible
    notes</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3,082,020</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Discounted
    cash flow model</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Remaining
    maturities discount rate</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5-27
    months (9 months) 4% - 10% (4%)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Not
    applicable</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; vertical-align: top; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Aptorum
    Therapeutics &ndash; related party</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">757,647</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Manager
    recommendation</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Unadjusted
    purchase price of prepaid patented and prepaid unpatented license agreements plus net working capital</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Not
    applicable</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Not
    applicable</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="padding: 0; text-align: left; vertical-align: top; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Warrants</FONT></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: right; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,907,470</FONT></TD><TD STYLE="padding: 0; text-align: left; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Black-Scholes
    Model</FONT></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Estimated
    time to exit Historical Volatility</FONT></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding: 0; text-align: center; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2-64
    months 125% - 134%</FONT></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10%
    increase (decrease) in volatility would result in increase (decrease) in fair value by US$116,211</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; vertical-align: top; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total</FONT></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD><TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: right; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">17,982,135</FONT></TD><TD STYLE="padding: 0; text-align: left; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding: 0; text-align: center; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding: 0; text-align: center; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding: 0; text-align: center; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding: 0; text-align: center; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
</TABLE>




<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
significant unobservable inputs used in the fair value measurement of the entity&rsquo;s asset-backed securities are the probability
of default and loss severity in the event of default. Significant increases or decreases in either of those inputs in isolation
would result in a significantly lower or higher fair value measurement. Generally, a change in the assumption used for the probability
of default is accompanied by a directionally similar change in the assumption used for the loss severity and a directionally opposite
change in the assumption used for prepayment rates.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
the normal course of business, the Company utilizes derivative financial instruments in connection with its proprietary trading
activities. Investments in derivative contracts are subject to additional risks that can result in a loss of all or part of an
investment. In addition to its primary underlying risks, the Company is also subject to additional counterparty risk should its
counterparties fail to meet the terms of their contracts. The Company records its derivative activities at fair value. Derivative
contracts include warrants.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Derivative
contracts</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
the normal course of business, the Company utilizes derivative contracts in connection with its proprietary trading activities.
Investments in derivative contracts are subject to additional risks that can result in a loss of all or part of an investment.
The Company&rsquo;s derivative activities and exposure to derivative contracts are classified by the following primary underlying
risk: equity price. In addition to its primary underlying risk, the Company is also subject to additional counterparty risk due
to inability of its counterparties to meet the terms of their contacts. As of December 31, 2016 and February 28, 2017, the Company&rsquo;s
financial instruments and derivative instruments are not subject to a master netting arrangement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 183; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->24<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt; font: 10pt Times New Roman, Times, Serif"><A HREF="#toc">Table of Contents</A>&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>APTORUM
GROUP LIMITED</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>NOTES
TO FINANCIAL STATEMENTS (PREDECESSOR BASIS)</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(Stated
in U.S. Dollars)</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Warrants</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company may receive warrants in the normal course of pursuing its investment objectives or warrants from its portfolio companies
upon an investment in the debt or equity of a portfolio company. Warrants provide the Company with exposure and potential gains
upon equity appreciation of the portfolio company&rsquo;s share price. The value of a warrant has two components&mdash;time value
and intrinsic value. A warrant has a limited life and expires on a certain date.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of December 31, 2016 and February 28, 2017, the volume of the Company&rsquo;s derivative activities based on their notional amount
and number of contracts, categorized by primary underlying risk, are as follows:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></TD>
    <TD COLSPAN="14" STYLE="text-align: center; border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Long
    Exposure</B></FONT></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></TD></TR>
<TR STYLE="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></TD>
    <TD COLSPAN="6" STYLE="text-align: center; border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>December
    31, 2016</B></FONT></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></TD>
    <TD COLSPAN="6" STYLE="text-align: center; border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>February
    28, 2017</B></FONT></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></TD></TR>
<TR STYLE="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Primary
    underlying risk</FONT></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: center; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Notional
    Amounts</FONT></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: center; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Number
    of Contracts</FONT></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: center; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Notional
    Amounts</FONT></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: center; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Number
    of Contracts</FONT></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Equity
    Price</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 20%; text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Warrants
    (a)(b)</FONT></TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD><TD STYLE="width: 17%; text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,373,680</FONT></TD><TD STYLE="width: 1%; text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="width: 17%; text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,418,898</FONT></TD><TD STYLE="width: 1%; text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD><TD STYLE="width: 17%; text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,459,632</FONT></TD><TD STYLE="width: 1%; text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="width: 17%; text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,418,898</FONT></TD><TD STYLE="width: 1%; text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
</TABLE>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="width: 100%; margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; width: 0.3in; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Outstanding
    contracts and notional amounts at year-end are indicative of the volume of activity during the period.</FONT></TD></TR>
</TABLE>


<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="width: 100%; margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; width: 0.3in; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Notional
    options and warrants are based on the number of contracts times the fair value of the underlying investments as if exercised
    at December 31, 2016 and February 28, 2017.</FONT></TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table identifies the fair value amounts of derivative instruments included in the statement of financial condition as
derivative contracts, categorized by primary underlying risk, at December 31, 2016 and February 28, 2017. The following table
also identifies the net gain and loss amounts included in the statements of operations as net unrealized gain from derivative
contracts, categorized by primary underlying risk, for the year ended December 31, 2016 and the period January 1, 2017 through
February 28, 2017:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></TD>
    <TD COLSPAN="14" STYLE="text-align: center; border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Year
    ended December 31, 2016</B></FONT></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></TD></TR>
<TR STYLE="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Primary
    underlying risk</FONT></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Derivative
    </FONT><FONT STYLE="font-family: Times New Roman, Times, Serif"><BR><FONT STYLE="font-size: 10pt">assets</FONT></FONT></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Derivative
    </FONT><FONT STYLE="font-family: Times New Roman, Times, Serif"><BR><FONT STYLE="font-size: 10pt">liabilities</FONT></FONT></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Realized
    </FONT><FONT STYLE="font-family: Times New Roman, Times, Serif"><BR><FONT STYLE="font-size: 10pt">gain (loss)</FONT></FONT></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Unrealized
    </FONT><FONT STYLE="font-family: Times New Roman, Times, Serif"><BR><FONT STYLE="font-size: 10pt">gain</FONT></FONT></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 52%; font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Equity
    Price</FONT></TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="width: 9%; text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="width: 1%; text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="width: 9%; text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="width: 1%; text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="width: 9%; text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="width: 1%; text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="width: 9%; text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="width: 1%; text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Warrants</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,822,990</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,436,859</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></TD>
    <TD COLSPAN="14" STYLE="text-align: center; border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>January
    1, 2017 through February 28, 2017</B></FONT></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></TD></TR>
<TR STYLE="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Primary
    underlying risk</FONT></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Derivative
    </FONT><FONT STYLE="font-family: Times New Roman, Times, Serif"><BR><FONT STYLE="font-size: 10pt">assets</FONT></FONT></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Derivative
    </FONT><FONT STYLE="font-family: Times New Roman, Times, Serif"><BR><FONT STYLE="font-size: 10pt">liabilities</FONT></FONT></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Realized
    </FONT><FONT STYLE="font-family: Times New Roman, Times, Serif"><BR><FONT STYLE="font-size: 10pt">gain (loss)</FONT></FONT></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Unrealized
    </FONT><FONT STYLE="font-family: Times New Roman, Times, Serif"><BR><FONT STYLE="font-size: 10pt">gain</FONT></FONT></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 52%; font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Equity
    Price</FONT></TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="width: 9%; text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="width: 1%; text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="width: 9%; text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="width: 1%; text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="width: 9%; text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="width: 1%; text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="width: 9%; text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="width: 1%; text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Warrants</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,922,625</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">99,635</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
significant accounting policies related to recording of derivatives and related gains, by primary underlying risks, have been
summarized in Note 9.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 184; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->25<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt; font: 10pt Times New Roman, Times, Serif"><A HREF="#toc">Table of Contents</A>&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>APTORUM
GROUP LIMITED</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>NOTES
TO FINANCIAL STATEMENTS (PREDECESSOR BASIS)</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(Stated
in U.S. Dollars)</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>6.&nbsp;INVESTMENTS
IN APTORUM THERAPEUTICS - RELATED PARTY</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 30pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
the year ended December 31, 2016, the Company purchased an investment in a related party for $1,000,000 and the value of each
unconsolidated direct and indirect wholly and majority owned subsidiary, on a predecessor basis, in the aggregate is presented
as such in the schedule of investments as of December 31, 2016 and February 28, 2017.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
fair value of subsidiaries as of the effective date of the change in status on March 1, 2017 was $757,647 (see Note 5).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>7.
FUND TERMS AND RELATED PARTY TRANSACTIONS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company is managed by the Manager, a company incorporated in Hong Kong. The Manager is responsible, subject to the policies, controls
and approval of the board of directors, for the investment of the Company&rsquo;s assets. As at December 31, 2016 and February
28, 2017, the Manager held ten management shares of the Company. Details of the fees to which the Manager is entitled are set
out below.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Management
fees</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Manager is entitled to receive a management fee at an annual rate of 2.5% on NAV of the Company, which is calculated and payable
monthly in arrears. The management fees for the year ended December 31, 2016 and the period January 1, 2017 through February 28,
2017 was $641,807 and $108,958, respectively. As of December 31, 2016 and February 28, 2017, management fees of $167,788 and $108,958,
respectively, were payable to the Manager.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Performance
fees</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Manager is also entitled to receive an annual performance fees of 15% of the appreciation in the NAV per share during the period
above the &ldquo;high water mark&rdquo; of the share, which is payable annually in arrears. The performance fees are paid on a
&ldquo;high water mark&rdquo; basis, that is, only to the extent that the increase in NAV of the shares (before deduction of any
accrued performance fees) exceeds the highest cumulative level of such increase in NAV of such shares as of the most recent financial
period end valuation date. The performance fees for the year ended December 31, 2016 and the period January 1, 2017 through February
28, 2017 was $nil. Accordingly, as of December 31, 2016 and February 28, 2017, performance fees of $nil were payable to the Manager,
respectively.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Director
transaction</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chung
Yuen Ian Huen, a director of the Company, is also a Managing Director and Senior Economist of the Manager. No director fee was
paid to him the year ended December 31, 2016 and the period January 1, 2017 through February 28, 2017. As of December 31, 2016
and February 28, 2017, Mr. Huen holds a direct interest in 223,113.149 and 223,075.963 redeemable participating shares of the
Company, respectively.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 185; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->26<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt; font: 10pt Times New Roman, Times, Serif"><A HREF="#toc">Table of Contents</A>&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>APTORUM
GROUP LIMITED</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>NOTES
TO FINANCIAL STATEMENTS (PREDECESSOR BASIS)</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(Stated
in U.S. Dollars)</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>8.
SHARE CAPITAL AND REDEEMABLE PARTICIPATING SHARES </B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>December&nbsp;31,
    </B></FONT><FONT STYLE="font-family: Times New Roman, Times, Serif"><BR><FONT STYLE="font-size: 10pt"><B>2016</B></FONT></FONT></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>February&nbsp;28,</B></FONT><FONT STYLE="font-family: Times New Roman, Times, Serif"><BR>
    <FONT STYLE="font-size: 10pt"><B>2017</B></FONT></FONT></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></TD></TR>
<TR STYLE="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Authorized:</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 76%; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10
    management shares of US$0.01 each</FONT></TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD><TD STYLE="width: 9%; text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.10</FONT></TD><TD STYLE="width: 1%; text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD><TD STYLE="width: 9%; text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.10</FONT></TD><TD STYLE="width: 1%; text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4,999,990
    redeemable participating shares of US$0.01 each</FONT></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: right; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">49,999.90</FONT></TD><TD STYLE="padding: 0; text-align: left; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: right; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">49,999.90</FONT></TD><TD STYLE="padding: 0; text-align: left; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD><TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: right; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">50,000.00</FONT></TD><TD STYLE="padding: 0; text-align: left; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD><TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: right; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">50,000.00</FONT></TD><TD STYLE="padding: 0; text-align: left; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Issued
    and fully paid:</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10
    management shares of US$0.01 each as of December 31, 2016 and February 28, 2017</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.10</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.10</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="padding: 0 0 0 10pt; font: 10pt Times New Roman, Times, Serif; text-indent: -10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">256,664.088
    and 256,571.123 redeemable participating shares of US$0.01 each as of December 31, 2016 and February 28, 2017</FONT></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: right; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,566.64</FONT></TD><TD STYLE="padding: 0; text-align: left; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: right; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,565.71</FONT></TD><TD STYLE="padding: 0; text-align: left; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD><TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: right; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,566.74</FONT></TD><TD STYLE="padding: 0; text-align: left; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD><TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: right; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,565.81</FONT></TD><TD STYLE="padding: 0; text-align: left; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
at December 31, 2016 and February 28, 2017, ten management shares have been issued to the Manager. The management shares are issued
for the purpose of enabling all the redeemable participating shares to be redeemed without liquidating the Company. The management
shares carry the right to return the nominal amount paid up thereon the winding up of the Company. The management shares carry
no right to any dividend and may not be redeemed.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Redeemable
participating shares of such class or classes as the directors may from time to time designate may be issued by the Company on
any dealing day, i.e., the first business day of each calendar month at NAV per share calculated in accordance with the PPM. The
shareholder may request such redemption three months prior to the relevant dealing date. Applications must be received together
with application moneys in cleared funds on the business day immediately preceding the relevant dealing date.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
redeemable participating shares are issued at a time when the NAV per redeemable participating share of the relevant class is
less than the peak NAV per redeemable participating share, the investor will be required to pay performance fees with respect
to any subsequent appreciation in the value of those redeemable participating shares.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">However,
if redeemable participating shares are issued at a time when the NAV per redeemable participating share of the relevant class
is greater than the peak NAV per share, the shareholder will be required to pay an additional equalization credit equal to 15
percent of the difference between the then current NAV per redeemable participating share, before deduction of any accrued performance
fees, and the peak NAV per share.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Redeemable
participating shares do not carry the right to vote, except in the event of a proposal that would vary the rights of the redeemable
participating shares. The holders are entitled to receive all dividends declared and paid by the Company. Upon winding up, the
holders are entitled to a return of capital based on the NAV per share of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
movement of the number of issued and fully paid redeemable participating shares was as below:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Year
    ended December 31, 2016</B></FONT></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.8pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 1.8pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>January
                                         1, 2017 through February 28, 2017</B></FONT></P></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></TD></TR>
<TR STYLE="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 76%; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">At
    beginning of the period</FONT></TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="width: 9%; text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">228,244</FONT></TD><TD STYLE="width: 1%; text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="width: 9%; text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">256,664</FONT></TD><TD STYLE="width: 1%; text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Issued
    during the period</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">28,420</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Equalization
    debit</FONT></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: right; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD><TD STYLE="padding: 0; text-align: left; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: right; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(93</FONT></TD><TD STYLE="padding: 0; text-align: left; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">At
    end of the period</FONT></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: right; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">256,664</FONT></TD><TD STYLE="padding: 0; text-align: left; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: right; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">256,571</FONT></TD><TD STYLE="padding: 0; text-align: left; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 186; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->27<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt; font: 10pt Times New Roman, Times, Serif"><A HREF="#toc">Table of Contents</A>&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>APTORUM
GROUP LIMITED</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>NOTES
TO FINANCIAL STATEMENTS (PREDECESSOR BASIS)</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(Stated
in U.S. Dollars)</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
movement of NAV of issued and fully paid redeemable participating shares was as below:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Year
    ended December 31, 2016</B></FONT></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;&nbsp;January
    1, 2017 through February 28, 2017 &nbsp;</B></FONT></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></TD></TR>
<TR STYLE="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 76%; text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Beginning
    net assets</FONT></TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD><TD STYLE="width: 9%; text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">24,358,924</FONT></TD><TD STYLE="width: 1%; text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD><TD STYLE="width: 9%; text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">25,114,746</FONT></TD><TD STYLE="width: 1%; text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Net
    decrease in net assets resulting from operations</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2,134,515</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(626,084</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Amounts
    issued</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,900,000</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Returns
    of capital</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(9,663</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Equalization
    (debit) credit</FONT></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: right; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(9,663</FONT></TD><TD STYLE="padding: 0; text-align: left; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</FONT></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: right; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">9,663</FONT></TD><TD STYLE="padding: 0; text-align: left; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ending
    net assets</FONT></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD><TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: right; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">25,114,746</FONT></TD><TD STYLE="padding: 0; text-align: left; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD><TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: right; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">24,488,662</FONT></TD><TD STYLE="padding: 0; text-align: left; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
</TABLE>




<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
the year ended December 31, 2016, 28,420 redeemable participating shares were issued to seven holders at a price of net asset
value from $101 to $107 per share, the Company has received gross proceeds of $2,525,000 and $375,000 in year 2016 and 2015, respectively.
Redeemable participating shares do not carry the right to vote, except in the event of a proposal that would vary the rights of
the redeemable participating shares. The holders are entitled to receive all dividends declared and paid by the Company. Upon
winding up, the holders are entitled to a return of capital based on the net asset value per share of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
February 28, 2017, the Company entered into a restructuring plan with shareholders (the &ldquo;Restructuring Plan&rdquo;), according
to which, the Company changed from an investment fund with management shares and non-voting participating redeemable preference
shares to a holding company with operating subsidiaries. (See Note 4 for further discussion regarding the change in status)</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>9.
PRINCIPAL RISKS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-variant: small-caps"><B><I><U>INTRODUCTION</U></I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Risk
is inherent in the Company&rsquo;s activities but it is managed through a process of ongoing identification, measurement and monitoring,
subject to risk limits and other controls. The process of risk management is critical to the Company&rsquo;s continuing profitability.
The Company is exposed to market risk (which includes interest rate risk, currency risk and price risk), liquidity risk and credit
risk arising from the financial instruments it holds.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
board of directors is ultimately responsible for identifying and controlling risks.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company&rsquo;s risks are measured using a method which reflects both the expected loss likely to arise in normal circumstances
and also unexpected losses, which are an estimate of the ultimate actual loss based on statistical models. The model makes use
of the probabilities derived from historical experience, adjusted to reflect the economic environment. Management believes that
these estimates are reasonable and prudent. Actual results could differ from their estimates and the difference could be material.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Monitoring
and controlling risks is primarily performed based on limits established by the Company. These limits reflect the business strategy
and market environment of the Company as well as the level of the risk that Company is willing to accept. In addition, the Company
monitors and measures the overall risk bearing capacity in relation to the aggregate risk exposure across all risk types and activities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company has investment guidelines that set out its overall business strategies, its tolerance for risk along with its general
risk management philosophy and have established processes to monitor and control economic hedging transactions in a timely and
accurate manner. The Company uses derivatives and other instruments for trading purposes and also in connection with its risk
management activities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 187; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->28<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt; font: 10pt Times New Roman, Times, Serif"><A HREF="#toc">Table of Contents</A>&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.8pt 0pt 0; text-align: center"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>APTORUM
GROUP LIMITED</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>NOTES
TO FINANCIAL STATEMENTS (PREDECESSOR BASIS)</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(Stated
in U.S. Dollars)</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Concentration
arises when a number of counterparties are engaged in similar business activities, activities in the same geographic region, or
have similar economic features that would cause their ability to meet contractual obligations to be similarly affected by changes
in economic, political or other conditions. Concentration indicates the relative sensitivity of the Company&rsquo;s performance
to developments affecting a particular industry or geographical location.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
order to avoid excessive concentration of risk, the Company&rsquo;s policies and procedures include specific guidelines that require
focusing on maintaining a diversified portfolio.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-variant: small-caps"><B><I><U>MARKET
RISK</U></I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Market
risk is the risk that the fair value or future cash flows of a financial instrument will fluctuate because of changes in market
variables such as interest rate, foreign exchange rates and equity prices.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
maximum risk resulting from financial instruments equals their fair value.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>(a)
Interest rate risk</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Interest
rate risk arises from the possibility that changes in interest rates will affect future cash flows or the fair values of financial
instruments.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Interest
rate risk sensitivity analysis</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company invests in debt securities particularly in corporate bonds mostly concentrated in the financial industry, of which their
market value changes subject to fluctuations in the prevailing levels of market interest rates. An increase of 100 basis points
in interest rates as at the end of reporting period would have decreased the net assets attributable to holders of redeemable
participating shares by $8,564 and $8,293 as of December 31, 2016 and February 28, 2017, respectively. A decrease in 100 basis
points would have had an equal but opposite effect.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Apart
from the exposure resulted from the aforementioned debt securities holdings at the end of reporting period, the Company&rsquo;s
cash held with the Cash Custodian and Credit Suisse AG, Hong Kong Branch (&ldquo;Credit Suisse,&rdquo; the &ldquo;Custodian&rdquo;
or the &ldquo;Prime Broker&rdquo;) are exposed to interest rate risk. However, the directors consider the risk to be minimal as
they are short-term with terms less than one month.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>(b)
Currency risk</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Currency
risk is the risk that the value of financial assets or liabilities will fluctuate due to changes in foreign exchange rates.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company is exposed to foreign currency risk from its investments which are denominated in currencies other than US$. Consequently,
the exchange rate to its currency relative to other foreign currencies may change in a manner that has an adverse effect on the
value of that portion of the Company&rsquo;s assets or liabilities denominated in currencies other than US$.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company&rsquo;s currency exposure is measured and monitored on a regular basis by the Manager.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Currency
risk sensitivity analysis </I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">At
December 31, 2016 and February 28, 2017, the Company has no significant foreign currency risk because its business is principally
conducted in Hong Kong and most of the transactions are denominated in Hong Kong dollar. Since the Hong Kong dollar is pegged
to the United States dollar, the Company&rsquo;s exposure to foreign currency risk in respect of the balances denominated in Hong
Kong dollars is considered to be minimal.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 188; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->29<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt; font: 10pt Times New Roman, Times, Serif"><A HREF="#toc">Table of Contents</A>&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>APTORUM
GROUP LIMITED</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>NOTES
TO FINANCIAL STATEMENTS (PREDECESSOR BASIS)</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(Stated
in U.S. Dollars)</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>(c)
Equity price risk</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Equity
price risk is the risk of unfavorable changes in the fair values of equities or equity-linked derivatives as the result of changes
in the levels of equity indices and the value of individual shares. The Company has been exposed to price risk on all of its equities
investments and equities-linked derivatives.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Management&rsquo;s
best estimate of the effect on net assets and profit due to a reasonably possible change of relevant benchmarks, with all other
variables held constant is as follows. In practice, the actual trading results may differ from the sensitivity analysis below
and the difference could be material.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-variant: small-caps"><B><I><U>LIQUIDITY
RISK</U></I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Liquidity
risk is the risk that the Company will encounter difficulty in raising funds to meet commitments associated with financial assets
and liabilities. Liquidity risk may result from an inability to sell a financial asset quickly at an amount close to its fair
value.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company is exposed to cash redemptions of its redeemable participating shares on a regular basis. Shares are redeemable at the
holder&rsquo;s option based on the Company&rsquo;s NAV per share at the time of redemption calculated and are subject to redemption terms
in accordance with the Company&rsquo;s PPM as disclosed in note 8 to the financial statements. This is managed by requiring a three-month
notice period before redemption.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company invests in private equities which are generally unquoted and not readily marketable. The Company manages its liquidity
risk by setting investment limits on unlisted securities that cannot be readily disposed of. Investment of the Company&rsquo;s
assets in unquoted securities may restrict the ability of the Company to dispose of its investment at a price and time it wishes
to do so. The Company is restricted to invest not more than 30 percent of its latest available NAV in unquoted securities provided
that it may hold any of such securities which the Manager expects to be listed within 12 months from the end of reporting period.
The majority investors agreed to waive the restriction.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-variant: small-caps"><B><I><U>CREDIT
RISK</U></I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Credit
risk is the risk that an issuer or counterparty will be unable or unwilling to meet a commitment (including the payment of amounts
arising from derivative contracts) in full when due, that the issuer or counterparty have entered into with the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Financial
assets which potentially subject the Company to concentrations of credit risk consist principally of bank deposits and balances,
assets held with the Custodian/Prime Broker, derivatives where the brokers are the counterparty and the Company&rsquo;s debt securities
investments.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Custodian/Prime Broker provides the clearing and depository operations for the Company&rsquo;s security transactions. The Custodian/Prime
Broker also provides loans and financing to the Company and assets held by the Custodian/Prime Broker will be charged as a continuing
security for the payment and discharge of all liabilities of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company is also exposed to credit risk on the cash held with the Custodian/Prime Broker amounting to $140,760 and $9,655 as of
December 31, 2016 and February 28, 2017. The credit rating ascribed by Standard and Poor&rsquo;s to Credit Suisse as of December
31, 2016 and February 28, 2017 was A, respectively.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Furthermore,
the Company takes on exposure to credit risk on cash balances held with DBS Bank Ltd, Hong Kong Branch for the purposes of subscriptions
and redemptions into/out of the Company or for the purposes of payments of Company expenses such as management fee, administration
fee and other Company-related fees.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 189; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->30<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt; font: 10pt Times New Roman, Times, Serif"><A HREF="#toc">Table of Contents</A>&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.8pt 0pt 0; text-align: center"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>APTORUM
GROUP LIMITED</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>NOTES
TO FINANCIAL STATEMENTS (PREDECESSOR BASIS)</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(Stated
in U.S. Dollars)</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">All
transactions in listed securities are settled or paid for upon delivery using approved and reputable brokers. The risk of default
is considered minimal, as delivery of securities sold is only made when the broker has received payment. Payment is made on a
purchase when the securities have been received by the broker. The trade will fail if either party fails to meet its obligation.
The Company limits its exposure to credit risk by transacting all of its securities and contractual commitment activities with
broker-dealers, banks and regulated exchanges with high credit ratings and that the Company considers to be well established.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company is also exposed to credit risk on its investment in debt securities. The Manager monitors the credit risk of each individual
debt securities and its issuer by monitoring their credit quality and financial position.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-variant: small-caps"><B><I><U>CONCENTRATION
RISK</U></I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-variant: small-caps"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
table below analyses the Company&rsquo;s concentration of equity price risk by distribution:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>December
    31, </B></FONT><FONT STYLE="font-family: Times New Roman, Times, Serif"><BR><FONT STYLE="font-size: 10pt"><B>2016</B></FONT></FONT></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>February
    28, </B></FONT><FONT STYLE="font-family: Times New Roman, Times, Serif"><BR><FONT STYLE="font-size: 10pt"><B>2017</B></FONT></FONT></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></TD></TR>
<TR STYLE="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: italic bold 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Country
    and Region</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 76%; text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">United
    States of America</FONT></TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD><TD STYLE="width: 9%; text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">23,604,329</FONT></TD><TD STYLE="width: 1%; text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD><TD STYLE="width: 9%; text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">23,259,579</FONT></TD><TD STYLE="width: 1%; text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Hong
    Kong</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,063,984</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">976,105</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mainland
    China</FONT></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: right; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">314,160</FONT></TD><TD STYLE="padding: 0; text-align: left; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: right; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">316,296</FONT></TD><TD STYLE="padding: 0; text-align: left; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total</FONT></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD><TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: right; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">24,982,473</FONT></TD><TD STYLE="padding: 0; text-align: left; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD><TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: right; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">24,551,980</FONT></TD><TD STYLE="padding: 0; text-align: left; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: italic bold 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Industry</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pharmaceutical
    and biotechnology</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">21,856,085</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">21,339,387</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Healthcare</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,604,325</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,677,839</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Financial
    services</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">207,903</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">218,458</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Bank</FONT></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: right; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">314,160</FONT></TD><TD STYLE="padding: 0; text-align: left; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: right; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">316,296</FONT></TD><TD STYLE="padding: 0; text-align: left; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total</FONT></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD><TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: right; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">24,982,473</FONT></TD><TD STYLE="padding: 0; text-align: left; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD><TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: right; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">24,551,980</FONT></TD><TD STYLE="padding: 0; text-align: left; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-variant: small-caps"><B><I><U>INVESTMENTS
IN DERIVATIVES RISK </U></I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Warrants</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Since
warrants have a limited life, as the expiration date of a warrant approaches, the time value of a warrant will decline. In addition,
if the stock underlying the warrant declines in price, the intrinsic value of an &ldquo;in the money&rdquo; warrant will decline.
Further, if the price of the stock underlying the warrant does not exceed the strike price of the warrant on the expiration date,
the warrant will expire worthless. As a result, there is the potential for the Company to lose its entire investment in a warrant.
The Company is exposed to counterparty risk from the potential failure of an issuer to settle its exercised warrants. The maximum
risk of loss from counterparty risk to the Company is the fair value of the contracts and the purchase price of the warrants.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>10.
LINE OF CREDIT</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company entered into a line of credit agreement with its Custodian on February 24, 2014, subsequently renewed on November 22,
2016 for investment leverage and hedging purposes and cancelled on August 22, 2017.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
line of credit included sub-limits on fixed advances and overdraft advances with annual interest rate of 1.5% and 2.0%, respectively;
and interest on which would be charged at a spread above the cost of funds and/or the overdraft rate for the relevant currency
as determined by Credit Suisse.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Page; Sequence: 190; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->31<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt; font: 10pt Times New Roman, Times, Serif"><A HREF="#toc">Table of Contents</A>&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.8pt 0pt 0; text-align: center"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>APTORUM
GROUP LIMITED</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>NOTES
TO FINANCIAL STATEMENTS (PREDECESSOR BASIS)</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(Stated
in U.S. Dollars)</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
line of credit had the following termination events: (a) any breach the clause in the line of credit agreement; (b) any breach
of the Company or its affiliates in respect of and including but not limited to the constitutive documents, the memorandum and
article of association, then management agreement and disclosure documents and any prospectus, subscription agreement, custody
agreement, agency agreement or any other document or agreement to which it was a party or was binding on it as amended from time
to time or any other related agreement; (c) any change of Ian Huen as the director of the Company without the prior written consent
of Credit Suisse; (d) Guardian Capital Management Limited ceased to act as the Manager without the prior written consent of Credit
Suisse; (e) Ian Huen ceased to be the director of the Manager without the prior written consent of Credit Suisse; (f) the Manager
ceased to hold all of the management shares of the Company; (g) the Company was not owned as to 90% or more, directly or indirectly
by Ian Huen, and Huen Ng Sui Fong, Isabel (each a &ldquo;Specified Owner&rdquo;) or if the Company was owned more than 10% by
any person singly other than a Specified Owner; (h) the custody agreement was terminated or Credit Suisse ceased to be the sole
custodian in respect of the Company&rsquo;s listed securities; (i) the NAV of the Company declined by 30% or more within a 12
months rolling period; or by 20% or more within a three months rolling period; or by 15% or more for the most recent month end;
(j) any listing of the Company or its affiliates at a stock change; (k) creation of one or more new class of shares which had
the result that less than 100% of the assets of the Company were available to Credit Suisse to satisfy the Company&rsquo;s obligation
towards Credit Suisse without the prior written consent of Credit Suisse; (l) an event had occurred or a situation new to the
Bank had arisen which might have an impact on Credit Suisse&rsquo;s reputation and made it impossible for Credit Suisse to continue
the grant of the facilities; (m) material reservations of the auditors (if any) of the Company; (n) in Credit Suisse&rsquo;s opinion,
a material change in the direct or indirect ownership/control structure of the Company had occurred; and (o) any default or event
of default, or failure to comply with any payment obligation occurred under any document executed pursuant to any credit or trading
facilities extended by Credit Suisse, any of its branches or its affiliates to the Company or any one of the Company&rsquo;s affiliates.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Borrowings
of $2,086,702 have been repaid by the Company during the year ended December 31, 2016. The Company was in compliance with all
covenants. The Company had unused line of credit of $10,000,000 as of December 31, 2016.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>11.
GUARANTEES</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
the normal course of its operations, the Company enters into contracts and agreements that contain indemnifications and warranties.
The Company&rsquo;s maximum exposure under these arrangements is unknown as this would involve future claims that may be made
against the Company that have not yet occurred. However, the Company has not had prior claims or losses pursuant to these contracts
and expects the risk of loss to be remote.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>12.
FINANCIAL HIGHLIGHTS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Financial
highlights for the year ended December 31, 2016 and the period January 1, 2017 through February 28, 2017 are as follows:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-align: center; border-bottom: Black 1.5pt solid; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">Year
    ended<BR>
    December&nbsp;31,<BR>
    2016</FONT></TD><TD STYLE="padding: 0; font: bold 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-align: center; border-bottom: Black 1.5pt solid; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">January&nbsp;1,<BR>
    2017 through February&nbsp;28,<BR>
    2017</FONT></TD><TD STYLE="padding: 0; font: bold 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">Per
    Share Operating Performance:</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 72%; font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">Net
    Asset Value - Beginning</FONT></TD><TD STYLE="width: 1%; font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="width: 9%; font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-align: right; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">106.72</FONT></TD><TD STYLE="width: 3%; font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="width: 1%; font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="width: 9%; font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-align: right; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">97.85</FONT></TD><TD STYLE="width: 3%; font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">Decrease
    in net assets resulting from operations:</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">Net
    investment loss</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">(3.30</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">(0.85</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">Net
    realized and unrealized loss on investments</FONT></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: right; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">(5.57</FONT></TD><TD STYLE="padding: 0; text-align: left; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: right; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">(1.55</FONT></TD><TD STYLE="padding: 0; text-align: left; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">Net
    Asset Value - Ending</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 4pt double; font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="border-bottom: Black 4pt double; font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-align: right; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">97.85</FONT></TD><TD STYLE="padding: 0; font: bold 10pt Times New Roman, Times, Serif; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 4pt double; font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="border-bottom: Black 4pt double; font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-align: right; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">95.45</FONT></TD><TD STYLE="padding: 0; font: bold 10pt Times New Roman, Times, Serif; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">Total
    Return:</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">Total
    return before performance fees</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">(8.31</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">%)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">(2.45</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">%)</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">Performance
    fees</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">Total
    Return After Performance Fees</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">(8.31</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">%)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">(2.45</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">%)</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">Ratio
    to Average Net Assets:</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">Operating
    expenses (including interest)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">3.55</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">%</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">0.92</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">%</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">Performance
    fees</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">Total
    Expenses</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-align: right; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">3.55</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">%</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-align: right; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">0.92</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">%</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">Net
    Investment Loss, Before Performance Fees</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-align: right; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">(3.20</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">%)</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-align: right; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">(0.90</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">%)</FONT></TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Financial
highlights are calculated for each permanent, non-managing class of participating shares. An individual shareholder&rsquo;s end
of year NAV per share, total return and ratios may vary based on participation in different management fee and performance fees
arrangements and the timing of shareholder transactions. The ratios are computed using a weighted-average of the net assets for
the year ended December 31, 2016 and for the period January 1, 2017 through February 28, 2017, respectively. Due to the change
in status from an investment company to an operating company (see Note 4) the ratios for the period from January 1, 2017 through
February 28, 2017 was not annualized. The net investment loss ratio does not reflect the effects of performance fees.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 191; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->32<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt; font: 10pt Times New Roman, Times, Serif"><A HREF="#toc">Table of Contents</A>&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>APTORUM
GROUP LIMITED</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><A NAME="f_013"></A><FONT STYLE="font-size: 10pt"><B>NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS (SUCCESSOR BASIS)</B></FONT></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(Stated
in U.S. Dollars)</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>13.
ORGANIZATION</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
consolidated financial statements include the financial statements the Company and its subsidiaries. The Company and its subsidiaries
are hereinafter collectively referred to as the &ldquo;Group&rdquo;.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">After
the Restructure as on March 1, 2017 (see Note 1 and 2), the Company has become a Hong Kong based pharmaceutical company currently
in the preclinical stage. The Company researches and develops life science and biopharmaceutical products within its wholly-owned
subsidiary, Aptorum Therapeutics Limited, formerly known as APTUS Therapeutics Limited (&ldquo;Aptorum Therapeutics&rdquo;) and
its indirect subsidiary companies (collectively, &ldquo;Aptorum Therapeutics Group&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Below
summarizes the list of the subsidiaries consolidated as of December 31, 2017:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Name</B></FONT></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: center; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Incorporation
    date</B></FONT></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: center; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Ownership</B></FONT></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: center; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Place
    of incorporation</B></FONT></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: center; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Principle
    activities</B></FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 23%; text-align: left; vertical-align: top; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Aptorum
    Therapeutics Limited</FONT></TD><TD STYLE="width: 1%; text-align: left; vertical-align: top; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 17%; text-align: center; vertical-align: top; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">June
    30, 2016</FONT></TD><TD STYLE="width: 1%; text-align: left; vertical-align: top; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 10%; text-align: left; vertical-align: top; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">100%</FONT></TD><TD STYLE="width: 1%; text-align: left; vertical-align: top; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 20%; text-align: left; vertical-align: top; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cayman
    Islands</FONT></TD><TD STYLE="width: 1%; text-align: left; vertical-align: top; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 26%; text-align: left; vertical-align: top; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Research
    and development of life science and biopharmaceutical products</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; vertical-align: top; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">APTUS
    MANAGEMENT LIMITED</FONT></TD><TD STYLE="text-align: left; vertical-align: top; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; vertical-align: top; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">May
    16, 2017</FONT></TD><TD STYLE="text-align: left; vertical-align: top; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; vertical-align: top; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">100%</FONT></TD><TD STYLE="text-align: left; vertical-align: top; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; vertical-align: top; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Hong
    Kong</FONT></TD><TD STYLE="text-align: left; vertical-align: top; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; vertical-align: top; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Provision
    of management services to its holding company and fellow subsidiaries</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; vertical-align: top; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Aptus
    Therapeutics (Hong Kong) Limited</FONT></TD><TD STYLE="text-align: left; vertical-align: top; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; vertical-align: top; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">June
    30, 2016</FONT></TD><TD STYLE="text-align: left; vertical-align: top; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; vertical-align: top; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">100%</FONT></TD><TD STYLE="text-align: left; vertical-align: top; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; vertical-align: top; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Hong
    Kong</FONT></TD><TD STYLE="text-align: left; vertical-align: top; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; vertical-align: top; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Research
    and development of life science and biopharmaceutical products</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; vertical-align: top; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">APTUS
    BIOTECHNOLOGY (MACAO) LIMITED</FONT></TD><TD STYLE="text-align: left; vertical-align: top; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; vertical-align: top; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">June
    6, 2016</FONT></TD><TD STYLE="text-align: left; vertical-align: top; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; vertical-align: top; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">99%</FONT></TD><TD STYLE="text-align: left; vertical-align: top; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; vertical-align: top; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Macao</FONT></TD><TD STYLE="text-align: left; vertical-align: top; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; vertical-align: top; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Inactive</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; vertical-align: top; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Videns
    Incorporation Limited (Formally named Videns Biosciences Limited and VIDENS CORPORATION)</FONT></TD><TD STYLE="text-align: left; vertical-align: top; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; vertical-align: top; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">March
    2, 2017</FONT></TD><TD STYLE="text-align: left; vertical-align: top; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; vertical-align: top; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">100%</FONT></TD><TD STYLE="text-align: left; vertical-align: top; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; vertical-align: top; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cayman
    Islands</FONT></TD><TD STYLE="text-align: left; vertical-align: top; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; vertical-align: top; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Research
    and development of life science and biopharmaceutical products</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; vertical-align: top; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">mTOR
    (Hong Kong) Limited</FONT></TD><TD STYLE="text-align: left; vertical-align: top; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; vertical-align: top; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">November
    4, 2016</FONT></TD><TD STYLE="text-align: left; vertical-align: top; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; vertical-align: top; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">90%</FONT></TD><TD STYLE="text-align: left; vertical-align: top; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; vertical-align: top; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Hong
    Kong</FONT></TD><TD STYLE="text-align: left; vertical-align: top; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; vertical-align: top; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Research
    and development of life science and biopharmaceutical products</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; vertical-align: top; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Videns
    Incorporation (Hong Kong) Limited</FONT></TD><TD STYLE="text-align: left; vertical-align: top; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; vertical-align: top; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">July
    3, 2017</FONT></TD><TD STYLE="text-align: left; vertical-align: top; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; vertical-align: top; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">100%</FONT></TD><TD STYLE="text-align: left; vertical-align: top; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; vertical-align: top; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Hong
    Kong</FONT></TD><TD STYLE="text-align: left; vertical-align: top; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; vertical-align: top; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Inactive</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; vertical-align: top; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Nativus
    Life Sciences Limited</FONT></TD><TD STYLE="text-align: left; vertical-align: top; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; vertical-align: top; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">July
    7, 2017</FONT></TD><TD STYLE="text-align: left; vertical-align: top; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; vertical-align: top; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">100%</FONT></TD><TD STYLE="text-align: left; vertical-align: top; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; vertical-align: top; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cayman
    Islands</FONT></TD><TD STYLE="text-align: left; vertical-align: top; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; vertical-align: top; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Research
    and development of life science and biopharmaceutical products</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; vertical-align: top; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Scipio
    Life Sciences Limited</FONT></TD><TD STYLE="text-align: left; vertical-align: top; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; vertical-align: top; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">July
    19, 2017</FONT></TD><TD STYLE="text-align: left; vertical-align: top; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; vertical-align: top; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">100%</FONT></TD><TD STYLE="text-align: left; vertical-align: top; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; vertical-align: top; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cayman
    Islands</FONT></TD><TD STYLE="text-align: left; vertical-align: top; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; vertical-align: top; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Research
    and development of life science and biopharmaceutical products</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; vertical-align: top; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Claves
    Life Sciences Limited</FONT></TD><TD STYLE="text-align: left; vertical-align: top; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; vertical-align: top; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">August
    2, 2017</FONT></TD><TD STYLE="text-align: left; vertical-align: top; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; vertical-align: top; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">100%</FONT></TD><TD STYLE="text-align: left; vertical-align: top; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; vertical-align: top; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cayman
    Islands</FONT></TD><TD STYLE="text-align: left; vertical-align: top; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; vertical-align: top; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Research
    and development of life science and biopharmaceutical products</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; vertical-align: top; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Nativus
    Life Sciences (Hong Kong) Limited</FONT></TD><TD STYLE="text-align: left; vertical-align: top; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; vertical-align: top; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">August
    8, 2017</FONT></TD><TD STYLE="text-align: left; vertical-align: top; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; vertical-align: top; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">100%</FONT></TD><TD STYLE="text-align: left; vertical-align: top; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; vertical-align: top; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Hong
    Kong</FONT></TD><TD STYLE="text-align: left; vertical-align: top; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; vertical-align: top; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Inactive</FONT></TD></TR>
</TABLE>




<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 192; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->33<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt; font: 10pt Times New Roman, Times, Serif"><A HREF="#toc">Table of Contents</A>&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>APTORUM
GROUP LIMITED</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS (SUCCESSOR BASIS)</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(Stated
in U.S. Dollars)</B></FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Name</B></FONT></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: center; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Incorporation
    date</B></FONT></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: center; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Ownership</B></FONT></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: center; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Place
    of incorporation</B></FONT></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: center; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Principle
    activities</B></FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="width: 23%; padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Scipio
    Life Sciences (Hong Kong) Limited</FONT></TD>
    <TD STYLE="width: 1%; padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 17%; padding: 0; font: 10pt Times New Roman, Times, Serif; text-align: center; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">August
    10, 2017</FONT></TD>
    <TD STYLE="width: 1%; padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 10%; padding: 0; font: 10pt Times New Roman, Times, Serif; text-align: center; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">100%</FONT></TD>
    <TD STYLE="width: 1%; padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 20%; padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Hong
    Kong</FONT></TD>
    <TD STYLE="width: 1%; padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 26%; padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Inactive</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Signate
    Life Sciences (Hong Kong) Limited</FONT></TD>
    <TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-align: center; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">August
    10, 2017</FONT></TD>
    <TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-align: center; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">100%</FONT></TD>
    <TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Hong
    Kong</FONT></TD>
    <TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Inactive</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Claves
    Life Sciences (Hong Kong) Limited</FONT></TD>
    <TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-align: center; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">August
    22, 2017</FONT></TD>
    <TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-align: center; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">100%</FONT></TD>
    <TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Hong
    Kong</FONT></TD>
    <TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Inactive</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Aptorum
    Pharmaceutical Development Limited</FONT></TD>
    <TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-align: center; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">August
    28, 2017</FONT></TD>
    <TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-align: center; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">100%</FONT></TD>
    <TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cayman
    Islands</FONT></TD>
    <TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Research
    and development of life science and biopharmaceutical products</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Aptorum
    Medical Limited</FONT></TD>
    <TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-align: center; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">August
    28, 2017</FONT></TD>
    <TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-align: center; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">100%</FONT></TD>
    <TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cayman
    Islands</FONT></TD>
    <TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Provision
    of medical clinic services</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Signate
    Life Sciences Limited</FONT></TD>
    <TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-align: center; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">August
    28, 2017</FONT></TD>
    <TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-align: center; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">100%</FONT></TD>
    <TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cayman
    Islands</FONT></TD>
    <TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Research
    and development of life science and biopharmaceutical products</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Acticule
    Life Sciences Limited</FONT></TD>
    <TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-align: center; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">June
    30, 2017</FONT></TD>
    <TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-align: center; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">100%*</FONT></TD>
    <TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cayman
    Islands</FONT></TD>
    <TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Research
    and development of life science and biopharmaceutical products</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Acticule
    Life Sciences (Hong Kong) Limited</FONT></TD>
    <TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-align: center; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">July
    27, 2017</FONT></TD>
    <TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-align: center; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">100%</FONT></TD>
    <TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Hong
    Kong</FONT></TD>
    <TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Inactive</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="width: 100%; margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; padding: 0; text-indent: 0; width: 0.3in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</FONT></TD>
    <TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    total shares of Acticule Life Sciences Limited is 1,000,001, which the Company held 1,000,000 shares, approximately 100% equity
    interest of Acticule Life Sciences Limited.</FONT></TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>14.
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Basis
of presentation</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
consolidated financial statements are prepared in accordance with U.S. GAAP.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of March 1, 2017, after the change of business purpose, legal form and substantive activities, the Company&rsquo;s status changed
to an operating company from an investment company since it no longer met the criteria to qualify as an investment company under
the ASC 946. The Company discontinued applying the guidance in ASC 946 and began to account for the change in status prospectively
by accounting for its investments in accordance with other U.S. GAAP topics.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Principles
of consolidation</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
consolidated financial statements of the Group are presented on the accrual basis of accounting in accordance with U.S. GAAP and
include the accounts of the Company, its direct and indirect wholly and majority owned subsidiaries and a variable interest entity.
All material intercompany balances and transactions have been eliminated in preparation of the consolidated financial statements.
Non-controlling interests represent the equity interest that is not owned by the Group.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Use
of estimates</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
preparation of the consolidated financial statements on successor basis in conformity with U.S. GAAP requires management to make
estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities
at the date of the financial statements and the reported amounts of increases and decreases in net assets from operations as well
as income and expenses during the reporting period. Significant accounting estimates reflected in the Group&rsquo;s consolidated
financial statements include fair value of investments in securities, the useful lives of intangible assets and equipment, impairment
of long-lived assets, collectability of receivables. Actual results could differ from those estimates.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Page; Sequence: 193; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->34<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt; font: 10pt Times New Roman, Times, Serif"><A HREF="#toc">Table of Contents</A>&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>APTORUM
GROUP LIMITED</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS (SUCCESSOR BASIS)</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(Stated
in U.S. Dollars)</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Foreign
currency translation and transaction</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">USD
is the reporting currency. The functional currency of subsidiaries in the Cayman Islands is USD, the functional currency of subsidiaries
in Hong Kong is Hong Kong Dollars (&ldquo;HKD&rdquo;) and the functional currency of subsidiaries in Macao is Macanese Pataca
(&ldquo;MOP&rdquo;). An entity&rsquo;s functional currency is the currency of the primary economic environment in which it operates,
normally that is the currency of the environment in which it primarily generates and expends cash. The management considered various
indicators, such as cash flows, market expenses, financing and inter-company transactions and arrangements in determining the
Group&rsquo;s functional currency.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
the consolidated financial statements, the financial information of the Company and its subsidiaries, which use HKD and MOP as
their functional currency, has been translated into USD. Assets and liabilities are translated from each subsidiary&rsquo;s functional
currency at the exchange rates on the balance sheet date, equity amounts are translated at historical exchange rates, and revenues,
expenses, gains, and losses are translated using the average rate for the year. Translation adjustments are reported as cumulative
translation adjustments and are shown as a separate component of other comprehensive income or loss in the statement of shareholders&rsquo;
equity and comprehensive income.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Cash</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cash
consists of cash on hand and bank deposits and cash denominated in foreign currencies, which is unrestricted as to withdrawal
and use.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Restricted
Cash</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Restricted
cash relates to cash deposited into the escrow account from investors for the purpose of the subscription of convertible notes.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Marketable
Securities</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Marketable
Securities are accounted for as trading securities or available-for-sale based on the trading purpose, which are measured at fair
value. Gains or losses from changes in fair value of trading securities are recorded through earnings. Gains or losses from changes
in the fair value of available-for-sale securities are recorded in accumulated other comprehensive income, until the investment
is sold or otherwise disposed of, or until the investment is determined to be other-than-temporarily impaired, at which time the
cumulative gain or loss previously reported in equity is included in income. The specific identification method is used to determine
the realized gain or loss on investments sold or otherwise disposed.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Group measures the investments in marketable securities at fair value based on quoted market prices. Gains from the marketable
securities amounting to $3,912,500 were recognized in the consolidated statement of operations for the period from March 1, 2017
to December 31, 2017. The Group recognized the unrealized loss on investments in available-for-sale securities amounting to $367,782
for the period from March 1, 2017 to December 31, 2017.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
the period from March 1, 2017 to December 31, 2017, the Group disposed the trading securities and available-for-sale securities,
with sales proceeds of $15,738,517 and $310,550 received, and recognized a gain of $3,917,046 and a loss of $4,546 in the consolidated
statement of operations for the period from March 1, 2017 to December 31, 2017, respectively.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Investments
in Derivatives</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Investments
in derivatives consisted of warrants, which are measured at fair value, with gains or losses from changes in fair value recorded
through earnings.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Loss
on the warrants amounted to $827,501 was recognized in the consolidated statement of operations for the period from March 1, 2017
to December 31, 2017.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 194; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->35<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt; font: 10pt Times New Roman, Times, Serif"><A HREF="#toc">Table of Contents</A>&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>APTORUM
GROUP LIMITED</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS (SUCCESSOR BASIS)</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(Stated
in U.S. Dollars)</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Non-marketable
investments</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Non-marketable
investments are comprising of investments in non-redeemable preferred shares of privately-held companies accounted for under the
cost method and are not required to be consolidated under the variable interest or voting models. Non-marketable investments are
classified as non-current assets on the Consolidated Balance Sheet as those investments do not have stated contractual maturity
dates. Non-marketable equity investments are measured at purchase cost with appropriate consideration given to impairment.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of December 31, 2017, investments accounted for under the cost method had a carrying value of $7,394,713.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Fair
value measurement</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Fair
value is defined as the price that would be received from selling an asset or paid to transfer a liability in an orderly transaction
between market participants at the measurement date. When determining the fair value measurements for assets and liabilities required
or permitted to be recorded at fair value, the Group considers the principal or most advantageous market in which it would transact
its business, and it considers assumptions that market participants would use when pricing the asset or liability.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
a basis for considering such assumptions, a three-tier fair value hierarchy prioritizes the inputs utilized in measuring fair
value as follows:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%"><TR STYLE="vertical-align: top; text-align: justify; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"></TD><TD STYLE="width: 0.25in; text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level
                                         1 applies to assets or liabilities for which there are quoted prices in active markets
                                         for identical assets or liabilities.</FONT></TD>
</TR>
<TR STYLE="vertical-align: top; text-align: justify; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; text-align: justify; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level
                                         2 applies to assets or liabilities for which there are inputs other than quoted prices
                                         included within Level 1 that are observable for the asset or liability such as quoted
                                         prices for similar assets or liabilities in active markets; quoted prices for identical
                                         assets or liabilities in markets with insufficient volume or infrequent transactions
                                         (less active markets); or model-derived valuations in which significant inputs are observable
                                         or can be derived principally from, or corroborated by, observable market data.</FONT></TD>
</TR>
<TR STYLE="vertical-align: top; text-align: justify; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; text-align: justify; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level
                                         3 applies to assets or liabilities for which there are unobservable inputs to the valuation
                                         methodology that are significant to the measurement of the fair value of the assets or
                                         liabilities.</FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
hierarchy requires the Group to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring
fair value. A financial instrument&rsquo;s categorization within the fair value hierarchy is based upon the lowest level of input
that is significant to the fair value measurement. The Group has estimated the fair value amounts of its financial instruments
using the available market information and valuation methodologies considered to be appropriate and has determined that the carrying
value of the Group&rsquo;s cash, restricted cash, receivables related to investment, interest receivable, receivables from brokers,
other receivable and prepayments, amounts due from/to related parties, accounts payable and accrued expenses as of December 31,
2017 approximate fair value.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Equipment</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Equipment
is stated at cost less accumulated depreciation. Cost represents the purchase price of the asset and other costs incurred to bring
the asset into its existing use. Maintenance, repairs and betterments, including replacement of minor items, are charged to expense;
major additions to physical properties are capitalized.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Depreciation
of equipment is provided using the straight-line method over their estimated useful lives:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 45%; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Computer
    equipment</FONT></TD>
    <TD STYLE="width: 1%; padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 54%; padding: 0; text-align: right; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3
    years</FONT></TD>
    </TR>
<TR STYLE="vertical-align: bottom; background-color: White; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Laboratory
    equipment</FONT></TD>
    <TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding: 0; text-align: right; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5
    years</FONT></TD>
    </TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Upon
sale or disposal, the applicable amounts of asset cost and accumulated depreciation are removed from the accounts and the net
amount less proceeds from disposal is charged or credited to income.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 195; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->36<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt; font: 10pt Times New Roman, Times, Serif"><A HREF="#toc">Table of Contents</A>&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>APTORUM
GROUP LIMITED</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS (SUCCESSOR BASIS)</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(Stated
in U.S. Dollars)</B></FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Intangible
assets</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Indefinite-lived
intangible assets are tested for impairment at least annually and are reviewed for impairment whenever events or changes in circumstances
indicate that the carrying amount of an asset may not be recoverable. Indefinite-lived intangible assets are impaired if their
estimated fair values are less than their carrying values.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Finite-lived
intangible assets are initially recorded at fair value when acquired, in which the finite intangible assets are amortized over
their estimated useful life, which is the period over which the assets are expected to contribute directly or indirectly to the
future cash flows of the Group. These intangible assets are tested for impairment at the time of a triggering event, if one were
to occur. Finite-lived intangible assets may be impaired when the estimated undiscounted future cash flows generated from the
assets are less than their carrying amounts.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><BR>
<FONT STYLE="font-size: 10pt">The Group may rely on a qualitative assessment when performing its intangible asset impairment test.
Otherwise, the impairment evaluation is performed at the lowest level of identifiable cash flows independent of other assets.</FONT></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Group&rsquo;s intangible assets mainly consist of exclusive rights in prepaid patented and unpatented licenses. The prepaid patented
licenses are for clinical purpose or further development into other products. Prepaid unpatented license is for further development,
once the associated research and development efforts are completed, the prepaid unpatented license will be reclassified as a finite-lived
asset and is amortized over its useful life. The estimated useful life of the exclusive rights in using patents is generally the
remaining patent life from the acquisition date to expiration date under the law, which is 17 to 20 years, the Group will reassess
the remaining patent life on annual basis, and the Group will assess the intangible assets for impairment whenever events or changes
in circumstances indicate that the carrying amount of an asset may no longer be recoverable.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Impairment
of long-lived assets</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Group reviews its long-lived assets for impairment whenever events or changes in circumstances indicate that the carrying amount
of an asset may no longer be recoverable. When these events occur, the Group measures impairment by comparing the carrying value
of the long-lived assets to the estimated undiscounted future cash flows expected to result from the use of the assets and their
eventual disposition. If the sum of the expected undiscounted cash flow is less than the carrying amount of the assets, the Group
would recognize an impairment loss, which is the excess of carrying amount over the fair value of the assets, using the expected
future discounted cash flows.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Convertible
promissory notes</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Group determines the appropriate accounting treatment of its convertible promissory notes in accordance with the terms in relation
to the conversion feature, call and put option, beneficial conversion feature and settlement feature. After considering the impact
of such features, the Group concludes that, as of December 31, 2017, the convertible promissory notes contain a contingent beneficial
conversion, which shall not be recognized in earnings until the contingency is resolved, and therefore accounts for such instrument
as a liability in its entirety.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Convertible
promissory notes are classified as a current liability if their maturity is or will be within one year from the balance sheet
date.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Revenue
recognition</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dividend
income is recorded on the ex-dividend date, and interest income is recorded on an accrual basis.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">After
the Restructure, the Group has yet to generate operating income stream from its pharmaceutical products for the period from March
1, 2017 to December 31, 2017.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 196; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->37<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt; font: 10pt Times New Roman, Times, Serif"><A HREF="#toc">Table of Contents</A>&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>APTORUM
GROUP LIMITED</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS (SUCCESSOR BASIS)</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(Stated
in U.S. Dollars)</B></FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Research
and development expenses</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Research and development costs are expensed
as incurred. Research and development expenses are comprised of costs incurred in performing research and development activities,
including amortization of the patent license, depreciation of laboratory equipment, external costs of outside vendors engaged
to conduct preclinical development activities and trials.</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Income
taxes</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Group accounts for income taxes under the asset and liability method. Under this method, deferred income taxes are determined
based on differences between the financial carrying amounts of existing assets and liabilities and their tax bases. Income taxes
are provided for in accordance with the laws of the relevant taxing authorities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
valuation allowance is provided for deferred tax assets if it is more likely than not that these items will either expire before
the Group is able to realize their benefits, or that future deductibility is uncertain. Valuation allowances are established,
when necessary, to reduce deferred tax assets to the amount expected to be realized.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Uncertain
tax positions</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Group accounts for uncertainty in income taxes using a two-step approach to recognizing and measuring uncertain tax positions.
The first step is to evaluate the tax position for recognition by determining if the weight of available evidence indicates that
it is more likely than not that the position will be sustained on audit, including resolution of related appeals or litigation
processes, if any. The second step is to measure the tax benefit as the largest amount that is more than 50% likely of being realized
upon settlement. Interest and penalties related to uncertain tax positions are recognized and recorded as necessary in the provision
for income taxes. The Group recognizes interest on non-payment of income taxes and penalties associated with tax positions when
a tax position does not meet more likely than not thresholds be sustained under examination. The tax returns of the Group&rsquo;s Hong
Kong subsidiaries and VIEs are subject to examination by the relevant tax authorities. According to the Hong Kong Inland Revenue
Department, the statute of limitation is six years if any company chargeable with tax has not been assessed or has been assessed
at less than the proper amount, the statute of limitation is extended to ten years if the underpayment of taxes is due to fraud
or willful evasion. The Group did not have any material interest or penalties associated with tax positions for the period ended
December 31, 2017 and did not have any significant unrecognized uncertain tax positions as of December 31, 2017. The Group does
not believe that its assessment regarding unrecognized tax benefits will materially change over the next twelve months.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Comprehensive
income or loss</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">U.S.
GAAP generally requires that recognized revenue, expenses, gains and losses be included in net income or loss. Although certain
changes in assets and liabilities are reported as separate components of the equity section of the consolidated balance sheet,
such items, along with net income, are components of comprehensive income or loss. The components of other comprehensive income
or loss consist of unrealized gain or loss on available for sale short term investments.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Loss
per share</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">After
the Restructure, basic loss per share is computed by dividing net loss attributable to ordinary shareholders by the weighted average
number of ordinary shares outstanding during the period. Diluted earnings per share reflects the potential dilution that could
occur if securities or other contracts to issue ordinary shares were exercised or converted into ordinary shares. Potential dilutive
securities are excluded from the calculation of diluted EPS in loss periods as their effect would be anti-dilutive.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<!-- Field: Page; Sequence: 197; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->38<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt; font: 10pt Times New Roman, Times, Serif"><A HREF="#toc">Table of Contents</A>&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>APTORUM
GROUP LIMITED</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS (SUCCESSOR BASIS)</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(Stated
in U.S. Dollars)</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Recently
issued accounting standards</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
May 2014, the FASB issued Accounting Standards Update 2014-09, <I>Revenue from Contracts with Customers, </I>or ASU 2014-09. This
new standard (Topic 606) will replace all current U.S. GAAP guidance on this topic and eliminate all industry-specific guidance.
The new revenue recognition standard provides a unified model to determine when and how revenue is recognized. The core principle
is that a company should recognize revenue to correlate with the transfer of promised goods or services to customers in an amount
that reflects the consideration for which the entity expects to be entitled in exchange for those goods or services. In July 2015,
the FASB voted to defer the effective date of ASU 2014-09 by one year, while allowing a company to adopt the new revenue standard
early but not before the original effective date.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
March 2016, the FASB issued ASU 2016-08, which amends the principal-versus-agent implementation guidance and illustrations in
the new revenue standard. ASU No. 2016-08 specifically provides clarification around performance obligations for goods or services
provided by another entity, assisting in determining whether the entity is the provider of the goods or services, the principal,
or whether the entity is providing for the arrangement of the goods or services, the agent.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
April 2016, the FASB issued ASU No. 2016-10, <I>Revenue from Contracts with Customers</I> (Topic 606): Identifying Performance
Obligations and Licensing. ASU No. 2016-10 provides guidance around identifying whether promised goods or services are distinct
and separately identifiable, whether promised goods or services are material or immaterial to the contract, and whether shipping
and handling is considered an activity to fulfill a promise or an additional promised service. ASU No. 2016-10 also provides guidance
around an entity&rsquo;s promise to grant a license providing a customer with either a right to use or a right to access the license,
which then determines whether the obligation is satisfied at a point in time or over time, respectively.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
May 2016, the FASB issued ASU No. 2016-11, <I>Revenue Recognition</I> (Topic 605) and <I>Derivatives and Hedging</I> (Topic 815):
Rescission of SEC Guidance Because of Accounting Standards Updates 2014-09 and 2014-16. Pursuant to Staff Announcements at the
March 3, 2016 EITF Meeting, which rescinds various standards codified as part of Topic 605, Revenue Recognition in relation to
the future adoption of Topic 606. These rescissions include changes to topics pertaining to revenue and expense recognition including
accounting for shipping and handling fees and costs and accounting for consideration given by a vendor to a customer.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
above standards will be effective for us on January 1, 2019 and can be applied either retrospectively to each period presented
or as a cumulative-effect adjustment as of the date of adoption. The Group&nbsp;is&nbsp;an&nbsp;&ldquo;emerging&nbsp;growth company&rdquo;&nbsp;as&nbsp;defined&nbsp;in&nbsp;the&nbsp;Jumpstart
Our Business Startups Act of 2010 (the &ldquo;JOBS Act&rdquo;). Under the JOBS&nbsp;Act,&nbsp;emerging&nbsp;growth&nbsp;companies&nbsp;(&ldquo;EGCs&rdquo;)&nbsp;can
delay adopting new or revised accounting standards issued&nbsp;subsequent&nbsp;to&nbsp;the&nbsp;enactment&nbsp;of&nbsp;the JOBS
Act until such time as those standards&nbsp;apply&nbsp;to&nbsp;private&nbsp;companies. Therefore, the Group will not be subject
to the same new or revised accounting standards as public companies that are not EGCS. The management has not yet selected a transition
method.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Management
is developing an adoption plan based on which the Group is in the process of evaluating the effects of adopting ASC606, including
the selection of the adoption method, the identification of differences using sample contracts, if any, from the application of
current revenue recognition standard and the impact of such differences, if any, on its consolidated financial statements. The
Group is currently evaluating the impact of adopting ASU No. 2016-11 on its consolidated financial statements.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<!-- Field: Page; Sequence: 198; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->39<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt; font: 10pt Times New Roman, Times, Serif"><A HREF="#toc">Table of Contents</A>&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>APTORUM
GROUP LIMITED</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS (SUCCESSOR BASIS)</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(Stated
in U.S. Dollars)</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
January 2016, the FASB issued ASU No. 2016-01, <I>Financial Instruments - Recognition and Measurement of Financial Assets and
Financial Liabilities. </I>The amendments in this update address certain aspects of recognition, measurement, presentation, and
disclosure of financial instruments. The amendments in this update require public business entities that are required to disclose
fair value of financial instruments measured at amortized cost on the balance sheet to measure that fair value using the exit
price notion consistent with Topic 820, Fair Value Measurement. The amendments in this update require an entity to present separately
in other comprehensive income the portion of the total change in the fair value of a liability resulting from a change in the
instrument-specific credit risk when the entity has elected to measure the liability at fair value in accordance with the fair
value option. The amendments in this Update require separate presentation of financial assets and financial liabilities by measurement
category and form of financial asset (that is, securities or loans and receivables) on the balance sheet or in the accompanying
notes to the financial statements. In addition, according to ASU No. 2016-01, all equity investments in unconsolidated entities
(other than those accounted for using the equity method of accounting) will generally be measured at fair value through earnings.
For equity investments without readily determinable fair values, the cost method is also eliminated. However, entities will be
able to elect to record equity investments without readily determinable fair values at cost, less impairment, adjusted for subsequent
observable price changes. Entities that elect this measurement alternative will report changes in the carrying value of the equity
investments in current earnings. This election only applies to equity investments that do not qualify for the net asset value
practical expedient. The impairment model for equity investments subject to this election is a single-step model. Under the single-step
model, an entity is required to perform a qualitative assessment each reporting period to identify impairment. When a qualitative
assessment indicates an impairment exists, the entity would estimate the fair value of the investment and recognize in current
earnings an impairment loss equal to the difference between the fair value and the carrying amount of the equity investment. The
measurement alternative may be elected separately on an investment by investment basis for each equity investment without a readily
determinable fair value. Once elected, it should be applied consistently as long as the investment meets the qualifying criteria.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
amendments in this update are effective for fiscal years beginning after December 15, 2017, including interim periods within those
fiscal years. For non-public business entities, early adoption is not permitted. The Group is currently evaluating the impact
of adopting ASU No. 2016-01 on its consolidated financial statements.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
February 2018, the FASB issued ASU 2018-02, Income Statement&mdash;Reporting Comprehensive Income (Topic 220). The amendments
in this Update allow a reclassification from accumulated other comprehensive income to retained earnings for stranded tax effects
resulting from the Tax Cuts and Jobs Act. Consequently, the amendments eliminate the stranded tax effects resulting from the Tax
Cuts and Jobs Act and will improve the usefulness of information reported to financial statement users. However, because the amendments
only relate to the reclassification of the income tax effects of the Tax Cuts and Jobs Act, the underlying guidance that requires
that the effect of a change in tax laws or rates be included in income from continuing operations is not affected. The amendments
in this Update also require certain disclosures about stranded tax effects. Public business entities should apply the amendments
in ASU 2018-02 for fiscal years beginning after December 15, 2018, and interim periods within those fiscal years. Early adoption
of the amendments in this Update is permitted, including adoption in any interim period, (1) for public business entities for
reporting periods for which financial statements have not yet been issued and (2) for all other entities for reporting periods
for which financial statements have not yet been made available for issuance. The adoption of this guidance is not expected to
have a material impact on the Company&rsquo;s consolidated financial condition, results of operations or cash flows.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
March 2018, the FASB issued ASU No. 2018-05, Income Tax (Topic 740) - Amendments to SEC Paragraphs Pursuant to SEC Staff Accounting
Bulletin No. 118. This update adds SEC paragraphs pursuant to the SEC Staff Accounting Bulletin No. 118, which expresses the view
of the staff regarding application of Topic 740, Income Taxes, in the reporting period that includes December 22, 2017 - the date
on which the Tax Act was signed into law. The adoption of this guidance is not expected to have a material impact on the Company&rsquo;s
consolidated financial condition, results of operations or cash flows.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 30pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Group does not believe other recently issued but not yet effective accounting standards, if currently adopted, would have a material
effect on the consolidated financial position, statements of operations and cash flows.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Page; Sequence: 199; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->40<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt; font: 10pt Times New Roman, Times, Serif"><A HREF="#toc">Table of Contents</A>&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>APTORUM
GROUP LIMITED</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS (SUCCESSOR BASIS)</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(Stated
in U.S. Dollars)</B></FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>15.
CHANGE IN STATUS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Prior
to the March 1, 2017 change in status as an investment company, the Company recorded its investments at fair value and recorded
the changes in the fair value as unrealized gain or loss. In addition, the Company recorded its direct and indirect wholly and
majority owned subsidiaries at fair value since they were operating companies not providing services to the Company and not investment
companies (See Note 2).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Upon
the effective date of the change in status, the fair value accounting as an investment company was no longer applicable to the
Company, rather the Company began presenting such subsidiaries on a consolidated basis. The investments in unaffiliated issuers
are measured at fair value or cost, less impairment (See Note 14). The Company&rsquo;s initial carrying value of the net assets
of the investments in subsidiaries was the fair value on the effective date of the change in status determined as follows:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 76%; text-align: left; text-indent: 0; padding: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Fair
    value of subsidiaries as of the effective date of the change in status&nbsp;on March 1, 2017</FONT></TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="width: 9%; text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="width: 1%; text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD><TD STYLE="width: 9%; text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">757,647</FONT></TD><TD STYLE="width: 1%; text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total
    net assets of the combined properties</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Intangible
    assets, net</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">194,146</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cash</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">593,800</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Prepayments</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">256</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">An
    amount due to a related party</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(28,717</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accounts
    payable and accrued expenses</FONT></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding: 0; text-align: left; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding: 0; text-align: right; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(207,692</FONT></TD><TD STYLE="padding: 0; text-align: left; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</FONT></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: right; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">551,793</FONT></TD><TD STYLE="padding: 0; text-align: left; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Increase
    to the initial carrying value of the net assets&nbsp;on the effective date of the change in status on March 1, 2017</FONT></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding: 0; text-align: left; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding: 0; text-align: right; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding: 0; text-align: left; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD><TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: right; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">205,854</FONT></TD><TD STYLE="padding: 0; text-align: left; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>16.
VARIABLE INTEREST ENTITY</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On July 28, 2017, the Company, through
one of its subsidiaries, Aptorum Therapeutics Limited, entered into a convertible loan agreement (the &ldquo;Agreement&rdquo;)
with Acticule Life Sciences Limited (&ldquo;Acticule&rdquo;), at interest rate of 0% but no amount or maturity limits.</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Acticule
was incorporated by an individual on June 30, 2017, with paid-in capital of $1. Acticule mainly engaged in research and development
of life science and biopharmaceutical products. From July 28, 2017 to December 22, 2017, Acticule has drawn down the loan in aggregate
amount of $1,000,000. Other than that, Acticule has not obtained any financial support for its business operation.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">After
evaluation of the design of Acticule as the basis for determining its variability in applying the variable interest entity model,
the Company believes that Acticule was a variable interest entity (&ldquo;VIE&rdquo;), and the Company is the primary beneficiary,
due to the Company has the power to ultimately direct the activities and significantly affect its economic performance, as well
as the obligation to absorb losses or the right to receive benefit from Acticule that could potentially be significant to Acticule.
Therefore, the financial statement of Acticule was consolidated by the Company since the first loan drawn down to Acticule on
July 28, 2017.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
December 22, 2017, Acticule accepted the election made by the Company to convert the entire loan of $1,000,000 into shares in
Acticule. After the conversion, the Company held approximately 100% equity interest of Acticule, which ceased to be a VIE but
consolidated by the Company under the voting interest entity model thereafter.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">From
July 28, 2017 to December 22, 2017, Acticule was consolidated under the VIE model, and its operating expense and net loss are
listed below:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>July
    28,</B></FONT><FONT STYLE="font-family: Times New Roman, Times, Serif"><BR>
    <FONT STYLE="font-size: 10pt"><B>2017 through December&nbsp;22, 2017</B></FONT></FONT></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></TD></TR>
<TR STYLE="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 88%; text-align: left; text-indent: 0; padding: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total
    expense</FONT></TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD><TD STYLE="width: 9%; text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">559,850</FONT></TD><TD STYLE="width: 1%; text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: 0; padding: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Net
    loss</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">559,850</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
</TABLE>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 200; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->41<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt; font: 10pt Times New Roman, Times, Serif"><A HREF="#toc">Table of Contents</A>&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>APTORUM
GROUP LIMITED</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS (SUCCESSOR BASIS)</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(Stated
in U.S. Dollars)</B></FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>17.
FAIR VALUE MEASUREMENT </B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table provides the assets and liabilities carried at fair value measured on a recurring basis as of December 31, 2017:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding: 0; border-bottom: Black 1.5pt solid; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">December
    31, 2017</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-align: center; border-bottom: Black 1.5pt solid; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level
    1</FONT></TD><TD STYLE="padding: 0; font: bold 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-align: center; border-bottom: Black 1.5pt solid; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level
    2</FONT></TD><TD STYLE="padding: 0; font: bold 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-align: center; border-bottom: Black 1.5pt solid; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level
    3</FONT></TD><TD STYLE="padding: 0; font: bold 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-align: center; border-bottom: Black 1.5pt solid; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total</FONT></TD><TD STYLE="padding: 0; font: bold 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Current
    Assets</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Marketable
    securities</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 52%; text-align: left; text-indent: 0; font: 10pt Times New Roman, Times, Serif; padding: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Common
    stocks</FONT></TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD><TD STYLE="width: 9%; text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD><TD STYLE="width: 1%; text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD><TD STYLE="width: 9%; text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,972,648</FONT></TD><TD STYLE="width: 1%; text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD><TD STYLE="width: 9%; text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD><TD STYLE="width: 1%; text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD><TD STYLE="width: 9%; text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,972,648</FONT></TD><TD STYLE="width: 1%; text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: 0; font: 10pt Times New Roman, Times, Serif; padding: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Investment
    in derivatives</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Warrants</FONT></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: right; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">24,182</FONT></TD><TD STYLE="padding: 0; text-align: left; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: right; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD><TD STYLE="padding: 0; text-align: left; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: right; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,070,940</FONT></TD><TD STYLE="padding: 0; text-align: left; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: right; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,095,122</FONT></TD><TD STYLE="padding: 0; text-align: left; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total
    assets at fair value</FONT></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD><TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: right; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">24,182</FONT></TD><TD STYLE="padding: 0; text-align: left; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD><TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: right; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,972,648</FONT></TD><TD STYLE="padding: 0; text-align: left; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD><TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: right; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,070,940</FONT></TD><TD STYLE="padding: 0; text-align: left; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD><TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: right; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3,067,770</FONT></TD><TD STYLE="padding: 0; text-align: left; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following is a reconciliation of Level 3 assets for the period February 28, 2017 through December 31, 2017:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="padding: 0 0 0 10pt; text-indent: -10pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.8pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Aptorum
                                         Therapeutics&ndash;</B></FONT></P>
                                                                                 <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.8pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>related
                                         party</B></FONT></P></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.8pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Common</B></FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.8pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Stocks</B></FONT></P></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.8pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Preferred</B></FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.8pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Stocks</B></FONT></P></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-align: center; border-bottom: Black 1.5pt solid; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Warrants</FONT></TD><TD STYLE="padding: 0; font: bold 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.8pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Convertible</B></FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.8pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Notes</B></FONT></P></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-align: center; border-bottom: Black 1.5pt solid; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total</FONT></TD><TD STYLE="padding: 0; font: bold 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 28%; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.8pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Balance
at February 28, 2017</B></FONT></P></TD><TD STYLE="width: 1%; font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD><TD STYLE="width: 9%; border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-align: right; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">757,647</FONT></TD><TD STYLE="width: 1%; padding: 0; font: bold 10pt Times New Roman, Times, Serif; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="width: 1%; font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD><TD STYLE="width: 9%; border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-align: right; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">7,920,000</FONT></TD><TD STYLE="width: 1%; padding: 0; font: bold 10pt Times New Roman, Times, Serif; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="width: 1%; font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD><TD STYLE="width: 9%; border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-align: right; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4,314,998</FONT></TD><TD STYLE="width: 1%; padding: 0; font: bold 10pt Times New Roman, Times, Serif; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="width: 1%; font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD><TD STYLE="width: 9%; border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-align: right; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,907,470</FONT></TD><TD STYLE="width: 1%; padding: 0; font: bold 10pt Times New Roman, Times, Serif; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="width: 1%; font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD><TD STYLE="width: 9%; border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-align: right; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3,082,020</FONT></TD><TD STYLE="width: 1%; padding: 0; font: bold 10pt Times New Roman, Times, Serif; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="width: 1%; font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD><TD STYLE="width: 9%; border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-align: right; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">17,982,135</FONT></TD><TD STYLE="width: 1%; padding: 0; font: bold 10pt Times New Roman, Times, Serif; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; padding: 0 0 0 10pt; text-indent: -10pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Transfer
    out to of Level 3 due to change in status - consolidated subsidiary (a)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(757,647</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(757,647</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; padding: 0 0 0 10pt; text-indent: -10pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Transfer
    out of fair value leveling since recorded as cost method (b)</FONT></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: right; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD><TD STYLE="padding: 0; text-align: left; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: right; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(7,920,000</FONT></TD><TD STYLE="padding: 0; text-align: left; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</FONT></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: right; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(4,314,998</FONT></TD><TD STYLE="padding: 0; text-align: left; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</FONT></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: right; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD><TD STYLE="padding: 0; text-align: left; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: right; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD><TD STYLE="padding: 0; text-align: left; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: right; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(12,234,998</FONT></TD><TD STYLE="padding: 0; text-align: left; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding: 0 0 0 10pt; text-indent: -10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Balance
    at March 1, 2017</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-align: right; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD><TD STYLE="padding: 0; font: bold 10pt Times New Roman, Times, Serif; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-align: right; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD><TD STYLE="padding: 0; font: bold 10pt Times New Roman, Times, Serif; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-align: right; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD><TD STYLE="padding: 0; font: bold 10pt Times New Roman, Times, Serif; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-align: right; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,907,470</FONT></TD><TD STYLE="padding: 0; font: bold 10pt Times New Roman, Times, Serif; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-align: right; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3,082,020</FONT></TD><TD STYLE="padding: 0; font: bold 10pt Times New Roman, Times, Serif; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-align: right; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4,989,490</FONT></TD><TD STYLE="padding: 0; font: bold 10pt Times New Roman, Times, Serif; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; padding: 0 0 0 10pt; text-indent: -10pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Reclassification
    between different investment type (c)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3,079,715</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3,079,715</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; padding: 0 0 0 10pt; text-indent: -10pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Transfer
    out of fair value leveling since recorded as cost method (c)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3,079,715</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3,079,715</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; padding: 0 0 0 10pt; text-indent: -10pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Change
    in unrealized depreciation</FONT></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: right; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD><TD STYLE="padding: 0; text-align: left; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: right; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD><TD STYLE="padding: 0; text-align: left; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: right; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD><TD STYLE="padding: 0; text-align: left; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: right; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(836,530</FONT></TD><TD STYLE="padding: 0; text-align: left; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</FONT></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: right; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2,305</FONT></TD><TD STYLE="padding: 0; text-align: left; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</FONT></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: right; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(838,835</FONT></TD><TD STYLE="padding: 0; text-align: left; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding: 0 0 0 10pt; text-indent: -10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Balance
    at December 31, 2017</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 4pt double; font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD><TD STYLE="border-bottom: Black 4pt double; font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-align: right; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD><TD STYLE="padding: 0; font: bold 10pt Times New Roman, Times, Serif; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 4pt double; font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD><TD STYLE="border-bottom: Black 4pt double; font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-align: right; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD><TD STYLE="padding: 0; font: bold 10pt Times New Roman, Times, Serif; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 4pt double; font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD><TD STYLE="border-bottom: Black 4pt double; font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-align: right; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD><TD STYLE="padding: 0; font: bold 10pt Times New Roman, Times, Serif; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 4pt double; font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD><TD STYLE="border-bottom: Black 4pt double; font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-align: right; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,070,940</FONT></TD><TD STYLE="padding: 0; font: bold 10pt Times New Roman, Times, Serif; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 4pt double; font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD><TD STYLE="border-bottom: Black 4pt double; font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-align: right; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD><TD STYLE="padding: 0; font: bold 10pt Times New Roman, Times, Serif; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 4pt double; font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD><TD STYLE="border-bottom: Black 4pt double; font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-align: right; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,070,940</FONT></TD><TD STYLE="padding: 0; font: bold 10pt Times New Roman, Times, Serif; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; padding: 0 0 0 10pt; text-indent: -10pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Net
    change in unrealized depreciation relating to investments still held at December 31, 2017</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(836,530</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(836,530</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</FONT></TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"></TD><TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a.</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Upon
                                         the effective date of the change in status, March 1, 2017, the subsidiaries were no longer
                                         recognized at fair value and were instead consolidated when preparing the financial statements.</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"></TD><TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">b.</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                         equity investments of common stock and preferred stock were non-marketable investments
                                         under cost method upon change in status. Subsequently, Athenex Inc. was listed on the
                                         NASDAQ stock exchange on June 14, 2017 and common stock with an amount of $7,920,000
                                         has been transferred to common stock in Level 1 with amount of $7,920,000, which was
                                         subsequently sold in December 2017 with a gain from the marketable securities of $3,722,234
                                         recognized.</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"></TD><TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">c.</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><P STYLE="margin: 0pt 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">On
                                         March 9, 2017, the convertible promissory notes (including its accrued interest, totally
                                         $520,822) of Centrexion Therapeutics Corporation was converted into preferred stock (Series
                                         C) of the same company. On May 25, 2017, the convertible promissory notes (including
                                         its accrued interest, totaling $2,558,893) of Alzheon Inc., was converted into preferred
                                         stock (Series B) of the same company. The preferred stocks are considered non-marketable
                                         investments and were therefore reclassified out of the fair value hierarchy to be reported
                                         under cost method.</FONT></P></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Page; Sequence: 201; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->42<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt; font: 10pt Times New Roman, Times, Serif"><A HREF="#toc">Table of Contents</A>&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>APTORUM
GROUP LIMITED</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS (SUCCESSOR BASIS)</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(Stated
in U.S. Dollars)</B></FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table presents the quantitative information about the Group&rsquo;s Level 3 fair value measurements of investment as
of December 31, 2017, which utilized significant unobservable internally-developed inputs:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom; background-color: White; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 13%; padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="width: 1%; padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 17%; text-align: center; border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Valuation
    technique</B></FONT></TD><TD STYLE="width: 1%; font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 20%; font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-align: center; border-bottom: Black 1.5pt solid; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Unobservable
    input</FONT></TD><TD STYLE="width: 1%; padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 20%; border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><P STYLE="margin-top: 0; margin-bottom: 0; text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Range</B></FONT></P> <P STYLE="margin-top: 0; margin-bottom: 0; text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(weighted
                                         average)</B></FONT></P></TD><TD STYLE="width: 1%; font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 26%; font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-align: center; border-bottom: Black 1.5pt solid; text-indent: 0"><P STYLE="margin-top: 0; margin-bottom: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Sensitivity
                                         of fair</FONT></P>
                                                                                <P STYLE="margin-top: 0; margin-bottom: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">value
                                         to input</FONT></P></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; vertical-align: top; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Warrants</FONT></TD><TD STYLE="text-align: left; vertical-align: top; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; vertical-align: top; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Black-Scholes
    Model</FONT></TD><TD STYLE="text-align: left; vertical-align: top; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; vertical-align: top; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Estimated
    time to exit Historical Volatility</FONT></TD><TD STYLE="text-align: left; vertical-align: top; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; vertical-align: top; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10-54
    months 123% - 131% &nbsp;</FONT></TD><TD STYLE="text-align: left; vertical-align: top; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; vertical-align: top; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10%
    increase (decrease) in volatility would result in increase (decrease) in fair value by $122,664</FONT></TD></TR>
</TABLE>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Warrants</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of December 31, 2017, the volume of the Group&rsquo;s derivative activities based on their notional amount and number of contracts,
categorized by primary underlying risk, are as follows:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: center; padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></TD>
    <TD COLSPAN="6" STYLE="text-align: center; border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Long
    Exposure</B></FONT></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></TD></TR>
<TR STYLE="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></TD>
    <TD COLSPAN="6" STYLE="text-align: center; border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>December
    31, 2017</B></FONT></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></TD></TR>
<TR STYLE="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Primary
    underlying risk</FONT></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Notional
    Amounts</FONT></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Number
    of Contracts</FONT></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 76%; font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Equity
    Price</FONT></TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="width: 9%; text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="width: 1%; text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="width: 9%; text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="width: 1%; text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Warrants</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,261,530</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,338,290</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
</TABLE>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table identifies the fair value amounts of derivative instruments included in the statement of financial condition as
derivative contracts, categorized by primary underlying risk, at December 31, 2017. The following table also identifies the net
gain and loss amounts included in the statements of operations as net unrealized gain from derivative contracts, categorized by
primary underlying risk, for the period March 1, 2017 through December 31, 2017:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></TD>
    <TD COLSPAN="14" STYLE="text-align: center; border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>March
    1, 2017 through December 31, 2017</B></FONT></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></TD></TR>
<TR STYLE="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: center; border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Primary
    underlying risk</FONT></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Derivative
    </FONT><FONT STYLE="font-family: Times New Roman, Times, Serif"><BR><FONT STYLE="font-size: 10pt">assets</FONT></FONT></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Derivative
    </FONT><FONT STYLE="font-family: Times New Roman, Times, Serif"><BR><FONT STYLE="font-size: 10pt">liabilities</FONT></FONT></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Realized
    </FONT><FONT STYLE="font-family: Times New Roman, Times, Serif"><BR><FONT STYLE="font-size: 10pt">loss</FONT></FONT></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Unrealized
    </FONT><FONT STYLE="font-family: Times New Roman, Times, Serif"><BR><FONT STYLE="font-size: 10pt">loss</FONT></FONT></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 52%; font: bold 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Equity
    Price</FONT></TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="width: 9%; text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="width: 1%; text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="width: 9%; text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="width: 1%; text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="width: 9%; text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="width: 1%; text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="width: 9%; text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="width: 1%; text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Warrants</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,095,122</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(7,094</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(820,407</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</FONT></TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>18.&nbsp;OTHER
RECEIVABLES AND PREPAYMENTS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other
receivables and prepayments as of December 31, 2017 consisted of:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><P STYLE="margin-top: 0; margin-bottom: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>December&nbsp;31,</B></FONT></P>
                                                                                <P STYLE="margin-top: 0; margin-bottom: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>2017</B></FONT></P></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></TD></TR>
<TR STYLE="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 88%; text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Prepaid
    insurance</FONT></TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD><TD STYLE="width: 9%; text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">107,842</FONT></TD><TD STYLE="width: 1%; text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Prepaid
    service fee</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">91,002</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Rental
    deposits</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">61,333</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Prepaid
    rental expenses</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">11,910</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Others</FONT></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: right; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">38,243</FONT></TD><TD STYLE="padding: 0; text-align: left; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD><TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: right; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">310,330</FONT></TD><TD STYLE="padding: 0; text-align: left; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 202; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->43<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt; font: 10pt Times New Roman, Times, Serif"><A HREF="#toc">Table of Contents</A>&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>APTORUM
GROUP LIMITED</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS (SUCCESSOR BASIS)</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(Stated
in U.S. Dollars)</B></FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>19.
EQUIPMENT, NET</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Equipment
as of December 31, 2017 consisted of:&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><P STYLE="margin-top: 0; margin-bottom: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>December&nbsp;31,</B></FONT></P>
                                                                                <P STYLE="margin-top: 0; margin-bottom: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>2017</B></FONT></P></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></TD></TR>
<TR STYLE="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 88%; text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Computer
    equipment</FONT></TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD><TD STYLE="width: 9%; text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">14,057</FONT></TD><TD STYLE="width: 1%; text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Laboratory
    equipment</FONT></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: right; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">339,000</FONT></TD><TD STYLE="padding: 0; text-align: left; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">353,057</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Less:
    accumulated depreciation</FONT></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: right; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6,470</FONT></TD><TD STYLE="padding: 0; text-align: left; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Equipment,
    net</FONT></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD><TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: right; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">346,587</FONT></TD><TD STYLE="padding: 0; text-align: left; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Depreciation
expenses for equipment amounted to $6,470 for the period from March 1, 2017 through December 31, 2017.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>20.
INTANGIBLE ASSETS, NET</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><P STYLE="margin-top: 0; margin-bottom: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>December&nbsp;31,</B></FONT></P>
                                                                                <P STYLE="margin-top: 0; margin-bottom: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>2017</B></FONT></P></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Gross
    carrying amount</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 88%; text-align: left; text-indent: 0; padding: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Prepaid
    unpatented license</FONT></TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD><TD STYLE="width: 9%; text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">200,000</FONT></TD><TD STYLE="width: 1%; text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Prepaid
    patented licenses</FONT></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: right; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,325,140</FONT></TD><TD STYLE="padding: 0; text-align: left; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-indent: 0; padding: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,525,140</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: 0; padding: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Less:
    accumulated amortization</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Prepaid
    patented licenses</FONT></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: right; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">52,433</FONT></TD><TD STYLE="padding: 0; text-align: left; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-indent: 0; padding: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">52,433</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: 0; padding: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Intangible
    assets, net</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: 0; padding: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Prepaid
    unpatented license</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">200,000</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Prepaid
    patented licenses</FONT></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: right; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,272,707</FONT></TD><TD STYLE="padding: 0; text-align: left; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD><TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: right; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,472,707</FONT></TD><TD STYLE="padding: 0; text-align: left; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.8pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of December 31, 2017, the Group entered into seven exclusive license agreements with third-party licensors, for seven patented
and one unpatented technologies in the areas of neurology, infectious diseases, gastroenterology, oncology, surgical robotics
and natural health. Pursuant to the license agreements, the Group paid upfront payments and became the exclusive licensee to prosecute
certain patents developed or licensed under the applicable agreements.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Group recognized the prepaid unpatented
license to reflect the fair value of the subsidiaries as of the date of the change in status from an investment company. The Group
capitalizes the prepaid patented license for the exclusive rights with completed filing of patents in certain jurisdictions (e.g.,
the United States of America and Europe) and alternative future uses.</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Prepaid
unpatented license is indefinite-lived intangible assets which are tested for impairment annually. Prepaid patented licenses are
finite-lived intangible assets which are amortized over their estimated useful life. Amortization expenses for finite-lived intangible
assets amounted to $52,433 for the period March 1, 2017 through December 31, 2017.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Group expects amortization expense related to its finite-lived intangible assets for the next five years and thereafter to be
as follows as of December 31, 2017:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>For
    the years ending December 31,</B></FONT></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Amount</B></FONT></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 88%; text-align: left; text-indent: 0; padding: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2018</FONT></TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD><TD STYLE="width: 9%; text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">105,139</FONT></TD><TD STYLE="width: 1%; text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: 0; padding: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2019</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">102,820</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: 0; padding: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2020</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">102,820</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: 0; padding: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2021</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">102,820</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: 0; padding: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2022</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">102,820</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="padding: 0; text-indent: 0; text-align: left; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Thereafter</FONT></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: right; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">756,288</FONT></TD><TD STYLE="padding: 0; text-align: left; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="padding: 0; text-indent: 0; text-align: left; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total</FONT></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD><TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: right; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,272,707</FONT></TD><TD STYLE="padding: 0; text-align: left; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<!-- Field: Page; Sequence: 203; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->44<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt; font: 10pt Times New Roman, Times, Serif"><A HREF="#toc">Table of Contents</A>&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>APTORUM
GROUP LIMITED</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS (SUCCESSOR BASIS)</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(Stated
in U.S. Dollars)</B></FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>21.
LONG-TERM DEPOSITS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Long-term
deposits as of December 31, 2017 consisted of:&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>December&nbsp;31,
    2017</B></FONT></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 88%; text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Rental
    deposit</FONT></TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD><TD STYLE="width: 9%; text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">20,092</FONT></TD><TD STYLE="width: 1%; text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Deposits
    for equipment</FONT></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: right; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,737,664</FONT></TD><TD STYLE="padding: 0; text-align: left; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD><TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: right; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,757,756</FONT></TD><TD STYLE="padding: 0; text-align: left; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>22.
ACCOUNTS PAYABLE AND ACCRUED EXPENSES</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accounts
payable and accrued expenses as of December 31, 2017 consisted of:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>December&nbsp;31,
    2017</B></FONT></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 88%; text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">License
    agreements payable</FONT></TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD><TD STYLE="width: 9%; text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">356,410</FONT></TD><TD STYLE="width: 1%; text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Research
    and development expenses payable</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">104,013</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Professional
    fees payable</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">154,429</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Others</FONT></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: right; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">38,496</FONT></TD><TD STYLE="padding: 0; text-align: left; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD><TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: right; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">653,348</FONT></TD><TD STYLE="padding: 0; text-align: left; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>23.
INCOME TAXES</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The&nbsp;Company
and&nbsp;its subsidiaries file tax returns separately.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Income
taxes</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cayman
Islands: under the current laws of the Cayman Islands, the Company and its subsidiaries in the Cayman Islands are not subject
to taxes on their income and capital gains.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Hong
Kong: in accordance with the relevant tax laws and regulations of Hong Kong, a company registered in the Hong Kong is subject
to income taxes within Hong Kong at the applicable tax rate on taxable income. All the Hong Kong subsidiaries that are not entitled
to any tax holiday were subject to income tax at a rate of 16.5%. The subsidiaries in Hong Kong did not have assessable profits
that were derived Hong Kong during the period March 1, 2017 through December 31, 2017. Therefore, no Hong Kong profit tax has
been provided for in the period presented.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Macao:
Taxpayers in Macao are divided into Group A and Group B, Group A taxpayers are companies that have maintained proper accounting
books and records, with capital of MOP1,000,000 and above or average assessed annual taxable profits in the past three years of
more than MOP500,000, those who do not meet the criteria of Group A taxpayers are assigned to Group B. Group B taxpayers are assessed
by the Macao Finance Bureau on a deemed profit basis, and Group B taxpayers are unable to carry forward tax losses. The capital
of the subsidiary in Macao is MOP100,000 and it is assigned to Group B taxpayer. The tax loss of subsidiary in Macao cannot be
utilized.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<!-- Field: Page; Sequence: 204; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->45<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt; font: 10pt Times New Roman, Times, Serif"><A HREF="#toc">Table of Contents</A>&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>APTORUM
GROUP LIMITED</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS (SUCCESSOR BASIS)</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(Stated
in U.S. Dollars)</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
components of the provision for income taxes expenses are:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>March
    1, 2017 through </B></FONT><FONT STYLE="font-family: Times New Roman, Times, Serif"><BR> <FONT STYLE="font-size: 10pt"><B>December&nbsp;31,
    2017</B></FONT></FONT></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 88%; text-indent: 0; padding: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Current</FONT></TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD><TD STYLE="width: 9%; text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;-</FONT></TD><TD STYLE="width: 1%; text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Deferred</FONT></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: right; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD><TD STYLE="padding: 0; text-align: left; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total
    income taxes expense</FONT></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD><TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: right; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD><TD STYLE="padding: 0; text-align: left; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
</TABLE>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
reconciliation of income taxes expenses computed at the Hong Kong statutory tax rate applicable to income tax expense is as follows:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>March
    1, 2017 through December 31, 2017</B></FONT></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 88%; text-align: left; text-indent: 0; padding: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Net
    loss before tax</FONT></TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD><TD STYLE="width: 9%; text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2,561,507</FONT></TD><TD STYLE="width: 1%; text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-indent: 0; padding: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: 0; padding: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Provision
    for income taxes at Hong Kong statutory income tax rate (16.5%)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(422,649</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: 0; padding: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Impact
    of different tax rates in other jurisdictions</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">393,217</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Change
    in valuation allowance</FONT></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: right; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">29,432</FONT></TD><TD STYLE="padding: 0; text-align: left; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Effective
    income tax expense</FONT></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD><TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: right; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD><TD STYLE="padding: 0; text-align: left; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
</TABLE>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Deferred
tax asset, net</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Deferred
tax assets and deferred tax liabilities reflect the tax effects of temporary differences between the carrying amounts of assets
and liabilities for financial reporting purpose and the tax bases used for income tax purpose. The following represents the tax
effect of each major type of temporary difference.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>March
    1, 2017 through December 31, 2017</B></FONT></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 88%; text-align: left; text-indent: 0; padding: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Tax
    loss carry forward</FONT></TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD><TD STYLE="width: 9%; text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">29,432</FONT></TD><TD STYLE="width: 1%; text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Valuation
    allowance</FONT></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: right; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(29,432</FONT></TD><TD STYLE="padding: 0; text-align: left; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Deferred
    taxes assets, net</FONT></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD><TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: right; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD><TD STYLE="padding: 0; text-align: left; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
</TABLE>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of December 31, 2017, the Group had net operating loss carry-forwards of $178,378 from its Hong Kong operations, which are available
to reduce future taxable income; and all of these losses can be carried forward indefinitely.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Valuation
allowance was provided against deferred tax assets in entities where it was determined, it was more likely than not that the benefits
of the deferred tax assets will not be realized. The Group had deferred tax assets which consisted of tax loss carry forward,
which can be carried forward to offset future taxable income. The Group maintains a full valuation allowance on its net deferred
tax assets. The management determines it is more likely than not that all of its deferred tax assets will not be utilized. The
valuation allowance increased by $29,432 for the period March 1, 2017 through December 31, 2017.<B>&#9;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<!-- Field: Page; Sequence: 205; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->46<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt; font: 10pt Times New Roman, Times, Serif"><A HREF="#toc">Table of Contents</A>&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>APTORUM
GROUP LIMITED</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS (SUCCESSOR BASIS)</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(Stated
in U.S. Dollars)</B></FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>24.
RELATED PARTY BALANCES AND TRANSACTIONS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following is a list of a director and related parties to which the Group has transactions with:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"></TD><TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ian
                                         Huen, the Chief Executive Officer and Executive Director of the Group;</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"></TD><TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">AENEAS
                                         CAPITAL LIMITED, an entity controlled by Ian Huen;</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"></TD><TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Aeneas
                                         Limited, formerly known as Aptus Financial Holdings Limited, an entity controlled by
                                         Ian Huen;</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"></TD><TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Aeneas
                                         Group Limited, formerly known as Aptus Asia Financial Holdings Limited, an entity controlled
                                         by Ian Huen.</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"></TD><TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Jurchen
                                         Investment Corporation, the holding company and an entity controlled by Ian Huen.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Amounts
due from related parties</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Amounts
due from related parties consisted of the following as of December 31, 2017:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><P STYLE="margin-top: 0; margin-bottom: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>December&nbsp;31,</B></FONT></P>
                                                                                <P STYLE="margin-top: 0; margin-bottom: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>2017</B></FONT></P></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 88%; text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">AENEAS
    CAPITAL LIMITED (b)</FONT></TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD><TD STYLE="width: 9%; text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">106,942</FONT></TD><TD STYLE="width: 1%; text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Aeneas
    Limited (c)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">190,427</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Aeneas
    Group Limited (d)</FONT></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: right; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">7,451</FONT></TD><TD STYLE="padding: 0; text-align: left; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total</FONT></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD><TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: right; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">304,820</FONT></TD><TD STYLE="padding: 0; text-align: left; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Amount
due to a related party</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Amount
due to a related party consisted of the following as of December 31, 2017:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><P STYLE="margin-top: 0; margin-bottom: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>December&nbsp;31,</B></FONT></P>
                                                                                <P STYLE="margin-top: 0; margin-bottom: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>2017</B></FONT></P></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 88%; text-align: left; padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">AENEAS
    CAPITAL LIMITED (b)</FONT></TD><TD STYLE="width: 1%; padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD><TD STYLE="width: 9%; border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: right; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">197,386</FONT></TD><TD STYLE="width: 1%; padding: 0; text-align: left; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total</FONT></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD><TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: right; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">197,386</FONT></TD><TD STYLE="padding: 0; text-align: left; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Related
party transactions</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Related
party transactions consisted of the following for the period March 1, 2017 through December 31, 2017:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><P STYLE="margin-top: 0; margin-bottom: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>March
                                         1,</B></FONT></P>
                                                                                <P STYLE="margin-top: 0; margin-bottom: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>2017
                                         through December&nbsp;31, 2017</B></FONT></P></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
    borrowing from a related party (Note I)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 88%; text-align: left; padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-
    Ian Huen (a)</FONT></TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD><TD STYLE="width: 9%; text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6,410</FONT></TD><TD STYLE="width: 1%; text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-indent: 0; padding: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: 0; padding: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Payments
    on behalf of the Group (Note II)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-
    AENEAS CAPITAL LIMITED (b)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">64,038</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-indent: 0; padding: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: 0; padding: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Expense
    reimbursement (Note II)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding-top: 0; padding-right: 0; padding-bottom: 0">-
AENEAS CAPITAL LIMITED (b)</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">66,881</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-indent: 0; padding: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: 0; padding: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Payments
    on behalf of related parties (Note III)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: 0; padding: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-
    Aeneas Limited (c)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">132,074</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: 0; padding: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-
    Aeneas Group Limited (d)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,853</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: 0; padding: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-
    AENEAS CAPITAL LIMITED (b)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">109,025</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-indent: 0; padding: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: 0; padding: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Management
    and administrative fees (Note IV)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: 0; font: 10pt Times New Roman, Times, Serif; padding: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-
    AENEAS CAPITAL LIMITED (b)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">640,932</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
</TABLE>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Page; Sequence: 206; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->47<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt; font: 10pt Times New Roman, Times, Serif"><A HREF="#toc">Table of Contents</A>&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>APTORUM
GROUP LIMITED</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS (SUCCESSOR BASIS)</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(Stated
in U.S. Dollars)</B></FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Note
I: The non-interest-bearing loan was borrowed from management for operation purpose and the loan was due on demand.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Note
II: AENEAS CAPITAL LIMITED has paid the audit fee and legal fee on behalf of the Group and received the expense reimbursement.
Some of the amounts were repaid during the periods. The balances were non-interest bearing.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Note
III: The Group has paid the expenses on behalf of Aeneas Limited and Aeneas Group Limited, of which the whole amounts have not
been repaid and were non-interest bearing.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Note
IV: AENEAS CAPITAL LIMITED provides certain management and administrative services to the Group. For the period March 1, 2017
through December 31, 2017, AENEAS CAPITAL LIMITED was entitled to receive a fixed amount of administrative fees of HKD500,000
(approximately $64,103) per calendar month.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
November 11, 2017, the Group sold 100% of the ownership of Aeneas Limited and its subsidiary, Aeneas Group Limited, to Jurchen
Investment Corporation for cash proceeds of $1. The Group recognized a gain on disposal of entity under common control of $67,874,
net of net liabilities of Aeneas Limited and its subsidiary of $67,873 in consolidated statement of shareholders&rsquo; equity.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>25.
<FONT STYLE="text-transform: uppercase">CONVERTIBLE PROMISSORY NOTES</FONT></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of December 31, 2017, the Group issued an aggregated amounted of $480,000 of convertible promissory notes (the &ldquo;Notes&rdquo;).
The Notes will be redeemed by the Group on the earlier of (i) the twelve months anniversary of the issuance date; and (ii) the
date that the Group redeems the Notes if it has not consummated the Initial Public Offering (the &ldquo;IPO&rdquo;) within twelve
months of the issuance date. Interest on the Notes is accrued at a rate of 1% per annum and shall be compounded annually.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Notes are convertible into the Class A Ordinary Shares of the Company at a price of 56% discount to the actual price per Class
A Ordinary Share to be issued in the IPO at the time that the Group consummates an initial closing of the IPO.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>26.
ORDINARY SHARES</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">According
to the Restructuring Plan, the ten management shares of par value of $0.01 have been cancelled, and the 256,571 issued participating
shares of par value of $0.01 have been compulsorily redeemed and 4,743,419 unissued participating shares of par value of $0.01
each have been cancelled. Meanwhile, the Company has an authorized share capital consisting of 100,000,000 ordinary shares (the
&ldquo;Ordinary Shares&rdquo;), par value $1.00 per share, and 25,657,110 shares was issued to the original investors.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
the period March 1, 2017 through October 13, 2017, 2,207,025 of the Company&rsquo;s Ordinary Shares were issued at a price of
$3.90 per share.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
October 13, 2017, a resolution was passed at a general meeting of the Company that: (i) 72,135,865 of authorized but unissued
Ordinary Shares of the Company were replaced with 54,573,619 Class A ordinary shares (the &ldquo;Class A Ordinary Shares&rdquo;)
of par value of $1.00 per share and 17,562,246 Class B ordinary shares (the &ldquo;Class B Ordinary Shares&rdquo;) of par value
of $1.00 per share, respectively; (ii) 24,930,839 issued Ordinary Shares, which were issued to three shareholders, were converted
into 2,493,085 Class A Ordinary Shares of par value of $1.00 per share and 22,437,754 Class B Ordinary Shares of par value of
$1.00 per share; and (iii) 2,933,296 issued Ordinary Shares, which were issued to 24 shareholders, were converted into 2,933,296
Class A Ordinary Shares of par value of $1.00 per share.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Holders
of Class A Ordinary Shares and Class B Ordinary Shares have the same rights except for the following: (i) each Class A Ordinary
Share is entitled to one vote while each Class B Ordinary Share is entitled to ten votes; and (ii) each Class B Ordinary Share
is convertible into one Class A Ordinary Share at any time while Class A Ordinary Shares are not convertible under any circumstances.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<!-- Field: Page; Sequence: 207; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->48<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt; font: 10pt Times New Roman, Times, Serif"><A HREF="#toc">Table of Contents</A>&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>APTORUM
GROUP LIMITED</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS (SUCCESSOR BASIS)</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(Stated
in U.S. Dollars)</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
total of 5,500,000 Class A Ordinary Shares (subject to subsequent adjustments described more fully below) may be issued pursuant
to awards under the 2017 Omnibus Incentive Plan (the &ldquo;2017 Share Option Plan&rdquo;). Subsequent adjustments include that
on each January 1, starting with January 1, 2020, an additional number of shares equal to the lesser of (i) 2% of the outstanding
number of Class A Ordinary Shares (on a fully diluted basis) on the immediate preceding December 31, and (ii) such lower number
of Class A Ordinary Shares as may be determined by the board of directors, subject in all cases to adjustments as provided in
Section 10 of the 2017 Share Option Plan. Awards will be made pursuant to agreements and may be subject to vesting and other restrictions
as determined by the board of directors. As of December 31, 2017, 5,500,000 shares were available for future grant under the 2017
Share Option Plan.&#9;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>27.
NON-CONTROLLING INTEREST</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of December 31, 2017, non-controlling interest related to the 1% minority interest in APTUS BIOTECHNOLOGY (MACAO) LIMITED and
10% minority interest in mTOR (Hong Kong) Limited in the consolidated balance sheet was $14,045 in total.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
the period March 1, 2017 through December 31, 2017, non-controlling interest related to APTUS BIOTECHNOLOGY (MACAO) LIMITED and
mTOR (Hong Kong) Limited in the consolidated statements of operations was loss of $14,045 in total.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>28.
NET LOSS PER SHARE</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 30pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table sets forth the computation of basic and diluted loss per share:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><P STYLE="margin-top: 0; margin-bottom: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>March
1,</B></FONT></P>
                                                                                                                                                       <P STYLE="margin-top: 0; margin-bottom: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>2017</B></FONT></P>
                                                                                <P STYLE="margin-top: 0; margin-bottom: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>through
                                         December&nbsp;31,</B></FONT></P>
                                                                                <P STYLE="margin-top: 0; margin-bottom: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>2017</B></FONT></P></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Numerator:</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 88%; text-align: left; padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Net
    loss attributable to Aptorum Group Limited</FONT></TD><TD STYLE="width: 1%; padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD><TD STYLE="width: 9%; border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: right; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2,547,462</FONT></TD><TD STYLE="width: 1%; padding: 0; text-align: left; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Denominator:</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Basic
    and diluted weighted average common shares outstanding</FONT></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: right; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">26,963,435</FONT></TD><TD STYLE="padding: 0; text-align: left; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-indent: 0; font: 10pt Times New Roman, Times, Serif; padding: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Basic
    and diluted loss per share</FONT></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD><TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: right; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(0.09</FONT></TD><TD STYLE="padding: 0; text-align: left; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</FONT></TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>29.
PRINCIPAL RISK</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-variant: small-caps"><B><I><U>MARKET
RISK</U></I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Market
risk is the risk that the fair value or future cash flows of a financial instrument will fluctuate because of changes in market
variables such as interest rate, foreign exchange rates and equity prices.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
maximum risk resulting from financial instruments equals their fair value.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>(a)
Interest rate risk</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Interest
rate risk arises from the possibility that changes in interest rates will affect future cash flows or the fair values of financial
instruments.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Interest
rate risk sensitivity analysis</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Group&rsquo;s cash held with the Cash Custodian and the Custodian are exposed to interest rate risk. However, Management considers
the risk to be minimal as they are short-term with terms less than one month.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>(b)
Currency risk</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Currency
risk is the risk that the value of financial assets or liabilities will fluctuate due to changes in foreign exchange rates.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<!-- Field: Page; Sequence: 208; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->49<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt; font: 10pt Times New Roman, Times, Serif"><A HREF="#toc">Table of Contents</A>&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>APTORUM
GROUP LIMITED</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS (SUCCESSOR BASIS)</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(Stated
in U.S. Dollars)</B></FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Currency
risk sensitivity analysis </I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">At
December 31, 2017, the Group has no significant foreign currency risk because its business is principally conducted in Hong Kong
and most of the transactions are denominated in Hong Kong dollar. Since the Hong Kong dollar is pegged to the United States dollar,
the Group&rsquo;s exposure to foreign currency risk in respect of the balances denominated in Hong Kong dollars is considered
to be minimal.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>(c)
Equity price risk</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Equity
price risk is the risk of unfavorable changes in the fair values of equities or equity-linked derivatives as the result of changes
in the levels of equity indices and the value of individual shares. The Group has been exposed to price risk on all of its equities
investments and equities-linked derivatives.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Management&rsquo;s
best estimate of the effect on net assets and profit due to a reasonably possible change of relevant benchmarks, with all other
variables held constant is as follows. In practice, the actual trading results may differ from the sensitivity analysis below
and the difference could be material.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-variant: small-caps"><B><I><U>LIQUIDITY
RISK</U></I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Liquidity
risk is the risk that the Group will encounter difficulty in raising funds to meet commitments associated with financial assets
and liabilities. Liquidity risk may result from an inability to sell a financial asset quickly at an amount close to its fair
value.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Group invests in private equities which are generally unquoted and not readily marketable. The Group manages its liquidity risk
by setting investment limits on unlisted securities that cannot be readily disposed of. Investment of the Group&rsquo;s assets
in unquoted securities may restrict the ability of the Group to dispose of its investment at a price and time it wishes to do
so.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-variant: small-caps"><B><I><U>CREDIT
RISK</U></I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-variant: small-caps"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Financial
assets which potentially subject the Group to concentrations of credit risk consist principally of bank deposits and balances,
assets held with the Custodian/Prime Broker, derivatives where the brokers are the counterparty and the Group&rsquo;s debt securities
investments.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Custodian/Prime Broker provides the clearing and depository operations for the Group&rsquo;s security transactions. The Custodian/Prime
Broker also provides loans and financing to the Group and assets held by the Custodian/Prime Brokers will be charged as a continuing
security for the payment and discharge of all liabilities of the Group.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Group is also exposed to credit risk on the cash held with the Custodian/Prime Broker amounting to $122,127 as of December 31,
2017. The credit rating ascribed by Standard and Poor&rsquo;s to Credit Suisse as of December 31, 2017 was A.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Furthermore,
the Group takes on exposure to credit risk on cash balances held with DBS Bank Ltd, Hong Kong Branch, Industrial and Commercial
Bank of China (Macao) Limited and Bank of China (Hong Kong) Limited for the purposes of payments of Group expenses.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">All
transactions in listed securities are settled or paid for upon delivery using approved and reputable brokers. The risk of default
is considered minimal, as delivery of securities sold is only made when the broker has received payment. Payment is made on a
purchase when the securities have been received by the broker. The trade will fail if either party fails to meet its obligation.
The Group limits its exposure to credit risk by transacting all of its securities and contractual commitment activities with broker-dealers,
banks and regulated exchanges with high credit ratings and that the Group considers to be well established.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<!-- Field: Page; Sequence: 209; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->50<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt; font: 10pt Times New Roman, Times, Serif"><A HREF="#toc">Table of Contents</A>&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>APTORUM
GROUP LIMITED</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS (SUCCESSOR BASIS)</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(Stated
in U.S. Dollars)</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-variant: small-caps"><B><I><U>CONCENTRATION
RISK</U></I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-variant: small-caps"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
table below analyses the Group&rsquo;s concentration of equity price risk by distribution:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>December&nbsp;31,
    </B></FONT><FONT STYLE="font-family: Times New Roman, Times, Serif"><BR><FONT STYLE="font-size: 10pt"><B>2017</B></FONT></FONT></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: italic bold 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Country
    and Region</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 88%; text-align: left; padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">United
    States of America</FONT></TD><TD STYLE="width: 1%; padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD><TD STYLE="width: 9%; border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: right; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10,462,483</FONT></TD><TD STYLE="width: 1%; padding: 0; text-align: left; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total</FONT></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD><TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: right; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10,462,483</FONT></TD><TD STYLE="padding: 0; text-align: left; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: italic bold 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Industry</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pharmaceutical
    and biotechnology</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10,443,175</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Healthcare</FONT></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: right; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">19,308</FONT></TD><TD STYLE="padding: 0; text-align: left; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total</FONT></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD><TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: right; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10,462,483</FONT></TD><TD STYLE="padding: 0; text-align: left; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-variant: small-caps"><B><I><U>INVESTMENTS
IN DERIVATIVES RISK </U></I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Warrants</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Since
warrants have a limited life, as the expiration date of a warrant approaches, the time value of a warrant will decline. In addition,
if the stock underlying the warrant declines in price, the intrinsic value of an &ldquo;in the money&rdquo; warrant will decline.
Further, if the price of the stock underlying the warrant does not exceed the strike price of the warrant on the expiration date,
the warrant will expire worthless. As a result, there is the potential for the Group to lose its entire investment in a warrant.
The Group is exposed to counterparty risk from the potential failure of an issuer to settle its exercised warrants. The maximum
risk of loss from counterparty risk to the Group is the fair value of the contracts and the purchase price of the warrants.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>30.
COMMITMENTS AND CONTINGENCIES</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Lease
Commitments</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
total future minimum lease payments under the non-cancellable operating leases with respect to the offices&nbsp;and the <FONT STYLE="background-color: white">laboratory
</FONT>as of December 31, 2017 are as follows:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>For
    the years ending December 31,</B></FONT></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Amount</B></FONT></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></TD></TR>
<TR STYLE="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 88%; text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2018</FONT></TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD><TD STYLE="width: 9%; text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">68,518</FONT></TD><TD STYLE="width: 1%; text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2019</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">55,632</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2020</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">54,885</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2021
    and thereafter</FONT></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: right; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD><TD STYLE="padding: 0; text-align: left; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="padding: 0; text-align: left; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total</FONT></TD><TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD><TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: right; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">179,035</FONT></TD><TD STYLE="padding: 0; text-align: left; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Rental
expenses for the year ended December 31, 2016, period January 1, 2017 through February 28, 2017 and March 1, 2017 through December
31, 2017 were $nil, $nil and $49,518, respectively.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Capital
Commitments</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Group has entered into agreements
with independent third parties for purchasing office and laboratory equipment. As of December 31, 2017, the Group had non-cancellable
purchase commitments of $1,756,560.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">The
Company has additional contingency payment obligations under each of the license agreements, such as milestone payments, royalties,
research and development funding, if certain condition or milestone is met. For the period March 1, 2017 through December 31, 2017,
the Company did not owe any milestone payments, royalties or research and development funding. As of December 31, 2017, no milestone
payments had been triggered under any of the existing license agreements.</FONT>&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 210; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->51<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt; font: 10pt Times New Roman, Times, Serif"><A HREF="#toc">Table of Contents</A>&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>APTORUM
GROUP LIMITED</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS (SUCCESSOR BASIS)</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(Stated
in U.S. Dollars)</B></FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>31.
SEGMENT REPORTING</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Group&rsquo;s chief operating decision maker, the Chief Executive Officer, reviews the consolidated results when making decisions
about allocating resources and accessing performance of the Group as a whole and hence, the Group has only one reportable segment.
The Group does not distinguish between markets or segments for the purpose of internal reporting. The Group&rsquo;s long-lived
assets are substantially all located in Hong Kong and substantially all of the Group&rsquo;s expense is derived from within Hong
Kong. Therefore, no geographical segments are presented.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>32.
SUBSEQUENT EVENTS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Group has evaluated subsequent events
through July 13, 2018, the date of issuance of the consolidated financial statements, and except for the following events with
material financial impact on the Group&rsquo;s consolidated financial statements, no other subsequent event is identified that
would have required adjustment or disclosure in the consolidated financial statements.</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
March 6, 2018, the Group established a subsidiary named Forum Property Holding Limited with a consideration of $0.01. On March
26, 2018, the Group established a subsidiary named APTORUM INTERNATIONAL LIMITED with a consideration of one British Pound. On
April 3, 2018, Aptorum Medical Limited issued 9,999 shares to the Company and 526 shares to a director of the Company, decreasing
the equity interest of the Company from 100% to 95%. On April 4, 2018, the Group established a subsidiary named Lanither Life
Sciences Limited with a consideration of $1. On May 18, 2018, Acticule issued 249,999 shares to a director of Acticule, decreasing
the equity interest of the Company from 100% to 80%. On May 25, 2018, the Group established a subsidiary named Lanither Life Sciences
(Hong Kong) Limited with a consideration of HKD1.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">From
January 2018 to the date of issuance of the consolidated financial statements, the Group has additionally issued $1,120,400 of
convertible promissory notes under the same terms as disclosed in Note 25, and as of the date of issuance of the consolidated
financial statements, $1,600,400 of convertible promissory notes were issued accumulatively.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
April 6, 2018, the Group has entered into a subscription agreement (the &ldquo;Bond Subscription Agreement&rdquo;) with Peace
Range Limited (&ldquo;Peace Range&rdquo;). Pursuant to the Bond Subscription Agreement, the Group issued Peace Range a $15,000,000
convertible bond (the &ldquo;Bond&rdquo; and the &ldquo;Bond Offering&rdquo;), minus a structuring fee equal to 2% of the principal
amount of the Bond, on April 25, 2018. The Group also agreed to pay certain expenses, up to an aggregate limit of $250,000, incurred
by Peace Range in connection with the Bond Offering. The closing of the transaction contemplated by the Bond Subscription Agreement
and the issuance of the Bond are subject to standard closing conditions, which may be satisfied or waived by the impacted party.
The Bond earns interest at the rate of 8% per annum, payable semi-annually. The payment of the Bond is guaranteed by the holding
company, Jurchen Investment Corporation. In addition, the repayment of the principal of the Bond and interest payables is secured
by a fund the Group set aside in a debt service reserve account, with the funds in the debt service reserve account to be released
in an amount pro rata to the principal amount of the Bond being converted. The Bond shall mature on the twelfth calendar month
following the issuance date, or with prior written consent of the holders of the Bond, the business day falling six calendar months
thereafter. 10% of the principal amount of the Bond shall be automatically converted into our Class A Ordinary Shares upon the
closing of this Offering and the rest of the Bond is convertible at the option of the holder commencing on the closing of this
Offering until the earlier of the date falling 12 calendar months after the maturity of the Bond and the date falling 12 calendar
months after the closing of this Offering. The Group closed the Bond Offering on April 25, 2018 and issued a Bond to Peace Range
pursuant to the Bond Subscription Agreement. The contingent beneficial conversion is contained in convertible bonds, which shall
not be recognized in earnings until the contingency event, initial closing of the IPO, is resolved.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">One of the underwriters in this Offering,
Boustead, also served as a placement agent for the Bond Offering and received (i) a cash success fee of $600,000 and (ii) warrants
to purchase a number of Class A Ordinary Shares equal to 5.5% of the number of Class A Ordinary Shares issuable upon conversion
of the Bond, at an exercise price equal to a 23% discount to this Offering price, subject to adjustment (the &ldquo;Bond PA Warrants&rdquo;).
The Bond PA Warrants are exercisable on a cashless basis. China Renaissance also served as a placement agent for the Bond Offering;
for such services, China Renaissance will receive a cash success fee of $150,000. Boustead also participated in the Series A Note
Offering as an investor with a purchase of Series A Notes in the amount of $150,000.</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 211; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->52<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt; font: 10pt Times New Roman, Times, Serif"><A HREF="#toc">Table of Contents</A>&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 0; margin-bottom: 0"><DIV STYLE="font-size: 1pt; border-top: Black 2pt solid; border-bottom: Black 1pt solid; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>



<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 2pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 2pt; text-align: center; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>[&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
] Class A Ordinary Shares</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 2pt"><FONT STYLE="font-family: Times New Roman, Times, Serif"><BR>
<BR>
<FONT STYLE="font-size: 10pt">&nbsp;</FONT></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 2pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Aptorum
Group Limited</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif"><BR>
<BR>
<BR>
<BR>
<BR>
<BR></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 0; margin-bottom: 0"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 2pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 2pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>PRELIMINARY
PROSPECTUS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 2pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 2pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 2pt; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B></B></FONT></P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 0; margin-bottom: 0"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 2pt; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 2pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 2pt"><FONT STYLE="font-family: Times New Roman, Times, Serif"><BR>
<BR>
<BR></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; text-align: left; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 33%; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><IMG SRC="img_017.jpg" ALT=""><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif"></FONT></TD>
    <TD STYLE="width: 34%; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 33%; text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><IMG SRC="img_018.jpg" ALT=""><FONT STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></FONT></TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 2pt"><FONT STYLE="font-family: Times New Roman, Times, Serif"><BR></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 2pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 2pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 0; margin-bottom: 0"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 2pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Through
and including [&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#9;], 2018 (the 25th day after the date of this prospectus), all dealers effecting
transactions in these securities, whether or not participating in this Offering, may be required to deliver a prospectus. This
is in addition to a dealer&rsquo;s obligation to deliver a prospectus when acting as an underwriter and with respect to their
unsold allotments or subscriptions.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B></B></FONT></P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 0; margin-bottom: 0"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid; border-bottom: Black 2pt solid; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 212 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt; font: 10pt Times New Roman, Times, Serif"><A HREF="#toc">Table of Contents</A>&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 2pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>PART
II</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 2pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 2pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>INFORMATION
NOT REQUIRED IN PROSPECTUS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 2pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Item
6. Indemnification of Directors, Officers and Employees.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 2pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cayman
Islands law does not limit the extent to which a company&rsquo;s memorandum and articles of association may provide for indemnification
of officers and directors, except to the extent any such provision may be held by the Cayman Islands courts to be contrary to
public policy, such as to provide indemnification against civil fraud or the consequences of committing a crime. Our Memorandum
and Articles permit indemnification of officers and directors for losses, damages, costs and expenses incurred in their capacities
as such unless such losses or damages arise from dishonesty of such directors or officers. This standard of conduct is generally
the same as permitted under the Delaware General Corporation Law for a Delaware corporation.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Insofar
as indemnification for liabilities arising under the Securities Act of 1933, as amended, or the Securities Act, may be permitted
to our directors, officers or persons controlling us under the foregoing provisions, we have been informed that in the opinion
of the Securities and Exchange Commission, or the SEC, such indemnification is against public policy as expressed in the Securities
Act and is therefore unenforceable.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Item
7. Recent Sales of Unregistered Securities.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 2pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
the past three years, we have issued the following securities. We believe that each of the following issuances was exempt from
registration under Section 4(a)(2) of the Securities Act regarding transactions not involving a public offering and/or Regulation
S promulgated thereunder regarding offshore offers and sales.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">On May 15, 2018, we closed
a private financing pursuant to a note purchase agreement with the Series A Note Investors who purchased an aggregate of approximately
$1.6 million of convertible notes, at a purchase price of $10,000 per note convertible into our Class A Ordinary Shares at a conversion
price of $[&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ] per share, which represents a 56% discount to this offering price the Series
A Notes. Boustead, who is an underwriter of this Offering, together with other affiliates of the Company, purchased Series A Notes
in the aggregate amount of $[ &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;]. We refer to the private placement transaction as the &ldquo;Series
A Note Offering&rdquo;. The Series A Note Investors entered into a lock-up agreement, pursuant to which they agreed not to sell
or otherwise transfer or dispose of the Series A Note or the Class A Ordinary Shares underlying the Series A Notes during the
six-month period commencing on the date of our Class A Ordinary Shares commence trading on a national securities exchange. The
Series A Notes will automatically convert into [&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ] Class A Ordinary Shares at the closing
of the Offering and at the commencement of trading on NASDAQ Global Market of our Class A Ordinary Shares. As a result, the investors
in this Offering will experience immediate dilution when the Series A Notes are automatically converted. (See Risk Factor &ndash;
&ldquo;You will experience immediate and substantial dilution as a result of this Offering and may experience additional dilution
in the future&rdquo;) The issuance and sale of Series A Notes, PA Warrants and the underlying Class A Ordinary Shares to the investors
and the placement agent in the Series A Note Offering was made in reliance on an exemption from registration contained in either
Regulation D or Regulation S of the Securities. The securities sold in the Series A Note Offering may be offered or sold only
pursuant to an effective registration statement or pursuant to an available exemption from the registration requirements of the
Securities Act.</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">On
April 6, 2018, we entered into subscription agreement with one investor pursuant to which we issued a $15,000,000 8% convertible
bond that matures in April 2019 (the &ldquo;Bond&rdquo;). The Bond is guaranteed by our parent company, Jurchen Investment Corporation.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<!-- Field: Page; Sequence: 213; Options: NewSection; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">II-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt; font: 10pt Times New Roman, Times, Serif"><A HREF="#toc">Table of Contents</A>&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Item
8. Exhibits and Financial Statement Schedules.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 2pt; text-align: justify; text-indent: 20.25pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
Exhibits</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 2pt; text-align: justify; text-indent: 20.25pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
exhibits of the registration statement are listed in the Exhibit Index to this registration statement and are incorporated herein
by reference.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 2pt; text-align: justify; text-indent: 20.25pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 2pt; text-align: justify; text-indent: 20.25pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
Financial Statement Schedules</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 2pt; text-align: justify; text-indent: 20.25pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Schedules
have been omitted because the information required to be set forth therein is not applicable or is shown in the financial statements
or consolidated financial statements or the notes thereto.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 2pt; text-align: justify; text-indent: 20.25pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Item
9. Undertakings.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
undersigned registrant hereby undertakes to provide to the underwriters at the closing specified in the underwriting agreements,
certificates in such denominations and registered in such names as required by the underwriters to permit prompt delivery to each
purchaser.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 2pt; text-align: justify; text-indent: 20.25pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Insofar
as indemnification for liabilities arising under the Securities Act may be permitted to directors, officers and controlling persons
of the registrant under the provisions described in Item 6, or otherwise, the registrant has been advised that in the opinion
of the SEC such indemnification is against public policy as expressed in the Securities Act and is therefore unenforceable. In
the event that a claim for indemnification against such liabilities (other than the payment by the registrant of expenses incurred
or paid by a director, officer or controlling person of the registrant in the successful defense of any action, suit or proceeding)
is asserted by such director, officer or controlling person in connection with the securities being registered, the registrant
will, unless in the opinion of its counsel the matter has been settled by controlling precedent, submit to a court of appropriate
jurisdiction the question whether such indemnification by it is against public policy as expressed in the Securities Act and will
be governed by the final adjudication of such issue.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 2pt; text-align: justify; text-indent: 20.25pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
undersigned registrant hereby undertakes that:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 2pt; text-align: justify; text-indent: 20.25pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)&#9;For
purposes of determining any liability under the Securities Act, the information omitted from the form of prospectus filed as part
of this registration statement in reliance upon Rule 430A and contained in a form of prospectus filed by the registrant under
Rule 424(b)(1) or (4) or 497(h) under the Securities Act shall be deemed to be part of this registration statement as of the time
it was declared effective.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 2pt; text-align: justify; text-indent: 20.25pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)&#9;For
the purpose of determining any liability under the Securities Act, each post-effective amendment that contains a form of prospectus
shall be deemed to be a new registration statement relating to the securities offered therein, and the offering of such securities
at that time shall be deemed to be the initial bona fide offering thereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 2pt; text-align: justify; text-indent: 20.25pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 2pt; text-align: justify; text-indent: 20.25pt"></P>

<!-- Field: Page; Sequence: 214; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">II-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt; font: 10pt Times New Roman, Times, Serif"><A HREF="#toc">Table of Contents</A>&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 2pt; text-align: justify; text-indent: 20.25pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center; margin-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif"><A NAME="sign"></A><FONT STYLE="font-size: 10pt"><B>SIGNATURES</B></FONT></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center; margin-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to the requirements of the Securities Act of 1933, as amended, the registrant certifies that it has reasonable grounds to believe
that it meets all of the requirements for filing on Form F-1 and has duly caused this registration statement to be signed on its
behalf by the undersigned, thereunto duly authorized, in the City of New York, State of New York, on September 5, 2018.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
<TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="vertical-align: top; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="vertical-align: bottom; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Aptorum
    Group Limited</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="vertical-align: top; width: 60%; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; width: 4%; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; width: 36%; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="vertical-align: top; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="vertical-align: bottom; padding: 0; text-indent: 0; border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif">/s/
    Ian Huen</TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="vertical-align: top; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:
    Ian Huen</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="vertical-align: top; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><P STYLE="margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title: &nbsp;&nbsp;Chief Executive Officer and</FONT></P>
                                                                                <P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font: 10pt Times New Roman, Times, Serif">Executive Director</FONT></P></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-top: 0; text-align: center; margin-bottom: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>POWER
OF ATTORNEY</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Each
person whose signature appears below hereby appoints Ian Huen and Sabrina Khan, and each of them severally, acting alone and
without the other, his or her true and lawful attorney-in-fact with full power of substitution or re-substitution, for such
person and in such person&rsquo;s name, place and stead, in any and all capacities, to sign on such person&rsquo;s behalf,
individually and in each capacity stated below, any and all amendments, including post-effective amendments to this
Registration Statement, and to sign any and all additional registration statements relating to the same offering of
securities of the Registration Statement that are filed pursuant to Rule 462 of the Securities Act of 1933, and to file the
same, with all exhibits thereto, and other documents in connection therewith, with the Securities and Exchange Commission,
granting unto said attorneys-in-fact, full power and authority to do and perform each and every act and thing requisite or
necessary to be done in and about the premises, as fully to all intents and purposes as such person might or could do in
person, hereby ratifying and confirming all that said attorneys-in-fact, or their substitute or substitutes, may lawfully do
or cause to be done by virtue hereof.</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to the requirements of the Securities Act of 1933, as amended, this Registration Statement has been signed by the following persons
in the capacities set forth below on September 5, 2018.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 2pt; text-indent: 20.25pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 2pt; text-indent: 20.25pt"></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
<TR>
    <TD STYLE="vertical-align: top; width: 36%; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/ Ian Huen</FONT></TD>
    <TD STYLE="vertical-align: bottom; width: 4%">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; width: 60%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief Executive Officer (principal executive officer) and Executive Director</FONT></TD></TR>
<TR>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name: Ian Huen</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD></TR>
<TR>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/ Sabrina Khan</FONT></TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief Financial Officer (principal financial
officer and principal accounting officer)</FONT></TD></TR>
<TR>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name: Sabrina Khan</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD></TR>
<TR>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD></TR>
<TR>
    <TD STYLE="vertical-align: top; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/
Darren Lui</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">President, Chief Business Officer and Executive Director</FONT></TD></TR>
<TR>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name: Darren Lui</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD></TR>
<TR>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD></TR>
<TR>
    <TD STYLE="vertical-align: top; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/
Clark Cheng</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief Medical Officer and Executive Director</FONT></TD></TR>
<TR>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name: Clark Cheng</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD></TR>
<TR>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD></TR>
<TR>
    <TD STYLE="vertical-align: top; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/
Douglas Arner</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director</FONT></TD></TR>
<TR>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name: Douglas Arner</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD></TR>
<TR>
    <TD STYLE="vertical-align: top; padding-left: 2pt">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD></TR>
<TR>
    <TD STYLE="vertical-align: top; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/
Charles Bathurst</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director</FONT></TD></TR>
<TR>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name: Charles Bathurst</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD></TR>
<TR>
    <TD STYLE="vertical-align: top; padding-left: 2pt">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD></TR>
<TR>
    <TD STYLE="vertical-align: top; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/
Mirko Scherer</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director</FONT></TD></TR>
<TR>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name: Mirko Scherer</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD></TR>
<TR>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD></TR>
<TR>
    <TD STYLE="vertical-align: top; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/
Justin Wu</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director </FONT></TD></TR>
<TR>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name: Justin Wu</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 2pt; text-indent: 20.25pt">&nbsp;<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<!-- Field: Page; Sequence: 215; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">II-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt; font: 10pt Times New Roman, Times, Serif"><A HREF="#toc">Table of Contents</A>&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>




<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; text-align: center; margin-bottom: 0; margin-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>SIGNATURE
OF AUTHORIZED REPRESENTATIVE IN THE UNITED STATES</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; text-align: center; margin-bottom: 0; margin-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to the requirements of the Securities Act of 1933, the Registrant&rsquo;s duly authorized representative has signed this registration
statement on Form F-1 in the City of New York, State of New York, on September 5, 2018.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
<TR>
    <TD STYLE="vertical-align: top; width: 60%">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; width: 4%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="vertical-align: bottom; width: 36%; border-bottom: black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/ Louis Taubman</FONT></TD></TR>
<TR>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name: Louis Taubman</FONT></TD></TR>
<TR>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title: Authorized Representative in the United States</FONT></TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 2pt; text-align: center"></P>

<!-- Field: Page; Sequence: 216; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">II-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt; font: 10pt Times New Roman, Times, Serif"><A HREF="#toc">Table of Contents</A>&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 2pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 2pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>EXHIBIT
INDEX</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 2pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
<I>Exhibits. </I>The following exhibits are included herein or incorporated herein by reference:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 24pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following documents are filed as part of this registration statement:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255); font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 8%; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.1</FONT></TD>
    <TD STYLE="width: 92%; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: justify; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Form
    of Underwriting Agreement **</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: White; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: justify; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255); font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.1</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><A HREF="ff12018ex3-1_aptorum.htm"><FONT STYLE="font-size: 10pt">Second
                                         Amended and Restated Memorandum and Articles of Association of Aptorum Group Limited
                                         *</FONT></A></FONT></P></TD></TR>
<TR STYLE="vertical-align: top; background-color: White; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255); font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.1</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><A HREF="ff12018ex4-1_aptorum.htm"><FONT STYLE="font-size: 10pt">Specimen
                                         Ordinary Share Certificate *</FONT></A></FONT></P></TD></TR>
<TR STYLE="vertical-align: top; background-color: White; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255); font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.2</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><A HREF="ff12018ex4-2_aptorum.htm"><FONT STYLE="font-size: 10pt">Form
                                         of Series A Convertible Promissory Note *</FONT></A></FONT></P></TD></TR>
<TR STYLE="vertical-align: top; background-color: White; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255); font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.3</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Form
                                         of Underwriter Warrant **</FONT></P></TD></TR>
<TR STYLE="vertical-align: top; background-color: White; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255); font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.4</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Form
                                         of Series A Convertible Promissory Note Placement Agent Warrant, dated [&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;],
                                         2018 **</FONT></P></TD></TR>
<TR STYLE="vertical-align: top; background-color: White; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255); font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.5</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Form
                                         of Bond Placement Agent Warrant, dated [&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;], 2018 **</FONT></P></TD></TR>
<TR STYLE="vertical-align: top; background-color: White; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255); font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.1</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Opinion
                                         of Cayman Islands counsel of Aptorum Group Limited, as to the validity of the Ordinary
                                         Shares **</FONT></P></TD></TR>
<TR STYLE="vertical-align: top; background-color: White; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255); font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.2</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Opinion
                                         of US Counsel of Aptorum Group Limited, as to the validity of the Ordinary Shares **</FONT></P></TD></TR>
<TR STYLE="vertical-align: top; background-color: White; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255); font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8.1</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: justify; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Opinion
    of [&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;], counsel of Aptorum Group Limited, as to U.S. federal tax matters **</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: White; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: justify; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255); font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.1</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><A HREF="ff12018ex10-1_aptorum.htm"><FONT STYLE="font-size: 10pt">Appointment
                                         Letter between the Company and Ian Huen (Founder, Chief Executive Officer &amp; Executive
                                         Director), dated September 25, 2017 *</FONT></A></FONT></P></TD></TR>
<TR STYLE="vertical-align: top; background-color: White; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255); font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.2</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><A HREF="ff12018ex10-2_aptorum.htm"><FONT STYLE="font-size: 10pt">Employment
                                         Letter between the Company and Sabrina Khan (Chief Financial Officer), dated September
                                         1, 2017 *</FONT></A></FONT></P></TD></TR>
<TR STYLE="vertical-align: top; background-color: White; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255); font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.3</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><A HREF="ff12018ex10-3_aptorum.htm"><FONT STYLE="font-size: 10pt">Addendum
                                         to Employment Letter between Company and Sabrina Khan (Chief Financial Officer) dated
                                         April 24, 2018 *</FONT></A></FONT></P></TD></TR>
<TR STYLE="vertical-align: top; background-color: White; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255); font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.4</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><A HREF="ff12018ex10-4_aptorum.htm"><FONT STYLE="font-size: 10pt">Appointment
                                         Letter between the Company and Darren Lui (Chief Business Officer, President &amp; Director),
                                         dated September 25, 2017 *</FONT></A></FONT></P></TD></TR>
<TR STYLE="vertical-align: top; background-color: White; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255); font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.5</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><A HREF="ff12018ex10-5_aptorum.htm"><FONT STYLE="font-size: 10pt">Employment
                                         Letter between the Company and Clark Cheng (Chief Medical Officer &amp; Director), dated
                                         August 31, 2017 *</FONT></A></FONT></P></TD></TR>
<TR STYLE="vertical-align: top; background-color: White; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255); font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.6</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><A HREF="ff12018ex10-6_aptorum.htm"><FONT STYLE="font-size: 10pt">Addendum
                                         to Appointment Letter between the Company and Clark Cheng (Chief Medical Officer &amp;
                                         Director), dated September 25, 2017 *</FONT></A></FONT></P></TD></TR>
<TR STYLE="vertical-align: top; background-color: White; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255); font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.7</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><A HREF="ff12018ex10-7_aptorum.htm"><FONT STYLE="font-size: 10pt">Second
                                         Addendum to Appointment Letter between the Company and Clark Cheng (Chief Medical Officer
                                         &amp; Director), dated October 30, 2017 *</FONT></A></FONT></P></TD></TR>
<TR STYLE="vertical-align: top; background-color: White; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255); font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0">10.8</TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><A HREF="ff12018ex10-8_aptorum.htm">Third Addendum to
    Appointment Letter between the Company and Clark Cheng (Chief Medical Officer &amp; Director), dated January 2, 2018*</A></TD></TR>
<TR STYLE="vertical-align: top; background-color: White; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255); font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.9</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><A HREF="ff12018ex10-9_aptorum.htm"><FONT STYLE="font-size: 10pt">Appointment
                                         Letter between the Company and Keith Chan (Chief Scientific Officer), dated August 18,
                                         2017 *</FONT></A></FONT></P></TD></TR>
<TR STYLE="vertical-align: top; background-color: White; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0">&nbsp;</TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255); font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.10</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><A HREF="ff12018ex10-10_aptorum.htm"><FONT STYLE="font-size: 10pt">Appointment
                                         Letter between the Company and Charles Bathurst (Independent Non-Executive Director),
                                         dated September 24, 2017 *</FONT></A></FONT></P></TD></TR>
<TR STYLE="vertical-align: top; background-color: White; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255); font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.11</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><A HREF="ff12018ex10-11_aptorum.htm"><FONT STYLE="font-size: 10pt">Appointment
                                         Letter between the Company and Mirko Scherer (Independent Non-Executive Director), dated
                                         September 24, 2017 *</FONT></A></FONT></P></TD></TR>
<TR STYLE="vertical-align: top; background-color: White; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255); font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.12</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><A HREF="ff12018ex10-12_aptorum.htm"><FONT STYLE="font-size: 10pt">Employment
                                         Agreement between the Company and Justin Wu (Independent Non-Executive Director), dated
                                         September 18, 2017 *</FONT></A></FONT></P></TD></TR>

<TR STYLE="vertical-align: top; background-color: White; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255); font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.13</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; padding: 0; text-indent: 0"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><A HREF="ff12018ex10-13_aptorum.htm"><FONT STYLE="font-size: 10pt">Employment
                                         Agreement between the Company and Douglas Arner (Independent Non-Executive Director),
                                         dated February 13, 2018 *</FONT></A></FONT></P></TD></TR>
<TR STYLE="vertical-align: top; background-color: White; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255); font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.14</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><A HREF="ff12018ex10-14_aptorum.htm"><FONT STYLE="font-size: 10pt">Management
                                         Agreement between the Company and Guardian Capital Management Limited, dated March 1,
                                         2017 *</FONT></A></FONT></P></TD></TR>
<TR STYLE="vertical-align: top; background-color: White; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255); font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.15</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif"><A HREF="ff12018ex10-15_aptorum.htm"><FONT STYLE="font-size: 10pt">Consulting
    Agreement between the Company and GloboAsia, LLC (includes provisions for the appointment of Keith Chan as Chief Scientific
    Officer) dated August 18, 2017 *</FONT></A></FONT></TD></TR>

<TR STYLE="vertical-align: top; background-color: White; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0">&nbsp;</TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255); font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0; width: 8%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.16</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0; width: 92%"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><A HREF="ff12018ex10-16_aptorum.htm"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Management Agreement between the Company and APTUS CAPITAL LIMITED, dated October 26, 2010 *</FONT></A></P></TD></TR>
<TR STYLE="vertical-align: top; background-color: White; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255); font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.17</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><A HREF="ff12018ex10-17_aptorum.htm"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">First Addendum to the Management Agreement between the Company and APTUS CAPITAL LIMITED, dated February 10, 2012 *</FONT></A></TD></TR>
</TABLE>
<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<!-- Field: Page; Sequence: 217; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">II-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt; font: 10pt Times New Roman, Times, Serif"><A HREF="#toc">Table of Contents</A>&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255); font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0; width: 8%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.18</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0; width: 92%"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><A HREF="ff12018ex10-18_aptorum.htm"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Second Addendum to the Management Agreement between the Company and APTUS CAPITAL LIMITED, December 9, 2016 *</FONT></A></P></TD></TR>
<TR STYLE="vertical-align: top; background-color: White; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255); font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.19</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><A HREF="ff12018ex10-19_aptorum.htm"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Subscription Agreement between the Company and Peace Range Limited, dated April 6, 2018 *</FONT></A></P></TD></TR>
<TR STYLE="vertical-align: top; background-color: White; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255); font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.20</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><A HREF="ff12018ex10-20_aptorum.htm"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Share Charge Agreement between the Company, Jurchen Investment Corporation and Peace Range Limited, dated April 25, 2018 *</FONT></A></P></TD></TR>
<TR STYLE="vertical-align: top; background-color: White; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255); font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.21</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><A HREF="ff12018ex10-21_aptorum.htm"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Deed of Guarantee of Jurchen Investment Corporation, acknowledged by Peace Range Limited, dated April 25, 2018 *</FONT></A></P></TD></TR>
<TR STYLE="vertical-align: top; background-color: White; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255); font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.22</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><A HREF="ff12018ex10-22_aptorum.htm"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Charge Account Agreement between the Company and Peace Range Limited, dated April 25, 2018 *</FONT></A></P></TD></TR>
<TR STYLE="vertical-align: top; background-color: White; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255); font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.23</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><A HREF="ff12018ex10-23_aptorum.htm"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Bond Certificate between the Company and Peace Range Limited, dated April 25, 2018 *</FONT></A></P></TD></TR>
<TR STYLE="vertical-align: top; background-color: White; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255); font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.24</FONT></P></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: justify; text-indent: 0"><A HREF="ff12018ex10-24_aptorum.htm"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Escrow Agreement between the Company and Peace Range Limited, dated April 25, 2018 *</FONT></A></TD></TR>
<TR STYLE="vertical-align: top; background-color: White; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: justify; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255); font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.25</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><A HREF="ff12018ex10-25_aptorum.htm"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2017 Share Option Plan *</FONT></A></P></TD></TR>
<TR STYLE="vertical-align: top; background-color: White; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255); font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.26</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><A HREF="ff12018ex10-26_aptorum.htm"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Form of Securities Purchase Agreement for the Series A Convertible Promissory Notes, dated May 15, 2018 *</FONT></A></P></TD></TR>
<TR STYLE="vertical-align: top; background-color: White; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255); font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.27</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><A HREF="ff12018ex10-27_aptorum.htm"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Lock-up Agreement for Series A Convertible Promissory Notes, dated May 15, 2018 *</FONT></A></P></TD></TR>
<TR STYLE="vertical-align: top; background-color: White; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255); font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.28</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><A HREF="ff12018ex10-28_aptorum.htm"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exclusive License agreement for NLS-1 dated July 3, 2017 #</FONT></A></P></TD></TR>
<TR STYLE="vertical-align: top; background-color: White; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255); font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.29</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="ff12018ex10-29_aptorum.htm">Addendum to License Agreement for NLS-1 dated February 9, 2018 *</A></FONT></P></TD></TR>
<TR STYLE="vertical-align: top; background-color: White; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255); font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.30</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="ff12018ex10-30_aptorum.htm">Exclusive Patent License agreement for ALS-1 #</A></FONT></P></TD></TR>
<TR STYLE="vertical-align: top; background-color: White; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255); font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.31</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="ff12018ex10-31_aptorum.htm">First Amendment to the Exclusive Patent License Agreement for ALS-1 dated June 7, 2018 *</A></FONT></P></TD></TR>
<TR STYLE="vertical-align: top; background-color: White; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255); font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.32</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="ff12018ex10-32_aptorum.htm">Exclusive Patent License agreement for ALS-4 #</A></FONT></P></TD></TR>
<TR STYLE="vertical-align: top; background-color: White; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255); font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.33</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="ff12018ex10-33_aptorum.htm">First Amendment to the Exclusive Patent License Agreement dated June 7, 2018 *</A></FONT></P></TD></TR>
<TR STYLE="vertical-align: top; background-color: White; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255); font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.34</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: justify; text-indent: 0"><A HREF="ff12018ex10-34_aptorum.htm"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Sub-Tenancy Agreement for Guangdong Investment Tower *</FONT></A></TD></TR>

<TR STYLE="vertical-align: top; background-color: White; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: justify; text-indent: 0">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.35</FONT></TD>
    <TD STYLE="text-align: justify"><A HREF="ff12018ex10-35_aptorum.htm"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Service
    Agreement between Covar Pharmaceuticals Incorporated and Videns Incorporation Limited dated May 15, 2017 *</FONT></A></TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.36</FONT></TD>
    <TD STYLE="text-align: justify"><A HREF="ff12018ex10-36_aptorum.htm"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Appointment
    Letter and Addendum to Service Agreement with Covar Pharmaceuticals Incorporated and Dr. Kwok Chow dated December 15, 2017
    *</FONT></A></TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.37</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="ff12018ex10-37_aptorum.htm">Appointment Letter and Addendum to Service Agreement with Covar Pharmaceuticals Incorporated and Mr. Austin Freedman dated December 26, 2017 *</A></FONT></TD></TR>

<TR STYLE="vertical-align: top; background-color: White; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: justify; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255); font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">14.1</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><A HREF="ff12018ex14-1_aptorum.htm"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Code of Business Conduct and Ethics of the Company *</FONT></A></P></TD></TR>
<TR STYLE="vertical-align: top; background-color: White; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255); font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">21.1</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><A HREF="ff12018ex21-1_aptorum.htm"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">List of Subsidiaries *</FONT></A></P></TD></TR>
<TR STYLE="vertical-align: top; background-color: White; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255); font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">23.1</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><A HREF="ff12018ex23-1_aptorum.htm"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Consent of Marcum Bernstein &amp; Pinchuk LLP *</FONT></A></P></TD></TR>
<TR STYLE="vertical-align: top; background-color: White; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255); font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">23.2</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Consent
                                         of Cayman Islands counsel of Aptorum Group Limited (included in Exhibit 5.1) **</FONT></P></TD></TR>
<TR STYLE="vertical-align: top; background-color: White; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255); font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">23.3</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Consent
                                         of US counsel of Aptorum Group Limited (included in Exhibit 5.2) **</FONT></P></TD></TR>
<TR STYLE="vertical-align: top; background-color: White; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255); font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">24.1</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><A HREF="#sign"><FONT STYLE="font-size: 10pt">Power
                                         of Attorney (included on signature page) *</FONT></A></FONT></P></TD></TR>
<TR STYLE="vertical-align: top; background-color: White; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255); font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">99.1</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><A HREF="ff12018ex99-1_aptorum.htm"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Charter of the Audit Committee *</FONT></A></P></TD></TR>
<TR STYLE="vertical-align: top; background-color: White; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255); font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">99.2</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><A HREF="ff12018ex99-2_aptorum.htm"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Charter of the Compensation Committee *</FONT></A></P></TD></TR>
<TR STYLE="vertical-align: top; background-color: White; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255); font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">99.3</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><A HREF="ff12018ex99-3_aptorum.htm"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Charter of the Nominating and Corporate Governance Committee *</FONT></A></P></TD></TR>
</TABLE>

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255); font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; background-color: White; width: 5%; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; background-color: White; width: 95%; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Filed
    herewith.</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255); font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; background-color: White; text-indent: 0">#</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; background-color: White; text-indent: 0; text-align: justify">Filed herewith. Portions of the exhibit have been omitted pursuant to a request for confidential treatment
under Rule 24b-2 of the Securities Exchange Act of 1934, as amended, and the agreement with the omitted portions has been separately
  filed with the Securities and Exchange Commission.</TD></TR>
<TR STYLE="vertical-align: top; background-color: White; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">**</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">To
    be filed by Amendment.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; text-align: center; margin-bottom: 0">II-6</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P>

<!-- Field: Rule-Page --><DIV ALIGN="CENTER" STYLE="margin-top: 0; margin-bottom: 0"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-3.1
<SEQUENCE>2
<FILENAME>ff12018ex3-1_aptorum.htm
<DESCRIPTION>SECOND AMENDED AND RESTATED MEMORANDUM AND ARTICLES OF ASSOCIATION OF APTORUM GROUP LIMITED
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0; text-align: right"><B>Exhibit 3.1</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Aptorum
Group Limited</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<DIV STYLE="padding: 1pt 0in; border-top: Black 1.5pt solid; border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Second
Amended and Restated Memorandum</B><BR>
<B>and Articles of Association</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(Amended
and Restated by special resolutions dated __________ 2017)</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

</DIV>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="color: Red; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><IMG SRC="ex3-1_001.jpg" ALT=""></P>

<P STYLE="margin: 0pt 0; font: 10pt Times New Roman, Times, Serif; color: Red"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Floor
4, Willow House, Cricket Square</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Grand
Cayman KY1-9010</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cayman
Islands</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">campbellslegal.com</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">12574-27374</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Aptorum
Group Limited</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 0; margin-bottom: 0"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Companies
Law (as revised)</B><BR>
Company Limited by Shares</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Second
Amended and Restated Memorandum of Association</B><BR>
<B>(Amended and Restated by special resolutions dated ___________ 2017)</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B></B></FONT></P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 0; margin-bottom: 0"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B></B></FONT></P>



<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>1</B></FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Company
                                         Name</B></FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
name of the Company is <B>Aptorum Group Limited</B>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>2</B></FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Registered
                                         Office</B></FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
registered office of the Company will be situate at the offices of Campbells Corporate Services Limited, Floor 4, Willow House,
Cricket Square, Grand Cayman KY1-9010, Cayman Islands or such other place as the Directors may from time to time decide.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>3</B></FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Objects</B></FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
objects for which the Company is established are unrestricted and the Company shall have full power and authority to carry out
any object not prohibited by law as provided by Section 7(4) of the Companies Law (as revised).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>4</B></FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Powers
                                         of Company</B></FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Except
as prohibited or limited by the Companies Law (as revised) (as amended from time to time) and subject to the rules and regulations
of the trading market on which the Company&rsquo;s outstanding shares then trade, if any, the Company shall have and be capable
of from time to time and all times exercising any and all of the powers at any time or from time to time exercisable by a natural
person or body corporate in doing in any part of the world whether as principal, agent, contractor or otherwise whatever may be
considered by it necessary for the attainment of its objects and whatever else may be considered by it as incidental or conducive
thereto or consequential thereon, including, but without in any way restricting the generality of the foregoing, the power to
make any alterations or amendments to this memorandum of association and the articles of association of the Company and the power
to pay all expenses of and incidental to the promotion, formation and incorporation of the Company; to register the Company to
do business in any other jurisdiction; to sell, lease or dispose of any property of the Company; to draw, make, accept, endorse,
discount, execute and issue promissory notes, debentures, bills of exchange, bills of lading, options, warrants and other negotiable
or transferable instruments; to lend money or other assets and to act as guarantors; to borrow or raise money on the security
of the undertaking or on all or any of the assets of the Company or without security; to invest monies of the Company in such
manner as the directors determine; to promote other companies; to sell the undertaking of the Company for cash or any other consideration;
to distribute assets in specie to shareholders of the Company; to make charitable or benevolent donations; to pay pensions or
gratuities or provide other benefits in cash or kind to directors, officers, employees, past or present, and their families; to
carry on any trade or business and generally to do all acts and things which, in the opinion of the Company or the directors,
may be conveniently or profitably or usefully acquired and dealt with, carried on, executed or done by the Company in connection
with the business aforesaid.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">&nbsp;</TD><TD STYLE="width: 33%; text-align: right"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>5</B></FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Limited
                                         Liability</B></FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
liability of each member is limited to the amount from time to time unpaid on such member&rsquo;s shares.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>6</B></FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Authorised
                                         Capital</B></FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
capital of the Company is USD 100,000,000.00 divided into 60,000,000 Class A Ordinary Shares with a nominal or par value of USD
1.00 each and 40,000,000 Class B Ordinary Shares with a nominal or par value of USD 1.00 each, provided always that the Company
acting by its board of directors shall have power to purchase and/or redeem any or all of such shares and to increase or reduce
the said capital of the Company and to sub-divide or consolidate the said shares or any of them subject to the provisions of the
Companies Law and the articles of association and the rules of the applicable trading market on which the capital is then traded
and to issue all or any part of its capital whether original, purchased, redeemed, increased or reduced with or without any preference,
priority or special privilege or subject to any restrictions whatsoever and so that unless the conditions of issue shall otherwise
expressly provide every issue of shares whether stated to be ordinary, preference or otherwise shall be subject to the powers
on the part of the Company hereinbefore provided.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>7</B></FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Part
                                         VII of the Companies Law (as revised)</B></FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
the Company is registered as an exempted company in accordance with Part VII of the Companies Law (as revised), the Company will
comply with the provisions of such law relating to exempted companies and, subject to the provisions of the Companies Law and
the Articles of Association, it shall have the power to register by way of continuation as a body corporate limited by shares
under the laws of any jurisdiction outside the Cayman Islands and to be deregistered in the Cayman Islands.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>8</B></FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Amendment</B></FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company shall have power to amend this memorandum of association by special resolution.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 3; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">&nbsp;</TD><TD STYLE="width: 33%; text-align: right"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Aptorum
Group Limited</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 1pt; margin-bottom: 1pt; font: 10pt Times New Roman, Times, Serif"><DIV STYLE="font: 10pt Times New Roman, Times, Serif; border-top: Black 1.5pt solid; width: 100%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Companies
Law (as revised)</B><BR>
Company Limited by Shares</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Second
Amended and Restated Articles of Association</B><BR>
<B>(Amended and Restated by special resolutions dated ___________ 2017)</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 1pt; margin-bottom: 1pt; font: 10pt Times New Roman, Times, Serif"><DIV STYLE="font: 10pt Times New Roman, Times, Serif; border-top: Black 1.5pt solid; width: 100%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></DIV></DIV><!-- Field: /Rule-Page -->

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>1</B></FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Preliminary</B></FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.1</FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                         regulations contained in Table A of the Companies Law (as revised) do not apply to the
                                         Company and the following are the articles of association of the Company.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.2</FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
                                         these Articles:</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                         following terms shall have the meanings set opposite if not inconsistent with the subject
                                         context:</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 0.5in">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: justify; text-indent: 0; width: 25%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Articles</B>&rdquo;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">means
                                         the articles of association of the Company as originally framed as from time to time
                                         amended by Special Resolution;</FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD>&nbsp;</TD>
    <TD STYLE="padding: 0; text-align: justify; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Audit
    Committee</B>&rdquo;</FONT></TD>
    <TD STYLE="padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">means
                                         the committee appointed by the Board in accordance with Article 35 or a successor committee;</FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD>&nbsp;</TD>
    <TD STYLE="padding: 0; text-align: justify; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Auditors</B>&rdquo;</FONT></TD>
    <TD STYLE="padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">means
                                         the persons for the time being performing the duties of auditors of the Company;</FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD>&nbsp;</TD>
    <TD STYLE="padding: 0; text-align: justify; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Board</B>&rdquo;</FONT></TD>
    <TD STYLE="padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">means
                                         the board of Directors of the Company or the Directors present at a meeting of Directors
                                         of the Company at which a quorum is present;</FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD>&nbsp;</TD>
    <TD STYLE="padding: 0; text-align: justify; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Chairman</B>&rdquo;</FONT></TD>
    <TD STYLE="padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">means
                                         the Chairman of the board of Directors from time to time;</FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD>&nbsp;</TD>
    <TD STYLE="padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Class
    A Ordinary Shares&rdquo;</B></FONT></TD>
    <TD STYLE="padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">means
                                         the Class A Ordinary Shares in the capital of the Company having a par value of USD 1.00
                                         each having the rights, and subject to the restrictions, provided in these Articles;</FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD>&nbsp;</TD>
    <TD STYLE="padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Class
    B Ordinary Shares</B>&rdquo;</FONT></TD>
    <TD STYLE="padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">means
                                         the Class B Ordinary Shares in the capital of the Company having a par value of USD 1.00
                                         each having the rights, and subject to the restrictions, provided in these Articles;</FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD>&nbsp;</TD>
    <TD STYLE="padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Clearing
    House</B>&rdquo;</FONT></TD>
    <TD STYLE="padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">means
a clearing house recognised by the laws of a jurisdiction in which the shares of the Company (or depository receipts therefor)
are listed or quoted on a stock exchange or interdealer quotation system in such jurisdiction;</FONT></P></TD></TR>
</TABLE>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0"></P>

<!-- Field: Page; Sequence: 4; Options: NewSection; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">&nbsp;</TD><TD STYLE="width: 33%; text-align: right"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0"></P>

<P STYLE="margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 0.5in">&nbsp;</TD>
    <TD STYLE="padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif; width: 25%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Company</B>&rdquo;</FONT></TD>
    <TD STYLE="padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">means
                                         the above-named Company;</FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD>&nbsp;</TD>
    <TD STYLE="padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Companies
    Law</B>&rdquo;</FONT></TD>
    <TD STYLE="padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">means
                                         the Companies Law (2016 Revision) as amended, of the Cayman Islands;</FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD>&nbsp;</TD>
    <TD STYLE="padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&ldquo;debenture</B>&rdquo;</FONT></TD>
    <TD STYLE="padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">includes
                                         debenture stock, mortgages, bonds and any other securities of the Company whether constituting
                                         a charge on the assets of the Company or not;</FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD>&nbsp;</TD>
    <TD STYLE="padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Designated
    Stock Exchange</B>&rdquo;</FONT></TD>
    <TD STYLE="padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">means
                                         the Nasdaq Global Market or such other exchange or interdealer system upon which the
                                         Company&rsquo;s securities are listed or quoted;</FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD>&nbsp;</TD>
    <TD STYLE="padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Directors</B>&rdquo;</FONT></TD>
    <TD STYLE="padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">means
                                         the persons for the time being occupying the position of directors of the Company, or
                                         as the case may be, the directors assembled as a board and the term a &ldquo;Director&rdquo;
                                         shall be construed accordingly and shall, where the context admits, include an alternate
                                         Director;</FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD>&nbsp;</TD>
    <TD STYLE="padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>dividend</B>&rdquo;</FONT></TD>
    <TD STYLE="padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">includes
                                         a distribution or interim dividend or interim distribution;</FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD>&nbsp;</TD>
    <TD STYLE="padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Electronic
    Record</B>&rdquo;</FONT></TD>
    <TD STYLE="padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">has
                                         the same meaning as in the Electronic Transactions Law;</FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD>&nbsp;</TD>
    <TD STYLE="padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Electronic
    Transactions Law</B>&rdquo;</FONT></TD>
    <TD STYLE="padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">means
                                         the Electronic Transactions Law of the Cayman Islands;</FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD>&nbsp;</TD>
    <TD STYLE="padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Exchange
    Act</B>&rdquo;</FONT></TD>
    <TD STYLE="padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">means
                                         the United States Securities Exchange Act of 1934, as amended;</FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD>&nbsp;</TD>
    <TD STYLE="padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Head
    Office</B>&rdquo;</FONT></TD>
    <TD STYLE="padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">means
                                         such office of the Company as the Directors may from time to time determine to be the
                                         principal office of the Company;</FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD>&nbsp;</TD>
    <TD STYLE="padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Issue
    Price</B>&rdquo;</FONT></TD>
    <TD STYLE="padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">means
                                         the total consideration payable for the issue of Shares including for the avoidance of
                                         doubt both the par value and any premium payable;</FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD>&nbsp;</TD>
    <TD STYLE="padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;L<B>aw</B>&rdquo;</FONT></TD>
    <TD STYLE="padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">means
                                         all applicable laws, rules and regulations, domestic or foreign, state, provincial, local
                                         or self-regulatory, including without limitation as to all applicable laws, rules and
                                         regulations of or related to the Companies Law, the United States, the SEC and the Designated
                                         Stock Market;</FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD>&nbsp;</TD>
    <TD STYLE="padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>member</B>&rdquo;</FONT></TD>
    <TD STYLE="padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">has
                                         the meaning assigned to it in the Companies Law and the term &ldquo;shareholder&rdquo;
                                         shall also mean a member;</FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P></TD></TR>
</TABLE>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0"></P>

<!-- Field: Page; Sequence: 5; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">&nbsp;</TD><TD STYLE="width: 33%; text-align: right"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0"></P>

<P STYLE="margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif; width: 25%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Memorandum</B>&rdquo;</FONT></TD>
    <TD STYLE="padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">means
                                         the Memorandum of Association of the Company;</FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Month</B>&rdquo;</FONT></TD>
    <TD STYLE="padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">means
                                         calendar month;</FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>NASDAQ</B>&rdquo;</FONT></TD>
    <TD STYLE="padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">means
                                         the National Association of Securities Dealers Automated Quotations;</FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Ordinary
    Resolution</B>&rdquo;</FONT></TD>
    <TD STYLE="padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">means
    a resolution:</FONT></TD></TR>
</TABLE>

<P STYLE="margin: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD>
    <TD STYLE="width: 25%">&nbsp;</TD>
    <TD STYLE="width: 0.25in">&nbsp;</TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">passed
by simple majority of such members as, being entitled to do so, vote in person or, where proxies are allowed, by proxy at a general
meeting of the Company on a show of hands or a poll and where a poll is taken regard shall be had in computing a majority to the
number of votes to which each member is entitled; or</FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD>
    <TD STYLE="width: 25%">&nbsp;</TD>
    <TD STYLE="width: 0.25in">&nbsp;</TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">approved
in writing by all of the members entitled to vote at a general meeting of the Company in one or more instruments each signed by
one or more of the members and the effective date of the resolution so adopted shall be the date on which the instrument, or the
last of such instruments, if more than one, is executed.</FONT></TD>
</TR></TABLE>



<P STYLE="margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 0.5in">&nbsp;</TD>
    <TD STYLE="padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif; width: 25%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>paid-up</B>&rdquo;</FONT></TD>
    <TD STYLE="padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">has
                                         the meaning assigned to it in the Companies Law currently meaning paid-up and/or credited
                                         as paid-up as to the nominal or par value only excluding any premium payable in respect
                                         of the issue of any shares;</FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD>&nbsp;</TD>
    <TD STYLE="padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Register</B>&rdquo;</FONT></TD>
    <TD STYLE="padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">means
                                         the register of members of the Company required to be kept by the Companies Law; and
                                         includes (except where otherwise stated or the context otherwise requires) any branch
                                         or duplicate register of members;</FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD>&nbsp;</TD>
    <TD STYLE="padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>registered
    office</B>&rdquo;</FONT></TD>
    <TD STYLE="padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">means
                                         the registered office for the time being of the Company;</FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD>&nbsp;</TD>
    <TD STYLE="padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Registration
    Office</B>&rdquo;</FONT></TD>
    <TD STYLE="padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">means
                                         in respect of any class of share capital such place as the Board may from time to time
                                         determine to keep a branch Register in respect of that class of share capital and where
                                         (except in cases where the Board otherwise directs the transfers or other documents of
                                         title or such class of share capital are to be lodged for registration and are registered;</FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD>&nbsp;</TD>
    <TD STYLE="padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>SEC</B>&rdquo;</FONT></TD>
    <TD STYLE="padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">means
                                         the United States Securities Exchange Commission;</FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P></TD></TR>
</TABLE>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0"></P>

<!-- Field: Page; Sequence: 6; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">&nbsp;</TD><TD STYLE="width: 33%; text-align: right"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0"></P>

<P STYLE="margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 0.5in">&nbsp;</TD>
    <TD STYLE="padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif; width: 25%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Seal</B>&rdquo;</FONT></TD>
    <TD STYLE="padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">means
                                         the common seal of the Company and includes every duplicate seal;</FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD>&nbsp;</TD>
    <TD STYLE="padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Secretary</B>&rdquo;</FONT></TD>
    <TD STYLE="padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">includes
                                         an assistant secretary and any persons appointed to perform the duties of the secretary
                                         of the Company;</FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD>&nbsp;</TD>
    <TD STYLE="padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>share</B>&rdquo;</FONT></TD>
    <TD STYLE="padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">means
                                         a share in the Company and shall, where the context so permits, includes fractions of
                                         a share in the Company;</FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD>&nbsp;</TD>
    <TD STYLE="padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Special
    Resolution</B>&rdquo;</FONT></TD>
    <TD STYLE="padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">has
                                         the meaning assigned to it in the Companies Law;</FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD>&nbsp;</TD>
    <TD STYLE="padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Treasury
    Share</B>&rdquo;</FONT></TD>
    <TD STYLE="padding: 0; text-align: justify; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">means
    a share held in the name of the Company as a treasury share in accordance with the Companies Law.</FONT></TD></TR>
</TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>
<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">words
                                         importing the singular include the plural and vice versa;</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)</FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">words
                                         importing any gender include all genders;</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)</FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">words
                                         importing persons include corporations as well as any other legal or natural person;</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)</FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">expressions
                                         referring to writing shall, unless the contrary intention appears, be construed as including
                                         references to printing, lithography, photography and other modes of representing or reproducing
                                         words in a visible form and include all modes of representing or reproducing words in
                                         visible form, including in the form of an Electronic Record;</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(f)</FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">references
                                         to provisions of any law or regulation shall be construed as references to those provisions
                                         as amended, modified, re-enacted or replaced;</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(g)</FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">any
                                         phrase commencing with the words &ldquo;including&rdquo;, &ldquo;include&rdquo;, &ldquo;in
                                         particular&rdquo; or any similar expression shall be deemed to be followed by the words
                                         &ldquo;without limitation&rdquo;;</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(h)</FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">headings
                                         are inserted for reference only and shall be ignored in construing the Articles;</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)</FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">subject
                                         as aforesaid, any words or expressions defined in the Companies Law shall, if not inconsistent
                                         with the subject or context hereof, bear the same meanings as in the Articles;</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(j)</FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                         word &ldquo;may&rdquo; shall be construed as permissive and the word &ldquo;shall&rdquo;
                                         shall be construed as imperative;</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(k)</FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">where
                                         an Ordinary Resolution is expressed to be required for any purpose, a Special Resolution
                                         is also effective for that purpose; and</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(l)</FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">where
                                         any period to lapse under the provisions of these Articles is counted by a number of
                                         days, the first day of such period counted shall be the day immediately after the notice
                                         is given or deemed to be given and the period of such notice shall be deemed to be complete
                                         and final at the end of the last day of such period. The relevant then permitted actions
                                         shall be effected the day immediately following such last day.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 7; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">&nbsp;</TD><TD STYLE="width: 33%; text-align: right"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>2</B></FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Commencement
                                         of Business</B></FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.1</FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                         business of the Company may be commenced as soon after incorporation as the Directors
                                         shall see fit, notwithstanding that part only of its shares may have been allotted.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.2</FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                         Directors may pay, out of the capital or any other monies of the Company, all expenses
                                         incurred in or about the formation and establishment of the Company including the expenses
                                         of registration.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>3</B></FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Alteration
                                         of Articles</B></FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Subject
to any other provision of these Articles, the Company may from time to time alter or add to these Articles by passing a Special
Resolution so long as such alteration does not disparately impact the members&rsquo; voting rights.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>4</B></FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Issue
                                         of Shares, Principal and Branch Registers and Offices</B></FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.1</FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Subject
                                         to the Law and to any direction that may be given by the Company in general meeting and
                                         without prejudice to any special rights previously conferred on the holders of any existing
                                         shares or class of shares, the shares of the Company shall be under the Directors&rsquo;
                                         general and unconditional authority to allot and/or issue (with or without rights of
                                         renunciation), grant options over, offer or otherwise deal with or dispose of any unissued
                                         shares of the Company (whether forming part of the original or any increased share capital),
                                         either at a premium or at par, with or without preferred, deferred or other special rights
                                         or restrictions, whether in regard to dividend, voting, return of capital or otherwise
                                         and to such persons, on such terms and conditions, and at such times as the Directors
                                         may decide and they may allot or otherwise dispose of them to such persons (including
                                         any Director) on such terms and conditions and at such time as the Directors may determine.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.2</FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                         Company may, at its discretion, issue fractions of a share and, save where the Articles
                                         otherwise provide, a fraction of a share shall have proportionately the same rights as
                                         a whole share of the same class.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.3</FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                         Directors may accept non-cash consideration for the issue of Shares.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.4</FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                         Company shall be prohibited from issuing shares, certificates or coupons in bearer form.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.5</FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                         Directors may accept contributions to the capital of the Company otherwise than in consideration
                                         of the issue of shares and the amount of any such contribution may be treated as share
                                         premium (in which case it shall be subject to the provisions of the Companies Law and
                                         these Articles applicable to share premium).</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.6</FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                         Company shall maintain or cause to be maintained the Register in accordance with the
                                         Companies Law.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.7</FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                         Directors may determine that the Company shall maintain one or more branch registers
                                         of members in accordance with the Companies Law provided that a duplicate of such branch
                                         registers shall be maintained with the principal register in accordance with the Companies
                                         Law. The Directors shall also determine which register of members shall constitute the
                                         principal register and which shall constitute the branch register or registers, and may
                                         vary such determination from time to time.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 8; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">&nbsp;</TD><TD STYLE="width: 33%; text-align: right"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.8</FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Subject
                                         to the provisions of the Law, the Company by resolution of the Directors may change the
                                         location of its registered office.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.9</FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                         Company, in addition to its registered office, may establish and maintain such other
                                         offices, places of business and agencies in the Islands and elsewhere as the Directors
                                         may from time to time determine.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>5</B></FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Treasury
                                         Shares</B></FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.1</FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                         Directors may, prior to the purchase, redemption or surrender of any share, determine
                                         that such share shall be held as a Treasury Share.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.2</FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                         Directors may resolve to cancel a Treasury Share or transfer a Treasury Share on such
                                         terms as they think proper (including, without limitation, for nil consideration).</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>6</B></FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Redemption,
                                         Purchase and Surrender of Own Shares</B></FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.1</FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Subject
                                         to the provisions of the Companies Law, the Memorandum and these Articles:</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">shares
                                         may be issued on the terms that they are, or at the option of the Company or the member
                                         are, liable to be redeemed on such terms and in such manner as the Company, by resolution,
                                         or as the Directors, before the issue of the shares, may determine; and</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                         Company may purchase shares, including any redeemable shares, issued by the Company upon
                                         the terms and in such manner as the Directors or the Company, by resolution, may from
                                         time to time determine, and such authority may be general in respect of any number of
                                         purchases, for a set period, or indefinite;</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)</FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                         Company may make payment in respect of any redemption or purchase of its own shares in
                                         any manner authorised by the Companies Law, including out of capital</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)</FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Subject
                                         to the provisions of these Articles, the rights attaching to any issued shares may, by
                                         Special Resolution, be varied so as to provide that such shares are, or at the option
                                         of the Company or the member are, liable to be redeemed on such terms and in such manner
                                         as the Company may, determine.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.2</FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                         Directors may accept the surrender for no consideration of any fully paid-up share.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.3</FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                         Directors may, when making a payment in respect of the redemption or purchase of shares,
                                         make such payment in cash or in specie (or partly in one and partly in the other).</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.4</FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Upon
                                         the date of redemption or purchase of a share, the holder shall cease to be entitled
                                         to any rights in respect thereof (excepting always the right to receive (i) the price
                                         therefor and (ii) any dividend which had been declared in respect thereof prior to such
                                         redemption or purchase being effected) and accordingly his name shall be removed from
                                         the Register with respect thereto and the share shall be cancelled.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 9; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">&nbsp;</TD><TD STYLE="width: 33%; text-align: right"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>7</B></FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Class
                                         A Ordinary Shares</B></FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">7.1</FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Voting
                                         Rights</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
holder of Class A Ordinary Shares shall have the right to one (1) vote for each such share and shall be entitled to notice of
any shareholders&rsquo; meeting and, subject to the terms of these Articles, to vote thereat.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">7.2</FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Redemption</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Class A Ordinary Shares are not redeemable at the option of the holder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">7.3</FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Conversion</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Class A Ordinary Shares are not convertible into shares of any other class.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>8</B></FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Class
                                         B Ordinary Shares</B></FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8.1</FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Voting
                                         Rights</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
holder of Class B Ordinary Shares shall have the right to ten (10) votes for each such share, and shall be entitled to notice
of any shareholders&rsquo; meeting and, subject to the terms of these Articles, to vote thereat.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8.2</FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Redemption</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Class B Ordinary Shares are not redeemable at the option of the holder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8.3</FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Conversion</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
holders of the Class B Ordinary Shares shall have the conversion rights set out in the following paragraphs (the &ldquo;<B>Conversion
Rights</B>&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Right
                                         to Convert</I></FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Each
Class B Ordinary Share shall be convertible, at the option of the holder thereof, at any time after the date of issuance of such
share at the Head Office of the Company or the office of any transfer agent for such shares, into such number of fully paid and
non-assessable Class A Ordinary Shares on the basis that one (1) Class B Ordinary Share shall be converted into one (1) Class
A Ordinary Share (being a 1:1 ratio and hereafter referred to as the &ldquo;<B>Conversion Rate</B>&rdquo;), on the date the written
notice to convert (together with any certificate representing the Class B Ordinary Shares to which it relates, if any) is received,
as provided for in these Articles, by the Company at its Head Office or by any transfer agent for the Class B Ordinary Shares.
The Conversion Rate for Class B Ordinary Shares shall be subject to adjustment as set out in this Article 8.3.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0in"></P>

<!-- Field: Page; Sequence: 10; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">&nbsp;</TD><TD STYLE="width: 33%; text-align: right"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Mechanics
                                         of Conversion</I></FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Before
any holder of Class B Ordinary Shares shall be entitled to voluntarily convert the same into Class A Ordinary Shares, such holder
shall lodge, at the Company&rsquo;s Head Office or at the office of any transfer agent for the Class B Ordinary Shares, a written
notice of the election to convert the same (together with any certificate, if any, representing the Class B Ordinary Shares to
which it relates) and such written notice shall state therein the name or names that shall be entered on the Register and, if
certificates are to be issued, the name or names in which the certificate or certificates for Class A Ordinary Shares are to be
issued. A conversion shall be effected as a simultaneous redemption of the relevant Class B Ordinary Shares and the allotment
and issue of the new Class A Ordinary Shares with the proceeds of such redemption of Class B Ordinary Shares being applied to
purchase the new Class A Ordinary Shares. Such conversion shall be deemed to have been made immediately prior to the close of
business on the date of delivery of notice of conversion and, if certificates are then issued, such surrender of the certificate
or certificates for the Class B Ordinary Shares to be converted, and the person or persons entitled to receive the Class A Ordinary
Shares issuable upon such conversion shall be entered on the Register as the holder or holders of such Class A Ordinary Shares
on such date. Certificates evidencing the Class A Ordinary Shares issued on conversion, and any remaining Class B Ordinary Shares
of such Member may be issued in accordance with the terms of these Articles.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)</FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Conversion
                                         Price Adjustments of Class B Ordinary Shares for Certain Dilutive Splits, and Consolidations
                                         </I></FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Conversion Rate of the Class B Ordinary Shares shall be subject to adjustment from time to time as follows:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 1in; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)</FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
                                         the Company on or after the date of the adoption of these Articles (the &ldquo;<B>Adoption
                                         Date</B>&rdquo;), fixes a record date for the effectuation of a split or subdivision of
                                         the outstanding Class A Ordinary Shares then, as of such record date (or the date of
                                         such split or subdivision if no record date is fixed), the Conversion Rate of the Class
                                         B Ordinary Shares shall be appropriately adjusted so that the number of Class A Ordinary
                                         Shares issuable on conversion of each share shall be increased in proportion to such
                                         increase of the aggregate of Class A Ordinary Shares outstanding.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 1in; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)</FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
                                         the number of Class A Ordinary Shares outstanding at any time after the Adoption Date
                                         is decreased by a consolidation or other combination of the outstanding Class A Ordinary
                                         Shares, then, following the record date of such combination, the Conversion Rate for
                                         the Class B Ordinary Shares shall be appropriately adjusted so that the number of Class
                                         A Ordinary Shares issuable on conversion of each share shall be decreased in proportion
                                         to such decrease in outstanding shares.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)</FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Recapitalisations</I></FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
at any time or from time to time there shall be a recapitalisation of the Class A Ordinary Shares (other than a subdivision or
combination provided for elsewhere in this Article 8.3), provision shall be made so that the holders of the Class B Ordinary Shares
shall thereafter be entitled to receive upon conversion of the Class B Ordinary Shares the number of shares of the Company, to
which a holder of Class A Ordinary Shares deliverable upon conversion would have been entitled on such recapitalisation. In any
such case, appropriate adjustment shall be made in the application of the provisions of this Article 8.3 with respect to the rights
of the holders of the Class B Ordinary Shares after the recapitalisation to the end that the provisions of this Article 8.3 (including
adjustment of the Conversion Rate then in effect and the number of shares purchasable upon conversion of the Class B Ordinary
Shares) shall be applicable after that event as nearly equivalent as may be practicable.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 11; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">&nbsp;</TD><TD STYLE="width: 33%; text-align: right"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)</FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>No
                                         Fractional Shares and Certificate as to Adjustments</I></FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 1in; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)</FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">No
                                         fractional shares shall be issued upon the conversion of any Class B Ordinary Shares,
                                         and the aggregate number of Class A Ordinary Shares to be issued to particular shareholders
                                         shall be rounded down to the nearest whole share and the Company shall pay in cash the
                                         fair market value of any fractional shares as of the time when entitlement to receive
                                         such fractions is determined. Whether or not fractional shares would be issuable upon
                                         such conversion shall be determined on the basis of the total number of Class B Ordinary
                                         Shares the holder is at the time converting into Class A Ordinary Shares and the number
                                         of Class A Ordinary Shares issuable upon such conversion.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 1in; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)</FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Upon
                                         the occurrence of each adjustment or readjustment of the Conversion Price of the Class
                                         B Ordinary Shares pursuant to this Article 8.3, the Company, at its expense, shall promptly
                                         compute such adjustment or readjustment in accordance with the terms hereof and prepare
                                         and furnish to each holder of Class B Ordinary Shares a certificate setting forth such
                                         adjustment or readjustment and showing in detail the facts upon which such adjustment
                                         or readjustment is based. The Company shall, upon the written request at any time of
                                         any holder of Class B Ordinary Shares, furnish or cause to be furnished to such holder
                                         a like certificate setting forth (A) such adjustment and readjustment, (B) the Conversion
                                         Rate for such Class B Ordinary Shares at the time in effect, and (C) the number of Class
                                         A Ordinary Shares that at the time would be received upon the conversion of a Class B
                                         Ordinary Share.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(f)</FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Reservation
                                         of Shares Issuable Upon Conversion</I></FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 1in; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)</FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                         Company shall at all times reserve and keep available out of its authorised but unissued
                                         Class A Ordinary Shares, solely for the purpose of effecting the conversion of the Class
                                         B Ordinary Shares, such number of its Class A Ordinary Shares as shall from time to time
                                         be sufficient to effect the conversion of all outstanding Class B Ordinary Shares; and
                                         if at any time the number of authorised but unissued Class A Ordinary Shares shall not
                                         be sufficient to effect the conversion of all then outstanding Class B Ordinary Shares,
                                         in addition to such other remedies as shall be available to the holder of such Class
                                         B Ordinary Shares, the Company will take such corporate action as may, in the opinion
                                         of its counsel, be necessary to increase its authorised but unissued Class A Ordinary
                                         Shares to such number of shares as shall be sufficient for such purposes, including,
                                         without limitation, engaging in best efforts to obtain the requisite shareholder approval
                                         of any necessary amendment to the Memorandum and Articles.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 12; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">&nbsp;</TD><TD STYLE="width: 33%; text-align: right"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(g)</FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>No
                                         Impairment</I></FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Subject
to the right of the Company to amend its Memorandum and Articles or take any other corporate action upon obtaining the necessary
approvals required by these Articles and applicable law, the Company will not, by amendment of these Articles or through any reorganisation,
recapitalisation, transfer of assets, consolidation, merger, amalgamation, scheme of arrangement, dissolution, issue or sale of
securities or any other voluntary action, avoid or seek to avoid the observance or performance of any of the terms to be observed
or performed hereunder by the Company, but will at all times in good faith assist in the carrying out of all the provisions of
this Article 8.3 and in the taking of all such action as may be necessary or appropriate to protect the conversion rights of the
holders of Class B Ordinary Shares against impairment.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(h)</FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Waiver
                                         of Adjustment to Conversion Rate</I></FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Notwithstanding
anything herein to the contrary, any downward adjustment of the Conversion Rate of any of the Class B Ordinary Shares may be waived,
either prospectively or retroactively and either generally or in a particular instance, by the consent or vote of the holders
of Class B Ordinary Shares representing a majority of the votes attributable to all then outstanding Class B Ordinary Shares (voting
together as a single class and on an as-converted basis). Any such waiver shall bind all future holders of Class B Ordinary Shares.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>9</B></FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Variation
                                         of Rights of Shares</B></FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">9.1</FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
                                         at any time the share capital of the Company is divided into different classes of shares,
                                         the rights attached to any class (unless otherwise provided by the terms of issue of
                                         the shares of that class) may, whether or not the Company is being wound up, be varied
                                         with the consent in writing of the holders of at least two-thirds of the issued shares
                                         of that class or with the sanction of a resolution passed at a meeting of the holders
                                         of such class of shares by the holder or holders of at least two-thirds of such shares
                                         present in person or by proxy at such meeting. To the extent not inconsistent with this
                                         Article, the provisions of these Articles relating to general meetings shall apply to
                                         every such meeting of the holders of one class of shares except that the necessary quorum
                                         shall be one person holding or representing by proxy at least one third of the issued
                                         shares of the class and that any holder of shares of the class present in person or by
                                         proxy may demand a poll.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">9.2</FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                         rights conferred upon the holders of the shares of any class issued with preferred or
                                         other rights shall not, unless otherwise expressly provided by the terms of the issue
                                         of the shares of that class, be deemed to be varied by the creation or issue of further
                                         shares ranking pari passu therewith and, for the avoidance of doubt shall not be varied
                                         by the increase in the number of shares issuable under any employee share plan adopted
                                         by the Company from time to time.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">9.3</FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
                                         the purposes of a separate class meeting, the Directors may treat two or more or all
                                         the classes of Shares as forming one class of Shares if the Directors consider that such
                                         class of Shares would be affected in the same way by the proposals under consideration,
                                         but in any other case shall treat them as separate classes of Shares.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>10</B></FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Commission
                                         on Sale of Shares</B></FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">When
permitted by Law the Company may pay to any person a commission in consideration of his subscribing or agreeing to subscribe (whether
absolute or conditional) for any shares or debentures of the Company, or procuring or agreeing to procure subscriptions (whether
absolute or conditional) for any shares or debentures in the Company. Any such commission may be satisfied by the payment of cash
or in fully paid-up shares or debentures of the Company or partly in one way and partly in the other.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 13; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">&nbsp;</TD><TD STYLE="width: 33%; text-align: right"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>11</B></FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Non-Recognition
                                         of Trusts</B></FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Except
as required by law or otherwise provided by these Articles, no person shall be recognised by the Company as holding any shares
upon any trust, and the Company shall not be bound by or be compelled in any way to recognise (even when having notice thereof)
any equitable, contingent, future or partial interest in any share or any interest in any fractional part of a share or any other
rights in respect of any share except an absolute right to the entirety thereof in the registered holder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>12</B></FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Certificates
                                         for Shares</B></FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">12.1</FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Share
                                         certificates shall generally not be issued, unless the Directors determine to so issue
                                         either generally or in a specific circumstance. A certificate may be issued under Seal
                                         or executed in such other manner as the Directors may prescribe. Provided that in respect
                                         of a share or shares held jointly by several persons the Company shall not be bound to
                                         issue more than one certificate and delivery of a certificate for a share to one of several
                                         joint holders shall be sufficient delivery to all such holders.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">12.2</FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Certificates
                                         representing shares shall be in such form as shall be determined by the Directors. Such
                                         certificates shall be signed by such person or persons as are authorised from time to
                                         time by the Directors or by the Articles. All certificates for shares shall be consecutively
                                         numbered or otherwise identified. The name and address of the person to whom the shares
                                         represented thereby are issued, with the number of shares and date of issue, shall be
                                         entered in the Register. All certificates surrendered to the Company for transfer shall
                                         be cancelled and no new certificate shall be issued until the former certificate for
                                         a like number of shares shall have been surrendered and cancelled. Notwithstanding the
                                         foregoing, if a share certificate is defaced, lost or destroyed, it may be renewed on
                                         such terms (if any) as to evidence and indemnity and the payment of out of pocket expenses
                                         of the Company incurred in investigating evidence as the Directors think fit.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>13</B></FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Joint
                                         Ownership of Shares</B></FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
several persons are registered as joint holders of any shares they shall be severally as well as jointly liable for any liability
in respect of such shares, but the first named upon the Register shall, as regards service or notices, be deemed the sole owner
thereof. Any of such persons may give effectual receipt for any dividend or other distribution.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>14</B></FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Lien</B></FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">14.1</FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                         Company shall have a first and paramount lien and charge on every share for all monies,
                                         whether presently payable or not, called or payable at a fixed time in respect of that
                                         share, and the Company shall also have a first and paramount lien and charge on all shares
                                         standing registered in the name of a member (whether solely or jointly with others) for
                                         all monies, liabilities or engagements presently owing by him or his estate to the Company
                                         either alone or jointly with any other person, whether a member or not; but the Directors
                                         may at any time declare any share to be wholly or in part exempt from the provisions
                                         of this Article. The Company&rsquo;s lien and charge, if any, on a share shall extend
                                         to all dividends or other monies payable in respect thereof. The registration of a transfer
                                         of any such share shall operate as a waiver of the Company&rsquo;s lien and charge (if
                                         any) thereon.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 14; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">&nbsp;</TD><TD STYLE="width: 33%; text-align: right"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">14.2</FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                         Company may sell, in such manner as the Directors think fit, any shares on which the
                                         Company has a lien and charge, but no sale shall be made unless a sum in respect of which
                                         the lien and charge exists is presently payable, nor until the expiration of fourteen
                                         days after a notice in writing, stating and demanding payment of such part of the amount
                                         in respect of which the lien and charge exists as is presently payable, has been given
                                         to the registered holder or holders for the time being of the share, or the person, of
                                         which the Company has notice, entitled thereto by reason of his death or bankruptcy.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">14.3</FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">To
                                         give effect to any such sale the Directors may authorise some person to transfer the
                                         shares sold to the purchaser thereof. The purchaser shall be registered as the holder
                                         of the shares comprised in any such transfer, and he shall not be bound to see to the
                                         application of the purchase money, nor shall his title to the shares be affected by any
                                         irregularity or invalidity in the proceedings in reference to the sale.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">14.4</FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                         proceeds of the sale shall be received by the Company and applied in payment of such
                                         part of the amount in respect of which the lien and charge exists as is presently payable,
                                         and the residue, if any, shall (subject to a like lien and charge for sums not presently
                                         payable as existed upon the shares before the sale) be paid to the person entitled to
                                         the shares prior to the sale.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>15</B></FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Calls
                                         on Shares</B></FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">15.1</FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                         Directors may from time to time make calls upon the members in respect of any monies
                                         unpaid on their shares for the Issue Price (whether on account of the nominal value of
                                         the shares or by way of premium or otherwise) and not by the conditions of allotment
                                         thereof made payable at fixed times. Each member shall (subject to receiving at least
                                         fourteen days&rsquo; notice specifying the time or times and place of payment) pay to
                                         the Company at the time or times and place so specified the amount called on his shares.
                                         A call may be revoked or postponed as the Directors may determine. A person upon whom
                                         a call is made shall remain liable for calls made upon him notwithstanding the subsequent
                                         transfer of the shares in respect of which the call was made.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">15.2</FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
                                         call shall be deemed to have been made at the time when the resolution of the Directors
                                         authorising the call was passed and may be required to be paid by instalments. The joint
                                         holders of a share shall be jointly and severally liable to pay all calls in respect
                                         thereof.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">15.3</FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
                                         a sum called in respect of a share is not paid before or on the day appointed for payment
                                         thereof, the person from whom the sum is due shall pay interest on the sum from the day
                                         appointed for payment thereof to the time of actual payment at such rate fixed by the
                                         terms of allotment or issue of the share or in the notice of the call or at such rate
                                         as prescribed by the Designated Stock Exchange or as the Directors may otherwise determine,
                                         but the Directors shall be at liberty to waive payment of such interest wholly or in
                                         part.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">15.4</FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Any
                                         sum which by the terms of issue of a share becomes payable on allotment or at any fixed
                                         date (whether on account of the nominal value of the share or by way of premium or otherwise)
                                         shall for the purposes of the Articles be deemed to be a call duly made and payable on
                                         the date on which by the terms of issue the same becomes payable, and in case of non-payment
                                         all the relevant provisions of the Articles as to payment of interest and expenses, forfeiture
                                         or otherwise shall apply as if such sum had become payable by virtue of a call duly made
                                         and notified.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 15; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">&nbsp;</TD><TD STYLE="width: 33%; text-align: right"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">15.5</FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                         Directors may, on the issue of shares, differentiate between the holders as to the amount
                                         of calls or interest to be paid and the times of payment.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">15.6</FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                         Directors may, if they think fit, receive from any member willing to advance the same,
                                         all or any part of the monies uncalled and unpaid upon any shares held by him, and upon
                                         all or any of the monies so advanced may (until the same would, but for such advance,
                                         become payable) pay interest at such rate as may be agreed upon between the Directors
                                         and the member paying such sum in advance.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">15.7</FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">No
                                         such sum paid in advance of calls shall entitle the member paying such sum to any portion
                                         of a dividend declared in respect of any period prior to the date upon which such sum
                                         would but for such payment become presently payable.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>16</B></FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Transfer
                                         of Shares</B></FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">16.1</FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Every
                                         instrument of transfer shall be left at the registered office for registration, accompanied
                                         by the certificate (if any) covering the shares to be transferred and such other evidence
                                         as the Directors may require to prove the title of the transferor to, or his right to
                                         transfer, the shares.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">16.2</FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                         instrument of transfer of any share (which need not be under Seal) shall be signed by
                                         or on behalf of the transferor and, unless the share is fully paid up or the transferee
                                         otherwise consents or agrees thereto, by or on behalf of the transferee. The transferor
                                         shall be deemed to remain the holder of the share until the name of the transferee is
                                         entered in the Register in respect thereof. If the transferor or the transferee is a
                                         Clearing House or central depository house or its nominee(s), by hand or by machine imprinted
                                         signature or by such other manner of execution as the Board may approved from time to
                                         time.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">16.3</FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Subject
                                         to such of the restrictions of the Articles as may be applicable, any member may transfer
                                         all or any of his shares by instrument in writing in any usual or common form or any
                                         other form which the Directors may approve or in a form prescribed by the Designated
                                         Stock Exchange. Upon every transfer of shares any certificate held by the transferor
                                         shall be given up to be cancelled and shall forthwith be cancelled accordingly and a
                                         new certificate may be issued. The Company shall also retain the transfer.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">16.4</FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                         Directors may, in their absolute discretion and without assigning any reason therefor,
                                         refuse to register any transfer of any share, whether or not it is a fully paid up share
                                         as to Issue Price.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">16.5</FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Without
                                         limitation, the Directors may decline to recognise any instrument of transfer if:</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                         instrument of transfer is not accompanied by the certificate covering shares to which
                                         it relates (if any), and/or such other evidence as the Directors may require to prove
                                         the title of the transferor to, or his right to transfer, the shares; or</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                         instrument of transfer is in respect of more than one class of share.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">16.6</FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
                                         the Directors refuse to register a transfer they shall within two months after the date
                                         on which the transfer was lodged with the Company send to the transferee notice of the
                                         refusal.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">16.7</FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                         registration of transfers may be suspended at such times and for such periods as the
                                         Directors may from time to time determine, provided always that such registration shall
                                         not be suspended for more than thirty days in any year.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 16; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">&nbsp;</TD><TD STYLE="width: 33%; text-align: right"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>17</B></FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Transmission
                                         of Shares</B></FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">17.1</FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
                                         case of the death of a member, the survivor or survivors where the deceased was a joint
                                         holder, and the legal personal representatives of the deceased where he was a sole holder,
                                         shall be the only persons recognised by the Company as having any title to his interest
                                         in the shares but nothing herein contained shall release the estate of a deceased holder
                                         from any liability in respect of any share which had been held by him solely or jointly
                                         with other persons.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">17.2</FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Any
                                         person becoming entitled to a share in consequence of the death or bankruptcy of a member
                                         may, upon such evidence being produced as may from time to time be properly required
                                         by the Directors to show his title to the share, elect either to be registered himself
                                         as holder of the share or to make such transfer of the share to such other person nominated
                                         by him as the aforesaid member could have made and to have such person registered as
                                         the transferee thereof, but the Directors shall, in either case, have the same right
                                         to decline or suspend registration as they would have had in the case of a transfer of
                                         the share by that member before his death or bankruptcy, as the case may be.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">17.3</FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
                                         person becoming entitled to a share by reason of the death or bankruptcy of a member
                                         shall be entitled to the same dividends and other advantages to which he would be entitled
                                         if he were the registered holder of the share, except that he shall not, before being
                                         registered as a member in respect of the share, be entitled in respect of it to exercise
                                         any right conferred by membership in relation to meetings of the Company; provided always
                                         that the Directors may at any time give notice requiring any such person to elect either
                                         to be registered himself or to transfer the share, and if the notice is not complied
                                         with within fourteen days the Directors may thereafter withhold payment of all dividends,
                                         bonuses or other monies payable in respect of the share until the requirements of the
                                         notice have been complied with.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>18</B></FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Forfeiture
                                         of Shares</B></FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">18.1</FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
                                         a member fails to pay any call or instalment of a call for any part of the Issue Price
                                         on the day appointed for payment thereof, the Directors may, at any time thereafter during
                                         such time as any part of the call or instalment remains unpaid, serve a notice on him
                                         requiring payment of so much of the call or instalments together with any interest which
                                         may have accrued and all expenses that may have been incurred by the Company by reason
                                         of such non-payment.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">18.2</FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                         aforesaid notice shall name a further day (not earlier than the expiration of fourteen
                                         days from the date of service of the notice) on or before which the payment required
                                         by the notice is to be made, and shall state that in the event of non-payment at or before
                                         the time appointed the shares in respect of which the call was made will be liable to
                                         be forfeited.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">18.3</FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
                                         the requirements of any such notice as aforesaid are not complied with, any share in
                                         respect of which the notice has been given may at any time thereafter, before the payment
                                         required by the notice has been made, be forfeited, by a resolution of the Directors
                                         to that effect. Such forfeiture shall include all dividends declared or other monies
                                         due in respect of the forfeited shares and not actually paid before forfeiture.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">18.4</FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
                                         forfeited share may be sold or otherwise disposed of on such terms and in such manner
                                         as the Directors think fit, and at any time before a sale or disposition the forfeiture
                                         may be cancelled on such terms as the Directors think fit.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 17; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">&nbsp;</TD><TD STYLE="width: 33%; text-align: right"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">18.5</FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
                                         person whose shares have been forfeited shall cease to be a member in respect of the
                                         forfeited shares but shall, notwithstanding, remain liable to pay to the Company all
                                         monies (including any unpaid component of the Issue Price and interest which shall continue
                                         to accrue) which, at the date of forfeiture, were payable by him to the Company in respect
                                         of the shares, but his liability shall cease if and when the Company shall have received
                                         payment in full of all such monies in respect of the shares. The Directors may waive
                                         payment wholly or in part or enforce payment without any allowance for the value of the
                                         shares at the time of forfeiture or for any consideration received on their disposal.
                                         When any share shall have been forfeited, notice of the Directors&rsquo; resolution to that
                                         effect shall be given to the member in whose name it stood immediately prior to the forfeiture,
                                         and an entry of the forfeiture, with the date thereof, shall forthwith be made in the
                                         Register. Where for the purposes of its disposal a forfeited share is to be transferred
                                         to any person the Directors may authorize any person to execute an instrument of transfer
                                         of the share to that person.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">18.6</FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
                                         declaration in writing that the declarant is a Director or Secretary of the Company,
                                         and that a share in the Company has been duly forfeited on a date stated in the declaration,
                                         shall be conclusive evidence of the facts therein stated as against all persons claiming
                                         to be entitled to the share. The Company may receive the consideration, if any, given
                                         for the share on any sale or disposition thereof and may execute a transfer of the share
                                         in favour of the person to whom the share is sold or disposed of and he shall thereupon
                                         be registered as the holder of the share, and shall not be bound to see to the application
                                         of the purchase money, if any, nor shall his title to the share be affected by any irregularity
                                         or invalidity in the proceedings in reference to the forfeiture, sale or disposal of
                                         the share.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>19</B></FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Amendment
                                         of Memorandum of Association and Alteration of Capital</B></FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">19.1</FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Subject
                                         to and insofar as permitted by provisions of the Companies Law, the Company may from
                                         time to time by Ordinary Resolution (or where an Ordinary Resolution is disallowed by
                                         the Companies Law and a Special Resolution is required, by Special Resolution) alter
                                         or amend its memorandum of association otherwise than with respect to its name and objects
                                         and may hereby, without restricting the generality of the foregoing:</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">increase
                                         the share capital by such sum to be divided into shares of such amount or without nominal
                                         or par value as the resolution shall prescribe and with such rights priorities and privileges
                                         annexed thereto as may be determined;</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">consolidate
                                         and divide all or any of its share capital into shares of larger amount than its existing
                                         shares;</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)</FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">convert
                                         all or any of its paid-up shares into stock, and reconvert that stock into paid-up shares
                                         of any denomination;</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)</FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">by
                                         subdivision of its existing shares or any of them divide the whole or any part of its
                                         share capital into shares of smaller amount than is fixed by the memorandum of association
                                         of the Company or into shares without nominal or par value;</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)</FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">cancel
                                         any shares which at the date of the passing of the resolution have not been taken or
                                         agreed to be taken by any person and diminish the amount of its share capital by the
                                         amount of any shares so cancelled; and</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(f)</FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">reduce
                                         its share capital and any capital redemption reserve fund subject to any consent, order,
                                         Court approval or other matter required by law.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 18; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">&nbsp;</TD><TD STYLE="width: 33%; text-align: right"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">19.2</FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">All
                                         new shares created hereunder shall be subject to the same provisions with reference to
                                         the payment of calls, liens, transfer, transmission, forfeiture and otherwise as the
                                         shares in the original share capital.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">19.3</FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Subject
                                         to the provisions of the Companies Law, the Company may by Special Resolution change
                                         its name or alter its objects.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>20</B></FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>General
                                         Meetings</B></FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">20.1</FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                         annual general meeting of the Company shall be held in each year other than the year
                                         in which these Articles were adopted at such time and place as determined by the Directors.
                                         The Directors may, whenever they think fit, convene an extraordinary general meeting.
                                         If at any time there are not sufficient Directors capable of acting to form a quorum,
                                         any Director or any one or more members may convene an extraordinary general meeting
                                         in the same manner as nearly as possible as that in which meetings may be convened by
                                         the Directors.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">20.2</FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                         Directors shall, upon the requisition in writing of one or more members holding in the
                                         aggregate not less than one-tenth of such paid-up capital (as to Issue Price) of the
                                         Company as at the date of the requisition carries the right of voting at general meetings,
                                         convene an extraordinary general meeting. Any such requisition shall express the object
                                         of the meeting proposed to be called, and shall be left at or posted to the registered
                                         office and may consist of several documents in like form each signed by one or more requisitionists.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">20.3</FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
                                         the Directors do not proceed to convene a general meeting within twenty-one days from
                                         the date of such requisition being left as aforesaid, the requisitionist(s) or any one
                                         or more of them or any other member or members holding in the aggregate not less than
                                         one-tenth of such paid-up capital (as to Issue Price) of the Company as at the date of
                                         the requisition carries the right of voting at general meetings, may convene an extraordinary
                                         general meeting to be held at the registered office or at some convenient place at such
                                         time, subject to the Articles as to notice, as the person(s) convening the meeting fix.
                                         The requisitionists shall be reimbursed by the Company for all reasonable expenses incurred
                                         by them as a result of the failure by the Directors to convene the general meeting.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">20.4</FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Subject
                                         to the provisions of the Companies Law relating to Special Resolutions, seven days&rsquo;
                                         notice at the least specifying the place, the day and the hour of meeting and, in case
                                         of special business, the general nature of that business shall be given in manner hereinafter
                                         provided, or in such other manner (if any) as may be prescribed by the Company in general
                                         meeting, to such persons as are, under the Articles, entitled to receive such notices
                                         from the Company; but with the consent of members entitled to receive notice of some
                                         particular meeting or their proxies holding at least in the aggregate not less than ninety
                                         percent (90%) of the paid-up share capital of the Company (as to Issue Price) giving
                                         the right to attend and vote at general meetings of the Company, that meeting may be
                                         convened by such shorter notice and in such manner as those members or their proxies
                                         may think fit.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">20.5</FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                         accidental omission to give notice of a meeting to, or the non-receipt of a notice of
                                         a meeting by, any member entitled to receive notice shall not invalidate the proceedings
                                         at any meeting.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 19; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">&nbsp;</TD><TD STYLE="width: 33%; text-align: right"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">20.6</FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">All
                                         business that is transacted at an extraordinary general meeting and all that is transacted
                                         at any annual general meeting, with the exception of the sanctioning of a dividend and
                                         the consideration of the accounts, balance sheet, the annual report of the Directors
                                         and the Auditors&rsquo; report shall be deemed to be special.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">20.7</FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">When
                                         all members entitled to be present and vote sign either personally or by proxy the minutes
                                         of a general meeting, the same shall be deemed to have been duly held notwithstanding
                                         that the members have not actually come together or that there may have been technical
                                         defects in the proceedings and a resolution in writing (in one or more counterparts)
                                         signed by all members personally or by proxy as aforesaid (a person being a proxy for
                                         one or more members being entitled to sign such resolution on behalf of each such member)
                                         shall be as valid and effectual as if it had been passed at a meeting of the members
                                         duly called and constituted.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>21</B></FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Proceedings
                                         at General Meetings</B></FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">21.1</FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">No
                                         business shall be transacted at any general meeting unless a quorum of members is present
                                         at the time when the meeting proceeds to business; two (2) members present in person
                                         or by proxy, one of whom shall be the holder of the majority of the shares in the Company,
                                         shall be a quorum provided always that if the Company has one member of record the quorum
                                         shall be that one (1) member present in person or by proxy.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">21.2</FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If,
                                         within half an hour from the time appointed for the meeting a quorum is not present,
                                         the meeting, if convened upon the requisition of member(s), shall be dissolved; in any
                                         other case it shall stand adjourned to the same day in the next week, at the same time
                                         and place or to such other day and at such other time and place as the Directors may
                                         determine and if at the adjourned meeting a quorum is not present within half an hour
                                         from the time appointed for the meeting the members present shall be a quorum.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">21.3</FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                         Chairman, if any, of the board of Directors shall preside as Chairman at every general
                                         meeting of the Company, or if there is no such Chairman, or if he shall not be present
                                         within fifteen minutes after the time appointed for the holding of the meeting or is
                                         unwilling to act, the Directors present shall elect one of their number to be Chairman
                                         of the meeting.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">21.4</FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
                                         at any meeting no Director is willing to act as Chairman or if no Director is present
                                         within fifteen minutes after the time appointed for holding the meeting, the members
                                         present shall choose one of their number to be Chairman of the meeting.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">21.5</FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                         Chairman may, with the consent of any meeting at which a quorum is present (and shall
                                         if so directed by the meeting), adjourn the meeting from time to time and from place
                                         to place but no business shall be transacted at any adjourned meeting other than the
                                         business left unfinished at the meeting from which the adjournment took place. When a
                                         meeting is adjourned for thirty days or more, notice of the adjourned meeting shall be
                                         given as in the case of an original meeting. Save as aforesaid, it shall not be necessary
                                         to give any notice of an adjournment or of the business to be transacted at an adjourned
                                         meeting.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">21.6</FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">At
                                         any general meeting a resolution put to the vote of the meeting shall be decided on a
                                         show of hands unless a poll is (before or on the declaration of the result of the show
                                         of hands) demanded</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">by
                                         the Chairman; or</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 20; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">&nbsp;</TD><TD STYLE="width: 33%; text-align: right"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">by
                                         any member or members present in person or by proxy and representing not less than one
                                         tenth of the total voting rights of all the members having the right to vote at the meeting;
                                         or</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)</FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">by
                                         a member or members holding shares conferring a right to vote at the meeting being shares
                                         on which an aggregate sum has been paid-up (as to Issue Price) equal to not less than
                                         one tenth of the total sum paid up (as to Issue Price) on all the shares conferring that
                                         right.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">21.7</FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Unless
                                         a poll be so demanded, a declaration by the Chairman that a resolution has on a show
                                         of hands been carried, or carried unanimously, or by a particular majority, or lost,
                                         and an entry to that effect in the book containing the minutes of the proceedings of
                                         the Company shall be conclusive evidence of the fact without proof of the number or portion
                                         of the votes recorded in favour of or against such resolution. A demand for a poll may
                                         be withdrawn.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">21.8</FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
                                         the case of an equality of votes, whether on a show of hands or on a poll, the Chairman
                                         of the meeting at which the show of hands takes place or at which the poll is demanded,
                                         shall be entitled to a casting vote.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">21.9</FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
                                         poll demanded on the election of a Chairman or on a question of adjournment shall be
                                         taken forthwith. A poll demanded on any other question shall be taken at such time and
                                         in such manner as the Chairman of the meeting directs and the result of the poll shall
                                         be deemed to be the resolution of the meeting at which the poll was demanded. Any business
                                         other than that upon which a poll has been demanded may be proceeded with pending the
                                         taking of the poll.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">21.10</FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
                                         for so long as the Company has only one member:</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">in
                                         relation to a general meeting, the sole member or a proxy for that member or (if the
                                         member is a corporation) a duly authorized representative of that member is a quorum;
                                         and</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                         sole member may agree that any general meeting be called by shorter notice than that
                                         provided for by the Articles; and</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)</FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">all
                                         other provisions of the Articles apply with any necessary modification (unless the provision
                                         expressly provides otherwise).</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>22</B></FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Votes
                                         of Members</B></FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">22.1</FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Subject
                                         to any rights or restrictions for the time being attached to any class or classes of
                                         shares, on a show of hands every member present in person or by proxy at a general meeting
                                         shall have one vote and on a poll every member present in person or by proxy shall have
                                         one vote for each share registered in his name on the Register.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">22.2</FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
                                         the case of joint holders the vote of the senior who tenders a vote, whether in person
                                         or by proxy, shall be accepted to the exclusion of the votes of the other joint holders;
                                         and for this purpose seniority shall be determined by the order in which the names stand
                                         in the Register.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">22.3</FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
                                         member of unsound mind, or in respect of whom an order has been made by any court having
                                         jurisdiction in lunacy, may vote, whether on a show of hands or on a poll, by his committee,
                                         receiver, curator bonis, or other person in the nature of a committee, receiver or curator
                                         bonis appointed by that court, and any such committee, receiver, curator bonis or other
                                         person may, on a poll, vote by proxy.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 21; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">&nbsp;</TD><TD STYLE="width: 33%; text-align: right"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">22.4</FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">No
                                         person shall be entitled to vote at any general meeting unless he is registered as a
                                         member in the Register on the date of such meeting and unless all calls or other sums
                                         presently payable by him in respect of shares of the Company have been paid.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">22.5</FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">No
                                         objection shall be raised to the qualifications of any voter except at the meeting or
                                         adjourned meeting at which the vote objected to is given or tendered and every vote not
                                         disallowed at such meeting shall be valid for all purposes. Any such objection made in
                                         due time shall be referred to the Chairman of the meeting, whose decision shall be final
                                         and conclusive.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">22.6</FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
                                         a poll or on a show of hands votes may be given either personally or by proxy. On a poll,
                                         a member entitled to more than one vote need not, if he votes, use all his votes or cast
                                         all votes he uses the same way.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>23</B></FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Proxies</B></FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">23.1</FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                         instrument appointing a proxy shall be in writing under the hand of the appointor or
                                         of his attorney duly authorised in writing or, if the appointor is a corporation, either
                                         under seal or under the hand of an officer or attorney duly authorised. A proxy need
                                         not be a member of the Company. Deposit or delivery of a form of appointment of a proxy
                                         does not preclude a member from attending and voting at the meeting or at any adjournment
                                         of it.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">23.2</FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                         instrument appointing a proxy shall be deposited at the registered office or the Registration
                                         Office or at such other place as is specified for that purpose in the notice convening
                                         the meeting no later than <FONT STYLE="color: windowtext">four (4) hours prior to the
                                         commencement of the meeting at such time as scheduled,</FONT>, or adjourned meeting,
                                         provided that the Chairman of the meeting may at his discretion direct that an instrument
                                         of proxy shall be deemed to have been duly deposited upon receipt of confirmation from
                                         the appointor that the instrument of proxy duly signed is in the course of transmission
                                         to the Company. The Directors may require the production of any evidence which they consider
                                         necessary to determine the validity of any appointment pursuant to this Article.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">23.3</FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                         instrument appointing a proxy may be in any form acceptable to the Directors and may
                                         be expressed to be for a particular meeting and/or any adjournment thereof or generally
                                         until revoked.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">23.4</FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                         instrument appointing a proxy shall be deemed to confer authority to demand and to join
                                         in demanding a poll.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">23.5</FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
                                         vote given in accordance with the terms of an instrument of proxy shall be valid notwithstanding
                                         the previous death or insanity of the principal or revocation of the proxy or of the
                                         authority under which the proxy was executed or the transfer of the share in respect
                                         of which the proxy is given, provided that no intimation in writing of such death, insanity,
                                         revocation or transfer as aforesaid shall have been received by the Company at the registered
                                         office before the commencement of the meeting or adjourned meeting at which the proxy
                                         is used.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"></P>

<!-- Field: Page; Sequence: 22; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">&nbsp;</TD><TD STYLE="width: 33%; text-align: right"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"></P>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>24</B></FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Corporations
                                         Acting by Representatives at Meetings and Clearing House</B></FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">24.1</FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Any
                                         corporation which is a member may by resolution of its directors or other governing body
                                         authorise such person as it thinks fit to act as its representative at any meeting of
                                         the Company or of any class of members and the person so authorised shall be entitled
                                         to exercise the same powers on behalf of the corporation which he represents as that
                                         corporation could exercise if it were an individual member.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">24.2</FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
                                         a Clearing House (or its nominee(s)) or a central depository entity, being a corporation,
                                         is a member, it may authorise such persons at it thinks fit to act as its representatives
                                         at any meeting of the Company or at any meeting of any class of member provided that
                                         the authorisation shall specify the number and class of shares in respect of which each
                                         such representative is so authorised. Each person so authorised under the provisions
                                         of this Article shall be deemed to have been duly authorised without further evidence
                                         of the facts and be entitled to exercise the same rights and powers on behalf of the
                                         Clearing House or central depository entity (or its nominee(s)) as if such person was
                                         the registered holder of the shares of the Company held by the Clearing House or a central
                                         depository entity (or its nominee(s)) including the right to vote.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>25</B></FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Directors</B></FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">25.1</FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                         Company shall have a Board of Directors consisting of not less than three (3) Directors.
                                         The Board may impose a maximum or minimum number of Directors required to hold office
                                         at any of time and vary such limits from time to time, so that the number of Directors
                                         shall not be less than three (3)<B>.</B></FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">25.2</FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                         remuneration to be paid to the Directors shall be such remuneration as the Directors
                                         shall determine and as is in accordance with the Charter of the Compensation Committee
                                         of the Board (the &ldquo;<B>Compensation Charter</B>&rdquo;), as applicable and the Company&rsquo;s
                                         other corporate governance documents. Such remuneration shall be deemed to accrue from
                                         day to day. The Directors may also be paid travelling, hotel and other expenses properly
                                         incurred by them in attending and returning from meetings of the Directors or any committee
                                         of the Directors or general meetings of the Company or in connection with the business
                                         of the Company or the discharge of their duties as a Director, or receive a fixed allowance
                                         in respect thereof as may be determined by the Directors from time to time or a combination
                                         of partly of one such method and partly the other. The Directors may provide benefits,
                                         whether by the payment of gratuities or pensions or by insurance or otherwise, for any
                                         existing Director or any Director who has held but no longer holds any executive office
                                         or employment with the Company or with any body corporate which is or has been a subsidiary
                                         of the Company or a predecessor in business of the Company or of any such subsidiary,
                                         and for any member of his family (including a spouse and a former spouse) or any person
                                         who is or was dependent on him, and may (as well before as after he ceases to hold such
                                         office or employment) contribute to any fund and pay premiums for the purchase or provision
                                         of any such benefit.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">25.3</FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                         shareholding qualification for Directors may be fixed by the Company in general meeting,
                                         and unless and until so fixed no qualification shall be required.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 23; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">&nbsp;</TD><TD STYLE="width: 33%; text-align: right"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">25.4</FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Subject
                                         to the Company&rsquo;s Code of Ethics, especially Article III thereof, a Director or
                                         alternate Director may be or become a Director or other officer of, or otherwise interested
                                         in, any company promoted by the Company or in which the Company may be interested as
                                         shareholder or otherwise, and no such Director shall be accountable to the Company for
                                         any remuneration or other benefits received by him as a Director or officer of, or from
                                         his interest in, such other company unless the Company otherwise directs in general meeting.
                                         Notwithstanding the foregoing, no &ldquo;Independent Director&rdquo; as defined in the
                                         rules of the Designated Stock Exchange or in Rule 10A-3 under the Exchange Act and with
                                         respect of whom the Board has determined constitutes an &ldquo;Independent Director&rdquo;
                                         for purposes of compliance with applicable law or the Company&rsquo;s listing requirements,
                                         shall without the consent of the Audit Committee take any of the foregoing actions or
                                         any other action that would reasonably be likely to affect such Director&rsquo;s status
                                         as an &ldquo;Independent Director&rdquo; of the Company;</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">25.5</FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                         Directors may by resolution award special remuneration to any Director undertaking any
                                         special work or services which in the opinion of the Directors are beyond his ordinary
                                         routine work as a Director. Any fees paid to a Director who is also counsel or attorney-at-law
                                         to the Company, or otherwise serves it in a professional capacity, shall be in addition
                                         to his remuneration as a Director.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">25.6</FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
                                         Director or alternate Director may act by himself or his firm in a professional capacity
                                         for the Company, and he or his firm shall be entitled to remuneration for professional
                                         services as if he were not a Director or alternate Director; provided that nothing herein
                                         obtained shall authorise a Director or alternate Director or his firm to act as Auditor
                                         of the Company; provided, further that such Director or alternate Director, as the case
                                         may be, obtains written approval from the Audit Committee before performing any such
                                         act or providing such services and accepting any remuneration therefor. All fees paid
                                         pursuant to this Article 25.6 are subject to, and shall be paid in accordance with the
                                         Compensation Charter.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>26</B></FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Alternate
                                         Directors and Proxy Directors</B></FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">26.1</FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
                                         Director may by writing appoint any person to be an alternate Director in his place.
                                         Any appointment or removal of an alternate Director shall be by notice to the Company
                                         signed by the Director making or revoking the appointment or in any other manner approved
                                         by the Directors. The person so appointed shall be entitled to attend, speak and vote
                                         at meetings of the Directors, and at all meetings of committees of Directors that his
                                         appointor is a member of, when the Director appointing him is not personally present
                                         and to sign any written resolution of the Directors and shall automatically vacate his
                                         office on the expiration of the term for or the happening of the event until which he
                                         is by the terms of his appointment to hold office or if the appointor in writing revokes
                                         the appointment or himself ceases for any reason to hold office as a Director. An appointment
                                         of an alternate Director under this Article shall not prejudice the right of the appointor
                                         to attend and vote at meetings of the Directors and the powers of the alternate Director
                                         shall automatically be suspended during such time as the Director appointing him is himself
                                         present in person at a meeting of the Directors. An alternate Director shall be deemed
                                         to be appointed by the Company and not deemed to be the agent of the Director appointing
                                         him and shall alone be responsible for his own acts and defaults.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">26.2</FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
                                         Director may be represented at any meetings of the Directors by a proxy appointed by
                                         him in which event the presence or vote of the proxy shall for all purposes be deemed
                                         to be that of the Director.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">26.3</FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                         provisions of these Articles applicable to alternate Directors shall <I>mutatis mutandis
                                         </I>apply to the appointment of proxies by Directors, save that any person appointed
                                         as a proxy pursuant to paragraph 26.2 above shall be the agent of the Director, and not
                                         an officer of the Company.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 24; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">&nbsp;</TD><TD STYLE="width: 33%; text-align: right"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->21<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>27</B></FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Powers
                                         and Duties of Directors</B></FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">27.1</FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                         business of the Company shall be managed by the Directors (or a sole Director if only
                                         one is appointed) who may exercise all the powers of the Company save where inconsistent
                                         with the Companies Law or these Articles PROVIDED HOWEVER that no regulations made by
                                         the Company in general meeting shall invalidate any prior act of the Directors which
                                         would have been valid if that regulation had not been made. The powers given by this
                                         Article shall not be limited by any special power given to the Directors by the Articles
                                         and a meeting of Directors at which a quorum is present may exercise all powers exercisable
                                         by the Directors.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">27.2</FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Without
                                         limitation, the Directors may exercise all the powers of the Company to borrow or raise
                                         monies, and to mortgage or charge its undertaking, property and uncalled capital, or
                                         any part thereof, and to issue debentures, debenture stock, and other securities whether
                                         outright or as security for any debt liability or obligation of the Company or of any
                                         third party.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">27.3</FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">All
                                         cheques, promissory notes, drafts, bills of exchange or other negotiable instruments,
                                         and all receipts for monies paid to the Company shall be signed, drawn, accepted, endorsed
                                         or otherwise executed, as the case may be, in such manner as the Directors shall from
                                         time to time determine by resolution.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">27.4</FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                         Directors shall cause minutes to be made in books provided for the purpose:</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">of
                                         all appointments of officers made by the Directors;</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">of
                                         the names of the Directors or their alternates present at each meeting of the Directors
                                         and of any committee of the Directors;</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)</FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">of
                                         all resolutions and proceedings at all meetings of the Company, and of the Directors,
                                         and of committees of Directors.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">27.5</FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                         Directors on behalf of the Company may pay a gratuity or pension or allowance on retirement
                                         to any Director who has held any other salaried office or place of profit with the Company
                                         or to his widow or dependents and make contributions to any fund and pay premiums for
                                         the purchase or provision of any such gratuity, pension or allowance, in accordance with
                                         the Compensation Charter.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>28</B></FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Director
                                         or Officer Contracting with Company</B></FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">28.1</FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">So
                                         long as it does not adversely affect such person&rsquo;s performance of duties or responsibilities
                                         to the Company and so long as it is not in direct competition with the Company and the
                                         Company&rsquo;s business, no Director or officer shall be disqualified by his office
                                         from contracting and/or dealing with the Company as vendor, purchaser or otherwise; nor
                                         shall any such contract or any contract or arrangement entered into by or on behalf of
                                         the Company in which any Director or officer shall be in any way interested be or be
                                         liable to be avoided; nor shall any Director or officer so contracting or being so interested
                                         be liable to account to the Company for any profit realised by any such contract or arrangement
                                         by reason of such Director or officer holding that office or the fiduciary relationship
                                         thereby established. However, any such transaction that would reasonably be likely to
                                         affect a Director&rsquo;s status as an &ldquo;Independent Director&rdquo;, or that would
                                         constitute a &ldquo;related party transaction&rdquo; pursuant to the laws or rules promulgated
                                         by the SEC or Designated Stock Exchange shall require the review and approval of the
                                         Audit Committee. The nature of the Director&rsquo;s interest must be disclosed by him
                                         at the meeting of the Directors at which the contract or arrangement is considered if
                                         his interest then exists, or in any other case, at the first meeting of the Directors
                                         after the acquisition of his interest. A Director, having disclosed his interest as aforesaid,
                                         shall not be counted in the quorum and shall refrain from voting as a Director in respect
                                         of any contract or arrangement in which he is so interested as aforesaid.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 25; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">&nbsp;</TD><TD STYLE="width: 33%; text-align: right"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->22<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">28.2</FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
                                         general written notice to the Board and the Audit Committee that a Director is a member
                                         of a specified firm or company and is to be regarded as interested in all transactions
                                         with that firm or company shall be a sufficient disclosure under the immediately preceding
                                         Article as regards such Director and the said transactions and after such general notice
                                         it shall not be necessary for such Director to give a special notice relating to any
                                         particular transaction with that firm or company, so long as the transactions are approved
                                         by the Board. An interest of which a Director has no knowledge and of which it is unreasonable
                                         to expect him to have knowledge shall not be treated as an interest of his.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">28.3</FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
                                         Director may hold any other office or place of profit under the Company (other than the
                                         office of Auditor) in conjunction with his office of Director for such period and on
                                         such terms (as to remuneration and otherwise) as the Directors may determine.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>29</B></FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Appointment
                                         and Removal of Directors</B></FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">29.1</FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
                                         Director may be appointed by Ordinary Resolution or by the Directors. Any appointment
                                         may be either to fill a casual vacancy or as an addition to the existing Directors but
                                         so that the total number of Directors (exclusive of alternate Directors) shall not at
                                         any time exceed the number fixed in accordance with these Articles.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">29.2</FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
                                         Director may be removed by the Directors or by Ordinary Resolution. In addition at any
                                         time and from time to time, the holder or holders of more than half of the paid-up share
                                         capital of the Company (as to Issue Price) having the right to attend and vote at general
                                         meetings of the Company may appoint any person to be a Director and may in like manner
                                         remove any Director and may in like manner appoint another person in his stead.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">29.3</FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                         Company may from time to time, by Ordinary Resolution, set, increase or reduce the maximum
                                         number of Directors who may constitute the board of Directors.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">29.4</FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
                                         so long as shares are listed on a Designated Stock Exchange, the Directors shall include
                                         at least such number of independent directors as applicable law, rules or regulations
                                         or the Designated Stock Exchange rules require as determined by the Board.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>30</B></FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Board&rsquo;s
                                         Power to appoint Directors</B></FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">30.1</FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Without
                                         prejudice to the Company&rsquo;s power to appoint a person to be a Director pursusant
                                         to these Articles, the Board shall have power at any time to appoint any person who is
                                         willing to act as a Director, either to fill a vacancy or as an addition to the existing
                                         Board, sujbect to the total number of Directors not exceeding any maximum number fixed
                                         by or in accordance with these Articles.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">30.2</FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Any
                                         Director so appointed shall, if still a Director, retire at the next annual general meeting
                                         after his appointment and be eligible to stand for election as a Director at such meeting.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 26; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">&nbsp;</TD><TD STYLE="width: 33%; text-align: right"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->23<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>31</B></FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Appointment
                                         at Annual General Meeting</B></FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Unless
re-appointed pursuant to the provisions of Article 29.1 or removed from office pursuant to the provisions of Article 32.1, each
Director shall be appointed for a term expiring at the next-following annual general meeting of the Company. At any such annual
general meeting, Directors will be elected by Ordinary Resolution. At each annual general meeting of the Company, each Director
elected at such meeting shall be elected to hold office for one-year term and until the election of their respective successors
in office or in removal pursuant to Articles 29.1 and 32.1.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>32</B></FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Removal
                                         of Directors</B></FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">32.1</FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Directors
                                         shall be removed in accordance with Article 29.2.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>33</B></FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Resignation
                                         of Directors</B></FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">33.1</FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
                                         Director may at any time resign office by giving to the Company notice in writing or,
                                         if permitted pursuant to the notice provisions, in an Electronic Record delivered in
                                         either case in accordance with those provisions.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">33.2</FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Unless
                                         the notice specifies a different date, the Director shall be deemed to have resigned
                                         on the date that the notice is delivered to the Company.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>34</B></FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Termination
                                         of Directors</B></FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">34.1</FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
                                         Director may retire from office as a Director by giving notice in writing to that effect
                                         to the Company at the registered office, which notice shall be effective upon such date
                                         as may be specified in the notice, failing which upon delivery to the registered office.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">34.2</FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Without
                                         prejudice to the provisions in these Articles for retirement, a Director&rsquo;s office
                                         shall be terminated forthwith if the Director:</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">is
                                         prohibited by law from serving as a Director;</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">becomes
                                         bankrupt or makes any arrangement or composition with his creditors; or</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)</FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">dies
                                         or is found to be or becomes of unsound mind;</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)</FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">resigns
                                         his office by notice in writing to the Company or otherwise pursuant to any agreement
                                         between the Company and such Director;</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)</FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">is
                                         removed from office by notice of the holder or holders of more than half of the paid-up
                                         share capital of the Company (as to Issue Price) having the right to attend and vote
                                         at general meetings of the Company notwithstanding anything in the Articles or any agreement
                                         between the Company and such Director;</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(f)</FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">is
                                         requested by all the other Directors (numbering at least two) to resign; or</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(g)</FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">if
                                         he absents himself (without being represented by proxy or an alternate Director appointed
                                         by him) from three consecutive meetings of the Board without special leave of absence
                                         from the Directors, and they pass a resolution that he has by reason of such absence
                                         vacated office.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 27; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">&nbsp;</TD><TD STYLE="width: 33%; text-align: right"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->24<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>35</B></FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Proceedings
                                         of Directors</B></FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">35.1</FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                         Directors may meet together for the dispatch of business, adjourn and otherwise regulate
                                         their meetings as they think fit. The Directors shall meet at least twice a year or more
                                         frequently as may be required. Questions arising at any meeting shall be decided by a
                                         majority of votes. In case of an equality of votes, the Chairman shall have a second
                                         or casting vote. The Chairman or any Directors may, and the Secretary on the requisition
                                         of a Director shall, at any time summon a meeting of the Directors. Every Director shall
                                         receive notice of a board meeting. Notice of a board meeting is deemed to be duly given
                                         to a Director if it is given to him personally or by word of mouth or by electronic communication
                                         to an address given by him to the Company for that purpose or sent in writing to him
                                         at his last known address or other address given by him to the Company for that purpose.
                                         A Director or his alternate may waive the requirement that notice be given to the Director
                                         of a meeting of the board of Directors or committee of the Directors, either prospectively
                                         or retrospectively.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">35.2</FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                         quorum necessary for the transaction of the business of the Directors shall be two Directors
                                         present in person or by this alternate provided that at least one (1) of whom shall be
                                         the Chairman. A Director and his appointed alternate Director being considered only one
                                         person for this purpose, PROVIDED ALWAYS that if there shall at any time be only a sole
                                         Director the quorum shall be one. If within half an hour from the time appointed for
                                         a meeting of Directors a quorum is not present the meeting shall be adjourned to such
                                         time and place as the Chairman may determine or failing which, to the same day of the
                                         next week at the same time and place. If no quorum is present at the adjourned meeting
                                         the meeting shall be dissolved. One person may represent more than one Director by alternate
                                         and for the purposes of determining whether or not a quorum is present and voting each
                                         appointment of an alternate shall be counted.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">35.3</FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                         continuing Directors or sole continuing Director may act notwithstanding any vacancy
                                         in their body but, if and so long as their number is reduced below the number fixed by
                                         or pursuant to the Articles as the necessary quorum of Directors, the continuing Directors
                                         or Director may act for the purpose of increasing the number of Directors to that number,
                                         or of summoning a general meeting of the Company, but for no other purpose.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">35.4</FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
                                         no Chairman is appointed, Directors may elect a Chairman of their meetings and determine
                                         the period for which he is to hold office; but if no such Chairman is elected, or if
                                         at any meeting the Chairman is not present within five minutes after the time appointed
                                         for holding the same, the Directors present may choose one of their number to be Chairman
                                         of the meeting.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">35.5</FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
                                         not otherwise designated by the Board, a committee may elect a Chairman of its meetings;
                                         if no such Chairman is elected, or if at any meeting the Chairman is not present the
                                         members present may choose one of their number to be Chairman of the Meeting, in accordance
                                         with the committee&rsquo;s charter, if any.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">35.6</FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
                                         committee may meet and adjourn as it thinks proper. Questions arising at any meeting
                                         shall be determined by a majority of votes of the members present, and in the case of
                                         an equality of votes the Chairman shall have a second or casting vote.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">35.7</FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">All
                                         acts done by any meeting of the Directors or of a committee of the Directors (including
                                         any person acting as an alternate Director) shall, notwithstanding that it is afterwards
                                         discovered that there was some defect in the appointment of any Director or alternate
                                         Director, and/or that they or any of them were disqualified, and/or had vacated their
                                         office and/or were not entitled to vote, be as valid as if every such person had been
                                         duly appointed and/or not disqualified to be a Director or alternate Director and/or
                                         had not vacated their office and/or had been entitled to vote, as the case may be.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 28; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">&nbsp;</TD><TD STYLE="width: 33%; text-align: right"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->25<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">35.8</FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
                                         resolution in writing signed by all the Directors entitled to receive notice of a meeting
                                         of Directors (or their respective alternates) shall be as valid and effective for all
                                         purposes as a resolution of Directors duly passed at a meeting of the Directors duly
                                         convened, held and constituted. Any such resolution may consist of several documents,
                                         provided that each such document is signed by one or more Directors.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">35.9</FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Any
                                         Director or Directors or any committee thereof may participate in any meeting of the
                                         board of Directors or of such committee by means of conference telephone or similar communications
                                         equipment by means of which all persons participating in the meeting can hear each other
                                         and participation in a meeting pursuant to this provision shall constitute presence in
                                         person at such meeting. All business transacted in this way by the Directors or a committee
                                         of Directors is for the purpose of the Articles deemed to be validly and effectively
                                         transacted at a meeting of the Directors or of a committee of Directors although fewer
                                         than two Directors or alternate Directors are physically present at the same place.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">35.10</FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
                                         and for so long as there is a sole Director of the Company:</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">he
                                         may exercise all powers conferred on the Directors by the Articles by any means permitted
                                         by the Articles or the Companies Law;</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                         quorum for the transaction of business is one; and</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)</FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">all
                                         other provisions of the Articles apply with any necessary modification (unless the provision
                                         expressly provides otherwise).</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>36</B></FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Managing
                                         Director</B></FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">36.1</FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                         Directors may from time to time appoint one or more of their body to the office of managing
                                         director for such period and on such terms as they think fit and, subject to the terms
                                         of any agreement entered into in any particular case, may revoke such appointment. A
                                         Director so appointed shall be subject to the same provisions as regards removal and
                                         disqualification as the other Directors and his appointment shall be automatically determined
                                         if he ceases for any cause to be a Director.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">36.2</FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
                                         managing director shall receive such remuneration (whether by way of salary, commission
                                         or participation in profits, or partly in one way and partly in another) as the Directors
                                         may determine.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">36.3</FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                         Directors may entrust to and confer upon a managing director any powers, authorities
                                         and discretions exercisable by them upon such terms and conditions and with such restrictions
                                         as they may think fit, and either collaterally with or to the exclusion of their own
                                         powers and may from time to time revoke, alter, withdraw or vary all or any of such powers.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>37</B></FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Presumption
                                         of Assent</B></FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
Director who is present at a meeting of the board of Directors at which action on any Company matter is taken shall be presumed
to have assented to the action taken unless his dissent shall be entered in the minutes of the meeting or unless he shall file
his written dissent to such action with the person acting as secretary of the meeting before the adjournment thereof or shall
forward such dissent by registered mail to the Secretary immediately after the adjournment of the meeting. Such right to dissent
shall not apply to a Director who voted in favour of such action.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 29; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">&nbsp;</TD><TD STYLE="width: 33%; text-align: right"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->26<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>38</B></FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Management</B></FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">38.1</FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                         Directors may from time to time provide for the management of the affairs of the Company
                                         in such manner as they think fit and the provisions contained in the three next following
                                         Articles shall be without prejudice to the general powers conferred by this Article.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">38.2</FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                         Directors from time to time and at any time may establish any committees, (including
                                         without limitation on Audit Committee) boards or agencies, may appoint any persons to
                                         be members of such committees or boards, may appoint any managers or agents, and may
                                         fix their remuneration. Any committee so formed shall in the exercise of powers so delegated
                                         conform to any regulations that may be imposed on it by the Directors.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">38.3</FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                         Directors from time to time and at any time may delegate to any such committee, board,
                                         manager or agent any of the powers, authorities and discretions for the time being vested
                                         in the Directors and may authorise the members for the time being of any such board,
                                         or any of them, to fill up any vacancy therein, and to act notwithstanding vacancies,
                                         and any such appointment or delegation may be made on such terms and subject to such
                                         conditions as the Directors may think fit, and the Directors may at any time remove any
                                         person so appointed, and may annul or vary any such delegation, but no person dealing
                                         in good faith and without notice of any such annulment or variation shall be affected
                                         thereby. Where a provision of the Articles refers to the exercise of a power, authority
                                         or discretion by the Directors and that power, authority or discretion has been delegated
                                         by the Directors to a committee, the provision shall be construed as permitting the exercise
                                         of the power, authority or discretion by the committee.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">38.4</FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                         Directors may from time to time and at any time by power of attorney appoint any company,
                                         firm or person or body of persons, whether nominated directly or indirectly by the Directors,
                                         to be the attorney or attorneys of the Company for such purposes and with such powers,
                                         authorities and discretions (not exceeding those vested in or exercisable by the Directors
                                         under the Articles) and for such period and subject to such conditions as they may think
                                         fit, and any such powers of attorney may contain such provisions for the protection and
                                         convenience of persons dealing with any such attorney as the Directors may think fit
                                         and may also authorise any such attorney to delegate all or any of the powers, authorities
                                         and discretions vested in him.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">38.5</FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Any
                                         such delegates as aforesaid may be authorised by the Directors to sub-delegate all or
                                         any of the powers, authorities and discretions for the time being vested in them.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>39</B></FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Audit
                                         Committee</B></FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">39.1</FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Without
                                         prejudice to the freedom of the Directors to establish any other committees, for so long
                                         as the shares of the Company (or depository receipts therefor) are listed or quoted on
                                         the Designated Stock Exchange, the Board shall establish and maintain an Audit Committee
                                         as a committee of the Board, the composition and responsibilities of which shall comply
                                         with the rules of the Designated Stock Exchange and the rules and regulations of the
                                         SEC.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 30; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">&nbsp;</TD><TD STYLE="width: 33%; text-align: right"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->27<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">39.2</FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                         Board shall adopt a formal written audit committee charter and review and assess the
                                         adequacy of the formal written charter on an annual basis.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">39.3</FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                         Audit Committee shall meet at least once every financial quarter or more frequently as
                                         circumstances dictate.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">39.4</FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
                                         so long as the Shares of the Company (or depository receipts therefor) are listed or
                                         quoted on the Designated Stock Exchange, the Company shall conduct an appropriate review
                                         of all related party transactions on an ongoing basis and shall utilize the Audit Committee
                                         for the review and approval of potential conflicts of interest. Specifically, the Audit
                                         Committee shall approve any transaction or transactions between the Company and any of
                                         the following parties: (i) any shareholder owning an interest in the voting power of
                                         the Company or any subsidiary of the Company that gives such shareholder significant
                                         influence over the Company or any subsidiary of the Company, (ii) any Director or executive
                                         officer of the Company or any subsidiary of the Company and any relative of such Director
                                         or executive officer, (iii) any person in which a substantial interest in the voting
                                         power of the Company is owned, directly or indirectly, by any person described in (i)
                                         or (ii) or over which such a person is able to exercise significant influence, and (iv)
                                         any affiliate (other than a subsidiary) of the Company.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>40</B></FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Officers</B></FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">40.1</FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Officers
                                         of the Company may be elected by the Company in general meeting by Ordinary Resolution
                                         or appointed by the Directors and may consist of a president, one or more vice presidents,
                                         a Secretary, one or more assistant secretaries, a treasurer, one or more assistant treasurers
                                         and such other officers as the Company in general meeting by Ordinary Resolution or the
                                         Directors may from time to time think necessary and all such officers shall perform such
                                         duties as may be prescribed by the Company in general meeting by Ordinary Resolution
                                         or the Directors. They shall hold office until their successors are elected or appointed
                                         but any officer may be removed at any time by the Company in general meeting by Ordinary
                                         Resolution or by the Directors. If any office becomes vacant the Company in general meeting
                                         by Ordinary Resolution or the Directors may fill the same. Any person may hold more than
                                         one of these offices and no officer need be a member or Director.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>41</B></FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>The
                                         Seal</B></FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">41.1</FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                         Company may, if the Directors so determine, have a Seal. The Directors shall provide
                                         for the safe custody of the Seal which shall only be used with the authority of the Directors
                                         or a committee of the Directors authorised in that regard. Every instrument to which
                                         the Seal shall be affixed shall be signed by a Director or other person authorised by
                                         the Directors for that purpose. Notwithstanding the provisions hereof, a Director, Secretary
                                         or other officer may affix the Seal to returns, lists, notices, certificates or any other
                                         documents required to be authenticated by him under Seal or to be filed with the Registrar
                                         of Companies in the Cayman Islands or elsewhere under his signature alone.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">41.2</FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                         Company may exercise the powers conferred by the Companies Law with regard to having
                                         a duplicate seal for use abroad and such powers shall be vested in the Directors.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 31; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">&nbsp;</TD><TD STYLE="width: 33%; text-align: right"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->28<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>42</B></FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Dividends
                                         and Reserve</B></FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">42.1</FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Subject
                                         to the Companies Law and these Articles, the Directors may from time to time declare
                                         dividends (including interim dividends) and distributions on issued shares of the Company
                                         and authorise payment of the same out of funds of the Company lawfully available therefor.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">42.2</FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">No
                                         dividend or distribution shall be paid except out of the profits of the Company, realised
                                         or unrealised, or out of the share premium account or as otherwise permitted by the Companies
                                         Law.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">42.3</FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                         Directors may, before declaring any dividends or distributions, set aside such sums as
                                         they think proper as a reserve or reserves which shall at the discretion of the Directors
                                         be applicable for any purpose of the Company and pending such application may, at the
                                         like discretion, be employed in the business of the Company.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">42.4</FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Subject
                                         to the rights of persons, if any, entitled to shares with special rights as to dividends
                                         or distributions, if dividends or distributions are to be declared on a class of shares
                                         they shall be declared and paid according to the amounts paid or credited as paid on
                                         the shares of such class issued on the record date for such dividend or distribution
                                         but no amount paid or credited as paid on a share in advance of calls shall be treated
                                         for the purposes of this Article as paid on the share. If at any time the share capital
                                         is divided into different classes of shares the Directors may pay dividends on shares
                                         which confer deferred or non-preferred rights with regard to dividends as well as on
                                         shares which confer preferential rights with regard to dividends, but no dividend shall
                                         be paid on shares carrying deferred or non-preferred rights if, at the time of payment,
                                         any preferential dividend is in arrears. The Directors may also pay at intervals settled
                                         by them any dividend payable at a fixed rate if it appears that there are sufficient
                                         funds of the Company lawfully available for distribution to justify the payment. Provided
                                         the Directors act in good faith they shall not incur any liability to the holders of
                                         shares conferring preferred rights for any loss they may suffer by the lawful payment
                                         of a dividend on any shares having deferred or non-preferred rights.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">42.5</FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                         Directors may deduct from any dividend or distribution payable to any member all sums
                                         of money (if any) presently payable by him to the Company on account of calls or otherwise.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">42.6</FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                         Directors may declare that any dividend or distribution be paid wholly or partly by the
                                         distribution of specific assets and in particular of paid-up shares (as to issue price),
                                         debentures or debenture stock of any other company or in any one or more of such ways
                                         and where any difficulty arises in regard to such distribution, the Directors may settle
                                         the same as they think expedient and in particular may issue fractional certificates
                                         and fix the value for distribution of such specific assets or any part thereof and may
                                         determine that cash payments shall be made to any members upon the footing of the value
                                         so fixed in order to adjust the rights of all members and may vest any such specific
                                         assets in trustees as may seem expedient to the Directors.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">42.7</FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Any
                                         dividend, distribution, interest or other monies payable in cash in respect of shares
                                         may be paid by cheque or warrant sent through the post directed to the registered address
                                         of the holder, or, in the case of joint holders, to the holder who is first named on
                                         the Register or to such person and to such address as such holder or joint holders may
                                         in writing direct. Every such cheque or warrant shall be made payable to the order of
                                         the person to whom it is sent. Any one of two or more joint holders may give effectual
                                         receipts for any dividends, distributions, bonuses or other monies payable in respect
                                         of the shares held by them as joint holders.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 32; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">&nbsp;</TD><TD STYLE="width: 33%; text-align: right"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->29<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">42.8</FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">No
                                         dividend or distribution shall bear interest against the Company, save as otherwise provided.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">42.9</FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Except
                                         as otherwise provided by the rights attached to any shares, dividends and other distributions
                                         may be paid in any currency. The Directors may determine the basis of conversion for
                                         any currency conversions that may be required and how any costs involved are to be met.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">42.10</FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                         Directors may, before resolving to pay any dividend or other distribution, set aside
                                         such sums as they think proper as a reserve or reserves which shall, at the discretion
                                         of the Directors, be applicable for any purpose of the Company and pending such application
                                         may, at the discretion of the Directors, be employed in the business of the Company.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">42.11</FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Any
                                         dividend or distribution which cannot be paid to a member and/or which remains unclaimed
                                         after six months from the date on which such dividend or distribution becomes payable
                                         may, in the discretion of the Directors, be paid into a separate account in the Company&rsquo;s
                                         name, provided that the Company shall not be constituted as a trustee in respect of that
                                         account and the dividend or distribution shall remain as a debt due to the Member. Any
                                         dividend or distribution which remains unclaimed after a period of six years from the
                                         date on which such dividend or distribution becomes payable shall be forfeited and shall
                                         revert to the Company.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>43</B></FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Payment
                                         by allotment of Shares</B></FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">43.1</FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Whenever
                                         the Board has resolved that a dividend be paid or declared on any class of the share
                                         capital of the Company, the Board may further resolve either:</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">that
                                         such dividend be satisfied wholly or in part in the form of an allotment of shares credited
                                         as fully paid up, provided that the members entitled thereto will be entitled to elect
                                         to receive such dividend (or part thereof if the Board so determines) in cash in lieu
                                         of such allotment. In such case, the following provisions shall apply:</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 1in; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)</FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                         basis of any such allotment shall be determined by the Board;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 1in; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)</FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                         Board, after determining the basis of allotment, shall give not less than ten (10) days&rsquo;
                                         notice in writing to the holders of the relevant shares of the right of election accorded
                                         to them and shall send with such notice forms of election and specify the procedure to
                                         be followed and the place at which and the latest date and time by which duly completed
                                         forms of election must be lodged in order to be effective;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 1in; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii)</FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                         right of election may be exercised in respect of the whole or part of that portion of
                                         the dividend in respect of which the right of election has been accorded; and</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify"></P>

<!-- Field: Page; Sequence: 33; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">&nbsp;</TD><TD STYLE="width: 33%; text-align: right"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->30<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 1in; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iv)</FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                         dividend (or that part of the dividend to be satisfied by the allotment of shares as
                                         aforesaid) shall not be payable in cash on shares in respect whereof the cash election
                                         has not been duly exercised (&ldquo;<B>the non-elected shares</B>&rdquo;) and in satisfaction
                                         thereof shares of the relevant class shall be allotted credited as fully paid up to the
                                         holders of the non-elected shares on the basis of allotment determined as aforesaid and
                                         for such purpose the Board shall capitalise and apply out of any part of the undivided
                                         profits of the Company (including profits carried and standing to the credit of any reserves
                                         or other special account, share premium account, capital redemption reserve other than
                                         the Subscription Rights Reserve) as the Board may determine, such sum as may be required
                                         to pay up in full the appropriate number of shares of the relevant class for allotment
                                         and distribution to and amongst the holders of the non-elected shares on such basis;
                                         or</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">that
                                         the members entitled to such dividend shall be entitled to elect to receive an allotment
                                         of shares credited as fully paid up in lieu of the whole or such part of the dividend
                                         as the Board may think fit. In such case, the following provisions shall apply:</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 1in; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)</FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                         basis of any such allotment shall be determined by the Board;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 1in; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)</FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                         Board, after determining the basis of allotment, shall give not less than ten (10) days&rsquo;
                                         notice in writing to the holders of the relevant shares of the right of election accorded
                                         to them and shall send with such notice forms of election and specify the procedure to
                                         be followed and the place at which and the latest date and time by which duly completed
                                         forms of election must be lodged in order to be effective;</FONT></TD></TR></TABLE>

<P STYLE="color: #005595; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 1in; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii)</FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                         right of election may be exercised in respect of the whole or part of that portion of
                                         the dividend in respect of which the right of election has been accorded; and</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 1in; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iv)</FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                         dividend (or that part of the dividend in respect of which a right of election has been
                                         accorded) shall not be payable in cash on shares in respect whereof the Share election
                                         has been duly exercised (&ldquo;<B>the elected shares</B>&rdquo;) and in satisfaction thereof
                                         shares of the relevant class shall be allotted credited as fully paid up to the holders
                                         of the elected shares on the basis of allotment determined as aforesaid and for such
                                         purpose the Board shall capitalise and apply out of any part of the undivided profits
                                         of the Company (including profits carried and standing to the credit of any reserves
                                         or other special account, share premium account, capital redemption reserve other than
                                         the Subscription Rights Reserve) as the Board may determine, such sum as may be required
                                         to pay up in full the appropriate number of shares of the relevant class for allotment
                                         and distribution to and amongst the holders of the elected shares on such basis.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">43.2</FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 31.5pt; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 40.5pt; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                         shares allotted pursuant to the provisions this Article 43 shall rank pari passu in all
                                         respects with shares of the same class (if any) then in issue save only as regards participation
                                         in the relevant dividend or in any other distributions, bonuses or rights paid, made,
                                         declared or announced prior to or contemporaneously with the payment or declaration of
                                         the relevant dividend unless, contemporaneously with the announcement by the Board of
                                         their proposal to apply the provisions of sub-paragraph (i) or (ii) of paragraph (b)
                                         of this Article 43 in relation to the relevant dividend or contemporaneously with their
                                         announcement of the distribution, bonus or rights in question, the Board shall specify
                                         that the shares to be allotted pursuant to the provisions of paragraph (a) of this Article
                                         shall rank for participation in such distribution, bonus or rights.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 34; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">&nbsp;</TD><TD STYLE="width: 33%; text-align: right"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->31<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 31.5pt; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 40.5pt; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                         Board may do all acts and things considered necessary or expedient to give effect to
                                         any capitalisation pursuant to the provisions of paragraph (a) of this Article 39, with
                                         full power to the Board to make such provisions as it thinks fit in the case of shares
                                         becoming distributable in fractions (including provisions whereby, in whole or in part,
                                         fractional entitlements are aggregated and sold and the net proceeds distributed to those
                                         entitled, or are disregarded or rounded up or down or whereby the benefit of fractional
                                         entitlements accrues to the Company rather than to the members concerned). The Board
                                         may authorise any person to enter into on behalf of all members interested, an agreement
                                         with the Company providing for such capitalisation and matters incidental thereto and
                                         any agreement made pursuant to such authority shall be effective and binding on all concerned.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">43.3</FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                         Board may resolve in respect of any one particular dividend of the Company that notwithstanding
                                         the provisions of paragraph (a) of this Article 43 a dividend may be satisfied wholly
                                         in the form of an allotment of shares credited as fully paid up without offering any
                                         right to shareholders to elect to receive such dividend in cash in lieu of such allotment.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">43.4</FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                         Board may on any occasion determine that rights of election and the allotment of shares
                                         under this Article 39 shall not be made available or made to any shareholders with registered
                                         addresses in any territory where, in the absence of a registration statement or other
                                         special formalities, the circulation of an offer of such rights of election or the allotment
                                         of shares would or might, in the opinion of the Board, be unlawful or impracticable,
                                         and in such event the provisions aforesaid shall be read and construed subject to such
                                         determination. Members affected as a result of the foregoing sentence shall not be or
                                         be deemed to be a separate class of members for any purpose whatsoever.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">43.5</FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Any
                                         resolution declaring a dividend on shares of any class may specify that the same shall
                                         be payable or distributable to the persons registered as the holders of such shares at
                                         the close of business on a particular date, notwithstanding that it may be a date prior
                                         to that on which the resolution is passed, and thereupon the dividend shall be payable
                                         or distributable to them in accordance with their respective holdings so registered,
                                         but without prejudice to the rights inter se in respect of such dividend of transferors
                                         and transferees of any such shares. The provisions of this Article shall mutatis mutandis
                                         apply to bonuses, capitalisation issues, distributions of realised capital profits or
                                         offers or grants made by the Company to the members.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>44</B></FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Accounts</B></FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">44.1</FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                         Directors shall cause proper books of account to be kept with respect to:</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">all
                                         sums of money received and expended by the Company and the matters in respect of which
                                         the receipt and expenditure takes place;</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">all
                                         sales and purchases of goods by the Company; and</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 35; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">&nbsp;</TD><TD STYLE="width: 33%; text-align: right"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->32<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)</FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                         assets and liabilities of the Company.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">44.2</FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Proper
                                         books shall not be deemed to be kept if there are not kept such books of account as are
                                         necessary to give a true and fair view of the state of the Company&rsquo;s affairs and
                                         to explain its transactions.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">44.3</FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                         books of account shall be kept at such place or places as the Directors think fit, and
                                         shall always be open to the inspection of the Directors. The books of accounts shall
                                         be retained for five (5) years from the date of their preparation, or such other period
                                         as specified by the Companies Law.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">44.4</FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                         Directors shall from time to time determine whether and to what extent and at what times
                                         and places and under what conditions or regulations the accounts and books of the Company
                                         or any of them shall be open to the inspection of members not being Directors and no
                                         member (not being a Director) shall have any right of inspecting any account or book
                                         or document of the Company except as conferred by Companies Law or authorised by the
                                         Directors or by the Company in general meeting.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">44.5</FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                         Directors shall from time to time cause to be prepared and to be laid before the Company
                                         in general meeting profit and loss accounts, balance sheets, group accounts (if any)
                                         and such other reports and accounts as may be required by Companies Law.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>45</B></FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Audit</B></FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">45.1</FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Subject
                                         to applicable law and the rules of the Designated Stock Exchange, the Directors may appoint
                                         an Auditor or Auditors on such terms as the Directors determine who shall hold office
                                         until otherwise resolved.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">45.2</FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Every
                                         Auditor shall have the right of access at all times to the books and accounts and vouchers
                                         of the Company and shall be entitled to require from the Directors and officers of the
                                         Company such information and explanation as may be necessary for the performance of the
                                         duties of the auditors.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">45.3</FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Auditors
                                         shall at any time during their term of office, upon request of the Directors or any general
                                         meeting of the members, make a report on the accounts of the Company in general meeting
                                         during their tenure of office.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>46</B></FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Fiscal
                                         Year</B></FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
fiscal year of the Company shall end on the 31st day of December in each year unless the Directors prescribe some other period
therefor.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 36; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">&nbsp;</TD><TD STYLE="width: 33%; text-align: right"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->33<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>47</B></FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Capitalisation
                                         of Profit and Share Premium</B></FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">47.1</FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                         Directors or the Company in general meeting, by Ordinary Resolution upon the recommendation
                                         of the Directors, may resolve that it is desirable to capitalise any part of the amount
                                         for the time being standing to the credit of any of the Company&rsquo;s reserve accounts
                                         (including, without limitation, the share premium account and capital redemption reserve
                                         fund) or to the credit of the profit and loss account or otherwise available for distribution,
                                         and accordingly that such sum be set free from distribution amongst the members who would
                                         have been entitled thereto if distributed by way of dividend and in the same proportions
                                         on condition that the same be not paid in cash but be applied in or towards paying up
                                         any amounts for the time being unpaid on any shares held by such members respectively
                                         or paying up in full unissued shares or debentures of the Company to be allotted and
                                         distributed credited as fully paid-up (as to Issue Price) to and amongst such members
                                         in the proportions aforesaid, or partly in the one way and partly in the other, and the
                                         Directors shall give effect to such resolution. Provided that a share premium account
                                         and a capital redemption reserve fund may, for the purpose of this Article, only be applied
                                         in the paying up of unissued shares to be issued to members of the Company as fully paid
                                         bonus shares.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">47.2</FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Whenever
                                         such a resolution as aforesaid shall have been passed, the Directors shall make all appropriations
                                         and applications of the undivided profits resolved to be capitalised thereby, and all
                                         allotments and issues of fully paid shares or debentures, if any, and generally shall
                                         do all acts and things required to give effect thereto, with full power to the Directors
                                         to make such provision by the issue of fractional certificates or by payment in cash
                                         or otherwise as they think fit for the class of shares or debentures becoming distributable
                                         in fractions, and also to authorise any person to enter into, on behalf of all the members
                                         entitled thereto, an agreement with the Company providing for the allotment to them respectively,
                                         credited as fully paid-up (as to Issue Price), of any further shares or debentures to
                                         which they may be entitled upon such capitalisation, or (as the case may require) for
                                         the payment up by the Company on their behalf, by the application thereto of their respective
                                         proportions of the profits resolved to be capitalised of the amounts or any part of the
                                         amounts remaining unpaid on their existing shares, and any agreement made under such
                                         authority shall be effective and binding on all such members.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">47.3</FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                         Directors shall in accordance with the Companies Law establish a share premium account
                                         and shall carry to the credit of such account from time to time a sum equal to the amount
                                         or value of the premium paid on the issue of any share and may treat any contributed
                                         capital or capital surplus as if it were credited to such account. There shall be debited
                                         to any share premium account:</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">on
                                         the redemption or purchase of a share the difference between the nominal value of such
                                         share and the redemption or purchase price provided always that at the discretion of
                                         the Directors such sum may be paid out of the profits of the Company or, if permitted
                                         by the Companies Law, out of capital; and</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">any
                                         other amounts paid out of any share premium account as permitted by the Companies Law.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>48</B></FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Subscription
                                         Rights Reserve</B></FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">48.1</FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                         following provisions shall have effect to the extent that they are not prohibited by
                                         and are in compliance with the Companies Law.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">48.2</FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If,
                                         so long as any of the rights attached to any warrants issued by the Company to subscribe
                                         for shares of the Company shall remain exercisable, the Company does any act or engages
                                         in any transaction which, as a result of any adjustments to the subscription price in
                                         accordance with the provisions of the conditions of the warrants, would reduce the subscription
                                         price to below the par value of a share, then the following provisions shall apply:</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">as
                                         from the date of such act or transaction the Company shall establish and thereafter (subject
                                         as provided in this Article 48) maintain in accordance with the provisions of this Article
                                         48 a reserve (the &ldquo;<B>Subscription Rights Reserve</B>&rdquo;) the amount of which
                                         shall at no time be less than the sum which for the time being would be required to be
                                         capitalised and applied in paying up in full the nominal amount of the additional shares
                                         required to be issued and allotted credited as fully paid pursuant to sub-paragraph (c)
                                         below on the exercise in full of all the subscription rights outstanding and shall apply
                                         the Subscription Rights Reserve in paying up such additional shares in full as and when
                                         the same are allotted;</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 37; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">&nbsp;</TD><TD STYLE="width: 33%; text-align: right"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->34<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                         Subscription Rights Reserve shall not be used for any purpose other than that specified
                                         above unless all other reserves of the Company (other than share premium account) have
                                         been extinguished and will then only be used to make good losses of the Company if and
                                         so far as is required by the Companies Law;</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)</FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">upon
                                         the exercise of all or any of the subscription rights represented by any warrant, the
                                         relevant subscription rights shall be exercisable in respect of a nominal amount of shares
                                         equal to the amount in cash which the holder of such warrant is required to pay on exercise
                                         of the subscription rights represented thereby (or, as the case may be the relevant portion
                                         thereof in the event of a partial exercise of the subscription rights) and, in addition,
                                         there shall be allotted in respect of such subscription rights to the exercising warrantholder,
                                         credited as fully paid, such additional nominal amount of shares as is equal to the difference
                                         between:</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 1in; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)</FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                         said amount in cash which the holder of such warrant is required to pay on exercise of
                                         the subscription rights represented thereby (or, as the case may be, the relevant portion
                                         thereof in the event of a partial exercise of the subscription rights); and</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 1in; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)</FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                         nominal amount of shares in respect of which such subscription rights would have been
                                         exercisable having regard to the provisions of the conditions of the warrants, had it
                                         been possible for such subscription rights to represent the right to subscribe for shares
                                         at less than par and immediately upon such exercise so much of the sum standing to the
                                         credit of the Subscription Rights Reserve as is required to pay up in full such additional
                                         nominal amount of shares shall be capitalised and applied in paying up in full such additional
                                         nominal amount of shares which shall forthwith be allotted credited as fully paid to
                                         the exercising warrantholders; and</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)</FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">if,
                                         upon the exercise of the subscription rights represented by any warrant, the amount standing
                                         to the credit of the Subscription Rights Reserve is not sufficient to pay up in full
                                         such additional nominal amount of shares equal to such difference as aforesaid to which
                                         the exercising warrantholder is entitled, the Board shall apply any profits or reserves
                                         then or thereafter becoming available (including, to the extent permitted by the Companies
                                         Law, share premium account) for such purpose until such additional nominal amount of
                                         shares is paid up and allotted as aforesaid and until then no dividend or other distribution
                                         shall be paid or made on the fully paid shares of the Company then in issue. Pending
                                         such payment and allotment, the exercising warrant holder shall be issued by the Company
                                         with a certificate evidencing his right to the allotment of such additional nominal amount
                                         of shares. The rights represented by any such certificate shall be in registered form
                                         and shall be transferable in whole or in part in units of one share in the like manner
                                         as the shares for the time being are transferable, and the Company shall make such arrangements
                                         in relation to the maintenance of a register therefor and other matters in relation thereto
                                         as the Board may think fit and adequate particulars thereof shall be made known to each
                                         relevant exercising warrantholder upon the issue of such certificate.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 38; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">&nbsp;</TD><TD STYLE="width: 33%; text-align: right"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->35<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">48.3</FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Shares
                                         allotted pursuant to the provisions of this Article shall rank pari passu in all respects
                                         with the other shares allotted on the relevant exercise of the subscription rights represented
                                         by the warrant concerned. Notwithstanding anything contained in paragraph (a) of this
                                         Article, no fraction of any share shall be allotted on exercise of the subscription rights.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">48.4</FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                         provision of this Article as to the establishment and maintenance of the Subscription
                                         Rights Reserve shall not be altered or added to in any way which would vary or abrogate,
                                         or which would have the effect of varying or abrogating the provisions for the benefit
                                         of any warrantholder or class of warrantholders under this Article without the sanction
                                         of a special resolution of such warrantholders or class of warrantholders.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">48.5</FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
                                         certificate or report by the Auditors for the time being of the Company as to whether
                                         or not the Subscription Rights Reserve is required to be established and maintained and
                                         if so the amount thereof so required to be established and maintained, as to the purposes
                                         for which the Subscription Rights Reserve has been used, as to the extent to which it
                                         has been used to make good losses of the Company, as to the additional nominal amount
                                         of shares required to be allotted to exercising warrantholders credited as fully paid,
                                         and as to any other matter concerning the Subscription Rights Reserve shall (in the absence
                                         of manifest error) be conclusive and binding upon the Company and all warrantholders
                                         and shareholders.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>49</B></FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>RECORD
                                         DATE</B></FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">49.1</FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
                                         the purpose of determining members entitled to attend meetings, receive payment of any
                                         dividend or capitalisation or for any other purpose, the Directors may provide that the
                                         Register may, after compliance with any notice requirement of the Designated Stock Exchange,
                                         be suspended or closed for transfers for a stated period which shall not in any case
                                         exceed thirty (30) days in any year as the Board may determine. In lieu of, or apart
                                         from, closing the Register, the Directors may fix in advance or arrears a date as the
                                         record date for any such determination of members provided that the record date for a
                                         meeting may not be earlier than the date of notice of such meeting.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">49.2</FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
                                         the Register is not so closed and no record date is fixed for the determination of members
                                         entitled to attend meetings, receive payment of a distribution or capitalisation, the
                                         date on which the notice of the meeting is given or resolution of the Directors declaring
                                         such dividend or capitalisation is adopted, as the case may be, shall be the record date
                                         for such determination of members.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">49.3</FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
                                         determination of the members of record entitled to notice of or to vote at a meeting
                                         of the members shall apply at any adjournment of the meeting, provided however, that
                                         the Board may fix a new record date for the adjourned meeting.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>50</B></FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Notices</B></FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">50.1</FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
                                         notice may be given by the Company to any member either personally or by sending it by
                                         courier, post, cable, telex, telefax or e-mail to him or to his registered address, or
                                         (if he has no registered address) to the address, if any, within or without the Cayman
                                         Islands supplied by him to the Company for the giving of notice to him. A notice may
                                         also be served by advertisement in appropriate newspapers in accordance with the requirements
                                         of the Designated Stock Exchange or, to the extent permitted by the applicable laws,
                                         by placing it on the Company&rsquo;s website and giving to the member a notice stating
                                         that the notice and other document(s) are available there (a &ldquo;<B>notice of availability</B>&rdquo;).
                                         The notice of availability may be given to the member by any of the means set out above.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 39; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">&nbsp;</TD><TD STYLE="width: 33%; text-align: right"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->36<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">50.2</FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Where
                                         a notice is sent by courier, service of the notice shall be deemed to be effected by
                                         delivery of the notice to a courier company, and shall be deemed to have been received
                                         on the third day (not including Saturdays or Sundays or public holidays) following the
                                         day on which the notice was delivered to the courier. Where a notice is sent by post,
                                         service of the notice shall be deemed to be effected by properly addressing, pre-paying
                                         and posting a letter containing the notice, and to have been effected in the case of
                                         a notice of a meeting at the expiration of fourteen days after the letter containing
                                         the same is posted, and in any other case at the time at which the letter would be delivered
                                         in the ordinary course of post. Any letter sent to an address outside the Cayman Islands
                                         shall be sent by courier or airmail.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">50.3</FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Where
                                         a notice is sent by cable, telex, telefax or e-mail, service of the notice shall be deemed
                                         to be effected by properly addressing and sending such notice and to have been effected
                                         on the day received or, if such day is not a working day, on the next working day.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">50.4</FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
                                         notice may be given by the Company to the person or persons where the Company has been
                                         advised are entitled to a share in consequence of the death or bankruptcy of a member
                                         by sending it through the post in prepaid letter addressed to them by name, or by the
                                         title of representatives of the deceased or trustee of the bankrupt, or by any like description,
                                         at the address, if any, within or without the Cayman Islands supplied for that purpose
                                         by the persons claiming to be so entitled, or (until such an address has been supplied)
                                         by giving the notice in any manner in which the same might have been given if the death
                                         or bankruptcy had not occurred.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">50.5</FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
                                         notice shall be sufficiently given by the Company to the joint holders of record of a
                                         share by giving the notice to the joint holder first named on the Register in respect
                                         of the share.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">50.6</FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Notice
                                         of every general meeting shall be given in any manner hereinbefore authorised to:</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">every
                                         person shown as a member in the Register subject, in each case, to the immediately preceding
                                         Article; and</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">every
                                         person upon whom the ownership of a share devolves by reason of his being a legal personal
                                         representative or a trustee in bankruptcy of a member where the member but for his death
                                         or bankruptcy would be entitled to receive notice of the meeting.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">50.7</FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">No
                                         other person shall be entitled to receive notices of general meetings.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">50.8</FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
                                         member who is present, either in person or by proxy, at any meeting of the Company or
                                         of the holders of any class of shares in the Company shall be deemed to have received
                                         notice of the meeting, and, where requisite, of the purpose for which it was called.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">50.9</FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Every
                                         person who becomes entitled to any share shall be bound by any notice in respect of that
                                         share which, before his name is entered in the Register, has been given to the person
                                         from whom he derives his title.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 40; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">&nbsp;</TD><TD STYLE="width: 33%; text-align: right"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->37<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">50.10</FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Subject
                                         to the rights attached to shares, the Directors may fix any date as the record date for
                                         a dividend, allotment or issue. The record date may be on or at any time before or after
                                         a date on which the dividend, allotment or issue is declared, made or paid.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>51</B></FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Winding
                                         Up</B></FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">51.1</FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
                                         the Company is, or is likely to become, unable to pay its debts, the Directors shall
                                         have power to present a winding up petition in the name of the Company and/or to apply
                                         for the appointment of provisional liquidators in respect of the Company.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">51.2</FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
                                         the Company shall be wound up, the liquidator may, with the sanction of an Ordinary Resolution
                                         of the Company and any other sanction required by law, divide amongst the members in
                                         specie or kind the whole or any part of the assets of the Company (whether they shall
                                         consist of property of the same kind or not) and may, for such purpose, set such value
                                         as he deems fair upon any property to be divided as aforesaid and may determine how such
                                         division shall be carried out as between the members or different classes of members.
                                         The liquidator may, with the like sanction, vest the whole or any part of such assets
                                         in trustees upon such trusts for the benefit of the members as the liquidator, with the
                                         like sanction, shall think fit, but so that no member shall be compelled to accept any
                                         shares or other securities whereon there is any liability.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">51.3</FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
                                         the Company shall be wound up and the assets available for distribution amongst the members
                                         as such shall be insufficient to repay the whole of the paid-up capital, such assets
                                         shall be distributed so that, as nearly as may be, the losses shall be borne by the members
                                         in proportion to the capital paid up, or which ought to have been paid up, at the commencement
                                         of the winding up on the shares held by them respectively. And if in a winding up the
                                         assets available for distribution amongst the members shall be more than sufficient to
                                         repay the whole of the capital at the commencement of the winding up, the excess shall
                                         be distributed amongst the members in proportion to the capital at the commencement of
                                         the winding up paid up on the shares held by them respectively. But this Article is to
                                         be without prejudice to the rights of the holders of shares issued upon special terms
                                         and conditions.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>52</B></FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Indemnity</B></FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">52.1</FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Every
                                         Director, Secretary, or other officer of the Company (including alternate directors,
                                         proxy directors and former directors and officers), any trustee for the time being acting
                                         in relation to the Company (including any nominee shareholder holding shares in the Company)
                                         and their heirs and personal representatives (each an &ldquo;<B>Indemnified Person</B>&rdquo;)
                                         shall be entitled to be indemnified out of the assets of the Company against all actions,
                                         proceedings, costs, damages, expenses, claims, losses or liabilities which they or any
                                         of them may sustain or incur by reason of any act done or omitted in or about the execution
                                         of the duties of their respective offices or trusts or otherwise in relation thereto,
                                         including any liability incurred by him in defending any proceedings, whether civil or
                                         criminal, in which judgement is given in his favour or in which he is acquitted except
                                         to the extent that any of the foregoing arise through his dishonesty.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 41; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">&nbsp;</TD><TD STYLE="width: 33%; text-align: right"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->38<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">52.2</FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">No
                                         Indemnified Person shall be liable (a) for any loss, damage or misfortune whatsoever
                                         which may happen to or be incurred by the Company in the execution of the duties, powers,
                                         authorities or discretions of his office or in relation thereto, (b) for the acts, receipts,
                                         neglects, defaults or omissions of any other such Director or person or (c) by reason
                                         of his having joined in any receipt for money not received by him personally or (d) for
                                         any loss on account of defect of title to any property of the Company or (e) on account
                                         of the insufficiency of any security in or upon which any money of the Company shall
                                         be invested or (f) for any loss incurred through any bank, broker or other agent or (g)
                                         for any loss occasioned by any negligence, default, breach of duty, breach of trust,
                                         error of judgement or oversight on his part or (h) for any other loss or damage due to
                                         any such cause as aforesaid except to the extent that any of the foregoing arise through
                                         his dishonesty.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">52.3</FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                         Company shall advance to each Indemnified Person reasonable attorneys&rsquo; fees and other
                                         costs and expenses incurred in connection with the defence of any action, suit, proceeding
                                         or investigation involving such Indemnified Person for which indemnity will or could
                                         be sought. In connection with any advance of any expenses hereunder, the Indemnified
                                         Person shall execute an undertaking to repay the advanced amount to the Company if it
                                         shall be determined by final judgment or other final adjudication that such Indemnified
                                         Person was not entitled to indemnification pursuant to this Article. If it shall be determined
                                         by a final judgment or other final adjudication that such Indemnified Person was not
                                         entitled to indemnification with respect to such judgment, costs or expenses, then such
                                         party shall not be indemnified with respect to such judgment, costs or expenses and any
                                         advancement shall be returned to the Company (without interest) by the Indemnified Person.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">52.4</FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                         Directors, on behalf of the Company, may purchase and maintain insurance for the benefit
                                         of any Director or other officer of the Company against any liability which, by virtue
                                         of any rule of law, would otherwise attach to such person in respect of any negligence,
                                         default, breach of duty or breach of trust of which such person may be guilty in relation
                                         to the Company.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>53</B></FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Registration
                                         by Way of Continuation</B></FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">53.1</FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                         Company, if registered as an exempted company under the Companies Law, may by Special
                                         Resolution resolve to be registered by way of continuation in a jurisdiction outside
                                         the Cayman Islands which permits or does not prohibit the transfer of the Company to
                                         such jurisdiction.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">53.2</FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
                                         furtherance of a resolution passed pursuant to the immediately preceding Article, the
                                         Directors shall cause an application to be made to the Registrar of Companies to de-register
                                         the Company in the Cayman Islands or such other jurisdiction in which it is for the time
                                         being incorporated, registered or existing and may cause all further steps as they consider
                                         appropriate to be taken to effect the transfer by way of continuation of the Company.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>54</B></FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Untraceable
                                         Members</B></FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">54.1</FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Without
                                         prejudice to the rights of the Company in this Article 54, the Company may cease sending
                                         cheques for dividend entitlements or dividend warrants by post if such cheques or warrants
                                         have been left uncashed on two (2) consecutive occasions. However, the Company may exercise
                                         the power to cease sending cheques for dividend entitlements or dividend warrants after
                                         the first occasion on which such a cheque or warrant is returned undelivered.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">54.2</FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                         Company shall have the power to sell, in such manner as the Board thinks fit, any shares
                                         of a member who is untraceable, but no such sale shall be made unless:</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">all
                                         cheques or warrants in respect of dividends of the shares in question, being not less
                                         than three (3) in total number, for any sum payable in cash to the holder of such shares
                                         sent during the relevant period in the manner authorized by these Articles have remained
                                         uncashed;</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 42; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">&nbsp;</TD><TD STYLE="width: 33%; text-align: right"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->39<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">so
                                         far as it is aware at the end of the relevant period, the Company has not at any time
                                         during the relevant period received any indication of the existence of the member who
                                         is the holder of such shares or of a person entitled to such shares by death, bankruptcy
                                         or operation of law; and</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)</FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                         Company, if so required by the rules governing the listing of the shares on the Designated
                                         Stock Exchange, has given notice to, and caused advertisement in newspapers to be made
                                         in accordance with the requirements of the Designated Stock Exchange of its intention
                                         to sell such shares in the manner required by the Designated Stock Exchange, and a period
                                         of three (3) months or such shorter period as may be allowed by the Designated Stock
                                         Exchange has elapsed since the date of such advertisement.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
the purpose of the foregoing, the &ldquo;<B>relevant period</B>&rdquo; means the period commencing twelve (12) years before the
date of publication of the advertisement referred to in paragraph (c) of this Article and ending at the expiry of the period referred
to in that paragraph.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">54.3</FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">To
                                         give effect to any such sale the Board may authorize some person to transfer the said
                                         shares and an instrument of transfer signed or otherwise executed by or on behalf of
                                         such person shall be as effective as if it had been executed by the registered holder
                                         or the person entitled by transmission to such shares, and the purchaser shall not be
                                         bound to see to the application of the purchase money nor shall his title to the shares
                                         be affected by any irregularity or invalidity in the proceedings relating to the sale.
                                         The net proceeds of the sale will belong to the Company and upon receipt by the Company
                                         of such net proceeds. No trust shall be created in respect of such debt and no interest
                                         shall be payable in respect of it and the Company shall not be required to account for
                                         any money earned from the net proceeds which may be employed in the business of the Company
                                         or as it thinks fit. Any sale under this Article 54 shall be valid and effective notwithstanding
                                         that the Member holding the Shares sold is dead, bankrupt or otherwise under any legal
                                         disability or incapacity.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>55</B></FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Disclosure</B></FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Directors and the officers including any secretary or assistant secretary and/or any its service providers (including the registered
office provider for the Company), shall be entitled to disclose to any regulatory or judicial authority, or to any stock exchange
on which the shares may from time to time be listed, any information regarding the affairs of the Company including, without limitation,
any information contained in the Register and books of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>56</B></FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Merger
                                         and Consolidation</B></FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company shall, with the approval of a Special Resolution, have the power to merge or consolidate with one or more constituent
companies (as defined in the Companies Law), upon such terms as the Directors may determine.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 43; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">&nbsp;</TD><TD STYLE="width: 33%; text-align: right"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->40<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center"><FONT STYLE="font: normal 10pt Times New Roman, Times, Serif">Table
of Contents</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center"><FONT STYLE="font: normal 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="text-align: left; font: bold 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0 0 1.5pt; text-align: left; text-indent: 0"><FONT STYLE="font-variant: normal"><B>Article</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0 0 1.5pt; text-align: left; text-indent: 0"><FONT STYLE="font-variant: normal"><B>&nbsp;</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-top: 0; padding-right: 0; border-bottom: Black 1.5pt solid; padding-left: 0; text-align: center"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><FONT STYLE="font-variant: normal"><B>Page</B></FONT></P>


</TD></TR>
<TR STYLE="text-align: left; font: bold 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-top: 0; padding-right: 0; padding-left: 0; text-align: left; text-indent: 0">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-top: 0; padding-right: 0; padding-left: 0; text-align: left; text-indent: 0">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-top: 0; padding-right: 0; padding-left: 0; text-align: center">&nbsp;</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: bold 10pt Times New Roman, Times, Serif; text-transform: uppercase; background-color: rgb(204,238,255)">
    <TD STYLE="width: 5%; text-align: left; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1</FONT></TD>
    <TD STYLE="width: 85%; text-align: left; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Company Name</FONT></TD>
    <TD STYLE="width: 10%; text-align: center; padding: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1</FONT></TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: bold 10pt Times New Roman, Times, Serif; text-transform: uppercase; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Registered Office</FONT></TD>
    <TD STYLE="text-align: center; padding: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1</FONT></TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: bold 10pt Times New Roman, Times, Serif; text-transform: uppercase; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Objects</FONT></TD>
    <TD STYLE="text-align: center; padding: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1</FONT></TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: bold 10pt Times New Roman, Times, Serif; text-transform: uppercase; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Powers of Company</FONT></TD>
    <TD STYLE="text-align: center; padding: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1</FONT></TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: bold 10pt Times New Roman, Times, Serif; text-transform: uppercase; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Limited Liability</FONT></TD>
    <TD STYLE="text-align: center; padding: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2</FONT></TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: bold 10pt Times New Roman, Times, Serif; text-transform: uppercase; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Authorised Capital</FONT></TD>
    <TD STYLE="text-align: center; padding: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2</FONT></TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: bold 10pt Times New Roman, Times, Serif; text-transform: uppercase; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">7</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Part VII of the Companies Law (as revised)</FONT></TD>
    <TD STYLE="text-align: center; padding: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2</FONT></TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: bold 10pt Times New Roman, Times, Serif; text-transform: uppercase; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Amendment</FONT></TD>
    <TD STYLE="text-align: center; padding: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2</FONT></TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: bold 10pt Times New Roman, Times, Serif; text-transform: uppercase; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Preliminary</FONT></TD>
    <TD STYLE="text-align: center; padding: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1</FONT></TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: bold 10pt Times New Roman, Times, Serif; text-transform: uppercase; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Commencement of Business</FONT></TD>
    <TD STYLE="text-align: center; padding: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5</FONT></TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: bold 10pt Times New Roman, Times, Serif; text-transform: uppercase; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Alteration of Articles</FONT></TD>
    <TD STYLE="text-align: center; padding: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5</FONT></TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: bold 10pt Times New Roman, Times, Serif; text-transform: uppercase; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Issue of Shares, Principal and Branch Registers and
Offices</FONT></TD>
    <TD STYLE="text-align: center; padding: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5</FONT></TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: bold 10pt Times New Roman, Times, Serif; text-transform: uppercase; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Treasury Shares</FONT></TD>
    <TD STYLE="text-align: center; padding: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6</FONT></TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: bold 10pt Times New Roman, Times, Serif; text-transform: uppercase; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Redemption, Purchase and Surrender of Own Shares</FONT></TD>
    <TD STYLE="text-align: center; padding: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6</FONT></TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: bold 10pt Times New Roman, Times, Serif; text-transform: uppercase; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">7</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Class A Ordinary Shares</FONT></TD>
    <TD STYLE="text-align: center; padding: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">7</FONT></TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: bold 10pt Times New Roman, Times, Serif; text-transform: uppercase; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Class B Ordinary Shares</FONT></TD>
    <TD STYLE="text-align: center; padding: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">7</FONT></TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: bold 10pt Times New Roman, Times, Serif; text-transform: uppercase; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">9</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Variation of Rights of Shares</FONT></TD>
    <TD STYLE="text-align: center; padding: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10</FONT></TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: bold 10pt Times New Roman, Times, Serif; text-transform: uppercase; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Commission on Sale of Shares</FONT></TD>
    <TD STYLE="text-align: center; padding: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10</FONT></TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: bold 10pt Times New Roman, Times, Serif; text-transform: uppercase; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">11</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Non-Recognition of Trusts</FONT></TD>
    <TD STYLE="text-align: center; padding: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">11</FONT></TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: bold 10pt Times New Roman, Times, Serif; text-transform: uppercase; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">12</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Certificates for Shares</FONT></TD>
    <TD STYLE="text-align: center; padding: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">11</FONT></TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: bold 10pt Times New Roman, Times, Serif; text-transform: uppercase; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">13</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Joint Ownership of Shares</FONT></TD>
    <TD STYLE="text-align: center; padding: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">11</FONT></TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: bold 10pt Times New Roman, Times, Serif; text-transform: uppercase; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">14</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Lien</FONT></TD>
    <TD STYLE="text-align: center; padding: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">11</FONT></TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: bold 10pt Times New Roman, Times, Serif; text-transform: uppercase; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">15</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Calls on Shares</FONT></TD>
    <TD STYLE="text-align: center; padding: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">12</FONT></TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: bold 10pt Times New Roman, Times, Serif; text-transform: uppercase; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">16</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Transfer of Shares</FONT></TD>
    <TD STYLE="text-align: center; padding: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">13</FONT></TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: bold 10pt Times New Roman, Times, Serif; text-transform: uppercase; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">17</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Transmission of Shares</FONT></TD>
    <TD STYLE="text-align: center; padding: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">14</FONT></TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: bold 10pt Times New Roman, Times, Serif; text-transform: uppercase; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">18</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Forfeiture of Shares</FONT></TD>
    <TD STYLE="text-align: center; padding: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">14</FONT></TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: bold 10pt Times New Roman, Times, Serif; text-transform: uppercase; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">19</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Amendment of Memorandum of Association and Alteration
of Capital</FONT></TD>
    <TD STYLE="text-align: center; padding: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">15</FONT></TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: bold 10pt Times New Roman, Times, Serif; text-transform: uppercase; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">20</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">General Meetings</FONT></TD>
    <TD STYLE="text-align: center; padding: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">16</FONT></TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: bold 10pt Times New Roman, Times, Serif; text-transform: uppercase; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">21</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Proceedings at General Meetings</FONT></TD>
    <TD STYLE="text-align: center; padding: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">17</FONT></TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: bold 10pt Times New Roman, Times, Serif; text-transform: uppercase; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">22</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Votes of Members</FONT></TD>
    <TD STYLE="text-align: center; padding: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">18</FONT></TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: bold 10pt Times New Roman, Times, Serif; text-transform: uppercase; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">23</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Proxies</FONT></TD>
    <TD STYLE="text-align: center; padding: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">19</FONT></TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: bold 10pt Times New Roman, Times, Serif; text-transform: uppercase; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">24</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Corporations Acting by Representatives at Meetings and
Clearing House</FONT></TD>
    <TD STYLE="text-align: center; padding: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">20</FONT></TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: bold 10pt Times New Roman, Times, Serif; text-transform: uppercase; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">25</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Directors</FONT></TD>
    <TD STYLE="text-align: center; padding: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">20</FONT></TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: bold 10pt Times New Roman, Times, Serif; text-transform: uppercase; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">26</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Alternate Directors and Proxy Directors</FONT></TD>
    <TD STYLE="text-align: center; padding: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">21</FONT></TD></TR>
</TABLE>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0"></P>

<!-- Field: Page; Sequence: 44 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0"></P>

<P STYLE="margin: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="text-align: left; font: bold 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0 0 1.5pt; text-align: left; text-indent: 0; width: 5%"><FONT STYLE="font-variant: normal"><B>Article</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0 0 1.5pt; text-align: left; text-indent: 0; width: 85%"><FONT STYLE="font-variant: normal"><B>&nbsp;</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-top: 0; padding-right: 0; border-bottom: Black 1.5pt solid; padding-left: 0; text-align: center; width: 10%"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><FONT STYLE="font-variant: normal"><B>Page</B></FONT></P>


</TD></TR>

<TR STYLE="text-align: left; font: bold 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-top: 0; padding-right: 0; padding-left: 0; text-align: left; text-indent: 0">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-top: 0; padding-right: 0; padding-left: 0; text-align: left; text-indent: 0">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-top: 0; padding-right: 0; padding-left: 0; text-align: center">&nbsp;</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: bold 10pt Times New Roman, Times, Serif; text-transform: uppercase; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0; width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">27</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0; width: 85%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Powers and Duties of Directors</FONT></TD>
    <TD STYLE="text-align: center; padding: 0; font: 10pt Times New Roman, Times, Serif; width: 10%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">22</FONT></TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: bold 10pt Times New Roman, Times, Serif; text-transform: uppercase; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">28</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director or Officer Contracting with Company</FONT></TD>
    <TD STYLE="text-align: center; padding: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">22</FONT></TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: bold 10pt Times New Roman, Times, Serif; text-transform: uppercase; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">29</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Appointment and Removal of Directors</FONT></TD>
    <TD STYLE="text-align: center; padding: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">23</FONT></TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: bold 10pt Times New Roman, Times, Serif; text-transform: uppercase; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">30</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Board&rsquo;s Power to appoint Directors</FONT></TD>
    <TD STYLE="text-align: center; padding: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">23</FONT></TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: bold 10pt Times New Roman, Times, Serif; text-transform: uppercase; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">31</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Appointment at Annual General Meeting</FONT></TD>
    <TD STYLE="text-align: center; padding: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">24</FONT></TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: bold 10pt Times New Roman, Times, Serif; text-transform: uppercase; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">32</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Removal of Directors</FONT></TD>
    <TD STYLE="text-align: center; padding: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">24</FONT></TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: bold 10pt Times New Roman, Times, Serif; text-transform: uppercase; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">33</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Resignation of Directors</FONT></TD>
    <TD STYLE="text-align: center; padding: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">24</FONT></TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: bold 10pt Times New Roman, Times, Serif; text-transform: uppercase; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">34</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Termination of Directors</FONT></TD>
    <TD STYLE="text-align: center; padding: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">24</FONT></TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: bold 10pt Times New Roman, Times, Serif; text-transform: uppercase; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">35</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Proceedings of Directors</FONT></TD>
    <TD STYLE="text-align: center; padding: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">25</FONT></TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: bold 10pt Times New Roman, Times, Serif; text-transform: uppercase; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">36</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Managing Director</FONT></TD>
    <TD STYLE="text-align: center; padding: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">26</FONT></TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: bold 10pt Times New Roman, Times, Serif; text-transform: uppercase; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">37</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Presumption of Assent</FONT></TD>
    <TD STYLE="text-align: center; padding: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">26</FONT></TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: bold 10pt Times New Roman, Times, Serif; text-transform: uppercase; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">38</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Management</FONT></TD>
    <TD STYLE="text-align: center; padding: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">27</FONT></TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: bold 10pt Times New Roman, Times, Serif; text-transform: uppercase; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">39</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Audit Committee</FONT></TD>
    <TD STYLE="text-align: center; padding: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">27</FONT></TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: bold 10pt Times New Roman, Times, Serif; text-transform: uppercase; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">40</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Officers</FONT></TD>
    <TD STYLE="text-align: center; padding: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">28</FONT></TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: bold 10pt Times New Roman, Times, Serif; text-transform: uppercase; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">41</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Seal</FONT></TD>
    <TD STYLE="text-align: center; padding: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">28</FONT></TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: bold 10pt Times New Roman, Times, Serif; text-transform: uppercase; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">42</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dividends and Reserve</FONT></TD>
    <TD STYLE="text-align: center; padding: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">29</FONT></TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: bold 10pt Times New Roman, Times, Serif; text-transform: uppercase; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">43</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Payment by allotment of Shares</FONT></TD>
    <TD STYLE="text-align: center; padding: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">30</FONT></TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: bold 10pt Times New Roman, Times, Serif; text-transform: uppercase; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">44</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accounts</FONT></TD>
    <TD STYLE="text-align: center; padding: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">32</FONT></TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: bold 10pt Times New Roman, Times, Serif; text-transform: uppercase; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">45</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Audit</FONT></TD>
    <TD STYLE="text-align: center; padding: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">33</FONT></TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: bold 10pt Times New Roman, Times, Serif; text-transform: uppercase; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">46</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Fiscal Year</FONT></TD>
    <TD STYLE="text-align: center; padding: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">33</FONT></TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: bold 10pt Times New Roman, Times, Serif; text-transform: uppercase; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">47</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Capitalisation of Profit and Share Premium</FONT></TD>
    <TD STYLE="text-align: center; padding: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">34</FONT></TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: bold 10pt Times New Roman, Times, Serif; text-transform: uppercase; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">48</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Subscription Rights Reserve</FONT></TD>
    <TD STYLE="text-align: center; padding: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">34</FONT></TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: bold 10pt Times New Roman, Times, Serif; text-transform: uppercase; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">49</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">RECORD DATE</FONT></TD>
    <TD STYLE="text-align: center; padding: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">36</FONT></TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: bold 10pt Times New Roman, Times, Serif; text-transform: uppercase; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">50</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Notices</FONT></TD>
    <TD STYLE="text-align: center; padding: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">36</FONT></TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: bold 10pt Times New Roman, Times, Serif; text-transform: uppercase; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">51</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Winding Up</FONT></TD>
    <TD STYLE="text-align: center; padding: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">38</FONT></TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: bold 10pt Times New Roman, Times, Serif; text-transform: uppercase; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">52</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Indemnity</FONT></TD>
    <TD STYLE="text-align: center; padding: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">38</FONT></TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: bold 10pt Times New Roman, Times, Serif; text-transform: uppercase; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">53</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Registration by Way of Continuation</FONT></TD>
    <TD STYLE="text-align: center; padding: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">39</FONT></TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: bold 10pt Times New Roman, Times, Serif; text-transform: uppercase; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">54</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Untraceable Members</FONT></TD>
    <TD STYLE="text-align: center; padding: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">39</FONT></TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: bold 10pt Times New Roman, Times, Serif; text-transform: uppercase; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">55</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Disclosure</FONT></TD>
    <TD STYLE="text-align: center; padding: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">40</FONT></TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: bold 10pt Times New Roman, Times, Serif; text-transform: uppercase; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">56</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Merger and Consolidation</FONT></TD>
    <TD STYLE="text-align: center; padding: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">40</FONT></TD></TR>
</TABLE>


<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"></P>

<!-- Field: Page; Sequence: 45; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-4.1
<SEQUENCE>3
<FILENAME>ff12018ex4-1_aptorum.htm
<DESCRIPTION>SPECIMEN ORDINARY SHARE CERTIFICATE
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin-top: 0; text-align: right; margin-bottom: 0; font: 10pt Times New Roman, Times, Serif"><B>Exhibit 4.1</B></P>

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<P STYLE="margin-top: 0; text-align: center; margin-bottom: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Share
Certificate</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 50%; padding: 0; font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Number</B></FONT></TD>
    <TD STYLE="width: 50%; padding: 0; font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Shares</B></FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Aptorum
Group Limited</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(the
&ldquo;<B>Company</B>&rdquo;)</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Incorporated
under the laws of the Cayman Islands</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
capital of the Company is US$100,000,000.00 divided into 60,000,000 Class A Ordinary Shares with a nominal or par value of</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">USD
1.00 each and 40,000,000 Class B Ordinary Shares with a nominal or par value of USD1.00 each</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
is to certify that <B> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B>is the registered</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">holder
of <B>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B> fully paid US$1.00 [Class x] shares in the Company subject</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">to
the Memorandum and Articles of Association thereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dated:
_____________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 65%; padding: 0; text-align: center; font: 10pt Times New Roman, Times, Serif"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Director</B></FONT></P></TD>
    <TD STYLE="width: 35%; padding: 0; text-align: center; font: 10pt Times New Roman, Times, Serif"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">________________________________</FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="padding: 0; text-align: center; font: 10pt Times New Roman, Times, Serif"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Secretary</B></FONT></P></TD>
    <TD STYLE="padding: 0; text-align: center; font: 10pt Times New Roman, Times, Serif"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">________________________________</FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">for
        <B>Campbells Secretaries Limited</B></FONT></P></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-4.2
<SEQUENCE>4
<FILENAME>ff12018ex4-2_aptorum.htm
<DESCRIPTION>FORM OF SERIES A CONVERTIBLE PROMISSORY NOTE
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif; text-align: right"><B>Exhibit 4.2<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></B></P>

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">THIS
NOTE AND THE SECURITIES ISSUABLE UPON THE CONVERSION HEREOF HAVE NOT BEEN REGISTERED UNDER THE UNITED STATES SECURITIES ACT OF
1933, AS AMENDED (THE &ldquo;<B>ACT</B>&rdquo;), OR UNDER THE SECURITIES LAWS OF ANY STATE. THESE SECURITIES MAY NOT BE OFFERED,
SOLD OR OTHERWISE TRANSFERRED, PLEDGED OR HYPOTHECATED EXCEPT AS PERMITTED UNDER THE ACT AND APPLICABLE STATE SECURITIES LAWS
PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT OR AN EXEMPTION THEREFROM.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">THIS
NOTE AND THE SECURITIES ISSUALBE UPON THE CONVERSION HEREOF AND WARRANT SHARES MAY NOT BE OFFERED OR SOLD IN HONG KONG BY MEANS
OF ANY DOCUMENT OTHER THAN (I) IN CIRCUMSTANCES WHICH DO NOT CONSTITUTE AN OFFER TO THE PUBLIC WITHIN THE MEANING OF THE COMPANIES
(WINDING UP AND MISCELLANEOUS PROVISIONS) ORDINANCE (CAP. 32, LAWS OF HONG KONG), OR (II) TO &ldquo;PROFESSIONAL INVESTORS&rdquo;
(AS DEFINED IN THE SECURITIES AND FUTURES ORDINANCE (CAP. 571, LAWS OF HONG KONG)), OR (III) IN OTHER CIRCUMSTANCES WHICH DO NOT
RESULT IN THE DOCUMENT BEING A &ldquo;PROSPECTUS&rdquo; WITHIN THE MEANING OF THE COMPANIES (WINDING UP AND MISCELLANEOUS PROVISIONS)
ORDINANCE (CAP. 32, LAWS OF HONG KONG) AND NO ADVERTISEMENT, INVITATION OR DOCUMENT RELATING TO THE SECURITIES MAY BE ISSUED OR
MAY BE IN THE POSSESSION OF ANY PERSON FOR THE PURPOSE OF ISSUE (IN EACH CASE WHETHER IN HONG KONG OR ELSEWHERE), WHICH IS DIRECTED
AT, OR THE CONTENTS OF WHICH ARE LIKELY TO BE ACCESSED OR READ BY, THE PUBLIC IN HONG KONG (EXCEPT IF PERMITTED TO DO SO UNDER
THE LAWS OF HONG KONG) OTHER THAN WITH RESPECT TO THE SECURITIES WHICH ARE OR ARE INTENDED TO BE DISPOSED OF ONLY TO PERSONS OUTSIDE
HONG KONG OR ONLY TO &ldquo;PROFESSIONAL INVESTORS&rdquo; AS DEFINED IN THE SECURITIES AND FUTURES ORDINANCE (CAP. 571, LAWS OF
HONG KONG).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>APTORUM
GROUP LIMITED</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>SERIES
A CONVERTIBLE PROMISSORY NOTE</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">USD$____________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">May
15, 2018 (&ldquo;<B>Issuance Date</B>&rdquo;)</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">FOR
VALUE RECEIVED, APTORUM GROUP LIMITED, a Cayman Islands company limited by shares with its registered address at c/o Floor 4,
Willow House, Cricket Square, Grand Cayman KY1-9010, Cayman Islands (the &ldquo;<B>Company</B>&rdquo;), promises to pay to _________________________with
a principal office at ___________________________________________________________, or its successor or permitted assigns (&ldquo;<B>Investor</B>&rdquo;
or &ldquo;<B>Holder</B>&rdquo;), in lawful money of the United States of America the principal sum of _______________________________U.S.
Dollars (USD$____________ (the &ldquo;<B>Principal Amount</B>&rdquo;), together with interest from the Issuance Date of this Series
A Convertible Promissory Note (this &ldquo;<B>Note</B>&rdquo;) as set forth below.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;</FONT></P>

<!-- Field: Page; Sequence: 1; Options: NewSection; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following is a statement of the rights of Investor and the conditions to which this Note is subject, and to which Investor, by
the acceptance of this Note, agrees:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-indent: 0in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.
<U>Payments.</U></FONT></P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)&nbsp;<I>Interest.</I>&nbsp;Subject
to Section 3, for the period commencing on the Issuance Date of this Note and until the Interest Payment Date, interest shall
accrue on the outstanding unconverted and unpaid Principal Amount at 1% per annum and shall be compounded annually. &ldquo;<B>Interest
Payment Date</B>&rdquo; means the first to occur of (i) the Maturity Date, and (ii) the date of any conversion of this Note in
full pursuant to the terms hereof, and (iii) the date of any other repayment or redemption of this Note in full in accordance
with the terms hereof. Interest with respect to any partial year shall be computed on the basis of a 360-day year comprised of
30-day months (or in the case of a partial month, the actual number of days elapsed therein).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)&nbsp;<I>Payment
Schedule.</I>&nbsp;Subject to the rights of Investor in Section 3, unless otherwise converted, redeemed or repaid pursuant to
the terms of this Note, the full outstanding and unpaid Principal Amount shall be repaid in full by the Company on the Maturity
Date. Any accrued and unpaid interest on the Note is due and payable by the Company in cash on the Interest Payment Date.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
<I>Prepayment</I>. Company shall have the right to prepay this Note in full or any portion thereof at its then outstanding Principal
Amount and accrued interest, at any time after the Issuance Date and prior to the Maturity Date or the date on which this Note
is fully converted, whichever is earlier, provided that the Company give written notice to the Purchasers at least ten (10) business
days before the prepayment.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)
Whenever any amount expressed to be due by the terms of this Note is due on any day which is not a Business Day, the same shall
instead be due on the next succeeding day which is a Business Day, and interest shall accrue during such extension. Investor shall
notify the Company in writing no less than five (5) Business Days prior to any scheduled or agreed payment under this Note of
the details of the account of Investor to which such payment shall be made, though the failure to provide such information on
a timely basis will not relieve the Company&rsquo;s obligation to make such payment under this Note (to the extent such obligation
remains outstanding) promptly upon receipt of such information.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-indent: 0in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.
<U>Events of Default.</U>&nbsp;The occurrence of any of the following shall constitute an &ldquo;<B>Event of Default</B>&rdquo;
under this Note:</FONT></P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)&nbsp;<I>Failure
to Pay</I>. The Company shall fail to pay to the Investor when due any Principal Amount, any interest payment or other cash payment
required under this Note (if any), and such failure shall not have been cured within three (3) days after the due date; or</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)&nbsp;<I>Breaches
of Covenants</I>. The Company shall fail to observe or perform in any material respect any of the covenants, obligations, conditions
or agreements contained in Sections 4, 5, 7(a), 7(c) and 7(d) of this Note and such failure shall continue for thirty (30) days
after the Company&rsquo;s receipt of written notice from the Investor of such failure; or</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)&nbsp;<I>Voluntary
Bankruptcy or Insolvency Proceedings</I>. The Company, or any of its Significant Subsidiaries, or any group of subsidiaries of
the Company that together would constitute a Significant Subsidiary, shall (i) apply for or consent to the appointment of a receiver,
trustee, liquidator or custodian of itself or of all or substantially all of its property, (ii) admit in writing its inability
to pay its debts generally as they mature, (iii) make a general assignment for the benefit of its creditors, (iv) be dissolved
or liquidated, or (v) commence a voluntary case or other proceeding seeking liquidation, reorganization or other relief with respect
to itself or its debts under any bankruptcy, insolvency or other similar law now or hereafter in effect, or consent to any such
relief or to the appointment of or taking possession of its property by any official in an involuntary case or other bankruptcy
proceeding commenced against it, in the case of each of (i) through (v), other than in connection with a solvent dissolution,
liquidation, reorganization or similar corporate proceedings; or</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;</FONT></P>

<!-- Field: Page; Sequence: 2; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)&nbsp;<I>Involuntary
Bankruptcy or Insolvency Proceedings</I>. Proceedings for the appointment of a receiver, trustee, liquidator or custodian of the
Company or any of its Significant Subsidiaries or any group of subsidiaries that together would constitute a Significant Subsidiary
or of all or substantially all of the Company&rsquo;s property, or an involuntary case or other proceedings seeking liquidation,
reorganization or other relief with respect to the Company, any of its Significant Subsidiaries or any group of subsidiaries that
together would constitute a Significant Subsidiary or its or their debts under any bankruptcy, insolvency or other similar law
now or hereafter in effect shall be commenced and an order for relief entered or such proceeding shall not be stayed, dismissed
or discharged within sixty (60) days of commencement; or</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)&nbsp;<I>Cross
Default.</I>&nbsp;Any default by the Company or any Significant Subsidiary with respect to any mortgage, agreement or other instrument
under which there is outstanding, or by which there is secured or evidenced, any indebtedness for borrowed money incurred or guaranteed
by the Company and/or any such Significant Subsidiary in excess of USD$500,000 (or the foreign currency equivalent thereof) in
the aggregate, whether such indebtedness now exists or shall hereafter be created, (A) resulting in such indebtedness becoming
or being declared due and payable before its maturity or (B) constituting a failure to pay such indebtedness when due and payable,
whether at its stated maturity, upon required repurchase, upon acceleration or otherwise, in each case in accordance with such
mortgage, agreement or instrument; or</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(f)&nbsp;<I>Adverse
Judgment.</I>&nbsp;A final judgment for the payment of USD$500,000 (or the foreign currency equivalent thereof) or more (excluding
any amounts covered by insurance) is rendered against the Company or any Significant Subsidiary, which judgment is not paid, bonded
or otherwise discharged or stayed within sixty (60) days after the earlier of (i) the date on which the right to appeal thereof
has expired if no such appeal has commenced and (ii) the date on which all rights to appeal have been extinguished.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-indent: 0in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.
<U>Rights of Investor upon an Event of Default</U>.</FONT></P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
Upon the occurrence of any Event of Default (other than an Event of Default described in Sections 2(c) or 2(d)) and at any time
thereafter during the continuance of such Event of Default, Investor may, by written notice to the Company, declare all outstanding
and unconverted and unpaid Principal Amount and accrued and unpaid interest payable by the Company hereunder to be immediately
due and payable without presentment, demand, protest or any other notice of any kind, all of which are hereby expressly waived,
anything contained herein to the contrary notwithstanding. Upon the occurrence of any Event of Default described in Sections 2(c)
or 2(d), immediately and without notice, all outstanding and unconverted and unpaid Principal Amount and accrued and unpaid interest
payable by the Company hereunder shall automatically become immediately due and payable, without presentment, demand, protest
or any other notice of any kind, all of which are hereby expressly waived, anything contained herein to the contrary notwithstanding.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
In the case of an Event of Default under Section 2(a), during the period when such Event of Default is continuing and not cured,
in lieu of (and not in addition to) the interest rate described in Section 1(a), interest shall accrue at 10% per annum on any
such undisputed Principal Amount or interest (or portion thereof) that remains overdue.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
Upon the occurrence and during the continuance of any Event of Default, Investor may also exercise any other right, power or remedy
granted to it by law, either by suit in equity or by action at law, or both.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;</FONT></P>

<!-- Field: Page; Sequence: 3; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4. <U>Conversion.</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a) <I>Automatic
Conversion.</I>&nbsp;All outstanding Notes (including the outstanding and unpaid Principal Amount and excluding any then-accrued
and unpaid interest) shall be converted automatically into the number of fully paid and non-assessable shares (the &ldquo;<B>Conversion
Shares</B>&rdquo;) of Class A ordinary share with a nominal or par value at USD$1.00 each (the &ldquo;<B>Class A Shares</B>&rdquo;)
without any action by the Holders and whether or not the document representing such Notes are surrendered to the Company or its
transfer agent, upon the commencement of trading on a U.S. national securities exchange of the Company&rsquo;s securities to be
issued in an initial public offering (&ldquo;<B>IPO</B>&rdquo;) at <U>a price</U> <FONT STYLE="text-underline-style: double">of
56% discount to the actual price per Class A Share to be issued in the IPO (the &ldquo;Conversion Price&rdquo;). The Conversion
Price may be adjusted after the Issuance Date and prior to the initial closing of the IPO in accordance with <U>Exhibit B</U>.
As soon as practicable after the occurrence of an automatic conversion, the Company shall send a written notice substantially
in the form attached hereto as Exhibit A (the &ldquo;<B>Conversion Notice</B>&rdquo;) to all Holders notifying them to surrender
the original form of the Note (or an affidavit of loss mutilation or destruction, together with an undertaking to provide customary
indemnification to the Company in respect thereof ) to the Company in exchange a certificate or certificates for the number of
full shares of Conversion Shares issuable upon the conversion of Notes pursuant to this Section 4.</FONT></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b) <I>Intentionally
Left Blank</I>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
<I>Conversion Procedure. </I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 8%; font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: top; width: 4%; font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)</FONT></TD>
    <TD STYLE="vertical-align: top; width: 88%; font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
    connection with any conversion pursuant to Section 4(a), as soon as reasonably practicable following the receipt of a Conversion
    Notice, Investor shall surrender to the Company this Note (or a notice to the effect that the original Note has been lost,
    stolen or destroyed and an agreement acceptable to the Company whereby Investor agrees to indemnify the Company from any loss
    incurred by it in connection with such loss or destruction of this Note).</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 8%; text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: top; width: 4%; text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)</FONT></TD>
    <TD STYLE="vertical-align: top; width: 88%; text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Promptly
    following such surrender of the Note to the Company, (A) the Company shall update its transfer agent to record the number
    of Conversion Shares to which Investor shall be entitled upon such conversion, issued as fully paid to Investor and deliver
    to Investor a certified true copy of such updated shareholder list, (B) the Company shall issue and deliver to Investor a
    certificate or certificates for the Conversion Shares, and a check payable to Investor for any cash amounts payable as described
    in Section 4(c)(iii).</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 8%; text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: top; width: 4%; text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii)</FONT></TD>
    <TD STYLE="vertical-align: top; width: 88%; text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;No
    fractional shares or securities shall be issued upon conversion of this Note. In lieu of the Company issuing any fractional
    shares to Investor upon the conversion of this Note, the Company shall pay to Investor an amount equal to the product obtained
    by multiplying the applicable Conversion Price in such conversion, by the fraction of a share or such other security not issued
    pursuant to the previous sentence.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)&nbsp;<I>Reservation
of Shares Issuable Upon Conversion.</I>&nbsp;The Company shall at all times reserve and keep available out of its authorized but
unissued Class A Shares solely for the purpose of effecting the conversion of this Note such number of Class A Shares as shall
from time to time be sufficient to effect the conversion of the Note; and if at any time the number of authorized but unissued
Class A Shares shall not be sufficient to effect the conversion of the entire outstanding Principal Amount of this Note, without
limitation of such other remedies as shall be available to the holder of this Note, Company will use its reasonable best efforts
to take such corporate action as may, in the opinion of counsel, be necessary to increase its authorized but unissued Class A
Shares to such number of shares as shall be sufficient for such purposes.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;&nbsp;</P>

<!-- Field: Page; Sequence: 4; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)
Whenever the Conversion Price is adjusted as herein provided, the Company shall promptly prepare a notice of such adjustment of
the Conversion Price setting forth the adjusted Conversion Price, the manner of calculation of such adjusted Conversion Price
and the date on which such adjustment becomes effective, and shall promptly send such notice to the Investor.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5. <U>Discharge
of Obligations</U>. Upon the earlier of (i) the full conversion of this Note and the Company&rsquo;s delivery of the required
consideration, if any, in respect thereof pursuant to Section 4 and (ii) the full repayment or redemption of the outstanding
and unpaid Principal Amount and any then-accrued and unpaid interest under this Note in accordance with the terms of this
Note, the Company shall be forever released from all its obligations and liabilities under this Note and this Note shall be
deemed of no further force or effect, without any further action of any party, whether or not the original of this Note
has been delivered to the Company for cancellation.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.
<U>&ldquo;Lock-UP&rdquo; Agreement</U>. Investor hereby agrees to enter into a lock-up agreement under which Investor agrees not
to sell or otherwise transfer or dispose of the Note and the Conversion Shares during six-month period commencing on the date
of the commencement of trading on a national securities exchange of the Company&rsquo;s shares in connection with the IPO.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-indent: 0in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">7.
<U>Protective Provisions</U>.</FONT></P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)&nbsp;<I>Indebtedness</I>.
Investor&rsquo;s consent will be required for the Company to (i) incur any additional borrowing or issue any additional debt securities
ranking&nbsp;<I>pari passu</I>&nbsp;with this Note in excess of US$20,000,000 in the aggregate in one or a series of related transactions,
and (ii) incur any borrowing or issue any debt securities ranking senior to this Note, including any secured borrowing or debt
securities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)&nbsp;<I>Information</I>.
The Company will deliver to Investor the documents and information set out in the Securities Purchase Agreement dated November
_____, 2017 between the Company and the Investor (the &ldquo;Securities Purchase Agreement&rdquo;), and the Investor shall be
entitled to the same information rights set out in Securities Purchase Agreement, subject to the same terms, conditions, restrictions
and exceptions as set out in the Securities Purchase Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)&nbsp;<I>Stay,
Extension and Usury Laws.</I>&nbsp;The Company covenants (to the extent it may lawfully do so) that it shall not at any time insist
upon, plead, or in any manner whatsoever claim or take the benefit or advantage of, any stay, extension or usury law or other
law that would prohibit or forgive the Company from paying all or any portion of the principal of or interest on this Note as
contemplated herein, wherever enacted, now or at any time hereafter in force, or that may affect the covenants or the performance
of this Note; and the Company (to the extent it may lawfully do so) hereby expressly waives all benefit or advantage of any such
law, and covenants that it will not, by resort to any such law, hinder, delay or impede the execution of any power herein granted
to the Investor, but will suffer and permit the execution of every such power as though no such law had been enacted.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">(d)&nbsp;<I>Corporate
Existence; Assumption of Obligations by Successor Company</I>. During the term of this Note, the Company shall (i) do or cause
to be done all things reasonably necessary to preserve and keep in full force and effect its corporate existence, or (ii) make
adequate provisions such that the resulting, surviving or transferee Person (the &ldquo;<B>Successor Company</B>&rdquo;), if not
the Company, shall expressly assume, by a duly executed amendment delivered to the Investor and reasonably satisfactory in form
to the Investor, all of the obligations of the Company under this Note, and upon such assumption, such Successor Company shall
succeed to and, except in the case of a lease of all or substantially all of the Company&rsquo;s properties and assets, shall
be substituted for the Company, with the same effect as if it had been named herein as the party of the first part. Such Successor
Company thereupon may cause the Note to be signed and reissued in its own name, with such changes in phraseology and form (but
not in substance) as may be appropriate. The Note as so re-issued shall in all respects have the same benefit as though it had
been issued at the date of the execution hereof. In the event of any such Reorganization or election relating to a Change of Control
to which the foregoing clause (ii) is applicable, upon compliance with the foregoing clause (ii) the Person named as the &ldquo;Company&rdquo;
in the first paragraph of this Note (or any successor that shall thereafter have become such in the manner prescribed in this
Section) may be dissolved, wound up and liquidated at any time thereafter and, except in the case of a lease, such Person shall
be released from its liabilities as obligor and maker of this Note and from its obligations under this Note.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;</FONT></P>

<!-- Field: Page; Sequence: 5; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)&nbsp;<I>Notice
to Investor Prior to Certain Actions.</I>&nbsp;In case of: (x) any action by the Company that would require an adjustment to the
Conversion Price pursuant to the terms hereof; (y) a Change of Control or Reorganization; or (z) voluntary or involuntary dissolution,
liquidation or winding up of the Company, then, in each case (unless notice of such event is otherwise required pursuant to another
provision of this Note) and to the extent applicable, the Company shall send to the Investor, a notice stating the date on which
a record is to be taken for the purpose of such action by the Company or, if a record is not to be taken, the date as of which
the holders of Class A Shares of record are to be determined for the purposes of such action by the Company no later than the
earlier of (1) the date notice of such date is required to be provided under applicable law or applicable rules of any stock exchange
the Class A Shares are listed on at such time and (2) such date is publicly announced by the Company. In addition, the Company
shall notify the Investor of any IPO Commencement Date within two (2) Business Days of such date.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(f)&nbsp;<I>Tax
Matters.</I>&nbsp;The Company has not made, nor will it without the prior writer consent of Investor make, any election to be
treated as other than a corporation for all U.S. federal and applicable state and local income tax purposes. The Company shall
use commercially reasonable efforts to avoid classification as a &ldquo;passive foreign investment company&rdquo; (a &ldquo;<B>PFIC</B>&rdquo;)
as defined in Section 1297 of the U.S. Internal Revenue of Code of 1986, as amended (the &ldquo;<B>Code</B>&rdquo;) for the current
and any future taxable year. Within ninety (90) days from the end of each taxable year of the Company beginning with the tax year
in which this Note is issued, including, for the avoidance of doubt, taxable years prior to, including and after any conversion
pursuant to Section 4 hereof, the Company shall determine, in consultation with a reputable accounting or law firm, whether it
was a PFIC in such taxable year. If it is determined that the Company was a PFIC in such taxable year (or if a governmental authority
informs the Company that it has so determined), the Company shall, within ninety (90) days from the end of such taxable year,
inform Investor of such determination and shall provide or cause to be provided such information as Investor may reasonably request
to enable Investor (or its direct or indirect owners) to elect to treat the Company as a &ldquo;qualified electing fund&rdquo;
(within the meaning of Section 1295 of the Code), and shall provide to Investor a complete and accurate &ldquo;PFIC Annual Information
Statement&rdquo; for the Company as described in Section 1.1295-1(g)(1) of the U.S. Treasury Regulations.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(g)<B>&nbsp;</B><I>Termination</I>.
The provisions of Sections 7(a), 7(b) and 7(e) shall terminate and be of no further force and effect upon the closing of an IPO.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-indent: 0in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8.
<U>Representations and Warranties.</U></FONT></P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(I)&nbsp;<U>Representations
and Warranties of the Company</U>.&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company hereby represents and warrants to the Investor as of the Issuance Date as follows:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)&nbsp;<I>Organization
and Qualification.</I>&nbsp;The Company is a company duly organized and validly existing under the laws of the Cayman Islands.
The Company has the requisite corporate power to carry on its business as now conducted.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;&nbsp;</P>

<!-- Field: Page; Sequence: 6; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)&nbsp;<I>Capitalization.&nbsp;</I>The
Company has provided to Investor the fully-diluted capitalization of the Company containing a list of all outstanding shareholders
of the Company as of the Issuance Date and immediately following the issuance of this Note (the &ldquo;<B>Capitalization Tables</B>&rdquo;).
Except as set forth in the Capitalization Tables, in the Option Plan or in the Transaction Documents, there are no outstanding
preemptive rights, options, warrants, notes, conversion privileges or rights (including but not limited to rights of first refusal
or similar rights), orally or in writing, to purchase or acquire any securities from the Company including, without limitation,
any ordinary or preferred shares, or any securities convertible into or exchangeable or exercisable for ordinary or preferred
shares.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)&nbsp;<I>Authorization.</I>&nbsp;All
corporate action on the part of the Company, its directors and its shareholders necessary for the authorization of this Note and
the delivery and performance of all obligations of the Company hereunder, including the reservation of the Class A Shares issuable
upon conversion of the Notes has been taken or will be taken prior to the issuance of such Conversion Shares. This Note constitutes
a valid and binding obligation of the Company enforceable in accordance with its terms, subject to applicable bankruptcy, insolvency,
moratorium, reorganization and similar laws affecting creditors&rsquo; rights generally, general equitable principles and federal
and state securities laws. The Conversion Shares, when issued in compliance with the provisions hereof will be validly issued,
fully paid and non-assessable and free of any liens or encumbrances.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)&nbsp;<I>Governmental
Consents</I>. All material consents, approvals, orders, or authorizations of, or registrations, qualifications, designations,
declarations, or filings with, any governmental authority, required on the part of the Company in connection with the issuance
of this Note and the Conversion Shares or the consummation of any other transaction contemplated hereby have been obtained or
will be effective at such time as required by applicable law.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)&nbsp;<I>Compliance
with Other Instruments</I>. Other than authorizations, approvals, consents and waivers that have been obtained prior to the Issuance
Date, the issuance of this Note and the Conversion Shares will not (i) result in any violation of or be in conflict with, or constitute,
with or without the passage of time and giving of notice, a default under, any provision, instrument, judgment, decree, order
or writ binding on the Company, (ii) result in the creation of any lien, charge or encumbrance upon any assets of the Company,
or (iii) result in the suspension, revocation, impairment, forfeiture, or nonrenewal of any material permit, license, authorization
or approval required by the Company, its business or operations or any of its assets or properties, in the case of each of (i)
through (iii), except as would not materially and adversely affect the rights of the Investor or the Company&rsquo;s ability to
perform its obligations hereunder. The issuance of this Note and the subsequent issuance of the Conversion Shares (if any) are
not and will not be subject to any preemptive rights or rights of first refusal that have not been properly waived or complied
with.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(f)&nbsp;<I>Financial
Statements</I>. The Company has delivered to the Investor the unaudited consolidated balance sheet of the Company and its subsidiaries
as of December 31, 2016, and statements of income and cash flows for the six-month period ended June 30, 2017 (the &ldquo;<B>Financial
Statements</B>&rdquo;). The Financial Statements were prepared in all material respects in conformity with GAAP consistently applied,
having regard to the purpose for which they were created, are consistent in all material respects with the books and records of
the Company, and fairly present in all material respects (except as may be indicated in the notes thereto) the financial position
of the Company and its subsidiaries as of the dates thereof and the results of operations and cash flows of the Company and its
subsidiaries for the periods shown therein (subject to the absence of footnotes and normal year-end adjustments in the case of
the unaudited statements). None of the Company and its subsidiaries have any material liabilities of any kind whatsoever, whether
accrued, contingent, absolute, known, unknown, determined, determinable or otherwise, that are required to be set forth in the
Financial Statements pursuant to GAAP, and there is no existing condition, situation or set of circumstances which could reasonably
be expected to result in such a liability, other than liabilities provided for in the Financial Statements, or otherwise incurred
in the ordinary course since June 30, 2017.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(g)&nbsp;<I>Compliance
with Law.</I>&nbsp;Each of the Company and its subsidiaries have conducted its business in accordance with applicable laws and
regulations in all material respects, including (a) the U.S. Foreign Corrupt Practices Act of 1977, any rules or regulations under
this law, or any other applicable anti-corruption or anti-kickback law or regulation and (b) the economic sanctions administered
by the U.S. Office of Foreign Assets Control.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;</FONT></P>

<!-- Field: Page; Sequence: 7; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(II)&nbsp;<U>Representations
and Warranties of the Investor.</U>&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Investor hereby represents and warrants to the Company as of the Issuance Date as follows:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)&nbsp;<I>Organization
and Qualification.</I>&nbsp;The Investor is a company duly organized and validly existing under the laws of its jurisdiction of
incorporation. The Investor has the requisite corporate power to carry on its business as now conducted.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)&nbsp;<I>Authorization.</I>&nbsp;All
corporate action on the part of the Investor, its directors and its shareholders necessary for the authorization of this Note
and the delivery and performance of all obligations of the Investor hereunder has been taken. This Note constitutes a valid and
binding obligation of the Investor enforceable in accordance with its terms, subject to applicable bankruptcy, insolvency, moratorium,
reorganization and similar laws affecting creditors&rsquo; rights generally and general equitable principles.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)&nbsp;<I>Governmental
Consents</I>. All material consents, approvals, orders, or authorizations of, or registrations, qualifications, designations,
declarations, or filings with, any governmental authority, required on the part of the Investor in connection with the issuance,
execution and performance of this Note or the consummation of any other transaction contemplated hereby have been obtained or
will be effective at such time as required by applicable law.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)&nbsp;<I>Compliance
with Other Instruments</I>. The Investors&rsquo; execution and delivery of this Note and the performance by the Investors of its
obligations hereunder will not (i) result in any violation of or be in conflict with, or constitute, with or without the passage
of time and giving of notice, a default under, any provision, instrument, judgment, decree, order or writ binding on the Investor
or its Affiliates, (ii) result in the creation of any lien, charge or encumbrance upon any assets of the Investor or its Affiliates,
or (iii) result in the suspension, revocation, impairment, forfeiture, or nonrenewal of any material permit, license, authorization
or approval required by the Investor, its Affiliates and their business or operations or any of their assets or properties, in
the case of each of (i) through (iii), except as would not materially and adversely affect the rights of the Company or the Investor&rsquo;s
ability to perform its obligations hereunder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)&nbsp;<I>Investigation;
Economic Risk</I>. The Investor is able to fend for itself in the transactions contemplated by this Note and has the ability to
bear the economic risks of its investment in this Note and the Conversion Shares.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(f)&nbsp;<I>Purchase
for Own Account</I>. The Investor is, or will be, acquiring this Note and the Conversion Shares for its own account, not as a
nominee or agent, and not with a view to or in connection with the sale or distribution of any part thereof. By executing this
Note, the Investor further represents that it does not have any contract, undertaking, agreement or arrangement with any person
to sell, transfer or grant participation to such person or any third person, with respect to any such securities, assets or property.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(g)&nbsp;<I>Investment
Experience</I>. The Investor has experience in evaluating and investing in transactions of securities in companies and has such
knowledge and experience in financial and business matters.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;</FONT></P>

<!-- Field: Page; Sequence: 8; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-indent: 0in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">9.
<U>Definitions</U>. Except as set forth below, capitalized terms used but not defined herein shall have the respective meanings
ascribed to such terms in the Securities Purchase Agreement (as defined below).</FONT></P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Affiliate</B>&rdquo;
shall mean, in respect of a Person, any other Person that, directly or indirectly, through one or more intermediaries, Controls,
is Controlled by, or is under common Control with, such Person.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Business
Day</B>&rdquo; shall mean a day (other than Saturdays, Sundays or statutory holidays) on which banks generally are open to the
public for business in Hong Kong and the United States of America.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Control</B>&rdquo;
shall mean, with respect to any Person, having the ability to direct the management and affairs of such Person, whether through
the ownership of voting securities or by contract, and such ability shall also be deemed to exist when any Person or &ldquo;group&rdquo;
(as that term is used in Sections 13(d) and 14(d) of the United States Securities Exchange Act of 1934, as amended) attains a
level of ownership of more than 50% of the voting securities on a fully-diluted and as-converted basis, or the economic rights
and benefits, of such Person; and &ldquo;<B>Controlled</B>&rdquo; shall be construed accordingly.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Change
of Control</B>&rdquo; shall mean (i) any merger or consolidation, scheme of arrangement or other similar transaction (including,
without limitation, an acquisition of the Company by way of a share acquisition), of the Company or any of its subsidiaries with
or into another entity outside the Group, where such merger or consolidation, scheme of arrangement or other similar transaction
(including, without limitation, an acquisition of the Company by way of a share acquisition), results in a change of Control of
the Company, (ii) the sale, license or lease of all or substantially all of the Company&rsquo;s and its subsidiaries&rsquo; assets
in one transaction or a series of related transactions, or (iii) the sale (or exclusive license) of all or substantially all of
the Company&rsquo;s intellectual property, provided that, for purposes of this Note, any internal restructuring of the Group,
the IPO and any restructuring in connection with the IPO (each an &ldquo;<B>Internal Restructuring</B>&rdquo;) shall not be deemed
a Change of Control.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Group</B>&rdquo;
shall mean, collectively, the Company, its subsidiaries and any other Person (excluding any natural person) Controlled by the
Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>GAAP</B>&rdquo;
means the United States generally accepted accounting principles applied on a consistent basis during the periods involved.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>IPO
Commencement Date</B>&rdquo; shall mean the date on which the Company first files publicly any preliminary registration statement,
prospectus or other similar document with any applicable securities regulator or stock exchange in connection with an IPO.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Maturity
Date</B>&rdquo; shall mean the earlier of the 12<SUP>th</SUP> month anniversary of the Issuance Date and the date when the Company
redeems this Note at its outstanding Principal Amount, provided that the Company has not consummated the IPO within 12 months
of the Issuance Date; otherwise, the Maturity Date means the date of the initial closing of the IPO of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Option
Plan</B>&rdquo; shall mean the share incentive plan established by the Company on October 13, 2017, as amended.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Class
A Shares</B>&rdquo; shall mean the Class A ordinary shares in the share capital of the Company, with a par value of USD$1.00 each,
with the rights and privileges as set forth in the Articles.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Class
B Shares</B>&rdquo; shall mean the Class B ordinary shares in the share capital of the Company, with a par value of USD$1.00 each,
with the rights and privileges as set forth in the Articles.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Person</B>&rdquo;
shall mean any corporation, company, partnership, firm, limited liability company, other business organization, entity, government,
state or agency of state or any joint venture, association, works council or employee representative body (whether or not having
separate legal personality) and any individual.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;&nbsp;</P>

<!-- Field: Page; Sequence: 9; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Reorganization</B>&rdquo;
shall mean any capital reorganization, reclassification, recapitalization or statutory exchange of the shares of the Company in
such a way that holders of Class A Shares shall be entitled to receive shares, securities or assets in exchange for Class A Shares
(in each case other than an Internal Restructuring).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Significant
Subsidiary</B>&rdquo; shall mean any subsidiary of the Company that meets the definition of &ldquo;significant subsidiary&rdquo;
in Article 1, Rule 1-02 of Regulation S-X under the United States Securities Exchange Act of 1934, as amended, as in effect on
the date of this Note.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Transaction
Documents</B>&rdquo; shall mean, collectively, (i) the Company&rsquo;s Memorandum and Articles of Association of the Company,
each as may be amended or restated from time to time (the &ldquo;<B>Articles</B>&rdquo;), (ii) a securities purchase agreement
among the Company and Investors dated May 15, 2018 (the &ldquo;Securities Purchase Agreement&rdquo;), (iii) a lock-up agreement
among the Company and Investors dated May 15, 2018 and (iv) an escrow deposit agreement among the Company, Signature Bank and
Boustead.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Voting
Ordinary Shares</B>&rdquo; shall mean the voting ordinary shares of the Company carrying one vote per share as set forth in the
Articles.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-indent: 0in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.
<U>Miscellaneous</U>.</FONT></P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
<I>Successors and Assigns</I>. Subject to the restrictions on transfer described in this Section 10(a), the rights and obligations
of the Company and Investor shall be binding upon and benefit the successors, permitted assigns, heirs, administrators and permitted
transferees of the parties. Neither this Note nor any of the rights, interests or obligations hereunder may be assigned or transferred,
by operation of law or otherwise, in whole or in part, by the Company or Investor without the prior written consent of the other
party; provided that, (i) the Investor or any of its direct or indirect permitted transferees under this Section 10(a)(i) may
assign its rights and interests (together with the related obligations) in connection with a transfer of this Note in whole or
in part to an Affiliate of the Investor (provided that there shall be no more than four (4) transfers pursuant to this Section
10(a)(i) in the aggregate) (each, a &ldquo;<B>Permitted Transfer</B>&rdquo;); provided, however, that (A) the Company is given
a written notice at the time of each Permitted Transfer stating the name and address of the transferee and identifying the amount
of the Note being transferred; and (B) any such transferee shall receive such rights and interests, subject to all the terms and
conditions of this Note, including the provisions of this Section 10, and agree to abide by this Note by executing a joinder agreement
substantially in the form of&nbsp;<U>Exhibit C</U>&nbsp;hereto, and (ii) for purposes of this Note, a Change of Control shall
not be deemed to be an assignment or transfer and shall not be subject to this Section 10(a), and following such Change of Control,
the rights and obligations of the Company shall be binding upon and benefit the successor of the Company or such other surviving
or resulting entity of such Change of Control. Any permitted transferee of Investor shall be subject to all the terms and conditions
of this Note and such transferee shall agree to abide by the terms of this Note by executing a joinder agreement substantially
in the form of&nbsp;<U>Exhibit C</U>&nbsp;hereto. At any time that the Investor elects to transfer less than all of this Note
in accordance with this Section 10, upon written notice to the Company, the Company will (x) issue a new note (consistent in all
respects with this Note other than with respect to principal amount) to the transferee in the aggregate principal amount equal
to such portion of this Note that the Investor requests to be transferred to the transferee and (y) will issue a new note (consistent
in all respects with this Note other than with respect to principal amount) to the Investor in the aggregate principal amount
equal to such portion of the Note not transferred to the transferee.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;</FONT></P>

<!-- Field: Page; Sequence: 10; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
<I>Waiver and Amendment</I>. This Note and the other documents delivered pursuant hereto constitute the full and entire understanding
and agreement between the parties with regard to the subjects hereof and thereof. Any provision of this Note may be amended and
the observance of any term may be waived (either generally or in a particular instance and either retroactively or prospectively),
with the written consent of the Company and Investor. No delay or omission on the part of either party hereto in exercising any
right hereunder shall operate as a waiver of such right or of any other right. A waiver on any one occasion shall not be construed
as a bar to or waiver of any such right and/or remedy in any future occasion.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0pt; margin-left: 0.5in; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
<I>Confidentiality</I>.</FONT></P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 47.25pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 47.25pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)&nbsp;<U>Disclosure
of Terms</U>. Each party hereto acknowledges that the terms and conditions of this Note, the Transaction Documents, and all exhibits,
schedules, restatements and amendments hereto and thereto, including their existence and any negotiations in connection with them,
shall be considered confidential information and shall not be disclosed by it to any third party except in accordance with the
provisions set forth below.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 11.25pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)&nbsp;<U>Permitted
Disclosures</U>. The confidentiality obligations set out in this Section 10(c) do not apply to:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 11%; text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: top; width: 4%; text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(A)</FONT></TD>
    <TD STYLE="vertical-align: top; width: 85%; text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">information
    which was in the public domain or otherwise known to the relevant party before it was furnished to it by the other party or,
    after it was furnished to that party, entered the public domain otherwise than as a result of (i) a breach by that party of
    this Section 10(c), or (ii) a breach of a confidentiality obligation by that party, where the breach was known to that party;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 11%; text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: top; width: 4%; text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(B)</FONT></TD>
    <TD STYLE="vertical-align: top; width: 85%; text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">disclosure
    which is necessary in order to comply with any applicable law, the order of any competent court or authority, the requirements
    of a stock exchange, parliamentary body, governmental agency or to obtain tax or other clearances or consents from any relevant
    authority or in connection with responding to any request from any tax authority; or</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 11%; text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: top; width: 4%; text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(C)</FONT></TD>
    <TD STYLE="vertical-align: top; width: 85%; text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">disclosure
    by either party hereto to its Affiliates, and its and their employees, financial advisers, consultants, auditors, insurers
    and legal or other advisers and to their respective existing and potential investors.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 9%; text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: top; width: 3%; text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii)</FONT></TD>
    <TD STYLE="vertical-align: top; text-align: justify; text-indent: 8.25pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Announcements</U>.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 76.5pt; text-align: justify; text-indent: -22.5pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 11%"></TD><TD STYLE="width: 4%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(A)</FONT></TD><TD STYLE="vertical-align: top; text-align: justify; font: 10pt Times New Roman, Times, Serif; width: 85%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">No
party shall make or authorize the making of any announcement concerning the existence or subject matter of this Note unless the
other party shall have given their prior consent to such announcement (such consent not to be unreasonably withheld or delayed).</FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 11%; text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: top; width: 4%; text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(B)</FONT></TD>
    <TD STYLE="vertical-align: top; text-align: justify; font: 10pt Times New Roman, Times, Serif; width: 85%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
    10(c)(iii)(A) shall not apply to:</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 94.55pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 94.55pt; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">(1)
any information which is required to be announced pursuant to any applicable laws or any requirement of any competent governmental
or statutory authority or rules or regulations of any relevant regulatory, administrative or supervisory body (including without
limitation, any relevant stock exchange or securities council); or</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 94.55pt; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 94.55pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)
any information which is required to be announced pursuant to any legal process issued by any court or tribunal of competent jurisdiction.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 94.55pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT>&nbsp;</P>

<!-- Field: Page; Sequence: 11; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 94.55pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)
<I>Applicable Law: Disputes</I>. All questions concerning the construction, validity, enforcement and interpretation of the Transaction
Documents shall be governed by and construed and enforced in accordance with the internal laws of the State of New York, without
regard to the principles of conflicts of law thereof. Each party agrees that all legal proceedings concerning the interpretations,
enforcement and defense of the transactions contemplated by this Agreement and any other Transaction Documents (whether brought
against a party hereto or its respective affiliates, directors, officers, shareholders, partners, members, employees or agents)
shall be commenced exclusively in the state and federal courts sitting in the City of New York. Each party hereby irrevocably
submits to the exclusive jurisdiction of the state and federal courts sitting in the City of New York, Borough of Manhattan for
the adjudication of any dispute hereunder or in connection herewith or with any transaction contemplated hereby or discussed herein
(including with respect to the enforcement of any of the Transaction Documents), and hereby irrevocably waives, and agrees not
to assert in any Action, any claim that it is not personally subject to the jurisdiction of any such court, that such Action is
improper or is an inconvenient venue for such Action. Each party hereby irrevocably waives personal service of process and consents
to process being served in any such Action by mailing a copy thereof via registered or certified mail or overnight delivery (with
evidence of delivery) to such party at the address in effect for notices to it under this Agreement and agrees that such service
shall constitute good and sufficient service of process and notice thereof. Nothing contained herein shall be deemed to limit
in any way any right to serve process in any other manner permitted by law. If any party shall commence an Action to enforce any
provisions of the Transaction Documents, the prevailing party in such Action shall be reimbursed by the non-prevailing party for
its reasonable attorneys&rsquo; fees and other costs and expenses incurred with the investigation, preparation and prosecution
of such Action.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)
<I>WAIVER OF JURY TRIAL</I>.&nbsp;IN ANY ACTION, SUIT, OR PROCEEDING IN ANY JURISDICTION BROUGHT BY ANY PARTY AGAINST ANY OTHER
PARTY UNDER THIS AGREEMENT, THE PARTIES EACH KNOWINGLY AND INTENTIONALLY, TO THE GREATEST EXTENT PERMITTED BY APPLICABLE LAW,
HEREBY ABSOLUTELY, UNCONDITIONALLY, IRREVOCABLY AND EXPRESSLY WAIVES FOREVER TRIAL BY JURY.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(f)
<I>Notices</I>. Except as may be otherwise provided herein, all notices, requests, waivers and other communications made pursuant
to this Note shall be in writing and shall be conclusively deemed to have been duly given: (a) when hand delivered to a party;
(b) when sent by facsimile at the number set forth below, upon a successful transmission report being generated by the sender&rsquo;s
machine; (c) when sent by email at the time the email is sent (provided that a copy of the notice is sent by another method referred
to in this Section 10(f) within one (1) Business Day of sending the email) or (d) three (3) Business Days after deposit with an
internationally reputable delivery service provider, postage prepaid, provided that the sending party receives a confirmation
of delivery from the delivery service provider.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR>
    <TD STYLE="vertical-align: top; width: 13%; padding-left: 1.55pt; text-indent: -1.55pt"><FONT STYLE="font-size: 10pt">To the Company:</FONT></TD>
    <TD STYLE="vertical-align: bottom; width: 4%; text-align: justify">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; width: 83%">
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Aptorum Group Limited</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">17<SUP>th</SUP> Floor, Guangdong Investment Tower</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">148 Connaught Road</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Central, Hong Kong</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Telephone: +852 2117 6611</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Facsimile: +852 2850 7286<BR>
        Attention: Investor Relations</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Email: investor.relations@aptorumgroup.com</P></TD></TR>
<TR>
    <TD STYLE="vertical-align: top; padding-left: 1.55pt; text-indent: -1.55pt">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: justify">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: justify">&nbsp;</TD></TR>
<TR>
    <TD STYLE="vertical-align: top; padding-left: 12pt; text-align: justify; text-indent: -12pt"><FONT STYLE="font-size: 10pt">To Investor:</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: justify">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: justify"><FONT STYLE="font-size: 10pt">___________________________</FONT></TD></TR>
<TR>
    <TD STYLE="vertical-align: top; padding-left: 12pt; text-align: justify; text-indent: -12pt">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: justify">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: justify"><FONT STYLE="font-size: 10pt">___________________________</FONT></TD></TR>
<TR>
    <TD STYLE="vertical-align: top; padding-left: 12pt; text-align: justify; text-indent: -12pt">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: justify">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: justify"><FONT STYLE="font-size: 10pt">___________________________</FONT></TD></TR>
<TR>
    <TD STYLE="vertical-align: top; padding-left: 12pt; text-align: justify; text-indent: -12pt">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: justify">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom">Telephone: _______________</TD></TR>
<TR>
    <TD STYLE="vertical-align: top; padding-left: 12pt; text-align: justify; text-indent: -12pt">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: justify">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: justify"><FONT STYLE="font-size: 10pt">Facsimile:&nbsp;&nbsp;&nbsp;_________________</FONT></TD></TR>
<TR>
    <TD STYLE="vertical-align: top; padding-left: 12pt; text-align: justify; text-indent: -12pt">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: justify">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: justify"><FONT STYLE="font-size: 10pt">Attention:&nbsp;&nbsp;&nbsp;_________________</FONT></TD></TR>
<TR>
    <TD STYLE="vertical-align: top; padding-left: 12pt; text-align: justify; text-indent: -12pt">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: justify">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: justify"><FONT STYLE="font-size: 10pt">Email:&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>______________<FONT STYLE="font-size: 10pt">___</FONT></TD></TR>
<TR>
    <TD STYLE="vertical-align: top; padding-left: 12pt; text-align: justify; text-indent: -12pt">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: justify">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: justify">&nbsp;</TD></TR>
<TR>
    <TD STYLE="vertical-align: top">
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">with copies (which will not constitute notice)</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 12pt; text-align: justify; text-indent: -12pt">to the</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 12pt; text-align: justify; text-indent: -12pt">following:</P></TD>
    <TD STYLE="vertical-align: bottom; text-align: justify">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom">
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Hunter Taubman Fischer &amp; Li LLC</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">1450 Broadway, 26<SUP>th</SUP> Floor</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">New York, New York 10018</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Attention: Louis E. Taubman (General Counsel)</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Facsimile: 212-202-6380</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Email: LTaubman@htflawyers.com</P></TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">A
party may change or supplement the addresses and numbers given above, or designate additional addresses and numbers, for purposes
of this Section 10(f) by giving the other parties written notice of the new address or number (as relevant) in the manner set
forth above.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(g)
<I>Payment</I>. Unless converted pursuant to the terms hereof, payment shall be made in lawful tender of the United States.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(h)
<I>Expenses</I>. All costs and expenses incurred in connection with this Note shall be paid by the party incurring such cost or
expense.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)
<I>Counterparts</I>. This Note may be executed in any number of counterparts and by different parties on separate counterparts,
each of which, when executed and delivered, shall be deemed to be an original, and all of which, when taken together, shall constitute
but one and the same Note.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>(Signature
Page Follows</I>)</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;</FONT></P>

<!-- Field: Page; Sequence: 12; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">IN
WITNESS WHEREOF, the Company has executed and delivered this Note the date and year first above written.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 100%; font-size: 10pt; text-align: justify"><FONT STYLE="font-size: 10pt"><B>THE COMPANY</B></FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>APTORUM GROUP LIMITED</B></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">a Cayman Islands company</P></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 4%; font-size: 10pt; text-align: justify"><FONT STYLE="font-size: 10pt">By:</FONT></TD>
    <TD STYLE="width: 36%; font-size: 10pt; text-align: justify; border-bottom: Black 1.5pt solid">&nbsp;</TD>
    <TD STYLE="width: 60%">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt; text-align: justify"><FONT STYLE="font-size: 10pt">Name:&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: justify"> <FONT STYLE="font-size: 10pt">Ian Huen</FONT></TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt; text-align: justify"><FONT STYLE="font-size: 10pt">Title:</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: justify"><FONT STYLE="font-size: 10pt">Executive Director &amp; CEO</FONT></TD>
    <TD>&nbsp;</TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">SIGNATURE
PAGE TO CONVERTIBLE PROMISSORY NOTE</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;</FONT></P>

<!-- Field: Page; Sequence: 13; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>EXHIBIT
A TO NOTES</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>CONVERSION
NOTICE</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dear
Noteholder,</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
refer to the Convertible Promissory Note (the &ldquo;<B>Note</B>&rdquo;) dated May 15, 2018 issued by the Aptorum Group Limited
(the &ldquo;<B>Company</B>&rdquo;) to you. Capitalized terms used but not defined in this Conversion Notice shall have the meanings
specified in the Note.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
hereby give you the Conversion Notice pursuant to Section 4 of the Note that this Note has been automatically converted into ___________
shares of Class A Shares at a price of $________<SUP>1</SUP> per Class A Share on __________, 20____.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Please
kindly deliver the original form of this Note (or an affidavit of loss mutilation or destruction, together with an undertaking
to provide customary indemnification to the Company in respect thereof) to :</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Aptorum
        Group Limited</FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">17<SUP>th
        </SUP>Floor, Guangdong Investment Tower</FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">148
        Connaught Road</FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Central,
        Hong Kong</FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Telephone:
        +852 2117 6688</FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Facsimile:
        +852 2850 7286<BR>
        Attention: Investor Relations</FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Email
        address: investor.relations@aptorumgroup.com</FONT></P></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 60%; font-size: 10pt; text-align: justify"><FONT STYLE="font-size: 10pt">Yours faithfully,</FONT></TD>
    <TD STYLE="width: 40%; font-size: 10pt; text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt; text-align: justify">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 10pt">Aptorum Group Limited</FONT></TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 60%">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name: </FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 35%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ian Huen</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title: </FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Executive Director &amp; CEO</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><SUP></SUP></FONT></P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 0; margin-bottom: 0"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid; width: 25%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><SUP>1
</SUP>The initial conversion price shall be equal to a 56% discount to the actual price per Class A Share at the applicable initial
public offering and at the commencement of trading on a U.S. national securities exchange of the Company&rsquo;s securities to
be issued in such offering.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<!-- Field: Page; Sequence: 14; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>EXHIBIT
B TO NOTES</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>ADJUSTMENTS
TO CONVERSION PRICE</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 4%; font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
    case the Company, at any time or from time to time, shall subdivide its outstanding Class A Shares into a greater number of
    shares (by any share split, share dividend or otherwise), the Conversion Price in effect immediately prior to such subdivision
    shall be proportionately reduced and, conversely, in case the Company, at any time or from time to time, shall combine its
    outstanding Class A Shares into a smaller number of shares (by any reverse share split or otherwise), the Conversion Price
    in effect immediately prior to such combination shall be proportionately increased. In the case of any such subdivision, no
    further adjustment shall be made pursuant to Section 2 below by reason thereof.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 4%; font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If,
    the Company, at any time or from time to time, shall effect any capital reorganization, reclassification, recapitalization
    or statutory exchange of the shares of the Company in such a way that holders of Class A Shares shall be entitled to receive
    shares, securities or assets in exchange for Class A Shares (in each case other than an Internal Restructuring) (a &ldquo;<B>Reorganization</B>&rdquo;),
    then, lawful and adequate provisions shall be made whereby the Investor shall thereupon have the right to receive, upon the
    basis and upon the terms and conditions specified herein and in lieu of the Voting Ordinary Shares immediately theretofore
    receivable upon the full conversion of any unpaid and unconverted Principal Amount then remaining outstanding, such shares,
    securities or assets as may be issued or payable in exchange for a number of outstanding Voting Ordinary Shares equal to the
    number of Voting Ordinary Shares immediately theretofore receivable for such full conversion of such unpaid and unconverted
    Principal Amount remaining outstanding had such Reorganization not taken place.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 4%; font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Prior
    to the IPO, except as provided in Section 4 below and except in the case of an event described in Sections 1 or 2 above, if
    the Company shall issue or sell, or is, in accordance with this Section 3, deemed to have issued or sold, any new Class A
    Share for a consideration per share less than the Conversion Price in effect immediately prior to such issuance or sale (the
    &ldquo;<B>Pre-Adjustment Conversion Price</B>&rdquo;), then, upon such issuance or sale (or deemed issuance or sale), the
    Conversion Price shall be determined as follows:</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 47.25pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 47.25pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">NCP
= OCP * (OS + (NP/OCP))/(OS + NS)</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 47.25pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 47.25pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">WHERE:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 47.25pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 47.25pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">NCP
= the new Conversion Price,</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 47.25pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 47.25pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">OCP
= the Pre-Adjustment Conversion Price,</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 47.25pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 47.25pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">OS
= the total outstanding Class A Shares immediately before the issuance or sale of the new Class A Shares<I>&nbsp;plus</I>&nbsp;the
total Class A Shares issuable upon conversion of all the outstanding preference shares and exercise of outstanding options and
convertible securities,</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 47.25pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 47.25pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">NP
= the total consideration received for the issuance or sale of the new Class A Shares, and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 47.25pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 47.25pt; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">NS
= the number of new Class A Shares issued or sold.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;&nbsp;</P>

<!-- Field: Page; Sequence: 15; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
purposes of this Section 3, the following shall also be applicable:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 5%; font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Issuance
    of Rights or Options</I>&nbsp;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 59.1pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 59.1pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
the Company at any time or from time to time, shall in any manner grant (whether directly or by assumption in a merger or otherwise)
any warrants or other rights to subscribe for or to purchase, or any options for the purchase of, Class A Shares or any shares
or security convertible into or exchangeable for Class A Shares (such warrants, rights or options being called &ldquo;<B>Options</B>&rdquo;
and such convertible or exchangeable shares or securities being called &ldquo;<B>Convertible Securities</B>&rdquo;), in each case
for consideration per share (determined as provided in this paragraph and in Section 3(v) below) less than the Conversion Price
then in effect, whether or not such Options or the right to convert or exchange any such Convertible Securities are immediately
exercisable, then the total maximum number of Class A Shares issuable upon the exercise of such Options, or upon conversion or
exchange of the total maximum amount of such Convertible Securities issuable upon exercise of such Options, shall be deemed to
have been issued as of the date of granting of such Options, at a price per share equal to the amount determined by dividing (A)
the total amount, if any, received or receivable by the Company as consideration for the granting of such Options, plus the minimum
aggregate amount of additional consideration payable to the Company upon the exercise of all such Options, plus, in the case of
such Options which relate to Convertible Securities, the minimum aggregate amount of additional consideration, if any, payable
upon the issuance or sale of such Convertible Securities and upon the conversion or exchange thereof, by (B) the total maximum
number of Class A Shares deemed to have been so issued. Except as otherwise provided in Section 3(iii) below, no adjustment of
the Conversion Price shall be made upon the actual issuance of such Class A Shares or of such Convertible Securities upon exercise
of such Options or upon the actual issuance of such Class A Shares upon conversion or exchange of such Convertible Securities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 5%; font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Issuance
    of Convertible Securities</I>&nbsp;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 59.1pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 59.1pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
the Company at any time or from time to time, shall in any manner issue or sell any Convertible Securities for consideration per
share (determined as provided in this paragraph and in Section 3(v) below) less than the Conversion Price then in effect, whether
or not the rights to exchange or convert any such Convertible Securities are immediately exercisable, then the total maximum number
of Class A Shares issuable upon conversion or exchange of all such Convertible Securities shall be deemed to have been issued
as of the date of the issuance or sale of such Convertible Securities, at a price per share equal to the amount determined by
dividing (A) the total amount, if any, received or receivable by the Company as consideration for the issuance or sale of such
Convertible Securities, plus the minimum aggregate amount of additional consideration, if any, payable to the Company upon the
conversion or exchange thereof, by (B) the total maximum number of Class A Shares deemed to have been so issued;&nbsp;<U>provided</U>,
that (1) except as otherwise provided in Section 3(iii) below, no adjustment of the Conversion Price shall be made upon the actual
issuance of such Class A Shares upon conversion or exchange of such Convertible Securities and (2) if any such issuance or sale
of such Convertible Securities is made upon exercise of any Options to purchase any such Convertible Securities, no further adjustment
of the Conversion Price shall be made by reason of such issuance or sale.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;</FONT></P>

<!-- Field: Page; Sequence: 16; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 5%; font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Change
    in Option Price or Conversion Rate</I>&nbsp;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 59.1pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 59.1pt; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">If,
at any time or from time to time, there shall occur a change in (A) the maximum number of Class A Shares issuable in connection
with any Option referred to in Section 3(i) above or any Convertible Securities referred to in Section 3(i) or Section 3(ii) above,
(B) the purchase price provided for in any Option referred to in Section 3(i) above, (C) the additional consideration, if any,
payable upon the conversion or exchange of any Convertible Securities referred to in Section 3(i) or Section 3(ii) above or (D)
the rate at which Convertible Securities referred to in Section 3(i) or Section 3(ii) above are convertible into or exchangeable
for Class A Shares (in each case, other than in connection with an event described in Section 4 below), then the Conversion Price
in effect at the time of such event shall be readjusted to the relevant Conversion Price that would have been in effect at such
time had such Options or Convertible Securities that are still outstanding provided for such changed maximum number of shares,
purchase price, additional consideration or conversion rate, as the case may be, at the time initially granted, issued or sold,
but only if as a result of such adjustment the Conversion Price then in effect is thereby reduced; and on the termination of any
such Option or any such right to convert or exchange such Convertible Securities, the Conversion Price then in effect hereunder
shall be increased to the Conversion Price that would have been in effect at the time of such termination had such Option or Convertible
Securities, to the extent outstanding immediately prior to such termination (i.e., to the extent that fewer than the number of
Class A Shares deemed to have been issued in connection with such Option or Convertible Securities were actually issued), never
been issued or sold or been issued or sold at such higher price, as the case may be.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 5%; font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iv)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Share
    Dividends</I>&nbsp;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 59.1pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 59.1pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
the Company, at any time or from time to time, shall declare or make, or fix a record date for the determination of holders of
Class A Shares entitled to receive, a dividend or make any other distribution upon any shares of the Company payable in Class
A Shares, Options or Convertible Securities, any Class A Shares, Options or Convertible Securities, as the case may be, issuable
in payment of such dividend or distribution shall be deemed to have been issued or sold without consideration, the Conversion
Price will be adjusted pursuant to this Section 3;&nbsp;<U>provided</U>, that no adjustment shall be made to the conversion price
as a result of such dividend or distribution if the holders of the Note are entitled to, and do, receive such dividend or distribution
in accordance with Article 42 of the Articles; and,&nbsp;<U>provided</U>,&nbsp;<U>further</U>, that if any adjustment is made
to the Conversion Price as a result of the declaration of a dividend and such dividend is not effected, the Conversion Price shall
be appropriately readjusted to the Conversion Price that would have been in effect had such dividend not been declared.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 5%; font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(v)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Consideration
    for Shares</I>&nbsp;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 59.1pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 59.1pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
the Company, at any time or from time to time, shall issue or sell, or is deemed to have issued or sold, any Class A Shares for
cash, the consideration received therefor shall be deemed to be the amount received or to be received by the Company therefor
(determined with respect to deemed issuances and sales in connection with Options and Convertible Securities in accordance with
clause (A) of Section 3(i) or Section 3(ii) above, as appropriate) as determined in good faith by the board of directors of the
Company. In case any Class A Shares shall be issued or sold, or deemed issued or sold, for a consideration other than cash, the
amount of the consideration other than cash received by the Company (the &ldquo;<B>Board</B>&rdquo;) shall be deemed to be the
fair value of such consideration received or to be received by the Company (determined with respect to deemed issuances and sales
in connection with Options and Convertible Securities in accordance with clause (A) of Section 3(i) or Section 3(ii) above, as
appropriate) as determined in good faith by the Board and the holders of a majority of the Class A Shares then outstanding. In
case any Options shall be issued in connection with the issuance and sale of other securities of the Company, together comprising
one integral transaction in which no specific consideration is allocated to such Options by the parties thereto, such Options
shall be deemed to have been issued for such consideration as determined in good faith by the Board and the holders of a majority
of the Class A Shares then outstanding.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;</FONT></P>

<!-- Field: Page; Sequence: 17; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 5%; font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(vi)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Record
    Date</I>&nbsp;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 59.1pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 59.1pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
the Company, at any time or from time to time, shall take a record of the holders of its Class A Shares for the purpose of entitling
them (A) to receive a dividend or other distribution payable in Class A Shares, Options or Convertible Securities or (B) to subscribe
for or purchase Class A Shares, Options or Convertible Securities, then such record date shall be deemed to be the date of the
issuance or sale of the Class A Shares deemed to have been issued or sold upon the declaration of such dividend or the making
of such other distribution or the granting of such right of subscription or purchase, as the case may be.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 5%; font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(vii)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Treasury
    Shares</I>&nbsp;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 59.1pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 59.1pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
number of Class A Shares outstanding at any given time shall not include shares owned or held by or for the account of the Company;&nbsp;<U>provided</U>,
that the disposition of any such shares shall be considered an issuance or sale of Class A Shares for the purpose of this Section
3.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 5%; font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(viii)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Other
    Issuances or Sales</I>&nbsp;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 59.1pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 59.1pt; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">In
calculating any adjustment to the Conversion Price pursuant to this Section 3: any Options or Convertible Securities that provide,
as of the effective date of such adjustment, for the issuance upon exercise, conversion or exchange thereof of an indeterminable
number of Class A Shares shall (together with the Class A Shares issuable upon exercise, conversion or exchange thereof) be disregarded;&nbsp;<U>provided</U>,
that at such time as the number of Class A Shares issuable upon exercise, conversion or exchange of such Options or Convertible
Securities becomes determinable, the Conversion Price shall be adjusted as provided in Section 3(iii) above.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 4%; font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Certain
    Issues or Transfer Excepted</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 47.25pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 59.1pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Anything
in this Note to the contrary notwithstanding, the Company shall not be required to make any adjustment of the Conversion Price
in the case of the issuance or transfer of (i) Class A Shares upon conversion of this Note; (ii) Class A Shares or other awards
to acquire Class A Shares under the Option Plan and any other employee incentive plan of the Company and/or outside of the Option
Plan as approved in accordance with the Articles, or (iii) any Class A Shares issued by the Company in exchange for the assets
or shares of another Person in connection with the acquisition of such Person by the Company, whether by merger, purchase of all
or substantially all of the assets of such Person, or otherwise, which acquisition has been approved in accordance with the Articles.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 47.25pt; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 59.1pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Capitalized
terms used in this&nbsp;<U>Exhibit B</U>&nbsp;but not defined herein have the meanings given to them in the Note.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 47.25pt; text-align: justify">&nbsp;&nbsp;</P>

<!-- Field: Page; Sequence: 18; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 47.25pt; text-align: justify">&nbsp;<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>EXHIBIT
C TO NOTES</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">JOINDER
AGREEMENT</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
Joinder Agreement (&ldquo;<B>Joinder Agreement</B>&rdquo;) is executed by the undersigned (the &ldquo;<B>Transferee</B>&rdquo;)
pursuant to the terms of that certain Convertible Promissory Note dated as of May 15, 2018 (as may be amended, restated or otherwise
modified form time to time, the &ldquo;<B>Note</B>&rdquo;) by and between Aptorum Group Limited, a company limited by shares incorporated
in the Cayman Islands (the &ldquo;<B>Company</B>&rdquo;) and ___________________________________(&ldquo;<B>Investor</B>&rdquo;),
and in consideration of the Note purchased by the Transferee and other good and valuable consideration, the receipt and sufficiency
of which are hereby acknowledged. Capitalized terms used but not defined herein shall have the respective meanings ascribed to
such terms in the Note. By the execution of this Joinder Agreement, the Transferee agrees as follows:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 47.25pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.&nbsp;<U>Acknowledgment</U>.
Transferee acknowledges that Transferee is acquiring _____ in Principal Amount of the Note and the rights, interests and obligations
thereunder from _______________ (the &ldquo;<B>Transferor</B>&rdquo;), subject to the terms and conditions of the Note (the &ldquo;<B>Transfer</B>&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 47.25pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 47.25pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.&nbsp;<U>Agreement</U>.
Immediately upon the Transfer, Transferee (i) agrees that the Transferee shall be bound by and subject to the terms of the Note
applicable to the Transferor, including those set forth in the Lock-Up Agreement, if applicable and in such case, to provide the
Company with a copy of the Lock-Up Agreement signed by the Transferee at the time of such transfer, and (ii) hereby adopts the
Note and shall have all of the rights and obligations of the &ldquo;Investor&rdquo; thereunder with the same force and effect
as if Transferee were originally a party thereunder in the capacity of the Investor and agrees to duly and punctually perform
and discharge all liabilities and obligations whatsoever from time to time to be performed or discharged by Transferee under or
by virtue of the Note in all respects as if named as a party therein. The Transferee hereby ratifies, as of the date hereof, and
agrees to be bound by, all of the terms, provisions and conditions contained in the Note.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 47.25pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 47.25pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.&nbsp;<U>Notice</U>.
Any notice required or permitted by the Note shall be given to Transferee at the address listed beside Transferee&rsquo;s signature
below.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 47.25pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 47.25pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.&nbsp;<U>Joinder
Agreement to be Construed in Conjunction with Agreement</U>. This Joinder Agreement shall hereafter be read and construed in conjunction
and as one document with the Note and references in the Note to &ldquo;the Note&rdquo; or &ldquo;this Note&rdquo;, and references
in all other instruments and documents executed thereunder or pursuant to the Note, shall for all purposes refer to the Note incorporating
and as supplemented by this Joinder Agreement. Except to the extent that it is expressly amended by this Joinder Agreement, the
Note and all other documents or instruments executed pursuant to, or in connection with, the Note shall remain in full force and
effect.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 47.25pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 47.25pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.&nbsp;<U>Governing
Law</U>. This Joinder Agreement shall be governed by, and construed and enforced in accordance with, the laws of the State of
New York without reference to its conflict of laws principles.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">IN
WITNESS WHEREOF, the undersigned has executed this Joinder Agreement as of the date written below.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 5%; font-size: 10pt"><FONT STYLE="font-size: 10pt">Signature:&nbsp;&nbsp;</FONT></TD>
    <TD STYLE="width: 35%; border-bottom: Black 1.5pt solid">&nbsp;</TD>
    <TD STYLE="width: 60%; font-size: 10pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">Date:</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">19</FONT></P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 0; margin-bottom: 0"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.1
<SEQUENCE>5
<FILENAME>ff12018ex10-1_aptorum.htm
<DESCRIPTION>APPOINTMENT LETTER BETWEEN THE COMPANY AND IAN HUEN (FOUNDER, CHIEF EXECUTIVE OFFICER & EXECUTIVE DIRECTOR), DATED SEPTEMBER 25, 2017
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit
10.1</B></FONT></P>

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin: 0; text-align: center; font: 10pt Times New Roman, Times, Serif"><IMG SRC="ex10-1_001.jpg" ALT=""></P>

<P STYLE="margin: 6pt 0 0; text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Aptorum
Group Limited</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Aptus
Management Limited</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Unit
B, 17/F Guangdong Investment Tower, 148 Connaught Road Central, Hong Kong</FONT></P>

<P STYLE="margin: 0; text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Tel:
(852) 2117 6611 &#9679; Fax: (852) 2850 7286</FONT></P>



<P STYLE="margin: 0; text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">25
September 2017</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Attn:
Mr. Chung Yuen Ian Huen</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dear
Mr. Huen,</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Appointment
Letter</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
are pleased and welcome your acceptance to be appointed as the Chief Executive Officer and an Executive Director of <B>Aptorum
Group Limited</B> (&ldquo;<B>AGL</B>&rdquo; or the &ldquo;<B>Company</B>&rdquo;). You shall also be required to be appointed as
Executive Director of the group companies of AGL from time to time. You shall be employed full-time under the hiring entity APTUS
Management Limited (&ldquo;<B>AML</B>&rdquo;), a wholly owned subsidiary of the Company. The Company is incorporated with limited
liabilities under the laws of Cayman Islands and AML is duly incorporated with limited liabilities in Hong Kong. The Company also
has subsidiary companies in the Cayman Islands, Hong Kong, and Macau, whereby collectively, shall be depicted as &ldquo;Aptorum&rdquo;
or the &ldquo;Group&rdquo;.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following letter seeks to illustrate the context of your employment under AML and appointment by AGL, and the terms and conditions
as set out herewith (the &ldquo;<B>Agreement</B>&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 22.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
letter will supersede all previous appointment contract or agreement, if applicable, entered into between yourself and the Company
(or its affiliated subsidiaries). By signing this letter and therefore accepting the appointment as stated, you agree to terminate
all other previous appointments with the Group commencing from the Effective Date.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 22.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 3%; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>1.</B></FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>The
                                         Company and the Group</B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 3%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Aptorum
focuses on the licensing of, and acquisition of early stage preclinical assets with the intention to engage in drug research,
development, and commercialization purposes. Assets are acquired via open and public platforms such as the technology transfer
offices of accredited universities and academic institutions. In addition, the Group seeks to be a facilitator across the financing
spectrum for biotech companies, entrepreneurs, and commercializing agents, to bolster innovations adding value to health care
needs in the marketplace; and to assist in furthering the research capabilities of institutions the Group works with.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 3%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company is a privately held company that has engaged in plans to pursue an initial public offering on the Nasdaq Global Market
in the near future (<B>the &ldquo;Listing&rdquo;</B>).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 3%; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>2.</B></FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Position
                                         and Appointment</B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 3%; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 33pt; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">You
                                         will be appointed to act as the <B>Chief Executive Officer (&ldquo;CEO&rdquo;)</B> and
                                         <B>Executive Director (&ldquo;ED&rdquo;)</B> on the board of directors (the &ldquo;Board&rdquo;)
                                         of the Company (&ldquo;Appointments&rdquo; or &ldquo;Roles&rdquo;).</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 3%; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 33pt; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                         Appointment is subject to the Company&rsquo;s Memorandum and Articles of Association
                                         (&quot;Articles&quot;) and nothing in this letter shall be taken to exclude or vary the
                                         terms of the Articles as they apply to your Appointment.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="margin: 0; text-align: center; font: 10pt Times New Roman, Times, Serif"><IMG SRC="ex10-1_001.jpg" ALT=""></P>

<P STYLE="margin: 0; text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Aptorum
Group Limited</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Aptus
Management Limited</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Unit
B, 17/F Guangdong Investment Tower, 148 Connaught Road Central, Hong Kong</FONT></P>

<P STYLE="margin: 0; text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Tel:
(852) 2117 6611 &#9679; Fax: (852) 2850 7286</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 3%; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 33pt; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)</FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">You
                                         shall be an Officer of the Company as covered in the Rule 16a-1(f) under the Securities
                                         and Exchange Act of 1934.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 3%; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 33pt; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)</FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                         continuation of the Appointment is contingent to your ongoing fulfillment of your obligations
                                         and successful re-election by the Company&rsquo;s shareholders at the Company&rsquo;s
                                         Annual General Meeting (the &ldquo;AGM&rdquo;). It is further subject to your agreement
                                         to apply yourself and discharge your duties as an Executive Director in accordance with
                                         the Articles of the Company and the Cayman Islands Company Law (2016 Revision) (as amended)
                                         (&quot;Company Law&quot;), as well as you upholding the high standards of corporate governance
                                         as set forth in the Nasdaq Listing Rule 5600 Series subsequent to the Listing.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 3%; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>3.</B></FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Date
                                         of Commencement</B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 3%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Your
official date of appointment as the CEO and Executive Director of the Company shall commence on <B>1 October 2017</B> (&ldquo;Effective
Date&rdquo;), as mutually agreed upon between yourself and the Executive Board of Directors of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 3%; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>4.</B></FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Duties
                                         and Responsibilities</B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 3%; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 33pt; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">You
                                         shall be the key member ultimately responsible for the day-to-day management decisions
                                         and supervisory requirements of the Group. You shall be responsible for leading the development
                                         and execution of the Group&rsquo;s long term strategy across all its business segments
                                         with a view to creating shareholder value.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 3%; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 33pt; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
                                         the CEO of the Company, you shall be responsible towards the overall strategic direction
                                         of business development activities, and the implementation of long and short term plans
                                         for the Group. Other members of the Board shall also draw upon your leadership, insight,
                                         and expertise where suitable. You shall provide guidance, steering, and access of expert
                                         networks to the Company where appropriate and required.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 3%; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 33pt; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)</FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">You
                                         shall act as a direct liaison between the Board and management of the Company and Group,
                                         and communicate to the Board on behalf of the management.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 3%; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 33pt; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)</FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">You
                                         shall communicate on behalf of the Company and Group to shareholders, employees, Government
                                         authorities, other stakeholders and the public.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 3%; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 33pt; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)</FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">You
                                         are expected to fulfill management duties as required by the Company, the shareholders
                                         of the Company, and members of the Non-Executive Board, on a day-to-day basis during
                                         official office hours where necessary. Your contribution shall be vital and appreciated
                                         in regards to the execution of business decisions made by the Executive Board.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 3%; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 33pt; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(f)</FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">You
                                         will exercise your powers of your Appointment having regard to the relevant obligations
                                         under prevailing law and regulation, including the Cayman Islands Company Law, and while
                                         in pursuit of and subsequent to the Listing, also the rules and responsibilities stipulated
                                         by the U.S. Securities and Exchange Commission (&ldquo;SEC&rdquo;), and the Nasdaq Regulatory
                                         Authority; including but not limited to the Listing Rule 5600 Series.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P>

<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="margin: 0; text-align: center; font: 10pt Times New Roman, Times, Serif"><IMG SRC="ex10-1_001.jpg" ALT=""></P>

<P STYLE="margin: 0; text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Aptorum
Group Limited</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Aptus
Management Limited</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Unit
B, 17/F Guangdong Investment Tower, 148 Connaught Road Central, Hong Kong</FONT></P>

<P STYLE="margin-top: 0; font: 10pt Times New Roman, Times, Serif; margin-bottom: 0; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Tel:
(852) 2117 6611 &#9679; Fax: (852) 2850 7286</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 3%; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 33pt; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(g)</FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
                                         concert with Board members, you are to develop Board agendas and to request that special
                                         meeting of the Board be called when appropriate. You shall also determine the date, time,
                                         and location of the annual meeting of shareholders and to develop the agenda for the
                                         meeting.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 3%; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 33pt; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(h)</FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Subsequent
                                         to the Listing, you as an ED along with other Directors of the board are to meet when
                                         possible in executive session, where such sessions should occur at least four times a
                                         year. Furthermore, you are to sit on the committees of the Board where appropriate as
                                         determined by the Board.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Additionally,
you shall during your Appointment:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 3%; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 33pt; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)</FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ensure
                                         the Company is appropriately organized and staffed, and has authority to hire and terminate
                                         staff as necessary to enable it to achieve the approved strategy.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 3%; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 33pt; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(j)</FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
                                         conjunction with other members of management, ensure that expenditures of the Company
                                         are within the authorized annual budget of the Company.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 3%; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 33pt; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(k)</FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Assess
                                         the principal risks of the Company and to ensure that these risks are being monitored
                                         and managed.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 3%; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 33pt; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(l)</FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ensure
                                         effective internal controls and management information systems are in place.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 3%; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 33pt; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(m)</FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ensure
                                         that the Company has appropriate systems to enable it to conduct its business activities
                                         both lawfully and ethically.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 3%; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 33pt; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(n)</FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Observe
                                         and comply with the Company&rsquo;s adopted Code of Business Conduct and Ethics, where
                                         that any waivers given to directors or executive officers must be approved by the Board.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 3%; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 33pt; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(o)</FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Observe
                                         and comply with all statutory rules, and regulations where applicable as governed by
                                         the laws of your residence and jurisdictions in which operate on behalf of the Group.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 3%; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 33pt; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(p)</FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Confirm
                                         you are able to, and will devote sufficient time to perform your Roles.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 3%; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 33pt; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(q)</FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Consider
                                         the interests of the Company and its employees when implementing executive decisions.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -31.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 3%; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 33pt; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(r)</FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Keep
                                         abreast of all material undertakings and activities of the Company and all material external
                                         factors affecting the Company and to ensure that processes and systems are in place to
                                         ensure that you and management of the Company are adequately informed.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 3%; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 33pt; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(s)</FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ensure
                                         that the Directors are properly informed and that sufficient information is provided
                                         to the Board to enable the Directors to form appropriate judgment.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P>

<!-- Field: Page; Sequence: 3; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="margin: 0; text-align: center; font: 10pt Times New Roman, Times, Serif"><IMG SRC="ex10-1_001.jpg" ALT=""></P>

<P STYLE="margin: 0; text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Aptorum
Group Limited</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Aptus
Management Limited</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Unit
B, 17/F Guangdong Investment Tower, 148 Connaught Road Central, Hong Kong</FONT></P>

<P STYLE="margin-top: 0; font: 10pt Times New Roman, Times, Serif; margin-bottom: 0; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Tel:
(852) 2117 6611 &#9679; Fax: (852) 2850 7286</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 3%; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 33pt; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(t)</FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ensure
                                         the integrity of all public disclosure of the Company.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 3%; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 33pt; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(u)</FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Provide
                                         traceable contact during and after office hours, on weekdays and weekends, or during
                                         public holidays, whereby your availability may occasionally and reasonably be sought.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -31.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 3%; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 33pt; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(v)</FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Declare
                                         any conflicts that are apparent at present, or become apparent, between the Group and
                                         your external activities, interests, or roles. Should any potential conflicts of interest
                                         arise, you will disclose this to the Board as soon as they become apparent.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -31.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 3%; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 33pt; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(w)</FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Obtain
                                         clearance from the Board prior to dealing in publicly traded shares in the Company subsequent
                                         to the Listing and shall adhere to the Insider Trading Policy as adopted by the Company.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 3%; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 33pt; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(x)</FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Observe
                                         and comply with the disclosure requirements and obligations of you and/or your affiliated
                                         party(s) as applicable in accordance with U.S. securities laws, regulations and SEC disclosure
                                         requirements.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 3%; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>5.</B></FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Salary
                                         and Cash Bonus</B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 3%; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 33pt; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Your
                                         starting salary will be <B>HKD 180,000</B> per month, paid out in an equivalent amount
                                         of thirteen (13) months per calendar year.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -31.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 3%; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 33pt; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Annual
                                         increment of your salary will be assessed on the basis of professional merit and the
                                         Group&rsquo;s performance, and is awarded at the discretion of the Board of Directors
                                         of the Company and as approved by the Compensation Committee.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 3%; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 33pt; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)</FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">With
                                         completion of one full year&rsquo;s service (or a pro-rata portion thereof if service
                                         is less than one year), you may be entitled to a bonus as determined at the full discretion
                                         of the Board of Directors of the Company and approval of the Compensation Committee.
                                         Any bonus will only be payable only if you are still in the employment of the Company
                                         on the bonus payment date which shall be payable in December or subsequent January of
                                         each calendar year.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 3%; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>6.</B></FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Share
                                         Bonus:</B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -22.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 3%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">You
shall be entitled to receive share bonuses for your services rendered as an ED with the amount, cap, timing of payouts, vesting
rate and schedule, subject to the full discretion of the Company and approval of the Compensation Committee. All terms and conditions
of share bonuses shall be assessed based on the overall financial position and performance of the Group, as well as your contribution
and performance upon rendering services by yourself during your Appointment under this Agreement. Any particulars associated to
your eligibility to share bonuses shall be definitively defined at a future date as mutually agreed upon between yourself and
the Executive Board of Directors, and as approved by the Compensation Committee.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 4; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="margin: 0; text-align: center; font: 10pt Times New Roman, Times, Serif"><IMG SRC="ex10-1_001.jpg" ALT=""></P>

<P STYLE="margin: 0; text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Aptorum
Group Limited</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Aptus
Management Limited</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Unit
B, 17/F Guangdong Investment Tower, 148 Connaught Road Central, Hong Kong</FONT></P>

<P STYLE="margin: 0; text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Tel:
(852) 2117 6611 &#9679; Fax: (852) 2850 7286</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 3%; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>7.</B></FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Share
                                         Option</B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 3%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">You
shall be granted an option to purchase Class A ordinary shares of the authorized share capital in the Company as pursuant to the
particulars described by the Company&rsquo;s Share Option Plan subject to the ongoing effect of your Appointments.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 3%; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>8.</B></FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Restriction
                                         on Other Activities</B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 3%; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 33pt; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
                                         your employment, you shall diligently and faithfully serve the Company and not act in
                                         any way which is in conflict with the interest of the Group.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 3%; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 33pt; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">You
                                         shall not during your employment be engaged or interested directly or indirectly in any
                                         capacity in any other trade, business, occupation, or assignment outside the Company,
                                         unless otherwise approved and consented by the Board of Directors in writing.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 3%; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 33pt; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)</FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Consult
                                         with the Chairman of the Board prior to accepting any other (or further) directorships
                                         of companies or any major external appointments and promptly inform the Board of acceptance
                                         of any such appointment.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 3%; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>9.</B></FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Privacy
                                         of Information</B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -28.35pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 3%; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 33pt; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">You
                                         shall not except as authorized by the Company or required by your responsibilities reveal
                                         to any person or company any of the trade secrets or any information concerning the organization,
                                         business, finances, transactions or affairs of the Group which may come to your knowledge
                                         during your contract with the Company and shall keep with complete secrecy confidential
                                         information entrusted to you and shall not use or attempt to use any such information
                                         in any manner which may injure or cause loss either directly or indirectly to the Group
                                         or may be likely to do so. This restriction shall continue to apply if and when after
                                         the termination of your appointment without limit in time.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 3%; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 33pt; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">You
                                         shall not either during the period of your appointment or afterwards use or permit to
                                         be used any books, documents, moneys, assets, records or other property belonging to
                                         or relating to any dealings, affair or business of the Group other than for the benefit
                                         of the Group. You shall immediately deliver and return to the Group all such books, documents,
                                         moneys, securities, records or other property which you then have or should have in your
                                         possession upon termination of your appointment hereunder.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 3%; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 33pt; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)</FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                         Company however, agrees to provide you with any information concerning areas of interest
                                         and relevance of the Group as required by you in order to enable you to fulfill your
                                         Roles of the Group.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 3%; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>10.</B></FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Insurance
                                         and Indemnity</B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 3%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company shall establish directors&rsquo; and officers&rsquo; liability coverage and it is intended to maintain such coverage through
the period of your Appointments.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 5; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="margin: 0; text-align: center; font: 10pt Times New Roman, Times, Serif"><IMG SRC="ex10-1_001.jpg" ALT=""></P>

<P STYLE="margin: 0; text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Aptorum
Group Limited</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Aptus
Management Limited</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Unit
B, 17/F Guangdong Investment Tower, 148 Connaught Road Central, Hong Kong</FONT></P>

<P STYLE="margin: 0; text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Tel:
(852) 2117 6611 &#9679; Fax: (852) 2850 7286</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 3%; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>11.</B></FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Termination</B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -28.35pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 3%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Your
Appointments with the Company and Group may only be terminated:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -28.35pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 3%; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 33pt; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By
                                         you after giving the Company not less than three (3) months&rsquo; notice in writing;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -22.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 3%; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 33pt; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By
                                         the Company after giving you three (3) months&rsquo; notice in writing; or</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 3%; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 33pt; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)</FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By
                                         the Company with immediate effect in the event that you:</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 48pt; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 35.7pt; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)</FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Conduct
                                         dishonesty, fraud, gross negligence, willful default or refusal to carry out any lawful
                                         order or instructions, or the repeated breach of any rules or regulations of the Company,
                                         or those as governed by the laws of your residency or jurisdictions in which you operate
                                         on behalf of the Group.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 48pt; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 35.7pt; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)</FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Commit
                                         a material breach of your obligations under this letter;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 48pt; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 35.7pt; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii)</FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Commit
                                         any serious or repeated breach or non-observance of your obligations to the Company and
                                         Group;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 48pt; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 35.7pt; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iv)</FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Are
                                         convicted of a criminal offence other than an offence under road traffic legislation
                                         in the jurisdiction of your residency or elsewhere for which a fine or non-custodial
                                         penalty is imposed;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 48pt; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 35.7pt; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(v)</FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Declare
                                         bankruptcy or have made an arrangement with or for the benefit of your creditors; or</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 48pt; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 35.7pt; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(vi)</FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Are
                                         disqualified from acting as a director.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Please
signify your acceptance of the above terms and conditions by signing and returning to us the enclosed duplicate copy of this letter.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Yours
faithfully,</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif; width: 40%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
    and on behalf of</FONT></TD>
    <TD STYLE="padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif; width: 20%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif; width: 40%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>APTORUM
    GROUP LIMITED</B></FONT></TD>
    <TD STYLE="padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Agreed
    and accepted by:</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD>
    <TD STYLE="padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:
    Huen Chung Yuen Ian</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Position:
    Director</FONT></TD>
    <TD STYLE="padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">HKID
    No.:</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date</FONT></TD>
    <TD STYLE="padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date</FONT></TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 0; margin-bottom: 0"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.2
<SEQUENCE>6
<FILENAME>ff12018ex10-2_aptorum.htm
<DESCRIPTION>EMPLOYMENT LETTER BETWEEN THE COMPANY AND SABRINA KHAN (CHIEF FINANCIAL OFFICER), DATED SEPTEMBER 1, 2017
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif; text-align: right"><B>Exhibit 10.2</B></P>

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<P STYLE="margin-top: 0; text-align: center; margin-bottom: 0; font: 10pt Times New Roman, Times, Serif"><IMG SRC="ex10-2_001.jpg" ALT=""></P>

<P STYLE="margin-top: 0; text-align: center; margin-bottom: 0; font: 10pt Times New Roman, Times, Serif">APTUS Management Limited</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Unit B, 17/F Guangdong Investment Tower,
148 Connaught Road Central, Hong Kong</P>

<P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">Tel: (852) 2117 6611&#9679;  Fax: (852) 2850 7286</P>



<P STYLE="margin-top: 0; text-align: center; margin-bottom: 0; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1<SUP>st
</SUP>September 2017</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ms.
Sabrina Khan</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dear
Ms. Khan,</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Employment
Letter</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
are pleased and welcome your acceptance to be appointed as the Chief Financial Officer for <B>APTUS Holdings Limited (&ldquo;AHL&rdquo;
</B>or the <B>&ldquo;Company&rdquo;)</B>. You shall be employed full-time under the hiring entity <B>APTUS Management Limited
(&ldquo;AML&rdquo;)</B>, a wholly owned subsidiary of the Company. The Company is incorporated with limited liabilities under
the laws of Cayman Islands and AML is duly incorporated with limited liabilities in Hong Kong. The Company also has subsidiary
companies in the Cayman Islands, Hong Kong, and Macau, whereby collectively, shall be depicted as &ldquo;APTUS&rdquo; or the &ldquo;Group&rdquo;.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following letter seeks to illustrate the context of your employment under AML and appointment by AHL, and the terms and conditions
as set out herewith (the &ldquo;Agreement&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 22.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 4%; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>1.</B></FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>The
                                         Group</B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 4%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">APTUS
and its affiliates focus on the licensing of, and acquisition of early stage preclinical assets with the intention to engage in
drug research, development, and commercialization purposes. Assets are acquired via open and public platforms such as the technology
transfer offices of accredited universities and academic institutions. In addition, the Group seeks to be a facilitator across
the financing spectrum for biotech companies, entrepreneurs, and commercializing agents, to bolster innovations adding value to
health care needs in the market place; and to assist in furthering the research capabilities of institutions the Group works with.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 4%; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>2.</B></FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Position
                                         and Responsibilities</B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 21.3pt; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 33pt; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">You
                                         will be enlisted to act as the <B>Chief Financial Officer </B>for the Company.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 21.3pt; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 33pt; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">You
                                         shall report to Mr. Ian Huen, the Chief Executive Officer and Executive Director of the
                                         Group.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 21.3pt; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 33pt; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)</FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
                                         the Chief Financial Officer of the Company, you shall be responsible towards overseeing
                                         the finance and accounting, administrative, and risk management operations of the Company,
                                         including but not limited to the development of financial and operational strategies,
                                         metrics tied to such strategies, and the ongoing development and monitoring of control
                                         systems designed to preserve company assets and report accurate financial results.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 21.3pt; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 33pt; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)</FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Your
                                         role is a management role and you shall be expected to oversee, manage, and motivate
                                         the staff of the Finance and Accounting department to execute and achieve departmental
                                         milestones and targets, while collaborating with other members of the Company to further
                                         Group objectives.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="margin-top: 0; text-align: center; margin-bottom: 0; font: 10pt Times New Roman, Times, Serif"><IMG SRC="ex10-2_001.jpg" ALT=""></P>

<P STYLE="margin-top: 0; text-align: center; margin-bottom: 0; font: 10pt Times New Roman, Times, Serif">APTUS Management Limited</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Unit B, 17/F Guangdong Investment Tower,
148 Connaught Road Central, Hong Kong</P>

<P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">Tel: (852) 2117 6611&#9679;  Fax: (852) 2850 7286</P>


<P STYLE="margin-top: 0; text-align: center; margin-bottom: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 21.3pt; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 33pt; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)</FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Your
                                         principal accountabilities include:</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 54.3pt; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 40.2pt; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)</FONT></TD><TD STYLE="padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Planning:</U>&nbsp;Assist
                                         in formulating the Group&rsquo;s future direction, monitor and manage the capital request
                                         and budgeting processes;</FONT></TD></TR>                                                                                  <TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0; text-align: justify">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0; text-align: justify">&nbsp;</TD><TD STYLE="padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
</TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 54.3pt; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif; text-align: justify"></TD><TD STYLE="width: 40.2pt; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)</FONT></TD><TD STYLE="padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Operations:
                                         </U>Participate in key decisions as a member of the management team, oversee the Group&rsquo;s
                                         transaction processing systems, implement operational best practices;</FONT></TD></TR>                                                                                                                               <TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0; text-align: justify">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0; text-align: justify">&nbsp;</TD><TD STYLE="padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
</TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 54.3pt; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif; text-align: justify"></TD><TD STYLE="width: 40.2pt; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii)</FONT></TD><TD STYLE="padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Financial
                                         Information:</U> Oversee the issuance of financial information, report financial results
                                         to the Board of Directors;</FONT></TD></TR>                                                                                    <TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0; text-align: justify">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0; text-align: justify">&nbsp;</TD><TD STYLE="padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
</TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 54.3pt; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif; text-align: justify"></TD><TD STYLE="width: 40.2pt; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iv)</FONT></TD><TD STYLE="padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Risk
                                         Management:</U> Understand and mitigate key elements of the Group&rsquo;s risk profile,
                                         construct and monitor reliable control systems, ensure that record keeping meets the
                                         requirements of auditors and regulatory bodies, report risk issues to the Board of Directors;</FONT></TD></TR>                                                                                                                                                       <TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0; text-align: justify">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0; text-align: justify">&nbsp;</TD><TD STYLE="padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
</TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 54.3pt; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif; text-align: justify"></TD><TD STYLE="width: 40.2pt; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(v)</FONT></TD><TD STYLE="padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Funding:
                                         </U>Monitor cash balances and cash forecasts, arrange debt and equity financing when
                                         relevant;</FONT></TD></TR>                                                                   <TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0; text-align: justify">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0; text-align: justify">&nbsp;</TD><TD STYLE="padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
</TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 54.3pt; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif; text-align: justify"></TD><TD STYLE="width: 40.2pt; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(vi)</FONT></TD><TD STYLE="padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Third
                                         Parties:</U> Maintain banking relationships, represent the Company and the Group with
                                         investment bankers and investors when relevant.</FONT></TD></TR>                                                                                                         <TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0; text-align: justify">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0; text-align: justify">&nbsp;</TD><TD STYLE="padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
</TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 21.3pt; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif; text-align: justify"></TD><TD STYLE="width: 33pt; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(f)</FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">You
                                         are expected to fulfill operational and leadership duties as requested by the Chief Executive
                                         Officer, the Company, the shareholders of the Company, and members of the Executive and
                                         Non-Executive Board, on a day-to-day basis during official office hours where necessary.
                                         Your contribution shall be vital and appreciated in regards to the execution of business
                                         decisions made by the Executive Board.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 21.3pt; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 33pt; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(g)</FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">You
                                         shall:</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.75in; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)</FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Observe
                                         and comply with all statutory rules, and regulations where applicable as governed by
                                         the internal policies and guidelines of the Company, and the laws of Hong Kong Special
                                         Administrative Region;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.75in; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)</FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Provide
                                         traceable contact during and after office hours, on weekdays and weekends, or during
                                         public holidays, whereby your availability may occasionally and reasonably be sought.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 4%; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>3.</B></FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Date
                                         of Commencement</B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 4%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Your
official date of appointment as the Chief Financial Officer of the Company shall commence on <B>[ _______________ ]</B> (&ldquo;Effective
Date&rdquo;), as mutually agreed upon between yourself and the Executive Board of Directors of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 4%; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>4.</B></FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Salary
                                         and Cash Bonus</B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 21.3pt; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 33pt; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Your
                                         starting salary will be <B>HKD 102,500</B> (Hong Kong Dollars One Hundred Two Thousand
                                         Five Hundred) per month, paid out in an equivalent amount of twelve months per calendar
                                         year.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -31.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -31.5pt"></P>

<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -31.5pt">&nbsp;</P>

<P STYLE="margin-top: 0; text-align: center; margin-bottom: 0; font: 10pt Times New Roman, Times, Serif"><IMG SRC="ex10-2_001.jpg" ALT=""></P>

<P STYLE="margin-top: 0; text-align: center; margin-bottom: 0; font: 10pt Times New Roman, Times, Serif">APTUS Management Limited</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Unit B, 17/F Guangdong Investment Tower,
148 Connaught Road Central, Hong Kong</P>

<P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">Tel: (852) 2117 6611&#9679;  Fax: (852) 2850 7286</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -31.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 21.3pt; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 33pt; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Annual
                                         increment of your salary will be assessed on the basis of professional merit and the
                                         Group&rsquo;s performance, and is awarded at the discretion of the Board of Directors
                                         of the Company and approved by the remuneration committee.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -31.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 21.3pt; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 33pt; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)</FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">With
                                         completion of one full year&rsquo;s service (or a pro-rata portion thereof if service
                                         is less than one year), you may be entitled to a bonus as determined at the full discretion
                                         of the Board of Directors of the Company and approval of the remuneration committee.
                                         Any bonus will only be payable only if you are still in the employment of the Company
                                         on the bonus payment date which shall be payable in December or subsequent January of
                                         each calendar year.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 4%; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>5.</B></FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Stock
                                         Bonus:</B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -22.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 4%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">You
may be entitled to receive stock bonuses with the amount, cap, timing of payouts, vesting rate and schedule, subject to the full
discretion of the Company. All terms and conditions of stock bonuses shall be assessed based on the overall financial position
and performance of the Company, as well as your contribution and performance upon rendering services by yourself during your employment
under this Agreement. Any particulars associated to your eligibility to stock bonuses shall be definitively defined in a subsequent
&ldquo;Stock Option and Stock Bonus Addendum&rdquo; at a future date as mutually agreed upon between yourself and the Executive
Board of Directors and approved by the remuneration committee.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 4%; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>6.</B></FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Stock
                                         Option</B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 4%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">You
may be granted an option to purchase shares of the stock in the Company with the particulars of: the amount (percentage of issued
and outstanding stock of the Company), the term, extended terms (if any), option pricing and valuation method, and any other particulars
associated to eligibility of stock option purchases, shall be definitively defined in a subsequent &ldquo;Stock Option and Stock
Bonus Addendum&rdquo; at a future date as mutually agreed upon between yourself and the Executive Board of Directors.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 4%; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>7.</B></FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Mandatory
                                         Provident Fund</B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -4.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 4%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">You
will be entitled to become a member of AML&rsquo;s standard Mandatory Provident Fund scheme in accordance with the Company&rsquo;s
policy and the statutory requirements.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -14.15pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 4%; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>8.</B></FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Medical
                                         Insurance</B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -28.35pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 4%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">You
will be admitted to the Group&rsquo;s Medical scheme, which provides reimbursement of consultation and hospitalization expenses
in accordance with the terms of the scheme. Your role shall entitle you to the highest coverage bracket available to the Group&rsquo;s
management personnel, where the service provider and scheme may be subject to review or alteration in alignment to Group business
needs and conditions.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 3; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="margin-top: 0; text-align: center; margin-bottom: 0; font: 10pt Times New Roman, Times, Serif"><IMG SRC="ex10-2_001.jpg" ALT=""></P>

<P STYLE="margin-top: 0; text-align: center; margin-bottom: 0; font: 10pt Times New Roman, Times, Serif">APTUS Management Limited</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Unit B, 17/F Guangdong Investment Tower,
148 Connaught Road Central, Hong Kong</P>

<P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">Tel: (852) 2117 6611&#9679;  Fax: (852) 2850 7286</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 4%; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>9.</B></FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Restriction
                                         on Other Activities</B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 21.3pt; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 33pt; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
                                         your employment, you shall diligently and faithfully serve the Company and not act in
                                         any way which is in conflict with the interest of the Group.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 21.3pt; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 33pt; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">You
                                         shall not during your employment be engaged or interested directly or indirectly in any
                                         capacity in any other trade, business, occupation or assignment of whatsoever nature
                                         outside the Company, unless otherwise approved and consented by the Board of Directors
                                         in writing.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 4%; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>10.</B></FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Privacy
                                         of Information</B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -28.35pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 21.3pt; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 33pt; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">You
                                         shall not except as authorized by the Company or required by your responsibilities reveal
                                         to any person or company any of the trade secrets or any information concerning the organization,
                                         business, finances, transactions or affairs of the Group which may come to your knowledge
                                         during your contract with the Group and shall keep with complete secrecy confidential
                                         information entrusted to you and shall not use or attempt to use any such information
                                         in any manner which may injure or cause loss either directly or indirectly to the Group
                                         or may be likely to do so. This restriction shall continue to apply if and when after
                                         the termination of your appointment without limit in time.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 21.3pt; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 33pt; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">You
                                         shall not either during the period of your appointment or afterwards use or permit to
                                         be used any books, documents, moneys, assets, records or other property belonging to
                                         or relating to any dealings, affair or business of the Group other than for the benefit
                                         of the Group. You shall immediately deliver and return to the Group all such books, documents,
                                         monies, securities, records or other property which you then have or should have in your
                                         possession upon termination of your appointment hereunder.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 21.3pt; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 33pt; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)</FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                         Company however, agrees to provide you with any information concerning areas of interest
                                         and relevance of the Group as required by you in order to enable you to fulfill your
                                         role as the Chief Financial Officer of the Company.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 4%; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>11.</B></FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Annual
                                         Holiday</B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 4%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">You
shall be entitled to an annual leave of 21 working days (exclusive of statutory holidays) during each twelve-month period to be
taken at such time as the Group shall consider most convenient having regard to the requirements of the business of the Companies.
The said holiday shall not be accumulated beyond each twelve-month period and if not taken in full in any particular period you
shall not be entitled to salary or remuneration in lieu of taking such holiday.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 4%; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>12.</B></FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Termination</B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -28.35pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 4%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Your
appointment as the Chief Financial Officer of the Company may be terminated:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -28.35pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 21.3pt; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 33pt; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By
                                         you after giving the Company not less than three (3) months&rsquo; notice in writing;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -22.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 21.3pt; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 33pt; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By
                                         the Company after giving you three (3) months&rsquo; notice in writing; or</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 21.3pt; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 33pt; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)</FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By
                                         the Company without notice or compensation in the event of your dishonesty, fraud, gross
                                         negligence, willful default or refusal to carry out any lawful order or instructions,
                                         or the repeated breach of any rules or regulations of the Company, or those as governed
                                         by the laws of Hong Kong Special Administrative Region.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 4; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="margin-top: 0; text-align: center; margin-bottom: 0; font: 10pt Times New Roman, Times, Serif"><IMG SRC="ex10-2_001.jpg" ALT=""></P>

<P STYLE="margin-top: 0; text-align: center; margin-bottom: 0; font: 10pt Times New Roman, Times, Serif">APTUS Management Limited</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Unit B, 17/F Guangdong Investment Tower,
148 Connaught Road Central, Hong Kong</P>

<P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">Tel: (852) 2117 6611&#9679;  Fax: (852) 2850 7286</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Please
signify your acceptance of the above terms and conditions by signing and returning to us the enclosed duplicate copy of this letter.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Yours
faithfully, &#9;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif; width: 40%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
    and on behalf of</FONT></TD>
    <TD STYLE="padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif; width: 20%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif; width: 40%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>APTUS
    MANAGEMENT LIMITED</B></FONT></TD>
    <TD STYLE="padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Agreed
    and accepted by:</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:
    Huen Chung Yuen Ian</FONT></TD>
    <TD STYLE="padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:
    Sabrina Khan</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Position:
    Director &amp; CEO</FONT></TD>
    <TD STYLE="padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">HKID
    No.:</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date</FONT></TD>
    <TD STYLE="padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center">5</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 0; margin-bottom: 0"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.3
<SEQUENCE>7
<FILENAME>ff12018ex10-3_aptorum.htm
<DESCRIPTION>ADDENDUM TO EMPLOYMENT LETTER BETWEEN COMPANY AND SABRINA KHAN (CHIEF FINANCIAL OFFICER) DATED APRIL 24, 2018
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit
10.3&nbsp;</B></FONT></P>

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-top: 0; text-align: center; margin-bottom: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;<IMG SRC="ex10-3_001.jpg" ALT="" STYLE="width: 19px; height: 25px"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">APTUS
Management Limited</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">17/F
Guangdong Investment Tower, 148 Connaught Road Central, Hong Kong</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Tel:
(852) 2117 6611 &#9679; Fax: (852) 2850 7286</FONT></P>



<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">24
April 2018</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ms.
Khan Sabrina</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Present</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dear
Sabrina,</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>Addendum
to Employment Letter (the &ldquo;Addendum&rdquo;)</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
letter supplements and serves to be an addendum to the Employment Letter dated 1 September 2017 (&ldquo;Employment Letter&rdquo;)
executed between yourself and APTUS Management Limited (the &ldquo;Company&rdquo;) in relation to your employment as the Chief
Financial Officer. This Addendum should be read together with, and forms part of, the Employment Letter.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
Addendum serves to describe the following amendments and/or additions to the Employment Letter.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 21.3pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>i.</B></FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Change
                                         of the Date of Commencement</B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 21.3pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 21.3pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to Clause 3 of Employment Letter, the official commencement date of your employment shall be on <B>16 October 2017</B> (the &ldquo;Effective
Date&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 21.3pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 21.3pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>ii.</B></FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Adjustment
                                         of &ldquo;Salary and Cash Bonus&rdquo;</B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 21.3pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 21.3pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to Clause 4 of Employment Letter, your base salary will be adjusted to <B>HKD 122,500</B> with effect from 1 April 2018.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Please
signify your acceptance of the above amendments described in this Addendum by signing and returning to us the enclosed duplicate
copy of this letter.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Yours
faithfully, &#9;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 49%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">For and on behalf of</FONT></TD>
    <TD STYLE="width: 2%; text-align: justify">&nbsp;</TD>
    <TD STYLE="width: 49%; text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>APTUS MANAGEMENT LIMITED</B></FONT></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Agreed and accepted by:</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify; border-bottom: Black 1.5pt solid">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify; border-bottom: Black 1.5pt solid">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Huen Chung Yuen Ian</FONT></TD>
    <TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Khan Sabrina</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Director</FONT></TD>
    <TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">HKID No. Z002647(7)</FONT></TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.4
<SEQUENCE>8
<FILENAME>ff12018ex10-4_aptorum.htm
<DESCRIPTION>APPOINTMENT LETTER BETWEEN THE COMPANY AND DARREN LUI (CHIEF BUSINESS OFFICER, PRESIDENT & DIRECTOR), DATED SEPTEMBER 25, 2017
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif; text-align: right"><B>Exhibit 10.4</B></P>

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-top: 0; text-align: center; margin-bottom: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT><IMG SRC="ex10-4_001.jpg" ALT=""></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Aptorum Group Limited</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Aptus Management Limited</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Unit B, 17/F Guangdong Investment Tower,
148 Connaught Road Central, Hong Kong</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Tel: (852) 2117 6611 &#9679; Fax: (852) 2850
7286</P>



<P STYLE="margin-top: 0; text-align: center; margin-bottom: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">25
September 2017</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Attn:
Mr. Lui Wang Yip Darren</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dear
Mr. Lui,</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Appointment
Letter</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
are pleased and welcome your acceptance to be appointed as the President, Chief Business Officer, and an Executive Director of
<B>Aptorum Group Limited</B> (&ldquo;<B>AGL</B>&rdquo; or the &ldquo;<B>Company</B>&rdquo;). You shall also be required to be
appointed as Executive Director of the group companies of AGL from time to time. You shall be employed full-time under the hiring
entity APTUS Management Limited (&ldquo;<B>AML</B>&rdquo;), a wholly owned subsidiary of the Company. The Company is incorporated
with limited liabilities under the laws of Cayman Islands and AML is duly incorporated with limited liabilities in Hong Kong.
The Company also has subsidiary companies in the Cayman Islands, Hong Kong, and Macau, whereby collectively, shall be depicted
as &ldquo;Aptorum&rdquo; or the &ldquo;Group&rdquo;.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following letter seeks to illustrate the context of your employment under AML and appointment by AGL, and the terms and conditions
as set out herewith (the &ldquo;<B>Agreement</B>&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
letter will supersede all previous appointment contract or agreement, if applicable, entered into between yourself and the Company
(or its affiliated subsidiaries). By signing this letter and therefore accepting the appointment as stated, you agree to terminate
all other previous appointments with the Group commencing from the Effective Date.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 22.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 21.3pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>1.</B></FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>The
                                         Company and the Group</B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 21.3pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Aptorum
focuses on the licensing of, and acquisition of early stage preclinical assets with the intention to engage in drug research,
development, and commercialization purposes. Assets are acquired via open and public platforms such as the technology transfer
offices of accredited universities and academic institutions. In addition, the Group seeks to be a facilitator across the financing
spectrum for biotech companies, entrepreneurs, and commercializing agents, to bolster innovations adding value to health care
needs in the marketplace; and to assist in furthering the research capabilities of institutions the Group works with.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 21.3pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 21.3pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company is a privately held company that has engaged in plans to pursue an initial public offering on the Nasdaq Global Market
in the near future (<B>the &ldquo;Listing&rdquo;</B>).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 21.3pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;&nbsp;</B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 21.3pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>2.</B></FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Position
                                         and Appointment</B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 21.3pt; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 33pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">You
                                         will be appointed to act as the <B>President</B>, <B>Chief Business Officer (&ldquo;CBO&rdquo;)
                                         </B>and <B>Executive Director (&ldquo;ED&rdquo;)</B> of the Company (&ldquo;Appointments&rdquo;
                                         or &ldquo;Roles&rdquo;).</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 21.3pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 21.3pt; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 33pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                         Appointment is subject to the Company&rsquo;s Memorandum and Articles of Association
                                         (&quot;Articles&quot;) and nothing in this letter shall be taken to exclude or vary the
                                         terms of the Articles as they apply to your Appointment.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;</FONT></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT><IMG SRC="ex10-4_001.jpg" ALT=""></P><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Aptorum Group Limited</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Aptus Management Limited</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Unit B, 17/F Guangdong Investment Tower,
148 Connaught Road Central, Hong Kong</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Tel: (852) 2117 6611 &#9679; Fax: (852) 2850
7286</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 21.3pt; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 33pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">You
                                         shall be an Officer of the Company as covered in the Rule 16a-1(f) under the Securities
                                         and Exchange Act of 1934.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 21.3pt; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 33pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                         continuation of the Appointment is contingent to your ongoing fulfillment of your obligations
                                         and successful re-election by the Company&rsquo;s shareholders at the Company&rsquo;s
                                         Annual General Meeting (the &ldquo;AGM&rdquo;). It is further subject to your agreement
                                         to apply yourself and discharge your duties as an Executive Director in accordance with
                                         the Articles of the Company and the Cayman Islands Company Law (2016 Revision) (as amended)
                                         (&quot;Company Law&quot;), as well as you upholding the high standards of corporate governance
                                         as set forth in the Nasdaq Listing Rule 5600 Series subsequent to the Listing.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 54.3pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date
                                         of Commencement</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 21.25pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Your
official date of appointment as the President, CBO, and Executive Director of the Company shall commence on <B>1 October 2017
</B>(&ldquo;Effective Date&rdquo;), as mutually agreed upon between yourself and the Executive Board of Directors of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>4.</B></FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Duties
                                         and Responsibilities</B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">You
                                         shall be a key member of the day-to-day management and supervisory body of the Company,
                                         which will help lead and spearhead the strategic management, steering, and execution
                                         of business, medical, and financial initiatives of the Group.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
                                         the CBO of the Company, you shall be responsible towards the management and supervision
                                         of the Group, and overall strategic direction of business development activities of the
                                         Group. Other members of the Board shall draw upon your business insight and financial
                                         expertise where suitable. You shall provide guidance, steering, and access of expert
                                         networks to the Company where appropriate and required.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">You
                                         are expected to fulfill operational and management duties as required by the Company,
                                         the shareholders of the Company, and members of the Non-Executive Board, on a day-to-day
                                         basis during official office hours where necessary. Your contribution shall be vital
                                         and appreciated in regards to the execution of business decisions made by the Executive
                                         Board.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">You
                                         will exercise your powers of your Appointment having regard to the relevant obligations
                                         under prevailing law and regulation, including the Cayman Islands Company Law, and while
                                         in pursuit of and subsequent to the Listing, also the rules and responsibilities stipulated
                                         by the U.S. Securities and Exchange Commission (&ldquo;SEC&rdquo;), and the Nasdaq Regulatory
                                         Authority; including but not limited to the Listing Rule 5600 Series.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;</FONT></P>

<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;<IMG SRC="ex10-4_001.jpg" ALT=""></FONT></P><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Aptorum Group Limited</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Aptus Management Limited</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Unit B, 17/F Guangdong Investment Tower,
148 Connaught Road Central, Hong Kong</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Tel: (852) 2117 6611 &#9679; Fax: (852) 2850
7286</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Subsequent
                                         to the Listing, you as an ED along with other Directors of the board are to meet when
                                         possible in executive session, where such sessions should occur at least four times a
                                         year.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Additionally,
you shall during your Appointment:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(f)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Observe
                                         and comply with the Company&rsquo;s adopted Code of Business Conduct and Ethics, where
                                         that any waivers given to directors or executive officers must be approved by the Board.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(g)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Observe
                                         and comply with all statutory rules, and regulations where applicable as governed by
                                         the laws of your residence and jurisdictions in which operate on behalf of the Group.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: -31.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(h)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Confirm
                                         you are able to, and will devote sufficient time to perform your Roles.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: -31.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Consider
                                         the interests of the Company and its employees when implementing executive decisions.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: -31.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(j)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Provide
                                         traceable contact during and after office hours, on weekdays and weekends, or during
                                         public holidays, whereby your availability may occasionally and reasonably be sought.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: -31.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(k)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Declare
                                         any conflicts that are apparent at present, or become apparent, between the Group and
                                         your external activities, interests, or roles. Should any potential conflicts of interest
                                         arise, you will disclose this to the Board as soon as they become apparent.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: -31.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(l)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Obtain
                                         clearance from the Board prior to dealing in publicly traded shares in the Company subsequent
                                         to the Listing and shall adhere to the Insider Trading Policy as adopted by the Company.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: -31.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(m)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Observe
                                         and comply with the disclosure requirements and obligations of you and/or your affiliated
                                         party(s) as applicable in accordance with U.S. securities laws, regulations and SEC disclosure
                                         requirements.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;<B>&nbsp;</B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>5.</B></FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Salary
                                         and Cash Bonus</B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Your
                                         starting salary will be <B>HKD 150,000</B> per month, paid out in an equivalent amount
                                         of thirteen (13) months per calendar year.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: -33pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Annual
                                         increment of your salary will be assessed on the basis of professional merit and the
                                         Group&rsquo;s performance, and is awarded at the discretion of the Board of Directors
                                         of the Company and as approved by the Compensation Committee.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 54.3pt; text-align: justify; text-indent: -33pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">With
                                         completion of one full year&rsquo;s service (or a pro-rata portion thereof if service
                                         is less than one year), you may be entitled to a bonus as determined at the full discretion
                                         of the Board of Directors of the Company and approval of the Compensation Committee.
                                         Any bonus will only be payable only if you are still in the employment of the Company
                                         on the bonus payment date which shall be payable in December or subsequent January of
                                         each calendar year.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 22.5pt; text-align: justify">&nbsp;</P>

<!-- Field: Page; Sequence: 3; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>&nbsp;<IMG SRC="ex10-4_001.jpg" ALT=""></B></FONT></P><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Aptorum Group Limited</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Aptus Management Limited</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Unit B, 17/F Guangdong Investment Tower,
148 Connaught Road Central, Hong Kong</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Tel: (852) 2117 6611 &#9679; Fax: (852) 2850
7286</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>6.</B></FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #333333"><B>Share
                                         Bonus:</B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 22.5pt; text-align: justify; text-indent: -22.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; color: #333333"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">You
shall be entitled to receive share bonuses for your services rendered as an ED with the amount, cap, timing of payouts, vesting
rate and schedule, subject to the full discretion of the Company and approval of the Compensation Committee. All terms and conditions
of share bonuses shall be assessed based on the overall financial position and performance of the Group, as well as your contribution
and performance upon rendering services by yourself during your Appointment under this Agreement. Any particulars associated to
your eligibility to share bonuses shall be definitively defined at a future date as mutually agreed upon between yourself and
the Executive Board of Directors, and as approved by the Compensation Committee.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; color: #333333"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;<B>&nbsp;</B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0pt; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 18pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>7.</B></FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Share
                                         Option</B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; color: #333333"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">You
shall be granted an option to purchase Class A ordinary shares of the authorized share capital in the Company as pursuant to the
particulars described by the Company&rsquo;s Share Option Plan subject to the ongoing effect of your Appointments.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 22.5pt; text-align: justify; color: #333333"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;<B>&nbsp;</B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0pt; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 18pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>8.</B></FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Restriction
                                         on Other Activities</B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: -58.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
                                         your employment, you shall diligently and faithfully serve the Company and not act in
                                         any way which is in conflict with the interest of the Group.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">You
                                         shall not during your employment be engaged or interested directly or indirectly in any
                                         capacity in any other trade, business, occupation, or assignment outside the Company,
                                         unless otherwise approved and consented by the Board of Directors in writing.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Consult
                                         with the Chairman of the Board prior to accepting any other (or further) directorships
                                         of companies or any major external appointments and promptly inform the Board of acceptance
                                         of any such appointment.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 54.3pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;<B>&nbsp;</B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>9.</B></FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Privacy
                                         of Information</B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">You
                                         shall not except as authorized by the Company or required by your responsibilities reveal
                                         to any person or company any of the trade secrets or any information concerning the organization,
                                         business, finances, transactions or affairs of the Group which may come to your knowledge
                                         during your contract with the Company and shall keep with complete secrecy confidential
                                         information entrusted to you and shall not use or attempt to use any such information
                                         in any manner which may injure or cause loss either directly or indirectly to the Group
                                         or may be likely to do so. This restriction shall continue to apply if and when after
                                         the termination of your appointment without limit in time.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;</FONT></P>

<!-- Field: Page; Sequence: 4; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;<IMG SRC="ex10-4_001.jpg" ALT=""></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Aptorum Group Limited</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Aptus Management Limited</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Unit B, 17/F Guangdong Investment Tower,
148 Connaught Road Central, Hong Kong</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Tel: (852) 2117 6611 &#9679; Fax: (852) 2850
7286</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">You
                                         shall not either during the period of your appointment or afterwards use or permit to
                                         be used any books, documents, moneys, assets, records or other property belonging to
                                         or relating to any dealings, affair or business of the Group other than for the benefit
                                         of the Group. You shall immediately deliver and return to the Group all such books, documents,
                                         moneys, securities, records or other property which you then have or should have in your
                                         possession upon termination of your appointment hereunder.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                         Company however, agrees to provide you with any information concerning areas of interest
                                         and relevance of the Group as required by you in order to enable you to fulfill your
                                         Roles of the Group.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 22.5pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>10.</B></FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Insurance
                                         and Indemnity</B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 22.5pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 22.5pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company shall establish directors&rsquo; and officers&rsquo; liability coverage and it is intended to maintain such coverage through
the period of your Appointments.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 22.5pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;&nbsp;</B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 22.5pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>11.</B></FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Termination</B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 28.35pt; text-align: justify; text-indent: -28.35pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 22.5pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Your
Appointments with the Company and Group may only be terminated:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 28.35pt; text-align: justify; text-indent: -28.35pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 21.3pt; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 1.2pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By
                                         you after giving the Company not less than three (3) months&rsquo; notice in writing;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 22.5pt; text-align: justify; text-indent: -22.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 21.3pt; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 1.2pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By
                                         the Company after giving you three (3) months&rsquo; notice in writing; or</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 21.3pt; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 1.2pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By
                                         the Company with immediate effect in the event that you:</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 54.3pt; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 35.7pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Conduct
                                         dishonesty, fraud, gross negligence, willful default or refusal to carry out any lawful
                                         order or instructions, or the repeated breach of any rules or regulations of the Company,
                                         or those as governed by the laws of your residency or jurisdictions in which you operate
                                         on behalf of the Group.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 54.3pt; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 35.7pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Commit
                                         a material breach of your obligations under this letter;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 54.3pt; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 35.7pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Commit
                                         any serious or repeated breach or non-observance of your obligations to the Company or
                                         Group;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 54.3pt; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 35.7pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iv)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Are
                                         convicted of a criminal offence other than an offence under road traffic legislation
                                         in the jurisdiction of your residency or elsewhere for which a fine or non-custodial
                                         penalty is imposed;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 54.3pt; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 35.7pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(v)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Declare
                                         bankruptcy or have made an arrangement with or for the benefit of your creditors; or</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 54.3pt; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 35.7pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(vi)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Are
                                         disqualified from acting as a director.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;</FONT></P>

<!-- Field: Page; Sequence: 5; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;<IMG SRC="ex10-4_001.jpg" ALT=""></FONT></P><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Aptorum Group Limited</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Aptus Management Limited</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Unit B, 17/F Guangdong Investment Tower,
148 Connaught Road Central, Hong Kong</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Tel: (852) 2117 6611 &#9679; Fax: (852) 2850
7286</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Please
signify your acceptance of the above terms and conditions by signing and returning to us the enclosed duplicate copy of this letter.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Yours
faithfully, &#9;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 49%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">For and on behalf of</FONT></TD>
    <TD STYLE="width: 2%; text-align: justify">&nbsp;</TD>
    <TD STYLE="width: 49%; text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>APTORUM GROUP LIMITED</B></FONT></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Agreed and accepted by:</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify; border-bottom: Black 1.5pt solid">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify; border-bottom: Black 1.5pt solid">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Name: Huen Chung Yuen Ian</FONT></TD>
    <TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Name: Lui Wang Yip Darren</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Position: Director</FONT></TD>
    <TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">HKID No.: Z302315(0)</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left; border-bottom: Black 1.5pt solid">&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: left; border-bottom: Black 1.5pt solid">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Date</FONT></TD>
    <TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Date</FONT></TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>



<P STYLE="margin-top: 0; text-align: center; margin-bottom: 0; font: 10pt Times New Roman, Times, Serif">6</P>

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"></P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 0; margin-bottom: 0"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.5
<SEQUENCE>9
<FILENAME>ff12018ex10-5_aptorum.htm
<DESCRIPTION>EMPLOYMENT LETTER BETWEEN THE COMPANY AND CLARK CHENG (CHIEF MEDICAL OFFICER & DIRECTOR), DATED AUGUST 31, 2017
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0; text-align: right; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit
10.5</B></FONT></P>

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-top: 0; text-align: center; margin-bottom: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;<IMG SRC="ex10-5_001.jpg" ALT=""></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">APTUS Management Limited</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Unit B, 17/F Guangdong Investment Tower,
148 Connaught Road Central, Hong Kong</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Tel: (852) 2117 6611 &#9679; Fax: (852) 2850
7286</P>



<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">31<SUP>st
</SUP>August 2017</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dr.
Clark Cheng</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dear
Dr. Cheng,</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Employment
Letter</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
are pleased and welcome your acceptance to be appointed as an Executive Director of the Board of Directors for both <B>APTUS Holdings
Limited (&ldquo;AHL&rdquo;)</B> and <B>Aptorum Medical Limited (&ldquo;APML&rdquo;) </B>(whereby together shall be known as the
&ldquo;Companies&rdquo;)<B>.</B> You shall be employed full-time under the hiring entity <B>APTUS Management Limited (&ldquo;AML&rdquo;)</B>,
a wholly owned subsidiary of AHL. Additionally, you shall be appointed the designation of <B>Chief Medical Officer</B> of AHL.
The Companies are incorporated with limited liabilities under the laws of Cayman Islands and AML is duly incorporated with limited
liabilities in Hong Kong. The Companies have affiliate companies in the Cayman Islands, Hong Kong, and Macau, whereby collectively,
shall be depicted as &ldquo;APTUS&rdquo; or the &ldquo;Group&rdquo;.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following letter seeks to illustrate the context of your employment with AML, and appointment by AHL and APML, and the terms and
conditions as set out herewith (the &ldquo;Agreement&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>1.</B></FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>The
                                         Group</B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">APTUS
and its affiliates focus on the licensing of, and acquisition of early stage preclinical assets with the intention to engage in
drug research, development, and commercialization purposes. Assets are acquired via open and public platforms such as the technology
transfer offices of accredited universities and academic institutions. In addition, the Group seeks to be a facilitator across
the financing spectrum for biotech companies, entrepreneurs, and commercializing agents, to bolster innovations adding value to
health care needs in the market place; and to assist in furthering the research capabilities of institutions the Group works with.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>2.</B></FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Position
                                         and Responsibilities</B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">You
                                         will be enlisted to act as an <B>Executive Director </B>on the Board of Directors for
                                         both AHL and APML, and appointed as the <B>Chief Medical Officer (&ldquo;CMO&rdquo;)
                                         </B>of AHL (collectively the <B>&ldquo;Roles&rdquo;</B>).</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">You
                                         shall be a member of the management team of the Companies, which will have a duty to
                                         oversee and manage the operations of the Group.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 54.3pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
                                         an Executive Director of the Companies and CMO of AHL, you shall be responsible towards
                                         the management and supervision of the Companies, particularly in aspects associated to
                                         the business, research, and development activities of the Companies. Other members of
                                         the Executive Board shall draw upon your academic insight and medical expertise where
                                         suitable. You shall provide guidance, steering, and access of expert networks to the
                                         Group where appropriate and required.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;</FONT></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;<IMG SRC="ex10-5_001.jpg" ALT=""></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">APTUS Management Limited</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Unit B, 17/F Guangdong Investment Tower,
148 Connaught Road Central, Hong Kong</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Tel: (852) 2117 6611 &#9679; Fax: (852) 2850
7286</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">You
                                         are expected to fulfill operational and management duties as requested by the Companies,
                                         the shareholders of the Companies, and members of the Non-Executive Board, on a day-to-day
                                         basis during official office hours where necessary. Your contribution shall be vital
                                         and appreciated in regards to the execution of business decisions made by the Executive
                                         Board.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 54.3pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">You
                                         shall:</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.75in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Observe
                                         and comply with all statutory rules, and regulations where applicable as governed by
                                         the internal policies and guidelines of the Company, and the laws of Hong Kong Special
                                         Administrative Region;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.75in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Provide
                                         traceable contact during and after office hours, on weekdays and weekends, or during
                                         public holidays, whereby your availability may occasionally and reasonably be sought.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>3.</B></FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Date
                                         of Commencement</B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 21.25pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 21.25pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Your
official date of appointment of the said Roles for the Companies shall commence on ________________ (&ldquo;Effective Date&rdquo;),
as mutually agreed upon between yourself and the Executive Board of Directors of the Companies.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 21.25pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>4.</B></FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Salary
                                         and Cash Bonus</B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Your
                                         starting salary will be <B>HKD 150,000</B> (Hong Kong Dollars One Hundred Fifty Thousand)
                                         per month paid out in twelve instalments per calendar year.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: -31.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Annual
                                         increment of your salary will be assessed on the basis of professional merit and the
                                         Group&rsquo;s performance, and is awarded at the discretion of the Board of Directors
                                         of the Companies and approval of the remuneration committee.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: -31.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">With
                                         completion of one full year&rsquo;s service (or a pro-rata portion thereof if service
                                         is less than one year), you may be entitled to a bonus as determined at the full discretion
                                         of the Board of Directors of the Companies and approval of the remuneration committee.
                                         Any bonus will only be payable only if you are still in the employment of the Companies
                                         on the bonus payment date which shall be payable in December or subsequent January of
                                         each calendar year.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>5.</B></FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Stock
                                         Bonus:</B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">You
shall be entitled to receive upon employment a stock bonus in the amount of 5% of issued ordinary share capital of Aptorum Medical
Limited, with investor rights on a parri passu basis to founding shareholders of APML. Such said shares shall be allocated to
your provided shareholder name at a timely but practical date subsequent to the Effective Date of this Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">At
each anniversary date from the Effective Date, your ownership APML is eligible to increase by 1% of issued ordinary share capital
per year up to a maximum additional amount of 5% of issued ordinary share capital by the 5<SUP>th</SUP> anniversary from the Effective
Date. Effective ownership is subjected to dilution effects in alignment of all ordinary shareholders in the event of external
financing activities whereby ordinary shares are to be issued to new investors.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;</FONT></P>

<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;<IMG SRC="ex10-5_001.jpg" ALT=""></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">APTUS Management Limited</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Unit B, 17/F Guangdong Investment Tower,
148 Connaught Road Central, Hong Kong</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Tel: (852) 2117 6611 &#9679; Fax: (852) 2850
7286</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">All
terms and conditions of stock bonuses shall be assessed based on the overall financial position and performance of the Group,
as well as your contribution and performance upon rendering services by yourself during your employment under this Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>6.</B></FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Stock
                                         Option</B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">You
may be granted an option to purchase shares of the stock in the Companies with the particulars of: the amount (percentage of issued
and outstanding stock of the Companies), the term, extended terms (if any), option pricing and valuation method, and any other
particulars associated to eligibility of stock option purchases, shall be definitively defined in a subsequent &ldquo;Stock Option
and Stock Bonus Addendum&rdquo; at a future date as mutually agreed upon between yourself and the Executive Board of Directors.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>7.</B></FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Mandatory
                                         Provident Fund</B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: -4.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 21.25pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">You
will be entitled to become a member of AML&rsquo;s Mandatory Provident Fund scheme in accordance with the company&rsquo;s policy
and the statutory requirements.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 14.15pt; text-align: justify; text-indent: -14.15pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>8.</B></FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Medical
                                         Insurance</B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 28.35pt; text-align: justify; text-indent: -28.35pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 21.25pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">You
will be admitted to the Group&rsquo;s Medical scheme, which provides reimbursement of consultation and hospitalization expenses
in accordance with the terms of the scheme.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>9.</B></FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Restriction
                                         on Other Activities</B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
                                         your employment, you shall diligently and faithfully serve the Companies and not act
                                         in any way which is in conflict with the interest of the Group.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 54.3pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">You
                                         shall not during your employment be engaged or interested directly or indirectly in any
                                         capacity in any other trade, business, occupation or assignment of whatsoever nature
                                         outside the Companies, unless otherwise approved and consented by the Board of Directors
                                         in writing.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 54.3pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>10.</B></FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Privacy
                                         of Information</B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 28.35pt; text-align: justify; text-indent: -28.35pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">You
                                         shall not except as authorized by the Companies or required by your responsibilities
                                         reveal to any person or company any of the trade secrets or any information concerning
                                         the organization, business, finances, transactions or affairs of the Group which may
                                         come to your knowledge during your contract with the Group and shall keep with complete
                                         secrecy confidential information entrusted to you and shall not use or attempt to use
                                         any such information in any manner which may injure or cause loss either directly or
                                         indirectly to the Group or may be likely to do so. This restriction shall continue to
                                         apply if and when after the termination of your appointment without limit in time.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">You
                                         shall not either during the period of your appointment or afterwards use or permit to
                                         be used any books, documents, moneys, assets, records or other property belonging to
                                         or relating to any dealings, affair or business of the Group other than for the benefit
                                         of the Group. You shall immediately deliver and return to the Group all such books, documents,
                                         moneys, securities, records or other property which you then have or should have in your
                                         possession upon termination of your appointment hereunder.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;</FONT></P>

<!-- Field: Page; Sequence: 3; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;<IMG SRC="ex10-5_001.jpg" ALT=""></FONT></P><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">APTUS Management Limited</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Unit B, 17/F Guangdong Investment Tower,
148 Connaught Road Central, Hong Kong</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Tel: (852) 2117 6611 &#9679; Fax: (852) 2850
7286</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                         Companies however, agrees to provide you with any information concerning areas of interest
                                         and relevance of the Group as required by you in order to enable you to fulfill your
                                         Roles for the Companies.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>11.</B></FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Annual
                                         Holiday</B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 28.35pt; text-align: justify; text-indent: -28.35pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">You
shall be entitled to an annual leave of 20 working days (exclusive of statutory holidays) during each twelve-month period to be
taken at such time as the Group shall consider most convenient having regard to the requirements of the business of the Companies.
The said holiday shall not be accumulated beyond each twelve-month period and if not taken in full in any particular period you
shall not be entitled to salary or remuneration in lieu of taking such holiday.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>12.</B></FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Termination</B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 28.35pt; text-align: justify; text-indent: -28.35pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Your
appointment as an Executive Director of the Companies and CMO of AHL may individually or wholly be terminated:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 28.35pt; text-align: justify; text-indent: -28.35pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By
                                         you after giving one or both Companies not less than three (3) months&rsquo; notice in
                                         writing respectively;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By
                                         one or both the Companies after giving you three (3) months&rsquo; notice in writing
                                         respectively; or</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By
                                         both the Companies without notice or compensation in the event of your dishonesty, fraud,
                                         gross negligence, willful default or refusal to carry out any lawful order or instructions,
                                         or the repeated breach of any rules or regulations of the Companies, or those as governed
                                         by the laws of Hong Kong Special Administrative Region.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Please
signify your acceptance of the above terms and conditions by signing and returning to us the enclosed duplicate copy of this letter.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Yours
faithfully, &#9;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 49%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">For and on behalf of</FONT></TD>
    <TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 49%; text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>APTUS MANAGEMENT LIMITED</B></FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Agreed and accepted by:</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify; border-bottom: Black 1.5pt solid">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify; border-bottom: Black 1.5pt solid">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Name: Huen Chung Yuen Ian</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Name: Clark Cheng</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Position: Director</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">HKID No.:</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left; border-bottom: Black 1.5pt solid">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: left; border-bottom: Black 1.5pt solid">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Date</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Date</FONT></TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">4</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 0; margin-bottom: 0"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.6
<SEQUENCE>10
<FILENAME>ff12018ex10-6_aptorum.htm
<DESCRIPTION>ADDENDUM TO APPOINTMENT LETTER BETWEEN THE COMPANY AND CLARK CHENG (CHIEF MEDICAL OFFICER & DIRECTOR), DATED SEPTEMBER 25, 2017
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0; text-align: right"><B>Exhibit 10.6</B></P>

<P STYLE="margin: 0; text-align: right"><B>&nbsp;</B></P>

<P STYLE="margin-top: 0; text-align: center; margin-bottom: 0"><IMG SRC="ex10-6_001.jpg" ALT=""></P>

<P STYLE="margin-top: 0; text-align: center; margin-bottom: 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Aptorum Group Limited</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Aptus Management Limited</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Unit B, 17/F Guangdong Investment Tower,
148 Connaught Road Central, Hong Kong</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Tel: (852) 2117 6611 &#9679; Fax: (852) 2850
7286</P>



<P STYLE="margin-top: 0; text-align: center; margin-bottom: 0"></P>

<P STYLE="margin-top: 0; text-align: center; margin-bottom: 0">&nbsp;</P>

<P STYLE="margin: 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">25
September 2017</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Attn:
Dr. Clark Cheng</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dear
Dr. Cheng,</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Addendum
to Appointment Letter (the &ldquo;Addendum&rdquo;)</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
letter supplements and serves to be an addendum to the Appointment Letter dated 31 August 2017 executed between yourself and APTUS
Management Limited as appended in Appendix A; and in relation to your Appointments as the Chief Medical Officer (&ldquo;<B>CMO</B>&rdquo;)
of Aptorum Group Limited (formerly APTUS Holdings Limited) (&ldquo;<B>AGL</B>&rdquo;), and as an Executive Director of both AGL
and Aptorum Medical Limited (&ldquo;<B>AML</B>&rdquo;) (whereby together is known as the &ldquo;Companies&rdquo;). This Addendum
should be read together with, and forms part of, the Appointment Letter.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
Addendum is to be effected on the date of which you agree with the Board of Directors on the commencement date of your Appointments
as pursuant to Clause 3 of the Appointment Letter.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Words
and expressions defined in the Appointment Letter shall have the same meanings in this Addendum. All other provisions contained
in the Appointment Letter, unless inconsistent with the provisions set forth in this Addendum shall continue to apply.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
Addendum serves to describe the following amendments and/or additions to the Appointment Letter:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>i.</B></FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Company
                                         Name Change</B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">All
references to APTUS Holdings Limited (&ldquo;AHL&rdquo;) shall be removed in its entirety and replaced with &ldquo;Aptorum Group
Limited (&ldquo;AGL&rdquo;)&rdquo;.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>ii.</B></FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Clause
                                         1: &ldquo;The Group&rdquo;</B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following paragraph is to be added subsequent to the single paragraph in the original clause:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&ldquo;AGL
is a privately held company that has engaged in plans to pursue an initial public offering on the Nasdaq Global Market in the
near future (<B>the &ldquo;Listing&rdquo;</B>).&rdquo;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>iii.</B></FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Clause
                                         2: &ldquo;Position and Responsibilities&rdquo;</B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
original clause shall be removed in its entirety. The title of the clause shall be renamed <B>&ldquo;Position and Appointment&rdquo;
</B>and subsequent bullet points are to be added as follows:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&ldquo;</I></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 21.3pt; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 33pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>(a)</I></FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>You
                                         will be appointed to act as the <B>Chief Medical Officer (&ldquo;CMO&rdquo;)</B> of AGL
                                         and <B>Executive Director (&ldquo;ED&rdquo;)</B> of both the Companies AGL and AML (&ldquo;Appointments&rdquo;
                                         or &ldquo;Roles&rdquo;).</I></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 21.3pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 21.3pt; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><I></I></FONT></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><IMG SRC="ex10-6_001.jpg" ALT=""></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Aptorum Group Limited</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Aptus Management Limited</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Unit B, 17/F Guangdong Investment Tower,
148 Connaught Road Central, Hong Kong</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Tel: (852) 2117 6611 &#9679; Fax: (852) 2850
7286</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 21.3pt; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><I></I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 21.3pt; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><I>&nbsp;</I></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 21.3pt; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 33pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>(b)</I></FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>The
                                         Appointment is subject to the Company&rsquo;s Memorandum and Articles of Association
                                         (&quot;Articles&quot;) and nothing in this letter shall be taken to exclude or vary the
                                         terms of the Articles as they apply to your Appointment.</I></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I></I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 21.3pt; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 33pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>(c)</I></FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>You
                                         shall be an Officer of the Company as covered in the Rule 16a-1(f) under the Securities
                                         and Exchange Act of 1934.</I></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I></I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 21.3pt; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 33pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>(d)</I></FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>The
                                         continuation of the Appointment is contingent to your ongoing fulfillment of your obligations
                                         and successful re-election by the Company&rsquo;s shareholders at the Company&rsquo;s
                                         Annual General Meeting (the &ldquo;AGM&rdquo;). It is further subject to your agreement
                                         to apply yourself and discharge your duties as an Executive Director in accordance with
                                         the Articles of the Company and the Cayman Islands Company Law (2016 Revision) (as amended)
                                         (&quot;Company Law&quot;), as well as you upholding the high standards of corporate governance
                                         as set forth in the Nasdaq Listing Rule 5600 Series subsequent to the Listing.&rdquo;</I></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;&nbsp;</I></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>iv.</B></FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Expanded
                                         &ldquo;Duties and Responsibilities&rdquo;</B></FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;<B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following points shall be added as a clause titled &ldquo;Duties and Responsibilities&rdquo; subsequent to Clause 3 &ldquo;Date
of Commencement&rdquo;:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&ldquo;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>(a)</I></FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>You
                                         shall be a key member of the day-to-day management and supervisory body of the Company,
                                         which will help lead and spearhead the strategic management, steering, and execution
                                         especially in relation to medical initiatives of the Group.</I></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>(b)</I></FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>As
                                         the CMO of the Company, you shall be responsible towards the management and supervision
                                         of the Group, and overall strategic direction of clinical and medical administration
                                         activities of the Group. Other members of the Board shall draw upon your medical expertise
                                         where suitable. You shall provide guidance, steering, and access of expert networks to
                                         the Company where appropriate and required.</I></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I></I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>(c)</I></FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>You
                                         are expected to fulfill operational and management duties as required by the Company,
                                         the shareholders of the Company, and members of the Non-Executive Board, on a day-to-day
                                         basis during official office hours where necessary. Your contribution shall be vital
                                         and appreciated in regards to the execution of business decisions made by the Executive
                                         Board.</I></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>(d)</I></FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>You
                                         will exercise your powers of your Appointment having regard to the relevant obligations
                                         under prevailing law and regulation, including the Cayman Islands Company Law, and while
                                         in pursuit of and subsequent to the Listing, also the rules and responsibilities stipulated
                                         by the U.S. Securities and Exchange Commission (&ldquo;SEC&rdquo;), and the Nasdaq Regulatory
                                         Authority; including but not limited to the Listing Rule 5600 Series.</I></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>(e)</I></FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Subsequent
                                         to the Listing, you as an ED along with other Directors of the board are to meet when
                                         possible in executive session, where such sessions should occur at least four times a
                                         year.</I></FONT></TD></TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"></P>

<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><IMG SRC="ex10-6_001.jpg" ALT=""></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Aptorum Group Limited</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Aptus Management Limited</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Unit B, 17/F Guangdong Investment Tower,
148 Connaught Road Central, Hong Kong</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Tel: (852) 2117 6611 &#9679; Fax: (852) 2850
7286</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Additionally,
you shall during your Appointment:</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>(f)</I></FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Observe
                                         and comply with the Company&rsquo;s adopted Code of Business Conduct and Ethics, where
                                         that any waivers given to directors or executive officers must be approved by the Board.</I></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>(g)</I></FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Observe
                                         and comply with all statutory rules, and regulations where applicable as governed by
                                         the laws of your residence and jurisdictions in which operate on behalf of the Group.
                                         </I></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 22.5pt; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 31.5pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>(h)</I></FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Confirm
                                         you are able to, and will devote sufficient time to perform your Roles.</I></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 22.5pt; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 31.5pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>(i)</I></FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Consider
                                         the interests of the Company and its employees when implementing executive decisions.</I></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: -31.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 22.5pt; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 31.5pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>(j)</I></FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Provide
                                         traceable contact during and after office hours, on weekdays and weekends, or during
                                         public holidays, whereby your availability may occasionally and reasonably be sought.</I></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: -31.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 22.5pt; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 31.5pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>(k)</I></FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Declare
                                         any conflicts that are apparent at present, or become apparent, between the Group and
                                         your external activities, interests, or roles. Should any potential conflicts of interest
                                         arise, you will disclose this to the Board as soon as they become apparent.</I></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: -31.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 22.5pt; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 31.5pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>(l)</I></FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Obtain
                                         clearance from the Board prior to dealing in publicly traded shares in the Company subsequent
                                         to the Listing and shall adhere to the Insider Trading Policy as adopted by the Company.</I></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 22.5pt; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 31.5pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>(m)</I></FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Observe
                                         and comply with the disclosure requirements and obligations of you and/or your affiliated
                                         party(s) as applicable in accordance with U.S. securities laws, regulations and SEC disclosure
                                         requirements.&rdquo;</I></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>v.</B></FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Clause
                                         4: &ldquo;Salary and Cash Bonus&rdquo;</B></FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">References
to &ldquo;Compensation Committee&rdquo; shall be added to paragraph (b) as follows:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&ldquo;(b)&nbsp;&nbsp;Annual
increment of your salary will be assessed on the basis of professional merit and the Group&rsquo;s performance, and is awarded
at the discretion of the Board of Directors of the Company <U>and as approved by the Compensation Committee</U>.&rdquo;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Paragraph
(c) shall be removed in its entirety and replaced by:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&ldquo;(c)&nbsp;&nbsp;With
completion of one full year&rsquo;s service (or a pro-rata portion thereof if service is less than one year), you may be entitled
to a bonus as determined at the full discretion of the Board of Directors of the Company and approval of the Compensation Committee.
Any bonus will only be payable only if you are still in the employment of the Company on the bonus payment date which shall be
payable in December or subsequent January of each calendar year.&rdquo;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 3; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><IMG SRC="ex10-6_001.jpg" ALT=""></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Aptorum Group Limited</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Aptus Management Limited</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Unit B, 17/F Guangdong Investment Tower,
148 Connaught Road Central, Hong Kong</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Tel: (852) 2117 6611 &#9679; Fax: (852) 2850
7286</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>vi.</B></FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Clause
                                         5: &ldquo;Stock Bonus&rdquo;</B></FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">All
references to <I>&ldquo;Stock Bonus&rdquo;</I> shall be replaced with <I>&ldquo;Share Bonus&rdquo;.</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>vii.</B></FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Clause
                                         6: &ldquo;Stock Option&rdquo;</B></FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">All
references to <I>&ldquo;Stock Option&rdquo;</I> shall be replaced with <I>&ldquo;Share Option&rdquo;. Additionally, </I>the contents
of this clause shall be removed in its entirety and replaced by:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; color: #333333"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&ldquo;You
shall be granted an option to purchase Class A ordinary shares of the authorized share capital in the Company as pursuant to the
particulars described by the Company&rsquo;s Share Option Plan subject to the ongoing effect of your Appointments.&rdquo;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; color: #333333"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>viii.</B></FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Addition
                                         of clause: &ldquo;Restriction on Other Activities&rdquo;</B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following clause titled &ldquo;Restriction on Other Activities&rdquo; shall be added between clauses 6 and 7 of the original Appointment
Letter:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&ldquo;</I></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 21.3pt; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 33pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>(a)</I></FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>During
                                         your employment, you shall diligently and faithfully serve the Company and not act in
                                         any way which is in conflict with the interest of the Group.</I></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 54.3pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 21.3pt; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 33pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>(b)</I></FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>You
                                         shall not during your employment be engaged or interested directly or indirectly in any
                                         capacity in any other trade, business, occupation, or assignment outside the Company,
                                         unless otherwise approved and consented by the Board of Directors in writing.</I></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 54.3pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 21.3pt; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 33pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>(c)</I></FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Consult
                                         with the Chairman of the Board prior to accepting any other (or further) directorships
                                         of companies or any major external appointments and promptly inform the Board of acceptance
                                         of any such appointment.</I></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>ix.</B></FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Addition
                                         of clause: &ldquo;Insurance and Indemnity&rdquo;</B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following clause titled &ldquo;Insurance and Indemnity&rdquo; shall be added subsequent to clause 7 of the original Appointment
Letter:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&ldquo;The
Company shall establish directors&rsquo; and officers&rsquo; liability coverage and it is intended to maintain such coverage through
the period of your Appointments.&rdquo;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 4; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><IMG SRC="ex10-6_001.jpg" ALT="" STYLE="width: 19px; height: 25px"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Aptorum Group Limited</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Aptus Management Limited</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Unit B, 17/F Guangdong Investment Tower,
148 Connaught Road Central, Hong Kong</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Tel: (852) 2117 6611 &#9679; Fax: (852) 2850
7286</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>x.</B></FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Clause
                                         8: &ldquo;Termination&rdquo;</B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Paragraph
(c) shall be removed in its entirety and replaced by:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&ldquo;</I></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>(c)</I></FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>By
                                         the Company with immediate effect in the event that you:</I></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 54.3pt; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 35.7pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>(i)</I></FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Conduct
                                         dishonesty, fraud, gross negligence, willful default or refusal to carry out any lawful
                                         order or instructions, or the repeated breach of any rules or regulations of the Company,
                                         or those as governed by the laws of your residency or jurisdictions in which you operate
                                         on behalf of the Group.</I></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 54.3pt; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 35.7pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>(ii)</I></FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Commit
                                         a material breach of your obligations under this letter;</I></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 54.3pt; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 35.7pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>(iii)</I></FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Commit
                                         any serious or repeated breach or non-observance of your obligations to the Company or
                                         Group;</I></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 54.3pt; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 35.7pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>(iv)</I></FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Are
                                         convicted of a criminal offence other than an offence under road traffic legislation
                                         in the jurisdiction of your residency or elsewhere for which a fine or non-custodial
                                         penalty is imposed;</I></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 54.3pt; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 35.7pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>(v)</I></FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Declare
                                         bankruptcy or have made an arrangement with or for the benefit of your creditors; or</I></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 54.3pt; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 35.7pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(vi)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Are
                                         disqualified from acting as a director.&rdquo;</I></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Please
signify your acceptance of the above amendments described in this Addendum by signing and returning to us the enclosed duplicate
copy of this letter.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Yours
faithfully, &#9;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
and on behalf of</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 40%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>APTORUM GROUP LIMITED</B></FONT></TD>
    <TD STYLE="width: 20%; text-align: justify">&nbsp;</TD>
    <TD STYLE="width: 40%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Agreed and accepted by:</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify; border-bottom: Black 1.5pt solid">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify; border-bottom: Black 1.5pt solid">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Name: Huen Chung Yuen Ian</FONT></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Name: Clark CHENG</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Position: Director</FONT></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">HKID No.:</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify; border-bottom: Black 1.5pt solid">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify; border-bottom: Black 1.5pt solid">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Date</FONT></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Date</FONT></TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 5; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><IMG SRC="ex10-6_001.jpg" ALT=""></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Aptorum Group Limited</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Aptus Management Limited</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Unit B, 17/F Guangdong Investment Tower,
148 Connaught Road Central, Hong Kong</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Tel: (852) 2117 6611 &#9679; Fax: (852) 2850
7286</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>APPENDIX
A</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[Appointment
Letter dated 31 August 2017 executed between Clark CHENG and APTUS Management Limited]</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 0; margin-bottom: 0"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.7
<SEQUENCE>11
<FILENAME>ff12018ex10-7_aptorum.htm
<DESCRIPTION>SECOND ADDENDUM TO APPOINTMENT LETTER BETWEEN THE COMPANY AND CLARK CHENG (CHIEF MEDICAL OFFICER & DIRECTOR), DATED OCTOBER 30, 2017
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0; text-align: right"><B>Exhibit 10.7</B></P>

<P STYLE="margin: 0; text-align: right"><B>&nbsp;</B></P>

<P STYLE="margin-top: 0; text-align: center; margin-bottom: 0"><IMG SRC="ex10-7_001.jpg" ALT="">&nbsp;</P>

<P STYLE="margin-top: 0; text-align: center; margin-bottom: 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Aptorum Group Limited</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Aptus Management Limited</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Unit B, 17/F Guangdong Investment Tower,
148 Connaught Road Central, Hong Kong</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Tel: (852) 2117 6611 &#9679; Fax: (852) 2850
7286</P>



<P STYLE="margin-top: 0; text-align: center; margin-bottom: 0"></P>

<P STYLE="margin-top: 0; text-align: center; margin-bottom: 0">&nbsp;</P>

<P STYLE="margin: 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">30 October 2017</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Attn: Dr. Clark Cheng</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Dear Dr. Cheng,</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Second Addendum to Appointment Letter
(the &ldquo;2<SUP>nd</SUP> Addendum&rdquo;)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">This letter supplements and serves to be
an addendum to the Appointment Letter dated 31 August 2017 executed between yourself and APTUS Management Limited, and the Addendum
to Appointment Letter dated 25 September 2017, executed between yourself and Aptorum Group Limited, both appended in Appendix A;
and in relation to your Appointments as the Chief Medical Officer (&ldquo;<B>CMO</B>&rdquo;) of Aptorum Group Limited (&ldquo;<B>AGL</B>&rdquo;),
and as an Executive Director of both AGL and Aptorum Medical Limited (&ldquo;<B>AML</B>&rdquo;) (whereby together is known as the
&ldquo;Companies&rdquo;). Collectively, the Addendum, and this 2<SUP>nd</SUP> Addendum should be read together with, and forms
part of, the Appointment Letter.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">This 2<SUP>nd</SUP> Addendum is to be effected
on the date when first fully executed by both yourself on behalf of the Consultant, and the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Words and expressions defined in the Appointment
Letter or the Addendum shall (both herein appended in Appendix A) have the same meanings in this 2<SUP>nd</SUP> Addendum. All other
provisions contained in the Appointment Letter or the Addendum, unless inconsistent with the provisions set forth in this 2<SUP>nd</SUP>
Addendum shall continue to apply.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">This 2<SUP>nd</SUP> Addendum serves to
describe the following amendments and/or additions to the Appointment Letter and/or the Addendum:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><B>i.</B></TD><TD STYLE="text-align: justify"><B>Change in the appointed counter-party:</B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">All references to Clark Cheng,
&ldquo;You&rdquo;, or &ldquo;Your&rdquo; as a natural individual (HKID No. Z243983(3)) (<B>the &ldquo;Individual&rdquo;</B>), unless
otherwise described, shall be removed and replaced with, or refer to &ldquo;Cheng, Clark&rdquo;, a unlimited company duly incorporated
in Hong Kong with a registered business address at Flat D, 5/F Block 6, Hillview Court, Ka Shue Road, Clear Water Bay, Sai King,
New Territories, Hong Kong and with the Certificate No. 56061911 (<B>the &ldquo;Consultant&rdquo;</B>).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><B>ii.</B></TD><TD STYLE="text-align: justify"><B>Clause iii of the Addendum and Clause 2 of the Appointment Letter both titled &ldquo;Position
and Responsibilities&rdquo;:</B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">Both clauses shall be renamed
to &ldquo;Scope of Service&rdquo;.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">All references to &ldquo;You&rdquo;
or the Individual under the said clauses shall refer the Clark Cheng, as the Individual and sole director of the Consultant being
appointed to render services provided under the Appointment.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in; text-align: left"><B>iii.</B></TD><TD STYLE="text-align: justify"><B>Clause iv of the Addendum titled &lsquo;Expanded &ldquo;Duties
and Responsibilities&rdquo;&rsquo;:</B></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0in; text-indent: 0in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0in; text-indent: 0in; text-align: justify">All contents of this clause shall be consolidated under the clause titled &ldquo;Scope of Service&rdquo; as described above.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><IMG SRC="ex10-7_001.jpg" ALT=""></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Aptorum Group Limited</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Aptus Management Limited</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Unit B, 17/F Guangdong Investment Tower,
148 Connaught Road Central, Hong Kong</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Tel: (852) 2117 6611 &#9679; Fax: (852) 2850
7286</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">All references to &ldquo;You&rdquo;
or the Individual under the said clauses shall refer the Clark Cheng, as the Individual and sole director of the Consultant being
appointed to render services provided under the Appointment.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><I>&nbsp;</I></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><B>iv.</B></TD><TD STYLE="text-align: justify"><B>Clause v of the Addendum and Clause 4 of the Appointment Letter both titled &ldquo;Salary and
Cash Bonus&rdquo;</B></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">Both clauses shall be renamed
&ldquo;Service Fees and Compensation&rdquo;.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">All references to &ldquo;Salary&rdquo;
shall be removed in entirety and replaced with &ldquo;Service Fees&rdquo;; All references to &ldquo;Bonus&rdquo; shall be in the
context of monetary compensation (if any), to be paid to the Consultant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><B></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><B>v.</B></TD><TD STYLE="text-align: justify"><B>Clause vi of the Addendum and Clause 5 of the Appointment Letter both titled &ldquo;Stock Bonus&rdquo;;
and Clause vii of the Addendum and Clause 6 of the Appointment Letter both titled &ldquo;Stock Option&rdquo;:</B></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">All entitlements in the above
said clauses refer to compensation and potential ownership to be rewarded to the Consultant and not the Individual, subject to
the same terms, conditions, and restrictions as stipulated in the respective and original clauses of The Appointment Letter.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><B>vi.</B></TD><TD STYLE="text-align: justify"><B>Clause 7 of the Appointment Letter: &ldquo;Mandatory Provident Fund&rdquo;</B></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">This clause shall be removed
in its entirety. For avoidance of doubt, neither the Consultant nor the Individual will be required to make periodic contributions,
nor shall the Consultant or the Company be subjected to statutory requirements of the Mandatory Provident Fund Schemes Ordinance,
nor shall the Company be obligated to make contributions to the beneficiary of the Consultant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Please signify your acceptance of the above
amendments described in this 2<SUP>nd</SUP> Addendum by signing and returning to us the enclosed duplicate copy of this letter.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Yours faithfully, &#9;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 40%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">For and on behalf of</FONT></TD>
    <TD STYLE="width: 20%">&nbsp;</TD>
    <TD STYLE="width: 40%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Agreed and accepted for on behalf of:</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>APTORUM GROUP LIMITED</B></FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>CHENG, CLARK</B></FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify; border-bottom: Black 1.5pt solid">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify; border-bottom: Black 1.5pt solid">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Name: HUEN Chung Yuen Ian</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Name: Clark CHENG</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Position: Director</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">HKID No.: Z243983(3)</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify">Position: Sole Director </TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify; border-bottom: Black 1.5pt solid">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify; border-bottom: Black 1.5pt solid">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Date</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Date</FONT></TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><IMG SRC="ex10-7_001.jpg" ALT=""></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Aptorum Group Limited</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Aptus Management Limited</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Unit B, 17/F Guangdong Investment Tower,
148 Connaught Road Central, Hong Kong</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Tel: (852) 2117 6611 &#9679; Fax: (852) 2850
7286</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>APPENDIX A</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">[Appointment Letter dated 31 August 2017
executed between Clark CHENG and APTUS Management Limited]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">[The Addendum dated 25 September 2017 executed
between Clark CHENG and Aptorum Group Limited]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">3</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 0; margin-bottom: 0"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.8
<SEQUENCE>12
<FILENAME>ff12018ex10-8_aptorum.htm
<DESCRIPTION>THIRD ADDENDUM TO APPOINTMENT LETTER BETWEEN THE COMPANY AND CLARK CHENG (CHIEF MEDICAL OFFICER & DIRECTOR), DATED JANUARY 2, 2018
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0; text-align: right"><B>Exhibit 10.8</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; color: Red">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; color: Red"><IMG SRC="ex10-8_1.jpg" ALT="">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">APTUS Management Limited</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">17/F Guangdong Investment Tower, 148 Connaught
Road Central, Hong Kong</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Tel: (852) 2117 6611  &#9679; Fax:
(852) 2850 7286</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">2 January 2018</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Dr. Clark Cheng</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><U>Present</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Dear Clark,</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><U>Addendum to Employment Letter (the
&ldquo;Addendum&rdquo;)</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">This letter supplements and serves to be
an addendum to the Employment Letter dated 31<SUP>st</SUP> August 2017 (&ldquo;Employment Letter&rdquo;) executed between yourself
and APTUS Management Limited (the &ldquo;Company&rdquo;) in relation to your employment as Executive Director and Chief Medical
Officer of Aptorum Group Limited and Executive Director of Aptorum Medical Limited. This Addendum should be read together with,
and forms part of, the Employment Letter.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">This Addendum serves to describe the following
amendments and/or additions to the Employment Letter.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 21.3pt"><B>i.</B></TD><TD STYLE="text-align: justify"><B>Date of Commencement</B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 21.3pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 21.3pt; text-align: justify">Pursuant to Clause 3 of Employment
Letter, the official commencement date of your employment shall be on <B>2 January 2018</B> (the &ldquo;Effective Date&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Please signify your acceptance of the above
amendment described in this Addendum by signing and returning to us the enclosed duplicate copy of this letter.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 40%"><FONT STYLE="font-size: 10pt">Yours faithfully,</FONT></TD>
    <TD STYLE="width: 20%">&nbsp;</TD>
    <TD STYLE="width: 40%">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">For and on behalf of</FONT></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt"><B>APTUS MANAGEMENT LIMITED</B></FONT></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Agreed and accepted by:</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify; border-bottom: Black 1.5pt solid">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify; border-bottom: Black 1.5pt solid">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Huen Chung Yuen Ian</FONT></TD>
    <TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cheng Clark</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Director</FONT></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">HKID No. Z243983(3)</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.9
<SEQUENCE>13
<FILENAME>ff12018ex10-9_aptorum.htm
<DESCRIPTION>APPOINTMENT LETTER BETWEEN THE COMPANY AND KEITH CHAN (CHIEF SCIENTIFIC OFFICER), DATED AUGUST 18, 2017
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0; text-align: right"><B>Exhibit 10.9</B></P>

<P STYLE="margin: 0; text-align: right"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><IMG SRC="ex10-8_001.jpg" ALT=""></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">APTUS Holdings Limited</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Unit B, 17/F Guangdong Investment Tower,
148 Connaught Road Central, Hong Kong</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Tel: (852) 2117 6611 &#9679; Fax: (852) 2850
7286</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">18<SUP>th</SUP> August 2017</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Dr. Keith Chan, Ph.D.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Dear Dr. Chan,</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><U>Appointment Letter</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We are pleased and welcome your acceptance
to be appointed as a Chief Scientific Officer of APTUS Holdings Limited (the &ldquo;Company&rdquo;), a company incorporated with
limited liabilities under the laws of Cayman Islands, with wholly owned subsidiaries in the Cayman Islands, Hong Kong, and Macau,
whereby collectively, shall be depicted as &ldquo;APTUS&rdquo; or the &ldquo;Group&rdquo;.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The following letter (the &ldquo;Letter&rdquo;)
seeks to illustrate the context of your appointment by the Company. However, this letter shall be read together as one instrument
with, and supplement, the <B>Consultancy Agreement (the &ldquo;Agreement&rdquo;) dated 18<SUP>th</SUP> August 2017</B> and executed
between the Company and GloboAsia LLC. The Agreement is attached herein as Appendix A.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 22.5pt"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 22.5pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 21.3pt"><B>1.</B></TD><TD STYLE="text-align: justify"><B>The Company and the Group</B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 21.3pt; text-align: justify">APTUS and its affiliates focus
on the licensing of, and acquisition of early stage preclinical assets with the intention to engage in drug research, development,
and commercialization purposes. Assets are acquired via open and public platforms such as the technology transfer offices of accredited
universities and academic institutions. In addition, the Group seeks to be a facilitator across the financing spectrum for biotech
companies, entrepreneurs, and commercializing agents, to bolster innovations adding value to health care needs in the market place;
and to assist in furthering the research capabilities of institutions the Group works with.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 21.3pt; text-align: justify"><B></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 21.3pt; text-align: justify"><B>&nbsp;</B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 21.3pt"><B>2.</B></TD><TD STYLE="text-align: justify"><B>Position and Responsibilities</B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 21.3pt"></TD><TD STYLE="width: 33pt">(a)</TD><TD STYLE="text-align: justify">You will be enlisted to act as a <B>Chief Scientific Officer</B> of the Company.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 21.3pt; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 21.3pt"></TD><TD STYLE="width: 33pt">(b)</TD><TD STYLE="text-align: justify">You shall be a member of the management team of the Company, which will contribute to the management,
steering, and execution of business and medical initiatives of the Company.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 21.3pt"></TD><TD STYLE="width: 33pt">(c)</TD><TD STYLE="text-align: justify">As a Chief Scientific Officer of the Company your role involves managing the regulatory aspects
of APTUS' clinical programs including, but not limited to, the liaison with regulatory authorities such as the U.S. Food &amp;
Drug Administration (FDA) or the China Food &amp; Drug Administration (cFDA).</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 21.3pt"></TD><TD STYLE="width: 33pt">(d)</TD><TD STYLE="text-align: justify">As you are not an Executive Director on the Board of Directors for the Company, you ultimately
do not have legal nor professional authority to dictate the commercial decisions of the Executive Board.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><IMG SRC="ex10-8_001.jpg" ALT=""></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">APTUS Holdings Limited</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Unit B, 17/F Guangdong Investment Tower,
148 Connaught Road Central, Hong Kong</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Tel: (852) 2117 6611 &#9679; Fax: (852) 2850
7286</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 21.3pt"></TD><TD STYLE="width: 33pt">(e)</TD><TD STYLE="text-align: justify">You shall:</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.5in">(i)</TD><TD STYLE="text-align: justify">Provide your services in all aspects of the Group where reasonably sought at least for one working
day per week;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.25in; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.5in">(ii)</TD><TD STYLE="text-align: justify">Be responsive to the Group&rsquo;s needs and interests, whereby your deliverables to APTUS should
be provided in good faith so that effort and quality is commensurable to compensation provided to you, with details described more
fully below;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.25in; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.5in">(iii)</TD><TD STYLE="text-align: justify">Observe and comply with all statutory rules, and regulations where applicable as governed by the
laws of your residence;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.25in; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.5in">(iv)</TD><TD STYLE="text-align: justify">Provide traceable contact during and after office hours, on weekdays and weekends, or during public
holidays, whereby your availability may occasionally and reasonably be sought.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.25in; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in">3.</TD><TD STYLE="text-align: justify">Date of Commencement</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 21.25pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">Your official date of appointment
as a Chief Scientific Officer of the Company shall correspond to the Date of Commencement as effected by the Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><B>4.</B></TD><TD STYLE="text-align: justify"><B>Compensation</B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">All Compensation shall be received
on your behalf by GloboAsia LLC with terms as stipulated in the particulars of the Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><B>5.</B></TD><TD STYLE="text-align: justify"><FONT STYLE="color: #333333"><B>Stock Bonus:</B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 22.5pt; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">All Stock Bonus shall be received
on your behalf by GloboAsia LLC with terms as stipulated in the particulars of the Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 22.5pt; text-align: justify"><B>&nbsp;</B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><B>6.</B></TD><TD STYLE="text-align: justify"><FONT STYLE="color: #333333"><B>Expense Reimbursements</B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 22.5pt; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">All Expense Reimbursements shall
be received on your behalf by GloboAsia LLC with terms as stipulated in the particulars of the Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 22.5pt; text-align: justify"><B>&nbsp;</B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><B>7.</B></TD><TD STYLE="text-align: justify"><B>Privacy of Information</B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 28.35pt; text-align: justify; text-indent: -28.35pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">(a)</TD><TD STYLE="text-align: justify">You shall not except as authorized by the Company or its affiliates, or required by your responsibilities
reveal to any person or company any of the trade secrets or any information concerning the organization, business, finances, transactions
or affairs of the Group which may come to your knowledge during your contract with the Group and shall keep with complete secrecy
confidential information entrusted to you and shall not use or attempt to use any such information in any manner which may injure
or cause loss either directly or indirectly to the Group or may be likely to do so. This restriction shall continue to apply if
and when after the termination of your appointment without limit in time.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">(b)</TD><TD STYLE="text-align: justify">You shall not either during the period of your appointment or afterwards use or permit to be used
any books, documents, moneys, assets, records or other property belonging to or relating to any dealings, affair or business of
the Group other than for the benefit of the Group. You shall immediately deliver and return to the Group all such books, documents,
moneys, securities, records or other property which you then have or should have in your possession upon termination of your appointment
hereunder.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"></P>

<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><IMG SRC="ex10-8_001.jpg" ALT=""></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">APTUS Holdings Limited</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Unit B, 17/F Guangdong Investment Tower,
148 Connaught Road Central, Hong Kong</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Tel: (852) 2117 6611 &#9679; Fax: (852) 2850
7286</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">(c)</TD><TD STYLE="text-align: justify">The Company however, agrees to provide you in good faith with any information concerning areas
of interest and relevance of the Group as required by you in order for you to fulfill your role as a Chief Scientific Officer of
the Company.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><B>8.</B></TD><TD STYLE="text-align: justify"><B>Term and Termination</B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 28.35pt; text-align: justify; text-indent: -28.35pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">The particulars of your Appointment&rsquo;s
Term and Termination shall correspond to the particulars stipulated in the Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Please signify your acceptance of the above
terms and conditions by signing and returning to us the enclosed duplicate copy of this letter.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Yours faithfully, &#9;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">For and on behalf of</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 40%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>APTUS HOLDINGS LIMITED</B></FONT></TD>
    <TD STYLE="width: 20%">&nbsp;</TD>
    <TD STYLE="width: 40%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Agreed and accepted by:</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify; border-bottom: Black 1.5pt solid">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify; border-bottom: Black 1.5pt solid">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Name: HUEN Chung Yuen Ian</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Name: Dr. Keith CHAN, Ph.D.</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Position: Director</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left; border-bottom: Black 1.5pt solid">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: left; border-bottom: Black 1.5pt solid">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Date</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Date</FONT></TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>


<!-- Field: Page; Sequence: 3; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><IMG SRC="ex10-8_001.jpg" ALT=""></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">APTUS Holdings Limited</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Unit B, 17/F Guangdong Investment Tower,
148 Connaught Road Central, Hong Kong</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Tel: (852) 2117 6611 &#9679; Fax: (852) 2850
7286</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>APPENDIX A</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">[Consultancy Agreement dated 18<SUP>th</SUP>
August 2017, executed between the Company and GloboAsia LLC.]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"></P>

<!-- Field: Page; Sequence: 4; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.10
<SEQUENCE>14
<FILENAME>ff12018ex10-10_aptorum.htm
<DESCRIPTION>APPOINTMENT LETTER BETWEEN THE COMPANY AND CHARLES BATHURST (INDEPENDENT NON-EXECUTIVE DIRECTOR), DATED SEPTEMBER 24, 2017
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0; text-align: right"><B>Exhibit 10.10</B></P>

<P STYLE="margin: 0; text-align: right">&nbsp;</P>

<P STYLE="margin-top: 0; text-align: center; margin-bottom: 0"><IMG SRC="ex10-9_001.jpg" ALT=""></P>

<P STYLE="margin-top: 0; text-align: center; margin-bottom: 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Aptorum Group Limited</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Unit B, 17/F Guangdong Investment Tower,
148 Connaught Road Central, Hong Kong</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Tel: (852) 2117 6611 &#9679; Fax: (852) 2850
7286</P>



<P STYLE="margin-top: 0; text-align: center; margin-bottom: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">18 September 2017</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Attn: Mr. Charles A. Bathurst</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Dear Mr. Bathurst,</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><U>Appointment Letter for Independent
Non-Executive Director</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We are pleased and welcome your acceptance
to be appointed as an Independent Non-Executive Director of Aptorum Group Limited (the &ldquo;Company&rdquo;), a company incorporated
with limited liabilities under the laws of the Cayman Islands, with wholly owned subsidiaries in the Cayman Islands, Hong Kong,
and Macau, whereby collectively, shall be depicted as &ldquo;Aptorum&rdquo; or the &ldquo;Group&rdquo;.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The following letter seeks to illustrate
the context of your appointment by the Company, and the terms and conditions as set out herewith. It is agreed that on acceptance
of this offer, this letter will constitute a contract for services and not a contract of employment.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">For the purposes of independence, this
letter will supersede all previous appointment contract or agreement, if applicable, entered into between yourself and the Company
(or its affiliated subsidiaries). By signing this letter and therefore accepting the appointment as stated, you agree to terminate
all other previous appointments with the Group commencing from the Effective Date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 22.5pt"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 22.5pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 21.3pt"><B>1.</B></TD><TD STYLE="text-align: justify"><B>The Company and the Group</B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 21.3pt; text-align: justify">Aptorum focuses on the licensing
of, and acquisition of early stage preclinical assets with the intention to engage in drug research, development, and commercialization
purposes. Assets are acquired via open and public platforms such as the technology transfer offices of accredited universities
and academic institutions. In addition, the Group seeks to be a facilitator across the financing spectrum for biotech companies,
entrepreneurs, and commercializing agents, to bolster innovations adding value to health care needs in the marketplace; and to
assist in furthering the research capabilities of institutions the Group works with.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 21.3pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 21.3pt; text-align: justify">The Company is a privately held
company that has engaged in plans to pursue an initial public offering on the Nasdaq Global Market in the near future (<B>the &ldquo;Listing&rdquo;</B>).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 21.3pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 21.3pt; text-align: justify"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 21.3pt; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><IMG SRC="ex10-9_001.jpg" ALT=""></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Aptorum Group Limited</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Unit B, 17/F Guangdong Investment Tower,
148 Connaught Road Central, Hong Kong</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Tel: (852) 2117 6611 &#9679; Fax: (852)
2850 7286</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 21.3pt; text-align: justify"><B>&nbsp;</B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 21.3pt"><B>2.</B></TD><TD STYLE="text-align: justify"><B>Appointment</B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 21.3pt; text-align: justify"><B>&nbsp;</B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 21.3pt"></TD><TD STYLE="width: 32.7pt">(a)</TD><TD STYLE="text-align: justify">You will be nominated by the Nominating Committee and appointed by the Board of Directors of the
Company (the &ldquo;Board&rdquo;) to act as an <B>Independent Non-Executive Director (&ldquo;INED&rdquo;)</B> of the Company.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 21.3pt"></TD><TD STYLE="width: 32.7pt">(b)</TD><TD STYLE="text-align: justify">You shall agree to being appointed by the Board as a member and/or chair of the following committees:</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 57.3pt"></TD><TD STYLE="width: 18pt">a.</TD><TD STYLE="text-align: justify"><B>Chair and member</B> of the Audit Committee;</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 57.3pt"></TD><TD STYLE="width: 18pt">b.</TD><TD STYLE="text-align: justify"><B>Member</B> of the Nominating and Corporate Governance Committee; and</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 57.3pt"></TD><TD STYLE="width: 18pt">c.</TD><TD STYLE="text-align: justify"><B>Member</B> of the Compensation Committee;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 39.3pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 57.3pt; text-align: justify">Whereby all three committees
shall collectively be depicted as the &ldquo;Committees&rdquo;; and roles for (a) and (b) shall collectively be described as the
&ldquo;Appointment&rdquo; or &ldquo;Roles&rdquo;.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 57.3pt; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 21.3pt"></TD><TD STYLE="width: 32.7pt">(c)</TD><TD STYLE="text-align: justify">The Appointment is subject to the Company&rsquo;s Memorandum and Articles of Association (&quot;Articles&quot;)
and nothing in this letter shall be taken to exclude or vary the terms of the Articles as they apply to your Appointment.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 39.3pt; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 21.3pt"></TD><TD STYLE="width: 32.7pt">(d)</TD><TD STYLE="text-align: justify">The continuation of the Appointment is contingent to your ongoing fulfillment of your obligations
and successful re-election by the Company&rsquo;s shareholders at the Company&rsquo;s Annual General Meeting (the &ldquo;AGM&rdquo;).
It is further subject to your agreement to apply yourself and discharge your duties as a Non-Executive Director in accordance with
the Articles of the Company and the Cayman Islands Company Law (2016 Revision) (as amended) (&quot;Company Law&quot;), as well
as you upholding the high standards of corporate governance as set forth in the Nasdaq Listing Rule 5600 Series subsequent to the
Listing.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 21.3pt; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 21.3pt; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in">3.</TD><TD STYLE="text-align: justify">Date of Commencement and Term</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">The official commencement date
of your Appointment shall be on <B>15 October 2017</B> (the &ldquo;Effective Date&rdquo;), or as mutually agreed upon between yourself
and the Executive Board of Directors of the Company. The Term of this Appointment shall be <B>3 years</B> from the Effective Date
and subject to the terms of Termination and the re-election by the Company&rsquo;s shareholders at the AGM as set forth in 2(d)
herein above.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><B></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><B>&nbsp;</B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><B>4.</B></TD><TD STYLE="text-align: justify"><B>Duties and Responsibilities</B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">As an INED of the Company:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 21.3pt"></TD><TD STYLE="width: 33pt">(a)</TD><TD STYLE="text-align: justify">You have the same general legal responsibilities to the Company as any other Director and will
advise where necessary, the Executive Board of Directors of the Company.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 54.3pt; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 21.3pt"></TD><TD STYLE="width: 33pt">(b)</TD><TD STYLE="text-align: justify">You will exercise your powers of your Appointment having regard to the relevant obligations under
prevailing law and regulation, including the Cayman Islands Company Law, and while in pursuit of and subsequent to the Listing,
also the rules stipulated by the Nasdaq Regulatory Authority; including but not limited to the Listing Rule 5600 Series.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 54.3pt; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 21.3pt"></TD><TD STYLE="width: 33pt">(c)</TD><TD STYLE="text-align: justify">You shall remain mindful and ensure your status of independence remains compliant as stipulated
by requirements of Nasdaq Rule 5605(a)(2) and Securities Exchange Act Rule 10A-3. Should your independent status cease to remain
compliant, you must notify the Board of the Company of such said change as soon as practical, and if subsequent to the Listing,
notification must additionally be made to Nasdaq no later than the sooner of (i) the next annual shareholders meeting or (ii) one
year from occurrence of the event causing failure to comply. You shall further facilitate any director independence disclosures
in annual meeting proxy statements or annual report on Form 10-K, including transactions and arrangements considered by the Board
in assessing director independence.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 54.3pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 54.3pt; text-align: justify"></P>

<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 54.3pt; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 54.3pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><IMG SRC="ex10-9_001.jpg" ALT=""></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Aptorum Group Limited</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Unit B, 17/F Guangdong Investment Tower,
148 Connaught Road Central, Hong Kong</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Tel: (852) 2117 6611 &#9679; Fax: (852) 2850
7286</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 54.3pt; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 21.3pt"></TD><TD STYLE="width: 33pt">(d)</TD><TD STYLE="text-align: justify">Subsequent to the Listing, you along with other Directors of the Board, are to meet when possible
in executive session, where such sessions should occur at least four times a year. Additionally, you are to meet with other INEDs
without executive management at least twice a year.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 54.3pt; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 21.3pt"></TD><TD STYLE="width: 33pt">(e)</TD><TD STYLE="text-align: justify">Additionally, you may be sought within reason, to engage in ad hoc strategic discussions that may
require you reviewing and execution of documents pertinent to Board decisions. Such meetings shall take place in person, or by
telephone conferencing, at a sensible time of day in relation to your primary place of residence.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 54.3pt; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 21.3pt"></TD><TD STYLE="width: 33pt">(f)</TD><TD STYLE="text-align: justify">You shall not directly be responsible for the management of the Company. Your role is neither operational
nor managerial in nature however; members of the Executive Board may draw upon your professional insight and business expertise
where suitable. You shall provide guidance, steering, and access of expert networks to the Company where appropriate and required.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 21.3pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 21.3pt; text-align: justify">As the Chair and/or member of
the said Committees described in Clause 2(b):</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 54.3pt; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 21.3pt"></TD><TD STYLE="width: 33pt">(g)</TD><TD STYLE="text-align: justify">You shall review and uphold the functions of your relevant committee(s) as pursuant to individually
adopted Audit, Compensation, and Nominating and Corporate Governance Committee Charters (&ldquo;Charters&rdquo;) that shall be
made available to you upon a practical date subsequent to your Appointment and before the Listing.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 54.3pt; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 21.3pt"></TD><TD STYLE="width: 33pt">(h)</TD><TD STYLE="text-align: justify">You must along with other Committee members, review annually and assess the adequacy of the same
said Charters.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 54.3pt; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 21.3pt"></TD><TD STYLE="width: 33pt">(i)</TD><TD STYLE="text-align: justify">You must along with other Committee members, ensure compliance with Nasdaq listing rules at all
times subsequent to the Listing with respect to Committee composition requirements, and assist the Company in regaining compliance
if required by curing the event that caused failure to comply within the time frame provided by the Nasdaq Regulatory Authority.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 21.3pt"></TD><TD STYLE="width: 33pt">(j)</TD><TD STYLE="text-align: justify">You must refrain from accepting any direct or indirect consulting, advisory, or other compensatory
fee from the Company or the Group subsequent to the Listing, other than fees for director service as described more fully below
in Clause 5.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 54.3pt; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 21.3pt"></TD><TD STYLE="width: 33pt">(k)</TD><TD STYLE="text-align: justify">Additionally as the Audit Committee Chair and member, you must refrain from participating in preparation
of financial statements of the Company or the Group. However, along with other members you shall be directly responsible for appointing
and terminating the Company&rsquo;s independent auditor(s).</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 54.3pt; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 21.3pt"></TD><TD STYLE="width: 33pt">(l)</TD><TD STYLE="text-align: justify">You shall maintain your financial literacy and expertise requirements in order to maintain your
individual financial sophistication and qualify as the Audit Committee financial expert.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 54.3pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 54.3pt; text-align: justify"></P>

<!-- Field: Page; Sequence: 3; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 54.3pt; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 54.3pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><IMG SRC="ex10-9_001.jpg" ALT=""></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Aptorum Group Limited</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Unit B, 17/F Guangdong Investment Tower,
148 Connaught Road Central, Hong Kong</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Tel: (852) 2117 6611 &#9679; Fax: (852) 2850
7286</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 54.3pt; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 21.3pt"></TD><TD STYLE="width: 33pt">(m)</TD><TD STYLE="text-align: justify">You shall assist the Audit Committee in review of related person transactions and conducting oversight
for potential conflict of interest situations on an ongoing basis, and more generally, oversight with respect to the code of conduct
compliance by senior management of the Company.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 54.3pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 21.3pt">Additionally, you
shall during the Term of your Appointment:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.5in">(i)</TD><TD STYLE="text-align: justify">Observe and comply with the Company&rsquo;s adopted adopted Code of Business Conduct and Ethics,
where that any waivers given to directors or executive officers must be approved by the Board.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.25in; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.5in">(ii)</TD><TD STYLE="text-align: justify">Observe and comply with all statutory rules, and regulations where applicable as governed by the
laws of your residence;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.5in">(iii)</TD><TD STYLE="text-align: justify">Confirm you are able to, and will devote sufficient time to perform your Roles.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.25in; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.5in">(iv)</TD><TD STYLE="text-align: justify">Provide traceable contact during and after office hours, on weekdays and weekends, or during public
holidays, whereby your availability may occasionally and reasonably be sought.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.25in; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.5in">(v)</TD><TD STYLE="text-align: justify">Declare any conflicts that are apparent at present, or become apparent, between the Group and your
other business interests. Should any potential conflicts of interest arise, you will disclose this to the Board as soon as they
become apparent.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.25in; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.5in">(vi)</TD><TD STYLE="text-align: justify">Consult with the Chairman of the Board prior to accepting any other (or further) directorships
of publicly quoted companies or any major external appointments.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.25in; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.5in">(vii)</TD><TD STYLE="text-align: justify">Obtain clearance from the Chairman of the Board prior to dealing in publicly traded shares in the
Company subsequent to the Listing.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.25in; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.5in">(viii)</TD><TD STYLE="text-align: justify">Observe and comply with the disclosure requirements and obligations of you and/or your affiliated
party(s) as applicable in accordance with U.S. securities laws, regulations and SEC disclosure requirements.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 21.25pt; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><B>5.</B></TD><TD STYLE="text-align: justify"><B>Fees and Expenses</B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.5in">(a)</TD><TD STYLE="text-align: justify">The combined basic fee for being an INED of the Company and your roles as chair and/or member of
relevant Committees is <B>GBP 35,000 per annum</B> (GBP Sterling Thirty Five Thousand), paid to you by the Company in arrears in
twelve monthly installments on or about the last business day of each month.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.5in">(b)</TD><TD STYLE="text-align: justify">You will be entitled to bonus during the Appointment and entitled to participate in any share plan
operated by the Company. You will also be entitled to an increase in basic fees during the Appointment. For the avoidance of doubt,
your entitlement as stated in this paragraph is in relation to your capacity as independent non-executive director only.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"></P>

<!-- Field: Page; Sequence: 4; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><IMG SRC="ex10-9_001.jpg" ALT=""></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Aptorum Group Limited</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Unit B, 17/F Guangdong Investment Tower,
148 Connaught Road Central, Hong Kong</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Tel: (852) 2117 6611 &#9679; Fax: (852) 2850
7286</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.5in">(c)</TD><TD STYLE="text-align: justify">The Company will reimburse all reasonable travelling, hotel and other expenses incurred by you
in connection with the Company&rsquo;s business on production of appropriate receipts.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><B></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"><B>&nbsp;</B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 22.5pt"><B>6.</B></TD><TD STYLE="text-align: justify"><B>Privacy of Information</B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 28.35pt; text-align: justify; text-indent: -28.35pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.5in">(a)</TD><TD STYLE="text-align: justify">You shall not except as authorized by the Group or required by your responsibilities reveal to
any person or company any of the trade secrets or any information concerning the organization, business, finances, transactions
or affairs of the Group which may come to your knowledge during your contract with the Company and shall keep with complete secrecy
confidential information entrusted to you and shall not use or attempt to use any such information in any manner which may injure
or cause loss either directly or indirectly to the Group or may be likely to do so. This restriction shall continue to apply if
and when after the termination of your appointment without limit in time.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.5in">(b)</TD><TD STYLE="text-align: justify">You shall not either during the period of your Appointment or afterwards use or permit to be used
any books, documents, moneys, assets, records or other property belonging to or relating to any dealings, affair or business of
the Group other than for the benefit of the Group. You shall immediately deliver and return to the Group all such books, documents,
moneys, securities, records or other property which you then have or should have in your possession upon termination of your Appointment
hereunder.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.5in">(c)</TD><TD STYLE="text-align: justify">The Company however, agrees to provide you in good faith with any information concerning areas
of interest and relevance of the Group as required by you in order to enable you to fulfill your Roles with the Company.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><B>7.</B></TD><TD STYLE="text-align: justify"><B>Data Protection</B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><B>&nbsp;</B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 22.5pt"></TD><TD STYLE="width: 31.5pt">(a)</TD><TD STYLE="text-align: justify">By executing this letter, you consent to the Company holding and processing information about you
for legal, personnel, administrative, and management purposes and in particular to the processing of any sensitive personal data
as and when appropriate.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 22.5pt"></TD><TD STYLE="width: 31.5pt">(b)</TD><TD STYLE="text-align: justify">You consent to the transfer of such personal information to other offices the Company may have
or to other third parties for administrative purposes and other purposes in connection with the Appointment, where it is necessary
or desirable to do so.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><B>8.</B></TD><TD STYLE="text-align: justify"><B>Insurance and Indemnity</B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">The Company shall establish
directors&rsquo; and officers&rsquo; liability coverage and it is intended to maintain such coverage for the full Term of the Appointment.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"></P>

<!-- Field: Page; Sequence: 5; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><IMG SRC="ex10-9_001.jpg" ALT=""></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Aptorum Group Limited</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Unit B, 17/F Guangdong Investment Tower,
148 Connaught Road Central, Hong Kong</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Tel: (852) 2117 6611 &#9679; Fax: (852) 2850
7286</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"><B>9.</B></TD><TD STYLE="text-align: justify"><B>Termination</B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 28.35pt; text-align: justify; text-indent: -28.35pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">Your Appointment with respect
to the Roles with the Company may only be terminated:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 28.35pt; text-align: justify; text-indent: -28.35pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">(a)</TD><TD STYLE="text-align: justify">By you after giving the Company not less than two (2) months&rsquo; notice in writing;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 22.5pt; text-align: justify; text-indent: -22.5pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">(b)</TD><TD STYLE="text-align: justify">By the Company after giving you two (2) months&rsquo; notice in writing; or</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">(c)</TD><TD STYLE="text-align: justify">By the Company with immediate effect in the event that you:</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 54.3pt"></TD><TD STYLE="width: 35.7pt">(i)</TD><TD STYLE="text-align: justify">Conduct dishonesty, fraud, gross negligence, willful default or refusal to carry out any lawful
order or instructions, or the repeated breach of any rules or regulations of the Company, or those as governed by the laws of your
residency;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.25in; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 54.3pt"></TD><TD STYLE="width: 35.7pt">(ii)</TD><TD STYLE="text-align: justify">Commit a material breach of your obligations under this letter;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 54.3pt"></TD><TD STYLE="width: 35.7pt">(iii)</TD><TD STYLE="text-align: justify">Commit any serious or repeated breach or non-observance of your obligations to the Company;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 54.3pt"></TD><TD STYLE="width: 35.7pt">(iv)</TD><TD STYLE="text-align: justify">Are convicted of a criminal offence other than an offence under road traffic legislation in the
jurisdiction of your residency or elsewhere for which a fine or non-custodial penalty is imposed;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 54.3pt"></TD><TD STYLE="width: 35.7pt">(v)</TD><TD STYLE="text-align: justify">Declare bankruptcy or have made an arrangement with or for the benefit of your creditors; or</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 54.3pt"></TD><TD STYLE="width: 35.7pt">(vi)</TD><TD STYLE="text-align: justify">Are disqualified from acting as a director.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Please signify your acceptance of the above
terms and conditions by signing and returning to us the enclosed duplicate copy of this letter.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Yours faithfully, &#9;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">For and on behalf of</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 40%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>APTORUM GROUP LIMITED</B></FONT></TD>
    <TD STYLE="width: 20%; text-align: justify">&nbsp;</TD>
    <TD STYLE="width: 40%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Agreed and accepted by:</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left; border-bottom: Black 1.5pt solid">&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: left; border-bottom: Black 1.5pt solid">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Name: Huen Chung Yuen Ian</FONT></TD>
    <TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Name: Charles A. Bathurst</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Position: Director</FONT></TD>
    <TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left; border-bottom: Black 1.5pt solid">&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: left; border-bottom: Black 1.5pt solid">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Date</FONT></TD>
    <TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Date</FONT></TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 6; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.11
<SEQUENCE>15
<FILENAME>ff12018ex10-11_aptorum.htm
<DESCRIPTION>APPOINTMENT LETTER BETWEEN THE COMPANY AND MIRKO SCHERER (INDEPENDENT NON-EXECUTIVE DIRECTOR), DATED SEPTEMBER 24, 2017
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0; text-align: right"><B>Exhibit 10.11</B></P>

<P STYLE="margin: 0; text-align: right"><B>&nbsp;</B></P>

<P STYLE="margin-top: 0; text-align: center; margin-bottom: 0"><IMG SRC="ex10-10_001.jpg" ALT=""></P>

<P STYLE="margin: 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Aptorum Group Limited</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Unit B, 17/F Guangdong Investment Tower,
148 Connaught Road Central, Hong Kong</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Tel: (852) 2117 6611 &#9679; Fax: (852) 2850
7286</P>



<P STYLE="margin: 0"></P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">24
September 2017</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Attn:
Dr. Mirko Scherer</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dear
Dr. Scherer,</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Appointment
Letter for Independent Non-Executive Director</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
are pleased and welcome your acceptance to be appointed as an Independent Non-Executive Director of Aptorum Group Limited (the
&ldquo;Company&rdquo; , formerly known as Aptus Holdings Limited), a company incorporated with limited liabilities under the laws
of the Cayman Islands, with wholly owned subsidiaries in the Cayman Islands, Hong Kong, and Macau, whereby collectively, shall
be depicted as &ldquo;Aptorum&rdquo; or the &ldquo;Group&rdquo;.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following letter seeks to illustrate the context of your appointment by the Company, and the terms and conditions as set out herewith.
It is agreed that on acceptance of this offer, this letter will constitute a contract for services and not a contract of employment.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
the purposes of independence, this letter will supersede all previous appointment contract or agreement, if applicable, entered
into between yourself and the Company (or its affiliated subsidiaries). By signing this letter and therefore accepting the appointment
as stated, you agree to terminate all other previous appointments with the Group commencing from the Effective Date.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 22.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 22.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>1.</B></FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>The
                                         Company and the Group</B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 21.3pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Aptorum
focuses on the licensing of, and acquisition of early stage preclinical assets with the intention to engage in drug research,
development, and commercialization purposes. Assets are acquired via open and public platforms such as the technology transfer
offices of accredited universities and academic institutions. In addition, the Group seeks to be a facilitator across the financing
spectrum for biotech companies, entrepreneurs, and commercializing agents, to bolster innovations adding value to health care
needs in the marketplace; and to assist in furthering the research capabilities of institutions the Group works with.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 21.3pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 21.3pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company is a privately held company that has engaged in plans to pursue an initial public offering on the Nasdaq Global Market
in the near future (<B>the &ldquo;Listing&rdquo;</B>).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 21.3pt; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 21.3pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>2.</B></FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Appointment</B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 21.3pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">You
                                         will be nominated by the Nominating Committee and appointed by the Board of Directors
                                         of the Company (the &ldquo;Board&rdquo;) to act as an <B>Independent Non-Executive Director
                                         (&ldquo;INED&rdquo;)</B> of the Company.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><IMG SRC="ex10-9_001.jpg" ALT=""></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Aptorum Group Limited</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Unit B, 17/F Guangdong Investment Tower,
148 Connaught Road Central, Hong Kong</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Tel: (852) 2117 6611 &#9679; Fax: (852) 2850
7286</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">To
                                         the extent required if the required quorum for the below committees is not reached for
                                         a board meeting, you shall agree to being appointed by the Board as a member and/or chair
                                         of the following committees:</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.75in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a.</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Nominating
                                         and Corporate Governance Committee; and</FONT></TD></TR>                                                                                                 <TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
</TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.75in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">b.</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Compensation
                                         Committee.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 39.3pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Whereby
both committees shall collectively be depicted as the &ldquo;Committees&rdquo;; and roles for (a) and (b) (if relevant) shall
collectively be described as the &ldquo;Appointment&rdquo; or &ldquo;Roles&rdquo;.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 57.3pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                         Appointment is subject to the Company&rsquo;s Memorandum and Articles of Association
                                         (&quot;Articles&quot;) and nothing in this letter shall be taken to exclude or vary the
                                         terms of the Articles as they apply to your Appointment.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: -32.7pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                         continuation of the Appointment is contingent to your ongoing fulfillment of your obligations
                                         and successful re-election by the Company&rsquo;s shareholders at the Company&rsquo;s
                                         Annual General Meeting (the &ldquo;AGM&rdquo;). It is further subject to your agreement
                                         to apply yourself and discharge your duties as a Non-Executive Director in accordance
                                         with the Articles of the Company and the Cayman Islands Company Law (2016 Revision) (as
                                         amended) (&quot;Company Law&quot;), as well as you upholding the high standards of corporate
                                         governance as set forth in the Nasdaq Listing Rule 5600 Series subsequent to the Listing.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 21.3pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 21.3pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>3.</B></FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Date
                                         of Commencement and Term</B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 21.25pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
official commencement date of your Appointment shall be on <B>15 October 2017</B> (the &ldquo;Effective Date&rdquo;), or as mutually
agreed upon between yourself and the Executive Board of Directors of the Company. The Term of this Appointment shall be <B>3 years
</B>from the Effective Date and subject to the terms of Termination and the re-election by the Company&rsquo;s shareholders at
the AGM as set forth in 2(d) herein above.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>4.</B></FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Duties
                                         and Responsibilities</B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
an INED of the Company:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">You
                                         have the same general legal responsibilities to the Company as any other Director and
                                         will advise where necessary, the Executive Board of Directors of the Company.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 54.3pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">You
                                         will exercise your powers of your Appointment having regard to the relevant obligations
                                         under prevailing law and regulation, including the Cayman Islands Company Law, and while
                                         in pursuit of and subsequent to the Listing, also the rules stipulated by the Nasdaq
                                         Regulatory Authority; including but not limited to the Listing Rule 5600 Series.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 54.3pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">You
                                         shall remain mindful and ensure your status of independence remains compliant as stipulated
                                         by requirements of Nasdaq Rule 5605(a)(2) and Securities Exchange Act Rule 10A-3. Should
                                         your independent status cease to remain compliant, you must notify the Board of the Company
                                         of such said change as soon as practical, and if subsequent to the Listing, notification
                                         must additionally be made to Nasdaq no later than the sooner of (i) the next annual shareholders
                                         meeting or (ii) one year from occurrence of the event causing failure to comply. You
                                         shall further facilitate any director independence disclosures in annual meeting proxy
                                         statements or annual report on Form 10-K, including transactions and arrangements considered
                                         by the Board in assessing director independence.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 54.3pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 54.3pt; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT>&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><IMG SRC="ex10-9_001.jpg" ALT=""></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Aptorum Group Limited</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Unit B, 17/F Guangdong Investment Tower,
148 Connaught Road Central, Hong Kong</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Tel: (852) 2117 6611 &#9679; Fax: (852) 2850
7286</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 54.3pt; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 54.3pt; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Subsequent
                                         to the Listing, you along with other Directors of the Board, are to meet when possible
                                         in executive session, where such sessions should occur at least four times a year. Additionally,
                                         you are to meet with other INEDs without executive management at least twice a year.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 54.3pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Additionally,
                                         you may be sought within reason, to engage in ad hoc strategic discussions that may require
                                         you reviewing and execution of documents pertinent to Board decisions. Such meetings
                                         shall take place in person, or by telephone conferencing, at a sensible time of day in
                                         relation to your primary place of residence.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 54.3pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(f)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">You
                                         shall not directly be responsible for the management of the Company. Your role is neither
                                         operational nor managerial in nature however; members of the Executive Board may draw
                                         upon your professional insight and business expertise where suitable. You shall provide
                                         guidance, steering, and access of expert networks to the Company where appropriate and
                                         required.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 21.3pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Should
at any period within the Term you be appointed as a Chair and/or member of the said Committees described in Clause 2(b):</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 54.3pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(g)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">You
                                         shall review and uphold the functions of your relevant committee(s) as pursuant to individually
                                         adopted Compensation, and Nominating and Corporate Governance Committee Charters (&ldquo;Charters&rdquo;)
                                         that shall be made available to you upon a practical date subsequent to your Appointment
                                         and before the Listing.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 54.3pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(h)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">You
                                         must along with other Committee members, review annually and assess the adequacy of the
                                         same said Charters.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 54.3pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">You
                                         must along with other Committee members, ensure compliance with Nasdaq listing rules
                                         at all times subsequent to the Listing with respect to Committee composition requirements,
                                         and assist the Company in regaining compliance if required by curing the event that caused
                                         failure to comply within the time frame provided by the Nasdaq Regulatory Authority.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(j)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">You
                                         must refrain from accepting any direct or indirect consulting, advisory, or other compensatory
                                         fee from the Company or the Group subsequent to the Listing, other than fees for director
                                         service as described more fully below in Clause 5.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 54.3pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 21.3pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Additionally,
you shall during the Term of your Appointment:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.75in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Observe
                                         and comply with the Company&rsquo;s adopted Code of Business Conduct and Ethics, where
                                         that any waivers given to directors or executive officers must be approved by the Board.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.75in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Observe
                                         and comply with all statutory rules, and regulations where applicable as governed by
                                         the laws of your residence;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 3; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><IMG SRC="ex10-10_001.jpg" ALT=""></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Aptorum Group Limited</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Unit B, 17/F Guangdong Investment Tower,
148 Connaught Road Central, Hong Kong</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Tel: (852) 2117 6611 &#9679; Fax: (852) 2850
7286</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.75in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Confirm
                                         you are able to, and will devote sufficient time to perform your Roles.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.75in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iv)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Provide
                                         traceable contact during and after office hours, on weekdays and weekends, or during
                                         public holidays, whereby your availability may occasionally and reasonably be sought.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.75in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(v)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Declare
                                         any conflicts that are apparent at present, or become apparent, between the Group and
                                         your other business interests. Should any potential conflicts of interest arise, you
                                         will disclose this to the Board as soon as they become apparent.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.75in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(vi)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Consult
                                         with the Chairman of the Board prior to accepting any other (or further) directorships
                                         of publicly quoted companies or any major external appointments.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.75in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(vii)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Obtain
                                         clearance from the Chairman of the Board prior to dealing in publicly traded shares in
                                         the Company subsequent to the Listing.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.75in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(viii)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Observe
                                         and comply with the disclosure requirements and obligations of you and/or your affiliated
                                         party(s) as applicable in accordance with U.S. securities laws, regulations and SEC disclosure
                                         requirements.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 21.25pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>5.</B></FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Fees
                                         and Expenses</B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                         basic fee for being an INED of the Company is <B>USD 30,000 per annum</B> (U.S. Dollars
                                         Thirty Thousand), paid to you by the Company in arrears in twelve monthly installments
                                         on or about the last business day of each month.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">You
                                         will be entitled to bonus during the Appointment and entitled to participate in any share
                                         plan operated by the Company. You will also be entitled to an increase in basic fees
                                         during the Appointment. For the avoidance of doubt, your entitlement as stated in this
                                         paragraph is in relation to your capacity as independent non-executive director only.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                         Company will reimburse all reasonable travelling, hotel and other expenses incurred by
                                         you in connection with the Company&rsquo;s business on production of appropriate receipts.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 22.5pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>6.</B></FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Privacy
                                         of Information</B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 28.35pt; text-align: justify; text-indent: -28.35pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">You
                                         shall not except as authorized by the Group or required by your responsibilities reveal
                                         to any person or company any of the trade secrets or any information concerning the organization,
                                         business, finances, transactions or affairs of the Group which may come to your knowledge
                                         during your contract with the Company and shall keep with complete secrecy confidential
                                         information entrusted to you and shall not use or attempt to use any such information
                                         in any manner which may injure or cause loss either directly or indirectly to the Group
                                         or may be likely to do so. This restriction shall continue to apply if and when after
                                         the termination of your appointment without limit in time.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 4; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><IMG SRC="ex10-10_001.jpg" ALT=""></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Aptorum Group Limited</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Unit B, 17/F Guangdong Investment Tower,
148 Connaught Road Central, Hong Kong</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Tel: (852) 2117 6611 &#9679; Fax: (852) 2850
7286</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">You
                                         shall not either during the period of your Appointment or afterwards use or permit to
                                         be used any books, documents, moneys, assets, records or other property belonging to
                                         or relating to any dealings, affair or business of the Group other than for the benefit
                                         of the Group. You shall immediately deliver and return to the Group all such books, documents,
                                         moneys, securities, records or other property which you then have or should have in your
                                         possession upon termination of your Appointment hereunder.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                         Company however, agrees to provide you in good faith with any information concerning
                                         areas of interest and relevance of the Group as required by you in order to enable you
                                         to fulfill your Roles with the Company.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>7.</B></FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Data
                                         Protection</B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By
                                         executing this letter, you consent to the Company holding and processing information
                                         about you for legal, personnel, administrative, and management purposes and in particular
                                         to the processing of any sensitive personal data as and when appropriate.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">You
                                         consent to the transfer of such personal information to other offices the Company may
                                         have or to other third parties for administrative purposes and other purposes in connection
                                         with the Appointment, where it is necessary or desirable to do so.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>8.</B></FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Insurance
                                         and Indemnity</B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company shall establish directors&rsquo; and officers&rsquo; liability coverage and it is intended to maintain such coverage for
the full term of the Appointment.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>9.</B></FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Termination</B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 28.35pt; text-align: justify; text-indent: -28.35pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 22.5pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Your
Appointment with respect to the Roles with the Company may only be terminated:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 28.35pt; text-align: justify; text-indent: -28.35pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By
                                         you after giving the Company not less than two (2) months&rsquo; notice in writing;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 22.5pt; text-align: justify; text-indent: -22.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By
                                         the Company after giving you two (2) months&rsquo; notice in writing; or</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By
                                         the Company with immediate effect in the event that you:</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 54.3pt; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 35.7pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Conduct
                                         dishonesty, fraud, gross negligence, willful default or refusal to carry out any lawful
                                         order or instructions, or the repeated breach of any rules or regulations of the Company,
                                         or those as governed by the laws of your residency;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 54.3pt; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 35.7pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Commit
                                         a material breach of your obligations under this letter;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 5; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><IMG SRC="ex10-10_001.jpg" ALT=""></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Aptorum Group Limited</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Unit B, 17/F Guangdong Investment Tower,
148 Connaught Road Central, Hong Kong</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Tel: (852) 2117 6611 &#9679; Fax: (852) 2850
7286</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 54.3pt; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 35.7pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Commit
                                         any serious or repeated breach or non-observance of your obligations to the Company;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 54.3pt; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 35.7pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iv)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Are
                                         convicted of a criminal offence other than an offence under road traffic legislation
                                         in the jurisdiction of your residency or elsewhere for which a fine or non-custodial
                                         penalty is imposed;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 54.3pt; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 35.7pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(v)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Declare
                                         bankruptcy or have made an arrangement with or for the benefit of your creditors; or</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 54.3pt; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 35.7pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(vi)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Are
                                         disqualified from acting as a director.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Please
signify your acceptance of the above terms and conditions by signing and returning to us the enclosed duplicate copy of this letter.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Yours
faithfully, &#9;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
and on behalf of</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 40%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>APTORUM GROUP LIMITED</B></FONT></TD>
    <TD STYLE="width: 20%; text-align: justify">&nbsp;</TD>
    <TD STYLE="width: 40%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Agreed and accepted by:</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left; border-bottom: Black 1.5pt solid">&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: left; border-bottom: Black 1.5pt solid">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Name: Huen Chung Yuen Ian</FONT></TD>
    <TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Name: Dr. Mirko Scherer</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Position: Director</FONT></TD>
    <TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left; border-bottom: Black 1.5pt solid">&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: left; border-bottom: Black 1.5pt solid">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Date</FONT></TD>
    <TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Date</FONT></TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>



<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"></P>

<!-- Field: Page; Sequence: 6; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.12
<SEQUENCE>16
<FILENAME>ff12018ex10-12_aptorum.htm
<DESCRIPTION>EMPLOYMENT AGREEMENT BETWEEN THE COMPANY AND JUSTIN WU (INDEPENDENT NON-EXECUTIVE DIRECTOR), DATED SEPTEMBER 18, 2017
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0; text-align: right"><B>Exhibit 10.12</B></P>

<P STYLE="margin: 0; text-align: right"><B>&nbsp;</B></P>

<P STYLE="margin-top: 0; text-align: center; margin-bottom: 0"><IMG SRC="ex10-11_001.jpg" ALT=""></P>

<P STYLE="margin-top: 0; text-align: center; margin-bottom: 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Aptorum Group Limited</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Unit B, 17/F Guangdong Investment Tower,
148 Connaught Road Central, Hong Kong</P>

<P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">Tel: (852) 2117 6611 &#9679; Fax: (852) 2850 7286</P>



<P STYLE="margin-top: 0; text-align: center; margin-bottom: 0"></P>

<P STYLE="margin-top: 0; text-align: center; margin-bottom: 0">&nbsp;</P>

<P STYLE="margin: 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">18
September 2017</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Attn:
Dr. Wu Che Yuen Justin</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dear
Dr. Wu,</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Appointment
Letter for Independent Non-Executive Director</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
are pleased and welcome your acceptance to be appointed as an Independent Non-Executive Director of Aptorum Group Limited (the
&ldquo;Company&rdquo;), a company incorporated with limited liabilities under the laws of the Cayman Islands, with wholly owned
subsidiaries in the Cayman Islands, Hong Kong, and Macau, whereby collectively, shall be depicted as &ldquo;Aptorum&rdquo; or
the &ldquo;Group&rdquo;.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following letter seeks to illustrate the context of your appointment by the Company, and the terms and conditions as set out herewith.
It is agreed that on acceptance of this offer, this letter will constitute a contract for services and not a contract of employment.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
the purposes of independence, this letter will supersede all previous appointment contract or agreement, if applicable, entered
into between yourself and the Company (or its affiliated subsidiaries). By signing this letter and therefore accepting the appointment
as stated, you agree to terminate all other previous appointments with the Group commencing from the Effective Date.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 22.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 22.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 21.3pt; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>1.</B></FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>The
                                         Company and the Group</B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 21.3pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Aptorum
focuses on the licensing of, and acquisition of early stage preclinical assets with the intention to engage in drug research,
development, and commercialization purposes. Assets are acquired via open and public platforms such as the technology transfer
offices of accredited universities and academic institutions. In addition, the Group seeks to be a facilitator across the financing
spectrum for biotech companies, entrepreneurs, and commercializing agents, to bolster innovations adding value to health care
needs in the marketplace; and to assist in furthering the research capabilities of institutions the Group works with.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 21.3pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 21.3pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company is a privately held company that has engaged in plans to pursue an initial public offering on the Nasdaq Global Market
in the near future (<B>the &ldquo;Listing&rdquo;</B>).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 21.3pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 21.3pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 21.3pt; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>2.</B></FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Appointment</B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 21.3pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 21.3pt; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 32.7pt; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">You
                                         will be nominated by the Nominating Committee and appointed by the Board of Directors
                                         of the Company (the &ldquo;Board&rdquo;) to act as an <B>Independent Non-Executive Director
                                         (&ldquo;INED&rdquo;)</B> of the Company.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><IMG SRC="ex10-11_001.jpg" ALT=""></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Aptorum Group Limited</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Unit B, 17/F Guangdong Investment Tower,
148 Connaught Road Central, Hong Kong</P>

<P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">Tel: (852) 2117 6611 &#9679; Fax: (852) 2850 7286</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 21.3pt; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 32.7pt; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">You
                                         shall agree to being appointed by the Board as a member and/or chair of the following
                                         committees:</FONT></TD></TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 57.3pt; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 18pt; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a.</FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Chair
                                         and member</B> of the Compensation Committee;</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 57.3pt; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 18pt; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">b.</FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Member
                                         </B>of the Audit Committee; and</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 57.3pt; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 18pt; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">c.</FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Member
                                         </B>of the Nominating and Corporate Governance Committee;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 39.3pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 57.3pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Whereby
all three committees shall collectively be depicted as the &ldquo;Committees&rdquo;; and roles for (a) and (b) shall collectively
be described as the &ldquo;Appointment&rdquo; or &ldquo;Roles&rdquo;.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 57.3pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 21.3pt; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 32.7pt; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)</FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                         Appointment is subject to the Company&rsquo;s Memorandum and Articles of Association
                                         (&quot;Articles&quot;) and nothing in this letter shall be taken to exclude or vary the
                                         terms of the Articles as they apply to your Appointment.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 39.3pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 21.3pt; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 32.7pt; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)</FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                         continuation of the Appointment is contingent to your ongoing fulfillment of your obligations
                                         and successful re-election by the Company&rsquo;s shareholders at the Company&rsquo;s
                                         Annual General Meeting (the &ldquo;AGM&rdquo;). It is further subject to your agreement
                                         to apply yourself and discharge your duties as a Non-Executive Director in accordance
                                         with the Articles of the Company and the Cayman Islands Company Law (2016 Revision) (as
                                         amended) (&quot;Company Law&quot;), as well as you upholding the high standards of corporate
                                         governance as set forth in the Nasdaq Listing Rule 5600 Series subsequent to the Listing.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 21.3pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 21.3pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.25in; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>3.</B></FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Date
                                         of Commencement and Term</B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 21.25pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
official commencement date of your Appointment shall be on <B>15 October 2017</B> (the &ldquo;Effective Date&rdquo;), or as mutually
agreed upon between yourself and the Executive Board of Directors of the Company. The Term of this Appointment shall be <B>3 years
</B>from the Effective Date and subject to the terms of Termination and the re-election by the Company&rsquo;s shareholders at
the AGM as set forth in 2(d) herein above.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.25in; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>4.</B></FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Duties
                                         and Responsibilities</B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
an INED of the Company:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 21.3pt; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 33pt; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">You
                                         have the same general legal responsibilities to the Company as any other Director and
                                         will advise where necessary, the Executive Board of Directors of the Company.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 54.3pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 21.3pt; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 33pt; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">You
                                         will exercise your powers of your Appointment having regard to the relevant obligations
                                         under prevailing law and regulation, including the Cayman Islands Company Law, and while
                                         in pursuit of and subsequent to the Listing, also the rules stipulated by the Nasdaq
                                         Regulatory Authority; including but not limited to the Listing Rule 5600 Series.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 54.3pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 21.3pt; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 33pt; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)</FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">You
                                         shall remain mindful and ensure your status of independence remains compliant as stipulated
                                         by requirements of Nasdaq Rule 5605(a)(2) and Securities Exchange Act Rule 10A-3. Should
                                         your independent status cease to remain compliant, you must notify the Board of the Company
                                         of such said change as soon as practical, and if subsequent to the Listing, notification
                                         must additionally be made to Nasdaq no later than the sooner of (i) the next annual shareholders
                                         meeting or (ii) one year from occurrence of the event causing failure to comply. You
                                         shall further facilitate any director independence disclosures in annual meeting proxy
                                         statements or annual report on Form 10-K, including transactions and arrangements considered
                                         by the Board in assessing director independence.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 54.3pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 54.3pt; text-align: justify"></P>

<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 54.3pt; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><IMG SRC="ex10-11_001.jpg" ALT=""></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Aptorum Group Limited</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Unit B, 17/F Guangdong Investment Tower,
148 Connaught Road Central, Hong Kong</P>

<P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">Tel: (852) 2117 6611 &#9679; Fax: (852) 2850 7286</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 54.3pt; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 21.3pt; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 33pt; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)</FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Subsequent
                                         to the Listing, you along with other Directors of the Board, are to meet when possible
                                         in executive session, where such sessions should occur at least four times a year. Additionally,
                                         you are to meet with other INEDs without executive management at least twice a year.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 54.3pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 21.3pt; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 33pt; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)</FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Additionally,
                                         you may be sought within reason, to engage in ad hoc strategic discussions that may require
                                         you reviewing and execution of documents pertinent to Board decisions. Such meetings
                                         shall take place in person, or by telephone conferencing, at a sensible time of day in
                                         relation to your primary place of residence.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 54.3pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 21.3pt; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 33pt; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(f)</FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">You
                                         shall not directly be responsible for the management of the Company. Your role is neither
                                         operational nor managerial in nature however; members of the Executive Board may draw
                                         upon your professional insight and business expertise where suitable. You shall provide
                                         guidance, steering, and access of expert networks to the Company where appropriate and
                                         required.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 21.3pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 21.3pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
the Chair and/or member of the said Committees described in Clause 2(b):</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 54.3pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 21.3pt; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 33pt; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(g)</FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">You
                                         shall review and uphold the functions of your relevant committee(s) as pursuant to individually
                                         adopted Audit, Compensation, and Nominating and Corporate Governance Committee Charters
                                         (&ldquo;Charters&rdquo;) that shall be made available to you upon a practical date subsequent
                                         to your Appointment and before the Listing.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 54.3pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 21.3pt; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 33pt; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(h)</FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">You
                                         must along with other Committee members, review annually and assess the adequacy of the
                                         same said Charters.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 54.3pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 21.3pt; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 33pt; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)</FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">You
                                         must along with other Committee members, ensure compliance with Nasdaq listing rules
                                         at all times subsequent to the Listing with respect to Committee composition requirements,
                                         and assist the Company in regaining compliance if required by curing the event that caused
                                         failure to comply within the time frame provided by the Nasdaq Regulatory Authority.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 21.3pt; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 33pt; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(j)</FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">You
                                         must refrain from accepting any direct or indirect consulting, advisory, or other compensatory
                                         fee from the Company or the Group subsequent to the Listing, other than fees for director
                                         service as described more fully below in Clause 5.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 54.3pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 21.3pt; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 33pt; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(k)</FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Additionally
                                         as an Audit Committee member, you must refrain from participating in preparation of financial
                                         statements of the Company or the Group. However, along with other members you shall be
                                         directly responsible for appointing and terminating the Company&rsquo;s independent auditor(s).</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 54.3pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 21.3pt; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 33pt; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(l)</FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">You
                                         shall maintain your financial literacy and expertise requirements in order to maintain
                                         your individual financial sophistication and qualify as an Audit Committee member.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 54.3pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 54.3pt; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 3; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 54.3pt; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><IMG SRC="ex10-11_001.jpg" ALT=""></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Aptorum Group Limited</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Unit B, 17/F Guangdong Investment Tower,
148 Connaught Road Central, Hong Kong</P>

<P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">Tel: (852) 2117 6611 &#9679; Fax: (852) 2850 7286</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 54.3pt; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 21.3pt; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 33pt; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(m)</FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">You
                                         shall assist the Audit Committee in review of related person transactions and conducting
                                         oversight for potential conflict of interest situations on an ongoing basis, and more
                                         generally, oversight with respect to the code of conduct compliance by senior management
                                         of the Company.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 54.3pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 21.3pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Additionally,
you shall during the Term of your Appointment:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.75in; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)</FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Observe
                                         and comply with the Company&rsquo;s adopted Code of Business Conduct and Ethics, where
                                         that any waivers given to directors or executive officers must be approved by the Board.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.75in; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)</FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Observe
                                         and comply with all statutory rules, and regulations where applicable as governed by
                                         the laws of your residence;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.75in; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii)</FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Confirm
                                         you are able to, and will devote sufficient time to perform your Roles.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.75in; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iv)</FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Provide
                                         traceable contact during and after office hours, on weekdays and weekends, or during
                                         public holidays, whereby your availability may occasionally and reasonably be sought.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.75in; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(v)</FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Declare
                                         any conflicts that are apparent at present, or become apparent, between the Group and
                                         your other business interests. Should any potential conflicts of interest arise, you
                                         will disclose this to the Board as soon as they become apparent.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.75in; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(vi)</FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Consult
                                         with the Chairman of the Board prior to accepting any other (or further) directorships
                                         of publicly quoted companies or any major external appointments.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.75in; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(vii)</FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Obtain
                                         clearance from the Chairman of the Board prior to dealing in publicly traded shares in
                                         the Company subsequent to the Listing.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.75in; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(viii)</FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Observe
                                         and comply with the disclosure requirements and obligations of you and/or your affiliated
                                         party(s) as applicable in accordance with U.S. securities laws, regulations and SEC disclosure
                                         requirements.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 21.25pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.25in; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>5.</B></FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Fees
                                         and Expenses</B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.25in; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                         combined basic fee for being an INED of the Company and your roles as chair and/or member
                                         of relevant Committees is <B>USD 30,000 per annum</B> (U.S. Dollars Thirty Thousand),
                                         paid to you by the Company in arrears in twelve monthly installments on or about the
                                         last business day of each month.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.25in; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">You
                                         will be entitled to bonus during the Appointment and entitled to participate in any share
                                         plan operated by the Company. You will also be entitled to an increase in basic fees
                                         during the Appointment. For the avoidance of doubt, your entitlement as stated in this
                                         paragraph is in relation to your capacity as independent non-executive director only.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 4; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><IMG SRC="ex10-11_001.jpg" ALT=""></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Aptorum Group Limited</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Unit B, 17/F Guangdong Investment Tower,
148 Connaught Road Central, Hong Kong</P>

<P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">Tel: (852) 2117 6611 &#9679; Fax: (852) 2850 7286</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.25in; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)</FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                         Company will reimburse all reasonable travelling, hotel and other expenses incurred by
                                         you in connection with the Company&rsquo;s business on production of appropriate receipts.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 22.5pt; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>6.</B></FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Privacy
                                         of Information</B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 28.35pt; text-align: justify; text-indent: -28.35pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.25in; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">You
                                         shall not except as authorized by the Group or required by your responsibilities reveal
                                         to any person or company any of the trade secrets or any information concerning the organization,
                                         business, finances, transactions or affairs of the Group which may come to your knowledge
                                         during your contract with the Company and shall keep with complete secrecy confidential
                                         information entrusted to you and shall not use or attempt to use any such information
                                         in any manner which may injure or cause loss either directly or indirectly to the Group
                                         or may be likely to do so. This restriction shall continue to apply if and when after
                                         the termination of your appointment without limit in time.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.25in; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">You
                                         shall not either during the period of your Appointment or afterwards use or permit to
                                         be used any books, documents, moneys, assets, records or other property belonging to
                                         or relating to any dealings, affair or business of the Group other than for the benefit
                                         of the Group. You shall immediately deliver and return to the Group all such books, documents,
                                         moneys, securities, records or other property which you then have or should have in your
                                         possession upon termination of your Appointment hereunder.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.25in; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)</FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                         Company however, agrees to provide you in good faith with any information concerning
                                         areas of interest and relevance of the Group as required by you in order to enable you
                                         to fulfill your Roles with the Company.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.25in; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>7.</B></FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Data
                                         Protection</B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 22.5pt; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 31.5pt; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By
                                         executing this letter, you consent to the Company holding and processing information
                                         about you for legal, personnel, administrative, and management purposes and in particular
                                         to the processing of any sensitive personal data as and when appropriate.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 22.5pt; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 31.5pt; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">You
                                         consent to the transfer of such personal information to other offices the Company may
                                         have or to other third parties for administrative purposes and other purposes in connection
                                         with the Appointment, where it is necessary or desirable to do so.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.25in; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>8.</B></FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Insurance
                                         and Indemnity</B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company shall establish directors&rsquo; and officers&rsquo; liability coverage and it is intended to maintain such coverage for
the full Term of the Appointment.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 5; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><IMG SRC="ex10-11_001.jpg" ALT=""></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Aptorum Group Limited</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Unit B, 17/F Guangdong Investment Tower,
148 Connaught Road Central, Hong Kong</P>

<P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">Tel: (852) 2117 6611 &#9679; Fax: (852) 2850 7286</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.25in; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>9.</B></FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Termination</B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 28.35pt; text-align: justify; text-indent: -28.35pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 22.5pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Your
Appointment with respect to the Roles with the Company may only be terminated:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 28.35pt; text-align: justify; text-indent: -28.35pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 22.5pt; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 31.5pt; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By
                                         you after giving the Company not less than two (2) months&rsquo; notice in writing;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 22.5pt; text-align: justify; text-indent: -22.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 22.5pt; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 31.5pt; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By
                                         the Company after giving you two (2) months&rsquo; notice in writing; or</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 22.5pt; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 31.5pt; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)</FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By
                                         the Company with immediate effect in the event that you:</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 54.3pt; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 35.7pt; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)</FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Conduct
                                         dishonesty, fraud, gross negligence, willful default or refusal to carry out any lawful
                                         order or instructions, or the repeated breach of any rules or regulations of the Company,
                                         or those as governed by the laws of your residency;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 54.3pt; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 35.7pt; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)</FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Commit
                                         a material breach of your obligations under this letter;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 54.3pt; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 35.7pt; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii)</FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Commit
                                         any serious or repeated breach or non-observance of your obligations to the Company;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 54.3pt; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 35.7pt; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iv)</FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Are
                                         convicted of a criminal offence other than an offence under road traffic legislation
                                         in the jurisdiction of your residency or elsewhere for which a fine or non-custodial
                                         penalty is imposed;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 54.3pt; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 35.7pt; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(v)</FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Declare
                                         bankruptcy or have made an arrangement with or for the benefit of your creditors; or</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 54.3pt; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 35.7pt; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(vi)</FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Are
                                         disqualified from acting as a director.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Please
signify your acceptance of the above terms and conditions by signing and returning to us the enclosed duplicate copy of this letter.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Yours
faithfully, &#9;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
and on behalf of</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B></B></FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 40%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>APTORUM GROUP LIMITED</B></FONT></TD>
    <TD STYLE="width: 20%; text-align: justify">&nbsp;</TD>
    <TD STYLE="width: 40%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Agreed and accepted by:</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left; border-bottom: Black 1.5pt solid">&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: left; border-bottom: Black 1.5pt solid">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Name: Huen Chung Yuen Ian</FONT></TD>
    <TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Name: Wu Che Yuen Justin</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Position: Director</FONT></TD>
    <TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left; border-bottom: Black 1.5pt solid">&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: left; border-bottom: Black 1.5pt solid">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Date</FONT></TD>
    <TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Date</FONT></TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>



<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"></P>

<!-- Field: Page; Sequence: 6; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"></P>

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.13
<SEQUENCE>17
<FILENAME>ff12018ex10-13_aptorum.htm
<DESCRIPTION>EMPLOYMENT AGREEMENT BETWEEN THE COMPANY AND DOUGLAS ARNER (INDEPENDENT NON-EXECUTIVE DIRECTOR), DATED FEBRUARY 13, 2018
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif; text-align: right"><B>Exhibit 10.13</B></P>

<P STYLE="margin-top: 0; text-align: center; margin-bottom: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;</FONT></P>

<P STYLE="margin-top: 0; text-align: center; margin-bottom: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;<IMG SRC="ex10-12_001.jpg" ALT=""></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Aptorum Group Limited</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Unit B, 17/F Guangdong Investment Tower,
148 Connaught Road Central, Hong Kong</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Tel: (852) 2117 6611 &#9679; Fax: (852) 2850
7286</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">13
February 2018</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Attn:
Prof. Douglas W. Arner</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dear
Prof. Arner,</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Appointment
Letter for Independent Non-Executive Director</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
are pleased and welcome your acceptance to be appointed as an Independent Non-Executive Director of Aptorum Group Limited (the
&ldquo;Company&rdquo;), a company incorporated with limited liabilities under the laws of the Cayman Islands, with wholly owned
subsidiaries in the Cayman Islands, Hong Kong, and Macau, whereby collectively, shall be depicted as &ldquo;Aptorum&rdquo; or
the &ldquo;Group&rdquo;.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following letter seeks to illustrate the context of your appointment by the Company, and the terms and conditions as set out herewith.
It is agreed that on acceptance of this offer, this letter will constitute a contract for services and not a contract of employment.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
the purposes of independence, this letter will supersede all previous appointment contract or agreement, if applicable, entered
into between yourself and the Company (or its affiliated subsidiaries). By signing this letter and therefore accepting the appointment
as stated, you agree to terminate all other previous appointments with the Group commencing from the Effective Date.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 22.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>1.</B></FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>The
                                         Company and the Group</B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Aptorum
focuses on the licensing of, and acquisition of early stage preclinical assets with the intention to engage in drug research,
development, and commercialization purposes. Assets are acquired via open and public platforms such as the technology transfer
offices of accredited universities and academic institutions. In addition, the Group seeks to be a facilitator across the financing
spectrum for biotech companies, entrepreneurs, and commercializing agents, to bolster innovations adding value to health care
needs in the marketplace; and to assist in furthering the research capabilities of institutions the Group works with.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company is a privately held company that has engaged in plans to pursue an initial public offering on the Nasdaq Global Market
in the near future (<B>the &ldquo;Listing&rdquo;</B>).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;<B>&nbsp;</B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>2.</B></FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Appointment</B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">You
                                         will be nominated by the Nominating Committee and appointed by the Board of Directors
                                         of the Company (the &ldquo;Board&rdquo;) to act as an <B>Independent Non-Executive Director
                                         (&ldquo;INED&rdquo;)</B> of the Company.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT>&nbsp;&nbsp;</P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;<IMG SRC="ex10-12_001.jpg" ALT=""></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Aptorum Group Limited</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Unit B, 17/F Guangdong Investment Tower,
148 Connaught Road Central, Hong Kong</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Tel: (852) 2117 6611 &#9679; Fax: (852) 2850
7286</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">You
                                         shall agree to being appointed by the Board as a member and/or chair of the following
                                         committees:</FONT></TD></TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.75in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 18pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a.</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Chair
                                         and member</B> of the Nominating and Corporate Governance Committee;</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.75in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 18pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">b.</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Member
                                         </B>of the Audit Committee; and</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.75in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 18pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">c.</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Member
                                         </B>of the Compensation Committee;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 39.3pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Whereby
all three committees shall collectively be depicted as the &ldquo;Committees&rdquo;; and roles for (a) and (b) shall collectively
be described as the &ldquo;Appointment&rdquo; or &ldquo;Roles&rdquo;.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                         Appointment is subject to the Company&rsquo;s Memorandum and Articles of Association
                                         (&quot;Articles&quot;) and nothing in this letter shall be taken to exclude or vary the
                                         terms of the Articles as they apply to your Appointment.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                         continuation of the Appointment is contingent to your ongoing fulfillment of your obligations
                                         and successful re-election by the Company&rsquo;s shareholders at the Company&rsquo;s
                                         Annual General Meeting (the &ldquo;AGM&rdquo;). It is further subject to your agreement
                                         to apply yourself and discharge your duties as a Non-Executive Director in accordance
                                         with the Articles of the Company and the Cayman Islands Company Law (2016 Revision) (as
                                         amended) (&quot;Company Law&quot;), as well as you upholding the high standards of corporate
                                         governance as set forth in the Nasdaq Listing Rule 5600 Series subsequent to the Listing.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>3.</B></FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Date
                                         of Commencement and Term</B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 21.25pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
official commencement date of your Appointment shall be on <B>1 March 2018</B> (the &ldquo;Effective Date&rdquo;), or as mutually
agreed upon between yourself and the Executive Board of Directors of the Company. The Term of this Appointment shall be <B>3 years
</B>from the Effective Date and subject to the terms of Termination and the re-election by the Company&rsquo;s shareholders at
the AGM as set forth in 2(d) herein above.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;&nbsp;</B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>4.</B></FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Duties
                                         and Responsibilities</B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
an INED of the Company:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">You
                                         have the same general legal responsibilities to the Company as any other Director and
                                         will advise where necessary, the Executive Board of Directors of the Company.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 54.3pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">You
                                         will exercise your powers of your Appointment having regard to the relevant obligations
                                         under prevailing law and regulation, including the Cayman Islands Company Law, and while
                                         in pursuit of and subsequent to the Listing, also the rules stipulated by the Nasdaq
                                         Regulatory Authority; including but not limited to the Listing Rule 5600 Series.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 54.3pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">You
                                         shall remain mindful and ensure your status of independence remains compliant as stipulated
                                         by requirements of Nasdaq Rule 5605(a)(2) and Securities Exchange Act Rule 10A-3. Should
                                         your independent status cease to remain compliant, you must notify the Board of the Company
                                         of such said change as soon as practical, and if subsequent to the Listing, notification
                                         must additionally be made to Nasdaq no later than the sooner of (i) the next annual shareholders
                                         meeting or (ii) one year from occurrence of the event causing failure to comply. You
                                         shall further facilitate any director independence disclosures in annual meeting proxy
                                         statements or annual report on Form 6-K, including transactions and arrangements considered
                                         by the Board in assessing director independence.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 54.3pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT>&nbsp;</P>

<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;<IMG SRC="ex10-12_001.jpg" ALT=""></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Aptorum Group Limited</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Unit B, 17/F Guangdong Investment Tower,
148 Connaught Road Central, Hong Kong</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Tel: (852) 2117 6611 &#9679; Fax: (852) 2850
7286</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Subsequent
                                         to the Listing, you along with other Directors of the Board, are to meet when possible
                                         in executive session, where such sessions should occur at least four times a year. Additionally,
                                         you are to meet with other INEDs without executive management at least twice a year.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 54.3pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Additionally,
                                         you may be sought within reason, to engage in ad hoc strategic discussions that may require
                                         you reviewing and execution of documents pertinent to Board decisions. Such meetings
                                         shall take place in person, or by telephone conferencing, at a sensible time of day in
                                         relation to your primary place of residence.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 54.3pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(f)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">You
                                         shall not directly be responsible for the management of the Company. Your role is neither
                                         operational nor managerial in nature however; members of the Executive Board may draw
                                         upon your professional insight and business expertise where suitable. You shall provide
                                         guidance, steering, and access of expert networks to the Company where appropriate and
                                         required.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
the Chair and/or member of the said Committees described in Clause 2(b):</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 54.3pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(g)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">You
                                         shall review and uphold the functions of your relevant committee(s) as pursuant to individually
                                         adopted Audit, Compensation, and Nominating and Corporate Governance Committee Charters
                                         (&ldquo;Charters&rdquo;) that shall be made available to you upon a practical date subsequent
                                         to your Appointment and before the Listing.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 54.3pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(h)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">You
                                         must along with other Committee members, review annually and assess the adequacy of the
                                         same said Charters.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 54.3pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">You
                                         must along with other Committee members, ensure compliance with Nasdaq listing rules
                                         at all times subsequent to the Listing with respect to Committee composition requirements,
                                         and assist the Company in regaining compliance if required by curing the event that caused
                                         failure to comply within the time frame provided by the Nasdaq Regulatory Authority.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(j)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">You
                                         must refrain from accepting any direct or indirect consulting, advisory, or other compensatory
                                         fee from the Company or the Group subsequent to the Listing, other than fees for director
                                         service as described more fully below in Clause 5.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 54.3pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(k)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Additionally
                                         as an Audit Committee member, you must refrain from participating in preparation of financial
                                         statements of the Company or the Group. However, along with other members you shall be
                                         directly responsible for appointing and terminating the Company&rsquo;s independent auditor(s).</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 54.3pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;</FONT></P>

<!-- Field: Page; Sequence: 3; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;<IMG SRC="ex10-12_001.jpg" ALT=""></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Aptorum Group Limited</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Unit B, 17/F Guangdong Investment Tower,
148 Connaught Road Central, Hong Kong</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Tel: (852) 2117 6611 &#9679; Fax: (852) 2850
7286</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(l)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">You
                                         shall maintain your financial literacy and expertise requirements in order to maintain
                                         your individual financial sophistication and qualify as an Audit Committee member.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 54.3pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(m)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">You
                                         shall assist the Audit Committee in review of related person transactions and conducting
                                         oversight for potential conflict of interest situations on an ongoing basis, and more
                                         generally, oversight with respect to the code of conduct compliance by senior management
                                         of the Company.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 54.3pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Additionally,
you shall during the Term of your Appointment:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.75in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Observe
                                         and comply with the Company&rsquo;s adopted Code of Business Conduct and Ethics, where
                                         that any waivers given to directors or executive officers must be approved by the Board.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.75in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Observe
                                         and comply with all statutory rules, and regulations where applicable as governed by
                                         the laws of your residence;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.75in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Confirm
                                         you are able to, and will devote sufficient time to perform your Roles.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.75in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iv)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Provide
                                         traceable contact during and after office hours, on weekdays and weekends, or during
                                         public holidays, whereby your availability may occasionally and reasonably be sought.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.75in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(v)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Declare
                                         any conflicts that are apparent at present, or become apparent, between the Group and
                                         your other business interests. Should any potential conflicts of interest arise, you
                                         will disclose this to the Board as soon as they become apparent.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.75in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(vi)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Consult
                                         with the Chairman of the Board prior to accepting any other (or further) directorships
                                         of publicly quoted companies or any major external appointments.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.75in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(vii)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Obtain
                                         clearance from the Chairman of the Board prior to dealing in publicly traded shares in
                                         the Company subsequent to the Listing.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.75in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(viii)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Observe
                                         and comply with the disclosure requirements and obligations of you and/or your affiliated
                                         party(s) as applicable in accordance with U.S. securities laws, regulations and SEC disclosure
                                         requirements.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>5.</B></FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Fees
                                         and Expenses</B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                         combined basic fee for being an INED of the Company and your roles as chair and/or member
                                         of relevant Committees is <B>USD 30,000 per annum</B> (U.S. Dollars Thirty Thousand),
                                         paid to you by the Company in arrears in twelve monthly installments on or about the
                                         last business day of each month.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">You
                                         will be entitled to bonus during the Appointment and entitled to participate in any share
                                         plan operated by the Company. You will also be entitled to an increase in basic fees
                                         during the Appointment. For the avoidance of doubt, your entitlement as stated in this
                                         paragraph is in relation to your capacity as independent non-executive director only.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;</FONT></P>

<!-- Field: Page; Sequence: 4; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;<IMG SRC="ex10-12_001.jpg" ALT=""></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Aptorum Group Limited</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Unit B, 17/F Guangdong Investment Tower,
148 Connaught Road Central, Hong Kong</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Tel: (852) 2117 6611 &#9679; Fax: (852)
2850 7286</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                         Company will reimburse all reasonable travelling, hotel and other expenses incurred by
                                         you in connection with the Company&rsquo;s business on production of appropriate receipts.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;&nbsp;</B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 22.5pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>6.</B></FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Privacy
                                         of Information</B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 28.35pt; text-align: justify; text-indent: -28.35pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">You
                                         shall not except as authorized by the Group or required by your responsibilities reveal
                                         to any person or company any of the trade secrets or any information concerning the organization,
                                         business, finances, transactions or affairs of the Group which may come to your knowledge
                                         during your contract with the Company and shall keep with complete secrecy confidential
                                         information entrusted to you and shall not use or attempt to use any such information
                                         in any manner which may injure or cause loss either directly or indirectly to the Group
                                         or may be likely to do so. This restriction shall continue to apply if and when after
                                         the termination of your appointment without limit in time.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">You
                                         shall not either during the period of your Appointment or afterwards use or permit to
                                         be used any books, documents, moneys, assets, records or other property belonging to
                                         or relating to any dealings, affair or business of the Group other than for the benefit
                                         of the Group. You shall immediately deliver and return to the Group all such books, documents,
                                         moneys, securities, records or other property which you then have or should have in your
                                         possession upon termination of your Appointment hereunder.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                         Company however, agrees to provide you in good faith with any information concerning
                                         areas of interest and relevance of the Group as required by you in order to enable you
                                         to fulfill your Roles with the Company.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>7.</B></FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Data
                                         Protection</B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 22.5pt; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 31.5pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By
                                         executing this letter, you consent to the Company holding and processing information
                                         about you for legal, personnel, administrative, and management purposes and in particular
                                         to the processing of any sensitive personal data as and when appropriate.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 22.5pt; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 31.5pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">You
                                         consent to the transfer of such personal information to other offices the Company may
                                         have or to other third parties for administrative purposes and other purposes in connection
                                         with the Appointment, where it is necessary or desirable to do so.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>8.</B></FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Insurance
                                         and Indemnity</B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company shall establish directors&rsquo; and officers&rsquo; liability coverage and it is intended to maintain such coverage for
the full Term of the Appointment.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;</FONT></P>

<!-- Field: Page; Sequence: 5; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;<IMG SRC="ex10-12_001.jpg" ALT=""></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Aptorum Group Limited</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Unit B, 17/F Guangdong Investment Tower,
148 Connaught Road Central, Hong Kong</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Tel: (852) 2117 6611 &#9679; Fax: (852)
2850 7286<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>9.</B></FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Termination</B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 28.35pt; text-align: justify; text-indent: -28.35pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Your
Appointment with respect to the Roles with the Company may only be terminated:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 28.35pt; text-align: justify; text-indent: -28.35pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By
                                         you after giving the Company not less than two (2) months&rsquo; notice in writing;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 22.5pt; text-align: justify; text-indent: -22.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By
                                         the Company after giving you two (2) months&rsquo; notice in writing; or</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By
                                         the Company with immediate effect in the event that you:</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.75in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Conduct
                                         dishonesty, fraud, gross negligence, willful default or refusal to carry out any lawful
                                         order or instructions, or the repeated breach of any rules or regulations of the Company,
                                         or those as governed by the laws of your residency;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.75in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Commit
                                         a material breach of your obligations under this letter;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.75in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Commit
                                         any serious or repeated breach or non-observance of your obligations to the Company;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.75in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iv)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Are
                                         convicted of a criminal offence other than an offence under road traffic legislation
                                         in the jurisdiction of your residency or elsewhere for which a fine or non-custodial
                                         penalty is imposed;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.75in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(v)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Declare
                                         bankruptcy or have made an arrangement with or for the benefit of your creditors; or</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.75in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(vi)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Are
                                         disqualified from acting as a director.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Please
signify your acceptance of the above terms and conditions by signing and returning to us the enclosed duplicate copy of this letter.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Yours
faithfully, &#9;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 49%"><FONT STYLE="font-size: 10pt">For and on behalf of</FONT></TD>
    <TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 49%">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt"><B>APTORUM GROUP LIMITED</B></FONT></TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">Agreed and accepted by:</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="border-bottom: Black 1.5pt solid">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt">Name: Huen Chung Yuen Ian</FONT></TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">Name: Douglas W. Arner</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt">Position: Director</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="border-bottom: Black 1.5pt solid">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt">Date</FONT></TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">Date</FONT></TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">6</P>



<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"></P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 0; margin-bottom: 0"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.14
<SEQUENCE>18
<FILENAME>ff12018ex10-14_aptorum.htm
<DESCRIPTION>MANAGEMENT AGREEMENT BETWEEN THE COMPANY AND GUARDIAN CAPITAL MANAGEMENT LIMITED, DATED MARCH 1, 2017
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif; text-align: right"><B>Exhibit 10.14<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></B></P>

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">Deacons D3: 22.03 2017</P>

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif; text-align: right">&nbsp;<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>DATED&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2017</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>APTUS
HOLDINGS LIMITED</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>GUARDIAN
CAPITAL MANAGEMENT LIMITED</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>MANAGEMENT
AGREEMENT</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Deacons
</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5<SUP>th
</SUP>Floor</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Alexandra
House</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">18
Chater Road</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Central</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Hong
Kong</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Fax
: +852 2810 0431</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Tel
: +852 2825 9211</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<DIV STYLE="margin-right: 70.95pt; margin-left: 70.9pt; padding: 1pt 4pt; border: Black 1.5pt double; font: 10pt Times New Roman, Times, Serif"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&copy;
Copyright Deacons March, 2017</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>All
rights reserved. Not to be reproduced without prior permission.</I></FONT></P>

</DIV>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;</FONT></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">Deacons D3: 22.03 2017</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>TABLE
OF CONTENTS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;&nbsp;</B></FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 8%; text-align: justify"><B>Clause</B></TD>
    <TD STYLE="width: 80%; text-align: justify"><B>Heading</B></TD>
    <TD STYLE="width: 12%; text-align: center; border-bottom: Black 1.5pt solid"><B>Page <BR>
Number</B></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="text-transform: uppercase; font-weight: bold"><FONT STYLE="font-weight: normal">1.</FONT></TD>
    <TD STYLE="text-transform: uppercase; font-weight: bold">INTERPRETATION</TD>
    <TD STYLE="text-align: center; text-transform: uppercase; font-weight: bold">1</TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD STYLE="text-transform: uppercase; font-weight: bold"><FONT STYLE="font-weight: normal">2.</FONT></TD>
    <TD STYLE="text-transform: uppercase; font-weight: bold">APPOINTMENT OF THE MANAGER</TD>
    <TD STYLE="text-align: center; text-transform: uppercase; font-weight: bold">2</TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="text-transform: uppercase; font-weight: bold"><FONT STYLE="font-weight: normal">3.</FONT></TD>
    <TD STYLE="text-transform: uppercase; font-weight: bold">FUNCTIONS, POWERS AND OBLIGATIONS OF THE MANAGER</TD>
    <TD STYLE="text-align: center; text-transform: uppercase; font-weight: bold">3</TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD STYLE="text-transform: uppercase; font-weight: bold"><FONT STYLE="font-weight: normal">4.</FONT></TD>
    <TD STYLE="text-transform: uppercase; font-weight: bold">CONTINUATION AND EXERCISE OF MANAGER'S POWERS</TD>
    <TD STYLE="text-align: center; text-transform: uppercase; font-weight: bold">5</TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="text-transform: uppercase; font-weight: bold"><FONT STYLE="font-weight: normal">5.</FONT></TD>
    <TD STYLE="text-transform: uppercase; font-weight: bold">FEES OF THE MANAGER</TD>
    <TD STYLE="text-align: center; text-transform: uppercase; font-weight: bold">5</TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD STYLE="text-transform: uppercase; font-weight: bold"><FONT STYLE="font-weight: normal">6.</FONT></TD>
    <TD STYLE="text-transform: uppercase; font-weight: bold">EXPENSES</TD>
    <TD STYLE="text-align: center; text-transform: uppercase; font-weight: bold">5</TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="text-transform: uppercase; font-weight: bold"><FONT STYLE="font-weight: normal">7.</FONT></TD>
    <TD STYLE="text-transform: uppercase; font-weight: bold">SERVICES OF THE MANAGER NOT TO BE EXCLUSIVE</TD>
    <TD STYLE="text-align: center; text-transform: uppercase; font-weight: bold">6</TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD STYLE="text-transform: uppercase; font-weight: bold"><FONT STYLE="font-weight: normal">8.</FONT></TD>
    <TD STYLE="text-transform: uppercase; font-weight: bold">POWER OF DELEGATION</TD>
    <TD STYLE="text-align: center; text-transform: uppercase; font-weight: bold">7</TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="text-transform: uppercase; font-weight: bold"><FONT STYLE="font-weight: normal">9.</FONT></TD>
    <TD STYLE="text-transform: uppercase; font-weight: bold">CONFLICTS OF INTEREST</TD>
    <TD STYLE="text-align: center; text-transform: uppercase; font-weight: bold">7</TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD STYLE="text-transform: uppercase; font-weight: bold"><FONT STYLE="font-weight: normal">10.</FONT></TD>
    <TD STYLE="text-transform: uppercase; font-weight: bold">LIABILITY OF THE MANAGER</TD>
    <TD STYLE="text-align: center; text-transform: uppercase; font-weight: bold">9</TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="text-transform: uppercase; font-weight: bold"><FONT STYLE="font-weight: normal">11.</FONT></TD>
    <TD STYLE="text-transform: uppercase; font-weight: bold">LEGAL ACTION BY THE MANAGER</TD>
    <TD STYLE="text-align: center; text-transform: uppercase; font-weight: bold">10</TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD STYLE="text-transform: uppercase; font-weight: bold"><FONT STYLE="font-weight: normal">12.</FONT></TD>
    <TD STYLE="text-transform: uppercase; font-weight: bold">ASSIGNMENT</TD>
    <TD STYLE="text-align: center; text-transform: uppercase; font-weight: bold">11</TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="text-transform: uppercase; font-weight: bold"><FONT STYLE="font-weight: normal">13.</FONT></TD>
    <TD STYLE="text-transform: uppercase; font-weight: bold">RESIGNATION AND TERMINATION</TD>
    <TD STYLE="text-align: center; text-transform: uppercase; font-weight: bold">11</TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD STYLE="text-transform: uppercase; font-weight: bold"><FONT STYLE="font-weight: normal">14.</FONT></TD>
    <TD STYLE="text-transform: uppercase; font-weight: bold">CONFIDENTIALITY AND REPUTATION</TD>
    <TD STYLE="text-align: center; text-transform: uppercase; font-weight: bold">12</TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="text-transform: uppercase; font-weight: bold"><FONT STYLE="font-weight: normal">15.</FONT></TD>
    <TD STYLE="text-transform: uppercase; font-weight: bold">MISCELLANEOUS PROVISIONS</TD>
    <TD STYLE="text-align: center; text-transform: uppercase; font-weight: bold">12</TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD STYLE="text-transform: uppercase; font-weight: bold"><FONT STYLE="font-weight: normal">16.</FONT></TD>
    <TD STYLE="text-transform: uppercase; font-weight: bold">NOTICES</TD>
    <TD STYLE="text-align: center; text-transform: uppercase; font-weight: bold">13</TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="text-transform: uppercase; font-weight: bold"><FONT STYLE="font-weight: normal">17.</FONT></TD>
    <TD STYLE="text-transform: uppercase; font-weight: bold">LAW OF THE CONTRACT</TD>
    <TD STYLE="text-align: center; text-transform: uppercase; font-weight: bold">13</TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD STYLE="text-transform: uppercase; font-weight: bold"><FONT STYLE="font-weight: normal; font-style: normal">18.</FONT></TD>
    <TD STYLE="text-transform: uppercase; font-weight: bold">EXCLUSION OF THIRD PARTY RIGHTS</TD>
    <TD STYLE="text-align: center; text-transform: uppercase; font-weight: bold">13</TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD COLSPAN="2" STYLE="text-transform: uppercase; font-weight: bold">Schedule 1 &ndash; Investment Guidelines </TD>
    <TD STYLE="text-align: center; text-transform: uppercase; font-weight: bold">15</TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD COLSPAN="2" STYLE="text-transform: uppercase; font-weight: bold">Schedule 2 &ndash; Remuneration of the Manager </TD>
    <TD STYLE="text-align: center; text-transform: uppercase; font-weight: bold">16</TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 67.5pt; text-align: justify; text-indent: -67.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;<FONT STYLE="text-transform: none">&nbsp;&nbsp;</FONT></FONT></P>

<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-transform: uppercase">&nbsp;</P>

<P STYLE="font: normal 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-transform: uppercase; text-align: right"><FONT STYLE="font-weight: normal; font-style: normal">Deacons
D3: 22.03 2017</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-transform: uppercase">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 35%; font-size: 10pt"><B>AN AGREEMENT</B> made the</TD>
    <TD STYLE="width: 30%; font-size: 10pt; text-align: left">day of</TD>
    <TD STYLE="width: 35%; font-size: 10pt; text-align: left">2017.</TD></TR>
</TABLE>


<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-transform: uppercase"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>BETWEEN:-</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>APTUS
                                         HOLDINGS LIMITED</B> a company incorporated under the laws of the Cayman Islands whose
                                         registered office is at c/o Campbell Corporate Services Limited, Floor 4, Willow House,
                                         Cricket Square, Grand Cayman KY1-9010, Cayman Islands (the &ldquo;<B>Company</B>&rdquo;);
                                         and</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>GUARDIAN
                                         CAPITAL MANAGEMENT LIMITED</B> a company incorporated under the laws of Hong Kong whose
                                         principal place of business is at 17/F Guangdong Investment Tower, 148 Connaught Road
                                         Central, Hong Kong (the &ldquo;<B>Manager</B>&rdquo;).</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>WHEREBY
IT IS AGREED AND DECLARED</B> as follows:-</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">1.</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">INTERPRETATION</FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.1</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
                                         this Agreement the following words and expressions shall, where not inconsistent with
                                         the context, have the following meanings respectively:-</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 3.15in; text-align: justify; text-indent: -170.1pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in">&nbsp;</TD>
    <TD>&ldquo;<B>Articles</B>&rdquo;</TD>
    <TD STYLE="text-align: justify; width: 50%">means the Articles of Association for the time being of the Company and any reference herein to an Article shall be taken to refer to the Articles unless otherwise specified;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&ldquo;<B>Auditors</B>&rdquo;</TD>
    <TD STYLE="text-align: justify">means such entity for the time being acting as auditors of the Company;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&ldquo;<B>Effective Date</B>&rdquo;</TD>
    <TD STYLE="text-align: justify">means the date of execution of this Agreement, or such earlier or later date as agreed by the Company and the Manager;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&ldquo;<B>Investment Objective and Strategy</B>&rdquo;</TD>
    <TD>means the investment objectives and strategy of the Company as agreed between the Company and the Manager from time to time and set out in Schedule 1 attached to this Agreement;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&ldquo;<B>Investments</B>&rdquo;</TD>
    <TD STYLE="text-align: justify">means investments of any type held directly or indirectly by or on behalf of the Company;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&ldquo;<B>Investment Restrictions</B>&rdquo;</TD>
    <TD STYLE="text-align: justify">means the investment restrictions (if any) as agreed between the Company and the Manager and set out in Schedule 1 attached to this Agreement, within which the Investments must be managed;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&ldquo;<B>Laws</B>&rdquo;</TD>
    <TD STYLE="text-align: justify">means the laws of Hong Kong (including delegated legislation and regulations of any competent authority) and any other applicable laws and regulations for the time being in force;</TD></TR>
</TABLE>

<P STYLE="margin: 0">&nbsp;&nbsp;</P>

<!-- Field: Page; Sequence: 3; Options: NewSection; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --> -</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in">&nbsp;</TD>
    <TD>&ldquo;<B>Proper Instructions</B>&rdquo;</TD>
    <TD STYLE="text-align: justify; width: 50%">means written, faxed or e-mailed instructions in respect of any of the matters referred to in this Agreement signed or emailed or purporting to be signed or emailed by such one or more person or persons as the Company shall from time to time have authorised to give the particular class of instructions in question.&nbsp;&nbsp;In instances indicated in advance by the Company, the Manager may also act pursuant to telephonic instructions given by designated persons and such telephonic instructions shall be deemed to be &ldquo;Proper Instructions&rdquo; within the meaning of this definition.&nbsp;&nbsp;Different persons may be authorised to give instructions for different purposes and such persons may also include officers of corporations other than the Company so authorised by the Company.&nbsp;&nbsp;A certified copy of a resolution of the Company may be received and accepted by the Manager as conclusive evidence of the authority of any such person to act and may be considered as in full force and effect until receipt of written notice to the contrary;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&ldquo;<B>Securities</B>&rdquo;</TD>
    <TD STYLE="text-align: justify">means shares, debentures and other securities of any class issued by the Company, including, without limitation the Shares;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&ldquo;<B>Share</B>&rdquo;</TD>
    <TD STYLE="text-align: justify">means an ordinary share in the capital of the Company;</TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 3.15in; text-align: justify; text-indent: -170.1pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.2</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">References
                                         to Clauses are to Clauses of this Agreement.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.3</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                         headings to the Clauses of this Agreement are for convenience only and shall not affect
                                         the construction or interpretation thereof.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.4</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Unless
                                         the context otherwise requires words and expressions contained in this Agreement shall
                                         bear the same meaning as in the Articles PROVIDED THAT any alteration or amendment of
                                         the Articles shall not be effective for the purposes of this Agreement unless the party
                                         hereto affected (to the extent that its rights or duties hereunder are affected by such
                                         alteration or amendment) shall, by endorsement hereon or otherwise, have consented thereto.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.5</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">References
                                         to &ldquo;HK$&rdquo; and to &ldquo;HK dollars&rdquo; are to Hong Kong dollars, the lawful
                                         currency of Hong Kong.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">2.</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">APPOINTMENT
OF THE MANAGER</FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 191.25pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.1</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                         Company HEREBY APPOINTS the Manager and the Manager shall act with effect from the Effective
                                         Date as manager of the Company upon the terms hereinafter contained and in accordance
                                         with the Laws, the Articles, the Investment Objectives and Strategy and the Investment
                                         Restrictions until its appointment shall be terminated as hereinafter provided and the
                                         Manager hereby accepts such appointment and agrees to assume the obligations set forth
                                         herein.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;</FONT></P>

<!-- Field: Page; Sequence: 4; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --> -</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.2</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
                                         the purpose of carrying out its functions, powers and obligations stated herein, the
                                         Company hereby undertakes and agrees with the Manager that the Company will from time
                                         to time provide the latest editions of the documents relating to the Company, including
                                         but not limited to its Articles, all lawful resolutions of the Company and other lawful
                                         orders and discretions given to the Manager from time to time by the Company in the form
                                         of Proper Instructions and all other information documents or materials in its possession
                                         as may reasonably be necessary to enable the Manager to carry out its duties hereunder.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">3.</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>FUNCTIONS,
                                         POWERS AND OBLIGATIONS OF THE MANAGER</B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.1</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
                                         the continuance of its appointment the Manager shall (subject to the overall policy and
                                         supervision of the Company and subject to Clause 3.4) have full power, authority and
                                         right, either itself or wholly or in part through its authorised agents or delegates,
                                         to manage the investment and re-investment of the Investments with a view to achieving
                                         the then current Investment Objective and Strategy, to provide recommendations on the
                                         investment and business strategy of the Company, to manage all or a part of the general
                                         business, operations and administration of the Company, and to perform such other functions,
                                         duties, powers and discretions as may be required of the Manager under this Agreement
                                         and/or as may otherwise be agreed between the parties from time to time.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.2</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                         Manager shall keep or cause to be kept on behalf of the Company such books, records and
                                         statements expressed in such currencies as may be necessary to give a complete record
                                         of all transactions carried out by the Manager on behalf of the Company and such other
                                         books, records and statements as may be required by the Laws, the Articles and otherwise
                                         as may be agreed between the parties and shall permit the Company and its employees and
                                         agents and the Auditors to inspect such books, records and statements at all reasonable
                                         times.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.3</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Without
                                         limiting the generality of Clause 3.1, the Manager shall have and is hereby granted the
                                         authority, power and right for the account and/or in the name of the Company but subject
                                         to the supervision of the Company and the Laws:-</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.3.1</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">to
                                         issue orders and instructions with respect to the transfer or disposition of the Investments,
                                         moneys and other assets of the Company;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 113.4pt; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.3.2</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">to
                                         purchase (or otherwise acquire), sell (or otherwise dispose of) and invest in the Investments,
                                         moneys and other assets for the account of the Company and effect foreign exchange transactions
                                         on behalf of the Company and for the account of the Company in connection with any such
                                         purchase, other acquisition, sale or other disposal or the protection of the value of
                                         Investments;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 113.4pt; text-align: center; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.3.3</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">to
                                         take such steps as may be necessary or appropriate in relation to the Company&rsquo;s
                                         assets and rights (including for the protection or maintenance of intellectual property
                                         assets and other intangible assets), including without limitation, attending to any relevant
                                         filings, registrations and administrative or operational matters, taking legal proceedings
                                         against third parties and/or entering into and maintaining any relevant licences, permits
                                         or approvals for intellectual property assets;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 113.4pt; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;</FONT></P>

<!-- Field: Page; Sequence: 5; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --> -</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 113.4pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.3.4</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">to
                                         enter into, make and perform all contracts, agreements and other undertakings as may
                                         in the opinion of the Manager be necessary or advisable or incidental to the carrying
                                         out of its functions and duties under this Agreement in accordance with the rules, regulations
                                         and practices of relevant markets; and</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 113.4pt; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.3.5</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">to
                                         negotiate in accordance with the instructions of the Company all borrowing arrangements
                                         of the Company and to supervise the implementation of such arrangements.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 113.4pt; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.4</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                         Manager shall observe and comply with the Laws, the Articles and the Investment Restrictions
                                         and all lawful resolutions of the Company and other lawful orders and directions given
                                         to it from time to time by the Company in the form of Proper Instructions and all activities
                                         engaged in by the Manager hereunder shall at all times be subject to the control of and
                                         review by the Company and without limiting the generality of the foregoing the Company
                                         may from time to time:-</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.4.1</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">prohibit
                                         the Manager from investing in any Investment or in any currency or country or with any
                                         institution;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 113.4pt; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.4.2</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">require
                                         the Manager to sell or transfer any Investment or (subject to the availability of funds)
                                         to purchase any Investment;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 113.4pt; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.4.3</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">define
                                         the Investment Objective and Strategy of the Company and specify the manner in which
                                         it wishes the Manager to give effect to such policy within approved credit limits, provided
                                         that any changes to the Investment Objective and Strategy shall only be made with the
                                         approval of the Manager (such approval not to be unreasonably withheld);</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 113.4pt; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.4.4</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">withdraw
                                         from the management of the Manager money or other assets which up to the time of such
                                         withdrawal were being managed by the Manager;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 113.4pt; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.4.5</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">instruct
                                         the Manager as to the exercise of the rights attached to the Investments managed by the
                                         Manager; and</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 113.4pt; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.4.6</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">change
                                         the Investment Restrictions with the approval of the Manager (such approval not to be
                                         unreasonably withheld);</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 113.4pt; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">and
the Manager shall and shall procure that any person firm or company to whom it delegates any of its functions hereunder shall
give effect to all such decisions.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.5</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Subject
                                         to the terms of this Agreement, to such orders and directions as may from time to time
                                         be given by the Company and to the overall policy and supervision of the Company, in
                                         exercising its rights and carrying out its duties hereunder the Manager is authorised
                                         to act for the Company and on the Company's behalf either itself or wholly or in part
                                         through its authorised agents or delegates in the same manner and with the same force
                                         and effect as the Company might or could do.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;</FONT></P>

<!-- Field: Page; Sequence: 6; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --> -</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.6</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Where
                                         there are rights of voting conferred by relevant Investments, such voting rights shall
                                         be exercised in such manner as the Manager may determine (subject to the right of the
                                         Company to give instructions) and subject as aforesaid the Manager may in its discretion
                                         refrain from the exercise of such voting rights. The Company shall from time to time
                                         upon written request from the Manager execute and deliver or, if appropriate, cause to
                                         be executed and delivered, to the Manager or its nominees such powers of attorney or
                                         proxies authorising such attorney or proxies to exercise any rights conferred by, or
                                         otherwise act in respect of all or any part of the Investments.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.7</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                         Manager shall provide all necessary office facilities, equipment and personnel to enable
                                         it to carry out its functions hereunder and shall liaise with the Auditors and other
                                         service providers of the Company as reasonably required so as to enable them to perform
                                         their respective duties and obligations.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">4.</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>CONTINUATION
                                         AND EXERCISE OF MANAGER'S POWERS</B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.1</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                         authorities herein contained are continuing ones and shall remain in full force and effect
                                         until revoked by termination of this Agreement as hereinafter provided, but such revocation
                                         shall not affect any liability in any way resulting from transactions initiated prior
                                         to such revocation.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">5.</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">FEES
OF THE MANAGER</FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.1</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
                                         consideration of the performance of the Manager&rsquo;s services under this agreement,
                                         the Company agrees to pay to the Manager such fees as set out in Schedule 2 (as may be
                                         amended from time to time by the Company and the Manager).</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">6.</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">EXPENSES</FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.1</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">So
                                         far as permitted by the Laws the Company undertakes to pay or reimburse the Manager in
                                         respect of all the out-of-pocket expenses incurred by it, in the performance of its duties
                                         including (without limitation):-</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.1.1</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">all
                                         expenses of every nature of or incidental to deposits of cash made by the Company;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.1.2</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">any
                                         stamp and other duties, taxes, governmental charges, commissions, brokerage, transfer
                                         fees, registration or licensing fees and other charges payable in respect of the acquisition,
                                         licensing, developing, holding or realisation of any Investment, asset or right and any
                                         foreign exchange transactions carried out in connection therewith;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 112.5pt; text-align: justify; text-indent: -0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.1.3</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">all
                                         taxes and corporate fees payable by the Company to any government or official department,
                                         body or organisation or other authority or to any agency of such government, department,
                                         body or organisation or authority whether in the Cayman Islands or elsewhere;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 112.5pt; text-align: justify; text-indent: -0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;</FONT></P>

<!-- Field: Page; Sequence: 7; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --> -</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 112.5pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.1.4</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">all
                                         fees and expenses incurred in relation to the incorporation and initial organisation
                                         of the Company, the initial issue of its Securities, the listing of the Company on any
                                         exchange (including any restructuring or other actions taken in connection with such
                                         listing), the production, printing and distribution of any prospectuses or any placing
                                         or explanatory memorandum or any other similar document and the advertising and promotion
                                         generally of Securities of the Company;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.1.5</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">all
                                         expenses incurred or to be incurred in the alteration or amendment of the Articles and
                                         or the offering document (if any) of the Company including the costs of any meetings
                                         convened to sanction the same;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 112.5pt; text-align: justify; text-indent: -0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.1.6</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                         Manager's legal and professional expenses incurred in relation to the negotiation, preparation
                                         and settling of this Agreement and the proper performance of its duties hereunder and
                                         all legal and professional expenses necessarily incurred or to be incurred in the preparation
                                         of any documents amending the provisions of this Agreement;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.1.7</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">all
                                         audit fees of the Company and legal expenses in connection with the Company's corporate
                                         existence, corporate and financial structure and relations with its shareholders and
                                         third parties and all other professional and other charges in respect of services rendered
                                         to the Company at the request of the Company;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 112.5pt; text-align: justify; text-indent: -0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.1.8</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">interest
                                         on and charges and expenses of the Company of arranging, and arising out of, all borrowings
                                         made by the Company (if any);</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 112.5pt; text-align: justify; text-indent: -0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.1.9</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">all
                                         charges for postage, photocopy, telephone, printing, faxing and other communications
                                         charges incurred by the Manager in the proper performance of its duties hereunder;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.1.10</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                         fees and expenses of any service provider of the Company, and with the consent of the
                                         Company (not to be unreasonably withheld), any other person; and</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 112.5pt; text-align: justify; text-indent: -0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.1.11</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">all
                                         other expenses, costs, fees or charges paid by the Manager on behalf of the Company but
                                         so that the liability of the Company is limited to expenses authorised to be paid out
                                         of the assets of the Company by the applicable laws of its jurisdiction of incorporation.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">7.</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">SERVICES
OF THE MANAGER NOT TO BE EXCLUSIVE</FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">7.1</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                         services of the Manager to the Company hereunder are not to be deemed exclusive and the
                                         Manager shall be free to render similar services to others so long as its services hereunder
                                         are not impaired thereby and to retain for its own use and benefit all fees or other
                                         moneys payable thereby and the Manager shall not be deemed to be affected with notice
                                         of or to be under any duty to disclose to the Company any fact or thing which comes to
                                         the notice of the Manager or any servant or agent of the Manager in the course of the
                                         Manager rendering similar services to others or in the course of its business in any
                                         other capacity or in any manner whatsoever otherwise than in the course of carrying out
                                         its duties hereunder.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;</FONT></P>

<!-- Field: Page; Sequence: 8; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --> -</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">7.2</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
                                         connection with its activities hereunder, the Manager shall have no duty (a) to ascertain
                                         whether any director, officer or employee of the Manager possesses any information which
                                         has not been publicly disclosed and which, if generally known, might have significant
                                         impact on any decision whether to acquire, retain or dispose of or otherwise deal with
                                         any property in connection with this Agreement or (b) to take into account any such information
                                         in making a recommendation as to the sale or purchase of any Investments.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">8.</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">POWER
OF DELEGATION</FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8.1</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                         Manager shall have full power to delegate the whole or any part of its function hereunder
                                         to any person firm or company.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8.2</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                         Manager shall be entitled to obtain investment, management and other advice from such
                                         source or sources and on such terms as it thinks fit to perform its duties and obligations
                                         hereunder (including, without prejudice to the generality of the foregoing, full power
                                         to appoint one or more investment advisers, approved by the Company, to advise as to
                                         the investment and re-investment of the Investments).</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">9.</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">CONFLICTS
OF INTEREST</FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">9.1</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                         Manager will not and will procure that any of its Associated Persons (as defined below)
                                         and any person to whom it delegates investment management functions will not (a) deal
                                         with the Company as beneficial owner on the sale or purchase to or from the Company (except
                                         on a basis approved by the Company from time to time), or (b) without the consent of
                                         the Company otherwise deal with the Company as principal PROVIDED THAT:-</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">9.1.1</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                         Manager, any of its Associated Persons and/or any person to whom it delegates investment
                                         management functions (together, hereinafter called the &ldquo;interested party&rdquo;)
                                         may acquire or dispose of any investments upon its own account notwithstanding that the
                                         same or similar investments may be held by or for the account of or otherwise connected
                                         with the Company and nothing herein contained shall prevent an interested party from
                                         acquiring, holding or disposing of investments notwithstanding that such investments
                                         have been acquired at prices lower than those paid by or on behalf of the Company in
                                         respect of the acquisition of investments of the same class or disposed of at prices
                                         higher than those received by or on behalf of the Company by virtue of a transaction
                                         effected by the Company at or about the same time PROVIDED THAT the acquisition by an
                                         interested party of such investments is in accordance with the terms and conditions on
                                         which such investments have been offered or made available on an arm's length basis and
                                         the investments of the same class held by the Company were acquired on the best terms
                                         reasonably obtainable having regard to the interests of the Company;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 112.5pt; text-align: justify; text-indent: -0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">9.1.2</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">an
                                         interested party may become the owner of Securities and may hold, dispose or otherwise
                                         deal with the same as it thinks fit;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 112.5pt; text-align: justify; text-indent: -0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;</FONT></P>

<!-- Field: Page; Sequence: 9; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --> -</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 112.5pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">9.1.3</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">nothing
                                         herein contained shall prevent an interested party, in its capacity as agent for a third
                                         party, from selling investments to or vesting investments in the Company or from contracting
                                         or entering into any financial, banking, currency or other transaction with the Company
                                         or any investor(s) in the Company or any company or body any of whose securities are
                                         held by or for the account of or otherwise connected with the Company and the interested
                                         party shall not be called upon to account in respect of any such contract or transaction
                                         or benefit derived therefrom PROVIDED THAT nothing herein contained shall permit any
                                         such sale or vesting or the entering into of any such contract or transaction as aforesaid
                                         with the Company unless such transaction is on the best terms reasonably obtainable with
                                         reliable counterparties having regard to the interests of the Company or the size and
                                         nature of the transaction; and</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 112.5pt; text-align: justify; text-indent: -0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">9.1.4</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">nothing
                                         herein contained shall prevent an interested party from receiving any commissions which
                                         it may negotiate in relation to any sale or purchase of investments effected by it for
                                         the account of the Company as agent for the Company or a third party and the interested
                                         party shall be entitled to retain for its own benefit any profit or benefit derived therefrom
                                         PROVIDED THAT the amount of such commission is not in excess of rates commonly receivable
                                         by security dealers in transactions of the kind contemplated and that in effecting any
                                         such sales or purchases the interested party shall do so on the best terms reasonably
                                         obtainable having regard to the interests of the Company as aforesaid and provided further
                                         that such commission does not arise in circumstances in which the Company could itself
                                         have acquired such investments without payment of commission.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">9.2</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                         Manager, its Associated Person and/or any person to whom it delegates investment management
                                         functions reserves the right to effect transactions by or through the agency of another
                                         person with whom the Manager and/or its Associated Person have an arrangement under which
                                         that party will from time to time provide to or procure for the Manager and/or its Associated
                                         Person goods, services or other benefits (such as research and advisory services, computer
                                         hardware associated with specialised software or research services and performance measures)
                                         the nature of which is such that their provision can reasonably be expected to benefit
                                         the Company as a whole and may contribute to an improvement in the performance of the
                                         Company or of the Manager its Associated Person in providing services to the Company.
                                         The Manager and its Associated Person shall not receive any direct payment from such
                                         party. The Manager and/or its Associated Person may however undertake to place business
                                         with that party. For the avoidance of doubt, such goods and services do not include travel,
                                         accommodation, entertainment, general administrative goods or services, general office
                                         equipment or premises, membership fees, employee salaries or direct money payments.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">9.3</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
                                         used in this Clause 9 Associated Person means:-</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 112.5pt; text-align: justify; text-indent: -0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">9.3.1</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a
                                         person or company beneficially owning, directly or indirectly, 20 per cent. or more of
                                         the ordinary share capital of the Manager or able to exercise, directly or indirectly,
                                         20 per cent. or more of the total votes in the Manager;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 112.5pt; text-align: justify; text-indent: -0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;</FONT></P>

<!-- Field: Page; Sequence: 10; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --> -</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 112.5pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">9.3.2</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">any
                                         person or company controlled by a person who meets one or both of the descriptions given
                                         in Clause 9.3.1;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 112.5pt; text-align: justify; text-indent: -0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">9.3.3</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">any
                                         company 20 per cent. or more of whose ordinary share capital is beneficially owned, directly
                                         or indirectly, by the Manager, and any company 20 per cent. or more of the total votes
                                         in which can be exercised, directly or indirectly, by the Manager; or</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 112.5pt; text-align: justify; text-indent: -0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">9.3.4</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">any
                                         director or officer of the Manager or of any associated person of the Manager, as defined
                                         in Clauses 9.3.1, 9.3.2 and 9.3.3.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 112.5pt; text-align: justify; text-indent: -0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">10.</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">LIABILITY
OF THE MANAGER</FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 112.5pt; text-align: justify; text-indent: -0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.1</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                         Manager shall not be liable to the Company or any investor in the Company or otherwise
                                         for any error of judgment or for any loss suffered by the Company or any such investors
                                         in connection with the subject matter of this Agreement or in the course of the discharge
                                         of the Manager's functions hereunder (including in particular, but without limiting the
                                         foregoing, any loss suffered or incurred by the Company or any investor in the Company
                                         following upon or arising out of any estimation, determination or calculation made by
                                         the Manager or any delay in the making or implementation of any such estimation, determination
                                         or calculation or in effecting payments or instructing the Company's bankers or other
                                         service providers of the Company to effect payments or in countermanding payment instructions
                                         or any loss or other disadvantage suffered or incurred by the Company or any investor
                                         in the Company following upon or arising out of any foreign exchange transactions or
                                         any delay in effecting or failure to effect foreign exchange transactions or the bankruptcy
                                         or insolvency of or failure to pay by foreign exchange dealers or any bank or other institution
                                         or country or governmental department or authority in which the moneys of the Company
                                         are from time to time invested or deposited or generally in relation to the purchase,
                                         holding or sale of any investments, assets or rights by the Company or any failure on
                                         the part of the Manager to make necessary registrations of prospectuses or other similar
                                         documents or any action or omission taken or suffered by the Manager in good faith in
                                         reliance on or in accordance with the opinion or advice of legal counsel, the Auditors
                                         or other competent professional advisors) howsoever any such loss may have occurred unless
                                         such loss arises from fraud, bad faith, wilful default or negligence in the performance
                                         or non-performance by the Manager or persons designated by it of its obligations or functions.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 112.5pt; text-align: justify; text-indent: -0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.2</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Subject
                                         to Clause 6, the Company hereby undertakes to hold harmless and indemnify the Manager
                                         against all actions proceedings claims costs demands and expenses which may be brought
                                         against suffered or incurred by the Manager by reason of its performance or non-performance
                                         of its obligations or functions under the terms of this Agreement (other than due to
                                         fraud, bad faith, wilful default or negligence on the part of the Manager or persons
                                         designated by it) including all legal professional and other expenses incurred by the
                                         Manager or persons designated by it in the performance of its obligations or functions
                                         and including indemnity obligations owed by the Manager to persons designated by it (except
                                         such as shall arise from fraud, bad faith, wilful default or negligence in the performance
                                         or non-performance of such obligations or functions) and in particular (but without limitation)
                                         this protection and indemnity shall extend to any such items aforesaid as shall arise
                                         as a result of any such loss suffered or incurred by the Company or any investor in the
                                         Company as is mentioned specifically in Clause 10.1 or any loss delay misdelivery or
                                         error in transmission of any cable or telegraphic communication or as a result of acting
                                         upon any forged document or signature but not tax on the overall income or profits of
                                         the Manager.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;</FONT></P>

<!-- Field: Page; Sequence: 11; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --> -</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.3</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Notwithstanding
                                         any other provision of this Agreement, the Manager shall not be liable to the Company
                                         or any investor in the Company or otherwise for any taxation assessed upon or payable
                                         by the Company wheresoever the same may be assessed or imposed and whether directly or
                                         indirectly except for such taxation as shall be attributable to fraud, bad faith, wilful
                                         default or negligence in the performance or non-performance by the Manager or persons
                                         designated by it of its obligations or functions. The Company shall indemnify and keep
                                         indemnified the Manager from and against all taxes not attributable to fraud, bad faith,
                                         wilful default or negligence as aforesaid (wheresoever and by whomsoever imposed) on
                                         profits or gains of the Company which may be assessed upon or become payable by the Manager
                                         and against all costs claims demands actions and proceedings in connection therewith.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.4</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
                                         the avoidance of doubt it is hereby agreed and declared that references to the Manager
                                         in this Clause shall be deemed to include references to the officers, servants, agents
                                         and delegates of the Manager. Any such person, not being a party to this Agreement, may
                                         enforce any rights granted to it pursuant to this Clause in its own right as if it were
                                         a party to this Agreement.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.5</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Any
                                         indemnity expressly given to the Manager in this Agreement is in addition to and without
                                         prejudice to any indemnity provided by the Laws and (unless Clause 13.3.2 applies) shall
                                         survive termination of this Agreement.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.6</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                         Manager shall send to the Company as soon as possible all claims, demands, summonses,
                                         writs and related documents which it receives from third parties and in respect of which
                                         it may be indemnified in this Agreement and shall give such assistance as the Company
                                         may reasonably require in defending or resisting the same and the Manager shall not admit
                                         liability or offer any settlement without the written consent of the Company which may,
                                         if it so desires, take over the defence of any such actions or prosecute any such claim
                                         in the name of the Manager.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.7</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                         Manager shall be entitled to rely on and shall not incur any liability in respect of
                                         any act or omission in reliance upon Proper Instructions or upon any document reasonably
                                         believed in good faith to be authentic and not fraudulent but may require documents to
                                         be authenticated to its reasonable satisfaction.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">11.</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">LEGAL
ACTION BY THE MANAGER</FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">11.1</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                         Manager shall not be required to take any legal action unless fully indemnified to its
                                         reasonable satisfaction for all costs and liabilities that may be incurred or suffered
                                         by the Manager and not attributable to its fraud, bad faith, wilful default or negligence
                                         in the performance or non-performance of its obligations or functions and if the Company
                                         requires the Manager to take any action of whatsoever nature which in the reasonable
                                         opinion of the Manager might make the Manager liable for the payment of money or liable
                                         in any other way the Manager shall be and be kept indemnified in any reasonable amount
                                         and form satisfactory to the Manager as a prerequisite to taking action.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;</FONT></P>

<!-- Field: Page; Sequence: 12; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --> -</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">12.</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ASSIGNMENT</FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">12.1</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                         Manager may with the consent in writing of the Company assign all its rights and obligations
                                         hereunder to any other company, person, firm or institution acceptable to the Company
                                         and permitted under the Laws and the assignee shall, upon filing with the Company an
                                         instrument in writing whereby it shall assume the obligations of the Manager hereunder
                                         and agree to be bound by the provisions hereof, become the successor to the Manager hereunder
                                         and thereafter such successor may exercise all of the powers and enjoy all of the rights
                                         and be subject to all of the duties and obligations of the Manager hereunder as fully
                                         as though originally named as a party to this Agreement.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">13.</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">RESIGNATION
AND TERMINATION</FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">13.1</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                         Manager shall be entitled to resign its appointment hereunder by notice in writing to
                                         the Company:-</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">13.1.1</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">by
                                         giving not less than one month&rsquo;s notice to expire at any time;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 112.5pt; text-align: justify; text-indent: -0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">13.1.2</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">at
                                         any time if the Company shall go into liquidation (except a voluntary liquidation for
                                         the purposes of reconstruction or amalgamation upon terms previously approved in writing
                                         by the Manager) or be unable to pay its debts or commit any act of bankruptcy under the
                                         laws of the Cayman Islands or if a receiver is appointed of any of the assets of the
                                         Company or if some event having an equivalent effect occurs;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 112.5pt; text-align: justify; text-indent: -0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">13.1.3</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">at
                                         any time if the Company shall commit any material breach of its obligations under this
                                         Agreement and (if such breach shall be capable of remedy) shall fail within 15 days of
                                         receipt of notice served by the Manager requiring it so to do to make good such breach;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 112.5pt; text-align: justify; text-indent: -0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">13.1.4</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">at
                                         any time if the Manager ceases to be permitted to act as such under the Laws.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">13.2</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                         Company may terminate the appointment of the Manager by giving not less than one month&rsquo;s
                                         notice in writing to the Manager to expire at any time.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">13.3</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                         Company may without such notice as is referred to in Clause 13.2 terminate the appointment
                                         of the Manager at any time by giving notice in writing to the Manager in any of the following
                                         events:-</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 112.5pt; text-align: justify; text-indent: -0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">13.3.1</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">if
                                         the Manager goes into liquidation (except a voluntary liquidation for the purpose of
                                         reconstruction or amalgamation upon terms previously approved in writing by the Company)
                                         or is unable to pay its debts or commits any act of bankruptcy or if a receiver is appointed
                                         of any of the assets of the Manager or if some event having an equivalent effect occurs;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 112.5pt; text-align: justify; text-indent: -0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">13.3.2</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">if
                                         the Manager shall commit any material breach of its obligations under this Agreement
                                         and (if such breach shall be capable of remedy) shall fail within 15 days of receipt
                                         of notice served by the Company requiring it so to do to make good such breach; or</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;</FONT></P>

<!-- Field: Page; Sequence: 13; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --> -</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">13.3.3</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">if
                                         the Manager ceases to be permitted to act as such under the Laws.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">13.4</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
                                         termination of the appointment of the Manager under the provisions of this Clause 13
                                         the Manager shall be entitled to receive all fees and other moneys accrued due up to
                                         the date of such termination but shall not be entitled to compensation in respect of
                                         such termination; and the Manager shall deliver or procure to be delivered to the Company,
                                         or as it shall direct, all books of account, records, registers, correspondence, documents
                                         and assets relating to the affairs of or belonging to the Company in the possession of
                                         or under the control of the Manager or its nominees or delegates and shall take all necessary
                                         steps to vest in the Company or any new Manager any assets previously held in the name
                                         of or to the order of the Manager on behalf of the Company and the Manager shall not
                                         be entitled to any lien in respect of any of the foregoing. Termination is without prejudice
                                         to accrued rights and provisions intended to survive termination and to the right of
                                         the Manager to settle outstanding obligations for transactions in progress.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">14.</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">CONFIDENTIALITY
AND REPUTATION</FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">14.1</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                         parties hereto shall not (except under compulsion of law or in accordance with the Laws)
                                         either before or after the termination of this Agreement disclose to any person not authorised
                                         by the relevant party to receive the same any confidential information relating to such
                                         party or to the affairs of such party of which the party disclosing the same shall have
                                         become possessed during the period of this Agreement and each party shall use all reasonable
                                         endeavours to prevent any such disclosure as aforesaid.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">14.2</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                         parties shall not knowingly do or suffer any act or matter or thing which would or might
                                         reasonably be expected to prejudice materially or bring into disrepute the business or
                                         reputation of the other party.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">15.</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">MISCELLANEOUS
PROVISIONS</FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">15.1</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">No
                                         failure on the part of a party to exercise, and no delay on its part in exercising, any
                                         right or remedy under this Agreement will operate as a waiver thereof nor will any single
                                         or partial exercise of any right or remedy preclude any other or further exercise thereof
                                         or the exercise of any other right or remedy. The rights and remedies provided in this
                                         Agreement are cumulative and not exclusive of any rights or remedies provided by law.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">15.2</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Any
                                         provision of this Agreement may be amended only if the parties so agree in writing.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">15.3</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                         illegality, invalidity or unenforceability of any provision of this Agreement under the
                                         law of any jurisdiction shall not affect its legality, validity or enforceability under
                                         the law of any other jurisdiction nor the legality, validity or enforceability of any
                                         other provision.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;</FONT></P>

<!-- Field: Page; Sequence: 14; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --> -</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">15.4</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Except
                                         to the extent that the Laws admit variations by contract and are so varied by the terms
                                         of this Agreement, the powers, duties, rights and obligations of the parties under this
                                         Agreement shall be overridden by, and to the extent that they may conflict, be subject
                                         to, the Laws and the Manager shall have all the powers and perform its functions in accordance
                                         with the Laws.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">15.5</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
                                         Agreement may be entered into in any number of counterparts and by the parties to it
                                         on separate counterparts, each of which when so executed and delivered shall be an original,
                                         but all the counterparts shall together constitute one and the same document.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">15.6</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                         Manager undertakes that no advertisement, statement, circular, booklet, prospectus, explanatory
                                         memorandum or other document will be published and no money will be raised by the Manager
                                         on behalf of the Company unless and until all necessary consents and permissions of whatever
                                         jurisdiction have been obtained in connection therewith and the Manager further undertakes
                                         to comply with all securities and other laws and regulations which may be applicable
                                         to the Manager or the Company in connection with the offering and issue of Securities
                                         of the Company.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">16.</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">NOTICES</FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">16.1</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Any
                                         notice given hereunder shall be in writing and shall be served by hand at or by being
                                         sent by fax (to such fax number as each party may nominate in writing from time to time
                                         for receipt of notices) or by prepaid airmail post to the principal place of business
                                         specified herein or last notified to the sender by the addressee. Any such notice shall
                                         be deemed duly served at the time of delivery (if delivered by hand), upon confirmation
                                         by telephone (if sent by fax) or five days after the date of posting (if sent by prepaid
                                         airmail post). Evidence that the notice was properly addressed, stamped and put into
                                         the post shall be conclusive evidence of posting. This Clause is without prejudice to
                                         the ability to give or receive Proper Instructions in accordance with the definition
                                         of that term.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">17.</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">LAW
OF THE CONTRACT</FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">17.1</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
                                         Agreement shall be governed by and construed in accordance with the laws of Hong Kong.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">17.2</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                         Company and the Manager hereby irrevocably submit to the non-exclusive jurisdiction of
                                         the courts of Hong Kong for the settlement of any dispute or difference arising between
                                         the parties hereto, provided always that any party shall be at liberty to take proceedings
                                         against the other party in whatever other jurisdiction that other party may from time
                                         to time be resident.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">18.</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>EXCLUSION
                                         OF THIRD PARTY RIGHTS</B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">18.1</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Except
                                         as expressly provided in Clause 10.4, a person who is not a party to this Agreement shall
                                         not have any rights to enforce any of the provisions of this Agreement, and the application
                                         of the Contracts (Rights of Third Parties) Ordinance (Chapter 623 of the laws of Hong
                                         Kong) and/or any comparable law in any jurisdiction giving to or conferring on third
                                         parties the right to enforce any term of this Agreement is expressly excluded.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">18.2</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Notwithstanding
                                         any term of this Agreement, the consent or notice to any person who is not a party to
                                         this Agreement (including without limitation any of the Indemnified Persons other than
                                         the Investment Manager) is not required for any termination, rescission or agreement
                                         to any variation, waiver, assignment, novation, release or settlement under this Agreement
                                         at any time.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;</FONT></P>

<!-- Field: Page; Sequence: 15; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --> -</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>IN
WITNESS</B> whereof this Agreement has been entered into the day and year first above written.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 49%"><FONT STYLE="font-size: 10pt"><B>EXECUTED </B>by <B>APTUS HOLDINGS LIMITED</B></FONT></TD>
    <TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 49%">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="border-bottom: Black 1.5pt solid">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt">Signature of Director</FONT></TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">Signature of Witness</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="border-bottom: Black 1.5pt solid">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt">Name of Director</FONT></TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">Name of Witness</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt"><B>EXECUTED </B>by <B>GUARDIAN CAPITAL MANAGEMENT LIMITED</B></FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="border-bottom: Black 1.5pt solid">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt">Signature of Director</FONT></TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">Signature of Witness</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="border-bottom: Black 1.5pt solid">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt">Name of Director</FONT></TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">Name of Witness</FONT></TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;</FONT></P>

<!-- Field: Page; Sequence: 16; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --> -</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Schedule
1 &ndash; Investment Guidelines</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Investment
Objective and Strategy of the Company</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company is a holding company that will own and oversee the management, operations and investments of its subsidiaries. The Company&rsquo;s
investment objective is to generate long-term capital appreciation by acquiring, holding and/or investing in, by itself or through
one or more of its subsidiaries or other investment vehicles, a wide range of Investments, assets and/or rights, with a focus
on the healthcare industry.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">While
there is no limitation on the means by which the Company may seek to achieve the Company&rsquo;s investment objective, it is currently
expected that the Company (or its subsidiaries or investment vehicles) may:-</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">invest
                                         in a portfolio of Investments predominantly comprised of both private and public healthcare
                                         related stocks; and/or</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">acquire
                                         and hold certain intangible assets (including intellectual property rights) associated
                                         with early stage medical technologies, research, and companies<I>.</I></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company may target a range of technologies, research, and/or companies for investment, including the licensing and sublicensing
of therapeutic drug candidates and medical devices designed to address a broad range of medical indications, and the acquisition
of intellectual properties, and commercialization and/or distribution rights to technologies and products. For drug candidates,
the Company may invest into pre-clinical, clinical, or commercial assets without any restriction. For medical equipment and devices,
the Company may also invest into assets that are yet to be prototype-enabled or which are within any stage of their product development
cycles. The Company may, from time to time, vary the aforementioned investment strategy and approach, for the purposes of achieving
its investment objective.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company will seek to:-</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0%; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 18pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">facilitate
                                         the financing needs of companies engaged in the development of product candidates which
                                         address significant unmet medical needs and that require a unique pairing of knowledge
                                         and resources;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 21pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0%; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 18pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">finance
                                         and incubate portfolio companies that commit to creating innovative solutions for health
                                         care advancement;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0%; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 18pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">finance
                                         academic research, inventors, and institutions focusing on medical innovations with the
                                         potential for commercial development; and/or</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0%; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 18pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">pursue
                                         any other strategies and approaches deemed appropriate by the Manager having regard to
                                         investment objectives of the Company.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cash,
liquidity, and risk management functions will be performed by the Manager to facilitate all or part of the aforementioned initiatives.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Investment
Restrictions</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">There
are currently no Investment Restrictions instituted by the Company or the Manager.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company is free to invest as it sees fit into and to dispose of any asset class (tangible or intangible), market, geographic region,
and across the capital market investment spectrum in so far that it is believed to further the Company&rsquo;s objectives in enhancing
value for the shareholders of the Company, by facilitating portfolio companies, inventors, researchers, or commercial partners
in advancing medical technologies, products, and services.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;&nbsp;</P>

<!-- Field: Page; Sequence: 17; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --> -</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Schedule
2 &ndash; Remuneration of the Manager</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
consideration of the services to be performed by the Manager hereunder, the Manager shall be entitled to receive a fixed amount
of management fee of HK$500,000 per calendar month from the Company. Such management fee shall accrue and be payable monthly in
arrears on the last day of each month or, if such day is not a business day in Hong Kong, on the next following business day in
Hong Kong.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">There
is currently no separate performance fee payable by the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
parties may agree from time to time in writing such other remuneration of the Manager and the related calculation or payment methods.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt">- <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">16
-</FONT></P>



<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"></P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 0; margin-bottom: 0"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.15
<SEQUENCE>19
<FILENAME>ff12018ex10-15_aptorum.htm
<DESCRIPTION>CONSULTING AGREEMENT BETWEEN THE COMPANY AND GLOBOASIA, LLC (INCLUDES PROVISIONS FOR THE APPOINTMENT OF KEITH CHAN AS CHIEF SCIENTIFIC OFFICER) DATED AUGUST 18, 2017
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif; text-align: right"><B>Exhibit 10.15</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;<IMG SRC="ex10-14_001.jpg" ALT="" STYLE="width: 19px; height: 25px"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">APTUS Holdings Limited</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Unit B, 17/F Guangdong Investment Tower,
148 Connaught Road Central, Hong Kong</P>

<P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">Tel: (852) 2117 6611 &#9679; Fax: (852) 2850 7286</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">18<SUP>th
</SUP>August 2017</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">GloboAsia
LLC</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">11427
Potomac Oaks Drive</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Rockville,
MD 20850, USA</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Attn:
Dr. Keith Chan, Ph.D.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Consultancy
Agreement</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
are pleased and welcome the acceptance of GloboAsia LLC <B>(&ldquo;GloboAsia&rdquo;)</B>, with its business address at 11427 Potomac
Oaks Drive, Rockville, MD 20850, USA, to enter into this Consultancy Agreement <B>(the &ldquo;Agreement&rdquo;)</B> with APTUS
Holdings Limited <B>(the &ldquo;Company&rdquo;)</B>, a company incorporated with limited liabilities under the laws of Cayman
Islands, with its business address at Unit B, 17/F Guangdong Investment Tower, 148 Connaught Road Central, Hong Kong. The Company
has wholly owned subsidiaries in the Cayman Islands, Hong Kong, and Macau, whereby collectively, shall be depicted as <B>&ldquo;APTUS&rdquo;
</B>or the <B>&ldquo;Group&rdquo;</B>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following seeks to illustrate the context of the Agreement and the services to be rendered by GloboAsia for the Company, and the
terms and conditions as set out herewith.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 22.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>1.</B></FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>The
                                         Company and the Group</B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">APTUS
and its affiliates focus on the licensing of, and acquisition of early stage preclinical assets with the intention to engage in
drug research, development, and commercialization purposes. Assets are acquired via open and public platforms such as the technology
transfer offices of accredited universities and academic institutions. In addition, the Group seeks to be a facilitator across
the financing spectrum for biotech companies, entrepreneurs, and commercializing agents, to bolster innovations adding value to
health care needs in the market place; and to assist in furthering the research capabilities of institutions the Group works with.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;&nbsp;</B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>2.</B></FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Scope
                                         of Services</B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">GloboAsia
                                         agrees to enter into this Agreement to provide certain consultancy, advisory, and management
                                         services to APTUS through correspondence and man-hours as <U>represented by Dr. Keith
                                         Chan (&ldquo;Dr. Chan&rdquo;)</U>.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 54.3pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dr.
                                         Chan is to be enlisted and act as a <B>Chief Scientific Officer </B>of the Company, or
                                         otherwise agreed from time to time (the &ldquo;Appointment&rdquo;).</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">He
                                         shall advise where necessary, the Executive Board of Directors of the Company and its
                                         affiliates.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 54.3pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
                                         a Chief Scientific Officer of the Company Dr. Chan&rsquo;s role involves managing the
                                         regulatory aspects of APTUS' clinical programs including, but not limited to, the liaison
                                         with regulatory authorities such as the U.S. Food &amp; Drug Administration (FDA) or
                                         the China Food &amp; Drug Administration (cFDA).</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;</FONT></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;<IMG SRC="ex10-14_001.jpg" ALT=""></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">APTUS Holdings Limited</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Unit B, 17/F Guangdong Investment Tower,
148 Connaught Road Central, Hong Kong</P>

<P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">Tel: (852) 2117 6611 &#9679; Fax: (852) 2850 7286</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
                                         he is not an Executive Director on the Board of Directors for the Company, he ultimately
                                         does not have legal nor professional authority to dictate the commercial decisions of
                                         the Executive Board.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 54.3pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(f)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">He
                                         shall:</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.75in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Provide
                                         services on behalf of GloboAsia in all aspects for the Group where reasonably sought
                                         at least for one working day per week;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.75in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Be
                                         responsive to the Group&rsquo;s needs and interests, whereby deliverables to APTUS should
                                         be provided in good faith so that effort and quality is commensurable to fees provided
                                         to GloboAsia, with details described more fully below;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.75in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Observe
                                         and comply with all statutory rules, and regulations where applicable as governed by
                                         the laws of his residence and that of GloboAsia&rsquo;s incorporation;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.75in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iv)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Provide
                                         traceable contact during and after office hours, on weekdays and weekends, or during
                                         public holidays, whereby your availability may occasionally and reasonably be sought.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>3.</B></FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Date
                                         of Commencement</B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 21.25pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 21.25pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">GloboAsia
shall officially commence its services to the Company beginning on <B>18<SUP>th</SUP> August 2017</B>, or as mutually agreed upon
between Dr. Chan and the Executive Board of Directors of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 21.25pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>4.</B></FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Service
                                         Fees</B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Service
                                         Fees shall be provided to GloboAsia with the expectation that its representative(s) devotes
                                         at least one working date per week in providing services to the Company and its affiliates,
                                         or a suitable amount of time to adequately fulfill duties outlined in the Scope of Services
                                         for the Company; Such duties may include, but not limited to, the overall steering in
                                         regulatory matters, the attendance of meetings, reviewing documentation associated to
                                         the Group&rsquo;s licensing, research &amp; development, and other operational activities
                                         where necessary.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 54.3pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Such
                                         Service Fees shall equate to a <B>monthly rate of US$10,000 (USD Ten Thousand) </B>and
                                         shall be duly paid to GloboAsia in full on the last business day of each calendar month
                                         subsequent to aforementioned commencement date, and subject to the ongoing effect of
                                         the Appointment as pursuant to Section 8. Term and Termination.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;&nbsp;&nbsp;</B></FONT></P>

<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>&nbsp;<IMG SRC="ex10-14_001.jpg" ALT=""></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">APTUS Holdings Limited</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Unit B, 17/F Guangdong Investment Tower,
148 Connaught Road Central, Hong Kong</P>

<P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">Tel: (852) 2117 6611 &#9679; Fax: (852) 2850 7286</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>5.</B></FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Stock
                                         Bonus:</B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 22.5pt; text-align: justify; text-indent: -22.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">GloboAsia
<FONT STYLE="color: #333333">may be entitled to receive stock bonuses with the amount, cap, timing of payouts, vesting rate and
schedule, subject to the full discretion of the Company. All terms and conditions of stock bonuses shall be assessed based on
the overall financial position and performance of the Group, as well as your contribution and performance upon rendering services
by your representative(s) during the appointment under this Agreement. Any particulars associated to your eligibility to stock
bonuses shall be definitively defined in a subsequent &ldquo;Stock Option and Stock Bonus Addendum&rdquo; at a future date as
mutually agreed upon between </FONT>GloboAsia <FONT STYLE="color: #333333">and the Executive Board of Directors the Company.</FONT></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; color: #333333"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;<B>&nbsp;</B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>6.</B></FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Expense
                                         Reimbursements</B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">GloboAsia
is entitled to apply for reimbursement to expense outlays from time to time, deriving from expenses such as traveling and transportation
costs, accommodation cost, and other expenses where reasonably incurred in relation to your representative(s) rendering said services
for the Company and its affiliates in accordance to duties and tasks described in Section 2. Scope of Services.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;&nbsp;</B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>7.</B></FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Privacy
                                         of Information</B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 28.35pt; text-align: justify; text-indent: -28.35pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">GloboAsia
                                         and its representative(s) shall not except as authorized by the Company or its affiliates,
                                         or required by your responsibilities reveal to any person or company any of the trade
                                         secrets or any information concerning the organization, business, finances, transactions
                                         or affairs of the Group which may come to your knowledge during your contract with the
                                         Group and shall keep with complete secrecy confidential information entrusted to you
                                         or your representative(s) and shall not use or attempt to use any such information in
                                         any manner which may injure or cause loss either directly or indirectly to the Group
                                         or may be likely to do so. This restriction shall continue to apply if and when after
                                         the termination of this appointment without limit in time.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">GloboAsia
                                         and its representative(s) shall not either during the period of this appointment or afterwards
                                         use or permit to be used any books, documents, moneys, assets, records or other property
                                         belonging to or relating to any dealings, affair or business of the Group other than
                                         for the benefit of the Group. You shall immediately deliver and return to the Group all
                                         such books, documents, monies, securities, records or other property which you then have
                                         or should have in your possession upon termination of this appointment hereunder.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                         Company however, agrees to provide you in good faith with any information concerning
                                         areas of interest and relevance of the Group as required by you in order for you to fulfill
                                         the Scope of your Services for the Group.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;</FONT></P>

<!-- Field: Page; Sequence: 3; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;<IMG SRC="ex10-14_001.jpg" ALT=""></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">APTUS Holdings Limited</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Unit B, 17/F Guangdong Investment Tower,
148 Connaught Road Central, Hong Kong</P>

<P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">Tel: (852) 2117 6611 &#9679; Fax: (852) 2850 7286</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0%; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>8.</B></FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Term
                                         and Termination</B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 28.35pt; text-align: justify; text-indent: -28.35pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
appointment of GloboAsia by the Company shall persist for a period of <B>2 years</B> from the Date of Commencement (the &ldquo;Term&rdquo;)
as defined within this Appointment Letter. The terms and conditions of this Appointment Letter shall remain in effect until expiration
of the Term, unless it is terminated prior to expiration subsequent to the following circumstances:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 28.35pt; text-align: justify; text-indent: -28.35pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By
                                         GloboAsia after giving the Company not less than two (2) months&rsquo; notice in writing;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 22.5pt; text-align: justify; text-indent: -22.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By
                                         the Company after giving GloboAsia two (2) months&rsquo; notice in writing; or</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By
                                         the Company without notice or compensation in the event of any dishonesty, fraud, gross
                                         negligence, willful default or refusal to carry out any lawful order or instructions,
                                         or the repeated breach of any rules or regulations of the Company, or those as governed
                                         by the laws of your residency or incorporation by GloboAsia or its representative(s).</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Renewal
of this appointment shall be negotiated three months prior to the expiration of the Term, and subject to the mutual agreement
between the Company and GloboAsia as defined in writing.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Please
signify your acceptance of the above terms and conditions by signing and returning to us the enclosed duplicate copy of this Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Yours
faithfully, &#9;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 49%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">For and on behalf of</FONT></TD>
    <TD STYLE="width: 2%; text-align: justify">&nbsp;</TD>
    <TD STYLE="width: 49%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Agreed on behalf of </FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>APTUS HOLDINGS LIMITED</B></FONT></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>GLOBOASIA LLC</B></FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify; border-bottom: Black 1.5pt solid">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify; border-bottom: Black 1.5pt solid">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Name: HUEN Chung Yuen Ian</FONT></TD>
    <TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Name: Dr. Keith CHAN, Ph.D.</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Position: Director &amp; CEO</FONT></TD>
    <TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Position: </FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left; border-bottom: Black 1.5pt solid">&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: left; border-bottom: Black 1.5pt solid">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Date</FONT></TD>
    <TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Date</FONT></TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="margin-top: 0; text-align: center; margin-bottom: 0; font: 10pt Times New Roman, Times, Serif">4</P>

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"></P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 0; margin-bottom: 0"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.16
<SEQUENCE>20
<FILENAME>ff12018ex10-16_aptorum.htm
<DESCRIPTION>MANAGEMENT AGREEMENT BETWEEN THE COMPANY AND APTUS CAPITAL LIMITED, DATED OCTOBER 26, 2010
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif; text-align: right"><B>Exhibit 10.16</B></P>

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">STRIKER
CAPITAL MANAGEMENT LIMITED</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">STRIKER
ASIA OPPORTUNITIES FUND CORPORATION</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>MANAGEMENT
AGREEMENT</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[&nbsp;&nbsp;&nbsp;
] October, 2010</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>TABLE
OF CONTENTS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>



<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">PART 1. INVESTMENT MANAGEMENT SERVICES</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1</FONT></TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD STYLE="width: 7%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.1</FONT></TD>
    <TD STYLE="text-align: left; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif; width: 86%"><FONT STYLE="font-family: Times New Roman, Times, Serif">Investment
    Programme</FONT></TD>
    <TD STYLE="text-align: center; padding: 0; font: 10pt Times New Roman, Times, Serif; width: 7%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1</FONT></TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">1.2</FONT></TD>
    <TD STYLE="text-align: left; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">Authority
    of the Investment Manager</FONT></TD>
    <TD STYLE="text-align: center; padding: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2</FONT></TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">1.3</FONT></TD>
    <TD STYLE="text-align: left; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">Delegation</FONT></TD>
    <TD STYLE="text-align: center; padding: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3</FONT></TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">1.4</FONT></TD>
    <TD STYLE="text-align: left; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">Custody</FONT></TD>
    <TD STYLE="text-align: center; padding: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3</FONT></TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">1.5</FONT></TD>
    <TD STYLE="text-align: left; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">Investments
    for the Accounts of Others</FONT></TD>
    <TD STYLE="text-align: center; padding: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4</FONT></TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">1.6</FONT></TD>
    <TD STYLE="text-align: left; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">Establishment
    of subsidiaries</FONT></TD>
    <TD STYLE="text-align: center; padding: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4</FONT></TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">PART 2. ADMINISTRATIVE SERVICES</FONT></TD>
    <TD STYLE="text-align: center; padding: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5</FONT></TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">PART 3. PLACEMENT AND ADVISORY SERVICES</FONT></TD>
    <TD STYLE="text-align: center; padding: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5</FONT></TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">3.1</FONT></TD>
    <TD STYLE="text-align: left; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">Provision
    of Placement Duties and Advisory Services</FONT></TD>
    <TD STYLE="text-align: center; padding: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5</FONT></TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">3.2</FONT></TD>
    <TD STYLE="text-align: left; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">Placement
    of Participating Shares</FONT></TD>
    <TD STYLE="text-align: center; padding: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6</FONT></TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">3.3</FONT></TD>
    <TD STYLE="text-align: left; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">Authorized
    Dealers</FONT></TD>
    <TD STYLE="text-align: center; padding: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6</FONT></TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">3.4</FONT></TD>
    <TD STYLE="text-align: left; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">Offering
    Materials</FONT></TD>
    <TD STYLE="text-align: center; padding: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6</FONT></TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">3.5</FONT></TD>
    <TD STYLE="text-align: left; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">Certain
    Legal Restrictions</FONT></TD>
    <TD STYLE="text-align: center; padding: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">7</FONT></TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">PART 4. COMPENSATION</FONT></TD>
    <TD STYLE="text-align: center; padding: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8</FONT></TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">4.1</FONT></TD>
    <TD STYLE="text-align: left; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">Management
    Fee</FONT></TD>
    <TD STYLE="text-align: center; padding: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8</FONT></TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">4.2</FONT></TD>
    <TD STYLE="text-align: left; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">Performance
    Fee</FONT></TD>
    <TD STYLE="text-align: center; padding: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8</FONT></TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">4.3</FONT></TD>
    <TD STYLE="text-align: left; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">Initial
    Charge</FONT></TD>
    <TD STYLE="text-align: center; padding: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10</FONT></TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">PART 5. GENERAL PROVISIONS</FONT></TD>
    <TD STYLE="text-align: center; padding: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10</FONT></TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">5.1</FONT></TD>
    <TD STYLE="text-align: left; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">Expenses</FONT></TD>
    <TD STYLE="text-align: center; padding: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10</FONT></TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">5.2</FONT></TD>
    <TD STYLE="text-align: left; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">Soft
    Commissions</FONT></TD>
    <TD STYLE="text-align: center; padding: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">11</FONT></TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">5.3</FONT></TD>
    <TD STYLE="text-align: left; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">Rebates</FONT></TD>
    <TD STYLE="text-align: center; padding: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">11</FONT></TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">5.4</FONT></TD>
    <TD STYLE="text-align: left; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">Scope
    of Liabilities</FONT></TD>
    <TD STYLE="text-align: center; padding: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">11</FONT></TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD><P STYLE="margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">5.5</FONT></P></TD>
    <TD STYLE="text-align: left; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">Indemnification</FONT></TD>
    <TD STYLE="text-align: center; padding: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">12</FONT></TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">5.6</FONT></TD>
    <TD STYLE="text-align: left; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">Independent
    Contractor</FONT></TD>
    <TD STYLE="text-align: center; padding: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">13</FONT></TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">5.7</FONT></TD>
    <TD STYLE="text-align: left; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">Information
    Concerning Activities</FONT></TD>
    <TD STYLE="text-align: center; padding: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">13</FONT></TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">5.8</FONT></TD>
    <TD STYLE="text-align: left; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">Term,
    Termination and Renewal</FONT></TD>
    <TD STYLE="text-align: center; padding: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">13</FONT></TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">5.9</FONT></TD>
    <TD STYLE="text-align: left; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">Modification,
    Waiver</FONT></TD>
    <TD STYLE="text-align: center; padding: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">14</FONT></TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">5.10</FONT></TD>
    <TD STYLE="text-align: left; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">Binding
    Effect; Assignment</FONT></TD>
    <TD STYLE="text-align: center; padding: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">14</FONT></TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD><P STYLE="margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">5.11</FONT></P></TD>
    <TD STYLE="text-align: left; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">Governing
    Law</FONT></TD>
    <TD STYLE="text-align: center; padding: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">14</FONT></TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">5.12</FONT></TD>
    <TD STYLE="text-align: left; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">Counterparts</FONT></TD>
    <TD STYLE="text-align: center; padding: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">14</FONT></TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">5.13</FONT></TD>
    <TD STYLE="text-align: left; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">Entire
    Agreement</FONT></TD>
    <TD STYLE="text-align: center; padding: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">14</FONT></TD></TR>
</TABLE>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"></P>

<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>MANAGEMENT
AGREEMENT</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>STRIKER
ASIA OPPORTUNITIES FUND CORPORATION</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 27pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">AGREEMENT
(the &ldquo;Agreement&rdquo;) dated as of &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;by and between Striker Capital Management Limited, a limited liability company organized
under the laws of Hong Kong whose registered office is at 17th Floor, Guangdong Investment Tower, 148 Connaught Road Central,
Hong Kong (the &ldquo;Investment Manager&rdquo;) and Striker Asia Opportunities Fund Corporation, a limited liability company organized
under the laws of the Cayman Islands whose registered office is at 4th Floor, Scotia Centre, P.O. Box 268, Grand Cayman KY1-1104,
Cayman Islands (the &ldquo;Company&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 27pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">WHEREAS,
the Company has been formed as an open-ended investment company, the objective of which is to achieve capital appreciation in
accordance with the investment objectives and programme as more fully described in the Private Placing Memorandum of the Company
dated <B>[date]</B> (the &ldquo;Private Placing Memorandum&rdquo;), the receipt of which by the Investment Manager is hereby acknowledged;
WHEREAS, the Company desires to avail itself of the experience, advice and assistance of the Investment Manager with respect to
the investment of its assets and the performance of investment management, placement and other services on behalf of the Company;
and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 27pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 27pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">NOW,
THEREFORE, in consideration of the mutual premises and covenants contained herein, the parties hereby agree to the following terms
and conditions. Terms not otherwise defined herein shall be used herein as defined in the Articles of Association of the Company
(the &ldquo;Articles&rdquo;) (and words and expressions contained in this Agreement but not contained in the Articles shall bear
the same meaning as in the Private Placing Memorandum) PROVIDED THAT any alteration or amendment of the Articles or the Private
Placing Memorandum shall not be effective for the purposes of this Agreement unless the party hereto affected (to the extent that
its rights or duties hereunder are affected by such alteration or amendment) shall, by endorsement hereon or otherwise, have consented
thereto.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">PART
1. INVESTMENT MANAGEMENT SERVICES</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: italic 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 24pt; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal">1.1</FONT></TD><TD STYLE="padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Investment
                                         Programme</I></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
accordance with the investment objectives, policies, guidelines and restrictions which are set forth in the Private Placing Memorandum
or which are otherwise communicated to the Investment Manager in writing, and under the ultimate supervision of the Board of directors
of the Company, the Investment Manager shall develop, update and effect an overall investment strategy for the investment of the
assets of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P>

<!-- Field: Page; Sequence: 3; Options: NewSection; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: italic 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 24pt; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal">1.2</FONT></TD><TD STYLE="padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Authority
                                         of the Investment Manager</I></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Investment Manager shall have full discretion and authority, without obtaining the Company&rsquo;s prior approval, but subject as aforesaid,
to invest the assets of the Company in such manner as the Investment Manager considers appropriate, subject to the investment
objectives, policies, guidelines and restrictions as set forth in the Private Placing Memorandum (which may be amended from time
to time). In furtherance of, and subject to the foregoing, the Company hereby designates and appoints the Investment Manager as
its agent and attorney-in-fact, with full power and authority and without the need for further approval of the Company (except
as may be required by law), to carry out the following with respect to the assets of the Company:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 27pt; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 18pt; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a)</FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">to
                                         effect purchases and sales (including short sales) of (i) equity or debt securities,
                                         as well as warrants, convertible securities or other securities which combine features
                                         of equity and debt securities, denominated in any currency, of publicly-listed or privately
                                         owned companies anywhere in the world, (ii) any put or call options thereon (including
                                         the writing of options), or (iii) any futures contracts or contracts to borrow such securities;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -27pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 27pt; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 18pt; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">b)</FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">to
                                         engage in foreign currency transactions in the spot, forward and outright markets;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -27pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 27pt; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 18pt; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">c)</FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">to
                                         make all decisions relating to the manner, method and timing of investment transactions,
                                         and the selection of brokers and dealers for the execution, clearance and settlement
                                         of any transactions;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 27pt; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 18pt; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">d)</FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">to
                                         borrow from banks, brokers or other financial institutions and pledge assets of the Company
                                         in connection therewith;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 27pt; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 18pt; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">e)</FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">to
                                         direct custodians to deliver funds or securities for the purpose of effecting transactions,
                                         and to instruct custodians to exercise or abstain from exercising any privilege or right
                                         attaching to such assets;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 27pt; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 18pt; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">f)</FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">to
                                         appoint Mr. Chung Yuen Ian HUEN and Mr. Don K. W. SO (collectively, the &ldquo;Key Investment
                                         Personnel&rdquo;) as the investment personnel responsible for making investment decisions
                                         in respect of the assets of the Company;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 4; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 27pt; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 18pt; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">g)</FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">to
                                         promptly notify the Company if any of the Key Investment Personnel will be unable to
                                         continue to involve in making investment decisions in respect of the assets of the Company
                                         as a result of any of the following reasons:</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 51pt; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 24pt; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.</FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                         resignation of such person ; or</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 51pt; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 24pt; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.</FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">such
                                         person becoming of unsound mind or a patient for any purpose relating to mental health
                                         and the directors of the Investment Manager resolve that his office be vacated; or</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 51pt; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 24pt; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.</FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                         death of such person.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 27pt; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 18pt; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">h)</FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">unless
                                         otherwise instructed by the Company, to make and execute, in the name and on behalf of
                                         the Company, all such documents and take all other such actions which the Investment
                                         Manager considers necessary or advisable to carry out its duties hereunder. For the avoidance
                                         of doubt, the Investment Manager shall not, without the approval of the Company, enter
                                         into a side letter arrangements with the shareholders of the Company.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: italic 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 24pt; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal">1.3</FONT></TD><TD STYLE="padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Delegation</I></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 27pt; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 27pt; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a)</FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
                                         connection with the provision of the services set forth in Sections 1.1 and 1.2 hereof,
                                         the Investment Manager shall have full authority and discretion to delegate its responsibilities
                                         and obligations to third parties. The performance of the responsibilities and obligations
                                         by such third parties shall be subject to the oversight and supervision of the Investment
                                         Manager. Except to the extent caused directly by the Investment Manager&rsquo;s negligence,
                                         fraud or willful default, the Investment Manager shall not be liable for the acts and
                                         omissions of such third parties.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 27pt; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 27pt; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">b)</FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                         Investment Manager shall be entitled to obtain investment and other advice from such
                                         source or sources and on such terms as it thinks fit (including, without prejudice to
                                         the generality of the foregoing, full power to appoint one or more investment advisers,
                                         approved by the Company, to advise as to the investment and re-investment of the Investments).</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: italic 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 24pt; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal">1.4</FONT></TD><TD STYLE="padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Custody</I></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Portfolio
securities and other financial assets of the Company shall be maintained at all times in the custody of the Administrator or in
the custody of one or more banks, trust companies, brokerage firms or other financial institutions as shall have been selected
for that purpose by the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P>

<!-- Field: Page; Sequence: 5; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: italic 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 24pt; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal">1.5</FONT></TD><TD STYLE="padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Investments
                                         for the Accounts of Others</I></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 27pt; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 18pt; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a)</FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                         services of the Investment Manager to the Company under this Agreement are not to be
                                         deemed exclusive. It is understood that the Investment Manager and its affiliates may
                                         effect investment transactions for their own account and for the accounts of other customers,
                                         and the Company further understands and agrees that nothing herein shall restrict the
                                         ability of the Investment Manager and its affiliates to engage in any such transactions
                                         notwithstanding the fact that the Company may have or may take a position of any kind;
                                         provided, however, that neither the Investment Manager nor any of its affiliates shall,
                                         without the consent of the Company, cause the Company to purchase any asset from or sell
                                         any asset to the Investment Manager or any of its affiliates or any other person or entity
                                         for which the Investment Manager or its affiliates is acting, unless such transaction
                                         involves the purchase or sale of a security listed on a recognized securities exchange
                                         and such transaction is effected at current market prices.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 27pt; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 18pt; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">b)</FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                         Investment Manager hereby agrees to act on a fair and equitable basis in allocating suitable
                                         investment and trading opportunities among the account of the Company and any other accounts
                                         managed by the Investment Manager. In furtherance of the foregoing, the Investment Manager
                                         will consider participation by the Company in all appropriate opportunities within the
                                         purpose and scope of the Company&rsquo;s objectives, which are under consideration for the
                                         accounts of other clients of the Investment Manager. When the Investment Manager determines
                                         that it would be appropriate for the Company and any such other accounts to participate
                                         in an investment opportunity, the Investment Manager will seek to execute orders on a
                                         basis consistent with the principles of fairness and equity.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: italic 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 24pt; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal">1.6</FONT></TD><TD STYLE="padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Establishment
                                         of subsidiaries</I></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Investment Manager may, if in its discretion it determines that it is in the best interest of the Company to do so, establish
one or more sub-accounts or arrange for the establishment of or acquisition of one or more business entities, which will be wholly-owned
by the Company and whose assets will be managed by the Investment Manager, through which the Company may invest its assets in
any jurisdiction.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 6; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">PART
2. ADMINISTRATIVE SERVICES</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal">2.1
The Investment Manager shall be responsible for assisting the Company in selecting the appropriate entities to perform all
necessary custodian and registrar services and certain administrative services for the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal">2.2
The Investment Manager shall take reasonable measures to (i) monitor the performance by the Administrator of their duties
with respect to the Company, (ii) coordinate such performance with the performance of the services contemplated hereunder,
and (iii) assist the Company in procuring the future performance of administrative services whenever necessary.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal">2.3
The Investment Manager shall hold and store certain information for the Company, reconcile financial statements of the
Company with the Administrator and with brokers, and send acceptances of trades placed where applicable. Upon the reasonable
request of the Company, it shall perform other administrative services appropriate in connection with the operations of the
Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">PART
3. PLACEMENT AND ADVISORY SERVICES</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: italic 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 24pt; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal">3.1</FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Provision
                                         of Placement Duties and Advisory Services</I></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
accordance with provisions of the Articles, and under the ultimate supervision of the Board of directors of the Company from time
to time as provided therein, the Investment Manager shall be responsible for performing (or procuring the performance of), and
is hereby authorized and empowered to perform (or procure the performance of), all duties and functions necessary or appropriate
in connection with the placement of the Participating Shares and advising the Company on general matters affecting its structure
and operations, including from time to time advising the Board of directors of the Company concerning:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 24pt; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 18pt; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a)</FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                         suitability of the Company&rsquo;s structure and operating procedures in light of the expectations
                                         of prospective investors;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -27pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 24pt; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 18pt; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">b)</FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">steps
                                         which may be taken to enhance the marketability of the Participating Shares and to improve
                                         investor relations;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -27pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 24pt; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 18pt; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">c)</FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">general
                                         economic and financial developments in international securities and capital markets affecting
                                         the Company&rsquo;s investment programme.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P>

<!-- Field: Page; Sequence: 7; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: italic 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 24pt; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal">3.2</FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Placement
                                         of Participating Shares</I></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Investment Manager shall act as the exclusive placing agent for the Company&rsquo;s Participating Shares in accordance with all relevant
and applicable law. The Investment Manager shall use its best efforts to procure applications for the purchase of Participating
Shares by eligible investors, either directly or through securities dealers and other financial institutions selected by the Investment
Manager pursuant to Section 3.3 hereof (&ldquo;authorized dealers&rdquo;). The Participating Shares shall be offered at the subscription
price and on the terms and conditions set forth herein and in the Private Placing Memorandum. All applicants shall be subject
to acceptance by the Company (it being understood that the Company shall have the right to reject applications or to receive or
accept on behalf of the Company any funds or other property tendered as payment for Participating Shares).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: italic 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 24pt; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal">3.3</FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Authorized
                                         Dealers</I></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 27pt; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 18pt; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a)</FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                         Investment Manager may appoint securities dealers and other financial institutions as
                                         authorized dealers to solicit applications to purchase the Participating Shares, one
                                         or more of whom may be affiliates of the Investment Manager. The Investment Manager shall
                                         use reasonable efforts to ensure that any such authorized dealer shall conduct solicitation
                                         activities in accordance with all of the conditions, restrictions and limitations applicable
                                         to the Investment Manager&rsquo;s direct placement activities as set forth in this Agreement
                                         or in the Private Placing Memorandum.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: -27pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 27pt; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 18pt; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">b)</FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                         Investment Manager shall pay commissions, if any, to any such authorized dealers solely
                                         out of the proceeds received by the Investment Manager as either Management Fees, the
                                         Performance Fees and/or the Initial Charge (as described in Section 4 hereof).</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 27pt; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 18pt; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">c)</FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                         Investment Manager shall promptly furnish to the Company a copy of any written agreement
                                         (and a written summary of any oral agreement) with any authorized dealer relating to
                                         the solicitation of applications for the Participating Shares.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: italic 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 24pt; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal">3.4</FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Offering
                                         Materials</I></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 27pt; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 18pt; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a)</FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                         Investment Manager shall deliver, or arrange for the delivery by any authorized dealer
                                         selected by the Investment Manager, to each person to whom the Participating Shares are
                                         offered a copy of the Company&rsquo;s most recently published Private Placing Memorandum which
                                         the Company shall have provided to the Investment Manager.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 27pt; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 18pt; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">b)</FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
                                         any form of offering materials (including any form of advertisement or other solicitation
                                         materials calculated to result in an expression of interest in subscribing for the Participating
                                         Shares) concerning the Company or the Participating Shares other than the Private Placing
                                         Memorandum is required or permitted to be given to any prospective investor under the
                                         laws of any jurisdiction in which the Participating Shares are offered by or through
                                         the Investment Manager, the Investment Manager agrees that any such document (i) shall
                                         not contain any information concerning the Company or the Participating Shares which
                                         is inconsistent with the Private Placing Memorandum, and (ii) shall comply in all respects
                                         with the laws of the jurisdiction in which it is furnished. The Investment Manager shall
                                         not (and shall not permit any authorized dealer appointed by the Investment Manager to)
                                         publish or furnish any such offering literature which contains any reference to the Company
                                         without the prior approval of the Company.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 8; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 27pt; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 18pt; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">c)</FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                         Investment Manager acknowledges and agrees that no person is authorized to make any representations,
                                         whether written or oral, concerning the Company and the Participating Shares which are
                                         inconsistent with the Private Placing Memorandum and that all offers of the Participating
                                         Shares shall be made in conformity with the terms and conditions set forth therein.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: italic 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 24pt; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal">3.5</FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Certain
                                         Legal Restrictions</I></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 27pt; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 18pt; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a)</FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">None
                                         of the Participating Shares shall be offered by the Investment Manager or any authorized
                                         dealer to any person who is not reasonably believed by the Investment Manager or the
                                         authorized dealer to be an eligible investor as set forth in the Private Placing Memorandum.
                                         Furthermore, none of the Participating Shares shall be offered or sold to any person
                                         to whom it would be illegal to offer of sell the Participating Shares.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 27pt; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 18pt; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">b)</FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                         Participating Shares and the Company have not been and will not be registered or qualified
                                         for offer and sale under the applicable laws of any jurisdiction governing the offer
                                         or sale of investment company shares or other securities. Neither the Investment Manager
                                         nor any authorized dealer shall (i) solicit any applications or otherwise extend any
                                         offers for the purchase of the Participating Shares, or (ii) deliver (or have in their
                                         possession for the purpose of delivery) the Private Placing Memorandum or any other offering
                                         literature relating to the Company or the Participating Shares, to any person in any
                                         jurisdiction in which such solicitation or delivery would be unlawful. The Investment
                                         Manager represents to the Company that it has informed itself as to the applicable legal
                                         restrictions governing the offer and sale of the Participating Shares under the laws
                                         of any jurisdiction in which it intends to place share applications and that based on
                                         the methods of placement contemplated by the Investment Manager, the sale of the Participating
                                         Shares by the Company to any person in any such jurisdiction will not be in violation
                                         of any applicable laws by reason of the activities of the Investment Manager. The Investment
                                         Manager undertakes to comply with the foregoing representations in connection with its
                                         placement activities (including the appointment of any authorized dealers) during the
                                         term of this Agreement.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 9; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">PART
4. COMPENSATION</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
its services hereunder, the Investment Manager shall be entitled to receive from the Company:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: italic 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 24pt; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal">4.1</FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Management
                                         Fee</I></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Investment Manager will receive a basic management fee (the &ldquo;Management Fee&rdquo;) equal to 1.5 per cent. per annum of the
Net Asset Value (before deduction of any accrued Management Fee and Performance Fee (as defined below)) accrued and calculated
on the basis of the Net Asset Value of the Company as at each Valuation Point and payable monthly in arrears. If the Investment
Management Agreement is terminated as of a date other than the last day of a month, the Management Fee will be prorated through
the termination date. A pro rata fee will also be charged to reflect subscriptions as of any date other than the beginning of
a month. Such monthly Management Fee shall be payable generally in arrears on the first Business Day of each calendar month.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: italic 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 24pt; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal">4.2</FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Performance
                                         Fee</I></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 27pt; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 18pt; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a)</FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                         Investment Manager will also receive a Performance Fee (the &ldquo;Performance Fee&rdquo;)
                                         from the Company calculated on a Share-by-Share basis so that each Participating Share
                                         is charged a Performance Fee which equates as nearly as reasonably practicable with that
                                         Participating Share&rsquo;s performance. The Performance Fee for each Performance Period
                                         (as defined in the Private Placing Memorandum) in respect of each Participating Share
                                         will be equal to 20% of the appreciation in the Net Asset Value per Participating Share
                                         (before deduction of any accrued performance fee) during the Performance Period above
                                         the High Water Mark of that Participating Share. The High Water Mark is the greater of:</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -28.35pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 45pt; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 27pt; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)</FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                         Net Asset Value per Participating Share of the relevant class at the time of issue of
                                         that Participating Share; and</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -27pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 45pt; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 27pt; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)</FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                         highest Net Asset Value per Participating Share of the relevant class (after deduction
                                         of any accrued Performance Fee) in respect of which a Performance Fee (other than a Performance
                                         Fee Redemption (as defined below)) have been paid at the end of any previous Performance
                                         Period (if any) during which such Participating Share was in issue.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 10; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 45pt; text-align: justify; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Performance Fee in respect of each Performance Period will be calculated by reference to the Net Asset Value before deduction
for any accrued Performance Fee.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 45pt; text-align: justify; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 45pt; text-align: justify; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Performance Fee is normally payable in arrears within 20 Business Days of the end of each Performance Period. However, in the
case of Participating Shares redeemed part way through a Performance Period, the Performance Fee accrued in respect of those Participating
Shares is payable within 20 Business Days after the date of redemption.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 45pt; text-align: justify; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 45pt; text-align: justify; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
an investor subscribes for Participating Shares at a time when the NAV per Participating Share is other than the Peak Net Asset
Value per Participating Share, certain adjustments as described in the Private Placing Memorandum (the Peak Net Asset Value being
defined therein) will be made to reduce inequities that could otherwise result to the subscriber or to the Investment Manager.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 45pt; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 45pt; text-align: justify; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Investment Manager may reallocate all or part of such fees to third parties assisting in the placement of Participating Shares.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 45pt; text-align: justify; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 45pt; text-align: justify; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Investment Manager has no obligation to restore to the Company any Performance Fee previously accrued in one financial year, notwithstanding
a loss in a subsequent financial year.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -27pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 27pt; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 18pt; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">b)</FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
                                         the event that this Agreement is terminated part way through a Performance Period, the
                                         Company shall pay, in respect of all Participating Shares, the Performance Fee accrued
                                         as at the last Valuation Point before such termination (subject to any adjustments as
                                         set out in the Private Placing Memorandum).</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -27pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 27pt; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 18pt; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">c)</FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                         Company acknowledges that the Performance Fee may create an incentive for the Investment
                                         Manager to make investments that may involve more risk than would be the case in the
                                         absence of a fee based on the performance of the Company. In addition, the Performance
                                         Fee shall be based on unrealized as well as realized, appreciation and depreciation of
                                         the investments of the Company.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -27pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 27pt; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 18pt; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">d)</FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                         Performance Fee shall be computed in a manner consistent with the Articles and the Private
                                         Placing Memorandum.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 11; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: italic 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 24pt; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal">4.3</FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Initial
                                         Charge</I></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Investment Manager will also be entitled to receive an initial charge (the &ldquo;Initial Charge&rdquo;) of up to 3 per cent.
of the subscription proceeds for the issue of the relevant Participating Shares.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">PART
5. GENERAL PROVISIONS</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: italic 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 24pt; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal">5.1</FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Expenses</I></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 27pt; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 18pt; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a)</FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Except
                                         as otherwise provided below, the Investment Manager shall bear all of its own costs and
                                         expenses incurred in the performance of its services provided pursuant to this Agreement,
                                         including those attributable to such officer personnel, office space, office equipment
                                         and office services as may be required by the Investment Manager.</FONT></TD></TR>                                                                                                                           <TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0; text-align: justify">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0; text-align: justify">&nbsp;</TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
</TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 27pt; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif; text-align: justify"></TD><TD STYLE="width: 18pt; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">b)</FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Except
                                         as set forth above, the Company shall bear the following costs and expenses:</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -27pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 54pt; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif; text-align: justify"></TD><TD STYLE="width: 27pt; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif; text-align: justify">&#9679;</TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                         preliminary expenses of the Company (including fees in connection with the incorporation
                                         of the Company in the Cayman Islands), the costs incurred in connection with the preparation
                                         and execution of the material contracts referred to below under paragraph 1 of the section
                                         headed &ldquo;General Information&rdquo; in the Private Placing Memorandum and other initial
                                         documents, and all initial legal and printing costs;</FONT></TD></TR>                                                                                                              <TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0; text-align: justify">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0; text-align: justify">&nbsp;</TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
</TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 54pt; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif; text-align: justify"></TD><TD STYLE="width: 27pt; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                         charges and expenses of legal advisers and auditors;</FONT></TD></TR>                                                                                                              <TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0; text-align: justify">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0; text-align: justify">&nbsp;</TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
</TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 54pt; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif; text-align: justify"></TD><TD STYLE="width: 27pt; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">brokers&rsquo;
                                         commissions (if any), borrowing charges on securities sold short and any issue or transfer
                                         taxes or stamp duties chargeable in connection with any securities transactions;</FONT></TD></TR>                                                                                                                                          <TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0; text-align: justify">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0; text-align: justify">&nbsp;</TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
</TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 54pt; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif; text-align: justify"></TD><TD STYLE="width: 27pt; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">all
                                         taxes and corporate fees payable to governments or agencies;</FONT></TD></TR>                                                                                                                      <TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0; text-align: justify">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0; text-align: justify">&nbsp;</TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
</TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 54pt; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif; text-align: justify"></TD><TD STYLE="width: 27pt; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                         fees of the Directors (which are not expected to exceed US$25,000 per Director per annum)
                                         and the reasonable travel and per diem expenses of the Directors;</FONT></TD></TR>                                                                                                                           <TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0; text-align: justify">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0; text-align: justify">&nbsp;</TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
</TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 54pt; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif; text-align: justify"></TD><TD STYLE="width: 27pt; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">interest
                                         on borrowings, including borrowings from the Prime Brokers/Custodian;</FONT></TD></TR>                                                                                                                               <TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0; text-align: justify">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0; text-align: justify">&nbsp;</TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
</TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 54pt; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif; text-align: justify"></TD><TD STYLE="width: 27pt; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">communication
                                         expenses with respect to investor services including periodic investor meetings and all
                                         expenses of meetings of Shareholders and of preparing, printing and distributing financial
                                         and other reports, proxy forms, prospectuses and similar documents;</FONT></TD></TR>                                                                                                                             <TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0; text-align: justify">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0; text-align: justify">&nbsp;</TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
</TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 54pt; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif; text-align: justify"></TD><TD STYLE="width: 27pt; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                         cost of insurance (if any) for the benefit of the Directors;</FONT></TD></TR>                                                                                                                      <TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0; text-align: justify">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0; text-align: justify">&nbsp;</TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
</TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 54pt; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif; text-align: justify"></TD><TD STYLE="width: 27pt; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                         cost of printing and distributing the annual and statements;</FONT></TD></TR></TABLE>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0"></P>

<!-- Field: Page; Sequence: 12; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0">&nbsp;</P>


<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 54pt; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 27pt; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">investment
                                         specific research and investment consultancy expenses;</FONT></TD></TR>                                                                                                                <TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0">&nbsp;</TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
</TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 54pt; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 27pt; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">due
                                         diligence expenses for on-site research and due diligence;</FONT></TD></TR>                                                                                                                    <TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0">&nbsp;</TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
</TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 54pt; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 27pt; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">litigation
                                         and indemnification expenses and extraordinary expenses not incurred in the ordinary
                                         course of business;</FONT></TD></TR>                                                                             <TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0">&nbsp;</TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
</TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 54pt; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 27pt; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                         cost of obtaining and maintaining any future listing of the Participating Shares on any
                                         stock exchange; and</FONT></TD></TR>                                                                             <TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0">&nbsp;</TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
</TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 54pt; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 27pt; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">all
                                         other operating and administrative expenses.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: italic 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 24pt; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal">5.2</FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Soft
                                         Commissions</I></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Investment Manager and/or any company associated with it may effect transactions by or through the agency of another person with
whom the Investment Manager and/or any company associated with it may have an arrangement under which that party will from time
to time provide to or procure for the Investment Manager and/or any company associated with it goods, services and other benefits,
such as research and advisory services, computer hardware, telecommunications equipment, software, database services and other
similar services, the nature of which is such that their provision can reasonably be expected to benefit the Company as a whole
and may contribute to an improvement in the performance of the Company or of the Investment Manager and/or any company associated
with it in providing services to the Company. The Manager and/or any company associated with it shall not receive any direct payment
from such party. The Manager and/or any company associated with it may however undertake to place business with that party. For
the avoidance of doubt, such goods and services do not include travel, accommodation, entertainment, general administrative goods
or services, general office equipment or premises, membership fees, employee salaries or direct money payments. In any event,
the execution of transactions will be consistent with best execution standards, and brokerage rates will not be in excess of customary
institutional full-service brokerage rates.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: italic 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 24pt; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal">5.3</FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Rebates</I></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Investment Manager and/or any company associated with it may enter into portfolio transactions for or with the Company either
as agent in which case they may receive and retain customary brokerage commission and/or cash commission rebates, or with the
approval of the directors of the Company, deal as a principal with the Company in accordance with normal market practice, provided
that commissions charged to the Company in these circumstances do not exceed customary full service brokerage rates.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: italic 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 24pt; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal">5.4</FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Scope
                                         of Liabilities</I></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Investment Manager shall not be liable to the Company or its shareholders for any losses, damages, expenses or claims occasioned
by any acts of omissions of the Investment Manager in connection with the performance of its services hereunder, other than as
a result of its own wilful default, fraud or negligence and contains provisions for the indemnification of the Investment Manager
by the Company hereunder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 13; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: italic 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 24pt; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal">5.5</FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Indemnification</I></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 27pt; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 18pt; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a)</FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                         Company shall indemnify the Investment Manager (which shall include, solely for purposes
                                         of this Section 5.3, the Investment Manager&rsquo;s directors, officers, employees and shareholders)
                                         and hold the Investment Manager harmless from and against any expense, loss, liability
                                         or damage arising out of any claim asserted or threatened to be asserted in connection
                                         with the Investment Manager&rsquo;s serving or having served in good faith pursuant to this
                                         Agreement; provided, however, that the Investment Manager shall not be entitled to any
                                         such indemnification with respect to any expense, loss, liability or damage which was
                                         caused by the Investment Manager&rsquo;s own willful default, fraud or negligence.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 27pt; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 18pt; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">b)</FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                         Investment Manager shall indemnify the Company against, and hold it harmless from, any
                                         expense, loss, liability or damage arising out of any claim asserted or threatened to
                                         be asserted by any third party as a consequence (i) of any misstatement of any material
                                         fact or any other misrepresentation concerning the Company or the Participating Shares
                                         by the Investment Manager or (ii) willful default, fraud or negligence on the part of
                                         the Investment Manager.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: -27pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 27pt; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 18pt; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">c)</FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
                                         the event that either party hereto is or becomes a party to any action or proceeding
                                         in respect of which it may be entitled to seek indemnification hereunder (the &ldquo;indemnitee&rdquo;),
                                         the indemnitee shall promptly notify the other party (the &ldquo;indemnitor&rdquo;) thereof.
                                         The indemnitor shall be entitled to participate in any such suit or proceeding and, to
                                         the extent that it may wish, to assume the defense thereof with counsel reasonably satisfactory
                                         to the indemnitee. After notice of an election by the indemnitor so to assume the defense
                                         thereof, the indemnitor will not be liable to the indemnitee hereunder for any legal
                                         or other expenses subsequently incurred by the indemnitee in connection with the defense
                                         thereof other than reasonable costs of investigation or reasonable legal expenses incurred
                                         as a result of (i) potential conflicts of interest between the indemnitee and indemnitor
                                         or (ii) the protection of proprietary or privacy interests of other clients of the indemnitee.
                                         The indemnitor shall advance to the indemnitee the reasonable costs and expenses of investigating
                                         and/or defending such claim, subject to receiving a written undertaking from the indemnitee
                                         to repay such amounts if and to the extent of any subsequent determination by a court
                                         or other tribunal of competent jurisdiction that the indemnitee was not entitled to indemnification
                                         hereunder.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: -27pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 27pt; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 18pt; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">d)</FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                         indemnitor shall not be liable hereunder for any settlement of any action or claim effected
                                         without its written consent thereto.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P>

<!-- Field: Page; Sequence: 14; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: italic 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 24pt; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal">5.6</FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Independent
                                         Contractor</I></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
all purposes of this Agreement, the Investment Manager shall be an independent contractor and not an employee or agent of the
Company nor shall anything herein be construed as making the Company a partner or co-venturer with the Investment Manager or any
of its affiliates.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: italic 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 24pt; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal">5.7</FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Information
                                         Concerning Activities</I></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Investment Manager shall provide to the Company from time to time information regarding the Investment Manager and any authorized
dealers and concerning the activities undertaken by them for the Company as the Company may reasonably request.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: italic 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 24pt; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal">5.8</FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Term,
                                         Termination and Renewal</I></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 27pt; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 18pt; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a)</FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
                                         Agreement shall have an initial term of five (5) years. Thereafter, this Agreement will
                                         be automatically renewed for successive five-year periods, subject to termination as
                                         of the close of any calendar year by either party upon not less than four (4) months&rsquo;
                                         prior written notice to the other.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -27pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 27pt; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 18pt; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">b)</FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                         Company or the Manager may terminate this Agreement at any time by notice to the other
                                         party, if the other party commits any material breach of its obligations under this Agreement
                                         and (if such breach shall be capable of remedy) shall fail within [thirty] days of receipt
                                         of notice requiring it so to do to make good such breach; or if the other party shall
                                         go into liquidation (except a voluntary liquidation for the purposes of reconstruction
                                         or amalgamation upon terms previously approved in writing by the other party) or be unable
                                         to pay its debts or commit any act of bankruptcy under the laws of the relevant jurisdiction;
                                         or if a receiver is appointed of any of the assets of the other party or if some event
                                         having an equivalent effect occurs. The Investment Manager may also terminate this Agreement
                                         at any time by notice to the Company if the Investment Manager ceases to be permitted
                                         to render the services contemplated under this Agreement pursuant to the applicable laws
                                         of the relevant jurisdiction.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: -27pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 27pt; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 18pt; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">c)</FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
                                         the event of any termination of this Agreement, the provisions of Part 5 shall survive.
                                         All amounts accrued and otherwise payable to the Investment Manager shall be due and
                                         payable to the Investment Manager as of the date of termination (subject to any adjustments
                                         as set out in the Private Placing Memorandum).</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P>

<!-- Field: Page; Sequence: 15; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: italic 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 24pt; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal">5.9</FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Modification,
                                         Waiver</I></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Except
as otherwise expressly provided herein, this Agreement shall not be amended, nor shall any provision of this Agreement be considered
modified or waived, unless evidenced by a writing signed by the party to be charged with such amendment, waiver or modification.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: italic 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 24pt; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal">5.10</FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Binding
                                         Effect; Assignment</I></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
Agreement shall be binding upon and inure to the benefit of the parties hereto and their respective successors, but the rights
and obligations hereunder shall not be assignable, transferable or delegable without the written consent of the other party hereto
and any attempted assignment, transfer or delegation thereof without such consent shall be void. The foregoing shall not prevent
an assignment by the Investment Manager to any of its affiliates without obtaining the written consent of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: italic 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 24pt; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal">5.11</FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Governing
                                         Law</I></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
Agreement shall be governed by and construed in accordance with the substantive laws of the Cayman Islands.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: italic 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 24pt; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal">5.12</FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Counterparts</I></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
Agreement may be signed in any number of counterparts. Any single counterpart or a set of counterparts signed in either case by
the parties hereto, shall constitute a full and original Agreement for all purposes and all such counterparts together shall constitute
one and the same Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: italic 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 24pt; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal">5.13</FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Entire
                                         Agreement</I></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
Agreement contains the entire Agreement between the parties with respect to the subject matter hereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 16; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">IN
WITNESS WHEREOF, the parties have executed this Agreement as of the day and year first above written.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="padding: 0; text-indent: 0">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="padding: 0; text-indent: 0">STRIKER CAPITAL MANAGEMENT LIMITED</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding: 0; text-indent: 0">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="padding: 0; text-indent: 0">(the &ldquo;Investment Manager&rdquo;)</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding: 0; text-indent: 0; width: 60%">&nbsp;</TD>
    <TD STYLE="padding: 0; text-indent: 0; width: 5%">&nbsp;</TD>
    <TD STYLE="padding: 0; text-indent: 0; width: 35%">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding: 0; text-indent: 0">&nbsp;</TD>
    <TD STYLE="padding: 0; text-indent: 0">By:</TD>
    <TD STYLE="padding: 0; text-indent: 0; border-bottom: Black 1.5pt solid">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding: 0; text-indent: 0">&nbsp;</TD>
    <TD STYLE="padding: 0; text-indent: 0">Name:</TD>
    <TD STYLE="padding: 0; text-indent: 0">Michael Ching</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding: 0; text-indent: 0">&nbsp;</TD>
    <TD STYLE="padding: 0; text-indent: 0">Title:</TD>
    <TD STYLE="padding: 0; text-indent: 0">Executive Director</TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 207pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">STRIKER
    ASIA OPPORTUNITIES FUND CORPORATION</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(the
    &ldquo;Company&rdquo;)</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding: 0; text-indent: 0; width: 60%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="padding: 0; text-indent: 0; width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="padding: 0; text-indent: 0; width: 35%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">By:</FONT></TD>
    <TD STYLE="padding: 0; text-indent: 0; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">Name:</FONT></TD>
    <TD STYLE="padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">John Lewis</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">Title:</FONT></TD>
    <TD STYLE="padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">Director</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 207pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 207pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; text-align: center; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">15</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 207pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 0; margin-bottom: 0"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 207pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.17
<SEQUENCE>21
<FILENAME>ff12018ex10-17_aptorum.htm
<DESCRIPTION>FIRST ADDENDUM TO THE MANAGEMENT AGREEMENT BETWEEN THE COMPANY AND APTUS CAPITAL LIMITED, DATED FEBRUARY 10, 2012
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif; text-align: right"><B>Exhibit 10.17</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>ADDENDUM
TO THE INVESMENT MANAGEMENT AGREEMENT</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B></B>THIS ADDENDUM TO THE INVESTMENT MANAGEMENT AGREEMENT (this &ldquo;Addendum&rdquo;) is
made and entered into as of the ____ day of __________, 2012 by and between Striker Capital Management Limited (the &ldquo;Investment
Manager&rdquo;) and Striker Asia Opportunities Fund Corporation (the &ldquo;Company&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">WHEREAS,
the parties have entered into an Investment Management Agreement dated 26<SUP>th</SUP> October, 2010 (the &ldquo;Agreement&rdquo;);
and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">WHEREAS,
the Agreement provides for investment management services by the Investment Manager for the Company; and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">WHEREAS,
the Investment Manager, given its adoption to a more conservative approach to the Company&rsquo;s portfolio structure and investment
style, wishes to adjust the Management Fee and the Performance Fee, in accordance with this Addendum, as further described herein.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">NOW,
THEREFORE, in consideration of the foregoing and the mutual covenants, the parties agree as follows:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 24pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Capitalized
                                         terms not defined herein have the meanings set forth in the Agreement.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 24pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
                                         4.1 in the Agreement is deleted and replaced with the followings:</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 24pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Investment Manager will receive a basis management fee (the &ldquo;Management Fee&rdquo;) equal to 2.5 per cent. per annum of
the Net Asset Value (before deduction of any accrued Management Fee and Performance Fee (as defined below)) accrued and calculated
on the basis of the Net Asset Value of the Company as at each Valuation Point and payable monthly in arrears. If the Investment
Management Agreement is terminated as of a date other than the last day of a month, the Management Fee will be prorated through
the termination date. A pro rata fee will also be charged to reflect subscriptions as of any date other than the beginning of
a month. Such monthly Management Fee shall be payable generally in arrears on the first Business Day of each calendar month.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 24pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">First
                                         paragraph of Section 4.2(a) in the Agreement is deleted and replaced with the followings:</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 24pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 24pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Investment Manager will also receive a Performance Fee (the &ldquo;Performance Fee&rdquo;) from the Company calculated on a Share-by-Share
basis so that each Participating Share is charged a Performance Fee which equates as nearly as reasonably practicable with that
Participating Share&rsquo;s performance. The Performance Fee for each Performance Period (as defined in the Private Placing Memorandum)
in respect of each Participating share will equal to 15% of the appreciation in the Net Asset Value per Participating Share (before
deduction of any accrued of any accrued performance fee) during the Performance Period above the High Water Mark of that Participating
Share. The High Water Mark is the greater of:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 24pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 48pt; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 36pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                         Net Asset Value per Participating Share of the relevant class at the time of issue of
                                         that Participating Share; and</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 48pt; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 36pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                         highest Net Asset Value per Participating Share of the relevant class (after deduction
                                         of any accrued Performance Fee) in respect of which a Performance Fee (other than a Performance
                                         Fee Redemption (as defined below)) shall have been paid at the end of any previous Performance
                                         Period (if any) during which such Participating Share was in issue.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 24pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Except
                                         as expressly set forth herein, the terms and conditions of the Agreement shall continue
                                         in full force and effect.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 24pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
                                         Addendum may be executed in one or more counterparts, each of which when executed shall
                                         be deemed to be an original, but all of which taken together shall constitute one and
                                         the same instrument.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 24pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
                                         the event of a conflict between the Agreement and this Addendum, the terms and conditions
                                         of this Addendum shall control.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">WHEREFORE,
the parties hereto have executed this Addendum as of the date first stated above.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: justify; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">STRIKER
    CAPITAL MANAGEMENT LIMITED</FONT></TD>
    </TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: justify; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">(the
    &ldquo;Investment Manager&rdquo;)</FONT></TD>
    </TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: justify; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    </TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 60%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 5%; text-align: justify; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">By:</FONT></TD>
    <TD STYLE="width: 35%; text-align: justify; padding: 0; text-indent: 0; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    </TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">Name:</FONT></TD>
    <TD STYLE="text-align: justify; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">Michael
    Ching</FONT></TD>
    </TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">Title:</FONT></TD>
    <TD STYLE="text-align: justify; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">Executive
    Director</FONT></TD>
    </TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: justify; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    </TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: left; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">STRIKER
    ASIA OPPORTUNITIES FUND CORPORATION</FONT></TD>
    </TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: justify; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">(the
    &ldquo;Company&rdquo;)</FONT></TD>
    </TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    </TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">By:</FONT></TD>
    <TD STYLE="text-align: justify; padding: 0; text-indent: 0; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    </TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">Name:</FONT></TD>
    <TD STYLE="text-align: justify; padding: 0; text-indent: 0"></TD>
    </TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">Title:</FONT></TD>
    <TD STYLE="text-align: justify; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">Director</FONT></TD>
    </TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 3; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B></B></FONT></P>



<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.18
<SEQUENCE>22
<FILENAME>ff12018ex10-18_aptorum.htm
<DESCRIPTION>SECOND ADDENDUM TO THE MANAGEMENT AGREEMENT BETWEEN THE COMPANY AND APTUS CAPITAL LIMITED, DECEMBER 9, 2016
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0; text-align: right"><B>Exhibit 10.18</B></P>

<P STYLE="margin-top: 0; text-align: center; margin-bottom: 0">&nbsp;</P>

<P STYLE="margin: 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>SECOND
ADDENDUM TO THE INVESTMENT MANAGEMENT AGREEMENT</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">THIS
SECOND ADDENDUM TO THE INVESTMENT MANAGEMENT AGREEMENT (this &ldquo;2<SUP>nd</SUP> Addendum&rdquo;) is made and entered into as
of the ____ day of ______________, 2016 by and between Guardian Capital Management Limited (the &ldquo;Investment Manager&rdquo;)
and Striker Asia Opportunities Fund Corporation (the &ldquo;Company&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">WHEREAS,
the parties have entered into an Investment Management Agreement dated 26 October 2010 (the &ldquo;Agreement&rdquo;), and an addendum
to the Investment Management Agreement dated 10 February 2012 (&ldquo;1<SUP>st</SUP> Addendum&rdquo;); and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">WHEREAS,
the Agreement collectively with 1<SUP>st</SUP> Addendum and 2<SUP>nd</SUP> Addendum, together provides for investment management
services by the Investment Manager for the Company; and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">WHEREAS,
the Investment Manager wishes to terminate Performance Fee, in accordance with this 2<SUP>nd</SUP> Addendum, as further described
herein with full effect as of <B>1 January 2017</B>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">NOW,
THEREFORE, in consideration of the foregoing and the mutual covenants, the parties agree as follows:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Capitalized
                                         terms not defined herein have the meanings set forth in the Agreement.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">References
                                         to Performance Fee in <B>Point 3</B> of the 1<SUP>st</SUP> Addendum, and all sub-sections
                                         of <B>Section 4.2</B> of the Agreement shall be deleted in entirety.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Except
                                         as expressly set forth herein, the terms and conditions of the Agreement, read together
                                         with the 1<SUP>st</SUP> Addendum, shall continue in full force and effect.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
                                         2<SUP>nd</SUP> Addendum may be executed in one or more counterparts, each of which when
                                         executed shall be deemed to be original, but all of which taken together shall constitute
                                         one and the same instrument.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
                                         the event of a conflict between the Agreement or the 1<SUP>st</SUP> Addendum, and this
                                         2<SUP>nd</SUP> Addendum, the terms and conditions of this 2<SUP>nd</SUP> Addendum shall
                                         control.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">WHEREFORE,
the parties hereto have executed this 2<SUP>nd</SUP> Addendum as of the date first stated above.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">GUARDIAN CAPITAL MANAGEMENT LIMITED</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">(the &ldquo;Investment Manager&rdquo;)</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 60%; text-align: justify">&nbsp;</TD>
    <TD STYLE="width: 6%; text-align: left">&nbsp;</TD>
    <TD STYLE="width: 34%; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">By:</FONT></TD>
    <TD STYLE="text-align: left; border-bottom: Black 1.5pt solid">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Name:</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">HUEN Chung Yuen Ian</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Title:</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Managing Director</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">STRIKER ASIA OPPORTUNITIES FUND CORPORATION</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">(the &ldquo;Company&rdquo;)</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">By:</FONT></TD>
    <TD STYLE="text-align: left; border-bottom: Black 1.5pt solid">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Name:</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Kenrick Henry Fok</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Title:</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Authorised Signer</FONT></TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 2; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>



<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.19
<SEQUENCE>23
<FILENAME>ff12018ex10-19_aptorum.htm
<DESCRIPTION>SUBSCRIPTION AGREEMENT BETWEEN THE COMPANY AND PEACE RANGE LIMITED, DATED APRIL 6, 2018
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif; text-align: right"><B>Exhibit 10.19</B></P>

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif">&nbsp;&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 32%; padding: 0; text-align: left; font-size: 10pt; text-indent: 0"><IMG SRC="ex10-18_001.jpg" ALT=""></TD>
    <TD STYLE="width: 68%; text-align: right; font-size: 10pt; vertical-align: top; padding: 0; text-indent: 0"><B>EXECUTION VERSION</B></TD></TR>
</TABLE>


<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right; text-indent: 0.5in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 71.25pt"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 71.25pt"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">SUBSCRIPTION AGREEMENT</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 10pt; text-transform: uppercase">Aptorum
Group Limited </FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 10pt">as Issuer</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 10pt; text-transform: uppercase">Jurchen
Investment Corporation</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 10pt">as Guarantor</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 10pt">and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 10pt; text-transform: uppercase">Peace
Range Limited</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">as Subscriber</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">US$15,000,000 8.00 per cent.
Convertible Bonds due 2019 convertible into shares of Aptorum Group Limited</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">6 April
2018&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</P>



<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>&nbsp;</B></FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">CONTENTS</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: left"></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>



<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; text-transform: uppercase; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; text-indent: -39.1pt; padding-top: 0in; border-bottom: Black 1.5pt solid; padding-left: 39.1pt"><B>CLAUSE</B></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-top: 0in; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><B>PAGE</B></P>


</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; text-transform: uppercase; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; text-indent: -39.1pt; padding-top: 0in; padding-bottom: 0pt; padding-left: 39.1pt">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-top: 0in; padding-bottom: 0pt">&nbsp;</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; text-transform: uppercase; background-color: rgb(204,238,255)">
    <TD STYLE="width: 90%; text-align: left; text-indent: -39.1pt; padding-top: 0in; padding-bottom: 0pt; padding-left: 39.1pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.&nbsp;&nbsp;&nbsp;Interpretation</FONT></TD>
    <TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 9%; text-align: center; padding-top: 0in; padding-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1</FONT></TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; text-transform: uppercase; background-color: White">
    <TD STYLE="text-align: left; text-indent: -39.1pt; padding-top: 0in; padding-bottom: 0pt; padding-left: 39.1pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.&nbsp;&nbsp;&nbsp;ISSUE
    AND SUBSCRIPTION</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center; padding-top: 0in; padding-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4</FONT></TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; text-transform: uppercase; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; text-indent: -39.1pt; padding-top: 0in; padding-bottom: 0pt; padding-left: 39.1pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.&nbsp;&nbsp;&nbsp;REPRESENTATIONS
    and WARRANTIES of the Issuer and Guarantor</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center; padding-top: 0in; padding-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5</FONT></TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; text-transform: uppercase; background-color: White">
    <TD STYLE="text-align: left; text-indent: -39.1pt; padding-top: 0in; padding-bottom: 0pt; padding-left: 39.1pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.&nbsp;&nbsp;&nbsp;UNDERTAKINGS
    OF THE ISSUER and the guarantor</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center; padding-top: 0in; padding-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">19</FONT></TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; text-transform: uppercase; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; text-indent: -39.1pt; padding-top: 0in; padding-bottom: 0pt; padding-left: 39.1pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.&nbsp;&nbsp;&nbsp;GUARANTOR&rsquo;s
    buyback right</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center; padding-top: 0in; padding-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">26</FONT></TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; text-transform: uppercase; background-color: White">
    <TD STYLE="text-align: left; text-indent: -39.1pt; padding-top: 0in; padding-bottom: 0pt; padding-left: 39.1pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.&nbsp;&nbsp;&nbsp;Subscriber&rsquo;s
    rights</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center; padding-top: 0in; padding-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">27</FONT></TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; text-transform: uppercase; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; text-indent: -39.1pt; padding-top: 0in; padding-bottom: 0pt; padding-left: 39.1pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">7.&nbsp;&nbsp;&nbsp;ESG</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center; padding-top: 0in; padding-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">28</FONT></TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; text-transform: uppercase; background-color: White">
    <TD STYLE="text-align: left; text-indent: -39.1pt; padding-top: 0in; padding-bottom: 0pt; padding-left: 39.1pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8.&nbsp;&nbsp;&nbsp;subscriber&rsquo;s
    REPRESENTATIONS and warranties</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center; padding-top: 0in; padding-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">28</FONT></TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; text-transform: uppercase; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; text-indent: -39.1pt; padding-top: 0in; padding-bottom: 0pt; padding-left: 39.1pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">9.&nbsp;&nbsp;&nbsp;Subscriber&rsquo;s
    undertakingS</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center; padding-top: 0in; padding-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">29</FONT></TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; text-transform: uppercase; background-color: White">
    <TD STYLE="text-align: left; text-indent: -39.1pt; padding-top: 0in; padding-bottom: 0pt; padding-left: 39.1pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.&nbsp;SUBSCRIBER&rsquo;S
    acknowledgement</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center; padding-top: 0in; padding-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">30</FONT></TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; text-transform: uppercase; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; text-indent: -39.1pt; padding-top: 0in; padding-bottom: 0pt; padding-left: 39.1pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">11.&nbsp;CONDITIONS
    PRECEDENT</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center; padding-top: 0in; padding-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">30</FONT></TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; text-transform: uppercase; background-color: White">
    <TD STYLE="text-align: left; text-indent: -39.1pt; padding-top: 0in; padding-bottom: 0pt; padding-left: 39.1pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">12.&nbsp;ISSUANCE</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center; padding-top: 0in; padding-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">32</FONT></TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; text-transform: uppercase; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; text-indent: -39.1pt; padding-top: 0in; padding-bottom: 0pt; padding-left: 39.1pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">13.&nbsp;EXPENSES
    AND PAYMENTS</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center; padding-top: 0in; padding-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">33</FONT></TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; text-transform: uppercase; background-color: White">
    <TD STYLE="text-align: left; text-indent: -39.1pt; padding-top: 0in; padding-bottom: 0pt; padding-left: 39.1pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">14.&nbsp;TERMINATION</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center; padding-top: 0in; padding-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">34</FONT></TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; text-transform: uppercase; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; text-indent: -39.1pt; padding-top: 0in; padding-bottom: 0pt; padding-left: 39.1pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">15.&nbsp;COMMUNICATIONS</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center; padding-top: 0in; padding-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">35</FONT></TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; text-transform: uppercase; background-color: White">
    <TD STYLE="text-align: left; text-indent: -39.1pt; padding-top: 0in; padding-bottom: 0pt; padding-left: 39.1pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">16.&nbsp;ENTIRE
    AGREEMENT</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center; padding-top: 0in; padding-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">36</FONT></TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; text-transform: uppercase; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; text-indent: -39.1pt; padding-top: 0in; padding-bottom: 0pt; padding-left: 39.1pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">17.&nbsp;TIME</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center; padding-top: 0in; padding-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">36</FONT></TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; text-transform: uppercase; background-color: White">
    <TD STYLE="text-align: left; text-indent: -39.1pt; padding-top: 0in; padding-bottom: 0pt; padding-left: 39.1pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">18.&nbsp;GOVERNING
    LAW AND JURISDICTION</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center; padding-top: 0in; padding-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">36</FONT></TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; text-transform: uppercase; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; text-indent: -39.1pt; padding-top: 0in; padding-bottom: 0pt; padding-left: 39.1pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">19.&nbsp;GENERAL</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center; padding-top: 0in; padding-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">36</FONT></TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; text-transform: uppercase; background-color: White">
    <TD STYLE="text-align: left; text-indent: -39.1pt; padding-top: 0in; padding-bottom: 0pt; padding-left: 39.1pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">20.&nbsp;THIRD
    PARTY RIGHTS</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center; padding-top: 0in; padding-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">37</FONT></TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B></B></FONT></P>

<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>THIS
AGREEMENT</B> is made on 6 April 2018 (the &ldquo;<B>Signing Date</B>&rdquo;) between</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 39.1pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>APTORUM
                                         GROUP LIMITED</B>, a Cayman Islands exempted limited liability company with Hong Kong
                                         business registration number no. F0023235 with a registered address of Floor 4, Willow
                                         House, Cricket Square, Grand Cayman KY1-9010, Cayman Islands (the&nbsp;&ldquo;<B>Issuer</B>&rdquo;);</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 39.1pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>JURCHEN
                                         INVESTMENT CORPORATION</B> a company incorporated with limited liability under the laws
                                         of British Virgin Islands with business registration no. 511328 with a registered office
                                         is at Vistra Corporation Services Centre, Wickhams Cay II, Road Town, Tortola, VG1110,
                                         British Virgin Islands (the &ldquo;<B>Guarantor</B>&rdquo;); and</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 39.1pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>PEACE
                                                                                                                                                                                                                                 RANGE LIMITED</B> a company incorporated under the laws of the British Virgin Islands
                                                                                                                                                                                                                                 with business registration no. 1839278 with a registered address at [ ](the &ldquo;<B>Subscriber</B>&rdquo;).</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>RECITALS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 39.1pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(A)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                         Issuer, the Guarantor and the Subscriber have agreed to enter into this Agreement whereby
                                         the Issuer has agreed to issue US$15,000,000 in aggregate principal amount (&ldquo;<B>Principal
                                         Amount</B>&rdquo;) of 8.00 per cent. convertible bonds (the &ldquo;<B>Bonds</B>&rdquo;)
                                         due 2019 convertible into fully paid Class A ordinary shares of the Issuer (the &ldquo;<B>Shares</B>&rdquo;)
                                         as governed by the terms and subject to the terms and conditions in relation to the Bonds
                                         set out in Schedule 1 to this Agreement (the &ldquo;<B>Conditions</B>&rdquo;).</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 39.1pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(B)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                         Subscriber has agreed to subscribe the Principal Amount of the Bonds on the Issue Date.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 39.1pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(C)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                         Bonds will be guaranteed by the Guarantor pursuant to a deed of guarantee (&ldquo;<B>Deed
                                         of Guarantee</B>&rdquo;) entered into by the Issuer and the Guarantor in favour of the
                                         holders of the Bonds.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 39.1pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(D)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                         Bonds will be convertible into Shares upon and subsequent to the listing of the Issuer
                                         on NASDAQ or any principal stock exchange or securities market satisfactory to the Subscriber.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 39.1pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(E)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                         Issuer, the Guarantor and the Subscriber wish to record the arrangements agreed between
                                         them for the issue of, and subscription for, the Bonds as set out below.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>THE
PARTIES AGREE AS FOLLOWS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; text-transform: uppercase; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 39.1pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">1.</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Interpretation</B></FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 39.1pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.1</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
                                         this Agreement (including the recitals hereto), the following expressions have the following
                                         meanings:</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 39.1pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&ldquo;Account
Bank&rdquo;</B> has the meaning given to it in the Conditions;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 39.1pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 39.1pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&ldquo;Accounting
Items&rdquo;</B> means the (I) net profit after tax, (II) cash, (III) investment and (IV) net asset value as stated in any relevant
financial statement, and &ldquo;<B>Accounting Item</B>&rdquo; means any one of them;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 39.1pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 39.1pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&ldquo;Account
Charge&rdquo;</B> has the meaning given to it in the Conditions;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 39.1pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 39.1pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&ldquo;Applicable
Laws&rdquo;</B> means with respect to any person, any laws, rules, regulations, guidelines, directives, treaties, judgments, decrees,
orders or notices of any government agency that is applicable to and binding on such person;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 39.1pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 39.1pt; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 3; Options: NewSection; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 39.1pt; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 39.1pt; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 39.1pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&ldquo;Affiliate&rdquo;
</B>means, in relation to any specified person, any Person that directly or indirectly Controls the specified person or is directly
or indirectly Controlled by the specified person, or any Person that is under direct or indirect common Control with the specified
person;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 39.1pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 39.1pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&ldquo;Alternative
Stock Exchange&rdquo;</B> has the meaning given to it in the Conditions;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 39.1pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 39.1pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&ldquo;Bondholder&rdquo;
</B>has the meaning given to it in the Conditions;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 39.1pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 39.1pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&ldquo;Business
Days&rdquo; </B>has the meaning given to it in the Conditions;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 39.1pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 39.1pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&ldquo;Claim&rdquo;
</B>means, in relation to a person, any claim, allegation, cause of action, proceeding, liability, suit or demand made against
the person concerned, however it arises and whether it is present or future, fixed or unascertained, actual or contingent;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 39.1pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 39.1pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&ldquo;Control&rdquo;
</B>means possession, directly or indirectly, of the power to direct or cause the direction of the operations and management or
policies of a person, whether through the ownership of voting securities, by contract or otherwise, and <B>&ldquo;Controlled&rdquo;
</B>and <B>&ldquo;Controls&rdquo;</B> shall be construed accordingly;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 39.1pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 39.1pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&ldquo;Conversion
Price&rdquo;</B> has the meaning given to it in the Conditions;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 39.1pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 39.1pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&ldquo;Conversion
Right&rdquo;</B> has the meaning given to it in the Conditions;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 39.1pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 39.1pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&ldquo;Debt
Service Reserve Account&rdquo; </B>has the meaning given to it in the Conditions;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 39.1pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 39.1pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&ldquo;Direct
Shareholder&rdquo;</B> means, in respect of the Subscriber, the limited partnership that directly owns 100% of the legal interest
in the Subscriber as of the Signing Date;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 39.1pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 39.1pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&ldquo;Encumbrance&rdquo;
</B>means any encumbrance or security interest of any kind whatsoever including but not limited to a mortgage, charge, pledge,
lien, hypothecation, restriction, claim, defect, right to acquire, agreement for sale and purchase, right of first refusal, right
of pre-emption, option, conversion right, third party right or interest; and with respect to Intellectual Property, preference
granted to third party, sub-licensing or royalty arrangement; right of set-off or counterclaim, equity, trust arrangement or any
other type of preferential agreement (such as a retention of title arrangement), lease, tenancy, licence or other right of occupation,
easement, restrictive covenant, caveat or similar restriction over property, any security or other interest or arrangement of
any kind that in substance secures the payment of money or the performance of an obligation, or that gives a creditor priority
over unsecured creditors in relation to any property or any other agreement affecting the same having similar effect or any other
rights exercisable by or Claims by third parties;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 39.1pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 39.1pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&ldquo;Employees&rsquo;
Share Options&rdquo;</B> has the meaning given to it in the Conditions;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 39.1pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 39.1pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&ldquo;Executed
Private Placements&rdquo;</B> has the meaning given to it in the Conditions;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 39.1pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 39.1pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&ldquo;Exposure&rdquo;
</B>has the meaning given to it in the Conditions;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 39.1pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 39.1pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>First
Interest Payment Date</B>&rdquo; has the meaning given to it in the Conditions;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 39.1pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 39.1pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&ldquo;Group&rdquo;
</B>has the meaning given to it in the Conditions;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 39.1pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 39.1pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&ldquo;Intellectual
Property&rdquo;</B> has the meaning given to it in the Conditions;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 39.1pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 39.1pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&ldquo;Licenced
IP&rdquo;</B> means any and all Intellectual Property that is licensed by or otherwise permitted to be exploited commercialized
and/or use by the relevant licensor(s) under any Licence;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 39.1pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 39.1pt; text-align: justify; text-indent: 0in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 4; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 39.1pt; text-align: justify; text-indent: 0in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 39.1pt; text-align: justify; text-indent: 0in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 39.1pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&ldquo;Licences&rdquo;
</B>means the agreements that the relevant members of the Group have entered into prior to the Signing Date and disclosed by the
Issuer to the Subscriber prior to the Signing Date, and <B>&ldquo;Licence&rdquo;</B> means any one of them;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 39.1pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 39.1pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&ldquo;Interest
Period&rdquo; </B>has the meaning given to it in the Conditions;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 39.1pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 39.1pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&ldquo;IPO
Share Price&rdquo;</B> has the meaning given to it in the Conditions;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 39.1pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 39.1pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&ldquo;Material
Adverse Effect&rdquo;</B> means a material adverse effect on the condition (financial or otherwise), business, properties, prospects,
result of operations, profitability, shareholders&rsquo; equity or general affairs of the Issuer or of any other member of the
Group taken as a whole, or the ability of the Issuer or of any other member of the Group to perform their respective obligations
under the Transaction Documents or the Bonds (as applicable), or which are otherwise material in the context of the issue, offering
and distribution of the Bonds;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 39.1pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 39.1pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&ldquo;Market
Capitalisation at IPO&rdquo;</B> has the meaning given to it in the Conditions;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 39.1pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 39.1pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&ldquo;NASDAQ&rdquo;
</B>means the Nasdaq Stock Market;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 39.1pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 39.1pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&ldquo;Other
Share Options&rdquo;</B> has the meaning given to it in the Conditions;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 39.1pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 39.1pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Permitted
Offerings</B>&rdquo; has the meaning given to it in the Conditions;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 39.1pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 39.1pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&ldquo;Permitted
Use of Proceeds&rdquo;</B> has the meaning given to it in the Conditions;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 39.1pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 39.1pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Post-IPO
Secondary Offerings</B>&rdquo; has the meaning given to it in the Conditions;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 39.1pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 39.1pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&ldquo;Private
Placements&rdquo; </B>has the meaning given to it in the Conditions;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 39.1pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 39.1pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&ldquo;Related
Person&rdquo;</B> has the meaning given to it in the Conditions;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 39.1pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 39.1pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&ldquo;Release
Conditions&rdquo;</B> has the meaning given to it in the Conditions;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 39.1pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 39.1pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&ldquo;Outstanding&rdquo;
</B>has the meaning given to it in the Conditions;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 39.1pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 39.1pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&ldquo;QIPO&rdquo;
</B>has the meaning given to it in the Conditions;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 39.1pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 39.1pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&ldquo;Share
Charge&rdquo;</B> has the meaning given to it in the Conditions;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 39.1pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 39.1pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
<B>&ldquo;Subsidiary&rdquo;</B> has the meaning given to it in the Conditions;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 39.1pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 39.1pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&ldquo;Subsidiary
Share Grants and Share Options&rdquo;</B> has the meaning given to it in the Conditions;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 39.1pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 39.1pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&ldquo;Warrants&rdquo;
</B>has the meaning given to it in the Conditions; and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 39.1pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 39.1pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&ldquo;US
dollars&rdquo;</B> and <B>&ldquo;US$&rdquo;</B> are to the lawful currency for the time being of the United States of America.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 39.1pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 39.1pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.2</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Capitalized
                                         terms used but not otherwise defined herein have the meanings given to them in the Conditions.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 39.1pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.3</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                         Issuer, the Guarantor and the Subscriber are collectively referred to herein as the &ldquo;<B>Parties</B>&rdquo;
                                         and each individually as a &ldquo;<B>Party</B>&rdquo;.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 39.1pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.4</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">References
                                         in this agreement to this Agreement or any other document are to this Agreement or those
                                         documents as amended, supplemented, restated or replaced from time to time and include
                                         any document which amends, supplements, restates or replaces them.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 5; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 39.1pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.5</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                         schedules are part of this agreement and have effect accordingly.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 39.1pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.6</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">References
                                         to any person shall include its successors in title, permitted assigns and permitted
                                         transferees.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 39.1pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.7</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Save
                                         as otherwise expressly stated herein, references to any statute or statutory provision
                                         includes a reference to that statute or statutory provision as from time to time amended,
                                         extended or re-enacted.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 39.1pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.8</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
                                         this Agreement, references to:</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 39.1pt; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 31.2pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Recitals
                                         and Clauses are to the recitals and clauses of this Agreement;</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 39.1pt; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 31.2pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                         singular includes the plural and vice versa;</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 39.1pt; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 31.2pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">words
                                         importing gender or the neuter include both genders and the neuter; and</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 39.1pt; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 31.2pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">persons
                                         include bodies corporate or unincorporate.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 39.1pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.9</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Headings
                                         shall be ignored in construing this Agreement.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; text-transform: uppercase; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 39.1pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">2.</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>ISSUE
                                         AND SUBSCRIPTION</B></FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 39.1pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.1</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Agreement
                                         to Issue Bonds</B></FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 39.1pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Subject
to the satisfaction (or waiver) of the conditions set forth in Clause 11.1, the Issuer agrees to issue the Bonds in the Principal
Amount to the Subscriber on the date falling 21 Business Days after the Signing Date, or such other date as the Issuer and the
Subscriber may agree in writing (the &ldquo;<B>Issue Date</B>&rdquo;) for completion of the subscription in accordance with Clause
12 (&ldquo;<B>Issue</B>&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 39.1pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 39.1pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.2</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Agreement
                                         to subscribe and pay for Bonds</B></FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 39.1pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Subject
to the terms of this Agreement, the Subscriber agrees to subscribe and pay for the Bonds in the Principal Amount at the Subscription
Price (as defined below) to the order of the Issuer, subject to the Conditions, on the Issue Date.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 39.1pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 39.1pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.3</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Subscription</B></FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 39.1pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Subject
to the satisfaction (or waiver) of the conditions set forth in Clause 11.1, the Bonds will be subscribed at a price equal to 100.0
per. cent of the Principal Amount of the Bonds on the Issue Date less (i) a fee of 2.00 per cent. of the Principal Amount (the
&ldquo;<B>Structuring Fee</B>&rdquo;) payable to the Subsidiaries and (ii) any Subscriber&rsquo;s Expenses (as defined in Clause 13.3)
(the amount of which shall be agreed in writing between the Issuer and the Subscriber five Hong Kong business days prior to the
Issue Date) (the &ldquo;<B>Subscription Price</B>&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 39.1pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 39.1pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.4</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Shares</B></FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 39.1pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Issuer agrees that the Shares will, when allotted and issued, rank <I>pari passu</I> in all respects with the other shares then
in issue or to be issued by the Issuer as at the Issue Date until the conversion of all the Bonds into Shares, including the rights
to vote and to participate in all dividends and other distributions declared, made or paid at any time after the allotment and
issue.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 39.1pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 39.1pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.5</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Transaction
                                         Documents and Contracts</B></FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 39.1pt; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 31.2pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                         Issuer and the Subscriber shall enter into this Agreement in respect of the Bonds.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 6; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 39.1pt; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 31.2pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Upon
                                         the Issue:</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 70.3pt; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 31.2pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                         terms and conditions of the Bonds shall be substantially in the form of the Conditions
                                         set out in Schedule 1 hereto; and</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 70.3pt; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 31.2pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                         Issuer will enter into (and provide the Subscriber with copies of) the Deed of Guarantee,
                                         the Share Charge and the Account Charge. No amendment shall be made to such terms and
                                         conditions without the prior written approval of the Subscriber.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 39.1pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
Agreement, the Deed of Guarantee, the Share Charge, the Account Charge, an escrow agreement dated the Issue Date among the Guarantor,
the Subscriber and The Law Debenture Trust (Asia) Limited as escrow agent in connection with the Share Charge, and each of the
other agreements entered into by the Parties in connection with the transactions contemplated by this Agreement are together referred
to as the &ldquo;<B>Contracts</B>&rdquo;. The Contracts and the Bonds are together referred to as the &ldquo;<B>Transaction Documents</B>&rdquo;.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 39.1pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; text-transform: uppercase; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 39.1pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">3.</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>REPRESENTATIONS
                                         and WARRANTIES of the Issuer and Guarantor</B></FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 39.1pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.1</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Each
                                         of the Issuer and Guarantor jointly and severally represents, warrants and undertakes
                                         to the Subscriber that:</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 39.1pt; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 31.2pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Incorporation</B></FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.3pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Each
of the Issuer, the Guarantor and their respective Subsidiaries is a separate legal and independent entity duly incorporated or
established and validly existing under the laws of its jurisdiction of incorporation, is in compliance with all laws and regulations
to which it is subject, is not in liquidation or receivership, has full power and authority to own its properties and to conduct
its business and is lawfully qualified to do business in those jurisdictions in which business is conducted by it and has full
power and authority to enter into and perform its obligations under the Transaction Documents.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.3pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 39.1pt; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 31.2pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Validity
                                         of Transaction Documents</B></FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.3pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
Agreement has been duly authorised, executed and delivered by each of the Issuer and the Guarantor and constitutes, and the other
Transaction Documents to which any of the Issuer or any member of the Group is a party have been duly authorised by each of the
Issuer or such member of the Group (as the case may be), and upon due execution and delivery prior to or on the Issue Date will
constitute, valid and legally binding and enforceable obligations of the Issuer or such member of the Group (as the case may be).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.3pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 39.1pt; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 31.2pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Validity
                                         of the Bonds</B></FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.3pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Bonds have been duly authorised by the Issuer and, when duly executed, issued and delivered in accordance with the Conditions,
the Bonds will constitute valid and legally binding obligations of the Issuer.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.3pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 39.1pt; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 31.2pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Status</B></FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 70.3pt; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 31.2pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                         Bonds (when issued) will constitute direct, senior, unconditional and unsubordinated
                                         obligations of the Issuer, secured as set out in the Conditions and will at all times
                                         rank at least <I>pari passu</I> with all other present and future unsubordinated obligations
                                         of the Issuer (including but not limited to the Executed Private Placements) other than
                                         those preferred by statute or applicable law.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 7; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 70.3pt; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 31.2pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                         payment obligations of the Guarantor under the Deed of Guarantee when entered into shall,
                                         save for such exceptions as may be provided by applicable legislation and subject to
                                         Condition 2(b) of the Conditions, at all times rank at least equally with all other present
                                         and future unsecured and unsubordinated obligations of the Guarantor.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 39.1pt; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 31.2pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Authorised
                                         Share Capital</B></FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.3pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
at the Signing Date and Issue Date, the authorised share capital of the Issuer is 27,864,135, of which 5,426,381 shares are designated
as Class A ordinary shares and 22,437,754 shares are designated as Class B ordinary shares. The Issuer shall maintain at all times
sufficient authorised but unissued share capital to satisfy the issue of Shares at the Conversion Price.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.3pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 39.1pt; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 31.2pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(f)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Shares</B></FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.3pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Shares resulting from exercise of the Conversion Right, when allotted, issued and delivered in the manner contemplated by the
Bonds:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.3pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 70.3pt; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 31.2pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">will
                                         be duly and validly allotted and issued, fully-paid or credited as fully paid and non-assessable;</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 70.3pt; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 31.2pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">will
                                         rank <I>pari passu</I> and carry the same rights and privileges in all respects with
                                         all other Shares then in issue and shall be entitled to all dividends and other distributions
                                         declared, paid or made thereon;</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 70.3pt; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 31.2pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">subject
                                         to any restriction under applicable laws and lock-up restrictions as agreed by the Subscriber
                                         in Clause 9.2, will be freely transferable, free and clear of all liens, charges, Encumbrances,
                                         security interests or claims of third parties and will not be subject to calls for further
                                         funds; and</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 70.3pt; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 31.2pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iv)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">shall
                                         be registered in the registration statement on Form F-1 which the Issuer will submit
                                         to the U.S. Securities and Exchange Commission for the purpose of the intended QIPO.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 39.1pt; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 31.2pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(g)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>No
                                         interest in other companies </B></FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 70.3pt; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 31.2pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
                                         at the Issue Date, none of the Issuer or any other member of the Group (other than the
                                         Guarantor) owns any interest in any other company, partnership, joint venture, trust,
                                         profit-sharing arrangement or other legal entity other than (a) the Subsidiaries of the
                                         Issuer and (ii) the entities disclosed to the Subscriber.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 70.3pt; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 31.2pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
                                         at the Issue Date, the Guarantor does not own any interest in any other company, partnership,
                                         joint venture, trust, profit-sharing arrangement or other legal entity other than (a)
                                         the Issuer and its Subsidiaries and (b) the entities disclosed to the Subscriber.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 39.1pt; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 31.2pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(h)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Pre-emptive
                                         Rights and Options</B></FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 70.3pt; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 31.2pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                         issue of the Bonds and the Shares will not be subject to any pre-emptive or similar rights;</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 70.3pt; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 31.2pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Save
                                         for the Permitted Offerings that otherwise comply with the Conditions and this Agreement,
                                         there are no outstanding securities issued or contracted to be issued by the Issuer or
                                         any other member of the Group (other than the Guarantor) convertible into or exchangeable
                                         for, or warrants, rights or options, or agreements to grant warrants, rights or options,
                                         to purchase or to subscribe for, shares of the Issuer or any other member of the Group
                                         (other than the Guarantor) and the Issuer has obtained or will obtain all consents required
                                         under the Executed Private Placements or Private Placements for the Issuer to issue the
                                         Bonds and enter into the transaction contemplated by the Bonds and the Transaction Documents;</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 8; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 70.3pt; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 31.2pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Save
                                         for the Permitted Offerings that otherwise comply with the Conditions and this Agreement,
                                         there are no arrangements approved by the board of directors of the Issuer or any other
                                         member of the Group (other than the Guarantor) or a general meeting of shareholders of
                                         the Issuer or any other member of the Group (other than the Guarantor) providing for
                                         the issue or purchase of, or subscription for, Ordinary Shares or securities issued by
                                         the Issuer or any other member of the Group (other than the Guarantor) convertible into
                                         or exchangeable for, or warrants, rights or options, or agreements to grant warrants,
                                         rights or options, to purchase or to subscribe for, shares of the Issuer or any other
                                         member of the Group (other than the Guarantor); and</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 70.3pt; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 31.2pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iv)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other
                                         than in relation to the Permitted Offerings and Post-IPO Secondary Offerings that otherwise
                                         comply with the Conditions and this Agreement, no issued or unissued share capital of
                                         the Issuer or any other member of the Group (other than the Guarantor) is or, so long
                                         as any Bond remains Outstanding, will be under option or agreed conditionally or unconditionally
                                         to be put under option.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 39.1pt; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 31.2pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Restrictions</B></FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.3pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">There
are no restrictions on transfers of the Bonds or the voting or transfer of any of the Ordinary Shares or payments of dividends
with respect to the Ordinary Shares pursuant to the Issuer&rsquo;s memorandum and articles of association, or pursuant to any agreement
or other instrument to which the Issuer is a party or by which it may be bound.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.3pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 39.1pt; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 31.2pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(j)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Capitalisation</B></FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.3pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">All
the outstanding shares, capital stock and other equity interests of the Issuer and each other member of the Group have been duly
and validly authorised and issued, are fully paid and non-assessable, and were issued in compliance with applicable laws; all
such shares, capital stock and equity interests are owned directly or indirectly by the relevant holders, free and clear of Encumbrances,
restrictions on transfer or restrictions on voting.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.3pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 39.1pt; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 31.2pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(k)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Laws
                                         and Listing Rules</B></FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.3pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Each
of the Issuer and the other members of the Group, and, to the best of the Issuer&rsquo;s knowledge having made all reasonable enquiries,
their respective directors and officers is in compliance with and will comply with all applicable laws and, upon and subsequent
to the occurrence of a QIPO, the listing rules of NASDAQ or the New York Stock Exchange and any relevant regulatory authority
in respect of the Listing (including, without limitation, the Financial Industry Regulatory Authority and the U.S. Securities
and Exchange Commission) or, as the case may be, the Alternative Stock Exchange (the &ldquo;<B>Listing Rules</B>&rdquo;) and the
Issuer will comply with all applicable laws and the applicable requirements of the Listing Rules in connection with the issue,
offering and sale of the Bonds and the issue of the Shares.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.3pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.3pt; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 9; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.3pt; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.3pt; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 39.1pt; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 31.2pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(l)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Consents</B></FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.3pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Save
for:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.3pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 70.3pt; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 31.2pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                         approval for listing of and dealing in the Shares to be granted by the NASDAQ, the New
                                         York Stock Exchange and any relevant regulatory authority in respect of the Listing (including,
                                         without limitation, the Financial Industry Regulatory Authority and the U.S. Securities
                                         and Exchange Commission) or, as the case may be, the Alternative Stock Exchange subsequent
                                         to the occurrence of a QIPO;</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 70.3pt; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 31.2pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                         registration of the Account Charge with the Companies Registries of Hong Kong within
                                         one calendar month of the date of the Account Charge; and</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 70.3pt; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 31.2pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                         registration requirements set out in Clause 4.8 of this Agreement,</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 101.5pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">no
consent, clearance, approval, authorisation, order, registration or qualification of or with any court, governmental agency or
regulatory body having jurisdiction over the Issuer or any relevant member of the Group is required and no other action or thing
is required to be taken, fulfilled or done (including without limitation the obtaining of any consent or licence or the making
of any filing or registration) for the execution and delivery by the Issuer or any relevant member of the Group of the Contracts,
the issue, sale and delivery of the Bonds, the issue of the Shares to any subscriber, the carrying out of the other transactions
contemplated by the Transaction Documents or the Bonds or the compliance by the Issuer or any relevant member of the Group with
the Conditions.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 101.5pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 39.1pt; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 31.2pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(m)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Compliance</B></FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.3pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
execution, delivery and performance of the Contracts, the issue and delivery of the Bonds, the issue of the Shares resulting from
exercise of the Conversion Rights, the carrying out of the other transactions contemplated by the Transaction Documents and the
compliance by the Issuer or any other member of the Group with the Conditions do not and will not:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.3pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 70.3pt; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 31.2pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">conflict
                                         with or result in a breach of any of the terms or provisions of, or constitute a default
                                         (nor has any event occurred which, with the giving of notice and/or the passage of time
                                         and/or the fulfilment of any other requirement would result in a default) by the Issuer
                                         or any other member of the Group under, (a) the documents constituting the Issuer or
                                         the Guarantor, or (b) any indenture, contract, lease, mortgage, deed of trust, note agreement,
                                         loan agreement or other agreement, obligation, condition, covenant or instrument to which
                                         the Issuer or any other member of the Group is a party or by which any of their respective
                                         assets are bound (collectively, the &ldquo;<B>Existing Obligations</B>&rdquo;) which, in
                                         the case of (b) only, has had or reasonably could be expected to have a Material Adverse
                                         Effect; or</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 70.3pt; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 31.2pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">violate
                                         any existing applicable law, rule, regulation, judgment, order, authorisation or decree
                                         of any government, governmental or regulatory body or court, domestic or foreign, having
                                         jurisdiction over the Issuer or any other member of the Group or any of their respective
                                         assets, provided that such violations either (A) have resulted in a loss to the Issuer
                                         and/or any other member of the Group having an aggregate value of at least (if such loss
                                         is related to financing or operational matters) US$400,000, or (if such loss is in respect
                                         of all other kinds of loss) US$250,000, or (B) had or is reasonably expected to have
                                         a Material Adverse Effect; or</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 70.3pt; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 31.2pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">upon
                                         and subsequent to the occurrence of a QIPO, infringe the rules and regulations of any
                                         stock exchange on which securities of the Issuer are listed as determined by the relevant
                                         stock exchange.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 10; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 39.1pt; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 31.2pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(n)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Financial
                                         Statements</B></FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 70.3pt; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 31.2pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">That
                                         the audited financial statements of the Issuer as of and for the two years ended 31 December
                                         2015 and 2016 were prepared under the International Financial Reporting Standards, and
                                         the unaudited financial statements of the Issuer as of and for the two months ended 28
                                         February 2017 and the unaudited consolidated financial statements of the Issuer and its
                                         Subsidiaries as of and for the ten months ended 31 December 2017 were prepared in accordance
                                         with the requirements of law and the Generally Accepted Accounting Principles (United
                                         States)(together, the &ldquo;<B>GAAP</B>&rdquo;) (together, the &ldquo;<B>Financial Statements</B>&rdquo;),
                                         and that they present fairly the financial condition of the Issuer and the Group as at
                                         the dates which they were prepared and the results of the operations of the Group in
                                         respect of the periods for which they were prepared, and that there has been no Material
                                         Adverse Effect or development involving a prospective Material Adverse Effect since 31
                                         December 2017.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 70.3pt; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 31.2pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Each
                                         of the Issuer and the Guarantor has reviewed the management accounts of the Issuer as
                                         of and for the two months ended 28 February 2017 and the consolidated management accounts
                                         of the Issuer and its Subsidiaries as of and for the ten months ended 31 December 2017
                                         prepared in accordance with the requirements of law and with the GAAP (the &ldquo;<B>Management
                                         Accounts</B>&rdquo;) and such accounts present fairly and accurately in all material respects
                                         the financial position of the Issuer as at 31 December 2017, and the results of operations
                                         and changes in financial position of the Issuer for the periods in respect of which they
                                         have been prepared.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 70.3pt; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 31.2pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">None
                                         of the Accounting Items stated in the audited financial statements of the Issuer as of
                                         and for the two months ended 28 February 2017, and the audited consolidated financial
                                         statements of the Issuer and its Subsidiaries as of and for the ten months ended 31 December
                                         2017 (together, the &ldquo;<B>2017 Financial Statements</B>&rdquo;), as compared to the
                                         Management Accounts, shall vary by more than US$1,500,000 (any such difference shall
                                         be irrespective of any goodwill impact due to any changes in the business nature of any
                                         member of the Group), and there is no material adverse change or development involving
                                         a prospective Material Adverse Effect since 31 December 2017.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 70.3pt; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 31.2pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iv)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                         Management Accounts have been prepared and presented on a basis consistent with the accounting
                                         policies normally adopted by the Issuer and the Guarantor and applied in preparing the
                                         audited financial statements of the Issuer.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 70.3pt; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 31.2pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(v)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Since
                                         31 December 2017 there has been no change (nor any development or event involving a prospective
                                         change of which the Issuer or the Guarantor is, or might reasonably be expected to be,
                                         aware) which has a Material Adverse Effect to the condition (financial or other), prospects,
                                         results of operations, general affairs or profitability of the Issuer or of the Group,
                                         respectively.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 11; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 39.1pt; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 31.2pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(o)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Internal
                                         Accounting and Disclosure Controls</B></FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.3pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Each
of the Issuer and each other member of the Group maintains a system of internal control and accounting controls sufficient to
provide reasonable assurances that:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.3pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 70.3pt; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 31.2pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">transactions
                                         are executed in accordance with management&rsquo;s general or specific authorisations and in
                                         compliance with applicable laws, rules and regulations;</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 70.3pt; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 31.2pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">transactions
                                         are recorded as necessary to permit preparation of financial statements in conformity
                                         with GAAP and to maintain asset accountability;</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 70.3pt; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 31.2pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">access
                                         to material assets is permitted only in accordance with management&rsquo;s general or specific
                                         authorisation;</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 70.3pt; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 31.2pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iv)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                         recorded accountability for material assets is compared with the existing assets at reasonable
                                         intervals and appropriate action is taken with respect to any differences; and</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 70.3pt; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 31.2pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(v)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">each
                                         of the Issuer and each other member of the Group has made and kept books, records and
                                         accounts which, in reasonable detail, accurately and fairly reflect the transactions
                                         and dispositions of assets of such entity and provide a sufficient basis for the preparation
                                         of the Group&rsquo;s consolidated financial statements in accordance with GAAP.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 39.1pt; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 31.2pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(p)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Contingent
                                         Liabilities </B></FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.3pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Save
as disclosed in the Financial Statements and for any contingent liabilities and payment obligations which may arise from the provision
of financing guarantees in the ordinary course of business of the Issuer and any other member of the Group, there are no outstanding
guarantees or contingent payment obligations of the Issuer and such other members of the Group in respect of indebtedness of third
parties (if such indebtedness is related to financing or operational matters) exceeding US$400,000, or (in respect of all other
kinds of indebtedness) US$250,000, or other than those disclosed in the Financial Statements referred to in Clause 3.1(n); the
Issuer and each other member of the Group is in compliance with all of its obligations under any outstanding guarantees or contingent
payment obligations as disclosed in the Financial Statements referred to in Clause 3.1(n).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.3pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 39.1pt; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 31.2pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(q)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Off-balance
                                         Sheet Arrangements</B></FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.3pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Neither
the Issuer nor any other member of the Group has any off-balance sheet transactions which, individually or in the aggregate, would,
or is likely to, have a Material Adverse Effect, and neither the Issuer nor any other member of the Group has any relationships
with unconsolidated entities that are contractually limited to narrow activities that facilitate the transfer of or access to
assets by the Issuer or such other member of the Group, such as structured finance entities and special purpose entities that
could have a Material Adverse Effect on the liquidity of the Issuer or such other member of the Group or the availability thereof
or the requirements of the Issuer or such other member of the Group for capital resources. For the purposes of this Clause 3.1(q),
the issue of the Bonds, the giving of the Deed of Guarantee, Account Charge and/or the Share Charge by the Issuer or the Guarantor,
as the case may be, as contemplated in the Transaction Documents shall not be deemed as off-balance sheet transactions.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.3pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.3pt; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 12; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.3pt; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.3pt; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 39.1pt; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 31.2pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(r)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Title</B></FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.3pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Each
of the Issuer and each other member of the Group has good title to all real property, personal property and any other assets owned
by it or any rights or interests thereto, in each case as is necessary to conduct the business now operated by it (&ldquo;<B>Assets</B>&rdquo;);
and save for any charges created by operation of law and other than those set out in the Financial Statements, there are no Encumbrances
or other third party rights or interests, conditions, planning consents, orders, regulations, defects or other restrictions affecting
any of the Issuer or the relevant member of the Group, which could have a Material Adverse Effect on the value of such Assets,
or limit, restrict or otherwise have a Material Adverse Effect on the ability of the Issuer or the relevant member of the Group
to utilise or develop any such Assets and, where any such Assets are held under lease, each lease is a legal, valid, subsisting
and enforceable lease.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.3pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 39.1pt; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 31.2pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(s)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Status
                                         of the charged security</B></FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.3pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Each
of the Guarantor and the Issuer (as applicable) has and will have, directly or indirectly, as of the Issue Date, good and valid
title, free and clear of all liens, Encumbrances, security interest or claims, to (i) the assets charged in favour of the Subscriber
pursuant to the Share Charge and Account Charge respectively, and (ii) to the extent applicable, Assets owned by the Guarantor
and the Issuer (as the case may be) or any rights or interests thereto.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.3pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 39.1pt; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 31.2pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(t)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Approvals</B></FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.3pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">To
the Issuer&rsquo;s and the Guarantor&rsquo;s best knowledge, information and belief (after due enquiry):</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.3pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 70.3pt; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 31.2pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                         Issuer and each other member of the Group possess all certificates, authorisations, licences,
                                         orders, consents, approvals and permits (&ldquo;<B>Approvals</B>&rdquo;) issued by, and
                                         has made all declarations and filings with, all appropriate national, state, local and
                                         other governmental and regulatory or self-regulatory agencies and bodies, all exchanges
                                         and all courts and other tribunals, domestic and foreign, necessary to own or lease,
                                         as the case may be, and to operate its assets and to conduct the business now operated
                                         by them;</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 70.3pt; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 31.2pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                         Issuer and each other member of the Group are in compliance with the terms and conditions
                                         of all such Approvals;</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 70.3pt; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 31.2pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">all
                                         of such Approvals are valid and in full force and effect; and</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 70.3pt; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 31.2pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iv)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">neither
                                         the Issuer nor any other member of the Group has received any notice of proceedings relating
                                         to the revocation or modification of any such Approvals or is otherwise aware that any
                                         such revocation or modification is contemplated or threatened,</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.3pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">except
for any non-possession, non-compliance, invalidity, revocation, modification or proceedings (that if determined adversely to the
Issuer or any member of the Group) would not individually or in the aggregate have any Material Adverse Effect.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.3pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 39.1pt; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 31.2pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(u)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Taxes
                                         and Assessments</B></FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.3pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">To
the Issuer&rsquo;s and the Guarantor&rsquo;s best knowledge, information and belief (after due enquiry):</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.3pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 70.3pt; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 31.2pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">all
                                         returns, reports and filings which ought to have been made by or in respect of the Issuer
                                         and each other member of the Group for taxation purposes have been made and all such
                                         returns, reports and filings are correct in all material respects and on a proper basis
                                         and are not the subject of any dispute with the relevant revenue or other appropriate
                                         authorities and to the best knowledge, information and belief of the Issuer and the Guarantor
                                         (after due inquiry) do not reveal any circumstances likely to give rise to any such dispute
                                         and the provisions, charges, accruals and reserves included in the financial statements
                                         are sufficient to cover all taxation of the Issuer and each other member of the Group
                                         existing in all accounting periods ended on or before the accounting reference date to
                                         which the financial statements relate whether payable then or at any time thereafter.
                                         No liability for tax which has not been provided for in the financial statements of the
                                         Issuer or any other member of the Group has arisen or has been asserted by the tax authorities
                                         against the Issuer or any other member of the Group which would have a Material Adverse
                                         Effect.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"></P>

<!-- Field: Page; Sequence: 13; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"></P>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 70.3pt; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 31.2pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                         Issuer and each other member of the Group have duly and in a timely manner paid all taxes
                                         that have become due, including, without limitation, all taxes reflected in the tax returns
                                         referred to in Clause 3.1(u)(i) above, or any assessment, proposed assessment, or notice,
                                         either formal or informal, received by the relevant member of the Group except for any
                                         such taxes that are being contested in good faith and by appropriate proceedings or where
                                         the failure to file or make payment would not, individually or in the aggregate, have
                                         a Material Adverse Effect.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 39.1pt; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 31.2pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(v)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Taxes/Duties</B></FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.3pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">To
the Issuer&rsquo;s and the Guarantor&rsquo;s best knowledge, information and belief (after due enquiry), no tax or duty (including any stamp
or issuance or transfer tax or duty, any service tax and any tax or duty on capital gains or income, whether chargeable on a withholding
basis or otherwise) is assessable or payable in, and no withholding or deduction for any taxes, duties, assessments or governmental
charges of whatever nature is imposed or made for or on account of any income, registration, transfer, service or turnover taxes,
customs or other duties or taxes of any kind, levied, collected, withheld or assessed by or within, Cayman Islands, British Virgin
Islands, United States or Hong Kong or any other relevant jurisdiction or by any sub-division of or authority therein or thereof
having power to tax, in connection with the creation, issue or offering of the Bonds, the Shares or the execution or delivery
of the Contracts, the Bonds or the performance of the obligations hereunder or thereunder (including, without limitation, issuance
of the Shares and payment of any bonus thereunder).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.3pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 39.1pt; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 31.2pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(w)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Litigation</B></FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.3pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">To
the Issuer&rsquo;s and the Guarantor&rsquo;s best knowledge, information and belief (after due enquiry), there are no pending actions, suits
or proceedings against or affecting the Issuer or any other member of the Group or any of their respective assets, which if determined
adversely to the Issuer, the Guarantor or any other member of the Company would individually or in the aggregate have a Material
Adverse Effect and, to the best knowledge, information and belief of the Issuer and the Guarantor (after due enquiry), no such
actions, suits or proceedings are threatened or contemplated.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.3pt; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 39.1pt; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 31.2pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(x)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Investigation</B></FONT></TD></TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.3pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.3pt; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">To
the best knowledge, information and belief of the Issuer and the Guarantor (after due enquiry), there are no police, legal, governmental,
stock exchange or regulatory inquiries or investigations nor any pending actions, suits or proceedings against or affecting the
Issuer or any other member of the Group or any of their respective directors or officers (in their capacities as such), or assets,
which, if determined adversely to the Issuer or any other member of the Group or any of their respective directors, officers or
assets, would individually or in the aggregate have a Material Adverse Effect, and no such investigations, actions, suits or proceedings
are threatened or contemplated.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.3pt; text-align: justify">&nbsp;</P>

<!-- Field: Page; Sequence: 14; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.3pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 39.1pt; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 31.2pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(y)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Environmental
                                         laws</B></FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.3pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">To
the best knowledge, information and belief of the Issuer and the Guarantor (after due enquiry), save and except where any non-compliance
with Environmental Laws, non-possession, invalidity, revocation, modification, failure to receive required permits, licences or
other approvals, or liability would not, individually or in the aggregate, have a Material Adverse Effect, the Issuer and each
other member of the Group (i) have received, are in compliance with and will comply with all necessary permits, licences or other
approvals required of them under applicable Environmental Laws to conduct their businesses and (ii) have not received notice of
any actual or potential liability under any Environmental Law.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.3pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.3pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
the purpose of this Clause 3.1(y), &ldquo;<B>Environmental Laws</B>&rdquo; means any and all supra-national, national, state, local
and foreign statutes, laws, regulations, ordinances, rules, judgments, orders, decrees, permits, concessions, grants, franchises,
licences, agreements or other governmental restrictions relating to the protection of the environment (including, without limitation,
human, animal and plant life, ambient air, surface water, ground water, or land), the protection of property and proprietary rights
or for the compensation of harm to the environment whether by clean-up, remediation, containment or other treatment or the payment
of monies to any competent authority.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.3pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 39.1pt; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 31.2pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(z)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Insurance</B></FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.3pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">To
the best knowledge, information and belief of the Issuer and the Guarantor (after due enquiry), the Issuer and each other member
of the Group have in place all insurance policies necessary for the conduct of their businesses as currently operated and for
compliance with all requirements of law, such policies are in full force and effect, and all premiums with respect thereto have
been paid, and no notice of cancellation or termination has been received with respect to any such policy, and the Issuer and
each other member of the Group have complied in all material respects with the terms and conditions of such policies.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.3pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 39.1pt; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 31.2pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(aa)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Licences</B></FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 70.3pt; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 31.2pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Upon
                                         the terms and conditions of each Licence, the relevant member of the Group is granted
                                         an exclusive and worldwide right to exploit, commercialise and use the Licenced IP.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 70.3pt; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 31.2pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
                                         at the Signing Date, no member of the Group has received any notice or is aware of any
                                         circumstance which could be expected to adversely affect any member of the Group&rsquo;s right
                                         to exploit, commercialise and use the Licensed IP pursuant to the relevant Licence.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 70.3pt; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 31.2pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Each
                                         Licence constitutes legal, valid and binding obligations of the parties to the respective
                                         Licence, enforceable against each party to the respective Licence in accordance with
                                         its terms. No Licence is voidable or liable to rescission for any reason.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 70.3pt; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 31.2pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iv)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">No
                                         Licence contains terms entitling any of the other parties to take a step unfavourable
                                         to any member of the Group (such as to terminate or suspend the agreement or arrangement,
                                         or to require a payment or the adoption of less favourable terms) because of the subscription
                                         of the Bonds or any other transactions contemplated by this Agreement or compliance with
                                         any provision of this Agreement.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 70.3pt; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 31.2pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(v)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">No
                                         Licence is affected by waiver by any party thereto of any of its provisions, that could
                                         result in a Material Adverse Effect.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 15; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 70.3pt; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 31.2pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(vi)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">No
                                         Licence or its performance or the use of any Licenced IP by the relevant member of the
                                         Group contravenes any Applicable Law.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 70.3pt; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 31.2pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(vii)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">To
                                         the best knowledge, information and belief of each member of the Group (after using best
                                         endeavours to complete all inquiries necessary for such confirmation), no Licence or
                                         its performance or the use of any Licenced IP by the relevant member of the Group infringes
                                         any right of any third party.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 70.3pt; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 31.2pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(viii)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
                                         at the Issue Date, each:</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 101.5pt; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 31.15pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(A)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">licensee
                                         to each Licence; and</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 101.5pt; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 31.15pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(B)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">to
                                         the best knowledge, information and belief of each member of the Group (after using best
                                         endeavours to complete all inquiries necessary for such confirmation), each licensor
                                         to each Licence,</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 101.5pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">has
duly complied with all its obligations under the respective Licence.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 101.5pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 70.3pt; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 31.2pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ix)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">To
                                         the best knowledge, information and belief of the Issuer and the Guarantor (after using
                                         their best endeavours to complete all inquiries necessary for such confirmation), no
                                         event has occurred which may be a ground for unilateral termination of any Licence by
                                         the licensor.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 70.3pt; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 31.2pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(x)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
                                         at the Signing Date, no member of the Group has received any written notice:</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 101.5pt; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 31.2pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(A)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">alleging
                                         that any member of the Group is in breach of or in default under any Licence; or</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 101.5pt; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 31.2pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(B)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">of
                                         termination of any Licence.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 70.3pt; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 31.2pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(xi)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">No
                                         member of the Group nor (to any member of the Group&rsquo;s knowledge) any other party to a
                                         Licence is in breach of or in default under, or but for the requirements of notice or
                                         lapse of time or both would be in breach of or in default under, a Licence.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 70.3pt; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 31.2pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(xii)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">No
                                         event has occurred or is alleged to have occurred which would (or would but for a requirement
                                         to give notice or but for lapse of time or both) be an event of default, or would give
                                         rise to an obligation to repay, or would lead to an Encumbrance becoming enforceable,
                                         in connection with any Licence, such as a Contract for financial accommodation. For the
                                         avoidance of doubt, the Encumbrance under this Clause 3.1(aa)(xii) shall not cover any
                                         Encumbrance held by or owed to a licensor pursuant to a License.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 101.5pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
the purpose of this Clause 3.1(aa)(xii) only, &ldquo;<B>Contract</B>&rdquo; means each agreement, arrangement, contract, covenant,
deed, instrument, lease, licence, security, trust, understanding or undertaking to which any member of the Group is a party or
which binds any member of the Group or any of its assets or under which any member of the Group has rights, and if the context
so requires, includes a past Contract.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 101.5pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 70.3pt; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 31.2pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(xiii)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">To
                                         the best knowledge, information and belief of the Issuer and the Guarantor (after using
                                         best endeavours to complete all inquiries necessary for such confirmation), there is
                                         no event, fact or circumstance which would entitle a licensor of any Licence to terminate
                                         or suspend the agreement or arrangement, or require the acceleration of a payment or
                                         the adoption of less favourable terms pursuant to the terms of a License.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 16; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 70.3pt; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 31.2pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(xiv)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">There
                                         has not been any act or omission by any member of the Group which would entitle a licensor
                                         to any Licence to terminate or suspend the agreement or arrangement, require the acceleration
                                         of a payment or the adoption of less favourable terms pursuant to the terms of the License.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 70.3pt; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 31.2pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(xv)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">There
                                         is no litigation pending or threatened in connection with or arising out of any Licence.
                                         There is no dispute or Claim connected with or arising out of any Licence which may give
                                         rise to litigation that could result in a Material Adverse Effect. Nothing has happened
                                         which may give rise to litigation concerning any Licence.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 70.3pt; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 31.2pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(xvi)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">There
                                         has been no legal or arbitral dispute, or any other dispute that could result in a Material
                                         Adverse Effect, between any member of the Group and any licensor or other party to any
                                         Licence about the validity of the Licence, the interpretation of the Licence or the performance
                                         of the Licence by any party.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 70.3pt; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 31.2pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(xvii)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
                                         at the Issue Date, no member of the Group has received any notice under a Licence (such
                                         as a notice of termination, of intention to terminate, or of non-renewal, a show cause
                                         notice, a notice of exercise of an option, a notice to repay a loan, or a notice concerning
                                         enforcement of a guarantee or of an Encumbrance over any asset.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 39.1pt; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 31.2pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(bb)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Licenced
                                         IP</B></FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.3pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Each
Licenced IP as at the Issue Date:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.3pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 70.3pt; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 31.2pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">is
                                         legally and beneficially owned by the entity/entities who is the licensor under each
                                         respective Licence and the Issuer and the respective member of the Group shall exercise
                                         commercially reasonable efforts to procure the licensor to use its best endeavours to
                                         fully protect each Licenced IP;</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 70.3pt; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 31.2pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">is
                                         not subject to any Encumbrance or third party interest; for clarify, the Encumbrance
                                         under this Clause 3.1(bb)(ii) shall not include any Encumbrance held by or owed to a
                                         licensor pursuant to the relevant License;</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 70.3pt; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 31.2pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">is
                                         valid and subsisting;</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 70.3pt; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 31.2pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iv)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">to
                                         the best knowledge, information and belief of the Issuer and the Guarantor (after using
                                         best endeavours to complete all inquiries necessary for such confirmation), does not
                                         infringe any Intellectual Property or third party rights;</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 70.3pt; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 31.2pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(v)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">is
                                         not liable to cancellation, forfeiture or modification for any reason;</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 70.3pt; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 31.2pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(vi)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">is
                                         not subject to any challenge (such as a challenge to its validity or to its registration)
                                         made or threatened; and</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 70.3pt; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 31.2pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(vii)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">to
                                         the best knowledge, information and belief of the Issuer and the Guarantor (after using
                                         best endeavours to complete all inquiries necessary for such confirmation), is not subject
                                         to any third party infringement or wrongful use.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 39.1pt; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 31.2pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(cc)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Related
                                         Party Transactions</B></FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.3pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Neither
the Issuer nor any other member of the Group is engaged and so long as any Bond remains Outstanding, will engage, in any transactions
with any related party on terms that are less favourable to the Issuer or the relevant member of the Group than those available
from other parties on an arm&rsquo;s length basis and such transactions as described in the audited consolidated financial statements
of the Issuer, the Guarantor and the Group are true, complete and accurate and not misleading in any material respect. All related
party transactions have been negotiated in good faith and on an arm&rsquo;s length basis.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.3pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.3pt; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 17; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.3pt; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.3pt; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 39.1pt; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 31.2pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(dd)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Events
                                         of Default</B></FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.3pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Prior
to the Issue Date, no event has occurred or circumstance arisen which, had the Bonds already been issued, could reasonably be
expected to (whether or not with the giving of notice and/or the passage of time and/or the fulfilment of any other requirement):
(i) constitute an event described under &ldquo;<B>Events of Default</B>&rdquo; in Condition 11; or (ii) require an adjustment of
the initial Conversion Price.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.3pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 39.1pt; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 31.2pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ee)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Labour
                                         Disputes</B></FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.3pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">No
labour dispute having a Material Adverse Effect with the employees of the Issuer or any other member of the Group exists or, to
the best knowledge, information and belief of the Issuer and the Guarantor (after due inquiry), is imminent. To the best knowledge,
information and belief of the Issuer and the Guarantor (after due inquiry), neither the Issuer nor the Guarantor is aware of any
existing or threatened labour disturbance by the employees of any principal suppliers, manufacturers or contractors of any member
of the Group which could result in a Material Adverse Effect.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.3pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 39.1pt; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 31.2pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ff)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Information</B></FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.3pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">All
information supplied or disclosed in writing or orally by the Issuer, each other member of the Group and their respective representatives
to the Subscriber, their respective agents or professional advisers is true and accurate in all material respects and not misleading
in any respect and all forecasts, opinions and estimates relating to the Issuer and each other member of the Group so supplied
or disclosed have been made after due, careful and proper consideration, are based on reasonable assumptions and represent reasonable
and fair expectations honestly held based on facts known to such persons (or any of them); there has been no development or occurrence
relating to the financial or business condition of the Issuer or any other member of the Group (including, without limitation,
with respect to any corporate event, acquisition, disposal or related matter) which is not in the public domain and which would
reasonably be expected to be material to the Subscriber; and each of the Issuer and the Guarantor has disclosed all information
regarding the financial or business condition of the Group, which is relevant and material in relation to the Group, in the context
of the issue or offering of the Bonds.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.3pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.3pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Notwithstanding
the above, all information supplied or disclosed by the Issuer, each other member of the Group and their respective representatives
to the Subscriber pursuant to the terms of the Transaction Documents shall be subject to the applicable laws and/or regulation
or rules of NASDAQ, an Alternative Stock Exchange, the Financial Industry Regulatory Authority or the U.S. Securities and Exchange
Commission.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.3pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 39.1pt; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 31.2pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(gg)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Anti-Money
                                         Laundering</B></FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.3pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">To
the best knowledge, information and belief of the Issuer and the Guarantor (after due enquiry), the operations of the Issuer and
each other member of the Group are and have been conducted at all times, and so long as any Bond remains Outstanding, will be,
in compliance with all applicable anti-money laundering laws, regulations, rules and guidelines in Hong Kong, the Cayman Islands,
the British Virgin Islands and the United States, and in each other jurisdiction in which such entity, conducts business (collectively,
the &ldquo;<B>Money Laundering Laws</B>&rdquo;) and no action, suit or proceeding by or before any court or governmental or regulatory
agency, authority or body or any arbitrator involving the Issuer or any other member of the Group with respect to any of the Money
Laundering Laws is pending or, to the best knowledge, information and belief of the Issuer and the Guarantor (after due enquiry),
threatened or contemplated.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.3pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.3pt; text-align: justify"></P>

<!-- Field: Page; Sequence: 18; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.3pt; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.3pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 39.1pt; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 31.2pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(hh)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Foreign
                                         Corrupt Practices</B></FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.3pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Neither
the Issuer, any other member of the Group nor any director, officer, or to the best knowledge, information and belief of the Issuer
and the Guarantor (after due enquiry), any director, officer, employee, or agent, is aware of or has taken any action, and so
long as any Bond remains Outstanding, will take any action, directly or indirectly, that would result in a violation by such persons
of:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.3pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 70.3pt; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 31.2pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                         Foreign Corrupt Practices Act of 1977, as amended, and the rules and regulations thereunder
                                         (the &ldquo;<B>FCPA</B>&rdquo;), including, without limitation, making use of the mails
                                         or any means or instrumentality of interstate commerce corruptly in furtherance of an
                                         offer, payment, promise to pay or authorisation of the payment of any money, or other
                                         property, gift, promise to give, or authorisation of the giving of anything of value
                                         to any &ldquo;foreign official&rdquo; (as such term is defined in the FCPA) or any foreign
                                         political party or official thereof or any candidate for foreign political office, in
                                         contravention of the FCPA; or</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 70.3pt; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 31.2pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">any
                                         provision of equivalent laws of any other jurisdiction in which the Issuer or any other
                                         member of the Group conducts its business or operations,</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.3pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">and,
to the best knowledge, information and belief of the Issuer and the Guarantor (after due enquiry), their respective Affiliates
have conducted their businesses in compliance with the FCPA and such other equivalent laws and have instituted and maintain policies
and procedures designed to ensure, and which are reasonably expected to continue to ensure, continued compliance therewith.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.3pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 39.1pt; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 31.2pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Sanctions
                                         administered by OFAC</B></FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.3pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Neither
the Issuer, any other member of the Group nor any director, officer, or to the best knowledge, information and belief of the Issuer
and the Guarantor (after due enquiry), any agent, employee, is an individual or entity (&ldquo;<B>Person</B>&rdquo;) that is, or
is owned or controlled by a Person that is currently subject to any U.S. sanctions administered by the Office of Foreign Assets
Control of the U.S. Department of the Treasury (&ldquo;<B>OFAC</B>&rdquo;) or any sanctions administered by the European Union or
the United Nations (collectively, the &ldquo;<B>Sanctions</B>&rdquo;) or located, organised or resident in a country or territory
that is the subject of Sanctions.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.3pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 39.1pt; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 31.2pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(jj)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Private
                                         Placements </B></FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 70.3pt; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 31.2pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                         information disclosed to the Subscriber with respect to the Private Placements (&ldquo;<B>Disclosure
                                         on Private Placements</B>&rdquo;) is complete, true, accurate and not misleading; and</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 70.3pt; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 31.2pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                         terms of any Private Placements that the Issuer will or may enter into subsequent to
                                         the Signing Date shall be substantially the same as or no more favourable than the terms
                                         disclosed in the Disclosure on Private Placements.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 19; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 39.1pt; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 31.2pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(kk)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Other
                                         Transactions</B></FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.3pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Neither
the Issuer nor any other member of the Group is, and so long as any Bond remains Outstanding, will be, a party to any other transaction
which, if executed in accordance with its terms, has or would have a Material Adverse Effect.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.3pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 39.1pt; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 31.2pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ll)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Use
                                         of Proceeds</B></FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.3pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
use by the Issuer or any other member of the Group of the proceeds from the issue of the Bonds for Permitted Use of Proceeds will
not violate any existing laws or regulations of any relevant jurisdiction.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.3pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 39.1pt; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 31.2pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(mm)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>No
                                         General Solicitation</B></FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.3pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Neither
the Issuer, any of other member of the Group, nor any person acting on its or their behalf, has engaged, and so long as any Bond
remains Outstanding, will, in any form of general solicitation or general advertising (within the meaning of Regulation D under
the Securities Act of 1933 as amended (the &ldquo;<B>Securities Act</B>&rdquo;) in connection with the offer or sale of the Bonds
or the Shares.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.3pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 39.1pt; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 31.2pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(nn)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Non-Integration</B></FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.3pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Neither
the Issuer, the Guarantor, any of its Affiliates, nor any person acting on its or their behalf has made or will make offers or
sales of any security, or solicited or will solicit offers to buy, or otherwise negotiated or will negotiate in respect of, any
security, under circumstances that would require the registration of the Bonds or the Shares upon conversion of the Bonds under
the Securities Act.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.3pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 39.1pt; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 31.2pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(oo)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>No
                                         Registration Required</B></FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.3pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Subject
to the representations and warranties of the Subscriber herein, the offer and issuance by the Issuer of the Bonds or the Shares
upon conversion of the Bonds in the manner contemplated by this Agreement is exempt from registration under the Securities Act
pursuant to Section 4(a)(2) of the Securities Act and/or Regulation S promulgated pursuant to the Securities Act.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.3pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 39.1pt; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 31.2pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(pp)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Directed
                                         Selling Efforts</B></FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.3pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Neither
the Issuer, the Guarantor, any of its Affiliates, nor any person acting on its or their behalf has engaged or will engage in any
directed selling efforts (as defined in Regulation S under the Securities Act (&ldquo;<B>Regulation S</B>&rdquo;)) with respect
to the Bonds and the Shares and the Issuer and they have complied and will comply with the offering restrictions requirement of
such Regulation.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.3pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 39.1pt; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 31.2pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(qq)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Foreign
                                         Issuer and U.S. Market Interest</B></FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.3pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Issuer is a &ldquo;foreign issuer&rdquo; (as such term is defined in Regulation S) which reasonably believes that there is no &ldquo;substantial
U.S. market interest&rdquo; (as such term is defined in Regulation S) in its debt securities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.3pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 39.1pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.2</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Each
                                         of the representations and warranties contained in each of Clause 3.1 shall be construed
                                         separately and independently.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 39.1pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.3</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">It
                                         is acknowledged that the Subscriber has entered into this Agreement in reliance upon
                                         the representations and warranties contained in, or given pursuant to, Clause 3.1.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 39.1pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.4</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Repetition</B></FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 39.1pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Unless
otherwise specified therein, the representations and warranties contained in, or given pursuant to, Clause&nbsp;3.1 shall be made
on the Signing Date and be deemed to have been repeated on the Issue Date and on a continuous basis so long as any Bond remains
Outstanding, taking into account facts and circumstances subsisting on the Issue Date and any relevant dates until the Expiration
Date.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 39.1pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 39.1pt; text-align: justify"></P>

<!-- Field: Page; Sequence: 20; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 39.1pt; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 39.1pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 39.1pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.5</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Indemnity</B></FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 39.1pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
commitment of the Subscriber under this Agreement is being made on the basis of the foregoing representations, warranties, undertakings
and agreements of the Issuer and the Guarantor with the intention that such representations and warranties shall remain true and
accurate in all material respects on such dates when they are repeated with reference to the facts and circumstances then subsisting
and that the undertakings and agreements shall have been performed as set out herein and the Issuer (failing whom, the Guarantor)
undertakes to pay the Subscriber on demand an amount which is equal to any liability and damages suffered and any cost, claim,
loss or expenses (including, without limitation, legal fees, costs and expenses) (a &ldquo;<B>Loss</B>&rdquo;) incurred by the Subscriber
in respect of or in connection with any breach or alleged breach of any of the representations, warranties, undertakings or agreements
contained in, this Agreement or any certificate issued by the Issuer and the Guarantor, as the case may be.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 39.1pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; text-transform: uppercase; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 39.1pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">4.</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>UNDERTAKINGS
                                         OF THE ISSUER and the guarantor</B></FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 39.1pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Each
of the Issuer and the Guarantor undertakes with the Subscriber to comply with the following obligations:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 39.1pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 39.1pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.1</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Taxes</B></FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 39.1pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Issuer (failing whom, the Guarantor) shall pay:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 39.1pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 39.1pt; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 31.2pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">any
                                         stamp, issue, registration, documentary or other taxes and duties, including interest
                                         and penalties in Hong Kong, the Cayman Islands, the British Virgin Islands and the United
                                         States and all other relevant jurisdictions payable on or in connection with the creation
                                         and issue of the Bonds, the issue of the Shares or the execution or delivery of the Transaction
                                         Documents; and</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 39.1pt; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 31.2pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">in
                                         addition to any amount payable by it under this Agreement, any value added, service,
                                         turnover or similar tax payable in respect thereof (and references in this Agreement
                                         to such amount shall be deemed to include any such taxes so payable in addition to it).</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 39.1pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Subscriber shall pay all, if any, taxes imposed and arising by reference to any disposal or deemed disposal of a Bond or interest
therein otherwise than in connection with the exercise of Conversion Rights by the Subscriber.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 39.1pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 39.1pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.2</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Warranties</B></FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 39.1pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Issuer (failing whom, the Guarantor) shall forthwith notify the Subscriber if at any time prior to payment of the Subscription
Price to the Issuer on the Issue Date anything occurs which renders or may render untrue or incorrect in any respect any of its
representations, warranties, undertakings, agreements and indemnities herein and will forthwith take such steps as the Subscriber
may reasonably require to remedy the fact.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 39.1pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 39.1pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.3</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Use
                                         of Proceeds</B></FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 39.1pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Issuer (failing whom, the Guarantor) shall use the net proceeds from the issue of the Bonds for the Permitted Use of Proceeds,
provided that neither the Issuer nor any other member of the Group shall knowingly use, directly or indirectly, the proceeds of
the offering of the Bonds hereunder, or knowingly lend, contribute or otherwise make available such proceeds to any member of
the Group, joint venture partner or other person or entity, for the purpose of financing the activities of any person currently
subject to any U.S. sanctions administered by OFAC or any Sanctions.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 39.1pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 39.1pt; text-align: justify"></P>

<!-- Field: Page; Sequence: 21; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 39.1pt; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 39.1pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 39.1pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.4</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Limitation
                                         on indebtedness</B></FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 39.1pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">So
long as the Subscriber continues to have an Exposure,</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 39.1pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 39.1pt; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 31.2pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>before</U>
                                                                                                                                                                                                                                      the occurrence of the QIPO, none of the Issuer or any other member of the Group, without the prior written consent of
                                                                                                                                                                                                                                      the Subscriber (which shall not be unreasonably withheld or delayed), shall enter into or incur any Financial
                                                                                                                                                                                                                                      Indebtedness.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 39.1pt; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 31.2pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>following</U>
                                                                                                                                                                                                                                      the occurrence of the QIPO, none of the Issuer or any other member of the Group shall, without the prior written consent
                                                                                                                                                                                                                                      of the Subscriber (which shall not be unreasonably withheld or delayed), enter into or incur any Financial Indebtedness <U>unless</U>:</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 67.45pt; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 35.45pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">any
                                         such Financial Indebtedness is, in aggregate, less than US$60,000,000; and</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 67.45pt; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 35.45pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                         Issuer shall at all times maintain a ratio of total consolidated liabilities to total
                                         consolidated assets of the Issuer (as calculated by reference to its most recent audited
                                         financial statements) of not more than 50.0 per cent.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 42.55pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
these Conditions, &ldquo;<B>Financial Indebtedness</B>&rdquo; means any indebtedness for monies borrowed or raised, which shall
include any interest or premium to be paid thereunder. Any limitation under Clauses 4.4(a) and 4.4(b) shall not apply to:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 42.55pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 42.55pt; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 28.35pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(I)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                         issue of the Bonds;</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 42.55pt; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 28.35pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(II)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                         entry into the Share Charge or Account Charge or any other security interests in relation
                                         to the Bonds;</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 42.55pt; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 28.35pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(III)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                         Private Placements;</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 42.55pt; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 28.35pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(IV)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                         Employees&rsquo; Share Options;</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 42.55pt; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 28.35pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(V)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                         Other Share Options and Warrants;</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 42.55pt; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 28.35pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(VI)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                         Subsidiary Share Grants and Share Options; or</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 42.55pt; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 28.35pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(VII)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                         QIPO.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 42.55pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(items
(I) to (VII) above collectively known as &ldquo;<B>Permitted Offerings</B>&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 42.55pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 39.1pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.5</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Limitation
                                         on equity offerings</B></FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 39.1pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Employees&rsquo;
Share Options </B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 39.1pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 39.1pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">So
long as the Subscriber continues to have an Exposure, the Issuer and the Guarantor undertake that:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 39.1pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 39.1pt; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 31.2pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                         total number of Ordinary Shares to be issued under any such Employees&rsquo; Share Options
                                         shall not exceed 5.0 per cent. of the total aggregate number of Ordinary Shares in issue
                                         immediately following the QIPO on a fully diluted basis taking into account the total
                                         number of Ordinary Shares at issue following the QIPO, any Ordinary Shares falling to
                                         be issued pursuant to the Permitted Offerings; and</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 39.1pt; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 31.2pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">any
                                         Permitted Offerings, if fully exercised for Ordinary Shares, would not trigger any Change
                                         of Control.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 22; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 39.1pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Other
Share Options and Warrants</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 39.1pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 39.1pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">So
long as the Subscriber continues to have an Exposure, the Issuer and the Guarantor undertake that:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 39.1pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 39.1pt; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 31.2pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">any
                                         Other Share Options and Warrants shall be granted by the Issuer only and not by the Issuer&rsquo;s
                                         Subsidiaries; and</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 39.1pt; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 31.2pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                         total number of Ordinary Shares to be issued under any such Other Share Options and Warrants
                                         shall not exceed 5.0 per cent. of the total aggregate number of Ordinary Shares in issue
                                         immediately following the QIPO on a fully diluted basis taking into account the total
                                         number of Ordinary Shares at issue following the QIPO, any Ordinary Shares falling to
                                         be issued pursuant to the Permitted Offerings; and</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 39.1pt; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 31.2pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">any
                                         Permitted Offerings, if fully exercised for Ordinary Shares, would not trigger any Change
                                         of Control.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 39.1pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Subsidiary
Share Grants and Share Options</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 39.1pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 39.1pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">So
long as the Subscriber continues to have an Exposure, the Issuer and the Guarantor undertake that:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 39.1pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 39.1pt; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 31.2pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(f)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">any
                                         Subsidiary Share Grants and Share Options shall be granted by the Issuer&rsquo;s Subsidiaries
                                         only and not by the Issuer; and</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 39.1pt; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 31.2pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(g)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">any
                                         Permitted Offerings, if fully exercised for shares, would not trigger any Change of Control.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 39.1pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Permitted
Offerings</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 39.1pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 39.1pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Notwithstanding
the above, the Issuer and the Guarantor undertake and will procure that if any of the Permitted Offerings occurs after the occurrence
of the QIPO, the market capitalisation of the Issuer (translated if necessary into US dollars at the then prevailing relevant
exchange rate) calculated based on the issue price per Share immediately following such Permitted Offering (being the product
of the issue price per Share at the relevant time multiplied by the total number of Ordinary Shares in issue following such Permitted
Offering) shall be equal to or greater than the Issuer&rsquo;s Market Capitalisation at IPO.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 39.1pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 39.1pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Limitation
before and after QIPO</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 39.1pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 39.1pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">So
long as the Subscriber continues to have an Exposure, and other than in relation to the Permitted Offerings that otherwise comply
with these Conditions,</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 39.1pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 39.1pt; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 31.2pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(h)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>before</U>
                                                                                                                                                                                                                                      the occurrence of the QIPO,</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 70.9pt; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 35.45pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">none
                                         of the Issuer and any other member of the Group (other than the Guarantor) shall, without
                                         the prior written consent of the Subscriber (which shall not be unreasonably withheld
                                         or delayed), offer (publicly or privately), or enter into any transaction which is designed
                                         to, or might reasonably be expected to, result in any public or private offering by any
                                         other member of the Group (other than the Guarantor), or announce any public or private
                                         offering of, any shares or securities convertible into or exchangeable for, or warrants,
                                         rights or options, or agreements to grant warrants, rights or options, to purchase or
                                         to subscribe for, any shares issued by, or shares held by, the Issuer or any other member
                                         of the Group (other than the Guarantor); or issue any additional shares of other class(es)
                                         in its capital (other than the Shares), including without limitation any Class B ordinary
                                         shares of the Issuer; and</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 70.9pt; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 35.45pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">no
                                         shares of the Issuer and any other member of the Group (other than (I) the Guarantor
                                         and (II) the Issuer in respect of the QIPO) shall, without the prior written consent
                                         of the Subscriber (which shall not be unreasonably withheld or delayed), be listed, quoted,
                                         admitted to trading or dealt in on any stock exchange.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 23; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->21<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 39.1pt; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 31.2pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>following</U>
                                                                                                                                                                                                                                      the occurrence of the QIPO, the Issuer may have its Shares listed, quoted, admitted to trading or dealt in on a stock
                                                                                                                                                                                                                                      exchange other than the stock exchange in respect of the Listing by way of secondary listing, or conduct any private
                                                                                                                                                                                                                                      placement or public offering of its Shares (each a &ldquo;<B>Post-IPO Secondary Offering</B>&rdquo;), <U>provided
                                                                                                                                                                                                                                      that</U>:</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 70.9pt; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 35.45pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                         offering size for such Post-IPO Secondary Offering (being the product of the issue price
                                         for such offering multiplied by the number of shares to be issued in such Post-IPO Secondary
                                         Offering), as determined by an Independent Investment Bank and/or Independent Firm of
                                         Auditors, shall be less than US$50,000,000; and</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 70.9pt; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 35.45pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iv)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                         offering price per Share at such Post-IPO Secondary Offering shall not be below the IPO
                                         Share Price in the opinion of an Independent Investment Bank and/or Independent Firm
                                         of Auditors; and</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 70.9pt; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 35.45pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(v)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                         market capitalisation of the Issuer (translated if necessary into US dollars at the then
                                         prevailing relevant exchange rate) calculated based on the issue price per Share for
                                         the relevant Post-IPO Secondary Offering following such Post-IPO Secondary Offering (being
                                         the product of the issue price per Share multiplied by the total number of Shares in
                                         issue following such Post-IPO Secondary Offering), as determined by an Independent Investment
                                         Bank and/or Independent Firm of Auditors, shall be greater than the Issuer&rsquo;s Market Capitalisation
                                         at IPO.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 39.1pt; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 31.2pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(j)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Subject
                                         to Condition 4.5(i) above, other than the Permitted Offerings and Post-IPO Secondary
                                         Offerings that otherwise comply with these Conditions, <U>following</U> the occurrence
                                         of the QIPO, none of the Issuer or any other member of the Group (other than the Guarantor)
                                         shall, offer (publicly or privately), or enter into any transaction which is designed
                                         to, or might reasonably be expected to, result in any public or private offering by any
                                         other member of the Group (other than the Guarantor), or announce any public or private
                                         offering of, any shares or securities convertible into or exchangeable for, or warrants,
                                         rights or options, or agreements to grant warrants, rights or options, to purchase or
                                         to subscribe for, any shares issued by, or shares held by, the Issuer or any other member
                                         of the Group (other than the Guarantor); or issue any additional shares of other class(es)
                                         in its capital (other than the Shares), including without limitation any Class B ordinary
                                         shares of the Issuer.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 39.1pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.6</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Corporate
                                         actions </B></FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 39.1pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">So
long as any Bonds remain Outstanding, neither the Issuer nor any member of the Group shall enter into any form of corporate reorganisation,
including but not limited to merging, consolidating or amalgamating any business currently controlled by any member of the Group,
or any part of it, with any other business that is not controlled by any member of the Group, entering into any share swap transaction,
demerger or divestiture with any other business that is not controlled by any member of the Group, <U>unless</U> any such corporate
reorganisation is entered into among the members of the Group.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 39.1pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 39.1pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.7</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Announcements
                                         </B></FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 39.1pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Unless
required by any law, regulation or listing rules binding on the Issuer or the Guarantor (including any disclosure and/or publication
requirement binding on the Issuer or the Guarantor in respect of the Listing), or otherwise consented in writing by the Subscriber
(which consent shall not be unreasonably withheld or delayed), none of the Issuer or any other members of the Group or any other
parties acting on its or their behalf shall issue any announcement concerning the Bonds. The Issuer or the Guarantor may make
any announcement based on information that has previously come into the public domain.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 42.75pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 42.75pt; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 24; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->22<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 42.75pt; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 42.75pt; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 42.75pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Notwithstanding
the above, the Issuer may disclose the terms and conditions of the Transaction Documents and the background of the initial Bondholders:
(i) in any governmental filing or to other authorities as required by the applicable laws and/or regulation or rules of NASDAQ,
an Alternative Stock Exchange, the Financial Industry Regulatory Authority or the U.S. Securities and Exchange Commission and
(ii) in connection with any action or claim to enforce its rights thereunder. The Issuer may disclose the terms and conditions
of the Transaction Documents to underwriters, investors, lenders and financial advisors in preforming due diligence in any other
transaction otherwise permitted in the Subscription Agreement or these Conditions.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 42.75pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 39.1pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.8</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Registration
                                         of the Share Charge </B></FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 39.1pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Guarantor undertakes that it will as soon as reasonably practicable and, in any event, within ten Business Days of the date of
the Share Charge (i) register or cause to be registered with the Registrar of Corporate Affairs in the BVI, and update of its
register of charges with details of the security interests created by, the Share Charge, in accordance with the BVI Business Companies
Act, (ii) use its best endeavours to complete such registration and obtain a registration record from its registered agent in
the BVI and a certificate of registration of charge from the Registrar of Corporate Affairs in the BVI, (iii) deliver to the Subscriber
copies of such registration record, certificate of registration of charge, and a certificate signed by a director or duly authorised
officer of the Guarantor confirming the completion of the registration of the Share Charge and (iv) comply with all applicable
laws of the British Virgin Islands (&ldquo;<B>BVI laws</B>&rdquo;) and regulations in relation to the Share Charge.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 39.1pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 39.1pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.9</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Registration
                                         of the Account Charge</B></FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 39.1pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Issuer undertakes that it will, after execution of the Account Charge, (i) register or cause to be registered with the Companies
Registry of Hong Kong the Account Charge within one (1) calendar month of the date of the Account Charge and (ii) deliver to the
Subscriber a certificate signed by a director or duly authorised officer of the Issuer confirming the completion of the registration
of the Account Charge.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 39.1pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 39.1pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.10</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Debt
                                         Service Reserve Account </B></FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 39.1pt; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 31.2pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Prior
                                         to the Issue Date, the Issuer (failing whom, the Guarantor) shall have deposited into
                                         the Debt Service Reserve Account the total amount of (i) the Structuring Fee, <I>plus
                                         </I>(ii) the Subscriber&rsquo;s Expenses, <I>plus</I> (iii) an amount in US dollars equal to
                                         the aggregate amount of interest due and payable for two consecutive Interest Periods
                                         commencing from, and including, the Issue Date.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 39.1pt; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 31.2pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Upon
                                         payment of the Subscription Price of the Bonds by the Bondholders on the Issue Date pursuant
                                         to this Agreement, the Issuer (failing whom, the Guarantor) shall procure that on the
                                         Issue Date, such net proceeds of the issue of the Bonds shall be deposited in the Debt
                                         Service Reserve Account.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 39.1pt; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 31.2pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
                                         the event that the Maturity Date is extended to the Extended Maturity Date as defined
                                         and subject to Condition 9, each of the Issuer and Guarantor undertakes to procure that
                                         the aggregate amount of interest due and payable for the Interest Period commencing on,
                                         and including, the Scheduled Maturity Date and ending on, and including, the Extended
                                         Maturity Date shall be deposited and made immediately available as a condition of such
                                         extension in the Debt Service Reserve Account to the satisfaction of the Bondholders.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 39.1pt; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 31.2pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                         Debt Service Reserve (or the relevant part thereof) will be released from the Debt Service
                                         Reserve Account on satisfaction of any one of the Release Conditions in accordance with
                                         the Account Charge.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 39.1pt; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 31.2pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
                                         any Bond has been converted into Shares on a Conversion Upon QIPO or exercise of a Conversion
                                         Right or redeemed in accordance with the Conditions, the Debt Service Reserve (or the
                                         relevant part thereof) may be released in accordance with the Account Charge from the
                                         Debt Service Reserve Account in an amount <I>pro rata</I> to the principal amount of
                                         the Bond or Bonds being converted or redeemed, as the case may be.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 25; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->23<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 39.1pt; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 31.2pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(f)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
                                         the date falling two Business Days prior to each Interest Payment Date commencing on,
                                         and including the First Interest Payment Date and ending on, and including the Maturity
                                         Date, the Account Bank shall upon instructions being provided by the Issuer and/or Bondholders
                                         in accordance with the Account Charge release from the Debt Service Reserve Account and
                                         pay to the account of the Bondholders such amount of the proceeds deposited in the Debt
                                         Service Reserve Account as is equal to the aggregate amount of interest due and payable
                                         on the immediately following Interest Payment Date or, as the case may be, the Maturity
                                         Date, in accordance with Condition 6.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 39.1pt; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 31.2pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(g)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Any
                                         operational costs and expenses or bank account service fees to be imposed or charged
                                         by the Account Bank in respect of the Debt Service Reserve Account shall be agreed in
                                         writing with the Account Bank prior to the establishment of such account. If such costs,
                                         expenses and fees are to be borne by the Issuer, the Issuer shall settle such amounts
                                         with funds other than the Debt Service Reserve.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 39.1pt; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 31.2pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(h)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">So
                                         long as any Bond remains Outstanding, neither the Issuer nor any member of the Group
                                         shall, without the prior written consent of the Bondholders, change (nor instruct the
                                         Account Bank to change) any bank mandate or authorised signatory in respect of the Debt
                                         Service Reserve Account.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 39.1pt; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 31.2pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">At
                                         the Maturity Date, the Early Redemption Date, the Relevant Event Put Date or any other
                                         dates on which the principal, interest or premium on the Bonds are payable by the Issuer
                                         pursuant to these Conditions, as the case may be, the Issuer may repay and redeem the
                                         Bonds that remain Outstanding with the Debt Service Reserve pursuant to the Account Charge.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 39.1pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.11</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Listing
                                         applications</B></FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 39.1pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Each
of the Issuer and Guarantor shall use their respective best endeavours to obtain all approvals required for (i) the shares of
the Issuer to be listed or quoted or dealt in NASDAQ or an Alternative Stock Exchange as soon as practicable after the Issue Date,
and (ii) the listing of and permission to deal in the Shares to be allotted and issued for the purposes of the conversion of the
Bonds.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 39.1pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 39.1pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">So
long as any Bond remains Outstanding, as soon as practicable upon the request of the Subscriber from time to time, each of the
Issuer and Guarantor shall furnish the Subscriber with any submissions, documents or materials in connection with the listing
applications abovementioned.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 39.1pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 39.1pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.12</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Financial
                                         Statements etc.</B></FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 39.1pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">So
long as any Bond remains Outstanding, the Subscriber shall have the right to request from each of the Issuer and the Guarantor,
in each case in the English language, a copy of:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 39.1pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 39.1pt; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 31.2pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                         relevant annual audited consolidated income statement, consolidated balance sheet, consolidated
                                         cash flow statement and consolidated statement of changes in shareholders&rsquo; equity of
                                         the Issuer and the Guarantor together with any statements, reports (including any directors&rsquo;
                                         and auditors&rsquo; reports) and notes attached to or intended to be read with any of them
                                         within 120 days after the end of their respective financial years;</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 26; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->24<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 39.1pt; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 31.2pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">subject
                                         to the applicable laws, by-laws, regulations and rules of the relevant jurisdiction or
                                         stock exchange binding on the Issuer or the Guarantor, including those with respect to
                                         the disclosure of non-public information,</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 70.9pt; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 28.35pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                         quarterly (or any other interim reporting period required by applicable law or regulations)
                                         unaudited consolidated income statement, consolidated balance sheet, consolidated cash
                                         flow statement and consolidated statement of changes in shareholders&rsquo; equity of the Issuer
                                         together with any statements, reports (including any directors&rsquo; and auditors&rsquo; review
                                         reports, if any) and notes attached to or intended to be read with any of them within
                                         60 days after the end of their respective financial years; and</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 70.9pt; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 28.35pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">as
                                         soon as practicable upon the request of the Subscriber from time to time, each of the
                                         Issuer and Guarantor shall furnish the Subscriber with any documentation or materials
                                         in relation to the key performance indicators of the Issuer or any other member of the
                                         Group (other than the Guarantor).</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 39.1pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.13</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Disposals
                                         by any member in the Group (other than the Guarantor)</B></FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 39.1pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Disposals
of Intellectual Property</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 39.1pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 39.1pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">So
long as the Subscriber continues to have an Exposure,</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 39.1pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 39.1pt; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 31.2pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>before</U>
                                                                                                                                                                                                                                      the occurrence of the QIPO, none of the Issuer or any member in the Group (other than the Guarantor) will, without the
                                                                                                                                                                                                                                      prior written consent of the Subscriber (such consent shall not be unreasonably withheld or delayed), enter into a single
                                                                                                                                                                                                                                      transaction or a series of transactions (whether related or not and whether voluntary or involuntary) to sell (through any
                                                                                                                                                                                                                                      kind of trade sale, placement or otherwise), lease, transfer, grant any sub-licence of or dispose of (through any kind of
                                                                                                                                                                                                                                      offering, reverse takeover or otherwise) any Intellectual Property, <U>unless</U> such proposed sale, lease, transfer or
                                                                                                                                                                                                                                      disposal is made by a member of the Group to the Issuer and/or its Subsidiaries.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 39.1pt; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 31.2pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>following</U>
                                                                                                                                                                                                                                      the occurrence of the QIPO, the Issuer or its Subsidiaries may conduct any such transaction as referred to in Clause
                                                                                                                                                                                                                                      4.13(a) above without the prior written consent of the Subscriber <U>provided that</U>:</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 70.9pt; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 28.35pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                         consideration to be received for the relevant Intellectual Property under the proposed
                                         transaction, as determined by an Independent Investment Bank and/or Independent Firm
                                         of Auditors, is more than 75.0 per cent. of the Issuer&rsquo;s Market Capitalisation at IPO;
                                         or</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 70.9pt; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 28.35pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">such
                                         proposed sale, lease, transfer or disposal is made by a member of the Group to the Issuer
                                         and/or its Subsidiaries.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 39.1pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Disposals
of assets (other than Intellectual Property)</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 39.1pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 39.1pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">So
long as the Subscriber continues to have an Exposure,</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 39.1pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 39.1pt; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 31.2pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Subject
                                         to Clauses 4.4, 4.5, 4.13(a) and 4.13(b), the Issuer will not, and will ensure that no
                                         members of the Group (other than the Guarantor) will, enter into a single transaction
                                         or a series of transactions (whether related or not and whether voluntary or involuntary)
                                         to sell, lease, transfer or otherwise dispose of any assets (including without limitation
                                         any investment securities and machinery but excluding any cash), <U>unless</U> such proposed
                                         sale, lease, transfer or disposal:</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 70.9pt; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 28.35pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">is
                                         made in the ordinary course of business of the Group <U>and</U> will not result in, or
                                         be expected to result in:</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 99.25pt; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 35.45pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(A)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                         total consolidated assets of the Issuer being equal to or less than 60.0 per cent. of
                                         the total consolidated assets as shown in its audited consolidated financial statements
                                         of the Group as of and for the year ended 31 December 2017; and</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 27; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->25<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 99.25pt; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 35.45pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(B)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                         sale price of such asset shall not be equal to or less than 60.0 per cent. of its fair
                                         value as shown in the audited consolidated financial statements of the Group as of and
                                         for the year ended 31 December 2017; or</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 70.9pt; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 28.35pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">is
                                         of assets in exchange for or to be replaced by other assets comparable or superior as
                                         to type, value and quality; or</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 70.9pt; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 28.35pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">is
                                         made by a member of the Group to another member of Group.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 39.1pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Disposals
of subsidiaries</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 39.1pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 39.1pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Subject
to Clauses 4.4, 4.5, 4.13(a) and 4.13(b), so long as the Subscriber continues to have an Exposure,</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 39.1pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 39.1pt; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 31.2pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>before</U>
                                                                                                                                                                                                                                      the occurrence of the QIPO, other than the Permitted Offerings that otherwise comply with these Conditions, no member of
                                                                                                                                                                                                                                      the Group (other than the Guarantor) shall dispose any of its legal or beneficial interest in any company, partnership, joint
                                                                                                                                                                                                                                      venture, trust, profit-sharing arrangement or other legal entity without the prior written consent of the Subscriber (which
                                                                                                                                                                                                                                      shall not be unreasonably withheld or delayed).</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 39.1pt; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 31.2pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>following</U>
                                                                                                                                                                                                                                      the occurrence of the QIPO, other than the Permitted Offerings and Post-IPO Secondary Offerings that otherwise comply
                                                                                                                                                                                                                                      with these Conditions, the Issuer or its Subsidiaries may conduct any transaction as referred to in Clause 4.13(d) without
                                                                                                                                                                                                                                      the prior written consent of the Subscriber <U>provided that</U> the consideration to be received for the relevant
                                                                                                                                                                                                                                      subsidiaries under the proposed transaction, as determined by an Independent Investment Bank and/or Independent Firm of
                                                                                                                                                                                                                                      Auditors, is more than 75.0 per cent. of the Market Capitalisation at IPO.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 39.1pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.14</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Disposals
                                         by the Guarantor</B></FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 39.1pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">So
long as the Subscriber continues to have an Exposure, the Guarantor shall not dispose any of its legal or beneficial interest
in the Issuer without the prior written consent of the Subscriber (which shall not be unreasonably withheld or delayed) <U>unless:</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 39.1pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 39.1pt; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 31.2pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">such
                                         disposal occurs after the occurrence of the QIPO; and</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 39.1pt; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 31.2pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">such
                                         disposal shall not trigger a Change of Control.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 39.1pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.15</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Consent
                                         from lenders</B></FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 39.1pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Issuer undertakes to obtain all consents and approvals required in relation to the issue of the Bonds and the performance of the
Issuer&rsquo;s and the Guarantor&rsquo;s obligations under the Transaction Documents (including but not limited to any consents and approvals
required from all relevant lenders of the Private Placements and any lenders to any member of the Group).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 39.1pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; text-transform: uppercase; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 39.1pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">5.</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>GUARANTOR&rsquo;s
                                         buyback right</B></FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 39.1pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Subscriber hereby grants an option to the Guarantor, following the enforcement of the Share Charge by the Subscriber, for the
Guarantor (or its nominated affiliate) to purchase the Issuer&rsquo;s Class B ordinary shares charged under the Share Charge (the &ldquo;<B>Charged
Shares</B>&rdquo;) provided that:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 39.1pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 39.1pt; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 31.2pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                         total consideration payable by the Guarantor (or its affiliates, as the case may be),
                                         for the Charged Shares shall be the higher of (A) the highest quotation of the Charged
                                         Shares obtained by the Subscriber from any potential purchasers, and (B) the total amount
                                         of any outstanding Secured Obligations (as defined in the Share Charge); and</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 28; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->26<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 39.1pt; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 31.2pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                         other terms offered by the Guarantor (or its affiliate, as the case may be) in respect
                                         of the purchase of the Charged Shares shall be substantially the same as those offered
                                         to the Subscriber by any potential purchasers of the Charged Shares.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; text-transform: uppercase; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 39.1pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">6.</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Subscriber&rsquo;s
                                         rights</B></FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 39.1pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.1</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Right
                                         of nomination in respect of board members</B></FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 39.1pt; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 31.2pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Subject
                                         to Clauses 6.1(c) and 6.1(d), regardless of whether any of the Bonds is redeemed or converted
                                         into Shares, the Guarantor agrees that it shall exercise its voting rights in any general
                                         meeting of the Issuer to appoint (A) one observer or (B) one non-executive director,
                                         in each case nominated by the Subscriber to the board of directors of the Issuer (and
                                         shall cause the Issuer to exercise its voting rights in any general meeting of any Subsidiaries
                                         to appoint one such observer or one such non-executive director to the board of directors
                                         of any of its Subsidiaries). The appointment of such candidate nominated by the Subscriber
                                         shall be subject to the consent of the Guarantor (such consent shall not be unreasonably
                                         withheld or delayed). Each of the Issuer and the Guarantor consents to each of Paul Heffner,
                                         Barry Lau and Reuben Lee sitting (and one of which at a time will sit) as a non-executive
                                         director or observer in the Issuer&rsquo;s board of directors. In the event that the Subscriber
                                         nominates a non-executive director to the board of directors of the Issuer or its Subsidiaries,
                                         in the avoidance of conflicts of interest, <I>inter alias</I>, such non-executive director
                                         is required to disclose to the board the Subscriber&rsquo;s equity and security interests
                                         in other relevant companies.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 39.1pt; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 31.2pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
                                         any such candidate nominated by the Subscriber is appointed as an observer to the Issuer&rsquo;s
                                         board of directors, the Subscriber shall have the right to appoint a substitute non-executive
                                         director to replace such observer.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 39.1pt; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 31.2pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Following
                                         the occurrence of a QIPO, if the Bondholders cease to have an Exposure, the Guarantor
                                         shall have the right to remove such observer or non-executive director nominated by the
                                         Subscriber and/or the Transferee, as the case may be, from the relevant board of directors
                                         in accordance with Clauses 6.1(a) and 6.1(d).</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 39.1pt; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 31.2pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
                                         and only if the Subscriber transfers all of the aggregate outstanding amount of the Bonds
                                         to any third party (the &ldquo;<B>Transferee</B>&rdquo;) in accordance with the Conditions,
                                         the Issuer agrees that such Transferee shall be entitled to the nomination right as provided
                                         in Clause 6.1(a) above and the Subscriber shall cease to have such nomination right upon
                                         such transfer. The Issuer will, promptly following request by the Subscriber, do all
                                         such acts and/or execute all such documents (including corporate authorisations) as is
                                         necessary for the purposes of conferring such right on the Transferee.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 39.1pt; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 31.2pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Following
                                         the Issue Date, up to the Expiration Date, any change in the composition of the board
                                         of directors of the Issuer or the Guarantor without any prior written consent of the
                                         Subscriber (such consent shall not be unreasonably withheld or delayed) will trigger
                                         an Event of Default pursuant to the Conditions.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 29; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->27<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 39.1pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.2</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Right
                                         to subscribe for shares subsequent to QIPO</B></FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 39.1pt; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 31.2pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Following
                                         the occurrence of a QIPO, regardless of whether the Issuer has redeemed any or all of
                                         the Bonds during the Conversion Period in accordance with or as provided in the Conditions,
                                         up to one year following a QIPO, the Subscriber shall have the right from and including
                                         the date of any such redemption, up to and including the date on which the Conversion
                                         Period for such Bonds would otherwise have ended to subscribe for such number of Shares
                                         that would have been resulted from the exercise of the Conversion Rights attaching to
                                         such redeemed Bonds at the relevant Conversion Price as determined in accordance with
                                         the Conditions as if none of such Bond had been redeemed by the Issuer (the &ldquo;<B>Subscription
                                         Right</B>&rdquo;). The provision of Condition 7 shall continue to apply with full force
                                         and effect in relation to such subscription rights notwithstanding any redemption of
                                         the relevant Bonds as though such provisions were set out in full herein.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 39.1pt; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 31.2pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
                                         the Subscriber transfers any of the Bonds to any Transferee in accordance with the Conditions,
                                         the Issuer agrees that such Transferee shall be entitled to the Subscription Right in
                                         respect of such number of Shares that would have been resulted from the exercise of the
                                         Conversion Rights attaching to the principal amount of the Bond or Bonds such Transferee
                                         at the time holds. The Issuer will, promptly following request by the Subscriber, do
                                         all such acts and/or execute all such documents (including assignments, transfers, mortgages,
                                         charges, notices and instructions) as is necessary for the purposes of conferring such
                                         right on the Transferee.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 39.1pt; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 31.2pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Any
                                         Subscription Right attached to a Bond shall extinguish after the Subscriber or the Transferee,
                                         as the case may be, exercises such subscription right in respect of the relevant Bond.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 39.1pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.3</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Tag-along
                                         rights before the QIPO</B></FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 39.1pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
the Guarantor proposes to sell or transfer its legal or beneficial interest in the Issuer to a third party (other than a Related
Person) before the occurrence of the QIPO, the Guarantor shall:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 39.1pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 39.1pt; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 31.2pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">procure
                                         that any such sale or transfer shall not trigger a Change of Control under the Conditions;</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 39.1pt; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 31.2pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">give
                                         the Subscriber a written notice of such proposed transfer at least 30 days prior to effecting
                                         such transfer; and</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 39.1pt; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 31.2pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">promptly
                                         cause any such intended Transferee to offer in writing to purchase from the Subscriber
                                         a <I>pro rata</I> portion of the Subscriber&rsquo;s Shares on the terms that are substantially
                                         the same (including with respect to price, representations, warranties and indemnification)
                                         as those offered to the Guarantor but the Subscriber shall not be obliged to sell or
                                         transfer its shares to the offeror.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; text-transform: uppercase; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 39.1pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">7.</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>ESG</B></FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 39.1pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Issuer shall use its best endeavours to comply with the ESG guidelines as set out in Schedule 3 hereto.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 39.1pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; text-transform: uppercase; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 39.1pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">8.</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>subscriber&rsquo;s
                                         REPRESENTATIONS and warranties</B></FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 39.1pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8.1</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Authorisation</B></FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 39.1pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Subscriber is an independent entity duly incorporated or established and validly existing under the laws of its jurisdiction of
incorporation, is in compliance with all laws and regulations to which it is subject, is not in liquidation or receivership, has
full power and authority to own its properties and to conduct its business and is lawfully qualified to do business in those jurisdictions
in which business is conducted by it and has full power and authority to enter into and perform its obligations under the Transaction
Documents.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 39.1pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 39.1pt; text-align: justify; text-indent: 0in"></P>

<!-- Field: Page; Sequence: 30; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->28<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 39.1pt; text-align: justify; text-indent: 0in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 39.1pt; text-align: justify; text-indent: 0in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 39.1pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8.2</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Validity
                                         of Transaction Documents</B></FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 39.1pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
Agreement and the other Transaction Documents to which the Subscriber is a party have been duly authorised, executed and delivered
by the Subscriber and, upon due execution and delivery prior to or on the Issue Date will constitute, valid and legally and binding
obligations of the Subscriber.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 39.1pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 39.1pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8.3</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Compliance</B></FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 39.1pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
execution and delivery of this Agreement and the Transaction Documents, and compliance with their terms by the Subscriber do not
and will not infringe any existing applicable law, rule, regulation, judgment, order, authorisation or decree of any government,
governmental or regulatory body or court, domestic or foreign, of Hong Kong.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 39.1pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 39.1pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8.4</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>OFAC/FCPA
                                         compliance</B></FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 39.1pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">To
the best knowledge, information and belief of the Subscriber (after due and careful inquiry), as of the Issue Date,</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 39.1pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 39.1pt; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 31.2pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">none
                                         of the Subscriber or its Direct Shareholder is under investigations for breach of the
                                         OFAC and/or FCPA; and</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 39.1pt; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 31.2pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">none
                                         of the investors of the Subscriber is on the Specially Designated and Block Persons List,
                                         or from the Sanctioned Countries, where:</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.3pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Complete
Specially Designated Nationals&nbsp;List</B>&rdquo; means the list bearing the same name published on <U>https://www.treasury.gov/resource-center/sanctions/SDN-List/Pages/default.aspx</U>
as of the Signing Date.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.3pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.3pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Sanctioned
Countries</B>&rdquo; means Balkans, Belarus, Burma (Myanmar), Cote d&rsquo; Ivoire (Ivory Coast), Cuba, Democratic Republic of Congo,
Iran, Iraq, Lebanon, Liberia, Libya, North Korea, Somalia, Sudan, Syria and Zimbabwe.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.3pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 39.1pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8.5</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Each
                                         of the representations and warranties contained in each of Clauses 8.1 to 8.4 shall be
                                         construed separately and independently.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 39.1pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8.6</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">It
                                         is acknowledged that the Issuer and Guarantor have entered into this Agreement in reliance
                                         upon the representations and warranties contained in, or given pursuant to, Clauses 8.1
                                         to 8.4.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; text-transform: uppercase; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 39.1pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>9.</B></FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Subscriber&rsquo;s
                                         undertakingS</B></FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 39.1pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">9.1</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Conversion
                                         of Bonds</B></FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 39.1pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Subscriber shall, and shall procure any Transferee to, undertake any and all actions required for and to cause such Transferee
to undertake any and all actions required for the Conversion Upon QIPO under Condition 7.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 39.1pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 39.1pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">9.2</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Lockup
                                         period</B></FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 39.1pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Provided
that no Event of Default has occurred and is continuing, following the exercise of Conversion Right by the Subscriber, the Subscriber
shall not, and shall procure that its Transferee(s) shall not, directly or indirectly, sell or otherwise transfer any Shares during
a period of up to 90 calendar days following the first Trading Day after the occurrence of a QIPO.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 39.1pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 39.1pt; text-align: justify; text-indent: 0in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 31; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->29<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 39.1pt; text-align: justify; text-indent: 0in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 39.1pt; text-align: justify; text-indent: 0in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 39.1pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">9.3</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Change
                                         of control in the Subscriber</B></FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 39.1pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
the Direct Shareholder of the Subscriber as at the Signing Date ceases to hold more than 50.0 per cent. of the Voting Rights in
the Subscriber, the Subscriber shall give a written notice to the Issuer specifying such change within 15 Business Days after
such change becomes effective.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 39.1pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 39.1pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">9.4</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Release
                                         conditions</B></FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 39.1pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
any Release Condition has been satisfied and the Subscriber&rsquo;s consent is required from the Subscriber to release the Debt Service
Reserve pursuant to this Agreement and/or the Account Charge, the Subscriber shall not (and if the Bonds are transferred to a
Transferee, shall procure that its Transferee(s) shall not) unreasonably withhold or delay its consent.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 39.1pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 39.1pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">9.5</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>OFAC/FCPA</B></FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 39.1pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
the Subscriber is aware of any investigation taken against it in relation to breach of OFAC or FCPA, the Subscriber shall notify
the Issuer in writing as soon as practicable after it becomes aware of such investigation.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 39.1pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; text-transform: uppercase; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 39.1pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>10.</B></FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>SUBSCRIBER&rsquo;S
                                         acknowledgement</B></FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 39.1pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.1</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Certificates
                                         of Shares</B></FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 39.1pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Subscriber acknowledges that the certificates evidencing the Shares underlying such Bond, when issued and delivered, may bear
the following or any similar legend:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 39.1pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 39.1pt; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 31.2pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;The
                                         securities represented hereby may not be transferred unless (i) such securities have
                                         been registered for sale pursuant to the Securities Act, (ii) such securities may be
                                         sold pursuant to Rule 144 or Regulation S under said Act, or (iii) the Issuer has received
                                         an opinion of counsel reasonably satisfactory to it that such transfer may lawfully be
                                         made without registration under the Securities Act or qualification under applicable
                                         state securities laws.&rdquo;; and</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 39.1pt; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 31.2pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">any
                                         legend required by regulatory authorities of any applicable jurisdiction in connection
                                         with the issuance or sale of the Shares.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 39.1pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.2</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Listing
                                         and conduct of business of the Issuer</B></FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 39.1pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Subscriber acknowledges (i) the Issuer&rsquo;s plan to achieve a QIPO, and (ii) that the Issuer shall conduct its ordinary course
of business (including but not limited to its right to enter into arm&rsquo;s-length transactions with third parties with respect to
its Intellectual Property) subject to this Agreement and the Conditions.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 39.1pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; text-transform: uppercase; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 39.1pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">11.</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>CONDITIONS
                                         PRECEDENT</B></FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 39.1pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">11.1</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                         obligations of the Subscriber to subscribe and pay for the Bonds are conditional upon:</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 39.1pt; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 31.2pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Other
                                         Transaction Documents</B></FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.3pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
or before the Issue Date, the execution and delivery of the Transaction Documents, each in a form satisfactory to the Subscriber,
by the respective parties.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.3pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 39.1pt; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 31.2pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Business
                                         and financial due diligence</B></FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.3pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
or before the Issue Date, the Subscriber having received due diligence reports and/or financial statements in relation to the
business, operation and financial status of the Issuer and the Group in form and substance satisfactory to the Subscriber. None
of the Accounting Items stated in the 2017 Financial Statements shall vary by more than US$1,500,000 (any such difference shall
be irrespective of any goodwill impact due to any changes in the business nature of any member of the Group), as compared to the
Management Accounts, and there is no material adverse change or development involving a prospective Material Adverse Effect since
31 December 2017.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.3pt; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.3pt; text-align: justify; text-indent: 0in"></P>

<!-- Field: Page; Sequence: 32; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->30<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.3pt; text-align: justify; text-indent: 0in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.3pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 39.1pt; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 31.2pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>ESG
                                         due diligence</B></FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.3pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
or before the Issue Date, the Subscriber having received due diligence reports on ESG of the Issuer and the Group (other than
the Guarantor) in form and substance satisfactory to the Subscriber. This condition precedent shall be deemed satisfied unless
otherwise communicated by the Subscriber to the Issuer in writing prior to the Issue Date.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.3pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 39.1pt; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 31.2pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Perfection
                                         of Security</B></FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.3pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
or before the Issue Date, the perfection of the Share Charge and Account Charge having been completed, including without limitation
the necessary registration and filing.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.3pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 39.1pt; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 31.2pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>No
                                         change in senior management</B></FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.3pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mr.
Ian Huen and Mr. Darren Lui having continued to hold the position of chief executive director and president respectively, and
to be actively involved in the management or operation, of the Issuer.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.3pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 39.1pt; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 31.2pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(f)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>No
                                         litigation</B></FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.3pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">There
are no police, legal, arbitral, governmental or any regulatory investigations or pending claims, actions, suits or proceedings
against or affecting the Issuer or any other member of the Group or any of their respective directors, officers or any of their
respective properties or to the best knowledge of the Issuer and the Guarantor (after due and careful inquiry), the employees,
which, if determined adversely to the Issuer or any other member of the Group or any of their respective directors, officers or
any of their respective properties, would individually or in the aggregate have a Material Adverse Effect, and, to the best of
the Issuer&rsquo;s and the Guarantor&rsquo;s knowledge (after due and careful inquiry), no such investigations, actions, suits or proceedings
are threatened or contemplated.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.3pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 39.1pt; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 31.2pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(g)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Debt
                                         Service Reserve Account</B></FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 70.3pt; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 31.2pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Before
                                         the Issue Date, the Debt Service Reserve Account having been funded in accordance with
                                         Clauses 4.10, 12.1 and 12.2; and</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 70.3pt; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 31.2pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
                                         or before the Issue Date, the Subscriber having obtained adequate control as a secured
                                         creditor over the Debt Service Reserve Account.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 39.1pt; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 31.2pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(h)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>No
                                         material adverse change</B></FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.3pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">After
the Signing Date up to and including the Issue Date, there shall not have occurred any change (nor any development or event involving
prospective change) in the condition (financial or other), prospects, results of operations or general affairs of the Issuer or
the Group which has a Material Adverse Effect in the context of the issue of the Bonds.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.3pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 39.1pt; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 31.2pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Officer&rsquo;s
                                         certificates</B></FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.3pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
the Signing Date and on the Issue Date, there having been delivered to the Subscriber a certificate substantially in the form
attached as Schedule 2 hereto dated such dates and signed by an authorised officer of the Issuer and the Guarantor respectively.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.3pt; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.3pt; text-align: justify; text-indent: 0in"></P>

<!-- Field: Page; Sequence: 33; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->31<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.3pt; text-align: justify; text-indent: 0in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.3pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 39.1pt; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 31.2pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(j)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Legal
                                         opinions</B></FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.3pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
or before the Issue Date, there having been delivered to Subscriber, in form and substance satisfactory to the Subscriber and
dated the Issue Date, of:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.3pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 70.3pt; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 31.2pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">legal
                                         opinion from Ashurst Hong Kong, legal advisors to the Subscriber as to Hong Kong law;
                                         and</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 70.3pt; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 31.2pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">legal
                                         opinion of Ogier, legal advisors to the Subscriber as to the laws of British Virgin Islands
                                         and Cayman Islands.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.3pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
condition precedent shall be deemed satisfied unless otherwise communicated by the Subscriber to the Issuer in writing prior to
the Issue Date.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.3pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 39.1pt; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 31.2pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(k)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Guarantor&rsquo;s
                                         existing loans</B></FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.3pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Before
the Issue Date, the Guarantor having repaid or settled all of its the existing loans by way of debt-to-equity swap or otherwise,
as supported by evidence to the satisfaction of the Subscriber.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.3pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 39.1pt; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 31.2pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(l)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Compliance</B></FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.3pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
the Issue Date, (i) the representations and warranties of the Issuer and the Guarantor in the Transaction Documents being true,
accurate and correct in all respects and not misleading in any respect at, and as if made on, such date; and (ii) the Issuer and
the Guarantor having performed all of their respective obligations under the Transaction Documents to be performed on or before
such date.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.3pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 39.1pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">11.2</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Waiver</B></FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 39.1pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
any of the conditions set out in Clause 11.1 is not satisfied on or before the Issue Date, the Subscriber may in its discretion
and by notice to the Issuer waive satisfaction of any of the above conditions or of any part of them.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 39.1pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; text-transform: uppercase; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 39.1pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">12.</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>ISSUANCE</B></FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 39.1pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">12.1</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
                                         the date falling three Hong Kong business days prior to the Issue Date, the Issuer (failing
                                         whom, the Guarantor) shall deposit into the Debt Service Reserve Account the total amount
                                         of (i) the Structuring Fee, <I>plus</I> (ii) the amount of Subscriber&rsquo;s Expenses (the
                                         amount of which shall be agreed in writing between the Issuer and the Subscriber five
                                         Hong Kong business days prior to the Issue Date), <I>plus</I> (iii) an amount in US dollars
                                         equal to the aggregate amount of interest due and payable for two consecutive Interest
                                         Periods commencing from, and including, the Issue Date.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 39.1pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">12.2</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
                                         the Issue Date, against compliance with Clauses 12.1, 12.3 and 12.4, respectively, by
                                         the Issuer or the Guarantor, the Subscriber shall pay the Subscription Price in immediately
                                         available funds to the Issuer into the Debt Service Reserve Account on the Issue Date.
                                         Evidence of such payment shall be satisfied by the delivery to the Issuer of an irrevocable
                                         instruction giving effect to the above and shall constitute a complete discharge of the
                                         Subscriber&rsquo;s payment obligations in respect of the Bonds.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 39.1pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">12.3</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
                                         the Issue Date, against compliance with Clause 12.2 by the Subscriber, the Issuer shall:</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 39.1pt; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 31.2pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">deliver
                                         the Bond Certificate representing the aggregate principal amount of the Bonds duly executed
                                         on behalf of the Issuer;</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 39.1pt; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 31.2pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">procure
                                         the entry in the register of Bondholders of the name of the Subscriber as the registered
                                         holder of the Bonds issued on the Issue Date; and</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 34; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->32<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 39.1pt; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 31.2pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">deliver
                                         to the Subscriber each of the Contracts other than this Agreement, duly executed by each
                                         party thereto other than the Subscriber.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 39.1pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">12.4</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Delivery
                                         of the Bond Certificate and completion of the register of Bondholders shall constitute
                                         the issue and delivery of the Bonds issued on the Issue Date.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; text-transform: uppercase; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 39.1pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">13.</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>EXPENSES
                                         AND PAYMENTS</B></FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 39.1pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">13.1</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Structuring
                                         Fee</B></FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 39.1pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
the Issue Date, the Issuer (failing whom, the Guarantor) shall pay to the Subscriber the Structuring Fee, which shall be deducted
from the proceeds of the issue of the Bonds payable by the Subscriber on the Issue Date.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 39.1pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 39.1pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">13.2</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Issuer&rsquo;s
                                         General Expenses</B></FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 39.1pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Issuer (failing whom, the Guarantor) is responsible for paying the (i) fees and expenses of the legal, accountancy and other professional
advisers instructed by the Issuer in connection with the creation and issue and offering of the Bonds, (ii) upon and subsequent
to the occurrence of a QIPO, fees and expenses of the listing and conversion of the Shares on NASDAQ or an Alternative Stock Exchange,
and (iii) costs incurred by it in connection with the preparation and execution of the Transaction Documents<I>. </I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 39.1pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 39.1pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">13.3</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Subscriber&rsquo;s
                                         Expenses</B></FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 39.1pt; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 31.2pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Regardless
                                         of whether the arrangements for the subscription and issue of the Bonds have been completed,
                                         the Issuer (failing whom, the Guarantor) shall pay:</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 70.3pt; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 31.2pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                         out-of-pocket costs and expenses incurred by the Subscriber (including its directors,
                                         officers and employees and legal, accountancy and other third party professional advisers
                                         instructed by any of them) in connection with or arising out of the issuance and offering
                                         of the Bonds, including, but not limited to, legal, due diligence and other professional
                                         fees and expenses incurred by the Subscriber; and</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 70.3pt; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 31.2pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">all
                                         other out-of-pocket costs and expenses incurred by the Subscriber in connection with
                                         or arising out of the issuance and offering of the Bonds hereunder for which provision
                                         is not otherwise made in this Clause 13.3,</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.3pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(collectively,
&ldquo;<B>Aggregate Subscriber&rsquo;s Expenses</B>&rdquo;, subject to an aggregate limit of US$250,000). The Subscriber&rsquo;s Expenses means
the Aggregate Subscriber&rsquo;s Expenses <I>less</I> US$180,000 (which has been paid by the Issuer to the Subscriber prior to the Signing
Date).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.3pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 39.1pt; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 31.2pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Notwithstanding
                                         the foregoing, the Issuer (failing whom, the Guarantor) shall also reimburse to the Subscriber
                                         any costs and expenses in relation to the on-going monitoring of the business operation
                                         and performance of the Group incurred by the Subscriber following the Issue of the Bonds,
                                         subject to a limit of US$25,000 per annum.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 39.1pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">13.4</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Payment</B></FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 39.1pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">All
payments due under this Agreement are to be made in US dollars and are stated exclusive of any applicable tax whether income taxes,
withholding taxes, value added taxes, goods and services taxes, business or services taxes or similar taxes other than taxes imposed
in respect of net income by a taxing jurisdiction wherein the recipient is incorporated or resident for tax purposes (&ldquo;<B>Taxes</B>&rdquo;).
If any deduction or withholding for or on account of Taxes is required to be made from any payment to the Subscriber, then the
Issuer (failing whom, the Guarantor) shall pay an additional amount so that the Subscriber receives, free from any such withholding,
deduction, assessment or levy, the full amount of the payments set out herein. The Issuer (failing whom, the Guarantor) shall
make appropriate payments and returns in respect of such Taxes and provide the Subscriber with an original or authenticated copy
of the tax receipt.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 39.1pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 39.1pt; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 35; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->33<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 39.1pt; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 39.1pt; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; text-transform: uppercase; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 39.1pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>14.</B></FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>TERMINATION</B></FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 39.1pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">14.1</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Expiration
                                         </B></FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 39.1pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
Agreement shall expire on the latest of (i) the Maturity Date, and (ii) the date on which the Subscriber has fully exercised the
subscription right as provided in Clause 6.2 (the &ldquo;<B>Expiration Date</B>&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 39.1pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 39.1pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">14.2</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Survival
                                         of representations and obligations </B></FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 39.1pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Notwithstanding
completion of the arrangements for the subscription and issue of the Bonds, at any time before the Expiration Date, Clauses 3
(Representations and Warranties of the Issuer and the Guarantor), 4 (Undertakings of the Issuer and the Guarantor), 5 (Subscriber&rsquo;s
Rights), 7 (ESG), 8 (Subscriber&rsquo;s Representations, Warranties and Undertakings), 13.3 (Subscriber&rsquo;s Expenses), 14 (Termination),
15 (Communications) and Clauses 16 to 20 continue with full force and effect. For the avoidance of doubt, Clause 5 (Subscriber&rsquo;s
Rights) shall survive and in full force and effect despite the Bonds being fully redeemed, converted and/or repaid up to the period
stated in Clause 6 of this Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 39.1pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 39.1pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">14.3</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Ability
                                         of the Subscriber to Terminate</B></FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 39.1pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Notwithstanding
anything contained herein, the Subscriber may, by notice to the Issuer and the Guarantor, given at any time prior to the Issue
Date, terminate this Agreement, in any of the following circumstances:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 39.1pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 39.1pt; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 31.2pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">there
                                         shall have come to the notice of the Subscriber any breach of, or any event rendering
                                         untrue or incorrect in any respect, any of the warranties, representations and undertakings
                                         contained in this Agreement or any failure to perform any of the Issuer&rsquo;s or the Guarantor&rsquo;s
                                         undertakings or agreements in this Agreement; or</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 39.1pt; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 31.2pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">any
                                         of the conditions specified in Clause 11.1 have not been satisfied or waived by the Subscriber
                                         on or prior to the Issue Date; or</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 39.1pt; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 31.2pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">in
                                         the opinion of the Subscriber, there shall have been such a change, whether or not foreseeable
                                         at the Signing Date, in national or international financial, political or economic conditions
                                         or currency exchange rates or exchange controls as would in its view be likely to prejudice
                                         materially the success of the offering and distribution of the Bonds or dealings in the
                                         Bonds in the secondary market.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 39.1pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">14.4</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Termination
                                         due to the failure to set up the Debt Service Reserve Account prior to Issue Date</B></FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 39.1pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
the Debt Service Reserve Account is not set up to the satisfaction of the Subscriber prior to the Issue Date, this Agreement shall
terminate and be of no further effect and no party shall be under any liability to any other in respect of this Agreement, except
that the Issuer shall remain liable for the payment of (i) a termination fee of 0.50 per cent. of the aggregate principal amount
of US$15,000,000 (the &ldquo;<B>Termination Fee</B>&rdquo;) and (ii) all costs and expenses referred to in Clauses 13.2, 13.3(a)
and any applicable taxes under 13.4.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 39.1pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 39.1pt; text-align: justify; text-indent: 0in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 36; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->34<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 39.1pt; text-align: justify; text-indent: 0in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 39.1pt; text-align: justify; text-indent: 0in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 39.1pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">14.5</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Consequences
                                         of Termination by Subscriber</B></FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 39.1pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Subject
to Clause 14.4 above, upon such notice being given by the Subscriber pursuant to Clause 14.3, this Agreement shall terminate and
be of no further effect and no party shall be under any liability to any other in respect of this Agreement, except that:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 39.1pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 39.1pt; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 31.2pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">if
                                         the Agreement is terminated pursuant to Clause 14.3(a) or 14.3(b), the Issuer (failing
                                         whom, the Guarantor) shall remain liable for the payment of (i) the Structuring Fee,
                                         (ii) the Termination Fee and (iii) all costs and expenses referred to in Clauses 13.2,
                                         13.3(a) and 13.4.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 39.1pt; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 31.2pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">if
                                         the Agreement is terminated pursuant to Clause 14.3(c), the Issuer (failing whom, the
                                         Guarantor) shall remain liable for the payment of all costs and expenses referred to
                                         in Clauses 13.2, 13.3(a) and 13.4.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 39.1pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">14.6</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Ability
                                         of the Issuer to Terminate</B></FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 39.1pt; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 31.2pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Notwithstanding
                                         anything contained herein, the Issuer or the Guarantor may, by notice to the Subscriber,
                                         given at any time prior to the Issue Date, terminate this Agreement, if there shall have
                                         come to the notice of the Issuer or the Guarantor any breach of, or any event rendering
                                         untrue or incorrect in any respect, any of the Subscriber&rsquo;s warranties or representations
                                         contained in this Agreement.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 39.1pt; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 31.2pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Subject
                                         to Clause 14.4 above, upon such notice being given by the Issuer or the Guarantor pursuant
                                         to Clause 14.6(a), this Agreement shall terminate and be of no further effect and no
                                         party shall be under any liability to any other in respect of this Agreement, except
                                         that the Issuer (failing whom, the Guarantor) shall remain liable for the payment of
                                         all costs and expenses referred to in Clauses 13.2, 13.3(a) and 13.4.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 39.1pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>15.</B></FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>COMMUNICATIONS</B></FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 39.1pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">15.1</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Addresses</B></FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 39.1pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Any
communication shall be given by letter or fax in the case of notices</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 39.1pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 39.1pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>to
the Issuer, to it at:</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 39.1pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 39.1pt; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 39.1pt">&nbsp;</TD>
    <TD STYLE="text-align: left; width: 25%"><FONT STYLE="font-family: Times New Roman, Times, Serif">Aptorum Group Limited </FONT></TD>
    <TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Address:</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">17/F, Guangdong Investment Tower</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">148 Connaught Road Central</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Hong Kong</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Fax no.:</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">(+852) 2850 7286</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Attention:</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Mr. Ian Huen, CEO &amp; Executive Director</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>to the Guarantor, to it at:</B></FONT></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Jurchen Investment Corporation</FONT></TD>
    <TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Address:</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">17/F, Guangdong Investment Tower</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">148 Connaught Road Central</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Hong Kong</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Fax no.:</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">(+852) 2850 7286</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Attention:</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Mr. Ian Huen, Director</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>to the Subscriber, to it at:</B></FONT></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: left">Peace Range Limited</TD>
    <TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: left">Address:</TD>
    <TD STYLE="text-align: left"></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: left"></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: left"></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: left">Fax no.:</TD>
    <TD STYLE="text-align: left"></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: left">Attention:</TD>
    <TD STYLE="text-align: left">Mr. Andy Cheuk / Mr. Philip Wong</TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 39.1pt; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 39.1pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 39.1pt; text-align: left"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 37; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->35<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 39.1pt; text-align: left"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 39.1pt; text-align: left"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 39.1pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">15.2</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Effectiveness</B></FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 39.1pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Any
such communication shall take effect, in the case of a letter, at the time of delivery, and in the case of fax, at the time of
despatch.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 39.1pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 39.1pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">15.3</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Confirmations</B></FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 39.1pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Any
communication not by letter shall be confirmed by letter but failure to send or receive the letter of confirmation shall not invalidate
the original communication.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 39.1pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; text-transform: uppercase; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 39.1pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">16.</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>ENTIRE
                                         AGREEMENT</B></FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 39.1pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
Agreement, together with any documents referred to in it, constitutes the whole agreement between the parties relating to the
issue of and the subscription for the Bonds and supersedes and extinguishes any other prior drafts, agreements, undertakings,
representations, warranties and arrangements of any nature, whether in writing or oral, relating to the issue of, and the subscription
for, the Bonds.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 39.1pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; text-transform: uppercase; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 39.1pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">17.</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>TIME</B></FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 39.1pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Any
date or period specified herein may be postponed or extended by mutual agreement among the Parties but, as regards any date or
period originally fixed or so postponed or extended, time shall be of the essence.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 39.1pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; text-transform: uppercase; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 39.1pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">18.</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>GOVERNING
                                         LAW AND JURISDICTION</B></FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 39.1pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">18.1</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Governing
                                         law</B></FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 39.1pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
Agreement and any non-contractual obligations arising out of or in connection with this Agreement shall be governed by and construed
in accordance with Hong Kong laws.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 39.1pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 39.1pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">18.2</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Arbitration</B></FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 39.1pt; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 31.2pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Any
                                         dispute, controversy, difference or claim arising out of or relating to this Agreement,
                                         including the existence, validity, interpretation, performance, breach or termination
                                         thereof or any dispute regarding non-contractual obligations arising out of or relating
                                         to it shall be referred to and finally resolved by arbitration administered by the Hong
                                         Kong International Arbitration Centre (&ldquo;<B>HKIAC</B>&rdquo;) under the HKIAC Administered
                                         Arbitration Rules in force when the Notice of Arbitration is submitted.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 39.1pt; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 31.2pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                         law of this arbitration clause shall be Hong Kong law.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 39.1pt; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 31.2pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                         seat of arbitration shall be Hong Kong.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 39.1pt; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 31.2pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                         number of arbitrators shall be three. The arbitration proceedings shall be conducted
                                         in English.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 39.1pt; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 31.2pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
                                         the avoidance of doubt, any dispute, controversy, difference or claim arising out of
                                         or relating to the Account Charge or Share Charge shall be referred to and finally resolved
                                         by the courts of Hong Kong pursuant to the provisions of the Account Charge or Share
                                         Charge, as the case may be.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; text-transform: uppercase; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 39.1pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">19.</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>GENERAL</B></FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 39.1pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">19.1</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>COUNTERPARTS</B></FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 39.1pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
Agreement may be executed in any number of counterparts, each of which shall be deemed an original.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 39.1pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 39.1pt; text-align: justify"></P>

<!-- Field: Page; Sequence: 38; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->36<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 39.1pt; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 39.1pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 39.1pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">19.2</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Assignment</B></FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 39.1pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">No
party shall (nor shall it purport to) assign, transfer, charge, put in trust or otherwise deal with the benefit of all or any
of its rights or interests under this Agreement, nor subcontract or otherwise deal with all or any of its obligations under this
Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 39.1pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 39.1pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">19.3</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Variation
                                         and Waiver</B></FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 39.1pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">No
variation of this Agreement shall be effective unless made in writing, expressed to be a variation of this Agreement and signed
on behalf of the parties. No failure or delay by any party in exercising any right, power or remedy provided by law or under this
Agreement shall operate as a waiver of that right, power or remedy or of some other right, power or remedy nor shall any partial
exercise thereof preclude any further exercise of the same or of some other right, power or remedy. The rights and remedies provided
under this Agreement are cumulative and are not exclusive of any rights and remedies provided by law or otherwise. Any waiver
of any right, power or remedy under this Agreement shall be in writing and may be given subject to such conditions as the grantor
may in its absolute discretion decide. Any such waiver (unless otherwise specified) shall only be a waiver in the particular instance
and for the particular purpose for which it was given.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 39.1pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 39.1pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">19.4</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Invalidity</B></FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 39.1pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Each
of the provisions of this Agreement is severable. If any provision is held to be invalid or unenforceable in any respect, but
would be valid and enforceable if deleted in part or reduced in application, such provision shall apply with such deletion or
modification as may be necessary to make it valid and enforceable. Without prejudice to the foregoing, if any provision is held
to be invalid or unenforceable, such provision shall to that extent be deemed not to form part of this Agreement, but the validity
and enforceability of the remaining provisions of this Agreement shall not in any way be affected or impaired (as long as the
fundamental relations between the parties are not materially altered).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 39.1pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; text-transform: uppercase; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 39.1pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">20.</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>THIRD
                                         PARTY RIGHTS</B></FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 39.1pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
person who is not a party to this Agreement has no right under the Contracts (Rights of Third Parties) Ordinance (Cap. 623 of
the Laws of Hong Kong) to enforce any term of this Agreement, but this does not affect any right or remedy of a third party which
exists or is available apart from that Ordinance.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 39.1pt; text-align: left"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;<BR STYLE="clear: both"></FONT></P>


<!-- Field: Page; Sequence: 39; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->37<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>THIS
AGREEMENT</B> has been entered into on the date stated at the beginning</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Issuer</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Aptorum
Group Limited </B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 5%; text-align: justify">By</TD>
    <TD STYLE="width: 35%; text-align: justify; border-bottom: Black 1.5pt solid">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
    <TD STYLE="width: 60%; text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">Name:</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">Title:</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Signature Page &ndash; Subscription Agreement</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 40 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Guarantor</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Jurchen
Investment Corporation</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 5%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">By</FONT></TD>
    <TD STYLE="width: 35%; text-align: justify; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
    <TD STYLE="width: 60%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Name:</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Title:</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Signature Page &ndash; Subscription Agreement</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>



<!-- Field: Page; Sequence: 41 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Subscriber</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Peace
Range Limited</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 5%; text-align: justify">By</TD>
    <TD STYLE="width: 35%; text-align: justify; border-bottom: Black 1.5pt solid">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>
    <TD STYLE="width: 60%; text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">Name:</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">Title:</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Signature Page &ndash; Subscription Agreement</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>


<!-- Field: Page; Sequence: 42 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Schedule
1</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: center; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>TERMS
AND CONDITIONS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: center; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 43; Options: NewSection -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">1-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Schedule
2</B><BR>
<BR>
<B>OFFICER&rsquo;S CERTIFICATE</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">To:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Peace
Range Limited</B><BR>
<BR>
<BR>
Attention: Mr. Andy Cheuk / Mr. Philip Wong</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(the
&ldquo;<B>Subscriber</B>&rdquo;)</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[Signing
Date]/[Issue Date] 2018</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dear
Sirs</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Subscription
Agreement relating to US$15,000,000 8.00 per cent. Convertible Bonds due 2019 convertible into shares of the Issuer</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to the Subscription Agreement dated 6 April 2018 (the &ldquo;<B>Subscription Agreement</B>&rdquo;) made between the Issuer, the
Guarantor and the Subscriber, we hereby confirm that as at today&rsquo;s date:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 39.1pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                         representations and warranties of each of the Issuer and the Guarantor in the Subscription
                                         Agreement are true, accurate and correct in all respects and not misleading in any respect
                                         as of today&rsquo;s date; and</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 39.1pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">each
                                         of the Issuer and the Guarantor has performed all of their respective obligations under
                                         the Subscription Agreement as of today&rsquo;s date.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Terms
defined in the Subscription Agreement have the same meanings in this letter except where otherwise defined in this letter.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Yours
faithfully</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Aptorum
Group Limited </B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 5%; text-align: justify">By</TD>
    <TD STYLE="width: 35%; text-align: justify; border-bottom: Black 1.5pt solid">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>
    <TD STYLE="width: 60%; text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">Name:</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">Title:</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Jurchen
Investment Corporation</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 5%; text-align: justify">By</TD>
    <TD STYLE="width: 35%; text-align: justify; border-bottom: Black 1.5pt solid">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>
    <TD STYLE="width: 60%; text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">Name:</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">Title:</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 44; Options: NewSection; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">2-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Schedule
3</B><BR>
<BR>
ESG Guideline</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following ESG Guidelines are extracted from, and shall be read in conjunction with, the ESG due diligence report issued by Pacific
Risk Advisors dated 27 February 2018.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>RECOMMENDED
E&amp;S ACTIONS&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top; background-color: white">
    <TD STYLE="padding-right: 2.85pt; padding-left: 2.85pt; text-align: center; font-size: 10pt; width: 5%; padding-bottom: 1.5pt; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">#</FONT></TD>
    <TD STYLE="width: 1%; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="padding-right: 2.85pt; padding-left: 2.85pt; text-align: left; font-size: 10pt; width: 16%; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Topic</FONT></TD>
    <TD STYLE="width: 1%; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="padding-right: 2.85pt; padding-left: 2.85pt; text-align: justify; font-size: 10pt; width: 60%; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Recommended Actions</FONT></TD>
    <TD STYLE="width: 1%; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="padding-right: 2.85pt; padding-left: 2.85pt; text-align: justify; font-size: 10pt; width: 16%; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Priority</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 2.85pt; padding-left: 2.85pt; text-align: center; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="padding-right: 2.85pt; padding-left: 2.85pt; text-align: left">
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><B>E&amp;S Licences &amp; Registrations</B></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 8.5pt; text-indent: -5.65pt; text-align: left">-&#9;IFC PS1</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 8.5pt; text-indent: -5.65pt; text-align: left">&nbsp;</P></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="padding-right: 2.85pt; padding-left: 2.85pt; text-align: justify; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ensure all required E&amp;S related licences and registrations are obtained from the regulatory authorities for all laboratory locations in Hong Kong. Copies of valid E&amp;S licenses and registrations should be provided to Peace Range Limited&rsquo;s E&amp;S Officer for record.</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="padding-right: 2.85pt; padding-left: 2.85pt">
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">HIGH</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Internal Resources</P></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 2.85pt; padding-left: 2.85pt; text-align: center; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="padding-right: 2.85pt; padding-left: 2.85pt; text-align: left">
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><B>E&amp;S Policy</B></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 8.5pt; text-indent: -5.65pt; text-align: left">-&#9;IFC PS1</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 8.5pt; text-indent: -5.65pt; text-align: left">&nbsp;</P></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="padding-right: 2.85pt; padding-left: 2.85pt; text-align: justify; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Formalise the E&amp;S Policy and include provision for periodic policy review, implementation monitoring, up-date, target setting, and oversight of the company&rsquo;s supply chain. The Policy should be reviewed at least annually, dated and signed by a senior management representative.</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="padding-right: 2.85pt; padding-left: 2.85pt">
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">LOW</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Internal Resources</P></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 2.85pt; padding-left: 2.85pt; text-align: center; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="padding-right: 2.85pt; padding-left: 2.85pt; text-align: left">
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><B>E&amp;S Management System</B></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 8.5pt; text-indent: -5.65pt; text-align: left">-&#9;IFC PS1</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 8.5pt; text-indent: -5.65pt; text-align: left">&nbsp;</P></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="padding-right: 2.85pt; padding-left: 2.85pt; text-align: justify; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Develop an E&amp;S Management System (ESMS) commensurate to the nature and scale of Aptorum Group Limited&rsquo;s operations (Office, Laboratory, etc.) and cover oversight of Aptorum Group Limited&rsquo;s subsidiaries, and Contract Research Organisations. The management system should include (i) policy; (ii) identification of risks and impacts; (iii) management programs; (iv) organizational capacity and competency; (v) emergency preparedness and response; (vi) stakeholder engagement; and (vii) monitoring and review. Where necessary, existing procedures, such as those outlined in the HKSTP SHE Handbook should be incorporated into the company&rsquo;s ESMS.</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="padding-right: 2.85pt; padding-left: 2.85pt">
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">MEDIUM</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Internal Resources, or USD 25,000-50,000
        if developed externally (depended on the extent of existing documentation).</P></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 2.85pt; padding-left: 2.85pt; text-align: center; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="padding-right: 2.85pt; padding-left: 2.85pt; text-align: left">
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><B>Supply Chain/CRO E&amp;S Assessment
        &amp; Monitoring</B></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 8.5pt; text-indent: -5.65pt; text-align: left">-&#9;IFC PS1</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 8.5pt; text-indent: -5.65pt; text-align: left">&nbsp;</P></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="padding-right: 2.85pt; padding-left: 2.85pt">
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As part of the ESMS development, establish
        a formal procedure for the E&amp;S assessment, monitoring and oversight of Contract Research Organisations/Supply Chain. The procedure
        should cover legally required E&amp;S permits and management procedures for suppliers&rsquo; operations, and incorporate efficiency,
        cost, saving, fair deal, GMP/GLP requirements, and include review of suppliers&rsquo; track record, site visits and license records.</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The E&amp;S assessment and monitoring elements
        may be incorporated into an overall supplier assessment procedure, rather than an E&amp;S specific standalone procedure.</P></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="padding-right: 2.85pt; padding-left: 2.85pt">
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">MEDIUM</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Internal Resources</P></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 2.85pt; padding-left: 2.85pt; text-align: center; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="padding-right: 2.85pt; padding-left: 2.85pt; text-align: left">
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><B>Grievance Mechanism (External)</B></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 8.5pt; text-indent: -5.65pt; text-align: left">-&#9;IFC PS1</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 8.5pt; text-indent: -5.65pt; text-align: left">&nbsp;</P></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="padding-right: 2.85pt; padding-left: 2.85pt; text-align: justify; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Develop an appropriately scaled external grievance mechanism to receive and facilitate resolution of concerns and grievances from external stakeholders, regarding the E&amp;S performance of the company. The grievance mechanism should seek to resolve concerns promptly, using an understandable and transparent consultative process that is appropriate and readily accessible, and at no cost and without retribution to the party that originated the issue or concern. The mechanism should not impede access to judicial or administrative remedies.</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="padding-right: 2.85pt; padding-left: 2.85pt">
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">MEDIUM</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Internal Resources</P></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 2.85pt; padding-left: 2.85pt; text-align: center; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="padding-right: 2.85pt; padding-left: 2.85pt; text-align: left">
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><B>Grievance Mechanism (Internal)</B></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 8.5pt; text-indent: -5.65pt; text-align: left">-&#9;IFC PS2</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 8.5pt; text-indent: -5.65pt; text-align: left"></P></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="padding-right: 2.85pt; padding-left: 2.85pt; text-align: justify; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Refine the internal grievance mechanism for employees to allow for anonymous complaints to the raise and investigated. The up-dated grievance mechanism should be included in the employee handbook and disseminated to all staff.</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="padding-right: 2.85pt; padding-left: 2.85pt">
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">MEDIUM</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Internal Resources</P></TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><I>Note.
A review of Aptorum Group Limited&rsquo;s laboratory operations should be completed once the laboratories become operational (i.e.
after end of April 2018), in order to assess the company&rsquo;s operational E&amp;S management approach.</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><I>&nbsp;</I></FONT></P>


<!-- Field: Page; Sequence: 45; Options: NewSection; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">3-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>E&amp;S
PROVISIONS &amp; SANCTIONS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>RECOMMENDED
E&amp;S PROVISIONS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The E&amp;S Provisions provided below,
for inclusion in the legal documentation with Aptorum Group Limited, have been developed based on the outcome of the E&amp;S Due
Diligence Review.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 0px"></TD>
    <TD STYLE="width: 24px; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.</FONT></TD>
    <TD STYLE="text-align: justify; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Aptorum Group Limited must not carry on or finance any activity on Peace Range Limited&rsquo;s Exclusion List below.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 0px"></TD>
    <TD STYLE="width: 24px; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.</FONT></TD>
    <TD STYLE="text-align: justify; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Aptorum Group Limited must use all reasonable efforts to ensure the E&amp;S performance of the operations is in compliance with Peace Range Limited&rsquo;s E&amp;S Requirements which comprise the Peace Range Limited&rsquo;s E&amp;S Policy, applicable E&amp;S laws, rules, regulations, any Environmental and Social Action Plans (ESAPs), and best practice standards (i.e. IFC Performance Standards)</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 0px"></TD>
    <TD STYLE="width: 24px; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.</FONT></TD>
    <TD STYLE="text-align: justify; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Aptorum Group Limited must comply with all applicable E&amp;S laws, rules, regulations (including international treaty obligations) and the terms of any related permits, licenses, consents, approvals or other authorisations held by the Aptorum Group Limited applicable in each jurisdiction in which the Aptorum Group Limited carries on business.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 0px"></TD>
    <TD STYLE="width: 24px; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.</FONT></TD>
    <TD STYLE="text-align: justify; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Aptorum Group Limited has not received nor is aware of any existing or threatened complaint, order, directive, claim, citation or notice from any Authority under applicable Hong Kong law and local requirements which has, or could reasonably be expected to have, a Material Adverse Effect or any material impact on the implementation or operations of the Aptorum Group Limited.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 0px"></TD>
    <TD STYLE="width: 24px; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.</FONT></TD>
    <TD STYLE="text-align: justify; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Aptorum Group Limited must appoint senior operational officer(s) or other appropriate personnel satisfactory to Peace Range Limited to be responsible for the implementation, operation and maintenance of the E&amp;S Management System and must notify the Peace Range Limited in writing immediately of the removal or replacement (for whatever reason) of that person. Different officers or personnel may be responsible for different aspects of the E&amp;S Management System (i.e. Environmental, Health &amp; Safety, Human Resources, Community liaison, etc.).</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 0px"></TD>
    <TD STYLE="width: 24px; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.</FONT></TD>
    <TD STYLE="text-align: justify; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Aptorum Group Limited must implement, maintain and continuously improve the E&amp;S Management System, including deploying employees of sufficient expertise and seniority as is necessary for this purpose.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 0px"></TD>
    <TD STYLE="width: 24px; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">7.</FONT></TD>
    <TD STYLE="text-align: justify; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Aptorum Group Limited must implement the environmental &amp; social mitigation and management measures specified, subject to any period permitted to achieve compliance, in the ESAP.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 0px"></TD>
    <TD STYLE="width: 24px; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8.</FONT></TD>
    <TD STYLE="text-align: justify; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Aptorum Group Limited should consider the potential for positive environmental and social impact from their business activities and how these could also benefit the business, for example through cost savings, reduced staff turnover or improved stakeholder relations. These should include adopting, developing, offering or marketing:</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 24px">&nbsp;</TD>
    <TD STYLE="width: 24px; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a.</FONT></TD>
    <TD STYLE="text-align: justify; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">products, services, skills or employment opportunities that could benefit community stakeholders;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.7pt; text-align: justify; text-indent: -17.85pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 24px">&nbsp;</TD>
    <TD STYLE="width: 24px; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">b.</FONT></TD>
    <TD STYLE="text-align: justify; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a living wage that is sufficient to meet workers&rsquo; needs; and</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.7pt; text-align: justify; text-indent: -17.85pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 24px">&nbsp;</TD>
    <TD STYLE="width: 24px; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">c.</FONT></TD>
    <TD STYLE="text-align: justify; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">resource efficient, greenhouse gas reducing or low carbon technologies or working practices.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in"></P>

<!-- Field: Page; Sequence: 46; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">3-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 0px"></TD>
    <TD STYLE="width: 24px; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">9.</FONT></TD>
    <TD STYLE="text-align: justify; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Aptorum Group Limited must, as soon as it is available, but in any event no later than 90 days after each financial year end, deliver to Peace Range Limited an E&amp;S annual monitoring report (AMR) in the Agreed Form. The monitoring report must set out in detail the progress the Aptorum Group Limited has made towards implementing the ESAP, the E&amp;S covenants, or identifying any non-compliance or failure, the actions being taken to remedy any such deficiency, and include measures of development impact (KPIs). The monitoring report must be approved annually by the Aptorum Group Limited&rsquo;s board of directors.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 0px"></TD>
    <TD STYLE="width: 24px; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.</FONT></TD>
    <TD STYLE="text-align: justify; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Aptorum Group Limited must, as soon as it is available, but in any event no later than 10 days after each half year end, deliver to Peace Range Limited a Regular Monitoring Report (RMR) in the Agreed Form. The monitoring report must set out progress Aptorum Group Limited has made towards implementing the ESAP, provide details on any E&amp;S incidents or non-compliances, and provide an up-date on KPIs and agreed targets.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in; text-align: left">11.</TD><TD STYLE="text-align: justify">The Aptorum Group Limited must promptly send Peace Range
Limited any internal audit report prepared for the Aptorum Group Limited which addresses the Investee&rsquo;s compliance with
all or any part of the E&amp;S Requirements.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in; text-align: left">12.</TD><TD STYLE="text-align: justify">At the request of Peace Range Limited, Aptorum Group Limited
shall, as promptly as possible, but in any event not more than 30 days after such request by Peace Range Limited, provide Peace
Range Limited with certifications of compliance from any Governmental Authorities in relation to the matters described in this
Section.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in; text-align: left">13.</TD><TD STYLE="text-align: justify">Aptorum Group Limited must inform Peace Range Limited in
writing immediately upon becoming aware of:</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">a.</TD><TD STYLE="text-align: justify">any E&amp;S Claim being commenced or threatened against
Aptorum Group Limited or any facts or circumstances which will or are reasonably likely to result in such an E&amp;S Claim being
commenced;</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.7pt; text-align: justify; text-indent: -17.85pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">b.</TD><TD STYLE="text-align: justify">any written notice or other allegation received by, or
brought to the attention of Aptorum Group Limited to the effect that any E&amp;S Requirements has been breached;</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.7pt; text-align: justify; text-indent: -17.85pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">c.</TD><TD STYLE="text-align: justify">any actions which may constitute a E&amp;S Crime committed
by or on behalf of the Aptorum Group Limited; and</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.7pt; text-align: justify; text-indent: -17.85pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">d.</TD><TD STYLE="text-align: justify">any enquires from government enforcement authorities concerning
any act that may constitute a E&amp;S Crime by or on behalf of Aptorum Group Limited.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in; text-align: left">14.</TD><TD STYLE="text-align: justify">If Peace Range Limited notifies Aptorum Group Limited that
it believes that there may have been a breach of the E&amp;S Requirements, the Company must cooperate in good faith with Peace
Range Limited in determining whether a breach has occurred. Aptorum Group Limited must respond promptly and in reasonable detail
to any request for information from Peace Range Limited and provide documentary support for the response if requested.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in; text-align: left">15.</TD><TD STYLE="text-align: justify">Aptorum Group Limited must notify the Peace Range Limited
of the following events promptly, but in any event within 3 days after their occurrence. The Aptorum Group Limited must supply
to Peace Range Limited within 14 days of the event a report incorporating, in each case, details of (1) the nature of the incident
and the on-site and off-site effects and (2) any action the Aptorum Group Limited proposes to take to remedy the effect of the
event. The Company must keep Peace Range Limited informed about the progress of any remedial action. The events are any of the
following which affect any employee, customer, supplier or other person who has dealings with, or is affected by the activities
of, Aptorum Group Limited or which occur on or nearby any site, plant, equipment or facility of the Aptorum Group Limited:</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">a.</TD><TD STYLE="text-align: justify">incident resulting in death or permanent injury to any
person;</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.7pt; text-align: justify; text-indent: -17.85pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">b.</TD><TD STYLE="text-align: justify">any other incident which has a material negative impact
on the environment or the health, safety and security situation (including without limitation any explosion, spill or workplace
accident which results in death, serious or multiple injuries or material environmental contamination); and</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.7pt; text-align: justify; text-indent: -17.85pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">c.</TD><TD STYLE="text-align: justify">any incident of a social nature (including without limitation
any violent labour unrest or dispute with local communities), which has or is reasonably likely to have a material negative effect
on the social and cultural context.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in"></P>

<!-- Field: Page; Sequence: 47; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">3-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0; text-align: justify"></TD><TD STYLE="width: 0.25in; text-align: justify">16.</TD><TD STYLE="text-align: justify">Aptorum Group Limited must permit Peace Range Limited,
and their appointed advisers unrestricted access to Aptorum Group Limited at all reasonable times and on reasonable notice to:</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in; text-align: justify"></TD><TD STYLE="width: 0.25in; text-align: justify">a.</TD><TD STYLE="text-align: justify">meet with senior management of the Aptorum Group Limited
to discuss any questions or issues in relation to E&amp;S Requirements;</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.7pt; text-align: justify; text-indent: -17.85pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in; text-align: justify"></TD><TD STYLE="width: 0.25in; text-align: justify">b.</TD><TD STYLE="text-align: justify">investigate any failure to comply with or implement the
E&amp;S Requirements (including the non-implementation of any ESAP);</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.7pt; text-align: justify; text-indent: -17.85pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in; text-align: justify"></TD><TD STYLE="width: 0.25in; text-align: justify">c.</TD><TD STYLE="text-align: justify">inspect and to take copies and extracts from the records
of the Aptorum Group Limited; and</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.7pt; text-align: justify; text-indent: -17.85pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in; text-align: justify"></TD><TD STYLE="width: 0.25in; text-align: justify">d.</TD><TD STYLE="text-align: justify">view the premises of the Aptorum Group Limited.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0; text-align: justify"></TD><TD STYLE="width: 0.25in; text-align: justify">17.</TD><TD STYLE="text-align: justify">If Peace Range Limited consider that an E&amp;S Breach
has (or may have) have occurred, Peace Range Limited shall inform Aptorum Group Limited of their suspicions and shall have the
right to appoint consultants to investigate the possible breach. Thereafter, Peace Range Limited and Aptorum Group Limited shall
meet to discuss possible remedies for the E&amp;S Breach.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0; text-align: justify"></TD><TD STYLE="width: 0.25in; text-align: justify">18.</TD><TD STYLE="text-align: justify">Aptorum Group Limited must ensure compliance with the following
working conditions and labour rights:</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in; text-align: justify"></TD><TD STYLE="width: 0.25in; text-align: justify">a.</TD><TD STYLE="text-align: justify">not employ or make use of forced labour;</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.7pt; text-align: justify; text-indent: -17.85pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in; text-align: justify"></TD><TD STYLE="width: 0.25in; text-align: justify">b.</TD><TD STYLE="text-align: justify">not employ or make use of child labour;</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.7pt; text-align: justify; text-indent: -17.85pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in; text-align: justify"></TD><TD STYLE="width: 0.25in; text-align: justify">c.</TD><TD STYLE="text-align: justify">pay wages which meet or exceed industry or legal national
minima;</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in; text-align: justify"></TD><TD STYLE="width: 0.25in; text-align: justify">d.</TD><TD STYLE="text-align: justify">not discriminate in terms of recruitment, progression,
terms and conditions of work and representation, on the basis of personal characteristics unrelated to inherent job requirements,
including gender, race, colour, caste, disability, political opinion, sexual orientation, age, religion, social or ethnic origin,
marital status, membership of workers&rsquo; organisations, legal migrants, or HIV status (unless positive discrimination is permitted
by law and is intended to address a historical imbalance);</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in; text-align: justify"></TD><TD STYLE="width: 0.25in; text-align: justify">e.</TD><TD STYLE="text-align: justify">adopt an open attitude towards workers&rsquo; organisations
and respect the right of all workers to join or form workers&rsquo; organisations of their own choosing, to bargain collectively
and to carry out their representative functions in the workplace in accordance with Hong Kong Legal Requirements</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in; text-align: justify"></TD><TD STYLE="width: 0.25in; text-align: justify">f.</TD><TD STYLE="text-align: justify">provide reasonable working conditions including a safe
and healthy work environment, working hours that are not excessive and clearly documented terms of employment, respecting conditions
established, by collective agreement or otherwise, for work in the trade or industry concerned in the area where the work is carried
out;</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in; text-align: justify"></TD><TD STYLE="width: 0.25in; text-align: justify">g.</TD><TD STYLE="text-align: justify">provide an appropriate grievance mechanism that is available
to all workers and where appropriate other stakeholders, and which includes grievances brought by those affected by the operation
of Aptorum Group Limited; and</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in; text-align: justify"></TD><TD STYLE="width: 0.25in; text-align: justify">h.</TD><TD STYLE="text-align: justify">implement policies and procedures for, and encourage, the
reporting of wrongdoing and misconduct by staff, employees and contractors in their dealings with each other or with third parties.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 48; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">3-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B><U>EXCLUSION
LIST</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif; text-align: justify"></TD><TD STYLE="width: 24pt; font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">1.</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Forced
                                         labor<SUP>1</SUP> or child labor<SUP>2</SUP>.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif; text-align: justify"></TD><TD STYLE="width: 24pt; font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">2.</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Activities
                                         or materials deemed illegal under host country laws or regulations or international conventions
                                         and agreements, or subject to international phase-outs or bans, such as:</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 24pt; font: 10pt Times New Roman, Times, Serif; text-align: justify"></TD><TD STYLE="width: 18pt; font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">a)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Ozone
                                         depleting substances, PCB&rsquo;s (Polychlorinated Biphenyl&rsquo;s) and other specific,
                                         hazardous pharmaceuticals, pesticides/herbicides or chemicals;</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 24pt; font: 10pt Times New Roman, Times, Serif; text-align: justify"></TD><TD STYLE="width: 18pt; font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">b)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Wildlife
                                         or products regulated under the Convention on International Trade in Endangered Species
                                         or Wild Fauna and Flora (CITES); or</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 24pt; font: 10pt Times New Roman, Times, Serif; text-align: justify"></TD><TD STYLE="width: 18pt; font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">c)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Unsustainable
                                         fishing methods (e.g. blast fishing and drift net fishing in the marine environment using
                                         nets in excess of 2.5 km in length).</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif; text-align: justify"></TD><TD STYLE="width: 24pt; font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">3.</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Cross-border
                                         trade in waste and waste products, unless compliant to the Basel Convention and the underlying
                                         regulations.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif; text-align: justify"></TD><TD STYLE="width: 24pt; font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">4.</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Destruction3
                                         of High Conservation Value areas<SUP>4</SUP>.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif; text-align: justify"></TD><TD STYLE="width: 24pt; font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">5.</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Radioactive
                                         materials<SUP>5</SUP> and unbounded asbestos fibres.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif; text-align: justify"></TD><TD STYLE="width: 24pt; font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">6.</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Construction
                                         of new and extension of any existing coal fired thermal power plants.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif; text-align: justify"></TD><TD STYLE="width: 24pt; font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">7.</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Pornography
                                         and/or prostitution.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif; text-align: justify"></TD><TD STYLE="width: 24pt; font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">8.</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Racist
                                         and/or anti-democratic media.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif; text-align: justify"></TD><TD STYLE="width: 24pt; font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">9.</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
                                         the event that any of these following products form a substantial part of a project&rsquo;s
                                         primary financed business activities:<SUP>6</SUP></FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 24pt; font: 10pt Times New Roman, Times, Serif; text-align: justify"></TD><TD STYLE="width: 18pt; font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">a)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Alcohol
                                         beverages (except beer and wine);</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 24pt; font: 10pt Times New Roman, Times, Serif; text-align: justify"></TD><TD STYLE="width: 18pt; font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">b)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Tobacco;</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 24pt; font: 10pt Times New Roman, Times, Serif; text-align: justify"></TD><TD STYLE="width: 18pt; font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">c)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Weapons
                                         and munitions; or</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 24pt; font: 10pt Times New Roman, Times, Serif; text-align: justify"></TD><TD STYLE="width: 18pt; font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">d)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Gambling,
                                         casinos and equivalent enterprises.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"></P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 0; margin-bottom: 0"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid; width: 25%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"></P>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.2pt"></TD><TD STYLE="width: 11.8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><SUP>1</SUP></FONT></TD><TD STYLE="text-align: justify">Forced labor means all work or service, not voluntarily performed, that is extracted from an individual
under threat of force or penalty as defined by ILO conventions.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.2pt"></TD><TD STYLE="width: 11.8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><SUP>2</SUP></FONT></TD><TD STYLE="text-align: justify">Persons may only be employed if they are at least 15 years old, as defined in the ILO Fundamental
Human Rights Conventions (Minimum Age Convention C138, Art.2), unless local legislation specifies compulsory school attendances
or the minimum age for working. In such cases the higher age shall apply.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.2pt"></TD><TD STYLE="width: 11.8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><SUP>3</SUP></FONT></TD><TD STYLE="text-align: justify">Destruction means the (1) elimination or severe diminution of the integrity of an area caused by
a major, long-term change in land or water use or (2) modification of a habitat in such a way that the area&rsquo;s ability to
maintain its role is lost.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.2pt"></TD><TD STYLE="width: 11.8pt"><SUP>4</SUP></TD><TD STYLE="text-align: justify">High Conservation Value
                                         (HCV) areas are defined as natural habitats where these values are considered to be of
                                         outstanding significance or critical importance (see <U>http://www.hcvnetwork.org</U>).</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.2pt"></TD><TD STYLE="width: 11.8pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><SUP>5</SUP></FONT></TD><TD STYLE="text-align: justify">This does not apply to the purchase of medical equipment,
quality control (measurement) equipment or any other equipment
where the radioactive source is understood to be trivial and/or adequately shielded.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 39.1pt; text-align: justify; text-indent: -39.1pt"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 39.1pt; text-align: justify; text-indent: -39.1pt"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 39.1pt; text-align: justify; text-indent: -39.1pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 12pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><SUP>6</SUP></FONT></TD><TD STYLE="text-align: justify">For Portfolio Companies, &ldquo;<B>substantial</B>&rdquo; means more than 10% of their consolidated
balance sheets or earnings. For financial institutions (banks), &ldquo;<B>substantial</B>&rdquo; means more than 10% of their underlying
portfolio.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"></P>

<!-- Field: Page; Sequence: 49; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">3-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>



<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"></P>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.20
<SEQUENCE>24
<FILENAME>ff12018ex10-20_aptorum.htm
<DESCRIPTION>SHARE CHARGE AGREEMENT BETWEEN THE COMPANY, JURCHEN INVESTMENT CORPORATION AND PEACE RANGE LIMITED, DATED APRIL 25, 2018
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit
10.20</B></FONT></P>

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 50%; text-align: left; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;<IMG SRC="ex10-19_001.jpg" ALT=""></FONT></TD>
    <TD STYLE="width: 50%; text-align: right; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Execution
    version</I></B></FONT></TD></TR>
</TABLE>


<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Share
Charge</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">JURCHEN
INVESTMENT CORPORATION</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">as
Chargor</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Aptorum
Group Limited</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">as
Issuer</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Peace
Range Limited</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">as
Chargee</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">________________
2018</FONT></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;</FONT></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">CONTENTS</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 8%; text-align: left; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>CLAUSE</B></FONT></TD>
    <TD STYLE="width: 84%; text-align: left; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 8%; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>PAGE</B></FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">1.</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">INTERPRETATION</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">1</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">2.</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">COVENANT
    TO PAY</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">5</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">3.</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">SHARE
    CHARGE</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">6</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">4.</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">FURTHER
    ASSURANCE</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">7</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">5.</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">REPRESENTATIONS
    AND WARRANTIES</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">8</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">6.</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">UNDERTAKINGS</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">10</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">7.</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">Voting
    and Distribution</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">13</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">8.</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">ENFORCEMENT
    AND POWERS OF THE Chargee</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">13</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">9.</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">ATTORNEY</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">14</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">10.</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">EXTENSION
    and variation of statutory powers</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">15</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">11.</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">STATUS,
    POWERS, REMOVAL AND REMUNERATION OF RECEIVER</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">15</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">12.</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">APPLICATION
    OF ENFORCEMENT PROCEEDS</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">18</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">13.</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">PROTECTION
    OF Security</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">19</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">14.</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">Protection
    of third parties</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">22</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">15.</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">PROTECTION
    OF Secured Parties</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">22</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">16.</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">DELEGATION</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">23</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">17.</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">Costs
    and Expenses</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">24</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">18.</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">SET-OFF</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">24</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">19.</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">NOTICES</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">24</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">20.</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">Changes
    to Parties</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">25</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">21.</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">CURRENCY
    CLAUSES</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">25</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">22.</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">MISCELLANEOUS</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">25</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">23.</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">Governing
    Law</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">26</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">24.</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">ENFORCEMENT</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">26</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">25.</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">Service
    of Process</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">26</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">26.</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">Waiver
    of immunities</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">27</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD COLSPAN="2" STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">schedule
    1</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">28</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD COLSPAN="2" STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Shares</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">28</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD COLSPAN="2" STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Part
    I, Part II</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">28</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD COLSPAN="2" STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">schedule
    2</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">29</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD COLSPAN="2" STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Form
    of Instrument of Transfer</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">29</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD COLSPAN="2" STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">schedule
    3</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">30</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD COLSPAN="2" STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Irrevocable
    appointment of proxy and power of attorney</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">30</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD COLSPAN="2" STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">schedule
    4</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">31</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD COLSPAN="2" STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Form
    of Letter of Authority and Undertaking</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">31</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD COLSPAN="2" STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">schedule
    5</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">32</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD COLSPAN="2" STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Form
    of Resolutions</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">32</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD COLSPAN="2" STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">schedule
    6</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">33</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD COLSPAN="2" STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Form
    of Deed of Undertaking</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">33</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD COLSPAN="2" STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">schedule
    7</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">34</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD COLSPAN="2" STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Form
    of Letter of Instructions to Registered Agent</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">34</FONT></TD></TR>
</TABLE>


<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;</FONT></P>

<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>THIS
DEED</B> is made on _____________________ 2018</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">BETWEEN:</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">(1)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>JURCHEN
                                         INVESTMENT CORPORATION</B></FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">,
                                         a limited liability company incorporated in the British Virgin Islands and whose registered
                                         office is at Vistra Corporation Services Centre, Wickhams Cay II, Road Town, Tortola,
                                         VG1110, the British Virgin Islands with business registration number 511328 (the <B>&ldquo;Chargor&rdquo;</B>);
                                         and</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">(2)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>APTORUM
                                         GROUP LIMITED, </B>a Cayman Islands exempt company with company number 245310 and with
                                         Hong Kong business registration no. F0023235 and whose registered office is at c/o Campbells
                                         Corporate Services Limited, Floor 4, Willow House, Cricket Square, Grand Cayman KY1-9010,
                                         Cayman Islands (the <B>&ldquo;Issuer&rdquo;</B>);</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>PEACE
                                         RANGE LIMITED </B></FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a
                                         limited liability company incorporated in the British Virgin Islands with company number
                                         1839278 and whose registered address is at [ ] (the <B>&ldquo;Chargee&rdquo;</B>,
                                         which expression shall include any person from time to time appointed as a successor,
                                         replacement or additional trustee in relation to the interests created by this deed).</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">RECITALS:</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(A)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                         Chargor is the registered legal and beneficial owner of the Shares (as defined below).</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(B)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                         Issuer has issued or will issue the Bonds (as defined below).</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(C)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                         Chargor and Issuer are entering into this deed in connection with the Bonds.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">THE
PARTIES AGREE AS FOLLOWS:</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; text-transform: uppercase; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>INTERPRETATION</B></FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.1</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Definitions</B></FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
this deed:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&ldquo;Account
Charge&rdquo;</B> has the meaning given to that term in the Conditions;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&ldquo;Articles&rdquo;
</B>means the articles of association of the Issuer;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&ldquo;Bonds&rdquo;
</B>means the US$15,000,000 aggregate principal amount of 8.00 per cent. convertible bonds due 2019 issued or to be issued by
the Issuer pursuant to the Subscription Agreement, which term shall include, unless the context requires otherwise, any further
bonds issued in accordance with Condition 16 (Further Issues) of the Conditions and consolidated and forming a single series therewith;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&ldquo;BVI
Act&rdquo;</B> means the BVI Business Companies Act, 2004 of the British Virgin Islands as amended and supplemented from time to
time;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&ldquo;Business
Day&rdquo;</B> has the meaning given to that term in the Conditions;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&ldquo;Cayman
Act&rdquo; </B>means the Companies Law (2016 Revision) of the Cayman Islands as amended and supplemented from time to time;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&ldquo;Charged
Property&rdquo;</B> means the assets charged to the Chargee pursuant to clause 3 (Share Charge) of this deed;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;</FONT></P>

<!-- Field: Page; Sequence: 3; Options: NewSection; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&ldquo;Companies
Ordinance&rdquo;</B> means the Companies Ordinance (Cap. 622) of the Laws of Hong Kong;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&ldquo;Conditions&rdquo;
</B>has the meaning given to that term in the Bonds;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>CPO</B>&rdquo;
means the Conveyancing and Property Ordinance (Cap. 219) of the Laws of Hong Kong;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&ldquo;Custodian&rdquo;
</B>means The Law Debenture Trust (Asia) Limited or such other custodian appointed pursuant to the terms of the Custodian Agreement
or otherwise as agreed between the Chargor and the Chargee;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&ldquo;Custodian
Agreement&rdquo;</B> means the escrow agreement dated on or about the date of this deed and entered into between the Chargor, the
Chargee and Custodian;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&ldquo;Delegate&rdquo;
</B>means any delegate, agent, attorney or co-trustee appointed by the Chargee;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&ldquo;Distribution&rdquo;
</B>means all dividends, distributions and other income paid or payable on any Share, together with all shares or other property
derived from that Share and all other allotments, accretions, rights, benefits and advantages of all kinds accruing, offered or
otherwise derived from or incidental to that Share (whether by way of conversion, redemption, bonus, preference, option or otherwise);</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&ldquo;Events
of Default&rdquo; </B>has the meaning given to that term in the Conditions;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&ldquo;Hong
Kong&rdquo;</B> means the Hong Kong Special Administrative Region of the People&rsquo;s Republic of China;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&ldquo;Insolvency
Proceedings&rdquo;</B> means, in relation to the Chargor, any corporate action, legal proceedings or other procedure or step referred
to in Conditions 11(vi)(Security Enforced), 11(vii)(Winding-up) or 11(viii)(Insolvency) of the Conditions or any analogous procedure
or step taken in any relevant jurisdiction;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>QIPO</B>&rdquo;
has the meaning given to that term in the Conditions;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&ldquo;Receiver&rdquo;
</B>means a receiver and manager or administrative receiver in each case appointed under this deed;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&ldquo;Register
of Directors&rdquo;</B> means the register of directors of the Issuer maintained by the Issuer in accordance with the Cayman Act;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&ldquo;Register
of Members&rdquo; </B>means the register of members of the Issuer maintained by the Issuer in accordance with the Cayman Act;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&ldquo;Registrar
of Corporate Affairs&rdquo;</B> means the Registrar of Corporate Affairs of the British Virgin Islands appointed under section
229 of the BVI Act;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&ldquo;Secured
Obligations&rdquo;</B> means all present and future obligations and liabilities (whether actual or contingent and whether owed
jointly or severally or in any other capacity whatsoever) of the Transaction Obligors to any Secured Party under the Bonds and
the Transaction Documents;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Secured
Party</B>&rdquo; means the Chargee, any Bondholder and a Receiver or any Delegate;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&ldquo;Security&rdquo;
</B>means a mortgage, charge, pledge, lien or other security interest securing any obligation of any person or any other agreement
or arrangement having a similar effect;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;</FONT></P>

<!-- Field: Page; Sequence: 4; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&ldquo;Shares&rdquo;
</B>means:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,393,207
                                         Class B ordinary shares of the Issuer held by the Chargor which are described in Part
                                         II of schedule 1 (Shares);</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">all
                                         rights relating to any of the shares described in paragraph (a) above which are deposited
                                         with or registered in the name of any depositary, custodian, nominee, clearing house
                                         or system, investment manager, chargee or other similar person or their nominee, in each
                                         case whether or not on a fungible basis (including any rights against any such person);
                                         and</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">all
                                         warrants, options and other rights to subscribe for, purchase or otherwise acquire any
                                         of the shares described in paragraph (a) above,</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">in
each case now or in the future owned by the Chargor or (to the extent of its interest) in which the Chargor now or in the future
has an interest;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&ldquo;Subscription
Agreement&rdquo;</B> means the subscription agreement dated 6 April 2018 between, amongst others, the Issuer as issuer, the Chargor
as guarantor and Peace Range Limited as subscriber, including the Conditions;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&ldquo;Tax&rdquo;
</B>means any tax, levy, impost, duty or other charge or withholding of a similar nature (including any penalty or interest payable
in connection with any failure to pay or any delay in paying any of the same);</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&ldquo;Transaction
Obligors&rdquo;</B> means the Chargor (including in its capacity as guarantor under the Deed of Guarantee) and the Issuer; and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Transaction
Documents</B>&rdquo; has the meaning given to that term in the Conditions.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.2</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Construction</B></FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
this deed, unless a contrary intention appears, a reference to:</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 1in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">words
                                         and expressions defined in the Conditions have the same meanings when used in this deed
                                         unless otherwise defined in this deed;</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 1in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&ldquo;assets&rdquo;
                                         </B>includes present and future properties, revenues and rights of every description;</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 1in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">an
                                         <B>&ldquo;agreement&rdquo;</B> includes any legally binding arrangement, concession, contract,
                                         deed or franchise (in each case whether oral or written);</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 1in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iv)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">an
                                         <B>&ldquo;assignment&rdquo;</B> includes a novation, transfer and reassignment and retransfer
                                         and <B>&ldquo;assign&rdquo;</B>, <B>&ldquo;assigning&rdquo;</B> and <B>&ldquo;assigned&rdquo;
                                         </B>shall be construed accordingly;</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 1in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(v)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">an
                                         <B>&ldquo;amendment&rdquo;</B> includes any amendment, supplement, variation, novation,
                                         modification, replacement or restatement and <B>&ldquo;amend&rdquo;</B>, <B>&ldquo;amending&rdquo;
                                         </B>and <B>&ldquo;amended&rdquo;</B> shall be construed accordingly;</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 1in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(vi)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a
                                         <B>&ldquo;consent&rdquo;</B> includes an authorisation, approval, exemption, licence, order,
                                         permission or waiver;</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 1in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(vii)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                         <B>&ldquo;Chargee&rdquo;</B>, the <B>&ldquo;Chargor&rdquo;</B>, any &ldquo;<B>Bondholder</B>&rdquo;
                                         any <B>&ldquo;Secured Party&rdquo;,</B> any <B>&ldquo;Transaction Obligor&rdquo;</B> or any
                                         other person shall be construed so as to include its successors in title, permitted assignees
                                         and transferees and, in the case of the Chargee, any person for the time being appointed
                                         as Chargee or Chargees in accordance with the Bonds or the Transaction Documents;</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;</FONT></P>

<!-- Field: Page; Sequence: 5; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 1in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(viii)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&ldquo;including&rdquo;
                                         </B>means including without limitation and <B>&ldquo;includes&rdquo;</B> and <B>&ldquo;included&rdquo;
                                         </B>shall be construed accordingly;</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 1in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ix)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&ldquo;losses&rdquo;
                                         </B>includes losses, actions, damages, claims, proceedings, costs, demands, expenses
                                         (including fees) and liabilities and <B>&ldquo;loss&rdquo;</B> shall be construed accordingly;</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 1in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(x)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a
                                         <B>&ldquo;person&rdquo;</B> includes any person, firm, company, corporation, government,
                                         state or agency of a state or any association, trust or partnership (whether or not having
                                         separate legal personality) or any two or more of the foregoing;</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 1in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(xi)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a
                                         <B>&ldquo;regulation&rdquo;</B> includes any regulation, rule, official directive, request
                                         or guideline (whether or not having the force of law) of any governmental, intergovernmental
                                         or supranational body, agency, department or regulatory, self-regulatory or other authority
                                         or organisation;</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 1in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(xii)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a
                                         <B>&ldquo;Bond &ldquo;</B>, a <B>&ldquo;Transaction Document</B>&rdquo; or the &ldquo;<B>Conditions</B>&rdquo;
                                         or any other agreement or instrument is a reference to that or other agreement or instrument
                                         as amended, novated, supplemented, extended or restated (however fundamentally);</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 1in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(xiii)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a
                                         provision of law is a reference to that provision as amended or re-enacted;</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 1in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(xiv)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">any
                                         clause or schedule is a reference to, respectively, a clause of and schedule to this
                                         deed and any reference to this deed includes its schedules;</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                         parties intend that this document shall take effect as a deed, notwithstanding the fact
                                         that a party may only execute it under hand;</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                         index to and the headings in this deed are inserted for convenience only and are to be
                                         ignored in construing this deed;</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Words
                                         importing the plural shall include the singular and vice versa; and</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Unless
                                         the context otherwise requires, a reference to a Charged Property includes:</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 1in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">any
                                         part of that Charged Property; and</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 1in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                         proceeds of sale of that Charged Property;</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(f)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&ldquo;$&rdquo;</B>,
                                         <B>&ldquo;US$&rdquo;</B>, <B>&ldquo;US dollar&rdquo; </B>and <B>&ldquo;US dollars&rdquo;</B>,
                                         denote lawful currency of the United States of America; and</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(g)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">To
                                         the fullest extent permitted by law and unless a contrary indication applies, the following
                                         provisions of the CPO shall apply to this deed:</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 1in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">section
                                         15 (Construction of words and expressions), as if this deed was an instrument affecting
                                         land (as that expression appears in the CPO);</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;</FONT></P>

<!-- Field: Page; Sequence: 6; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 1in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">section
                                         35(1) (Implied covenants) and Part V of the First Schedule as if:</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 1.5in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(A)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">this
                                         deed was a legal charge (as that expression appears in the CPO);</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 1.5in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(B)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                         expression &ldquo;charge&rdquo; in section 35(1)(e) was construed as &ldquo;mortgage, charge,
                                         assign or otherwise grant a security interest&rdquo;; and</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 1.5in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(C)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">references
                                         in Part V of the First Schedule to the &ldquo;borrower&rdquo; were construed as references
                                         to the Chargor, to the &ldquo;Chargee&rdquo; were construed as references to the Chargee
                                         and to &ldquo;land&rdquo; were construed as references to anything in action, and any interest
                                         in real or personal property;</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 1in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">section
                                         50 (Power to appoint receiver), as if:</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 1.5in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(A)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">this
                                         deed was a legal charge, equitable mortgage and/or mortgage deed (as those expressions
                                         appear in the CPO); and</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 1.5in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(B)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">references
                                         in section 50 to &ldquo;land&rdquo; were construed as references to anything in action,
                                         and any interest in real or personal property; and</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 1in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iv)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">section
                                         51 (Powers of mortgagee and receiver) and the Fourth Schedule as if:</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 1.5in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(A)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">this
                                         deed was a legal charge, equitable mortgage and/or mortgage deed (as those expressions
                                         appear in the CPO); and</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 1.5in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(B)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">references
                                         in the Fourth Schedule to &ldquo;land&rdquo; were construed as references to anything in
                                         action, and any interest in real or personal property.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.3</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Third
                                         party rights</B></FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Any
                                         Receiver or Delegate will have the right to enforce the provisions of this deed which
                                         are given in its favour in accordance with the Contracts (Rights of Third Parties) Ordinance
                                         (Cap. 623) of the Laws of Hong Kong (the <B>&ldquo;Third Parties Ordinance&rdquo;</B>).</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Subject
                                         to clause 1.3(a) and unless expressly provided to the contrary in the Bonds or the Transaction
                                         Documents, a person who is not a party to this deed has no right under the Third Parties
                                         Ordinance to enforce or enjoy the benefit of any term of this deed.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Notwithstanding
                                         any term of the Bonds or the Transaction Documents, the consent of any person who is
                                         not a party (including any Receiver or Delegate) is not required to rescind or vary this
                                         deed at any time.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; text-transform: uppercase; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">2.</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>COVENANT
                                         TO PAY</B></FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Chargor as primary obligor covenants with the Chargee that it will on demand pay the Secured Obligations when they fall due for
payment in the manner provided for in the Bonds and the Transaction Documents.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;</FONT></P>

<!-- Field: Page; Sequence: 7; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; text-transform: uppercase; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">3.</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>SHARE
                                         CHARGE</B></FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.1</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Charging
                                         Clause</B></FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Chargor, as security for the Secured Obligations, charges in favour of the Chargee, as legal and beneficial owner, its right,
title and interest in all of the Shares and all corresponding Distribution by way of first fixed charge.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.2</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Title
                                         documents and documentation supporting security</B></FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Chargor shall, upon the execution of this deed, deliver or procure that there shall be delivered to the Custodian the following
documents to be held by the Custodian pursuant to the terms of the Custodian Agreement:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">valid
                                         and duly issued share certificate(s) or other documents of title relating to the Shares
                                         specified in Part II of schedule 1 (Shares) together with an instrument of transfer,
                                         duly executed, undated and in blank, in respect of such Shares in the form set out in
                                         schedule 2 (Form of Instrument of Transfer);</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">signed
                                         and dated letters of authority and undertaking from all the directors of the Issuer authorising
                                         the Chargee to date each of the blank instrument of transfer referred to in clause 3.2(a),
                                         the resolutions referred to in clause 3.2(c) and undertaking to approve transfers of
                                         the Shares by or in favour of the Chargee and/or its nominee (in each case, subject to
                                         the provisions of this deed) in the form set out in schedule 4 (Form of Letter of Authority
                                         and Undertaking);</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a
                                         signed and undated board resolution of all the directors of the Issuer to approve transfers
                                         of the Shares by or in favour of the Chargee and/or its nominee in the form set out in
                                         schedule 5 (Form of Resolutions);</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">original
                                         of duly executed proxy and power of attorney in respect of the Shares in the form set
                                         out in schedule 3 (Irrevocable appointment of proxy and power of attorney);</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">original
                                         of an irrevocable deed of undertaking and confirmation from the Issuer to the Chargee
                                         in the form set out in schedule 6 (Form of Deed of Undertaking) duly executed and dated
                                         by the Issuer; and</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(f)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">certified
                                         true copy of an irrevocable letter of instructions to the registered agent of the Issuer
                                         in the form set out in schedule 7 (Form of Letter of Instructions to Registered Agent)
                                         duly signed and dated by the Issuer (the original of which shall be delivered by or on
                                         behalf of the Issuer to its registered agent immediately after execution of this deed
                                         and promptly thereafter, and in any event no later than 10 Business Days from the date
                                         of execution of this deed, the Chargor shall deliver, or cause to be delivered to the
                                         Chargee, a copy of such letter signed by the registered agent of the Issuer acknowledging
                                         and agreeing to the terms of such letter).</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Notwithstanding
any provision of the Custodian Agreement, for the avoidance of doubt, if any of the documents referred to in clauses 3.2(a) to
3.2(f) are returned or delivered by the Custodian to the Chargor for any reason, any such return or delivery shall not in any
way affect or prejudice the security interest created or Chargee&rsquo;s rights or interest under or in connection with this deed and
the security and terms of the deed shall continue in full force and effect.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;</FONT></P>

<!-- Field: Page; Sequence: 8; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; text-transform: uppercase; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">4.</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>FURTHER
                                         ASSURANCE</B></FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.1</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>General</B></FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
                                         addition and without prejudice to the covenant in paragraph 5 of Part V of the First
                                         Schedule to the CPO (as varied pursuant to this deed), the Chargor will, promptly following
                                         request by the Chargee, do all such acts and/or execute all such documents (including
                                         assignments, transfers, mortgages, charges, notices and instructions) as is necessary:</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 1in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">to
                                         perfect or register the Security created or intended to be created under or evidenced
                                         by this deed (which may include the execution of a mortgage, charge, assignment or other
                                         Security over all or any of the assets which are, or are intended to be, the subject
                                         of this deed) or for the exercise of any rights, powers and remedies of the Chargee or
                                         any Receiver provided by or pursuant to the Bonds and the Transaction Documents or by
                                         law; and/or</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 1in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">to
                                         facilitate the realisation of the assets which are, or are intended to be, the subject
                                         of the Security created by this deed.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                         Chargor shall take all such action (including making all filings and registrations) as
                                         may reasonably be necessary for the purpose of the creation, perfection, registration,
                                         protection or maintenance of any Security conferred or intended to be conferred on the
                                         Chargee by or pursuant to this deed.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.2</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>HK
                                         Registration</B></FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
the event the Chargor becomes a Non-Hong Kong Company under (and as defined in) Part 16 of the Companies Ordinance, the Chargor
shall ensure that details of the Security created by this deed are duly registered with the Companies Registry in Hong Kong within
five (5) Business Days after the Chargor becomes a Non-Hong Kong Company under (and as defined in) Part 16 of the Companies Ordinance.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.3</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>BVI
                                         and Cayman Registration </B></FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                         Chargor shall:</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 1in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">as
                                         soon as reasonably practicable after execution of this deed, and in any event within
                                         ten (10) Business Day of the date of this deed, create and maintain a register of charges
                                         (the &ldquo;<B>Register of Charges</B>&rdquo;) for the Chargor (to the extent this has
                                         not already been done in accordance with section 162 of the BVI Act), enter particulars
                                         of the security created pursuant to this deed in the Register of Charges as required
                                         by section 162 of the BVI Act and provide a certified copy of the Register of Charges
                                         to the Chargee;</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 1in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">as
                                         soon as reasonably practicable after execution of this deed and in any event within ten
                                         (10) Business Day of the date of this deed, effect registration, or assist the Chargee
                                         in effecting registration, of this deed with the Registrar of Corporate Affairs pursuant
                                         to section 163 of the BVI Act by making the required filing, or assisting the Chargee
                                         in making the required filing, in the approved form with the Registrar of Corporate Affairs
                                         and (if applicable) provide confirmation in writing to the Chargee that such filing has
                                         been made;</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 1in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">to
                                         the extent received by the Chargor, as soon as reasonably practicable after execution
                                         of this deed and in any event within ten (10) Business Days of receipt, deliver or procure
                                         to be delivered to the Chargee the certificate of registration of charge issued by the
                                         Registrar of Corporate Affairs evidencing that the requirements of Part VIII of the BVI
                                         Act as to registration have been complied with, together with the filed stamped copy
                                         of any application made by or on behalf of the Chargor containing the relevant particulars
                                         of charge;</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;</FONT></P>

<!-- Field: Page; Sequence: 9; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 1in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iv)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">as
                                         soon as reasonably practicable after the execution of this deed and in any event within
                                         three (3) Business Day of the date of this deed procure that the following notation be
                                         entered on the Register of Members and promptly thereafter:</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<I>All
of the Class B ordinary shares issued under certificate number [ *****], as fully paid up and registered in the name of JURCHEN
INVESTMENT CORPORATION are charged in favour of Peace Range Limited as chargee pursuant to a share charge dated [ *** insert date
***], as amended from time to time. This notation was made in this Register of Members on [ *** insert date *** ].&rdquo;; </I>and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 1in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(v)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">as
                                         soon as reasonably practicable after the execution of this deed and in any event within
                                         three (3) Business Days of the date of this deed, deliver or procure to be delivered
                                         to the Chargee evidence that such annotation has been made and deliver or procure the
                                         delivery to the Chargee of a certified copy of the annotated Register of Members.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; text-transform: uppercase; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">5.</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>REPRESENTATIONS
                                         AND WARRANTIES</B></FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.1</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Matters
                                         Represented</B></FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Chargor represents and warrants to the Chargee in the terms set out in clauses 5.2 (General representations and warranties) to
5.11 (Information) (inclusive) below as of the date of this dead and on each day for so long as any Security constituted by this
deed remains in force, with reference to the facts and circumstances then existing.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.2</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>General
                                         representations and warranties</B></FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Chargor represents and warrants to the Chargee with respect to itself in the terms as set out in clause 3 (Representations and
Warranties) of the Subscription Agreement for so long as any Security constituted by this deed remains in force, the provisions
of which are incorporated herein <I>mutatis mutandis</I> as if set out herein as if references therein to &ldquo;the Guarantor&rdquo;,
&ldquo;the Transaction Documents&rdquo; or &ldquo;a Transaction Document&rdquo; were a referent to the Chargor, the Bonds or the Transaction
Documents.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.3</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Governing
                                         Law and Enforcement</B></FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                         choice of governing law of this deed will be recognised and enforced in its jurisdiction
                                         of incorporation; and</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Any
                                         judgment obtained in relation to this deed in the jurisdiction of the governing law of
                                         this deed will be recognised and enforced in its jurisdiction of incorporation.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;</FONT></P>

<!-- Field: Page; Sequence: 10; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.4</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Insolvency</B></FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">No
                                         Insolvency Proceedings has been taken or, to the knowledge of the Chargor, threatened
                                         in relation to it.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">No
                                         distress, attachment, execution or other legal decision is levied, enforced or sued out
                                         on or against substantially all of the property, assets or revenues (as applicable) of
                                         the Chargor having an aggregate value of at least US$400,000 and is not discharged or
                                         stayed within 30 days of having been so levied, enforced or sued out on.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.5</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>No
                                         Filing or Stamp Taxes</B></FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">It
is not necessary that this deed be filed, recorded or enrolled with any court or other authority or that any stamp, registration,
notarial or similar taxes or fees be paid on or in relation to this deed or the transactions contemplated by this deed except
for registration of this deed with the Registrar of Corporate Affairs and payment of associated fees, which registration and fees
will be made and paid promptly after the date of this deed.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.6</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Deduction
                                         of Tax </B></FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">It
is not required to make any deduction for or on account of Tax from any payment it may make under this deed.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.7</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Ranking</B></FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Security under this deed has the ranking in priority which it is expressed to have in and is not subject to any prior ranking
or pari passu ranking Security.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.8</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Shares</B></FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">It
                                         is the legal and beneficial owner of the shares detailed in part II of schedule 1 (Shares)
                                         and all of those shares are fully paid.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Except
                                         as provided in the Bonds or other Transaction Documents, no person has or is entitled
                                         to any conditional or unconditional option, warrant or other right to subscribe for,
                                         purchase or otherwise acquire any issued or unissued shares, or any interest in shares
                                         in the Issuer.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                         Charged Property comprises 5 per cent. of the aggregate of the entire issued Class A
                                         ordinary shares and the entire issued Class B ordinary shares of the Issuer as at the
                                         date of this deed and the documents referred to in clause 3.2 (Title documents and documentation
                                         supporting security) that have been delivered to the Custodian pursuant to clause 3.2
                                         (Title documents and documentation supporting security) are in respect of 5 per cent.
                                         of the aggregate of the entire issued Class A ordinary shares and the entire issued Class
                                         B ordinary shares of the Issuer as at the date of this deed.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                         Charged Property is free from any encumbrance, attachment or precautionary measure other
                                         than as created under or pursuant to this deed.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">There
                                         are no covenants or agreements, which could adversely affect the Charged Property or
                                         any part thereof.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(f)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other
                                         than the share certificates delivered to the Custodian pursuant to clause 3.2 (Title
                                         documents and documentation supporting security), no share certificates or interim certificates
                                         have been issued evidencing the Charged Property.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(g)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">There
                                         is no and may not be a public market for the Charged Property herein. The Charged Property
                                         has not been and is not being registered under the&nbsp;U.S. Securities Act of 1933,
                                         as amended (the &ldquo;<B>Securities Act</B>&rdquo;)&nbsp;or any applicable state securities
                                         laws, and may not be transferred in a public market unless (i) the Charged Property&nbsp;has&nbsp;been
                                         registered for sale pursuant to the&nbsp; Securities Act, (ii) the Charged Property may
                                         be sold pursuant to Rule 144 or Regulation S under the Securities Act, or (iii) the Issuer
                                         has received an opinion of counsel reasonably satisfactory to it that such transfer may
                                         lawfully be made without registration under the Securities Act or qualification under
                                         applicable state securities laws.&nbsp;</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;</FONT></P>

<!-- Field: Page; Sequence: 11; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.9</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Financial
                                         Assistance</B></FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Chargor&rsquo;s entry into this deed does not cause any infringement of any applicable financial assistance legislation, including Part
5, Division 5 of the Companies Ordinance.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.10</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Non-Hong
                                         Kong Company</B></FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Chargor is not registered as a non-Hong Kong company under Part 16 of the Companies Ordinance nor has it made any application
to be so registered.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.11</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Information</B></FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Chargor represents that:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                         shares specified in Part I of schedule 1 (Shares) amount to the entire issued Class B
                                         ordinary shares of the Issuer as at the date of this deed; and</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                         shares specified in Part II of schedule 1 (Shares) amount to 5 per cent. of the aggregate
                                         of the entire issued Class A ordinary shares and the entire issued Class B ordinary shares
                                         of the Issuer as at the date of this deed.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; text-transform: uppercase; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">6.</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>UNDERTAKINGS</B></FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.1</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Duration
                                         of Undertakings</B></FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">All
of the undertakings given by the Chargor to the Chargee in this deed are given from the date of this deed and for so long as any
Security constituted by this deed remains in force.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.2</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Negative
                                         Pledge </B></FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Chargor may not, for so long as any Security constituted by this deed remains in force, create or agree to create or permit to
subsist any Security over all or any part of the Charged Property, except as expressly permitted under the Bonds or Transaction
Documents or with the prior written consent of the Chargee.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.3</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Disposal
                                         Restrictions</B></FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Chargor shall not, for so long as any Security constituted by this deed remains in force and except as expressly permitted under
the Bonds or the Transaction Documents or with the prior written consent of the Chargee:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">sell,
                                         transfer, assign, lend or otherwise dispose of all or any part of the Charged Property
                                         or the right to receive or to be paid the proceeds arising on the disposal of the same,
                                         or agree or attempt to do so; or</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">dispose
                                         of the equity of redemption in respect of all or any part of the Charged Property.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.4</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>General
                                         Undertakings</B></FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Charged
                                         Property</B></FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 1in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 35.4pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">It
                                         will observe and perform all covenants and stipulations from time to time affecting the
                                         Charged Property, make all payments, carry out all necessary registrations or renewals
                                         and generally take all steps which are reasonably necessary to preserve, maintain and
                                         renew when necessary or desirable all the Charged Property.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;</FONT></P>

<!-- Field: Page; Sequence: 12; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 1in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 35.4pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">It
                                         will pay all reasonable payments which may become due in respect of safekeeping and preservation
                                         of the Charged Property or any part thereof.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Constitutional
                                         Documents of the Issuer </B></FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Chargor will not amend the constitutional documents of the Issuer in any manner which would reduce, jeopardise or otherwise prejudice
the value to the Secured Parties of the Charged Property or would likely prejudice or adversely affect the rights of the Secured
Parties, without consent of the Chargee.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Maintenance</B></FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">It
will maintain all and any rights being subject to the Security so that these at all times will be kept in force.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Registration
                                         as Non-Hong Kong Company</B></FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Chargor shall inform the Chargee in writing if it becomes or purports to make any application to be so registered as a non-Hong
Kong company under Part 16 of the Companies Ordinance.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>New
                                         directors of the Issuer </B></FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Where
there is any change in the directors of the Issuer, deliver or procure that there shall be delivered to the Custodian the following
documents to be held by the Custodian pursuant to the terms of the Custodian Agreement (i) the documents described in paragraph
(b) of clause 3.2 (Title documents and documentation supporting security) in respect of the new director(s), (ii) a replacement
of the resolutions referred to in paragraph (c) of clause 3.2 (Title documents and documentation supporting security) and (iii)
a certified copy of the updated Register of Directors.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.5</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Continuing
                                         Obligations</B></FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Chargor shall:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ensure
                                         that the Charged Property remains free from any restrictions on transfer other than any
                                         restrictions set out or permitted in the Bonds and Transaction Documents;</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">warrant
                                         and defend the rights and interest of the Chargee to and in the Charged Property against
                                         the claims and demands of all persons whomsoever; and</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">promptly
                                         notify the Chargee in writing of any fact or circumstance (other than those facts or
                                         circumstances which are immaterial) which may adversely affect any of its rights hereunder.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.6</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Power
                                         to Remedy</B></FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
the Chargor fails to comply with any non-payment undertaking given in this deed and that failure is not remedied to the satisfaction
of the Chargee within 30 days of the Chargor becoming aware of such breach or after written notice of such failure to comply has
been given by the Chargee notifying the Chargor that remedy is required, it will allow (and irrevocably authorises) the Chargee,
or any Delegate, to take any action on behalf of the Chargor which is necessary to ensure that those undertakings are complied
with.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;</FONT></P>

<!-- Field: Page; Sequence: 13; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.7</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Additional
                                         Title Documents</B></FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">To
the extent not already held by the Custodian under the terms of the Custodian Agreement, the Chargor will:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">deposit
                                         with the Chargee (or as it shall direct) all other documents relating to the Charged
                                         Property which the Chargee from time to time reasonably requires in accordance with this
                                         deed;</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">if
                                         requested by the Chargee, issue interim certificates or share certificates or any other
                                         documents of title or evidence of ownership or other rights in relation to the Shares
                                         to the extent such certificates have not been issued; and</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">if,
                                         at any time, any share certificates in respect of the Shares cannot be located or have
                                         been mutilated, defaced, lost, stolen or destroyed, the Chargor undertakes to without
                                         delay cancel such share certificates.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.8</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Memorandum
                                         and articles</B></FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Notwithstanding
anything contained in the Articles, for so long as any Security constituted by this deed remains in force, each of the Chargor
and the Issuer undertakes and agrees in favour of the Chargee as follows:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                         Issuer shall not redeem, repurchase, or surrender any Shares in accordance with Article
                                         6 of the Articles except with the prior written consent of the Chargee;</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">all
                                         Shares shall be exempt from any present or future lien in favour of the Issuer that would
                                         otherwise have arisen under Article 14 of the Articles and the Issuer undertakes not
                                         to assert any lien against any such Shares;</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">all
                                         Shares shall be exempt from any present or future call upon shareholders by the Issuer
                                         that would otherwise have arisen under Article 15 of the Articles and the Issuer shall
                                         not make any calls on any of the Shares;</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                         Issuer shall not (and shall ensure that the Issuer&rsquo;s directors do not take any action
                                         to) exercise any right or discretion under Article 16.4 or Article 16.7 of the Articles
                                         to refuse, delay or suspend the registration of any transfer of any Shares:</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 1in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">in
                                         favour of the Chargee (or its nominee) pursuant to any enforcement of the Chargee&rsquo;s rights
                                         under this deed in accordance with clause 8.1 (Exercise of Enforcement Powers); or</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 1in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">from
                                         the Chargee (or its nominee) pursuant to a power of sale, other right of enforcement
                                         (if any) or otherwise in accordance with this deed;</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                         Issuer shall promptly register any transfer of Shares at the time such Shares are transferred
                                         as described in sub-paragraphs (d)(i) and (d)(ii) above and shall not register any transfer
                                         of Shares (other than as described in sub-paragraphs (d)(i) and (d)(ii) above) without
                                         the prior written consent of the Chargee except as expressly permitted under the Bonds
                                         or the Transaction Documents; and</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(f)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">all
                                         Shares shall be exempt from the provisions of Article 18 of the Articles relating to
                                         forfeiture and the Issuer shall not exercise any rights of forfeiture in respect of any
                                         of the Shares.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;</FONT></P>

<!-- Field: Page; Sequence: 14; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; text-transform: uppercase; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">7.</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Voting
                                         and Distribution</B></FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">7.1</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Until
                                         the Security under this deed has become enforceable in accordance with clause 8.1 (Exercise
                                         of Enforcement Powers), the Chargor shall be entitled to:</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">pay,
                                         receive and retain all Distributions and other monies paid on or derived from the Shares
                                         to the extent permitted under the Bonds or the Transaction Documents; and</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">exercise
                                         all voting and other rights and powers attaching to the Shares provided that it shall
                                         not exercise any such voting rights or powers in a manner which is prejudicial to the
                                         interests of the Secured Parties in the Security created pursuant to any Bond or Transaction
                                         Document or the validity and enforceability of this deed.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">7.2</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">After
                                         the Security under this deed has become enforceable in accordance with clause 8.1 (Exercise
                                         of Enforcement Powers):</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                         Chargor will promptly pay all dividends and any other Distributions and other monies
                                         paid on or derived from the Shares received by it as directed by the Chargee;</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                         Chargee or any Receiver shall be entitled to exercise or direct the exercise of the voting
                                         and other rights attached to any Share in such manner as it or he sees fit; and</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                         Chargor shall comply or procure the compliance with any directions of the Chargee or
                                         any Receiver in respect of the exercise of those rights and shall promptly execute and/or
                                         deliver to the Chargee or any Receiver such forms of proxy in relation to the Shares
                                         as it or he requires with a view to enabling such person as it or he selects to exercise
                                         those rights.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">7.3</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">At
                                         any time when any Shares are registered in the name of the Chargee or its nominee, the
                                         Chargee will not be under any duty to ensure that any Distributions or other monies payable
                                         in respect of those Shares are duly and promptly paid or received by it or its nominee,
                                         or to verify that the correct amounts are paid or received, or to take any action in
                                         connection with the taking up of any (or any offer of any) stocks, shares, rights, monies
                                         or other property paid, distributed, accruing or offered at any time by way of interest,
                                         dividend, redemption, bonus, rights, preference, option, warrant or otherwise on or in
                                         respect of or in substitution for, any of those Shares.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; text-transform: uppercase; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">8.</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>ENFORCEMENT
                                         AND POWERS OF THE Chargee</B></FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8.1</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exercise
                                         of Enforcement Powers</B></FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">At
                                         any time after:</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 1in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">an
                                         Event of Default has occurred; or</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 1in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a
                                         written request from the Chargor to the Chargee that it exercise any of its powers under
                                         this deed,</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
Security created by or pursuant to this deed is immediately enforceable and the Chargee and/or any Receiver may in its absolute
discretion, without notice:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 1in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">at
                                         the times and in the manner it thinks fit enforce all or any part of the Security and
                                         take possession of and hold, sell or otherwise dispose and/or deal with all or part of
                                         the Charged Property in such manner and for such consideration (whether payable or deliverable
                                         immediately or by instalments) as the Chargee considers appropriate;</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 1in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iv)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">instruct
                                         the Custodian (by signing the Transfer Notice under (and as defined in) the Custodian
                                         Agreement) to deliver in accordance with the terms of the Custodian Agreement to the
                                         Chargee the title documents and other documentation referred to in clause 3.2 (Title
                                         documents and documentation supporting security);</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<!-- Field: Page; Sequence: 15; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 1in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(v)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">exercise
                                         the power of sale and all other rights and powers conferred by this deed or by statute
                                         (as varied or extended by this deed) on the Chargee or on a Receiver, irrespective of
                                         whether the Chargee has taken possession or appointed a Receiver of the Charged Property;</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 1in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(vi)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">apply
                                         all dividends, distributions and other monies paid on or derived from the Shares as directed
                                         by the Chargee; and</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 1in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(vii)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">dispose
                                         of all or any of the Chargee&rsquo;s other rights under this deed for such consideration (whether
                                         payable or deliverable immediately or by instalments) and in such manner as the Chargee
                                         considers appropriate.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
                                         the purpose of all rights and powers implied or granted by statute, the Secured Obligations
                                         are deemed to have fallen due on the date of this deed. The power of sale and other powers
                                         conferred by the CPO and all other enforcement powers conferred by this deed shall be
                                         immediately exercisable at any time after the Security under this deed has become enforceable
                                         in accordance with clause 8.1 (Exercise of Enforcement Powers).</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Any
                                         Secured Party may, at its discretion and without further notice, take such proceedings
                                         or enforce the Security under this deed as it may think fit to enforce its rights under
                                         the Bonds or Transaction Documents and to enforce all or any of the security interests
                                         created therein in accordance with the terms thereof, provided that, to the extent practicable
                                         the Secured Parties shall enforce their rights under the Account Charge prior to enforcing
                                         their rights under this deed.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8.2</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Appointment
                                         of Receiver </B></FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">At
any time after the Security created by or pursuant to this deed has become enforceable under clause 8.1 (Exercise of Enforcement
Powers), or if the Chargor so requests the Chargee in writing at any time, the Chargee may, without prior notice to the Chargor,
by deed, under seal or by writing under hand signed by any officer or manager of the Chargee, appoint any person (or persons)
to be a Receiver of all or any part of the Charged Property (including in respect of separate parts of the Charged Property).
Any restriction on the right of the Chargee to appoint a Receiver conferred by law does not apply to this deed.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; text-transform: uppercase; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">9.</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>ATTORNEY</B></FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">9.1</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Appointment
                                         and power</B></FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Chargor, by way of security, irrevocably appoints the Chargee, each Receiver and any of its Delegates or sub-delegates and any
person nominated for the purpose by the Chargee or any Receiver (in writing and signed by an officer of the Chargee or Receiver)
as its attorney (with full power of substitution and delegation) in its name and on its behalf and as its act and deed to, execute,
seal and deliver (using the company seal where appropriate) and perfect any deed, agreement or other instrument and to do any
act or thing:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">which
                                         the Chargor is required to do by the terms of any Bond or Transaction Document (including
                                         the execution and delivery of deeds, charges, assignments or other security and any transfers
                                         of Charged Property and perfecting and/or releasing the Security created or intended
                                         to be crated in respect of the Charged Property); and/or</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;</FONT></P>

<!-- Field: Page; Sequence: 16; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">which
                                         is for the purpose of enabling the exercise of any rights or powers conferred on the
                                         Chargee or any Receiver by any Bond or Transaction Document or by law (including the
                                         exercise of any right of a legal or beneficial owner of the Charged Property).</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">9.2</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Ratification</B></FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-transform: uppercase; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal; text-transform: none">The
Chargor ratifies, confirms and agrees to ratify and confirm whatever any such attorney shall do in the exercise or purported exercise
of the power of attorney granted by it in clause 9.1 (Appointment and power).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-transform: uppercase; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; text-transform: uppercase; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">10.</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>EXTENSION
                                         and variation of statutory powers</B></FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.1</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Statutory
                                         Powers</B></FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                         powers conferred on mortgagees or receivers by statute shall apply to the Security created
                                         by this deed, unless they are expressly or impliedly excluded. If there is ambiguity
                                         or conflict between the powers conferred by statute and those contained in this deed,
                                         those contained in this deed shall prevail.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                         statutory power of sale, of appointing a Receiver and the other statutory powers conferred
                                         on mortgagees by section 51 (Powers of mortgagee and receiver) and section 53 (Sale by
                                         mortgagee) of the CPO and the Fourth Schedule (Powers of mortgagee and receiver) to the
                                         CPO as varied and extended by this deed shall arise on the date of this deed, and for
                                         that purpose the Secured Obligations are deemed to have fallen due on the date of this
                                         deed, and no restriction imposed by any ordinance or other statutory provision in relation
                                         to the exercise of any power of sale shall apply to this deed.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Each
                                         Receiver and Chargee is entitled to all the rights, powers, privileges and immunities
                                         conferred by law (including the CPO) on mortgagees and receivers duly appointed under
                                         any law (including the CPO).</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.2</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exercise
                                         of Powers</B></FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">All
or any of the powers conferred upon mortgagees by the CPO as varied or extended by this deed, and all or any of the rights and
powers conferred by this deed on a Receiver (whether expressly or impliedly), may be exercised by the Chargee without further
notice to the Chargor at any time after the Security under this deed has become enforceable in accordance with clause 8.1 (Exercise
of Enforcement Powers), irrespective of whether the Chargee has taken possession or appointed a Receiver of the Charged Property.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.3</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Statutory
                                         Restrictions</B></FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">No
restriction imposed by any ordinance (including paragraph 11 of the Fourth Schedule to the CPO) or other statutory provision in
relation to the exercise of any power of sale, application of proceeds or any other right or on the consolidation of mortgages
or other security shall apply to the Security constituted by this deed which powers may be exercised by the Chargee without notice
to the Chargor on or at any time after the Security under this deed has become enforceable in accordance with clause 8.1 (Exercise
of Enforcement Powers).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; text-transform: uppercase; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">11.</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>STATUS,
                                         POWERS, REMOVAL AND REMUNERATION OF RECEIVER</B></FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">11.1</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Receiver
                                         as Agent</B></FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Each
Receiver shall be the agent of the Chargor which shall be solely responsible for his or her acts or defaults, and for his or her
remuneration and expenses, and be liable on any contracts, engagements, acts, omissions, defaults and losses of a Receiver and
the liabilities incurred by a Receiver. No Secured Party will incur any liability (either to the Chargor or to any other person)
by reason of the appointment of a Receiver or for any other reason, including for any misconduct, negligence or default of a Receiver.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;</FONT></P>

<!-- Field: Page; Sequence: 17; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">11.2</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Relationship
                                         with Chargee</B></FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">To
the fullest extent allowed by law, any right, power or discretion conferred by this deed (either expressly or impliedly) or by
law on a Receiver may, after the Security created by or pursuant to this deed becomes enforceable, be exercised by the Chargee
in relation to any Charged Property without first appointing a Receiver and notwithstanding the appointment of a Receiver.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">11.3</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Powers
                                         of Receiver</B></FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Each
Receiver appointed under this deed shall have all the powers conferred from time to time on receivers by the CPO (which is deemed
incorporated in this deed), so that the powers set out in the Fourth Schedule to the CPO (to the extent not amended and/or varied
under this deed) shall extend to every Receiver. In addition, notwithstanding any liquidation of the Chargor, each Receiver shall
have power to:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">take
                                         immediate possession of, collect and get in the Charged Property (including any income
                                         accruing from time to time);</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">sell,
                                         transfer, assign, exchange, lend or otherwise dispose of or realise all or any part of
                                         the Charged Property in such manner and generally on such terms as he thinks fit;</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">borrow
                                         or raise money or incur any other liability in connection with the Charged Property on
                                         any terms for whatever purpose which the Receiver thinks fit, whether secured or unsecured,
                                         and whether to rank for payment in priority to this security or not;</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">enter
                                         into bonds, covenants, guarantees, indemnities and other commitments in connection with
                                         the Charged Property and to make all payments needed to effect, maintain or satisfy them;</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">manage
                                         and use the Charged Property and to exercise and do (or permit the Chargor or any nominee
                                         of it to exercise and do) all such powers, authorities, rights and things as the Receiver
                                         would be capable of exercising or doing if he were the absolute beneficial owner of the
                                         Charged Property;</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(f)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">redeem
                                         any prior Security on or relating to the Charged Property and settle and pass the accounts
                                         of the person entitled to that prior Security, so that any accounts so settled and passed
                                         shall (subject to any manifest error) be conclusive and binding on the Chargor and the
                                         money so paid shall be deemed to be an expense properly incurred by the Receiver;</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(g)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">appoint,
                                         hire and employ officers, employees, contractors, agents, advisors and others for any
                                         of the purposes of this deed and/or to protect or realise the Charged Property upon terms
                                         as to remuneration or otherwise as he may think fit and to discharge any such persons
                                         and any such persons appointed, hired or employed by the Chargor;</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(h)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">bring,
                                         prosecute, enforce, defend and abandon any action, suit or proceedings in relation to
                                         any Charged Property and to submit to arbitration, negotiation, compromise which the
                                         Receiver thinks fit. A Receiver may also settle any applications, claims, accounts, disputes,
                                         questions and demands with or by any person who is or claims to be a creditor of the
                                         Chargor or relating to any of the Charged Property and in addition to take or defend
                                         proceeding for the compulsory winding-up of the Chargor;</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;</FONT></P>

<!-- Field: Page; Sequence: 18; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">exercise
                                         all voting and other rights attaching to the Shares and stocks, shares and other securities
                                         owned by the Chargor and comprised in the Charged Property;</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(j)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">do
                                         all other acts and things (including signing and executing all documents and deeds) as
                                         the Receiver may consider to be desirable, conducive, incidental or conducive to any
                                         of the matters or powers in this clause 11.3 (Powers of Receiver) or provided under law,
                                         or otherwise incidental or conducive to the preservation, improvement or realisation
                                         of the Charged Property, and use the name of the Chargor for all such purposes;</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(k)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">in
                                         the exercise of any of its powers, to spend such sums as it thinks fit and the Chargor
                                         shall within 3 Business Days on written demand repay to the Chargee or Receiver (as the
                                         case may be) all sums so spent together with interest on those sums at such rates as
                                         the Chargee may from time to time determine from the time they are paid or incurred and
                                         until repayment, those sums (together with such interest) shall be secured by this deed;</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(l)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">give
                                         a valid receipt for any moneys and execute any assurance or thing which may be proper
                                         or desirable for realising any Charged Property;</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(m)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">sell,
                                         exchange, convert into money and realise any Charged Property by public auction or private
                                         contract and generally in any manner and on any terms which the Receiver thinks fit.
                                         The consideration for any such transaction may consist of cash, debentures or other obligations,
                                         shares, stock or other valuable consideration and any such consideration may be payable
                                         in a lump sum or by instalments spread over any period which the Receiver thinks fit;
                                         and</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(n)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">to
                                         do anything else he may think fit for the realisation of the Charged Property or incidental
                                         to the exercise of any of the rights conferred on the Receiver under or by virtue of
                                         any Bond or Transaction Document to which the Chargor is party, the CPO, the Companies
                                         Ordinance and other applicable statutory provisions and common law,</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">and
in each case may use the name of the Chargor and exercise the relevant power in relation to the Charged Property in any manner
which he may think fit.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">11.4</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Removal
                                         of Receiver</B></FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Chargee may by notice remove from time to time any Receiver appointed by it and, whenever it may deem appropriate, appoint a new
Receiver in the place of any Receiver whose appointment has terminated, for whatever reason.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">11.5</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Remuneration
                                         of Receiver</B></FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Chargee may from time to time fix the remuneration of any Receiver appointed by it and any maximum rate imposed by any law will
not apply.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">11.6</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Several
                                         Receivers</B></FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
at any time there is more than one Receiver, each Receiver may separately exercise all of the powers conferred by this deed and
to the exclusion of any other Receiver (unless the document appointing such Receiver states otherwise).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;</FONT></P>

<!-- Field: Page; Sequence: 19; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; text-transform: uppercase; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">12.</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>APPLICATION
                                         OF ENFORCEMENT PROCEEDS</B></FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">12.1</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Order
                                         of Application</B></FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">All
                                         proceeds of enforcement (whether cash or non-cash) received or recovered by the Chargee
                                         or any Receiver pursuant to this deed shall (subject to any claims having priority under
                                         mandatory provisions of the CPO and other claims of any creditors mandatorily preferred
                                         by law) be applied in the following order:</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 1in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">first,
                                         in or towards the payment of all costs, losses, liabilities, expenses and remuneration
                                         of and incidental to the appointment of any Receiver or Delegate and the exercise of
                                         any of his rights, including his remuneration and all outgoings paid by him under or
                                         in connection with this deed; and</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 1in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">secondly,
                                         in or towards payment pro rata of any accrued interest, fee or commission due but unpaid
                                         under the Bond Documents;</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 1in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">thirdly,
                                         in or towards payment pro rata of any principal due but unpaid under the Bonds and Transaction
                                         Documents;</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 1in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iv)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">fourthly,
                                         in or towards payment pro rata of any other sum due but unpaid under the Bonds and Transaction
                                         Documents; and</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 1in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(v)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">fifthly,
                                         the balance (if any) after payment of the amounts referred to in paragraphs (a)(i) to
                                         (iv) of clause 12.1 (Application of Proceeds) above, in payment or distribution to the
                                         Chargor</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
Chargee may vary the order as set out in paragraphs (a)(i) to (d)(iv) of clause 12.1 (Order of Application) above.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 7.7pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
                                         clause 12.1 (Order of Application) is subject to the payment of any claims having priority
                                         over this deed. This clause 12.1 (Order of Application) does not prejudice the right
                                         of any Secured Party to recover any shortfall from a Transaction Obligor.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">12.2</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Application
                                         against Secured Obligations</B></FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Subject
to clause 12.1 (Order of Application), any moneys or other proceeds (whether cash or non-cash) received or realised by the Chargee
from the Chargor or a Receiver under this deed may be applied by the Chargee to any item of account or liability or transaction
forming part of the Secured Obligations to which they may be applicable in any order or manner which the Chargee may determine.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">12.3</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Suspense
                                         Account</B></FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Until
                                         the Secured Obligations are paid in full, each Secured Party may place and keep (for
                                         such time as it shall determine) any recoveries or other proceeds of enforcement (whether
                                         cash or non-cash) received pursuant to this deed or on account of the Chargor&rsquo;s liability
                                         in respect of the Secured Obligations in a separate suspense account (to the credit of
                                         either the Chargor or the Chargee as the Chargee shall think fit) and the Receiver may
                                         retain the same for the period which he and the Chargee consider expedient without having
                                         any obligation to apply all or any part of the same in or towards discharge of the Secured
                                         Obligations.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
                                         the Security created by this deed is enforced at a time when no amount is due under the
                                         Bonds and Transaction Documents but at the time when amounts may or will become due,
                                         a Secured Party may pay any recoveries or other proceeds of enforcement into a suspense
                                         account.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;</FONT></P>

<!-- Field: Page; Sequence: 20; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; text-transform: uppercase; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">13.</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>PROTECTION
                                         OF Security</B></FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">13.1</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Continuing
                                         Security</B></FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Security created pursuant to this deed is to be a continuing security notwithstanding any intermediate payment or settlement of
all or any part of the Secured Obligations or any other matter or thing.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">13.2</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Other
                                         Security</B></FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
                                         Security is to be in addition to, independent of and shall neither be merged in nor in
                                         any way exclude or prejudice or be affected by any other security or other right which
                                         the Chargee or any other Secured Party may now or after the date of this deed hold for
                                         any of the Secured Obligations or any other obligations, or any rights, powers and remedies
                                         provided by law and notwithstanding any receipt, release or discharge endorsed on or
                                         given in respect of or under any such other security.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                         Chargor waives any right it may have of first requiring the Chargee (or any trustee or
                                         agent on its behalf) to proceed against or enforce any other rights or security or claim
                                         payment from any person before claiming from the Chargor under this deed. This waiver
                                         applies irrespective of any law or any provision of a Bond or Transaction Document to
                                         the contrary.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">13.3</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Cumulative
                                         Powers</B></FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                         powers which this deed confers on the Chargee and the other Secured Parties are cumulative,
                                         without prejudice to their respective powers under the general law, and may be exercised
                                         as often as the relevant person thinks appropriate.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                         Chargee or the other Secured Parties may, in connection with the exercise of their powers,
                                         join or concur with any person in any transaction, scheme or arrangement whatsoever.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                         respective powers of the Chargee and the other Secured Parties will in no circumstances
                                         be suspended, waived or otherwise prejudiced by anything other than an express consent
                                         or amendment.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">13.4</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Amounts
                                         Avoided</B></FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
any discharge, release or arrangement (whether in respect of the obligations of the Chargor or any security for those obligations
or otherwise) is made in whole or in part on the basis that any amount paid by the Chargor in respect of the Secured Obligations
is capable of being avoided or set aside on insolvency, liquidation or administration of the Chargor or otherwise, without limitation,
then amount shall not be considered to have been paid and the liabilities of the Chargor and the Security created pursuant to
this deed shall continue or be reinstated.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">13.5</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Discharge
                                         Conditional</B></FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
any discharge, release arrangement (whether in respect of the obligations of the Chargor or any other Transaction Obligor, or
in respect of any security for those obligations or otherwise) is made by a Secured Party in whole or in part on the basis of
any payment, security or other disposition which is avoided or must be restored in insolvency, liquidation, administration or
otherwise, without limitation, then the liability of the Chargor under this deed will continue or be reinstated as if the discharge,
release or arrangement had not occurred.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;</FONT></P>

<!-- Field: Page; Sequence: 21; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">13.6</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Waiver
                                         of Defences</B></FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
obligations assumed by the Chargor under this deed, the Security created under this deed and the rights, powers and remedies of
the Chargee provided by or pursuant to this deed or by law will not be affected by an act, omission, matter or thing which, but
for this provision, would reduce, release or prejudice any of its obligations under this deed (without limitation and whether
or not known to it or any Secured Party) including:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">any
                                         time, waiver or consent granted to, or composition with, any person (including any Transaction
                                         Obligor);</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                         release of any person (including any Transaction Obligor) under the terms of any composition
                                         or arrangement;</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                         taking, variation, compromise, exchange, renewal or release of, or refusal or neglect
                                         to perfect, take up or enforce, any rights against, or security over assets of, any person
                                         (including any Transaction Obligor);</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">any
                                         incapacity or lack of power, authority or legal personality of or dissolution or change
                                         in the members or status of any person (including any Transaction Obligor);</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">any
                                         amendment, novation, supplement, extension, restatement (however fundamental and whether
                                         or not more onerous) or replacement of a Bond or Transaction Document or any other document
                                         or security including without limitation any change in the purpose of, any extension
                                         of or any increase in any facility or the addition of any new facility under any Bond
                                         or Transaction Document or other document or security;</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(f)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">any
                                         unenforceability, illegality or invalidity of any obligation of any person under any
                                         Bond or Transaction Document or any other document or security;</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(g)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">any
                                         insolvency, liquidation, winding-up, provisional supervision, supervision, administration,
                                         receivership or similar proceedings;</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(h)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">any
                                         other Security, guarantee or indemnity now or thereafter held by the Chargee or any other
                                         person in respect of the Secured Obligations or any other liabilities; or</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">any
                                         postponement, discharge, reduction, non-provability or other similar circumstance affecting
                                         any obligations of the Chargor or other person under any Bond or Transaction Document
                                         resulting from any insolvency, liquidation or dissolution proceedings or from any law,
                                         regulation or order.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">13.7</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Chargor
                                         intention</B></FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Without
prejudice to the generality of clause 13.6 (Waiver of defence), the Chargor expressly confirms that it intends that the Security
created pursuant to this deed shall extend from time to time to any (however fundamental) variation, increase, extension or addition
of or to any of the Bonds or Transaction Documents and/or any facility or amount made available under any of the Bonds or other
Transaction Documents as agreed by the Issuer and/or the Chargor for the purposes of or in connection with any of the following:
business acquisitions of any nature; increasing working capital; enabling investor distributions to be made; carry out restructurings;
refinancing existing facilities; refinancing any other indebtedness; making facilities available to new borrower; any other variation
or extension of the purposes for which any such facility or amount might be made available from time to time; and any fees, costs
and/or expenses associated with any of the foregoing.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;</FONT></P>

<!-- Field: Page; Sequence: 22; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">13.8</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Deferral
                                         of rights</B></FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Until
all the Secured Obligations have been irrevocably paid in full and facilities which might give rise to Secured Obligations have
been terminated and unless the Chargee otherwise directs or except as permitted under the Bonds or Transaction Documents, the
Chargor will not exercise any rights which it may have by reason of performance by it of its obligations under the Bonds or Transaction
Documents or by reason of any amount being payable, or liability arising, under this deed:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">to
                                         be indemnified by any person;</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">to
                                         claim any contribution from any other provider of Security for or any other guarantor
                                         of the Chargor&rsquo;s obligations under the Bonds or Transaction Documents;</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">to
                                         take the benefit (in whole or in part and whether by way of subrogation or otherwise)
                                         of any rights of the Secured Parties under the Bonds or Transaction Documents or of any
                                         guarantee or other security taken pursuant to, or in connection with, the Bond Documents
                                         by any Finance Party;</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">to
                                         bring legal or other proceedings for an order requiring any Finance Party to make any
                                         payment, or perform any obligation, in respect of which the Chargor has given a guarantee,
                                         undertaking or indemnity;</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">to
                                         exercise any right of set-off against any person; and/or</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(f)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">to
                                         claim or prove as a creditor of any person in competition with any Finance Party.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
the Chargor receives any benefit, payment or distribution in relation to such rights it shall hold that benefit, payment or distribution
to the extent necessary to enable all amounts which may be or become payable to the Secured Parties under or in connection with
the Bonds or Transaction Documents to be repaid in full on trust for the Secured Parties and shall promptly pay or transfer the
same to the Chargee or as the Chargee may direct for application in accordance with clause 12.1 (Order of Application).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">13.9</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Subsequent
                                         Security &ndash; Ruling-off Accounts</B></FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
the Chargee or any other Secured Party receives notice of any subsequent Security or other interest affecting any of the Charged
Property (except as permitted by the Bonds or Transaction Documents) it may open a new account for the Chargor in its books. If
it does not do so then (unless it gives express notice to the contrary to the Chargor), as from the time it receives that notice,
all payments made by the Chargor to it shall (in the absence of any express appropriation to the contrary) be treated as having
been credited to a new account of the Chargor and not as having been applied in reduction of the Secured Obligations.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">13.10</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Redemption
                                         of Prior Charges</B></FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">To
the extent applicable, the Chargee may redeem any prior Security on or relating to any of the Charged Property or procure the
transfer of that Security to itself, and may settle and pass the accounts of any person entitled to that prior Security. Any account
so settled and passed shall (subject to any manifest error) be conclusive and binding on the Chargor. The Chargor will on demand
pay to the Chargee all principal monies and interest and all costs, expenses and losses incidental to any such redemption or transfer.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;</FONT></P>

<!-- Field: Page; Sequence: 23; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->21<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; text-transform: uppercase; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">14.</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Protection
                                         of third parties</B></FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">14.1</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>No
                                         Obligation to Enquire</B></FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">No
purchaser from, or other person dealing with, the Chargee or any Receiver (or Delegate) shall be obliged or concerned to enquire
whether:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                         right of the Chargee or any Receiver to exercise any of the powers conferred by this
                                         deed has arisen or become exercisable or as to the propriety or validity of the exercise
                                         or purported exercise of any such power; or</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">any
                                         of the Secured Obligations remains outstanding or be concerned with notice to the contrary
                                         and the title and position of such a purchaser or other person shall not be impeachable
                                         by reference to any of those matters.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">14.2</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Receipt
                                         Conclusive</B></FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
receipt of the Chargee or any Receiver shall be an absolute and a conclusive discharge to a purchaser, and shall relieve him of
any obligation to see to the application of any moneys or other consideration paid to or by the direction of the Chargee or any
Receiver.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; text-transform: uppercase; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">15.</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>PROTECTION
                                         OF Secured Parties</B></FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">15.1</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Liabilities
                                         of the Secured Parties</B></FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Neither
the Chargee nor any Receiver or Delegate shall be liable in respect of any of the Charged Property or for any loss or damage which
arises out of the exercise or the attempted or purported exercise of, or the failure to exercise any of, their respective powers,
unless caused by its or his gross negligence, wilful misconduct, fraud or wilful breach of any obligations under the Bonds or
Transaction Documents. The Chargee will not be liable in respect of any gross negligence or wilful misconduct or fraud of a Receiver
or Delegate.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">15.2</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>No
                                         obligations in relation to Charged Property</B></FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Chargee is not obliged to do any of the following in respect of any Charged Property:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">perform
                                         any obligation of the Chargor;</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">make
                                         any payment;</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">make
                                         any enquiry as to the nature or sufficiency of any payment received by it or the Chargor;</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">present
                                         or file any claim or take any other action to collect or enforce the payment of any amount
                                         to which it or the Chargor may be entitled; or</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">exercise
                                         any rights to which it or the Chargor may be entitled.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">15.3</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Possession
                                         of Charged Property</B></FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Without
prejudice to clause 15.1 (Liabilities of the Secured Parties), if the Chargee or the Receiver or Delegate enters into possession
of the Charged Property, it will not be liable:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">to
                                         account as mortgagee in possession or for any loss on realisation or enforcement of rights
                                         and may at any time at its discretion go out of such possession or</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">for
                                         any default or omission for which a mortgagee in possession might be liable.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;</FONT></P>

<!-- Field: Page; Sequence: 24; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->22<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">15.4</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Liability
                                         of the Chargor</B></FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Chargor shall be deemed to be a principal debtor and the sole, original and independent obligor for the Secured Obligations and
the Charged Property shall be deemed to be a principal security for the Secured Obligations. The liability of the Chargor under
this deed and the charges contained in this deed shall not be impaired by any forbearance, neglect, indulgence, extension of time,
release, surrender or loss of securities, dealing, variation or arrangement by the Chargee, or by any other act, event or matter
whatsoever whereby the liability of the Chargor (as a surety only) or the charges contained in this deed (as secondary or collateral
charges only) would, but for this provision, have been discharged.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">15.5</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Indemnity</B></FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                         Chargor shall promptly indemnify the Chargee and every Receiver and Delegate against
                                         any cost, loss or liability incurred by any of them as a result of:</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 1in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">acting
                                         or relying on any notice, request or instruction issued or given by the Chargor under
                                         this deed which it reasonably believes to be genuine, correct and appropriately authorised
                                         provided such costs, loss or liability was not directly caused by the wilful misconduct,
                                         gross negligence or fraud on the part of the relevant Secured Party;</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 1in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                         taking, holding, protection or enforcement of the Security constituted by this deed;</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 1in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                         exercise of any of the rights, powers, discretions, authorities and remedies vested in
                                         the Chargee and each Receiver and Delegate by this deed or by law;</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 1in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iv)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">any
                                         default by the Chargor in the performance of any of the obligations expressed to be assumed
                                         by it in this deed;</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 1in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(v)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">actual
                                         or alleged breach by any person of any applicable law or regulation) incurred in connection
                                         with this deed by any Secured Party, Receiver, attorney, manager, agent or other person
                                         appointed by the Chargee under this deed, including any arising from any actual or alleged
                                         breach by any person of any applicable law or regulation; or</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 1in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(vi)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">acting
                                         as Chargee, Receiver or Delegate (otherwise, in each case, than by reason of the relevant
                                         Chargee&rsquo;s, Receiver&rsquo;s or Delegate&rsquo;s gross negligence, wilful misconduct or fraud).</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                         Chargor expressly acknowledges and agrees that the continuation of its indemnity obligations
                                         under this clause 15.5 (Indemnity) will not be prejudiced by any release of security
                                         or disposal of any Charged Property.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                         Chargor and every Receiver and Delegate may, in priority to any payment to the other
                                         Secured Parties, indemnify itself out of the Charged Property in respect of, and pay
                                         and retain, all sums necessary to give effect to the indemnity in this clause 15.5 (Indemnity).</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">15.6</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Discretion</B></FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Any
liberty or power which may be exercised by or any determination which may be made under this deed by the Chargee or any Receiver
may, subject to the provisions of the Bonds or Transaction Documents, be exercised or made in its absolute and unfettered discretion
without any obligation to give reasons.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; text-transform: uppercase; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">16.</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>DELEGATION</B></FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Chargee may delegate by power of attorney or in any other manner all or any of the powers, authorities and discretions which are
for the time being exercisable by it under this deed to any person or persons upon such terms and conditions (including the power
to sub-delegate) as it may think fit. The Chargee will not be liable or responsible to the Chargor or any other person for any
losses arising from any wilful default, gross misconduct or gross negligence on the part of any delegate.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;</FONT></P>

<!-- Field: Page; Sequence: 25; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->23<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; text-transform: uppercase; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">17.</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Costs
                                         and Expenses</B></FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">17.1</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Initial
                                         Expenses</B></FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
provisions of clause 13 (Expenses and Payments) of the Subscription Agreement shall be deemed incorporated into this deed as if
fully set out herein <I>mutatis mutandis</I> as if any reference therein to &ldquo;this Agreement&rdquo; or a Bond or the Transaction
Documents were a reference to this deed.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">17.2</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Enforcement
                                         and preservation costs and expenses</B></FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Upon
the Security under this deed has become enforceable in accordance with clause 8.1 (Exercise of Enforcement Powers), the Chargor
shall, within 3 Business Days of demand, pay to each Secured Party the amount of all costs and expenses (including legal fees)
incurred by it in connection with the enforcement of, or the preservation of any rights under, any Bond or Transaction Document
and any proceedings instituted by or against that Secured Party as a consequence of it entering into a Bond or Transaction Document,
taking or holding the Security created pursuant to this deed, or enforcing those rights.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">17.3</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Stamp
                                         Taxes</B></FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Chargor shall:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">pay
                                         all stamp duty, registration and other similar Taxes payable in respect of this deed;
                                         and</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">within
                                         3 Business Days of demand, indemnify the Chargee against any cost, loss or liability
                                         that the Chargee incurs in relation to any stamp duty, registration or other similar
                                         Tax paid or payable in respect of this deed.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">17.4</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Default
                                         Interest</B></FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
provisions of Condition 6(b) (Interest applicable upon Default) of the Conditions shall be deemed incorporated into this deed
as if fully set out herein <I>mutatis mutandis</I> as if any reference therein to &ldquo;this Condition&rdquo; or a Bond or Transaction
Document were a reference to this deed.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; text-transform: uppercase; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">18.</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>SET-OFF</B></FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Any
                                         Secured Party may set off any matured obligation due from the Chargor under the Bonds
                                         or Transaction Documents (to the extent beneficially owned by that Secured Party) against
                                         any matured obligation owed by that Secured Party to the Chargor, regardless of the place
                                         of payment, booking branch or currency of either obligation. If the obligations are in
                                         different currencies, the Chargee may convert either obligation at a market rate of exchange
                                         in its usual course of business for the purpose of the set-off.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
                                         the relevant obligation or liability of the Chargor is unliquidated or unascertained,
                                         the Secured Party may set-off the amount which it estimates (in good faith) will be the
                                         final amount of that obligation or liability once it becomes liquidated or ascertained.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; text-transform: uppercase; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">19.</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>NOTICES</B></FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Clause
15 (Communications) in the Subscription Agreement shall apply also to this deed.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT>&nbsp;</P>

<!-- Field: Page; Sequence: 26; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->24<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; text-transform: uppercase; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">20.</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Changes
                                         to Parties</B></FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">20.1</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Assignment
                                         by the Chargee</B></FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Chargee may at any time assign or otherwise transfer all or any part of its rights under this deed in accordance with the Bonds
and Transaction Documents.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">20.2</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Changes
                                         to Parties</B></FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                         Chargor authorises and agrees to change the parties under condition 3(b) (Transfer) of
                                         the Conditions and authorises the Chargee to execute on its behalf any document required
                                         to effect the necessary transfer of rights or obligations contemplated by those provisions.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                         Chargor may not assign, novate, transfer, sub-participate, encumber, declare a trust
                                         over or otherwise deal with all or any of its rights and/or obligations under this deed.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; text-transform: uppercase; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">21.</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>CURRENCY
                                         CLAUSES</B></FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">21.1</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Conversion</B></FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">All
monies received or held by the Chargee or any Receiver under this deed may be converted into any other currency which the Chargee
considers necessary to discharge any obligations and liabilities comprised in the Secured Obligations in that other currency at
a market rate of exchange then prevailing.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">21.2</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>No
                                         Discharge</B></FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Subject
to clause 22.5 (Covenant to release), no payment to the Chargee (whether under any judgement or court order or otherwise) shall
discharge the obligation or liability of the Chargor in respect of which it was made unless and until the Chargee has received
payment in full in the currency in which the obligation or liability is payable or, if the currency of payment is not specified,
was incurred. To the extent that the amount of any such payment shall on actual conversion into that currency fall short of that
obligation or liability expressed in that currency, the Chargee shall have a further separate cause of action against the Chargor
and shall be entitled to enforce the security constituted by this deed to recover the amount of the shortfall.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; text-transform: uppercase; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">22.</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>MISCELLANEOUS</B></FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">22.1</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Certificates
                                         Conclusive</B></FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Provided
that calculation in reasonable detail has been provided, a certificate or determination of the Chargee as to any amount payable
under this deed will be conclusive and binding on the Chargor, except in the case of manifest error or wilful default.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">22.2</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Invalidity
                                         of any Provision</B></FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
any provision of this deed is or becomes invalid, illegal or unenforceable in any respect under any law, the validity, legality
and enforceability of the remaining provisions shall not be affected or impaired in any way.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">22.3</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Counterparts</B></FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
deed may be executed in any number of counterparts, and this has the same effect as if the signatures on the counterparts were
on a single copy of this deed.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;</FONT></P>

<!-- Field: Page; Sequence: 27; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->25<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">22.4</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Failure
                                         to Execute</B></FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Failure
by one or more parties (<B>&ldquo;Non-Signatories&rdquo;</B>) to execute this deed on the date hereof will not invalidate the provisions
of this deed as between the other parties who do execute this deed. Such Non-Signatories may execute this deed on a subsequent
date and will thereupon become bound by its provisions.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">22.5</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Covenant
                                         to Release</B></FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
the earlier of:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">all
                                         the Secured Obligations have been paid in full and none of the Chargee nor any Secured
                                         Party has any actual or contingent liability to advance further monies to, or incur liability
                                         on behalf of, any member of the Group (as defined in Subscription Agreement), but not
                                         otherwise; and</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                         successful QIPO,</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">provided
no Event of Default has occurred, the Chargee and each other Secured Party shall, at the request and cost of the Chargor, take
any action which may be necessary to release the Charged Property from the security constituted by this deed and procure the reassignment
to the Chargor of the property and assets assigned to the Chargee pursuant to this deed (in each case subject to clause 13.4 (Amounts
Avoided)) without recourse to, or any representation or warranty by, the Chargee or any of other Secured Party and instruct the
Custodian (by signing the Release Notice under (and as defined in) the Custodian Agreement) to deliver in accordance with the
terms of the Custodian Agreement to the Chargor the title documents and other documentation referred to in clause 3.2 (Title documents
and documentation supporting security).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; text-transform: uppercase; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">23.</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Governing
                                         Law</B></FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
deed is governed by the laws of Hong Kong.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; text-transform: uppercase; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">24.</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>ENFORCEMENT</B></FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                         courts of Hong Kong are to have exclusive jurisdiction to settle any disputes which may
                                         arise out of or in connection with this deed and accordingly any legal action or proceedings
                                         arising out of or in connection with this deed (&ldquo;<B>Proceedings</B>&rdquo;) may be
                                         brought in such courts. Pursuant to this deed, the Chargor irrevocably submits to the
                                         jurisdiction of such courts and waives any objection to Proceedings in any such courts
                                         whether on the ground of venue or on the ground that the Proceedings have been brought
                                         in an inconvenient forum.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
                                         clause 24 (Enforcement) is for the benefit of the Chargee only. As a result, the Chargee
                                         shall not be prevented from taking proceedings relating to ant Proceedings in any other
                                         courts with jurisdiction. To the extent allowed by law, the Chargee may take concurrent
                                         proceedings in any number of jurisdictions.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; text-transform: uppercase; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">25.</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Service
                                         of Process</B></FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Without
                                         prejudice to any other mode of service allowed under any relevant law, the Chargor:</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 1in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">irrevocably
                                         appoints Aptorum Group Limited with its address at 17/F, Guangdong Investment Tower,
                                         148 Connaught Road Central, Hong Kong as its agent for service of process in relation
                                         to any proceedings before the Hong Kong courts in connection with any Bond Documents;
                                         and</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 1in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">agrees
                                         that failure by a process agent to notify the Chargor of the process will not invalidate
                                         the proceedings concerned.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;</FONT></P>

<!-- Field: Page; Sequence: 28; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->26<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                         Chargor shall inform the Chargee, in writing, of any change in the address of its process
                                         agent within 5 Business Days of such change.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
                                         such process agent ceases to be able to act as such or to have an address in Hong Kong,
                                         the Chargor agrees to promptly appoint a new process agent in Hong Kong reasonably acceptable
                                         to the Chargee and to deliver to the Chargee within 5 Business Days a copy of a written
                                         acceptance of appointment by the new process agent.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; text-transform: uppercase; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">26.</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Waiver
                                         of immunities</B></FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Chargor irrevocably waives, to the extent permitted by applicable law, with respect to itself and its revenues and assets (irrespective
of their use or intended use), all immunity on the grounds of sovereignty or other similar grounds from:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">suit;</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">jurisdiction
                                         of any court;</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">relief
                                         by way of injunction or order for specific performance or recovery of property;</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">attachment
                                         of its assets (whether before or after judgment); and</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">execution
                                         or enforcement of any judgment to which it or its revenues or assets might otherwise
                                         be entitled in any proceedings in the courts of any jurisdiction (and irrevocably agrees,
                                         to the extent permitted by applicable law, that it will not claim any immunity in any
                                         such proceedings).</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>IN
WITNESS</B> whereof this deed has been duly executed and delivered as a deed on the date first above written.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;</FONT></P>

<!-- Field: Page; Sequence: 29; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->27<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">schedule
1</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 191.4pt; text-transform: uppercase; text-align: center; text-indent: -198.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Shares</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Part
I</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total
issued Class A shares of the Issuer</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font-weight: bold; text-align: justify; border-bottom: Black 1.5pt solid">Registered Shareholder(s)</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: justify; border-bottom: Black 1.5pt solid">Number of share(s)</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="font-weight: bold; text-align: left; border-bottom: Black 1.5pt solid">Share Certificate Number(s)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 66%; text-align: left">JURCHEN INVESTMENT CORPORATION</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 15%; text-align: right">1,784,608</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 15%; text-align: justify">Nil</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify">Other shareholders</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">3,641,773</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: justify">Nil</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify">Total:</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">5,426,381</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total
issued Class B shares of the Issuer</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font-weight: bold; text-align: justify; border-bottom: Black 1.5pt solid">Registered Shareholder(s)</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: justify; border-bottom: Black 1.5pt solid">Number of share(s)</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="font-weight: bold; text-align: left; border-bottom: Black 1.5pt solid">Share Certificate Number(s)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 66%; text-align: left">JURCHEN INVESTMENT CORPORATION</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 15%; text-align: right">16,061,469</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 15%; text-align: justify">Nil</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify">Other shareholders</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">6,376,285</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: justify">Nil</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify">Total:</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">22,437,754</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD></TR>
</TABLE>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Part
II</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
number of Class B Shares of the Issuer subject to the Security created pursuant to this deed</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font-weight: bold; text-align: justify; border-bottom: Black 1.5pt solid">Registered Shareholder(s)</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: justify; border-bottom: Black 1.5pt solid">Number of share(s)</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="font-weight: bold; text-align: left; border-bottom: Black 1.5pt solid">Share Certificate Number(s)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 66%; text-align: left">JURCHEN INVESTMENT CORPORATION</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 15%; text-align: right">1,393,207</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 15%; text-align: justify">Number 1</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify">Total:</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,393,207</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;</FONT></P>

<!-- Field: Page; Sequence: 30; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->28<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-transform: uppercase; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">schedule
2</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 191.4pt; text-transform: uppercase; text-align: justify; text-indent: -14.2pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Form
of Instrument of Transfer</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">INSTRUMENT
OF TRANSFER</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Aptorum
Group Limited</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="padding-right: 1.45pt; padding-left: 1.45pt; text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">I/We,</FONT></TD>
    <TD COLSPAN="4" STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 0.1in; padding-left: 0.1in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="padding-right: 1.45pt; padding-left: 1.45pt; text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">of</FONT></TD>
    <TD COLSPAN="4" STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 0.1in; padding-left: 0.1in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD COLSPAN="4" STYLE="padding-right: 1.45pt; padding-left: 1.45pt; text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
    value received from / in consideration of the sum of</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 0.1in; padding-left: 0.1in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD COLSPAN="3" STYLE="padding-right: 1.45pt; padding-left: 1.45pt; text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">paid
    to me/us by (name)</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 0.1in; padding-left: 0.1in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD COLSPAN="2" STYLE="padding-right: 1.45pt; padding-left: 1.45pt; text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(occupation)</FONT></TD>
    <TD COLSPAN="3" STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 0.1in; padding-left: 0.1in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD COLSPAN="2" STYLE="padding-right: 1.45pt; padding-left: 1.45pt; text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">of
    (address)</FONT></TD>
    <TD COLSPAN="3" STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 0.1in; padding-left: 0.1in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 7%; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 7%; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 11%; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 5%; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 70%; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(hereinafter
&ldquo;<B>the said Transferee</B>&rdquo;)</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD COLSPAN="2" STYLE="padding-right: 1.45pt; padding-left: 1.45pt; text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">do
    hereby transfer to the said Transferee the</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt; padding-left: 1.45pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">share(s)</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="padding-right: 1.45pt; padding-left: 1.45pt; text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Numbered</FONT></TD>
    <TD COLSPAN="3" STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt; padding-left: 1.45pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 12%; font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 33%; font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 40%; font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 15%; font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">standing
in my/our name in the register of:-</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Aptorum
Group Limited</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">to
hold unto the said Transferee his executors, administrators or assigns, subject to the several conditions upon which I/we hold
the same at the time of execution hereof. And I/we, the said Transferee do hereby agree to take the said share(s) subject to the
same conditions.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Witness
our hands the ____________________ .</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 49%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Witness to the signature(s) of the Transferor -</FONT></TD>
    <TD STYLE="width: 2%; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</FONT></TD>
    <TD STYLE="width: 49%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>For and on behalf of</I></FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</FONT></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Witness&rsquo;s name and address:</I></FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</FONT></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</FONT></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</FONT></TD>
    <TD>
</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid">
</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Authorized Signature(s)</I></FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</FONT></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 49%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Witness to the signature(s) of the Transferee &ndash;</FONT></TD>
    <TD STYLE="width: 2%; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</FONT></TD>
    <TD STYLE="width: 49%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>For and on behalf of</I></FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</FONT></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</FONT></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</FONT></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Witness&rsquo;s name and address:</I></FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</FONT></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</FONT></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid">
</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Authorized Signature(s)</I></FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</FONT></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<!-- Field: Page; Sequence: 31; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->29<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-transform: uppercase; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">schedule
3</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-transform: uppercase; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Irrevocable
appointment of proxy and power of attorney</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Aptorum
Group Limited</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We,
<B>JURCHEN INVESTMENT CORPORATION,</B> hereby irrevocably appoint [&#9679;] as our:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">proxy
                                         to vote at meetings of the shareholders of <B>Aptorum Group Limited</B> (the &ldquo;<B>Company</B>&rdquo;)
                                         in respect of the shares in the Company charged pursuant to the share charge dated [&#9679;]
                                         2018 between Jurchen Investment Corporation, the Company and Peace Range Limited which
                                         may have been or may from time to time be issued and/or registered in our name (the &ldquo;<B>Shares</B>&rdquo;);
                                         and</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">duly
                                         authorised representative and duly appointed attorney-in-fact to sign resolutions in
                                         writing of the Company in respect of any Shares.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
proxy and this power of attorney are irrevocable by reason of being coupled with the interest of [&#9679;] as chargee of the Shares.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>IN
WITNESS </B>whereof this instrument has been duly executed as a deed this [&nbsp;&nbsp;&nbsp;] day of [&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;].</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 49%; text-align: left"><B>EXECUTED</B> as a <B>DEED</B> and <B>DELIVERED</B> by <B>JURCHEN INVESTMENT CORPORATION:</B></TD>
    <TD STYLE="width: 2%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD>
    <TD STYLE="width: 49%; text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left">Director/authorised signatory signature: </TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify; border-bottom: Black 1.5pt solid">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left">Director/authorised signatory name:</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">Occupation:</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<!-- Field: Page; Sequence: 32; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->30<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-transform: uppercase; text-align: center">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-transform: uppercase; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">schedule
4</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 191.4pt; text-transform: uppercase; text-align: left; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Form
of Letter of Authority and Undertaking</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">To:&#9;[Chargee]</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[Address
details]</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dear
Sirs</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Aptorum
Group Limited (the &ldquo;Company&rdquo;)</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">I
irrevocably authorise you or any of your officers to complete, date and put into effect the attached blank share transfer form
and resolution signed by me, in accordance with the provisions of the Share Charge relating to the Company dated [&#9679;] 2018
(the <B>&ldquo;Share Charge&rdquo;</B>) when the security constituted by the Share Charge has become enforceable.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">After
the security constituted by the Share Charge has become enforceable, I also irrevocably undertake to vote in favour of any resolution
approving that any Shares of the Company comprised in the Charged Property (as defined in the Share Charge) be registered in your
name or in the name of your nominees and, in the name of any purchaser of those shares or its nominee.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
letter has been executed as a deed and is delivered as a deed on the date stated at the beginning of it.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Yours
faithfully</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 49%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>SIGNED, SEALED AND DELIVERED</B> as a deed<BR>
 by [<B><I>insert name of director</I></B>]<BR>
 in the presence of:</FONT></TD>
    <TD STYLE="width: 2%">
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">)</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">)</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">)</P></TD>
    <TD STYLE="width: 49%; text-align: right">&nbsp;<IMG SRC="ex10-19_002.jpg" ALT=""></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="padding-top: 1px; padding-left: 204px; text-align: left"></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Signature</FONT></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: left; border-bottom: Black 1.5pt solid">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Signature of witness</FONT></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: left; border-bottom: Black 1.5pt solid">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name of witness</FONT></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: left; border-bottom: Black 1.5pt solid">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Address of witness</FONT></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: left; border-bottom: Black 1.5pt solid">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: left; border-bottom: Black 1.5pt solid">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: left; border-bottom: Black 1.5pt solid">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Occupation of witness</FONT></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: left; border-bottom: Black 1.5pt solid">&nbsp;</TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;</FONT></P>

<!-- Field: Page; Sequence: 33; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->31<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-transform: uppercase; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">schedule
5</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 191.4pt; text-transform: uppercase; text-align: left; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Form
of Resolutions</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Aptorum
Group Limited</B><BR>
<B>(the &ldquo;Company&rdquo;)</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>WRITTEN
RESOLUTIONS OF THE BOARD OF DIRECTORS</B> made pursuant to Article ____ of the Articles of Association of the Company<SUP>1</SUP></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>1.</B></FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>TRANSFER
                                         OF SHARES</B></FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>IT
IS RESOLVED</B> that the following transfers be approved, subject to stamping and that the Share Certificates be issued by the
Company in favour of the transferees:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 0.25in; background-color: White">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Transferor(s)</B></FONT></TD>
    <TD STYLE="width: 1%; text-align: center; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="width: 29%; font: 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Transferee(s)</B></FONT></TD>
    <TD STYLE="width: 1%; text-align: center; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="width: 29%; font: 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>No.
    of Shares</B></FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="background-color: White">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
</TABLE>
<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>2.</B></FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>REGISTER
                                         OF MEMBERS</B></FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">IT
IS RESOLVED that the Register of Members of the Company be updated to record the transfer of the shares to the transferee referred
to above and the secretary of the Company be hereby authorised and instructed to:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 18pt; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 21.25pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a.</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">update
                                         the original Register of Members to record the transferee as the registered holder of
                                         the relevant shares; and</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 18pt; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 21.25pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">b.</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">provide
                                         to the Transferee a copy of the updated extract of the Register of Members showing the
                                         holding of the Transferee only.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dated:
______________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 49%; text-align: left; padding-bottom: 1.5pt; border-bottom: Black 1.5pt solid">&nbsp;</TD>
    <TD STYLE="width: 2%; text-align: left; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="width: 49%; text-align: left; padding-bottom: 1.5pt; border-bottom: Black 1.5pt solid">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left">[Director]</TD>
    <TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: left">[Director]</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left">[Include signature blocks for all other Directors]</TD>
    <TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="margin-top: 0; margin-bottom: 0"></P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 0; margin-bottom: 0"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid; width: 25%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="margin-top: 0; margin-bottom: 0"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in; text-align: left"><SUP>1</SUP></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Note:
To be signed by all directors of the Company</FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<!-- Field: Page; Sequence: 34; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->32<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-transform: uppercase; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">schedule
6</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-transform: uppercase; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Form
of Deed of Undertaking</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;<B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Aptorum
Group Limited</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[Date]</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[&#9679;]</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dear
Sirs</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Aptorum
Group Limited (the &ldquo;Company&rdquo;)</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
refer to the share charge in respect of shares of the Company dated [&#9679;] 2018 between Jurchen Investment Corporation (the
&ldquo;<B>Chargor</B>&rdquo;), the Company and Peace Range Limited as Chargee (the &ldquo;<B>Chargee</B>&rdquo;) whereby, inter alia,
the Chargor, granted a charge over the Charged Property in favour of the Chargee (the &ldquo;<B>Charge</B>&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Capitalised
words and expressions used in this deed poll which are not expressly defined herein have the meanings ascribed to them in the
Charge.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
deed of undertaking and confirmation is given pursuant to the Charge.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
                                         valuable consideration receipt of which is hereby acknowledged, the Company hereby irrevocably
                                         and unconditionally undertakes to register (and hereby permits the Chargee or its nominee(s)
                                         or, as the case may be, the Company&rsquo;s registered agent if they have custody of the original
                                         Register of Members to register) in the Register of Members any and all share transfers
                                         to the Chargee or its nominee in respect of the Charged Property submitted to the Company
                                         by the Chargee in the event the Charge has become enforceable.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                         Company hereby confirms that it has instructed its registered agent to make an annotation
                                         of the existence of the Charge and the security interests created thereby in the Register
                                         of Members pursuant to the Charge.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                         Company hereby confirms that the Register of Members provided to the Chargee pursuant
                                         to the Charge is a certified copy of the original Register of Members and that the Company
                                         will not redesignate or otherwise seek to recreate the Register of Members.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>IN
WITNESS</B> whereof this deed poll has been executed by the parties on the day and year first above written.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 49%; text-align: left"><B>EXECUTED</B> as a <B>DEED</B> and <B>DELIVERED</B> by<BR>
 <B>APTORUM GROUP LIMITED:</B></TD>
    <TD STYLE="width: 2%; text-align: center"><P STYLE="margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></P>
                                              <P STYLE="margin-top: 0; margin-bottom: 0">)</P></TD>
    <TD STYLE="width: 49%; text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left">Director/authorised signatory signature: </TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: justify; border-bottom: Black 1.5pt solid">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left">Director/authorised signatory name:</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">Occupation:</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;</FONT></P>

<!-- Field: Page; Sequence: 35; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->33<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-transform: uppercase; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">schedule
7</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 191.4pt; text-transform: uppercase; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Form
of Letter of Instructions to Registered Agent</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Aptorum
Group Limited</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[Date]</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[Registered
Agent]</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[Address
details]</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">cc:</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[<B><I>Insert
name and address of Chargee</I></B>]</FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dear
Sirs</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Aptorum
Group Limited (the &ldquo;Company&rdquo;) &ndash; instructions to Registered Agent</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
                                         irrevocably instruct you that during the period starting from the date on which Peace
                                         Range Limited (the &ldquo;<B>New Instructing Party</B>&rdquo;) (or any of its successor
                                         in title) informs you that there has been an Event of Default (as defined in the share
                                         charge between Jurchen Investment Corporation as chargor, the Company and the New Instructing
                                         Party dated [&nbsp;&nbsp;&nbsp;] in respect of shares in the Company (the &ldquo;<B>Charge</B>&rdquo;))
                                         and ending on the date on which the New Instructing Party (or its successor-in-title)
                                         informs you that such Event of Default no longer subsists or has been waived, you will
                                         be irrevocably instructed to regard the New Instructing Party (or its successor-in-title)
                                         as the sole instructing party for the Company in relation to the shares the subject of
                                         the Charge and without limiting the foregoing if at any time the New Instructing Party
                                         instructs you to in relation to the shares the subject of the Charge register the New
                                         Instructing Party or its nominee (or any successor in title) as the registered holder
                                         of any of the shares the subject of the Charge you are hereby authorised and instructed
                                         to do so and update the original Register of Members of the Company accordingly without
                                         notice to us or consent from us.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
                                         irrevocably instruct you to make an annotation of the existence of the Charge and the
                                         security interests created thereby in the Company&rsquo;s Register of Members pursuant to the
                                         Charge, and to provide a copy of the undated, filed Register of Member to the New Instructing
                                         Party.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Please
confirm by countersigning below and returning a copy of such countersigned letter to us with a copy to the New Instructing Party
that you have received this correspondence and that you have actioned the above and updated your records accordingly.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Yours
faithfully</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
and on behalf of <B>Aptorum Group Limited</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>[Name
of Director]</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Director</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;&nbsp;&nbsp;&nbsp;</B></FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 40%; text-align: justify">Acknowledged and agreed.</TD>
    <TD STYLE="width: 60%; text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify; border-bottom: Black 1.5pt solid">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">[&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;]</TD>
    <TD STYLE="text-align: justify"></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">For and on behalf of</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify"><B>[Registered Agent]</B></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;&nbsp;</P>

<!-- Field: Page; Sequence: 36; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->34<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">SIGNATORIES
TO THE SHARE CHARGE</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>The
Chargor</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 49%; text-align: left"><B>EXECUTED</B> as a <B>DEED</B> and <B>DELIVERED</B> by<BR>
 <B>JURCHEN INVESTMENT CORPORATION</B>:</TD>
    <TD STYLE="width: 2%; text-align: center"><P STYLE="margin-top: 0; margin-bottom: 0; text-align: center">&nbsp;<FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT>&nbsp;</P><FONT STYLE="font-family: Times New Roman, Times, Serif">)</Font></TD>
    <TD STYLE="width: 49%; text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left">Director/authorised signatory signature: </TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: justify; border-bottom: Black 1.5pt solid">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left">Director/authorised signatory name:</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">Occupation:</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left">Witness signature: </TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: justify; border-bottom: Black 1.5pt solid">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left">Witness name:</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">Occupation:</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;</FONT></P>

<!-- Field: Page; Sequence: 37 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt; text-align: right">Project Life - Borrower Share Charge</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>The
Issuer</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 49%; text-align: left"><B>EXECUTED</B> as a <B>DEED</B> and <B>DELIVERED</B> by <B><BR>
APTORUM GROUP LIMITED:</B></TD>
    <TD STYLE="width: 2%; text-align: center"><P STYLE="margin-top: 0; margin-bottom: 0; text-align: center">&nbsp;<FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT>&nbsp;</P><FONT STYLE="font-family: Times New Roman, Times, Serif">)</Font></TD>
    <TD STYLE="width: 49%; text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left">Director/authorised signatory signature: </TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: justify; border-bottom: Black 1.5pt solid">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left">Director/authorised signatory name:</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">Occupation:</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left">Witness signature: </TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: justify; border-bottom: Black 1.5pt solid">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left">Witness name:</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">Occupation:</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<!-- Field: Page; Sequence: 38 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt; text-align: right">Project Life - Borrower Share Charge</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>The
Chargee</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 49%; text-align: left">Signed for and on behalf of </TD>
    <TD STYLE="width: 2%; text-align: center">)</TD>
    <TD STYLE="width: 49%; text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left"><FONT STYLE="text-transform: uppercase"><B>PEACE RANGE LIMITED </B></FONT>by</TD>
    <TD STYLE="text-align: center">)</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: center">)</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: justify; border-bottom: Black 1.5pt solid">&nbsp;</TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;Project Life - Borrower Share Charge</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 0; margin-bottom: 0"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.21
<SEQUENCE>25
<FILENAME>ff12018ex10-21_aptorum.htm
<DESCRIPTION>DEED OF GUARANTEE OF JURCHEN INVESTMENT CORPORATION, ACKNOWLEDGED BY PEACE RANGE LIMITED, DATED APRIL 25, 2018
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif; text-align: right"><B>Exhibit 10.21</B></P>

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; text-align: left">
    <TD STYLE="width: 33%; text-align: left"><IMG SRC="ex10-20_001.jpg" ALT="">&nbsp;</TD>
    <TD STYLE="width: 34%">&nbsp;</TD>
    <TD STYLE="width: 33%; text-align: right"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>EXECUTION
VERSION</B></FONT></TD></TR>
</TABLE>

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Deed
of Guarantee</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Jurchen
Investment Corporation</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">as
Guarantor of the Bonds issued by</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Aptorum
Group Limited</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">as
acknowledged by</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Peace
Range Limited</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">in
favour of the Bondholders</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">in
relation to USD15,000,000 8.00 per cent. <BR>
Convertible Bonds due 2019 convertible into <BR>
shares of Aptorum Group Limited</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">25
April 2018</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; text-align: center; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>CONTENTS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD COLSPAN="2" STYLE="padding-top: 0; padding-right: 0; font: 10pt Times New Roman, Times, Serif; padding-left: 0; text-align: left"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>CLAUSE</B></FONT></TD>
    <TD STYLE="padding-top: 0; padding-right: 0; border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding-left: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>PAGE</B></FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif; width: 8%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif; width: 85%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding: 0; text-align: center; font: 10pt Times New Roman, Times, Serif; width: 7%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.</FONT></TD>
    <TD STYLE="padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">INTERPRETATION</FONT></TD>
    <TD STYLE="padding: 0; text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD STYLE="padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding: 0; text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.</FONT></TD>
    <TD STYLE="padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">GUARANTEE
    AND INDEMNITY</FONT></TD>
    <TD STYLE="padding: 0; text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD STYLE="padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding: 0; text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.</FONT></TD>
    <TD STYLE="padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">PAYMENTS</FONT></TD>
    <TD STYLE="padding: 0; text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD STYLE="padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding: 0; text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.</FONT></TD>
    <TD STYLE="padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">UNDERTAKING
    TO REGISTER SECURITY</FONT></TD>
    <TD STYLE="padding: 0; text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD STYLE="padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding: 0; text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.</FONT></TD>
    <TD STYLE="padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">AMENDMENT
    AND TERMINATION</FONT></TD>
    <TD STYLE="padding: 0; text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD STYLE="padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding: 0; text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.</FONT></TD>
    <TD STYLE="padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">BENEFIT</FONT></TD>
    <TD STYLE="padding: 0; text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD STYLE="padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding: 0; text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">7.</FONT></TD>
    <TD STYLE="padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">GOVERNING
    LAW AND JURISDICTION</FONT></TD>
    <TD STYLE="padding: 0; text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5</FONT></TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P>

<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>THIS
DEED </B>is made on 25 April 2018</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>BETWEEN:</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 39pt; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</FONT></TD><TD STYLE="padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>JURCHEN
                                         INVESTMENT CORPORATION </B>(the <B>&ldquo;Guarantor&rdquo;</B>) of the bonds issued by</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 39pt; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</FONT></TD><TD STYLE="padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>APTORUM
                                         GROUP LIMITED </B>as issuer (the &ldquo;<B>Issuer</B>&rdquo;),</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>AS
ACKNOWLEDGED BY:</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 39pt; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3)</FONT></TD><TD STYLE="padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>PEACE
                                         RANGE LIMITED </B>as subscriber under the Subscription Agreement (the <B>&ldquo;Subscriber&rdquo;</B>).</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>IN
FAVOUR OF:</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 39pt; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(4)</FONT></TD><TD STYLE="padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>THE
                                         HOLDERS </B>for the time being and from time to time of the Bonds referred to below (each
                                         a &ldquo;<B>Bondholder&rdquo;</B> or the &ldquo;<B>holder</B>&rdquo; of a Bond).</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>RECITALS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 39pt; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(A)</FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                         Issuer proposes to issue USD15,000,000 principal amount of Bonds to be known as its 8.00
                                         per cent. Convertible Bonds due 2019 (the <B>&ldquo;Bonds&rdquo;</B>) convertible into
                                         Class A ordinary shares of the Issuer.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 39pt; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(B)</FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                         Guarantor has agreed to unconditionally and irrevocably guarantee to the Bondholders
                                         the payment of all sums expressed to be payable from time to time by the Issuer under
                                         the Bonds on the following terms and conditions.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 39pt; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(C)</FONT></TD><TD STYLE="padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                         parties hereto intend this document to take effect as a deed.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>THE
PARTIES AGREE AS FOLLOWS:</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 39pt; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.</FONT></TD><TD STYLE="padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>INTERPRETATION</B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 38pt; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.1</FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
                                         this Deed of Guarantee, unless otherwise defined herein, capitalised terms shall have
                                         the same meaning given to them in the terms and conditions of the Bonds (the <B>&ldquo;Conditions&rdquo;</B>).</FONT></TD></TR>                                                                                                                                                                        <TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0">&nbsp;</TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.2</FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">Headings
                                         </FONT>shall be ignored in construing this Deed of Guarantee.</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 38pt; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.3</FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">References
                                         in this Deed of Guarantee to this Deed of Guarantee or any other document are to this
                                         Deed of Guarantee or these documents as amended, supplemented or replaced from time to
                                         time in relation to the Bonds and includes any document that amends, supplements or replaces
                                         them.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 39pt; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.</FONT></TD><TD STYLE="padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>GUARANTEE
                                         AND INDEMNITY</B></FONT></TD></TR>                                                                           <TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.1</FONT></TD><TD STYLE="padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Guarantee</B></FONT></TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 39pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Guarantor unconditionally and irrevocably guarantees that if the Issuer does not pay any sum payable by it under the Bonds or
any Transaction Documents by the time and on the date specified for such payment (whether on the normal due date, on acceleration
or otherwise), the Guarantor shall pay that sum to each Bondholder before close of business on that date in the city to which
payment is so to be made. All payments under this Deed of Guarantee by the Guarantor shall be made subject to and in accordance
with the Conditions.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P>

<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 39pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.2</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Guarantor
as Principal Debtor</B></FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 39pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
between the Guarantor and the Bondholders but without affecting the Issuer&rsquo;s obligations, the Guarantor shall be
liable under this Deed of Guarantee as if it were the sole principal debtor and not merely a surety. Accordingly, its
obligations shall not be discharged, nor shall its liability be affected, by anything that would not discharge it or affect
its liability if it were the sole principal debtor, including (1) any time, indulgence, waiver or consent at any time given
to the Issuer or any other person, (2) any amendment to any other provisions of this Deed of Guarantee or the Conditions or
to any security or other guarantee or indemnity, (3) the making or absence of any demand on the Issuer or any other person
for payment, (4) the enforcement or absence of enforcement of this Deed of Guarantee, the Bonds or of any security or other
guarantee or indemnity, (5) the taking, existence or release of any security, guarantee or indemnity, (6)&nbsp; the
dissolution, amalgamation, reconstruction or reorganisation of the Issuer or (7) the illegality, invalidity or
unenforceability of or any defect in any provision of this Deed of Guarantee, the Bonds, any Transaction Documents or any of
the Issuer&rsquo;s obligations under any of them.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 39pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.3</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Guarantor&rsquo;s
Obligations Continuing</B></FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 39pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Guarantor&rsquo;s obligations under this Deed of Guarantee (i) are and shall remain in full force and effect by way of continuing security
until no sum remains payable under the Bonds, this Deed of Guarantee or any other Transaction Document and (ii) shall be released
upon the maturity, redemption and/or conversion of all of the Bonds. Furthermore, those obligations of the Guarantor are additional
to, and not instead of, any security or other guarantee or indemnity at any time existing in favour of any person, whether from
the Guarantor or otherwise and may be enforced without first having recourse to the Issuer, any other person, any security or
any other guarantee or indemnity. The Guarantor irrevocably waives all notices and demands of any kind.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 39pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.4</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exercise
of Guarantor&rsquo;s Rights</B></FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 39pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">So
long as any sum remains payable under the Bonds, this Deed of Guarantee or any Transaction Documents, the Guarantor shall not
exercise or enforce any right, by reason of the performance of any of its obligations under this Deed of Guarantee, to be indemnified
by the Issuer or to take the benefit of or enforce any security or other guarantee or indemnity.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 39pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.5</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Avoidance
of Payments</B></FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 39pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Guarantor shall on demand indemnify the Bondholders, on an after tax basis, against any cost, loss, expense or liability sustained
or incurred by it as a result of it being required for any reason (including any bankruptcy, insolvency, winding-up, dissolution
or similar law of any jurisdiction) to refund all or part of any amount received or recovered by it in respect of any sum payable
by the Issuer under the Bonds, this Deed of Guarantee or any other Transaction Document and shall in any event pay to it on demand
the amount as refunded by it.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 39pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.6</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Debts
of Issuer</B></FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 39pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">After
the occurrence of any Event of Default, the Guarantor shall procure that the Issuer shall not (except in the event of the liquidation
of the Issuer), so long as any amounts payable pursuant to the Bonds, this Deed of Guarantee and/or any other Transaction Document
remain unpaid, pay any moneys for the time being due from the Issuer to the Guarantor.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P>

<!-- Field: Page; Sequence: 4 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 39pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.7</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Indemnity</B></FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 39pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
separate, independent and alternative stipulations, the Guarantor unconditionally and irrevocably agrees: (1) that any sum that,
although expressed to be payable by the Issuer under the Bonds, this Deed of Guarantee and/or any other Transaction Document,
is for any reason (whether or not now existing and whether or not now known or becoming known to the Issuer, the Guarantor or
a Bondholder) not recoverable from the Guarantor on the basis of a guarantee shall nevertheless be recoverable from it as if it
were the sole principal debtor and shall be paid by it to the Bondholders on demand pursuant to the Bonds, this Deed of Guarantee
and/or any other Transaction Document; and (2) as a primary obligation to indemnify each Bondholder against any loss suffered
by it as a result of any sum expressed to be payable by the Issuer under the Bonds, this Deed of Guarantee and/or any other Transaction
Document not being paid on the date and otherwise in the manner specified in this Deed of Guarantee or in the Conditions or any
payment obligation of the Issuer under the Bonds, this Deed of Guarantee and/or any other Transaction Document being or becoming
void, voidable or unenforceable for any reason (whether or not now existing and whether or not now known or becoming known to
a Bondholder) other than fraud, wilful misconduct or gross negligence on the part of the Subscriber, the amount of that loss being
the amount expressed to be payable by the Issuer in respect of the relevant sum.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 39pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.8</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Incorporation
of Terms</B></FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 39pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Guarantor agrees that it will comply with and be bound by all such provisions contained in the Conditions which relate to it.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 39pt; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.</FONT></TD><TD STYLE="padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>PAYMENTS</B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 39pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.1</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Payments
Free of Taxes</B></FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 39pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Save
in respect of any amounts payable to the Bondholders for their own account, all payments by the Guarantor under this Deed of Guarantee
shall be made free and clear of, and without withholding or deduction for, any present or future taxes, duties, assessments or
governmental charges of whatever nature imposed, levied, collected, withheld or assessed by or within Hong Kong, the British Virgin
Islands, the Cayman Islands or the United States or any political subdivision or any authority therein or thereof having power
to tax, unless such withholding or deduction is required by law. In such event, the Guarantor shall pay such additional amounts
(<B>&ldquo;Additional Tax Amounts&rdquo;</B>) as will result in receipt by the Bondholders of such amounts as would have been received
by them had no such withholding or deduction been required, except that no Additional Tax Amounts shall be payable in respect
of any Bond:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 39.1pt; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 30.9pt; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT></TD><TD STYLE="padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Other
                                         connection</B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 70pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">to
a holder (or to a third party on behalf of a holder) who is liable to such taxes, duties, assessments or governmental charges
in respect of such Bond by reason of such holder having some connection with a Relevant Jurisdiction other than the mere holding
of the Bond or by the receipt of amounts in respect of the Bond; or</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 39.1pt; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 30.9pt; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT></TD><TD STYLE="padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Surrender
                                         more than 30 days after the Relevant Date</B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 70pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(in
the case of a payment of principal or premium) if the Bond Certificate in respect of such Bond is surrendered more than 30 days
after the Relevant Date except to the extent that the holder of it would have been entitled to such additional amounts on surrendering
the relevant Bond Certificate for payment on the last day of such period of 30 days; or</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 39.1pt; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 30.9pt; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)</FONT></TD><TD STYLE="padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Tax
                                         declaration</B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 70pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">for
or on account of any tax, assessment, withholding or deduction required by FATCA, any current or future U.S. Treasury
Regulations or rulings promulgated </FONT>thereunder, any intergovernmental agreement between the United States and any other
jurisdiction to implement FATCA, any law, regulation or other official guidance enacted or published in any jurisdiction
implementing FATCA or an intergovernmental agreement with respect thereto, or any agreement with the U.S. Internal Revenue
Service under FATCA.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P>

<!-- Field: Page; Sequence: 5 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 39pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.2</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Stamp
Duties</B></FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 39pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Guarantor will pay any stamp, issue, registration, documentary, transfer or other similar taxes and duties, including interest
and penalties, payable in the British Virgin Islands, Hong Kong, the Cayman Islands, the United States or any other relevant jurisdiction
or any political subdivision or taxing authority thereof or therein in respect of the execution or delivery of this Deed of Guarantee.
The Bondholders shall not be liable to pay any such taxes and duties in any jurisdiction and shall not be concerned with, or obligated
or required to enquire into, the sufficiency of any amount paid by the Guarantor for this purpose and shall not be liable for
any losses as a result of any non-payment by the Guarantor of any such taxes and duties in any jurisdiction. The Guarantor will
indemnify the Bondholders, on an after tax basis, from and against all stamp, issue, registration, documentary, transfer or other
similar taxes paid by any of them in any jurisdiction in connection with any action taken by or on behalf of the Bondholders to
enforce the Guarantor&rsquo;s obligations under this Deed of Guarantee.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 39pt; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.</FONT></TD><TD STYLE="padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>UNDERTAKING
                                         TO REGISTER SECURITY</B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 39pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Guarantor, as the chargor of the Share Charge granted in favour of the Subscriber, undertakes that it will as soon as reasonably
practicable and, in any event, within ten Business Days of the date of the Share Charge (i) register or cause to be registered
with the Registrar of Corporate Affairs in the BVI, and update of its register of charges with details of the security interests
created by, the Share Charge, in accordance with the BVI Business Companies Act, (ii) use its best endeavours to complete such
registration and obtain a registration record from its registered agent in the BVI and a certificate of registration of charge
from the Registrar of Corporate Affairs in the BVI, (iii) deliver to the Bondholders copies of such registration record, certificate
of registration of charge, and a certificate signed by a director or duly authorised officer of the Guarantor confirming the completion
of the registration of the Share Charge and (iv) comply with all applicable laws of the British Virgin Islands (&ldquo;<B>BVI laws</B>&rdquo;)
and regulations in relation to the Share Charge.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 39pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Guarantor together with the Issuer will give a notice to the Subscriber confirming the completion of the BVI Registration Conditions
within five Business Days after completion of such BVI Registration Conditions.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 39pt; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.</FONT></TD><TD STYLE="padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>AMENDMENT
                                         AND TERMINATION</B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 39pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Guarantor may not amend, vary, terminate or suspend this Deed of Guarantee or its obligations hereunder unless such amendment,
variation, termination or suspension shall have been approved by the Subscriber. Unless otherwise agreed mutually by the Subscriber
and the Guarantor, nothing in this clause 5 shall prevent the Guarantor from increasing or extending its obligations hereunder
by way of supplement to this Deed of Guarantee at any time.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 39pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
Deed of Guarantee, along with the Guarantor&rsquo;s obligations hereunder, shall terminate on the Expiration Date.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 39pt; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.</FONT></TD><TD STYLE="padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>BENEFIT</B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 39pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
Deed of Guarantee shall enure for the benefit of the Bondholders.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 6 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>




<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 39pt; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">7.</FONT></TD><TD STYLE="padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>GOVERNING
                                         LAW AND JURISDICTION</B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 39pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">7.1</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Governing
Law</B></FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 39pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
Deed of Guarantee shall be governed by and construed in accordance with Hong Kong laws.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 39pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">7.2</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Arbitration</B></FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 39.1pt; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 30.9pt; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Any
                                         dispute, controversy, difference or claim arising out of or relating to this Agreement,
                                         including the existence, validity, interpretation, performance, breach or termination
                                         thereof or any dispute regarding non-contractual obligations arising out of or relating
                                         to it shall be referred to and finally resolved by arbitration administered by the Hong
                                         Kong International Arbitration Centre (&ldquo;<B>HKIAC</B>&rdquo;) under the HKIAC Administered
                                         Arbitration Rules in force when the Notice of Arbitration is submitted.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 39.1pt; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 30.9pt; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT></TD><TD STYLE="padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                         law of this arbitration clause shall be Hong Kong law.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 39.1pt; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 30.9pt; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)</FONT></TD><TD STYLE="padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                         seat of arbitration shall be Hong Kong.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 39.1pt; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 30.9pt; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)</FONT></TD><TD STYLE="padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                         number of arbitrators shall be three. The arbitration proceedings shall be conducted
                                         in English.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 39.1pt; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 30.9pt; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)</FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
                                         the avoidance of doubt, any dispute, controversy, difference or claim arising out of
                                         or relating to the Account Charge or Share Charge shall be referred to and finally resolved
                                         by the courts of Hong Kong pursuant to the provisions of the Account Charge or Share
                                         Charge, as the case may be.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 39pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">7.3</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Independence
and Waiver of Immunity</B></FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 39pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Guarantor represents and warrants to and for the benefit of the Bondholders that (i)&nbsp; it is a separate legal and
independent entity organised under the laws of British Virgin Islands; and (ii) it has the capacity independently to assume
civil liabilities to the extent permitted by applicable laws. The Guarantor hereby waives any right to claim sovereign or
other immunity from jurisdiction or execution and any similar defence, and irrevocably consents to the giving of any relief
or the issue of any process, including, without limitation, the making, enforcement or execution against any property
whatsoever (irrespective of its use or intended use) of any order or judgment made or given in connection with any
Proceedings.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT>&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P>

<!-- Field: Page; Sequence: 7 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>IN
WITNESS </B>whereof this Deed of Guarantee has been executed and delivered as a deed on the date first above written.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>EXECUTION</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif; width: 60%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>EXECUTED
    </B>as a <B>DEED </B>and <B>DELIVERED </B>by</FONT></TD>
    <TD STYLE="padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif; width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</FONT></TD>
    <TD STYLE="padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif; width: 35%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>JURCHEN
    INVESTMENT CORPORATION:</B></FONT></TD>
    <TD STYLE="padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</FONT></TD>
    <TD STYLE="padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</FONT></TD>
    <TD STYLE="padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</FONT></TD>
    <TD STYLE="padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="padding-top: 0; padding-right: 0; font: 10pt Times New Roman, Times, Serif; padding-left: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director/authorised
    signatory signature:</FONT></TD>
    <TD STYLE="padding: 0 0 1.5pt; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-top: 0; padding-right: 0; border-bottom: Black 1.5pt solid; padding-left: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/
Ian Huen</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director/authorised
    signatory name:</FONT></TD>
    <TD STYLE="padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ian
    Huen</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Occupation:</FONT></TD>
    <TD STYLE="padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director</FONT></TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">DEED
OF GUARANTEE (SIGNATURE PAGE)</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P>

<!-- Field: Page; Sequence: 8 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif; width: 60%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>EXECUTED
    </B>as a <B>DEED </B>and <B>DELIVERED </B>by</FONT></TD>
    <TD STYLE="padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif; width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</FONT></TD>
    <TD STYLE="padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif; width: 35%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><B>APTORUM GROUP LIMITED:</B></TD>
    <TD STYLE="padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</FONT></TD>
    <TD STYLE="padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</FONT></TD>
    <TD STYLE="padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</FONT></TD>
    <TD STYLE="padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="padding-top: 0; padding-right: 0; font: 10pt Times New Roman, Times, Serif; padding-left: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director/authorised
    signatory signature:</FONT></TD>
    <TD STYLE="padding: 0 0 1.5pt; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-top: 0; padding-right: 0; border-bottom: Black 1.5pt solid; padding-left: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/
Ian Huen</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director/authorised
    signatory name:</FONT></TD>
    <TD STYLE="padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ian
    Huen</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Occupation:</FONT></TD>
    <TD STYLE="padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif">Executive Director &amp; CEO</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">DEED
OF GUARANTEE (SIGNATURE PAGE)</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 9 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">Acknowledged by:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><B>PEACE RANGE LIMITED</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; text-align: left">
    <TD STYLE="width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif">By:</FONT></TD>
    <TD STYLE="width: 35%; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">/s/ Paul Lincoln Heffner</FONT></TD>
    <TD STYLE="width: 60%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">Name:</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">Paul Lincoln Heffner</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">Title:</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">Director</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">DEED
OF GUARANTEE (SIGNATURE PAGE)</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 0; margin-bottom: 0"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.22
<SEQUENCE>26
<FILENAME>ff12018ex10-22_aptorum.htm
<DESCRIPTION>CHARGE ACCOUNT AGREEMENT BETWEEN THE COMPANY AND PEACE RANGE LIMITED, DATED APRIL 25, 2018
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif; text-align: right"><B>Exhibit 10.22</B></P>

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif; text-align: right">&nbsp;</P>

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif; text-align: right"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B><I>Execution version</I></B></P>

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif; text-align: left"><IMG SRC="ex10-21_001.jpg" ALT=""></P>

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Charge
over Accounts</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">APTORUM
GROUP LIMITED</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">as
Chargor</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">PEACE
RANGE LIMITED</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">as
Chargee</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">_________________
2018</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>




<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-transform: uppercase; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">CONTENTS</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-transform: uppercase; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>



<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; text-transform: uppercase">
    <TD COLSPAN="2" STYLE="text-align: left"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>CLAUSE</B></FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-top: 0; padding-right: 0; border-bottom: Black 1.5pt solid; padding-left: 0; text-align: center"><B>PAGE</B></TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; text-transform: uppercase; background-color: rgb(204,238,255)">
    <TD STYLE="width: 7%">1.</TD>
    <TD STYLE="width: 85%; text-align: left; text-indent: 0; padding: 0; font: 10pt Times New Roman, Times, Serif">Definitions
and Interpretation</TD>
    <TD STYLE="width: 7%; text-align: center; padding: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3</FONT></TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; text-transform: uppercase; background-color: White">
    <TD>2.</TD>
    <TD STYLE="text-align: left; text-indent: 0; padding: 0; font: 10pt Times New Roman, Times, Serif">Covenant to Pay</TD>
    <TD STYLE="text-align: center; padding: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">7</FONT></TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; text-transform: uppercase; background-color: rgb(204,238,255)">
    <TD>3.</TD>
    <TD STYLE="text-align: left; text-indent: 0; padding: 0; font: 10pt Times New Roman, Times, Serif">Charging Clause</TD>
    <TD STYLE="text-align: center; padding: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">7</FONT></TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; text-transform: uppercase; background-color: White">
    <TD>4.</TD>
    <TD STYLE="text-align: left; text-indent: 0; padding: 0; font: 10pt Times New Roman, Times, Serif">Further Assurance</TD>
    <TD STYLE="text-align: center; padding: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8</FONT></TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; text-transform: uppercase; background-color: rgb(204,238,255)">
    <TD>5.</TD>
    <TD STYLE="text-align: left; text-indent: 0; padding: 0; font: 10pt Times New Roman, Times, Serif">Representations and Warranties</TD>
    <TD STYLE="text-align: center; padding: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">9</FONT></TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; text-transform: uppercase; background-color: White">
    <TD>6.</TD>
    <TD STYLE="text-align: left; text-indent: 0; padding: 0; font: 10pt Times New Roman, Times, Serif">Undertakings &ndash; General</TD>
    <TD STYLE="text-align: center; padding: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10</FONT></TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; text-transform: uppercase; background-color: rgb(204,238,255)">
    <TD>7.</TD>
    <TD STYLE="text-align: left; text-indent: 0; padding: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">cONTROL
    Account</FONT></TD>
    <TD STYLE="text-align: center; padding: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">11</FONT></TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; text-transform: uppercase; background-color: White">
    <TD>8.</TD>
    <TD STYLE="text-align: left; text-indent: 0; padding: 0; font: 10pt Times New Roman, Times, Serif">Enforcement and powers
of the chargee</TD>
    <TD STYLE="text-align: center; padding: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">15</FONT></TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; text-transform: uppercase; background-color: rgb(204,238,255)">
    <TD>9.</TD>
    <TD STYLE="text-align: left; text-indent: 0; padding: 0; font: 10pt Times New Roman, Times, Serif">Attorney</TD>
    <TD STYLE="text-align: center; padding: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">16</FONT></TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; text-transform: uppercase; background-color: White">
    <TD>10.</TD>
    <TD STYLE="text-align: left; text-indent: 0; padding: 0; font: 10pt Times New Roman, Times, Serif">Extension and Variation
of Statutory Powers</TD>
    <TD STYLE="text-align: center; padding: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">16</FONT></TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; text-transform: uppercase; background-color: rgb(204,238,255)">
    <TD>11.</TD>
    <TD STYLE="text-align: left; text-indent: 0; padding: 0; font: 10pt Times New Roman, Times, Serif">Status, Powers, Removal
and Remuneration of Receiver</TD>
    <TD STYLE="text-align: center; padding: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">17</FONT></TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; text-transform: uppercase; background-color: White">
    <TD>12.</TD>
    <TD STYLE="text-align: left; text-indent: 0; padding: 0; font: 10pt Times New Roman, Times, Serif">Application of Enforcement
proceeds</TD>
    <TD STYLE="text-align: center; padding: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">19</FONT></TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; text-transform: uppercase; background-color: rgb(204,238,255)">
    <TD>13.</TD>
    <TD STYLE="text-align: left; text-indent: 0; padding: 0; font: 10pt Times New Roman, Times, Serif">Protection of Security</TD>
    <TD STYLE="text-align: center; padding: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">20</FONT></TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; text-transform: uppercase; background-color: White">
    <TD>14.</TD>
    <TD STYLE="text-align: left; text-indent: 0; padding: 0; font: 10pt Times New Roman, Times, Serif">Protection of third parties</TD>
    <TD STYLE="text-align: center; padding: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">23</FONT></TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; text-transform: uppercase; background-color: rgb(204,238,255)">
    <TD>15.</TD>
    <TD STYLE="text-align: left; text-indent: 0; padding: 0; font: 10pt Times New Roman, Times, Serif">Protection of Secured Parties</TD>
    <TD STYLE="text-align: center; padding: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">23</FONT></TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; text-transform: uppercase; background-color: White">
    <TD>16.</TD>
    <TD STYLE="text-align: left; text-indent: 0; padding: 0; font: 10pt Times New Roman, Times, Serif">Delegation</TD>
    <TD STYLE="text-align: center; padding: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">25</FONT></TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; text-transform: uppercase; background-color: rgb(204,238,255)">
    <TD>17.</TD>
    <TD STYLE="text-align: left; text-indent: 0; padding: 0; font: 10pt Times New Roman, Times, Serif">Costs and Expenses</TD>
    <TD STYLE="text-align: center; padding: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">25</FONT></TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; text-transform: uppercase; background-color: White">
    <TD>18.</TD>
    <TD STYLE="text-align: left; text-indent: 0; padding: 0; font: 10pt Times New Roman, Times, Serif">Set-off</TD>
    <TD STYLE="text-align: center; padding: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">26</FONT></TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; text-transform: uppercase; background-color: rgb(204,238,255)">
    <TD>19.</TD>
    <TD STYLE="text-align: left; text-indent: 0; padding: 0; font: 10pt Times New Roman, Times, Serif">Notices</TD>
    <TD STYLE="text-align: center; padding: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">26</FONT></TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; text-transform: uppercase; background-color: White">
    <TD>20.</TD>
    <TD STYLE="text-align: left; text-indent: 0; padding: 0; font: 10pt Times New Roman, Times, Serif">Changes to Parties</TD>
    <TD STYLE="text-align: center; padding: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">26</FONT></TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; text-transform: uppercase; background-color: rgb(204,238,255)">
    <TD>21.</TD>
    <TD STYLE="text-align: left; text-indent: 0; padding: 0; font: 10pt Times New Roman, Times, Serif">CURRENCY</TD>
    <TD STYLE="text-align: center; padding: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">27</FONT></TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; text-transform: uppercase; background-color: White">
    <TD>22.</TD>
    <TD STYLE="text-align: left; text-indent: 0; padding: 0; font: 10pt Times New Roman, Times, Serif">Miscellaneous</TD>
    <TD STYLE="text-align: center; padding: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">27</FONT></TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; text-transform: uppercase; background-color: rgb(204,238,255)">
    <TD>23.</TD>
    <TD STYLE="text-align: left; text-indent: 0; padding: 0; font: 10pt Times New Roman, Times, Serif">Governing Law</TD>
    <TD STYLE="text-align: center; padding: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">28</FONT></TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; text-transform: uppercase; background-color: White">
    <TD>24.</TD>
    <TD STYLE="text-align: left; text-indent: 0; padding: 0; font: 10pt Times New Roman, Times, Serif">ENFORCEMENT</TD>
    <TD STYLE="text-align: center; padding: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">28</FONT></TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; text-transform: uppercase; background-color: rgb(204,238,255)">
    <TD>25.</TD>
    <TD STYLE="text-align: left; text-indent: 0; padding: 0; font: 10pt Times New Roman, Times, Serif">Waiver of immunities</TD>
    <TD STYLE="text-align: center; padding: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">28</FONT></TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; text-transform: uppercase; background-color: White">
    <TD COLSPAN="2"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">schedule 1</FONT></TD>
    <TD STYLE="text-align: center; padding: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">29</FONT></TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD COLSPAN="2"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Control Account</FONT></TD>
    <TD STYLE="text-align: center; padding: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">29</FONT></TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; text-transform: uppercase; background-color: White">
    <TD COLSPAN="2"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">schedule 2</FONT></TD>
    <TD STYLE="text-align: center; padding: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">30</FONT></TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD COLSPAN="2"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Form of notice to Account Banks</FONT></TD>
    <TD STYLE="text-align: center; padding: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">30</FONT></TD></TR>
</TABLE>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>THIS
DEED</B> is made on ___________________ 2018</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif; text-transform: uppercase"><B>BETWEEN:</B></FONT></P>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 52px; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">(1)</FONT></TD>
    <TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>APTORUM
    GROUP LIMITED, </B>a Cayman Islands exempt company with company number 245310 and with Hong Kong business registration no.
    F0023235 and whose registered office is at c/o Campbells Corporate Services Limited, Floor 4, Willow House, Cricket Square,
    Grand Cayman KY1-9010, Cayman Islands (the <B>&ldquo;Chargor&rdquo;</B>); and</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 52px; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">(2)</FONT></TD>
    <TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>PEACE
    RANGE LIMITED </B>a limited liability company incorporated in the British Virgin Islands with company number 1839278 and whose
    registered address is at [ ] (the
    &ldquo;<B>Chargee</B>&rdquo; which expression shall include any person from time to time appointed as a successor, replacement
    or additional trustee in relation to the interests created by this deed).</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif; text-transform: uppercase"><B>RECITALS:</B></FONT></P>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 52px; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">(A)</FONT></TD>
    <TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">The
    Chargor has issued or will issue the Bonds.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 52px; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">(B)</FONT></TD>
    <TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">The
    Chargor and Chargee are entering into this deed in connection with the Bonds.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif; text-transform: uppercase"><B>THE
PARTIES AGREE AS FOLLOWS:</B></FONT></P>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 52px; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif; text-transform: uppercase">1.</FONT></TD>
    <TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif; text-transform: uppercase"><B>Definitions
    and Interpretation</B></FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 52px; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">1.1</FONT></TD>
    <TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Definitions</B></FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 52px; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">In
this deed:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 52px; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 52px; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>&ldquo;Account
Bank&rdquo;</B> means MUFG Bank, Ltd., Hong Kong Branch;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 52px; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 52px; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>&ldquo;Bonds&rdquo;
</B>means the US$15,000,000 aggregate principal amount of 8.00 per cent. convertible bonds due 2019 issued or to be issued by
the Chargor pursuant to the Subscription Agreement, which term shall include, unless the context requires otherwise, any further
bonds issued in accordance with Condition 16 (Further Issues) of the Conditions and consolidated and forming a single series therewith;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 52px; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 52px; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>&ldquo;Business
Days&rdquo;</B> has the meaning given to that term in the Conditions;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 52px; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 52px; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>&ldquo;Charged
Property&rdquo;</B> means the assets mortgaged, charged or assigned to the Chargee pursuant to clause 3 (Charging Clause) of this
deed;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 52px; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 52px; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>&ldquo;Companies
Ordinance&rdquo;</B> means the Companies Ordinance (Cap. 622) of the Laws of Hong Kong;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 52px; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 52px; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>&ldquo;Conditions&rdquo;
</B>has the meaning given to that term in the Bonds;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 52px; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 52px; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>&ldquo;Control
Account&rdquo;</B> means the bank account(s) listed in schedule 1 (Control Account) and any replacement account or any sub-division
or sub-account of those accounts;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 52px; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 52px; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>&ldquo;Conversion
Right&rdquo; </B>has the meaning given to that term in the Conditions;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 52px; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 52px; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>&ldquo;Conversion
Upon QIPO&rdquo; </B>has the meaning given to that term in the Conditions;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 52px; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 52px; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>&ldquo;CPO&rdquo;
</B>means the Conveyancing and Property Ordinance (Cap. 219) of the Laws of Hong Kong;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 52px; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 52px; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>&ldquo;Debt
Service Reserve&rdquo; </B>has the meaning given to that term in the Conditions;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 52px; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 52px; text-align: justify"></P>

<!-- Field: Page; Sequence: 3; Options: NewSection; Value: 3 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 52px; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 52px; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>&ldquo;Delegate&rdquo;
</B>means any delegate, agent, attorney or co-trustee appointed by the Chargee;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 52px; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 52px; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>&ldquo;Deposit&rdquo;
</B>means all monies in any currency together with all interest and other sums accruing thereon from time to time standing to
the credit of the Control Account and all rights of the Chargor in relation to the Control Account;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 52px; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 52px; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>&ldquo;Early
Redemption Date&rdquo;</B> has the meaning given to that term in the Conditions;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 52px; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 52px; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>&ldquo;Events
of Default&rdquo;</B> has the meaning given to that term in the Conditions;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 52px; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 52px; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>&ldquo;Extended
Maturity Date&rdquo; </B>has the meaning given to that term in the Conditions;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 52px; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 52px; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>&ldquo;Floating
Charge Asset&rdquo;</B> means an asset charged under clause 3.43.3 (Floating Charge);</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 52px; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 52px; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>&ldquo;Guarantor&rdquo;
</B>means JURCHEN INVESTMENT CORPORATION, a limited liability company incorporated in the British Virgin Islands whose registered
office is at c/o Vistra Corporate Services Centre, Wickhams Cay II, Road Town, Tortola, British Virgin Islands with company number
511328;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 52px; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 52px; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>&ldquo;Hong
Kong&rdquo;</B> means the Hong Kong Special Administrative Region of the People&rsquo;s Republic of China;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 52px; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 52px; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>&ldquo;Insolvency
Proceedings&rdquo;</B> means, in relation to the Chargor, any corporate action, legal proceedings or other procedure or step referred
to in Conditions 11(vi)(Security Enforced), 11(vii)(Winding-up) or 11(viii)(Insolvency) of the Conditions;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 52px; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 52px; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>&ldquo;Interest
Period&rdquo;</B> has the meaning given to that term in the Conditions;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 52px; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 52px; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>&ldquo;Issuer&rsquo;s
Redemption Price&rdquo;</B> has the meaning given to that term in the Conditions;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 52px; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 52px; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>&ldquo;Maturity
Date</B>&rdquo; has the meaning given to that term in the Conditions;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 52px; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 52px; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>&ldquo;Notice
of Potential Event of Default&rdquo;</B> has the meaning given to that term in the Conditions;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 52px; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 52px; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>&ldquo;Optional
Redemption&rdquo;</B> means the redemption of any Outstanding Bonds by the Chargor in accordance with Condition 9(b) of the Conditions;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 52px; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 52px; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>&ldquo;Outstanding&rdquo;
</B>has the meaning given to that term in the Conditions;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 52px; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 52px; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>&ldquo;Receiver&rdquo;
</B>means a receiver or receiver and manager or administrative receiver in each case appointed under this deed;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 52px; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 52px; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>&ldquo;Related
Rights&rdquo;</B> means, in relation to any asset:</FONT></P>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 52px; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 42px; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">(a)</FONT></TD>
    <TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">any
    monies and proceeds paid or payable in relation to that asset; and</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 52px; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 42px; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">(b)</FONT></TD>
    <TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">the
    benefit of all other rights, powers, claims, consents, contracts, warranties, security, guarantees, indemnities or covenants
    for title in respect of that asset;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 52px; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>&ldquo;Release
Conditions&rdquo;</B> has the meaning given to that term in in the Conditions;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 52px; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 52px; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>&ldquo;Relevant
Event Put Date&rdquo;</B> has the meaning given to that term in the Conditions;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 52px; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 52px; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>&ldquo;Scheduled
Maturity Date&rdquo; </B>has the meaning given to that term in the Conditions;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 52px; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 52px; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>&ldquo;Secured
Obligations&rdquo;</B> means all present and future obligations and liabilities (whether actual or contingent and whether owed
jointly or severally or in any other capacity whatsoever) of the Transaction Obligors to the Secured Parties under the Bonds and
the Transaction Documents;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 52px; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 52px; text-align: justify"></P>

<!-- Field: Page; Sequence: 4; Value: 3 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 52px; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 52px; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>&ldquo;Secured
Parties&rdquo;</B> means the Chargee, any Bondholder and any Receiver or Delegate;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 52px; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 52px; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>&ldquo;Security&rdquo;
</B>means a mortgage, charge, pledge, lien or other security interest securing any obligation of any person or any other agreement
or arrangement having a similar effect;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 52px; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 52px; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>&ldquo;Subscription
Agreement&rdquo;</B> means the subscription agreement dated 6 April 2018 between Aptorum Group Limited, JURCHEN INVESTMENT CORPORATION
and Peace Range Limited (as amended, supplemented or restated from time to time);</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 52px; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 52px; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>&ldquo;Tax&rdquo;
</B>means any tax, levy, impost, duty or other charge or withholding of a similar nature (including any penalty or interest payable
in connection with any failure to pay or any delay in paying any of the same);</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 52px; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 52px; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>&ldquo;Transaction
Documents&rdquo; </B>has the meaning given to that term in the Conditions; and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 52px; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 52px; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>&ldquo;Transaction
Obligors&rdquo; </B>means the Chargor and the Guarantor.</FONT></P>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 52px; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">1.2</FONT></TD>
    <TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Construction</B></FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 52px; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 42px; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">(a)</FONT></TD>
    <TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">In
    this deed, unless a contrary intention appears, a reference to:</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 94px; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 42px; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">(i)</FONT></TD>
    <TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">words
    and expressions defined in the Conditions have the same meanings when used in this deed unless otherwise defined in this deed;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 94px; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 42px; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">(ii)</FONT></TD>
    <TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">an
    <B>&ldquo;agreement&rdquo;</B> includes any legally binding arrangement, concession, contract, deed or franchise (in each case
    whether oral or written);</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 94px; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 42px; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">(iii)</FONT></TD>
    <TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">an
    <B>&ldquo;amendment&rdquo;</B> includes any amendment, supplement, variation, novation, modification, replacement or restatement
    and <B>&ldquo;amend&rdquo;</B>, <B>&ldquo;amending&rdquo; </B>and <B>&ldquo;amended&rdquo;</B> shall be construed accordingly;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 94px; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 42px; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">(iv)</FONT></TD>
    <TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>&ldquo;assets&rdquo;
    </B>includes present and future properties, revenues and rights of every description;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 94px; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 42px; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">(v)</FONT></TD>
    <TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">an
    <B>&ldquo;assignment&rdquo;</B> includes a novation, transfer and reassignment and retransfer and <B>&ldquo;assign&rdquo;</B>,
    <B>&ldquo;assigning&rdquo;</B> and <B>&ldquo;assigned&rdquo; </B>shall be construed accordingly;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 94px; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 42px; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">(vi)</FONT></TD>
    <TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">a
    <B>&ldquo;consent&rdquo;</B> includes an authorisation, approval, exemption, licence, order, permission or waiver;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 94px; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 42px; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">(vii)</FONT></TD>
    <TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">the
    <B>&ldquo;Chargee&rdquo;</B>, the <B>&ldquo;Chargor&rdquo;</B>, any <B>&ldquo;Secured Party&rdquo;, any &ldquo;Transaction Obligor&rdquo;
    </B>or any other person shall be construed so as to include its successors in title, permitted assignees and transferees;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 94px; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 42px; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">(viii)</FONT></TD>
    <TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">a
    <B>&ldquo;Bond&rdquo;</B> or a <B>&ldquo;Transaction Document&rdquo;</B> or any other agreement or instrument is a reference to
    that agreement or instrument as amended, novated, supplemented, extended, restated or replaced;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 94px; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 42px; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">(ix)</FONT></TD>
    <TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>&ldquo;including&rdquo;
    </B>means including without limitation and <B>&ldquo;includes&rdquo;</B> and <B>&ldquo;included&rdquo; </B>shall be construed
    accordingly;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 94px; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 42px; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">(x)</FONT></TD>
    <TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>&ldquo;losses&rdquo;
    </B>includes losses, actions, damages, claims, proceedings, costs, demands, expenses (including fees) and liabilities and
    <B>&ldquo;loss&rdquo;</B> shall be construed accordingly;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P>

<!-- Field: Page; Sequence: 5; Value: 3 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 94px; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 42px; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">(xi)</FONT></TD>
    <TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">a
    <B>&ldquo;person&rdquo;</B> includes any person, firm, company, corporation, government, state or agency of a state or any association,
    trust or partnership (whether or not having separate legal personality) or any two or more of the foregoing;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 94px; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 42px; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">(xii)</FONT></TD>
    <TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">a
    <B>&ldquo;regulation&rdquo;</B> includes any regulation, rule, official directive, request or guideline (whether or not having
    the force of law) of any governmental, intergovernmental or supranational body, agency, department or regulatory, self-regulatory
    or other authority or organisation;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 94px; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 42px; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">(xiii)</FONT></TD>
    <TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">a
    provision of law is a reference to that provision as amended or re-enacted;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 94px; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 42px; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">(xiv)</FONT></TD>
    <TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">any
    clause or schedule is a reference to, respectively, a clause of and schedule to this deed and any reference to this deed includes
    its schedules; and</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 52px; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 42px; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">(b)</FONT></TD>
    <TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">The
    parties intend that this document shall take effect as a deed, notwithstanding the fact that a party may only execute it under
    hand;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 52px; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 42px; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">(c)</FONT></TD>
    <TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">The
    index to and the headings in this deed are inserted for convenience only and are to be ignored in construing this deed;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 52px; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 42px; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">(d)</FONT></TD>
    <TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Words
    importing the plural shall include the singular and vice versa;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 52px; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 42px; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">(e)</FONT></TD>
    <TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Unless
    the context otherwise requires, a reference to a Charged Property includes:</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 94px; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 42px; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">(i)</FONT></TD>
    <TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">any
    part of that Charged Property; and</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 94px; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 42px; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">(ii)</FONT></TD>
    <TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">the
    proceeds of sale of that Charged Property;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 52px; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 42px; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">(f)</FONT></TD>
    <TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>&ldquo;$&rdquo;</B>,
    <B>&ldquo;US$&rdquo;</B>, <B>&ldquo;US dollar&rdquo; </B>and <B>&ldquo;US dollars&rdquo;</B>, denote lawful currency of the United
    States of America; and</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 52px; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 42px; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">(g)</FONT></TD>
    <TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">To
    the fullest extent permitted by law and unless a contrary indication applies, the following provisions of the CPO shall apply
    to this deed:</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 94px; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 42px; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">(i)</FONT></TD>
    <TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">section
    15 (Construction of words and expressions), as if this deed was an instrument affecting land (as that expression appears in
    the CPO);</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 94px; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 42px; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">(ii)</FONT></TD>
    <TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">section
    35(1) (Implied covenants) and Part V of the First Schedule as if:</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 135px; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 42px; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">(A)</FONT></TD>
    <TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">this
    deed was a legal charge (as that expression appears in the CPO);</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 135px; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 42px; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">(B)</FONT></TD>
    <TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">the
    expression &ldquo;charge&rdquo; in section 35(1)(e) was construed as &ldquo;mortgage, charge, assign or otherwise grant a security
    interest&rdquo;; and</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 135px; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 42px; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">(C)</FONT></TD>
    <TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">references
    in Part V of the First Schedule to the &ldquo;borrower&rdquo; were construed as references to the Chargor, to the &ldquo;lender&rdquo;
    were construed as references to the Chargee and to &ldquo;land&rdquo; were construed as references to anything in action, and
    any interest in real or personal property;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 94px; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 42px; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">(iii)</FONT></TD>
    <TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">section
    50 (Power to appoint receiver), as if:</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 135px; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 42px; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">(A)</FONT></TD>
    <TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">this
    deed was a legal charge, equitable mortgage and/or mortgage deed (as those expressions appear in the CPO); and</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P>

<!-- Field: Page; Sequence: 6; Value: 3 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 135px; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 42px; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">(B)</FONT></TD>
    <TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">references
    in section 50 to &ldquo;land&rdquo; were construed as references to anything in action, and any interest in real or personal
    property; and</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 94px; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 42px; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">(iv)</FONT></TD>
    <TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">section
    51 (Powers of mortgagee and receiver) and the Fourth Schedule as if:</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 135px; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 42px; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">(A)</FONT></TD>
    <TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">this
    deed was a legal charge, equitable mortgage and/or mortgage deed (as those expressions appear in the CPO); and</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 135px; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 42px; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">(B)</FONT></TD>
    <TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">references
    in the Fourth Schedule to &ldquo;land&rdquo; were construed as references to anything in action, and any interest in real or
    personal property</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 52px; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">1.3</FONT></TD>
    <TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Third
    party rights</B></FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 52px; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 42px; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">(a)</FONT></TD>
    <TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Any
    Receiver or Delegate will have the right to enforce the provisions of this deed which are given in its favour in accordance
    with the Contracts (Rights of Third Parties) Ordinance (Cap. 623) of the Laws of Hong Kong (the <B>&ldquo;Third Parties Ordinance&rdquo;</B>).</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 52px; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 42px; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">(b)</FONT></TD>
    <TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Subject
    to clause 1.3(a) and unless expressly provided to the contrary in a Bond or Transaction Document, a person who is not a party
    to this deed has no right under the Third Parties Ordinance to enforce or enjoy the benefit of any term of this deed.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 52px; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 42px; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">(c)</FONT></TD>
    <TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Notwithstanding
    any term of a Bond or Transaction Document, the consent of any person who is not a party (including any Receiver or Delegate)
    is not required to rescind or vary this deed at any time.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 52px; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif; text-transform: uppercase">2.</FONT></TD>
    <TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif; text-transform: uppercase"><B>Covenant
    to Pay</B></FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 52px; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">The
Chargor as primary obligor covenants with the Chargee that it will on demand pay the Secured Obligations when they fall due for
payment in the manner provided for in the Bonds and the Transaction Documents.</FONT></P>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 52px; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif; text-transform: uppercase">3.</FONT></TD>
    <TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif; text-transform: uppercase"><B>Charging
    Clause</B></FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 52px; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">3.1</FONT></TD>
    <TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Fixed
    Charges</B></FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 52px; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">The
Chargor, as legal and beneficial owner and as security for the payment and discharge of the Secured Obligations, charges in favour
of the Chargee by way of first fixed charge, all its present and future rights, title and interest in or to the Control Account,
the Deposit and all Related Rights.</FONT></P>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 52px; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">3.2</FONT></TD>
    <TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Fixed
    Security</B></FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 52px; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Clause
3.1 (Fixed Charges) shall be construed as creating a separate and distinct mortgage or fixed charge over each relevant asset within
any particular class of assets specified in this deed. Any failure to create effective fixed security (for whatever reason) over
any such asset under clause 3.1 (Fixed Charges) shall not affect the fixed nature of the security on any other asset specified
in this deed, whether within the same class of assets or not.</FONT></P>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 52px; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">3.3</FONT></TD>
    <TD STYLE="text-align: justify; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Floating
    Charge</B></FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 52px; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">As
further security for the payment and discharge of the Secured Obligations, the Chargor charges, as legal and beneficial owner,
in favour of the Chargee by way of first floating charge, all its present and future rights, title and interest in or to the Control
Account, the Deposit and all Related Rights to the extent not effectively charged by way of fixed charge under clause 3.1 (Fixed
Charges).</FONT></P>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="margin-top: 0; margin-bottom: 0"></P>

<!-- Field: Page; Sequence: 7; Value: 3 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 52px; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">3.4</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Conversion
    of Floating Charge</B></FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 52px; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">If:</FONT></P>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 52px; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 42px; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">(a)</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">an
    Event of Default has occurred;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 52px; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 42px; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">(b)</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">the
    Chargee is reasonably of the view that any legal process or execution is being enforced against any Floating Charge Asset
    or that any Floating Charge Asset is in danger of being seized or sold under any form of distress, attachment, execution or
    other legal process or otherwise in jeopardy;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 52px; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 42px; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">(c)</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">the
    Chargor fails to comply or takes or threatens to take any action which in the reasonable opinion of the Chargee is likely
    to result in it failing to comply with its obligations under clause 6.2 (Negative Pledge) or clause 6.3 (Disposal Restrictions);
    or</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 52px; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 42px; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">(d)</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">the
    Chargee reasonably considers that it is necessary to protect the priority of the security,</FONT> <FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 52px; text-align: justify">the
Chargee may, by written notice to the Chargor, convert the floating charge created under this deed into a fixed charge as regards
those assets which it specifies in the notice.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 52px; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">3.5</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Automatic
    Conversion of Floating Charge</B></FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 52px; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">If:</FONT></P>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 52px; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 42px; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">(a)</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">the
    Chargor creates (or purports to create) any Security in breach of clause 6.2 (Negative Pledge) over any Floating Charge Asset;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 52px; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 42px; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">(b)</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">any
    person levies or attempts to levy any distress, attachment, execution or other legal process against any Floating Charge Asset;
    or</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 52px; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 42px; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">(c)</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">an
Insolvency Proceeding in respect of the Chargor is commenced or has occurred,</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 52px; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
floating charge created under this deed over the relevant Floating Charge Asset will automatically and immediately be converted
into a fixed charge.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 52px; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif; text-transform: uppercase">4.</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif; text-transform: uppercase"><B>Further
    Assurance</B></FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 52px; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 42px; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">(a)</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">In
    addition and without prejudice to the covenant in paragraph 5 of Part V of the First Schedule to the CPO (as varied pursuant
    to this deed), the Chargor will, promptly following request by the Chargee, do all such acts and/or execute all such documents
    (including assignments, transfers, mortgages, charges, notices and instructions) as is necessary:</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 94px; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 42px; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">(i)</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">to
    perfect the Security created or intended to be created under or evidenced by this deed (which may include the execution of
    a mortgage, charge, assignment or other Security over all or any of the assets which are, or are intended to be, the subject
    of this deed) or for the exercise of any rights, powers and remedies of the Chargee or any Receiver provided by or pursuant
    to the Bonds or Transaction Documents or by law; and/or</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 94px; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 42px; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">(ii)</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">to
    facilitate the realisation of the assets which are, or are intended to be, the subject of the Security created by this deed.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 52px; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 42px; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">(b)</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">The
    Chargor shall take all such action (including making all filings and registrations) as may reasonably be necessary for the
    purpose of the creation, perfection, protection or maintenance of any Security conferred or intended to be conferred on the
    Chargee by or pursuant to this deed.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P>

<!-- Field: Page; Sequence: 8; Value: 3 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 52px; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">4.2</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Hong
    Kong Registration</B></FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 52px; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">The
Chargor shall ensure that details of the Security created by this deed are duly registered with the Companies Registry in Hong
Kong forthwith upon execution of this deed and in any event within one month of the date of this deed and to provide a certified
copy of the certificate of registration of charge upon receipt of such certificate and in any event within one month of the date
of this deed.</FONT></P>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 52px; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">4.3</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Cayman
    Register of Charges</B></FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 52px; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">The
Chargor shall, as soon as reasonably practicable after execution of this deed, and in any event within 5 Business Days of the
date of this deed, create and maintain a register of mortgages and charges (the &ldquo;<B>Register of Charges</B>&rdquo;) for the
Chargor (to the extent this has not already been done in accordance with section 52 of the Cayman Act) and instruct its registered
agent to enter particulars of the security created pursuant to this deed in the Register of Charges as required by section 54
of the Cayman Act and provide a certified copy of the Register of Charges to the Chargee within 10 Business Days after the date
of this Deed.</FONT></P>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 52px; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif; text-transform: uppercase">5.</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif; text-transform: uppercase"><B>Representations
    and Warranties</B></FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 52px; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">5.1</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Matters
    Represented</B></FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 52px; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">The
Chargor represents and warrants to the Chargee as set out this clause 5 (Representations and Warranties) on the date of this deed
and on each day the Secured Obligations remains outstanding with reference to the facts and circumstances then existing.</FONT></P>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 52px; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">5.2</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>General
    representations and warranties</B></FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 52px; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">The
Chargor represents and warrants to the Chargee with respect to itself in the terms as set out in clause 3 (Representations and
Warranties of the Issuer and Guarantor) of the Subscription Agreement, the provisions of which are incorporated herein <I>mutatis
mutandis</I> as if set out herein as if references therein to &ldquo;the Guarantor&rdquo; or the &ldquo;Issuer&rdquo; were a referent
to the Chargor, and references therein to &ldquo;the Transaction Documents&rdquo; or &ldquo;a Transaction Document&rdquo; were a referent
to the Bonds or Transaction Documents or a Transaction Document.</FONT></P>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 52px; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">5.3</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Governing
    Law and Enforcement</B></FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 52px; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 42px; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">(a)</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">The
    choice of governing law of this deed will be recognised and enforced in its jurisdiction of incorporation; and</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 52px; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 42px; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">(b)</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Any
    judgment obtained in relation to this deed in the jurisdiction of the governing law of this deed will be recognised and enforced
    in its jurisdiction of incorporation.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 52px; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">5.4</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Insolvency</B></FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 52px; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 42px; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">(a)</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">No
    Insolvency Proceedings has been taken or, to the knowledge of the Chargor, threatened in relation to it.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 52px; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 42px; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">(b)</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">No
    distress, attachment, execution or other legal decision is levied, enforced or sued out on or against substantially all of
    the property, assets or revenues (as applicable) of the Chargor having an aggregate value of at least US$400,000 and is not
    discharged or stayed within 30 days of having been so levied, enforced or sued out on.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P>

<!-- Field: Page; Sequence: 9; Value: 3 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 52px; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">5.5</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>No
    Filing or Stamp Taxes</B></FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 52px; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">It
is not necessary that this deed be filed, recorded or enrolled with any court or other authority or that any stamp, registration,
notarial or similar taxes or fees be paid on or in relation to this deed or the transactions contemplated by this deed except
for registration of this deed with the Hong Kong Companies Registry and payment of associated fees, which registration and fees
will be made and paid promptly after the date of this deed.</FONT></P>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 52px; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">5.6</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Deduction
    of Tax </B></FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 52px; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">It
is not required to make any deduction for or on account of Tax from any payment it may make under this deed.</FONT></P>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 52px; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">5.7</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Ranking</B></FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 52px; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">The
Security under this deed has the ranking in priority which it is expressed to have in and is not subject to any prior ranking
or pari passu ranking Security.</FONT></P>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 52px; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">5.8</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Non-Hong
    Kong Company</B></FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 52px; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">It
is registered as a Non-Hong Kong Company under (and as defined in) Part 16 of the Companies Ordinance.</FONT></P>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 52px; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">5.9</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Control
    Account</B></FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 52px; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 42px; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">(a)</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">It
    has full power to establish and maintain the Control Account and the Deposit;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 52px; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 42px; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">(b)</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">it
    is the legal and beneficial owner of the Charged Property;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 52px; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 42px; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">(c)</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">except
    as expressly permitted under the Bonds, it has not assigned, transferred or otherwise disposed the Charged Property (or its
    rights, title and interest to or in the Charged Property), either in whole or in part, nor agreed to do so; and</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 52px; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 42px; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">(d)</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">other
    than the Security created under this deed, no Security exists on or over all or any party of the Charged Property.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 52px; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif; text-transform: uppercase">6.</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif; text-transform: uppercase"><B>Undertakings
    &ndash; General</B></FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 52px; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">6.1</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Duration
    of Undertakings</B></FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 52px; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">All
of the undertakings given by the Chargor to the Chargee in this deed are given from the date of this deed and for so long as any
Security constituted by this deed remains in force.</FONT></P>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 52px; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">6.2</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Negative
    Pledge</B></FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 52px; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">The
Chargor will not create or agree to create or permit to subsist any Security over all or any part of the Charged Property, except
as expressly permitted under the Bonds or the Transaction Documents or with the prior written consent of the Chargee.</FONT></P>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 52px; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">6.3</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Disposal
    Restrictions</B></FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 52px; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">The
Chargor will not enter into a single transaction or a series of transactions (whether related or not) and whether voluntary or
involuntary to sell, lease, transfer, declare a trust over or otherwise dispose of all or any part of the Charged Property, except
as expressly permitted under the Bonds or the Transaction Documents or with the prior written consent of the Chargee.</FONT></P>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="margin-top: 0; margin-bottom: 0"></P>

<!-- Field: Page; Sequence: 10; Value: 3 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 52px; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">6.4</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Preservation
    of Charged Property</B></FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 52px; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 42px; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">(a)</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">The
    Chargor will observe and perform all covenants and stipulations under the Bonds and the Transaction Documents from time to
    time affecting the Charged Property, make all payments, carry out all registrations or renewals and generally take all steps
    which are necessary to preserve, maintain and renew when necessary; and</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 52px; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 42px; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">(b)</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">the
    Chargor will not vary any contract or other document relevant to its interest in any Charged Property where such variation
    would have a material adverse effect on the value of the relevant Charged Property or the rights of the Secured Parties under
    the Bonds or the Transaction Documents.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 52px; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">6.5</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Documents
    relating to Charged Property</B></FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 52px; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 42px; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">(a)</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Without
    prejudice to any specific requirements in this deed for the delivery of documents, the Chargor will promptly deliver to the
    Chargee all relevant documents relating to the Charged Property which the Chargee reasonably requires.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 52px; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 42px; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">(b)</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">The
    Chargee may retain any document delivered to it under this deed for so long as any Security constituted by this deed remains
    in force and, if for any reason it returns any document to the Chargor (or its nominee) before that time, it may by notice
    to the Chargor require that the relevant document be redelivered to it and the Chargor shall promptly comply (or procure compliance)
    with that notice.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 52px; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">6.6</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Information</B></FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 52px; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">The
Chargor shall provide to the Chargee, promptly on request, such information regarding the Control Account as the Chargee may reasonably
request.</FONT></P>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 52px; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">6.7</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Power
    to Remedy</B></FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 52px; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">If
the Chargor fails to comply with any undertaking given in this deed and that failure is not remedied to the reasonable satisfaction
of the Chargee within 30 days of the Chargor becoming aware of such breach or after written notice of such failure to comply has
been given to the Chargor by the Chargee notifying the Chargor that remedy is required, it will allow (and irrevocably authorises)
the Chargee, or any Delegate, to take any action on behalf of the Chargor which is necessary to ensure that those undertakings
are complied with.</FONT></P>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 52px; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif; text-transform: uppercase">7.</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif; text-transform: uppercase"><B>cONTROL
    Account</B></FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 52px; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">7.1</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Control
    Account</B></FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 52px; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 42px; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">(a)</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">The
    Chargor must establish on or prior to the date of this deed and thereafter maintain the Control Account with the Account Bank.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 52px; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 42px; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">(b)</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Prior
    to security becoming enforceable under this deed in accordance with clauses 8.1(a)(i) or 8.1(a)(ii) (Exercise of Enforcement
    Powers) or (in each case) prior to the Maturity Date, the Early Redemption Date, the Relevant Event Put Date or any other
    date on which the principal, interest or premium on the Bonds are payable by the Chargor pursuant to the Conditions, the Chargor
    and the Chargee shall have joint signing rights in relation to the Control Account provided that the prior written consent
    of the Chargee is required for the withdrawal or transfer of any funds from the Control Account permitted in accordance with
    the Bonds or Transaction Documents.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P>

<!-- Field: Page; Sequence: 11; Value: 3 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 52px; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 42px; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">(c)</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Upon
    security becoming enforceable under this deed in accordance with clauses 8.1(a)(i) or 8.1(a)(ii) (Exercise of Enforcement
    Powers) or (in each case) on or after the Maturity Date, the Early Redemption Date, the Relevant Event Put Date or any other
    date on which the principal, interest or premium on the Bonds are payable by the Chargor pursuant to the Conditions, the Chargee
    shall have sole signing rights in relation to the Control Account and may by delivering an enforcement notice notify the Account
    Bank that the Chargor no longer has any signing rights in relation to the Control Account and that the Chargee shall have
    the sole right and authority to instruct the Account Bank to withdraw, release or transfer funds from the Control Account.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 52px; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">7.2</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Deposits
    and Withdrawals</B></FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 52px; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 42px; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">(a)</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">The
    Chargor must ensure, on the Issue Date (subject to the Chargee subscribing and paying for the Bonds in accordance with the
    terms of the Subscription Agreement) that:</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 94px; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 42px; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">(i)</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">the
    entire Principal Amount of the Bonds; and</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 94px; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 42px; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">(ii)</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">an
amount in US dollars equal to the aggregate amount of interest due and payable for two consecutive Interest Periods commencing
from, and including, the Issue Date,</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 96px; text-align: justify">shall <FONT STYLE="font-family: Times New Roman, Times, Serif">be
deposited in the Control Account.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 52px; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 42px; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">(b)</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Subject
    to paragraphs (c), (e) and (f) of clause 7.2 (Deposits and withdrawals) below, for the purposes of the following:</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 94px; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 42px; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">(i)</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">the
    release of the Debt Service Reserve from the Control Account to the Bondholders in an amount sufficient to satisfy the Chargor&rsquo;s
    obligations to pay the principal, interest and premium in accordance with the Conditions; and/or</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 94px; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 42px; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">(ii)</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">following
the occurrence of a QIPO and any Bond being converted into Shares on a Conversion Upon QIPO or exercise of a Conversion Right
in accordance with the Conditions, the release of the Debt Service Reserve from the Control Account in an amount <I>pro rata </I>to
the principal amount of the Bond or Bonds being converted,</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 96px; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">the
Chargor may request the release from the Control Account, subject to the prior written consent of the Chargee being provided (such
consent not to be unreasonably withheld or delayed) and no Event of Default having occurred, such proceeds deposited in the Control
Account solely on satisfaction of the following requirements (the &ldquo;<B>Release Notice Requirements</B>&rdquo;):</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 135px; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 42px; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">(A)</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">delivery
    by the Chargor to the Bondholders of a written notice detailing satisfaction of the relevant Release Conditions in relation
    to the matters referred to in sub-paragraphs (b)(i) or (b)(ii) above (as the case may be), duly signed by any two directors
    or duly authorised officers of the Chargor (each, a &ldquo;<B>Release Notice</B>&rdquo;); and</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 135px; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 42px; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">(B)</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">each
    relevant Release Notice sets out the exact amounts of Debt Service Reserve to be released from the Control Account and, as
    the case may be, certifying that such amounts are or will be designated to be applied by the Chargor for all or any of the
    Permitted Use of Proceeds.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 94px; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">For
the purposes of this clause 7.2(b), satisfaction of the Release Notice Requirements shall be deemed to have occurred only upon
written confirmation being provided by the Chargee to the Chargor (such confirmation not to be unreasonably withheld or delayed).</FONT></P>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="margin-top: 0; margin-bottom: 0"></P>

<!-- Field: Page; Sequence: 12; Value: 3 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 52px; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 42px; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">(c)</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Provided
    that the Release Notice Requirements have been satisfied pursuant to clause 7.2(b) above:</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 94px; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 42px; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">(i)</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">the
    Debt Service Reserve (or the relevant part thereof) will be released from the Control Account on satisfaction of the requirements
    relating to the relevant Release Conditions specified in either clause 7.2(b)(i) or 7.2(b)(ii); and</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 94px; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 42px; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">(ii)</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">if
    any Bond has been converted into Shares or redeemed in accordance with the Conditions, the Debt Service Reserve (or the relevant
    part thereof) may be released from the Control Account on satisfaction of the requirements relating to the relevant Release
    Conditions specified in either clause 7.2(b)(i) or 7.2(b)(ii) in an amount <I>pro rata</I> to the principal amount of the
    Bond or Bonds being converted or redeemed, as the case may be.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 52px; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 42px; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">(d)</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">In
    the event that the Scheduled Maturity Date is extended to the Extended Maturity Date in accordance with Condition 9 of the
    Conditions, the Chargor shall ensure that the aggregate amount of interest due and payable for the Interest Period commencing
    on, and including, the Scheduled Maturity Date and ending on, and including, the Extended Maturity Date shall be made immediately
    available as a condition of such extension in the Control Account to the satisfaction of the Chargee.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 52px; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 42px; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">(e)</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
    the date falling two Business Days prior to each Interest Payment Date commencing on, and including <U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U>2018
    and ending on, and including the Scheduled Maturity Date and if the Scheduled Maturity Date is extended to the Extended Maturity
    Date in accordance with Condition 9 of the Conditions, the Extended Maturity Date, the Chargor may request the release from
    the Control Account, subject to the prior written consent of the Chargee being provided (such consent not to be unreasonably
    withheld or delayed) and no Event of Default having occurred, such amount of the proceeds deposited in the Control Account
    as is equal to the aggregate amount of interest due and payable on the immediately following Interest Payment Date or, as
    the case may be, the Scheduled Maturity Date or, if the Scheduled Maturity Date is extended to the Extended Maturity Date
    in in accordance with Condition 9 of the Conditions, the Extended Maturity Date, in accordance with Condition 6 of the Conditions
    and upon the release of such amounts from the Control Account with the consent of the Chargee, the Chargor shall pay such
    released amounts to the account of the Bondholders. For the avoidance of doubt, the release of any amounts from the Control
    Account under this clause 7.2(e) shall be subject to the requirement that, following any such release, the remaining amounts
    standing to the credit of the Control Account shall be no less than the aggregate amounts required to repay the Principal
    Amount of the Outstanding Bonds and balance of interest due and payable for the remaining Interest Periods.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 52px; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 42px; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">(f)</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">On
    the Maturity Date, the Early Redemption Date, the Relevant Event Put Date or any other date on which the principal, interest
    or premium on the Bonds are payable by the Chargor pursuant to the Conditions, the Chargor may request the release from the
    Control Account, subject to the prior written consent of the Chargee being provided (such consent not to be unreasonably withheld
    or delayed) and no Event of Default having occurred, the monies standing to the credit of the Control Account to be applied
    by the Chargee in or towards repayment or redemption of the Outstanding Bonds and/or in or towards payment of any other Secured
    Obligations.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 52px; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 42px; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">(g)</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Except
    as expressly allowed under the Bonds or Transaction Documents or otherwise with the prior written consent of the Chargee,
    the Chargor must not withdraw or transfer (and must not instruct the Account Bank to withdraw or transfer) any cash (including,
    for the avoidance of doubt, any interest paid or otherwise deposited into the Control Account).</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P>

<!-- Field: Page; Sequence: 13; Value: 3 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 52px; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 42px; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">(h)</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Notwithstanding
    any provision in any Bond or Transaction Document, if an Event of Default has occurred, the Chargee may, and is irrevocably
    authorised to, operate the Control Account by delivering an enforcement notice notifying the Account Bank in accordance with
    clause 7.1(c).</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 52px; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 42px; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">(i)</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Notwithstanding
    any provision in any Bond or Transaction Document, if a Notice of Potential Event of Default has been given in accordance
    with the Conditions, but prior to the occurrence of an Event of Default, the Chargee may allow the release of amounts from
    the Control Account pursuant to clauses 7.2(b), 7.2(c), 7.2(e) or 7.2(f) if the Chargor has exercised its right of an Optional
    Redemption under Condition 9(b) of the Conditions and the Chargee is satisfied that the Debt Service Reserve as at the date
    of such redemption is no less than the Issuer&rsquo;s Redemption Price.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 52px; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">7.3</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Miscellaneous
    Control Account Provisions</B></FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 52px; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 42px; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">(a)</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">The
    Chargor must ensure that the Control Account does not go into overdraft.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 52px; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 42px; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">(b)</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">The
    Chargor shall not change (or instruct the Account Bank to change) any bank mandate entered into and any authorised signatory
    appointed, in each case, on or prior to the date of this deed in respect of the Control Account, without the prior written
    consent of the Chargee.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 52px; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 42px; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">(c)</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">On
    the Maturity Date, the Early Redemption Date, the Relevant Event Put Date or any other date on which the principal, interest
    or premium on the Bonds are payable by the Chargor pursuant to the Conditions or at any time after circumstances in clauses
    8.1(a)(i) or 8.1(a)(ii) (Exercise of Enforcement Powers) has occurred, the monies standing to the credit of the Control Account
    may be applied by the Chargee in or towards repayment or redemption of the Bonds and/or in or towards payment of any other
    Secured Obligations (to the extent that the Chargor has not requested that such amounts be withdrawn and applied in accordance
    with clause 7.2(f) above. Without prejudice to the Chargee&rsquo;s rights under this clause 7.3(c), the Chargor shall on or prior
    to the Issue Date deliver a signed but undated irrevocable authority addressed to the Account Bank which provides for an irrevocable
    payment instruction to be given to the Account Bank to release and pay such amounts standing to the credit of the Control
    Account to the Chargee or to its order on the Maturity Date.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 52px; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 42px; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">(d)</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">No
    Secured Party is responsible or liable to any Transaction Obligor for:</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 95px; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 38px; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">(i)</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">any
    non-payment of any liability of a Transaction Obligor which could be paid out of moneys standing to the credit of the Control
    Account; or</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 95px; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 38px; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">any
withdrawal wrongly made, if made in good faith,</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 95px; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">unless
such non-payment or withdrawal is caused by the gross negligence, wilful misconduct or fraud of such Secured Party.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 52px; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 42px; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">(e)</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">The
    Chargor must, as soon as practicable and in any event, within five Business Days of any relevant request by the Chargee, supply
    the Chargee with the following information in relation to any payment received in the Control Account:</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 95px; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 38px; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">(i)</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">the
    date of payment or receipt;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 95px; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 38px; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">(ii)</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">the
    payer; and</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 95px; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 38px; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">(iii)</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">the
    purpose of the payment or receipt.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P>

<!-- Field: Page; Sequence: 14; Value: 3 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 52px; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 42px; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">(f)</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">The
    Control Account may earn interest at such rate as the Chargor may from time to time agree with the Account Bank at which the
    Control Account is held. Any such interest shall be deposited by the Account Bank into the Control Account as and when payable
    and shall form part of the Charged Property to be dealt with and applied in accordance with the terms of this deed.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 52px; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 42px; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">(g)</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Any
    operational costs and expenses or bank account service fees imposed or charged by the Account Bank in respect of the Control
    Account shall be agreed in writing with the Account Bank prior to the establishment of such account. If such costs, expenses
    and fees are to be borne by the Chargor, the Chargor shall settle such amounts with funds other than the Debt Service Reserve.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 52px; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">7.4</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Perfection
    of Control Account Security</B></FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 52px; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">The
Chargor will, following execution of this deed:</FONT></P>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 52px; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 42px; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">(a)</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">promptly
    give notice (substantially in the form set out in schedule 2 (Form of notice to Account Banks)) to the Account Bank of the
    Security created by this deed over those accounts and provide evidence reasonably satisfactory to the Chargee of the delivery
    of that notice; and</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 52px; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 42px; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">(b)</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">procure
    that the Account Bank promptly and in any event, on or prior to the Issue Date, acknowledges that notice by countersigning
    a copy of it and delivering that copy to the Chargee.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 52px; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif; text-transform: uppercase">8.</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif; text-transform: uppercase"><B>Enforcement
    and powers of the chargee</B></FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 52px; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">8.1</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Exercise
    of Enforcement Powers</B></FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 52px; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 42px; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">(a)</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">At
    any time after:</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 94px; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 42px; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">(i)</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">an
    Event of Default has occurred; or</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 94px; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 42px; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">(ii)</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a
written request from the Chargor to the Chargee that it exercise any of its powers under this deed,</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 94px; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
Security created by or pursuant to this deed is immediately enforceable and the Chargee may (in addition to giving notice in accordance
with the Conditions that the Bonds are and shall become immediately due and repayable) its absolute discretion, without any additional
notice:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 94px; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 42px; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">(iii)</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">at
    the times and in the manner it thinks fit, enforce all or any part of the Security and take possession of and hold, sell or
    otherwise dispose and/or deal with all or any part of the Charged Property (including whether for cash or non-cash consideration);</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 94px; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 42px; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">(iv)</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">to
    the extent applicable, exercise the power of sale and all other rights and powers conferred by this deed or by statute (as
    varied or extended by this deed) on the Chargee or on a Receiver, irrespective of whether the Chargee has taken possession
    or appointed a Receiver of the Charged Property; and</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 94px; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 42px; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">(v)</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">dispose
    of all or any of the Chargee&rsquo;s other rights under this deed for such consideration (whether payable or deliverable immediately
    or by instalments) and in such manner as the Chargee considers appropriate.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 52px; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 42px; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">(b)</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">For
    the purpose of all rights and powers implied or granted by statute, the Secured Obligations are deemed to have fallen due
    on the date of this deed. The power of sale and other powers conferred by the CPO and all other enforcement powers conferred
    by this deed shall be immediately exercisable at any time after the Security under this deed has become enforceable in accordance
    with clause 8.1 (Exercise of Enforcement Powers).</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P>

<!-- Field: Page; Sequence: 15; Value: 3 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 52px; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">8.2</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Appointment
    of Receiver</B></FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 52px; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">At
any time after the Security created by or pursuant to this deed has become enforceable under clause 8.1 (Exercise of Enforcement
Powers), or if the Chargor so requests the Chargee in writing at any time, the Chargee may (in addition to giving notice in accordance
with the Conditions that the Bonds are and shall become immediately due and repayable), without prior notice to the Chargor, by
deed, under seal or by writing under hand signed by any officer or manager of the Chargee, appoint any person (or persons) to
be a Receiver of all or any part of the Charged Property (including in respect of separate parts of the Charged Property). Any
restriction on the right of the Chargee to appoint a Receiver conferred by law does not apply to this deed.</FONT></P>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 52px; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif; text-transform: uppercase">9.</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif; text-transform: uppercase"><B>Attorney</B></FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 52px; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">9.1</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Appointment
    and power</B></FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 52px; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">The
Chargor, by way of security, irrevocably appoints the Chargee, each Receiver and any of its Delegates or sub-delegates and any
person nominated for the purpose by the Chargee or any Receiver (in writing and signed by an officer of the Chargee or Receiver)
as its attorney (with full power of substitution and delegation) in its name and on its behalf and as its act and deed to execute,
seal and deliver (using the company seal where appropriate) and perfect any deed, agreement or other instrument and to do any
act or thing:</FONT></P>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 52px; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 42px; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">(a)</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">which
    the Chargor is required to do by the terms of any Bond or Transaction Document (including the execution and delivery of deeds,
    charges, assignments or other security and any transfers of Charged Property and perfecting and/or releasing the Security
    created or intended to be created in respect of the Charged Property); and/or</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 52px; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 42px; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">(b)</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">which
    is for the purpose of enabling the exercise of any rights or powers conferred on the Chargee or any Receiver by any Bond or
    Transaction Document or by any applicable laws and regulations (including the exercise of any right of a legal or beneficial
    owner of the Charged Property).</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 52px; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">9.2</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Ratification</B></FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 52px; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">The
Chargor ratifies, confirms and agrees to ratify and confirm whatever any such attorney shall do in the exercise or purported exercise
of the power of attorney granted by it in clause 9.1 (Appointment and power).</FONT></P>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 52px; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif; text-transform: uppercase">10.</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif; text-transform: uppercase"><B>Extension
    and Variation of Statutory Powers</B></FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 52px; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">10.1</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Statutory
    Powers</B></FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 52px; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 42px; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">(a)</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">The
    powers conferred on mortgagees or receivers by statute shall apply to the Security created by this deed, unless they are expressly
    or impliedly excluded. If there is ambiguity or conflict between the powers conferred by statute and those contained in this
    deed, those contained in this deed shall prevail.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 52px; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 42px; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">(b)</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">The
    statutory power of sale, of appointing a Receiver and the other statutory powers conferred on mortgagees by section 51 (Powers
    of mortgagee and receiver) and section 53 (Sale by mortgagee) of the CPO and the Fourth Schedule (Powers of mortgagee and
    receiver) to the CPO as varied and extended by this deed shall arise on the date of this deed, and for that purpose the Secured
    Obligations are deemed to have fallen due on the date of this deed, and no restriction imposed by any ordinance or other statutory
    provision in relation to the exercise of any power of sale shall apply to this deed.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P>

<!-- Field: Page; Sequence: 16; Value: 3 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 52px; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 42px; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">(c)</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Each
    Receiver and Chargee is entitled to all the rights, powers, privileges and immunities conferred by law (including the CPO)
    on mortgagees and receivers duly appointed under any law (including the CPO).</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 52px; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">10.2</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Exercise
    of Powers</B></FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 52px; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Subject
to the terms of this deed, all or any of the powers conferred upon mortgagees by the CPO as varied or extended by this deed, and
all or any of the rights and powers conferred by this deed on a Receiver (whether expressly or impliedly), may be exercised by
the Chargee without further notice to the Chargor at any time after the Security under this deed has become enforceable in accordance
with clause 8.1 (Exercise of Enforcement Powers), irrespective of whether the Chargee has taken possession or appointed a Receiver
of the Charged Property.</FONT></P>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 52px; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">10.3</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Statutory
    restrictions disapplied</B></FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 52px; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">No
restriction imposed by any ordinance (including paragraph 11 of the Fourth Schedule to the CPO) or other statutory provision in
relation to the exercise of any power of sale, application of proceeds or any other right or on the consolidation of mortgages
or other security shall apply to the security constituted by this deed which powers may be exercised by the Chargee without notice
to the Chargor on or at any time after the Security under this deed has become enforceable in accordance with clause 8.1 (Exercise
of Enforcement Powers).</FONT></P>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 52px; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif; text-transform: uppercase">11.</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif; text-transform: uppercase"><B>Status,
    Powers, Removal and Remuneration of Receiver</B></FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 52px; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">11.1</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Receiver
    as Agent</B></FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 52px; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Each
Receiver shall be the agent of the Chargor which shall be solely responsible for his or her acts or defaults, and for his or her
remuneration and expenses, and be liable on any contracts, engagements, acts, omissions, defaults and losses of a Receiver and
the liabilities incurred by a Receiver. No Secured Party will incur any liability (either to the Chargor or to any other person)
by reason of the appointment of a Receiver or for any other reason, including for any misconduct, negligence or default of a Receiver.</FONT></P>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 52px; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">11.2</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Relationship
    with Chargee</B></FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 52px; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">To
the fullest extent allowed by law, any right, power or discretion conferred by this deed (either expressly or impliedly) or by
law on a Receiver may, after the Security created by or pursuant to this deed becomes enforceable under clause 8.1 (Exercise of
Enforcement Powers), be exercised by the Chargee in relation to any Charged Property without first appointing a Receiver and notwithstanding
the appointment of a Receiver.</FONT></P>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 52px; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">11.3</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Powers
    of Receiver</B></FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 52px; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Each
Receiver appointed under this deed shall have all the powers conferred from time to time on receivers by the CPO (which is deemed
incorporated in this deed), so that the powers set out in the Fourth Schedule to the CPO (to the extent not amended and/or varied
under this deed) shall extend to every Receiver. In addition, notwithstanding any winding up, dissolution or liquidation of the
Chargor, each Receiver shall have power to:</FONT></P>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 52px; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 42px; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">(a)</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">take
    immediate possession of, collect and get in the Charged Property (including rents and other income accruing from time to time);</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P>

<!-- Field: Page; Sequence: 17; Value: 3 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 52px; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 42px; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">(b)</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">sell,
    transfer, assign, vary the terms of, or otherwise deal with or realise all or any part of the Charged Property in such manner
    and generally on such terms as he thinks fit;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 52px; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 42px; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">(c)</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">borrow
    or raise money or incur any other liability in connection with the Charged Property on any terms for whatever purpose which
    the Receiver thinks fit, whether secured or unsecured, and whether to rank for payment in priority to this security or not;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 52px; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 42px; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">(d)</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">enter
    into bonds, covenants, guarantees, indemnities and other commitments in connection with the Charged Property and to make all
    payments needed to effect, maintain or satisfy them;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 52px; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 42px; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">(e)</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">manage
    and use the Charged Property and to exercise and do (or permit the Chargor or any nominee of it to exercise and do) all such
    powers, authorities, rights and things as the Receiver would be capable of exercising or doing if he were the absolute beneficial
    owner of the Charged Property;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 52px; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 42px; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">(f)</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">redeem
    any prior Security on or relating to the Charged Property and settle and pass the accounts of the person entitled to that
    prior Security, so that any accounts so settled and passed shall (subject to any manifest error) be conclusive and binding
    on the Chargor and the money so paid shall be deemed to be an expense properly incurred by the Receiver;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 52px; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 42px; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">(g)</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">appoint,
    hire and employ officers, employees, contractors, agents, advisors and others for any of the purposes of this deed and/or
    to protect or realise the Charged Property upon terms as to remuneration or otherwise as he may think fit and to discharge
    any such persons and any such persons appointed, hired or employed by the Chargor;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 52px; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 42px; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">(h)</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">bring,
    prosecute, enforce, defend and abandon any action, suit or proceedings in relation to any Charged Property and to submit to
    arbitration, negotiation, compromise which the Receiver thinks fit. A Receiver may also settle any applications, claims, accounts,
    disputes, questions and demands with or by any person who is or claims to be a creditor of the Chargor or relating to any
    of the Charged Property and in addition to take or defend proceeding for the compulsory winding-up of the Chargor;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 52px; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 42px; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">(i)</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">do
    all other acts and things (including signing and executing all documents and deeds) as the Receiver may consider to be desirable,
    conducive, incidental or conducive to any of the matters or powers in this clause 11.3 (Powers of Receiver) or provided under
    law, or otherwise incidental or conducive to the preservation, improvement or realisation of the Charged Property, and use
    the name of the Chargor for all such purposes;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 52px; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 42px; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">(j)</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">in
    the exercise of any of its powers, to spend such sums as it thinks fit and the Chargor shall within 3 Business Days on written
    demand repay to the Chargee or Receiver (as the case may be) all sums so spent together with interest on those sums at such
    rates as the Chargee may from time to time determine from the time they are paid or incurred and until repayment, those sums
    (together with such interest) shall be secured by this deed;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 52px; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 42px; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">(k)</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">give
    a valid receipt for any moneys and execute any assurance or thing which may be proper or desirable for realising any Charged
    Property;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 52px; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 42px; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">(l)</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">sell,
    exchange, convert into money and realise any Charged Property by public auction or private contract and generally in any manner
    and on any terms which the Receiver thinks fit. The consideration for any such transaction may consist of cash, debentures
    or other obligations, shares, stock or other valuable consideration and any such consideration may be payable in a lump sum
    or by instalments spread over any period which the Receiver thinks fit; and</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P>

<!-- Field: Page; Sequence: 18; Value: 3 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 52px; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 42px; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">(m)</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">to
do anything else he may think fit for the realisation of the Charged Property or incidental to the exercise of any of the rights
conferred on the Receiver under or by virtue of any Bond or Transaction Document to which the Chargor is party, the CPO, the Companies
Ordinance and other applicable statutory provisions and common law,</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 52px; text-align: justify">and <FONT STYLE="font-family: Times New Roman, Times, Serif">in
each case may use the name of the Chargor and exercise the relevant power in any manner which he may think fit.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 52px; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">11.4</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Removal
    of Receiver</B></FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 52px; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">The
Chargee may by notice remove from time to time any Receiver appointed by it and, whenever it may deem appropriate, appoint a new
Receiver in the place of any Receiver whose appointment has terminated, for whatever reason.</FONT></P>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 52px; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">11.5</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Remuneration
    of Receiver</B></FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 52px; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">The
Chargee may from time to time fix the remuneration of any Receiver appointed by it and the maximum rate imposed by any law will
not apply.</FONT></P>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 52px; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">11.6</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Several
    Receivers</B></FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 52px; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">If
at any time there is more than one Receiver, each Receiver may separately exercise all of the powers conferred by this deed and
to the exclusion of any other Receiver (unless the document appointing such Receiver states otherwise).</FONT></P>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 52px; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif; text-transform: uppercase">12.</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif; text-transform: uppercase"><B>Application
    of Enforcement proceeds</B></FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 52px; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">12.1</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Application
    of Proceeds</B></FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 57px; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 47px; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">(a)</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">All
    proceeds of enforcement (whether cash or non-cash) received or recovered by the Chargee or any Receiver pursuant to this deed
    shall (subject to any claims having priority under mandatory provisions of the CPO and other claims of any creditors mandatorily
    preferred by law) be applied in the following order:</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 104px; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 31px; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">(i)</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">first,
    in or towards the payment of all costs, losses, liabilities, expenses and remuneration of and incidental to the appointment
    of any Receiver or Delegate and the exercise of any of his rights, including his remuneration and all outgoings paid by him
    under or in connection with this deed; and</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 104px; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 31px; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">(ii)</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">secondly,
    in or towards payment pro rata of any accrued interest, fee or commission due but unpaid under the Bonds or Transaction Documents;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 104px; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 31px; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">(iii)</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">thirdly,
    in or towards payment pro rata of any principal due but unpaid under the Bonds or Transaction Documents;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 104px; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 31px; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">(iv)</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">fourthly,
    in or towards payment pro rata of any other Secured Obligations due but unpaid under the Bonds or Transaction Documents, and</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 104px; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 31px; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">(v)</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">fifthly,
    the balance (if any) after payment of the amounts referred to in paragraphs (a)(i) to (iv) of clause 12.1 (Application of
    Proceeds) above, in payment or distribution to the Chargor.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 7.7pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 104px; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">The
Chargee may vary the order as set out in paragraphs (a)(i) to (iv) of clause 12.1 (Application of Proceeds) above.</FONT></P>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="margin-top: 0; margin-bottom: 0"></P>

<!-- Field: Page; Sequence: 19; Value: 3 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 52px; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 42px; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">(b)</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">This
    clause 12.1 (Application of Proceeds) is subject to the payment of any claims having priority over this deed. This clause
    12.1 (Application of Proceeds) does not prejudice the right of any Secured Party to recover any shortfall from a Transaction
    Obligor.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 52px; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">12.2</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Application
    against Secured Obligations</B></FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 52px; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Subject
to clause 12.1 (Application of Proceeds), any moneys or other proceeds (whether cash or non-cash) received or realised by the
Chargee from the Chargor or a Receiver under this deed may be applied by the Chargee to any item of account or liability or transaction
forming part of the Secured Obligations to which they may be applicable in any order or manner which the Chargee may determine.</FONT></P>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 52px; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">12.3</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Suspense
    Account</B></FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 52px; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 42px; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">(a)</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">At
    any time after the Security under this deed has become enforceable in accordance with clause 8.1 (Exercise of Enforcement
    Powers), until the Secured Obligations are paid in full, each Secured Party may place and keep (to the extent possible and
    for such time as it shall determine) any recoveries or other proceeds of enforcement (whether cash or non-cash) received pursuant
    to this deed or otherwise on account of the Chargor&rsquo;s liability in respect of the Secured Obligations in a separate suspense
    account (to the credit of either the Chargor or the Chargee as the Chargee shall think fit) and the Receiver may retain the
    same for the period which he and the Chargee consider expedient, without having any obligation to apply all or any part of
    the same in or towards discharge of the Secured Obligations.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 52px; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 42px; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">(b)</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">If
    the Security created by this deed is enforced at a time when no amount is due under the Bonds or Transaction Documents but
    at the time when amounts may or will become due, a Secured Party may pay any recoveries or other proceeds of enforcement into
    a suspense account.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 52px; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif; text-transform: uppercase">13.</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif; text-transform: uppercase"><B>Protection
    of Security</B></FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 52px; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">13.1</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Continuing
    Security</B></FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 52px; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">The
Security created pursuant to this deed is to be a continuing security notwithstanding any intermediate payment or settlement of
all or any part of the Secured Obligations or any other matter or thing.</FONT></P>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 52px; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">13.2</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Other
    Security</B></FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 52px; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 42px; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">(a)</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">This
    security is to be in addition to, independent of and shall neither be merged in nor in any way exclude or prejudice or be
    affected by any other security or other right which the Chargee or any other Secured Party may now or after the date of this
    deed hold for any of the Secured Obligations or any other obligations, or any rights, powers and remedies provided by law
    and notwithstanding any receipt, release or discharge endorsed on or given in respect of or under any such other security.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 52px; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 42px; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">(b)</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">The
    Chargor waives any right it may have of first requiring the Chargee (or any trustee or agent on its behalf) to proceed against
    or enforce any other rights or security or claim payment from any person before claiming from the Chargor under this deed.
    This waiver applies irrespective of any law or any provision of a Bond or Transaction Document to the contrary.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P>

<!-- Field: Page; Sequence: 20; Value: 3 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 52px; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">13.3</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Cumulative
    Powers</B></FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 52px; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 42px; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">(a)</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">The
    powers which this deed confers on the Chargee and the other Secured Parties are cumulative, without prejudice to their respective
    powers under the general law, and may be exercised as often as the relevant person thinks appropriate.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 52px; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 42px; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">(b)</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">The
    Chargee and the other Secured Parties may, in connection with the exercise of their powers, join or concur with any person
    in any transaction, scheme or arrangement whatsoever.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 52px; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 42px; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">(c)</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">The
    respective powers of the Chargee and the other Secured Parties will in no circumstances be suspended, waived or otherwise
    prejudiced by anything other than an express consent or amendment.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 52px; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">13.4</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Amounts
    Avoided</B></FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 52px; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">If
any discharge, release or arrangement (whether in respect of the obligations of the Chargor or any security for those obligations
or otherwise) is made in whole or in part on the basis that any amount paid by the Chargor in respect of the Secured Obligations
is capable of being avoided or set aside on insolvency, liquidation or administration of the Chargor or otherwise, without limitation,
then amount shall not be considered to have been paid and the liabilities of the Chargor and the Security created pursuant to
this deed shall continue or be reinstated.</FONT></P>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 52px; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">13.5</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Discharge
    Conditional</B></FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 52px; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">If
any discharge or release arrangement (whether in respect of the obligations of the Chargor or any other Transaction Obligor, or
in respect of any security for those obligations or otherwise) is made by a Secured Party in whole or in part on the basis of
any payment, security or other disposition which is avoided or must be restored in insolvency, liquidation, administration or
otherwise, without limitation, then the liability of the Chargor under this deed will continue or be reinstated as if the discharge,
release or arrangement had not occurred.</FONT></P>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 52px; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">13.6</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Waiver
    of Defences</B></FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 52px; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">The
obligations assumed by the Chargor under this deed, the Security created under this deed and the rights, powers and remedies of
the Chargee provided by or pursuant to this deed or by law will not be affected by an act, omission, matter or thing which, but
for this provision, would reduce, release or prejudice any of its obligations under this deed (without limitation and whether
or not known to it or any Secured Party) including:</FONT></P>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 52px; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 42px; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">(a)</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">any
    time, waiver or consent granted to, or composition with, any person (including any Transaction Obligor);</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 52px; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 42px; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">(b)</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">the
    release of any person (including any Transaction Obligor) under the terms of any composition or arrangement;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 52px; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 42px; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">(c)</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">the
    taking, variation, compromise, exchange, renewal or release of, or refusal or neglect to perfect, take up or enforce, any
    rights against, or security over assets of, any person (including any Transaction Obligor);</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 52px; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 42px; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">(d)</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">any
    incapacity or lack of power, authority or legal personality of or dissolution or change in the members or status of any person
    (including any Transaction Obligor);</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 52px; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 42px; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">(e)</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">any
    amendment, novation, supplement, extension, restatement (however fundamental and whether or not more onerous) or replacement
    of a Bond or Transaction Document or any other document or security including without limitation any change in the purpose
    of, any extension of or any increase in any facility or the addition of any new facility under any Bond or Transaction Document
    or other document or security;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P>

<!-- Field: Page; Sequence: 21; Value: 3 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->21<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 52px; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 42px; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">(f)</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">any
    unenforceability, illegality or invalidity of any obligation of any person under any Bond or Transaction Document or any other
    document or security;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 52px; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 42px; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">(g)</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">any
    insolvency, liquidation, winding-up, provisional supervision, supervision, administration, receivership or similar proceedings;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 52px; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 42px; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">(h)</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">any
    other Security, guarantee or indemnity now or thereafter held by the Chargee or any other person in respect of the Secured
    Obligations or any other liabilities; or</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 52px; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 42px; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">(i)</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">any
    postponement, discharge, reduction, non-provability or other similar circumstance affecting any obligations of the Chargor
    or other person under any Bond or Transaction Document resulting from any insolvency, liquidation or dissolution proceedings
    or from any law, regulation or order.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 52px; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">13.7</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Chargor
    intention</B></FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 52px; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Without
prejudice to the generality of clause 13.6 (Waiver of defence), the Chargor expressly confirms that it intends that the Security
created pursuant to this deed shall extend from time to time to any (however fundamental) variation, increase, extension or addition
of or to any of the Bonds or Transaction Documents and/or any facility or amount made available under any of the Bonds or Transaction
Documents as agreed by the Chargor, and/or the Guarantor for the purposes of or in connection with any of the following: business
acquisitions of any nature; increasing working capital; enabling investor distributions to be made; carry out restructurings;
refinancing existing facilities; refinancing any other indebtedness; making facilities available to new borrower; any other variation
or extension of the purposes for which any such facility or amount might be made available from time to time; and any fees, costs
and/or expenses associated with any of the foregoing.</FONT></P>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 52px; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">13.8</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Deferral
    of rights</B></FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 52px; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Unless
otherwise permitted under the Bonds or Transaction Documents, until all the Secured Obligations have been irrevocably paid in
full and facilities which might give rise to Secured Obligations have been terminated and unless the Chargee otherwise directs,
the Chargor will not exercise any rights which it may have by reason of performance by it of its obligations under the Bonds or
Transaction Documents or by reason of any amount being payable, or liability arising, under this deed:</FONT></P>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 52px; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 42px; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">(a)</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">to
    be indemnified by any person;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 52px; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 42px; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">(b)</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">to
    claim any contribution from any other provider of Security for or any other guarantor of the Chargor&rsquo;s obligations under the
    Bonds or Transaction Documents;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 52px; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 42px; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">(c)</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">to
    take the benefit (in whole or in part and whether by way of subrogation or otherwise) of any rights of the Secured Parties
    under the Bonds or Transaction Documents or of any guarantee or other security taken pursuant to, or in connection with, the
    Bonds or Transaction Documents by any Secured Party;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 52px; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 42px; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">(d)</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">to
    bring legal or other proceedings for an order requiring any Secured Party to make any payment, or perform any obligation,
    in respect of which the Chargor has given a guarantee, undertaking or indemnity;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 52px; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 42px; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">(e)</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">to
    exercise any right of set-off against any person; and/or</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 52px; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 42px; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">(f)</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">to
    claim or prove as a creditor of any person in competition with any Secured Party.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 52px; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">If
the Chargor receives any benefit, payment or distribution in relation to such rights it shall hold that benefit, payment or distribution
to the extent necessary to enable all amounts which may be or become payable to the Secured Parties under or in connection with
the Bonds or Transaction Documents to be repaid in full on trust for the Secured Parties and shall promptly pay or transfer the
same to the Chargee or as the Chargee may direct for application in accordance with clause 12.1 (Application of proceeds).</FONT></P>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="margin-top: 0; margin-bottom: 0"></P>

<!-- Field: Page; Sequence: 22; Value: 3 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->22<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 52px; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">13.9</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Subsequent
    Security &ndash; Ruling-off Accounts</B></FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 52px; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">If
the Chargee or any other Secured Party receives notice of any subsequent Security or other interest affecting any of the Charged
Property (except as permitted by the Bonds or Transaction Documents) it may open a new account for the Chargor in its books. If
it does not do so then (unless it gives express notice to the contrary to the Chargor), as from the time it receives that notice,
all payments made by the Chargor to it shall (in the absence of any express appropriation to the contrary) be treated as having
been credited to a new account of the Chargor and not as having been applied in reduction of the Secured Obligations.</FONT></P>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 52px; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">13.10</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Redemption
    of Prior Charges</B></FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 52px; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">To
the extent applicable, the Chargee may redeem any prior Security on or relating to any of the Charged Property or procure the
transfer of that Security to itself, and may settle and pass the accounts of any person entitled to that prior Security. Any account
so settled and passed shall (subject to any manifest error) be conclusive and binding on the Chargor. The Chargor will on demand
pay to the Chargee all principal monies and interest and all costs, expenses and losses incidental to any such redemption or transfer.</FONT></P>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 52px; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif; text-transform: uppercase">14.</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif; text-transform: uppercase"><B>Protection
    of third parties</B></FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 52px; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">14.1</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>No
    Obligation to Enquire</B></FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 52px; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">No
purchaser from, or other person dealing with, the Chargee or any Receiver (or Delegate) shall be obliged or concerned to enquire
whether:</FONT></P>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 57px; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 47px; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">(a)</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">the
    right of the Chargee or any Receiver to exercise any of the powers conferred by this deed has arisen or become exercisable
    or as to the propriety or validity of the exercise or purported exercise of any such power; or</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 57px; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 47px; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">(b)</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">any
    of the Secured Obligations remains outstanding or be concerned with notice to the contrary and the title and position of such
    a purchaser or other person shall not be impeachable by reference to any of those matters.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 52px; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">14.2</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Receipt
    Conclusive</B></FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 52px; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">The
receipt of the Chargee or any Receiver shall be an absolute and a conclusive discharge to a purchaser, and shall relieve him of
any obligation to see to the application of any moneys or other consideration paid to or by the direction of the Chargee or any
Receiver.</FONT></P>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 52px; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif; text-transform: uppercase">15.</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif; text-transform: uppercase"><B>Protection
    of Secured Parties</B></FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 52px; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">15.1</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Liabilities
    of the Secured Parties</B></FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 52px; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Neither
the Chargee nor any Receiver or Delegate shall be liable in respect of any of the Charged Property or for any loss or damage which
arises out of the exercise or the attempted or purported exercise of, or the failure to exercise any of, their respective powers,
unless caused by its or his or her gross negligence, wilful misconduct or wilful breach of any obligations under the Bonds or
Transaction Documents. The Chargee will not be liable in respect of any gross negligence, wilful misconduct or fraud of a Receiver
or Delegate.</FONT></P>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="margin-top: 0; margin-bottom: 0"></P>

<!-- Field: Page; Sequence: 23; Value: 3 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->23<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 52px; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">15.2</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>No
    obligations in relation to Charged Property</B></FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 52px; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">The
Chargee is not obliged to do any of the following in respect of any Charged Property:</FONT></P>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 52px; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 42px; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">(a)</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">perform
    any obligation of the Chargor;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 52px; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 42px; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">(b)</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">make
    any payment;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 52px; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 42px; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">(c)</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">make
    any enquiry as to the nature or sufficiency of any payment received by it or the Chargor;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 52px; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 42px; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">(d)</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">present
    or file any claim or take any other action to collect or enforce the payment of any amount to which it or the Chargor may
    be entitled; or</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 52px; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 42px; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">(e)</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">exercise
    any rights to which it or the Chargor may be entitled under this deed or at law.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 52px; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">15.3</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Possession
    of Charged Property</B></FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 52px; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Without
prejudice to clause 15.1 (Liabilities of the Secured Parties), if the Chargee, any Delegate or any Receiver enters into possession
of the Charged Property, it will not be liable:</FONT></P>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 52px; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 42px; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">(a)</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">to
    account as mortgagee in possession or for any loss on realisation or enforcement of rights and may at any time at its discretion
    go out of such possession; or</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 52px; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 42px; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">(b)</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">for
    any default or omission for which a mortgagee in possession might be liable.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 52px; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">15.4</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Liability
    of the Chargor</B></FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 52px; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">The
Chargor shall be deemed to be a principal debtor and the sole, original and independent obligor for the Secured Obligations and
the Charged Property shall be deemed to be a principal security for the Secured Obligations. The liability of the Chargor under
this deed and the charges contained in this deed shall not be impaired by any forbearance, neglect, indulgence, extension of time,
release, surrender or loss of securities, dealing, variation or arrangement by the Chargee, or by any other act, event or matter
whatsoever whereby the liability of the Chargor (as a surety only) or the charges contained in this deed (as secondary or collateral
charges only) would, but for this provision, have been discharged.</FONT></P>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 52px; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">15.5</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Indemnity</B></FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 52px; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 42px; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">(a)</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">The
    Chargor shall promptly indemnify the Chargee and every Receiver and Delegate against any cost, loss or liability incurred
    (including legal fees) by any of them as a result of:</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 94px; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 42px; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">(i)</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">acting
    or relying on any notice, request or instruction which it reasonably believes to be genuine, correct and appropriately authorised;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 94px; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 42px; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">(ii)</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">the
    taking, holding, protection or enforcement of the security constituted by this deed;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 94px; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 42px; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">(iii)</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">the
    exercise of any of the rights, powers, discretions, authorities and remedies vested in the Chargee and each Receiver and Delegate
    by this deed or by law;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P>

<!-- Field: Page; Sequence: 24; Value: 3 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->24<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 94px; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 42px; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">(iv)</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">any
    default by the Chargor in the performance of any of the obligations expressed to be assumed by it in this deed;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 94px; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 42px; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">(v)</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">actual
    or alleged breach by any person of any law or regulation whether relating to the environment or otherwise) incurred in connection
    with this deed by any Secured Party, Receiver, attorney, manager, agent or other person appointed by the Chargee under this
    deed, including any arising from any actual or alleged breach by any person of any law or regulation, whether relating to
    the environment or otherwise;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 94px; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 42px; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">(vi)</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">having
    the Charged Property (or any part thereof) credited to any account maintained by the Chargee; or</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 94px; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 42px; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">(vii)</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">acting
    as Chargee, Receiver or Delegate (otherwise, in each case, than by reason of the relevant Chargee&rsquo;s, Receiver&rsquo;s or Delegate&rsquo;s
    respective gross negligence, wilful misconduct or fraud).</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 52px; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 42px; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">(b)</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">The
    Chargor expressly acknowledges and agrees that the continuation of its indemnity obligations under this clause 15.5 (Indemnity)
    will not be prejudiced by any release of security or disposal of any Charged Property.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 52px; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 42px; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">(c)</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">The
    Chargee and every Receiver and Delegate may, in priority to any payment to the other Secured Parties, indemnify itself out
    of the Charged Property in respect of, and pay and retain, all sums necessary to give effect to the indemnity in this clause
    15.5 (Indemnity).</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 52px; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">15.6</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Discretion</B></FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 52px; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Any
liberty or power which may be exercised by or any determination which may be made under this deed by the Chargee or any Receiver
may, subject to the provisions of the Bonds or Transaction Documents, be exercised or made in its absolute and unfettered discretion
without any obligation to give reasons.</FONT></P>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 52px; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif; text-transform: uppercase">16.</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif; text-transform: uppercase"><B>Delegation</B></FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 52px; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">The
Chargee or any Receiver may delegate by power of attorney or in any other manner all or any of the rights, powers, authorities
and discretions which are for the time being exercisable by it under this deed to any person or persons upon such terms and conditions
(including the power to sub-delegate) as it may think fit. Neither the Chargee nor any Receiver will be in any way responsible
or liable to the Chargor or any other person for any cost, expense, loss or liability arising from any act, default, omission
or misconduct on the part of any Delegate or sub-delegate.</FONT></P>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 52px; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif; text-transform: uppercase">17.</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif; text-transform: uppercase"><B>Costs
    and Expenses</B></FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 52px; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">17.1</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Initial
    Expenses</B></FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 52px; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">The
provisions of clause 12 (Expenses and Payments) of the Subscription Agreement shall be deemed incorporated into this deed as if
fully set out herein <I>mutatis mutandis</I> as if any reference therein to the Bonds or the Transaction Documents were a reference
to this deed and any reference to the &ldquo;Issuer&rdquo; were a reference to the Chargor.</FONT></P>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 52px; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">17.2</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Enforcement
    and preservation Expenses</B></FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 52px; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">If
the Security under this deed has become enforceable in accordance with clause 8.1 (Exercise of Enforcement Powers), the Chargor
shall, within 3 Business Days of demand, pay to each of the Secured Party the amount of all costs and expenses (including legal
fees) incurred by it in connection with the enforcement of or the preservation of any rights under any Bond or Transaction Document
and any proceedings instituted by or against that Secured Party as a consequence of it entering into a Bond or Transaction Document,
taking or holding the Security created pursuant to this deed or enforcing these rights.</FONT></P>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="margin-top: 0; margin-bottom: 0"></P>

<!-- Field: Page; Sequence: 25; Value: 3 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->25<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 52px; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">17.3</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Stamp
    Taxes</B></FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 52px; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">The
Chargor shall:</FONT></P>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 52px; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 42px; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">(a)</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">pay
    all stamp duty, registration and other similar Taxes payable in respect of this deed; and</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 52px; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 42px; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">(b)</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">within
    3 Business Days of written demand by the Chargee, indemnify the Chargee against any cost, loss or liability that the Chargee
    incurs in relation to any stamp duty, registration or other similar Tax paid or payable in respect of this deed.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 52px; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">17.4</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Default
    Interest</B></FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 52px; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">The
provisions of Condition 6(b) (Interest applicable upon Default) of the Conditions shall be deemed incorporated into this deed
as if fully set out herein <I>mutatis mutandis</I> as if any reference therein to &ldquo;this Condition&rdquo; or the Bonds were
a reference to this deed and as if any reference therein to the &ldquo;Bondholder&rdquo; were a reference to the Chargee.</FONT></P>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 52px; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif; text-transform: uppercase">18.</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif; text-transform: uppercase"><B>Set-off</B></FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 52px; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 42px; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">(a)</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Any
    Secured Party may set off any matured obligation due from the Chargor under the Bonds or Transaction Documents (to the extent
    beneficially owned by that Secured Party) against any balance standing to the credit of the Control Account (notwithstanding
    any specified maturity of any such deposit) and any matured obligation owed by that Secured Party to the Chargor, regardless
    of the place of payment, booking branch or currency of either obligation. If the obligations are in different currencies,
    the Secured Party may convert either obligation at a market rate of exchange in its usual course of business for the purpose
    of the set-off.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 52px; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 42px; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">(b)</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">If
    the relevant obligation or liability of the Chargor is unliquidated or unascertained, the Secured Party may set-off the amount
    which it estimates (in good faith) will be the final amount of that obligation or liability once it becomes liquidated or
    ascertained.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 52px; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif; text-transform: uppercase">19.</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif; text-transform: uppercase"><B>Notices</B></FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 52px; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Clause
15 (Communications) of the Subscription Agreement shall be deemed incorporated into this deed as if fully set out herein <I>mutatis
mutandis</I>.</FONT></P>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 52px; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif; text-transform: uppercase">20.</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif; text-transform: uppercase"><B>Changes
    to Parties</B></FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 52px; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">20.1</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Assignment
    by the Chargee</B></FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 52px; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">The
Chargee may at any time assign or otherwise transfer all or any part of its rights under this deed to other Bondholders or any
third parties in accordance with the Bonds or Transaction Documents.</FONT></P>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 52px; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">20.2</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Changes
    to Parties</B></FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 57px; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 47px; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">(a)</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">The
    Chargor authorises and agrees to change the parties under Condition 3(b) (Transfer) of the Conditions and authorises the Chargee
    to execute on its behalf any document required to effect the necessary transfer of rights or obligations contemplated by those
    provisions.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 57px; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 47px; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">(b)</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">The
    Chargor may not assign, novate, transfer, sub-participate, encumber, declare a trust over or otherwise deal with all or any
    of its rights and/or obligations under this deed.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P>

<!-- Field: Page; Sequence: 26; Value: 3 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->26<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 52px; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif; text-transform: uppercase">21.</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif; text-transform: uppercase"><B>CURRENCY</B></FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 52px; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">21.1</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Conversion</B></FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 52px; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">All
monies received or held by the Chargee or any Receiver under this deed may be converted into any other currency which the Chargee
considers necessary to discharge any obligations and liabilities comprised in the Secured Obligations in that other currency at
a market rate of exchange then prevailing.</FONT></P>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 52px; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">21.2</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>No
    Discharge</B></FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 52px; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">No
payment to the Chargee (whether under any judgment or court order or otherwise) shall discharge any obligation or liability of
the Chargor in respect of which it was made unless and until the Chargee has received payment in full in the currency in which
the obligation or liability is payable or, if the currency of payment is not specified, was incurred. To the extent that the amount
of any such payment shall on actual conversion into that currency fall short of that obligation or liability expressed in that
currency, the Chargee shall have a further separate cause of action in relation to the shortfall and shall be entitled to enforce
the Security constituted by this deed to recover the amount of the shortfall.</FONT></P>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 52px; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif; text-transform: uppercase">22.</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif; text-transform: uppercase"><B>Miscellaneous</B></FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 52px; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">22.1</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Certificates
    Conclusive</B></FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 52px; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Provided
that calculation in reasonable detail has been provided, a certificate or determination of the Chargee as to any amount or rate
under this deed will be conclusive and binding on the Chargor, in the absence of manifest error.</FONT></P>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 52px; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">22.2</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Invalidity
    of any Provision</B></FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 52px; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">If
any provision of this deed is or becomes invalid, illegal or unenforceable in any respect under any law, the validity, legality
and enforceability of the remaining provisions shall not be affected or impaired in any way.</FONT></P>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 52px; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">22.3</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Counterparts</B></FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 52px; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">This
deed may be executed in any number of counterparts, and this has the same effect as if the signatures on the counterparts were
on a single copy of this deed.</FONT></P>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 52px; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">22.4</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Failure
    to Execute</B></FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 52px; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Failure
by one or more parties (<B>&ldquo;Non-Signatories&rdquo;</B>) to execute this deed on the date hereof will not invalidate the provisions
of this deed as between the other parties who do execute this deed. Such Non-Signatories may execute this deed on a subsequent
date and will thereupon become bound by its provisions.</FONT></P>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 52px; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">22.5</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Covenant
    to Release</B></FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 52px; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Once
all the Secured Obligations have been paid in full and none of the Chargee nor any Secured Party has any actual or contingent
liability to advance further monies to the Transaction Obligors under the Bonds or Transaction Documents, or incur liability,
but not otherwise, the Chargee and each other Secured Party shall, at the request and cost of the Chargor, take any action which
may be necessary to release the Charged Property from the Security constituted by this deed and procure the reassignment to the
Chargor of the property and assets assigned to the Chargee pursuant to this deed (in each case subject to clause 13.4 (Amounts
Avoided)) and without recourse to, or any representation or warranty by, the Chargee or any of its nominees.</FONT></P>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="margin-top: 0; margin-bottom: 0"></P>

<!-- Field: Page; Sequence: 27; Value: 3 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->27<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 52px; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif; text-transform: uppercase">23.</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif; text-transform: uppercase"><B>Governing
    Law</B></FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 52px; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">This
deed is governed by the laws of Hong Kong.</FONT></P>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 52px; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif; text-transform: uppercase">24.</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif; text-transform: uppercase"><B>ENFORCEMENT</B></FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 52px; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 42px; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">(a)</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">The
    courts of Hong Kong are to have exclusive jurisdiction to settle any disputes which may arise out of or in connection with
    this deed and accordingly any legal action or proceedings arising out of or in connection with this deed (&ldquo;<B>Proceedings</B>&rdquo;)
    may be brought in such courts. The Chargor irrevocably submits to the jurisdiction of such courts and has waived any objection
    to Proceedings in any such courts whether on the ground of venue or on the ground that the Proceedings have been brought in
    an inconvenient forum.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 52px; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 42px; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">(b)</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">This
    clause 24 (Enforcement) is for the benefit of the Chargee only. As a result, the Chargee shall not be prevented from taking
    proceedings relating to any Proceedings in any other courts with jurisdiction. To the extent allowed by law, the Chargee may
    take concurrent proceedings in any number of jurisdictions.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 52px; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif; text-transform: uppercase">25.</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif; text-transform: uppercase"><B>Waiver
    of immunities</B></FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 52px; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">The
Chargor irrevocably waives, to the extent permitted by applicable law, with respect to itself and its revenues and assets (irrespective
of their use or intended use), all immunity on the grounds of sovereignty or other similar grounds from:</FONT></P>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 52px; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 42px; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">(a)</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">suit;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 52px; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 42px; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">(b)</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">jurisdiction
    of any court;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 52px; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 42px; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">(c)</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">relief
    by way of injunction or order for specific performance or recovery of property;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 52px; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 42px; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">(d)</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">attachment
    of its assets (whether before or after judgment); and</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 52px; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 42px; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">(e)</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">execution
    or enforcement of any judgment to which it or its revenues or assets might otherwise be entitled in any proceedings in the
    courts of any jurisdiction (and irrevocably agrees, to the extent permitted by applicable law, that it will not claim any
    immunity in any such proceedings).</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>IN
WITNESS</B> whereof this deed has been duly executed and delivered on the date first above written.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P>

<!-- Field: Page; Sequence: 28; Value: 3 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->28<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif; text-transform: uppercase"><B>schedule
1&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif; text-transform: uppercase"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Control
Account</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Account Bank</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt; text-align: center">&nbsp;</TD>
    <TD STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Name of Control Account</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt; text-align: center">&nbsp;</TD>
    <TD STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Account Number</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 33%; text-align: left; padding-bottom: 1.5pt; vertical-align: top"></TD><TD STYLE="width: 1%; text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="width: 33%; text-align: center; padding-bottom: 1.5pt; vertical-align: top">&nbsp;</TD><TD STYLE="width: 1%; text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="width: 32%; text-align: center; padding-bottom: 1.5pt; vertical-align: top"></TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"></P>

<!-- Field: Page; Sequence: 29 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>schedule
2</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif; text-transform: uppercase"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Form
of notice to Account Banks</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">To:</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">MUFG
Bank, Ltd., Hong Kong Branch</FONT></TD>
</TR>     <TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: justify"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Date:
____________________ 2018</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Dear
Sirs,</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">We
hereby give you notice that by an account charge (as amended, supplemented or restated from time to time, the &ldquo;<B>Account
Charge</B>&rdquo;) dated __________________________ 2018 between (1) Aptorum Group Limited (the &ldquo;<B>Company</B>&rdquo;) and
(2) Peace Range Limited (the &ldquo;<B>Chargee</B>&rdquo; which expression shall include its successors, assigns and transferees),
the Company has charged, by way of first fixed charge, to the Chargee all of the Company&rsquo;s right, title and interest in and to
each of the accounts maintained with you listed below (including any replacement, renewal or re-designation thereof) and all monies
and/or assets standing to the credit of such account(s) from time to time (the &ldquo;<B>Charged Account(s)</B>&rdquo;):</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font-weight: bold; border-bottom: Black 1.5pt solid">NAME OF CONTROL ACCOUNT</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="font-weight: bold; text-align: justify; border-bottom: Black 1.5pt solid">ACCOUNT NUMBER</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 80%; text-align: justify; padding-bottom: 1.5pt">Savings Account opened by Aptorum Group Limited</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 19%; text-align: center; padding-bottom: 1.5pt"></TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">With
effect from the date of your receipt of this notice, the (i) terms and conditions of any or all of the Charged Account(s) (and
the rights of the Company relating thereto); and (ii) the signatories to the Charged Accounts(s), may not be amended, varied or
waived without the Chargee&rsquo;s consent.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">With
effect from the time when you receive a notice from the Chargee to the effect that the security created by the Account Charge
has become enforceable (an &ldquo;<B>Enforcement Notice</B>&rdquo;):</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 0px; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 38px; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">(a)</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">any
    existing instructions affecting any or all of the Charged Account(s) are to be terminated and all communications in respect
    of any or all of the Charged Account(s) should be made, or sent, to the Chargee or as it shall direct; and</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -28.35pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 0px; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 38px; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">(b)</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">all
    rights, powers, discretions, interests and benefits whatsoever accruing to or for the benefit of the Company arising from
    any or all of the Charged Account(s) (including without limitation monies and/or securities standing to the credit thereof
    from time to time) belong to the Chargee.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -28.35pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">The
Company hereby irrevocably authorises and instructs you, with effect from your receipt of an Enforcement Notice from the Chargee:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 0px; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 38px; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">(i)</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">to
    hold all sums and assets from time to time standing to the credit in the Charged Account(s) to the order of the Chargee;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -28.35pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 0px; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 38px; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">(ii)</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">to
    pay, transfer or release all or any part of the sums and/or assets from time to time standing to the credit of the Charged
    Account(s) in accordance with (and only in accordance with) the written instructions of the Chargee at any time or times (to
    the exclusion of the Company);</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -28.35pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -28.35pt"></P>

<!-- Field: Page; Sequence: 30 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -28.35pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 0px; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 38px; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">(iii)</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">to
    comply with the terms of any written notice or instructions in any way relating to, or purporting to relate to, the Account
    Charge, the sums and/or assets standing to the credit of the Charged Account(s) from time to time or the debts represented
    thereby which you receive at any time from the Chargee without any reference to or further authority from the Company and
    without any enquiry by you as to the justification for or validity or such notice or instruction; and</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -28.35pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 0px; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 38px; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">(iv)</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">not
    to comply with the terms of any written notice or instructions in any way relating to, or purporting to relate to, the Account
    Charge, the sums and/or assets standing to the credit of the Charged Account(s) from time to time or the debts represented
    thereby which you receive from any other person (including the Company) other than the Chargee.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -28.35pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">We
also hereby irrevocably authorise and instruct you to disclose to the Chargee without any reference to or further authority from
us and without any enquiry by you as to the justification of such disclosure, such information relating to any or all of the Charged
Account(s) and the sums and/or assets therein as the Chargee may at any time and from time to time request.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">We
shall continue to be solely responsible for the performance of our obligations in respect of any or all of the Charged Account(s)
and any documentation which we have entered into with you in relation to any or all of the Charged Account(s).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">We
shall also remain entitled to exercise all the existing rights, powers and discretions which under the terms of the Charged Account(s)
were vested in us (except for the right to withdraw amounts from the Charged Account(s) which would require joint instructions
provided by the Company and the Chargee) without requiring any prior notice of consent of the Chargee to be provided to you, unless
and until you have received an Enforcement Notice from the Chargee that the security under the Account Charge has become enforceable.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Neither
this notice nor any of the instructions herein may be revoked or varied without the prior written consent of the Chargee.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Please
confirm your consent to the charge over the Charged Account(s) and acknowledge receipt of this notice and your agreement to
the terms hereof by signing the acknowledgement on a copy of this notice and returning it to the Chargee at
___________________ marked for the attention of Mr. Andy Cheuk / Mr. Philip Wong.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">This
notice and/or the acknowledgment hereto may be executed in any number of counterparts, and this has the same effect as if signatures
on such counterparts were on a single copy of this letter and the acknowledgement hereto.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">This
notice is governed by the laws of Hong Kong.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Yours
faithfully</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 0; margin-bottom: 0"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid; width: 40%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
and on behalf of</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Aptorum
Group Limited</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 31 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Acknowledgement</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">To:</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Peace
Range Limited as Chargee</FONT></TD>
</TR>     <TR STYLE="vertical-align: top; text-align: justify">
<TD>&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: justify">
<TD>&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Aptorum
Group Limited (the &ldquo;<B>Company</B>&rdquo;)</FONT></TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Date:&#9;__________________________
2018</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">At
the request of the Company we acknowledge receipt of the notice of charge from the Company dated _____________________________
2018 (the &ldquo;<B>Notice</B>&rdquo;) in respect of the Charged Account(s). Unless otherwise defined herein, terms and expressions
herein shall have the meaning ascribed to them in the Notice.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">We
confirm that:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 0px; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 38px; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">(i)</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">we
    consent to the charge over the Charged Account(s) and acknowledge the instructions and authorisations contained in the Notice
    and we undertake to act in accordance with the terms of the Notice;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -28.35pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 0px; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 38px; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">(ii)</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">the
    balance standing to each of the Charged Account(s) at today&rsquo;s date comprises _________________________;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -28.35pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 0px; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 38px; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">(iii)</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">no
    fees or periodic charges are payable in respect of any of the Charged Account(s)except for the fees and periodic charges set
    out in our bank&rsquo;s standard tariff charged or incurred by us in the ordinary course of the account bank services provided
    by us to the Company that are agreed to be payable to us under the terms of the Charged Account(s);</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -28.35pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 0px; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 38px; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">(iv)</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">we
    have not received notice of any previous assignments of, charges over or trusts in respect of, any of the Charged Account(s)
    and we will not, without the Chargee&rsquo;s prior written consent (a) exercise any right of combinations, consolidation or set-off
    which we may have in respect of any of the Charged Account(s) or (b) amend or vary any rights attaching to any of the Charged
    Account(s) or (c) amend or vary the signatories to the Charged Accounts(s);</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -28.35pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 0px; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 38px; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">(v)</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">with
    effect from our receipt of an Enforcement Notice from the Chargee, we will act only in accordance with the instructions given
    by persons authorised by the Chargee in respect of any or all of the Charged Account(s);</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -28.35pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 0px; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 38px; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">(vi)</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">we
    shall send all statements and other notices given by us relating to the Charged Account(s) to the Chargee as well as to the
    Company; and</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -28.35pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 0px; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 38px; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">(vii)</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">with
    effect from our receipt of an Enforcement Notice from the Chargee, we shall not permit any amount or asset to be withdrawn
    or transferred from any of the Charged Account(s) without the prior written consent of the Chargee.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -28.35pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">The
Notice and this acknowledgment may be executed in any number of counterparts, and this has the same effect as if signatures on
such counterparts were on a single copy of the Notice and this acknowledgment.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">This
acknowledgment is governed by the laws of Hong Kong.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">For
and on behalf of</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>MUFG
Bank, Ltd., Hong Kong Branch</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 0; margin-bottom: 0"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid; width: 40%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 32 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif; text-transform: uppercase"><B>SIGNATORIES
TO THE Account Charge</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif; text-transform: uppercase"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Chargor</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 53%; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>EXECUTED
        </B>as a <B>DEED</B> and <B>DELIVERED</B> by</FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>APTORUM
        GROUP LIMITED</B>:</FONT></P></TD>
    <TD STYLE="width: 3%; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">)</FONT></P></TD>
    <TD STYLE="width: 44%; text-align: justify; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Director/authorised
        signatory signature:</FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Director/authorised
        signatory name:</FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Occupation:</FONT></P></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">___________________________</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right">Project Life - Account Charge</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 33 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif; text-transform: uppercase"><B>SIGNATORIES
TO THE Account charge</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif; text-transform: uppercase"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Chargee</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 58%; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Signed
    for and on behalf of <BR>
    <B>PEACE RANGE LIMITED</B></FONT></TD>
    <TD STYLE="width: 2%; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</FONT></P></TD>
    <TD STYLE="width: 2%; text-align: justify; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"></TD>
    <TD STYLE="width: 38%; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></P>
                                                                                                 <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>
                                                                                                 <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U>&nbsp;</P>
                                                                                                 <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></P></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Project
Life - Account Charge</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 0; margin-bottom: 0"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.23
<SEQUENCE>27
<FILENAME>ff12018ex10-23_aptorum.htm
<DESCRIPTION>BOND CERTIFICATE BETWEEN THE COMPANY AND PEACE RANGE LIMITED, DATED APRIL 25, 2018
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif; text-align: right"><B>Exhibit 10.23</B></P>

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>BOND
CERTIFICATE</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Certificate
No.: 1</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Amount:
US$15,000,000</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Aptorum
Group Limited</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Incorporated
in Cayman Islands with limited liability)</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Aggregate
Principal Amount of US$15,000,000 </B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>8.00
per cent. Convertible Bonds due 2019</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Aptorum
Group Limited (the <B>&ldquo;Issuer&rdquo;) </B>hereby CERTIFIES that Peace Range Limited whose address is situated at [ ]
(the <B>&ldquo;Bondholder&rdquo;) </B>is, at the date hereof, entered in the Issuer&rsquo;s Register of Bondholders as the
holder of the 8.00 per cent. convertible bonds due 2019 (the <B>&ldquo;Bonds&rdquo;) </B>in the principal amount of
US$15,000,000. For value received, the Issuer promises to pay the Bondholder who appears at the relevant time on the Register
of Bondholders of the Issuer as the holder of the Bonds in respect of which this Certificate is issued, such amount or
amounts as shall become due in respect of the Bonds and otherwise to comply with the Terms and Conditions of the Bonds
endorsed hereon (the <B>&ldquo;Conditions&rdquo;).</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Bonds are issued with the benefit and subject to the Conditions. The Bonds in respect of which this Certificate is issued are
convertible into fully-paid class A ordinary shares of the Issuer in accordance with the Conditions.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Bonds in respect of which this Certificate is issued are in registered form. This Certificate is evidence of entitlement only.
Title to the Bonds passes only on due registration in the Register of Bondholders and only the duly registered holder is entitled
to payments on the Bonds in respect of which this Certificate is issued.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Bonds in respect of which this Certificate is issued form part of all the Bonds in the aggregate principal amount of US$15,000,000
issued by the Issuer on 25 April 2018.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
certificate is governed by, and shall be construed in accordance with the laws of Hong Kong.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
witness whereof the Issuer has caused this Certificate to be executed and delivered as a deed on 25 April 2018.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Note:
The Bonds cannot be transferred to bearer on delivery and is deliverable only to the extent permitted by the Conditions. The Bonds
must be delivered. to the Issuer for cancellation and the reissue of an appropriate certificate in the event of any such transfer.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dated
25 April 2018</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">EXECUTED
and DELIVERED</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">as
a DEED by <B>Aptorum Group Limited </B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">and
SIGNED by Ian Huen</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">as
CEO &amp; Executive Director</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><U>/s/ Ian Huen &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">in
the presence of:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><U>/s/ Lee Manhei Monique &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Witness
signature </FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Witness
name: LEE MANHEI MONIQUE</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Occupation:
LAWYER</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>


<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid">&nbsp;&nbsp;</DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Schedule
1</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>TERMS
AND CONDITIONS OF THE BONDS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
issue of US$15,000,000 aggregate principal amount (the &ldquo;<B>Principal Amount</B>&rdquo;) of 8.00 per cent. convertible bonds
due 2019 (the &ldquo;<B>Bonds</B>&rdquo;, which term shall include, unless the context requires otherwise, any further bonds issued
in accordance with Condition 16 and consolidated and forming a single series therewith) of Aptorum Group Limited (the &ldquo;<B>Issuer</B>&rdquo;),
a Cayman Islands exempted company with Hong Kong business registration no. F0023235 and with a registered address of Floor 4,
Willow House, Cricket Square, Grand Cayman KY1-9010, Cayman Islands, and the right of conversion into Shares was authorised by
the board of directors of the Issuer on 27 March 2018.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Bonds, issued on the Issue Date as defined in the Subscription Agreement (defined below), have the benefit of (i) a deed of
guarantee dated the Issue Date granted by Jurchen Investment Corporation, incorporated in the British Virgin Islands (the
&ldquo;<B>Guarantor</B>&rdquo;) in favour of the Bondholders, as &ldquo;amended or supplemented from time to time (the
&ldquo;<B>Deed of Guarantee</B>&rdquo;); (ii) a Share Charge dated the Issue Date between Jurchen Investment Corporation as
chargor and Peace Range Limited, a British Virgin Islands company with a registered address at [ ], as chargee (the
&ldquo;<B>Share Charge</B>&rdquo;); and (iii) an Account Charge dated the Issue Date between the Issuer as chargor and Peace
Range Limited as chargee (the &ldquo;<B>Account Charge</B>&rdquo;). The giving of the Deed of Guarantee and the Share Charge
was authorised by resolutions of the board of directors of the Guarantor passed on 3 April 2018 and the giving of the Account
Charge was authorised by resolutions of the board of directors of the Issuer passed on 27 March 2018.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
subscription agreement dated 6 April 2018 among the Issuer, the Guarantor and Peace Range Limited as subscriber in relation to
the issue and subscription of the Bonds (the &ldquo;<B>Subscription Agreement</B>&rdquo;), the escrow agreement dated the Issue
Date among the Guarantor, Peace Range Limited and The Law Debenture Trust (Asia) Limited as escrow agent in connection with the
Share Charge, the Deed of Guarantee, the Share Charge and the Account Charge are together known as the &ldquo;<B>Transaction Documents</B>&rdquo;.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Bonds are subject to these terms and conditions (the &ldquo;<B>Conditions</B>&rdquo;). In these Conditions, &ldquo;<B>Bondholder</B>&rdquo;
and (in relation to a Bond) &ldquo;<B>holder</B>&rdquo; means the person in whose name a Bond is registered.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&rdquo;<B>Business
Day</B>&rdquo; means a day other than a Saturday, Sunday or public holiday, on which banks are open for business in Hong Kong,
New York City, the Cayman Islands and the British Virgin Islands.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
these Conditions, unless the context requires otherwise, words importing the singular include the plural and <I>vice versa </I>and
words importing gender or the neuter include both genders and the neuter; references to these Conditions or any document shall
be construed as references to such document as the same may be amended or supplemented from time to time. Condition headings are
inserted for reference only and shall be ignored in construing these Conditions.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Form, Denomination and Title</B></FONT></TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Form and Denomination</I></B></FONT></TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Bonds are issued in registered form in the denomination of US$250,000 (an &ldquo;<B>Authorised Denomination</B>&rdquo;). A bond
certificate (each a &ldquo;<B>Bond Certificate</B>&rdquo;) substantially in the form set out in schedule 1 hereto will be issued
to each Bondholder in respect of its registered holding of Bonds. Each Bond Certificate will be numbered serially with an identifying
number which will be recorded on the relevant Bond Certificate and in the register of Bondholders (the &ldquo;<B>Register</B>&rdquo;)
which the Issuer will procure to be kept by the Registrar.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">1-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Title</I></B></FONT></TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title
to the Bonds will pass only by transfer and registration in the Register as described in Condition 3. The holder of any Bond will
(except as otherwise required by law or as ordered by a court of competent jurisdiction) be treated as its absolute owner for
all purposes (whether or not it is overdue and regardless of any notice of ownership, trust or any interest in it or any writing
on, or the theft or loss of, the Bond Certificate issued in respect of it) and no person will be liable for so treating the holder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Status and Guarantee</B></FONT></TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Status</I></B></FONT></TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Bonds constitute direct, unconditional and unsubordinated obligations of the Issuer and shall at all times rank <I>pani passu
</I>and without any preference or priority among themselves. The payment obligations of the Issuer under the Bonds shall, save
for such exceptions as may be provided by mandatory provisions of applicable legislation and subject to Condition 4, at all times
rank at least equally with all of its other present and future unsubordinated obligations (including but not limited to the Executed
Private Placements). The Bonds are secured as set out in Condition 5.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Guarantee</I></B></FONT></TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Guarantor has unconditionally and irrevocably guaranteed the due payment of all sums expressed to be payable by the Issuer under
the Bonds. The Guarantor&rsquo;s obligations in respect of the Bonds are contained in the Deed of Guarantee. The obligations of
the Guarantor under the Deed of Guarantee shall, save for such exceptions as may be provided by applicable legislation, at all
times rank at least <I>pani passu </I>with all its other present and future unsecured and unsubordinated obligations.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">At
any time after the Bonds have become due and repayable, any Bondholder may, at its discretion and without further notice, take
any action against the Issuer or the Guarantor, as the case may be, as it may think fit to enforce repayment of the Bonds and
to enforce the provisions of the Conditions pursuant to the Transaction Documents.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Transfers of Bonds; Issue of Bond Certificates</B></FONT></TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Register</I></B></FONT></TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Issuer will cause the Register to be kept at the specified office of the Registrar in the Cayman Islands on which shall be entered
the names and addresses of the holders of the Bonds and the particulars of the Bonds held by them and of all transfers, redemptions
and conversions of the Bonds. Each Bondholder shall be entitled to receive only one Bond Certificate in respect of its entire
holding of Bonds.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Issuer and the Guarantor shall treat the Bondholder as recorded in the Register as the absolute owner of the Bonds for all purposes
(whether or not it is overdue and regardless of any notice of ownership, trust or any other interest therein, any writing on the
Bond Certificates relating thereto or any notice of any previous loss or theft of such Bond Certificates).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>(b)</I></B></FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Transfer</I></B></FONT></TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Subject
to this Condition 3(b), the Bonds are transferrable (in whole or in <FONT STYLE="font: 10pt Times New Roman, Times, Serif">part)
by any Bondholder to any person provided that:</FONT></FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(A)</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">such
Bondholder shall notify the Issuer in writing of the intended transfer on or before the date falling 10 Business Days prior to
such transfer, provided that the Issuer shall have the right to exercise its redemption right pursuant to Condition 9(b);</FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 3; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">1-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 1in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(B)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">prior
                                         to the instruction to transfer under Condition 3(b)(i)(A), if the Bondholder-transferor
                                         reasonably believes that the transferee is conducting any business that is in competition
                                         with the Issuer or any of its Subsidiaries, such Bondholder shall ask the Issuer to confirm
                                         whether the proposed transferee is a competitor of the Issuer or any of the Issuer&rsquo;s
                                         subsidiaries and, if the transferee is confirmed by the Issuer to be a competitor of
                                         the Issuer or any such subsidiary, such Bondholder shall not purport to make any instructions
                                         to transfer the relevant Bonds under Condition 3(b)(i)(A) and any such proposed transfer
                                         shall be void. Nothing contained in this Condition 3(b)(i)(B) shall require any Bondholder-transferor
                                         to undertake any investigation into any transferee nor shall any Bondholder-transferor
                                         be liable for failing to enquire whether any transferee is a competitor of the Issuer
                                         or any of the Issuer&rsquo;s subsidiaries, if the Bondholder-transferor reasonably believes
                                         it is not;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.45in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 1in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(C)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                         transfer of Bonds (or parts thereof in authorised denominations) will be effected without
                                         charge by or on behalf of the Issuer; and</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.45in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 1in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(D)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">such
                                         transfer shall comply with any applicable laws, regulations and requirements of the regulatory
                                         authority.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.45in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">No
                                         transfer of a Bond will be valid unless and until entered on the Register.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.4in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
                                         relation to any transfer of Bonds permitted under or otherwise pursuant to this Condition
                                         3:</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.4in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 1in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(A)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                         relevant Bond that is the subject of a transfer may only be transferred by execution
                                         of a form of transfer (the &ldquo;<B>Transfer Form</B>&rdquo;) which is annexed to these
                                         Conditions as schedule 2 under the hand of the Bondholder-transferor and the transferee
                                         (or their duly authorised representatives) or, where either the Bondholder-transferor
                                         or transferee is a corporation, under its common seal (if any) and under the hand of
                                         one of its officers duly authorised in writing or otherwise executed by a duly authorised
                                         officer thereof. In this Condition &ldquo;Bondholder-transferor&rdquo; shall, where the
                                         context permits or requires, include joint transferors and be construed accordingly;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.45in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 1in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(B)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                         relevant Bond Certificate must be delivered for cancellation to the Issuer accompanied
                                         by (i) a duly executed Transfer Form; (ii) in the case of the execution of the Transfer
                                         Form on behalf of a corporation by its officers, the authority of that person or those
                                         persons to do so; (iii) such other evidence as the Issuer may reasonably require if the
                                         Transfer Form is executed by some other person on behalf of the Bondholders; and (iv)
                                         such other evidence as the Issuer may reasonably require to support that the conditions
                                         and requirements of this Condition 3 are satisfied. The Issuer shall, within five Business
                                         Days of receipt of such documents from the Bondholders, enter the transfer on the Register
                                         and cancel the original Bond Certificate in respect of the existing Bond being transferred
                                         in the name of the Bondholder-transferor and issue a new certificate in respect of the
                                         Bond being transferred under the seal of the Issuer, in favour of the transferee.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.45in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Delivery of New Bond Certificates</I></B></FONT></TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Each
new Bond Certificate to be issued upon a transfer of Bonds will, within five Business Days of receipt by the Issuer of the Transfer
Form, be mailed by registered mail or delivered by hand, to the address specified in the Transfer Form, or made available for
collection by the holder entitled to the Bond at the specified office of the Issuer.</FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 4; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">1-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Where
only some of the Bonds (being that of one or more Bonds) in respect of which a Bond Certificate is issued is to be transferred,
converted, redeemed or repurchased, a new Bond Certificate in respect of the Bonds not so transferred, converted, redeemed or
repurchased will, within seven Business Days of delivery of the original Bond Certificate to the Registrar be made available for
collection at the specified office of the Registrar or, if so requested in the form of transfer, be mailed by registered mail
(but free of charge to the holder and at the Issuer&rsquo;s (failing which, the Guarantor&rsquo;s) expense) to the address of
such holder appearing on the Register.</FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.4in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Formalities Free of Charge</I></B></FONT></TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Registration
of transfer of Bonds (or parts thereof in authorised denominations) will be effected without charge by or on behalf of the Issuer,
but upon payment (or the giving of such indemnity as the Issuer may reasonably require) by the transferee or the Bondholder-transferor
in respect of any taxes, duties or other government charges which may be imposed in relation to such transfer.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Covenants</B></FONT></TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Debt Service Reserve Account</I></B></FONT></TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Prior
                                         to the Issue Date, the Issuer (failing whom, the Guarantor) shall have deposited into
                                         the Debt Service Reserve Account the total amount of (i) the 2.0 per cent. of the Principal
                                         Amount (the &rsquo;<B>Structuring Fee</B>&rsquo;), <I>plus </I>(ii) the amount of subscriber&rsquo;s expenses
                                         (the &rsquo;<B>Subscriber&rsquo;s Expenses</B>&rsquo;) which shall be agreed in writing between the Issuer
                                         and the Subscriber five Hong Kong business days prior to the Issue Date, <I>plus </I>(iii)
                                         an amount in US dollars equal to the aggregate amount of interest due and payable for
                                         two consecutive Interest Periods commencing from, and including, the Issue Date.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.4in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Upon
                                         payment of the subscription price of the Bonds (which shall net off the Structuring Fee
                                         and the Subscriber&rsquo;s Expenses) by the Bondholders on the Issue Date pursuant to the Subscription
                                         Agreement, the Issuer (failing whom, the Guarantor) shall procure that on the Issue Date,
                                         such net proceeds of the issue of the Bonds shall be deposited in the Debt Service Reserve
                                         Account.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.4in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
                                         the event that the Maturity Date is extended to the Extended Maturity Date as defined
                                         and subject to Condition 9 below, each of the Issuer and Guarantor undertakes to procure
                                         that the aggregate amount of interest due and payable for the Interest Period commencing
                                         on, and including, the Scheduled Maturity Date and ending on, and including, the Extended
                                         Maturity Date shall be deposited and made immediately available as a condition of such
                                         extension in the Debt Service Reserve Account to the satisfaction of the Bondholders.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.4in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iv)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                         Debt Service Reserve (or the relevant part thereof) will be released from the Debt Service
                                         Reserve Account on satisfaction of any one of the Release Conditions in accordance with
                                         the Account Charge.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.4in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(v)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
                                         any Bond has been converted into Shares on a Conversion Upon QIPO or exercise of a Conversion
                                         Right or redeemed in accordance with the Conditions, the Debt Service Reserve (or the
                                         relevant part thereof) may be released in accordance with the Account Charge from the
                                         Debt Service Reserve Account in an amount <I>pro rata </I>to the principal amount of
                                         the Bond or Bonds being converted or redeemed, as the case may be.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.4in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(vi)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
                                         the date falling two Business Days prior to each Interest Payment Date commencing on,
                                         and including the First Interest Payment Date and ending on, and including the Maturity
                                         Date, the Account Bank shall upon instructions being provided by the Issuer and/or Bondholders
                                         in accordance with the Account Charge release from the Debt Service Reserve Account and
                                         pay to the account of the Bondholders such amount of the proceeds deposited in the Debt
                                         Service Reserve Account as is equal to the aggregate amount of interest due and payable
                                         on the immediately following Interest Payment Date or, as the case may be, the Maturity
                                         Date, in accordance with Condition 6.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: left"></P>

<!-- Field: Page; Sequence: 5; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">1-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: left">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(vii)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Any
                                         operational costs and expenses or bank account service fees to be imposed or charged
                                         by the Account Bank in respect of the Debt Service Reserve Account shall be agreed in
                                         writing with the Account Bank prior to the establishment of such account. If such costs,
                                         expenses and fees are to be borne by the Issuer, the Issuer shall settle such amounts
                                         with funds other than the Debt Service Reserve.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.4in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(viii)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">So
                                         long as any Bond remains Outstanding, neither the Issuer nor any member of the Group
                                         shall, without the prior written consent of the Bondholders, change (nor instruct the
                                         Account Bank to change) any bank mandate or authorised signatory in respect of the Debt
                                         Service Reserve Account.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.4in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ix)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">At
                                         the Maturity Date, the Early Redemption Date, the Relevant Event Put Date or any other
                                         dates on which the principal, interest or premium on the Bonds are payable by the Issuer
                                         pursuant to these Conditions, as the case may be, the Issuer may repay and redeem the
                                         Bonds that remain Outstanding with the Debt Service Reserve pursuant to the Account Charge.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.4in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Limitation on indebtedness</I></B></FONT></TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">So
long as the Bondholders continue to have an Exposure,</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>before</U>
                                                                                                                                                                                                                                    the occurrence of the QIPO, none of the Issuer or any other member of the Group, without the prior written consent of
                                                                                                                                                                                                                                    the Bondholders (which shall not be unreasonably withheld or delayed), shall enter into or incur any Financial
                                                                                                                                                                                                                                    Indebtedness.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.4in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>following</U>
                                                                                                                                                                                                                                     the occurrence of the QIPO, none of the Issuer or any other member of the Group shall, without the prior written consent
                                                                                                                                                                                                                                     of the Bondholders (which shall not be unreasonably withheld or delayed), enter into or incur any Financial Indebtedness <U>unless</U>:</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.4in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 1in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(A)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">any
                                         such Financial Indebtedness is, in aggregate, less than US$60,000,000; and</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.45in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 1in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(B)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                         Issuer shall at all times maintain a ratio of total consolidated liabilities to total
                                         consolidated assets of the Issuer (as calculated by reference to its most recent audited
                                         financial statements) of not more than 50.0 per cent.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.45in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
these Conditions, &ldquo;<B>Financial Indebtedness</B>&rdquo; means any indebtedness for monies borrowed or raised, which shall
include any interest or premium to be paid thereunder. Any limitation under Conditions 4(b)(i) and 4(b)(ii) shall not apply to:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(I)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                         issue of the Bonds;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: -0.4in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(II)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                         entry into the Share Charge or Account Charge or any other security interests in relation
                                         to the Bonds;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.4in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(III)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                         Private Placements;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.4in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(IV)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                         Employees&rsquo; Share Options;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.4in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(V)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                         Other Share Options and Warrants;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.4in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(VI)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                         Subsidiary Share Grants and Share Options; or</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.4in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(VII)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                         QIPO.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.4in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(items
(I) to (VII) above collectively known as &ldquo;<B>Permitted Offerings</B>&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P>

<!-- Field: Page; Sequence: 6; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">1-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)</FONT></TD><TD STYLE="padding-right: 3.2in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Limitation
                                         on equity offerings </I></B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: -0.45in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Employees&rsquo;
Share Options</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: -0.45in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">So
long as the Bondholders continue to have an Exposure, the Issuer and the Guarantor undertake that:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                         total number of Ordinary Shares to be issued under any such Employees&rsquo; Share Options
                                         shall not exceed 5.0 per cent. of the total aggregate number of Ordinary Shares in issue
                                         immediately following the QIPO on a fully diluted basis taking into account the total
                                         number of Ordinary Shares at issue following the QIPO, any Ordinary Shares falling to
                                         be issued pursuant to the Permitted Offerings; and</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.45in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">any
                                         Permitted Offerings, if fully exercised for Ordinary Shares, would not trigger any Change
                                         of Control.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.45in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Other
Share Options and Warrants</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">So
long as the Bondholders continue to have an Exposure, the Issuer and the Guarantor undertake that:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">any
                                         Other Share Options and Warrants shall be granted by the Issuer only and not by the Issuer&rsquo;s
                                         Subsidiaries; and</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.45in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iv)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                         total number of Ordinary Shares to be issued under any such Other Share Options and Warrants
                                         shall not exceed 5.0 per cent. of the total aggregate number of Ordinary Shares in issue
                                         immediately following the QIPO on a fully diluted basis taking into account the total
                                         number of Ordinary Shares at issue following the QIPO, any Ordinary Shares falling to
                                         be issued pursuant to the Permitted Offerings; and</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.45in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(v)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">any
                                         Permitted Offerings, if fully exercised for Ordinary Shares, would not trigger any Change
                                         of Control.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.45in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Subsidiary
Share Grants and Share Options</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">So
long as the Bondholders continue to have an Exposure, the Issuer and the Guarantor undertake that:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(vi)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">any
                                         Subsidiary Share Grants and Share Options shall be granted by the Issuer&rsquo;s Subsidiaries
                                         only and not by the Issuer; and</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.45in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(vii)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">any
                                         Permitted Offerings, if fully exercised for shares, would not trigger any Change of Control.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.45in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Permitted
Offerings</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Notwithstanding
the above, the Issuer and the Guarantor undertake and will procure that if any of the Permitted Offerings occurs after the occurrence
of the QIPO, the market capitalisation of the Issuer (translated if necessary into US dollars at the then prevailing relevant
exchange rate) calculated based on the issue price per Share immediately following such Permitted Offering (being the product
of the issue price per Share at the relevant time multiplied by the total number of Ordinary Shares in issue following such Permitted
Offering) shall be equal to or greater than the Issuer&rsquo;s Market Capitalisation at IPO.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B></B></FONT></P>

<!-- Field: Page; Sequence: 7; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">1-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Limitation
before and after QIPO</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">So
long as the Bondholders continue to have an Exposure, and other than in relation to the Permitted Offerings that otherwise comply
with these Conditions,</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(viii)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>before</U>
                                                                                                                                                                                                                                       the occurrence of the QIPO,</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: -0.45in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 1in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(A)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">none
                                         of the Issuer and any other member of the Group (other than the Guarantor) shall, without
                                         the prior written consent of the Bondholders (which shall not be unreasonably withheld
                                         or delayed), offer (publicly or privately), or enter into any transaction which is designed
                                         to, or might reasonably be expected to, result in any public or private offering by any
                                         other member of the Group (other than the Guarantor), or announce any public or private
                                         offering of, any shares or securities convertible into or exchangeable for, or warrants,
                                         rights or options, or agreements to grant warrants, rights or options, to purchase or
                                         to subscribe for, any shares issued by, or shares held by, the Issuer or any other member
                                         of the Group (other than the Guarantor); or issue any additional shares of other class(es)
                                         in its capital (other than the Shares), including without limitation any Class B ordinary
                                         shares of the Issuer; and</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 1in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(B)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">no
                                         shares of the Issuer and any other member of the Group (other than (I) the Guarantor
                                         and (II) the Issuer in respect of the QIPO) shall, without the prior written consent
                                         of the Bondholders (which shall not be unreasonably withheld or delayed), be listed,
                                         quoted, admitted to trading or dealt in on any stock exchange.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ix)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>following
</U>the occurrence of the QIPO, the Issuer may have its Shares listed, quoted, admitted to trading or dealt in on a stock exchange
other than the stock exchange in respect of the Listing by way of secondary listing, or conduct any private placement or public
offering of its Shares (each a &ldquo;<B>Post-IPO Secondary Offering</B>&rdquo;), <U>provided that:</U></FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.45in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 1in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(A)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                         offering size for such Post-IPO Secondary Offering (being the product of the issue price
                                         for such offering multiplied by the number of shares to be issued in such Post-IPO Secondary
                                         Offering), as determined by an Independent Investment Bank and/or Independent Firm of
                                         Auditors, shall be less than US$50,000,000; and</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 1in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(B)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                         offering price per Share at such Post-IPO Secondary Offering shall not be below the IPO
                                         Share Price in the opinion of an Independent Investment Bank and/or Independent Firm
                                         of Auditors; and</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 1in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(C)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                         market capitalisation of the Issuer (translated if necessary into US dollars at the then
                                         prevailing relevant exchange rate) calculated based on the issue price per Share for
                                         the relevant Post-IPO Secondary Offering following such Post-IPO Secondary Offering (being
                                         the product of the issue price per Share multiplied by the total number of Shares in
                                         issue following such Post-IPO Secondary Offering), as determined by an Independent Investment
                                         Bank and/or Independent Firm of Auditors, shall be greater than the Issuer&rsquo;s Market Capitalisation
                                         at IPO.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(x)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Subject
to Condition 4(c)(ix) above, other than the Permitted Offerings and Post-IPO Secondary Offerings that otherwise comply with these
Conditions, <U>following</U> the occurrence of the QIPO, none of the Issuer or any other member of the Group (other than the Guarantor)
shall, offer (publicly or privately), or enter into any transaction which is designed to, or might reasonably be expected to,
result in any public or private offering by any other member of the Group (other than the Guarantor), or announce any public or
private offering of, any shares or securities convertible into or exchangeable for, or warrants, rights or options, or agreements
to grant warrants, rights or options, to purchase or to subscribe for, any shares issued by, or shares held by, the Issuer or
any other member of the Group (other than the Guarantor); or issue any additional shares of other class(es) in its capital (other
than the Shares), including without limitation any Class B ordinary shares of the Issuer.</FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 8; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">1-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Corporate actions</I></B></FONT></TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">So
long as any Bonds remain Outstanding, neither the Issuer nor any member of the Group shall enter into any form of corporate reorganisation,
including but not limited to merging, consolidating or amalgamating any business currently controlled by any member of the Group,
or any part of it, with any other business that is not controlled by any member of the Group, entering into any share swap transaction,
demerger or divestiture with any other business that is not controlled by any member of the Group, <U>unless</U> any such corporate
reorganisation is entered into among the members of the Group.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Financial statements etc.</I></B></FONT></TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">So
long as any Bond remains Outstanding, the Bondholders shall have the right to request from each of the Issuer and the Guarantor,
in each case in the English language, a copy of:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                         relevant annual audited consolidated income statement, consolidated balance sheet, consolidated
                                         cash flow statement and consolidated statement of changes in shareholders&rsquo; equity of
                                         the Issuer and the Guarantor together with any statements, reports (including any directors&rsquo;
                                         and auditors&rsquo; reports) and notes attached to or intended to be read with any of them
                                         within 120 days after the end of their respective financial years;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.45in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">subject
                                         to the applicable laws, by-laws, regulations and rules of the relevant jurisdiction or
                                         stock exchange binding on the Issuer or the Guarantor, including those with respect to
                                         the disclosure of non-public information,</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.45in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 1in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(A)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                         quarterly (or any other interim reporting period required by applicable law or regulations)
                                         unaudited consolidated income statement, consolidated balance sheet, consolidated cash
                                         flow statement and consolidated statement of changes in shareholders&rsquo; equity of the Issuer
                                         together with any statements, reports (including any directors&rsquo; and auditors&rsquo; review
                                         reports, if any) and notes attached to or intended to be read with any of them within
                                         60 days after the end of their respective financial years; and</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.45in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 1in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(B)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">as
                                         soon as practicable upon the request of any Bondholder from time to time, each of the
                                         Issuer and Guarantor shall furnish the Bondholders with any documentation or materials
                                         in relation to the key performance indicators of the Issuer or any other member of the
                                         Group (other than the Guarantor).</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.45in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(f)</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Undertakings relating to the registration of the
Share Charge</I></B></FONT></TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Guarantor has undertaken in the Subscription Agreement that it will as soon as reasonably practicable and, in any event, within
ten Business Days of the date of the Share Charge (i) register or cause to be registered with the Registrar of Corporate Affairs
in the BVI, and to update the register of charges of the Guarantor with details of the security interests created by, the Share
Charge, in accordance with the BVI Business Companies Act, (ii) use its best endeavours to complete such registration and obtain
a registration record from its registered agent in the BVI and a certificate of registration of charge from the Registrar of Corporate
Affairs in the BVI on or before the BVI Registration Deadline (as defined in Condition 9(c) below), (iii) deliver to the Bondholders
copies of such registration record and certificate of registration of charge, and (iv) to comply with all applicable laws of the
British Virgin Islands (&ldquo;<B>BVI law</B>&rdquo;) and regulations in relation to the Share Charge. In addition, the Issuer
and the Guarantor will give a notice to the Holders confirming the completion of the BVI Registration Conditions within five Business
Days after completion of such BVI Registration Conditions. The Bondholders shall not have any obligation to monitor or ensure
the registration of the Share Charge with the Registrar of Corporate Affairs in the BVI on or before the BVI Registration Deadline
or to verify the accuracy, validity and/or genuineness of any documents in relation to or in connection with such registration
and/or any relevant registration documents. Upon completion of the BVI Registration Conditions, the Guarantor shall give a notice
to the Holders confirming such completion of the BVI Registration Conditions within five (5) Business Days.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 9; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">1-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(g)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Undertakings
                                         relating to the registration of the Account Charge</I></B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: -0.45in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Issuer further undertakes that it will, after execution of the Account Charge, register or cause to be registered with the Companies
Registry of Hong Kong the Account Charge within one calendar month of the date of the Account Charge.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(h)</FONT></TD><TD STYLE="text-align: justify; padding-right: 0.6in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Disposals
by any member in the Group (other than the Guarantor) </I></B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: left; margin-left: 0.5in; text-indent: 0"><B>Disposals
of Intellectual Property</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">So
long as the Bondholders continue to have an Exposure,</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>before</U>
                                                                                                                                                                                                                                        the occurrence of the QIPO, none of the Issuer or any member in the Group (other than the Guarantor) will, without the
                                                                                                                                                                                                                                        prior written consent of the Bondholders (such consent shall not be unreasonably withheld or delayed), enter into a single
                                                                                                                                                                                                                                        transaction or a series of transactions (whether related or not and whether voluntary or involuntary) to sell (through any
                                                                                                                                                                                                                                        kind of trade sale, placement or otherwise), lease, transfer, grant any sub-licence of or dispose of (through any kind of
                                                                                                                                                                                                                                        offering, reverse takeover or otherwise) any Intellectual Property, <U>unless</U> such proposed sale, lease, transfer or
                                                                                                                                                                                                                                        disposal is made by a member of the Group to the Issuer and/or its Subsidiaries.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.9in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>following</U>
                                                                                                                                                                   the occurrence of the QIPO, the Issuer or its Subsidiaries may conduct any such transaction as referred to in Condition
                                                                                                                                                                   4(h)(i) above without the prior written consent of the Bondholders <U>provided that</U>:</FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 1in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(A)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                         consideration to be received for the relevant Intellectual Property under the proposed
                                         transaction, as determined by an Independent Investment Bank and/or Independent Firm
                                         of Auditors, is more than 75.0 per cent. of the Issuer&rsquo;s Market Capitalisation at IPO;
                                         or</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.55in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 1in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(B)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">such
                                         proposed sale, lease, transfer or disposal is made by a member of the Group to the Issuer
                                         and/or its Subsidiaries.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.55in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Disposals
of assets (other than Intellectual Property) </B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">So long as the Bondholders continue to have an Exposure,</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Subject
to Conditions 4(b), 4(c), 4(h)(i) and 4(h)(ii), the Issuer will not, and will
ensure that no members of the Group (other than the Guarantor) will, enter into a single transaction or a series of transactions
(whether related or not and whether voluntary or involuntary) to sell, lease, transfer or otherwise dispose of any assets (including
without limitation any investment securities and machinery but excluding any cash), <U>unless</U> such proposed sale, lease, transfer
or disposal:</FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(A)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">is
                                         made in the ordinary course of business of the Group <U>and</U> will not result in, or
                                         be expected to result in:</FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 1.5in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(I)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                         total consolidated assets of the Issuer being equal to or less than 60.0 per cent. of
                                         the total consolidated assets as shown in its audited consolidated financial statements
                                         of the Group as of and for the year ended 31 December 2017; and</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 1.5in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(II)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
sale price of such asset shall not be equal to or less than 60.0 per cent. of its fair value as shown in the audited consolidated
financial statements of the Group as of and for the year ended 31 December 2017; or</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.5in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 10; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">1-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: left"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">                                                                                                                                                                                                                                                                                                                                                                                                                              <TR STYLE="vertical-align: top">
<TD>&nbsp;</TD><TD STYLE="text-align: left">(B)</TD><TD STYLE="text-align: justify">is of assets in exchange for or to be replaced by other assets comparable or superior as to type, value and quality; or</TD></TR>
<TR STYLE="vertical-align: top">
<TD>&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(C)</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">is
made by a member of the Group to another member of Group.</FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.45in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Disposals
of subsidiaries</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.45in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Subject
to Conditions 4(b), 4(c), 4(h)(i) and 4(h)(ii), so long as the Bondholders continue to have an Exposure,</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iv)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>before</U>
                                                                                                                                                                                                                                     the occurrence of the QIPO, other than the Permitted Offerings that otherwise comply with these Conditions, no member of
                                                                                                                                                                                                                                     the Group (other than the Guarantor) shall dispose any of its legal or beneficial interest in any company, partnership, joint
                                                                                                                                                                                                                                     venture, trust, profit-sharing arrangement or other legal entity without the prior written consent of the Bondholders (which
                                                                                                                                                                                                                                     shall not be unreasonably withheld or delayed).</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.45in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(v)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>following</U>
                                                                                                                                                                                                                                    the occurrence of the QIPO, other than the Permitted Offerings and Post-IPO Secondary Offerings that otherwise comply
                                                                                                                                                                                                                                    with these Conditions, the Issuer or its Subsidiaries may conduct any transaction as referred to in Condition 4(h)(iv)
                                                                                                                                                                                                                                    without the prior written consent of the Bondholders <U>provided that</U> the consideration to be received for the relevant
                                                                                                                                                                                                                                    subsidiaries under the proposed transaction, as determined by an Independent Investment Bank and/or Independent Firm of
                                                                                                                                                                                                                                    Auditors, is more than 75.0 per cent. of the Market Capitalisation at IPO.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.45in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Disposals by the Guarantor</I></B></FONT></TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">So
long as the Bondholders continue to have an Exposure, the Guarantor shall not dispose any of its legal or beneficial interest
in the Issuer without the prior written consent of the Bondholders (which shall not be unreasonably withheld or delayed) <U>unless:
</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(A)</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">such
disposal occurs after the occurrence of the QIPO; and</FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(B)</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">such
disposal shall not trigger a Change of Control.</FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(j)</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Business Activities</I></B></FONT></TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">So
long as any Bond remains outstanding, the Issuer will not, and will ensure that none of its Subsidiaries will, directly or indirectly,
principally engage in any business other than the business currently conducted by it as at the Issue Date or as otherwise approved
by the Bondholders.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(k)</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Announcements</I></B></FONT></TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Unless
required by any law, regulation or listing rules binding on the Issuer or the Guarantor (including any disclosure and/or publication
requirement binding on the Issuer or the Guarantor in respect of the Listing), or otherwise consented in writing by the Bondholders
(which consent shall not be unreasonably withheld or delayed), none of the Issuer or any other members of the Group or any other
parties acting on its or their behalf shall issue any announcement concerning the Bonds. The Issuer or the Guarantor may make
any announcement based on information that has previously come into the public domain.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Notwithstanding
the above, the Issuer may disclose the terms and conditions of the Transaction Documents and the background of the initial Bondholders:
(i) in any governmental filing or to other authorities as required by the applicable laws and/or regulation or rules of NASDAQ,
an Alternative Stock Exchange, the Financial Industry Regulatory Authority or the U.S. Securities and Exchange Commission and
(ii) in connection with any action or claim to enforce its rights thereunder. The Issuer may disclose the terms and conditions
of the Transaction Documents to underwriters, investors, lenders and financial advisors in preforming due diligence in any other
transaction otherwise permitted in the Subscription Agreement or these Conditions.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 11; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">1-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Security</B></FONT></TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Security</I></B></FONT></TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
obligations of the Issuer and the Guarantor to the Bondholders under the Bonds and in connection with the Transaction Documents
and the Security Documents (the &ldquo;<B>Secured Obligations</B>&rdquo;) will be secured by:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                         security interest over 1,393,207 Class B ordinary shares representing 5.0 per cent. of
                                         the total authorised and issued Ordinary Shares of the Issuer as of the Issue Date granted
                                         by the Guarantor pursuant to the Share Charge; and</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.4in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                         security interest granted by the Issuer over the Debt Service Reserve Account pursuant
                                         to the Account Charge.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.4in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Release of Security</I></B></FONT></TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Security Documents contain provisions for the immediate release of all or any security interests created therein or discharge
in full of the Secured Obligations.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Enforcement of Security</I></B></FONT></TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Subject
                                         to an Event of Default under the Conditions and in accordance with the Security Documents,
                                         the Share Charge and/or the Account Charge, as the case may be, shall become enforceable
                                         upon the Bonds becoming immediately due and repayable following the occurrence of an
                                         Event of Default.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.4in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Any
                                         Bondholder may, at its discretion and without further notice, take such proceedings against
                                         the Issuer and/or the Guarantor as it may think fit to enforce its rights under the Bonds
                                         and to enforce all or any of the security interests created therein in accordance with
                                         the terms thereof, provided that, to the extent practicable the Bondholders shall enforce
                                         their rights under the Account Charge prior to enforcing their rights under the Share
                                         Charge.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.4in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Interest</B></FONT></TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Interest</I></B></FONT></TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Bonds bear interest from and including the Issue Date at the rate of 8.00 per cent. per annum (the &ldquo;<B>Rate of Interest</B>&rdquo;)
payable semi-annually in arrear in equal instalments of US$10,000 per Calculation Amount (as defined below) (the &ldquo;<B>Interest
Amount</B>&rdquo;) on the date falling on the 6th calendar month following the Issue Date (the &ldquo;<B>First Interest Payment
Date</B>&rdquo;) and the date falling on the 12th calendar month following the Issue Date, and if the Maturity Date is extended
to the Extended Maturity Date, on the date falling on the 18th calendar month following the Issue Date, and if any such date is
not a Business Day, the next following Business Day (each an &ldquo;<B>Interest Payment Date</B>&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Each
Bond will cease to bear interest from and including the earlier of (a) where the Conversion Right attached to it shall have been
exercised by a Bondholder, the relevant Conversion Date (as defined below), subject to conversion of the relevant Bonds in accordance
with the provisions of Condition 7(c); or (b) where such Bond is redeemed or repaid pursuant to Condition 9 or Condition 11, the
due date for redemption or repayment thereof unless, upon due presentation thereof, payment of principal is improperly withheld
or refused.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
interest is required to be calculated for a period of less than a complete Interest Period, the relevant day-count fraction will
be determined on the actual number of days elapsed and on the basis of a 360-day year.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"></P>

<!-- Field: Page; Sequence: 12; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">1-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
these Conditions, the period beginning on and including the Issue Date and ending on but excluding the first Interest Payment
Date (the &ldquo;<B>First Interest Period</B>&rdquo;) and each successive period beginning on and including an Interest Payment
Date and ending on but excluding the next succeeding Interest Payment Date is called an &ldquo;<B>Interest Period</B>&rdquo;, provided
that any Interest Period (other than a Default Interest Period) shall end on the Maturity Date.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Interest
in respect of any Bond shall be calculated per US$250,000 in principal amount of the Bonds (the &ldquo;<B>Calculation Amount</B>&rdquo;).
The amount of interest payable per Calculation Amount for any period shall, save as provided above in relation to equal instalments,
be equal to the product of 8.00 per cent. per annum, the Calculation Amount and the day-count fraction (determined in the same
manner as stated above in this Condition 6) for the relevant period, rounding the resulting figure to the nearest cent (US$0.005
being rounded upward).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Interest applicable upon Default</I></B></FONT></TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Following
service of a Notice of Event of Default on the Issuer and the Guarantor, the Issuer (failing whom, the Guarantor) shall pay to
the Bondholders:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">if
                                         any such Event of Default occurs <U>on or before</U> the date falling 12 calendar months
                                         after the Issue Date:</FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 1in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(A)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">an
                                         amount of premium that would give the Bondholders an internal rate of return equal to
                                         the Exit IRR calculated by reference to the principal amount of the Outstanding Bonds
                                         from (and including) the Issue Date up to (but excluding) the Scheduled Maturity Date;
                                         and</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.45in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 1in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(B)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">an
                                         amount of premium that would give the Bondholder an internal rate of return equal to
                                         the 15.0 per cent. per annum calculated by reference to the principal amount of the Outstanding
                                         Bonds from (and including) the earliest of (X) the date of a Notice of Potential Event
                                         of Default (if any), (Y) the date of any such proceedings referred to in Condition 11(v)
                                         is being levied, enforced or sued out on (if applicable), and (Z) an Event of Default
                                         up to (but excluding) the day on which all sums due in respect of the Bonds (which shall
                                         include sums due under this Condition 6(b)) are received by the Holders (the &ldquo;<B>Default
                                         Interest Period</B>&rdquo;); or</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.45in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">if
any such Event of Default occurs <U>after</U> the date falling 12 calendar months after the Issue Date:</FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 1in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(A)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">an
                                         amount of premium that would give the Bondholders an internal rate of return equal to
                                         the Exit IRR calculated by reference to the principal amount of the Outstanding Bonds
                                         from (and including) the Issue Date up to (but excluding) the earliest of (X) the date
                                         of a Notice of Potential Event of Default (if any), (Y) the date of any such proceedings
                                         referred to in Condition 11(v) is being levied, enforced or sued out on (if applicable),
                                         and (Z) an Event of Default; and</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.45in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 1in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(B)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">an
                                         amount of premium that would give the Bondholder an internal rate of return equal to
                                         the Default IRR calculated by reference to the principal amount of the Outstanding Bonds
                                         from (and including) the earliest of (X) the date of a Notice of Potential Event of Default
                                         (if any), (Y) the date of any such proceedings referred to in Condition 11(v) is being
                                         levied, enforced or sued out on (if applicable), and (Z) an Event of Default, up to (and
                                         excluding) the end of the Default Interest Period.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.45in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Exit IRR, the Default IRR and the premium provided in Condition 6(b)(i)(B) above shall take into account any principal, interest
(including Interest Amount) and premium accrued on the Outstanding Bonds and paid to the Bondholders, but exclude any Structuring
Fee payable by the Issuer to the initial Bondholders as provided in the Subscription Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">No
interest shall accrue on any Bond from and including the Conversion Date in respect of such Bond.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 13; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">1-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">7.</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Conversion</B></FONT></TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Partial Conversion upon a QIPO</I></B></FONT></TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Provided
that none of the Bonds has been redeemed by the Issuer, upon the occurrence of a QIPO and subject as provided in these Conditions:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">an
                                         aggregate nominal amount representing 10% of the Principal Amount of the Bonds shall
                                         be converted automatically into Shares (the &ldquo;<B>Conversion Upon QIPO</B>&rdquo;); and</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.4in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                         Issuer shall deliver a written notice in accordance with Condition 13 to notify the Bondholders,
                                         together with such evidence provided by an Independent Investment Bank to support, that
                                         the QIPO has occurred as provided in the Conditions. Upon the receipt of such notice,
                                         a Bondholder shall as soon as practicable deliver to the Issuer a written notice in accordance
                                         with Condition 13 (the &ldquo;<B>Certification</B>&rdquo;) on behalf of itself:</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.4in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 1in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(A)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">providing
                                         an address (if different from the corresponding addresses recorded in the Register) to
                                         which the Shares shall be delivered;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 1in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(B)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">designating
                                         a person or persons (if different from the registered Holder) as holder(s) of the relevant
                                         number of Shares in the Issuer&rsquo;s share register;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 1in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(C)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">providing
                                         a certification that such Conversion Upon QIPO is being made outside of the United States
                                         (as such term is defined in Regulation S (&ldquo;<B>Regulation S</B>&rdquo;) under the
                                         United States Securities Act of 1933, as amended) and it is not a U.S. person (as such
                                         term is defined in Regulation S) and it is not acting as agent for, or on behalf of,
                                         a U.S. person;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 1in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(D)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">providing
                                         any certification as may be required under the laws of the jurisdiction of incorporation
                                         of the Issuer; and</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 1in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(E)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">surrendering
                                         the Bond Certificate in respect of such Bond which shall be converted automatically into
                                         Shares as a result of the occurrence of a QIPO.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Conversion Right</I></B></FONT></TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Conversion
                                         Period</I>: Upon the occurrence of a QIPO and subject as provided in these Conditions,
                                         each Bond shall entitle the holder to convert such Bond into Shares credited as fully
                                         paid at any time during the Conversion Period referred to below (the &ldquo;<B>Conversion
                                         Right</B>&rdquo;).</FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Subject
to and upon compliance with these Conditions, the Conversion Right in respect of a Bond may be exercised, at the option of the
holder thereof, on the occurrence of a QIPO at any time (subject to any applicable fiscal or other laws or regulations and as
hereinafter provided) on or after the Issue Date to the earlier of:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 1in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(A)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                         date falling 12 calendar months after the Maturity Date or the Extended Maturity Date,
                                         as the case may be (both days inclusive); and</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 1in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(B)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
date falling 12 calendar months after the occurrence of the QIPO (both days inclusive),</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: left; margin-left: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(each
a &ldquo;<B>Conversion Period</B>&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.5in"></P>

<!-- Field: Page; Sequence: 14; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">1-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">                                                                                                                                          <TR STYLE="vertical-align: top">
<TD>&nbsp;</TD><TD STYLE="text-align: left">(ii)</TD><TD STYLE="text-align: justify">A Bondholder may only exercise its Conversion Right during the Conversion Period.</TD></TR>
<TR STYLE="vertical-align: top">
<TD>&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Conversion
                                         Price</I>: The price at which Shares will be issued upon a Conversion Upon QIPO or exercise
                                         of a Conversion Right (the &ldquo;<B>Conversion Price</B>&rdquo;) is subject to any adjustment
                                         in the circumstances described in Condition 7(d) and the discount (if applicable) to
                                         the IPO Share Price as follows:</FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.35in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 1in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(A)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">if
                                         a QIPO has occurred on or before the date falling 12 calendar months after the Issue
                                         Date, at a discount of 23.0% to the IPO Share Price pursuant to the QIPO; or</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.55in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 1in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(B)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">if
                                         a QIPO has occurred after the date falling 12 calendar months after the Issue Date, at
                                         a discount of 28.0% to the IPO Share Price pursuant to the QIPO,</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.55in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">in
each case subject to adjustment in the circumstances described in Condition 7(d).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
the event that any Interest Amount has been accrued and/or paid by the Issuer to the Bondholders prior to the occurrence of the
QIPO, in determining the applicable Conversion Price, 50.0 per cent. of such Interest Amount accrued and/or paid will be deducted
from the absolute value of the discount as calculated in accordance with Conditions 7(b)(iii)(A) or 7(b)(iii)(B) above (as applicable).
Schedule 5 sets out certain possible circumstances of the application of the discounts described herein for illustrative purposes
only.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iv)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
number of Shares to be issued on Conversion Upon QIPO or exercise of a Conversion Right shall be determined by dividing the principal
amount of the Bonds to be converted by the Conversion Price in effect on the relevant Conversion Date (defined below). Conversion
Upon QIPO may only be effected and a Conversion Right may only be exercised in respect of one or more Bonds. If more than one
Bond held by the same holder is converted at any one time by the same holder, the number of Shares to be issued upon such conversion
will be calculated on the basis of the aggregate principal amount of the Bonds to be converted.</FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.35in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(v)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Fractions
                                         of Shares</I>: Fractions of Shares will not be issued on exercise of Conversion Rights
                                         and no cash payment or other adjustment will be made in lieu thereof. However, if the
                                         Conversion Right in respect of more than one Bond is exercised at any one time such that
                                         Shares to be issued on conversion are to be registered in the same name, the number of
                                         such Shares to be issued in respect thereof shall be calculated on the basis of the aggregate
                                         principal amount of such Bonds being so converted and rounded down to the nearest whole
                                         number of Shares. Notwithstanding the foregoing, in the event of a consolidation or re-classification
                                         of Shares by operation of law or otherwise occurring after the Issue Date which reduces
                                         the number of Shares outstanding, the Issuer will upon conversion of Bonds pay in cash
                                         in U.S. Dollars a sum equal to such portion of the principal amount of the Bond or Bonds
                                         evidenced by the Bond Certificate deposited in connection with the exercise of Conversion
                                         Rights, aggregated as provided in Condition 7(b)(i), as corresponds to any fraction of
                                         a Share not issued as a result of such consolidation or re-classification aforesaid,
                                         provided that such sum exceeds US$1.00. Any such sum shall be paid not later than five
                                         Business Days after the relevant Conversion Date by transfer to a U.S. dollar account
                                         maintained by the payee with, a bank in Hong Kong, in accordance with instructions given
                                         by the relevant Bondholder in the Conversion Notice.</FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(vi)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Share
                                         Lockup Period</I>: Provided that no Event of Default has occurred and is continuing,
                                         following the exercise of the Conversion Right by a Bondholder, such Bondholder shall
                                         not, directly or indirectly, sell or otherwise transfer any Shares during a period of
                                         up to 90 calendar days following the first Trading Day after the occurrence of a QIPO
                                         (the &ldquo;Share Lockup Period&rdquo;).</FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.35in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.35in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 15; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">1-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.35in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Subject
to the Share Lockup Period provided above, the Bondholders may sell or transfer the Shares resulting from conversion of the Bonds.
The Issuer shall register the Shares in the registration statement on the Form F-1 which it will submit to the U.S. Securities
and Exchange Commission for the purpose of the intended QIPO.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Conversion Procedure</I></B></FONT></TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Conversion
                                         Notice</I>: Subject to Condition 7(a), Conversion Rights may be exercised by a Bondholder
                                         during the Conversion Period, by delivering the relevant Bond Certificate to the Issuer
                                         during its usual business hours (being 9:00 a.m. to 5:00 p.m., Monday to Friday other
                                         than public holidays) at the specified office of the Issuer accompanied by a duly completed
                                         and signed notice of conversion (a &ldquo;<B>Conversion Notice</B>&rdquo;) substantially
                                         in the form set out in schedule 4 hereto, together with certification by the Bondholder
                                         that such conversion is being made outside of the United States (as such term is defined
                                         in Regulation S) and it is not a U.S. person (as such term is defined in Regulation S)
                                         and it is not acting as agent for, or on behalf of, a U.S. person, and as may be required
                                         under the laws of the jurisdiction of incorporation of the Issuer. Conversion Rights
                                         shall be exercised subject in each case to any applicable fiscal or other laws or regulations
                                         applicable in the jurisdiction of the Issuer.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.4in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
such delivery is made after the end of normal business hours (being 5.00 p.m. in the place of the specified office) or on a day
which is not a Business Day in the place of the Issuer, such delivery shall be deemed for all purposes of these Conditions to
have been made on the next following such Business Day.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Conversion
                                         Date: </I>For the purposes of Conversion Upon QIPO and exercise of Conversion Rights,
                                         the conversion date in respect of a Bond (the &ldquo;<B>Conversion Date</B>&rdquo;) shall
                                         be deemed to be the Business Day (as defined in Condition 7(h)) immediately following
                                         the date of the surrender of the Bond Certificate in respect of such Bond and delivery
                                         of such Conversion Notice or Certification, as the case may be, and, if applicable, any
                                         such abovementioned certification or any payment to be made or indemnity given under
                                         these Conditions in connection with the Conversion Upon QIPO and the exercise of such
                                         Conversion Right, as the case may be. Conversion Upon QIPO may only be effected and Conversion
                                         Rights may only be exercised in respect of an Authorised Denomination. A Conversion Notice
                                         or Certification, as the case may be, once delivered shall be irrevocable and may not
                                         be withdrawn unless the Issuer consents in writing to such withdrawal.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.4in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Stamp
                                         Duty etc.</I>: the Issuer must pay directly to the relevant authorities any taxes and/or
                                         capital, stamp, issue and registration and transfer taxes and duties arising from a Bondholder
                                         effecting the Conversion Upon QIPO or exercising Conversion Rights (including without
                                         limitation any Duties payable in Cayman Islands, British Virgin Islands, Hong Kong and
                                         the United States and, if relevant, in the place of the Alternative Stock Exchange, in
                                         respect of the allotment and issue of Shares and listing of the Shares on the Relevant
                                         Stock Exchange on conversion)(collectively the &ldquo;<B>Taxes</B>&rdquo;). The Issuer
                                         will also pay all other expenses arising on the issue of Shares on conversion of Bonds
                                         and all charges of the share transfer agent for the Shares. The Bondholder (and, if different,
                                         the person to whom the Shares are to be issued) must declare in the relevant Conversion
                                         Notice or Certification that any amounts payable to the relevant tax authorities in settlement
                                         of any Taxes payable pursuant to this Condition 7(c)(iii) have been, or (where permitted
                                         by law) will be, paid.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.4in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.4in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><I></I></FONT></P>

<!-- Field: Page; Sequence: 16; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">1-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: left"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
the Issuer shall fail to pay any Taxes, the relevant holder shall be entitled to tender and pay the same and the Issuer as a separate
and independent stipulation, covenants to reimburse and indemnify each Bondholder in respect of any payment thereof and any penalties
payable in respect thereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Bondholder shall pay all, if any, taxes imposed and arising by reference to any disposal or deemed disposal of a Bond or interest
therein otherwise than in connection with the exercise of Conversion Rights by any Bondholder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iv)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Registration</I>:
Upon (A) Conversion Upon QIPO or (B) exercise of Conversion Rights and compliance with Conditions 7(c)(i) and 7(c)(iii) the Issuer
(Y) will, as soon as practicable, and in any event not later than seven Business Days after the Conversion Date, register the
person or persons designated for the purpose in the Conversion Notice or Certification (as the case may be) as holder(s) of the
relevant number of Shares in the Issuer&rsquo;s share register and (Z) will, within ten Business Days after the Conversion Date,
if the Bondholder has also requested in the Conversion Notice or Certification (as the case may be) and to the extent permitted
under applicable law and the rules and procedures of the Nasdaq Clearing AB (the &ldquo;<B>NASDAQ Clearing</B>&rdquo;) or the
equivalent clearing system of an Alternative Stock Exchange effective from time to time, take all necessary action to procure
that Shares are delivered through NASDAQ Clearing or the equivalent clearing system of an Alternative Stock Exchange for so long
as the Shares are listed on the NASDAQ or an Alternate Stock Exchange; or will make such certificate or certificates available
for collection at the office of the Issuer&rsquo;s share registrar in the United States or, as the case may be, the relevant jurisdiction
of the Alternate Stock Exchange notified to Bondholders in accordance with Condition 13 or, if so requested in the relevant Conversion
Notice or Certification (as the case may be), will cause its share registrar to mail such certificate or certificates to the person
and at the place specified in the Conversion Notice or Certification (as the case may be), together (in either case) with any
other securities, property or cash required to be delivered upon conversion and such assignments and other documents (if any)
as may be required by law to effect the transfer thereof, in which case a single share certificate will be issued in respect of
all Shares issued on conversion of Bonds subject to the same Conversion Notice or Certification (as the case may be) and which
are to be registered in the same name.</FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.35in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
delivery of the Shares to the converting Bondholder (or such person or persons designated in the relevant Conversion Notice or
Certification (as the case may be)) in the manner contemplated above in this Condition 7(c)(iv) will be deemed to satisfy the
Issuer&rsquo;s obligation to pay the principal, interest and premium (if any) on such converted Bonds.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
the Conversion Date in relation to the conversion of any Bond shall be after the record date for any issue, distribution, grant,
offer or other event as gives rise to the adjustment of the Conversion Price pursuant to Condition 7(d), but before the relevant
adjustment becomes effective (the &ldquo;<B>Relevant Effective Date</B>&rdquo;) under the relevant Condition (a &ldquo;<B>Retroactive
Adjustment</B>&rdquo;), upon the relevant adjustment becoming effective the Issuer shall procure the issue to the converting Bondholder
(or in accordance with the instructions contained in the Conversion Notice or Certification (as the case may be)(subject to applicable
exchange control or other laws or other regulations)), such additional number of Shares (&ldquo;<B>Additional Shares</B>&rdquo;)
as is, together with Shares to be issued on conversion of the Bond(s), equal to the number of Shares which would have been required
to be issued on conversion of such Bond if the relevant adjustment to the Conversion Price had been made and become effective
on or immediately after the relevant record date and in such event and in respect of such Additional Shares references in this
Condition 7(c)(iv) to the Conversion Date shall be deemed to refer to the Relevant Effective Date (notwithstanding that the Relevant
Effective Date falls after the end of the Conversion Period).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 17; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">1-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
person or persons specified for that purpose in the Conversion Notice or Certification (as the case may be) will become the holder
of record of the number of Shares issuable upon conversion with effect from the date he is or they are registered as such in the
Issuer&rsquo;s register of members (the &ldquo;<B>Registration Date</B>&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Shares issued upon Conversion Upon QIPO or upon exercise of Conversion Rights will be fully paid and will in all respects rank
<I>pari passu </I>with the fully paid Shares in issue on the relevant Registration Date except for any right excluded by mandatory
provisions of applicable law and except that such Shares will not rank for (or, as the case may be, the relevant holder shall
not be entitled to receive) any rights, distributions or payments the record or other due date for the establishment of entitlement
for which falls prior to the relevant Registration Date.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
the record date for the payment of any dividend or other distribution in respect of the Shares is on or after the Conversion Date
in respect of any Bond, but before the Registration Date (disregarding any Retroactive Adjustment of the Conversion Price referred
to in this Condition 7(c)(iv) prior to the time such Retroactive Adjustment shall have become effective), the Issuer will calculate
and pay to the converting Bondholder or such Bondholder&rsquo;s designee an amount in U.S. dollars (the &ldquo;<B>Equivalent Amount</B>&rdquo;)
equal to the Fair Market Value (as defined below) of such dividend or other distribution to which he would have been entitled
had he on that record date been such a shareholder of record and will make the payment at the same time as it makes payment of
the dividend or other distribution, or as soon as practicable thereafter, but, in any event, not later than seven days thereafter.
The Equivalent Amount shall be paid by transfer to a U.S. dollar account maintained by the payee with, a bank in Hong Kong, in
accordance with instructions given by the relevant Bondholder in the Conversion Notice or Certification (as the case may be).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Adjustments to Conversion Price</I></B></FONT></TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Conversion Price will be subject to adjustment as follows:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Consolidation,
                                         Subdivision or Re-classification</I>: If and whenever there shall be an alteration to
                                         the nominal value of the Shares as a result of consolidation, subdivision or re-classification,
                                         the Conversion Price shall be adjusted by multiplying the Conversion Price in force immediately
                                         before such alteration by the following fraction:</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I><U>A</U></I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>B</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Where:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">A</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">is
the nominal amount of one Share immediately after such alteration; and</FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">B</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">is
the nominal amount of one Share immediately before such alteration.</FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Such
adjustment shall become effective on the date the alteration takes effect.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 18; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">1-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Capitalisation of Profits or Reserves:</I></B></FONT></TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
and whenever the Issuer shall issue any Shares credited as fully paid to the holders of Shares (&ldquo;<B>Shareholders</B>&rdquo;)
by way of capitalisation of profits or reserves including, Shares paid up out of distributable profits or reserves and/or share
premium account (except any Scrip Dividend) and which would not have constituted a Capital Distribution, the Conversion Price
shall be adjusted by multiplying the Conversion Price in force immediately before such issue by the following fraction:</FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I><U>A</U></I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; text-align: center; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>B</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: left; margin-left: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Where:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">A</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">is
the aggregate nominal amount of the issued Shares immediately before such issue; and</FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">B</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">is
the aggregate nominal amount of the issued Shares immediately after such issue.</FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Such
adjustment shall become effective on the date of issue of such Shares or if a record date is fixed therefor, immediately after
such record date.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
the case of an issue of Shares by way of a Scrip Dividend where the Current Market Price on the date of announcement of the terms
of such issue of Shares multiplied by the number of Shares issued exceeds the amount of the Relevant Cash Dividend or the relevant
part thereof and which would not have constituted a Capital Distribution, the Conversion Price shall be adjusted by multiplying
the Conversion Price in force immediately before the issue of such Shares by the following fraction:</FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; text-align: center; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I><U>A
+ B</U></I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; text-align: center; margin-bottom: 0"><I>A + C</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: left; margin-left: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Where:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">A</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">is
the aggregate nominal amount of the issued Shares immediately before such issue;</FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">B</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">is
the aggregate nominal amount of Shares issued by way of such
Scrip Dividend multiplied by a fraction of which (i) the numerator is the amount of the whole, or the relevant part, of the Relevant
Cash Dividend and (ii) the denominator is such Current Market Price of the Shares issued by way of Scrip Dividend in respect of
each existing Share in lieu of the whole, or the relevant part, of the Relevant Cash Dividend; and</FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">C</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">is
the aggregate nominal amount of Shares issued by way of such
Scrip Dividend; or by making such other adjustment as an Independent Investment Bank and/or Independent Firm of Auditors deem
fair and reasonable.</FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: justify; margin-left: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Such
adjustment shall become effective on the date of issue of such Shares or if a record date is fixed therefor, immediately after
such record date.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Capital
                                         Distributions</I>: If and whenever the Issuer shall pay or make any Capital Distribution
                                         to the Shareholders (except to the extent that the Conversion Price falls to be adjusted
                                         under Condition 7(e) above), the Conversion Price shall be adjusted by multiplying the
                                         Conversion Price in force immediately before such Capital Distribution by the following
                                         fraction:</FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.35in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I><U>A
&minus; B</U></I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>A</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: left; margin-left: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Where:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">A</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">is
the Current Market Price of one Share on the date on which the Capital Distribution is publicly announced; and</FONT></TD>
</TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P>

<!-- Field: Page; Sequence: 19; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">1-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0pt; width: 100%">
<TR STYLE="vertical-align: top">
<TD STYLE="width: 1in">&nbsp;</TD><TD STYLE="text-align: left; width: 0.5in">B</TD><TD STYLE="text-align: justify">is the Fair Market Value on the date of such announcement of the portion of the Capital Distribution attributable to one Share.</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: justify; margin-left: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Such
adjustment shall become effective on the date that such Capital Distribution is actually made or if a record date is fixed therefor,
immediately after such record date.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: justify; margin-left: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
making any calculation pursuant to this Condition 7(e)(iii), such adjustments (if any) shall be made as an Independent Investment
Bank and/or Independent Firm of Auditors may consider appropriate to reflect (a) any consolidation or subdivision of the Shares,
(b) issues of Shares by way of capitalisation of profits or reserves, or any like or similar event, (c) the modification of any
rights to dividends of Shares or (d) any change in the fiscal year of the Issuer.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iv)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Rights
Issues of Shares or Options over Shares</I>: If and whenever the Issuer shall issue Shares to all or substantially all Shareholders
as a class by way of rights, or issue or grant to all or substantially all Shareholders as a class by way of rights, options,
warrants or other rights to subscribe for, purchase or otherwise acquire any Shares, in each case at less than 95 per cent. of
the Current Market Price per Share on the date of the announcement of the terms of the issue or grant, the Conversion Price shall
be adjusted by multiplying the Conversion Price in force immediately before such issue or grant by the following fraction:</FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.35in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I><U>A
+ B</U></I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; text-align: center; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>A
+ C</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: justify; margin-left: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Where:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">A</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">is
the number of Shares in issue immediately before such announcement;</FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">B</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">is
the number of Shares which the aggregate amount (if any) payable for the Shares issued by way of rights or for the options or
warrants or other rights issued or granted by way of rights and for the total number of Shares comprised therein would subscribe
for, purchase or otherwise acquire at such Current Market Price per Share; and</FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">C</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">is
the aggregate number of Shares issued or, as the case may be, comprised in the issue or grant.</FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: justify; margin-left: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Such
adjustment shall become effective on the date of issue of such Shares or issue or grant of such options, warrants or other rights
(as the case may be) or where a record date is set, the first date on which the Shares are traded ex-rights, ex-options or ex-warrants,
as the case may be.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(v)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Rights
Issues of Other Securities</I>: If and whenever the Issuer shall issue any securities (other than Shares or options, warrants
or other rights to subscribe for, purchase or otherwise acquire Shares) to all or substantially all Shareholders as a class by
way of rights, or issue or grant to all or substantially all Shareholders as a class by way of rights, options, warrants or other
rights to subscribe for, purchase or otherwise acquire any securities (other than Shares or options, warrants or other rights
to subscribe for, purchase or otherwise acquire Shares), the Conversion Price shall be adjusted by multiplying the Conversion
Price in force immediately before such issue or grant by the following fraction:</FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I><U>A
&minus; B</U></I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>A</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: justify; margin-left: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Where:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">A</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">is
the Current Market Price of one Share on the date on which such issue or grant is publicly announced; and</FONT></TD>
</TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 20; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">1-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0pt; width: 100%">
<TR STYLE="vertical-align: top">
<TD STYLE="width: 1in">&nbsp;</TD><TD STYLE="text-align: left; width: 0.5in">B</TD><TD STYLE="text-align: justify">is the Fair Market Value on the date of such announcement of the portion of the rights attributable to one Share.</TD></TR>
</TABLE></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: justify; margin-left: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Such
adjustment shall become effective on the date of issue of the securities or the issue or grant of such rights, options or warrants
(as the case may be) or where a record date is set, the first date on which the Shares are traded ex-rights, ex-options or ex-warrants,
as the case may be.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(vi)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Issues
at less than Current Market Price</I></B>: If and whenever the Issuer shall issue (otherwise than as mentioned in Condition 7(e)(iv)
above or in connection with any Post-IPO Secondary Offering or Permitted Offering that otherwise complies with these Conditions)
any Shares (other than Shares issued on the exercise of Conversion Rights or on the exercise of any other rights of conversion
into, or exchange or subscription for, Shares) or issue or grant (otherwise than as mentioned in Condition 7(e)(iv) above) options,
warrants or other rights to subscribe for, purchase or otherwise acquire Shares in each case at a price per Share which is less
than 95 per cent. of the Current Market Price on the date of announcement of the terms of such issue, the Conversion Price shall
be adjusted by multiplying the Conversion Price in force immediately before such issue by the following fraction:</FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.35in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I><U>A
+ B</U></I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>C</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: justify; margin-left: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Where:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">A</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">is
the number of Shares in issue immediately before the issue of such additional Shares or the grant of such options, warrants or
other rights to subscribe for, purchase or otherwise acquire any Shares;</FONT></TD>
</TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">&nbsp;</TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
</TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">B</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">is
the number of Shares which the aggregate consideration (if any) receivable for the issue of such additional Shares would purchase
at such Current Market Price per Share; and</FONT></TD>
</TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">&nbsp;</TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
</TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">C</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">is
the number of Shares in issue immediately after the issue of such additional Shares.</FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: justify; margin-left: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">References
to additional Shares in the above formula shall, in the case of an issue by the Issuer of options, warrants or other rights to
subscribe or purchase Shares, mean such Shares to be issued assuming that such options, warrants or other rights are exercised
in full at the initial exercise price on the date of issue or grant of such options, warrants or other rights.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: justify; margin-left: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Such
adjustment shall become effective on the date of issue of such additional Shares or, as the case may be, the issue or grant of
such options, warrants or other rights.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(vii)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Other
                                         Issues at less than Current Market Price</I>: Save in the case of an issue of securities
                                         arising from a conversion or exchange of other securities in accordance with the terms
                                         applicable to such securities themselves falling within this Condition 7(e)(vii), if
                                         and whenever the Issuer or any of its Subsidiaries (otherwise than as mentioned in Condition
                                         7(e)(iv), Condition 7(e)(v) or Condition 7(e)(vi)), or (at the direction or request of
                                         or pursuant to any arrangements with the Issuer or any of its Subsidiaries) any other
                                         company, person or entity shall issue any securities (other than the Bonds, which shall
                                         be deemed to exclude any further bonds issued pursuant to Condition 16) which by their
                                         terms of issue carry rights of conversion into, or exchange or subscription for, Shares
                                         to be issued by the Issuer upon conversion, exchange or subscription at a consideration
                                         per Share which is less than 95 per cent. of the Current Market Price on the date of
                                         announcement of the terms of issue of such securities, the Conversion Price shall be
                                         adjusted by multiplying the Conversion Price in force immediately before such issue by
                                         the following fraction:</FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.35in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I><U>A
+ B</U></I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>A
+ C</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: justify; margin-left: 1in"></P>

<!-- Field: Page; Sequence: 21; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">1-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: justify; margin-left: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: justify; margin-left: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Where:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">A</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">is
the number of Shares in issue immediately before such issue;</FONT></TD>
</TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">&nbsp;</TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
</TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">B</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">is
the number of Shares which the aggregate consideration receivable by the Issuer for the Shares to be issued on conversion or exchange
or on exercise of the right of subscription attached to such securities would purchase at such Current Market Price per Share;
and</FONT></TD>
</TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">&nbsp;</TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
</TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">C</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">is
the maximum number of Shares to be issued on conversion or exchange of such securities or on the exercise of such rights of subscription
attached thereto at the initial conversion, exchange or subscription price or rate.</FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: justify; margin-left: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Such
adjustment shall become effective on the date of issue of such securities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(viii)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Modification
of Rights of Conversion etc.</I>: If and whenever there shall be any modification of the rights of conversion, exchange or subscription
attaching to any such securities as are mentioned in Condition 7(e)(vii) (other than in accordance with the terms of such securities)
so that the consideration per Share (for the number of Shares available on conversion, exchange or subscription following the
modification) is reduced and is less than 95 per cent. of the Current Market Price on the date of announcement of the proposals
for such modification, the Conversion Price shall be adjusted by multiplying the Conversion Price in force immediately before
such modification by the following fraction:</FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.35in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I><U>A
+ B</U></I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>A
+ C</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: justify; margin-left: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Where:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">A</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">is
the number of Shares in issue immediately before such modification;</FONT></TD>
</TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">&nbsp;</TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
</TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">B</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">is
the number of Shares which the aggregate consideration receivable by the Issuer for the Shares to be issued on conversion or exchange
or on exercise of the right of subscription attached to the securities so modified would purchase at such Current Market Price
per Share or, if lower, the existing conversion, exchange or subscription price of such securities; and</FONT></TD>
</TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">&nbsp;</TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
</TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">C</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">is
the maximum number of Shares to be issued on conversion or exchange of such securities or on the exercise of such rights of subscription
attached thereto at the modified conversion, exchange or subscription price or rate but giving credit in such manner as an Independent
Investment Bank and/or Independent Firm of Auditors considers appropriate (if at all) for any previous adjustment under this Condition
7(e)(viii) or Condition 7(e)(vii).</FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: justify; margin-left: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Such
adjustment shall become effective on the date of modification of the rights of conversion, exchange or subscription attaching
to such securities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 22; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">1-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->21<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ix)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Other
Offers to Shareholders</I>: Other than the Permitted Offerings and Post-IPO Secondary Offerings that otherwise comply with these
Conditions, if and whenever the Issuer or any of its Subsidiaries or (at the direction or request of or pursuant to any arrangements
with the Issuer or any of its Subsidiaries) any other company, person or entity issues, sells or distributes any securities in
connection with an offer pursuant to which the Shareholders generally are entitled to participate in arrangements whereby such
securities may be acquired by them (except where the Conversion Price falls to be adjusted under Condition 7(e)(iv), Condition
7(e)(v), Condition 7(e)(vi) or Condition 7(e)(vii)), the Conversion Price shall be adjusted by multiplying the Conversion Price
in force immediately before such issue by the following fraction:</FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.35in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I><U>A
                                                                                                         -
                                                                                                         B</U></I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>A</I></FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.35in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: justify; margin-left: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Where:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">A</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">is
the Current Market Price of one Share on the date on which such issue is publicly announced; and</FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">B</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">is
the Fair Market Value on the date of such announcement of the portion of the rights attributable to one Share.</FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: justify; margin-left: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Such
adjustment shall become effective on the date of issue, sale or delivery of the securities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(x)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Cash
                                         Dividends</I>: If and whenever the Issuer shall pay or make any Cash Dividend to the
                                         Shareholders, the Conversion Price shall be adjusted by multiplying the Conversion Price
                                         in force immediately before such Cash Dividend by the following fraction:</FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I><U>A
                                         - B</U></I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><I>A</I></FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: justify; margin-left: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Where:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">A</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">is
the Current Market Price of one Share on the date for the determination of Shareholders entitled to receive such Cash Dividend;
and</FONT></TD>
</TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">&nbsp;</TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
</TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">B</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">is
the portion of the Fair Market Value of the aggregate dividend attributable to one Share, which such portion being determined
by dividing the Fair Market Value of the aggregate Cash Dividend by the number of the Shares entitled to receive the relevant
Cash Dividend.</FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: justify; margin-left: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Such
adjustment shall become effective on the date on which such Cash Dividend is actually made or if a record date is fixed therefore,
immediately after such record date.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(xi)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Other
                                         Events</I>: If the Issuer determines that an adjustment should be made to the Conversion
                                         Price as a result of one or more events or circumstances not referred to in this Condition
                                         7, the Issuer shall, at its own expense, consult an Independent Investment Bank and/or
                                         Independent Firm of Auditors to determine as soon as practicable what adjustment (if
                                         any) to the Conversion Price is fair and reasonable to take account thereof, if the adjustment
                                         would result in a reduction in the Conversion Price, and the date on which such adjustment
                                         should take effect and upon such determination by the Independent Investment Bank and/or
                                         Independent Firm of Auditors such adjustment (if any) shall be made and shall take effect
                                         in accordance with such determination, provided that where the events or circumstances
                                         giving rise to any adjustment pursuant to this Condition 7 have already resulted or will
                                         result in an adjustment to the Conversion Price or where the events or circumstances
                                         giving rise to any adjustment arise by virtue of events or circumstances which have already
                                         given rise or will give rise to an adjustment to the Conversion Price, such modification
                                         (if any) shall be made to the operation of the provisions of this Condition 7 as may
                                         be advised by the Independent Investment Bank and/or Independent Firm of Auditors to
                                         be in its opinion appropriate to give the intended result. Notwithstanding the foregoing,
                                         the per Share value of any such adjustment shall not exceed the per Share value of the
                                         dilution in the Shareholders&rsquo; interest in the Issuer&rsquo;s equity caused by such
                                         events or circumstances.</FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.35in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.35in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 23; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">1-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->22<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.35in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(xii)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Exceptions
                                         for Post-IPO Secondary Offerings and Permitted Offerings</I>: <I>Condition 7(e) shall
                                         not apply in respect of any Post-IPO Secondary Offering and Permitted Offering that otherwise
                                         complies with these Conditions.</I></FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.45in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(f)</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Undertakings</I></B></FONT></TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Issuer has undertaken that so long as any Bond remains Outstanding, save with the approval of the Bondholders:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">following
                                         the occurrence of a QIPO, it will (a) maintain a listing for all the issued Shares on
                                         the NASDAQ or, if applicable, an Alternative Stock Exchange (as defined in Condition
                                         7(h)), and (b) obtain and maintain a listing for all the Shares issued on the exercise
                                         of the Conversion Rights on the NASDAQ or, if applicable, an Alternative Stock Exchange,
                                         and (c) if the Issuer is unable to obtain or maintain such listing or such listing is
                                         unduly onerous, obtain and maintain a listing for all the issued Shares on an Alternative
                                         Stock Exchange as the Issuer may from time to time determine and will forthwith give
                                         notice to the Bondholders in accordance with Condition 13 of the listing or delisting
                                         of the Shares (as a class) by any of such stock exchange;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.4in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">it
                                         will pay the expenses of the issue of, and all expenses of obtaining listing for, Shares
                                         arising on conversion of the Bonds;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.4in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">it
                                         will not make any voluntary reduction of its ordinary share capital or any uncalled liability
                                         in respect thereof or of any share premium account except, in each case, where the reduction
                                         is permitted by applicable law and results in (or would, but for the provision of these
                                         Conditions relating to rounding or the carry forward of adjustments, result in) an adjustment
                                         to the Conversion Price or is otherwise taken into account for the purposes of determining
                                         whether such an adjustment should be made provided always that the Issuer shall not be
                                         prohibited from purchasing its Shares to the extent permitted by law;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.4in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iv)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">it
                                         will reserve, free from any other pre-emptive or other similar rights (unless otherwise
                                         provided herein), out of its authorised but unissued ordinary share capital the full
                                         number of Shares liable to be issued on conversion of the Bonds from time to time remaining
                                         Outstanding and shall ensure that all Shares delivered on conversion of the Bonds will
                                         be duly and validly issued as fully-paid and non-assessable; and</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.4in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(v)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">it
                                         will not make any offer, issue, grant or distribute or take any action the effect of
                                         which would be to reduce the Conversion Price below the par value of the Shares of the
                                         Issuer, provided always that the Issuer shall not be prohibited from purchasing its Shares
                                         to the extent permitted by law.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.4in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Issuer has also given certain other undertakings in the Subscription Agreement for the protection of the Conversion Rights.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(g)</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Provisions Relating to Changes in Conversion Price</I></B></FONT></TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Minor
                                         adjustments</I>: On any adjustment, the resultant Conversion Price, if not an integral
                                         multiple of one U.S. Dollars cent, shall be rounded down to the nearest U.S. Dollars
                                         cent. No adjustment shall be made to the Conversion Price if such adjustment (rounded
                                         down if applicable) would be less than one per cent. of the Conversion Price then in
                                         effect. Any adjustment not required to be made, and/or any amount by which the Conversion
                                         Price has been rounded down, shall be carried forward and taken into account in any subsequent
                                         adjustment, and such subsequent adjustment shall be made on the basis that the adjustment
                                         not required to be made had been made at the relevant time and/or, as the case may be,
                                         that the relevant rounding down had not been made. Notice of any adjustment shall be
                                         given by the Issuer to the Bondholders in accordance with Condition 13 after the determination
                                         thereof.</FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 24; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">1-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->23<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Decision
                                         of an Independent Investment Bank and/or Independent Firm of Auditors</I>: If any doubt
                                         shall arise as to whether an adjustment falls to be made to the Conversion Price or as
                                         to how an adjustment to the Conversion Price under Condition 7(d) should be made, following
                                         consultation between the Issuer and an Independent Investment Bank and/or Independent
                                         Firm of Auditors, a written opinion of such Independent Investment Bank and/or Independent
                                         Firm of Auditors in respect thereof shall be conclusive and binding on the Issuer, the
                                         Guarantor and the Bondholders, save in the case of manifest error. Notwithstanding the
                                         foregoing, the per Share value of any such adjustment shall not exceed the per Share
                                         value of the dilution in the Shareholders&rsquo; interest in the Issuer&rsquo;s equity
                                         caused by such events or circumstances.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.4in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Minimum
                                         Conversion Price</I>: Notwithstanding the provisions of this Condition 7, the Issuer
                                         undertakes that: (a) the Conversion Price shall not in any event be reduced to below
                                         the nominal or par value of the Shares as a result of any adjustment hereunder unless
                                         under applicable law then in effect the Bonds may be converted at such reduced Conversion
                                         Price into legally issued, fully paid and non-assessable Shares; and (b) it shall not
                                         take any action, and shall procure that no action is taken, that would otherwise result
                                         in an adjustment to the Conversion Price to below such nominal or par value or any minimum
                                         level permitted by applicable laws or regulations.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.4in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iv)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Reference
                                         to &ldquo;fixed&rdquo;</I>: Any references herein to the date on which a consideration
                                         is &ldquo;fixed&rdquo; shall, where the consideration is originally expressed by reference
                                         to a formula which cannot be expressed as an actual cash amount until a later date, be
                                         construed as a reference to the first day on which such actual cash amount can be ascertained.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.4in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(v)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Multiple
                                         events</I>: Where more than one event which gives or may give rise to an adjustment to
                                         the Conversion Price occurs within such a short period of time that in the opinion of
                                         an Independent Investment Bank and/or Independent Firm of Auditors, the foregoing provisions
                                         would need to be operated subject to some modification in order to give the intended
                                         result, such modification shall be made to the operation of the foregoing provisions
                                         as may be advised by such Independent Investment Bank and/or Independent Firm of Auditors
                                         to be in its opinion appropriate in order to give such intended result.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.4in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Upward/downward
                                         adjustment</I>: No adjustment involving an increase in the Conversion Price will be made,
                                         except in the case of a consolidation or reclassification of the Shares as referred to
                                         in Condition 7(d)(i) above. The Issuer may at any time and for a specified period of
                                         time only, following notice being given to the Bondholders in accordance with Condition
                                         13, reduce the Conversion Price, subject to Condition 7(g)(iii).</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.4in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Bondholders
                                         not obliged to monitor or make calculations</I>: The Bondholders shall not be under any
                                         duty to monitor whether any event or circumstance has happened or exists which may require
                                         an adjustment to be made to the Conversion Price or to make any calculation or determination
                                         (or verification thereof) in connection with the Conversion Price.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.4in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Notice
                                         of change in Conversion Price</I>: The Issuer shall give notice to the Bondholders in
                                         accordance with Condition 13 of any change in the Conversion Price. Any such notice relating
                                         to a change in the Conversion Price shall set forth the event giving rise to the adjustment,
                                         the Conversion Price prior to such adjustment, the adjusted Conversion Price and the
                                         effective date of such adjustment.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.4in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.4in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B><I></I></B></FONT></P>

<!-- Field: Page; Sequence: 25; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">1-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->24<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: left"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B><I>&nbsp;</I></B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(h)</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Definitions</I></B></FONT></TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
the purposes of these Conditions:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Account
Bank</B>&rdquo; means the financial institution acting as such in accordance with the terms of the Account Charge;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Capital
Distribution</B>&rdquo; means any distribution of assets in specie by the Issuer for any financial period whenever paid or made
and however described (and for these purposes a distribution of assets in specie includes without limitation an issue of Shares
or other securities credited as fully or partly paid (other than Shares credited as fully paid) by way of capitalisation of reserves);</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Cash
Dividend</B>&rdquo; means any cash dividend or distribution of any kind made or declared by the Issuer for any financial period
(whenever paid and however described);</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Closing
Price</B>&rdquo; means, in respect of a Share for any Trading Day, the closing market price published in the daily quotation sheet
published by the NASDAQ or, as the case may be, the equivalent quotation sheet of the Alternative Stock Exchange for such Trading
Day;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Current
Market Price</B>&rdquo; means, in respect of a Share on a particular date, the average of the daily Closing Price on each of the
20 consecutive Trading Days ending on and including the Trading Day immediately preceding such date; provided that if at any time
during such 20 Trading Day period the Closing Price shall have been based on a price ex-dividend (or ex-any other entitlement)
and during some other part of that period the Closing Price shall have been based on a price cum-dividend (or cum-any other entitlement)
then:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(I)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">if
                                         the Shares to be issued or transferred and delivered do not rank for the <FONT STYLE="font: 10pt Times New Roman, Times, Serif">dividend
(or entitlement) in question, the Closing Price on the dates on which the Shares shall have been based on a price cum-dividend
(or cum-any other entitlement) shall for the purpose of this definition be deemed to be the amount thereof reduced by an amount
equal to the Fair Market Value of any such dividend or entitlement per Share; or</FONT></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(II)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">if
                                         the Shares to be issued or transferred and delivered rank for the dividend or entitlement
                                         in question, the Closing Price on the dates on which the Shares shall have been based
                                         on a price ex-dividend (or ex-any other entitlement) shall for the purpose of this definition
                                         be deemed to be the amount thereof increased by the Fair Market Value of any such dividend
                                         or entitlement per Share;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.4in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">and
provided that if on each of the said 20 Trading Days the Closing Price shall have been based on a price cum-dividend (or cum-any
other entitlement) in respect of a dividend (or other entitlement) which has been declared or announced but the Shares to be issued
or transferred and delivered do not rank for that dividend (or other entitlement), the Closing Price on each of such dates shall
for the purposes of this definition be deemed to be the amount thereof reduced by an amount equal to the Fair Market Value of
any such dividend or entitlement per Share;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Debt
Service Reserve Account</B>&rdquo; means an account established and maintained by the Issuer or any of its subsidiaries denominated
in US dollars and held with the Account Bank subject to the terms of the Account Charge;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Debt
Service Reserve</B>&rdquo; means any amount standing to the credit of the Debt Service Reserve Account including any income or
interest earned thereon from time to time;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Default
IRR</B>&rdquo; means an internal rate of return equal to 23.0 per cent. per annum. For the avoidance of doubt, the Default IRR
to which the Bondholders are entitled to shall be independent from any other recourse that such Bondholders may have pursuant
to the Transaction Documents or the Bonds;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 26; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">1-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->25<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&ldquo;<B>Employees&rsquo;
Share Options</B>&rdquo; means, in respect of the Issuer, any options granted or to be granted to the Issuer&rsquo;s eligible directors
or employees including, but not limited to, principal investigators, research collaborators, research consultants and relevant
external academic institutions to acquire at the discretion of the Issuer the Ordinary Shares pursuant to the relevant option
agreements to be granted under the Issuer&rsquo;s share option plan;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Executed
Private Placements</B>&rdquo; means all of the private placements of unsecured convertible notes convertible into the Shares that
has been entered into by the Issuer and other investors prior to the Signing Date;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Exit
IRR</B>&rdquo; means an internal rate of return equal to 8.0 per cent. per annum. For the avoidance of doubt, the Exit IRR to which
the Bondholders are entitled shall be independent from any other recourse that such Bondholders may have pursuant to the Transaction
Documents or the Bonds;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Exposure</B>&rdquo;
means,</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">at
                                         any time before the occurrence of the QIPO, the aggregate principal amount of the Bonds
                                         held by the Bondholders is more or equal to US$7,500,000; or</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.65in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">at
                                         any time after the occurrence of the QIPO, the aggregate economic interest of the Bondholders
                                         calculated in accordance with the following formula:</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.65in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>A
+ B &ge; C*50%&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">where:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 1in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(A)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">means
                                         the aggregate number of Shares actually held by the Bondholders at the relevant time
                                         following the conversion of the Bonds; and</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.4in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 1in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(B)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">means
                                         the aggregate number of Shares falling to be issued on conversion of the aggregate principal
                                         amount of Outstanding Bonds held by the Bondholders at the relevant time; and</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.4in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 1in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(C)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">means
                                         the aggregate number of Shares falling to be issued on conversion of the Principal Amount
                                         of the Bonds divided by the Conversion Price applicable at the relevant time.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.4in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Fair
Market Value</B>&rdquo; means, with respect to any asset, security, option, warrant or other right on any date, the fair market
value of that asset, security, option, warrant or other right as determined by an Independent Investment Bank and/or Independent
Firm of Auditors, provided that (i) the fair market value of a cash dividend paid or to be paid per Share shall be the amount
of such cash dividend per Share determined as at the date of announcement of such dividend; (ii) where options, warrants or other
rights are publicly traded in a market of adequate liquidity (as determined by such Independent Investment Bank and/or Independent
Firm of Auditors) the fair market value of such options, warrants or other rights shall equal the arithmetic mean of the daily
closing prices of such options, warrants or other rights during the period of five trading days on the relevant market commencing
on the first such trading day such options, warrants or other rights are publicly traded;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Group</B>&rdquo;
means the Issuer, the Guarantor and any of the Issuer&rsquo;s Subsidiaries, taken as a whole;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Independent
Firm of Auditors</B>&rdquo; means an independent firm of auditors of international repute selected by the Issuer and accepted in
writing by the Bondholders;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 27; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">1-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->26<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&ldquo;<B>Independent
Investment Bank</B>&rdquo; means an independent investment bank of international repute selected by the Issuer and accepted in
writing by the Bondholders;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Intellectual
Property</B>&rdquo; means any and all intellectual property including all patents, patent rights, licences, inventions, copyrights,
know-how (including trade secrets and other unpatented and/or unpatentable proprietary or confidential information, systems or
procedures), trademarks, service marks, business names, trade names, domain names, brands, copyright, know how and other intellectual
property owned by the Issuer or any other member of the Group (other than the Guarantor) as of the Signing Date;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>IPO
Share Price</B>&rdquo; means the price per Share at which such Shares are offered at the Listing;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Market
Capitalisation at IPO</B>&rdquo; means the product of the IPO Share Price multiplied by the number of Ordinary Shares at issue
at the QIPO;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>NASDAQ</B>&ldquo;
means Nasdaq Stock Market;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Notice
of Potential Event of Default</B>&rdquo; means a written notice of default given to the Issuer or the Guarantor by the Bondholders
in respect of the occurrence of an event or circumstance which could with the giving of notice, lapse of time, and/or fulfilment
of any other requirement provided for in Conditions 11(iii), 11(iv) and 11(xiv) become an Event of Default;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&ldquo;Ordinary
Shares&rdquo; </B>means the Shares and class B ordinary shares in the capital of the Issuer in issue at the relevant time;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&ldquo;Other
Share Options&rdquo; </B>means any options granted or to be granted by the Issuer to its employees, principal investigators, advisors,
industry and collaboration partners and research institutes to acquire the shares of the Issuer&rsquo;s Subsidiaries from time-to-time;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Outstanding</B>&rdquo;
means, in relation to the Bonds, all the Bonds issued except:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">those
                                         which have been redeemed in accordance with the Conditions; or</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: -0.4in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">those
                                         in respect of which the date for redemption has occurred and the redemption moneys (including
                                         the premium if any), all interest accrued on such Bonds to the date for such redemption
                                         and any interest payable under the Conditions after such date have been duly paid to
                                         the Bondholders as provided this Agreement and remain available for payment in accordance
                                         with the Conditions; or</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.4in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">those
                                         which have become void or in respect of which claims have become prescribed; or</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.4in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iv)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">those
                                         which have been converted into Shares, purchased and cancelled as provided in the Conditions;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.4in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Permitted
Use of Proceeds</B>&rdquo; means, within China, general research and development expenses, working capital, deposits, repayment
or settlement of outstanding liabilities of the Issuer or its Subsidiaries;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&ldquo;Private
Placements&rdquo; </B>means the private placements of unsecured convertible notes in an aggregate principal amount of up to US$10,000,000
convertible into the Shares that has been (and/or will be) entered into by the Issuer and the other investors, which includes
all of the Executed Private Placements;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"></P>

<!-- Field: Page; Sequence: 28; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">1-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->27<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>QIPO</B>&rdquo;
(qualifying initial public offering) means the occurrence of the last of all of the conditions below being satisfied in the sole
opinion of an Independent Investment Bank (which may include Boustead Securities)(as supported by any such evidence provided by
such Independent Investment Bank), subject to Condition 12:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">all
                                         the Shares of the Issuer being listed, quoted, admitted to trading or dealt in on NASDAQ
                                         or any principal stock exchange or securities market satisfactory to the Bondholders
                                         (an &ldquo;<B>Alternative Stock Exchange</B>&rdquo;) (the &ldquo;<B>Listing</B>&rdquo;);</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.4in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                         Market Capitalisation at IPO being not less than US$380,000,000; and</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.4in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                         total number of issued Shares of the Issuer that are held by the public having satisfied
                                         the applicable public float requirements of NASDAQ or the Alternative Stock Exchange.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.4in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Registrar</B>&rdquo;
means the Issuer or such other person, firm or company as for the time being maintains the register of the holders of the Bonds;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Release
Conditions</B>&rdquo; means each of the following:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                         relevant requirements relating to the Issuer&rsquo;s obligation to pay the principal, interest
                                         and premium to the Bondholders in accordance with the applicable Conditions, including
                                         but not limited to Conditions 6 and 9, to enable the release of the Debt Service Reserve
                                         in an amount equal to such principal, interest and/or premium payable; and/or</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.4in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">following
                                         the occurrence of a QIPO and any Bond being converted into Shares, the relevant requirements
                                         relating to a Conversion Upon QIPO or exercise of a Conversion Right in accordance with
                                         Condition 7, to enable the release of the Debt Service Reserve in an amount <I>pro rata
                                         </I>to the principal amount of the Bond or Bonds being converted,</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.4in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">in
each case, subject to the Issuer delivering to the Bondholders a written notice in accordance with the Account Charge detailing
satisfaction of the relevant condition specified in paragraph (i) or (ii) above (as the case may be), duly signed by any two directors
or duly authorised officers of the Issuer, setting out the exact amounts of Debt Service Reserve to be released from the Debt
Service Reserve Account and, as the case may be, certifying that such amounts are designated for all or any of the Permitted Use
of Proceeds. No such Release Conditions will be deemed satisfied unless and until the Bondholders confirm the same in writing
(and such confirmation shall not be unreasonably withheld or delayed) in accordance with the Account Charge.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Relevant
Cash Dividend</B>&rdquo; means the aggregate cash dividend or distribution declared by the Issuer, including any cash dividend
in respect of which there is any Scrip Dividend;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Relevant
Stock Exchange</B>&rdquo; means, at any time, in respect of the Shares, the NASDAQ or an Alternative Stock Exchange;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Shareholders</B>&rdquo;
means the registered holders from time to time of Shares;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Shares</B>&rdquo;
means the Class A ordinary shares of the Issuer or shares of any class or classes resulting from any subdivision, consolidation
or re-classification of those Shares, which as between themselves have no preference in respect of dividends or of amounts payable
in the event of any voluntary or involuntary liquidation or dissolution of the Issuer;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Scrip
Dividend</B>&rdquo; means any Shares issued in lieu of the whole or any part of any Relevant Cash Dividend, being a dividend which
the Shareholders concerned would or could otherwise have received (and for the avoidance of doubt, to the extent that an adjustment
is made under Condition 7(e)(iii) in respect of the Relevant Cash Dividend, no adjustment is to be made for the amount by which
the Current Market Price of the Shares exceeds the Relevant Cash Dividend or part thereof for which an adjustment is already made
under Condition 7(e)(ii));</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Security
Documents</B>&rdquo; means the (i) Share Charge and (ii) Account Charge;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 29; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">1-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->28<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&ldquo;<B>Subsidiary</B>&rdquo;
of any person means (a) any company or other business entity of which that person owns or controls (either directly or through
one or more other Subsidiaries) more than 50 per cent. of the issued share capital or other ownership interest having ordinary
voting power to elect directors, managers or trustees of such company or other business entity, or (b) any company or other business
entity which at any time has its accounts consolidated with those of that person or which, under the law, regulations or generally
accepted accounting principles of the jurisdiction of incorporation of such person from time to time, should have its accounts
consolidated with those of that person;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Subsidiary
Share Grants and Share Options</B>&rdquo; means, in respect of the Issuer&rsquo;s Subsidiaries, any shares or options granted or to be
granted to their respective employees including, but not limited to, principal investigators, research collaborators, research
consultants and relevant external academic institutions to acquire the shares of the relevant Subsidiary as an acknowledgement
in their participation in relevant research projects with the Issuer;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Trading
Day</B>&rdquo; means a day when the NASDAQ or, as the case may be an Alternative Stock Exchange (or in respect of any other security,
the relevant stock exchange or securities market), is open for dealing business, provided that if no closing price is reported
for one or more consecutive dealing days such day or days will be disregarded in any relevant calculation and shall be deemed
not to have been dealing days when ascertaining any period of dealing days;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>U.S.
Dollars</B>&rdquo; and &ldquo;<B>US$</B>&rdquo; mean the lawful currency of the United States of America;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Warrants</B>&rdquo;
means any warrants granted or to be granted by the Issuer to sponsors, investment banks, placement agents, brokers or related
parties in connection with the Issuer&rsquo;s offerings at the closing of the Private Placement, this Bond offering, and the QIPO
respectively pursuant to engagement agreements between such parties and the Issuer.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">References
to any issue or offer or grant to Shareholders &ldquo;as a class&rdquo; or &ldquo;by way of rights&rdquo; shall be taken to be references
to an issue or offer or grant to all or substantially all Shareholders, other than Shareholders by reason of the laws of any territory
or requirements of any recognised regulatory body or any other stock exchange or securities market in any territory or in connection
with fractional entitlements, it is determined not to make such issue or offer or grant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8.</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Payments</B></FONT></TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Method of Payment</B></FONT></TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Payment
of principal, premium (if any) and interest due other than on an Interest Payment Date will be made by transfer to the registered
account of the Bondholder. Such payment will only be made after surrender of the relevant Bond Certificate at the specified office
of Issuer.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Interest
on Bonds due on an Interest Payment Date will be paid on the due date for the payment of interest to the holder shown on the Register
at the close of business on the fifteenth day before the due date for the payment of interest (the &ldquo;<B>Interest Record Date</B>&rdquo;).
Payments of interest on each Bond will be made by transfer to the registered account of the Bondholder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
an amount which is due on the Bonds is not paid in full, the Registrar will annotate the Register with a record of the amount
(if any) in fact paid.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Registered Accounts</I></B></FONT></TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
the purposes of this Condition 8, a Bondholder&rsquo;s registered account means the U.S. dollar account maintained by or on behalf of
it with a bank in Hong Kong, details of which appear on the Register at the close of business on the second Payment Business Day
(as defined in Condition 8(f)) before the due date for payment, and a Bondholder&rsquo;s registered address means its address appearing
on the Register at that time.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 30; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">1-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->29<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Fiscal Laws</I></B></FONT></TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">All
payments are subject in all cases to (i) any applicable fiscal or other laws and regulations in the place of payment, but without
prejudice to the provisions of Condition 10 and (ii) any tax, assessment, withholding or deduction required by section 1471 through
1474 of the U.S. Internal Revenue Code of 1986, as amended (&ldquo;<B>FATCA</B>&rdquo;), any current or future U.S. Treasury Regulations
or rulings promulgated thereunder, any intergovernmental agreement between the United States and any other jurisdiction to implement
FATCA, any law, regulation or other official guidance enacted or published in any jurisdiction implementing FATCA or an intergovernmental
agreement with respect thereto, or any agreement with the U.S. Internal Revenue Service under FATCA.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>No Commissions</I></B></FONT></TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">No
commissions or expenses shall be charged to the Bondholders in respect of such payments.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Payment Initiation</I></B></FONT></TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Where
payment is to be made by transfer to a registered account, payment instructions (for value on the due date or, if that is not
a Payment Business Day (as defined below in Condition 8(g)), for value on the first following day which is a Payment Business
Day) will be initiated on the due date for payment (or, if it is not a Payment Business Day, the immediately following Payment
Business Day) or, in the case of a payment of principal, premium (if any) and interest due other than on an Interest Payment Date,
if later, on the Payment Business Day on which the relevant Bond Certificate is surrendered at the specified office of the Issuer.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(f)</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Delay in Payment</I></B></FONT></TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Bondholders
will not be entitled to any interest or other payment for any delay after the due date in receiving the amount due if the due
date is not a Payment Business Day, if the Bondholder is late in surrendering its Bond Certificate (if required to do so).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(g)</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Payment Business Day</I></B></FONT></TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
this Condition 8, &ldquo;<B>Payment Business Day</B>&rdquo; means a day other than a Saturday or Sunday on which commercial banks
are open for business in New York City, the Cayman Islands, the British Virgin Islands and Hong Kong and, in the case of the surrender
of a Bond Certificate, in the place where the Bond Certificate is surrendered.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">9.</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Redemption, Purchase and Cancellation</B></FONT></TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Maturity</I></B></FONT></TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Unless
previously redeemed, converted or purchased and cancelled as provided in the Conditions, the Issuer will redeem each Outstanding
Bond at its principal amount plus any interest accrued but unpaid up to the maturity date on the date falling on the 12th calendar
month following the Issue Date (the &ldquo;<B>Scheduled Maturity Date</B>&rdquo;), or, with prior written consent of the Bondholders
(which shall not be unreasonably withheld or delayed), the Business Day falling six calendar months thereafter (the &ldquo;<B>Extended
Maturity Date</B>&rdquo;, and together with the Scheduled Maturity Date, a &ldquo;<B>Maturity Date</B>&rdquo;). Upon the Bondholders&rsquo;
receipt of the payment as provided in these Conditions on the Maturity Date, any Outstanding Bonds shall be fully redeemed on
the Maturity Date.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"></P>

<!-- Field: Page; Sequence: 31; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">1-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->30<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Issuer shall give not less than 90 Business Days&rsquo; notice to the Bondholders in accordance with Condition 13 specifying its
intention to extend the maturity date, and provide evidence to the satisfaction of the Bondholders that the Debt Service Reserve
Account has been funded with (i) the principal amount on the Outstanding Bonds and (ii) the aggregate amount of interest due and
payable for the Interest Period commencing on, and including, the Scheduled Maturity Date and ending on, and including, the Extended
Maturity Date in accordance with Condition 4(a)(iii). Any such notice shall be irrevocable.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Upon
the receipt of such notice and having been satisfied that the Debt Service Reserve Account has been prefunded as provided above,
the Bondholders may give written consent for the extension of the maturity date.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">At
the time of the Issuer exercising its option to extend the maturity date specified in this Condition 9(a), in the event that any
aggregate principal amount of the Bonds have been converted (in part and not in whole) as a result of any Bondholder exercising
its Conversion Right, the Issuer may apply the sum of monies up to such portion of the aggregate principal amount of the Outstanding
Bond or Bonds being converted to settle the Issuer&rsquo;s Redemption Price.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Optional Redemption</I></B></FONT></TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Subject
to this Condition 9, so long as any Bond remains Outstanding, such Outstanding Bonds may be redeemed at the option of the Issuer
in whole, but not in part, at the Issuer&rsquo;s Redemption Price (defined below) if the Issuer gives not less than 15 days&rsquo; notice
substantially in the form set out in schedule 3 hereto (the &ldquo;<B>Optional Redemption Notice</B>&rdquo;) to the Bondholders
in accordance with Condition 13 specifying the date for redemption. Any such notice shall be irrevocable. The Issuer shall be
entitled to exercise this option in accordance with this Condition 9(b) notwithstanding that it has received any Notice of Potential
Event of Default from the Bondholders, provided that an Optional Redemption Notice may not be served, and any Optional Redemption
Notice that has been previously served by the Issuer shall become null and void, if an Event of Default has occurred and is continuing.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
the purpose of Condition 9, &ldquo;<B>Issuer&rsquo;s Redemption Price</B>&rdquo; means the total sum of:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(I)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">100.0
                                         per cent. of the principal amount of the Outstanding Bonds as at the date fixed for redemption
                                         (the &ldquo;<B>Early Redemption Date</B>&rdquo;);</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.45in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(II)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">any
                                         unpaid interest on the aggregate principal amount of the Outstanding Bonds accrued at
                                         the Rate of Interest, together with the amount of premium payable (if any) on the aggregate
                                         principal amount of the Outstanding Bonds in accordance with Condition 6(b), from (and
                                         including) the Issue Date up to (but excluding) such date fixed for redemption; and</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.45in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(III)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                         aggregate amount of all scheduled interest payments on the principal amount of the Outstanding
                                         Bonds, together with the amount of premium payable (if any) on the aggregate principal
                                         amount of the Outstanding Bonds in accordance with Condition 6(b), from (and including)
                                         the date fixed for redemption up to (but excluding) the Maturity Date.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.45in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
amount of premium payable in provided in Conditions 9(b)(II) and 9(b)(III) above (if any) shall take into account any principal,
interest (including Interest Amount) and premium accrued on the Outstanding Bonds and paid to the Bondholders, but exclude any
Structuring Fee payable by the Issuer to the initial Bondholders as provided in the Subscription Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">At
the time of the Issuer exercising its option specified in this Condition 9(b), in the event that any aggregate principal amount
of the Bonds have been converted (in part and not in whole) as a result of any Bondholder exercising its Conversion Right, the
Issuer may apply the sum of monies up to such portion of the aggregate principal amount of the Outstanding Bond or Bonds being
converted to settle the Issuer&rsquo;s Redemption Price.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"></P>

<!-- Field: Page; Sequence: 32; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">1-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->31<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"></P>
<P STYLE="margin: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in; text-align: left">(c)</TD><TD STYLE="text-align: justify"><B><I>Redemption for Relevant Event</I></B></TD>
</TR></TABLE>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Following the occurrence of a Relevant
Event, the holder of each Bond will have the right at such holder&rsquo;s option, to require the Issuer to redeem all but not some only
of such holder&rsquo;s Bonds on the Relevant Event Put Date (defined below) at 100.0 per cent. of the Outstanding Bonds as at such date
together with the interest and premium as follows (together, the &ldquo;<B>Early Redemption Amount</B>&rdquo;):</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in; text-align: left">(i)</TD><TD STYLE="text-align: justify">if any such Relevant Event occurs <U>on or before</U>
the date falling 12 calendar months after the Issue Date:</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(A)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">an
amount of premium that would give the Bondholders an internal rate of return equal to the Exit IRR calculated by reference to
the principal amount of the Outstanding Bonds from (and including) the Issue Date up to (but excluding) the Scheduled Maturity
Date (if any); and</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(B)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">an
amount of premium that would give the Bondholder an internal rate of return equal to the 15.0 per cent. per annum calculated by
reference to the principal amount of the Outstanding Bonds from (and including) the date of the occurrence of any such Relevant
Event up to (and excluding) the Relevant Event Put Date (as defined below).</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in; text-align: left">(ii)</TD><TD STYLE="text-align: justify">if any such Relevant Event occurs <U>after</U> the date
falling 12 calendar months after the Issue Date:</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(A)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">an
amount of premium that would give the Bondholders an internal rate of return equal to the Exit IRR calculated by reference to
the principal amount of the Outstanding Bonds from (and including) the Issue Date up to (but excluding) the Scheduled Maturity
Date; and</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(B)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">an
amount of premium that would give the Bondholder an internal rate of return equal to the Default IRR calculated by reference to
the principal amount of the Outstanding Bonds from (and including) the date of the occurrence of any such Relevant Event up to
(and excluding) the Relevant Event Put Date (as defined below).</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0">The Exit IRR, the Default IRR and the premium
provided in this Condition 9(c) shall take into account any principal, interest (including Interest Amount) and premium accrued
on the Outstanding Bonds and paid to the Bondholders, but exclude any Structuring Fee payable by the Issuer to the initial Bondholders
as provided in the Subscription Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0">No interest shall accrue on any Bond from
and including the Conversion Date in respect of such Bond.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0">To exercise such right, the Bondholder
must deposit during normal business hours at the specified office of the Issuer a duly completed and signed notice of redemption,
in the form for the time being current, obtainable during normal business hours from the specified office of the Issuer (a &ldquo;<B>Relevant
Event Put Exercise Notice</B>&rdquo;), together with the Bond Certificate evidencing the Bonds to be redeemed by not later than
60 days following a Relevant Event, or, if later, 60 days following the date upon which notice thereof is given to Bondholders
by the Issuer in accordance with Condition 13. The &ldquo;<B>Relevant Event Put Date</B>&rdquo; shall be the fourteenth day (other
than a No Registration Event) or the fifth day (in the case of a redemption for a No Registration Event) after the expiry of such
period of 60 days as referred to above.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0">A Relevant Event Put Exercise Notice, once
delivered, shall be irrevocable and may not be withdrawn without the Issuer&rsquo;s written consent. The Issuer shall redeem the Bonds
the subject of the Relevant Event Put Exercise Notice (subject to delivery of the relevant Bond Certificate as aforesaid) on the
Relevant Event Put Date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0"></P>

<!-- Field: Page; Sequence: 33; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">1-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->32<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0"> Within 14 days of the
occurrence of a Relevant Event (in the case of a redemption other than a No Registration Event) or five days (in the case of a
redemption for a No Registration Event), the Issuer shall give notice thereof in writing to the Bondholders in accordance with
Condition 13. The notice regarding the Relevant Event shall contain a statement informing Bondholders of their entitlement to exercise
their Conversion Rights as provided in these Conditions and their entitlement to exercise their rights to require redemption of
their Bonds pursuant to this Condition. Such notice shall also specify: (A) the date of such Relevant Event and, all information
material to Bondholders concerning the Relevant Event; (B) the Relevant Event Put Date; (C) the last date by which a Relevant Event
Put Exercise Notice must be given; (D) the procedures that Bondholders must follow and the requirements that Bondholders must satisfy
in order to exercise the Relevant Event put right or Conversion Right; and (E) the information required by Condition 9(f).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The Bondholders shall not be required to
monitor or to take any steps to ascertain or verify the accuracy, validity and/or genuineness of any documents in relation to whether
a Relevant Event, No Registration Event or any event which could lead to a Relevant Event or No Registration Event has occurred
or may occur, and none of them shall be liable to any other Bondholder, the Issuer, the Guarantor or any other person for not doing
so.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">For the purposes of this Condition 9(c):</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">a &ldquo;<B>Change of Control</B>&rdquo; occurs when:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(I)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mr.
Ian Huen, Mr. Darren Lui and/or their respective Related Persons together with any Voting Rights controlled directly or indirectly
by that person or persons, including through any voting consent agreement, cease(s) to hold more than 63.0% of the Voting Rights
in the Issuer; or</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(II)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Issuer or its Related Persons together with any Voting Rights controlled directly or indirectly by that person or persons, including
through any voting consent agreement, cease(s) to hold more than 70.0% of the Voting Rights in every Subsidiary of the Issuer.</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&ldquo;<B>BVI</B>&rdquo; means the British Virgin
Islands;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&ldquo;<B>BVI Registration Conditions</B>&rdquo; means the receipt
by the Bondholders of:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(I)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a
certificate signed by any one member of the board of directors of Jurchen Investment Corporation from time to time, or one of
its duly authorised officer, confirming the completion of the registration of the Share Charge with the Registrar of Corporate
Affairs in the BVI and the updating of the register of charges of Jurchen Investment Corporation with details of the security
interests created by the Share Charge together with a copy of the relevant certificate of registration of charge and the updated
register of charges; and</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(II)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a
legal opinion as to BVI law issued by a reputable BVI law firm in connection with the issue of the Bonds, addressed to the Bondholders
and otherwise in form and substance satisfactory to the Bondholders, that the Share Charge (x) constitutes legal, valid and binding
obligations of Jurchen Investment Corporation and (y) is enforceable against Jurchen Investment Corporation;</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&ldquo;<B>BVI Registration Deadline</B>&rdquo;
means the date falling 20 Business Days after the date of the Share Charge;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&ldquo;<B>Hong Kong</B>&rdquo; means Hong
Kong Special Administrative Region of the People&rsquo;s Republic of China;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<!-- Field: Page; Sequence: 34; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">1-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->33<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&ldquo;<B>HK Registration Conditions</B>&rdquo;
means the receipt by the Bondholders of:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in; text-align: left">(I)</TD><TD STYLE="text-align: justify">a certificate signed by any one member of the board
of directors of Aptorum Group Limited from time to time, or one of its duly authorised officer, confirming the completion of the
registration of the Account Charge with the Companies Registry of Hong Kong within one calendar month of the date of the Account
Charge; and</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in; text-align: left">(I)</TD><TD STYLE="text-align: justify">a legal opinion as to Hong Kong law issued by a reputable
Hong Kong law firm in connection with the issue of the Bonds, addressed to the Bondholders and otherwise in form and substance
satisfactory to the Bondholders, that the Account Charge (x) constitutes legal, valid and binding obligations of Aptorum Group
Limited and (y) is enforceable against Aptorum Group Limited;</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&ldquo;<B>HK Registration Deadline</B>&rdquo;
means the date falling one calendar month of the date of the Account Charge;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">a &ldquo;<B>No Registration Event</B>&rdquo;
occurs when either the HK Registration Conditions or the BVI Registration Conditions are not complied with on or before the HK
Registration Deadline or BVI Registration Deadline, as the case may be;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">a &ldquo;<B>person</B>&rdquo; includes any
individual, company, corporation, firm, partnership, joint venture, undertaking, association, organisation, trust, state or agency
of a state (in each case whether or not being a separate legal entity) but does not include the Issuer&rsquo;s board of directors or
any other governing board and does not include the Issuer&rsquo;s direct or indirect Subsidiaries;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">a &ldquo;<B>Related Person</B>&rdquo;
means with respect to any shareholder (i) any trusts established for the benefit of such shareholders and/or their immediate family
members and/or siblings, (ii) any of their executors and/or beneficiaries of their estate, (iii) any companies in which they control,
directly or indirectly, a majority of the Voting Rights and have the ability to appoint and/or remove all the members of the board
of directors or other governing body or (iv) their extended family members including spouses, children, parents and siblings;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">a
&ldquo;<B>Relevant Event</B>&rdquo; means:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(I)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">following
the occurrence of a QIPO, when the Shares cease to be listed or admitted to trading or are suspended for a period equal to or
exceeding 30 consecutive Trading Days on the Relevant Stock Exchange; or</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(II)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
occurrence of a No Registration Event; or</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(III)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
occurrence of a Change of Control,</FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">and
none of the above Relevant Events shall constitute an Event of Default.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&ldquo;<B>Voting Rights</B>&rdquo; means
the right generally to vote at a general meeting of shareholders of a specified person.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in; text-align: left">(d)</TD><TD STYLE="text-align: justify"><B><I>Purchase</I></B></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The Issuer or any of its Subsidiaries may,
subject to applicable laws and regulations, at any time and from time to time purchase Bonds at any price in the open market or
otherwise.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in; text-align: left">(e)</TD><TD STYLE="text-align: justify"><B><I>Cancellation</I></B></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">All Bonds which are redeemed, converted
or purchased by the Issuer or any of its Subsidiaries will forthwith be cancelled. Bond Certificates in respect of all Bonds cancelled
will be forwarded to or to the order of the Registrar and such Bonds may not be reissued or resold.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"></P>

<!-- Field: Page; Sequence: 35; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">1-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->34<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in; text-align: left">(f)</TD><TD STYLE="text-align: justify"><B><I>Redemption Notices</I></B></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">All notices to Bondholders
given by or on behalf of the Issuer pursuant to this Condition 9 will be irrevocable and will be given in accordance with Condition
13 specifying: (a) the Conversion Price as at the date of the relevant notice (if applicable); (b) the last day on which Conversion
Rights may be exercised (if applicable); (c) the Closing Price and Current Market Price of the Shares on the latest practicable
date prior to the publication of the notice (if applicable); (d) the Early Redemption Amount or Issuer&rsquo;s Redemption Price or any
redemption price as agreed between the Issuer and the Bondholders, as the case may be, and accrued interest payable (if any); (e)
the date for redemption; (f) the manner in which redemption will be effected; (g) the aggregate principal amount of the Bonds Outstanding
as at the latest practicable date prior to the publication of the notice; and (h) such other information as the Bondholders may
require. If more than one notice of redemption is given (being a notice given by either the Issuer or a Bondholder pursuant to
this Condition 9), the first in time shall prevail.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in; text-align: left">10.</TD><TD STYLE="text-align: justify"><B>Taxation</B></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in; text-align: left">(a)</TD><TD STYLE="text-align: justify"><B><I>Payment without Withholding</I></B></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">All payments of principal, premium (if
any) and interest made by or on behalf of the Issuer or the Guarantor in respect of the Bonds or under the Deed of Guarantee or
Transaction Documents shall be made free from any restriction or condition and be made without deduction or withholding for or
on account of any present or future taxes, duties, assessments or governmental charges of whatever nature imposed, levied collected,
withheld or assessed by or on behalf of Hong Kong, the British Virgin Islands, the United States or the Cayman Islands or any jurisdiction
in which the Issuer is tax resident, in each case including any political subdivision thereof or any authority thereof or therein
having power to tax (each, a &ldquo;<B>Relevant Taxing Jurisdiction</B>&rdquo;) or any jurisdiction through which payments by or
on behalf of the Issuer are made including any political subdivision thereof or any authority thereof on therein having the power
to tax (together with a Relevant Taxing Jurisdiction, a &ldquo;<B>Relevant Jurisdiction</B>&rdquo;) unless deduction or withholding
of such taxes, duties, assessments or governmental charges is compelled by the law. In such event, the Issuer or the Guarantor
shall pay such additional amounts (&ldquo;<B>Additional Tax Amounts</B>&rdquo;) as will result in the receipt by the Bondholders
of such amounts as would have been received by them had no such deduction or withholding been required, except that no Additional
Tax Amounts shall be payable in respect of any Bond:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">to
a holder (or to a third party on behalf of a holder) who is liable to such taxes, duties, assessments or governmental charges
in respect of such Bond by reason of such holder having some connection with a Relevant Jurisdiction other than the mere holding
of the Bond or by the receipt of amounts in respect of the Bond; or</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(in
the case of a payment of principal or premium) if the Bond Certificate in respect of such Bond is surrendered more than 30 days
after the Relevant Date except to the extent that the holder of it would have been entitled to such additional amounts on surrendering
the relevant Bond Certificate for payment on the last day of such period of 30 days; or</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">for
or on account of any tax, assessment, withholding or deduction required by FATCA, any current or future U.S. Treasury Regulations
or rulings promulgated thereunder, any intergovernmental agreement between the United States and any other jurisdiction to implement
FATCA, any law, regulation or other official guidance enacted or published in any jurisdiction implementing FATCA or an intergovernmental
agreement with respect thereto, or any agreement with the U.S. Internal Revenue Service under FATCA; or</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify">&ldquo;<B>Relevant Date</B>&rdquo; means
whichever is the later of (a) the date on which such payment first becomes due and (b) if the full amount payable has not been
received by the Bondholders on or prior to such due date, the date on which, the full amount having
been so received, notice to that effect shall have been given to the Bondholders and cheques despatched or payment made.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"></P>

<!-- Field: Page; Sequence: 36; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">1-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->35<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify">References in these Conditions
to principal, premium and interest shall be deemed also to refer to any additional amounts which may be payable under this Condition
10(a) or any undertaking or covenant given in addition thereto or in substitution therefor pursuant to the Transaction Documents.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in; text-align: left">(b)</TD><TD STYLE="text-align: justify"><B><I>No liability of Bondholders</I></B></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The Bondholders shall not be responsible
for paying any tax, duty, charges, withholding or other payment referred to in this Condition 10(b) or for determining whether
such amounts are payable or the amount thereof, and none of them shall be responsible or liable for any failure by the Issuer,
the Guarantor, or any third party to pay such tax, duty, charges, withholding or other payment in any jurisdiction or to provide
any notice or information to the Issuer that would permit, enable or facilitate the payment of any principal, premium (if any),
interest or other amount under or in respect of the Bonds without deduction or withholding for or on account of any tax, duty,
charge, withholding or other payment imposed by or in any jurisdiction.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in; text-align: left">(c)</TD><TD STYLE="text-align: justify"><B><I>Tax obligations of Bondholders</I></B></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The Subscriber shall be solely responsible
for any income, corporate, capital gains and indirect taxes applicable to and payable by the Bondholders in their respective jurisdictions.
Under no circumstances shall the Issuer be responsible to pay for or indemnify the Bondholders on such taxes.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in; text-align: left">11.</TD><TD STYLE="text-align: justify"><B>Events of Default</B></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Subject to the provisions of these Conditions
(including Condition 9(b)), if any of the following events (each an &ldquo;<B>Event of Default</B>&rdquo;) occurs, a Bondholder may
(subject in any such case to being indemnified and/or secured and/or prefunded to its satisfaction) give notice to the Issuer and
the Guarantor (a &ldquo;<B>Notice of Event of Default</B>&rdquo;) that the Bonds are, and they shall immediately become, due and
repayable at their principal amount together with the amounts set out in Condition 6(b) (subject as provided below and without
prejudice to the right of Bondholders to exercise the Conversion Right in respect of their Bonds in accordance with Condition 7)
if:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Non-Payment</I>:
there has been a failure to pay the principal, premium or any interest on any of the Bonds when due and the default continues,
in the case of principal and premium, for a period of five Payment Business Days from the date on which such amount is due and
payable, and in the case of interest only, for a period of five Payment Business Days from the date on which such amount is due
and payable; or</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Failure
to deliver Shares</I>: any failure by the Issuer to deliver any Shares as and when the Shares are required to be delivered following
Conversion of Bonds (unless such failure to deliver is caused by the Bondholders or any agents acting on their behalf); or</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Breach
of Other Obligations</I>: any of the Issuer, its Subsidiaries or the Guarantor does not perform or comply with any one or more
of its other obligations, undertakings, covenants, representation, warranties or other terms in these Conditions (other than those
referred to in Conditions 11(i) and 11(ii)), the Transaction Documents and/or the Security Documents, and which breach of obligations
or failure to perform is not remedied within 30 days after a Notice of Potential Event of Default shall have been given to the
Issuer or the Guarantor by the Bondholders. If on the occurrence of any such breach, the Issuer believes in good faith that the
occurrence of such event is the result of any unsubstantiated or inaccurate third party claims, the Issuer may notify the Bondholders
thereof, with a review to initiating a discussion of the relevant events. Nothing herein shall be taken as a waiver of the Bondholder&rsquo;s
right to declare an Event of Default following such discussion, unless the Issuer has received a legal opinion from a reputable
law firm (which is mutually accepted by the Issuer and the Bondholders and such cost to be borne by the Issuer) opining that such
claim is unsubstantiated or inaccurate; or</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 37; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">1-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->36<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iv)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Cross-Default</I>:
                                         (a) any other present or future indebtedness of any of the Issuer, its Subsidiaries or
                                         the Guarantor, for or in respect of moneys borrowed or raised becomes (or becomes capable
                                         of being declared) due and payable prior to its stated maturity by reason of any default,
                                         event of default or the like (howsoever described but always taking into account any
                                         applicable grace period), or (b) any such indebtedness is not paid when due or, as the
                                         case may be, within any applicable grace period, or (c) the Issuer, any of its Subsidiaries
                                         or the Guarantor fails to pay when due or, as the case may be, within any applicable
                                         grace period, any amount having an aggregate value of at least US$400,000 payable by
                                         it under any present or future guarantee for, or indemnity in respect of, any moneys
                                         borrowed or raised, and which such indebtedness is not repaid or failure to pay is not
                                         remedied within 30 days after a Notice of Potential Event of Default shall have been
                                         given to the Issuer or the Guarantor by the Bondholders; or</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(v)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Enforcement
Proceedings</I>: a distress, attachment, execution or other legal decision is levied, enforced or sued out on or against substantially
all of the property, assets or revenues (as applicable) of any of the Issuer, its Subsidiaries or the Guarantor having an aggregate
value of at least US$400,000 and is not discharged or stayed within 30 days of having been so levied, enforced or sued out on;
or</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(vi)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Security
Enforced</I>: any mortgage, charge, pledge, lien or other encumbrance, present or future, created or assumed by any of the Issuer,
its Subsidiaries or the Guarantor becomes enforceable and any step is taken to enforce it (including the taking of possession
or the appointment of a receiver, manager or other similar person) against substantially all of the property, assets or revenues
of the Issuer, any of its Subsidiaries or the Guarantor, unless the aggregate amount of any such enforced security is less than
US$400,000; or</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(vii)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Winding-up</I>:
an order is made or an effective resolution passed for the winding-up or dissolution, judicial management or administration of
any of the Issuer, its Subsidiaries or the Guarantor (except for a members&rsquo; voluntary solvent winding up of a Subsidiary), or
any of the Issuer, its Subsidiaries or the Guarantor ceases or threatens to cease to carry on all or substantially all of its
Ordinary Business or operations, except for the purpose of and followed by a reconstruction, amalgamation, reorganisation, merger
or consolidation (a) on terms approved by the Bondholders, or (b) in the case of a Subsidiary, whereby the undertaking and assets
of such Subsidiary are transferred to or otherwise vested in any of the Issuer, its Subsidiaries or the Guarantor; or</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(viii)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Insolvency</I>:
any of the Issuer, its Subsidiaries or the Guarantor is (or is, or could be, deemed by law or a court to be) insolvent or bankrupt
or unable to pay its debts, stops, suspends or threatens to stop or suspend payment of all or substantially all of its debts,
proposes or makes any agreement for the deferral, rescheduling or other readjustment of all of its debts, proposes or makes a
general assignment or an arrangement or composition with or for the benefit of the relevant creditors in respect of any substantial
part of such debts or a moratorium is agreed or declared in respect of or affecting all or any substantial part of (or of a particular
type of) the debts of any of the Issuer, its Subsidiaries or the Guarantor except for the purpose of and followed by a reconstruction,
amalgamation, reorganisation, merger or consolidation (a) on terms approved by the Bondholders, or (b) in the case of a Subsidiary,
whereby the undertaking and assets of such Subsidiary are transferred to or otherwise vested in any of the Issuer, its Subsidiaries
or the Guarantor; an administrator or liquidator of any of the Issuer, its Subsidiaries or the Guarantor or all or substantially
all of the assets and turnover of any of the Issuer, its Subsidiaries or the Guarantor is appointed; or</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 38; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">1-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->37<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ix)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Nationalisation</I>:
(a) any step is lawfully taken by any competent governmental authority with a view to the seizure, compulsory acquisition, expropriation
or nationalisation of all or substantially all of the assets of any of the Issuer, its Subsidiaries or the Guarantor or (b) any
of the Issuer, its Subsidiaries or the Guarantor is prevented by any competent governmental authority from exercising normal control
over all or substantially all of its property, assets and turnover; or</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(x)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Authorisation
and Consents</I>: any action, condition or thing (including the obtaining or effecting of any necessary consent, approval, authorisation,
exemption, filing, licence, order, recording or registration) at any time required to be taken, fulfilled or done in order (a)
to enable the Issuer, its Subsidiaries and/or the Guarantor lawfully to enter into, exercise its rights and perform and comply
with its obligations under the Bonds and/or the Security Documents, or (b) to ensure that those obligations are legally binding
and enforceable against the Issuer, its Subsidiaries and the Guarantor, or (c) to make the Bonds, the Transaction Documents and/or
the Security Documents admissible in evidence in the courts of Cayman Islands and Hong Kong is not taken, fulfilled or done; or</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(xi)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Illegality</I>:
it is or will become unlawful for any of the Issuer, its Subsidiaries and/or the Guarantor to perform or comply with any one or
more of its obligations under any of the Bonds, the Transaction Documents and/or the Security Documents;</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(xii)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Analogous
Events</I>: any event occurs which under the laws of any relevant jurisdiction has an analogous effect to any of the events referred
to in any of Conditions 11(v) to 11(xi) (both inclusive);</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(xiii)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Key
Man</I>: Either of Mr. Ian Huen or Mr. Darren Lui ceases to hold the position of chief executive director or president respectively,
or to be actively involved in the management or operation, of the Issuer; or any change in the composition of the board of directors
of the Issuer or the Guarantor occurs without any prior written consent of the Bondholders;</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(xiv)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Material
Adverse Change</I>: there shall have occurred any change (nor any development or event involving a prospective change) in the
condition (financial or other), assets, liabilities, business, management, prospects, shareholders&rsquo; equity, results of operations
or performance of the Group as a whole or general affairs of the Issuer or the Group which, in the reasonable opinion of the Bondholders,
is material and adverse in the context of the issue and offering of the Bonds, which default is not remedied within 30 days after
a Notice of Potential Event of Default shall have been given to the Issuer or the Guarantor by the Bondholders;</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(xv)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Debt
Service Reserve Account</I>: the Bondholders determine that they cease to have adequate control as a secured creditor over the
Debt Service Reserve Account (including without limitation any unilateral change of any authorised signatory or bank mandate in
respect of the Debt Service Reserve Account by any other member of the Group without any prior written consent of the Bondholders),
unless such event or default is caused by the wilful misconduct, gross negligence or fraud on the part of the Bondholders;</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(xvi)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Security
                                                                                                                                                                           Documents not in force</I>: the validity of any of the Security Document is contested by the Issuer or the Guarantor through
                                                                                                                                                                           an official action, or any of the Issuer or the Guarantor through an official action denies any of its obligations pursuant
                                                                                                                                                                           to any Security Document or it is or will become unlawful for the Issuer or the Guarantor to perform or comply with any of
                                                                                                                                                                           its obligations pursuant to any Security Documents or any of such obligations are or become unenforceable or invalid, or any
                                                                                                                                                                           Security Documents is not (or
is claimed by the Guarantor not to be) in full force and effect; and</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 39; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">1-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->38<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in; text-align: left">(xvii)</TD><TD STYLE="text-align: justify"><I>Guarantee not in force</I>: the validity of the Deed
of Guarantee is contested by the Guarantor through an official action, or the Guarantor through an official action denies any
of its obligations pursuant to the Deed of Guarantee or it is or will become unlawful for the Guarantor to perform or comply with
any of its obligations pursuant to the Deed of Guarantee or any of such obligations are or become unenforceable or invalid, or
the Deed of Guarantee is not (or is claimed by the Guarantor not to be) in full force and effect.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: -0.35in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Each of the Issuer and the Guarantor undertakes
to notify in writing the Bondholders upon the occurrence of any of the events specified in Conditions 11(i) to 11(xvii) if either
the Issuer or the Guarantor is aware of or has determined that such event has occurred. Nothing herein constitutes or shall be
deemed to constitute a waiver of any rights or remedies available to the Issuer or the Guarantor resulting from or based upon any
wrongful acceleration to call an Event of Default.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in; text-align: left">12.</TD><TD STYLE="text-align: justify"><B>QIPO</B></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">For the purposes of a QIPO, if the Issuer
designates any entity other than itself (the &ldquo;<B>Listing Entity</B>&rdquo;) to be listed, and the ordinary shares of such Listing
Entity become listed, quoted, admitted to trading or dealt in, on NASDAQ or an Alternative Stock Exchange and such listing would
constitute a QIPO if the shares listed had been Shares of the Issuer, the Issuer agrees to make such modification to these Conditions,
the Bonds and/or the Transaction Documents as the Bondholders deem necessary to maintain the same commercial effect as if the Listing
Entity had been the Issuer. Any such modification shall not be prejudicial to the interests of the Bondholders. The Issuer shall,
upon a modification pursuant to this Condition 12, give notice to the Bondholders in accordance with Condition 13.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in; text-align: left">13.</TD><TD STYLE="text-align: justify"><B>Notices</B></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">All notices to Bondholders shall be validly
given if mailed to them at their respective addresses in the Register via reputable courier services. Any such notice shall be
deemed to have been given at the time of delivery to the Bondholder after being so mailed via reputable courier services.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Notices to be given by any Bondholder
shall be in writing and given by lodging the same, together with the relative Certificate, with the Registrar or the Issuer.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in; text-align: left">14.</TD><TD STYLE="text-align: justify"><B>Prescription</B></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Claims in respect of amounts due in respect
of the Bonds shall be prescribed and become void unless made as required by Condition 8 within 10 years (in the case of principal
and premium) and 5 years (in the case of interest) from the appropriate Relevant Date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in; text-align: left">15.</TD><TD STYLE="text-align: justify"><B>Replacement of Bond Certificates</B></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">If any Bond Certificate is lost, stolen,
mutilated, defaced or destroyed, it may be replaced at the specified office of the Registrar, subject to all applicable laws, upon
payment by the claimant of the expenses incurred in connection with such replacement and on such terms as to evidence and indemnity
as the Issuer, the Guarantor and such Registrar may require. Mutilated or defaced Bond Certificates must be surrendered before
replacements will be issued.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in; text-align: left">16.</TD><TD STYLE="text-align: justify"><B>Further Issues</B></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The Issuer may from time to time without
the consent of the Bondholders to create and issue further securities either having the same terms and conditions as the Bonds
in all respects (or in all respects except for the first payment of interest on them) and so that such
further issue shall be consolidated and form a single series with the outstanding securities of any series (including the Bonds)
or upon such terms as the Issuer may determine at the time of their issue. References in these Conditions to the Bonds include
(unless the context requires otherwise) any other securities issued pursuant to this Condition 16 and forming a single series with
the Bonds.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"></P>

<!-- Field: Page; Sequence: 40; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">1-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->39<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in; text-align: left">17.</TD><TD STYLE="text-align: justify"><B>Governing Law and Submission to Jurisdiction</B></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in; text-align: left">(a)</TD><TD STYLE="text-align: justify"><B><I>Governing Law</I></B></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The Bonds and the Transaction Documents
and any non-contractual obligations arising out of or in connection with them are governed by, and shall be construed in accordance
with, Hong Kong law.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in; text-align: left">(b)</TD><TD STYLE="text-align: justify"><B><I>Arbitration</I></B></TD>
</TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Any
dispute, controversy, difference or claim arising out of or relating to this Agreement, including the existence, validity, interpretation,
performance, breach or termination thereof or any dispute regarding non-contractual obligations arising out of or relating to
it shall be referred to and finally resolved by arbitration administered by the Hong Kong International Arbitration Centre (&ldquo;<B>HKIAC</B>&rdquo;)
under the HKIAC Administered Arbitration Rules in force when the Notice of Arbitration is submitted.</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
law of this arbitration clause shall be Hong Kong law.</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
seat of arbitration shall be Hong Kong.</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iv)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
number of arbitrators shall be three. The arbitration proceedings shall be conducted in English.</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(v)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
the avoidance of doubt, any dispute, controversy, difference or claim arising out of or relating to the Account Charge or Share
Charge shall be referred to and finally resolved by the courts of Hong Kong pursuant to the provisions of the Account Charge or
Share Charge, as the case may be.</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in; text-align: left">18.</TD><TD STYLE="text-align: justify"><B>Rights of Third Parties</B></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">No person shall have any right to enforce
any term or Condition of the Bonds or any provision of the Transaction Documents under the Contracts (Rights of Third Parties)
Ordinance (Cap. 623 of the Laws of Hong Kong) save where expressly provided for.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in; text-align: left">19.</TD><TD STYLE="text-align: justify"><B>Termination</B></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">These Conditions shall be of no further
effect when none of the Bonds remains Outstanding.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"></P>

<!-- Field: Page; Sequence: 41; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">1-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->40<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>SCHEDULE 1</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>FORM OF BOND CERTIFICATES</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Certificate No.: <U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Amount: <U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><I>Aptorum Group Limited</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(Incorporated in Cayman Islands with limited
liability)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Aggregate Principal Amount of US$15,000,000<BR>
8.00 per cent. Convertible Bonds due 2019</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Aptorum Group Limited (the
&ldquo;<B>Issuer</B>&rdquo;) hereby CERTIFIES that Peace Range Limited whose address is situated at [ ] (the
&ldquo;<B>Bondholder</B>&rdquo;) is, at the date hereof, entered in the Issuer&rsquo;s Register of Bondholders as the holder
of the 8.00 per cent. convertible bonds due 2019 (the &ldquo;<B>Bonds</B>&rdquo;) in the principal amount of US$15,000,000.
For value received, the Issuer promises to pay the Bondholder who appears at the relevant time on the Register of Bondholders
of the Issuer as the holder of the Bonds in respect of which this Certificate is issued, such amount or amounts as shall
become due in respect of the Bonds and otherwise to comply with the Terms and Conditions of the Bonds endorsed hereon (the
&ldquo;<B>Conditions</B>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Bonds are issued with the benefit and
subject to the Conditions. The Bonds in respect of which this Certificate is issued are convertible into fully-paid class A ordinary
shares of the Issuer in accordance with the Conditions.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Bonds in respect of which this Certificate
is issued are in registered form. This Certificate is evidence of entitlement only. Title to the Bonds passes only on due registration
in the Register of Bondholders and only the duly registered holder is entitled to payments on the Bonds in respect of which this
Certificate is issued.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0; text-align: justify">The Bonds in respect of
which this Certificate is issued form part of all the Bonds in the aggregate principal amount of US$15,000,000 issued by the Issuer
on <U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U>&nbsp;2018.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: -0.95in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">This certificate is governed by, and shall
be construed in accordance with the laws of Hong Kong.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In witness whereof the Issuer has
caused this Certificate to be executed and delivered as a deed
on&#9;<U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U>
2018.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Note: The Bonds cannot be transferred to
bearer on delivery and is deliverable only to the extent permitted by the Conditions. The Bonds must be delivered to the Issuer
for cancellation and the re-issue of an appropriate certificate in the event of any such transfer.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Dated the________&#9;day of________________&#9;2018</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 42; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">1-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->41<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">EXECUTED and DELIVERED&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">as a DEED by <B>Aptorum Group Limited</B>&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">and SIGNED by __________________&#9;<BR>
as __________________&#9;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">in the presence of:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U>&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Witness signature</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Witness name:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Occupation:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 43; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">1-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->42<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>SCHEDULE 2</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>FORM OF TRANSFER</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Aptorum Group Limited</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(Incorporated in Cayman Islands with limited
liability)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Aggregate Principal Amount of US$15,000,000<BR>
8.00 per cent. Convertible Bonds due 2019</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">FOR VALUE RECEIVED the undersigned hereby transfers to:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U>&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">(Please print or typewrite name and registered address of transferee)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">US$ <U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U>&nbsp;principal
amount of the Bonds in respect of which this Certificate is issued, and all rights in respect thereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">All payments in respect of the Bonds hereby transferred are
to be made (unless otherwise instructed by the transferee) to the following account, which shall (until further notice) be the
registered account of the transferee for the purposes of Condition 3(b):</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Name of bank:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">U.S. dollar account number:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">For the account of:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The registered address of the transferee for the purposes of
Condition 3 is stated above.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Date: <U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Bondholder-Transferor&rsquo;s name : <U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Bondholder-Transferor&rsquo;s signature&#9;: <U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Bondholder-Transferor&rsquo;s witness&#9;: <U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Transferee&rsquo;s name&#9;: <U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Transferee&rsquo;s signature : <U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Transferee&rsquo;s witness&#9;: <U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Notes:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">(i) &nbsp;&nbsp;&nbsp;&nbsp; A representative of the Bondholder
should state the capacity in which he signs, e.g. director.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">(ii) &nbsp;&nbsp;&nbsp; The signature of the person effecting
a transfer shall conform to any list of authorised specimen signatures supplied by the registered holder or be certified by a recognised
bank, notary public or in such other manner as the Registrar requires.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">(iii) &nbsp; Any transfer of the Bonds shall be in accordance
with Condition 3 of the Terms and Conditions attached to the Bonds.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 44; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">1-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->43<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>SCHEDULE 3</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>FORM OF REDEMPTION NOTICE</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Aptorum Group Limited</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(Incorporated in Cayman Islands with limited
liability)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Aggregate Principal Amount of US$15,000,000<BR>
8.00 per cent. Convertible Bonds due 2019</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">To the Bondholder:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">[&#9679;]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Aptorum Group Limited (the &ldquo;<B>Issuer</B>&rdquo;)
hereby notifies the holders of the 8.00 per cent. Convertible Bonds due 2019 (the &ldquo;<B>Bonds</B>&rdquo;) (pursuant to the Subscription
Agreement and the Conditions in relation to the Bonds as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Effective
[&#9679;], 20[&#9679;] (the &ldquo;<B>Redemption Date</B>&rdquo;), the Issuer shall redeem US$15,000,000 aggregate principal
amount of the Bonds pursuant to Clause 9(b) of the Conditions at [insert redemption amount calculated in accordance with the Conditions]
per cent of their outstanding principal amount (the &ldquo;<B>Issuer&rsquo;s Redemption Price</B>&rdquo;).</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
aggregate principal amount of the Bonds, as of [&#9679;] 20[&#9679;], being the latest practicable date prior to the date hereof,
is US$[ &#9679; ], and the Bond Certificate representing such Bonds bears the certificate number of [&#9679;].</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
the Redemption Date, the Issuer&rsquo;s Redemption Price will become due and payable by the Issuer.</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
relevant Bond Certificate should be surrendered for payment of the Redemption Amount to the following addresses:</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">[&#9679;]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Capitalized terms used but not otherwise
defined herein have the meanings given to them in the Subscription Agreement and the Conditions.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Very truly yours,</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">[&#9679;]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">By: <U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Name:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Title:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 45; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">1-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->44<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>SCHEDULE 4</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>FORM OF CONVERSION
NOTICE</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Aptorum Group Limited</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;(Incorporated in Cayman Islands with
limited liability)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><B>Aggregate Principal Amount of US$15,000,000</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><B>8.00 per cent. Convertible Bonds due 2019</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: -0.15in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">(Please read the notes overleaf before completing this Notice.)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Name: ____________________________&#9;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Date: ___________________________&#9;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Address: ___________________________&#9;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Tel No: __________________________&#9;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Fax No: __________________________&#9;<BR></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Signature<SUP>1</SUP>:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U>&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">To: <B>Aptorum Group Limited</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">I/We, being the holders of the Bonds specified
below, hereby irrevocably elect to convert such Bonds into fully-paid class A ordinary shares of the Issuer (the <B>&ldquo;Shares&rdquo;</B>)
with no par value in accordance with the terms and conditions of the Bonds.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in; text-align: left">1.</TD><TD STYLE="text-align: justify">Total principal amount, number and identifying numbers of
Bonds to be converted:</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Total principal amount: <U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Total number of Bonds: <U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Identifying numbers of Bonds
(if relevant)*: <U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Identifying numbers of Bond
Certificates deposited in respect of Bonds to be converted&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">(if relevant): ______________&#9;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">N.B. If necessary, the identifying
numbers of Bonds and Certificates can be attached separately.&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0">&nbsp;</P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 0; margin-bottom: 0"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid; width: 15%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in; text-align: left"><SUP>1</SUP></TD><TD STYLE="text-align: justify">A corporation should sign under hand by an authorised official
who must state his/her capacity and print the name of the relevant corporation.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B></B>&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 46; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">1-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->45<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in; text-align: left">2.</TD><TD STYLE="text-align: justify">Name(s) and address(es) of person(s) in whose name(s) the
Shares required to be delivered on conversion are to be registered:</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in">&nbsp;</TD>
    <TD STYLE="width: 1.3in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD>
    <TD STYLE="width: 2in; border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Address: </FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Telephone Number: </FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Fax Number: </FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in; text-align: left">3.</TD><TD STYLE="text-align: justify">I/We certify that the amount of (if any) stamp, issue, registration
or other similar taxes and duties (<B>&ldquo;Duties&rdquo;</B>):</TD>
</TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">arising
upon exercise of the Conversion Right in the country in which such Conversion Rights are exercised is:</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in">Amount: <U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in">Country in which Conversion Rights are exercised:
<U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in">and/or</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0pt; width: 100%">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in">&nbsp;</TD>
    <TD STYLE="width: 0.5in; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT></TD>
    <TD STYLE="text-align: justify; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">payable
    in any jurisdiction consequent upon the issue or transfer of Shares to or to the order of a person other than the exercising
    Bondholder is:</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in">Amount: <U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in">Country in which Duties are payable:&nbsp;<U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in; text-align: left">4.</TD><TD STYLE="text-align: justify">The Issuer shall pay all stamp, issue, registration, excise
and similar taxes and duties (if any) (<B>&ldquo;Duties&rdquo;</B>) arising on conversion of the Bonds or payable consequent upon
the issue, delivery or transfer of Shares or any other property or cash upon conversion and the expenses arising on the issue
of Shares on conversion of the Bonds.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 0; margin-bottom: 0"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid; width: 15%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in; text-align: left"><SUP>2</SUP></TD><TD STYLE="text-align: justify">The Issuer&rsquo;s register of shareholders will be closed
on the following dates: [&nbsp;&#9679;&nbsp;]</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in; text-align: left"><SUP>3</SUP></TD><TD STYLE="text-align: justify">Payment Instructions</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">Please make payment in respect of the above Bonds as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">*(a) by transfer to the registered account of the holder appearing
in the Register.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">*(b) by transfer to the following U.S. dollar account in [&nbsp;&#9679;&nbsp;]:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">Bank: [&nbsp;&#9679;&nbsp;]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">Branch Address: [&nbsp;&#9679;&nbsp;]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">Branch Code: [&nbsp;&#9679;&nbsp;]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">Account Number: [&nbsp;&#9679;&nbsp;]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">Account Name: [&nbsp;&#9679;&nbsp;]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">*Delete as appropriate Signature of holder</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 47; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">1-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->46<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B></B>N.B.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
Conversion Notice will be void unless the introductory details and Sections 1 to 3 are completed.</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Your
attention is drawn to Condition 7(c) of the Bonds with respect to the conditions precedent which must be fulfilled before the
Bonds specified above will be treated as effectively eligible for conversion.</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
converting Bondholder will be required to submit any necessary documents required in order to effect despatch in the manner specified.</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iv)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
a retroactive adjustment contemplated by the terms and conditions of the Bonds is required in respect of a conversion of Bonds,
certificates for the additional Shares deliverable pursuant to such retroactive adjustment (together with any other securities,
property or cash) will be delivered or despatched in the same manner as the Shares, other securities, property and cash or, as
the case may be, Equivalent Amount previously issued pursuant to the relevant Conversion Notice.</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">For Issuer&rsquo;s use only:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in">1</TD><TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif"></FONT>(A)</TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Bond
conversion identification reference: [&nbsp;&#9679;&nbsp;] Aptorum Group Limited</FONT> US$15,000,000 8.00 per cent. Convertible
Bonds due 2019</TD>
</TR>                                                                                                                                                           <TR STYLE="vertical-align: top; text-align: justify">
<TD>&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: justify">
<TD>&nbsp;</TD><TD STYLE="text-align: left">(B)</TD><TD STYLE="text-align: justify">Deposit Date: <U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U></TD></TR>
<TR STYLE="vertical-align: top; text-align: justify">
<TD>&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: justify">
<TD>&nbsp;</TD><TD STYLE="text-align: left">(C)</TD><TD STYLE="text-align: justify">Conversion Date: <U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U></TD></TR>
<TR STYLE="vertical-align: top; text-align: justify">
<TD>&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: justify">
<TD>2</TD><TD STYLE="text-align: left">(A)</TD><TD STYLE="text-align: justify">Aggregate principal amount of Bonds in respect
of which Certificates have been deposited for conversion:</TD></TR>
<TR STYLE="vertical-align: top; text-align: justify">
<TD>&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: justify">
<TD>&nbsp;</TD><TD STYLE="text-align: left">(B)</TD><TD STYLE="text-align: justify">Conversion Price on Conversion Date:</TD></TR>
<TR STYLE="vertical-align: top; text-align: justify">
<TD>&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: justify">
<TD>&nbsp;</TD><TD STYLE="text-align: left">(C)</TD><TD STYLE="text-align: justify">Number of Shares issuable:</TD></TR>
<TR STYLE="vertical-align: top; text-align: justify">
<TD>&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: justify">
<TD>&nbsp;</TD><TD STYLE="text-align: left">(D)</TD><TD STYLE="text-align: justify">Interest payable:</TD></TR>
<TR STYLE="vertical-align: top; text-align: justify">
<TD>&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: justify">
<TD>3</TD><TD COLSPAN="2" STYLE="text-align: justify">(if applicable) amount of cash payment due to converting Bondholder under
          Condition 7(b)(iv) in respect of fractions of Shares: <U></U></TD></TR>
<TR STYLE="vertical-align: top; text-align: justify">
<TD>&nbsp;</TD><TD COLSPAN="2" STYLE="text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: justify">
<TD>&nbsp;</TD><TD COLSPAN="2" STYLE="text-align: justify"><U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U></TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">The Issuer must complete items 1, 2 and (if applicable) 3</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Page; Sequence: 48; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">1-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->47<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>SCHEDULE 5</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Applicable discounts provided in Conditions
7(b)(iii)(A) and 7(b)(iii)(B)</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The table below sets out the applicable
discounts provided in Conditions 7(b)(iii)(A) and 7(b)(iii)(B) and is for illustrative purposes only. The following scenarios only
describe certain possible circumstances and are not exhaustive.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font-weight: bold; border-bottom: Black 1.5pt solid; padding-left: 10pt; text-indent: -10pt">The date on which
    a QIPO has occurred</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid">On&#9;the&nbsp; <BR>date falling&#9; 6 calendar months after&#9;the<BR>
    Issue Date</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid">On&#9;the date falling&#9;12 calendar months after&#9;the<BR>
    Issue Date</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid">On&#9;the date falling 18 calendar months after&#9;the<BR>
    Issue Date</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 64%; font-weight: bold; text-align: left; padding-bottom: 1.5pt; padding-left: 10pt; text-indent: -10pt"><FONT STYLE="font-weight: normal; font-style: normal">The&#9;pro&#9;rata&#9;Rate
    of Interest accrued and/or paid as of such date (</FONT><FONT STYLE="font-style: normal">W<FONT STYLE="font-weight: normal">)</FONT></FONT></TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">4</TD><TD STYLE="width: 1%; padding-bottom: 1.5pt; text-align: left">%</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">8</TD><TD STYLE="width: 1%; padding-bottom: 1.5pt; text-align: left">%</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">12</TD><TD STYLE="width: 1%; padding-bottom: 1.5pt; text-align: left">%</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: bold; text-align: left; padding-bottom: 1.5pt; padding-left: 10pt; text-indent: -10pt"><FONT STYLE="font-weight: normal; font-style: normal">Original&#9;discount&#9;before&#9;any
    offset (</FONT><FONT STYLE="font-style: normal">X<FONT STYLE="font-weight: normal">)</FONT></FONT></TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">23</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">%</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">23</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">%</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">28</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">%</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt; padding-left: 10pt; text-indent: -10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Offset
    amount (<B>Y</B> = W*50%)</FONT></TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">%</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">4</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">%</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">6</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">%</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt; padding-left: 10pt; text-indent: -10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Discount
    to the IPO Share Price after offset (<B>Z</B> = X - Y) to be applied to the IPO Share Price</FONT></TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">21</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">%</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">19</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">%</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">22</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">%</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt">1-48</P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 0; margin-bottom: 0"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.24
<SEQUENCE>28
<FILENAME>ff12018ex10-24_aptorum.htm
<DESCRIPTION>ESCROW AGREEMENT BETWEEN THE COMPANY AND PEACE RANGE LIMITED, DATED APRIL 25, 2018
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0; text-align: right; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit
10.24</B></FONT></P>

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>DOCUMENT
ESCROW AGREEMENT</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">THIS
AGREEMENT is made on __________________ 2018 between:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>Jurchen
                                         Investment Corporation</B></FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">,
                                         a company incorporated in the British Virgin Islands and having its registered/principal
                                         office at Vistra Corporation Services Centre, Wickhams Cay II, Road Town, Tortola, VG1110,
                                         the British Virgin Islands (&quot;Party A&quot;)</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>Peace
                                         Range Limited</B></FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">,
                                         a company incorporated in the British Virgin Islands and having its registered/principal
                                         office [ ] (&quot;Party B&quot;); and</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>THE
                                         LAW DEBENTURE TRUST (ASIA) LIMITED</B>, whose registered office is at Suite 413, Hutchison
                                         House, 10 Harcourt Road, Central, Hong Kong (the &ldquo;Escrow Agent&rdquo;).</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>WHEREAS:</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 36.85pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">A.</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Party
                                         A and Party B (individually an &ldquo;Appointer&rdquo; and together the &ldquo;Appointers&rdquo;)
                                         are parties to the Supplemental Agreement (as defined below) pursuant to which Party
                                         A will deliver to the Escrow Agent the documents specified in <U>Schedule 4</U> on or
                                         about ______________________ 2018.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 36.85pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">B.</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                         Escrow Agent has agreed with the other Parties to act as escrow agent in relation to
                                         the Escrow Documents (as defined below) subject to the conditions and on the terms of
                                         this Agreement.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; background-color: white"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 35.45pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Definitions</B></FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; background-color: white"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 35.45pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.1</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
                                         this Agreement the following words and expressions shall have the following meanings:-</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&ldquo;Authorised
Signatories&rdquo;</B> means those persons whose names and specimen signatures are set out in <U>Schedule 3</U> or such other
persons as shall be notified to the Escrow Agent in writing by a notice, signed by two Authorised Signatories or two Directors
of the relevant Party, and incorporating specimen signatures of such persons;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&ldquo;Business
Day&rdquo;</B> means a day (other than a Saturday or a Sunday) on which banks are generally open for the transaction of normal
commercial banking business in Hong Kong;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&ldquo;Escrow
Documents&rdquo; </B>means (i) the documents specified in <U>Schedule 4</U>; and (ii) any other documents delivered to the Escrow
Agent and identified by the Party A delivering such documents as being Escrow Documents;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&ldquo;Fee
Letter&rdquo;</B> means the letter dated on or about the date hereof between the Escrow Agent and the Party A setting out the
terms of the remuneration and costs and expenses payable under this Agreement to the Escrow Agent;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 1; Options: NewSection -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --> of 16</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&ldquo;Insolvency
Event&rdquo;</B> means the making of a bankruptcy order, the presentation of a winding-up petition which is not withdrawn or dismissed
within 30 days, the making of a winding-up order or passing of a winding-up resolution, the appointment of an administrator or
receiver, an insolvent reorganisation (by way of voluntary arrangement, scheme of arrangement or otherwise) or the occurrence
of any similar or analogous insolvency event in any jurisdiction;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&ldquo;Parties&rdquo;
</B>means the parties to this Agreement;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&ldquo;Release
Notice&rdquo; </B>means a notice substantially in the form set out in <U>Schedule 2</U> signed by an Authorised Signatory on behalf
of Party A and an Authorised Signatory on behalf of Party B;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&ldquo;Standard
Conditions&rdquo;</B> means the Escrow Agent&rsquo;s standard terms and conditions for document escrows applicable current at
the date of this Agreement and attached hereto;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&ldquo;Supplemental
Agreement&rdquo;</B> means the share charge dated on or about the date of this Agreement and made between Jurchen Investment Corporation
as chargor, Peace Range Limited as the chargee and Aptorum Group Limited as the issuer and other agreements between one or both
of the Appointers and/or any other party which relates to or is in connection with the Supplemental Agreement;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&ldquo;Transfer
Document&rdquo;</B> means the Escrow Documents referred to in a Transfer Notice;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&ldquo;Transfer
Notice&rdquo; </B>means a notice substantially in the form set out in <U>Schedule 1</U> signed by an Authorised Signatory on behalf
of Party B;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; background-color: white"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 35.45pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.2</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Headings
                                         and sub-headings are for ease of reference only and shall not affect the construction
                                         of this Agreement or any of the Schedules hereto.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; background-color: white"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 35.45pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Standard
                                         Conditions</B></FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; background-color: white"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 35.45pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.1</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                         Standard Conditions (as amended pursuant to this Agreement) shall be deemed to be incorporated
                                         in this Agreement which the Parties hereby confirm and acknowledge.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; background-color: white"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 35.45pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.2</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                         Parties agree that the following paragraphs referred to in the Standard Conditions shall
                                         be amended and/or supplemented as follows:</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; background-color: white"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 35.45pt; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 35.4pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Paragraph
                                         2.3(i): </I>The provisions of paragraph 2.3 (i) of the Standard Conditions shall also
                                         apply <I>mutatis mutandis </I>in respect of any Release Notice delivered in accordance
                                         with this Agreement as if references therein to a &quot;Transfer Notice&quot; were a
                                         reference to a Release Notice.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; background-color: white"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 35.45pt; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 35.4pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Paragraph
                                         4.1: </I>Notwithstanding any other provision of this Agreement, Party B shall have the
                                         sole right and power to remove the Escrow Agent and appoint a new Escrow Agent in accordance
                                         with paragraph 4 of the Standard Conditions should the Escrow Agent refuse or fail to
                                         comply with Clause 4 to deliver all or any of the Transfer Documents to the Party B upon
                                         receipt of a Transfer Notice, including without limitation, as a result of any of the
                                         matters referred to in paragraph 2.3(g) or paragraph 6.6 of the Standard Conditions or
                                         an Insolvency Event relating to the Escrow Agent or the Party A.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --> of 16</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; background-color: white"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 35.45pt; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 35.4pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Paragraph
                                         4.3: Notwithstanding any other provision of this Agreement, a replacement escrow agent
                                         shall be appointed in accordance with Clause 8.3 of this Agreement and if the Escrow
                                         Agent has resigned for any reason, the Escrow Documents shall be dealt with and delivered
                                         by the Escrow Agent strictly in accordance with Clause 8.3 of this Agreement.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; background-color: white"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 35.45pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.3</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">To
                                         the extent there are any inconsistencies between the terms of this Agreement and the
                                         Standard Conditions, the Standard Conditions shall prevail.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; background-color: white"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 35.45pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>The
                                         Escrow Agent</B></FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; background-color: white"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 35.45pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.1</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Party
                                         A and Party B hereby appoint and instruct the Escrow Agent to act, and the Escrow Agent
                                         acknowledges that it has been appointed and will act, as escrow agent subject to the
                                         conditions and on the terms of this Agreement.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; background-color: white"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 35.45pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.2</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                         Escrow Agent shall hold the Escrow Documents delivered to it in accordance with the terms
                                         of this Agreement.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; background-color: white"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 35.45pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Deposit,
                                         transfer and/or release of the Escrow Documents</B></FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; background-color: white"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 35.45pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.1</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                         Escrow Documents will be held by the Escrow Agent for safekeeping upon delivery of any
                                         such documents to it by Party A from time to time. Upon receipt of the Escrow Documents,
                                         the Escrow Agent will issue a receipt to Party A and Party B in the form set out in <U>Schedule
                                         5</U> (Form of Receipt) to this Agreement. Each of Party A and Party B acknowledges that
                                         the Escrow Agent shall not, at any time, be responsible for verifying, validating, endorsing
                                         or authenticating, any Escrow Documents provided to it in accordance with this Agreement.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; background-color: white"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 35.45pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.2</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Subject
                                         to the Escrow Agent having possession of the relevant Transfer Document(s), as soon as
                                         reasonably practicable upon the receipt by the Escrow Agent of a Transfer Notice duly
                                         executed by the Party B, or if later the date specified in the Transfer Notice, the Escrow
                                         Agent shall arrange for all Transfer Documents specified in the Transfer Notice to be
                                         delivered to Party B as specified in the Transfer Notice. In arranging for the delivery
                                         of the Transfer Documents the Escrow Agent&rsquo;s sole responsibility shall be to hand
                                         the Transfer Documents, properly addressed in accordance with the Transfer Notice, to
                                         a reputable courier (or, if specified in the Transfer Notice, to the courier so specified)
                                         and the Escrow Agent shall incur no liability to any person should the Transfer Document(s)
                                         subsequently not be received by the relevant party. The costs of the courier shall be
                                         for the account of party supplying the courier. As soon as is reasonably practicable
                                         after handing the Transfer Documents to the courier the Escrow Agent shall notify Party
                                         A and Party B thereof.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --> of 16</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; background-color: white"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 35.45pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.3</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Subject
                                         to the Escrow Agent having possession of the relevant Escrow Document(s) and subject
                                         to any prior exercise by Party B of its right to deliver a Transfer Notice in accordance
                                         with Clause 4.2, the Escrow Agent shall arrange for the Escrow Documents to be delivered
                                         to Party A as specified in a Release Notice duly executed by the Party A and Party B.
                                         In arranging for the delivery of the Escrow Documents the Escrow Agent&rsquo;s sole responsibility
                                         shall be to hand the Escrow Documents, properly addressed in accordance with the Release
                                         Notice, to a reputable courier (or, if specified in the Release Notice, to the courier
                                         so specified) and the Escrow Agent shall incur no liability to any person should the
                                         Escrow Documents subsequently not be received by the relevant party. The costs of the
                                         courier shall be for the account of party supplying the courier. As soon as is reasonably
                                         practicable after handing the Escrow Documents to the courier the Escrow Agent shall
                                         notify Party A and Party B thereof.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; background-color: white"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 35.45pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.4</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Save
                                         as expressly permitted hereunder, no other deliveries of the Escrow Documents shall be
                                         made unless Party A and Party B agree otherwise.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; background-color: white"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 35.45pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Escrow
                                         Agent&rsquo;s remuneration, costs and expenses</B></FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; background-color: white"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 35.45pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.1</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Party
                                         A shall be liable to the Escrow Agent for the payment of remuneration to it for its services
                                         hereunder as set out in the Fee Letter and for the Escrow Agent&rsquo;s costs and expenses
                                         all as additionally provided for in the Standard Conditions.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; background-color: white"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 35.45pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Benefit
                                         of Agreement</B></FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; background-color: white"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 35.45pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.1</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
                                         Agreement shall be binding upon and inure to the benefit of each Party and its successors
                                         and permitted assigns.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; background-color: white"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 35.45pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.2</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Subject
                                         to Clause 6.3, no Party may assign or transfer or purport to assign or transfer any of
                                         its rights or obligations under this Agreement without the written consent of all the
                                         other Parties.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; background-color: white"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 35.45pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.3</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Party
                                         B may at any time assign or otherwise transfer all or any part of its rights under this
                                         Agreement in accordance with Clause 20.1 of the Supplemental Agreement.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; background-color: white"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 35.45pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.4</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
                                         the event the Party B exercises their rights pursuant to Clause 6.3 above, the Escrow
                                         Agent will be notified as soon as reasonably practicable and shall complete the necessary
                                         money laundering checks on any assignee or successor and will be entitled to charge for
                                         its properly incurred time in accordance with the terms set out in the Standard Conditions.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; background-color: white"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 35.45pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">7.</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Notices</B></FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; background-color: white"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 35.45pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">7.1</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Any
                                         notice to be given under this Agreement (including a Transfer Notice) shall be in writing,
                                         shall be signed by or on behalf of the person giving it and;</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; background-color: transparent"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 35.45pt; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 35.4pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">be
                                         in English; and</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; background-color: transparent"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 35.45pt; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 35.4pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">if
                                         accompanied by any other documents, such accompanying documents must be:</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; background-color: transparent"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 70.85pt; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 35.45pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">in
                                         English; or</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 4 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --> of 16</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; background-color: transparent"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 70.85pt; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 35.45pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">if
                                         not in English, and if so required by the Escrow Agent, accompanied by a certified English
                                         translation and, in this case, the English translation will prevail unless the document
                                         is a constitutional, statutory or other official document.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; background-color: white"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 35.45pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">7.2</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Effectiveness</B></FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; background-color: transparent"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 35.45pt; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 35.4pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Any
                                         communication or document made or delivered in connection with this Agreement will only
                                         be effective:</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; background-color: transparent"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 70.85pt; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 35.45pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">if
                                         by way of fax, at the time shown on the transmission report as being successfully sent;</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; background-color: transparent"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 70.85pt; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 35.45pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">if
                                         delivered personally, at the time of delivery;</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; background-color: transparent"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 70.85pt; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 35.45pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">if
                                         sent by courier, (a) in the case of communications to the Escrow Agent, upon receipt
                                         by the department or officer of the Escrow Agent named in Clause 7.3 below and (b) otherwise,
                                         three (3) Business Days after being couriered with a reputable international courier
                                         company in an envelope addressed to the relevant Party at the relevant address;</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; background-color: transparent"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 70.85pt; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 35.45pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iv)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">if
                                         sent by email; (a) in the case of communications to the Escrow Agent, written confirmation
                                         of receipt from the Escrow Agent (for the avoidance of doubt an automatically generated
                                         &ldquo;received&rdquo; or &ldquo;read&rdquo; receipt will not constitute written confirmation)
                                         and (b) otherwise, when received as evidenced by a read receipt,</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.9pt; text-align: justify; background-color: transparent"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">and,
where a particular department or officer is specified as part of its address details provided under Clause 7.3, if addressed to
that department or officer.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.9pt; text-align: justify; background-color: transparent"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; background-color: transparent"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 35.45pt; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 35.4pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Any
                                         communication or document which becomes effective, in accordance with paragraph (a) above,
                                         after 5.00pm, or on a non- Business Day, in the place of receipt shall be deemed only
                                         to become effective on the next following Business Day in the place of receipt.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; background-color: white"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 35.45pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">7.3</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Addresses</B></FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; background-color: white"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 35.45pt; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 35.4pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                         Escrow Agent&rsquo;s address for the service of notices is:</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Law
Debenture Trust (Asia) Limited</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 71.45pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Suite
413, Hutchison House,</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 71.45pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10
Harcourt Road</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 71.45pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Central</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 71.45pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Hong
Kong</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 71.45pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Fax
number: +852 2234 9765</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 71.45pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Marked
for the attention of: Trust Manager</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 71.45pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Email:
<U>hong.kong@lawdeb.com</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 5 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --> of 16</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; background-color: white"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 35.45pt; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 35.4pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Party
                                         A&rsquo;s address for the service of notices is:</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.85pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Aptorum
Group Limited</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.85pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">17/F,
Guangdong Investment Tower,</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.85pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">148
Connaught Road Central</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.85pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Hong
Kong</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.85pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.85pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Fax
number: +852 2850 7286</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.85pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Marked
for the attention of: Legal Department</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; background-color: white"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 35.45pt; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 35.4pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Party
                                         B&rsquo;s address for the service of notices is:</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Peace
Range Limited</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Fax
number: </FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Marked
for the attention of: Mr. Andy Cheuk / Mr. Philip Wong</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
communication given under this Clause 7 but received on a non-Business Day, or after close of business on a Business Day in the
place of receipt will only be deemed to be given on the next Business Day in that place.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; background-color: white"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 35.45pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8.</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Termination,
                                         extension and resignation of Escrow Agent</B></FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; background-color: white"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 35.45pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8.1</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Subject
                                         to Clauses 8.2 to 8.5, this Agreement shall automatically terminate on the earlier of
                                         the following dates:</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; background-color: white"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 35.45pt; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 35.4pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">on
                                         the date when all Escrow Documents have been delivered pursuant to the delivery of the
                                         Transfer Notice;</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; background-color: white"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 35.45pt; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 35.4pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">on
                                         the date when all Escrow Documents have been delivered pursuant to the delivery of the
                                         Release Notice as provided under Clause 22.5 of the Supplemental Agreement.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; background-color: white"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 35.45pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8.2</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                         Parties agree, in the event that any Escrow Documents are held in accordance with the
                                         provisions of Clause 4 after the expiration of 30 months from the date hereof, that they
                                         shall extend this Agreement for such term and for such additional fees (payable by Party
                                         A to the Escrow Agent), as shall be agreed at the relevant time.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; background-color: white"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 35.45pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8.3</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Subject
                                         to Clause 8.4, the Escrow Agent may give not less than 30 days' prior written notice
                                         to resign and be discharged from all its duties and obligations hereunder (such notice
                                         referred to in this Clause as the &ldquo;Notice of Resignation&rdquo;). Upon giving a
                                         Notice of Resignation, the Escrow Agent will, at the cost of Party A, cooperate with
                                         Party A and Party B in good faith so that, while Party A and Party B are making all reasonable
                                         efforts to find and appoint a successor escrow agent (the &ldquo;Successor Agent&rdquo;)
                                         the Escrow Agent&rsquo;s resignation from its appointment hereunder will not become effective
                                         until the appointment of the Successor Agent, provided always that:</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; background-color: white"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 35.45pt; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 35.4pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">if
                                         no Successor Agent mutually agreed by the Party A and Party B shall have been appointed
                                         within 15 days of the Notice of Resignation, Party B may in its sole discretion select
                                         and appoint an accounting firm, law firm or professional escrow agent (being an institutional
                                         of similar standing to the Escrow Agent) to be the Successor Agent, on the same or substantially
                                         the same terms as this Agreement subject to the aggregate remuneration and fees of such
                                         Successor Agent being capped at US$10,000; and</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 6 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --> of 16</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; background-color: white"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 35.45pt; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 35.4pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">if
                                         no Successor Agent shall have been appointed within 30 days of the Notice of Resignation,
                                         the Escrow Agent may then resign forthwith and its resignation shall be effective immediately.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify; text-indent: 0in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Upon
its resignation, the Escrow Agent shall promptly, but at no risk or expense to it, deliver the Escrow Documents to the Successor
Agent or, if a Transfer Notice has not been delivered by Party B prior to such time, on the joint instructions of Party A and
Party B, to such person as they may nominate or, failing such instructions, it shall deliver the same to Party B and the Escrow
Agent&rsquo;s sole responsibility in relation to such delivery shall be to hand the Escrow Document(s), properly addressed to
such person in accordance with this Clause 8.3, to a reputable courier and the Escrow Agent shall incur no liability to any person
should the Escrow Document(s) subsequently not be received by the relevant person. Should the Escrow Documents be delivered by
the Escrow Agent to Party B in accordance with this Clause 8.3 where a Successor Agent has not been appointed prior to the resignation
of the Escrow Agent, Party B agrees that it shall hold such documents in accordance with the terms of the Supplemental Agreement
pending the appointment of a Successor Agent, and shall thereafter deliver the Escrow Documents to the Successor Agent promptly
upon its appointment.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify; text-indent: 0in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; background-color: white"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 35.45pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8.4</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
                                         Party may terminate this Agreement with immediate effect by giving a notice (&quot;Default
                                         Notice&quot;) to another Party (the &ldquo;Defaulting Party&rdquo;) copying in the remaining
                                         Party should any of the following occur to a Defaulting Party:</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; background-color: white"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 35.45pt; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 35.4pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">it
                                         has committed a material breach or is in persistent breach of the terms of this Agreement
                                         and has not remedied the specified breach which is capable of being remedied within 30
                                         days of a Default Notice served on it by a non-defaulting party specifying the breach
                                         which must be remedied; or</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; background-color: white"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 35.45pt; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 35.4pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">an
                                         Insolvency Event has occurred in relation to the Defaulting Party.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify; text-indent: 0in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Each
Party shall immediately notify the other Parties as soon as practicable on becoming aware that it is or may become subject to
an Insolvency Event.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify; text-indent: 0in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; background-color: white"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 35.45pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8.5</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Any
                                         termination of this Agreement under this Clause 8 shall be without prejudice to the completion
                                         of transactions entered into but not completed prior to termination and following termination,
                                         the Escrow Agent will continue to hold the Escrow Documents on the terms of this Agreement
                                         until the Escrow Documents are delivered to the person(s) entitled in accordance with
                                         the aforementioned clauses. Any fees payable under this Agreement shall be calculated
                                         up to the later of the delivery of the Escrow Documents or the expiry of any notice period
                                         and will be payable on or before the proposed day of delivery of the Escrow Documents.
                                         The Escrow Agent is not required to undertake such delivery until its fees, costs and
                                         expenses payable under this Agreement pursuant to Clause 5 have been paid in full. All
                                         remedies under the Agreement shall survive the termination of the Agreement.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 7 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --> of 16</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; background-color: white"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 35.45pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">9.</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Governing
                                         law and Jurisdiction</B></FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; background-color: white"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 35.45pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">9.1</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
                                         Agreement shall be interpreted and construed in accordance with the laws of Hong Kong.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; background-color: white"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 35.45pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">9.2</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Each
                                         of the Appointers, for the benefit of the other Parties, irrevocably submits to the exclusive
                                         jurisdiction of the Courts of Hong Kong in respect of any claim, dispute or difference
                                         arising out of or in connection with this Agreement (&ldquo;Proceedings&rdquo;), provided
                                         that nothing contained in this Clause shall be taken to have limited the right of the
                                         Escrow Agent to proceed in the courts of any other competent jurisdiction.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; background-color: white"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 35.45pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">9.3</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Party
                                         A agrees that the process by which any Proceedings are commenced in Hong Kong pursuant
                                         to Clause 9.2 may be served on it by being delivered to Aptorum Group Limited at the
                                         address referred to in Clause 7.3(b). If such person is not or ceases to be effectively
                                         appointed to accept service of process on behalf of Party A, Party A shall, on the written
                                         demand of the other Parties to this Agreement, appoint a further person in Hong Kong
                                         to accept service of process on its behalf and, failing such appointment within 14&nbsp;days,
                                         the other Parties to this Agreement shall be entitled to appoint such a person by written
                                         notice to Party A. Nothing in this paragraph shall affect the right of the other Parties
                                         to serve process in any other manner permitted by law.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; background-color: white"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 35.45pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">9.4</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Party
                                         B agrees that the process by which any Proceedings are commenced in Hong Kong pursuant
                                         to Clause 9.2 may be served on it by being delivered to Peace Range Limited at the address
                                         referred to in Clause 7.3(c). If such person is not or ceases to be effectively appointed
                                         to accept service of process on behalf of Party B, Party B shall, on the written demand
                                         of the other Parties to this Agreement, appoint a further person in Hong Kong to accept
                                         service of process on its behalf and, failing such appointment within 14&nbsp;days, the
                                         other Parties to this Agreement shall be entitled to appoint such a person by written
                                         notice to Party B. Nothing in this paragraph shall affect the right of the other Parties
                                         to serve process in any other manner permitted by law.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; background-color: white"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 35.45pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">9.5</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
                                         the event that any dispute or controversy arises involving the Parties or any of them
                                         or any other person, firm or entity with respect to this Agreement or the Escrow Document,
                                         or if the Escrow Agent should be in doubt as to what action to take, the Escrow Agent
                                         shall have the right, but not the obligation to stop all proceedings in the performance
                                         of the services constituted by this Agreement and withhold transfer or release of the
                                         Escrow Document until such dispute or conflicting demands or determinations have been
                                         resolved and written confirmation thereof by an Authorised Signatory of each of the other
                                         Parties has been delivered to the Escrow Agent.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; background-color: white"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 35.45pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Counterparts</B></FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; background-color: white"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 35.45pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.1</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
                                         Agreement may be executed in one or more counterparts, all of which when taken together
                                         shall constitute one instrument.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; background-color: white"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 35.45pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.2</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Any
                                         notice served pursuant to this Agreement may be executed in any number of counterparts,
                                         each of which shall be deemed to be an original but all of which taken together shall
                                         constitute one and the same notice.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Parties have executed this Agreement on the date and year first written above</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>[Signature
pages to follow]</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 8 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --> of 16</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif; text-transform: uppercase"><B></B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; text-align: left">
    <TD COLSPAN="2"><FONT STYLE="font: 10pt Times New Roman, Times, Serif; text-transform: uppercase"><B>Jurchen Investment corporation</B></FONT></TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD STYLE="width: 4%">&nbsp;</TD>
    <TD STYLE="width: 36%">&nbsp;</TD>
    <TD STYLE="width: 60%">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD><FONT STYLE="font: 10pt Times New Roman, Times, Serif">By:</FONT></TD>
    <TD>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
</TABLE>

<P STYLE="margin: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; text-align: left">
    <TD STYLE="width: 40%; border-bottom: Black 1.5pt solid">&nbsp;</TD>
    <TD STYLE="width: 30%">&nbsp;</TD>
    <TD STYLE="width: 30%">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Authorised
Signatory</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>&nbsp;</B>&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 9 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --> of 16</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; text-align: left">
    <TD COLSPAN="2"><FONT STYLE="font: 10pt Times New Roman, Times, Serif; text-transform: uppercase"><B>Peace Range Limited</B></FONT></TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD STYLE="width: 4%">&nbsp;</TD>
    <TD STYLE="width: 36%">&nbsp;</TD>
    <TD STYLE="width: 60%">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD><FONT STYLE="font: 10pt Times New Roman, Times, Serif">By:</FONT></TD>
    <TD>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
</TABLE>

<P STYLE="margin: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; text-align: left">
    <TD STYLE="width: 40%; border-bottom: Black 1.5pt solid">&nbsp;</TD>
    <TD STYLE="width: 30%">&nbsp;</TD>
    <TD STYLE="width: 30%">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Authorised
Signatory</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 10 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --> of 16</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; text-align: left">
    <TD COLSPAN="2"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>LAW DEBENTURE TRUST (ASIA) LIMITED</B></FONT></TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD STYLE="width: 4%">&nbsp;</TD>
    <TD STYLE="width: 36%">&nbsp;</TD>
    <TD STYLE="width: 60%">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD><FONT STYLE="font: 10pt Times New Roman, Times, Serif">By:</FONT></TD>
    <TD>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; text-align: left">
    <TD STYLE="width: 40%; border-bottom: Black 1.5pt solid">&nbsp;</TD>
    <TD STYLE="width: 30%">&nbsp;</TD>
    <TD STYLE="width: 30%">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Authorised
Signatory</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 11 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --> of 16</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>SCHEDULE
1</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Form
of Transfer Notice</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">To
:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Law
Debenture Trust (Asia) Limited</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Suite
413, Hutchison House</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10
Harcourt Road</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Central</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Hong
Kong</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Attention:
The Trust Manager</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date:
[&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;]</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dear
Sirs,</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Escrow
Agreement dated [&nbsp;&nbsp; ] between Jurchen Investment Corporation, Peace Range Limited and Law Debenture Trust (Asia) Limited (the &ldquo;Agreement&rdquo;)</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to Clause 4 of the Agreement, we the undersigned hereby irrevocably instruct you to deliver as soon as reasonably practicable
after the date hereof by handing to the courier firm [ ] all Escrow Document(s) (any delivery charges shall be for our account
and be paid to you prior to your handing the Escrow Document(s) to the courier):</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
courier is to be instructed to deliver the above Escrow Documents to:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[address
and contact details]</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 0; margin-bottom: 0"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid; width: 40%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Authorised
Signatory &#9;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Signed
for and on behalf of&#9;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Peace
Range Limited&#9;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Note
delivery charges, if not otherwise paid, are to be credited to the account of the Escrow Agent, please quote [&nbsp;&nbsp; ] Escrow Agreement
/ Reference [ ]:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="width: 100%; margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify; width: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">To:</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Hongkong and Shanghai Banking Corporation Ltd</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">1
Queen&rsquo;s Road Central, Hong Kong</FONT></TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="width: 100%; margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify; width: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Favour:</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Law Debenture Trust (Asia) Limited</FONT></TD></TR>
</TABLE>


<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="width: 100%; margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify; width: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">A/C No:</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">USD Savings Account No.</FONT></TD></TR>
</TABLE>


<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="width: 100%; margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify; width: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">SWIFT:</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">HSBCHKHHHKH</FONT></TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>or</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="width: 100%; margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify; width: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">To:</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Hongkong and Shanghai Banking Corporation Ltd</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">1
Queen&rsquo;s Road Central, Hong Kong</FONT></TD></TR>
</TABLE>


<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="width: 100%; margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify; width: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Favour:</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Law Debenture Trust (Asia) Limited</FONT></TD></TR>
</TABLE>


<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="width: 100%; margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify; width: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">A/C No:</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">HKD Savings Account No. </FONT></TD></TR>
</TABLE>


<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="width: 100%; margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify; width: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">SWIFT:</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">HSBCHKHHHKH</FONT></TD></TR>
</TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>



<!-- Field: Page; Sequence: 12 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --> of 16</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>SCHEDULE
2</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Form
of Release Notice</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">To
:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Law
Debenture Trust (Asia) Limited</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Suite
413, Hutchison House</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10
Harcourt Road</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Central</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Hong
Kong</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Attention:
The Trust Manager</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date:
[&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;]</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dear
Sirs,</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Escrow
Agreement dated [ ] between Jurchen Investment Corporation, Peace Range Limited and Law Debenture Trust (Asia) Limited (the &ldquo;Agreement&rdquo;)</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to Clause 8.2 of the Agreement, we the undersigned hereby irrevocably instruct you to deliver as soon as reasonably practicable
after the date hereof by handing to the courier firm [ ] all Escrow Document(s) (any delivery charges shall be for our account
and be paid to you prior to your handing the Escrow Document(s) to the courier).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
courier is to be instructed to deliver the above Escrow Documents to:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[address
and contact details]</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; text-align: left">
    <TD STYLE="width: 33%; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 34%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 33%; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Authorised Signatory</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">Authorised Signatory</FONT></TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Signed for and on behalf of</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">Signed for and on behalf of</FONT></TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Jurchen Investment Corporation</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">Peace Range Limited</FONT></TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Note
delivery charges, if not otherwise paid, are to be credited to the account of the Escrow Agent, please quote [ ] Escrow Agreement
/ Reference [ ]:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="width: 100%; margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify; width: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">To:</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Hongkong and Shanghai Banking Corporation Ltd</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">1
Queen&rsquo;s Road Central, Hong Kong</FONT></TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="width: 100%; margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify; width: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Favour:</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Law Debenture Trust (Asia) Limited</FONT></TD></TR>
</TABLE>


<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="width: 100%; margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify; width: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">A/C No:</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">USD Savings Account No. </FONT></TD></TR>
</TABLE>


<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="width: 100%; margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify; width: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">SWIFT:</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">HSBCHKHHHKH</FONT></TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>or</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="width: 100%; margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify; width: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">To:</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Hongkong and Shanghai Banking Corporation Ltd</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">1
Queen&rsquo;s Road Central, Hong Kong</FONT></TD></TR>
</TABLE>


<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="width: 100%; margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify; width: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Favour:</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Law Debenture Trust (Asia) Limited</FONT></TD></TR>
</TABLE>


<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="width: 100%; margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify; width: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">A/C No:</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">HKD Savings Account No. </FONT></TD></TR>
</TABLE>


<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="width: 100%; margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify; width: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">SWIFT:</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">HSBCHKHHHKH</FONT></TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Page; Sequence: 13 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --> of 16</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>SCHEDULE
3</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Authorised
Signatories</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD COLSPAN="2" STYLE="border: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>For
        Party A</B></FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 25%; border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Name</B></FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P></TD>
    <TD STYLE="width: 75%; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; border-right: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Specimen
    Signature</B></FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
minimum number of ____ person(s) shall be required to sign any Release Notice</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD COLSPAN="2" STYLE="border: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>For
        Party B</B></FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 25%; border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Name</B></FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P></TD>
    <TD STYLE="width: 75%; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; border-right: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Specimen
    Signature</B></FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
minimum number of ____ person(s) shall be required to sign any Transfer Notice or Release Notice</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 14 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --> of 16</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>Schedule
4</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Description
of Escrow Document(s)</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 39.1pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Share
                                         certificate relating to certain Class B shares in Aptorum Group Limited (the &quot;<B>Shares</B>&quot;)
                                         referred to in Clause 3.2(a) of the Supplemental Agreement; </FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 39.1pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Instrument
                                         of Transfer in respect of the Shares referred to in Clause 3.2(a) of and in the form
                                         set out in schedule 2 of the Supplemental Agreement;</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 39.1pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Letter
                                         of Authority and Undertaking from directors of Aptorum Group Limited referred to in Clause
                                         3.2(b) of and in the form set out in schedule 4 of the Supplemental Agreement;</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 39.1pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Board
                                         resolution of the directors of Aptorum Group Limited referred to in Clause 3.2(c) of
                                         and in the form set out in schedule 5 of the Supplemental Agreement;</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 39.1pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Proxy
                                         and Power of Attorney in respect of the Shares referred to in Clause 3.2(d) of and in
                                         the form set out in schedule 3 of the Supplemental Agreement;</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 39.1pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Deed
                                         of Undertaking and Confirmation from Aptorum Group Limited referred to in Clause 3.2(e)
                                         of and in the form set out in schedule 6 of the Supplemental Agreement; and</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 39.1pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">7.</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Letter
                                         of Instructions to Registered Agent and Acknowledgement referred to in Clause 3.2(f)
                                         of and in the form set out in schedule 7 of the Supplemental Agreement.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 15 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --> of 16</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>Schedule
5</B></FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Form
of Receipt</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Law
Debenture Trust (Asia) Limited</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Suite
413, Hutchison House</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10
Harcourt Road</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Central</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Hong
Kong</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">To:</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">Jurchen
                                         Investment Corporation (as Party A)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><BR>
                                         <FONT STYLE="font-weight: normal">17/F, Guangdong Investment Tower, 148 Connaught Road
                                         Central, Hong Kong</FONT></FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="width: 100%; margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">Copy:</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">Peace Range Limited (as
Party B)<BR>
[<I>Insert address</I>]</FONT></TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">[<I>Insert
date</I>]</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">In
connection with the Escrow Agreement entered into between us, Law Debenture Trust (Asia) Limited, Jurchen Investment Corporation
and Peace Range Limited dated [&#9679;] 2018, we hereby acknowledge receipt of the following documents into our safe keeping:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date
deposited<FONT STYLE="font-weight: normal">:</FONT></FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">[<I>Insert
date</I>]</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Escrow
Document(s)<FONT STYLE="font-weight: normal">:</FONT></FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">[<I>Insert
name of documents and, if applicable, date of document</I>]</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Escrow Agent hereby makes no representation or warranties as to the authenticity or validity of the documents provided to it for
safekeeping.</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 0; margin-bottom: 0"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid; width: 40%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">Authorised
Signatory</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Law
Debenture Trust (Asia) Limited</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt">Page 16 of 16</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in"></P>

<!-- Field: Rule-Page --><DIV ALIGN="CENTER" STYLE="margin-top: 0; margin-bottom: 0"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>



<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.25
<SEQUENCE>29
<FILENAME>ff12018ex10-25_aptorum.htm
<DESCRIPTION>2017 SHARE OPTION PLAN
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0; text-align: right"><B>Exhibit 10.25</B></P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>APTORUM GROUP LIMITED</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#30693;&#33256;&#38598;&#22296;&#26377;&#38480;&#20844;&#21496;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>2017 SHARE OPTION PLAN</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><B>1.</B></TD><TD STYLE="text-align: justify"><B>Purposes of the Plan</B>. The purposes of this Plan are to attract and retain the best available
personnel, to provide additional incentives to Employees, Directors and Consultants and to promote the success of the Company&rsquo;s
business.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><B>2.</B></TD><TD STYLE="text-align: justify"><B>Definitions.</B> The following definitions shall apply as used herein and in the individual
Share Option Agreements except as defined otherwise in an individual Share Option Agreement. In the event a term is separately
defined in an individual Share Option Agreement, such definition shall supersede the definition contained in this Section.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 18pt">(a)</TD><TD STYLE="text-align: justify">&ldquo;<B>Administrator</B>&rdquo; means the Board or any of the Committees appointed to administer
the Plan or such Officer or Officers as authorized by the Board or any of the Committees appointed to administer the Plan.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 18pt">(b)</TD><TD STYLE="text-align: justify">&ldquo;<B>Affiliate</B>&rdquo; and &ldquo;<B>Associate</B>&rdquo; shall have the respective meanings
ascribed to such terms in Rule 12b-2 promulgated under the Exchange Act.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 18pt">(c)</TD><TD STYLE="text-align: justify">&ldquo;<B>Applicable Laws</B>&rdquo; means the legal requirements relating to the Plan and the
Options under applicable provisions of the corporate and securities laws of any jurisdiction, the Code, the rules of any applicable
stock exchange or national market system, and the rules of any jurisdiction applicable to Option granted to residents therein.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 18pt">(d)</TD><TD STYLE="text-align: justify"><B>&ldquo;Appointment Letter&rdquo;</B> refers to documentation that describes the terms and conditions
in which each Employee, Director, or Consultant is employed, appointed, or enlisted to service the Company and/or its subsidiaries
and affiliated companies.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 18pt">(e)</TD><TD STYLE="text-align: justify"><B>&ldquo;Articles&rdquo;</B> refers to the Company&rsquo;s Second Amended and Restated Memorandum
of Articles of Association (Amended and Restated by special resolutions dated ____________ 2017).</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 18pt">(f)</TD><TD STYLE="text-align: justify">&ldquo;<B>Board</B>&rdquo; means the Board of Directors of the Company.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 18pt">(g)</TD><TD STYLE="text-align: justify">&ldquo;<B>Change in Control</B>&rdquo; means a change in ownership or control of the Company effected
through either of the following transactions:</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">i.</TD><TD STYLE="text-align: justify">the direct or indirect acquisition by any person or related group of persons (other than an acquisition
from or by the Company or by a Company-sponsored employee benefit plan or by a person that directly or indirectly controls, is
controlled by, or is under common control with, the Company) of beneficial ownership (within the meaning of Rule13d-3 of the Exchange
Act) of securities possessing more than fifty percent (50%) of the total combined voting power of the Company&rsquo;s outstanding
securities pursuant to a tender or exchange offer made directly to the Company&rsquo;s shareholders, or</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 1; Options: NewSection; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">ii.</TD><TD STYLE="text-align: justify">a change in the composition of the Board over a period of thirty-six (36) months or less such that
a majority of the Board members (rounded up to the next whole number) ceases, by reason of one or more contested elections for
Board membership, to be comprised of individuals who are Continuing Directors.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><B>&nbsp;</B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 18pt">(h)</TD><TD STYLE="text-align: justify"><B>&ldquo;Class A Ordinary Shares&rdquo;</B> means the Class A Ordinary Shares in the capital of
the Company having a par value of USD 1.00 each having rights, and subject to the restrictions provided in the Company&rsquo;s
Articles. One Class A Ordinary Share shall equate to one vote per share for each share held by the shareholder and cannot be converted
to any other class of share at any time.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 31.5pt; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 18pt">(i)</TD><TD STYLE="text-align: justify"><B>&ldquo;Class B Ordinary Shares&rdquo; </B>means the Class B Ordinary Shares in the capital of
the Company having a par value of USD 1.00 each having the rights, and subject to the restrictions provided in the Company&rsquo;s
Articles. One Class B Ordinary Share shall equate to ten votes per share for each share held by the shareholder and can be converted
to Class A Shares on a 1-to-1 basis at any time.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 18pt">(j)</TD><TD STYLE="text-align: justify">&ldquo;<B>Code</B>&rdquo; means the Internal Revenue Code of 1986, as amended.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 18pt">(k)</TD><TD STYLE="text-align: justify">&ldquo;<B>Committee</B>&rdquo; means any committee composed of members of the Board appointed by
the Board to administer the Plan, including but not limited to the Compensation Committee as appointed by the Board.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 18pt">(l)</TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&ldquo;<B>Company</B>&rdquo; means Aptorum Group Limited</FONT>, <FONT STYLE="font-family: Times New Roman, Times, Serif">an
exempt company incorporated in Cayman Islands.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 18pt">(m)</TD><TD STYLE="text-align: justify">&ldquo;<B>Consultant</B>&rdquo; means any person (other than an Employee or a Director, solely
with respect to rendering services in such person&rsquo;s capacity as a Director) who is engaged by the Company or any Related
Entity to render consulting or advisory services to the Company or such Related Entity.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 18pt">(n)</TD><TD STYLE="text-align: justify">&ldquo;<B>Continuing Directors</B>&rdquo; means members of the Board who either (i) have been Board
members continuously for a period of at least thirty-six (36) months or (ii) have been Board members for less than thirty-six (36)
months and were elected or nominated for election as Board members by at least a majority of the Board members described in clause
(i) who were still in office at the time such election or nomination was approved by the Board.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 18pt">(o)</TD><TD STYLE="text-align: justify">&ldquo;<B>Continuous Service</B>&rdquo; means that the provision of services to the Company or
a Related Entity in any capacity of Employee, Director or Consultant (collectively, &ldquo;Service Provider&rdquo;) is not interrupted
or terminated. In jurisdictions requiring notice in advance of an effective termination as an Employee, Director or Consultant,
Continuous Service shall be deemed terminated upon the actual cessation of providing services to the Company or a Related Entity
notwithstanding any required notice period that must be fulfilled before a termination as an Employee, Director or Consultant can
be effective under Applicable Laws. An Optionee&rsquo;s Continuous Service shall be deemed to have terminated either upon an actual
termination of Continuous Service or upon the entity for which the Optionee provides services ceasing to be a Related Entity. Continuous
Service shall not be considered interrupted in the case of (i) any approved leave of absence, (ii) transfers among the Company,
any Related Entity, or any successor, in any capacity of Employee, Director or Consultant, or (iii) any change in status as long
as the individual remains in the service of the Company or a Related Entity in any capacity of Employee, Director or Consultant
(except as otherwise provided in the Option Agreement). An approved leave of absence shall include sick leave, military leave,
or any other authorized personal leave.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"></P>

<!-- Field: Page; Sequence: 2; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 18pt">(p)</TD><TD STYLE="text-align: justify">&ldquo;<B>Corporate Transaction</B>&rdquo; means any of the following transactions, provided, however,
that the Administrator shall determine under parts (iv) and (v) whether multiple transactions are related, and its determination
shall be final, binding and conclusive:</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">i.</TD><TD STYLE="text-align: justify">a merger or consolidation in which the Company is not the surviving entity, except for a transaction
the principal purpose of which is to change the jurisdiction in which the Company is incorporated&#894;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">ii.</TD><TD STYLE="text-align: justify">the sale, transfer or other disposition of all or substantially all of the assets of the Company&#894;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">iii.</TD><TD STYLE="text-align: justify">the complete liquidation or dissolution of the Company&#894;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">iv.</TD><TD STYLE="text-align: justify">any reverse merger or series of related transactions culminating in a reverse merger (including,
but not limited to, a tender offer followed by a reverse merger) in which the Company is the surviving entity but (A) the Ordinary
Shares outstanding immediately prior to such merger are converted or exchanged by virtue of the merger into other property, whether
in the form of securities, cash or otherwise, or (B) in which securities possessing more than forty percent (40%) of the total
combined voting power of the Company&rsquo;s outstanding securities are transferred to a person or persons different from those
who held such securities immediately prior to such merger or the initial transaction culminating in such merger, but excluding
any such transaction or series of related transactions that the Administrator determines shall not be a Corporate Transaction&#894;
or</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">v.</TD><TD STYLE="text-align: justify">acquisition in a single or series of related transactions by any person or related group of persons
(other than the Company or by a Company-sponsored employee benefit plan) of beneficial ownership (within the meaning of Rule 13d-3
of the Exchange Act) of securities possessing more than fifty percent (50%) of the total combined voting power of the Company&rsquo;s
outstanding securities but excluding any such transaction or series of related transactions that the Administrator determines shall
not be a Corporate Transaction.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 18pt">(q)</TD><TD STYLE="text-align: justify">&ldquo;<B>Director</B>&rdquo; means a member of the Board or the board of directors of any Related
Entity.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 18pt">(r)</TD><TD STYLE="text-align: justify">&ldquo;<B>Disability</B>&rdquo; means as defined under the long-term disability policy of the Company
or the Related Entity to which the Optionee provides services regardless of whether the Optionee is covered by such policy. If
the Company or the Related Entity to which the Optionee provides service does not have a long-term disability plan in place, &ldquo;Disability&rdquo;
means that an Optionee is unable to carry out the responsibilities and functions of the position held by the Optionee by reason
of any medically determinable physical or mental impairment for a period of not less than ninety (90) consecutive days. An Optionee
will not be considered to have incurred a Disability unless he or she furnishes proof of such impairment sufficient to satisfy
the Administrator in its discretion.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"></P>

<!-- Field: Page; Sequence: 3; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 18pt">(s)</TD><TD STYLE="text-align: justify"><B>&ldquo;Effective Date&rdquo;</B> means the date The Plan is adopted and approved by the shareholders
of the Company, whether it be the first time the Plan is approved, or each date the Plan is renewed pursuant to shareholder approval
in subsequent terms.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 18pt">(t)</TD><TD STYLE="text-align: justify">&ldquo;<B>Employee</B>&rdquo; means any person, including an Officer or Director, who is in the
employment of the Company or any Related Entity, subject to the control and direction of the Company or any Related Entity as to
both the work to be performed and the manner and method of performance. The payment of a director&rsquo;s fee by the Company or
a Related Entity shall not be sufficient to constitute &ldquo;employment&rdquo; by the Company.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 18pt">(u)</TD><TD STYLE="text-align: justify">&ldquo;<B>Exchange Act</B>&rdquo; means the Securities Exchange Act of 1934, as amended.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 18pt">(v)</TD><TD STYLE="text-align: justify">&ldquo;<B>Fair Market Value</B>&rdquo; means, as of any date, the value of the subject Shares determined
as follows:</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">i.</TD><TD STYLE="text-align: justify">If the Shares at issue are listed on one or more established stock exchanges or national market
systems, including without limitation the American Stock Exchange or The Nasdaq Global Market, its Fair Market Value shall be the
closing sales price for such shares (or the closing bid, if no sales were reported) as quoted on the principal exchange or system
on which the subject Shares are listed (as determined by the Administrator) on the date of determination (or, if no closing sales
price or closing bid was reported on that date, as applicable, on the last trading date such closing sales price or closing bid
was reported), as reported in The Wall Street Journal or such other source as the Administrator deems reliable&#894;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">ii.</TD><TD STYLE="text-align: justify">If the subject Shares are regularly quoted on an automated quotation system (including the OTC
Bulletin Board) or by a recognized securities dealer, its Fair Market Value shall be the closing sales price for such shares as
quoted on such system on the date of determination, but if selling prices are not reported, the Fair Market Value of the subject
Shares shall be the mean between the high bid and low asked prices for the Shares on the date of determination (or, if no such
prices were reported on that date, on the last date such prices were reported), as reported in The Wall Street Journal or such
other source as the Administrator deems reliable&#894; or</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">iii.</TD><TD STYLE="text-align: justify">In the absence of an established market for the subject Shares of the type described in (i) and
(ii), above, the Fair Market Value thereof shall be determined by the Administrator in good faith.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 18pt">(w)</TD><TD STYLE="text-align: justify">&ldquo;<B>Listing</B>&rdquo; refers to a successful initial public offering in the Company&rsquo;s
Class A Ordinary Shares to be traded on a globally accredited stock exchange.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 31.5pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 31.5pt; text-align: justify"></P>

<!-- Field: Page; Sequence: 4; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 31.5pt; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 18pt">(x)</TD><TD STYLE="text-align: justify">&ldquo;<B>Incentive Share Option</B>&rdquo; means an Option that is to qualify as an Incentive
Share Option as such term is defined in Section 422 of the Code.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 18pt">(y)</TD><TD STYLE="text-align: justify">&ldquo;<B>Officer</B>&rdquo; means a person who is an officer of the Company or a Related Entity
within the meaning of Section 16 of the Exchange Act and the rules and regulations promulgated thereunder.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 18pt">(z)</TD><TD STYLE="text-align: justify">&ldquo;<B>Option</B>&rdquo; means an option to purchase Class A Ordinary Shares pursuant to an
Option Agreement granted under the Plan.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 18pt">(aa)</TD><TD STYLE="text-align: justify">&ldquo;<B>Option Agreement</B>&rdquo; means the written agreement evidencing the grant of an Option
executed by the Company and the Optionee, including any amendments thereto.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 18pt">(bb)</TD><TD STYLE="text-align: justify">&ldquo;<B>Optionee</B>&rdquo; means an Employee, Director or Consultant who receives an Option
under the Plan.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 18pt">(cc)</TD><TD STYLE="text-align: justify"><B>&ldquo;Ordinary Shares&rdquo;</B> means the ordinary shares in the capital of the Company having
a par value of USD 1.00 each, inclusive of Class A Ordinary Shares and Class B Ordinary Shares, having rights, and subject to restrictions,
provided in the Company&rsquo;s Articles.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 18pt">(dd)</TD><TD STYLE="text-align: justify">&ldquo;<B>Plan</B>&rdquo; means this Aptorum Group Limited&#30693;&#33256;&#38598;&#22296;&#26377;&#38480;&#20844;&#21496;
2017 Share Option Plan.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 18pt">(ee)</TD><TD STYLE="text-align: justify">&ldquo;<B>Related Entity</B>&rdquo; means any Parent or Subsidiary of the Company and any business,
corporation, partnership, limited liability company or other entity in which the Company or a Parent or a Subsidiary of the Company
holds a substantial ownership interest, directly or indirectly.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 18pt">(ff)</TD><TD STYLE="text-align: justify">&ldquo;<B>Replaced</B>&rdquo; means that pursuant to a Corporate Transaction the Option is replaced
with a comparable share Option or a cash incentive program of the Company, the successor entity (if applicable) or Parent of either
of them which preserves the compensation element of such Option existing at the time of the Corporate Transaction and provides
for subsequent payout in accordance with the same (or a more favorable) vesting schedule applicable to such Option. The determination
of Option comparability shall be made by the Administrator and its determination shall be final, binding and conclusive.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 18pt">(gg)</TD><TD STYLE="text-align: justify">&ldquo;<B>Share</B>&rdquo; or &ldquo;Shares&rdquo; means Class A Ordinary Shares of the Company.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 18pt">(hh)</TD><TD STYLE="text-align: justify">&ldquo;<B>Subsidiary</B>&rdquo; means a &ldquo;subsidiary corporation&rdquo;, whether now or hereafter
existing, as defined in Section 424(f) of the Code.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 18pt">(ii)</TD><TD STYLE="text-align: justify">&ldquo;<B>Trading Market Approval</B>&rdquo; means the pre-approval required from the globally
accredited stock exchange or other stock exchange on which the Company&rsquo;s Shares are then listed for trading for certain Share
issuances.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 5; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><B>3.</B></TD><TD STYLE="text-align: justify"><B>Shares Subject to the Plan.</B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 18pt">(a)</TD><TD STYLE="text-align: justify">Subject to the provisions of Section 10 below, the maximum aggregate number of Class A Ordinary
Shares reserved and available pursuant to this Plan shall be the aggregate of (i) 5,500,000 Shares, and (ii) on each January 1,
starting with January 1, 2020, an additional number of shares equal to the lesser of (A) 2% of the outstanding number of Ordinary
Shares (on a fully-diluted basis) on the immediately preceding December 31, and (B) such lower number of Ordinary Shares as may
be determined by the Committee, subject in all cases to adjustment as provided in Section 10 below (the &ldquo;Evergreen Plan&rdquo;).</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -22.5pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 18pt">(b)</TD><TD STYLE="text-align: justify">Further, if, after the Effective Date of the Plan, any Shares underlying an Option are forfeited,
or if an Option otherwise terminates without the delivery of Shares or of other consideration, then the Shares underlying such
Option, or the number of Shares otherwise counted against the aggregate number of Shares available under the Plan with respect
to the Option, to the extent of any such forfeiture or termination, shall again be, or shall become, available for granting options
under the Plan.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -22.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">For the avoidance of doubt it
is noted that, no Class B Ordinary Shares may be issued under the Plan.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><B>4.</B></TD><TD><B>Administration of the Plan.</B></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 18pt">(a)</TD><TD STYLE="text-align: justify"><U>Plan Administrator.</U></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">i.</TD><TD STYLE="text-align: justify"><U>Administration with Respect to Directors and Officers.</U> With respect to grants of Options
to Directors or Employees who are also Officers or Directors of the Company, the Plan shall be administered by (A) the Board or
(B) the Compensation Committee designated by the Board, which Compensation Committee shall be constituted in such a manner as to
satisfy the Applicable Laws. Once appointed, such Compensation Committee shall continue to serve in its designated capacity contingent
to its members&rsquo; ongoing fulfillment of obligations, the terms of termination of Committee members as stipulated by their
Appointment Letters, or until otherwise directed by the Board. In the case of Options for Employees or Consultants who are neither
Directors nor Officers of the Company, the Board may authorize one or more Officers to grant such Options and may limit such authority
as the Board determines from time to time.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">ii.</TD><TD STYLE="text-align: justify"><U>Administration Errors</U><B>.</B> In the event an Option is granted in a manner inconsistent
with the provisions of this subsection (a), such Option shall be presumptively valid as of its grant date to the extent permitted
by the Applicable Laws.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 18pt">(b)</TD><TD STYLE="text-align: justify"><U>Powers of the Administrator.</U> Subject to Applicable Laws, especially but not limited to those
regarding shareholders approval, and the provisions of the Plan (including any other powers given to the Administrator hereunder),
and except as otherwise provided by the Board, the Administrator shall have the authority, in its discretion:</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">i.</TD><TD STYLE="text-align: justify">To select the Employees, Directors and Consultants to whom Options may be granted&#894;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"></P>

<!-- Field: Page; Sequence: 6; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">ii.</TD><TD STYLE="text-align: justify">To determine whether and to what extent Options are granted hereunder&#894;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">iii.</TD><TD STYLE="text-align: justify">To determine the number of Shares or the amount of other consideration to be covered by each Option
granted hereunder&#894;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">iv.</TD><TD STYLE="text-align: justify">To approve forms of Option Agreements for use under the Plan&#894;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">v.</TD><TD STYLE="text-align: justify">To determine the terms and conditions of any Option subject to the terms and conditions contained
herein;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">vi.</TD><TD STYLE="text-align: justify">To amend the terms of any outstanding Option granted under the Plan, provided that (A) any amendment
that would adversely affect the Optionee&rsquo;s rights under an outstanding Option shall not be made without the Optionee&rsquo;s
written consent, (B) the reduction of the exercise price of any Option shall be subject to the Optionee&rsquo;s written consent
and (C) canceling an Option at a time when its exercise price exceeds the Fair Market Value of the underlying Shares, in exchange
for another Option shall be subject to the Optionee&rsquo;s approval, unless the cancellation and exchange occurs in connection
with a Corporate Transaction. Notwithstanding the foregoing, canceling an Option in exchange for another Option with an exercise
price, purchase price that is equal to or greater than the exercise price of the original Option shall not be subject to the Optionee&rsquo;s
approval&#894;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">vii.</TD><TD STYLE="text-align: justify">To construe and interpret the terms of the Plan and Options, including without limitation, any
notice of Option or Option Agreement, granted pursuant to the Plan&#894;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">viii.</TD><TD STYLE="text-align: justify">To take such other action, not inconsistent with the terms of the Plan, as the Administrator deems
appropriate.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 18pt">(c)</TD><TD STYLE="text-align: justify"><U>Indemnification.</U> In addition to such other rights of indemnification as they may have as
members of the Board or as Officers or Employees of the Company or a Related Entity, members of the Board and any Officers or Employees
of the Company or a Related Entity to whom authority to act for the Board, the Administrator or the Company is delegated shall
be defended and indemnified by the Company to the extent permitted by law on an after-tax basis against all reasonable expenses,
including attorneys&rsquo; fees, actually and necessarily incurred in connection with the defense of any claim, investigation,
action, suit or proceeding, or in connection with any appeal therein, to which they or any of them may be a party by reason of
any action taken or failure to act under or in connection with the Plan, or any Option granted hereunder, and against all amounts
paid by them in settlement thereof (provided such settlement is approved by the Company) or paid by them in satisfaction of a judgment
in any such claim, investigation, action, suit or proceeding, except in relation to matters as to which it shall be adjudged in
such claim, investigation, action, suit or proceeding that such person is liable for gross negligence, bad faith or intentional
misconduct&#894; provided, however, that within thirty (30) days after the institution of such claim, investigation, action, suit
or proceeding, such person shall offer to the Company, in writing, the opportunity at the Company&rsquo;s expense to defend the
same.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">For the purpose of this clause
&ldquo;gross negligence&rdquo; means in relation to a person a standard of conduct constituting extreme carelessness, beyond ordinary
negligence, whereby that person&rsquo;s actions or inactions demonstrate reckless disregards for the duty of care owed to another.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 7; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><B>5.</B></TD><TD STYLE="text-align: justify"><B>Eligibility.</B> The Optionees shall be such persons as the Administrator may select from among
the Employees and Consultants.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><B>6.</B></TD><TD STYLE="text-align: justify"><B>Terms and Conditions of Options.</B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 18pt">(a)</TD><TD STYLE="text-align: justify"><U>Designation of Option.</U> Each Option shall be designated in the Option Agreement.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 31.5pt; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 18pt">(b)</TD><TD STYLE="text-align: justify"><U>Conditions of Option.</U> Subject to the terms of the Plan, the Administrator shall determine
the provisions, terms, and conditions of each Option including, but not limited to, the Option vesting schedule, repurchase provisions,
rights of first refusal, forfeiture provisions, form of payment (cash, Shares, cashless settlement, or other consideration) upon
settlement of the Option, payment contingencies and the exercise price.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 31.5pt; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 18pt">(c)</TD><TD STYLE="text-align: justify"><U>Deferral of Option Payment.</U> The Administrator may establish one or more programs under the
Plan to permit selected Optionees the opportunity to elect to defer receipt of consideration upon exercise of an Option, or other
event that absent the election would entitle the Optionee to payment or receipt of Shares or other consideration under an Option.
The Administrator may establish the election procedures, the timing of such elections, the mechanisms for payments of, and accrual
of interest or other earnings, if any, on amounts, Shares or other consideration so deferred, and such other terms, conditions,
rules and procedures that the Administrator deems advisable for the administration of any such deferral program.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 18pt">(d)</TD><TD STYLE="text-align: justify"><U>Early Exercise.</U> The Option Agreement may, but need not, include a provision whereby the
Optionee may elect at any time while an Employee, Director or Consultant to exercise any part or all of the Option prior to full
vesting of the Option. Any unvested Shares received pursuant to such exercise may be subject to a repurchase right in favor of
the Company or a Related Entity or to any other restriction the Administrator determines to be appropriate.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 18pt">(e)</TD><TD STYLE="text-align: justify"><U>Term of Option.</U> The term of each Option shall be the term stated in the Option Agreement,
provided, however that in the case of an option that is to qualify as an Incentive Share Option, the term shall not exceed ten
(10) years.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 18pt">(f)</TD><TD STYLE="text-align: justify"><U>Transferability of Options.</U> Options shall be transferable (i) by will and by the laws of
succession and distribution and (ii) during the lifetime of the Optionee, to the extent and in the manner authorized by the Administrator.
Notwithstanding the foregoing, the Optionee may designate one or more beneficiaries of the Optionee&rsquo;s Option in the event
of the Optionee&rsquo;s death on a beneficiary designation form provided by the Administrator.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"></P>

<!-- Field: Page; Sequence: 8; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 18pt">(g)</TD><TD STYLE="text-align: justify"><U>Termination of Employment Other than by Death or Disability.</U></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">i.</TD><TD STYLE="text-align: justify">If an Optionee ceases to be an Employee for any reason other than his or her death or disability,
the Optionee shall have the right, subject to the provisions of this Section 6, to exercise any Option held by the Optionee at
any time within ninety (90) days after his or her termination of employment, but not beyond the otherwise applicable term of the
Option and only to the extent that on such date of termination of employment the Optionee&rsquo;s right to exercise such Option
has vested.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">ii.</TD><TD STYLE="text-align: justify">For purposes of this Section 6(j), the employment relationship shall be treated as continuing intact
while the Optionee is an active Employee of the Company or any Affiliate, or is on military leave, sick leave, or other bona fide
leave of absence to be determined in the sole discretion of the Administrator.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 18pt">(h)</TD><TD STYLE="text-align: justify"><U>Death of Optionee.</U> If an Optionee dies while an Employee, or after ceasing to be an Employee
but during the period while he or she could have exercised an Option under Section 6(j), any Option granted to the Optionee may
be exercised, to the extent it had vested at the time of death and subject to the Plan, at any time within twelve (12) months after
the Optionee&rsquo;s death, by the executors or administrators of his or her estate or by any person or persons who acquire the
Option by will or the laws of succession and distribution, but not beyond the otherwise applicable term of the Option.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 31.5pt; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 18pt">(i)</TD><TD STYLE="text-align: justify"><U>Disability of Optionee.</U> If an Optionee ceases to be an Employee due to becoming totally
and permanently disabled within the meaning of Section 22(e)(3) of the Code, any Option granted to the Optionee may be exercised
to the extent it had vested at the time of cessation and, subject to the Plan, at any time within twelve (12) months after the
Optionee&rsquo;s termination of employment, but not beyond the otherwise applicable term of the Option.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 18pt">(j)</TD><TD STYLE="text-align: justify"><U>Time of Granting Options.</U> The date of grant of an Option shall for all purposes be on the
date which the Administrator makes the determination to grant such Option, or such other date as is determined by the Administrator.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><B>7.</B></TD><TD STYLE="text-align: justify"><B>Option Exercise or Purchase Price, Consideration and Taxes.</B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 18pt">(a)</TD><TD STYLE="text-align: justify"><U>Exercise or Purchase Price.</U> The Administrator shall determine the exercise or purchase price
in accordance with the Applicable Laws and/or pursuant to the Option Agreement to be executed between the Company and Optionee,
if applicable or other relevant agreement between such parties.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 31.5pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 31.5pt; text-align: justify"></P>

<!-- Field: Page; Sequence: 9; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 31.5pt; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 18pt">(b)</TD><TD STYLE="text-align: justify"><U>Consideration.</U> Subject to Applicable Laws, the consideration to be paid for the Shares to
be issued upon exercise or purchase of an Option including the method of payment shall be determined by the Administrator. In addition
to any other types of consideration the Administrator may determine, the Administrator is authorized to accept as consideration
for Shares issued under the Plan the following:</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">i.</TD><TD STYLE="text-align: justify">cash&#894;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">ii.</TD><TD STYLE="text-align: justify">cheque&#894;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">iii.</TD><TD STYLE="text-align: justify">with respect to Options, payment through a broker-dealer sale and remittance procedure pursuant
to which the Optionee (A) shall provide written instructions to a Company designated brokerage firm to effect the immediate sale
of some or all of the purchased Shares and remit to the Company sufficient funds to cover the aggregate exercise price payable
for the purchased Shares and (B) shall provide written directives to the Company to deliver the certificates for the purchased
Shares directly to such brokerage firm in order to complete the sale transaction&#894;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">iv.</TD><TD STYLE="text-align: justify">cashless election; or</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">v.</TD><TD STYLE="text-align: justify">any combination of the foregoing methods of payment.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 18pt">(c)</TD><TD STYLE="text-align: justify"><U>Taxes.</U> No Shares shall be delivered under the Plan to any Optionee or other person until
such Optionee or other person has made arrangements acceptable to the Administrator for the satisfaction of any national, provincial
or local income and employment tax withholding obligations. Upon exercise of an Option the Company shall have the right, but not
the obligation (except as required by applicable law), to withhold or collect from Optionee an amount sufficient to satisfy such
tax obligations. The Optionee will be solely responsible for his/her own tax obligations.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><B>8.</B></TD><TD STYLE="text-align: justify"><B>Exercise of Option.</B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 18pt">(a)</TD><TD STYLE="text-align: justify"><U>Procedure for Exercise&#894; Rights as a Shareholder.</U></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">i.</TD><TD STYLE="text-align: justify">Any Option granted hereunder shall be exercisable at such times and under such conditions as determined
by the Administrator under the terms of the Plan and specified in the Option Agreement.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">ii.</TD><TD STYLE="text-align: justify">An Option shall be deemed to be exercised when written notice of such exercise has been given to
the Company in accordance with the terms of the Option by the person entitled to exercise the Option and when the Company receives
full payment for the Shares with respect to which the Option is exercised, including, to the extent selected, use of the broker-dealer
sale and remittance procedure to pay the purchase price as provided in Section 7(b)(iii).</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 10; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><B>9.</B></TD><TD STYLE="text-align: justify"><B>Conditions Upon Issuance of Shares.</B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 18pt">(a)</TD><TD STYLE="text-align: justify">Shares shall not be issued pursuant to the exercise of an Option unless the exercise of such Option
and the issuance and delivery of such Shares pursuant thereto shall comply with all Applicable Laws, and shall be further subject
to the approval of counsel for the Company with respect to such compliance.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 31.5pt; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 18pt">(b)</TD><TD STYLE="text-align: justify">As a condition to the exercise of an Option, the Company may require the person exercising such
Option to represent and warrant at the time of any such exercise that the Shares are being purchased only for investment and without
any present intention to sell or distribute such Shares if, in the opinion of counsel for the Company, such a representation is
required by any Applicable Laws.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><B>10.</B></TD><TD STYLE="text-align: justify"><B>Adjustments Upon Changes in Capitalization.</B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">Subject to any required action
by the shareholders of the Company, the number of Shares covered by each outstanding Option, and the number of Shares which have
been authorized for issuance under the Plan but as to which no Options have yet been granted or which have been returned to the
Plan, the exercise or purchase price of each such outstanding Option, the maximum number of Shares with respect to which Options
may be granted to any Optionee in any fiscal year of the Company, as well as any other terms that the Administrator determines
require adjustment shall be proportionately adjusted for (i) any increase or decrease in the number of issued Ordinary Shares resulting
from a share split, reverse share split, share dividend, combination or reclassification of the Ordinary Shares, or similar transaction
affecting the Shares , (ii) any other increase or decrease in the number of issued Ordinary Shares effected without receipt of
consideration by the Company, or (iii) as the Administrator may determine in its discretion, any other transaction with respect
to Ordinary Shares including a corporate merger, consolidation, acquisition of property or equity, separation (including a spin-off
or other distribution of shares or property), reorganization, liquidation (whether partial or complete) or any similar transaction&#894;
provided, however that conversion of any convertible securities of the Company, including conversion of Class B Ordinary Shares,
shall not be deemed to have been &ldquo;effected without receipt of consideration.&rdquo; Such adjustment shall be made by the
Administrator and its determination shall be final, binding and conclusive. Except as the Administrator determines, no issuance
by the Company of shares of any class, or securities convertible into shares of any class, shall affect, and no adjustment by reason
hereof shall be made with respect to, the number or price of Shares subject to an Option. In the event of a spin-off transaction,
the Administrator may in its discretion make such adjustments and take such other action as it deems appropriate with respect to
outstanding Options under the Plan, including but not limited to: (i) adjustments to the number and kind of shares, the exercise
or purchase price per share and the vesting periods of outstanding Options, (ii) prohibit the exercise of Options during certain
periods of time prior to the consummation of the spin-off transaction, or (iii) the substitution, exchange or grant of Options
to purchase securities of the Subsidiary&#894; provided that the Administrator shall not be obligated to make any such adjustments
or take any such action hereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 11; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><B>11.</B></TD><TD STYLE="text-align: justify"><B>Corporate Transactions and Changes in Control.</B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 18pt">(a)</TD><TD STYLE="text-align: justify"><U>Termination of Option to Extent Not Assumed in Corporate Transaction.</U> Effective upon the
consummation of a Corporate Transaction, all outstanding Options under the Plan shall terminate; provided, however, that to extent
any Options are assumed in connection with the Corporate Transaction (&ldquo;Assumed&rdquo;), such Options shall not terminate.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 31.5pt; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 18pt">(b)</TD><TD STYLE="text-align: justify"><U>Acceleration of Option Upon Corporate Transaction or Change in Control.</U></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">i.</TD><TD STYLE="text-align: justify"><U>Corporate Transaction.</U> The Administrator may determine, in the event of a Corporate Transaction,
for the portion of each Option that is neither Assumed nor Replaced, such portion of the Option shall automatically become fully
vested and exercisable and be released from any repurchase or forfeiture rights (other than repurchase rights exercisable at Fair
Market Value) for all of the Shares (or other consideration) at the time represented by such portion of the Option, immediately
prior to the specified effective date of such Corporate Transaction, provided that the Optionee&rsquo;s Continuous Service has
not terminated prior to such date.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">ii.</TD><TD STYLE="text-align: justify"><U>Change in Control.</U> The Administrator may determine, in the event of a Change in Control
(other than a Change in Control which also is a Corporate Transaction), each Option which is at the time outstanding under the
Plan automatically shall become fully vested and exercisable and be released from any repurchase or forfeiture rights (other than
repurchase rights exercisable at Fair Market Value), immediately prior to the specified effective date of such Change in Control,
for all of the Shares (or other consideration) at the time represented by such Option, provided that the Optionee&rsquo;s Continuous
Service has not terminated prior to such date.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><B>12.</B></TD><TD STYLE="text-align: justify"><B>Effective Date and Term of Plan. </B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">The Plan shall become effective
upon its approval by the shareholders of the Company. It shall continue in effect for a term of ten (10) years unless sooner terminated
or unless renewed for another period not to exceed 10 years pursuant to shareholder approval. Subject to Section 17, below, and
Applicable Laws, Options may be granted under the Plan upon its becoming effective.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><B>13.</B></TD><TD STYLE="text-align: justify"><B>Amendment, Suspension or Termination of the Plan.</B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 18pt">(a)</TD><TD STYLE="text-align: justify">The Board may at any time amend, suspend or terminate the Plan&#894; provided, however, that no
such amendment shall be made without the approval of the Company&rsquo;s shareholders to the extent such approval is required by
Applicable Laws, or if such amendment would change any of the provisions of Section 3(a), Section 4(b)(vi) or this Section 13(a).</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 31.5pt; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 18pt">(b)</TD><TD STYLE="text-align: justify">No Option may be granted during any suspension of the Plan or after termination of the Plan.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 18pt">(c)</TD><TD STYLE="text-align: justify">No suspension or termination of the Plan (including termination of the Plan under Section 12 above)
shall adversely affect any rights under Options already granted to an Optionee.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 12; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><B>14.</B></TD><TD STYLE="text-align: justify"><B>Reservation of Shares.</B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 18pt">(a)</TD><TD STYLE="text-align: justify">The Company, during the term of the Plan, will at all times reserve and keep available out of its
authorized but unissued Shares, such number of Shares as shall be sufficient to satisfy the requirements of the Plan.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 31.5pt; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 18pt">(b)</TD><TD STYLE="text-align: justify">The inability of the Company to obtain authority from any regulatory body having jurisdiction,
which authority is deemed by the Company&rsquo;s counsel to be necessary to the lawful issuance and sale of any Shares hereunder,
shall relieve the Company of any liability in respect of the failure to issue or sell such Shares as to which such requisite authority
shall not have been obtained.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><B>15.</B></TD><TD><B>No Effect on Terms of Employment/Consulting Relationship. </B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">The Plan shall not confer upon
any Optionee any right with respect to the Optionee&rsquo;s Continuous Service, nor shall it interfere in any way with his or her
right or the right of the Company or any Related Entity to terminate the Optionee&rsquo;s Continuous Service at any time, with
or without Cause, and with or without notice. The ability of the Company or any Related Entity to terminate the employment of an
Optionee who is employed at will is in no way affected by its determination that the Optionee&rsquo;s Continuous Service has been
terminated for Cause for the purposes of this Plan. For Cause shall have the meaning and conditions set forth under Termination
clauses, where applicable, in each such Optionee&rsquo;s Appointment Letter with the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><B>16.</B></TD><TD STYLE="text-align: justify"><B>No Effect on Retirement and Other Benefit Plans. </B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">Except as specifically provided
in a retirement or other benefit plan of the Company or a Related Entity, Options shall not be deemed compensation for purposes
of computing benefits or contributions under any retirement plan of the Company or a Related Entity, and shall not affect any benefits
under any other benefit plan of any kind or any benefit plan subsequently instituted under which the availability or amount of
benefits is related to level of compensation. The Plan is not a &ldquo;Retirement Plan&rdquo; or &ldquo;Welfare Plan&rdquo; under
the Employee Retirement Income Security Act of 1974, as amended.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><B>17.</B></TD><TD STYLE="text-align: justify"><B>Shareholder and Trading Market Approval. </B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 18pt">(a)</TD><TD STYLE="text-align: justify">Subject to the Applicable Laws, including but not limited to Nasdaq Rule 5635(c), once this Plan
is approved by the shareholders of the Company, the granting of individual Options hereunder will not require any further shareholder
approvals, unless such approval is required under Applicable Laws.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 18pt">(b)</TD><TD STYLE="text-align: justify">If required by the Applicable Laws, no Options shall be granted unless and until the Company received
Trading Market Approval of such Options and the Shares underlying such Options.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"></P>

<!-- Field: Page; Sequence: 13; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><B>18.</B></TD><TD STYLE="text-align: justify"><B>Unfunded Obligation. </B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">Optionees shall have the status
of general unsecured creditors of the Company. Any amounts payable to Optionees pursuant to the Plan shall be unfunded and unsecured
obligations for all purposes. Neither the Company nor any Related Entity shall be required to segregate any monies from its general
funds, or to create any trusts, or establish any special accounts with respect to such obligations. The Company shall retain at
all times beneficial ownership of any investments, including trust investments, which the Company may make to fulfill its payment
obligations hereunder. Any investments or the creation or maintenance of any trust or any Optionee account shall not create or
constitute a trust or fiduciary relationship between the Administrator, the Company or any Related Entity and an Optionee, or otherwise
create any vested or beneficial interest in any Optionee or the Optionee&rsquo;s creditors in any assets of the Company or a Related
Entity. The Optionees shall have no claim against the Company or any Related Entity for any changes in the value of any assets
that may be invested or reinvested by the Company with respect to the Plan.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><B>19.</B></TD><TD STYLE="text-align: justify"><B>Shareholder Rights</B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0in">Except as
otherwise provided in this Plan an Optionee shall have none of the rights of a shareholder of the Company with respect to the Shares
covered by any Option until the Optionee becomes the recorded owner of such Shares, which typically occurs upon the exercise of
any such Option and then only with respect to the Shares received upon such exercise.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><B>20.</B></TD><TD STYLE="text-align: justify"><B>Construction. </B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">Captions and titles contained
herein are for convenience only and shall not affect the meaning or interpretation of any provision of the Plan. Except when otherwise
indicated by the context, the singular shall include the plural and the plural shall include the singular. Use of the term &ldquo;or&rdquo;
is not intended to be exclusive, unless the context clearly requires otherwise.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><B>21.</B></TD><TD STYLE="text-align: justify"><B>Information to Optionees. </B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">Each Optionee shall be provided
with such information regarding the Company as the Board or the Committee from time to time deems necessary or appropriate&#894;
provided, however, that each Optionee shall at all times be provided with such information as is required to be provided from time
to time pursuant to applicable regulatory requirements.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><B>22.</B></TD><TD STYLE="text-align: justify"><B>Governing Law</B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">The Plan and any Agreements
under the Plan hereunder shall be administered, interpreted and enforced under the laws of the Cayman Islands without regard to
conflicts of laws thereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(The remainder of this page is intentionally
left blank)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">14</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Rule-Page --><DIV ALIGN="CENTER" STYLE="margin-top: 0; margin-bottom: 0"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>



<P STYLE="margin: 0"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.26
<SEQUENCE>30
<FILENAME>ff12018ex10-26_aptorum.htm
<DESCRIPTION>FORM OF SECURITIES PURCHASE AGREEMENT FOR THE SERIES A CONVERTIBLE PROMISSORY NOTES, DATED MAY 15, 2018
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif; text-align: right"><B>Exhibit 10.26</B></P>

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">APTORUM
GROUP LIMITED</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">SECURITIES
PURCHASE AGREEMENT</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
SECURITIES PURCHASE AGREEMENT (this &ldquo;Agreement&rdquo;) is made and entered into as of May 15, 2018, by and between Aptorum
Group Limited, a Cayman Islands company (the &ldquo;Company&rdquo;), and the Investors set forth on the signature pages affixed
hereto (each an &ldquo;Investor&rdquo; and collectively the &ldquo;Investors&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>WHEREAS</B>,
the Investors wish to purchase from the Company, and the Company wishes to sell and issue to the Investors, upon the terms and
conditions stated in this Agreement, in the aggregate a minimum of USD$500,000 (the &ldquo;Minimum Amount&rdquo;) and a maximum
of USD$10,000,000 (the &ldquo;Maximum Amount&rdquo;) of Series A convertible promissory notes (the &ldquo;Notes&rdquo;) of the
Company, at a purchase price of USD$10,000 per Note (subject to adjustment), automatically convertibleinto shares (the &ldquo;Converted
Shares&rdquo;) of the Company&rsquo;s Class A ordinary shares with par value USD$1.00 each (the &ldquo;Class A Shares&rdquo;)
at a price of 56% discount to the actual price per Class A Share to be issued in an IPO (defined herein below) at the time that
the Company consummates an initial closing of the IPO, and have the rights and preferences set forth in the form of Series A Convertible
Note (the &ldquo;Form of Notes&rdquo;) attached hereto as Exhibit A, upon the terms and conditions set forth in this Agreement;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>WHEREAS</B>,
the Notes and the Converted Shares issued pursuant to this Agreement are together referred to herein as the &ldquo;Securities&rdquo;;
and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>WHEREAS</B>,
in connection with the Investors&rsquo; purchase of the Securities, the Investors will receive certain rights to participate in
the proposed initial public offering of Company stock, and will be subject to certain restrictions on the transfer of the Securities,
all as more fully set forth in this Agreement;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>NOW,
THEREFORE</B>, in consideration of the mutual terms, conditions and other agreements set forth herein and for other good and valuable
consideration, the receipt and sufficiency of which are hereby acknowledged, and intending to be legally bound hereby, the parties
hereto hereby agree to the sale and purchase of the Securities as set forth herein.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.&nbsp;Definitions.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
purposes of this Agreement, the terms set forth below shall have the corresponding meanings provided below.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;1933
Act&rdquo; means the Securities Act of 1933, as amended.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;1934
Act&rdquo; means the Securities Exchange Act of 1934, as amended.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;Affiliate&rdquo;
shall mean, with respect to any specified Person, (i) if such Person is an individual, the spouse, heirs, executors, or legal
representatives of such individual, or any trusts for the benefit of such individual or such individual&rsquo;s spouse and/or
lineal descendants, or (ii) otherwise, another Person that directly, or indirectly through one or more intermediaries, controls,
is controlled by, or is under common control with, the Person specified. As used in this definition, &ldquo;control&rdquo; shall
mean the possession, directly or indirectly, of the sole and unilateral power to cause the direction of the management and policies
of a Person, whether through the ownership of voting securities or by contract or other written instrument.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;Blue
Sky Application&rdquo; is defined in Section 5.4(a) hereto.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt"></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;Business
Day&rdquo; shall mean any day on which banks located in New York, New York and Hong Kong are not required or authorized by law
to remain closed.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;Class
A Shares&rdquo; is defined in the recitals above.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;Closing&rdquo;
and &ldquo;Closing Date&rdquo; are defined in Section 2.2(c).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;Company&rsquo;s
knowledge&rdquo; means the knowledge of that each of the executive officers and directors (as defined in Rule 405 under the 1933
Act) of the Company, and the knowledge that each such person would have reasonably obtained after making due and appropriate inquiry.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;Converted
Shares&rdquo; is defined in the recitals above.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;First
Closing&rdquo; and &ldquo;First Closing Date&rdquo; are defined in Section 2.2(a).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;IPO&rdquo;
shall mean the initial public offering of securities of the Company pursuant to a registration statement filed in accordance with
the requirements of the 1933 Act and the commencement of trading on a U.S. national securities exchange of the Company&rsquo;s
securities to be issued in such offering.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;Liens&rdquo;
means any mortgage, lien, title claim, assignment, encumbrance, security interest, adverse claim, contract of sale, restriction
on use or transfer or other defect of title of any kind.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;Material
Adverse Effect&rdquo; means a material adverse effect on (i) the assets, liabilities, results of operations, condition (financial
or otherwise), business, or prospects of the Company and its Subsidiaries taken as a whole, (ii) the ability of the Company to
perform its obligations under the Transaction Documents, or (iii) the legality, validity or enforceability of any Transaction
Documents.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;Notes&rdquo;
is defined in the recitals above.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;Person&rdquo;
shall mean an individual, entity, corporation, partnership, association, limited liability company, limited liability partnership,
joint-stock company, trust or unincorporated organization.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;Piggyback
Registration&rdquo; is defined in Section 5.1 hereto.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;Placement
Agent&rdquo; is defined in Section 4.8 hereto.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;Private
Placement Term Sheet&rdquo; means the Company&rsquo;s Term Sheet/Business Summary and Risk Factors Booklet, dated December 21,
2017, and any amendments or supplements thereto.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;Purchase
Price&rdquo; shall mean the per Note purchase price of USD$10,000 and the aggregate purchase price of up to USD$10,000,000.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;Registrable
Securities&rdquo; shall mean the Converted Shares and any shares issuable upon exercise of any warrants issued to registered broker-dealers
and their affiliates as compensation in connection with the transactions contemplated hereby; provided, however, that a security
shall cease to be a Registrable Security upon (A) sale pursuant to a Registration Statement or Rule 144 or Regulation S under
the 1933 Act, or (B) such security becoming eligible for sale by the Investors pursuant to Rule 144 or Regulation S without volume
limitations.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;Registration
Statement&rdquo; shall mean any registration statement of the Company filed under the 1933 Act that covers the resale of any of
the Registrable Securities pursuant to the provisions of this Agreement, amendments and supplements to such Registration Statement,
including post-effective amendments, all exhibits and all material incorporated by reference in such Registration Statement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;Regulation
D&rdquo; is defined in Section 3.7 hereto.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;Regulation
S&rdquo; means Regulation S under the 1933 Act, as amended (or a successor rule).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;Rule
144&rdquo; is defined in Section 6.1(a)(C) hereto.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;SEC&rdquo;
means the United States Securities and Exchange Commission.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;Securities&rdquo;
is defined in the recitals above.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;Subsequent
Closing&rdquo; and &ldquo;Subsequent Closing Date&rdquo; are defined in Section 2.2(b).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;Subsidiaries&rdquo;
shall mean any corporation or other entity or organization, whether incorporated or unincorporated, in which the Company owns,
directly or indirectly, any equity or other ownership interest or otherwise controls through contract or otherwise.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;Transaction
Documents&rdquo; shall mean this Agreement, the Form of Notes and the Escrow Deposit Agreement, the exhibits, schedules, appendices
and any other documents or agreements executed in connection with the transactions contemplated hereunder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;Transfer&rdquo;
shall mean any sale, transfer, assignment, conveyance, charge, pledge, mortgage, encumbrance, hypothecation, security interest
or other disposition, or to make or effect any of the above.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;Underwriter&rdquo;
is defined in Section 5.2 hereto.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;Underwriting
Documents&rdquo; shall mean an underwriting agreement in customary form and all other agreements and other documents reasonably
requested by an underwriter in connection with an underwritten public offering of equity securities (including, without limitation,
questionnaires, powers of attorney, indemnities, custody agreements and lock-up agreements).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.&nbsp;Sale
and Purchase of Notes.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 45pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.1&nbsp;Subscription
for Notes by Investors. Subject to the terms and conditions of this Agreement, on the Closing Date (as hereinafter defined) each
of the Investors shall severally, and not jointly, purchase, and the Company shall sell and issue to the Investors, the Notes,
in the respective amounts set forth on the signature pages attached hereto in exchange for the Purchase Price.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 45pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 45pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.2&nbsp;Closings.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 45pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)&nbsp;First
Closing. Subject to the terms and conditions set forth in this Agreement, the Company shall issue and sell to each Investor, and
each Investor shall, severally and not jointly, purchase from the Company on the First Closing Date, such number of Notes set
forth on the signature pages attached hereto provided that that Investors shall subscribe in an aggregate no less than the Minimum
Amount of Notes (the &ldquo;First Closing&rdquo;). The date of the First Closing is hereinafter referred to as the &ldquo;First
Closing Date.&rdquo; Notwithstanding anything to the contrary in this Agreement, a maximum of 1,000 Notes may be issued and sold
at the First Closing.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 3; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)&nbsp;Subsequent
Closing(s). In the event that the Maximum Amount of Notes has not been sold in the First Closing, the Company reserves the right
to issue and sell Notes to other investors (a &ldquo;Subsequent Closing&rdquo;). There may be more than one Subsequent Closing;
provided, however that the final Subsequent Closing shall take place within the time periods set forth in the Private Placement
Term Sheet. The date of any Subsequent Closing is hereinafter referred to as a &ldquo;Subsequent Closing Date&rdquo;). Notwithstanding
the foregoing, the aggregate maximum number of Notes to be sold at the First Closing and all Subsequent Closings shall be 1,000
Notes.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)&nbsp;Closing.
The First Closing and any applicable Subsequent Closings are each referred to in this Agreement as a &ldquo;Closing.&rdquo; The
First Closing Date and any Subsequent Closing Dates are sometimes referred to herein as a &ldquo;Closing Date.&rdquo; All Closings
shall occur within the time periods set forth in the Private Placement Term Sheet at the offices of Hunter Taubman Fischer &amp;
Li LLC, counsel to the Company, at 1450 Broadway, 26th Floor, New York, New York 10018, or remotely via the exchange of documents
and signatures.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 45pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.3&nbsp;Closing
Deliveries. At each Closing, the Company shall deliver to the Investors, against delivery by each Investor of the Purchase Price
(as provided below), duly issued Form of Notes representing the Notes. At each Closing, each Investor shall deliver or cause to
be delivered to the Company the Purchase Price set forth in its counterpart signature page annexed hereto by paying United States
dollars by wire transfer to the following escrow account:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 45pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 8%; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 31%; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Acct.
    Name:</FONT></TD>
    <TD STYLE="width: 61%; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Signature
    Bank, as Escrow Agent for Aptorum Group Limited</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ABA
    Number: </FONT></TD>
    <TD STYLE="padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Swift
    Code:</FONT></TD>
    <TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Acct
    Number: </FONT></TD>
    <TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.&nbsp;Representations,
Warranties and Acknowledgments of the Investors.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Each
Investor severally and not jointly represents and warrants to the Company solely as to such Investor that:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 45pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.1&nbsp;Authorization.
The execution, delivery and performance by such Investor of the Transaction Documents to which such Investor is a party have been
duly authorized and will each constitute the valid and legally binding obligation of such Investor, enforceable against such Investor
in accordance with their respective terms, subject to bankruptcy, insolvency, fraudulent transfer, reorganization, moratorium
and similar laws of general applicability, relating to or affecting creditors&rsquo; rights generally.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 45pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 45pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.2&nbsp;Purchase
Entirely for Own Account. The Securities to be received by such Investor hereunder will be acquired for such Investor&rsquo;s
own account, not as nominee or agent, and not with a view to the resale or distribution of any part thereof in violation of the
1933 Act, and such Investor has no present intention of selling, granting any participation in, or otherwise distributing the
same in violation of the 1933 Act, without prejudice, however, to such Investor&rsquo;s right at all times to sell or otherwise
dispose of all or any part of such Securities in compliance with applicable federal and state securities laws. Nothing contained
herein shall be deemed a representation or warranty by such Investor to hold the Securities for any period of time. Such Investor
is not a broker-dealer registered with the SEC under the 1934 Act or an entity engaged in a business that would require it to
be so registered.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 45pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 45pt"></P>

<!-- Field: Page; Sequence: 4; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 45pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 45pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.3&nbsp;Investment
Experience. Such Investor acknowledges that the purchase of the Notes is a speculative investment and that it can bear the economic
risk and complete loss of its investment in the Securities and has such knowledge and experience in financial or business matters
that it is capable of evaluating the merits and risks of the investment contemplated hereby.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 45pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 45pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.4&nbsp;Disclosure
of Information. Such Investor has had an opportunity to receive all information related to the Company and the Securities requested
by it and to ask questions of and receive answers from the Company regarding the Company, its business and the terms and conditions
of the offering of the Securities. Neither such inquiries nor any other due diligence investigation conducted by such Investor
shall modify, amend or affect such Investor&rsquo;s right to rely on the Company&rsquo;s representations and warranties contained
in this Agreement. Such Investor acknowledges that it has received and reviewed the Private Placement Term Sheet describing the
offering of the Securities. </FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 45pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 45pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.5&nbsp;Restricted
Securities. Such Investor understands that the Securities are characterized as &ldquo;restricted securities&rdquo; under the U.S.
federal securities laws inasmuch as they are being acquired from the Company in a transaction not involving a public offering
and that under such laws and applicable regulations such securities may be resold without registration under the 1933 Act only
in certain limited circumstances.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 45pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 45pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.6&nbsp;Legends.
It is understood that, except as provided below, Form of Notes evidencing the Notes and the certificates evidencing the Converted
Shares, when issued and delivered, may bear the following or any similar legend:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 45pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 67.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(A)&nbsp;&ldquo;The
securities represented hereby may not be transferred unless (i) such securities have been registered for sale pursuant to the
Securities Act of 1933, (ii) such securities may be sold pursuant to Rule 144 or Regulation S under said Act, or (iii) the Company
has received an opinion of counsel reasonably satisfactory to it that such transfer may lawfully be made without registration
under the Securities Act of 1933 or qualification under applicable state securities laws.&rdquo;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 67.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(B)&nbsp;If
required by the authorities of any state in connection with the issuance of sale of the Securities, the legend required by such
state authority.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 45pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.7&nbsp;Eligible
Investor. Such Investor is an accredited investor as defined in Rule 501(a) of Regulation D under the 1933 Act (&ldquo;Regulation
D&rdquo;) or a &ldquo;non-U.S. Person&rdquo; as defined in Regulation S promulgated under the Securities Act. </FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 45pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 45pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.8&nbsp;If
the Investor is a non-U.S. Person, the Investor further represents the following in connection with the Regulation S compliance.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 45pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)&nbsp;The
Investor is not a U.S. Person as such term is defined under Rule 902 of Regulation S (&ldquo;U.S. Person&rdquo;). The Investor
is at the time of the offer and execution of this Agreement, domiciled outside the United States.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)&nbsp;The
Investor agrees that all offers and sales of the Securities from the date hereof and through the expiration of any restricted
period set forth in Rule 903 of Regulation S (as the same may be amended from time to time hereafter) shall not be made to U.S.
Persons or for the account or benefit of U.S. Persons and shall otherwise be made in compliance with the provisions of Regulation
S and any other applicable provisions of the Securities Act.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 5; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii)&nbsp;The
Investor shall not engage in hedging transactions with regard to the Securities unless in compliance with the 1933 Act. This Agreement
and the transactions contemplated herein are not part of a plan or scheme to evade the registration provisions of the Securities
Act, and the Shares are being acquired for investment purposes by the Investor.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iv)&nbsp;The
Investor acknowledges that the Company will refuse to register any transfer of any of the Securities not made in accordance with
the provisions of Regulation S, pursuant to an effective registration statement under the 1933 Act or pursuant to an available
exemption from, or in a transaction not subject to, the registration requirements of the 1933 Act.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(v)&nbsp;Investor
acknowledges and agrees that the certificate(s) representing the Securities will bear a legend substantially as follows:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">THE
SHARES REPRESENTED BY THIS CERTIFICATE HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE &ldquo;SECURITIES
ACT&rdquo;), AND ARE RESTRICTED SECURITIES AS THAT TERM IS DEFINED IN RULE 144 UNDER THE SECURITIES ACT. THE SHARES HAVE BEEN
ISSUED IN AN OFFSHORE TRANSACTION BY APTORUM GROUP LIMITED, IN RELIANCE UPON AN EXEMPTION FROM THE REGISTRATION REQUIREMENTS OF
THE SECURITIES ACT PROVIDED BY REGULATION S. THE SECURITIES MAY NOT BE OFFERED FOR SALE, SOLD OR OTHERWISE TRANSFERRED, EITHER
DIRECTLY OR INDIRECTLY, IN THE UNITED STATES (AS DEFINED IN REGULATION S) OR TO U.S. PERSONS EXCEPT IN ACCORDANCE WITH REGULATION
S, PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT UNDER THE SECURITIES ACT OR PURSUANT TO AN EXEMPTION FROM REGISTRATION UNDER
THE SECURITIES ACT, THE AVAILABILITY OF WHICH IS TO BE ESTABLISHED TO THE REASONABLE SATISFACTION OF APTORUM GROUP LIMITED. HEDGING
TRANSACTIONS INVOLVING THE SECURITIES MAY NOT BE CONDUCTED UNLESS IN COMPLIANCE WITH THE SECURITIES ACT.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 45pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.9&nbsp;No
General Solicitation. Such Investor did not learn of the investment in the Securities as a result of any public advertising or
general solicitation. The Investor confirms that it has had a substantive pre-existing relationship and direct contact with the
Company and its representatives other than in connection with an IPO, it was not identified or contacted through the marketing
of an IPO and it did not independently contact the Company as a result of the general solicitation by means of a registration
statement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 45pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 45pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.10&nbsp;Brokers
and Finders. No Investor will have, as a result of the transactions contemplated by the Transaction Documents, any valid right,
interest or claim against or upon the Company, any Subsidiary or any other Investor for any commission, fee or other compensation
pursuant to any agreement, arrangement or understanding entered into by or on behalf of such Investor.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 45pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 45pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.11&nbsp;Hong
Kong Securities Law Compliance. If applicable, each of the Company and the Investor represents, warrants and agrees that: (i)
it has not offered or sold and will not offer or sell in Hong Kong, by means of any document, any Notes or Securities other than
(a) to &ldquo;professional investors&rdquo; as defined in the Securities and Futures Ordinance (Cap. 571) (&ldquo;Ordinance&rdquo;)
of Hong Kong and any rules made under that Ordinance; or (b) in other circumstances which do not result in the document being
a &ldquo;prospectus&rdquo; as defined in the Companies Ordinance (Cap. 32) of Hong Kong or which do not constitute an offer to
the public within the meaning of that Ordinance; and (ii) it has not issued or had in its possession for the purposes of issue,
and will not issue or have in its possession for the purposes of issue, whether in Hong Kong or elsewhere, any advertisement,
invitation or document relating to the Notes or the Securities, which is directed at, or the contents of which are likely to be
accessed or read by, the public of Hong Kong (except if permitted to do so under the securities laws of Hong Kong) other than
with respect to the Notes or the Securities which are or are intended to be disposed of only to persons outside Hong Kong or only
to &ldquo;professional investors&rdquo; as defined in the Ordinance and any rules made under that Ordinance.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 45pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 45pt"></P>

<!-- Field: Page; Sequence: 6; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 45pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.&nbsp;Representations
and Warranties of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company represents, warrants and covenants to the Investors that:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 45pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.1&nbsp;Organization:
Execution, Delivery and Performance.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 45pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)&nbsp;The
Company and each of its Subsidiaries, if any, is a corporation or other entity duly organized, validly existing and in good standing
under the laws of the jurisdiction in which it is incorporated or organized, with full power and authority (corporate and other)
to own, lease, use and operate its properties and to carry on its business as and where now owned, leased, used, operated and
conducted. The Company and each of its Subsidiaries is duly qualified as a foreign corporation to do business and is in good standing
in every jurisdiction in which its ownership or use of property or the nature of the business conducted by it makes such qualification
necessary except where the failure to be so qualified or in good standing would not have a Material Adverse Effect.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)&nbsp;(i)
The Company has all requisite corporate power and authority to enter into and perform the Transaction Documents and to consummate
the transactions contemplated hereby and thereby and to issue the Securities, in accordance with the terms hereof and thereof,
(ii) the execution and delivery of the Transaction Documents by the Company and the consummation by the Company of the transactions
contemplated hereby and thereby (including without limitation, the issuance of the Shares, and the issuance and reservation for
issuance of the Converted Shares) have been duly authorized by the Company&rsquo;s Board of Directors and no further consent or
authorization of the Company, its Board of Directors, or its stockholders, is required, (iii) each of the Transaction Documents
has been duly executed and delivered by the Company by its authorized representative, and such authorized representative is a
true and official representative with authority to sign each such document and the other documents or certificates executed in
connection herewith and bind the Company accordingly, and (iv) each of the Transaction Documents constitutes, and upon execution
and delivery thereof by the Company will constitute, a legal, valid and binding obligation of the Company enforceable against
the Company in accordance with its terms, except to the extent limited by applicable bankruptcy, insolvency, reorganization, moratorium
or other laws of general application affecting enforcement of creditors&rsquo; rights and general principles of equity that restrict
the availability of equitable or legal remedies.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 45pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.2&nbsp;Notes
and Converted Shares Duly Authorized. The Notes to be issued to each such Investor pursuant to this Agreement, when issued and
delivered in accordance with the terms of this Agreement, will be duly and validly issued and will be fully paid and non-assessable
and free from all taxes or Liens with respect to the issue thereof and shall not be subject to preemptive rights or other similar
rights of stockholders of the Company. The Converted Shares will be duly authorized and reserved for future issuance and, upon
conversion of the Notes in accordance with its terms, will be duly and validly issued, fully paid and non-assessable, and free
from all taxes or Liens with respect to the issue thereof and shall not be subject to preemptive rights or other similar rights
of stockholders of the Company. The Company has reserved from its duly authorized capital stock the maximum number of shares of
ordinary shares issuable pursuant to this Agreement. It is not necessary in connection with the issuance and sale of the Securities
to register the Securities under the 1933 Act or to qualify or register the Securities under applicable U.S. state securities
laws. None of the Company, its Subsidiaries or their respective Affiliates or any Person acting on its or their behalf have engaged
in any &ldquo;directed selling efforts&rdquo; within the meaning of Rule 903 of Regulation S.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 45pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 45pt"></P>

<!-- Field: Page; Sequence: 7; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 45pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 45pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.3&nbsp;Capitalization.
As of the date of this Agreement, the authorized capital stock of the Company consists of (i) 60,000,000 Class A Shares with a
nominal or par value of USD$1.00 each, of which approximately 5,426,381 shares are issued and outstanding or otherwise reserved
for issuance pursuant to securities (other than the Converted Shares) exercisable for, or convertible into or exchangeable for
shares of Class A Shares, and (ii) 40,000,000 Class B Ordinary Shares with a nominal or par value of USDS1.00 each (the &ldquo;Class
B Shares&rdquo;), of which 22,437,754 shares are issued and outstanding or otherwise reserved for issuance pursuant to securities
exercisable for, or convertible into or exchangeable for shares of Class B Shares, provided that (A) the Company acting by its
board of directors shall have power to purchase and/or redeem any or all of such shares and to increase or reduce the said capital
of the Company and to sub-divide or consolidate the said shares or any of them subject to the provisions of the Cayman Islands
Company Law (2016 Revision) (as amended) (&ldquo;Company Law&rdquo;) and the articles of association (the &ldquo;Articles&rdquo;)
of the Company and to issue all or any part of its capital whether original, purchased, redeemed, increased or reduced with or
without any preference, priority or special privilege or subject to any restrictions whatsoever and so that unless the conditions
of issue shall otherwise expressly provide every issue of shares whether stated to be ordinary, preference or otherwise shall
be subject to the powers on the part of the Company hereinbefore provided, (B) the holders of Class A Shares are entitled to one
vote for each such share and Class A shares are not redeemable at the option of the holders and not convertible into shares of
any other class; and (C) the holders of Class B Shares are entitled to ten votes for each such share and the Class B shares are
not redeemable at the option of the holders but convertible into Class A Shares at any time after the issuance at the option of
the holders on 1 to 1 basis. Except as described above, upon the consummation of the transactions contemplated hereby, (i) there
are no outstanding options, warrants, scrip, rights to subscribe for, puts, calls, rights of first refusal, agreements, understandings,
claims or other commitments or rights of any character whatsoever relating to, or securities or rights convertible into or exchangeable
for any shares of capital stock of the Company or any of its Subsidiaries, or arrangements by which the Company or any of its
Subsidiaries is or may become bound to issue additional shares of capital stock of the Company or any of its Subsidiaries, (ii)
there are no agreements or arrangements under which the Company or any of its Subsidiaries is obligated to register the sale of
any of its or their securities under the 1933 Act (except for the registration rights provisions contained herein) and (iii) there
are no anti-dilution or price adjustment provisions contained in any security issued by the Company (or in any agreement providing
rights to security holders) that will be triggered by the issuance of the Shares or the Converted Shares. All of such outstanding
shares of capital stock are, or upon issuance will be, duly authorized, validly issued, fully paid and non-assessable. No shares
of capital stock of the Company are subject to preemptive rights or any other similar rights of the stockholders of the Company
or any Lien imposed through the actions or failure to act of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 45pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 45pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.4&nbsp;No
General Solicitation. Neither the Company nor any person participating on the Company&rsquo;s behalf in the transactions contemplated
hereby has conducted any &ldquo;general solicitation,&rdquo; as such term is defined in Regulation D promulgated under the 1933
Act, with respect to any of the Securities being offered hereby.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 45pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 45pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.5&nbsp;No
Integrated Offering. Neither the Company, nor any of its affiliates, nor any person acting on its or their behalf, has directly
or indirectly made any offers or sales in any security or solicited any offers to buy any security under circumstances that would
require registration under the 1933 Act of the issuance of the Securities to the Investors. The issuance of the Securities to
the Investors will not be integrated with any other issuance of the Company&rsquo;s securities (past, current or future) for purposes
of any stockholder approval provisions applicable to the Company or its securities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 45pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 45pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.6&nbsp;No
Brokers. Except as set forth in Section 9.1, the Company has taken no action which would give rise to any claim by any person
for brokerage commissions, transaction fees or similar payments relating to this Agreement or the transactions contemplated hereby.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 45pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 45pt"></P>

<!-- Field: Page; Sequence: 8; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 45pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 45pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.7&nbsp;Disclosure.
All information relating to or concerning the Company or any of its Subsidiaries, officers, directors, employees, customers or
clients: (i) set forth in this Agreement and/or (ii) as disclosed in any exhibit or certification thereto is true and correct
in all material respects and the Company has not omitted to state any material fact necessary in order to make the statements
made herein or therein, in light of the circumstances under which they were made, not misleading.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 45pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 45pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.8&nbsp;Form
D; Blue Sky Laws. To the extent applicable, the Company agrees to file a Form D with respect to the Securities as required under
Regulation D and to provide a copy thereof to Boustead Securities, LLC (the &ldquo;Placement Agent&rdquo;) promptly after such
filing. The Company shall, on or before the Closing Date, take such action as the Company shall reasonably determine is necessary
to qualify the Securities for sale to the Investors in the applicable closing pursuant to this Agreement under applicable securities
or &ldquo;blue sky&rdquo; laws of the states of the United States (or to obtain an exemption from such qualification), and shall
provide evidence of any such action so taken to the Placement Agent on or prior to the Closing Date.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 45pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.&nbsp;Registration
Rights.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 45pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.1&nbsp;Participation
in Registrations. Following an IPO, whenever the Company proposes to register any of its securities under the 1933 Act, whether
for its own account or for the account of another stockholder (except for the registration of securities (A) to be offered pursuant
to an employee benefit plan on Form S-8 or (B) pursuant to a registration made on Form S-4, or any successor forms then in effect)
at any time and the registration form to be used may be used for the registration of the Registrable Securities (a &ldquo;Piggyback
Registration&rdquo;), it will so notify in writing all holders of Registrable Securities no later than the earlier to occur of
(i) the tenth (10th) day following the Company&rsquo;s receipt of notice of exercise of other demand registration rights, or (ii)
thirty (30) days prior to the anticipated filing date. Subject to the provisions of this Agreement, the Company will include in
the Piggyback Registration all Registrable Securities, on a pro rata basis based upon the total number of Registrable Securities
with respect to which the Company has received written requests for inclusion within fifteen (15) business days after the applicable
holder&rsquo;s receipt of the Company&rsquo;s notice.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 45pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 45pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.2&nbsp;Underwritten
Offerings. In the event a registration giving rise to the Investors&rsquo; rights pursuant to Section 5.1 relates to an underwritten
offering of securities, the Investors&rsquo; right to registration pursuant to Section 5.1 shall be conditioned upon its (i) participation
in such underwriting, (ii) inclusion of the Registrable Securities therein and (iii) execution of all underwriting documents requested
by the underwriter with respect thereto (the &ldquo;Underwriter&rdquo;). If the managing underwriter gives the Company its written
opinion that the total number or dollar amount of securities requested to be included in the registration exceeds the number or
dollar amount of securities that can be sold, the Company will include the securities in the registration in the following order
of priority: (A) first, all securities the Company proposes to sell; and (B) second, pro rata among all other holders of securities
(including the holders of Registrable Securities) that have registration rights, if any, in each case, on the basis of the dollar
amount or number of securities requested to be included, as the case may be.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 45pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 45pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.3&nbsp;Expenses.
All fees and expenses incident to the performance of or compliance with this Agreement by the Company shall be borne by the Company
whether or not any Registrable Securities are sold pursuant to the Registration Statement. The fees and expenses referred to in
the foregoing sentence shall include, without limitation, (i) all registration and filing fees (including, without limitation,
fees and expenses (A) with respect to filings required to be made with the trading market on which the Common Stock is then listed
for trading, and (B) in compliance with applicable state securities or Blue Sky laws, (ii) printing expenses, (iii) messenger,
telephone and delivery expenses, (iv) fees and disbursements of counsel and independent public accountants for the Company, and
(v) fees and disbursements of one counsel to the Investors not to exceed $5,000.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 45pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 45pt"></P>

<!-- Field: Page; Sequence: 9; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 45pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 45pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.4&nbsp;Indemnification.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 45pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)&nbsp;Indemnification
by the Company. The Company will indemnify and hold harmless each Investor and its officers, directors, members, employees and
agents, successors and assigns, and each other person, if any, who controls such Investor within the meaning of the 1933 Act,
against any losses, claims, damages or liabilities, joint or several, to which they may become subject under the 1933 Act or otherwise,
insofar as such losses, claims, damages or liabilities (or actions in respect thereof) arise out of or are based upon: (i) any
untrue statement or alleged untrue statement of any material fact contained in any Registration Statement, any preliminary prospectus
or final prospectus contained therein, or any amendment or supplement thereof; (ii) any blue sky application or other document
executed by the Company specifically for that purpose or based upon written information furnished by the Company filed in any
state or other jurisdiction in order to qualify any or all of the Registrable Securities under the securities laws thereof (any
such application, document or information herein called a &ldquo;Blue Sky Application&rdquo;); (iii) the omission or alleged omission
to state therein a material fact required to be stated therein or necessary to make the statements therein not misleading; (iv)
any violation by the Company or its agents of any rule or regulation promulgated under the 1933 Act applicable to the Company
or its agents and relating to action or inaction required of the Company in connection with such registration; or (v) any failure
to register or qualify the Registrable Securities included in any such registration in any state where the Company or its agents
has affirmatively undertaken or agreed in writing that the Company will undertake such registration or qualification on an Investor&rsquo;s
behalf and will reimburse such Investor, and each such officer, director or member and each such controlling person for any legal
or other expenses reasonably incurred by them in connection with investigating or defending any such loss, claim, damage, liability
or action; provided, however, that the Company will not be liable in any such case if and to the extent that any such loss, claim,
damage or liability arises out of or is based upon an untrue statement or alleged untrue statement or omission or alleged omission
so made in conformity with information furnished by such Investor or any such controlling person in writing specifically for use
in such Registration Statement or related prospectus.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)&nbsp;Indemnification
by the Investors. Each Investor agrees, severally but not jointly, to indemnify and hold harmless, to the fullest extent permitted
by law, the Company, its directors, officers, employees, stockholders and each person who controls the Company (within the meaning
of the 1933 Act) against any losses, claims, damages, liabilities and expense (including reasonable attorney fees) resulting from
any untrue statement of a material fact or any omission of a material fact required to be stated in the Registration Statement
or related prospectus or preliminary prospectus or amendment or supplement thereto or necessary to make the statements therein
not misleading, to the extent, but only to the extent that such untrue statement or omission is contained in any information furnished
in writing by such Investor to the Company specifically for inclusion in such Registration Statement or related prospectus or
amendment or supplement thereto. In no event shall the liability of an Investor be greater in amount than the dollar amount of
the proceeds (net of all expense paid by such Investor in connection with any claim relating to this Section 5.4 and the amount
of any damages such Investor has otherwise been required to pay by reason of such untrue statement or omission) received by such
Investor upon the sale of the Registrable Securities included in the Registration Statement giving rise to such indemnification
obligation.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 10; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)&nbsp;Conduct
of Indemnification Proceedings. Any person entitled to indemnification hereunder shall (i) give prompt notice to the indemnifying
party of any claim with respect to which it seeks indemnification and (ii) permit such indemnifying party to assume the defense
of such claim with counsel reasonably satisfactory to the indemnified party; provided that any person entitled to indemnification
hereunder shall have the right to employ separate counsel and to participate in the defense of such claim, but the fees and expenses
of such counsel shall be at the expense of such person unless (a) the indemnifying party has agreed to pay such fees or expenses,
or (b) the indemnifying party shall have failed to assume the defense of such claim and employ counsel reasonably satisfactory
to such person or (c) in the reasonable judgment of any such person, based upon written advice of its counsel, a conflict of interest
exists between such person and the indemnifying party with respect to such claims (in which case, if the person notifies the indemnifying
party in writing that such person elects to employ separate counsel at the expense of the indemnifying party, the indemnifying
party shall not have the right to assume the defense of such claim on behalf of such person); and provided, further, that the
failure of any indemnified party to give notice as provided herein shall not relieve the indemnifying party of its obligations
hereunder, except to the extent that such failure to give notice shall materially adversely affect the indemnifying party in the
defense of any such claim or litigation. It is understood that the indemnifying party shall not, in connection with any proceeding
in the same jurisdiction, be liable for fees or expenses of more than one separate firm of attorneys at any time for all such
indemnified parties. No indemnifying party will, except with the consent of the indemnified party, consent to entry of any judgment
or enter into any settlement that does not include as an unconditional term thereof the giving by the claimant or plaintiff to
such indemnified party of a release from all liability in respect of such claim or litigation,</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)&nbsp;Contribution.
If for any reason the indemnification provided for in the preceding paragraphs (a) and (c) is unavailable to an indemnified party
or insufficient to hold it harmless, other than as expressly specified therein, then the indemnifying party shall contribute to
the amount paid or payable by the indemnified party as a result of such loss, claim, damage or liability in such proportion as
is appropriate to reflect the relative fault of the indemnified party and the indemnifying party, as well as any other relevant
equitable considerations. No person guilty of fraudulent misrepresentation within the meaning of Section 11(f) of the 1933 Act
shall be entitled to contribution from any person not guilty of such fraudulent misrepresentation. In no event shall the contribution
obligation of a holder of Registrable Securities be greater in amount than the dollar amount of the proceeds (net of all expenses
paid by such holder in connection with any claim relating to this Section 5.4 and the amount of any damages such holder has otherwise
been required to pay by reason of such untrue or alleged untrue statement or omission or alleged omission) received by it upon
the sale of the Registrable Securities giving rise to such contribution obligation.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 45pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.5&nbsp;Cooperation
by Investor. Each Investor shall furnish to the Company or the Underwriter, as applicable, such information regarding the Investor
and the distribution proposed by it as the Company may reasonably request in connection with any registration or offering referred
to in this Section 5. Each Investor shall cooperate as reasonably requested by the Company in connection with the preparation
of the registration statement with respect to such registration, and for so long as the Company is obligated to file and keep
effective such registration statement, shall provide to the Company, in writing, for use in the registration statement, all such
information regarding the Investor and its plan of distribution of the Shares included in such registration as may be reasonably
necessary to enable the Company to prepare such registration statement, to maintain the currency and effectiveness thereof and
otherwise to comply with all applicable requirements of law in connection therewith.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 45pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.&nbsp;Transfer
Restrictions.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 45pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.1&nbsp;Transfer
or Resale. Each Investor understands that:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 45pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)&nbsp;Except
as provided in the registration rights provisions set forth above, the sale or resale of all or any portion or component of the
Securities has not been and is not being registered under the 1933 Act or any applicable state securities laws, and that all or
any portion or component of Securities may not be transferred unless:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(A)&nbsp;the
Securities are sold pursuant to an effective registration statement under the 1933 Act,</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"></P>

<!-- Field: Page; Sequence: 11; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(B)&nbsp;the
Investor shall have delivered to the Company, at the cost of the Company, a customary opinion of counsel that shall be in form,
substance and scope reasonably acceptable to the Company, to the effect that the Securities to be sold or transferred may be sold
or transferred pursuant to an exemption from such registration,</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(C)&nbsp;the
Securities are sold or transferred to an &ldquo;affiliate&rdquo; (as defined in Rule 144 promulgated under the 1933 Act (or a
successor rule) (&ldquo;Rule 144&rdquo;)) of the Investor who agrees to sell or otherwise transfer the Securities only in accordance
with this Section 6.1 and who is an Accredited Investor, as such term is defined in Rule 501(a) of Regulation D,</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(D)&nbsp;the
Securities are sold pursuant to Rule 144, or</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(E)&nbsp;the
Securities are sold pursuant to Regulation S;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">and,
in each case, the Investor shall have delivered to the Company, at the cost of the Company, a customary opinion of counsel, in
form, substance and scope reasonably acceptable to the Company. Notwithstanding the foregoing or anything else contained herein
to the contrary, the Securities may be pledged as collateral in connection with a bona fide margin account or other lending arrangement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 45pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.2&nbsp;Transfer
Agent Instructions. The Company shall issue irrevocable instructions to its transfer agent to issue certificates, registered in
the name of each Investor or its nominee, for any Converted Shares in such amounts as specified from time to time by each Investor
to the Company upon conversion of the Converted Shares in accordance with the terms thereof (the &ldquo;Irrevocable Transfer Agent
Instructions&rdquo;). Prior to registration of the Converted Shares under the 1933 Act or the date on which the Converted Shares
may be sold pursuant to Rule 144 without any restriction as to the number of Securities as of a particular date that can then
be immediately sold, all such certificates shall bear the restrictive legend specified in Section 3.6(A) or 3.8(v), as applicable
of this Agreement. Nothing in this Section shall affect in any way the Investor&rsquo;s obligations and agreement set forth in
Section 6.1 hereof to comply with all applicable prospectus delivery requirements, if any, upon re-sale of the Securities. If
an Investor provides the Company with a customary opinion of counsel, that shall be in form, substance and scope reasonably acceptable
to such counsel, to the effect that a public sale or transfer of such Securities may be made without registration under the 1933
Act and such sale or transfer is effected, the Company shall permit the transfer, and, in the case of the Converted Shares, promptly
instruct its transfer agent to issue one or more certificates, free from restrictive legend, in such name and in such denominations
as specified by such Investor. The Company acknowledges that a breach by it of its obligations hereunder will cause irreparable
harm to the Investors, by vitiating the intent and purpose of the transactions contemplated hereby. Accordingly, the Company acknowledges
that the remedy at law for a breach of its obligations under this Section 6.2 may be inadequate and agrees, in the event of a
breach or threatened breach by the Company of the provisions of this Section, that the Investors shall be entitled, in addition
to all other available remedies, to an injunction restraining any breach and requiring immediate transfer, without the necessity
of showing economic loss and without any bond or other security being required.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 45pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.3&nbsp;Lock-Up.
Each Investor hereby agrees to take all actions reasonably requested by the Company in connection with the proposed IPO including
the execution of customary lock-up agreements with the Company and/or the underwriter(s) of the IPO, the terms of which shall
provide that (a) the Notes and Converted Shares shall not be sold or otherwise Transferred by the holder(s) of the Notes and/or
Converted Shares for a period of six months period commencing on the date of the commencement of trading on a U.S. national securities
exchange of the Company&rsquo;s securities to be issued in the IPO and (b) the Company and/or underwriter(s) may require the holder(s)
of the Notes and/or Converted Shares to provide evidence of compliance with such lock-up agreement including through the provision
of account statements for such brokerage accounts holding the Converted Shares.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 12; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">7.&nbsp;Conditions
to Closing of the Investors.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
obligation of each Investor to purchase the Notes at the Closing is subject to the fulfillment to such Investor&rsquo;s satisfaction,
on or prior to the Closing Date, of the following conditions, any of which may be waived by such Investor (as to itself only):</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 45pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">7.1&nbsp;Representations
and Warranties. The representations and warranties made by the Company in Section 4 hereof qualified as to materiality shall be
true and correct at all times prior to and on the Closing Date, except to the extent any such representation or warranty expressly
speaks as of an earlier date, in which case such representation or warranty shall be true and correct as of such earlier date,
and, the representations and warranties made by the Company in Section 4 hereof not qualified as to materiality shall be true
and correct in all material respects at all times prior to and on the Closing Date, except to the extent any such representation
or warranty expressly speaks as of an earlier date, in which case such representation or warranty shall be true and correct in
all material respects as of such earlier date. The Company shall have performed in all material respects all obligations and covenants
herein required to be performed by it on or prior to the Closing Date.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 45pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 45pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">7.2&nbsp;Approvals.
The Company shall have obtained any and all consents, permits, approvals, registrations and waivers necessary or appropriate for
consummation of the purchase and sale of the Securities and the consummation of the other transactions contemplated by the Transaction
Documents, all of which shall be in full force and effect.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 45pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 45pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">7.3&nbsp;Judgments,
Etc. No judgment, writ, order, injunction, award or decree of or by any court, or judge, justice or magistrate, including any
bankruptcy court or judge, or any order of or by any governmental authority, shall have been issued, and no action or proceeding
shall have been instituted by any governmental authority, enjoining or preventing the consummation of the transactions contemplated
hereby or in the other Transaction Documents.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 45pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 45pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">7.4&nbsp;Company
CEO/CFO Certificate. The Company shall have delivered a Certificate, executed on behalf of the Company by its Chief Executive
Officer or its Chief Financial Officer, dated as of the Closing Date, certifying to the fulfillment of the conditions specified
in subsections 7.1, 7.2 and 7.3.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 45pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 45pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">7.5&nbsp;Company
Secretary Certificate. The Company shall have delivered a Certificate, executed on behalf of the Company by its Secretary, dated
as of the Closing Date, certifying the resolutions adopted by the Board of Directors of the Company approving the transactions
contemplated by this Agreement and the other Transaction Documents and the issuance of the Securities, certifying the current
versions of the Articles of Incorporation and By-laws of the Company and certifying as to the signatures and authority of persons
signing the Transaction Documents and related documents on behalf of the Company. The foregoing certificate shall only be required
to be delivered on the First Closing Date, unless any information contained in the certificate has changed.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 45pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8.&nbsp;Conditions
to Closing of the Company. The obligations of the Company to effect the transactions contemplated by this Agreement are subject
to the fulfillment at or prior to each Closing Date of the conditions listed below.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 45pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8.1&nbsp;Representations
and Warranties. The representations and warranties made by the Investor in Section 3 shall be true and correct in all material
respects at the time of Closing as if made on and as of such date.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 45pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 45pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8.2&nbsp;Corporate
Proceedings. All corporate and other proceedings required to be undertaken by the Investor in connection with the transactions
contemplated hereby shall have occurred and all documents and instruments incident to such proceedings shall be reasonably satisfactory
in substance and form to the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 45pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 45pt"></P>

<!-- Field: Page; Sequence: 13; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 45pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">9.&nbsp;Miscellaneous.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 45pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">9.1&nbsp;Compensation
of Brokers. The Investor acknowledges that it is aware that Boustead Securities, LLC will receive from the Company, in consideration
of its services as placement agent in respect of the transactions contemplated hereby, (i) a success fee of 7% of the Purchase
Price of the Securities purchased by Investors introduced by Boustead Securities, LLC, and 4% of the Purchase Price of the Securities
purchased by Investors procured by the Company, at each Closing, payable in cash, and (ii) at each Closing, a two and one half-year
warrant to purchase a number of Class A Shares equal to 5.5% of the principal amount of the Notes sold at each closing, divided
by and exercisable on a cashless basis, at a 56% discount to the actual price per Class A Share, subject to adjustment, at the
IPO.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 45pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 45pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">9.2&nbsp;Notices.
All notices, requests, demands and other communications provided in connection with this Agreement shall be in writing and shall
be deemed to have been duly given at the time when hand delivered, delivered by express courier, or sent by facsimile (with receipt
confirmed by the sender&rsquo;s transmitting device) in accordance with the contact information provided below or such other contact
information as the parties may have duly provided by notice.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 45pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 45pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company:</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Aptorum Group Limited</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">With a copy to:</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Hunter Taubman Fischer &amp; Li LLC</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">17<SUP>th </SUP>Floor, Guangdong Investment Tower</FONT></TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1450 Broadway, 26<SUP>th</SUP> Fl.</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">148 Connaught Road</FONT></TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">New York, New York 10018</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Central, Hong Kong</FONT></TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Telephone: +1 (212) 530-2207</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Telephone: +852 2117 6611</FONT></TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Facsimile: +1(212) 202-6380</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Facsimile: +852 2850 7286</FONT></TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Attention: Louis E. Taubman, Esq.</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Attention: Mr. Ian Huen, Executive Director and Chief Executive Officer</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>

<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Investors:</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD COLSPAN="3"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">As per the contact information provided on the signature page hereof.</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Placement Agent:</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Boustead Securities, LLC</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">With a copy to:</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pryor Cashman LLP</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">7 Times Square</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">New York, NY 10036</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Telephone: +1 (949) 295 1580</FONT></TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Telephone: 212-326-0199</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Facsimile: +1 (949) 266-5789</FONT></TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Facsimile: 212-326-0806</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Attention: Mr. Keith Moore, CEO</FONT></TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Attention: Elizabeth Fei Chen, Esq.</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 45pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">9.3&nbsp;Survival
of Representations and Warranties. Each party hereto covenants and agrees that the representations and warranties of such party
contained in this Agreement shall survive the Closing.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 45pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 45pt"></P>

<!-- Field: Page; Sequence: 14; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 45pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 45pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">9.4&nbsp;Entire
Agreement. This Agreement contains the entire agreement between the parties hereto in respect of the subject matter contained
herein and supersedes all prior agreements and understandings of the parties, oral and written, with respect to the subject matter
contained herein.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 45pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 45pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">9.5&nbsp;Third
Party Beneficiaries. This Agreement is intended for the benefit of the parties hereto and their respective permitted successors
and assigns, and, except for the Placement Agent, which is specifically agreed to be and acknowledged by each party as a third
party beneficiary hereof, is not for the benefit of, nor may any provision hereof be enforced by, any other person.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 45pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 45pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">9.6&nbsp;Successors
and Assigns. This Agreement shall be binding upon and inure to the benefit of the parties and their successors and assigns. Neither
the Company nor any Investor shall assign this Agreement or any rights or obligations hereunder without the prior written consent
of the other. Notwithstanding the foregoing, but subject to the provisions of Section 6.1 and 6.3 hereof, any Investor may, without
the consent of the Company, assign its rights hereunder to any person that purchases Securities in a private transaction from
an Investor or to any of its &ldquo;affiliates,&rdquo; as that term is defined under the 1934 Act.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 45pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 45pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">9.7&nbsp;Publicity.
The Company and the Placement Agent shall have the right to review a reasonable period of time before issuance of any press releases
or SEC or other regulatory filings, or any other public statements with respect to the transactions contemplated hereby; provided,
however, that the Company shall be entitled, without the prior approval of the Placement Agent or the Investors, to make any press
release or SEC or other regulatory filings with respect to such transactions as is required by applicable law and regulations
(although the Placement Agent shall be consulted by the Company in connection with any such press release prior to its release
and shall be provided with a copy thereof and be given an opportunity to comment thereon).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 45pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 45pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">9.8&nbsp;Binding
Effect; Benefits. This Agreement and all the provisions hereof shall be binding upon and inure to the benefit of the parties hereto
and their respective successors and permitted assigns; nothing in this Agreement, expressed or implied, is intended to confer
on any persons other than the parties hereto or their respective successors and permitted assigns, any rights, remedies, obligations
or liabilities under or by reason of this Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 45pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 45pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">9.9&nbsp;Amendment;
Waivers. All modifications, amendments or waivers to this Agreement shall require the written consent of both the Company and
a majority in interest of the Investors (based on the number of Shares purchased hereunder).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 45pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 42.55pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">9.10&nbsp;Applicable
Law: Disputes. All questions concerning the construction, validity, enforcement and interpretation of the Transaction Documents
shall be governed by and construed and enforced in accordance with the internal laws of the State of New York, without regard
to the principles of conflicts of law thereof. Each party agrees that all legal proceedings concerning the interpretations, enforcement
and defense of the transactions contemplated by this Agreement and any other Transaction Documents (whether brought against a
party hereto or its respective affiliates, directors, officers, shareholders, partners, members, employees or agents) shall be
commenced exclusively in the state and federal courts sitting in the City of New York. Each party hereby irrevocably submits to
the exclusive jurisdiction of the state and federal courts sitting in the City of New York, Borough of Manhattan for the adjudication
of any dispute hereunder or in connection herewith or with any transaction contemplated hereby or discussed herein (including
with respect to the enforcement of any of the Transaction Documents), and hereby irrevocably waives, and agrees not to assert
in any Action, any claim that it is not personally subject to the jurisdiction of any such court, that such Action is improper
or is an inconvenient venue for such Action. Each party hereby irrevocably waives personal service of process and consents to
process being served in any such Action by mailing a copy thereof via registered or certified mail or overnight delivery (with
evidence of delivery) to such party at the address in effect for notices to it under this Agreement and agrees that such service
shall constitute good and sufficient service of process and notice thereof. Nothing contained herein shall be deemed to limit
in any way any right to serve process in any other manner permitted by law. If any party shall commence an Action to enforce any
provisions of the Transaction Documents, then, in addition to the obligations of the Company under Section 5.4, the prevailing
party in such Action shall be reimbursed by the non-prevailing party for its reasonable attorneys&rsquo; fees and other costs
and expenses incurred with the investigation, preparation and prosecution of such Action. For purposes of this Section &ldquo;Action&rdquo;
means any notice of noncompliance or violation, or any claim, demand, charge, action, suit, litigation, audit, settlement, complaint,
stipulation, assessment or arbitration, or any request (including any request for information), inquiry, hearing, proceeding or
investigation, by or before any federal, state, local, foreign or other governmental, quasi-governmental or administrative body,
instrumentality, department or agency or any court, tribunal, administrative hearing body, arbitration panel, commission, or other
similar dispute-resolving panel or body.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 42.55pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 42.55pt"></P>

<!-- Field: Page; Sequence: 15; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 42.55pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 45pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">9.11&nbsp;Further
Assurances. Each party hereto shall do and perform or cause to be done and performed all such further acts and shall execute and
deliver all such other agreements, certificates, instruments and documents as any other party hereto reasonably may request in
order to carry out the intent and accomplish the purposes of this Agreement and the consummation of the transactions contemplated
hereby.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 45pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 45pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">9.12&nbsp;Counterparts.
This Agreement may be executed in any number of counterparts, each of which shall be deemed to be an original and all of which
taken together shall constitute one and the same instrument. This Agreement may also be executed via facsimile or .pdf transmission,
which shall be deemed an original.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 45pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 45pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">9.13&nbsp;<B>WAIVER
OF JURY TRIAL. IN ANY ACTION, SUIT, OR PROCEEDING IN ANY JURISDICTION BROUGHT BY ANY PARTY AGAINST ANY OTHER PARTY UNDER THIS
AGREEMENT, THE PARTIES EACH KNOWINGLY AND INTENTIONALLY, TO THE GREATEST EXTENT PERMITTED BY APPLICABLE LAW, HEREBY ABSOLUTELY,
UNCONDITIONALLY, IRREVOCABLY AND EXPRESSLY WAIVES FOREVER TRIAL BY JURY.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 45pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">[Signature
Pages Immediately Follow]</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><BR STYLE="clear: both">
</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 16; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>IN
WITNESS WHEREOF</B>, the undersigned Investors and the Company have caused this Securities Purchase Agreement to be duly executed
as of the date first above written.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="padding: 0; text-indent: 0">&nbsp;</TD>
    <TD COLSPAN="3" STYLE="padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Aptorum Group Limited</B></FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding: 0; text-indent: 0">&nbsp;</TD>
    <TD COLSPAN="3" STYLE="padding: 0; text-indent: 0">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding: 0; text-indent: 0">&nbsp;</TD>
    <TD STYLE="padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD COLSPAN="2" STYLE="padding: 0; text-indent: 0; border-bottom: Black 1.5pt solid">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding: 0; text-indent: 0; width: 60%">&nbsp;</TD>
    <TD STYLE="padding: 0; text-indent: 0; width: 4%">&nbsp;</TD>
    <TD STYLE="padding: 0; text-indent: 0; width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD>
    <TD STYLE="padding: 0; text-indent: 0; width: 31%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ian Huen</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding: 0; text-indent: 0">&nbsp;</TD>
    <TD STYLE="padding: 0; text-indent: 0">&nbsp;</TD>
    <TD STYLE="padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</FONT></TD>
    <TD STYLE="padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Executive Director &amp; CEO</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="padding: 0; text-indent: 0; width: 60%">&nbsp;</TD>
    <TD STYLE="padding: 0; text-indent: 0; width: 40%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>INVESTORS:</B></FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding: 0; text-indent: 0">&nbsp;</TD>
    <TD STYLE="padding: 0; text-indent: 0">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding: 0; text-indent: 0">&nbsp;</TD>
    <TD STYLE="text-align: justify; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Investors executing the Signature Page in the form attached hereto as Annex A and delivering the same to the Company or its agents shall be deemed to have executed this Agreement and agreed to the terms hereof.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 17; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>



<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Annex
A<BR>
Securities Purchase Agreement<BR>
Investor Counterpart Signature Page</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
undersigned desiring to (i) enter into this Securities Purchase Agreement dated as of May 15, 2018 (the &ldquo;Agreement&rdquo;),
between the undersigned Aptorum Group Limited, a Cayman Islands company (the &ldquo;Company&rdquo;), and the other parties hereto,
in or substantially in the form furnished to the undersigned and (ii) purchase the securities of the Company as set forth below,
hereby agrees to purchase such securities from the Company as of the Closing and further agrees to join the Agreement as a party
thereto, with all the rights and privileges appertaining thereto, and to be bound in all respects by the terms and conditions
thereof. The undersigned specifically acknowledges having read the representations in the Agreement section entitled &ldquo;Representations,
Warranties and Acknowledgements of the Investors,&rdquo; and hereby represents that the statements contained therein are complete
and accurate with respect to the undersigned as an Investor.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; text-align: left">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">Name of Investor:</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif"><I>All Investors:</I></FONT></TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD STYLE="width: 40%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 20%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 8%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 32%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif"><I>If an entity:</I></FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif"><I>Address:</I></FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">Print Name of Entity:</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="padding: 0 0 1pt; font-size: 10pt; text-indent: 0; width: 40%; border-bottom: Black 1.5pt solid">&nbsp;</TD>
    <TD STYLE="width: 20%">&nbsp;</TD>
    <TD STYLE="padding-right: 0; padding-left: 0; font-size: 10pt; padding-top: 0; text-indent: 0; width: 12%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Telephone No.:</FONT></TD>
    <TD STYLE="padding: 0 0 1pt; font-size: 10pt; text-indent: 0; width: 28%; border-bottom: Black 1.5pt solid">&nbsp;</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="padding: 0 0 1pt; text-indent: 0; width: 4%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="padding: 0 0 1pt; text-indent: 0; width: 36%; border-bottom: Black 1.5pt solid">&nbsp;</TD>
    <TD STYLE="width: 20%">&nbsp;</TD>
    <TD STYLE="padding: 0 0 1pt; text-indent: 0; width: 12%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Facsimile No.:</FONT></TD>
    <TD STYLE="padding: 0 0 1pt; text-indent: 0; width: 28%; border-bottom: Black 1.5pt solid">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 0; padding-left: 0; padding-top: 0; text-indent: 0">&nbsp;</TD>
    <TD STYLE="padding-right: 0; padding-left: 0; padding-top: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="padding-right: 0; padding-left: 0; padding-top: 0; text-indent: 0">&nbsp;</TD>
    <TD STYLE="padding-right: 0; padding-left: 0; padding-top: 0; text-indent: 0">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 0; padding-left: 0; padding-top: 0; text-indent: 0">&nbsp;</TD>
    <TD STYLE="padding-right: 0; padding-left: 0; padding-top: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="padding-right: 0; padding-left: 0; padding-top: 0; text-indent: 0">&nbsp;</TD>
    <TD STYLE="padding-right: 0; padding-left: 0; padding-top: 0; text-indent: 0">&nbsp;</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD COLSPAN="2" STYLE="padding-right: 0; padding-left: 0; padding-top: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><I>If an individual:</I></FONT></TD>
    <TD STYLE="padding-right: 0; padding-left: 0; padding-top: 0; text-indent: 0">&nbsp;</TD>
    <TD STYLE="padding-right: 0; padding-left: 0; padding-top: 0; text-indent: 0">&nbsp;</TD>
    <TD STYLE="padding-right: 0; padding-left: 0; padding-top: 0; text-indent: 0">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 0; padding-left: 0; padding-top: 0; text-indent: 0; width: 10%">&nbsp;</TD>
    <TD STYLE="width: 30%">&nbsp;</TD>
    <TD STYLE="padding-right: 0; padding-left: 0; padding-top: 0; text-indent: 0; width: 20%">&nbsp;</TD>
    <TD STYLE="padding-right: 0; padding-left: 0; padding-top: 0; text-indent: 0; width: 12%">&nbsp;</TD>
    <TD STYLE="padding-right: 0; padding-left: 0; padding-top: 0; text-indent: 0; width: 28%">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 0; padding-left: 0; padding-top: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Print Name:</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid">&nbsp;</TD>
    <TD STYLE="padding-right: 0; padding-left: 0; padding-top: 0; text-indent: 0">&nbsp;</TD>
    <TD STYLE="padding-right: 0; padding-left: 0; padding-top: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Email Address:</FONT></TD>
    <TD STYLE="padding-right: 0; padding-left: 0; padding-top: 0; text-indent: 0; border-bottom: Black 1.5pt solid">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 0; padding-left: 0; padding-top: 0; text-indent: 0">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="padding-right: 0; padding-left: 0; padding-top: 0; text-indent: 0">&nbsp;</TD>
    <TD STYLE="padding-right: 0; padding-left: 0; padding-top: 0; text-indent: 0">&nbsp;</TD>
    <TD STYLE="padding-right: 0; padding-left: 0; padding-top: 0; text-indent: 0">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 0; padding-left: 0; padding-top: 0; text-indent: 0">
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Signature:</P></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid">&nbsp;</TD>
    <TD STYLE="padding-right: 0; padding-left: 0; padding-top: 0; text-indent: 0">&nbsp;</TD>
    <TD STYLE="padding-right: 0; padding-left: 0; padding-top: 0; text-indent: 0">&nbsp;</TD>
    <TD STYLE="padding-right: 0; padding-left: 0; padding-top: 0; text-indent: 0">&nbsp;</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 60%">&nbsp;</TD>
    <TD STYLE="padding-right: 0; padding-left: 0; padding-top: 0; text-indent: 0; width: 40%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Investor hereby elects to purchase _________ Notes (to be completed by Investor) under the Securities Purchase Agreement at a price of $10,000 per Note for a total Purchase Price of $_________ (to be completed by Investor).</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt">18</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Rule-Page --><DIV ALIGN="CENTER" STYLE="margin-top: 0; margin-bottom: 0"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>



<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.27
<SEQUENCE>31
<FILENAME>ff12018ex10-27_aptorum.htm
<DESCRIPTION>LOCK-UP AGREEMENT FOR SERIES A CONVERTIBLE PROMISSORY NOTES, DATED MAY 15, 2018
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0; text-align: right"><B>Exhibit 10.27</B></P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>LOCK-UP AGREEMENT</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Aptorum Group Limited</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">17<SUP>th</SUP> Floor, Guangdong Investment Tower</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">148 Connaught Road</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Central, Hong Kong<BR>
Attention: Mr. Ian Huen, Executive Director &amp; CEO</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Ladies and Gentlemen:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The undersigned, an
owner of Series A Convertible Promissory Notes (the &ldquo;<B>Notes</B>&rdquo;) of Aptorum Group Limited, a Cayman Islands company
(the <B>&ldquo;Company&rdquo;</B>), convertible into shares (the &ldquo;<B>Convertible Shares</B>&rdquo;) of Class A ordinary share
of the Company with a nominal or par value of USD$1.00 each (the <B>&ldquo;Class A Shares&rdquo;</B>), understands that the Company
proposes to file with the U.S. Securities and Exchange Commission a registration statement for the registration of certain securities
of the Company (the <B>&ldquo;Registration Statement&rdquo;</B>) in connection with a proposed initial public offering of such
securities (the <B>&ldquo;Offering&rdquo;</B>). The undersigned further understands that Boustead Securities, LLC (the <B>&ldquo;Underwriter&rdquo;</B>)
is the proposed underwriter for the Offering.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In order to induce
the Underwriter to proceed with the Offering, the undersigned agrees, for the benefit of the Company and the Underwriter, that
should the Offering become effective, the undersigned will not, without the Underwriter&rsquo;s prior written consent (and, if
required by applicable state blue sky laws, the securities commissions in any such states), offer, sell, assign, hypothecate, pledge,
transfer or otherwise dispose of, directly or indirectly, any of the abovementioned securities, or any Convertible Shares issued
in connection with the conversion of such securities, or by reason of any stock split or other distribution of stock, or grant
of options, warrants or other rights with respect to any such options (collectively, the <B>&ldquo;Securities&rdquo;</B>), during
the six-month period commencing on the date of the commencement of trading on a U.S. national securities exchange of the Company&rsquo;s
securities to be issued in the Offering) (the <B>&ldquo;Effective Date&rdquo;</B>); provided that the foregoing shall not apply
to (i) Securities acquired by the undersigned in the Offering or Securities acquired by the undersigned in the after-market after
the Effective Date; and (ii) the transfer without consideration to family members or a trust established for their benefit in connection
with which the proposed transferee agrees in writing to be bound by all of the provisions of this agreement prior to the consummation
of such transfer. The undersigned further agrees that if it transfers any part or whole of the Note pursuant to the terms herein,
it shall provide the Company with a copy of this agreement signed by the transferee at the time of the transfer.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Furthermore, the undersigned
will permit all certificates evidencing any such Securities to be endorsed with an appropriate restrictive legend reflecting the
terms of this agreement, and consents to the placement of appropriate stop transfer orders with the transfer agent for the Company.
A copy of this agreement will be available from the Company or the Company&rsquo;s transfer agent upon request and without charge.
The terms and conditions of this agreement can be modified (including premature termination of this agreement) only with the prior
written consent of the Underwriter.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; text-align: left">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dated: May 15, 2018</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD STYLE="width: 60%"></TD>
    <TD STYLE="width: 4%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="width: 36%; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Signature</FONT></TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Rule-Page --><DIV ALIGN="CENTER" STYLE="margin-top: 0; margin-bottom: 0"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>



<P STYLE="margin: 0"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.28
<SEQUENCE>32
<FILENAME>ff12018ex10-28_aptorum.htm
<DESCRIPTION>EXCLUSIVE LICENSE AGREEMENT FOR NLS-1 DATED JULY 3, 2017
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0; text-align: right"><B>Exhibit 10.28</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">[CONFIDENTIAL TREATMENT HAS BEEN REQUESTED AS TO CERTAIN PORTIONS
OF THIS DOCUMENT. EACH SUCH PORTION, WHICH HAS BEEN OMITTED HEREIN AND REPLACED WITH BLACK BARS, HAS BEEN FILED SEPARATELY WITH
THE SECURITIES AND EXCHANGE COMMISSION.]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt">Dated this 3<SUP>rd
</SUP>day of July 2017</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">POLYU TECHNOLOGY AND CONSULTANCY
COMPANY LIMITED<BR>
 MCGILL UNIVERSITY</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt">WAYNE STATE UNIVERSITY</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt">H. LEE MOFFITT CANCER CENTER
AND RESEARCH INSTITUTE INC. <BR>
THE CHINESE UNIVERSITY OF HONG KONG</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">APTUS THERAPEUTICS LIMITED</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Rule-Page --><DIV ALIGN="CENTER" STYLE="margin-top: 0; margin-bottom: 0"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid; width: 40%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">EXCLUSIVE LICENSE AGREEMENT</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Rule-Page --><DIV ALIGN="CENTER" STYLE="margin-top: 0; margin-bottom: 0"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid; width: 40%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0">THIS AGREEMENT is made on the 3rd day of July, 2017</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0">BETWEEN</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36pt; padding-top: 0; padding-right: 0; padding-bottom: 0"><FONT STYLE="font-size: 10pt">(1)</FONT></TD><TD STYLE="text-align: justify; padding-right: 0; padding-top: 0; padding-bottom: 0">PolyU Technology and Consultancy Company Limited (&ldquo; PTeC&rdquo;), a
company duly incorporated under the laws of Hong Kong and having its registered address at QR603, The Hong Kong Polytechnic University
(&ldquo;PolyU&rdquo;), Hunghom, Kowloon, Hong Kong;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36pt; text-align: justify; padding-top: 0; padding-right: 0; padding-bottom: 0">(2)</TD><TD STYLE="text-align: justify; padding-right: 0; padding-top: 0; padding-bottom: 0">The Royal Institution for the Advancement of Learning/McGill University
a Canadian university with its principal place of business located at 845 Sherbrooke Street West, Montreal, Quebec, H3A 0G4 (&ldquo;McGill&rdquo;);</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36pt; text-align: justify; padding-top: 0; padding-right: 0; padding-bottom: 0">(3)</TD><TD STYLE="text-align: justify; padding-right: 0; padding-top: 0; padding-bottom: 0">Wayne State University, a non-profit Michigan educational institution ,
with an office at 5057 Woodward Ave., Suite 6400, Detroit, Michigan, U.S.A. 48202 (&ldquo;WSU&rdquo;);</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36pt; text-align: justify; padding-top: 0; padding-right: 0; padding-bottom: 0">(4)</TD><TD STYLE="text-align: justify; padding-right: 0; padding-top: 0; padding-bottom: 0">H. Lee Moffitt Cance r Center and Research Institute Inc., a not-for-profit
Florida corporation, organized pursuant to Section 1004.43 , Florida Statutes, represented by the Office of Technology Management
and Commercialization with an address at 12902 Magnolia Drive, Tampa, Florida, U.S. A. 33612-9497 (hereinafter &ldquo;MCC&rdquo;);</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36pt; text-align: justify; padding-top: 0; padding-right: 0; padding-bottom: 0">(5)</TD><TD STYLE="text-align: justify; padding-right: 0; padding-top: 0; padding-bottom: 0">The Chinese University of Hong Kong, a university in Hong Kong with address
at Shatin, Hong Kong (&ldquo;CUHK&rdquo;); and</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36pt; text-align: justify; padding-top: 0; padding-right: 0; padding-bottom: 0">(6)</TD><TD STYLE="text-align: justify; padding-right: 0; padding-top: 0; padding-bottom: 0">APTUS Therapeutics Limited, a company duly incorporated under the laws
of Hong Kong and having its registered address at Floor 4, Willow House, Cricket Square, Grand Cayman KY1-9010, Cayman Islands
(&ldquo; Licensee&rdquo; ).</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0">PTeC,
McGill, WSU, MCC and CUHK are hereinafter referred to collectively as the &ldquo;Licensors&rdquo;.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0">WHEREAS:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 35.05pt; padding-top: 0; padding-right: 0; padding-bottom: 0"><FONT STYLE="font-size: 10pt">(1)</FONT></TD><TD STYLE="text-align: justify; padding-right: 0; padding-top: 0; padding-bottom: 0">Tak-Hang Chan of both McGill and Poly U; Ming-Cheung Chow, Wai-Har Lam and
Sheng-Biao Wan of PolyU; Qing-Ping Dou, Deborah Joyce Kuhn and Kristin R.
Landis-Piwowar of WSU; Aslamuzzaman Kazi of MCC have developed the Technology One. Tak-Hang Chan of PolyU and Chi-Chiu Wang of
CUHK have developed the Technology Two. All foregoing inventors are hereinafter referred to collectively as the &ldquo;Inventors&rdquo;.
Technology One and Technology Two are hereinafter referred to collectively as the &ldquo;Technology&rdquo;.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.15in 0pt 87.4pt; text-align: justify; text-indent: 0.55pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.15in 0pt 87.4pt; text-align: justify; text-indent: 0.55pt"></P>

<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.15in 0pt 87.4pt; text-align: justify; text-indent: 0.55pt">&nbsp;</P>




<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 35pt; padding-top: 0; padding-right: 0; padding-bottom: 0">(2)</TD><TD STYLE="text-align: justify; padding-right: 0; padding-top: 0; padding-bottom: 0">PolyU has appointed PTeC as its legal agent to deal with any third parties
on the licensing of the Patent Rights and Technology and to act on behalf of PolyU in all matters pertaining thereto.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36pt; padding-top: 0; padding-right: 0; padding-bottom: 0">(3)</TD><TD STYLE="text-align: justify; padding-right: 0; padding-top: 0; padding-bottom: 0">PolyU, McGill, WSU and MCC acquired through assignment from the respective
Inventors and jointly own the intellectual properties in the Technology One. PolyU and CUHK acquired through assignment from the
respective Inventors and jointly own the intellectual properties in the Technology Two. Licensors agree that PolyU takes the lead
to license the Technology.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36pt; padding-top: 0; padding-right: 0; padding-bottom: 0">(4)</TD><TD STYLE="text-align: justify; padding-right: 0; padding-top: 0; padding-bottom: 0">Licensee desires to obtain, and Licensors are willing to grant, an exclusive
license, for Licensee to use the Patent Rights and Technology (as defined below) for the benefit of the public and for commercial
application in accordance with the terms and conditions set out below.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0">IT IS HEREBY AGREED THAT</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in; text-align: left">1</TD><TD STYLE="text-align: justify">DEFINITIONS AND INTERPRETATION</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0pt; text-indent: 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0pt; text-align: justify; text-indent: 0">1.1
For purpose of this Agreement, unless the context requires otherwise, the capitalized terms used herein shall have the following
meanings:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.7in; padding-top: 0; padding-right: 0; padding-bottom: 0"></TD><TD STYLE="padding-top: 0; padding-right: 0; padding-bottom: 0; width: 30%"><B>&ldquo;Affiliate&rdquo;&#9;</B></TD><TD STYLE="text-align: justify; padding-right: 0; padding-top: 0; padding-bottom: 0">shall mean any legal entity (such as a
                                                                                                                                                                                                      corporation, partnership, or limited liability company) that is either controlled by, or shares the same beneficial
                                                                                                                                                                                                      ownership
                                                                                                                                                                                                      structure as any of the Licensors or the Licensee, or is the parent company that controls, directly or indirectly more than
                                                                                                                                                                                                      fifty percent (50%) of the voting securities of any of the Licensors or the Licensee. For the purposes of this definition,
                                                                                                                                                                                                      the term &ldquo;control&rdquo; means (i) beneficial ownership of more than fifty percent (50%) of the voting securities of a
                                                                                                                                                                                                      corporation or other business organization with voting securities or (ii) a more than fifty percent (50%) interest in the net
                                                                                                                                                                                                      assets or profits of a partnership or other business organization without voting securities. In addition, the &ldquo;same
                                                                                                                                                                                                      beneficial ownership structure&rdquo; refers to any group corporation in which more than fifty percent (50%) of its voting securities
are controlled by the same parent company.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 258.35pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 258.35pt"></P>

<!-- Field: Page; Sequence: 3; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 258.35pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 258.35pt"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.7in; padding: 0; text-indent: 0">&nbsp;</TD>
    <TD STYLE="padding: 0; font-weight: bold; width: 30%; text-indent: 0">&ldquo;Agreement&rdquo;</TD>
    <TD STYLE="padding: 0; font-weight: bold; text-indent: 0; text-align: justify"><FONT STYLE="font-weight: normal">shall mean this Exclusive License Agreement;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding: 0; text-indent: 0">&nbsp;</TD>
    <TD STYLE="padding: 0; text-indent: 0">&nbsp;</TD>
    <TD STYLE="padding: 0; text-indent: 0; text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding: 0; text-indent: 0">&nbsp;</TD>
    <TD STYLE="padding: 0; text-indent: 0"><B>&ldquo;Authority&rdquo;</B></TD>
    <TD STYLE="padding: 0; text-align: justify; text-indent: 0">shall mean any national, supra-national, regional or local government or governmental, administrative, fiscal, judicial or government owned body, department, commission, authority, tribunal, agency or entity, or regulator (or any Person, whether or not government owned and howsoever constituted or called, that exercises the functions of a regulator);</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding: 0; text-indent: 0">&nbsp;</TD>
    <TD STYLE="padding: 0; text-indent: 0">&nbsp;</TD>
    <TD STYLE="padding: 0; text-indent: 0; text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding: 0; text-indent: 0">&nbsp;</TD>
    <TD STYLE="padding: 0; text-indent: 0"><B>&ldquo;Business Day&rdquo;</B></TD>
    <TD STYLE="padding: 0; text-indent: 0; text-align: justify">shall mean any day (excluding Saturdays, Sundays, public holidays in Hong Kong, and public holidays established under Federal law in the United States) on which banks in Hong Kong and the United States are generally open for business;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding: 0; text-indent: 0">&nbsp;</TD>
    <TD STYLE="padding: 0; text-indent: 0">&nbsp;</TD>
    <TD STYLE="padding: 0; text-indent: 0; text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding: 0; text-indent: 0">&nbsp;</TD>
    <TD STYLE="padding: 0; text-indent: 0"><B>&ldquo;Claim&rdquo;</B></TD>
    <TD STYLE="padding: 0; text-indent: 0; text-align: justify">shall mean any claim of an issued patent of <B>Schedule A </B>and <B>Schedule B </B>which has not expired; or any claim of a pending patent application of <B>Schedule A </B>and <B>Schedule B </B>which was filed in good faith and is pending;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding: 0; text-indent: 0">&nbsp;</TD>
    <TD STYLE="padding: 0; text-indent: 0">&nbsp;</TD>
    <TD STYLE="padding: 0; text-indent: 0; text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding: 0; text-indent: 0">&nbsp;</TD>
    <TD STYLE="padding: 0; text-indent: 0"><B>&ldquo;CFDA&rdquo;</B></TD>
    <TD STYLE="padding: 0; text-indent: 0; text-align: justify">
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0pt; text-align: justify; text-indent: 0">shall have the meaning
given to it in Clause 4.2 herein;</P></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding: 0; text-indent: 0">&nbsp;</TD>
    <TD STYLE="padding: 0; text-indent: 0">&nbsp;</TD>
    <TD STYLE="padding: 0; text-indent: 0; text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding: 0; text-indent: 0">&nbsp;</TD>
    <TD STYLE="padding: 0; text-indent: 0"><B>&ldquo;Dispute&rdquo;</B></TD>
    <TD STYLE="padding: 0; text-indent: 0; text-align: justify">
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0pt; text-align: justify; text-indent: 0">shall have the meaning
given to it in Clause 15.13 herein;</P></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding: 0; text-indent: 0">&nbsp;</TD>
    <TD STYLE="padding: 0; text-indent: 0">&nbsp;</TD>
    <TD STYLE="padding: 0; text-indent: 0; text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding: 0; text-indent: 0">&nbsp;</TD>
    <TD STYLE="padding: 0; text-indent: 0"><B>&ldquo;Effective Date&rdquo;</B></TD>
    <TD STYLE="padding: 0; text-indent: 0; text-align: justify">shall mean the date on which this Agreement is signed by all parties;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding: 0; text-indent: 0">&nbsp;</TD>
    <TD STYLE="padding: 0; text-indent: 0">&nbsp;</TD>
    <TD STYLE="padding: 0; text-indent: 0; text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding: 0; text-indent: 0">&nbsp;</TD>
    <TD STYLE="padding: 0; text-indent: 0"><B>&ldquo;EU EMA&rdquo;</B></TD>
    <TD STYLE="padding: 0; text-indent: 0; text-align: justify">
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0pt; text-align: justify; text-indent: 0">shall have the
meaning given to it in Clause 4.2 herein;</P></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding: 0; text-indent: 0">&nbsp;</TD>
    <TD STYLE="padding: 0; text-indent: 0">&nbsp;</TD>
    <TD STYLE="padding: 0; text-indent: 0; text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding: 0; text-indent: 0">&nbsp;</TD>
    <TD STYLE="padding: 0; text-indent: 0"><B>&ldquo;Executive Officers&rdquo;</B></TD>
    <TD STYLE="padding: 0; text-indent: 0; text-align: justify">
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0pt; text-align: justify; text-indent: 0">shall have the
meaning given to it in Clause 15.13 herein;</P></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 258pt; text-indent: -0.35pt"></P>


<!-- Field: Page; Sequence: 4; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 96.95pt">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 96.95pt"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">
<TR STYLE="vertical-align: top">
    <TD STYLE="padding: 0; font-weight: bold; width: 0.7in; text-indent: 0">&nbsp;</TD>
    <TD STYLE="padding: 0; font-weight: bold; width: 30%; text-indent: 0">&ldquo;Field&rdquo;</TD>
    <TD STYLE="padding: 0; font-weight: bold; text-indent: 0; text-align: justify"><FONT STYLE="font-weight: normal">shall mean all fields and applications including but not limited to therapeutics, diagnostics, research tools, and business methods and all activities related to the foregoing;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding: 0; text-indent: 0">&nbsp;</TD>
    <TD STYLE="padding: 0; text-indent: 0">&nbsp;</TD>
    <TD STYLE="padding: 0; text-indent: 0; text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding: 0; text-indent: 0">&nbsp;</TD>
    <TD STYLE="padding: 0; text-indent: 0"><B>&ldquo;Hong Kong&rdquo;</B></TD>
    <TD STYLE="padding: 0; text-indent: 0; text-align: justify">shall&#9;mean&#9;the&#9;Hong&#9;Kong&#9;Special Administrative Region of the PRC;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding: 0; text-indent: 0">&nbsp;</TD>
    <TD STYLE="padding: 0; text-indent: 0">&nbsp;</TD>
    <TD STYLE="padding: 0; text-indent: 0; text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding: 0; text-indent: 0">&nbsp;</TD>
    <TD STYLE="padding: 0; text-indent: 0"><B>&ldquo;Hong Kong Dollars&rdquo; or &ldquo;HK$&rdquo;</B></TD>
    <TD STYLE="padding: 0; text-indent: 0; text-align: justify">shall mean the lawful currency of Hong Kong;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding: 0; text-indent: 0">&nbsp;</TD>
    <TD STYLE="padding: 0; text-indent: 0">&nbsp;</TD>
    <TD STYLE="padding: 0; text-indent: 0; text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding: 0; text-indent: 0">&nbsp;</TD>
    <TD STYLE="padding: 0; text-indent: 0"><B>&ldquo;IND&rdquo;</B></TD>
    <TD STYLE="padding: 0; text-indent: 0; text-align: justify">
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0pt; text-align: justify; text-indent: 0">shall have the
meaning given to it in Clause 4.2 herein;</P></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding: 0; text-indent: 0">&nbsp;</TD>
    <TD STYLE="padding: 0; text-indent: 0">&nbsp;</TD>
    <TD STYLE="padding: 0; text-indent: 0; text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding: 0; text-indent: 0">&nbsp;</TD>
    <TD STYLE="padding: 0; text-indent: 0"><B>&ldquo;ITF&rdquo;</B></TD>
    <TD STYLE="padding: 0; text-indent: 0; text-align: justify">shall have the meaning given to it in Clause 6.1(b) herein;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding: 0; text-indent: 0">&nbsp;</TD>
    <TD STYLE="padding: 0; text-indent: 0">&nbsp;</TD>
    <TD STYLE="padding: 0; text-indent: 0; text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding: 0; text-indent: 0">&nbsp;</TD>
    <TD STYLE="padding: 0; text-indent: 0"><B>&ldquo;Licensee Inventions&rdquo;</B></TD>
    <TD STYLE="padding: 0; text-indent: 0; text-align: justify">
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0pt; text-align: justify; text-indent: 0">shall have the
meaning given to it in Clause 8.1 herein;</P></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding: 0; text-indent: 0">&nbsp;</TD>
    <TD STYLE="padding: 0; text-indent: 0">&nbsp;</TD>
    <TD STYLE="padding: 0; text-indent: 0; text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding: 0; text-indent: 0">&nbsp;</TD>
    <TD STYLE="padding: 0; text-indent: 0"><B>&ldquo;Licensors' lndemnitees&rdquo;</B></TD>
    <TD STYLE="padding: 0; text-indent: 0; text-align: justify">
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0pt; text-align: justify; text-indent: 0">shall have the
meaning given to it in Clause 11.1 herein;</P></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding: 0; text-indent: 0">&nbsp;</TD>
    <TD STYLE="padding: 0; text-indent: 0">&nbsp;</TD>
    <TD STYLE="padding: 0; text-indent: 0; text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding: 0; text-indent: 0">&nbsp;</TD>
    <TD STYLE="padding: 0; text-indent: 0"><B>&ldquo;NDA&rdquo;</B></TD>
    <TD STYLE="padding: 0; text-indent: 0; text-align: justify">shall have the meaning given to it in Clause 4.3(a)(iv) herein;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding: 0; text-indent: 0">&nbsp;</TD>
    <TD STYLE="padding: 0; text-indent: 0">&nbsp;</TD>
    <TD STYLE="padding: 0; text-indent: 0; text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding: 0; text-indent: 0">&nbsp;</TD>
    <TD STYLE="padding: 0; text-indent: 0"><B>&ldquo;Net Sales&rdquo;</B></TD>
    <TD STYLE="padding: 0; text-indent: 0; text-align: justify">shall mean sales amount of Products invoiced to third parties, less normal trade discounts actually granted, insurance, freight, or any relevant tax, duties or similar government levies. If (i) the Products are&nbsp;&nbsp;sold&nbsp;&nbsp;to Licensee&rsquo;s or sublicensee&rsquo;s related companies with a selling price lower than that to Licensee&rsquo;s or sublicensee&rsquo;s unrelated companies, or (ii) the Products are sold to Licensee&rsquo;s or sublicensee&rsquo;s unrelated companies which are then subsequently sold by those Licensee&rsquo;s or sublicensee&rsquo;s unrelated companies to a Licensee or sublicensee related company at a higher selling price, in both cases (i) and (ii) the higher selling price should be used; if any Product is to be consumed in the course of a service provided <FONT STYLE="font-size: 10pt">by Licensee or sublicensee then the parties shall negotiate the appropriate Net Sales amount, in principle the Net Sales amount for such Products shall be the price such Product is sold to unrelated companies. If no Product has been sold to any unrelated companies, all parties shall negotiate a fair price for the Net Sales;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 5; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 8.6pt 0pt 258.1pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 8.6pt 0pt 258.1pt; text-align: justify"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">
<TR STYLE="vertical-align: top">
    <TD STYLE="padding: 0; font-weight: bold; width: 0.7in; text-indent: 0">&nbsp;</TD>
    <TD STYLE="padding: 0; font-weight: bold; width: 30%; text-indent: 0">&ldquo;Owner&rdquo;</TD>
    <TD STYLE="padding: 0; text-indent: 0; text-align: justify">shall have the meaning given to it in Clause
    12.1 herein;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding: 0; text-indent: 0">&nbsp;</TD>
    <TD STYLE="padding: 0; text-indent: 0">&nbsp;</TD>
    <TD STYLE="padding: 0; text-indent: 0; text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding: 0; text-indent: 0">&nbsp;</TD>
    <TD STYLE="padding: 0; text-indent: 0"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0"><B>&ldquo;Patent Rights&rdquo;</B></P>



</TD>
    <TD STYLE="padding: 0; text-indent: 0; text-align: justify"><P STYLE="margin: 0; text-indent: 0">shall mean any and all issued patents and pending patent applications (together with all divisions, continuations,
continuations-in part, re-examinations, reissues, renewals or supplemental protection certificates thereof) in the Territory that
are owned by Licensors and that disclose the Products, the manufacture of the Products, the use of the Products in the Field, and/or
the use of the Technology in connection with any of the foregoing. For clarity, the Patent Rights shall include, without limitation
, all the granted patents and pending patent applications listed in <B>Schedule A </B>and <B>Schedule B, </B>together with all
foreign counterparts of any of the foregoing;</P>


</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding: 0; text-indent: 0">&nbsp;</TD>
    <TD STYLE="padding: 0; text-indent: 0">&nbsp;</TD>
    <TD STYLE="padding: 0; text-indent: 0; text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding: 0; text-indent: 0">&nbsp;</TD>
    <TD STYLE="padding: 0; text-indent: 0"><B>&ldquo;Person&rdquo;</B></TD>
    <TD STYLE="padding: 0; text-indent: 0; text-align: justify">shall mean any natural person, corporation, company, partnership, firm, voluntary <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">association,
joint venture, trust, unincorporated organization, Authority or any other entity whether acting in an individual, fiduciary or
other capacity;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding: 0; text-indent: 0">&nbsp;</TD>
    <TD STYLE="padding: 0; text-indent: 0">&nbsp;</TD>
    <TD STYLE="padding: 0; text-indent: 0; text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding: 0; text-indent: 0">&nbsp;</TD>
    <TD STYLE="padding: 0; text-indent: 0"><B>&ldquo;PRC&rdquo;</B></TD>
    <TD STYLE="padding: 0; text-indent: 0; text-align: justify">shall mean the People's Republic of China which for the purpose of this Agreement does not include Hong
Kong , the Macau Special Administrative Region of the PRC and Taiwan;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding: 0; text-indent: 0">&nbsp;</TD>
    <TD STYLE="padding: 0; text-indent: 0">&nbsp;</TD>
    <TD STYLE="padding: 0; text-indent: 0; text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding: 0; text-indent: 0">&nbsp;</TD>
    <TD STYLE="padding: 0; text-indent: 0"><P STYLE="margin: 0; text-indent: 0"><B>&ldquo;Products&rdquo;</B></P>


</TD>
    <TD STYLE="padding: 0; text-indent: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">shall
mean any drug product and non-drug product, including but not limited to dietary supplement and special food, (i) that is derived
from, made with, uses or incorporates, in whole or in part, any epigallocatechin gallate derivative that is covered by a Claim or that incorporates and/or utilizes the Technology; or
(ii) whose manufacture, use, sale, lease or import is covered, in whole or in part, by a Claim or that incorporates and/or utilizes
the Technology;</FONT></TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 8.6pt 0pt 258.1pt; text-align: justify">&nbsp;</P>


<!-- Field: Page; Sequence: 6; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">
<TR STYLE="vertical-align: top">
    <TD STYLE="padding: 0; font-weight: bold; width: 0.7in; text-indent: 0">&nbsp;</TD>
    <TD STYLE="padding: 0; font-weight: bold; width: 30%; text-indent: 0"><B>&ldquo;Proprietary Information&rdquo;</B></TD>
    <TD STYLE="padding: 0; text-indent: 0; text-align: justify">shall have the meaning given to it in Clause <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">12.1
herein;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding: 0; text-indent: 0">&nbsp;</TD>
    <TD STYLE="padding: 0; text-indent: 0"><B>&nbsp;</B></TD>
    <TD STYLE="padding: 0; text-indent: 0; text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding: 0; text-indent: 0">&nbsp;</TD>
    <TD STYLE="padding: 0; text-indent: 0"><B>&ldquo;Recipient&rdquo;</B></TD>
    <TD STYLE="padding: 0; text-indent: 0; text-align: justify">shall have the meaning given to it in Clause 12.1 herein;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding: 0; text-indent: 0">&nbsp;</TD>
    <TD STYLE="padding: 0; text-indent: 0"><B>&nbsp;</B></TD>
    <TD STYLE="padding: 0; text-indent: 0; text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding: 0; text-indent: 0">&nbsp;</TD>
    <TD STYLE="padding: 0; text-indent: 0"><B>&ldquo;Technology&rdquo;</B></TD>
    <TD STYLE="padding: 0; text-indent: 0; text-align: justify">shall mean Technology One and Technology Two;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding: 0; text-indent: 0">&nbsp;</TD>
    <TD STYLE="padding: 0; text-indent: 0"><B>&nbsp;</B></TD>
    <TD STYLE="padding: 0; text-indent: 0; text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding: 0; text-indent: 0">&nbsp;</TD>
    <TD STYLE="padding: 0; text-indent: 0"><B>&ldquo;Technology One&rdquo;</B></TD>
    <TD STYLE="padding: 0; text-indent: 0; text-align: justify">shall mean any and all proprietary data, information, know-how, processes, methods, materials and specifications
stated in the patent applications as listed in <B>Schedule A </B>owned or controlled by Licensors and in existence as of the Effective
Date that are necessary for the development, manufacture, use or commercialization of Products in the Field;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding: 0; text-indent: 0">&nbsp;</TD>
    <TD STYLE="padding: 0; text-indent: 0"><B>&nbsp;</B></TD>
    <TD STYLE="padding: 0; text-indent: 0; text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding: 0; text-indent: 0">&nbsp;</TD>
    <TD STYLE="padding: 0; text-indent: 0"><B>&ldquo;Technology Two&rdquo;</B></TD>
    <TD STYLE="padding: 0; text-indent: 0; text-align: justify">shall mean any and all proprietary data, information, know-how, processes, methods, materials and specifications
stated in the patent applications as listed in <B>Schedule B </B>owned by Licensors and in existence as of the Effective Date that
are necessary for the development , manufacture, use or commercialization of Products in the Field;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding: 0; text-indent: 0">&nbsp;</TD>
    <TD STYLE="padding: 0; text-indent: 0"><B>&nbsp;</B></TD>
    <TD STYLE="padding: 0; text-indent: 0; text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding: 0; text-indent: 0">&nbsp;</TD>
    <TD STYLE="padding: 0; text-indent: 0"><B>&ldquo;Territory&rdquo;</B></TD>
    <TD STYLE="padding: 0; text-indent: 0; text-align: justify">shall mean worldwide;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding: 0; text-indent: 0">&nbsp;</TD>
    <TD STYLE="padding: 0; text-indent: 0"><B>&nbsp;</B></TD>
    <TD STYLE="padding: 0; text-indent: 0; text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding: 0; text-indent: 0">&nbsp;</TD>
    <TD STYLE="padding: 0; text-indent: 0"><B>&ldquo;US Dollars&quot; or &quot;US$&rdquo;</B></TD>
    <TD STYLE="padding: 0; text-indent: 0; text-align: justify">shall mean the lawful currency of The United States of America;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding: 0; text-indent: 0">&nbsp;</TD>
    <TD STYLE="padding: 0; text-indent: 0"><B>&nbsp;</B></TD>
    <TD STYLE="padding: 0; text-indent: 0; text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding: 0; text-indent: 0">&nbsp;</TD>
    <TD STYLE="padding: 0; text-indent: 0"><B>&ldquo;US FDA&rdquo;</B></TD>
    <TD STYLE="padding: 0; text-indent: 0; text-align: justify">shall
have the meaning given to it in Clause 4.2 herein.</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 7; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>




<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in; padding-top: 0; padding-right: 0; padding-bottom: 0">1.2</TD><TD STYLE="text-align: justify; padding-right: 0; padding-top: 0; padding-bottom: 0">Any references, express or implied, to statutes or statutory provisions
shall be construed as references to those statutes or provisions as respectively amended or re-enacted or as their application
is modified from time to time by other provisions (whether before or after the date hereof) and shall include any statutes or provisions
of which they are re-enactments (whether with or without modification) and any orders, regulations, instruments or other subordinate
legislation under the relevant statute or statutory provision. References to sections of consolidating legislation shall, wherever
necessary or appropriate in the context, be construed as including references to the sections of the previous legislation from
which the consolidating legislation has been prepared.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in; padding-top: 0; padding-right: 0; padding-bottom: 0">1.3</TD><TD STYLE="text-align: justify; padding-right: 0; padding-top: 0; padding-bottom: 0">This Agreement shall be construed according to its fair language. The rule
of construction to the effect that ambiguities are to be resolved against the drafting party shall not be employed in interpreting
this Agreement. The titles of the clauses and subclauses of this Agreement are for convenience of reference only and are not to
be considered in construing this Agreement. Unless otherwise expressly provided herein, all references to Clauses and Schedules
herein are to Clauses and Schedules of this Agreement.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in; padding-top: 0; padding-right: 0; padding-bottom: 0">1.4</TD><TD STYLE="text-align: justify; padding-right: 0; padding-top: 0; padding-bottom: 0">Headings are inserted for convenience only and shall not affect the construction
of this Agreement.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in; padding-top: 0; padding-right: 0; padding-bottom: 0">1.5</TD><TD STYLE="text-align: left; padding-top: 0; padding-right: 0; padding-bottom: 0">The singular number shall include the plural and vice versa.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in; padding-top: 0; padding-right: 0; padding-bottom: 0"><B>2</B></TD><TD STYLE="padding-top: 0; padding-right: 0; padding-bottom: 0"><B>LICENSE
                                         GRANTS</B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in; padding-top: 0; padding-right: 0; padding-bottom: 0">2.1</TD><TD STYLE="text-align: justify; padding-right: 0; padding-top: 0; padding-bottom: 0">Subject to the terms and conditions of this Agreement, Licensors hereby
grant to Licensee and Licensee hereby accepts an exclusive, royalty-bearing license to use the Technology and the Patent Rights
in the Territory to develop, make, use, sell and commercialize Products in the Field. Licensee has the limited right to grant sublicenses
to the licenses granted under this Clause 2.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in; padding-top: 0; padding-right: 0; padding-bottom: 0">2.2</TD><TD STYLE="text-align: justify; padding-right: 0; padding-top: 0; padding-bottom: 0">Licensee does have the right, subject to
                                                                                      prior written approval by Licensors, to grant sublicenses of the rights granted under Clauses 2.1 in the Territory. Any
                                                                                      sublicense of rights under Clauses 2.1 that is granted by Licensee shall be limited to rights licensed to the Licensee and
                                                                                      shall be consistent with Licensee's obligations to Licensors under this Agreement. Licensee shall notify Licensors in writing
                                                                                      of any proposed sublicense, which notice shall identify the proposed sublicensee and shall clearly define the scope of rights
                                                                                      proposed to be granted. Licensors shall, within thirty (30) days after receipt of such notice, inform Licensee in writing as
                                                                                      to whether Licensors accept or reject the proposed sublicense at the Licensors ' sole discretion. Such approval shall not to
                                                                                      be unreasonably withheld. <FONT STYLE="font-size: 10pt">If </FONT>Licensors approve the sublicense, Licensee shall be
                                                                                      responsible for ensuring the full compliance of its sublicensee with the terms and conditions of this Agreement. Licensee
                                                                                      shall ensure that it is a term of the sublicense agreement that any change in control of the sublicensee must be approved in
                                                                                      writing by Licensors. Each sublicense agreement shall state that: (i) the sublicensed party shall use its best efforts to
                                                                                      develop and commercialize the Products in the field in the territory that are the subject of the sublicense;
(ii) the sublicense agreement shall terminate immediately upon termination of this Agreement; (iii) an acknowledgement that the
Technology and Patent Rights are and shall remain in the respective names of the Licensors; and (iv) a documentation retention
requirement as provided in Clause 6.3 and an audit right by Licensors of the same scope as provided in Clause 6.4 herein. To the
extent any terms, conditions or limitations of any sublicense agreement are inconsistent with this Agreement, those terms, conditions
and limitations are null and void against Licensors.</TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>


<!-- Field: Page; Sequence: 8; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 11.85pt 0pt 85.5pt; text-align: justify; text-indent: 0.65pt"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0%; padding-top: 0; padding-right: 0; padding-bottom: 0"></TD><TD STYLE="width: 0.5in; padding-top: 0; padding-right: 0; padding-bottom: 0">2.3</TD><TD STYLE="text-align: justify; padding-right: 0; padding-top: 0; padding-bottom: 0">For clarity, Licensee shall have no licenses or other rights under the Patent
Rights and/or to use the Technology for any purpose in the Territory outside of the Field or outside of the Territory. Nothing
in this Agreement shall be construed (expressly, by estoppel, by implication, or otherwise) as granting or conveying to Licensee,
or as otherwise creating, any licenses or other rights or interests in or to any patents or other intellectual property owned or
controlled by Licensors other than the specific licenses to the Patent Rights and Technology that are expressly granted under this
Agreement.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0%; padding-top: 0; padding-right: 0; padding-bottom: 0"></TD><TD STYLE="width: 0.5in; padding-top: 0; padding-right: 0; padding-bottom: 0">2.4</TD><TD STYLE="text-align: justify; padding-right: 0; padding-top: 0; padding-bottom: 0">Except as expressly provided herein, nothing in this Agreement will be
construed as conferring any ownership interest, license or other rights upon the Licensee by estoppel, implication or otherwise
as to any technology, intellectual property rights products or materials of the Licensors, or of any other entity, regardless of
whether those technology, intellectual property rights products or materials are relevant to the Technology and Patent Rights.
Title to the Patent Rights and Technology shall at all times remain vested in the respective Licensors.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0%; padding-top: 0; padding-right: 0; padding-bottom: 0"></TD><TD STYLE="width: 0.5in; padding-top: 0; padding-right: 0; padding-bottom: 0">2.5</TD><TD STYLE="text-align: justify; padding-right: 0; padding-top: 0; padding-bottom: 0">Notwithstanding Clause 15.3, Licensors and Licensee agree that Licensee
retains the right to assign its rights in whole pertaining to its exclusive license of the Technology and Patent Rights granted
under this Agreement, to any Affiliate of Licensee at any time subsequent to the Effective Date. Licensee shall serve Licensors
a sixty (60) days prior written notice for such transfer. In the event Licensee desires to assign its rights hereunder to its Affiliate(s),
Licensee shall cause such Affiliate(s) to enter into this Agreement, or a joinder agreement in a form satisfactory to Licensors,
agreeing to be bound by all of the conditions of this Agreement as if such Affiliate(s) were an original party to this Agreement.
To the extent that any Affiliate wishes to exercise any rights granted to Licensee hereunder, Licensee will be liable to Licensors
for the duties and obligations of any Affiliate hereunder and any act or omission of an Affiliate that would be deemed to be a
breach of this Agreement.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0%; padding-top: 0; padding-right: 0; padding-bottom: 0"></TD><TD STYLE="width: 0.5in; padding-top: 0; padding-right: 0; padding-bottom: 0">2.6</TD><TD STYLE="text-align: justify; padding-right: 0; padding-top: 0; padding-bottom: 0">Should the Licensee and/or its
                                                                                                                                                                      Affiliates at any point subsequent to the Effective Date seek to issue common or preferred stock to the public or private
                                                                                                                                                                      investors with the intent of engaging in capital raising activities to further the Licensee's reasonable efforts in
                                                                                                                                                                      commercializing any and all Products, and subject to the Licensee and /or its Affiliate selling, cumulatively and in
                                                                                                                                                                      aggregate , less than fifty percent (50%) of its equity and voting interests to the public or private investors, the
                                                                                                                                                                      Licensors agree that such activities do not constitute the transfer of any rights of the Licensee under
this Agreement to third-party interests whatsoever and shall not be considered in breach of this Agreement.</TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>


<!-- Field: Page; Sequence: 9; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 8.25pt 0pt 86.25pt; text-indent: -0.35pt"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0%; padding-top: 0; padding-right: 0; padding-bottom: 0"></TD><TD STYLE="width: 0.5in; padding-top: 0; padding-right: 0; padding-bottom: 0">2.7</TD><TD STYLE="text-align: justify; padding-right: 0; padding-top: 0; padding-bottom: 0">The Licensors agree that the Licensee and/or its Affiliates may enter into
license agreements with respect to other technologies which are related to Technology and owned by the any one or more of the Licensors
or any other party, with such undertakings acted upon good faith and intent to develop and commercialize such products either independently
or jointly with the Products stipulated in the Agreement.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0%; padding-top: 0; padding-right: 0; padding-bottom: 0"></TD><TD STYLE="width: 0.5in; padding-top: 0; padding-right: 0; padding-bottom: 0">2.8</TD><TD STYLE="text-align: justify; padding-right: 0; padding-top: 0; padding-bottom: 0">Licensee shall mark all Products and their containers in accordance with
the patent marking laws of the jurisdiction in which such Products are manufactured, used or sold. At a minimum, all Products shall
bear a notice indicating that the product is the subject of a patent or pending application and identifying same. Licensee shall
notify Licensors in writing of any changes to patent markings on Products.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0%; padding-top: 0; padding-right: 0; padding-bottom: 0"></TD><TD STYLE="width: 0.5in; padding-top: 0; padding-right: 0; padding-bottom: 0">2.9</TD><TD STYLE="text-align: justify; padding-right: 0; padding-top: 0; padding-bottom: 0">Licensee shall comply with and shall ensure that its sublicensees comply
in all material respects with all government statutes and regulations that relate to Products, including but not limited to the
United States Federal Patent Policy (the provisions of 35 United States Code&sect;&sect; 201-211 and the regulations promulgated
thereunder); the United States Food, Drug and Cosmetic Act of 1941 , as amended, and the regulations promulgated thereunder; and
the United States Export Administration Act of 1979, as amended , and the regulations promulgated thereunder.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0%; padding-top: 0; padding-right: 0; padding-bottom: 0"></TD><TD STYLE="width: 0.5in; padding-top: 0; padding-right: 0; padding-bottom: 0"><B>3</B></TD><TD STYLE="padding-top: 0; padding-right: 0; padding-bottom: 0"><B>TERM
                                         OF AGREEMENT</B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0%; padding-top: 0; padding-right: 0; padding-bottom: 0"></TD><TD STYLE="width: 0.5in; padding-top: 0; padding-right: 0; padding-bottom: 0">3.1</TD><TD STYLE="text-align: justify; padding-right: 0; padding-top: 0; padding-bottom: 0">This Agreement and all rights hereunder shall be in effect from the Effective
Date till the latest date of the following: (1) the expiry of the term of the last to expire patents as listed in Schedule A and
Schedule B; (2) final disposition of the last of the pending patent applications as listed in <B>Schedule A </B>and <B>Schedule
B, </B>and (3) ten (10) years following the first commercial sale of Products, unless this Agreement is earlier terminated pursuant
to the termination provisions of this Agreement.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0%; padding-top: 0; padding-right: 0; padding-bottom: 0"></TD><TD STYLE="width: 0.5in; padding-top: 0; padding-right: 0; padding-bottom: 0">3.2</TD><TD STYLE="text-align: justify; padding-right: 0; padding-top: 0; padding-bottom: 0">Unless it is exempted or extended by the Licensors at their exclusive discretion,
if Licensee does not meet any of the milestones as detailed in Schedule C, Licensors may at their discretion elect to terminate
this Agreement pursuant to Clause 14.1.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0%; padding-top: 0; padding-right: 0; padding-bottom: 0"></TD><TD STYLE="width: 0.5in; padding-top: 0; padding-right: 0; padding-bottom: 0"><B>4</B></TD><TD STYLE="padding-top: 0; padding-right: 0; padding-bottom: 0"><B>CONSIDERATION</B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in; padding-top: 0; padding-right: 0; padding-bottom: 0">4.1</TD><TD STYLE="text-align: justify; padding-right: 0; padding-top: 0; padding-bottom: 0"><U>Upfront License Fee</U>. In partial consideration for the licenses being
granted to Licensee under this Agreement, Licensee shall pay to Licensors a one-time up-front non-refundable license fee payment
of <FONT STYLE="background-color: black">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT> by two instalments
as follows:</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in; padding-top: 0; padding-right: 0; padding-bottom: 0"><FONT STYLE="background-color: black"></FONT></TD><TD STYLE="text-align: justify; padding-right: 0; padding-top: 0; padding-bottom: 0"><FONT STYLE="background-color: black">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>


<!-- Field: Page; Sequence: 10; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in; padding-top: 0; padding-right: 0; padding-bottom: 0"><FONT STYLE="background-color: black"></FONT></TD><TD STYLE="text-align: justify; padding-right: 0; padding-top: 0; padding-bottom: 0"><FONT STYLE="background-color: black">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD></TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0%; padding-top: 0; padding-right: 0; padding-bottom: 0"></TD><TD STYLE="width: 0.5in; padding-top: 0; padding-right: 0; padding-bottom: 0">4.2</TD><TD STYLE="text-align: justify; padding-right: 0; padding-top: 0; padding-bottom: 0"><U>Annual License Fee</U>. In further consideration of the licenses being
granted to Licensee under this Agreement, Licensee shall pay to Licensors <FONT STYLE="background-color: black">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT> within thirty (30) days of each anniversary of the date upon which an application
for an Investigational New Drug (&ldquo;IND&rdquo;) to the United States Food and Drug Administration (&ldquo;US FDA&rdquo;), European
Union European Medicines Agency (&ldquo;EU EMA&rdquo;) or the Chinese Food and Drug Administration (&ldquo;CFDA&rdquo;) is accepted
by such agency, whichever agency is first. <FONT STYLE="font-size: 10pt">If </FONT>within three (3) years after the Effective Date
and no agency as named above has accepted an IND application or no IND application has been filed, the annual minimum license fee
of <FONT STYLE="background-color: black">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT> will come into effect. In this case, the first annual minimum license
fee shall be made at the end of the fourth (4<FONT STYLE="font-size: 10pt">th) </FONT>year from the Effective Date.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0%; padding-top: 0; padding-right: 0; padding-bottom: 0"></TD><TD STYLE="width: 0.5in; padding-top: 0; padding-right: 0; padding-bottom: 0">4.3</TD><TD STYLE="text-align: justify; padding-right: 0; padding-top: 0; padding-bottom: 0"><U>Milestone Payments</U>. In further consideration of the licenses being
granted to Licensee under this Agreement, Licensee shall pay to the Licensors non-refundable, non-creditable, one-time milestone
payments upon achievement of each of the following events strictly related to the drug research development, and commercialization
activities of Licensee, its Affiliate, or its sublicensee. For avoidance of doubt, the terms of this Clause only apply to research,
development, and commercialization of drug products that will undergo accredited clinical trials with US FDA, EU EMA, or CFDA,
and do not apply to non-drug products, including but not limited to dietary supplement and special food, except for Clause 4.3(e)(i).
Such milestone payments shall be determined as follows:</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in; padding: 0; text-indent: 0">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD STYLE="width: 0.5in; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: black">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD><TD STYLE="text-align: left; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: black">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><BR>
                                         <FONT STYLE="background-color: black">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in; padding-top: 0; padding-right: 0; padding-bottom: 0">&nbsp;&nbsp;&nbsp;&nbsp;</TD><TD STYLE="width: 0.5in; padding-top: 0; padding-right: 0; padding-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: black">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD><TD STYLE="text-align: justify; padding-right: 0; padding-top: 0; padding-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: black">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><BR>
                                         <FONT STYLE="background-color: black">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in; padding-top: 0; padding-right: 0; padding-bottom: 0">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD><TD STYLE="width: 0.5in; padding-top: 0; padding-right: 0; padding-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: black">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD><TD STYLE="text-align: justify; padding-right: 0; padding-top: 0; padding-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: black">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><BR>
                                         <FONT STYLE="background-color: black">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></FONT></TD></TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in; padding-top: 0; padding-right: 0; padding-bottom: 0">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD><TD STYLE="width: 0.5in; padding-top: 0; padding-right: 0; padding-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: black">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD><TD STYLE="text-align: justify; padding-right: 0; padding-top: 0; padding-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: black">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><BR>
                                         <FONT STYLE="background-color: black">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></FONT></TD></TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in; padding-top: 0; padding-right: 0; padding-bottom: 0">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD><TD STYLE="width: 0.5in; padding-top: 0; padding-right: 0; padding-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: black">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD><TD STYLE="text-align: justify; padding-right: 0; padding-top: 0; padding-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: black">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><BR>
                                         <FONT STYLE="background-color: black">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></FONT></TD></TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in; padding-top: 0; padding-right: 0; padding-bottom: 0">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD><TD STYLE="width: 0.5in; padding-top: 0; padding-right: 0; padding-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: black">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD><TD STYLE="text-align: justify; padding-right: 0; padding-top: 0; padding-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: black">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><BR>
                                         <FONT STYLE="background-color: black">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></FONT></TD></TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 11; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in; padding-top: 0; padding-right: 0; padding-bottom: 0"></TD><TD STYLE="width: 0.5in; padding-top: 0; padding-right: 0; padding-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: black">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD><TD STYLE="text-align: justify; padding-right: 0; padding-top: 0; padding-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: black">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><BR>
                                         <FONT STYLE="background-color: black">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></FONT></TD></TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in; padding-top: 0; padding-right: 0; padding-bottom: 0"></TD><TD STYLE="width: 0.5in; padding-top: 0; padding-right: 0; padding-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: black">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD><TD STYLE="text-align: justify; padding-right: 0; padding-top: 0; padding-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: black">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><BR>
                                         <FONT STYLE="background-color: black">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></FONT></TD></TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in; padding-top: 0; padding-right: 0; padding-bottom: 0"></TD><TD STYLE="width: 0.5in; padding-top: 0; padding-right: 0; padding-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: black">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD><TD STYLE="text-align: justify; padding-right: 0; padding-top: 0; padding-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: black">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><BR>
                                         <FONT STYLE="background-color: black">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></FONT></TD></TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in; padding-top: 0; padding-right: 0; padding-bottom: 0"></TD><TD STYLE="width: 0.5in; padding-top: 0; padding-right: 0; padding-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: black">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD><TD STYLE="text-align: justify; padding-right: 0; padding-top: 0; padding-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: black">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><BR>
                                         <FONT STYLE="background-color: black">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></FONT></TD></TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in; padding-top: 0; padding-right: 0; padding-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: black">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD><TD STYLE="text-align: left; padding-right: 0; padding-top: 0; padding-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: black">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><BR>
                                         <FONT STYLE="background-color: black">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in; padding-top: 0; padding-right: 0; padding-bottom: 0"></TD><TD STYLE="width: 0.5in; padding-top: 0; padding-right: 0; padding-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: black">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD><TD STYLE="text-align: justify; padding-right: 0; padding-top: 0; padding-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: black">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><BR>
                                         <FONT STYLE="background-color: black">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in; padding-top: 0; padding-right: 0; padding-bottom: 0"></TD><TD STYLE="width: 0.5in; padding-top: 0; padding-right: 0; padding-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: black">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD><TD STYLE="text-align: justify; padding-right: 0; padding-top: 0; padding-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: black">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><BR>
                                         <FONT STYLE="background-color: black">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></FONT></TD></TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in; padding-top: 0; padding-right: 0; padding-bottom: 0"></TD><TD STYLE="width: 0.5in; padding-top: 0; padding-right: 0; padding-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: black">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD><TD STYLE="text-align: justify; padding-right: 0; padding-top: 0; padding-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: black">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><BR>
                                         <FONT STYLE="background-color: black">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></FONT></TD></TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in; padding-top: 0; padding-right: 0; padding-bottom: 0"></TD><TD STYLE="width: 0.5in; padding-top: 0; padding-right: 0; padding-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: black">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD><TD STYLE="text-align: justify; padding-right: 0; padding-top: 0; padding-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: black">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><BR>
                                         <FONT STYLE="background-color: black">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></FONT></TD></TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in; padding-top: 0; padding-right: 0; padding-bottom: 0"></TD><TD STYLE="width: 0.5in; padding-top: 0; padding-right: 0; padding-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: black">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD><TD STYLE="text-align: justify; padding-right: 0; padding-top: 0; padding-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: black">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><BR>
                                         <FONT STYLE="background-color: black">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></FONT></TD></TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in; padding-top: 0; padding-right: 0; padding-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: black">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD><TD STYLE="text-align: left; padding-right: 0; padding-top: 0; padding-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: black">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><BR>
                                         <FONT STYLE="background-color: black">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in; padding-top: 0; padding-right: 0; padding-bottom: 0"></TD><TD STYLE="width: 0.5in; padding-top: 0; padding-right: 0; padding-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: black">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD><TD STYLE="text-align: justify; padding-right: 0; padding-top: 0; padding-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: black">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><BR>
                                         <FONT STYLE="background-color: black">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 12; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in; padding-top: 0; padding-right: 0; padding-bottom: 0"></TD><TD STYLE="width: 0.5in; padding-top: 0; padding-right: 0; padding-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: black">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD><TD STYLE="text-align: justify; padding-right: 0; padding-top: 0; padding-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: black">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><BR>
                                         <FONT STYLE="background-color: black">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></FONT></TD></TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in; padding-top: 0; padding-right: 0; padding-bottom: 0"></TD><TD STYLE="width: 0.5in; padding-top: 0; padding-right: 0; padding-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: black">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD><TD STYLE="text-align: justify; padding-right: 0; padding-top: 0; padding-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: black">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><BR>
                                         <FONT STYLE="background-color: black">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></FONT></TD></TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in; padding-top: 0; padding-right: 0; padding-bottom: 0"></TD><TD STYLE="width: 0.5in; padding-top: 0; padding-right: 0; padding-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: black">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD><TD STYLE="text-align: justify; padding-right: 0; padding-top: 0; padding-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: black">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><BR>
                                         <FONT STYLE="background-color: black">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></FONT></TD></TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in; padding-top: 0; padding-right: 0; padding-bottom: 0"></TD><TD STYLE="width: 0.5in; padding-top: 0; padding-right: 0; padding-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: black">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD><TD STYLE="text-align: justify; padding-right: 0; padding-top: 0; padding-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: black">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><BR>
                                         <FONT STYLE="background-color: black">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></FONT></TD></TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in; padding-top: 0; padding-right: 0; padding-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: black">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD><TD STYLE="text-align: left; padding-right: 0; padding-top: 0; padding-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: black">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><BR>
                                         <FONT STYLE="background-color: black">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></FONT></TD></TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in; padding-top: 0; padding-right: 0; padding-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: black">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD><TD STYLE="text-align: left; padding-right: 0; padding-top: 0; padding-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: black">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><BR>
                                         <FONT STYLE="background-color: black">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></FONT></TD></TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in; padding-top: 0; padding-right: 0; padding-bottom: 0"></TD><TD STYLE="width: 0.5in; padding-top: 0; padding-right: 0; padding-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: black">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD><TD STYLE="text-align: justify; padding-right: 0; padding-top: 0; padding-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: black">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><BR>
                                         <FONT STYLE="background-color: black">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></FONT></TD></TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in">&nbsp;</TD>
    <TD STYLE="width: 0.5in; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(f)</FONT></TD>
    <TD STYLE="text-align: justify; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Milestone payments in subclauses (a), (b), (c) and (e) above, if and when relevant, shall be paid by Licensee within thirty (30) Business Days after the occurrence of each stated milestone.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 8.6pt 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.4</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Royalties. </U>In further consideration of the licenses being granted to Licensee under this Agreement, Licensee shall provide a sales and royalty report for each calendar year within fifteen (15) Business Days after that calendar year end (i.e., 31st December), (&ldquo;Calendar Year End&quot;), and pay to the Licensors royalty payments for drug Products and/or non-drug Products. All such royalties are to be paid every year, within thirty (30) Business Days after each Calendar Year End and shall be determined as follows:</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 8.6pt 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in">&nbsp;</TD>
    <TD STYLE="width: 0.5in; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT></TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">For drug Products, licensee shall pay royalty payments :</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 8.6pt 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 1in">&nbsp;</TD>
    <TD STYLE="width: 0.5in; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)</FONT></TD>
    <TD STYLE="text-align: justify; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: black">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">of Net Sales of Products for the amount of annual Net Sales which is less than or equal to <FONT STYLE="background-color: black">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="background-color: lightgrey">; </FONT>and</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<!-- Field: Page; Sequence: 13; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin-top: 0; margin-bottom: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>




<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 1in; padding-top: 0; padding-right: 0; padding-bottom: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; padding-top: 0; padding-right: 0; padding-bottom: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: black">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD><TD STYLE="text-align: justify; padding-right: 0; padding-top: 0; padding-bottom: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: black">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
                                         </FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">of Net
                                         Sales of Products for the amount of annual Net Sales which is more than <FONT STYLE="background-color: black">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; padding-top: 0; padding-right: 0; padding-bottom: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; padding-top: 0; padding-right: 0; padding-bottom: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT></TD><TD STYLE="text-align: left; padding-top: 0; padding-right: 0; padding-bottom: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
                                         non-drug Products, licensee shall pay royalty payments:</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 1in; padding-top: 0; padding-right: 0; padding-bottom: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; padding-top: 0; padding-right: 0; padding-bottom: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)</FONT></TD><TD STYLE="text-align: justify; padding-right: 0; padding-top: 0; padding-bottom: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: black">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
                                         </FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">of Net
                                         Sales of Products for the amount of annual Net Sales which is less than or equal to <FONT STYLE="background-color: black">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
                                         </FONT>and</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 1in; padding-top: 0; padding-right: 0; padding-bottom: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; padding-top: 0; padding-right: 0; padding-bottom: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: lightgrey">(ii)</FONT></TD><TD STYLE="text-align: justify; padding-right: 0; padding-top: 0; padding-bottom: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: black">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
                                         </FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">of Net
                                         Sales of Products for the amount of annual Net Sales which is more than <FONT STYLE="background-color: black">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; padding-top: 0; padding-right: 0; padding-bottom: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.5</FONT></TD><TD STYLE="text-align: justify; padding-right: 0; padding-top: 0; padding-bottom: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Sublicensee
                                         Royalties</U>. In consideration of the limited sublicense right being granted to Licensee
                                         under this Agreement, Licensee shall include the details of sublicensee royalties in
                                         the sales and royalty report in accordance with Clause 4.4 and pay to Licensors sublicensee
                                         royalties per each sublicense granted. For the avoidance of doubt, the Licensee and/or
                                         its Affiliates shall have no payment obligation under this section for any payment received
                                         by the Licensee in consideration for the issuance of common or preferred stock or with
                                         respect to collaborative research and development activities performed by Licensee or
                                         its collaborative partners. All such sublicensee royalties are to be paid every year,
                                         within forty-five (45) days after each Calendar Year End, and shall be determined as
                                         follows:</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 1in; padding-top: 0; padding-right: 0; padding-bottom: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; padding-top: 0; padding-right: 0; padding-bottom: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: black">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD><TD STYLE="text-align: justify; padding-right: 0; padding-top: 0; padding-bottom: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: black">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><BR>
                                         <FONT STYLE="background-color: black">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><BR>
                                         <FONT STYLE="background-color: black">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></FONT></TD></TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 1in; padding-top: 0; padding-right: 0; padding-bottom: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; padding-top: 0; padding-right: 0; padding-bottom: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: black">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD><TD STYLE="text-align: justify; padding-right: 0; padding-top: 0; padding-bottom: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: black">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><BR>
                                         <FONT STYLE="background-color: black">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><BR>
                                         <FONT STYLE="background-color: black">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></FONT></TD></TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 1in; padding-top: 0; padding-right: 0; padding-bottom: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; padding-top: 0; padding-right: 0; padding-bottom: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: black">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD><TD STYLE="text-align: justify; padding-right: 0; padding-top: 0; padding-bottom: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: black">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><BR>
                                         <FONT STYLE="background-color: black">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><BR>
                                         <FONT STYLE="background-color: black">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></FONT></TD></TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 1in; padding-top: 0; padding-right: 0; padding-bottom: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; padding-top: 0; padding-right: 0; padding-bottom: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: black">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD><TD STYLE="text-align: justify; padding-right: 0; padding-top: 0; padding-bottom: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: black">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><BR>
                                         <FONT STYLE="background-color: black">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><BR>
                                         <FONT STYLE="background-color: black">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></FONT></TD></TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 1in; padding-top: 0; padding-right: 0; padding-bottom: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; padding-top: 0; padding-right: 0; padding-bottom: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: black">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD><TD STYLE="text-align: justify; padding-right: 0; padding-top: 0; padding-bottom: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: black">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><BR>
                                         <FONT STYLE="background-color: black">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></FONT></TD></TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 14; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>




<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 1in; padding-top: 0; padding-right: 0; padding-bottom: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; padding-top: 0; padding-right: 0; padding-bottom: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(f)</FONT></TD><TD STYLE="text-align: justify; padding-right: 0; padding-top: 0; padding-bottom: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Sublicensee
                                         shall comply with the Milestones Payments and Royalties arrangement same as Licensee's
                                         obligations to the Licensors as stipulated in Clause 4.3 and Clause 4.4.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0%; padding-top: 0; padding-right: 0; padding-bottom: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; padding-top: 0; padding-right: 0; padding-bottom: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.6</FONT></TD><TD STYLE="text-align: justify; padding-right: 0; padding-top: 0; padding-bottom: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
                                         any payments under this Clause 4 are not paid within the time specified, the Licensee
                                         shall be liable to pay an additional interest at the rate of two percent (2%) per annum
                                         on such outstanding amount starting from the date the payment was due.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0%; padding-top: 0; padding-right: 0; padding-bottom: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; padding-top: 0; padding-right: 0; padding-bottom: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.7</FONT></TD><TD STYLE="text-align: justify; padding-right: 0; padding-top: 0; padding-bottom: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Failure
                                         of payment of any consideration under this Clause 4 in the prescribed time frame shall
                                         be considered a material breach of this Agreement.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0%; padding-top: 0; padding-right: 0; padding-bottom: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; padding-top: 0; padding-right: 0; padding-bottom: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>5</B></FONT></TD><TD STYLE="padding-top: 0; padding-right: 0; padding-bottom: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>OBLIGATIONS
                                         OF LICENSORS</B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0%; padding-top: 0; padding-right: 0; padding-bottom: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; padding-top: 0; padding-right: 0; padding-bottom: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.1</FONT></TD><TD STYLE="text-align: justify; padding-right: 0; padding-top: 0; padding-bottom: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Subject
                                         to the receipt of full payment of the upfront license fee in accordance with Clause 4.1
                                         (a), Licensors or Inventors shall deliver to Licensee the proprietary information of
                                         the Technology as available on &ldquo;as-is&rdquo; and &ldquo;where as&rdquo; basis within
                                         thirty (30) Business Days after the receipt of a written request from Licensee.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0%; padding-top: 0; padding-right: 0; padding-bottom: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; padding-top: 0; padding-right: 0; padding-bottom: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>6</B></FONT></TD><TD STYLE="padding-top: 0; padding-right: 0; padding-bottom: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>OBLIGATIONS
                                         OF LICENSEE</B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0%; padding-top: 0; padding-right: 0; padding-bottom: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; padding-top: 0; padding-right: 0; padding-bottom: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.1</FONT></TD><TD STYLE="text-align: left; padding-top: 0; padding-right: 0; padding-bottom: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>In
                                         relation to funding:</U></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; padding-top: 0; padding-right: 0; padding-bottom: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; padding-top: 0; padding-right: 0; padding-bottom: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT></TD><TD STYLE="text-align: justify; padding-right: 0; padding-top: 0; padding-bottom: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Licensee
                                         shall provide research and development funding of three million Hong Kong Dollars (HK$3,000,000)
                                         by phases within three (3) years after the Effective Date to support the Inventors to
                                         continue the research on the Technology.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; padding-top: 0; padding-right: 0; padding-bottom: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; padding-top: 0; padding-right: 0; padding-bottom: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT></TD><TD STYLE="text-align: justify; padding-right: 0; padding-top: 0; padding-bottom: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Licensee
                                         shall use three million Hong Kong Dollars funding stated in subclause (a) above to apply
                                         for matching funds under the Innovation and Technology Fund (&quot;ITF&quot;) of the
                                         Government of Hong Kong with the objective to make up a total budget of six million Hong
                                         Kong Dollars (HK$6,000,000) to support the related research on the Technology to be conducted
                                         by Professor Ming-Cheung Chow and Professor Tak-Hang Chan of PolyU, and Professor Chi-Chiu
                                         Wang of CUHK. The three million Hong Kong Dollars funding contributed by the Licensee
                                         is subject to the successful application and outcome of the ITF matching scheme. In the
                                         event that the application to the ITF matching scheme is unsuccessful, new funding terms
                                         to support the ongoing research of the Technology can be proposed and executed subject
                                         to the mutual agreement between both the Licensors and Licensee.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0%; padding-top: 0; padding-right: 0; padding-bottom: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; padding-top: 0; padding-right: 0; padding-bottom: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.2</FONT></TD><TD STYLE="text-align: justify; padding-right: 0; padding-top: 0; padding-bottom: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Licensee
                                         acknowledges that Licensors are and shall remain as the exclusive owner of all Intellectual
                                         Property Rights of any nature related to the Technology. Licensee shall not do anything
                                         that is inconsistent with Licensors&rsquo; ownership, including any acts that may cause
                                         the Licensors to be unable to patent the Technology. Licensee shall also not do any acts
                                         or omit to do any acts that may cause the Licensors to abandon or withdraw the patent
                                         applications in respect of any of the pending patent applications or to lose any of the
                                         granted patents listed in <B>Schedule A</B> and <B>Schedule B</B> hereto.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 15; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 7.25pt 0pt 89.55pt; text-align: justify; text-indent: 0.55pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0%; padding-top: 0; padding-right: 0; padding-bottom: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; padding-top: 0; padding-right: 0; padding-bottom: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.3</FONT></TD><TD STYLE="text-align: justify; padding-right: 0; padding-top: 0; padding-bottom: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Licensee
                                         shall maintain necessary information, including but not limited to accounting and sale
                                         books and records of Products sold, regarding Licensors&rsquo; royalties for no less
                                         than seven (7) years from the termination date of this Agreement.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0%; padding-top: 0; padding-right: 0; padding-bottom: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; padding-top: 0; padding-right: 0; padding-bottom: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.4</FONT></TD><TD STYLE="text-align: justify; padding-right: 0; padding-top: 0; padding-bottom: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Licensee
                                         shall permit the Licensors and/or PolyU to inspect and/or audit relevant accounting and
                                         sale books and records of Products maintained by Licensee for the purpose of determining
                                         the accuracy of the royalties to be paid and/or paid under this Agreement. If such inspection
                                         should disclose any underreporting, Licensee shall promptly pay Licensors such amount.
                                         Furthermore, if there is more than three percent (3%) or fifty thousand Hong Kong Dollars
                                         (HK$50,000) discrepancies on royalty payments, whichever is lower, Licensee shall be
                                         responsible for all costs related to the inspection and/or audit of the accounts.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0%; padding-top: 0; padding-right: 0; padding-bottom: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; padding-top: 0; padding-right: 0; padding-bottom: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.5</FONT></TD><TD STYLE="text-align: justify; padding-right: 0; padding-top: 0; padding-bottom: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Licensee
                                         shall use its commercially reasonable efforts to develop and commercialize the Products
                                         for which regulatory approval, if applicable, in any country within the Territory is
                                         obtained. Licensee shall submit a report within 30 days after each of the calendar year
                                         end or upon receiving a request of Licensors of the latest development and commercialization
                                         status of the Technology and/or Product.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0%; padding-top: 0; padding-right: 0; padding-bottom: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; padding-top: 0; padding-right: 0; padding-bottom: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>7</B></FONT></TD><TD STYLE="padding-top: 0; padding-right: 0; padding-bottom: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>RESPONSIBILITY
                                         FOR PATENT RIGHTS</B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0%; padding-top: 0; padding-right: 0; padding-bottom: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; padding-top: 0; padding-right: 0; padding-bottom: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">7.1</FONT></TD><TD STYLE="text-align: justify; padding-right: 0; padding-top: 0; padding-bottom: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Licensors
                                         will retain sole and exclusive ownership of all rights, title and interest in and to
                                         the Patent Rights and the Technology, subject to the licenses granted to Licensee under
                                         this Agreement. Licensors will also retain all rights under the Patent Rights and Technology
                                         that are not expressly granted to Licensee (including, without limitation, all rights
                                         outside of the Field), and shall have the right to grant further licenses to third parties
                                         with respect to such retained rights.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0%; padding-top: 0; padding-right: 0; padding-bottom: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; padding-top: 0; padding-right: 0; padding-bottom: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">7.2</FONT></TD><TD STYLE="text-align: justify; padding-right: 0; padding-top: 0; padding-bottom: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">After
                                         the Effective Date, Licensee shall be responsible for all costs and expenses involved
                                         in the prosecution, maintenance, enforcement and defense of all patent applications and
                                         patents that are included in the Patent Rights. Licensee shall notify Licensors in writing
                                         before taking any substantive actions before any jurisdiction patent office related to
                                         the Patent Rights, and Licensee shall seek Licensors' input and advice concerning substantive
                                         amendments to any Claim before taking such action. In the event that Licensee elects
                                         not to file, prosecute or maintain any patent or patent application included in the Patent
                                         Rights, Licensee shall so notify Licensors in writing at least thirty (30) days before
                                         any applicable statutory bar date or response date to permit Licensors (at their own
                                         expense) to prosecution or maintain such right.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-top: 0; margin-bottom: 0; font: 10pt Times New Roman, Times, Serif"></P>

<!-- Field: Page; Sequence: 16; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin-top: 0; margin-bottom: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>




<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0%; padding-top: 0; padding-right: 0; padding-bottom: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; padding-top: 0; padding-right: 0; padding-bottom: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">7.3</FONT></TD><TD STYLE="text-align: justify; padding-right: 0; padding-top: 0; padding-bottom: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Licensee
                                         shall promptly notify Licensors upon becoming aware of any third-party actions which
                                         may constitute infringement of the Patent Rights in the Territory, or if any third party
                                         initiates actions seeking to invalidate or contest the enforceability or validity of
                                         one or more granted patents that are included in the Patent Rights. Any such notice shall
                                         identify the third party and describe the relevant actions in sufficient detail to enable
                                         Licensors to evaluate the alleged infringement or other action. Licensors and Licensee
                                         shall consult with each other to decide how to address such alleged infringement subject
                                         to terms to be agreed amongst the parties on a case by case basis.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 34.85pt; padding-top: 0; padding-right: 0; padding-bottom: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>8</B></FONT></TD><TD STYLE="padding-top: 0; padding-right: 0; padding-bottom: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>RIGHTS
                                         TO IMPROVEMENTS AND NEW DEVELOPMENTS</B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0%; padding-top: 0; padding-right: 0; padding-bottom: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; padding-top: 0; padding-right: 0; padding-bottom: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8.1</FONT></TD><TD STYLE="text-align: justify; padding-right: 0; padding-top: 0; padding-bottom: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Licensors
                                         and Licensee shall jointly own all rights, title and interest in or to any new discoveries
                                         or inventions made on or after the Effective Date by employees, contractors, sub-contractors,
                                         agents, sub-agents, licensee or otherwise of Licensee in connection with the development
                                         , manufacture or commercialization of Products in the Field (collectively, &ldquo;Licensee
                                         Inventions&rdquo;). For clarity, Licensee Inventions shall include, without limitation,
                                         any and all patent applications covering Licensee Inventions that are filed in the Territory
                                         by or on behalf of Licensee at any time on or after the Effective Date, and any and all
                                         granted patents that directly or indirectly result from such patent applications, or
                                         any divisions, continuations or continuations-in-part or other patent applications claiming
                                         priority thereto. Licensee will solely be responsible for all the patenting costs of
                                         the Licensee Inventions.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0%; padding-top: 0; padding-right: 0; padding-bottom: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; padding-top: 0; padding-right: 0; padding-bottom: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>9</B></FONT></TD><TD STYLE="padding-top: 0; padding-right: 0; padding-bottom: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>EDUCATION
                                         PURPOSE</B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Notwithstanding
anything to the contrary in this Agreement, the Licensors shall retain all rights, and the Licensee hereby grants the Licensors,
a worldwide, non exclusive, irrevocable, royalty-free, paid-up license to use the Patent Rights, Technology and Licensee Inventions
for any research, academic and/or educational purposes in any Territory and in any Field.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0%; padding-top: 0; padding-right: 0; padding-bottom: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; padding-top: 0; padding-right: 0; padding-bottom: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>10</B></FONT></TD><TD STYLE="padding-top: 0; padding-right: 0; padding-bottom: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>REPRESENTATIONS
                                         AND WARRANTIES</B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0%; padding-top: 0; padding-right: 0; padding-bottom: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; padding-top: 0; padding-right: 0; padding-bottom: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.1</FONT></TD><TD STYLE="text-align: justify; padding-right: 0; padding-top: 0; padding-bottom: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Mutual
                                         Representations</U>. Each of Licensors and Licensee hereby represents and warrants to
                                         the other party that as of the Effective Date:</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; padding-top: 0; padding-right: 0; padding-bottom: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; padding-top: 0; padding-right: 0; padding-bottom: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT></TD><TD STYLE="text-align: justify; padding-right: 0; padding-top: 0; padding-bottom: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">it
                                         is a corporation or other business entity duly organized and validly existing under the
                                         laws of its place of incorporation or formation;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; padding-top: 0; padding-right: 0; padding-bottom: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; padding-top: 0; padding-right: 0; padding-bottom: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT></TD><TD STYLE="text-align: justify; padding-right: 0; padding-top: 0; padding-bottom: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">it
                                         has the power and authority to execute and deliver this Agreement and to perform its
                                         obligations hereunder.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 17; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 12.5pt 0pt 85.05pt; text-align: justify; text-indent: -0.05pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0%; padding-top: 0; padding-right: 0; padding-bottom: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; padding-top: 0; padding-right: 0; padding-bottom: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.2</FONT></TD><TD STYLE="text-align: justify; padding-right: 0; padding-top: 0; padding-bottom: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Warranty
                                         Disclaimer</U>. EXCEPT AS OTHERWISE EXPRESSLY SET FORTH IN THIS CLAUSE 10, LICENSORS
                                         MAKE NO EXPRESS OR IMPLIED WARRANTIES OR REPRESENTATIONS OF ANY KIND AS TO ANY OF THE
                                         SUBJECT MATTER OF THIS AGREEMENT, INCLUDING WITHOUT LIMITATION, THE PATENT RIGHTS AND
                                         TECHNOLOGY LICENSED HEREUNDER. IN PARTICULAR, LICENSORS HEREBY EXPRESSLY DISCLAIM ANY
                                         WARRANTIES (EXPRESS OR IMPLIED) OF PATENT VALIDITY, NON-INFRINGEMENT, MERCHANTABILITY,
                                         FITNESS FOR A PARTICULAR PURPOSE, OR SUITABILITY FOR LICENSEE' S PURPOSES. LICENSORS
                                         DISCLAIM ALL WARRANTIES, WHETHER EXRPESS, IMPLIED, STATUTORY, OR OTHER ARISING FROM COURSE
                                         OF DEALING, USAGE, OR TRADE. IN NO EVENT WILL THE POLYU, THE LICENSORS AND / OR THE INVENTORS
                                         BE LIABLE FOR DIRECT, INDIRECT, SPECIAL, INCIDENTAL, OR CONSEQUENTIAL DAMAGES, THAT ARE
                                         IN ANYWAY RELATED TO THE TECHNOLOGY AND ITS USE.</FONT></TD></TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 12.5pt 0pt 85.05pt; text-align: justify; text-indent: -0.05pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0%; padding-top: 0; padding-right: 0; padding-bottom: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; padding-top: 0; padding-right: 0; padding-bottom: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>11</B></FONT></TD><TD STYLE="padding-top: 0; padding-right: 0; padding-bottom: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>INDEMNIFICATION</B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0%; padding-top: 0; padding-right: 0; padding-bottom: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; padding-top: 0; padding-right: 0; padding-bottom: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">11.1</FONT></TD><TD STYLE="text-align: justify; padding-right: 0; padding-top: 0; padding-bottom: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Licensee
                                         shall indemnify, defend and hold harmless Licensors (their Affiliates, and their respective
                                         officers, directors, employees, professors, agents, representatives and sub-contractors),
                                         collectively, &ldquo;Licensors&rsquo; Indemnitees&rdquo;, from any and against any and
                                         all claims, actions, suits, liability, damages, losses, costs, expenses (including reasonable
                                         legal fees) and any other sums which directly or indirectly result from or arise out
                                         of (a) the development, manufacture, storage, distribution, marketing, promotion, use
                                         or sale of Products by or on behalf of Licensee or any of its customers or clients; (b)
                                         the breach by Licensee of one or more of its obligations under this Agreement; or (c)
                                         the breach by Licensee of one or more of its representations, warranties or covenants
                                         under this Agreement, except , with respect to each of (a), (b) and (c) above, to the
                                         extent caused by Licensors&rsquo; gross negligence or wilful misconduct or breach of
                                         one or more of its obligations under this Agreement. Licensee shall require its sublicensees
                                         to indemnify, defend and hold harmless Licensors&rsquo; Indemnitees under the same terms
                                         as stated in this Clause 11.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0%; padding-top: 0; padding-right: 0; padding-bottom: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; padding-top: 0; padding-right: 0; padding-bottom: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>12</B></FONT></TD><TD STYLE="padding-top: 0; padding-right: 0; padding-bottom: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>CONFIDENTIALITY</B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0%; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; text-align: left; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">12.1</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Each
                                         party, each in its sole discretion, may disclose or otherwise make available certain
                                         confidential information to the other party on the terms and subject to the conditions
                                         of this Agreement. For purposes of this Agreement, &ldquo;Owner&rdquo; means a party
                                         disclosing information to the other party, and &ldquo;Recipient&rdquo; means a party
                                         receiving information from the other party. &ldquo;Proprietary Information&rdquo; means
                                         without limitation, all technical, financial, and business information of any kind whatsoever,
                                         and all tangible and intangible embodiments thereof, disclosed by Owner or obtained by
                                         Recipient through observation or examination of the foregoing, but only to the extent
                                         such information or embodiments is maintained as confidential by Owner, and any information
                                         which the Recipient knows or reasonably should know is the Proprietary Information of
                                         the Owner.</FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 18; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 7.45pt 0pt 89.9pt; text-align: justify; text-indent: 1.15pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 7.45pt 0pt 89.9pt; text-align: justify; text-indent: 1.15pt"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0%; padding-top: 0; padding-right: 0; padding-bottom: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; padding-top: 0; padding-right: 0; padding-bottom: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">12.2</FONT></TD><TD STYLE="text-align: justify; padding-right: 0; padding-top: 0; padding-bottom: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
                                         the term of this Agreement and for a period of seven (7) years following the expiration
                                         or earlier termination hereof, Recipient shall (a) maintain in confidence and make best
                                         efforts to prevent the unauthorized use of Proprietary Information; and (b) exercise
                                         the same degree of care as it uses for its own confidential information, but not less
                                         than reasonable care. Recipient shall disclose Proprietary Information only to those
                                         of its directors, officers, employees, advisors or agents as reasonably necessary to
                                         facilitate the purposes of this Agreement, provided that such Persons are required to
                                         maintain in confidence and not use Proprietary Information except as permitted by this
                                         Agreement. Within thirty (30) days after termination of this Agreement, Recipient shall,
                                         upon the request of the Owner, return to Owner or destroy all tangible items relating
                                         to Proprietary Information made available by the Owner to the Recipient, and all copies
                                         thereof in Recipient&rsquo;s control or possession except for one copy which may be retained
                                         by the Recipient for monitoring compliance with this Clause 12.2.</FONT></TD></TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 7.45pt 0pt 89.9pt; text-align: justify; text-indent: 1.15pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0%; padding-top: 0; padding-right: 0; padding-bottom: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; padding-top: 0; padding-right: 0; padding-bottom: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">12.3</FONT></TD><TD STYLE="text-align: justify; padding-right: 0; padding-top: 0; padding-bottom: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Notwithstanding
                                         the foregoing (a) Recipient may disclose Proprietary Information to the extent required
                                         by applicable law, legal process or regulation, provided that Recipient shall, to the
                                         extent permitted by such applicable law, legal process or regulation, give Owner prompt
                                         written notice and sufficient opportunity at the own costs of the Owner to object to
                                         such disclosure, or to request confidential treatment; and (b) Recipient's non-use and
                                         non-disclosure obligations shall not apply to such Proprietary Information as Recipient
                                         can establish by written documentation to have been:</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; padding-top: 0; padding-right: 0; padding-bottom: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; padding-top: 0; padding-right: 0; padding-bottom: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #212121">(a)</FONT></TD><TD STYLE="text-align: justify; padding-right: 0; padding-top: 0; padding-bottom: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Public
                                         knowledge at the time of such disclosure by Recipient, and not as a result of wrongful
                                         acts attributable to Recipient;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; padding-top: 0; padding-right: 0; padding-bottom: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; padding-top: 0; padding-right: 0; padding-bottom: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #212121">(b)</FONT></TD><TD STYLE="text-align: justify; padding-right: 0; padding-top: 0; padding-bottom: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Rightfully
                                         known by Recipient (as shown by its written records) prior to the date of disclosure
                                         by Owner;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; padding-top: 0; padding-right: 0; padding-bottom: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; padding-top: 0; padding-right: 0; padding-bottom: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #212121">(c)</FONT></TD><TD STYLE="text-align: justify; padding-right: 0; padding-top: 0; padding-bottom: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Disclosed
                                         to Recipient on an unrestricted basis from a third party, who according to the knowledge
                                         of Recipient is not under a duty of confidentiality to Owner; or</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; padding-top: 0; padding-right: 0; padding-bottom: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; padding-top: 0; padding-right: 0; padding-bottom: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #212121">(d)</FONT></TD><TD STYLE="text-align: justify; padding-right: 0; padding-top: 0; padding-bottom: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Independently
                                         developed by employees or agents of Recipient (as shown by its written records) without
                                         access to or use of Proprietary Information.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0%; padding-top: 0; padding-right: 0; padding-bottom: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; padding-top: 0; padding-right: 0; padding-bottom: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">12.4</FONT></TD><TD STYLE="text-align: justify; padding-right: 0; padding-top: 0; padding-bottom: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Promptly
                                         upon obtaining knowledge thereof, Recipient shall immediately disclose to Owner any attempt
                                         by any Person to improperly use or disclose any Proprietary Information.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0%; padding-top: 0; padding-right: 0; padding-bottom: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; padding-top: 0; padding-right: 0; padding-bottom: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">12.5</FONT></TD><TD STYLE="text-align: justify; padding-right: 0; padding-top: 0; padding-bottom: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Licensee
                                         shall not disclose the material terms or conditions of this Agreement to any third party
                                         without the prior written consent of Licensors, except that Licensee may, under customary
                                         non-disclosure terms, disclose the financial terms which are relevant to a potential
                                         investor or acquirer.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0%; padding-top: 0; padding-right: 0; padding-bottom: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; padding-top: 0; padding-right: 0; padding-bottom: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>13</B></FONT></TD><TD STYLE="padding-top: 0; padding-right: 0; padding-bottom: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>NON-COMPETITION</B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0%; padding-top: 0; padding-right: 0; padding-bottom: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; padding-top: 0; padding-right: 0; padding-bottom: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">13.1</FONT></TD><TD STYLE="text-align: justify; padding-right: 0; padding-top: 0; padding-bottom: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
                                         the continuance of this Agreement and for a period of two (2) years after its expiration
                                         or termination for whatever reason (whether in breach of contract or otherwise), Licensee
                                         shall not without the prior written consent of Licensors in any country, in any capacity
                                         and whether directly or indirectly or solely or jointly with others, engage in the design,
                                         manufacture, production, importation, consultation or development or sale of any products
                                         which may directly compete with the Product.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 19; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 8.25pt 0pt 90.3pt; text-indent: -0.05pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in; text-align: left">13.2</TD><TD STYLE="text-align: justify">In the event that any restriction contained in this Clause
13 shall be found to be void, but would be valid if some part of the relevant restriction were deleted, the relevant restriction
shall apply with such modifications as may be necessary to make it valid and effective.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in; text-align: left">14</TD><TD STYLE="text-align: justify">TERMINATION</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in; text-align: left">14.1</TD><TD STYLE="text-align: justify">Licensors or Licensee may terminate this Agreement (a)
upon or after the breach of any material provision of this Agreement by the other party if the other party has not cured such
breach within sixty (60) days after receiving written notice thereof from the non-breaching party; (b) if the other party voluntarily
commences any action or seeks any relief regarding its liquidation, reorganization, dissolution or similar act or under any bankruptcy,
insolvency or similar law; or (c) if a proceeding is commenced or an order, judgment, or decree is entered seeking the liquidation,
reorganization, dissolution or similar act or any other relief under any bankruptcy, insolvency or similar law against the other
party, without its consent, which continues un-dismissed or un-stayed for a period of sixty (60) days; or (d) there is any act
or omission attributable to Licensee that could tarnish the reputation of any of the Licensors; or (e) in accordance with Clause
3.2.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in; text-align: left">14.2</TD><TD STYLE="text-align: justify">Upon the termination of this Agreement for cause pursuant
to the above provisions of Clause 14.1, all rights granted by Licensors to Licensee under this Agreement shall terminate. Expiration
or termination of this Agreement shall not relieve the parties of any obligations accruing prior to such expiration or termination.
Upon termination of this Agreement for any reason, each party shall promptly: (a) return all property of the other party in its
possession; (b) certify that it has complied with the confidentiality provisions set forth in this Agreement; (c) deliver all
documentation, tangible material and anything else related to or embodying confidential information and intellectual property
rights of the other party; and (d) pay any outstanding amounts due to the other party. Any terms and conditions of this Agreement,
which by their nature extend beyond the term or expiry of this Agreement, shall survive the termination or expiry of this Agreement,
including but not limited to Clauses 11 to 15.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in; text-align: left">15</TD><TD STYLE="text-align: justify">MISCELLANEOUS</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in; text-align: left">15.1</TD><TD STYLE="text-align: justify"><U>Publication</U>. Licensee recognizes that under some
of Licensors&rsquo; respective university policies , the results of Licensors&rsquo; research involving Patents and Licensed Technology
must be available for publication and agrees that Licensors&rsquo; researchers shall be permitted to present at symposia and professional
meetings, and to publish in journals, theses or dissertations, or otherwise of their own choosing, research methods and results
provided, however, that Licensee shall have been furnished copies of any proposed publication or presentation reporting research
results utilizing Technology or Patents for review at least thirty (30) days in advance of the submission of such proposed publication
or presentation to a journal, editor, or other third party. Licensee shall have thirty (30) days after receipt of said copies,
to object to such proposed presentation or proposed publication because Proprietary Information disclosed by the Licensee pursuant
to Clause 12.1, above, is contained therein. In the event Licensee makes such objection based on disclosure of Licensee&rsquo;s
Proprietary Information, Licensors will comply with Licensee&rsquo;s request to delete or modify Licensee Proprietary Information.</TD>
</TR></TABLE>




<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 10.5pt 0pt 87.4pt; text-align: justify; text-indent: 0.4pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 10.5pt 0pt 87.4pt; text-align: justify; text-indent: 0.4pt"></P>

<!-- Field: Page; Sequence: 20; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 10.5pt 0pt 87.4pt; text-align: justify; text-indent: 0.4pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in; text-align: left">15.2</TD><TD STYLE="text-align: justify"><U>Governing Law</U>. This Agreement shall be governed
by and construed, interpreted and enforced in accordance with, and the respective rights and obligations of the parties shall
be governed by, the laws of Hong Kong., unless the sole defendant is WSU, in which case any such dispute or claim must be brought
in the Michigan Court of Claims and shall be governed by and construed in accordance with the laws of the State of Michigan, United
States of America. Notwithstanding anything to the contrary, WSU shall retain all rights and protections afforded it under the
laws of the State of Michigan and the United States of America. Irrespective of the governing law of this Agreement, the parties
agree that MCC shall enjoy and receive the rights and protections as set out in Florida Statute, 1004.43.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in; text-align: left">15.3</TD><TD STYLE="text-align: justify"><U>Successors and Assigns</U>. Except as otherwise expressly
provided herein, the provisions hereof shall inure to the benefit of, and be binding upon, the successors, assigns, heirs, executors
and administrators of the parties hereto whose rights or obligations hereunder are affected by such amendments. Neither this Agreement
nor any rights or obligations of Licensee hereunder may be assigned by Licensee in whole or in part without the prior written
approval of Licensor, with the explicit exception set out in Clause 2.5 in respect of Licensee&rsquo;s right to assign its rights
in whole or in part pertaining to its exclusive license of the Technology and Patent Rights granted under this Agreement, to any
Affiliate of Licensee at any time subsequent to the Effective Date. For the purpose of this Clause 15.3, a change in the Persons
or entities who control fifty percent (50%) or more of the equity, securities or voting interest of Licensee shall be considered
an assignment of Licensee&rsquo;s rights. Licensors may exercise full transfer and assignment rights in any manner at Licensors&rsquo;
discretion and specifically may sell, pledge, or otherwise transfer its right to receive royalties under this Agreement.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in; text-align: left">15.4</TD><TD STYLE="text-align: justify">All parties agree that when a claim, demand, action, infringement
or breach of this Agreement is only related to Technology One, that of the Licensors only PolyU, McGill, WSU and MCC, as the owners
of the related patents, may be responsible for such claim, demand, action, infringement or breach. All parties agree that when
a claim, demand, action, infringement or breach of this Agreement is only related to Technology Two, that of the <FONT STYLE="font-size: 10pt">Li</FONT>censors
only PolyU and CUHK, as the owners of the related patents, may be responsible for such claim, demand, action, infringement or
breach.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in; text-align: left">15.5</TD><TD STYLE="text-align: justify"><U>Entire Agreement</U>. This Agreement and the schedules
hereto and thereto, which are hereby expressly incorporated herein by this reference constitute the entire understanding and agreement
between the parties with regard to the subject matter hereof and thereof, PROVIDED THAT nothing in this Agreement or related agreements
shall be deemed to terminate or supersede the prov1s1ons of any confidentiality and non-disclosure agreements executed by the
parties hereto prior to the date hereof, which agreements shall continue in full force and effect until terminated in accordance
with their respective terms.</TD>
</TR></TABLE>




<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 6.9pt 0pt 90.9pt; text-align: justify; text-indent: 0.05pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 6.9pt 0pt 90.9pt; text-align: justify; text-indent: 0.05pt"></P>

<!-- Field: Page; Sequence: 21; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->21<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 6.9pt 0pt 90.9pt; text-align: justify; text-indent: 0.05pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in; text-align: left">15.6</TD><TD STYLE="text-align: justify"><U>Amendments and Waivers</U>. Any term of this Agreement
may be amended only with the written consent of all of the parties hereto. Any amendment or waiver effected in accordance with
this Clause 15.6 shall be binding upon all of the parties hereto, and their respective assigns.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-size: 10pt">15.7</FONT></TD><TD STYLE="text-align: justify"><U>Delays or Omissions</U>. No delay or omission in exercising
any right, power or remedy accruing to any party hereto, upon any breach or default of any party hereto under this Agreement,
shall impair any such right, power or remedy of such party nor shall it be construed to be a waiver of any such breach or default,
or an acquiescence therein, or of any similar breach of default thereafter occurring; nor shall it be construed to be a waiver
of any other breach or default theretofore or thereafter occurring. Any waiver, permit, consent or approval of any kind or character
on the part of any party hereto of any breach of default under this Agreement or any waiver on the part of any party hereto of
any provisions or conditions of this Agreement, must be in writing and shall be effective only to the extent specifically set
forth in such writing. All remedies, either under this Agreement, or by law or otherwise afforded to the parties hereto shall
be cumulative and not alternative.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-size: 10pt">15.8</FONT></TD><TD STYLE="text-align: justify"><U>Counterparts</U>. This Agreement may be executed in
any number of counterparts, each of which shall be an original, but all of which together shall constitute one instrument.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-size: 10pt">15.9</FONT></TD><TD STYLE="text-align: justify"><U>Severability</U>. If any provision of this Agreement
is found to be invalid or unenforceable, then such provision shall be construed, to the extent feasible, so as to render the provision
enforceable and to provide for the consummation of the transactions contemplated hereby on substantially the same terms as originally
set forth herein, and if no feasible interpretation would save such provision, it shall be severed from the remainder of this
Agreement, which shall remain in full force and effect unless the severed provision is essential to the rights or benefits intended
by the parties. In such event, the parties shall use best efforts to negotiate, in good faith, a substitute, valid and enforceable
provision or agreement that most nearly effects the parties&rsquo; intent in entering into this Agreement.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-size: 10pt">15.10</FONT></TD><TD STYLE="text-align: justify"><U>Force Majeure</U>. Neither Licensors nor Licensee or
PolyU shall be held liable or responsible to the other parties nor be deemed to have defaulted under or breached this Agreement
for failure or delay in fulfilling or performing any obligation under this Agreement (other than an obligation for the payment
of money by Licensee) to the extent, and for so long as, such failure or delay is caused by or results from causes beyond the
reasonable control of the affected party including but not limited to fires, earthquakes, floods, embargoes, wars, acts of war
(whether war is declared or not), acts of terrorism, insurrections , riots, civil disturbances , strikes, lockouts or other labour
disturbances, acts of God, or any acts, omissions, denial or failure of issuance of an export license, or delays in acting by
any governmental authority or the other party.</TD>
</TR></TABLE>




<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 8.25pt 0pt 84.4pt; text-indent: 0.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 8.25pt 0pt 84.4pt; text-indent: 0.5pt"></P>

<!-- Field: Page; Sequence: 22; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->22<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 8.25pt 0pt 84.4pt; text-indent: 0.5pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in; text-align: left">15.11</TD><TD STYLE="text-align: justify"><U>No Partnership or Agency</U>. Nothing in this Agreement
is intended to, or shall be deemed to, establish any partnership or joint venture between any of the parties, constitute any party
the agent of another party, nor authorise any party to make or enter into any commitments for or on behalf of any other party
except as expressly provided in this Agreement.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in; text-align: left">15.12</TD><TD STYLE="text-align: justify"><U>Further Assurances</U>. Each party shall from time to
time and at all times hereafter make, do, execute, or cause or procure to be made, done and executed such further acts, deeds,
conveyances, consents and assurances without further consideration, which may reasonably be required to effect the transactions
contemplated by this Agreement.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in; text-align: left">15.13</TD><TD STYLE="text-align: justify"><U>Dispute Resolution</U>. The parties to the Agreement
will encourage the prompt and equitable settlement of all controversies or claims (each a &ldquo;Dispute&rdquo;) between them
amicably and shall first attempt to negotiate and resolve their differences directly without litigation. If a Dispute is not resolved
within thirty (30) days after notice is sent from one party to another (with a copy to all other parties), then a party, by written
notice to the other parties, shall have the disputed matter referred to the senior officers (collectively, the &ldquo;Executive
Officers&rdquo;) for resolution. If the Executive Officers are unable to determine resolution in a timely matter, which shall
in no case be more than thirty (30) days after the matter was referred to them, the matter shall be first submitted to a mutually
acceptable mediator, qualified by education and experience, to review the matter. If the parties cannot agree on a mediator or
if, after non-binding mediation the Dispute is not resolved, the parties are free to exercise all other legal and equitable remedies.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in; text-align: left">15.14</TD><TD STYLE="text-align: justify"><U>No Use of Name</U>. Except as expressly set forth in
this Agreement or as otherwise required by applicable law, regulation, or order of a governmental agency or court of competent
jurisdiction, Licensee shall not use the name of Inventors and/or Licensors and/or PolyU or their directors, officers, employees
or agents in any advertising, news release, or other publications, without the prior express written consent of the Licensors.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in; text-align: left">15.15</TD><TD STYLE="text-align: justify"><U>Third Parties</U>. Unless expressly provided to the
contrary in this Agreement, a person who is not a party of this Agreement has no right under the Contracts (Rights of Third Parties)
Ordinance (Chapter 623 of the Laws of Hong Kong) to enforce or to enjoy the benefit of any term of this Agreement. Notwithstanding
any term of this Agreement, the consent of any person who is not a party to this Agreement is not required to rescind or vary
this Agreement at any time.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in; text-align: left">15.16</TD><TD STYLE="text-align: justify"><U>English Language</U>. This Agreement was negotiated
and executed in the English language and the parties agree that this English language version of the Agreement shall control over
all other versions.</TD>
</TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="margin-top: 0; margin-bottom: 0"></P>

<!-- Field: Page; Sequence: 23; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->23<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>




<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in; text-align: left">15.17</TD><TD STYLE="text-align: justify"><U>Notice</U>. Except for those communications which specifically
under this Agreement may be sent via e-mail or other electronic communication (such as notification of license fees and milestone
payments incurred and due, and other routine communications), all notices, requests or communication required or permitted to
be given by either party hereunder shall be given by registered mail or certified mail, return receipt requested, or sent by overnight
courier, such as Federal Express, to the other party at its respective address set forth below or to such other address as one
party shall give notice of to the other from time to time hereunder. Notices shall be deemed effective when received.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 25%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If to Licensee:</FONT></TD>
    <TD><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">APTUS
        Therapeutics Limited</FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Unit
        B, 17<SUP>th</SUP> Floor, Guangdong Investment Tower </FONT><BR>
        <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">148 Connaught Road Central, Hong Kong.</FONT></P></TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If to PTeC:</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">PolyU Technology and Consultancy Company Limited<BR>
    <FONT STYLE="background-color: black">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><BR>
    <FONT STYLE="background-color: black">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If to McGill:</FONT></TD>
    <TD><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">McGill
        University</FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: black">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></P></TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If to WSU:</FONT></TD>
    <TD><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Wayne
        State University<BR>
        <FONT STYLE="background-color: black">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: black">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: black">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></P></TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If to MCC:</FONT></TD>
    <TD><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">H.
        Lee Moffitt Cancer Center and Research Institute Inc. <BR>
        <FONT STYLE="background-color: black">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: black">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></P></TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If to CUHK:</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Chinese University of Hong Kong<BR>
    Shatin, Hong Kong</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 24; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->24<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 20pt; margin-bottom: 0pt; text-align: left">IN WITNESS whereof the parties
hereto have signed this Agreement on the date first above written.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: left">SIGNED for and on behalf of</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: left">PolyU Technology and Consultancy<BR>

Company Ltd.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 40%; border-bottom: Black 1.5pt solid">&nbsp;</TD>
    <TD STYLE="width: 60%">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Miranda Lou</FONT></TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director</FONT></TD>
    <TD>&nbsp;</TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><I>[The remainder of this page is intentionally
left blank.]</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt">&nbsp;</P>


<!-- Field: Page; Sequence: 25; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->25<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 264.3pt; margin-bottom: 0pt; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: left">SIGNED for and on behalf
of</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: left">McGill University</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 40%; border-bottom: Black 1.5pt solid">&nbsp;</TD>
    <TD STYLE="width: 60%">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Mark Weber, Ph.D.,P.Eng.</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Associate Director,</P></TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>Invention Development and</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD> Entrepreneurship Assistance</TD>
    <TD>&nbsp;</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt">[The remainder of this page is intentionally
left blank.]</P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt">&nbsp;</P>


<!-- Field: Page; Sequence: 26; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->26<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left">SIGNED for and on behalf
of</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left">Wayne State University</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 40%; border-bottom: Black 1.5pt solid">&nbsp;</TD>
    <TD STYLE="width: 60%">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="font-weight: normal; text-indent: 0in"><FONT STYLE="font-size: 10pt">Joan Dunbar</FONT></TD>
    <TD STYLE="font-weight: normal; text-indent: 0in">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>Associate Vice President, Technology Commercialization</TD>
    <TD>&nbsp;</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><I>[The remainder of this page is intentionally
left blank.]</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt">&nbsp;</P>


<!-- Field: Page; Sequence: 27; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->27<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left">SIGNED for and on behalf of</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left">H. Lee Moffitt Cancer Center and<BR>
 Research Institute
Inc.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 40%; border-bottom: Black 1.5pt solid">&nbsp;</TD>
    <TD STYLE="width: 60%">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>Dr. James J. Mule</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>Associate Venter Director,</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>Translation Science</TD>
    <TD>&nbsp;</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt">[The remainder of this page is intentionally
left blank.]</P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"></P>

<!-- Field: Page; Sequence: 28; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->28<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: left; margin-bottom: 0pt">SIGNED for and on behalf of</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: left; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: left; margin-bottom: 0pt">The Chinese University of Hong Kong</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 40%; border-bottom: Black 1.5pt solid">&nbsp;</TD>
    <TD STYLE="width: 60%">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>Walter K. K. Ho (Prof)</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>Director</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>Office of Research and <BR>
Knowledge Transfer Services</TD>
    <TD>&nbsp;</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><I>[The remainder of this page is intentionally left
blank.]</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt">&nbsp;</P>


<!-- Field: Page; Sequence: 29; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->29<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left">SIGNED for and on behalf
of</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left">APTUS Therapeutics Limited</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 40%; border-bottom: Black 1.5pt solid">&nbsp;</TD>
    <TD STYLE="width: 60%">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>HUEN Chung Yuen Ian </TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>Director</TD>
    <TD>&nbsp;</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><I>[The remainder of this page is intentionally
left blank.]</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt">&nbsp;</P>


<!-- Field: Page; Sequence: 30; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->30<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>Schedule A</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B><U>Patents on the Technology
One</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: left; margin-bottom: 0pt"><B>Title: </B>Epigallocatechin Gallate Derivatives
for Inhibiting Proteasome</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: left; margin-bottom: 0pt"><B>WSU Tech. ID: </B>05-726</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: left; margin-bottom: 0pt"><B>Owners: </B>Wayne State
University, The Hong Kong Polytechnic University, Moffitt Cancer Centre and Research Institute, and McGill University</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 23%; border-bottom: Black 1.5pt solid; text-align: center">Country</TD>
    <TD STYLE="width: 2%; text-align: center">&nbsp;</TD>
    <TD STYLE="width: 23%; border-bottom: Black 1.5pt solid; text-align: center">Status</TD>
    <TD STYLE="width: 2%; text-align: center">&nbsp;</TD>
    <TD STYLE="width: 23%; border-bottom: Black 1.5pt solid; text-align: center">Filing Date</TD>
    <TD STYLE="width: 2%; text-align: center">&nbsp;</TD>
    <TD STYLE="width: 25%; border-bottom: Black 1.5pt solid; text-align: center">Filing No./ Patent No.</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>US</TD>
    <TD>&nbsp;</TD>
    <TD>Granted</TD>
    <TD>&nbsp;</TD>
    <TD>19 Aug 2004</TD>
    <TD>&nbsp;</TD>
    <TD>US7,544,816 B2</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>US (Provisional)</TD>
    <TD>&nbsp;</TD>
    <TD>Expired</TD>
    <TD>&nbsp;</TD>
    <TD>4 Feb 2005</TD>
    <TD>&nbsp;</TD>
    <TD>60/649,569</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>US</TD>
    <TD>&nbsp;</TD>
    <TD>Granted</TD>
    <TD>&nbsp;</TD>
    <TD>13 Nov 2007</TD>
    <TD>&nbsp;</TD>
    <TD>US8,193,377 B2</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>US</TD>
    <TD>&nbsp;</TD>
    <TD>Granted</TD>
    <TD>&nbsp;</TD>
    <TD>9 Mar 2012</TD>
    <TD>&nbsp;</TD>
    <TD>US8,710 ,248 B2</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>US</TD>
    <TD>&nbsp;</TD>
    <TD>Granted</TD>
    <TD>&nbsp;</TD>
    <TD>28 Mar 2014</TD>
    <TD>&nbsp;</TD>
    <TD>US9 ,169,230 B2</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>International Procedure</TD>
    <TD>&nbsp;</TD>
    <TD>Entered National Phase</TD>
    <TD>&nbsp;</TD>
    <TD>15 Aug 2005</TD>
    <TD>&nbsp;</TD>
    <TD>PCT/CN2005/001262</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>China</TD>
    <TD>&nbsp;</TD>
    <TD>Granted</TD>
    <TD>&nbsp;</TD>
    <TD>15 Aug 2005</TD>
    <TD>&nbsp;</TD>
    <TD>ZL200580035478.7</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>India</TD>
    <TD>&nbsp;</TD>
    <TD>Granted</TD>
    <TD>&nbsp;</TD>
    <TD>15 Aug 2005</TD>
    <TD>&nbsp;</TD>
    <TD>263365</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>Japan</TD>
    <TD>&nbsp;</TD>
    <TD>Granted</TD>
    <TD>&nbsp;</TD>
    <TD>15 Aug 2005</TD>
    <TD>&nbsp;</TD>
    <TD>526915</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>European Patent</TD>
    <TD>&nbsp;</TD>
    <TD>Pending</TD>
    <TD>&nbsp;</TD>
    <TD>15 Aug 2005</TD>
    <TD>&nbsp;</TD>
    <TD>05779886.0</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></P>

<!-- Field: Page; Sequence: 31; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->31<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>Schedule B</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><B><U>Patents on the Technology Two</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: left; margin-bottom: 0pt"><B>Title: Prodrug of Green Tea Epigallocatchin-3-Gallate
(Pro-EGCG) for Use in the Treatment of Endometriosis</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: left; margin-bottom: 0pt"><B>Owners: </B>The Hong Kong Polytechnic University,
The Chinese University of Hong Kong</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 23%; border-bottom: Black 1.5pt solid; text-align: center">Country</TD>
    <TD STYLE="width: 2%; text-align: center">&nbsp;</TD>
    <TD STYLE="width: 23%; border-bottom: Black 1.5pt solid; text-align: center">Status</TD>
    <TD STYLE="width: 2%; text-align: center">&nbsp;</TD>
    <TD STYLE="width: 23%; border-bottom: Black 1.5pt solid; text-align: center">Filing Date</TD>
    <TD STYLE="width: 2%; text-align: center">&nbsp;</TD>
    <TD STYLE="width: 25%; border-bottom: Black 1.5pt solid; text-align: center">Filing No./ Patent No.</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>International Procedure</TD>
    <TD>&nbsp;</TD>
    <TD>Entered National Phase</TD>
    <TD>&nbsp;</TD>
    <TD>20 Aug 2013</TD>
    <TD>&nbsp;</TD>
    <TD>PCT/CN2013/081900</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>US</TD>
    <TD>&nbsp;</TD>
    <TD>Filed</TD>
    <TD>&nbsp;</TD>
    <TD>19 Feb 2015</TD>
    <TD>&nbsp;</TD>
    <TD>14/422,642</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>China</TD>
    <TD>&nbsp;</TD>
    <TD>Filed</TD>
    <TD>&nbsp;</TD>
    <TD>9 Apr 2015</TD>
    <TD>&nbsp;</TD>
    <TD>201380052717.4</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>Hong Kong</TD>
    <TD>&nbsp;</TD>
    <TD>Filed</TD>
    <TD>&nbsp;</TD>
    <TD>3 Dec 2015</TD>
    <TD>&nbsp;</TD>
    <TD>15111955.3</TD></TR>
</TABLE>



<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></P>

<!-- Field: Page; Sequence: 32; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->32<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">Schedule C</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B><U>Milestones</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><B>&nbsp;</B></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 20%; border-bottom: Black 1.5pt solid; text-align: center">Milestones</TD>
    <TD STYLE="width: 1%; text-align: center">&nbsp;</TD>
    <TD STYLE="width: 58%; border-bottom: Black 1.5pt solid; text-align: center">Details</TD>
    <TD STYLE="width: 1%; text-align: center">&nbsp;</TD>
    <TD STYLE="width: 20%; border-bottom: Black 1.5pt solid; text-align: center">Deadline</TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="background-color: black">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="background-color: black">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="background-color: black">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="background-color: black">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></P></TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="background-color: black">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="background-color: black">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="background-color: black">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="background-color: black">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></P></TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="background-color: black">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="background-color: black">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="background-color: black">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>



<P STYLE="margin: 0"></P>

<!-- Field: Page; Sequence: 33; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->33<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.29
<SEQUENCE>33
<FILENAME>ff12018ex10-29_aptorum.htm
<DESCRIPTION>ADDENDUM TO LICENSE AGREEMENT FOR NLS-1 DATED FEBRUARY 9, 2018
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif; text-align: right"><B>Exhibit 10.2<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">9</FONT></B></P>

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; color: #1C1C1C"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ADDENDUM
TO LICENSE AGREEMENT</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 7.1pt 0pt 0; text-align: justify; text-indent: -0.15pt; color: #1C1C1C"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
Addendum, effective as of 9 February 2018, is hereby made a part of the License Agreement entered into as of 3 July 2017 (&ldquo;Agreement&rdquo;)
between Aptorum Therapeutics Limited (formerly known as APTUS Therapeutics Limited), hereinafter &ldquo;Aptorum&rdquo; on the
one part and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 7.1pt 0pt 0; text-align: justify; text-indent: -0.15pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; color: #1C1C1C; margin-top: 0; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">PolyU
Technology and Consultancy Co. Ltd. (&ldquo;PTeC&rdquo;),</FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; color: #1C1C1C; margin-top: 0; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Royal Institution for the Advancement of Learning/McGill University (&ldquo;McGill&rdquo;),</FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; color: #1C1C1C; margin-top: 0; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Wayne
State University (&ldquo;WSU&rdquo;),</FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; color: #1C1C1C; margin-top: 0; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(4)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">H.
Lee Moffitt Cancer Center and Research Institute Inc. (&ldquo;MCC&rdquo;) and</FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; color: #1C1C1C; margin-top: 0; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(5)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Chinese University of Hong Kong (&ldquo;CUHK&rdquo;)</FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 2.4pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 2.4pt 0pt 0; text-align: justify; text-indent: 0in; color: #1C1C1C"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">are
hereinafter referred to collectively as the &ldquo;Licensors&rdquo;.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 2.4pt 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 6.15pt 0pt 0; text-align: justify; text-indent: 0.3pt; color: #1C1C1C"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">WHEREAS,
the Parties have entered into a License Agreement dated 3 July 2017 whereby Licensors have licensed certain patent rights to APTUS
Therapeutics Limited as set out in the Agreement:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 6.15pt 0pt 0; text-align: justify; text-indent: 0.3pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.3pt; color: #1C1C1C"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">WHEREAS,
APTUS Therapeutics Limited changed its company name to Aptorum Therapeutics Limited effective from 19 September 2017;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.3pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.45pt; color: #1C1C1C"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">WHEREAS,
the company name change will have no impact on the Agreement and Aptorum will continue to perform all of its obligations under
the Agreement;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.45pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 4.6pt 0pt 0; text-align: justify; text-indent: 0.4pt; color: #1C1C1C"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">WHEREAS,
it is in the mutual best interests of Aptorum and Licensors to amend the Agreement to reflect this company name change; and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 4.6pt 0pt 0; text-align: justify; text-indent: 0.4pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: -0.1pt; color: #1C1C1C"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">WHEREAS,
all parties agree to amend said Agreement. NOW, THEREFORE, the parties hereto agree as follows:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: -0.1pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; color: #1C1C1C"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1)</FONT></TD><TD STYLE="text-align: justify; padding-right: 6.6pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Effective
                                         as of 19 September 2017 APTUS Therapeutics Limited changed its legal company name to
                                         Aptorum Therapeutics Limited.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 6.6pt 0pt 0.5in; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; color: #1C1C1C"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2)</FONT></TD><TD STYLE="text-align: justify; padding-right: 6.35pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Aptorum
                                         will continue to perform all of its duties, responsibilities, and obligations under the
                                         Agreement.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 6.35pt 0pt 0.5in; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; color: #1C1C1C"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Licensors
                                         hereby consent to continuing the Agreement with Aptorum.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; color: #1C1C1C"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4)</FONT></TD><TD STYLE="text-align: justify; padding-right: 5.85pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Where
                                         the term APTUS Therapeutics Limited shall appear in the original Agreement as amended,
                                         the term shall hereinafter mean and refer to Aptorum Therapeutics Limited.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 5.85pt 0pt 0.5in; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; color: #1C1C1C"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5)</FONT></TD><TD STYLE="text-align: justify; padding-right: 6pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Except
                                         as expressly amended hereby, all the remaining provisions of the Agreement shall remain
                                         in full force and effect.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 6pt 0pt 0.5in; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;</FONT></P>

<!-- Field: Page; Sequence: 1; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; color: #1C1C1C"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
Witness whereof the parties hereto have signed this Agreement on the date first above written.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; color: #1C1C1C"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">SIGNED
for and on behalf of</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 40%"><FONT STYLE="font-size: 10pt; color: #1C1C1C"><B>PolyU Technology and Consultancy Co. Ltd.</B></FONT></TD>
    <TD STYLE="width: 60%">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="border-bottom: Black 1.5pt solid"><FONT STYLE="font-size: 10pt">/s/ Miranda Lou</FONT></TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt"><I>Signature</I></FONT></TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="border-bottom: Black 1.5pt solid"><FONT STYLE="font-size: 10pt">Dr. Miranda Lou</FONT></TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt"><I>Printed Name</I></FONT></TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="border-bottom: Black 1.5pt solid"><FONT STYLE="font-size: 10pt">Director</FONT></TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt"><I>Title</I></FONT></TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="border-bottom: Black 1.5pt solid"><FONT STYLE="font-size: 10pt">12 JAN 2018</FONT></TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt"><I>Date</I></FONT></TD>
    <TD>&nbsp;</TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>[The
remainder of this page is intentionally left blank.]</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;&nbsp;</I></FONT></P>

<!-- Field: Page; Sequence: 2; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; color: #1C1C1C"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
Witness whereof the parties hereto have signed this Agreement on the date first above written.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; color: #1C1C1C"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">SIGNED
for and on behalf of</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; color: #1C1C1C"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>The
Royal Institution for the Advancement of Learning/McGill University</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; color: #1C1C1C"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;&nbsp;</B></FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 40%; border-bottom: Black 1.5pt solid">/<FONT STYLE="font-size: 10pt">s/ Martha Crago</FONT></TD>
    <TD STYLE="width: 60%">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt"><I>Signature</I></FONT></TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="border-bottom: Black 1.5pt solid"><FONT STYLE="font-size: 10pt">Prof. Martha Crago</FONT></TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt"><I>Printed Name</I></FONT></TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="border-bottom: Black 1.5pt solid"><FONT STYLE="font-size: 10pt">Vice-Principal Research &amp; Innovation</FONT></TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt"><I>Title</I></FONT></TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="border-bottom: Black 1.5pt solid"><FONT STYLE="font-size: 10pt">11/14/17</FONT></TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt"><I>Date</I></FONT></TD>
    <TD>&nbsp;</TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>[The
remainder of this page is intentionally left blank.]</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;&nbsp;</I></FONT></P>

<!-- Field: Page; Sequence: 3; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; color: #1C1C1C"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
Witness whereof the parties hereto have signed this Agreement on the date first above written.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; color: #1C1C1C"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">SIGNED
for and on behalf of</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; color: #1C1C1C"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Wayne
State University</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; color: #1C1C1C"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;&nbsp;</B></FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 40%; border-bottom: Black 1.5pt solid"><FONT STYLE="font-size: 10pt">/s/ Joan Dunbar</FONT></TD>
    <TD STYLE="width: 60%">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt"><I>Signature</I></FONT></TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="border-bottom: Black 1.5pt solid"><FONT STYLE="font-size: 10pt">Joan Dunbar, PhD</FONT></TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt"><I>Printed Name</I></FONT></TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="border-bottom: Black 1.5pt solid"><FONT STYLE="font-size: 10pt">Associate Vice President Technology Committee</FONT></TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt"><I>Title</I></FONT></TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="border-bottom: Black 1.5pt solid"><FONT STYLE="font-size: 10pt">Nov 3, 2017</FONT></TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt"><I>Date</I></FONT></TD>
    <TD>&nbsp;</TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>[The
remainder of this page is intentionally left blank.]</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I>&nbsp;</FONT></P>

<!-- Field: Page; Sequence: 4; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; color: #1C1C1C"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
Witness whereof the parties hereto have signed this Agreement on the date first above written.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; color: #1C1C1C"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">SIGNED
for and on behalf of</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; color: #1C1C1C"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>H.
Lee Moffitt Cancer Center and Research Institute Inc.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; color: #1C1C1C"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;&nbsp;</B></FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 40%; border-bottom: Black 1.5pt solid"><FONT STYLE="font-size: 10pt">/s/ James K. Mule</FONT></TD>
    <TD STYLE="width: 60%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt"><I>Signature</I></FONT></TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="border-bottom: Black 1.5pt solid"><FONT STYLE="font-size: 10pt">James J. Mule, PhD</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt"><I>Printed Name</I></FONT></TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="border-bottom: Black 1.5pt solid"><FONT STYLE="font-size: 10pt">Associate Center Director, Translational Science</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt"><I>Title</I></FONT></TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="border-bottom: Black 1.5pt solid"><FONT STYLE="font-size: 10pt">11/6/17</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt"><I>Date</I></FONT></TD>
    <TD>&nbsp;</TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>[The
remainder of this page is intentionally left blank.]</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I>&nbsp;</FONT></P>

<!-- Field: Page; Sequence: 5; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; color: #1C1C1C"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
Witness whereof the parties hereto have signed this Agreement on the date first above written.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; color: #1C1C1C"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">SIGNED
for and on behalf of</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; color: #1C1C1C"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>The
Chinese University of Hong Kong</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; color: #1C1C1C"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;&nbsp;</B></FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 40%; border-bottom: Black 1.5pt solid"><FONT STYLE="font-size: 10pt">/s/ Walter K.K. Ho</FONT></TD>
    <TD STYLE="width: 60%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt"><I>Signature</I></FONT></TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="border-bottom: Black 1.5pt solid"><FONT STYLE="font-size: 10pt">Walter K.K. Ho (Prof)</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt"><I>Printed Name</I></FONT></TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="border-bottom: Black 1.5pt solid"><FONT STYLE="font-size: 10pt">Director</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt"><I>Title</I></FONT></TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="border-bottom: Black 1.5pt solid"><FONT STYLE="font-size: 10pt">03 JAN 2018</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt"><I>Date</I></FONT></TD>
    <TD>&nbsp;</TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>[The
remainder of this page is intentionally left blank.]</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<!-- Field: Page; Sequence: 6; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 157.2pt"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.30
<SEQUENCE>34
<FILENAME>ff12018ex10-30_aptorum.htm
<DESCRIPTION>EXCLUSIVE PATENT LICENSE AGREEMENT FOR ALS-1
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin-top: 0; text-align: right; margin-bottom: 0"><B>Exhibit 10.30</B></P>

<P STYLE="margin-top: 0; text-align: right; margin-bottom: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">[CONFIDENTIAL TREATMENT HAS BEEN REQUESTED AS TO CERTAIN PORTIONS
OF THIS DOCUMENT. EACH SUCH PORTION, WHICH HAS BEEN OMITTED HEREIN AND REPLACED WITH BLACK BARS, HAS BEEN FILED SEPARATELY WITH
THE SECURITIES AND EXCHANGE COMMISSION.]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B> VERSITECH LIMITED</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>and</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="text-transform: uppercase"><B>ACTICULE
LIFE SCIENCES</B></FONT><B> LIMITED</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Rule-Page --><DIV ALIGN="CENTER" STYLE="margin-top: 0; margin-bottom: 0"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid; width: 50%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>EXCLUSIVE PATENT LICENSE AGREEMENT</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Rule-Page --><DIV ALIGN="CENTER" STYLE="margin-top: 0; margin-bottom: 0"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid; width: 50%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>


<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><U>TABLE OF CONTENTS</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD COLSPAN="2">R E C I T A L S</TD>
    <TD STYLE="text-align: center">1</TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD STYLE="width: 4%">1.&nbsp;&nbsp;</TD>
    <TD STYLE="width: 84%">DEFINITIONS</TD>
    <TD STYLE="text-align: center; width: 10%">2</TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD>2.&nbsp;&nbsp;</TD>
    <TD>Grant of Rights</TD>
    <TD STYLE="text-align: center">7</TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD>3.&nbsp;&nbsp;</TD>
    <TD>LICENSEE Diligence Obligations</TD>
    <TD STYLE="text-align: center">10</TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD>4.&nbsp;&nbsp;</TD>
    <TD>Royalties and Payment Terms</TD>
    <TD STYLE="text-align: center">11</TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD>5.&nbsp;&nbsp;</TD>
    <TD>Reports and Records</TD>
    <TD STYLE="text-align: center">14</TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD>8.&nbsp;&nbsp;</TD>
    <TD>Infringement</TD>
    <TD STYLE="text-align: center">18</TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD>9.&nbsp;&nbsp;</TD>
    <TD>Indemnification and Insurance</TD>
    <TD STYLE="text-align: center">20</TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD>11.&nbsp;&nbsp;</TD>
    <TD>Assignment</TD>
    <TD STYLE="text-align: center">21</TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD>12.&nbsp;&nbsp;</TD>
    <TD>General Compliance with Laws</TD>
    <TD STYLE="text-align: center">22</TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD>13.&nbsp;&nbsp;</TD>
    <TD>Termination</TD>
    <TD STYLE="text-align: center">23</TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD>14.&nbsp;&nbsp;</TD>
    <TD>Dispute Resolution</TD>
    <TD STYLE="text-align: center">25</TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD>15.&nbsp;&nbsp;</TD>
    <TD>GOVERNING LAW</TD>
    <TD STYLE="text-align: center">25</TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD>16.&nbsp;&nbsp;</TD>
    <TD>Miscellaneous</TD>
    <TD STYLE="text-align: center">25</TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD COLSPAN="2"><B>SCHEDULE 1</B></TD>
    <TD STYLE="text-align: center">29</TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD COLSPAN="2"><B>SCHEDULE 2</B></TD>
    <TD STYLE="text-align: center">30</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.5in 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 2; Options: NewSection -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: LowerRoman; Name: PageNo -->i<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>THIS LICENCE AGREEMENT (&ldquo;Agreement&rdquo;) </B>is
made the &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; day of 2017. (&ldquo;<FONT STYLE="font-family: Times New Roman, Times, Serif">EFFECTIVE
DATE&rdquo;)</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">BETWEEN:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0"></TD><TD STYLE="width: 40pt; text-align: left">(1)</TD><TD STYLE="text-align: justify"><B>VERSITECH LIMITED</B>, a company incorporated and existing
under the laws of Hong Kong with its office at Room 405A, Cyberport 4, 100 Cyberport Road, Hong Kong (&ldquo;LICENSOR&rdquo;); and</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">(2)</TD><TD STYLE="text-align: justify"><FONT STYLE="text-transform: uppercase"><B>ACTICULE LIFE SCIENCES </B></FONT><B>LIMITED</B><FONT STYLE="font-family: Times New Roman, Times, Serif">,
with incorporation number CB-324541, a company incorporated</FONT> and existing under the laws of the Cayman Islands, with its
<FONT STYLE="font-family: Times New Roman, Times, Serif">registered office at Floor 4, Willow House, Cricket Square, Grand Cayman
KY1-9010, Cayman Islands with its management office at Floor 17, Guangdong Investment Tower, 148 Connaught Road Central, Hong Kong</FONT>
(&ldquo;LICENSEE&rdquo;).</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in">(&ldquo;LICENSOR&rdquo; and &ldquo;LICENSEE&rdquo;
shall be hereinafter referred to separately by a &ldquo;PARTY&rdquo; or jointly by &ldquo;PARTIES&rdquo;)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center"><U>R E C I T
A L S</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">(A)</TD><TD STYLE="text-align: justify">WHEREAS, LICENSOR is the OWNER of certain LICENSED PATENT (as later defined herein);</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(B)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">WHEREAS, LICENSOR</FONT> has the right
to grant licenses under such LICENSED PATENT;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(C)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">WHEREAS, LICENSOR</FONT> desires to have
the LICENSED PATENT developed and commercialized to benefit the public and is willing to grant a license thereunder;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(D)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">WHEREAS, LICENSEE </FONT>has represented
to LICENSOR, to induce LICENSOR to enter into this Agreement, that LICENSEE shall commit itself to use COMMERCIALLY REASONABLE
EFFORTS to exploit the LICENSED PATENT so that public utilization shall eventually result therefrom; and</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">(E)</TD><TD STYLE="text-align: justify">WHEREAS, LICENSEE desires to obtain a license under the LICENSED PATENT upon the terms and conditions
hereinafter set forth.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">NOW IT IS HEREBY AGREED as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-transform: uppercase; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><U>1.
</U></FONT><U>DEFINITIONS.</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">1.1</TD><TD STYLE="text-align: justify">&ldquo;DEFINITIONS. All capitalized terms used but not otherwise defined herein shall have the meaning
set forth in the Agreement.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">1.2</TD><TD STYLE="text-align: justify">&ldquo;APPLICABLE LAWS&rdquo; shall mean applicable laws, rules and regulations, including any
rules, regulations, guidelines or other requirements of the REGULATORY AUTHORITIES (as defined below), that may be in effect from
time to time, including but not limited to those of the FDA, the cGMP and FDA Act, if applicable.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">1.3</TD><TD STYLE="text-align: justify">&ldquo;<U>AFFILIATE</U>&rdquo; shall mean any legal entity (such as a corporation, partnership, or
limited liability company) that is controlled by LICENSEE. For the purposes of this definition, the term &ldquo;control&rdquo; means
(i) beneficial ownership of at least fifty percent (50%) of the voting securities of a corporation or other business organization
with voting securities or (ii) a fifty percent (50%) or greater interest in the net assets or profits of a partnership or other
business organization without voting securities.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">1.4</TD><TD STYLE="text-align: justify">&ldquo;CMC&rdquo; means chemistry, manufacturing, and controls activities related to LICENSED PRODUCT.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<!-- Field: Page; Sequence: 4; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">1.5</TD><TD STYLE="text-align: justify">&ldquo;<U>COMMERCIALLY REASONABLE EFFORTS</U>&rdquo; shall mean, with respect to a Party, those
commercially reasonable efforts by that Party similar to the efforts that Party, in good faith, would make in similar circumstances
for its own operations without procrastination, taking into consideration safety and efficacy, costs, the market potential of the
product, the stage of its development or product life, the clinical setting in which it is expected to be used, competitiveness
of the marketplace, regulatory environment, the patent or other proprietary position of the product, and other conditions then
prevailing. It is understood that a party&rsquo;s COMMERCIALLY REASONABLE EFFORTS will not in any event require that Party to take
any action that would be reasonably likely to result in a breach of any other provision of this Agreement, or that the Party in
good faith believes may violate any Applicable Law or any order, permit, direction or license of any court or governmental authority
having appropriate jurisdiction over the party and subject matter.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">1.6</TD><TD STYLE="text-align: justify">&ldquo;CONFIDENTIAL INFORMATION&rdquo; shall mean all proprietary materials or other information
(whether or not patentable) regarding a Party&rsquo;s technology, products, business information or objectives, including CMC,
manufacturing and marketing information, and clinical data, that is identified as proprietary or confidential by the disclosing
Party or that would be reasonably understood to be the type of materials or information that should be treated as proprietary or
confidential. The terms and conditions of this Agreement, the transactions described herein, and the Parties&rsquo; rights or obligations
hereunder shall be considered Confidential Information of both Parties.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">1.7</TD><TD STYLE="text-align: justify">&ldquo;<U>EFFECTIVE DATE</U>&rdquo; shall mean the date of this Agreement.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 24pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">1.8</TD><TD STYLE="text-align: justify">&ldquo;<U>EXCLUSIVE PERIOD</U>&rdquo; shall mean the period of time set forth in Clause 2.2.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 24pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">1.9</TD><TD STYLE="text-align: justify">&ldquo;<U>FDA</U>&rdquo; shall mean the United States Food and Drug Administration or any successor
agency.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">1.10</TD><TD>&ldquo;<U>FDA Act</U>&rdquo; shall mean the U.S. Federal Food, Drug, and Cosmetic Act, as amended from time to time, and the
regulations promulgated thereunder.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">1.11</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&ldquo;<U>FIELD</U>&rdquo; shall mean</FONT>
any and all human and non-human therapeutic uses, prescription and over-the-counter medications and preventatives, for <FONT STYLE="font-family: Times New Roman, Times, Serif">the
treatment or prevention of Influenza.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 24pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">1.12</TD><TD STYLE="text-align: justify">&ldquo;<U>HONG KONG</U>&rdquo; shall mean the Hong Kong Special Administrative Region.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 24pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">1.13</TD><TD STYLE="text-align: justify">&ldquo;<U>IMPROVEMENT</U>&rdquo; shall mean any development or modification in the FIELD related
to the LICENSED PATENT or part thereof, or relating to the production and/or exploitation thereof, whether or not patented or patentable,
that is conceived, reduced to practice, discovered, developed or otherwise made at any time during the TERM of this Agreement.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<!-- Field: Page; Sequence: 5; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">1.14</TD><TD STYLE="text-align: justify">&ldquo;<U>IND</U>&rdquo; shall mean (a) an Investigational New Drug Application (as defined in
21 U.S. Code of Federal Regulations 312.3) that is required to be filed with the FDA before beginning clinical testing of a product
in human subjects, or any successor application or procedure or (b) any counterpart of a U.S. Investigational New Drug Application
that is required in any other country or region in the Territory before beginning clinical testing of a product in human subjects
in such country or region.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">1.15</FONT></TD><TD STYLE="text-align: justify">&ldquo;<U>LICENSED PRODUCT</U>&rdquo; shall mean any product that, in whole or in part:</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in; text-align: left">(i)</TD><TD STYLE="text-align: justify">absent THE LICENSE granted hereunder, would infringe
one or more claims of the LICENSED PATENT in the country of sale; or</TD>
</TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(ii)</TD><TD STYLE="text-align: justify">is manufactured by using any method that, absent THE LICENSE granted, would infringe one or more
claims of the <FONT STYLE="font-family: Times New Roman, Times, Serif">LICENSED PATENT</FONT>.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">1.16</TD><TD STYLE="text-align: justify">&ldquo;<U>LICENSED PATENT</U>&rdquo; shall mean:</TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(i)</TD><TD STYLE="text-align: justify">The United States and foreign patents, patent applications, and provisional applications listed
in <U>Schedule 1</U>, and all applications and patents claiming priority thereto or common priority therewith and any resulting
patents therefrom; and</TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(ii)</TD><TD STYLE="text-align: justify">any divisions, reissues, reexaminations, renewals, continuations, continuations-in-part and extensions
of the patent applications or patent listed in <U>Schedule 1</U> including their relevant international equivalents thereof and
any patens that result therefrom.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 71.4pt; text-align: justify; text-indent: 0in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">1.17</TD><TD STYLE="text-align: justify">&ldquo;<U>NDA</U>&rdquo; shall mean New Drug Application to market the LICENSED PRODUCT in the
Territory or similar application submitted to the FDA, or its foreign equivalent submitted to any Regulatory Authority in the Territory,
and all supplements and amendments thereto.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">1.18</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&ldquo;<U>NET SALES</U>&rdquo; shall mean
the invoiced price of LICENSED PRODUCT sold by LICENSEE and/ or its AFFILIATES </FONT>to independent third parties in arm&rsquo;s length
transactions exclusively for money or, where the sale is not at arm&rsquo;s length, the price that would have been so invoiced if it
had been at arm&rsquo;s length, after deduction of:-</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(i)</FONT></TD><TD STYLE="text-align: justify">normal trade discounts actually granted and credits actually given to the returned goods<FONT STYLE="font-family: Times New Roman, Times, Serif">;
</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<!-- Field: Page; Sequence: 6; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(ii)</FONT></TD><TD STYLE="text-align: justify">costs of packaging, freight and its corresponding insurance; and</TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(iii)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">import expenses and other relevant tax,
duties or similar government levies actually paid </FONT>on LICENSED PRODUCT.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The calculation of NET SALES
is set out in <U>Schedule 2</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif">In
the event </FONT>LICENSED PRODUCT <FONT STYLE="font-family: Times New Roman, Times, Serif">sold in combination with other licensed
products or patents, the NET SALES of such LICENSED PRODUCT used for determining the ROYALTY due to LICENSOR shall be calculated
<FONT STYLE="background-color: black">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="background-color: black">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="background-color: black"></FONT></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">No deductions
shall be made for commissions paid to individuals whether they be with independent sales agencies or regularly employed by LICENSEE
and on its payroll, or for cost of collections. NET SALES shall occur on the date of billing for a LICENSED PRODUCT. If a LICENSED
PRODUCT is distributed at a discounted price that is substantially lower than the customary price charged by LICENSEE, or distributed
for non-cash consideration (whether or not at a discount), NET SALES shall be calculated based on the non-discounted amount of
LICENSED PRODUCT charged to an independent third party during the same REPORTING PERIOD or, in the absence of such sales, on the
fair market value of LICENSED PRODUCT.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Non-monetary
consideration shall <B><U>NOT</U></B> be accepted by LICENSEE for any LICENSED PRODUCT without the prior written consent of LICENSOR.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">1.19</FONT></TD><TD STYLE="text-align: justify">&ldquo;<U>NON-COMMERCIAL RESEARCH, TEACHING, AND EDUCATIONAL PURPOSES</U>&rdquo; shall mean use
of LICENSED PATENT for academic research or other not-for-profit scholarly purposes which are undertaken at a nonprofit or governmental
institution that does not use the LICENSED PATENT in the production or manufacture of products for sale or the performance of services
for a fee.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">1.20</TD><TD STYLE="text-align: justify">&ldquo;<U>REGULATORY APPROVAL</U>&rdquo; shall mean approval by corresponding REGULATORY AUTHORITY,
including but not limited to FDA, to market LICENSED PRODUCT in the FIELD in the TERRITORY.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<!-- Field: Page; Sequence: 7; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">1.21</TD><TD STYLE="text-align: justify">&ldquo;<U>REGULATORY AUTHORITY</U>&rdquo; shall mean any applicable supra-national, federal, national,
regional, state, provincial or local regulatory agencies, departments, bureaus, commissions, councils or other government entities
regulating or otherwise exercising authority with respect to the distribution, importation, exportation, manufacture, production,
use, storage, transport, or clinical testing, pricing or sale of LICENSED PRODUCT in the FIELD in the TERRITORY, including the
FDA or any counterpart of the FDA outside the United States.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">1.22</TD><TD STYLE="text-align: justify">&ldquo;<U>REPORTING PERIOD</U>&rdquo; shall begin on the first day of each calendar year and end
on the last day of such calendar year and (i) the first REPORTING PERIOD shall mean the period from the EFFECTIVE DATE to the last
day of the next following calendar year; and (ii) the last REPORTING PERIOD shall mean the period from the first day of the calendar
year to which this Agreement is terminated to the termination date of this Agreement.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 71.4pt; text-align: justify; text-indent: 0in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">1.23</TD><TD STYLE="text-align: justify">&ldquo;<U>SUBLICENSEES</U>&rdquo; shall mean any non-AFFILIATE sublicensees of the rights granted
by LICENSEE under Clause 2.3.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">1.24</TD><TD STYLE="text-align: justify">&ldquo;<U>SUBLICENSE INCOME</U>&rdquo; shall mean all considerations that LICENSEE or an AFFILIATE
receives from SUBLICENSEES in consideration of the sublicense of the rights granted LICENSEE and AFFILIATES under Clause 2.1, including
without limitation license fees, milestone payments, license maintenance fees, and other payments.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">1.25</TD><TD STYLE="text-align: justify">&ldquo;<U>TERM</U>&rdquo; shall mean the term of this Agreement, which shall commence on the EFFECTIVE
DATE and shall remain in effect until the expiration of all issued patents and filed patent application within the LICENSED PATENT
unless earlier terminated in accordance with the provisions of this Agreement.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 24pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">1.26</TD><TD STYLE="text-align: justify">&ldquo;<U>TERRITORY</U>&rdquo; shall mean worldwide.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">1.27</TD><TD STYLE="text-align: justify">&ldquo;<U>US DOLLARS</U>&rdquo; shall mean the United States Dollars, the lawful currency of the
United States of America.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">1.28</TD><TD STYLE="text-align: justify">&ldquo;VALID CLAIM&rdquo; shall mean a claim of an unexpired issued patent or pending patent application
falling within LICENSED PATENT, which claim shall not have been withdrawn, cancelled, disclaimed, or held invalid by a court, tribunal,
arbitrator, or governmental agency of competent jurisdiction in a final or unappealed or unappealable decision.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<!-- Field: Page; Sequence: 8; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center"><U>2. Grant
of Rights.</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">2.1</FONT></TD><TD STYLE="text-align: justify"><U>License Grants</U>. Subject to the terms and conditions of this Agreement, LICENSOR hereby grants
to LICENSEE and its AFFILIATES for the TERM an exclusive and royalty-bearing license (&ldquo;THE LICENSE&rdquo;), with the right
to grant sublicenses pursuant to Clause 2.3, under the LICENSED PATENT in the FIELD to develop, make, have made, use, sell, offer
for sell, and import LICENSED PRODUCT in the FIELD in the TERRITORY during the TERM of this Agreement.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">2.2</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><U>Exclusivity</U>. In order to establish
an exclusive period for LICENSEE, LICENSOR agrees that it shall not grant any other license under LICENSED PATENT in the FIELD
to </FONT>develop, make, have made, use, sell, offer for sell, and import <FONT STYLE="font-family: Times New Roman, Times, Serif">LICENSED
PRODUCT in the FIELD in the TERRITORY during the period of time commencing on the EFFECTIVE DATE and terminating with the first
occurrence of:</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 24pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">(i)</FONT></TD><TD STYLE="text-align: justify">the end of the TERM; or</TD>
</TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">(ii)</FONT></TD><TD STYLE="text-align: justify">the expiration of all the LICENSED PATENT; or</TD>
</TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">(iii)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">all
LICENSED PATENT are finally and irrevocably</FONT> invalidated by a court or government agency with competent jurisdiction<FONT STYLE="font-family: Times New Roman, Times, Serif">.</FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">Upon expiration
of the EXCLUSIVE PERIOD, THE LICENSE granted hereunder shall become nonexclusive and shall extend to the end of the TERM (if any),
unless sooner terminated as provided in this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 24pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">2.3</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><U>Sublicenses</U>.
During the EXCLUSIVE PERIOD, LICENSEE and/ or its AFFILIATES shall have the right to grant sublicenses, without the right to further
sublicense, </FONT>to any non-Affiliates sublicensees (&ldquo;SUBLICENSEES&rdquo;) under THE LICENSE subject to a sublicensing
agreement. Any sublicensing agreements shall be consistent with and subject to the terms and conditions of this Agreement, any
such sublicense shall oblige the SUBLICENSEES to comply with all the terms of this Agreement (except those provisions which, by
their clear meaning, are not applicable to a SUBLICENSEES) and that LICENSEE will remain liable to LICENSOR for all material acts
and omissions of any such SUBLICENSEES. THE LICENSE granted under this Agreement and any sublicensing agreements do not include
rights to trade names of LICENSOR. LICENSEE shall promptly furnish LICENSOR with notice of any sublicense granted pursuant to
this Section 2.3, and provide a copy of the executed sublicense agreement (which may be redacted for financial terms).</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<!-- Field: Page; Sequence: 9; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">2.4</TD><TD STYLE="text-align: justify"><U>Retained Rights.</U></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(a)</FONT></TD><TD STYLE="text-align: justify"><U>LICENSOR</U>. LICENSOR retains the right to use the LICENSED PATENT solely for NON-COMMERCIAL
RESEARCH, TEACHING, AND EDUCATIONAL PURPOSES in the FIELD in the TERRITORY.</TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(b)</FONT></TD><TD STYLE="text-align: justify"><U>Academic and Not-For-Profit Research Institutes</U>. LICENSOR retains the right to grant licenses
to academic and not-for-profit research institutes to practice under the LICENSED PATENT solely NON-COMMERCIAL RESEARCH, TEACHING,
AND EDUCATIONAL PURPOSES in the FIELD in the TERRITORY.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">2.5</FONT></TD><TD STYLE="text-align: justify"><U>No Additional Rights</U>. Nothing in this Agreement shall be construed to confer any rights
upon LICENSEE by implication, estoppel, or otherwise as to any technology or patent rights of LICENSOR or any other entity other
than the LICENSED PATENT, regardless of whether such technology or patent rights shall be dominant or subordinate to any LICENSED
PATENT.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">2.6</TD><TD STYLE="text-align: justify"><U>Confidentiality obligations</U>. Each Party (&ldquo;RECEIVING PARTY&rdquo;) shall:</TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">maintain as secret and
confidential all CONFIDENTIAL INFORMATION of the other PARTY (</FONT>&ldquo;<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">DISCLOSING
PARTY&rdquo;) in the course of or in anticipation of this Agreement and to respect the DISCLOSING PARTY&rsquo;s rights therein,</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(b)</TD><TD STYLE="text-align: justify">use the CONFIDENTIAL INFORMATION of the other PARTY only to the extent necessary for the purposes
of, or as contemplated or permitted by, this Agreement,</TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(c)</TD><TD STYLE="text-align: justify">protect the other PARTY&rsquo;S CONFIDENTIAL INFORMATION using not less than the same standard
of care with which the RECEIVING PARTY treats its own CONFIDENTIAL INFORMATION, and at all times using at least reasonable care.</TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(d)</TD><TD STYLE="text-align: justify">not at any time disclose any CONFIDENTIAL INFORMATION of the other PARTY to persons other than
those listed under Clause 2.8 with a need to know, except where permitted by this Agreement and subject to a written undertakings
of confidentiality at least as restrictive as Clauses 2.6 and 2.7, and only to the extent that such disclosure is reasonably necessary
for the purposes of, or as contemplated or permitted by, this Agreement.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<!-- Field: Page; Sequence: 10; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-weight: normal">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-weight: normal">2.7</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-weight: normal"><U>Exceptions to obligations</U>. The provisions of Clause 2.6
shall not apply to any CONFIDENTIAL INFORMATION which the RECEIVING PARTY can demonstrate by reasonable written evidence:</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(a)</TD><TD STYLE="text-align: justify">was, prior to its receipt by the RECEIVING PARTY from the DISCLOSING PARTY, known by the RECEIVING
PARTY and at its free disposal; or</TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(b)</TD><TD STYLE="text-align: justify">is subsequently disclosed to the RECEIVING PARTY without any obligations of confidence by a third
party owing to the DISCLOSING PARTY; or</TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(c)</TD><TD STYLE="text-align: justify">is or becomes generally available to the public through no breach or default of this Agreement
by RECEIVING PARTY or its agents, employees, AFFILIATES or SUBLICENSEES; or</TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(d)</TD><TD STYLE="text-align: justify">is independently developed as established by the RECEIVING PARTY without use of the DISCLOSING
PARTY&rsquo;s CONFIDENTIAL INFORMATION as proven by the contemporaneous written records of the RECEIVING PARTY; or</TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 34.9pt"></TD><TD STYLE="width: 0.5in">(e)</TD><TD STYLE="text-align: justify">the RECEIVING PARTY is required to disclose to the courts of any competent jurisdiction, or to
any government regulatory agency or financial authority, provided that the RECEIVING PARTY shall:</TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in; text-align: left">(i)</TD><TD STYLE="text-align: justify">inform the DISCLOSING PARTY as soon as is reasonably
practicable, and</TD>
</TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in; text-align: left">(ii)</TD><TD STYLE="text-align: justify">at the DISCLOSING PARTY&rsquo;s request and cost seek
to persuade the court, agency or authority to have the information treated in a confidential manner, where this is possible under
the court, agency or authority&rsquo;s procedures; or</TD>
</TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in; text-align: left">(f)</TD><TD STYLE="text-align: justify">the RECEIVING PARTY is obligated by applicable law
to disclose provided that the RECEIVING PARTY shall inform the DISCLOSING PARTY before such disclosure; or</TD>
</TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(g)</TD><TD STYLE="text-align: justify">in the case of information disclosed by LICENSOR to LICENSEE, is disclosed to actual or potential
customers for LICENSED PRODUCT in so far as such disclosure is reasonably necessary to promote the sale or use of LICENSED PRODUCT.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-weight: normal">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-weight: normal">2.8</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-weight: normal"><U>Disclosure to employees.</U> The RECEIVING PARTY shall procure
that all of its employees, contractors, affiliates, any appointed agents and/or distributors pursuant to this Agreement (if any)
who have access to any of the DISCLOSING PARTY&rsquo;s information to which Clause 2.6 applies, shall be made aware of and subject
to these obligations and shall have entered into written undertakings of confidentiality at least as restrictive as Clauses 2.6
and 2.7 and which apply to the DISCLOSING PARTY&rsquo;s information.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<!-- Field: Page; Sequence: 11; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center"><U>3. LICENSEE
Diligence Obligations.</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0"></TD><TD STYLE="width: 40pt; text-align: left"><FONT STYLE="font-weight: normal">3.1</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-weight: normal"><U>Diligence
Requirements.</U>&nbsp;LICENSEE shall use its COMMERCIALLY REASONABLE EFFORTS to develop LICENSED PRODUCT for commercial use as
soon as practicable, and to continue active, diligent marketing efforts for LICENSED PRODUCT throughout the TERM of this Agreement.
During the continuance of the EXCLUSIVE PERIOD, LICENSEE shall make its best efforts to raise no less than <FONT STYLE="background-color: black">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>of fund in 10 years from the EFFECTIVE DATE for fulfilling the DILIGENCE REQUIREMENT (as defined below) including no less
than <FONT STYLE="background-color: black">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>prior to the pre-clinical studies and such <FONT STYLE="background-color: black">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>shall be used for the pre-clinical studies. LICENSEE shall, or shall cause its AFFILIATES and SUBLICENSEES to, use COMMERCIALLY
REASONABLE EFFORTS to develop LICENSED PRODUCT, to obtain any regulatory approvals and to introduce LICENSED PRODUCT in the FIELD
in the TERRITORY. Specifically, LICENSEE shall, or shall cause its AFFILIATES and SUBLICENSEES to, conduct the followings <FONT STYLE="background-color: black">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in; text-align: justify"></TD><TD STYLE="width: 0.5in; text-align: justify"><FONT STYLE="background-color: black">&nbsp;&nbsp;&nbsp;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="background-color: black">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<BR>
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in; text-align: justify"></TD><TD STYLE="width: 0.5in; text-align: justify"><FONT STYLE="background-color: black">&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="background-color: black">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<BR>
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in; text-align: justify"></TD><TD STYLE="width: 0.5in; text-align: justify"><FONT STYLE="background-color: black">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="background-color: black">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<BR>
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">
<TR STYLE="vertical-align: top">
<TD STYLE="text-align: justify; width: 1in"></TD><TD STYLE="text-align: justify; width: 0.5in"><FONT STYLE="background-color: black">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="background-color: black">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<BR>
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD></TR>
</TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in; text-align: justify"></TD><TD STYLE="width: 0.5in; text-align: justify"><FONT STYLE="background-color: black">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="background-color: black">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<BR>
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">
<TR STYLE="vertical-align: top">
<TD STYLE="text-align: justify; width: 1in"></TD><TD STYLE="text-align: justify; width: 0.5in">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD><TD STYLE="text-align: justify"><FONT STYLE="background-color: black">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<BR>
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD></TR>
</TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">
<TR STYLE="vertical-align: top">
<TD STYLE="text-align: justify; width: 1in"></TD><TD STYLE="text-align: justify; width: 0.5in">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD><TD STYLE="text-align: justify"><FONT STYLE="background-color: black">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<BR>
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD></TR>
</TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">
<TR STYLE="vertical-align: top">
<TD STYLE="text-align: justify; width: 1in"></TD><TD STYLE="text-align: justify; width: 0.5in">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD><TD STYLE="text-align: justify"><FONT STYLE="background-color: black">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<BR>
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD></TR>
</TABLE>

<!-- Field: Page; Sequence: 12; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">
<TR STYLE="vertical-align: top">
<TD STYLE="text-align: justify; width: 1in"></TD><TD STYLE="text-align: justify; width: 0.5in">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD><TD STYLE="text-align: justify"><FONT STYLE="background-color: black">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<BR>
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD></TR>
</TABLE>

<P STYLE="margin: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">
<TR STYLE="vertical-align: top">
<TD STYLE="text-align: justify; width: 1in"><P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>
                                <P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P></TD><TD STYLE="text-align: justify; width: 0.5in">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD><TD STYLE="text-align: justify"><FONT STYLE="background-color: black">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<BR>
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
<TD STYLE="text-align: justify">&nbsp;</TD><TD STYLE="text-align: justify">&nbsp;</TD><TD STYLE="text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
<TD STYLE="text-align: justify"></TD><TD STYLE="text-align: justify">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD><TD STYLE="text-align: justify"><FONT STYLE="background-color: black">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<BR>
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">
<TR STYLE="vertical-align: top">
<TD STYLE="text-align: justify; width: 1in"><P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>
                                <P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P></TD><TD STYLE="text-align: justify; width: 0.5in">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD><TD STYLE="text-align: justify"><FONT STYLE="background-color: black">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<BR>
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
<TD STYLE="text-align: justify">&nbsp;</TD><TD STYLE="text-align: justify">&nbsp;</TD><TD STYLE="text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
<TD STYLE="text-align: justify"></TD><TD STYLE="text-align: justify">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD><TD STYLE="text-align: justify"><FONT STYLE="background-color: black">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<BR>
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">LICENSEE
shall furnish LICENSOR with a written report annually on the progress of its efforts to develop and commercialize LICENSED PRODUCT
in according to Clause 3 hereto.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">If LICENSEE
intentionally delays or has failed to perform its diligence obligations under this Clause 3.1 and does not provide any reasonable
remedy within one (1) month from a written notice issued by LICENSOR, LICENSOR may treat such delay or failure as a material breach
in accordance with Clause 13.4(b).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center"><U>4. Royalties
and Payment Terms.</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0"></TD><TD STYLE="width: 40pt; text-align: left">4.1</TD><TD STYLE="text-align: justify"><U>Consideration for Grant of Rights</U>.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">4.1.1</TD><TD STYLE="text-align: justify"><U>Patent Cost Reimbursement.</U> LICENSEE shall reimburse LICENSOR for all its actual expenses
incurred in connection with filing, prosecuting and maintaining the LICENSED PATENT as set forth in Clause 7.4 within thirty (30)
days from the date of receiving an original signed invoice. These payments are non-refundable.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">4.1.2</TD><TD STYLE="text-align: justify"><U>Upfront Fee.</U> LICENSEE shall pay to LICENSOR an upfront fee of <FONT STYLE="background-color: black">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
                                                                 &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>
                                                                 within thirty (30) days from the date of receiving an original signed invoice after the EFFECTIVE DATE. Such UPFRONT FEE is
                                                                 non-refundable.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 24pt">&nbsp;</P>

<!-- Field: Page; Sequence: 13; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 24pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in; text-align: left">4.1.3</TD><TD STYLE="text-align: justify"><U>Royalties</U>. LICENSEE shall pay to LICENSOR a
royalty (&ldquo;ROYALTY&rdquo;) equal to <FONT STYLE="background-color: black">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT> of NET SALES of LICENSED
PRODUCT in the TERRITORY by LICENSEE or its AFFILIATES. For the avoidance of doubt and subject to the Sublicense Royalty as set
forth in this Clause 4.1.3, income generated from NET SALES of LICENSED PRODUCT does not include income generated from SUBLICENSE
INCOME.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 24pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.9pt; text-align: justify; text-indent: 0in">ROYALTY shall
be payable for each REPORTING PERIOD and shall be due to LICENSOR within sixty (60) days of the end of each REPORTING PERIOD. ROYALTY
shall only be payable once with respect to the same unit of LICENSED PRODUCT.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.9pt; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.9pt; text-align: justify; text-indent: 0in">Such ROYALTY
shall be paid, on a LICENSED PRODUCT by LICENSED PRODUCT and country by country basis.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.9pt; text-align: justify; text-indent: 0in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">4.1.4</TD><TD STYLE="text-align: justify"><U>Sublicense Royalty</U>. <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">LICENSEE
                                                                 shall pay LICENSOR a total of <FONT STYLE="background-color: black">thirteen percent (13%)</FONT> of total SUBLICENSE
                                                                 INCOME. Such amount shall be payable for each REPORTING PERIOD and shall be due to LICENSOR within sixty (60) days of the end
                                                                 of each REPORTING PERIOD.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.9pt; text-align: justify; text-indent: 0in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">4.1.5</TD><TD STYLE="text-align: justify"><U>Milestone Payment</U>. LICENSEE shall pay to LICENSOR the following milestone payment on the
events set forth below within 30 days after the achievement of the corresponding milestones by LICENSEE or its AFFILIATES or SUBLICENSEES:</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
<TR>
    <TD STYLE="width: 0.5in; padding-top: 4.5pt; padding-bottom: 4.5pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding: 4.5pt 5.4pt; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: black">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><BR>
    <FONT STYLE="background-color: black">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></FONT></TD>
    <TD STYLE="border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding: 4.5pt 5.4pt"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: black">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><BR>
        <FONT STYLE="background-color: black">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></FONT></P></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="padding-top: 4.5pt; padding-bottom: 4.5pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding: 4.5pt 5.4pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: black">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><BR>
    <FONT STYLE="background-color: black">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding: 4.5pt 5.4pt; border-right: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: black">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><BR>
        <FONT STYLE="background-color: black">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></FONT></P></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="padding-top: 4.5pt; padding-bottom: 4.5pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding: 4.5pt 5.4pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: black">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><BR>
    <FONT STYLE="background-color: black">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding: 4.5pt 5.4pt; border-right: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: black">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><BR>
        <FONT STYLE="background-color: black">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></FONT></P></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="padding-top: 4.5pt; padding-bottom: 4.5pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding: 4.5pt 5.4pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: black">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><BR>
    <FONT STYLE="background-color: black">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding: 4.5pt 5.4pt; border-right: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: black">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><BR>
        <FONT STYLE="background-color: black">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><BR>
        <FONT STYLE="background-color: black">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></FONT></P></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="padding-top: 4.5pt; padding-bottom: 4.5pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding: 4.5pt 5.4pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: black">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding: 4.5pt 5.4pt; border-right: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: black">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><BR>
        <FONT STYLE="background-color: black">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><BR>
        <FONT STYLE="background-color: black">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></FONT></P></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="padding-top: 4.5pt; padding-bottom: 4.5pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding: 4.5pt 5.4pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: black">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><BR>
    <FONT STYLE="background-color: black">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding: 4.5pt 5.4pt; border-right: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: black">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><BR>
        <FONT STYLE="background-color: black">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></FONT></P></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="padding-top: 4.5pt; padding-bottom: 4.5pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding: 4.5pt 5.4pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: black">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding: 4.5pt 5.4pt; border-right: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: black">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><BR>
        <FONT STYLE="background-color: black">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></FONT></P></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="padding-top: 4.5pt; padding-bottom: 4.5pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding: 4.5pt 5.4pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: black">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><BR>
    <FONT STYLE="background-color: black">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding: 4.5pt 5.4pt; border-right: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: black">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><BR>
        <FONT STYLE="background-color: black">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></FONT></P></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="padding-top: 4.5pt; padding-bottom: 4.5pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding: 4.5pt 5.4pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: black">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><BR>
    <FONT STYLE="background-color: black">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding: 4.5pt 5.4pt; border-right: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: black">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><BR>
        <FONT STYLE="background-color: black">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></FONT></P></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: 0in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.9pt; text-align: justify; text-indent: 0in">These Milestone Payments are non-refundable.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.85pt; text-indent: -0.5in">&nbsp;</P>

<!-- Field: Page; Sequence: 14; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.85pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0"></TD><TD STYLE="width: 40pt; text-align: left">4.2</TD><TD STYLE="text-align: justify"><U>Payments</U>.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in; text-align: left">(a)</TD><TD STYLE="text-align: justify"><U>Method of Payment</U>. All payments under this Agreement
shall be made payable to &ldquo;Versitech Limited&rdquo; and be wired to the bank account of LICENSOR as follows:</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0in"><FONT STYLE="background-color: black">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0in"><FONT STYLE="background-color: black">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0in"><FONT STYLE="background-color: black">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0in"><FONT STYLE="background-color: black">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0in">LICENSEE shall
notify LICENSOR within seven (7) days after LICENSEE has made the relevant payments and provide LICENSOR with copies of the corresponding
bank remittance receipts when available.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0in">Payment receipts
shall be sent to the address identified in Clause 15.2. Each payment should reference this Agreement and identify the obligation
under this Agreement that the payment satisfies.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 64.9pt; text-align: justify; text-indent: -29.5pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in; text-align: left">(b)</TD><TD STYLE="text-align: justify"><U>Payments in US Dollars</U>. All payments due under
this Agreement shall be payable in US DOLLARS, subject to (d) below. Such payments shall be without deduction of exchange, collection,
or other charges, and, specifically, without deduction of withholding or similar taxes or other government imposed fees or taxes,
except as permitted in the definition of NET SALES. Conversion of foreign currency to US DOLLARS shall be made at the conversion
rate routinely used in Hong Kong as reported by the Hongkong and Shanghai Banking Corporation Limited on the last working day
of the calendar year of the applicable REPORTING PERIOD. The average of the bid and the ask rate shall be used as the conversion
rate if both rates are available.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 64.9pt; text-align: justify; text-indent: -29.5pt">&nbsp;</P>

<!-- Field: Page; Sequence: 15; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 64.9pt; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in; text-align: left">(c)</TD><TD STYLE="text-align: justify"><U>Late Payments</U>. Any payments by LICENSEE that
are not paid on or before the date such payments are due under this Agreement shall bear interest, to the extent permitted by
law, at two percentage points above the Prime Rate of interest as announced by the Hong Kong &amp; Shanghai Banking Corporation
Limited on the date payment is due or the next working day if the payment due date is a bank holiday.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(d)</TD><TD STYLE="text-align: justify"><U>Blocked Currency</U>. In each country where the local currency is blocked and cannot be removed
from the country, royalties accrued in that country will be paid to LICENSOR in the country in local currency by deposit in a local
bank designated by LICENSOR, unless the parties otherwise agree.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.6pt; text-align: justify; text-indent: -35.3pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center"><U>5. Reports
and Records.</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1.1pt"></TD><TD STYLE="width: 34.9pt">5.1</TD><TD><U>Frequency of Reports</U>.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(a)</TD><TD STYLE="text-align: justify"><U>Before First Commercial Sale</U>. Prior to the first commercial sale of any LICENSED PRODUCT,
LICENSEE shall deliver reports to LICENSOR annually, within sixty (60) days of the end of each calendar year, containing information
concerning the immediately preceding calendar year on the diligent efforts of LICENSEE, its AFFILIATES or SUBLICENSEES to develop
LICENSED PRODUCT as stipulated in Clause 3.1.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 106.15pt; text-indent: -35.35pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(b)</TD><TD STYLE="text-align: justify"><U>Upon First Commercial Sale of a LICENSED PRODUCT</U>. LICENSEE shall report to LICENSOR the
date of first commercial sale of a LICENSED PRODUCT within sixty (60) days of occurrence in each country.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.85pt; text-align: justify; text-indent: -35.35pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(c)</TD><TD STYLE="text-align: justify"><U>After First Commercial Sale</U>. After the first commercial sale of a LICENSED PRODUCT, LICENSEE
shall deliver reports to LICENSOR within sixty (60) days of the end of each REPORTING PERIOD, containing information concerning
the immediately preceding REPORTING PERIOD, as further described in Clause 5.2.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<!-- Field: Page; Sequence: 16; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in; text-align: left">5.2</TD><TD STYLE="text-align: justify"><U>Content of Reports and Payments</U>. Each report delivered
by LICENSEE to LICENSOR pursuant to Clause 5.1(c) shall contain at least the following information for the immediately preceding
REPORTING PERIOD:</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-size: 10pt">(i)</FONT></TD><TD STYLE="text-align: justify">the number and description of each LICENSED PRODUCT
sold, leased or distributed by LICENSEE, its AFFILIATES and SUBLICENSEES to independent third parties in each country, and, if
applicable, the number of LICENSED PRODUCT used by LICENSEE, its AFFILIATES and SUBLICENSEES in the provision of services in each
country;</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-size: 10pt">(ii)</FONT></TD><TD STYLE="text-align: justify">the gross price charged by LICENSEE, its AFFILIATES and SUBLICENSEES for each LICENSED PRODUCT
and, if applicable, the gross price charged for each LICENSED PRODUCT used to provide services in each country;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 24pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-size: 10pt">(iii)</FONT></TD><TD STYLE="text-align: justify">calculation of NET SALES for the applicable REPORTING PERIOD in each country, including a listing
of applicable deductions;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 24pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-size: 10pt">(iv)</FONT></TD><TD STYLE="text-align: justify">total royalty payable on NET SALES in US Dollars, together with the exchange rates used for conversion;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 24pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-size: 10pt">(v)</FONT></TD><TD STYLE="text-align: justify">the amount of SUBLICENSE INCOME received by LICENSEE and its AFFILIATES from each SUBLICENSEE and
the amount due to LICENSOR and its AFFILIATES from such SUBLICENSE INCOME, including an itemized breakdown of the sources of income
comprising the SUBLICENSE INCOME; and</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 24pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-size: 10pt">(vi)</FONT></TD><TD STYLE="text-align: justify">the number of sublicenses entered into for the LICENSED PATENT and LICENSED PRODUCT.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">All the reports
shall be verified and duly signed by Managing Director or the authorized person of LICENSEE. If no amounts are due to LICENSOR
for any REPORTING PERIOD, the report shall so state.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">5.3</TD><TD STYLE="text-align: justify"><U>Financial Statements</U>. On or before the ninetieth (90<SUP>th</SUP>) day following the close
of LICENSEE&rsquo;s fiscal year, LICENSEE shall provide LICENSOR with (i) a statement setting out the information required by Clause
5.2 for the preceding fiscal year, certified by LICENSEE&rsquo;s treasurer or chief financial officer or by an independent auditor and
(ii) an updated Certificate of Good Standing issued by the Registrar of Corporate Affairs, &lt;Place of Registry&gt;.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.85pt; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<!-- Field: Page; Sequence: 17; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.85pt; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">5.4</TD><TD STYLE="text-align: justify"><U>Records</U>. LICENSEE shall maintain, and shall cause its AFFILIATES and SUBLICENSEES to maintain,
complete and accurate records relating to the rights and obligations under this Agreement and any amounts payable to LICENSOR in
relation to this Agreement, which records shall contain sufficient information to permit LICENSOR to confirm the accuracy of any
reports delivered to LICENSOR and compliance in other respects with this Agreement. The relevant party shall retain such records
for at least five (5) years following the end of the calendar year to which they pertain, during which time LICENSOR, or LICENSOR&rsquo;s
appointed agents, shall have the right, at LICENSOR&rsquo;s expense, to inspect such records during normal business hours by prior appointment
to verify any reports and payments made or compliance in other respects under this Agreement. In the event that the aforesaid inspection
is carried out by an independent auditor and any audit performed under this Clause reveals an underpayment in excess of five percent
(5%), LICENSEE shall bear the full reasonable cost of such audit and shall remit any shortfall due to LICENSOR within thirty (30)
days of receiving notice thereof from LICENSOR.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.85pt; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0pt; text-align: center"><U>6. IMPROVEMENT</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.85pt; text-align: center; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">6.1</TD><TD STYLE="text-align: justify">If LICENSEE solely makes an IMPROVEMENT, LICENSEE shall immediately inform LICENSOR thereof. LICENSEE
shall have the right to use such IMPROVEMENT. LICENSOR shall be entitled to use such IMPROVEMENT for academic and research purposes
only.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">6.2</TD><TD STYLE="text-align: justify">Provided that such IMPROVEMENT made by LICENSEE do not incorporate or contain, in part or in whole,
the LICENSED PATENT, LICENSEE shall own such IMPROVEMENT and shall be free to register any intellectual property rights for such
IMPROVEMENT and to license these IMPROVEMENT to third parties.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.85pt; text-align: center; text-indent: -0.5in"><U>7.
PATENT PROSECUTION </U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.85pt; text-align: center; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in; text-align: left">7.1</TD><TD STYLE="text-align: justify"><U>Responsibility for LICENSED PATENT</U>. During the continuance
of the EXCLUSIVE PERIOD, LICENSOR shall prepare, file, prosecute, and maintain all of the LICENSED PATENT and in countries as
may be designated by LICENSEE in written notice to LICENSOR within a reasonable time in advance of the required filing dates.
LICENSOR shall use reasonable efforts to seek prompt issuance of the LICENSED PATENT during the TERM of this Agreement. LICENSOR
and LICENSEE will discuss and decide on the strategy with regard to the filing, prosecution and maintenance of the LICENSED PATENTS.
LICENSEE shall have reasonable opportunities to advise LICENSOR and shall cooperate with LICENSOR in such filing, prosecution
and maintenance of the LICENSED PATENT in the TERRITORY.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<!-- Field: Page; Sequence: 18; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">7.2</TD><TD STYLE="text-align: justify"><U>Payment of Expenses</U>. Payment of all fees and costs incurred on or after the EFFECTIVE DATE
of this Agreement under Clause 7.1, including attorneys&rsquo; fees, relating to the filing, prosecution and maintenance of the
LICENSED PATENT that have not already been reimbursed by LICENSEE shall be the responsibility of LICENSEE. LICENSEE shall reimburse
LICENSOR for all fees and costs, including attorney&rsquo;s fees, relating to the filing, prosecution and maintenance of the LICENSED
PATENT incurred prior to the EFFECTIVE DATE and such amount is <FONT STYLE="background-color: black">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT> as of
the EFFECTIVE DATE based on relevant receipts or invoices. LICENSEE shall reimburse all amounts due pursuant to this Clause within
thirty (30) days after the EFFECTIVE DATE; late payments shall accrue interest pursuant to Clause 4.2(c). These payments are non-refundable.
LICENSEE shall also be responsible for payment of all such expenses incurred on or after the EFFECTIVE DATE (&ldquo;Patent Cost&rdquo;)
and shall reimburse LICENSEOR with such amount within thirty (30) days from the date of receiving an original invoice from LICENSOR.
In all instances, LICENSOR shall pay the fees prescribed for large entities to the United States Patent and Trademark Office.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">7.3</TD><TD STYLE="text-align: justify"><U>Discontinue of Payment of Expenses</U>. In the event LICENSEE elects not to continue the LICENSE
under and the payment for the Patent Cost on any, but not all, of the patents, patent applications, and provisional applications
listed in <U>Schedule 1 (&ldquo;Suspended Patent License&rdquo;), LICENSEE shall provide a written notice (&ldquo;Notice of Payment
Suspension&rdquo;) to LICENCEE, in which case the LICENSE granted to LICENSEE on the Suspended Patent License shall end sixty (60)
days after the date of receipt of such Notice of Payment Suspension (the &ldquo;End Date&rdquo;). In no event shall the Notice
of Payment Suspension release LICENSEE from the obligation to pay any outstanding amount and/or invoices that became due on or
before the date of the End Date. For the avoidance of doubt, upon the END DATE, LICENSOR shall have full rights under the Suspended
Patent License, including but not limited to </U>file, prosecute, and maintain such Suspended Patent License, and to grant license
under such Suspended Patent License to any third party.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<!-- Field: Page; Sequence: 19; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center"><U>8. Infringement</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 29.5pt; text-indent: -29.5pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1.1pt"></TD><TD STYLE="width: 34.9pt">8.1</TD><TD STYLE="text-align: justify"><U>Notification of Infringement.</U> Each party agrees to provide written notice to the other party
promptly after becoming aware of any infringement of the LICENSED PATENT.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in; text-align: left">8.2</TD><TD STYLE="text-align: justify"><U>Right to Prosecute Infringements</U>.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in; text-align: left">(a)</TD><TD STYLE="text-align: justify"><U>LICENSEE Right to Prosecute</U>. So long as LICENSEE
remains the exclusive licensee of the LICENSED PATENT in the FIELD in the TERRITORY, LICENSEE, to the extent permitted by law,
shall have the first right and option but not the obligation, at its own expense, to prosecute any third party infringement of,
or seek a declaratory judgment to confirm or rectify LICENSOR&rsquo;s and/or LICENSEE&rsquo;s rights and interests in, the LICENSED
PATENT in the FIELD in the TERRITORY, subject to Clauses&nbsp;8.4 and 8.5. If required by law or advised by the legal counsel
representing LICENSEE in the action, LICENSOR shall permit any action under this Clause to be brought in its name, including being
joined as a party-plaintiff, provided that LICENSEE shall hold LICENSOR harmless from, and indemnify LICENSOR against, any costs,
expenses, or liability that LICENSOR incurs in connection with such action.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.1pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.1pt">Prior to
commencing any such action, LICENSEE shall consult with LICENSOR and shall consider the views of LICENSOR regarding the advisability
of the proposed action and its effect on the public interest. LICENSEE shall not enter into any settlement, consent judgment, or
other voluntary final disposition of any infringement action under this Clause without the prior written consent of LICENSOR, which
consent shall not be unreasonably withheld or delayed.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in; text-align: left">(b)</TD><TD STYLE="text-align: justify"><U>LICENSOR Right to Prosecute</U>. In the event that
LICENSEE is unsuccessful in persuading the alleged infringer to desist or fails to have initiated an infringement action, then
LICENSOR shall have the right, at their sole discretion, to prosecute such infringement under their sole control and at their
sole expense, and any recovery obtained shall belong to LICENSOR.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in; text-align: left">8.3</TD><TD STYLE="text-align: justify"><U>Declaratory Judgment Actions</U>. In the event that
a declaratory judgment action is brought against LICENSOR or LICENSEE by a third party alleging invalidity, unenforceability,
or non-infringement of the LICENSED PATENT or that any of the LICENSED PATENT has infringed the rights of the third party, LICENSOR
and LICENSEE shall jointly determine within twenty (20) days after commencement of such action which of them is to take over the
sole defense of the action at their own expense, subject to Clauses 8.4 and 8.5 in the case of defense by LICENSEE. If LICENSOR
does not exercise this right, LICENSEE may take over the sole defense of the action at LICENSEE&rsquo;s sole expense, subject to Clauses
8.4 and 8.5.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<!-- Field: Page; Sequence: 20; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in; text-align: left">8.4</TD><TD STYLE="text-align: justify"><U>Award</U>. Any award received by LICENSEE from the action
under Clauses 8.2 or 8.3, including but not limited to award of costs and/or damages/compensation, shall first be applied to reimburse
all costs and expenses incurred by LICENSEE and LICENSOR in such action. If such award is not sufficient to cover the costs and
expenses incurred by LICENSEE and LICENSOR in such action, LICENSEE may offset a total of fifty percent (50%) of any expenses
incurred under Clauses 8.2 and 8.3 against any payments due to LICENSOR under Clause 4, provided that in no event shall such payments
under Clause 4, when aggregated with any other offsets and credits allowed under this Agreement, be reduced by more than fifty
percent (50%) in any REPORTING PERIOD. In the event that such award is more than sufficient to cover the costs and expenses incurred
by LICENSEE and LICENSOR in the action, the surplus shall be applied to cover the loss of profits suffered by LICENSEE due to
the infringement under Clauses 8.2 or 8.3 (&ldquo;Loss of Profits Compensation&rdquo;). Upon receipt of Loss of Profits Compensation,
LICENSEE shall pay to LICENSOR a reasonable approximation, based upon the amount of Loss of Profits Compensation, as ROYALTY.
Any remaining balance of the award after deducting all costs and expenses incurred by LICENSEE in the action as well as Loss of
Profits Compensation shall be shared equally between LICENSOR and LICENSEE.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1.1pt"></TD><TD STYLE="width: 34.9pt">8.5</TD><TD STYLE="text-align: justify"><U>Cooperation</U>. Each party agrees to cooperate in any action under this Clause which is controlled
by the other party.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.5in">8.6</TD><TD STYLE="text-align: justify"><U>Right to Sublicense</U>. So long
                                         as LICENSEE remains the exclusive licensee of the LICENSED PATENT in the FIELD in the
                                         TERRITORY, LICENSEE shall have the sole right to sublicense any alleged infringer in
                                         the FIELD in the TERRITORY for future use of the LICENSED PATENT in accordance with the
                                         terms and conditions of this Agreement relating to sublicenses. Any upfront fees as part
                                         of such sublicense shall be <FONT STYLE="background-color: Black">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
                                         &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
                                         &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
                                         &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
                                         &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
                                         &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
                                         &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<!-- Field: Page; Sequence: 21; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center"><U>9. Indemnification
and Insurance</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in; text-align: left">9.1</TD><TD STYLE="text-align: justify"><U>Indemnification</U>.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in; text-align: left">(a)</TD><TD STYLE="text-align: justify"><U>Indemnity</U>. LICENSEE shall indemnify, defend,
and hold harmless LICENSOR, The University of Hong Kong and their trustees, officers, faculty, students, employees, and agents
and their respective successors, heirs and assigns (the &ldquo;Indemnitees&rdquo;), against any liability, damage, loss, or expense
(including reasonable attorneys fees and expenses) incurred by or imposed upon any of the Indemnitees in connection with any claims,
suits, actions, demands or judgments arising out of any theory of liability (including without limitation actions in the form
of tort, warranty, or strict liability and regardless of whether such action has any factual basis) concerning any product, process,
or service that is made, used, sold, imported, or performed pursuant to any right or license granted under this Agreement.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in; text-align: left">(b)</TD><TD STYLE="text-align: justify"><U>Procedures</U>. The Indemnitees agree to provide
LICENSEE with prompt written notice of any claim, suit, action, demand, or judgment for which indemnification is sought under
this Agreement. LICENSEE agrees, at its own expense, to provide attorneys reasonably acceptable to LICENSOR to defend against
any such claim. The Indemnitees shall cooperate fully with LICENSEE in such defense and will permit LICENSEE to conduct and control
such defense and the disposition of such claim, suit, or action (including all decisions relative to litigation, appeal, and settlement);
provided, however, that any Indemnitee shall have the right to retain its own counsel (to be elected by LICENSEE), at the expense
of LICENSEE, if representation of such Indemnitee by the counsel retained by LICENSEE would be inappropriate because of actual
or potential differences in the interests of such Indemnitee and any other party represented by such counsel. LICENSEE agrees
to keep LICENSOR informed of the progress in the defense and disposition of such claim and to consult with LICENSOR with regard
to any proposed settlement.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in; text-align: left">9.2</TD><TD STYLE="text-align: justify"><U>Insurance</U>. LICENSEE shall obtain and carry in full
force and effect commercial general liability insurance, including product liability and errors and omissions insurance which
shall protect LICENSEE and Indemnitees with respect to events covered by Clause 8.1(a) above.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<!-- Field: Page; Sequence: 22; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in; text-align: left">9.3</TD><TD STYLE="text-align: justify">EXCEPT TO THE EXTENT OTHERWISE EXPRESSLY SET FORTH IN THIS
AGREEMENT, LICENSOR MAKES NO REPRESENTATIONS OR WARRANTIES OF ANY KIND CONCERNING THE LICENSED PATENT, EXPRESS OR IMPLIED, INCLUDING
WITHOUT LIMITATION WARRANTIES OF MERCHANTABILITY, FITNESS FOR A PARTICULAR PURPOSE, NONINFRINGEMENT, VALIDITY OF LICENSED PATENT
CLAIMS, WHETHER ISSUED OR PENDING, AND THE ABSENCE OF LATENT OR OTHER DEFECTS, WHETHER OR NOT DISCOVERABLE. Specifically, and
not to limit the foregoing, LICENSOR makes no warranty or representation (i)&nbsp;regarding the validity or scope of the LICENSED
PATENT, and (ii)&nbsp;that the exploitation of the LICENSED PATENT or any LICENSED PRODUCT will not infringe any patents or other
intellectual property rights of LICENSOR or of a third party.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">IN NO EVENT SHALL LICENSOR,
THE UNIVERSITY OF HONG KONG, THEIR TRUSTEES, DIRECTORS, OFFICERS, EMPLOYEES AND AFFILIATES BE LIABLE FOR INCIDENTAL OR CONSEQUENTIAL
DAMAGES OF ANY KIND, INCLUDING ECONOMIC DAMAGES OR INJURY TO PROPERTY AND LOST PROFITS, REGARDLESS OF WHETHER LICENSOR SHALL BE
ADVISED, SHALL HAVE OTHER REASON TO KNOW, OR IN FACT SHALL KNOW OF THE POSSIBILITY OF THE FOREGOING.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><U>10. REPRESENTATIONS
AND COVENANTS</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in; text-align: left">10.1</TD><TD STYLE="text-align: justify">Each PARTY represents and warrants that it has the authority
and right to enter into and perform this Agreement and grant the rights embodied herein and is not aware of any legal impediment
that could inhibit its ability to perform its obligations under this Agreement.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in; text-align: left">10.2</TD><TD STYLE="text-align: justify">LICENSOR has no knowledge of any litigation or proceeding
pending or, threatened concerning the validity or enforceability of any LICENSED PATENT.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in; text-align: left">10.3</TD><TD STYLE="text-align: justify">This Agreement is signed by a duly authorized official
of the LICENSOR and LICENSOR is the sole and exclusive owner of the entire and unencumbered right, title and interest in and to
each of the LICENSED PATENT.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center"><U>11. Assignment.</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">This Agreement is personal
to LICENSEE and no rights or obligations may be assigned by LICENSEE without the prior written consent of LICENSOR, except that
LICENSEE may, subject to prior consent of LICENSOR, assign this Agreement and the rights, obligations, and interests of as such
Party hereunder to any purchaser of all of its assets or all of its assets to which this Agreement relates or to any successor
corporation resulting from any merger or consolidation of such Party with or into such corporation. Any attempted assignment in
violation of this Clause shall be null, void and of no effect. This Agreement shall be binding upon and inure to the benefit of
all permitted successors-in-interest and assigns</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<!-- Field: Page; Sequence: 23; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->21<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-transform: uppercase; text-align: center"><U>12. General
Compliance with Laws</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">12.1</TD><TD STYLE="text-align: justify"><U>Compliance with Laws</U>. LICENSEE shall use reasonable commercial efforts to comply with all
commercially material local, state, federal, and international laws and regulations relating to the development, manufacture, use,
and sale of LICENSED PRODUCT.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in; text-align: left">12.2</TD><TD STYLE="text-align: justify"><U>Non-Use of Names</U>. LICENSEE and its AFFILIATES and
SUBLICENSEES shall not use the name of &ldquo;Versitech,&rdquo; &ldquo;The University of Hong Kong&rdquo; or any variation, adaptation,
or abbreviation thereof, or of any of their trustees, officers, faculties, students, employees, or agents, or any trademark or
logo owned by LICENSOR or &ldquo;The University of Hong Kong&rdquo; or any terms of this Agreement in any promotional material or
other public announcement or disclosure without the prior written consent of LICENSOR. The foregoing notwithstanding, without
the consent of LICENSOR, LICENSEE may state that it is licensed by LICENSOR under one or more of the patents and/or patent applications
comprising the LICENSED PATENT.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in; text-align: left">12.3</TD><TD STYLE="text-align: justify"><U>Export Control</U>. LICENSEE and its AFFILIATES and
SUBLICENSEES shall comply with all applicable laws and regulations controlling the export of certain commodities and technical
data when dealing with LICENSED PRODUCT. Among other things, these laws and regulations prohibit or require a license for the
export of certain types of commodities and technical data to specified countries. LICENSEE hereby gives written assurance that
it will comply with, and will cause its AFFILIATES and SUBLICENSEES to comply with, all applicable export control laws and regulations
when dealing with LICENSED PRODUCT, that it bears sole responsibility for any violation of such laws and regulations by itself
or its AFFILIATES or SUBLICENSEES, and that it will indemnify, defend, and hold LICENSOR harmless (in accordance with Clause 8.1)
for the consequences of any such violation.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">12.4</TD><TD STYLE="text-align: justify"><U>Marking of LICENSED PRODUCT</U>. To the extent commercially feasible and consistent with prevailing
business practices, LICENSEE shall mark, and shall cause its AFFILIATES and SUBLICENSEES to mark, all LICENSED PRODUCT that are
manufactured or sold under this Agreement with the number of each issued patent under the LICENSED PATENT that applies to such
LICENSED PRODUCT.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<!-- Field: Page; Sequence: 24; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->22<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-transform: uppercase; text-align: center"><U>13. Termination.</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">13.1</TD><TD STYLE="text-align: justify">Term. This Agreement shall be in effect during the TERM.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">13.2</TD><TD STYLE="text-align: justify"><U>Voluntary Termination by LICENSEE.</U> LICENSEE shall have the right to terminate this Agreement
any time by written notice at least six (6) months in advance and fully settle all payments due to LICENSOR on or before the effective
date of termination. In no event shall the termination of the Agreement release LICENSEE from the obligation to pay any amounts
that became due on or before the effective date of termination.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">13.3</TD><TD STYLE="text-align: justify">Cessation of Business. If LICENSEE ceases to carry on its business related to this Agreement, liquidates
or dissolves, LICENSOR shall have the right to terminate this Agreement immediately upon written notice to LICENSEE.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">13.4</TD><TD STYLE="text-align: justify"><U>Termination for Insolvency</U>. To the extent permitted by law, each PARTY shall have the right
to terminate this Agreement immediately upon notice to the other PARTY, if such other PARTY files for protection under bankruptcy
laws, makes an assignment for the benefit of creditors, appoints or suffers appointment of a receiver or trustee over its property,
files a petition under any bankruptcy or insolvency act, has any such petition filed against it (which petition not dismissed within
ninety days following such filing) or is unable to pay its debts as they become due.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">13.5</TD><TD STYLE="text-align: justify"><U>Legal Challenge on LICENSED PATENT</U>. LICENSOR may terminate this Agreement by giving written
notice to LICENSEE (such notice to take effect forthwith or as stated in the notice) if LICENSEE commences legal proceedings, or
assists any third party to commence legal proceedings, to challenge the validity or ownership of the LICENSED PATENT.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">13.6</TD><TD STYLE="text-align: justify"><U>Termination for Default.</U></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36.05pt"></TD><TD STYLE="width: 0.5in">(a)</TD><TD STYLE="text-align: justify"><U>Nonpayment</U>. In the event LICENSEE fails to pay any amounts due and payable to LICENSOR under
Clause 4.1, and fails to make such overdue payments within thirty (30) days after receiving written notice of such failure, LICENSOR
may terminate this Agreement immediately upon written notice to LICENSEE.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 106.25pt; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<!-- Field: Page; Sequence: 25; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->23<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 106.25pt; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in; text-align: left">(b)</TD><TD STYLE="text-align: justify"><U>Material Breach</U>. In the event LICENSEE commits
a material breach of its obligations under this Agreement including but not limited to the DILIGENCE REQUIREMENT, except for breach
as described in Clause 13.4(a), and fails to cure that breach thirty (30) days after receiving written notice thereof, LICENSOR
may terminate this Agreement immediately upon written notice to LICENSEE.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">13.7</TD><TD STYLE="text-align: justify"><U>Effect of Termination. </U></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in; text-align: left">(a)</TD><TD STYLE="text-align: justify"><U>Survival</U>. The following provisions shall survive
the expiration or termination of this Agreement: Clauses 1, 6, 9, 14 and 15, and Clauses 5.2 (obligation to provide final report
and payment), 5.4, 12.1, 12.2 and 13.5.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.85pt; text-align: justify; text-indent: 0in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in; text-align: left">(b)</TD><TD STYLE="text-align: justify"><U>Inventory</U>. Upon the early termination of this
Agreement, LICENSEE and its AFFILIATES and SUBLICENSEES may complete and sell any work-in-progress and inventory of LICENSED PRODUCT
that exist as of the effective date of termination, provided that (i)&nbsp;LICENSEE pays LICENSOR the applicable running royalty
or other amounts due on such sales of LICENSED PRODUCT in accordance with the terms and conditions of this Agreement, and (ii)&nbsp;LICENSEE
and its AFFILIATES and SUBLICENSEES shall complete and sell all work-in-progress and inventory of LICENSED PRODUCT within six
(6) months after the effective date of termination.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 24pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in; text-align: left">(c)</TD><TD STYLE="text-align: justify"><U>Pre-termination Obligations</U>. In no event shall
termination of this Agreement release LICENSEE, AFFILIATES, or SUBLICENSEES from the obligation to pay any amounts that became
due on or before the effective date of termination.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.75pt; text-align: justify; text-indent: -35.35pt">&nbsp;</P>

<!-- Field: Page; Sequence: 26; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->24<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.75pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center"><U>14. Dispute
Resolution.</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">In any disagreement or
dispute that may arise between the parties in relation to, resulting from, arising, touching, concerning, or affecting this Agreement,
such matter shall first be referred for resolution as follows.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in; text-align: left">(a)</TD><TD STYLE="text-align: justify">The PARTIES shall first attempt to settle the dispute by
informal means and negotiation for settlement in good faith. Such good faith negotiation may include the appointment by either
PARTY of an unaffiliated consultant, who shall be chosen based on such person&rsquo;s experience and expertise in the particular
type of issue which is unresolved, to advise on the matter ; and</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in; text-align: left">(b)</TD><TD STYLE="text-align: justify">If no settlement is reached within 28 days after commencement
of negotiations, the disagreement or dispute shall be resolved by binding arbitration in HONG KONG to a single arbitrator nominated
jointly by the parties, failing which such arbitrator shall be nominated by the Hong Kong International Arbitration Centre (&ldquo;HKIAC&rdquo;).
The arbitrator&rsquo;s decision shall be final and binding on the parties. The language of arbitration shall be English;</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 24pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in; text-align: left">(c)</TD><TD STYLE="text-align: justify">Neither PARTY shall be released from performing its obligations
under this Agreement by reason of any arbitration proceeding being instituted.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center"><U>15. GOVERNING
LAW.</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 49.4pt; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">This Agreement shall
be governed by and construed in accordance with the laws of HONG KONG.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 49.4pt; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center"><U>16. Miscellaneous.</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">16.1&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Title</U>.
LICENSOR shall hold title to all LICENSED PATENT.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">16.2</TD><TD STYLE="text-align: justify"><U>Notice</U>. Any notices required or permitted under this Agreement shall be in writing, shall
specifically refer to this Agreement, and shall be sent by hand, recognized courier, confirmed facsimile transmission, confirmed
electronic mail, or registered or certified mail, postage prepaid, return receipt requested, to the following addresses or facsimile
numbers of the parties:</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 24pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">If to LICENSOR, all matters relating to
the license:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in">Versitech Limited</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in"><FONT STYLE="background-color: black">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in"><FONT STYLE="background-color: black">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in"><FONT STYLE="background-color: black">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in"><FONT STYLE="background-color: black">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in"><FONT STYLE="background-color: black">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in"><FONT STYLE="background-color: black">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in"><FONT STYLE="background-color: black">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in">&nbsp;</P>

<!-- Field: Page; Sequence: 27; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->25<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 99.25pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">If to LICENSEE:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in">Acticule Life Sciences Limited</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in"><FONT STYLE="background-color: black">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in"><FONT STYLE="background-color: black">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in"><FONT STYLE="background-color: black">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in"><FONT STYLE="background-color: black">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">All notices
under this Agreement shall be deemed effective upon receipt. A party may change its contact information immediately upon written
notice to the other party in the manner provided in this Clause.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">16.3</TD><TD STYLE="text-align: justify"><U>Force Majeure</U>. Neither party will be responsible for delays resulting from causes beyond
the reasonable control of such party, including without limitation fire, explosion, flood, war, strike, or riot, provided that
the nonperforming party uses commercially reasonable efforts to avoid or remove such causes of nonperformance and continues performance
under this Agreement with reasonable dispatch whenever such causes are removed.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">16.4</TD><TD STYLE="text-align: justify"><U>Amendment and Waiver</U>. This Agreement may be amended, supplemented, or otherwise modified
only by means of a written instrument signed by both parties. Any waiver of any rights or failure to act in a specific instance
shall relate only to such instance and shall not be construed as an agreement to waive any rights or fail to act in any other instance,
whether or not similar.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">16.5</TD><TD STYLE="text-align: justify"><U>No agency</U>. This Agreement shall not constitute either party as an agent or legal representative
of the other party for any purpose whatsoever nor create any form of partnership between the parties.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">16.6</TD><TD STYLE="text-align: justify"><U>Severability</U>. In the event that any provision of this Agreement shall be held invalid or
unenforceable for any reason, such invalidity or unenforceability shall not affect any other provision of this Agreement, and the
parties shall negotiate in good faith to modify the Agreement to preserve (to the extent possible) their original intent. If the
parties fail to reach a modified agreement within thirty (30) days after the relevant provision is held invalid or unenforceable,
then the dispute shall be resolved in accordance with the procedures set forth in Clause 13. While the dispute is pending resolution,
this Agreement shall be construed as if such provision were deleted by agreement of the parties.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<!-- Field: Page; Sequence: 28; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->26<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">16.7</TD><TD STYLE="text-align: justify"><U>Binding Effect</U>. This Agreement shall be binding upon and inure to the benefit of the parties
and their respective permitted successors and assigns.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">16.8</TD><TD STYLE="text-align: justify"><U>Headings</U>. All headings are for convenience only and shall not affect the meaning of any
provision of this Agreement.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">16.9</TD><TD STYLE="text-align: justify"><U>Entire Agreement</U>. This Agreement constitutes the entire agreement between the parties with
respect to its subject matter and supersedes all prior agreements or understandings between the parties relating to its subject
matter.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 29; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->27<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">IN WITNESS WHEREOF, the parties have caused
this Agreement to be executed by their duly authorized representatives. </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-weight: normal">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif">For and on behalf of</FONT></TD>
    <TD>&nbsp;</TD>
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif">For and on behalf of</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif">VERSITECH LIMITED</FONT></TD>
    <TD>&nbsp;</TD>
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; text-transform: uppercase">Acticule Life Sciences Limited</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 5%">&nbsp;</TD>
    <TD STYLE="width: 35%">&nbsp;</TD>
    <TD STYLE="width: 20%">&nbsp;</TD>
    <TD STYLE="width: 5%">&nbsp;</TD>
    <TD STYLE="width: 35%">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">Name:</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid">Mr. YU Hailson</TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">Name:</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">Dr. Richard Kao</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">Title:</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid">Deputy Managing Director</TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">Title:</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid">&nbsp;</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 30; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->28<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center"><B>SCHEDULE 1</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><U>LICENSED PATENT</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in; text-align: left">A.</TD><TD STYLE="text-align: justify">Title: Antiviral Compounds and Methods of Making and Using
Thereof</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">1.</TD><TD STYLE="text-align: justify">US PATENT NO. 9,212,177 B2 issued on 15 December 2015</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">2.</TD><TD>PRC Patent No. CN102596946 B, issued on 17 Jun 2015</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">3.</TD><TD>EP Patent No. 2462138 issued on 24 Sep 2014 (validated in DE, FR, GB and CH)</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">4.</TD><TD>German Patent No. 602010019171.0</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in">(The Following patents have been abandoned)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">5.</TD><TD>US Serial No. 61/231,431</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">6.</TD><TD>PCT WOCN2010001187</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">7.</TD><TD>SG178106A1</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">8.</TD><TD>BR11202002331</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">9.</TD><TD>RU201204214</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">10.</TD><TD>IN1254DEN2012A</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">11.</TD><TD>KR20120092567A</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">12.</TD><TD>IL217745A1</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">13.</TD><TD>CA2770140</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">14.</TD><TD>AU2010281265</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">15.</TD><TD>JP201301008</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">16.</TD><TD>MX2021001504</TD></TR></TABLE>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>


<!-- Field: Page; Sequence: 31; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->29<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center"><B>SCHEDULE 2</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><U>Calculations of NET SALES</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD COLSPAN="2">Invoice Price of LICENSED PRODUCT</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">xxx,xxx</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-style: italic; text-align: left; width: 8%">(Less)</TD>
    <TD STYLE="text-align: left; width: 80%">(1) Normal trade discounts</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="text-align: left; width: 1%">&nbsp;</TD><TD STYLE="text-align: right; width: 9%"><FONT STYLE="font-family: Times New Roman, Times, Serif">(xxx,xxx</FONT></TD><TD STYLE="text-align: left; width: 1%">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: left">(2) Any credits given to the returned goods</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(xxx,xxx</FONT></TD><TD STYLE="text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD>
    <TD>(3) Cost of packaging</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(xxx,xxx</FONT></TD><TD STYLE="text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: left">(4) Freight and its corresponding insurance</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(xxx,xxx</FONT></TD><TD STYLE="text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="text-align: left; padding-bottom: 1.5pt">(5) Government levies</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="text-align: left; border-bottom: Black 1.5pt solid">&nbsp;</TD><TD STYLE="text-align: right; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">(xxx,xxx</FONT></TD><TD STYLE="text-align: left; padding-bottom: 1.5pt">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold; text-align: left; padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="font-weight: bold; text-align: left; padding-bottom: 4pt">NET SALES</TD><TD STYLE="font-weight: bold; padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="font-weight: bold; text-align: left; border-bottom: Black 4pt double">&nbsp;</TD><TD STYLE="font-weight: bold; text-align: right; border-bottom: Black 4pt double"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>xxx,xxx</B></FONT></TD><TD STYLE="font-weight: bold; text-align: left; padding-bottom: 4pt">&nbsp;</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<!-- Field: Page; Sequence: 32; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->30<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.31
<SEQUENCE>35
<FILENAME>ff12018ex10-31_aptorum.htm
<DESCRIPTION>FIRST AMENDMENT TO THE EXCLUSIVE PATENT LICENSE AGREEMENT FOR ALS-1 DATED JUNE 7, 2018
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0; text-align: right"><B>Exhibit 10.31</B></P>

<P STYLE="margin: 0; text-align: right">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>FIRST AMENDMENT TO</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><U>EXCLUSIVE PATENT LICENSE AGREEMENT</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">THIS FIRST AMENDMENT
TO EXCLUSIVE PATENT LICENSE AGREEMENT (the &ldquo;<B>Amendment</B>&rdquo;) is made effective as of <U>7<SUP>th</SUP> June</U>,
2018 by and between <B>Versitech Limited</B>, a company incorporated and existing under the laws of Hong Kong with its office at
Room 405A, Cyberport 4, 100 Cyberport Road, Hong Kong (the <B>&ldquo;Licensor&rdquo;</B>); and <B>Acticule Life Sciences Limited,
</B>with incorporation number CB-324541, a company incorporated and existing under the laws of the Cayman Islands, with its registered
office at Floor 4, Willow House, Cricket Square, Grand Cayman KY1-9010, Cayman Islands with its management office at Floor 17,
Guangdong Investment Tower, 148 Connaught Road, Central, Hong Kong (the <B>&ldquo;Company&rdquo;</B>).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><U>W</U>&nbsp;<U>I</U>&nbsp;<U>T</U>&nbsp;<U>N</U>&nbsp;<U>E</U>&nbsp;<U>S</U>&nbsp;<U>S</U>&nbsp;<U>E</U>&nbsp;<U>T</U>&nbsp;<U>H</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>WHEREAS,</B> the
Company and the Licensor have entered into that certain Exclusive Patent License Agreement dated as of October 18, 2017 by and
between Company and the Licensor (HKU Ref No. IP299) (the &ldquo;<B>Agreement</B>&rdquo;) (a copy of the Agreement is set forth
in <B>Appendix A</B>);</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>WHEREAS,</B> the
Company and the Licensor desire to amend the Agreement as follows.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>NOW, THEREFORE,</B>
the parties hereto, in consideration of the mutual promises herein contained and for other good and valuable consideration, the
receipt and sufficiency of which is hereby acknowledged, hereby agree to amend the Agreement as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">1.&nbsp;<U>Definitions</U>.
Unless otherwise specified herein, each term used herein that is defined in the Agreement shall have the meaning assigned to such
term in the Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">2. <U>Amendments.</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left; margin-left: 0.75in">Section 1.11 of the Agreement
is hereby replaced by the following:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; margin-left: 0.75in">&ldquo;FIELD&rdquo;
shall mean any and all human and non-human therapeutic uses, prescription and over-the-counter medications and preventatives, for
the treatment or prevention of viral infections, including influenza.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">3. <U>Date
of Effectiveness</U>. The amendment to Section 1.11 of the Agreement set forth in this Amendment is expressly made retroactive
to the Effective Date of the Agreement. This Amendment will become effective as of the date first written above when the Licensor
shall have received counterparts of this Amendment duly executed and delivered by the parties hereto. Notwithstanding the above,
the amendment to Section 1.11 of the Agreement set forth in this Amendment is expressly made retroactive to the Effective Date
of the Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">4. <U>Effect
of Amendment</U>. Except as expressly amended by this Amendment, all of the terms and provisions of the Agreement are and shall
remain in full force and effect and are hereby ratified and confirmed by the parties hereto. Without limiting the generality of
the forgoing, the amendments contained herein will not be construed as an amendment to or waiver of any other provision of the
Agreement or as a waiver of or consent to any further or future action on the part of any party hereto that would require the waiver
or consent of any other party hereto. Each reference in the Agreement to &ldquo;this Agreement&rdquo;, &ldquo;the Agreement&rdquo;,
&ldquo;hereunder&rdquo;, &ldquo;hereof&rdquo;, &ldquo;herein&rdquo; or words of like import will mean and be a reference to the
Agreement as amended by this Amendment.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">5. <U>Governing
Law</U>. This Amendment is governed by and construed in accordance with, the laws of Hong Kong.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">6. <U>Counterparts</U>.
This Amendment may be executed in two counterparts or by separate instruments and all of such counterparts and instruments
shall constitute one agreement, binding on all of the parties hereto.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid">&nbsp;</DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>IN WITNESS WHEREOF</B>,
the parties hereto have caused this Amendment to be duly executed on the date first above written.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD COLSPAN="2" STYLE="text-align: left"><B>ACTICULE LIFE SCIENCES LIMITED </B></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify; width: 4%">&nbsp;</TD>
    <TD STYLE="text-align: justify; width: 36%">&nbsp;</TD>
    <TD STYLE="text-align: justify; width: 60%">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">By:</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid">/s/ Ian Huen</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">Name: Mr. Ian Huen</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">Title: Director</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD COLSPAN="2" STYLE="text-align: justify"><B>VERSITECH LIMITED </B></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">By:</TD>
    <TD STYLE="text-align: justify; border-bottom: Black 1.5pt solid">/s/ Hailson Yu</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">Name:</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">Title:&nbsp;&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
</TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><U>Appendix A</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><U>Exclusive Patent License Agreement
(VER REF. 416-17)</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B></B></P>

<!-- Field: Page; Sequence: 3; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid">&nbsp;</DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>



<P STYLE="margin: 0"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.32
<SEQUENCE>36
<FILENAME>ff12018ex10-32_aptorum.htm
<DESCRIPTION>EXCLUSIVE PATENT LICENSE AGREEMENT FOR ALS-4
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0; text-align: right"><B>Exhibit 10.32</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">[CONFIDENTIAL TREATMENT HAS BEEN REQUESTED AS TO CERTAIN PORTIONS
OF THIS DOCUMENT. EACH SUCH PORTION, WHICH HAS BEEN OMITTED HEREIN AND REPLACED WITH BLACK BARS, HAS BEEN FILED SEPARATELY WITH
THE SECURITIES AND EXCHANGE COMMISSION.]</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>VERSITECH LIMITED</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>and</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="text-transform: uppercase"><B>ACTICULE
LIFE SCIENCES</B></FONT><B> LIMITED</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Rule-Page --><DIV ALIGN="CENTER" STYLE="margin-top: 0; margin-bottom: 0"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid; width: 35%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>EXCLUSIVE PATENT LICENSE AGREEMENT</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Rule-Page --><DIV ALIGN="CENTER" STYLE="margin-top: 0; margin-bottom: 0"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid; width: 35%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>


<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid">&nbsp;</DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><U>TABLE OF CONTENTS</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 91%; padding-right: 0">R E C I T A L S</TD>
    <TD STYLE="width: 9%; padding-right: 0; text-align: center">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="padding-right: 0">1.&nbsp;&nbsp;DEFINITIONS</TD>
    <TD STYLE="padding-right: 0; text-align: center">2</TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD STYLE="padding-right: 0">2.&nbsp;&nbsp;Grant of Rights</TD>
    <TD STYLE="padding-right: 0; text-align: center">6</TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="padding-right: 0">3.&nbsp;&nbsp;LICENSEE Diligence Obligations</TD>
    <TD STYLE="padding-right: 0; text-align: center">10</TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD STYLE="padding-right: 0">4.&nbsp;&nbsp;Royalties and Payment Terms</TD>
    <TD STYLE="padding-right: 0; text-align: center">11</TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="padding-right: 0">5.&nbsp;&nbsp;Reports and Records</TD>
    <TD STYLE="padding-right: 0; text-align: center">14</TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD STYLE="padding-right: 0">8.&nbsp;&nbsp;Infringement</TD>
    <TD STYLE="padding-right: 0; text-align: center">17</TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="padding-right: 0">9.&nbsp;&nbsp;Indemnification and Insurance</TD>
    <TD STYLE="padding-right: 0; text-align: center">19</TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD STYLE="padding-right: 0">11.&nbsp;&nbsp;Assignment</TD>
    <TD STYLE="padding-right: 0; text-align: center">21</TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="padding-right: 0">12.&nbsp;&nbsp;General Compliance with Laws</TD>
    <TD STYLE="padding-right: 0; text-align: center">22</TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD STYLE="padding-right: 0">13.&nbsp;&nbsp;Termination</TD>
    <TD STYLE="padding-right: 0; text-align: center">23</TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="padding-right: 0">14.&nbsp;&nbsp;Dispute Resolution</TD>
    <TD STYLE="padding-right: 0; text-align: center">24</TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD STYLE="padding-right: 0">15.&nbsp;&nbsp;GOVERNING LAW</TD>
    <TD STYLE="padding-right: 0; text-align: center">25</TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="padding-right: 0">16.&nbsp;&nbsp;Miscellaneous</TD>
    <TD STYLE="padding-right: 0; text-align: center">25</TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD STYLE="padding-right: 0"><B>SCHEDULE 1</B></TD>
    <TD STYLE="padding-right: 0; text-align: center">28</TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="padding-right: 0"><B>SCHEDULE 2</B></TD>
    <TD STYLE="padding-right: 0; text-align: center">29</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.5in 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: LowerRoman; Name: PageNo -->ii<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>THIS LICENCE AGREEMENT (&ldquo;Agreement&rdquo;) </B>is
made the &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; day of 2017. (&ldquo;<FONT STYLE="font-family: Times New Roman, Times, Serif">EFFECTIVE
DATE&rdquo;)</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">BETWEEN:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">(1)</TD><TD STYLE="text-align: justify"><B>VERSITECH LIMITED</B>, a company incorporated and existing under the laws of Hong Kong with
its office at Room 405A, Cyberport 4, 100 Cyberport Road, Hong Kong (&ldquo;LICENSOR&rdquo;); and</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">(2)</TD><TD STYLE="text-align: justify"><FONT STYLE="text-transform: uppercase"><B>ACTICULE LIFE SCIENCES </B></FONT><B>LIMITED</B><FONT STYLE="font-family: Times New Roman, Times, Serif">,
with incorporation number CB-324541, a company incorporated</FONT> and existing under the laws of the Cayman Islands, with its
<FONT STYLE="font-family: Times New Roman, Times, Serif">registered office at Floor 4, Willow House, Cricket Square, Grand Cayman
KY1-9010, Cayman Islands with its management office at Floor 17, Guangdong Investment Tower, 148 Connaught Road Central, Hong Kong</FONT>
(&ldquo;LICENSEE&rdquo;).</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in">(&ldquo;LICENSOR&rdquo; and &ldquo;LICENSEE&rdquo;
shall be hereinafter referred to separately by a &ldquo;PARTY&rdquo; or jointly by &ldquo;PARTIES&rdquo;)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-transform: uppercase; text-align: center"><U>R
E C I T A L S</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 35.45pt">(A)</TD><TD STYLE="text-align: justify">WHEREAS, LICENSOR is the OWNER of certain LICENSED PATENT (as later defined herein);</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 35.45pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">(B)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">WHEREAS, LICENSOR</FONT> has the right
to grant licenses under such LICENSED PATENT;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 35.45pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">(C)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">WHEREAS, LICENSOR</FONT> desires to have
the LICENSED PATENT developed and commercialized to benefit the public and is willing to grant a license thereunder;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 35.45pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">(D)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">WHEREAS, LICENSEE </FONT>has represented
to LICENSOR, to induce LICENSOR to enter into this Agreement, that LICENSEE shall commit itself to use COMMERCIALLY REASONABLE
EFFORTS to exploit the LICENSED PATENT so that public utilization shall eventually result therefrom; and</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 35.45pt">(E)</TD><TD STYLE="text-align: justify">WHEREAS, LICENSEE desires to obtain a license under the LICENSED PATENT upon the terms and conditions
hereinafter set forth.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify; text-indent: -35.45pt"></P>

<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid">&nbsp;</DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">NOW IT IS HEREBY AGREED as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-transform: uppercase; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><U>1.
</U></FONT><U>DEFINITIONS.</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1.2pt"></TD><TD STYLE="width: 34.8pt">1.1</TD><TD STYLE="text-align: justify">DEFINITIONS. All capitalized terms used but not otherwise defined herein shall have the meaning
set forth in the Agreement.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.4pt; text-align: justify; text-indent: 0in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1.2pt"></TD><TD STYLE="width: 34.8pt">1.2</TD><TD STYLE="text-align: justify">&ldquo;APPLICABLE LAWS&rdquo; shall mean applicable laws, rules and regulations, including any
rules, regulations, guidelines or other requirements of the REGULATORY AUTHORITIES (as defined below), that may be in effect from
time to time, including but not limited to those of the FDA, the cGMP and FDA Act, if applicable.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.4pt; text-align: justify; text-indent: 0in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1.2pt"></TD><TD STYLE="width: 34.8pt">1.3</TD><TD STYLE="text-align: justify">&ldquo;<U>AFFILIATE</U>&rdquo; shall mean any legal entity (such as a corporation, partnership, or
limited liability company) that is controlled by LICENSEE. For the purposes of this definition, the term &ldquo;control&rdquo; means
(i) beneficial ownership of at least fifty percent (50%) of the voting securities of a corporation or other business organization
with voting securities or (ii) a fifty percent (50%) or greater interest in the net assets or profits of a partnership or other
business organization without voting securities.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.4pt; text-align: justify; text-indent: 0in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1.2pt"></TD><TD STYLE="width: 34.8pt">1.4</TD><TD STYLE="text-align: justify">&ldquo;CMC&rdquo; means chemistry, manufacturing, and controls activities related to LICENSED PRODUCT.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.4pt; text-align: justify; text-indent: 0in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1.2pt"></TD><TD STYLE="width: 34.8pt">1.5</TD><TD STYLE="text-align: justify">&ldquo;<U>COMMERCIALLY REASONABLE EFFORTS</U>&rdquo; shall mean, with respect to a Party, those
commercially reasonable efforts by that Party similar to the efforts that Party, in good faith, would make in similar circumstances
for its own operations without procrastination, taking into consideration safety and efficacy, costs, the market potential of the
product, the stage of its development or product life, the clinical setting in which it is expected to be used, competitiveness
of the marketplace, regulatory environment, the patent or other proprietary position of the product, and other conditions then
prevailing. It is understood that a party&rsquo;s COMMERCIALLY REASONABLE EFFORTS will not in any event require that Party to take
any action that would be reasonably likely to result in a breach of any other provision of this Agreement, or that the Party in
good faith believes may violate any Applicable Law or any order, permit, direction or license of any court or governmental authority
having appropriate jurisdiction over the party and subject matter.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.4pt; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.4pt; text-align: justify; text-indent: 0in"></P>

<!-- Field: Page; Sequence: 4; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.4pt; text-align: justify; text-indent: 0in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1.2pt"></TD><TD STYLE="width: 34.8pt">1.6</TD><TD STYLE="text-align: justify">&ldquo;CONFIDENTIAL INFORMATION&rdquo; shall mean all proprietary materials or other information
(whether or not patentable) regarding a Party&rsquo;s technology, products, business information or objectives, including CMC,
manufacturing and marketing information, and clinical data, that is identified as proprietary or confidential by the disclosing
Party or that would be reasonably understood to be the type of materials or information that should be treated as proprietary or
confidential. The terms and conditions of this Agreement, the transactions described herein, and the Parties&rsquo; rights or obligations
hereunder shall be considered Confidential Information of both Parties.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.4pt; text-align: justify; text-indent: 0in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1.2pt"></TD><TD STYLE="width: 34.8pt">1.7</TD><TD STYLE="text-align: justify">&ldquo;<U>EFFECTIVE DATE</U>&rdquo; shall mean the date of this Agreement.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 24pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1.2pt"></TD><TD STYLE="width: 34.8pt">1.8</TD><TD STYLE="text-align: justify">&ldquo;<U>EXCLUSIVE PERIOD</U>&rdquo; shall mean the period of time set forth in Clause 2.2.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 24pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1.2pt"></TD><TD STYLE="width: 34.8pt">1.9</TD><TD STYLE="text-align: justify">&ldquo;<U>FDA</U>&rdquo; shall mean the United States Food and Drug Administration or any successor
agency.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.4pt; text-align: justify; text-indent: 0in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1.2pt"></TD><TD STYLE="width: 34.8pt">1.10</TD><TD>&ldquo;<U>FDA Act</U>&rdquo; shall mean the U.S. Federal Food, Drug, and Cosmetic Act, as amended from time to time, and the
regulations promulgated thereunder.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.4pt; text-align: justify; text-indent: 0in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1.2pt"></TD><TD STYLE="width: 34.8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">1.11</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&ldquo;<U>FIELD</U>&rdquo; shall mean</FONT>
any and all human and non-human therapeutic uses, prescription and over-the-counter medications and preventatives, for <FONT STYLE="font-family: Times New Roman, Times, Serif">the
treatment or prevention of Influenza.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 24pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1.2pt"></TD><TD STYLE="width: 34.8pt">1.12</TD><TD STYLE="text-align: justify">&ldquo;<U>HONG KONG</U>&rdquo; shall mean the Hong Kong Special Administrative Region.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 24pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1.2pt"></TD><TD STYLE="width: 34.8pt">1.13</TD><TD STYLE="text-align: justify">&ldquo;<U>IMPROVEMENT</U>&rdquo; shall mean any development or modification in the FIELD related
to the LICENSED PATENT or part thereof, or relating to the production and/or exploitation thereof, whether or not patented or patentable,
that is conceived, reduced to practice, discovered, developed or otherwise made at any time during the TERM of this Agreement.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.4pt; text-align: justify; text-indent: 0in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1.2pt"></TD><TD STYLE="width: 34.8pt">1.14</TD><TD STYLE="text-align: justify">&ldquo;<U>IND</U>&rdquo; shall mean (a) an Investigational New Drug Application (as defined in
21 U.S. Code of Federal Regulations 312.3) that is required to be filed with the FDA before beginning clinical testing of a product
in human subjects, or any successor application or procedure or (b) any counterpart of a U.S. Investigational New Drug Application
that is required in any other country or region in the Territory before beginning clinical testing of a product in human subjects
in such country or region.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.4pt; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.4pt; text-align: justify; text-indent: 0in"></P>

<!-- Field: Page; Sequence: 5; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.4pt; text-align: justify; text-indent: 0in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1.2pt"></TD><TD STYLE="width: 34.8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">1.15</FONT></TD><TD STYLE="text-align: justify">&ldquo;<U>LICENSED PRODUCT</U>&rdquo; shall mean any product that, in whole or in part:</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 35.5pt"></TD><TD STYLE="width: 35.4pt">(i)</TD><TD STYLE="text-align: justify">absent THE LICENSE granted hereunder, would infringe one or more claims of the LICENSED PATENT
in the country of sale; or</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 35.5pt"></TD><TD STYLE="width: 35.4pt">(ii)</TD><TD STYLE="text-align: justify">is manufactured by using any method that, absent THE LICENSE granted, would infringe one or more
claims of the <FONT STYLE="font-family: Times New Roman, Times, Serif">LICENSED PATENT</FONT>.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1.2pt"></TD><TD STYLE="width: 34.8pt">1.16</TD><TD STYLE="text-align: justify">&ldquo;<U>LICENSED PATENT</U>&rdquo; shall mean:</TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(i)</TD><TD STYLE="text-align: justify">The United States and foreign patents, patent applications, and provisional applications listed
in <U>Schedule 1</U>, and all applications and patents claiming priority thereto or common priority therewith and any resulting
patents therefrom; and</TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(ii)</TD><TD STYLE="text-align: justify">any divisions, reissues, reexaminations, renewals, continuations, continuations-in-part and extensions
of the patent applications or patent listed in <U>Schedule 1</U> including their relevant international equivalents thereof and
any patens that result therefrom.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 71.4pt; text-align: justify; text-indent: 0in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1.2pt"></TD><TD STYLE="width: 34.8pt">1.17</TD><TD STYLE="text-align: justify">&ldquo;<U>NDA</U>&rdquo; shall mean New Drug Application to market the LICENSED PRODUCT in the
Territory or similar application submitted to the FDA, or its foreign equivalent submitted to any Regulatory Authority in the Territory,
and all supplements and amendments thereto.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.4pt; text-align: justify; text-indent: 0in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1.2pt"></TD><TD STYLE="width: 34.8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">1.18</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&ldquo;<U>NET SALES</U>&rdquo; shall mean
the invoiced price of LICENSED PRODUCT sold by LICENSEE and/ or its AFFILIATES </FONT>to independent third parties in arm&rsquo;s length
transactions exclusively for money or, where the sale is not at arm&rsquo;s length, the price that would have been so invoiced if it
had been at arm&rsquo;s length, after deduction of:-</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 35.7pt"></TD><TD STYLE="width: 28.1pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">(i)</FONT></TD><TD STYLE="text-align: justify">normal trade discounts actually granted and credits actually given to the returned goods<FONT STYLE="font-family: Times New Roman, Times, Serif">;
</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 35.7pt"></TD><TD STYLE="width: 28.1pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">(ii)</FONT></TD><TD STYLE="text-align: justify">costs of packaging, freight and its corresponding insurance; and</TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 35.7pt"></TD><TD STYLE="width: 28.1pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">(iii)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">import expenses and other relevant tax,
duties or similar government levies actually paid </FONT>on LICENSED PRODUCT.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.4pt; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify">The calculation of NET SALES
is set out in <U>Schedule 2</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.4pt; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.4pt; text-align: justify; text-indent: 0in"></P>

<!-- Field: Page; Sequence: 6; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.4pt; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.4pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif">In
the event </FONT>LICENSED PRODUCT <FONT STYLE="font-family: Times New Roman, Times, Serif">sold in combination with other
licensed products or patents, the NET SALES of such LICENSED PRODUCT used for determining the ROYALTY due to LICENSOR shall
be calculated <FONT STYLE="background-color: black">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.4pt; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.4pt; text-align: justify; text-indent: 0in">No deductions
shall be made for commissions paid to individuals whether they be with independent sales agencies or regularly employed by LICENSEE
and on its payroll, or for cost of collections. NET SALES shall occur on the date of billing for a LICENSED PRODUCT. If a LICENSED
PRODUCT is distributed at a discounted price that is substantially lower than the customary price charged by LICENSEE, or distributed
for non-cash consideration (whether or not at a discount), NET SALES shall be calculated based on the non-discounted amount of
LICENSED PRODUCT charged to an independent third party during the same REPORTING PERIOD or, in the absence of such sales, on the
fair market value of LICENSED PRODUCT.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 24pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.4pt; text-align: justify; text-indent: 0in">Non-monetary
consideration shall <B><U>NOT</U></B> be accepted by LICENSEE for any LICENSED PRODUCT without the prior written consent of LICENSOR.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.4pt; text-align: justify; text-indent: 0in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1.2pt"></TD><TD STYLE="width: 34.8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">1.19</FONT></TD><TD STYLE="text-align: justify">&ldquo;<U>NON-COMMERCIAL RESEARCH, TEACHING, AND EDUCATIONAL PURPOSES</U>&rdquo; shall mean use
of LICENSED PATENT for academic research or other not-for-profit scholarly purposes which are undertaken at a nonprofit or governmental
institution that does not use the LICENSED PATENT in the production or manufacture of products for sale or the performance of services
for a fee.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.4pt; text-align: justify; text-indent: 0in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1.2pt"></TD><TD STYLE="width: 34.8pt">1.20</TD><TD STYLE="text-align: justify">&ldquo;<U>REGULATORY APPROVAL</U>&rdquo; shall mean approval by corresponding REGULATORY AUTHORITY,
including but not limited to FDA, to market LICENSED PRODUCT in the FIELD in the TERRITORY.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.4pt; text-align: justify; text-indent: 0in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1.2pt"></TD><TD STYLE="width: 34.8pt">1.21</TD><TD STYLE="text-align: justify">&ldquo;<U>REGULATORY AUTHORITY</U>&rdquo; shall mean any applicable supra-national, federal, national,
regional, state, provincial or local regulatory agencies, departments, bureaus, commissions, councils or other government entities
regulating or otherwise exercising authority with respect to the distribution, importation, exportation, manufacture, production,
use, storage, transport, or clinical testing, pricing or sale of LICENSED PRODUCT in the FIELD in the TERRITORY, including the
FDA or any counterpart of the FDA outside the United States.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.4pt; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.4pt; text-align: justify; text-indent: 0in"></P>

<!-- Field: Page; Sequence: 7; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.4pt; text-align: justify; text-indent: 0in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1.2pt"></TD><TD STYLE="width: 34.8pt">1.22</TD><TD STYLE="text-align: justify">&ldquo;<U>REPORTING PERIOD</U>&rdquo; shall begin on the first day of each calendar year and end
on the last day of such calendar year and (i) the first REPORTING PERIOD shall mean the period from the EFFECTIVE DATE to the last
day of the next following calendar year; and (ii) the last REPORTING PERIOD shall mean the period from the first day of the calendar
year to which this Agreement is terminated to the termination date of this Agreement.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 71.4pt; text-align: justify; text-indent: 0in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1.2pt"></TD><TD STYLE="width: 34.8pt">1.23</TD><TD STYLE="text-align: justify">&ldquo;<U>SUBLICENSEES</U>&rdquo; shall mean any non-AFFILIATE sublicensees of the rights granted
by LICENSEE under Clause 2.3.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.4pt; text-align: justify; text-indent: 0in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1.2pt"></TD><TD STYLE="width: 34.8pt">1.24</TD><TD STYLE="text-align: justify">&ldquo;<U>SUBLICENSE INCOME</U>&rdquo; shall mean all considerations that LICENSEE or an AFFILIATE
receives from SUBLICENSEES in consideration of the sublicense of the rights granted LICENSEE and AFFILIATES under Clause 2.1, including
without limitation license fees, milestone payments, license maintenance fees, and other payments.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.4pt; text-align: justify; text-indent: 0in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1.2pt"></TD><TD STYLE="width: 34.8pt">1.25</TD><TD STYLE="text-align: justify">&ldquo;<U>TERM</U>&rdquo; shall mean the term of this Agreement, which shall commence on the EFFECTIVE
DATE and shall remain in effect until the expiration of all issued patents and filed patent application within the LICENSED PATENT
unless earlier terminated in accordance with the provisions of this Agreement.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 24pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1.2pt"></TD><TD STYLE="width: 34.8pt">1.26</TD><TD STYLE="text-align: justify">&ldquo;<U>TERRITORY</U>&rdquo; shall mean worldwide.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.4pt; text-align: justify; text-indent: 0in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1.2pt"></TD><TD STYLE="width: 34.8pt">1.27</TD><TD STYLE="text-align: justify">&ldquo;<U>US DOLLARS</U>&rdquo; shall mean the United States Dollars, the lawful currency of the
United States of America.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.4pt; text-align: justify; text-indent: 0in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1.2pt"></TD><TD STYLE="width: 34.8pt">1.28</TD><TD STYLE="text-align: justify">&ldquo;VALID CLAIM&rdquo; shall mean a claim of an unexpired issued patent or pending patent application
falling within LICENSED PATENT, which claim shall not have been withdrawn, cancelled, disclaimed, or held invalid by a court, tribunal,
arbitrator, or governmental agency of competent jurisdiction in a final or unappealed or unappealable decision.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.4pt; text-align: justify; text-indent: -35.4pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-transform: uppercase; text-align: center"><U>2.
Grant of Rights.</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1.1pt"></TD><TD STYLE="width: 34.9pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">2.1</FONT></TD><TD STYLE="text-align: justify"><U>License Grants</U>. Subject to the terms and conditions of this Agreement, LICENSOR hereby grants
to LICENSEE and its AFFILIATES for the TERM an exclusive and royalty-bearing license (&ldquo;THE LICENSE&rdquo;), with the right
to grant sublicenses pursuant to Clause 2.3, under the LICENSED PATENT in the FIELD to develop, make, have made, use, sell, offer
for sell, and import LICENSED PRODUCT in the FIELD in the TERRITORY during the TERM of this Agreement.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify; text-indent: 0in"></P>

<!-- Field: Page; Sequence: 8; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify; text-indent: 0in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1.1pt"></TD><TD STYLE="width: 34.9pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">2.2</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><U>Exclusivity</U>. In order to establish
an exclusive period for LICENSEE, LICENSOR agrees that it shall not grant any other license under LICENSED PATENT in the FIELD
to </FONT>develop, make, have made, use, sell, offer for sell, and import <FONT STYLE="font-family: Times New Roman, Times, Serif">LICENSED
PRODUCT in the FIELD in the TERRITORY during the period of time commencing on the EFFECTIVE DATE and terminating with the first
occurrence of:</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 24pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 35.4pt"></TD><TD STYLE="width: 36pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">(i)</FONT></TD><TD STYLE="text-align: justify">the end of the TERM; or</TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 35.4pt"></TD><TD STYLE="width: 36pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">(ii)</FONT></TD><TD STYLE="text-align: justify">the expiration of all the LICENSED PATENT; or</TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 35.4pt"></TD><TD STYLE="width: 36pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">(iii)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">all LICENSED PATENT are finally and irrevocably</FONT>
invalidated by a court or government agency with competent jurisdiction<FONT STYLE="font-family: Times New Roman, Times, Serif">.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.4pt; text-align: justify; text-indent: 0in">Upon expiration
of the EXCLUSIVE PERIOD, THE LICENSE granted hereunder shall become nonexclusive and shall extend to the end of the TERM (if any),
unless sooner terminated as provided in this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 24pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1.1pt"></TD><TD STYLE="width: 34.9pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">2.3</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><U>Sublicenses</U>. During the EXCLUSIVE
PERIOD, LICENSEE and/ or its AFFILIATES shall have the right to grant sublicenses, without the right to further sublicense, </FONT>to
any non-Affiliates sublicensees (&ldquo;SUBLICENSEES&rdquo;) under THE LICENSE subject to a sublicensing agreement. Any sublicensing
agreements shall be consistent with and subject to the terms and conditions of this Agreement, any such sublicense shall oblige
the SUBLICENSEES to comply with all the terms of this Agreement (except those provisions which, by their clear meaning, are not
applicable to a SUBLICENSEES) and that LICENSEE will remain liable to LICENSOR for all material acts and omissions of any such
SUBLICENSEES. THE LICENSE granted under this Agreement and any sublicensing agreements do not include rights to trade names of
LICENSOR. LICENSEE shall promptly furnish LICENSOR with notice of any sublicense granted pursuant to this Section 2.3, and provide
a copy of the executed sublicense agreement (which may be redacted for financial terms).</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify; text-indent: 0in"></P>

<!-- Field: Page; Sequence: 9; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify; text-indent: 0in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1.1pt"></TD><TD STYLE="width: 34.9pt">2.4</TD><TD STYLE="text-align: justify"><U>Retained Rights.</U></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify; text-indent: 0in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 35.4pt"></TD><TD STYLE="width: 36pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">(a)</FONT></TD><TD STYLE="text-align: justify"><U>LICENSOR</U>. LICENSOR retains the right to use the LICENSED PATENT solely for NON-COMMERCIAL
RESEARCH, TEACHING, AND EDUCATIONAL PURPOSES in the FIELD in the TERRITORY.</TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 35.4pt"></TD><TD STYLE="width: 36pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">(b)</FONT></TD><TD STYLE="text-align: justify"><U>Academic and Not-For-Profit Research Institutes</U>. LICENSOR retains the right to grant licenses
to academic and not-for-profit research institutes to practice under the LICENSED PATENT solely NON-COMMERCIAL RESEARCH, TEACHING,
AND EDUCATIONAL PURPOSES in the FIELD in the TERRITORY.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1.1pt"></TD><TD STYLE="width: 34.9pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">2.5</FONT></TD><TD STYLE="text-align: justify"><U>No Additional Rights</U>. Nothing in this Agreement shall be construed to confer any rights
upon LICENSEE by implication, estoppel, or otherwise as to any technology or patent rights of LICENSOR or any other entity other
than the LICENSED PATENT, regardless of whether such technology or patent rights shall be dominant or subordinate to any LICENSED
PATENT.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1.1pt"></TD><TD STYLE="width: 34.9pt">2.6</TD><TD STYLE="text-align: justify"><U>Confidentiality obligations</U>. Each Party (&ldquo;RECEIVING PARTY&rdquo;) shall:</TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 34.9pt"></TD><TD STYLE="width: 36pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">maintain as secret and
confidential all CONFIDENTIAL INFORMATION of the other PARTY (</FONT>&ldquo;<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">DISCLOSING
PARTY&rdquo;) in the course of or in anticipation of this Agreement and to respect the DISCLOSING PARTY&rsquo;s rights therein,</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 34.9pt"></TD><TD STYLE="width: 36pt">(b)</TD><TD STYLE="text-align: justify">use the CONFIDENTIAL INFORMATION of the other PARTY only to the extent necessary for the purposes
of, or as contemplated or permitted by, this Agreement,</TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 34.9pt"></TD><TD STYLE="width: 36pt">(c)</TD><TD STYLE="text-align: justify">protect the other PARTY&rsquo;S CONFIDENTIAL INFORMATION using not less than the same standard
of care with which the RECEIVING PARTY treats its own CONFIDENTIAL INFORMATION, and at all times using at least reasonable care.</TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 34.9pt"></TD><TD STYLE="width: 36pt">(d)</TD><TD STYLE="text-align: justify">not at any time disclose any CONFIDENTIAL INFORMATION of the other PARTY to persons other than
those listed under Clause 2.8 with a need to know, except where permitted by this Agreement and subject to a written undertakings
of confidentiality at least as restrictive as Clauses 2.6 and 2.7, and only to the extent that such disclosure is reasonably necessary
for the purposes of, or as contemplated or permitted by, this Agreement.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify; text-indent: -35.45pt"><FONT STYLE="font-weight: normal">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 35.45pt"><FONT STYLE="font-weight: normal">2.7</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-weight: normal"><U>Exceptions to obligations</U>. The provisions of Clause 2.6
shall not apply to any CONFIDENTIAL INFORMATION which the RECEIVING PARTY can demonstrate by reasonable written evidence:</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 34.9pt"></TD><TD STYLE="width: 36pt">(a)</TD><TD STYLE="text-align: justify">was, prior to its receipt by the RECEIVING PARTY from the DISCLOSING PARTY, known by the RECEIVING
PARTY and at its free disposal; or</TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="margin-top: 0; margin-bottom: 0"></P>

<!-- Field: Page; Sequence: 10; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 34.9pt"></TD><TD STYLE="width: 36pt">(b)</TD><TD STYLE="text-align: justify">is subsequently disclosed to the RECEIVING PARTY without any obligations of confidence by a third
party owing to the DISCLOSING PARTY; or</TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 34.9pt"></TD><TD STYLE="width: 36pt">(c)</TD><TD STYLE="text-align: justify">is or becomes generally available to the public through no breach or default of this Agreement
by RECEIVING PARTY or its agents, employees, AFFILIATES or SUBLICENSEES; or</TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 34.9pt"></TD><TD STYLE="width: 36pt">(d)</TD><TD STYLE="text-align: justify">is independently developed as established by the RECEIVING PARTY without use of the DISCLOSING
PARTY&rsquo;s CONFIDENTIAL INFORMATION as proven by the contemporaneous written records of the RECEIVING PARTY; or</TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 34.9pt"></TD><TD STYLE="width: 36pt">(e)</TD><TD STYLE="text-align: justify">the RECEIVING PARTY is required to disclose to the courts of any competent jurisdiction, or to
any government regulatory agency or financial authority, provided that the RECEIVING PARTY shall:</TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 71pt"></TD><TD STYLE="width: 42.4pt">(i)</TD><TD STYLE="text-align: justify">inform the DISCLOSING PARTY as soon as is reasonably practicable, and</TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 71pt"></TD><TD STYLE="width: 42.4pt">(ii)</TD><TD STYLE="text-align: justify">at the DISCLOSING PARTY&rsquo;s request and cost seek to persuade the court, agency or authority
to have the information treated in a confidential manner, where this is possible under the court, agency or authority&rsquo;s procedures;
or</TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 34.9pt"></TD><TD STYLE="width: 36pt">(f)</TD><TD STYLE="text-align: justify">the RECEIVING PARTY is obligated by applicable law to disclose provided that the RECEIVING PARTY
shall inform the DISCLOSING PARTY before such disclosure; or</TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 34.9pt"></TD><TD STYLE="width: 36pt">(g)</TD><TD STYLE="text-align: justify">in the case of information disclosed by LICENSOR to LICENSEE, is disclosed to actual or potential
customers for LICENSED PRODUCT in so far as such disclosure is reasonably necessary to promote the sale or use of LICENSED PRODUCT.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify; text-indent: -35.45pt"><FONT STYLE="font-weight: normal">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 35.45pt"><FONT STYLE="font-weight: normal">2.8</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-weight: normal"><U>Disclosure to employees.</U> The RECEIVING PARTY shall procure
that all of its employees, contractors, affiliates, any appointed agents and/or distributors pursuant to this Agreement (if any)
who have access to any of the DISCLOSING PARTY&rsquo;s information to which Clause 2.6 applies, shall be made aware of and subject
to these obligations and shall have entered into written undertakings of confidentiality at least as restrictive as Clauses 2.6
and 2.7 and which apply to the DISCLOSING PARTY&rsquo;s information.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 11; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center"><U>3. LICENSEE
Diligence Obligations.</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0pt"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-weight: normal">3.1</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-weight: normal"><U>Diligence Requirements.</U> LICENSEE shall use its COMMERCIALLY
REASONABLE EFFORTS to develop LICENSED PRODUCT for commercial use as soon as practicable, and to continue active, diligent marketing
efforts for LICENSED PRODUCT throughout the TERM of this Agreement. During the continuance of the EXCLUSIVE PERIOD, LICENSEE shall
make its best efforts to raise no less than <FONT STYLE="background-color: black">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT> of fund in 10 years from
the EFFECTIVE DATE for fulfilling the DILIGENCE REQUIREMENT (as defined below) including no less than <FONT STYLE="background-color: black">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT> prior to the pre-clinical studies and such <FONT STYLE="background-color: black">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT> shall be used
for the pre-clinical studies. LICENSEE shall, or shall cause its AFFILIATES and SUBLICENSEES to, use COMMERCIALLY REASONABLE EFFORTS
to develop LICENSED PRODUCT, to obtain any regulatory approvals and to introduce LICENSED PRODUCT in the FIELD in the TERRITORY.
Specifically, LICENSEE shall, or shall cause its AFFILIATES and SUBLICENSEES to, conduct the followings <FONT STYLE="background-color: black">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 85.05pt"></TD><TD STYLE="width: 35.45pt"><FONT STYLE="background-color: black">&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD><TD><FONT STYLE="background-color: black">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD></TR>                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            <TR STYLE="vertical-align: top">
<TD>&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD></TR>
</TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 85.05pt"></TD><TD STYLE="width: 35.45pt"><FONT STYLE="background-color: black">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="background-color: black">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<BR>
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD></TR>                                                                                                                                                                                                                                                                                                                                                                                   <TR STYLE="vertical-align: top">
<TD>&nbsp;</TD><TD>&nbsp;</TD><TD STYLE="text-align: justify">&nbsp;</TD></TR>
</TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 85.05pt"></TD><TD STYLE="width: 35.45pt"><FONT STYLE="background-color: black">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD><TD><FONT STYLE="background-color: black">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 85.05pt"></TD><TD STYLE="width: 35.45pt"><FONT STYLE="background-color: black">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD><TD><FONT STYLE="background-color: black">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD></TR>                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    <TR STYLE="vertical-align: top">
<TD>&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD></TR>
</TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 85.05pt"></TD><TD STYLE="width: 35.45pt"><FONT STYLE="background-color: black">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="background-color: black">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<BR>
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<BR>
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<BR>
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<BR>
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<BR>
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 12; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify; text-indent: 0in">LICENSEE
shall furnish LICENSOR with a written report annually on the progress of its efforts to develop and commercialize LICENSED PRODUCT
in according to Clause 3 hereto.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify; text-indent: 0in">If LICENSEE
intentionally delays or has failed to perform its diligence obligations under this Clause 3.1 and does not provide any reasonable
remedy within one (1) month from a written notice issued by LICENSOR, LICENSOR may treat such delay or failure as a material breach
in accordance with Clause 13.4(b).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center"><U>4. Royalties
and Payment Terms.</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in; text-align: left">4.1</TD><TD STYLE="text-align: justify"><U>Consideration for Grant of Rights</U>.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 35.3pt"></TD><TD STYLE="width: 35.6pt">4.1.1</TD><TD STYLE="text-align: justify"><U>Patent Cost Reimbursement.</U> LICENSEE shall reimburse LICENSOR for all its actual expenses
incurred in connection with filing, prosecuting and maintaining the LICENSED PATENT as set forth in Clause 7.4 within thirty (30)
days from the date of receiving an original signed invoice. These payments are non-refundable.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.55pt; text-align: justify; text-indent: 0in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 35.3pt"></TD><TD STYLE="width: 35.6pt">4.1.2</TD><TD STYLE="text-align: justify"><U>Upfront Fee.</U> LICENSEE                                          shall pay to LICENSOR
                                                                   an upfront fee of <FONT STYLE="background-color: black">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
                                                                   &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
                                                                   </FONT>within thirty (30) days from the date of receiving an original signed invoice
                                                                   after the EFFECTIVE DATE. Such UPFRONT FEE is non-refundable.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 24pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 35.3pt"></TD><TD STYLE="width: 35.6pt">4.1.3</TD><TD STYLE="text-align: justify"><U>Royalties</U>. LICENSEE shall pay to LICENSOR a royalty (&ldquo;ROYALTY&rdquo;) equal to <FONT STYLE="background-color: black">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT> of NET SALES of LICENSED PRODUCT in the TERRITORY by LICENSEE or its AFFILIATES. For the avoidance of doubt
and subject to the Sublicense Royalty as set forth in this Clause 4.1.3, income generated from NET SALES of LICENSED PRODUCT does
not include income generated from SUBLICENSE INCOME.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 24pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.9pt; text-align: justify; text-indent: 0in">ROYALTY shall
be payable for each REPORTING PERIOD and shall be due to LICENSOR within sixty (60) days of the end of each REPORTING PERIOD. ROYALTY
shall only be payable once with respect to the same unit of LICENSED PRODUCT.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.9pt; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.9pt; text-align: justify; text-indent: 0in"></P>

<!-- Field: Page; Sequence: 13; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.9pt; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.9pt; text-align: justify; text-indent: 0in">Such ROYALTY
shall be paid, on a LICENSED PRODUCT by LICENSED PRODUCT and country by country basis.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.9pt; text-align: justify; text-indent: 0in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5202in"></TD><TD STYLE="width: 0.4798in">4.1.4</TD><TD STYLE="text-align: justify"><U>Sublicense Royalty</U>. LICENSEE shall pay LICENSOR a total of <FONT STYLE="background-color: black">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT> of total SUBLICENSE INCOME. Such amount shall be payable for each REPORTING PERIOD and shall be due to LICENSOR
within sixty (60) days of the end of each REPORTING PERIOD.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.9pt; text-align: justify; text-indent: 0in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5327in"></TD><TD STYLE="width: 0.4673in">4.1.5</TD><TD STYLE="text-align: justify"><U>Milestone Payment</U>. LICENSEE shall pay to LICENSOR the following milestone payment on the
events set forth below within 30 days after the achievement of the corresponding milestones by LICENSEE or its AFFILIATES or SUBLICENSEES:</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR>
    <TD STYLE="width: 1in; padding-top: 5.4pt; padding-bottom: 5.4pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; vertical-align: top; padding-top: 5.4pt; padding-bottom: 5.4pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; background-color: black">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif"><BR>
    <FONT STYLE="background-color: black">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></FONT></TD>
    <TD STYLE="width: 2%; padding-top: 5.4pt; padding-bottom: 5.4pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 30%; text-align: left; vertical-align: top; padding-top: 5.4pt; padding-bottom: 5.4pt"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; background-color: black">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif"><BR>
        <FONT STYLE="background-color: black">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P></TD></TR>
<TR>
    <TD STYLE="padding-top: 5.4pt; padding-bottom: 5.4pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; vertical-align: top; padding-top: 5.4pt; padding-bottom: 5.4pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; background-color: black">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif"><BR>
    <FONT STYLE="background-color: black">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></FONT></TD>
    <TD STYLE="padding-top: 5.4pt; padding-bottom: 5.4pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; vertical-align: top; padding-top: 5.4pt; padding-bottom: 5.4pt"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; background-color: black">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif"><BR>
        <FONT STYLE="background-color: black">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P></TD></TR>
<TR>
    <TD STYLE="padding-top: 5.4pt; padding-bottom: 5.4pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; vertical-align: top; padding-top: 5.4pt; padding-bottom: 5.4pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; background-color: black">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif"><BR>
    <FONT STYLE="background-color: black">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></FONT></TD>
    <TD STYLE="padding-top: 5.4pt; padding-bottom: 5.4pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; vertical-align: top; padding-top: 5.4pt; padding-bottom: 5.4pt"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; background-color: black">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif"><BR>
        <FONT STYLE="background-color: black">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P></TD></TR>
<TR>
    <TD STYLE="padding-top: 5.4pt; padding-bottom: 5.4pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; vertical-align: top; padding-top: 5.4pt; padding-bottom: 5.4pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; background-color: black">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif"><BR>
    <FONT STYLE="background-color: black">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></FONT></TD>
    <TD STYLE="padding-top: 5.4pt; padding-bottom: 5.4pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; vertical-align: top; padding-top: 5.4pt; padding-bottom: 5.4pt"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; background-color: black">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif"><BR>
        <FONT STYLE="background-color: black">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P></TD></TR>
<TR>
    <TD STYLE="padding-top: 5.4pt; padding-bottom: 5.4pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; vertical-align: top; padding-top: 5.4pt; padding-bottom: 5.4pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; background-color: black">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif"><BR>
    <FONT STYLE="background-color: black">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></FONT></TD>
    <TD STYLE="padding-top: 5.4pt; padding-bottom: 5.4pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; vertical-align: top; padding-top: 5.4pt; padding-bottom: 5.4pt"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; background-color: black">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif"><BR>
        <FONT STYLE="background-color: black">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P></TD></TR>
<TR>
    <TD STYLE="padding-top: 5.4pt; padding-bottom: 5.4pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; vertical-align: top; padding-top: 5.4pt; padding-bottom: 5.4pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; background-color: black">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif"><BR>
    <FONT STYLE="background-color: black">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></FONT></TD>
    <TD STYLE="padding-top: 5.4pt; padding-bottom: 5.4pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; vertical-align: top; padding-top: 5.4pt; padding-bottom: 5.4pt"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; background-color: black">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif"><BR>
        <FONT STYLE="background-color: black">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P></TD></TR>
<TR>
    <TD STYLE="padding-top: 5.4pt; padding-bottom: 5.4pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; vertical-align: top; padding-top: 5.4pt; padding-bottom: 5.4pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; background-color: black">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif"><BR>
    <FONT STYLE="background-color: black">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></FONT></TD>
    <TD STYLE="padding-top: 5.4pt; padding-bottom: 5.4pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; vertical-align: top; padding-top: 5.4pt; padding-bottom: 5.4pt"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; background-color: black">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><BR></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; background-color: black">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></P></TD></TR>
<TR>
    <TD STYLE="padding-top: 5.4pt; padding-bottom: 5.4pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; vertical-align: top; padding-top: 5.4pt; padding-bottom: 5.4pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; background-color: black">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif"><BR>
    <FONT STYLE="background-color: black">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><BR>
    <FONT STYLE="background-color: black">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></FONT></TD>
    <TD STYLE="padding-top: 5.4pt; padding-bottom: 5.4pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; vertical-align: top; padding-top: 5.4pt; padding-bottom: 5.4pt"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; background-color: black">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif"><BR>
        <FONT STYLE="background-color: black">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.8pt; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.8pt; text-indent: 0in">These Milestone Payments are nonrefundable.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.8pt; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.8pt; text-indent: 0in"></P>

<!-- Field: Page; Sequence: 14; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.8pt; text-indent: 0in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in; text-align: left">4.2</TD><TD STYLE="text-align: justify"><U>Payments</U>.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 35.4pt"></TD><TD STYLE="width: 0.5in">(a)</TD><TD STYLE="text-align: justify"><U>Method of Payment</U>. All payments under this Agreement shall be made payable to &ldquo;Versitech
Limited&rdquo; and be wired to the bank account of LICENSOR as follows:</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.8pt; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.8pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; background-color: black">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.8pt; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.8pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; background-color: black">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.8pt; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.8pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; background-color: black">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.8pt; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.8pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; background-color: black">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.8pt; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.8pt; text-align: justify; text-indent: 0in">LICENSEE shall
notify LICENSOR within seven (7) days after LICENSEE has made the relevant payments and provide LICENSOR with copies of the corresponding
bank remittance receipts when available.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.8pt; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.8pt; text-align: justify; text-indent: 0in">Payment receipts
shall be sent to the address identified in Clause 15.2. Each payment should reference this Agreement and identify the obligation
under this Agreement that the payment satisfies.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 64.9pt; text-align: justify; text-indent: -29.5pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 37.8pt"></TD><TD STYLE="width: 34.2pt">(b)</TD><TD STYLE="text-align: justify"><U>Payments in US Dollars</U>. All payments due under this Agreement shall be payable in US DOLLARS,
subject to (d) below. Such payments shall be without deduction of exchange, collection, or other charges, and, specifically, without
deduction of withholding or similar taxes or other government imposed fees or taxes, except as permitted in the definition of NET
SALES. Conversion of foreign currency to US DOLLARS shall be made at the conversion rate routinely used in Hong Kong as reported
by the Hongkong and Shanghai Banking Corporation Limited on the last working day of the calendar year of the applicable REPORTING
PERIOD. The average of the bid and the ask rate shall be used as the conversion rate if both rates are available.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 64.9pt; text-align: justify; text-indent: -29.5pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 37.65pt"></TD><TD STYLE="width: 34.35pt">(c)</TD><TD STYLE="text-align: justify"><U>Late Payments</U>. Any payments by LICENSEE that are not paid on or before the date such payments
are due under this Agreement shall bear interest, to the extent permitted by law, at two percentage points above the Prime Rate
of interest as announced by the Hong Kong &amp; Shanghai Banking Corporation Limited on the date payment is due or the next working
day if the payment due date is a bank holiday.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 38.1pt"></TD><TD STYLE="width: 33.9pt">(d)</TD><TD STYLE="text-align: justify"><U>Blocked Currency</U>. In each country where the local currency is blocked and cannot be removed
from the country, royalties accrued in that country will be paid to LICENSOR in the country in local currency by deposit in a local
bank designated by LICENSOR, unless the parties otherwise agree.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.6pt; text-align: justify; text-indent: -35.3pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.6pt; text-align: justify; text-indent: -35.3pt"></P>

<!-- Field: Page; Sequence: 15; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.6pt; text-align: justify; text-indent: -35.3pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center"><U>5. Reports
and Records.</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1.1pt"></TD><TD STYLE="width: 34.9pt">5.1</TD><TD><U>Frequency of Reports</U>.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 35.4pt"></TD><TD STYLE="width: 0.5in">(a)</TD><TD STYLE="text-align: justify"><U>Before First Commercial Sale</U>. Prior to the first commercial sale of any LICENSED PRODUCT,
LICENSEE shall deliver reports to LICENSOR annually, within sixty (60) days of the end of each calendar year, containing information
concerning the immediately preceding calendar year on the diligent efforts of LICENSEE, its AFFILIATES or SUBLICENSEES to develop
LICENSED PRODUCT as stipulated in Clause 3.1.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 106.15pt; text-indent: -35.35pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 35.5pt"></TD><TD STYLE="width: 0.5in">(b)</TD><TD STYLE="text-align: justify"><U>Upon First Commercial Sale of a LICENSED PRODUCT</U>. LICENSEE shall report to LICENSOR the
date of first commercial sale of a LICENSED PRODUCT within sixty (60) days of occurrence in each country.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.85pt; text-align: justify; text-indent: -35.35pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 35.5pt"></TD><TD STYLE="width: 0.5in">(c)</TD><TD STYLE="text-align: justify"><U>After First Commercial Sale</U>. After the first commercial sale of a LICENSED PRODUCT, LICENSEE
shall deliver reports to LICENSOR within sixty (60) days of the end of each REPORTING PERIOD, containing information concerning
the immediately preceding REPORTING PERIOD, as further described in Clause 5.2.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1.1pt"></TD><TD STYLE="width: 34.9pt">5.2</TD><TD STYLE="text-align: justify"><U>Content of Reports and Payments</U>. Each report delivered by LICENSEE to LICENSOR pursuant
to Clause 5.1(c) shall contain at least the following information for the immediately preceding REPORTING PERIOD:</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 35.4pt"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-size: 10pt">(i)</FONT></TD><TD STYLE="text-align: justify">the number and description of each LICENSED PRODUCT sold, leased or distributed by LICENSEE, its
AFFILIATES and SUBLICENSEES to independent third parties in each country, and, if applicable, the number of LICENSED PRODUCT used
by LICENSEE, its AFFILIATES and SUBLICENSEES in the provision of services in each country;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.8pt; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.8pt; text-align: justify; text-indent: 0in"></P>

<!-- Field: Page; Sequence: 16; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.8pt; text-align: justify; text-indent: 0in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 35.4pt"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-size: 10pt">(ii)</FONT></TD><TD STYLE="text-align: justify">the gross price charged by LICENSEE, its AFFILIATES and SUBLICENSEES for each LICENSED PRODUCT
and, if applicable, the gross price charged for each LICENSED PRODUCT used to provide services in each country;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 24pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 35.4pt"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-size: 10pt">(iii)</FONT></TD><TD STYLE="text-align: justify">calculation of NET SALES for the applicable REPORTING PERIOD in each country, including a listing
of applicable deductions;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 24pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 35.4pt"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-size: 10pt">(iv)</FONT></TD><TD STYLE="text-align: justify">total royalty payable on NET SALES in US Dollars, together with the exchange rates used for conversion;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 24pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 35.4pt"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-size: 10pt">(v)</FONT></TD><TD STYLE="text-align: justify">the amount of SUBLICENSE INCOME received by LICENSEE and its AFFILIATES from each SUBLICENSEE and
the amount due to LICENSOR and its AFFILIATES from such SUBLICENSE INCOME, including an itemized breakdown of the sources of income
comprising the SUBLICENSE INCOME; and</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 24pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 35.4pt"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-size: 10pt">(vi)</FONT></TD><TD STYLE="text-align: justify">the number of sublicenses entered into for the LICENSED PATENT and LICENSED PRODUCT.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.4pt; text-align: justify; text-indent: 0in">All the reports
shall be verified and duly signed by Managing Director or the authorized person of LICENSEE. If no amounts are due to LICENSOR
for any REPORTING PERIOD, the report shall so state.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 35.45pt">5.3</TD><TD STYLE="text-align: justify"><U>Financial Statements</U>. On or before the ninetieth (90<SUP>th</SUP>) day following the close
of LICENSEE&rsquo;s fiscal year, LICENSEE shall provide LICENSOR with (i) a statement setting out the information required by Clause
5.2 for the preceding fiscal year, certified by LICENSEE&rsquo;s treasurer or chief financial officer or by an independent auditor and
(ii) an updated Certificate of Good Standing issued by the Registrar of Corporate Affairs, &lt;Place of Registry&gt;.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.85pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 35.45pt">5.4</TD><TD STYLE="text-align: justify"><U>Records</U>. LICENSEE shall maintain, and shall cause its AFFILIATES and SUBLICENSEES to maintain,
complete and accurate records relating to the rights and obligations under this Agreement and any amounts payable to LICENSOR in
relation to this Agreement, which records shall contain sufficient information to permit LICENSOR to confirm the accuracy of any
reports delivered to LICENSOR and compliance in other respects with this Agreement. The relevant party shall retain such records
for at least five (5) years following the end of the calendar year to which they pertain, during which time LICENSOR, or LICENSOR&rsquo;s
appointed agents, shall have the right, at LICENSOR&rsquo;s expense, to inspect such records during normal business hours by prior appointment
to verify any reports and payments made or compliance in other respects under this Agreement. In the event that the aforesaid inspection
is carried out by an independent auditor and any audit performed under this Clause reveals an underpayment in excess of five percent
(5%), LICENSEE shall bear the full reasonable cost of such audit and shall remit any shortfall due to LICENSOR within thirty (30)
days of receiving notice thereof from LICENSOR.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.85pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.85pt; text-align: justify; text-indent: -35.45pt"></P>

<!-- Field: Page; Sequence: 17; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.85pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><U>6. IMPROVEMENT</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.85pt; text-align: center; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 35.45pt">6.1</TD><TD STYLE="text-align: justify">If LICENSEE solely makes an IMPROVEMENT, LICENSEE shall immediately inform LICENSOR thereof. LICENSEE
shall have the right to use such IMPROVEMENT. LICENSOR shall be entitled to use such IMPROVEMENT for academic and research purposes
only.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 35.45pt">6.2</TD><TD STYLE="text-align: justify">Provided that such IMPROVEMENT made by LICENSEE do not incorporate or contain, in part or in whole,
the LICENSED PATENT, LICENSEE shall own such IMPROVEMENT and shall be free to register any intellectual property rights for such
IMPROVEMENT and to license these IMPROVEMENT to third parties.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><U>7. PATENT PROSECUTION
</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.85pt; text-align: center; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1.1pt"></TD><TD STYLE="width: 34.9pt">7.1</TD><TD STYLE="text-align: justify"><U>Responsibility for LICENSED PATENT</U>. During the continuance of the EXCLUSIVE PERIOD, LICENSOR
shall prepare, file, prosecute, and maintain all of the LICENSED PATENT and in countries as may be designated by LICENSEE in written
notice to LICENSOR within a reasonable time in advance of the required filing dates. LICENSOR shall use reasonable efforts to seek
prompt issuance of the LICENSED PATENT during the TERM of this Agreement. LICENSOR and LICENSEE will discuss and decide on the
strategy with regard to the filing, prosecution and maintenance of the LICENSED PATENTS. LICENSEE shall have reasonable opportunities
to advise LICENSOR and shall cooperate with LICENSOR in such filing, prosecution and maintenance of the LICENSED PATENT in the
TERRITORY.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify; text-indent: -35.45pt"></P>

<!-- Field: Page; Sequence: 18; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1.1pt"></TD><TD STYLE="width: 34.9pt">7.2</TD><TD STYLE="text-align: justify"><U>Payment of Expenses</U>. Payment of all fees and costs incurred on or after the EFFECTIVE DATE
of this Agreement under Clause 7.1, including attorneys&rsquo; fees, relating to the filing, prosecution and maintenance of the
LICENSED PATENT that have not already been reimbursed by LICENSEE shall be the responsibility of LICENSEE. LICENSEE shall reimburse
LICENSOR for all fees and costs, including attorney&rsquo;s fees, relating to the filing, prosecution and maintenance of the LICENSED
PATENT incurred prior to the EFFECTIVE DATE and such amount is <FONT STYLE="background-color: black">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT> as of
the EFFECTIVE DATE based on relevant receipts or invoices. LICENSEE shall reimburse all amounts due pursuant to this Clause within
thirty (30) days after the EFFECTIVE DATE; late payments shall accrue interest pursuant to Clause 4.2(c). These payments are non-refundable.
LICENSEE shall also be responsible for payment of all such expenses incurred on or after the EFFECTIVE DATE (&ldquo;Patent Cost&rdquo;)
and shall reimburse LICENSEOR with such amount within thirty (30) days from the date of receiving an original invoice from LICENSOR.
In all instances, LICENSOR shall pay the fees prescribed for large entities to the United States Patent and Trademark Office.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1.1pt"></TD><TD STYLE="width: 34.9pt">7.3</TD><TD STYLE="text-align: justify"><U>Discontinue of Payment of Expenses</U>. In the event LICENSEE elects not to continue the LICENSE
under and the payment for the Patent Cost on any, but not all, of the patents, patent applications, and provisional applications
listed in <U>Schedule 1 (&ldquo;Suspended Patent License&rdquo;), LICENSEE shall provide a written notice (&ldquo;Notice of Payment
Suspension&rdquo;) to LICENCEE, in which case the LICENSE granted to LICENSEE on the Suspended Patent License shall end sixty (60)
days after the date of receipt of such Notice of Payment Suspension (the &ldquo;End Date&rdquo;). In no event shall the Notice
of Payment Suspension release LICENSEE from the obligation to pay any outstanding amount and/or invoices that became due on or
before the date of the End Date. For the avoidance of doubt, upon the END DATE, LICENSOR shall have full rights under the Suspended
Patent License, including but not limited to </U>file, prosecute, and maintain such Suspended Patent License, and to grant license
under such Suspended Patent License to any third party.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-transform: uppercase; text-align: center"><U>8.
Infringement</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 29.5pt; text-indent: -29.5pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1.1pt"></TD><TD STYLE="width: 34.9pt">8.1</TD><TD STYLE="text-align: justify"><U>Notification of Infringement.</U> Each party agrees to provide written notice to the other party
promptly after becoming aware of any infringement of the LICENSED PATENT.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify; text-indent: -35.45pt"></P>

<!-- Field: Page; Sequence: 19; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1.1pt"></TD><TD STYLE="width: 34.9pt">8.2</TD><TD><U>Right to Prosecute Infringements</U>.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 35.4pt"></TD><TD STYLE="width: 0.5in">(a)</TD><TD STYLE="text-align: justify"><U>LICENSEE Right to Prosecute</U>. So long as LICENSEE remains the exclusive licensee of the LICENSED
PATENT in the FIELD in the TERRITORY, LICENSEE, to the extent permitted by law, shall have the first right and option but not the
obligation, at its own expense, to prosecute any third party infringement of, or seek a declaratory judgment to confirm or rectify
LICENSOR&rsquo;s and/or LICENSEE&rsquo;s rights and interests in, the LICENSED PATENT in the FIELD in the TERRITORY, subject to
Clauses&nbsp;8.4 and 8.5. If required by law or advised by the legal counsel representing LICENSEE in the action, LICENSOR shall
permit any action under this Clause to be brought in its name, including being joined as a party-plaintiff, provided that LICENSEE
shall hold LICENSOR harmless from, and indemnify LICENSOR against, any costs, expenses, or liability that LICENSOR incurs in connection
with such action.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.8pt; text-align: justify; text-indent: 0.1pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.8pt; text-align: justify; text-indent: 0.1pt">Prior to
commencing any such action, LICENSEE shall consult with LICENSOR and shall consider the views of LICENSOR regarding the advisability
of the proposed action and its effect on the public interest. LICENSEE shall not enter into any settlement, consent judgment, or
other voluntary final disposition of any infringement action under this Clause without the prior written consent of LICENSOR, which
consent shall not be unreasonably withheld or delayed.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 35.4pt"></TD><TD STYLE="width: 0.5in">(b)</TD><TD STYLE="text-align: justify"><U>LICENSOR Right to Prosecute</U>. In the event that LICENSEE is unsuccessful in persuading the
alleged infringer to desist or fails to have initiated an infringement action, then LICENSOR shall have the right, at their sole
discretion, to prosecute such infringement under their sole control and at their sole expense, and any recovery obtained shall
belong to LICENSOR.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1.1pt"></TD><TD STYLE="width: 34.9pt">8.3</TD><TD STYLE="text-align: justify"><U>Declaratory Judgment Actions</U>. In the event that a declaratory judgment action is brought
against LICENSOR or LICENSEE by a third party alleging invalidity, unenforceability, or non-infringement of the LICENSED PATENT
or that any of the LICENSED PATENT has infringed the rights of the third party, LICENSOR and LICENSEE shall jointly determine within
twenty (20) days after commencement of such action which of them is to take over the sole defense of the action at their own expense,
subject to Clauses 8.4 and 8.5 in the case of defense by LICENSEE. If LICENSOR does not exercise this right, LICENSEE may take
over the sole defense of the action at LICENSEE&rsquo;s sole expense, subject to Clauses 8.4 and 8.5.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 20; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1.1pt"></TD><TD STYLE="width: 34.9pt">8.4</TD><TD STYLE="text-align: justify"><U>Award</U>. Any award received by LICENSEE from the action under Clauses 8.2 or 8.3, including
but not limited to award of costs and/or damages/compensation, shall first be applied to reimburse all costs and expenses incurred
by LICENSEE and LICENSOR in such action. If such award is not sufficient to cover the costs and expenses incurred by LICENSEE and
LICENSOR in such action, LICENSEE may offset a total of fifty percent (50%) of any expenses incurred under Clauses 8.2 and 8.3
against any payments due to LICENSOR under Clause 4, provided that in no event shall such payments under Clause 4, when aggregated
with any other offsets and credits allowed under this Agreement, be reduced by more than fifty percent (50%) in any REPORTING PERIOD.
In the event that such award is more than sufficient to cover the costs and expenses incurred by LICENSEE and LICENSOR in the action,
the surplus shall be applied to cover the loss of profits suffered by LICENSEE due to the infringement under Clauses 8.2 or 8.3
(&ldquo;Loss of Profits Compensation&rdquo;). Upon receipt of Loss of Profits Compensation, LICENSEE shall pay to LICENSOR a reasonable
approximation, based upon the amount of Loss of Profits Compensation, as ROYALTY. Any remaining balance of the award after deducting
all costs and expenses incurred by LICENSEE in the action as well as Loss of Profits Compensation shall be shared equally between
LICENSOR and LICENSEE.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1.1pt"></TD><TD STYLE="width: 34.9pt">8.5</TD><TD STYLE="text-align: justify"><U>Cooperation</U>. Each party agrees to cooperate in any action under this Clause which is controlled
by the other party.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1.2pt"></TD><TD STYLE="width: 34.8pt">8.6</TD><TD STYLE="text-align: justify"><U>Right to Sublicense</U>. So long as LICENSEE remains the exclusive licensee of the
                                                                LICENSED PATENT in the FIELD in the TERRITORY, LICENSEE shall have the sole right to sublicense any alleged infringer in the
                                                                FIELD in the TERRITORY for future use of the LICENSED PATENT in accordance with the terms and conditions of this Agreement
                                                                relating to sublicenses. Any upfront fees as part of such sublicense shall be <FONT STYLE="background-color: black">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
                                                                &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
                                                                &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
                                                                &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
                                                                &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
                                                                &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
                                                                &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
                                                                &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
                                                                &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
                                                                &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
                                                                &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
                                                                &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
                                                                &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
                                                                &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
                                                                &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
                                                                &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.4pt; text-align: justify; text-indent: -35.4pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-transform: uppercase; text-align: center"><U>9.
Indemnification and Insurance</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in; text-align: left">9.1</TD><TD STYLE="text-align: justify"><U>Indemnification</U>.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 35.4pt"></TD><TD STYLE="width: 0.5in">(a)</TD><TD STYLE="text-align: justify"><U>Indemnity</U>. LICENSEE shall indemnify, defend, and hold harmless LICENSOR, The University
of Hong Kong and their trustees, officers, faculty, students, employees, and agents and their respective successors, heirs and
assigns (the &ldquo;Indemnitees&rdquo;), against any liability, damage, loss, or expense (including reasonable attorneys fees and
expenses) incurred by or imposed upon any of the Indemnitees in connection with any claims, suits, actions, demands or judgments
arising out of any theory of liability (including without limitation actions in the form of tort, warranty, or strict liability
and regardless of whether such action has any factual basis) concerning any product, process, or service that is made, used, sold,
imported, or performed pursuant to any right or license granted under this Agreement.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 21; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 35.4pt"></TD><TD STYLE="width: 0.5in">(b)</TD><TD STYLE="text-align: justify"><U>Procedures</U>. The Indemnitees agree to provide LICENSEE with prompt written notice of any
claim, suit, action, demand, or judgment for which indemnification is sought under this Agreement. LICENSEE agrees, at its own
expense, to provide attorneys reasonably acceptable to LICENSOR to defend against any such claim. The Indemnitees shall cooperate
fully with LICENSEE in such defense and will permit LICENSEE to conduct and control such defense and the disposition of such claim,
suit, or action (including all decisions relative to litigation, appeal, and settlement); provided, however, that any Indemnitee
shall have the right to retain its own counsel (to be elected by LICENSEE), at the expense of LICENSEE, if representation of such
Indemnitee by the counsel retained by LICENSEE would be inappropriate because of actual or potential differences in the interests
of such Indemnitee and any other party represented by such counsel. LICENSEE agrees to keep LICENSOR informed of the progress in
the defense and disposition of such claim and to consult with LICENSOR with regard to any proposed settlement.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1.4pt"></TD><TD STYLE="width: 34.6pt">9.2</TD><TD STYLE="text-align: justify"><U>Insurance</U>. LICENSEE shall obtain and carry in full force and effect commercial general liability
insurance, including product liability and errors and omissions insurance which shall protect LICENSEE and Indemnitees with respect
to events covered by Clause 8.1(a) above.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 22; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in; text-align: left">9.3</TD><TD STYLE="text-align: justify">EXCEPT TO THE EXTENT OTHERWISE EXPRESSLY SET FORTH IN THIS
AGREEMENT, LICENSOR MAKES NO REPRESENTATIONS OR WARRANTIES OF ANY KIND CONCERNING THE LICENSED PATENT, EXPRESS OR IMPLIED, INCLUDING
WITHOUT LIMITATION WARRANTIES OF MERCHANTABILITY, FITNESS FOR A PARTICULAR PURPOSE, NONINFRINGEMENT, VALIDITY OF LICENSED PATENT
CLAIMS, WHETHER ISSUED OR PENDING, AND THE ABSENCE OF LATENT OR OTHER DEFECTS, WHETHER OR NOT DISCOVERABLE. Specifically, and
not to limit the foregoing, LICENSOR makes no warranty or representation (i)&nbsp;regarding the validity or scope of the LICENSED
PATENT, and (ii)&nbsp;that the exploitation of the LICENSED PATENT or any LICENSED PRODUCT will not infringe any patents or other
intellectual property rights of LICENSOR or of a third party.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">IN NO EVENT SHALL LICENSOR,
THE UNIVERSITY OF HONG KONG, THEIR TRUSTEES, DIRECTORS, OFFICERS, EMPLOYEES AND AFFILIATES BE LIABLE FOR INCIDENTAL OR CONSEQUENTIAL
DAMAGES OF ANY KIND, INCLUDING ECONOMIC DAMAGES OR INJURY TO PROPERTY AND LOST PROFITS, REGARDLESS OF WHETHER LICENSOR SHALL BE
ADVISED, SHALL HAVE OTHER REASON TO KNOW, OR IN FACT SHALL KNOW OF THE POSSIBILITY OF THE FOREGOING.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><U>10. REPRESENTATIONS
AND COVENANTS</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in; text-align: left">10.1</TD><TD STYLE="text-align: justify">Each PARTY represents and warrants that it has the authority
and right to enter into and perform this Agreement and grant the rights embodied herein and is not aware of any legal impediment
that could inhibit its ability to perform its obligations under this Agreement.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in; text-align: left">10.2</TD><TD STYLE="text-align: justify">LICENSOR has no knowledge of any litigation or proceeding
pending or, threatened concerning the validity or enforceability of any LICENSED PATENT.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in; text-align: left">10.3</TD><TD STYLE="text-align: justify">This Agreement is signed by a duly authorized official
of the LICENSOR and LICENSOR is the sole and exclusive owner of the entire and unencumbered right, title and interest in and to
each of the LICENSED PATENT.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center"><U>11. Assignment.</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">This Agreement is personal
to LICENSEE and no rights or obligations may be assigned by LICENSEE without the prior written consent of LICENSOR, except that
LICENSEE may, subject to prior consent of LICENSOR, assign this Agreement and the rights, obligations, and interests of as such
Party hereunder to any purchaser of all of its assets or all of its assets to which this Agreement relates or to any successor
corporation resulting from any merger or consolidation of such Party with or into such corporation. Any attempted assignment in
violation of this Clause shall be null, void and of no effect. This Agreement shall be binding upon and inure to the benefit of
all permitted successors-in-interest and assigns</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"></P>

<!-- Field: Page; Sequence: 23; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->21<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center"><U>12. General
Compliance with Laws</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">12.1</TD><TD STYLE="text-align: justify"><U>Compliance with Laws</U>. LICENSEE shall use reasonable commercial efforts to comply with all
commercially material local, state, federal, and international laws and regulations relating to the development, manufacture, use,
and sale of LICENSED PRODUCT.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">12.2</TD><TD STYLE="text-align: justify"><U>Non-Use of Names</U>. LICENSEE and its AFFILIATES and SUBLICENSEES shall not use the name of
&ldquo;Versitech,&rdquo; &ldquo;The University of Hong Kong&rdquo; or any variation, adaptation, or abbreviation thereof, or of any
of their trustees, officers, faculties, students, employees, or agents, or any trademark or logo owned by LICENSOR or &ldquo;The
University of Hong Kong&rdquo; or any terms of this Agreement in any promotional material or other public announcement or disclosure
without the prior written consent of LICENSOR. The foregoing notwithstanding, without the consent of LICENSOR, LICENSEE may state
that it is licensed by LICENSOR under one or more of the patents and/or patent applications comprising the LICENSED PATENT.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">12.3</TD><TD STYLE="text-align: justify"><U>Export Control</U>. LICENSEE and its AFFILIATES and SUBLICENSEES shall comply with all applicable
laws and regulations controlling the export of certain commodities and technical data when dealing with LICENSED PRODUCT. Among
other things, these laws and regulations prohibit or require a license for the export of certain types of commodities and technical
data to specified countries. LICENSEE hereby gives written assurance that it will comply with, and will cause its AFFILIATES and
SUBLICENSEES to comply with, all applicable export control laws and regulations when dealing with LICENSED PRODUCT, that it bears
sole responsibility for any violation of such laws and regulations by itself or its AFFILIATES or SUBLICENSEES, and that it will
indemnify, defend, and hold LICENSOR harmless (in accordance with Clause 8.1) for the consequences of any such violation.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">12.4</TD><TD STYLE="text-align: justify"><U>Marking of LICENSED PRODUCT</U>. To the extent commercially feasible and consistent with prevailing
business practices, LICENSEE shall mark, and shall cause its AFFILIATES and SUBLICENSEES to mark, all LICENSED PRODUCT that are
manufactured or sold under this Agreement with the number of each issued patent under the LICENSED PATENT that applies to such
LICENSED PRODUCT.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"></P>

<!-- Field: Page; Sequence: 24; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->22<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-transform: uppercase; text-align: center"><U>13.
Termination.</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">13.1</TD><TD STYLE="text-align: justify"><U>Term.</U> This Agreement shall
                                         be in effect during the TERM.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">13.2</TD><TD STYLE="text-align: justify"><U>Voluntary Termination by LICENSEE.</U> LICENSEE shall have the right to terminate this Agreement
any time by written notice at least six (6) months in advance and fully settle all payments due to LICENSOR on or before the effective
date of termination. In no event shall the termination of the Agreement release LICENSEE from the obligation to pay any amounts
that became due on or before the effective date of termination.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">13.3</TD><TD STYLE="text-align: justify"><U>Cessation of Business.</U> If LICENSEE
                                         ceases to carry on its business related to this Agreement, liquidates or dissolves, LICENSOR
                                         shall have the right to terminate this Agreement immediately upon written notice to LICENSEE.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">13.4</TD><TD STYLE="text-align: justify"><U>Termination for Insolvency</U>. To the extent permitted by law, each PARTY shall have the right
to terminate this Agreement immediately upon notice to the other PARTY, if such other PARTY files for protection under bankruptcy
laws, makes an assignment for the benefit of creditors, appoints or suffers appointment of a receiver or trustee over its property,
files a petition under any bankruptcy or insolvency act, has any such petition filed against it (which petition not dismissed within
ninety days following such filing) or is unable to pay its debts as they become due.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">13.5</TD><TD STYLE="text-align: justify"><U>Legal Challenge on LICENSED PATENT</U>. LICENSOR may terminate this Agreement by giving written
notice to LICENSEE (such notice to take effect forthwith or as stated in the notice) if LICENSEE commences legal proceedings, or
assists any third party to commence legal proceedings, to challenge the validity or ownership of the LICENSED PATENT.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">13.6</TD><TD STYLE="text-align: justify"><U>Termination for Default.</U></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36.05pt"></TD><TD STYLE="width: 34.8pt">(a)</TD><TD STYLE="text-align: justify"><U>Nonpayment</U>. In the event LICENSEE fails to pay any amounts due and payable to LICENSOR under
Clause 4.1, and fails to make such overdue payments within thirty (30) days after receiving written notice of such failure, LICENSOR
may terminate this Agreement immediately upon written notice to LICENSEE.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 106.25pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 35.4pt"></TD><TD STYLE="width: 0.5in">(b)</TD><TD STYLE="text-align: justify"><U>Material Breach</U>. In the event LICENSEE commits a material breach of its obligations under
this Agreement including but not limited to the DILIGENCE REQUIREMENT, except for breach as described in Clause 13.4(a), and fails
to cure that breach thirty (30) days after receiving written notice thereof, LICENSOR may terminate this Agreement immediately
upon written notice to LICENSEE.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.8pt; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.8pt; text-align: justify; text-indent: 0in"></P>

<!-- Field: Page; Sequence: 25; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->23<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.8pt; text-align: justify; text-indent: 0in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">13.7</TD><TD STYLE="text-align: justify"><U>Effect of Termination. </U></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 37.7pt"></TD><TD STYLE="width: 34.3pt">(a)</TD><TD STYLE="text-align: justify"><U>Survival</U>. The following provisions shall survive the expiration or termination of this Agreement:
Clauses 1, 6, 9, 14 and 15, and Clauses 5.2 (obligation to provide final report and payment), 5.4, 12.1, 12.2 and 13.5.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.85pt; text-align: justify; text-indent: 0in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 37.9pt"></TD><TD STYLE="width: 34.1pt">(b)</TD><TD STYLE="text-align: justify"><U>Inventory</U>. Upon the early termination of this Agreement, LICENSEE and its AFFILIATES and
SUBLICENSEES may complete and sell any work-in-progress and inventory of LICENSED PRODUCT that exist as of the effective date of
termination, provided that (i)&nbsp;LICENSEE pays LICENSOR the applicable running royalty or other amounts due on such sales of
LICENSED PRODUCT in accordance with the terms and conditions of this Agreement, and (ii)&nbsp;LICENSEE and its AFFILIATES and SUBLICENSEES
shall complete and sell all work-in-progress and inventory of LICENSED PRODUCT within six (6) months after the effective date of
termination.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 24pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 37.9pt"></TD><TD STYLE="width: 34.1pt">(c)</TD><TD STYLE="text-align: justify"><U>Pre-termination Obligations</U>. In no event shall termination of this Agreement release LICENSEE,
AFFILIATES, or SUBLICENSEES from the obligation to pay any amounts that became due on or before the effective date of termination.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.75pt; text-align: justify; text-indent: -35.35pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center"><U>14. Dispute
Resolution.</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">In any disagreement or
dispute that may arise between the parties in relation to, resulting from, arising, touching, concerning, or affecting this Agreement,
such matter shall first be referred for resolution as follows.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1.15pt"></TD><TD STYLE="width: 34.85pt">(a)</TD><TD STYLE="text-align: justify">The PARTIES shall first attempt to settle the dispute by informal means and negotiation for settlement
in good faith. Such good faith negotiation may include the appointment by either PARTY of an unaffiliated consultant, who shall
be chosen based on such person&rsquo;s experience and expertise in the particular type of issue which is unresolved, to advise
on the matter ; and</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify; text-indent: 0in"></P>

<!-- Field: Page; Sequence: 26; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->24<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify; text-indent: 0in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1.15pt"></TD><TD STYLE="width: 34.85pt">(b)</TD><TD STYLE="text-align: justify">If no settlement is reached within 28 days after commencement of negotiations, the disagreement
or dispute shall be resolved by binding arbitration in HONG KONG to a single arbitrator nominated jointly by the parties, failing
which such arbitrator shall be nominated by the Hong Kong International Arbitration Centre (&ldquo;HKIAC&rdquo;). The arbitrator&rsquo;s
decision shall be final and binding on the parties. The language of arbitration shall be English;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 24pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1.15pt"></TD><TD STYLE="width: 34.85pt">(c)</TD><TD STYLE="text-align: justify">Neither PARTY shall be released from performing its obligations under this Agreement by reason
of any arbitration proceeding being instituted.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify; text-indent: -35.4pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center"><U>15. GOVERNING
LAW.</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 49.4pt; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">This Agreement shall
be governed by and construed in accordance with the laws of HONG KONG.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center"><U>16. Miscellaneous.</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in; text-align: left">16.1</TD><TD STYLE="text-align: justify"><U>Title</U>. LICENSOR shall hold title to all LICENSED
PATENT.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">16.2</TD><TD STYLE="text-align: justify"><U>Notice</U>. Any notices required or permitted under this Agreement shall be in writing, shall
specifically refer to this Agreement, and shall be sent by hand, recognized courier, confirmed facsimile transmission, confirmed
electronic mail, or registered or certified mail, postage prepaid, return receipt requested, to the following addresses or facsimile
numbers of the parties:</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 24pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">If to LICENSOR, all matters relating to
the license:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 99.25pt">Versitech Limited</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 99.25pt"><FONT STYLE="background-color: black">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 99.25pt"><FONT STYLE="background-color: black">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 99.25pt"><FONT STYLE="background-color: black">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 99.25pt"><FONT STYLE="background-color: black">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 99.25pt"><FONT STYLE="background-color: black">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 99.25pt"><FONT STYLE="background-color: black">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 99.25pt"><FONT STYLE="background-color: black">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 99.25pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 99.25pt"></P>

<!-- Field: Page; Sequence: 27; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->25<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 99.25pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">If to LICENSEE:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 99.25pt">Acticule Life Sciences Limited</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 99.25pt"><FONT STYLE="background-color: black">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<BR>
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 99.25pt"><FONT STYLE="background-color: black">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 99.25pt"><FONT STYLE="background-color: black">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 99.25pt"><FONT STYLE="background-color: black">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.4pt; text-align: justify; text-indent: 0in">All notices
under this Agreement shall be deemed effective upon receipt. A party may change its contact information immediately upon written
notice to the other party in the manner provided in this Clause.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify; text-indent: 0in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">16.3</TD><TD STYLE="text-align: justify"><U>Force Majeure</U>. Neither party will be responsible for delays resulting from causes beyond
the reasonable control of such party, including without limitation fire, explosion, flood, war, strike, or riot, provided that
the nonperforming party uses commercially reasonable efforts to avoid or remove such causes of nonperformance and continues performance
under this Agreement with reasonable dispatch whenever such causes are removed.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">16.4</TD><TD STYLE="text-align: justify"><U>Amendment and Waiver</U>. This Agreement may be amended, supplemented, or otherwise modified
only by means of a written instrument signed by both parties. Any waiver of any rights or failure to act in a specific instance
shall relate only to such instance and shall not be construed as an agreement to waive any rights or fail to act in any other instance,
whether or not similar.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">16.5</TD><TD STYLE="text-align: justify"><U>No agency</U>. This Agreement shall not constitute either party as an agent or legal representative
of the other party for any purpose whatsoever nor create any form of partnership between the parties.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">16.6</TD><TD STYLE="text-align: justify"><U>Severability</U>. In the event that any provision of this Agreement shall be held invalid or
unenforceable for any reason, such invalidity or unenforceability shall not affect any other provision of this Agreement, and the
parties shall negotiate in good faith to modify the Agreement to preserve (to the extent possible) their original intent. If the
parties fail to reach a modified agreement within thirty (30) days after the relevant provision is held invalid or unenforceable,
then the dispute shall be resolved in accordance with the procedures set forth in Clause 13. While the dispute is pending resolution,
this Agreement shall be construed as if such provision were deleted by agreement of the parties.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"></P>

<!-- Field: Page; Sequence: 28; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->26<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">16.7</TD><TD STYLE="text-align: justify"><U>Binding Effect</U>. This Agreement shall be binding upon and inure to the benefit of the parties
and their respective permitted successors and assigns.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">16.8</TD><TD STYLE="text-align: justify"><U>Headings</U>. All headings are for convenience only and shall not affect the meaning of any
provision of this Agreement.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">16.9</TD><TD STYLE="text-align: justify"><U>Entire Agreement</U>. This Agreement constitutes the entire agreement between the parties with
respect to its subject matter and supersedes all prior agreements or understandings between the parties relating to its subject
matter.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">IN WITNESS WHEREOF, the parties have caused
this Agreement to be executed by their duly authorized representatives. </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-weight: normal">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif">For and on behalf of</FONT></TD>
    <TD>&nbsp;</TD>
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif">For and on behalf of</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif">VERSITECH LIMITED</FONT></TD>
    <TD>&nbsp;</TD>
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; text-transform: uppercase">Acticule Life Sciences Limited</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 5%">&nbsp;</TD>
    <TD STYLE="width: 35%">&nbsp;</TD>
    <TD STYLE="width: 20%">&nbsp;</TD>
    <TD STYLE="width: 5%">&nbsp;</TD>
    <TD STYLE="width: 35%">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">Name:</FONT></TD>
    <TD>Mr. YU Hailson</TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">Name:</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">Dr. Richard Kao</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">Title:</FONT></TD>
    <TD>Deputy Managing Director</TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">Title:</FONT></TD>
    <TD>&nbsp;</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 29; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->27<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center"><B>SCHEDULE 1</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><U>LICENSED PATENT</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in; text-align: left">A.</TD><TD STYLE="text-align: justify">Title: Antimicrobial Compounds and Methods for Use Thereof:</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">1.</TD><TD STYLE="text-align: justify">US PROVISIONAL PATENT APPLICATION NO.62/535,540</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in">&nbsp;</P>


<!-- Field: Page; Sequence: 30; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->28<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center"><B>SCHEDULE 2</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><U>Calculations of NET SALES</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 88%; font: 10pt Times New Roman, Times, Serif">Invoice Price of LICENSED PRODUCT</TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">xxx,xxx</FONT></TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><I>(Less)</I> &nbsp;(1) Normal trade discounts</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(xxx,xxx</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt; text-align: left; padding-left: 0.375in">&nbsp;<FONT STYLE="font-family: Times New Roman, Times, Serif">(2) Any credits given to the returned goods</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(xxx,xxx</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; padding-left: 0.375in">&nbsp;<FONT STYLE="font-family: Times New Roman, Times, Serif">(3) Cost of packaging</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(xxx,xxx</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt; text-align: left; padding-left: 0.375in">&nbsp;<FONT STYLE="font-family: Times New Roman, Times, Serif">(4) Freight and its corresponding insurance</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(xxx,xxx</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-align: left; padding-bottom: 1.5pt; padding-left: 0.375in">&nbsp;<FONT STYLE="font-family: Times New Roman, Times, Serif">(5) Government levies</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(xxx,xxx</FONT></TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-align: left; padding-left: 0.375in; padding-bottom: 4pt">&nbsp;<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>NET SALES</B></FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left; border-bottom: Black 4pt double">&nbsp;</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: right; border-bottom: Black 4pt double"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>xxx,xxx</B></FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 4pt">&nbsp;</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 2.5pt 0pt 0"><B>&nbsp;</B></P>


<!-- Field: Page; Sequence: 31; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->29<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.33
<SEQUENCE>37
<FILENAME>ff12018ex10-33_aptorum.htm
<DESCRIPTION>FIRST AMENDMENT TO THE EXCLUSIVE PATENT LICENSE AGREEMENT DATED JUNE 7, 2018
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif; text-align: right"><B>Exhibit 10.33</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>FIRST
AMENDMENT TO</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>EXCLUSIVE
PATENT LICENSE AGREEMENT</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">THIS
FIRST AMENDMENT TO EXCLUSIVE PATENT LICENSE AGREEMENT (the &ldquo;<B>Amendment</B>&rdquo;) is made effective as of <U>7<SUP>th </SUP>June</U>,
2018 by and between <B>Versitech Limited</B>, a company incorporated and existing under the laws of Hong Kong with its office
at Room 405A, Cyberport 4, 100 Cyberport Road, Hong Kong (the <B>&ldquo;Licensor&rdquo;</B>); and <B>Acticule Life Sciences
Limited, </B>with incorporation number CB-324541, a company incorporated and existing under the laws of the Cayman Islands,
with its registered office at Floor 4, Willow House, Cricket Square, Grand Cayman KY1-9010, Cayman Islands with its
management office at Floor 17, Guangdong Investment Tower, 148 Connaught Road, Central, Hong Kong (the <B>&ldquo;Company&rdquo;</B>).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B><U>W</U>&nbsp;<U>I</U>&nbsp;<U>T</U>&nbsp;<U>N</U>&nbsp;<U>E</U>&nbsp;<U>S</U>&nbsp;<U>S</U>&nbsp;<U>E</U>&nbsp;<U>T</U>&nbsp;<U>H</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>WHEREAS,
</B>the Company and the Licensor have entered into that certain Exclusive Patent License Agreement dated as of October 18, 2017
by and between Company and the Licensor (HKU Ref No. IP662) (the &ldquo;<B>Agreement</B>&rdquo;) (a copy of the Agreement is set
forth in <B>Appendix A</B>);</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>WHEREAS,
</B>the Company and the Licensor desire to amend the Agreement as follows.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>NOW,
THEREFORE,</B> the parties hereto, in consideration of the mutual promises herein contained and for other good and valuable consideration,
the receipt and sufficiency of which is hereby acknowledged, hereby agree to amend the Agreement as follows:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.
<U>Definitions</U>. Unless otherwise specified herein, each term used herein that is defined in the Agreement shall have the meaning
assigned to such term in the Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.
<U>Amendments.</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
1.11 of the Agreement is hereby replaced by the following:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;FIELD&rdquo;
shall mean any and all human and non-human therapeutic uses, prescription and over-the-counter medications and preventatives,
for the treatment or prevention of staphylococcal infections, including MRSA, and bacterial virulence.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.
<U>Date of Effectiveness</U>. The amendment to Section 1.11 of the Agreement set forth in this Amendment is expressly made retroactive
to the Effective Date of the Agreement. This Amendment will become effective as of the date first written above when the Licensor
shall have received counterparts of this Amendment duly executed and delivered by the parties hereto. Notwithstanding the above,
the amendment to Section 1.11 of the Agreement set forth in this Amendment is expressly made retroactive to the Effective Date
of the Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4. <U>Effect
of Amendment</U>. Except as expressly amended by this Amendment, all of the terms and provisions of the Agreement are and
shall remain in full force and effect and are hereby ratified and confirmed by the parties hereto. Without limiting the
generality of the forgoing, the amendments contained herein will not be construed as an amendment to or waiver of any other
provision of the Agreement or as a waiver of or consent to any further or future action on the part of any party hereto that
would require the waiver or consent of any other party hereto. Each reference in the Agreement to &ldquo;this
Agreement&rdquo;, &ldquo;the Agreement&rdquo;, &ldquo;hereunder&rdquo;, &ldquo;hereof&rdquo;, &ldquo;herein&rdquo; or words
of like import will mean and be a reference to the Agreement as amended by this Amendment.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid">&nbsp;</DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5. <U>Governing
Law</U>. This Amendment is governed by and construed in accordance with, the laws of Hong Kong.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.
<U>Counterparts</U>. This Amendment may be executed in two counterparts or by separate instruments and all of such counterparts
and instruments shall constitute one agreement, binding on all of the parties hereto.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>IN
WITNESS WHEREOF</B>, the parties hereto have caused this Amendment to be duly executed on the date first above written.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>ACTICULE LIFE SCIENCES LIMITED </B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; width: 35%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; width: 60%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/
    Ian Huen</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:
    Mr. Ian Huen</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:
    Director</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD COLSPAN="2" STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>VERSITECH LIMITED </B></FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/
    Hailson Yu</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:&nbsp;&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U STYLE="text-decoration: none">&nbsp;</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B><U>Appendix
A</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>Exclusive
Patent License Agreement (VER 432-17)</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"></P>

<!-- Field: Page; Sequence: 3; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid">&nbsp;</DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>



<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.34
<SEQUENCE>38
<FILENAME>ff12018ex10-34_aptorum.htm
<DESCRIPTION>SUB-TENANCY AGREEMENT FOR GUANGDONG INVESTMENT TOWER
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif; text-align: right"><B>Exhibit 10.34</B></P>

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 171pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 171pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Dated
the 15 day of January 2018</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">JURCHEN
INVESTMENT CORPORATION</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">APTUS
MANAGEMENT LIMITED</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">****************************************</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>SUB
- TENANCY AGREEMENT</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">****************************************</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">MESSRS.
NG, LIE, LAI &amp; CHAN,</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">SOLICITORS
&amp; NOTARIES</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ROOM
808, 8/F, NAN FUNG TOWER,</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">173
DES VOEUX ROAD CENTRAL,</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">HONG
KONG</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">REF.
NO. : CON/AT/</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">DOC.
SUB-TA-Guangdong Inv Tower 17 Fl.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid">&nbsp;</DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;</FONT></P>

<P STYLE="margin: 0"></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt"><B>THIS SUB-TENANCY AGREEMENT</B></FONT></TD>
    <TD>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">made the 15th day of January</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Two thousand and eighteen</P></TD></TR>
</TABLE>


<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0"></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt; text-align: left; width: 25%"><FONT STYLE="font-size: 10pt">Parties</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: justify; width: 2%">&nbsp;</TD>
    <TD STYLE="width: 73%">
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>BETWEEN </B>the Landlord and the Tenant
        whose names addresses and descriptions are more particularly described and set out in the First Schedule hereto.</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: justify">&nbsp;</TD>
    <TD>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>WHEREAS </B>by a tenancy agreement (&ldquo;<B>the
        Head Lease</B>&rdquo;) dated the 15 day of January 2018, <B>SUPER ALPHA LIMITED </B>(&ldquo;<B>the Head Landlord</B>&rdquo;), a
        company incorporated and existing under the laws of the Hong Kong, let and the Landlord, as tenant, took the said premises (as
        hereinbelow defined) at such rent and on such terms and conditions as more particularly contained therein.</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>AND WHEREAS</B> it was provided in the
        Head Lease that the Landlord may assign, underlet, or sub-let the said premises at such consideration and on such terms and conditions
        as the Landlord in its absolute discretion may determine <B>PROVIDED THAT</B> the Landlord must give written notice of any such
        assignment, underletting or sub-letting to the Head Landlord within one month of its date, and forward a certified copy of the
        instrument to the Head Landlord. At all times during the term of this tenancy, the Landlord must give to the Head Landlord, on
        written request by the Head Landlord, the name, address and other reasonable particulars of any person to whom a derivative interest
        in the said premises has been granted.</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: justify">&nbsp;</TD>
    <TD>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>WHEREBY IT IS AGREED</B> as follows
        :-</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left">
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">Premises</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">Term Rent</P></TD>
    <TD STYLE="font-size: 10pt; text-align: justify">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: justify"><FONT STYLE="font-size: 10pt">1. The Landlord shall let and the Tenant shall take All That the premises more particularly described and set out in Part 1 of the Second Schedule hereto (hereinafter called &ldquo;the said premises&rdquo;) Together with the use in common with the Landlord and all others having the like right of the entrance staircases passages landings and lavatories (if any) of the building of which the said premises form part more particularly described in the Second Schedule hereto (hereinafter called &ldquo;the said building&rdquo;) in so far as the same are necessary for the proper use and enjoyment of the said premises (and except in so far as the Landlord may from time to time restrict such use) and together with the use in common with others of the lifts escalators and central air-conditioning, if any (whenever the same shall be operating) for the term and at the rent and in manner more particularly described and set out in the Third Schedule hereto Subject to and with the benefit of the Deed of Mutual Covenant and the Management Agreement (if any) of the said building as described in Part 2 of the Second Schedule hereto (hereinafter called &ldquo;the said Deed of Covenant and the said Management Agreement&rdquo; respectively).</FONT></TD></TR>
</TABLE>


<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0"></P>

<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0"></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">Tenant&rsquo;s Covenants</FONT></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD COLSPAN="2">
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">2. The Tenant hereby agrees with the Landlord
        as follows :-</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left; width: 25%"><FONT STYLE="font-size: 10pt">To pay rent</FONT></TD>
    <TD STYLE="text-align: justify; width: 2%">&nbsp;</TD>
    <TD STYLE="text-align: justify; width: 5%"><FONT STYLE="font-size: 10pt">(a)</FONT></TD>
    <TD STYLE="width: 68%">
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">To pay the said rent on the days and in
        manner described and set out in the Third Schedule hereto.</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">To pay air-conditioning &amp; other charges</FONT></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">(b)</FONT></TD>
    <TD>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">To pay or discharge all air-conditioning
        (if any), maintenance or management fees or charges in respect of the said premises duly and in accordance with the provisions
        of the Deed of Covenant and/or the said Management Agreement (if any) of the said building.</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">To pay taxes etc.</FONT></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">(c)</FONT></TD>
    <TD>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Subject to Clause 3(a), to pay and discharge
        all taxes, assessments, duties, charges impositions and outgoings of an annual or recurring nature now or hereafter to be assessed,
        imposed or charged by the Government of Hong Kong or other lawful authority upon the said premises or upon the owner or occupier
        thereof (Government Rent, rates and Property Tax (if any) and outgoings of a capital or non-recurring nature only (if any) excepted)
        provided that all charge and outgoings in relation to the Tenant&rsquo;s own installation shall be borne by the Tenant solely.</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">To pay gas, water and electricity charges</FONT></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">(d)</FONT></TD>
    <TD>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">To pay and discharge all charges for gas,
        water, electricity and telephone rental and other outgoings now or at any time hereafter consumed by the Tenant and chargeable
        in respect of the said premises and to make all necessary deposits therefor.</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">User</FONT></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">(e)</FONT></TD>
    <TD>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Not to use the said premises for any purpose
        other than for the purpose and under the name as described and set out in the Third Schedule hereto.</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">Not to use premises as sleeping quarters or domestic premises</FONT></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">(f)</FONT></TD>
    <TD>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Not to use or permit or suffer
the said premises or any part thereof to be used as sleeping quarters or as domestic premises within the meaning of the Landlord
and Tenant (Consolidation) Ordinance or similar legislation for the time being in force nor to allow any person to remain in the
said premises overnight except night-watchman.</P></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 3; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left; width: 25%"><FONT STYLE="font-size: 10pt">Not to permit illegal or immoral use</FONT></TD>
    <TD STYLE="text-align: justify; width: 2%">&nbsp;</TD>
    <TD STYLE="text-align: justify; width: 5%"><FONT STYLE="font-size: 10pt">(g)</FONT></TD>
    <TD STYLE="width: 68%">
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Not to use or permit or suffer the said
        premises to be used for any illegal or immoral purpose or for any purpose which is in contravention of the terms and conditions
        contained in the Government Lease or Conditions under which the said premises are held from the Government and not to carry on
        any trade or business thereon which is now or may hereafter be declared to be an offensive trade under the Public Health &amp;
        Urban Services Ordinance or any other Ordinances or Regulations and any enactment amending or substituting the same.</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">To keep interior etc. in repair</FONT></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">(h)</FONT></TD>
    <TD>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">To keep all the interior of the said premises
        including the flooring and interior plaster or other finishes or rendering to walls, floors and ceilings and the Landlord&rsquo;s
        fixtures therein including all doors, windows, installations / wiring / pipes / drains in the said premises for the supply of water,
        gas, electricity, and for sanitation (inclusive of basins, sinks, baths and sanitary conveniences) in good, clean and tenantable
        repair and condition and properly reserved and painted and so to maintain the same at the expense of the Tenant and to deliver
        up the same to the Landlord at the expiration or sooner determination of the term in like condition (fair wear and tear excepted).</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">To protect interior from approaching typhoons</FONT></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">(i)</FONT></TD>
    <TD>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">To take all precautions to protect the
        interior of the said premises against damage by storm or typhoon or the like.</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">To repair and replace electrical wiring etc. within the premises</FONT></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">(j)</FONT></TD>
    <TD>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">To repair or place, if so required by the
        appropriate supply company, statutory undertaker or authority (as the case may be) under the terms of any Electricity Supply or
        similar Ordinance for the time being in force or any Orders in Council or Regulations made thereunder, all electrical wiring installations
        and fittings within the said premises from the Tenant&rsquo;s meter or meters to and within the same.</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">To keep sanitary and water apparatus used exclusively in good repair</FONT></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">(k)</FONT></TD>
    <TD>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">To keep the sanitary and water
apparatus used exclusively by the Tenant and his servants, agents and licensees in good, clean and tenantable repair and condition
to the satisfaction of the Landlord and in accordance with the Regulations or by-laws of all Public Health and other Government
Authorities concerned.</P></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 4; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">To permit Landlord to enter and view, to repair, etc.</FONT></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">(l)</FONT></TD>
    <TD COLSPAN="2">
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">To permit the Landlord and all persons
        authorised by him at all reasonable times to enter and :-</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 25%; text-align: left">&nbsp;</TD>
    <TD STYLE="width: 2%; text-align: justify">&nbsp;</TD>
    <TD STYLE="width: 5%; text-align: justify">&nbsp;</TD>
    <TD STYLE="width: 5%; text-align: justify"><FONT STYLE="font-size: 10pt">(i)</FONT></TD>
    <TD STYLE="width: 63%">
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">view the state of repair of the said premises,
        take inventories of the fixtures therein, carry out any works or repairs which may be required to be done and, during the last
        three months of the said terms, show the said premises to prospective tenants or purchasers; and/or</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">(ii)</FONT></TD>
    <TD>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">carry out any works or repairs in respect
        of other premises in the said building PROVIDED that in this connection the Landlord shall be responsible to make good all damage
        done to the said premises and the chattels of the Tenant.</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">To execute repair on receipt of notice</FONT></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">(m)</FONT></TD>
    <TD COLSPAN="2">
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On receipt of any notice from the Landlord
        or his authorised representatives specifying any works or repairs which they require to be done and which are the responsibility
        of the Tenant hereunder, forthwith to put in hand and execute the same with all possible despatch and without any delay.</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left">
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">Not to erect install or alter
partitioning fixtures etc. without Landlord&rsquo;s consent</P></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">(n)</FONT></TD>
    <TD COLSPAN="2">
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Not without the previous written
consent of the Landlord (which consent shall not be unreasonably withheld) to erect, install or alter any fixtures partitioning
or other erection or installation in the said premises or any part thereof.</P></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left">
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">To remove illegal structures</P></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">(o)</FONT></TD>
    <TD COLSPAN="2">
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">To remove at any time during the said term
        at the cost of the Tenant any structures erections partitions and other alterations put up by the Tenant with or without the consent
        of the Landlord if required by the Building Authority or other competent Government Departments and to make good all damage caused
        by such removal. The Landlord shall not be responsible to the Tenant for any loss suffered by the Tenant in any way as a result
        of such removal.</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">Not to cut injure or maim walls, etc.</FONT></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">(p)</FONT></TD>
    <TD COLSPAN="2">
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Not to cut, maim, injure, drill into, mark
        or deface or permit or suffer to be cut, maimed, injured, drilled into, marked or defaced any doors, windows, walls, beams, structural
        members or any part of the fabric of the said premises nor any of the plumbing or sanitary apparatus or installations included
        therein without the previous consent of the Landlord which consent shall not be unreasonably withheld.</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">Not to drive nails etc. into ceilings walls or floors</FONT></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">(q)</FONT></TD>
    <TD COLSPAN="2">
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Not to drive or insert or permit
or suffer to be driven or inserted any nails, screws, hooks, brackets or similar articles into the ceilings walls or floor of
the said premises without the previous consent of the Landlord which shall not be unreasonably withheld, nor without the like
consent to lay or use any floor covering which may damage the existing flooring.</P></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 5; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">Not to display signs except name etc. in places provided</FONT></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">(r)</FONT></TD>
    <TD COLSPAN="2">
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Not to affix or display or permit or suffer
        to be affixed or displayed outside the said premises any signboard, sign, decoration, or other device whether illuminated or not
        which may be visible from outside the said premises save that :-</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left; width: 25%">&nbsp;</TD>
    <TD STYLE="text-align: justify; width: 2%">&nbsp;</TD>
    <TD STYLE="text-align: justify; width: 5%">&nbsp;</TD>
    <TD STYLE="text-align: justify; width: 5%"><FONT STYLE="font-size: 10pt">(i)</FONT></TD>
    <TD STYLE="width: 63%">
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">if the said premises hereby agreed to be
        let is a shop abutting a street or road, the Tenant may at its own expenses with the previous written consent of the Landlord erect
        and/or display a sign advertising the nature of the business carried on at the said premises by the Tenant provided always that
        the said sign shall in all respect comply with the provisions of the said Deed of Covenant, the said Management Agreement (if any),
        and the applicable Ordinances and Regulations.</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">(ii)</FONT></TD>
    <TD>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">the Tenant shall be entitled at his own
        expense to display his name exhibited in English and Chinese in such form or lettering or characters to be approved by the Landlord
        on the Directory Boards (if the same are provided in the said Building) and to have his name similarly printed on the Tenant&rsquo;s
        entrance door or doors.</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD COLSPAN="2">
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">If the Tenant carries on business under
        a name other than his own name, he shall notify the Landlord of the name under which his business is carried on and shall be entitled
        to have that name displayed, painted or affixed as aforesaid but the Tenant shall not be entitled to change the business name without
        the previous written consent of the Landlord which the Landlord may give or withhold at his discretion and without prejudice to
        the foregoing, the Landlord may, in connection with any application for consent under this Clause, require the Tenant to produce
        such evidence as it may think fit to show that no breach of Clause 2(aj) has taken place or is about to take place.</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">No hanging in common parts</FONT></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">(s)</FONT></TD>
    <TD COLSPAN="2">
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Not to use or cause or permit
the use of the corridors, staircases or other common passages of the said building for the purpose of drying laundry or hanging
or placing or storing any article or thing thereon or therein and not to permit the Tenant&rsquo;s agents servants employees guests
invitees to use the same for loitering or eating.</P></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 6; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left; width: 25%"><FONT STYLE="font-size: 10pt">Not to encumber or obstruct passages and common areas, etc.</FONT></TD>
    <TD STYLE="text-align: justify; width: 2%">&nbsp;</TD>
    <TD STYLE="text-align: justify; width: 5%"><FONT STYLE="font-size: 10pt">(t)</FONT></TD>
    <TD STYLE="width: 68%">
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Not to encumber or obstruct or permit to
        be encumbered or obstructed with any box, packaging or other obstruction of any kind or nature any of the entrances, staircases,
        landings, passages, lifts, lobbies or other parts of the said building in common use and not to leave rubbish or any other article
        or thing in any part of the said building not in the exclusive occupation of the Tenant.</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">Not to lay wiring or cable etc. in the public areas</FONT></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">(u)</FONT></TD>
    <TD>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Not to lay install affix or attach any
        wiring, cables or other article or thing in or upon any of the entrances, staircases, landings, passage-ways, lobbies or, public
        areas.</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left">
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">No supports etc. erected on exterior
        walls</P></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">(v)</FONT></TD>
    <TD>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Not to install or fix or erect any supports
        or any iron brackets or venetian blinds or sun blinds of any description to or on any part of the exterior walls of the said building
        for any purpose including the installation of air-conditioners without prior written approval of the Landlord.</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left">
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">No openings on exterior wall</P></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">(w)</FONT></TD>
    <TD>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Not to make any openings on any
part of the exterior walls of the said building.</P></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">No shelters on flat roofs etc.</FONT></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">(x)</FONT></TD>
    <TD>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Not to erect any shelters or coverings
        on any part of the flat-roofs or roof of the said building.</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left">
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">No wiring from</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">window</P></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">(y)</FONT></TD>
    <TD>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Not to erect or hang any wire or aerial
        wiring from the windows or outside the exterior walls of the said building.</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">Not to overload</FONT></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">(z)</FONT></TD>
    <TD>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Tenant shall not without the
prior written consent of the Landlord make or permit or suffer to be made alterations in or additions to the electrical wiring
and installations or to install or permit or suffer to be installed any equipment, apparatus or machinery which imposes a weight
on any part of the flooring in excess of that for which it is designed, or which requires any additional electrical main wiring
or which consumes electricity not metered through the Tenant&rsquo;s separate meter. An application by the Tenant for the Landlord&rsquo;s
consent under this Clause shall be accompanied by a plan showing the proposed changes. The Landlord shall be entitled to prescribe
the maximum weight and permitted location of safes and other heavy equipment and to require that the same stand on supports of
such dimensions and material to distribute the weight as the Landlord may deem necessary. In carrying out any electrical, mechanical
or other building services work in the said premises the Tenant shall use only a contractor nominated and approved by the Landlord
in writing for the purpose.</P></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 7; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left; width: 25%"><FONT STYLE="font-size: 10pt">Not to use premises for manufacture or storage of goods</FONT></TD>
    <TD STYLE="text-align: justify; width: 2%">&nbsp;</TD>
    <TD STYLE="text-align: justify; width: 5%"><FONT STYLE="font-size: 10pt">(aa)</FONT></TD>
    <TD STYLE="width: 68%">
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Tenant shall not use or permit or suffer
        the said premises to be used for the purpose of the manufacture of goods and merchandise or for the storage of goods and merchandise
        other than samples and exhibits reasonably required in connection with the Tenant&rsquo;s business carried on therein.</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">Not to alter smoke lobby doors</FONT></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">(ab)</FONT></TD>
    <TD>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Not to alter the position of the smoke
        lobby doors or to make any additions to such doors.</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left">
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">Delivery of bulky goods</P></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">(ac)</FONT></TD>
    <TD>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Not to take delivery of furniture or fixtures
        or bulky items of goods in and out of the said building during normal office hours and under no circumstances shall passenger lifts
        be used for delivery purposes at all times.</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">Not to overload lifts</FONT></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">(ad)</FONT></TD>
    <TD>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Not to overload the lifts in the said building
        in excess of their maximum capacity and to be responsible for any damage caused by any breach hereof.</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">Not to prepare food or permit odorous</FONT></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">(ae)</FONT></TD>
    <TD>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Not to prepare or permit or suffer to be
        prepared any food in the said premises or to cause or permit any offensive or unusual odorous to be produced upon, permeate through
        or emanate from the said premises.</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">Not to produce music or noise audible outside</FONT></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">(af)</FONT></TD>
    <TD>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Not to produce or permit or suffer to be
        produced any music or noise (including sound produced by broadcasting or any apparatus or equipment capable of producing, reproducing,
        receiving or recording sound) so as to cause a nuisance to other users of the said building, and where music is to be regularly
        played, to install at the Tenant&rsquo;s cost or expense and to the satisfaction of the Landlord adequate sound proving or insulation
        devices in the said premises.</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">Not to permit any nuisance or annoyance</FONT></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">(ag)</FONT></TD>
    <TD>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Not to do or permit or suffer to be done
        any thing which may be or become a nuisance or annoyance to the Landlord or to the tenant or occupiers of other premises in the
        said building or in any adjoining or neighbouring building.</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left">
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">Not to keep items of combustible
or hazardous goods</P></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">(ah)</FONT></TD>
    <TD>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Not to keep or store or permit
or suffer to be kept or stored in the said premises any arms, ammunition, gun-powder, salt-petre, kerosene or other explosive
or combustible substance or otherwise unlawful or dangerous or hazardous goods.</P></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 8; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">Not to keep animals or pets and to prevent infection</FONT></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">(ai)</FONT></TD>
    <TD COLSPAN="2">
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Not to keep or permit or suffer to be kept
        any animals or pets inside the said premises and to take all such steps and precautions to the satisfaction of the Landlord to
        prevent the said premises or any part thereof from becoming infested by termites, rats, mice roaches, or any other pests or vermin.</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">Not to assign underlet etc.</FONT></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">(aj)</FONT></TD>
    <TD COLSPAN="2">
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Not to assign, underlet, part with the
        possession of, or transfer the said premises or any part thereof or any interest therein, nor permit or suffer any arrangement
        or transaction whereby any person who is not a party to this Agreement obtains to use, possession, occupation or enjoyment of the
        said premises or any part thereof irrespective of whether any rental or other consideration is given therefor. The Tenancy shall
        be personal to the Tenant named in this Agreement and without in any way limiting the generality of the foregoing, the following
        acts and events shall, unless approved in writing be deemed to be breaches of this Clause :-</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left; width: 25%">&nbsp;</TD>
    <TD STYLE="text-align: justify; width: 2%">&nbsp;</TD>
    <TD STYLE="text-align: justify; width: 5%">&nbsp;</TD>
    <TD STYLE="text-align: justify; width: 5%"><FONT STYLE="font-size: 10pt">(i)</FONT></TD>
    <TD STYLE="width: 63%">
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">in the case of a tenant which is a partnership,
        the taking in of one or more new partners whether on the death or retirement of an existing partner or otherwise.</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">(ii)</FONT></TD>
    <TD>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">in the case of a tenant who is an individual
        (including a sole surviving partner of a partnership tenant) the death, insanity or other disability of that individual, to the
        intent that no right to use, possess, occupy or enjoy the said premises or any part thereof shall vest in the executors, administrators,
        personal representatives, next of kin, trustee or committee of any such individual.</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">(iii)</FONT></TD>
    <TD>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">in the case of a corporation, any reconstruction,
        amalgamation, merger or voluntary liquidation, or any change in shareholding or in the control of ultimate beneficial ownership.</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">(iv)</FONT></TD>
    <TD>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">the giving by the Tenant of a
Power of Attorney or similar authority whereby the donee of the Power obtains the right to use, possess, occupy or enjoy the said
premises or any part thereof or does in fact use, possess, occupy or enjoy the same.</P></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 9; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: left; vertical-align: top; width: 25%"><FONT STYLE="font-size: 10pt">Not to breach Government Lease or cause insurance to be voided or premium increased &nbsp;</FONT></TD>
    <TD STYLE="text-align: center; width: 2%">&nbsp;</TD>
    <TD STYLE="text-align: left; vertical-align: top; width: 5%"><FONT STYLE="font-size: 10pt">(ak) &nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; width: 68%"><FONT STYLE="font-size: 10pt">Not to do or permit or suffer to be done any act, deed, matter or thing whatsoever which amounts to a breach of any of the terms and conditions under which the land on which the said building stands is held from the Government or whereby any insurance on the said building against loss or damage by fire and/or claims by third parties for the time being in force may be rendered void or voidable or whereby the premium thereon may be increased Provided that if as the result of any act, deed, matter or thing done permitted or suffered by the Tenant, the premium on any such policy of insurance shall be increased, the Landlord shall be entitled at his option either to terminate this Agreement or to continue the same upon payment by the Tenant of the additional premium and upon such other terms and conditions as the Landlord may, at his discretion, think fit to impose. &nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: left; vertical-align: top">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: left; vertical-align: top">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">To comply with Deed of Mutual Covenants and Ordinances etc.</FONT></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">(al)</FONT></TD>
    <TD>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">To obey and comply with and to indemnify
        the Landlord against the breach of the said Deed of Covenant and the said Management Agreement (if any) of the said building and
        all ordinances, regulations, by-laws, rules and requirements of any Governmental or other competent authority relating to the conduct
        and carrying on of the Tenant&rsquo;s business on the said premises or to any other acts, deed, matter or thing done, permitted
        suffered or omitted therein or thereon by the Tenant or any employee, agent or licensee of the Tenant.</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">To make good damage to building</FONT></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">(am)</FONT></TD>
    <TD>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">To make good at the expenses of the Tenant
        any portion of the said building which may be damaged through any omission act or default of the Tenant or of any of his servants
        visitors or through the escape of water, fire, smoke or fumes from or explosion in the said premises.</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">To reimburse Landlord for work done</FONT></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">(an)</FONT></TD>
    <TD>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">To reimburse the Landlord for the costs
        of any work which the Tenant is liable to perform hereunder and has defaulted in performing the same including but not limited
        to all costs incurred by the Landlord in cleansing or clearing any of the drains, pipes or sanitary or plumbing apparatus choked
        or stopped up owing to the careless or improper use or neglect by the Tenant or any employee agent or licensee of the Tenant.</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">To be responsible for loss or damage caused by interior defects</FONT></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">(ao)</FONT></TD>
    <TD>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">To be wholly responsible for any
loss, damage or injury caused to any other person whomsoever directly or indirectly through the defective or damaged condition
of any part of the interior of the said premises and to make good the same by payment or otherwise and to indemnify the Landlord
against all actions, proceedings, claims and demands made upon the Landlord in respect of any such loss, damage or injury and
all costs and expenses incidental thereto.</P></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 10; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 25%; text-align: left">
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">To be responsible for contractors,
servants, agents and licensees</P></TD>
    <TD STYLE="text-align: justify; width: 2%">&nbsp;</TD>
    <TD STYLE="text-align: justify; width: 5%"><FONT STYLE="font-size: 10pt">(ap)</FONT></TD>
    <TD STYLE="width: 68%">
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">To be responsible to the Landlord for the
        acts, neglects and defaults of all contractors, servants, agents and licensees of the Tenant as if they were the acts, neglects
        and defaults of the Tenant himself and for the purpose of this Agreement &ldquo;licensee&rdquo; shall include any person present
        in, using or visiting the said premises with the consent of the Tenant express or implied.</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">To notify Landlord of accidents and defects in fittings and fixtures</FONT></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">(aq)</FONT></TD>
    <TD>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">To notify the Landlord of any accidents
        to or defects in the water pipes gas pipes electrical wire or fittings or other facilities provided by the Landlord in the said
        premises whether or not the Tenant is liable hereunder for the repair of the same upon the same coming to the knowledge of the
        Tenant.</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left">
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">To remove refuse to a place specified
by Landlord</P></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">(ar)</FONT></TD>
    <TD>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">To remove each day from the said premises
        all refuse and rubbish to such spot as shall be specified by the Landlord from time to time and subject to such reasonable rules
        and regulations as the Landlord may from time to time determine.</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left">
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">Replacement of windows</P></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">(as)</FONT></TD>
    <TD>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">To pay to or reimburse the Landlord the
        cost of replacing all broken and damaged windows (if any) and glass and any part of the glass curtain wall (if any) whether or
        not the same be broken or damaged by the negligence of the Tenant or owing to circumstances beyond the control of the Tenant.</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">Re-instate premises</FONT></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">(at)</FONT></TD>
    <TD>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Unless the Landlord otherwise agrees in
        writing, to re-instate and restore the said premises to their original condition and to make good all damage caused or occasioned
        by the erection and removal of alterations partitions or other erections.</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">To yield up at the end of term</FONT></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">(au)</FONT></TD>
    <TD>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Quietly to yield up the said premises
together with all fixtures, fittings and additions therein and thereto which the Landlord agrees to retain at the expiration or
sooner determination of this tenancy in good, clean and tenantable repair and condition (fair wear and tear excepted).</P></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 11; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Landlord&rsquo;s covenants</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">3.
        THE LANDLORD HEREBY AGREES WITH THE TENANT as follows:-</FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 25%; text-align: left"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">To
        pay Government rent etc.</FONT></P></TD>
    <TD STYLE="text-align: justify; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT></TD>
    <TD STYLE="width: 68%"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">That
        the Landlord will pay the Government rent and rates payable in respect of the said premises and the Property Tax (if any)
        payable in respect of the said premises and any expenses of a capital or non-recurring nature provided that all charges
        and outgoings in relation to the Tenant&rsquo;s own installations shall be borne by the Tenant solely.</FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">That Tenant shall have
    quiet enjoyment</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT></TD>
    <TD><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">That
        the Tenant paying the rent and management fees and maintenance charges hereby agreed to be paid on the days and in manner
        herein provided for payment of the same and observing and performing the agreements, stipulations and conditions herein
        contained and on the Tenant&rsquo;s part to be observed and performed shall peaceably hold and enjoy the said premises
        during the said term without any interruption by the Landlord or any person lawfully claiming under or in trust for the
        Landlord.</FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">To keep in repair the
    outside main walls and roof, etc.</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)</FONT></TD>
    <TD><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">To
        keep the outside main walls and roof of the said building and the lift entrance hall corridor passages staircases and
        the convenience (if any) intended for the common use of the occupants at all times in repair in accordance with the relevant
        provisions of the said Deed of Covenant and/or the said Management Agreement.</FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">4.
        IT IS HEREBY FURTHER EXPRESSLY AGREED AND DECLARED as follows :-</FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: left; vertical-align: top"><P STYLE="margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">Other
                                         provisions <BR></FONT></P>
                                                      <P STYLE="margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Landlord&rsquo;s
                                         right of re-entry &nbsp;</FONT></P></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
    &nbsp;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If the rent and/or
    air-conditioning charges and/or management fees and maintenance charges and/or other charges hereby agreed to be paid or any
    part thereof shall be unpaid for seven working days after the same shall become payable (whether legally or formally demanded
    or not) or if the Tenant shall fail or neglect to observe or perform any of the agreement, stipulations or conditions herein
    contained and on the Tenant&rsquo;s part to be observed and performed or if the Tenant shall become bankrupt, or being a corporation
    shall go into liquidation or if any petition shall be filed for the winding up of the Tenant, or if the Tenant otherwise becomes
    insolvent or makes any composition or arrangement with creditors or shall suffer any execution to be levied on the said premises
    or otherwise on the Tenant&rsquo;s goods, then and in any such case it shall be lawful for the Landlord at any time thereafter
    to re-enter the said premises or any part thereof in the name of the whole whereupon this Agreement shall absolutely cease
    and determine but without prejudice to any right of action by the Landlord in respect of any outstanding breach or non-observance
    or non-performance of any of the agreement, stipulations and conditions herein contained and on the Tenant&rsquo;s part to
    be observed and performed and to the Landlord&rsquo;s right to deduct all loss and damage thereby incurred from the deposit
    paid by the Tenant in accordance with Clause 5 hereof. &nbsp;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 12; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 25%; text-align: left">
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">Written notice sufficient exercise
of right</P></TD>
    <TD STYLE="text-align: justify; width: 2%">&nbsp;</TD>
    <TD STYLE="text-align: justify; width: 5%"><FONT STYLE="font-size: 10pt">(b)</FONT></TD>
    <TD STYLE="width: 68%">
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">A written notice served by the Landlord
        on the Tenant in manner hereinafter mentioned to the effect that the Landlord thereby exercise the power of re-entry herein contained
        shall be full and sufficient exercise of such power without actual entry on the part of the Landlord.</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">Acceptance of rent not waiver of breach of covenant</FONT></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">(c)</FONT></TD>
    <TD>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Acceptance of rent (or management fees)
        by the Landlord shall not be deemed to operate as a waiver by the Landlord of any right to proceed against the Tenant in respect
        of any breach non-observance or non-performance by the Tenant of any of the agreements, stipulations and conditions herein contained
        and on the Tenant&rsquo;s part to be observed and performed.</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left">
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">Landlord not liable for overflow of water</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">Tenant to indemnify Landlord against
        certain claims</P></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">(d)</FONT></TD>
    <TD>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Landlord shall not be under any liability
        to the Tenant or to any other person whomsoever in respect of any loss or damage to person or property sustained by the Tenant
        or any such other person caused by or through or in any way owing to the overflow of water from anywhere within the said building.
        The Tenant shall fully and effectually indemnify the Landlord from and against all claims and demands made against the Landlord
        by any person in respect of any loss, damage or injury caused by or through or in any way owing to the overflow of water from the
        said premises or to the neglect or default of the Tenant, his servants, agents or licensees or to the defective or damaged condition
        of the interior of the said premises or any fixtures or fittings for the repair of which the Tenant is responsible hereunder and
        against all costs and expenses incurred by the Landlord in respect of any such claim or demand.</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">No advance payment of rent</FONT></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">(e)</FONT></TD>
    <TD>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">No advance payment of rent has been paid
        to the Landlord except in pursuance to Clause 1 hereof.</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left">
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">Landlord not liable for breakdown
in air-conditioning or lifts</P></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">(f)</FONT></TD>
    <TD>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Landlord shall not in any
circumstances be liable to the Tenant for any defect in or failure or breakdown of electricity gas or water supply, lifts services
and air-conditioning system nor shall the rent or management fees and maintenance charges abate or cease to be payable on account
thereof.</P></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 13; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 25%; text-align: left">
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">Suspension or abatement of rent in
case of fire etc. </P></TD>
    <TD STYLE="text-align: justify; width: 2%">&nbsp;</TD>
    <TD STYLE="text-align: justify; width: 5%"><FONT STYLE="font-size: 10pt">(g)</FONT></TD>
    <TD STYLE="width: 68%">
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">If the said premises or the said building
        or any part thereof shall be at any time during the tenancy be inaccessible or so destroyed or damaged owing to fire water storm
        wind typhoon defective construction white ants earthquake subsidence of the ground or any calamity beyond the control of the Landlord
        as to render the said premises unfit for habitation and use and the policy or policies of insurance effected by the Landlord shall
        not have been vitiated or payment of the policy moneys refused in whole or in part in consequence of any act or default of the
        Tenant or if at any time during the continuance of this tenancy the said premises or the said building shall be condemned as a
        dangerous structure or a demolition order or closing order shall become operative in respect of the said premises or the said building
        then the rent hereby reserved or a fair proportion thereof according to the nature and extent of the damage sustained or order
        made shall after the expiration of the then current month be suspended and ceased until the said premises or said building shall
        again be rendered accessible or fit for habitation and use (as the case may be) provided that should the said premises or the said
        building not have been reinstated in the meantime either the Landlord or the Tenant may at any time after three months from the
        occurrence of such damage or destruction or order give to the other of them notice in writing to determine this present tenancy
        and thereupon the same and everything herein contained shall determine as from the date of the occurrence of such destruction or
        damage or order of the said premises or of the said building becoming inaccessible but without prejudice to the rights and remedies
        of either party against the other in respect of any antecedent claim or breach of the agreements stipulations terms and conditions
        herein contained or of the Landlord in respect of the rent and management fees and other charges payable hereunder prior to the
        coming into effect of the suspension.</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">For the purpose of distraint of rent in arrears if not paid in advance on due date</FONT></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">(h)</FONT></TD>
    <TD>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">For the purposes of Part III of
the Landlord and Tenant (Consolidation) Ordinance (Chapter 7) and of these presents, the rent and management fees and other charges
payable in respect of the said premises shall be and be deemed to be in arrears if not paid in advance at the time and in manner
hereinbefore provided for payment thereof. All costs and expenses for and incidental to any distraint shall be paid by the Tenant
and is recoverable from him as a debt on a full indemnity basis. For the purpose of distraint and these presents, any outstanding
management fees payable in respect of the said premises shall be deemed to be arrears of rent.</P></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 14; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left; width: 25%"><FONT STYLE="font-size: 10pt">No waiver by Landlord</FONT></TD>
    <TD STYLE="text-align: justify; width: 2%">&nbsp;</TD>
    <TD STYLE="text-align: justify; width: 5%"><FONT STYLE="font-size: 10pt">(i)</FONT></TD>
    <TD STYLE="width: 68%">
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">No condoning, excusing or waiving by the
        Landlord of any default, breach or non-observance or non-performance by the Tenant at any time or times of any of the Tenant&rsquo;s
        obligations herein contained shall operate as a waiver of the Landlord&rsquo;s rights hereunder in respect of any continuing or
        subsequent default, breach or non-observance or non-performance or so as to defeat or affect in any way the rights and remedies
        of the Landlord hereunder in respect of any such continuing or subsequent default or breach and no waiver by the Landlord shall
        be inferred from or implied by anything done or omitted by the Landlord unless expressed in writing and signed by the Landlord.
        Any consent given by the Landlord shall operate as a consent only for the particular matter to which it relates and in no way shall
        be considered as a waiver or release of any of the provisions hereof nor shall it be construed as dispensing with the necessity
        of obtaining the specific written consent of the Landlord in the future, unless expressly so provided.</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">Landlord can exhibit letting notices during last three months of term</FONT></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">(j)</FONT></TD>
    <TD>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">During the three months immediately preceding
        the expiration of the term hereby created, the Landlord shall be at liberty to affix and maintain without interference upon any
        external part of the said premises a notice stating that the said premises are to be let and such other information in connection
        therewith as the Landlord shall reasonably require.</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">Landlord is entitled to change the name of the building</FONT></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">(k)</FONT></TD>
    <TD>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Landlord shall at any time during the
        term hereby granted be entitled to change the name of the said building on giving reasonable notice to the Tenant and in respect
        thereof the Landlord shall not be liable in damages to the Tenant or be made a party to any other proceedings or for costs or expenses
        of whatsoever nature incurred by the Tenant as a result of such change.</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">No warranty as to user</FONT></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">(l)</FONT></TD>
    <TD>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Landlord does not warrant that the
        said premises are suitable for any particular purpose.</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">Service of notice</FONT></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">(m)</FONT></TD>
    <TD>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Any notice required to be served
hereunder shall, if to be served on the Tenant, be sufficiently served if addressed to the Tenant and sent by prepaid post to
or delivered at the said premises or the Tenant&rsquo;s last known place of business or residence in Hong Kong and if to be served
on the Landlord, shall be sufficiently served if addressed to the Landlord and sent by prepaid post to or delivered to the Landlord&rsquo;s
address as shown in this Agreement.</P></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 15; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">Stamp Duty &amp; Costs</FONT></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">(n)</FONT></TD>
    <TD COLSPAN="2">
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The legal costs of Messrs. Ng, Lie, Lai
        &amp; Chan and the stamp duty and other disbursements on this Agreement and its counterpart shall be borne by the Landlord and
        the Tenant in equal shares.</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left; width: 25%"><FONT STYLE="font-size: 10pt">Tenant&rsquo;s deposit</FONT></TD>
    <TD STYLE="text-align: justify; width: 2%">&nbsp;</TD>
    <TD STYLE="text-align: justify; width: 5%"><FONT STYLE="font-size: 10pt">5.</FONT></TD>
    <TD STYLE="text-align: justify; width: 5%"><FONT STYLE="font-size: 10pt">(a)</FONT></TD>
    <TD STYLE="width: 63%">
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Tenant shall on the signing hereof
        deposit and maintain with the Landlord a deposit of the amount as set out in the Third Schedule hereto to secure the due observance
        and performance by the Tenant of the agreements, stipulations and conditions herein contained and on the Tenant&rsquo;s part to
        be observed and performed. The said deposit shall be retained by the Landlord throughout the said term free of any interest to
        the Tenant and in the event of any breach or non-observance or non-performance by the Tenant of any of the said agreements, stipulations
        or conditions aforesaid, the Landlord shall be entitled to terminate this Agreement and to forfeit the said deposit by way of liquidated
        damages without prejudice to the Landlord&rsquo;s right to claim against the Tenant for further damages suffered by the Landlord
        as a result of the Tenant&rsquo;s breach of this Agreement. Notwithstanding the foregoing, the Landlord may in any such event at
        his option elect not to terminate this Agreement and forfeit the deposit but to deduct therefrom the amount of any monetary loss
        incurred by the Landlord in consequence of the breach, non-observance or non-performance by the Tenant in which event the Tenant
        shall as a condition precedent to the continuation of the tenancy deposit with the Landlord the amount so deducted and if the Tenant
        shall fail so to do, the Landlord shall forthwith be entitled to re-enter the said premises and to determine this Agreement and
        forfeit the deposit as hereinbefore provided.</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">Repayment of deposit</FONT></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">(b)</FONT></TD>
    <TD>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Subject as aforesaid, the said
deposit shall be refunded to the Tenant by the Landlord without interest within thirty days after the expiration or sooner determination
of this Agreement and the delivery of vacant possession to the Landlord or within thirty days of the settlement of the last outstanding
claim by the Landlord against the Tenant in respect of any breach, non-observance or non-performance of any of the agreements,
stipulations or conditions herein contained and on the part of the Tenant to be observed and performed, whichever is the later.</P></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 16; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left; width: 25%">&nbsp;</TD>
    <TD STYLE="text-align: justify; width: 2%">&nbsp;</TD>
    <TD STYLE="text-align: justify; width: 5%">&nbsp;</TD>
    <TD STYLE="text-align: justify; width: 5%"><FONT STYLE="font-size: 10pt">(c)</FONT></TD>
    <TD STYLE="width: 63%">
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In the event that the Landlord
shall assign its reversionary interest in the said premises, the Tenant shall agree to the Landlord transferring the said Deposit
to the assignee and shall waive its right to recover the said Deposit from the Landlord upon receipt of a written notice from
the Landlord that such transfer has been effected.</P></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left; width: 25%"><FONT STYLE="font-size: 10pt">Resumption</FONT></TD>
    <TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="text-align: justify; width: 5%">6. </TD>
    <TD STYLE="width: 68%">
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Notwithstanding anything herein contained,
        the parties hereto agree that if the said premises form the subject matter of resumption by the Hong Kong SAR Government or similar
        authority under the Lands Resumption Ordinance or similar legislation direct or through Urban Renewal Authority or other authority,
        the only compensation that the Tenant may have for early termination of the term herein created as a result of the resumption shall
        be such that is available to the Tenant as contained in the provisions of the Lands Resumption Ordinance Cap.124. The Landlord
        undertakes to give notice to the Tenant as soon as practicable once such resumption notice shall have been duly served on the Landlord.</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">Third Party Rights</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify">7. </TD>
    <TD>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Any person, firm, company or corporation
        who is not a party to this Agreement shall have no right under the Contracts (Rights of Third Parties) Ordinance to enforce any
        of its terms except and to the extent that this Agreement expressly provides otherwise and without prejudice to any right of the
        Landlord provided in this Agreement which is also applicable to and enforceable by or against such third party without resorting
        to the Contracts (Rights of Third Parties) Ordinance.</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">Break Clause</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify">8. </TD>
    <TD>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Tenant has an option to terminate
        this Agreement after twenty four months from 1st February 2018 by giving to the Landlord not less than three months&rsquo; prior
        written notice or by payment of three months&rsquo; rent in lieu of such notice and during the said three months period the Tenant
        shall allow the Landlord together with the intended tenant to enter the said premises at any reasonable time with prior appointment.
        For the avoidance of doubt, the said notice shall not be served on the Landlord on or before 31st January 2020.</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">Law</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify">9. </TD>
    <TD>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">This Agreement shall be construed and
        take effect in accordance with Hong Kong law.</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">Marginal notes</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">10.&nbsp;</Font></TD>
    <TD STYLE="text-align: justify">The marginal notes are intended for guidance only and do not form part of this Agreement nor
shall any of the provisions in this Agreement be construed or interpreted by reference thereto or in any way affected or limited
thereby.</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>



<P STYLE="margin: 0"></P>

<!-- Field: Page; Sequence: 17; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>THE
FIRST SCHEDULE ABOVE REFERRED TO</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 18%; padding-right: 1.4pt; padding-left: 1.4pt; text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">LANDLORD</FONT></TD>
    <TD STYLE="width: 8%; padding-right: 1.4pt; padding-left: 1.4pt; text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">:</FONT></TD>
    <TD STYLE="width: 74%; padding-right: 1.4pt; padding-left: 1.4pt; font: 10pt Times New Roman, Times, Serif"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">JURCHEN
        INVESTMENT CORPORATION (&#29575;&#28982;&#25237;&#36039;&#26377;&#38480;&#20844;&#21496;) a company incorporated in the
        British Virgin Islands with its registered office at Vistra Corporate Services Centre, Wickhams Cay II, Road Town, Tortola,
        VG1110, British Virgin Islands.</FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(hereinafter
        called &ldquo;the Landlord&rdquo;)</FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-right: 1.4pt; padding-left: 1.4pt; text-align: justify">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-right: 1.4pt; padding-left: 1.4pt; text-align: justify">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-right: 1.4pt; padding-left: 1.4pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="padding-right: 1.4pt; padding-left: 1.4pt; text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">TENANT</FONT></TD>
    <TD STYLE="padding-right: 1.4pt; padding-left: 1.4pt; text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">:</FONT></TD>
    <TD STYLE="padding-right: 1.4pt; padding-left: 1.4pt; font: 10pt Times New Roman, Times, Serif"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">APTUS
        MANAGEMENT LIMITED whose registered office is situate at 17th Floor, Guangdong Investment Tower, 148 Connaught Road Central,
        Hong Kong.</FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(hereinafter
        called &ldquo;the Tenant&rdquo;)</FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>THE
SECOND SCHEDULE ABOVE REFERRED TO</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Part
1 : The Premises</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ALL
THAT PORTION of the SEVENTEENTH FLOOR of GUANGDONG INVESTMENT TOWER, No.148 Connaught Road Central, Hong Kong as shown within
the area outlined or delineated in pink on the Plan annexed hereto standing on ALL THAT piece or parcel of ground registered in
the Land Registry as Marine Lot No.332, Marine Lot No.333, Section A of Marine Lot No.334, The Remaining Portion of Marine Lot
No.334, Marine Lot No.335, Section A of Marine Lot No.336, The Remaining Portion of Marine Lot No.336, Inland Lot No.2142 and
Inland Lot No.2143 subject to the right of access in favour of the Landlord, its assigns, nominees and tenants over the portion
of the said Seventeenth Floor hatched black on the Plan annexed hereto.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Part
2</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Deed
of Mutual Covenant incorporation Management Agreement registered in the Land Registry by Memorial No.6911305.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 18; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>THE
THIRD SCHEDULE ABOVE REFERRED TO</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 18%; font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Term</FONT></TD>
    <TD STYLE="width: 8%; font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">:</FONT></TD>
    <TD STYLE="width: 74%; font: 10pt Times New Roman, Times, Serif"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
the term of THREE (3) YEARS commencing from the 1st day of February 2018 to the 31st day of January 2021 (both dates inclusive)</FONT></P></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Rent</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">HK$130,000.00
per calendar month (exclusive of management fee but inclusive of rates) payable in advance clear of all deductions on the first
day of each and every calendar month, the first of such payments to be made on the signing hereof</FONT></P></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">User</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
commercial purpose</FONT></P></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Deposit</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Hong
        Kong Dollars Three Hundred and Ninety Thousand Only</FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(HK$390,000.00)</FONT></P></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 19; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">AS
WITNESS the hands of the parties hereto the day and year first above written.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 40%; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">SIGNED
    by</FONT></TD>
    <TD STYLE="width: 60%; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">for
    and on behalf of the Landlord</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">in
    the presence of :-</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 40%; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">SIGNED
    by</FONT></TD>
    <TD STYLE="width: 60%; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">for
    and on behalf of the Tenant in the</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">presence
    of :-</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 56%; font: 10pt Times New Roman, Times, Serif; padding-left: 0.375in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">RECEIVED&nbsp;&nbsp;of
    and from the Tenant the</FONT></TD>
    <TD STYLE="width: 4%; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</FONT></TD>
    <TD STYLE="width: 20%; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 20%">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">sum
    of Hong Kong Dollars Three Hundred and Ninety</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 4pt double; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">HK$390,000.00</FONT></TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Thousand
    Only being the deposit money above</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">expressed
    to be paid by the Tenant to the Landlord.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD>&nbsp;</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 60%; font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 40%; font: 10pt Times New Roman, Times, Serif; text-align: justify; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    Landlord</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"></P>

<!-- Field: Page; Sequence: 20; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.35
<SEQUENCE>39
<FILENAME>ff12018ex10-35_aptorum.htm
<DESCRIPTION>SERVICE AGREEMENT BETWEEN COVAR PHARMACEUTICALS INCORPORATED AND VIDENS INCORPORATION LIMITED DATED MAY 15, 2017
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif; text-align: right"><B>Exhibit 10.35</B></P>

<P STYLE="margin-top: 0; text-align: center; margin-bottom: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>SERVICE
AGREEMENT</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>THIS
SERVICE AGREEMENT </B>(this &ldquo;Agreement&rdquo;) is entered into as of May 15, 2017 by and between Covar Pharmaceuticals Incorporated,
a Corporation having its principal place of business located at 5276 Champlain Trail, Mississauga, Ontario, Canada (the &ldquo;Consultant&rdquo;),
and <B>Videns Incorporation Limited </B>(and associated companies), a company having its correspondence address at Unit B, 17/F,
Guangdong Investment Tower, 148 Connaught Road Central, Hong Kong (the &ldquo;Corporation&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>W
I T N E S S E T H :</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>WHEREAS
</B>the Corporation desires to engage the services of Consultant, and Consultant is willing to render services to the Corporation,
each upon the terms and conditions herein set forth.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>NOW,
THEREFORE, </B>in consideration of the mutual promises set forth herein and other good and valuable consideration, the receipt
and sufficiency of which are hereby acknowledged, the parties hereto agree as follows:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0%"></TD><TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>1.</B></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>SERVICES</B></FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Consultant
shall be engaged as &ldquo;Product and Clinical Development Advisor&rdquo; of the Corporation.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Consultant
shall be available to perform and shall perform for the Corporation the development of contrast agents (including, but not limited
to, Curcumin Conjugated Magnetic Nanoparticles (CCMN)) for MRI imaging applicable to the human brain (the &ldquo;Program&rdquo;).
Examples of the services shall include, but are not limited to, the following:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(a)</B></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Program
Management Services</B></FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0; text-align: justify"></TD><TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Lead
                                         and support strategic planning to complete a Phase I (First Time in Humans [FTIH]) clinical
                                         study and, where possible, proof of concept clinical studies</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: -0.2in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"></TD><TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Project
                                         Plan Development</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: -0.2in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">o</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">High
level strategic plan and timeline</FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">o</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Detailed
plan, timeline and budget</FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"></TD><TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Project
                                         Management</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: -0.2in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">o</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Set
goals and define responsibilities of team members</FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">o</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Coordinate
core project team meetings</FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">o</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Attend,
coordinate and support functional project team meetings if required</FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">o</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Review
and update of project plan and budget at regular intervals or as required</FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">o</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Follow
up action items with team members</FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">o</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Risk
assessment and mitigation strategies</FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P>

<!-- Field: Page; Sequence: 1; Options: NewSection; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 50%">&nbsp;</TD><TD STYLE="width: 50%; text-align: right">Page | <!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>




<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"></TD><TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify; padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Provide
                                         development services or support and identify outsourcing to service providers for services
                                         including, but not limited to:</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.2in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">o</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Preclinical
(non-clinical) toxicology studies</FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">o</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ADME</FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">o</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Functional
ingredient sourcing/qualification/characterization/supplier site auditing</FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">o</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Excipient
sourcing/qualification/characterization/supplier site auditing</FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">o</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Clinical
trial batches (CTM batches) manufacturer</FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">o</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">GLP/GMP
testing laboratories</FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"></TD><TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify; padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Evaluate
                                         service providers including preparation of &ldquo;Request for Proposal&rdquo; details,
                                         reference checks, auditing, evaluation of proposals, recommendations and contract negotiation.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.2in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"></TD><TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify; padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Recruit
                                         experts to support the development program for strategic planning, protocol development,
                                         regulatory document preparation and filing, preclinical studies, material characterization
                                         and CMC development.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.2in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(b)</B></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Technical
Services by Consultant or Contractors</B></FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"></TD><TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify; padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Develop
                                         feasible, regulatory compliant manufacturing process for toxicology and clinical batches</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.2in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"></TD><TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Develop
                                         regulatory acceptable method to characterize the contrast agents (including CCMN)</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.2in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"></TD><TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify; padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Develop
                                         method of administration of contrast agents (including CCMN) to animals for pre-clinical
                                         studies and to humans for FTIH</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.2in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"></TD><TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify; padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Develop
                                         sufficiently stable contrast agents (including CCMN) formulation if required. For example,
                                         stabilizer(s) for nanoparticles may be added or lyophilization excipients may be included
                                         in the formulation</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.2in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"></TD><TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify; padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Source
                                         or fabricate (if needed by contractor) equipment for the manufacture of the pre-clinical/toxicology
                                         or clinical batches</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.2in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"></TD><TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify; padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Develop
                                         and qualify suitable physical and/or chemical testing methods suitable for GLP or GMP
                                         product characterization or release</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.2in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"></TD><TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Develop
                                         and qualify stability-indicating physical and chemical testing methods</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.2in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"></TD><TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Technology
                                         transfer for CTM manufacturing site</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.2in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"></TD><TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Support
                                         definition of animal and FTIH dosing ranges</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.2in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"></TD><TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Support
                                         or perform audits to qualify contractors</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.2in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"></TD><TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Coordinate
                                         the preparation of documentation for regulatory submission</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.2in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 50%">&nbsp;</TD><TD STYLE="width: 50%; text-align: right">Page | <!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Consultant
shall perform such services at such times and such places as may be reasonably designated by:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mr
Ian Huen</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dr
Owen Ko</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mr
Kenrick Fok</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mr
Darren Lui</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Professor
Thomas Lee</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dr
Vincent Mok</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Corporation retains the right to amend the list of authorized individuals above at any time by written notification to the Consultant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Consultant
shall perform such services in a manner consistent with industry standards for similar professional consulting work. Upon mutual
agreement and under the request of the Corporation, Consultant may need to travel from time to time to perform the services described
herein.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0%"></TD><TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>2.</B></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>COMPENSATION</B></FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
consideration of Consultant&rsquo;s performance of the consulting services described above, the Corporation shall compensate Consultant
based on:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
                                         fixed fee approach with a defined scope to be agreed between the Consultant and the Corporation
                                         for each critical study, project or milestone;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
                                         all other circumstances, the hourly rate of its employees who perform the services. Both
                                         Mr. Austin Freedman, Dr. Kwok Chow and technical and supporting staff at the Consultant
                                         company will provide the technical services. The Consultant may bring qualified external
                                         consultants with the Corporation&rsquo;s agreement to support the Program. Austin Freedman
                                         shall provide his services at an hourly rate of USD $150 per hour; Dr. Kwok Chow shall
                                         provide technical and consulting services, including pharmaceutical and analytical development
                                         services, at an hourly rate of USD $200 per hour. The technical and supporting staff
                                         will provide services at an hourly rate of USD $65 to $100 per hour depending on their
                                         backgrounds and experience. The fee for external consulting will be determined on a case
                                         by case basis with prior Corporation approval.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Both
parties agree that:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mr.
                                         Austin Freedman, Executive Director, Cover Pharmaceuticals Incorporated, will provide
                                         the lead program management services for the Project;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dr.
                                         Kwok Chow, President, Cover Pharmaceuticals Incorporated, will also provide program management
                                         support when needed.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.25in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 3; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 50%">&nbsp;</TD><TD STYLE="width: 50%; text-align: right">Page | <!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.25in">&nbsp;</P>




<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>3.</B></FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>EXPENSES</B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Corporation shall reimburse Consultant for all direct out-of-pocket expenses of Consultant actually and reasonably incurred in
connection with the performance of Consultant&rsquo;s obligations under this Agreement insofar as such expenses relate to travel
expenses, third party payments and other reasonable expenses, provided that such expenses are specifically approved in advance
in writing by the Corporation.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>4.</B></FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>RECORDS
                                         AND REPORTS </B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>4.1.</B></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Books
and Records</B></FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Consultant
shall maintain books and records adequate for the determination of all services rendered, expenses and other data, which shall
be available for inspection by the Corporation through its agents or representatives during normal working hours as the Corporation
shall reasonably request.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>4.2.</B></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Payment
of Invoices</B></FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Consultant
shall submit invoices to the Corporation within ten (10) days after the end of each calendar month during the term of this Agreement,
specifying in reasonable detail the nature and extent of the services performed by Consultant for the preceding month, and the
amount of expenses incurred by Consultant which are subject to reimbursement by the Corporation in accordance with <B>Article
3</B>. The Corporation shall remit payment for all such compensation and expenses in the amounts called for by this Agreement
within 30 days after receipt of such invoices.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
retainer fee of USD $10,000 will be provided by the Corporation upon execution of this Agreement and the retainer fee will be
deducted from the last payment upon termination of the Agreement or completion of the Program. Any remaining funds, if any, will
be refunded.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Consultant will provide the Corporation a quotation with estimated time and cost for individual service items exceeding USD $10,000
for approval before execution.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>4.3.</B></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Monthly
Status Reports</B></FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Upon
request by the Corporation, Consultant shall prepare and submit to the Corporation on a monthly basis a status report setting
forth a summary of Consultant&rsquo;s activities and progress during the preceding month with respect to the matters set forth in Article
1.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>5.</B></FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>TERM
                                         AND TERMINATION</B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>5.1.</B></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Term</B></FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Subject
to the termination provisions set forth in <B>Article 5.2, </B>this Agreement shall have an initial term of 12 months,
commencing on the date this agreement is executed, which term may be automatically renewable for another 12 months, and
thereafter extended from time to time by the mutual written agreement of Consultant and the Corporation.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 4; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 50%">&nbsp;</TD><TD STYLE="width: 50%; text-align: right">Page | <!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>5.2.</B></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Termination
and Actions Thereafter</B></FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"></TD><TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
                                         Agreement may be terminated by the Corporation by written notice to Consultant at any
                                         time upon (i) Consultant&rsquo;s permanent disability or incapacity to perform services hereunder;
                                         or (ii) a breach by Consultant of any of the provisions of this Agreement.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.3in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"></TD><TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Either
                                         party may, at any time and with or without cause, terminate this Agreement upon written
                                         notice to the other party given not less than fifteen (15) days prior to such termination.
                                         Such notice shall specify the effective date of termination for all purposes hereunder.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.3in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"></TD><TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Upon
                                         termination or expiration of this Agreement, Consultant (or his representatives) shall
                                         promptly submit to the Corporation an invoice covering all unbilled compensation and
                                         expenses to date, together with an estimate of the compensation and expenses that would
                                         be chargeable to the Corporation if any particular services for work then in progress
                                         were to be completed by Consultant. Except in the case of termination under <B>Article5.2(a)(i),
                                         </B>upon request by <B>the </B>Corporation (but not otherwise) Consultant shall complete
                                         such work in progress as the Corporation shall designate, and this Agreement shall in
                                         such case be deemed extended until such work is completed and paid for. The Corporation
                                         shall pay Consultant for any services performed to and including the date of termination
                                         in accordance with the provisions for compensation set forth in <B>Articles 2 </B>and
                                         <B>3.</B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.3in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"></TD><TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                         provisions of <B>Articles 7 </B>and <B>8 </B>shall survive expiration or termination
                                         of this Agreement for any reason whatsoever.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.3in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0%"></TD><TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>6.</B></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>RELATIONSHIP
OF THE PARTIES</B></FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>6.1.</B></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Independent
Status</B></FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
relationship of Consultant to the Corporation hereunder shall be that of an independent contractor, Nothing in this Agreement
is intended or shall be construed to constitute Consultant an employee, agent or partner of the Corporation nor shall Consultant
have authority to bind the Corporation in any respect. The Corporation shall not be liable for any act or omission of Consultant
or his employees or agents, and Consultant agrees to indemnify and hold harmless the Corporation from any and all losses, damages,
costs and expenses (including attorneys&rsquo; fees) in any manner resulting from or arising out of any such act or omission or any
breach of Consultant&rsquo;s obligations under this Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>6.2.</B></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Services
for Third Parties</B></FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Nothing
in this Agreement shall be construed to prevent Consultant from concurrently providing services to persons other than the Corporation,
subject to the limitations set forth in <B>Articles 7 </B>and <B>8.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 5; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 50%">&nbsp;</TD><TD STYLE="width: 50%; text-align: right">Page | <!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>6.3.</B></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Certain
Tax Matters</B></FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Consultant
shall not be treated as an employee for tax purposes with respect to the services performed pursuant to this Agreement. Consultant
shall be responsible for the filing of all necessary income tax returns and the payment of all taxes required by law. Consultant
acknowledges that he understands his tax obligations.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>6.4.</B></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Disclosure
of Consultant Relationship by Corporation</B></FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Subject
to article 6.1 above, the Corporation may include and disclose, for example, in its corporate presentations, marketing materials,
due diligence related documentation to third parties, the credentials and advisory role of the Consultant and its employees (for
example, Dr Kwok Chow and Mr. Austin Freedman). On this basis, the Corporation will seek the Consultant&rsquo;s approval prior to such
inclusion.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0%"></TD><TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>7.</B></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>RESTRICTIVE
COVENANTS</B></FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>7.1.</B></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Confidential
Information</B></FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Unless
authorized or instructed in writing by the Corporation, Consultant shall not, during or at any time after the term of this Agreement
except as required in the conduct of the Corporation&rsquo;s business, disclose to others, or use, or permit to be disclosed to others
or used, any of the Corporation&rsquo;s inventions, discoveries, works, ideas, information, knowledge or data (whether in oral, written,
or machine-readable form) which Consultant may develop or obtain during the course of or in connection with Consultant&rsquo;s engagement,
including such inventions, discoveries, works, ideas, information, knowledge, or data relating to machines, equipment, products,
systems, software, research and/or development, designs, compositions, formulae, processes, manufacturing procedures, business
methods, present and prospective customers of the Corporation, business dealings with such customers, prospective marketing, promotion,
sales and advertising programs and strategies, and agreements with representatives or prospective representatives of the Corporation,
present or prospective sources of supply or any other business arrangements of the Corporation, including but not limited to customers,
customer lists, costs, prices and earnings, whether or not developed by Consultant, by others in the Corporation or obtained by
the Corporation from third parties, and irrespective of whether or not such inventions, discoveries, works, ideas, information,
knowledge or data have been identified by the Corporation as secret or confidential, unless and until, and then to the extent
and only to the extent that, such inventions, discoveries, works, ideas, information, knowledge or data become available to the
public otherwise than by Consultant&rsquo;s act or omission. All inventions, discoveries, works, ideas, information, knowledge, and
data described or referred to in this <B>Article 7.1</B> are referred to herein collectively as &ldquo;Confidential Information&rdquo;.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>7.2.</B></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Essence
of Agreement</B></FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Consultant
acknowledges (i) that the use, misappropriation or disclosure of the Confidential Information (as defined in <B>Article
7.1</B>) would constitute a breach of trust and cause irreparable injury to the Corporation, (ii) that all such
Confidential Information is the property of the Corporation and (iii) that it is essential to the protection of the
Corporation&rsquo;s goodwill and to the maintenance of the Corporation&rsquo;s competitive position that the Confidential Information be
kept secret and that the Confidential Information not be disclosed by Consultant to others or used by Consultant to
Consultant&rsquo;s own advantage or the advantage of others. Consultant further acknowledges that Consultant&rsquo;s agreement to the
provisions of this <B>Article 7 </B>and the enforceability of such provisions against Consultant are an essential element of
this Agreement and that, absent such provisions and the enforceability thereof, the Corporation would not (a) engage
Consultant nor (b) permit Consultant access to and use of Confidential Information.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 6; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 50%">&nbsp;</TD><TD STYLE="width: 50%; text-align: right">Page | <!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>7.3.</B></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Non-solicitation/Noncompetition</B></FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Consultant
further recognizes and acknowledges that it is essential for the proper protection of the business of the Corporation that Consultant
be restrained (a) from soliciting or inducing any employee of the Corporation to leave the employ of the Corporation, (b) from
hiring or attempting to hire any employee of the Corporation, (c) from soliciting the business of the customers (actual or potential)
and suppliers of the Corporation for any business purpose, and (d) from competing against the Corporation, including, but not
limited to, provides services relating to generic drug development to any third party in China.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>7.4.</B></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Ability
to Earn Livelihood</B></FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Consultant
represents that his experience and capabilities are such that the provisions of this <B>Article 7 </B>will not prevent him from
earning his livelihood, and acknowledges that it would cause the Corporation serious and irreparable injury and cost if Consultant
were to use his ability and knowledge in competition with the Corporation or to otherwise breach the obligations contained in
<B>Article 7.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0%"></TD><TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>8.</B></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>PROPRIETARY
RIGHTS</B></FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>8.1.</B></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Assignment
of Rights</B></FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
the term of this Agreement, the Corporation hereby grants to the Consultant, a non-exclusive, paid-up, royalty-free, non-transferable
license of Client&rsquo;s Intellectual Property which the Consultant must use in order to perform the Services.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">All
Intellectual Property generated or derived by the Consultant in the course of performing the Services, to the extent it is specific
to the development. manufacture, use and sale of the Client&rsquo;s Product that is the subject of the Services, will be the exclusive
property of the Corporation.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">All
Intellectual Property generated or derived by the Consultant while performing the Services which is not specific to, or dependent
upon, the Corporation&rsquo;s Product and which has application to manufacturing processes or formulation development of pharmaceutical
products or pharmaceutical delivery systems will be the exclusive property of the Consultant. The Consultant hereby grants to
the Corporation, a non-exclusive, paid-up, royalty-free, transferable license of the Intellectual Property which the Corporation
may use for the manufacture of Client&rsquo;s Product.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 7; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 50%">&nbsp;</TD><TD STYLE="width: 50%; text-align: right">Page | <!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>8.2.</B></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Return
of Materials</B></FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Upon
expiration or termination of this Agreement, Consultant agrees to return to the Corporation all computer software, computer programs,
source codes, object codes, magnetic tapes, printouts, designs, proposals, samples, notes, records, reports, documents, customer
and prospective customer lists, memoranda, plans, blue prints, correspondence, proposals, drawings, letters, flow-charts, manuals,
strategies, techniques, photographs, catalogs and writings and all copies thereof, directly or indirectly, related to, or developed,
prepared or created during, Consultant&rsquo;s engagement by the Corporation and, without limiting the foregoing, Consultant shall promptly
deliver to the Corporation any and all documents or materials constituting or, directly or indirectly, relating to any Confidential
Information. The Corporation may withhold Consultant&rsquo;s outstanding compensation against return of these materials and any other
materials of the Corporation or its customers.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0%"></TD><TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>9.</B></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>REPRESENTATIONS
AND WARRANTIES BY CONSULTANT</B></FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Consultant
represents and warrants to the Corporation that neither the execution and delivery of this Agreement nor the carrying out of any
of the transactions contemplated hereby will in any respect result in any violation of or be in conflict with any term or provision
of any agreement, document or instrument to which Consultant is a party or by which he is bound. Consultant further represents
and warrants to the Corporation that he has furnished the Corporation with copies of all such agreements, documents or instruments
to which Consultant is a party or by which he is bound. Consultant agrees not to divulge to the Corporation any information which
would violate any such agreement, document or instrument, nor to divulge to the Corporation any trade secrets of prior employers
or contracting parties.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0%"></TD><TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>10.</B></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>MISCELLANEOUS</B></FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>10.1.</B></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Additional
Actions and Documents</B></FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Each
of the parties hereto hereby agrees to take or cause to be taken such further actions, to execute, deliver and file or cause to
be executed, delivered and filed such further documents, and will obtain such consents, as may be necessary or as may be reasonably
requested in order to fully effectuate the purposes, terms and conditions of this Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>10.2.</B></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Assignment</B></FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Consultant
shall not assign his rights and obligations under this agreement, in whole or in part, whether by operation of law or otherwise,
without the prior written consent of the Corporation, and any such assignment contrary to the terms hereof shall be null and void
and of no force and effect.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>10.3.</B></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Entire
Agreement; Amendment</B></FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
Agreement constitutes the entire agreement between the parties hereto with respect to the transactions contemplated herein, and
it supersedes all prior oral or written agreements, commitments or understandings with respect to the matters provided for herein.
No amendment, modification or discharge of this Agreement shall be valid or binding unless set forth in</FONT> <FONT STYLE="font: 10pt Times New Roman, Times, Serif">writing
and duly executed and delivered by the party against whom enforcement of the amendment, modification, or discharge is sought.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 8; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 50%">&nbsp;</TD><TD STYLE="width: 50%; text-align: right">Page | <!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>10.4.</B></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Waiver</B></FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">No
delay or failure on the part of any party hereto in exercising any right, power or privilege under this Agreement or under any
other documents furnished in connection with or pursuant to this Agreement shall impair any such right, power or privilege or
be construed as a waiver of any default or any acquiescence therein. No single or partial exercise of any such right, power or
privilege shall preclude the further exercise of such right, power or privilege, or the exercise of any other right, power or
privilege. No waiver shall be valid against any party hereto unless made in writing and signed by the party against whom enforcement
of such waiver is sought and then only to the extent expressly specified therein.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>10.5.</B></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Governing
Law</B></FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
Agreement, the rights and obligations of the parties hereto, and any claims or disputes relating thereto, shall be governed by
and construed in accordance with the laws of Ontario, excluding the choice of law rules thereof).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>10.6.</B></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Notices</B></FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">All
notices, demands, requests, or other communications that may be or are required to be given, served, or sent by any party to any
other party pursuant to this Agreement shall be in writing and shall be hand delivered, sent by overnight courier or mailed by
first-class, registered or certified mail, return receipt requested, postage prepaid, or transmitted by telegram, telecopy or
telex, to the addresses indicated at the beginning of this agreement for each party.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Each
party may designate by notice in writing a new address to which any notice, demand, request or communication may thereafter be
so given, served or sent. Each notice, demand, request, or communication that shall be hand delivered, sent, mailed, telecopied
or telexed in the manner described above, or that shall be delivered to a telegraph Corporation, shall be deemed sufficiently
given, served, sent, received or delivered for all purposes at such time as it is delivered to the addressee (with the return
receipt, the delivery receipt, or (with respect to a telecopy or telex) the answerback being deemed conclusive, but not exclusive,
evidence of such delivery) or at such time as delivery is refused by the addressee upon presentation.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>10.7.</B></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Execution
in Counterparts</B></FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">To
facilitate execution, this Agreement may be executed in as many counterparts as may be required. It shall not be necessary that
the signatures of, or on behalf of, each party, or that the signatures of all persons required to bind any party, appear on each
counterpart; but it shall be sufficient that the signature of, or on behalf of, each party, or that the signatures of the persons
required to bind any party, appear on one or more of the counterparts. Ail counterparts shall collectively constitute a single
agreement. It shall not be necessary in making proof of this Agreement to produce or account for more than a number of counterparts
containing the respective signatures of, or on behalf of, all of the parties hereto.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 9; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 50%">&nbsp;</TD><TD STYLE="width: 50%; text-align: right">Page | <!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>10.8.</B></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Limitation
on Benefits</B></FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 1in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
covenants, undertakings and agreements set forth in this Agreement shall be solely for the benefit of, and shall be enforceable
only by, the parties hereto and their respective successors, heirs, executors, administrators, legal representatives and permitted
assigns.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 1in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%">
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify; padding: 0; text-indent: 0; width: 0.5in">&nbsp;</TD>
    <TD STYLE="padding: 0; font-size: 10pt; text-indent: 0; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>10.9.</B></FONT></TD>
    <TD STYLE="padding: 0; font-size: 10pt; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Binding Effect</B></FONT></TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 1in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Subject
to any provisions hereof restricting assignment, this Agreement shall be binding upon and shall inure to the benefit of the parties
hereto and their respective successors, heirs, executors, administrators, legal representatives and assigns.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>IN
WITNESS WHEREOF, </B>the Corporation has caused this Agreement to be executed by its duly authorized officer and Consultant has
hereunto set his hand as of the date first above written.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Videns
Incorporation Limited</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="padding: 0 0 1.5pt; text-indent: 0; width: 4%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By: </FONT></TD>
    <TD STYLE="padding-top: 0; padding-right: 0; border-bottom: Black 1.5pt solid; padding-left: 0; text-indent: 0; width: 36%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/ Ian Huen</FONT></TD>
    <TD STYLE="padding: 0 0 1.5pt; text-indent: 0; width: 20%">&nbsp;</TD>
    <TD STYLE="padding: 0 0 1.5pt; text-indent: 0; width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date:</FONT></TD>
    <TD STYLE="padding-top: 0; padding-right: 0; border-bottom: Black 1.5pt solid; padding-left: 0; text-indent: 0; width: 35%"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">May 31, 2017</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding: 0; text-indent: 0">&nbsp;</TD>
    <TD STYLE="padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name: Ian Huen</FONT></TD>
    <TD STYLE="padding: 0; text-indent: 0">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="padding: 0; text-indent: 0">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding: 0; text-indent: 0">&nbsp;</TD>
    <TD STYLE="padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title: Chief Executive Officer</FONT></TD>
    <TD STYLE="padding: 0; text-indent: 0">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="padding: 0; text-indent: 0">&nbsp;</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt">&nbsp;<B></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>Covar Pharmaceuticals Incorporated</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="padding: 0 0 1.5pt; width: 4%; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:
    </FONT></TD>
    <TD STYLE="padding-top: 0; padding-right: 0; border-bottom: Black 1.5pt solid; padding-left: 0; width: 36%; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/
Kwok Chow</FONT></TD>
    <TD STYLE="padding: 0 0 1.5pt; width: 20%; text-indent: 0">&nbsp;</TD>
    <TD STYLE="padding: 0 0 1.5pt; width: 5%; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date:</FONT></TD>
    <TD STYLE="padding-top: 0; padding-right: 0; border-bottom: Black 1.5pt solid; padding-left: 0; width: 35%; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">May
25, 2017</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding: 0; text-indent: 0">&nbsp;</TD>
    <TD STYLE="padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:
    Kwok Chow, Ph.D.</FONT></TD>
    <TD STYLE="padding: 0; text-indent: 0">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="padding: 0; text-indent: 0">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding: 0; text-indent: 0">&nbsp;</TD>
    <TD STYLE="padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:
    President</FONT></TD>
    <TD STYLE="padding: 0; text-indent: 0">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="padding: 0; text-indent: 0">&nbsp;</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt">&nbsp;</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; text-align: right; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Page
| 10</FONT></P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.36
<SEQUENCE>40
<FILENAME>ff12018ex10-36_aptorum.htm
<DESCRIPTION>APPOINTMENT LETTER AND ADDENDUM TO SERVICE AGREEMENT WITH COVAR PHARMACEUTICALS INCORPORATED AND DR. KWOK CHOW DATED DECEMBER 15, 2017
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit
10.36</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;<IMG SRC="ex10-36_01.jpg" ALT=""></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Aptorum
Group Limited</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">17/F
Guangdong Investment Tower, 148 Connaught Road Central, Hong Kong</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Tel:
(852) 2117 6611 &bull; Fax: (852) 2850 7286</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Covar
Pharmaceuticals Incorporated</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5276
Champlain Trail</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mississauga,
ON L5R 2Y9</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Canada</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dr.
Kwok Chow</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5276
Champlain Trail,</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mississauga,
Ontario,</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Canada
L5R 2Y9</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Appointment
Letter and Addendum to Service Agreement</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Whereas,
</B>Videns Incorporated Limited (&ldquo;<B>Videns</B>&rdquo;), a wholly owned subsidiary of Aptorum Group Limited (&ldquo;<B>Aptorum</B>&rdquo;),
(together with its affiliates and subsidiaries, &ldquo;<B>Group</B>&rdquo;), have entered into a Service Agreement with Covar
Pharmaceuticals Incorporated (&ldquo;<B>Covar</B>&rdquo;) on May 15, 2017 (&ldquo;<B>Agreement</B>&rdquo;) (the Agreement is attached
herein as <U>Annex A</U>);</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Whereas,
</B>under the Agreement, Videns would engage Covar to develop certain contrasting agents (including, but not limited to, Curcumin
Conjugated Magnetic Nanoparticles (CCMN) for MRI imaging applicable to the human brain (&ldquo;<B>Original Service Scope</B>&rdquo;);</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; color: red"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Whereas,
</B>under the Agreement, Dr. Chow has been enlisted to provide certain program management services and technical services in relation
to the Original Service Scope;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Whereas,
</B>beginning from August 1, 2017, the services provided by Covar and Dr. Chow had expanded beyond the Original Service Scope
as they began to advise on other research and development projects of the Group;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Whereas,
</B>given the contribution of Dr. Chow to other research and development projects of the Group, Aptorum would like to issue this
appointment letter and addendum to service agreement (&ldquo;<B>Letter</B>&rdquo;) to expand the Original Service Scope of the
Agreement and to appoint Dr. Chow to the position of &ldquo;Senior Clinical Development Manager&rdquo; of Aptorum, effective retroactive
to August 1, 2017;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Whereas,
</B>Dr. Chow is willing to accept such appointment, given that the arrangement that his services under this Letter will be engaged
through Covar and will be under the terms set out in the Agreement and this Letter.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; color: #555555"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>NOW,
THEREFORE, </B>in consideration of the mutual promises set forth herein and other good and valuable consideration, the receipt
and sufficiency of which are hereby acknowledged, the parties hereto agree as follows:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0; padding-right: 0"></TD><TD STYLE="width: 21.3pt; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>1.</B></FONT></TD><TD STYLE="text-align: justify; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Aptorum
                                         and the Group</B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 21.3pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Group focuses on the licensing of, and acquisition of early stage preclinical assets with the intention to engage in drug research,
development, and commercialization purposes. Assets are acquired via open and public platforms such as the technology transfer
offices of accredited universities and academic institutions. In addition, the Group seeks to be a facilitator across the financing
spectrum for biotech companies, entrepreneurs, and commercializing agents, to bolster innovations adding value to health care
needs in the market place; and to assist in furthering the research capabilities of institutions the Group works with.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B></B></FONT></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0; padding-right: 0"></TD><TD STYLE="width: 21.3pt; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>2.</B></FONT></TD><TD STYLE="text-align: justify; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Appointment
                                         of Position</B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 22.5pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Aptorum
hereby offers, and Dr. Chow hereby accept, the position of &ldquo;Senior Clinical Development Manager&rdquo; of Aptorum (&ldquo;<B>Position</B>&rdquo;).
As a Senior Clinical Development Manager, Dr. Chow will provide certain consultancy, advisory, and management services to Aptorum
through correspondence and man-hours set out herein.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 21.3pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0; padding-right: 0"></TD><TD STYLE="width: 21.3pt; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>3.</B></FONT></TD><TD STYLE="text-align: justify; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Scope
                                         of Services for Position</B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 54.3pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 21.3pt; padding-right: 0"></TD><TD STYLE="width: 33pt; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT></TD><TD STYLE="text-align: justify; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dr.
                                         Chow&rsquo;s duties are limited to the following services:</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I><U>Program
Management Services:</U></I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 54pt; padding-right: 0"></TD><TD STYLE="width: 27pt; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)</FONT></TD><TD STYLE="text-align: justify; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Lead
                                         and support strategic planning to complete a Phase I (First Time in Humans (&ldquo;<B>FTIH</B>&rdquo;)
                                         clinical study and, where possible, proof of concept clinical studies.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 54pt; padding-right: 0"></TD><TD STYLE="width: 27pt; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)</FONT></TD><TD STYLE="text-align: justify; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Project
                                         Plan Development, including:</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 81pt; padding-right: 0"></TD><TD STYLE="width: 13.5pt; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">High
                                         level strategic plan and timeline; and</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 81pt; padding-right: 0"></TD><TD STYLE="width: 13.5pt; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Detailed
                                         plan, timeline and budget.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 54pt; padding-right: 0"></TD><TD STYLE="width: 27pt; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii)</FONT></TD><TD STYLE="text-align: justify; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Project
                                         Management, including:</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 81pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 81pt; padding-right: 0"></TD><TD STYLE="width: 13.5pt; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Set
                                         goals and define responsibilities of team members;</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 81pt; padding-right: 0"></TD><TD STYLE="width: 13.5pt; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Coordinate
                                         core project team meetings;</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 81pt; padding-right: 0"></TD><TD STYLE="width: 13.5pt; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Attend,
                                         coordinate and support functional project team meetings if required;</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 81pt; padding-right: 0"></TD><TD STYLE="width: 13.5pt; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Review
                                         and update of project plan and budget at regular intervals or as required;</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 81pt; padding-right: 0"></TD><TD STYLE="width: 13.5pt; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Follow
                                         up action items with team members; and</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 81pt; padding-right: 0"></TD><TD STYLE="width: 13.5pt; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Risk
                                         assessment and mitigation strategies.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 54pt; padding-right: 0"></TD><TD STYLE="width: 27pt; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iv)</FONT></TD><TD STYLE="text-align: justify; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Provide
                                         development services or support and identify outsourcing to service providers for services
                                         including, but not limited to:</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 81pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 81pt; padding-right: 0"></TD><TD STYLE="width: 13.5pt; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Preclinical
                                         (non-clinical) toxicology studies;</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 81pt; padding-right: 0"></TD><TD STYLE="width: 13.5pt; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ADME;</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 81pt; padding-right: 0"></TD><TD STYLE="width: 13.5pt; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Functional
                                         ingredient sourcing / qualification / characterization / supplier site auditing;</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 81pt; padding-right: 0"></TD><TD STYLE="width: 13.5pt; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Excipient
                                         sourcing/qualification/characterization/supplier site auditing;</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 81pt; padding-right: 0"></TD><TD STYLE="width: 13.5pt; padding-right: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&#9679;</FONT></TD><TD STYLE="text-align: justify; padding-right: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Clinical
                                         trial batches (CTM batches) manufacturer; and</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 81pt; padding-right: 0"></TD><TD STYLE="width: 13.5pt; padding-right: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&#9679;</FONT></TD><TD STYLE="text-align: justify; padding-right: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">GLP/GMP
                                         testing laboratories.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: -0.25in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>


<P STYLE="margin-top: 0; margin-bottom: 0"></P>

<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 54pt; padding-right: 0"></TD><TD STYLE="width: 27pt; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(v)</FONT></TD><TD STYLE="text-align: justify; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Evaluate
                                         service providers including preparation of &ldquo;Request for Proposal&rdquo; details,
                                         reference checks, auditing, evaluation of proposals, recommendations and contract negotiation.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 81pt; text-align: justify; text-indent: -27pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 54pt; padding-right: 0"></TD><TD STYLE="width: 27pt; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(vi)</FONT></TD><TD STYLE="text-align: justify; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Recruit
                                         experts to support the development program for strategic planning, protocol development,
                                         regulatory document preparation and filing, preclinical studies, material characterization
                                         and CMC development.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 58.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I><U>Technical
Services: </U></I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 58.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 57pt; padding-right: 0"></TD><TD STYLE="width: 24pt; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)</FONT></TD><TD STYLE="text-align: justify; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Develop
                                         feasible, regulatory compliant manufacturing process for toxicology and clinical batches.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 81pt; text-align: justify; text-indent: -24pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 57pt; padding-right: 0"></TD><TD STYLE="width: 24pt; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)</FONT></TD><TD STYLE="text-align: justify; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Develop
                                         regulatory acceptable method to characterize the contrast agents.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 81pt; text-align: justify; text-indent: -24pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 57pt; padding-right: 0"></TD><TD STYLE="width: 24pt; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii)</FONT></TD><TD STYLE="text-align: justify; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Develop
                                         method of administration of contrast agents to animals for preclinical studies and to
                                         humans for FTIH.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 81pt; text-align: justify; text-indent: -24pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 57pt; padding-right: 0"></TD><TD STYLE="width: 24pt; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iv)</FONT></TD><TD STYLE="text-align: justify; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Develop
                                         sufficiently stable contrast agents formulation if required. For example, stabilizer(s)
                                         for nanoparticles may be added or lyophilization excipients may be included in the formulation.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 57pt; padding-right: 0"></TD><TD STYLE="width: 24pt; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(v)</FONT></TD><TD STYLE="text-align: justify; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Source
                                         or fabricate (if needed by contractor) equipment for the manufacture of the preclinical
                                         / toxicology or clinical batches.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 81pt; text-align: justify; text-indent: -24pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 57pt; padding-right: 0"></TD><TD STYLE="width: 24pt; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(vi)</FONT></TD><TD STYLE="text-align: justify; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Develop
                                         and qualify suitable physical and/or chemical testing methods suitable for GLP or GMP
                                         product characterization or release.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 81pt; text-align: justify; text-indent: -24pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 57pt; padding-right: 0"></TD><TD STYLE="width: 24pt; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(vii)</FONT></TD><TD STYLE="text-align: justify; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Develop
                                         and qualify stability-indicating physical and chemical testing methods.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 81pt; text-align: justify; text-indent: -24pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 57pt; padding-right: 0"></TD><TD STYLE="width: 24pt; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(viii)</FONT></TD><TD STYLE="text-align: justify; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Technology
                                         transfer for CTM manufacturing site.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 81pt; text-align: justify; text-indent: -24pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 57pt; padding-right: 0"></TD><TD STYLE="width: 24pt; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ix)</FONT></TD><TD STYLE="text-align: justify; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Support
                                         definition of animal and FTIH dosing ranges.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 81pt; text-align: justify; text-indent: -24pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 57pt; padding-right: 0"></TD><TD STYLE="width: 24pt; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(x)</FONT></TD><TD STYLE="text-align: justify; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Support
                                         or perform audits to qualify contractors.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 81pt; text-align: justify; text-indent: -24pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 57pt; padding-right: 0"></TD><TD STYLE="width: 24pt; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(xi)</FONT></TD><TD STYLE="text-align: justify; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Coordinate
                                         the preparation of documentation for regulatory submission.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 57pt; padding-right: 0"></TD><TD STYLE="width: 24pt; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(xii)</FONT></TD><TD STYLE="text-align: justify; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Conduct
                                         any other technical services as directed by the Group.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 81pt; text-align: justify; text-indent: -24pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 21.3pt; padding-right: 0"></TD><TD STYLE="width: 33pt; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT></TD><TD STYLE="text-align: justify; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dr.
                                         Chow shall advise where necessary, the Executive Board of Directors of the Group.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 54.3pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 54.3pt; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 54.3pt; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 21.3pt; padding-right: 0"></TD><TD STYLE="width: 33pt; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)</FONT></TD><TD STYLE="text-align: justify; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
                                         Dr. Chow is not an Executive Director on the Board of Directors for the Group, he shall
                                         not have legal nor professional authority to dictate the commercial decisions of the
                                         Executive Board.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 54.3pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 21.3pt; padding-right: 0"></TD><TD STYLE="width: 33pt; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)</FONT></TD><TD STYLE="text-align: justify; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dr.
                                         Chow shall:</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 54pt; padding-right: 0"></TD><TD STYLE="width: 27pt; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)</FONT></TD><TD STYLE="text-align: justify; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">be
                                         responsive to the Group&rsquo;s needs and interests, whereby deliverables to us should
                                         be provided in good faith so that effort and quality is commensurable;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 81pt; text-align: justify; text-indent: -27pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 54pt; padding-right: 0"></TD><TD STYLE="width: 27pt; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)</FONT></TD><TD STYLE="text-align: justify; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">observe
                                         and comply with all statutory rules, and regulations where applicable as governed by
                                         the laws of Canada; and</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 81pt; text-align: justify; text-indent: -27pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 54pt; padding-right: 0"></TD><TD STYLE="width: 27pt; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii)</FONT></TD><TD STYLE="text-align: justify; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">respond
                                         to queries from the Group addressed to him at his earliest convenience.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0; padding-right: 0"></TD><TD STYLE="width: 22.5pt; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.</FONT></TD><TD STYLE="text-align: justify; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Retroactive
                                         Effectiveness</FONT></TD></TR></TABLE>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 22.5pt; text-align: justify; text-indent: -22.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 22.5pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">This
Letter shall be effective retroactive to August 1, 2017 (&ldquo;</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Effective
Date<FONT STYLE="font-weight: normal">&rdquo;), and shall be binding upon all signatories stated in this Letter.</FONT></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0; padding-right: 0"></TD><TD STYLE="width: 22.5pt; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>5.</B></FONT></TD><TD STYLE="text-align: justify; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Service
                                         Fees</B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 22.5pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 22.5pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dr.
Chow shall provide the services, including pharmaceutical and analytical development services, at an hourly rate of US$200 per
hour, or otherwise pre-agreed on a case by case basis by both Aptorum and Covar.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 27pt; text-align: justify; text-indent: -4.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0; padding-right: 0"></TD><TD STYLE="width: 22.5pt; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>6.</B></FONT></TD><TD STYLE="text-align: justify; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Privacy
                                         of Information</B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 28.35pt; text-align: justify; text-indent: -28.35pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 21.3pt; padding-right: 0"></TD><TD STYLE="width: 33pt; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT></TD><TD STYLE="text-align: justify; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dr.
                                         Chow and Covar shall not, except as authorized by the Group or required by his responsibilities,
                                         reveal to any person or company any of the trade secrets or any information concerning
                                         the organization, business, finances, transactions or affairs of the Group which may
                                         come to his knowledge during his contract with the Group and shall keep with complete
                                         secrecy confidential information entrusted to him or his representative(s) and shall
                                         not use or attempt to use any such information in any manner which may injure or cause
                                         loss either directly or indirectly to the Group or may be likely to do so. This restriction
                                         shall continue to apply if and when after the termination of this appointment without
                                         limit in time.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 21.3pt; padding-right: 0"></TD><TD STYLE="width: 33pt; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT></TD><TD STYLE="text-align: justify; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dr.
                                         Chow and Covar shall not either during the period of this appointment or afterwards use
                                         or permit to be used any books, documents, moneys, assets, records or other property
                                         belonging to or relating to any dealings, affair or business of the Group other than
                                         for the benefit of the Group. They shall immediately deliver and return to the Group
                                         all such books, documents, monies, securities, records or other property which they then
                                         have or should have in his possession upon termination of his appointment hereunder.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 21.3pt; padding-right: 0"></TD><TD STYLE="width: 33pt; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)</FONT></TD><TD STYLE="text-align: justify; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                         Group, however, agrees to provide Dr. Chow and Covar in good faith with any information
                                         concerning areas of interest and relevance of the Group as required by Dr. Chow in order
                                         for him to fulfill the aforementioned services for the Group.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 4 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0; padding-right: 0"></TD><TD STYLE="width: 22.5pt; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>7.</B></FONT></TD><TD STYLE="text-align: justify; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Term
                                         and Termination</B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 28.35pt; text-align: justify; text-indent: -28.35pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 22.5pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
appointment of Dr. Chow by Aptorum shall persist for a period of two (2) years from the Effective Date (&ldquo;<B>Term</B>&rdquo;)
as defined within this Letter. The terms and conditions of this Letter shall remain in effect until expiration of the Term, unless
it is terminated prior to expiration subsequent to the following circumstances:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 28.35pt; text-align: justify; text-indent: -28.35pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 21.3pt; padding-right: 0"></TD><TD STYLE="width: 33pt; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT></TD><TD STYLE="text-align: justify; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                         Agreement is terminated;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 54.3pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 21.3pt; padding-right: 0"></TD><TD STYLE="width: 33pt; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT></TD><TD STYLE="text-align: justify; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dr.
                                         Chow is no longer a member or affiliate of Covar;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 21.3pt; padding-right: 0"></TD><TD STYLE="width: 33pt; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)</FONT></TD><TD STYLE="text-align: justify; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">terminated
                                         by Covar after giving Aptorum no less than two (2) months&rsquo; notice in writing;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 22.5pt; text-align: justify; text-indent: -22.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 21.3pt; padding-right: 0"></TD><TD STYLE="width: 33pt; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)</FONT></TD><TD STYLE="text-align: justify; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">terminated
                                         by Aptorum immediately after giving written notice to Covar; or</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 21.3pt; padding-right: 0"></TD><TD STYLE="width: 33pt; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)</FONT></TD><TD STYLE="text-align: justify; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">terminated
                                         by Aptorum without notice or compensation in the event of any dishonesty, fraud, gross
                                         negligence, willful default or refusal to carry out any lawful order or instructions,
                                         or the repeated breach of any rules or regulations of the Group, or those as governed
                                         by the laws of Canada.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 21.3pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Renewal
of this appointment shall be negotiated three months prior to the expiration of the Term, and subject to the mutual consent among
Aptorum, Covar and Dr. Chow as defined in writing.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0; padding-right: 0"></TD><TD STYLE="width: 22.5pt; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>8.</B></FONT></TD><TD STYLE="text-align: justify; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Order
                                         of Precedence</B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 22.5pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 22.5pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">All
terms and provisions set forth in the Agreement (except to the extent expressly modified herein) are hereby incorporated herein
by reference. This Letter intends to supplement the Agreement and should not be interpreted to amend or replace any provisions
therein. Notwithstanding the above, To the extent that the terms set forth in this Letter are inconsistent with the terms of the
Agreement, the terms set forth herein shall apply.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>[Signature
page to follow]</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 5 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Please
signify Aptorum, Covar and Dr. Chow acceptance of the above terms and conditions by signing and returning to us the enclosed duplicate
copy of this Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Yours
faithfully, &#9;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
and on behalf of&#9;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 40%; text-align: justify; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Aptorum Group Limited</B></FONT></TD>
    <TD STYLE="width: 20%; padding-right: 0">&nbsp;</TD>
    <TD STYLE="width: 40%; text-align: justify; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Videns Incorporation Limited</B></FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify; padding-right: 0">&nbsp;</TD>
    <TD STYLE="padding-right: 0">&nbsp;</TD>
    <TD STYLE="text-align: justify; padding-right: 0">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify; border-bottom: Black 1.5pt solid; padding-right: 0">/s/ HUEN Chung Yuen Ian</TD>
    <TD STYLE="padding-right: 0">&nbsp;</TD>
    <TD STYLE="text-align: justify; border-bottom: Black 1.5pt solid; padding-right: 0">/s/ LUI Darren</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left; padding-right: 0"><FONT STYLE="font-size: 10pt">Name: HUEN Chung Yuen Ian</FONT></TD>
    <TD STYLE="padding-right: 0">&nbsp;</TD>
    <TD STYLE="text-align: left; padding-right: 0"><FONT STYLE="font-size: 10pt">Name: LUI Darren</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left; padding-right: 0"><FONT STYLE="font-size: 10pt">Position: Director &amp; CEO</FONT></TD>
    <TD STYLE="padding-right: 0">&nbsp;</TD>
    <TD STYLE="text-align: left; padding-right: 0"><FONT STYLE="font-size: 10pt">Position: Director</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left; padding-right: 0"><FONT STYLE="font-size: 10pt">Date: 14 Dec 2017</FONT></TD>
    <TD STYLE="padding-right: 0">&nbsp;</TD>
    <TD STYLE="text-align: left; padding-right: 0"><FONT STYLE="font-size: 10pt">Date: 14 Dec 2017</FONT></TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Agreed
on behalf of</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 40%; text-align: justify; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Covar Pharmaceuticals Incorporated</B></FONT></TD>
    <TD STYLE="width: 20%; padding-right: 0">&nbsp;</TD>
    <TD STYLE="width: 40%; text-align: justify; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Dr. Kwok Chow</B></FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify; padding-right: 0">&nbsp;</TD>
    <TD STYLE="padding-right: 0">&nbsp;</TD>
    <TD STYLE="text-align: justify; padding-right: 0">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify; border-bottom: Black 1.5pt solid; padding-right: 0">/s/ Kwok Chow</TD>
    <TD STYLE="padding-right: 0">&nbsp;</TD>
    <TD STYLE="text-align: justify; border-bottom: Black 1.5pt solid; padding-right: 0">/s/ Kwok Chow</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left; padding-right: 0"><FONT STYLE="font-size: 10pt">Name: Kwok Chow, Ph.D.</FONT></TD>
    <TD STYLE="padding-right: 0">&nbsp;</TD>
    <TD STYLE="text-align: left; padding-right: 0"><FONT STYLE="font-size: 10pt">Name: Dr. Kwok Chow </FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left; padding-right: 0"><FONT STYLE="font-size: 10pt">Position: President</FONT></TD>
    <TD STYLE="padding-right: 0">&nbsp;</TD>
    <TD STYLE="text-align: left; padding-right: 0"><FONT STYLE="font-size: 10pt">Date: Dec 15, 2017</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left; padding-right: 0"><FONT STYLE="font-size: 10pt">Date: Dec 15, 2017</FONT></TD>
    <TD STYLE="padding-right: 0">&nbsp;</TD>
    <TD STYLE="text-align: left; padding-right: 0">&nbsp;</TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 6 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>Annex</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>Service
Agreement<BR>
</U></B></FONT></P>




<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 7 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>SERVICE
AGREEMENT</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>THIS
SERVICE AGREEMENT </B>(this &ldquo;Agreement&rdquo;) is entered into as of May 15, 2017 by and between Covar Pharmaceuticals Incorporated,
a Corporation having its principal place of business located at 5276 Champlain Trail, Mississauga, Ontario, Canada (the &ldquo;Consultant&rdquo;),
and <B>Videns Incorporation Limited </B>(and associated companies), a company having its correspondence address at Unit B, 17/F,
Guangdong Investment Tower, 148 Connaught Road Central, Hong Kong (the &ldquo;Corporation&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>W
I T N E S S E T H :</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.45in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.45in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>WHEREAS
</B>the Corporation desires to engage the services of Consultant, and Consultant is willing to render services to the Corporation,
each upon the terms and conditions herein set forth.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.45in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.45in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>NOW,
THEREFORE, </B>in consideration of the mutual promises set forth herein and other good and valuable consideration, the receipt
and sufficiency of which are hereby acknowledged, the parties hereto agree as follows:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0%"></TD><TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>1.</B></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>SERVICES</B></FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.65in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Consultant
shall be engaged as &ldquo;Product and Clinical Development Advisor&rdquo; of the Corporation.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.65in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.65in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Consultant
shall be available to perform and shall perform for the Corporation the development of contrast agents (including, but not limited
to, Curcumin Conjugated Magnetic Nanoparticles (CCMN)) for MRI imaging applicable to the human brain (the &ldquo;Program&rdquo;).
Examples of the services shall include, but are not limited to, the following:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Program
Management Services</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.45in; text-indent: -0.2in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in; padding-right: 0"></TD><TD STYLE="width: 0.2in; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Lead
                                         and support strategic planning to complete a Phase I (First Time in Humans [FTIH]) clinical
                                         study and, where possible, proof of concept clinical studies</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.45in; text-indent: -0.2in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in; padding-right: 0"></TD><TD STYLE="width: 0.2in; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Project
                                         Plan Development</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.7in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.7in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">o&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;High
level strategic plan and timeline</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.7in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">o&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Detailed
plan, timeline and budget</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.7in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in; padding-right: 0"></TD><TD STYLE="width: 0.2in; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Project
                                         Management</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.7in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.7in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">o&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Set
goals and define responsibilities of team members</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.7in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">o&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Coordinate
core project team meetings</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.7in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">o&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Attend,
coordinate and support functional project team meetings if required</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.7in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">o&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Review
and update of project plan and budget at regular intervals or as required</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.7in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">o&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Follow
up action items with team members</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.7in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">o&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Risk
assessment and mitigation strategies</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 8 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>




<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.15in; padding-right: 0"></TD><TD STYLE="width: 0.2in; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Provide
                                         development services or support and identify outsourcing to service providers for services
                                         including, but not limited to:</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.6in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.6in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">o&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Preclinical
(non-clinical) toxicology studies</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.6in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">o&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;ADME</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.6in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">o&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Functional
ingredient sourcing/qualification/characterization/supplier site auditing</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.6in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">o&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Excipient
sourcing/qualification/characterization/supplier site auditing</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.6in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">o&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Clinical
trial batches (CTM batches) manufacturer</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.6in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">o&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;GLP/GMP
testing laboratories</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.6in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.15in; padding-right: 0"></TD><TD STYLE="width: 0.2in; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Evaluate
                                         service providers including preparation of &ldquo;Request for Proposal&rdquo; details,
                                         reference checks, auditing, evaluation of proposals, recommendations and contract negotiation.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.1in 0pt 0.35in; text-align: justify; text-indent: -0.2in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.15in; padding-right: 0"></TD><TD STYLE="width: 0.2in; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Recruit
                                         experts to support the development program for strategic planning, protocol development,
                                         regulatory document preparation and filing, preclinical studies, material characterization
                                         and CMC development.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.15in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.15in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Technical
Services by Consultant or Contractors</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.1in 0pt 0.35in; text-align: justify; text-indent: -0.2in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.15in; padding-right: 0"></TD><TD STYLE="width: 0.2in; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Develop
                                         feasible, regulatory compliant manufacturing process for toxicology and clinical batches</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.35in; text-align: justify; text-indent: -0.2in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.15in; padding-right: 0"></TD><TD STYLE="width: 0.2in; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Develop
                                         regulatory acceptable method to characterize the contrast agents (including CCMN)</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.1in 0pt 0.35in; text-align: justify; text-indent: -0.2in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.15in; padding-right: 0"></TD><TD STYLE="width: 0.2in; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Develop
                                         method of administration of contrast agents (including CCMN) to animals for pre-clinical
                                         studies and to humans for FTIH</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.1in 0pt 0.35in; text-align: justify; text-indent: -0.2in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.15in; padding-right: 0"></TD><TD STYLE="width: 0.2in; padding-right: 0">&#9679;</TD><TD STYLE="text-align: justify; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Develop
                                         sufficiently stable contrast agents (including CCMN) formulation if required. For example,
                                         stabilizer(s) for nanoparticles may be added or lyophilization excipients may be included
                                         in the formulation</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.1in 0pt 0.35in; text-align: justify; text-indent: -0.2in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.15in; padding-right: 0"></TD><TD STYLE="width: 0.2in; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Source
                                         or fabricate (if needed by contractor) equipment for the manufacture of the pre-clinical/toxicology
                                         or clinical batches</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.1in 0pt 0.35in; text-align: justify; text-indent: -0.2in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.15in; padding-right: 0"></TD><TD STYLE="width: 0.2in; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Develop
                                         and qualify suitable physical and/or chemical testing methods suitable for GLP or GMP
                                         product characterization or release</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.35in; text-align: justify; text-indent: -0.2in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.15in; padding-right: 0"></TD><TD STYLE="width: 0.2in; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Develop
                                         and qualify stability-indicating physical and chemical testing methods</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.35in; text-align: justify; text-indent: -0.2in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.15in; padding-right: 0"></TD><TD STYLE="width: 0.2in; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Technology
                                         transfer for CTM manufacturing site</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.35in; text-align: justify; text-indent: -0.2in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.15in; padding-right: 0"></TD><TD STYLE="width: 0.2in; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Support
                                         definition of animal and FTIH dosing ranges</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.35in; text-align: justify; text-indent: -0.2in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.15in; padding-right: 0"></TD><TD STYLE="width: 0.2in; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Support
                                         or perform audits to qualify contractors</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.35in; text-align: justify; text-indent: -0.2in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.15in; padding-right: 0"></TD><TD STYLE="width: 0.2in; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Coordinate
                                         the preparation of documentation for regulatory submission</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 9 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Consultant
shall perform such services at such times and such places as may be reasonably designated by:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mr
Ian Huen</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dr
Owen Ko</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mr
Kenrick Fok</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mr
Darren Lui</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Professor
Thomas Lee</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dr
Vincent Mok</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Corporation retains the right to amend the list of authorized individuals above at any time by written notification to the Consultant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Consultant
shall perform such services in a manner consistent with industry standards for similar professional consulting work. Upon mutual
agreement and under the request of the Corporation, Consultant may need to travel from time to time to perform the services described
herein.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0%"></TD><TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>2.</B></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>COMPENSATION</B></FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
consideration of Consultant&rsquo;s performance of the consulting services described above, the Corporation shall compensate Consultant
based on:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0; padding-right: 0"></TD><TD STYLE="width: 0.25in; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT></TD><TD STYLE="text-align: justify; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
                                         fixed fee approach with a defined scope to be agreed between the Consultant and the Corporation
                                         for each critical study, project or milestone;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0; padding-right: 0"></TD><TD STYLE="width: 0.25in; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT></TD><TD STYLE="text-align: justify; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
                                         all other circumstances, the hourly rate of its employees who perform the services. Both
                                         Mr. Austin Freedman, Dr. Kwok Chow and technical and supporting staff at the Consultant
                                         company will provide the technical services. The Consultant may bring qualified external
                                         consultants with the Corporation&rsquo;s agreement to support the Program. Austin Freedman
                                         shall provide his services at an hourly rate of USD $150 per hour; Dr. Kwok Chow shall
                                         provide technical and consulting services, including pharmaceutical and analytical development
                                         services, at an hourly rate of USD $200 per hour. The technical and supporting staff
                                         will provide services at an hourly rate of USD $65 to $100 per hour depending on their
                                         backgrounds and experience. The fee for external consulting will be determined on a case
                                         by case basis with prior Corporation approval.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Both
parties agree that:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0; padding-right: 0"></TD><TD STYLE="width: 0.25in; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT></TD><TD STYLE="text-align: justify; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mr.
                                         Austin Freedman, Executive Director, Cover Pharmaceuticals Incorporated, will provide
                                         the lead program management services for the Project;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0; padding-right: 0"></TD><TD STYLE="width: 0.25in; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)</FONT></TD><TD STYLE="text-align: justify; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dr.
                                         Kwok Chow, President, Cover Pharmaceuticals Incorporated, will also provide program management
                                         support when needed.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 10 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>




<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0; padding-right: 0"></TD><TD STYLE="width: 0.5in; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>3.</B></FONT></TD><TD STYLE="padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>EXPENSES</B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Corporation shall reimburse Consultant for all direct out-of-pocket expenses of Consultant actually and reasonably incurred in
connection with the performance of Consultant&rsquo;s obligations under this Agreement insofar as such expenses relate to travel
expenses, third party payments and other reasonable expenses, provided that such expenses are specifically approved in advance
in writing by the Corporation.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0; padding-right: 0"></TD><TD STYLE="width: 0.5in; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>4.</B></FONT></TD><TD STYLE="padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>RECORDS
                                         AND REPORTS </B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>4.1.</B></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Books
and Records</B></FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Consultant
shall maintain books and records adequate for the determination of all services rendered, expenses and other data, which shall
be available for inspection by the Corporation through its agents or representatives during normal working hours as the Corporation
shall reasonably request.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>4.2.</B></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Payment
of Invoices</B></FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Consultant
shall submit invoices to the Corporation within ten (10) days after the end of each calendar month during the term of this Agreement,
specifying in reasonable detail the nature and extent of the services performed by Consultant for the preceding month, and the
amount of expenses incurred by Consultant which are subject to reimbursement by the Corporation in accordance with <B>Article
3</B>. The Corporation shall remit payment for all such compensation and expenses in the amounts called for by this Agreement
within 30 days after receipt of such invoices.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
retainer fee of USD $10,000 will be provided by the Corporation upon execution of this Agreement and the retainer fee will be
deducted from the last payment upon termination of the Agreement or completion of the Program. Any remaining funds, if any, will
be refunded.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Consultant will provide the Corporation a quotation with estimated time and cost for individual service items exceeding USD $10,000
for approval before execution.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>4.3.</B></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Monthly
Status Reports</B></FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Upon
request by the Corporation, Consultant shall prepare and submit to the Corporation on a monthly basis a status report setting
forth a summary of Consultant&rsquo;s activities and progress during the preceding month with respect to the matters set forth in Article
1.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0; padding-right: 0"></TD><TD STYLE="width: 0.5in; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>5.</B></FONT></TD><TD STYLE="padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>TERM
                                         AND TERMINATION</B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>5.1.</B></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Term</B></FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Subject
to the termination provisions set forth in <B>Article 5.2, </B>this Agreement shall have an initial term of 12 months,
commencing on the date this agreement is executed, which term </FONT>may be automatically renewable for another 12 months,
and thereafter extended from time to time by the mutual written agreement of Consultant and the Corporation.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B></B></FONT></P>

<!-- Field: Page; Sequence: 11 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>5.2.</B></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Termination
and Actions Thereafter</B></FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.35in; text-align: justify; text-indent: -0.3in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT></TD><TD STYLE="text-align: justify; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
                                         Agreement may be terminated by the Corporation by written notice to Consultant at any
                                         time upon (i) Consultant&rsquo;s permanent disability or incapacity to perform services hereunder;
                                         or (ii) a breach by Consultant of any of the provisions of this Agreement.</FONT></TD></TR>
<TR STYLE="vertical-align: top">
<TD STYLE="padding-right: 0">&nbsp;</TD><TD STYLE="text-align: justify; padding-right: 0">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
<TD STYLE="padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT></TD><TD STYLE="text-align: justify; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Either
                                         party may, at any time and with or without cause, terminate this Agreement upon written
                                         notice to the other party given not less than fifteen (15) days prior to such termination.
                                         Such notice shall specify the effective date of termination for all purposes hereunder.</FONT></TD></TR>
<TR STYLE="vertical-align: top">
<TD STYLE="padding-right: 0">&nbsp;</TD><TD STYLE="text-align: justify; padding-right: 0">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
<TD STYLE="padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)</FONT></TD><TD STYLE="text-align: justify; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Upon
                                         termination or expiration of this Agreement, Consultant (or his representatives) shall
                                         promptly submit to the Corporation an invoice covering all unbilled compensation and
                                         expenses to date, together with an estimate of the compensation and expenses that would
                                         be chargeable to the Corporation if any particular services for work then in progress
                                         were to be completed by Consultant. Except in the case of termination under <B>Article5.2(a)(i),
                                         </B>upon request by <B>the </B>Corporation (but not otherwise) Consultant shall complete
                                         such work in progress as the Corporation shall designate, and this Agreement shall in
                                         such case be deemed extended until such work is completed and paid for. The Corporation
                                         shall pay Consultant for any services performed to and including the date of termination
                                         in accordance with the provisions for compensation set forth in <B>Articles 2 </B>and
                                         <B>3.</B></FONT></TD></TR>
<TR STYLE="vertical-align: top">
<TD STYLE="padding-right: 0">&nbsp;</TD><TD STYLE="text-align: justify; padding-right: 0">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
<TD STYLE="padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)</FONT></TD><TD STYLE="text-align: justify; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                         provisions of <B>Articles 7 </B>and <B>8 </B>shall survive expiration or termination
                                         of this Agreement for any reason whatsoever.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.05in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0%"></TD><TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>6.</B></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>RELATIONSHIP
OF THE PARTIES</B></FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>6.1.</B></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Independent
Status</B></FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.05in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.05in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
relationship of Consultant to the Corporation hereunder shall be that of an independent contractor, Nothing in this Agreement
is intended or shall be construed to constitute Consultant an employee, agent or partner of the Corporation nor shall Consultant
have authority to bind the Corporation in any respect. The Corporation shall not be liable for any act or omission of Consultant
or his employees or agents, and Consultant agrees to indemnify and hold harmless the Corporation from any and all losses, damages,
costs and expenses (including attorneys&rsquo; fees) in any manner resulting from or arising out of any such act or omission or any
breach of Consultant&rsquo;s obligations under this Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>6.2.</B></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Services
for Third Parties</B></FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.05in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.05in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Nothing
in this Agreement shall be construed to prevent Consultant from concurrently providing services to persons other than the Corporation,
subject to the limitations set forth in <B>Articles 7 </B>and <B>8.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 12 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>6.3.</B></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Certain
Tax Matters</B></FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Consultant
shall not be treated as an employee for tax purposes with respect to the services performed pursuant to this Agreement. Consultant
shall be responsible for the filing of all necessary income tax returns and the payment of all taxes required by law. Consultant
acknowledges that he understands his tax obligations.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>6.4.</B></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Disclosure
of Consultant Relationship by Corporation</B></FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Subject
to article 6.1 above, the Corporation may include and disclose, for example, in its corporate presentations, marketing materials,
due diligence related documentation to third parties, the credentials and advisory role of the Consultant and its employees (for
example, Dr Kwok Chow and Mr. Austin Freedman). On this basis, the Corporation will seek the Consultant&rsquo;s approval prior to such
inclusion.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0%"></TD><TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>7.</B></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>RESTRICTIVE
COVENANTS</B></FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>7.1.</B></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Confidential
Information</B></FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Unless
authorized or instructed in writing by the Corporation, Consultant shall not, during or at any time after the term of this Agreement
except as required in the conduct of the Corporation&rsquo;s business, disclose to others, or use, or permit to be disclosed to others
or used, any of the Corporation&rsquo;s inventions, discoveries, works, ideas, information, knowledge or data (whether in oral, written,
or machine-readable form) which Consultant may develop or obtain during the course of or in connection with Consultant&rsquo;s engagement,
including such inventions, discoveries, works, ideas, information, knowledge, or data relating to machines, equipment, products,
systems, software, research and/or development, designs, compositions, formulae, processes, manufacturing procedures, business
methods, present and prospective customers of the Corporation, business dealings with such customers, prospective marketing, promotion,
sales and advertising programs and strategies, and agreements with representatives or prospective representatives of the Corporation,
present or prospective sources of supply or any other business arrangements of the Corporation, including but not limited to customers,
customer lists, costs, prices and earnings, whether or not developed by Consultant, by others in the Corporation or obtained by
the Corporation from third parties, and irrespective of whether or not such inventions, discoveries, works, ideas, information,
knowledge or data have been identified by the Corporation as secret or confidential, unless and until, and then to the extent
and only to the extent that, such inventions, discoveries, works, ideas, information, knowledge or data become available to the
public otherwise than by Consultant&rsquo;s act or omission. All inventions, discoveries, works, ideas, information, knowledge, and
data described or referred to in this <B>Article 7.1</B> are referred to herein collectively as &ldquo;Confidential Information&rdquo;.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>7.2.</B></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Essence
of Agreement</B></FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Consultant
acknowledges (i) that the use, misappropriation or disclosure of the Confidential Information (as defined in <B>Article7.1</B>)
would constitute a breach of trust and cause irreparable injury to the Corporation, (ii) that all such Confidential
Information is the property of the Corporation and (iii) that it is essential to the protection of the Corporation&rsquo;s
goodwill and to the maintenance of the Corporation&rsquo;s competitive position that the Confidential Information be kept
secret and that the Confidential Information not be disclosed by Consultant to others or used by Consultant to
Consultant&rsquo;s own advantage or the advantage of others. Consultant further acknowledges that Consultant&rsquo;s
agreement to the provisions of this <B>Article 7 </B>and the enforceability of such provisions against Consultant are an
essential element of this Agreement and that, absent such provisions and the enforceability thereof, the Corporation would
not (a) engage Consultant nor (b) permit Consultant access to and use of Confidential Information.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B></B></FONT></P>

<!-- Field: Page; Sequence: 13 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>7.3.</B></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Non-solicitation/Noncompetition</B></FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Consultant
further recognizes and acknowledges that it is essential for the proper protection of the business of the Corporation that Consultant
be restrained (a) from soliciting or inducing any employee of the Corporation to leave the employ of the Corporation, (b) from
hiring or attempting to hire any employee of the Corporation, (c) from soliciting the business of the customers (actual or potential)
and suppliers of the Corporation for any business purpose, and (d) from competing against the Corporation, including, but not
limited to, provides services relating to generic drug development to any third party in China.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>7.4.</B></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Ability
to Earn Livelihood</B></FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Consultant
represents that his experience and capabilities are such that the provisions of this <B>Article 7 </B>will not prevent him from
earning his livelihood, and acknowledges that it would cause the Corporation serious and irreparable injury and cost if Consultant
were to use his ability and knowledge in competition with the Corporation or to otherwise breach the obligations contained in
<B>Article 7.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0%"></TD><TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>8.</B></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>PROPRIETARY
RIGHTS</B></FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>8.1.</B></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Assignment
of Rights</B></FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.15in 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
the term of this Agreement, the Corporation hereby grants to the Consultant, a non-exclusive, paid-up, royalty-free, non-transferable
license of Client&rsquo;s Intellectual Property which the Consultant must use in order to perform the Services.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">All
Intellectual Property generated or derived by the Consultant in the course of performing the Services, to the extent it is specific
to the development. manufacture, use and sale of the Client&rsquo;s Product that is the subject of the Services, will be the exclusive
property of the Corporation.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">All
Intellectual Property generated or derived by the Consultant while performing the Services which is not specific to, or dependent
upon, the Corporation&rsquo;s Product and which has application to manufacturing processes or formulation development of pharmaceutical
products or pharmaceutical delivery systems will be the exclusive property of the Consultant. The Consultant hereby grants to
the Corporation, a non-exclusive, paid-up, royalty-free, transferable license of the Intellectual Property which the Corporation
may use for the manufacture of Client&rsquo;s Product.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 14 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>8.2.</B></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Return
of Materials</B></FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.05in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.05in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Upon
expiration or termination of this Agreement, Consultant agrees to return to the Corporation all computer software, computer programs,
source codes, object codes, magnetic tapes, printouts, designs, proposals, samples, notes, records, reports, documents, customer
and prospective customer lists, memoranda, plans, blue prints, correspondence, proposals, drawings, letters, flow-charts, manuals,
strategies, techniques, photographs, catalogs and writings and all copies thereof, directly or indirectly, related to, or developed,
prepared or created during, Consultant&rsquo;s engagement by the Corporation and, without limiting the foregoing, Consultant shall promptly
deliver to the Corporation any and all documents or materials constituting or, directly or indirectly, relating to any Confidential
Information. The Corporation may withhold Consultant&rsquo;s outstanding compensation against return of these materials and any other
materials of the Corporation or its customers.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.05in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0%"></TD><TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>9.</B></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>REPRESENTATIONS
AND WARRANTIES BY CONSULTANT</B></FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.05in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.05in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Consultant
represents and warrants to the Corporation that neither the execution and delivery of this Agreement nor the carrying out of any
of the transactions contemplated hereby will in any respect result in any violation of or be in conflict with any term or provision
of any agreement, document or instrument to which Consultant is a party or by which he is bound. Consultant further represents
and warrants to the Corporation that he has furnished the Corporation with copies of all such agreements, documents or instruments
to which Consultant is a party or by which he is bound. Consultant agrees not to divulge to the Corporation any information which
would violate any such agreement, document or instrument, nor to divulge to the Corporation any trade secrets of prior employers
or contracting parties.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.05in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0%"></TD><TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>10.</B></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>MISCELLANEOUS</B></FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>10.1.</B></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Additional
Actions and Documents</B></FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.05in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.05in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Each
of the parties hereto hereby agrees to take or cause to be taken such further actions, to execute, deliver and file or cause to
be executed, delivered and filed such further documents, and will obtain such consents, as may be necessary or as may be reasonably
requested in order to fully effectuate the purposes, terms and conditions of this Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>10.2.</B></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Assignment</B></FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.05in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.05in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Consultant
shall not assign his rights and obligations under this agreement, in whole or in part, whether by operation of law or otherwise,
without the prior written consent of the Corporation, and any such assignment contrary to the terms hereof shall be null and void
and of no force and effect.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>10.3.</B></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Entire
Agreement; Amendment</B></FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.05in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.05in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
Agreement constitutes the entire agreement between the parties hereto with respect to the transactions contemplated herein,
and it supersedes all prior oral or written agreements, commitments or understandings with respect to the matters provided
for herein. No amendment, modification or discharge of this Agreement shall be valid or binding unless set forth in </FONT>writing
and duly executed and delivered by the party against whom enforcement of the amendment, modification, or discharge is
sought.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B></B></FONT></P>

<!-- Field: Page; Sequence: 15 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>10.4.</B></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Waiver</B></FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">No
delay or failure on the part of any party hereto in exercising any right, power or privilege under this Agreement or under any
other documents furnished in connection with or pursuant to this Agreement shall impair any such right, power or privilege or
be construed as a waiver of any default or any acquiescence therein. No single or partial exercise of any such right, power or
privilege shall preclude the further exercise of such right, power or privilege, or the exercise of any other right, power or
privilege. No waiver shall be valid against any party hereto unless made in writing and signed by the party against whom enforcement
of such waiver is sought and then only to the extent expressly specified therein.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>10.5.</B></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Governing
Law</B></FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
Agreement, the rights and obligations of the parties hereto, and any claims or disputes relating thereto, shall be governed by
and construed in accordance with the laws of Ontario, excluding the choice of law rules thereof).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>10.6.</B></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Notices</B></FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">All
notices, demands, requests, or other communications that may be or are required to be given, served, or sent by any party to any
other party pursuant to this Agreement shall be in writing and shall be hand delivered, sent by overnight courier or mailed by
first-class, registered or certified mail, return receipt requested, postage prepaid, or transmitted by telegram, telecopy or
telex, to the addresses indicated at the beginning of this agreement for each party.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Each
party may designate by notice in writing a new address to which any notice, demand, request or communication may thereafter be
so given, served or sent. Each notice, demand, request, or communication that shall be hand delivered, sent, mailed, telecopied
or telexed in the manner described above, or that shall be delivered to a telegraph Corporation, shall be deemed sufficiently
given, served, sent, received or delivered for all purposes at such time as it is delivered to the addressee (with the return
receipt, the delivery receipt, or (with respect to a telecopy or telex) the answerback being deemed conclusive, but not exclusive,
evidence of such delivery) or at such time as delivery is refused by the addressee upon presentation.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>10.7.</B></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Execution
in Counterparts</B></FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">To
facilitate execution, this Agreement may be executed in as many counterparts as may be required. It shall not be necessary that
the signatures of, or on behalf of, each party, or that the signatures of all persons required to bind any party, appear on each
counterpart; but it shall be sufficient that the signature of, or on behalf of, each party, or that the signatures of the persons
required to bind any party, appear on one or more of the counterparts. Ail counterparts shall collectively constitute a single
agreement. It shall not be necessary in making proof of this Agreement to produce or account for more than a number of counterparts
containing the respective signatures of, or on behalf of, all of the parties hereto.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>




<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>10.8.</B></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Limitation
on Benefits</B></FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>




<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
covenants, undertakings and agreements set forth in this Agreement shall be solely for the benefit of, and shall be enforceable
only by, the parties hereto and their respective successors, heirs, executors, administrators, legal representatives and permitted
assigns.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>10.9.</B></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Binding
Effect</B></FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Subject
to any provisions hereof restricting assignment, this Agreement shall be binding upon and shall inure to the benefit of the parties
hereto and their respective successors, heirs, executors, administrators, legal representatives and assigns.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B></B></FONT></P>

<!-- Field: Page; Sequence: 16 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>IN
WITNESS WHEREOF, </B>the Corporation has caused this Agreement to be executed by its duly authorized officer and Consultant has
hereunto set his hand as of the date first above written.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Videns
Incorporation Limited</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 4%; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 36%; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 20%; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 5%; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 35%; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="padding: 0; text-indent: 0; border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/
    Ian Huen</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date:</FONT></TD>
    <TD STYLE="padding: 0; text-indent: 0; border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">May
    31, 2017</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name: Ian
    Huen</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title: &nbsp;Chief
    Executive Officer</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;<B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Covar
Pharmaceuticals Incorporated</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 4%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="width: 36%; padding: 0; text-indent: 0; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/
    Kwok Chow</FONT></TD>
    <TD STYLE="width: 20%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 5%"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Date:</FONT></TD>
    <TD STYLE="width: 35%; padding: 0; text-indent: 0; border-bottom: Black 1.5pt solid">May 25, 2017</TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name: Kwok
    Chow, Ph.D.</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title: &nbsp;&nbsp;President</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="padding: 0; text-indent: 0"></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Page
17</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B></B></FONT></P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 0; margin-bottom: 0"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.37
<SEQUENCE>41
<FILENAME>ff12018ex10-37_aptorum.htm
<DESCRIPTION>APPOINTMENT LETTER AND ADDENDUM TO SERVICE AGREEMENT WITH COVAR PHARMACEUTICALS INCORPORATED AND MR. AUSTIN FREEDMAN DATED DECEMBER 26, 2017
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right; color: Red"><FONT STYLE="color: Black"><B>Exhibit
10.37</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><IMG SRC="ex10-37_01.jpg" ALT=""></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Aptorum
Group Limited</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">-17/F
Guangdong Investment Tower, 148 Connaught Road Central, Hong Kong</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">Tel:
(852) 2117 6611 &#9679; Fax: (852) 2850 7286</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Covar
Pharmaceuticals Incorporated</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5276
Champlain Trail</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mississauga,
ON L5R 2Y9</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Canada</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mr.
Austin Freedman</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">261
Aberdeen Avenue</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Woodbridge,
ON L4L 1C5</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Canada</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Appointment
Letter and Addendum to Service Agreement</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Whereas,
</B>Videns Incorporated Limited (&ldquo;<B>Videns</B>&rdquo;), a wholly owned subsidiary of Aptorum Group Limited (&ldquo;<B>Aptorum</B>&rdquo;),
(together with its affiliates and subsidiaries, &ldquo;<B>Group</B>&rdquo;), have entered into a Service Agreement with Covar
Pharmaceuticals Incorporated (&ldquo;<B>Covar</B>&rdquo;) on May 15, 2017 (&ldquo;<B>Agreement</B>&rdquo;) (the Agreement is attached
herein as <U>Annex A</U>);</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Whereas,
</B>under the Agreement, Videns would engage Covar to develop certain contrasting agents (including, but not limited to, Curcumin
Conjugated Magnetic Nanoparticles (CCMN) for MRI imaging applicable to the human brain (&ldquo;<B>Original Service Scope</B>&rdquo;);</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; color: red"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Whereas,
</B>under the Agreement, Mr. Freedman has been enlisted to provide certain program management services and technical services
in relation to the Original Service Scope;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Whereas,
</B>beginning from August 1, 2017, the services provided by Covar and Mr. Freedman had expanded beyond the Original Service Scope
as they began to advise on other research and development projects of the Group;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Whereas,
</B>given the contribution of Mr. Freedman to other research and development projects of the Group, Aptorum would like to issue
this appointment letter and addendum to service agreement (&ldquo;<B>Letter</B>&rdquo;) to expand the Original Service Scope of
the Agreement and to appoint Mr. Freedman to the position of &ldquo;Senior Clinical Development Manager&rdquo; of Aptorum, effective
retroactive to August 1, 2017;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Whereas,
</B>Dr. Chow is willing to accept such appointment, given that the arrangement that his services under this Letter will be engaged
through Covar and will be under the terms set out in the Agreement and this Letter.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; color: #555555"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; color: #555555"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 1; Options: NewSection -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; color: #555555"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; color: #555555"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>NOW,
THEREFORE, </B>in consideration of the mutual promises set forth herein and other good and valuable consideration, the receipt
and sufficiency of which are hereby acknowledged, the parties hereto agree as follows:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 21.3pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>1.</B></FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Aptorum
                                         and the Group</B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 21.3pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Group focuses on the licensing of, and acquisition of early stage preclinical assets with the intention to engage in drug research,
development, and commercialization purposes. Assets are acquired via open and public platforms such as the technology transfer
offices of accredited universities and academic institutions. In addition, the Group seeks to be a facilitator across the financing
spectrum for biotech companies, entrepreneurs, and commercializing agents, to bolster innovations adding value to health care
needs in the market place; and to assist in furthering the research capabilities of institutions the Group works with.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 21.3pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>2.</B></FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Appointment
                                         of Position</B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 22.5pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Aptorum
hereby offers, and Mr. Freedman hereby accept, the position of &ldquo;Senior Clinical Development Manager&rdquo; of Aptorum (&ldquo;<B>Position</B>&rdquo;).
As a Senior Clinical Development Manager, Mr. Freedman will provide certain consultancy, advisory, and management services to
Aptorum through correspondence and man-hours set out herein.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 21.3pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 21.3pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>3.</B></FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Scope
                                         of Services for Position</B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 54.3pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 21.3pt; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 33pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mr.
                                         Freedman&rsquo;s duties are limited to the following services:</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I><U>Program
Management Services:</U></I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 54pt; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 27pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Lead
                                         and support strategic planning to complete a Phase I (First Time in Humans (&ldquo;<B>FTIH</B>&rdquo;)
                                         clinical study and, where possible, proof of concept clinical studies.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 54pt; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 27pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Project
                                         Plan Development, including:</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 81pt; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 13.5pt; font: 10pt Times New Roman, Times, Serif">&#9679;<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">High
                                         level strategic plan and timeline; and</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 81pt; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 13.5pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Detailed
                                         plan, timeline and budget.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 54pt; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 27pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Project
                                         Management, including:</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 81pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 81pt; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 13.5pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Set
                                         goals and define responsibilities of team members;</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 81pt; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 13.5pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Coordinate
                                         core project team meetings;</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 81pt; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 13.5pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Attend,
                                         coordinate and support functional project team meetings if required;</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 81pt; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 13.5pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Review
                                         and update of project plan and budget at regular intervals or as required;</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 81pt; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 13.5pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Follow
                                         up action items with team members; and</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 81pt; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 13.5pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Risk
                                         assessment and mitigation strategies.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 54pt; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 27pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iv)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Provide
                                         development services or support and identify outsourcing to service providers for services
                                         including, but not limited to:</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 81pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 81pt; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 13.5pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Preclinical
                                         (non-clinical) toxicology studies;</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 81pt; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 13.5pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ADME;</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 81pt; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 13.5pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Functional
                                         ingredient sourcing / qualification / characterization / supplier site auditing;</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 81pt; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 13.5pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Excipient
                                         sourcing/qualification/characterization/supplier site auditing;</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 81pt; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 13.5pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Clinical
                                         trial batches (CTM batches) manufacturer; and</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 81pt; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 13.5pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">GLP/GMP
                                         testing laboratories.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: -0.25in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: -0.25in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: -0.25in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 54pt; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 27pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(v)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Evaluate
                                         service providers including preparation of &ldquo;Request for Proposal&rdquo; details,
                                         reference checks, auditing, evaluation of proposals, recommendations and contract negotiation.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 81pt; text-align: justify; text-indent: -27pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 54pt; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 27pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(vi)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Recruit
                                         experts to support the development program for strategic planning, protocol development,
                                         regulatory document preparation and filing, preclinical studies, material characterization
                                         and CMC development.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 58.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I><U>Technical
Services: </U></I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 58.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 57pt; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 24pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Develop
                                         feasible, regulatory compliant manufacturing process for toxicology and clinical batches.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 81pt; text-align: justify; text-indent: -24pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 57pt; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 24pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Develop
                                         regulatory acceptable method to characterize the contrast agents.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 81pt; text-align: justify; text-indent: -24pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 57pt; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 24pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Develop
                                         method of administration of contrast agents to animals for preclinical studies and to
                                         humans for FTIH.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 81pt; text-align: justify; text-indent: -24pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 57pt; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 24pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iv)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Develop
                                         sufficiently stable contrast agents formulation if required. For example, stabilizer(s)
                                         for nanoparticles may be added or lyophilization excipients may be included in the formulation.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 57pt; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 24pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(v)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Source
                                         or fabricate (if needed by contractor) equipment for the manufacture of the preclinical
                                         / toxicology or clinical batches.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 81pt; text-align: justify; text-indent: -24pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 57pt; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 24pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(vi)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Develop
                                         and qualify suitable physical and/or chemical testing methods suitable for GLP or GMP
                                         product characterization or release.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 81pt; text-align: justify; text-indent: -24pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 57pt; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 24pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(vii)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Develop
                                         and qualify stability-indicating physical and chemical testing methods.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 81pt; text-align: justify; text-indent: -24pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 57pt; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 24pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(viii)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Technology
                                         transfer for CTM manufacturing site.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 81pt; text-align: justify; text-indent: -24pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 57pt; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 24pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ix)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Support
                                         definition of animal and FTIH dosing ranges.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 81pt; text-align: justify; text-indent: -24pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 57pt; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 24pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(x)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Support
                                         or perform audits to qualify contractors.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 81pt; text-align: justify; text-indent: -24pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 57pt; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 24pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(xi)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Coordinate
                                         the preparation of documentation for regulatory submission.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 57pt; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 24pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(xii)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Conduct
                                         any other technical services as directed by the Group.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 81pt; text-align: justify; text-indent: -24pt"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 81pt; text-align: justify; text-indent: -24pt"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 21.3pt; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 33pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mr.
                                         Freedman shall advise where necessary, the Executive Board of Directors of the Group.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 54.3pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 54.3pt; text-align: justify"></P>

<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 54.3pt; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 54.3pt; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 21.3pt; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 33pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
                                         Mr. Freedman is not an Executive Director on the Board of Directors for the Group, he
                                         shall not have legal nor professional authority to dictate the commercial decisions of
                                         the Executive Board.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 54.3pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 21.3pt; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 33pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mr.
                                         Freedman shall:</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 54pt; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 27pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">be
                                         responsive to the Group&rsquo;s needs and interests, whereby deliverables to us should
                                         be provided in good faith so that effort and quality is commensurable;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 81pt; text-align: justify; text-indent: -27pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 54pt; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 27pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">observe
                                         and comply with all statutory rules, and regulations where applicable as governed by
                                         the laws of Canada; and</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 81pt; text-align: justify; text-indent: -27pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 54pt; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 27pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">respond
                                         to queries from the Group addressed to him at his earliest convenience.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 21.3pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>4.</B></FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Retroactive
                                         Effectiveness</B></FONT></TD></TR></TABLE>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 22.5pt; text-align: justify; text-indent: -22.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 22.5pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">This
Letter shall be effective retroactive to August 1, 2017 (&ldquo;</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Effective
Date<FONT STYLE="font-weight: normal">&rdquo;), and shall be binding upon all signatories stated in this Letter.</FONT></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 21.3pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>5.</B></FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Service
                                         Fees</B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 22.5pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 22.5pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mr.
Freedman shall provide the services, including pharmaceutical and analytical development services, at an hourly rate of US$200
per hour, or otherwise pre-agreed on a case by case basis by both Aptorum and Covar.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 27pt; text-align: justify; text-indent: -4.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 21.3pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>6.</B></FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Privacy
                                         of Information</B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 28.35pt; text-align: justify; text-indent: -28.35pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 21.3pt; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mr.
                                         Freedman and Covar shall not, except as authorized by the Group or required by his responsibilities,
                                         reveal to any person or company any of the trade secrets or any information concerning
                                         the organization, business, finances, transactions or affairs of the Group which may
                                         come to his knowledge during his contract with the Group and shall keep with complete
                                         secrecy confidential information entrusted to him or his representative(s) and shall
                                         not use or attempt to use any such information in any manner which may injure or cause
                                         loss either directly or indirectly to the Group or may be likely to do so. This restriction
                                         shall continue to apply if and when after the termination of this appointment without
                                         limit in time.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 21.3pt; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mr.
                                         Freedman and Covar shall not either during the period of this appointment or afterwards
                                         use or permit to be used any books, documents, moneys, assets, records or other property
                                         belonging to or relating to any dealings, affair or business of the Group other than
                                         for the benefit of the Group. They shall immediately deliver and return to the Group
                                         all such books, documents, monies, securities, records or other property which they then
                                         have or should have in his possession upon termination of his appointment hereunder.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 21.3pt; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                         Group, however, agrees to provide Mr. Freedman and Covar in good faith with any information
                                         concerning areas of interest and relevance of the Group as required by Mr. Freedman in
                                         order for him to fulfill the aforementioned services for the Group.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 4 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 21.3pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>7.</B></FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Term
                                         and Termination</B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 28.35pt; text-align: justify; text-indent: -28.35pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 22.5pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
appointment of Mr. Freedman by Aptorum shall persist for a period of two (2) years from the Effective Date (&ldquo;<B>Term</B>&rdquo;)
as defined within this Letter. The terms and conditions of this Letter shall remain in effect until expiration of the Term, unless
it is terminated prior to expiration subsequent to the following circumstances:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 28.35pt; text-align: justify; text-indent: -28.35pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 21.3pt; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                         Agreement is terminated;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 54.3pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 21.3pt; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mr.
                                         Freedman is no longer a member or affiliate of Covar;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 21.3pt; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">terminated
                                         by Covar after giving Aptorum no less than two (2) months&rsquo; notice in writing;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 22.5pt; text-align: justify; text-indent: -22.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 21.3pt; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">terminated
                                         by Aptorum immediately after giving written notice to Covar; or</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 21.3pt; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">terminated
                                         by Aptorum without notice or compensation in the event of any dishonesty, fraud, gross
                                         negligence, willful default or refusal to carry out any lawful order or instructions,
                                         or the repeated breach of any rules or regulations of the Group, or those as governed
                                         by the laws of Canada.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 21.3pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Renewal
of this appointment shall be negotiated three months prior to the expiration of the Term, and subject to the mutual consent among
Aptorum, Covar and Mr. Freedman as defined in writing.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 21.3pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>8.</B></FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Order
                                         of Precedence</B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 22.5pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 22.5pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">All
terms and provisions set forth in the Agreement (except to the extent expressly modified herein) are hereby incorporated herein
by reference. This Letter intends to supplement the Agreement and should not be interpreted to amend or replace any provisions
therein. Notwithstanding the above, To the extent that the terms set forth in this Letter are inconsistent with the terms of the
Agreement, the terms set forth herein shall apply.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>[Signature
page to follow]</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 5 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Please
signify Aptorum, Covar and Mr. Freedman acceptance of the above terms and conditions by signing and returning to us the enclosed
duplicate copy of this Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Yours
faithfully, &#9;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
and on behalf of&#9;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B></B></FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 40%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Aptorum Group Limited</B></FONT></TD>
    <TD STYLE="width: 20%; text-align: justify">&nbsp;</TD>
    <TD STYLE="width: 40%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Videns Incorporation Limited</B></FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/ HUEN Chung Yuen Ian</FONT></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/ LUI Darren</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">Name: HUEN Chung Yuen Ian</FONT></TD>
    <TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">Name: LUI Darren</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">Position: Director &amp; CEO</FONT></TD>
    <TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">Position: Director</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">Date: 18/12/2017</FONT></TD>
    <TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">Date: 18/12/2017</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Agreed on behalf of</FONT></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Covar Pharmaceuticals Incorporated</B></FONT></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Mr. Austin Freedman</B></FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/ Kwok Chow</FONT></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/ Austin Freedman</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">Name: Kwok Chow, Ph.D.</FONT></TD>
    <TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">Name: Mr. Austin Freedman </FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">Position: President</FONT></TD>
    <TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">Date: 19 December 2017</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">Date: Dec 26, 2017</FONT></TD>
    <TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 4in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 4in"></P>

<!-- Field: Page; Sequence: 6 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 4in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>Annex</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>Service
Agreement</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 7 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>SERVICE
AGREEMENT</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>THIS
SERVICE AGREEMENT </B>(this &ldquo;Agreement&rdquo;) is entered into as of May 15, 2017 by and between Covar Pharmaceuticals Incorporated,
a Corporation having its principal place of business located at 5276 Champlain Trail, Mississauga, Ontario, Canada (the &ldquo;Consultant&rdquo;),
and <B>Videns Incorporation Limited </B>(and associated companies), a company having its correspondence address at Unit B, 17/F,
Guangdong Investment Tower, 148 Connaught Road Central, Hong Kong (the &ldquo;Corporation&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.95in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>W
I T N E S S E T H :</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.45in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>WHEREAS
</B>the Corporation desires to engage the services of Consultant, and Consultant is willing to render services to the Corporation,
each upon the terms and conditions herein set forth.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.45in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.45in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>NOW,
THEREFORE, </B>in consideration of the mutual promises set forth herein and other good and valuable consideration, the receipt
and sufficiency of which are hereby acknowledged, the parties hereto agree as follows:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.45in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0"></TD><TD STYLE="width: 21.3pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>1.</B></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>SERVICES</B></FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Consultant
shall be engaged as &ldquo;Product and Clinical Development Advisor&rdquo; of the Corporation.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.95in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Consultant
shall be available to perform and shall perform for the Corporation the development of contrast agents (including, but not limited
to, Curcumin Conjugated Magnetic Nanoparticles (CCMN)) for MRI imaging applicable to the human brain (the &ldquo;Program&rdquo;).
Examples of the services shall include, but are not limited to, the following:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.95in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(a)</B></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Program
Management Services</B></FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Lead
                                         and support strategic planning to complete a Phase I (First Time in Humans [FTIH]) clinical
                                         study and, where possible, proof of concept clinical studies</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Project
                                         Plan Development</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">o</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">High
level strategic plan and timeline</FONT></TD>
</TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">o</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Detailed
plan, timeline and budget</FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.7in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.2in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Project
                                         Management</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">o</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Set
goals and define responsibilities of team members</FONT></TD>
</TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">o</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Coordinate
core project team meetings</FONT></TD>
</TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">o</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Attend,
coordinate and support functional project team meetings if required</FONT></TD>
</TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">o</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Review
and update of project plan and budget at regular intervals or as required</FONT></TD>
</TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">o</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Follow
up action items with team members</FONT></TD>
</TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">o</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Risk
assessment and mitigation strategies</FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"></P>

<!-- Field: Page; Sequence: 8 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right; text-indent: 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; text-align: justify"></TD><TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify; padding-right: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Provide
                                         development services or support and identify outsourcing to service providers for services
                                         including, but not limited to:</FONT></TD></TR></TABLE>

<P STYLE="margin: 0; text-indent: 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in; text-align: justify"></TD><TD STYLE="width: 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">o</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Preclinical
(non-clinical) toxicology studies</FONT></TD>
</TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in; text-align: justify"></TD><TD STYLE="width: 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">o</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ADME</FONT></TD>
</TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in; text-align: justify"></TD><TD STYLE="width: 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">o</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Functional
ingredient sourcing/qualification/characterization/supplier site auditing</FONT></TD>
</TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in; text-align: justify"></TD><TD STYLE="width: 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">o</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Excipient
sourcing/qualification/characterization/supplier site auditing</FONT></TD>
</TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in; text-align: justify"></TD><TD STYLE="width: 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">o</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Clinical
trial batches (CTM batches) manufacturer</FONT></TD>
</TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in; text-align: justify"></TD><TD STYLE="width: 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">o</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">GLP/GMP
testing laboratories</FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; text-align: justify"></TD><TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify; padding-right: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Evaluate
                                         service providers including preparation of &ldquo;Request for Proposal&rdquo; details,
                                         reference checks, auditing, evaluation of proposals, recommendations and contract negotiation.</FONT></TD></TR></TABLE>

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; text-align: justify"></TD><TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify; padding-right: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Recruit
                                         experts to support the development program for strategic planning, protocol development,
                                         regulatory document preparation and filing, preclinical studies, material characterization
                                         and CMC development.</FONT></TD></TR></TABLE>

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0; text-align: justify"></TD><TD STYLE="width: 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(b)</B></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Technical
Services by Consultant or Contractors</B></FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; text-align: justify"></TD><TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify; padding-right: 0.1in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Develop
                                         feasible, regulatory compliant manufacturing process for toxicology and clinical batches</FONT></TD></TR></TABLE>

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; text-align: justify"></TD><TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Develop
                                         regulatory acceptable method to characterize the contrast agents (including CCMN)</FONT></TD></TR></TABLE>

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; text-align: justify"></TD><TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify; padding-right: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Develop
                                         method of administration of contrast agents (including CCMN) to animals for pre-clinical
                                         studies and to humans for FTIH</FONT></TD></TR></TABLE>

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; text-align: justify; padding-right: 0"></TD><TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; text-align: justify; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify; padding-right: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Develop
                                         sufficiently stable contrast agents (including CCMN) formulation if required. For example,
                                         stabilizer(s) for nanoparticles may be added or lyophilization excipients may be included
                                         in the formulation</FONT></TD></TR></TABLE>

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; text-align: justify; padding-right: 0"></TD><TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; text-align: justify; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify; padding-right: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Source
                                         or fabricate (if needed by contractor) equipment for the manufacture of the pre-clinical/toxicology
                                         or clinical batches</FONT></TD></TR></TABLE>

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; text-align: justify; padding-right: 0"></TD><TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; text-align: justify; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify; padding-right: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Develop
                                         and qualify suitable physical and/or chemical testing methods suitable for GLP or GMP
                                         product characterization or release</FONT></TD></TR></TABLE>

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; text-align: justify"></TD><TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Develop
                                         and qualify stability-indicating physical and chemical testing methods</FONT></TD></TR></TABLE>

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; text-align: justify"></TD><TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Technology
                                         transfer for CTM manufacturing site</FONT></TD></TR></TABLE>

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; text-align: justify"></TD><TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Support
                                         definition of animal and FTIH dosing ranges</FONT></TD></TR></TABLE>

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; text-align: justify"></TD><TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Support
                                         or perform audits to qualify contractors</FONT></TD></TR></TABLE>

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; text-align: justify"></TD><TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Coordinate
                                         the preparation of documentation for regulatory submission</FONT></TD></TR></TABLE>

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0">&nbsp;</P>

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"></P>

<!-- Field: Page; Sequence: 9 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"></P>

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Consultant
shall perform such services at such times and such places as may be reasonably designated by:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mr
Ian Huen</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dr
Owen Ko</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mr
Kenrick Fok</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mr
Darren Lui</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Professor
Thomas Lee</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dr
Vincent Mok</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Corporation retains the right to amend the list of authorized individuals above at any time by written notification to the Consultant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Consultant
shall perform such services in a manner consistent with industry standards for similar professional consulting work. Upon mutual
agreement and under the request of the Corporation, Consultant may need to travel from time to time to perform the services described
herein.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0"></TD><TD STYLE="width: 21.3pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>2.</B></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>COMPENSATION</B></FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
consideration of Consultant&rsquo;s performance of the consulting services described above, the Corporation shall compensate Consultant
based on:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
                                         fixed fee approach with a defined scope to be agreed between the Consultant and the Corporation
                                         for each critical study, project or milestone;</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
                                         all other circumstances, the hourly rate of its employees who perform the services. Both
                                         Mr. Austin Freedman, Dr. Kwok Chow and technical and supporting staff at the Consultant
                                         company will provide the technical services. The Consultant may bring qualified external
                                         consultants with the Corporation&rsquo;s agreement to support the Program. Austin Freedman
                                         shall provide his services at an hourly rate of USD $150 per hour; Dr. Kwok Chow shall
                                         provide technical and consulting services, including pharmaceutical and analytical development
                                         services, at an hourly rate of USD $200 per hour. The technical and supporting staff
                                         will provide services at an hourly rate of USD $65 to $100 per hour depending on their
                                         backgrounds and experience. The fee for external consulting will be determined on a case
                                         by case basis with prior Corporation approval.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Both
parties agree that:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mr.
                                         Austin Freedman, Executive Director, Cover Pharmaceuticals Incorporated, will provide
                                         the lead program management services for the Project;</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dr.
                                         Kwok Chow, President, Cover Pharmaceuticals Incorporated, will also provide program management
                                         support when needed.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 10 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 21.3pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>3.</B></FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>EXPENSES</B></FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Corporation shall reimburse Consultant for all direct out-of-pocket expenses of Consultant actually and reasonably incurred in
connection with the performance of Consultant&rsquo;s obligations under this Agreement insofar as such expenses relate to travel
expenses, third party payments and other reasonable expenses, provided that such expenses are specifically approved in advance
in writing by the Corporation.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.95in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 21.3pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>4.</B></FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>RECORDS
                                         AND REPORTS </B></FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>4.1.
Books and Records</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Consultant
shall maintain books and records adequate for the determination of all services rendered, expenses and other data, which shall
be available for inspection by the Corporation through its agents or representatives during normal working hours as the Corporation
shall reasonably request.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.95in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>4.2.&nbsp;Payment
of Invoices</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Consultant
shall submit invoices to the Corporation within ten (10) days after the end of each calendar month during the term of this Agreement,
specifying in reasonable detail the nature and extent of the services performed by Consultant for the preceding month, and the
amount of expenses incurred by Consultant which are subject to reimbursement by the Corporation in accordance with <B>Article
3</B>. The Corporation shall remit payment for all such compensation and expenses in the amounts called for by this Agreement
within 30 days after receipt of such invoices.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.95in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
retainer fee of USD $10,000 will be provided by the Corporation upon execution of this Agreement and the retainer fee will be
deducted from the last payment upon termination of the Agreement or completion of the Program. Any remaining funds, if any, will
be refunded.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Consultant will provide the Corporation a quotation with estimated time and cost for individual service items exceeding USD $10,000
for approval before execution.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>4.3.&#9;Monthly
Status Reports</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Upon
request by the Corporation, Consultant shall prepare and submit to the Corporation on a monthly basis a status report setting
forth a summary of Consultant&rsquo;s activities and progress during the preceding month with respect to the matters set forth in Article
1.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.95in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 21.3pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>5.</B></FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>TERM
                                         AND TERMINATION</B></FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>5.1.&#9;Term</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Subject
to the termination provisions set forth in <B>Article 5.2, </B>this Agreement shall have an initial term of 12 months, commencing
on the date this agreement is executed, which term&nbsp;may be automatically renewable for another 12 months, and thereafter extended
from time to time by the mutual written agreement of Consultant and the Corporation.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.05in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.05in; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 11 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.05in; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.05in; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>5.2.
Termination and Actions Thereafter</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.3in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
                                         Agreement may be terminated by the Corporation by written notice to Consultant at any
                                         time upon (i) Consultant&rsquo;s permanent disability or incapacity to perform services hereunder;
                                         or (ii) a breach by Consultant of any of the provisions of this Agreement.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.3in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Either
                                         party may, at any time and with or without cause, terminate this Agreement upon written
                                         notice to the other party given not less than fifteen (15) days prior to such termination.
                                         Such notice shall specify the effective date of termination for all purposes hereunder.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.3in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Upon
                                         termination or expiration of this Agreement, Consultant (or his representatives) shall
                                         promptly submit to the Corporation an invoice covering all unbilled compensation and
                                         expenses to date, together with an estimate of the compensation and expenses that would
                                         be chargeable to the Corporation if any particular services for work then in progress
                                         were to be completed by Consultant. Except in the case of termination under <B>Article5.2(a)(i),
                                         </B>upon request by <B>the </B>Corporation (but not otherwise) Consultant shall complete
                                         such work in progress as the Corporation shall designate, and this Agreement shall in
                                         such case be deemed extended until such work is completed and paid for. The Corporation
                                         shall pay Consultant for any services performed to and including the date of termination
                                         in accordance with the provisions for compensation set forth in <B>Articles 2 </B>and
                                         <B>3.</B></FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.3in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                         provisions of <B>Articles 7 </B>and <B>8 </B>shall survive expiration or termination
                                         of this Agreement for any reason whatsoever.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0"></TD><TD STYLE="width: 21.3pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>6.</B></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>RELATIONSHIP
OF THE PARTIES</B></FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.05in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>6.1.
Independent Status</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
relationship of Consultant to the Corporation hereunder shall be that of an independent contractor, Nothing in this Agreement
is intended or shall be construed to constitute Consultant an employee, agent or partner of the Corporation nor shall Consultant
have authority to bind the Corporation in any respect. The Corporation shall not be liable for any act or omission of Consultant
or his employees or agents, and Consultant agrees to indemnify and hold harmless the Corporation from any and all losses, damages,
costs and expenses (including attorneys&rsquo; fees) in any manner resulting from or arising out of any such act or omission or any
breach of Consultant&rsquo;s obligations under this Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.05in; text-align: justify; text-indent: 0.9in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>6.2.
Services for Third Parties</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Nothing
in this Agreement shall be construed to prevent Consultant from concurrently providing services to persons other than the Corporation,
subject to the limitations set forth in <B>Articles 7 </B>and <B>8.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.05in; text-align: justify; text-indent: 0.9in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.05in; text-align: justify; text-indent: 0.9in"></P>

<!-- Field: Page; Sequence: 12 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.05in; text-align: justify; text-indent: 0.9in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.05in; text-align: justify; text-indent: 0.9in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.05in; text-align: justify; text-indent: 0.9in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>6.3.&nbsp;&nbsp;Certain
Tax Matters</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Consultant
shall not be treated as an employee for tax purposes with respect to the services performed pursuant to this Agreement. Consultant
shall be responsible for the filing of all necessary income tax returns and the payment of all taxes required by law. Consultant
acknowledges that he understands his tax obligations.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.95in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>6.4.&nbsp;&nbsp;Disclosure
of Consultant Relationship by Corporation</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Subject
to article 6.1 above, the Corporation may include and disclose, for example, in its corporate presentations, marketing materials,
due diligence related documentation to third parties, the credentials and advisory role of the Consultant and its employees (for
example, Dr Kwok Chow and Mr. Austin Freedman). On this basis, the Corporation will seek the Consultant&rsquo;s approval prior to such
inclusion.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.95in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0"></TD><TD STYLE="width: 21.3pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>7.</B></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>RESTRICTIVE
COVENANTS</B></FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>7.1.&nbsp;&nbsp;Confidential
Information</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Unless
authorized or instructed in writing by the Corporation, Consultant shall not, during or at any time after the term of this Agreement
except as required in the conduct of the Corporation&rsquo;s business, disclose to others, or use, or permit to be disclosed to others
or used, any of the Corporation&rsquo;s inventions, discoveries, works, ideas, information, knowledge or data (whether in oral, written,
or machine-readable form) which Consultant may develop or obtain during the course of or in connection with Consultant&rsquo;s engagement,
including such inventions, discoveries, works, ideas, information, knowledge, or data relating to machines, equipment, products,
systems, software, research and/or development, designs, compositions, formulae, processes, manufacturing procedures, business
methods, present and prospective customers of the Corporation, business dealings with such customers, prospective marketing, promotion,
sales and advertising programs and strategies, and agreements with representatives or prospective representatives of the Corporation,
present or prospective sources of supply or any other business arrangements of the Corporation, including but not limited to customers,
customer lists, costs, prices and earnings, whether or not developed by Consultant, by others in the Corporation or obtained by
the Corporation from third parties, and irrespective of whether or not such inventions, discoveries, works, ideas, information,
knowledge or data have been identified by the Corporation as secret or confidential, unless and until, and then to the extent
and only to the extent that, such inventions, discoveries, works, ideas, information, knowledge or data become available to the
public otherwise than by Consultant&rsquo;s act or omission. All inventions, discoveries, works, ideas, information, knowledge, and
data described or referred to in this <B>Article 7.1</B> are referred to herein collectively as &ldquo;Confidential Information&rdquo;.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.95in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>7.2.&nbsp;&nbsp;Essence
of Agreement</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Consultant
acknowledges (i) that the use, misappropriation or disclosure of the Confidential Information (as defined in <B>Article7.1</B>)
would constitute a breach of trust and cause irreparable injury to the Corporation, (ii) that all such Confidential Information
is the property of the Corporation and (iii) that it is essential to the protection of the Corporation&rsquo;s goodwill and to the</FONT>
<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">maintenance of the Corporation&rsquo;s competitive position
that the Confidential Information be kept secret and that the Confidential Information not be disclosed by Consultant to others
or used by Consultant to Consultant&rsquo;s own advantage or the advantage of others. Consultant further acknowledges that Consultant&rsquo;s
agreement to the provisions of this <B>Article 7 </B>and the enforceability of such provisions against Consultant are an essential
element of this Agreement and that, absent such provisions and the enforceability thereof, the Corporation would not (a) engage
Consultant nor (b) permit Consultant access to and use of Confidential Information.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 13 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>7.3.&nbsp;&nbsp;Non-solicitation/Noncompetition</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Consultant
further recognizes and acknowledges that it is essential for the proper protection of the business of the Corporation that Consultant
be restrained (a) from soliciting or inducing any employee of the Corporation to leave the employ of the Corporation, (b) from
hiring or attempting to hire any employee of the Corporation, (c) from soliciting the business of the customers (actual or potential)
and suppliers of the Corporation for any business purpose, and (d) from competing against the Corporation, including, but not
limited to, provides services relating to generic drug development to any third party in China.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.95in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.95in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>7.4.&nbsp;&nbsp;Ability
to Earn Livelihood</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Consultant
represents that his experience and capabilities are such that the provisions of this <B>Article 7 </B>will not prevent him from
earning his livelihood, and acknowledges that it would cause the Corporation serious and irreparable injury and cost if Consultant
were to use his ability and knowledge in competition with the Corporation or to otherwise breach the obligations contained in
<B>Article 7.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.95in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0"></TD><TD STYLE="width: 21.3pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>8.</B></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>PROPRIETARY
RIGHTS</B></FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>8.1.&nbsp;&nbsp;Assignment
of Rights</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
the term of this Agreement, the Corporation hereby grants to the Consultant, a non-exclusive, paid-up, royalty-free, non-transferable
license of Client&rsquo;s Intellectual Property which the Consultant must use in order to perform the Services.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">All
Intellectual Property generated or derived by the Consultant in the course of performing the Services, to the extent it is specific
to the development. manufacture, use and sale of the Client&rsquo;s Product that is the subject of the Services, will be the exclusive
property of the Corporation.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">All
Intellectual Property generated or derived by the Consultant while performing the Services which is not specific to, or dependent
upon, the Corporation&rsquo;s Product and which has application to manufacturing processes or formulation development of pharmaceutical
products or pharmaceutical delivery systems will be the exclusive property of the Consultant. The Consultant hereby grants to
the Corporation, a non-exclusive, paid-up, royalty-free, transferable license of the Intellectual Property which the Corporation
may use for the manufacture of Client&rsquo;s Product.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.1in 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.1in 0pt 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 14 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.1in 0pt 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>8.2.&nbsp;&nbsp;Return
of Materials</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Upon
expiration or termination of this Agreement, Consultant agrees to return to the Corporation all computer software, computer programs,
source codes, object codes, magnetic tapes, printouts, designs, proposals, samples, notes, records, reports, documents, customer
and prospective customer lists, memoranda, plans, blue prints, correspondence, proposals, drawings, letters, flow-charts, manuals,
strategies, techniques, photographs, catalogs and writings and all copies thereof, directly or indirectly, related to, or developed,
prepared or created during, Consultant&rsquo;s engagement by the Corporation and, without limiting the foregoing, Consultant shall promptly
deliver to the Corporation any and all documents or materials constituting or, directly or indirectly, relating to any Confidential
Information. The Corporation may withhold Consultant&rsquo;s outstanding compensation against return of these materials and any other
materials of the Corporation or its customers.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.05in; text-align: justify; text-indent: 0.9in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0"></TD><TD STYLE="width: 21.3pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>9.</B></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>REPRESENTATIONS
AND WARRANTIES BY CONSULTANT</B></FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.05in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Consultant
represents and warrants to the Corporation that neither the execution and delivery of this Agreement nor the carrying out of any
of the transactions contemplated hereby will in any respect result in any violation of or be in conflict with any term or provision
of any agreement, document or instrument to which Consultant is a party or by which he is bound. Consultant further represents
and warrants to the Corporation that he has furnished the Corporation with copies of all such agreements, documents or instruments
to which Consultant is a party or by which he is bound. Consultant agrees not to divulge to the Corporation any information which
would violate any such agreement, document or instrument, nor to divulge to the Corporation any trade secrets of prior employers
or contracting parties.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.05in; text-align: justify; text-indent: 0.9in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0"></TD><TD STYLE="width: 21.3pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>10.</B></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>MISCELLANEOUS</B></FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.05in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>10.1.
Additional Actions and Documents</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Each
of the parties hereto hereby agrees to take or cause to be taken such further actions, to execute, deliver and file or cause to
be executed, delivered and filed such further documents, and will obtain such consents, as may be necessary or as may be reasonably
requested in order to fully effectuate the purposes, terms and conditions of this Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.05in; text-align: justify; text-indent: 0.9in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>10.2.
Assignment</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Consultant
shall not assign his rights and obligations under this agreement, in whole or in part, whether by operation of law or otherwise,
without the prior written consent of the Corporation, and any such assignment contrary to the terms hereof shall be null and void
and of no force and effect.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.05in; text-align: justify; text-indent: 0.9in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>10.3.
Entire Agreement; Amendment</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
Agreement constitutes the entire agreement between the parties hereto with respect to the transactions contemplated herein, and
it supersedes all prior oral or written agreements, commitments or understandings with respect to the matters provided for herein.
No amendment, modification or discharge of this Agreement shall be valid or binding unless set forth in writing and duly executed
and delivered by the party against whom enforcement of the amendment, modification, or discharge is sought.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 15 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>10.4.
Waiver</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">No
delay or failure on the part of any party hereto in exercising any right, power or privilege under this Agreement or under any
other documents furnished in connection with or pursuant to this Agreement shall impair any such right, power or privilege or
be construed as a waiver of any default or any acquiescence therein. No single or partial exercise of any such right, power or
privilege shall preclude the further exercise of such right, power or privilege, or the exercise of any other right, power or
privilege. No waiver shall be valid against any party hereto unless made in writing and signed by the party against whom enforcement
of such waiver is sought and then only to the extent expressly specified therein.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.95in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>10.5.
Governing Law</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
Agreement, the rights and obligations of the parties hereto, and any claims or disputes relating thereto, shall be governed by
and construed in accordance with the laws of Ontario, excluding the choice of law rules thereof).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.95in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>10.6.
Notices</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">All
notices, demands, requests, or other communications that may be or are required to be given, served, or sent by any party to any
other party pursuant to this Agreement shall be in writing and shall be hand delivered, sent by overnight courier or mailed by
first-class, registered or certified mail, return receipt requested, postage prepaid, or transmitted by telegram, telecopy or
telex, to the addresses indicated at the beginning of this agreement for each party.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.95in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Each
party may designate by notice in writing a new address to which any notice, demand, request or communication may thereafter be
so given, served or sent. Each notice, demand, request, or communication that shall be hand delivered, sent, mailed, telecopied
or telexed in the manner described above, or that shall be delivered to a telegraph Corporation, shall be deemed sufficiently
given, served, sent, received or delivered for all purposes at such time as it is delivered to the addressee (with the return
receipt, the delivery receipt, or (with respect to a telecopy or telex) the answerback being deemed conclusive, but not exclusive,
evidence of such delivery) or at such time as delivery is refused by the addressee upon presentation.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.95in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>10.7.
Execution in Counterparts</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">To
facilitate execution, this Agreement may be executed in as many counterparts as may be required. It shall not be necessary that
the signatures of, or on behalf of, each party, or that the signatures of all persons required to bind any party, appear on each
counterpart; but it shall be sufficient that the signature of, or on behalf of, each party, or that the signatures of the persons
required to bind any party, appear on one or more of the counterparts. Ail counterparts shall collectively constitute a single
agreement. It shall not be necessary in making proof of this Agreement to produce or account for more than a number of counterparts
containing the respective signatures of, or on behalf of, all of the parties hereto.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.95in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.95in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.95in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.95in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>10.8.&nbsp;&nbsp;Limitation
on Benefits</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
covenants, undertakings and agreements set forth in this Agreement shall be solely for the benefit of, and shall be enforceable
only by, the parties hereto and their respective successors, heirs, executors, administrators, legal representatives and permitted
assigns.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.95in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>10.9.&nbsp;&nbsp;Binding
Effect</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Subject
to any provisions hereof restricting assignment, this Agreement shall be binding upon and shall inure to the benefit of the parties
hereto and their respective successors, heirs, executors, administrators, legal representatives and assigns.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.95in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.95in"></P>

<!-- Field: Page; Sequence: 16 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.95in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.95in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>IN
WITNESS WHEREOF, </B>the Corporation has caused this Agreement to be executed by its duly authorized officer and Consultant has
hereunto set his hand as of the date first above written.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Videns
Incorporation Limited</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 4%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="width: 36%; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/
    Ian Huen</FONT></TD>
    <TD STYLE="width: 20%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date:</FONT></TD>
    <TD STYLE="width: 35%; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>May
    31, 2017</U></FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">Name: <FONT STYLE="font-size: 10pt">Ian Huen</FONT></FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">Title: <FONT STYLE="font-size: 10pt">Chief Executive Officer</FONT></FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Covar
Pharmaceuticals Incorporated</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR>
    <TD STYLE="width: 4%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="width: 36%; border-bottom: black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/ Kwok Chow</FONT></TD>
    <TD STYLE="width: 20%">&nbsp;</TD>
    <TD STYLE="width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date:</FONT></TD>
    <TD STYLE="width: 35%; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>May
    25, 2017</U></FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name: Kwok Chow, Ph.D.</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title: President</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Page; Sequence: 17; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>



</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-14.1
<SEQUENCE>42
<FILENAME>ff12018ex14-1_aptorum.htm
<DESCRIPTION>CODE OF BUSINESS CONDUCT AND ETHICS OF THE COMPANY
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0; text-align: right; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit
14.1</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>APTORUM
GROUP LIMITED</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>CODE
OF BUSINESS CONDUCT AND ETHICS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">I.
PURPOSE</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
Code of Business Conduct and Ethics (the &ldquo;<B>Code</B>&rdquo;) contains general guidelines for conducting the business of
Aptorum Group Limited, a Cayman Islands company, and its subsidiaries and affiliates (collectively, the &ldquo;<B>Company</B>&rdquo;)
consistent with the highest standards of business ethics, and is intended to qualify as a &ldquo;code of ethics&rdquo; within
the meaning of Section 406(c) of the Sarbanes-Oxley Act of 2002 and the rules promulgated thereunder. To the extent this Code
requires a higher standard than required by commercial practice or applicable laws, rules or regulations, we adhere to these higher
standards.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
Code is designed to deter wrongdoing and to promote:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 48px; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 24px; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">honest
    and ethical conduct, including the ethical handling of actual or apparent conflicts of interest between personal and professional
    relationships;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 48px; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 24px; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">full,
    fair, accurate, timely, and understandable disclosure in reports and documents that the Company files with, or submits to,
    the U.S. Securities and Exchange Commission (the &ldquo;<B>SEC</B>&rdquo;) and in other public communications made by the
    Company;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 48px; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 24px; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">compliance
    with applicable laws, rules and regulations;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 48px; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 24px; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">prompt
    internal reporting of violations of the Code; and</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 48px; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 24px; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">accountability
    for adherence to the Code.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">II.
APPLICABILITY</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
Code applies to all directors, officers and employees of the Company, whether they work for the Company on a full-time, part-time,
consultative or temporary basis (each, an &ldquo;<B>employee</B>&rdquo; and collectively, the &ldquo;<B>employees</B>&rdquo;).
Certain provisions of the Code apply specifically to our chief executive officer, chief financial officer, senior finance officer
and any other persons who perform similar functions for the Company (each, a &ldquo;<B>senior officer</B>,&rdquo; and collectively,
the &ldquo;<B>senior officers</B>&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Board of Directors of the Company (the &ldquo;<B>Board</B>&rdquo;) has appointed the Company&rsquo;s Chief Financial Officer as
the Compliance Officer for the Company (the &ldquo;<B>Compliance Officer</B>&rdquo;). If you have any questions regarding the
Code or would like to report any violation of the Code, please contact the Compliance Officer.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
Code has been adopted by the Board and shall become effective (the &quot;<B>Effective Time</B>&quot;) upon the effectiveness of
the Company's registration statement on Form F-1 filed by the Company with the SEC relating to the Company's initial public offering.
Following the Effective Time, the Board and the Compliance Officer, as well as any duly appointed committee charged with enforcing
this Code, shall be entitled to enforce this Code to the full extent permitted by law.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 1; Options: NewSection; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">III.
CONFLICTS OF INTEREST</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Identifying
Conflicts of Interest</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
conflict of interest occurs when an employee&rsquo;s private interest interferes, or appears to interfere, in any way with the
interests of the Company as a whole. An employee should actively avoid any private interest that may impact such employee&rsquo;s
ability to act in the interests of the Company or that may make it difficult to perform the employee&rsquo;s work objectively
and effectively. In general, the following should be considered conflicts of interest:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 24px; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 24px; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Competing
    Business</U>. No employee may be employed by a business that competes with the Company or deprives it of any business.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 24px; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 24px; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Corporate
    Opportunity</U>. No employee should use corporate property, information or his/her position with the Company to secure a business
    opportunity that would otherwise be available to the Company. If an employee discovers a business opportunity that is in the
    Company&rsquo;s line of business through the use of the Company&rsquo;s property, information or position, the employee must
    first present the business opportunity to the Company and obtain approval from the Company&rsquo;s Audit Committee before
    pursuing the opportunity in his/her individual capacity.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 24px; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 24px; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Financial
    Interests</U></FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 54px; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 24px; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">i.</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">No
    employee may have any financial interest (ownership or otherwise), either directly or indirectly through a spouse or other
    family member, in any other business or entity if such interest adversely affects the employee&rsquo;s performance of duties
    or responsibilities to the Company, or requires the employee to devote time to it during such employee&rsquo;s working hours
    at the Company; provided, however that an Officer or Director may devote time to such other interest during working hours
    so long as it does not interfere with his/her ability to carry out his/her duties at the Company;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 58.5pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 54px; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 24px; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ii.</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">No
    employee may hold any ownership interest in a privately held company that is in competition with the Company;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 58.5pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 54px; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 24px; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">iii.</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">An
    employee may hold up to 5% ownership interest in a publicly traded company that is in competition with the Company; provided
    that if the employee&rsquo;s ownership interest in such publicly traded company increases to more than 5%, the employee must
    immediately report such ownership to the Compliance Officer;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 2; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 54px; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 24px; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">iv.</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">No
    employee may hold any ownership interest in a company that has a business relationship with the Company if such employee&rsquo;s
    duties at the Company include managing or supervising the Company&rsquo;s business relations with that company; and</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 58.5pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 54px; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 24px; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">v.</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Notwithstanding
    the other provisions of this Code,</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 58.5pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 84px; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 24px; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a
    director or any immediate family member of such director (collectively, &ldquo;<B>Director Affiliates</B>&rdquo;) or a senior
    officer or any immediate family member of such senior officer (collectively, &ldquo;<B>Officer Affiliates</B>&rdquo;) may
    continue to hold his/her investment or other financial interest in a business or entity (an &ldquo;<B>Interested Business</B>&rdquo;)
    that:</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 94.5pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 108px; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">was
    made or obtained either (x) before the Company invested in or otherwise became interested in such business or entity; or (y)
    before the director or senior officer joined the Company (for the avoidance of doubt, regardless of whether the Company had
    or had not already invested in or otherwise become interested in such business or entity at the time the director or senior
    officer joined the Company); or</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 108px; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">may
    in the future be made or obtained by the director or senior officer, provided that at the time such investment or other financial
    interest is made or obtained, the Company has not yet invested in or otherwise become interested in such business or entity;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">provided
that such director or senior officer shall disclose such investment or other financial interest to the Board;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 76.5pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 84px; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 24px; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">an
    interested director or senior officer shall refrain from participating in any discussion among senior officers of the Company
    relating to an Interested Business and shall not be involved in any proposed transaction between the Company and an Interested
    Business; and</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 94.5pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 84px; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 24px; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">before
    any Director Affiliate or Officer Affiliate (i) invests, or otherwise acquires any equity or other financial interest, in
    a business or entity that is in competition with the Company; or (ii) enters into any transaction with the Company, the related
    director or senior officer shall obtain prior approval from the Audit Committee of the Board.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"></P>

<!-- Field: Page; Sequence: 3; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
purposes of this Code, a company or entity is deemed to be &ldquo;in competition with the Company&rdquo; if it competes with the
Company&rsquo;s business of providing biomedical or biopharmaceutical products and services, or engaging in research and development
of biomedical or biopharmaceutical innovations that may result in such said products or services, and/or any other business in
which the Company is engaged.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 24px; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 24px; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Loans
    or Other Financial Transactions</U>. No employee may obtain loans or guarantees of personal obligations from, or enter into
    any other personal financial transaction with, any company that is a material customer, supplier or competitor of the Company.
    This guideline does not prohibit arms-length transactions with recognized banks or other financial institutions.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 24px; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 24px; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Service
    on Boards and Committees</U>. No employee shall serve on a board of directors or trustees or on a committee of any entity
    (whether profit or not-for-profit) whose interests could reasonably be expected to conflict with those of the Company. Employees
    must obtain prior approval from the Board or the Company&rsquo;s Audit Committee, as required by the rules of NASDAQ, before
    accepting any such board or committee position. The Company may revisit its approval of any such position at any time to determine
    whether an employee&rsquo;s service in such position is still appropriate.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
above is in no way a complete list of situations where conflicts of interest may arise. The following questions might serve as
a useful guide in assessing a potential conflict of interest situation not specifically addressed above:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 48px; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 24px; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Is
    the action to be taken legal?</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 48px; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 24px; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Is
    it honest and fair?</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 48px; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 24px; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Is
    it in the best interests of the Company?</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Disclosure
of Conflicts of Interest</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company requires that employees fully disclose any situations that could reasonably be expected to give rise to a conflict of
interest. If an employee suspects that he/she has a conflict of interest, or a situation that others could reasonably perceive
as a conflict of interest, the employee must report it immediately to the Compliance Officer. Conflicts of interest may only be
waived by the Board, the appropriate committee of the Board and in some cases, as in accordance with NASDAQ rules, only by the
Company&rsquo;s Audit Committee, and will be promptly disclosed to the public to the extent required by law and applicable rules
of Nasdaq.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Family
Members and Work</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
actions of family members outside the workplace may also give rise to conflicts of interest because they may influence an employee&rsquo;s
objectivity in making decisions on behalf of the Company. If a member of an employee&rsquo;s family is interested in doing business
with the Company, the criteria as to whether to enter into or continue the business relationship and the terms and conditions
of the relationship must be no less favorable to the Company compared with those that would apply to an unrelated party seeking
to do business with the Company under similar circumstances.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 4; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Employees
should report any situation involving family members that could reasonably be expected to give rise to a conflict of interest
to their supervisor or the Compliance Officer. For purposes of this Code, &ldquo;family members&rdquo; or &ldquo;members of employee&rsquo;s
family&rdquo; include an employee&rsquo;s spouse, siblings, parents, in-laws and children.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">IV.
GIFTS AND ENTERTAINMENT</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
giving and receiving of appropriate gifts may be considered common business practice. Appropriate business gifts and entertainment
are welcome courtesies designed to build relationships and understanding among business partners. However, gifts and entertainment
should never compromise, or appear to compromise, an employee&rsquo;s ability to make objective and fair business decisions.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">It
is the responsibility of employees to use good judgment in this area. As a general rule, employees may give or receive gifts or
entertainment to or from customers or suppliers only if the gift or entertainment is in compliance with applicable law, insignificant
in amount and not given in consideration or expectation of any action by the recipient. All gifts and entertainment expenses made
on behalf of the Company must be properly accounted for on expense reports.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
encourage employees to submit gifts received to the Company. While it is not mandatory to submit small gifts, gifts of over USD
100 must be submitted immediately to the administration department of human resource center of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Bribes
and kickbacks are criminal acts, strictly prohibited by law. An employee must not offer, give, solicit or receive any form of
bribe or kickback anywhere in the world.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">V.
FCPA COMPLIANCE</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
U.S. Foreign Corrupt Practices Act (&ldquo;<B>FCPA</B>&rdquo;) prohibits giving anything of value, directly or indirectly, to
officials of foreign governments or foreign political candidates in order to obtain or retain business. A violation of FCPA does
not only violate the Company&rsquo;s policy but also constitute a civil or criminal offense under FCPA which the Company is subject
to after the Effective Time. No employee shall give or authorize directly or indirectly any illegal payments to government officials
of any country. While the FCPA does, in certain limited circumstances, allow nominal &ldquo;facilitating payments&rdquo; to be
made, any such payment must be discussed with and approved by an employee&rsquo;s supervisor in advance before it can be made.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 5; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">VI.
PROTECTION AND USE OF COMPANY ASSETS</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Employees
should protect the Company&rsquo;s assets and ensure their efficient use for legitimate business purposes only. Theft,
carelessness and waste have a direct impact on the Company&rsquo;s profitability. Any use of the funds or assets of the
Company, whether for personal gain or not, for any unlawful or improper purpose is strictly prohibited.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">To
ensure the protection and proper use of the Company&rsquo;s assets, each employee should:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 48px; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 24px; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exercise
    reasonable care to prevent theft, damage or misuse of Company property;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 48px; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 24px; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Promptly
    report any actual or suspected theft, damage or misuse of Company property;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 48px; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 24px; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Safeguard
    all electronic programs, data, communications and written materials from unauthorized access; and</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 48px; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 24px; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Use
    Company property only for legitimate business purposes.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Except
as approved in advance by the Chief Executive Officer or Chief Financial Officer of the Company, the Company prohibits political
contributions (directly or through trade associations) by any employee on behalf of the Company. Prohibited political contributions
include:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 48px; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 24px; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">any
    contributions of the Company&rsquo;s funds or other assets for political purposes;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 48px; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 24px; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">encouraging
    individual employees to make any such contribution; and</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 48px; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 24px; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">reimbursing
    an employee for any political contribution.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">VII.
INTELLECTUAL PROPERTY AND CONFIDENTIALITY</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Employees
should abide by the Company&rsquo;s rules and policies in protecting the intellectual property and confidential information, including
the following:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 48px; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 24px; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">All
    inventions, creative works, computer software, and technical or trade secrets developed by an employee in the course of performing
    the employee&rsquo;s duties or primarily through the use of the Company&rsquo;s assets or resources while working at the Company
    shall be the property of the Company.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 48px; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 24px; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Employees
    should maintain the confidentiality of information entrusted to them by the Company or entities with which the Company has
    business relations, except when disclosure is authorized or legally mandated. Confidential information includes all non-public
    information that might be of use to competitors, or harmful to the company or its business associates, if disclosed.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 6; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 48px; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 24px; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    Company maintains a strict confidentiality policy. During an employee&rsquo;s term of employment with the Company, the employee
    shall comply with any and all written or unwritten rules and policies concerning confidentiality and shall fulfill the duties
    and responsibilities concerning confidentiality applicable to the employee.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 48px; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 24px; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
    addition to fulfilling the responsibilities associated with his/her position in the Company, an employee shall not, without
    obtaining prior approval from the Company, disclose, announce or publish trade secrets or other confidential business information
    of the Company, nor shall an employee use such confidential information outside the course of his/her duties to the Company.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 48px; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 24px; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Even
    outside the work environment, an employee must maintain vigilance and refrain from disclosing important information regarding
    the Company or its business, business associates or employees.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 48px; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 24px; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">An
    employee&rsquo;s duty of confidentiality with respect to the confidential information of the Company survives the termination
    of such employee&rsquo;s employment with the Company for any reason until such time as the Company discloses such information
    publicly or the information otherwise becomes available in the public sphere through no fault of the employee.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 48px; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 24px; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Upon
    termination of employment, or at such time as the Company requests, an employee must return to the Company all of its property
    without exception, including all forms of medium containing confidential information, and may not retain duplicate materials.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">VIII.
ACCURACY OF FINANCIAL REPORTS AND OTHER PUBLIC COMMUNICATIONS</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Upon
the Effective Time, the Company will be required to report its financial results and other material information about its business
to the public and the SEC. It is the Company&rsquo;s policy to promptly disclose accurate and complete information regarding its
business, financial condition and results of operations. Employees must strictly comply with all applicable standards, laws, regulations
and policies for accounting and financial reporting of transactions, estimates and forecasts. Inaccurate, incomplete or untimely
reporting will not be tolerated and can severely damage the Company and result in legal liability.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 7; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Employees
should be on guard for, and promptly report, any possibility of inaccurate or incomplete financial reporting. Particular attention
should be paid to:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 48px; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 24px; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Financial
    results that seem inconsistent with the performance of the underlying business;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 48px; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 24px; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Transactions
    that do not seem to have an obvious business purpose; and</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 48px; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 24px; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Requests
    to circumvent ordinary review and approval procedures.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company&rsquo;s senior financial officers and other employees working in the finance department have a special responsibility
to ensure that all of the Company&rsquo;s financial disclosures are full, fair, accurate, timely and understandable. Any practice
or situation that might undermine this objective should be reported to the Compliance Officer.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Employees
are prohibited from directly or indirectly taking any action to coerce, manipulate, mislead or fraudulently influence the Company&rsquo;s
independent auditors for the purpose of rendering the financial statements of the Company materially misleading. Prohibited actions
include but are not limited to:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 48px; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 24px; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">issuing
    or reissuing a report on the Company&rsquo;s financial statements that is not warranted in the circumstances (due to material
    violations of U.S. GAAP, generally accepted auditing standards or other professional or regulatory standards);</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 48px; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 24px; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">not
    performing audit, review or other procedures required by generally accepted auditing standards or other professional standards;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 48px; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 24px; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">not
    withdrawing an issued report when withdrawal is warranted under the circumstances; or</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 48px; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 24px; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">not
    communicating matters required to be communicated to the Company&rsquo;s Audit Committee.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">IX.
COMPANY RECORDS</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accurate
and reliable records are crucial to the Company&rsquo;s business and form the basis of its earnings statements, financial
reports and other disclosures to the public. The Company&rsquo;s records are a source of essential data that guides business
decision-making and strategic planning. Company records include, but are not limited to, booking information, payroll,
timecards, travel and expense reports, e-mails, accounting and financial data, measurement and performance records,
electronic data files and all other records maintained in the ordinary course of business.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">All
Company records must be complete, accurate and reliable in all material respects. There is never an acceptable reason to make
false or misleading entries. Undisclosed or unrecorded funds, payments or receipts are strictly prohibited. An employee is responsible
for understanding and complying with the Company&rsquo;s recordkeeping policy. An employee should contact the Compliance Officer
if he/she has any questions regarding the recordkeeping policy.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 8; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">X.
COMPLIANCE WITH LAWS AND REGULATIONS</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Each
employee has an obligation to comply with the laws of the cities, provinces, regions and countries in which the Company operates.
This includes, without limitation, laws covering commercial bribery and kickbacks, patent, copyrights, trademarks and trade secrets,
information privacy, insider trading, offering or receiving gratuities, employment harassment, environmental protection, occupational
health and safety, false or misleading financial information, misuse of corporate assets and foreign currency exchange activities.
Employees are expected to understand and comply with all laws, rules and regulations that apply to their positions at the Company.
If any doubt exists about whether a course of action is lawful, the employee should seek advice immediately from the Compliance
Officer.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">XI.
DISCRIMINATION AND HARASSMENT</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company is firmly committed to providing equal opportunity in all aspects of employment and will not tolerate any illegal discrimination
or harassment based on race, ethnicity, religion, gender, age, national origin or any other protected class. For further information,
employees should consult the Compliance Officer.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">XII.
FAIR DEALING</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Each
employee should endeavor to deal fairly with the Company&rsquo;s customers, suppliers, competitors and employees. None should
take unfair advantage of anyone through manipulation, concealment, abuse of privileged information, misrepresentation of material
facts, or any other unfair-dealing practice.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">XIII.
HEALTH AND SAFETY</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company strives to provide employees with a safe and healthy work environment. Each employee has responsibility for maintaining
a safe and healthy workplace for other employees by following environmental, safety and health rules and practices and reporting
accidents, injuries and unsafe equipment, practices or conditions. Violence or threats of violence are not permitted.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Each
employee is expected to perform his/her duty to the Company in a safe manner, not under the influence of alcohol, illegal drugs
or other controlled substances. The use of illegal drugs or other controlled substances in the workplace is prohibited.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 9; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">XIV.
VIOLATIONS OF THE CODE</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">All
employees have a duty to report any known or suspected violation of this Code, including any violation of laws, rules, regulations
or policies that apply to the Company. Reporting a known or suspected violation of this Code by others will not be considered
an act of disloyalty, but an action to safeguard the reputation and integrity of the Company and its employees.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
an employee knows of or suspects a violation of this Code, it is such employee&rsquo;s responsibility to immediately report the
violation to the Compliance Officer, who will work with the employee to investigate his/her concern. All questions and reports
of known or suspected violations of this Code will be treated with sensitivity and discretion. The Compliance Officer and the
Company will protect the employee&rsquo;s confidentiality to the extent possible, consistent with the law and the Company&rsquo;s
need to investigate the employee&rsquo;s concern.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">It
is the Company&rsquo;s policy that any employee who violates this Code will be subject to appropriate discipline, including termination
of employment, based upon the facts and circumstances of each particular situation. An employee&rsquo;s conduct, if it does not
comply with the law or with this Code, can result in serious consequences for both the employee and the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company strictly prohibits retaliation against an employee who, in good faith, seeks help or reports known or suspected violations.
An employee inflicting reprisal or retaliation against another employee for reporting a known or suspected violation will be subject
to disciplinary action, including termination of employment.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">XV.
WAIVERS OF THE CODE</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Waivers
of this Code will be granted on a case-by-case basis and only in extraordinary circumstances. Waivers of this Code may be made
only by the Board, or the appropriate committee of the Board, and may be promptly disclosed to the public if so required by applicable
laws and regulations and rules of the Nasdaq. Notwithstanding the foregoing, any waiver of this Code for a senior officer or a
director may only be granted by the Board and must be publicly disclosed in accordance with the applicable rules of the Nasdaq.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">XVI.
CONCLUSION</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
Code contains general guidelines for conducting the business of the Company consistent with the highest standards of business
ethics. If employees have any questions about these guidelines, they should contact the Compliance Officer. We expect all employees
to adhere to these standards. Each employee is separately responsible for his/her actions. Conduct that violates the law or this
Code cannot be justified by claiming that it was ordered by a supervisor or someone in higher management positions. If an employee
engages in conduct prohibited by the law or this Code, such employee will be deemed to have acted outside the scope of his/her
employment. Such conduct will subject the employee to disciplinary action, including termination of employment.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">*
* * * * * * * * * * * *</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<!-- Field: Page; Sequence: 10; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>



<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-21.1
<SEQUENCE>43
<FILENAME>ff12018ex21-1_aptorum.htm
<DESCRIPTION>LIST OF SUBSIDIARIES
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0; text-align: right"><B>Exhibit 21.1</B></P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin-top: 0; text-align: center; margin-bottom: 0">List of subsidiaries</P>

<P STYLE="margin: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="width: 60%; font-weight: bold; border-bottom: Black 1.5pt solid">Name</TD><TD STYLE="width: 1%; font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="width: 39%; font-weight: bold; border-bottom: Black 1.5pt solid">Jurisdiction</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Aptorum Group Limited</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">Cayman Islands</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Aptorum Therapeutics Limited</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">Cayman Islands</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">APTUS MANAGEMENT LIMITED</TD><TD>&nbsp;</TD>
    <TD>HK</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Aptorum Medical Limited</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">Cayman Islands</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Aptus Therapeutics (Hong Kong) Limited</TD><TD>&nbsp;</TD>
    <TD>HK</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Aptus Biotechnology (Macao) Limited</TD><TD>&nbsp;</TD>
    <TD>Macao</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Aptorum International Limited</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">United Kingdom</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Aptorum Pharmaceutical Development Limited</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">Cayman Islands</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Forum Property Holding Limited</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">Cayman Islands</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Videns Incorporation Limited</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">Cayman Islands</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">mTOR (Hong Kong) Limited</TD><TD>&nbsp;</TD>
    <TD>HK</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Videns Incorporation (Hong Kong) Limited</TD><TD>&nbsp;</TD>
    <TD>HK</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Nativus Life Sciences Limited</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">Cayman Islands</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Nativus Life Sciences (Hong Kong) Limited</TD><TD>&nbsp;</TD>
    <TD>HK</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Scipio Life Sciences Limited</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">Cayman Islands</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Scipio Life Sciences (Hong Kong) Limited</TD><TD>&nbsp;</TD>
    <TD>HK</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Claves Life Sciences Limited</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">Cayman Islands</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Claves Life Sciences (Hong Kong) Limited</TD><TD>&nbsp;</TD>
    <TD>HK</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Signate Life Sciences Limited</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">Cayman Islands</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Signate Life Sciences (Hong Kong) Limited</TD><TD>&nbsp;</TD>
    <TD>HK</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Acticule Life Sciences Limited</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">Cayman Islands</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Acticule Life Sciences (Hong Kong) Limited</TD><TD>&nbsp;</TD>
    <TD>HK</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Lanither Life Sciences Limited</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">Cayman Islands</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Lanither Life Sciences (Hong Kong) Limited</TD><TD>&nbsp;</TD>
    <TD>HK</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>



<P STYLE="margin: 0"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-23.1
<SEQUENCE>44
<FILENAME>ff12018ex23-1_aptorum.htm
<DESCRIPTION>CONSENT OF MARCUM BERNSTEIN & PINCHUK LLP
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0; text-align: right"><B>Exhibit 23.1</B></P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"></P>



<P STYLE="margin-top: 0; text-align: center; margin-bottom: 0">&nbsp;<IMG SRC="logo.jpg" ALT=""></P>

<P STYLE="margin-top: 0; text-align: center; margin-bottom: 0">&nbsp;</P>

<P STYLE="margin-top: 0; text-align: center; margin-bottom: 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><U>INDEPENDENT REGISTERED PUBLIC ACCOUNTING
FIRM&rsquo;S CONSENT</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">We consent to the inclusion in this Registration
Statement of Aptorum Group Limited (formally known as APTUS Holdings Limited and STRIKER ASIA OPPORTUNITIES FUND CORPORATION, the
&ldquo;Company&rdquo;) on Form F-1 of our report dated July 13, 2018, with respect to our audits of the statements of net assets
(predecessor basis) including the schedule of portfolio investments of the &ldquo;Company&rdquo; as of December 31, 2016 and February
28, 2017, and the related statements (predecessor basis) of operations, changes in net assets, and cash flows for the year ended
December 31, 2016, the statements (predecessor basis) of operations, changes in net assets, and cash flows for the period January
1, 2017 through February 28, 2017, the consolidated balance sheet (successor basis) as of December 31, 2017, the related consolidated
statements (successor basis) of operations and comprehensive loss, stockholders&rsquo; equity and cash flows for the period March
1, 2017 through December 31, 2017, and the related notes (collectively referred to as the &ldquo;financial statements&rdquo;),
which report appears in the Prospectus, which is part of this Registration Statement. We also consent to the reference to our Firm
under the heading &ldquo;Experts&rdquo; in such Prospectus.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-size: 10pt">/s/ Marcum Bernstein &amp; Pinchuk
</FONT>LLP</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-size: 10pt">Marcum Bernstein &amp; Pinchuk </FONT>LLP<FONT STYLE="font-size: 10pt">&#9;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">New York, New York</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">September 4, 2018</P>



<P STYLE="margin-top: 0; text-align: center; margin-bottom: 0">&nbsp;</P>

<P STYLE="margin-top: 0; text-align: center; margin-bottom: 0">&nbsp;</P>

<P STYLE="margin-top: 0; text-align: center; margin-bottom: 0">&nbsp;</P>

<P STYLE="margin-top: 0; text-align: center; margin-bottom: 0">&nbsp;</P>

<P STYLE="margin-top: 0; text-align: center; margin-bottom: 0"><IMG SRC="image_002.jpg" ALT=""></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>NEW YORK OFFICE <FONT STYLE="color: #0070C0">&bull;</FONT></B>
7 Penn Plaza <FONT STYLE="color: #0070C0"><B>&bull;</B></FONT> Suite 830 <FONT STYLE="color: #0070C0"><B>&bull;</B></FONT> New
York, New York 10001 <FONT STYLE="color: #0070C0"><B>&bull;</B></FONT><B> Phone</B> 646.442.4845 <FONT STYLE="color: #0070C0"><B>&bull;</B></FONT><B>
Fax</B> 646.349.5200 <FONT STYLE="color: #0070C0"><B>&bull;</B></FONT><B> marcumbp.com</B><BR>
<BR>
</P>



<P STYLE="margin-top: 0; text-align: center; margin-bottom: 0"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>45
<FILENAME>ff12018ex99-1_aptorum.htm
<DESCRIPTION>CHARTER OF THE AUDIT COMMITTEE
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0; text-align: right; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit
99.1</B></FONT></P>

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>CHARTER
OF THE AUDIT COMMITTEE</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>OF
THE BOARD OF DIRECTORS OF</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>APTORUM
GROUP LIMITED</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(Adopted
by the Board of Directors of Aptorum Group Limited (the &ldquo;Company&rdquo;) on October 13, 2017; effective upon the effectiveness
of the Company&rsquo;s registration statement on Form F-1 relating to the Company&rsquo;s initial public offering)</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; border-bottom: Black 1.5pt solid">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>I.
PURPOSE OF THE COMMITTEE</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
purpose of the Audit Committee (the &ldquo;<B>Committee</B>&rdquo;) of the Board of Directors (the &ldquo;<B>Board</B>&rdquo;)
of the Company is to oversee the accounting and financial reporting processes of the Company and its subsidiaries and the audits
of the financial statements of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>II.
COMPOSITION OF THE COMMITTEE</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Committee shall consist of three or more directors, as determined from time to time by the Board. Members of the Committee shall
be qualified to serve on the Committee pursuant to the requirements of the Nasdaq Listing Rules (or rules of the trading market
on which the Company&rsquo;s securities then trade) (collectively with Nasdaq, the &ldquo;Trading Market&rdquo;) and Rule 10A-3
under the Securities Exchange Act of 1934, as amended, and any additional requirements that the Board deems appropriate.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
chairperson of the Committee shall be designated by the Board, provided that if the Board does not so designate a chairperson,
the members of the Committee, by a majority vote, may designate a chairperson.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Any
vacancy on the Committee shall be filled by majority vote of the Board. No member of the Committee shall be removed except by
majority vote of the Board.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Each
member of the Committee (i) must be able to read and understand fundamental financial statements, including the Company&rsquo;s
balance sheet, income statement and cash flow statement, (ii) shall not have participated in the preparation of the financial
statements of the Company or any current subsidiary of the Company at any time during the past three years, (iii) must not accept
any consulting, advisory, or other compensatory fee from the Company other than for board service and (iv) must not be an affiliated
person of the Company. In addition, at least one member of the Committee must be designated by the Board who qualifies as an &ldquo;audit
committee financial expert,&rdquo; under Item 407(d)(5)(ii) and (iii) of Regulation S-K.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 1; Options: NewSection; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>III.
MEETINGS OF THE COMMITTEE</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Committee shall meet as often as it determines necessary to carry out its duties and responsibilities, but no less frequently
than once every fiscal quarter. The Committee, in its discretion, may ask members of management or others to attend its meetings
(or portions thereof) and to provide pertinent information as necessary.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
majority of the members of the Committee present in person or by means of a conference telephone or other communications equipment
by means of which all persons participating in the meeting can hear each other shall constitute a quorum.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Committee shall maintain minutes of its meetings and records relating to those meetings.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>IV.
DUTIES AND RESPONSIBILITIES OF THE COMMITTEE</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
carrying out its duties and responsibilities, the Committee&rsquo;s policies and procedures should remain flexible, so that it
may be in a position to best address, react or respond to changing circumstances or conditions. The following duties and responsibilities
are within the authority of the Committee and the Committee shall, consistent with and subject to applicable law and rules and
regulations promulgated by the U.S. Securities and Exchange Commission (&ldquo;<B>SEC</B>&rdquo;) , the Trading Market, or any
other applicable regulatory authority:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Selection,
Evaluation, and Oversight of the Auditors</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 24px; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 24px; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a)</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Be
    directly responsible for the appointment, compensation, retention and oversight of the work of any registered public accounting
    firm engaged for the purpose of preparing or issuing an audit report or performing other audit, review or attest services
    for the Company, and each such registered public accounting firm must report directly to the Committee (the registered public
    accounting firm engaged for the purpose of preparing or issuing an audit report for inclusion in the Company&rsquo;s Annual
    Report on Form 20-F (or comparable form) is referred to herein as the &ldquo;<B>independent auditors</B>&rdquo;);</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 24px; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 24px; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">b)</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Review
    and, in its sole discretion, approve in advance the Company&rsquo;s independent auditors&rsquo; annual engagement letter,
    including the proposed fees contained therein, as well as all audit and, as provided in the Sarbanes-Oxley Act of 2002 (the
    &ldquo;<B>Act</B>&rdquo;) and the SEC rules and regulations promulgated thereunder, all permitted non-audit engagements and
    relationships between the Company and such independent auditors (which approval should be made after receiving input from
    the Company&rsquo;s management, if desired). Approval of audit and permitted non-audit services will be made by the Committee
    or by one or more members of the Committee as shall be designated by the Committee/the chairperson of the Committee and the
    person[s] granting such approval shall report such approval to the Committee at the next scheduled meeting;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 24px; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 24px; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">c)</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Review
    the performance of the Company&rsquo;s independent auditors, including the lead partner and reviewing partner of the independent
    auditors, and, in its sole discretion, make decisions regarding the replacement or termination of the independent auditors
    when circumstances warrant; and</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 24px; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 24px; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">d)</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Evaluate
    the independence of the Company&rsquo;s independent auditors to ensure compliance with the Act, rules and regulations promulgated
    by the SEC, as well as the Trading Market rules by, among other things:</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 72px; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 24px; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">i.</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">obtaining
    and reviewing from the Company&rsquo;s independent auditors a formal written statement delineating all relationships between
    the independent auditors and the Company, consistent with Independence Standards Board Standard 1;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 72px; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 24px; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ii.</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">actively
    engaging in a dialogue with the Company&rsquo;s independent auditors with respect to any disclosed relationships or services
    that may impact the objectivity and independence of the auditors;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 72px; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 24px; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">iii.</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">taking,
    or recommending that the Board take, appropriate action to oversee the independence of the Company&rsquo;s independent auditors;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 72px; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 24px; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">iv.</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">monitoring
    compliance by the Company&rsquo;s independent auditors with the audit partner rotation requirements contained in the Act and
    the rules and regulations promulgated by the SEC thereunder;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 72px; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 24px; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">v.</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">monitoring
    compliance by the Company of the employee conflict of interest requirements contained in the Act and the rules and regulations
    promulgated by the SEC thereunder; and</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 72px; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 24px; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">vi.</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">engaging
    in a dialogue with the independent auditors to confirm that audit partner compensation is consistent with applicable SEC rules;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Oversight
of Annual Audit and Quarterly Reviews</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 24px; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 24px; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a)</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Review
    and discuss with the independent auditors their annual audit plan, including the timing and scope of audit activities, and
    monitor such plan&rsquo;s progress and results during the year;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 24px; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 24px; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">b)</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Review
    with management, the Company&rsquo;s independent auditors and the director of the Company&rsquo;s internal auditing department,
    the following information which is required to be reported by the independent auditor:</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 72px; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 24px; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">i.</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">all
    critical accounting policies and practices to be used;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 72px; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 24px; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ii.</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">all
    alternative treatments of financial information that have been discussed by the independent auditors and management, ramifications
    of the use of such alternative disclosures and treatments, and the treatment preferred by the independent auditors;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 3; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 72px; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 24px; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">iii.</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">all
    other material written communications between the independent auditors and management, such as any management letter and any
    schedule of unadjusted differences; and</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 72px; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 24px; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">iv.</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">any
    material financial arrangements of the Company which do not appear on the financial statements of the Company; and</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 24px; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 24px; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">c)</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Resolve
    all disagreements between the Company&rsquo;s independent auditors and management regarding financial reporting;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Oversight
of Financial Reporting Process and Internal Controls</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 24px; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 24px; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a)</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Review:</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 72px; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 24px; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">i.</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    adequacy and effectiveness of the Company&rsquo;s accounting and internal control policies and procedures on a regular basis,
    including the responsibilities, budget, compensation and staffing of the Company&rsquo;s internal audit function, through
    inquiry and discussions with the Company&rsquo;s independent auditors and management;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 72px; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 24px; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ii.</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    yearly report prepared by management, and attested to by the Company&rsquo;s independent auditors, if required, assessing
    the effectiveness of the Company&rsquo;s internal control over financial reporting and stating management&rsquo;s responsibility
    for establishing and maintaining adequate internal control over financial reporting prior to its inclusion in the Company&rsquo;s
    Annual Report on Form 20-F; and</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 72px; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 24px; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">iii.</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    Committee&rsquo;s level of involvement and interaction with the Company&rsquo;s internal audit function, including the Committee&rsquo;s
    line of authority and role in appointing and compensating employees in the internal audit function;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 24px; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 24px; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">b)</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Review
    with the executive chairperson, chief executive officer, chief financial officer and independent auditors, periodically, the
    following:</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 72px; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 24px; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">i.</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">all
    significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which
    are reasonably likely to adversely affect the Company&rsquo;s ability to record, process, summarize and report financial information;
    and</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 4; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 72px; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 24px; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ii.</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">any
    fraud, whether or not material, that involves management or other employees who have a significant role in the Company&rsquo;s
    internal control over financial reporting;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 24px; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 24px; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">c)</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Discuss
    guidelines and policies governing the process by which senior management of the Company and the relevant departments of the
    Company, including the internal auditing department, assess and manage the Company&rsquo;s exposure to risk, as well as the
    Company&rsquo;s major financial risk exposures and the steps management has taken to monitor and control such exposures;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 24px; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 24px; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">d)</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Review
    with management the progress and results of all internal audit projects, and, when deemed necessary or appropriate by the
    Committee, direct the Company&rsquo;s chief executive officer to assign additional internal audit projects to the director
    of the Company&rsquo;s internal auditing department;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 24px; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 24px; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">e)</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Receive
    periodic reports from the Company&rsquo;s independent auditors, management and director of the Company&rsquo;s internal auditing
    department to assess the impact on the Company of significant accounting or financial reporting developments that may have
    a bearing on the Company;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 24px; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 24px; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">f)</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Establish
    and maintain free and open means of communication between and among the Committee, the Company&rsquo;s independent auditors,
    the Company&rsquo;s internal auditing department and management, including providing such parties with appropriate opportunities
    to meet separately and privately with the Committee on a periodic basis; and</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 24px; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 24px; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">g)</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Review
    the type and presentation of information to be included in the Company&rsquo;s earnings press releases (especially the use
    of &ldquo;pro forma&rdquo; or &ldquo;adjusted&rdquo; information not prepared in compliance with generally accepted accounting
    principles), as well as financial information and earnings guidance provided by the Company to analysts and rating agencies
    (which review may be done generally (i.e., discussion of the types of information to be disclosed and type of presentations
    to be made), and the Committee need not discuss in advance each earnings release or each instance in which the Company may
    provide earnings guidance);</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Miscellaneous</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 24px; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 24px; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a)</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Establish
    and implement policies and procedures for the Committee&rsquo;s review and approval or disapproval of proposed transactions
    or courses of dealings with respect to which executive officers or directors or members of their immediate families have an
    interest (including all transactions required to be disclosed by Item 404(a) of Regulation S-K);</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<!-- Field: Page; Sequence: 5; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 24px; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 24px; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">b)</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Establish
    and implement policies and procedures for the Committee&rsquo;s review and approval or disapproval of proposed transactions
    or courses of dealings that may impact a director&rsquo;s independence, as such term is defined by Item 407 of Regulation
    S-K and applicable Trading Market rules;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 24px; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 24px; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">c)</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Meet
    periodically with the general counsel, and outside counsel when appropriate, to review legal and regulatory matters, including
    (i) any matters that may have a material impact on the financial statements of the Company and (ii) any matters involving
    potential or ongoing material violations of law or breaches of fiduciary duty by the Company or any of its directors, officers,
    employees, or agents or breaches of fiduciary duty to the Company;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 24px; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 24px; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">d)</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Review
    the Company&rsquo;s policies relating to the ethical handling of conflicts of interest and review past or proposed transactions
    between the Company and members of management as well as policies and procedures with respect to officers&rsquo; expense accounts
    and perquisites, including the use of corporate assets, and consider the results of any review of these policies and procedures
    by the Company&rsquo;s independent auditors;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 24px; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 24px; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">e)</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Review
    and pre-approve any proposed transaction between the Company or any of its subsidiaries or consolidated affiliated entities
    and any of the officers, directors or shareholders of the Company (each, a &ldquo;<B>Related Party</B>&rdquo;) and/or any
    affiliate of a Related Party involving over US$100 (FINRA gift limit) in a single transaction or a series of related transactions;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 24px; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 24px; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">f)</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Review
    and approve in advance any services provided by the Company&rsquo;s independent auditors to the Company&rsquo;s executive
    officers or members of their immediate family;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 24px; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 24px; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">g)</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Review
    the Company&rsquo;s program to monitor compliance with the Company&rsquo;s Code of Business Conduct and Ethics (the &ldquo;<B>Code
    of Conduct</B>&rdquo;), and meet periodically with the Company&rsquo;s compliance officer to discuss compliance with the Code
    of Conduct;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 24px; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 24px; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">h)</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Establish
    procedures for (i) the receipt, retention and treatment of complaints received by the Company regarding accounting, internal
    accounting controls or auditing matters, and (ii) the confidential, anonymous submission by employees of the Company of concerns
    regarding questionable accounting or auditing matters;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 24px; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 24px; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">i)</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Establish
    procedures for the receipt, retention and treatment of reports of evidence of a material violation made by attorneys appearing
    and practicing before the SEC in the representation of the Company or any of its subsidiaries, or reports made by the Company&rsquo;s
    chief executive officer or general counsel in relation thereto;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 24px; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 24px; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">j)</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Propose
    appropriate funding to compensate the Company&rsquo;s accountants, auditors and advisors employed by the audit committee,
    to pay for ordinary administrative expenses of the audit committee and to fund or pay any other applicable items so as to
    satisfy Nasdaq Rule 5605;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 6; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 24px; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 24px; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">k)</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Secure
    independent expert advice to the extent the Committee determines it to be appropriate, including retaining, with or without
    Board approval, independent counsel, accountants, consultants or others, to assist the Committee in fulfilling its duties
    and responsibilities, the cost of such independent expert advisors to be borne by the Company;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 24px; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 24px; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">l)</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Review
    and assess the adequacy of this Charter on an annual basis; and</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 24px; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 24px; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">m)</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Perform
    such additional activities, and consider such other matters, within the scope of its responsibilities, as the Committee or
    the Board deems necessary or appropriate.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>V.
INVESTIGATIONS AND STUDIES; OUTSIDE ADVISERS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Committee may conduct or authorize investigations into or studies of matters within the Committee&rsquo;s scope of responsibilities,
and may retain, at the Company&rsquo;s expense, such independent counsel or other consultants or advisers as it deems necessary.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">*
* *</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">While
the Committee has the duties and responsibilities set forth in this charter, the Committee is not responsible for preparing or
certifying the financial statements, for planning or conducting the audit, or for determining whether the Company&rsquo;s financial
statements are complete and accurate and are in accordance with generally accepted accounting principles.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
fulfilling their responsibilities hereunder, it is recognized that members of the Committee are not full-time employees of the
Company, it is not the duty or responsibility of the Committee or its members to conduct &ldquo;field work&rdquo; or other types
of auditing or accounting reviews or procedures or to set auditor independence standards, and each member of the Committee shall
be entitled to rely on (i) the integrity of those persons and organizations within and outside the Company from which it receives
information and (ii) the accuracy of the financial and other information provided to the Committee absent actual knowledge to
the contrary.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Nothing
contained in this Charter is intended to create, or should be construed as creating, any responsibility or liability of the members
of the Committee, except to the extent otherwise provided under applicable federal or state law.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 7; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>



<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.2
<SEQUENCE>46
<FILENAME>ff12018ex99-2_aptorum.htm
<DESCRIPTION>CHARTER OF THE COMPENSATION COMMITTEE
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0; text-align: right"><B>Exhibit 99.2</B></P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>CHARTER OF THE COMPENSATION COMMITTEE
OF THE BOARD OF DIRECTORS OF</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>APTORUM GROUP LIMITED</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>(Adopted by the Board of Directors of
Aptorum Group Limited (the &ldquo;Company&rdquo;) on October 13, 2017, effective upon the effectiveness of the Company&rsquo;s
registration statement on Form F-1 relating to the Company&rsquo;s initial public offering)</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; border-bottom: Black 1.5pt solid">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>I. PURPOSE OF THE COMMITTEE</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The purposes of the
Company&rsquo;s Compensation Committee (the &ldquo;<B>Committee</B>&rdquo;) of the Board of Directors (the &ldquo;<B>Board</B>&rdquo;)
shall be to oversee the Company&rsquo;s compensation and employee benefit plans and practices, including its executive compensation
plans, and to perform such further functions as may be consistent with this Charter or assigned by applicable law, the Company's
memorandum and articles of association or the Board.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>II. COMPOSITION OF THE COMMITTEE</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Committee shall
consist of three or more directors as determined from time to time by the Board. Each member of the Committee shall be qualified
to serve on the Committee pursuant to the requirements of the Nasdaq, and any additional requirements that the Board deems appropriate.
Composition of the Committee shall also comply with any other applicable laws and regulations. In addition, in affirmatively determining
the independence of any director who will serve on the Committee, the Board must consider all factors specifically relevant to
determining whether a director has a relationship to the Company which is material to that director&rsquo;s ability to be independent
from management in connection with the duties of a Committee member, including but not limited to (i) the source of compensation
of such director, including any consulting, advisory or other compensatory fee paid by the Company to such director; and (ii) whether
such director is affiliated with the Company, a subsidiary of the Company or an affiliated of a subsidiary of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The chairperson of
the Committee shall be designated by the Board. Any vacancy on the Committee shall be filled by majority vote of the Board. No
member of the Committee shall be removed except by majority vote of the Board.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>III. MEETINGS AND PROCEDURES OF THE
COMMITTEE</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Committee shall
meet as often as it determines necessary to carry out its duties and responsibilities, but no less than once annually. The Committee,
in its discretion, may ask members of management or others to attend its meetings (or portions thereof) and to provide pertinent
information as necessary, provided, that the Chief Executive Officer of the Company may not be present during any portion of a
Committee meeting in which deliberation or any vote regarding his or her compensation occurs.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 1; Options: NewSection; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">A majority of the members
of the Committee present in person or by means of a conference telephone or other communications equipment by means of which all
persons participating in the meeting can hear each other shall constitute a quorum.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Committee shall
maintain minutes of its meetings and records relating to those meetings and shall report regularly to the Board on its activities,
as appropriate.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>IV. DUTIES AND RESPONSIBILITIES OF THE
COMMITTEE</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>A. Executive Compensation</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Committee shall
have the following duties and responsibilities with respect to the Company&rsquo;s executive compensation plans:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 48px">&nbsp;</TD>
    <TD STYLE="width: 24px; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a)</FONT></TD>
    <TD STYLE="text-align: justify; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">To review at least annually the goals and objectives of the Company&rsquo;s executive compensation plans, and amend, or recommend that the Board amend, these goals and objectives if the Committee deems it appropriate.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 48px">&nbsp;</TD>
    <TD STYLE="width: 24px; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">b)</FONT></TD>
    <TD STYLE="text-align: justify; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">To review at least annually the Company&rsquo;s executive compensation plans in light of the Company&rsquo;s goals and objectives with respect to such plans, and, if the Committee deems it appropriate, adopt, or recommend to the Board the adoption of, new, or the amendment of existing, executive compensation plans.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 48px">&nbsp;</TD>
    <TD STYLE="width: 24px; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">c)</FONT></TD>
    <TD STYLE="text-align: justify; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">To evaluate annually the performance of the Chief Executive Officer in light of the goals and objectives of the Company&rsquo;s executive compensation plans, and, either as a Committee or together with the other independent directors (as directed by the Board), determine and approve the Chief Executive Officer&rsquo;s compensation level based on this evaluation. In determining the long-term incentive component of the Chief Executive Officer&rsquo;s compensation, the Committee shall consider factors as it determines relevant, which may include, for example the Company's performance and relative shareholder return, the value of similar awards to chief executive officers of comparable companies, and the awards given to the Chief Executive Officer of the Company in past years. The Committee may discuss the Chief Executive Officer&rsquo;s compensation with the Board if it chooses to do so.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 48px">&nbsp;</TD>
    <TD STYLE="width: 24px; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">d)</FONT></TD>
    <TD STYLE="text-align: justify; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">To evaluate annually the performance of the other executive officers of the Company in light of the goals and objectives of the Company&rsquo;s compensation plans, and either as a Committee or together with the other independent directors (as directed by the Board) determine and approve the compensation of such other executive officers. To the extent that long-term incentive compensation is a component of such executive officer&rsquo;s compensation, the Committee shall consider all relevant factors in determining the appropriate level of such compensation, including the factors applicable with respect to the Chief Executive Officer.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"></P>

<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 48px">&nbsp;</TD>
    <TD STYLE="width: 24px; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">e)</FONT></TD>
    <TD STYLE="text-align: justify; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">To evaluate annually the appropriate level of compensation for Board and Committee service by non-employee directors.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 48px">&nbsp;</TD>
    <TD STYLE="width: 24px; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">f)</FONT></TD>
    <TD STYLE="text-align: justify; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">To review and approve any severance or termination arrangements to be made with any executive officer of the Company.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 48px">&nbsp;</TD>
    <TD STYLE="width: 24px; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">g)</FONT></TD>
    <TD STYLE="text-align: justify; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">To perform such duties and responsibilities as may be assigned to the Board or the Committee under the terms of any executive compensation plan.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 48px">&nbsp;</TD>
    <TD STYLE="width: 24px; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">h)</FONT></TD>
    <TD STYLE="text-align: justify; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">To review perquisites or other personal benefits to the Company&rsquo;s executive officers and directors and recommend any changes to the Board.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 48px">&nbsp;</TD>
    <TD STYLE="width: 24px; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">i)</FONT></TD>
    <TD STYLE="text-align: justify; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">To review compensation arrangements for the Company's employees to evaluate whether incentive and other forms of pay encourage unnecessary or excessive risk taking, and review and discuss, at least annually, the relationship between risk management policies and practices, corporate strategy and the Company&rsquo;s compensation arrangements.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 48px">&nbsp;</TD>
    <TD STYLE="width: 24px; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">j)</FONT></TD>
    <TD STYLE="text-align: justify; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">To review and approve the description of executive compensation included in the Company&rsquo;s annual report on Form 20-F.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 48px">&nbsp;</TD>
    <TD STYLE="width: 24px; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">k)</FONT></TD>
    <TD STYLE="text-align: justify; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">To perform such other functions as assigned by law, the Company's memorandum and articles of association or the Board.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>B. General Compensation and Employee
Benefit Plans</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Committee shall
have the following duties and responsibilities with respect to the Company&rsquo;s general compensation and employee benefit plans,
including incentive compensation and equity-based plans:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 48px">&nbsp;</TD>
    <TD STYLE="width: 24px; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a)</FONT></TD>
    <TD STYLE="text-align: justify; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">To review at least annually the goals and objectives of the Company&rsquo;s general compensation plans and other employee benefit plans, including incentive-compensation and equity-based plans, and amend, or recommend that the Board amend, these goals and objectives if the Committee deems it appropriate.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 48px">&nbsp;</TD>
    <TD STYLE="width: 24px; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">b)</FONT></TD>
    <TD STYLE="text-align: justify; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">To review at least annually the Company&rsquo;s general compensation plans and other employee benefit plans, including incentive-compensation and equity-based plans, in light of the goals and objectives of these plans, and recommend that the Board amend these plans if the Committee deems it appropriate.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 48px">&nbsp;</TD>
    <TD STYLE="width: 24px; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">c)</FONT></TD>
    <TD STYLE="text-align: justify; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">To review all equity-compensation plans to be submitted for shareholder approval under the Nasdaq listing standards, and to review and, in the Committee&rsquo;s sole discretion, approve all equity-compensation plans that are exempt from such shareholder approval requirement.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"></P>

<!-- Field: Page; Sequence: 3; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 48px">&nbsp;</TD>
    <TD STYLE="width: 24px; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">d)</FONT></TD>
    <TD STYLE="text-align: justify; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">To perform such duties and responsibilities as may be assigned to the Board or the Committee under the terms of any compensation or other employee benefit plan, including any incentive-compensation or equity-based plan.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>V. ROLE OF CHIEF EXECUTIVE OFFICER</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Chief Executive
Officer may make, and the Committee may consider, recommendations to the Committee regarding the Company&rsquo;s compensation and
employee benefit plans and practices, including its executive compensation plans, its incentive compensation and equity-based plans
with respect to executive officers other than the Chief Executive Officer and the Company&rsquo;s director compensation arrangements.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>VI. EVALUATION OF THE COMMITTEE</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Committee shall,
no less frequently than annually, evaluate its own performance. In conducting this review, the Committee shall evaluate whether
this Charter appropriately addresses the matters that are or should be within its scope and shall recommend such changes as it
deems necessary or appropriate to the Board for its consideration. The Committee shall address all matters that the Committee considers
relevant to its performance, including at least the following: the adequacy, appropriateness and quality of the information and
recommendations presented by the Committee to the Board, the manner in which they were discussed or debated, and whether the number
and length of meetings of the Committee were adequate for the Committee to complete its work in a thorough and thoughtful manner.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Committee shall
deliver to the Board a report, which may be oral, setting forth the results of its evaluation, including any recommended amendments
to this Charter and any recommended changes to the Company's or the Board's policies or procedures.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>VII. INVESTIGATIONS AND STUDIES; OUTSIDE
ADVISERS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Committee may conduct
or authorize investigations into or studies of matters within the Committee's scope of responsibilities, and may, in its sole discretion,
retain or obtain the advice of a compensation consultant, legal counsel or other adviser. The Committee shall be directly responsible
for the appointment, compensation and oversight of the work of any compensation consultant, legal counsel or other adviser retained
by the Committee, the expense of which shall be borne by the Company. The Committee may select a compensation consultant, legal
counsel or other adviser to the Committee, other than in-house legal counsel, only after taking into consideration all factors
relevant to that person's independence from management, including the following:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 48px">&nbsp;</TD>
    <TD STYLE="width: 24px; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a)</FONT></TD>
    <TD STYLE="text-align: justify; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The provision of other services to the Company by the person that employs the compensation consultant, legal counsel or other adviser;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"></P>

<!-- Field: Page; Sequence: 4; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 48px">&nbsp;</TD>
    <TD STYLE="width: 24px; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">b)</FONT></TD>
    <TD STYLE="text-align: justify; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The amount of fees received from the Company by the person that employs the compensation consultant, legal counsel or other adviser, as a percentage of the total revenue of the person that employs the compensation consultant, legal counsel or other adviser;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 48px">&nbsp;</TD>
    <TD STYLE="width: 24px; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">c)</FONT></TD>
    <TD STYLE="text-align: justify; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The policies and procedures of the person that employs the compensation consultant, legal counsel or other adviser that are designed to prevent conflicts of interest;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 48px">&nbsp;</TD>
    <TD STYLE="width: 24px; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">d)</FONT></TD>
    <TD STYLE="text-align: justify; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Any business or personal relationship of the compensation consultant, legal counsel or other adviser with a member of the Committee;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 48px">&nbsp;</TD>
    <TD STYLE="width: 24px; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">e)</FONT></TD>
    <TD STYLE="text-align: justify; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Any stock of the Company owned by the compensation consultant, legal counsel or other adviser; and</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 48px">&nbsp;</TD>
    <TD STYLE="width: 24px; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">f)</FONT></TD>
    <TD STYLE="text-align: justify; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Any business or personal relationship of the compensation consultant, legal counsel, other adviser or the person employing the adviser with an executive officer of the Company.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Committee shall
conduct the independence assessment with respect to any compensation consultant, legal counsel or other adviser that provides advice
to the Committee, other than: (1) in-house legal counsel; and (2) any compensation consultant, legal counsel or other adviser whose
role is limited to the following activities for which no disclosure would be required under Item 407(e)(3)(iii) of Regulation S-K:
consulting on any broad-based plan that does not discriminate in scope, terms, or operation, in favor of executive officers or
directors of the Company, and that is available generally to all salaried employees; or providing information that either is not
customized for the Company or that is customized based on parameters that are not developed by the compensation consultant, and
about which the compensation consultant does not provide advice.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Nothing herein requires
a compensation consultant, legal counsel or other compensation adviser to be independent, only that the Committee consider the
enumerated independence factors before selecting or receiving advice from a compensation consultant, legal counsel or other compensation
adviser. The Committee may select or receive advice from any compensation consultant, legal counsel or other compensation adviser
it prefers, including ones that are not independent, after considering the six independence factors outlined above.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Nothing herein shall
be construed: (1) to require the Committee to implement or act consistently with the advice or recommendations of the compensation
consultant, legal counsel or other adviser to the Committee; or (2) to affect the ability or obligation of the Committee to exercise
its own judgment in fulfillment of its duties.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">* * *</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">While the members of
the Committee have the duties and responsibilities set forth in this Charter, nothing contained in this Charter is intended to
create, or should be construed as creating, any responsibility or liability of members of the Committee, except to the extent otherwise
provided under applicable federal or state law.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<!-- Field: Page; Sequence: 5; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.3
<SEQUENCE>47
<FILENAME>ff12018ex99-3_aptorum.htm
<DESCRIPTION>CHARTER OF THE NOMINATING AND CORPORATE GOVERNANCE COMMITTEE
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0; text-align: right"><B>Exhibit 99.3</B></P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>CHARTER OF THE NOMINATING AND CORPORATE
GOVERNANCE</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>COMMITTEE</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>OF THE BOARD OF DIRECTORS OF</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>APTORUM GROUP LIMITED</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>(Adopted by the Board of Directors of
Aptorum Group Limited (the &ldquo;Company&rdquo;) on October 13, 2017, effective upon the effectiveness of the Company&rsquo;s
registration statement on Form F-1 relating to the Company&rsquo;s initial public offering)</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; border-bottom: Black 1.5pt solid">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>I. PURPOSE OF THE COMMITTEE</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The purpose of the
Corporate Governance and Nominating Committee (the &ldquo;<B>Committee</B>&rdquo;) of the Board is to assist the Board in discharging
the Board&rsquo;s responsibilities regarding:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">a)</TD><TD STYLE="text-align: justify">identification of qualified candidates to become Board members;</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">b)</TD><TD STYLE="text-align: justify">selection of nominees for election as directors at the next annual meeting of shareholders (or
special meeting of shareholders at which directors are to be elected);</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">c)</TD><TD STYLE="text-align: justify">selection of candidates to fill any vacancies on the Board or any committee thereof;</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">d)</TD><TD STYLE="text-align: justify">annual review of the composition of the Board in light of the characteristics of independence,
experience and availability of the Board members;</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">e)</TD><TD STYLE="text-align: justify">oversight of the evaluation of the Board; and</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">f)</TD><TD STYLE="text-align: justify">compliance with the Company&rsquo;s Code of Business Conduct and Ethics, including reviewing the
adequacy and effectiveness of the Company&rsquo;s procedures to ensure proper compliance.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In addition to the
powers and responsibilities expressly delegated to the Committee in this Charter, the Committee may exercise any other powers and
carry out any other responsibilities delegated to it by the Board from time to time consistent with the Company&rsquo;s memorandum
and articles of association (collectively, the &ldquo;<B>Articles</B>&rdquo;). The powers and responsibilities delegated by the
Board to the Committee in this Charter or otherwise shall be exercised and carried out by the Committee as it deems appropriate
without requirement of Board approval, and any decision made by the Committee (including any decision to exercise or refrain from
exercising any of the powers delegated to the Committee hereunder) shall be at the Committee&rsquo;s sole discretion. While acting
within the scope of the powers and responsibilities delegated to it, the Committee shall have and may exercise all the powers and
authority of the Board. To the fullest extent permitted by law, the Committee shall have the power to determine which matters are
within the scope of the powers and responsibilities delegated to it.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 1; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>II. MEMBERSHIP</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Committee shall
be comprised of three or more directors, as determined by the Board, each of whom (a) satisfies the independence requirements of
the Nasdaq, and (b) has experience, in the business judgment of the Board, that would be helpful in addressing the matters delegated
to the Committee; provided, however, that all but one of the members of the Committee may be exempt from the independence requirements
of clause (a) for 90 days from the date of effectiveness of the registration statement for the Company&rsquo;s initial public offering,
and that a minority of the members of the Committee may be exempt from such independence requirements for one year from the date
of effectiveness of such registration statement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The members of the
Committee, including the chairperson of the Committee (the &ldquo;<B>Chair</B>&rdquo;), shall be appointed by the Board. Committee
members may be removed from the Committee, with or without cause, by the Board. Any action duly taken by the Committee shall be
valid and effective, whether or not the members of the Committee at the time of such action are later determined not to have satisfied
the requirements for membership provided herein.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>III. MEETINGS AND PROCEDURES</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Chair (or in his
or her absence, a member designated by the Chair) shall preside at each meeting of the Committee and set the agendas for Committee
meetings. The Committee shall have the authority to establish its own rules and procedures for notice and conduct of its meetings
so long as they are not inconsistent with any provisions of the Company&rsquo;s Articles that are applicable to the Committee.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Committee shall
meet on a regularly scheduled basis at least once per year, or more frequently as the Committee deems necessary or desirable. A
meeting of the Committee may be conducted in person or via telephone conference or similar communications equipment where every
meeting participant can hear each other.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">All non-management
directors who are not members of the Committee may attend and observe meetings of the Committee, but shall not participate in any
discussion or deliberation unless invited to do so by the Committee, and in any event shall not be entitled to vote. The Committee
may, at its discretion, include in its meetings members of the Company&rsquo;s management, or any other person whose presence the
Committee believes to be desirable and appropriate. Notwithstanding the foregoing, the Committee may exclude from its meetings
any person it deems inappropriate, including but not limited to, any non-management director who is not a member of the Committee.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Committee may retain
any independent counsel, experts or advisors that the Committee believes to be desirable and appropriate. The Committee may also
use the services of the Company&rsquo;s regular legal counsel or other advisors to the Company. The Company shall provide for appropriate
funding, as determined by the Committee, for payment of compensation to any such persons employed by the Committee and for ordinary
administrative expenses of the Committee that are necessary or appropriate in carrying out its duties. The Committee shall have
sole authority to retain and terminate any search firm to be used to identify director candidates, including sole authority to
approve such search firm&rsquo;s fees and other retention terms.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 2; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Chair shall report
to the Board regarding the activities of the Committee at appropriate times and as otherwise requested by the Chairperson of the
Board. Minutes of the meetings shall be kept by a person designated by the Chair. Draft and final versions of the minutes of meetings
shall be sent to all Committee members for their comments and records respectively, in both cases within a reasonable time after
the meetings.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>IV. DUTIES AND RESPONSIBILITIES</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">a)</TD><TD STYLE="text-align: justify">At an appropriate time prior to each annual meeting of shareholders at which directors are to be
elected or re-elected, the Committee shall recommend to the Board for nomination by the Board such candidates as the Committee,
in the exercise of its judgment, has found to be well qualified and willing and available to serve.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">b)</TD><TD STYLE="text-align: justify">At an appropriate time after a vacancy arises on the Board or a director advises the Board of his
or her intention to resign, the Committee shall recommend to the Board for appointment by the Board to fill such vacancy, such
prospective member of the Board as the Committee, in the exercise of its judgment, has found to be well qualified and willing and
available to serve.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">c)</TD><TD STYLE="text-align: justify">For purposes of (a) and (b) above, the Committee may consider the following criteria, among others
the Committee shall deem appropriate, in recommending candidates for election to the Board:</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.25in">i.</TD><TD STYLE="text-align: justify">personal and professional integrity, ethics and values;</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.25in">ii.</TD><TD STYLE="text-align: justify">experience in corporate management, such as serving as an officer or former officer of a publicly
held company, and a general understanding of marketing, finance and other elements relevant to the success of a publicly-traded
company in today&rsquo;s business environment;</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.25in">iii.</TD><TD STYLE="text-align: justify">experience in the Company&rsquo;s industry and with relevant social policy concerns;</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.25in">iv.</TD><TD STYLE="text-align: justify">experience as a board member of another publicly held company;</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.25in">v.</TD><TD STYLE="text-align: justify">academic expertise in an area of the Company&rsquo;s operations;</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.25in">vi.</TD><TD STYLE="text-align: justify">practical and mature business judgment, including ability to make independent analytical inquiries;
and,</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"></P>

<!-- Field: Page; Sequence: 3; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.25in">vii.</TD><TD STYLE="text-align: justify">if applicable, for re-election, the director&rsquo;s past attendance at meetings and participation
in and contributions to the activities of the Board.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">d)</TD><TD STYLE="text-align: justify">The foregoing notwithstanding, if the Company is legally bound by contract or otherwise to permit
a third party to designate one or more of the directors to be elected or appointed (for example, pursuant to rights contained in
shareholders&rsquo; agreement), then the nomination or appointment of such directors shall be governed by such requirements.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">e)</TD><TD STYLE="text-align: justify">The Committee shall advise the Board periodically with respect to significant developments in the
law and practice of corporate governance as well as the Company&rsquo;s compliance with applicable laws and regulations, and make
recommendations to the Board on all matters of corporate governance and on any corrective action to be taken.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">f)</TD><TD STYLE="text-align: justify">The Committee shall monitor compliance with the Company&rsquo;s Code of Business Conduct and Ethics,
including reviewing the adequacy and effectiveness of the Company&rsquo;s procedures to ensure proper compliance.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">g)</TD><TD STYLE="text-align: justify">The Committee shall, at least annually, review the performance of each current director and shall
consider the results of such evaluation when determining whether or not to recommend the nomination of such director for an additional
term.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">h)</TD><TD STYLE="text-align: justify">The Committee shall oversee the Board in the Board&rsquo;s annual review of its performance (including
its composition and organization), and will make appropriate recommendations to improve performance; the Committee will also be
responsible for establishing the evaluation criteria and implementing the process for such evaluation.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">i)</TD><TD STYLE="text-align: justify">The Committee shall consider, develop and recommend to the Board such policies and procedures with
respect to the nomination of directors or other corporate governance matters as may be required pursuant to any rules promulgated
by the U.S. Securities and Exchange Commission or otherwise considered to be desirable and appropriate in the discretion of the
Committee.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">j)</TD><TD STYLE="text-align: justify">The Committee shall evaluate its own performance on an annual basis, including its compliance with
this Charter, and provide the Board with any recommendations for changes in procedures or policies governing the Committee. The
Committee shall conduct such evaluation and review in such manner as it deems appropriate.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">k)</TD><TD STYLE="text-align: justify">The Committee shall periodically report to the Board on its findings and actions.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">l)</TD><TD STYLE="text-align: justify">The Committee shall review and reassess this Charter at least annually and submit any recommended
changes to the Board for its consideration.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>V. DELEGATION OF DUTIES</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In fulfilling its responsibilities,
the Committee shall be entitled to delegate any or all of its responsibilities to a subcommittee of the Committee, to the extent
consistent with the Company&rsquo;s Articles and applicable laws, regulations and rules of the markets in which the Company&rsquo;s
securities then trade.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 4; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>



<P STYLE="margin: 0"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>48
<FILENAME>img_001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 img_001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1"  = .L# 2(  A$! Q$!_\0
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M^*?^$?3PW=W%Y)&T\)CN8@LD0.-P)(Q]#S6AX?\ &6G^(+V[T^.*YM=1L_\
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6W9FZLQ]3S6EFE[14W[J!5*CC9,__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>49
<FILENAME>img_002.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 img_002.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" !- +\# 2(  A$! Q$!_\0
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M_"8FE7SBE@,+1R[A;!YA/(N%<CHX/*,/#,<QEG>=9A]+_P##K[_@GY_T:?\
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MY;BZ6-GB9X?+*.(EAJ\LQHXZM&IE4Z&)26-HSRZ6*_:LF^C3G69>''B!'A[
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MK+7-?\5_$#P->:=X7U&Y.N:!I_PX\/:-<^.=5^)=I_PE?B(Q>$=$\%ZM</\
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M (*3?M0?\$K/ OQZN[/X5>-OV;_V@/\ @FW#^U)I5Q\4/!OPFTCXK>+OB/\
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M/_VU?VD/BS^T'\2/#>A^,?&7Q)^(7AV\UW0/!]M\#O".E>"O"7BN70+;7/\
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C0%%%% !1110 4444 %%%% !1110 4444 %%%% !1110!_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>50
<FILENAME>img_003.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 img_003.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" ,*#)4# 2(  A$! Q$!_\0
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M>IQ1:M?I&EW*JHMRX"@.< #/ K/_ .$CUS_H,ZC_ .!3_P"-'B/_ )&?5O\
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MG_09U'_P*?\ QH_X2/7/^@SJ/_@4_P#C69119!<T_P#A(]<_Z#.H_P#@4_\
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M_"1ZY_T&=1_\"G_QK,HHL@N:?_"1ZY_T&=1_\"G_ ,:/^$CUS_H,ZC_X%/\
MXUF44607-/\ X2/7/^@SJ/\ X%/_ (T?\)'KG_09U'_P*?\ QK,HHL@N:?\
MPD>N?]!G4?\ P*?_ !H_X2/7/^@SJ/\ X%/_ (UF44607-/_ (2/7/\ H,ZC
M_P"!3_XT?\)'KG_09U'_ ,"G_P :S**+(+FG_P )'KG_ $&=1_\  I_\:/\
MA(]<_P"@SJ/_ (%/_C69119!<T_^$CUS_H,ZC_X%/_C1_P )'KG_ $&=1_\
M I_\:S**+(+FG_PD>N?]!G4?_ I_\:/^$CUS_H,ZC_X%/_C69119!<T_^$CU
MS_H,ZC_X%/\ XT?\)'KG_09U'_P*?_&LRBBR"YI_\)'KG_09U'_P*?\ QH_X
M2/7/^@SJ/_@4_P#C69119!<T_P#A(]<_Z#.H_P#@4_\ C1_PD>N?]!G4?_ I
M_P#&LRBBR"YI_P#"1ZY_T&=1_P# I_\ &C_A(]<_Z#.H_P#@4_\ C69119!<
MT_\ A(]<_P"@SJ/_ (%/_C1_PD>N?]!G4?\ P*?_ !K,HHL@N:?_  D>N?\
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MG4?_  *?_&C_ (2/7/\ H,ZC_P"!3_XUF44607-/_A(]<_Z#.H_^!3_XT?\
M"1ZY_P!!G4?_  *?_&LRBBR"YI_\)'KG_09U'_P*?_&C_A(]<_Z#.H_^!3_X
MUF44607-/_A(]<_Z#.H_^!3_ .-'_"1ZY_T&=1_\"G_QK,HHL@N:?_"1ZY_T
M&=1_\"G_ ,:/^$CUS_H,ZC_X%/\ XUF44607-/\ X2/7/^@SJ/\ X%/_ (T?
M\)'KG_09U'_P*?\ QK,HHL@N:?\ PD>N?]!G4?\ P*?_ !H_X2/7/^@SJ/\
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MZ#.H_P#@4_\ C1_PD>N?]!G4?_ I_P#&LRBBR"YI_P#"1ZY_T&=1_P# I_\
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MKG_09U'_ ,"G_P :/^$CUS_H,ZC_ .!3_P"-9E%%D%S3_P"$CUS_ *#.H_\
M@4_^-'_"1ZY_T&=1_P# I_\ &LRBBR"YI_\ "1ZY_P!!G4?_  *?_&C_ (2/
M7/\ H,ZC_P"!3_XUF44607-/_A(]<_Z#.H_^!3_XT?\ "1ZY_P!!G4?_  *?
M_&LRBBR"YI_\)'KG_09U'_P*?_&C_A(]<_Z#.H_^!3_XUF44607-/_A(]<_Z
M#.H_^!3_ .-'_"1ZY_T&=1_\"G_QK,HHL@N:?_"1ZY_T&=1_\"G_ ,:/^$CU
MS_H,ZC_X%/\ XUF44607-/\ X2/7/^@SJ/\ X%/_ (T?\)'KG_09U'_P*?\
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MLRBBR"YI_P#"1ZY_T&=1_P# I_\ &C_A(]<_Z#.H_P#@4_\ C69119!<T_\
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M(]<_Z#.H_P#@4_\ C69119!<T_\ A(]<_P"@SJ/_ (%/_C1_PD>N?]!G4?\
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M-'_"1ZY_T&=1_P# I_\ &LRBBR"YI_\ "1ZY_P!!G4?_  *?_&C_ (2/7/\
MH,ZC_P"!3_XUF44607/:/@Q>76J?VW_:%S-=^7Y&S[1(9-N?,SC.<9P/RHJ#
MX%?\Q_\ [=__ &K16,]S6.QYCXC_ .1GU;_K]F_]#-9E:?B/_D9]6_Z_9O\
MT,UF5LMC)A1113 **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** /8?@
M5_S'_P#MW_\ :M%'P*_YC_\ V[_^U:*PG\1I'8\Q\1_\C/JW_7[-_P"AFLRM
M/Q'_ ,C/JW_7[-_Z&:S*V6QFPHHHI@%%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% 'L/P*_P"8_P#]N_\ [5HH^!7_ #'_ /MW_P#:M%83^(TCL>8^
M(_\ D9]6_P"OV;_T,UF5I^(_^1GU;_K]F_\ 0S696RV,V%%%%, HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MM%>%RXMX5C#'(ZX S7F=>K_''_D*Z1_UQD_]"%:VE:#X)\(>#X];U-+75Y&
M1Y5VW"LY_@C4G;D8//7@\]JS@[0N^Y<U>5EV/$JGLK1[^_M[.(JLD\JQ*6Z
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M)"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 :&AZM-H6MVFJ0*'DMI ^T]&'0C\02
M*]:E\4_##Q-;F?6+%+6Y9]T@:V=9&;'4O$,L.>Y[=*\5HI-7!.Q[:/B#X'\(
M:4]OX7MGN))"6V(CJ-W;>\GS8^F>G:O&;V[FO[ZXO+AMTT\C2.?5B<G^=044
ME%)W&Y:6"BBBJ$%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M![#\"O\ F/\ _;O_ .U:*/@5_P Q_P#[=_\ VK16$_B-(['F/B/_ )&?5O\
MK]F_]#-9E:?B/_D9]6_Z_9O_ $,UF5LMC-A1113 **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M/^$9O_\ GXTG_P &UK_\<H_X1F__ .?C2?\ P;6O_P <HN%C'HK8_P"$9O\
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MG_P;6O\ \<HN%C'HK8_X1F__ .?C2?\ P;6O_P <H_X1F_\ ^?C2?_!M:_\
MQRBX6,>BMC_A&;__ )^-)_\ !M:__'*/^$9O_P#GXTG_ ,&UK_\ '*+A8QZ*
MV/\ A&;_ /Y^-)_\&UK_ /'*/^$9O_\ GXTG_P &UK_\<HN%C'HK8_X1F_\
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MG_P;6O\ \<HN%C'HK8_X1F__ .?C2?\ P;6O_P <H_X1F_\ ^?C2?_!M:_\
MQRBX6,>BMC_A&;__ )^-)_\ !M:__'*?#X3U2XFCAADTR261@B(FJVI9F)P
M ).2:+H+&)16Q_PC-_\ \_&D_P#@VM?_ (Y1_P (S?\ _/QI/_@VM?\ XY1<
M+&/16Q_PC-__ ,_&D_\ @VM?_CE'_",W_P#S\:3_ .#:U_\ CE%PL8]%;'_"
M,W__ #\:3_X-K7_XY1_PC-__ ,_&D_\ @VM?_CE%PL8]%;'_  C-_P#\_&D_
M^#:U_P#CE'_",W__ #\:3_X-K7_XY1<+&/16Q_PC-_\ \_&D_P#@VM?_ (Y1
M_P (S?\ _/QI/_@VM?\ XY1<+&/16Q_PC-__ ,_&D_\ @VM?_CE'_",W_P#S
M\:3_ .#:U_\ CE%PL8]%;'_",W__ #\:3_X-K7_XY1_PC-__ ,_&D_\ @VM?
M_CE%PL8]%;'_  C-_P#\_&D_^#:U_P#CE'_",W__ #\:3_X-K7_XY1<+&/16
MQ_PC-_\ \_&D_P#@VM?_ (Y1_P (S?\ _/QI/_@VM?\ XY1<+&/16Q_PC-__
M ,_&D_\ @VM?_CE'_",W_P#S\:3_ .#:U_\ CE%PL8]%;'_",W__ #\:3_X-
MK7_XY1_PC-__ ,_&D_\ @VM?_CE%PL8]%;'_  C-_P#\_&D_^#:U_P#CE'_"
M,W__ #\:3_X-K7_XY1<+&/16Q_PC-_\ \_&D_P#@VM?_ (Y1_P (S?\ _/QI
M/_@VM?\ XY1<+&/16Q_PC-__ ,_&D_\ @VM?_CE'_",W_P#S\:3_ .#:U_\
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M/_@VM?\ XY1<+&/16Q_PC-__ ,_&D_\ @VM?_CE'_",W_P#S\:3_ .#:U_\
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M6,>BMC_A&;__ )^-)_\ !M:__'*/^$9O_P#GXTG_ ,&UK_\ '*+A8QZ*V/\
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MC_A&;_\ Y^-)_P#!M:__ !RC_A&;_P#Y^-)_\&UK_P#'*+A8QZ*V/^$9O_\
MGXTG_P &UK_\<H_X1F__ .?C2?\ P;6O_P <HN%C'HK8_P"$9O\ _GXTG_P;
M6O\ \<H_X1F__P"?C2?_  ;6O_QRBX6,>BMC_A&;_P#Y^-)_\&UK_P#'*/\
MA&;_ /Y^-)_\&UK_ /'*+A8QZ*V/^$9O_P#GXTG_ ,&UK_\ '*/^$9O_ /GX
MTG_P;6O_ ,<HN%C'HK8_X1F__P"?C2?_  ;6O_QRC_A&;_\ Y^-)_P#!M:__
M !RBX6,>BMC_ (1F_P#^?C2?_!M:_P#QRC_A&;__ )^-)_\ !M:__'*+A8QZ
M*V/^$9O_ /GXTG_P;6O_ ,<H_P"$9O\ _GXTG_P;6O\ \<HN%C'HK8_X1F__
M .?C2?\ P;6O_P <H_X1F_\ ^?C2?_!M:_\ QRBX6,>BMC_A&;__ )^-)_\
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M6,>BMC_A&;__ )^-)_\ !M:__'*/^$9O_P#GXTG_ ,&UK_\ '*+A8QZ*V/\
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MC_A&;_\ Y^-)_P#!M:__ !RC_A&;_P#Y^-)_\&UK_P#'*+A8QZ*V/^$9O_\
MGXTG_P &UK_\<H_X1F__ .?C2?\ P;6O_P <HN%C'HK8_P"$9O\ _GXTG_P;
M6O\ \<H_X1F__P"?C2?_  ;6O_QRBX6,>BMC_A&;_P#Y^-)_\&UK_P#'*/\
MA&;_ /Y^-)_\&UK_ /'*+A8QZ*V/^$9O_P#GXTG_ ,&UK_\ '*/^$9O_ /GX
MTG_P;6O_ ,<HN%C'HK8_X1F__P"?C2?_  ;6O_QRC_A&;_\ Y^-)_P#!M:__
M !RBX6,>BMC_ (1F_P#^?C2?_!M:_P#QRC_A&;__ )^-)_\ !M:__'*+A8QZ
M*V/^$9O_ /GXTG_P;6O_ ,<H_P"$9O\ _GXTG_P;6O\ \<HN%C'HK8_X1F__
M .?C2?\ P;6O_P <H_X1F_\ ^?C2?_!M:_\ QRBX6,>BMC_A&;__ )^-)_\
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M6,>BMC_A&;__ )^-)_\ !M:__'*/^$9O_P#GXTG_ ,&UK_\ '*+A8QZ*V/\
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MC_A&;_\ Y^-)_P#!M:__ !RC_A&;_P#Y^-)_\&UK_P#'*+A8QZ*V/^$9O_\
MGXTG_P &UK_\<H_X1F__ .?C2?\ P;6O_P <HN%C'HK8_P"$9O\ _GXTG_P;
M6O\ \<H_X1F__P"?C2?_  ;6O_QRBX6,>BMC_A&;_P#Y^-)_\&UK_P#'*/\
MA&;_ /Y^-)_\&UK_ /'*+A8QZ*V/^$9O_P#GXTG_ ,&UK_\ '*/^$9O_ /GX
MTG_P;6O_ ,<HN%C'HK8_X1F__P"?C2?_  ;6O_QRC_A&;_\ Y^-)_P#!M:__
M !RBX6,>BMC_ (1F_P#^?C2?_!M:_P#QRC_A&;__ )^-)_\ !M:__'*+A8QZ
M*V/^$9O_ /GXTG_P;6O_ ,<H_P"$9O\ _GXTG_P;6O\ \<HN%C'HK8_X1F__
M .?C2?\ P;6O_P <H_X1F_\ ^?C2?_!M:_\ QRBX6,>BMC_A&;__ )^-)_\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !6Q<_\ (F:9_P!A"[_]%VU8];%S_P B9IG_ &$+O_T7;4F!CT444P"B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "MCPE_R.>A?]A"W_\ 1BUCUL>$O^1ST+_L
M(6__ *,6D]@1CT444P"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH *V-9_Y!7AW_ +![_P#I5/6/6QK/_(*\._\
M8/?_ -*IZ0&/1113 **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** /8?@5_S'_^W?\ ]JT4
M? K_ )C_ /V[_P#M6BL)_$:1V/,?$?\ R,^K?]?LW_H9K,K3\1_\C/JW_7[-
M_P"AFLRMEL9L****8!1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 5L7/_ ")FF?\ 80N__1=M6/6Q<_\ (F:9
M_P!A"[_]%VU)@8]%%%, HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ K8\)?\CGH7_8
M0M__ $8M8];'A+_D<]"_["%O_P"C%I/8$8]%%%, HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "MC6?^05X=_P"P
M>_\ Z53UCUL:S_R"O#O_ &#W_P#2J>D!CT444P"BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@#V'X%?\Q__MW_ /:M%'P*_P"8_P#]N_\ [5HK"?Q&D=CS'Q'_ ,C/JW_7
M[-_Z&:S*T_$?_(SZM_U^S?\ H9K,K9;&;"BBBF 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %;%S_P B9IG_
M &$+O_T7;5CUL7/_ ")FF?\ 80N__1=M28&/1113 **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH *V/"7_(YZ%_V$+?_P!&+6/6QX2_Y'/0O^PA;_\ HQ:3V!&/1113
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ K8UG_D%>'?\ L'O_ .E4]8];&L_\@KP[_P!@]_\ TJGI 8]%%%,
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M-R.ARDB^JG_)I<RO8?*[7,FBBBJ$%%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110![#\"O^8__ -N__M6BCX%?\Q__ +=__:M%83^(TCL>8^(_^1GU;_K]
MF_\ 0S696GXC_P"1GU;_ *_9O_0S696RV,V%%%%, HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *V+G_D3-,_
M["%W_P"B[:L>MBY_Y$S3/^PA=_\ HNVI,#'HHHI@%%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %;'A+_D<]"_["%O_ .C%K'K8\)?\CGH7_80M_P#T8M)[ C'HHHI@
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 5L:S_ ,@KP[_V#W_]*IZQZV-9_P"05X=_[![_ /I5/2 QZ***8!11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 >P? O[^N?2#_ -GKAOB)_P C
M_K/_ %W_ /917<_ O[^N?2#_ -GK4\1?"'^W_$%YJG]N>1]I??Y7V3=MX Z[
MQGIZ5$]*B?D5'X&O,\^^%4;R?$/3RN<(LK-CT\MA_45V_P 7X8[_ %OPQI[$
M S3.C'N%9D'^-=#X6\$:/\/[>YU.YO\ S9_+VRW<P$:(F>BC)QGCN<XX]*\?
M\:^+CXA\7_VI:[EM[8JEKNZX4YW$>YR?RHYE*I&W0$G&,GW/<?&.AZIJWA<:
M1H-Q!9EBL;F1V0>2 05&T'KP/IFL?X=>$/$'A&2Z@U"]M)K"50R10R.VR3/4
M!E &1U^@J75(+#XI^!E^P74<<X995#<^3* 04<#D#DC/T(S7*Z5\%4BL[J7Q
M#JJQ,JDQM:/\B #EG+J./;CIU](5X\URG9J-C&\77(\)_&'^TH%*1^9'<.J#
M&Y6 $@_'YOSKJ/C!H;:MIVE:O8J)9/,%O\O5UD^Y^O\ Z%7CFIV]K::E/;V5
MX;RWC;:EQY>SS,=P,GC\:][^&6IQ>(O!%O;7:B673Y5B8/S]PAHV_#C_ +YJ
MN7W$^WY"<O??G^92\<SIX/\ A=;Z- 1YLT:V@([\9D;\>?\ OJK'P>L([7P1
M]K11YUW,[.W^Z=H'TX/YFO/_ (OZV-2\7"QC;,6GQ^6?3>W+?T'X5TWP<\3V
M?]G2^';J5([@2-);AS@2*V,J/<')QW!]C2C>4)2ZL)6BXQZ(AC^''C=/% U\
MZQIYO/.\QG\^7)&?N_<^[CC'3'%;/QHL4G\(07A0>;;7*X;'(5@01^>W\JP9
M?@G=OK[%-1MUTAI=V?F\X)UV@8VY[9S[X[5R_P 0?"6C>$[R*WT_59;B=\%K
M6159HEQU9QCKV&WI2T:BKE;2;/4OA[_R2:#_ *XW'_H;US'P/T^!GU746 ,Z
M;(4/=5.2?SP/RKI_A[_R2:#_ *XW'_H;UYW\*/%EKX>UBXLM0E6&TO@H\YCA
M8W&<9] <D9[<5;_B37D9_8CZF;\2M:O-5\9WT,\SFWLY3#!%GY4 X) ]21DG
MZ>@KU7X8:G/XC\#2P:HQN?+E>U9I3DR(5!P3WX;%8WC3X57.OZX^KZ->VJ"Z
MP\L<[, &P/F4J#D'KC_'C:673/A3X(%O)<K/=MN=$/#7$I]!V4<9/8>YJ$TJ
M7*]RVFZET<G\([46/CK7;13E8(GB!]0LH']*R_C'J]U<^+/[,:5Q:6L2%8L_
M*789+8]<'%7?@O,]QXLU6:4[I)+8NQ]27!-=%X]\ #QAK)NM(O[6/48%6*[@
MG8@8QE6X!(.#CI@^O!IRNI1OV%%IJ5NYH?"G4Y];\$-%?NUQY$SVV9.2R;00
M#Z\-CZ5S?P?@6U\3^([=/N181?H'85U=A#8_"[P&5O+I))5+2'''G3$<*HZG
MH!]!DXKCO@I,]QK6N32G=))&CL?4EB33WG)KL+:$4^YA_%W5+NY\;RV;S/\
M9[-$$488X!*ABV/7GK["O5WU>ZMOA4NJB5C=C2ED$AY.\QCYN>IR<UXY\5?^
M2BZE](O_ $6M>IWO_)$1_P!@>/\ ] %0_P" 7_R^_KR///A%?73>/6#SR/\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %;'A+_D<]"_["%O_P"C
M%K'K8\)?\CGH7_80M_\ T8M)[ C'HHHI@%%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 5L:S_P @KP[_ -@]_P#T
MJGK'K8UG_D%>'?\ L'O_ .E4](#'HHHI@%%%% !1110 4444 %%%% !1110
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M &LOBGQ"D8C37M46-1M"B\D  ],9K)HHH T;?7]9M+06EMJ]_#; $"&*Y=4
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MUEK'["VKWYM-GE^0;E_+V_W=N<8]JSJ*5N@$]G?7>GW N+*ZGMI@"!)#(48
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ K8\)?\CGH7_80M_P#T
M8M8];'A+_D<]"_["%O\ ^C%I/8$8]%%%, HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "MC6?^05X=_[![_^E4]8
M];&L_P#(*\._]@]__2J>D!CT444P"BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M4$KLQNZYXSFDY+EYAV=['GE%%%,04444 %%%% !1110 4444 %%%% !1110
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MC2?_  ;6O_QRL>B@#8_X1F__ .?C2?\ P;6O_P <H_X1F_\ ^?C2?_!M:_\
MQRL>B@#8_P"$9O\ _GXTG_P;6O\ \<H_X1F__P"?C2?_  ;6O_QRL>B@#8_X
M1F__ .?C2?\ P;6O_P <H_X1F_\ ^?C2?_!M:_\ QRL>B@#8_P"$9O\ _GXT
MG_P;6O\ \<H_X1F__P"?C2?_  ;6O_QRL>B@#8_X1F__ .?C2?\ P;6O_P <
MH_X1F_\ ^?C2?_!M:_\ QRL>B@#8_P"$9O\ _GXTG_P;6O\ \<H_X1F__P"?
MC2?_  ;6O_QRL>B@#8_X1F__ .?C2?\ P;6O_P <H_X1F_\ ^?C2?_!M:_\
MQRL>B@#8_P"$9O\ _GXTG_P;6O\ \<H_X1F__P"?C2?_  ;6O_QRL>B@#8_X
M1F__ .?C2?\ P;6O_P <H_X1F_\ ^?C2?_!M:_\ QRL>B@#8_P"$9O\ _GXT
MG_P;6O\ \<H_X1F__P"?C2?_  ;6O_QRL>B@#8_X1F__ .?C2?\ P;6O_P <
MH_X1F_\ ^?C2?_!M:_\ QRL>B@#8_P"$9O\ _GXTG_P;6O\ \<H_X1F__P"?
MC2?_  ;6O_QRL>B@#8_X1F__ .?C2?\ P;6O_P <H_X1F_\ ^?C2?_!M:_\
MQRL>B@#;B\)ZI.Y2*33)&"LY":K:DA5!+'_6=  2?0"F?\(S?_\ /QI/_@VM
M?_CE'AG_ )"L_P#V#[W_ -)9:QZ-0-C_ (1F_P#^?C2?_!M:_P#QRC_A&;__
M )^-)_\ !M:__'*QZ* -C_A&;_\ Y^-)_P#!M:__ !RC_A&;_P#Y^-)_\&UK
M_P#'*QZ* -C_ (1F_P#^?C2?_!M:_P#QRC_A&;__ )^-)_\ !M:__'*QZ* -
MC_A&;_\ Y^-)_P#!M:__ !RC_A&;_P#Y^-)_\&UK_P#'*QZ* -C_ (1F_P#^
M?C2?_!M:_P#QRC_A&;__ )^-)_\ !M:__'*QZ* -C_A&;_\ Y^-)_P#!M:__
M !RC_A&;_P#Y^-)_\&UK_P#'*QZ* -C_ (1F_P#^?C2?_!M:_P#QRC_A&;__
M )^-)_\ !M:__'*QZ* -C_A&;_\ Y^-)_P#!M:__ !RC_A&;_P#Y^-)_\&UK
M_P#'*QZ* -C_ (1F_P#^?C2?_!M:_P#QRC_A&;__ )^-)_\ !M:__'*QZ* -
MC_A&;_\ Y^-)_P#!M:__ !RC_A&;_P#Y^-)_\&UK_P#'*QZ* -C_ (1F_P#^
M?C2?_!M:_P#QRC_A&;__ )^-)_\ !M:__'*QZ* -C_A&;_\ Y^-)_P#!M:__
M !RC_A&;_P#Y^-)_\&UK_P#'*QZ* -C_ (1F_P#^?C2?_!M:_P#QRC_A&;__
M )^-)_\ !M:__'*QZ* -C_A&;_\ Y^-)_P#!M:__ !RC_A&;_P#Y^-)_\&UK
M_P#'*QZ* -C_ (1F_P#^?C2?_!M:_P#QRGCPGJC0M,)-,,2,$9QJMKM#$$@$
M^9U.UL?0^E8E;%M_R)FI_P#80M/_ $7<T:@'_",W_P#S\:3_ .#:U_\ CE'_
M  C-_P#\_&D_^#:U_P#CE8]% &Q_PC-__P _&D_^#:U_^.4?\(S?_P#/QI/_
M (-K7_XY6/10!L?\(S?_ //QI/\ X-K7_P".4?\ ",W_ /S\:3_X-K7_ ..5
MCT4 ;'_",W__ #\:3_X-K7_XY1_PC-__ ,_&D_\ @VM?_CE8]% &Q_PC-_\
M\_&D_P#@VM?_ (Y1_P (S?\ _/QI/_@VM?\ XY6/10!L?\(S?_\ /QI/_@VM
M?_CE'_",W_\ S\:3_P"#:U_^.5CT4 ;'_",W_P#S\:3_ .#:U_\ CE'_  C-
M_P#\_&D_^#:U_P#CE8]% &Q_PC-__P _&D_^#:U_^.4?\(S?_P#/QI/_ (-K
M7_XY6/10!L?\(S?_ //QI/\ X-K7_P".4?\ ",W_ /S\:3_X-K7_ ..5CT4
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M]4C2-Y)-,595WQEM5M0'7)&1^\Y&01]0:9_PC-__ ,_&D_\ @VM?_CE&L_\
M(*\._P#8/?\ ]*IZQZ-0-C_A&;__ )^-)_\ !M:__'*/^$9O_P#GXTG_ ,&U
MK_\ '*QZ* -C_A&;_P#Y^-)_\&UK_P#'*/\ A&;_ /Y^-)_\&UK_ /'*QZ*
M-C_A&;__ )^-)_\ !M:__'*/^$9O_P#GXTG_ ,&UK_\ '*QZ* -C_A&;_P#Y
M^-)_\&UK_P#'*/\ A&;_ /Y^-)_\&UK_ /'*QZ* -C_A&;__ )^-)_\ !M:_
M_'*/^$9O_P#GXTG_ ,&UK_\ '*QZ* -C_A&;_P#Y^-)_\&UK_P#'*/\ A&;_
M /Y^-)_\&UK_ /'*QZ* -C_A&;__ )^-)_\ !M:__'*/^$9O_P#GXTG_ ,&U
MK_\ '*QZ* -C_A&;_P#Y^-)_\&UK_P#'*/\ A&;_ /Y^-)_\&UK_ /'*QZ*
M-C_A&;__ )^-)_\ !M:__'*/^$9O_P#GXTG_ ,&UK_\ '*QZ* -C_A&;_P#Y
M^-)_\&UK_P#'*/\ A&;_ /Y^-)_\&UK_ /'*QZ* -C_A&;__ )^-)_\ !M:_
M_'*/^$9O_P#GXTG_ ,&UK_\ '*QZ* -C_A&;_P#Y^-)_\&UK_P#'*/\ A&;_
M /Y^-)_\&UK_ /'*QZ* -C_A&;__ )^-)_\ !M:__'*/^$9O_P#GXTG_ ,&U
MK_\ '*QZ* -C_A&;_P#Y^-)_\&UK_P#'*/\ A&;_ /Y^-)_\&UK_ /'*QZ*
M-C_A&;__ )^-)_\ !M:__'*?-X3U2WFDAFDTR.6-BCH^JVH96!P009."*Q*V
M/%O_ ".>N_\ 80N/_1C4:@'_  C-_P#\_&D_^#:U_P#CE'_",W__ #\:3_X-
MK7_XY6/10!L?\(S?_P#/QI/_ (-K7_XY1_PC-_\ \_&D_P#@VM?_ (Y6/10!
ML?\ ",W_ /S\:3_X-K7_ ..4?\(S?_\ /QI/_@VM?_CE8]% &Q_PC-__ ,_&
MD_\ @VM?_CE'_",W_P#S\:3_ .#:U_\ CE8]% &Q_P (S?\ _/QI/_@VM?\
MXY1_PC-__P _&D_^#:U_^.5CT4 ;'_",W_\ S\:3_P"#:U_^.4?\(S?_ //Q
MI/\ X-K7_P".5CT4 ;'_  C-_P#\_&D_^#:U_P#CE'_",W__ #\:3_X-K7_X
MY6/10!L?\(S?_P#/QI/_ (-K7_XY1_PC-_\ \_&D_P#@VM?_ (Y6/10!L?\
M",W_ /S\:3_X-K7_ ..4?\(S?_\ /QI/_@VM?_CE8]% &Q_PC-__ ,_&D_\
M@VM?_CE'_",W_P#S\:3_ .#:U_\ CE8]% &Q_P (S?\ _/QI/_@VM?\ XY1_
MPC-__P _&D_^#:U_^.5CT4 ;'_",W_\ S\:3_P"#:U_^.4?\(S?_ //QI/\
MX-K7_P".5CT4 ;'_  C-_P#\_&D_^#:U_P#CE'_",W__ #\:3_X-K7_XY6/1
M0!L?\(S?_P#/QI/_ (-K7_XY1_PC-_\ \_&D_P#@VM?_ (Y6/10!L?\ ",W_
M /S\:3_X-K7_ ..4^+PGJD[E(I-,D8*SD)JMJ2%4$L?]9T !)] *Q*V/#/\
MR%9_^P?>_P#I++1J ?\ ",W_ /S\:3_X-K7_ ..4?\(S?_\ /QI/_@VM?_CE
M8]% &Q_PC-__ ,_&D_\ @VM?_CE'_",W_P#S\:3_ .#:U_\ CE8]% &Q_P (
MS?\ _/QI/_@VM?\ XY1_PC-__P _&D_^#:U_^.5CT4 ;'_",W_\ S\:3_P"#
M:U_^.4?\(S?_ //QI/\ X-K7_P".5CT4 ;'_  C-_P#\_&D_^#:U_P#CE'_"
M,W__ #\:3_X-K7_XY6/10!L?\(S?_P#/QI/_ (-K7_XY1_PC-_\ \_&D_P#@
MVM?_ (Y6/10!L?\ ",W_ /S\:3_X-K7_ ..4?\(S?_\ /QI/_@VM?_CE8]%
M&Q_PC-__ ,_&D_\ @VM?_CE'_",W_P#S\:3_ .#:U_\ CE8]% &Q_P (S?\
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M_P#Z,6L>MCPE_P CGH7_ &$+?_T8M)[ C'HHHI@%%%% !1110 4444 %%%%
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M7_K0JRYW$^=J***V,PHHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MM_Y'/7?^PA<?^C&K'K8\6_\ (YZ[_P!A"X_]&-6/26P,****8!1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!L
M>&?^0K/_ -@^]_\ 266L>MCPS_R%9_\ L'WO_I++6/2 ****8!1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5
ML6W_ ")FI_\ 80M/_1=S6/6Q;?\ (F:G_P!A"T_]%W-)@8]%%%, HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** -C6?\ D%>'?^P>_P#Z53UCUL:S_P @KP[_ -@]_P#TJGK'I( HHHI@
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !6QXM_Y'/7?^PA<?^C&K'K8\6_\CGKO_80N/_1C4NH&/1113 **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "MCPS_P A6?\ [!][_P"DLM8];'AG_D*S_P#8/O?_ $EEI,$8]%%%
M, HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MTL;9620]<'N .,^YJ*MI-1Z]2J>B<NAYU1116I 4444 %%%% !1110 4444
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MF 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M@ HHHH *V+G_ )$S3/\ L(7?_HNVK'K8N?\ D3-,_P"PA=_^B[:DP,>BBBF
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 5L>$O^1ST+_L(6__ *,6L>MCPE_R.>A?
M]A"W_P#1BTGL",>BBBF 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MCGKO_80N/_1C5CUL>+?^1SUW_L(7'_HQJQZ2V!A1113 **** "BBB@ HHHH
M*]S^)O\ R2S3?]^W_P#0#7AE>Y_$W_DEFF_[]O\ ^@&HJ?"O5%4_C^3/#*V?
M#7AC4O%6I&RTY%RJ[I)9"0D8]20#UK&KW#X+0PIX6U2X)VNUR5=QU"J@(_\
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M**** "BBB@ HHHH V/#/_(5G_P"P?>_^DLM8];'AG_D*S_\ 8/O?_266L>D
M4444P"BBB@ HHHH **** "N\^$'_ "/T/_7"7^5<'7>?"#_D?H?^N$O\J:_S
M_)B?]?>B+XL_\E"O?^N<7_H KB*[?XL_\E"O?^N<7_H KB1R16=)7BD:5/B?
M]=#M_#?PVN]9TDZQJ6HP:1IA7*33C);D '!( 4\\D_ASFD\2_#:[T721K&FZ
MA!J^F8!:> 8*\D$X!(*CU!_#C->J^-K/PW_PBFGV6O:C<V&GJZ+$;4$[BJ'
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M -C6?^05X=_[![_^E4]8];&L_P#(*\._]@]__2J>L>D@"BBBF 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M;'BW_D<]=_["%Q_Z,:L>MCQ;_P CGKO_ &$+C_T8U+J!CT444P"BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MK8\,_P#(5G_[!][_ .DLM8];'AG_ )"L_P#V#[W_ -)9:3!&/1113 **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@#V'X%?\ ,?\ ^W?_ -JT4? K_F/_ /;O_P"U:*PG\1I'8\Q\1_\
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MN-D*.TC+MRQ&3@=A^==K\+Y[;1_&MYH$NGPSW0FE5+XXWQA P('!.#CU%/\
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MXAT"]N]7L?M$L5P45O.D3"[0<85AZFM.SLO@_?WL5G;A#-*VU \ET@)]-S$
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M[G(45[]JJ77P\T:RLO"/AU[^ZF_X^+@6SRY"]W*8))+' S@<XK,\8Z'%XH\
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MIMM:ES6H4445H0%%%% !1110![#\"O\ F/\ _;O_ .U:*/@5_P Q_P#[=_\
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MQ+XVN/#_ -BU_0K:TLKK8XFCB?@YR 6WD*>/NGGVK/TOXN^*--LEMG:TO0F
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MW'BJ]EUNVBMM18KYL41RJ_*,8^9NV.].^JL%M[F%172:9X!\4ZQ9K=V6CRM
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MN^U"\U.[:ZOKJ6YG;K)*Y8_3GM[4*+NGV"ZLUW/??'NH>*4TW3]3\'S/-;2
MF5;>!)F8-@HP!4DCKT]:XOQ%-\2K;PD;W5[^ Z?<QE9X&CA22-6XPP* Y.>B
MDD>U<7HWC3Q%X?MS;Z;JDL,!Z1,JR*O)/RA@0O).<8S5?6O$VM>(I%;5=0EN
M0GW4.%13ZA5 4'WQFER6T0^;JS)HHHK0@]NUG_D@-O\ ]>T'_H:UXC6Y-XOU
MVX\/KH4M]NTU55!#Y*# 4Y'S;=W4>M8=2E[S?<=_=2[!1115""BBB@ HHHH
M*V/%O_(YZ[_V$+C_ -&-6/6QXM_Y'/7?^PA<?^C&I=0,>BBBF 4444 %%%%
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M1_\ (SZM_P!?LW_H9K,K3\1_\C/JW_7[-_Z&:S*V6QFPHHHI@%%%% !1110
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M/>W/B=9K;[$L<49C+'S,YV\#&,<CO6I\6_\ DG^D?]=XO_1;5FO@7K_F:?\
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M"/.,#^'"_2N7OOA]J?@I[+6]6FL)[*"[B\R.!W9B-V3P4 Z UZ#XZ\-3>/\
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M^DLM8];'AG_D*S_]@^]_])9:3!&/1113 **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#V'X%?\Q__MW_
M /:M%'P*_P"8_P#]N_\ [5HK"?Q&D=CS'Q'_ ,C/JW_7[-_Z&:S*T_$?_(SZ
MM_U^S?\ H9K,K9;&;"BBBF 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %;%S_P B9IG_ &$+O_T7;5CUL7/_
M ")FF?\ 80N__1=M28&/1113 **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *V/"7_(
MYZ%_V$+?_P!&+6/6QX2_Y'/0O^PA;_\ HQ:3V!&/1113 **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ K8UG_D%>
M'?\ L'O_ .E4]8];&L_\@KP[_P!@]_\ TJGI 8]%%%, HHK9\)V-MJ?BS2[*
M\Q]GFN%60$X##/W?QZ?C32N[";LKGL?@VW7QA\+!H^H6T]M&J>0DQ0@. <JZ
M9ZX. ?<&LCQ;=Z7X#\"'P?:S27-_=1[G9EP &/S.>PS@@*/Q]3<^)OC/5O"V
MI:78Z2%MX @F<[!B0!L"/V  YQZBNCL[7P_\0K#2M?GLA(T!;$<J@C.,,C C
M#*#R/I]16#]Z\NC>IJO=M%[K8^:Z.]=/\019)XVU"'3[!+*"%A'Y21^6"0!E
M@O8'VZC![USEO&DMS%'))Y<;N%9\9V@GDX]JU@^9)HB2Y6TSZ"UO3W^('@"S
M3P_J,=NK;"T98JC #!C?;DC!YQ@\@?6O/=-B\=_#3[3,FE&2TE4F3<#-"NW^
M,^6WR\=SCCZ<2Z]X-U[X>6T.JZ)K-U<0LP,[V\9C5,<J7 9@R]>O'YUT?PS\
M<^)?$.K-8ZA$EW:*C-)>"+8T9_A!*X7!P>,9YSGBH6[<1[)*1YK96=[X]\9E
M$2""XOI3+*8U(2,=6;!)/Z\DUWE_I7PS\,ZI#H.I6EY=7? ENS*VV,MTW[64
M# (Z*>,9K2T:UT[2?CEJ-M;!8EGM"RQKP!(P5F _ $U7\8^,=)T?Q7=6-YX&
ML+ZX!4BYEV;I@5&#S&3[=3TH3NHI;,;6LF^AQ/Q!\#_\(??0/;3//I]T#Y3R
M8WJPQE6(&#UR#_A7>?%O_DG^D?\ 7>+_ -%M7(_$'QO<>(;.#2KSP_-I4]M*
M)=LLA+ ;2,;2BD=0:Z_XM?\ (@:/_P!=XO\ T6U+5Q2?=#5N?3L8>F>"?#OA
MOPG%XA\8">X:X5?+LXF*XW<J.""6P"3R .?K1J?@KP[XC\)2^(?!XGMVMPWF
MV<K%L[>6'))#8((Y(/'K7=>-==L-+\)V&I3:%;ZU9.R;4FV[8PRG:W*M]/QK
MCK?XHQV6BS26/@1;33I6,;2P2;(BY&,$B+!;%$G)\UMT*-O=OU.?^'W@2W\2
M17.JZM.\&EVAPVPX,A R<GLH&,_7M72:5HWPU\827NG:5:7EA<0H9%N&E8;E
M!Y9=S,,=,[@#@_E?\!@7_P '=3L[3+7 2YC*+U+%<@?B"*\AT?0M2\07K6>E
MVIN+A4,A0,JX48R<L0.XJI:R<>R$M(J7F>B_#"'1=,\9W.FR@7FIH[BTOK>3
M="8PIST;'(]CBG?%ZZ\.?;[BV^P7/]O[8C]JW'R]GIC?UQ_LUB_#"SNK#XEV
MMM>6\MO.D4NZ*9"C#*$C(//2F?%[_D?Y_P#KA%_*E->]$<=I&Q\1/"&A:%X/
MTZ_TVQ\BYFE19'\YVR"A)X9B.HIGASP!HUAX87Q/XNFD%JR"2.T0E<J>%W$?
M,2<@@ C'<GG&]\6_^2?Z1_UWB_\ 1;5)\25;4OA9IUU8GS+9&AE?8.-FPC/X
M$BAR:4O\5@BD^6_:YDZ=X9\!^.[.XA\.QW>E:A "P29RQ8<8)!9@5SQP01W[
M9YSP-X4M[OQ[/H>OV?F"".0/%O9?F4C!!4@X_P :N?!FVN)?&<EQ&K>3#;.)
M6QQR0 /SY_"NHTFXAN/CYJCP,&5;<H2/[RH@8?F"*>T[=TR=XM]FC-U;1/AS
MX5\1/9:K%=W3W# K#$S>79H<8W$,&/<]2<=AQG+^)O@73_#45KJ>D%UL[A_+
M:%G+!&QD%2><$ ]2?\,GXH,6^(NIY[&,?^0UKT'XP_\ (C:9_P!?,?\ Z+:H
MN^2,O,NRYW'R/#:***V,PHHHH V/%O\ R.>N_P#80N/_ $8U8];'BW_D<]=_
M["%Q_P"C&K'I+8&%%%%, HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ KV/P/I_A/PB#K]UXJLKF9[9=L(*AX=V"PV!F9FZ#@#'/'IXY12>
MUD'74VO%FO-XD\37FJ;66.5L1(QY5 ,+^@S]36+110DDK(;=W<****8@HHHH
M V/#/_(5G_[!][_Z2RUCUL>&?^0K/_V#[W_TEEK'I %%%%, HHHH *]DUO6M
M*E^"EO81ZG9/>"VMU-NLZF0$,N1MSGBO&Z*4ES*PXNSN%%%%,04444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %;%M_R)FI_P#80M/_
M $7<UCUL6W_(F:G_ -A"T_\ 1=S28&/1113 **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#8UG_D%>'?
M^P>__I5/6/6QK/\ R"O#O_8/?_TJGK'I( HHHI@%%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !6QXM_Y'/7?^
MPA<?^C&K'K8\6_\ (YZ[_P!A"X_]&-2Z@8]%%%, HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *V/#/\ R%9_
M^P?>_P#I++6/6QX9_P"0K/\ ]@^]_P#266DP1CT444P"BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ]A
M^!7_ #'_ /MW_P#:M%'P*_YC_P#V[_\ M6BL)_$:1V/,?$?_ ",^K?\ 7[-_
MZ&:S*T_$?_(SZM_U^S?^AFLRMEL9L****8!1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5L7/_(F:9_V$+O\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M,>BBBF 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MY4>,_P#"C)_^@_'_ . I_P#BJ/\ A1D__0?C_P# 4_\ Q5>S44<\@Y4>,_\
M"C)_^@_'_P" I_\ BJ/^%&3_ /0?C_\  4__ !5>S44<\@Y4>,_\*,G_ .@_
M'_X"G_XJC_A1D_\ T'X__ 4__%5[-11SR#E1XS_PHR?_ *#\?_@*?_BJ/^%&
M3_\ 0?C_ / 4_P#Q5>S44<\@Y4>,_P#"C)_^@_'_ . I_P#BJ/\ A1D__0?C
M_P# 4_\ Q5>S44<\@Y4>,_\ "C)_^@_'_P" I_\ BJ/^%&3_ /0?C_\  4__
M !5>S44<\@Y4>,_\*,G_ .@_'_X"G_XJC_A1D_\ T'X__ 4__%5[-11SR#E1
MXS_PHR?_ *#\?_@*?_BJ/^%&3_\ 0?C_ / 4_P#Q5>S44<\@Y4>,_P#"C)_^
M@_'_ . I_P#BJ/\ A1D__0?C_P# 4_\ Q5>S44<\@Y4>,_\ "C)_^@_'_P"
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MY4>,_P#"C)_^@_'_ . I_P#BJ/\ A1D__0?C_P# 4_\ Q5>S44<\@Y4>,_\
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M@_'_ . I_P#BJ/\ A1D__0?C_P# 4_\ Q5>S44<\@Y4>,_\ "C)_^@_'_P"
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MX]_PHR?_ *#\?_@*?_BJ/^%&3_\ 0?C_ / 4_P#Q5>S44<\A<J/&?^%&3_\
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M_P"%&3_]!^/_ ,!3_P#%4?\ "C)_^@_'_P" I_\ BJ]FHHYY!RH\9_X49/\
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M $'X_P#P%/\ \51_PHR?_H/Q_P#@*?\ XJO9J*.>0<J/&?\ A1D__0?C_P#
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M_'_X"G_XJC_A1D__ $'X_P#P%/\ \57LU%'/(.5'C/\ PHR?_H/Q_P#@*?\
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M_P 51_PHR?\ Z#\?_@*?_BJ]FHHYY!RH\9_X49/_ -!^/_P%/_Q5'_"C)_\
MH/Q_^ I_^*KV:BCGD'*CQG_A1D__ $'X_P#P%/\ \51_PHR?_H/Q_P#@*?\
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M)_\ H/Q_^ I_^*H_X49/_P!!^/\ \!3_ /%5[-11SR#E1XS_ ,*,G_Z#\?\
MX"G_ .*JW'\'9HM)N-,_MJ,FXGBN/,^SGY?+61<8W=_-_3WKUNHF_P"/J/\
MW&_FM'.Q\J/'O^%&3_\ 0?C_ / 4_P#Q5'_"C)_^@_'_ . I_P#BJ]FHHYY"
MY4>,_P#"C)_^@_'_ . I_P#BJ/\ A1D__0?C_P# 4_\ Q5>S44<\@Y4>,_\
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M@_'_ . I_P#BJ/\ A1D__0?C_P# 4_\ Q5>S44<\@Y4>,_\ "C)_^@_'_P"
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M $'X_P#P%/\ \51_PHR?_H/Q_P#@*?\ XJO9J*.>0<J/&?\ A1D__0?C_P#
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M)_\ H/Q_^ I_^*H_X49/_P!!^/\ \!3_ /%5[-11SR#E1XS_ ,*,G_Z#\?\
MX"G_ .*H_P"%&3_]!^/_ ,!3_P#%5[-11SR#E1XS_P *,G_Z#\?_ ("G_P"*
MH_X49/\ ]!^/_P !3_\ %5[-11SR#E1XS_PHR?\ Z#\?_@*?_BJ/^%&3_P#0
M?C_\!3_\57LU%'/(.5'C/_"C)_\ H/Q_^ I_^*JWI_P=FTNY>X.M1R;X)K?:
M+<C'FQM%G[W;?GWQ7K=13_ZL?[Z?^A"CG8^5'CW_  HR?_H/Q_\ @*?_ (JC
M_A1D_P#T'X__  %/_P 57LU%'/(7*CQG_A1D_P#T'X__  %/_P 51_PHR?\
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M@_'_ . I_P#BJ]FHHYY!RH\9_P"%&3_]!^/_ ,!3_P#%4?\ "C)_^@_'_P"
MI_\ BJ]FHHYY!RH\9_X49/\ ]!^/_P !3_\ %4?\*,G_ .@_'_X"G_XJO9J*
M.>0<J/&?^%&3_P#0?C_\!3_\51_PHR?_ *#\?_@*?_BJ]FHHYY!RH\9_X49/
M_P!!^/\ \!3_ /%4?\*,G_Z#\?\ X"G_ .*KV:BCGD'*CQG_ (49/_T'X_\
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M_'U)_N+_ #:I:B7_ (^I/]Q?YM0!+1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 5%<_\ 'K-_N'^52U%<_P#'K-_N'^5 $M%%% !1110 4444 %%%% !1110
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M /):7_XBCV]+^9?>']F8[_GS+_P%_P"1UM%<E_PLSPA_T%__ "6E_P#B*/\
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M^S,=_P ^9?\ @+_R.MHKDO\ A9GA#_H+_P#DM+_\11_PLSPA_P!!?_R6E_\
MB*/;TOYE]X?V9CO^?,O_  %_Y'6T5R7_  LSPA_T%_\ R6E_^(H_X69X0_Z"
M_P#Y+2__ !%'MZ7\R^\/[,QW_/F7_@+_ ,CK:*Y+_A9GA#_H+_\ DM+_ /$4
M?\+,\(?]!?\ \EI?_B*/;TOYE]X?V9CO^?,O_ 7_ )'6T5R7_"S/"'_07_\
M):7_ .(H_P"%F>$/^@O_ .2TO_Q%'MZ7\R^\/[,QW_/F7_@+_P CJ+;_ (]8
M?]P?RJ6N/@^)7A%((U;5L$* 1]FE]/\ =I__  LSPA_T%_\ R6E_^(H]O2_F
M7WA_9F._Y\R_\!?^1UM%<E_PLSPA_P!!?_R6E_\ B*/^%F>$/^@O_P"2TO\
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M_P"%F>$/^@O_ .2TO_Q%'_"S/"'_ $%__):7_P"(H]O2_F7WA_9F._Y\R_\
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M** "BBB@ J)?^/J3_<7^;5+42_\ 'U)_N+_-J ):*** "BBB@ HHHH ****
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MM8^LDK8R<9P!U8\' &2:YW1_BIX(U[44L-/U^!KF3A$ECDAWDD *"Z@%B2,
M')H6KL@>BNSL:*** "BBB@ HHHH **** "L3Q)_R*GB'_KSG_P#1-;=8GB3_
M )%3Q#_UYS_^B:F?POT?Y&^%_CT_\4?S1\ST445\V?M04444 %%%% !1110
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MHH **** "BBB@ J*?_5C_?3_ -"%2U%/_JQ_OI_Z$* ):*** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH S-7_ .6/_ OZ44:O_P L?^!?THH O6O_ !Z0_P#7-?Y5+45K_P >D/\
MUS7^52T %%%% !117EVJ_'KPEI&N76E36VJR26L[02310QF/<IP2"7!(SGM1
MUL'2YZC134=9(U=&#(P!4CH0:XK7_BCHGAWQC:^&+NUU![VY,022&-#&/,;:
M,DN#UZ\4=;=0Z7Z';T44C,%4LQ 4#))Z"@!:*\NU?X^^"M+OVM8FO]1"Y#36
M4*F,$$@@%V7/3J,@Y&":W?!_Q3\+^-9_LNG74L%\06%I=ILD('<8)5O7 )..
MU"UV!Z;G:4444 %%87B[Q;IG@K0GU;53(80ZQK'" 9)&)Z*"0#QD]>@-3^&?
M$-IXJ\/6FM6,<\=M=!BBSJ XPQ7D D=1ZT+6]N@/2QK4444 %%%% !1110 4
M444 %%%% !1110 4444 %1+_ ,?4G^XO\VJ6HE_X^I/]Q?YM0!+1110 45'<
M7$-I;27%S-'#!$I>221@JHHY))/ %>6ZA^T)X*LKQH(4U2^1<8GMK=0C?3>R
MM^E*^MAVZGJU%<OX0^(/AWQO"QT>\)N(T#RVLR[)8P?4="/=21R.:ZBJ:L2G
M<****0PHHHH **J:IJ$6DZ3>:E<*[0VD#SR+& 6*JI8@9(&<#UKFU^(VCM\.
MSXV%M??V:/\ EEL3SO\ 6>7TW;>O^UTHOOY#L]/,Z^BJ>D:E#K.C66J6ZR+!
M>0)/&L@ 8*P! ."1GGUJY3::=F).^H4444@"BBB@ HHKG+3QKIMYX[OO"$<%
MT-0L[<7$DC(OE%2$. =V<_..WK1N[!TN='1110 4444 %%%% !17.^,_&>G>
M!M'BU/4X;J:"2=8 MLJLVX@D'YF Q\I[UT*L&4,.A&:.EPV%HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "HKG_CUF_W#_*I:BN?^/6;_</\J ):*** "OGJ:Q\87WQT\6IX.U6S
MTZ[6.,S272A@R;8^!E'YSCL*^A:\B\'?\G"^-O\ KUC_ )1415YKT?Y().T/
MFOU%@\/_ !N6XC,WC'1&B#@NHA7)7/(_X]ZE^.,US=V/AWPU!,T46M:DD$S+
MW4%<#\V!_P" BO5Z\Z^,'AC4]=\/66HZ)&9=4T>Y%W#$HRT@'4*.YX!QWQ@<
MD4FUI?:ZN-)ZVWL[>I;U+X3>#KKPM+I$&AVD#B$K%=I&!.K@<,9/O,<]<G!K
MSG2]6NM3_9AUB*[=G>Q)M%9CD[%="H_ -CZ 5HW?QZ_M'2)-*TOPUJA\4RHT
M/V7R@R1RX(;&#O.W!.-HZ<XZU+>>$[CP=^S?JFGWH OI8_M%PH(.QVD3Y<CK
M@  ^X-*=^6;>SM]]_P#((6YH+K?\+?YG1_"OP5H-EX(T34GTNTGU.>);MKR:
M%7E#MR-KD97 P!CT]<FO1ZYGX=_\DX\.?]@^'_T$5TU:U/C:,X?"F>(W'A[1
M)OVCUL9='T][.33#,]NULAC:0Y)8KC!;WZU'\2] L]>^-'A#1;A2EE+:%7CB
M.S,:ER5&.@(&..QIWCO7$\"?&^Q\3ZE8WDNF3::8!) H)+_,"!D@9'RY!(ZY
MJYK][%J/QV\!7UN28;G3VFCSUVLLA&?SK."NH>K_ /;OT+EHY^G_ ,C^HOQD
M\#>&M.^&MS?:=HME8W-D\1CEMH5C8@L%(8CEN#WSSS6-\5_$C?\ "#>"+#49
M;G[%J4<5QJ+08,DB(B$@9(!)+$\GJ!7=?&[_ ))-J_UA_P#1JUSOBSPSJ^J?
M#OP7K^@1>?JNA007,< &3*NQ"0 /O'*KQW&<<X!%L[[<R_+_ (8=M5;>TOT.
M0U#QU\';WP_)I4?@Z^MP8MD=Q%90+,A ^5O,\S<2#@\DY[YKTSX':W<ZU\-;
M873M))93/:J['ED7!7\@P'X5@G]H.QEM_L=MX9U=_$)_="QV*5\[."F0=YP<
M_P &>V!7I7A*YU^\\.6USXFM[6VU.7+O!;*RK$I^Z#EF^;'7GOCM5K9OT(?1
M$_B.PL]1\/7T%]:074/DN_ESQAUW $@X/&0:\W^ 6DZ;_P (%#JG]GVG]H?:
M)D^U^2OF[<CC?C./;->JWT)N-/N80"3)$R #W!%>*_ _Q=:Z;"/ 5_97EMK,
M<\[G>@"# R5/.0W!XQVZU"WDO+]7^A4OA3\_T_S*WP2\'Z+K*:_JNKZ=;:A(
MEZUM%'=1"5(U'S$A6!&26'/M[G.9X_\ $GAV#XQ?9?%-A=7.AZ+;)%:6%HBE
M#(55LLI91MYQCOM4$8R*['X _P#(O:__ -A>3_T%:K^,X=8\ ?$MO'UAILNH
MZ1>6P@U*.$'?"% R_L,(IR>.""1D&GLX=K+[^5#>KGWN_P SSSQKXX^'^J6%
MO<^%-!O-%UVSF26VN8;2&!.""0P1^?4'!.1Z$UZGXZ/@_6/#7ASQ'XTO[N"V
M$2W$.G0O\MS(R!BI4*6/IG( SR1FJ!^-EWXHGATWP%X<O+O47<>9)J$0$,"9
M W-Y;GCW)&/?I4'Q9@N]&\7>%O%VIZ5_:VDZ?'Y=['$A*1N3]_:<@#+ C)ZJ
M 3THV26VN_;3^O*XMV_1_P##?UT.,\9>,? GB7PM>6OACP#+'=1@2/>1V44'
MV50<;RT6XD9(&&P.>N0*ZCX@P07_ .SUHNJ75O#+?I:VBI<O&#(H.W(#'D9[
M^M4_'/Q6E\=^#M1TWPKH&IM:B+?J%[<HJK!&OS8^4L,G:>I!X. <\:WB"TFU
MK]F33Q80R7#Q6=NY6,9.(V <X]L$_A4R^"7JOZ_KS''XX_,TO'FDZ;I7P#O_
M .SM/M+/S[6U>7[/"L?F-OCY;:!D^YJ[X,^&OAF?X=6(U#2;:[O+^R66>[N(
MQ),&=!]USDKM& -I&,9ZYKE];\=:;XS^ NMQV,-S#+IT%I#.LX49;>G*D$Y'
MRGDX^E>L>#_^1&T+_L'0?^BQ5U-JC\_PLR(OW8?/[_=/(_@9X.TG6?#UUJFM
M6L6IM#</9VL-XOFQP1C#G:C94$LQ.<?S.=+P1IUKX;^.WB[3--C^SZ>+%)Q;
MH?D!/EMP/8LV/3.!Q5_]G[_D0KS_ +"<O_H*4W0 &_:/\5@C(.FQ _\ ?,-.
M5^>R_E?_ *2OU*:5I>3_ /;K?D>7^&O'?@I-9U?7?&FBWFKZO>W#% T$4T,,
M7&%"NX&1TSC@ 8[UIZ-XR\,-\8-!O_!>FW>F0WS_ &/4+5XTCBD#$!2JJS 8
MX) P,J/4UMZ/K][\#M3U/1M=TF\N?#US<M/8WUJH;EAPOS$+G"C(R""I/((-
M=;X8^)&N>._$\"^'M"-MX9CS]JO]0C.]B!]V/:VT-GCJW7)QTI0M>+73_+6_
M]:A4^U?K_GI;^M#E]2\,:=XJ_:4N[75(?/M+>RCN6A)P)"J( #ZC+9QWQ3_C
M5X7T7P[9:#KNB:;:Z;?0ZC'&&LXA$&&"P)"X&05'/6M?3O\ DYS5O^P2O\HZ
M7]H+_D4-(_["L?\ Z ]*&BIV[K_TICEK*=^W_MI3^.NFV#GPQ=M96QN9]3CA
MEF,2[Y(\?<8XR5]CQ7KNGZ;8:3:BUTVRMK.W!+"*VB6- 3U.% %>8?'>WN%\
M,:+JD-M+/%IVHQSS^6/NI@\GT&<#/O7<^#?&&G>-]#_M;3([B. 2M$4N%57#
M#'921W'>B'PR2[_HB7O%OM_F<S\;]7N=)^&=X+1VCDO)4M693@A&SN'X@$?C
M5O1_A/X0M/"D.E7.AV=S(T($UU)$#,SD?,PD^\O/3!&*M?$_PK/XQ\"WNF6>
MTWJE9[<,0 SJ<[<GID9&?>N T_X[_P!F:1%H^K>&]5_X2B!%@^S",*LLF %S
MD[U+<' 4]>,TE;WEUT^ZW^93O[KZ:_?_ ,,7_@[:H]AXJ\%ZI''J&GZ5J)BC
MCND612I9N"IX^\F[ZDU#\%="T>:?Q+=2Z58O<6FLR+;2M;H7A Z!#C*@>U=!
M\'_#.J:-HNHZOKL1AU76[HW<L+##1J<D CL<LQQVR ><UG_!'[OB_P#[#<M4
MKJ6N_+KZZ$NW+IMS?AJ>KUY'X;4^#_CKKFBL-ECX@A^W6HSP9!DL!_Y%_(5Z
MY7EGQHM;C3;+1O&E@N;O0KQ7<=-\3D @GTS@?1C4WY9*3]/O_P"#8JW,G%?T
MU_3(;=!XP^/]S<'+V/A>U$:>GVA\_P"+?B@J'X3?\E%^)/\ V$1_Z,FK:^"^
MBRZ?X&&J7BG[?K,SWTSL/F8,?ES^'S?\"-8OPF_Y*+\2?^PB/_1DU4ER^Z^D
M7][:;_KR$WS1<EW7W*Z7]>9B?!+P?HNLIK^JZOIUMJ$B7K6T4=U$)4C4?,2%
M8$9)8<^WN<]%\2+?X?:)KFFZUXJGN;B6U@$=EHD:J\+*#C(BP !_O,%.W'.,
M5'\ ?^1>U_\ ["\G_H*UD^.+S_A!OC/%XPUK1YM0T:>U6&&>- WV>4#^'=P'
M^4X&1PQ(Z&I>G(MM%_Z3^HVKN;\W^9P_CWQ7X3\0:-;W'A'P7-IS6EPK2:FE
MJENL3'[J'R\ALXR-Q!&.,Y->C_%=S)XO^&<C?>;403^+PUQOQ/\ B+=^/O"A
M_L70K^#P_:S))=7]TH7=)G:$&"1P6!X)/(X '/6_$V9+CQ'\+)XSF.2]1U/J
M"T!%7#>/^)?DR7U_PR/:*\A^,'_(\?#C_L*?^U(:]>KR'XP?\CQ\./\ L*?^
MU(:4?CCZK]2OLR]'^1F?%#0K7Q+\:_"6D7H8VL]L?-56VEE5G8C(Z9QC\:O?
M&7P-X:L/AQ<ZAIVBV5C=63Q&.6UA6-B"ZJ0Q7&[@]\\U/XN_Y.'\%_\ 7I)_
M*2MKXW?\DFU?ZP_^C5K-Z4DUW?\ Z4BEK5L^R_)E7Q?:VNL? XZEJ-I;W5[%
MHRS13S1*[QNT:DLK$94GU%8D36GA/]GM=?TG3[6UU6?3(HFNX8525B[!=Q<#
M)(SGGN!70:[_ ,F]R?\ 8"C_ /1:U'I?AT^+/V?[#14=4EN=,C\IFZ!UPRY]
ML@9]JNJM:J7=?F[F=)Z4[^?Z'EWA3QM\*-"\.6]E?^%+S4+XH#=7-Q903%Y"
M/FVEI,JOH!CUZYKH/@YXHT^WU_Q98Z*EW'X?6 ZC:077WX=N R\,W7('4G"C
MO5G0/C&/!&CVWAOQGH.JV^I:?&(%:&-2)8U^56^9E],9&0<9![5W/@?7_$OC
M.#4+S6M&BTO19EV64+JXN)%(Y9B3C;CH0HSGCIRY7?,X]GZ>0+2REW7KYG(?
M!WPEI7B70[WQ;XBL;75=2U.[E):[B$JHH/0*V0#G//I@5V'AWX:VGA;QAJ>K
M:5=B'2M1AV2Z3Y.8PW7<&W=/O87;P&('%>>^'_%UQ\%&O/#'B?2;^;3?M#RZ
M=>VJAA*IQD?,0.F"<'()Y'.:Z;P'J/B/QOXWN_%LXU#3O#,</D6%E+*RK<'_
M )Z%,[3P2<XQD@ G:30K-KEVM^FS^?\ F#ND^;>_Z[HQO!'AW1)?C7XRM9-&
MT][:T$;6T+6J%(3QR@QA3]*T-#_Y.<\2_P#8+3_T&"L63Q1;?#KXX^(I]:L;
MW[-JZQ"VEB12#]WYN2,KG<#CD8Z5M:%S^TYXE_[!:?\ H,%*GJH>C^^S'+3G
M]5]UT9_PO\.Z=XXUSQ+XN\16D6HSOJ#VT$5T@DCC50/X3P< J!GICBG^(=$L
M_ /QE\*:EH$"V5OK,C6EU:PC;&>5!PO0#YE.!QE0:HV6N7?P1\3ZS9ZQI5W<
M^&]2N3<VEW:H#M8Y^7D@9P,$$@_+D9!JWI-WJ/Q;^)6D>(8M+N;+PQHF9()K
ME<&>3/;L3N49 ) "\G) HI_8MLK7^[6_S^\*GV[];V^_0KZEX8T[Q5^TI=VN
MJ0^?:6]E'<M"3@2%40 'U&6SCOBG_&KPOHOAVRT'7=$TVUTV^AU&.,-9Q"(,
M,%@2%P,@J.>M:^G?\G.:M_V"5_E'2_M!?\BAI'_85C_] >B&BIV[K_TICEK*
M=^W_ +:5?CAINH->>'=?_LA]8T?37=[RR4MM[-EL X7"G+8(&.>M<[)XE^#?
MC:R33KW26\,SY1EN;>TCA(?H5#QA@5YZNH&.>#T]$^(VL>+O#-QI6N:'%)?Z
M/!D:EI\<2LS+C(?=M+* ,Y(.!@9&,UYSXM^(/A+X@Z?=Z=HG@F]O_$5X@2*=
M[.,2IC^/>C,YVXZ=,=>*E::+77;K_78.S>FF_0^@K(1BPMQ%<&YC\I=DY8,9
M!@8;(X.>N1Q4]<_X&T:Z\/>"-'TJ];==6ULJR_-G:W4KGN!G'X5T%:2^)D1^
M%!1114E!1110 4444 %8GB3_ )%3Q#_UYS_^B:VZQ/$G_(J>(?\ KSG_ /1-
M3/X7Z/\ (WPO\>G_ (H_FCYGHHHKYL_:@HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ I02""#@CH1244 >
MS_#SXAC41%HVLRXO!\L%PQ_UW^RQ_O>_?Z]?3*^7-$T:^UW5(K'3XR\S'.[H
M$'=B>P%?3&EVL]CI=M:W-V]W-%&%>=Q@N?7_ #^.:]G!59SC:73J?FO$V7X;
M"UU.BTG+5Q[>?DGV^[0MT445VGS 4444 %%%% !1110 4444 %%%% !43?\
M'U'_ +C?S6I:B;_CZC_W&_FM $M%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 11?ZR?_?'_ *"*
MEJ*+_63_ .^/_014M !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %16W_'K#_N#^52U%;?\>L/^X/Y4
M 2T444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M3YD!.0V0,G(.>:\M\5:%J/P2\8Z?=:)KKSK< R^61L8H'_U<J@X=2,<\9(.
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M2?M#P@XWE0X* CG.P@ YR1S5W]H*-9/ VG*Z@@ZK$#]"DE=SXQC1?A[KT:J
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M ,>LW^X?Y4 2T444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 5B>)/^14\0_]><__ *)K;K$\2?\ (J>(?^O.
M?_T34S^%^C_(WPO\>G_BC^:/F>BBBOFS]J"BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M^K'^^G_H0H EHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M#C(''%<U\+O!VH>"?#-QINI36LLTEX\X:V9F7:P4 ?,H.>#VKMJ*;;;<N_\
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M?2;/0M'M-+L(_+M;6,1QKU.!W/J3U)]35VBG<5@HHHI#"BBB@ HHHH ****
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M_P#0!U3_ , Y/\*^G:*/[.C_ #/\ _URK_\ /J/WL^8O^$6\0_\ 0!U3_P
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MG^%?3M%']G1_F?X!_KE7_P"?4?O9\Q?\(MXA_P"@#JG_ (!R?X4?\(MXA_Z
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MGS%_PBWB'_H ZI_X!R?X4?\ "+>(?^@#JG_@')_A7T[11_9T?YG^ ?ZY5_\
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M!R?X4?\ "+>(?^@#JG_@')_A7T[11_9T?YG^ ?ZY5_\ GU'[V?,7_"+>(?\
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M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 11?ZR?\
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M\1/N,V5=.03M=2&7.!G!Y[U3\._#_P *^$YWN-%T:&VG?@S,S2N!Z!G)*CU
M(S1#2R[!/5MKJ</XM&/VAO!8'_/I)_*2MOXW?\DFU?ZP_P#HU:ZN\\,:/?\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M*BG_ -6/]]/_ $(5+44_^K'^^G_H0H EHHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#,U?_ )8_
M\"_I11J__+'_ (%_2B@"]:_\>D/_ %S7^52U%:_\>D/_ %S7^52T %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 5$O_ !]2?[B_S:I:B7_CZD_W%_FU $M%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !45S_ ,>LW^X?Y5+45S_QZS?[A_E0!+1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !5&_P!%TK598)=1TRRO)+<YA>X@60QG
MCE2P..@Z>E7J* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH *BB_P!9/_OC_P!!%2U%%_K)_P#?
M'_H(H EHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@"*V_X]8?\ <'\JEJ*V_P"/6'_<'\JEH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@"*?_ %8_WT_]"%2U%/\ ZL?[Z?\ H0J6@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"HF_X^H_]QOYK4M1-_Q]1_[C?S6@"6BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** (HO]9/_ +X_
M]!%2U%%_K)_]\?\ H(J6@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "HK;_CUA_P!P?RJ6HK;_ (]8
M?]P?RH EHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "HI_\ 5C_?3_T(5+44_P#JQ_OI_P"A"@"6BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** ,S5_^6/\ P+^E%&K_ /+'_@7]** +UK_QZ0_]<U_E4M5;
M99OLL.)(P-BXRA]/K4NV?_GI'_W[/^- $M%1;9_^>D?_ '[/^-&V?_GI'_W[
M/^- $M%1;9_^>D?_ '[/^-&V?_GI'_W[/^- $M%1;9_^>D?_ '[/^-&V?_GI
M'_W[/^- $M%1;9_^>D?_ '[/^-&V?_GI'_W[/^- $M%1;9_^>D?_ '[/^-&V
M?_GI'_W[/^- $M%1;9_^>D?_ '[/^-&V?_GI'_W[/^- $M%1;9_^>D?_ '[/
M^-&V?_GI'_W[/^- $M%1;9_^>D?_ '[/^-&V?_GI'_W[/^- $M%1;9_^>D?_
M '[/^-&V?_GI'_W[/^- $M%1;9_^>D?_ '[/^-&V?_GI'_W[/^- $M%1;9_^
M>D?_ '[/^-&V?_GI'_W[/^- $M%1;9_^>D?_ '[/^-&V?_GI'_W[/^- $M%1
M;9_^>D?_ '[/^-&V?_GI'_W[/^- $M%1;9_^>D?_ '[/^-&V?_GI'_W[/^-
M$M1+_P ?4G^XO\VHVS_\](_^_9_QJ-5F^TO^\CSL7^ ^I]Z +-%1;9_^>D?_
M '[/^-&V?_GI'_W[/^- $M%1;9_^>D?_ '[/^-&V?_GI'_W[/^- $M%1;9_^
M>D?_ '[/^-&V?_GI'_W[/^- $M%1;9_^>D?_ '[/^-&V?_GI'_W[/^- $M%1
M;9_^>D?_ '[/^-&V?_GI'_W[/^- $M%1;9_^>D?_ '[/^-&V?_GI'_W[/^-
M$M%1;9_^>D?_ '[/^-&V?_GI'_W[/^- $M%1;9_^>D?_ '[/^-&V?_GI'_W[
M/^- $M%1;9_^>D?_ '[/^-&V?_GI'_W[/^- $M%1;9_^>D?_ '[/^-&V?_GI
M'_W[/^- $M%1;9_^>D?_ '[/^-&V?_GI'_W[/^- $M%1;9_^>D?_ '[/^-&V
M?_GI'_W[/^- $M%1;9_^>D?_ '[/^-&V?_GI'_W[/^- $M%1;9_^>D?_ '[/
M^-&V?_GI'_W[/^- $M%1;9_^>D?_ '[/^-&V?_GI'_W[/^- $M%1;9_^>D?_
M '[/^-&V?_GI'_W[/^- $M%1;9_^>D?_ '[/^-&V?_GI'_W[/^- $M%1;9_^
M>D?_ '[/^-&V?_GI'_W[/^- $M%1;9_^>D?_ '[/^-&V?_GI'_W[/^- $M%1
M;9_^>D?_ '[/^-&V?_GI'_W[/^- $M%1;9_^>D?_ '[/^-&V?_GI'_W[/^-
M$M%1;9_^>D?_ '[/^-&V?_GI'_W[/^- $M%1;9_^>D?_ '[/^-&V?_GI'_W[
M/^- $M%1;9_^>D?_ '[/^-&V?_GI'_W[/^- $M%1;9_^>D?_ '[/^-&V?_GI
M'_W[/^- $M%1;9_^>D?_ '[/^-&V?_GI'_W[/^- $M%1;9_^>D?_ '[/^-&V
M?_GI'_W[/^- $M%1;9_^>D?_ '[/^-&V?_GI'_W[/^- $M%1;9_^>D?_ '[/
M^-&V?_GI'_W[/^- $M%1;9_^>D?_ '[/^-&V?_GI'_W[/^- $M%1;9_^>D?_
M '[/^-&V?_GI'_W[/^- $M%1;9_^>D?_ '[/^-&V?_GI'_W[/^- $M%1;9_^
M>D?_ '[/^-&V?_GI'_W[/^- $M%1;9_^>D?_ '[/^-&V?_GI'_W[/^- $M%1
M;9_^>D?_ '[/^-&V?_GI'_W[/^- $M%1;9_^>D?_ '[/^-&V?_GI'_W[/^-
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M_P"_9_QH EHJ+;/_ ,](_P#OV?\ &C;/_P ](_\ OV?\: ):*BVS_P#/2/\
M[]G_ !HVS_\ /2/_ +]G_&@"6BHML_\ STC_ ._9_P :-L__ #TC_P"_9_QH
M EHJ+;/_ ,](_P#OV?\ &C;/_P ](_\ OV?\: ):*BVS_P#/2/\ []G_ !HV
MS_\ /2/_ +]G_&@"6BHML_\ STC_ ._9_P :-L__ #TC_P"_9_QH EHJ+;/_
M ,](_P#OV?\ &C;/_P ](_\ OV?\: ):*BVS_P#/2/\ []G_ !HVS_\ /2/_
M +]G_&@"6BHML_\ STC_ ._9_P :-L__ #TC_P"_9_QH EHJ+;/_ ,](_P#O
MV?\ &C;/_P ](_\ OV?\: ):*BVS_P#/2/\ []G_ !HVS_\ /2/_ +]G_&@"
M6BHML_\ STC_ ._9_P :-L__ #TC_P"_9_QH EHJ+;/_ ,](_P#OV?\ &C;/
M_P ](_\ OV?\: ):*BVS_P#/2/\ []G_ !HVS_\ /2/_ +]G_&@"6BHML_\
MSTC_ ._9_P :-L__ #TC_P"_9_QH EHJ+;/_ ,](_P#OV?\ &C;/_P ](_\
MOV?\: ):*BVS_P#/2/\ []G_ !HVS_\ /2/_ +]G_&@"6BHML_\ STC_ ._9
M_P :-L__ #TC_P"_9_QH EHJ+;/_ ,](_P#OV?\ &C;/_P ](_\ OV?\: ):
M*BVS_P#/2/\ []G_ !HVS_\ /2/_ +]G_&@"6BHML_\ STC_ ._9_P :-L__
M #TC_P"_9_QH EHJ+;/_ ,](_P#OV?\ &C;/_P ](_\ OV?\: ):*BVS_P#/
M2/\ []G_ !HVS_\ /2/_ +]G_&@"6BHML_\ STC_ ._9_P :-L__ #TC_P"_
M9_QH EHJ+;/_ ,](_P#OV?\ &C;/_P ](_\ OV?\: ):*BVS_P#/2/\ []G_
M !HVS_\ /2/_ +]G_&@"6HHO]9/_ +X_]!%&V?\ YZ1_]^S_ (U'&LWF38DC
M^_S\A_NCWH LT5%MG_YZ1_\ ?L_XT;9_^>D?_?L_XT 2T5%MG_YZ1_\ ?L_X
MT;9_^>D?_?L_XT 2T5%MG_YZ1_\ ?L_XT;9_^>D?_?L_XT 2T5%MG_YZ1_\
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M_P ](_\ OV?\: ):*BVS_P#/2/\ []G_ !HVS_\ /2/_ +]G_&@"6BHML_\
MSTC_ ._9_P :-L__ #TC_P"_9_QH EHJ+;/_ ,](_P#OV?\ &C;/_P ](_\
MOV?\: ):*BVS_P#/2/\ []G_ !HVS_\ /2/_ +]G_&@ G_U8_P!]/_0A4M5I
MUF\L9DC^^O1#_>'O4FV?_GI'_P!^S_C0!+146V?_ )Z1_P#?L_XT;9_^>D?_
M '[/^- $M%1;9_\ GI'_ -^S_C1MG_YZ1_\ ?L_XT 2T5%MG_P">D?\ W[/^
M-&V?_GI'_P!^S_C0!+146V?_ )Z1_P#?L_XT;9_^>D?_ '[/^- $M%1;9_\
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M>D?_ '[/^- $M%1;9_\ GI'_ -^S_C1MG_YZ1_\ ?L_XT 2T5%MG_P">D?\
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M-&V?_GI'_P!^S_C0!+146V?_ )Z1_P#?L_XT;9_^>D?_ '[/^- $M%1;9_\
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M9_QHVS_\](_^_9_QH EHJ+;/_P ](_\ OV?\:-L__/2/_OV?\: ):*BVS_\
M/2/_ +]G_&C;/_STC_[]G_&@"6BHML__ #TC_P"_9_QHVS_\](_^_9_QH EH
MJ+;/_P ](_\ OV?\:-L__/2/_OV?\: ):*BVS_\ /2/_ +]G_&C;/_STC_[]
MG_&@"6BHML__ #TC_P"_9_QHVS_\](_^_9_QH EHJ+;/_P ](_\ OV?\:-L_
M_/2/_OV?\: ):*BVS_\ /2/_ +]G_&C;/_STC_[]G_&@"6BHML__ #TC_P"_
M9_QHVS_\](_^_9_QH EHJ+;/_P ](_\ OV?\:-L__/2/_OV?\: ):*BVS_\
M/2/_ +]G_&C;/_STC_[]G_&@"6BHML__ #TC_P"_9_QHVS_\](_^_9_QH EH
MJ+;/_P ](_\ OV?\:-L__/2/_OV?\: *.K_\L?\ @7]**;J@D'E;V5NN-JX]
M/<T4 :%K_P >D/\ US7^52U%:_\ 'I#_ -<U_E4M !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %1+_
M ,?4G^XO\VJ6HE_X^I/]Q?YM0!+1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M5%<_\>LW^X?Y5+45S_QZS?[A_E0!+1110 445X[K'Q"^(,WQ"UGPUX4T32;]
M=/"M^_RK["JG))E4'ENU*^M@Z7/8J*\?_P"$A^.?_0F:'_W^7_Y(KT[P_-JU
MQH-G-KEM%:ZH\>;F&$Y1']!\S?S-585S2HHHI#"BBB@ HKD)O&S+\4+?P;%9
MC#69NI;EG]CA57\ <D^V.]5-=\::CIGQ4\/^%X8;5K'48'DFD=&,BD!_ND,
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M1110 4444 %%%% $5M_QZP_[@_E4M16W_'K#_N#^52T %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!%
M/_JQ_OI_Z$*EJ*?_ %8_WT_]"%2T %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5$W_ !]1_P"XW\UJ
M6HF_X^H_]QOYK0!+1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% $47^LG_WQ_P"@BI:BB_UD_P#O
MC_T$5+0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !45M_QZP_[@_E4M16W_'K#_N#^5 $M%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 5%/_JQ_OI_Z$*EJ*?_ %8_WT_]"% $M%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 9FK_
M /+'_@7]**-7_P"6/_ OZ44 7K7_ (](?^N:_P JEJ*U_P"/2'_KFO\ *I:
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH *B7_CZD_W%_FU2U$O_'U)_N+_ #:@"6BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MYQGJ,&M)?'+RM_7_  28Z0B^]SOOAMXJUJ]O=8\+>*6B?7='<;IXP +B)NC
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MXS\)Z/H-Q+<ZH-4CDO))IQ(\:;TVHP4!5/4],XZ]17<^)/\ DY;PG_V#G_\
M09ZJ&KB_.7_I(FK*7^']4>O4445(!1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %4KC4++3EEFOKN"UB:4*'GD"*3M!QDGKP?RJ[7F_Q?_Y%2/\
M["2?^B6K.K/D@Y+H=F7X98K%4Z$G92=K_?\ Y'9?\)3X>_Z#VE_^!D?^-'_"
M4^'O^@]I?_@9'_C7S%17F_VC+^5?B?:?ZFT/^?LON1]._P#"4^'O^@]I?_@9
M'_C1_P )3X>_Z#VE_P#@9'_C7S%11_:,OY5^(?ZFT/\ G[+[D?3O_"4^'O\
MH/:7_P"!D?\ C1_PE/A[_H/:7_X&1_XU\Q44?VC+^5?B'^IM#_G[+[D?3O\
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M_H/:7_X&1_XU\Q44?VC+^5?B'^IM#_G[+[D?3O\ PE/A[_H/:7_X&1_XT?\
M"4^'O^@]I?\ X&1_XU\Q44?VC+^5?B'^IM#_ )^R^Y'T[_PE/A[_ *#VE_\
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MT9?RK\0_U-H?\_9?<CZ=_P"$I\/?]![2_P#P,C_QH_X2GP]_T'M+_P# R/\
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M!+1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% $47^LG_ -\?^@BI:BB_UD_^^/\ T$5+0 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !45M_P >L/\ N#^52U%;?\>L/^X/Y4 2T444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !44_\
MJQ_OI_Z$*EJ*?_5C_?3_ -"% $M%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 9FK_\ +'_@7]**
M-7_Y8_\  OZ44 7K7_CTA_ZYK_*I:BM?^/2'_KFO\JEH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MK#_N#^52U%;?\>L/^X/Y4 2T444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !44_P#JQ_OI_P"A"I:BG_U8
M_P!]/_0A0!+1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% &9J_\ RQ_X%_2BC5_^6/\ P+^E% %Z
MU_X](?\ KFO\JEJ*U_X](?\ KFO\JEH **** "O$-8_:+MM,U^]T^'PZ;JWM
MKAH1<B^V[PIP6"^6?3CFO2/B'X@_X1CP)JVJ*^R=(3' >_F-\J_D3G\*^?\
M2O  N_@)JOB!X\WIN1=Q,>ODQ95O_0I#^ J;ZM]%;\65;1+J_P#(^H[>XBN[
M:*X@</%*@=&'0J1D'\J\Z\4_%C_A&OB#8^%?[%^T_:FA'VG[5LV^8VW[NPYQ
M]>:3X'>(CKOPZMK>5]UQIKFT;/78.4_\=('_  &O-_BE_P G!Z'_ +]E_P"C
M*T:M5C'HW^!FG>G*75(^DJBN;F"RM9;JYE2&"%"\DCG"JH&22?2I:YCXB:3>
MZ[\/]:TW3MQNYK<^6JG!?!!*_B 1^-9R;46T:12;29YKJ_[2>F6U^T6DZ!<7
MULN1Y\UP(-QR>0NUN,8()P>>@KH_ GQLT3QEJ,6EW%I+I>I2Y\J-W$D<F.RO
M@'=C/!4>Q)KS7X0?$GP]X'M+K1]=T^:SNI+@E[Y(=Q  QLD'WQM(.  ?O'@=
M_0D\)?#SXB>*(?%.CZY)_:$92X:*PF2-BR-P[QLF\$G R<9X^M:))-=49MW3
MZ,]6HHHJ2C$\6^*+'P?X;NM9OSE(1B.('!E<_=0>Y/Y#)[5A?#7XA_\ "P].
MOKO^R_[/^RRK'M^T>;NR,YSM7%>0^/\ 4[[XJ>(M7CTV4KX=\-VLT[3#E9'5
M3\WH2Q&%_P!D$^U=-^S7_P B]KG_ %]I_P"@44];M]KK^O,)Z62[V?\ D>X4
M444 %%%% !1110 4444 %%%% !1110 4444 %1+_ ,?4G^XO\VJ6HE_X^I/]
MQ?YM0!+1110!4U34[+1=,N-2U&X6WM+="\LK9PH^@Y)]AR:\J_X7=J>HLT_A
MSX>:WJNG9VI= ,NYAU&$C<<'_:_*NI^+?A_4/$GPZU"QTQ6DNE*3+"O64(P)
M4>^.0.Y KEO"GQP\)VVEVVDZQ!=:'<V,"P21O;LT:LGR[5V98=.A48Z4EJWY
M#>B1TW@CXH:7XRO9M*>TN=+UNW4F:QNAR"#A@IXSCN"%/MP:[JN'MM(\)>-?
M%&F^--)U;S[VPC S93)AE8'"S*5+ X+#!VGJ*Y[Q[XZ\2>'OBCI.C:/&;R&[
ML"4T\(@$L[&15+.1N"@A2<$# -4^BMJ_Z_$26[3T1ZS17ANL>*_B7\-]3L=4
M\77EAJFB7<QBE@L8U!ASS\I*(=P&<9)!P<GH:FUS5_C NDS>,+:73K'28U^T
MC2"BO,L .<N2G)*\G#@^@!XI7TO_ $@MK;^F>V45Q,/CJYO/A=!XKT_1KF]O
M9X 8[&VC:0F7.T\+D[003GTKCQ9?'/4[/^U(]9TC3_.3S5TTPH'CXX3YHFP?
M]YSC/)%#T;3Z FFD^YZOK>I?V/H.H:GY7G?8[:2X\O=MW[%+8S@XSCKBN/3X
MF;OA*WCK^R,8!_T+[3_TV\O[^S\?N^WO6=I'C&Z\:?!SQ)=ZC;Q0:C:VUW:W
M*19"[EB)R 2<<$=^H-<C%_R:4_T/_I72E=*7ER_C_P  J*3<?5K[E_F>VZ#J
MG]M^'M.U7R?)^VVT=QY6[=LWJ&QG SC/7 K1KGO 7_)/?#G_ &#;?_T6M4OB
M=K6H>'OAWJNJZ5<?9[V 1F.78K[<R*IX8$'@GM5U;0D_)_J133DEYG745XFF
MK?%SQ5X:M]>T*YL=-LH[4%8YD1KB]*J-TF"C*NY@VT97\L&ET7QYX^^).C0P
M^%(++2;JU7&HZC= &,RY^5(E(?JO)RIQTR."R:=VNJ_JXT]$_P"O0]KHKS#X
M:>,?$EYXBUCPAXN6*35M-7S1<Q*H$B$CKMP.C*00!P>1D5F:EXQ\<>-O%NH:
M)X >TL+'2W\NXU*Y4,'D&05Y5@ 2#@!2?ER2 <4NUNNOR#O?H>Q5R%CXY^V_
M$[4O!O\ 9VS[%:BX^U^?G?D(<;-O'W^N3T]ZY;PIXU\5Z+XVB\&>/5MYKB[0
MO8ZE;J%68\G!P "."!\JD$<@Y!J'0O\ DYSQ+_V"T_\ 08*<5>2[-/\ ! _A
MEW5OQ9Z]17C][XL\>>.O$.HZ?X">RT[2]-F,,FIW2AO.D'!495N.XPO8$D9
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M;=+;^5YWE8RK'.=K?W>F.]=:C;D5L8R,UXA\8[R?4/@KX<O;I_,N+B>UEE?
M&YFA<DX' Y/:NR\?^-]0\.+I6C>'K!+_ ,0ZH=MM#)]U%'5FY'X9('!).!@T
MU9-/?FM^ M^5K9J_XG?45XK>ZA\7_ UK_;VN7NF:[I<./M=M JJ\:$C+Y$:'
M(Z9&X#.2,#(]>TK4[;6=)M-3LW+VUU$LT9(P=K#(S[T6TN*Y<HHHI#"BBB@
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M_#37?&.G_#2ZNK[2K&+2=/TEY]+G!RT[*&.' D)QQZ+75^&OB"MS\*8O&?B
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 445U'@SP9=^*[_ "=T.GQ-^_GQ_P".
MKZM_+\@:A"4Y<L=S'$8BEAJ3JU7:*-OX36NN-KCW%B_EZ8ORW9D!*/Z*!_>]
M^W?K@^UM_P ?4?\ N-_-:BT[3K32K"*RLH5AMXEPJ+_/W/O4K?\ 'U'_ +C?
MS6O>P]'V4.6]S\GS?,%C\2ZRCRK9=[>?G_PQ+1116QY@4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% $4
M7^LG_P!\?^@BI:BB_P!9/_OC_P!!%2T %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5%;?\>L/^X/Y5
M+45M_P >L/\ N#^5 $M%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 5%/_JQ_OI_Z$*EJ*?\ U8_WT_\
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M_I,:")PV\L&4$M@C/O\ K7(VOP+O7BAT_5_'NKWVB1@ Z<@:-"%^Z!F1E !
M_A[<8JY:SD^^WW?YF<=(I?UN8GPN6%?@SXZ6W9F@!NQ&S=2OD#!/X41?\FE/
M]#_Z5UWWAKX8IX:\->)-"@U7?::N9?)!MR/LH="F.7._ QZ9Q[TJ?#/;\)6\
M"_VOG(/^F_9O^FWF?<W_ (?>]_:E+6+\U'\-RX-)KU;^]&]X"_Y)[X<_[!MO
M_P"BUK#^-'_))=<_W8O_ $<E=9H.E_V)X>T[2O.\[[%;1V_F[=N_8H7.,G&<
M=,FJ7C3PU_PE_A*^T+[7]D^U!!Y_E^9MVNK?=R,_=QUHK^\Y6[_J*C[MKAX-
M18_ >@HHPHTZ  ?]LQ7"_L^@#P'>D  G4Y<^_P J5Z5H^G?V3H=CIOF^;]EM
MT@\S;MW;5"YQDXSCIFL+X?>"O^$$T";2_P"T/MWF7+W'F>3Y6-P QC<WIUS5
MR:=2;[__ "5R(I^SBNW^1R6@?\G(>*_^P;%_Z##4/P(FBAMO%&ERD+J,&JR/
M,A/S;2 H/YJU=EI_@K[#\2-5\7_VAO\ M]LEO]E\G'E[0@SOW<_<Z8'6L/Q9
M\(X-<\0-X@T/7+WP]J\O$\]KDB08P3@,I#'C)!P<=,G-9QT4?2WXW+EJWZI_
M@D9/Q*EBN_BY\/["V(:]AN6GE"GE8RRGG\$<_A3-'!;]I?Q0JG#'25 /OM@K
MI/!'PML?"6IS:U>ZE=:SKLRE7OKKL#UV@DD$C )+$\<8!(J]8^!OL7Q.U+QE
M_:._[;:BW^R>1C9@(,[]W/W.F!U]J:25D^TOQ0F[W?I^#N>*?##P3K?B33=2
MCT_QYJ6A36=XT<]A;[^#@?.0LJ]2".G\-=C#\,)M-\8Z#=Z]\3I+Z[M[A9;2
MTOP?,EPPRL>^8GG ' -;_BCX06VK:_)K_A_7+WPYJLY_TB6TSMDSU.%92&)Q
MD[L''3)S5CP?\*;7P[K1U[5M8O->UO!5+N[SB-<8X!+'.,C)8\= *<7JF]+?
MUH$];^?Z]S$\&2+9_'SQK:WA"W5S%');E\ M& IP/P*_]\^U=SXK\;:9X/?3
M8[Z*YGGU&X%O;PVJJSDGOAF'&2!GW%9?CKX:6/C*XM]2AOKC2=;M0!!J%M]X
M '(# $$XYP0003U[5G>%OA''I'B&/7_$'B"^\1ZG;C;:R7>0L(]<,S$D9..<
M#.<9P0H;13Z?BM?\PENVNOYF5XRD6']H/P4\C!5:W= 3T)/F #\R/SK6^.EU
M#;_"O4(Y9%5YY88XE)Y9O,#8'KP"?PK5^('PYT[Q]:6WGW,ME?VA)MKN( E<
MXR&'&X< ]0<CKUSRTOP/;4-'O8=<\67^KZG*@CM;V\1I%M%W*QVHTA.X[2,[
MAP>GK-FX<OF_S3*3M/F\E^IB_%;_ )(1X4_W[/\ ]$-4/Q-TNZO_ (S^&K>+
M6Y]$-Y8"&#4(<Y1\O\HPRGDD+U_B%>@^*_AO_P )/X#TKPQ_:WV;[ 83]I^S
M[_,\N,I]W<,9SGJ:U?&7@31_'&CQV&JHX:$[H+F$@21'O@D$8..0>OU (TF_
M><E_,W\FK$Q^&,7_ "V^=TSSS4?A%XA33;@ZI\6]46P\LB<W0D$6SONW3XQ]
M:]&\!:3;:'X)TS3;/58M5MH481WD.-DH+D\89AQG'4]*X&+X'WUX\-OXB\>Z
MQJVEQD,;([T!(''+2.!^ SCH17K5G9V^GV4%G:0K#;0((XHT& J@8 %+9,6[
M1/1112&%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %17/_ !ZS?[A_E4M17/\ QZS?[A_E0!+1110 5Y!\)O\
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M[(1BT"WL0WIGJ,&)\#Z''4X&:Z_P'\/?^$5&HWNJZD^KZQJF/MEQ(ORXQ]P
MY)&2>3U ' QBAKF372W7>_3_ ((T^5IVUOTV/+OAWI'Q3O/!%C-X8\4:/::4
M2XB@EB4NA#G=N_<-SG)ZGJ*ZWPQX!\>VWQ&M?%/B?6M*O3';O;R&VRKLA4[1
M@1*IP2#SZ>U0O\+O&7A74;IOAYXH@L=-NW,CV5\NY83Q]W*.#]< X !+=:Z#
MP1\.[[1]<G\3^*-7.K^(9XS'Y@'[NW4GD)G'Z!0 2 *=^9WV_P"&L2U9<O\
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MMLRL:<<8/S]/7OMZK\.O%'BOP5;VOB/7;;_A);"Z:XLK^U!" 8&%;"H1R/O
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MUA_W!_*I:BMO^/6'_<'\J ):*** "BBB@ HHHH **** "BBB@ HHHH ****
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M:I:B7_CZD_W%_FU $M%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MEN(=&<-Y*.J@#DN1C()("C.<9]?0J*%HT^P/56"BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ J*+_ %D_^^/_ $$5+447^LG_ -\?
M^@B@"6BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** (K;_CUA_P!P?RJ6HK;_ (]8?]P?RJ6@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** (I_\ 5C_?3_T(5+44_P#JQ_OI_P"A"I: "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
MB;_CZC_W&_FM2U$W_'U'_N-_-: ):*** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH BB_UD_\ OC_T
M$5+447^LG_WQ_P"@BI: "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH *BMO^/6'_ '!_*I:BMO\ CUA_
MW!_*@"6BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH *BG_P!6/]]/_0A4M13_ .K'^^G_ *$* ):*** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH S-7_Y8_P# OZ44:O\ \L?^!?THH O6O_'I#_US7^52U%:_
M\>D/_7-?Y5+0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !42_\?4G^XO\ -JEJ)?\ CZD_W%_FU $M
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MS?J2?QIGPF_Y*+\2?^PB/_1DU2GHK?RO\P:MS?XE^@RV^/*WT,]OI_A._O\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !43?\?4?^XW\UJ6HF_X^H_\ <;^:T 2T444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110!%%_K)_P#?'_H(J6HHO]9/_OC_ -!%2T %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5%;?\
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MW_'K#_N#^5 $M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M4_\ S\2?DO\ A4M% $7E/_S\2?DO^%'E/_S\2?DO^%2T4 1>4_\ S\2?DO\
MA1Y3_P#/Q)^2_P"%2T4 1>4__/Q)^2_X4>4__/Q)^2_X5+10!%Y3_P#/Q)^2
M_P"%'E/_ ,_$GY+_ (5+10!%Y3_\_$GY+_A1Y3_\_$GY+_A4M% $7E/_ ,_$
MGY+_ (4>4_\ S\2?DO\ A4M% $7E/_S\2?DO^%'E/_S\2?DO^%2T4 1>4_\
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MGY+_ (5+10!%Y3_\_$GY+_A1Y3_\_$GY+_A4M% $7E/_ ,_$GY+_ (4>4_\
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M2_X4>4__ #\2?DO^%2T4 5HXW\R;]_(,/Z+S\H]JD\I_^?B3\E_PHB_UD_\
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M?_GXD_)?\*/*?_GXD_)?\*EHH B\I_\ GXD_)?\ "CRG_P"?B3\E_P *EHH
MB\I_^?B3\E_PH\I_^?B3\E_PJ6B@"+RG_P"?B3\E_P */*?_ )^)/R7_  J6
MB@"+RG_Y^)/R7_"CRG_Y^)/R7_"I:* (O*?_ )^)/R7_  H\I_\ GXD_)?\
M"I:* (O*?_GXD_)?\*/*?_GXD_)?\*EHH B\I_\ GXD_)?\ "CRG_P"?B3\E
M_P *EHH B\I_^?B3\E_PH\I_^?B3\E_PJ6B@"+RG_P"?B3\E_P *CGC<1C]_
M(?G7J%_O#VJS44_^K'^^G_H0H /*?_GXD_)?\*/*?_GXD_)?\*EHH B\I_\
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M_</\J ):*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M![2__ R/_&C_ (2GP]_T'M+_ / R/_&CGCW7WH/JM?\ Y]R_\!?^1K45D_\
M"4^'O^@]I?\ X&1_XT?\)3X>_P"@]I?_ (&1_P"-'/'NOO0?5:__ #[E_P"
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M![2__ R/_&C_ (2GP]_T'M+_ / R/_&CGCW7WH/JM?\ Y]R_\!?^1K45D_\
M"4^'O^@]I?\ X&1_XT?\)3X>_P"@]I?_ (&1_P"-'/'NOO0?5:__ #[E_P"
MO_(UJ*BMKJWO+=;BUGBGA?[LD3AE;Z$<5+5&+33LPHHHH$%%%% !1110 444
M4 %%%% !1110 4444 %1-_Q]1_[C?S6I:B;_ (^H_P#<;^:T 2T444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110!%%_K)_]\?^@BI:BB_UD_\ OC_T$5+0 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !45M_
MQZP_[@_E4M16W_'K#_N#^5 $M%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 5%/\ ZL?[Z?\ H0J6HI_]
M6/\ ?3_T(4 2T444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110!F:O_ ,L?^!?THHU?_EC_ ,"_I10!
M>M?^/2'_ *YK_*I:BM?^/2'_ *YK_*I: "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *B7_ (^I/]Q?
MYM4M1+_Q]2?[B_S:@"6BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ J*Y_X]9O
M]P_RJ6HKG_CUF_W#_*@"6BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "N.^)'_(@ZW_ +\/_H<==C7'?$C_
M )$'6_\ ?A_]#CK*O_"EZ,[LL_WZC_BC^:/GVBBBOGC]C"BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M "BBB@ HHHH **** "BBB@ HHHH BB_UD_\ OC_T$5+447^LG_WQ_P"@BI:
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH *BMO^/6'_ '!_*I:BMO\ CUA_W!_*@"6BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M *BG_P!6/]]/_0A4M13_ .K'^^G_ *$* ):*** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH S-7_Y8
M_P# OZ44:O\ \L?^!?THH O6O_'I#_US7^52U%:_\>D/_7-?Y5+0 4444 %%
M>2?%SXHZWX!U?3K32[73YH[F!I7-U&[$$-CC:ZUZ#X2\1VWBSPO8ZU:@*MS'
MEX\Y\MQPR_@0:(^\FUT!Z-)FU17E?A[XEZSJWQAU'PC/;6"Z?;-.J21QN)3L
MZ9)8C]*@\9_%'6_#OQ2T[PQ:6NGO97+6X>2:-S(/,?:<$.!TZ<41][EM]K8'
MIS7Z'K=%%5-3U*UT?2[K4KZ7RK6VC:65\9PH&3QWI-V5V"5]$6Z*^?I/CKXP
MUW4)QX0\(K<VD(^8-;S74@R3AF\L@+D#ISR#R:W?!'QMN-4\11>'/%>D+IFI
M2R&)9$#(HD/W4>-\LI/3.3R1P*I)O03=CV2BBBD,**\\^*/Q/MO FF"&R>VN
M-<F(\JUDRP1,\NX4@@8X'(R?8&M[P!XAN_%7@C3=:OHX([FZ5RZP*0@P[+P"
M2>@]:%JFUT!Z63ZG2T444 %%%% !1110 4444 %%%% !1110 4444 %1+_Q]
M2?[B_P VJ6HE_P"/J3_<7^;4 2T444 %%9?B+Q!8>%]!N]9U)V6UMEW,$&68
MDX"J.Y)( KR^W\>?%CQ# FI^'O ]A'I<P!A^VS?O&&/O9,D>0>H.W'N:5QVZ
MGLE%><>"_B9>:MXB?PKXIT5M&U]$+*N<Q7&,YV9Z< D8+ @$YKT>JMU)OT"B
MBBD,**** "BLWQ%J$ND^&M4U*W5&FM+26>-9 2I94+ '!!QD>M<$GQ&UAO@<
MWC8VUC_:0!_=;'\G_7^7TW;NG^UUI7T;[6_$:3=O/_AST^BLKPSJ4VL^%M)U
M2X6-9[RSBGD6,$*&902!DDXY]:U:J2<6TR4[JX4444AA1110 445PFF^-=2O
M/C%J_A"2"U&GV=DMQ'(J-YI8B,X)W8Q\Y[>E"U=OZT#HV=W1110 4444 %%%
M% !17#?%7QGJ/@;PO;ZGID-K-/)>) 5N59EVE6)/RL#GY1WKMT8M&K'J0#0M
M5?Y ]+>8ZBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MM5<-G8**** "BBO'%^)'C[Q)XCU.V\&^&M/GTW3[G[-+-=O\V02-W,B#G&<
M$CUYH6KY0>BN>QT4@S@9Z]\5Y5XV\?>,]-^(<'A;PKI6F7TLMF+A5N00Q.6W
M?-YBKC"T=;!TN>K45X__ ,)#\<_^A,T/_O\ +_\ )%=IX'O_ !K?V]X?&>D6
M6G2HZBV6U<,'7!W$XD?V]*:0FSK****0PHHKA?B?XTU'P5IFE7.FPVLKW=\M
MM(+E&8!2"<C:PYXHZI=]/O!Z)OL=U1110 4444 %%%% !1110 45R&B^-FUK
MX@ZYX:2S$4.DQJ6G9\M*[8Z#^$#)]<^W2NOHZ)]PZM!17.^,[SQ39:/%+X1T
MVUU#4#.JO%<L%418.6Y=.<[>_?I70KDJ-PP<<T=+@+1110 445D>)[C6[7P[
M=S>'+."\U90OD03D!'^89R2R_P .3U'2DW8:5W8UZ*IZ1)?S:-92ZI!'!J#P
M(US%&<JDA W <G@'/<_6KE4U9V$G<****0!1110 4444 %%%% !7'?$C_D0=
M;_WX?_0XZ[&N.^)'_(@ZW_OP_P#H<=95_P"%+T9W99_OU'_%'\T?/M%%%?/'
M[&%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% '6>"?&USX5O?+DW3:;*W[Z'/*G^\OO_/\B/?[&^MM
M2LHKRSF6:WE7<CJ>"/\ /:OE2O6O@_:ZXGGW!?9HKY^20$[Y/5/3'<]#T^GH
M8*O)2]F]5^1\?Q/E5"5)XR+49+?^]_P?SZ]SUFBBBO6/SX**** "BBB@ HHH
MH **** "BBB@ J)O^/J/_<;^:U+43?\ 'U'_ +C?S6@"6BBB@ HHHH ****
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MQGER3GYFZ\<#FO7_ (-?\DGT+_<D_P#1CUD_'_\ Y)A)_P!?D/\ 6M;X-?\
M))]"_P!R3_T8].#NI^J_(4UK'YG=T444AA1110 4444 %%%% !1110 4444
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MQ))Y)Q@ENJX(Y%>=_#CX:>%_%<^JZ7KNH:A::]8W3QM:PS1INC'&X!D).&#
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M.V2PQGK@^E*GI[-KJU^>OW!4UYUV3_+]3<^*/B[6M+N-(\,^%]BZYK$FU)G
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MT?/M%%%?/'[&%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M (^H_P#<;^:U+43?\?4?^XW\UH EHHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@"*+_63_[X_P#0
M14M11?ZR?_?'_H(J6@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "HK;_CUA_W!_*I:BMO^/6'_ '!_
M*@"6BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH *BG_U8_P!]/_0A4M13_P"K'^^G_H0H EHHHH ****
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M5"D?*H&,*.U=-11?2P'E^L_ /P5JU^UU$E]IN[):&RF58R22<@.K;>N,#
MP*T_"GP>\)>$;U+ZVMI[R]C?=%<7L@=H_P#=50%]P<9'K7>T4+38'KN%%%%
M&!XP\)6'C706T?4IKF*W,BR[K9E5\KTY92,<^E6?#/AZT\*^'K31;&2>2VM0
MP1IV!<Y8MR0 .I]*UJ*%I>W4'K;R"BBB@ HHHH **** "BBB@ HHHH ****
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MR1LZ^4% 09 VYS\@[^M='157=[BZ6.&\8_"7PMXUO1?7T-Q:WQP'N;.0(T@
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M** "BBB@ HHHH **** "BBB@ J*Y_P"/6;_</\JEJ*Y_X]9O]P_RH EHHHH
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M<-]DCN!Y6!C*Y*E\'_>SSP17JM%'6X7TL4]*TFPT/2[?3=,M8[:SMUVQQ)T
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M/PAXHU5]2E2[L+F5BTQL9502L<?,596 /TQG))R:WO!W@'0/ UH\6CVS>=*
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M_P!.?_)O^ ?)E%?6=%']G?WOP#_7/_IS_P"3?\ ^3**^LZ*/[._O?@'^N?\
MTY_\F_X!\F45]9T4?V=_>_ /]<_^G/\ Y-_P#Y,HKZSHH_L[^]^ ?ZY_].?_
M ";_ (!\F45]9T4?V=_>_ /]<_\ IS_Y-_P#Y,HKZSHH_L[^]^ ?ZY_].?\
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M_7/_ *<_^3?\ ^3**^LZ*/[._O?@'^N?_3G_ ,F_X!\F45]9T4?V=_>_ /\
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M_P JEH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ J)?^/J3_<7^;5+42_\?4G^XO\ -J ):*** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "HKG_CUF_W#_*I:BN?^/6;_ '#_ "H EHHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ J*+_63_ .^/_014M11?ZR?_ 'Q_Z"* ):*** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M BMO^/6'_<'\JEJ*V_X]8?\ <'\JEH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@"*?_5C_ 'T_]"%2
MU%/_ *L?[Z?^A"I: "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH *B;_ (^H_P#<;^:U+43?\?4?^XW\
MUH EHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@"*+_63_[X_P#014M11?ZR?_?'_H(J6@ HHHH
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !45S_QZS?[A_E4M17/_ !ZS?[A_E0!+1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !447^LG_WQ_Z"
M*EJ*+_63_P"^/_010!+1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% $5M_QZP_[@_E4M16W_ !ZP
M_P"X/Y5+0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% $4_^K'^^G_H0J6HI_P#5C_?3_P!"%2T %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 5$W_'U'_N-_-:EJ)O^/J/_<;^:T 2T444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!
M%%_K)_\ ?'_H(J6HHO\ 63_[X_\ 014M !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %16W_'K#_N#^
M52U%;?\ 'K#_ +@_E0!+1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %13_ZL?[Z?^A"I:BG_ -6/]]/_
M $(4 2T444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110!F:O_RQ_P"!?THHU?\ Y8_\"_I10!>M?^/2
M'_KFO\JEKG5N)E0 32  8 #&E^TS_P#/:3_OHT =#17/?:9_^>TG_?1H^TS_
M //:3_OHT =#17/?:9_^>TG_ 'T:/M,__/:3_OHT =#17/?:9_\ GM)_WT:/
MM,__ #VD_P"^C0!T-%<]]IG_ .>TG_?1H^TS_P#/:3_OHT =#17/?:9_^>TG
M_?1H^TS_ //:3_OHT =#17/?:9_^>TG_ 'T:/M,__/:3_OHT =#17/?:9_\
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M3_OHT?:9_P#GM)_WT: .AHKGOM,__/:3_OHT?:9_^>TG_?1H Z&BN>^TS_\
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M]IG_ .>TG_?1H Z&BN>^TS_\]I/^^C1]IG_Y[2?]]&@#H:*Y[[3/_P ]I/\
MOHT?:9_^>TG_ 'T: .AHKGOM,_\ SVD_[Z-'VF?_ )[2?]]&@#H:*Y[[3/\
M\]I/^^C1]IG_ .>TG_?1H Z&BN>^TS_\]I/^^C1]IG_Y[2?]]&@#<MO^/6'_
M '!_*I:YT7$R@ 32 #@ ,:7[3/\ \]I/^^C0!T-%<]]IG_Y[2?\ ?1H^TS_\
M]I/^^C0!T-%<]]IG_P">TG_?1H^TS_\ /:3_ +Z- '0T5SWVF?\ Y[2?]]&C
M[3/_ ,]I/^^C0!T-%<]]IG_Y[2?]]&C[3/\ \]I/^^C0!T-%<]]IG_Y[2?\
M?1H^TS_\]I/^^C0!T-%<]]IG_P">TG_?1H^TS_\ /:3_ +Z- '0T5SWVF?\
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MVF?_ )[2?]]&C[3/_P ]I/\ OHT =#17/?:9_P#GM)_WT:/M,_\ SVD_[Z-
M'0T5SWVF?_GM)_WT:/M,_P#SVD_[Z- '0T5SWVF?_GM)_P!]&C[3/_SVD_[Z
M- '0T5SWVF?_ )[2?]]&C[3/_P ]I/\ OHT =#17/?:9_P#GM)_WT:/M,_\
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M_?1H^TS_ //:3_OHT =#17/?:9_^>TG_ 'T:/M,__/:3_OHT =#17/?:9_\
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<]&@"]J__ "Q_X%_2BLYY)),;W9L=-QS10!__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>51
<FILENAME>img_004.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 img_004.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" )+!-@# 2(  A$! Q$!_\0
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MC\#^!?#/P1_9[^.W[0&L7_B.>S2[@@UJR^!_PZ^(,W@W3)HH9$B\1>-%\/\
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M%Q9^-KG_ ((O6DFNI>:1IK-I^D7[W;/+J&DV6RUTR]DN+&"&".!88\*$85L
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MOAR?POHGB"^U33/#OBOQ?X@\4_\ !,71/"'@SP'XAO\ 1-7@T7XC>+O$.A^
M-073;Z[@\3-8V=S<Q>]_L?\ _!J=_P $<?VUOV;?A5^U'\*_C)_P4PT#X?\
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MA3XB^(W[17C'XT^-_B5\4_!_[3/[06DZ-#XO3XA_'WX)>(6NM<\,V,?Q%O\
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MIU V\%]+<VE[#;?7>F_\&77_  2FUC3M/U;3OV@OV_[C3]4LK74;&X_X6?\
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MT)T:=6EB*]##XE8G&9GE53+Z$\%#&3CQ/_$%3_P2R_Z+Y^W_ /\ AT_V=?\
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M\"]2UCPXG[1S^"G\'_ /PIX5\):-\9?#WQE_9O\ %GQ!\$^-OB+X@U;7!-X
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MC4M TCP9>0:/X*_8\\2>(+Z+6M2\3Z';QR:=I5W';I?"[NW@L8;BZBZ;4?\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MX/5O^467P#_[/_\ A9_ZSK^U57]?M?R!?\'JW_*++X!_]G__  L_]9U_:JH
M_?[_ ()._P#*++_@FG_V8!^QO_ZSK\.:^_Z^ /\ @D[_ ,HLO^":?_9@'[&_
M_K.OPYK[_H **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MF_\ 2L?^W_\ ^#']HK_Z &OZ_:* /Y O^(CO_@J;_P!*Q_[?_P#X,?VBO_H
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M $ -'_$1W_P5-_Z5C_V__P#P8_M%?_0 U_7[10!_(%_Q$=_\%3?^E8_]O_\
M\&/[17_T -'_ !$=_P#!4W_I6/\ V_\ _P &/[17_P! #7]?M% '\@7_ !$=
M_P#!4W_I6/\ V_\ _P &/[17_P! #1_Q$=_\%3?^E8_]O_\ \&/[17_T -?U
M^T4 ?R!?\1'?_!4W_I6/_;__ /!C^T5_] #1_P 1'?\ P5-_Z5C_ -O_ /\
M!C^T5_\ 0 U_7[10!_(%_P 1'?\ P5-_Z5C_ -O_ /\ !C^T5_\ 0 T?\1'?
M_!4W_I6/_;__ /!C^T5_] #7]?M% '\@7_$1W_P5-_Z5C_V__P#P8_M%?_0
MU^0'_!:O]N#_ (*F_P#!8/\ 98\ _LT?\."/V_\ ]G?_ (0?]H#PK\=/^$U_
MX5]^T5\6_P"U/^$9^'7Q5\ ?\(M_PCG_  R-\,OL7VW_ (6;_:W]M_V]=_9O
M[$^P?V1<?VE]LL/]'RB@#X@_X)D^$_%7@+_@FW_P3Y\"^.O#/B#P7XV\%_L0
M?LH>$_&/@[Q9HVH^'/%7A/Q5X<^ W@'1_$/AGQ-X>UBVL]7T'Q!H6KV=YI>L
MZ-JEG:ZCI>HVMS8WUM!<P2Q+]OT44 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 5\ ?\$T_P#DW7XC?]G_ /\ P5B_]>F_MD5]_P!? '_!-/\
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MX<\2>//"WAK0/B)\.(M5\$>,=&_X6-\.-2\6^!I-:\+Z]HT7B!]4TJ]M(?\
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M;D\&:SH4>K_#N[^).@ZOJWV*YT?4[[P[=QZ]56V_X(!_\$/[FP\/?$<>*?\
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MWVL6 \$ZK_;]OJ_AO0[*U-QI_P#9VH:IYMR;3]3/V._V2O%/[)G[8W_!)_\
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MX?@\5ZAJ?B.SU;Q9)X9T66_;Q@WP=T/XG00W.BZC;^&9O%!GT=]5_=SX<?L
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M_P 'JW_*++X!_P#9_P#\+/\ UG7]JJ@#]_O^"3O_ "BR_P"":?\ V8!^QO\
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M #QJ/^'L7_!++_I)9^P!_P")D?LZ_P#SQJ /O^BO@#_A[%_P2R_Z26?L ?\
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M7_!++_I)9^P!_P")D?LZ_P#SQJ /O^BO@#_A[%_P2R_Z26?L ?\ B9'[.O\
M\\:C_A[%_P $LO\ I)9^P!_XF1^SK_\ /&H ^_Z*^ /^'L7_  2R_P"DEG[
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M[_HKX _X>Q?\$LO^DEG[ '_B9'[.O_SQJ/\ A[%_P2R_Z26?L ?^)D?LZ_\
MSQJ /O\ HKX _P"'L7_!++_I)9^P!_XF1^SK_P#/&H_X>Q?\$LO^DEG[ '_B
M9'[.O_SQJ /O^BO@#_A[%_P2R_Z26?L ?^)D?LZ__/&H_P"'L7_!++_I)9^P
M!_XF1^SK_P#/&H ^_P"BO@#_ (>Q?\$LO^DEG[ '_B9'[.O_ ,\:C_A[%_P2
MR_Z26?L ?^)D?LZ__/&H ^_Z*^ /^'L7_!++_I)9^P!_XF1^SK_\\:C_ (>Q
M?\$LO^DEG[ '_B9'[.O_ ,\:@#[_ **^ /\ A[%_P2R_Z26?L ?^)D?LZ_\
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M6?L ?^)D?LZ__/&H _ '_ALC_@\D_P"D3O[ '_AQO W_ -,LH_X;(_X/)/\
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M1_P>2?\ 2)W]@#_PXW@;_P"F65^_W_#V+_@EE_TDL_8 _P#$R/V=?_GC4?\
M#V+_ ()9?])+/V /_$R/V=?_ )XU 'X _P##9'_!Y)_TB=_8 _\ #C>!O_IE
ME'_#9'_!Y)_TB=_8 _\ #C>!O_IEE?O]_P /8O\ @EE_TDL_8 _\3(_9U_\
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MX _\&5/_ "BR^/G_ &?_ /%/_P!9U_95H ^__P#B%Q_X(4?]&,_^;,_MA_\
MT05'_$+C_P $*/\ HQG_ ,V9_;#_ /H@J_?ZB@#\ ?\ B%Q_X(4?]&,_^;,_
MMA__ $05'_$+C_P0H_Z,9_\ -F?VP_\ Z(*OWE\1^(-(\)^'M=\4^(+V#3-!
M\-:-J>OZWJ-RZQV]AI.CV4^HZC>SR,0J0VMG;S3RNQ 5$8DX%?S<?\$J_P#@
MH5^VA\5OVN=%\-?M?_$#3?$WP/\ ^"A?[/?CS]L/]@'P^GP[\%^!+WX2^"?
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M*XM_&.K^(_BO\7/B'=?$J;PSH?[-/C'3M#T[0O@UXUL/!$%_XB\7Q:O87[F
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M2OVB]3_9\N_"=QX2^#7Q9UJ_OM3^.NDZAHTGP^U[P[J^EV7B^71_#VJ^+_\
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M??\ VK4[J]O;C]?'_P"#73_@A+&CR2?L.*D<:L[N_P"TW^V&JHB@LS,Q_:"
M554$DDX !)IW_!KC_P H*/V&?^[F?_6P_P!H*OU4_;@T_P"/6N?LE_'KPO\
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MK]H#XFZG:Z1\2]#\5:4O@36-4G\*_#3PK;AO#/A;4OB?;^!/%AUCQEXDFNO
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MXO$WP[^-G_!/?]AK]FSXN>"/V-OB3_P31D\2?#?Q=^SCX9U33_&_@7XCZO\
MMHI_:5GX<M_$^N#QGX+\>_LL?%2\U>X\0/XKEU2U$]EX,U>X^^]&_9)_:Y^$
M_AS_ (*_^.?A/\&/!FH?&7]HC]K7X:?$_P#9\NO&LWP:\6:I\2OACX#^&/P
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M^C&?_-F?VP__ *(*OW^HH _ '_B%Q_X(4?\ 1C/_ )LS^V'_ /1!5\(^%?\
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MNE0?M4O?1Z#\/=9TC5=(\<:Q) NG>$]4TS4-/U^YT^[LKF*+YR_9W_X)H_\
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MT_\ LP#]C?\ ]9U^'-??] !1110 4444 %%%% !1110 4444 %%%% !1110
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M4*>)C_(=_P $O?\ @WF^*O[&/[1E[XK^+'P9_P"";UIX"L?@Q\5OA)H_Q_\
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MUG^V_ VN;M UC54TW^S=7:PUC3_[3J_D"_;(_P"5R3_@D[_V8!\1_P#U!O\
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M^*KG2-8<V/P(\(W,[ZK7][%? '_!6+_E%E_P4L_[, _;(_\ 6=?B-0!\ ?\
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M<M=:FX2G#DK_ -FJNHPG.,'6J4HSFJ"G,HHHKG- HHHH _D"_P"#U;_E%E\
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M_P 'JW_*++X!_P#9_P#\+/\ UG7]JJ@#]_O^"3O_ "BR_P"":?\ V8!^QO\
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MA/@_\2/@C\0/^"3G["8\'_$_PCK'@_7+G0OBGX"TW7]-MM6M7@BUGP]J4O\
MP4CO(]-\0Z)=?9]7T'4GM+I;#5[*SNVMIQ"8F]'TO]KS_@\GTW3-.TZ3_@E9
M^P;JDEA8VEE)J>I?$CX>MJ.HO:V\<#7^H-9?\%(K*S:]O&C-Q=-:6=I;&>20
MP6L$12)/Z#/^'L7_  2R_P"DEG[ '_B9'[.O_P \:C_A[%_P2R_Z26?L ?\
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MKG_#9'_!Y)_TB=_8 _\ #C>!O_IEE?O]_P /8O\ @EE_TDL_8 _\3(_9U_\
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M_;(K[_KX _X)I_\ )NOQ&_[/_P#^"L7_ *]-_;(H ^_Z*** "BBB@ K^$/\
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M9^P!_P")D?LZ_P#SQJDH_ '_ (;(_P"#R3_I$[^P!_X<;P-_],LH_P"&R/\
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MC/\ YLS^V'_]$%1_Q"X_\$*/^C&?_-F?VP__ *(*OW^HH _ '_B%Q_X(4?\
M1C/_ )LS^V'_ /1!4?\ $+C_ ,$*/^C&?_-F?VP__H@J_?ZB@#\ ?^(7'_@A
M1_T8S_YLS^V'_P#1!4?\0N/_  0H_P"C&?\ S9G]L/\ ^B"K]_J* /P!_P"(
M7'_@A1_T8S_YLS^V'_\ 1!4?\0N/_!"C_HQG_P V9_;#_P#H@J_?ZB@#\ ?^
M(7'_ ((4?]&,_P#FS/[8?_T05'_$+C_P0H_Z,9_\V9_;#_\ H@J_?ZB@#\ ?
M^(7'_@A1_P!&,_\ FS/[8?\ ]$%1_P 0N/\ P0H_Z,9_\V9_;#_^B"K]_J*
M/X@_^"]7_!!7_@D]^Q=_P2>_:L_:7_9H_93_ .%:_&WX:_\ "C/^$*\:_P#"
M\_VDO&/]B_\ "8_M)_!WP!XC_P"*<\?_ !B\5>$M1_M'PEXJU[2?^)MH-_\
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M0E"DL3*HJV(Q>)G2MBJ&$GC*7]3G_$+C_P $*/\ HQG_ ,V9_;#_ /H@J/\
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M2^!_"WQE^%=A^TO\?/VE/AW\8-?_ ."@?[;_ (9\3_"OQ)\<[CXAZO+)I7[
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ML_#]M%J_[2FB+X:MK&?QEXJTSQMX4\5^!5\7Z5XFT:'3KJ?0;G3=3TVY\?\
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M>&-1\?:YJWQ4\)6<7Q2\ ?VQX%OX=1CS_ ?_  1G_P""''Q6\*_\%+KK2?\
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MAJWP/^)OB+1&^ 'BO3I)=:/C.^T5X+P_95C_ ,$3_P!JFU_8M_;-_9RD\?\
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M $=/_P %1?\ Q:=^WE_\_:C_ (=.?!O_ *.G_P""HO\ XM._;R_^?M7ZBT4
M?EU_PZ<^#?\ T=/_ ,%1?_%IW[>7_P _:C_ATY\&_P#HZ?\ X*B_^+3OV\O_
M )^U?J+10!^77_#ISX-_]'3_ /!47_Q:=^WE_P#/VK^;K_@I-_P20^,W[4'[
M*/[5WQV^*6O_ +7'[._[-W[)GP&_:*^/OPF^&G[47[<GQ^_;(_:*^-/COX0_
M";QUXB\-:OXL\'>-?C3\1_V?OV=OAWK=SI5JTUAH\_Q1^+^N:(TME>:M\,IK
MR:V3^XJO@#_@K%_RBR_X*6?]F ?MD?\ K.OQ&H ^ /\ @UQ_Y04?L,_]W,_^
MMA_M!5^_U?@#_P &N/\ R@H_89_[N9_];#_:"K]_J "BBB@ HHHH **** /G
MSQU^TQ\-_AU\2]5^&?B9/$4-SX8^ _C/]HWQSXJL-*AU/PKX"^&_@W6=/T4R
M^)A97TOB@ZWXIFE\0W?@_2M!\,:XVL6?@7QD99[*ZT^PM=4[6\^,GPWT_P 0
M?"?PM=^(_*U[XXV^MW7PML?['UZ3_A*(/#GA?_A,]9D^U1:6]GHGV/PT/[2V
M^(KC2'N/^/.U6>__ -%K\F/B?H/B36/VR?\ @K;X=AT;5-:\1^-?^"8/[/-K
M\+M,TK2+K4-7U[3A_P -K:)J.C>'[6S-[=ZO?R^-=0MX!I]E:I<S7NHZ=;QV
M4LLD4]UY+\9OV1?VU/#3?LU:I\-_VI/VL?CO\0[?]G7]JKP[X,M_BYX!_9<\
M/^#O@1\4?$7[*.L:+\.M6E\0? ']E+X&:_X<U2;QG)8>%]*?XF>+M=T][K;"
MMG)K:?;5AS<(8&<U%PKX3 8JI57.H7QL_$657#-4H8JI2G@UPMDU"MB(T*U.
ME[?%SK8>6+Q6 PE?6K2;K2H4YQH2>.P^"C+%Q<:5*G5CX;1>957&5Y8)_P"M
M^<XM).-6IALKC*@O9X/'U%_0?17\PGB;X Z!XL^&G[06C_L<_LC?''X'^ =6
M_P"">G[1'PP_:@\*:S^SG\7_ ($>*OCK^U!XJO/A<GP\N;:U\4^%_"_BK]I#
MXO:7IVD_& Z]^T3X'?XA0^(T\2V45K\5O$EUJ5DL'G__  4!^#FF?LF>-/B-
M\./@K^S?8V_[,_Q<\1_\$X]1U#X"6W@OXK+\#/VG?BJ?BI^U!=?'WPOXO\/?
M!CX,_'OXF?&3Q?XS^&O@SX=7OQTTGX>?"#XP_$3Q9I&F^%O$WQ8\*>)/!PUV
M\F[ZF%A3M?%4OWE:.&HR493C.I]:5'ZPX4YSK/!XG#VQN7.BJV+Q-&M152E3
M?M9+EH3JXBG7G2HMSPV4RSG$8>4_9UJ=&*PL9Y;SU:-.@\YPE?%>SS"@V\%A
MJ>'Q->&,JQA*&'_JA\2^(M&\(>'=?\6>(KS^SO#_ (7T75/$.NZA]GNKO[#H
M^BV,^I:G>?9;&"YO;G[-96T\WV>SMKBZFV>7;P2RLD;>)?#O]JWX!?%GQ;X1
M\"_#GQZ/%OBGQM\%O#/[0VC:7I?A?QFPLO@_XU:U7P5XL\77\_AV#3/A_)XS
M^T2MX0\-^/+SPWXL\3QZ3XEET+0K^/PIXE?2?S-_X)W?";X4^!_^"9?Q^\"?
M CPUX"TSQ+XFUO\ :U\0_$/X4_"+X.^./A*WPW^+7Q,G\3^++3X'2_#;XB_"
M/X(_&?\ M/X;^$O$?@?P!X1G^)OPA\#>-/$/@G2?!U[9>$M"\.7GAS1+'X2_
M9G^ /[57[./[$?B+]E#4?A1\</%_BWXO_#/]EK]HJZ^-^F>$/&-M\5/B#\*M
M(O/@GH?[3_[(/Q>\3Z;IN@K\/?CE\+/A-IGB3X7? WPH][X-N/%'PNNM(T'P
M;:P^-O!GC:<Q[",,;CL-5J0A3P^"R6MAZ]::IT*N)S/#>TQD)XBA#%0E@LJI
MU*N;5,9AHUEC\KR?$PR]3Q.9X1P4:BJSPT:$XUH5\1G5&=6G"I:E0RS%T:6&
MQ<J=?V56G/'2@\LC@*L88G#YEG.75L6J>!RW,I+^J:BOYMY_V:/!WQ0T_P"*
M'A[]G;]E;XE?"']@[QS\9O\ @FK::/\  D_L[_%G]E.*[\<^!/VG]7\0_M*_
M$?0_@!K?A+X7_$3X=^##X O/AS!\0/&=SX(\(:)XPD\-:WX@GO-;TVSU+7;K
MY!_:^^'B_ ;XLW/[-.A?LB>%/B'^RY)^VC\6_$WP<_8R\7_"+X^ZQ^S7XA^'
M3_L(_ J]U;QGX)^!?[+W[*/[6'CGQ/X*\ ?M#^-/%GBC3[WPK\!=:^#G@_XL
M7GB'_A(-?\$^.[OPYJEM%6CR4(U(RC[:M&#P^&J2A3J>T5.C4J4,3)3E&A.?
MMJ;PTXJI2C1F\7CY8;#87'O#;TXRJO&.G*E5I9?1PN)Q52G.:C*CC<;]2I_5
M75HTO;U<#/FGF]-QA'#JC.G@ZN,G6P<ZW]34/QZ\'/\ M$7_ .S+=6'B+3/B
M!#\(-/\ C9HNHZA::9'X5\7^#YO%U]X*U^#PO?P:Q<:K=ZWX&UJ/0#XQLK_1
M--MK"S\;^#[C3[[5#J-Y'IOME?SP_L6^ /@[\.?C-_P1V^%_[.OB#PMXT\-_
M"K_@G]^V5I7BOQIX'\#M\.M'UC3[3QA^R_X7\87&M^")=(T/5/"'B;6/CM8Z
ME<^(O#_BW0]*\;V_B[1_%$?B_'BNS\013?T/5T8W"T\*X0IU)UDL1G&&^L3I
M>PCBX9;GN/RZACJ%'VE1T\/C,+3P\Z:<WS2H5*L?<KQ;RC4C4FY0G2G3J83+
M,5!4I2DZ/UW!5ZM2A6<W[15E4P?UF5.K3H5L/3S*EA*U"G5P=1S****X30**
M** "BBB@#^0+_@]6_P"467P#_P"S_P#X6?\ K.O[55?O]_P2=_Y19?\ !-/_
M +, _8W_ /6=?AS7X _\'JW_ "BR^ ?_ &?_ /"S_P!9U_:JK]_O^"3O_*++
M_@FG_P!F ?L;_P#K.OPYH ^_Z*** "OYU/V4_P#@FAH_[0/A'XY_%VZ_;@_X
M*6?!^X\7?M__ /!43S/AU^S_ /MF>._A1\(_#O\ 8/\ P4G_ &K_  PO_")>
M -&L9M-T#^UTT5==U[[-(W]J^)M3UK6IMMQJ,JC^BNO@#_@FG_R;K\1O^S__
M /@K%_Z]-_;(H ^;O^'-?A[_ *25_P#!9#_Q8A\3O_E91_PYK\/?])*_^"R'
M_BQ#XG?_ "LK]D** /QO_P"'-?A[_I)7_P %D/\ Q8A\3O\ Y64?\.:_#W_2
M2O\ X+(?^+$/B=_\K*_9"B@#^8/]M'_@G3\7/AS'X-^#W[,_QF_X+<_M5?%?
MXV6/B/3;/4_$W_!2+QSX!_93^%&A6,^AZ1K?B7]I/XK:OI&J7=CHJV7B6;5=
M*^&W@;P?XU\?_$NPT#Q%HNAZ782*FHK_ "\?\$K?V+-<_P"">?\ P=<? +]D
M3Q/XS\/^/O$OPNMOB+JGB+Q'X2T75=!\*'7?BK_P35\??&/5]!\,6.NZKK.N
M7'AWP?J'Q N/"&B:WK-W!JOB73-"M?$>HZ1X?O-5FT'3?]0.OX _^=Z[_/\
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M#RR_LH?%WQ'KWA#]JO\ ;L^(?[/?[$/Q^_X)\_M$_M4_!/XH>$O'/QVO-9\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@#\ ?^#H[_E!1^W-_P!VS?\
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MY\#?_2TZ^_\ _B*._P""%'_1\W_FLW[8?_T/M'_$4=_P0H_Z/F_\UF_;#_\
MH?: /@#_ (8W_P"#R3_I+%^P!_X;GP-_]+3H_P"&-_\ @\D_Z2Q?L ?^&Y\#
M?_2TZ^__ /B*._X(4?\ 1\W_ )K-^V'_ /0^T?\ $4=_P0H_Z/F_\UF_;#_^
MA]H ^ /^&-_^#R3_ *2Q?L ?^&Y\#?\ TM.C_AC?_@\D_P"DL7[ '_AN? W_
M -+3K[__ .(H[_@A1_T?-_YK-^V'_P#0^T?\11W_  0H_P"CYO\ S6;]L/\
M^A]H ^ /^&-_^#R3_I+%^P!_X;GP-_\ 2TZ/^&-_^#R3_I+%^P!_X;GP-_\
M2TZ^_P#_ (BCO^"%'_1\W_FLW[8?_P!#[1_Q%'?\$*/^CYO_ #6;]L/_ .A]
MH _+V[_X)P_\'<][\5-$^-D__!43]@#_ (6?X>\"^(OAIIGB>#P;X?M&'@?Q
M5KGASQ+K.@ZAI%K_ ,$Y(=!UJ)M<\*:+J&FWFLZ7J&HZ#*FHIH-YID.NZ[%J
M7H?_  QO_P 'DG_26+]@#_PW/@;_ .EIU]__ /$4=_P0H_Z/F_\ -9OVP_\
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M&E"[U<G&G"$$Y.4N6*3E)N4I_ '_  QO_P 'DG_26+]@#_PW/@;_ .EIT?\
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M?:/^(H[_ ((4?]'S?^:S?MA__0^T ?B#^VM_P1!_X.=/^"B7PLT#X*?MB_\
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MV@#X _X8W_X/)/\ I+%^P!_X;GP-_P#2TZ/^&-_^#R3_ *2Q?L ?^&Y\#?\
MTM.OO_\ XBCO^"%'_1\W_FLW[8?_ -#[1_Q%'?\ !"C_ */F_P#-9OVP_P#Z
M'V@#X _X8W_X/)/^DL7[ '_AN? W_P!+3H_X8W_X/)/^DL7[ '_AN? W_P!+
M3K[_ /\ B*._X(4?]'S?^:S?MA__ $/M'_$4=_P0H_Z/F_\ -9OVP_\ Z'V@
M#X _X8W_ .#R3_I+%^P!_P"&Y\#?_2TZ/^&-_P#@\D_Z2Q?L ?\ AN? W_TM
M.OO_ /XBCO\ @A1_T?-_YK-^V'_]#[1_Q%'?\$*/^CYO_-9OVP__ *'V@#X
M_P"&-_\ @\D_Z2Q?L ?^&Y\#?_2TZ/\ AC?_ (/)/^DL7[ '_AN? W_TM.OO
M_P#XBCO^"%'_ $?-_P":S?MA_P#T/M'_ !%'?\$*/^CYO_-9OVP__H?: /@#
M_AC?_@\D_P"DL7[ '_AN? W_ -+3H_X8W_X/)/\ I+%^P!_X;GP-_P#2TZ^_
M_P#B*._X(4?]'S?^:S?MA_\ T/M'_$4=_P $*/\ H^;_ ,UF_;#_ /H?: /@
M#_AC?_@\D_Z2Q?L ?^&Y\#?_ $M.C_AC?_@\D_Z2Q?L ?^&Y\#?_ $M.OO\
M_P"(H[_@A1_T?-_YK-^V'_\ 0^T?\11W_!"C_H^;_P UF_;#_P#H?: /R^^&
MO_!.'_@[F^#^BZQX<^''_!4'_@GYX8T+7?&OC?XB:CI5MX(\-WMD?%_Q'\3Z
MEXS\:ZI8P:I_P3BODTF'7?%.L:KK<VDZ2++1;6^U"[>PTZT6=T/H7_#&_P#P
M>2?])8OV /\ PW/@;_Z6G7W_ /\ $4=_P0H_Z/F_\UF_;#_^A]H_XBCO^"%'
M_1\W_FLW[8?_ -#[1=VBFVU&%.G&[;Y:=*G2HTH*[;4:=&C1I4XWM"G2I0C:
M-."BVW*4Y-MRJ3J59R>LIU*M2=6K4DWK*=2K4G4J2=Y3G.<Y-RE)O\M;3_@F
MO_P=P6/Q>USX\6__  5"_8#_ .%K>(OA]X>^%FI^*9_"6BW8_P"$"\+:_P"(
M/%&D>'].T&[_ ."=$_AK1(QKWB?5]1U._P!$T;3]5U^5M.CU^_U.WT+0X=.]
M+_X8W_X/)/\ I+%^P!_X;GP-_P#2TZ^__P#B*._X(4?]'S?^:S?MA_\ T/M'
M_$4=_P $*/\ H^;_ ,UF_;#_ /H?:+^["&T*<7"G%:1A&52K6E&$4DHJ56O7
MJR27O5*U6I)RG4E)C;E*4Y.\Y<G-)ZRE[.E3H4^9[ODHT:-&%[\M*E3IJT81
M2^ /^&-_^#R3_I+%^P!_X;GP-_\ 2TZ/^&-_^#R3_I+%^P!_X;GP-_\ 2TZ^
M_P#_ (BCO^"%'_1\W_FLW[8?_P!#[1_Q%'?\$*/^CYO_ #6;]L/_ .A]H$?
M'_#&_P#P>2?])8OV /\ PW/@;_Z6G1_PQO\ \'DG_26+]@#_ ,-SX&_^EIU]
M_P#_ !%'?\$*/^CYO_-9OVP__H?:/^(H[_@A1_T?-_YK-^V'_P#0^T ? '_#
M&_\ P>2?])8OV /_  W/@;_Z6G1_PQO_ ,'DG_26+]@#_P -SX&_^EIU]_\
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M6G7W_P#\11W_  0H_P"CYO\ S6;]L/\ ^A]H_P"(H[_@A1_T?-_YK-^V'_\
M0^T@/@#_ (8W_P"#R3_I+%^P!_X;GP-_]+3H_P"&-_\ @\D_Z2Q?L ?^&Y\#
M?_2TZ^__ /B*._X(4?\ 1\W_ )K-^V'_ /0^T?\ $4=_P0H_Z/F_\UF_;#_^
MA]H ^ /^&-_^#R3_ *2Q?L ?^&Y\#?\ TM.C_AC?_@\D_P"DL7[ '_AN? W_
M -+3K[__ .(H[_@A1_T?-_YK-^V'_P#0^T?\11W_  0H_P"CYO\ S6;]L/\
M^A]H ^ /^&-_^#R3_I+%^P!_X;GP-_\ 2TZ/^&-_^#R3_I+%^P!_X;GP-_\
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M: /W^HK\ ?\ B*._X(4?]'S?^:S?MA__ $/M'_$4=_P0H_Z/F_\ -9OVP_\
MZ'V@#]_J*_ '_B*._P""%'_1\W_FLW[8?_T/M'_$4=_P0H_Z/F_\UF_;#_\
MH?: /W^HK\ ?^(H[_@A1_P!'S?\ FLW[8?\ ]#[1_P 11W_!"C_H^;_S6;]L
M/_Z'V@#]_J*_ '_B*._X(4?]'S?^:S?MA_\ T/M'_$4=_P $*/\ H^;_ ,UF
M_;#_ /H?: /W^HK\ ?\ B*._X(4?]'S?^:S?MA__ $/M'_$4=_P0H_Z/F_\
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MM"TS^T-0N/L&CZ9I^F6OE65E;01?M]_PZ=_X)9?](T_V /\ Q#?]G7_YW-?
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M.)_%GPTL/A=^W/\ LD?LX_"S5_'4?C/QY;>._A;\9?V;O!U]X5T6"R^'6D>
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M6SW.G6<L/]3O_!)W_E%E_P $T_\ LP#]C?\ ]9U^'-?@#_P>K?\ *++X!_\
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MX96'@7X%?#']G?Q[%\/_ (7>'OA9XC\%?%"3XE?#WX3Z%)IE_P")?BS\+6\
M>)=6U75;BQ\>V%O9Z*W7AJ>&YJ<*]2?/]8PT5*2HRH/$/-)1S6GB94YP:R>A
MD,J>)RG$0=.>*S2,J$\1*MS8:)5DI4.>G[9-Y=1E)1A%5U-Y;AW5G1IU[1>;
M?VRL52^K57]46!]C4<51E&N_2?AE_P %5M)\7VGQ9U3Q;\&G\.V6B^"_!'Q
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MMMXCMO ]OXAO/!OB^WT/2^*/P]_X-W_@KK/Q"T'XI?L@_P#!//P=J/PI\(?
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M=.G++JF(FYK_ &5_"_[*E]_P;_\ [5%M\*?#FC?\$Y?V-_"/QR^)W@X>-7^
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M.U:U\57NO7WB"#49]3TN'$>I7GYL^.?^"</[1'PR_90\!^&OC/KOP5B^$O\
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M":FD_"WQAX:\4?&+4[72?A6^O?#;XB_LV^&/B/I'A7X@W=Y"_A/X@7_A.W\
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M/,_[-,7QX\9ZSXJ\)+)XO\'KX-^'.O6WB_PC!<^*O#-QJWA^UN-1B;-\&O\
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M+Q]X.;QY_P *@^ /C"7]B3Q%K_QL\;Z1X7-AJ<MW\0_ 7[.G@]X_$/AVVO\
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ME1/,O&7A/_@A[XPO_'/P1_9@_8"_8=\;_M0W_P -?CKX@^!<6O?\$G-9U?\
M9^\=^*O@KI%Y#XAN8/C?8?L]>$?@KXP\#^%?'!TCP7XUUCPK\;['3[#Q3J=I
MX*_X2.P\7W]CILG97'_!*K]H&W\/?&O3K?QA\()#X\_X+-_"W_@HOX>,GB'Q
MS<RP? [P!K7PNU/4O"NKD_#XRGXMW5KX&U1+#1+7[=X4N[JYT];KQU:+/<RV
MGY=_\$]/C?X*_9\\17GC^Z\6_!_X[7NJ_"#_ (*%>//COI6C67QZTGXT_P#!
M-_PQX:\7^,?BO<Z!\5/A]\2OVN?C!\&_@!:_'/Q)9Z7I-_\ #?X8? C]E<>)
MO$&BZ5=C_A8EIX:?6X>"O*$LNQ<?;UX9A1X8QN8N.%IQ==YD^&*>8894J,J>
M*>'IX//XYCEM5SIXW#U)Y7#"8NM0KYQE<\QZZ$)PS'"2IX6.+PM3/,+@81G&
M5>@X_P!NX'"QIXB<'AXXJGC\!BJ%:-*F\+BZU*O4EEU&O+#8^EE_Z#>.? /_
M  2D\%?\$FX?^"GVG_\ !(C_ ()_^-H8_P!F/P9^T#+\*!^R]^SMX,%]J'B'
M2-"NM5\(_P#"4M\'?&CZ)_9>IZI>6)O'T/7)$-B4D@D=VD7LOC3^SK_P2E^#
M7QZ_9B\,^,/V#O\ @E!X$^%?Q7_9]_:/^-OCWPYXE_8/T+Q/\9KNR^"G@WP1
MXYEU7X8:QX#^!VJ?#.#PUX,T+6/$%W\0K'Q[<:=XM\1+)X=@^&VDZK?)K%I%
MM^"_V#?C+\7/^#>#P#^PCH<WAKP9\<?B/^Q3X(\*(OQ-O=8T3PSX7\:>*K72
M?&6H:9XJO?#?A_Q9K>G6NCW-]=:7<-I_A[6;V&6W5&MIG$CAOQU_8(_;F_:K
M^(?P ^(GQ)\.?LG_  =N/@A^RM^W'^SE+H?@?]HKXP?&:'Q)>_M(_!#P7\//
MAYXKCU?7OV1?@F^DVNG^)M$U:3QII#:3J,ND:$NG:AH=_P"*-0O+G1M.]?B"
M+P68\4T\#A:/M<OX@S#^SL(Y2JX7ZA2X0XX?U+#S]LHXZE1XSH9#ET+U_K'+
M'!XB%9X>4JRX\H^J8G!9)*KBZE3#XO 5*>(QLG'ZW4C4XMX(H9?F%5JC%4*]
M?@^IQ!FLJU/#JBYRQ?/AU*='#RX<>(/^#:1]-U;58/V1_P!AR]M=)^&'A_XW
MI%IW_!+V34M2\1?!'Q' +B+XU^ M&T_]ERYUCXD_!SP_&)5^('Q3^'UCXF\!
M?#">TU"V^(_B#PK<Z=?Q6_RA^TAX]_X)'?LR?%#XLV%Q_P $R_\ @F;^T3X"
MT[XC?L#^#?AQX2^ 7_!/?6]?^)GA;PI^U\]RFI_$?XJ^,_#7[)WQ*^%'BFVO
MM.4>)O@?X/\ A==7&N_$1K,?#Z>ZM/'GB3PU97?W/:?\$KOV@[?7OAOJC^,?
M@T;?P=_P1+\4_P#!-O4T7Q#XV,T_QRUM?"PM/%=@I^'BI+\*(SHEW]HURXDM
M?%Z>9;^7X%EWR>5\\Z9_P16_:ET?0/B/=1>./@#J'BL^$O\ @COJ'PVT>3QG
M\1--\/:]\0?^";*Z;>_$/P[XX\1K\']4U+P=X-^(E_I[Z;X,\8Z#X6\=ZW9V
MERNL:YX%M9K8Z)=;.CEM+-Y1>+E/+,-C\73E7=-XB.+RVCQ/C<NA56'IQI3E
M6Q6095@<YHRH3IUX4\]Q&'PT83=&IAN6E/%5LLISG15+'XG*<#B'0<XT)83-
MJ^287'5<+*M>K&-+"9MC\5E5>-2,Z4Y991KXB<Z5*K2Q?UIJOP:_X(#Z%X_\
M(_#+7?V$_P!B70O%WC"7P%8I#K?_  32T32- \$^(/BG:65Y\-/!/QG\::C^
MSE;>"O@#\1O'R:CI]KX0^&GQQ\0?#SQ_XAU2]M-&TOPW=:O<16+?'/[4MO\
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M_87A'PGIND>'](_M?Q!J^JZ[J?\ 9^GV_P!OUC4]0U.Z\V]O;F>4KT#]C?\
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MX_\ _$JOVO/_ )_%?JG10!^5G_#E/_@F]_T13Q__ .)5?M>?_/XH_P"'*?\
MP3>_Z(IX_P#_ !*K]KS_ .?Q7ZIT4 ?E9_PY3_X)O?\ 1%/'_P#XE5^UY_\
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M7_!ZM_RBR^ ?_9__ ,+/_6=?VJJ_?[_@D[_RBR_X)I_]F ?L;_\ K.OPYK\
M?^#U;_E%E\ _^S__ (6?^LZ_M55^_P!_P2=_Y19?\$T_^S /V-__ %G7X<T
M??\ 1110 5^!O['G_!-;]E/]H#X?_&KXM_$JV_:*D\:^+/V__P#@J5_;+^ _
MVW_VW?@_X5;^PO\ @I=^UIX9T[^R_AW\(/VA_ OP\\/8TG1K 7O_  C_ (6T
MO^UM1%YKFK?;=<U/4]1O/WRKX _X)I_\FZ_$;_L__P#X*Q?^O3?VR* /.?\
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M:?L*WG@K0],U'0_BQX7\?>'O$_CGX]Z/)=OK/A3Q/82PQ77Z/>(/V1H/#_Q
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M6(KYO#%4J<7/$T*67XB4,%&G@ZD:55XO-I4XY;3H8F=".!S#&4WCO=P\H/\
MI*HK^<GP5^R!\/OC1\2/ACX?LOV2O%OAS_@GSJ7[:VO>,OAI^S]\0?@=XY^$
M7@#PYX*L?V#?B!X,\9ZSXA_9N\5^'_"E[\)O@MX]^,\[Z=9_"_XH^ O!WAOQ
M=XIN]1UB[\#7,'CK3[G7/S>_:@\">(+:W^"W[*WQ,_9RB^)_PRT7PE_P5C\)
M^#/@Y\8O@O\ M3_%KPE^S]\,[C]KS2O 7[,W[0?@?X'_ +-_[)O[5/CK[5\*
M_@[+-8?L_>*_&7A/X;?#D_#Z]FT7P#\:O",EY&;W&5%_5XU(M0Q-:#J8?!XJ
MI0PU1\D<2IX;%5GB)8?"8F<\.JD*E2?U##8&O3S#,Z^#H4L9'![8:E&M/%.=
M>FL+@:F!HXG$T8U:WM)YC%2H5L!0Y%5QV&P]JE+&*'+BWC*+P.!HXC$XG K$
M_P!=7A/X^>"O%WQR^+W[/-M:>(-*^(OP;\-?#3QKK=OK5GI]OIGB/P7\5HO$
MT?A?Q7X/N[/5;ZYU+1X];\%^+O"VK'4K+1KZP\0>'[R+[%-IUSIFI7_MM?BU
M^R9IWPFLOVX?@KHO[.&N^#O$OPA\#?\ !([X4Z1)XC^'VDZ'H/A#Q%X6U[XR
M@? G6-+T;PS9V>@:39ZI8>$_B]K&FZ3IEGIMKIT>I7T4%J8Y/+MOVEK3%8>.
M']E",JLFI9C1G.M1GAZE9Y?G_$63PQ3PU2$*F%CC:&4X7&1PTU*5#VE6FZE1
MJ<H\&'KU:TJOM<-4PDE#+*JH590FZ3S#(,BS:K05:G[N(6$Q688S"?6%&'M9
M4)ODBJ=.Y1117*=(4444 %%%% !1110 4444 %%%% '\@7[&_P#RN2?\%8O^
MS /AQ_Z@W_!-.BC]C?\ Y7)/^"L7_9@'PX_]0;_@FG10!_7[1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %?,'[;OP4\5?M*?L7_ +7?[.?@74/#^D^-OC]^S!\?
M?@IX.U3Q9=:C8^%=-\5?%3X4^+/ OA[4/$U]H^E:]J]GX?L]7UVSN-9NM+T/
M6=1M].CN9K'2M1N4BLYOI^B@#^(/]ES_ ())_P#!U?\ L7? GP-^S1^S1_P4
MH_8 ^&OP2^&O_"3?\(5X*_X1^W\8_P!B_P#"8^,?$/C_ ,1_\5'X_P#^">GB
MKQ;J/]H^+?%6O:M_Q-M>O_L?V_[!8?9=,M;*RM_?_P#AC?\ X/)/^DL7[ '_
M (;GP-_]+3K^OVB@#^0+_AC?_@\D_P"DL7[ '_AN? W_ -+3H_X8W_X/)/\
MI+%^P!_X;GP-_P#2TZ_K]HH _D"_X8W_ .#R3_I+%^P!_P"&Y\#?_2TZ/^&-
M_P#@\D_Z2Q?L ?\ AN? W_TM.OZ_:* /XSOB/_P3R_X.\/B[X \:?"WXC_\
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M4)RB]),J$Y4YPJ0E*$Z<HSA.+<90G"49PG&2U4H3A"46M5*,6M4C^,GX9?\
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M\N-&NM4T/1M1N-.DMIK[2M.N7ELX?I^B@ HHHH *^ /^":?_ ";K\1O^S_\
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M3_I+%^P!_P"&Y\#?_2TZ/^&-_P#@\D_Z2Q?L ?\ AN? W_TM.OO_ /XBCO\
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MTXJ$(J,8WM%7LKN4F]7)MRE.<I2E*<YSG.<YSG.<Y_ '_#&__!Y)_P!)8OV
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M<^!O_I:=??\ _P 11W_!"C_H^;_S6;]L/_Z'VC_B*._X(4?]'S?^:S?MA_\
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M9$^#-Y\%-3_90_:3\(_"3PG\5_''CWQ;XST#XP_#*P\"_ KX8_L[^/8OA_\
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M?&D?@_QWX2U:PU+PU?:I<^)+SPD=+U>QB-[:7O[W5\9_M[?LCR_MK_LWZ_\
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M3_8 _P#$-_V=?_G<T?\ #IW_ ()9?](T_P!@#_Q#?]G7_P"=S7W_ $5RFA\
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MV887,.(JN=U<!B<%A:!IE_)4GA'F"=&$L9E:QD8<S5/!SPW!\\4Z<J?M9/\
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M!*V>@Z9IND>)/ GB+[-/=WC_ (6_\$:_!_P<\:Z#XE\$?&W5SI>D_L&_'?\
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M3_$$'Q^\:? [7K^_^)%_J4,>_P %Z+XMTSP>D4\GCS4?"ZK'YOM'[(G["O[
M?C']I+_@H1^S[\6?^">W_!/;Q)>_ #XU?#SQ!\+)A^Q3^RCIVJZ1\#?CG\'_
M  OXW\(^%=9A\,?"32K2]N?"7C&Q^(>AVVL7QU/6=0TRVL/[3UK5IX!J%S^>
MFN?L4_&K]E?]I"Q'PO\ !/QY^+'[3W[-_P '/V _@/\ L4^-M1_89^$?Q/\
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MCX-LM0\6>#OAYHM_X5D'CG69+;4]/TV__FL_X)_?L9>#O^"?/_!WE\'OV1?
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M>?%WQ;\+_A;K'B#PA\3/@%JFE^+- \:?$/P%)>:!K$VIZ3>76LZ=%H>I]/\
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M%"<^)(_$T;Z"^F#5$:U'C$_[?_[!]K8^+M4N?VV/V1[?3/A_8>&-5\>:C/\
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M1^&\&B645IJ+Z??Z@/[1QPLHRA"=>/OTL/F-:K!\\*=24)\;4,)3JNRG"K?
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M@L+B\VXGP<Z3CBK3=)8# Y=C\)3BZV/GAX/&XJ>'H2J86?Z5T445S%!1110
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MT/MB6ZW]K975MV7_  2=_P"467_!-/\ [, _8W_]9U^'-??] 'YJZS_P1_\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M+W7]IV0N;O4/ZO:_G!_;U_X.@?V!?^"=O[6/Q6_8Z^-?PB_:_P#%'Q-^#_\
MP@O_  DVN_"WP#\%];\"7W_"P/AMX.^*6C?V%J?BSX_^"?$%S]F\/^-M*L]3
M_M#PQIGDZQ;ZA;VOVVRBMM0NP#Y _P"(<3_@J;_TLX?M_P#_ (+OVBO_ */Z
MC_B'$_X*F_\ 2SA^W_\ ^"[]HK_Z/ZC_ (C5O^"67_1 _P!O_P#\-9^SK_\
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M).322<Y.<VDDY3:@G.323E)JG33E)RDU""<FH04#_B'$_P""IO\ TLX?M_\
M_@N_:*_^C^H_XAQ/^"IO_2SA^W__ ."[]HK_ .C^H_XC5O\ @EE_T0/]O_\
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M1JW_  2R_P"B!_M__P#AK/V=?_HJJ #_ (AQ/^"IO_2SA^W_ /\ @N_:*_\
MH_J/^(<3_@J;_P!+.'[?_P#X+OVBO_H_J/\ B-6_X)9?]$#_ &__ /PUG[.O
M_P!%51_Q&K?\$LO^B!_M_P#_ (:S]G7_ .BJH /^(<3_ (*F_P#2SA^W_P#^
M"[]HK_Z/ZC_B'$_X*F_]+.'[?_\ X+OVBO\ Z/ZC_B-6_P""67_1 _V__P#P
MUG[.O_T55'_$:M_P2R_Z('^W_P#^&L_9U_\ HJJ #_B'$_X*F_\ 2SA^W_\
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M?LT_LT?\)3_PG'_#._[/_P &_@7_ ,)K_8G_  C/_"8?\*D^'7ASP!_PE/\
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MZ6</V_\ _P %W[17_P!']1_Q&K?\$LO^B!_M_P#_ (:S]G7_ .BJH_XC5O\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MC[X4V7PK\+^#X#:?"/XE_%;Q5\.O%OQ0^+7A/Q9;>,-)OKG2/B-JGPST:_\
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MXI^&-1BUW4=.U/P==726FL6_)7<_[+FJ4::S2CE=;"8>%-RJ86>95<DXBQ>
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M-%^(>K?$^SU3PJ?!OC&6'5_'OPK\">#O&%OX7UF[\ >(O%%G#;S7'R_\,/\
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MSA[:,/:XBCBN**&+BIP>(G@J699C@%6PLVL6L@RBK1E*.*Q$<7<T/_@KW<>
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M.\)?!"']G#PYJ>@1ZGX7\-1_%6./6_#OB)-1']B^"TOO#*^"M-L[;2E\0>)
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M\0Z;X5\<:KXQ^)?AA[2]NY-;^&^JK+;6UCJR?\$0O ^A>!_VI?AC\-?C??\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH *_%3]AW]A#]A[XS?"KXP?$KXP?L:?LI?%
M?XB^)/V__P#@JC_PD7C_ .)7[._PB\=>-=>_L?\ X*;_ +76@:1_;7BKQ1X/
MU37=4_LO0M+TS1=.^W7\_P!ATG3K#3K;RK.SMX8_VKKX _X)I_\ )NOQ&_[/
M_P#^"L7_ *]-_;(H UI/^"7?_!,Z9&CE_P""=O["TL;8W1R?LD? %T;!##<K
M?#\J<, PR." 1R!5&7_@E1_P2\G79-_P3<_8(F0$,$E_8]_9YD4, 0&VO\.R
M,@$@'&0"?6OO>B@#X _X=._\$LO^D:?[ '_B&_[.O_SN:/\ AT[_ ,$LO^D:
M?[ '_B&_[.O_ ,[FOO\ HH _"/\ ;$_X(Z?"?XB#P/\ #C]C7]A__@D;^SUX
M:\4+XA7XR?M(_$']A7X(?%;XM_#73K:SA_X1VS^!'P-G^$VF?#+Q5XKU[496
M2\\5_%+QV/#GA+2[6\F3P!XNU&XL$@_DZ_8K_9"^$_[!G_!XG\,/V3_@A)XE
MN/AG\*(/%2Z#>>,;W1[_ ,2ZC?>-_P#@ECXF^(WBG5-6E\.Z%X7\.03ZKXN\
M7Z]J*:=X<\->'_#VD6]U#I6A:+I>DV=G90?Z4-?P!_\ .]=_G_I#Q0!_?Y11
M10 4444 %%%% !1110 4444 %%%% !2$A068@  DD\  #))/8 <FEK.UBUGO
MM(U6RM93!<WFG7UK;SJ55H9[BVEBBE4O'*@,<CJX+12J",M&XRIPQ52I1PV)
MK4J3K5:.&Q-:E15[UJM+#UZM*BK:WK5*5.DK:WJJVMBZ48SJ4X3FJ<)U*<)U
M&FU3A.I"$JC2U:IQE*;2U:@TM6C\[=+_ ."D?@[4O 7PX\2Z5\'?B9\1O'GQ
MZ^(OQO\ #'[.7P1^"]WX,\7?$3XO_#[X*>--;\,:A\8O[7\?^(OA)\*_AYX)
MU/1]*L/%LVJ_$3XC^'O#NEV?BCPKH,?B?5?%&O:;I%S]#6_[7OP/T3PW\,=6
M^-WBW1_V5O%/Q<U^;P;X+^%7[3WBSX??"?XE:QX\M;\Z9<^!_#^E7OC+4-"\
M>Z]]N"1Z=/\ #'Q'XX\/^([:>SU/PMKFN:3?65_<?BI^QA\)OCEX$^$7_!,/
M]JWX8_"[6_VA-6_9;_96^/W[#W[0'P*\&>,OAMX5^*!\17'Q,^'VB^*/%O@&
M\^+OBWX7_"W6/$'A#XF? +5-+\6:!XT^(?@*2\T#6)M3TF\NM9TZ+0]3Z?\
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M =8\0^)O$WB'6/ -YJ^O>(-=U>\O-4UG6=4O+K4=4U&ZN;Z^N9[F>65OM_\
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M!F&,H4JT%&4Z6$S'&X["P=:,<1:#]M"FY4J=(HHHKC.L**** "BBB@ HHHH
M**** "BBB@#^0+]C?_E<D_X*Q?\ 9@'PX_\ 4&_X)IT4?L;_ /*Y)_P5B_[,
M ^''_J#?\$TZ* /Z_:*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M%W[17_T?U'_$:M_P2R_Z('^W_P#^&L_9U_\ HJJ/^(U;_@EE_P!$#_;_ /\
MPUG[.O\ ]%50 ?\ $.)_P5-_Z6</V_\ _P %W[17_P!']1_Q#B?\%3?^EG#]
MO_\ \%W[17_T?U'_ !&K?\$LO^B!_M__ /AK/V=?_HJJ/^(U;_@EE_T0/]O_
M /\ #6?LZ_\ T55 !_Q#B?\ !4W_ *6</V__ /P7?M%?_1_4?\0XG_!4W_I9
MP_;_ /\ P7?M%?\ T?U'_$:M_P $LO\ H@?[?_\ X:S]G7_Z*JC_ (C5O^"6
M7_1 _P!O_P#\-9^SK_\ 154 '_$.)_P5-_Z6</V__P#P7?M%?_1_4?\ $.)_
MP5-_Z6</V_\ _P %W[17_P!']1_Q&K?\$LO^B!_M_P#_ (:S]G7_ .BJH_XC
M5O\ @EE_T0/]O_\ \-9^SK_]%50 ?\0XG_!4W_I9P_;_ /\ P7?M%?\ T?U'
M_$.)_P %3?\ I9P_;_\ _!=^T5_]']1_Q&K?\$LO^B!_M_\ _AK/V=?_ **J
MC_B-6_X)9?\ 1 _V_P#_ ,-9^SK_ /154 '_ !#B?\%3?^EG#]O_ /\ !=^T
M5_\ 1_4?\0XG_!4W_I9P_;__ /!=^T5_]']1_P 1JW_!++_H@?[?_P#X:S]G
M7_Z*JC_B-6_X)9?]$#_;_P#_  UG[.O_ -%50!@>'O\ @V9_X*2^$H=3MO"G
M_!R9^W!X9M]:U[6/%.LP>'O"WQYT6'5O$_B*\DU'Q!XCU.+3?V]K9+_7M=U"
M66_UC5[I9=0U.\DDNKVXGG=G._\ \0XG_!4W_I9P_;__ /!=^T5_]']1_P 1
MJW_!++_H@?[?_P#X:S]G7_Z*JC_B-6_X)9?]$#_;_P#_  UG[.O_ -%51LDE
MHHQC&*6BC&$8PA&*VC&$(QA",4HPA&,(QC&,8Q'JVWJY2E*3>KE*4G*4I-W<
MI2DW*4I-RE)N4I2DW)\U8?\ !LC_ ,%'=*\4>(?'&E_\'(O[;6F^-/%UAH.E
M>+/%]AX1^.UGXH\3Z7X6_M/_ (1C3?$/B"W_ &](]6UJP\.?VUK/]@V>I7=S
M;Z1_:VI_V?';_;[KS>E_XAQ/^"IO_2SA^W__ ."[]HK_ .C^H_XC5O\ @EE_
MT0/]O_\ \-9^SK_]%51_Q&K?\$LO^B!_M_\ _AK/V=?_ **JB[M%7=HQ4(J[
MM&"<VH16T8IU*C48J,4ZDVHISFYI))R:23G)SFTDG*;4$YR:2<I-4Z:<I.4F
MH03DU""@?\0XG_!4W_I9P_;_ /\ P7?M%?\ T?U'_$.)_P %3?\ I9P_;_\
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M_$:M_P $LO\ H@?[?_\ X:S]G7_Z*JC_ (C5O^"67_1 _P!O_P#\-9^SK_\
M154 '_$.)_P5-_Z6</V__P#P7?M%?_1_4?\ $.)_P5-_Z6</V_\ _P %W[17
M_P!']1_Q&K?\$LO^B!_M_P#_ (:S]G7_ .BJH_XC5O\ @EE_T0/]O_\ \-9^
MSK_]%50 ?\0XG_!4W_I9P_;_ /\ P7?M%?\ T?U'_$.)_P %3?\ I9P_;_\
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M5Y<:-=:IH>C:C<:=);37VE:=<O+9P^/_ /$:M_P2R_Z('^W_ /\ AK/V=?\
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M (AQ/^"IO_2SA^W_ /\ @N_:*_\ H_J/^(U;_@EE_P!$#_;_ /\ PUG[.O\
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M6$8QB?\ $.)_P5-_Z6</V_\ _P %W[17_P!']7E'QB_X-3/VV_VB/"@\!_M
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M'4);C^R](M;?3;'R+.&.%>I_XAQ/^"IO_2SA^W__ ."[]HK_ .C^H_XC5O\
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M.O\ ]%50 ?\ $.)_P5-_Z6</V_\ _P %W[17_P!']1_Q#B?\%3?^EG#]O_\
M\%W[17_T?U'_ !&K?\$LO^B!_M__ /AK/V=?_HJJ/^(U;_@EE_T0/]O_ /\
M#6?LZ_\ T55 !_Q#B?\ !4W_ *6</V__ /P7?M%?_1_4?\0XG_!4W_I9P_;_
M /\ P7?M%?\ T?U'_$:M_P $LO\ H@?[?_\ X:S]G7_Z*JC_ (C5O^"67_1
M_P!O_P#\-9^SK_\ 154 '_$.)_P5-_Z6</V__P#P7?M%?_1_4?\ $.)_P5-_
MZ6</V_\ _P %W[17_P!']1_Q&K?\$LO^B!_M_P#_ (:S]G7_ .BJH_XC5O\
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M7XS^%7Q-C\6O'X:^$NBZ9\0_@'HKM<Z=KFIS_$V">70JY3]HW_@H3XS^,/\
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MN?M#?M!_''XH_L?>+?B]XN^'?C/Q['^SYX;NO$\WQD\"7/P\UO1OB!HGP7^
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M6F;1Y]1?P1%_PLCPI+I4L<^E?$W5KN*\L;7M/ G[#VG_  E^*_BCQ_\ !_\
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MN[[_ (+0^+_!VF^.-9'[(M]XD^$WP3_:I^ G['/C?QL_[1>ES_$C6_%OQ_\
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MB^)7A'XA?%&T\7Z7);W7B+2_ LUY9VL_3?\ #!ECX?\ BQ>_&/X0_M1?M0_
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MQ1_X)I3?'[X^?\%&?AW\5+7Q1H7[*7[<OA3]D#XF/\0OAGXH\(Z3XWTGXV_
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M^*?[)'_!2?XK?\$V/@I_P3!^('[9'Q-^'_\ P@O_  C,WPM^./B.+QW\1O\
MA*_@+X.^/6L_V%\'_"?[,?Q1\0+_ ,(AX?\ $FJKJ?\ 9^M:[G1_"^H>*+K^
MS+(W-IIX!Y__ ,05/_!++_HOG[?_ /X=/]G7_P"A5H_X@J?^"67_ $7S]O\
M_P##I_LZ_P#T*M'_ !$=_P#!4W_I6/\ V_\ _P &/[17_P! #1_Q$=_\%3?^
ME8_]O_\ \&/[17_T - !_P 05/\ P2R_Z+Y^W_\ ^'3_ &=?_H5:/^(*G_@E
ME_T7S]O_ /\ #I_LZ_\ T*M'_$1W_P %3?\ I6/_ &__ /P8_M%?_0 T?\1'
M?_!4W_I6/_;_ /\ P8_M%?\ T - !_Q!4_\ !++_ *+Y^W__ .'3_9U_^A5H
M_P"(*G_@EE_T7S]O_P#\.G^SK_\ 0JT?\1'?_!4W_I6/_;__ /!C^T5_] #1
M_P 1'?\ P5-_Z5C_ -O_ /\ !C^T5_\ 0 T '_$%3_P2R_Z+Y^W_ /\ AT_V
M=?\ Z%6C_B"I_P""67_1?/V__P#PZ?[.O_T*M'_$1W_P5-_Z5C_V_P#_ ,&/
M[17_ - #1_Q$=_\ !4W_ *5C_P!O_P#\&/[17_T - !_Q!4_\$LO^B^?M_\
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M:/\ B"I_X)9?]%\_;_\ _#I_LZ__ $*M'_$1W_P5-_Z5C_V__P#P8_M%?_0
MT?\ $1W_ ,%3?^E8_P#;_P#_  8_M%?_ $ - !_Q!4_\$LO^B^?M_P#_ (=/
M]G7_ .A5H_X@J?\ @EE_T7S]O_\ \.G^SK_]"K1_Q$=_\%3?^E8_]O\ _P#!
MC^T5_P#0 T?\1'?_  5-_P"E8_\ ;_\ _!C^T5_] #0 ?\05/_!++_HOG[?_
M /X=/]G7_P"A5H_X@J?^"67_ $7S]O\ _P##I_LZ_P#T*M'_ !$=_P#!4W_I
M6/\ V_\ _P &/[17_P! #1_Q$=_\%3?^E8_]O_\ \&/[17_T - !_P 05/\
MP2R_Z+Y^W_\ ^'3_ &=?_H5:/^(*G_@EE_T7S]O_ /\ #I_LZ_\ T*M'_$1W
M_P %3?\ I6/_ &__ /P8_M%?_0 T?\1'?_!4W_I6/_;_ /\ P8_M%?\ T -
M!_Q!4_\ !++_ *+Y^W__ .'3_9U_^A5H_P"(*G_@EE_T7S]O_P#\.G^SK_\
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M3_9U_P#H5:/^(*G_ ()9?]%\_;__ /#I_LZ__0JT?\1'?_!4W_I6/_;_ /\
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M_"%?VW_PDW_"'_\ "V_AUX<\?_\ "+?\)'_9'A__ (2#_A'_ /A(/[)_MO\
ML'1/[5^R?;_[(TW[1]CA]_H **** "BBB@#^6+]H7_@T4_X)M_M*?'WXX?M&
M>.OC;^V_I/C;X_?&#XE_&OQCI?A/XD_ :Q\*Z;XJ^*GC36O'7B'3_#-CK'[-
M6O:O9^'[/5]=O+?1K75-<UG4;?3H[:&^U74;E);R;Q__ (@J?^"67_1?/V__
M /PZ?[.O_P!"K1X]_P"#GC]J?_AJ?]K_ /9H_9H_X(F_M ?M@?\ #'_[0'Q)
M^!?C7QK\"_BU\1?&O_(E?$7QUX \.>*?%/ASP!^QW\0/^%?_ /"P/^%?Z]JV
MB:)JVO:A_P @_5["PU?6O[%O;RC_ (B._P#@J;_TK'_M_P#_ (,?VBO_ * &
M@ _X@J?^"67_ $7S]O\ _P##I_LZ_P#T*M'_ !!4_P#!++_HOG[?_P#X=/\
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M -*Q_P"W_P#^#']HK_Z &C_B([_X*F_]*Q_[?_\ X,?VBO\ Z &@ _X@J?\
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M_P#0JT?\05/_  2R_P"B^?M__P#AT_V=?_H5:/\ B([_ ."IO_2L?^W_ /\
M@Q_:*_\ H :/^(CO_@J;_P!*Q_[?_P#X,?VBO_H : #_ (@J?^"67_1?/V__
M /PZ?[.O_P!"K1_Q!4_\$LO^B^?M_P#_ (=/]G7_ .A5H_XB._\ @J;_ -*Q
M_P"W_P#^#']HK_Z &C_B([_X*F_]*Q_[?_\ X,?VBO\ Z &@ _X@J?\ @EE_
MT7S]O_\ \.G^SK_]"K1_Q!4_\$LO^B^?M_\ _AT_V=?_ *%6C_B([_X*F_\
M2L?^W_\ ^#']HK_Z &C_ (B._P#@J;_TK'_M_P#_ (,?VBO_ * &@ _X@J?^
M"67_ $7S]O\ _P##I_LZ_P#T*M'_ !!4_P#!++_HOG[?_P#X=/\ 9U_^A5H_
MXB._^"IO_2L?^W__ .#']HK_ .@!H_XB._\ @J;_ -*Q_P"W_P#^#']HK_Z
M&@#]'_\ @E__ ,&]/[%__!)GX^^+_P!HS]G/XG?M/^-/&WC3X/Z_\%-4TOXU
M^-/A3XC\*V_A7Q'XT^'_ (ZOM0T^Q\"_!7X<:O%X@BU?X<:';VMU<:Y=:<FG
M76JPS:5/<SV=Y8E>/_\ !*;_ (+T_%/_ (*)?MQ?%O\ 86^-?_!.GX@?L+_$
MWX/_ +/^K?'3Q-I_Q2^*WB/6_'=C]D\6_!K0M&\+:[\+?%G[/7P;\0>&_P#A
M)/#_ ,9-*\9Z9K>H7S^=H]OI\MKI%[9:_;:G:% ']'U%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 5\ ?\$T_P#DW7XC?]G_ /\ P5B_
M]>F_MD5]_P!?SJ?LI_\ !87_ ()L_LL^$?CG\!_C]^U1X2^&_P 6_ O[?_\
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MGX6Z''H_A'P_HNB6T?A3X<Z VHK8#5O$4FM^(+S4=7O/ACP9_P $5OA7X1^
MG@O]EFZ_:X_;(\8_LZ?#7XH> ?B_\.OA1XGG_9)@T[P=XS^'GQMLOCUI5Q8^
M+_"/[)/A3XF:QI^I>,;:[L-9L/%GCCQ#')X<U?4++36TO48M)U;3-:,\-'-%
M5<72P4Y<$XAN//7CA*F5\58;->):&&5:+Q-25?)Y5\%A,94H1>/EAJ<,;AZ*
MG&G**\:O]G5*5.HJ^+AB.*:=.?LX866*PV8\'YME&25:L8RG0HPH9[7P>-KX
M+VTUA:<G7PU6I.G^Z_.?X+_\%.?BA^SMXT_X**?'_P#;$N_ 0U&[_P""CW_#
M"'[/FE>,/VY?BAX8_9X\$ZOI_A+PUK.E^%/$6E>-_A)HGP4^"7PI\'^'X=4^
M('C;]IK2O >L_%OQ9/J7B#P]JW@#4TT3PM%X@_6;X4_MX^/_ -L+]@?]H?X_
M?L?>#/AMXS_:)^&L'QV^&O@3P?X5^*&C?&7X(>-?CU\+M/NH] 7X>_&+3H?A
MWI7Q/^%_BW4;C0M0\,^*KBQ^'T^KZ=J*6NLZ=X5OH[V*SZFX_P""7?P"_P"$
M>^,NG:/XQ^,GACQ9\7/VO]1_;GT[XJ:%XC\')\0?@[^T1>:1I&@V?B3X3R:I
MX!U3P?;Z+I&C:2^E0^%_B%X0^(>CZUI>L:[I7B^W\2Z9J3V:?5OA;X-^*M)^
M$>I_##QE^T9\=?BMKVI'4B/C7XI/P;\$_%S3_M<\=SIXTR7X"_!WX.?#>V&@
M211C3MWPWE^WP"2T\3_\)#:3W$$W"USY2\)-SCBZ.1Y%@,-5H<L*D<5A<GR*
MGF->%64U"KB)YK'B:6*J8E4H9@L;@\93Q.'J1<8]LJL(YS'&4*5*6#J9WF68
M8BABHRJ4:F&GCL9+!865"G*-2G@I8"EDM.%*C4J5\']7QE!TZD<1.;_'7]G[
M_@JIX?\ #7[/>K7_ (@^)GQX_:,_:E7XP_L]?L_:U^S%^TQ\&?"7[*'Q\^%7
M[2'[1M^NE^'O!'CBS\(_"?P3HFD_ H7,EWK>B^/M&^'7Q3U;2O!OA'Q=>0>-
M?C+KL4&EVA\?O^"C<G[)/[7/B#QO^U1X'^+7P]F^&7_!,/XG?'7Q]\-? 7[3
M6G_$/]G2ZU#P?^T/X6\&::/ WP^U'X6> G\6>/\ QGJFMZ=IG@_XV>,=8^&&
MK:=X0OV\.>*/A+H,LUS?67V)J7_!*?X&^+-$^)]Y\3OB?\<_BK\=?BMXI^"G
MC?6?VK?%M]\']'^.V@^+/V;-=F\2_ '5_!UG\./@UX#^!WA^/X6:S<7-YI6A
MQ?!:?PUXG:]U)?B)HOC-=7U87T_C3_@E5\ _BQXUU+X@_'+XA_'KXX>*?$G[
M)_C?]D+QO?\ CWQCX1L!XS\"^/\ Q_I7Q*UKQG=Q_#WX?^!5\(_$6Q\4:+I\
M_AB?X8'P%X$\)V\$<?AWP%ITT%M<0=E2K2G5I8CV=.E57USZQ2P\:GU6G2Q'
M#57!TL/E*J\M>"I9I5Q4'6S5XJJH5\JG[>M2RO$8_'8T(4*=.="I[:MAW[)0
M>(J2ECJM6CQ!DV-E6S'$4'&A*E4R[#XJ,(9=2PE3VU/%5)T:%3,L/E^"^(-'
M_P""]W@_6+%-'\._##X)?&7XCI^T?^RA\!KFW_9=_;&\,_'SX+K9_M@S^-=-
M^'GB"V^.%G\)/"5J_B[PCKG@C4=*^*'PUO\ P7I<_AL2PZAH_BCQ-97&GR:C
M[EX8_P""L?C'Q9J&E? W3?V:/#2?MK:K^UM\8/V0Q\'9OC[JC? FS\3_  4^
M%MG\;O%WQ'NOVB+?X#S^-1\,G^&FK^'I+"]A_9ME\5'QKX@L/"EYX4L[%+KQ
M/![]XE_X)PV7Q,\)_#/P=\>/VP/VM?C_ *;\'?V@O@;^T=\-[OXAI^RGH.L>
M'?%WP$U*]U7PUX?GU+X/_LK_  MF\2>$_$ES=PCQH?%HU[Q?J"Z?:/HOB_P_
M<S:G<:CG:Y_P2P^"-[XG\9?$;PK\3_CM\-OC#XB_:P\4_MC^%OC%X-U;X57G
MC3X3_%7QQ\*-'^"GC'2O .F>//A%XV^'E_X \2_#K27T;4_"_P 3? OQ&=KC
M4KK5K?4K?5;'P_>:+5)X)3BJJJSI.K^\<&U5]C2>2_5W23484I57+-WF5.3Q
M+J4<-*.%KTL3C\'+#96K>SA:=*.(5.=W5A*>$>(G4S>,G.%-QKU,)3I_V94P
M<8?5ZU.=:E3Q$*M/ 8Q8SY;_ &L/^"Y7PI_9,^*WB/X3?$#PM\(_#/BOX._#
M'X5_%']H/P5\4_VJO ?PR^+%K:_%2[U6*T\$?LM_#N/PGXQB_:J^)'AC2]'F
M\3>)O#MGXI^%VG0Z#K'A6/3=>U+Q%KI\/6/UM^R[_P %"]._:9_:9_:$_9]L
M_!7@OP3+\#/$>N^'!HNM_&2V3]HZ]M/#]SI]M%\2/&'[->L>!/#>H>$_@Q\0
M%U*VO_A'\2?"7Q!^*-IXNTR6WN?$6E^!9KRSM9^KU_\ 8*L!\4Q\:?A+^U'^
MU)^S[\2M<\!^!?AW\5_$?P[U3X$>.F^.NA?#6ZU>Z\$WOQ0TW]I/X!_'O25\
M3Z&/$7B2RC\5?#VQ\ Z_=Z3K<NCW]_=:9I7ARTT3K/#'[$_@C1?VHX/VLO$G
MQ.^,GQ.\?^'/!_CCP%\*] ^(.L>!;OPG\&_"7Q-UG1/$/Q#T7P9>>&?AYX7^
M(?B2R\3ZQX<T6YB@^,'C_P"*$7@^WL8])^'B>$-%DFTZ3+#>Q2H_6FI2]GFB
MQ,J<:BIJO*C7^H2PE+FE.5!XB&"5&&*K4Y86C6S&5;VM:EA%B+Q%Y*O]6O32
MI98\+&;]I4DZ=?#+'4\34:A"&(G1GF$\1B*$*U"JJ.64L-3@ZF-</D7X7_M.
M?&/QA^V'_P %DO@_XU\:ZMJGPH_9?\#_ +.]]\&_#6@6GA;P?KO@E/B%^SQX
ME\:^.GT7QSI/A=O$D^K:SK]E#J.G:MXIN/%1\.7D<)T>T@LHVL)?AGX!_P#!
M8WQOX'_9.\ MX/\ V:O'OQHT[X+_ /!+#X+?M\_$/Q]\>/VO[?7OBEK'PVOM
M4\<^&?&.@^(_'8^ *WOQ2^.%OI'P\N/$FD>(+CPMX-\,?$C7;W4+#Q+J/PKC
MM['4M8_4C5_^";7AZ7]I3]H;]I3P7^U+^U#\+K_]JRT^'VF_'SX4^#8OV7M6
M^%GCS2OAKX%E^'?A_3-_Q+_9C^(/Q4\+P3^'+J_75+CP9\4?#NHW%[?SW5O?
M6GDV,=IYEX,_X(R?LO\ @?X6>,?A'I/CSX]W'AOQO^P!X>_X)Q:K>ZCXH^'L
MVN6_P0\-7GCF^L?%.GW-M\+;2PB^*LLOQ UE;O7+G3;OPC)';:8(? T#0W3W
MO-3G6IY:XQ4/KL>'LMPT:55*<*^>Y73XOE'$8NO&RJX7&8G-,C]I4C5I5:N'
MH8BGBN7V%&5/L7U.>9R]O[3^SJF=O$.K13C4P^48ZGP!A<92PM!M.GB\+A<J
MXNG1C*G6P_UK%86OAXRJ8J9\-_MA_P#!6.^UCX)?%70/%'PB^,7P<U+1_!?_
M  3Z_:K^%FK_  %_:GMO WQ%\:? _P#:6_:4\*^"= L/&OC:V^"^OVGPN\5V
M&L:9=:7\6/A9H-A\5O"_C'P#JEYX?TCXL02ZY>WFA]%X-_X*M?M ? *__P""
MIOQ._;,TGX03? C]FC]LCPG\ ?@N^D_&:WTK4_#6N_$7PI\![7X??#K5[N__
M &;OAQH-O\-+J;XC3?$;Q[\;O'OCS5_$7@*XU#Q)X9B\)^)O"GA72?%&H_8_
MQ:_X(T_LP_&33;G2_$_COX\V%O=?L]?LJ_LU2/H/B?X>VLR^!?V0?BU;_&3X
M:ZLC:A\+M40>+-<\3VT=AXYOFC;1]2T$O:Z!H/AG4"NJ+ZEXP_X)D? OQKK7
M[3U[J'C;XP:=X;_:K\;?#OXP^-/ >AZQX TW0/!7[0OPIC^'R>!?VAOAAXA7
MX;R_$[PY\2]%;X6^!+A-.U;X@>(OA=/=Z(UU<?#B2?5=9?4?0G/ TIYC'#QK
MSP]:MCZ6&4^6518-9CE<,+BKUK>RS;$</99/#4L0G"EA<WQDL17PT,)5QJGY
MM)8BKA\K6+G"&(I8/*IXZ5*,5".92P]6MFE"'LTG5RJCG>,G7=!.53%Y5A7A
M:&(^L?4N3XZ^&?\ P6ST7XTWG@KX2_!WX<? KXN?M->.?VF=?_9PT;1_A9^U
MW;?$#]DW5AX3^"4'[0WBKXF>%OVL/#7P,OM:\3^$M&^'5W;Z+-86O[/UKXAC
M^*KR>"+_ $[3M(MY_&D?K_\ P1%^*?Q2^,/[&WC+QC\8?%7CGQ7XS7]L3]M'
MP^\OQ"\9ZEX]\0>'-%\-_M&>/='T#P1'XAU+4]6\S1?!6E6MMX;T.QTV];1-
M.TS3[>TT6.'3HK>,>W>+O^"?$GQ&TCX6W/Q)_;'_ &LO'/Q?^!GQ6O?BO\%O
MVB]0L?V1?#GQ;^&MUK7@J_\ A[XI\&Z1I?@#]D[P?\%O$'@GQ;X3UC7-.UVU
M\>_"'Q?XC\W5Y;_2?$VE:AIGA^YT?VO]C_\ 9$^&?[$_PEU#X,_";6?'NN^%
M=1^)OQ3^*\U]\2/$-KXJ\3_\)'\7?&^K^/O$]O)KMOI&CSW^G6^M:U>1Z9+J
MT>H:X;,1G6-:UB_,]_,J<\+"&8-Q7M\1@,-A824:DJ4JM'.<HQZJX>G-VP4)
M8*EF5/%PFZU6>.J>SP^*GEDZ-*#KQJ5/J*IN4:=#&2Q-6$I)SY:F69Y@JM.I
M548_6N7$8C*IX;W*-..%C.56@\=1=>I]34445Q&P4444 %%%% !1110 5_(%
M_P 'JW_*++X!_P#9_P#\+/\ UG7]JJOZ_:_D"_X/5O\ E%E\ _\ L_\ ^%G_
M *SK^U50!^_W_!)W_E%E_P $T_\ LP#]C?\ ]9U^'-??]?SO_P#!,W_@K;^P
M-X"_X)Y_\$_/A;XL^,'B_2?&O@O]C+]E+P!XFL/^&=?VFK[2M-\4>'/@AX"\
M.ZS:?\)5IOP<O/"=YI]GJUG<P_\ "0:?KEUX=N+:/^T;759]->.\;[\U3_@K
MQ_P3KT.PGU36OVC]/T?3+7ROM.HZI\./C#I]A;^?-';P^?>7?P]AMX?.N)HH
M(O,D7S)I8XDR[JI -[]J7XB?'KX=?M._L&V'A'XHZ/HGP=^,O[1.I_";Q_\
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MG@CXC>)?#-YH^I>+;CP5#:R66IZ;X4T_Q%:+K3VX_P!JW_@CMXI^,=QXL/\
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M&]0O)?"F@R7.MRW$%W/>_4=U^Q-8Z1\>_&GQ[^#_ .T7^T'^S]>?%GQ9X/\
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MMM=U*+^VHX=;\.^*_"Z1Z=H'BR]TC4_%6F:C<:(=$.L:CI_1:#_P3%_9_P!
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MY)?$,ND:3>:9>1>-I6O;35;;PXL?A='^!?\ @D_^SM\/[3X&V>C>,_C3<Q?
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MU^T444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M?M?R!?\ !ZM_RBR^ ?\ V?\ _"S_ -9U_:JH _?[_@D[_P HLO\ @FG_ -F
M?L;_ /K.OPYK[_KX _X)._\ *++_ ()I_P#9@'[&_P#ZSK\.:^_Z "BBB@ K
MX2_:D_9,^+'[57CG0?#NO?M4?$+X1_LCVOA6V@\?_ _X#6EQ\-OBK\:O%TVK
M:TVK67CG]I73=>D\;^%OA#-X<;P_I3^ OA+I7@'Q7K=T_B=_$7Q+OM#U+3]
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MMF]C^*G[6/A'X-_'GPQ\)O']OH_AGP1J?[-OQU_:0\5_%_Q!XJAT?1/ V@?
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MQZUG^PO@_P"$_P!F/XH^(%_X1#P_XDU5=3_L_6M=SH_A?4/%%U_9ED;FTT\
M\_\ ^(*G_@EE_P!%\_;_ /\ PZ?[.O\ ]"K1_P 05/\ P2R_Z+Y^W_\ ^'3_
M &=?_H5:/^(CO_@J;_TK'_M__P#@Q_:*_P#H :/^(CO_ (*F_P#2L?\ M_\
M_@Q_:*_^@!H /^(*G_@EE_T7S]O_ /\ #I_LZ_\ T*M'_$%3_P $LO\ HOG[
M?_\ X=/]G7_Z%6C_ (B._P#@J;_TK'_M_P#_ (,?VBO_ * &C_B([_X*F_\
M2L?^W_\ ^#']HK_Z &@ _P"(*G_@EE_T7S]O_P#\.G^SK_\ 0JT?\05/_!++
M_HOG[?\ _P"'3_9U_P#H5:/^(CO_ (*F_P#2L?\ M_\ _@Q_:*_^@!H_XB._
M^"IO_2L?^W__ .#']HK_ .@!H /^(*G_ ()9?]%\_;__ /#I_LZ__0JT?\05
M/_!++_HOG[?_ /X=/]G7_P"A5H_XB._^"IO_ $K'_M__ /@Q_:*_^@!H_P"(
MCO\ X*F_]*Q_[?\ _P"#']HK_P"@!H /^(*G_@EE_P!%\_;_ /\ PZ?[.O\
M]"K1_P 05/\ P2R_Z+Y^W_\ ^'3_ &=?_H5:/^(CO_@J;_TK'_M__P#@Q_:*
M_P#H :/^(CO_ (*F_P#2L?\ M_\ _@Q_:*_^@!H /^(*G_@EE_T7S]O_ /\
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M:*_^@!H /^(*G_@EE_T7S]O_ /\ #I_LZ_\ T*M'_$%3_P $LO\ HOG[?_\
MX=/]G7_Z%6C_ (B._P#@J;_TK'_M_P#_ (,?VBO_ * &C_B([_X*F_\ 2L?^
MW_\ ^#']HK_Z &@ _P"(*G_@EE_T7S]O_P#\.G^SK_\ 0JT?\05/_!++_HOG
M[?\ _P"'3_9U_P#H5:/^(CO_ (*F_P#2L?\ M_\ _@Q_:*_^@!H_XB._^"IO
M_2L?^W__ .#']HK_ .@!H /^(*G_ ()9?]%\_;__ /#I_LZ__0JT?\05/_!+
M+_HOG[?_ /X=/]G7_P"A5H_XB._^"IO_ $K'_M__ /@Q_:*_^@!H_P"(CO\
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MG7_Z%6C_ (B._P#@J;_TK'_M_P#_ (,?VBO_ * &C_B([_X*F_\ 2L?^W_\
M^#']HK_Z &@ _P"(*G_@EE_T7S]O_P#\.G^SK_\ 0JT?\05/_!++_HOG[?\
M_P"'3_9U_P#H5:/^(CO_ (*F_P#2L?\ M_\ _@Q_:*_^@!H_XB._^"IO_2L?
M^W__ .#']HK_ .@!H /^(*G_ ()9?]%\_;__ /#I_LZ__0JT?\05/_!++_HO
MG[?_ /X=/]G7_P"A5H_XB._^"IO_ $K'_M__ /@Q_:*_^@!KQ_XU_P#!U_\
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M_P"A5H_X@J?^"67_ $7S]O\ _P##I_LZ_P#T*M'_ !$=_P#!4W_I6/\ V_\
M_P &/[17_P! #1_Q$=_\%3?^E8_]O_\ \&/[17_T - !_P 05/\ P2R_Z+Y^
MW_\ ^'3_ &=?_H5:/^(*G_@EE_T7S]O_ /\ #I_LZ_\ T*M'_$1W_P %3?\
MI6/_ &__ /P8_M%?_0 T?\1'?_!4W_I6/_;_ /\ P8_M%?\ T - !_Q!4_\
M!++_ *+Y^W__ .'3_9U_^A5H_P"(*G_@EE_T7S]O_P#\.G^SK_\ 0JT?\1'?
M_!4W_I6/_;__ /!C^T5_] #1_P 1'?\ P5-_Z5C_ -O_ /\ !C^T5_\ 0 T
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M5:/^(*G_ ()9?]%\_;__ /#I_LZ__0JT?\1'?_!4W_I6/_;_ /\ P8_M%?\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M]EKXL_#']D+Q7\1-$M_VT_$ND>,? 'BS2?VD?V@]6T7X6?LZ>(/"GQ!T:X\
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M_P#L[?M)>!O"GQBN_@S\#?B;KFE^*_'_ .SWXL_:1^&'Q(\,>$-6T/3WO/\
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M:*_8Y_9Y_:K\#_#_ .'7QH\&Z[J'A?X4^._"OQ-^&:^ /B=\5O@CX@\!>//
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MFC4>+I2^XJ***YAA1110 4444 %%%% !7\@7_!ZM_P HLO@'_P!G_P#PL_\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !7P!_P $T_\ DW7XC?\ 9_\ _P %
M8O\ UZ;^V17W_7P!_P $T_\ DW7XC?\ 9_\ _P %8O\ UZ;^V10!]_T444 %
M%%% 'Q#^V!^QKJ7[9-QX#\'>+OVD?CG\+OV=M*36)?C%\#?@9KMG\,KO]HMK
MJ_\ #\FD^&/B%\:-#MD^+OASX8QZ-9^*= \7>"/AAXD\$7OCFR\69U/Q39KH
M=E#-_$I\&O@O\)?V>/\ @]A\(?!?X%_#KPA\)_A1X"TZ72_!_@#P)H=CX=\,
M:%:W7_!(>[U;4&L],T^*&%K[5]9U#4M=UW5)Q-J>O:_J>IZ[K-W?:OJ5]>S_
M .B37^>'\4OBQ\+/@=_P>YZ[\4OC7\2_A_\ !_X9>%_[,_X2;XB_%+QEX<^'
M_@3P[_;?_!)'3_#NC?V[XN\6:EI'A_2/[7\0:OI6A:9_:&H6_P!OUC4]/TRU
M\V]O;:"4 _T/**^ /^'L7_!++_I)9^P!_P")D?LZ_P#SQJ/^'L7_  2R_P"D
MEG[ '_B9'[.O_P \:@#[_HKX _X>Q?\ !++_ *26?L ?^)D?LZ__ #QJ/^'L
M7_!++_I)9^P!_P")D?LZ_P#SQJ /O^BO@#_A[%_P2R_Z26?L ?\ B9'[.O\
M\\:C_A[%_P $LO\ I)9^P!_XF1^SK_\ /&H ^_Z*^ /^'L7_  2R_P"DEG[
M'_B9'[.O_P \:C_A[%_P2R_Z26?L ?\ B9'[.O\ \\:@#[_HKX _X>Q?\$LO
M^DEG[ '_ (F1^SK_ //&H_X>Q?\ !++_ *26?L ?^)D?LZ__ #QJ /O^BO@#
M_A[%_P $LO\ I)9^P!_XF1^SK_\ /&H_X>Q?\$LO^DEG[ '_ (F1^SK_ //&
MH ^_ZAN)X[6WGN9FV0V\,L\K'HL<*-)(Q^BJ3^%? W_#V+_@EE_TDL_8 _\
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M"7@VXT&V^).H>%K_ %W]H[2M"\%Q_#EO$NCR:K=?&S5_A3IOC**^LI/A'?\
MQ'&IZ2+_ /-34OVEO^"8?B3_ (*_?#KXUQ?\%)_V/(?A9\'_ -D7P[X@\7B_
M_:@^ MA\*/&G[2EI=?$;X-?!SQ;X?UVX\>G2]9^(G@KX+^-/C3I_C#2M-U6Z
MN?#^B^(?AK/JT6^\T.>+Z:^!_P =O^"67P:_X8L_XV__ + 'B3_AD#]G_P"+
M7P+_ .3D?V=='_X6'_PM'_A5G_%4_P#)==4_X1+^PO\ A6?_ "!/^*F_M/\
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M83$U73@\5C<-6SWZG-T7*$*4<SH4,A^LTJG+'!SQ6*5'V2Y'0^V/VG/VX/\
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M:'^T)#X?LOASKO[6_P 6O$5]XO\ B/XBTV\T_P 7>-+_ .*4FD643:%<>'/
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M@#_A[%_P2R_Z26?L ?\ B9'[.O\ \\:C_A[%_P $LO\ I)9^P!_XF1^SK_\
M/&KB.L^_Z*^ /^'L7_!++_I)9^P!_P")D?LZ_P#SQJ/^'L7_  2R_P"DEG[
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 5\ ?\$T_^3=?B-_V?_P#\%8O_ %Z;
M^V17W_7P!_P33_Y-U^(W_9__ /P5B_\ 7IO[9% 'W_1110 4444 %?D#^U'_
M ,$%?^"3W[:/QV\<_M+_ +2_[*?_  LKXV_$K_A&?^$U\:_\+S_:2\'?VU_P
MAW@[P]X \.?\4YX ^,7A7PEIW]G>$O"N@Z3_ ,2G0;#[9]@^WW_VK4[J]O;C
M]?J_C"_;U_X+N_\ !7#X?_\ !9SXK?\ !*/_ ()^_LT?L@?''Q!I'_""_P#"
MI-'^*6C^-](\=^*/M_[*G@[]I#QY_;OC?4OVH/@_\,K?^Q+*]\9W6F>=;>'?
M-T?2-/TB/^U_$$L<FI@'Z?\ _$+C_P $*/\ HQG_ ,V9_;#_ /H@J/\ B%Q_
MX(4?]&,_^;,_MA__ $05? '_  V1_P 'DG_2)W]@#_PXW@;_ .F64?\ #9'_
M  >2?](G?V /_#C>!O\ Z990!]__ /$+C_P0H_Z,9_\ -F?VP_\ Z(*C_B%Q
M_P""%'_1C/\ YLS^V'_]$%7P!_PV1_P>2?\ 2)W]@#_PXW@;_P"F64?\-D?\
M'DG_ $B=_8 _\.-X&_\ IEE 'W__ ,0N/_!"C_HQG_S9G]L/_P"B"H_XA<?^
M"%'_ $8S_P";,_MA_P#T05? '_#9'_!Y)_TB=_8 _P##C>!O_IEE'_#9'_!Y
M)_TB=_8 _P##C>!O_IEE 'W_ /\ $+C_ ,$*/^C&?_-F?VP__H@J/^(7'_@A
M1_T8S_YLS^V'_P#1!5\ ?\-D?\'DG_2)W]@#_P .-X&_^F64?\-D?\'DG_2)
MW]@#_P .-X&_^F64 ??_ /Q"X_\ !"C_ *,9_P#-F?VP_P#Z(*C_ (A<?^"%
M'_1C/_FS/[8?_P!$%7P!_P -D?\ !Y)_TB=_8 _\.-X&_P#IEE'_  V1_P '
MDG_2)W]@#_PXW@;_ .F64 ??_P#Q"X_\$*/^C&?_ #9G]L/_ .B"H_XA<?\
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M?]&,_P#FS/[8?_T05? '_#9'_!Y)_P!(G?V /_#C>!O_ *991_PV1_P>2?\
M2)W]@#_PXW@;_P"F64 ??_\ Q"X_\$*/^C&?_-F?VP__ *(*C_B%Q_X(4?\
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M_P";,_MA_P#T05? '_#9'_!Y)_TB=_8 _P##C>!O_IEE'_#9'_!Y)_TB=_8
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M .;,_MA__1!5\ ?\-D?\'DG_ $B=_8 _\.-X&_\ IEE'_#9'_!Y)_P!(G?V
M/_#C>!O_ *990!]__P#$+C_P0H_Z,9_\V9_;#_\ H@J/^(7'_@A1_P!&,_\
MFS/[8?\ ]$%7P!_PV1_P>2?](G?V /\ PXW@;_Z991_PV1_P>2?](G?V /\
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M"C_HQG_S9G]L/_Z(*O@#_ALC_@\D_P"D3O[ '_AQO W_ -,LH_X;(_X/)/\
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M?_-F?VP__H@J^ /^&R/^#R3_ *1._L ?^'&\#?\ TRRC_ALC_@\D_P"D3O[
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M'O"GAZ*_T[X@_'#3/&^@^,=?U.[T2T\/Z-9>%=<UROTW_;Q^*/Q'\+_MO_\
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M)_"&E^.[7P?J$2:?IK:"NEZ1I-E9>D_&+]CCX ?M _L^Z=^S!\9?#_C?Q_\
M"#2YO =Y:VNM?&SXX#XA/JOPSUW2?$W@CQ!??&^Q^(UI\;]4\4Z+XAT/2M9;
MQ7J?Q$O/$FJ:C:"ZUG5-0EEG:7.&(A&&!G4I>WQ&#S3@W%3E.2BJV!X=GP2L
M;A*+2E3I4L5@N&L7EWU;%4J]'$.5#&SY%C\RH)XJ$:U;,'1E*A1QV$XNIJT6
MY4L5Q!2XUCA,14BIKVDL/C.(LNS+VU"=+$X:5#$X2E.4,+@*LOPJ_P""W_Q6
M\=_#[XZZW;?!^Q^'O@OXM1_\$@/^"BGC/1OC_K%A\6M9^(_@CPWX.U7X/ZGX
MF\'^ =/\)_&SX<^ M)O/%]HBS:?XW\0^$/%GB7P7XITSP_KVD276CVFN>$_$
MOE7PE_;R^.'[&/P-^!W[)/[./P,\%>*_&/P:_80^!O[5_B?PQ^S_ /\ !.+]
MK?Q_X8^/VM?'*;Q=J>@_!OPIIG[,?BOQWH?[.'Q%\4VOA;4;OQE^TQ\:]5\9
M^$/&OQ*U/5O$,7PUMH6U_3] _=#6?^"8_P"QMXJM5M_'?@?XG?$^Z7X.?&7]
MGX^(/B[^U!^U/\7O&4OP>_: ?1W^+'@BY\<_$WXT^*_&5U8>(SH.DK8WUSKL
MNL>$8K4P>"]2\/0W%U'/V'CO]@/]E_Q_<?#_ %"Y\+?$7P%KOPP^'FC?"/PA
MXM^ _P"T1^T=^S7XYA^%OAT1GP_\//$'CO\ 9Y^+'PP\8^-O!FB3QF^TGPYX
MVUSQ%I.GZG/>:K:6L6I7U[=3YX.<<+1A0E.=6,\?2JXE\BY9X6AC>*,?A:7L
MZDVI8?#8O/,/7Q& A[.EF%6.*K3G'%>PQ,[K36(J4IS@HQH8:4:=/GG[V(EA
M>&,#5G.I0<*G/7P.4YKA:&+3EB<LIXRA#"N%.6(I1^?O^"C^E?M??$+X!? [
MQ1^S'X0^)OB#3M.^*'@KQQ^TY^S_ /#'XRW'[-7[0OQ,^ UWX1UY?$OPY^&7
MQD@U3P?K'@7Q[H'BG4_#/B&^M-&\??#'7_$5CX8U3PKIWC72;G4_LE]\R_LL
M_P#!1[Q9^UKXR^$7P._8:N([/0O#_P"S?JG[07Q&UO\ ;CT7QOXI^*]RNC_'
M/QE\"Y?V9;V_\*>/=#U3P[\0?"/BSP3XET3Q?\>M;NOV@4T:UT71+C4_"7Q2
MUKQ++XEN/UV^,?[/'PR^._AG1_"WQ 7XA6]OX>F6?0O$7PW^-/QH^"?Q'TEC
M#%;74>G_ !9^"_Q \ ?%"UMM7MH8[7Q!9Q>+UM/$ELIM]?AU*%G1O'K[_@GI
M^Q[=VWPKM++X/Q^%+;X,Z%JGA/P1!\//'7Q,^&4<W@K7M7_X2'Q)\/\ QZ/A
MWXS\,?\ "V_ASXJ\0Y\1>+OAY\6/^$V\$^*_$!;7/$6@ZGJK-=EX:=*EB<2Z
ME./U*KFD\;1HQYJE2G&>'Q5&FL14J24\;@,&_J%2AE-:5&M*K3QJ69/"8_$8
M985E.I@\'!/FQ^'RZG@ZN)<HTH5;8G!XG$VI4H>RHX_&..84GFM&U.E0KX:,
ML"ZV!P.(H_@AX&_X*4^+/@=\</VH?V=O@O\ !WPO\.?'_P 6O^"F?[9]E??$
MSP?^S#^VM^V[I-MI7P7^%7P-\3^)_'OC7X ? _XC:U\5_%_Q ^(.M^-_#GA1
MC\.-=^$_PK\%Z5"_BRY\*VYT^?2O$GTM??\ !4']NWQKXG\"_#OP?\'/A%^S
MS\0=<_X)G_$W]N#Q=H/[2OPD^.E[XA\+>/O@Y\67\":SX"N?AY+X^^"7C+2_
M"_Q%T>**_P##<WBB/0_%?@:'5++7M8TWQCY+^%KG]/\ 6?\ @FO^QIK*>,94
M^%WB+PSK?CGXZ>)/VE=8\<?#SXV?'GX7?$[3?C7XR\/:7X2\6^,_ _Q6^&_Q
M.\*_$GX:+XG\+Z-IWA[7_#7PY\5>%?".K:/#+IU]H$]K=WD5QV5M^PQ^S/%X
MKT[QY?\ @[Q=XH\=:;^SOXG_ &4D\;^/?C3\<?B+XQU#X#^,]<B\2>)O!WB'
MQ1X\^(_B/7?%.HZKK,,5W+X[\2W^K?$2!8TM+3Q9;V2BWKDE[99;2H4YQ^OX
M?)EA*%:<4Z"S'"<&3RO*:J@E)?4<)Q#1RZKB<)5A]7Q& POUBGAU5J5L ^Q2
MPW]I5J[I-8"MCWBIT4^:M*GB.(<FQN8^TF_9-U<5E-+.XTJD)SK4L;C84JE=
M4IPKX;X/_97_ ."BOQ]_;9^(FC0?!_PA\(?AMX#^'O[+7['W[27QHT#XE:7X
MW\6>,_'T_P"UGX-\1^-7\$?"KQ3X9\4^&;+X>6GPST+PZ]U%XVU[X<_&"T^(
MNNW3>#X]"\"R:?>^)$\$_9<_X*V?M<?M,W%IXW^'?[*GC'XD> OBO\)?VC?'
MOPK\#6_[)?[6OP-A^%_B;X3VFHW?P9\(?$/]LGXN6=Q^S!\<V_:*_LU].M[_
M .$MCX+@^&WB2ZM]!DD\>PI<:U%^I^@?\$\?V0O"FL?"+7/"WPMU/PU>_!'X
M;>!/@_X+@T#XJ_&/1M'UCX8_"Y)1\-/!7Q:\/:=\0+;0/C]HGP^GN+K4O!5O
M\=],^)#^%];O+[7M%DLM:O;N_FM>#OV!/V8?A_K_ (RUGP=X;^)>@Z1X]MO&
M=MXC^%=G^T?^TFW[/##X@RS77C"YT+]F.X^+<W[.WA'4=:U"YO-7DU7PC\+]
M#U.TUV_U'7M/N[36=0O;Z?NS&6$K8O'RR^%;"X*M0S>E@J;5.5?#5<3FG$=7
M"8EU*LZZO_96/X<HX6C:JLGQ7#]2/ML9A\TQU>KQX7VU'#X&-=TL3B:-7*9X
MJ<U.-.OA\-@\EAB\+.-)T95JE3'X'.,3B<<JF$J9EA<]EAUA\+6RW NEYA_P
M3Y_;"\2_M/? WQQXL^(^N^$]0^+/PKU^X\-?%KP/H?P-^,?[-/B[X4^,U\*Z
M7XNO/AE\0?@K\<O$_CCQ9H?B#P_9:O:1:?XQL?'&N>%?B5H\UEXP\/VWA^RO
MO[&M?P _9I_:(^.GPYG_ ."''Q&\!Z-^T-\9+O\ ;(UO_@IE^T;\<_@;\'?B
M/\/_  ]JGQG\4?$9KOQ]HUQXKLOB_P#%?X$?!_Q/!\+X];MG\/6_C?Q@DWAG
M3=%2T\)-J%_!9077]3OP*_9D^#'[-VB^+-%^$_AS7+)_'_B&3Q9X^\3^-_B'
M\2/C!\1O'OB)],L]$@U;QS\4_C#XN\>?$KQC<Z;H.G:;X>T0>)/%>IQ:#X=T
MW3= T6.PT;3[.QA^-_V-?^";_@[X#^$O@/:?%[2O#'CKXA_L<?$?]J?_ (9+
M\?>&/$/C32QX,^#/[0/C;Q#J6GZ)XA\+68\*^%M2\56OP_U?3/!>N1:UHWC*
MQM+C0EUKP_K45YJ,[PE.I26:RQ<$L/0CA,AG.%.FG3J3PU;BB&<8+"4<1]8Y
MJ57%9QD>,HK'5W7G@<KG6K5<1F.#PTY54BUEM;"<T\54JXK/:=&I6FJ510QF
M5932RC&8GZK"E&E/"U,!G%.K+!*G"AB,TH4Z%&GAL5BJ>'_*C]BS_@H!^U=K
M6L?$#X+:3/K6A_'7]J'_ (*[_MO_  ?^'U]^V#=ZA\<= _96^&'P7^%^F_%;
M4? FH>#_ (8_'BPT7Q3/H%O8CPEX0^&?PN^/^B^"[2[U;6?$6B>)=0T?0[FV
MU3V?P+_P55_;#^,'QD_9W_9C\$^'/V:O!WQ5\?\ BG_@I!\&?BG\2/$_@7XH
M^,_AS8?$[]A3Q!X1TS0_B#\.O!6B?&'PCJ^H> ?B%8:O=W&L?#[5/B/<ZWX;
MU'4X],B^)]W<>#]07Q3^J.I_\$W_ -C?4_#GB[PT/A5J^B1^-/VA?%'[5NI>
M)?!_Q=^-G@7XD:)^T)XVM?[.\5_$_P"'OQ9\%_$;0/BA\*=:U[26N-$U"S^&
M'B_PAHDN@7^JZ -+71M7U2QN^F\)?L&_LF^!?$_P,\:>$_A':Z-XI_9OT3XM
M:#\(-:@\6^/IKO0;;X\26EQ\8M1U[[7XKN(OB'XH^(E]91:MXF\9_$>/Q;XO
MOM<EOM=.N)K&IZC?77.FG@\-1E'DK4<JP6"J2C*4U+%8/AFEEN'Q%&O-^VI4
ML+F.&IJO"K"O6SAU(YUC*T,5AZN$QNM:?[S'SHJ$I8G'9GB\-.K2A%TH8S.Z
MF,E3KT:<G1JRKX&M!4'2C1HY+]2J9?A:&(I9D\5A/P_C_P""P_[<WQT^&'P!
M;]F'X-_#:R^.7Q3_ &4= ^-X\,3?LV?M'_M7>$/&GQ2U#XR^-?@OJ'P[O-6^
M#?Q2^%6F?LG> ?MG@74?&6@_&3]H[QA/X/UO3[F\\,6]P-2\*ZYJY^C?^"S?
M[0O[3O[,VB?\$V_%_P ('\7^/?BG/^U5<6GC'X4_"7Q%KOPMT+]H:_T/]F#X
MV>)Y/ASJFAGQ;JZ77@KQ!XPT+3]3M/!OB77_ !@EM+9::B7>MZS96=[-Y5^T
M_P#\$0O[=\7:QH7[,WP/_8MN?A1JG[*&A?LU_!SQ?\>=1\=3_';]A3Q5IOQ'
M^)OCZ]^/?P"\57OPE^-?BWXG>,7U/XH3Z]H>E:M\7O@?K'AGQ!X0T6'1OB':
MZ9J5S_9O[;^)?V6_A1\1[3]FVX^+^E7WQ,\7_LL>*/#OQ$^%?C/4]?\ $VB:
MEI_Q1T#P3J?@1_'FH6?AK7-*T[7[[4M%UW7A=Z/XEM]<T!I]4DNCIKWEM9W,
M&E2-.O@\-6A4CA,4^(:..K\L'[:CA(4,[C5P^%P[FX4<+AZU7"RC0E4GA\9]
M:P4\%7I_V9B%3514Z&-KJ">-P<LCQF"H8:I*I"A*O5J8&KAZN-Q<+5ZN(K46
M\'4Q%)T\9@W@<SJ58U5F.!JS_'?]FC]JSXXZKX%_8?\ @5^SS^TEX)^.WQQ_
M;<^"OQT_;5\:_M:_M%>$/B-\4?A1HEOX4UKP#'XF^%WPZ^".@_&7X.Z[X8TW
M1_$_Q$L?A[X8^'NG?$7P]:_"G0?"&J:MXCT#Q!XFN-5M[[S?PC_P6!_:[_:
MO?"7AWX)^"_V</AMKNH?\$^OV@OVLO$^I?%+PC\3_B9HUI\3OV8OVA=<^"7C
M3P;X;MO"/Q4^&#ZW\/?B"WA^ZF\)>)CJ\-_X7CO+;Q'<)XY@A/AFZ_6O5/\
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M_!++_I)9^P!_XF1^SK_\\:@#[_HKX _X>Q?\$LO^DEG[ '_B9'[.O_SQJ/\
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M@S7+GQ^1K_CCPI^SGX,T_P $>,8M.OKF#0=+\6^';*XG-U>R)'],? _X[?\
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M!7G1HSCYSE6K5,)%/#5<VP-2DZD84*M.E6S3BEXFG&GAW4BU/)EEU>>&Y:.
MR]4J%#FK9A[&H_Z Z*^ /^'L7_!++_I)9^P!_P")D?LZ_P#SQJ/^'L7_  2R
M_P"DEG[ '_B9'[.O_P \:N8H^_Z*^ /^'L7_  2R_P"DEG[ '_B9'[.O_P \
M:C_A[%_P2R_Z26?L ?\ B9'[.O\ \\:@#[_HKX _X>Q?\$LO^DEG[ '_ (F1
M^SK_ //&H_X>Q?\ !++_ *26?L ?^)D?LZ__ #QJ /O^BO@#_A[%_P $LO\
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MRO[;TC[?]G_M*R\[^GW_ (>Q?\$LO^DEG[ '_B9'[.O_ ,\:@#[_ **^ /\
MA[%_P2R_Z26?L ?^)D?LZ_\ SQJ/^'L7_!++_I)9^P!_XF1^SK_\\:@#[_HK
MX _X>Q?\$LO^DEG[ '_B9'[.O_SQJ/\ A[%_P2R_Z26?L ?^)D?LZ_\ SQJ
M/O\ HKX _P"'L7_!++_I)9^P!_XF1^SK_P#/&H_X>Q?\$LO^DEG[ '_B9'[.
MO_SQJ /O^BO@#_A[%_P2R_Z26?L ?^)D?LZ__/&H_P"'L7_!++_I)9^P!_XF
M1^SK_P#/&H ^_P"BO@#_ (>Q?\$LO^DEG[ '_B9'[.O_ ,\:C_A[%_P2R_Z2
M6?L ?^)D?LZ__/&H ^_Z*^ /^'L7_!++_I)9^P!_XF1^SK_\\:C_ (>Q?\$L
MO^DEG[ '_B9'[.O_ ,\:@#QOXO\ [:7Q"\ >(_\ @I5\0M&\1>%K;X9_L/\
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M'PX_]0;_ ()IT5Y__P $Y?BQ\+/CC_P=T_\ !47XI?!3XE_#_P",'PR\4?L
M>#/^$9^(OPM\9>'/B!X$\1?V)X>_X)Q^'=9_L+Q=X3U+5_#^K_V1X@TC5="U
M/^S]0N/L&L:9J&F77E7ME<P1% ']GM%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M *990!]__P#$+C_P0H_Z,9_\V9_;#_\ H@J/^(7'_@A1_P!&,_\ FS/[8?\
M]$%7P!_PV1_P>2?](G?V /\ PXW@;_Z9952__;8_X/%M*L;W5-4_X)5?\$]=
M-TS3;2YO]1U&_P#B?X L[&PL;.%[B[O;V[N/^"E\=O:VEK;QR3W-S/)'#!#&
M\LKJBLPF4HPC*<Y1A"$93G.<HPA"$(RE.<YSE&$(0C&4I2E*,8QC*4I1C&4H
MN,92E&,8RE*4E&,8Q<I2E)J,8QC%2E*4I2C&,8QE*4I1C&,I22?Z%?\ $+C_
M ,$*/^C&?_-F?VP__H@J/^(7'_@A1_T8S_YLS^V'_P#1!5^8VE?\%&O^#MC7
M?AQ:_&+1/^"<7_!,76?A%?>$_P#A/;+XIZ5\=/A-J/PXO/ W]FMK/_":6OCB
MT_X*>3>&;CPG_8Z-JO\ PD4.J/H_]FJU]]L^R@RC:\)_MZ_\'??CSPQX?\;>
M!O\ @F'_ ,$X/&?@SQ;HVG>(_"OB[PG\7_AIXB\,>)O#VL6D5_I&N^']?T?_
M (*:WFE:UHVJV,\%[IVJ:;=W-C?6DT5S;3RPR(YUE"<)583A.$Z$XTZ\)PG"
M="I)U5&G6A.$9T:DG0KJ,*T*4Y.C6482=&LJ4J47&$U).%3F]G--.-3D4)3]
MG)-QJ<D:E.4_9RGR1J4Y3Y%.#G^C_P#Q"X_\$*/^C&?_ #9G]L/_ .B"H_XA
M<?\ @A1_T8S_ .;,_MA__1!5\ ?\-D?\'DG_ $B=_8 _\.-X&_\ IEE'_#9'
M_!Y)_P!(G?V /_#C>!O_ *994#/O_P#XA<?^"%'_ $8S_P";,_MA_P#T05'_
M !"X_P#!"C_HQG_S9G]L/_Z(*OS!U?\ X*/_ /!VEX?\47O@?7O^"<__  3!
MT3QKIO@;4/B?J/@_5_CQ\)--\46'PTTF^&F:K\0[WP_>_P#!3V'5K7P-IFI$
M:?J'BV>TCT"ROB+2YU".X(CJ7X:_\%&?^#MGXS^"="^)?P>_X)P_\$QOBO\
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MP_\ Z(*OS0\&?\%"_P#@[F^(]EJ^I?#S_@FM_P $T/'FG>'_ !/XA\$Z_?\
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M_P!&,_\ FS/[8?\ ]$%1_P 0N/\ P0H_Z,9_\V9_;#_^B"KX _X;(_X/)/\
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M_2)W]@#_ ,.-X&_^F64?\-D?\'DG_2)W]@#_ ,.-X&_^F64 ??\ _P 0N/\
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MKJW_  4YM)_$OB>YTK2-6U.#0-%CO=5FT_2]1O8[1K:RN98NP_X;(_X/)/\
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M_9E\>>!?B?\ \'E'P4^(/PRU/QGK'P_\7?#/P=K7A'4_B-JNKZY\0;S1+O\
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MX)FZY?QN(V,*Q:;>_MS>'K>99)0B2N^JP&&-FE1)V41. 6?VP6\=>&?VK?\
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M'6Q"IUGCZV>5?K>*H\SC'$T,#F&5</X?E4X1R[*IXBOSU5DSP,W_  ;B<_\
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MAV6[?2?"=MK1\2>,(]"MK)/%OC7QAKJWNOWWW5IO["?[$&C:E\3M8T?]C?\
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M^;_S6;]L/_Z'VC_B*._X(4?]'S?^:S?MA_\ T/M '[_45^ /_$4=_P $*/\
MH^;_ ,UF_;#_ /H?:/\ B*._X(4?]'S?^:S?MA__ $/M '[_ %%?@#_Q%'?\
M$*/^CYO_ #6;]L/_ .A]H_XBCO\ @A1_T?-_YK-^V'_]#[0!^_U%?@#_ ,11
MW_!"C_H^;_S6;]L/_P"A]H_XBCO^"%'_ $?-_P":S?MA_P#T/M '[_45^ /_
M !%'?\$*/^CYO_-9OVP__H?:/^(H[_@A1_T?-_YK-^V'_P#0^T ?O]17X _\
M11W_  0H_P"CYO\ S6;]L/\ ^A]H_P"(H[_@A1_T?-_YK-^V'_\ 0^T ?O\
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M_:$TS69O CSV/AW1_@S;_$[QAJWAF'0]71/$/PF\4>"X_%IE;^V[3Q;X:?\
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MQ<U6T;4]6T?V5?\ @H'\;8-3G^!VI?LO?#^U_;-E^..D_!G1OA+;?M+ZG>_
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ML/\ ^A]H_P"(H[_@A1_T?-_YK-^V'_\ 0^T ?O\ 45^ /_$4=_P0H_Z/F_\
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MQDE"EA*^9Y90>%KQPM;&O"5?VCU3_@H'^T!8^(- ^"-G^R/X)U;]JRZ^/;_
MGQ/\/;?]IZ>T^">@?VA^SGXE_:-\+_%#3?CAJ/P"M/&7B+X=ZCH&@#P[K41^
M 6C^/]%UF/7'T[P+XE@TK31XA\S\=?\ !6?QW8?#?PUJ7PT_9@\*>)_C';_#
MO]L?XC?%SP%\2/VBKWX5?#/P%9_L*?$*U^$WQS\/>$?C+IGP'^)=_P#$SQ+J
M/C^]MH?AE:'X6^#+#Q'X3%QXH\7ZE\/I(X=%N?S3^&W_  6F_P"#>CP!XG\(
M?$76?^"F/QC^*WQ:\/?%S6_C7XE^+'Q)_9[_ &A&\6_$[QKJ_P &=;^ EI'X
MSTOP%^QMX#\ :/X:\-?#?6ETWPSX6^%W@KX<:)I^H:9::M-:7E[?>(I-<_(O
M]MS_ (*A?\$2+KXQ_!WQ-\,_VBOC/\=OAUX*A_:M\?:%=> OV1O@K\3/B/X(
M_:)_:<_:&T[X^:GK6O>'_P#@I!^R5??!_0_A3X>U.&ZL_#'BOX.>&;C]H#08
M5ATF[UCQ!ITUW<S\E25!4*=&<IK%8A2C/%8/#59T\/B84L9*G+#8:O6BJF&E
M3AAY?4\77H+,,SC]3>991A<?0KX/IPWL%+&5ZL)RIX>6!^I82O6BOK6%JN$,
MTEC\10A*=/$4*TKX6O@X5/JN7U:F,_L_-,3EM3"8O^OW]FOXU_%?7?VT+G1?
MB#/<Z/X=_:;_ &$O@E^U+X?^%4/C?Q5X_P#"_P (OB%X7\4ZAX$^*6A^"M8\
M6^$OA_JEMH6O:%XV^$UU=6\_P]\"-?\ B/1M<UJX\,V6KZCK!D_4VOXS_P!E
MO_@XG_X)FW7[2]U^T)^UE^VGX*LO%WA;]C#X"?L^:=J'@/\ 9Q_:UF\+>*OB
M=J6K:W\3OVE_%?A73(O@;=ZOH/A%_%9^'WA#0[?7K+1=0U*7P?JFI6^EIHLN
MD7%Q^F7_ !%'?\$*/^CYO_-9OVP__H?:Z<;&E"5*G26'4:;S*$(X6L\11IX5
M<1\4/*Z2Q$J=*KB)4<GEEU-UZ\/K%:G]4JUVYU81I>;A/K+=:6)J1K3E'++U
M8T)8;VN(CP[P[3S*M[!RE"G[;-J6/J\E"V'BYRA1BO95W/\ ?ZBOP!_XBCO^
M"%'_ $?-_P":S?MA_P#T/M'_ !%'?\$*/^CYO_-9OVP__H?:XCK/W^HK\ ?^
M(H[_ ((4?]'S?^:S?MA__0^T?\11W_!"C_H^;_S6;]L/_P"A]H _?ZBOP!_X
MBCO^"%'_ $?-_P":S?MA_P#T/M'_ !%'?\$*/^CYO_-9OVP__H?: /W^HK\
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M_P />%?%NG?V=XM\*Z]I/_$VT&P^V?8/M]A]JTRZLKVX* /[?**** "BBB@
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MD:?[ '_B&_[.O_SN:^_Z* /@#_AT[_P2R_Z1I_L ?^(;_LZ__.YH_P"'3O\
MP2R_Z1I_L ?^(;_LZ_\ SN:^_P"B@#X _P"'3O\ P2R_Z1I_L ?^(;_LZ_\
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M* /@#_AT[_P2R_Z1I_L ?^(;_LZ__.YH_P"'3O\ P2R_Z1I_L ?^(;_LZ_\
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MO^SK_P#.YH_X=._\$LO^D:?[ '_B&_[.O_SN:^_Z* /@#_AT[_P2R_Z1I_L
M?^(;_LZ__.YH_P"'3O\ P2R_Z1I_L ?^(;_LZ_\ SN:^_P"B@#X _P"'3O\
MP2R_Z1I_L ?^(;_LZ_\ SN:/^'3O_!++_I&G^P!_XAO^SK_\[FOO^B@#X _X
M=._\$LO^D:?[ '_B&_[.O_SN:/\ AT[_ ,$LO^D:?[ '_B&_[.O_ ,[FOO\
MHH ^ /\ AT[_ ,$LO^D:?[ '_B&_[.O_ ,[FC_AT[_P2R_Z1I_L ?^(;_LZ_
M_.YK[_HH ^ /^'3O_!++_I&G^P!_XAO^SK_\[FC_ (=._P#!++_I&G^P!_XA
MO^SK_P#.YK[_ ** .?\ "?A/PKX"\*^&? O@7PSX?\%^"?!?A_1O"?@[P=X3
MT;3O#GA7PGX5\.:=;:/X>\,^&?#VCVUGI&@^']"TBSL]+T;1M+L[73M+TZUM
MK&QMH+:"*)>@HHH **** "BBB@#X@\6?\$R?^";?CWQ5XF\=>.O^"?/[$'C3
MQMXT\0:SXL\8^,?%G[*'P&\1^*O%GBKQ'J-SK'B'Q-XF\0ZQX!O-7U[Q!KNK
MWEYJFLZSJEY=:CJFHW5S?7US/<SRRMS_ /PZ=_X)9?\ 2-/]@#_Q#?\ 9U_^
M=S7W_10!\ ?\.G?^"67_ $C3_8 _\0W_ &=?_G<T?\.G?^"67_2-/]@#_P 0
MW_9U_P#G<U]_T4 ? '_#IW_@EE_TC3_8 _\ $-_V=?\ YW-'_#IW_@EE_P!(
MT_V /_$-_P!G7_YW-??]% 'P!_PZ=_X)9?\ 2-/]@#_Q#?\ 9U_^=S1_PZ=_
MX)9?](T_V /_ !#?]G7_ .=S7W_10!\ ?\.G?^"67_2-/]@#_P 0W_9U_P#G
M<T?\.G?^"67_ $C3_8 _\0W_ &=?_G<U]_T4 ? '_#IW_@EE_P!(T_V /_$-
M_P!G7_YW-'_#IW_@EE_TC3_8 _\ $-_V=?\ YW-??]% 'P!_PZ=_X)9?](T_
MV /_ !#?]G7_ .=S1_PZ=_X)9?\ 2-/]@#_Q#?\ 9U_^=S7W_10!\ ?\.G?^
M"67_ $C3_8 _\0W_ &=?_G<T?\.G?^"67_2-/]@#_P 0W_9U_P#G<U]_T4 ?
M '_#IW_@EE_TC3_8 _\ $-_V=?\ YW-'_#IW_@EE_P!(T_V /_$-_P!G7_YW
M-??]% 'P!_PZ=_X)9?\ 2-/]@#_Q#?\ 9U_^=S1_PZ=_X)9?](T_V /_ !#?
M]G7_ .=S7W_10!\ ?\.G?^"67_2-/]@#_P 0W_9U_P#G<T?\.G?^"67_ $C3
M_8 _\0W_ &=?_G<U]_T4 ? '_#IW_@EE_P!(T_V /_$-_P!G7_YW-'_#IW_@
MEE_TC3_8 _\ $-_V=?\ YW-??]% 'P!_PZ=_X)9?](T_V /_ !#?]G7_ .=S
M1_PZ=_X)9?\ 2-/]@#_Q#?\ 9U_^=S7W_10!\ ?\.G?^"67_ $C3_8 _\0W_
M &=?_G<T?\.G?^"67_2-/]@#_P 0W_9U_P#G<U]_T4 ? '_#IW_@EE_TC3_8
M _\ $-_V=?\ YW-'_#IW_@EE_P!(T_V /_$-_P!G7_YW-??]% 'P!_PZ=_X)
M9?\ 2-/]@#_Q#?\ 9U_^=S1_PZ=_X)9?](T_V /_ !#?]G7_ .=S7W_10!\
M?\.G?^"67_2-/]@#_P 0W_9U_P#G<T?\.G?^"67_ $C3_8 _\0W_ &=?_G<U
M]_T4 ? '_#IW_@EE_P!(T_V /_$-_P!G7_YW-'_#IW_@EE_TC3_8 _\ $-_V
M=?\ YW-??]% 'S!\%/V(OV+_ -FOQ5J'CK]G/]D3]F#X ^-M6\/W7A/5/&/P
M4^ 7PI^%?BK4O"M]J.E:Q?>&=0\0^!?">@ZO>>'[S5]"T/5+K1KB\DTZXU'1
1M*OIK9[G3K.6$KZ?HH __]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>52
<FILENAME>img_005.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 img_005.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" Q #)4# 2(  A$! Q$!_\0
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M>IQ1:M?I&EW*JHMRX"@.< #/ K/_ .$CUS_H,ZC_ .!3_P"-'B/_ )&?5O\
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MG_09U'_P*?\ QH_X2/7/^@SJ/_@4_P#C69119!<T_P#A(]<_Z#.H_P#@4_\
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M_"1ZY_T&=1_\"G_QK,HHL@N:?_"1ZY_T&=1_\"G_ ,:/^$CUS_H,ZC_X%/\
MXUF44607-/\ X2/7/^@SJ/\ X%/_ (T?\)'KG_09U'_P*?\ QK,HHL@N:?\
MPD>N?]!G4?\ P*?_ !H_X2/7/^@SJ/\ X%/_ (UF44607-/_ (2/7/\ H,ZC
M_P"!3_XT?\)'KG_09U'_ ,"G_P :S**+(+FG_P )'KG_ $&=1_\  I_\:/\
MA(]<_P"@SJ/_ (%/_C69119!<T_^$CUS_H,ZC_X%/_C1_P )'KG_ $&=1_\
M I_\:S**+(+FG_PD>N?]!G4?_ I_\:/^$CUS_H,ZC_X%/_C69119!<T_^$CU
MS_H,ZC_X%/\ XT?\)'KG_09U'_P*?_&LRBBR"YI_\)'KG_09U'_P*?\ QH_X
M2/7/^@SJ/_@4_P#C69119!<T_P#A(]<_Z#.H_P#@4_\ C1_PD>N?]!G4?_ I
M_P#&LRBBR"YI_P#"1ZY_T&=1_P# I_\ &C_A(]<_Z#.H_P#@4_\ C69119!<
MT_\ A(]<_P"@SJ/_ (%/_C1_PD>N?]!G4?\ P*?_ !K,HHL@N:?_  D>N?\
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MG4?_  *?_&C_ (2/7/\ H,ZC_P"!3_XUF44607-/_A(]<_Z#.H_^!3_XT?\
M"1ZY_P!!G4?_  *?_&LRBBR"YI_\)'KG_09U'_P*?_&C_A(]<_Z#.H_^!3_X
MUF44607-/_A(]<_Z#.H_^!3_ .-'_"1ZY_T&=1_\"G_QK,HHL@N:?_"1ZY_T
M&=1_\"G_ ,:/^$CUS_H,ZC_X%/\ XUF44607-/\ X2/7/^@SJ/\ X%/_ (T?
M\)'KG_09U'_P*?\ QK,HHL@N:?\ PD>N?]!G4?\ P*?_ !H_X2/7/^@SJ/\
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MZ#.H_P#@4_\ C1_PD>N?]!G4?_ I_P#&LRBBR"YI_P#"1ZY_T&=1_P# I_\
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MKG_09U'_ ,"G_P :/^$CUS_H,ZC_ .!3_P"-9E%%D%S3_P"$CUS_ *#.H_\
M@4_^-'_"1ZY_T&=1_P# I_\ &LRBBR"YI_\ "1ZY_P!!G4?_  *?_&C_ (2/
M7/\ H,ZC_P"!3_XUF44607-/_A(]<_Z#.H_^!3_XT?\ "1ZY_P!!G4?_  *?
M_&LRBBR"YI_\)'KG_09U'_P*?_&C_A(]<_Z#.H_^!3_XUF44607-/_A(]<_Z
M#.H_^!3_ .-'_"1ZY_T&=1_\"G_QK,HHL@N:?_"1ZY_T&=1_\"G_ ,:/^$CU
MS_H,ZC_X%/\ XUF44607-/\ X2/7/^@SJ/\ X%/_ (T?\)'KG_09U'_P*?\
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MLRBBR"YI_P#"1ZY_T&=1_P# I_\ &C_A(]<_Z#.H_P#@4_\ C69119!<T_\
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M(]<_Z#.H_P#@4_\ C69119!<T_\ A(]<_P"@SJ/_ (%/_C1_PD>N?]!G4?\
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M-'_"1ZY_T&=1_P# I_\ &LRBBR"YI_\ "1ZY_P!!G4?_  *?_&C_ (2/7/\
MH,ZC_P"!3_XUF44607/:/@Q>76J?VW_:%S-=^7Y&S[1(9-N?,SC.<9P/RHJ#
MX%?\Q_\ [=__ &K16,]S6.QYCXC_ .1GU;_K]F_]#-9E:?B/_D9]6_Z_9O\
MT,UF5LMC)A1113 **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** /8?@
M5_S'_P#MW_\ :M%'P*_YC_\ V[_^U:*PG\1I'8\Q\1_\C/JW_7[-_P"AFLRM
M/Q'_ ,C/JW_7[-_Z&:S*V6QFPHHHI@%%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% 'L/P*_P"8_P#]N_\ [5HH^!7_ #'_ /MW_P#:M%83^(TCL>8^
M(_\ D9]6_P"OV;_T,UF5I^(_^1GU;_K]F_\ 0S696RV,V%%%%, HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@#V'X%?\Q__MW_ /:M%'P*_P"8_P#]N_\ [5HK"?Q&D=CS'Q'_ ,C/
MJW_7[-_Z&:S*T_$?_(SZM_U^S?\ H9K,K9;&;"BBBF 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MHJY!\2?!_B3PX+/Q+F)V4":!XG968?Q*R D<_0BCP]\1O!6E--IME&=-TV$
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M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110![#\"O\
MF/\ _;O_ .U:*/@5_P Q_P#[=_\ VK16$_B-(['F/B/_ )&?5O\ K]F_]#-9
ME:?B/_D9]6_Z_9O_ $,UF5LMC-A1113 **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M_P"$9O\ _GXTG_P;6O\ \<HN%C'HK8_X1F__ .?C2?\ P;6O_P <H_X1F_\
M^?C2?_!M:_\ QRBX6,>BMC_A&;__ )^-)_\ !M:__'*/^$9O_P#GXTG_ ,&U
MK_\ '*+A8QZ*V/\ A&;_ /Y^-)_\&UK_ /'*/^$9O_\ GXTG_P &UK_\<HN%
MC'HK8_X1F_\ ^?C2?_!M:_\ QRC_ (1F_P#^?C2?_!M:_P#QRBX6,>BMC_A&
M;_\ Y^-)_P#!M:__ !RC_A&;_P#Y^-)_\&UK_P#'*+A8QZ*V/^$9O_\ GXTG
M_P &UK_\<H_X1F__ .?C2?\ P;6O_P <HN%C'HK8_P"$9O\ _GXTG_P;6O\
M\<H_X1F__P"?C2?_  ;6O_QRBX6,>BMC_A&;_P#Y^-)_\&UK_P#'*/\ A&;_
M /Y^-)_\&UK_ /'*+A8QZ*V/^$9O_P#GXTG_ ,&UK_\ '*/^$9O_ /GXTG_P
M;6O_ ,<HN%C'HK8_X1F__P"?C2?_  ;6O_QRGGPGJBPK,9-,$3L45SJMKM+
M D ^9U&Y<_4>M%T%C$HK8_X1F_\ ^?C2?_!M:_\ QRC_ (1F_P#^?C2?_!M:
M_P#QRBX6,>BMC_A&;_\ Y^-)_P#!M:__ !RC_A&;_P#Y^-)_\&UK_P#'*+A8
MQZ*V/^$9O_\ GXTG_P &UK_\<H_X1F__ .?C2?\ P;6O_P <HN%C'HK8_P"$
M9O\ _GXTG_P;6O\ \<H_X1F__P"?C2?_  ;6O_QRBX6,>BMC_A&;_P#Y^-)_
M\&UK_P#'*/\ A&;_ /Y^-)_\&UK_ /'*+A8QZ*V/^$9O_P#GXTG_ ,&UK_\
M'*/^$9O_ /GXTG_P;6O_ ,<HN%C'HK8_X1F__P"?C2?_  ;6O_QRC_A&;_\
MY^-)_P#!M:__ !RBX6,>BMC_ (1F_P#^?C2?_!M:_P#QRC_A&;__ )^-)_\
M!M:__'*+A8QZ*V/^$9O_ /GXTG_P;6O_ ,<H_P"$9O\ _GXTG_P;6O\ \<HN
M%C'HK8_X1F__ .?C2?\ P;6O_P <H_X1F_\ ^?C2?_!M:_\ QRBX6,>BMC_A
M&;__ )^-)_\ !M:__'*/^$9O_P#GXTG_ ,&UK_\ '*+A8QZ*V/\ A&;_ /Y^
M-)_\&UK_ /'*/^$9O_\ GXTG_P &UK_\<HN%C'HK8_X1F_\ ^?C2?_!M:_\
MQRC_ (1F_P#^?C2?_!M:_P#QRBX6,>BMC_A&;_\ Y^-)_P#!M:__ !RC_A&;
M_P#Y^-)_\&UK_P#'*+A8QZ*V/^$9O_\ GXTG_P &UK_\<H_X1F__ .?C2?\
MP;6O_P <HN%C'HK8_P"$9O\ _GXTG_P;6O\ \<H_X1F__P"?C2?_  ;6O_QR
MBX6,>BMC_A&;_P#Y^-)_\&UK_P#'*/\ A&;_ /Y^-)_\&UK_ /'*+A8QZ*V/
M^$9O_P#GXTG_ ,&UK_\ '*/^$9O_ /GXTG_P;6O_ ,<HN%C'HK8_X1F__P"?
MC2?_  ;6O_QRC_A&;_\ Y^-)_P#!M:__ !RBX6,>BMC_ (1F_P#^?C2?_!M:
M_P#QRC_A&;__ )^-)_\ !M:__'*+A8QZ*V/^$9O_ /GXTG_P;6O_ ,<H_P"$
M9O\ _GXTG_P;6O\ \<HN%C'HK8_X1F__ .?C2?\ P;6O_P <H_X1F_\ ^?C2
M?_!M:_\ QRBX6,>BMC_A&;__ )^-)_\ !M:__'*/^$9O_P#GXTG_ ,&UK_\
M'*+A8QZ*V/\ A&;_ /Y^-)_\&UK_ /'*/^$9O_\ GXTG_P &UK_\<HN%C'HK
M8_X1F_\ ^?C2?_!M:_\ QRC_ (1F_P#^?C2?_!M:_P#QRBX6,>BMC_A&;_\
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M /GXTG_P;6O_ ,<H_P"$9O\ _GXTG_P;6O\ \<HN%C'HK8_X1F__ .?C2?\
MP;6O_P <H_X1F_\ ^?C2?_!M:_\ QRBX6,>BMC_A&;__ )^-)_\ !M:__'*/
M^$9O_P#GXTG_ ,&UK_\ '*+A8QZ*V/\ A&;_ /Y^-)_\&UK_ /'*/^$9O_\
MGXTG_P &UK_\<HN%C'HK8_X1F_\ ^?C2?_!M:_\ QRC_ (1F_P#^?C2?_!M:
M_P#QRBX6,>BMC_A&;_\ Y^-)_P#!M:__ !RC_A&;_P#Y^-)_\&UK_P#'*+A8
MQZ*V/^$9O_\ GXTG_P &UK_\<H_X1F__ .?C2?\ P;6O_P <HN%C'HK8_P"$
M9O\ _GXTG_P;6O\ \<H_X1F__P"?C2?_  ;6O_QRBX6,>BMC_A&;_P#Y^-)_
M\&UK_P#'*?#X3U2XFCAADTR261@B(FJVI9F)P  ).2:+H+&)16Q_PC-__P _
M&D_^#:U_^.4?\(S?_P#/QI/_ (-K7_XY1<+&/16Q_P (S?\ _/QI/_@VM?\
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M16Q_PC-__P _&D_^#:U_^.4?\(S?_P#/QI/_ (-K7_XY1<+&/16Q_P (S?\
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M&D_^#:U_^.4?\(S?_P#/QI/_ (-K7_XY1<+&/16Q_P (S?\ _/QI/_@VM?\
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M16Q_PC-__P _&D_^#:U_^.4?\(S?_P#/QI/_ (-K7_XY1<+&/16Q_P (S?\
M_/QI/_@VM?\ XY1_PC-__P _&D_^#:U_^.47"QCT5L?\(S?_ //QI/\ X-K7
M_P".4?\ ",W_ /S\:3_X-K7_ ..47"QCT5L?\(S?_P#/QI/_ (-K7_XY1_PC
M-_\ \_&D_P#@VM?_ (Y1<+&/16Q_PC-__P _&D_^#:U_^.4]_">J1I&\DFF*
MLJ[XRVJVH#KDC(_><C((^H-%T%C$HK8_X1F__P"?C2?_  ;6O_QRC_A&;_\
MY^-)_P#!M:__ !RBX6,>BMC_ (1F_P#^?C2?_!M:_P#QRC_A&;__ )^-)_\
M!M:__'*+A8QZ*V/^$9O_ /GXTG_P;6O_ ,<H_P"$9O\ _GXTG_P;6O\ \<HN
M%C'HK8_X1F__ .?C2?\ P;6O_P <H_X1F_\ ^?C2?_!M:_\ QRBX6,>BMC_A
M&;__ )^-)_\ !M:__'*/^$9O_P#GXTG_ ,&UK_\ '*+A8QZ*V/\ A&;_ /Y^
M-)_\&UK_ /'*/^$9O_\ GXTG_P &UK_\<HN%C'HK8_X1F_\ ^?C2?_!M:_\
MQRC_ (1F_P#^?C2?_!M:_P#QRBX6,>BMC_A&;_\ Y^-)_P#!M:__ !RC_A&;
M_P#Y^-)_\&UK_P#'*+A8QZ*V/^$9O_\ GXTG_P &UK_\<H_X1F__ .?C2?\
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M?_!M:_\ QRBX6,>BMC_A&;__ )^-)_\ !M:__'*/^$9O_P#GXTG_ ,&UK_\
M'*+A8QZ*V/\ A&;_ /Y^-)_\&UK_ /'*/^$9O_\ GXTG_P &UK_\<HN%C'HK
M8_X1F_\ ^?C2?_!M:_\ QRC_ (1F_P#^?C2?_!M:_P#QRBX6,>BMC_A&;_\
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M /GXTG_P;6O_ ,<H_P"$9O\ _GXTG_P;6O\ \<HN%C'HK8_X1F__ .?C2?\
MP;6O_P <H_X1F_\ ^?C2?_!M:_\ QRBX6,>BMC_A&;__ )^-)_\ !M:__'*/
M^$9O_P#GXTG_ ,&UK_\ '*+A8QZ*V/\ A&;_ /Y^-)_\&UK_ /'*/^$9O_\
MGXTG_P &UK_\<HN%C'HK8_X1F_\ ^?C2?_!M:_\ QRC_ (1F_P#^?C2?_!M:
M_P#QRBX6,>BMC_A&;_\ Y^-)_P#!M:__ !RC_A&;_P#Y^-)_\&UK_P#'*+A8
MQZ*V/^$9O_\ GXTG_P &UK_\<H_X1F__ .?C2?\ P;6O_P <HN%C'HK8_P"$
M9O\ _GXTG_P;6O\ \<H_X1F__P"?C2?_  ;6O_QRBX6,>BMC_A&;_P#Y^-)_
M\&UK_P#'*/\ A&;_ /Y^-)_\&UK_ /'*+A8QZ*V/^$9O_P#GXTG_ ,&UK_\
M'*/^$9O_ /GXTG_P;6O_ ,<HN%C'HK8_X1F__P"?C2?_  ;6O_QRC_A&;_\
MY^-)_P#!M:__ !RBX6,>BMC_ (1F_P#^?C2?_!M:_P#QRC_A&;__ )^-)_\
M!M:__'*+A8QZ*V/^$9O_ /GXTG_P;6O_ ,<H_P"$9O\ _GXTG_P;6O\ \<HN
M%C'HK8_X1F__ .?C2?\ P;6O_P <H_X1F_\ ^?C2?_!M:_\ QRBX6,>BMC_A
M&;__ )^-)_\ !M:__'*/^$9O_P#GXTG_ ,&UK_\ '*+A8QZ*V/\ A&;_ /Y^
M-)_\&UK_ /'*/^$9O_\ GXTG_P &UK_\<HN%C'HK8_X1F_\ ^?C2?_!M:_\
MQRC_ (1F_P#^?C2?_!M:_P#QRBX6,>BMC_A&;_\ Y^-)_P#!M:__ !RC_A&;
M_P#Y^-)_\&UK_P#'*+A8QZ*V/^$9O_\ GXTG_P &UK_\<H_X1F__ .?C2?\
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M?_!M:_\ QRBX6,>BMC_A&;__ )^-)_\ !M:__'*/^$9O_P#GXTG_ ,&UK_\
M'*+A8QZ*V/\ A&;_ /Y^-)_\&UK_ /'*/^$9O_\ GXTG_P &UK_\<HN%C'HK
M8_X1F_\ ^?C2?_!M:_\ QRC_ (1F_P#^?C2?_!M:_P#QRBX6,>BMC_A&;_\
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M /GXTG_P;6O_ ,<H_P"$9O\ _GXTG_P;6O\ \<HN%C'HK8_X1F__ .?C2?\
MP;6O_P <H_X1F_\ ^?C2?_!M:_\ QRBX6,>BMC_A&;__ )^-)_\ !M:__'*/
M^$9O_P#GXTG_ ,&UK_\ '*+A8QZ*V/\ A&;_ /Y^-)_\&UK_ /'*/^$9O_\
MGXTG_P &UK_\<HN%C'HK8_X1F_\ ^?C2?_!M:_\ QRC_ (1F_P#^?C2?_!M:
M_P#QRBX6,>BMC_A&;_\ Y^-)_P#!M:__ !RC_A&;_P#Y^-)_\&UK_P#'*+A8
MQZ*V/^$9O_\ GXTG_P &UK_\<H_X1F__ .?C2?\ P;6O_P <HN%C'HK8_P"$
M9O\ _GXTG_P;6O\ \<H_X1F__P"?C2?_  ;6O_QRBX6,>BMC_A&;_P#Y^-)_
M\&UK_P#'*/\ A&;_ /Y^-)_\&UK_ /'*+A8QZ*V/^$9O_P#GXTG_ ,&UK_\
M'*/^$9O_ /GXTG_P;6O_ ,<HN%C'HK8_X1F__P"?C2?_  ;6O_QRC_A&;_\
MY^-)_P#!M:__ !RBX6,>BMC_ (1F_P#^?C2?_!M:_P#QRC_A&;__ )^-)_\
M!M:__'*+A8QZ*V/^$9O_ /GXTG_P;6O_ ,<H_P"$9O\ _GXTG_P;6O\ \<HN
M%C'HK8_X1F__ .?C2?\ P;6O_P <H_X1F_\ ^?C2?_!M:_\ QRBX6,>BMC_A
M&;__ )^-)_\ !M:__'*/^$9O_P#GXTG_ ,&UK_\ '*+A8QZ*V/\ A&;_ /Y^
M-)_\&UK_ /'*/^$9O_\ GXTG_P &UK_\<HN%C'HK8_X1F_\ ^?C2?_!M:_\
MQRC_ (1F_P#^?C2?_!M:_P#QRBX6,>BMC_A&;_\ Y^-)_P#!M:__ !RC_A&;
M_P#Y^-)_\&UK_P#'*+A8QZ*V/^$9O_\ GXTG_P &UK_\<H_X1F__ .?C2?\
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M?_!M:_\ QRBX6,>BMC_A&;__ )^-)_\ !M:__'*/^$9O_P#GXTG_ ,&UK_\
M'*+A8QZ*V/\ A&;_ /Y^-)_\&UK_ /'*/^$9O_\ GXTG_P &UK_\<HN%C'HK
M8_X1F_\ ^?C2?_!M:_\ QRC_ (1F_P#^?C2?_!M:_P#QRBX6,>BMC_A&;_\
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M /GXTG_P;6O_ ,<H_P"$9O\ _GXTG_P;6O\ \<HN%C'HK8_X1F__ .?C2?\
MP;6O_P <H_X1F_\ ^?C2?_!M:_\ QRBX6,>BMC_A&;__ )^-)_\ !M:__'*/
M^$9O_P#GXTG_ ,&UK_\ '*+A8QZ*V/\ A&;_ /Y^-)_\&UK_ /'*/^$9O_\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"MCPE_R.>A?]A"W_ /1BUCUL>$O^1ST+_L(6_P#Z,6D]@1CT444P"BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
MV-9_Y!7AW_L'O_Z53UCUL:S_ ,@KP[_V#W_]*IZ0&/1113 **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ K8\)?\CGH7_80M_P#T8M8];'A+_D<]"_["%O\ ^C%I/8$8
M]%%%, HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "MC6?^05X=_[![_^E4]8];&L_P#(*\._]@]__2J>D!CT444P
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@#V'X%?\Q_\ [=__ &K11\"O^8__ -N__M6B
ML)_$:1V/,?$?_(SZM_U^S?\ H9K,K3\1_P#(SZM_U^S?^AFLRMEL9L****8!
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 5L7/_(F:9_V$+O_ -%VU8];%S_R)FF?]A"[_P#1=M28&/1113 *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH *V/"7_(YZ%_V$+?\ ]&+6/6QX2_Y'/0O^
MPA;_ /HQ:3V!&/1113 **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ K8UG_D%>'?^P>__I5/6/6QK/\ R"O#O_8/
M?_TJGI 8]%%%, HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** .P\"^!?^
M$U:^']H_8_LH3_EAYF[=N_VAC[OZUV/_  HK_J8__)'_ .V4GP+^_KGT@_\
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M_P"$;^U_\N?V7[1Y?^SC=MS^F:\&UWP-=Z7XOA\.6,QU"YF161A'Y?7/49.
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH *V/"7_(YZ%_V$+?\ ]&+6/6QX2_Y'/0O^PA;_ /HQ:3V!&/11
M13 **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ K8UG_D%>'?^P>__I5/6/6QK/\ R"O#O_8/?_TJGI 8]%%%, HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M"\_Z_F_] 2O/M!NHK/XQ+-,P6/\ M*9"S' &YF4?J:T_Y??(A_POF=)\<_\
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MV%%%%, HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH *V+G_D3-,_["%W_Z+MJQZV+G_D3-,_["%W_Z+MJ3 QZ*
M**8!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !6QX2_P"1ST+_ +"%O_Z,6L>MCPE_
MR.>A?]A"W_\ 1BTGL",>BBBF 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !6QK/_(*\._\ 8/?_ -*IZQZV-9_Y
M!7AW_L'O_P"E4](#'HHHI@%%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M!<L-6U+2_,_L_4+NT\S&_P"SS-'NQTS@C/4U<_X2WQ)_T,.K?^!LG^-8]% %
MJ]U/4-296OKZYNBO0SS,^/S-5:** +%I?7>GS>=974]M+TWPR%&_,5/>ZWJV
MI1"*^U2]NHP<A9[AW /T)JA10 5<L=7U/2PXT_4;NT$F-_V>=H]V.F<$9ZU3
MHH ?--+<3/-/(\LLC%G=V+,Q/4DGJ:8"0<@X(HHH U1XG\0+"(5US4Q$!@(+
MN3&/3&:RR2S%F)))R2>])10!HV^OZS:6@M+;5[^&V ($,5RZH >OR@XYR:SJ
M** -"SUW6-.A\FQU6^MHLYV07#HOY U4N+F>[F::YFDFE;[SR.68_4FHJ* /
M4/@A_P C)J/_ %Y_^SK6;\3KV[T_XDWD]E=36TPBB DAD*-C8.XKB['4K_3)
M6ET^]N;21AM9K>5HR1Z$@]*9=WMU?W#7%[<S7,[  R32%V..G)YJ9*\E+L.+
MLFNXZ]U&]U*837UY<74H& \\K.0/3)-.L=4U#2V=M/O[JT9QAS;S-&6'O@C-
M5**H1-=WES?W+7%Y<S7$[XW2S.78X&!DGGI5MM?UEK'["VKWYM-GE^0;E_+V
M_P!W;G&/:LZBE;H!/9WUWI]P+BRNI[:8 @20R%& /49'-/OM2O\ 4Y5EO[VY
MNY%&U6N)6D('H"3TJK13 L6E]=Z?-YUE=3VTO3?#(4;\Q4][K>K:E$(K[5+V
MZC!R%GN'< _0FJ%% $D$\UK.D]O*\4T9W))&Q5E/J".AJS?:QJ>J*BZAJ-W=
MB,DH+B=I-N>N,DXJE10!?L=<U;3(6AL-4O;2)FW%(+AXU)]< ]>!5*21YI7E
ME=GD=BS.QR6)ZDGN:;10!ICQ)KHMOLPUK4?(V[?*^U/MQZ8SC%9E%% !5RRU
M;4M,W?8-0N[3=U\B9H\_D:IT4 7[S7-7U&+R[[5;ZYC_ +L]P[C\B:H444 7
M;'5]3TL.-/U&[M _WOL\[1[OK@C-0W5]=WMS]IN[J>>?C][+(7;CW/-044 :
M-SX@UJ\MC;76KW\\!ZQ2W+LI_ G%)!KVL6MG]CM]6OH;7!'D1W+JF#U&T''.
M36?12L@.X\ ^$M&\6QW5O<ZE/::E$P:)$*X=,=0",D@]<'N*ZK4/A?XPN7-G
M_P )6;G33@;;FXFSC_KGRO'U_*O'E9D8,I*L#D$'!%:H\5>(E38NO:H$QC:+
MR3'\Z4DWL-:'L_Q!U"S\,?#I=!6X5[F2WCM8D)^9D7 9B.PP#^)KP($@Y!P1
M3YII;B9IIY7EE<Y9W8L2?<FF41C9MO=@W=)+9&J/$_B!81"NN:F(@,!!=R8Q
MZ8S66268LQ)).23WI**H04444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110![#\"O\ F/\ _;O_ .U:*/@5_P Q_P#[=_\ VK16$_B-(['F/B/_ )&?
M5O\ K]F_]#-9E:?B/_D9]6_Z_9O_ $,UF5LMC-A1113 **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "MBY_Y$
MS3/^PA=_^B[:L>MBY_Y$S3/^PA=_^B[:DP,>BBBF 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 5L>$O\ D<]"_P"PA;_^C%K'K8\)?\CGH7_80M__ $8M)[ C'HHH
MI@%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 5L:S_R"O#O_ &#W_P#2J>L>MC6?^05X=_[![_\ I5/2 QZ***8!
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110![#\"O\ F/\ _;O_ .U:*/@5_P Q_P#[=_\
MVK16$_B-(['F/B/_ )&?5O\ K]F_]#-9E:?B/_D9]6_Z_9O_ $,UF5LMC-A1
M113 **** "BO2_AW\/-)\6Z%<7U_<7L<L=R8@('0+@*I[J>>377?\*3\-_\
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MGH7_ &$+?_T8M)[ C'HHHI@%%%% !1110 4444 %%%% !1110 4444 %%%%
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M;4,K X((,G!%,_X1F_\ ^?C2?_!M:_\ QRCQ;_R.>N_]A"X_]&-6/1J!L?\
M",W_ /S\:3_X-K7_ ..4?\(S?_\ /QI/_@VM?_CE8]% &Q_PC-__ ,_&D_\
M@VM?_CE'_",W_P#S\:3_ .#:U_\ CE8]% &Q_P (S?\ _/QI/_@VM?\ XY1_
MPC-__P _&D_^#:U_^.5CT4 ;'_",W_\ S\:3_P"#:U_^.4?\(S?_ //QI/\
MX-K7_P".5CT4 ;'_  C-_P#\_&D_^#:U_P#CE'_",W__ #\:3_X-K7_XY6/1
M0!L?\(S?_P#/QI/_ (-K7_XY1_PC-_\ \_&D_P#@VM?_ (Y6/10!L?\ ",W_
M /S\:3_X-K7_ ..4?\(S?_\ /QI/_@VM?_CE8]% &Q_PC-__ ,_&D_\ @VM?
M_CE'_",W_P#S\:3_ .#:U_\ CE8]% &Q_P (S?\ _/QI/_@VM?\ XY1_PC-_
M_P _&D_^#:U_^.5CT4 ;'_",W_\ S\:3_P"#:U_^.4?\(S?_ //QI/\ X-K7
M_P".5CT4 ;'_  C-_P#\_&D_^#:U_P#CE'_",W__ #\:3_X-K7_XY6/10!L?
M\(S?_P#/QI/_ (-K7_XY1_PC-_\ \_&D_P#@VM?_ (Y6/10!L?\ ",W_ /S\
M:3_X-K7_ ..4?\(S?_\ /QI/_@VM?_CE8]% &Q_PC-__ ,_&D_\ @VM?_CE'
M_",W_P#S\:3_ .#:U_\ CE8]% &W%X3U2=RD4FF2,%9R$U6U)"J"6/\ K.@
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M1_PC-_\ \_&D_P#@VM?_ (Y6/10!L?\ ",W_ /S\:3_X-K7_ ..4?\(S?_\
M/QI/_@VM?_CE8]% &Q_PC-__ ,_&D_\ @VM?_CE'_",W_P#S\:3_ .#:U_\
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M2?\ P;6O_P <H_X1F_\ ^?C2?_!M:_\ QRL>B@#8_P"$9O\ _GXTG_P;6O\
M\<H_X1F__P"?C2?_  ;6O_QRL>B@#8_X1F__ .?C2?\ P;6O_P <H_X1F_\
M^?C2?_!M:_\ QRL>B@#8_P"$9O\ _GXTG_P;6O\ \<H_X1F__P"?C2?_  ;6
MO_QRL>B@#8_X1F__ .?C2?\ P;6O_P <H_X1F_\ ^?C2?_!M:_\ QRL>B@#8
M_P"$9O\ _GXTG_P;6O\ \<H_X1F__P"?C2?_  ;6O_QRL>B@#8_X1F__ .?C
M2?\ P;6O_P <H_X1F_\ ^?C2?_!M:_\ QRL>B@#8_P"$9O\ _GXTG_P;6O\
M\<H_X1F__P"?C2?_  ;6O_QRL>B@#8_X1F__ .?C2?\ P;6O_P <H_X1F_\
M^?C2?_!M:_\ QRL>B@#8_P"$9O\ _GXTG_P;6O\ \<H_X1F__P"?C2?_  ;6
MO_QRL>B@#8_X1F__ .?C2?\ P;6O_P <H_X1F_\ ^?C2?_!M:_\ QRL>B@#8
M_P"$9O\ _GXTG_P;6O\ \<H_X1F__P"?C2?_  ;6O_QRL>B@#8_X1F__ .?C
M2?\ P;6O_P <H_X1F_\ ^?C2?_!M:_\ QRL>B@#8_P"$9O\ _GXTG_P;6O\
M\<H_X1F__P"?C2?_  ;6O_QRL>B@#8_X1F__ .?C2?\ P;6O_P <H_X1F_\
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M.""#)P16)6QXM_Y'/7?^PA<?^C&HU /^$9O_ /GXTG_P;6O_ ,<H_P"$9O\
M_GXTG_P;6O\ \<K'HH V/^$9O_\ GXTG_P &UK_\<H_X1F__ .?C2?\ P;6O
M_P <K'HH V/^$9O_ /GXTG_P;6O_ ,<H_P"$9O\ _GXTG_P;6O\ \<K'HH V
M/^$9O_\ GXTG_P &UK_\<H_X1F__ .?C2?\ P;6O_P <K'HH V/^$9O_ /GX
MTG_P;6O_ ,<H_P"$9O\ _GXTG_P;6O\ \<K'HH V/^$9O_\ GXTG_P &UK_\
M<H_X1F__ .?C2?\ P;6O_P <K'HH V/^$9O_ /GXTG_P;6O_ ,<H_P"$9O\
M_GXTG_P;6O\ \<K'HH V/^$9O_\ GXTG_P &UK_\<H_X1F__ .?C2?\ P;6O
M_P <K'HH V/^$9O_ /GXTG_P;6O_ ,<H_P"$9O\ _GXTG_P;6O\ \<K'HH V
M/^$9O_\ GXTG_P &UK_\<H_X1F__ .?C2?\ P;6O_P <K'HH V/^$9O_ /GX
MTG_P;6O_ ,<H_P"$9O\ _GXTG_P;6O\ \<K'HH V/^$9O_\ GXTG_P &UK_\
M<H_X1F__ .?C2?\ P;6O_P <K'HH V/^$9O_ /GXTG_P;6O_ ,<H_P"$9O\
M_GXTG_P;6O\ \<K'HH V/^$9O_\ GXTG_P &UK_\<H_X1F__ .?C2?\ P;6O
M_P <K'HH V/^$9O_ /GXTG_P;6O_ ,<I\7A/5)W*12:9(P5G(35;4D*H)8_Z
MSH "3Z 5B5L>&?\ D*S_ /8/O?\ TEEHU /^$9O_ /GXTG_P;6O_ ,<H_P"$
M9O\ _GXTG_P;6O\ \<K'HH V/^$9O_\ GXTG_P &UK_\<H_X1F__ .?C2?\
MP;6O_P <K'HH V/^$9O_ /GXTG_P;6O_ ,<H_P"$9O\ _GXTG_P;6O\ \<K'
MHH V/^$9O_\ GXTG_P &UK_\<H_X1F__ .?C2?\ P;6O_P <K'HH V/^$9O_
M /GXTG_P;6O_ ,<H_P"$9O\ _GXTG_P;6O\ \<K'HH V/^$9O_\ GXTG_P &
MUK_\<H_X1F__ .?C2?\ P;6O_P <K'HH V/^$9O_ /GXTG_P;6O_ ,<H_P"$
M9O\ _GXTG_P;6O\ \<K'HH V/^$9O_\ GXTG_P &UK_\<H_X1F__ .?C2?\
MP;6O_P <K'HH V/^$9O_ /GXTG_P;6O_ ,<H_P"$9O\ _GXTG_P;6O\ \<K'
MHH V/^$9O_\ GXTG_P &UK_\<H_X1F__ .?C2?\ P;6O_P <K'HH V/^$9O_
M /GXTG_P;6O_ ,<H_P"$9O\ _GXTG_P;6O\ \<K'HH V/^$9O_\ GXTG_P &
MUK_\<H_X1F__ .?C2?\ P;6O_P <K'HH V/^$9O_ /GXTG_P;6O_ ,<H_P"$
M9O\ _GXTG_P;6O\ \<K'HH V/^$9O_\ GXTG_P &UK_\<H_X1F__ .?C2?\
MP;6O_P <K'HH V/^$9O_ /GXTG_P;6O_ ,<H_P"$9O\ _GXTG_P;6O\ \<K'
MHH ]M^#&F7&G?VWY\EH_F>1C[/=Q3XQYG7RV;'7OU_"BJ?P*_P"8_P#]N_\
M[5HK&>YK'8\Q\1_\C/JW_7[-_P"AFLRM/Q'_ ,C/JW_7[-_Z&:S*V6QDPHHH
MI@%%%% 'O'P3_P"10O/^OYO_ $!*\:\09_X2C5-N=WVV7&.N=YKV7X)_\BA>
M?]?S?^@)5B]^,7AZQOKBTEL]4,D$K1,5BCP2IP<?/TXK.>E1M=O\BHZPMYEC
MX4?VQ_PB'_$V\_'G'[-Y^=WE8'KSC.<?X8KS&'0[#Q+\6[_3)7DCM)KNX):
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MY[GP2\<S,RV]T\<>3T7"M@?BQKRO2[;7[OQY?0^')98KTSR[GC?8%3?R6/\
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M?*=VS&[KWSBM/XE:#X6NII]4U357BU&&W79:1W,2-(H)Z*P)).3^5<=\&?\
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M_P!TVX0H>&+,.-QY]\G)]X/@9_QXZS_UUB_DU>+T4*-D[[L&[VMLC?\ &O\
MR/6L_P#7X_\ .O:OBK_R3B[_ -Z'_P!#6OG:BDX>XH]A\WO.044459(4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !6QK/\
MR"O#O_8/?_TJGK'K8UG_ )!7AW_L'O\ ^E4](#'HHHI@%%%% !1110 4444
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MVP4445J9A1110 4444 %%%% &QXM_P"1SUW_ +"%Q_Z,:L>MCQ;_ ,CGKO\
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M0N__ $7;4F!CT444P"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MHH **** "BBB@ K8MO\ D3-3_P"PA:?^B[FL>MBV_P"1,U/_ +"%I_Z+N:3
MQZ***8!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 ;&L_P#(*\._]@]__2J>L>MC6?\ D%>'?^P>_P#Z
M53UCTD 4444P"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ K8\6_\CGKO_80N/_1C5CUL>+?^1SUW_L(7'_HQ
MJ74#'HHHI@%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !6QX9_P"0K/\ ]@^]_P#266L>MCPS_P A6?\ [!][
M_P"DLM)@C'HHHI@%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110![#\"O^8_\ ]N__ +5HH^!7_,?_ .W?
M_P!JT5A/XC2.QYCXC_Y&?5O^OV;_ -#-9E:?B/\ Y&?5O^OV;_T,UF5LMC-A
M1113 **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "MBY_Y$S3/^PA=_P#HNVK'K8N?^1,TS_L(7?\ Z+MJ3 QZ
M***8!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !6QX2_Y'/0O^PA;_ /HQ:QZV/"7_
M ".>A?\ 80M__1BTGL",>BBBF 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M +"%Q_Z,:L>MCQ;_ ,CGKO\ V$+C_P!&-6/26P,****8!1110 4444 %%%%
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MFW);/W2/057\'>'-)U7XDW^DWMIYMC$TX2+S'7&U\+R"#P/>M_X&?\?>M?\
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M>1>;;3SA)$W%=P^H(->LZWX?^%GAR[2UU6U^SSNGF*OF73Y7)&<J2.H->7>
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ML%CGD#U%:R>'8?#7QMTZTM01:RR">%3_  JRM\OX$'\,5+\3?^2I:+_N6_\
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M*** "MCPS_R%9_\ L'WO_I++6/6QX9_Y"L__ &#[W_TEEI,$8]%%%, HHHH
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M3&2=V",Y!PH'W01DCUHY]&WT#EVMU/"**]9UGQ\+O0Y]/\9>$Y%OW!$)$1B
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 5L>$O^1ST+_L(6_\ Z,6L>MCPE_R.
M>A?]A"W_ /1BTGL",>BBBF 4444 %%%% !1110 4444 %%%% !1110 4444
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M^(FB:9JE_:WMO<N7\L*03@':'4Y&&88ZG/-8<7Q*\80VX@76Y2@&,O%&S?\
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M8<$_NU[9[FI4[J_F4XV=CSJBNV_X57XCDTRQOK86MRMX$*1Q.VY R[LME0
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MOOL\$K;W7R4?)QC.64GH*PR<G)J6KS<AIVC;S%9F=R[L69CDDG))KVWXM_\
M)/\ 2/\ KO%_Z+:O$:W-7\7Z[KNGPV&I7WGVT+!HT\E%P0,#E5!Z&B2NDEW"
M+L[^1ZK\%_\ D4=4_P"OIO\ T!:K?!BRM#I>K7\<<3ZDLWEJ7'*+MR!GL"<Y
MQZ>U>9Z+XPU[P]9RVFE7WV>"5M[KY*/DXQG+*3T%5-(U[5-!O#=Z7>26TQ&&
M*X(8>A4Y!_$425VWW5@3LDO.Y[/X'G\<ZGXIN+GQ$+FWL8(W41/%Y2%R1@*
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MI-8RCJ58?9H>0?\ @%3)2;;0XM)),Y&BBBM"0HHHH **** "MCPS_P A6?\
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MU.+YFY]_T%)<J40HHHJR0HHHH V/#/\ R%9_^P?>_P#I++6/6QX9_P"0K/\
M]@^]_P#266L>D 5<TF1(M8L9)/\ 5I<1LWT##-4Z*I.SN)JZL>X?&^&5] TR
M903$ER0Q'0$KQ_(UX?7LOAGX@:%K_AU?#_B\JK[1%YLN=DP'W26'W6'KQTSG
MM4]CX>^&7A^\&JG78;KRCO2*2\24(<Y!"(-QQ[YK**Y&T]C1OF2MN7_B(#;?
M".""XXFV6T>#UW#&?Y&EU#4KG2O@?;7-G(\<_P!B@C61."NXJ"0>W!/->>?$
M7QX/%MW%:V2O'IEL24W\-*_3<1V&. /KZX'IT;Z4GP?L5UKS!I\EE#'*T8RR
M;MH##Z'![].AZ5,DW"3?5CC92BNR. ^#>J7<7BZ2P$SFVN879XRQQO&"&QZ]
MOQK;T^TBL_V@KB.%0J,KR8 [M#N/ZDU)X9M?!G@$W.LOXGM]3G>,I$D&TNJG
MG 0,3DX')P/I7(^'_&,+?%)?$6IX@@GD</C+>4I4JOUQQDUIO-6[,BUH._5H
M=\7O^1_G_P"N$7\J[/XM_P#)/](_Z[Q?^BVK#^)]CH6IRS^(;/Q+8W%P4CC6
MRA=79L$ G(;/0YQCM5[XH:SI6H>!]+M[+4[.YG2:,O'#.KLH$; Y .1S6:^!
M+S_S-/MM^1L>+KZ>Q^#%D;>5HWFMK:(LIP=I49'X@8IOPBO9AX OF9BWV:XE
M\L$]!L5L?F365XSUK2KKX2Z;96^IV<UVB6P:".=6=<+SE0<C%)\,-9TK3_ F
MJV][J5G;3O/*4CFG5&8&-0" 3D\TY[5"8_\ +LS?A!J5W=>.;Y[BXDE:ZMGD
ME+-G<P9<$_F?SISHJ?M X48'VL'\3%DUE?"74++3?&$D]]=V]K";1U\R>0(N
M<KQDGK5V34[ _'(:@+ZV^Q?:5;[3YJ^7CR@,[LXZ\5=OWD?1D7]R7JA/C3_R
M.=O_ ->2?^A/70_"KP?%IMB?%6KJL;&,M;>;@"./',ASTR.GM]:J^*)/#WB'
MXKZ6;O5+)]+2U!EE6X3RR5+D(6S@9../>NJ\7W.C>)M(73+;QKI.G6[']]MF
MC<R =%_U@P/7UX_'--QII+=_YLTDE*>NR_R/)_'?C&X\7:^HM3(+&!MEI&,Y
M8_W\?WB>GH,5UMYX-UR_T:U;QOXPAL;>,YBAF97;)'(+$KEL ]VKGM1\-:-X
M3^R:S9>*[#5Y;:ZB?[)"$W, V2>)&]/2NU\6KX1\?6=A?GQ5:V!@#921EWE3
MC*E"P(/'7G\:K112CW%JY7?;^D7_ !C'9GX-2K9W,EW:QP0B&>7[S@.H!/ _
ME5'X9_\ )*M2_P!ZX_\ 18HU[6O#-]\*[O3-'U:UQ#"L<,,\RI*XC<'.UB"2
M0N1QSGI69\+_ !'HT?A*_P!"U'48+&9WD*M.X12KJ!D$X&00>*EIN-1+J-.S
M@WT,#X.?\CV/^O63^E=)!I]OJ'Q_N_M"!UMU$ZJ1QN6-,'\"<_A69X/MM%\)
M_$=(U\16-W:?8G+79=8XPY/W<[B,\>M9VO>*4TCXMW&NZ=-%=P*Z9,,@994,
M:A@&&1Z_B*TO><6NS(M:,EZ"?%O5[RZ\:36+RR"VLU011YP 2H8MCUYZ^U=I
MI<K^*?@G='52T\L$$VV5^6)CR5;/KP!GOS6=X@LO!?Q N8M7A\30:5=% LZ7
M(52P'3AF7D=,@D<55\5>,-#T3P</"?A><W(9#'-<CD!2<MST9FYZ<8-9V_=\
MG7^M32_OJ73^M#?\!W<EC\&[J[A?9+#'<NC8Z,,D'\ZY/X.7UU)XTNDDN)76
M>U=Y0S$[V#+@G/4\GGWK5\,:SI5O\&[^QFU.SCO&AN0MN\ZB0DYQA2<\US7P
MEU"RTWQA)/?7=O:PFT=?,GD"+G*\9)ZUHOCEZ?H9_P#+M>OZE'XFHJ?$/5@H
MQED)^I1:Y*NI^(MW;7WCO4KBTN(KB!RFV6)PZM\BC@C@URU*G\"'4^)A6Q;?
M\B9J?_80M/\ T7<UCUL6W_(F:G_V$+3_ -%W-4R3'HHHI@%%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4Y)'BD5XW9'4Y#*
M<$&FT4 :S>*/$+QF-M=U-D(P5-W(01],UE$DDDG)/4FDHHL 4444 ;&L_P#(
M*\._]@]__2J>L>MC6?\ D%>'?^P>_P#Z53UCTD 4444P"BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ K8\6_\
MCGKO_80N/_1C5CUL>+?^1SUW_L(7'_HQJ74#'HHHI@%%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !6QX9_P"0
MK/\ ]@^]_P#266L>MCPS_P A6?\ [!][_P"DLM)@C'HHHI@%%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0![#\"O^8_\ ]N__ +5HH^!7_,?_ .W?_P!JT5A/XC2.QYCXC_Y&?5O^OV;_
M -#-9E:?B/\ Y&?5O^OV;_T,UF5LMC-A1113 **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "MBY_Y$S3/^PA=
M_P#HNVK'K8N?^1,TS_L(7?\ Z+MJ3 QZ***8!1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !6QX2_Y'/0O^PA;_ /HQ:QZV/"7_ ".>A?\ 80M__1BTGL",>BBBF 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M7'_HQJQZ2V!A1113 **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "MCPE_R.>A?]A"W_\ 1BUCUL>$O^1ST+_L(6__ *,6D]@1CT444P"BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M *V-9_Y!7AW_ +![_P#I5/6/6QK/_(*\._\ 8/?_ -*IZ0&/1113 **** .Z
MTKXM>)]+LTMF>VO5085KN-F8#ZJP)_')J'4?BIXKOYXY$O4LQ&VX1VT8"D^^
M[)(]B<5Q=%*RO<+O8W/$OBW5O%=S%+J4JE8EVQQ1C:B^IQGJ>Y_I6'110DEL
M#=SK/#WQ&\1>&[9;6VN(Y[5/N0W*;U3Z$$$#VSBM._\ C#XIO;=HHS9V9(P7
MMX3N_P#'F;%<!10TGN--K8E6ZN$NQ=K/(+D/Y@EW'=OSG=GKG/.:[VU^,OBB
MWMEAD2PN&48\V6%MQ^NU@/TKSVBAI-6%YFKKWB/5/$M\+O5+DRNHVHH&%0>@
M Z5J>(O'VJ^)M'MM,O;>SC@MW5T:%&#$A2HSEB.A]*Y:BCE5K#N[W.J\-?$/
M7O"]K]DLY89K4$E8+E"RH3R<8((^F<5-XA^)?B+Q'9-97$D%M;.,21VJ%=X]
M"22<>V:X^BAI/<2;6QJZ#XBU3PU??:]+N3$Y&'4C*N/1AWKK+OXR>*+FU:&-
M;"V9ACS886WCZ;F(_2O/J*&D]P3ML7K'6+_3M8CU:WN7%\DAD\UOF+,>N<]<
MY.?K72^(/B;K?B31I-+O(+!()"I9H8F#'!!')8CJ/2N,HH:3W"[3N=3XB\?:
MKXFT>VTR]M[.."W=71H48,2%*C.6(Z'TJOX;\;:YX6W)IUR#;L=S6\R[HR?7
M'4?@17/44[;^8=O([C6/BOXFUBS:U\RWLHW!5S:1E68>F6)(_#%<_P"&O$EY
MX6U;^TK&."2;RVCVSJ2N#CT(/;UK'HI)); VWN:6NZU<^(=:N-4NTB2><@LL
M0(48 '&23V]:V?$GC_5?%.E0:=?6]E'#"XD5H$8,2 1SECZURE%%E:P[N]PH
MHHIB"BBB@#8\6_\ (YZ[_P!A"X_]&-6/6QXM_P"1SUW_ +"%Q_Z,:L>DM@84
M444P"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@#8\,_\ (5G_ .P?>_\ I++6/6QX9_Y"L_\ V#[W_P!)9:QZ
M0!1113 **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M'WO_ *2RTF",>BBBF 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% 'L/P*_YC_P#V[_\ M6BCX%?\Q_\
M[=__ &K16$_B-([&7JGP\BO=6O+LZN\9GG>0I]E!V[F)QG>,]:J?\*RA_P"@
MT_\ X!C_ ..5WTW^OD_WC_.F5W1I1LCC=65SA/\ A64/_0:?_P  Q_\ '*/^
M%90_]!I__ ,?_'*[NBJ]C$7M9'"?\*RA_P"@T_\ X!C_ ..4?\*RA_Z#3_\
M@&/_ (Y7=T4>QB'M9'"?\*RA_P"@T_\ X!C_ ..4?\*RA_Z#3_\ @&/_ (Y7
M=T4>QB'M9'"?\*RA_P"@T_\ X!C_ ..4?\*RA_Z#3_\ @&/_ (Y7=T4>QB'M
M9'"?\*RA_P"@T_\ X!C_ ..4?\*RA_Z#3_\ @&/_ (Y7=T4>QB'M9'"?\*RA
M_P"@T_\ X!C_ ..4?\*RA_Z#3_\ @&/_ (Y7=T4>QB'M9'"?\*RA_P"@T_\
MX!C_ ..4?\*RA_Z#3_\ @&/_ (Y7=T4>QB'M9'"?\*RA_P"@T_\ X!C_ ..4
M?\*RA_Z#3_\ @&/_ (Y7=T4>QB'M9'"?\*RA_P"@T_\ X!C_ ..4?\*RA_Z#
M3_\ @&/_ (Y7=T4>QB'M9'"?\*RA_P"@T_\ X!C_ ..4?\*RA_Z#3_\ @&/_
M (Y7=T4>QB'M9'"?\*RA_P"@T_\ X!C_ ..4?\*RA_Z#3_\ @&/_ (Y7=T4>
MQB'M9'"?\*RA_P"@T_\ X!C_ ..4?\*RA_Z#3_\ @&/_ (Y7=T4>QB'M9'"?
M\*RA_P"@T_\ X!C_ ..4?\*RA_Z#3_\ @&/_ (Y7=T4>QB'M9'"?\*RA_P"@
MT_\ X!C_ ..4?\*RA_Z#3_\ @&/_ (Y7=T4>QB'M9'"?\*RA_P"@T_\ X!C_
M ..5=D\ PR:-:Z?_ &LX\BXFG\S[*/F\Q8UQC?QCR^OO[5UU%+V,0]K(X3_A
M64/_ $&G_P# ,?\ QRC_ (5E#_T&G_\  ,?_ !RN[HI^QB'M9'"?\*RA_P"@
MT_\ X!C_ ..4?\*RA_Z#3_\ @&/_ (Y7=T4>QB'M9'"?\*RA_P"@T_\ X!C_
M ..4?\*RA_Z#3_\ @&/_ (Y7=T4>QB'M9'"?\*RA_P"@T_\ X!C_ ..4?\*R
MA_Z#3_\ @&/_ (Y7=T4>QB'M9'"?\*RA_P"@T_\ X!C_ ..4?\*RA_Z#3_\
M@&/_ (Y7=T4>QB'M9'"?\*RA_P"@T_\ X!C_ ..4?\*RA_Z#3_\ @&/_ (Y7
M=T4>QB'M9'"?\*RA_P"@T_\ X!C_ ..4?\*RA_Z#3_\ @&/_ (Y7=T4>QB'M
M9'"?\*RA_P"@T_\ X!C_ ..4?\*RA_Z#3_\ @&/_ (Y7=T4>QB'M9'"?\*RA
M_P"@T_\ X!C_ ..4?\*RA_Z#3_\ @&/_ (Y7=T4>QB'M9'"?\*RA_P"@T_\
MX!C_ ..4?\*RA_Z#3_\ @&/_ (Y7=T4>QB'M9'"?\*RA_P"@T_\ X!C_ ..4
M?\*RA_Z#3_\ @&/_ (Y7=T4>QB'M9'"?\*RA_P"@T_\ X!C_ ..4?\*RA_Z#
M3_\ @&/_ (Y7=T4>QB'M9'"?\*RA_P"@T_\ X!C_ ..4?\*RA_Z#3_\ @&/_
M (Y7=T4>QB'M9'"?\*RA_P"@T_\ X!C_ ..4?\*RA_Z#3_\ @&/_ (Y7=T4>
MQB'M9'"?\*RA_P"@T_\ X!C_ ..4?\*RA_Z#3_\ @&/_ (Y7=T4>QB'M9'"?
M\*RA_P"@T_\ X!C_ ..4?\*RA_Z#3_\ @&/_ (Y7=T4>QB'M9'"?\*RA_P"@
MT_\ X!C_ ..4?\*RA_Z#3_\ @&/_ (Y7=T4>QB'M9'"?\*RA_P"@T_\ X!C_
M ..4?\*RA_Z#3_\ @&/_ (Y7=T4>QB'M9'"?\*RA_P"@T_\ X!C_ ..4?\*R
MA_Z#3_\ @&/_ (Y7=T4>QB'M9'"?\*RA_P"@T_\ X!C_ ..4?\*RA_Z#3_\
M@&/_ (Y7=T4>QB'M9'"?\*RA_P"@T_\ X!C_ ..4?\*RA_Z#3_\ @&/_ (Y7
M=T4>QB'M9'"?\*RA_P"@T_\ X!C_ ..4?\*RA_Z#3_\ @&/_ (Y7=T4>QB'M
M9'"?\*RA_P"@T_\ X!C_ ..4?\*RA_Z#3_\ @&/_ (Y7=T4>QB'M9'"?\*RA
M_P"@T_\ X!C_ ..4?\*RA_Z#3_\ @&/_ (Y7=T4>QB'M9'"?\*RA_P"@T_\
MX!C_ ..4?\*RA_Z#3_\ @&/_ (Y7=T4>QB'M9'"?\*RA_P"@T_\ X!C_ ..4
M?\*RA_Z#3_\ @&/_ (Y7=T4>QB'M9'"?\*RA_P"@T_\ X!C_ ..4?\*RA_Z#
M3_\ @&/_ (Y7=T4>QB'M9'"?\*RA_P"@T_\ X!C_ ..4?\*RA_Z#3_\ @&/_
M (Y7=T4>QB'M9'"?\*RA_P"@T_\ X!C_ ..4?\*RA_Z#3_\ @&/_ (Y7=T4>
MQB'M9'"?\*RA_P"@T_\ X!C_ ..4?\*RA_Z#3_\ @&/_ (Y7=T4>QB'M9'"?
M\*RA_P"@T_\ X!C_ ..4?\*RA_Z#3_\ @&/_ (Y7=T4>QB'M9'"?\*RA_P"@
MT_\ X!C_ ..4?\*RA_Z#3_\ @&/_ (Y7=T4>QB'M9'"?\*RA_P"@T_\ X!C_
M ..4?\*RA_Z#3_\ @&/_ (Y7=T4>QB'M9'"?\*RA_P"@T_\ X!C_ ..4?\*R
MA_Z#3_\ @&/_ (Y7=T4>QB'M9'"?\*RA_P"@T_\ X!C_ ..4?\*RA_Z#3_\
M@&/_ (Y7=T4>QB'M9'"?\*RA_P"@T_\ X!C_ ..4?\*RA_Z#3_\ @&/_ (Y7
M=T4>QB'M9'"?\*RA_P"@T_\ X!C_ ..4?\*RA_Z#3_\ @&/_ (Y7=T4>QB'M
M9'"?\*RA_P"@T_\ X!C_ ..4?\*RA_Z#3_\ @&/_ (Y7=T4>QB'M9'"?\*RA
M_P"@T_\ X!C_ ..4?\*RA_Z#3_\ @&/_ (Y7=T4>QB'M9'"?\*RA_P"@T_\
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MLH?^@T__ (!C_P".4?\ "LH?^@T__@&/_CE=W11[&(>UD<)_PK*'_H-/_P"
M8_\ CE'_  K*'_H-/_X!C_XY7=T4>QB'M9'"?\*RA_Z#3_\ @&/_ (Y1_P *
MRA_Z#3_^ 8_^.5W=%'L8A[61PG_"LH?^@T__ (!C_P".4?\ "LH?^@T__@&/
M_CE=W11[&(>UD<)_PK*'_H-/_P" 8_\ CE'_  K*'_H-/_X!C_XY7=T4>QB'
MM9'"?\*RA_Z#3_\ @&/_ (Y1_P *RA_Z#3_^ 8_^.5W=%'L8A[61PG_"LH?^
M@T__ (!C_P".4?\ "LH?^@T__@&/_CE=W11[&(>UD<)_PK*'_H-/_P" 8_\
MCE'_  K*'_H-/_X!C_XY7=T4>QB'M9'"?\*RA_Z#3_\ @&/_ (Y1_P *RA_Z
M#3_^ 8_^.5W=%'L8A[61PG_"LH?^@T__ (!C_P".4?\ "LH?^@T__@&/_CE=
MW11[&(>UD<)_PK*'_H-/_P" 8_\ CE'_  K*'_H-/_X!C_XY7=T4>QB'M9'"
M?\*RA_Z#3_\ @&/_ (Y1_P *RA_Z#3_^ 8_^.5W=%'L8A[61PG_"LH?^@T__
M (!C_P".4?\ "LH?^@T__@&/_CE=W11[&(>UD<)_PK*'_H-/_P" 8_\ CE'_
M  K*'_H-/_X!C_XY7=T4>QB'M9'"?\*RA_Z#3_\ @&/_ (Y1_P *RA_Z#3_^
M 8_^.5W=%'L8A[61PG_"LH?^@T__ (!C_P".4?\ "LH?^@T__@&/_CE=W11[
M&(>UD<)_PK*'_H-/_P" 8_\ CE'_  K*'_H-/_X!C_XY7=T4>QB'M9'"?\*R
MA_Z#3_\ @&/_ (Y1_P *RA_Z#3_^ 8_^.5W=%'L8A[61PG_"LH?^@T__ (!C
M_P".4?\ "LH?^@T__@&/_CE=W11[&(>UD<)_PK*'_H-/_P" 8_\ CE'_  K*
M'_H-/_X!C_XY7=T4>QB'M9'"?\*RA_Z#3_\ @&/_ (Y1_P *RA_Z#3_^ 8_^
M.5W=%'L8A[61PG_"LH?^@T__ (!C_P".4?\ "LH?^@T__@&/_CE=W11[&(>U
MD<)_PK*'_H-/_P" 8_\ CE'_  K*'_H-/_X!C_XY7=T4>QB'M9'"?\*RA_Z#
M3_\ @&/_ (Y1_P *RA_Z#3_^ 8_^.5W=%'L8A[61PG_"LH?^@T__ (!C_P".
M4?\ "LH?^@T__@&/_CE=W11[&(>UD<)_PK*'_H-/_P" 8_\ CE'_  K*'_H-
M/_X!C_XY7=T4>QB'M9'"?\*RA_Z#3_\ @&/_ (Y1_P *RA_Z#3_^ 8_^.5W=
M%'L8A[61PG_"LH?^@T__ (!C_P".4?\ "LH?^@T__@&/_CE=W11[&(>UD<)_
MPK*'_H-/_P" 8_\ CE'_  K*'_H-/_X!C_XY7=T4>QB'M9'"?\*RA_Z#3_\
M@&/_ (Y1_P *RA_Z#3_^ 8_^.5W=%'L8A[61PG_"LH?^@T__ (!C_P".4?\
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M90_]!I__  #'_P <H_X5E#_T&G_\ Q_\<KNZ*/8Q#VLCA/\ A64/_0:?_P
MQ_\ '*/^%90_]!I__ ,?_'*[NBCV,0]K(X3_ (5E#_T&G_\  ,?_ !RC_A64
M/_0:?_P#'_QRN[HH]C$/:R.$_P"%90_]!I__  #'_P <H_X5E#_T&G_\ Q_\
M<KNZ*/8Q#VLCA/\ A64/_0:?_P  Q_\ '*/^%90_]!I__ ,?_'*[NBCV,0]K
M(X3_ (5E#_T&G_\  ,?_ !RC_A64/_0:?_P#'_QRN[HH]C$/:R.$_P"%90_]
M!I__  #'_P <H_X5E#_T&G_\ Q_\<KNZ*/8Q#VLCA/\ A64/_0:?_P  Q_\
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M!I__  #'_P <H_X5E#_T&G_\ Q_\<KNZ*/8Q#VLCA/\ A64/_0:?_P  Q_\
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M90_]!I__  #'_P <H_X5E#_T&G_\ Q_\<KNZ*/8Q#VLCA/\ A64/_0:?_P
MQ_\ '*/^%90_]!I__ ,?_'*[NBCV,0]K(X3_ (5E#_T&G_\  ,?_ !RC_A64
M/_0:?_P#'_QRN[HH]C$/:R.$_P"%90_]!I__  #'_P <H_X5E#_T&G_\ Q_\
M<KNZ*/8Q#VLCA/\ A64/_0:?_P  Q_\ '*/^%90_]!I__ ,?_'*[NBCV,0]K
M(X3_ (5E#_T&G_\  ,?_ !RC_A64/_0:?_P#'_QRN[HH]C$/:R.$_P"%90_]
M!I__  #'_P <H_X5E#_T&G_\ Q_\<KNZ*/8Q#VLCA/\ A64/_0:?_P  Q_\
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M*RA_Z#3_ /@&/_CE'_"LH?\ H-/_ . 8_P#CE=W11[&(>UD<)_PK*'_H-/\
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MK3:1UTFW!-E*;_7R?[Q_G3*?-_KY/]X_SIE>C'9'#+=A1113)"BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH T-,_Y:_A_6BC3/\ EK^']:*\^O\ Q&=]'X$4IO\
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M:'?S7NG67D7,X*R/YKMN!.3PQ(ZU7LWSQET2?XD\ZY9+O8\P^,'_ "-VD_\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MGY5W%%'UF8?5XG#_ -DW_P#SZR?E1_9-_P#\^LGY5W%%'UF8?5XG#_V3?_\
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MLGY4G]E7V<?99,CG&*[FHE_X^I/]Q?YM1]9F'U>)QG]DW_\ SZR?E1_9-_\
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M)^5=Q11]9F'U>)P_]DW_ /SZR?E1_9-__P ^LGY5W%%'UF8?5XG#_P!DW_\
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MR?E7<44?69A]7B</_9-__P ^LGY4?V3?_P#/K)^5=Q11]9F'U>)P_P#9-_\
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MXG#_ -DW_P#SZR?E1_9-_P#\^LGY5W%%'UF8?5XG#_V3?_\ /K)^5']DW_\
MSZR?E7<44?69A]7B</\ V3?_ //K)^5']DW_ /SZR?E7<44?69A]7B</_9-_
M_P ^LGY4?V3?_P#/K)^5=Q11]9F'U>)P_P#9-_\ \^LGY4?V3?\ _/K)^5=Q
M11]9F'U>)P_]DW__ #ZR?E1_9-__ ,^LGY5W%%'UF8?5XG#_ -DW_P#SZR?E
M2#2KXD@6LG'!XZ5W-11?ZR?_ 'Q_Z"*/K,P^KQ.,_LF__P"?63\J/[)O_P#G
MUD_*NXHH^LS#ZO$X?^R;_P#Y]9/RH_LF_P#^?63\J[BBCZS,/J\3A_[)O_\
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M63\J[BBCZS,/J\3A_P"R;_\ Y]9/RH_LF_\ ^?63\J[BBCZS,/J\3A_[)O\
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MF_\ ^?63\J[BBCZS,/J\3ACI5\!DVL@[<BE_LF__ .?63\J[.?\ U8_WT_\
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MXG#_ -DW_P#SZR?E1_9-_P#\^LGY5W%%'UF8?5XG#_V3?_\ /K)^5']DW_\
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M_P#SZR?E7<44?69A]7B</_9-_P#\^LGY4?V3?_\ /K)^5=Q11]9F'U>)P_\
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MO$X?^R;_ /Y]9/RH_LF__P"?63\J[BBCZS,/J\3A_P"R;_\ Y]9/RH_LF_\
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M\3A_[)O_ /GUD_*D.E7P&3:R#MR*[FHI_P#5C_?3_P!"%'UF8?5XG&?V3?\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5%<_\
M'K-_N'^52U%<_P#'K-_N'^5 $M%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %11?ZR?_?'_ *"*EJ*+_63_
M .^/_010!+1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% $5M_P >L/\ N#^52U%;?\>L/^X/Y5+0
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% $4_\ JQ_OI_Z$*EJ*?_5C_?3_ -"%2T %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 5$W_'U'_N-_-:EJ)O^/J/_ '&_FM $M%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 11?ZR?\
MWQ_Z"*EJ*+_63_[X_P#014M !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %16W_ !ZP_P"X/Y5+45M_
MQZP_[@_E0!+1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %13_P"K'^^G_H0J6HI_]6/]]/\ T(4 2T44
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110!F:O_P L?^!?THHU?_EC_P "_I10!>M?^/2'_KFO\JEJ
M*U_X](?^N:_RJ6@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "HE_X^I/\ <7^;5+42_P#'U)_N+_-J
M ):*** "BJ&M:Q9:!HUUJNHRB*TM8S)(W?V ]23@ =R17DMGXH^*7Q$#WOA6
M"QT'1MQ$%S>*&>8 X[J^?P7'49.*-]@Z79[317B[>-/B#\.]0M1X\BM-3T2X
MD$;:E9H 8B?]T+TZX*@GL>,5[-'(DT22QN'C=0RLIR"#T(IVTN@ZV8ZBBBD
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M$=#[CI5^AIIV8D[JZ"BBBD,**** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ J*Y_X]9O\ </\ *I:BN?\ CUF_W#_*@"6B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "HHO\ 63_[X_\ 014M><_$GQ+J_AZ2Q_LJ[^S^>\OF?NT?=M6/
M'W@<=332N[";LKGHU%?/O_"RO%W_ $%O_):+_P")H_X65XN_Z"W_ )+1?_$U
MI[*1/M$?05%?/O\ PLKQ=_T%O_):+_XFC_A97B[_ *"W_DM%_P#$T>RD'M$?
M05%?/O\ PLKQ=_T%O_):+_XFC_A97B[_ *"W_DM%_P#$T>RD'M$?05%?/O\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %1-_P ?4?\ N-_-:EJ)O^/J/_<;^:T 2T444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!%%_
MK)_]\?\ H(J6HHO]9/\ [X_]!%2T %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5%;?\>L/^X/Y5+45
MM_QZP_[@_E0!+1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %13_ZL?[Z?^A"I:BG_P!6/]]/_0A0!+11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% &9J_P#RQ_X%_2BC5_\ EC_P+^E% %ZU_P"/2'_KFO\
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M(KV%(XXU"JBA6   X %2?$#XK6*:?_8?@V_74O$-\RQ6[6)$BQ9/7<,J3C(
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M/_Y(^W_7:XK@O"/@B3Q7\%5O--S'KNF:A+/92(<,Q 0E,^^ 1[@>]=[\#_\
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MFBBDW=W8TK*P4444AA1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MDDG@ #O4=C?V>IVB7=A=P7=M)G9-!()$;!P<,.#R"* +%%%% !1110 4444
M%%4M0UC3-($1U+4;2R$S;(S<SK'O;T&XC)^E7: "BBB@ HJM?ZA9:7:-=ZA>
M6]I;(0&FN)5C09.!EB0.M9'_  G?@_\ Z&O0_P#P8P__ !5 '0456L=1L=4M
MQ<:?>V]W >DEO*LB_F"13=1U73M'MUN-3O[6R@9@@DN9EC4L>0,L0,\'CVH
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH *B;_CZC_P!QOYK4M1-_Q]1_[C?S6@"6BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** (HO\
M63_[X_\ 014M11?ZR?\ WQ_Z"*EH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ J*V_X]8?]P?RJ6HK
M;_CUA_W!_*@"6BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M.US0]-\2:3-I>K6HN;*;:7C+,N<$$<J01R!T-36.EV6FZ3#I=I (K*"(0QQ
MD[4 QC).3QWSFK=%'2P&3H?AK2/#>CG2=)M/L]B2S>5YCORW7EB3^M+X>\-:
M1X5TS^SM%M/LMIYAD\OS'?YCC)RQ)[#O6K11<+%35-,LM9TRXTW4;=;BSN$*
M2Q-G##ZCD?4<BJNB>'-)\.Z,-(TJT^SV(+$1>8[_ 'NO+$G]:U:*+;^8&5X>
M\-:1X5TS^SM%M/LMIYAD\OS'?YCC)RQ)[#O6K110W<$K!1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5%
M<_\ 'K-_N'^52U%<_P#'K-_N'^5 $M%%% !7A%GX2T/Q?\>O&%KKMC]K@AAC
MDC7S7CPVV,9RA!Z&O=Z^>IO#&J>*?CIXMMM+\2WF@RQ1QR/-:ALR#;&-IVNO
M'.>O:DOC7H_T!_!\U^IZ+_PI+X>?]"]_Y.W'_P <KJ5&B^"_#(4O'8:1I\6
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MFAU>/S;:X4)*@*M@X!((]P371_#^QM]>^,/C?6]1C2>ZT^Z%M:^9\WE*"RY
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M5W?[0Y!^'UD1R/[3B_\ 0)*I7?(WO=+[FOS5F.%E-I>;^]/\G<Z/QE\4=$\
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MVD[CW$+<#IC)Y![DT/XK>2_$%\-_,]S\*>,]$\::<U[HMUYHC(66)UVR1$]
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M HHHH **** "BBB@ HHHH **** "BBB@"*?_ %8_WT_]"%2U%/\ ZL?[Z?\
MH0J6@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "HF_X^H_]QOYK4M1-_Q]1_[C?S6@"6BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** (HO]9/_ +X_]!%2U%%_K)_]\?\ H(J6@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "HK;
M_CUA_P!P?RJ6HK;_ (]8?]P?RH EHHHH **** "BBB@ HHHH **** "BBB@
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M0^R]*]6?YP,GW#5LM>^,/BMXJU>UT/7Y= \.Z7,8!<6X/FS2#OE2I.<$XW
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M1@T?2+S4KDX@M(7F?Z*"?Z5X)X8!\+:Q\./$: K:ZO9?V9=D#C<6^0G\2O\
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M^B**\A^*&M:IIWP7T:_LM2O+:\D^R[[B&=DD;,9)RP.3D]:I3^#/B9KNB?\
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MD5NTNH7=TS -&HR53<B]2,8&[KV&36S;6-W?_LOQ6EG:SW%S)9?NX88R[O\
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MM+6Z*WXW*;O>_7_*QYEX9UCXB^+/$]M?7NFMX9\.P*3):S(KS7+=E)==RCW
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M4 %%%% !1110 4444 %%%% $4_\ JQ_OI_Z$*EJ*?_5C_?3_ -"%2T %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 5$W_'U'_N-_-:EJ)O^/J/_ '&_FM $M%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M11?ZR?\ WQ_Z"*EJ*+_63_[X_P#014M !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %16W_ !ZP_P"X
M/Y5+45M_QZP_[@_E0!+1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %13_P"K'^^G_H0J6HI_]6/]]/\
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MEJ*Y_P"/6;_</\J ):*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH *YKQ%X/T_Q9)']OFNH_LSML\AE&=RIG
M.5/]T5TM11?ZR?\ WQ_Z"*:=M@:N<'_PI[P__P _FI_]_8__ (BC_A3WA_\
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M?_Y_-3_[^Q__ !%'_"GO#_\ S^:G_P!_8_\ XBO0:*.>7<.5=CS[_A3WA_\
MY_-3_P"_L?\ \11_PI[P_P#\_FI_]_8__B*]!HHYY=PY5V//O^%/>'_^?S4_
M^_L?_P 11_PI[P__ ,_FI_\ ?V/_ .(KT&BCGEW#E78\^_X4]X?_ .?S4_\
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MHH **** "BBB@ HHHH **** "HI_]6/]]/\ T(5+44_^K'^^G_H0H EHHHH
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MBB@ HHHH **** "BBB@ HHHH BMO^/6'_<'\JEJ*V_X]8?\ <'\JEH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@"*?_5C_ 'T_]"%2U%/_ *L?[Z?^A"I: "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *B;_
M (^H_P#<;^:U+43?\?4?^XW\UH EHHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@"*+_63_[X_P#0
M14M11?ZR?_?'_H(J6@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "HK;_CUA_W!_*I:BMO^/6'_ '!_
M*@"6BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH *BG_U8_P!]/_0A4M13_P"K'^^G_H0H EHHHH ****
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M:_\ S[R?FO\ C0!+147FO_S[R?FO^-'FO_S[R?FO^- $M%1>:_\ S[R?FO\
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M:_\ S[R?FO\ C0!+147FO_S[R?FO^-'FO_S[R?FO^- $M%1>:_\ S[R?FO\
MC1YK_P#/O)^:_P"- $M%1>:__/O)^:_XT>:__/O)^:_XT 2T5%YK_P#/O)^:
M_P"-'FO_ ,^\GYK_ (T 2T5%YK_\^\GYK_C1YK_\^\GYK_C0!+147FO_ ,^\
MGYK_ (T>:_\ S[R?FO\ C0!+147FO_S[R?FO^-'FO_S[R?FO^- $M%1>:_\
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M)^:_XT 2T5%YK_\ /O)^:_XT>:__ #[R?FO^- $M%1>:_P#S[R?FO^-'FO\
M\^\GYK_C0!+147FO_P ^\GYK_C1YK_\ /O)^:_XT 2T5%YK_ //O)^:_XT>:
M_P#S[R?FO^- $M%1>:__ #[R?FO^-'FO_P ^\GYK_C0!+147FO\ \^\GYK_C
M1YK_ //O)^:_XT 2T5%YK_\ /O)^:_XT>:__ #[R?FO^- $M%1>:_P#S[R?F
MO^-'FO\ \^\GYK_C0!+147FO_P ^\GYK_C1YK_\ /O)^:_XT 2T5%YK_ //O
M)^:_XT>:_P#S[R?FO^- $M%1>:__ #[R?FO^-'FO_P ^\GYK_C0!+147FO\
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M4K_>'O0!9HJ+S7_Y]Y/S7_&CS7_Y]Y/S7_&@"6BHO-?_ )]Y/S7_ !H\U_\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH *BN?^/6;_</\JEJ*Y_X]9O]P_RH EHHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ J*+_63_P"^/_014M11?ZR?_?'_ *"* ):*** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH BMO^/6
M'_<'\JEJ*V_X]8?]P?RJ6@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MB@"]:_\ 'I#_ -<U_E4M16O_ !Z0_P#7-?Y5+0 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !42_P#'
MU)_N+_-JEJ)?^/J3_<7^;4 2T444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %17
M/_'K-_N'^52U%<_\>LW^X?Y4 2T444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MY.?_ &%'_"Z?^H!_Y.?_ &%'LY=@YXGJU%>4_P#"Z?\ J ?^3G_V%'_"Z?\
MJ ?^3G_V%'LY=@YXGJU%>4_\+I_Z@'_DY_\ 84?\+I_Z@'_DY_\ 84>SEV#G
MB>K45Y3_ ,+I_P"H!_Y.?_84?\+I_P"H!_Y.?_84>SEV#GB>K45Y3_PNG_J
M?^3G_P!A1_PNG_J ?^3G_P!A1[.78.>)ZM17E/\ PNG_ *@'_DY_]A1_PNG_
M *@'_DY_]A1[.78.>)ZM17E/_"Z?^H!_Y.?_ &%'_"Z?^H!_Y.?_ &%'LY=@
MYXGJ-M_QZP_[@_E4M>31_&;RXD3^P,[5 S]L_P#L*?\ \+I_Z@'_ ).?_84>
MSEV#GB>K45Y3_P +I_Z@'_DY_P#84?\ "Z?^H!_Y.?\ V%'LY=@YXGJU%>4_
M\+I_Z@'_ ).?_84?\+I_Z@'_ ).?_84>SEV#GB>K45Y3_P +I_Z@'_DY_P#8
M4?\ "Z?^H!_Y.?\ V%'LY=@YXGJU%>4_\+I_Z@'_ ).?_84?\+I_Z@'_ ).?
M_84>SEV#GB>K45Y3_P +I_Z@'_DY_P#84?\ "Z?^H!_Y.?\ V%'LY=@YXGJU
M%>4_\+I_Z@'_ ).?_84?\+I_Z@'_ ).?_84>SEV#GB>K45Y3_P +I_Z@'_DY
M_P#84?\ "Z?^H!_Y.?\ V%'LY=@YXGJU%>4_\+I_Z@'_ ).?_84?\+I_Z@'_
M ).?_84>SEV#GB>K45Y3_P +I_Z@'_DY_P#84?\ "Z?^H!_Y.?\ V%'LY=@Y
MXGJU%>4_\+I_Z@'_ ).?_84?\+I_Z@'_ ).?_84>SEV#GB>K45Y3_P +I_Z@
M'_DY_P#84?\ "Z?^H!_Y.?\ V%'LY=@YXGJU%>4_\+I_Z@'_ ).?_84?\+I_
MZ@'_ ).?_84>SEV#GB>K45Y2/C0,C.@<=\7G_P!A7H^C:S9:]IL=_82[XGZ@
M_>1NZL.Q%)Q:W&I)[%^BBBI&13_ZL?[Z?^A"I:BG_P!6/]]/_0A4M !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %1-_P ?4?\ N-_-:EJ)O^/J/_<;^:T 2T444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M!%%_K)_]\?\ H(J6HHO]9/\ [X_]!%2T %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5%;?\>L/^X/Y
M5+45M_QZP_[@_E0!+1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %13_ZL?[Z?^A"I:BG_P!6/]]/_0A0
M!+1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% &9J_P#RQ_X%_2BC5_\ EC_P+^E% %ZU_P"/2'_K
MFO\ *I:BM?\ CTA_ZYK_ "J6@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "HE_X^I/]Q?YM4M1+_Q]
M2?[B_P VH EHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *BN?^/6;_</\JEJ*
MY_X]9O\ </\ *@"6BBB@ KP:\TWQ+XQ^,GB?1;'QKJVC6UDB2HD$TC)RJ# 4
M2*!R<U[S7SU-?>,+'XZ>+7\':59ZC=M'&)H[I@H5-L?(RZ<YQW-)?&K]G^@.
M_+IW7ZG2_P#"H/&'_16=<_*;_P"/UZ=X?TVYT?0;/3[S49=1N((]DEW-G?*?
M4Y)/ZFO-8/$'QN:XC$W@[1%B+@.PF7(7/)_X^*N?&O5M1BT72?#^F3M!<:[>
MK:M*I((3(R,CU++GVR.]-MI675V!6OKT5SO(O$N@W&HG3H=;TV2^!VFV2[0R
M9]-H.:NWE[:Z?:27=[<PVUM&,O--($11TY8\"O+=1^ ?A/\ X1B2VL([B+5H
MXLQWYG<LT@&1N7.W!/H![&L.+Q%>>(_V9]5EU"1I;NT7[))(YRS[73!)[G!
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 5$W_'U'_N-_-:EJ)O^/J/_ '&_FM $M%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 11?Z
MR?\ WQ_Z"*EJ*+_63_[X_P#014M !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %16W_ !ZP_P"X/Y5+
M45M_QZP_[@_E0!+1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %13_P"K'^^G_H0J6HI_]6/]]/\ T(4
M2T444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110!F:O_P L?^!?THHU?_EC_P "_I10!>M?^/2'_KFO
M\JEJ*U_X](?^N:_RJ6@ HHHH Q++Q=H6H>);OP[;7V[5K12TUNT3J5''()4
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M(ZC[QJ7?1(I6ZEO3_BSX%U2_6RM?$-N9W;:HECDB4GT#.H7]:[.O-/B'\/\
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M4&/<3Z?=YQCU"Z%_R<YXE_[!:?\ H,%>J6&FV.EVPM].LK:S@'(BMXEC4?@
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "MWPMXIO?"VI"XMSO@? G@)^61?Z$=C6%5_1M&O=
M>U*.PL(M\K]2?NHO=F/8"AVMJ->1]%:=K-EKVDPW]A+OB=TR#]Y&W#*L.Q%:
ME<]X>\,6?A;1UM;?YY7D1IYB.9&W#\@.PKH:Y':^ANO,****0PHHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
MB;_CZC_W&_FM2U$W_'U'_N-_-: ):*** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH BB_UD_\ OC_T
M$5+447^LG_WQ_P"@BI: "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH *BMO^/6'_ '!_*I:BMO\ CUA_
MW!_*@"6BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5%<_\>LW^X?Y5
M+45S_P >LW^X?Y4 2T444 %%%>):EK7Q(U[XI^(/#OA?Q#9V5OIZI(J74$>
MI5. WE,2<MWHZV#I<]MHKQR?3/CGIL#WG_"0Z-J/E#=]E2)-TF.P_<I_Z$*[
M#X9^.AX\\,&^E@6WOK>3R;J)#\H? .Y<\@$'H>G(YQFFE<3T.SHHHI#"BBO.
M=3\4:S;_ !ST?PY%>;=)N+!II;?RD.YP).=V-P^Z.A[4+5I=_P#*X/1-]CT:
MBBN<OK/Q5)XXTZ[L]3M8_#20E;RS91YLDF'P5.PG'*?Q#H>/4ZV#H='1110
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MWZUT=# **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M\D^,G^LTK_?G_P#08J];KR3XR?ZS2O\ ?G_]!BJZ?Q(F?PGEM%%%=)@%%%%
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M^K'^^G_H0H EHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@#,U?_ )8_\"_I11J__+'_ (%_2B@"
M]:_\>D/_ %S7^52U%:_\>D/_ %S7^52T %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5$O_ !]2?[B_
MS:I:B7_CZD_W%_FU $M%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !45S_ ,>L
MW^X?Y5+45S_QZS?[A_E0!+1110 5\]3>.]+\!?'3Q;?:I!>317$<<*"U16(.
MV,\[F7CBOH6O(O!W_)POC;_KUC_E%1&_.K=G^2"5N37NOU(9OVAM&NX7AT/0
M-:O-188AA>) &/OM9C^0J_\ "SPKXC\/^ M5N)4AM]?U61[B**ZRJQ,1A?,
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MKW2[:],.GSS*060#G /('W3CMDBKWNMORWZ?UJ1V>_Y['K->1?!;_D/>/?\
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MC32/#MA\<II_&UDTFAZO;*;>X+R(D<H55Y9"#QM(/IN4GCFCXN6^VN_>U_\
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M_/YIG_?V3_XBO;**OVLB>1'B?_"GO$'_ #^:9_W]D_\ B*/^%/>(/^?S3/\
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M]_9/_B*/^%/>(/\ G\TS_O[)_P#$5[911[60<B/$_P#A3WB#_G\TS_O[)_\
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M^R?_ !%'_"GO$'_/YIG_ ']D_P#B*]LHH]K(.1'B?_"GO$'_ #^:9_W]D_\
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M7_CZD_W%_FU2U$O_ !]2?[B_S:@"6BBB@ HHHH **** "BBB@ HHHH ****
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M*?\ U8_WT_\ 0A4M !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %1-_Q]1_[C?S6I:B;_CZC_W&_FM
M$M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 11?ZR?_ 'Q_Z"*EJ*+_ %D_^^/_ $$5+0 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !45M_QZP_[@_E4M16W_ !ZP_P"X/Y4 2T444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !44_^
MK'^^G_H0J6HI_P#5C_?3_P!"% $M%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 9FK_\L?\ @7]*
M*-7_ .6/_ OZ44 7K7_CTA_ZYK_*I:BM?^/2'_KFO\JEH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M J)?^/J3_<7^;5+42_\ 'U)_N+_-J ):*** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "HKG_CUF_P!P_P JEJ*Y_P"/6;_</\J ):*** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *BB_P!9/_OC
M_P!!%2U%%_K)_P#?'_H(H EHHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@"*V_X]8?\ <'\JEJ*V
M_P"/6'_<'\JEH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@"*?_ %8_WT_]"%2U%/\ ZL?[Z?\ H0J6
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "HF_X^H_]QOYK4M1-_Q]1_[C?S6@"6BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** (HO]9/_ +X_]!%2U%%_K)_]\?\ H(J6@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "HK;_CUA
M_P!P?RJ6HK;_ (]8?]P?RH EHHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "HI_\ 5C_?3_T(5+44_P#J
MQ_OI_P"A"@"6BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** ,S5_^6/\ P+^E%&K_ /+'_@7]** +
M-LTWV6'$<9&Q<9<^GTJ7=/\ \\X_^_A_PHM?^/2'_KFO\JEH BW3_P#/./\
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M_P \X_\ OX?\*EHH BW3_P#/./\ [^'_  HW3_\ /./_ +^'_"I:* (MT_\
MSSC_ ._A_P *-T__ #SC_P"_A_PJ6B@"+=/_ ,\X_P#OX?\ "HU:;[2_[N/.
MQ?XSZGVJS42_\?4G^XO\VH -T_\ SSC_ ._A_P *-T__ #SC_P"_A_PJ6B@"
M+=/_ ,\X_P#OX?\ "C=/_P \X_\ OX?\*EHH BW3_P#/./\ [^'_  HW3_\
M/./_ +^'_"I:* (MT_\ SSC_ ._A_P *-T__ #SC_P"_A_PJ6B@"+=/_ ,\X
M_P#OX?\ "C=/_P \X_\ OX?\*EHH BW3_P#/./\ [^'_  HW3_\ /./_ +^'
M_"I:* (MT_\ SSC_ ._A_P *-T__ #SC_P"_A_PJ6B@"+=/_ ,\X_P#OX?\
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M_P"_A_PJ6B@"+=/_ ,\X_P#OX?\ "C=/_P \X_\ OX?\*EHH BW3_P#/./\
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M_P \X_\ OX?\*EHH BW3_P#/./\ [^'_  HW3_\ /./_ +^'_"I:* (MT_\
MSSC_ ._A_P *-T__ #SC_P"_A_PJ6B@"+=/_ ,\X_P#OX?\ "C=/_P \X_\
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M'_W\/^%&Z?\ YYQ_]_#_ (5+10!%NG_YYQ_]_#_A1NG_ .><?_?P_P"%2T4
M1;I_^><?_?P_X4;I_P#GG'_W\/\ A4M% $6Z?_GG'_W\/^%&Z?\ YYQ_]_#_
M (5+10!%NG_YYQ_]_#_A1NG_ .><?_?P_P"%2T4 1;I_^><?_?P_X4;I_P#G
MG'_W\/\ A4M% $6Z?_GG'_W\/^%&Z?\ YYQ_]_#_ (5+10!%NG_YYQ_]_#_A
M1NG_ .><?_?P_P"%2T4 1;I_^><?_?P_X4;I_P#GG'_W\/\ A4M% $6Z?_GG
M'_W\/^%&Z?\ YYQ_]_#_ (5+10!%NG_YYQ_]_#_A1NG_ .><?_?P_P"%2T4
M1;I_^><?_?P_X4;I_P#GG'_W\/\ A4M% $6Z?_GG'_W\/^%&Z?\ YYQ_]_#_
M (5+10!%NG_YYQ_]_#_A1NG_ .><?_?P_P"%2T4 1;I_^><?_?P_X4;I_P#G
MG'_W\/\ A4M% $6Z?_GG'_W\/^%&Z?\ YYQ_]_#_ (5+10!%NG_YYQ_]_#_A
M1NG_ .><?_?P_P"%2T4 1;I_^><?_?P_X4;I_P#GG'_W\/\ A4M% $6Z?_GG
M'_W\/^%&Z?\ YYQ_]_#_ (5+10!%NG_YYQ_]_#_A1NG_ .><?_?P_P"%2T4
M1;I_^><?_?P_X4;I_P#GG'_W\/\ A4M% $6Z?_GG'_W\/^%&Z?\ YYQ_]_#_
M (5+10!%NG_YYQ_]_#_A1NG_ .><?_?P_P"%2T4 1;I_^><?_?P_X4;I_P#G
MG'_W\/\ A4M% $6Z?_GG'_W\/^%&Z?\ YYQ_]_#_ (5+10!%NG_YYQ_]_#_A
M1NG_ .><?_?P_P"%2T4 1;I_^><?_?P_X4;I_P#GG'_W\/\ A4M% $6Z?_GG
M'_W\/^%&Z?\ YYQ_]_#_ (5+10!%NG_YYQ_]_#_A1NG_ .><?_?P_P"%2T4
M1;I_^><?_?P_X4;I_P#GG'_W\/\ A4M% $6Z?_GG'_W\/^%&Z?\ YYQ_]_#_
M (5+10!%NG_YYQ_]_#_A4<;3>9-B./[_ #\Y_NCVJS447^LG_P!\?^@B@ W3
M_P#/./\ [^'_  HW3_\ /./_ +^'_"I:* (MT_\ SSC_ ._A_P *-T__ #SC
M_P"_A_PJ6B@"+=/_ ,\X_P#OX?\ "C=/_P \X_\ OX?\*EHH BW3_P#/./\
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MSC_[^'_"C=/_ ,\X_P#OX?\ "I:* (MT_P#SSC_[^'_"C=/_ ,\X_P#OX?\
M"I:* (MT_P#SSC_[^'_"C=/_ ,\X_P#OX?\ "I:* (MT_P#SSC_[^'_"C=/_
M ,\X_P#OX?\ "I:* (MT_P#SSC_[^'_"C=/_ ,\X_P#OX?\ "I:* (MT_P#S
MSC_[^'_"C=/_ ,\X_P#OX?\ "I:* (MT_P#SSC_[^'_"C=/_ ,\X_P#OX?\
M"I:* (MT_P#SSC_[^'_"C=/_ ,\X_P#OX?\ "I:* (MT_P#SSC_[^'_"C=/_
M ,\X_P#OX?\ "I:* (MT_P#SSC_[^'_"C=/_ ,\X_P#OX?\ "I:* (MT_P#S
MSC_[^'_"C=/_ ,\X_P#OX?\ "I:* (MT_P#SSC_[^'_"C=/_ ,\X_P#OX?\
M"I:* (MT_P#SSC_[^'_"HV:;[2G[N/.QOXSZCVJS43?\?4?^XW\UH -T_P#S
MSC_[^'_"C=/_ ,\X_P#OX?\ "I:* (MT_P#SSC_[^'_"C=/_ ,\X_P#OX?\
M"I:* (MT_P#SSC_[^'_"C=/_ ,\X_P#OX?\ "I:* (MT_P#SSC_[^'_"C=/_
M ,\X_P#OX?\ "I:* (MT_P#SSC_[^'_"C=/_ ,\X_P#OX?\ "I:* (MT_P#S
MSC_[^'_"C=/_ ,\X_P#OX?\ "I:* (MT_P#SSC_[^'_"C=/_ ,\X_P#OX?\
M"I:* (MT_P#SSC_[^'_"C=/_ ,\X_P#OX?\ "I:* (MT_P#SSC_[^'_"C=/_
M ,\X_P#OX?\ "I:* (MT_P#SSC_[^'_"C=/_ ,\X_P#OX?\ "I:* (MT_P#S
MSC_[^'_"C=/_ ,\X_P#OX?\ "I:* (MT_P#SSC_[^'_"C=/_ ,\X_P#OX?\
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M%&Z?_GG'_P!_#_A4M% $6Z?_ )YQ_P#?P_X4;I_^><?_ '\/^%2T4 1;I_\
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M% $6Z?\ YYQ_]_#_ (4;I_\ GG'_ -_#_A4M% $6Z?\ YYQ_]_#_ (4;I_\
MGG'_ -_#_A4M% $6Z?\ YYQ_]_#_ (4;I_\ GG'_ -_#_A4M% $6Z?\ YYQ_
M]_#_ (4;I_\ GG'_ -_#_A4M% $6Z?\ YYQ_]_#_ (4;I_\ GG'_ -_#_A4M
M% $6Z?\ YYQ_]_#_ (4;I_\ GG'_ -_#_A4M% $6Z?\ YYQ_]_#_ (4;I_\
MGG'_ -_#_A4M% $6Z?\ YYQ_]_#_ (4;I_\ GG'_ -_#_A4M% $6Z?\ YYQ_
M]_#_ (4;I_\ GG'_ -_#_A4M% $6Z?\ YYQ_]_#_ (4;I_\ GG'_ -_#_A4M
M% $6Z?\ YYQ_]_#_ (4;I_\ GG'_ -_#_A4M% $6Z?\ YYQ_]_#_ (4;I_\
MGG'_ -_#_A4M% $6Z?\ YYQ_]_#_ (4;I_\ GG'_ -_#_A4M% &5JAD/E;U5
M>N-K9]/844[5_P#EC_P+^E% %ZU_X](?^N:_RJ6HK7_CTA_ZYK_*I: "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH *B7_CZD_W%_FU2U$O_ !]2?[B_S:@"6BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ J*Y_X]9O\ </\ *I:BN?\ CUF_W#_*@"6BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "H
MHO\ 63_[X_\ 014M11?ZR?\ WQ_Z"* ):*** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH BMO^/6'_
M '!_*I:BMO\ CUA_W!_*I: "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH BG_P!6/]]/_0A4M13_ .K'
M^^G_ *$*EH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ J)O^/J/_<;^:U+43?\?4?^XW\UH EHHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@"*+_63_P"^/_014M11?ZR?_?'_ *"*EH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ J*V_X]8?\ <'\JEJ*V_P"/6'_<'\J ):*** "BBB@ HHHH **** "BBB@
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M)7'_ ,;K%^*I#>/OAN1T.I,1_P!]15W/_"">$/\ H5-#_P#!=%_\37#_ !5
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M@9?"7B+3+#3/M+CR;F-6;?A<GF%^.G>OHZ^_Y!]S_P!<F_D:\Q_9[_Y)H?\
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MO#^MVWB/0;/6+-)4M[N/S(UF #@>X!(_6JMU%?H:5%%%(84444 %%%<YXO\
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MA +NS' "@D GJ>O0&DW;<:5]C;HK(\,^([#Q9X?MM9TTR?9K@'"R !T()!#
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M@D'YF Q\I[U5@6NB.BHI%8,H8=",TM($[A1110 4444 %%%% !1110 4444
M%%%% !7G/Q<_Y%:/_L))_P"B6KT:O.?BY_R*T?\ V$D_]$M50^)$RV9XQ111
M748!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% &EH>N
M7WA_4X[ZQDVR+PRG[LB]U8=Q7T#X9\36/B?3!=VC;9%P)H&/S1MZ>X]#WKYL
MK2T/7+[P_J<=]8R;9%X93]V1>ZL.XJ)PYBHRL?3=%8OAGQ-8^)],%W:-MD7
MF@8_-&WI[CT/>MJN9JQN%%%% !1110 4444 %%%% !1110 4444 13_ZL?[Z
M?^A"I:BG_P!6/]]/_0A4M !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %1-_P ?4?\ N-_-:EJ)O^/J
M/_<;^:T 2T444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110!%%_K)_]\?\ H(J6HHO]9/\ [X_]!%2T
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 5%;?\>L/^X/Y5+45M_QZP_[@_E0!+1110 4444 %%%%
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M'7Q T_Q;XDT@Z)IFE(WV*RD.96=AC+9 /OD@=  .IKUZBB.EO():W\PHHHH
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M*3*\A]E2<GN!T[BO6_%/BO3O!GAB35]1?Y$4+%$#\TTA'"+[G]!D]JXOX?\
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M "BBB@"*+_63_P"^/_014M11?ZR?_?'_ *"*EH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ J*V_X]
M8?\ <'\JEJ*V_P"/6'_<'\J ):*** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ J*?_ %8_WT_]"%2U%/\
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M::3I\?EVMK&(XP3DGU)/<DY)]S5^BJN%M0HHHI %%%% !1110 4444 %%%%
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M0PHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M5_\ EC_P+^E% %ZU_P"/2'_KFO\ *I:BM?\ CTA_ZYK_ "J6@ HHHH ****
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M9/\ PB_A_P#Z 6F?^ D?^%'_  B_A_\ Z 6F?^ D?^%:U%%V%D9/_"+^'_\
MH!:9_P" D?\ A1_PB_A__H!:9_X"1_X5K447861D_P#"+^'_ /H!:9_X"1_X
M4?\ "+^'_P#H!:9_X"1_X5K447861D_\(OX?_P"@%IG_ ("1_P"%'_"+^'_^
M@%IG_@)'_A6M11=A9&3_ ,(OX?\ ^@%IG_@)'_A1_P (OX?_ .@%IG_@)'_A
M6M11=A9&3_PB_A__ * 6F?\ @)'_ (4?\(OX?_Z 6F?^ D?^%:U%%V%D9/\
MPB_A_P#Z 6F?^ D?^%'_  B_A_\ Z 6F?^ D?^%:U%%V%D9/_"+^'_\ H!:9
M_P" D?\ A1_PB_A__H!:9_X"1_X5K447861D_P#"+^'_ /H!:9_X"1_X4?\
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M** "BBB@ HHHH **** "BBB@ J*Y_P"/6;_</\JEJ*Y_X]9O]P_RH EHHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ J*+_63_[X_P#014M11?ZR?_?'_H(H EHHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@"*V
M_P"/6'_<'\JEJ*V_X]8?]P?RJ6@ HHHH **** "BBB@ HHHH **** "BBB@
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M6V?_ )Z1_P#?L_XT;9_^>D?_ '[/^- $M%1;9_\ GI'_ -^S_C1MG_YZ1_\
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M6V?_ )Z1_P#?L_XT;9_^>D?_ '[/^- $M%1;9_\ GI'_ -^S_C1MG_YZ1_\
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M>D?_ '[/^- $M%1;9_\ GI'_ -^S_C1MG_YZ1_\ ?L_XT 2T5%MG_P">D?\
MW[/^-&V?_GI'_P!^S_C0!+146V?_ )Z1_P#?L_XT;9_^>D?_ '[/^- $M%1;
M9_\ GI'_ -^S_C1MG_YZ1_\ ?L_XT 2T5%MG_P">D?\ W[/^-&V?_GI'_P!^
MS_C0!+146V?_ )Z1_P#?L_XT;9_^>D?_ '[/^- $M%1;9_\ GI'_ -^S_C1M
MG_YZ1_\ ?L_XT 2T5%MG_P">D?\ W[/^-&V?_GI'_P!^S_C0!+146V?_ )Z1
M_P#?L_XT;9_^>D?_ '[/^- $M%1;9_\ GI'_ -^S_C1MG_YZ1_\ ?L_XT 2T
M5%MG_P">D?\ W[/^-&V?_GI'_P!^S_C0!+146V?_ )Z1_P#?L_XT;9_^>D?_
M '[/^- $M17/_'K-_N'^5&V?_GI'_P!^S_C4=PLWV:7,D9&PYPA]/K0!9HJ+
M;/\ \](_^_9_QHVS_P#/2/\ []G_ !H EHJ+;/\ \](_^_9_QHVS_P#/2/\
M[]G_ !H EHJ+;/\ \](_^_9_QHVS_P#/2/\ []G_ !H EHJ+;/\ \](_^_9_
MQHVS_P#/2/\ []G_ !H EHJ+;/\ \](_^_9_QHVS_P#/2/\ []G_ !H EHJ+
M;/\ \](_^_9_QHVS_P#/2/\ []G_ !H EHJ+;/\ \](_^_9_QHVS_P#/2/\
M[]G_ !H EHJ+;/\ \](_^_9_QHVS_P#/2/\ []G_ !H EHJ+;/\ \](_^_9_
MQHVS_P#/2/\ []G_ !H EHJ+;/\ \](_^_9_QHVS_P#/2/\ []G_ !H EHJ+
M;/\ \](_^_9_QHVS_P#/2/\ []G_ !H EHJ+;/\ \](_^_9_QHVS_P#/2/\
M[]G_ !H EHJ+;/\ \](_^_9_QHVS_P#/2/\ []G_ !H EHJ+;/\ \](_^_9_
MQHVS_P#/2/\ []G_ !H EHJ+;/\ \](_^_9_QHVS_P#/2/\ []G_ !H EHJ+
M;/\ \](_^_9_QHVS_P#/2/\ []G_ !H EHJ+;/\ \](_^_9_QHVS_P#/2/\
M[]G_ !H EHJ+;/\ \](_^_9_QHVS_P#/2/\ []G_ !H EHJ+;/\ \](_^_9_
MQHVS_P#/2/\ []G_ !H EHJ+;/\ \](_^_9_QHVS_P#/2/\ []G_ !H EHJ+
M;/\ \](_^_9_QHVS_P#/2/\ []G_ !H EHJ+;/\ \](_^_9_QHVS_P#/2/\
M[]G_ !H EHJ+;/\ \](_^_9_QHVS_P#/2/\ []G_ !H EHJ+;/\ \](_^_9_
MQHVS_P#/2/\ []G_ !H EHJ+;/\ \](_^_9_QHVS_P#/2/\ []G_ !H EHJ+
M;/\ \](_^_9_QHVS_P#/2/\ []G_ !H EHJ+;/\ \](_^_9_QHVS_P#/2/\
M[]G_ !H EHJ+;/\ \](_^_9_QHVS_P#/2/\ []G_ !H EHJ+;/\ \](_^_9_
MQHVS_P#/2/\ []G_ !H EHJ+;/\ \](_^_9_QHVS_P#/2/\ []G_ !H EHJ+
M;/\ \](_^_9_QHVS_P#/2/\ []G_ !H EHJ+;/\ \](_^_9_QHVS_P#/2/\
M[]G_ !H EHJ+;/\ \](_^_9_QHVS_P#/2/\ []G_ !H EHJ+;/\ \](_^_9_
MQHVS_P#/2/\ []G_ !H EHJ+;/\ \](_^_9_QHVS_P#/2/\ []G_ !H EHJ+
M;/\ \](_^_9_QHVS_P#/2/\ []G_ !H EJ*+_63_ .^/_011MG_YZ1_]^S_C
M4<:S>9-B2/[_ #\A_NCWH LT5%MG_P">D?\ W[/^-&V?_GI'_P!^S_C0!+14
M6V?_ )Z1_P#?L_XT;9_^>D?_ '[/^- $M%1;9_\ GI'_ -^S_C1MG_YZ1_\
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M;/\ \](_^_9_QHVS_P#/2/\ []G_ !H EHJ+;/\ \](_^_9_QHVS_P#/2/\
M[]G_ !H EHJ+;/\ \](_^_9_QHVS_P#/2/\ []G_ !H EHJ+;/\ \](_^_9_
MQHVS_P#/2/\ []G_ !H EHJ+;/\ \](_^_9_QHVS_P#/2/\ []G_ !H EHJ+
M;/\ \](_^_9_QHVS_P#/2/\ []G_ !H EHJ+;/\ \](_^_9_QHVS_P#/2/\
M[]G_ !H EHJ+;/\ \](_^_9_QHVS_P#/2/\ []G_ !H EHJ+;/\ \](_^_9_
MQHVS_P#/2/\ []G_ !H EHJ+;/\ \](_^_9_QHVS_P#/2/\ []G_ !H EHJ+
M;/\ \](_^_9_QHVS_P#/2/\ []G_ !H EHJ+;/\ \](_^_9_QHVS_P#/2/\
M[]G_ !H EHJ+;/\ \](_^_9_QHVS_P#/2/\ []G_ !H EHJ+;/\ \](_^_9_
MQHVS_P#/2/\ []G_ !H )_\ 5C_?3_T(5+5:=9O+&9(_OKT0_P!X>]2;9_\
MGI'_ -^S_C0!+146V?\ YZ1_]^S_ (T;9_\ GI'_ -^S_C0!+146V?\ YZ1_
M]^S_ (T;9_\ GI'_ -^S_C0!+146V?\ YZ1_]^S_ (T;9_\ GI'_ -^S_C0!
M+146V?\ YZ1_]^S_ (T;9_\ GI'_ -^S_C0!+146V?\ YZ1_]^S_ (T;9_\
MGI'_ -^S_C0!+146V?\ YZ1_]^S_ (T;9_\ GI'_ -^S_C0!+146V?\ YZ1_
M]^S_ (T;9_\ GI'_ -^S_C0!+146V?\ YZ1_]^S_ (T;9_\ GI'_ -^S_C0!
M+146V?\ YZ1_]^S_ (T;9_\ GI'_ -^S_C0!+146V?\ YZ1_]^S_ (T;9_\
MGI'_ -^S_C0!+146V?\ YZ1_]^S_ (T;9_\ GI'_ -^S_C0!+146V?\ YZ1_
M]^S_ (T;9_\ GI'_ -^S_C0!+146V?\ YZ1_]^S_ (T;9_\ GI'_ -^S_C0!
M+146V?\ YZ1_]^S_ (T;9_\ GI'_ -^S_C0!+43?\?4?^XW\UHVS_P#/2/\
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M+146V?\ YZ1_]^S_ (T;9_\ GI'_ -^S_C0!+146V?\ YZ1_]^S_ (T;9_\
MGI'_ -^S_C0!+146V?\ YZ1_]^S_ (T;9_\ GI'_ -^S_C0!+146V?\ YZ1_
M]^S_ (T;9_\ GI'_ -^S_C0!+146V?\ YZ1_]^S_ (T;9_\ GI'_ -^S_C0!
M+146V?\ YZ1_]^S_ (T;9_\ GI'_ -^S_C0!+146V?\ YZ1_]^S_ (T;9_\
MGI'_ -^S_C0!+146V?\ YZ1_]^S_ (T;9_\ GI'_ -^S_C0!+146V?\ YZ1_
M]^S_ (T;9_\ GI'_ -^S_C0!+146V?\ YZ1_]^S_ (T;9_\ GI'_ -^S_C0!
M+146V?\ YZ1_]^S_ (T;9_\ GI'_ -^S_C0!+146V?\ YZ1_]^S_ (T;9_\
MGI'_ -^S_C0!+44_^K'^^G_H0HVS_P#/2/\ []G_ !J.=9O+&9(_OKT0_P!X
M>] %FBHML_\ STC_ ._9_P :-L__ #TC_P"_9_QH EHJ+;/_ ,](_P#OV?\
M&C;/_P ](_\ OV?\: ):*BVS_P#/2/\ []G_ !HVS_\ /2/_ +]G_&@"6BHM
ML_\ STC_ ._9_P :-L__ #TC_P"_9_QH EHJ+;/_ ,](_P#OV?\ &C;/_P ]
M(_\ OV?\: ):*BVS_P#/2/\ []G_ !HVS_\ /2/_ +]G_&@"6BHML_\ STC_
M ._9_P :-L__ #TC_P"_9_QH EHJ+;/_ ,](_P#OV?\ &C;/_P ](_\ OV?\
M: ):*BVS_P#/2/\ []G_ !HVS_\ /2/_ +]G_&@"6BHML_\ STC_ ._9_P :
M-L__ #TC_P"_9_QH EHJ+;/_ ,](_P#OV?\ &C;/_P ](_\ OV?\: ):*BVS
M_P#/2/\ []G_ !HVS_\ /2/_ +]G_&@"6BHML_\ STC_ ._9_P :-L__ #TC
M_P"_9_QH EHJ+;/_ ,](_P#OV?\ &C;/_P ](_\ OV?\: ):*BVS_P#/2/\
M[]G_ !HVS_\ /2/_ +]G_&@"CJ__ "Q_X%_2BFZH)!Y6]E;KC:N/3W-% &A:
M_P#'I#_US7^52U%:_P#'I#_US7^52T %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5$O_'U)_N+_-JE
MJ)?^/J3_ '%_FU $M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !45S_QZS?[A
M_E4M17/_ !ZS?[A_E0!+1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !447^LG_WQ_Z"*EJ*+_63_P"^/_01
M0!+1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% $5M_QZP_[@_E4M16W_ !ZP_P"X/Y5+0 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% $4_^K'^^G_H0J6HI_P#5C_?3_P!"%2T %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5$W_'
MU'_N-_-:EJ)O^/J/_<;^:T 2T444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!%%_K)_\ ?'_H(J6H
MHO\ 63_[X_\ 014M !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %16W_'K#_N#^52U%;?\ 'K#_ +@_
ME0!+1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %13_ZL?[Z?^A"I:BG_ -6/]]/_ $(4 2T444 %%%%
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M10!>M?\ CTA_ZYK_ "J6HK7_ (](?^N:_P JEH **** "BBB@ HHHH ****
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M5G%2ZV_%7">BE;I?\-#O_$GQ&T#PGX@M-(UAYX&N8'N!<[5,2*H;ACG=D[<
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MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ KR3XR?ZS2O]^?\
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MP!^[M&WKZFN+^%$3^*?&GB?Q]<9:.:=K*QSVB&#G_OD(/^^JL^#/^2\^._\
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M& R/>O4**=[/3M;\;AT^=PKR_P",^E:CJD'AD:?875X8=52246\+2;%Q]YL
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MM"GL=/LDME98ID0W%Z54;GP490&8' RO'X&DT/QYX_\ B1HL4/A6"QTNYM4
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M "BBB@ HHHH BB_UD_\ OC_T$5+447^LG_WQ_P"@BI: "BBB@ HHHH ****
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M;Y_\&S^1UG@KP\GA;P=I>CJ!OMX1YI'>0_,Y_P"^B:X;P9_R7GQW_P!<8/\
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M^78!DG/IBO /#L,D?[,7B&1E*QS7#O$#_=WQC^8/Y5U"_ >:14T^\\<:Q<:
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MV+-&5).Y6$BXY/:L_P#X5!XP_P"BLZY^4W_Q^B+W?7]/^#U^XBWNJ/33[_\
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M"DH1NJ[@#@_G7E]G\$WNKR&7Q9XQU?Q#;P.)([:=F5,CUW.YQ],5ZPJA5"J
M !@ =JKIJ3;70\Y^.O\ R2?4O^NL'_HQ:['PO_R*6B_]>$'_ *+6J/CKPI_P
MFOA.YT/[;]C\]T;SO*\S;M8-]W(]/6N!B^#?BR"%(8?BMK4<4:A41$E 4#@
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M5=/XD3/X3RVBBBNDP"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M "HI_P#5C_?3_P!"%2U%/_JQ_OI_Z$* ):*** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH S-7_P"6
M/_ OZ44:O_RQ_P"!?THH O6O_'I#_P!<U_E4M16O_'I#_P!<U_E4M !1110
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M^A"I: "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH *B;_CZC_P!QOYK4M1-_Q]1_[C?S6@"6BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** (HO\ 63_[X_\ 014M11?ZR?\ WQ_Z"*EH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MJ*V_X]8?]P?RJ6HK;_CUA_W!_*@"6BBB@ HHHH **** "BBB@ HHHH ****
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MG^XO\VJ6HE_X^I/]Q?YM0!+1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5%<_
M\>LW^X?Y5+45S_QZS?[A_E0!+1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !447^LG_ -\?^@BI:BB_UD_^
M^/\ T$4 2T444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110!%;?\>L/^X/Y5+45M_QZP_[@_E4M !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 13_ZL?[Z?^A"I:BG_P!6/]]/_0A4M !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %1-
M_P ?4?\ N-_-:EJ)O^/J/_<;^:T 2T444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!%%_K)_]\?\
MH(J6HHO]9/\ [X_]!%2T %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 5%;?\>L/^X/Y5+45M_QZP_[@
M_E0!+1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %13_ZL?[Z?^A"I:BG_P!6/]]/_0A0!+1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% &9J_P#RQ_X%_2BC5_\ EC_P+^E% %ZU_P"/2'_KFO\ *I:BM?\
MCTA_ZYK_ "J6@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "HE_X^I/]Q?YM4M1+_Q]2?[B_P VH EH
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH *BN?^/6;_</\JEJ*Y_X]9O\ </\
M*@"6BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "HHO]9/\ [X_]!%2U%%_K)_\ ?'_H(H EHHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@"*V_X]8?]P?RJ6HK;_CUA_P!P?RJ6@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** (I_]6/\
M?3_T(5+44_\ JQ_OI_Z$*EH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ J)O\ CZC_ -QOYK4M1-_Q
M]1_[C?S6@"6BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** (HO]9/_OC_ -!%2U%%_K)_]\?^@BI:
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M@]K/N:O_  D6H?WT_P"^*/\ A(M0_OI_WQ6511[&'8/:S[FK_P )%J']]/\
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MWQ6511[&'8/:S[FK_P )%J']]/\ OBC_ (2+4/[Z?]\5E44>QAV#VL^YJ_\
M"1:A_?3_ +XH_P"$BU#^^G_?%95%'L8=@]K/N:O_  D6H?WT_P"^*/\ A(M0
M_OI_WQ6511[&'8/:S[FK_P )%J']]/\ OBC_ (2+4/[Z?]\5E44>QAV#VL^Y
MJ_\ "1:A_?3_ +XH_P"$BU#^^G_?%95%'L8=@]K/N:O_  D6H?WT_P"^*1O$
M%^ZE69"",$;*RZ*/8P[![6?<U?\ A(M0_OI_WQ1_PD6H?WT_[XK*HH]C#L'M
M9]S5_P"$BU#^^G_?%'_"1:A_?3_OBLJBCV,.P>UGW-7_ (2+4/[Z?]\4?\)%
MJ']]/^^*RJ*/8P[![6?<U?\ A(M0_OI_WQ1_PD6H?WT_[XK*HH]C#L'M9]S5
M_P"$BU#^^G_?%'_"1:A_?3_OBLJBCV,.P>UGW-7_ (2+4/[Z?]\4?\)%J']]
M/^^*RJ*/8P[![6?<U?\ A(M0_OI_WQ1_PD6H?WT_[XK*HH]C#L'M9]S5_P"$
MBU#^^G_?%'_"1:A_?3_OBLJBCV,.P>UGW-7_ (2+4/[Z?]\4?\)%J']]/^^*
MRJ*/8P[![6?<U?\ A(M0_OI_WQ1_PD6H?WT_[XK*HH]C#L'M9]S5_P"$BU#^
M^G_?%'_"1:A_?3_OBLJBCV,.P>UGW-7_ (2+4/[Z?]\4?\)%J']]/^^*RJ*/
M8P[![6?<U?\ A(M0_OI_WQ1_PD6H?WT_[XK*HH]C#L'M9]S5_P"$BU#^^G_?
M%'_"1:A_?3_OBLJBCV,.P>UGW-7_ (2+4/[Z?]\4?\)%J']]/^^*RJ*/8P[!
M[6?<U?\ A(M0_OI_WQ1_PD6H?WT_[XK*HH]C#L'M9]S5_P"$BU#^^G_?%'_"
M1:A_?3_OBLJBCV,.P>UGW-7_ (2+4/[Z?]\4?\)%J']]/^^*RJ*/8P[![6?<
MU?\ A(M0_OI_WQ1_PD6H?WT_[XK*HH]C#L'M9]S5_P"$BU#^^G_?%'_"1:A_
M?3_OBLJBCV,.P>UGW-7_ (2+4/[Z?]\4?\)%J']]/^^*RJ*/8P[![6?<U?\
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MJ_\ "1:A_?3_ +XH_P"$BU#^^G_?%95%'L8=@]K/N:O_  D6H?WT_P"^*/\
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MOI_WQ6511[&'8/:S[FK_ ,)%J']]/^^*/^$BU#^^G_?%95%'L8=@]K/N:O\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MSSL;D?KNI46HSE!/3=?J55O**F]_ZL=%XC\<Z'X7D$-].[W)&[[/ NY\>IY
M'XD56\/_ !&\/^(KQ;.WEFM[I_N17*!2_P!""1GVSFN$^'ZIK?Q0U6_OPLTT
M8EECWC.UMX4$?0<"O1=2\#Z)JVOQ:S=0R?:HPO\ JY"@8J<ACMP2>G.>PITY
M3FHSZ/\ (4XPBW'JOS/-?BQXL:\U :'9RW44=JS+=(<*DK<%>AR0.>N*[.V\
M7:#XA\#:C/<V=Y)I]G&L=S$P"L_ ^[M?^HKEOC=_Q^Z-_P!<Y?YK7;^,O^29
MW_\ UYI_[+6*<E&HWK_7]:&C2;@D/\ W.A77A]Y/#UE/:67GL#'.Q+;\#)Y9
MN.G>J>K_ !3\-:1>/:^9<7DB':YM4#*I],D@'\,URW@^\FL/@UK5S;L4E224
M*PZ@E4&?UK2^#-A;+X<O+T1H;F2Y,3/CD*%4A?IR36W-*4E".FB9GRQ2<GWL
M=CX=\6:1XHA=]-N"SQX\R&1=KIGU'I[C(JE9^.]+O?%DGAR."\%Y&[H79%\O
M*@D\[L]O2I='\$:)H>L3ZI90RI<REO\ EH0B!CDJ%&!CV.:\XT#_ )+K=_\
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M%#;-&IB,?W=F.,>V*UIRYE>]S.I'E>UB:BBBK,PHHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MD^X<D>QD_P#".V'I)_WW1_PCMAZ2?]]UK44>TGW#DCV,G_A';#TD_P"^Z/\
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M$=L/23_ONM:BCVD^X<D>QD_\([8>DG_?='_".V'I)_WW6M11[2?<.2/8R?\
MA';#TD_[[H_X1VP])/\ ONM:BCVD^X<D>QD_\([8>DG_ 'W1_P ([8>DG_?=
M:U%'M)]PY(]C)_X1VP])/^^Z8GA^Q9Y 5D^5L#YO8'^M;-11?ZR?_?'_ *"*
M/:3[AR1[&=_PCMAZ2?\ ?='_  CMAZ2?]]UK44>TGW#DCV,G_A';#TD_[[H_
MX1VP])/^^ZUJ*/:3[AR1[&3_ ,([8>DG_?='_".V'I)_WW6M11[2?<.2/8R?
M^$=L/23_ +[H_P"$=L/23_ONM:BCVD^X<D>QD_\ ".V'I)_WW1_PCMAZ2?\
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M"G_\([8>DG_?=:,_^K'^^G_H0J6CVD^X<D>QD_\ ".V'I)_WW1_PCMAZ2?\
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M$=L/23_ONM:BCVD^X<D>QD_\([8>DG_?='_".V'I)_WW6M11[2?<.2/8R?\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5%
M<_\ 'K-_N'^52U%<_P#'K-_N'^5 $M%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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ML_ZE[_R=_P#M='_"[/\ J7O_ "=_^UT?7*/\WYA_JWF?_/K\8_YGK-%>3?\
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M^OQC_F>J6W_'K#_N#^52UY''\:?+B1/^$?SM4#/VS_["G_\ "[/^I>_\G?\
M[71]<H_S?F'^K>9_\^OQC_F>LT5Y-_PNS_J7O_)W_P"UT?\ "[/^I>_\G?\
M[71]<H_S?F'^K>9_\^OQC_F>LT5Y-_PNS_J7O_)W_P"UT?\ "[/^I>_\G?\
M[71]<H_S?F'^K>9_\^OQC_F>LT5Y-_PNS_J7O_)W_P"UT?\ "[/^I>_\G?\
M[71]<H_S?F'^K>9_\^OQC_F>LT5Y-_PNS_J7O_)W_P"UT?\ "[/^I>_\G?\
M[71]<H_S?F'^K>9_\^OQC_F>LT5Y-_PNS_J7O_)W_P"UT?\ "[/^I>_\G?\
M[71]<H_S?F'^K>9_\^OQC_F>LT5Y-_PNS_J7O_)W_P"UT?\ "[/^I>_\G?\
M[71]<H_S?F'^K>9_\^OQC_F>LT5Y-_PNS_J7O_)W_P"UT?\ "[/^I>_\G?\
M[71]<H_S?F'^K>9_\^OQC_F>LT5Y-_PNS_J7O_)W_P"UT?\ "[/^I>_\G?\
M[71]<H_S?F'^K>9_\^OQC_F>LT5Y-_PNS_J7O_)W_P"UT?\ "[/^I>_\G?\
M[71]<H_S?F'^K>9_\^OQC_F>LT5Y-_PNS_J7O_)W_P"UT?\ "[/^I>_\G?\
M[71]<H_S?F'^K>9_\^OQC_F>LT5Y-_PNS_J7O_)W_P"UT?\ "[/^I>_\G?\
M[71]<H_S?F'^K>9_\^OQC_F>LT5Y-_PNS_J7O_)W_P"UT?\ "[/^I>_\G?\
M[71]<H_S?F'^K>9_\^OQC_F>LT5Y-_PNS_J7O_)W_P"UT?\ "[/^I>_\G?\
M[71]<H_S?F'^K>9_\^OQC_F>LT5Y-_PNS_J7O_)W_P"UT?\ "[/^I>_\G?\
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MBBB@ HHHH **** "BBB@ HHHH BB_P!9/_OC_P!!%2U%%_K)_P#?'_H(J6@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "HK;_CUA_W!_*I:BMO^/6'_<'\J ):*** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ J*
M?_5C_?3_ -"%2U%/_JQ_OI_Z$* ):*** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH S-7_ .6/_ OZ
M44:O_P L?^!?THH O6O_ !Z0_P#7-?Y5+45K_P >D/\ US7^52T %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 5$O\ Q]2?[B_S:I:B7_CZD_W%_FU $M%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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ME>^'[S2;B4PP(\#V[[WN)7VXC";>/O'G=VZ$D"J6E_&LMXBM-)\2>%-1\/\
MVQ@EO-<LV&). 2&12!G R,X_6B/O6MU"7N[GIFI:MI^CVPN-1O(;:)G"*TC8
MW,>B@=23Z#FKE>"_'K7K]-8T33ET.Y:VM;J.YBO!NV3R<_NE^7&[CL2>>E>N
M>$->O_$>@KJ&I:'<Z+<&1D-I<[MX Z-\RJ>?I1'WHM^?]?B$M&D;U%5=2U*T
MT?3+G4;^98;2VC,DLC?PJ/Y_3O7DS_'>:427]AX'UBZT&)COU(9 4#J<!"HQ
M[N/PI75[!;2Y['7(ZM\3_!FAZJVF7^NPI>*VQHHXI)=K>A**0#[$T-X[@O\
MP#)XI\-Z?<:S@ )8Q K*6W!64@!B",YZ'@9Z'->)_"^\2]\5WPOOA\VJF_U0
M^=?3PF5=/RQ)4YC(!!.225-4DW/E?]?UW$W:',?30.1D445R7@_QL?%&JZ]I
MEQIOV"\T>Y\AT\_S/,7) <?*N =I_3FEN[#V5SK:Q])\4:-KNI:EI^FWGGW6
MF2>5=Q^4Z^6V2,98 'E3TSTK'UKQT=-^(&C^$K33#>7-^AEFE\_8+>/)^8C:
M=W"L<9'0>M5/!'B/3=9\5^+K&R\/6NFSZ?=B.XNH2NZ\;=(-SX0'/RD\D_>-
M"UU\G^%@>B^[\3NZ*\=B^.TE["T.E^$+[4=42:17L[25I-D2D 2,RQDC))XV
M]N3R*Z3Q'\4K3PU9:5%<:3>SZYJ4"S1Z3;_-)'D='.,CG(X!.0>.*.EPZV.^
MK'UCQ1HV@7VFV6IWGD7&I2^3:)Y3MYCY48RH('++UQUKSRS^-L]OJ=K;>*/!
M>J:#;W,@CCN9]Q4,3W#(G'KC)]J9\8/^1X^''_84_P#:D--+WHKHW8.C\DV>
MO5CZQXHT;0+[3;+4[SR+C4I?)M$\IV\Q\J,94$#EEZXZUL5PGCSQ'INB>(_"
M=I>^'K75)M0O?*M[B<KNLVW1C>F4;GY@>"/NCFDOB2[AT;\F=W17G_C;XJ6/
M@7Q-8Z9J-A)):W%L\[W,<F60C=A0FWYB2H&2P SSTKGV^.LMA?6YUWP5JVE:
M7</MCO9]V2/7:4 /')PQ_&B/O; ]-SUV66."%YII%CBC4L[N<*H')))Z"N7T
MCXE>$->UM=&TO64N;YMVV-(9,-M&3ARNT\#UKGOC+XCO=/\ !$MMI^C7&HVF
MIVTJS7D!;9:IA<.V%(P0QZD=*P/@K<V8TR(W/@A-*%E9&8:_/%C[3D_,0YC&
M!@D\,>!1'5N^R_X(2T2MU/:Z*\CN/C?-=7,K>&?!>KZWIT+;9+V)75<CK@!&
MXQSR0?85W7@WQGI7CC1?[1TMG78WES02C$D+^A _,$=?S %JK@]#HJ*\Q\0?
M&.*SUVXT;PWX<U#Q'>6C%;G[)D)&1P0"JL3@\'@#WK8\&_$JP\96>H+!97%I
MJU@I,^G3_?R,_=..1D8Z @]1R,I.ZN-JSLSJH]6T^;59=+BO(9+Z&,22P(V6
MC4]"P'3/O5.#Q1HUSXGN?#<-YNU>VB$TUOY3C:AV\[B-I^\O0]Z\$\'^-];M
M_BMK^HQ^#-0FN=2:-+FS4OOLAD#<_P"[SCOR%KUC3?$>FW'QBU?0(_#UK#J%
MO9++)JRE?-F4B/Y#\F<?,/XC]T<>E15[>:8G]KR_X!W=%><>*_BY;:'K[Z!H
MFB7OB#6(N9K>TR!'QDC(5B2 1G P.YS5KP3\4K#Q;J<VBW>G76CZY"I9[&Z'
M) Z[20#D YP0#CGGFE'WM@>FYWM%>:>)/C%9>%_&5[X?O-)N)3# CP/;OO>X
ME?;B,)MX^\>=W;H20*I:7\:RWB*TTGQ)X4U'P_\ ;&"6\URS88DX!(9%(&<#
M(SC]:(^]:W4)>[N>L45R?CCQ]IO@:TMC<PSW=]=L4M;*W&7E(Q^0R0.YYX!K
MCX?C=<6-S%_PE/@G6-"L97V+=RJ[*#[AHT^O&3[4+78&K'KE%-1UDC5T8,C
M%2.A!IU !1110 4444 %%%% !6)XD_Y%3Q#_ -><_P#Z)K;K$\2?\BIXA_Z\
MY_\ T34S^%^C_(WPO\>G_BC^:/F>BBBOFS]J"BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M/3(;6:>2\2 K<JS+M*L2?E8'/RCO7;HQ:-6/4@&A:J_R!Z6\QU%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 5%<_\>LW^X?Y5+45S_QZS?[A_E0!+1110 5\]3>!-+\>_'3Q;8ZI
M/>0Q6\<<R&U=5).V,<[E;CFOH6O.?#7A?6=/^,GBG7KJS\O3+Z!$MY_-0[R
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MQ_CG_P >OA+_ +"\?\J]=KSWXM>$=7\4^&['^PQ$^HZ?=K=1Q2$+YF 1@$\
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M "BBB@ J)O\ CZC_ -QOYK4M1-_Q]1_[C?S6@"6BBB@ HHHH **** "BBB@
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MP<9'7&:Y^+_DTI_H?_2NCX7-"_P9\=-;H4@)NS&I.2J^0,#\J(O^32G^A_\
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M2-5W1XVL04)SP._:HO&/P?\ #_C;73J^I7FIQ7'E+%MMI8U3"YQPR$YY]:]
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M@GQ'XVO!XETS4=0U'5M3W63[RJ1!F)&_;(#G)'9AQ7I?PFX^(WQ)_P"PB/\
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M@#Z$Y]J9X/\ BQX6\:7GV&PGGMKX@E+:\C"/( ,G:02IXYQG/M7#^)-/\6^
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M\17N%%'U&CY_>'^M69=X_P#@*_S/#_\ A3?B'_G\TO\ [^R?_$4?\*;\0_\
M/YI?_?V3_P"(KW"BCZC1\_O#_6K,N\?_  %?YGA__"F_$/\ S^:7_P!_9/\
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M^?S2_P#O[)_\17N%%'U&CY_>'^M69=X_^ K_ #/#_P#A3?B'_G\TO_O[)_\
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MHO\ /W/O5JBBNM*VB/GY2<FY2=VPHHHIDA1110 4444 %%%% !1110 4444
M%%%% !43?\?4?^XW\UJ6HF_X^H_]QOYK0!+1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% $47^LG
M_P!\?^@BI:BB_P!9/_OC_P!!%2T %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5%;?\>L/^X/Y5+45M
M_P >L/\ N#^5 $M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 5%/_JQ_OI_Z$*EJ*?\ U8_WT_\ 0A0!
M+1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% &9J__+'_ (%_2BC5_P#EC_P+^E% %ZU_X](?^N:_
MRJ6HK7_CTA_ZYK_*I: "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH *B7_CZD_W%_FU2U$O_ !]2?[B_
MS:@"6BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ J*Y_X]9O\ </\ *I:BN?\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ J)O^/J/_ '&_FM2U$W_'U'_N-_-: ):*** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH BB_P!9/_OC_P!!%2U%%_K)_P#?'_H(J6@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "HK;_C
MUA_W!_*I:BMO^/6'_<'\J ):*** "BBB@ HHHH **** "BBB@ HHHH ****
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M:I:B7_CZD_W%_FU $M%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !45S_QZS?[
MA_E4M17/_'K-_N'^5 $M%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %11?ZR?\ WQ_Z"*EJ*+_63_[X_P#0
M10!+1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% $5M_QZP_[@_E4M16W_'K#_N#^52T %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110!%/_JQ_OI_Z$*EJ*?_ %8_WT_]"%2T %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5$W_ !]1
M_P"XW\UJ6HF_X^H_]QOYK0!+1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% $47^LG_WQ_P"@BI:B
MB_UD_P#OC_T$5+0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !45M_QZP_[@_E4M16W_'K#_N#^5 $M
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 5%/_JQ_OI_Z$*EJ*?_ %8_WT_]"% $M%%% !1110 4444
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MC?XT 2T5%Y"?WI/^_C?XT>0G]Z3_ +^-_C0!+147D)_>D_[^-_C1Y"?WI/\
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MC?XT 2T5%Y"?WI/^_C?XT>0G]Z3_ +^-_C0!+147D)_>D_[^-_C1Y"?WI/\
MOXW^- $M%1>0G]Z3_OXW^-'D)_>D_P"_C?XT 2T5%Y"?WI/^_C?XT>0G]Z3_
M +^-_C0!+43?\?4?^XW\UH\A/[TG_?QO\:C:!/M*#,GW&_Y:-ZCWH LT5%Y"
M?WI/^_C?XT>0G]Z3_OXW^- $M%1>0G]Z3_OXW^-'D)_>D_[^-_C0!+147D)_
M>D_[^-_C1Y"?WI/^_C?XT 2T5%Y"?WI/^_C?XT>0G]Z3_OXW^- $M%1>0G]Z
M3_OXW^-'D)_>D_[^-_C0!+147D)_>D_[^-_C1Y"?WI/^_C?XT 2T5%Y"?WI/
M^_C?XT>0G]Z3_OXW^- $M%1>0G]Z3_OXW^-'D)_>D_[^-_C0!+147D)_>D_[
M^-_C1Y"?WI/^_C?XT 2T5%Y"?WI/^_C?XT>0G]Z3_OXW^- $M%1>0G]Z3_OX
MW^-'D)_>D_[^-_C0!+147D)_>D_[^-_C1Y"?WI/^_C?XT 2T5%Y"?WI/^_C?
MXT>0G]Z3_OXW^- $M%1>0G]Z3_OXW^-'D)_>D_[^-_C0!+147D)_>D_[^-_C
M1Y"?WI/^_C?XT $7^LG_ -\?^@BI:K1P(9)N9.'_ .>C?W1[U)Y"?WI/^_C?
MXT 2T5%Y"?WI/^_C?XT>0G]Z3_OXW^- $M%1>0G]Z3_OXW^-'D)_>D_[^-_C
M0!+147D)_>D_[^-_C1Y"?WI/^_C?XT 2T5%Y"?WI/^_C?XT>0G]Z3_OXW^-
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M "BBB@ HHHH BB_UD_\ OC_T$5+447^LG_WQ_P"@BI: "BBB@ HHHH ****
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MXO\ -JEJ)?\ CZD_W%_FU $M%%% !1110 4444 %%%% !1110 4444 %%%%
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M?B7X=WMM81M+=V[K=1QJ,E]G4 =SM)P.YK!TKX]>%%\+Q3:G+<PZM#$%EL1
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M]!_X7#X@_P"?/3/^_4G_ ,71_P +A\0?\^>F?]^I/_BZ\^HHY(]@YGW/0?\
MA</B#_GSTS_OU)_\71_PN'Q!_P ^>F?]^I/_ (NO/J*.2/8.9]SOW^+VONN#
M9Z9U!XBD['/]^G?\+A\0?\^>F?\ ?J3_ .+KSZBCDCV#F?<]!_X7#X@_Y\],
M_P"_4G_Q='_"X?$'_/GIG_?J3_XNO/J*.2/8.9]ST'_A</B#_GSTS_OU)_\
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MW%XB@6QOF6/5(U^@G _B'OZC\1[=O7.TT[,U3N%%%%(84444 %%%% !1110
M4444 %%%% !1110 5$W_ !]1_P"XW\UJ6HF_X^H_]QOYK0!+1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% $47^LG_WQ_P"@BI:BB_UD_P#OC_T$5+0 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !45M_Q
MZP_[@_E4M16W_'K#_N#^5 $M%%% !1110 4444 %%%% !1110 4444 %%%%
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M2U$O_'U)_N+_ #:@"6BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M=K?VDEI>6T-Q;2#:\,R!T8>A!X-1:?I>GZ1;?9M-L;:RM]Q;RK:%8UR>IPH
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MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ KR3XR?ZS2O]^?\
M]!BKUNO)/C)_K-*_WY__ $&*KI_$B9_">6T445TF 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!)#-+;3I
M/!(T<L;!D=3@J1T(->Y>!/'<7B*!;&^98]4C7Z"<#^(>_J/Q'MX34D,TMM.D
M\$C1RQL&1U."I'0@U,HJ2*C*Q]4T5Q'@/QW'XC@%C?,L>J1K]!.!_$/?U'XC
MV[>N9IIV9LG<****0PHHHH **** "BBB@ HHHH **** "HF_X^H_]QOYK4M1
M-_Q]1_[C?S6@"6BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** (HO]9/_ +X_]!%2U%%_K)_]\?\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH *BN?^/6;_</\JEJ*Y_X]9O\ </\
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MXOX\^&NC-\7M%LC<W_E^(9IY[L^8F4;);$?R\#/KFMSQK<_\(S_PC?PTT7Q
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MM9>9)MFU*5?WLV.%']U?;^?Y =7117,VV[LV2L%%%%(84444 %%%% !1110
M4444 %%%% !43?\ 'U'_ +C?S6I:B;_CZC_W&_FM $M%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 11?ZR?_?'_ *"*EJ*+_63_ .^/_014M !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %16W_'K#_N#
M^52U%;?\>L/^X/Y4 2T444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MA2:VNI.$W#&06Z 9WCVXZ5N>)OBDG_"0:+H'@N?3M7U&^N L[*3-%%%W.Y&
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M11?ZR?\ WQ_Z"*EH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ J*V_X]8?]P?RJ6HK;_CUA_W!_*@"
M6BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH *BG_U8_WT_P#0A4M13_ZL?[Z?^A"@"6BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** ,S5_P#EC_P+^E%&K_\ +'_@7]** +UK_P >D/\ US7^52U%:_\ 'I#_
M -<U_E4M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %1+_ ,?4G^XO\VJ6HE_X^I/]Q?YM0!+1110
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M EHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M"6BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MZ7WVL_P5_F1?!C_D(^.?^PW)_-JX7P=\3=%\ >)O&,.JVM_,UWJDCQFUC1@
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M*BB_UD_^^/\ T$5+447^LG_WQ_Z"* ):*** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH BMO\ CUA_
MW!_*I:BMO^/6'_<'\JEH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@"*?\ U8_WT_\ 0A4M13_ZL?[Z
M?^A"I: "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH *B;_CZC_W&_FM2U$W_ !]1_P"XW\UH EHHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@"*+_63_ .^/_014M11?ZR?_ 'Q_Z"*EH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M J*V_P"/6'_<'\JEJ*V_X]8?]P?RH EHHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "HI_P#5C_?3_P!"
M%2U%/_JQ_OI_Z$* ):*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH S-7_P"6/_ OZ44:O_RQ_P"!
M?THH O6O_'I#_P!<U_E4M16O_'I#_P!<U_E4M !1110 4444 %%%% !1110
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M/_OC_P!!%2T %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 5%;?\>L/^X/Y5+45M_P >L/\ N#^5 $M%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 5%/_JQ_OI_Z$*EJ*?\ U8_WT_\ 0A0!+1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% &9J__+'_ (%_2BC5_P#EC_P+^E% %FVMX6M8288R2BDDJ/2I?LT'_/&/
M_OD46O\ QZ0_]<U_E4M $7V:#_GC'_WR*/LT'_/&/_OD5+10!%]F@_YXQ_\
M?(H^S0?\\8_^^14M% $7V:#_ )XQ_P#?(H^S0?\ /&/_ +Y%2T4 1?9H/^>,
M?_?(H^S0?\\8_P#OD5+10!%]F@_YXQ_]\BC[-!_SQC_[Y%2T4 1?9H/^>,?_
M 'R*/LT'_/&/_OD5+10!%]F@_P">,?\ WR*/LT'_ #QC_P"^14M% $7V:#_G
MC'_WR*/LT'_/&/\ [Y%2T4 1?9H/^>,?_?(H^S0?\\8_^^14M% $7V:#_GC'
M_P!\BC[-!_SQC_[Y%2T4 1?9H/\ GC'_ -\BC[-!_P \8_\ OD5+10!%]F@_
MYXQ_]\BC[-!_SQC_ .^14M% $7V:#_GC'_WR*/LT'_/&/_OD5+10!%]F@_YX
MQ_\ ?(H^S0?\\8_^^14M% $7V:#_ )XQ_P#?(J-;>'[2X\F/ 13C:/4U9J)?
M^/J3_<7^;4 'V:#_ )XQ_P#?(H^S0?\ /&/_ +Y%2T4 1?9H/^>,?_?(H^S0
M?\\8_P#OD5+10!%]F@_YXQ_]\BC[-!_SQC_[Y%2T4 1?9H/^>,?_ 'R*/LT'
M_/&/_OD5+10!%]F@_P">,?\ WR*/LT'_ #QC_P"^14M% $7V:#_GC'_WR*/L
MT'_/&/\ [Y%2T4 1?9H/^>,?_?(H^S0?\\8_^^14M% $7V:#_GC'_P!\BC[-
M!_SQC_[Y%2T4 1?9H/\ GC'_ -\BC[-!_P \8_\ OD5+10!%]F@_YXQ_]\BC
M[-!_SQC_ .^14M% $7V:#_GC'_WR*/LT'_/&/_OD5+10!%]F@_YXQ_\ ?(H^
MS0?\\8_^^14M% $7V:#_ )XQ_P#?(H^S0?\ /&/_ +Y%2T4 1?9H/^>,?_?(
MH^S0?\\8_P#OD5+10!%]F@_YXQ_]\BC[-!_SQC_[Y%2T4 1?9H/^>,?_ 'R*
M/LT'_/&/_OD5+10!%]F@_P">,?\ WR*/LT'_ #QC_P"^14M% $7V:#_GC'_W
MR*/LT'_/&/\ [Y%2T4 1?9H/^>,?_?(H^S0?\\8_^^14M% $7V:#_GC'_P!\
MBC[-!_SQC_[Y%2T4 1?9H/\ GC'_ -\BC[-!_P \8_\ OD5+10!%]F@_YXQ_
M]\BC[-!_SQC_ .^14M% $7V:#_GC'_WR*/LT'_/&/_OD5+10!%]F@_YXQ_\
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M^^11]F@_YXQ_]\BI:* (OLT'_/&/_OD4?9H/^>,?_?(J6B@"+[-!_P \8_\
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M%'V:#_GC'_WR*EHH B^S0?\ /&/_ +Y%'V:#_GC'_P!\BI:* (OLT'_/&/\
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M+10!%]F@_P">,?\ WR*/LT'_ #QC_P"^14M% $7V:#_GC'_WR*/LT'_/&/\
M[Y%2T4 1?9H/^>,?_?(H^S0?\\8_^^14M% $7V:#_GC'_P!\BHVMX?M*#R8\
M%&.-H]15FHF_X^H_]QOYK0 ?9H/^>,?_ 'R*/LT'_/&/_OD5+10!%]F@_P">
M,?\ WR*/LT'_ #QC_P"^14M% $7V:#_GC'_WR*/LT'_/&/\ [Y%2T4 1?9H/
M^>,?_?(H^S0?\\8_^^14M% $7V:#_GC'_P!\BC[-!_SQC_[Y%2T4 1?9H/\
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M]\BC[-!_SQC_ .^14M% $7V:#_GC'_WR*/LT'_/&/_OD5+10!%]F@_YXQ_\
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MR*EHH B^S0?\\8_^^11]F@_YXQ_]\BI:* (OLT'_ #QC_P"^11]F@_YXQ_\
M?(J6B@"+[-!_SQC_ .^11]F@_P">,?\ WR*EHH B^S0?\\8_^^11]F@_YXQ_
M]\BI:* (OLT'_/&/_OD4?9H/^>,?_?(J6B@"+[-!_P \8_\ OD4?9H/^>,?_
M 'R*EHH RM4CCC\K8BKG.=HQZ44[5_\ EC_P+^E% %ZU_P"/2'_KFO\ *I:B
MM?\ CTA_ZYK_ "J6@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "HE_X^I/]Q?YM4M1+_Q]2?[B_P V
MH EHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH *BN?^/6;_</\JEJ*Y_X]9O\
M</\ *@"6BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "HHO]9/\ [X_]!%2U%%_K)_\ ?'_H(H EHHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@"*V_X]8?]P?RJ6HK;_CUA_P!P?RJ6@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** (I_]
M6/\ ?3_T(5+44_\ JQ_OI_Z$*EH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ J)O\ CZC_ -QOYK4M
M1-_Q]1_[C?S6@"6BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** (HO]9/_OC_ -!%2U%%_K)_]\?^
M@BI: "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH *BMO^/6'_<'\JEJ*V_X]8?\ <'\J ):*** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ J*?_5C_ 'T_]"%2U%/_ *L?[Z?^A"@"6BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** ,S5_
M^6/_  +^E%&K_P#+'_@7]** +UK_ ,>D/_7-?Y5+45K_ ,>D/_7-?Y5+0 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !42_\?4G^XO\VJ6HE_X^I/\ <7^;4 2T444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M+2%O)<_W68*%!Z]E/'0Y%$=;>>H/3Y'HU<YKOC*QT+Q'HNA2PS2WNK2%8MH
M5%'5F/\ (#]*Z.OGGXEV'C)OC%H:V^K6:37$K'1F9!BV'&=_[OGG_>I7]Y+N
M#^%L^AJ*\Q\5>-?$/@OPWH6D.D&K^,M2/DKL7]VS9P7P O<J , =3VYY_4=8
M^,'@:R&OZY/IFLZ8I!N;6%%#0*3URJ*>^,@L!U/'-/3Y=P_,]NHJCHVJVNNZ
M-9ZK9,6MKN)98\]0".A]QTJ]3::=F).ZN@HHHI#"BBB@ HHHH *XKXAZYJ.@
M:"+K3+CR)WODC9MBME3$3C# CJ!7:UYS\7/^16C_ .PDG_HEJJ'Q(4MC@_\
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MCV#F9U?_  LKQ=_T%O\ R6B_^)H_X65XN_Z"W_DM%_\ $URE%'+'L',SJ_\
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M44 %%%% !1110 5%/_JQ_OI_Z$*EJ*?_ %8_WT_]"% $M%%% !1110 4444
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MW^U(EC^R^1M\K&WG?N.?N^@ZT+XKOL_T"7PV7=%]? WA%'#IX6T164Y!&GQ
M@_\ ?-<#\;G2TO?!>HW(_P!!MM65IR>@&5//X*U>NUE>(_#NF^*M#GTC583)
M:S8SM.&1AR&4]B/\\4G=6:Z-,:MJGU37WEG4+ZTM-(N;ZYEC%G' TKR%OEV
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M>SG$FR7*D8.96'!.>AZ5J^'?A^=)\:ZMXKU/5/[3U&]^2$^1Y:VT?]U1N;/
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 5YS\7/^16C_P"PDG_HEJ]&KSGXN?\ (K1_]A)/_1+54/B1,MF>,444
M5U& 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M/_014M11?ZR?_?'_ *"*EH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MR1I5B--_Y\_LZ>3UW?<QMZ\].O-:%% $=O;PVEO';V\,<,$2A(XXU"JBC@
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MI_\ ?V/_ .(H]K$.1GB=%>V?\*>\/_\ /YJ?_?V/_P"(H_X4]X?_ .?S4_\
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MI_\ ?V/_ .(H]K$.1GB=%>V?\*>\/_\ /YJ?_?V/_P"(H_X4]X?_ .?S4_\
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M/_\ /YJ?_?V/_P"(H_X4]X?_ .?S4_\ O['_ /$4>UB'(SQ.BO;/^%/>'_\
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MBBB@ HHHH **** "BBB@ HHHH BB_P!9/_OC_P!!%2U%%_K)_P#?'_H(J6@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "HK;_CUA_W!_*I:BMO^/6'_<'\J ):*** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ J*
M?_5C_?3_ -"%2U%/_JQ_OI_Z$* ):*** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH S-7_ .6/_ OZ
M44:O_P L?^!?THH O6O_ !Z0_P#7-?Y5+45K_P >D/\ US7^52T %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 5$O\ Q]2?[B_S:I:B7_CZD_W%_FU $M%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %1-_P ?4?\ N-_-:EJ)O^/J/_<;^:T 2T444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!%%_
MK)_]\?\ H(J6HHO]9/\ [X_]!%2T %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5%;?\>L/^X/Y5+45
MM_QZP_[@_E0!+1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %13_ZL?[Z?^A"I:BG_P!6/]]/_0A0!+11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% &9J_P#RQ_X%_2BC5_\ EC_P+^E% %ZU_P"/2'_KFO\
M*I:BM?\ CTA_ZYK_ "J6@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "HE_X^I/]Q?YM4M1+_Q]2?[B
M_P VH EHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *BN?^/6;_</\JEJ*Y_X]
M9O\ </\ *@"6BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "HHO]9/\ [X_]!%2U%%_K)_\ ?'_H(H EHHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@"*V_X]8?]P?RJ6HK;_CUA_P!P?RJ6@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M(I_]6/\ ?3_T(5+44_\ JQ_OI_Z$*EH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ J)O\ CZC_ -QO
MYK4M1-_Q]1_[C?S6@"6BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** (HO]9/_OC_ -!%2U%%_K)_
M]\?^@BI: "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH *BMO^/6'_<'\JEJ*V_X]8?\ <'\J ):*** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ J*?_5C_ 'T_]"%2U%/_ *L?[Z?^A"@"6BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M%'VF#_GM'_WT*EHH B^TP?\ /:/_ +Z%'VF#_GM'_P!]"I:* (OM,'_/:/\
M[Z%'VF#_ )[1_P#?0J6B@"+[3!_SVC_[Z%'VF#_GM'_WT*EHH B^TP?\]H_^
M^A1]I@_Y[1_]]"I:* (OM,'_ #VC_P"^A4:W$/VESYT>"BC.X>IJS42_\?4G
M^XO\VH /M,'_ #VC_P"^A1]I@_Y[1_\ ?0J6B@"+[3!_SVC_ .^A1]I@_P">
MT?\ WT*EHH B^TP?\]H_^^A1]I@_Y[1_]]"I:* (OM,'_/:/_OH4?:8/^>T?
M_?0J6B@"+[3!_P ]H_\ OH4?:8/^>T?_ 'T*EHH B^TP?\]H_P#OH4?:8/\
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M%'VF#_GM'_WT*EHH B^TP?\ /:/_ +Z%'VF#_GM'_P!]"I:* (OM,'_/:/\
M[Z%'VF#_ )[1_P#?0J6B@"+[3!_SVC_[Z%'VF#_GM'_WT*EHH B^TP?\]H_^
M^A1]I@_Y[1_]]"I:* (OM,'_ #VC_P"^A1]I@_Y[1_\ ?0J6B@"+[3!_SVC_
M .^A1]I@_P">T?\ WT*EHH B^TP?\]H_^^A1]I@_Y[1_]]"I:* (OM,'_/:/
M_OH4?:8/^>T?_?0J6B@"+[3!_P ]H_\ OH5'<7$+6TH$T9)0@ ,/2K-17/\
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M]]"C[3!_SVC_ .^A4M% $7VF#_GM'_WT*/M,'_/:/_OH5+10!%]I@_Y[1_\
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M.X>HJS43?\?4?^XW\UH /M,'_/:/_OH4?:8/^>T?_?0J6B@"+[3!_P ]H_\
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M8/\ GM'_ -]"C[3!_P ]H_\ OH5+10!%]I@_Y[1_]]"C[3!_SVC_ .^A4M%
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M&N*\*?&7PIXNU6/3+5KRTO)3B&.\B"^:<9P"K,,_4BL+Q)_R<MX3_P"P<_\
MZ#/32]Y+O_DV'1OM_P  ]>HHHI %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 5%%_K)_P#?'_H(J6HHO]9/_OC_ -!% $M%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 16W_'K#_N#^52U%;?\>L/^X/Y5+0 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% $4_^K'^^G_H0J6H
MI_\ 5C_?3_T(5+0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !43?\ 'U'_ +C?S6I:B;_CZC_W&_FM
M $M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 11?ZR?_?'_ *"*EJ*+_63_ .^/_014M !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %16W_'K#_N#^52U%;?\>L/^X/Y4 2T444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !44_^K'^
M^G_H0J6HI_\ 5C_?3_T(4 2T444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110!F:O\ \L?^!?THHU?_
M )8_\"_I10!>M?\ CTA_ZYK_ "J6HK7_ (](?^N:_P JEH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ J)?^/J3_<7^;5+42_\?4G^XO\ -J ):*** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MM%OLWB:W8* 8LNJG;Z#!QBN)^)VIW+^%/ASI[6<VHP7,<4\UG$Q#W3*D8"<
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M+>7X=S:=IL:!Y+J_)S&H(PR!E3GITS4_C:>>\^$'P_T<RR)%J<EI#.X[J$
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M8D;$W#/C /(ZGN*N&\?67_I)+^U_A_4]2HHHJ0"BBB@ HHHH **** "BBB@
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M,P_L/+?^?,?Q_P ST/\ X7)XA_Y\]+_[]2?_ !='_"Y/$/\ SYZ7_P!^I/\
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M4?6JW\S#^P\M_P"?,?Q_S/0_^%R>(?\ GSTO_OU)_P#%T?\ "Y/$/_/GI?\
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M\^>E_P#?J3_XNO/**/K5;^9A_8>6_P#/F/X_YGH?_"Y/$/\ SYZ7_P!^I/\
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M_P#?'_H(J6@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "HK;_CUA_W!_*I:BMO^/6'_<'\J ):***
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ J*?_5C_?3_ -"%2U%/_JQ_OI_Z$* ):*** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
MS-7_ .6/_ OZ44:O_P L?^!?THH O6O_ !Z0_P#7-?Y5+45K_P >D/\ US7^
M52T %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 5$O\ Q]2?[B_S:I:B7_CZD_W%_FU $M%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !45S_QZS?[A_E4M17/_'K-_N'^5 $M%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M "BBB@ J*?\ U8_WT_\ 0A4M13_ZL?[Z?^A"@"6BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** ,S
M5_\ EC_P+^E%&K_\L?\ @7]** +UK_QZ0_\ 7-?Y5+45K_QZ0_\ 7-?Y5+0
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M9 RSD]/YFDXVE*/;_.P)^ZI=_P#(]B\/^)]%\4V)O-$U"*\@5MK%,AD/HRD
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MEE:@=.<%5*@G."#G(Q47Q1L?")MM)U'QKJETMO9R$Q64)PEU)QG* %CTQU
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MMMJLUO<"[CGOH8PZ[K?W(&&''W03]*?#\1/&O@O5+2T^(6D6YTRXD$*:K9]
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MIFM.X"^%?VAK>8 K:^);(QMCH)D[_P#CJ_\ ?=-6?+YW^]?\,Q/3F\K?<_\
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M^]U7X&^(M/TUMM[<3W,<)W;<L8UXSVSTS[US'A3Q9X(\,Z9'X?\ &7@(0ZC
M2DUS+9I*[Y/WFWX=?H,].*IZ2MY+YW#I?S?X,^D=/U&RU6RCO=/NH;JUE&4E
MA<,K?B*LUP?PML?"-EI%\W@[5I[VPN+CS7AE<'[.Y&-H4J&48 ^]G.WK7>4-
M"3"BBBD,*\W^+_\ R*D?_823_P!$M7I%>;_%_P#Y%2/_ +"2?^B6K#%?P9>A
MZN1_\C*C_B_1GBE%%%> ?K@4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %/BBDGE2*)&>1V"JBC)8GH *(HI)Y4BB1GD=@JHHR6)Z "O<
M_ '@"/P_$FI:DBOJCK\J]1;@]A_M>I_ >^U"A*M*RV/,S3-*.74>>>LGLN__
M  .[_4/ '@"/P_$FI:DBOJCK\J]1;@]A_M>I_ >_<-_Q]1_[C?S6I:B;_CZC
M_P!QOYK7NTZ<:<>6)^5XS&5L96=:L[M_AY+R):***LY0HHHH **** "BBB@
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M'_\ Y$C3?^PM#_Z!)7<^,_\ D0-?_P"P9<?^BFK>HJ6KP<>_^21:E:49=O\
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M\G\/_P#)R/BK_L&Q?^@PUS]CK5[\$_$VMVFK:3>77AK4+DW-K>6J [&/\/)
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M>OYHXCX4Z#K7VS7?&'B&W-K?ZW(&CMF!#11#. 0>1V !YPH]:I? '_D7M?\
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MI#.[6-[:H"LJDYXW$ COUR,X(K;\"V^L>-_B7/X^U+3)=.TVWMOLVG13##2
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MXT4>3VO?_,-M5OL>5?$+P=K5Y\%X-)2>XU35;$13RNSM)).RYWX)Y;[Q('7
MQ[5FZ5\9+CQ#I46@Z-X<U"3Q*\0@<2*%MX&QM,C,#N"CK@J/3->ST4GKS7V?
M^5@6B5MT>*?!JWU67X/:Q#HUT+;5?MDWV:8JK 2!$QD,",'IR.]5H_C#I]OI
M,6C?$7PK?SZM#\DJO91.DQ_O;7*@9XZ CTKW2BJD[N_I^ ))+3S_ !/'?@[H
M%U'XD\0^)DT6;0])O]L=E8RY4D9R6VGH/3M\Q X%>Q444-Z)=A):M]PHHHI#
M"O-_B_\ \BI'_P!A)/\ T2U>D5S/BWPM_P );IAL/MGV3R[M9M_E>9G$>,8R
M/[WZ5E7BYTI1CN>AE5>G0QM*K4=HIW?XGSE17K7_  I/_J8?_)+_ .V4?\*3
M_P"IA_\ )+_[97C_ %.M_+^1^B_ZR99_S]_"7^1Y+17K7_"D_P#J8?\ R2_^
MV4?\*3_ZF'_R2_\ ME'U.M_+^0?ZR99_S]_"7^1Y+17K7_"D_P#J8?\ R2_^
MV4?\*3_ZF'_R2_\ ME'U.M_+^0?ZR99_S]_"7^1Y+17K7_"D_P#J8?\ R2_^
MV4?\*3_ZF'_R2_\ ME'U.M_+^0?ZR99_S]_"7^1Y+17K7_"D_P#J8?\ R2_^
MV4?\*3_ZF'_R2_\ ME'U.M_+^0?ZR99_S]_"7^1Y+17K7_"D_P#J8?\ R2_^
MV4?\*3_ZF'_R2_\ ME'U.M_+^0?ZR99_S]_"7^1Y+17K7_"D_P#J8?\ R2_^
MV4?\*3_ZF'_R2_\ ME'U.M_+^0?ZR99_S]_"7^1Y+17K7_"D_P#J8?\ R2_^
MV4?\*3_ZF'_R2_\ ME'U.M_+^0?ZR99_S]_"7^1Y+17K7_"D_P#J8?\ R2_^
MV4?\*3_ZF'_R2_\ ME'U.M_+^0?ZR99_S]_"7^1Y+17K7_"D_P#J8?\ R2_^
MV4?\*3_ZF'_R2_\ ME'U.M_+^0?ZR99_S]_"7^1Y+17K7_"D_P#J8?\ R2_^
MV4?\*3_ZF'_R2_\ ME'U.M_+^0?ZR99_S]_"7^1Y+17K7_"D_P#J8?\ R2_^
MV4?\*3_ZF'_R2_\ ME'U.M_+^0?ZR99_S]_"7^1Y+17K7_"D_P#J8?\ R2_^
MV4?\*3_ZF'_R2_\ ME'U.M_+^0?ZR99_S]_"7^1Y+17K7_"D_P#J8?\ R2_^
MV4?\*3_ZF'_R2_\ ME'U.M_+^0?ZR99_S]_"7^1Y+17K7_"D_P#J8?\ R2_^
MV4?\*3_ZF'_R2_\ ME'U.M_+^0?ZR99_S]_"7^1Y+17J\?P6\R)'_P"$@QN4
M''V/_P"SI_\ PI/_ *F'_P DO_ME'U.M_+^0?ZR99_S]_"7^1Y+17K7_  I/
M_J8?_)+_ .V4?\*3_P"IA_\ )+_[91]3K?R_D'^LF6?\_?PE_D>2T5ZU_P *
M3_ZF'_R2_P#ME'_"D_\ J8?_ "2_^V4?4ZW\OY!_K)EG_/W\)?Y'DM%>M?\
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M.ORKU%N#V'^UZG\![][117L4Z<:<>6)^=XS&5L96=:L[M_AY+R"HF_X^H_\
M<;^:U+43?\?4?^XW\UJSE):*** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH BB_P!9/_OC_P!!%2U%
M%_K)_P#?'_H(J6@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "HK;_CUA_W!_*I:BMO^/6'_<'\J ):
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ J*?_5C_?3_ -"%2U%/_JQ_OI_Z$* ):*** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH S-7_ .6/_ OZ44:O_P L?^!?THH O6O_ !Z0_P#7-?Y5+45K_P >D/\
MUS7^52T %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 5$O\ Q]2?[B_S:I:B7_CZD_W%_FU $M%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !45S_QZS?[A_E4M17/_'K-_N'^5 $M%%%
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M6_NDJ3@^U %NBJ;ZKIT>IQZ9)J%JNH2)O2U:91*R\\A,Y(X/..QHU'5=.TB
M3ZGJ%K90DX$ES,L:D^F6(H N453T[5M-UB%IM,U"TO8E."]M,LB@^F5)JY0
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MHH **** "BBB@ HHHH **** "BBB@"*V_P"/6'_<'\JEJ*V_X]8?]P?RJ6@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** (I_P#5C_?3_P!"%2U%/_JQ_OI_Z$*EH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M J)O^/J/_<;^:U+43?\ 'U'_ +C?S6@"6BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** (HO]9/\
M[X_]!%2U%%_K)_\ ?'_H(J6@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "HK;_ (]8?]P?RJ6HK;_C
MUA_W!_*@"6BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH *BG_ -6/]]/_ $(5+44_^K'^^G_H0H EHHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@#,U?_ )8_\"_I11J__+'_ (%_2B@"]:_\>D/_ %S7^52U
M%:_\>D/_ %S7^52T %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MNG^,M)TZ'P^D]UIMK?QM<7[1&./S"K;(U# ,3C<3QQ@>M=7\9/\ D/\ P_\
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M.<GCM55?^7JZW?Y,B&T'TM^IS'PZUZ;PS\ _$6KVQ N(+N41$C.UV$:J?P+
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M33_+\-/D#OS7[Z_Y_P"?S+M%%%(84444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 5%%_K)_]\?\ H(J6HHO]9/\ [X_]
M!% $M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 16W_ !ZP_P"X/Y5+45M_QZP_[@_E4M !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 13_P"K'^^G_H0J6HI_]6/]]/\ T(5+0 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !43?
M\?4?^XW\UJ6HF_X^H_\ <;^:T 2T444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!%%_K)_P#?'_H(
MJ6HHO]9/_OC_ -!%2T %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 5%;?\ 'K#_ +@_E4M16W_'K#_N
M#^5 $M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 5%/_ *L?[Z?^A"I:BG_U8_WT_P#0A0!+1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% &9J__ "Q_X%_2BC5_^6/_  +^E% %ZU_X](?^N:_RJ6LZ#5+&
M.WC1[E RJ 1Z'%2?VOI__/TE/E?87,NY=HJE_:^G_P#/TE']KZ?_ ,_24<K[
M!S+N7:*I?VOI_P#S])1_:^G_ //TE'*^P<R[EVBJ7]KZ?_S])1_:^G_\_24<
MK[!S+N7:*I?VOI__ #])1_:^G_\ /TE'*^P<R[EVBJ7]KZ?_ ,_24?VOI_\
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M5]@YEW+M%4O[7T__ )^DH_M?3_\ GZ2CE?8.9=R[15+^U]/_ .?I*/[7T_\
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M5]@YEW+M%4O[7T__ )^DH_M?3_\ GZ2CE?8.9=R[15+^U]/_ .?I*/[7T_\
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M*^P<R[EVBJ7]KZ?_ ,_24?VOI_\ S])1ROL',NY=HJE_:^G_ //TE']KZ?\
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M']KZ?_S])1ROL',NY=HJE_:^G_\ /TE']KZ?_P _24<K[!S+N7:*I?VOI_\
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M*^P<R[EVBJ7]KZ?_ ,_24?VOI_\ S])1ROL',NY=HJE_:^G_ //TE']KZ?\
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M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#H_"O_+W_P
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M4[=(K\Q)*48WZR)]"M_%WQ!2YU@^(YM*MUD,<$5MN"DCG&%8<#(Y.36O\/\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH Z/PK_ ,O?
M_ /_ &:BCPK_ ,O?_ /_ &:BO/K_ ,1G?1^!'/S?Z^3_ 'C_ #IE/F_U\G^\
M?YTRN^.R.*6["N:O?!&FWWBN#Q'+/=B\A*%45U\L[>F1MS^M=+10XIM-]!)M
M;%;4+"WU33Y[&[3?!.A1U]C_ %K!\+>!=,\)7-Q/83WDC3H$83NI  .>,**Z
M>BCE7-S=1\SMR]#BM8^%GAS6-2DOG%U;22'=(MM(JJ[=S@J<$^V*23X6>'?M
M-E<6OVNSDM,%#!(OS,&W!FW*<G-=M14JG!;(?M)=S$\2^%-+\56D=OJ*29B)
M,<L3;73/7'!'.!U%9NG_  \T?3=!U#2()[TP7X F=Y%+C'3'RX'Y5UM%-TXN
M[MN"G))*^QC>&O#=GX6TQK"QEGDB:0R$SL"V2 .P''%5/%/@C2O%S6SW[W$4
MEN&"O;LJD@XX.5/''\ZZ2BB48R5FA*33NBMI]A!I>G6]C;*5@MXQ&@/7 &.?
M>L;Q-X*T?Q6(VU".1)XQM2>!@KA>N.001]1QVZUT5%.45+201DXNZ.%7X2^&
M4TV6T"W6^0@FY,BF48[ E<#WP*Z"U\+:7;^&4\/RQ-=6"*5VSD%CDDYR ,')
MZC%;5%)0BKZ;@YR?4\^E^#GAF2<R+-J,:YSY:3+M_52?UKK]$T'3?#U@+/3+
M80Q9W,<DLY]23R36E11&$8_"@E.4MV%%%%42<_XA\%:'XF82:A:D7 &!/$VU
M\>F>_P"(-8%K\'O#%O,'D>_N5'_+.68!3_WRH/ZUW]%1[.%[V+]I*UKD-K:6
M]C:QVMK"D,$2[4C08"BN,U/X3>&=1NVN%6ZLRYRR6LBA,_1E./H,"NYHIRA&
M7Q(49RCLS$\/>$](\+PNFFVY5Y,>9-(VYW^I]/88%4K/P)I=EXLD\1QSWAO)
M'=RC.OEY8$'C;GOZUU%%/E5T[;!S/7S*.L:5!K>D7.FW+R)#<+L=HR P&<\9
M!';TJIX:\-6?A;2VT^QDGDB:0R$SL"V2 .P''%;-%'*KWZBN[6.&U/X3>&=1
MNVN%6ZLRYRR6LBA,_1E./H,"M[P]X3TCPO"Z:;;E7DQYDTC;G?ZGT]A@5MT4
MHPC'5(J4Y2T;.-UGX8>&]:NY+IX9[6>1BTC6L@4,>YP00/P%3^'OAWH'AN[%
MW;133W2_<FN7#%/H  !]<9KJZ*4:<8NZ0.<FK-A1115D!1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M -\FCF7<.5]B.BI/(F_YY/\ ]\FCR)O^>3_]\FCF7<.5]B.BI/(F_P">3_\
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M_?)HYEW#E?8CHJ3R)O\ GD__ 'R:/(F_YY/_ -\FCF7<.5]B.BI/(F_YY/\
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MO^>3_P#?)HYEW#E?8CHJ3R)O^>3_ /?)H\B;_GD__?)HYEW#E?8CHJ3R)O\
MGD__ 'R:/(F_YY/_ -\FCF7<.5]B.BI/(F_YY/\ ]\FCR)O^>3_]\FCF7<.5
M]B.BI/(F_P">3_\ ?)H\B;_GD_\ WR:.9=PY7V(Z*D\B;_GD_P#WR:/(F_YY
M/_WR:.9=PY7V(Z*D\B;_ )Y/_P!\FCR)O^>3_P#?)HYEW#E?8CHJ3R)O^>3_
M /?)H\B;_GD__?)HYEW#E?8CHJ3R)O\ GD__ 'R:/(F_YY/_ -\FCF7<.5]B
M.BI/(F_YY/\ ]\FCR)O^>3_]\FCF7<.5]B.BI/(F_P">3_\ ?)H\B;_GD_\
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M -\FCF7<.5]B.BI/(F_YY/\ ]\FCR)O^>3_]\FCF7<.5]B.BI/(F_P">3_\
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M_?)HYEW#E?8CHJ3R)O\ GD__ 'R:/(F_YY/_ -\FCF7<.5]B.BI/(F_YY/\
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MO^>3_P#?)HYEW#E?8CHJ3R)O^>3_ /?)H\B;_GD__?)HYEW#E?8CHJ3R)O\
MGD__ 'R:/(F_YY/_ -\FCF7<.5]B.BI/(F_YY/\ ]\FCR)O^>3_]\FCF7<.5
M]B.BI/(F_P">3_\ ?)H\B;_GD_\ WR:.9=PY7V(Z*D\B;_GD_P#WR:/(F_YY
M/_WR:.9=PY7V(Z*D\B;_ )Y/_P!\FCR)O^>3_P#?)HYEW#E?8CHJ3R)O^>3_
M /?)H\B;_GD__?)HYEW#E?8CHJ3R)O\ GD__ 'R:/(F_YY/_ -\FCF7<.5]B
M.BI/(F_YY/\ ]\FCR)O^>3_]\FCF7<.5]B.BI/(F_P">3_\ ?)H\B;_GD_\
MWR:.9=PY7V(Z*D\B;_GD_P#WR:/(F_YY/_WR:.9=PY7V(Z*D\B;_ )Y/_P!\
MFCR)O^>3_P#?)HYEW#E?8CHJ3R)O^>3_ /?)H\B;_GD__?)HYEW#E?8CHJ3R
M)O\ GD__ 'R:/(F_YY/_ -\FCF7<.5]B.BI/(F_YY/\ ]\FCR)O^>3_]\FCF
M7<.5]B.BI/(F_P">3_\ ?)H\B;_GD_\ WR:.9=PY7V(Z*D\B;_GD_P#WR:/(
MF_YY/_WR:.9=PY7V(Z*D\B;_ )Y/_P!\FCR)O^>3_P#?)HYEW#E?8CHJ3R)O
M^>3_ /?)H\B;_GD__?)HYEW#E?8CHJ3R)O\ GD__ 'R:/(F_YY/_ -\FCF7<
M.5]B.BI/(F_YY/\ ]\FCR)O^>3_]\FCF7<.5]B.BI/(F_P">3_\ ?)H\B;_G
MD_\ WR:.9=PY7V(Z*D\B;_GD_P#WR:/(F_YY/_WR:.9=PY7V(Z*D\B;_ )Y/
M_P!\FCR)O^>3_P#?)HYEW#E?8CHJ3R)O^>3_ /?)H\B;_GD__?)HYEW#E?8C
MHJ3R)O\ GD__ 'R:/(F_YY/_ -\FCF7<.5]B.BI/(F_YY/\ ]\FCR)O^>3_]
M\FCF7<.5]B.BI/(F_P">3_\ ?)H\B;_GD_\ WR:.9=PY7V(Z*D\B;_GD_P#W
MR:/(F_YY/_WR:.9=PY7V(Z*D\B;_ )Y/_P!\FCR)O^>3_P#?)HYEW#E?8CHJ
M3R)O^>3_ /?)H\B;_GD__?)HYEW#E?8CHJ3R)O\ GD__ 'R:/(F_YY/_ -\F
MCF7<.5]B.BI/(F_YY/\ ]\FCR)O^>3_]\FCF7<.5]B.BI/(F_P">3_\ ?)H\
MB;_GD_\ WR:.9=PY7V(Z*D\B;_GD_P#WR:/(F_YY/_WR:.9=PY7V(Z*D\B;_
M )Y/_P!\FCR)O^>3_P#?)HYEW#E?8W_"O_+W_P  _P#9J*3PV1!]J\X^7NV8
MW\9Z^M%>?7UJ,[:/P(WK7_CTA_ZYK_*I:BM?^/2'_KFO\JEK(U"BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH *B7_CZD_P!Q?YM4M1+_ ,?4G^XO\VH EHHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH *BN?\ CUF_W#_*I:BN?^/6;_</\J ):*** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *BB_UD_^
M^/\ T$5+447^LG_WQ_Z"* ):*** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH BMO\ CUA_W!_*I:BM
MO^/6'_<'\JEH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@"*?\ U8_WT_\ 0A4M13_ZL?[Z?^A"I: "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH *B;_CZC_W&_FM2U$W_ !]1_P"XW\UH EHHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@"*+_63_ .^/_014M11?ZR?_ 'Q_Z"*EH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ J*V_P"/
M6'_<'\JEJ*V_X]8?]P?RH EHHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "HI_P#5C_?3_P!"%2U%/_JQ
M_OI_Z$* ):*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH S-7_P"6/_ OZ44:O_RQ_P"!?THH O6O
M_'I#_P!<U_E4M16O_'I#_P!<U_E4M !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %1+_P ?4G^XO\VJ
M6HE_X^I/]Q?YM0!+1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5%<_P#'K-_N
M'^52U%<_\>LW^X?Y4 2T444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MZMYG_P ^OQC_ )GK-%>3?\+L_P"I>_\ )W_[71_PNS_J7O\ R=_^UT?7*/\
M-^8?ZMYG_P ^OQC_ )GK-%>3?\+L_P"I>_\ )W_[71_PNS_J7O\ R=_^UT?7
M*/\ -^8?ZMYG_P ^OQC_ )GK-%>3?\+L_P"I>_\ )W_[71_PNS_J7O\ R=_^
MUT?7*/\ -^8?ZMYG_P ^OQC_ )GK-%>3?\+L_P"I>_\ )W_[71_PNS_J7O\
MR=_^UT?7*/\ -^8?ZMYG_P ^OQC_ )GK-%>3?\+L_P"I>_\ )W_[71_PNS_J
M7O\ R=_^UT?7*/\ -^8?ZMYG_P ^OQC_ )GK-%>3?\+L_P"I>_\ )W_[71_P
MNS_J7O\ R=_^UT?7*/\ -^8?ZMYG_P ^OQC_ )GK-%>3?\+L_P"I>_\ )W_[
M71_PNS_J7O\ R=_^UT?7*/\ -^8?ZMYG_P ^OQC_ )GK-%>3?\+L_P"I>_\
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MH **** "BBB@ J)O^/J/_<;^:U+43?\ 'U'_ +C?S6@"6BBB@ HHHH ****
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MY5+45S_QZS?[A_E0!+1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !7'?$C_ )$'6_\ ?A_]#CKL:X[XD?\
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M4O#GCOPQXLD>+1-8@NID&YHMK1R8]=K@$CWQBA:[ ]-SHJ*R+SQ/H]AXBLM
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M#/&=IXKL,';#J$2_OX,_^/+ZK_+\B?G>**2>5(HD9Y'8*J*,EB>@ KW3X?>
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MY/3^9KUSP?\ \B-H7_8.@_\ 18KA/V?O^1"O/^PG+_Z"E5+2I/\ K[5C./\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %17/_'K-_N'^52U%<_\ 'K-_N'^5 $M%%% !7SU-8^,+
M[XZ>+4\':K9Z==K'&9I+I0P9-L? RC\YQV%?0M>1>#O^3A?&W_7K'_**B*O-
M>C_)!)VA\U^HL'A_XW+<1F;QCHC1!P740KDKGD?\>]2_'&:YN['P[X:@F:*+
M6M22"9E[J"N!^; _\!%>KUYU\7_"^IZ]X?L=1T.,RZKH]TMW#$!DR =0!W/
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MT@G6=5 +;TY4@G(X/7!]J]8\'_\ (C:%_P!@Z#_T6*NIM4?G^C(B_=A\_O\
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MWQ3_ (T^%]%\.V6@ZYHFFVNFWL.HQQAK2(1!A@L"0N!D%1SUK7T[_DYS5O\
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M4MN,GWCDCD9QSCI7-?$[0/\ A%_@SX9T4NKO:ZA LCKT9RLA8CVR37JGC/\
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MI6UIO_)SFK?]@E?Y1U-/7V;\G]]F5+3G^7W716^.^EZ?I'PUL[;3+&VLK?\
MM6-O*MHEC3)CDR<* ,\4_P")MLWBGXA^#?!MQ(ZZ9.&N[A$;'F;0>,_16'_
MC5C]HC_DGUE_V$XO_0)*E^*6BZU;:IX>\;:!9M?76CG;/:H"6>(^@')ZL#C)
M^;/8TDU:[VYO_;?\[#DM$EORO\_^')_B+\,O"\O@'49=/T:SL;NPMFN()[:)
M8VRBYPQ'W@0".<]<]:Y3Q1'KWC;X%^&=2@MYM1DMY%DOK="2\ZIN3=@<GIDX
MYY)[4_Q%\79?'>@W'AGPGX=U235+Y/(G\U%VPJ>&Y!/N,MM Z^U=/K&D>+?
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M7_CZD_W%_FU2U$O_ !]2?[B_S:@"6BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ J*Y_X]9O\ </\ *I:BN?\ CUF_W#_*@"6BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MA_Y_-+_[^R?_ !%'_"F_$/\ S^:7_P!_9/\ XBO<**/J-'S^\/\ 6K,N\?\
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M%-^(?^?S2_\ O[)_\17N%%'U&CY_>'^M69=X_P#@*_S/#_\ A3?B'_G\TO\
M[^R?_$4?\*;\0_\ /YI?_?V3_P"(KW"BCZC1\_O#_6K,N\?_  %?YGA__"F_
M$/\ S^:7_P!_9/\ XBC_ (4WXA_Y_-+_ ._LG_Q%>X44?4:/G]X?ZU9EWC_X
M"O\ ,\/_ .%-^(?^?S2_^_LG_P 11_PIOQ#_ ,_FE_\ ?V3_ .(KW"BCZC1\
M_O#_ %JS+O'_ ,!7^9X?_P *;\0_\_FE_P#?V3_XBC_A3?B'_G\TO_O[)_\
M$5[A11]1H^?WA_K5F7>/_@*_S/#_ /A3?B'_ )_-+_[^R?\ Q%'_  IOQ#_S
M^:7_ -_9/_B*]PHH^HT?/[P_UJS+O'_P%?YGA_\ PIOQ#_S^:7_W]D_^(H_X
M4WXA_P"?S2_^_LG_ ,17N%%'U&CY_>'^M69=X_\ @*_S/#_^%-^(?^?S2_\
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MA_Y_-+_[^R?_ !%'_"F_$/\ S^:7_P!_9/\ XBO<**/J-'S^\/\ 6K,N\?\
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MG_CUF_W#_*@"6BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "HHO]9/_ +X_]!%2U%%_K)_]\?\ H(H EHHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@"*V_X]8?]P?RJ6HK;_CUA_W!_*I: "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
MBG_U8_WT_P#0A4M13_ZL?[Z?^A"I: "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *B;_CZC_P!QOYK4
MM1-_Q]1_[C?S6@"6BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** (HO\ 63_[X_\ 014M11?ZR?\
MWQ_Z"*EH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ J*V_X]8?]P?RJ6HK;_CUA_W!_*@"6BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH *BG_U8_WT_P#0A4M13_ZL?[Z?^A"@"6BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** ,S5
M_P#EC_P+^E%&K_\ +'_@7]** +UK_P >D/\ US7^52U%:_\ 'I#_ -<U_E4M
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %1+_ ,?4G^XO\VJ6HE_X^I/]Q?YM0!+1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 5%<_\>LW^X?Y5+45S_QZS?[A_E0!+1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!447^LG_ -\?^@BI:BB_UD_^^/\ T$4 2T444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!%;?\>L/
M^X/Y5+45M_QZP_[@_E4M !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 13_ZL?[Z?^A"I:BG_P!6/]]/
M_0A4M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %1-_P ?4?\ N-_-:EJ)O^/J/_<;^:T 2T444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110!%%_K)_]\?\ H(J6HHO]9/\ [X_]!%2T %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M5%;?\>L/^X/Y5+45M_QZP_[@_E0!+1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %13_ZL?[Z?^A"I:BG
M_P!6/]]/_0A0!+1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% &9J_P#RQ_X%_2BC5_\ EC_P+^E%
M %FVG06L((DX1>D;'M]*E\]/[LG_ '[;_"BU_P"/2'_KFO\ *I: (O/3^[)_
MW[;_  H\]/[LG_?MO\*EHH B\]/[LG_?MO\ "CST_NR?]^V_PJ6B@"+ST_NR
M?]^V_P *//3^[)_W[;_"I:* (O/3^[)_W[;_  H\]/[LG_?MO\*EHH B\]/[
MLG_?MO\ "CST_NR?]^V_PJ6B@"+ST_NR?]^V_P *//3^[)_W[;_"I:* (O/3
M^[)_W[;_  H\]/[LG_?MO\*EHH B\]/[LG_?MO\ "CST_NR?]^V_PJ6B@"+S
MT_NR?]^V_P *//3^[)_W[;_"I:* (O/3^[)_W[;_  H\]/[LG_?MO\*EHH B
M\]/[LG_?MO\ "CST_NR?]^V_PJ6B@"+ST_NR?]^V_P *//3^[)_W[;_"I:*
M(O/3^[)_W[;_  H\]/[LG_?MO\*EHH B\]/[LG_?MO\ "CST_NR?]^V_PJ6B
M@"+ST_NR?]^V_P *C6=/M+G$GW%_Y9MZGVJS42_\?4G^XO\ -J #ST_NR?\
M?MO\*//3^[)_W[;_  J6B@"+ST_NR?\ ?MO\*//3^[)_W[;_  J6B@"+ST_N
MR?\ ?MO\*//3^[)_W[;_  J6B@"+ST_NR?\ ?MO\*//3^[)_W[;_  J6B@"+
MST_NR?\ ?MO\*//3^[)_W[;_  J6B@"+ST_NR?\ ?MO\*//3^[)_W[;_  J6
MB@"+ST_NR?\ ?MO\*//3^[)_W[;_  J6B@"+ST_NR?\ ?MO\*//3^[)_W[;_
M  J6B@"+ST_NR?\ ?MO\*//3^[)_W[;_  J6B@"+ST_NR?\ ?MO\*//3^[)_
MW[;_  J6B@"+ST_NR?\ ?MO\*//3^[)_W[;_  J6B@"+ST_NR?\ ?MO\*//3
M^[)_W[;_  J6B@"+ST_NR?\ ?MO\*//3^[)_W[;_  J6B@"+ST_NR?\ ?MO\
M*//3^[)_W[;_  J6B@"+ST_NR?\ ?MO\*//3^[)_W[;_  J6B@"+ST_NR?\
M?MO\*//3^[)_W[;_  J6B@"+ST_NR?\ ?MO\*//3^[)_W[;_  J6B@"+ST_N
MR?\ ?MO\*//3^[)_W[;_  J6B@"+ST_NR?\ ?MO\*//3^[)_W[;_  J6B@"+
MST_NR?\ ?MO\*//3^[)_W[;_  J6B@"+ST_NR?\ ?MO\*//3^[)_W[;_  J6
MB@"+ST_NR?\ ?MO\*//3^[)_W[;_  J6B@"+ST_NR?\ ?MO\*//3^[)_W[;_
M  J6B@"+ST_NR?\ ?MO\*//3^[)_W[;_  J6B@"+ST_NR?\ ?MO\*//3^[)_
MW[;_  J6B@"+ST_NR?\ ?MO\*//3^[)_W[;_  J6B@"+ST_NR?\ ?MO\*//3
M^[)_W[;_  J6B@"+ST_NR?\ ?MO\*//3^[)_W[;_  J6B@"+ST_NR?\ ?MO\
M*//3^[)_W[;_  J6B@"+ST_NR?\ ?MO\*//3^[)_W[;_  J6B@"+ST_NR?\
M?MO\*//3^[)_W[;_  J6B@"+ST_NR?\ ?MO\*//3^[)_W[;_  J6B@"+ST_N
MR?\ ?MO\*//3^[)_W[;_  J6B@"+ST_NR?\ ?MO\*//3^[)_W[;_  J6B@"+
MST_NR?\ ?MO\*//3^[)_W[;_  J6B@"+ST_NR?\ ?MO\*//3^[)_W[;_  J6
MB@"+ST_NR?\ ?MO\*//3^[)_W[;_  J6B@"+ST_NR?\ ?MO\*//3^[)_W[;_
M  J6B@"+ST_NR?\ ?MO\*//3^[)_W[;_  J6B@"+ST_NR?\ ?MO\*//3^[)_
MW[;_  J6B@"+ST_NR?\ ?MO\*CN)T-M* ).4/6-AV^E6:BN?^/6;_</\J #S
MT_NR?]^V_P *//3^[)_W[;_"I:* (O/3^[)_W[;_  H\]/[LG_?MO\*EHH B
M\]/[LG_?MO\ "CST_NR?]^V_PJ6B@"+ST_NR?]^V_P *//3^[)_W[;_"I:*
M(O/3^[)_W[;_  H\]/[LG_?MO\*EHH B\]/[LG_?MO\ "CST_NR?]^V_PJ6B
M@"+ST_NR?]^V_P *//3^[)_W[;_"I:* (O/3^[)_W[;_  H\]/[LG_?MO\*E
MHH B\]/[LG_?MO\ "CST_NR?]^V_PJ6B@"+ST_NR?]^V_P *//3^[)_W[;_"
MI:* (O/3^[)_W[;_  H\]/[LG_?MO\*EHH B\]/[LG_?MO\ "CST_NR?]^V_
MPJ6B@"+ST_NR?]^V_P *//3^[)_W[;_"I:* (O/3^[)_W[;_  H\]/[LG_?M
MO\*EHH B\]/[LG_?MO\ "CST_NR?]^V_PJ6B@"+ST_NR?]^V_P *//3^[)_W
M[;_"I:* (O/3^[)_W[;_  H\]/[LG_?MO\*EHH B\]/[LG_?MO\ "CST_NR?
M]^V_PJ6B@"+ST_NR?]^V_P *//3^[)_W[;_"I:* (O/3^[)_W[;_  H\]/[L
MG_?MO\*EHH B\]/[LG_?MO\ "CST_NR?]^V_PJ6B@"+ST_NR?]^V_P *//3^
M[)_W[;_"I:* (O/3^[)_W[;_  H\]/[LG_?MO\*EHH B\]/[LG_?MO\ "CST
M_NR?]^V_PJ6B@"+ST_NR?]^V_P *//3^[)_W[;_"I:* (O/3^[)_W[;_  H\
M]/[LG_?MO\*EHH B\]/[LG_?MO\ "CST_NR?]^V_PJ6B@"+ST_NR?]^V_P *
M//3^[)_W[;_"I:* (O/3^[)_W[;_  H\]/[LG_?MO\*EHH B\]/[LG_?MO\
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M[LG_ '[;_"CST_NR?]^V_P *EHH B\]/[LG_ '[;_"CST_NR?]^V_P *EHH
MB\]/[LG_ '[;_"CST_NR?]^V_P *EHH B\]/[LG_ '[;_"CST_NR?]^V_P *
MEHH B\]/[LG_ '[;_"CST_NR?]^V_P *EHH B\]/[LG_ '[;_"CST_NR?]^V
M_P *EHH B\]/[LG_ '[;_"CST_NR?]^V_P *EHH B\]/[LG_ '[;_"CST_NR
M?]^V_P *EHH K6\Z"VB!$G"#I&Q[?2I//3^[)_W[;_"BV_X]8?\ <'\JEH B
M\]/[LG_?MO\ "CST_NR?]^V_PJ6B@"+ST_NR?]^V_P *//3^[)_W[;_"I:*
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M\]/[LG_?MO\ "CST_NR?]^V_PJ6B@"+ST_NR?]^V_P *//3^[)_W[;_"I:*
M(O/3^[)_W[;_  H\]/[LG_?MO\*EHH B\]/[LG_?MO\ "CST_NR?]^V_PJ6B
M@"+ST_NR?]^V_P *//3^[)_W[;_"I:* (O/3^[)_W[;_  H\]/[LG_?MO\*E
MHH B\]/[LG_?MO\ "CST_NR?]^V_PJ6B@"+ST_NR?]^V_P *//3^[)_W[;_"
MI:* (O/3^[)_W[;_  H\]/[LG_?MO\*EHH B\]/[LG_?MO\ "CST_NR?]^V_
MPJ6B@"+ST_NR?]^V_P *C:=/M*'$GW&_Y9MZCVJS43?\?4?^XW\UH //3^[)
M_P!^V_PH\]/[LG_?MO\ "I:* (O/3^[)_P!^V_PH\]/[LG_?MO\ "I:* (O/
M3^[)_P!^V_PH\]/[LG_?MO\ "I:* (O/3^[)_P!^V_PH\]/[LG_?MO\ "I:*
M (O/3^[)_P!^V_PH\]/[LG_?MO\ "I:* (O/3^[)_P!^V_PH\]/[LG_?MO\
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M[LG_ '[;_"CST_NR?]^V_P *EHH B\]/[LG_ '[;_"CST_NR?]^V_P *EHH
MB\]/[LG_ '[;_"CST_NR?]^V_P *EHH B\]/[LG_ '[;_"CST_NR?]^V_P *
MEHH B\]/[LG_ '[;_"HYYT,8XD^^O6-O[P]JLU%/_JQ_OI_Z$* #ST_NR?\
M?MO\*//3^[)_W[;_  J6B@"+ST_NR?\ ?MO\*//3^[)_W[;_  J6B@"+ST_N
MR?\ ?MO\*//3^[)_W[;_  J6B@"+ST_NR?\ ?MO\*//3^[)_W[;_  J6B@"+
MST_NR?\ ?MO\*//3^[)_W[;_  J6B@"+ST_NR?\ ?MO\*//3^[)_W[;_  J6
MB@"+ST_NR?\ ?MO\*//3^[)_W[;_  J6B@"+ST_NR?\ ?MO\*//3^[)_W[;_
M  J6B@"+ST_NR?\ ?MO\*//3^[)_W[;_  J6B@"+ST_NR?\ ?MO\*//3^[)_
MW[;_  J6B@"+ST_NR?\ ?MO\*//3^[)_W[;_  J6B@"+ST_NR?\ ?MO\*//3
M^[)_W[;_  J6B@"+ST_NR?\ ?MO\*//3^[)_W[;_  J6B@"+ST_NR?\ ?MO\
M*//3^[)_W[;_  J6B@"+ST_NR?\ ?MO\*//3^[)_W[;_  J6B@#*U20/Y6 P
MQG[RD>GK13M7_P"6/_ OZ44 7K7_ (](?^N:_P JEJ*U_P"/2'_KFO\ *I:
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH *B7_CZD_W%_FU2U$O_'U)_N+_ #:@"6BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ J*Y_X]9O]P_RJ6HKG_CUF_P!P_P J ):*** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH *BB_UD_P#OC_T$5+447^LG_P!\?^@B@"6BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** (K;_CU
MA_W!_*I:BMO^/6'_ '!_*I: "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH BG_U8_P!]/_0A4M13_P"K
M'^^G_H0J6@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "HF_P"/J/\ W&_FM2U$W_'U'_N-_-: ):**
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH BB_UD_^^/\ T$5+447^LG_WQ_Z"*EH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ J*V_X]8?]P?RJ6HK;_CUA_P!P?RH EHHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "HI_]6/\ ?3_T
M(5+44_\ JQ_OI_Z$* ):*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH S-7_Y8_\  OZ44:O_ ,L?
M^!?THH O6O\ QZ0_]<U_E4M16O\ QZ0_]<U_E4M !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %1+_Q
M]2?[B_S:I:B7_CZD_P!Q?YM0!+1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MI_\ ?J/_ .+KQ.BCV40YV>V?\+A\/_\ /GJ?_?J/_P"+H_X7#X?_ .?/4_\
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M?^A"@"6BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M %%%% !1110 4444 %1+_P ?4G^XO\VJ6HE_X^I/]Q?YM0!+1110 4451O\
M6=+TIX$U'4K.S>X;;"MQ.L9D/'"[B,GD=/44 7J*** "BBB@ HHHH **** "
MBBF12QSQB2*1)$.0&1@0<'!Y^M #Z*** "BBB@ HHIDLL<$32S2)'&O+.[
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M>[D!PQ^<X(!!Y((&!QR352.XTCX5^(M(NO"OC*+5M#N[@6]_IQO8IFC#?\M
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MJ=W'\TW^.A$ERQ<.RE^32_#4G^+'B>Z_X2#1_!MEKD6AI?*9[[49)1'Y4/(
M#$C!.UNX).!G!-<7JOA7PMX/TV77O!7Q'C_MNT'G&)]2@<7(')3:N"<\\'=G
MICG-:_QBTS3+7XD^'=<\264EUX<FA-I=%"XV,"Q!)0@_Q!L=PK=:DU?1O@1I
M&E/?LEG=@#*V]EJ<LLSGT"B7C\<#UK..D>;K=_G_ )&DOBMTLO\ @COBMKZ^
M)_@5I.M(H1KJX@=T'17PX8#Z,#3YO@E+KNA#6-:\3:G/XED@\Y9-Z^3$Y&X*
M%(R .G!'L!TJ+XI0:=;_  )TI=(TZXTZP:ZBD@M;DDR1JV]OFRS<G.>IZU[/
M%_R"$_ZX#_T&G/13:TU^[W28Z\B?;]3RWP#X]OHO@C?:[J;M=W>E>;"KRMDR
MD ; Q[\L!GVK$\-_":;X@:%!XH\7>(=3DU*^7SK<0NH6%#]W@@^QPNT#I4'P
M_P!(N-=_9]\2Z=:(7N9;F8QHO5V58V 'N<8KK?AK\2O##^ =.MM1UBSL+S3[
M=;>:&ZE6-OD& 5!^]D =,^E5*SE)O>R_%:O[Q*Z22[O\'H1_"S6=:L=?U_P+
MK]\U_<:5B2VNG)+/$<<$GG&"I&<XR1G@5Y_\+_ UYX]\.W=GJ6J75GX=MKUV
M6WM,*]Q,0,EB01A0%QP>IZ5V?PTNCXL^*'B[QC:I(-+=%L[>1UV^80%Y_) <
M=MPS6-\#/'.AZ/I&H:'J]_!I\WVI[F&6Y<1QR*0 0&/&05Z'KGC.#0M7[V_*
MOS_RU&]$^7;F_3_/0T?#UKJ?PL^)^G>%O[3N;[PYK,;?95N#DPR#/ ]#G .
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M% !1110 4444 %%%% !1110 4444 %1-_P ?4?\ N-_-:EJ)O^/J/_<;^:T
M2T444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110!%%_K)_]\?\ H(J6HHO]9/\ [X_]!%2T %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 5%;?\>L/^X/Y5+45M_QZP_[@_E0!+1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %13_ZL?[Z
M?^A"I:BG_P!6/]]/_0A0!+1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% &9J_P#RQ_X%_2BC5_\
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M'-(ATK2;?[/90[O+BWL^W)+'EB3U)[UH444-WW **** "BBB@ HHHH ****
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M62^N;S=EE4Y^7<BY]< ')QR!FNA^,'AG4KKPCHQ\/Z>]X^C7<<HMX\LYC52
M HY;^'@<UZE11TT[W^:#KKVM\F8'@[Q!?^)-"%_J6A76BW/FLAM+G=NP,8;Y
ME4X.?3M6IJB-)I-ZB*6=H'"JHR2=IX%6Z*4US)KN$7RM,\]^"VG7VE?#2TM-
M1LKBSN5FF)AN(FC< N<?*P!JC\$=*U'2="UN/4K"ZLWDU221%N86C++M7Y@&
M R/>O4**J_O.7=6_+_(27N\OG?\ /_,\K^('AKQ)IOC2Q\>>$;9;V[AA\B]L
MB>98_4#OP<8'((4@'FN>UJY\>?%Q;;0G\*W'AO1O.5[Z>\+;F .?EW*I/K@
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M&%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %<?\1?^1#UK_?A_]#CKL*YKQEIMWK'A/5;"PA\ZYE>/8FX+G#1D
M\D@= :<=T)['SO175_\ "M?%W_0)_P#)F+_XJC_A6OB[_H$_^3,7_P 575S1
M[F'*SE**ZO\ X5KXN_Z!/_DS%_\ %4?\*U\7?] G_P F8O\ XJCFCW#E9RE%
M=7_PK7Q=_P! G_R9B_\ BJ/^%:^+O^@3_P"3,7_Q5'-'N'*SE**ZO_A6OB[_
M *!/_DS%_P#%4?\ "M?%W_0)_P#)F+_XJCFCW#E9RE%=7_PK7Q=_T"?_ "9B
M_P#BJ/\ A6OB[_H$_P#DS%_\51S1[ARLY2BNK_X5KXN_Z!/_ ),Q?_%4?\*U
M\7?] G_R9B_^*HYH]PY6<I175_\ "M?%W_0)_P#)F+_XJC_A6OB[_H$_^3,7
M_P 51S1[ARLY2BNK_P"%:^+O^@3_ .3,7_Q5'_"M?%W_ $"?_)F+_P"*HYH]
MPY6<I175_P#"M?%W_0)_\F8O_BJ/^%:^+O\ H$_^3,7_ ,51S1[ARLY2BNK_
M .%:^+O^@3_Y,Q?_ !5'_"M?%W_0)_\ )F+_ .*HYH]PY6<I175_\*U\7?\
M0)_\F8O_ (JC_A6OB[_H$_\ DS%_\51S1[ARLY2BNK_X5KXN_P"@3_Y,Q?\
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M/_DS%_\ %4?\*U\7?] G_P F8O\ XJCFCW#E9RE%=7_PK7Q=_P! G_R9B_\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "HHO]9/_ +X_
M]!%2U%%_K)_]\?\ H(H EHHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@"*V_X]8?]P?RJ6HK;_CU
MA_W!_*I: "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH BG_U8_WT_P#0A4M13_ZL?[Z?^A"I: "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH *B;_CZC_P!QOYK4M1-_Q]1_[C?S6@"6BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** (
MHO\ 63_[X_\ 014M11?ZR?\ WQ_Z"*EH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ J*V_X]8?]P?R
MJ6HK;_CUA_W!_*@"6BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH *BG_U8_WT_P#0A4M13_ZL?[Z?^A"@
M"6BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** ,S5_P#EC_P+^E%&K_\ +'_@7]** +UK_P >D/\
MUS7^52U%:_\ 'I#_ -<U_E4M !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %1+_ ,?4G^XO\VJ6HE_X
M^I/]Q?YM0!+1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5%<_\>LW^X?Y5+45
MS_QZS?[A_E0!+1110 4444 %07ME;ZC87%E=Q"6VN(VBEC)(#*PP1Q[5/10U
M?1@8WAWPIH?A.S>TT/3H[.*1MS[2S,Y]V8DG\3Q6S111>X6"BBB@ K)TGPSI
M&AWVHWNG6GD7&I2^==OYCMYCY)SAB0/O'ICK6M10 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 5%%_K)_]\?^@BI:BB_UD_\ OC_T$4 2T444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110!%;?\>L/^X/Y5+45M_P >L/\ N#^52T %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!%/
M_JQ_OI_Z$*EJ*?\ U8_WT_\ 0A4M !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %1-_Q]1_[C?S6I:B
M;_CZC_W&_FM $M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 11?ZR?_ 'Q_Z"*EJ*+_ %D_^^/_
M $$5+0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !45M_QZP_[@_E4M16W_ !ZP_P"X/Y4 2T444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !44_^K'^^G_H0J6HI_P#5C_?3_P!"% $M%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 9
MFK_\L?\ @7]**-7_ .6/_ OZ44 7K7_CTA_ZYK_*I:JVTCBUA @D/R+R"O/'
MUJ7S7_Y]Y/S7_&@"6BHO-?\ Y]Y/S7_&CS7_ .?>3\U_QH EHJ+S7_Y]Y/S7
M_&CS7_Y]Y/S7_&@"6BHO-?\ Y]Y/S7_&CS7_ .?>3\U_QH EHJ+S7_Y]Y/S7
M_&CS7_Y]Y/S7_&@"6BHO-?\ Y]Y/S7_&CS7_ .?>3\U_QH EHJ+S7_Y]Y/S7
M_&CS7_Y]Y/S7_&@"6BHO-?\ Y]Y/S7_&CS7_ .?>3\U_QH EHJ+S7_Y]Y/S7
M_&CS7_Y]Y/S7_&@"6BHO-?\ Y]Y/S7_&CS7_ .?>3\U_QH EHJ+S7_Y]Y/S7
M_&CS7_Y]Y/S7_&@"6BHO-?\ Y]Y/S7_&CS7_ .?>3\U_QH EHJ+S7_Y]Y/S7
M_&CS7_Y]Y/S7_&@"6BHO-?\ Y]Y/S7_&CS7_ .?>3\U_QH EHJ+S7_Y]Y/S7
M_&CS7_Y]Y/S7_&@"6HE_X^I/]Q?YM1YK_P#/O)^:_P"-1K(_VESY$GW%XROJ
M?>@"S147FO\ \^\GYK_C1YK_ //O)^:_XT 2T5%YK_\ /O)^:_XT>:__ #[R
M?FO^- $M%1>:_P#S[R?FO^-'FO\ \^\GYK_C0!+147FO_P ^\GYK_C1YK_\
M/O)^:_XT 2T5%YK_ //O)^:_XT>:_P#S[R?FO^- $M%1>:__ #[R?FO^-'FO
M_P ^\GYK_C0!+147FO\ \^\GYK_C1YK_ //O)^:_XT 2T5%YK_\ /O)^:_XT
M>:__ #[R?FO^- $M%1>:_P#S[R?FO^-'FO\ \^\GYK_C0!+147FO_P ^\GYK
M_C1YK_\ /O)^:_XT 2T5%YK_ //O)^:_XT>:_P#S[R?FO^- $M%1>:__ #[R
M?FO^-'FO_P ^\GYK_C0!+147FO\ \^\GYK_C1YK_ //O)^:_XT 2T5%YK_\
M/O)^:_XT>:__ #[R?FO^- $M%1>:_P#S[R?FO^-'FO\ \^\GYK_C0!+147FO
M_P ^\GYK_C1YK_\ /O)^:_XT 2T5%YK_ //O)^:_XT>:_P#S[R?FO^- $M%1
M>:__ #[R?FO^-'FO_P ^\GYK_C0!+147FO\ \^\GYK_C1YK_ //O)^:_XT 2
MT5%YK_\ /O)^:_XT>:__ #[R?FO^- $M%1>:_P#S[R?FO^-'FO\ \^\GYK_C
M0!+147FO_P ^\GYK_C1YK_\ /O)^:_XT 2T5%YK_ //O)^:_XT>:_P#S[R?F
MO^- $M%1>:__ #[R?FO^-'FO_P ^\GYK_C0!+147FO\ \^\GYK_C1YK_ //O
M)^:_XT 2T5%YK_\ /O)^:_XT>:__ #[R?FO^- $M%1>:_P#S[R?FO^-'FO\
M\^\GYK_C0!+147FO_P ^\GYK_C1YK_\ /O)^:_XT 2T5%YK_ //O)^:_XT>:
M_P#S[R?FO^- $M%1>:__ #[R?FO^-'FO_P ^\GYK_C0!+147FO\ \^\GYK_C
M1YK_ //O)^:_XT 2T5%YK_\ /O)^:_XT>:__ #[R?FO^- $M%1>:_P#S[R?F
MO^-'FO\ \^\GYK_C0!+147FO_P ^\GYK_C1YK_\ /O)^:_XT 2T5%YK_ //O
M)^:_XT>:_P#S[R?FO^- $M%1>:__ #[R?FO^-'FO_P ^\GYK_C0!+147FO\
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M]!%'FO\ \^\GYK_C4<<C^9-^XD.7]5X^4>] %FBHO-?_ )]Y/S7_ !H\U_\
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M?FO^-'FO_P ^\GYK_C0!+147FO\ \^\GYK_C1YK_ //O)^:_XT 2T5%YK_\
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MU_\ GWD_-?\ &@"6BHO-?_GWD_-?\:/-?_GWD_-?\: ):*B\U_\ GWD_-?\
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M:_\ S[R?FO\ C0!+147FO_S[R?FO^-'FO_S[R?FO^- $M%1>:_\ S[R?FO\
MC1YK_P#/O)^:_P"- $M%1>:__/O)^:_XT>:__/O)^:_XT 2T5%YK_P#/O)^:
M_P"-'FO_ ,^\GYK_ (T 2T5%YK_\^\GYK_C1YK_\^\GYK_C0!+147FO_ ,^\
MGYK_ (T>:_\ S[R?FO\ C0!+147FO_S[R?FO^-'FO_S[R?FO^- $M%1>:_\
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M10 4444 %%%% !1110 4444 %1+_ ,?4G^XO\VJ6HE_X^I/]Q?YM0!+1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 5%<_\>LW^X?Y5+45S_QZS?[A_E0!+111
M0 445YIXD^-_AKPMXAO-%OK'5I+FU8*[011E#E0W!,@/0^E*_0+'I=%>/_\
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M;>>.[[PA'!=#4+.W%Q)(R+Y14A#@'=G/SCMZT+78._D='1110 4444 %%%%
M!1110 4444 %%%% !447^LG_ -\?^@BI:BB_UD_^^/\ T$4 2T444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110!%;?\>L/^X/Y5+45M_QZP_[@_E4M !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 13_ZL?[Z
M?^A"I:BG_P!6/]]/_0A4M !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %1-_P ?4?\ N-_-:EJ)O^/J
M/_<;^:T 2T444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110!%%_K)_]\?\ H(J6HHO]9/\ [X_]!%2T
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 5%;?\>L/^X/Y5+45M_QZP_[@_E0!+1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M13_ZL?[Z?^A"I:BG_P!6/]]/_0A0!+1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% &9J_P#RQ_X%
M_2BC5_\ EC_P+^E% %ZU_P"/2'_KFO\ *I:BM?\ CTA_ZYK_ "J6@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "HE_X^I/]Q?YM4M1+_Q]2?[B_P VH EHHHH **** "BBB@ HHHH
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M^T/I6Y\1=<DT'XN>#M6O;.6:XBT\E[6V&YGE;>H1>O\ $0._XUM2?\G/1?\
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M +"\?\J]=HAI%^K_ "7_  WH3+62?DOU,SQ!KMEX:T&\UC4'*VUK'O;;U8]
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M'XX> EM=GVT>89L<-Y6>,^V/,Q^-)8(K?M/:HS*"4TI2I]#MC'\B:(^\X_\
M;U_D)Z<WR_%FT?'FM^%? =SKOCW3+:TU!;CRK>RLG!\[(&WG>P'\1// 7IVK
MFI/B5\3;"Q_X2#4? ULOA_'F,J.1.D9[M\Y(QU),8'TJY\;?+_M+P1]J_P"/
M#^UE\_/W<97K^&[]:]5OO(_L^Y^T[?L_E-YN[IMP<Y_"I;?*Y]OT2_,=M5'O
M^K/+_B+XHO\ Q#\(/[6\+VL-SIM]"WVYIR ]O%@[L#</F##'&[Z=ZC^$6M^(
MK+P2L_B*QL[/PU96'FVEXC O(H)+%AO)Z9_A%<UX+W_\,U^)\[O*W7/E9_NX
M7^N:U-4,P_97A\DL#]CA#;?[OG#/X8JI>YSM>7X_Y"BN9P3\_P '^I:C^(_Q
M&\2J=2\(>"[>3102$EOG DE /)7]XOIV#<]S7;> O',/C73KDR6<FGZI8R>3
M>V,OWHFYQU .#@]0""".V3YOX9T3XPW'A?2YM'\7:'%IKVL9MHS"N4CVC /^
MCGD#@\GFMOPAX%\::!KOB'7]>U/3;RZU"P9,VA(+2@#:Q7RU7H#R/6B7N<WD
MGZW7^8E[UO-KTU_R$O\ XG^*M>UN]T[X>^&X=3@L)#'/>W;XC=AP0OS(/I\Q
M)'.*V/!'Q$OO$D^JZ'JND?V;XFTZ,NUJ2=DH[$9Z#)7N>&!!.>*'P %N/AFA
MB $QO)O/]2_&,_\  =M=>VI>%8_':Z=Y=J/$\EMOWBT)E,/O+MP!QT+>E-QM
M[OE^-KZ!S7][L_UZGA_@_4_B$GQ6U^:UT+3WU69HQJL#.-D"9'*'S1DX]VKU
MC3?&NI7GQBU?PA)!:C3[.R6XCD5&\TL1&<$[L8^<]O2N>\"_\EU\>?[D?_LM
M-T/_ ).;\2_]@M/_ $&"B#NH^C?YC:^-^:_-%G7_ (G:_>>*;OPWX"T"/5KR
MQ.+JYN&Q"A'5?O*.#D9+#D' /6K?@[XEZE?>)SX3\7Z*-(UW87B*-F*<#G"\
MGL"00S X/.1BLWX#>7_9WB??_P ?W]KOY^?O8P,9_'?^M)\3O+_X6M\//(_X
M_/M3;MO7R]R=?;[_ .M*&\$^MOQ5]/0)_:MTO^#_ %'^)_BOK6@_$B[\,6>B
M1ZGF"/[%#"&65YF"GYVR1L W'A>PY R:J1_%'QKX<\0Z?:>._#%I8V%_((X[
MBU;/EDG&20[@XR,C@XYJ>P16_:>U1F4$II2E3Z';&/Y$T[]H, ^$M'.!D:K'
M@_\  'HAM!OJ[?\ DS0Y*[DET7Z7/7**1/N+]*6@E:H****!A1110 4444 %
M11?ZR?\ WQ_Z"*EK-U2\DT[1]7OH55I;:&29 XR"5CR,X[<4 :5%>)_\+A\0
M?\^>F?\ ?J3_ .+H_P"%P^(/^?/3/^_4G_Q=:>RD1SH]LHKQ/_A</B#_ )\]
M,_[]2?\ Q='_  N'Q!_SYZ9_WZD_^+H]E(.='ME%>)_\+A\0?\^>F?\ ?J3_
M .+H_P"%P^(/^?/3/^_4G_Q='LI!SH]LHKQ/_A</B#_GSTS_ +]2?_%T?\+A
M\0?\^>F?]^I/_BZ/92#G1[917B?_  N'Q!_SYZ9_WZD_^+H_X7#X@_Y\],_[
M]2?_ !='LI!SH]LHKQ/_ (7#X@_Y\],_[]2?_%T?\+A\0?\ /GIG_?J3_P"+
MH]E(.='ME%>)_P#"X?$'_/GIG_?J3_XNC_A</B#_ )\],_[]2?\ Q='LI!SH
M]LHKQ/\ X7#X@_Y\],_[]2?_ !='_"X?$'_/GIG_ 'ZD_P#BZ/92#G1[917B
M?_"X?$'_ #YZ9_WZD_\ BZ/^%P^(/^?/3/\ OU)_\71[*0<Z/;**\3_X7#X@
M_P"?/3/^_4G_ ,71_P +A\0?\^>F?]^I/_BZ/92#G1[917B?_"X?$'_/GIG_
M 'ZD_P#BZ/\ A</B#_GSTS_OU)_\71[*0<Z/;**\3_X7#X@_Y\],_P"_4G_Q
M='_"X?$'_/GIG_?J3_XNCV4@YT>V45XG_P +A\0?\^>F?]^I/_BZ/^%P^(/^
M?/3/^_4G_P 71[*0<Z/;**\3_P"%P^(/^?/3/^_4G_Q='_"X?$'_ #YZ9_WZ
MD_\ BZ/92#G1[917B?\ PN'Q!_SYZ9_WZD_^+H_X7#X@_P"?/3/^_4G_ ,71
M[*0<Z/9[;_CUA_W!_*I:\13XO:_'&J"STS"@ 9BD_P#BZEA^,.MB=#/8Z>T(
M8;U1'5B.^"6.#^!H]E(.='M-%4-&UFRU[38[^PEWQ/U!^\C=U8=B*OUF6%%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% $4_P#JQ_OI_P"A"I:BG_U8_P!]/_0A4M !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %1-_Q]
M1_[C?S6I:B;_ (^H_P#<;^:T 2T444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!%%_K)_]\?^@BI:
MBB_UD_\ OC_T$5+0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !45M_QZP_[@_E4M16W_'K#_N#^5 $
MM%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 5%/\ ZL?[Z?\ H0J6HI_]6/\ ?3_T(4 2T444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110!F:O_ ,L?^!?THHU?_EC_ ,"_I10!>M?^/2'_ *YK_*I:BM?^/2'_
M *YK_*I: "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH *B7_ (^I/]Q?YM4M1+_Q]2?[B_S:@"6BBB@
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M0 4444 13_ZL?[Z?^A"I:BG_ -6/]]/_ $(5+0 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !43?\?4
M?^XW\UJ6HF_X^H_]QOYK0!+1110 4444 %%%% !1110 4444 %%%% !1110
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M]2*74?$ND:3K&G:3>W?E7VHEEM8O+=O,(QGD @=1U(KSGQQ_R7GP+_USD_\
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MK&GBZCG\,2.)+%9)29HV.,C&,8Y(//50<<FO0Z;MNA>3"BBBD 4444 %%%%
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MHH **** "BBB@ HHHH **** "HI_]6/]]/\ T(5+44_^K'^^G_H0H EHHHH
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MK)=Q7NPHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH *BN?^/6;_</\JEJ*Y_X]9O\ </\ *@"6BBB@ KQA/'&LWFM:K:?"
M_P $:?-##.5NK]T6%)Y!U/!0$]<98DYS@9KV>O$;/PW\3OA[JVIVOA*QT[5M
M&O;AKB/[2Z@Q$^N70YP #C(XSP:7VM>P_LF;!_PF'_"\O"4WB][%+N6*4PP6
M>,11['X)[\Y[FNC^&B)??%CX@ZA=X>^ANA;Q%EY2+<XX]B$3\JS+#P-\0/\
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MDX^27ZEKP-96]I\.]#M88PL1T^(E?4L@+$_4DG\:\N^&0"_ 7Q8 , ?;0/\
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M."<G\ :TG_%B_-?D3'^')>3_ #,3XS_\C%X!_P"PL/\ T*.NY\?D+\//$1)
M']G3]?\ <-8OQ5\$7WC+1+-M(N$@U73K@7%L9#@-ZC/8\ @^WXCE+S2OBUXR
M\/WNE>((+'2[1;9\BT=/.O7"_(A.]E52P&?N\9'2L7K"4?-_C;_(U6DXR]/S
M?^9/X9\*?\)I^SMI^BK<"WFE1GBD894.LS$9]CC!^M9<'B/XN^"K:*QU7PQ%
MKFGP+Y8EMX][-&!@<QYP,=V3/K72Z?\ #FZU7X(VGA+6$%EJ,:LZDLK^5*)&
M922I(((.#@]":R[6Y^.&F6\6DII.BWB1*(EU&2522!P&/[Q2?^^,UI/XY6Z_
M<]/Z1E!>Y&__  VIHZ/XH\/^)_A!XEDT'2XM*$%E<K<6,42H(W,1Y&T $''7
M Z>U<!J$TL7[*^DHC$)+>E),?W?.D/\ ,"O1_#OP]U'P_P##OQ+9W$\=_K^M
M17$D[1X56E=&"J"<#J2<G ^;TIOASX>W%Y\$X?"'B"$V=V5ESAED,+^:SHV5
M)!Z@XSTR*4MI?]N_@]47%VY?5_E9'?Z396EEH=G96D:"TBMTCC51\I7;Z5XS
M\/XTL]+^*>FVO%A;37 @51\J_+*,#\%7\JL6MI\;-%TU?#=G!I5U;1IY,.K-
M(N^-.@ZL#P/5"?K75^&/A]+X3^'.JZ0DHO=7OX9GN)@<"25D( !;L.!D]3D\
M9I5-5.2ZIK[]14].2+Z-?@5/@/:PP?"VSECC59)YYGE8#EB'*C/X "LSPHBP
M_M&^+UC4*K62,0.A)$1)_,FNK^%.@ZEX:^'MAI>KVWV:]B>4O'O5\ N2.5)'
M0CO6;H7A?6;/XV>(O$-Q9[-*O+1(X)_-0[V CR-H.X?=/4=JTE;VM_)_DB4O
MW;7FOS9Z-1114%!1110 4444 %8OB/\ Y%;Q!_UZ3?\ HFMJL7Q'_P BMX@_
MZ])O_1--;B>Q\V4445UG.%%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %=/X-\&W7BJ^R=T.GQ'
M]]/C_P =7U;^7Y G@WP;=>*K[)W0Z?$?WT^/_'5]6_E^0/ONGZ?:Z78Q65E"
ML-O$,*B_S]S[UG.=M$7&-]6&GZ?:Z78Q65E"L-O$,*B_S]S[U9HHKG-@HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@"
M*?\ U8_WT_\ 0A4M13_ZL?[Z?^A"I: "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *B;_CZC_W&_FM2
MU$W_ !]1_P"XW\UH EHHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@"*+_63_ .^/_014M11?ZR?_
M 'Q_Z"*EH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ J*V_P"/6'_<'\JEJ*V_X]8?]P?RH EHHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "HI_P#5C_?3_P!"%2U%/_JQ_OI_Z$* ):*** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M S-7_P"6/_ OZ44:O_RQ_P"!?THH O6O_'I#_P!<U_E4M16O_'I#_P!<U_E4
MM !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %1+_P ?4G^XO\VJ6HE_X^I/]Q?YM0!+1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 5%<_P#'K-_N'^52U%<_\>LW^X?Y4 2T444 %%%4
M[35M-U"YN;:RU"UN9[5MEQ%#,KM"W(PX!RIX/7T- %RO+O%/PUU__A+Y_%7@
MC7TTO4;M0MU%<#,;X &?NL.PX*GGG->HT4K:W'?H>5Z)\,_$6H>);+7_ !_X
MACU6?3VW6MI;IB%6ZAC\JCK@X"\D#)(&*]4JG%JNG3ZE-IL6H6LE_"NZ6U29
M3+&..63.0.1U'<5<JKZ6%U"BBBD 4444 %%%% !1110 4444 %%%% !1110
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ J*?\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%11?ZR?_ 'Q_Z"*EJ*+_ %D_^^/_ $$4 2T444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!%;?\>L
M/^X/Y5+45M_QZP_[@_E4M !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 13_ .K'^^G_ *$*EJ*?_5C_
M 'T_]"%2T %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 5$W_'U'_N-_-:EJ)O\ CZC_ -QOYK0!+111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% $47^LG_WQ_Z"*EJ*+_63_P"^/_014M !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %16W_'K#_N#^52U%;?\>L/^X/Y4 2T444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !44_P#JQ_OI_P"A
M"I:BG_U8_P!]/_0A0!+1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% &9J_\ RQ_X%_2BC5_^6/\
MP+^E% %ZU_X](?\ KFO\JEJ*U_X](?\ KFO\JEH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ J)?\
MCZD_W%_FU2U$O_'U)_N+_-J ):*** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 5%%_K)_]\?\ H(J6HHO]9/\ [X_]!% $M%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 16W_ !ZP_P"X/Y5+45M_QZP_[@_E4M !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 13_P"K
M'^^G_H0J6HI_]6/]]/\ T(5+0 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !43?\?4?^XW\UJ6HF_X^
MH_\ <;^:T 2T444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110!%%_K)_P#?'_H(J6HHO]9/_OC_ -!%
M2T %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 5%;?\ 'K#_ +@_E4M16W_'K#_N#^5 $M%%% !1110
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M^$HA_P"?9_\ OH4?\)1#_P ^S_\ ?0KF:*/J\ ]O,Z;_ (2B'_GV?_OH4?\
M"40_\^S_ /?0KF:*/J\ ]O,Z;_A*(?\ GV?_ +Z%'_"40_\ /L__ 'T*YFBC
MZO /;S.F_P"$HA_Y]G_[Z%'_  E$/_/L_P#WT*YFBCZO /;S.F_X2B'_ )]G
M_P"^A1_PE$/_ #[/_P!]"N9HH^KP#V\SIO\ A*(?^?9_^^A1_P )1#_S[/\
M]]"N9HH^KP#V\SIO^$HA_P"?9_\ OH4?\)1#_P ^S_\ ?0KF:*/J\ ]O,Z;_
M (2B'_GV?_OH4?\ "40_\^S_ /?0KF:*/J\ ]O,Z;_A*(?\ GV?_ +Z%'_"4
M0_\ /L__ 'T*YFBCZO /;S.F_P"$HA_Y]G_[Z%-'B6$2L_V=^5 QN';/^-<W
M11]7@'MYG3?\)1#_ ,^S_P#?0H_X2B'_ )]G_P"^A7,T4?5X![>9TW_"40_\
M^S_]]"C_ (2B'_GV?_OH5S-%'U> >WF=-_PE$/\ S[/_ -]"C_A*(?\ GV?_
M +Z%<S11]7@'MYG3?\)1#_S[/_WT*/\ A*(?^?9_^^A7,T4?5X![>9TW_"40
M_P#/L_\ WT*/^$HA_P"?9_\ OH5S-%'U> >WF=-_PE$/_/L__?0H_P"$HA_Y
M]G_[Z%<S11]7@'MYG3?\)1#_ ,^S_P#?0H_X2B'_ )]G_P"^A7,T4?5X![>9
MTW_"40_\^S_]]"C_ (2B'_GV?_OH5S-%'U> >WF=-_PE$/\ S[/_ -]"C_A*
M(?\ GV?_ +Z%<S11]7@'MYG3?\)1#_S[/_WT*/\ A*(?^?9_^^A7,T4?5X![
M>9TW_"40_P#/L_\ WT*/^$HA_P"?9_\ OH5S-%'U> >WF=-_PE$/_/L__?0H
M_P"$HA_Y]G_[Z%<S11]7@'MYG3?\)1#_ ,^S_P#?0H_X2B'_ )]G_P"^A7,T
M4?5X![>9TW_"40_\^S_]]"C_ (2B'_GV?_OH5S-%'U> >WF=-_PE$/\ S[/_
M -]"C_A*(?\ GV?_ +Z%<S11]7@'MYG3?\)1#_S[/_WT*/\ A*(?^?9_^^A7
M,T4?5X![>9TW_"40_P#/L_\ WT*/^$HA_P"?9_\ OH5S-%'U> >WF=-_PE$/
M_/L__?0H_P"$HA_Y]G_[Z%<S11]7@'MYG3?\)1#_ ,^S_P#?0H_X2B'_ )]G
M_P"^A7,T4?5X![>9TW_"40_\^S_]]"C_ (2B'_GV?_OH5S-%'U> >WF=-_PE
M$/\ S[/_ -]"C_A*(?\ GV?_ +Z%<S11]7@'MYG3?\)1#_S[/_WT*/\ A*(?
M^?9_^^A7,T4?5X![>9TW_"40_P#/L_\ WT*/^$HA_P"?9_\ OH5S-%'U> >W
MF=-_PE$/_/L__?0H_P"$HA_Y]G_[Z%<S11]7@'MYG3?\)1#_ ,^S_P#?0H_X
M2B'_ )]G_P"^A7,T4?5X![>9TW_"40_\^S_]]"C_ (2B'_GV?_OH5S-%'U>
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MT*YFBCZO /;S.F_X2B'_ )]G_P"^A1_PE$/_ #[/_P!]"N9HH^KP#V\SIO\
MA*(?^?9_^^A1_P )1#_S[/\ ]]"N9HH^KP#V\SIO^$HA_P"?9_\ OH4?\)1#
M_P ^S_\ ?0KF:*/J\ ]O,Z;_ (2B'_GV?_OH4?\ "40_\^S_ /?0KF:*/J\
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M#V\SIO\ A*(?^?9_^^A1_P )1#_S[/\ ]]"N9HH^KP#V\SIO^$HA_P"?9_\
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M2B'_ )]G_P"^A7,T4?5X![>9TW_"40_\^S_]]"C_ (2B'_GV?_OH5S-%'U>
M>WF=-_PE$/\ S[/_ -]"C_A*(?\ GV?_ +Z%<S11]7@'MYG3?\)1#_S[/_WT
M*/\ A*(?^?9_^^A7,T4?5X![>9TW_"40_P#/L_\ WT*/^$HA_P"?9_\ OH5S
M-%'U> >WF=(OB6%6<_9W.YL_>'' ']*=_P )1#_S[/\ ]]"N9HH^KP#V\SIO
M^$HA_P"?9_\ OH4?\)1#_P ^S_\ ?0KF:*/J\ ]O,Z;_ (2B'_GV?_OH4?\
M"40_\^S_ /?0KF:*/J\ ]O,Z;_A*(?\ GV?_ +Z%'_"40_\ /L__ 'T*YFBC
MZO /;S.F_P"$HA_Y]G_[Z%'_  E$/_/L_P#WT*YFBCZO /;S.F_X2B'_ )]G
M_P"^A1_PE$/_ #[/_P!]"N9HH^KP#V\SIO\ A*(?^?9_^^A1_P )1#_S[/\
M]]"N9HH^KP#V\SIO^$HA_P"?9_\ OH4?\)1#_P ^S_\ ?0KF:*/J\ ]O,Z;_
M (2B'_GV?_OH4?\ "40_\^S_ /?0KF:*/J\ ]O,Z;_A*(?\ GV?_ +Z%'_"4
M0_\ /L__ 'T*YFBCZO /;S.F_P"$HA_Y]G_[Z%'_  E$/_/L_P#WT*YFBCZO
M /;S.F_X2B'_ )]G_P"^A1_PE$/_ #[/_P!]"N9HH^KP#V\SIO\ A*(?^?9_
M^^A1_P )1#_S[/\ ]]"N9HH^KP#V\SIO^$HA_P"?9_\ OH4?\)1#_P ^S_\
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M/_WT*/\ A*(?^?9_^^A7,T4?5X![>9TW_"40_P#/L_\ WT*/^$HA_P"?9_\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#H_"O
M_+W_ , _]FHH\*_\O?\ P#_V:BO/K_Q&=]'X$<_-_KY/]X_SIE/F_P!?)_O'
M^=,KOCLCBENPKR'Q?J?B/P;XY75A/>76CRMO6!IG\GD89,<A3GD<>E>O4V2*
M.:-HY45T8896&0?J*F<'*S3LT.$E&]U=,\NU/XQZ-<:3/#;Z9>23RQE-DZH(
M\D8Y(8DC\.?:H_A'X>NUTC5;N[C>*VOXQ#$#P77#98#T^;@_6O1(O#FA03":
M+1=.CE!R'2U0-GZXK3J%2;;E-WTL4ZB4>6*/$O!.KQ?#SQ%JFD^(!);1R[=L
MVQF&5)P0 "2&!Z@=JZK2?B/=:_XR.F:1IBW6F9&;EMR,BX^9SU&.N!@$\>M=
MS>Z98:DBI?6-M=*O03Q*X'YBG6EC::?#Y-E:P6T6<[(8P@_(4X0G&R;T7]:A
M*<97=M6>0^*/^2X:;_UUMOZ5#\96=/%&F-'G>+8%<>N\XKU^71],GOEOIM.M
M)+M2"L[P*9 1TPQ&>*\C^,'_ "-VD_\ 7NO_ *&:QG!QC&-_M?F:TYJ4K_W3
MH=3^*>D?\(O<*1-'K#0M$UD\3 QR$8.21C /OGVJE\.-"NM-\$:UJ%U$T1OH
M&,2L,$HJ-AL>Y)Q^?>O1YM&TNZNEN[C3;.6Y7&)I(%9QCI\Q&:N.B21M&ZJR
M,"K*PR"/0BM73<N9R>K31DJB22BM+IGD?P:@6ZTO7[=R0DOEHV/0JXJAX0U0
M_#;Q-J&EZ_'+#;7&-LX0E?E)VN .JD$],D5[%8Z7IVF!Q86%K:!\;Q;PK'NQ
MTS@<U)=V-I?P^3>6L%S%UV31AQ^1H]FURN+U2L/VB?,FM'J>.>-M=7XA:OIV
MB>'(Y+F.-B[3%"JDG S@C(51U)'?\_8--LETW2[2Q1BRV\*1!CW"@#/Z4MEI
MUEIT1BL;.WM8R<E((E0$_0"K-73ARWONR)SYK);(X[QUXKL_#T$-OJ.ARZA:
MW/5F53%G/(.<_-CG&/QZUYIXN/P]GTAI_#YFCU)F!6%%D"C)YW;Q@<9^Z>N.
MU>\RQ1S1M'+&LD;##*XR"/<51@\/Z+:W N+?1]/AF!R)([9%8'Z@9K.=)S;N
M_P -2X5%&UC'^'=MJ%IX(L(M1#K, Q1)/O*A)*@_AV[# K:UNTN;_1+VUL[A
M[>YDB812HQ4JW8Y'(YJ_16TES*QFG9W/%?#/Q&O_  K+<Z7XI@U"Y97+!W??
M+&>FWYSRO&0<_GFJ/CCQC#X[DL--T?3+@NLA*M(H\QB1C: I.!WZ]AZ5[;>Z
M7I^I "^L;:Z"]!/"KX_,466EZ=IH(L;"UM0W7R(53/Y"L72G)<LGH:JI%/FB
MM3S/Q[X2O1\/=&V*9KC28@LRI\WRE0&(]0"!^%5+#QAX$@\*P27&@V,NJQ1*
MC6QL5S(X&-V_:1@]<DY]J]BK-/A[1&N?M+:/IYGSN\TVR;L^N<9IRIOF;CU$
MJBY4I=#G=,N=.U#P'J>H:=H2Z3'/:RY00I'YF$/S#;U')P37-?!'_CVUG_?B
M_DU>KO%'+$T4B*\;*59&&00>Q'I5:QTO3M,#BPL+6T#XWBWA6/=CIG YJE"U
M3G\K$N?N./G<\W^-O_(+TG_KN_\ Z"*C\=Z%<:I\.="O[6-I'L;>,NBC)\MD
M7)Q[$#\,UZ;?:9I^IHB7]C;7:H<J)XED"GVR.*L1QQPQ)%$BI&@"JBC 4#H
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110!T?A7_E[_ . ?^S44>%?^7O\ X!_[
M-17GU_XC.^C\".?F_P!?)_O'^=,I\W^OD_WC_.F5WQV1Q2W84444R0HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M[[KL**/K$P]A X__ (1W4/[B?]]TG_"/WX<+M3)!(&__ #ZUV-1-_P ?4?\
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MZA_<3_ONNPHH^L3#V$#C_P#A'=0_N)_WW1_PCNH?W$_[[KL**/K$P]A X_\
MX1W4/[B?]]T?\([J']Q/^^Z["BCZQ,/80./_ .$=U#^XG_?='_".ZA_<3_ON
MNPHH^L3#V$#C_P#A'=0_N)_WW1_PCNH?W$_[[KL**/K$P]A X_\ X1W4/[B?
M]]T?\([J']Q/^^Z["BCZQ,/80./_ .$=U#^XG_?='_".ZA_<3_ONNPHH^L3#
MV$#C_P#A'=0_N)_WW1_PCNH?W$_[[KL**/K$P]A X_\ X1W4/[B?]]T?\([J
M']Q/^^Z["BCZQ,/80./_ .$=U#^XG_?='_".ZA_<3_ONNPHH^L3#V$#C_P#A
M'=0_N)_WW1_PCNH?W$_[[KL**/K$P]A X_\ X1W4/[B?]]T?\([J']Q/^^Z[
M"BCZQ,/80./_ .$=U#^XG_?=(OA^_=0RJA!&0=]=C45M_P >L/\ N#^5'UB8
M>P@<I_PCNH?W$_[[H_X1W4/[B?\ ?==A11]8F'L(''_\([J']Q/^^Z/^$=U#
M^XG_ 'W7844?6)A["!Q__".ZA_<3_ONC_A'=0_N)_P!]UV%%'UB8>P@<?_PC
MNH?W$_[[H_X1W4/[B?\ ?==A11]8F'L(''_\([J']Q/^^Z/^$=U#^XG_ 'W7
M844?6)A["!Q__".ZA_<3_ONC_A'=0_N)_P!]UV%%'UB8>P@<?_PCNH?W$_[[
MH_X1W4/[B?\ ?==A11]8F'L(''_\([J']Q/^^Z/^$=U#^XG_ 'W7844?6)A[
M"!Q__".ZA_<3_ONC_A'=0_N)_P!]UV%%'UB8>P@<?_PCNH?W$_[[H_X1W4/[
MB?\ ?==A11]8F'L(''_\([J']Q/^^Z/^$=U#^XG_ 'W7844?6)A["!Q__".Z
MA_<3_ONC_A'=0_N)_P!]UV%%'UB8>P@<?_PCNH?W$_[[H_X1W4/[B?\ ?==A
M11]8F'L(''_\([J']Q/^^Z/^$=U#^XG_ 'W7844?6)A["!Q__".ZA_<3_OND
M;P_?J,E4 R!]_P!>*[&HI_\ 5C_?3_T(4?6)A["!RG_".ZA_<3_ONC_A'=0_
MN)_WW7844?6)A["!Q_\ PCNH?W$_[[H_X1W4/[B?]]UV%%'UB8>P@<?_ ,([
MJ']Q/^^Z/^$=U#^XG_?==A11]8F'L(''_P#".ZA_<3_ONC_A'=0_N)_WW784
M4?6)A["!Q_\ PCNH?W$_[[H_X1W4/[B?]]UV%%'UB8>P@<?_ ,([J']Q/^^Z
M/^$=U#^XG_?==A11]8F'L(''_P#".ZA_<3_ONC_A'=0_N)_WW7844?6)A["!
MQ_\ PCNH?W$_[[H_X1W4/[B?]]UV%%'UB8>P@<?_ ,([J']Q/^^Z/^$=U#^X
MG_?==A11]8F'L(''_P#".ZA_<3_ONC_A'=0_N)_WW7844?6)A["!Q_\ PCNH
M?W$_[[H_X1W4/[B?]]UV%%'UB8>P@<?_ ,([J']Q/^^Z/^$=U#^XG_?==A11
M]8F'L(''_P#".ZA_<3_ONC_A'=0_N)_WW7844?6)A["!Q_\ PCNH?W$_[[H_
MX1W4/[B?]]UV%%'UB8>P@<?_ ,([J']Q/^^Z/^$=U#^XG_?==A11]8F'L(&!
MI<,FC>;]J3_6XV["#TSG^8HJYJ__ "Q_X%_2BLI2<G=FD8J*LB]:_P#'I#_U
MS7^52U%:_P#'I#_US7^52U)04444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !42_\ 'U)_N+_-JEJ)?^/J
M3_<7^;4 2T444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %17/\ QZS?[A_E4M17
M/_'K-_N'^5 $M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %11?ZR?_ 'Q_Z"*EJ*+_ %D_^^/_ $$4 2T4
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110!%;?\>L/^X/Y5+45M_QZP_[@_E4M !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M 13_ .K'^^G_ *$*EJ*?_5C_ 'T_]"%2T %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5$W_'U'_N-_
M-:EJ)O\ CZC_ -QOYK0!+1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% $47^LG_WQ_Z"*EJ*+_63
M_P"^/_014M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %16W_'K#_N#^52U%;?\>L/^X/Y4 2T444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !44_P#JQ_OI_P"A"I:BG_U8_P!]/_0A0!+1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% &9J_\ RQ_X%_2BC5_^6/\ P+^E% %ZU_X](?\ KFO\JEJ*U_X](?\ KFO\
MJEH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ J)?\ CZD_W%_FU2U$O_'U)_N+_-J ):*** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "HKG_CUF_W#_*I:BN?^/6;_</\J ):*** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M //GJ?\ WZC_ /BZ\3HH]E$.=GMG_"X?#_\ SYZG_P!^H_\ XNC_ (7#X?\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %1-_Q]1_[C?S6I:B;_CZC_W&_FM $M%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 11?ZR?_ 'Q_Z"*EJ*+_ %D_^^/_ $$5+0 4444 %%%% !1110 4444
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MW(PR#@X(X/>K%#5M& 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MWJVEEXAMS.QPJSH\&XGH 9%4$^PYKL:+ %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !7DGQD_P!9I7^_/_Z#%7K=>2?&3_6:5_OS
M_P#H,573^)$S^$\MHHHKI, HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MBB@ HHHH **** "BBB@ HHHH **** "HF_X^H_\ <;^:U+43?\?4?^XW\UH
MEHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@"*+_ %D_^^/_ $$5+447^LG_ -\?^@BI: "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH *BMO^/6'_<'\JEJ*V_X]8?]P?RH EHHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "HI_]6/]
M]/\ T(5+44_^K'^^G_H0H EHHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M3/'EHD;.U]I(S@DD=,C':C2_A_X#\!>'A'XF?2+NXF9VDOM4C16F/)P@<DC
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MZ@([@ZDF[RXL,"H/RXRP/&2/I5^V\=32?"74=2U_P1(EMIT=O$ME?D[+Q24
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M^11?XX:CITB3:]\/M9TS36;:;I]W&>G#1J#]-U5_CUXAFE\$VEI9Z9-=:;J
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M "HF_P"/J/\ W&_FM2U$W_'U'_N-_-: ):*** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH BB_UD_^
M^/\ T$5+447^LG_WQ_Z"*EH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ J*V_X]8?]P?RJ6HK;_CUA
M_P!P?RH EHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "HI_]6/\ ?3_T(5+44_\ JQ_OI_Z$* ):***
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MKHQI[/JCR5_!GB _L]?\(L+#_B=>6%^S>='U^T;_ +V[;]WGK2^-?!FOZO\
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MHHH **** "BBB@ HHHH **** "BBB@ HHHH *BN?^/6;_</\JEJ*Y_X]9O\
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M 9)KV&BB/NV\M@EK\SS/QYX$UV;Q/:^,_!EW'!K<""*>WF.$N4';TSC@@\8
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MB[_H$_\ DS%_\51S1[ARLY2BNK_X5KXN_P"@3_Y,Q?\ Q5'_  K7Q=_T"?\
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MW)FT8V"BBBH*"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** (I_]6/\ ?3_T(5+44_\ JQ_OI_Z$*EH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ J)O\ CZC_ -QOYK4M1-_Q]1_[C?S6@"6BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** (HO]9/
M_OC_ -!%2U%%_K)_]\?^@BI: "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *BMO^/6'_<'\JEJ*V_X]
M8?\ <'\J ):*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ J*?_5C_ 'T_]"%2U%/_ *L?[Z?^A"@"6BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** ,S5_^6/_  +^E%&K_P#+'_@7]** +UK_ ,>D/_7-?Y5+
M45K_ ,>D/_7-?Y5+0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !42_\?4G^XO\VJ6HE_X^I/\ <7^;
M4 2T444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %17/_'K-_N'^52U%<_\ 'K-_
MN'^5 $M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %11?ZR?_?'_H(J6HHO]9/_ +X_]!% $M%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 16W_'K#_N#^52U%;?\ 'K#_ +@_E4M !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 13_ZL
M?[Z?^A"I:BG_ -6/]]/_ $(5+0 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !43?\?4?^XW\UJ6HF_X
M^H_]QOYK0!+1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% $47^LG_P!\?^@BI:BB_P!9/_OC_P!!
M%2T %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 5%;?\>L/^X/Y5+45M_P >L/\ N#^5 $M%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 5%/_JQ_OI_Z$*EJ*?\ U8_WT_\ 0A0!+1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% &9J_
M_+'_ (%_2BC5_P#EC_P+^E% %ZU_X](?^N:_RJ6HK7_CTA_ZYK_*I: "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH *B7_CZD_W%_FU2U$O_ !]2?[B_S:@"6BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ J*Y_X]9O\ </\ *I:BN?\ CUF_W#_*@"6BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "H
MHO\ 63_[X_\ 014M11?ZR?\ WQ_Z"* ):*** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH BMO^/6'_
M '!_*I:BMO\ CUA_W!_*I: "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH BG_P!6/]]/_0A4M13_ .K'
M^^G_ *$*EH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ J)O^/J/_<;^:U+43?\?4?^XW\UH EHHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@"*+_63_P"^/_014M11?ZR?_?'_ *"*EH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ J*V_X]8?\ <'\JEJ*V_P"/6'_<'\J ):*** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ J*?_ %8_WT_]
M"%2U%/\ ZL?[Z?\ H0H EHHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#,U?_EC_ ,"_I11J_P#R
MQ_X%_2B@"]:_\>D/_7-?Y5+7FUQ\8-&TRYEL)=/OVDM7,+LH3!*G!(^;IQ4?
M_"[M"_Z!NH_]\I_\55<K%='IM%>9?\+NT+_H&ZC_ -\I_P#%4?\ "[M"_P"@
M;J/_ 'RG_P 51ROL',CTVBO,O^%W:%_T#=1_[Y3_ .*H_P"%W:%_T#=1_P"^
M4_\ BJ.5]@YD>FT5YE_PN[0O^@;J/_?*?_%4?\+NT+_H&ZC_ -\I_P#%4<K[
M!S(]-HKS+_A=VA?] W4?^^4_^*H_X7=H7_0-U'_OE/\ XJCE?8.9'IM%>9?\
M+NT+_H&ZC_WRG_Q5'_"[M"_Z!NH_]\I_\51ROL',CTVBO,O^%W:%_P! W4?^
M^4_^*H_X7=H7_0-U'_OE/_BJ.5]@YD>FT5YE_P +NT+_ *!NH_\ ?*?_ !5'
M_"[M"_Z!NH_]\I_\51ROL',CTVBO,O\ A=VA?] W4?\ OE/_ (JC_A=VA?\
M0-U'_OE/_BJ.5]@YD>FT5YE_PN[0O^@;J/\ WRG_ ,51_P +NT+_ *!NH_\
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M?] W4?\ OE/_ (JC_A=VA?\ 0-U'_OE/_BJ.5]@YD>FT5YE_PN[0O^@;J/\
MWRG_ ,51_P +NT+_ *!NH_\ ?*?_ !5'*^P<R/3:*\R_X7=H7_0-U'_OE/\
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M_P"^4_\ BJ/^%W:%_P! W4?^^4_^*HY7V#F1Z;17F7_"[M"_Z!NH_P#?*?\
MQ5'_  N[0O\ H&ZC_P!\I_\ %4<K[!S(]-HKS+_A=VA?] W4?^^4_P#BJ/\
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M_P"*H_X7=H7_ $#=1_[Y3_XJCE?8.9'IM%>9?\+NT+_H&ZC_ -\I_P#%4?\
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MT5YE_P +NT+_ *!NH_\ ?*?_ !5'_"[M"_Z!NH_]\I_\51ROL',CTVBO,O\
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MS(]-HKS+_A=VA?\ 0-U'_OE/_BJ/^%W:%_T#=1_[Y3_XJCE?8.9'IM%>9?\
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ML',CTB?_ %8_WT_]"%2UY?)\:]"=0/[.U$?,#]U.QS_>I_\ PN[0O^@;J/\
MWRG_ ,51ROL',CTVBO,O^%W:%_T#=1_[Y3_XJC_A=VA?] W4?^^4_P#BJ.5]
M@YD>FT5YE_PN[0O^@;J/_?*?_%4?\+NT+_H&ZC_WRG_Q5'*^P<R/3:*\R_X7
M=H7_ $#=1_[Y3_XJC_A=VA?] W4?^^4_^*HY7V#F1Z;17F7_  N[0O\ H&ZC
M_P!\I_\ %4?\+NT+_H&ZC_WRG_Q5'*^P<R/3:*\R_P"%W:%_T#=1_P"^4_\
MBJ/^%W:%_P! W4?^^4_^*HY7V#F1Z;17F7_"[M"_Z!NH_P#?*?\ Q5'_  N[
M0O\ H&ZC_P!\I_\ %4<K[!S(]-HKS+_A=VA?] W4?^^4_P#BJ/\ A=VA?] W
M4?\ OE/_ (JCE?8.9'IM%>9?\+NT+_H&ZC_WRG_Q5'_"[M"_Z!NH_P#?*?\
MQ5'*^P<R/3:*\R_X7=H7_0-U'_OE/_BJ/^%W:%_T#=1_[Y3_ .*HY7V#F1Z;
M17F7_"[M"_Z!NH_]\I_\51_PN[0O^@;J/_?*?_%4<K[!S(]-HKS+_A=VA?\
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M%W:%_P! W4?^^4_^*HY7V#F1Z;17F7_"[M"_Z!NH_P#?*?\ Q5'_  N[0O\
MH&ZC_P!\I_\ %4<K[!S(]-HKS+_A=VA?] W4?^^4_P#BJ/\ A=VA?] W4?\
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M4?\ OE/_ (JCE?8.9'IM%>9?\+NT+_H&ZC_WRG_Q5'_"[M"_Z!NH_P#?*?\
MQ5'*^P<R/3:*\R_X7=H7_0-U'_OE/_BJ/^%W:%_T#=1_[Y3_ .*HY7V#F1Z;
M17F7_"[M"_Z!NH_]\I_\51_PN[0O^@;J/_?*?_%4<K[!S(]-HKS+_A=VA?\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH *V/"7_(YZ%_V$+?_P!&+6/6QX2_Y'/0O^PA;_\ HQ:3V!&/1113 ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH V/%O_(YZ[_V$+C_ -&-6/6QXM_Y'/7?
M^PA<?^C&K'I+8&%%%%, HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@#V'X%?\Q__MW_ /:M%'P*_P"8_P#]N_\ [5HK"?Q&
MD=CS'Q'_ ,C/JW_7[-_Z&:S*T_$?_(SZM_U^S?\ H9K,K9;&;"BBBF 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %;%S_P B9IG_ &$+O_T7;5CUL7/_ ")FF?\ 80N__1=M28&/1113 ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH *V/"7_(YZ%_V$+?_P!&+6/6QX2_Y'/0O^PA
M;_\ HQ:3V!&/1113 **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH V/%O_(YZ[_V
M$+C_ -&-6/6QXM_Y'/7?^PA<?^C&K'I+8&%%%%, HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MNW099;>)I"H]3@'%4(JT5)/!-:SO!<1/%-&=KQR*593Z$'H:M?V-JO\ 9_\
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MP"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M6-[=>*+@Z6D2YB*RHP &<L_48Z=QWK5^$.LV$$FJ^'5N\AYFEM)678THQM)
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MJ&B@"]9:WJNFQF.PU.]M4)R5@N&0'\ :JSSS7,S37$KRRN<L\C%F)]R:CHH
M]R\+?\D*O/\ KVNOYM7CAUS5S8BQ.J7ILPNW[/\ :'\O'IMSC%4**FWO-]QI
MV278FM+RZL+A;BSN9K>=<[9(7*,,\'!'-+>7UWJ%P;B]NI[F<@ R32%VP.G)
MYJ"BJ$7KW6=4U.-([_4KR[C0Y59YVD"GU )XHCUG58;!K"+4KQ+-@0;=9V$9
M!ZC;G'-4:*5@'PS2V\R302O%*ARKHQ5E/J".E7KO7]9OX#!>:O?W$1_Y9S7+
MNOY$UG44P+%G?WFG3^?8W<]K-@KYD$A1L>F1S3;J[N;ZY>XN[B6XG?[TLKEV
M;MR3S4-% %Z\UK5=1@6"^U.]NH4.5CGG9U4],@$TECJ^IZ6'&GZC=V@?[WV>
M=H]WUP1FJ5% $D]Q-=3O/<3233.<M)(Q9F^I/6HZ** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ]A^!7_ #'_
M /MW_P#:M%'P*_YC_P#V[_\ M6BL)_$:1V/,?$?_ ",^K?\ 7[-_Z&:S*T_$
M?_(SZM_U^S?^AFLRMEL9L****8!1110 4444 %%=>GPO\9.BNNCY5AD'[3#T
M_P"^ZKW_ ,//%FFVKW-SHTWE(,L8W20@>N%)-)R2&DWL<Q1113$%%%% !15O
M3--N]8U&&PL(?.NIB1&FX+G SU) Z"IM:T+4O#U\++5+;[/<%!($WJ_RG.#E
M21V- &=1110 4444 %%6+*RNM1NX[2RMY)[B0X2.-<DU#+&\,KQ2#:Z,58>A
M'6@!M%%% !1110 4444 %%%% !6Q<_\ (F:9_P!A"[_]%VU8];%S_P B9IG_
M &$+O_T7;4F!CT444P"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBM/2/#VKZ](R:7I\]R5^\R+\J_5CP/Q- &9173:A\/?%>F6S7%SH
MTWE+RQB=)2!ZD(20/>N9I)I[!9H****8!1110 4444 %%;NK>#M>T/38M0U*
MP\BUE8*DGG1MDD$CA6)Z TDWA#7;?P^NNRV.W3657$WG(<AC@?+NW=3Z4KH+
M&'116AHVB:CX@O\ [%I=OY]QL+[-ZKP.IRQ I@9]%7=5TF]T349=/U&#R;J+
M&^/>K8R 1RI(Z$52I)WV!JP445:33;V33I-16VD-G&X1IL84,>@SW-,"K111
M0 4444 %%:M[X;U;3]&M=7N[3RK&Z($,ID4[\@D?*#D< ]1650 45UL/PR\8
M7$$<T6D;HY%#J?M,(R",C^.N4=&CD9'4JZDA@>H-*ZO8+:7&T5U-E\.?%FHV
M,%Y:Z27MYT$D;&XB7<IZ'!8&N;N+>6TNI;:==DT+F-UR#A@<$9'O1=7L%M+D
M5%%%, HHK6T/PSJ_B26:/2+3[2\*AI!YB)@'I]XB@#)HJ>\M)["]GL[I/+G@
M<QR)D':P.",C@U!1N&P45)!#)<W$<$*[I97"(N<9). .:U-=\+:SX:, U>S^
MS&?/E_O4?=C&?NDXZB@#'HK<U?PAKNA:?#?ZE8^1;3,%C?SD;)(R.%8GH*S;
M;3;V\M[FXM[:22&V3?-(!\J#W-*X%6BBBF 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %;'A+_D<]"_["%O_ .C%K'K8\)?\CGH7
M_80M_P#T8M)[ C'HHHI@%%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 45HZ+H6I>(;XV6EVWVBX"&0IO5/E&,G+$#N*AU+3;O1]1FL+^+R;J
M$@2)N#8)&>H)'0BCR J4444 %%%:&C:)J/B"_P#L6EV_GW&POLWJO ZG+$"@
M#/HK6D\,ZQ%XA707L\:FQ $'FIU*[A\V=O3WJ/6M!U/P[>K9ZK;?9YV02!/,
M5\J21G*DCL:5T%F9M%%%, HHHH **L65E=:C=QVEE;R3W$APD<:Y)J2RTJ]U
M#54TRUA\R\=S&L>X#+#.1DG'8]Z *=%:6M:#J?AV]6SU6V^SSL@D">8KY4DC
M.5)'8UFTD[[ U8****8!1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110!L>+?^1SUW_L(7'_ *,:L>NM\3Z392>+-9D?Q%ID3-?3
MDQO'<ED)D;@XA(R/8D>]97]C6'_0S:3_ -^[K_XS23T&S'HK8_L:P_Z&;2?^
M_=U_\9H_L:P_Z&;2?^_=U_\ &:+B,>BMC^QK#_H9M)_[]W7_ ,9H_L:P_P"A
MFTG_ +]W7_QFBX&/16Q_8UA_T,VD_P#?NZ_^,T?V-8?]#-I/_?NZ_P#C-%P,
M>BMC^QK#_H9M)_[]W7_QFC^QK#_H9M)_[]W7_P 9HN!CT5L?V-8?]#-I/_?N
MZ_\ C-']C6'_ $,VD_\ ?NZ_^,T7 QZ*V/[&L/\ H9M)_P"_=U_\9H_L:P_Z
M&;2?^_=U_P#&:+@8]%;']C6'_0S:3_W[NO\ XS1_8UA_T,VD_P#?NZ_^,T7
MQZ*V/[&L/^AFTG_OW=?_ !FC^QK#_H9M)_[]W7_QFBX&/16Q_8UA_P!#-I/_
M '[NO_C-']C6'_0S:3_W[NO_ (S1<#'HK8_L:P_Z&;2?^_=U_P#&:/[&L/\
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MUA_T,VD_]^[K_P",T7"QCT5L?V-8?]#-I/\ W[NO_C-']C6'_0S:3_W[NO\
MXS1<#'HK8_L:P_Z&;2?^_=U_\9H_L:P_Z&;2?^_=U_\ &:+@8]%;']C6'_0S
M:3_W[NO_ (S1_8UA_P!#-I/_ '[NO_C-%P,>BMC^QK#_ *&;2?\ OW=?_&:/
M[&L/^AFTG_OW=?\ QFBX&/16Q_8UA_T,VD_]^[K_ .,T?V-8?]#-I/\ W[NO
M_C-%P,>BMC^QK#_H9M)_[]W7_P 9H_L:P_Z&;2?^_=U_\9HN!CT5L?V-8?\
M0S:3_P!^[K_XS1_8UA_T,VD_]^[K_P",T7 QZ*V/[&L/^AFTG_OW=?\ QFC^
MQK#_ *&;2?\ OW=?_&:+@8]%;']C6'_0S:3_ -^[K_XS1_8UA_T,VD_]^[K_
M .,T7 QZ*V/[&L/^AFTG_OW=?_&:/[&L/^AFTG_OW=?_ !FBX&/16Q_8UA_T
M,VD_]^[K_P",T?V-8?\ 0S:3_P!^[K_XS1<#'HK8_L:P_P"AFTG_ +]W7_QF
MC^QK#_H9M)_[]W7_ ,9HN!CT5L?V-8?]#-I/_?NZ_P#C-']C6'_0S:3_ -^[
MK_XS1<#'HK8_L:P_Z&;2?^_=U_\ &:/[&L/^AFTG_OW=?_&:+@8]%;']C6'_
M $,VD_\ ?NZ_^,U-=^&[:QO9[.Y\1Z2D\$C12)LN3M93@C(AP>11<+&#16Q_
M8UA_T,VD_P#?NZ_^,T?V-8?]#-I/_?NZ_P#C-%P,>BMC^QK#_H9M)_[]W7_Q
MFC^QK#_H9M)_[]W7_P 9HN!CT5L?V-8?]#-I/_?NZ_\ C-']C6'_ $,VD_\
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M^GK^%23.UE\ 5:S)0M:*&*\'YY '_F:Y#X-3S1^-GB3/ER6KB09XP""#^?\
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M88H<=-B\#\\9_&N?I0;<4V.:2=D%%%%62%%%% !1110 4444 %%%% !1110
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M&QX9_P"0K/\ ]@^]_P#266L>MCPS_P A6?\ [!][_P"DLM8]( HHHI@%%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !6Q;?\B9J?\ V$+3_P!%W-8];%M_R)FI_P#80M/_ $7<TF!CT444P"BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH V-9_Y!7AW_L'O_Z53UCUL:S_ ,@KP[_V#W_]*IZQZ2 ****8
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 5L>+?^1SUW_L(7'_HQJQZV/%O_ ".>N_\ 80N/_1C4NH&/1113
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M:?J%]-Y5K$[%Y-I; *D= ">I%:?Q/U[3/$7B:&\TJY^T0+:K&7\MDPP9CC#
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MA6?_ +!][_Z2RUCT %%%%, HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH *V+;_D3-3_["%I_Z+N:QZV+;_D3-
M3_["%I_Z+N:3 QZ***8!113XE#RHAZ,P!Q0E=V$]!E%>B>(? 6EZ3XYT/1(+
MB\:VO]GFO(ZEQEB/E(4#MW!K3U+P9\-])U5],OO$.IP7B;0R/C"Y (RPBQT(
M[U/,K)_UH5;^O4\HHKL?&'@5_"^IV7EW/VK3;UAY,XQGMD''&<$$'H:ZK6_
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MAZ^E2W&C:K:6BW=SIEY#;-C;-) RH<],,1BF(HT444 %%%% &QK/_(*\._\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "MCPE_R.>A?]A"W_ /1BUCUL>$O^1ST+_L(6_P#Z,6D]@1CT444P"BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M^#<VKZ0(_MT]R5><KNV_/M!P?0 8!XR>E7--\1:CXD^$7B"ZU,K)<1*\7G!
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MC+17[/[S.\,_\A6?_L'WO_I++6/6QX9_Y"L__8/O?_266L>K)"BBBF 4444
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M.UN-ML56XEBV+\[*^>N,CIC@U<E\.VUW\4+'Q.A4Z;)8_;C)_"74!0?R96_
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MGE[]N[VS@X_*LZ<;6OT_X)I4=[VZ_P# /1/'WB+4M1\<GPH]R(='>>"*6)5
MW;BK%BV,]3ZXXJ[\0/&NL^$M>M-'T00V=C;P(RIY*L)!SQST48QQ@]>:\T\3
M:\?$7B2YUA8#:M,5(C$F[;A0/O8'IZ5V-M\6C+9VZ:YX=LM5NK?_ %5S(0I!
M_O8*M@\=1BDHM1C^(Y2O)G4>(=%T_4_B%X1O;FV2.74(VDN82/O,B!EW#OSQ
M[@8K.U?XC^(].^(%_IUO:B^M(BT4=BD7)PN=V0"Q]3VQGZUP.L>--7UCQ)#K
MDDHBN+=@;=(_NQ '( '?WSUKKO\ A<2AC>#PO8#5S'L-[OY/X;=V/;=1RNR^
M>GKL*^OW:^AL^ WM;/P3KWB 20Z3<SW3J\Z6QE%JORX"QCG +'CZ9X%9WBSQ
M/H&L>!9+&Y\0QZOJ\,@DMY_[/>W)^89'3 ^7/IGBN9\._$74M%OM0ENX(]1M
MM0<O<V\IP&8]2#@XXXQ@C%+XF^(,NMZ7%I6G:7;Z1IR.)#!;G[S YZ@* ,\X
MQU[T.+;^[Y6_KYC3M^/SN>FV>J:3XI_LNXT+Q3)I5U;(B+IS,!&V/X6BRN_T
MR#C'2N9745\*?%V:]\416<1N+<[9[.-O+!. )-IRP)"D''<_C6%)\1;+4Q9S
M^(/#%OJ6H6BA8[H7+19 Y&Y0"&YYYXY/ S51/B5K2^+V\0[82[1^0;;!\ORO
M[O7.<\Y]?;BGROF^_P#'\2;^[;T_ ],FTR]O-"U<>'_$MMKUK=(=]MJ+F<ID
M'(1U8;3Z KU Z5X#7=K\0[+38;UO#WAFWTN]O%*RW/VEI< ]=JD +SSQQTXK
MA*44TQR=T>PW>JW/@?X5:)-H*QQSWY#SW)0,0Q7<>O&>W(/ INJ:E<>(_A'#
MXBU%475=/N08+D( 6(<#..G.>1TRM<OX:^(]QHNC'1M1TRWU;31G9#.0-O.<
M9(((SS@C\:J^+/'EUXEM(-/@LX=-TN @I:0'C(Z9. ,#L  *<D[NW>_H$6K*
M_9_,[KQ]XEU>'X>:!+'=X?4[<+>'RT_>AHP3VXZGIBO&*ZGQ#XQ_M[PWHVC_
M &#R/[-C">;YV[S,*%SC:,=/4URU-*SEZB;NEZ!1115""BBB@ HHHH ]A^!7
M_,?_ .W?_P!JT4? K_F/_P#;O_[5HK"?Q&D=CS'Q'_R,^K?]?LW_ *&:S*T_
M$?\ R,^K?]?LW_H9K,K9;&;"BBBF 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %;%S_R)FF?]A"[_P#1=M6/
M6Q<_\B9IG_80N_\ T7;4F!CT444P"BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "MCP
ME_R.>A?]A"W_ /1BUCUL>$O^1ST+_L(6_P#Z,6D]@1CT444P"BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** -CQ;_P CGKO_ &$+C_T8U8];'BW_ )'/7?\ L(7'
M_HQJQZ2V!A1113 **** "BBB@ HHHH **** "BNI\*WW@ZTMKA?$VE7E[,S@
MPM;L0%7'(.)%[_6N^U_2_AOX<L--O+SP]>/'J$?F1"&>0E1A3\V91_>'3-)N
MPTKGC%%=.OA#5->DGU+P]I$K:5-=/'; RIN49X!!8G@=2>/>M;0/"0MHO$=K
MKGA^YN;VRMU=##<(!;$JQ#-^\7<. >-W3IZIR25V%KNR."HK8T/PKK?B,2'2
M=/>X6(X=]RHH/IEB!GVJ+6/#VJ^'KI+?5K*2VD<97<058=\,"0?P-4MTA=+F
M917=?$_P]I?AW6+"#2K7[/%+:B1U\QGRVXC/S$^E<+2C*ZN#5@HHHI@%%%%
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MIO9L$J">6)-*ZT\QV>OD<M1113$%%%% !1110 4444 ;&L_\@KP[_P!@]_\
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M=L[S3[^W3<#*[$Y.<9!=@02,>M'PX\%^&]:\)M?:Q8>=.+IHMYFD7CY0!A6
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !6Q<_\ (F:9_P!A"[_]%VU8];%S_P B9IG_ &$+O_T7;4F!CT444P"B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "MCPE_R.>A?]A"W_\ 1BUCUL>$O^1ST+_L
M(6__ *,6D]@1CT444P"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M^MZ]?:D^<W$S. >RY^4?@,#\*J2O.WS?KM_P28Z1O\E^?_ ,ZBBBK)"BBB@
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MUO?^OD--)VZ6M_7S.=HHHK0@**** /8?@5_S'_\ MW_]JT4? K_F/_\ ;O\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M*V/%O_(YZ[_V$+C_ -&-6/6QXM_Y'/7?^PA<?^C&I=0,>BBBF 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M;'AG_D*S_P#8/O?_ $EEK'K8\,_\A6?_ +!][_Z2RTF",>BBBF 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M_P (EXD_Z%[5O_ *3_"C_A$O$G_0O:M_X!2?X5[+11[%]P]MY'C7_")>)/\
MH7M6_P# *3_"C_A$O$G_ $+VK?\ @%)_A7LM%'L7W#VWD>-?\(EXD_Z%[5O_
M  "D_P */^$2\2?]"]JW_@%)_A7LM%'L7W#VWD>-?\(EXD_Z%[5O_ *3_"C_
M (1+Q)_T+VK?^ 4G^%>RT4>Q?</;>1XU_P (EXD_Z%[5O_ *3_"C_A$O$G_0
MO:M_X!2?X5[+11[%]P]MY'C7_")>)/\ H7M6_P# *3_"C_A$O$G_ $+VK?\
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M/^A>U;_P"D_PH_X1+Q)_T+VK?^ 4G^%>RT4>Q?</;>1XU_PB7B3_ *%[5O\
MP"D_PH_X1+Q)_P!"]JW_ (!2?X5[+11[%]P]MY'C7_")>)/^A>U;_P  I/\
M"C_A$O$G_0O:M_X!2?X5[+11[%]P]MY'C7_")>)/^A>U;_P"D_PH_P"$2\2?
M]"]JW_@%)_A7LM%'L7W#VWD>-?\ ")>)/^A>U;_P"D_PH_X1+Q)_T+VK?^ 4
MG^%>RT4>Q?</;>1XU_PB7B3_ *%[5O\ P"D_PH_X1+Q)_P!"]JW_ (!2?X5[
M+11[%]P]MY'C7_")>)/^A>U;_P  I/\ "C_A$O$G_0O:M_X!2?X5[+11[%]P
M]MY'C7_")>)/^A>U;_P"D_PH_P"$2\2?]"]JW_@%)_A7LM%'L7W#VWD>-?\
M")>)/^A>U;_P"D_PH_X1+Q)_T+VK?^ 4G^%>RT4>Q?</;>1XU_PB7B3_ *%[
M5O\ P"D_PH_X1+Q)_P!"]JW_ (!2?X5[+11[%]P]MY'C7_")>)/^A>U;_P
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M]JW_ (!2?X4?\(EXD_Z%[5O_  "D_P *]EHH]B^XO;>1XU_PB7B3_H7M6_\
M *3_  H_X1+Q)_T+VK?^ 4G^%>RT4>Q?</;>1XU_PB7B3_H7M6_\ I/\*/\
MA$O$G_0O:M_X!2?X5[+11[%]P]MY'C7_  B7B3_H7M6_\ I/\*/^$2\2?]"]
MJW_@%)_A7LM%'L7W#VWD>-?\(EXD_P"A>U;_ , I/\*/^$2\2?\ 0O:M_P"
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M$2\2?]"]JW_@%)_A7LM%'L7W#VWD>-?\(EXD_P"A>U;_ , I/\*/^$2\2?\
M0O:M_P" 4G^%>RT4>Q?</;>1XU_PB7B3_H7M6_\  *3_  H_X1+Q)_T+VK?^
M 4G^%>RT4>Q?</;>1XU_PB7B3_H7M6_\ I/\*/\ A$O$G_0O:M_X!2?X5[+1
M1[%]P]MY'C7_  B7B3_H7M6_\ I/\*/^$2\2?]"]JW_@%)_A7LM%'L7W#VWD
M>-?\(EXD_P"A>U;_ , I/\*/^$2\2?\ 0O:M_P" 4G^%>RT4>Q?</;>1XU_P
MB7B3_H7M6_\  *3_  H_X1+Q)_T+VK?^ 4G^%>RT4>Q?</;>1XU_PB7B3_H7
MM6_\ I/\*/\ A$O$G_0O:M_X!2?X5[+11[%]P]MY'C7_  B7B3_H7M6_\ I/
M\*/^$2\2?]"]JW_@%)_A7LM%'L7W#VWD>-?\(EXD_P"A>U;_ , I/\*/^$2\
M2?\ 0O:M_P" 4G^%>RT4>Q?</;>1XU_PB7B3_H7M6_\  *3_  H_X1+Q)_T+
MVK?^ 4G^%>RT4>Q?</;>1XU_PB7B3_H7M6_\ I/\*/\ A$O$G_0O:M_X!2?X
M5[+11[%]P]MY'C7_  B7B3_H7M6_\ I/\*U?#WACQ!!J4SRZ%J<:FQO$!>TD
M +-;2!1TZDD >I->H44>Q?<?MO(\:_X1+Q)_T+VK?^ 4G^%'_")>)/\ H7M6
M_P# *3_"O9:*/8ON+VWD>-?\(EXD_P"A>U;_ , I/\*/^$2\2?\ 0O:M_P"
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M_H7M6_\  *3_  H_X1+Q)_T+VK?^ 4G^%>RT4>Q?</;>1G_!C2=2TO\ MO\
MM#3[NT\SR-GVB%H]V/,SC(&<9'YT5H45#PUW>Y:Q%N@^;_7R?[Q_G3*?-_KY
M/]X_SIE=,=D<\MV%%%%,D**** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M>=#"A41E6.W!0#.1G.*AUKP<E_6I:I>\D^O^1Z'I]['J6FVM]"KK%<Q+*@<
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M)R>E8QVC!/9_/?KZ&JLI>T?;Y;&Y\:O]7H/UF_\ 9*ZWXD +\.-2 Z!(@/\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** 'S?Z^3_>/\Z93YO]?)_O
M'^=,I1V14MV%%%%,D**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M[-!_SQC_ .^11]F@_P">,?\ WR*/K7D'U;S//Z*] ^S0?\\8_P#OD4?9H/\
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MU;S//Z*] ^S0?\\8_P#OD4?9H/\ GC'_ -\BCZUY!]6\SS^BO0/LT'_/&/\
M[Y%'V:#_ )XQ_P#?(H^M>0?5O,\_HKT#[-!_SQC_ .^11]F@_P">,?\ WR*/
MK7D'U;S//Z*] ^S0?\\8_P#OD4?9H/\ GC'_ -\BCZUY!]6\SS^BO0/LT'_/
M&/\ [Y%'V:#_ )XQ_P#?(H^M>0?5O,\_HKT#[-!_SQC_ .^11]F@_P">,?\
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M\SS^BO0/LT'_ #QC_P"^11]F@_YXQ_\ ?(H^M>0?5O,\_HKT#[-!_P \8_\
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MM>0?5O,\_HKT#[-!_P \8_\ OD4?9H/^>,?_ 'R*/K7D'U;S//Z*] ^S0?\
M/&/_ +Y%'V:#_GC'_P!\BCZUY!]6\SS^BO0/LT'_ #QC_P"^11]F@_YXQ_\
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MU;S//Z*] ^S0?\\8_P#OD4?9H/\ GC'_ -\BCZUY!]6\SS^BO0/LT'_/&/\
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M/^>,?_?(H^M>0?5O,\_HKT#[-!_SQC_[Y%'V:#_GC'_WR*/K7D'U;S//Z*]
M^S0?\\8_^^11]F@_YXQ_]\BCZUY!]6\SS^BO0/LT'_/&/_OD4?9H/^>,?_?(
MH^M>0?5O,\_HKT#[-!_SQC_[Y%'V:#_GC'_WR*/K7D'U;S//Z*] ^S0?\\8_
M^^11]F@_YXQ_]\BCZUY!]6\SS^BO0/LT'_/&/_OD5'/;PB,$0QCYU'"C^\*/
MK7D'U;S.#HKT#[-!_P \8_\ OD4?9H/^>,?_ 'R*/K7D'U;S//Z*] ^S0?\
M/&/_ +Y%'V:#_GC'_P!\BCZUY!]6\SS^BO0/LT'_ #QC_P"^11]F@_YXQ_\
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MK_QZ0_\ 7-?Y5+45K_QZ0_\ 7-?Y5+7(=04444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !42_\?4G^XO\
MVJ6HE_X^I/\ <7^;4 2T444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %17/_'K-
M_N'^52U%<_\ 'K-_N'^5 $M%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% $
M5M_QZP_[@_E4M16W_'K#_N#^52T %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110!%/_JQ_OI_Z$*EJ*?_
M %8_WT_]"%2T %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 5$W_ !]1_P"XW\UJ6HF_X^H_]QOYK0!+
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% $47^LG_WQ_P"@BI:BB_UD_P#OC_T$5+0 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !45M_QZP_[@_E4M16W_'K#_N#^5 $M%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5%/_JQ_OI_
MZ$*EJ*?_ %8_WT_]"% $M%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 9FK_ /+'_@7]**-7_P"6
M/_ OZ44 7K7_ (](?^N:_P JEJ*U_P"/2'_KFO\ *I: "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
MB7_CZD_W%_FU2U$O_'U)_N+_ #:@"6BBB@ HKF_'7BO_ (0KPG<ZY]B^V>0Z
M+Y/F^7NW,%^]@^OI7 Q?&3Q9/"DT/PIUJ2*10R.CRD,#R""(.123N![%17DV
MF_'"--9M]-\4^%]1\.M<,%BDN,LO)QE@R(0/< UZS56TN*^M@HHK!\:>)?\
MA$/"5]KOV3[7]E"'R/,\O=N=5^]@X^]GI4MI*[*2;=D;U%4M&U#^UM$L-2\K
MROM=O'/Y>[=LW*#C.!G&>N*NU333LR4TU=!1112&%%<YIGC*QU;QEJGANUAF
M\_3(U:XE< +N.,*O<]>O'XT6GB/4KCQW?:!)X>NH=/M[<2QZLQ;RIF(3Y!\F
M,_,?XC]T\>@M;>8=_(Z.BBB@ HHK.UO7--\.:3-J>JW26UI"/F=NY[ #J2>P
M%#=@2N:-%>/GXX7VH,TWASP!K6K6"DK]I 91D>R(X_6NJ\#_ !.T?QM--8Q1
M3V&JP#,ME= !N."5/< \'H?:FDV#T.VHHHI %%<YXP\96/@ZTLY;N&::2]N%
MMH(XP.7/<D] /Q^E5_B#XT_X03PVNK_V?]NS<)#Y7G>5]X'G.UO3TI7Z_+^O
MO';6QU=%,AD\Z".7&-ZAL>F13Z;5M"4[JX4444#"BN<\+^,K'Q;=ZO%80S+'
MIMQ]F>24 >8XSD@>G'?KZ"NCHZ7 **** "BBLOQ'K'_"/^&M2UCR/M'V*W>?
MRM^S?M&<9P<?7!I-V5V-*[LC4HKQFS^-GB;4+2.[LOA?JUS;2#*30RR.C#IP
MP@P:OZ9\;8AK%MIOBGPQJ7AR2Y(6*2ZR4],MN52!G R >O.!S5)-NQ-]+GJ]
M%<AXP\<_\(IKGAO3?[.^U?VU=?9_,\_9Y/S(-V-IW??Z9'2NOI=+C>F@445S
MGC#QE8^#K2SENX9II+VX6V@CC Y<]R3T _'Z4>0>9T=%4M8U6VT/1KS5;PL+
M:TA::3:,G &< >M<%X,^*6I>,=;@MXO!FH6NDS!RFJ2.QCPH.,_N]N21C[U"
MU=D#T5V>E4444 %%%% !1110 4444 %%>47?QFN9O$=WI7AWP;J6M16D_D3W
M,+, K X)PJ-QP<$D9Q7JXZ<T+5<P/1V"BBB@ HHJAK>I?V/H.H:GY7G?8[:2
MX\O=MW[%+8S@XSCKBDVDKL:3;LB_16%X-\2?\)=X3L=<^R?9/M2L?)\SS-N&
M*_>P,]/2MVJ::=F2FFKH***YS3/&5CJWC+5/#=K#-Y^F1JUQ*X 7<<85>YZ]
M>/QI=;#Z7.CHHHH **** "BBB@ HHHH **** "BBB@ HHHH ***YS3/&5CJW
MC+5/#=K#-Y^F1JUQ*X 7<<85>YZ]>/QHZV#I<Z.BN<M/$>I7'CN^T"3P]=0Z
M?;VXECU9BWE3,0GR#Y,9^8_Q'[IX].CHZ7#K8**** "HKG_CUF_W#_*I:BN?
M^/6;_</\J ):*** "BBN1T?QQ_:WQ#UOPI_9WE?V7$LGVKS]WFYV\;-HQ][U
M/2A:NP/17.NHHKD?#OCC^W_&?B'P]_9WD?V.RKY_G[O.R2/N[1MZ>IHZV_K0
M.ESKJ*** "BBB@ HHJCK6K6N@Z+>:K>[_LUI$99-BY; ]!ZTFTE=@E?0O45E
M>&]<B\2^';+6887ABNX_,2-R"P&2!G'?BM6J:MHQ)WU045X[)\;-:FU?4K'2
MOA]?ZHMA<O;R2VL[N,JQ )"PG;G&<9I)OC7XAL(C<ZG\,M9L[-.99W:0!!Z_
M-"!^9%).ZN-Z.Q['16+X6\5:9XPT*+5]*D=H')5DD7:\;CJK#U_,<UE^ /''
M_"<Z=?W?]G?8OLEVUMM\_P S?@ [L[1CKTIVUL%]+G74444@"BBN<TSQE8ZM
MXRU3PW:PS>?ID:M<2N %W'&%7N>O7C\:.M@Z7.CHKD;;QQ]H^)UWX,_L[;]G
MM!<_:_/SNSM^79MX^]USVKKJ.B8=;!1110 4444 %%%>.R?&S6IM7U*QTKX?
M7^J+87+V\DMK.[C*L0"0L)VYQG&:5];!TN>Q45X^/CC>:=*C^)? 6LZ/9L0O
MVA@S8)]G1/YUZIIFJ66LZ9!J.G7"7-I.F^*1#PP_H>V.H-/I<+ZV+E%<YX,\
M1ZCXFTNXN]3\/76AS1W#1+;W);<Z@ [QN1>#DCIVZUT=#5@"BBB@ HHHH **
M*R_$>L?\(_X:U+6/(^T?8K=Y_*W[-^T9QG!Q]<&DW978TKNR-2BL3PAX@_X2
MKPII^N?9?LOVM"_D^9OV88C[V!GIZ5MU333LR4TU=!1112&%%%% !117)^*_
M&O\ PC'B#PYI7]G_ &G^VKDV_F^=L\G!09QM.[[_ $R.E'5+N'1LZRBBB@ H
MHHH ***\S\0?&C2M/U>31M TN]\1:G&2&CLAE 1U&X!B2/92/>B_0+=3TRBO
M)K#XX10:E#9>+/"^I^'//.(IK@,R?5MRH0/< UZPCK(BNC!E89# Y!'K3MU#
MK86BBBD 4444 %%<CX_\<?\ "#6&G77]G?;?MEXMKM\_R]F03NSM.>G2K?B3
MQ'J6B:KHEI9>'KK5(=0N/*N+B MMLURHWOA&X^8GDC[IYH6NW>P?Y7.CHHHH
M **** "BBLOQ'K'_  C_ (:U+6/(^T?8K=Y_*W[-^T9QG!Q]<&DW978TKNR-
M2BO&;/XV>)M0M([NR^%^K7-M(,I-#+(Z,.G#"#!JU!\6_%TMQ'&_PIUN-7<*
M7)EPH)Z_ZBJ2;=B6TE<]<HKD/&'CG_A$]<\.:;_9WVK^VKK[/YGG[/)^9!G&
MT[OO],CI77TNEQO1V"BBB@ HHK#\6^*;'P=X=GUG4$FD@B*J$A4%F9C@ 9(%
M)M)78TKFY15>QNOMNGVUWLV>?$LFW.=NX XS^-6*IJSLR4[JZ"BBBD,****
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M079-]JN/^?B7_OLT?:KC_GXE_P"^S4-%%D%V3?:KC_GXE_[[-'VJX_Y^)?\
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MD_N_S(IJ\8^J7WZ?@2VWBKXD?$B]O+GP5-8Z/H=M,T45S=H&:X(^J/SC!P
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M-#''&WE/)EML9QA 3T%>[UXKH&CZ7K/[0'C.'5--L[Z)+>-D2Z@64*<1C(#
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M7_R2[P]_UZ#^9KL*VJ?$T8P^%,\ ^'?COPWX/\1^-8M>U+[(]QJKM$/(DDW
M.^?N*<=1UKMM0^.?@&"PFD@U.2]D"';;QVDJF0^F74 ?B:YKX4^']%UKQ!XY
M?5=(L+]HM681FZMDE* O)G&X'%2?$GP%#X5D@\<^$=.LX9M.;?>67V=6ADCS
MRP0C"D=#MQP<C!'.7V(\VUE^1HOBER]W^9H_ 71[[3_"FHW]W:FTAU*[,]M
M01B/&,X/8]O4#/I7"_#2[\;W=AK6B^#8K2U;^T'GN-3O.4CR %11M;+':3T/
MX=:]W\)^)[+QAX9M=9L3A)EQ)&3DQ2#[R'Z'\Q@]Z\^^ ('_  C_ (@.!DZM
M)D_\!6KM[[7:/Y-$I^Y?N_T9)X(\9>+K+Q_+X(\;&VN;MX3/;7D"JN\#G^$
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MZ;7A;PI9^&/"GC;[/XM@\0SW-O(;EX\;HI DF=^'<[B2>N#Q6M\# !\*-,P
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MB M#'U()V@G ZX<GZUN^*/&FJZG\((O&'A2Y-I.FR::/RTEPH.V1#N4]#SD
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MU'Q-\,]7U6YCCM=8TY;B&7RU^42(FX, <^HXY&0:Y\?"[Q-JEE]N\5_$?41
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M#^:5T'PZ 'PW\.@ #_B7P]/]T5J_CF^S7ZF2^"'G?]#A=1\9>-_&GBO4M$\
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MW"BBBI&%%%% &)J7_'K9?[G]!6;6EJ7_ !ZV7^Y_05FUUTOA1RU/B844459
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M "BBB@ HHHH *B;_ (^H_P#<;^:U+43?\?4?^XW\UH EHHHH **** "BBB@
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M ,)=X>32['4KC6K&UM+^,2VSW4ZP^8N > Q'3(R.U6=,U_1M;,BZ5JUA?F(
MR"UN4EV9Z9VDXZ&J>[L2MD>7_$#XPK:2QZ9X2E-Q.MS''=ZC'&)(8 6^X"05
M+-@C/3@XYZ>PUY/\8-*L-'\ 6%KIMG#:P?VO Q2% H+$MDGU)]37K%*/POU_
M1#E\7R_5A1110 4444 %%%% !1110 4444 %%%% !1110 4444 %1+_Q]2?[
MB_S:I:B7_CZD_P!Q?YM0!+1110!S?CKPI_PFOA.YT/[;]C\]T;SO*\S;M8-]
MW(]/6MG2[+^S=(LK#S/,^S0)#OVXW;5 SCMTJW10M+@]=3EO'W@>R\>^'3IE
MS+]GG1Q);W0CWF)N_&1D$9!&?Y"AO!<6I^!(O#'B2[_M55C$9NEC\ESM^XPY
M;# 8YSSSGJ174T4K*S7<=]4^QXXOP'FD5-/O/'&L7&@(P*:;R  .0,EROXA*
M[GQ!X'L]5^'TOA#3Y%TVT,4<43K'YGEA75NF1DG')SU.:ZJBF]59B6CNCR*Y
M^!\L<"6^B>,=3TFUDB5+RV@#>5.P4*S!0XV[L$D'=U].*[[PAX/TKP3HBZ7I
M4;["V^660@O*_P#>8C\L#BM^BG<#RS6?@NDNMW.J^%_$VH^&YKMBUPEKN*,2
M<\;70@9YQDCTQ71>!?ASI7@6.YEMYI[S4;O_ (^;VX.7?G. .PSSW)/4G KL
M:*2]U60/5W9YMK_PHFU#QL_B?1?%%]HMS/L^U1PJ6$NW'&0ZX!"C(.16U8>!
MOL7Q.U+QE_:._P"VVJVWV3R,;,!!NW[N?N=,=_:NOHH6FW]7!ZW\SSSQ?\*+
M7Q%K?]O:3K%YH.M%0LEU:$XD&,9(!4YP ,AA[YJ;P3\+[/PIJDVM7VIW6M:Y
M,I1KZZSE5/!P"2<D#&22<<<<Y[VBA>[L#UW"L[7=!TWQ)I,VEZM:I<VDO5&X
M(/8@CD$>HK1HI-7T8)V/'A\#M0TW=!X>^(.M:78DD_9QN/)_W'0?I75>"/A?
MHW@JXEOXY9]0U:8$27MT<MSUVCMD]>I]Z[>BFG8'J>?^.?A;!XMUBVURPUBZ
MT768%""[MUSN49QP&4@\D9!Z<<US=[\ H]4L)FU7Q9J6H:PX58[^Z4R")0<D
M!"^3GD<M@9Z5[)122L.[..\9> (/&?A*TT:\U"6&YM"CQ7D:=)%7:6*9Y!R>
M,_C6-J/PLU#5_A\GAC4O%MS>SK>"Y&H7$#2/@ X3!DSCGKN_"O2J*;U;??42
MTM;H1+!MLQ!NZ1[-V/;&:Y3P+X"A\&^%KK0KB[34X;F:220O;[%974*5*[FR
M,#]:["BC>_G_ ,."T22Z'D,OP.GLKN?_ (1CQMJ^AV$SEWM(BS#)[ JZY&..
M03[FNU\$^ M*\#64\5BTUQ=7+;[F[N"#)*?Z 9/'OWKJ:*$[ U=W/-;/X43:
M1X\D\0Z/XHO;.RN+K[5<Z:$)28Y)*LP< C).,J<9H\4?""VU;7Y->T#7+WP[
MJD^?/EL\[9">IPK*03WP<'KC.2?2J*5K)+L'=]SS[PA\*;3P[K7]O:IJ][KN
MM!2B75X3B,=,J"6.<$C)8]>,5IVW@?[/\3KOQG_:.[[1:"V^R>1C;C;\V_=S
M]WICO77455]4^WZBMHUW"LOQ'H__  D'AK4M'\_[/]MMW@\W9OV;AC.,C/TR
M*U**EJZLRD[.Z,3PAX?_ .$5\*:?H?VK[5]D0IYWE[-^6)^[DXZ^M;=%%4VV
M[LE))61R'C#P-_PEFN>'-2_M'[+_ &+=?:/+\C?YWS(<9W#;]SK@]:SO'/PM
M@\6ZQ;:Y8:Q=:+K,"A!=VZYW*,XX#*0>2,@]..:] HI>7S^\J_\ D>-WOP"C
MU2PF;5?%FI:AK#A5CO[I3((E!R0$+Y.>1RV!GI79^,O $'C/PE::->:A+#<V
MA1XKR-.DBKM+%,\@Y/&?QKL:*.EA=;G$VO@74!\.]0\+:EXEN=2GO%D4:A<1
MLSH&Q@8+DD#'][O6]X=T%-"\*6.A2RK=QVUN+=G:/:)0!@Y7)Z^F36Q10];^
M86M;R/(;GX&M:W<__",^,=5T/3[@[IK.(LRM[9#KQCCY@?K7=>"_!&D>!=';
M3]*61C(V^>>4@O*V,9..P[ =/J2:Z2BA:*P/5W.1\ >!_P#A!M.O[3^T?MOV
MN[:YW>1Y>S( VXW'/3K3K_P5]M^)6F>,/[0V?8;1K;[)Y.=^=_S;]W'W^F#T
MKK**.J?;_*WY ];^?_#G*?$#P7_PG6B6VF_VA]B\B[2Y\SR?-W;0PVXW#^]U
MSVK<UK3?[7T#4-+\[ROM=K);^;MW;-RE<XR,XSTS5^BDU=./1C3::?;_ (<P
MO!OAO_A$?"=CH?VO[7]E5AYWE^7NRQ;[N3CKZUNT453;;NR4DE9')^"/!7_"
M&C6!_:'VS^T;U[O_ %/E^7N_A^\<_7CZ5B>*_A';:YK[Z_HFMWOA_6)>)KBT
MR1)Q@G 92"0!G!P>XS7H]%3;;R'??S."\$_"VP\):G-K5WJ-UK&N3*5>^NCR
M >NT$DY(&,DDXXXYJ_;>!_L_Q.N_&?\ :.[[1:"V^R>1C;C;\V_=S]WICO77
M455]4^P6T:[A5#6]-_MC0=0TSS?)^V6TEOYFW=LWJ5SC(SC/3-7Z*EI-68TV
MG='+:%X._L3X>#PG]O\ .Q;2P?:O)V_?W<[-QZ;NF>U3>!O"O_"%^$[70_MO
MVSR&=O.\KR]VYBWW<G'7UKHZ*J[NWW)M9)=CD=,\#_V;\2-7\7?VCYG]H0+#
M]E\C'EX"<[]W/W/0=:Q-?^%$VH>-G\3Z+XHOM%N9]GVJ.%2PEVXXR'7 (49!
MR*])HI+2UN@WK>_4Y&V\#_9_B==^,O[1W?:+06WV3R,;<!?FW[N?N],=ZG\=
M>!].\>:&-.OWDADC?S(+B, M$^,=#U![C^5=/12MHEV_X<=];_UV/(H/@=->
M;(O$WC75];M(N8K:1G1%;& ?F=NGMCZUVW@'PD_@GPM%HCZC]O$4KNDOD^5@
M,<XQN;OGOWKIZ*JY-@KSCQ7\([;7-??7]$UN]\/ZQ+Q-<6F2).,$X#*02 ,X
M.#W&:]'HJ;=1WZ'!>"?A;8>$M3FUJ[U&ZUC7)E*O?71Y /7:"2<D#&22<<<<
MUPFH^$;+QE\=_%-A=33VTD5E!/;7,#;9(956+##\S_\ 6."/>*YZS\':?9>-
MM0\5QS71O[Z!8)8V9?*"J% *C;G/R#J3WI_:5]DF&R=MW;\_\CD= ^#D=IKL
M&L>)O$=_XDNK4YMA=YV1GJ"0S,3@\CD#V-=3XU\#:1X[TE;'4U=)(FWV]S%@
M20MWP3U!QR#U^H!'344/56!:.Z/((_@?=WCI!X@\=ZSJNF(P(LV+*O'099V'
MY ?A76^-?A_;^*_!UOX;M+I=+MK>2-HBD'F!50$!0NX>O7-=E10]= 6CNB$6
MT9LA:RJ)(S'Y;!APPQ@Y'O7D@^!ES87=PN@>.=7TG2YW+M90[N_4;ED4'TY4
MG'K7L-%#U=P6BLCS?PI\(+'P;XO@UK2=3F\A;0V\MM-'N:5CR7+[@!SMX"]J
M37_A1-J'C9_$^B^*+[1;F?9]JCA4L)=N.,AUP"%&0<BO2:*=]4^PK;KN<A8>
M!OL7Q.U+QE_:._[;:K;?9/(QLP$&[?NY^YTQW]JI_$GX:6_Q$@T]7U V$UF[
M$2B#S-R,!E<;ACD YY^E=W12MHEV*N[M]_\ ABM86,&FZ=;6%LFVWMHEAC7T
M51@?H*\RU7X*(-8N=1\*>)]1\-&Z.Z:&UW%"?]G:Z$#/."2!GC XKU:BAZOF
M>XEHK=#BO!'PUT[P;<W.HM>7.IZQ=+MFOKLY8CN%'. <#.23QUKL+G_CUF_W
M#_*I:BN?^/6;_</\J;=Q)6):***0PKD='\#_ -D_$/6_%?\ :/F_VI$L?V7R
M-OE8V\[]QS]WT'6NNHH6CN#U5@KD?#O@?^P/&?B'Q#_:/G_VPRMY'D;?)P2?
MO;CNZ^@KKJ*.M_ZU#I8\U\4?""VU;7Y->T#7+WP[JD^?/EL\[9">IPK*03WP
M<'KC.2;/A#X4VGAW6O[>U35[W7=:"E$NKPG$8Z94$L<X)&2QZ\8KT&BA>[L#
MUW/,_%7PA&L>)Y/$.A>([WP_J,XQ</;*2). ,C:RD$X&>2#CI68WP'@,UIJ)
M\37T^MPW:7,M_=H93(%Z*%WC'0<DL>*]?HHC[MK= ?O;G(ZOX'_M7XAZ+XL_
MM'RO[,B:/[+Y&[S,[N=^X8^]Z'I70ZOI=MK>CWFEW8;[/=PM#)L.&VL,'!]:
MNT4K*W+T_P QWUN<%\/_ (=W_@6XN%?Q3=ZEIS1[(+*6,JD'S9R/G(SUS@#.
M:[VBBJ;N2E8Y'P5X'_X0^_U^Z_M'[7_:UX;K;Y'E^5RQVYW'=][KQTKK)(TF
MB>*5%>-U*LK#(8'J"*=12Z6^0^MSA/ WPY?P+JVJ26.L&72+YRZ:>]O@PMGY
M2)-YS@<=.>/2KO@#P/\ \(-IU_:?VC]M^UW;7.[R/+V9 &W&XYZ=:ZZBA?I;
MY ]?ON<C>^!_M?Q-T_QE_:.S[):FW^R>1G?D/SOW<??Z8[5D?&^6P7X87\-X
M09IGC6U0$;FEW@C'KQG/MFO1:XFZ^%?AJ^\<GQ;=)<S7I=)/(=QY(=0 &VXR
M3\HZG'M2:NE%[?\ !N-.S<NO](U? N@#PSX)TG2=H$D, ,N.\C?,_P#X\37+
MZ_\ "B;4/&S^)]%\47VBW,^S[5'"I82[<<9#K@$*,@Y%>DT53=Y<W4E*T>4Y
M&V\#_9_B==^,O[1W?:+06WV3R,;<!?FW[N?N],=Z/B#X(_X3O2+.P_M'[#]G
MNUN=_D^;NP"-N-RXZ]:ZZBDM+>7^=_S'W??_ "M^1R7BKP3_ ,)-KWAO5/[0
M^S?V+<F?R_)W^=DH<9W#;]SK@]:O^-/#7_"7^$K[0OM?V3[4$'G^7YFW:ZM]
MW(S]W'6MZBDU=6&G9W11T?3O[)T.QTWS?-^RVZ0>9MV[MJA<XR<9QTS6%\/O
M!7_"":!-I?\ :'V[S+E[CS/)\K&X 8QN;TZYKJZ*IMMM]_\ .Y*5DEV_X8*\
M=D^">M0ZOJ5]I7Q!O]+6_N7N)(K6!T&68D E9ANQG&<5[%14VUN/I8\?'P-N
M=1EC'B?QUK6LVJ'<(&++^KN_Z"O5=-TNRT?3(-.TZW2VM($V1Q(.%']3W)ZD
MU;HIO56%;6YQ?@;X>0>$/#&H:'=7BZI;WT[RR;X/+!5U52A&YL_=ZY[URC?!
M"]L)7B\.>/=:TC3V8M]D0LP&>O*R(/S'YUZ_10]7<J_^9RO@GP%I7@>UN5LI
M)[F[NW#W-W<MNDE//Y#))_'DFN6UGX+I+K=SJOA?Q-J/AN:[8M<):[BC$G/&
MUT(&><9(],5ZG10]7<2T5CCO OPYTKP+'<RV\T]YJ-W_ ,?-[<'+OSG '89Y
M[DGJ3@4_PQX'_P"$<\5^(M<_M'[1_;,HD\GR-GDX+'&[<=WWO0=*ZZBG?6_R
M"VECG?&7@O2?'&C#3M55QL;S(9XCAXFQC(/\P>#^5<)!\$)IXI8M=\9:EK$*
M0NEG!<*QBMW92H<JTC;MN00!MY%>NT5-D.[T.8T;P38V/@"#PCJ3)J5FD)AD
M9H]@D!8MG&3M()X(.01FN$7X&WUINL],\?ZU9Z,2?]!7=T/495U7G_=KV*BF
M]6V^HDK*R.6T?P)I7A[P9=>&])W117,,B27$@WN[NNTNW3)Z<<#BIO WA7_A
M"_"=KH?VW[9Y#.WG>5Y>[<Q;[N3CKZUT=%.^K?<+:6//O&/PJM?$FMC7M,U>
M]T+6M@1KJT/WP. 2 5.<8&0PX%4]!^#L=IK5IJ_B3Q)J7B.\LWWVPNF8(AZ@
MX9F)P0#U XY!KTVBE'W=@>NX5Q?CGX>VWCG4=#GO+L1VVFRN\MNT.\7"MMRN
M=PV_=Z\]:[2BBP7/()/@4;JXCM;[QIK-UH$3YCTV1B=H'0;BQ4?@@_"O5[&Q
MM=,L(+&RA2"U@01Q1H.%4# %6*Q_%/AJQ\7>'KG1=1:9;:XVEFA8!U*L&!!(
M(ZCTH;:6@:-ZGF'AK1=.UG]H7Q#KED%>UTV-0SJ05-RZ!3C\ ^?>O9ZP?"7@
M_2/!6CC3-(B=8RV^225MTDK8QECQZ=@![5O4]$E%=!;MR?4*\PU_X*Z7?:S)
MK/A_5KWP[J,A)9[,_)D]2%!4C/?# >U>GT5-NI5^AY+8_ Z*XU&&\\6^*-3\
M1^0<QQ7!94^C;G8D>P(KO_$OA;3/%/AN;0KZ,I:2* GDX4Q%?NE>,#'_ -:M
MNBF]59B6CN>.VOP+NFACT_5?'>L7NBI@#3UW1IM!X7EV4#IT7Z8KI?"GPT3P
MKH'B#1H-4,MIJK2&$& C[,&4KC[YWX&.>,X]Z[VBAZIKN"T:?8YSP-X5_P"$
M+\)VNA_;?MGD,[>=Y7E[MS%ONY..OK6/XW^%]CXNU"'5[74+G1];@4+'?6O4
M@=-P!!)&3@@@_6N[HHE[SNP6BLCR&;X%B\LT?4/%-Y?ZP+F.5M1NXC*?+3=^
M[52^0#D9.X_='%=?XP\#?\)9KGAS4O[1^R_V+=?:/+\C?YWS(<9W#;]SK@]:
MZ^BG?;RU#_ACS_QS\+8/%NL6VN6&L76BZS H07=NN=RC.. RD'DC(/3CFN;O
M?@%'JEA,VJ^+-2U#6'"K'?W2F01*#D@(7R<\CEL#/2O9**E*P[LYKQ#X*TWQ
M7X5AT/6BTWE(FVYC&QUD5<;USG&>>#GK7"P? Q[BX@BU_P 9:MJ^DV[!HM/D
M+*HQT&2[8XX^4 _2O7Z*J^O,+I89##';PQPPQK'%&H1$48"@#  'I6=XCT?_
M (2#PUJ6C^?]G^VV[P>;LW[-PQG&1GZ9%:E%)J^X+38\9L_@GXFT^TCM++XH
M:M;6T8PD,,4B(HZ\*)\"IQ\(/%^?^2LZY^4W_P ?KU^BG?J!QOBOP(?%&K^&
M;]M3-N=$N!.5,&_S^4.,[AM^YUYZT>.OAQI7CE;>>:::QU2U_P"/>^M_OJ,Y
M /J >1R"#T(R<]E12_SN'^5OD>3V/P3:>_MY_%?B[5?$4-NX>*VN"RQY_P!K
M<[DCZ8KN?%G@_2?&6A-I.J1-Y((:*2(A7A8# 93TZ$C'2M^BAZJS!:.Z/((/
M@8]Q<01:_P",M6U?2;=@T6GR%E48Z#)=L<<?* ?I7H/BCPG8>*/"<_AZ?=;V
MLB*L9A 'E%2"N!TP,#CTK>HH>JLP6CN>:V'PMU&W\":OX7OO%USJ$=\L:033
MP,1:JI'RJID/' X! KM_#ND?V!X<T[2//\_[%;I!YNS;OVC&<9./IDUIT4[[
M^?Z"M_7J><>*_A';:YK[Z_HFMWOA_6)>)KBTR1)Q@G 92"0!G!P>XS5KP3\+
M;#PEJ<VM7>HW6L:Y,I5[ZZ/(!Z[023D@8R23CCCFN]HI1]W8;UW/!]1\(V7C
M+X[^*;"ZFGMI(K*">VN8&VR0RJL6&'YG_P"L<$=3H'P<CM-=@UCQ-XCO_$EU
M:G-L+O.R,]02&9B<'D<@>QKKK/P=I]EXVU#Q7'-=&_OH%@EC9E\H*H4 J-N<
M_(.I/>NAHC[J5MU_P0E[S=]O^ CD?&?@?_A+M1T"[_M'[)_9-V+G;Y'F>;RI
MVYW#;]WKSUK=U_2O[<\/:CI7G>1]LMG@\W;NV;E(SC(SC/3-:-%*RMR]!W::
M9A>#?#?_  B/A.QT/[7]K^RJP\[R_+W98M]W)QU]:\U\-:+IVL_M"^(=<L@K
MVNFQJ&=2"IN70*<?@'S[UZ?XI\-6/B[P]<Z+J+3+;7&TLT+ .I5@P()!'4>E
M0^$O!^D>"M'&F:1$ZQEM\DDK;I)6QC+'CT[ #VJDVY\[_JY+5H\J_KJ.\6>$
M]+\9Z%)I.JHYB9@Z21D!XG'1E)!YZCZ$UYV/@EJLJ?8KSXBZY/I!&QK(%@"G
M]W)D*_\ CM>P45-D.YQ^K?#W3[KX;R^"],E_L^T9%5)2GFD$.'+$9&22#W'7
M\*M2^"=-O_ 5KX3U7-W:P6L4!E4;&W(H =>NT\9[^G(KIJ*;UO?J"TM;H>.+
M\!YI%33[SQQK%QH","FF\@ #D#)<K^(2NY\0>![/5?A]+X0T^1=-M#%'%$ZQ
M^9Y85U;ID9)QR<]3FNJHH>JLP6CNCF9?!.FW_@*U\)ZKF[M8+6* RJ-C;D4
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MY(Y!-6O"WPY@T+6I-<U+49M6UA\XN)EP$SQD#).<<9STZ8I\KMRBYE>YQO\
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MT_\ 0A4M13_ZL?[Z?^A"@"6BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** ,S5_\ EC_P+^E%&K_\
ML?\ @7]** +UK_QZ0_\ 7-?Y5+45K_QZ0_\ 7-?Y5+0 5F^(=&@\1>'K_1[A
MBL5Y T18#)7(X/X'!_"M*BDTFK,:=G='B6D^)?B/\/=.BT#4?!4^OV]HOE6M
MW8.QW1CIG:C=N!D*<8S6CHMCXM\?>-])\2^(='_L+2M(WO:6DC$S22,,?-D
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MK7;B5@UL<I#L$C*2-T@.<*/XJYC6/'?QB\/Z5/J>J^%] M;. 9DE>53CG
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M!84444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !43?\?4?^XW\UJ6HF_X^H_\ <;^:T 2T444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110!%%_K)_P#?'_H(J6HHO]9/_OC_ -!%2T %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5%;?\
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MQ)::AK4-U&8U):.WAA&2^T*@R['9_"/N]32A]A/I;\'_ %^(Y_::ZI_BOZ_
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M_P"_I\CA]8\.?%>\T+4+GQ!XSL;#3TMI)98K.,;@H4DJ2$4XXQ]X]:A\-_\
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M/_ XJ=\0O^2U?#__ 'Y/YBNB\:^"]1\2>+O">K6<UJEOI%R9KA9G8,P+(?E
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MUC_!K_DD^A?[DG_HQZZ;Q/IDVM>%M5TNV:-)[NTD@C:0D*&92!G )QSZ5G^
M/#UWX5\$:;HM])!)<VJN':!B4.79N"0#T/I1'3F^7ZA+[/S_ $.EHHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MK_\ +'_@7]** +UK_P >D/\ US7^52U%:_\ 'I#_ -<U_E4M !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %1+_ ,?4G^XO\VJ6HE_X^I/]Q?YM0!+1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 5%<_\>LW^X?Y5+45S_QZS?[A_E0!+1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110!%;?\>L/^X/Y5+45M_QZP_[@_E4M !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 13_
M .K'^^G_ *$*EJ*?_5C_ 'T_]"%2T %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5$W_'U'_N-_-:EJ
M)O\ CZC_ -QOYK0!+1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% $47^LG_WQ_Z"*EJ*+_63_P"^
M/_014M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %16W_'K#_N#^52U%;?\>L/^X/Y4 2T444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !44_P#JQ_OI_P"A"I:BG_U8_P!]/_0A0!+1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% &9
MJ_\ RQ_X%_2BC5_^6/\ P+^E% %ZU_X](?\ KFO\JEJK;7$*VL(,T8(1006'
MI4OVF#_GM'_WT* ):*B^TP?\]H_^^A1]I@_Y[1_]]"@"6BHOM,'_ #VC_P"^
MA1]I@_Y[1_\ ?0H EHJ+[3!_SVC_ .^A1]I@_P">T?\ WT* ):*B^TP?\]H_
M^^A1]I@_Y[1_]]"@"6BHOM,'_/:/_OH4?:8/^>T?_?0H EHJ+[3!_P ]H_\
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M^^A1]I@_Y[1_]]"@"6BHOM,'_/:/_OH4?:8/^>T?_?0H EHJ+[3!_P ]H_\
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M]"C[3!_SVC_[Z% $M%1?:8/^>T?_ 'T*/M,'_/:/_OH4 2T5%]I@_P">T?\
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M^>T?_?0H^TP?\]H_^^A0!+147VF#_GM'_P!]"C[3!_SVC_[Z% $M%1?:8/\
MGM'_ -]"C[3!_P ]H_\ OH4 2T5%]I@_Y[1_]]"C[3!_SVC_ .^A0!+147VF
M#_GM'_WT*/M,'_/:/_OH4 2T5%]I@_Y[1_\ ?0H^TP?\]H_^^A0!+147VF#_
M )[1_P#?0H^TP?\ /:/_ +Z% $M%1?:8/^>T?_?0H^TP?\]H_P#OH4 2T5%]
MI@_Y[1_]]"C[3!_SVC_[Z% $M%1?:8/^>T?_ 'T*/M,'_/:/_OH4 2T5%]I@
M_P">T?\ WT*/M,'_ #VC_P"^A0!+147VF#_GM'_WT*/M,'_/:/\ [Z% $M%1
M?:8/^>T?_?0H^TP?\]H_^^A0!+147VF#_GM'_P!]"C[3!_SVC_[Z% $M%1?:
M8/\ GM'_ -]"C[3!_P ]H_\ OH4 %M_QZP_[@_E4M5K>XA6VB!FC!" $%AZ5
M)]I@_P">T?\ WT* ):*B^TP?\]H_^^A1]I@_Y[1_]]"@"6BHOM,'_/:/_OH4
M?:8/^>T?_?0H EHJ+[3!_P ]H_\ OH4?:8/^>T?_ 'T* ):*B^TP?\]H_P#O
MH4?:8/\ GM'_ -]"@"6BHOM,'_/:/_OH4?:8/^>T?_?0H EHJ+[3!_SVC_[Z
M%'VF#_GM'_WT* ):*B^TP?\ /:/_ +Z%'VF#_GM'_P!]"@"6BHOM,'_/:/\
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M_?0H EHJ+[3!_P ]H_\ OH4?:8/^>T?_ 'T* ):*B^TP?\]H_P#OH4?:8/\
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MM,'_ #VC_P"^A1]I@_Y[1_\ ?0H EHJ+[3!_SVC_ .^A1]I@_P">T?\ WT*
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M]]"C[3!_SVC_ .^A0!+147VF#_GM'_WT*/M,'_/:/_OH4 2T5%]I@_Y[1_\
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ME3S[.V]OQ&XV;7:_X'T)17D7B[Q3XT\$>#]*M]0O[&;6+VY>.34A%F*%/X>
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M;\Z/-D_YZ-^=,HK:QC<?YLG_ #T;\Z/-D_YZ-^=,HHL%Q_FR?\]&_.CS9/\
MGHWYTRBBP7'^;)_ST;\Z/-D_YZ-^=,HHL%Q_FR?\]&_.CS9/^>C?G3**+!<T
M;<EH%)))YY/UJ6HK;_CW7\?YU+6+W-5L9/B#Q+I'A:Q2]UF\%K;O((E?RV?+
M$$XPH)Z UB67Q5\$:A<K;P:_ )&.!YT4D2_]].H'ZUR_[0/_ ")-A_U_K_Z
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MX^\0,<>M9/B?X@)X>O?#T$6E3WB:RX"NK[/+!VXXP<GYNF1TZUY+X]D^(/\
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MFV%U>S+?*S1VT+2,!L<9(4'CD5VVA:!I6DVD$EGI%E9W#0J)&AMDC8G SD@
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M'H<CI5CX=:$DGBI+^+X=R^'K6&"13/=74[R%S@ *'(X(+?PGZBO9**48J/\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** (+G^'\:*+G^'\:*REN:QV)8O]4G^Z*=38O\ 5)_NBG5JC)A1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M (%/_C1_PDFN_P#0:U'_ ,"G_P :S**+(+FG_P ))KO_ $&M1_\  I_\:/\
MA)-=_P"@UJ/_ (%/_C69119!<T_^$DUW_H-:C_X%/_C1_P ))KO_ $&M1_\
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M-:C_ .!3_P"-'_"2:[_T&M1_\"G_ ,:S**+(+FG_ ,))KO\ T&M1_P# I_\
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M?\))KO\ T&M1_P# I_\ &LRBBR"YI_\ "2:[_P!!K4?_  *?_&C_ (237?\
MH-:C_P"!3_XUF44607-/_A)-=_Z#6H_^!3_XT?\ "2:[_P!!K4?_  *?_&LR
MBBR"YI_\))KO_0:U'_P*?_&C_A)-=_Z#6H_^!3_XUF44607-/_A)-=_Z#6H_
M^!3_ .-'_"2:[_T&M1_\"G_QK,HHL@N:?_"2:[_T&M1_\"G_ ,:/^$DUW_H-
M:C_X%/\ XUF44607-/\ X237?^@UJ/\ X%/_ (T?\))KO_0:U'_P*?\ QK,H
MHL@N:?\ PDFN_P#0:U'_ ,"G_P :/^$DUW_H-:C_ .!3_P"-9E%%D%S3_P"$
MDUW_ *#6H_\ @4_^-'_"2:[_ -!K4?\ P*?_ !K,HHL@N:?_  DFN_\ 0:U'
M_P "G_QH_P"$DUW_ *#6H_\ @4_^-9E%%D%S3_X237?^@UJ/_@4_^-'_  DF
MN_\ 0:U'_P "G_QK,HHL@N:?_"2:[_T&M1_\"G_QH_X237?^@UJ/_@4_^-9E
M%%D%S3_X237?^@UJ/_@4_P#C1_PDFN_]!K4?_ I_\:S**+(+FG_PDFN_]!K4
M?_ I_P#&C_A)-=_Z#6H_^!3_ .-9E%%D%S3_ .$DUW_H-:C_ .!3_P"-'_"2
M:[_T&M1_\"G_ ,:S**+(+FG_ ,))KO\ T&M1_P# I_\ &C_A)-=_Z#6H_P#@
M4_\ C69119!<T_\ A)-=_P"@UJ/_ (%/_C1_PDFN_P#0:U'_ ,"G_P :S**+
M(+FG_P ))KO_ $&M1_\  I_\:/\ A)-=_P"@UJ/_ (%/_C69119!<T_^$DUW
M_H-:C_X%/_C1_P ))KO_ $&M1_\  I_\:S**+(+FG_PDFN_]!K4?_ I_\:/^
M$DUW_H-:C_X%/_C69119!<T_^$DUW_H-:C_X%/\ XT?\))KO_0:U'_P*?_&L
MRBBR"YI_\))KO_0:U'_P*?\ QH_X237?^@UJ/_@4_P#C69119!<T_P#A)-=_
MZ#6H_P#@4_\ C1_PDFN_]!K4?_ I_P#&LRBBR"YI_P#"2:[_ -!K4?\ P*?_
M !H_X237?^@UJ/\ X%/_ (UF44607-/_ (237?\ H-:C_P"!3_XT?\))KO\
MT&M1_P# I_\ &LRBBR"YI_\ "2:[_P!!K4?_  *?_&C_ (237?\ H-:C_P"!
M3_XUF44607-/_A)-=_Z#6H_^!3_XT?\ "2:[_P!!K4?_  *?_&LRBBR"YI_\
M))KO_0:U'_P*?_&C_A)-=_Z#6H_^!3_XUF44607-/_A)-=_Z#6H_^!3_ .-'
M_"2:[_T&M1_\"G_QK,HHL@N:?_"2:[_T&M1_\"G_ ,:/^$DUW_H-:C_X%/\
MXUF44607-/\ X237?^@UJ/\ X%/_ (T?\))KO_0:U'_P*?\ QK,HHL@N:?\
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M?^@UJ/\ X%/_ (UF44607-/_ (237?\ H-:C_P"!3_XT?\))KO\ T&M1_P#
MI_\ &LRBBR"YI_\ "2:[_P!!K4?_  *?_&C_ (237?\ H-:C_P"!3_XUF446
M07-/_A)-=_Z#6H_^!3_XT?\ "2:[_P!!K4?_  *?_&LRBBR"YI_\))KO_0:U
M'_P*?_&C_A)-=_Z#6H_^!3_XUF44607-/_A)-=_Z#6H_^!3_ .-'_"2:[_T&
MM1_\"G_QK,HHL@N:?_"2:[_T&M1_\"G_ ,:/^$DUW_H-:C_X%/\ XUF44607
M-/\ X237?^@UJ/\ X%/_ (T?\))KO_0:U'_P*?\ QK,HHL@N:?\ PDFN_P#0
M:U'_ ,"G_P :/^$DUW_H-:C_ .!3_P"-9E%%D%S3_P"$DUW_ *#6H_\ @4_^
M-'_"2:[_ -!K4?\ P*?_ !K,HHL@N:?_  DFN_\ 0:U'_P "G_QH_P"$DUW_
M *#6H_\ @4_^-9E%%D%S3_X237?^@UJ/_@4_^-'_  DFN_\ 0:U'_P "G_QK
M,HHL@N:?_"2:[_T&M1_\"G_QH_X237?^@UJ/_@4_^-9E%%D%S3_X237?^@UJ
M/_@4_P#C1_PDFN_]!K4?_ I_\:S**+(+FG_PDFN_]!K4?_ I_P#&C_A)-=_Z
M#6H_^!3_ .-9E%%D%S3_ .$DUW_H-:C_ .!3_P"-'_"2:[_T&M1_\"G_ ,:S
M**+(+FG_ ,))KO\ T&M1_P# I_\ &C_A)-=_Z#6H_P#@4_\ C69119!<T_\
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MDFN_]!K4?_ I_P#&LRBBR"YI_P#"2:[_ -!K4?\ P*?_ !H_X237?^@UJ/\
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M -!K4?\ P*?_ !K,HHL@N:?_  DFN_\ 0:U'_P "G_QH_P"$DUW_ *#6H_\
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M^$DUW_H-:C_X%/\ XT?\))KO_0:U'_P*?_&LRBBR"YI_\))KO_0:U'_P*?\
MQH_X237?^@UJ/_@4_P#C69119!<T_P#A)-=_Z#6H_P#@4_\ C1_PDFN_]!K4
M?_ I_P#&LRBBR"YI_P#"2:[_ -!K4?\ P*?_ !H_X237?^@UJ/\ X%/_ (UF
M44607-/_ (237?\ H-:C_P"!3_XT?\))KO\ T&M1_P# I_\ &LRBBR"YI_\
M"2:[_P!!K4?_  *?_&C_ (237?\ H-:C_P"!3_XUF44607-/_A)-=_Z#6H_^
M!3_XT?\ "2:[_P!!K4?_  *?_&LRBBR"YI_\))KO_0:U'_P*?_&C_A)-=_Z#
M6H_^!3_XUF44607-/_A)-=_Z#6H_^!3_ .-'_"2:[_T&M1_\"G_QK,HHL@N:
M?_"2:[_T&M1_\"G_ ,:/^$DUW_H-:C_X%/\ XUF44607-/\ X237?^@UJ/\
MX%/_ (T?\))KO_0:U'_P*?\ QK,HHL@N:?\ PDFN_P#0:U'_ ,"G_P :/^$D
MUW_H-:C_ .!3_P"-9E%%D%S3_P"$DUW_ *#6H_\ @4_^-'_"2:[_ -!K4?\
MP*?_ !K,HHL@N:?_  DFN_\ 0:U'_P "G_QH_P"$DUW_ *#6H_\ @4_^-9E%
M%D%S3_X237?^@UJ/_@4_^-'_  DFN_\ 0:U'_P "G_QK,HHL@N:?_"2:[_T&
MM1_\"G_QH_X237?^@UJ/_@4_^-9E%%D%S3_X237?^@UJ/_@4_P#C1_PDFN_]
M!K4?_ I_\:S**+(+FG_PDFN_]!K4?_ I_P#&C_A)-=_Z#6H_^!3_ .-9E%%D
M%S3_ .$DUW_H-:C_ .!3_P"-'_"2:[_T&M1_\"G_ ,:S**+(+FG_ ,))KO\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@#V'X%?\Q_\ [=__ &K11\"O^8__ -N__M6BL)_$:1V/,?$?_(SZ
MM_U^S?\ H9K,K3\1_P#(SZM_U^S?^AFLRMEL9L****8!1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %?0 EC^'7PICN;2%#>-$C$
ML/O328Y/KCT]%Q7S_7T!XLMY/%'PCAGT\>:X@BN B<D[1\P'N.>/:HJ_!\T5
M3^,\AA\>>*8=0%Z-<O6DW;BCRDQGVV?=Q[8KU;QE#;^,OA7%KIA5+J& 7*%1
MG:>DB@^G7\A7A"(TCJB*69C@*!DD^E>^ZC$WAKX)-9WN$G^Q^248\AY#]WZC
M<?RI5$E"_H%-OGMZEWP/;:#%\/YH].O9YK%UD-S+(I#(Y0;P/E'3MP?QKB_
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MNG  /O@UA&_(TE<UE\2;=B'P?X)TCQ;XBU^&XFN8K>UF/D?9G505+L!U4\8
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M 'L/P*_YC_\ V[_^U:*/@5_S'_\ MW_]JT5A/XC2.QZ$GA'P[<QK//HEA)-*
M [NT"DLQY))QUS3O^$+\,?\ 0 T[_P !U_PK8M?^/2'_ *YK_*I:5V58PO\
MA"_#'_0 T[_P'7_"C_A"_#'_ $ -._\  =?\*W:*+L+&%_PA?AC_ * &G?\
M@.O^%'_"%^&/^@!IW_@.O^%;M%%V%C"_X0OPQ_T -._\!U_PH_X0OPQ_T -.
M_P# =?\ "MVBB["QA?\ "%^&/^@!IW_@.O\ A1_PA?AC_H :=_X#K_A6[11=
MA8PO^$+\,?\ 0 T[_P !U_PH_P"$+\,?] #3O_ =?\*W:*+L+&%_PA?AC_H
M:=_X#K_A1_PA?AC_ * &G?\ @.O^%;M%%V%C"_X0OPQ_T -._P# =?\ "C_A
M"_#'_0 T[_P'7_"MVBB["QA?\(7X8_Z &G?^ Z_X4?\ "%^&/^@!IW_@.O\
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MPH_X0OPQ_P! #3O_  '7_"MVBB["QA?\(7X8_P"@!IW_ (#K_A1_PA?AC_H
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M_A1_PA?AC_H :=_X#K_A6[11=A8PO^$+\,?] #3O_ =?\*/^$+\,?] #3O\
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M?\(7X8_Z &G?^ Z_X4?\(7X8_P"@!IW_ (#K_A6[11=A8PO^$+\,?] #3O\
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M^%'_  A?AC_H :=_X#K_ (5NT4786,+_ (0OPQ_T -._\!U_PH_X0OPQ_P!
M#3O_  '7_"MVBB["QA?\(7X8_P"@!IW_ (#K_A1_PA?AC_H :=_X#K_A6[11
M=A8PO^$+\,?] #3O_ =?\*/^$+\,?] #3O\ P'7_  K=HHNPL87_  A?AC_H
M :=_X#K_ (4?\(7X8_Z &G?^ Z_X5NT4786,+_A"_#'_ $ -._\  =?\*/\
MA"_#'_0 T[_P'7_"MVBB["QA?\(7X8_Z &G?^ Z_X4?\(7X8_P"@!IW_ (#K
M_A6[11=A8PO^$+\,?] #3O\ P'7_  H_X0OPQ_T -._\!U_PK=HHNPL87_"%
M^&/^@!IW_@.O^%1S^#?#*02,N@Z<"%)!^S+Z?2NAJ*Y_X]9O]P_RHNPL8_\
MPA?AC_H :=_X#K_A1_PA?AC_ * &G?\ @.O^%;M%%V%C"_X0OPQ_T -._P#
M=?\ "C_A"_#'_0 T[_P'7_"MVBB["QA?\(7X8_Z &G?^ Z_X4?\ "%^&/^@!
MIW_@.O\ A6[11=A8PO\ A"_#'_0 T[_P'7_"C_A"_#'_ $ -._\  =?\*W:*
M+L+&%_PA?AC_ * &G?\ @.O^%'_"%^&/^@!IW_@.O^%;M%%V%C"_X0OPQ_T
M-._\!U_PH_X0OPQ_T -._P# =?\ "MVBB["QA?\ "%^&/^@!IW_@.O\ A1_P
MA?AC_H :=_X#K_A6[11=A8PO^$+\,?\ 0 T[_P !U_PH_P"$+\,?] #3O_ =
M?\*W:*+L+&%_PA?AC_H :=_X#K_A1_PA?AC_ * &G?\ @.O^%;M%%V%C"_X0
MOPQ_T -._P# =?\ "C_A"_#'_0 T[_P'7_"MVBB["QA?\(7X8_Z &G?^ Z_X
M4?\ "%^&/^@!IW_@.O\ A6[11=A8PO\ A"_#'_0 T[_P'7_"C_A"_#'_ $ -
M._\  =?\*W:*+L+&%_PA?AC_ * &G?\ @.O^%'_"%^&/^@!IW_@.O^%;M%%V
M%C"_X0OPQ_T -._\!U_PH_X0OPQ_T -._P# =?\ "MVBB["QA?\ "%^&/^@!
MIW_@.O\ A1_PA?AC_H :=_X#K_A6[11=A8PO^$+\,?\ 0 T[_P !U_PH_P"$
M+\,?] #3O_ =?\*W:*+L+&%_PA?AC_H :=_X#K_A1_PA?AC_ * &G?\ @.O^
M%;M%%V%C"_X0OPQ_T -._P# =?\ "C_A"_#'_0 T[_P'7_"MVBB["QA?\(7X
M8_Z &G?^ Z_X4?\ "%^&/^@!IW_@.O\ A6[11=A8PO\ A"_#'_0 T[_P'7_"
MC_A"_#'_ $ -._\  =?\*W:*+L+&%_PA?AC_ * &G?\ @.O^%'_"%^&/^@!I
MW_@.O^%;M%%V%C"_X0OPQ_T -._\!U_PH_X0OPQ_T -._P# =?\ "MVBB["Q
MA?\ "%^&/^@!IW_@.O\ A1_PA?AC_H :=_X#K_A6[11=A8PO^$+\,?\ 0 T[
M_P !U_PH_P"$+\,?] #3O_ =?\*W:*+L+&%_PA?AC_H :=_X#K_A1_PA?AC_
M * &G?\ @.O^%;M%%V%C"_X0OPQ_T -._P# =?\ "C_A"_#'_0 T[_P'7_"M
MVBB["QA?\(7X8_Z &G?^ Z_X4?\ "%^&/^@!IW_@.O\ A6[11=A8PO\ A"_#
M'_0 T[_P'7_"C_A"_#'_ $ -._\  =?\*W:*+L+&%_PA?AC_ * &G?\ @.O^
M%'_"%^&/^@!IW_@.O^%;M%%V%C"_X0OPQ_T -._\!U_PH_X0OPQ_T -._P#
M=?\ "MVBB["QA?\ "%^&/^@!IW_@.O\ A1_PA?AC_H :=_X#K_A6[11=A8PO
M^$+\,?\ 0 T[_P !U_PH_P"$+\,?] #3O_ =?\*W:*+L+&%_PA?AC_H :=_X
M#K_A1_PA?AC_ * &G?\ @.O^%;M%%V%C"_X0OPQ_T -._P# =?\ "C_A"_#'
M_0 T[_P'7_"MVBB["QA?\(7X8_Z &G?^ Z_X4?\ "%^&/^@!IW_@.O\ A6[1
M1=A8PO\ A"_#'_0 T[_P'7_"C_A"_#'_ $ -._\  =?\*W:*+L+&%_PA?AC_
M * &G?\ @.O^%1Q^#?#+/*#H.G85L#_1E] ?3WKH:BB_UD_^^/\ T$4786,?
M_A"_#'_0 T[_ ,!U_P */^$+\,?] #3O_ =?\*W:*+L+&%_PA?AC_H :=_X#
MK_A1_P (7X8_Z &G?^ Z_P"%;M%%V%C"_P"$+\,?] #3O_ =?\*/^$+\,?\
M0 T[_P !U_PK=HHNPL87_"%^&/\ H :=_P" Z_X4?\(7X8_Z &G?^ Z_X5NT
M4786,+_A"_#'_0 T[_P'7_"C_A"_#'_0 T[_ ,!U_P *W:*+L+&%_P (7X8_
MZ &G?^ Z_P"%'_"%^&/^@!IW_@.O^%;M%%V%C"_X0OPQ_P! #3O_  '7_"C_
M (0OPQ_T -._\!U_PK=HHNPL87_"%^&/^@!IW_@.O^%'_"%^&/\ H :=_P"
MZ_X5NT4786,+_A"_#'_0 T[_ ,!U_P */^$+\,?] #3O_ =?\*W:*+L+&%_P
MA?AC_H :=_X#K_A1_P (7X8_Z &G?^ Z_P"%;M%%V%C"_P"$+\,?] #3O_ =
M?\*/^$+\,?\ 0 T[_P !U_PK=HHNPL87_"%^&/\ H :=_P" Z_X4?\(7X8_Z
M &G?^ Z_X5NT4786,+_A"_#'_0 T[_P'7_"C_A"_#'_0 T[_ ,!U_P *W:*+
ML+&%_P (7X8_Z &G?^ Z_P"%'_"%^&/^@!IW_@.O^%;M%%V%C"_X0OPQ_P!
M#3O_  '7_"C_ (0OPQ_T -._\!U_PK=HHNPL<]!X-\,O!&S:#IQ)4$G[,OI]
M*D_X0OPQ_P! #3O_  '7_"MBV_X]8?\ <'\JEHNPL87_  A?AC_H :=_X#K_
M (4?\(7X8_Z &G?^ Z_X5NT4786,+_A"_#'_ $ -._\  =?\*/\ A"_#'_0
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M_A1_PA?AC_H :=_X#K_A6[11=A8PO^$+\,?] #3O_ =?\*/^$+\,?] #3O\
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M :=_X#K_ (4?\(7X8_Z &G?^ Z_X5NT4786,+_A"_#'_ $ -._\  =?\*/\
MA"_#'_0 T[_P'7_"MVBB["QA?\(7X8_Z &G?^ Z_X4?\(7X8_P"@!IW_ (#K
M_A6[11=A8PO^$+\,?] #3O\ P'7_  H_X0OPQ_T -._\!U_PK=HHNPL87_"%
M^&/^@!IW_@.O^%'_  A?AC_H :=_X#K_ (5NT4786,+_ (0OPQ_T -._\!U_
MPH_X0OPQ_P! #3O_  '7_"MVBB["QA?\(7X8_P"@!IW_ (#K_A1_PA?AC_H
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MHH **** "BBB@ HHHH **** "HE_X^I/]Q?YM4M1+_Q]2?[B_P VH EHHHH
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M13_ZL?[Z?^A"I:BG_P!6/]]/_0A4M !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %1-_P ?4?\ N-_-
M:EJ)O^/J/_<;^:T 2T444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110!%%_K)_]\?\ H(J6HHO]9/\
M[X_]!%2T %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 5%;?\>L/^X/Y5+45M_QZP_[@_E0!+1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %13_ZL?[Z?^A"I:BG_P!6/]]/_0A0!+1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% &9J
M_P#RQ_X%_2BC5_\ EC_P+^E% %ZU_P"/2'_KFO\ *I:BM?\ CTA_ZYK_ "J6
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M?6M0BN);:%D5EMU5G.Y@HP"0.I]:\Z_X:.\'_P#0-US_ +\0_P#QVMGXZ_\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@#T3X6_\Q7_MC_[/11\+?^8K_P!L?_9Z*YJGQ,WA\)[):_\
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M!9ZA ,1S$\ 'L<GC(Q@X!'-=[XM\5:=X-\/3ZQJ3-Y49"I&F-TKGHJY[]?H
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MB+LI+S7Y!):I^3_,U_CSJL%A\,[FS=QYU_-'#$G<X8.3^ 7]17._%33Y-+^
MF@V$X(E@:TCD![,(SD?G6SH?PEU*[\16_B#QWKYUN[MCF"V52(4(.0><<9YV
MA0,]<]*Z'XI>#]0\;^$ETG39K6*<7*3;KEF5<*#GE5)SSZ4FK1MW:?R5O^"R
MHN\EV2?XG6V"+'IELB !5A0 #L,"O*_@"1_PC_B 9&1JTF1_P%:]9MXS%;11
MM@E$"G'L*\AG^%WC+P_XEU"_\">)K6PL]1E,LUO=)G82<X *.&QDX/!QQ[U3
M?[QONG^=R(K]VEVM^5A^L.K?M.:$JD$KI;!AZ?+*:?\ ##'_  M/XB?:L_;?
MMB[=_7RMSXQ[8V?I4VB?"O5-'^(VE^)IM634#';N-0GN';SIIV#C*K@J% *
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MY)YS5SX;^&+WP?X(L]%U"6WEN8&D9FMV9D.YRPP2 >A]*:T;]$ONN)[+U;_
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M** "BBB@ J*Y_P"/6;_</\JEJ*Y_X]9O]P_RH EHHHH **** "BBB@ HHHH
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 >B?"W_F*_\ ;'_V>BCX6_\ ,5_[8_\
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M>JEO:W1_U\]B7\-UY'M->1?'[_D ^'O^PO'_ .@M2/\ LY^$'=F.HZYDG/\
MKXO_ (U5+XU:?;Z%X&\):=#(YMK*_AA1Y6&=J1L 6( &<#GI0K<T6^\?S"?P
MR2[/\F>UUX]^T-&L/AC1=4CPMW::DOE/G!&58G'XHI_"O03X\\'@$_\ "5Z'
MQZ:A%_\ %5Y-XWUV#XL>,M$\)^'&:[TZUN/M-_=HI\L <$@GL!D9[E@!22O*
M*7=?@RKI)M]F;'QWD,OAGPS(1@OJD38^J-7L->0?M %(O#OA]F(5%U:,DDX
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M=++_ ()?\9?$NZN?A_X:DTF\ATW4/$16-KF1PBVJC E;<>F&.,^F2.:YNY\
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MU+LY13VO_G^MBM;-K>W]?J9/B+X12^!-!N/$WA/Q%JD>J6*>?/YKKMF4<MP
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MU;^/UO+-\,GDC0LL%Y%))@=%Y7/YL/SK/:G%_P!?$:K6J_Z^R>C1?\@A/^N
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M))UQP=PSTSN./?I776OQ3NG^!LWBEQ&VK0 VC<#:9]P4/CIT8-CIU%94FA_
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MM\3=90Q(43[1M4J,+^] X_"M[4/%/AKPIKTUDFGG[1(X>ZFCB VEN>>YP#G
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH ]$^%O_,5_P"V/_L]%'PM_P"8K_VQ_P#9Z*YJGQ,WA\)[
M):_\>D/_ %S7^52U%:_\>D/_ %S7^52U!04444 8NG^$]$TO7[[7+.R\O4[X
M8N+@RNY<9!QAB0!P.@'2MJBBCR#S,/4/"&A:IXAL]?N[$OJED (+A9I$*@$D
M#"L >IZ@]:R=8^%7@O7]6N-4U/1?/O;@@RR?:IEW$  <*X X Z"NRHHL!P ^
M"?P\!R/#W_D[<?\ QRNWN[&TO[-[.\MH;BV==KQ3('5AZ$'K5BBCI8.MSA7^
M#?P_>Y-P?#D6\G.!/*%_[Y#[?TKL;#3[+2[-+/3[2"UMH_N101A%7Z 59HH\
M@ZW"L7Q)X3T3Q=916>NV7VN"*3S43S7CPV",Y0@]":VJ*+ < /@G\/ 01X>'
M'K>7!_\ :E=9HGAS1O#=J;;1M-MK*(XW"% "^.A8]6/N2:TZ*+@8OB3PGHGB
MZRBL]=LOM<$4GFHGFO'AL$9RA!Z$US0^"?P\!!'AX<>MY<'_ -J5W]% &9HG
MAS1O#=J;;1M-MK*(XW"% "^.A8]6/N2:TZ** .0U?X6^"=<NFNK[P];&9R69
MX6>$L3U)\LKD^YK5\/\ A+0/"T+1:)I5O9AQAW09=QZ,YRQ_$UM44+31 ]=P
MHHHH **** "BBB@ HHHH *B7_CZD_P!Q?YM4M1+_ ,?4G^XO\VH EHHHH X;
MXM^*Y_"/@*ZN[*3R[ZY=;6W?NC-G+#W"AB/?%9?@/X2:!I>B07NN:?!JNL7<
M8FN9;U1,JLW)4*V1QGKU)SSVK/\ VA[2:;P)97<:[DM-01Y.,X!5E!_,@?C7
MJ6EWL&I:39WULX>"XA25&4\$$ BB&TGUO;Y6O^(2WBO*_P")YQXV^$EK="VU
M?P7;V^CZ_:3(\30?N8G&><J!@$=<@<\@YJK\=S<GX4VAO5B6Z^UP><(6)0/M
M;=M) )&<XR!7IFN:U8^'=&N=6U*4Q6ELNZ1@,GD@  =R20*\N^-^I6FM?"*S
MU&QD:2UN;N&2)RA0LI5L'# $5+O:R[K\T7'XDWV?Y,+OXW/:6XGTGPAJFJ:+
M;J$EU0!HXLC 8@[",#W(KT;P]XKTOQ+X8B\06<Q2R9&9S-A3%M^\&[#&/ZU8
MM+*VM_#,-C'"BVR6@B$04;=NS&,?2OG[P_<SVO[,WB0V[LI-\8B1V1FB##\0
M2/QJINW.NJ_SL9P5U#ST_"YW%Q\;YKJYE;PSX+U?6].A;;)>Q*ZKD=< (W&.
M>2#["NZ\'>--*\;Z)_:6ELZ[&V302C$D3^A _,$?XBO*O"VK?%^P\*Z7;Z+X
M.T-M,6V0V[^:H+H1D,?WXY.<G@<FMKX9Z#XTL?'.OZUXCT6WTR#5(0\B6TJ-
M&TP(P0H=B"07)SW)HDN6Z[)_>@O=)B67QT&I:27T[PK>W^L><Z_V;9R-,5C7
M'[QV"94$G &T]*M:9\<]&N]&NI;O3;RUUJ"86ZZ.H\R:60YP$X!/((.0,?B,
MU/V>;.&+P=JEVJ+YTVHNK/CDJJK@?AEOSIN@Z?:O^TQXDF,*[X;!)(SC[KLD
M0+?7!/YFG;WN7NK_ ()E2TYFNC_5HT_#'Q@&K>*(?#VO>&[WP_?7(_T=;IB=
MY[ AD4C.#C@@GBM/5_$>FVOQ>T/09?#UK/?W5HTD6JL5\V!0)/E7Y"<?*>C#
M[Q_' ^*R+_PL/X<2;1O_ +19<^VZ*H_$G_)RWA/_ +!S_P#H,]$-7'U:^Y">
MG-Z)_B=/XX^)>G>#;FWTY+*YU36;E=T-A:CYB.Q8\XS@XP">.E9GA;XNQ:QX
MBB\/Z]H%]X>U.X&;>.[SMD]!EE4@G!QQ@XQG. <SP;&E[\?O&EW=KFZM8HXK
M<,<[8R%!('T"_P#?7O7<^*M+\*7<VEWOB5[2&2TN UC-<71@*R\$!2&7)^4'
M'/3I2AM%OK_P?Q"6[2Z?\#\#/\;?$C3O!ES:Z?\ 8[K4M6NP3!8VBY<CL3Z
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M_%S_ )%:/_L))_Z):JA\2)ELSQBBBBNHP"BBB@ HHHH **** "BBB@ HHHH
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M['Q!JFG:I/J5I=>7>3[O,D\M3NW')X(QU]JJZAJ%UJM]+>WLOFW$N"[[0N<
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M/>(/^?S3/^_LG_Q%'_"GO$'_ #^:9_W]D_\ B*.>/<.5]CSZBO0?^%/>(/\
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M-,_[^R?_ !%'_"GO$'_/YIG_ ']D_P#B*.>/<.5]CSZBO0?^%/>(/^?S3/\
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M/>(/^?S3/^_LG_Q%'_"GO$'_ #^:9_W]D_\ B*.>/<.5]CSZBO0?^%/>(/\
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M +^R?_$4<\>X<K['GU%>@_\ "GO$'_/YIG_?V3_XBC_A3WB#_G\TS_O[)_\
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M +^R?_$4<\>X<K['GU%>@_\ "GO$'_/YIG_?V3_XBC_A3WB#_G\TS_O[)_\
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MRR?_ !%'/'N'*^QP%%>@_P#"GO$'_/YIG_?V3_XBC_A3WB#_ )_-,_[^R?\
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MO$'_ #^:9_W]D_\ B*/^%/>(/^?S3/\ O[)_\11SQ[AROL/^%O\ S%?^V/\
M[/170>%?!^H>$_M?V^:UD^T[-GD,QQMW9SE1_>%%83=Y:&L59'HEK_QZ0_\
M7-?Y5+45K_QZ0_\ 7-?Y5+4%!1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %1+_Q]2?[B_S:I:B7_CZD
M_P!Q?YM0!+1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M!QQ0O=LUWO\ A;\A?%=/M;\;G(?'G6;"S^'%UITMS&+R]DB$,.[YF <,6QZ
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MFNI)=6N/M$XG=2JMECA<*,#YCUS5SM*<GT::^]HB%XQ7=-/[KG)_ S6[*[\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% $5M_QZP_[@_E4M16W_ !ZP_P"X/Y5+0 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% $4_^
MK'^^G_H0J6HI_P#5C_?3_P!"%2T %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5$W_'U'_N-_-:EJ)O
M^/J/_<;^:T 2T444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110!%%_K)_\ ?'_H(J6HHO\ 63_[X_\
M014M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %16W_'K#_N#^52U%;?\ 'K#_ +@_E0!+1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %13_ZL?[Z?^A"I:BG_ -6/]]/_ $(4 2T444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!F:
MO_RQ_P"!?THHU?\ Y8_\"_I10!>M?^/2'_KFO\JEJK;6\+6L),,9)1225'I4
MOV:#_GC'_P!\B@"6BHOLT'_/&/\ [Y%'V:#_ )XQ_P#?(H EHJ+[-!_SQC_[
MY%'V:#_GC'_WR* ):*B^S0?\\8_^^11]F@_YXQ_]\B@"6BHOLT'_ #QC_P"^
M11]F@_YXQ_\ ?(H EHJ+[-!_SQC_ .^11]F@_P">,?\ WR* ):*B^S0?\\8_
M^^11]F@_YXQ_]\B@"6BHOLT'_/&/_OD4?9H/^>,?_?(H EHJ+[-!_P \8_\
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M^^11]F@_YXQ_]\B@"6BHOLT'_/&/_OD4?9H/^>,?_?(H EHJ+[-!_P \8_\
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M/_OD4 2T5%]F@_YXQ_\ ?(H^S0?\\8_^^10!+147V:#_ )XQ_P#?(H^S0?\
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M\BC[-!_SQC_[Y% $M%1?9H/^>,?_ 'R*/LT'_/&/_OD4 2T5%]F@_P">,?\
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M:*B^S0?\\8_^^11]F@_YXQ_]\B@"6BHOLT'_ #QC_P"^11]F@_YXQ_\ ?(H
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M!+147V:#_GC'_P!\BC[-!_SQC_[Y% $M%1?9H/\ GC'_ -\BC[-!_P \8_\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %11?ZR?_ 'Q_Z"*EJ*+_ %D_^^/_ $$4 2T444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!%;
M?\>L/^X/Y5+45M_QZP_[@_E4M !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 13_ .K'^^G_ *$*EJ*?
M_5C_ 'T_]"%2T %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 5$W_'U'_N-_-:EJ)O\ CZC_ -QOYK0!
M+1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% $47^LG_WQ_Z"*EJ*+_63_P"^/_014M !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %16W_'K#_N#^52U%;?\>L/^X/Y4 2T444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !44_P#JQ_OI
M_P"A"I:BG_U8_P!]/_0A0!+1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% &9J_\ RQ_X%_2BC5_^
M6/\ P+^E% %ZU_X](?\ KFO\JEJ*U_X](?\ KFO\JEH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ J
M)?\ CZD_W%_FU2U$O_'U)_N+_-J ):*** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "HKG_CUF_W#_*I:BN?^/6;_</\J ):*** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *BB_UD_\ OC_T$5+7
M->*_$_\ PB>F&_\ L?VKS+I8=GF[,9CSG.#_ '?UII7T!NQTM%>4_P#"Z?\
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M[.78.>)ZM17E/_"Z?^H!_P"3G_V%'_"Z?^H!_P"3G_V%'LY=@YXGJU%>4_\
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M\G/_ +"C_A=/_4 _\G/_ +"CV<NP<\3U:BO*?^%T_P#4 _\ )S_["C_A=/\
MU /_ "<_^PH]G+L'/$]6HKRG_A=/_4 _\G/_ +"C_A=/_4 _\G/_ +"CV<NP
M<\3U:BO*?^%T_P#4 _\ )S_["C_A=/\ U /_ "<_^PH]G+L'/$]6HKRG_A=/
M_4 _\G/_ +"C_A=/_4 _\G/_ +"CV<NP<\3U:BO*?^%T_P#4 _\ )S_["C_A
M=/\ U /_ "<_^PH]G+L'/$]6HKRG_A=/_4 _\G/_ +"C_A=/_4 _\G/_ +"C
MV<NP<\3U:BO*?^%T_P#4 _\ )S_["C_A=/\ U /_ "<_^PH]G+L'/$]6HKRG
M_A=/_4 _\G/_ +"C_A=/_4 _\G/_ +"CV<NP<\3U:BO*?^%T_P#4 _\ )S_[
M"C_A=/\ U /_ "<_^PH]G+L'/$]6HKRG_A=/_4 _\G/_ +"C_A=/_4 _\G/_
M +"CV<NP<\3U:BO*?^%T_P#4 _\ )S_["C_A=/\ U /_ "<_^PH]G+L'/$]6
MHKRG_A=/_4 _\G/_ +"C_A=/_4 _\G/_ +"CV<NP<\3U:BO*?^%T_P#4 _\
M)S_["C_A=/\ U /_ "<_^PH]G+L'/$]6HKRG_A=/_4 _\G/_ +"C_A=/_4 _
M\G/_ +"CV<NP<\3U&+_63_[X_P#014M>3+\9MK.?[ SN;/\ Q^=. /[GM3_^
M%T_]0#_R<_\ L*/9R[!SQ/5J*\I_X73_ -0#_P G/_L*/^%T_P#4 _\ )S_[
M"CV<NP<\3U:BO*?^%T_]0#_R<_\ L*/^%T_]0#_R<_\ L*/9R[!SQ/5J*\I_
MX73_ -0#_P G/_L*/^%T_P#4 _\ )S_["CV<NP<\3U:BO*?^%T_]0#_R<_\
ML*/^%T_]0#_R<_\ L*/9R[!SQ/5J*\I_X73_ -0#_P G/_L*/^%T_P#4 _\
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M]G+L'/$]6HKRG_A=/_4 _P#)S_["C_A=/_4 _P#)S_["CV<NP<\3U:BO*?\
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M/_4 _P#)S_["CV<NP<\3U:BO*?\ A=/_ % /_)S_ .PH_P"%T_\ 4 _\G/\
M["CV<NP<\3U:BO*?^%T_]0#_ ,G/_L*/^%T_]0#_ ,G/_L*/9R[!SQ/5J*\I
M_P"%T_\ 4 _\G/\ ["C_ (73_P!0#_R<_P#L*/9R[!SQ/5J*\I_X73_U /\
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M/]Q?YM4M1+_Q]2?[B_S:@"6BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ J*Y_
MX]9O]P_RJ6HKG_CUF_W#_*@"6BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "O.?BY_R*T?_ &$D_P#1+5Z-
M7G/Q<_Y%:/\ ["2?^B6JH?$B9;,\8HHHKJ, HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M[+_T4:W(/@;X7G\*$Z@MU<ZU/ 99=2>X??YK#<3MSM(SZ@GWSS53=G-OH_\
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MPN;V%DN+29HR\;1N1RI!P>#BO4Y8HYHS'+&LB'&589'KTKR;]HC_ ))]9?\
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M!R.W3-1S]D7R]V>1T5;N88Y]6GATV.26)IF%NBJ2S+D[>.O3%; \!>)S'O\
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M;"-9+RPNK9&.%::%D!/H"16G<>#/$5K9FZFTJ<1 9.,,P'^Z#G]*]!^+?_(
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M5?:Q=&VT^W:>8*7*J0, =^?J*=T%F4Z*V[7PAX@O9IHH-+G+0ML?=A #Z9)
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MQ1LTUY_C_6@N]_+\/ZU/GKQ=XST#7?%/A6T\,:>MOHFGZI$TEU':^3$\C,N
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M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ J[HRJVN:>K
M%3<Q@@^FX52I59D<.C%64Y!!P0: /8?BR[KX:M%4D(UV V#U^5L5X[7N-CJ&
MD_$+PPUG/($G*CS8@P#QN/XE]1[_ (>M8,'PILK*0W&IZSNM(QN<",1<#U8L
M<"LH2459FDHMNZ$^$FEQ&&^U5U5I0X@C)'*8&6P??(_*LJ/XE:NWB82>?%_9
MCSA1"T8 6/=C.>N<<Y)Z]L<5K?#O6].L=4U31EF5()+EI+-F;AQG&,^N I]Z
MGB^%J1>(5OOMZ"R6?SEA6/! SD+G.,=LTFUS/F'K96(/BWIT M[#4E4+.7,+
MD#[PQD9^F#^==+XT\0S^&] AN[6&.2XDD6%&DY"9!).._P!W_.,5Q/Q0\1VV
MHW-OI=G*LJ6S%YG7D;^@ /L,Y^OL:W?BM_R*MA_U]+_Z U)+X4POO8W/"VN3
M:WX1&I7\<;R(7WA5P&VG(X_*L3P3XWU#Q'X@N;2[BA2'R6EC" Y3# 8SWZ_I
M4O@(C_A7,W(X\_/Y5R?PH/\ Q5DW_7F__H24<J]X+O0T$@CM_CAY<2JJF0OA
M1CEH-Q/YDUK>._&VH>'=6AL=/A@!:(3222+N+9) &./[O7^6.<V0_P#%]!_O
M#_TGK,^*_P#R-D/_ %YI_P"A/5))R5^PKV3L>B>)=>?1_"XUB*WCDN"JB,/T
M4OC]/;OBJO@S6I_%OAJZ;4HXF;S'@?:ORNI4'D?\"Q5#QZ0?AQ"01@^1C]*C
M^$I'_"-7G/2[/_H"U%ER7*O[UBA\)-,B,-_JCJ&D#B",D<J,9;GWR/RK?TZV
M\:KXB%S?W%F=.=CNMT;.Q3TP=H)(XKF/A7KMK:M=:3<R+&\SB6$L<!CC!'UX
M'ZU>N_ 'B)M2<VGB.1;%F)7?/+O0<X&,X...<BJE\3N);*Q2\9V45M\3-%GB
M$:FXD@=U4\[A)C)'N /R-=#X_P#%=WX9CLUL(83/<[LRR#.U5QP!_P "_P#K
M<\<#>:;)I/Q TRTFU1M1D2X@+2MG*DN/EY)Z?UKH/C!_K='_ -V;_P!DIV5X
MH5]&;D]]_P )1\*KF]O(E$K6TCL%Z;XR<$?BH/XXJI\/H+?1O UUK;1[Y'66
M9R -Q2/.%'_?)_.C02/^%-7'_7K<_P WJ/X;:K9:AX;FT"Y9!*N]1&Q_UD;]
M<>O)/Z5+V?J5U1R\?Q.U_?<?:/LT\4R%1$8MHCR".".3SZY_"N\\*Z9=:;\/
MH3I20G4;J+S@\GRJ68\$]>BD?7'O7/M\+;+3UN;K4=7_ -$C1RH"A".."6)(
MX^G-:WA2_M_$W@8:/'>-;7T,/DDHQ#IC[CC!!(X&?Q%.5FO=%&]]37\,6GB6
MW%S%XBN+>ZC<#RV0@D>H/ XKE?!&AVT/CW77"HRV$C) %Y";F./Q !'YTL/P
M_P#$OF2&Z\4O%"I^5TED8D>I!( _,UE_#S5[;2?%=[97%TKQW1,:7+'AW5C@
MY_VLGOUQZT6T=F'57+NM?$C4M/\ %UQ;PK"^GVTIA>(IR^" QSUSD-CM[&M/
MXM_\@"Q_Z^O_ &5J=K/PZT^ZU^?6;K4%@L';SKB(J%Y_B^;/ /4GZU%\5Y$F
M\-Z=(ARCW 93Z@H:2Y;JP.]G<\CKV;1C'X2^&']IQ(AN'@$Y8K]YW.$!QV&Y
M1_A7C->Q^&+JR\6> CH4DR)<QP>0ZGDKC[C@=QP#]16E39$PW,[P#XUU;5=>
M.G:I<I.DL;-&Q158,.<#& 1C/:DDTZ#3OC19BW4(DZF8J!@ F-P?U&?QK4\+
M^"(_"-]/JU_J43JD14'&Q5!ZDDGVKGK#7(_$'Q=M+R#/V<%HX21@E1&W/XG)
M_&HT;;CM8KHKFWX[\:ZAX=U6&QTZ*!2\0FDED7<6R2  /^ ]?Y8YO>(#'XD^
M&;7\T:K)]G6Y7'\#CDX_4?0T>+O!EKXIU&.2+4%M[Z&-5D4C?F,DX.W((YSS
M]:K^-+VT\,^!TT2"3=-+$MO&IQNVC[S'\,_B:E6TMN-WUOL6O"NF76F_#Z$Z
M4D)U&ZB\X/)\JEF/!/7HI'UQ[U=\,6GB6W%S%XBN+>ZC<#RV0@D>H/ XK(\*
M7]OXF\##1X[QK:^AA\DE&(=,?<<8()' S^(K-A^'_B7S)#=>*7BA4_*Z2R,2
M/4@D ?F:'UN':Q!X)M([#XG:Q:PE/*B294"'( \Q<#\.GX5:\9>/[S2-:FTK
M3[:#9$N)6F4G<S#/&",<'\ZR?AHH3QS?()_/"P2@39_UGSK\WX]:Q?B#_P C
MSJ?^\G_HM:NR<]2;VCH=)I&H>.=4T:QM]'M$L[.")8UN'"CS HZ_/U!XZ#KW
MZUUEY;ZC+\.]0BUX12WB6DS.5 ()4$JWIG@'ZBDU.VN/$7@ZU3PQJ$=JI"%2
MC%!L QLRO*XXX]L4GV-]-^'VK6$VHB^N8+2<32;B2&*%MIR2> 1UJ&[E)&7\
M+=:O=2T^[LKEU:*Q6)(<* 0#OX/K]T5Q'B_Q3J>KW-QIMVT1M[:Z?RPJ8/RD
MJ,GZ&N@^$5Y!%>ZG:.X6:9(WC4_Q!2V?_0A6;X[\'G0S)JIO5E6[NVVQ>7@J
M&W-USSCI5JRFR7=Q.H^*W_(JV/\ U]+_ .@-5S6;H^!OA_;QV&Q+DA(5DV9!
MD(RSX]>&/.>W6J?Q6_Y%6P_Z^E_] :KQ%G\0_!4=O'<I%<J$9LC<8I%Z\<'D
M9&?0U*^%7V*>[*7P[\5W_B"2\L=4ECG>.,2(VP*S+G# @<$<CM5'PG81:9\5
M-7M(!B)(7**/X060X_#.*V/#?AVU\ V=]J&I:C&V]0"VW:%4=@.I))KGO FI
MG6/B/J6H%=HG@D95/4+N0 ?7 %/NUL+M<M^*OB#J.B>)Y=/L[>W%M;E?,##+
M2D@,>>W7'Z^U3_%NWBDT73[S;^]6<QJW^RRDD?\ CHKBOB#_ ,CSJ?\ O)_Z
M+6NY^*Q'_"+6'_7TO_H#4[).-A7NF;4ZWFJ^$+(^%-0@MBJIL.!M*@8*=#M(
M^G48KRSQC<>(VFM;3Q$@\V /Y4H4#S 2,G(X/0?UKK+#P'K6GSP7?AWQ%&MI
M* Y8DX(('.T J_'KCM1\6=1M'M['3U=7NTD,CA<'8N,<^F2?TI1LI60Y:K4\
MMKU_7O\ DC5O_P!>MK_-*\@KU_7O^2-6_P#UZVW\TJY[HF/4M^#KP:?\+TO3
M$)?L\<\NPG&XJ['&>W2JG@3QMJ7B+6;FROT@VB$RH8E*[<,!CJ<_>_2C0?\
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M10 ^6:2>5I9I'DD;JSL23^)IE%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110!Z)\+?^8K_VQ_\ 9Z*/A;_S%?\ MC_[
M/17-4^)F\/A/9+7_ (](?^N:_P JEJ*U_P"/2'_KFO\ *I:@H**** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ J)?^/J3_ '%_FU2U$O\ Q]2?[B_S:@"6BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ J*Y_P"/6;_</\JEJ*Y_X]9O]P_RH EHHHH **** "BBB@ HHHH
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MOX?_ .@%IG_@)'_A1[9=@]FSYHHKZ7_X1?P__P! +3/_  $C_P */^$7\/\
M_0"TS_P$C_PH]LNP>S9\T45]+_\ "+^'_P#H!:9_X"1_X4?\(OX?_P"@%IG_
M ("1_P"%'MEV#V;/FBBOI?\ X1?P_P#] +3/_ 2/_"C_ (1?P_\ ] +3/_ 2
M/_"CVR[![-GS117TO_PB_A__ * 6F?\ @)'_ (4?\(OX?_Z 6F?^ D?^%'ME
MV#V;/FBBOI?_ (1?P_\ ] +3/_ 2/_"C_A%_#_\ T M,_P# 2/\ PH]LNP>S
M9\T45]+_ /"+^'_^@%IG_@)'_A1_PB_A_P#Z 6F?^ D?^%'MEV#V;/FBBOI?
M_A%_#_\ T M,_P# 2/\ PH_X1?P__P! +3/_  $C_P */;+L'LV?-%%?2_\
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M'_A1[9=@]FSYHHKZ7_X1?P__ - +3/\ P$C_ ,*/^$7\/_\ 0"TS_P !(_\
M"CVR[![-GS117TO_ ,(OX?\ ^@%IG_@)'_A1_P (OX?_ .@%IG_@)'_A1[9=
M@]FSYHHKZ7_X1?P__P! +3/_  $C_P */^$7\/\ _0"TS_P$C_PH]LNP>S9\
MT45]+_\ "+^'_P#H!:9_X"1_X4?\(OX?_P"@%IG_ ("1_P"%'MEV#V;/FBBO
MI?\ X1?P_P#] +3/_ 2/_"C_ (1?P_\ ] +3/_ 2/_"CVR[![-GS117TO_PB
M_A__ * 6F?\ @)'_ (4?\(OX?_Z 6F?^ D?^%'MEV#V;/FBBOI?_ (1?P_\
M] +3/_ 2/_"C_A%_#_\ T M,_P# 2/\ PH]LNP>S9\T45])S^&- $8(T/3!\
MZCBTC_O#VJ3_ (1?P_\ ] +3/_ 2/_"CVR[![-GS117TO_PB_A__ * 6F?\
M@)'_ (4?\(OX?_Z 6F?^ D?^%'MEV#V;/FBBOI?_ (1?P_\ ] +3/_ 2/_"C
M_A%_#_\ T M,_P# 2/\ PH]LNP>S9\T45]+_ /"+^'_^@%IG_@)'_A1_PB_A
M_P#Z 6F?^ D?^%'MEV#V;/FBBOI?_A%_#_\ T M,_P# 2/\ PH_X1?P__P!
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ME_\ A%_#_P#T M,_\!(_\*/^$7\/_P#0"TS_ ,!(_P#"CVR[![-GS117TO\
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M\(OX?_Z 6F?^ D?^%'MEV#V;/FBBOI?_ (1?P_\ ] +3/_ 2/_"C_A%_#_\
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M_P#T M,_\!(_\*/^$7\/_P#0"TS_ ,!(_P#"CVR[![-GS117TO\ \(OX?_Z
M6F?^ D?^%'_"+^'_ /H!:9_X"1_X4>V78/9L^:**^E_^$7\/_P#0"TS_ ,!(
M_P#"C_A%_#__ $ M,_\  2/_  H]LNP>S9\T45]+_P#"+^'_ /H!:9_X"1_X
M4?\ "+^'_P#H!:9_X"1_X4>V78/9L^:**^E_^$7\/_\ 0"TS_P !(_\ "C_A
M%_#_ /T M,_\!(_\*/;+L'LV?-%%?2__  B_A_\ Z 6F?^ D?^%'_"+^'_\
MH!:9_P" D?\ A1[9=@]FSYHHKZ3C\,: 9)@=#TSA\#_1(^/E'M4G_"+^'_\
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M +3/_ 2/_"C_ (1?P_\ ] +3/_ 2/_"CVR[![-GS117TO_PB_A__ * 6F?\
M@)'_ (4?\(OX?_Z 6F?^ D?^%'MEV#V;/FBBOI?_ (1?P_\ ] +3/_ 2/_"C
M_A%_#_\ T M,_P# 2/\ PH]LNP>S9\T45]+_ /"+^'_^@%IG_@)'_A1_PB_A
M_P#Z 6F?^ D?^%'MEV#V;/FBBOI?_A%_#_\ T M,_P# 2/\ PH_X1?P__P!
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M_H!:9_X"1_X4?\(OX?\ ^@%IG_@)'_A1[9=@]FSYHHKZ7_X1?P__ - +3/\
MP$C_ ,*/^$7\/_\ 0"TS_P !(_\ "CVR[![-GS117TO_ ,(OX?\ ^@%IG_@)
M'_A1_P (OX?_ .@%IG_@)'_A1[9=@]FSYHHKZ7_X1?P__P! +3/_  $C_P *
M/^$7\/\ _0"TS_P$C_PH]LNP>S9\T45]+_\ "+^'_P#H!:9_X"1_X4?\(OX?
M_P"@%IG_ ("1_P"%'MEV#V;/FBBOI?\ X1?P_P#] +3/_ 2/_"C_ (1?P_\
M] +3/_ 2/_"CVR[![-GS117TO_PB_A__ * 6F?\ @)'_ (4?\(OX?_Z 6F?^
M D?^%'MEV#V;/FBBOI?_ (1?P_\ ] +3/_ 2/_"C_A%_#_\ T M,_P# 2/\
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M'_A1[9=@]FSYHHKZ7_X1?P__ - +3/\ P$C_ ,*/^$7\/_\ 0"TS_P !(_\
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M'_/:/_OH4?:8/^>T?_?0H EHJ+[3!_SVC_[Z%'VF#_GM'_WT* ):*B^TP?\
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M^^A1]I@_Y[1_]]"@"6BHOM,'_/:/_OH4?:8/^>T?_?0H EHJ+[3!_P ]H_\
MOH4?:8/^>T?_ 'T* ):*B^TP?\]H_P#OH4?:8/\ GM'_ -]"@"6BHOM,'_/:
M/_OH4?:8/^>T?_?0H EHJ+[3!_SVC_[Z%'VF#_GM'_WT* ):*B^TP?\ /:/_
M +Z%'VF#_GM'_P!]"@"6BHOM,'_/:/\ [Z%'VF#_ )[1_P#?0H EHJ+[3!_S
MVC_[Z%'VF#_GM'_WT* ):*B^TP?\]H_^^A1]I@_Y[1_]]"@"6BHOM,'_ #VC
M_P"^A1]I@_Y[1_\ ?0H EHJ+[3!_SVC_ .^A1]I@_P">T?\ WT* ):*B^TP?
M\]H_^^A1]I@_Y[1_]]"@"6BHOM,'_/:/_OH4?:8/^>T?_?0H EHJ+[3!_P ]
MH_\ OH4?:8/^>T?_ 'T* ):*B^TP?\]H_P#OH4?:8/\ GM'_ -]"@"6BHOM,
M'_/:/_OH4?:8/^>T?_?0H EHJ+[3!_SVC_[Z%'VF#_GM'_WT* ):*B^TP?\
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M]"C[3!_SVC_[Z% $M%1?:8/^>T?_ 'T*/M,'_/:/_OH4 2T5%]I@_P">T?\
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M^>T?_?0H^TP?\]H_^^A0!+147VF#_GM'_P!]"C[3!_SVC_[Z% $M%1?:8/\
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M]]"C[3!_SVC_ .^A0!+147VF#_GM'_WT*/M,'_/:/_OH4 2T5%]I@_Y[1_\
M?0H^TP?\]H_^^A0 6W_'K#_N#^52U6M[B%;:(&:,$( 06'I4GVF#_GM'_P!]
M"@"6BHOM,'_/:/\ [Z%'VF#_ )[1_P#?0H EHJ+[3!_SVC_[Z%'VF#_GM'_W
MT* ):*B^TP?\]H_^^A1]I@_Y[1_]]"@"6BHOM,'_ #VC_P"^A1]I@_Y[1_\
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MHF_X^H_]QOYK1]I@_P">T?\ WT*C:XA^TH?.CP$89W#U% %FBHOM,'_/:/\
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M!+147VF#_GM'_P!]"C[3!_SVC_[Z% $M%1?:8/\ GM'_ -]"C[3!_P ]H_\
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$0!__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>53
<FILENAME>img_006.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 img_006.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" $X!8@# 2(  A$! Q$!_\0
M'P   04! 0$! 0$           $" P0%!@<("0H+_\0 M1   @$# P($ P4%
M! 0   %] 0(#  01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T? D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$  P$! 0$!
M 0$! 0        $" P0%!@<("0H+_\0 M1$  @$"! 0#! <%! 0  0)W  $"
M Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,!  (1 Q$ /P#^A/\ X+<?
M\%1?C_\ \$V?^&9?^%&>$/@]XK_X7/\ \+G_ .$H_P"%L>'_ !KKOV#_ (5U
M_P *H_L3^P/^$/\ B#X$^R_:O^$[U?\ M7^T?[5\_P"S:;]D^P^3=?;/P:_X
MBBOV_O\ HD'['O\ X0'QI_\ H@:^PO\ @Z__ .;"/^[I?_?<Z_CWK['*L!@J
MV H5:N&I5*DO:<TY*3D[59Q5[5(K1)+9:(^=Q^+Q-+%584ZTX0CR6C%JRO3B
MW:\7NVWN?TC?\117[?W_ $2#]CW_ ,(#XT__ $0-'_$45^W]_P!$@_8]_P#"
M ^-/_P!$#7\W-%>A_9>7?] =#_P&7_RTX_KV,_Z"*OWQ_P#D#^D;_B**_;^_
MZ)!^Q[_X0'QI_P#H@:/^(HK]O[_HD'['O_A ?&G_ .B!K^;FBC^R\N_Z Z'_
M (#+_P"6A]>QG_015^^/_P @?TC?\117[?W_ $2#]CW_ ,(#XT__ $0-'_$4
M5^W]_P!$@_8]_P#" ^-/_P!$#7\W-%']EY=_T!T/_ 9?_+0^O8S_ *"*OWQ_
M^0/Z1O\ B**_;^_Z)!^Q[_X0'QI_^B!H_P"(HK]O[_HD'['O_A ?&G_Z(&OY
MN:*/[+R[_H#H?^ R_P#EH?7L9_T$5?OC_P#('](W_$45^W]_T2#]CW_P@/C3
M_P#1 T?\117[?W_1(/V/?_" ^-/_ -$#7\W-%']EY=_T!T/_  &7_P M#Z]C
M/^@BK]\?_D#^D;_B**_;^_Z)!^Q[_P"$!\:?_H@:/^(HK]O[_HD'['O_ (0'
MQI_^B!K^;FBC^R\N_P"@.A_X#+_Y:'U[&?\ 015^^/\ \@?TC?\ $45^W]_T
M2#]CW_P@/C3_ /1 T?\ $45^W]_T2#]CW_P@/C3_ /1 U_-S11_9>7?] =#_
M ,!E_P#+0^O8S_H(J_?'_P"0/Z1O^(HK]O[_ *)!^Q[_ .$!\:?_ *(&C_B*
M*_;^_P"B0?L>_P#A ?&G_P"B!K^;FBC^R\N_Z Z'_@,O_EH?7L9_T$5?OC_\
M@?TC?\117[?W_1(/V/?_  @/C3_]$#1_Q%%?M_?]$@_8]_\ " ^-/_T0-?S<
MT4?V7EW_ $!T/_ 9?_+0^O8S_H(J_?'_ .0/Z1O^(HK]O[_HD'['O_A ?&G_
M .B!H_XBBOV_O^B0?L>_^$!\:?\ Z(&OYN:*/[+R[_H#H?\ @,O_ ):'U[&?
M]!%7[X__ "!_2-_Q%%?M_?\ 1(/V/?\ P@/C3_\ 1 T?\117[?W_ $2#]CW_
M ,(#XT__ $0-?S<T4?V7EW_0'0_\!E_\M#Z]C/\ H(J_?'_Y _I&_P"(HK]O
M[_HD'['O_A ?&G_Z(&C_ (BBOV_O^B0?L>_^$!\:?_H@:_FYHH_LO+O^@.A_
MX#+_ .6A]>QG_015^^/_ ,@?TC?\117[?W_1(/V/?_" ^-/_ -$#1_Q%%?M_
M?]$@_8]_\(#XT_\ T0-?S<T4?V7EW_0'0_\  9?_ "T/KV,_Z"*OWQ_^0/Z1
MO^(HK]O[_HD'['O_ (0'QI_^B!H_XBBOV_O^B0?L>_\ A ?&G_Z(&OYN:*/[
M+R[_ * Z'_@,O_EH?7L9_P!!%7[X_P#R!_2-_P 117[?W_1(/V/?_" ^-/\
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M[_H#H?\ @,O_ ):'U[&?]!%7[X__ "!_2-_Q%%?M_?\ 1(/V/?\ P@/C3_\
M1 T?\117[?W_ $2#]CW_ ,(#XT__ $0-?S<T4?V7EW_0'0_\!E_\M#Z]C/\
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M=_T!T/\ P&7_ ,M#Z]C/^@BK]\?_ ) _I&_XBBOV_O\ HD'['O\ X0'QI_\
MH@:/^(HK]O[_ *)!^Q[_ .$!\:?_ *(&OYN:*/[+R[_H#H?^ R_^6A]>QG_0
M15^^/_R!_2-_Q%%?M_?]$@_8]_\ " ^-/_T0-'_$45^W]_T2#]CW_P (#XT_
M_1 U_-S11_9>7?\ 0'0_\!E_\M#Z]C/^@BK]\?\ Y _I&_XBBOV_O^B0?L>_
M^$!\:?\ Z(&C_B**_;^_Z)!^Q[_X0'QI_P#H@:_FYHH_LO+O^@.A_P" R_\
MEH?7L9_T$5?OC_\ ('](W_$45^W]_P!$@_8]_P#" ^-/_P!$#1_Q%%?M_?\
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M(#XT_P#T0-'_ !%%?M_?]$@_8]_\(#XT_P#T0-?S<T4?V7EW_0'0_P# 9?\
MRT/KV,_Z"*OWQ_\ D#^D;_B**_;^_P"B0?L>_P#A ?&G_P"B!H_XBBOV_O\
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M.A_X#+_Y:'U[&?\ 015^^/\ \@?TC?\ $45^W]_T2#]CW_P@/C3_ /1 T?\
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M45^W]_T2#]CW_P (#XT__1 U_-S11_9>7?\ 0'0_\!E_\M#Z]C/^@BK]\?\
MY _I&_XBBOV_O^B0?L>_^$!\:?\ Z(&C_B**_;^_Z)!^Q[_X0'QI_P#H@:_F
MYHH_LO+O^@.A_P" R_\ EH?7L9_T$5?OC_\ ('](W_$45^W]_P!$@_8]_P#"
M ^-/_P!$#1_Q%%?M_?\ 1(/V/?\ P@/C3_\ 1 U_-S11_9>7?] =#_P&7_RT
M/KV,_P"@BK]\?_D#^D;_ (BBOV_O^B0?L>_^$!\:?_H@:/\ B**_;^_Z)!^Q
M[_X0'QI_^B!K^;FBC^R\N_Z Z'_@,O\ Y:'U[&?]!%7[X_\ R!_2-_Q%%?M_
M?]$@_8]_\(#XT_\ T0-'_$45^W]_T2#]CW_P@/C3_P#1 U_-S11_9>7?] =#
M_P !E_\ +0^O8S_H(J_?'_Y _I&_XBBOV_O^B0?L>_\ A ?&G_Z(&C_B**_;
M^_Z)!^Q[_P"$!\:?_H@:_FYHH_LO+O\ H#H?^ R_^6A]>QG_ $$5?OC_ /('
M](W_ !%%?M_?]$@_8]_\(#XT_P#T0-'_ !%%?M_?]$@_8]_\(#XT_P#T0-?S
M<T4?V7EW_0'0_P# 9?\ RT/KV,_Z"*OWQ_\ D#^D;_B**_;^_P"B0?L>_P#A
M ?&G_P"B!H_XBBOV_O\ HD'['O\ X0'QI_\ H@:_FYHH_LO+O^@.A_X#+_Y:
M'U[&?]!%7[X__('](W_$45^W]_T2#]CW_P (#XT__1 T?\117[?W_1(/V/?_
M  @/C3_]$#7\W-%']EY=_P! =#_P&7_RT/KV,_Z"*OWQ_P#D#^D;_B**_;^_
MZ)!^Q[_X0'QI_P#H@:/^(HK]O[_HD'['O_A ?&G_ .B!K^;FBC^R\N_Z Z'_
M (#+_P"6A]>QG_015^^/_P @?TC?\117[?W_ $2#]CW_ ,(#XT__ $0-'_$4
M5^W]_P!$@_8]_P#" ^-/_P!$#7\W-%']EY=_T!T/_ 9?_+0^O8S_ *"*OWQ_
M^0/Z1O\ B**_;^_Z)!^Q[_X0'QI_^B!H_P"(HK]O[_HD'['O_A ?&G_Z(&OY
MN:*/[+R[_H#H?^ R_P#EH?7L9_T$5?OC_P#('](W_$45^W]_T2#]CW_P@/C3
M_P#1 T?\117[?W_1(/V/?_" ^-/_ -$#7\W-%']EY=_T!T/_  &7_P M#Z]C
M/^@BK]\?_D#^D;_B**_;^_Z)!^Q[_P"$!\:?_H@:/^(HK]O[_HD'['O_ (0'
MQI_^B!K^;FBC^R\N_P"@.A_X#+_Y:'U[&?\ 015^^/\ \@?TC?\ $45^W]_T
M2#]CW_P@/C3_ /1 T?\ $45^W]_T2#]CW_P@/C3_ /1 U_-S11_9>7?] =#_
M ,!E_P#+0^O8S_H(J_?'_P"0/Z1O^(HK]O[_ *)!^Q[_ .$!\:?_ *(&C_B*
M*_;^_P"B0?L>_P#A ?&G_P"B!K^;FBC^R\N_Z Z'_@,O_EH?7L9_T$5?OC_\
M@?TC?\117[?W_1(/V/?_  @/C3_]$#1_Q%%?M_?]$@_8]_\ " ^-/_T0-?S<
MT4?V7EW_ $!T/_ 9?_+0^O8S_H(J_?'_ .0/Z1O^(HK]O[_HD'['O_A ?&G_
M .B!H_XBBOV_O^B0?L>_^$!\:?\ Z(&OYN:*/[+R[_H#H?\ @,O_ ):'U[&?
M]!%7[X__ "!_2-_Q%%?M_?\ 1(/V/?\ P@/C3_\ 1 T?\117[?W_ $2#]CW_
M ,(#XT__ $0-?S<T4?V7EW_0'0_\!E_\M#Z]C/\ H(J_?'_Y _I&_P"(HK]O
M[_HD'['O_A ?&G_Z(&C_ (BBOV_O^B0?L>_^$!\:?_H@:_FYHH_LO+O^@.A_
MX#+_ .6A]>QG_015^^/_ ,@?TC?\117[?W_1(/V/?_" ^-/_ -$#1_Q%%?M_
M?]$@_8]_\(#XT_\ T0-?S<T4?V7EW_0'0_\  9?_ "T/KV,_Z"*OWQ_^0/Z1
MO^(HK]O[_HD'['O_ (0'QI_^B!H_XBBOV_O^B0?L>_\ A ?&G_Z(&OYN:*/[
M+R[_ * Z'_@,O_EH?7L9_P!!%7[X_P#R!_2-_P 117[?W_1(/V/?_" ^-/\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!]E_LI_\ !03]KO\
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M .$3^W]_] W1_P ,S?!;_I(;^Q[_ .$3^W]_] W7Q[17I\E3_G_/_P %4/\
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M\EI[ODBYN$9RBJ4;)V5YU;[1\_,^PO\ AF;X+?\ 20W]CW_PB?V_O_H&Z/\
MAF;X+?\ 20W]CW_PB?V_O_H&Z^/:*ODJ?\_Y_P#@JA_\B1S0_P"?4?\ P.K_
M )GV%_PS-\%O^DAO['O_ (1/[?W_ - W1_PS-\%O^DAO['O_ (1/[?W_ - W
M7Q[11R5/^?\ /_P50_\ D0YH?\^H_P#@=7_,^PO^&9O@M_TD-_8]_P#")_;^
M_P#H&Z/^&9O@M_TD-_8]_P#")_;^_P#H&Z^/:*.2I_S_ )_^"J'_ ,B'-#_G
MU'_P.K_F?87_  S-\%O^DAO['O\ X1/[?W_T#='_  S-\%O^DAO['O\ X1/[
M?W_T#=?'M%')4_Y_S_\ !5#_ .1#FA_SZC_X'5_S/L+_ (9F^"W_ $D-_8]_
M\(G]O[_Z!NC_ (9F^"W_ $D-_8]_\(G]O[_Z!NOCVBCDJ?\ /^?_ (*H?_(A
MS0_Y]1_\#J_YGV%_PS-\%O\ I(;^Q[_X1/[?W_T#='_#,WP6_P"DAO['O_A$
M_M_?_0-U\>T4<E3_ )_S_P#!5#_Y$.:'_/J/_@=7_,^PO^&9O@M_TD-_8]_\
M(G]O[_Z!NC_AF;X+?])#?V/?_")_;^_^@;KX]HHY*G_/^?\ X*H?_(AS0_Y]
M1_\  ZO^9]A?\,S?!;_I(;^Q[_X1/[?W_P! W1_PS-\%O^DAO['O_A$_M_?_
M $#=?'M%')4_Y_S_ /!5#_Y$.:'_ #ZC_P"!U?\ ,^PO^&9O@M_TD-_8]_\
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M (1/[?W_ - W1_PS-\%O^DAO['O_ (1/[?W_ - W7Q[11R5/^?\ /_P50_\
MD0YH?\^H_P#@=7_,^PO^&9O@M_TD-_8]_P#")_;^_P#H&Z/^&9O@M_TD-_8]
M_P#")_;^_P#H&Z^/:*.2I_S_ )_^"J'_ ,B'-#_GU'_P.K_F?87_  S-\%O^
MDAO['O\ X1/[?W_T#='_  S-\%O^DAO['O\ X1/[?W_T#=?'M%')4_Y_S_\
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M^DAO['O_ (1/[?W_ - W1_PS-\%O^DAO['O_ (1/[?W_ - W7Q[11R5/^?\
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M_20W]CW_ ,(G]O[_ .@;H_X9F^"W_20W]CW_ ,(G]O[_ .@;KX]HHY*G_/\
MG_X*H?\ R(<T/^?4?_ ZO^9]A?\ #,WP6_Z2&_L>_P#A$_M_?_0-T?\ #,WP
M6_Z2&_L>_P#A$_M_?_0-U\>T4<E3_G_/_P %4/\ Y$.:'_/J/_@=7_,^PO\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110!]A?MR?\EI\$_\ 9GO_  3R_P#6 ?V9J^/:^POV
MY/\ DM/@G_LSW_@GE_ZP#^S-7Q[65#^#2_P+\YEU?XD_\3_*(4445J0%%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110!]A?M,_\D6_X)Y?]F>^-O\ UO[]N2OCVOL+]IG_ )(M_P $\O\
MLSWQM_ZW]^W)7Q[65'^&O\=;_P!/URZGQO\ PT__ $U2"BBBM2 HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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ML=1RZE@\75P]"<J];%X.C[6M*A%?RDZ_^Q%^U-X5^%GQ8^,_B7X1ZKH7P_\
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M-+T^"^O]-TJ6*Z G2[72K.TNK53_ $1P_ME_"_P[^V7_ ,$Q_A=X_P#VAO\
M@FN?"WP9\0_%KQMXLN_V./!-Y\,/V=?@'%XD^$?C70;'PS8_'3Q9\;?$7@#Q
M#I/BW4]1CN+G1],\#?#^\L=<LM,;55^U7UE:W7RI)X^^ O[9O[%?[0G[%OA/
M]L'X"?LM_%3PU^WU\8OC6VJ_&GXB0?#SX._M"?#GQ)X\\5:GH>I-\2+*TU#3
M=8CM(]2T^^TFTM!K<LUUX-\,W362:=J&F:QIL+&XZ;P];V2J*&!S&G)8=3CA
MZZ7'F495'-Z\)TU)SR[)L3C:LL-AYVQ.&P\L50]I@5BL3A])87"1E&BZCHQK
MULMJ5*E=PG4PTI<+\2X^6!I2A.T8YCF.!RNA"KBHQ^JU\92AB/9U982GB?Q@
M\,_\$S?VZ?%_QK^(?[.>A_L[^*9/C5\+?![^/O&?@'4M:\%Z!J=MX.6ZL[&+
M7]"O-?\ $VF:/XSL;Z[U"TM]*/@O4?$$VKRR,NEQ7AAG\KI?B5_P2@_X*#?!
M_P 8_"+P)\1?V<-=\.>(_CMXIM?!'PN5O&?PQU71/$/B^]B>>S\-7OBS1/&V
MI>$_"NM75O%/<V^G^,-;T"XFMK6\N(T:"RNI(?ZJO@5^T%\%/C9^TMX[^$?P
MR^/Z>-;C]FK_ ())>*/@S\4/VR/#PU"^37?%EKK7@E-4\=Z#JROJ5_XCM_!A
MM;KQ3;ZQ83ZHMWJVK:C%I]]J4D!N)/D+]G+XH_LW_L0_!']C3]E'QY^VQ^SK
M^T+XUU[_ (*!>$/CU-XP^&'Q1T[Q1\)?@1\+]*V&^O?$GCW7WTVP\&2ZA<03
M7NHZ5JR>'[V+5O&6ODP7=A97VK:CI3Q^(EBL+AW[*:J+*YTYQP^*IO.,/C>)
MN+<EJ8W!4ZMJN54'D^18+B2DLT@DL//$X5U)NOA>7DJ4*<<%CL5&-15*$L93
ME0=6C4_LNMA^%.'\\C0QE6%Z>8U:>;YK5R*K3P,E6E.IAJLJ5.I0K\WXBZ__
M ,$6_P#@J!X9TRRU?5/V1/'+6FH>+X? ]M'I/B/X<>(M1_MVXU671H9[C1_#
MWC35-7L_#,E["S+XXO+&#P5_9[P:P?$ TBYM[Z7PGXO_ /!/3]L[X$?&3X>_
ML_\ Q/\ @'XLT7XN_%=;=OAOX0TB^\,^-7\9^?=?8V70M:\#:[XD\.7DEC-S
MK$:ZP)-#@*W>LK86K+,?W*M/VMO ']C_ /!P]-)^TKX)&H?%WQ!!;_ =F^+W
MAY;GXG:5'KGQ-\.J/A&O_"0!_&EHG@IM TGS/!JZD@\/-I%MO^PM9J?9OA5^
MW;^RY\)/&W_!#?QG\0_BW\/O$]C\.OV6OBQ\,/BCJNE^+]+\::Q\"O%?C/PE
MX!\.^';WXAZ/H-[JVM>%WC>TN="NK;7+6QGT_1Y]4OO+2VTBX\N,'C<?6E@)
M5:%-QKT>'L36HPHUZ=67^L'!W$W$$<%2J59JG1Q&7YGP_A,JQ-6M'E=7/*-"
MK2P->C@X8_IS'!X7!O,*=*I*M/#3SNA1JJM2G1YLFSCA+!_7)QA&52M0Q>!X
MEQN*I4*,N=K(<14H5L7&IB88+^?7X]_\$Q/V[/V8G\!?\+P_9[U_P5;?$SQ/
MI/@OP;JL?B?X?^*= O\ Q7KMPMKH_A_4?$7@WQ=XAT'PUJNI3%OLEIXGU'1I
M)8HKBX4?9[:XEB]-\:?\$8?^"F_P^\)>/?''BO\ 92\4V7AGX:6-SJ?BV^L?
M&GPJU^YATVRTZ'5KW4-"TCP]X\U76O&5E9V$XEN[KP9I^OP6SP7MM.\=UI]_
M#;?MQ^UY^U7X(\$?"+P_\)7^/7_!)G5M*^*G[8/PN\:CP+^PE\)]92:+PSX9
M^*7A3Q7/\;_BG\5K?X]7/@KX;^-Y+#1DMO%FGZ_\/?%5U>VT]Q::?XLO+3[;
MJVCW=/\ VPO@_+_P7 _;2^(-]^T[\+9?@=XC_9#U_P !>#O'5W\8O!TGPLUN
MXC^&WPSO=.\(^%O%4_B%O"E_>_\ "7)K\UKHVCW\EV^NG6UC@:\?4%;DEFN9
MO 8JO3P]%XBCA.)\92O0Q<J<WD7">5\0T,#4HJ-.JL3B<QQ.,R13ISJNI44'
M2I5LQPF)P,NF.78!8V%*>(F\.IY!2J<E6@IU5F_&>(X:J8RA7DY4E0IY8J.=
M\DZ,72ITYSJ.GEV+HXRC^3?[6_\ P1\^*'[+W[!_P _:VNK'Q+J>M^*;.\UK
M]H?3[[Q#\-D\,_";3?%>K^&]-^#MCH5CI>N7NO>*;SQ0FMM)JNHZ-?:]%9-)
M NI:5X;$$YEX_P#X)9_\$\_AS^VK:_M+?$GXR>*/BMI_PL_9@^'^G>,O$7@S
MX"Z%I6O_ !H^(%[K-MXHOK#1O UKKFG:UI?VN.U\(:FHMYM&OYM1O[K3;*(V
M4<EQ>P^[_M;:Q\*?C;_P1]_X)^W?@O\ :$^ 2^._V5].^)FA_$GX&:U\2-/T
MWX[W]]\0/'VB:9IK^$/AH+:XU;6+'3+>REU[6M1O)-*L8_#[+J&F3ZH5F@A\
MV_X(_P"O_"KP_KWQIO$_;@\6_L)?M1KX7LO^%!_$+6_$_@C2?V;?&9,D\FJ^
M$_CCI7C;P+XCTC4K&VU&#2;VRCU76M/LC#<W-_96-[J.C+:WWL*I74N,H.4O
M:8/&9S3RKV>&]O5PM!1RFI@*N&P\JE*GFD/J];$5:%*CB)5%3>+KN6(Q.%A@
MY>2E2>"X-JRA'GQF!RF6;\]9X:-7%?VEG%+,*6,K0IU9Y?-_5\/1K5Y8:-*G
M"OEM)0IT95L=/TO5O^"7G[*/[07CK]DJQ_8%_:*\5^*+7X\?$6[\#_%WX _'
M'Q)\&;7]K']G[1O"[ZM>^/?'7BOP/H6K^%+;^S?#FA>&?$MU)I$^EPS7-W%X
M?MM U3Q/)XDM(8?%_P!IG_@CG^U'X"_;?\5?LE_L^?";QO\ $^WN- ;XA_"W
M4M5\4_#7^T/$/PGANCH+>.?%FNP:SH/A/P7;W/BJSU72;6Q\62>&-1,R65M'
M97+W=I<7O[*_M1?M8_L]CPQ_P3XNOVJ/VC_V/OVD?VV?A[^V3\&O&WBSX\?L
MGRZ1KGA/P7\%/"_C.QG\47?C;QUH.G6]I=QW6EVNGWNIZ)!I?@^WEU5;:\TG
MPE#8^&9K[4=GPW#^QE9?M\?\%$/B)XT_;'_9,\=M^T;X'T7QI\#?"D_[8VO^
M!_V7?&NG:G)XA\/>)? /[3GB3X?7EIX;UG7-/.F:7<#X>:]!X^TE/#WBA]:T
M[1-;U/S!HGF1Q.*IRHU(SKU</AY<;.K;V^,I8ZM@\-PIB,IPV$KSP>!QU>C3
M_M',?JOUG"X:O'ZAGM"6)S&-"A7P_HRH4)TI.4*5.MB,/PU[*#]CA*^"IULY
MSW YABL91CC,9@HUJE##8.=7ZO7E3K4,9DN)EA<#*6+C6_FK^)?_  3?_;>^
M$/QM^'G[.GC[]GGQAI?QC^+"/)\./".EWWA?Q9%XPB@W-J$VC^)O"&OZ]X1G
MAT6)6NO$4SZ]'%X:L@;[7WTVS_?UV_QG_P""3G_!0;]GKP+\0?B7\8OV==3\
M%^!/A=8>&=2\:>)9_'WPGU?3["S\7ZNF@Z"^E_\ "/>/-7G\4RSZO+%8WMKX
M4AUNZT62:!];ATZ*:*1_ZN/"_P"U%\!O$7[8'_!+:#X:^)O@;\6Y?#WP*_:9
M^!?BC3/V-]*O_&&B? SQ?=:7\/\ 3+#Q#X;^%FF1^)?BCX4^%4+^$=7T/P_X
ML\0Z-9Z-+X2OG\67%_%X?EFN*^9/AC\-M-_8@_X)^?\ !0D_$']I3P#^UI8^
M#/VL_@)\1?&NG_#7Q#KWBWPGI$FE_'[X>:OX@\.ZUXDUFSL](;XP>+[32Y)O
MB5X/T>35)_#%]%H]KK&K:A<7T3KHLQQ"C35>5##?O,2GB:M&JZ6)I4^/,EX7
MA[*E&4?JWL\GS6&;SQ=>;P&(JXC#0HU_80JTQ4\#0J8JG3IJM752>74I86C5
MIQKT98GA'B7/ZU65><91GSYKD=+)Z6#C2CCZ*J5:]3#R]RH?SL>/_P#@E-_P
M4)^%OP2D_:(\>?LP>-M ^$UMHUMXBU'7)-5\&7^NZ)H-S&)AJ_B/X?Z5XGOO
MB+X:T^U@(N-3NM?\*:;%I%MFYU5K. &0?GM7]R_[47[>WP8T_2OVEOVDOA9^
MT9_P2<G^'_Q8^!\7A_POIMA\%/%7Q)_;U^+-QKGA=='F^$GQ?T+0?CC\,M9T
M71%OHU@L?$?B&PU#3?#E@UHOB#P5:0:2+W4OX:*VR['8S%XG&4\3A5AJ=*GA
MYQIM5E6P]>K6Q].M@<0ZD%"K4H4L-AJ_MJ=24FL3RU:<(SPDZN.+PF&H83"U
M:.(>(J5:M6G*I%T_88BC#"Y?6ABZ%-3=:E"=?%8C#^SJ04%[!)5)5Z6,ITRB
MBBO7/-"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M*8C["_;D_P"2T^"?^S/?^">7_K /[,U?'M?87[<G_):?!/\ V9[_ ,$\O_6
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M/_0[?L>_^+#?V ?_ *)BC_AAOXT_]#M^Q[_XL-_8!_\ HF*/;T?^?L/O?_R
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MV/?_ !8;^P#_ /1,4?\ ##?QI_Z';]CW_P 6&_L _P#T3%'MZ/\ S]A][_\
MD!>RJ?R2^Y?_ "1\>T5]A?\ ##?QI_Z';]CW_P 6&_L _P#T3%'_  PW\:?^
MAV_8]_\ %AO[ /\ ]$Q1[>C_ ,_8?>__ ) /95/Y)?<O_DCX]HK["_X8;^-/
M_0[?L>_^+#?V ?\ Z)BC_AAOXT_]#M^Q[_XL-_8!_P#HF*/;T?\ G[#[W_\
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M:PN[V5W=VWLN3I=7[75[70_95/Y)?<O_ )(^):*^PO\ AAOXT_\ 0[?L>_\
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M^Y?_ "1\>T5]A?\ ##?QI_Z';]CW_P 6&_L _P#T3%'_  PW\:?^AV_8]_\
M%AO[ /\ ]$Q1[>C_ ,_8?>__ ) /95/Y)?<O_DCX]HK["_X8;^-/_0[?L>_^
M+#?V ?\ Z)BC_AAOXT_]#M^Q[_XL-_8!_P#HF*/;T?\ G[#[W_\ (![*I_)+
M[E_\D?'M%?87_##?QI_Z';]CW_Q8;^P#_P#1,4?\,-_&G_H=OV/?_%AO[ /_
M -$Q1[>C_P _8?>__D ]E4_DE]R_^2/!?A'\7_B;\!OB)X:^+'P>\::U\/\
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M*/;T?^?L/O?_ ,@'LJG\DON7_P D?'M%?87_  PW\:?^AV_8]_\ %AO[ /\
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MXQT+4?!EC;:[9^&KKPW%HUW<ZCHERFIW%F-0D^8OB7^R;_P3-^+/PT_X*G>
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MZ5+\/-9UB\UV_P#$MKIMG\388;+QY)?WTYBN[5HO"5O 4@@\'1HBBN9_9_\
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MB\ETCX>W&MWFB7"Z?::%*LMJ+]=6NKZPBTNY\-3_ )3>+?\ @I;^T=XAT?\
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M_DBW_!0W_LSWP3_ZW]^PW65;^&_\='_T_0+I_&O\-3_TU5/CVBBBM2 HHHH
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MRRI2]A52K<ZH.4'#ZQ[24*=3X(HHHK4S"BBB@#["\$_\F _M,_\ 9X7[#?\
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ML(_[NE_]]SK^/>OLLE_Y%N&_[B_^GJA\YF7^^UO^X?\ Z:@%%%%>H<(4444
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M_&>BVOAV74O"]UK\JM'HEOKEM8S:K(K)8I.P(K^T_P +?MC_ ++'@SQK\"/
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M'QH,@^#L"?#SQ<TWQ8,-Y%I\P^&D2Z.7\=F*_G@L9!X675=EY-%;-B:1$/\
M6;\-_P!ICP/\1? WP.M?@I_P58^#'P(U3]G;]KGXQ_$3]KKQ-X[M=!_96O/V
MP]%\0^.)?$T?Q,\)_"GPM+-H/Q M?$VAQWNDVG@&:8V%XVHP7^K0:?K.E:)I
M]QF_#?\ X*+?L6>/+;]J#]H#5?$G@W0?%'[#OQ\_:'^.G["G@OQ=JVE^'M7^
M*6F_'WP%XCT>/0O#'AK7+K3O$&K)?_%O[=\2M2T72+*>^\*?V]HJW=K906B2
M17/-:]*->J\'.K2PF$>.KTJ$,5]9J82E2RZ/UC"1KX:C"I'-<9G&"ADV&JJ.
M/AAL)FU7-\'A)X6?U5K+Z<Y1I4\1&%7$8M8'#SKSPRP]+&8C$9I2HX;'3I8B
MHZ?]GT,HJ8C.<9AW6R^$,RRS^SL5B95'2Q'\K\_[,G[25KX1\7>/[K]GOXX6
MW@3P!JVK:#X\\;3_  G\>P^$?!.N:!?'3-=T;Q=XDDT!=&\-ZMHNI Z?JVG:
MS>V5YIU\#:7D,,_[NNQL/V'_ -M/5=(M/$&E_L@_M0ZEH-_H]EXAL=;L/@!\
M5[S2+W0-1L)=4T_7+34K?PE)97.CW^F03ZC9:G#,]E=6$,MY!/);QO(/ZW_@
M;_P4*_9I_P"&(/@7XVT[QQ^S'K'B+P)^SYXK\(_'?X4?&O\ ;N^+W[./B#6O
M'6MV=XOQ-9?V6/!'P?\ BUX5^/VJ?$+5]0UKQ%I_C+6/#%YK3W^NN-'NX[F6
M_N+7X._:9_X*6R_"/]JK_@E;KGPE_:#B\6? 'X7_ +.G[.K?%_X8?#KXIQ^*
M_A_INN7J:]X,^)&E>-?#GAK6;O1Y?B#HG@/4I;!;?Q+9'Q!HX%J!!9BX99.B
M-?,JN9?V12PV&>+JYI#**&(E+%/ O$RR[-*\,3.4*?MY8''8W X)8"O3E&V#
MS7#PQ4HXZE453!T<&L)6S!5JT\+A\LQ^;.BH4X8VO1PN89?AX86C";=*GCZ>
M%QE26*PU53J/$8:;P=.MAW[O\TLWPV^(MOX!M?BM<> ?&L'PNOO$DW@VQ^),
MWA778O -YXOM[)M2N/"MKXQ>P7P[<>)(-.1[^;0X=1?4XK)&NGM5@4R#Z-_;
MD_Y+3X)_[,]_X)Y?^L _LS5^H_\ P77N? GP(U;X"_L"?!ZYM1X ^#4/Q,^.
MGB2#38OLUI+XS_:%\?:]XM\/Z?=VYGN'-SX1\!2:;8Z?)+*<:5K40A2&!TB3
M\N/VY/\ DM/@G_LSW_@GE_ZP#^S-49?CO[1C#%QI.C0G5QM/#1FVZLJ5"& H
M59U5914O[0IYM1@J:Y)4,%1J?%6D:8W"1P3]@JRK3=+#5ZDHJ*@HXFKCJ^#4
M.6=36>53R?%54YRY*^85:4)2IT:<Y_'M%36]O<7EQ!:6D$US=74T5O;6UO&\
MT]Q<3NL4,$$,8:26:61ECCC16=W954%B!7[+VG_!"[]KJYTO3M+G^)?[)FE_
M'O5_!2^.]*_9 U?X]Z?I_P"U+J&CO8OJ,4,'P^FT$:$E[)9QRRL+CQC!8V[0
MSP7E];W$,L2>C7K4\-1]O7FJ5)RG!3DI/FE2HO$55"%.%6K4]CAXRQ%?V=&J
MJ&'BZ]=T:*]J<%*$JU7V-)<]7DC4<4XQY82K0P\)U)SG3I4H5,14IX>G*M6H
MQJUYQHTG4JM4S\8J<O#+G^\/YU]+?\,6?MBG2[K7$_90_:3ET.RTK4==N]<@
M^!OQ.N-%@T+1[B>TU77)-7@\,2:<-%TVZM;FWO=6^TG3[:6WF2:Y1HW ^@/"
MG_!+/]KKQ-\,O@#\8KKP)J_A[X=_M&:WK>E>"M;;X>?'#QYJ.D6.F:<VI:/X
MG\6^$/@W\)?B;XVT_P .>/(TD7X?7&D^&]<U'Q5;QOK=EI:^&E_MNB.*H4U&
MO[>@Z<:V%CS^VI<CJ8AU*F%IN4:CL\2L+7=&Z7M%3FX-VCS4Z%;FE3=*JIJ&
M*E*+IS34<'353%O6*7^S0E&59*3E!-7BV['ZV_\ !0?]E_X4_MA?&_X8_M%>
M!O\ @H#_ ,$T--\%>&OV?_@AX:U_P!\1/VM=!T;XA7U_\/\ 0GG\2:&N@Z!X
M>\4V"W%^LK:996TVLQ7CWIDM[JVM&4%OOO\ ;L_;?_9!^(/[-/Q3_P"$,^)7
M[-/B/X.?'KP%\*_!5I8P_MS?&76?C7\-8(+GP_'I?B'P9_P3_C^#WBCP%\,_
M$_PLOK;^VY%TCQ5\.GU]?#L%QXEU^TN+N"U;^15?V-OVL+O2[WQ)H/[-?[0'
MBCP7:P^)K^#QYX?^!_Q9N?!^HZ'X0U.?2?$7B.SU>[\&67EZ)I%[;R0:K=:C
M!82Z-.#9ZW;Z;?QS6L6OX!_8L_:(\8^/?AMX"\0?#'XE_"N;XN:-K?B'X>:]
MX\^"'[0>HZ;XOT70M!F\17>J>%-#^%_PC^)'C_QEIS:?'"YU+P9X*\1:=8Q7
MEMJ.L7>F:*+G5+?S)87#UJ-.D\9%X*AF>*SRGAG[*$D\=BL1G^-HU:L<1A\;
M.-7#X>K+"R_V;&8*EA:^(PBG6594NFE5JX2I[549K%0RK#Y+4Q,7.7[O+,-A
M,IPV(I4U1Q&%I5</B(4I8F<5B<-B)UJ>'Q2C0]DY_P!='B']H;]D3X)?!;XN
M^&?$_P"W)\+/VL/A[8?$7]CCXD^!M+\<?MC>-OVE?CCXF\$?#[XR>!==^(^M
M>(-$\=^)HO!?A_QA%;:?J6K1_!_X/^'#JCV6DSZCXDAO+;5-%\/>'/#_ -L;
MXW^&KC]E/_@J[)XI_P""FG[/'[3>A?M#ZA\._%_[+7P1\+_&W0?$?BOX>>#Q
MXYTZ\NO#&G>#KS4(9M!U:VTM;&PU+P3X/AU(0V_A<^,/$$5AK'B"^@3^7N#]
MB+]LR]\++X[TW]DK]IK5/ 4VBMXFM?'>G? +XM7'@Z]\+BS;45\3VOB+_A$%
MTR3P])IJ_P!I)JS3I9_8#]J>1(@S#!L/V2?VJM5\(>&_B#IO[,_[0%_X \97
M>A6'A'QU:?!OXBW'@SQ1>^*-3M]%\-6GA[Q3%X<;0M9N/$&L75KI6B0Z=?W$
MFJZC<065BL]S*D;8U<HI8N.(P\L<YU\0Z.%J.5+ NK'V]?)O94YX=JC3AF.(
MKY!@Z-'&/#X3'6^O8/#TU2JU,/A^^AF6(P,\); PC'!XBKB(PB\3%3K81XVK
M6A"O'VM6."P_US'5*^#I5Z^%<'1K8F5L/"O5^?**_1;XX?\ !+S]J3]G%_BC
M#\8= ?PS)\+/AUX/^)6H7=AX ^/7C#POX@TKQ<L:R:9HOQ%\%?!OQ%\,=)U'
MPK>R+I'BG4?'WC3P5X1MM;6;1](\4:S?V\\$?RQ=?LR?M)6/@[PK\1+W]GSX
MWV?P_P#'5[HVF^"?'5U\)_'EOX.\8ZCXCN%M/#UAX5\3S: FB>(;W7;ITMM&
MM=(OKR?5+AUAL8YY&"GUJ6)P]:[HUZ55*I1I<T)QE%U<14Q%*A14D^65:M5P
MN(ITJ,92K5)TI1ITJCE3]IY%2C6I*+J4ITU*G.LN>+B_8T\/AL74JN+2E&E2
MPV,PU>K4G&$*5.LI5I4>2JJ/B%%>]>//V5OVG_A9X:U'QG\3OV;_ (]?#GP?
MH^K0Z!JWBOQY\'_B%X0\-:7KMP8UM]%U'7?$'AW3]+LM6G,L0ATVYNHKR4RQ
MA(6+KGP6M(5*=2_LZE.IRM*7LZD*G*Y1C.*ER3GRN4)1G%2Y7*$HS2<)1G*)
M0G"W/"<.;FY>>$X<W+)PER\\(\W+.,H2M?EG&4)<LTX+["\$_P#)@/[3/_9X
M7[#?_JEO^"AM?'M?87@G_DP']IG_ +/"_8;_ /5+?\%#:^/:FEO6_P"O\O\
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MJ1S#.,#*E)T)U*;:_LJ,W[W-&5:5.<83I3A#["_X*&_\G_?MR?\ 9X7[3/\
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MW2M3-A=-!,MM=BU^SSM#*(I&,;@?7&C_ /!-?]J*_P#V./'7[<^M^'M$\#?
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M_P!+I'Q[1116I 5^P_PE_P""+WQJ^*WPG^ WQ8E_:B_89^%=O^TKI;ZE\'/
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M!8>*]7\-W^LIJ&N/%HUZMR]]=6O/6SG%0P.,Q<,%S5:6#RO&8;#-8J4HQQ^
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M;_U=/@FOCVOL+_@GE_R?]^PW_P!GA?LS?^KI\$U\>UDOX\O^O$/_ $]5+?\
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M?_T[(^QPO^[8?_KQ2_\ 2(GX]_\ !U__ ,V$?]W2_P#ON=?Q[U_81_P=?_\
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MX]K["_X*&_\ )_W[<G_9X7[3/_JZ?&U?'M%#^!0_Z\4?_3-$57^+5_Z^U/\
MTY4"BBBM2 HHHH **** "BBB@ HHHH *^PO&W_)@/[,W_9X7[<G_ *I;_@GE
M7Q[7V%XV_P"3 ?V9O^SPOVY/_5+?\$\JRJ[T?^O\?_3=<N&U3_KT_P#TND?'
MM%%%:D!1110 4444 %%%% !1110 4444 ?87_!/+_D_[]AO_ +/"_9F_]73X
M)KX]K["_X)Y?\G_?L-_]GA?LS?\ JZ?!-?'M9+^/+_KQ#_T]5+?\)?\ 7V7_
M *;@%%%%:D!1110 4444 %%%% !1110 4444 ?Z1G_! [_E$Q^RA_P!UU_\
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M_P#G&U_H+44?V]F/\U#_ ,$1_P#DP_LK!_RU?_!LO_D3_/I_XAP/V_O^@_\
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M;+_Y$_SZ?^(<#]O[_H/_  )_\&OQI_\ G&T?\0X'[?W_ $'_ ($_^#7XT_\
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MZMINCZJ]YI%CX5_Q#@?M_?\ 0?\ @3_X-?C3_P#.-K^_#PE_R"KO_L9O&O\
MZF6O5TU*.>9A"*BI4;15E>A%NVKWY_-E2RO"2;DXU+MW?[V7E_=\D?Y]/_$.
M!^W]_P!!_P"!/_@U^-/_ ,XVC_B' _;^_P"@_P# G_P:_&G_ .<;7^@M13_M
M[,?YJ'_@B/\ \F3_ &5@_P"6K_X-E_\ (G^?3_Q#@?M_?]!_X$_^#7XT_P#S
MC:/^(<#]O[_H/_ G_P &OQI_^<;7^@M11_;V8_S4/_!$?_DP_LK!_P M7_P;
M+_Y$_P ^G_B' _;^_P"@_P# G_P:_&G_ .<;1_Q#@?M_?]!_X$_^#7XT_P#S
MC:_T%J*/[>S'^:A_X(C_ /)A_96#_EJ_^#9?_(G^?3_Q#@?M_?\ 0?\ @3_X
M-?C3_P#.-H_XAP/V_O\ H/\ P)_\&OQI_P#G&U_H+44?V]F/\U#_ ,$1_P#D
MP_LK!_RU?_!LO_D3_/I_XAP/V_O^@_\  G_P:_&G_P"<;1_Q#@?M_?\ 0?\
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M &8_^",;_P#,1_ )_P 0X'[?W_0?^!/_ (-?C3_\XVC_ (AP/V_O^@_\"?\
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M'\ G_$.!^W]_T'_@3_X-?C3_ /.-H_XAP/V_O^@_\"?_  :_&G_YQM?W]_\
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MR_\ D3_/I_XAP/V_O^@_\"?_  :_&G_YQM>X>(O^"#W[:.K?LV_"#X"6VO\
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M:/\ B' _;^_Z#_P)_P#!K\:?_G&U_H+44?V]F/\ -0_\$1_^3#^RL'_+5_\
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M_P"!/_@U^-/_ ,XVC_B' _;^_P"@_P# G_P:_&G_ .<;7^@M11_;V8_S4/\
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MI3<<*\5)0HSIPP&(P682KK!8RAB7^E%%?E<O_!6/X76?P>U[X]>+/V9?VS?
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MW=^TGX"U#Q!J/A:S3Q-]H\5^+O@WX9\!>&='UCQ1XU\3#0+J.^TJ?4_^"O\
M\*K/XA^#O@1I?[,7[7OBC]J+Q3XI^(?@K5?V7M$\+_ B#XJ?#_Q+\-O _@KX
MG:O;>-?$/B+]H30/@>-$UKX=>.M*\7>$/''A+XP>+/A_XFM+/4]'T[Q4_BJ.
MRT"_^D/VTOV<OB+\;%_9X^)/P8UCP99?&7]E/XZVGQX^'GAWXE76M:5\-_B'
M<R?#OX@?"SQ+X \9>)?#.B^)_$G@NR\0>$/B1KHTSQOHOA/QE=>%==MM,U67
MP;XILX;G1[KXE^%__!/3]IF;_@HC\/\ _@H=\:/$_P $M/\ $M]<_&)/B/\
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MHPYBBBBL2@HHHH **** .9\)?\@J[_[&;QK_ .IEKU?//[3/A7]JG5+CX?\
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M[ ND^ _VJ?\ @F_^R[\,?CSX:\7^)?AS\'+*W_X**^#=(32[77?B#\'?@_\
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M*_C'QQ\5_!^@^#_"NB^'=2T_6+V[EMCK]M<_98+OQ'QS_P %<_A3\*=5\+>
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MJ=OJO]F#_@K'\,/VI/%?[,_A_0OV;_VK/A?H'[7_ (!\<_$G]G[XB_%SP_\
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MX?\ %;7QZ_Z,]X.?^%GB'_\ /8_S;/\ AU-_P46_Z-#^,/\ X)+7_P"3Z/\
MAU-_P46_Z-#^,/\ X)+7_P"3Z_TDZ*/^):^%?^BAXB_\%Y1_\SA_Q6U\>O\
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MAXB_\%Y1_P#,X?\ %;7QZ_Z,]X.?^%GB'_\ /8_S;/\ AU-_P46_Z-#^,/\
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MN8)H)!_#)&R]J_TFJYGPE_R"KO\ [&;QK_ZF6O4?\2U\*_\ 10\1?^"\H_\
MF</^*VOCU_T9[P<_\+/$/_Y['^<E_P .IO\ @HM_T:'\8?\ P26O_P GT?\
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MB-_T5/\ \LC0O_DB@#TRBO,_^$7^(W_14_\ RR-"_P#DBC_A%_B-_P!%3_\
M+(T+_P"2* /3**\S_P"$7^(W_14__+(T+_Y(H_X1?XC?]%3_ /+(T+_Y(H ]
M,HKS/_A%_B-_T5/_ ,LC0O\ Y(H_X1?XC?\ 14__ "R-"_\ DB@#TRBO,_\
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M /+(T+_Y(H ],HKS/_A%_B-_T5/_ ,LC0O\ Y(H_X1?XC?\ 14__ "R-"_\
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MF45YG_PB_P 1O^BI_P#ED:%_\D5#_P (_P"/C<&T'Q:A-VL*W+6O_"&^'OM
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M_A%_B-_T5/\ \LC0O_DBC_A%_B-_T5/_ ,LC0O\ Y(H /%'_ "4;X6?]SO\
M^F*WKTROGK7M!\:Q>-? -M<^/OM>H7?_  E7]F:G_P (MI,']D^1I,,E[_H4
M<Q@O_M\!6W_TAE^R[?-BW.Q%=S_PB_Q&_P"BI_\ ED:%_P#)% 'IE%>9_P#"
M+_$;_HJ?_ED:%_\ )%'_  B_Q&_Z*G_Y9&A?_)% 'IE%>9_\(O\ $;_HJ?\
MY9&A?_)%'_"+_$;_ **G_P"61H7_ ,D4 >F45YG_ ,(O\1O^BI_^61H7_P D
M4?\ "+_$;_HJ?_ED:%_\D4 >F45YG_PB_P 1O^BI_P#ED:%_\D4?\(O\1O\
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MU\0ZEJVN7=]W^D?\$[?V,M G)T7X&Z+I>EW/P,N?V;->\(V/B3QS;_#SQO\
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M !4_:\^ ^K_M:?$+0_B)J_[<OP@^#WA7XE_#;]D+]G;QU^UY\>H)?V%/A?\
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M:\\,L+"<G*I1PV'P]>E3P\FY5%RX=5_84N6K4C[&E"T^50C$HHHKB- HHHH
M**** "BBB@#\UOVD/^"G?[(G[%GQ8USX6_'[QGXD\.^,=?L=$\?Z;9:/X&\3
M^)[:7PSJNDVOAVSNI+_1;"ZM89WU3PKK,+6<DBW$<<$4SH([B)F\)_X?\?\
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M^#NBC_B8OCW_ *!>&_\ PV8K_P">8?\ %&;Z)G_0^\:G_P!WOD?Z<#']_/\
MP_X_X)I_]%2\<_\ AH_'_P#\IZ/^'_'_  33_P"BI>.?_#1^/_\ Y3U_ -11
M_P 3%\>_] O#?_ALQ7_SS#_BC+]$S_H?>-7_ (F^1?\ T#']_/\ P_X_X)I_
M]%2\<_\ AH_'_P#\IZ/^'_'_  33_P"BI>.?_#1^/_\ Y3U_ -11_P 3%\>_
M] O#?_ALQ7_SS#_BC+]$S_H?>-7_ (F^1?\ T#']_/\ P_X_X)I_]%2\<_\
MAH_'_P#\IZ/^'_'_  33_P"BI>.?_#1^/_\ Y3U_ -11_P 3%\>_] O#?_AL
MQ7_SS#_BC+]$S_H?>-7_ (F^1?\ T#']_/\ P_X_X)I_]%2\<_\ AH_'_P#\
MIZ/^'_'_  33_P"BI>.?_#1^/_\ Y3U_ -11_P 3%\>_] O#?_ALQ7_SS#_B
MC+]$S_H?>-7_ (F^1?\ T#']_/\ P_X_X)I_]%2\<_\ AH_'_P#\IZ/^'_'_
M  33_P"BI>.?_#1^/_\ Y3U_ -11_P 3%\>_] O#?_ALQ7_SS#_BC+]$S_H?
M>-7_ (F^1?\ T#']_/\ P_X_X)I_]%2\<_\ AH_'_P#\IZ/^'_'_  33_P"B
MI>.?_#1^/_\ Y3U_ -11_P 3%\>_] O#?_ALQ7_SS#_BC+]$S_H?>-7_ (F^
M1?\ T#']_/\ P_X_X)I_]%2\<_\ AH_'_P#\IZQ/#_\ P7J_X)MZ?8SP7/Q0
M\;K))K?B6^4+\)?'K@V^I^(]5U*T8E='P&>UNX6=>J,Q1L,I%?P0T4?\3%\>
M_P#0+PW_ .&S%?\ SS#_ (HR_1,_Z'WC5_XF^1?_ $#']_/_  _X_P"":?\
MT5+QS_X:/Q__ /*>C_A_Q_P33_Z*EXY_\-'X_P#_ )3U_ -11_Q,7Q[_ - O
M#?\ X;,5_P#/,/\ BC+]$S_H?>-7_B;Y%_\ 0,?W\_\ #_C_ ()I_P#14O'/
M_AH_'_\ \IZ/^'_'_!-/_HJ7CG_PT?C_ /\ E/7\ U%'_$Q?'O\ T"\-_P#A
MLQ7_ ,\P_P"*,OT3/^A]XU?^)OD7_P! Q_?S_P /^/\ @FG_ -%2\<_^&C\?
M_P#RGH_X?\?\$T_^BI>.?_#1^/\ _P"4]?P#44?\3%\>_P#0+PW_ .&S%?\
MSS#_ (HR_1,_Z'WC5_XF^1?_ $#']_/_  _X_P"":?\ T5+QS_X:/Q__ /*>
MC_A_Q_P33_Z*EXY_\-'X_P#_ )3U_ -11_Q,7Q[_ - O#?\ X;,5_P#/,/\
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M]-5I734 %%%% !1110 4444 %%%% !1110 5YG_S6/\ [IG_ .[37IE>9_\
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MOAZ\\2>%OB7K?Q/U#XH^#)M1T/P[H^DZK8>$?&>B:5JMC9_9]2L+J.XNA/\
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M8?/L[V".YM9O*G2*>+S8)4?RYHXY4W;9$1P5'D/QH_9U^#G[0K?"M_C!X/\
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MJ\4JCE&I&'\ME%?U)_\ $,-\2_\ H[?P-_X:K7__ )LJ/^(8;XE_]';^!O\
MPU6O_P#S95\;_P 09\3/^B5Q/_A;E/\ \\C^D_\ BI=]![_H_>2?^(OX@_\
MT%'\ME%?U)_\0PWQ+_Z.W\#?^&JU_P#^;*C_ (AAOB7_ -';^!O_  U6O_\
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M^>0?\5+OH/?]'[R3_P 1?Q!_^@H_ELHK^I/_ (AAOB7_ -';^!O_  U6O_\
MS94?\0PWQ+_Z.W\#?^&JU_\ ^;*C_B#/B9_T2N)_\+<I_P#GD'_%2[Z#W_1^
M\D_\1?Q!_P#H*/Y;**_J3_XAAOB7_P!';^!O_#5:_P#_ #94?\0PWQ+_ .CM
M_ W_ (:K7_\ YLJ/^(,^)G_1*XG_ ,+<I_\ GD'_ !4N^@]_T?O)/_$7\0?_
M *"C^6RBOZD_^(8;XE_]';^!O_#5:_\ _-E1_P 0PWQ+_P"CM_ W_AJM?_\
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MBB@ HHHH YGP5_R)OA+_ +%G0?\ TU6E=-7,^"O^1-\)?]BSH/\ Z:K2NFH
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M-B\S9NV>8F[&]<Z?_":^#?\ H;?#/_@^TK_Y+H Z:BN9_P"$U\&_]#;X9_\
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MK-?\"?#+X0?LX7'B/XV:[\"_V\?VFOA;X0^&]WJ_B3X-^)IM*\'^(OA-\-=
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M_P#9._:\T.T_;J^$O[=FJZ!^TEH5O_P44^-7Q2_9]^)E]\0/V:?VK_"WP/\
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M\)KX-_Z&WPS_ .#[2O\ Y+H Z:BN9_X37P;_ -#;X9_\'VE?_)='_":^#?\
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MP;_T-OAG_P 'VE?_ "71_P )KX-_Z&WPS_X/M*_^2Z #P5_R)OA+_L6=!_\
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M-OAG_P 'VE?_ "70!TU%<S_PFO@W_H;?#/\ X/M*_P#DNC_A-?!O_0V^&?\
MP?:5_P#)= '35YG_ ,UC_P"Z9_\ NTUTW_":^#?^AM\,_P#@^TK_ .2Z\]_X
M2CPU_P +7_M'_A(M"_L__A7GV+[?_:UA]C^V?\))Y_V3[5]H\C[5Y'[[[/O\
MWROWFS9S0![117,_\)KX-_Z&WPS_ .#[2O\ Y+H_X37P;_T-OAG_ ,'VE?\
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M4OE>;Y47F;-N_P M-V=BXT_^$*\&_P#0I>&?_!#I7_R)1:?\CEKW_8L^$O\
MTZ^-:Z:@#F?^$*\&_P#0I>&?_!#I7_R)1_PA7@W_ *%+PS_X(=*_^1*Z:B@#
MF?\ A"O!O_0I>&?_  0Z5_\ (E'_  A7@W_H4O#/_@ATK_Y$KIJ* .9_X0KP
M;_T*7AG_ ,$.E?\ R)1_PA7@W_H4O#/_ ((=*_\ D2NFHH YG_A"O!O_ $*7
MAG_P0Z5_\B4?\(5X-_Z%+PS_ ."'2O\ Y$KIJ* .9_X0KP;_ -"EX9_\$.E?
M_(E'_"%>#?\ H4O#/_@ATK_Y$KIJ* .9_P"$*\&_]"EX9_\ !#I7_P B4?\
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M"O!O_0I>&?\ P0Z5_P#(E'_"%>#?^A2\,_\ @ATK_P"1*Z:B@#F?^$*\&_\
M0I>&?_!#I7_R)1_PA7@W_H4O#/\ X(=*_P#D2NFHH YG_A"O!O\ T*7AG_P0
MZ5_\B4?\(5X-_P"A2\,_^"'2O_D2NFHH YG_ (0KP;_T*7AG_P $.E?_ ")1
M_P (5X-_Z%+PS_X(=*_^1*Z:B@#F?^$*\&_]"EX9_P#!#I7_ ,B4?\(5X-_Z
M%+PS_P""'2O_ )$KIJ* /./#'A'PG<:;<R3^&/#T[KXA\70*\VBZ;(ZPVWBS
M6K:VA#/;,1%;V\44$$8.R*&..*,*B*HZ'_A"O!O_ $*7AG_P0Z5_\B4>$O\
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M^A2\,_\ @ATK_P"1*Z:B@#F?^$*\&_\ 0I>&?_!#I7_R)1_PA7@W_H4O#/\
MX(=*_P#D2NFHH YG_A"O!O\ T*7AG_P0Z5_\B4?\(5X-_P"A2\,_^"'2O_D2
MNFHH YG_ (0KP;_T*7AG_P $.E?_ ")1_P (5X-_Z%+PS_X(=*_^1*Z:B@#F
M?^$*\&_]"EX9_P#!#I7_ ,B4?\(5X-_Z%+PS_P""'2O_ )$KIJ* .9_X0KP;
M_P!"EX9_\$.E?_(E'_"%>#?^A2\,_P#@ATK_ .1*Z:B@#F?^$*\&_P#0I>&?
M_!#I7_R)1_PA7@W_ *%+PS_X(=*_^1*Z:B@#F?\ A"O!O_0I>&?_  0Z5_\
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M@W_H4O#/_@ATK_Y$H_X0KP;_ -"EX9_\$.E?_(E?Q%_\1(7[?/\ T)O[,_\
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M?/\ T)O[,_\ X;WQ]_\ /8H_XF#\.?\ G]GW_ABK?_-X?\4?/IF_]"[PG_\
M%JY;_P#0H?VZ?\(5X-_Z%+PS_P""'2O_ )$KGO#'A'PG<:;<R3^&/#T[KXA\
M70*\VBZ;(ZPVWBS6K:VA#/;,1%;V\44$$8.R*&..*,*B*H_BL_XB0OV^?^A-
M_9G_ /#>^/O_ )[%4M/_ .#C/]O+38)+>W\'?LUF.2]U*_8R?#_QXS>?JNHW
M6J7(!7XK*!&+F\E$2X)2((K,[ NQ_P 3!^'/_/[/O_#%6_\ F\/^*/GTS?\
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M^$*\&_\ 0I>&?_!#I7_R)1_PA7@W_H4O#/\ X(=*_P#D2NFHH YG_A"O!O\
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MEDMF>261V9Y)'9G=V+,22370_P#"%>#?^A2\,_\ @ATK_P"1*/!7_(F^$O\
ML6=!_P#35:5TU ',_P#"%>#?^A2\,_\ @ATK_P"1*/\ A"O!O_0I>&?_  0Z
M5_\ (E=-10!S/_"%>#?^A2\,_P#@ATK_ .1*/^$*\&_]"EX9_P#!#I7_ ,B5
MTU% ',_\(5X-_P"A2\,_^"'2O_D2C_A"O!O_ $*7AG_P0Z5_\B5TU% ',_\
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MZ5_\B5TU% ',_P#"%>#?^A2\,_\ @ATK_P"1*/\ A"O!O_0I>&?_  0Z5_\
M(E=-10!S/_"%>#?^A2\,_P#@ATK_ .1*/^$*\&_]"EX9_P#!#I7_ ,B5TU%
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M1?$?Q>_9A\$^(OV?_C1<CX5?\%Q?VC/VAO&=[XF^ _Q/@\!:7\+_ (F?!O\
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M4 <SXU_Y$WQ;_P!BSKW_ *:KNNFKF?&O_(F^+?\ L6=>_P#35=UTU !1110
M4444 %%%% !1110 4444 %%%% 'F?A?_ )*-\4_^Y(_],5Q11X7_ .2C?%/_
M +DC_P!,5Q10!TUI_P CEKW_ &+/A+_TZ^-:Z:N9M/\ D<M>_P"Q9\)?^G7Q
MK734 %%%% !1110 4444 %%%% !1110 4444 <SX2_Y!5W_V,WC7_P!3+7JZ
M:N9\)?\ (*N_^QF\:_\ J9:]734 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!S
M/A+_ )!5W_V,WC7_ -3+7JZ:N9\)?\@J[_[&;QK_ .IEKU=-0 4444 %%%%
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M_#,> ?\ Y1U]G44?ZN\/?]$_D/\ X9,F_P#G2'_$9O&/_H[_ (L?^+1\2/\
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M_#)DW_SI#_B,WC'_ -'?\6/_ !:/B1_]'Y\8_P##N?\ 8&_Z,T_9G_\ #,>
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M?_=,_P#W::],KS/_ )K'_P!TS_\ =IH ],HHHH **** "BBB@ HHHH ****
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M*W5?_F*HHH /M?C+_H ^&?\ PK=5_P#F*H^U^,O^@#X9_P#"MU7_ .8JBB@
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MZK_\Q5'VOQE_T ?#/_A6ZK_\Q5%% !]K\9?] 'PS_P"%;JO_ ,Q5'VOQE_T
M?#/_ (5NJ_\ S%444 'VOQE_T ?#/_A6ZK_\Q5'VOQE_T ?#/_A6ZK_\Q5%%
M !]K\9?] 'PS_P"%;JO_ ,Q5'VOQE_T ?#/_ (5NJ_\ S%444 'VOQE_T ?#
M/_A6ZK_\Q5'VOQE_T ?#/_A6ZK_\Q5%% !]K\9?] 'PS_P"%;JO_ ,Q5'VOQ
ME_T ?#/_ (5NJ_\ S%444 9EA!XRL;K6KG^Q_#,O]L:G%J.S_A*=53[/Y6C:
M3I'D[O\ A#G\[=_9?VCS-L6//\K8?*\V33^U^,O^@#X9_P#"MU7_ .8JBB@
M^U^,O^@#X9_\*W5?_F*H^U^,O^@#X9_\*W5?_F*HHH /M?C+_H ^&?\ PK=5
M_P#F*H^U^,O^@#X9_P#"MU7_ .8JBB@ ^U^,O^@#X9_\*W5?_F*H^U^,O^@#
MX9_\*W5?_F*HHH /M?C+_H ^&?\ PK=5_P#F*H^U^,O^@#X9_P#"MU7_ .8J
MBB@ ^U^,O^@#X9_\*W5?_F*H^U^,O^@#X9_\*W5?_F*HHH /M?C+_H ^&?\
MPK=5_P#F*KF?$NC^,O$7_"/_ /$M\,V?]A>)M*\1?\C+JMQ]J_LSS_\ 0_\
MD48/(\_S_P#CX_?>5M_U$F[@HH Z;[7XR_Z /AG_ ,*W5?\ YBJ/M?C+_H ^
M&?\ PK=5_P#F*HHH /M?C+_H ^&?_"MU7_YBJ/M?C+_H ^&?_"MU7_YBJ**
M#[7XR_Z /AG_ ,*W5?\ YBJ/M?C+_H ^&?\ PK=5_P#F*HHH /M?C+_H ^&?
M_"MU7_YBJ/M?C+_H ^&?_"MU7_YBJ** #[7XR_Z /AG_ ,*W5?\ YBJ/M?C+
M_H ^&?\ PK=5_P#F*HHH /M?C+_H ^&?_"MU7_YBJ/M?C+_H ^&?_"MU7_YB
MJ** #[7XR_Z /AG_ ,*W5?\ YBJS-)@\9:7:RVW]C^&9_-U/6M1W_P#"4ZK%
MM_MC6;_5_)V_\(=)G[/]N^S^9N'G>5YNR+?Y2%% &G]K\9?] 'PS_P"%;JO_
M ,Q5'VOQE_T ?#/_ (5NJ_\ S%444 'VOQE_T ?#/_A6ZK_\Q5'VOQE_T ?#
M/_A6ZK_\Q5%% !]K\9?] 'PS_P"%;JO_ ,Q5'VOQE_T ?#/_ (5NJ_\ S%44
M4 'VOQE_T ?#/_A6ZK_\Q5'VOQE_T ?#/_A6ZK_\Q5%% !]K\9?] 'PS_P"%
M;JO_ ,Q5'VOQE_T ?#/_ (5NJ_\ S%444 'VOQE_T ?#/_A6ZK_\Q5'VOQE_
MT ?#/_A6ZK_\Q5%% ',ZIH_C+4O$?A;Q!_9OAF'_ (1K^W/]$_X2759/MO\
M;-A'9?\ 'Q_PB,?V;[-Y?F_ZF?SL[/W6-YZ;[7XR_P"@#X9_\*W5?_F*HHH
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M\)3JLWD?;K66V\[RO^$.B\WRO-W^7YL>_;MWIG<-/[7XR_Z /AG_ ,*W5?\
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!V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>54
<FILENAME>img_007.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 img_007.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  H'!PD'!@H)" D+"PH,#QD0#PX.
M#QX6%Q(9)" F)2,@(R(H+3DP*"HV*R(C,D0R-CL]0$! )C!&2T4^2CD_0#W_
MVP!# 0L+"P\-#QT0$!T]*2,I/3T]/3T]/3T]/3T]/3T]/3T]/3T]/3T]/3T]
M/3T]/3T]/3T]/3T]/3T]/3T]/3T]/3W_P  1" $D 7,# 2(  A$! Q$!_\0
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M*YS3]7=[]KA;-VAOGC2-DEC;&%Y) .>!S]*Z.F2U8**** "BBB@#/U;I9?\
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M+5?[=;>9;Q^?'ON03" W^L &21Z\5!%K>GSWXLHKN%KDKO$8;DB@"_535O\
MD#WO_7!__033H=0M;ABL,\;D.T?RMGYE^\OU%,U;_D#WO_7!_P#T$T 6+?\
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M=WMNDS017)A8S* 2$4'*@$$9W <'LQIUGH$Z6GV.]G\Z&*)XH9#C>0Q!!(
M!& ./2LK^VM8FLLD7T CC@6YE%D2Z-EQ*R*5.[&$' (P<C-5[_4/$-JJ-8)<
M,)IR6>2%@S'RX]H*[&VJ3NSC'(ZB@#3U/PYJ&H6"JMS'%=2+*9W5C@LP4 #@
M\87'3IV-9\/@FY%K;QS+;.PB>)R7YC4RH^Q2J*-N%88 '6GW>L:S;_;FD.HD
MHKAHH+,'R3O C\MBIW[@26^]@9.!C%)9RZW<&W5+^Z+S1H);S[%L.0)B0$=0
M!@A!D@=O6BXPNO!U\;RS^R_94M[6X,D($A4PKYN_ &T]5XP"N/<5/!X/D@EB
MG5+?ST:*3?O;.]92S-]2A"Y_#I72Z7+/<:5:2W:[;AX4:1=NW#$#/';FK6*!
M;F0FD.DVF2XB,ML7:9\<G<K9P?3<V:J7FA3^1=?8XXED:[$\(28P%!L"GY@I
MP>O8Y!KHJ,4AG(P^%-3M+RQGAU..1+:(IY;PC(_=E0 _7&XYJ9_#M^+@V]M-
M#;V@?STN5),J/Y7EXV8Q[YS[8KJ**8',:?H=]IT,-M-<).QU#[0LD<00)&%Y
MR!W/3\:W-5_Y U[_ ->[_P#H)JW535O^0/>_]<)/_030!8M_^/>+_<'\J*+?
M_CWB_P!P?RHH YGQ%)%)K<$?E><4@;)MKT6\\>2."=ZY4^GJ!6UHDEM)H]LU
MC$L5N%PB*P8+@D8R"0>0><US_B:VM?[>@,L5I;B6!F:Y;3OM+NP( 4G! &.>
M>OX5T>DA!I5L(Y%D0)A76+R@1_N=OI1T YZW29==M&M6U*53,WG+/81Q(J;3
MSO\ +!ZXQ@\UUM<-HT(_MVWMT:U%_;RNUU=I>!WN5P<KLZ]2,@_=QQ7<B@"G
MJ]\VFZ5<7:HKF)-P#-@?4GT'6N?3Q=>364<\%M:R"*)Y[EA*P5HU;;F/C.3@
MGYL=*Z6^LH]0M'MYBX1\'<C;64@Y!![$$ UE-X2LF2(-/>%E+>:_G'=< D$B
M0]P<#IB@#7GNX+6(27$J1(3@,YP,U5T%@VA6;*05,8(([BM"J&A_\@6T_P!R
M@"_1110 4444 %%%% $%];_:[&>#_GK&R9],BLBY1+W3;*^626*>4P([PR%"
MP+@,IQUZGZ=JWJPA\FG-!C'D:BB >QF5A^C"@!WB#3L^'OLUG#\D3H_EH,DA
M6R0.YSCGN1GUIFF7%I?WMK=:3$%A,1\]D3:G;"GCE@<_3!K>K%\.RNOVVVD.
M=ES+)'QCY&D;'Y$,* -JO/?B[)K]AH"ZCH=]+#!%F.\A15.4;@-R,\'@_7VK
MT*J.MJ&T*_# $&W?@C/\)H Y;X>Z5J,%BTNNWEU)J4^R[D!D( 5QPI4<9&TY
MKMZH3_N=;M9,'$T;Q$^XPP_0-5^@!DD22QLDBAD88*L,@BJ4+M83+:S,3"W$
M$C'_ ,<)]?0]Q6A5+519M8LFH*&@D8)@H6^8G P #SG%)E)]'L6PZG@,"?8T
MZN<\.O9VTAM'MQ%?;Y2KM;>694WD[AQTP1Q71TQ-6=C/U;I9?]?<=:%9^K=+
M+_K[CK0H$4[C45M[Q+803R2.AD&P#& <'DD<\C\Z=97RWHEVQ2Q^4_EL) .3
M@$XP3GKCZYINI6<EW"IMY5AN8FW0RE=P4]#D=P02,5+:6J65K'!%DJ@QD]2>
MY/N3S0!,:PM/\7:;J4MM%:RI+--$\CQ1R*[Q;0,AE!SGG%;IK*@T>STU+*3S
M-BV,;('; R" "6./:@"&'Q1;R3:<C6]Q$+X2;6<#]V58* W/&2<#WXJ:VUZ*
MY;3E6WG7[<C.K$?*F 3@GUXZ"HXM%T^3;#YQE"12QE-XSM=\D\<@AEP#[>M6
M+318;2#3HEEE<6"E8V<@E\KMRW'7F@!UUJT5J+K*LYMHU9@O4LWW5'N?ZBHI
M-=B2"RF2)W2YQG!'[L$A26^A8"F7>@0:A=S_ &Q1-:3M'(\+<AF0$ $=QT/U
M%1P:#IT4%S96\NR.57B2)&4>0#\Q"#MR0?;B@!\'B.*8L!;S9$LB8 !)5%W;
MP!V/&![U43Q@G]G_ &R:PG6,RI&-DB2\,>ORD\@#)7J/>M"'0;>"X\V.28-]
ME%KPV, ?Q CD-TY]JK6_AZ".[W3ZA/<W0:.7,GEAMJ$[00JC/).2>3ZT 61K
MB2>:(8))G28PJJ%?WF$#Y!)QC!%4?^$N4:7#?&Q<QM,89=L\9"$''RG.')/0
M+UP:GL_#]E:BZBM;B==SN2$D&Z N%^Z>HP%&/:F-X61[1H7U"\/FNS7##8//
M#  @KMVC@#E0".>>: -:WNTN))XP"KPOL<'Z @_B"*L52LK'[-<7<S8W3N"
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M5/D-E-Q^[N4Y(_O93_V:K]<?\0O&NG>%--CBNQ-)<W)#0QQ 9^5@<DG@#.*
M.PI#SUK%\*>*]/\ &&D"_P!-,@56\N2.1<-&V <'MW'2MN@"AHV4T\0$Y-L[
M0_@IPO\ X[BK]9]N?)UJ[ASQ,B3J/?[K?^@K^=:% !6?HV$LW@&?W$TD?/H&
M)'Z$5H50L\QZM?Q=F,<P'U7:?_0* +]%%% !45S ES \,@^5Q@XZCW^M2TE
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MG/YOS7 )!(DXY' Z8K=HH *S]"_Y EI_N5H5GZ%_R!+3_<H T**** "BBB@
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MU#S1:WD,@40QS!X-KD.'0@,X/#+TXR,UMZ%;FUT6UB;?D)D[]N<DD_PDC'/
M!/&*P?%<"S:U9^7=64=RB"14OB50JLBL2K?WN ",=#6]H5HMAHMK;QS).J+_
M *R/[AR2?E]AG ]A1T YO3-4EFU6QLFN -0AFD%Y(;B(I,OS94 '<><8& 5P
M<^_:5QGAV]2VN8+&*[B>V23RXV.GE"^X,RX?=W .&(YQ[UV= "T444 %9^A?
M\@2T_P!RM"L_0O\ D"6G^Y0!H4444 %%%% !1110 4444 4+'Y-0U"+!QYBR
M#/\ M(!Q^*FK]4!^[\0,. )K8'W.QC_\75^@!DL:S0O&XRKJ5(]C572)&ETJ
MWW_?1?+?_>7Y3^H-7:YZ&2_M]8FLH9[<1R3O(N^!F*@J&_OC/):@#H:HZTI.
MD7#+]Z-1*,#/*D-_2KBA@H#$%L<D# )^E5M569M)NUM8_,G,+!$W!=QQTR0<
M9^E %H$, 0<@\BEKR?P!\0M7\0^((=(:RFV0+^_=Y% B55 .0(P<[O<=?:O6
M* "BBB@ JKJ4:2Z;=)(H9&B;(/TJU534C.;-TMH!,\BE<%PN,CKF@"EX=46N
MGQ6623'&KJS=75AG)]3G(-:]8B"[@M8)IK7RGLXP#MD#^8F,,/TS^%;2,'16
M4@J1D$=Q278J6OO#J***9(4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% &)J%V6G=9O#MU>+$2%D"PL"/]D,V:OZ9=6U[IL%Q8@+;NN44)MV^HQV(
M.1BL-Y+N]U B#Q!>VRRW4END(M82 R D@,5)Q@'DUL00VV@Z0D48F:"!<<*T
MCMD\G &223D\4 <;HL^F-XAMY;:&Z:&21%5'N0R0R%9-@" 9.$!)!/R[QQZ>
M@BN*T>[NWO["1H[L3S3R?:(9=.\J*($'+*^P$'A>23N[^W:B@!DTZ6\+RRMM
M1!DFN>;Q<_V6&>/3)#^[>:X1Y0K0QJY0G_:;@G''0\UMZAIUMJEHUM>(7A8A
MB [*<@Y!RI!ZBL5/!=K!;16]K=W4,0#I*-P<S1L^XH2P)'/<<]?6@#H))HX4
M#RR(BG@%F %4]"(.AVA!!!C&"*NR0QS(%EC1U'.&7(JEH0 T.T   $8P!0!H
M4444 %%%% !1110 4444 4+P%-4T^0$X+/$>/5=W_LE7ZH:OA;>"8_\ +&XC
M;KC@L%/Z,:OT %<S,]W<^(HKVT$ 01RQ1QN2#,R-@Y/\/5L=>G-=-7-:Y9F#
M4+'R;B6*":X+3(I' (VL5.,KG=S^?!H W[6X6[M(;B,$)*@< ]<$9J212\;*
MKLA(P&7&1^>121QI#$D<:A40!54= !T%/H YCPWX:MM)U;5[N":;[1<79:?(
M3$F0&'\.1]XGC'-=/5"']UKMRN#B:%)/Q!*G]-M7Z "BBB@ HHHH 0C-4;'-
MM-)9-]U/GA]T/;\#Q],5?JEJ$3[%N(03- =Z@?Q#^)?Q'Z@4F5'L7*6HX94F
MA22,[D<!E/J*DIDA1110 4444 %%%% !1110 4444 %%%% !1110 4444 <+
M)86=WXA8^7JL%N][)$EQ%J#(HN-IW8C!^4'##/Z5V=I;BTMHX%DED"# >5R[
MGZD\FL:Y\&V-S<O.;K4HBTQGV17CHJN<Y8 ' ZG\ZV;6V%I;1P+)+($&-\KE
MW/U)Y- '(:;X-N-/UVTO?*M6=6W37/F,7) <'@CDN&4GG@@]:[6N,TF;7FUT
M17*ZAQ*K3F5 (-NUMX4],9V;<<^O>NSH 6BBB@ K/T+_ ) EI_N5H5GZ%_R!
M+3_<H T**** "BBB@ HHHH **** *>K1&?2;I%^\8F*\9Y R/UJQ!*)[>.5>
MDBAA^(S3R,C!Z51T7(TJ&-NL.Z$\8^XQ7^E %^L;5M'N[\2,M^5(1Q&GDJ0-
MP]3]!6S10!7L)_M-A;S$Y,D:L3C')%6*S])_=+<VIX^SSL%'^RWSK^C8_"M"
M@"A=YCU6PEXPQ>$GZC</U2K]9^M?)I_GXR;>1)OP5AG],UH4 %%%% !1110
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M6BBB@04444 %%%% !1110 4444 %%%% !1110 4444 %%%% !6?H7_($M/\
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M7L]OQ=VS8_YZ0_.OXCJ/R- <M]B]14$%W!<C,$J/ZA3R/J*FS3)>@M%)FEH
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MBCCMA^_MU3"S,/N''3@]?7 H Z*'Q!I4T*2KJ-H%=0P#3*",^HSQ3_[<TO\
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MPH J3WNAW)S->:>S?WO.0'\\YJ'[9IZ?\>^O11^S7"2#_P >.?UK1_LK3_\
MGQM?^_*_X4?V5I__ #XVO_?E?\*5AJ3,_P#ME$P!JVDR@8Y:4(?T)J>SUJ.Z
MN4A#VC,V?]3=JYX]N#5G^RM/_P"?&U_[\K_A4;Z1:>?;RPP00O!)ORD0!/RD
M8S^- [^1>I:3-+3)"BBB@ HHHH **** "BBB@ HHHH **** .9\0ZC=VVH/]
MGO3 +:!)EA 4BX9I"I4Y&<8 '&#EJ3Q!J5U;Z@_V:],"VT"3+"H4BX8R%2IR
M,XP,<8.6K?GL+6YGAFN+:&66 [HG>,,T9]5)Z?A3'TNQD>)WL[9GA<O$QB4E
M&)R2.."3SF@"I97-VWB+4;:XE1H8XHGA14QL#%P<GN?E%:U,$2+*T@11(P 9
M@.2!T!/XG\Z?0 4444 %%%% &;K]U+9Z-/-!((I 542$ [ S!2W/' )//I4&
MBSW,ME=PFZ%S+!.\,4\H'S@ $%@N <9P<8Z5K2Q)-&T<J*\;@JRL,AAZ$5%;
MZ?:6BQ+;6T$*Q*5C$<84(#R0,= <"@"EX;NKB]T&VGNY1+.P8.X4+N(8CIVZ
M5JTR*&.",1Q(J(.BJ, ?A3Z "BBB@ HHHH *R-3N;N#6M)2*9%M9Y625-F6<
M^6S#GL!@5KTQX4D=&=%9D.Y"1DJ<8R/3@F@!PZ4M%% !1110 4444 %<K?:E
MJ,5[J5N]XL:>;:QQR1H!Y"2,03DYR>.IXR>E=54$ME;3K,LUO#(LRA90Z AP
M.@/J* *>@W$T^G'SYC.T4TD0F( ,@5R QQQG [5IU'!;Q6L"0V\:11(-J(BA
M54>@ Z5)0 4444 %%%% $<PD,3^24$F/E+C(!]Q7%?VUJ4NE6LKZD89H[)[I
MF5$ N'5]NT@@\8[#!Y'-=S5232[&58!)9VSBW;="&B4^6?5>.#]* ,/2-1NY
M]9C,MXTJ7)N ]L0N+?RW"KC W=.N2<Y[5TPJ"*PM8+J6YBMH([B;'F2K& [X
MZ9/4U/0 M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5!=WMO86S
MW%W,D,*=7<X'M4]8VOQ2B33KQ()+F*SN?-EBC7<Q!1E# =RI8' Y]* +VGZI
M9ZK 9K&=9D4[6QD%3Z$'D'ZU:S7(ZG,=43[1_9-ZFG&X0716)DFN8PC=4 #E
M58KQU//&.N:NBW%Z9?M%O?BVCLKEK-'>163]X#$#SG< . >0,4 >@49KB$@N
MFU RW=KJ<FJ,L1LITW")%\I<ASG:!OW;@>3D8!XK+L]+U-M+NT;[?YDD42W*
M+;21%I?-3<V]I&+-C=\R #'?I0!Z/+<Q0O$DKJK3-LC!/+-@G _ $_A4F:X6
MYT00:I$HL;A[.TU0/  '<1JUOR1WV^9C/8'/O6??:-=1Z)I]O':7HE>Q:5G"
M2S,;G Z@, C<?>;CL* /0C?VPG:'S095=491DE689 ..F15C->>P:;?)J;7$
M-K<QWMS):RO,4;:W[A@=QZ</U'TIG]G7,UB8[*TU6 M%"M_YAD#23>='DJ2>
M2 ')9>,'K0!Z+FHKN[AL;62YNI%BAB7<[MT K&TBQGL(=8M;1)(HUF/V,2$E
M1F-3\I/;=G\<URD^CO>Z5+!%INH\VR?;DN!)^]N!(F&&3\Q WDLO&"/P /1H
M)TN((YHB2DBAE)!&0?8\T^N;\36H)TU)K>YGTF,N+B&V#LV=N(R0OS$ YZ=\
M&L>>TN6N<_8]5^WGR/[.ED+,(8P%W"1@=H.=V[=R01UH [RBN$A\/M-=VS7%
MO>%;B2]%UNDD 9=Y,0// [K5"RBN9[N5'AU)]71+(0RY?9"WEKOW\X4XSNW=
M1QS0!Z5FBN#%C>2W$B0VU^NJL;D7<[EQ%)&5<1@,3M/)3:!R,'..:;)'>:M)
M;K]DU*.$0V,,N]'B)*S'S/?@=3Z=\4 =]G%16US%>6T=Q;N)(9%#(XZ$>M<4
MVG/;.+>ZM-1ETF&ZG6**'S&*D[#$>#G:/GP>@)[54T^QOK.[T63['>2SI;VZ
M>5-%(!& ,.5D5MJD=65QR1Q0!Z#)<1Q/&DCA6E;:@/5CC/\ (5%J&I6FDV4E
MY?SK!;QXWR/T&3@?J:R]1:2/Q'$S'$8T^<Q'TDW+G\<8_6L*X%_JNEQPW$5W
M/%+;6)97B;#.)?WIZ=<8S0!U]SJME9W-O;W%PB37(8PH>KA1N;'T'-68Y$FC
M62-@R. RL#P0>]<39Z??OK6DS7-M/_H%RUFKLO6)(I/WGT8E1GVKH?"P8:#%
MG[GF2F+_ *Y^8VS_ ,=Q0!L4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4E%% !1110 48HHH **** "BBB@ HQ110
M 4444 %116D$-Q-/'&JRSD&5@.7P,#/T%%% $N****0!1113 BGM8;D 3QK(
M%SC<.F00?T)%2(BQHJ( %48 '8444 #HLD;(PRK#!'J*(XTBC5(U"HH"JH'
? [444 .HHHH **** "BBB@ HHHH **** "BBB@#_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>55
<FILENAME>img_008.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 img_008.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  H'!PD'!@H)" D+"PH,#QD0#PX.
M#QX6%Q(9)" F)2,@(R(H+3DP*"HV*R(C,D0R-CL]0$! )C!&2T4^2CD_0#W_
MVP!# 0L+"P\-#QT0$!T]*2,I/3T]/3T]/3T]/3T]/3T]/3T]/3T]/3T]/3T]
M/3T]/3T]/3T]/3T]/3T]/3T]/3T]/3W_P  1" #Z 1P# 2(  A$! Q$!_\0
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M_H*U<H **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M]1D9Y]Z (9='LY[LW4D1\XC!8.PYQC. <;L<;NOO43^'M-DDF=K<[YCEF$C
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M** "BBB@ HHHH **** "BBB@ K,\1?\ (%F_WH__ $-:TZS/$7_(%F_WH_\
MT-: .?HHHH U?#7^MOO]Y/\ T&MZL'PU_K;[_>3_ -!K>H 2BEHH 3%&*6B@
M!,44M% %.P_UEY_U\'_T%:N53L/]9>?]?!_]!6KE !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 45DS^(((+F:#[/<NT3;69%7&<
M ]S[BL]]<E:]W*;Y;<@DKY<60<C Z],9H Z:LSQ%_P @6;_>C_\ 0UJ.+Q%!
M)/%$;>Y0R.$#,JX!/3.#4GB'_D"3?[T?_H:T <_1110!J^&O];??[R?^@UO5
M@^&O];??[R?^@UO4 %%%)0 QYXDE2)I%623)1">6QUP/:HXK^UGN9;>&XB>>
M''F1JP+)]165<:+=GQ'%JD5X'6-6 @D0#&5P%#8R!GDUGZAX9U*[21(YX8D5
MG*%'(:97D#LK_*0.F.^: .LS3(9XKA"T,B2*&*DJ<C(."/P-<_#X7NE\F0ZQ
M>QRI:&WPKAE!/?E1G_\ 55_0M*FTK39+2:X$A,LCJZ($VJQ)''3- %FP_P!9
M>?\ 7P?_ $%:N50TM#']K5I'D(N#\SXR?E7T J_0 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 <A=?\ (4O_ /KO_P"R+4=277_(
M4O\ _KO_ .R+4= "Q?\ '[9_]?"?SK?\1?\ (%F_WH__ $-:P(O^/VS_ .OA
M/YUO^(O^0+-_O1_^AK0!S]%%% &KX:_UM]_O)_Z#6]6#X:_UM]_O)_Z#6]0
M4444 )12T4 %%%% %.P_UEY_U\'_ -!6KE4[#_67G_7P?_05JY0 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 <A=?\A2_P#^N_\
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M%$8'E@L6P/;YJT#?6ZW+VYD_?(JLR $D!C@'\P:E,BB58SG<P)'!QQ[_ (T
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MH8QG+*<YV[MO [\CBNMEB2:-HY45T<896&01Z$4D4:0QB.)%1$&%51@ >@%
M'(^3KT$L*3B\E;=;R221/\N &60=>OW20.O45'9'6[=;<R0ZE-&T5NUTKM\^
M?G#[.>#GRR0.HS7:&B@#F[*VO;?PM96WD7,<PFVR*&PRJ7;DX.2.G0YYK/":
MY/'9QWEI=O+&UM(DFX;1M^_O&>N[GOQC'>NUI* .+ACU;[1'<R6FH1W!2UCG
M;<#EEF/FXP?N;23Z8IT-MK5I:K!9Q7:3+'=9WOE&;S05.23R5W8-=E2T <;J
M$&KF23[.=3%LZ3M"J.0Z'RTV!CG.=X;&?Y5IWJ7UQ<Z+M^UHC*YN=C%5!V97
M?C_:K?HH XU;?5)8[*6ZBOY)TO8FFC<+L0JK;G0@_=)(YZ=..M$%KJLMQ;/=
M0WS11W4,N&DY4&)E?OSAL$]O05V5)WH Y?3+35'2P>X-YB:)H;I992&BVN65
M\9ZD#;D>HJYH$=^99WU)KM9<;'23;Y1()^9"#GD?3MQFMVB@#B[*RUJ#38K:
M-+J&1(%$#&3(682-O+\G*E=N,\8ST-;NIVEVVI6TULTIAD5K>=%E*A >1(!G
MJ,$>OS5KT4 <E%;ZE<:B(9O[26#S;K#>8RKC*F+)!SC[V*BMTUYK:1MEY'*L
M-OM68[EDD56$@.&RN3M.1['!&:[*B@#GM>.HXLS:1W88P3B58&SM;R_ER>YW
M8P:RC:ZC+)"MQ#J,L:7MK,"Y)*_N_P!X<YS@-V_*NVHH Y*+^V4A\ZXCU"1A
M*J7<"E1E?FRT1!R>2N>1P.F:#::A:ZC*\,>H$27-H1(7W;HPNU]W/L<\5UM%
M '(/'K?V>%V^VK)^Z6Y5&R3()5W,G^SLW9QQC'&:W- %PNG.EV)]R3RJAG.7
-*;SL.>_RXK3HH __V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>56
<FILENAME>img_009.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 img_009.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" %] 9 # 2(  A$! Q$!_\0
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M^*_^?/3?^_1_QKR.B@#US_AH?Q7_ ,^>F_\ ?H_XT?\ #0_BO_GSTW_OT?\
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M\X_M)?\ (=T7_KV?_P!"KP^O</VDO^0[HO\ U[/_ .A5X?0 444#K0!O^$=
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M?"@U$[Y@WEG[J+U;WK3O_AW82VY"PO;R <.IR0:]#TBRB@M,H!O(Y:KHM$W
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M4I5+:C43D?%?B%+UVM+63S(P?GD'0^PKDZ**YF[N[*"OIC]G#_D3]4_Z_?\
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MN]!G5> ]4^Q:Y]DD;$-ZOEG/9NJG\^/QKT[PUK&H:7XB33%NG-C+EA _S+^
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MZQXUL++3I+#0%RTPQ)/@C'Y\DUYX<FLYR3T0TA****S&%?3'[.'_ ")^J?\
M7[_[(*^9Z^F/V</^1/U3_K]_]D% 'L]%%% !0:** /G#]I+_ )#NB>OV9_\
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M):?9-6U::XMMP?RN%4D=. *^J_\ A5_@?_H7;+\C_C1_PJ[P1_T+ME_WR?\
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M7/?\(H/^@UJ__@3_ /6H_P"$4'_0:U?_ ,"?_K4 =#17/?\ "*#_ *#6K_\
M@3_]:C_A%!_T&M7_ / G_P"M0!T-%<VWAJ%&57U[5 SG"@W6"?IQ3O\ A%5_
MZ#6K?^!/_P!:@#HJ*YW_ (15?^@WJW_@3_\ 6H_X15?^@WJW_@3_ /6H Z*B
MN=_X15?^@UJW_@3_ /6H_P"$5'_0:U;_ ,"?_K4 =%17._\ "*K_ -!O5O\
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M'_"*#_H-:O\ ^!/_ -:@#H:*Y[_A%!_T&M7_ / G_P"M1_PB@_Z#6K_^!/\
M]:@#H31G-<^GA<1R(_\ ;&K-M8-@W&0<=CQ6^O2@!:*** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "D/2EHH \BU.+PY?>(/%T_C&[:
M&:RDC6SS,4>"'8"K0@=6+9Z9YJ;4/&NKV=_>26MY%]ETN>UMETZ:/,]ZLH7Y
MR>H/S9&!V.:]'O-#TK4;N"ZO=.M;BX@.8I)8@S)]":=-H^FW&I1:E-8V\E["
M,1W#1@NOT- 'F]OXU\1)J-K=S3V]Q937UY9"SCAPQ$2LRG=G[W&,5%_PF^MV
MG@^?56UG3[^ZN(H)4MX80&LO-?:=W."!TYQR*],31=-B:)DL;=3#*TT9"#Y9
M&^\P]SGK3(/#VCVT5U%!I=G''=DFX585 ES_ 'O6@#S6'Q;XKO)[#2%OK2WN
M)1>!KSRED+B$!E.U3@-S@C-95SXTU\78\0QZC"A_X1Q;M;)ES&9#)M)'/KS^
ME>P6^@:3:+;K;Z;:Q"W5DA"1@; WW@/KWIDGAO198H8I-*M&2&,PQJ8AA$/5
M1[>U(#S;Q'XTU[PZUM$-7AO+NU2&:]B%JL:,LKX ))SC!XVY/'-4],U6_C\4
M[KVZ342-?N5BB<'?"%@) 7GOP *]7O- TC4)DFO--M9Y$3RU>2($A?3/I3ET
M+2EOC?+I]L+HN)#,(QNW ;0<^N.*8'E#_$3Q!::,-1^WV5X]]827B11Q8%@R
M, %;G)!SCGG(KL_".M:M=>(==T?5;F&[:R2WFBEBCV'$J%BN/;'!KH!X;T51
M=A=*LP+S_CY A \W_>]:MPV%I;W,MS#;Q1SS!5DD5<,X484$^U 'E0\:Z_?!
M9DU&VB&I2W5HFGK$#-9>6K8D)SDGY<G/'S"H39FU_9VC5[D[[J..1YX\ALO(
M.<YY->J+H>E)?SWRZ=:B[N%V2S"(;W7I@FI#I5@VFKIS6<!LE 58"@V #D#%
M 'A7B'4;U[;Q%87TTO\ :&FZ(EM.V2HE_>@I(/\ >4C-=9X>\(:Q:Z=KDJJW
MARTN[6-8K:VN?M#*5!+R GA2PXXKT:YT32[QYGN=/MI7FC$4C/&"70'(4^H!
MJX8T,90J"A&TKCC'I0!\_P!W//-X-\'03&&6Q&FW-PRW5VT*R2(>/F')<#.!
MZFO0-:U(ZGH/@N%%N(K75;RW\U93\^P+O"L?<J/K78R^'M'GT^&PFTRTDLX"
M&BA>(%4([@=JCUO1(=9MK>%W:%[:XCN(9$'*,AR/P(R/QH \_C\>7]]'IMI)
M<6IDO+K4;>YC0898XE;9@=CP.:X'3I;G[!X=TG[5,5T>\@O&)8_.L[H4!/?J
MU>W:%X)T?1D=C:PW-R\\LOVB2(;QYA)(SZ8)%:@T'25Z:;:CB,?ZL=$Y3\NU
M(#G_  =/(GB3Q;IF7-M;7ZR1;CD+YB!F ]LY/XUV59.BZ)%H[W\JRO-/?7+7
M$TC\$D\ #V  %:U, HHHH **** "BBB@ HHHH **** "BC.:0G% "T444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M!X=J_C;XAWWQ*UCPUX9-E(MH2R+*BC" #N>O6EO?$'QGT"U?4K_2["ZM(1NE
MCC56.WN?E.:@T'4K'2_VB?$T^H7D%K$8F4/,X4$_+QDUZ-X@^(OA+3-#NKB7
M6;.X'ELJPPR!WD)'W0!0!=\#^+[3QKX:@U:U3RF8E)H2<F-QU'T[BNDKRKX$
M^'[[1O"5U=WT+VYU"X,L4+KAE0# )'O7JM !1110 444&@#'\0^(K;PY8I<3
M0SW$LKB."VMDWRS/Z*/ID_A3_#^OVOB+3OM=O'-"RN8YK>=-DD+CJK#L:YCQ
M]</*D<4.GZL+VTE22RN[$(6\Q@P.T,?F &<CWJY\/$"Z+<M)!J$=X]RS74FH
M;1-+)@?,0O &, #T% '8454.IV2ZFNFFZB^VM&91!N^;8#C./3FH9-?TJ'68
MM'DOX%U&5=R6Y;YB* -&BDS2T %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 ?/$'A32?%_Q^\2:?K$+RVZHTBJCE3N&T=1]:[6_P#@'X,GLY([6*[M9R/D
MF68MM/;@]:X2Z\2S>"_CAXBU=]&O;Z*3,2B%#U(4YSCVKHYOCK?74+0Z7X,U
M-KU@1$) 2N?4@#)H N_!CQ%J\]SK7A36KEKF?2)-L4S'+%02I!/<# Q]:]=K
MRWX.>#=4T*TU'7=>0QZKJTF]HV^\BY)Y]"2>GTKU*@ HHHH *#S110!YG\6;
M"P,6E7TEE=WE_'*RP10WC0*0%+-N(]@<8YK1^%CP'0+R.*SBM72[82+'=&Y+
M,5!W&0]2016GXT361;:?<:+I\>HR070::TD95$B;2#\S=",]JD\%03VVB&&;
MP[#H6V5MMK%*'!!YW9'J: ,N\THZ=\2UUVVTV5XVTN8W$L2[FD<,NU/K@<"L
M*ZTC5+OQ?+LTFX5;[4K348[UE 6&*.,!D8]0V1C'O7JM(10!Q6GWGB&R^(*Z
M/JFJ6]]9W-I+<Q*EL(VBVN !G)SP:[8=*XV[_P"2NZ;_ -@B;_T8M=D.E !1
M110 4444 %%%% !1110 4444 %%%% !1110 444FX4 +0>E0W5S#:6DMU<2+
M'#$A=W;HJ@9)KF?"'Q"T'QO)=QZ1-*9+4_/'*FTE3T8>HH J^-?B)'X,O+2"
M;0]1O4NL".:W4;2Y. G^][5UMM<^?8Q7,D36^^,2,DO!CR,X/TKQCX]>)M2T
MB]\/6EK: PQW"WJRLI(>5#P@_/\ 6O63.^H>%C<W-@^^XLR\EF3\Q)3)3^E
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M:P./WBUV@Z4 %%%% !1110 4444 %%%% !1110 4444 %%%-=PJDD@ #)).
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M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4AZ4M!H
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M.M>H#I0 B(J(J(H55&  , "EHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** .$^)TLPT[3+:)M1=+B[V2VN
MG<37"[2<!N@ QD^N*O?#^ P:#(AM-:M1Y[8CU>0-+T'3'1:I_$N)KO3]+L8;
M9[B\N+T+;QI=FV.0I).\>@S67\.=9NK34[CPY?:?-!)OE99)+\W1WIMW*2>@
MPRD4 =I-X4T.XU2?4I=/B-Y/$8I)1D$J1@_0XXSUH_X171/[2M=1_L^(W=J@
M2*4Y)  P,^I Z$\ULT=J ..N_P#DKNF#_J$3?^C%KL1TKCKO_DKNF?\ 8(F_
M]&+78CI0 4444 %%%% !1110 4444 %%%% &?K6LV.@:5-J>I3>3:0@%WVEL
M9.!P/<UP5YXGTKXDZKIN@:%=?:M/27[7JD@0J!&ARB<C^)L?@*W_ (FR21?#
MK66BO8[-_)P)I!D#)''U/3/O7GO[.%JB:)J]UY\3RR2HIC .]  <9/H<\4 >
MV[ =O XZ<=*7;3J* &[:=110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %!HHH X#XDR2_V-<_;K#2Y=-1X
MFBENKEHF#\Y*E>0PXQCKDU)\-K"Q?1(M1BL-.A<;XH9+.=I@R$Y)9FYW$]<\
M\"M3QCHFHZQ!I\NCM9+?V-R)XS>J6CQM(.0.^#6?X-T+Q3HNI7AU6;1VL[J1
MKAULXW5O-.!QG@# H ZL:I8'4SIHO(#>A-YM_,'F!?7;UJ2>\M[>:&&:>..2
M=MD2.P!D.,D =^*\M-G=6?C=Y)=-NC<V^KRZC+>I 6#6GDX"ANYSQMI=:M?$
ME[\2=!UC^RO/TY;I19R>85,$31G>73'!)[GT H Z>[_Y*[IG_8(F_P#1BUV0
MZ5YU8QZW'\7+;^VKBRFSILWV?[+&R[4\Q?O9/)KT4=* "BBB@ HHHH ****
M"BBB@ KB/%7Q'A\*Z];Z3+H6JWDMRH,+VT099#W5>>2.]=O7@OQF;Q/!\0_#
M]S8W!AM(U+VCJP 1QS(6_P" X_"@#T/QM*VNOIOA&!2#JI\V\)',-JA!;/H6
M.%'U-==9V%G81[+.UA@7 &(T"YQTSBN8\$V5Q=F[\5:C&R7VJA?+C;K#;K]Q
M?;/+'ZUV% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !2'I2T4 >9_$;2[BTU.SUZQU_4[&9W
M6%K*RC$KW+*&V^6A[X)SGC%=#X NY+S0'DGU6]U"<3,LGVZ 0S0,,?NV4=,=
M?QJ]XGT%=<M(#'?R:?>6DGG6UY& 3$V,'(/!!!((I?#&B1:'82Q_;9+^YGE,
MUS=R$;I9#WP.!P  /:@#;Q[T8]S2T=J ..N_^2NZ9_V")O\ T8M=B.E<==_\
ME=TS_L$3?^C%KL1TH **** "BBB@ HHI#TH 6L[7KVZT[0KR\LHH9;B&(NB3
MR;$./5NPKC/$_C;Q/HOC6PT*R\.V]U!J#8M9WN-I?: 7R.V!71>.+5+[P1JU
MM-;W4ZRVY4Q6@S*Q_P!D=^: ,3X9^.=3\<Z?>7UY8V=M#$P2/R)][%N<[AU'
M;'KFL#Q;X.L/B%\1X[<75[Y&FQ Z@Z2_NT8CY(T']\]6]L5R'PN.I>%K6_T.
MTTN^A\5:H4\I;N/;##",_O6[X&3UZG %>Z>'- MO#FD1V%NS2MDR3SR'+S2-
MRSL>Y)H U(D$4:QKG"J%&?:GT44 %%%% !1110 4444 %%%% !1110 4444
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MP _A4= HZ5T &*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MT8 (&[_= (]J .Q'3GK2U2_M;3_[3_LW[;!]NV>9]G\P;]OKCKBKM !1110
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*:/M!_N_K18#_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>57
<FILENAME>img_010.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 img_010.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" $L ID# 2(  A$! Q$!_\0
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M_H/Z7_X%I_C1_P )=X;_ .@_I?\ X%I_C0!LT5C?\)=X;_Z#^E_^!:?XT?\
M"6^&_P#H/Z7_ .!:?XT ;-%8W_"7>&_^@_I?_@6G^-'_  EWAO\ Z#^E_P#@
M6G^- &S16-_PEWAO_H/Z7_X%I_C1_P )=X;_ .@_I?\ X%I_C0!LT5C?\)=X
M;_Z#^E_^!:?XT?\ "7>&_P#H/Z7_ .!:?XT ;-%8W_"7>&_^@_I?_@6G^-'_
M  EWAO\ Z#^E_P#@6G^- &S16-_PEWAO_H/Z7_X%I_C1_P )=X;_ .@_I?\
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MKAF7?N..:&M"%08^9QQ2>.J]D+ZE3[L](7QOH;' N)/^_1J8>+=') $[\_\
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M=RZ!@%B0LS=L#_$U3MXS''YH R.@-:^GA[:W.2NR<<COP>]92?<F;TT)XAP
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M&BK8TALZK H[AA_XZ:WH?&CGKKW6>50Q_**N* /I31$(\#<&X[5-"JO*JL<
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MAJ4.HH]C/'!.T448$J[U4,LKL<=S^[450'B#Q'+,+=+NQ1EECB>3R"<F7!7
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M9E_]!%5+50TT9SSO7'YT_P 52;/%M_\ [R_^@BMJ:O!F#_BKT9%$JD]/RJP
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M;3[^TU_Q&MWK^HZC':W(MHH[I@54&-)-W ZY<CZ"O$]0O;N2]N%>\N659V8
MS-@$,<'KVKWWPM_R'_%O_837_P!)XJ^>[W_D(7/_ %U?^9KSLP;2C8^QX0IP
MG4K*23T6_JSTKX.W5S<:[J0GN9I0+8$"20MCYO>O8J\7^"__ "'M3_Z]5_\
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MTBN&00!3(N=H\O.!70WG_'E<?]<V_E65I'_(P:U];?\ ]%T 2?\ "*:!_P!
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M9?4 ?RZUL0S1SPI+$P9'&5([BE:Q+31E?\(IH'_0(M?^_8H_X1/0/^@1:_\
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M_P"C7KL: "BBO"=4UK5KNYO';6KU+K1[B6X:%,J%N)+H1P0'^\OEJ2!WWYH
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MN^;=Q@+CMQG\:K7US=+>VZ1KNY*LQ^4*,$;B?3/\ZV=/L#!;"*U@1+:$K%%
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M<_\ HPT >)?'+_DHS?\ 7G%_[-7 :;_R$8?][^E=_P#'+_DHS?\ 7G%_[-7
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MV@NT!LE"V_$?S;53 Y]>!7+];IJ?)UV/;7#^,>'^LI+EMS;]+7/::***Z3Q
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MUM1TF$2 9#>6,X^M%TP<$NALY5P&!!5AE64Y!_&AAQD"N;6Q'AYWO=#9KBR
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M7/\ Z,-;>EZW9:PUPMJTFZ!@&$D93(.<,N>JG!P>^*Q/AY_R+US_ -A"Y_\
M1AH \2^.7_)1F_Z\XO\ V:N TW_D(P_[W]*[_P".7_)1F_Z\XO\ V:N TW_D
M(P_[W]*_3*7_ "3[_P"O<ORD3@O]_I?XX_FCI:]W^$7_ ")/_;U)_2O"*]W^
M$7_(D_\ ;U)_2OQK ?Q?D?I?%O\ N"_Q+]3O*\9_:$_Y!.A_]=Y?_017LU>,
M_M"?\@G0_P#KO+_Z"*^QR#_D94?7]&?F57X&>!UUJ?ZM?]T5R5=:G^K7_=%>
MAXA_!A_67Y(^OX%_B5_2/YL]-^"__(>U+_KU7_T(5[17B_P7_P"0]J?_ %ZK
M_P"A5[17QF"_@HX^)O\ D93]%^05@3_\E L?^P9<?^C8JS_B?>W6G?#S5;JR
MN)+>XC5-DL;;67YU'!KYH/C+Q*;E;DZ[?F=4,:R><<A202,^F0/RKZ;+,BK9
MC2=2G)))VUOZGS<ZJ@[,]!^)O_(^ZA](_P#T 55\ ?\ (^:1_P!=C_Z":YB&
M_N]3B%W?7,MQ</\ >EE;<QQP,FNG\ ?\CYI'_78_^@FOC<31=#'3I2=W&5ON
M9^LTG?)$_P#IW_[:SZ/HHHKUS\K"BJ&J:O;:0EJ]SYF+FYCM8]B[OG<X&?;W
MJZQ*J2 3@=!WIM-*X#J#T-<IX7U"\N-2OQ<6=Y&L[^>?/8$6YPH\K@\'^+Z&
MNK/0U,7=7-*E-TY<K..^%?\ R3?2O^VW_HUZ[&N.^%?_ "3?2O\ MM_Z->NQ
MIF85XUJ7AK5H?$;Z6;_2(]$OG:T2XDN,3!6N//>$)WDR2OT(KV6O$)_!^KW;
MWZ7.B2^;'=/#;3%MP>:>Y$CW0] D:(,]>U 'J5B)S)>F(IM%^_F!QU7:O3WZ
M5B:]J&MCQ!:06.GN+(IY<ERD88@L>.>H -8NJZU/H7BF:X6>:2&6^96MT/RX
M"IE<=R=V:W)O$>LV>LW,4MG&FEQL&^U.I&(R,@#^\Q)QCUJ')/0[:=&4$IV3
M377^MRC96$LQFUOQ<(;;83'!(3@]> PZ$ C(J&TU:.PTF\GMS=ZK:M.L:R7;
M@"60DD[!U&*TM:TNR\3E;B[U.YLU@41RVJL"$9N<$>M0S'0].@M(8[?[3I>G
M*983 Q=C.,L=X[<<C/O4I-;&W/"2]Y-MO;HO^')[^&*[?38+F>.VU* &Y*,Q
M8Q+[GI^=.OQ;WMZEL+N,:EMWY4[ R]=V1TZ=:P;5[JXMH]6LH1%!JLS37ES=
MRAE6)3C9@]CSP*6Q6SN='O3;W]L$6(Q6XD)\R NWW">Z''![4U-] ="*W_I_
MUT["3^!=/U>[E,MY<VLS+OEW!3WYR?ZT_P#X57IR3;QKLJP%0$Q@,/7GTQ1$
MBLUE!=R WWV4R7,T#[RJ D?/V( X]:;%'!J-H8-/2:6*" A[4-^\4XW;U;HQ
M.1^ JE7D1*C;[7X:?T^A%+\*O"**9)-6N-D9R_[P=_7TY%5;?P;X0ANH[<+?
M.[2!':2?R@@(R-WX"K=[#;RPI$TA^U-*J0+*-JS2;>=^.X+?=]JN:L)[?4A]
MKN+2#SXE:^C;YMP5>0IQP"W'MBDZLAJCT;+6K-;Z9?V&B6%M+'N7>9(7 /E@
M_-@GN.,^U86MWUQ9Z<^N6E@8-0=FBCCE4L8?[Y4]&)RI'IS5RSANKG18XKW[
M+-!?2S)-=B7:;=6 PJ9Y/(!_"IK%KW3+G^S[ZU9M$MX5-M=3$%C*HSO4=]Q/
M3Z5+;DS2*C3\[;^?]=ALVM:MI#03W.,7$86.U/56";LMW&<$8]:UC<1W=_YI
M3RKDZ7<&6+.2F0A&?>N4<'2(;EM5U('S-TRS&)OM'GD]0I'&!C SCK5OPU]G
M6[DCB:XE==+N3Y\Y'[Q6*MQCMDFKCS+<PK1@X-K==CMM)S_8FG;N9/LL9W <
M ;!4?VZ"::2"1XMS,!$0.<FK6D&(:%IR/O(^RQ#V^X*B9;2QD:6VM81,HQND
M.#SR?Y53.:(LMB]W;21*7C\]2/,C&"A]LTQ=*NE,VV1IHY&&%? VCT'M[5FZ
M7XANKZ2^CF6XBEBVLFZ/"R*Q."GJ,"K>HM']G*7>IS",L&\R%MI4 \8Q2L5:
M2=BTFAQ1VOEI*K7 ')& ,9]*S-2!@@='!5HPY2,+U'49/YU3TJ;[9X@^RQ13
M11PVXDBN)#GS@QP3GOR.GO73*LTZ2VDIB='0A3CD#T/U%*Q7,XO5G,VCS.#<
M1-Y;H WJ5]C4DEA=6LXU'1KI+&2X.9D WV\S>I7^$_2K#VOV#647[/(82-C\
M?*0>_O@UJ/HTT,@,#+(BY(1NQI)-%SE&YSUY;:UKL)@US5;:TT[_ ):16!(:
M8>A;K@^@JU#!!9F"TL+1(K95^6W08/LQ]35F?1]2N)7,02W;<"KX&,=QBMS3
MM-6R1F=O-G<Y:0_R'M5:D.48K0-*L!86Q4DF1R68G^57Z**9SMW=V%<G'_R.
M+?\ 81;_ -)!765R<?\ R.+?]A%O_204".LHHHH Y3Q-;W-W<QPO"CV99%<H
MY$@3=ECQ[A:P['4-+N+RYGM;&YM0LCF.2/.2R@AB0>.F/K76ZOOA=KAU_<*H
M^8'&TY[^W>N&NK_3%$FEPV<T=NDJHTLDVQY'SN^4=Q@#Z\"LIZ.YZ6&]^'+;
M[C<35)+54>%(+]5!Q*#AE3Z#K@_SI9_$EHF6@@S?-AY'DR57^'(]<^WK6*;R
MQNKB$17=U:R0,(@WV<*LSD[CD#N. :M64&G7-YYB!TE$ZND3$;,$G;SVYZKV
MQ2YI;(T=&FM9IDTLT#&'SGNK2\N8PQ9,D(#@X(JE*S^3%"@*^<JJ6ECV9<,<
MX!Z8 !]*2\"0IO74)+BXF&Y7VXYR<Y/MS2232I;X,[R+Y(B0R#C+ %R<_E4M
MFD8I)6"6Z=I)9DE9V\L'<" QS]W@CD\$_2H'O(P4A:<$GYF,<8$1]FSRW7%5
MYI$^T/QE3A0C'< N.<>F *CWQM&+6.-UCF&Y<C?M8G+'GJ,#D>U2V[G1&G&V
MIM0ZQ)9.%%Q-*0 'ED0&%U_V>^T=!5V*2#4(Q) 4CD(X6-_D<9SWZ&N2>6X2
MVV+<0)''('^63(D&#GC'MG%)_:#M;/-YH^TH5^4Y0.,=,#@=,5K3JM.S,:N$
M37-$Z6[%Q&S"6,(I^\0N0#V'-5/$=N]QXJU%(KR.&1DA0(SX+DQ\8']:Q[35
M)F$7_'P\LAQ@9( [@@]O?M6MK&NW&G?$34;*VTZ*8R06\C7!&YH_E(  ^M;2
M=SDC"<*JMO9DZZ7%X;TJWDDGL8M5D8QS3.H9D4]%'OT]ZBN/"5O/;_;=4U9[
MH.X\L6P)(_.M^?1;Z>%;J*&UM)YHS)/-/\S0.1R5'3(%><R:UX-TF^\F3Q/=
M75S(!&#:@K'GMEO3/>I;Z&M*J]91E9^2_JQOV6H:7ILJM9^%[R_?<1YTJ $?
M0=ZU;F;4-=0"XTF6UA7[K&Y,/?A>/0=:U?!^JQ7+SV;2*]PH\P 2^:0ONPX'
MTKA]:L?$4VI:Q!=7URMGO+07,YQ&JYP5_(_C2>AI!*K4:EHUU;;^Y';06/\
M8-BLFCPQ27?E_OD>7<Q7J#GOUK1TIM8N3!/?W"1I(-PBB3@CW/:N>\+7-YIV
MCM/J%C(ULD0$4K#+R>@ '.#[U?O?$FJ172QPZ<%M9(MRRX)VL/O*W88XYJSD
MJ0FYNGHWW*VMVITJ\6\FCFO)I0VQ0V(UYSSWS@U4O/$E]:V8BTVSCMIYBQ Q
MEL #!/IWKI87@U;38S=/#-*3\R*^!O'93VJ2&PMUD8BSCBF"%E\QLCI_C3]1
MQKPC958W:^XY73M-U*]9+Z_OKB!<#?*6(9S_ +(KH]3U?0X-/%VS07)'R(P
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M_P!6O^Z*]#Q#^##^LOR1]?P+_$K^D?S9Z;\%_P#D/:G_ ->J_P#H5>T5XO\
M!?\ Y#VI_P#7JO\ Z%7M%?&8+^"CCXF_Y&4_1?D<3\6_^28ZQ_NQ_P#HQ:^4
MZ^K/BW_R3'6/]V/_ -&+7RG7Z?P?_ND_\7Z(^5Q'Q(Z/2_\ D'Q_C_.NP\ ?
M\CYI'_78_P#H)KC]+_Y!\?X_SKL/ '_(^:1_UV/_ *":_+<U_P"1M6_QO\S]
M>H_\B-?]>O\ VT^CZ***[C\L*6HZI::7'$]W)L$LR0)@9RSG:OZGK5O.4RI!
MR..>#7&?$'P;/XKCL3:"%9K=F9I9)&4E>HCX[,0,GJ,<5UUK!%9V4-O&BQ10
MQJBH#D* ,8R?2M91@J<9)ZN]UV["UN<AX0U[5=4\0:M;WB6ZQ1/D[)2V",+B
M/U7*MD^O%=J>AJA87&DW$C'3IK.1T7#?9V4D DGG';.35\]#6$4TK-F]>I&I
M/FC&RTT^1Q_PK_Y)OI7_ &V_]&O78UQWPK_Y)OI7_;;_ -&O78U1B%%%% &!
M9[0-4,\D<< O)"S,0,<+W-8&HWO_  D[VRZ+!<7=I'OC>4MLB<\#YLC+#Z5I
M:K\.] UF_N+R\2[,EPP:14NG5"< ?=!QV%6K?P=96D*PV]]J<42C"HET0 *3
M3>AK"<8:K<GT/0(-*@RR*TS#!P/E0?W5'85J&TMF.3;Q$^I05D_\(O#_ -!3
M5O\ P,:C_A%X?^@IJW_@8U.Q$IRD^9LT?[,L?/,XM(?-(P6V#-5K[P_IFH6[
M07%JI1NH7*]\]JK_ /"+P_\ 04U;_P #&H_X1>+_ *"FK?\ @8U*R!3DG=,N
M_P!D6A>%WC\QH0 A?DC&<?S-7L5B?\(O%_T%-6_\#&H_X1>+_H*:M_X&-3$V
MWNS;**>J@\8Y% 4#. !GKQ6+_P (Q%_T%-6_\"VI/^$7A_Z"FK?^!C4"-'5+
M]-+TR>^D@GG2%=QC@0N[?0#J:X]OB7I[<GP[XCSZ_P!FM6__ ,(O%G/]J:M_
MX&-3O^$:C_Z"VK_^!C4 <C-\2+?[4I&@>(!!MP0=.;<6J[::S%KF;N*TO;51
M9W:;+R$QN2!'S@]N:WW\+0R8WZIJYP<C_3&X-26OAJSMIWF:>\N'>)H?](N"
MX"MC.,],X%5?0=RUHO\ R =._P"O6+_T$5>Q6#'X3MH8DBCU+55C10JJ+ML
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MT>LR2&$3D$.(_L(7;GL-PQ]:Z[X;VDEKH]X?(FMK>2YW10R6OV<+\BAMJ9)
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8C:O>0K%,T6U>65>G.[&><8KIJ** /__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>58
<FILENAME>img_011.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 img_011.jpg
M_]C_X  02D9)1@ ! 0$ X@#B  #_X1OT17AI9@  34T *@    @ $ #^  0
M   !      $   0    !   )M@$!  0    !   #80$"  ,    #    S@$#
M  ,    !  4   $&  ,    !  (   $1  0   -A    U $2  ,    !  $
M  $5  ,    !  ,   $6  0    !     0$7  0   -A   .6 $:  4    !
M   ;W $;  4    !   ;Y $<  ,    !  $   $H  ,    !  (   $]  ,
M   !  (         "  (  @    (    E@   20   &R   "0    LX   -<
M   #Z@  !'@   4&   %E   !B(   :P   '/@  !]8   AN   )!P  ":
M  HY   *T@  "VL   P(   ,I0  #4(   W?   .?P  #Q\   _\   0W0
M$;X  !*4   3A0  %'4  !5;   6?P  %Y0  !B4   9J   &L<  !OF   =
M"0  'B@  !\V   @2   (68  "*(   CL   )-   "8#   G-@  *%0  "E=
M   J;@  *W\  "PA   LPP  +64  "X&   NFP  +S   "_%   P4P  ,.$
M #%O   Q_0  -J8  #MC  ! >   1:X  $L0  !0?P  5?D  %NF  !@T0
M9@(  &LF  !P.0  =54  'L]  "!I0  B!4  (Z&  "5#0  FW   *'<  "G
M[0  K3P  ++3  "XG   OEH  ,0"  #)J   SV8  -4I  #:UP  X(4  .8P
M  #KVP  \8H  /<T  #\TP ! G8  0@D  $-T0 !$VX  1D5  $>Q@ !)&T
M 2H%  $OMP !-3X  3K*  % 6@ !1?T  4N<  %1,P !5M   5QO  %B%0 !
M9\X  6V/  %S8P !>3D  7\/  &$O@ !BG0  9 7  &5V  !FZ   :%3  &G
M+@ !K00  ;+(  &XC  !OE,  <0&  ')G@ !SSX  =3D  ':50 !W\\  >4[
M  'JJ@ !\!T  ?5<  'ZP0 " #@  @6W  (+1  "$.0  A;&  (<\@ "(QX
M BD2  (O$  "-0P  CL'  )!"0 "1LD  DQF  )1^@ "5T4  ER<  )B&  "
M9X@  FSQ  )R70 "=[@  GT^  *"U@ "B*P  HZ^  *4TP "FNX  J$L  *G
M=0 "K:\  K-]  *Y6P "OQ\  L3K  +*AP "T!   M69  +;$  "X$H  N6&
M  +K$  "\+T  O:$  +\3P # B@  P?V  ,-OP #$UL  QD!  ,>G  #)%4
M RG]  ,OI  #-64  SL[  - _@ #1K,  TQ.  -1V  #5V(  UTP  -BY@ #
M:*<  VY+  -SR@ #>4D  WZU  .$$  #B5L  XZK  .4'@ #F7D  Y[!  .D
M&  #J5$  ZZ2  .SN0 #N,H  [W'  /"R0 #QXH  \QD  /1E@ #UL<  ]O\
M  /A2P #YJL  ^O@  /Q(0 #]GP  _P3  0!B0 $!QL ! T+  03$  $&3@
M!!].  0E8@ $*VL !#%_  0W<@ $/6H !$->  1)/  $3NL !%21  1:0P $
M7]< !&5P  1K%  $<.( !';+  1\L0 $@H$ !(A7  2.,  $D_  !)G9  2?
MPP $I;  !*NN  2QD@ $MV\ !+UU  3#@  $R8L !,_)  36"@ $W$H !.(L
M  3H;@ $[I@ !/3#  3ZU  % 1  !0<L  4-'  %$S4 !1EK  4?J  %):\
M!2OD  4R   %.$  !3YW  5$N  %2W$ !5)T  59P0 %858 !6CK  5P;  %
M=^L !7]J  6&Z@ %CB$ !94&  6;8P %H8T !:>,  6MB@ %LW< !;0[  6U
M!  %M<T !;:6  6Y20 %O2T !<%0  7%B0 %R@@ !<Z=  730  %U^, !=R<
M  7A5  %YA, !>K?  7OC  %]&P !?E(  7^V  &!)4 !@I*  8/\  &%:P
M!AM4  8@^P &)M$ !BS"  8RP@ &.0( !C]C  9%U  &3'X !E,F  99X  &
M8.< !F@K  9OB0 &=S( !G\F  :'"  &CNP !I;6  :>:0 &I@8 !JVG  :U
M/0 &O)< !L/]  ;+6  &TM  !MIW  ;BT  &ZW@ !O1&  ;]0@ '!GX !P_0
M  <9/  '(L  !RQ.  <U]  '/Z  !TDZ  =2ZP '7)T !V:"  =P8  '>CP
M!X.-  >,X@ 'EI\ !Z"?  >JI0 'M)P ![[5  ?(^  'TN@ !]SB  ?G*@ '
M\98 !_OC  @&9P ($08 "!OJ  @G!@ (,B@ "#U?  A(K@ (4YX "%Z[  AI
M]0 (=1X "'_L  B*Y  (E>\ "*#<  BK]@ (MQX ",)Q  C-H@ (V-8 ".0H
M  COY  (^YP "0;[  D2)@ )'9< "2ET  DU   )0'D "4Q,  E8"P )8Y,
M"6[7  EZ7P )A=D "9%)  F<FP )J!T ";.T  F_*P )RIL "=94  GB+0 )
M[C8 "?H9  H&.  *$ET "AYM  HJ6P *-I0 "D+E  I/80 *6]T "F@N  IT
M@@ *@+D "HR2  J8>P *I#D "K -  J\!  *R%  "M2H  KA+0 *[@4 "OLX
M  L(I  +%>D "R+^  LOW  +//  "TH7  M7*P +9$4 "W&   M^P@ +C P
M"YF$  NG!0 +M.@ "\-G  O1N0 +X!4 "^ZF  O],@ ,"X0 #!GO  PHJ@ ,
M-TH #$7\  Q4-P ,8:\ #&^$  Q]:@ ,B\\ #)I5  RHC0 ,MO< #,6&  S3
MV0 ,X>\ #._V  S^)0 -#$@ #1H@  TH$  --A< #41"  U200 -8%0 #6[.
M  U]1  -BZX #9H9  VH_@ -M]L #<9@  W4?P -XLX #?%"  W_[P .#L8
M#AW/  XLY0 ..^D #DK.  Y9M@ .:/L #GAV  Z'9  .EAH #J3)  ZS#  .
MP/@ #L[2  [=&0 .ZTH #OEJ  \'G  /%ET #R5S  \TWP /1$, #U/I  ]C
M<0 /<K0 #X&I  ^0;@ /GMP #ZU*  ^[\  /RFH #]C;  _F_0 /]+$ $ *.
M ! 0;  0'E\ $"PJ ! Z3P 02)X $%;6 !!D\P 0<KL $("6 !"..@ 0FX(
M$*C> !"V60 0P[D $-$J !#>?0 0Z_( $/CL !$%30 1$4X $1UP !$I%@ 1
M-&L $3_6 !%+1P 15J, $6'; !%LY@ 1>!H $8-% !&.(  1F-T $:.9 !&N
M7P 1N/$ $<-U !'-[  1V#H $>&_ !'J^  1]"\ $?V8 !(&SP 2#\D $AC.
M !(AU@ 2*HL $C,# !([7P 20\8 $DQ* !)4M0 273H $F74 !)MUP 2==8
M$GV> !*%@  2C1$ $I2S !*<,P 2HY$ $JKQ !*R&  2N08 $L ? !+'#P 2
MS=, $M0@ !+:4@ 2WRP $N/= !+H<0 2[.@ $O$H !+U;P 2^6( $OT2 !,
M&0 3 NX $P6. !,(,  3"M@ $PUV !,/W@ 3$+@ $Q&< !,2=  3&.P $Q\^
M !,G9@ 3,,< $SH$ !-#+P 33'L $U7< !-?3@ 3:*X $W(V !-[H@ 3A38
M$X[Y !.9 @ 3HP( $ZTE !.W?  3P;( $\OY !/6:P 3X.  $^M+ !/UQ0 4
M '4 % M' !06!@ 4(/8 %"OL !0VF@ 402H %$OV !16N0 485H %&O\ !1V
M90 4@1@ %(O5 !26J0 4H70 %*P; !2VU  4P9P %,QE !37+@ 4X=P %.Q9
M !3VH0 5 /H %0LX !45D@ 5'^L %2I< !4U9@ 50%\ %4M( !56(  58/<
M%6P' !5VW  5@8\ %8P) !66FP 5H2L %:NI !6VB@ 5P1H %<M\ !75G0 5
MW]\ %>G5 !7SU0 5_;\ %@?K !82+  6')4 %B<? !8QKP 6/$X %D<@ !91
M\@ 67,T %F>0 !9R9  6?20 %H>] !:2-  6G-X %J=6 !:QN0 6O"< %L:T
M !;100 6V_@ %N;! !;Q'@ 6^V@ %P5) !<//0 7&18 %R,? !<M3P 7-Z\
M%T'5 !=,$  75C, %V!R !=K'P 7==8 %W^N !>)0@ 7DGX %YNO !>DS  7
MKAX %[>4 !? S@ 7R?( %]+G !?;RP 7Y)$ %^TZ !?V#P 7_N, & >P !@0
M.0 8&,T &"%2 !@ITP 8,G< &#LF !A#P  83%< &%4# !A=W@ 89J$ &&^Q
M !AXF0 8@4P &(G1 !B2$P 8FC$ &*): !BJ:  8LIP &+J  !C"8@ 8RD8
M&-(' !C9J0 8X78 &.EO !CQW@ 8^CH &0*# !D*[@ 9$RH &1MK !DCV  9
M+$< &32R !D\^0 914( &4V% !E5W  97F$ &6=( !EP%@ 9>+\ &8&! !F*
M,0 9DL0 &9MQ !FD*  9K-4 &;6\ !F^C0 9QY$ &="\ !G9T@ 9XV, &>R1
M !GU?0 9_F$ &@;= !H/<  :&"$ &B$/ !HJ#0 :,O, &CO= !I$^P :3BX
M&E=] !I@I  ::48 &G') !IZQ0 :@YX &HQN !J5>P :GFP &J=J !JP3@ :
MN1  &L'7 !K*C@ :TYT &MQQ !KD]@ :[)  &O,P !KYJ0 ; !< &P=" !L.
MM  ;%C4 &QVJ !LAYP ;)B< &RAE !LH\P ;*8$ &RH/ !LJG0 ;*RL &RNY
M !LL1P ;+-4 &RUC    C@   (X   ".    C@   (X   ".    C@   (X
M  ".    C@   (X   ".    C@   )@   "8    F0   )D   "9    F0
M )D   "=    G0   )T   "=    H    *    #=    X0   .$   #6
M\0   /    #F   !)    14   $    !%    1\   $?   !(P   1\   $.
M   !$@   1X   $B   !*    2    $S   !,P   1X   $)   !$0   1$
M  "B    H@   *(   "A    E0   )4   "5    C@   (X   ".    C@
M!*D   2]   %%0  !38   5B   %;P  !7H   6M   %*P  !3$   4D   %
M$P  !1P   7H   &:   !G    9Q   &AP  !F,   9L   &$0  !4\   67
M   %R0  !;X   6H   %I@  !;X   7#   %K@  !:X   6K   %JP  !:\
M  6J   %GP  !:,   6N   %K0  !9T   6G   %L0  !:<   68   %L@
M!8<   6,   %D   !:,   6?   %EP  !9T   6?   %I@  !;D   7!   %
MU   !=8   76   %KP  !;8   6C   %P0  !<@   6S   %VP  !=8   7$
M   %Q   !<<   6S   %F   !:    6F   %<0  !7H   5L   %;P  !7,
M  4_   %90  !7<   5_   %C0  !:    7B   &+   !BP   7T   %_@
M!?P   7[   & @  !<    6=   %E   !4L   57   %?   !7    5I   %
M;   !5L   6&   %F   !=8   82   &%0  !AL   8^   &20  !CH   7.
M   %W@  !<0   7,   %G   !8D   6)   %=P  !3H   4\   %B@  !:T
M  7'   %RP  !=D   7.   %R0  !9P   6F   %FP  !;D   6H   %IP
M!<$   76   %PP  !;4   6;   %B@  !8H   7.   %M@  !<$   6D   %
M?P  !7\   5L   %6P  !4L   50   %<P  !5L   5(   %5P  !3D   5!
M   %)P  !1$   3]   % @  !,$   3:   %,@  !3$   4U   %3P  !6
M  4U   %00  !5L   67   %=@  !9(   7P   &!0  !B@   86   &%
M!@D   84   %\P  !?@   7T   %W@  !:\   6F   %L@  !90   69   %
MI   !<X   7I   %Y@  !=    76   %V0  !<    7I   %Z@  !>T   7^
M   %Y   !=T   8&   &"P  !@L   8^   &00  !D    7B   &0@  !BH
M  8K   &$0  !CP   8<   %\   !AD   8V   &/0  !@<   8U   &'
M!D    8W   &00  !KD   <#   '30  !Y4   >5   '@0  !W\   =_   '
M@   !S<   ;E   &70  !BH   7_   %_@  !>T   #$    R0   ,D   #)
M   "LP   ^0   0C   $.0  !'\   25   $HP  !*,   2Y   $N   !+\
M  3,   $K0  !.    3<   %D   !;T   6U   %I@  !;P   6H   %IP
M!=8   7Q   &    !D    9A   &<0  !JH   :H   &N@  !P<   =$   '
M7@  !ZD   ?T   'X@  !^0   ?J   'DP  !YT   >A   'E@  !UH   =F
M   '6P  !W@   >G   (60  "*@   C.   (_   "3P   E2   );   "80
M  F.   )I@  ":P   F:   )L0  ";(   GE   )W@  "=P   E1   )50
M";T   H    *!@  "?<   HY   *(P  "?    GZ   *2   "FP   I-   *
MA   "I\   KD   +'   "R(   LW   +3P  "O    L=   +.@  "RD   K.
M   *^   "PL   KM   +&@  "R@   M3   +,0  "S0   M2   +O   "[@
M  M?   +*P  "W$   O=   +C   "WD   O3   +OP  "X@   M$   +B
M"WH   MP   +4@  "X(   N7   +=P  "W    NY   +V0  # D   OC   ,
M'P  #"4   P0   +[@  ##D   Q1   ,?   #'P   Q1   ,5   ##<   O9
M   +Z0  "[X   O4   +]P  #$P   Q8   ,A0  #-@   TS   -;   #44
M  T5   ,W@  #10   TG   -%   #1H   T[   -0@  #4H   UX   -@0
M#>,   Y_   .4@  #EP   Z1   .C   #E(   YK   .NP  #J    ZR   .
M.P  #7@   W5   -Y@  #F4   Z&   ..   #FH   Z/   .4P  #A8   X'
M   .+P  #B,   W8   -\   #@<   XK   -_P  #A,   YZ   .=@  #FH
M  YK   .Y0  #MT   Z%   .'P  #D\   YT   .K0  #M<   \)   /%@
M#P0   [E   .Z   #T4   ][   .[@  #K8   ZO   .0P  #>P   W:   .
M1P  #C$   X@   .,@  #L$   \6   /;   #V0   ^F   /B   #T,   [U
M   .Q0  #FX   YN   .I@  #GH   YQ   .(@  #;0   W=   -W@  #?,
M  W+   .)0  #D\   XX   .'0  #<@   W;   -I   #4@   U<   ->P
M#6    UQ   -4P  #74   SZ   ,80  # $   PB   +I@  "U4   MK   +
M<0  "UP   LX   +"P  "S0   LK   *VP  "KT   J\   *Q@  "I(   J$
M   *=P  "DX   F%   ).0  "3<   EI   )-P  "/H   D%   )"   "+4
M  AX   (7   "&<   B$   (:P  "(4   B:   ( P  !_\   ?(   'X@
M!Y$   >B   '@   !UX   =@   ')P  !NX   <9   &\   !L0   9-   &
M,@  !-H   2Q   $E   !'<   1    $1P   _,   .P   #!P   M4   *@
M   "H@   J@   *>   ":    -H   #D    V   !G@   92   (*   "6$
M  D]   )*P  "4P   EA   )<@  "6    F(   );   "90   G#   *"0
M"@    HC   *5P  "C8   I'   *<@  "G4   IK   *>@  "K    K2   *
MOP  "O    KV   *K@  "I    K,   *PP  "J$   JB   *:0  "K,   J]
M   *U   "LL   JG   *N0  "L@   K)   *R0  "JX   I]   *2   "ED
M  H^   *6@  "ED   IQ   +"@  "OD   KI   *V   "M<   L0   *U0
M"K,   IZ   *D@  "I    I^   *X0  "I    IB   *(0  "D(   GV   *
M    ">H   HL   *00  "FD   J*   *D   "I\   K2   *T@  "ML   K#
M   *U   "L    J9   *=P  "JH   IX   *8P  "FX   J-   *C0  "K<
M  K)   *70  "DH   GA   )]   "=D   H)   *,   "F    HF   *.P
M"B,   H_   *K0  "K<   G8   )E   "3P   DQ   )'0  "5(   EV   )
M.@  "20   CU   (Y   ",8   BI   (U0  "-0   C-   (B0  ")0   B%
M   (@0  "*0   BO   (F@  ")<   BL   (VP  ",,   D0   (Z   "+,
M  B%   (0@  "!X   @I   (#@  "#0   ?D   'X@  !^0   ?!   'H@
M!\T   ?Y   (;P  "%P   A)   (:P  "#P   A!   (;0  "&\   AK   (
M1P  "$D   A#   (5P  "(4   CG   (S@  "*D   C"   (L   "),   BM
M   (MP  "*T   CG   (T0  "00   DK   )%@  "9$   DN   ([   ".0
M  A\   (DP  "+$   CN   (_@  ".8   CJ   )'@  "3,   E/   ))P
M"*(   B#   (_   "-D   C0   )#0  "/$   C^   (Y   ",(   C'   (
MMP  "0\   C4   (A0  !YH   :@   &>0  !FX   <K   '<@  !X$   =U
M   $/0  !$    (^    C@   (X   ".    C@   (X   ".    C@   (X
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MB@'(HH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M*K&5+F<2*Y8,OZG4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M7Q8\=:+;ZSJWBB:-;FXM4NH5D6TLY'C5X+<1LH95 +MDN7 0* >?_ W_ (/
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MHHH **** "BBB@ HHHH **** /S)^,?_  7ZF_8Q_P""Q.O? 7X_:%H7P_\
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M$@_X6;X\T>/0]4\V^#:=]F2&RA7RX=F5;;80<[CR7]0 OCK_ ()G_#?XB?\
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M&L6UM:W!TW6Q:V^R")8H]J>6V#M49YY/->0_\0?'['O_ #[_ !._\*4?_&:
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MN?\ P5:U2X_X(_?\%[_A;^U_-I,]U\)?B[IT/@[Q_?\ ^D3_ -D3JB6KS_)
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M? 7B#4([B2*>.4K#&KS"W'FI+:QPJ9CLBCFL9T&XR<?K1\7O^"G_ .SK\"_
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M"'@34/%'C#Q!H_A?PWH\?G7NIZK=I:VMLO3+2.0HR3@#J20!R:_AF_:O\?\
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M /!2+XX?LX?LWZ;\0I_AIX1NK6^A5F1;NYD\IRH/(7D+G/)/05^7/Q^^+WQ
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M]*_1S_@DY_P4JD_9D^-WA^]C^:W4+')%)<LJ#]WMR1T/X^E ']9"MD5\5_\
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M%-QQN:]OL#W/SU\!?\%G_"=QX;_;+UB2[+-=W66F./E#9Z#Z5\D4 ?M_<?\
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M*,/P-5T^./Q:BM;?;XH\8I'=ND,"_;I1YK,,J ,\Y'(]: /WK^)W_!T]\5O
M:R>3\*O -T5CWQ_Z==D2>W!KQKQ'_P 'H'Q?T+3DN#\'/ALI<[=DE_?!@?IF
MOQ@U[XQ^/)]2-OJ'B7Q#)=1OM*RWKEE/IUK.U:/Q-XJO;FVOFU*\GL(FN)DF
M<LT* 9+'/H.: /V0/_![=\9(_O?!?X9GT(O;WG_Q^MCP_P#\'I7QBUJ&21O@
MS\-HUC.W'V^]SG\^E?BCI6@>(-7L86L[749[>0_NO+4D.=ZQX7U.]E7 [FO5
MO@/X$U&\\.>-X]:T^Z>YL]-$UL+B/=);LKD.5SRI&0#WY% 'ZP:K_P 'C_Q2
MU"SV77P7^%ERJ_.L<][>.H;! .">O)Y]S7.O_P 'M?QEMW*GX+_#-2O&/MM]
M_P#%U^5OQ9%GI.BQPVL/FM<8W2XQY9XR*X^R\!VDE@S7$TGF$C;(IRH]L4 ?
ML%_Q&Y?&3_HC/PS_ / R^_\ BZ/^(W+XR?\ 1&?AG_X&7W_Q=?CKXF\$6>A>
M'UN%NS),S !3CG\*Y>@#]LO^(W+XR?\ 1&?AG_X&7W_Q='_$;E\9/^B,_#/_
M ,#+[_XNOQ-HH _;+_B-R^,G_1&?AG_X&7W_ ,71_P 1N7QD_P"B,_#/_P #
M+[_XNOQ-HH _;+_B-R^,G_1&?AG_ .!E]_\ %T?\1N7QD_Z(S\,__ R^_P#B
MZ_$VB@#]LO\ B-R^,G_1&?AG_P"!E]_\71_Q&Y?&3_HC/PS_ / R^_\ BZ_$
MVB@#]LC_ ,'N/QD!_P"2,_#/_P #+[_XNC_B-R^,G_1&?AG_ .!E]_\ %U^+
M=K):'29ED4BXZHV*ILC(?F!7OR* /VP_XC<OC)_T1GX9_P#@9??_ !='_$;E
M\9/^B,_#/_P,OO\ XNOQ-HH _;+_ (C<OC)_T1GX9_\ @9??_%T?\1N7QD_Z
M(S\,_P#P,OO_ (NOQ-HH _;+_B-R^,G_ $1GX9_^!E]_\71_Q&Y?&3_HC/PS
M_P# R^_^+K\3:* /VR_XC<OC)_T1GX9_^!E]_P#%T?\ $;E\9/\ HC/PS_\
M R^_^+K\3:* /VR_XC<OC)_T1GX9_P#@9??_ !='_$;E\9/^B,_#/_P,OO\
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M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!Q/[26L/X?\
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M>E1ZCJ%OI)7!Q<,ID.3T'4< "OF7XW_&:^T#XA6=U-JDUC);XP'D.&&2?SH
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MFE:%KURPN_+)9XMO()'O_6H?C[\7?"_[(GQ)M-/\"S3:MIMTF"]PV]W&YEW
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M _5;2_\ @L'XF\;6=UX@O[J34+6VN?W4++\REN#CVX''M7IVN_MU+)X0M?%
MM;>23585VJY_=1GO\OKS7YV?LH_L3^)OC3\)?^$HAUB2PT=90K.LF6GX)Z9K
MQ/\ :HT_Q/\ #B]FTNVUF_NK6WNOL\49NFXP<;@H..* /V8^#_\ P4RTGP%X
M,N+VYABAU/?A)H\-CN&QW'MWJ]^U7^WEIWC'X0:3JEYK5GXMN9'9D7[*MO\
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M.#G(.*Z[]E/]DG7K_P *>'_&W_"PO@OJ7@O1=26^:[M?[4BU)S#',%A2%K5
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M;E+@,NZ2#YV&!FOP=\!^&[7Q'J<)BU!X5TV)5#J=ID;@<BOU(_X)/_&/P_\
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M7;QQY,0D"[A@U\Q0_M47'[3UU#?:CKEW<0V,@^:6Z=UC_P!W)XZ]JYS]K/\
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M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ I"P!I:^5?\
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M[ *+R:<; 7_A7_ZU %?Q*]PNF>7*V]5;(;;\P]C7/Q[6D7<2B]VZXKV#Q?\
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M4AVC&5P?P-?L[_P9NR++XR^/&PMM:UTH@LQ8\O<>M 'S/_P>M?\ *3'X<_\
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M\,?@U?>$?BA>:CX9N](COO$LDOAL18NYXHXM98MIVKM]LM)+F( EO- N8C*
M??>ZD# FOD[]IO0/V@OA1X,^(OCRR^+VEQ^'/#=GJGB"UTI/#MHTR6D"2W$=
ML)'B.6$:JF]LY(R<U^1X^ /[:_[;/QLU+3?V>?VD/B1H=OI.@V.N:O9^)OB/
MJ2PVYO)KF*);9E260C_19"P=C@L,':0J@']$5%?S_?\ #G#_ (*U?]'3O_X<
MW5__ )'H_P"'.'_!6K_HZ=__  YNK_\ R/0!_0#17\_W_#G#_@K5_P!'3O\
M^'-U?_Y'H_X<X?\ !6K_ *.G?_PYNK__ "/0!_0#17\_W_#G#_@K5_T=._\
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MG#_@K5_T=.__ (<W5_\ Y'H_X<X?\%:O^CIW_P##FZO_ /(] '] -%?S_?\
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MA_$WP-HOB30[K[=HOB"Q@U/3[GR_ ,?VBWFC62)]K@,NY&4X8 C." >*UO\
MC>O_ )_X5]0!^_U%?@#_ ,;U_P#/_"OJ/^-Z_P#G_A7U '[_ %%?@#_QO7_S
M_P *^H_XWK_Y_P"%?4 ?O]17X _\;U_\_P#"OJ/^-Z_^?^%?4 ?O]17X _\
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M6#22>8T%NL:H@QC^[G% '\?S9W<]:EMA,9-L/F&1^-J#DU^WG[47_!(#X8?
M[Q7+<7C;;<._FH44E1N(!&%[\5\4:S!\%_V?_BC?7$EW]QS]E41[U8\\'Y>.
MO;% 'R-:_"?Q#/I7G.MQ#"I 9&+?)GID5[Q^S;^PE-XVD:;4KR:S66+=&BP[
MFD&#SU_2J/B[]K_3K#QC?1Z+':+87C*TA>'<A8 =,UV&A?MEW5AI O5O8+.3
M3^8I(>%8'C'4_E0!S?C_ /8$71M1O9DNKO[+#)L$LL7E@^YYKU+X)?L'_#K2
M/"T>I7WB:ZEUZ3"+;1[/+8D\ '<2/RKP[QC^VWXD^)!U""XN-UM<CRCG(60
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M#?[-YO?&MK-J7G6ZW'[Q59>F".<5]4?'+XQZ]J7A;3=+M;EOL^GH(HF *YP
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M_K7$>%];?PQJQCD0,&(*RD9)% ',^)8?$G@W0&TNUDD^RHOSHD9&_P"O/O7
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M-"MQ=6_[LEH?X)"6'!H ]H^'6M20V:6MJL4[R9$AV[LTW7O$?_"-1$-L4!R
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MT@PV-UQC- 'QS_P>M?\ *3+X<_\ 9,;3_P!.FJ5^.M?L5_P>M?\ *3+X<_\
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M0<\?%SPLWPTA\:#Q+X?/@VYL(]5AU[^T(O[,ELY$$D=RMSN\HPLC*RR!MI#
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M\F,?!?\ [$30_P#TWP5ZQ0 FP4;!2T4 )L%&P4M% ";!1L%+10 FP4;!2T4
M)L%&P4M% ";!1L%+10 FP4;!2T4 )L%&P4M% #2,&FD\_=ISU^-O_!PG^P5^
MU?\ M1?MK>&O$/P,T3Q=J7@^T\$6FG7<NE>*K;2H%OEO]0DD4Q2W43%O*E@)
M?:000,G:0/K.".&\+GN;0R[&XR&$A)2;J5/A5E=)ZK5[+7<PQ%:5*'/&+D^R
M/U^\0>--'\)"'^UM4TW2_M&[R_M=TD'F;<9V[B,XR,XZ9'K1;^-='NCIXCU3
M3)&U8,;$+=QG[:%QN\KGY\9&=N<9K\YO@C^Q!\7-9\$?LH^&_%VB^$X/%/@W
MX7^++3Q)=?$'PBWCG3[*\EU/P\T4#-#?01K=2)%(Z/Y[EHX)@%.UBGJ/B+X1
M^#_A!X]\5:7\5OA+??$*'Q NGP>!O^$2^'MWJ>FV]O%IUK%<:?;BW66/0]VH
M_:IO]+F@@*WJ,;J7R[@P?/8_"QP^*J8>$U-0DXJ2VDD[*2\GNO(UC*Z39]C:
MCX\T/2-9CTZZUC2;;4)BJQVLMY''/(6.% 1B&)8\#CG-:R@,.E? 6C^'_AWX
M"^./Q2L?BE\$/&OC#Q!X@FT1=%9?AUJ_C)KJ)/#^G6Q@&O\ V-[?<+F.:,S7
M-U%AP\LC1AB]?1_PVT'XU_#7]C3X6Z*LG@_Q5\5=%\/:5I_BN]\1:O=1VM[>
M16"I=W"SQ0222N]TN[+(NY69C@X!Y"CVA[V&.Y6$R1^=(K2)'N&YE4@,P'4@
M%E!/;</45)O^;[M?,/[4_P 1(O@?^WO\(?&FK>'_ !_JGAFV\ >,M$N+SPSX
M+UCQ-]DO+G4?"TUO%-'IMM<21>9'9W3*SJJGR' .>*\7^+?Q8^)WQ5_:\TO4
M/#=G\4M,\-:U<Z,W@^ZGT/QCI<=I;B4+J/VS3X[--/4LRS #6VA<*5=!Y7E,
MP!^@OF<?=/I3)KR*V>))'C22X?9$K-@R-@MA?4[58X'92>@-?G)X(TWX]?#'
M]FOX7ZG'JWQAU3Q1XV^!=QK7CZXUZ:YGFT[7K>3PTL$"PRJ(M/NX[2[UJ,10
M1Q7%TT#22_:;F'S1RR7]M\5/VHOAY?6,W[2/B+X7?#WXJZ7-IIOX_$TNJ:-;
M7GA'7XWFEB11JBVIU)[6)IM27>HFE5G%E,H< _42VNX[RWCFA:.:&90\<B-N
M5U(R"".H/7(X-"7<<D[0J\;31J&= WS(#G!(Z@'!QGK@U\4_\$U/@YXV^ 'A
MO]G'2;V3XD-I^N?!=Y/%]GKKW+6>AZI9IH$>G6"6S*MOIKP07&H0+%%'%+<+
M;,]P;B:)YJX_Q!^T1J'[-GC3PMKVN1>,[OQ1K'[2NO:%X^L?#>DW>LZA?Z8?
M#_B"30(OL=FDC36\6CIX>NF2V1MIBDED4W(N20#]"P1NZ4C,!VS7YI:5XB^.
M_P 8?@WXM\8V\W[0'AR]L=#\9>)?">ESZ9>:;>&^_P"$NU8Z*EQ9RPF262+3
M#:B.QE#0R0LGFP3*L6SZ6_9WL?C%X&^)_C[PK:0C6O /ASQY':6.I^-M4OGU
M6?29=$T2[FELYFA?[:/[0NM7 ,DJQQ.OV>/RXH%CC /H^35[6'S-]Q;H(I4@
M<F4?)(^W8AYX9MZ8'4[U]15O8*^*+/X-^'_A#\&/VVK7Q9IFK:9X(U#Q9)K5
MK>:@]Y)-?1CP=X=S?6]PQ-Q+(M_#,$FB9I%N("$(DCP/K#X,2^(W^$?A/_A,
M!M\6-HUH=:7]WQ?>0GV@?NOW?^MW_<)7TXQ0!T^P4;!2T4 ?EO\ \'?:[/\
M@CMJ'_8X:1_.:NL_X-1?^4(_PT_[">N?^G2YKE/^#O[_ )0[7_\ V.&D?SFK
MJ_\ @U%_Y0C_  T_[">N?^G2YH _1RBBB@ HHHH *_.K_@ZO/_&D#XJ?]?\
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M?6O[P/B-\'O#7Q<TS['XDT73]8MU&%%Q$'*>N#U%?FQ^WQ_P;<?#GXZ6;?\
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MLWN+0%V.3DX('. >:^UO^".WQ*L_$VCW5A;V=N&@M(E6Y5,/*H7KGWQ7G?\
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MCL?2OF@7LJV_E;V\OGY>U "6UPUK+N4*>,$,,BOWO_X,>#NUW]HH^L&A]/\
M>O:_ \!K:5=R#/7##@U^^7_!C\_FZ_\ M%,55=T&A\ <#F]H S/^#BOQ!JGP
MS_;R\?:Q!--':ZI'IEIWV@?V;;@X_*OR@\,Z/9CQ?<W\,-],LP?[3)(S2$AA
MSC(XK^D'_@J=^RCH/[3WQU\3Z;<^=-J 2UF:*,HKC%I&!]Y3VK\M/C#\#/\
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M6G-<K(H6-C]U#ZYH PJ*G>>-[/9Y8617)##N#C@_2H* #/%%%% !1110 44
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M%=1N#/YWVC1=,\(:7IEU:\J,QO?VDNZ'[L\:Q^9N4!%[;Q+\"?C!H?P"\/\
MPC/P]L/%WP^F_M@^)X+3Q+;V;:E8S:E<M::(@F4".S:SD19BN,1JMNBA69T
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M/_TWP5ZQ7D_[!/\ R8Q\%_\ L1-#_P#3?!7K% !1110 4444 %%%% !1110
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M?3IKF-G&5#A#MR/][%?Q5?\ !2[XIZQ\9?VUO'?B+6YQ<7VH:@\C,I^7&3C
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MC/ C>8/KBOXV?#7_  6E^->G6SVM_K2WUM(,8D><XZ?]-*^IOV1_^#F/XE_
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M9M0FUJZA02PR%0J XS@#MR:_HS^*O["\FKIOTW3XXXQ(Q+((U8^F/2N)M/\
M@FE;>(M"U*^\527;S9*J&:-RJ#H1D&@#^8S0_ ^N:18W@FM9BTBY ;L?:L+5
M/'_B+PBUO'=PM#"IRC+F-C[9'-?TR_"[_@E59S> [S6+?3M-OYK@OY"7,$;;
M5'.< CG_ #BODO\ :,_X(UZE\4;%M0M]"FDA$[0S7%O!&L<!YZ C/Y4 ?C/\
M._V@?$&G>+EGGO)(K'&&C\UF 'OSS7T9X+^/G_";^=(VH1(NFPM.)#P=JD#&
M3_O5ZIX\_P""+D=AJ$%C8C6X8[J5X[BZEA0>65)Z?*.I]J\QU/\ X)\:_P#!
MS6IH_L.H&.1=D"LB,LF3U^4#L* -+_A'+KXF^'OMJQW5\LF70QNSKM]ZX;X;
MP+X1_:5\)^3+(JMKNGQM#(^Y5/VJ(' /2OH?]FB^\;?LK+,N@V,=^-C/(D\3
M,"6SE2%9>!FO(]"^$NO?%#]JKPWK4UK<QW-SXDM+N8A<+'_I<;%0#R .1SZ4
M ?U)_M/_ ++/@?\ ;'^$=YX%^(6C0^(/"]_-%//9RG"N\;;D.?8\U\5^'/\
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M_@A'\4-/FO\ ['&J+-?VJ+]\LW"$]*^O/^"G_@33/%7[+&NW%]:0SO8Q[P[
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M,TM=,5E=H]IVM]_D\8/_ -<U[98^(M'\8VEQJ3K:V=FTI*0Q8"@GG'\J^?\
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MPT\16WA.]L=-\57&EW,6C7EY'YEO:7IB<022+@[D60HS#!R 1@U^;:_LS?\
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MFC-% !7]AG_!L]_RA1^"?_7IJ'_IQN:_CSK^PS_@V>_Y0H_!/_KTU#_TXW-
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M_P#I/KE?T]5_,+_P3/\ ^5R#Q-_V53XC_P#I/KE?T]4 &,T$9HHH ,48HHH
M ,5^7/\ P7F_Y.<^&/\ V3_Q1_Z6:-7ZC5^7/_!>;_DYSX8_]D_\4?\ I9HU
M 'W=^P3_ ,F,?!?_ +$30_\ TWP5ZQ7D_P"P3_R8Q\%_^Q$T/_TWP5ZQ0 44
M4'I0!#<:A!:G]Y-'&?\ :8"OS?\ ^#CZ_AN?!'[(_ES1OM_:3\)$[6SC]W?5
M\T_\',6G6]W^V?X)::"&1E\$P %D#$?Z=>U^<<GAS3[@KYFGV,WEL'0/;JVU
MAT(R.#[]:_/\VX\C@<9/"2H\W*[7YK7T3VL?U]P!]$^OQ1PWA>(*>9*G[>+E
MR.DW:TG&W,IJ^U]NI_6@VK6JDJUQ#E3@@N.*FC=70%2"O8BOY*WT6S"-_H=M
M_P!^EK^G;_@GNBQ_L%_!-5 55\!:$% ' ']G6]>IPWQ2LVG.*I\G*D][[_)'
MPOC9X"S\/<-A<1/&+$>WE)65/DMRI/\ FE>]_(]@HHHKZP_GL**** "FR9V\
M4ZFN,B@#\SO^"D7_  7A^,G[ _[1/C[PSI'[%?Q,^)/P_P# MK!?2>/[.^OK
M71[FW:PAN[B8R+I<T,<<#221NQF(!@8DKRJ\!^Q7_P '*'QE_;2^(WPYAT?]
MA?XFP?#_ ,?>(+/1G\<6>KWVH:/IEO)>K:W%Z9ETE87CMSYA?]Z@!A<,RX)'
MW9_P5J!'_!*W]I3_ +);XE_]-5S7@O\ P:Z_\H*/@;U_YC_3_L8=2H ^_P#>
M,]:6HQP:DH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH _
M+G_@[^_Y0ZW_ /V.&D?SFKJO^#47_E"/\-/^PGKG_ITN:Y3_ (._O^4.U_\
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M_KJ_X)K_  &\&_LE?"6$6*W,&K:D%9/G,BJ"BX!QP!D=Z_E!_8-NX=._:?\
M#-Q(@FN(9]UI$>DLN/E&>U?LM^VK\%_VO;#P99?%B^UBX^'N@Z7;HL>G:??O
M;V]S'@LID1'&]B#SD=J /%?^#COX]:C8^)+BS%Q]GU"^NY89$C<M'(A R<=.
ME?CD[;V+'J>37;?'KXI>)OB;\0=2N/$FN7^L7 N&.9KF26-3GG:&8XKB,YH
M*]F_8F^.U]\%_B]8_9VC6WU&YACD+Y^3#CD?F:\9IT4K0RJZG#*<@^AH _N0
M_8'^,&F_%G]F'PK=6>H6]Y+;V$,,VP@%&"#C%?*__!RQ\0H?#G_!/'6M/CNV
MAOIG%QM0;CL5&SFOS5_X(4?\%-M;^'O@2PT/3HXM0N+&W"S;]S,AP<=?857_
M ."\/[96I?&SX>W+ZI"UNLR>2YAD(P/F^5O;VH _$[4;QK^]EF9MS2-N)]:@
MK;E?1KS0;6...XM]068^=*S@Q^5VXQUK'N55+B18VW1JQ"DCJ* &4444 36R
M0,/WS.O^Z,U$^ QVYVYXS244 26UU):3"2-BK+T(K07Q1<?:%E98RT8P,+67
M3D1I&VJK,?0#- #KFX:ZG:1OO,<FND^%'Q-U7X7^)H[S2Y-LSGR]I)P<UE>&
M_#;>(KYK=9!%(HR 5Z^U;?ABVMO!GB^VN=25&M[64 HRYW<@YQ0!]K?"*[UC
MXLZ!NU"WCN[YDS#MC'XY_P#KUZ=X@_9J;Q)\+KJ.XAFM[B-1M*-M9B<<5P?[
M,?[>/@OX=^%[ZWL38V^H-'D+)""Q'?!QP>:X?X\?\%.=6O\ Q2D>FWMN=-V$
M_N2RR(^3W!^E '8_L[_\$Q]-C^*>G:MXBTW5]0TVQG2YN%27>G# X;;SCM53
M]N&Q\'V'C/4K;PSX:71[BU A@$?F8D/&22W?C]:P_@7_ ,%=O$7@TPZ:+R^A
MM[J3%T);AV252W?GTK["_8F\=?#/]M/X^Z?IWB"\T_3X'P]V90G*CDD9% 'X
MT^*+2\BUZZ6YCD$RR'=P3BJ(OI!9M;_\LRV[&.<U^T?_  4E_9Z^$6@>-=<M
M?!#6[6J'R[>06ZK]HQP2.!WS7Q)XJ_X)_P 7A:Z^W7RQQ6\C*^&PV[/) % '
MR;;_ !%UJV\)-H<>H3KI+/O-N#\N:9X8\?:MX1L[VVT^]FM;?4E5+E$;;YJ@
MY -?J;^T%_P0J_X67^P/X0^-_@?R]+MW66*_LQ N9CN54;Y<?W7[&OB'4O\
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MC^(D\5\%^(="DT"^,,BLN.,GO0!L?"+76T'QWI]P)&7RY >!GUK^J7_@@/\
MM+:/XM^%^G^'&;;J$]@KEFB9=[*%XR>.E?R>Z'J#:7JL,RL4V-R1Z=Z_>/\
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MKZ?_ &IO@?K7[?>BZ+X'\,V%U>:MI\ZL]PK;O+5B0!_X^.]?(?QM_8:\<?\
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M\%?VF+C5IK5M<@GN[R_'G!XSNR?;(K]P_P#@D7>PZS\.M4U :;'IMQ<0VV]
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M[_LG_A?_ -+-9K[N_;V_Y,8^-'_8B:Y_Z;YZ^$?^"#/_ "<Y\3O^R?\ A?\
M]+-9H _4:BBFNQW8% #J:QR,49.*Q?B#XTA^'7@?5]>NH9KBWT>TDO)(H0/,
MD5%+$+D@9.,#)'X4I-)795.G*I)0@KMZ+U9XO^U#_P $K_V?/VU_B1;>+OBI
M\+?#OC7Q)9V$>E0WU^TWF1VL<DDB1 )(JX#RR'IGYSSTK\M_^#=W_@DO^SC^
MUK^S/\9=6^(WPE\,^*M2\/\ QAUW0-.N+LSA[2PAMK!HK=2L@^5&ED(SD_,>
M:_3.+_@IWX2,B[O#OBC:3\Q"V_ _[^U\7?\ !#_XA77_  3R^ /Q0\-^/?#^
MH-J?C'XHZQXOL1IMQ;7,:V-S!91Q;V\P8D+0297L-I[\<7]I87^='UG^H?$%
M^7ZI/[C]6_#7AZR\'^'M/T?3+:.STW2[:.SM((\[8(HU"(@SV"@#\*O;N:\E
M_9]_:YT7]HG7]0T_3-+U;3Y--MUN':[$>UE+;<#8[<Y]>U>L]3753K0J1YX.
MZ/GLPRW%8"N\-C(.$U:Z>^NJ_ =1116AQ!117\ZO_!6W_@E?^T=_P2R_8NU3
MXN_\-Y_'#QU_9FHV6G#21-JFE^;]HE$>[SO[5FV[>N/+.>F1UH _HI9MHIHF
MW?PU^<G_  3H_P"")?QF_8F_:FTGX@>,_P!L[XG?&?0=.M+JVE\+ZW:WT=I=
MM-$T:2$RZI<)F-B&&8FY'&#@C["_;2_8I\ _\%!?V?\ 4/AI\2K&^U#PIJES
M;W<\-G>/:3,\$@DC(D0Y'S#G'44 >N Y'I31)DXVXS7\UVO?\$4O@%I__!RA
MHG[-,>@ZX/A3?>$FU66R.M3FZ-P--GGW"?.\#S$4XSCC'3BOWP_8;_81^'?_
M  3M^!4?PY^&.GZAIOA>&_GU)8;R]>\E\Z;;O/F/DX^5<#MB@#V.BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#^87_@F?_P KD'B;
M_LJGQ'_])]<K^GJOYA?^"9__ "N0>)O^RJ?$?_TGUROZ>J "BN=^*?Q9\+_
M_P $7WBCQIXDT#PAX9TSR_MFKZUJ$.GV-IYDBQ1^9-,RQIND=$7<PRSJHR2
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MT^-IO*\1Z>TLAX)_TJ+)S^= ']!/_!W)_P H9/$W_8RZ-_Z45_+?\%I/"O\
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MEACBOK?_ ();?\%+?&TOCVUT>.XDMM\Z*CHQ^8E^XS[T ?T!_M'?LVZ3\8=
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MH ^+_P#@]:_Y29?#G_LF-I_Z=-4K\=:_8K_@]:_Y28_#G_LF-I_Z=-4K\=:
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M(^-? <=O9ZJWV.SU!]IC\P;3S^E3>/)_$6E6D/AW3?.9K=?/D,;?,X/'X]*
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MK+P22?;FO7/V--8^+O[/FFQZI%XDOM/M68P.7F=T(XR ,XSQ0![5_P %X_\
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M/E'OC]:_+W_@L1\$8? GC'0]<FN,QZJK[84/S+@KGC_@5 'PRB-*X559F/0
M<FK&GS2V;LXC\R,<.K#@CWKJ_#?PWNO&EQYFCJT<=NN&?)5L]>OXBL;6]7GM
M(GT]HUC$4A$C@8:3UYH SKN\^TWBW$5NENJX(5,[01]:]!L?C*_CDV=AKL-N
MUO;JL<916!P!CG!KS_58/L4NV.1FAD4.O/8^OY5M_"/6-*T/QO9W&L0F2S5_
MF/\ =]Z .K_:.\)Z9HKZ3<Z;-N6XCV.AQE#_ #]>M>6GK73?%K5+;5/'5[)8
MSR360;$)8]!BL"=8?LT)C#>9R'R>I]J '_Z*=-_B^U;_ ,"*;+ILT5A'=,O[
MF1MJMGO5>G&1BFW<VT'(&>* 'V21R74:R';&6 8^@KN[+X?V5]'YEP\\=O,@
M,!& !GD']>_K7 #CFNUC\2WVO>!9(I&3R;.-8TP/FXP* ,'Q'X=GLI)IUQ);
M1OY8D!'7WQQ62R*(@=WS9P1Z5876KE-,>S$K?9Y&WLN>IJK0 4444 7_  YJ
M$.F:HLTRAD7MS3_$UU9WNH&6S#*KC+ C&#[5FT4 %%%% !7]AG_!L]_RA1^"
M?_7IJ'_IQN:_CSK^PS_@V>_Y0H_!/_KTU#_TXW- 'WA1110 45POBS]I/P9X
M+^-WA?X<WVL(OC3QA'--IVFQ0R3.(HHII3+,RJ5A1EMYPAD*^:T,H3<8Y-L/
MQP_:/T7X#OHMO?:;XGU[5/$$LJ66E^'M(FU6_>.&/?-<-#$"R6\>8D:9L(LE
MQ A.^:-6 /0**\:U?]NCP7H/BRQT>[L_%T,LW]GQZA<'0KC[+X>GOA&;:WOY
M=NVVF;SH?D?E?-7.,U/\"OVW? W[0_B>TTOP^VO1-K.D2>(-!N=0TJ:SM?$V
MF(\"/?6$C@+<0#[79G>O\-W"?XN ";]O;_DQCXT?]B)KG_IOGKX1_P""#/\
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M'_Z;X*]8H **** /Q*_X.7?^3SO!?_8E0?\ I=>U^=%?HO\ \'+O_)YW@O\
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M_P $;/@[^U#H]]-)HLVAZ])"1!>Z;(L+*X'RY#*1V&>*^MZ:PYS[4 ?RL_\
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MZ@OERK'#?"/'/0?9^.]<J_A+3Y'9F\5Z"68Y)\F]Y_\ )>@#GZ*WO^$/T_\
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M-8GTUI&:.X5-\;#C'(4#O7[]OX1M9_AU9WFZS\MU+HRQ2>6QP>GR9_,5Z/\
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M_%<*S/<PM]E&<QPW  _WOW5>4Q_"&S_X32WL]/U"P9;B0J$6VNRV1Z?N<9H
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M^;W_ .1Z ,&BM[_A#]/_ .AJT'_OS>__ "/1_P (?I__ $-6@_\ ?F]_^1Z
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M^/OB:]Q!I]Q))=R@92([0.GX"JW[#?@6UO/VAM)6/Q-I<R8;S%AAO/F''7=
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M65=J@,,D\"OV*^(W@?1_VO/V69+&18;^#7=.26%HV Q*%5A@\X^88K\X=)^
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M9\@4>,_A39^%]4\EO$6E0QNH*>=;WH+=,X_T>LD^$M/( _X2S0>.G[J]X_\
M)>@#GZ*WO^$/T_\ Z&K0?^_-[_\ (]'_  A^G_\ 0U:#_P!^;W_Y'H P:*WO
M^$/T_P#Z&K0?^_-[_P#(]'_"'Z?_ -#5H/\ WYO?_D>@#!HK>_X0_3_^AJT'
M_OS>_P#R/6AX=\ :9>7RM-XHT7[.AR[""]P/J?L] ')H%W#?NV^U6--T\:G<
MM&LBQG!*EVV@XKL/%.DZ3=WDD=EXF\,_9\ +MM[XM^9MA6(?!VG@\^*M!'L8
M;W_Y'H PI$\MV7CY3CCI7]A7_!L]_P H4?@G_P!>FH?^G&YK^1+_ (1#3_\
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MC\9XK_Y&=3Y?D-E^Y7;6'_(/M_\ KDO_ *#7$R_<KM['_CP@_P"N2_RK\O\
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M_P!B)H?_ *;X*]8H **** /Q*_X.7?\ D\[P7_V)4'_I=>U^=%?HO_P<N_\
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MB-\0K72_%GPWUCP?I-P KZA+?I,D9Q\Q.!P/2OYLY)&E<LS%F8Y)/4FF@XH
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M?OB%XT\ V.N>'5^$OB:R\,ZG%JVJ)>MKANOM86>,+&GD[6L9"4^<'S5Y^7D
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M8;V%I5Q;]2">.,^F?TK[@_9I\3:A/XY%WHZ2V6DV\P6. M\HX!Z=.A%?5_\
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M)3V9CCM=/2W,>U%"K&@&.!["ORO_ &LOV%O!/Q#\=>9J'CO0=0^SJ9!:AO\
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M;G@?]F?X5?'?]ES1-5M_!NB^#=:E9HM4TG2[:.*'3[N,@30J80BNJMD!P/F
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M K5OA9X:']GQ7+:M<.KQ11X7Y>I?UXX_.OE_PM\8]:\)W$MGI?F6<,YW0S0
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M=X!\4>%U\+:E'J^I7'VR12(0ZNSJ1GH1QZ5RVB7.DV\-[/<:Y>.N=JP[6WR
MD<^G_P"J@#CPQA+*57/0Y'2B"3R9E8JK[3G:W0UTGB;0M#MXDEL[Z7:ZY ="
M237/R11B#<K[CG!&,8H ;=3?:+AY!&D88Y"J/E7Z5Z5^SY^S%<?M"6^HR0^.
M/ACX/&G,JLOBSQ+#I#7&[)S$)/O@8YQTR*\Q KZ^_9"_9H\#_M%?!C4K'PO\
M-_$WQ4^)6AZ/?>(-<CL?&4.AC1;*$Q()%MI[<_:@K2 L(I"WS8V@#) .7_X=
MH7V?^2V_LU?^'&L_\*N1?\$[M6BT62P_X7;^S28)'W\_$:SRM>C?!;_@F1X:
M^,EEX5^']I=7<7Q*\6>!+_QY%KLNH*FDVL=O'-.EF8=A9B\*1JTF\;79OE(
MS\N_";]G34OBUIGQ N+.^TVU/P_TEM8N_M#N/M$:W,5N4CVJV6S,#S@8!YH
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M ()A_P#)3/%'_8,B_P#1M?:AZU\5_P#!,/\ Y*9XH_[!D7_HVOM0]:^ZR/\
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MP5-X=\*:UID=AJ#,TM\MS-8R&9=R(0L9M@K85N9EY&!N /TV_8)_Y,8^"_\
MV(FA_P#IO@KU:0G'%>4_L$_\F,?!?_L1-#_]-\%>K2J67CK0!\__ !U_X*I?
MLZ_LO?$N]\&?$+XQ^!?"/BK3DBENM+U+4!%<0+*BR1EE[;D96'L16#X-_P""
MT'[*OQ'\9Z3X?T'X]?#G5-<UZ]ATW3K*VU,/->7,TBQQ1(N.69V50/4UXG_P
M6D_X)&?L\?&W]G7X^_'+Q5\-[75?BII/P[U?4;776U;4(FAN+'2IC:/Y,<ZP
MGR_*CX,9!V_,#SGY3_X-E_\ @D7^SO\ M ?\$_/AC\;?%OPWMM6^*.C^)[N_
MM-=.L:C"\<]CJ+-:OY4=PL)\LQIP8R&V_,&R<@#_ /@Y=_Y/.\%_]B5!_P"E
MU[7YT5^B_P#P<N_\GG>"_P#L2H/_ $NO:_.BOYWXO_Y&]?U7Y(_V2^CK_P F
MXRK_  2_].3$?[A^E?TW?\$^O^3#O@K_ -B'H7_INMZ_F1?[A^E?TW?\$^O^
M3#O@K_V(>A?^FZWKZSPS_C5_2/YL_GWZ;W_(NRK_ !U?_28'K]%%%?KA_G>&
M:^0_^"L/_!/?XK?M]:%X)M?A;^T;XT_9YG\,W%W+J-QX=>]5M;2981&DGV:\
MMN(S&Y&[?_K#C;SGZZ;EJ^$]2_X.2_V.])U*XM;CXH:A'<6LK0R)_P (EK!V
MLI((_P"/;U%>YDG"^<9RYQRC"5*[A;F]G"4^6][7Y4[7L[7WLS.I6IT_XDDK
M]W8_-'X$_P#!-C]K'XW?\%'/CO\ L^)_P4"^.^FR_!&PT2];76U;695UC^T;
M.*YVBW_M0>3Y?F;<^8^[;G"YP/KC_@J+^SGXN_9,_P""*/PW^'WCSXEZY\8/
M%?A_QH/MWB[6&F:]U?SFU2XC\PS332?NHY4A&Z1OEB7&!A1XK^R7_P %F/V=
M?A=_P6O_ &M/B_KGCB\M?A_\4-)\+VWAO4E\/:E(VH26>FP07*F)8#+'LD1E
MS(JAL94D8)[+_@K_ /\ !83]GS]O7]EO3?!?PM\;7?B'Q)9^([;5I;630=0L
M0+:."YC=_,GA1.&EC&W=D[N 0#CFXQ\/N*,+D6+Q>)RZO"G"$G*4J511BEO=
MN*2MUNS]0\#<51EX@9/&,TW[>GU7<_,^BBBOY /]L#]N/^#9_P#Y,?\ &/\
MV/UY_P"F[3*_12OSK_X-G_\ DQ_QC_V/UY_Z;M,K]%*_I#AK_D58?_"OR/\
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M6E.HHKWC\I"BBB@ HHHH **** "BBB@#\N/^#O[_ )0[7_\ V.&D?SFKJ_\
M@U%_Y0C_  T_[">N?^G2YKE/^#O[_E#M?_\ 8X:1_.:NK_X-1?\ E"/\-/\
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M%AZ4JU;"PC&*NVZM-));MMRT''.L(W92U]&?B7_PQC\8?^B3_$K_ ,)B]_\
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M1_Q&"_&7_HE?PW_\";S_ .+H_P")5O$;_H#C_P"#(?\ R0?VY@_YOP9^+_\
MPQC\8O\ HD_Q*_\ "8O?_C5'_#&/QB_Z)/\ $K_PF+W_ .-5^T'_ !&"?&7'
M_)*_AO\ ^!-Y_P#%TO\ Q&!_&7'_ "2OX;_^!%Y_\71_Q*MXC_\ 0''_ ,&0
M_P#D@_MS!_S?@S\7O^&,?C%_T2?XE?\ A,7O_P :I5_8P^,)8?\ %I_B5_X3
M%[_\:K]G_P#B,%^,O_1*_AO_ .!-Y_\ %T?\1@OQE_Z)7\-__ F\_P#BZ/\
MB5;Q&_Z X_\ @R'_ ,D']N8/^;\&?C/J/[%7Q@MYP%^%/Q);<H;CPM?+C_R'
M77?"'_@G3\5O'EZXN_AU\0M/$; +YWAB]VMGUS&/YU^M7_$8+\9?^B6?#?\
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M8+\9?^B6?#?_ ,";S_XNC_B,%^,O_1*_AO\ ^!-Y_P#%T?\ $JOB/_T!Q_\
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M) -B(@"HN H XJ]_Q&"_&7_HE?PW_P# F\_^+H_XC!?C+_T2OX;_ /@3>?\
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MPIX@'DS;E>#PY<X8 CJ0M?24O_!X#\9HFP?A7\-Q_P!O-Y_\73?^(P7XR_\
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M&"_&7_HEGPW_ / F\_\ BZ/^(P7XR_\ 1+/AO_X$WG_Q='_$JOB/_P! <?\
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MG>:H8* $10-B*@"HN H  %?&_P#Q&"_&7_HEGPW_ / F\_\ BZ/^(P7XR_\
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MNK=LK+:^'[ECU(Y"(?0'\:^(=2_95^.=CKTFJR_#_P")UU=2$DD>&M0/7O\
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M:3KFEZEHNJ6MK?B:SO[5[:XASJ%P1N1P&7(((R.00:_,W_B,%^,G_1+/AO\
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M^9%_N'Z5_3=_P3Z_Y,.^"O\ V(>A?^FZWKS?#/\ C5_2/YL_!_IO?\B[*O\
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MW_!;4X_X)/?'C_L5+C^:U_(^!E:_TD^A-_R3F8?]?U_Z;B?'\2?Q8>GZ@/\
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MH*%N(\#$F"",\>W8BLX"C_/2EK.-.,6VEON $LY]37UQ_P $&?\ E+[\"_\
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M6MM_V.VF?^B;JOYK17]*7_!U]_RBUM?^QVTS_P!$W5?S6CI7YG]#C_D@I?\
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MRM<[OX._M0^*O@QXCTG4M)U2XM[K0]W]G2(L>ZSW,"Y7<I!SC^+->M_%+5_
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M'UJ$C!;Z5,9)[ )0>E!.* <L/K57 0]>E306<TD9D$3-&IY;'%1QG:W6O?\
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MW4GEBN.F/2OUV6*HTWR.6MKVZV]-S@Y6]3$#X-*.6W>U=;\5O!_AKPO=:?\
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M_E)+XH_[$6\_]*[2ORW;K7ZD?\&D?_*27Q1_V(MY_P"E=I7XW](#_DWN:_\
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M7_A7PWI&J7)A-OK2L\ 1MQ&WJ#[TWPQX*U?XA:O%9Z1I\U[<W$BQ1Q1+U9N
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MPW_+5:_G7Z57_)M,=_BH_P#IZF>OD?\ OD/G^1^WE%%%?Y&GWH4444 %%%%
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M%OAS_P!<M3_G9U\:CI7]8>%__).4/6?_ *7(_&>*_P#D9U/E^0V7[E=M8?\
M(/M_^N2_^@UQ,OW*[>Q_X\(/^N2_RK\O^D7_ +C@_P#%+\D?TA]%/_D98_\
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MT*\X2BGA.9_O*M6]G4C'5*S2]UKF3L?45\HA/#1Q6,G[-RC=7^UV2[=#YO\
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MKAE^M,SE:]$_9Y^-6E_"7Q\=1\0>&].\8:=<'_2+6]3=OR&4D-U!^;/&.@K
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M=I-87*<16FTXM15G)VV5]SY^_P""=O\ P3EN?VVOVK9/A;XF\3'X6ZA#H_\
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M1_\ TGUROZ>J_F%_X)G_ /*Y!XF_[*I\1_\ TGUROZ>J $*@FC8/2EHH 3:
M>E 0#M2T4  &VORY_P""\W_)SGPQ_P"R?^*/_2S1J_4:ORY_X+S?\G.?#'_L
MG_BC_P!+-&H ^[?V"O\ DQ?X+_\ 8B:'_P"F^"OC3_@ZI_Y1.:A_V->D_P#H
M;U]E_L%?\F+_  7_ .Q$T/\ ]-\%?&G_  =4_P#*)S4/^QKTG_T-Z_1/"/\
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M_P##1_\ 2JA\QQ)\-/U?Z&'7HG[,W_(_W'_7D_\ Z&E>=UZ)^S-_R/\ <?\
M7D__ *&E?TQ])[_DU.??]@T_T/M_H\_\G*R7_L(I_F>\4445_P YI_O8?MQ_
MP;/_ /)C_C'_ +'Z\_\ 3=IE?HI7YU_\&S__ "8_XQ_['Z\_]-VF5^BE?TAP
MU_R*L/\ X5^1_BMXW?\ )>YM_P!?Y_F%%%%>X?E@QR#7D7[1?[<_PM_9.^(/
MP]\*_$#Q0= U[XJ:@VE^%[7^S+R[_M2Y66WB,>^")TBP]W;C=*R+^\SG"L1U
MWQV\!ZY\3O@WXH\-^&_$TW@S7->TV?3[37H;=KB;2&E0H;B)%DC/G(&+(V\!
M7"L0P!4_S8_ML_%;XS:5^TKX/TC6OC-??M&7W[+M[<WM]K]AX0EO++P%*9K4
M/=SW*!)+UH;B&)B;EVB$MHL;%U>1#^K>%/AQA^+,;.C7Q*IQIQDY1]Y2?N2Y
M&I<DJ:3J<D6IN+?-:-Y-(X,?C'0BFEO_ %WOMV/Z>I#A?RK^3+3/^0=;_P#7
M-?Y5^[G_  1 @^)7Q-^'WB/XO>+OVE+?X^:'\1OLXM;1-,:S7PY-;C!C6$.L
M5G*?-D6>!8 &*0.'P#O_  DTS_D&V_\ US7^5?S?XV9/_9>-AE[J*HZ;DFXJ
M<5S)1YE:<827*[Q=XK57L?W[]!>ISU\VG:UXT?SJ]B:OL'_@@]_RD\\!?]>V
MJ?\ INN*^/J^P?\ @@]_RD\\!?\ 7MJG_INN*_)^'/\ D:8?_''\T?V%XT?\
MD'G'_8/5_P#2&?T%T445_21_B>%-D.$]:=2-TH _%+]O[X,>(/V)?VE?@#H?
MCKXO?M"?&+4?&OQ EU+0-2C\/Z5J)\)N]K/:1I8-?073M=K<75I,(D9$V6OF
M!!.D$L?ZA?L&?LN^+/V1_@U>>&/&/Q<\7?&C5+C59=037?$>[[7!$\4*"V7=
M)(?+5HV<?-UE;BO-?^"C/[-V@_'']I[]D'4M7NM5M[CPW\4I9[5;25$21H="
MU/5%#AD8D&?2;93@CY'E'!*LOUDAPOZ5^@<2\4?7LHP6%C\?+)U?=BDVJE3D
MY;17*E%ZJ-E)N\DVKG+1H\M24ON^Y7),\5FGPSIS^)UUIK*U_M9+4V2WGECS
MA 6#F,-UVEE5L=,@5<EG$2LS,%51R2<"OG']O+_@HYH'["_A3P=K%UH=UXNM
M?&6IOID#Z=>Q(L+(H)8L<ANN,#N#7YOBL12H4W5K.T5N_P #W\ER?'YKBX8#
M+:;J59W2BM+V3;6MELF]>Q])(N&IV:HQ:Q:2:E-9QW5N]W;J#+"LJF2('H67
M.0#GO5M6R*Z$>5RM:,_+O_@[^.?^".M__P!CAI'\YJZO_@U%_P"4(_PT_P"P
MGKG_ *=+FN3_ .#OW_E#I?\ _8X:1_.:NL_X-1?^4(_PT_[">N?^G2YH _1R
MBBB@ HHHH **** "BBB@#Y9_X+:#_C4_\>?^Q3N/YK7\F=]XMO=0\.V>ES32
M26=@7,"$_+'NR3@?4U_69_P6U./^"3WQX_[%2X_FM?R0%LI7^D7T**4)\.X]
MS5[5TUY?NT?'\2?Q8>GZCBV%STI23*W]WT]*;UX]!5S1],;6]6M;-62-KJ18
MPS'"J2<9-?VI5E&G!U);+4^=5WH165E->W"PV\<EQ*_W4C4LS?05WOP!_9=\
M6?M'^-;C1?#^EZA--9Q&:[>.REG%H@XW.$4D#WZ5ZE'^S]H/[+WA_0/&7B3Q
M!9ZE?ZA<-''X>,!69H>1YQD7<J\$$ C/J >!N?$?_@H%I^D_%G[=\,M!M/ U
MB]JMG+/9[C)*N/F9\;?,/U%?DN/X^S/,G/#\+89U+P;C6G%QIJ2E9K5)MK5J
MVYWQP<(6==VUVZGCOAGX:>'OAC^T0/#_ ,0-2\O2-)G7[=-91+/YJG:VU58C
MDJ3U/6O>O"/[0'P%^",VI2^'=%E\5:?JMI+!<6VK6*6]Q;LR,J-%M+(V"V>2
M.E?)_P 0M;'B/QIJ%\MY<:A]IEWFYG $DIQR2.WTJ[X/\:V'A[PGKFG7&CVN
MH7.J1A(+F3A[,CNM>EGW!L\YH4JF.KU;J,.:%.?LXMIIM]][Z7VT,J>)5-OE
M2^9D>(KBSNM<O)+%9%M)IF>)74*RJ22!@<<51QA_]WMBG6Q\N=#QM5@3N&1C
MZ?TKW#XEZ9\*?&/A#1[K3=?ETOQ(VT:H9(S]E*@8'E1)""IZ$EG;/-?4YEG$
M<ME1HRISG&6EXQ<[6V<K:I>9E"FYW::.B_9Y\2?"/7/AK<>'?&V@:3IUQ>0,
MAU]9474+20'*O&LK)&ZGO\V?0&OJS_@D9\%?V6V\=ZU??%Z^\!W%A8P-;Z!+
MXR>"QT_4R[*6GD,TJQ[U0817#*WFLRD,BY_/WX"_"?5OBY\;M%T+P_X-USXG
MB.\CN;G0]+ANVFU*RCD4SHS6R/-!&R95I57,>_<.0*_5C_@M-^U+:_M'_!3P
M;\/[;X6WW@WQ3_;B/<RZQ80+=>'[2W0F&"W975D,GFC<A38B!UV[F5A_#'TF
ML7F]?-Z'AOD=?$QAG"D\1B*.*I4ZF A&TE4C3E^\<9J+3M96]V+YFCZ7)XP4
M'BZJC>GLG%M2\K[:?UH>/_%W]E[XL?!7PE\2_#?[/_C7QIX;_9O\<:C%-:6>
MO1/;K=EER8K>YE3S$C<G:2&22:-8Q-O9<U\'ZO\ LK?$:/Q)>:>_A;7;J_MW
M_>A+61V/^UTY!]:_2'P/\>/''[)_ABZT?QUH][XR\&Z]9IJ*V&MRG=IP8CR[
MBT>W61HXPO.)5R,_A7GG@C7_ ($^+;O5-4TWXI?$[0]?N87N1&QM[Y=RY(A3
M?%E\Y/\ "/NC@=^'P7\1\TR#+,1-82-1.24\2J$I2Q$H14/:5JE-7G4<8IN4
MM7J^K*S'"4ZTE[UNROHO))[(\A_9L^$ZV$>D_"S7O!UK9>-O$MYYMQ=%7_M6
MPL H/G& @' (8C) Z\UP?[4/A^Q_9%^,>GZ+X3T^6'['!YLFI3VXAN=55F^\
MX^8#*C&5/<U])?LO:O>_M$:_J&O1^ -4;7KF>;3++Q?<Z@8I%MH<Q O''+$5
M)VL6"[ "V*U_VB/V$=%MM>\(^-/'/C&RT^T2=M/O5D2>\CE !/R%1(X)P<1_
M/P#R>M?(\(>)618[CO%<4<7NFZ3A*$8N+EKT:33LGJEVN=-;!U(X:-&AO>YP
M7[.GPJU[]OG]G[QGX-:XO(KJ.X@\1V,$Z_:+BW9$FC\N%/O-')E?FZ@KBOGW
MP+^S?)\.?%=\OCO2+H2Z7<26T^D21+'<E5ROF8D( RP^53RQQBOH3XQ_$+_A
M@J^LM1^ /B74/%2Z]I=Q%J%[?Z#=VXLXPRE%C$L<6<%WPP#8QT'%:GP?_:4\
M$_'?XA^%](M=+@UWQ9JGA",ZTNH G[9?Q S3LKDC:S;7Y[=!CK49;X]U,JQ.
M,R#()>SP5>JG2<5[U.,FN;EYMF[]=N@2RM3C&K5UDEKYGB_Q7\8V_P +_A]I
M>L^'?$'C3P[<WTWV.WTEHEM7TF#:Q;8 ^<G 4A@!Z5B>"_ ]_I&CV_B*_P#A
M;-#HL9\NX\6W]O+_ */(Y+B24[2@8@C )Y"@^M97[1'PGN8?$TEQ=:]:PK?:
MB5CTN><R?V:&W' .]^% P2?7WKU#Q1^T;K0_9XUCP=X5MX]6MXB&U)FC6XM8
MT6,*3N< $X&1C)&<<XK^A,'X;Y/A,/A,30PRQU>O/][6JM^ZF[N6ONIIZ+1I
M^9Y$L55DY)OD26B7Y'@/@;]HKQ9\+?C+H_B;2_%&L6]_X9OC<:?>6EQY;0D9
M4,@'RX*D@@@A@2"""0?U;^%6DZC_ ,'!*Z+IWQ5\:'PMX7\#J]Y)I/A*%[5O
M$,S1,JW$4DZS0*\;,/,R)"JX"I&)"X_%]OO%O4YX[5]%_LB?MVZQ^SG%:Z;8
MM#;P2![>>2YA\^W6-UVE@B[760@D%E;D$@BH^DUX#U,^RRGQ+P736'SW!TY4
M\/B84Z<JE&,_C<%)6;WLTU*+;<7>]ZR7,O9U'1Q#O3D[R3;L[;7L<7^W9^SI
MI7[)/[6_CKX<Z'XGL_&6E>%;Y;>VU:W=&\U7ACF,4GEDJ)X3(890,8EBD&%^
MZ/(\XK]8?^"DGPX_8_T__@EW;ZI\+]+\/Z?\0+B:QO["73(VDU$RM<,+N*]E
ME#.L(C:X81[U(*VNW,6W=^4. !G.?I7W'T7_ !<K\><'+$8RAB:>(PDWAJDL
M53C2J5ITHQ4JZA%M<E1MM6>Z:N[7.7.LO6%Q%HM-27,N5W23Z?(13M[]>>*"
M>?\ 9IRH6?Y=Q;K@#-=!X.\&6OB;3KRXN=7M+%K,J3;ODS3H2,F/C!(&>,]J
M_H;$8F%&#J5-EV5]_0\J*;T1S>.>E.')QZUZ=\6/@5H/@WPG;ZSH7C33]<CF
M(62Q>%X+RW)_O*R@$=>1Z5YI!;/<R!8U9F;IBN?+\QH8RE[:A?EO;5-;>328
MY0E%V9ZGH7QQ\.>'_"%G;Q>$+?\ MB @2WV_:VS!#;?<]>>_M7U=\._"%G#^
MP]XXUVXT?Q5X^TG[)'-YM]I96#3BS/AEE7*==HX/\(KY+^!OPYM;N'^W-4TF
MX\06*SK9+IL$GER7,C<D!^BG;G!/ -?0'BK]H[2_#7[+_B?2K/6M:\&WFK0K
M!:^!9R)[0Q!L99P-Y?JWSL!TXK^4?%2GE>/XRRW+LHI5*F,HU8RJ27.XPIR=
MVG*^G?R1[N!YXX><ZC2BUH?'^E^)+S1;T7%A<W%G(K$QF)RNP>GTJK<W,FH7
M#S2,TTTS%G<\LY/<UHZKH-C8>'-/N[?5K>ZNKDL+BS6-U>TQTR2,-GV-;/P?
M\4^&/"NM7$WBC0Y-=M7CVK$LS1;3D$\J00>",DD<]*_JJM6C2HRQ-*FYR6ED
MK2=G:VMK_D^AX48MNS./V_+QZYJ6TM9+Z9(88Y)9I"%1$4LSD]@!S7HWQ1;X
M:ZUXWTN;PVNK:/HUS'_IT,L@F:U;C[A*@D8SUS]>:9XK\!Z/X9U+3=0\"^(I
MO%$L47VNYB^PM')II7DA]PVMC'45A3SR,X0O"4)33:4HNR?:35U'YLKV1G^$
M_@-J^K?$G3?#>N!O!\VI NEQJUN\,:+C[QR,[3ZCBN9\5:%_PBWB.\T];N&^
M%C.\/G0',<NTXW+[&NB^)OQ[\1?%C7;'4=4N84O-/A\J&2WC$;*OU'7I7*VU
MI<:UJ4<,:M/=74@51GYI')X_,GO5X'Z]_&QTDO=UBMDTW=\SUM:V@2Y=HE8<
MOGWSS7UO_P $&3_QM\^!?_8:G_\ 2&YKYF\>_##7OACK?]F^(-+N=+O-B2"*
M7:2RNNY2""0000>M?3/_  0;X_X*_? O_L-3_P#I#<U\OXDUX5N#,SJ4I*47
MAZMFG=/W'LT:X.+6(@GW7YGZ&?\ !XU_Q[_ G_KIJO\ *WK\C/V>OA+XR^)5
MAKEUX6E\N'1;9K^];;E56)3(3T." N<U^N/_  >.-B'X$_[^J_RMZ_%7PS\0
M=<\&6MW#I.K:AI<6H1F&Y6VG:,3H1@JV.H(XP>U?D?T=<%5Q?A9@Z%+ENY5/
MCCS1M[65[KKIMYG?FTE'&R;\OR1TD_B[4?'WB<Q_99=<\431FUM]0CRUT%4'
M*JH'S8 /X9KK/V=OB)XE^ WQY\/WT&N^(CJEK_HVJ6-Q'Y;7ENS9:U7J<'KR
M .37D.EZQ=:+J<=Y9W$UO=0DE)HVVNA((.#]":W/!GQ#ET'QJNL7ZS:A*V0T
MA<><A_OHS C>,<9!'L:^@X[\!>&,\A7Q,L''VS@^5P;A+GMIM:-MNAGA<TKT
M[)RT\^Q^G7Q8\#?#_P".7P$G\2:7+H]YI.N*\,+VV)9_#\R*T9\Z.,Y5D8$Y
M'&0,]ZX'PC'X?\ ^'=)T&Z\2:7K5VUK';:O8W(B=8 '&V:3!+>;AN(R 2 3T
M%4?^";_QH\.ZKHWB;P#J&H0Q6/BNPN+C2-1U&W#C^T2&/V39&JJK,QX8* <^
MIS63^TY\+]#\;XM? <FN77C3PG (=7CBGCMDNIO,4F5PZ*9%50W*R$\]Z_C3
MA#)\^JXF7"N;UI4HT:C<_:+F<-+0DI/:-UO>VQ]#7J4XKV\%>ZZ'3>*?V>I=
M3^-E@?#O@AO$^GVZ[TO=,5T@D0,2)HG7$4KKG!126#*0<$&I/@;_ ,%#;OX'
MZMXDT_Q+KFD_%[0+RX6W_LV_UF.+4FBE&QHH@N8R &(*E@PKH/A'^V-<Z+\(
M?"VB^&;K2;&\T*]=-8GU"%VFU%0!YEO;';F%P2<&7 )/#>DG[9/[&?@;7_&F
M@ZUX9M9?#VFW!6\BOM/MXI(;F,X83%#AV"XQL0,YSP":^$PN1Y1B,WJY7QC*
MI2K+FY)PBK-+;FBE>TMT[;'3*K.--3P]FNQ]#_\ !+;]C#X:_&75O$FO:/KU
MS'I=F[AO#ENRV][HMU,0P#(P=6C"A@K$<L?08/EO[<W[?/A?6K'QU^S'XT\7
M:AXDT3P[?+'/XM^TI'-J,R;9#:[#)Y<B0L=IW2GE?NY48]?_ &?]>_99_8^_
M9SF\;:)\2--M?B!??9(]?CM_$>HM<7EV)3$=^DW#F2% KO\ .($&%W!L8)\!
M_;E_8)^&/Q:^.FK7UOXDD\.7^NQ)JFD795(M(U.VD42&4/LPTF"<KYBL  =N
M""?P7Z/,.%\X\0<?GG%V)KQPN&FH86-2@HJA7IM7KTW).5G:][+>[6D;>IFO
MMJ>$C2H17,]96>Z?0^.?B9_P3_U37M+;7/AO?MXZTQ<R+:V=OYFI+;CC[2T,
M1;,)8A0X)7+#FN!\<?L]6OPV^&,E]K6J)I_BIID$6C-&/-V'.[.3D,O&5QQD
M9KZR_8P\":A\,_BU9:#X5\13^+-?N+4365K(;FTLM0MXRHD11*B9A4LA=79"
M2%"@GD:7[87Q)\ ?$_Q9JWACXE>']/\ A_JBVZ165Y#936<?VI#\TD9,<KL"
M&3(9FW#;@#!K_1*C]*"AEV=PR;&XCV^&A-?OZ<5>4;;2777=Q6O0^3_L5SI^
MUBK-]&?G*(7N'9HXV=<XRJGG_P"O7LWP6_8C^+'QG\+PMX=^'>O:E;:XZII^
MHM:/';SO_=CD(VLV,G:.< GM7UWX5\(? _\ 88\,Z=;6>H>$OBY>>(E!\3ZE
M-"\S>'HE&3%#;&(L)"R@%STWD%AQ7$> _P#@J7;^ _!FD:'H?PXUR]T#0KP:
MA=7,>L3V\Z%2VUH3;[(X!\V#E6&*_6L9XM<0YTJD>#\M<Z<+6J5OW<7I=<JD
MXMZVMT?S.&.!I4O]YG\EJSB-3_X)'ZWX=TU6U7Q]X;L]0CD^S75E%8W5T]K<
M#&^ M&I4NF<,%^Z>M=)=?\$S?!/P(U31;CQU\8/#=A>22+=MIDDUOI]S)"IR
MLL?VJ6,-%(!PP]?7BO#O'O[8'C#XV?'/4=4CU^\\-Z;XBU8SK:I.?(L$<A=Q
M/.6V@%GZL<DU[5\=O@9\,?#FD6&I>-/BEXD\?:QY4<,,%IJ=M)Y$!( 1I-LI
M48/ 4<>@KQLZS#CC+N2/$F9<D:T7:&'P[G-.VJ;Y6M+VN73CAI?P8;/J_P#A
MCLOVB- N_P!ISP!K1U*+4)-0\%W8F3PQ8V8N-5C@DC BNF3 _P!&=5QY@R,[
M<9'->2?L_P#[(VI:)87GB#Q3X5UC3[6Q5YXX]0TUH5>/YMK*SX'/ [\UZQHW
MQ<\/?$31OC#I=I'>>"_%<!M;C1=2N-86W:2WMX0IM]TD0%V,R*QCWY)(P!BO
M//C?^UI\0?AAX/M_#OB*^O-1N-5TB"2,S65O!" P# C8O*[2#@,3Z\\5^ >#
MW'?$F92GP-E";ASRDZDI.,XT^?WK=G9NZM<]7,,+1BEBJGR72_0\+_:&^-4?
MQ#1M$L=-;3M#L[F62.W9@,.QP3M ]/?O7Z&_L\?MS?M*?\%BO@#'^SMX6TWX
M?Z&-.T6.R\<>,=2,4C:CI1/V9 EF\3+%-M*L7@!;S(0R-;9 K\T?#O@6;XDZ
M=KFJ)?6L-QIRBXDMW^4RAF"DJ3QQGN:]5_X)V?M"ZI^R!^TUIOBS3M3.DWEU
M;OI7FHPD$L%RRI(I RK<A6 8<,BL,%01^\?2%\)\MSS@R>+RO#4:N:Y4I5\'
M.O"554L0HI\[@FG-M:J_,E+EDXNUGY>4XZI2Q"C.34)Z22=KKL<M^W#^QKXJ
M_8-_:,UCX<^+O+N+O3XH;RRU&W@ECL]8M)DW1W$!D52RY#QL1D++#+'DE#7D
M9XK]N/\ @I!_P0KLO%D<WC[5OC-X@U/Q5J)73H9O%),L=VZ0NT%M',SG;\L3
M[=Q5,YR=S<_D]\.?V3-<^(WQ6U3PK%<6=E-HLLD=Y<W,J)# $W98G/0[>V:[
M_HV?2(R3C[@/#YQ4S"%?$4(*.)J1IRI1=2/NSE&$TI1C)JZ5EOHEH3G&4U<+
MBG3Y&E+6*NF[=KH\JQA.M=%\+;K3K?QMIBZL0-+>ZB^UDH'_ '08%N.^5!'X
MU[!KG['6BR65[IWACQ<OC#Q%8C)@L-.D2!F"@E/.?";AD=^<]Z\$O;.;2[Z2
M"5?+F@<HZY^Z1UK]]R_/,%G>'J0P<VM+7LXR5]FDU>W9V/+E2E2:YCVKXX^$
M_ _Q9^-5T/ -]HOA?PQ:VD48EU*:.UBFF^8L00Q7)XX!KQO6])_L'6KJR^T6
M]W]GD9/.MW$D4N#C*L."#C@U5^UO#"T:L?++;B,]Q5B]TJZM8(Y)X9(TF42(
MS'JO3-=F5X&I@81H.JYP44ES:R;75RW;9,Y*6MBFY^>@<-Z<TF>:7OSTKV[7
MW,10 6SUK4\.^$+SQ3'=-:Q[H[&(SS/CY8U'<^F2:S,YZ=/6K%AK%WIB31VU
MS- LR[)0C%1(OH?4>QK#$>TY;4VD_,J)"JX'S9ZU:U][%[M#I_GB'8I;S5"G
M?CG&#T'K4>DZ>VK:G;VWF>7Y[A VTMC/L,D_A73?%;X*ZU\)M3AAU"UN/L]U
M$)[:Y\LA+B,]&'L??!]JXZN886GBH8>I42J23<8WUDE:]EUL5&#:NEH<?GB@
M'-#)AJ-G'O7IIF844!<GK_\ 6HZ4P&MUK]2/^#2/_E)+XH_[$6\_]*[2ORW;
MK7ZD?\&DG_*27Q1_V(MY_P"E=I7XW](#_DWN:_\ 7I_FCT,K_P![AZGZ%?\
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MU[T4?Q&BO\US_6Y;'TQ_P3#_ .2F>*/^P9%_Z-K[4/6OBO\ X)A_\E,\4?\
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M -)]<K^GJOYA?^"9_P#RN0>)O^RJ?$?_ -)]<K^GJF2%%%% !1110 5^7/\
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M/PLO?BEX@M;?P+\0H=?T9[&/3]-<K=V,[859Y"5PPS]YLY))-?.OP6\=Z_\
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M7_\ B8K((8:>'S[#UL#4Y7:-6$DY:6]UV_$X/[)K<R=)J2\F>E_LX_"OP;\
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M $ZG-BZ*I5I4XNZ3&MUK]2/^#23_ )22^*/^Q%O/_2NTK\MVZU^I'_!I(/\
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MC?X<Z5;6T?B2PM](65K/7#"[6S7+M%=Q%&B%TBJISO65R=OEKD_X+5?!^'X
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M,MN5 "-'WY+'/IMKQ71[+5+^"X33X=0GCC'F3+;QNX0#^)MHX ]37J.N:D/
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M\(_\$&N?VG?B=_V3_P +_P#I9K-?=W[>W_)C'QH_[$37/_3?/7PC_P $&?\
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M\AGM1(\NEPPL9H)5\F:8*JR%)8_+1^U%X\'[ /\ ;']O'_A+?^%J_P#"J/\
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M>OT445^N'^=XUA\PK^)7XF?\E(\0?]A*Y_\ 1K5_;4Q^85_$K\3/^2D>(/\
ML)7/_HUJ_N[Z#W^^YO\ X:/_ *54/F.)/AI^K_0PZ]$_9F_Y'^X_Z\G_ /0T
MKSNO1/V9O^1_N/\ KR?_ -#2OZ8^D]_R:G/O^P:?Z'V_T>?^3E9+_P!A%/\
M,]XHHHK_ )S3_>P_;C_@V?\ ^3'_ !C_ -C]>?\ INTROT4K\Z_^#9__ ),?
M\8_]C]>?^F[3*_12OZ0X:_Y%6'_PK\C_ !6\;O\ DO<V_P"O\_S"BBBO</RP
M_FB_X.1?CSX[\"?\%:?'6FZ'XX\9:+IL.F:2R6FGZW=6L"%K"$L0B.%&3DG
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MK&E?\%1?V9_$&JVMAI_[1/P)OKZ^F2WM[:#Q[I4DUQ(Y"HB*LY+,S$  #))
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M_=2& R"$"D8&,UWW[07PNT^W_:HNKF;5Y-'_ +8EB9M%N[!G>"5W&8EAW$L
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M:7J4'4=^*\3^+'CE?B%\0]4U:&%K6UNIB;>!FW>1'T5,\9P,"G6_CB!/!O\
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M$9?&GPXD\%Z3KOB2#Q)J-Q;+<2W\TIN/.#$*8ED/5.3@=B/:N^\8K-IOQ?\
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MB"[CNH]:MM1>UWLVZ.:)D#9)_O$Y/TKQ'P>[1^);-H[3[<ROD0!]OG8'3/\
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M/B/_ .D^N5_3U7\PO_!,_P#Y7(/$W_95/B/_ .D^N5_3U7H'QH4444 %%%%
M!7Y<_P#!>;_DYSX8_P#9/_%'_I9HU?J-7Y<_\%YO^3G/AC_V3_Q1_P"EFC4
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M (-G_P#DQ_QC_P!C]>?^F[3*_12OZ0X:_P"15A_\*_(_Q6\;O^2]S;_K_/\
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M&O&>DW.BZI!'X;L(7FMKB-HI55UB#*2K$!@<CJ.:7X(?\' O[4W[//P<\*^
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MO[(_[(&B_M*Z'\3M>;XE0R6%C->^%=9@N]!\9ZS*[2W8W(J%8S&ESM*, D<
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MWY*S3ZV-'X]_M/>+?VA_%EQJ?B#6=2OFF96'VJ<S2$C'SNQZL3R3[XZ5[5\
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M5?%#Q!XBU36)(KG3;'5;6:2#7;C[D/SR2ON^_CYT;AB,$'%?17QS_:N\>?\
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M2B)I8[>)"LD+#;G=Y>< DM7['Q9])3QEQ&/P>4Y+PU6G5J8+ZRX3HI+VJO\
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MUKKS:=))-IDYA,9<*T<FTG!.&VL.N"*T_%?QRU/Q9\/9M!O-%A^TSSB>:_\
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M>M6ME<1Z6+2>S,Q2;SWF0R6\$L6Y5RP<!L*3BO\ %;_@L'X*^-W_  2&TO\
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MX/KXNTBQC_L"_P!*THW4 M7TFVDB$<DD,\)C*2*7+JS,?WCLS!R<UT7[.O\
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M$@=OLI4<Y9CE@<]2!BF^&X/!ECX!%YJ5_>_;[:9'D@M].$C$%R,,YE7:./O
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M'\$K[X<^(KO48DBM;W597\,HGV%PQ^T0?\26];S  -IA/_+04 ?0_P"WF?\
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MV[4?\+.TK_IZ_P# 9J_@;^S\3_(S_3;_ %TR+_H*A]Y]=?\ !,(_\7+\4?\
M8,C_ /1M?:AZU^5W[/\ ^WKIO[*.O:AJD?@OQ9XX_M>W6U-OI+V=M):[6W[V
M-W/"I4] %).>HQS7J_\ P_=LPW_) _BQ_P"#+0/_ )85]CE%*5/"QC-6>OYG
M\O\ B7C\/C>(*V(PLU.#4+-;:12/OJFG[]? _P#P_DL=VW_A0OQ7W8SC^TM
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MFG*Z:ZIGP.886M+$S:@]WT9Y3:_\?"_45]<M]X_6O'8OV%_BXDJM_P ()K&
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M%LA_QJ>^/7_8J7/\UK^2'[HK^MW_ (+7G/\ P2<^/&/^A4N/YI7\D;<+BO\
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M7YGWU_P>._ZKX$_[^J_RMZ_#^OW _P"#Q[_4_ G_ ']5_E;U^'^ZOB/HK_\
M)M\#ZU?_ $Y(Z<\_WN7R_)"H,O7IWP6_9EU3XY^'=3O-'DD\S25,DH,6Y=HQ
MR>>!R.1GK7E^>:V_!WQ'USP#J NM'U:_TV9>A@F**?J.AZ=Z_:^(*.95<'*.
M55(PK?9<E>-[]4M3SZ3BI7GMY">+_ FI^!M0:UU.UDMY%Y!;E7'J#WK&VEG_
M !KIM?\ B/J7C>QAL]2D-T8W_<-(P'DLWIP,#VZ53U[3;5+**2V%X)E&V53
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M.'^$LXRK X:5.A4H.I&[NH2<US05F[+9I)V70]S!U'5KTZDGJG;_ ()]B?\
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M6 ;\ZZO]J/7]-^$GQK\&Z%?>')]8UCX:V5O'<Z%8RR7%JR+&JHV[I;L0O*E
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M&%L+ZU8G#1+DE53F,J><QFJGCF?PU\,;+PWI[R1>+KBZMML]E<HEA);3=1<
ML^YE89_=I\O'KS73Z7\?;GX=_#W6/%5M#+/K6BP_V5I]M)J,C>9G,JK'92*8
M=FY\%BF,Y/-?S-'-^(L#Q)A>+G4]LXMPYG%P55):--7YN9;:;GL^SHSHRH-6
MOKZ'RI\4?"^C^"_#&GQ6%OJ-MK2MLN)I;@&.[!&"T2 94=L,>]=?X[\#V.H_
MLF:%X@L/W.H:7>FVU)@VXS*55HL^X8OP>17H7Q-T#P;\8]&M=2NM!C\ Z_-
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MPQF=%:$ 2EGS+0!]5?\ #F;]FW_HG=U_X4^L?_)5"_\ !&;]FUL_\6\N>/\
MJ:-8_P#DJO@?P3^U9^T1\%OVSO@KI.J>+OCI'X1^+GA?Q9<30?%"_P##*:I<
MS6.AWEXDT&DZ; 9+-([BW@=9I+F0.DOEE%'S2=!\"?%?[17B/PY^QE]L_::\
M;7FK?M=>&)X=?N9M$T\V_A>&WT>+5O.TN$1C9?O;VKVIN;AYX_,N9;@0 [8E
M /L#Q]_P2I_9+^%/A2XU[Q1X9T_PWH=J\4<VH:KXTU.SM(6EE2*)6EDO%12\
MDB(H)^9G51DD"MIO^",W[-@'_)/;G_PI]7_^2J^%?B_^TQ\1KC_@C/\ M<67
MBCQ;)X\U;X,_'J+P#HVM>(](L+ZZN]/@\0:"8VNHF@^S33#[5+A_)&W$94*4
M4BQXV\6?M&_&GX!_MW?%+1OVG?''@C_AG?Q[XMMO"&AZ?HFFS68MM*L[>_>W
MNGDB,DT<D1$,0#)Y#;Y&-P',8 /N";_@C3^S7;0/+)\/YHXXU+N[>*-7"J ,
MDD_:^@KQ'_A3/_!-LQ;E^(7P7VL,Y_X7$Y!'7_H(_C7V?\-?&5]\1OV2] \0
M:HT;ZEKWA&WU"[:--B---9K(Y5>PW,<#M7X^?\$UO^">'QU^)7[!_P ']<T7
M]G__ ()N^(?#VL>&K&XMM2\8^$M1N/$5] R ^9>R+:LCW#+RS!BI;G)% 'U1
M^SS_ ,$\?AS\6?VEO'&AZWX'U2^^%^F6ZW/A2X%]J,-E<1N4\N2&\253<*T;
M$@F1P0=P]:]]'_!&/]FV3YF^'MTQ/4_\)/K'_P E5]+:'H5GX=T6UTW3K6WT
M_3=/A2VM;6VB6*&VB10J1HB@*JJH     &!C%70-HH ^./BE_P $P_V0?@=X
M3DU_QMHNB^#]!AE2!]2USQSJ.GV:.YPBF6:\5 S'@#.2>E<3X%_9:_X)\_%#
MQ?8>'_#/B;X7>(M>U20Q66F:7\5I[R\O'"EBL<4>H%W;:I.%!. 3VK5_X. O
M"^I>-?V0O .CZ/IGA76]7U;XO^#;*QT[Q1 ]QH=_/)JT*1PWT:*SO:.S!955
M26C+@ DXK#_8=_X)]_%CX5_M*:'XB^(GP'_X)^^%] TF.>:+5?AGX4O+;Q+9
M71C*Q-;RSVR(BG<P<A@VUB!UH W/B_\ L/?L+?L^:[;:7X^O/ O@?4[RW^UP
M6GB#XE7>F7$\.XKYJ)-?JS)N5AN QE2,Y%=OX=_X)"_LN^+= L=6TKP2NJ:7
MJEO'=V=Y9^+=5GM[N&10T<L<BW95T92&#*2"""#BOC#_ ()\? ?X>_&+]B'7
M_B4/@+\)_P!IS]KS4M<E;XJ>'_%^K6$>IZ9JAU.]BDCF^V0W":>L2I(L<<<*
M+(ENH4L(U(X&'QWX3UG]BN3X3^(O!*_!'X)>%?VC].\"_%#PXOQ,?Q-HFC:8
MUA]JEMEU%4B-E9-J;6D<T2MB.62<,\>YPH!]J?"+]B/]A/\ : \13Z/X"O?
M?C;5K6V:]FL= ^)=WJ5Q# K(C2M'#?LPC#.BEB, NHSDBM#XQ_\ !/G]B?\
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M#^%_["WBC]G?QGHOBKXD>%='&E^&9%GN<W"ZA)>11-N/EC<=P*J< X]*^/\
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MN Z!(UD5U<D$C!8$GFO,-'_:/^)4\-UJWP[U:XT/1[J];^U=+UB3S?M*E_\
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M_P#PR7=MI#6^KPK.OVYK=+FWCCDBPC*2X D(*$[@2*^6WO;< 9L8_P#OZ_\
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MBN?^-GQ,UKXX_M2:MJ$4FF^&_AKHMEIJ:_I^CQ1--<F))1%^YC*><REFR3@
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M,>Y?S4;:O;VU/N=&2?[Y'Y_DS]O****_R5/O HHHH **\/\ ^"A/B_Q=\/\
M]G<:UX.\21^&;RP\0:,+V<6"74UU:2:E;0RV\1=MD1D$@5I"DA$9D"A7998\
M+]J2S\52?%_0[?P-X\\7+XVO)K66R\-6JVW]A65@DP%S=ZEF%I!$R"9%)D#/
M)M2)6*.0 ?1M%>$?M4?M^^#?V1/%NEZ+XDTWQ)?7.JV9O86TV*V:-4#E,-YL
M\9SD$\ CWKXJ_;H_X.2M0_9.T"7Q5X9^ \GCCP+:1QBZU"_\;1:+?VTKR+&
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M/QG_ .(YQ?\ HUYO_#C_ /WKH_XCG%_Z->;_ ,./_P#>N@#]GOV0OV"/@_\
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MCK%P(=1L+=XUL?/79+]G@W>3;ED+)F%$PCN@PKL#^1__ !'.+_T:\W_AQ_\
M[UT?\1SB_P#1KS?^''_^]= '[#?M=?\ !,;X!?MY:QINI?%SX6>%_&FK:3$+
M:UU*YA>&_C@4R,L!N(625H0TLC")F*!G9@NXYKHOV4?V'_A'^PUX+N/#_P )
M?A_X;\"Z;>/YEX=-M<7&H,'D=3<7#;II]AED">:[;%;:NU0 /Q7_ .(YQ?\
MHUYO_#C_ /WKH_XCG%_Z->;_ ,./_P#>N@#]_ ,"ODO]O#_@F1H/[?O[5'PA
MUOQ[H/A'Q9\,?!.A^)=-UO1M7\TW=Q<:@=-:UEM=B?*8VLI-T@EC=0P"[@S
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M+-,7!VDR%B5 7[H 'XE_\1SB_P#1KS?^''_^]='_ !'.+_T:\W_AQ_\ [UT
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M49-P5YV4_*S#Y@1SZXKXP_XC5OV6?^A!_: _\$>D?_+.C_B-6_99_P"A!_:
M_P#!'I'_ ,LZ /N+]I/_ ((R_LN_M>?$ZY\9_$+X+^$=>\57R!+O4T6:QGOB
M.CSFW>/SI ,+YDFY]JJN<* /5/ W['7PI^&O[/X^%.B_#GP79?#4VYM9?#7]
MD02:9=H<;O/A=2LS.0&=Y S.WS,68DU^9/\ Q&K?LL_]"#^T!_X(](_^6='_
M !&K?LL_]"#^T!_X(](_^6= 'WI^SQ_P24_9O_9-^.-Y\2/AS\(?"?A+QI>+
M<I_:%C%(!:K<-NE6WB9S%;@\J!"B!4)C7"$J9_VLO^"4_P"SM^W+XMLO$'Q5
M^$OA7Q;KUA%]GCU.6.2UO7BXQ')- R/*BX^59"P3+;0-S9^!/^(U;]EG_H0?
MV@/_  1Z1_\ +.C_ (C5OV6?^A!_: _\$>D?_+.@#]-/V6_V._A?^Q/\._\
MA%/A3X'\/^!M"DF-Q-!IEOL>[E/_ "TGE.9)GQA0TC,P4*H(4 #G_P#@HO\
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M5^5ZZ:-;-,^LQE1PHRE'=&]^UMK6N>+=6\"0ZO#I,,LFC^7IE]83QM%?P!W
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M6MEK*Q\M%-(JY^U,3@/'D,QR6YK]$P61X6ODGU^EF"=2#]Z@VXRY>K@[M/\
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M_$T,-H;_ #K&MRO%.3O<FU*0AMD87(5MO4<5^"49:\TE?^MV>ERI;&Y\>_\
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M:587N)$MVE!N&4@(H0%L["[9(X"FOG[P[X<N?%NM?9K1=BE\N[MMB@7/5V[
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M$]UGX5M9;6,&"16U#33$H/EMM52\?S$[]K'DU],:)^QMX%U"]UKQH?%GP_\
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MC7XP_&C_ )3 ^)/^R]^%/_2'P_0!^CJ?\$G/V6A][]FK]G\_]T\TC_Y'I?\
MAT[^RS_T;3^S_P#^&\TC_P"1Z^@** /G_P#X=._LL_\ 1M/[/_\ X;S2/_D>
MC_AT[^RS_P!&T_L__P#AO-(_^1Z^@** /G__ (=._LL_]&T_L_\ _AO-(_\
MD>C_ (=._LL_]&T_L_\ _AO-(_\ D>OH"B@#Y_\ ^'3O[+/_ $;3^S__ .&\
MTC_Y'H_X=._LL_\ 1M/[/_\ X;S2/_D>OH"B@#Y__P"'3O[+/_1M/[/_ /X;
MS2/_ )'H_P"'3O[+/_1M/[/_ /X;S2/_ )'KZ HH ^?_ /AT[^RS_P!&T_L_
M_P#AO-(_^1Z/^'3O[+/_ $;3^S__ .&\TC_Y'KZ HH ^?_\ AT[^RS_T;3^S
M_P#^&\TC_P"1Z/\ AT[^RS_T;3^S_P#^&\TC_P"1Z^@** /G_P#X=._LL_\
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MGT.+64&HG6)G-A?>;-HQQ:10I)']N4%W^QS&4 ]J'_!*+]E<_P#-M/P ]?\
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M]&T_L_\ _AO-(_\ D>OH"B@#^7/_ (. _@7X(_9W_P""]_PI\._#_P &^$_
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M6?B/X\Z#;WUKJ5];K<K*;;3U#7$VU@VT L@P<8.6 QU..1L_'C3]-T?XY?\
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M<[^V#^TQI/[6G[0'QD\6>%M:U/Q]X;TF"TBM=,UBQ3[*$BGVR7%D=Q*XRN
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MW6J6KON>S@<5&4:K5[M7/&_@A\-]2^+OCO4M%TBUFN+W5&,$:Q.L>[<_(RW
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M0C3$;UV]06R#SBN#T/PCI^J^%O&5EI=CI=K8Z]O.H&<+]LAE,HP0QRL4:O@
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M_P ;,=:_[$J^_P#2BVKJ\?)7\/LU_P"O3_-$Y7_O4/4]7_X/&/\ DM_P-_[
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MH$GB&9=<:;[A:!51621A@X;=V !/N0*^V_"'AK0?B[\!K6SLHVTG1M%E"_\
M"07-D0\KO*TKV\</#$_-@L"5QC(KX5^$.F3S7EU=P_99/LJ[C#-&7>?D#:@
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M+PA\2KW2+[Q#'=V,TNI6KZ?Y 5;1UD$0#K;QY\Q6(+,>1@  ^E=]?C%\:/\
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M>C-IT<GG):M91F!'P06";=H;#$9QGD^M;5% &??>&-/U/5+>^N-/L;B^L_\
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M&[@]"*_RHQ'$V93J87$35UADHP;CI:+ND^]GYGW'L86<5]K<\K^(7[/GC;X
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MAVU_:<^"\.HK;^-O"MUX,N)]-M_%4.F_;M-U: RM);QW4B,KPF*,J@+,R@#
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MX(Q245?=;WV]3+"X.&'7+37J>\_LF?"S2?L&G^'_  O#H^A?$SP6JZE+?ZM
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M&*R'CGD #Z D5P/>O4P.*^L1YW"4-6K25GIU]&1*/+H *K[U^GW_  :9'/\
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MPN=)LHK/PUI5Y:><[[0?-MHRNU8=NU7Q@ [AQQ7SG\-/"=Q!:7$S>5#=-/\
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M0!_,[_P<S?\ *Q!\*?\ L'^%O_3E-7],*]6^M?S/?\',W_*Q!\*?^P?X6_\
M3E-7],*]6^M "T&BB@#RO]K?X<>.OB[\*%T'P)XATGP[<7U[&NKR7J7"M>Z;
ML?SK6&>!UEMGD8QJTR?O%C\T1M%*T<\7S!\ O@!\7?V7]"\#^(-2^&=GXFD\
M&^+O'_E>&/ ESIUI<1Z=K.LR7=G/$M_>6]J(=JL^SSUDCCFMT,1=9=GWGBC%
M 'EO[$WPLUCX*?LI^"/"_B"&&VUK2=."7D,4HE6"1G:0H67Y69=^"5)7<#@L
M,$_E?_P<$_\ )TGQE_[('I7_ *4^+Z_:*OQ=_P"#@G_DZ3XR_P#9 ]*_]*?%
M] '[1444V0G''_ZZ '45\6_'G_@X4_8__9A^,7B+X?\ CGXO_P!A^+O"MXUA
MJMA_PBNMW/V690"5\R&S>-NHY1F'O3_V>O\ @X'_ &1?VK/C1H'P]\ _%S_A
M(/&'BJX-KI>G_P#"+:U:_:90C.5\R:T2-?E1CEW4<=>U 'V?1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110!_,/_P 'H_\ RE:^'?\ V2W3?_3QK%?T\5_,/_P>C_\ *5KX
M=_\ 9+=-_P#3QK%?T\4 %%%% !1110 4444 %%%% 'RS_P %MO\ E$[\>?\
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M,$9D/S$XWXWXYZ9KF>K?C1@T 5S8?"TZ+?LXI7=WYON5*3>X4JL<KCD]Z0G
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M[:KY:I]5U.K#XRK1O[-[G76GQ3NI[G;J$EY<6<+J]K%#,86M2OW=CK@J ,#
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M9HVV_M)>$B<,. (=0K]('U&W1C_I$(P?[XKP#6O"^F^)4MUU+3M/U!;.=;J
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M=?1?_0A7 5\OGO\ %CZ'QO$G\>'^']6%8^O?\?D?_7/^IK8K'U\9O(_^N?\
M4UV<'?\ (SCZ/\CT. _^1O'TE^13H/2@<4'I7[ ?NQ[)X1_Y%;2_^O6+_P!
M%::?=K,\(_\ (K:7_P!>L7_H K33[M?G]7XW\S\OJ_&_5BT44UUW+69F.HK
M\=>,5\$Z7'=-:W5TK2!&\I2=@/\ $3T'.!SC)/%>>67Q@6'XD7U])-J$FE/"
M%AM2IR&VISMZ#E6YZ_-7FXS-L/AIQIU'JVODG?7TT/'S#/,+A*L:-5ZR:7HF
MGKZ:'KS#YJX_XA2WFCRF\CU;[/%(OE+;F/=N^@Y'<\\8&/QV_!GB7_A+M!BO
MC;W%IYN[]W*I! SP1QR",$$<?B#5G5=#M=:\L74"3>6P=,CH<Y__ %^HKUL'
MB(WC56L?S7S/<P.*IWC66L7KMNOF><^#Q?/*NEKJ#:26<2F-HBK2\ YR><E<
M?+P"!]37J5N&5<,=Q  )QC)JK<:):W-_#=20QO<0C$;LN2G?BKD8QFML5B%6
M?,E;_,Z,;BE7ES)6_P _Z[CJ***Y3C"BBB@ HHH;I0 9HJGJ]^-,TN>X*22>
M2A8J@RS8]*K^&-?7Q'HT=XL<D*R9 5_8]O6JY'R\W0OV<N3GMIL:E%,&213Q
MTJ2#^9W_ (.9O^5B#X4_]@_PM_Z<IJ_IA7JWUK^9[_@YF_Y6(/A3_P!@_P +
M?^G*:OZ85ZM]: %HHHH **"<4A8#N* /)OVM?CMXP^!/AS1[SP?X!U+Q]=:A
M=-!<6]FDS-:($+"0^5&YP2 .0!SUK\@_^"M_Q#UOXR^(?BQXJ\4>&[OP3XBN
M/A(FD2Z#=!UFBM;?^WI8;S$B(^R9[NXC&4VYLWPS'<$_=;K7XN_\'!/_ "=)
M\9?^R!Z5_P"E/B^@#]H6Z5\$_P#!?6".?X#> ?,1),>)'(##./\ 1)J^]^M?
M!?\ P7T'_%B/ ?\ V,;_ /I)-7#F3?U:=NQ^?^*C:X4QK7\B_P#2D?E=<:-9
MWL#QS6=K+')PT<D*NK#W!&#26^CV=G L,-I:PQQC"HD*JJCV &!5JC%?#\S[
MG\#?6:MN7F=O5GZG_P#!-;X_^#?V3O\ @E???$+QYJR^'O!OA6_O[K4[\6LU
MR+6(W(0'RH4>1LLRC"(3STK,7_@Z+_834_\ )<__ "S/$/\ \@UW7_!'GPYI
MOB__ ()_6VF:QI]CJFFWFJZ@D]I>0+/!.OGDX9&!5AP#R*_/[_@J+\&?!_A_
M_@YY_8WT&Q\)^&;'0]0T.%KO3H-+@CM+HF[U,9DB"!&/RCJ#T'I7WV#UH0]%
M^1_H;P'=\.X*_P#S[C^2/U?_ &)?^"A7P?\ ^"B_@'5O%'P:\7_\)CH>AZA_
M9=]<_P!E7NG^1<^6DNS9=0Q.WR2(=R@KSC.017M%<_X'^&WAOX86$UKX:T'1
M/#MK<2^=-#IEA%9QRR8"[V6-0"VT 9/. !6^GW:Z#ZP6BBB@ S7R7_P43_9]
M_:Q^,_CCPW<?L[?M ^'/@WHEE921:Q9ZEX5L]9DU"X,@*2JT\$I0!,C:" >O
M-?5UY=QV,#332)%%&NYW=MJJ!W)K/C\:Z-+*JKJVF,S$!0+E,G]:#.I6IPTF
MTO5GX0_\$J_V@/\ @HW_ ,%5-,^)5QX?_:W\,^%?^%:ZXNB7"ZA\/M&F^VNP
MD/F(4L?E7]WT//-?O%X2M]0L?#.FV^JWD>H:I#:11WERD8C6YF" 22!1@*&;
M)P ,9Q7XQ_\ !H!KUCI/AC]J1KJ]M+99/'T.TRRJ@;Y+GIDU^SVF^)M-U:Y\
MJUO[&XFVEBD4ZNV/7 /TH#VU-2Y.97[7U-"BBC/%!H%%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% '\P__  >C_P#*5KX=_P#9+=-_
M]/&L5_3Q7\P__!Z/_P I6OAW_P!DMTW_ -/&L5_3Q0 4444 %%%% !1110 4
M44C-M% 'RU_P6U&?^"3WQY_[%.X_FM?R/XXK^P'_ (*H>//AE\//V!?B-J'Q
MDAU^;X:7%I;Z9KB:*A:_:.[NX+5/*P1SYL\>3G@9//2OQ0%G_P $J7L%NCI'
M[0"0R=-SS#_V>OZ\^CGX[</<"Y1B\#G$:DIU*BFN2*DK**CK>2UNCYW.,OGB
M:B<&M%U/RO'-&?\ .:_4;3+_ /X).ZI,T<=C\>E96V'?+,O/_?=3ZPG_  2A
MT1F66Q^/$A49Q'-,W_L]?T7_ ,3E<#\JFZ5>W?V<?_DSR_\ 5_$VO=??_P
M_+'.:,U^G-IXK_X),WDWEII7[0F[T/G?_'*N)J'_  2AD;"Z3^T$QZ<&8_\
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M1^T&%]2TW_QROTG_ (G0X"6G)7_\ C_\F<[R2LE=RC]Y^7E.C?:U?I_%J_\
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M_5<?IT>&TJBI1E5<GTY87_\ 3ASQ\(^*G'G6#G;_  R_R/Q+HQ7[77_["O\
MP3ATQ$:;1?C2JR=#]OE/_LU06/[$O_!-W4K:26#1?C9(D)P^+Z7Y3_WU71_Q
M._X=M-KVUEO[D/\ Y,P_XA;Q+S*'U6=WTY7_ )'XL$TJQLRLV/E7J<5^S]U^
MQO\ \$V;*(O/HOQNAC4??>\F"_\ H58>J? W_@E[H2&.2W^,W[P8VIJ$Q)_#
M?79A_IF\#5Z3K4:=>45U4(M?^EG!C> <ZP;Y<52<'YIK\T?CV3BDSFOW1_8<
M_P""8G_!/C_@H?XX\1Z'\-=!^,-Y+X3LHKW5+J^U5[:VMA,[)#'DN69Y-DI
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MR=H^>;K_ -]U'=VW_!*NQ@6231?V@U1^AW3?_'*]&7TI^&5=RP>*T_Z=1_\
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M?@W=W;793<<^6NP?05%GZ5^]7_#L3_@E+_T7SX<?^'HT[_X_1_P[$_X)2_\
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MY7 W_/JO_P" 1_\ DP_U>Q/=?>_\C\%0:*_>K_AV)_P2E_Z+W\./_#T:=_\
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M_AZ-._\ C]'_  [%_P""4O\ T7SX<?\ AZ=._P#C]1/Z8G <_BHUW_W#A_\
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MSP<5D^+K3YY<OR/P4I<XK]ZT_P""8'_!*>0_+\>?ARWT^-&G?_'Z&_X)A?\
M!*93@_'KX<@^_P :-._^/U]HOID<#V_A8C_P"/\ \F<_^K^)\OO/P5+YH' K
M]Z/^'8G_  2E_P"B]_#C_P /3IW_ ,?J9?\ @EQ_P2K?[OQV^'C?3XS:?_\
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MO_!1[Q/X=U#XJ?VE<:AX2MY[.R%AKAL=B2LCN'5>IR@Z]*^?_P#B&,_8Y/\
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M[O[>W1&U;)<75DI-K9+?L?S2NW--K^ES_B&+_8Y_Y]?%7_A6O1_Q#%_L<_\
M/KXJ_P#"M>OI?^)R.!O^?6(_\ C_ /)F/^K^)[K[S^:7.*,U_2U_Q#%_L<?\
M^WBK_P *UZ/^(8K]CD_\NWBK_P *UZK_ (G*X&_Y]8C_ , C_P#)A_J_B>Z^
M_P#X!_-+FBOZ6O\ B&*_8Y_Y]O%7_A6O1_Q#%_L<9_X]_%7_ (5KT?\ $Y7
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MV\5?^%<]?HZ^F5P-;^%B/_ (_P#R9Q_ZOXGNOO\ ^ ?S29I17]+0_P"#8O\
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MP"\.70^&L>N_&;7D*I EC;2Z5I9=ED)WW5Q'N^4H@(2)LB0$;L-C5\%^&?\
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MC!+R!<@ =>>E?:9?@JU'"K"4DU#>RZ^K/Q/-^(L5F6(5?%5&[=S^E;_@TU^
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MI-$\,2>)+KR[?Y H!);/<TI6W(C)Q;<F8GV"#/\ J8?^^!7]8O\ P:N(L?\
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MX?,\RS;9)N&.<D<?B#72HMIM;(ZXQDXMK9;^1J44F]?6E!R*1)_,[_P<S?\
M*Q!\*?\ L'^%O_3E-7],*]6^M?S/?\',W_*Q!\*?^P?X6_\ 3E-7],*]6^M
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M6OAW_P!DMTW_ -/&L5_3Q7\P_P#P>C_\I6OAW_V2W3?_ $\:Q7]/% !1110
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MVL'6OVT_C=<$;?,\(6A _N_Z:*_%&6,EMS-^&*_9[_@RE;_C,'XU?]B;:_\
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M "!;/_K@G_H(K^:O4?\ D'S_ /7-OY5_2IH?_(%L_P#K@G_H(K\ ^DMOE_\
MW%_]QG\Z_3 _YE7_ '&_]Q%JBBBOY9/XI/&_^"A?_)COQ4_[%N\_]%FOPE-?
MNU_P4+_Y,=^*G_8MWG_HLU^$IKY;/_XD?0_D?Z1/_(VPO_7M_P#I3%/WJI:O
M_JXO\]A5T_>JEJ_^KB_SV%?>>!?_ "6^!_Q/\F?0?0M_Y/+DO^.7_I$BC1WH
MH[U_IXS_ *1#]L/^"+W_ "CP\&_]?FJ?^G&XKZHKY7_X(O?\H\/!O_7YJG_I
MQN*^J*_S:XZ_Y*/'_P#7ZK_Z6S_(GQ*_Y*W,_P#L(K?^G)!1117RI\2%%%%
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MECC67HW[P]?H17)_$3PX=*U%9EQLF^8 #I7:>)/#EKKD.]F56Q\KKWKD]?\
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M HHHH *_&'XT?\I@?$G_ &7OPI_Z0^'Z_9ZOQA^-'_*8'Q)_V7OPI_Z0^'Z
M/V>KC?B1_P A.W_ZY_UKLJXWXD?\A.W_ .N?]:\W-_\ =9?+\SR,\_W27R_,
MYM?O?A0]"_>_"AZ^+_X)\$8-Z<W]Q_UT:HZDOO\ C_N/^NC5'7] 8'_=J?\
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MOB*?Q/?>=<-\W;C%?MI_P>T'_B\'[//_ &!M=_\ 1]C7X@6(4SC=U[5RK/\
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METV&Y:U\JRAAB=!*25,BLR@X# 9%5'GA%\M[:W_K\BJF!<(N5_AOT[;GY?\
MB"QDL]0D!7;'CC-?LA_P92C'[8?QH_[$VT_]+17Y9^-= _M33Y,+F13GIU%?
MJM_P9<6AL_VQ/C1E<'_A#K3GU_TX5T4:E]&>QE>)52R/E7_@K=KU]I?_  5:
M_: $5TT<;>,[P;1SQD<5\R:[=":\VJK-N;!8IC)KVO\ X+#^(9]!_P""O7Q^
MF3;NB\<WI4'^(;EX-4(OBOX7^(/P^'VR&'3]5AC$94)N\_W![5^C<(<*Y;G%
M.L\7BU1E"-TFOBMYGRF<2J8?$>TA"]WT/ =5GW7GE[3MSCKS45UI<>EW*21R
M;FR#C-7M?@MXKMI%(+;CWJKI\'VIVN&7<EL-[#L5%?"XB,:3<=SIC4;5T5?$
M47E!763YI!\P%%IH(BA5V_>,QXQ4.JZ@=9U+S%140<;1V%=5\(_L-WX\L?[2
MD6&T5_F)^Z<<@'V.*XE*VK-*DY4Z=S+T70VO+UU+Q6;0C<K2'&<=JU?''BB;
M7["QAN;B.\NH0094YV@8 'Z52^(J&_\ %U\8WCD4S,46+E #V%8T:-%;;E!+
M=,8Z5[F#SBMA\)4P]*3<:EKI-]'VZF?(I\M26_Y"M<K&S+(VXX_.J\D<TH_<
MJV.O3H/K72>'/!6H:Q<+MM5C/0L1@+[FN[\+:8W@*1;Z9M)^UV+ATBN(M\,F
M.[ \<U\Y6Q7LFUNV34QB@N5+7MW/&9XFMGW2.)&';.:0ZE-L*J[*K'. :] ^
M./Q;M_BAJ4EU_8VAZ3<,I5ET^V$4<C?WR!T_"O.$4L?[S=\5OA,95IPYU>,M
MM'T/0P\I5(<]2-GV)M->8W6^-?F4YZ=:[F716/A^V::W6-KB4LIQA@!_C5'X
M9^%%UWQ!:6LC^7&[[YG/\"@9YKTS4H+/Q-8^))%98X=+MXUM0#\P"N!G\03S
M7M9;E,L<^:-11:N]?0\O,,5:2C%&+8W=UXG\.7)OYO,M]/00PJS8VKUP!7E>
MN@RZA(%SM4X4>E=EHZO=7GV82/Y9.<=C5CQ-X,MX9XRO[LL.<]Z\S%8AU914
MFVTDG=WU7;R,\-4C2J.W74\Y,$F>%;\J]'^&6M6W@[PM(WV59M0N,[7S@I[T
MS1O#\8G&]&9!QTZ5U5M\*[CQ="HTV&5_+4L[J.(P.I)]J*56=.I[2"NUTL=,
MLT5/1]3S?5](FUK49)'F8S39.\G.:K7'AZZM#;V\D7F2R-E67GY>^:ZFX6*R
MU5K2&55@B?:6[$]S6+K7B:XTK4FAC1K=6X$F.7'^%>;S3;ND=5+VDU=[$=UK
ML7A:0K#_ ,?"C!(XQQZURTEPUUJ#,^69SDY.32W)_P!(8EMV3R?6H64NYP,F
MNBF^7WEHSMYO=Y>AU7@;2K6\U^)7F6T&WEI#\IH\0Z=9)JK0VC?:HBX#/$N%
MS4-II5G9:5N>5IKJ38X\K[J#G*GWK4L+?RY[>+YGC;!P!SG_ !K2%3G2IQC=
MOR.6JG">_0R]>TVUT&ZD@CMTFVJ-S]PQIW@74G\->(+>^C8^9"X=0.HJY\5/
M"-QX+UI;>\G5KJ9!.Z#[T>[!VM[XK&M((0FW:6;'S'TKJHUL5E]=3A>-2+3O
MLT_^ 3RJI!J6S.H^+?Q-O/BGXGW?:I/L+'Y8V;B+UQ6?X\^'^EZ%H=K=6^H)
M=3R$!HP>5KF+RYCLY=L?\//UJ*34X[B%LJ5<T\?C<1C:SQ>)FY3>K;W95/"^
MR453T12D7RPWL>/I4>234D\N\<MNXQ40/%<D9.YWPU0O6B@GBG+;RM:>>(W,
M.<;P/ES]:UN7&+>PT\BFN2$-.%%.[ O>&]4:TN8XP5&XX.:VM369FC"$/NP<
MJW2N58^6O'%(MY(G\7M713K\NC,*E'F?,C>UP1I:[KA4,GJ#\WYU_4[_ ,&K
MY_XTH_#/'3^T]>_]/%W7\H,CM)G<U?U>_P#!JX<_\$3_ (9_]A/7O_3O=U-2
MHI'HY;3Y&T?HC1116)ZP4444 %(7P:1FV]J^'?VT/VE_&UK^T1X4TU]+^*GA
M/PSH/Q'\-:39MI.DS"Q\5_:+NV$\]U>QY4V>V9HDME(+/'(\NX>7&@!]Q>8N
M:_&/XT'/_!8'Q)_V7OPI_P"D/A^OT^_:&\._&C5_$NGO\,M>\%:3I<=L5O(]
M:@EDFDGW'#(5C8;=N!U'-?ECXNBU.U_X*9Q6_B*:UNO%UO\ &KPLOB"YLP5L
M[F\\O1BK0 @$1BW:V4@JI+K(<8() /VNKC?B1_R$[?\ ZY_UKLJXWXD?\A.W
M_P"N?]:\W-_]UE\OS/(SS_=)?+\SFU^]^%#4+][\*&KXO_@GP1@WO%_<?]=&
MJ.I+W_C_ +C_ *Z&HZ_H# _[M3_PQ_)'].9;_NE+_#'\D7?#/_(RZ?\ ]?4?
M_H2U[2O45XMX9_Y&73_^OJ/_ -"6O:5ZBO!SW^)'T/F^)/XL?3]1U-;[XIU-
M;[XKPSYLS/&7_(L77T7_ -"%<!7?^,O^18NOHO\ Z$*X"OE\]_BQ]#XWB3^/
M#_#^K"L?7SB\C_ZY_P!36Q6/KW_'Y'_US_J:[.#O^1G'T?Y'H<!_\C>/I+\B
MF#F@]**#TK]@/W8]D\(_\BMI?_7K%_Z *TT^[69X1_Y%;2_^O6+_ - %::?=
MK\_J_&_F?E]7XWZL6FKVIU-7J*S,SRV3_7O_ +QHHD_U[_[QHK\]G\3/RV7Q
M,H^(/^/(?[X_D:QU/-;'B#_CR'^^/Y&L<5^L\%_\B[_MY_H?M_A__P BG_MY
M_H.KO?@E]S4OK'_[-7!5WOP2^YJ7UC_]FKV\V_W67R_-'T.>?[G+Y?FCNZ**
M*^-/@0)P*:KAJ).5KA_&=_/;^(952XGC4*N LA4=/8UR8S%1P\.>2OK8XL=C
M5A:?M)*^MC\I_P#@YP/_ !L9_P"";_M\2+K_ -.?AROV0?E<5\Q_'W]D+X;_
M +4GC;P+XD^(/A>U\4:Y\,[]M3\+WEU=7"2:-<M);RM+'Y<B@DO:P'YPP_=C
MC!8'U :M=;]WVNZ)S_SV;_&O.CGE-M)19Y4>(J3:2B[LY$'([_6EWEACG Z"
ME48 I!PWXU^N4[.*?DC]RI.\4_)&_P#"_)\;VG^[)_Z :]<7[M>2?"__ )'B
MU^C_ /H#5ZW7R^=_[PO1?J?&\1?[RO\ "OU/YG?^#F;_ )6(/A3_ -@_PM_Z
M<IJ_IA7JWUK^9[_@YF_Y6(/A3_V#_"W_ *<IJ_IA7JWUKQSP1:*** "BBB@!
M'<(.:_%W_@X';=^U)\9/^R!Z5_Z4^+J_5S]HS2OB=J^C::GPPU?POI&H+<,;
MY];B>2.2':=H38C?-NQUQQ7X^?\ !9"Q\6:7X^^+5M\1+S2-3\=+\'())[O2
M$9+!M-9O$0M(P&56\Y9EORYV@%9(<$X8  _<JO@O_@OI_P D(\!_]C&__I)-
M7WI7P7_P7T_Y(1X#_P"QC?\ ]))JX,S_ -VGZ'Y]XJ_\DGC?\"_]*1^6]%%%
M?#'\ &/??\?DO^]_A4=27W_'Y+_O?X5'7^MO _\ R3F _P"O%+_TB)_U0>"_
M_)O\C_[ \-_Z9@0ZC_R#Y_\ KFW\J_I4T/\ Y MG_P!<$_\ 017\U>H_\@^?
M_KFW\J_I4T/_ ) MG_UP3_T$5^ ?26WR_P#[B_\ N,_G7Z8'_,J_[C?^XBU1
M117\LG\4GC?_  4+_P"3'?BI_P!BW>?^BS7X2FOW:_X*%_\ )COQ4_[%N\_]
M%FOPE-?+9_\ Q(^A_(_TB?\ D;87_KV__2F*?O52U?\ U<7^>PJZ?O52U?\
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M2R:=>P*&WA1,)@LRQRA?F<!%<KMMT/1P-.*C)Q/D7]L;_@@U\(?BW^Q3XO\
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MU.[D\0Z=I=B+?[7$//Y*K\W_ .JOU[_8H_X*Z_#'_@F#_P $-[>V\%^(-/\
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M#@?KM>ABJG+.GMUOUM=>6OF3F2E5H1Y%S>1SWQ*U_P#MF]6/SUDA0<C[I/\
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M^:;Z65OWF0R]A7JQJ..S-L5%RJRYNY#+^\N.^.O)K:OKQ=.\,M:QL'N+P N
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M5XM-]UT[E8&HE'DEN=/X.^+4FDZ+);73SS;Q@ $;?QKH$TG3?'J6MQ]LAA9
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MJ?\ AC^2/Z<RW_=*7^&/Y(N^&?\ D9=/_P"OJ/\ ]"6O:5ZBO%O#/_(RZ?\
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M>(/^/(?[X_D:QU/-?K/!?_(N_P"WG^A^W^'_ /R*?^WG^@ZN]^"7W-2^L?\
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M-\P CV *>BX&!C%?E]_P<$_\G2?&7_L@>E?^E/B^@#]HJ^"_^"^G_)"/ ?\
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M0_=%?=W_  5C^,4WA7_@H;^TOI/E/=)?>+KV)5;.V/H,Y^@KX4O(@]SYT/U
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M *YM_*OZ5-#_ .0+9_\ 7!/_ $$5^ ?26WR__N+_ .XS^=?I@?\ ,J_[C?\
MN(M4445_+)_%)XW_ ,%"_P#DQWXJ?]BW>?\ HLU^$IK]VO\ @H7_ ,F._%3_
M +%N\_\ 19K\)37RV?\ \2/H?R/](G_D;87_ *]O_P!*8I^]5+5_]7%_GL*N
MG[U4M7_U<7^>PK[SP+_Y+? _XG^3/H/H6_\ )Y<E_P <O_2)%&CO11WK_3QG
M_2(?MA_P1>_Y1X>#?^OS5/\ TXW%?5%?*_\ P1>_Y1X>#?\ K\U3_P!.-Q7U
M17^;7'7_ "4>/_Z_5?\ TMG^1/B5_P E;F?_ &$5O_3D@HHHKY4^)/Y[_C]_
MR7WQY_V,NI_^E<M<F>E=9\?O^2^^//\ L9=3_P#2N6N3-?G=;XY>K/\ ,_-?
M]^K?XY?FSL/V=/\ DXGX>_\ 8TZ7_P"EL-?I9^W-_P &_P!\#/\ @H/^T/>_
M$SQYJ7Q)M_$5_9VUE+'HWB 6=IY<"[$Q'Y3$$CJ<\GGBORU\&>,)OAUXVT7Q
M%#;QW,^@:C;:G'!(2$F:"9)0C$<@$J 2.>:^RH/^#@/X@"93)X%\)-'N!95N
M9\D>@-?K7AWX>YYGV#JXK+*2G",K/WDM;;:M']U?1'\)^)>)<DQV89/052G&
MI&+?-%:J-[6;7='R1_P02_X(*?!3_@I5_P $Z].^)7Q'UCXG+XDOM;U'39?[
M*\1?9[<Q0N%3$;1/S@\Y)S^E?T*10+"BJN<* !D_A7X#_P#!)/\ ;T\>?\$O
M_P!CFQ^%,.@^$_$*V>K7NI?;#<7 W"=PP7[J],>E?I[_ ,$P_P#@HCXD_;GU
MOQI:Z]H.CZ*OAF"RE@:QEDD\XSM.&W;^F/*&,?WC7U&;>&/$669?+-,=0Y*4
M;7;E&ZNTE=7ONT?TMGG@WQ9D^52SK,<-[.C%)MN4;KF:BKQO>]VE:VA]?44U
M*=7P)^7A45]=16-G+-/)'##"ADDD=@JHH&223P !W-2UG^*_#=GXR\,:CH^I
M0?:M.U6VDL[J$LR^=%(I1URI!&5)&00>>"* / -$US]FS0_VA-4^*EIX[^',
M?C+6[,65W>_\)=;,DT>V),B,S%%8I#$N5 X7U+$Z_P"RYX4^!'@3QMXB'PMU
M;P/>^(/$LDNI:DFD:Q;W=P\?G,^U8HW/EP1M*%"HJJ 5SD\G\0?^#CS_ ()#
M?LZ_L%S?LYI\*?AS'X57QQXOETS7/^)YJ=[]OME^RXC/VBXDV?ZQ_F3:W/6O
MV0_8[_X(Q_LT_P#!/WXM7'CCX1?#./PAXHNM-ETB2^77M4OMUK*\<CQ^7<W,
MD?+0QG<%W#;@$ G,^SCO8X897@X352%**DFY)V5U*7Q->;ZOKU/1_P!L7]I^
M\_92^&5MXBLO!.N^.&EO8[>:TTQ7W6L+<-,SA'  )10IQN+=1@D? OA3_@IE
MJ5E_P4)\5>-)X_B]<^"9=,6*Q\#LLS7,,IMK9?-^P^:;>-0\<CE]V[$P8!BS
M8_3'XK^'-;\8?#'Q!I7AW6CX;U[4M/GMM/U40B8Z;.Z,J3!,_-L8AL9YQ7P[
M8_\ !%&\TKX&Z7=6GC*YL_CC:ZPFI3>*XKZZ,)4W"Y4 _.3'" ZM\K/,O+JK
M#9^I<#8[ANCA*T,XA[\_W:=Y-VE9\S7*U&,>6SE&\_>>CL?NGAOF7".'P%>G
MGT/WE2]).\F^6=GS-<K48P<;.4+S]]VB[7/KW]DGX^WO[2WP9LO%>H>$]8\%
M7EU+)&^EZB',B*#E)%=HX_,1T*L&"X!)7[RL!Z;6+\/]+U71/!VEV>N:HFM:
MQ:VD<5[J"6XMUO9@H#2B-3A-QYP.!6U7YQC)4I5YRH1Y87=DFVDKZ)-ZM>;U
M[GY+F%2C/%5)8:*C!R?*DVTE?1)R]YI+9O7OJ?S#_P#!Z/\ \I6OAW_V2W3?
M_3QK%?T\5_,/_P 'H_\ RE:^'?\ V2W3?_3QK%?T\5S'&%%%% !1110!P_[3
M'CG6/AA^SMX^\3>';6.^\0>'?#>HZGIEM) ]PEQ=0VLDL*&-"&<,Z*-JD,<X
M!!K\??\ @UI_8B^!?[8/[%OC3XK?%+P;X0^,OQ6\4>,KR/Q)J/C:S@\1W5NR
M!98\+=+)Y3R^>\KR??E+Y9F"(%_;:8X*U\'^#?\ @D!\ ?\ @G;^V9;?M&>"
M?%UW\#]#6'4T\1^&!K"VGA76?M,+R']U*X6W6(IYXAC/E+]FBV1QK%0!XU_P
M2K_X(_6_[*?_  5>_:(U+Q3X'U;6_!/A+3M+L_@MK7B-I=1M-!T>^:]FO-.T
MYI99400.Q@.?WRQDD[5NI/-\F_X."?"FF?L7_P#!4']C?XN?"/2]/\,_$KQ9
MXGETC64T>V6U/B"U2:PB NH[<)+<!HYY(3N8AHU5.@Q7Z0:9_P %@OV5-:U&
MVL[7]HOX,SW5W*L,,2^++(M([$*J@>9W) KR_P#9Z_X(J_!73OVSO$G[3FOZ
M[KGQH^(GB#Q-=^(?#NK:UJS7FF^%$:298;:RA1S&ZVZ.L4;2^9Y7V:$Q+"T8
M- %+_@Y9TX:M_P $5/C%:_=\VX\/#IZ>(=-_PK^5;1K"'P=XD5Y9/E4D\#.*
M_JG_ .#EB^;3?^"*GQ@GCY:.X\/$ _\ 8PZ:*_E)\37*ZK?M,K'YN",5G];]
ME5CRK5:GCYAS.HETL=7X@U:'Q=KL4T*XVX4''WL=Z]=^&7A-=7UJU6Z=56UV
MRLIZ<5Y1\']!CU.9/,+;D'&>!7L^E:#NMGNA)(LNPQ@(>OUKVJ&%JU8NMUJ/
MO9:'FX6O"GB5)ZJ.OS(O$WB :AXKFAM?E5IRH. .!5[4&:*U5689!KG?$MW8
M^$HDO)IMLBC(4CDFO,]2^)/BKXE^*?[.\.Z;J&K76TNMKIUI)=32(,9;:BEL
M#(YQ@9%3@_JF'DXTX6J1V>ZUW/.FI8FO*4=;L]H2W2\L"J[59#ZULZ8;._TI
M],NU&Z4[PSC*MGU]*^9]3U;QMX+L#)JVEZ_I4;W,EJ);VREMXVFC)$D09U W
MH5(9>H*D$#%>G_ ;QI=>)/#[_;6W2"3;O)[8'%=E?%X2<U0J4[0Z:7=WU-Z=
M&>%J.KTT)-;\&1^%M=NFM75FB_?;5^88KQCXD:I->ZO-O;8%8X6OH_Q;;+90
MM<*BR+_JW8=",5\Y_$@*=5F957YFP/>OE\=AUAZRI0E>-V;48KVCG_,KG/"2
M0(JHWWO0]>:TX-2FTZW7:"OK@U0L[ 31>9S'S@ "M$Z<;B#Y6;\JY*W)L=4J
MBV81>);H-\KR  Y.&ZUZ!X,^(L,FD9N(=DFX!AG.1VKSI=&EA3=\RX/>GZ;<
M-:6\BJ=\@.<5E&4(3C5@E=?B8U*:G'ECN=YXX:SOXVFM6'F Y*],BN*DU;:O
M(*_-D#-=+\-X]/U#4'_M)?X<*IX&:O?$_P )Z3IFG+<VC$R, 4 ['ZUU58^T
M;KZ13Z&5.7+[CW//;W5&9R3W/I4 N?)'F,#ZCBF987*M)G:.JFNDMGANM.,8
MMA(G=_2N2,^2TCK7NO4PK#4OMVI1*W[M9.,9XJ[>SS:9=R1>8VZ-OE.< 53O
M=+%E<M(N5V'O_2M+2-,_X2ZZ6$S!9&.<FNF.*FI*=-V*NGKV*]SXYU"Z,:M,
M (_N\\&NFTGQW8ZO9@:E;[YHARV?O5@>/?A[)X0=6\[SE<@ 8QM-<Z+AD&T\
M4\9#ZS).JWS+KLSKP>)E37-3?J>L)\;K/0O#\UAIEG'"LPPS'ES^>:Y+3/$,
MB7DT\BMNF'6N1\QO,W;L\UI65U))%RVT+QQ2Q-ZD%"3V,<1.<WS5'=FQ::<+
MJZ^T28*R-@Y'-=F/#\UI'!]GN#MD((&[@5P!N);*)9-W?(K6@^(ETT"JD(_=
M\T\/'#N+6)C?MKM_PYE'$3BN6+LCN(;B]N/$4_VAO)M88#EW.03CL*\UU7Q+
M':O)!#EEW'!Z4NO?$R]U$%=WE\;6V]ZYC=]IN5W=^:PA"]3:T>B.AR=1*YV7
MA>07TBQ[3_>8USWB XU63T#UTO@Y/)TV[9&61E_O'VKC[R7?>R!OO$YXKTLG
M_P!YDNB,;6T#S5_NFD\P#H#FF#IFG)]YOI7U'+;4+&OX0U^3PQKD-Q$S=>1G
MK^=>Z_';]K/XD_&C]G/P3\-=:\7ZA>_#/P#<S7>A>'1#!#:Z?/*7+3,8HU>=
MQYLP5YVD,8ED";0[ _.I!V\5WGP_N_\ A(HFT^:7RQL/S>GI7R_$7N1C76^S
M\SKP7[Q>R[G(WLD=IN19#R>F*A5_-PW0TS7[5K75IH=K$QL<GZ&JT4YC15]S
MUKBIW<;^AE*ERWYC4M[K< &RVWU/>OKC_@CIXVE'_!2/X!Z;+&7#>/-'*L>,
M9ND%?)-@T<%G\RJSR'.?2OIC_@D+?[?^"H?[/H;;^\^(.BJI'_7VE==+%U**
MY*3M?1V['-[LIQ]4?JY_P>N,4^!WP!^;'_%0ZK^/^BPU_/S%J:I_#[&OZ"/^
M#UY=_P #_@%P?^1AU7I_UZPU_/7Y'E$_*?FK.K'FEH>GB+<YH)J22#YQ0+V)
M#\J_CZ5GR?*?\*;N]JQ44]3DY;ZFT/$LMM%\N#OXK>\&_%"Y\.(\+!9K>7YB
MK8^5O:N)0;^U2):R2?=7=^!KIPM:>'E>D^5M-/S7F1*E!K70["]^(DEY?EAM
M5?0=*R-?ULWL8/<CTK.L[&2678%Y/'YUJ:UX+N-&L5DD3Y6Z$&HI<R5K<R7X
M&2C2A)/JSGY)#YGS<CZ4;P6XXH="9&IOW6^E+3H=FA-;.%DP_ 88K7L-+5@K
M1LPQC.:Q%?<?N_G5B"_D@_C8#T%1./,K(B<6XV.\B6*#2FW!6;/7TXK!DU-?
M-Z#\#6/+J\C)_K9?IVJJUT['K6&'PLHRW,J='74ZJVO_ +0@7^=0:A:-;'S!
MQW%9.E7D@8-EFVGD9XJSK6M3S)][:O85V4L+#V;J2E[W8CV:N3#5_-7#MN"T
ML&MQ^8N&(Y':L+SV/>HE=@?I67LXM)LUEAU;0]2\->&5\0JAWJH8]<UK>*/A
MC:Z+;K(DP:3 .W/&.]>6Z9XOO-,CV1S2*O?:V*TU\>WE['M>::4D<%F)Q7T5
M2IEL<#*G2I-U9;2;TC\NK/.EA:_->+T+MQ91NS1\MM/K5)['R02B]_7I4>EZ
MJ\5]EFPK>O>N@B@ADLOX69R2:^?Y7RWCND:2O%:'/QZI);MT^Z:TH-8DU>']
MX[,.@4GI576[58T7Y>W-0V4?[G]WQBBGBIJ'*F[/I<F4%*-^IH"&1>P)_G37
MT]9/O*K>HI-.OVBO87FA+*K L#T<9K7\27>GRK]HM0(NY0CBNS#X'VM"=95(
MIQ^S?5WZK3H<_M&I6.;GT2-3]W\<UK>'=&GFN#]G.&3N#4, ^U9_B^E:^B,^
MFA63Y9,]:Y,/6<*B;=M?U-*U1VUU)-=\0:OI]M';73'RT.Y"P_K70^#OCG:Z
M=:+'=6:3,JX#CY>:R_$4M[JUFK2V[NJXPS#/Y5@V>FV^\JR*K9].]?>8S.,9
ME^)CBJ#E4YDK.I&]_3FNFD>?&%*K3<'IZ'>:A\>EO8I+2.&%(9FW/WHU7Q=H
M]_HB,L8%QC;P.*Y,>!I)HQ(L/[L]3FMNW\'Z6--9FO/+DC'*MP*]3 TLYQ[F
ML73BVX:>TLDH[^[?2Z,91H4[*D<+XEN+62YD:,;>W2L66".;G=[UT/B&&WDD
M:*)1\I^]V/O67#I:QD,VTCZU^=5H^SJ."=[:'N0J>XFC-:S"M@?='0TW,<9^
M[6H[PJY^5>/:J[6\)8GY1FL_:&D*G<JLZW ^[7ZD?\&@L'D_\%9M2]_AUJW_
M *6:;7YDV]A&Z=*_I6_X-MO^"0'@O]G']G[X9_M'3WVM3_$[X@^#YS=11:@L
MND)I]_<K<VP6(PJZS"VBM _SE1)YN-PP:J,[Z';@[RJ770^;?^#RS7[71OB+
M\#89HP\D^B:YY9],3V/^-?@P]R7O2V"1DXK^@'_@\O\ V7_'GQ"T'X5_%#1?
M#MUJ'@/X?V.H6'B'5HIHMNE2WES9I;>9&6\W:[(5WJA16*AF4LN?P%M+=8E\
MR0-C.!WKU,;FU3$86AA:J2C134;+5WDY/F?J_N"I1C"O.HMY?\,7M&U:2"7>
M3'E>!N7/%0^)-3_M:\RV.G..E31Q(NW& K'<1[5G31;IVV[=N>.:\GVTNARP
MLYW14AM_M$A51WJ-T:%R,;2IJ\LGV-V96^?/4=ZC:*2[.[[VX\4O:,Z?:=QU
MG:F^F^8UV7A_P?;W%DK/<R2S2':D:GD?C7)'2)K2[6,M@L1WZ5W4_AU/">EV
M]Y#J#+><.$5PV,>U?2Y'EKQ*J8F4(RA"W-?2R\N[['FX^H[*,96OL5/&'@*;
MP*D<UTWRS9"C=GGK6?IOQ"C\.R^=:VJ238P'DSA#[ 8_6H_'_BRX\0K#YUU)
M,V265C]P]*YECM&6KR\R^I?7)5,LYE3Z*6^F[^;+PV'E*FG6U9>\2>*KSQ-,
MTMU/N9V)*J,**SH\ ?-S22.'QBFXS7F.5W=GHQBHJRV) $!IR,J#C^=0XI#Q
M[41DXNZ#?0Z70_A?XJ\4^&KK6]*\,^)-2T;3V9;G4+33)Y[2V*@%@\J*44@,
MI()&-P]:S_$GAS4_!VM7&F:QI^H:3J5KM\^TOK>2WN(=RAEW1N RY5E89'(8
M'H:_5_XD^*?%'Q[_ &:O^">^M?L]W.H:#X+^'VF6ND>,K?2M>M-(@T/Q#;7M
MNE_>7\4=PJP&X9)+D7-QM\V.Y1V(:0K7S]_P<YC/_!<WXZ_[V@_^H]IE:5'=
M79T2HJ,;GPGM_P YHV<#D_+[TT3KCO\ E09UQW_*LM.QCJ.(W#DG\Z&0,.?Y
MTGF G ^M+(-ZJ*TYF_=0K[-AL!IC,(Y!\OY5UL_PX9?!L>HJK+N;!+<5+\._
M!$.O:DT,JC:R'YA_#CO6GU6I[545K)G++&4E%R['.:==1^;^\9HU/<=_:K>I
M:G'<@+&&55['O3_$OAP:-?2QQLS+&<!L8S63 TDMRJC<V3CZUBZ>MK:A'EJ?
MO$=CX1O8_L$BLOS,K;?3%95[-.=/;=EAD\&NN\+PZ?H_A^ZAF5)+AURN1ROT
MKCKV5O,*B0CYL8S6V)RN%"G2Q$)J3G>Z6Z=S@HUN>M*RV,&;,3XY]Q^-+*"(
MVK4UO2EMK<-YBNQZ\Y-9]N//F5<G#'!K2I@YTYJ$]]-CUHU%*/,+:1-+T!;W
MJVD[63>8&PR\<5U%LEGI]ALW0YVY)('\ZY76;B.6X9H\;<]1WKHS/+XX:,6J
MBDY;]T<=.LZD]M#JO 7Q$FTF_CCG9?*D8#ITKTV[\46EG<K_ &9(GVJ0!I 1
M\K#WKP*S<><O#$YXKK](UZ3PZT-PXCD,GWAU.*^=Q.#C-\\-T<./R^$I<R1Z
M%#=V>O7[M>1#[0W'RG 'TS61XU^"EO>V#7-B6\P_,59LYJ\NK:7KEINCDMUG
M9 5VG# UJ>$O$L5O^XFN%9<8.XC!KSXUJD/>IWMV/+3J4?X5]#P'5=*N-(O&
M@D4(T9VD>E4R"#T]:]2_:$&E@QM9/;F=N7\H@X^M>9_X5[^&J2G34I'U&#Q$
MJU)3DK$(.:_:'_@RE&?VP_C5_P!B;:?^EJU^+PZ5^T7_  92G'[8OQI_[$VU
M_P#2T5N>AA_C/D#_ (+-WDT/_!5#]H"..1O+?QM>EEZYY%?+-PBAY-H[$^P-
M?4O_  6.W2_\%7OV@4P>?&EZ![_,*^7]5D\D>65"_-R#VK'F:>G<^7J2:K2]
M7^93M;.XF/'S'J0!S6E;VYW<8W=>G->M?LL:%I]WJGVR^A1MLHV>8,(X';Z^
MW>N>\?V:6VNWMQM6*2XE9@H3;M4MQQ7T53(X0RB.9N>LIN*CUT6K/+EF7-B'
MA[:I7.1L8&:\B\Q=R[P6&>WUKT'XD?&FXU*P@T[29Y;73XX%\V,* SL/4]3^
M=<!-?K%8S%"79OE_W:T_#&A77BRW:."/S)&(&0#P/RKQ\%CL?"G*AA)-1D[N
MWEW,Z].$K5*G1F1:W%QXJOHH%ADN+C.V-%.3BJ7CK2K?3(;:)?M"WD89;J&1
M=ODOG@#\*[+PMX U;3M=8V]O]HDMSG:"0P;/;BL_XP-JNL^('N=4T^:SN)(P
MIW0E ^!C\?K7A_6+XA0NO/O<[:.(2J1C&UK=SS=1M%.'6K5Q L+;6!WU5/WS
M7;T/7A*^H4'I10W2D:%C3-,:_DV[6;GHHR:W?$W@FWTC34N(OM2[@N!*N.:Q
M+.]DL)?,BD:-L=J]0^'OQB;48K71=0:Q2U;Y7N+B,R$#\:Y\1+ECS]CCQ%2<
M5SQV1Y.ML<8(/'M1Y7^U]*]J^(/@73[CYH;VPFC4@#[/QN]P.]9GQ$CL?&WA
MNUCT?0H;6XT6V5;NX@4_ON>';/3\*\^CFBDTN5V9SPS6,FDTSR=XMJ]:9T(/
M'XTXHR,RMZY'O4UC;+<W"K)(L*^K=*];FMHSTW*Q DI08W87T%(7W&K$UO'%
M.P#&7G"E1P13383;-WEL%YZU7/%BO$B _P :>MI(PR$;:PR,]Q3HK.:XG15C
M9N0.*]*^&?F>*;JWT._NK:PMX<L)+D!1'[Y/\JY,3BU2A[3==3&O65.'.M3S
MEM'F0!6PN1G)[BJMW9?91][.WT->J>*?"FG2>+O[+M[Z/4[>W.'NK=<(![$B
MN-UFTM=)UAUM)"T+$KDC<0:UIU'*G&LXV4KV^1-#%*I;0Y<CVHY]*Z(:5;3P
M/()NO(&W SWK*U<0Q'9'&H]6S51K7V.CFN4';BHSR?QJ1^GXTWO6R9M!:W =
M****HT"BBB@!".*0,/6G'D5"L#*10 ]_N^],0M(V&Y%34F-M $13:O%?U>_\
M&KW/_!%+X9_]A/7O_3Q=U_*,3L%?U=?\&KQS_P $4/AG_P!A/7O_ $[W=;0V
M.[ _$S]$****H](**** "BBB@ K\8?C1_P I@?$G_9>_"G_I#X?K]GJ_&'XT
M?\I@?$G_ &7OPI_Z0^'Z /V>KC?B1_R$[?\ ZY_UKLJXWXD?\A.W_P"N?]:\
MW-_]UE\OS/(SS_=)?+\SFU^]^%#4+][\*'KXO_@GP1@WO%_<?]=&J.I+W_C_
M +C_ *Z&HZ_H# _[M3_PQ_)'].9;_NE+_#'\D7?#/_(RZ?\ ]?4?_H2U[2O4
M5XMX9_Y&73_^OJ/_ -"6O:5ZBO!SW^)'T/F^)/XL?3]1U-;[XIU-;[XKPSYL
MS/&7_(L77T7_ -"%<!7?^,O^18NOHO\ Z$*X"OE\]_BQ]#XWB3^/#_#^K"L?
M7SB\C_ZY_P!36Q6/KW_'Y'_US_J:[.#O^1G'T?Y'H<!_\C>/I+\BF#F@]**#
MTK]@/W8]D\(_\BMI?_7K%_Z *TT^[69X1_Y%;2_^O6+_ - %::?=K\_J_&_F
M?E]7XWZL6FK3J:O45F9GELG^O?\ WC11)_KW_P!XT5^>S^)GY;+XF4?$'_'B
M/]\?R-8ZGFMCQ!_QY#_?'\C6.*_6>"_^1=_V\_T/V_P__P"13_V]+]!U=[\$
MON:E]8__ &:N"KO?@E]S4OK'_P"S5[>;?[K+Y?FCZ'//]SE\OS1W=%%%?&GP
M(C<K7!>./^1EF_W4_P#017>M]VN"\<?\C+-_NI_Z"*\?//\ =UZ_HSPN(?\
M=?FOU,A/NTO?\:1/NTO?\:^7I?&O4^,H_&O5',CH/\^E!ZCZT#H/\^E!ZCZU
M^_T?@CZ(_J"C_#CZ(W_A?_R/%K]'_P#0&KUNO)/A?_R/%K]'_P#0&KUNOF,\
M_P!X7HOU/C>(O]Y7^%?J?S._\',W_*Q!\*?^P?X6_P#3E-7],*]6^M?S/?\
M!S-_RL0?"G_L'^%O_3E-7],*]6^M>.>"+1110 4444 %?B[_ ,'!/_)TGQE_
M[('I7_I3XOK]HJ_%W_@X)_Y.D^,O_9 ]*_\ 2GQ?0!^T5?!?_!?3_DA'@/\
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MPS>;#)J$6GWUK:W\B81#)<P2/(L8\PR,SL_D_P"T)^T%XR_:J^-GB3XB^/\
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MD&G_ #R.7_ 5Q_P^\?R?#^]6^AAAFD6-H\.#D9XS79?"'Q-8VECJ=U>R*6U
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MY202 <$9YK\F/^#@IMO[47QF)( 'P"TLDGM_I'B^@#]HZ^"_^"^G_)"/ ?\
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M(:?%F9M?]!%;_P!.2.PHKC_^&A? /_0\>#__  <VW_Q='_#0O@'_ *'CP?\
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M<_BOIOP#^"OB_P =ZU#J%QH_@G1;W7KZ*PA\ZZD@M8'GD6)"0'D*QL%4D9)
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M.9Z?B>U3S/&0@J<*LDEHDI-)+LE<^)1_P0Q_:<4_\E5^ /\ X1VI?_)=8?\
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M>'[7PQ-J'EZCJMA;:I<ZE!#?-!%',(YK@EW1?*55.%!"@[02:]&J23\AH?\
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ME=9"DL<H4QR([$HI[F=2C"I'EJ14EV:NOQ/B?_AQC^T[_P!%6^ ?_A'ZE_\
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MHC3KW"GW_P#K42ISTEN]#ACA:S6L3\=$\>W=I#Y:LT;KP>/YU>M/&CZFH1Y
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MQ\.Z)!YERN0=M=--%%9V)\SY=PX)'>OL33?^#;C]MNUDRWP'U(;>F/$^A?\
MR=4NI?\ !N)^V]?E5_X4/J>PD9SXHT+@>W^FUA*$[['/6PM6<]M#X:\.:O\
MV+XCAGWE8]VUL>AKZ(^#G[/WC_\ :/EOU^'O@/QIX]DTM(Y+U/#VA76J-9)(
M6$9D$".4#;'"[L9*-CH:]\O_ /@VL_:VO=)18O@;JUO<H,$_\)+H9W\=_P#3
M*ZC]G+_@D5_P4X_8\OM6E^%_@CQIX+;7$BBOY-*\9Z);M>)$7,8?%]R%,CD9
MZ;CZU6.RZ+G&5[Z=#&>"^LR]Y-<OE:Y\\^)_^"='[3,)B^R_LY_':23.#M\
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M>\3R7$.[;(,5A0RQ6MK&I7#-SN%?1_AK_@EE^T!K<E\VH? 'X[6_V>$R1?\
M%O\ 5E\UO3YK?]!7)WW_  3,_:5DN@J_LY?M >6G0CX=ZQS_ .2U5Q-BL1CZ
M[S/$<O-5;=HO9^BV-L'AIPIJBHO3R9XZ]U#<.-ZX [^M27%Y%$&6//S@ 8[5
M[$W_  3%_:291_QCG\?O?_BWFL?_ "/3G_X)C_M)0E2O[.GQ\;';_A7>L?\
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M(^%UU)K:V-QJ,>GC/SL_W5_QKZ!\!_\ !++XZ>*+:\U'6O@/\=K.ZMQF*$>
M]4B\QO4!K;/Y5RNO?\$ZOVF+R^8K^SW\?I(X\JA;X?:N6V_46X%5+"J.'7)?
MF#V-96A"+^YL\2UNP;2=6FMTFCNUC8KYJCA^*U_ GAW3_%VE7D$UXEG<1_-&
M'[FO1Y/^"9W[2$T6]_V=_CXSKRH/P\UCC_R7JWI'_!.+]HR95M[G]F[X]*C$
M_O1\/=85U_'[/_2C#Q4&G4BY?@;?5ZK6L7]S//O!7A!K.Q6ZCD,S+(58QG(X
M/>K7B[6-0\$[;FSDN([68_,[#*ACV'K7?:+_ ,$[/VEO#=__ *'^S[^T J1O
MD!OA]K!0\]3_ */6YXG_ &!?VG?'TUO;WWP!^-T-NN/EC^'>L*@_."N/ZA"4
MI5:E^;HK:/U9,L/4<E%P=O1GSW?^-+W5+=H_,C6.8DN%[UIZO\8KJQ\$_P!A
MZ;;II\,HQ.ZG+2_CVKVNU_X)+_'IY@L/P-^.4(499I? >JX)]O\ 1OZUC^)/
M^"6O[1FES8A^ /QRN]W!*?#[5V _*WJJ7+"?NQ?W,JGAVG\#^X^?M($"I<&2
M%9YI/NR,?N?A3)M331U9-J;)AS@<YKVJ;_@FO^TI:6F(_P!G#X_R2DXR/AWK
M&W'T^SYK%N_^"8W[3ES*6;]F_P#: ;_NG6L8_P#2>NKV<Y-MIGHT\/4?V7]Q
MX_=Z_$%*V\+#<,?O6W8^E9?GNKEE8YKW#_AV#^TW_P!&W_M ?^&ZUC_Y&H;_
M ()A?M-$?\FV_M ?^&ZUC_Y&KKC1LK6-8X6:^R_N/#6NI)/O<^F>U-+[N,U[
MA_PZ^_:<Q_R;?^T!_P"&ZUC_ .1J/^'7W[3G_1M_[0'_ (;K6/\ Y&IQIM:)
M&BP\UM%GA_2@=:]P_P"'7W[3G_1M_P"T!_X;K6/_ )&H_P"'7W[3G_1M_P"T
M!_X;K6/_ )&JXQ9?L:G9GAYJ.2+>V:]T_P"'7W[3G_1M_P"T!_X;K6/_ )&I
MK_\ !,#]I[/R_LV_'[_PW6L?_(]59A[&IV9X8LOE_+BO1_A#^Q;\9OVAO"\N
MO?#_ .$/Q2\=:'#<O:/J/AWPI?ZI:).H5FB,L$3H' =25SD!E)'(KK/^'77[
M33<M^S?^T#^'PZUC_P"1Z]A^ 7@C_@HE^RIX(E\,_#7P-^UUX(\/S7;W\FGZ
M/X-UNV@>X=45Y2JV_P!XK&@)]%%.Q=.B[^\F>.?\.N?VGO\ HVSX_P#_ (;S
M5_\ Y'H_X=<_M/?]&V?'_P#\-YJ__P CU]-?\+>_X*I?\^_[;7_A,:[_ /(]
M'_"WO^"J7_/O^VU_X3.N_P#R/1RFOL8]F?,O_#KG]I[_ *-L^/\ _P"&\U?_
M .1Z/^'7/[3W_1MO[0'_ (;S5_\ Y'KZ:_X6]_P52_Y]_P!MK_PF-=_^1Z/^
M%O?\%4O^??\ ;:_\)C7/_D>M(A[&/9GQ3\:_V7OB=^S6VFK\2/AOX^^'K:V)
M3IP\3^'KO2#J'E;/-\G[1&GF;/,CW;<[?,7.,C/]0_\ P:O?\H4_AG_V$]>_
M]/%W7\_W[1OP%_;V_:^FT:3XI?##]JSQ\_AY9ETPZWX*UJZ^PB;R_-\O=;_+
MO\J+/KL7TK^B+_@VN^$?BSX&_P#!(7X>>&_&WA?Q)X-\1V6H:U)<:5KNF3:=
M?6ZR:I<R1EX9E5U#(RL"1R&!'!JC?#PY9.R=O,^\****#L"BBB@ HHHH ***
M* ,_Q2NI2>&[]='DL8=7:VD%C)>Q-+;1S[3Y;2HK*S1AL%E5E)&0"#S7Y5_&
MO]DKXD?&I-0D\2?L*Z!#\=-:5&O_ (I^ /B3;>&-)FU1HMB7QGAN8=7:T1C'
M+)!)%(3)"/EG9(Y6_60C--,:GM0!^7?[2O[,/[3UQ\=O ]WXF\._$[XW>&XO
MA=I.@^([;X>_$33O -AXC\0I'=1:C+JL@-K?2VS/+%- +>15B_>CRRLDD3<]
M_P $X?\ @FS\:OV>(_ .D>*/ ;:9'X#^&'Q'\&W%U#K=I>6EW>ZGXECU'3S;
MN9O/DAFMV)$DR1NIC82JA(W?K/MI-HH _/K_ ()9_L0?$3]GSXW^ M:\;^#X
M](MM%_9L\(?#ZYNI+NSN&M]7L[N]EO;$>7([D*LD#%ES$^%PS%>/"_$G_!)O
MXY:I_P $[/V=]#TJQ\0>%_$WP9\?>+/$VI^'?#7BJRT36Y+.]U'5Y+1]-O#'
M<V*72PW,+(LH5<3,AE@.77]>=H]*"H)H _/3_@CS^Q/\2/@U^T%\3_B=\2--
M^,VD7OB/3+#PY9_\+)^(^E^*M8U2"W/GB9TTVT2")(Y)I8XV:YED(W_)$"-W
MZ&4!0** $9=U?ES^WG_P3.^+7B[]K+XG>$_AEX;D?X$_M>+X;_X6?K%KKEO8
M7?A">POF75+BSA9EPUYIVP$^3<F6<-YFV/"G]1Z"NZ@#\[_VM/\ @G7XY^)O
M[8/QA_X0CPQI>C^ O%?[)=Y\(?#EZ;JWMM/L]7>]O?(LC"C&:.)(9H6WK$8P
MHP"6&VO/?B7\#_VGO$/[-G['\-A\+OBEH,?PKTBXT/QWX7\'^.]!T;Q'?-;V
MMA!9,NJ&4A=/G^S7/G0V]Q'(?,@) >*-X_U1*@FC:/2@#\BOV3O^":_Q:\!^
M,O",.H_!N^\*:!IO[1ME\5EM;SQ?;>)(]*T:;PM/9JKW=Q=/<SWEI=QQ+,"K
M /+&T$D\:ET]%_::_P""?OQ2\=_LG?\ !031=%\$)=>+/CEXJCN_"(6]L8Y]
M?LH].TN%,RM*!&B2Q7>U)V0K\Y"_/\WZ8!0.U+MS0!^7_P#P6*_X)^_&#]J'
M]I3XJ:]X#\&2Z]I/B+]FN\\!Z=<KJ=E;BYUN3Q':7BVFV:9&4_9XGD\Q@(\#
M&_=A:^@OVE/V3_$WB;_@J)^Q]X^\*>%+7_A!_A9IGC'3O$5];26MLFBQW>FV
ML&GPB(NLCQF2.5%6%'$?)(4'-?7NP>E+C% 'RC_P6G_9Y\4?M1_L!ZUX0\(>
M"_\ A8FK3^(/#^H2>'/M=K:#5[2UUBSN;J$R7+I" T$4H^=@#TYSBO$?V3/@
M7I_PI_:1\)ZYH?\ P37M?A'?PWAM_P#A,;37/"AE\/PSH\$T^VVNFF9?*D=6
M6,%BK, #G!_1PC-)M'I0 B?=KY7_ ."T_P"S[XJ_:I_X)N^.O W@OPG_ ,)U
MXAU34= N8M ^UVUK_:L%KKNGW=S%YERZ0KFW@E/SL <8Y) /U51C- 'YO_LK
M?!&R^$?[1_A'7_#_ /P32@^%.I0Z@+;_ (2^RU[PGYOA^"X5K>>YVV]V9618
M99-R1@LRE@H)(!PM*_9J^-7[*OP%\5_LUWW[/&H?M ? B?7+_5/#&N>$?B)!
MX7UU+2YU8ZLEMJ)EN;21;B*YFD'G6DBI(B*K1J"V_P#3S8/2C:/2@#\E/ 7_
M  1R^+-_\%O'_B#2-,M?ASXDL?B3X5^)OPH\ ^)/&U[XIM=&N-#B&;75;YVE
M<B[:6Y9X[>4B*1D"S/&@!^L[7]I']JWXD?$?3?"FF_LZ:/\ #*R^UE=6\;^)
M?%MEKVC6UO&Z;VL[*RFBO+IIE$BQ><+7;N1Y -K1'ZXVCTHVC'2@#\[O$GP!
M^-7[&_Q3^/WA_P *?!C_ (7]\#?VC-=OO%5['H_C*W\.^*- OM1L(;34;:22
MXEMXVMG\@&&2WD2>$.<L[8=;W_!*[]A3QE\#/VK?&GQ*N/ .M_!?X?ZUX2M/
M#^F^"-;^(EWXRU22_2\EFN-1GEDN+B&#<GE1I'%/("BJY\MF=*_0/:,4;%QT
MH 2+[@XQ7Y^_\%-O&/C#X=?\%4_V2]>\#_#E?BEKNE^&O';KH,>JVNF7DL3+
MHL<DEM-=%81*BOG:[INC\P!LD*WZ"=*YW7/A+X9\2_$;0?%^H:'IUYXG\+V]
MW::1J<L(:YTZ*Z\K[2D;=5$GDQ;L==@H _.2+_@GM\4_''[-#WFM?#G3]-\2
M?%#]IW1OB[XB\%&^L+F/PUH\=]8QSQSS"3[/=M]EL?/D$>2S7#(%<J2WL_[5
M_P !OB1\(?\ @I1X?_::^'/PY_X7)YWPXF^'.K^&[;6++1]2TL+J0O[>^M9;
MQEBE#F6>*6-I(RBJC*7R4K[5" =J-@QC% 'YI_ /_@CO\0_BIXD^*7Q(\=?%
MKXX?LZZQ\6O%]QXI7P1\+_'-I;V.EPRVMK$/MC_8Y$DU$M$_G20NT9.T*S8+
MMA_M8?L4:UKG_!3;XQ?$#Q1^Q?;?M->$/&&B^&K3PYJ%QJ_A^ :3+9P7:WBJ
ME_<I*OF-- #A0#Y'<!37ZD%0>U*5#4 ?GFW[(OB_XE?LE^%8?AK^SOH7[-OC
M#X,_$FS\=^$O!^LZUI[:+K\\<$D%PUQ)I9G\M)+>\NE7&UQ+'$QR@*MXM^V3
M^RE\:/\ @I-IEY)>_LF^._A)\7O%&DVVFGQQ??'!5\.^&)(T!>86.FW[^>%_
M>(@^R9D9T,FT;BOZZ;0>U&T4 ?%VI?#;XT?L5_M3_&#QY\/OAK9_&7P5\6AI
MFN7>FVGB.WTKQ%8ZU!;0:?(L8N_+M7LVMK>&3YI1*KB3[X956K\4?@W\?_\
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M+<;S'%)(J",#>P Q]S[0.U+MYH **** "BBB@ HHHH **** &N>: -W>BB@
M()H/ HHH  V*0MFBB@!"=U!X-%% #@N:-GUHHI@!.*,T44@#-&:**  G-(.:
M** %(Q29^M%% !GZTF:** %[4H7=ZT44 'E_6C!)HHH  O/-&RBB@ Q[4HS1
M10 F3N%!7-%% !MS2\T44 !.!2#YC110 ;<F@)@T44@ 9'I2XSUHHI@(#S]:
M=110 4444 %!Z444 ,S]:,_6BB@ S]:<JXHHH 4T444 &,4G-%% !\V*.:**
M #FFD\T44 &?K1GZT44 .3I2T44 -(Q29^M%% !GZTN,T44 &*-GUHHH 4#
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
&*** /__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>59
<FILENAME>img_012.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 img_012.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" &_ EH# 2(  A$! Q$!_\0
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MW:WPGGBFL_,3=&(0"YW9PW!& .2>*[^SNH[ZQ@NX=WE3QK*FX8.U@",CL>:
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M'^ZIR2..IKN]-FTO5K)+JTB@>-O^F8R#Z$=C7/*$H[B)?[;TK_H)V7_@0O\
MC1_;>E?]!.R_\"%_QJQ]CM?^?:'_ +]C_"C[':_\^T/_ '['^%2!7_MO2O\
MH)V7_@0O^-']MZ5_T$[+_P "%_QJQ]CM?^?:'_OV/\*/L=K_ ,^T/_?L?X4
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M9?\ @0O^-6/L=K_S[0_]^Q_A1]CM?^?:'_OV/\* *_\ ;>E?]!.R_P# A?\
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M;CSD'OWKL-/M[9X)VF@B<&^GR&0$D[SC.>M3)6=B9*SL:?\ ;>D_]!2R_P#
MA?\ &E_MO2O^@I9?^!"_XU%]EMI)P#:0%0 0=B\#Z8ZY&*M?9+7'%K#ST_=C
MG]*1)%_;>E?]!.R_\"%_QH_MO2?^@I9?^!"_XTZ2UME7<+6$D=1L7)'Y5322
MUF/R6</*Y >, D<\_3BG8:+7]MZ5_P!!.R_\"$_QKBM9\-Z)X@\:/JVHZW:F
MP-E';?9HKP(7992^'P<,IXX/<5UL<,+2C_1;?>!AAY8^O'%6A!:["?LD.X#D
M;%[]J&A6.4NO#?A"[M9H3JBQ-)?/?K-#?A)(I6&&*,#D CC'I2W/AKP/<Z F
MD>;810QPK#'-'.@F158, ),Y^]R>?6NI^RQ9'^BVVW)SA!T]N.M2K:6C#<+:
M @_[ _PI <;)X=\,SV#VMYXDNKQO.6>&>?5 TMO(H(#1L""O!Y]>],_X13P:
M--6T35F29;EKL7JZCBY\UAM9O,SGD#!'3CI78306J#:EI TA' \L?K[4BVML
M$!:V@R!EB8P.>_:BP['(/X3\%FRLK>VU3[$]FCQQW%KJ.R5D<Y<,V<L">3GO
MTQ70:/)X=T+2;?2]/OK**UMUVQI]I4D#.3R3DDDD_C4]Y JHPBLXD^7.\*IY
M[C&/U]ZDTZUA>WW36\&\GD!5..!QD"BV@6TN2?VWI7_03LO_  (7_&C^V]*_
MZ"=E_P"!"_XU)Y-ANV^5;;O3:N:D^QVO_/M#_P!^Q0(K_P!MZ5_T$[+_ ,"%
M_P :/[;TK_H)V7_@0O\ C5C[':_\^T/_ '['^%'V.U_Y]H?^_8_PH =#/%<0
MK+#*DL;='1@P/T(J6L?PZJI87"JH51>7&   !^];TK8H **** "BBB@!K?=/
MT-9WA[_D7K#_ *XBM%ONGZ&L[P]_R+UA_P!<10!IT444 %9VKZK9Z)ID^H7T
MHBMH5RS8)/L !U)/ JOX@\2:=X:L/M5_,5#'$<:C+.>N /ZUXWX\\5:AXLMH
M/(LI[;18V#D. 6D?G!."1@9P!GKD^E:4Z;DP-&77/^$DN_[6NPPBE+"UC8C$
M,><#('<X)/J3Z"L34%2339+A8O+VJ05(P6'0@XXR/_K57TVTU:RMH;1[9Y<J
MKQQH=S!2,@C'4?RJWKM[<7:Q6UQ8&W*PA=A782 >"1]>3^%=T4HZ(/4R(URQ
M !*[L$@<8 ZGWYI9F4(7&U&XQ@$]_3MUK1.C3K 9X\M@;2@! QU STSUZXSV
MYK.&,%B<L1D'&!GD$?\ UJM-%(LZ7JITN.]#10NTT10%UR5.#D@]/Z&M7P[X
MY?0-42.$FXLQ#'"8^09& RS =CN)QQT %8*Q(]G<F42F9U5+<(V%))&[=GJ,
M#H#UJO;;[N[M8%7;))* /+ #$LV">HQUX%1**DG<=CZ-T;7+/6[?S+9\2+CS
M(G&'0^XZUJU\^:_9S^#=>#Z;>W-N%VF.4L&9E.-V<<$ @@@^E>D> /'R>+(I
M+:YC6*^@7<0IXE7.-P'7/3(]ZXITFES+8FQW=%%%9""D/0_2EIK?=/T- ',^
M%?OQ?]@RV_G)745R_A7[\7_8,MOYR5T<T\5O'YDTJ1H.K.P _,T 2T5Q/B7X
MG>'?#RF(7(O[S('V>T8,W/J1P/SS[5Y;K/QM\3S7#KIT6GV2 ?*C1M*^2>A)
MP,@<G Q6L*,Y[(#W^\U"ST^'SKVZAMHAU>:0(/S-<_\ \+%\('>%\063E#AM
MC[CGVQU_"OG6XB\3ZS/'-J<)O[K4$,D<\A+E54DD( <*!@@C& *F^QW1-O.[
MD'R2L4<9QL4#! ]<GUKHC@[[L#VC6_C-X7TB,B)[F\G./+BCA90^?]I@ !7G
M]Y\3O$OB'4(H%O(=#LYNI0%C$O/+,!DDX[8 KD7TII&MW>0+&EPH) #9+< 9
M'UY/TIEU:F.0(6E*[F"L#\RXX).1R.,>]=$,+"/FP-5O$.O)+,DVM7MW;D@*
M1,P# YP<9R <8(X."34+Z-KLNC2:G*UU-;1S$M-'<NQ*G'R["> "3R>2?:K%
MG8/:Z6EPX>5+HLZR,0S$KP<D<*3@@#&#C-26US/!'<6CRRQQSG.0Q*N,#[P)
MY.,=NO%:<BMHM1V1E&ZE.&LC<&%I2%\XA<@8R">!WQG@5V+8&EV<#:E)>3Q%
M=LZN=JQ%V78,$ X(')]3CBLRS-A=VUIIMSAE61@L@1@%9C]W)XP<#J",G'O7
M4Z;X?TZTUVSM+V_2X@N(VCBBBB"!2#N"L.!DG(R.^.1Q45&EN"16M;W4;G4;
M:UL7>*12S221G&V-0=Y)Z$8Z=<G%;TFO^+_"-M;S:PL=Q8RX0.5W/&3SR01D
MXR #P3T-;4/A73;?0;]M#BE>>X3R7,DAWJF061<]#C./?&36SJG]GZ[X:N88
MYP$5?E8Y!CD7!7(/.00.*XZE6,I:+021SOA#XE2>(Y+F.729\6XR\UL"RC+
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M,#TZ]:6RCM);BY0.(K>2$ED4[4W C:2,CMD\#L*I?V=<6TUW<H0@NADI",C
MY(Y&"#SG&#UQ6J;G3[G36:.U::81D"*.,L5(QT '08/)]:]"-HJR!V+*Z?>1
M:=;W>G7*1SQ6_GS#>-RC=@LO&2".2,9%2:5']L-YIU[MN]2F22>U)8,C97(
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M/?(K9?51J8":]?ZS>!#\L$<BD,?<G@$?2I;?3--GB%W;2J^G(VT&_)W0,<9
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M(/ ;@8(P>.]<A;HW[HM$H(4 8X)ZGD=#U KTJ4N>-R&M3:M-,2:&6]<[8XB
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M'Y'GL*5G<#FYM,N+21;F2:TAU.-HXTM0,F1L !N. 3G)]Q67)93VQ:.6)TN
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MLO!4CA> !P>!VK#TBVM;;?=W>E+<P%"''VC!B)!VLP!W$9(R<< 5%%*EWJL
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M/[:3_GA_Y,1?_%4UM84J0L6UL<'SXCC_ ,>K'VTF)R9I0Q+#"D2*%5%   X
M%2'H?I7#;?$F?^1J/_@):_\ Q=36K:[#=1R7/B(W,*MEX?L]LF\>FX/D?45D
M(N>%?OQ?]@RV_G)745S.DV]UIGD-);^8#80Q$QRI@,I8D<D<88<C(K7_ +0E
M_P"?*3_O['_\50!?HJA_:$O_ #Y2?]_8_P#XJC^T)?\ GRD_[^Q__%4 7Z*H
M?VA+_P ^4G_?V/\ ^*H_M"7_ )\I/^_L?_Q5 %^BJ']H2_\ /E)_W]C_ /BJ
M/[0E_P"?*3_O['_\50!?HJA_:$O_ #Y2?]_8_P#XJC^T)?\ GRD_[^Q__%4
M7Z*H?VA+_P ^4G_?V/\ ^*H_M"7_ )\I/^_L?_Q5 %^BJ']H2_\ /E)_W]C_
M /BJ/[0E_P"?*3_O['_\50!?HJA_:$O_ #Y2?]_8_P#XJLV^;5;F</:WES9Q
M@8,:QV\@)]<LV?PH Z&N?N/^0_>?2T_]#:JGD:]_T&KO_P ![7_&I8+:]5[F
MYGW3,%@!=VC5I-C,6)"G:.".XZ4 =-167_;4?_/$?^!$7_Q5']M1_P#/$?\
M@1%_\50!J45E_P!M1_\ /$?^!$7_ ,51_;4?_/$?^!$7_P 50!FZUX#\/:]*
M)KNR"SC_ ):PG8WXXX/Y50G^&'AI]+>TAM6BD/*S[R74^OI^%=!_;2?\\?\
MR8B_^*H_MI/^>/\ Y,1?_%4U)]QW9Y%??#OQ;IMY'=VGE7R6[^8@23#$_P"Z
M<<X[5+'J#1!8;Z*6QF52&BO$8;B3GDD8( [^Y->L_P!M1_\ /$?^!$7_ ,53
M)-5@E7;);(X]&FB/_LU:*J^H^9GCMS?6P#);0F^8 #RK:,L21TR0.F?7M3-
M\$ZY?VUM=PVD]KJ!G>2XGN@51HR1M7!Y/0DC&*]CBU2WB&(K1$'HLT('Z-4G
M]M1_\\?_ "8B_P#BJ'5?0.8YR/X?Q:AJ"ZAX@D@N)PH7R[>(1H0#D9/4\_2N
MNL]/L].A\JSMHH(Q_#&@4?I57^VH_P#GB/\ P(B_^*H_MJ/_ )XC_P "(O\
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ME2<'GUS76H@10H' %4O[0E_Y\I/^_L?_ ,51_:$O_/E)_P!_8_\ XJDY.6[
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M.=HN2,%3VWCT(QR.YZ=Z]+!##(.0:\&U62>_U!KB_A"32'YFP02NW@ #J,
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M@+=SG\ YJS,?K.N6FD09FE42,/D4GK_]:O,[B\&K23W=W.6F)_=IMR ,]!V
MQS[T/)+K.H37,O[V:X<A%)^X,X"CT Q52.&5KD6Z@(SL%&2 ,YQS[5I"/5F\
M8I(CEAA#K*\ <C@J#C(/N*?%&K[#Y8#*"<$<#_\ 75R.U:*YD@GVDHQ0A&R!
MCT(JWY<21.0@&3DM_GO6I5B8ZL7TB*S-O&%B/##AB?IZ_P Z@T?4KC35GB=%
MDM'<2"/G=$3U*D=,D9(/&1[U6,!E5?+!^4DY+<9)Z9[ "GQQ!CN9P6;@@DX
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M#;P^'M0M]<MHWDCL6+36TS L%/REE8=>O0^U7+.\L+3[1$KN(0Y:-QDDC'?
M^GUK*U"[EUV;^S[%0D$KA9))A@E01ECSP.^._%:71+5]#V>TN8KRUAN86W1R
MH'4^H(R*GK-T<06UE!80B4?9XE0"488J. ?TK2K$Y&%(>A^E+2'H?I0(XG3M
M4MM'@MKNZ<*@TJ$#GECN; %<1K?B"7Q-J3>;=/%:1@-%"H++N!X)'?GN:B\8
MRA'T%6D?YM*4;%SS\_7'M_C6;; 1LH9U)!X"#G''XYJXK2YTTH*URS::8TZQ
M3./*AEE\N63@ 'J?8?RK3\BP@U46MI))/; *S L!\V>0#TQ[TQFO;51 RND=
MR 3'C(8'&#CU]ZN:1I\T[7-ND(DCE/EF0CYHP""0#P,GIGK57T-+]2::>*64
MA+6.+RY690220#@8SZ#%,VM%("H);&&&W ! [GN*L02P^?MA5K>U:0KAU$FT
M  $9ZGGMVSQ3 8W@(^8,O 4KP>O)-),:)'\MXY/(A>0[03ELF/'4'C!!]>U0
M6<4LTZK/MP75#*P)522.3V!QGBK]M:W-V@0':H5G0@'D#J!CGMP#39)&:WE5
M(HH1(?G5 <J , @$XS[XS2N&NR"33H(+N9(W:1%8@$J!DYYQS^%-WNEQ#%$H
M;RLA3@ DDY(8]R,D5+!$P0"%"K!1D=,CV![U9M+8QW:Y1I)223&3@@_44774
M-EJ/L\QWL$S!8D.Z,;3DG/KCIP<U.NB31VHN?LK2&%SOA8@>:OJ#U&/UJ)T6
MUN!Y9!;()4\C/7&#^-=-?:G%9P +'O8J?D&!CCT/7Z5-]3.;=]#(TC2H+RTR
MLRK"&)\@#+("#@$\<\YS@].#3K>^A\/VL5K+()7>1]YY)P!@'CH3@<?6L&VO
M'M97(+H&!!$+;2!Z#\3T/X5I7-]HVK6$=M+:3H8^5\HC(/(//IG.<T+?44HN
M^NIE17C2)'*[NSSV[!@,@*2Q'3MP!]<U'*H"C!&"" 3W'MGM3H4B+,(4"PJ0
M%#?,<=\GN3UJ'4)0MHSGYMW!/H>Q]LTUOH7:P:1XEN=-NS%I]F]TK M+""!P
M!R0>@( Y)XK=O]4MM8M[B^M6)BDTY>#P5(E&01V(KB;._DTWSIX-OF21M$">
M2H.,D>]6/"TC"VUJ @@+:QM@GH3)SQVZ42B95(JUSV6L6YU.W(CS)Y,A<C9*
MI.0I^;@>H& 3ZC%;5<)XZO0E]86R;A*"9%<'!C(Q\P'<@=/3ZU%FWH915V)X
MF\1F&=+"WW).Z[T&W;Y:G@,23U(S@=LYKF+>.)KL1RQ*SN<<'.XGCD]>M13Z
M>@8NWFNQ;!F\S<21DCKSGV/Z4R%&ED1Q(<E3)%(O&67(( ['(/'O[UJDDC:*
MLB_<VQTN]4!4=2A>-64L#D8( /2JUK CR-;M"/-8@K)GD'/0>G!'Z4Z6\:YN
M T\KLQ7!(; QWX/0G@&K,9,6GEU,?$BJ&. QR#@#/)&!_*C6Q2-O2M6;2HIM
M/OHWV1EL8&"F>NT]CDYQ[Y%07^MV,J6FGP61ALUE7<Y +C)P6!YP>N3R33?M
M$S6QVSL?/ ,JD CTP<YR<XY%5Q%*EK,GEJ%E8*)"N2I'93V'KCVJ?,7*KW&R
M">31M0NVLVNK>&YB8PH<>9;J6! QS@')/ODUAWW]GW>BEM.OY'4DE+/:2;>1
MB"4#<;AU('UKK=$DNK2WO%@7?)Y/RNJ[B@')&WOG).!U-9]Q;632))8M+;0W
M$S,(Y82J1."0?S(X'49Q335Q=;&4J21P_9[F17!0K@ @!LXZ?0D?6BTUZ>UE
M6-A.CHBPPRQQDJ\8[$CJ>U65MK;[/<F:)WN3@QF, A6SSG)J/!D6.*&UPZ@[
MS"6+3>Y&<=.P%5H-HAOYGETYIC"5)=0$<?=&22S$=,@  ?4UG6^BW&T:I;3/
M:3>8&CD1MN#V..XJY/;D%9&#&.5B OF?>(P22._;DTR5@YC0LTT*C,BH,$8[
M=\@#O0%CM5GM?'GA4QEE75;4!B%(W+(.A'^RV/UP>15[P'.\FCS0R$!H92I7
MNI[@UPVFZE;:-XGL;VU4QV;N(92<C*OP"?4 D'\*]"T2S?3_ !'K,94+'.8[
MA"!P200WZ@_G6$X6G=$/2+BR_P"(_P#D7[O_ '1_Z$*IZ>ZBWDC=ML<E_.K-
M[[R0,]LFKGB/_D7[O_='_H0J/288[BPO(I5#HUY."#_OFGT,4>926]QIU[<V
M3H?,@<Y /)4G(;'7!!X-.F#WEW',\<<$( !4 J"![=<GO6KXMM8_+@U")'9[
M>1K6:X4'YU ^0L1P<$D9]<BLZ&-+J#=O^95Q@CC\*WB[QN="982)9( D;DX7
M!3&W: 3C '4'.?6GXC-J4\IV8, 7'09[$_EC\:N6=JMPJRMLBV, [N<$YX!
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MH-]HEA^<1R*,A-H8_7(/ ]N]86IS(9&Q,K'(W1A<@8'))_*B+;8XM[LPS'/
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M/S$M],B,L8!)P7/('?&#^=1)<Z@[PV4C686]01AL9*)G/X$]/KQ7>>&@&FM
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M Y!P3TSQ7J%<]K>ER36-Y'$H*2*9% ZK(.<_B./QHBVF:0EJ>>7#2A4+.9$
M()"X*G/4#T-317;%'^;>,#DC'![DD<U-%=Q$!;J5E\LD':H)(ZD$>O;FEM(Q
M>RQR3.%A#$A@.2!_/ & *V>QLF7;2YFGD6)2H0 NRA""% ZY'/3TJS_:,OV.
M-!,[A?F"; ,9.<$]_P 363.^)RZ%Q#S&"1U).<?J!5DA8HY _F$@ ':.,'H<
MT)(-V6VF2>)B[^6"NU5VD@?4^_<^^:JR6D,EK#/"2#@B6.1LDL#@8QU!'\JI
MR7)6-F7<IQ@ G@_6G6VHO;*Q2%=C+C)&2N3S@GH3C'T-%F#78VM*O+>PL9I/
MM*RW4>5B5,LNX@XP.X '/I7/L\Q99ID.^0DM(#RV?;MWY]34W]LI!>K/;P11
ML"21L^7D8QU)_'W-4KF68AFW%2[$L.G))) '84):@EK<L1SQ6MZK>7*\:G!
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M<5+30-,D_MBX_P"@+J'Y1_\ Q5-.KW)4A=&OPV."1'U_[ZJ/[7K 8*6T@$]
M9G_PJ4-KY&1'IG_?R3_"@1A_;/&']U/_  7C_P"/U)!?>*5N$:Y@\R 'YTCL
M@K,/0$S$ ^^#6SNU_P#YYZ;_ -_)/\*0MK^/]7IG_?R3_"@#*TU+O29;,SV%
MU(!IT<3>2H;:X8D@\]>1[5K?VT?^@5J7_?@?XU6M]4U'4(+-[2"U5IK99W$T
MC8&>PP.>_-6=VO\ _//3?^_DG^% !_;1_P"@5J7_ 'X'^-']M'_H%:E_WX'^
M-&[7_P#GGIO_ '\D_P *-VO_ ///3?\ OY)_A0 ?VT?^@5J7_?@?XT?VT?\
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MG(QQ@X[5VNG$3^66Y+' 3&<@] 36[U146SV?P/K::A:36LEW&TL!&R+^)$
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MEHEM%)NM+@FS+$PK(I#HAY"'/7 )&>^*Q!']IG^URR-/,F(H@0 (T ("C
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M#@<\BK^CZ9:WQF82>;$D;23R&!BB*.Y)([],5ZK:_#?3;>1S]JN7C:02>6<
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MO@&K55=QW.$&A3VTJQW#P0(9"K R@,1V(&3W]:U-*TB\GO1%;0^8Y 8N "J
M]P<D ^_7-=-:>$Y_MR^="-FX%G('&,]/7/\ .NNTO2H-+M?)A!Y.6)ZDU,JK
ML)LY73_!DHFWW1*Y)W'()/O7:6MK#:0+%"H55   ]JGHK&4G+<38444UF5%+
M,0%49)J1#J*PO^$Q\/?]!6#\S_A4MMXHT2\N8[>WU*&2:0X1 3DG\J %T/\
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MH:NQ>*I]GSQ$@$@L4((Q[=ZKG74B5)WT)_[*U7_GW?\ \'$O_P 31_96J?\
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MK$N!GM]W\*2,+ 0 PVA@QP "3U_^O5A93]D= P8J 5+'E^G&>_&:E3E8T=&
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M@@U:KJ.!HS]<_P"0!J'_ %[2?^@FJVA?Z[4/^NR?^BDJSKG_ " -0_Z]I/\
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MK@-AF'0D#.,^M:XU&WEMS$TK+#(A *J27.< @'J!W/0TD.B74D$,1=(P,F8
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M-&I ?UP/0'(SWJG#++:7KJKDJ[@K@XPPZ$'MU(].?2MS[$ZQE[C:0BX9U&<
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MR?PDD]#U..@S7#PR@:E&1E8XD"(4P   1W!&#SU&.:]$\*-9R6CO P,_208
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MVD!=W:1R0%R<;CC 'T _E39YUB!A@C+SMCDG) ]21V&> !BI[#29[Z<&16!
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MUV3_ -%)3O\ A'K/R)(%DN4BD!#HDQ4,",<XQVJY%800O(\6]/-8,P#G!(
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MK*6:0X1$G4LQ]@#5O[!;_P!P?D/\*46,"D%4VD=".HH JZ5_Q^:Q_P!?H_\
<1,5:=5[>TBMFF:,'=._F.2Q)+;0O\E%6* /_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>60
<FILENAME>img_013.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 img_013.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_X0 B17AI9@  34T *@    @  0$2  ,
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MU]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$  P$! 0$! 0$! 0
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M !H^M4OY@]O#N?H;17YY?V__ ,%1/[O[ _\ WSXM_P :/[?_ ."HG]W]@?\
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M ,%1/[O[ _\ WSXM_P :/K5+^8/;P[GZ&T5^>7]O_P#!43^[^P/_ -\^+?\
M&C^W_P#@J)_=_8'_ .^?%O\ C1]:I?S![>'<_0VBOSR_M_\ X*B?W?V!_P#O
MGQ;_ (T?V_\ \%1/[O[ _P#WSXM_QH^M4OY@]O#N?H;17YY?V_\ \%1/[O[
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M=_8'_P"^?%O^-']O_P#!43^[^P/_ -\^+?\ &CZU2_F#V\.Y^AM%?GE_;_\
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MQH_M_P#X*B?W?V!_^^?%O^-'UJE_,'MX=S]#-PHW"OSS_M__ (*B?W?V!_\
MOGQ;_C7(?'W]H/\ X*7?LY_ KQM\0M;M?V%[O1O F@WWB'4(;&/Q4]U-;VEO
M)<2+$KNBF0I&P4,R@DC+ <TXXFD]%(/;0[GZ=FD&37X6?#[_ (+L_MV_$7P)
MH?B*Q\,_LFQV6O:?!J,"3:=X@65(YHUD4.!=D!L,,X)&>YK9_P"'U'[? /\
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M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %?G_ /\
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M&;7QMI6DIJWCWQ]XAA:[TWP':3KB!(8$XGU!@Z21I+F,_*&1E,KPQ0?L[?\
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M%?!VH1>9H\]Y=3I'+>26I!AF"(PBVL"HV1_*=O&5^UG^S/X%_P"">'_!9O\
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M^S/K6G^)--_:(\"?M-6*7$<6K^#O$G@&R\'2269D1I9;"]LI#_IFU2B"X(@
MD9F#%56OOX*&^M?D]_P5?\0?MC_\$[?"J_%JP_:Y7Q'X5U;QW9:;;>#'^%>B
MVJV5E>73;(#??O)9!%'B/?M#OC=N4U^LH?*C\\TU:5/F[-KS3M%V??1K[R7%
M*HX^2^>_^1^>_P#P7\\77'Q1^&WPK_9DT6XFCUW]I;QC::'>^0VV6VT.TECN
M]2G!'.%1(U/JKO7W?X5\*Z7\-_!.GZ/IEO#I^C:'9Q6=I GRQVT$2!$4>BJJ
M@?05\#?LL"X_;;_X+G?&;XK2R1W7@?\ 9STI/A?X9Z,AU>X"7&JSKQQ)'S;M
MS]UA7VY^TKH&H>+?V=_'6DZ5O;5-2\/W]I9A"0QFDMY%C (YSN(Z5SR;IX;V
MB6K][](KTM9_-FBA&=;EZ*R^>[?XV^1^?O@']K#]J#_@L3\0_%MW^SKXU\-?
ML]_ 'P?J\NCZ=X_OO#,7B77?&]W;[TF:TM+AA:K8;F7YSB3=&N'8F6*+W;]D
M_P"'/[8W[/O[0&G^'?BI\1? O[0GPIUJ"XEG\6IX?B\*^)?#UX(@T436=NQM
M9K,F/:"FZ?S+@LQ6., ^-_\ !OQ=7/Q>_P"""OA+PK\._$T?P]\<:3:ZQX?D
MU0Z;%J,OAK5OMMR_FR6DI"2./-CE\J0@,)!GK6-\&_B1^U)^RM_P61^$OP1^
M*?[2"_'#PC\0_"FKZW/&?A[I7ALVKVT<GE@-;!Y&.Y <^8!@D%3UKL]E&G5]
MC%WT>KUYK1;;6^Z5T8N7-3=1Z:[+=:VL_P F?H#XM_::^&O@"Y\40Z]\0O!&
MB2^![>WN_$:7^NVMNV@0W'$$MX'<?9TE_@:3:'[$UI?"'XU^"_C_ .#%\1>
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MO?\ ")6?AG[/;'5E5;;[/:LT;;65V\PG<?,QT456%BI2I7_E;UZOV;?YZ_\
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M'XV>)8?&WB%H3NCN/#6F1"[97]%G++L/]Z$5YA_P6&_X*9^&_#__  41T_X
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M<%A@GQ[_ ((B_&;XCP:S^T#\#_B9XVU3XDWOP#\7QZ-I'B?5L'4]3TVXA,T
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MC_A#4_N?^.UU'VJ+_9_.C[5%_L_G1[20<J.7_P"$-3^Y_P".T?\ "&I_<_\
M':ZC[5%_L_G1]JB_V?SH]I(.5'+_ /"&I_<_\=H_X0U/[G_CM=1]JB_V?SH^
MU1?[/YT>TD'*CE_^$-3^Y_X[1_PAJ?W/_':ZC[5%_L_G1]JB_P!G\Z/:2#E1
MR_\ PAJ?W/\ QVC_ (0U/[G_ ([74?:HO]G\Z/M47^S^='M)!RH_/#]N/1AI
M'_!=?_@GE@8\S_A9'Z>'X?\ &OT7K\_/^"A$JR?\%U_^"=>WM_PLK/\ X3\%
M?H'6,KMW9<=$%%%%(84444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M  EG_"0_\+T\26^O_8?[+^R?V'Y221^3YGG/Y^=^=VV/&/NFL_X/_P#!.0?
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MQ_X6-'_ST6C_ (6-'_ST6OD[_A?0_P">OZT?\+Z'_/7]:/[%J=@_M")]8_\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M[?'_ (=L?_(E'_#@"'_H\W]OC_P[8_\ D2C^S9_S!]3EW/N#SJ/.KX?_ .'
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M8_\ D2C_ (< 0_\ 1YO[?'_AVQ_\B4_[-G_,'U.7<^X/.H\ZOA__ (< 0_\
M1YO[?'_AVQ_\B4?\. (?^CS?V^/_  [8_P#D2C^S9_S!]3EW/N#SJ/.KX?\
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M>;^WQ_X=L?\ R)1_PX A_P"CS?V^/_#MC_Y$H_LV?\P?4Y=S[@\ZCSJ^'_\
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M[?'_ (=L?_(E'_#@"'_H\W]OC_P[8_\ D2C^S9_S!]3EW/N#SJ/.KX?_ .'
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MK/\ ^0*/^(5OX5_]'#?M=?\ A=6?_P @4?ZXX/\ Y\O[T'^KN(_Y^_F?/O\
MPMR3_GI1_P +<D_YZ5]!?\0K?PK_ .CAOVNO_"ZL_P#Y H_XA6_A7_T<-^UU
M_P"%U9__ "!1_KC@_P#GR_O0?ZNXC_G[^9\^_P#"W)/^>E'_  MR3_GI7T%_
MQ"M_"O\ Z.&_:Z_\+JS_ /D"C_B%;^%?_1PW[77_ (75G_\ (%'^N.#_ .?+
M^]!_J[B/^?OYGS[_ ,+<D_YZ4?\ "W)/^>E?07_$*W\*_P#HX;]KK_PNK/\
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M_P#/E_>@_P!7<1_S]_!GS[_PMR3_ )Z4?\+<D_YZ5]!?\0K?PK_Z.&_:Z_\
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M_O0?ZNXC_G[^9\^_\+<D_P">E'_"W)/^>E?07_$*W\*_^CAOVNO_  NK/_Y
MH_XA6_A7_P!'#?M=?^%U9_\ R!1_KC@_^?+^]!_J[B/^?OYGS[_PMR3_ )Z4
M?\+<D_YZ5]!?\0K?PK_Z.&_:Z_\ "ZL__D"C_B%;^%?_ $<-^UU_X75G_P#(
M%'^N&#_Y\O[T'^KN(_Y^_F?+_P"SQXL;Q5_P72_8T+-N^SGQM^&?#\G^%?N]
M7Y^_LC?\&[WPK_8__:O\%?&#3_BE\?/&GB;P#]N_LJV\6^)+/4;%/MEG+9S9
M1;..09CF)^21?F1"<@8/Z )UKXG-L9#%8J5>"LG;3T2/HL#AY4*$:4G=J^OS
M'4445YYV!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %)WI<\5X?^U1^V[I?[)]ZG]J>"?B)XBTNWM%U
M#5M6T+389['0;9I?+$MP\LT9/(8E8A(X522N,9EM(:39[=FA:\&\9_MU6NA?
M&:S\%^'?AU\2/']U/IUEJUQJ.@6UB;#3K:[9EADE>YNH7Y",Q"(QP.F>*R/C
M;_P4N\'_  /^(NM:'<>&?'NO:?X/^R_\)7K^CZ?!-I7A+[1@Q_:W>9).%(=O
M)CEVKUQTHCKIYM?=O_7<7EY)_?JOP/I \49P*\!MO^"BO@EOC!KWABZT_P 2
MZ?I>@P74S>*;BVA&AWCVL44MS##(LIF:2-9H\@Q $G"EJ]<^%OQ"B^*OP_TG
MQ';Z=JFEVVL0"Y@M]1A$-RL;$[&= S;=RX8 G(##(!R!5FTI+R?R8'245A>/
M/B-X?^%V@/JWB;7-'\.Z5&2'O-3O8[2W0A68YDD(4?*K'KT4GM7EG_#S3]G#
M_HX#X)_^%QIG_P >H ]PHKP[_AYK^S?_ -' _!/_ ,+C3/\ X]1_P\U_9O\
M^C@?@G_X7&F?_'J /<:*\._X>:_LW_\ 1P/P3_\ "XTS_P"/4?\ #S7]F_\
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MIG_QZ@#W&BO#O^'FO[-__1P/P3_\+C3/_CU'_#S7]F__ *.!^"?_ (7&F?\
MQZ@#W&BO#O\ AYK^S?\ ]' _!/\ \+C3/_CU'_#S7]F__HX'X)_^%QIG_P >
MH ]QHKP[_AYK^S?_ -' _!/_ ,+C3/\ X]1_P\U_9O\ ^C@?@G_X7&F?_'J
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M -' _!/_ ,+C3/\ X]1_P\U_9O\ ^C@?@G_X7&F?_'J /<:*\._X>:_LW_\
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M/_CU'_#S7]F__HX'X)_^%QIG_P >H ]QHKP[_AYK^S?_ -' _!/_ ,+C3/\
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M?S_R$G_Q->!_\/$/V?\ _HN'PA_\+'3O_CU'_#Q#]G__ *+A\(?_  L=._\
MCU'U.A_(ON0<[/?/^%BZQ_S^?^0D_P#B:/\ A8NL?\_G_D)/_B:\#_X>(?L_
M_P#1</A#_P"%CIW_ ,>H_P"'B'[/_P#T7#X0_P#A8Z=_\>H^IT/Y%]R#G9[Y
M_P +%UC_ )_/_(2?_$T?\+%UC_G\_P#(2?\ Q->!_P##Q#]G_P#Z+A\(?_"Q
MT[_X]1_P\0_9_P#^BX?"'_PL=._^/4?4Z'\B^Y!SL]\_X6+K'_/Y_P"0D_\
MB:/^%BZQ_P _G_D)/_B:\#_X>(?L_P#_ $7#X0_^%CIW_P >H_X>(?L__P#1
M</A#_P"%CIW_ ,>H^IT/Y%]R#G9[Y_PL76/^?S_R$G_Q-'_"Q=8_Y_/_ "$G
M_P 37@?_  \0_9__ .BX?"'_ ,+'3O\ X]1_P\0_9_\ ^BX?"'_PL=._^/4?
M4Z'\B^Y!SL]\_P"%BZQ_S^?^0D_^)H_X6+K'_/Y_Y"3_ .)KP/\ X>(?L_\
M_1</A#_X6.G?_'J/^'B'[/\ _P!%P^$/_A8Z=_\ 'J/J=#^1?<@YV>^?\+%U
MC_G\_P#(2?\ Q-'_  L76/\ G\_\A)_\37@?_#Q#]G__ *+A\(?_  L=._\
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ML?\ /Y_Y"3_XFO _^'B'[/\ _P!%P^$/_A8Z=_\ 'J/^'B'[/_\ T7#X0_\
MA8Z=_P#'J/J=#^1?<@YV>^?\+%UC_G\_\A)_\31_PL76/^?S_P A)_\ $UX'
M_P /$/V?_P#HN'PA_P#"QT[_ ./4?\/$/V?_ /HN'PA_\+'3O_CU'U.A_(ON
M0<[/?/\ A8NL?\_G_D)/_B:/^%BZQ_S^?^0D_P#B:\#_ .'B'[/_ /T7#X0_
M^%CIW_QZC_AXA^S_ /\ 1</A#_X6.G?_ !ZCZG0_D7W(.=GOG_"Q=8_Y_/\
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MA)_\31_PL76/^?S_ ,A)_P#$UX'_ ,/$/V?_ /HN'PA_\+'3O_CU'_#P_P"
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MFI26R$X#.L,C%5SQD\9H ]!HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MU-10!\L_\.1_V1?^C<_A+_X3T'^%'_#D?]D7_HW/X2_^$]!_A7U-10!\L_\
M#D?]D7_HW/X2_P#A/0?X4?\ #D?]D7_HW/X2_P#A/0?X5]344 ?+/_#D?]D7
M_HW/X2_^$]!_A1_PY'_9%_Z-S^$O_A/0?X5]344 ?+/_  Y'_9%_Z-S^$O\
MX3T'^%'_  Y'_9%_Z-S^$O\ X3T'^%?4U% 'RS_PY'_9%_Z-S^$O_A/0?X4?
M\.1_V1?^C<_A+_X3T'^%?4U% 'RS_P .1_V1?^C<_A+_ .$]!_A1_P .1_V1
M?^C<_A+_ .$]!_A7U-10!\L_\.1_V1?^C<_A+_X3T'^%'_#D?]D7_HW/X2_^
M$]!_A7U-10!\L_\ #D?]D7_HW/X2_P#A/0?X4?\ #D?]D7_HW/X2_P#A/0?X
M5]344 ?+/_#D?]D7_HW/X2_^$]!_A1_PY'_9%_Z-S^$O_A/0?X5]344 ?+/_
M  Y'_9%_Z-S^$O\ X3T'^%'_  Y'_9%_Z-S^$O\ X3T'^%?4U% 'RS_PY'_9
M%_Z-S^$O_A/0?X4?\.1_V1?^C<_A+_X3T'^%?4U% 'RS_P .1_V1?^C<_A+_
M .$]!_A1_P .1_V1?^C<_A+_ .$]!_A7U-10!\L_\.1_V1?^C<_A+_X3T'^%
M'_#D?]D7_HW/X2_^$]!_A7U-10!\L_\ #D?]D7_HW/X2_P#A/0?X4?\ #D?]
MD7_HW/X2_P#A/0?X5]344 ?+/_#D?]D7_HW/X2_^$]!_A1_PY'_9%_Z-S^$O
M_A/0?X5]344 ?+/_  Y'_9%_Z-S^$O\ X3T'^%'_  Y'_9%_Z-S^$O\ X3T'
M^%?4U% 'RS_PY'_9%_Z-S^$O_A/0?X4?\.1_V1?^C<_A+_X3T'^%?4U% 'RS
M_P .1_V1?^C<_A+_ .$]!_A1_P .1_V1?^C<_A+_ .$]!_A7U-10!\L_\.1_
MV1?^C<_A+_X3T'^%'_#D?]D7_HW/X2_^$]!_A7U-10!\L_\ #D?]D7_HW/X2
M_P#A/0?X4?\ #D?]D7_HW/X2_P#A/0?X5]344 ?+/_#D?]D7_HW/X2_^$]!_
MA1_PY'_9%_Z-S^$O_A/0?X5]344 ?+/_  Y'_9%_Z-S^$O\ X3T'^%'_  Y'
M_9%_Z-S^$O\ X3T'^%?4U% 'Q;\3_P#@C%^RCH_V'[+^SY\*H/,\S=LT"$;L
M;<=O<URO_#GS]EO_ *(+\+__  10_P"%?8WQBZZ;_P!M?_9*XFOKLK?^S1^?
MYLYJGQ'S?_PY\_9;_P"B"_"__P $4/\ A1_PY\_9;_Z(+\+_ /P10_X5](45
MWW9!\W_\.?/V6_\ H@OPO_\ !%#_ (4?\.?/V6_^B"_"_P#\$4/^%?2%%%V!
M\W_\.?/V6_\ H@OPO_\ !%#_ (4?\.?/V6_^B"_"_P#\$4/^%?2%%%V!\W_\
M.?/V6_\ H@OPO_\ !%#_ (4?\.?/V6_^B"_"_P#\$4/^%?2%%%V!\W_\.?/V
M6_\ H@OPO_\ !%#_ (4?\.?/V6_^B"_"_P#\$4/^%?2%%%V!\W_\.?/V6_\
MH@OPO_\ !%#_ (4?\.?/V6_^B"_"_P#\$4/^%?2%%%V!\W_\.?/V6_\ H@OP
MO_\ !%#_ (4?\.?/V6_^B"_"_P#\$4/^%?2%%%V!\W_\.?/V6_\ H@OPO_\
M!%#_ (4?\.?/V6_^B"_"_P#\$4/^%?2%%%V!\W_\.?/V6_\ H@OPO_\ !%#_
M (4?\.?/V6_^B"_"_P#\$4/^%?2%%%V!\W_\.?/V6_\ H@OPO_\ !%#_ (4?
M\.?/V6_^B"_"_P#\$4/^%?2%%%V!\W_\.?/V6_\ H@OPO_\ !%#_ (4?\.?/
MV6_^B"_"_P#\$4/^%?2%%%V!\W_\.?/V6_\ H@OPO_\ !%#_ (4?\.?/V6_^
MB"_"_P#\$4/^%?2%%%V!\W_\.?/V6_\ H@OPO_\ !%#_ (4?\.?/V6_^B"_"
M_P#\$4/^%?2%%%V!\W_\.?/V6_\ H@OPO_\ !%#_ (4?\.?/V6_^B"_"_P#\
M$4/^%?2%%%V!\W_\.?/V6_\ H@OPO_\ !%#_ (4?\.?/V6_^B"_"_P#\$4/^
M%?2%0WM_!ID'F7$T,"?WI'"C\S2E-15Y,J,)2=HH^=?^'/G[+?\ T07X8?\
M@BA_PH_X<^?LM_\ 1!?AA_X(H?\ "O8/$'Q[\&^%R?MGB+38SZ+)YG_H.:XO
M6OVY?!&G/Y=J^HZE*?NK!!PWXD_TKR<1Q!EU#2I6C?M=7^X]7#Y#F-?6G1E;
MT=OOV.3_ .'/O[+?_1!?AA_X(H?\*/\ ASY^RW_T07X7_P#@BA_PK1F_;'UW
MQ#(8_#_@+5;C^[)-NVM^&T?SI/\ A*OCGXSXM]&TOP^IZ-)C('ON+5Y_^MF%
ME_N\)U/\,7^;27XGH_ZIXN.N(E"GZR7Y)MF=_P .?/V6_P#H@OPO_P#!%#_A
M56__ ."3/[)^EQ;[GX(?">!>YDT>!<?I6U_PS[\4/%Z_\3OQXUEN^^MINY_[
MYVBK=A^PIH]U*)=9UW6M4F'7,@4'\P3^M3_;&9U?X&$:7>4DOP5V5_9&5TOX
M^+3?:,6_Q=D>6:]^P=^Q+X<W"?X3_!]G7JD6C0R,/P KC-8_9G_8NM@W]G?L
M]^!]58=HO#429/U(KZTT']DSP'X?VLFAQW$@QEYY'DS^!./TKLM'\#:+X> ^
MPZ3IMGCD&&V1#^@H]GG];XITZ:\DY/\ %I?@+VF04?AA4J/S:BOP3?XGP*?V
M+O@9XH/_ !3G[(7P_N$;E6N-"CZ>^T5,?^"2O@_QC]S]G3X):' W7=H<.]?Z
MU^A5!I_V!BJO^\XN;_PVBOP5_P 1?ZP86G_N^$@O\5Y/\7;\#X_^#G_!%GX!
M^&M!FC\4?!OX4ZM=R3;XVBT&/]TN/NDMG/->X>"/^"*W[)>H^&+6:X_9Y^%$
MTK;PSMX?@).'8>E>H&O4?AW_ ,B=9_\  _\ T-JZ,PPZH82%&+;2?5MOKNWJ
M>'5Q$J]:5622;[))?)'SI_PY'_9%_P"C<_A+_P"$]!_A1_PY'_9%_P"C<_A+
M_P"$]!_A7U-17A ?+/\ PY'_ &1?^C<_A+_X3T'^%?+7['W[-_@']E7_ (.5
M/B!X5^&_A#0? _AQO@+;7K:;H]JMM;/.^LPAI2B\;B%49]%%?J77YU_#[_E:
M5\??]F]V?_IZBH _12BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH *.E%% !1110!\H_\%R_^41OQ_P#^
MQ2N/YK7T)\"O^2)^#_\ L!V7_HA*^>_^"Y?_ "B-^/\ _P!BE<?S6OH3X%?\
MD3\'_P#8#LO_ $0E '54444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M['8>%;.3KG EC_\ 9JEL_P!BV\\2W N/%OC'5=5FSEEB8A6_%N:XO[?Q=?\
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MX_\ _8I7'\UKZ$^!7_)$_!__ & [+_T0E?/?_!<O_E$;\?\ _L4KC^:U]"?
MK_DB?@__ + =E_Z(2@#JJ*** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M/AU_R)]G_P #_P#0S7CYU_!7K^C-:6YN4445\V;A7YU_#[_E:5\??]F]V?\
MZ>HJ_12OSK^'W_*TKX^_[-[L_P#T]14 ?HI1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!
M\H_\%R_^41OQ_P#^Q2N/YK7T)\"O^2)^#_\ L!V7_HA*^>_^"Y?_ "B-^/\
M_P!BE<?S6OH3X%?\D3\'_P#8#LO_ $0E '54444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M)\"O^2)^#_\ L!V7_HA* .JHHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MX3"5)+HVE%/[VG^![$N&H4=,7BJ<'U2;DU_X"FOQ/HN[U*"RB,DDT4:CJSN
M!^=<QK?QY\'^']PN_$>D0LO5?M2,P_ '->0V_P#P3\M=1G6;6?%VO:A)_$-X
M53^/6NFT/]A+X>Z25>73[B]D7JT]R[ _AG%/Z_GU;^'AHP_Q3O\ @E^H?4<B
MI?Q,3.?^&%OQD_T)]=_;A^'>CEE75I;R1?X8+9VS^. /UKEKK_@H3I=],T6B
M^&M>U.1>F(U"G\B3^E>J:'^SSX+\.LK6?AG2877^/[.K-^9&:ZJTT2TL8U6&
MUMXE7H$C"@4?4\_K?Q<1"G_A@W^+?Z!]<R&E_#P\Y_XII?A%?J?._P#PU!\3
M_%A9=&^&]Q;*?N27)?!]^54?K0$_:$\5@[AHNAQL?E(VE@/?#,?TKZ11?]E:
M7I[4?ZM8BI_O.,J2_P +45^"_4G_ %DH4_\ =L'3CZIR?XO]#YM3]E[XI>*1
M_P 3WXD31JW5+0'Y?;HM6M/_ ."?&FS_ /(8\5>(=6W?>W3%,_J:^B,8I=OX
MU<>#<LOS58N;_O2D_P W;\!/C#,TN6E)07]V,8_DKGS9XY_8A^'OA?\ L_\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH ***,T %%%% !1110  TT'/O1T'/Y
MUR?Q ^.'A?X8P,VL:Q:6L@&1%OW2M]$&6_2N;$8JC0BZE>2BEU;LOQ-L/AZM
M>:IT8N3?1*[_  .M(S45Q<QV\9:1U55&26. !7SGJ_[;.K>.[Q[#X?\ A._U
M2;=M^USH5C3T; [?[Q%5X?V<?B=\:Y1-XX\5-I-FWS&QL3C'M\IQC_@1KYJ?
M%<*SY,LI2K/NE:/SD[+[KGTD.%YT5SYG5C179N\OE%7?WV/2OB3^USX'^&L;
MK<:K'>72]+>T_>N?Q!Q^M>9S_M%?$[XT2>3X)\+2:38N=HOKT=!V8%L+^C5Z
M9\-OV1_!'PUVR6^E1WEVO/VF[/FR9[]>/TKTJ"W2TAV1JJ(HP%48 'TJ/[/S
MG&ZXRLJ4/Y:>_P Y/]$BO[0R?!_[I1=6?\U3;Y17ZMGSGHW[$VK^.KY;[X@^
M*K_5I"=YM()"L2GZGC'T45[)X ^!WA?X96ZKH^C6=K(O_+4IOE/_  -LM^M=
M811MP*]/+^',!@WSTX7E_-+WI/YN[/-QW$&/Q:Y*D[1_EC[L5\E9#@-M%%%>
M\>*%%%% !1110 4444 %%%% '$_&+KIO_;7_ -DKB:[;XQ==-_[:_P#LE<37
MUF5_[M'Y_FSFJ?$%%%%>@0%%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4449P:  G HKFK;XO>&+_Q;K'A^TUS2[SQ!H%NM
MUJ&EV]RDEY:1L,HSQ [E#=LCFO _!O[<?B']L7]D'QUXL^!_A>\7QIH.H7&C
M:;IWB2-;1+JZA=-S9W;=I1B1EA\PP<$&O3PN3XJLN?EY8W@G*6D5S_"VWLG9
MN^UE<F51+\?P/J#=CK7'R_'[P9#\95^'I\1:9_PFLEB=171_-_THVXZR;?3]
M<<]*\H^)W[+_ (V_:G\ _">^\2^,]6^'?BCPCJ%KKFMV?AZ7?;ZA,B@O;,V1
M\F<C/S#D\'@UZA_PS?X''QM7XDGPUIA\>1V/]G#6_*_TO[/_ ,\]WI^%:_5<
M#2B_;5'*5I*T%HI)VC=O1Q:UO'6UA<TNB[;G#_!3]M)?CQ^T-X^\$:/X-\31
M:3X$9;:3Q+=6Y@T^^N_XX(PX#DJ<C< 0=I/3!//_  XT_P"/WQQ_9S^(NA^/
M)-!^&WC*\N;S3_#>JZ(6N!;VY&(;EE9C\PSZC/HM?1L4"1,=J*NXY; ZGUIW
M?-5+-*%.3^JT(Q^!IN\VG'=W>GOO5IJUK)(?*WN^_EO_ )'SIXP_X)[:?^T#
M^S'X%\!_%SQ'J_C#5?!T]I?S:U;2&RFU"Z@_C91D;6Z$'GW!KV?4?@_X7U;Q
MMI/B2[\/Z3=>(="B:#3]3GMDDN[-&&&"2D%ER,]#W/J:Z6BN:OF^,K>[.;LG
M)I+1+G^*R5DD^J6EM+ HI:V_I; % /2BBBO.*"BBB@ HHHH *]0^'?\ R)]G
M_P #_P#0VKR^O4/AU_R)]G_P/_T,UX^=?P5Z_HS6EN;E%%%?-FX5^=?P^_Y6
ME?'W_9O=G_Z>HJ_12OSK^'W_ "M*^/O^S>[/_P!/45 'Z*4444 %%%% !111
M0 449K&\;^/-%^&7A.^U[Q'JVFZ%HFEPFXO-0O[E+:VM8QU=Y'(55'J32NMV
M&YL YI:YCX5_%_PK\<?"$/B#P9XDT/Q9H-R[1Q:CI%]'>VLC*=K 21DJ2"""
M,\&NF9L4];@+1110 4444 %%%% !1110 4444 %%%% !1110 4&B@T -!P:\
M"_;%_;(\0_LH1?VE:_"S7_&/A72[-=0U_6[;4K:SATB!I?+^193NN91RQCCY
M V_WA7OJ_+7R?^WW\-_C5\7?B)X7T?PSX(\%^-OA+9JFH:YINH>*I-%N]6O8
MY-T4,A%K.K6JX5RO!9@,G P8=^9)=7\OF5&UG?\ KT+'QV_X*5S_  T\2ZW'
MX5^&?B/QYH/@?1[77O&6K6U];V*^'K.X0RH5BFP]S(L*2R-''RH0 \L*I_%?
M_@J?;^"M=UF\\._#OQ!XR^'_ (+@L;KQ?XJM;^WMH=#BND656CMY#YEULB8.
MXC^[TZUSO[0G[,_QNUGQ)\3K'P?HG@F^\-_'CP]::5K4NI:W);S>#)_(DMKB
M2%%@87J>5,2J[H3NB'.&XP?BM^PA\7M.TGXA?#'P=;>$-4^&WQ9LM.LKS7-1
MU*2VO_"XCMTM[IDM5B876]4WH/-CVDX)/6M(V>_R];ZI]DEL_P 2>U_G;HK:
M-7W=^AZC;_\ !3[P_#\=O$WAG4/#]S8^%O#]K<RQ>(O[1MY6OIK>*"22(6*G
M[0F?M"+&S#$K?=KW_P"%'C.^^(?P]TK6]1T.]\-W6J0_:#IEXZM<6JL24$FW
M@.5VDKU4D@\BODW]I3]F+1/BO^TIJGA729? WAOQV/ [:OHJ06JQZWXA:"2*
MU^UWER(MYM[<O##&-[%'GWE3A /8/^"?OP5\8? KX$2:1XTFN%OYM3FN[73Y
MO$5QXA;2+=E0+;_;[A5EG&Y7?+ 8\S;T6E!JUGNDM>[NT_TZ$ROI;Y^6B?\
M7F>;_P#!=7Q1I^F_\$H_CEI\UY"M]J'A>YAM[??^\E?&_&.OW48Y/'%>H?!;
M]K?X<V?P;\)12>*[!7CT6S5AY<O!\A/]FO+_ /@N+X4TN'_@EC^T%K":=8KJ
MTG@RXMGOA JW#Q;HSY9DQN*Y4'&<<#TKZ7^!IS\%/!__ &!++_T0E!1SW_#8
M'PU_Z&S3_P#OW+_\31_PV!\-?^ALT_\ []R__$UZ510!YK_PV!\-?^ALT_\
M[]R__$T?\-@?#7_H;-/_ ._<O_Q->E44 >:_\-@?#7_H;-/_ ._<O_Q-'_#8
M'PU_Z&S3_P#OW+_\37I5% 'FO_#8'PU_Z&S3_P#OW+_\31_PV!\-?^ALT_\
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MO^AFL_\ OB3_ .)H_P"&JOA]_P!#-9_]\2?_ !->A44 >>_\-5?#[_H9K/\
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M_#/]I$98PP 8:S"2.0.Q'YU^EE?G7\/C_P =2OC[_LWJS_\ 3U%0!^BE%%%
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M=7MU((X;=,@99CP.2!^-5&$IR48*[>B2U;;Z(+VU9L$X-+7B7[0/[=W@_P"
M7A_P%J[V^K>)M+^(FJ0Z7I=UH=L;V/\ >C*S,5_@P>O>K.K?$?XKP?MBZ3X=
MM?!NE3?"6ZT9[JZ\0M='[5!>@G$03.,'Y>""3R<C%>E#)L4X*K-*,6I-.32O
MR:22NU=IZ6W;V1/M%>R_JY[!+.L$;M(RJD8+,S' 4#J2:\U^/G[8'P__ &;/
M@G-\1/%&O1Q^$;>>*W:^LHVO59Y)!&H B#$_,<''3O7+_"+]F;QMI/B_XM'X
M@?$*Z\;>$?'\QCTG1VA,']AVCQO')"K@_P 0<#Y<?=SU-;_P(_8L^'G[._P"
M@^&>AZ*MSX/@EDG^Q:K(;\2.[^8Q8RYS\W(],5U1P^6X>:]O4=1)PT@K)Q:O
M)<TE=23LE[K3=W?8GWW\*MOO^']7,7XO?M4^(O"_Q ^$]GX.\ ZQXW\-_$2X
MQ?ZW9@B#0[8QJZ32\?*&#9^?:.",YXJYX?\ "/QAC_;'UC5]0\2:!)\'9M'2
M&PT>.V/]H1WNY<R,^,;<;\\\[E&.*]@AMX[:%8XXUCC0!551@*!T %2G-<[S
M*G"G[.A2BKQ<6W[S=Y73UT4DK*\4M/4KE;=VSQ;]G']A+P3^S5X1\8:#IK:Q
MKNE^-]1EU+4[?7;PWZ.T@PR ,,!,=N_>O6_#GAJP\'Z#:Z9I=G;Z?IMC$L-O
M;6\8CBA11@*JC@ 5>[45RXK,,3BINIB:CDY.[N]VE:_K96]!QC%*R04445QC
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *]0^'7_(GV?\ P/\
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M*,\U+2>@'AT?_!/CX;Q?"*3P.(_''_"/RZ@-38'QUK9O/."[1BZ^U_: F/\
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MX@:*O@&>Z^PIJX\PQFXWE/)V!?,$FY2-I7/'2M2U_;&^&U[\ )?BG%XHMV\
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M ^4?^"Y?_*(WX_\ _8I7'\UKZ$^!7_)$_!__ & [+_T0E?/?_!<O_E$;\?\
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MR?YG#6XDS2K\=>?WM?D8.E_#'P[HVW['H>EP[>A2V0'\\5MPVD=N@5(XU4=
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M_P#LE<37;?&+KIO_ &U_]DKB:^LRO_=H_/\ -G-4^(****] @**** "BBB@
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M^*H_X4]J'_0R7WY-_P#%5WNP4;14_4*';\7_ )AR(X+_ (4_J'_0QWWY-_\
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MZQ2I;VTQ2U1UCE@NMQEBG(5E !]Q4'FBB@!I/2@C!_"@BO _VL?VO]<_9O\
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M5QO_  T/X _Z'GP?_P"#FV_^+H_X:'\ ?]#SX/\ _!S;?_%T =E17&_\-#^
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M*/W2G@X5F#'!P#713RW%U%>%*3T;TBWI'XGMLNKV74ERBNI[(3037SK\.?\
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MP"\ ZAK_ (JANGLM.\/^)8'T][B2*94E8C<I*A"6&",D8XQ7<?##PO\ L_\
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M%T.Z\27?V_59K&RCMWU*XQCS9BH!=\?Q-DUTVT#@?I7'C]H7X?C_ )GCP?\
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M_A>W@?\ Z'+PK_X-K?\ ^+H_X7MX'_Z'+PK_ .#:W_\ BZ+ =717*?\ "]O
M_P#T.7A7_P &UO\ _%T?\+V\#_\ 0Y>%?_!M;_\ Q=%@.KHKE/\ A>W@?_H<
MO"O_ (-K?_XNC_A>W@?_ *'+PK_X-K?_ .+HL!U=%<I_PO;P/_T.7A7_ ,&U
MO_\ %T?\+V\#_P#0Y>%?_!M;_P#Q=%@.KHKE/^%[>!_^AR\*_P#@VM__ (NC
M_A>W@?\ Z'+PK_X-K?\ ^+HL!U=%<I_PO;P/_P!#EX5_\&UO_P#%T?\ "]O
M_P#T.7A7_P &UO\ _%T6 ZNBN4_X7MX'_P"AR\*_^#:W_P#BZ/\ A>W@?_H<
MO"O_ (-K?_XNBP'5UZA\.O\ D3[/_@?_ *&:\$_X7MX'_P"AR\*_^#:W_P#B
MZ]+^'W[07@*+PE:JWC?PBK+OR#K-N"/G;_;KQ\Z_@KU_0UI;GIE%<;_PT/X
M_P"AY\'_ /@YMO\ XNC_ (:'\ ?]#SX/_P#!S;?_ !=?-&YV5?G7\/O^5I7Q
M]_V;W9_^GJ*ON+_AH?P!_P!#SX/_ /!S;?\ Q=?!OP;\6:7XR_X.@/']YH^I
M:?JUK_PS]9Q^?97"3QAAK,1(W*2,X(X]Q0!^DE%%% !GB@GFO.T\3^/C^T6V
MEMX?T\?#S^S?-75_M ^T&ZX_=[,YQU[=LY[5!\//%7Q&U37_ !Q'X@\.:;I]
MCI\Y7PU)%=!CJ2;6P9,$[>0O4#[QXXKC^M1;M9[M;/HKW].PKGI=&:\;TCQU
M\7)OV;K_ %:[\(:3%\18WE%KI"W:F"50^$)?=C)7G&ZKGQ \9_%'3? 7@^YT
M'PKI=_KU]<6R^(+66["QZ?&P'G%&)&[:2>F>G0U/UV-KVELGL^O3U\A<QZNI
MI&.37G_B?Q+X]L_CKX>T_3- L+KP-=6TKZKJ;W 6>UE .Q53.3D[>QZGIBN1
M_P""@?P,\4?M%?LTZEX8\(R6?]K3WUG<M;W>L76D0W\$4Z22V[W5J#-$)$4K
MN09YK:-;FO9/1VU37;5=T:07,[,]M)P/6DZU^:.D>(].\4_#?PA\%[K3=0^&
M>EV?Q2_X1+QG8Z7XOO\ 5K?59&MVNX[6#59F6Z\N4,FX?NW5D9!P.>Z^#WQ"
M\1_L^?L@_M76O@_4-0U"Q^$>M:O:^#7OKR35)M/CCTZ"Y,7FR,\DJQ32R$!V
M8_PY.*Z-HREV5UYKW?\ Y)?(F'O245U=G][7YH^]!@FE4C Q7YX7_P (O#_[
M.-C^SS\2/ASXH\4ZAXU^(/B?1['5II_$]UJ47C"RO0#>N]O+*\.(T+3;H$39
MLST!%<C\2OA7I/@W]GSXJ?'2Q\5>*O"_Q2\/_$/48=(UD^(KZ:WN&75?L\5@
M;&25K9XI$;R]BQ XY!!%*]G[W31V[JVRW>__   C[R4H];6OYWW[?"?J **S
MO#%U=WOAVQFOHEM[V2WC>XB7I'(5!91[ Y%: Z4]G84975Q:***!A1110 44
M44 %%%% !1110 4444 (3D5\O?\ !0S]G?XQ?M"ZU\/%^&]Q\,[73?!?B*S\
M43MXF>_$]Q<VQD"0H+=2HC99.6)R".E?4!X848S4]4^SO\UL'-:Z[IK[SY._
M;1_9=^+G[5UE)X52R^"EEX3US3;>RU36KVWO+CQ#ICL0;E[']WY8(P?*+."#
M@G!%<U\;O^">WQ0\2ZOX^\*^$_%G@^/X6_%N"QM_$9UF&XDUO21#"D$[66P&
M&0RQH#^^(VL3U%?:N<"E*\U4;Q=U_P /K>WWV%LT^JV?;S7F?-O[17[#E[\>
M-8U>3^U-+TBSM-!%AX=CM[4K(M\4*&YO' W2!4 CC4'Y%>0CYF&-S_@GO^R]
MJW[)?P+D\-ZPVAPW%UJ4VH+IVAS7,NEZ4KJB^1;-<DS%,H7._P#BD;'&*]V
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M_P! 72/_  #C_P */^%?:#_T!=(_\ X_\*V** ,?_A7V@_\ 0%TC_P  X_\
M"C_A7V@_] 72/_ ./_"MBB@#'_X5]H/_ $!=(_\  ./_  H_X5]H/_0%TC_P
M#C_PK8HH Q_^%?:#_P! 72/_  #C_P */^%?:#_T!=(_\ X_\*V** ,?_A7V
M@_\ 0%TC_P  X_\ "C_A7V@_] 72/_ ./_"MBB@#'_X5]H/_ $!=(_\  ./_
M  H_X5]H/_0%TC_P#C_PK8S10!C_ /"OM!_Z ND?^ <?^%'_  K[0?\ H"Z1
M_P" <?\ A6Q10!C_ /"OM!_Z ND?^ <?^%'_  K[0?\ H"Z1_P" <?\ A6Q4
M<\ZV\9:1E11U9C@"@#)_X0#0<_\ (%TG_P  X_\ "E_X5]H/_0%TG_P#C_PK
M"^(_[0W@GX1>,?#'A_Q-XFTG1=:\:7#6FB6EW.(Y-3F4 LD8[D C\ZX?1?VZ
M/">O?MI:I\"X=/\ $B^*]*T8:Y+=/IS+IKQ%E&Q9\X+_ #CC&#SSP:[J.4XV
MK!U:=.7*HN;=G;E3LW?JD]&ULR?:1O:_D>J?\*^T'/\ R!=)_P# ./\ PIMQ
MX(\/VR;I-)T>->F6M(P/Y5X#\'?BM\>OC[X ^,6FZWX)M/A#XDTF^NM+\$ZG
M<R"^AOX_+;R;UTR=RAMI(X!ST&#6/XK_ &"_&O[4W["'AOX9_&;XG:U_PFMC
M>P:AJ?B3PHPT^2[DAE9T3&W&W8RJW R5##%>E_8=*C5Y,=B(02E&+Y7SM)J_
M.N7W9):)I2O=VMN1[1O6*;T]/D>S>-_B)\*_AO\ $+PWX3U^^\&Z/XF\8-(N
MBZ9=""*ZU0QX+B%",OC(SBN'\%?M4?#7QY^V#XN^"UCX;N/^$J\&Z9%J=[-)
MH@2R>.3&%24K@GYE]CDXZ&NR\4?L?_#[Q[XZ\"^*O$7AVSU[Q1\-XS'H6JWH
M,EU9DH%9MW\3':#DYYYZUZ-'IMO!>27"PPK<3 *\H0;G Z GJ<5S\^5TZ5E&
M<YN#3;:BHSYM&DDVX\BU3L[OLA^^WTM?\/\ ASYA^"7[5$OQ_P#A/\5M;TOX
M$ZYHVN?#W4+W2]-TG6;&&W?Q)+ A9'@;;]US@=^O&:Q?$/Q ^.7CK_@GWHGC
M/P?\#_">D_&G5/):Z\):VT<,=BAF*R'>X7YM@#!7P>3Z5]@# ;_ZU.Z-6_\
M:^$A5YZ.$A93C)*3G+1*S@]5>,GJ^O1.PO9R:U;V\OO/FOXX?#/XS:I\0?A#
M<>!+/X<Z7X=6\1_B%:7NGQS2R0;4+I;.5SUWJ".<D'I5RV_9?^(<7[=DWC23
MQEH4GP;?P_\ 8(_!?]D1AH[_ ' _:?,VXZ \YSSC&*^B,\?UH&>E8+/*L(>S
MITX+W90;Y$VU)WNVTWS+92T:2M<?LT];O[SYM^!W_!/V3X<:U\8)/$GC;4_&
M.F_%"\::SL[JTAB_X1J)HY$9+9E&02)!SQCRD.,YKF_A]_P1R^%/A;]A63X
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M?:#_ - 72/\ P#C_ ,*V** ,?_A7V@_] 72/_ ./_"C_ (5]H/\ T!=(_P#
M./\ PK8HH Q_^%?:#_T!=(_\ X_\*/\ A7V@_P#0%TC_ , X_P#"MBB@#'_X
M5]H/_0%TC_P#C_PH_P"%?:#_ - 72/\ P#C_ ,*V** ,?_A7V@_] 72/_ ./
M_"C_ (5]H/\ T!=(_P# ./\ PK8HH Q_^%?:#_T!=(_\ X_\*/\ A7V@_P#0
M%TC_ , X_P#"MBB@#'_X5]H/_0%TC_P#C_PH_P"%?:#_ - 72/\ P#C_ ,*V
M** ,?_A7V@_] 72/_ ./_"C_ (5]H/\ T!=(_P# ./\ PK8HH Q_^%?:#_T!
M=(_\ X_\*/\ A7V@_P#0%TC_ , X_P#"MBB@#'_X5]H/_0%TC_P#C_PH_P"%
M?:#_ - 72/\ P#C_ ,*V** ,?_A7V@_] 72/_ ./_"C_ (5]H/\ T!=(_P#
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M=%_Z ^E_^ <?^%:E%%P,O_A"=%_Z ^E_^ <?^%'_  A.B_\ 0'TO_P  X_\
M"M2BBX&7_P (3HO_ $!]+_\  ./_  H_X0G1?^@/I?\ X!Q_X5J447 R_P#A
M"=%_Z ^E_P#@''_A1_PA.B_] ?2__ ./_"M2BBX&7_PA.B_] ?2__ ./_"C_
M (0G1?\ H#Z7_P" <?\ A6I11<#+_P"$)T7_ * ^E_\ @''_ (4?\(3HO_0'
MTO\ \ X_\*U**+@9?_"$Z+_T!]+_ / ./_"C_A"=%_Z ^E_^ <?^%:E%%P,O
M_A"=%_Z ^E_^ <?^%'_"$Z+_ - ?2_\ P#C_ ,*U**+@9?\ PA.B_P#0'TO_
M , X_P#"C_A"=%_Z ^E_^ <?^%:E%%P,O_A"=%_Z ^E_^ <?^%'_  A.B_\
M0'TO_P  X_\ "M2BBX&7_P (3HO_ $!]+_\  ./_  H_X0G1?^@/I?\ X!Q_
MX5J447 R_P#A"=%_Z ^E_P#@''_A1_PA.B_] ?2__ ./_"M2BBX&7_PA.B_]
M ?2__ ./_"C_ (0G1?\ H#Z7_P" <?\ A6I11<#+_P"$)T7_ * ^E_\ @''_
M (4?\(3HO_0'TO\ \ X_\*U**+@9?_"$Z+_T!]+_ / ./_"C_A"=%_Z ^E_^
M <?^%:E%%P,O_A"=%_Z ^E_^ <?^%'_"$Z+_ - ?2_\ P#C_ ,*U**+@9?\
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M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!Q/QBZZ;_VU_\
M9*XFNV^,773?^VO_ +)7$U]9E?\ NT?G^;.:I\04445Z! 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MI?[9WC3QC\"?!NE^!_'WAWQIX\\:>*W\.S^(KWP;<Z##X;5%:21KC2)YO/\
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M_/\ -G-4^(****] @**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MK_P3_P#AG^T9XX_X2+Q1I=[<ZHT*0,\-]+"K*HPN54XSCO7'_P##H?X(X_Y
M>J?^#:?_ .*KZ<P&H*Y%>74R?!5)NI.E%M[MHETXMW:/F/\ X=#_  0_Z >J
M_P#@UG_^*H_X=#_!#_H!ZK_X-9__ (JOIW8*-JU/]A9?_P ^8_<B?90['S ?
M^"1'P1'_ # ]4Q_V%I__ (JM?XT_LR^'_A_^R-<> ?#/P@MOBWH<ERA?PMJ&
MJP6Z7.Z0.TK371VY4@,!G/'%?0_4TI%:X?*\)1ES4::B^Z2V+IQ4'>*/ST^&
MW[%/Q:^#WPETGQ)X9\$:/I=]X=^(#>)]&^%XUZ-X-'TIX3!-907IS"DSOFXR
M/W8+LM?17[!_P=\6?#[3_B%XJ\<:/:^'/$GQ.\4S>(YM%@OEOO['B^SP6\4#
MSI\DC[8-Y9/E^?':OH#ZTF.>.M>FJCU\TE\DE_\ (JXN6VW>[\]6_P!3Y LO
MV0_'4/P!N/#[6.G_ -J2?%A?%BI]M79_9XU)+C?NQC?Y8)V=<\5PNN_ GX\^
M*/ 7Q"^#-K\-M(TGPSXW\67^H/XXO?$5K=6L>GW%\;EL6"CSS*T?R '@,V2<
M"OOI>328_P#KUGRKJKJUK/9[?Y(J.D;+O=/JGK_FRGX>T2'P[H=GI]N-MO9P
MI!&#V5%"C]!5_K0!1UJF[ZLF,;*R"BBB@H**** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@#Y1_X+E_\HC?C_\ ]BE<?S6OH3X%?\D3\'_]@.R_]$)7
MSW_P7+_Y1&_'_P#[%*X_FM?0GP*_Y(GX/_[ =E_Z(2@#JJ*** "BBB@ HHS3
M7?8A-&VK H>)?$=GX0T&ZU*^E2WL[.,R2NQP%45\R?#W0+[]LSXOR>*M8BDC
M\&Z'*4L;9Q\MPP.1GU[%OP%3?&/Q=J'[5WQ5C\!^'9I%\.:;+OU6\3[KE3R,
M^@Z =SD]J^B_"7A73?AMX1M=-L8X[33]/BVC)P% ZDG\R37P\KY[C>1:X:D]
M>U2:Z><8_<V?:1MDF"YG_O-5:=X0?7RE+IU2-6.-88MB*%51@*!T%8GQ+\=Q
M?#7X=Z]XADL[[4H]"L)K]K2RC\VYN1%&SF.-?XG;;@#U(KRC]J[]K+Q%\!I/
MAZWA'X;^(/BA:^,M;33+VYT-EDCT: XS<R'D;>3CG'RGGI4GPJ_8GL_AC^V+
M\0_C OC#Q9J=U\0;2UM)-"N[K=IFF"! N84[%MN>>F3CK7ZCA\KITJ"Q.,ER
MIIN$5JYN,E%Q=G>&C;3:Z:)W/AY3;E:/S\O/S/,[N/Q%_P %7/V>OA9X\\$^
M+?'_ ,"[6SU]-8O=/N=/5+W4X(6*FVE7> %8C(;)'L:^K;3P[8V.K3:C'9VJ
MZC<1K#-=+ HFF5?NJS@9('8$X%78H8[>-5C540< *, 5(#6689I*NE1HKDI1
M<N6.C:4G>SE9.5M-7?RL.,;;[]1PYHHHKRRPHHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#B?C%UTW_ +:_
M^R5Q-=M\8NNF_P#;7_V2N)KZS*_]VC\_S9S5/B"BBBO0("BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M $,UY?7J'P\_Y$^S_P"!_P#H9K?./X*]?T9^4PDW)MFY1117S1L%?G7\/O\
ME:5\??\ 9O=G_P"GJ*OT4K\Z_A]_RM*^/O\ LWNS_P#3U%0!^BE%%% #,CK2
MCUKQ>/X+_$S_ (;8?QL_Q&+?"\Z)]B7P=]CQLN^/](\S.#R">F><=*K_  5^
M!WQ4\$>+_BO=^*/B<?$6G^+;LR^$[?[%L_X1B/9( O)P_+(<#CY/<US*M+;E
M>[73IUWV?0Y?K$^:W(]VKZ=.N^SZ'N'\Z:1D?_7KYI\,_LS_ !PTO]AW5_ M
M]\9/MGQ2O))WM/&/V%A]E1I0R)LSN^5,KG.>>.E:7QD_9Z^,7C+X1?#/1_#?
MQ:_X1_Q'X7NK*7Q-J_V#=_PD<<2*)UV@_)O8,<'CYN:7MYVOR/9/I]V^Z)^M
M5+7]F[V3MINWMONCZ%/':J&O^(K'PAHEUJ>J7EKI^FV,33W%S<RK%#;QJ,L[
MLQ 4  DDUY5X_P#@Y\2M?_:V\&>+M'^(1TKX=Z+8SP:SX7^R[O[6F=6"2;^V
MTE3STV<=36C^V7J/P_T?]GK7K[XG?V./"=@JW$SZG"9;>*93^Y8J 22)-N,
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MX 4H 6VMC)'%7=*UVTUJ+?:W$<R]]K9(^HKOC6@WRWU[=2R[11G%%:@%%%%
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M -C#_AH&YU1=2\13PZ=%H+:3X=L8;?$.C3N,2W;C=B9V 1,$#;'O5<%V)O\
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MUMK^CK?1YBA8D?O/EVD<5I(ZR+E2".Q!KMC.,EHRCSG_ (:]^&?_ $.6C?\
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MEHW_ '\/^%>D44 >;_\ #7OPS_Z'+1O^_A_PH_X:]^&?_0Y:-_W\/^%>D44
M>;_\->_#/_H<M&_[^'_"C_AKWX9_]#EHW_?P_P"%>D44 >;_ /#7OPS_ .AR
MT;_OX?\ "C_AKWX9_P#0Y:-_W\/^%>D44 >;_P##7OPS_P"ART;_ +^'_"C_
M (:]^&?_ $.6C?\ ?P_X5Z110!YO_P ->_#/_H<M&_[^'_"C_AKWX9_]#EHW
M_?P_X5Z110!YO_PU[\,_^ART;_OX?\*/^&O?AG_T.6C?]_#_ (5Z110!YO\
M\->_#/\ Z'+1O^_A_P */^&O?AG_ -#EHW_?P_X5Z110!YO_ ,->_#/_ *'+
M1O\ OX?\*/\ AKWX9_\ 0Y:-_P!_#_A7I%% 'F__  U[\,_^ART;_OX?\*/^
M&O?AG_T.6C?]_#_A7I%% 'F__#7OPS_Z'+1O^_A_PH_X:]^&?_0Y:-_W\/\
MA7I%% 'F_P#PU[\,_P#H<M&_[^'_  H_X:]^&?\ T.6C?]_#_A7I%% 'F_\
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M_P"ALTG_ +^'_"N^HH#<X'_AJ7X>_P#0V:3_ -_#_A576/VO_ACX>TZ2\O\
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M\H_\%R_^41OQ_P#^Q2N/YK7T)\"O^2)^#_\ L!V7_HA*^>_^"Y?_ "B-^/\
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M4P>)PG^[>_#2\9:K7I%ZM?-6/7PN;XO!S4\/.49*VL6]WV:ULN[MW-[XE_\
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M0UE>,Z4[MV7NK=*[5KZZ%?\ $+,%)?N\\P;]9S7YP/TZ\)_$6'Q5J#6Z6=W
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M:QS1MF.1 RGU!Y%**O'F_K^M2I>[)P>^J^[<L44#I13 **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@#Y1_X+E_\ *(WX_P#_ &*5Q_-:^A/@5_R1
M/P?_ -@.R_\ 1"5\]_\ !<O_ )1&_'__ +%*X_FM?0GP*_Y(GX/_ .P'9?\
MHA* .JHHHH **** "BBB@ HQBBB@ HHHH CDPWWAN![5YC\<?V.OAU^T3:.G
MBGPOIM],R[1<B/RKA/3$B8;CZXKU 4;?EKIP>.Q&$JJMAIN$ELXMI_>CLP.8
M8K!5E7PE24)+9Q;37S6I^5_[6G_!NKIGC*TN+CP??V6J!A\FGZS$"Z]\)<(
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MPT\6?M<-\-],UB6^\<-H*ZSM@4R6CVA; (D'REO;I^/%?$'[,?\ P3&_8O\
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MOC"SFUZ,Z8=,&E715[&-22?-5<;EDY/S*PKU33=;NKR\OXY;&:%;5BL3D_\
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MV2_V:9OV;?AKJ6FZEKI\2>(O$VKW?B#7M46T%I%=W]TVZ5HH0S>5$, *A9B
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M@K38_$WB/28_!=S!/'+:W'[R_$2JH68G[V=O)]SZUV2_$_0'.!J,.2<#AO\
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M_:&\-2_$[7/"DMQ/9ZAX>M$O;R>ZB\FT6-S@8E8XS^7UJ98JDM');VWZVO\
MD73A*<N2"NWH=Q17R+X]_P""U?P6\#V6IA;S5M3U+3[N2T2RM+4.URR]'5]V
MSRR>^<^U>$_$[_@H?^TC^T[X.N9/A7\,-6\'Z 0$DU:6$W%UAN,H64+@YZJC
M8]>*\JOQ#@Z:]R7.^T5=_AL?H^3^%>>XNDL5BH+#4.M2LU"-NZ3U?E9:GW)^
MT/\ M=_#W]EK0?MWC3Q'9::VTF*S5O,N[G'9(A\Q-?&^L_MZ_'C]O+5)]&^
M_@^Y\+>&RQBF\3:B KA<'E7(V)D<C;EJD^&O_!*Y?A[XY\'^)O'6EZO\:/$'
MB*[1M8N-0NC':Z,I ;>Z,Q:4J>/F8KQ]VOL[2)/%?AOXQVNA:=X=T.Q^&]KI
MI,=Q;_NI89P1B-8UPH7KP%_&N+FQN,?[UNG"Z5DFV[]WT7IMW/;_ +7X1X:]
MW+*7U_$K_EY435*+[QI[R]9:>1\V_L\_\$:/"_AO7O\ A*/BOK%Y\4/%LS^=
M,;YV-DKY_NL=TG_ ^/:OLK1]$L_#NEPV-A:V]G:6ZA(H8(PB1J!@  <"N+\
MV/Q";Q!XQ'B*ZT5=.FFQX=>U4EX8RIYE![@[>,GO6+IGPH^(.K?L\WWAW6?&
M_E^+KMY=FMVML 8(R^44*-N<+QG@UZ>$P]'#1M0I/6[Z7;7=MWU/@>(^,\XS
MVHJF8UG)+X8K2"7915DE\CUBHWN$2=8RZ[V&54GDCZ5YUXY^ =]X_P#!OA+3
MKGQ?KMG>^&Y[>XN+VSD\EM3:,+N\P#LQ'3W/6M77?@?I?B#XRZ-XWENM434]
M$MI+:&".X(MI%<$$NG<C/K7=[2I?2/;KWW^X^8O(ZJ#7+.ZOI[:.ZMWN;4!I
MHED!>('H6'4?C6'%\8_"]QX.U+7H=<T^XT?1VD2\NHI0\=NR?>5B.X]*J^%_
M@7X;\'_$;Q!XJL;%H]9\3(L=_*969957D *3@<U-X3^"?A7P/X8U'1=+T2RM
MM+U::2>\M@NZ.X=_O%@<]<#CVI7Q#Z);]6_3M\PU,GQC^T]X-\$?"_2_&%UJ
M;3>']9DCCM+JVA:82E\X.%&<<')[8JQXU^/&E>!OB)X5\-W%KJD]YXM8K:S0
M6S/!%@9S(W1?QKH[7P7H]GX>M])CTO3UTRS"K!:?9U,,07D;5Q@8K3,2EE.U
M<K]TXZ?2CEKO[26W3[^O7IV#4XG2_C%-J?QQU#P:?#NL01:?9+>#5W4?8YR2
M!L4]<\_H:H?#_P"*/C#QCI/C%[SP7<:)>:)<20Z1'=3#9JP"DJP(Z D 9]Z]
M'QQ13]C4O=S>[Z+9[+Y!:1Y+=:_\6O$'[.L5[9:/H.D_$25QNLIYBUK&@D()
MW'^(I@X/<UK>/M"^(NM-X+DT+6M)TDVLT;^(HI+?S5NEVKO6,]N=X'U![5Z)
M2%P.XJ?JM_BDWHEO;;KIW'&G*3M$XBZ\ ^)I?CQ;^(4\52IX5CL&MY-"\KY9
M)CG$N[\0?PJ'P/\ !B\\)^,O&&I7GBG6M6M_%4FZ*SG<>7IBX(VQ8Z=<#V K
M0\:_'GP7\/+=Y-;\4:'IWE_>6:[3>/\ @.=WZ5XKX_\ ^"LOP<\$EEMM8OM?
MDQP--M&=<^FY]HKVL#PMC\8[X:A.>M[I2:NU;?;;H?19;P?G68:X3#3EY\KM
M]]K?B>D>%?V4= \/_ K4/A]=7NL:KHVIR223R7-TWVCYF#8#CD8*C]?6M;6O
MV<O"/B+P5H'A_4-+%]I?AB2.73XYY&9H6084ELY/'7/6OE_4?^"IOC3Q_/Y'
M@'X0:]?!_P#57=Z7$3>F0JA1_P!]U5%Y^V!\:I=JR>&_ ,,O5 T7F*OL#YK?
MJ/PKW(>'=>E%?7YTJ"M;WYQO;MRQYG\K'U$/"W'TE?,Z]'#K^_.-_NCS/\#[
M$USP5X;NO%%CXBU'3]+;5M*C,5I?SHOFVR'J%<]!UKB_&?[2_P )?A#K-Y?:
MIXF\,Z=J=RH6=TF1KB?;T!VY+8KYEF_X)N>(_%MYN^)GQNUJ_P!XS-96K2;5
M_P"^F*_^.5Z)\-/^"8'P/\+Z4U])8WGB:.UY:6^NG(!'^RFP?F*T_LKA;"R_
MVC&2JO=JG"VO^*;7WV-O[!X.P7^^8^59_P M*%E_X%.WY'M7P _:)\&?M#Z'
M?7W@V^2\M[&Y\BYQ 8BLA&1D$#.1SFOH_P"'O_(GV?\ P/\ ]#:O /@UX;\)
M^$_#DEGX1TFSTBQCD^>*WMQ$&;'4X^\<=S7T!\/A_P 4;9_\#_\ 0VK\_P")
M)X65Y8)-4W+W>9INUGNTDCX/'RP<L7-Y>I*E]E2:;MYVLC<%%%%?)G.%?G7\
M/O\ E:5\??\ 9O=G_P"GJ*OT4K\Z_A]_RM*^/O\ LWNS_P#3U%0!^BE%%% $
M)F6'AV53[G%!NX1_RUC/_ A7QS^W'_P3"\9?M;?&/_A)M'^.'BKP/8BV2W32
M;..3R(F7JZF.:/[W4Y!.>_:O&_\ AP[\1 /^3H/'/_?JY_\ DNO%KX_&QJ.-
M/#.26SYHJ_R9^E95PGPOB,)3KXS.HTJDDG*'L*LN5]N9*SMW6A^E@NX?^>D?
M_?0H-W%C_61_]]"OS3_X<.?$3_HZ#QS_ -^KG_Y+H_X<.?$3_HZ#QS_WZN?_
M )+K'^TLQ_Z!'_X'$]+_ %)X-_Z*&'_A/7_R/TH%W#C_ %L?_?0KD_C7\<_#
M/[//PXOO%?BS4DT[1]/VJT@0R23R.P6.*-%RSR.Q"JH&22*^ Q_P0=^(O_1S
M_CG_ +]W/_R77M'C7]A[Q_\ #[]CKP?H&C^*+CXG>,/AKXFL_%=H-;?R/[=^
MRW F^QEV+E"5!$;LQPVTDXKIPV,Q=25J]!TUI=\T7U5]%KMJ?.\1\.Y#@<.J
MN5YI'%3O;D5*I3TL];S5MTEWU/7O@3^VEI/QJU'5K74/!OQ&^&]QI-NEVP\:
M:,-*2YA9BN^-_,=" PP02",CCFMSXN_M8>#OA+\%];\<F\D\3:1H,T=K/#X=
MV:E=23R2I"D"(C8,A>11M)'6OA_XM?"KX]?M8:%\:-+F\+_&.U\$^+/#]JMG
MX9\=7NA;$U)M4CDDCL&L7++ ELI'[^3/H2:[KXP_L :QI>G?';0_ASX3C\)Z
M-XX@\)2:8=":VL]UW;7C->W4:'Y%G2,1L7=?G*KG>17KVO34NO;KHU\M4?#Q
MBKIMZ7L_2T=?O;^YGMWP_P#^"DG@7QSH6J3W.D>./"^KZ'K>GZ#J6@:YHQM=
M6L9[\J+1WA#,/*DW9#AB, ^E>I6GQMT.[^.M]\.U^V?\)%I^B0:_,# 1;_99
MIYH$Q)T+;X'RO88]:^)_&G_!/WQU?>'/B-X(URQUGXB67B?Q7X<U3_A,;W4H
MK;5]<TV&5/.MKEX&AV/:*&"/"D>Y#D?-7KW[,O["VF_LK?MS>+-<\':#JVG^
M"=:\%:=9&[O=?N]5:6_BO;QWC!NYY94Q%)$>,)\WKFM(J#UZ6_&RO^-[$_8;
MZZ?C)+\M3ZNHHHK, HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@#Y1_X+E_\HC?C_\ ]BE<?S6OH3X%?\D3\'_]@.R_]$)7SW_P7+_Y1&_'
M_P#[%*X_FM?0GP*_Y(GX/_[ =E_Z(2@#JJ*** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** ,/Q7X%T_Q9%_I$6R8?=F3AU_QKEA)X@^&)
M^?=JFEKT/):,?S'\J]%YIK+N']#7'4PL92YX/EEW7Z]R7'6YD>&?&^G^+(LV
M\O[S&6B;AU_"K>N>'K'Q+I[VFHV5I?6LO#PW,*RQO]58$&N>\3_"NVU.;[7I
M[G3[Y3N#1\*Q]QV_"LZR^(.I>#;E;7Q!;,T?1;J,9S]?6L_K$J?NXA:=UM\^
MPM'I(^>?VF?^"&G[/G[2)GO/^$5_X1#7I6:4:EH$GV5Q(>C,G*-@]@!7PC^U
MG_P1N_:1^#WAB2S\/ZW9_'?P+9(PAT[5$#:E;1=2 DAR2>@$;L?0"OVHTK5;
M76K19K69)HVZ%3UJSC-8RRNA*2KT&X36JE!\K36S5NIXN*X?PE;WZ:Y)=XZ?
M?T?W'\J'@_PG>_ 7XSF\\(>(O%7[/'Q(LY!BWO/.CLO,[1R<;T7DX$B,HW<X
M'-?HY^RK_P ''_BOX#:GIOA']JGP?);PW6([/QOH""ZL+Y <&4K&2DB@8R\+
M,<DY45^G7[4?[$?PU_;&\'RZ/X\\+Z;JRLC+!>>4$O+-C_'%,/F0_0U^+_[=
MO_!&_P :?L>7MW'X>UB36O 6J2?N8]0B\ZSD[K%,IRJL.N3P2,BOTS#>+E6.
M'C@./,-_:&'6D:T?=Q--?X]>=+M.Z?5GB3P^:9<^>G:I'RT?S6S^1^IWQV^+
M&C_M&_L3^)/$?P!U#PQXDM]>BW:C/I#+YT]NRGSA^[PRSA#_ !?,.>*^%_V,
M/V._C5X9CT_Q1^S;\:I9-/AO8E\0^$/$\K-]C.[YN#N62+;DAAL8^F0:_-_2
M?"OQU_X)S^+[3QU\/KCQ)X#^T'<EQ92-/H^J*N"RL>8W4GJCC'H*^U?V /\
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M/_T]14 ?HI1110 4449H **** "BC-&: "BC-&: "BC.:,T %%&:,T %%%%
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MTLOJ37>"51??!R/LB/3[>*Y>988UFDX=PHW-]34"^';&&RFMDMHD@N<^8BC
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MOI_7S RM/U#4)=4ODN+18[6$_N)%;)F&/2HM/\903^'Y-0N(Y;&&)B&\Y2"
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MO_R#_P#)5'_"Y_VZO^B?^&__ "#_ /)5?H3E:,K79_KQA_\ H68?_P !E_\
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M _NBNDS57W2VNWZ?U^IG&-K>22_S_KR'44"BD:!1110 4444 %%%% !1110
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M<!M[(,E$PI^=L+D@9RP!]:^"O[57@FS^#GA&)[[5]R:+9*<:#J!&?(3N(,4
M>WT5YO\ \-8^!O\ H(:Q_P""#4/_ (Q1_P -8^!O^@AK'_@@U#_XQ0!Z117F
M_P#PUCX&_P"@AK'_ ((-0_\ C%'_  UCX&_Z"&L?^"#4/_C% 'I%%>;_ /#6
M/@;_ *"&L?\ @@U#_P",4?\ #6/@;_H(:Q_X(-0_^,4 >D45YO\ \-8^!O\
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M3?Q1?PS7KW[-&,EK>._;N<A^PU\3_&WP0^+MU\#?'MO>ZC]CC>XT'6 C/'-
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MRTY3D5_+'X=^,G[2W[/D@7Q%\9/C9X+D#XB_M6SNIU/.<DW,@[^QKWKX??\
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M12ZNG.WWVL>^V%]J4"ZA)>PP^7"2ULL1RTB@$\^_2FP>,K<>'(]2O(Y+&-R
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MW^$__!.3XZ#X>^+/#OCK6M;6RBOI7TFRA-O&DG*#?-+'N..NW('0G/%>$_\
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M43;*Y^D(4X_'\:^C/A5_P2:_9W^#HB;2?A3X3:XA.4N;VT6\F4^SR[C5?5^
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MGMDD8#ZD&JW_  K+P[_T =&_\ HO_B:W:*VCBJT5RQD[>K"R,/\ X5EX=_Z
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MD;C*LIRI'L:D/N*^0? '_!.#QE\$_B%INH>#?BYK<&BPW*2W5E>J9/,B!YC
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M4 ^I1CC\:Z'[PK\S_'7_  ;=^%] U'^T/A+\4O'7P[O(?GBA%T;F$OVRP96
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M6+LC.0V[=QY(Q[U],_&']FKQ;X^^-_PR\2:+\3->\-:#X'F9M4T2W0/%XB3
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M7G8KB;&8N36(Q,IVW3FW;Y7T/E,=QOF>.;6)QDI-;IS>G?2^AW2Q+&/E  '
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ME-Q7X'1];KMVC!+IK)'T!\3O^"['[,OPU656^(EOK5S'UM]*LI[AC]&V!/\
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M[!5R%2)>20.5QS7VY^S[XC^ OB'X0_$SX;>#_":KX1\ 7%S9^(-'?3)!#<N
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MU&."[CD>Q?&=LH!)0XYPV*\[3]AKX<1?MB2?'A='N%^),VD_V(U_]ME\IK;
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M8'/-5RI.TOZ_RMV>KZ%XA<DY1CK9M?-.R7G?NM$??M% &!14B"BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH ^4?^"Y?_ "B-^/\ _P!BE<?S6OH3
MX%?\D3\'_P#8#LO_ $0E?/?_  7+_P"41OQ__P"Q2N/YK7T)\"O^2)^#_P#L
M!V7_ *(2@#JJ*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH &&16?XA\.6OB;
M3VM[N,,IZ'^)3Z@UH4=:F45)<K6@'G*76I_":X\JX#W^BR'"OC)B_P /ITKS
MSXY?\$__ (9_M-VS:Q:VW]@ZW-\ZZGI>(G+]<R)]UCGJ2,^]?0=U;1WD#12H
MKQL,,K#((KA-6\(:AX O6U'0R\MJQS-:=>/8=_YUXN*P,.7DJQYZ?9ZN/H9R
MCI9ZH^53<_M&?L'+^\7_ (6MX%MSRWS/=6L8_P#'UP, <E?:O;_V>/\ @HE\
M.OV@VCL8]0;P_P"(.DFEZG^YD#=PK' ;'X'VKU_P?XUL_&%INA/ES*/WD+?>
M4_U%>4?M#?\ !/SX=?M$))=7FE?V-KC?,FIZ<!#,&Z@LH^5N>N1GWKDA@\5A
MDIY?4YX?RR=_N>Z]&1RR6L7=>9[1=Z;;:IITUO-##-:W2%)(V4,LJD8(([@B
MOFGXC?\ !)?X4^-;EKG3+?5O"MRSAV?3+LJIYSPK9"_ABO-_^$<_:)_8-.[3
M;C_A:O@>W.3"X9KJWC'MDNI^A<>U>R?L]?\ !23X=_'25=/N;M_"OB('9)IV
MJD19<=0DAPK?CM/M2^N8'%R5#'T^2?127Y/9_>/FA+22U\S4_::^'WQ:3P;X
M>A^$7B+3]/N-%00W,&HQK(U^JJJH3(P(R-ISD<[JQOV4OBK\<M8\>7>@_$_P
M98V.GVMJ9$UNU<*DT@.-N <'/L!7T.K!QN#9!Y!%.P0:]3^S_P!^J\*DEW5_
M=?R>WR-.76Z9X3H7_!1WX2:QXXU+P]/XD72=0TNZ>SD&H0M;I+(K;3L8]1GO
MQ7MVF:I;ZS80W5K-#=6\RAXY8G#)(#W!'!KS;XP?L9?#7XY&23Q!X4TV>\D)
M8W<*>1.6/\19,;C_ +V:QOBI^S?KVD_L[:;X,^$WB)O!<VAR)]DD<F021#<3
M$SD$@%FSD#MBHIU,=2YW6C&22NN6Z;\K/3\25S+?4]J)&:.@KY>_9S\3_M'>
M%/BK9>&_B%H>DZ]X;D1_-UZV=%:(@<$X(SGTV#ZUU_B/_@HC\+O!/Q:U+P;K
MFLW&CZGI<@BEDNK5Q 7(S@,,GOU( IT<VHNFJE6]/6UI::_DQJHK7>GJ>Z Y
MHZUE>$_&.E^.M#AU+1]0L]2T^<9CN+:421M^([^U:H.17J1FI*\=BPHHHJ@"
MC&:** $* ]A^51R6<,P^:&-OJH-2T4N5/<3BGN</XR_9M^'_ ,0PPUSP3X5U
M;S/O&[TN&;=]=R^YKR7QI_P2-_9O\=HPO/A#X/MS(""UC9BS/_D+;BOI##"A
MN37-4P="?QP3^2.6I@<-4^.G%^J1\)>+_P#@W5_9G\2>8]CX=U[09I"6W6>M
MW! )]%=F ^@XKS?4/^#:'P7HEW)=>$?BW\3/#=SU0)<12(I'3D*K=?>OTUP?
M2E&37)/),%+7V:^6GY'!4X=RZ>OLDO33\C\NS_P1A_:9^'<F?!7[6GB>&WCX
M2UO6N]I'09Q*5X'^S2GX#_\ !27X7N(]%^)G@GQ7;KU%\D&YAZ9DB)_6OU#"
MXH*Y_P#U5E_8M&/\.4H^DG_P3+_5W#Q_A3G'TD_U;/R\D_:S_P""B7PF^75O
M@OX5\:>7PSV?\7N/+D3U].U._P"'XGQT^%X_XN%^RKXMM]G+G3S*NW_OI7[9
MK]0 /QI#"A_A7\J/[-KQ_AUY?.S_ $%_8^*@OW6)E\TI?FC\X/!7_!RM\*"0
MOCCP7\0? <QP-MQIQN%!]R-I_2OH/X7_ /!8W]F_XMI$NG?%+P_:W4IP+>_<
MVLWY. /UKW?QM\%_"/Q,CV^(?"_A[71C'_$PTZ*Y_P#0U-?/OQ4_X(K?LT_%
MII);[X8Z38W4G_+?399+1D^BJVS_ ,=I^SS*'PRC+U37Y!['-Z7P3C4]4XO\
M+H^BO"WQ/\-^-XE?1]?T;5$< J;2\CFR#T^Z36\"KBOS7\4?\&U7P\TB=[KX
M<_$GXC> ;YB6WQ7BSHI[8V")N/=C6"__  3)_;6^ ,8'PU_:73Q#;Q\"'7@^
M9%'0?O4GY_X%^-+Z]C*?\6@W_A:?X.S)_M3'TG^_PS:[Q:?X:,_23XB?"'PM
M\7= FTOQ1X=T7Q!ILXQ);:A9QW$3_57!%?%/[1__  ;>?LO_ !\>XNM/\)W/
M@+5IONW7ARZ:UCB/J(#F'_QRO,3^U%_P42_9Z./$WPE\+?$/3+?Y6N]-V^=)
M[_NY0?\ R%5S2?\ @XFU+X>3>3\6/V?/B)X*6$[9KB&-Y4R.I ECB&/^!'ZU
M]%D/B5F62SY\!B:N'?9.23]4M'\]#.6?8"?NXJ$HO^]%K\;-?B>:W'_!"S]J
M/]C=WNOV<_VEM8FT^U^:VT'797CBD(SC=]^$C_MF*%_X*B?MY_L/OY?QJ^ L
M'Q T.S.)]:T*$JT@']UH,Q]/6,5]5?"S_@X*_9F^)21BX\87WAB:0<1ZQITL
M>#Z%HQ(H/XX]Z^COAY^V)\*/B_;PMX=^(7@W5C.,I%%JD/G'_MF6#C\J_2:/
MC53S)<N?X/#XWO)Q5.K_ .#*?*_O3.BA4P<_]UKV\E)/\&?$_P  _P#@Z _9
M[^)-_#IOC2'Q-\+]:9MLL&L69>W@_P!Z9!Q^*BON#X+_ +6OPS_:*T>&^\$>
M.?#/B:WN/]6;&_CD9O\ @&=WZ5SOQY_8"^"/[4UC(OC?X;^$?$7VGYFN7LDC
MN'SW\Z/;)_X]7P_\:_\ @UC^$NK:Q)K7PF\;>./A/KN[="]I=FZMX.^%&4E'
M_?VNU4_#K-O@E7R^;[I5Z2^:Y:EOD_F=M\7#:TU]S_R/U&5@X_O4'T(XK\>]
M+_8'_P""D_[*LS:;\/\ XZ>'/'GANU!-LFN3;KA@.S":)WR?^NQJX_QW_P""
MK7PS&R;X9?#GQDD>T%H1%N<=20?M47/;I^%9R\*J5;WLNS?"55TO5=.5O.-2
M,;/RN7]>:^.G)?*_Y'Z[/$DI7<JL5.02,X^E9<G@?1I/%2ZXVE:>VM1P&V6_
M-NOVA8B<E!)C=M]LU^4)_P""OG[=GPQW?\)?^R)+?!%WM_9\DO0G ^X9>]26
M7_!R[\0O#+[?&'[(GQ0T-8R?,DB6Y=<#[S#S+5!C/N?K6<O!/B6:OA8TJW^"
MO1E_[??\"99AA_MW7K%_Y'Z:>&_V;/ O@[6/%FH:1X7TG3=0\<LSZ]<VT CE
MU1F!!,C#DD[FY]237G/_  [9^&>A_L=:]\#_  [::IX9\%^(2[3BROY3<H[R
M*[,)7+-R448)QCBOB_2?^#L/X,Z8ZQ>*OAW\5/#=P<!E?3X9 K=Q\TJ' ^F?
M:O1O!G_!SM^RGXJV_:/$OB+1=P)_T_191CZ^67KR<5X+\745[^65'HU>,>;1
M[ZQON9NI@)Z/EV:[:/=?,^BOC+^PW<^//A1\-_"/AKXC>-/ ]G\.[ZUN!/I]
MV6N-5AA38(9W)RP/7ZUO>.?@W\2-<_:P\)>+-)^($>F_#K2=,EM=7\+/8B1M
M4N&9BLPDZ# *CID;>.M>5^%/^"['[)OC.55LOC1X;5FXVW,%S:D<9_Y:1+7J
M7A3_ (*&_ KQS&K:9\7?AW<>9MVJVO6T;G=TPK.#G\*^8QG ^<837%8*M#;X
MJ<X[;;I&D:.&D_=?;9]MMGM^9%\,=$^,D/[2'Q&?Q?=>%+OX4W$,"^$[*UA"
MWB-L'FB8XY!.[.XGMC S7S]X;_9M/BG]FWQQXP^*G[+'POOOB!H%U>2Z+H>A
MZ? \NLQ1MNAP[ D.Y]^?2OLCP]\8/"?C *=)\3:!J88?*;74(9LCIQM8]ZZ$
M2*1]Y?SKYW$95*+Y:J:>NDEW]5T)GEU.HK2;>^]GOZI[=#\ZO^"D>E^ _C%^
MQS\(O%GQD^"?BJ:]-U%9P^&]*EECNM!EN-B%6,)'[L!1P>.@XKD? /[.'P5_
MX)^?M:?#RS\$_"GQ<VO?$"WN+:/6([FYN[?1XPJLPE$CL%)S@], &OT/^+[K
MG3ON_P#+7_V2N+WKZC\Z^ERW+XNC&H[<VFME?1ZZ^?X''4RF#J^UTYE;6ROI
MOKYGP[XH_8]^ WQU_;L\9>$=<^"VM-J_V%->N_$K231Z??22GYE7:P ;Z=3G
MBNM_9W@^'OB;]FWXI_#^S^"NM:'X,\#WMY8R:+?P;QXC\O,GF1$\L7*C&2<9
M7FOK3S5'\2_G4-UJEOI\8::XAA7. SR!03^->E#+DI\T+7=[Z;I]/D1#*X1D
MYQLF[WT6J?1^GXGP'X=^"_P8\'?LDV'QQTS]E^_.N6DL<UMX7DCWWZ-YPC$G
MS C"_?R5[=*]>_:_MO"/CN3X4WOBCX W'Q$NO%=S'ISM-:QM-X7BD4.?-)!.
MT$G*@@94FO?-6^.?@O0/^/[Q;X;M/FV?OM3A3YO3EAS7+ZY^V[\'?#@;[;\4
M? ,.Q]C+_;ULS*WH5#D_I791X;Q<X^SI49-.VT+W:ZV2ZBCEU.,'!.*32OHK
M76[MYG#> =+\.?LY_M9V?@#P-\#K?0]'UG1?MM[XNTNSAM[5&5B%MY"J[F/'
M<_Q"LCX9?#GP;\2/CS\4=+U3]G31-&M_#URKVVO7.E6Q7Q.[ L74[,Y)[G/7
MFMKQ%_P5A_9T\*^9]L^+GA%?*8(WE7!FY_X IS^%<=K_ /P73_99T)9=WQ3L
M;N2,A3':Z?=R%OH?*VG\Z]RAX?Y_625+ U9*]]*,FK/I\/X@\/022E*-DV[6
M6UMOU.C\"_&'Q+XP_8I\1:Q>_ >XTS5?#YN(-.\#SQQ'^T%B;$?EIC: ?IV.
M*B\5>)M;^&/P/\#^-O"?[/MM=^-=;NK6'4=%M8((KG0HY0?-D9P!PH&#CIN&
M:\J\2?\ !QE^S3H(F\G7O$&I^7C'V;2)/WGTWE?UQ7':M_P<[? J.62+2_#?
MQ(U>X49C$6F0HDGKR9]PQ_NU[%+PCXNJ)6P%7:UW"WSU2L2_8V5ZFJ5KV6_?
M;Y'UQ\7O&_BBW_:$^'^@6OPKA\3>&=?AF.M>()1&ZZ"5&50Y'<_GVJWX&^('
MC6+]I[Q'X.?X=0Z/\.],TV&YTSQ%#(JI?SL!OBV#C@DCIQCO7Q+>_P#!R5I>
MKM_Q3?P-^)NL"2/=#_H^WS3W^XK\>XS6>_\ P79^./Q!;R/!?[)_C*1G V7%
M^URJDGV^SJO7/\?Y5ZD?!GBJ_/6HJFKW]^I2C96V=Y7L5[2CS\RF][Z+I:UM
MOF?:?P=^)GQ5\7>"?B1=^)/AEI?A_6]!OKN#PO;"YRFN1(I,#NW) 8[<D8SD
MX JAJ'Q/^/&I?L6VGB"U^'_AF'XO3-%YOA^XNF^Q1+YH#G=NSD1Y(&[K7QRW
M[7O_  48^*'_ " _@?X5\+V<P^6?4"C.@.,?>N0>A_N4QO@'_P %*/BL5:\^
M)G@?P5!)Q(MN8]R@\'&+>0]_[PZ=:E>%-2E'_;LTPU+I_%4W]T(RU)CJN6/.
M]&KV2WZ]-4?<_P 7?$WQATO4?AK_ ,(;X=\+W$%_>(OC+[5=$?V?"44MY'][
M#;N?8>M-\3?$'XB>'_VL[:.:[\$V?P>&CDW-Q<WR1ZBM_N/ 4D?+C'/3&>]?
M#O\ PY?_ &F_BH/,\<?M7>(+5GYD32XY^O7 VRPCKGM^%:FF_P#!M1X7\0\^
M-_C%\2_%6[_69N0F_P#[^>;6G^I?"M"[Q>=J3TTIT:DMNB<E%:]2N2M+X8O=
M/5I;=/1]3Z&\/_MNR?#+XD_$D_$[XF_"/3?#'VG'@W[/JB/.D6,9N%4Y'S8R
M"2>>.*\"E_X+.Z1X*_9!UVSU[XW_  YU'XR.;C^R[[0K)KRQA&_,.Y=BH3LX
MZ8Z9S7=^!_\ @W(_9I\(!?M6C^(]>(Z_VAJS'=]?+5*]@\%_\$A/V;?AZZMI
MOPE\+JRG(:X62Z/KSYKMFA8/P_P_QU<76>NT:=-:^LI/T%]3Q+6]MUNWO]VJ
MZ'P[\:?^#AO2]5^$'@>P\"^*=6G\=6%W;2>)KI?"P-OJ,2C]]'"K,=NX]P.W
M&,UF^/\ _@OI\4_B/\>_"NI?#;X4>.6\)Z9;R1ZIH\]CYG]L2N<*_F+&3&%R
M.]?J7X7_ &8?AQX+"_V1X#\'Z;M  -KH]O&WYA :[6TT^"QMUBAACCC7[J(@
M51] *M9[P5AU^XRJ=1]ZF(E^4(I#_L^L_BJ/IM?I\_O/R/T']O?]O?QG\6=<
M\1>'?@CJ'_".ZU#'#8:3J=J1;:454?O$<NA+'J<Y'/2K7A+P'_P4T\=Z+J-C
M)K^@^&[36IY)99[R6V%U9+)U2%MCNBKGY=I!&.M?K6$ [#\J6KCXA8.@K8+*
M,-#SE&=1_P#D\VOP-HY?WG)[]>Y^4J?\$6/VI/BMH44/CO\ :HU[R=H#6<,U
MU,H]<MYBJ3C/.*W=+_X-@/AJVL:7=ZU\1/'FO"*X$NI17,D2B^CQS&K* R<]
M\D\U^GM%9U/%KB=P]GAJRHQ[4H0I_P#I,4_Q+_L^A]I7]6SXI^''_! []GOX
M7_&ZV\6V7AO[=IEKIYM!X=U3&H6+2DG_ $AC-N<O@]"2.,UZ]^SY_P $]O O
M[-?B+XA7GA_[8MO\0)S++9'8EOI:%2OE6X51M49.,Y(XKWCO17Q>89]FF/ES
M8W$U*C_O3D_S9<<#0CJHJ]V_O5CP3PC_ ,$\/ WA/]D/4O@M]HU^\\)ZJTC3
MO+?M]J^>0285QC # <#^M;?Q!_8;^'OQ2^&?@CPGKNGZA>Z3\/KJWO-''VZ5
M)(Y85VH78$%Q@\@\&O8**\-T*;5FNEOD"P5!+EY5:R6W1;(\_P#$_P"R_P""
MO&/QP\._$;4-'\[Q=X5M9++3;SSY%$,3]04!VL?0D$CM5CPI^SCX+\$?%[Q%
MX[TO0[:S\5>*XXXM4OE)W72H %R,X' &<#G%=Q15>QA>]EO?Y[?D:?5Z5[\J
MO>^W6UK^MC@?!W[+_P /_ '@C7O#>D^$]'M-!\4333ZK8K ##?M+_K-ZGKG)
MXJQ)^SAX#N/A?8^"9O".@3^$=,,;6NDRV:26L!C.494((!!Y!ZYKML<4#@4>
MQ@EHEV^0U1I)645VVZ=C%UCX=:!XAU32;R^T72[R\T!B^FSS6R/)8,1M)B)&
M4...*M)X4TR/Q(^L+I]D-6DA%NUX(5\]HP<A"^,[<]LUH457+'L7[.&]BM9:
M+9Z9-<26]K;P27;^9.T<04S-C&6(')QZU)#8PV]MY*0Q)%_<5 %]>G2I:*=D
M/EB(4! Z<=..E+113'9!1110 4444 %>H?#O_D4+/_@?_H;5Y?7J'PZ_Y$^S
M_P"!_P#H;5X^=?P5Z_HS6EN;E%%%?-FX5^=?P^_Y6E?'W_9O=G_Z>HJ_12OS
MK^'W_*TKX^_[-[L__3U%0!^BE%%% !1110 4444 %%%% !1110 4444  &**
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** /E'_@N7_R
MB-^/_P#V*5Q_-:^A/@5_R1/P?_V [+_T0E?/?_!<O_E$;\?_ /L4KC^:U]"?
M K_DB?@__L!V7_HA* .JHHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** .-\8?#<W-U_:.CR?8]13YL+PLO_P!>G>#OB/\ VA<?V?JB?8]2C.TA
MAA9#[>]=<?E^E8?C+P):>+[;Y_W5T@_=SJ/F7Z^HKAJ8>4)>TH;]5T?^3)::
MU1N#YO?\*\6_:&_8-^'?[1MO)-JFCQZ?K./W>IV $-PC=B<<,,]C75Z-XUOO
M U\NFZ^&:'I#=CD$>Y[_ ,Z[N"X2ZB62-E9&&593D$5,HX?%P=.M%/NFMOZ[
MAI):GPP?AC^T/^PHWF>%M0;XG^";<Y-A< O=0Q@] OWU/<E,BO4/@K_P5.^'
M/Q%C6S\17$_@G7(ODGM=44K$&Z'$G3&?[V#7TTH[5YI\7_V0?AS\=97F\2^%
M=-O+N0;6NXU\FX(]Y$PWZUYG]EXK"ZX"I[O\LKM?)[HS]G*/P/[SM?"WCK1_
M&M@MUH^J:?JEL_W9+6=95/X@UK[J^-O%/_!(72]&O6U#X?>./$WA&_'^K!E,
MD<?T*[7_ %K+_P"$1_:W_9Z#?8-7TGXC:3;](IR&N)O^^AO_ /'J?]K8NC_O
M6'E;O%J2^[1_@'M)+XE]Q]N#D?\ UZX7XL?LV>!_C? R>)_#6E:JQ&!-)"!,
MGN''.17S)I?_  5;U[X>7JV7Q.^%FO\ A^X7_6W%K&S1(._RL#_Z%7L?PN_X
M*,?"'XL>2EGXLM+&ZFX2VU &VE/Y\?K6D<WR[%+V4Y+TDK/[F5[2,M#0O?V4
MH? ?[-^J>!/ACJESX'FN7:>VOD8RO#*SJSDD\X8+M..@/%>2_"*S_:D^$'Q+
MT;1?$#:+X[\*S7 CNM2,RK-%'_$Y8X?('0$<U]8Z5KEGKMMYUG>6UW#V>"59
M%_,$BK8Z5O4RVE4E&I2FX\MDN5V5ETML#@GJCQ'XR_M\?#[X!?%*/PGXHNM0
MT^\:!)S<?8W>W4-T&X#]1P*]-^''Q3\._%S01JGAK6+#6K'=M,MK,) C==K8
MZ'V-0_$;X.^%OBY8?9_$N@Z3K42J57[5;K(T?^ZQ&5_ URG@S]E#PW\'OAIX
MFT'X?QS>$YO$22$WD,KRR6\Q0JLB[F.-N> ,5<?KL*TG+EE#6VZDNR[,KWK^
M1ZH#FCK7Q7X<\#?M6_L^^(K*WM=:TKXE:"UPD<C7TG[[:6^9F9OWB@#/\1^E
M>W?M$?MP>#?V7-=TG3_%R:M;R:M"95FM[0S018XPS\#.:BCFT'"4Z\73Y;7Y
MM%KV?47M%:\M#V4<&E->5_ #]L?P#^TQ>7UMX3UD7UUI\0GN+>2(QR)&3C=@
M]LX%4;C]OCX.V6J36<GQ"\.I<6\IAD0S?=<'!&<8ZUTK,,+R*I[1<KV=U9^@
M^:-KW/8J,XK#B^(>A3>%H=<76-/_ +'N$#QWC7"B"0'IAB<4:+\1O#_B298]
M/US2;V5CA4@NXY&)^@.:Z/;4[I76I5S<HJO<:E;VCA99H8V;D!W )J8/D9ZC
MVK7F6P#J*-U&<4P"BBB@ Z4444 %%%% #=NX>U4]7\/6.N6_E7MC9WD7]R>%
M9%_(@U> Q37J;)[B<4]SQ'XI?\$X?@7\:)'D\2_"_P (:E-)UE^P+$X/3(*8
MP:^<?B-_P;B_L]^*KB>ZT&/Q3X.OYN8Y=-U1A'#]$8'^=??HY%(PQ7'5RW"U
M/C@ON/.KY1@JW\2E%_+7[S\NI?\ @@]\8/@I(UQ\'_VF_%FDS#)BBU0R;$SV
MRI?C_@/X4Q_"/_!2?]G3]W8:OX+^*>G6HR\DYB\Z<#TWE),_05^I!.?_ -=
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M#)5O[6\3^/\ 5MQ#+OU+9M/<_=.<UU&D_P#!N#^S+IDC,VB^)[LL,?Z1KDA
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MW[/I]C!M&%\N!5VCVP*NI$J#Y548[ 5^='VS_@HM_<^'_P"5K_\ $4T^%O\
M@H]J9\Y?$GPZLE?D0%+,[/\ R ?YUQRSF<G>5.;^7_!*6==J%3[O^"?HYCBB
MOSC_ .$'_P""C_\ T-WPY_[]V7_R/2-\.?\ @HUJ8\B?QI\/K:*3AI8TM R#
MU&+<&I_M5_\ /F?W?\$/[9E_SXJ?=_P3]':*_.(?L^?\% Q_S53PC_Y"_P#C
M-)_PSW_P4$_Z*IX1_P#(7_QFC^U)_P#/F7W+_,/[9J?] \_N7^9^CU%?G$/V
M2OV[?$9\V_\ C3HFGR+\JI;D;6'K\J 4G_#%/[;W_1>=/_-O_B:G^TZG2A+\
M/\R?[8J],//\/\S]'J*_.+_AB;]MUUVGX]6 #<$@MQ_X[3A_P3:_:[/)_:=N
M03R1NN>/_'J/[1K?\^9?A_F5_:V(>V'E^'^9^C=%?G)_P[:_:\_Z.>N?SN?_
M (JD?_@EW^U9K_RWW[5.K6J)RIMGNP6/OMD7^=']H8C_ )\2^]?YD_VIBNF'
ME]Z_S/T<HK\X#_P2,_:1O!Y5W^UEXIEMI/EE027WS+W'-QBG?\.6_C /^;G/
M&/\ WW<__':/KV+Z4']Z'_:6-Z89_>C]&FN8PWWD_P"^J8]_!&?FFB7ZN*_.
MI?\ @A7XMNE\R\_:%\<2W3\RN'?#-Z\OFGQ_\$!7UCYM:^.7Q O)4^6)D<?*
MO<?,3WH^N8WI1_%"_M#,'MAO_)D?H@VK6J#<;FW ]3(*9_;MC_S^6O\ W]7_
M !K\]?\ B'A\-:A^ZU'XN_$:ZM3]Z+?%\WIU!'Z4?\0X'PT_Z*)\2?\ O]:_
M_&J/K6/_ .?"_P# E_D'U[,?^@=?^!H^]S\4O#*G!\0Z'D<'_3HO_BJS]2^/
MW@?1KGR;KQAX;MY<9V2:E$#C_OJOBU?^#=;X0*@_XJ;QX3CD_;(^?_'*OZ=_
MP;S_  1M;7;<7_C*\DSGS)-1"G'I@*!1]8S#I2C_ .!!]:S1[48_^!?\ ^LM
M4_:J^&>BP+)=^/O"-O&S;5:3585!/I]ZL^;]M7X0VT+2/\3/ ZH@W,QUF# '
M_?5?-VF?\&_GP"LYRUQ;^*+Y",!)-6=0#Z_+@UH1?\$$/V=$D4MH&O. <E3K
M=QAO;[U'M<R_DC][_P @]MFSVIQ7S?\ D>V?\/#O@3_T5[X=?^#ZW_\ BJS;
MO_@IM\ ;.Y>)OBUX*+(<$IJ*.I^A'!KS?_AQ1^S1_P!"/??^#V]_^.UJ67_!
M%7]FZPM5B7X>Q.JC :34+EV/U)DR:.;,NT/O8<V<?RP^]_Y'2:O_ ,%6_P!G
MG1BF[XI>&9M_3R)C+CZ[1Q6;?_\ !8+]G73[-YF^).E.(QDK%'([GZ +DTFE
M?\$?/V=-'W^7\-M+DW]?.FEEQ]-S'%:-C_P2B_9[TZ[29/A?X<9HSD"2-G4_
M4$X-'_"G_<_$/^%A_P#/M?><W_P^N_9P_P"A^C_\ +C_ .(K)E_X+N_LU12,
MO_"::D=IQD:%>$'\?+KU#_AVA\!/^B3^"_\ P7I6I'^P!\#HHU4?"3X=X48&
M=!MB?S*9HY<R_FA]S_S*Y<X_FA]S/#;_ /X+X_LXVL^V'Q!KUVN,[X]$N  ?
M3YE!_2J&I_\ !P'\ +6WW6UUXIO9,X\M-(D4X]<G KZ1TS]BKX0:+ 8K3X8^
M [>,G<5CT.W4$^OW*OZ?^RM\,])N/-MOA_X.@DQC?'I$"G'UVT>RS+^>/W/_
M #%['-GO4BOD_P#,^4'_ .#A+X(JI(LO&#,!PO\ 9I^8^G6LD?\ !Q1\*?\
MH4?'O_@)'_\ %5]J+^S[X%1PR^#?# *G(/\ 9D/!_P"^:UO^%;^'O^@'H_\
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M_1"4 =51110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% %'
M6M$M?$%BUO=1K+&WJ.5/J#V-<.\>J?"2YW+YE]HKMR/XH?\ #^1KT8'(J.:%
M9XF5U#*PP0>017+6PZF^>+M);/\ S[H35RGH>O6OB2Q6XM9!)&W7U4^A':K^
M,+7!:[X'O?!U^^I^'V;;]Z:TZAAWP.];?A/XC6/B:WVNZVMTO#PR-@@^WK6=
M+$/F]G6TE^#]!<W1G1T4U7#CJ#]#3J[M"BGJVC6>O6;6]]:6UY _WHIXED0_
M4$$5XW\3_P#@GA\(_BN9)+WPG9V-U)_R\:>3;.OT ^3_ ,=KVXG'?]*,@BN7
M$8.A75JT%+U2$XI[GQ9JG_!*#5_AU<_:OAC\4/$7AUH3F.TN9&,1/NR$#\T-
M5/\ A*_VMOV?/^0AI>C_ !&TV'F2:$*TI4>FW8^?^ &ON#M32OTKR9</48ZX
M:<J;\F[?<[F?LDOAT/C;PS_P5[TK0;U++XA>!?$W@Z\8[2?),B ]R0X1@/H#
M7NOPU_;6^%WQ:C7^QO&6CM*W_+&XE^RR9],2;<GZ9KT#Q+X'T?QG9-;ZMI=A
MJ4,@VLMQ L@(_$5X/\3/^"6GPA^(<C30Z"_A^ZZK+I4QMPK>I7H:GV6;T?@E
M&HO-6?WK3\!6FMG<^B+>YCNX5DCD61&&Y2IR"/4&L[Q/X(T?QM9BWUC2=/U6
M 9PEW;),HSUP&!Q7QQ-_P38^)_P<G:;X8?%[5+>,'?\ 9-19@K_['&X$?7%-
M3]H']JCX#'R_%'P_L_&UFF%%QIRY;;TW$Q9Y^HJ99S*"Y<;AY)=TN:/X?Y!S
MO[2/KKP7\(/"_P .;FZFT+0-)TF:\ $[VMLL;2@= 2!T]J\Y\2_\$\/@SXLU
M*XO+[P'I;75TQ>22.2:/+'DG"N /RKQ=/^"NTWAA=OBCX5^+M-DZ'RU! /\
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MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ KU#X=?\B?9_P#
M_P#T-J\OKU#X=?\ (GV?_ __ $,UX^=?P5Z_HS6EN;E%%%?-FX5^=?P^_P"5
MI7Q]_P!F]V?_ *>HJ_12OSK^'W_*TKX^_P"S>[/_ -/45 'Z*4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 ?*/_!<O_E$;\?_ /L4KC^:U]"? K_DB?@__L!V7_HA*^>_
M^"Y?_*(WX_\ _8I7'\UKZ$^!7_)$_!__ & [+_T0E '54444 %%%% !1110
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M (>A_&S_ *,D^./_ (-=)_\ C]?;5&: /B7_ (>A_&S_ *,D^./_ (-=)_\
MC]'_  ]#^-G_ $9)\<?_  :Z3_\ 'Z^VJ* /AJQ_X*N?&#4KV\M;?]C#XTS7
M&GNL=U$FKZ06MW90ZJP\_@E65A[$5;_X>A_&S_HR3XX_^#72?_C]?6GA_P
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M%:QOJ^D!KAPI<JH\_DA59OHIJU_P]#^-G_1DGQQ_\&ND_P#Q^OK+Q_\ #_\
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MA7KUCX&73_B5J/B".X*_VE806<MLJ85GB>1A*QS\S;9 O(X"CFN@IQRJDO\
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MOM,BTZ:T5,+*T<KNLK'/+ .5&1P">>: .FHHHH **** "BBB@ HHHH ****
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M:%BN,\$[2.:SO@G\8=/^-_P?\+>,+*.6QMO%&C6NMQ6MRZ^?;PSQ+(H?!(R
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M3@UE^'/V1?$UY^R);^'OA_%\5/#FI7'Q$TO4H3XD\-Z=I+^'41OWES;6=J!
ML(^\Q W%B3UK[+*8KV"7:WSNU?\ -J_D<RM*2YNM_E9.WSTV\S[W^+'QE\/?
M!+X=ZGXJ\0WXM='TG GDC0S.SLXC6)$7+-(SLJJ@&2S =36)^S]^TUX;_:1L
M-6?0XM>T^]T&Y6UU'3=;TF?2]0LG9=Z&2"95=59<E3C!P<=*^=?&GPI\2?\
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M'0C(KY!_;Z\=:]\2/V*-$L]"^%?Q0U?6?$-WIER--M]&B-[I:6E_;3RBY4S
M1DI$^T!FW' XS7U/\/\ Q,WC/P/I>J-IFJ:.U];I*;'4X!!>6N1]R5 6"L.X
MR:7+H^]VOE96_&YAJXP?5J[_  _JQLT445 P->4^/_VTOA[\+OAWX\\4ZYJE
MS8Z/\-;Q;'7Y&LI2]K*PB9=J!=S@B:,@J",'VKU:OC']I+]E_P 3^//VU(]%
MLO#4UY\*_B=;V^I>+]0#)Y$-Q913P&&12<YFBDMPI ZP'D5,K\R2_K;]+_,T
MC9Q;?37UZ6^]H^FK+X^^&=1^(FA^%K>^DGUCQ#HSZ_9QI [(;-#&ID9\;4R9
M4P"03DXZ&NJLM8M-2B=K>ZM[A8SAVCD#!#[D'BOA?X"?L\_&#7?@#\8O[1TW
M4/"GC2W\/MX#\'":Y19&MK3S_+O(91G:LXD@P6Z&+D5P/P&_9'\4:7^S9\8-
M+\"V'Q@\+>+=?\/16B6FN^'-)\.6<UPK N]M]C41RSLH9?,E!RI /6M)6U2Z
M*_K=Z?<M_,C9KUM\TDF_OV\C[R^.W[06D_ OX/:EXSFCDUFQTR:V@DBL)49V
M::XB@&"3MX,H)YZ"O=O#GC72O"GPHFUC4]0M;#3=(MYKJ]N)I0L=I&A9V:0_
MP@+R<]J_)GX=_LEZM'^QS\7-$\%:'\7M&U;Q%+H_V;3/$'A/2="A@ECO(F:Y
MM;:T"PR2*BY=G'S")!R*^\?^"=7A+5/@9^SGXJL?$7@S5%\4:3J-W=:KJMLI
MN7\=R<NM["7<LSN@6/RV(",NU<+C'DY[&,<-OJG?\/T;?]7MK1:<8NVK;3]%
M:WI<]'^&G[<OP[^+?P.\1_$31=3OI/"_A6[N['4)YM.GAE26V;;(JQ,H=^<;
M=H.[(QG-7OV;/VMO"?[4MKK?_"/Q^(=-U'PW<K:ZGI.OZ/<:1J=BSH)$,EO.
MJR!75@5;&#@XZ5\S?L+?&#QI\,?A)\?-5NO@;\7+?5/^$JUKQAHVC:EI<%I-
MK\-U.7@MX&\YE\XC&Y6QM]37H/\ P32U+4O%8\<>*/%G@;XC>%/'WBR]AU+7
M9_$VCIIUNQ\ORX;.S"S2;HK>- A8XW,6?^/ ^7A&[U_E3]&[?\'[C:IIM_,T
MO1/3\.O4^K!THH!S10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 8Q111
M0 4444 %%%% !1110 4444 %%%% !BC%%% !1110 4444 %%%% !1110 444
M4 &**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH ,4444 %%%% '-_%'XL^%_@=X$OO%'C;Q+X?\
M!_AG2_+^V:OK>HPZ?86GF2+%'YD\K+&FZ1T0;B,LZ@<D"O,/#/\ P4U_9O\
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MG_\ /:\_[[7_ .)KJ:1_NUM#%UH+EA*R$XI[G+_\*ET__GM>?]]K_P#$T?\
M"I=/_P">UY_WVO\ \372T5I]=K_S,7*CFO\ A4NG_P#/:\_[[7_XFC_A4NG_
M //:\_[[7_XFNEHH^NU_YF'*CFO^%2Z?_P ]KS_OM?\ XFC_ (5+I_\ SVO/
M^^U_^)KI:*/KM?\ F8<J.:_X5+I__/:\_P"^U_\ B:/^%2Z?_P ]KS_OM?\
MXFNEHH^NU_YF'*CFO^%2Z?\ \]KS_OM?_B:/^%2Z?_SVO/\ OM?_ (FNEHH^
MNU_YF'*CFO\ A4NG_P#/:\_[[7_XFC_A4NG_ //:\_[[7_XFNEHH^NU_YF'*
MCFO^%2Z?_P ]KS_OM?\ XFC_ (5+I_\ SVO/^^U_^)KI:*/KM?\ F8<J.:_X
M5+I__/:\_P"^U_\ B:/^%2Z?_P ]KS_OM?\ XFNEHH^NU_YF'*CFO^%2Z?\
M\]KS_OM?_B:/^%2Z?_SVO/\ OM?_ (FNEHH^NU_YF'*CFO\ A4NG_P#/:\_[
M[7_XFC_A4NG_ //:\_[[7_XFNEHH^NU_YF'*CFO^%2Z?_P ]KS_OM?\ XFC_
M (5+I_\ SVO/^^U_^)KI:*/KM?\ F8<J.:_X5+I__/:\_P"^U_\ B:/^%2Z?
M_P ]KS_OM?\ XFNEHH^NU_YF'*CFO^%2Z?\ \]KS_OM?_B:/^%2Z?_SVO/\
MOM?_ (FNEHH^NU_YF'*CFO\ A4NG_P#/:\_[[7_XFC_A4NG_ //:\_[[7_XF
MNEHH^NU_YF'*CFO^%2Z?_P ]KS_OM?\ XFC_ (5+I_\ SVO/^^U_^)KI:*/K
MM?\ F8<J.:_X5+I__/:\_P"^U_\ B:/^%2Z?_P ]KS_OM?\ XFNEHH^NU_YF
M'*CFO^%2Z?\ \]KS_OM?_B:/^%2Z?_SVO/\ OM?_ (FNEHH^NU_YF'*CFO\
MA4NG_P#/:\_[[7_XFC_A4NG_ //:\_[[7_XFNEHH^NU_YF'*CFO^%2Z?_P ]
MKS_OM?\ XFC_ (5+I_\ SVO/^^U_^)KI:*/KM?\ F8<J.:_X5+I__/:\_P"^
MU_\ B:/^%2Z?_P ]KS_OM?\ XFNEHH^NU_YF'*CFO^%2Z?\ \]KS_OM?_B:W
M=%TA-"TZ.UC9FCCSM+8)Y)/8#UJTG2G'I653$U:GNS=T-12V"BBBLAA1110
B4444 %%%% !1110 4444 %%%% !1110 4444 %%%% '_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>61
<FILENAME>img_014.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 img_014.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" #F T@# 2(  A$! Q$!_\0
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MPOVJZ0AH8G&379(X8L , 8^A)).01P0>N1U)- #Z*** "BBB@ HHHH ****
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MU.T^)6@:-X*N_AY::7JEI?:E/#:V[^$+Z\T>[.G+:2W<5Q))/(\VV1>4L/\
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MKO\ X* :!\=OVA?A[;_\' '@G0?@3<?%CX2ZG:?M.?M#?L"Z5X3\5?\ "O\
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M=_97[8WPI^+NB?MX^-?^"5MI<:U)\./^"P/QR_9$_:Z\3Z]HB^)X=,TKP?\
M"C2_$.J_\%!](O=5\VQO/!__  L+Q#\&/AM/H>E6=O806J_$26QDM[+S8[)_
M[.)K*UEE@NI+:":[L_.^QW,L,<EQ:?:56.Y^RS.IE@\^,!)A$Z"15"OE0!7Q
M5X<_82^&FD?ML^)/V\_$?C;XM_$;XRWOPVN_@[\/-&\<>*K"]^&_P/\ AQK>
MK:=XA\5Z!\+O"6E:)I,>GS^*]=TZVOM9U[7KO7M<:UMX=)M;^VT]989P#[5L
M+.'3[6"PM8A!9V5O;VEG$"2([:V@C@A0%B6(2*-%&[GY<')&XW*** "BBB@
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MDN_6C%" ?T")-#+DQRQ2 $ E)%?!89 .TG!(Y /)'(XJ2OP2_P""5_PJ\$_
M7_@HA_P6@^ _PIT[4/#'PF^&GC[]A.#P'X+F\1^)/$.F>%X_%7[(/AGQ?XE.
MDOXFU?6+NV?6_$^LZIK>HNMQFXO[R25CM6)(_P![.Y_#\O\ ]>?\F@!:***
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHJ.1R@R%!&.22 .A/4D
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M:V5;# @ 'Z[4444 %%%% !11^G^?>O"/VG_V@_ _[)_[._QL_:7^)=OKU[X
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M_A%]>;5_"%Z]_I(35_L.H[+0S2.EU +7=-$=HEC;Y@ ?%'_!&/\ X+(>%O\
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M5/"_PY\$?$CQ4NL^-+_Q5^S5=^$)O#W@7Q3HG@3P9>6_B'4=1T[XTOXQLH?
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MY2W?\%V_^RB_\$]?_6'/ M?M30 444F1SSTY/Z_X'\J  D#&3C)P/J>U!(&
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MX_T?Q%\:?@;X:\#>*OBSX+TQIKB[\#Z7\2/[5?P?%K=TL?V*#4]5M=(N+_\
MLM9WOK6PGL;JZAA2]M]X!^:'[!W_ "EN_P""[7_91?\ @GK_ .L.>!:_:FOQ
M6_8._P"4MW_!=K_LHO\ P3U_]8<\"U^U- 'S_P#M+?#SXZ_$[X9OX8_9V_:
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MVT%M%YMQ/Y=O%'#'Y]W/)=74QCC55,MS<S37-Q)C?-/+)-(6DD9C^*__  1
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M\?/_ $P^!/\ .: /UUHHHH 9M S][)/)R1DGJ?H,].F0/2ODK]M+]B+]G/\
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M##2O$GB>Y:ZU[7K/P;X?LM"CU?5'W-'%<Z@;1KG[';;;+3XY$L+".*RMK>)
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MDLXM7UF.Q=S K)=7.T.=VW]0OVJ/^"VW_!,WQW^S/^T-X,\"_M/7E_XU\6?
M_P"*?AOPA8:?\%?VD;/4;[Q/K/@G6[#0K*PO#\);86M[=ZG<6UO:3FYMQ%<2
M1R-<0JID7_/M_P""0$NE3_M2ZQX5_P""B/Q'_:E^$W[,?C/X-?$'PYXB\9V%
M]\?M(U>PUN"WL-<\)V.C:OX0T'Q%K&FSWVN:/:02&+3C;75I]HL+EC#=/%*
M?UI:G_P7$_:Q_P""<7_!$7_@G-^U3\=_AMK7[1WQ]^/_ (]^)?P_^)EQ\;]2
MUKP!XMLUT?Q+\4M4T74KZWM?#UM=2W0TCP[I.F645SIUK')I21W@GN'*/-]V
M_LG_ /!Q!\,?'G_!+'6O^"G_ .UE\*=;^$?@;0/VA;WX"WGA?X3K=?$B[DO9
M#H*:)J\<>JRZ#-Y4TFLLNHAY56U,48@%PTJ*W\<GPZ^/O_!!_P#:@^/'@;X
M?&KX(_\ !13P[\/=5\=:KHL?Q8^(?[;/B[XN>&/!ZP#48+3Q='\.K#X::AXI
MN?[3A@CBDL](LQJUJNH>5,9(HIW'Z ?M,?L1_P#!M'IW[,7Q#\)_"3_@H/\
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MO&,^DWD7AC5=?TJUFM[K4]&T[7'LKS5;"VN()[RRAN+:&:*2177^9C_@G?\
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M0;<VGB6X2TCU.;7-5T:[@NTCCN;:\_K^_P"">?[>/Q/_ &W;'XM7GQ&_8?\
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MU\1)?%GB>""V^*WB[6+*:TTWP[+X:_:+'BCX4?#"PGO?&4]GI]QIRW]II%Z
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MEMWWG_P_K_X)68.?VB?'9/0$_LF?MEY'0D<_L^],X)'? S7T#_P\\_X)7_\
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M86\]YJ.HW]W!:6=K#+<7$L<2,X .HHKY,_9)_;K_ &1/V[O"/B/QS^R-\>?
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110!^*W[!W_*6[_@NW_V47_@GK_ZPYX%K]J:_%;]@[_E+=_P7;_[*
M+_P3U_\ 6'/ M?M30 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M(HT4!% XK]MZ_$__ ((@_P#)/O\ @HU_VF0_X*/_ /JXXJ /VP P,>G%%%%
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M,4?\/U?^"1__ $?1\'?R\7__ #,4 ?K-17Y,_P##]7_@D?\ ]'T?!W\O%_\
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MYIO]EZU8$7,T=M(9WEB\G,,FT _HRHK\4?\ AH;_ (+L?](Y_P!CW_Q,^_\
M_G>4?\-#?\%V/^D<_P"Q[_XF??\ _P [R@#]KJ*_%'_AH;_@NQ_TCG_8]_\
M$S[_ /\ G>4?\-#?\%V/^D<_['O_ (F??_\ SO* /VNHK\4?^&AO^"['_2.?
M]CW_ ,3/O_\ YWE'_#0W_!=C_I'/^Q[_ .)GW_\ \[R@#]KJ*_%'_AH;_@NQ
M_P!(Y_V/?_$S[_\ ^=Y1_P -#?\ !=C_ *1S_L>_^)GW_P#\[R@#]KJ*_%'_
M (:&_P""['_2.?\ 8]_\3/O_ /YWE'_#0W_!=C_I'/\ L>_^)GW_ /\ .\H
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M3_T3'X>_^$7X;_\ E;1_PJ/X4_\ 1,?A[_X1?AO_ .5M>A44 >>_\*C^%/\
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MM=/UF^U+3;/]%* //?\ A4?PI_Z)C\/?_"+\-_\ RMH_X5'\*?\ HF/P]_\
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M=!TJ;2(]5T[39M-&F^%K>Z@E=YM*T>-+/S-K#+)N/Z0_\*D^%/\ T3'X>_\
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MA7PDNA::-/>Z'%J$FM6 !Z'^TU^W=\)_V8O&7@'X9ZQX3^+/Q6^*?Q!T^_\
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M'1/C/IFF_M;>./"'B+P7\,-*CM?$%OX0T'X[>,?!>M77P7^'7COXNV?A_5_
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MD^ ?AYHOB3X2_$O2_#@?1-7N+F[T/6=8LX[V^ /[!O@C\'?@]\"/A[H_PY^
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M>>,=8TC6[+7VBA@U2UNIO-_VRO\ @HSX9\3:'^TG^R!_P3P^/'PY\=?\%0/
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M'P5HGA?4O%EU#=7>H7D#:[>:7/J"07^I:KJ$,4\<6H:MJEZD]_<>_4 %%%%
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MX9UKQKI(WZ;8>,[W2Y/$4&CS3Z8+_P"R2M#7PW_P3G_X)8^ ?V-/">EV.O\
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MP2O/C3KOAB"X"ZUJ^BZ5J'B/5[33GU._U;5=/\/:GXP\26^C7.IWR6-YY<S
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MKOACQ7X<UOX6^(9/$>OZ-I.KJ=)UZTT2^O4UWP]^TA&00>AX-?E)_P %"_\
M@FGH?[5.N^&/V@_@XGPG\%_MA_#WP^W@>P\2?&+X:V/Q/^!?[0'P6U#6[+6/
M%'[-/[6/PV=(9?B1\'M<N;4ZUX8O;"\T[QU\)O'4-EXV^'>O:3>G6+'7 #\.
MO^"//PT\-ZO^U1^QY?Z%<>//VBOV)?@E\-?VH/%'_!,WXZ>!OAUI'A&^^"_Q
M<^*5_K\7[6OPJ_X*BP^&GM]7T3]L?P-X.\<:=\-? 6L>(;.T^&_Q>T[5_%7Q
M.M+;7/B5KGVKPA_87#H^E)J<GB!-+TY=>N=-M=(N=92RMEU:?2+.ZO+VSTJ;
M41$+R73K*[U"_N[:Q>9K:"ZO+N:*-);B9W\,_9V_9*_9F_9'\/\ BKPG^S#\
M#?AI\!O"_C;Q7-XX\4>'?A=X4TOPCH>J^*9])TS1&U272])@M[. II>CZ?:0
M6EK#!86R0NUO:Q/<7#2_0RC: !TY.<^IR![]3SGM[T .HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH *8Z;P.<$'*GT/K_ )^AR"02B@!P& !G. !GUQWI:** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ Y^G3Z]>1TZ?KR>F,T?K_GVHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
EHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>62
<FILENAME>img_015.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 img_015.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  (! 0(! 0(" @(" @(" P4# P,#
M P8$! ,%!P8'!P<&!P<("0L)" @*" <'"@T*"@L,# P,!PD.#PT,#@L,# S_
MVP!# 0(" @,# P8# P8," <(# P,# P,# P,# P,# P,# P,# P,# P,# P,
M# P,# P,# P,# P,# P,# P,# P,# S_P  1" !B .4# 2(  A$! Q$!_\0
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MBCPHLVGWOA&#2I[B:?2D?5[;[0CF6-%6.0B*58T+!7>8Y.^OO[_@W)_Y0J?
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MP?2@1SG_  6LN;C_ (*L?\%UO@9^R;I%QYGA;X>#^VO%9">9%'++$+NX$JY
M(6SB@1<D?-=LO!->A_\ !1[P#\7O^"H'["GQV\"^)='T*VD^#MH_B#3TL=.*
MS-JE@7(MX2S8^>W6Z3*C^)1_&#5/_@V-_9R\8_%C]H[]HO\ :S^*/AS5M!\5
M?$/79]*TBVU2SDMIK>&647EWL60!O*&;2)"!C$#KV(K]@=,\(Z9HTVIR6MA:
MPMK4YN;\K&/]+E,:QEG]3L15^@KNPV*ITJ-2G*"DY)6;^SWMZK]#Y[-<FQ6+
MQ^$Q5'$2IPI2DYP3:51->ZGZ22?FKH_ 3XY_MG?\-F?\&?[3WMW]I\2?#W5=
M'\&:QN?<^^SOK86[MW):T>W))ZMO]*[K_@G_ /\ !)']LKXM_L0?"CQ/X._;
M>\1>#/"NO>%K"^TG0(K2Z:/1[9X%:.V4B8 A%(7@ <<5\2?M@?L_?$/]@G6?
MVR?V8])\ >-M8\"^/=:TG6/"=UI^BW5U:Q?9M0BO+<*Z(5YL;B2-R#]^W4'D
M8K^AW_@CYH=[X9_X)9?L_:?J5G=:??V7@32H;BVN86AF@=;9 5=& *D'J"*X
M3Z$_!C]EC]E;QK_P43_X*D:W^S)^VQ\>OBFNM^!;J272="GU%[BU\1RP@NZV
M\DK%(3);$31NL+-)$7P5(&?:_P#@O!\//#W[$7_!:O\ 8CUBQTVVT#X8>#]/
M\/:;80*"MMI]MIVMNTJ@G).R*:)B223NR22<U]3?\',W_!,OQ+\3O#'AC]J+
MX*V^HVWQG^#4T%Q<_P!D1%KW4K"*7S(YD502\UK)\X&/FB:4'.Q%J3]IK]FX
M_P#!R[_P2#\+ZX='N/A[\=?!<KR0VNLV$UE'::JD2+=VC>8NX6ETOER(Z[MI
M\G))C=2#/UBHK\-_V3?^#BCXE?\ !,[P5IOP?_;1^"_Q*LM8\'PIIEGXKT^S
M2634[>(;8S*)72*X(4 ?:(9F$F 2-VYFZ;X_?\'$OQ)_X*,>$;_X8_L3_!+X
MG:CXG\3QG3Y/&.L6<=K!H$4@VO,A1WBC< G;--*BH>=K'%*P7.O_ ."OG_!5
MWX-?M[?\$K/VL/ WPWU?5]4U_P"'5I91ZR)M*FAMHPFNVD 9)R/+<,Z,5PV6
M4$XP#CZ9_P"#<H8_X(J_ ?D'_B57O0_]1*[KRW]B3_@WHT#]GK_@DG\1_@5X
MAU:VNO'WQHTYI/%/B&V0O%;7JKNLXX@<,\%K( PW8,C-*WR[PJ_&?_!/;_@J
MM\2O^#>[P'<?L[?M3?!WQW-X5\-ZA<R^&/$V@6ZW,#032M(Z1O(T<5Q TC/(
MK+('3S&1DR,*P/U _P""\LZV_P#P1Z_:!9R%!\*3+D^IDC _4BOP'^/,9MO^
M"$'[!S/\JM\0?$S@GT_M0\_I7U]^WY_P5F^*'_!P!\//^&>?V5?@SX[@\+^*
MKRW_ .$G\4:_ EO"EM%*DBQR/&SPVT/F*CN[2EW";%0EB&7_ (+V_P#!/?4_
MV4_^"?W[&'PA\%:1KOC!/AYJ]U'J%UI>F37'FSN();BX98U8HLD[RLH/0'&3
MB@3/<?\ @J]J/_#M/_@O'^SI^TQ%_H7@WXL6[?#_ ,;3#Y8@05B6:9O012V\
M@'_4.-8W_!9BX/\ P4T_X+>?LY_LF6>Z\\(^ Y1XT\<Q*<Q$%?/:&4=C]DB5
M%/KJ(%?6O_!Q3^QA-^VQ_P $JOB!I6EZ?-J7BCP8L?B[0X8(C+-)/9[C+'&J
M@LSO:O<HJKR6=>M?)7_!JO\ LS?$/QIXU^,W[3OQHM-=_P"$_P#&$UOX4L+G
M6[)[6\EMX(H9+F78ZJ=C;;.-6 Q_HSB@9GZM<"7_ (/ ?%42@!;;X:O$ !@#
M_B21M_[-7K'_  3J_8=A_:B^'FOZK)XPUSPZVGZE]F\FR4%)!L#;C\PYYKS"
MW^'7B>Y_X.X_B#XC_P"$;\0#PY_PA#6L6JG39OL4C_\ "/VPVK-MV$[LKP?O
M CJ,5ZQ^PO\ M4^*?V-? ^M:+-\*_$FOG5+_ .V"96DMA& @7;CR7STZYK['
MAUXGZEB%@W^\O"VWG??0_!_%..4/B'*Y9\F\,HU^;2;UM3Y?X?O;GK'Q4_X(
MQSZWX6F.D?$75+_4[96DMK?5+?=#,^.%+!_DSTSM;Z5F?!K]MCQ)K?[ ?Q%L
M8U@\.^+_ (8Q6=O#<6%ND"^3)<*B_NP-BL-DBMM &&'?)K;\4?\ !3[XH^.-
M)ETWP9\$]?L]8NE,45S,)[T6['@-Y:P(,CJ"QQQR".*Y[PM^Q?XD^ __  3S
M^*=[K]K--XR\;)9R2V,(,\MO%'<H45MN<N3([-C. %SR#CU8/$2I1IYPXN7/
M#D7NM_$N:_+I:W?_ "/CJD<LIXVKB.!H5(TOJ^(]O*U50TIMTK.IKSJ>JY=;
M?,N?L[>!?VE_VC/@[H_C+3?C!9V5GK E,<%R&$L?ES/$<[82.J$\'H172VW_
M  2Z\9_&#QK8:G\8?B?>>)K#3W#KI]J\K*XR"55GVB('')5,GU! (]?_ ."9
MFCW>@?L3>#+2^M;FRNH?MHDAGB:.1/\ 39R,J0#R,$>H(KWFO"Q^>XFABJM/
M#J,4I22:C%.U[;V/T7AGPYRO,<GP>+S65:M*=.G.4:E:K*#DXJ3O!RMOT:MT
ML0:9IMOHVFV]G:0QV]K:1+##%&NU(D4 *H'8   5/117RN^K/V1))66P4444
M#"BBB@ KS;X0?M;_  _^._Q&\<^%/"^OQZCKGPYNULM<A,$L2P.6D0F-W4+,
MBRPSPL\995E@E0D,A%=KXVTK4=>\&ZM8Z1JAT/5;RSF@LM2%NMR=/F9"J3^4
MQ"OL8AMI.#MP>#7S#\ /^"1WA+]F?QIX/UGPSXW^(=V?#NDWOA[4K/7=6;4[
M77=-O TEQ Z-CRG>\\NZ\Q#G>)!C$C4 =Y\-O^"B?P\^+7B[2[#0[?QS=Z/X
M@NC9:-XG_P"$2U%?#NL3?, (+XP^4R-M;9*2(I,?([9&4U?_ (*+_#K3?'FH
MZ-;P^-]9L=$U-M%U7Q!I/A/4;_0M+OE<1O;2WD431[HW(20J66)LK(R%6 S?
MV?OV//B)^S]%X2\,6/QLO;SX7>!TCM-+T.3PO9C5);"&/R[:QN=0+,)(HT"+
MOCMXIF$:[I,EBU?PM^Q3X]^$VLZAI?@'XSW?A;X=:GK]UX@.B/X7M+_4=/>[
MNWO+RWM;Z5MJ0RSRS,!+;S/&)6"N $V@'1_%W_@H!X!^#WC[5_#<]OXU\1:C
MX8BBG\1-X:\+7^M0>&HY(_-0WDEM$ZQL8OWGEC,FPA]FUE)['P9^TUX(^(OC
MK1_#V@ZY;ZO?>(/#">,=-DM%:6UO=*>5(DN4F \LAFD3 SD@YQBO-?&/[''C
MC1_BCXVU_P"%_P 7)?A[9?$BZBU+7]/N?#5OK7E7Z6L%F;RRDDD3R)7M[:!6
M659XMT081@E@V3%_P3IG^$=[\/+[X.>.I/ FH?#[P</ <?\ ;&CKK]MJ>F"2
M*53+'YL#BX$L6_S4D /F."A&W: =CXO_ ."AWPC^']KX=N=<\4C2;/Q1XKOO
M!5C=75G.EN-4LYIH)XY9-FV)!+ Z"60K&3M^;YA6G\0OVS?!_P /3XP0VOBW
M7;GP'J5MI6NVN@^';S5)[&6>R2^C<I#&Q,7D2(QD&54L%)#<5POAG_@FSH-K
MX=\":?XCUVY\8Q^&M5\1ZUKR:EIUN;?Q9<:[%>+?I- H$<<!:]E*Q*" JJA+
M<L=+]EC]@2R_9:\.?$W2;3QCXD\267Q!O$>V?6"L]UHEI%I\-A;V@F^_<+#%
M"JK)*3(5"AV<@L0#:^'W[>7@'X@?L]ZU\5,>*?#_ ($T/35UB34]?\/7FE+=
MV;0^>D]NDT:O.K(1M\L$L650"2!3?%7_  4'^%'@G]F#0_C'JGB22T^'WB">
MVMH-1;3[@O!+/+Y.R>$(986CD#K*'0&(QR;PNUL8/C__ ()\V7Q)_9:^%?PA
MO?&?B6R\*?#I-(6]?2V%G>^(/[+MU6TWRJ280MS%;W)" Y:!5SM)SA^"O^"8
M>G?#_1I]%LO'WB^_\.GXAZ?\2+>UUF0:C<V]_#*)KR/[0YWM%=S#S6!'R/)*
M1G?@ 'J7CK]J3P3I=]J^D^7JGBR]TO0+#Q/)I^AZ/-K$MWI][<S6UO- D*/Y
MP9X)20F2$7<<*0:X'P9_P4X^%&K?![6/&D=KXXT'P?H,J6AOM2\&ZCI\-W=/
M>_8%M+4/"#/<&[(A\N,%MYP?6KO[+G_!/?0?V2_CWXQ\6>&M>U=O#WB+2;/1
M])\+SHC67A2W@N;NZ:"S?[XMVFO)62%LK""4CVQA46W;_L2KI'['.H_"2P\1
MP-'?7]_?'4-4T"SU6"3[7JDVH/#-97"M#+%F8Q$'#%1D,K88 '=_ S]H/3/C
MU9ZB]CH7C?P_<:5(D=Q:^)?#=YH\OS@E6C,\:I,I .3$S;>C8) KJ;K7M)O-
M?.@S7-C+J3VOVTV#NK2M 'V>9L/.S=@9QC->#?L4_L 0?LA>//%GB)=;T:2;
MQ39V=BVC>&?#J>&_#]HMNTSBX6Q2653=2&8J\V_E(XE"@+SV*?LB:8G[3/\
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M0](U,164TD=I>ZQ.L-A;&15*F1S)$S*#F-)HG?:KJ3P&C?\ !.G2-?\ A?\
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MRJE27^^- ^#_ (;\.?"^R\%Q:5!=>&-/M8[*&PU!GU!#"F-BN9R[28P.7)/
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0H **** "BBB@ HHHH __V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>63
<FILENAME>img_016.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 img_016.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  (! 0(! 0(" @(" @(" P4# P,#
M P8$! ,%!P8'!P<&!P<("0L)" @*" <'"@T*"@L,# P,!PD.#PT,#@L,# S_
MVP!# 0(" @,# P8# P8," <(# P,# P,# P,# P,# P,# P,# P,# P,# P,
M# P,# P,# P,# P,# P,# P,# P,# S_P  1"  Q &0# 2(  A$! Q$!_\0
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M/X7:[IOQPN/#7Q UF]MX=!TUM/CE%KIVBV]K<P16X\T!B[O?WTS\;=\J$9*
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HG_?UC_TRQ5]@?LZ_\G9:7_V1CP__ .EEY110#/IBBBB@04444 ?_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>64
<FILENAME>img_017.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 img_017.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1"  = .L# 2(  A$! Q$!_\0
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A;&PM4BAC^;IDLQZLQ/)8]R>:T?QIJ:C\(>TJ6Y;Z'__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>65
<FILENAME>img_018.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 img_018.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1"  ] +\# 2(  A$! Q$!_\0
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M1J(<RGJ]#HQ+I2H6C%<T7NCH]9U>ST'1[K5-0D\NUM8S([=3QV [DG 'N17
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M'4DX '3G/:F!ZS17F5EXXUGPUJ.O:5XQ-O=2Z=I_]I0W5I&4$\>=I4@\ [B
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M*7_A8?A?_H*+_P!^G_PK8&BZ61G^SK4_]LE_PJ.?3-'MX7FEL;..- 69FB4
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MU!HVA^*]"\"Z;IK^&+'5;?[3<&_TZYE3S"K.2C(Q)3H<D')Z=.<>NT4P/']
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MA67KNF:9KVG/:7CQE3]U@PW(W8CWK&_X5GX<_P">,_\ W_;_ !I/^%:^'/\
MGC<?]_VK1\[6QS15&+4HS?W?\$S]#\0W'AF]_L'7YP]N,_9;W/!4= Q[?T^F
M#4<\][\0]2:TM6DMO#\#XEE PTY'8?YXZGG K5'PT\.$?ZFX'_;=JZFRLK?3
M[.*UM(EBAC&%11P!41C)Z-Z&M7$4(OVE)>]^'J)8V,&G6D=K;1+'#&NU54<
M5;H[4@K=+L><VV[L6BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH _
"_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>66
<FILENAME>logo.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 logo.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" "6 8X# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MTD\MVABB*$X!X)D![^E>F5\>_$B-9OC!K$3C*/?HK#.,@A0: /9/^&C/"/\
MT#-<_P"_$/\ \=H_X:,\(_\ 0,US_OQ#_P#':WO^%)_#W_H '_P-N/\ XY0?
M@E\/B"!H+#W%[/\ _%T 1:)\;O!.M7*6[7TVGRN<*+Z+RU)_WP2H_$BO1 01
MD'-?.'Q2^"]IX:T677_#TT[6L!!N;29MY12<;D;K@$C(.>YSQ71?L^>,;G4;
M"\\,WTS2M8HLUFS'+"$G:R9]%)7'^]CH!0![=7FOB?XX>$O#T\EK;RRZK=)P
M5L@#&I]#(2!_WSNK@OCC\2KB6^G\(:/.8[:(;=0FC;F5B/\ 5 C^$#[WJ>.@
M.7?#3X'0:EIUOK?BP2>5.H>#3D8H2AZ-(PY&>H48[9/4  DD_:6EWGR_"J!>
MVZ_R?_1=:6D_M(:7/*$U;0;JT0X'F6\RSCZD$*<?3->GVW@7PG:0B*'PUI"K
MC!S9QL2/<D9/XUSGBCX,>$/$-JXMK"/2;S'[NXL4"*I]XQA6'X ^XH Z_0?$
M>C^)]/%]HU_#>6Y."8SRA]&4\J?8@5'XI\1V?A+PY=ZY?Q3RVUMLWI H+G<Z
MH, D#JP[U\IPW'B3X/>/&C;Y;B CS(PQ\J\A/3ZJ>QZJ1Z@BO=?BAK-GX@^
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M!NQ\Q![@UB?#ZV\:2>"(Y-%U31HK7[1=>3#=6<CMGSY.&<.!@MGMP#WKUW
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MVZ?[7<^0D<04EGW>Q X]ZYGX,A(O!+P?:K6>07DTK?9[I)\*YW+N*G()'.&
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M*^?OE]J/E]J/J*_F'_K%+_GW^/\ P#Z'5E=0RL&4]"#D&EK&\)_\BIIF/^>
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I44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 ?_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>67
<FILENAME>image_002.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_002.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1"  U &(# 2(  A$! Q$!_\0
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M74YL74J4Z,JE/=:FM8_$J:_2:2'0[@QP*&D<G  )4?U/Z?CWL$HGMXI5((=
MP([Y&:\MT.6*ST:;3<G[3<6+7<J@D87<FP\>Q_7W^;TZP.[3K8[@V8D.5Z'@
M=**JC&;4=AX6=2I1C.IN]2Q11169T!1110 4444 %)D;@N1DC(%<WXW\6#P?
MH]OJ'V<7 DNXH&CW8.UC@D>I']:J7WCNWLO$D.EF+?$+ WL\XZ*.-HP">N??
M^60#L**\XM?B3=WUOI8@LK1;N\F>)X9IMFS:5&<^AS^OL-TFG_$#4]6U;^Q+
M33(&U*-W$[+,#$J+M^96Z,?FZ?X<@'<ZG&\VF7,<:EF:,@ =_P#/X_0]*\M;
M1=>7QUIFIQZ5.VFBQ6UOE=>=G<!>YR.W49Z_Q=AI'BC5;CQ)%HFJZ,;.9H)9
M?-#[D8(R ;3WSN/^>N9HWQ';4/&]YX?N;$11PR211W"MD.R[<#KP2"QQ[<9X
MR; U=69@6&A>)/\ A,M=U&^TZ06US;"ULU10=J#;MSZ<!L_SY^;UBTC>*R@C
MD^^D:JWU KC](\>-K,<QM;19'^UF"W ;:)%&/F)R<=3Z_CQNT)?$5];S0V\U
MG")9IDC1EDRA# <[NQ]O<=>-UJ$I&%3$4Z6CZ>7X'39YQWHKEX?$]U/J!TV.
MTB>]&#\DF4V\9;=VQGI[CKQNG@\13C5TTN\M4BN2RCY6R"I&<@_T]_IENE)$
M+&4GU\MGOV]3H:*Y<>*+F37YM+BMH"8U#"5Y=JN,J./?G/X]^-VOHNJ#5].6
MY"!#N*, <@D=Q[4I4Y15V53Q-.I+DB]=?PW-&BBBH.@Q?$FA#7X+&%W CM[R
M.X9=N=VT]/U/^>#Q[?"MY+:QMY]6:7;*YNV8'=+"2"$!SVQW]><\Y]*HH X"
M3X86!\5P:BLI.GK"%>S<9!<#&[.<Y(/^>\=AX"U/P_?QWFCZA&1!OBCAF0?-
M$V#C/J,<$^_X^AUYHEWXQ'B::QD:Y73UU-IA<!?O197$8X)"\^GIUS\Q=O5B
MBE%66QJ'PMX@_M:UU]M7BEU1%>)HI(AY21L1POH1C\>>O?+3X7W,UO>S7&K8
MU"[G6Z,RIS'+@!L<],9&.>OUSII+K7_"RKN*26\_LU5C,0W_ +GD#(Z=>!^>
M._.;=W7C'^U;BT0W @EU#S8Y0 -D2E04R.@.X$=?Q_B"C7TSP3+I )L;M8WB
M91 2"05 &<\]^?S[\DO_ .$2GO-6@OKUH5CCD5VMD7*M@#DDGDY_K^-#6YM?
MC\;1FV;4'LT:$%8FQ"02-_&#SSWSU'KS8GGU4?$MHVDOETT+%L"R?N68CYLC
M\!_GKI&I*.QS5<)2JRYIHOGPO-97OVK39HXRCYB0KT#$;P3WZ?YYRDOAV_EN
MUU5KN/\ M,,K!0F$"CC'7W//_P!?.:L?B1/%Z7+W%Q_9[7?EF'S 5"$ YVYX
M&<<\]<<Y^;NZ:K2)^ITDK):;_/N<Q9^%=VJC4]3:*>9XV#Q[/E#$@Y'/L1^)
M]\])##';PI%$@1$& H[4^BHE.4]S2E0A2ORK<****DV"BBB@ HHHH *09VC<
:03CD@8HHH 6BBB@ HHHH **** "BBB@#_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>68
<FILENAME>ex3-1_001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 ex3-1_001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1"  4 &L# 2(  A$! Q$!_\0
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M:1W?]CV3LOVB, _F^.@?LWZ%X5_9M^-GQ0^*W_!PW\'_ -E#]K#XE^#OA/\
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MM^'?&_PSU'QV;[1O"-[X_P#AM?:S9V&A^$-8UJ+7(]"M=6U#3-/DTS4K.6Z
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DPQV]K:VMO&L-O;6UO"J106\$2)%##$BQQ1JJ(JJH ** /__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>69
<FILENAME>ex10-1_001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 ex10-1_001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1"  9 !,# 2(  A$! Q$!_\0
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69_P3$_\ $9?@\?U/@"BO\_ZB@#__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>70
<FILENAME>ex10-2_001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 ex10-2_001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1"  9 !,# 2(  A$! Q$!_\0
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69_P3$_\ $9?@\?U/@"BO\_ZB@#__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>71
<FILENAME>ex10-3_001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 ex10-3_001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1"  9 !,# 2(  A$! Q$!_\0
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69_P3$_\ $9?@\?U/@"BO\_ZB@#__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>72
<FILENAME>ex10-4_001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 ex10-4_001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1"  9 !,# 2(  A$! Q$!_\0
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69_P3$_\ $9?@\?U/@"BO\_ZB@#__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>73
<FILENAME>ex10-5_001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 ex10-5_001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1"  9 !,# 2(  A$! Q$!_\0
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69_P3$_\ $9?@\?U/@"BO\_ZB@#__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>74
<FILENAME>ex10-6_001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 ex10-6_001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1"  9 !,# 2(  A$! Q$!_\0
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69_P3$_\ $9?@\?U/@"BO\_ZB@#__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>75
<FILENAME>ex10-7_001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 ex10-7_001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1"  9 !,# 2(  A$! Q$!_\0
M'P   04! 0$! 0$           $" P0%!@<("0H+_\0 M1   @$# P($ P4%
M! 0   %] 0(#  01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T? D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$  P$! 0$!
M 0$! 0        $" P0%!@<("0H+_\0 M1$  @$"! 0#! <%! 0  0)W  $"
M Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,!  (1 Q$ /P"I-_P3+_X)
M,K%*3_P16_X*J.!&Y*#QS\96+@*25"_V\VXMT VMG.-IZ5]S?MN?\$[?^">?
MQ:^,'A3Q;\3/^"4/_!1GXR^(1^SY^SIH%EXM^%_BWXEVGAW3?"OA?X1^&?#W
MA+P+J$>G>(K.W/B[P'X?TVP\,^,))$:\F\06-]<WSO=SRRR_DE)^VO\ LO!'
MS_P<1?\ !=1<(Q)/P7^)"X&#SG^UDQCUWIC^\O4?=G_!1#]J/X"^!?C]X<TG
MQ5_P6W_X*]_ 34;[]G7]F;7[;P)\%OA3XWU7P?>Z3K/P3\'76F>/KV?3+NSM
MXO&OQ*ML>./']F\'VFQ\9:YK5C<2F6V,-O\ -PRKB!4ZD9\65ISDZ3IU5P_D
M<'24'4=2*@JLH5%64H1;G:5/V2=.[G,_><9XC>"M7&X#$8/Z-F5X/"8:EF$,
M=E\_&KQ<Q5/,JF)I8.&!K2Q<L!2QF"EE=2ABJL*>%YJ6.^ORIXSEAA<,WP7_
M  ZA_P""6/\ TA*_X*O_ /A;_%K_ .:ZBOE+_AM?]E[_ *6(?^"ZG_AEOB/_
M /+2BE_9/$'_ $5V(_\ $>R#_P"3-/\ B)7@G_TC'D?_ (N_QI_^93[?_P"&
M_P#]MD_\[5?_  3$_P#$9_@__P#._I\G[?W[:ZG"_P#!U7_P3#^ZIX_9G^#Q
MY(!.2/ <G0YXW<'/R)]T?Y_M6;K_ %B_]<HO_0!7TI^!']_ _P""@'[;'_2U
69_P3$_\ $9?@\?U/@"BO\_ZB@#__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>76
<FILENAME>ex10-8_001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 ex10-8_001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1"  9 !,# 2(  A$! Q$!_\0
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69_P3$_\ $9?@\?U/@"BO\_ZB@#__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>77
<FILENAME>ex10-9_001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 ex10-9_001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1"  9 !,# 2(  A$! Q$!_\0
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69_P3$_\ $9?@\?U/@"BO\_ZB@#__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>78
<FILENAME>ex10-10_001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 ex10-10_001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1"  9 !,# 2(  A$! Q$!_\0
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69_P3$_\ $9?@\?U/@"BO\_ZB@#__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>79
<FILENAME>ex10-11_001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 ex10-11_001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1"  9 !,# 2(  A$! Q$!_\0
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69_P3$_\ $9?@\?U/@"BO\_ZB@#__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>80
<FILENAME>ex10-12_001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 ex10-12_001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1"  9 !,# 2(  A$! Q$!_\0
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69_P3$_\ $9?@\?U/@"BO\_ZB@#__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>81
<FILENAME>ex10-14_001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 ex10-14_001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1"  9 !,# 2(  A$! Q$!_\0
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69_P3$_\ $9?@\?U/@"BO\_ZB@#__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>82
<FILENAME>ex10-18_001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 ex10-18_001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1"  S )<# 2(  A$! Q$!_\0
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M$ B@#^%S_@^+_P"2H_\ !.O_ +$']I#_ -2+X.U_1W_P:[_\H._V+OK\??\
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M5UG^&'C6#P_XX9;<1RI/<VVB7-BKQ/MNW0*[ '^6/_P6@_X(K^,_^"-WB/\
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MW0O!O_"SO'WA'P7IUMK'B)+2&Q\5?'3XHZMJFAZAJ>FZ5;P6'A_P9X56*/\
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MI_?_ /\ !F[_ ,HCO$/_ &=[\93_ .67\(_\#7\%&B?\$??VJM4_X):>.O\
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M:7)J3'1OB7\:+C3(;MD+EK/0=6^(^HZ#80AON6ECIMO:(/E2!5XHHH _@?\
M$%C:V/BG5M-M8O*LK;6KJT@AWR/LMX[MXDC\R1WE;;& N]Y&<]2Q/-?Z-_\
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!V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>83
<FILENAME>ex10-19_001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 ex10-19_001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1"  S )<# 2(  A$! Q$!_\0
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M$ B@#^%S_@^+_P"2H_\ !.O_ +$']I#_ -2+X.U_1W_P:[_\H._V+OK\??\
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M5UG^&'C6#P_XX9;<1RI/<VVB7-BKQ/MNW0*[ '^6/_P6@_X(K^,_^"-WB/\
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MW0O!O_"SO'WA'P7IUMK'B)+2&Q\5?'3XHZMJFAZAJ>FZ5;P6'A_P9X56*/\
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MI_?_ /\ !F[_ ,HCO$/_ &=[\93_ .67\(_\#7\%&B?\$??VJM4_X):>.O\
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M:7)J3'1OB7\:+C3(;MD+EK/0=6^(^HZ#80AON6ECIMO:(/E2!5XHHH _@?\
M$%C:V/BG5M-M8O*LK;6KJT@AWR/LMX[MXDC\R1WE;;& N]Y&<]2Q/-?Z-_\
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!V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>84
<FILENAME>ex10-19_002.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 ex10-19_002.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1"  T #P# 2(  A$! Q$!_\0
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8^(1;6D21PVT44442)]:T44 %%%% '__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>85
<FILENAME>ex10-21_001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 ex10-21_001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1"  S )<# 2(  A$! Q$!_\0
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M$ B@#^%S_@^+_P"2H_\ !.O_ +$']I#_ -2+X.U_1W_P:[_\H._V+OK\??\
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M5UG^&'C6#P_XX9;<1RI/<VVB7-BKQ/MNW0*[ '^6/_P6@_X(K^,_^"-WB/\
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MW0O!O_"SO'WA'P7IUMK'B)+2&Q\5?'3XHZMJFAZAJ>FZ5;P6'A_P9X56*/\
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MI_?_ /\ !F[_ ,HCO$/_ &=[\93_ .67\(_\#7\%&B?\$??VJM4_X):>.O\
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M:7)J3'1OB7\:+C3(;MD+EK/0=6^(^HZ#80AON6ECIMO:(/E2!5XHHH _@?\
M$%C:V/BG5M-M8O*LK;6KJT@AWR/LMX[MXDC\R1WE;;& N]Y&<]2Q/-?Z-_\
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!V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>86
<FILENAME>ex10-20_001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 ex10-20_001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1"  P 'L# 2(  A$! Q$!_\0
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M ,3[GP;+IWBKXE>(O$/B+7-,M?#?P]FU2S\*Z2NHZ+:S1:=/9>(/%US\2?\
M!P9_P39_;(_8 T3]E?4/VN?^"C'Q)_;KO?BSJOQ@A\':5\0=:^)^LI\-?^$,
ML?AF^OZAHTWQ(^(_CA\>*/\ A)M&M+YM+L=&ROA^Q^V27G^C1VGW)I7_  0!
M_P""H/[)ND?LQ?\ !2O_ ((Z_$L:[J_Q _9Q^"_Q2N/A]IGB30= ^+W@[5_B
M9\(_"?B#XB^&HM,^(<8^&OQ8^'.IZW?:C>V6B:QJ1U?['/I^C2^%=;O-&@UZ
M] /T7L/^#*+PI+ )?$?_  4M^+VH:O*?-O;S3_@EI5E;SSNJF:18+[XOZM=
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MWTOP_-H'AJ;4;4:+HDVL/KFK>9IND36-Y_K^R.L<<DCD*B([LQ( 554LQ).
M  "220 .M?YA/_!JY\./!GQA_P""YGQT^)-_:66M1?"CX6_M)?%KP#<SQQSB
MTUSQ+\4O!_PYL]:M,[T6<>$_B1XAMXI4):,7YDB<,JM0!\K_ +9_@/\ X*B_
M\$(?C%\./CM\4?VQHO%/[<G[7?P8^*FF^)-6M-6\1?&#Q/\ "CP!J>O>$;?4
M+]OB?\1!)I=[\0-9U&TO='LI]"T+6-/\*P:;JMYH6O/>3Z'JD'[4_!/_ (-)
M/VF?VIO 7A+XY_MT_P#!3#XCQ_%[XC:%IWB_6/#6EZ%XB^,FJ>'/^$EL8=8C
MTS6OB9X[^)NE3:SKL'VM(M:BTSP\-)M[^*X@T[5M8M1#J,G[A_\ !P5_P0SN
MO^"N_P .?ACXM^$?CCPW\./VFO@0GB*Q\&W_ (V&J)X%\>>"_%'V&\U;P1XH
MO]&L=5U70;JRUC2[35_#'B*UTG5X;&>YUO3;_2Y8-<34]&_G-\&_\%-O^#C?
M_@AUX?T/P'^W!^R[JO[17[,?P\M=-\,Z5XS\;:4WB32]&\+:4D.E:+IVB?M1
M?"636]-T]9K>&&+2T^,%CXIU](##9BPM%C2VB /RV_X+[?\ !$'PS_P1]T/]
MF+4_#_[2OCC]H!OCQJWQ7L+J'QAX,T_PFGA=?AY9_#^YAEL&L?%'B+[<VK'Q
MC(EPLBVHMQI\)0R^<P3]L?V:/^#/3X?_ !U_9R^ /QNN?^"@GQB\,7/Q@^"O
MPL^*-QX:L?A/H=]9>'I_'W@?0O%4NB6=[)\1;22[M=*DU5K&WN7M;=YH8$D:
M"(ML'YC_ /!Q%_P5V_9Z_P""NW[,7[ WQ/\ @[I/B'P#XW^&_CW]HGPY\7O@
M_P",+C3[WQ#X&U;7/#GP3OM#U"TU;2W^Q^)/"'B-+#5X_#OB-+32KB]GT75[
M34-$TF]L9;:O]'#_ ()V?\H_OV&_^S0/V:__ %3?@R@#M?V._P!G:T_9'_99
M^ 7[,5AXMU#QY9? GX6^$OAC:^,]6T^+2M3\3P^%-+ATR/6[_38+W48;*[OU
MA$\]O'?7:1R.RB>0?,?I*BB@#^(+_@]N^$GQ \4?LV?L5?%_0/#FJ:K\/_A1
M\5/BSX>^(6N6%K+=6?A>\^)^@^ %\&76M&$,;#3]4O/!6L:7#J-R([)=5GT[
M3'G2]U6PAN/M_P#8V_X.B/\ @D@O[&GP>O\ XL_&JX^!_P 4O 7PE\'^%O&G
MP+D^%GQ2UW5]-\2^#_#%AHEWI?@B_P#"7@G6/"NO>']2N=-+^%;Q-<LO*TRX
ML8_$$&@WD=Y:VO\ 35\1?AQX ^+W@?Q/\-/BGX+\,?$3X>^--(NM!\6^"O&6
MBZ?XB\,>(]&O%"W.FZSHNJ07-A?VDNU'\JX@<)*D<J;98T=?QJTS_@VP_P""
M(ND>,4\=6G[!G@N76TU$:HMEJ7Q1^/\ K7@_[2)DG$;?#S6/BS?^ 'T_>BJ=
M)?PRVE&$O;FR,$CQL ?Y\_\ P7H_;G^//_!5'QM\/_VZ9OA'XL^$O[$&E:WX
MH_9U_9+@\926T>J^,;[PV(O%7Q-\8SV]K+<6=UKNI7-]H%OXGFT2XO?#VA)9
M>'/!MIK.OZOX>U_4F_N4_8#_ ."]O_!(?PG^Q1^R3\._%G[<'PO\*>-?AI^S
M)\"/ 'C;PYXIT;X@^']0T/Q=X+^%GA7P[XDT=AJ_@NTAU!M.UG3KRT^V:3-?
MZ?=^49["[NK9XYG_ &@^+W["O[&GQ[^%/A?X&_&+]E_X'?$#X0^!;=+;P%\/
MM=^'/AF3PUX ACMDLD7P#8VVGVX\$,MG&EJLGA5](E%NHAW^7\M?F)K7_!L9
M_P $-->O9-0OOV$])@GE8LT>C?'O]J;PY9 M@D1Z9X>^..EZ="HQ\JPVB*HX
M4 $B@#^5[_@Y?_X*P?LA?\%4-+_9D_8Q_8%T+6/VG?BIHWQIC\26_P 5?#'@
M#Q59W7]I:YH6J^"K'X/?#'3]>T#2_%WBZY\;:KK6F:SXCGT[2HO#_G^$_"B:
M=<Z]=R32:%\F_P#!LO\ !CQO^SI_P<"0? ;XEVEKI_Q$^$'@W]IOX>>.=.LK
MJ.^MM,\6^%?"M[I/B#3(KV'-O>#3M4MKJR:ZMGDM;AX&EMI9K=XY7_T)OV2/
M^"2?_!.#]A76_P#A*OV6/V2/A?\ ##QFL,MM;^/98_$'CWXB6-K<0M;W5II?
MQ!^)>N>,?&FDVE[ S17UKIFNVEO?1DK=QS"N]\ ?\$X_V'?A9^TEXG_; ^'O
M[-OP\\*?M,>,]5\9:WXH^,>EV^JIXNUK5OB%+<3^-;Z\FFU2:Q:;Q%+=W#W^
MRR1&:5_*6(8  /M9@2,#U_QK_+R^,GQ?G_X(U?\ !TW\3/VE?V@O"GB6W^$?
MB;XZ_%3XI7.IZ;I,UY=:Q\&/VI?"OBRSD\;>$X X_P"$B@\%ZQXQOH]0M-/E
MDGNM6\%:[X?A5=3B,"?ZA]?%/[8W_!.;]B/_ (* :%HGA_\ ; _9U\"_&NW\
M,_:E\,ZOK#:[X>\9>&X;]XI;^S\/>/\ P5K'AGQSH>GZA+!!-J&G:5XBM+&^
MFMX)KNWFE@B= #^=7_@HG_P<S?LQ?%GX(ZE^R]_P2GU3Q]^U?^V7^U'I5Y\'
MOAA!X-^&OQ$\)67PYU'Q_8SZ#+XFG?Q[X8\+ZCK7BW2[2_N+CPQH^AV%_IUG
MJ\$>L>*=5TO1M,ECU#\.O^#.7P?KOP\_X*U?M8^ /%$,-OXF\#?LF?%KP?XB
M@MKF.\MX-=\,_M$? O1=7AM[N$F&ZACU"RN$BN8B8YT594)5@:_NH_8[_P""
M1?\ P3@_8$U^]\7_ +)O[*7@'X6^-+ZRGTV3QW<ZGXT^(OCVUTVZ!6\T[2O'
M/Q4\4>-_%NBZ??H0FH6.CZS8VNH1I''>13I%$J>C? '_ ()R?L/_ ++/Q=\;
M_'K]GO\ 9N^'GPI^,/Q(T_7]*\<^/O"]OJL6N^)=.\4^)-.\7^(;347O-3N[
M9H=5\2Z3INL70BMHB;NSA9"B H0#Y:_:>_X+H_\ !-C]C']IO7OV3OVH_C=J
MGP<^)^A>&O"GBI[S6_AQX]\0>#+_ $SQCI[ZEI:6WB7P/H'BJ.SNHK=1]MBU
MRTT>*(R(8IKA"77XG_;2_P"#F;_@CM\-_@'\1E\.?&?0/VMO$_B/P=X@\/Z-
M\"? O@KQ;J=IX^EUO2KO3!H?B[7?%/A/3O!.@^$KTW'V?Q-/K6H7%XNBR73Z
M;X?UZZ,&FW7Z=?M<_P#!([_@F_\ MV^*#XZ_:K_9,^''Q3\>/I]CI,_C[S_%
M7@?Q[>:9I<30:9I^H>-_AQXB\(>*=1M-.@8P6$%]JUQ'9PA8K98HT51\L_#G
M_@V[_P"")?PL\267BOPO^P7X$U#5=/GCN+:#XA?$?XZ_%WP^98CN0W7A+XL?
M%/QKX4OHP>6AOM%N87P-\;8% '^53J/_  3Z_:DM_P!B-_\ @H?>_"KQ)I/[
M-E_\7[7X6:5XDET;48K:ZEU"PO[H>+K/ST,I^'T&NVT'@:W\7,)=%O/&5P/#
M<>I-J\+VLG^B=_P3<_X.7O\ @DSX<_8/_9?\$?'/]HF;X*?%SX1_ 7X7_"WQ
M_P##_P 0_"OXQZ]<Q>(_AMX+TKP=?:AX?U?P1X!\5Z!K.BZ[)H?]KZ,UOJS7
ML-GJ%M::I:V6H17$"?U">(?A%\*_%GPUU#X->)_AQX'U_P"$>K>&AX,U+X8Z
MOX7T6_\  -YX16TCL8_#,_A*XLY-";0H;.*&VM]*^PBRMX(88X(8UBC"_C7J
M?_!L]_P0\U?Q)<^*KO\ 8/\ #46J75V][+;:;\9OVD]%\.+-(Y=DM_!VC_&6
MP\(VEH&8A+"TT."QC7"1VZHJJ #]1OV1?VL?@I^W%^SWX"_:B_9U\1:CXL^#
M?Q,F\91>#/$6J^'M:\*7NJIX%\>^*/AOKMP^@>(K+3M;T^$>)O!^M16:ZC8V
MEQ<6<<%WY$:7"+7TE7COP!_9^^#/[+/PB\'? 7]GSX>Z%\*_A!X AU>#P?X#
M\-+=+HVAIK_B#5O%>MM;&^N;V]EFU;Q)KNL:WJ%S=W=Q<76HZE=W,TK/*QKV
$*@#_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>87
<FILENAME>ex10-36_01.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 ex10-36_01.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1"  9 !,# 2(  A$! Q$!_\0
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69_P3$_\ $9?@\?U/@"BO\_ZB@#__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>88
<FILENAME>ex10-37_01.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 ex10-37_01.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1"  9 !,# 2(  A$! Q$!_\0
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69_P3$_\ $9?@\?U/@"BO\_ZB@#__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>89
<FILENAME>ex10-8_1.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 ex10-8_1.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1"  9 !,# 2(  A$! Q$!_\0
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69_P3$_\ $9?@\?U/@"BO\_ZB@#__V0$!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
